query_seqid	Accession_ID	species	pident	length	mismatch	gapopen	qstart	qend	sstart	send	evalue	bitscore	Entry.name	Status	Protein.names	Gene.names	Organism	sprot.length	Gene.ontology..GO.	Gene.ontology..cellular.component.	Gene.ontology..molecular.function.	Gene.ontology.IDs	Gene.ontology..biological.process.	interesting_genes	all_samples_module_color	amb_dec_samples_module_color	DEG_elev0_vs_elev2	DEG_low0_vs_low2	DEG_amb0_vs_amb2	DEG_amb0_vs_amb17
TRINITY_DN2085_c0_g1_i3	Q9C0C9	UBE2O_HUMAN	58.9	56	23	0	176	343	927	982	5.00E-11	68.9	UBE2O_HUMAN	reviewed	(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	UBE2O KIAA1734	Homo sapiens (Human)	1292	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003723; GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1460_c0_g1_i3	Q9C0C9	UBE2O_HUMAN	42.6	216	105	6	274	882	526	735	2.70E-38	161.8	UBE2O_HUMAN	reviewed	(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	UBE2O KIAA1734	Homo sapiens (Human)	1292	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003723; GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1460_c0_g1_i4	Q9C0C9	UBE2O_HUMAN	41.6	221	105	6	274	897	526	735	8.00E-38	160.2	UBE2O_HUMAN	reviewed	(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	UBE2O KIAA1734	Homo sapiens (Human)	1292	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003723; GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2085_c0_g1_i1	Q6ZPJ3	UBE2O_MOUSE	59.3	221	90	0	176	838	924	1144	2.00E-76	287.7	UBE2O_MOUSE	reviewed	(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	Ube2o Kiaa1734	Mus musculus (Mouse)	1288	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2085_c0_g1_i2	Q6ZPJ3	UBE2O_MOUSE	57.8	230	97	0	185	874	915	1144	1.40E-77	291.6	UBE2O_MOUSE	reviewed	(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	Ube2o Kiaa1734	Mus musculus (Mouse)	1288	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1460_c0_g1_i2	Q6ZPJ3	UBE2O_MOUSE	51.9	108	47	2	274	591	521	625	1.50E-22	107.8	UBE2O_MOUSE	reviewed	(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	Ube2o Kiaa1734	Mus musculus (Mouse)	1288	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2406_c0_g2_i1	Q8VD66	ABHD4_MOUSE	49.4	346	166	4	1239	208	4	342	7.10E-104	379	ABHD4_MOUSE	reviewed	(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4)	Abhd4	Mus musculus (Mouse)	342	lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]	lipid droplet [GO:0005811]; mitochondrion [GO:0005739]	carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophospholipase activity [GO:0004622]	GO:0004622; GO:0005739; GO:0005811; GO:0006654; GO:0016042; GO:0042171; GO:0052689; GO:0055088; GO:0070291; GO:0070292	lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]		NA	NA	NA	NA	NA	NA
TRINITY_DN2406_c0_g1_i1	Q8VD66	ABHD4_MOUSE	49.4	346	166	4	82	1113	4	342	7.10E-104	379	ABHD4_MOUSE	reviewed	(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4)	Abhd4	Mus musculus (Mouse)	342	lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]	lipid droplet [GO:0005811]; mitochondrion [GO:0005739]	carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophospholipase activity [GO:0004622]	GO:0004622; GO:0005739; GO:0005811; GO:0006654; GO:0016042; GO:0042171; GO:0052689; GO:0055088; GO:0070291; GO:0070292	lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]		NA	NA	NA	NA	NA	NA
TRINITY_DN15421_c0_g1_i1	O14874	BCKD_HUMAN	98.8	341	4	0	2	1024	47	387	1.00E-198	693.7	BCKD_HUMAN	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	BCKDK	Homo sapiens (Human)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0009063; GO:0009083; GO:0016301; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN15421_c0_g1_i2	O14874	BCKD_HUMAN	99.7	366	1	0	2	1099	47	412	6.60E-215	747.7	BCKD_HUMAN	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	BCKDK	Homo sapiens (Human)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0009063; GO:0009083; GO:0016301; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN1029_c0_g1_i1	O14874	BCKD_HUMAN	56.9	397	155	5	1278	94	30	412	7.70E-120	432.2	BCKD_HUMAN	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	BCKDK	Homo sapiens (Human)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0009063; GO:0009083; GO:0016301; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN1029_c0_g1_i3	O55028	BCKD_MOUSE	59.4	251	93	4	840	94	169	412	1.30E-77	291.2	BCKD_MOUSE	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	Bckdk	Mus musculus (Mouse)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005739; GO:0005947; GO:0009083; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN1029_c0_g1_i4	O14874	BCKD_HUMAN	59.6	109	36	3	414	94	310	412	2.00E-28	127.1	BCKD_HUMAN	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	BCKDK	Homo sapiens (Human)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0009063; GO:0009083; GO:0016301; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN1029_c0_g1_i6	O14874	BCKD_HUMAN	76.6	47	11	0	234	94	366	412	4.40E-15	82	BCKD_HUMAN	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	BCKDK	Homo sapiens (Human)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0009063; GO:0009083; GO:0016301; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN31285_c0_g1_i1	O55028	BCKD_MOUSE	100	91	0	0	3	275	40	130	9.20E-46	183.7	BCKD_MOUSE	reviewed	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	Bckdk	Mus musculus (Mouse)	412	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005739; GO:0005947; GO:0009083; GO:0016310; GO:0042593; GO:0047323; GO:1904183	branched-chain amino acid catabolic process [GO:0009083]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN12738_c0_g1_i2	Q86BA1	MICAL_DROME	65.5	194	64	1	189	770	53	243	3.20E-72	273.1	MICAL_DROME	reviewed	[F-actin]-monooxygenase Mical (EC 1.14.13.225) (Molecule interacting with CasL protein homolog)	Mical CG33208	Drosophila melanogaster (Fruit fly)	4723	"cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; terminal bouton [GO:0043195]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; neuron remodeling [GO:0016322]; oxidation-reduction process [GO:0055114]; regulation of neuron remodeling [GO:1904799]; sarcomere organization [GO:0045214]; skeletal muscle thin filament assembly [GO:0030240]; synapse assembly involved in innervation [GO:0060386]"	cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; terminal bouton [GO:0043195]	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003779; GO:0005815; GO:0005829; GO:0007015; GO:0007411; GO:0016322; GO:0016709; GO:0030036; GO:0030042; GO:0030047; GO:0030240; GO:0031941; GO:0043195; GO:0045214; GO:0046872; GO:0048813; GO:0055114; GO:0060386; GO:0071949; GO:1904799	actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; neuron remodeling [GO:0016322]; oxidation-reduction process [GO:0055114]; regulation of neuron remodeling [GO:1904799]; sarcomere organization [GO:0045214]; skeletal muscle thin filament assembly [GO:0030240]; synapse assembly involved in innervation [GO:0060386]		NA	NA	NA	NA	NA	NA
TRINITY_DN36633_c0_g1_i1	Q86BA1	MICAL_DROME	36.9	244	135	5	74	763	897	1135	3.20E-41	170.2	MICAL_DROME	reviewed	[F-actin]-monooxygenase Mical (EC 1.14.13.225) (Molecule interacting with CasL protein homolog)	Mical CG33208	Drosophila melanogaster (Fruit fly)	4723	"cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; terminal bouton [GO:0043195]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; neuron remodeling [GO:0016322]; oxidation-reduction process [GO:0055114]; regulation of neuron remodeling [GO:1904799]; sarcomere organization [GO:0045214]; skeletal muscle thin filament assembly [GO:0030240]; synapse assembly involved in innervation [GO:0060386]"	cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; terminal bouton [GO:0043195]	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003779; GO:0005815; GO:0005829; GO:0007015; GO:0007411; GO:0016322; GO:0016709; GO:0030036; GO:0030042; GO:0030047; GO:0030240; GO:0031941; GO:0043195; GO:0045214; GO:0046872; GO:0048813; GO:0055114; GO:0060386; GO:0071949; GO:1904799	actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; neuron remodeling [GO:0016322]; oxidation-reduction process [GO:0055114]; regulation of neuron remodeling [GO:1904799]; sarcomere organization [GO:0045214]; skeletal muscle thin filament assembly [GO:0030240]; synapse assembly involved in innervation [GO:0060386]		NA	NA	NA	NA	NA	NA
TRINITY_DN29596_c0_g1_i1	F1MH07	MICA1_BOVIN	53.7	54	24	1	198	37	88	140	1.30E-07	56.6	MICA1_BOVIN	reviewed	[F-actin]-monooxygenase MICAL1 (EC 1.14.13.225) (Molecule interacting with CasL protein 1) (MICAL-1)	MICAL1	Bos taurus (Bovine)	1070	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; actin filament depolymerization [GO:0030042]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; regulation of regulated secretory pathway [GO:1903305]; sulfur oxidation [GO:0019417]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; midbody [GO:0030496]	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]"	GO:0001933; GO:0003779; GO:0005737; GO:0005856; GO:0016174; GO:0016709; GO:0017124; GO:0017137; GO:0019417; GO:0019901; GO:0030042; GO:0030496; GO:0043154; GO:0045171; GO:0046872; GO:0055114; GO:0071949; GO:1903305; GO:1990026	actin filament depolymerization [GO:0030042]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; regulation of regulated secretory pathway [GO:1903305]; sulfur oxidation [GO:0019417]		NA	NA	NA	NA	NA	NA
TRINITY_DN31501_c0_g1_i1	Q8TDZ2	MICA1_HUMAN	99.2	119	1	0	359	3	73	191	1.70E-63	243	MICA1_HUMAN	reviewed	[F-actin]-monooxygenase MICAL1 (EC 1.14.13.225) (Molecule interacting with CasL protein 1) (MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains)	MICAL1 MICAL NICAL	Homo sapiens (Human)	1067	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]"	GO:0001933; GO:0003779; GO:0005737; GO:0005829; GO:0005882; GO:0005886; GO:0007010; GO:0007165; GO:0007596; GO:0015629; GO:0016174; GO:0016709; GO:0017124; GO:0017137; GO:0019417; GO:0019901; GO:0030042; GO:0030496; GO:0043154; GO:0045171; GO:0046872; GO:0051015; GO:0051017; GO:0055114; GO:0071949; GO:1903305; GO:1990026	actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]		NA	NA	NA	NA	NA	NA
TRINITY_DN37272_c0_g1_i1	O94851	MICA2_HUMAN	100	112	0	0	337	2	97	208	3.60E-60	231.9	MICA2_HUMAN	reviewed	[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2)	MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2	Homo sapiens (Human)	1124	"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]"	nucleus [GO:0005634]	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0055114; GO:0071949	actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; oxidation-reduction process [GO:0055114]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]		NA	NA	NA	NA	NA	NA
TRINITY_DN9943_c0_g1_i2	Q8CJ19	MICA3_MOUSE	65	60	21	0	183	4	1863	1922	1.30E-13	76.6	MICA3_MOUSE	reviewed	[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3)	Mical3 Kiaa0819 Kiaa1364	Mus musculus (Mouse)	1993	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]"	GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0017137; GO:0030042; GO:0042995; GO:0045171; GO:0046872; GO:0051301; GO:0055114; GO:0071949; GO:0090543	actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN40240_c0_g1_i1	Q08972	NEW1_YEAST	45.1	91	50	0	1	273	1014	1104	6.50E-20	97.8	NEW1_YEAST	reviewed	[NU+] prion formation protein 1	NEW1 YPL226W P1445	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1196	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation termination factor activity [GO:0008079]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translational termination [GO:0006449]; ribosomal small subunit biogenesis [GO:0042274]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysome [GO:0005844]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation termination factor activity [GO:0008079]	GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005844; GO:0006449; GO:0008079; GO:0016887; GO:0016973; GO:0042274; GO:0043022	poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translational termination [GO:0006449]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN38125_c0_g1_i1	Q8BFP9	PDK1_MOUSE	100	154	0	0	464	3	273	426	3.30E-88	325.5	PDK1_MOUSE	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)"	Pdk1	Mus musculus (Mouse)	434	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005886; GO:0005967; GO:0006006; GO:0006468; GO:0007166; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0018105; GO:0035556; GO:0042593; GO:0042802; GO:0044877; GO:0045254; GO:0097411; GO:1904183	cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]		NA	NA	NA	NA	NA	NA
TRINITY_DN27039_c0_g1_i1	Q15118	PDK1_HUMAN	100	96	0	0	289	2	135	230	2.90E-50	198.7	PDK1_HUMAN	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)"	PDK1 PDHK1	Homo sapiens (Human)	436	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0042593; GO:0097411; GO:1904183	cell population proliferation [GO:0008283]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]		NA	NA	NA	NA	NA	NA
TRINITY_DN35203_c0_g1_i1	Q15119	PDK2_HUMAN	100	128	0	0	385	2	245	372	4.10E-68	258.5	PDK2_HUMAN	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)"	PDK2 PDHK2	Homo sapiens (Human)	407	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005967; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0050848; GO:0072332; GO:1904183	cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]		NA	NA	NA	NA	NA	NA
TRINITY_DN29369_c0_g1_i1	Q15119	PDK2_HUMAN	54.2	59	27	0	35	211	302	360	3.00E-12	72	PDK2_HUMAN	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)"	PDK2 PDHK2	Homo sapiens (Human)	407	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005967; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0050848; GO:0072332; GO:1904183	cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]		NA	NA	NA	NA	NA	NA
TRINITY_DN36804_c0_g1_i1	Q922H2	PDK3_MOUSE	99.2	119	1	0	2	358	249	367	6.90E-62	237.7	PDK3_MOUSE	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3)"	Pdk3	Mus musculus (Mouse)	415	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0042593; GO:0071333; GO:0071398; GO:0097411; GO:1904183; GO:2000377	cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN27425_c0_g1_i1	Q15120	PDK3_HUMAN	100	151	0	0	453	1	238	388	8.20E-84	310.8	PDK3_HUMAN	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3)"	PDK3 PDHK3	Homo sapiens (Human)	406	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0042593; GO:0071333; GO:0071398; GO:0097411; GO:1904183; GO:2000377	cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN33863_c0_g1_i1	Q9SBJ1	PDK_ARATH	44.3	88	38	2	247	17	274	361	1.30E-14	80.1	PDK_ARATH	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (AtPDHK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2)"	PDK PDHK YA5 At3g06483 F24P17.1 F5E6.19	Arabidopsis thaliana (Mouse-ear cress)	366	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine phosphotransfer kinase activity [GO:0009927]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; protein autophosphorylation [GO:0046777]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine phosphotransfer kinase activity [GO:0009927]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005829; GO:0009927; GO:0042593; GO:0042803; GO:0046777; GO:1904183	glucose homeostasis [GO:0042593]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN512_c0_g1_i1	P91622	PDK_DROME	60.2	402	142	5	1337	144	16	403	7.40E-133	475.3	PDK_DROME	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2)"	Pdk CG8808	Drosophila melanogaster (Fruit fly)	413	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; pyruvate metabolic process [GO:0006090]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0006006; GO:0006090; GO:0042593; GO:1904183	glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; pyruvate metabolic process [GO:0006090]		NA	NA	NA	NA	NA	NA
TRINITY_DN512_c0_g1_i2	P91622	PDK_DROME	61.8	390	140	5	1292	144	16	403	7.20E-133	475.3	PDK_DROME	reviewed	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial (DmPDK) (Pyruvate dehydrogenase kinase) (EC 2.7.11.2)"	Pdk CG8808	Drosophila melanogaster (Fruit fly)	413	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; pyruvate metabolic process [GO:0006090]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0006006; GO:0006090; GO:0042593; GO:1904183	glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; negative regulation of pyruvate dehydrogenase activity [GO:1904183]; pyruvate metabolic process [GO:0006090]		blue	blue	NA	NA	NA	NA
TRINITY_DN32852_c0_g1_i1	Q5RA52	PDP1_PONAB	44.3	481	237	10	1518	124	63	528	7.30E-100	365.9	PDP1_PONAB	reviewed	"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1)"	PDP1 PPM2C	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	537	mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	mitochondrial matrix [GO:0005759]	[pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004741; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN26832_c0_g1_i1	C3ZAH2	MTND_BRAFL	78.8	33	7	0	60	158	138	170	4.30E-09	61.6	MTND_BRAFL	reviewed	"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD)"	BRAFLDRAFT_119977	Branchiostoma floridae (Florida lancelet) (Amphioxus)	177	cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]	GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010309; GO:0019509	L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]		NA	NA	NA	NA	NA	NA
TRINITY_DN26832_c0_g1_i2	Q2LZI9	MTND_DROPS	68.5	92	29	0	2	277	91	182	1.50E-34	146.7	MTND_DROPS	reviewed	"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD)"	GA16655	Drosophila pseudoobscura pseudoobscura (Fruit fly)	187	cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; positive regulation of reproductive process [GO:2000243]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]	GO:0005506; GO:0005634; GO:0005737; GO:0010309; GO:0019509; GO:2000243	L-methionine salvage from methylthioadenosine [GO:0019509]; positive regulation of reproductive process [GO:2000243]		NA	NA	NA	NA	NA	NA
TRINITY_DN25260_c0_g1_i1	B7PRF6	MTND_IXOSC	49.4	83	41	1	250	5	1	83	4.00E-17	88.6	MTND_IXOSC	reviewed	"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD)"	IscW_ISCW007295	Ixodes scapularis (Black-legged tick) (Deer tick)	183	cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]	GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010309; GO:0019509	L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]		NA	NA	NA	NA	NA	NA
TRINITY_DN32590_c0_g1_i1	Q9BV57	MTND_HUMAN	100	75	0	0	228	4	84	158	6.20E-40	164.1	MTND_HUMAN	reviewed	"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1) (MTCBP-1) (Submergence-induced protein-like factor) (Sip-L)"	ADI1 MTCBP1 HMFT1638	Homo sapiens (Human)	179	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006555; GO:0010309; GO:0016491; GO:0019509	L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]		NA	NA	NA	NA	NA	NA
TRINITY_DN36347_c0_g1_i1	Q04446	GLGB_HUMAN	100	97	0	0	293	3	602	698	2.70E-51	202.2	GLGB_HUMAN	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	GBE1	Homo sapiens (Human)	702	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005975; GO:0005977; GO:0005978; GO:0006091; GO:0043169; GO:0070062; GO:0102752	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN18175_c0_g1_i1	Q9D6Y9	GLGB_MOUSE	63.9	675	240	2	2109	85	25	695	1.90E-266	919.8	GLGB_MOUSE	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	Gbe1	Mus musculus (Mouse)	702	"cytoplasm [GO:0005737]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]"	cytoplasm [GO:0005737]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0043524; GO:0102752	carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]		blue	blue	NA	NA	NA	NA
TRINITY_DN29124_c0_g1_i1	Q9D6Y9	GLGB_MOUSE	98.6	70	1	0	1	210	600	669	1.90E-35	149.1	GLGB_MOUSE	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	Gbe1	Mus musculus (Mouse)	702	"cytoplasm [GO:0005737]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]"	cytoplasm [GO:0005737]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0043524; GO:0102752	carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]		NA	NA	NA	NA	NA	NA
TRINITY_DN34887_c0_g1_i1	Q9D6Y9	GLGB_MOUSE	100	73	0	0	221	3	460	532	1.40E-36	152.9	GLGB_MOUSE	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	Gbe1	Mus musculus (Mouse)	702	"cytoplasm [GO:0005737]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]"	cytoplasm [GO:0005737]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0043524; GO:0102752	carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]		NA	NA	NA	NA	NA	NA
TRINITY_DN35434_c0_g1_i1	Q9D6Y9	GLGB_MOUSE	100	58	0	0	124	297	547	604	5.80E-30	131.3	GLGB_MOUSE	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	Gbe1	Mus musculus (Mouse)	702	"cytoplasm [GO:0005737]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]"	cytoplasm [GO:0005737]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0043524; GO:0102752	carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]		NA	NA	NA	NA	NA	NA
TRINITY_DN35434_c0_g1_i1	Q9D6Y9	GLGB_MOUSE	95.1	41	2	0	2	124	506	546	7.40E-17	87.8	GLGB_MOUSE	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	Gbe1	Mus musculus (Mouse)	702	"cytoplasm [GO:0005737]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]"	cytoplasm [GO:0005737]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005975; GO:0005978; GO:0030246; GO:0043169; GO:0043524; GO:0102752	carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]		NA	NA	NA	NA	NA	NA
TRINITY_DN34779_c0_g1_i1	Q04446	GLGB_HUMAN	97.5	122	3	0	366	1	223	344	1.80E-65	249.6	GLGB_HUMAN	reviewed	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	GBE1	Homo sapiens (Human)	702	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005975; GO:0005977; GO:0005978; GO:0006091; GO:0043169; GO:0070062; GO:0102752	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN22976_c0_g1_i1	Q64433	CH10_MOUSE	60.6	99	38	1	388	95	1	99	1.60E-26	120.6	CH10_MOUSE	reviewed	"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10)"	Hspe1	Mus musculus (Mouse)	102	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005759; GO:0046872; GO:0051082; GO:0051085; GO:0051087	chaperone cofactor-dependent protein refolding [GO:0051085]		blue	blue	NA	NA	NA	NA
TRINITY_DN10710_c0_g2_i1	Q64433	CH10_MOUSE	99	102	1	0	362	57	1	102	2.20E-50	199.5	CH10_MOUSE	reviewed	"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10)"	Hspe1	Mus musculus (Mouse)	102	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005759; GO:0046872; GO:0051082; GO:0051085; GO:0051087	chaperone cofactor-dependent protein refolding [GO:0051085]		NA	NA	NA	NA	NA	NA
TRINITY_DN10710_c0_g1_i1	P61603	CH10_BOVIN	100	102	0	0	361	56	1	102	8.00E-51	201.1	CH10_BOVIN	reviewed	"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10)"	HSPE1	Bos taurus (Bovine)	102	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005759; GO:0046872; GO:0051082; GO:0051085; GO:0051087	chaperone cofactor-dependent protein refolding [GO:0051085]		NA	NA	NA	NA	NA	NA
TRINITY_DN5217_c0_g1_i1	F4JWP9	GFL_ARATH	58.8	85	35	0	26	280	159	243	8.50E-23	107.5	GFL_ARATH	reviewed	109 kDa U5 small nuclear ribonucleoprotein component GFL (Protein GFA1-LIKE) (SNU114 homolog)	GFL At5g25230	Arabidopsis thaliana (Mouse-ear cress)	973	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005730; GO:0009506; GO:0009536; GO:0016607; GO:0030623; GO:0046540; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23752_c0_g1_i1	A4FUD3	U5S1_BOVIN	100	173	0	0	523	5	800	972	1.50E-97	356.7	U5S1_BOVIN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116	Bos taurus (Bovine)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3424_c0_g1_i1	Q5F3X4	U5S1_CHICK	73.3	968	204	3	2999	96	57	970	0	1464.9	U5S1_CHICK	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116 RCJMB04_4m11	Gallus gallus (Chicken)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3424_c0_g1_i3	Q5F3X4	U5S1_CHICK	77.5	916	204	2	2843	96	57	970	0	1489.2	U5S1_CHICK	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116 RCJMB04_4m11	Gallus gallus (Chicken)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7383_c0_g1_i1	A4FUD3	U5S1_BOVIN	66.2	500	168	1	1559	60	471	969	3.80E-205	715.7	U5S1_BOVIN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116	Bos taurus (Bovine)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7383_c0_g1_i2	A4FUD3	U5S1_BOVIN	65.4	52	18	0	215	60	918	969	1.00E-13	77.8	U5S1_BOVIN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116	Bos taurus (Bovine)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7383_c0_g1_i2	A4FUD3	U5S1_BOVIN	53.3	60	28	0	392	213	471	530	3.60E-11	69.3	U5S1_BOVIN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116	Bos taurus (Bovine)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27395_c0_g1_i1	A4FUD3	U5S1_BOVIN	100	99	0	0	298	2	793	891	5.40E-52	204.5	U5S1_BOVIN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 SNRP116	Bos taurus (Bovine)	972	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17809_c0_g1_i1	Q15029	U5S1_HUMAN	100	740	0	0	23	2242	45	784	0	1494.6	U5S1_HUMAN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog) (hSNU114) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 KIAA0031 SNRP116	Homo sapiens (Human)	972	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to drug [GO:0035690]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016020; GO:0016607; GO:0030623; GO:0035690; GO:0042220; GO:0043231; GO:0046540; GO:0071005; GO:0071007; GO:0071013; GO:1990904	"cellular response to drug [GO:0035690]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17809_c0_g1_i2	Q15029	U5S1_HUMAN	100	740	0	0	23	2242	45	784	0	1494.6	U5S1_HUMAN	reviewed	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog) (hSNU114) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	EFTUD2 KIAA0031 SNRP116	Homo sapiens (Human)	972	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to drug [GO:0035690]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016020; GO:0016607; GO:0030623; GO:0035690; GO:0042220; GO:0043231; GO:0046540; GO:0071005; GO:0071007; GO:0071013; GO:1990904	"cellular response to drug [GO:0035690]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17644_c0_g1_i1	P42650	14333_ENTHI	68.7	67	19	1	202	2	17	81	2.70E-16	85.5	14333_ENTHI	reviewed	14-3-3 protein 3 (14-3-3-3) (Fragment)		Entamoeba histolytica	236							NA	NA	NA	NA	NA	NA
TRINITY_DN15767_c0_g1_i1	P93212	14337_SOLLC	63.7	146	53	0	530	93	90	235	5.30E-50	198.7	14337_SOLLC	reviewed	14-3-3 protein 7	TFT7	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	252							NA	NA	NA	NA	NA	NA
TRINITY_DN1619_c0_g1_i1	P93212	14337_SOLLC	65.6	154	53	0	550	89	84	237	6.30E-54	211.8	14337_SOLLC	reviewed	14-3-3 protein 7	TFT7	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	252							red	red	NA	NA	NA	NA
TRINITY_DN10425_c0_g1_i1	P31946	1433B_HUMAN	100	246	0	0	797	60	1	246	9.60E-134	477.6	1433B_HUMAN	reviewed	"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]"	YWHAB	Homo sapiens (Human)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; cytoplasmic sequestering of protein [GO:0051220]; hippo signaling [GO:0035329]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; protein targeting [GO:0006605]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774]	cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000165; GO:0005634; GO:0005737; GO:0005739; GO:0005774; GO:0005829; GO:0005925; GO:0006605; GO:0008022; GO:0016020; GO:0016032; GO:0017053; GO:0019899; GO:0019904; GO:0035308; GO:0035329; GO:0042470; GO:0042802; GO:0042826; GO:0043085; GO:0043488; GO:0044877; GO:0045296; GO:0045744; GO:0045892; GO:0048471; GO:0050815; GO:0051219; GO:0051220; GO:0061024; GO:0070062; GO:1900740	"cytoplasmic sequestering of protein [GO:0051220]; hippo signaling [GO:0035329]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; protein targeting [GO:0006605]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10425_c0_g1_i4	P31946	1433B_HUMAN	100	246	0	0	797	60	1	246	9.60E-134	477.6	1433B_HUMAN	reviewed	"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]"	YWHAB	Homo sapiens (Human)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; cytoplasmic sequestering of protein [GO:0051220]; hippo signaling [GO:0035329]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; protein targeting [GO:0006605]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774]	cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000165; GO:0005634; GO:0005737; GO:0005739; GO:0005774; GO:0005829; GO:0005925; GO:0006605; GO:0008022; GO:0016020; GO:0016032; GO:0017053; GO:0019899; GO:0019904; GO:0035308; GO:0035329; GO:0042470; GO:0042802; GO:0042826; GO:0043085; GO:0043488; GO:0044877; GO:0045296; GO:0045744; GO:0045892; GO:0048471; GO:0050815; GO:0051219; GO:0051220; GO:0061024; GO:0070062; GO:1900740	"cytoplasmic sequestering of protein [GO:0051220]; hippo signaling [GO:0035329]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; protein targeting [GO:0006605]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10425_c0_g1_i2	Q9CQV8	1433B_MOUSE	100	246	0	0	805	68	1	246	1.40E-132	473.8	1433B_MOUSE	reviewed	"14-3-3 protein beta/alpha (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]"	Ywhab	Mus musculus (Mouse)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; cytoplasmic sequestering of protein [GO:0051220]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; protein targeting [GO:0006605]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0005634; GO:0005737; GO:0005829; GO:0006605; GO:0008022; GO:0017053; GO:0019899; GO:0019904; GO:0032991; GO:0035308; GO:0042470; GO:0042802; GO:0042826; GO:0043085; GO:0044877; GO:0045744; GO:0045892; GO:0048471; GO:0050815; GO:0051219; GO:0051220	"cytoplasmic sequestering of protein [GO:0051220]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; protein targeting [GO:0006605]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9103_c0_g1_i1	P62261	1433E_BOVIN	100	127	0	0	419	39	129	255	1.20E-65	250.4	1433E_BOVIN	reviewed	14-3-3 protein epsilon (14-3-3E)	YWHAE	Bos taurus (Bovine)	255	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]		GO:0000165; GO:0005634; GO:0005737; GO:0034504; GO:0034605; GO:0042470; GO:0046827	cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN9103_c0_g1_i2	P62261	1433E_BOVIN	100	104	0	0	350	39	152	255	9.80E-53	207.2	1433E_BOVIN	reviewed	14-3-3 protein epsilon (14-3-3E)	YWHAE	Bos taurus (Bovine)	255	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]		GO:0000165; GO:0005634; GO:0005737; GO:0034504; GO:0034605; GO:0042470; GO:0046827	cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN14303_c0_g1_i1	P62261	1433E_BOVIN	100	99	0	0	298	2	1	99	8.90E-48	190.7	1433E_BOVIN	reviewed	14-3-3 protein epsilon (14-3-3E)	YWHAE	Bos taurus (Bovine)	255	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]		GO:0000165; GO:0005634; GO:0005737; GO:0034504; GO:0034605; GO:0042470; GO:0046827	cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN14303_c0_g2_i1	P62261	1433E_BOVIN	100	98	0	0	296	3	1	98	5.70E-47	188	1433E_BOVIN	reviewed	14-3-3 protein epsilon (14-3-3E)	YWHAE	Bos taurus (Bovine)	255	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]		GO:0000165; GO:0005634; GO:0005737; GO:0034504; GO:0034605; GO:0042470; GO:0046827	cellular response to heat [GO:0034605]; MAPK cascade [GO:0000165]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN5589_c0_g1_i1	P92177	1433E_DROME	71.1	97	28	0	1	291	145	241	1.40E-34	146.7	1433E_DROME	reviewed	14-3-3 protein epsilon (Suppressor of Ras1 3-9)	14-3-3epsilon 14-3-3e SR3-9 CG31196	Drosophila melanogaster (Fruit fly)	262	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; microtubule sliding [GO:0051012]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]	GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007093; GO:0007280; GO:0007294; GO:0007411; GO:0007444; GO:0007623; GO:0008103; GO:0008134; GO:0008340; GO:0009314; GO:0009411; GO:0035332; GO:0040008; GO:0042994; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815; GO:0051012; GO:0150013	axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; microtubule sliding [GO:0051012]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN1886_c0_g1_i1	P92177	1433E_DROME	84.3	268	36	1	43	846	1	262	5.90E-120	431.8	1433E_DROME	reviewed	14-3-3 protein epsilon (Suppressor of Ras1 3-9)	14-3-3epsilon 14-3-3e SR3-9 CG31196	Drosophila melanogaster (Fruit fly)	262	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; microtubule sliding [GO:0051012]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]	GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007093; GO:0007280; GO:0007294; GO:0007411; GO:0007444; GO:0007623; GO:0008103; GO:0008134; GO:0008340; GO:0009314; GO:0009411; GO:0035332; GO:0040008; GO:0042994; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815; GO:0051012; GO:0150013	axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; microtubule sliding [GO:0051012]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]		blue	blue	NA	NA	NA	NA
TRINITY_DN17899_c0_g1_i1	Q04917	1433F_HUMAN	100	126	0	0	379	2	82	207	1.90E-65	249.6	1433F_HUMAN	reviewed	14-3-3 protein eta (Protein AS1)	YWHAH YWHA1	Homo sapiens (Human)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; membrane organization [GO:0061024]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; substantia nigra development [GO:0021762]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]	GO:0002028; GO:0003779; GO:0005159; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006713; GO:0006886; GO:0014704; GO:0017080; GO:0019899; GO:0019904; GO:0021762; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045664; GO:0045893; GO:0046982; GO:0048167; GO:0050774; GO:0061024; GO:0070062; GO:0086010; GO:1900740; GO:2000649	"glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; membrane organization [GO:0061024]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; substantia nigra development [GO:0021762]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12115_c0_g1_i1	P68509	1433F_BOVIN	100	74	0	0	223	2	1	74	6.70E-33	141	1433F_BOVIN	reviewed	14-3-3 protein eta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAH	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of sodium ion transmembrane transporter activity [GO:2000649]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]	GO:0003779; GO:0005737; GO:0005886; GO:0006713; GO:0006886; GO:0017080; GO:0019899; GO:0019904; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045893; GO:0046982; GO:0050774; GO:0086010; GO:2000649	"glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of sodium ion transmembrane transporter activity [GO:2000649]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12115_c0_g1_i2	P68509	1433F_BOVIN	100	246	0	0	787	50	1	246	3.50E-133	475.7	1433F_BOVIN	reviewed	14-3-3 protein eta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAH	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of sodium ion transmembrane transporter activity [GO:2000649]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]	GO:0003779; GO:0005737; GO:0005886; GO:0006713; GO:0006886; GO:0017080; GO:0019899; GO:0019904; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045893; GO:0046982; GO:0050774; GO:0086010; GO:2000649	"glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of sodium ion transmembrane transporter activity [GO:2000649]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6823_c0_g1_i1	Q3SZI4	1433T_BOVIN	100	245	0	0	40	774	1	245	2.90E-135	482.6	1433T_BOVIN	reviewed	14-3-3 protein theta	YWHAQ	Bos taurus (Bovine)	245	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6823_c0_g1_i2	P68254	1433T_MOUSE	100	245	0	0	40	774	1	245	4.90E-135	481.9	1433T_MOUSE	reviewed	14-3-3 protein theta (14-3-3 protein tau)	Ywhaq	Mus musculus (Mouse)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; 14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of transcription, DNA-templated [GO:0045892]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]	GO:0005737; GO:0005829; GO:0006605; GO:0007165; GO:0007264; GO:0008022; GO:0019904; GO:0032991; GO:0034766; GO:0042802; GO:0044325; GO:0045202; GO:0045892; GO:0047485; GO:0071889	"negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of transcription, DNA-templated [GO:0045892]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30212_c1_g1_i1	Q2F637	1433Z_BOMMO	89.9	69	7	0	42	248	4	72	9.50E-26	117.1	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7615_c2_g1_i1	Q2F637	1433Z_BOMMO	86.2	65	9	0	197	3	4	68	9.20E-23	107.1	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23359_c5_g1_i2	Q2F637	1433Z_BOMMO	77.6	281	25	1	972	130	4	246	3.00E-113	409.8	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23359_c5_g1_i3	Q2F637	1433Z_BOMMO	89.7	243	25	0	858	130	4	246	1.60E-118	427.2	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23359_c5_g1_i4	Q2F637	1433Z_BOMMO	90.1	243	24	0	858	130	4	246	4.30E-119	429.1	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN23359_c5_g1_i5	Q2F637	1433Z_BOMMO	63.8	138	12	1	543	130	147	246	4.50E-41	169.5	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23359_c14_g1_i1	Q2F637	1433Z_BOMMO	66.7	54	18	0	217	56	140	193	1.90E-14	79.3	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN24072_c0_g1_i1	Q2F637	1433Z_BOMMO	89.8	127	13	0	23	403	4	130	1.60E-54	213.4	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN24072_c0_g1_i2	Q2F637	1433Z_BOMMO	82	89	16	0	23	289	4	92	1.50E-30	133.3	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN21705_c0_g1_i1	Q2F637	1433Z_BOMMO	81.1	106	20	0	2	319	67	172	4.20E-42	171.8	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21705_c0_g1_i3	Q2F637	1433Z_BOMMO	84.5	116	18	0	1	348	101	216	5.90E-50	198	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21705_c0_g1_i4	Q2F637	1433Z_BOMMO	90.7	86	8	0	83	340	4	89	1.50E-32	140.2	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN21705_c0_g1_i5	Q2F637	1433Z_BOMMO	85.8	169	24	0	83	589	4	172	8.40E-73	274.6	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21705_c0_g1_i6	Q2F637	1433Z_BOMMO	86.2	152	21	0	83	538	4	155	8.50E-64	244.6	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21705_c2_g1_i1	Q2F637	1433Z_BOMMO	89	73	8	0	220	2	4	76	3.80E-26	118.2	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20050_c0_g1_i1	Q2F637	1433Z_BOMMO	88.3	77	9	0	240	10	19	95	2.80E-30	132.5	1433Z_BOMMO	reviewed	14-3-3 protein zeta	14-3-3zeta	Bombyx mori (Silk moth)	247	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN6823_c0_g3_i1	P63103	1433Z_BOVIN	100	245	0	0	65	799	1	245	4.10E-132	472.2	1433Z_BOVIN	reviewed	14-3-3 protein zeta/delta (Factor activating exoenzyme S) (FAS) (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	Bos taurus (Bovine)	245	melanosome [GO:0042470]; protein phosphorylation [GO:0006468]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]	melanosome [GO:0042470]		GO:0006468; GO:0007165; GO:0042470; GO:0070372	protein phosphorylation [GO:0006468]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN6823_c0_g2_i1	P63101	1433Z_MOUSE	98.8	245	3	0	40	774	1	245	2.50E-131	469.5	1433Z_MOUSE	reviewed	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) (SEZ-2)	Ywhaz	Mus musculus (Mouse)	245	cell leading edge [GO:0031252]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; histamine secretion by mast cell [GO:0002553]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; protein targeting to mitochondrion [GO:0006626]; regulation of cell death [GO:0010941]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of synapse maturation [GO:0090128]; response to drug [GO:0042493]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	GO:0002553; GO:0005634; GO:0005739; GO:0005829; GO:0006468; GO:0006605; GO:0006626; GO:0007165; GO:0008039; GO:0008134; GO:0010941; GO:0014069; GO:0019901; GO:0019904; GO:0031252; GO:0031625; GO:0032991; GO:0042470; GO:0042493; GO:0042802; GO:0044325; GO:0044877; GO:0048471; GO:0051683; GO:0070372; GO:0090128; GO:0090168; GO:0098686; GO:0098978	establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; histamine secretion by mast cell [GO:0002553]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; protein targeting to mitochondrion [GO:0006626]; regulation of cell death [GO:0010941]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of synapse maturation [GO:0090128]; response to drug [GO:0042493]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN24917_c0_g1_i1	Q20655	14332_CAEEL	89.4	66	7	0	200	3	147	212	4.80E-28	124.4	14332_CAEEL	reviewed	14-3-3-like protein 2	ftt-2 F52D10.3	Caenorhabditis elegans	248	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor binding [GO:0008134]; cytoplasmic sequestering of protein [GO:0051220]; dauer larval development [GO:0040024]; negative regulation of protein import into nucleus [GO:0042308]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription factor binding [GO:0008134]	GO:0005634; GO:0005737; GO:0008134; GO:0040024; GO:0042308; GO:0051220	cytoplasmic sequestering of protein [GO:0051220]; dauer larval development [GO:0040024]; negative regulation of protein import into nucleus [GO:0042308]		NA	NA	NA	NA	NA	NA
TRINITY_DN21705_c0_g1_i7	Q20655	14332_CAEEL	87.5	72	9	0	2	217	145	216	2.10E-29	129	14332_CAEEL	reviewed	14-3-3-like protein 2	ftt-2 F52D10.3	Caenorhabditis elegans	248	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor binding [GO:0008134]; cytoplasmic sequestering of protein [GO:0051220]; dauer larval development [GO:0040024]; negative regulation of protein import into nucleus [GO:0042308]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription factor binding [GO:0008134]	GO:0005634; GO:0005737; GO:0008134; GO:0040024; GO:0042308; GO:0051220	cytoplasmic sequestering of protein [GO:0051220]; dauer larval development [GO:0040024]; negative regulation of protein import into nucleus [GO:0042308]		NA	NA	NA	NA	NA	NA
TRINITY_DN2322_c0_g1_i1	P42654	1433B_VICFA	54.6	141	62	2	11	430	99	238	4.00E-36	152.5	1433B_VICFA	reviewed	14-3-3-like protein B (VFA-1433B)		Vicia faba (Broad bean) (Faba vulgaris)	261							NA	NA	NA	NA	NA	NA
TRINITY_DN1619_c0_g2_i1	Q96453	1433D_SOYBN	65	237	78	2	791	87	11	244	8.70E-81	301.6	1433D_SOYBN	reviewed	14-3-3-like protein D (SGF14D)	GF14D	Glycine max (Soybean) (Glycine hispida)	261							NA	NA	NA	NA	NA	NA
TRINITY_DN19740_c0_g1_i1	O08699	PGDH_RAT	29.6	115	77	2	3	335	139	253	1.20E-06	54.3	PGDH_RAT	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Rattus norvegicus (Rat)	266	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]"	GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN6513_c0_g1_i1	Q9LVD0	RID2_ARATH	69	87	25	2	351	94	1	86	5.50E-27	121.7	RID2_ARATH	reviewed	18S rRNA (guanine-N(7))-methyltransferase RID2 (EC 2.1.1.309) (Protein ROOT INITIATION DEFECTIVE 2)	RID2 At5g57280 MJB24.9	Arabidopsis thaliana (Mouse-ear cress)	289	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rRNA (guanine) methyltransferase activity [GO:0016435]; callus formation [GO:1990110]; lateral root development [GO:0048527]; maintenance of root meristem identity [GO:0010078]; root development [GO:0048364]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0010078; GO:0016435; GO:0048364; GO:0048471; GO:0048527; GO:0070476; GO:1990110	callus formation [GO:1990110]; lateral root development [GO:0048527]; maintenance of root meristem identity [GO:0010078]; root development [GO:0048364]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN1843_c0_g1_i1	Q5HZH2	TSR3_MOUSE	56.2	194	80	1	626	45	55	243	1.00E-56	221.5	TSR3_MOUSE	reviewed	18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog)	Tsr3	Mus musculus (Mouse)	323	cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]	cytoplasm [GO:0005737]	S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0000455; GO:0005737; GO:0016740; GO:0030490; GO:1904047	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN1843_c0_g1_i2	Q5HZH2	TSR3_MOUSE	56.2	194	80	1	626	45	55	243	1.00E-56	221.5	TSR3_MOUSE	reviewed	18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog)	Tsr3	Mus musculus (Mouse)	323	cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]	cytoplasm [GO:0005737]	S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0000455; GO:0005737; GO:0016740; GO:0030490; GO:1904047	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN1843_c0_g1_i3	Q5HZH2	TSR3_MOUSE	56.2	194	80	1	626	45	55	243	1.00E-56	221.5	TSR3_MOUSE	reviewed	18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog)	Tsr3	Mus musculus (Mouse)	323	cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]	cytoplasm [GO:0005737]	S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0000455; GO:0005737; GO:0016740; GO:0030490; GO:1904047	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN1843_c0_g1_i4	Q5HZH2	TSR3_MOUSE	56.2	194	80	1	626	45	55	243	1.00E-56	221.5	TSR3_MOUSE	reviewed	18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog)	Tsr3	Mus musculus (Mouse)	323	cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]	cytoplasm [GO:0005737]	S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0000455; GO:0005737; GO:0016740; GO:0030490; GO:1904047	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN1843_c0_g1_i6	Q5HZH2	TSR3_MOUSE	56.2	194	80	1	626	45	55	243	1.00E-56	221.5	TSR3_MOUSE	reviewed	18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog)	Tsr3	Mus musculus (Mouse)	323	cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]	cytoplasm [GO:0005737]	S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0000455; GO:0005737; GO:0016740; GO:0030490; GO:1904047	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN40907_c0_g1_i1	Q9UJK0	TSR3_HUMAN	100	115	0	0	346	2	57	171	1.10E-64	246.9	TSR3_HUMAN	reviewed	18S rRNA aminocarboxypropyltransferase (EC 2.5.1.-) (20S S rRNA accumulation protein 3 homolog) (HsTsr3)	TSR3 C16orf42 UND313L	Homo sapiens (Human)	312	cytosol [GO:0005829]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]; rRNA modification [GO:0000154]	cytosol [GO:0005829]	S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0000154; GO:0000455; GO:0005829; GO:0016740; GO:0030490; GO:1904047	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]; rRNA modification [GO:0000154]		NA	NA	NA	NA	NA	NA
TRINITY_DN7791_c0_g1_i1	Q9NRZ5	PLCD_HUMAN	40.9	379	214	3	1224	88	7	375	2.50E-88	327.4	PLCD_HUMAN	reviewed	1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta)	AGPAT4 UNQ499/PRO1016	Homo sapiens (Human)	378	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746	CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]		NA	NA	NA	NA	NA	NA
TRINITY_DN13893_c0_g2_i1	Q9D1E8	PLCE_MOUSE	45.4	359	189	4	87	1157	12	365	6.80E-80	299.3	PLCE_MOUSE	reviewed	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon)	Agpat5 D8Ertd319e	Mus musculus (Mouse)	365	"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]"	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0002244; GO:0003841; GO:0005635; GO:0005739; GO:0005789; GO:0006639; GO:0012505; GO:0016021; GO:0016024; GO:0016746	acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]		NA	NA	NA	NA	NA	NA
TRINITY_DN13893_c0_g2_i2	Q9D1E8	PLCE_MOUSE	45	362	192	4	137	1216	9	365	6.00E-79	296.2	PLCE_MOUSE	reviewed	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon)	Agpat5 D8Ertd319e	Mus musculus (Mouse)	365	"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]"	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0002244; GO:0003841; GO:0005635; GO:0005739; GO:0005789; GO:0006639; GO:0012505; GO:0016021; GO:0016024; GO:0016746	acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]		NA	NA	NA	NA	NA	NA
TRINITY_DN13893_c0_g2_i4	Q9D1E8	PLCE_MOUSE	42.4	384	189	5	87	1232	12	365	8.30E-76	285.8	PLCE_MOUSE	reviewed	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon)	Agpat5 D8Ertd319e	Mus musculus (Mouse)	365	"endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]"	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0002244; GO:0003841; GO:0005635; GO:0005739; GO:0005789; GO:0006639; GO:0012505; GO:0016021; GO:0016024; GO:0016746	acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]		NA	NA	NA	NA	NA	NA
TRINITY_DN30638_c0_g1_i1	Q9D517	PLCC_MOUSE	100	70	0	0	210	1	158	227	2.20E-36	152.1	PLCC_MOUSE	reviewed	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma)	Agpat3 Lpaat3	Mus musculus (Mouse)	376	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; lysophosphatidic acid acyltransferase activity [GO:0042171]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; lysophosphatidic acid acyltransferase activity [GO:0042171]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003841; GO:0005635; GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0016024; GO:0016746; GO:0042171	CDP-diacylglycerol biosynthetic process [GO:0016024]		NA	NA	NA	NA	NA	NA
TRINITY_DN838_c0_g1_i2	A2AIG8	1A1L1_MOUSE	35.9	390	244	1	222	1373	90	479	5.10E-72	273.5	1A1L1_MOUSE	reviewed	1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1)	Accs	Mus musculus (Mouse)	502	catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]		catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0003824; GO:0009058; GO:0030170; GO:0042802	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN14688_c0_g1_i2	Q9Y2I7	FYV1_HUMAN	42.9	475	204	3	684	1907	1622	2096	4.10E-103	377.1	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14688_c0_g1_i3	Q9Y2I7	FYV1_HUMAN	57.4	68	29	0	67	270	1968	2035	5.30E-15	81.6	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14688_c0_g1_i4	Q9Y2I7	FYV1_HUMAN	44.3	454	186	3	64	1224	1643	2096	2.00E-103	377.5	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14688_c0_g1_i5	Q9Y2I7	FYV1_HUMAN	65.1	129	45	0	67	453	1968	2096	4.60E-46	185.7	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11082_c0_g1_i1	Q9Y2I7	FYV1_HUMAN	58	88	36	1	312	52	1310	1397	6.00E-24	111.7	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11082_c0_g1_i2	Q9Z1T6	FYV1_MOUSE	33.4	586	292	20	1656	52	858	1396	1.80E-72	275	FYV1_MOUSE	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) (p235)	Pikfyve Fab1 Kiaa0981 Pip5k3	Mus musculus (Mouse)	2097	"cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506]	1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0008270; GO:0010008; GO:0012506; GO:0016301; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11082_c0_g1_i3	Q9Y2I7	FYV1_HUMAN	53.8	158	71	2	522	52	1241	1397	2.50E-47	189.9	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4938_c0_g1_i1	Q9Y2I7	FYV1_HUMAN	32.6	794	426	18	90	2306	17	756	3.40E-93	344.4	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4938_c0_g1_i4	Q9Y2I7	FYV1_HUMAN	32.6	411	205	11	90	1196	17	397	1.20E-44	182.2	FYV1_HUMAN	reviewed	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	2098	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:1903100; GO:1903426; GO:1904562; GO:2000785	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6279_c0_g1_i1	P13217	PIPA_DROME	79.9	154	31	0	467	6	292	445	1.90E-72	273.1	PIPA_DROME	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase (EC 3.1.4.11) (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta) (No receptor potential A protein) (Phosphoinositide phospholipase C) (Phosphoinositide phospholipase C-beta)"	norpA PLC-beta CG3620	Drosophila melanogaster (Fruit fly)	1095	inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; adult locomotory behavior [GO:0008344]; calcium-mediated signaling [GO:0019722]; cellular response to light stimulus [GO:0071482]; circadian rhythm [GO:0007623]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; diacylglycerol biosynthetic process [GO:0006651]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; light-induced release of internally sequestered calcium ion [GO:0008377]; lipid catabolic process [GO:0016042]; mucosal immune response [GO:0002385]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; rhodopsin mediated signaling pathway [GO:0016056]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]	GO:0001580; GO:0002385; GO:0004435; GO:0004629; GO:0005509; GO:0006644; GO:0006651; GO:0007601; GO:0007602; GO:0007623; GO:0008344; GO:0008377; GO:0008654; GO:0009649; GO:0016027; GO:0016028; GO:0016042; GO:0016056; GO:0016059; GO:0019722; GO:0043052; GO:0043153; GO:0043547; GO:0045494; GO:0046488; GO:0046673; GO:0048015; GO:0051482; GO:0071482; GO:2000370	adult locomotory behavior [GO:0008344]; calcium-mediated signaling [GO:0019722]; cellular response to light stimulus [GO:0071482]; circadian rhythm [GO:0007623]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; diacylglycerol biosynthetic process [GO:0006651]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; light-induced release of internally sequestered calcium ion [GO:0008377]; lipid catabolic process [GO:0016042]; mucosal immune response [GO:0002385]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; rhodopsin mediated signaling pathway [GO:0016056]; thermotaxis [GO:0043052]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5659_c0_g1_i1	P25455	PIP1_DROME	78.6	98	21	0	297	4	626	723	3.10E-39	162.2	PIP1_DROME	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II (EC 3.1.4.11) (Phosphoinositide phospholipase C)"	Plc21C plc-21 CG4574	Drosophila melanogaster (Fruit fly)	1318	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0007629; GO:0016042; GO:0043153; GO:0048015; GO:0070050; GO:1900073	entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		NA	NA	NA	NA	NA	NA
TRINITY_DN5659_c0_g1_i2	P25455	PIP1_DROME	78.6	98	21	0	297	4	626	723	3.10E-39	162.2	PIP1_DROME	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II (EC 3.1.4.11) (Phosphoinositide phospholipase C)"	Plc21C plc-21 CG4574	Drosophila melanogaster (Fruit fly)	1318	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0007629; GO:0016042; GO:0043153; GO:0048015; GO:0070050; GO:1900073	entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		NA	NA	NA	NA	NA	NA
TRINITY_DN14509_c0_g2_i1	P25455	PIP1_DROME	38.8	129	78	1	74	457	1096	1224	4.80E-12	72.8	PIP1_DROME	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II (EC 3.1.4.11) (Phosphoinositide phospholipase C)"	Plc21C plc-21 CG4574	Drosophila melanogaster (Fruit fly)	1318	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0007629; GO:0016042; GO:0043153; GO:0048015; GO:0070050; GO:1900073	entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		NA	NA	NA	NA	NA	NA
TRINITY_DN14509_c0_g2_i3	P25455	PIP1_DROME	36.7	98	61	1	74	364	1096	1193	1.30E-06	54.3	PIP1_DROME	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II (EC 3.1.4.11) (Phosphoinositide phospholipase C)"	Plc21C plc-21 CG4574	Drosophila melanogaster (Fruit fly)	1318	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0007629; GO:0016042; GO:0043153; GO:0048015; GO:0070050; GO:1900073	entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		NA	NA	NA	NA	NA	NA
TRINITY_DN6279_c0_g2_i1	P25455	PIP1_DROME	77.2	114	26	0	343	2	292	405	1.90E-48	193	PIP1_DROME	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II (EC 3.1.4.11) (Phosphoinositide phospholipase C)"	Plc21C plc-21 CG4574	Drosophila melanogaster (Fruit fly)	1318	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0007629; GO:0016042; GO:0043153; GO:0048015; GO:0070050; GO:1900073	entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of neuromuscular synaptic transmission [GO:1900073]		blue	blue	NA	NA	NA	NA
TRINITY_DN21937_c0_g1_i1	A5D6R3	PLD3A_DANRE	54.3	92	41	1	280	5	291	381	4.90E-26	118.2	PLD3A_DANRE	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3-A (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3-A) (Phospholipase C-delta-3-A) (PLC-delta-3-A)"	plcd3a zgc:158396	Danio rerio (Zebrafish) (Brachydanio rerio)	784	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0005737; GO:0016020; GO:0016042; GO:0048015	lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]		NA	NA	NA	NA	NA	NA
TRINITY_DN32428_c0_g1_i1	Q8SPR7	PLCD4_PIG	49.4	77	35	2	1	222	273	348	2.20E-13	75.9	PLCD4_PIG	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)"	PLCD4	Sus scrofa (Pig)	772	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; G-protein alpha-subunit binding [GO:0001965]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; G-protein alpha-subunit binding [GO:0001965]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0001965; GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0007340; GO:0016020; GO:0016042; GO:0046488; GO:0048015	acrosome reaction [GO:0007340]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]		NA	NA	NA	NA	NA	NA
TRINITY_DN9275_c0_g1_i1	Q22070	PLCG_CAEEL	41	178	94	4	27	539	944	1117	2.20E-31	137.1	PLCG_CAEEL	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma plc-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma plc-3) (Phospholipase C-gamma plc-3) (PLC-gamma plc-3)"	plc-3 T01E8.3	Caenorhabditis elegans	1350	metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; intracellular signal transduction [GO:0035556]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; sleep [GO:0030431]		metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0009395; GO:0010634; GO:0030431; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN9275_c0_g1_i3	Q62077	PLCG1_MOUSE	42.1	330	177	7	9	968	909	1234	9.20E-68	258.8	PLCG1_MOUSE	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1)"	Plcg1 Plcg-1	Mus musculus (Mouse)	1302	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0001701; GO:0001726; GO:0004435; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0009306; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030971; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0050852; GO:0051219; GO:0051281; GO:0071364; GO:1901339; GO:1905564; GO:2000353	calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; inositol trisphosphate biosynthetic process [GO:0032959]; in utero embryonic development [GO:0001701]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN9275_c0_g1_i4	Q62077	PLCG1_MOUSE	42.2	332	179	7	9	983	909	1234	4.20E-68	260	PLCG1_MOUSE	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1)"	Plcg1 Plcg-1	Mus musculus (Mouse)	1302	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0001701; GO:0001726; GO:0004435; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0009306; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030971; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0050852; GO:0051219; GO:0051281; GO:0071364; GO:1901339; GO:1905564; GO:2000353	calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; inositol trisphosphate biosynthetic process [GO:0032959]; in utero embryonic development [GO:0001701]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN29304_c0_g1_i1	Q62077	PLCG1_MOUSE	100	82	0	0	248	3	264	345	6.50E-43	174.1	PLCG1_MOUSE	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1)"	Plcg1 Plcg-1	Mus musculus (Mouse)	1302	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0001701; GO:0001726; GO:0004435; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0009306; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030971; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0050852; GO:0051219; GO:0051281; GO:0071364; GO:1901339; GO:1905564; GO:2000353	calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; inositol trisphosphate biosynthetic process [GO:0032959]; in utero embryonic development [GO:0001701]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN3180_c0_g2_i1	P08487	PLCG1_BOVIN	100	74	0	0	1	222	333	406	3.00E-39	161.8	PLCG1_BOVIN	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)"	PLCG1	Bos taurus (Bovine)	1291	COP9 signalosome [GO:0008180]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]	COP9 signalosome [GO:0008180]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0001701; GO:0001726; GO:0004435; GO:0005509; GO:0008180; GO:0009395; GO:0010634; GO:0030027; GO:0035556; GO:0035924; GO:0071364	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]		NA	NA	NA	NA	NA	NA
TRINITY_DN3180_c0_g1_i1	P19174	PLCG1_HUMAN	37.5	499	264	13	140	1534	407	891	1.30E-88	328.6	PLCG1_HUMAN	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)"	PLCG1 PLC1	Homo sapiens (Human)	1290	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; activation of phospholipase C activity [GO:0007202]; axon guidance [GO:0007411]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; leukocyte migration [GO:0050900]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	cell-cell junction [GO:0005911]; cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007165; GO:0007173; GO:0007202; GO:0007411; GO:0008180; GO:0009395; GO:0010634; GO:0010863; GO:0016032; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030971; GO:0035254; GO:0038095; GO:0038096; GO:0042995; GO:0043536; GO:0043647; GO:0045766; GO:0050852; GO:0050900; GO:0051281; GO:0071364; GO:1905564; GO:2000353	activation of phospholipase C activity [GO:0007202]; axon guidance [GO:0007411]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol phosphate metabolic process [GO:0043647]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3180_c0_g1_i2	P19174	PLCG1_HUMAN	40.5	749	381	19	4	2106	160	891	1.30E-152	541.6	PLCG1_HUMAN	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)"	PLCG1 PLC1	Homo sapiens (Human)	1290	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; activation of phospholipase C activity [GO:0007202]; axon guidance [GO:0007411]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; leukocyte migration [GO:0050900]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	cell-cell junction [GO:0005911]; cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007165; GO:0007173; GO:0007202; GO:0007411; GO:0008180; GO:0009395; GO:0010634; GO:0010863; GO:0016032; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030971; GO:0035254; GO:0038095; GO:0038096; GO:0042995; GO:0043536; GO:0043647; GO:0045766; GO:0050852; GO:0050900; GO:0051281; GO:0071364; GO:1905564; GO:2000353	activation of phospholipase C activity [GO:0007202]; axon guidance [GO:0007411]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol phosphate metabolic process [GO:0043647]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN21119_c0_g1_i1	Q8CIH5	PLCG2_MOUSE	100	81	0	0	244	2	315	395	1.80E-45	182.6	PLCG2_MOUSE	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-gamma-2) (PLC-gamma-2)"	Plcg2	Mus musculus (Mouse)	1265	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; regulation of gene expression [GO:0010468]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to lipopolysaccharide [GO:0032496]; response to magnesium ion [GO:0032026]; T cell receptor signaling pathway [GO:0050852]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0002092; GO:0002316; GO:0004435; GO:0004629; GO:0005829; GO:0005886; GO:0006661; GO:0007204; GO:0009395; GO:0010468; GO:0010634; GO:0016020; GO:0030183; GO:0032026; GO:0032237; GO:0032481; GO:0032496; GO:0032959; GO:0033198; GO:0035556; GO:0043069; GO:0050852; GO:0050853; GO:0051209; GO:0140031	activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; regulation of gene expression [GO:0010468]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to lipopolysaccharide [GO:0032496]; response to magnesium ion [GO:0032026]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN26262_c0_g1_i1	P16885	PLCG2_HUMAN	100	67	0	0	204	4	313	379	5.20E-38	157.5	PLCG2_HUMAN	reviewed	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2)"	PLCG2	Homo sapiens (Human)	1265	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0002092; GO:0002223; GO:0002316; GO:0004435; GO:0004629; GO:0005829; GO:0005886; GO:0006661; GO:0009395; GO:0010634; GO:0016055; GO:0019722; GO:0030168; GO:0030183; GO:0032237; GO:0032481; GO:0032496; GO:0032959; GO:0038095; GO:0038096; GO:0043069; GO:0043647; GO:0050852; GO:0050853; GO:0051209; GO:0070062; GO:0140031	activation of store-operated calcium channel activity [GO:0032237]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of receptor internalization [GO:0002092]; positive regulation of type I interferon production [GO:0032481]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN37431_c0_g1_i1	Q5NCQ5	DPH1_MOUSE	97.1	104	3	0	3	314	298	401	2.70E-54	212.2	DPH1_MOUSE	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (Ovarian cancer-associated gene 1 protein homolog) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	Dph1 Dph2l1 Ovca1	Mus musculus (Mouse)	438	cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; transferase activity [GO:0016740]; cell population proliferation [GO:0008283]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	transferase activity [GO:0016740]	GO:0005654; GO:0005737; GO:0008283; GO:0016740; GO:0017183; GO:0030054	cell population proliferation [GO:0008283]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN27076_c0_g1_i1	Q9BZG8	DPH1_HUMAN	100	89	0	0	2	268	72	160	2.60E-45	182.2	DPH1_HUMAN	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (Ovarian cancer-associated gene 1 protein) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	DPH1 DPH2L DPH2L1 OVCA1	Homo sapiens (Human)	443	cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	transferase activity [GO:0016740]	GO:0005654; GO:0005829; GO:0016740; GO:0017183; GO:0030054	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN27961_c0_g1_i1	Q6C0S8	DPH1_YARLI	51.2	80	36	1	3	233	339	418	2.70E-14	79	DPH1_YARLI	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	DPH1 YALI0F22055g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	439	cytoplasm [GO:0005737]; transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytoplasm [GO:0005737]	transferase activity [GO:0016740]	GO:0005737; GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN36531_c0_g1_i1	Q8SUZ5	DPH1_ENCCU	50.7	71	30	1	239	27	273	338	2.50E-13	75.9	DPH1_ENCCU	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	DPH1 ECU07_0980	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	347	cytoplasm [GO:0005737]; transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytoplasm [GO:0005737]	transferase activity [GO:0016740]	GO:0005737; GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN8139_c0_g2_i1	A7SLX5	DPH1_NEMVE	56.8	74	31	1	1	222	195	267	7.90E-16	84	DPH1_NEMVE	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	dph1 v1g246101	Nematostella vectensis (Starlet sea anemone)	465	transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		transferase activity [GO:0016740]	GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN8139_c0_g1_i1	Q4PA25	DPH1_USTMA	56.9	130	51	1	394	5	54	178	1.60E-35	150.2	DPH1_USTMA	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	DPH1 UMAG_03038	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	609	cytoplasm [GO:0005737]; transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytoplasm [GO:0005737]	transferase activity [GO:0016740]	GO:0005737; GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN36623_c0_g1_i1	Q8SUZ5	DPH1_ENCCU	50.6	81	38	2	241	2	53	132	3.70E-17	88.6	DPH1_ENCCU	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	DPH1 ECU07_0980	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	347	cytoplasm [GO:0005737]; transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytoplasm [GO:0005737]	transferase activity [GO:0016740]	GO:0005737; GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN13465_c0_g1_i1	Q3T7C9	DPH1_PENVA	82.9	397	68	0	1257	67	21	417	9.10E-203	707.6	DPH1_PENVA	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1) (Tumor suppressor-like protein) (TSL)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	423	transferase activity [GO:0016740]; apoptotic process [GO:0006915]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		transferase activity [GO:0016740]	GO:0006915; GO:0016740; GO:0017183	apoptotic process [GO:0006915]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN7677_c0_g1_i1	Q5ZKI2	DPH2_CHICK	41.2	199	108	3	77	667	3	194	1.50E-35	151.8	DPH2_CHICK	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (EC 2.5.1.108) (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2)	DPH2 RCJMB04_10j16	Gallus gallus (Chicken)	477	transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		transferase activity [GO:0016740]	GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN7677_c0_g1_i3	Q5ZKI2	DPH2_CHICK	34	564	271	11	77	1741	3	474	2.50E-75	284.6	DPH2_CHICK	reviewed	2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (EC 2.5.1.108) (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2)	DPH2 RCJMB04_10j16	Gallus gallus (Chicken)	477	transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		transferase activity [GO:0016740]	GO:0016740; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN16750_c1_g1_i1	Q8Y2I3	GPMA_RALSO	90.8	153	14	0	461	3	76	228	8.10E-79	294.3	GPMA_RALSO	reviewed	"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11)"	gpmA RSc0353 RS03320	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	248	"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]"	GO:0006094; GO:0006096; GO:0046538	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN22302_c0_g1_i2	B8D995	GPMA_BUCA5	67.7	31	10	0	172	264	5	35	9.90E-08	57.8	GPMA_BUCA5	reviewed	"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11)"	gpmA BUAP5A_298	Buchnera aphidicola subsp. Acyrthosiphon pisum (strain 5A)	231	"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]"	GO:0006094; GO:0006096; GO:0046538	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN1135_c0_g1_i1	Q16698	DECR_HUMAN	64.5	299	106	0	127	1023	32	330	1.60E-104	380.9	DECR_HUMAN	reviewed	"2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)"	DECR1 DECR SDR18C1	Homo sapiens (Human)	335	"catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]"	catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]"	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494	fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]		blue	blue	NA	NA	NA	NA
TRINITY_DN1135_c0_g1_i2	Q16698	DECR_HUMAN	64.9	299	105	0	127	1023	32	330	2.90E-105	383.3	DECR_HUMAN	reviewed	"2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)"	DECR1 DECR SDR18C1	Homo sapiens (Human)	335	"catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]"	catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]"	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494	fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]		NA	NA	NA	NA	NA	NA
TRINITY_DN27174_c0_g1_i1	Q16698	DECR_HUMAN	100	179	0	0	539	3	138	316	2.40E-98	359.4	DECR_HUMAN	reviewed	"2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)"	DECR1 DECR SDR18C1	Homo sapiens (Human)	335	"catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]"	catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]"	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494	fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]		NA	NA	NA	NA	NA	NA
TRINITY_DN40843_c0_g1_i1	Q16698	DECR_HUMAN	100	102	0	0	3	308	27	128	4.80E-51	201.4	DECR_HUMAN	reviewed	"2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)"	DECR1 DECR SDR18C1	Homo sapiens (Human)	335	"catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]"	catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]"	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494	fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]		NA	NA	NA	NA	NA	NA
TRINITY_DN3258_c0_g1_i1	Q08DF7	PDE12_BOVIN	43.5	391	212	4	1253	84	227	609	1.00E-88	328.6	PDE12_BOVIN	reviewed	"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)"	PDE12	Bos taurus (Bovine)	609	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090324	"cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1133_c0_g1_i1	Q26499	IM23_SCHHA	30	243	138	4	842	114	4	214	7.00E-21	102.8	IM23_SCHHA	reviewed	23 kDa integral membrane protein (Sh23)		Schistosoma haematobium (Blood fluke)	218	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN16571_c0_g1_i1	Q26499	IM23_SCHHA	35.3	102	65	1	21	326	8	108	8.20E-09	61.6	IM23_SCHHA	reviewed	23 kDa integral membrane protein (Sh23)		Schistosoma haematobium (Blood fluke)	218	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN26489_c0_g1_i1	P19331	IM23_SCHMA	28.3	233	137	4	870	172	8	210	1.60E-15	85.1	IM23_SCHMA	reviewed	23 kDa integral membrane protein (Sm23)		Schistosoma mansoni (Blood fluke)	218	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN26489_c0_g2_i1	P19331	IM23_SCHMA	28.3	233	137	4	152	850	8	210	1.60E-15	85.1	IM23_SCHMA	reviewed	23 kDa integral membrane protein (Sm23)		Schistosoma mansoni (Blood fluke)	218	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN31365_c0_g1_i1	A8NU18	RASL_COPC7	40.4	94	53	2	318	40	68	159	1.30E-08	60.8	RASL_COPC7	reviewed	24 kDa Ras-like protein (EC 3.6.5.2)	CC-RAS CC1G_06445	Coprinopsis cinerea (strain Okayama-7 / 130 / ATCC MYA-4618 / FGSC 9003) (Inky cap fungus) (Hormographiella aspergillata)	215	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3863_c0_g1_i1	Q9V3P6	PSMD1_DROME	52.6	272	118	3	802	5	3	269	2.60E-73	276.9	PSMD1_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory complex subunit p110) (26S proteasome regulatory subunit RPN2)	Rpn2 CG11888	Drosophila melanogaster (Fruit fly)	1020	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]	GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008270; GO:0008540; GO:0030234; GO:0034515; GO:0042176; GO:0043161	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN3622_c0_g1_i1	Q9V3P6	PSMD1_DROME	51.2	80	39	0	92	331	940	1019	1.30E-16	87.4	PSMD1_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory complex subunit p110) (26S proteasome regulatory subunit RPN2)	Rpn2 CG11888	Drosophila melanogaster (Fruit fly)	1020	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]; zinc ion binding [GO:0008270]	GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008270; GO:0008540; GO:0030234; GO:0034515; GO:0042176; GO:0043161	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN14938_c0_g1_i1	Q5F418	PSMD1_CHICK	66.7	111	37	0	339	7	568	678	1.20E-36	153.7	PSMD1_CHICK	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)	PSMD1 RCJMB04_3m24	Gallus gallus (Chicken)	955	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN36467_c0_g1_i1	Q5F418	PSMD1_CHICK	100	163	0	0	2	490	422	584	1.20E-88	327	PSMD1_CHICK	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)	PSMD1 RCJMB04_3m24	Gallus gallus (Chicken)	955	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN13924_c0_g1_i1	Q99460	PSMD1_HUMAN	100	445	0	0	2	1336	378	822	9.60E-261	900.2	PSMD1_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112)	PSMD1	Homo sapiens (Human)	953	"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0034515; GO:0035578; GO:0038061; GO:0038095; GO:0042176; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14938_c0_g2_i1	O88761	PSMD1_RAT	50.9	110	53	1	17	346	705	813	9.10E-27	120.9	PSMD1_RAT	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112)	Psmd1	Rattus norvegicus (Rat)	953	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]	GO:0000502; GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0031625; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN3252_c0_g1_i1	O88761	PSMD1_RAT	76.2	449	104	2	1460	120	375	822	2.20E-199	696.4	PSMD1_RAT	reviewed	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112)	Psmd1	Rattus norvegicus (Rat)	953	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]	GO:0000502; GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0031625; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		blue	blue	NA	NA	NA	NA
TRINITY_DN437_c0_g1_i1	Q54HW1	PSD10_DICDI	34.6	127	81	2	890	510	74	198	4.00E-12	73.9	PSD10_DICDI	reviewed	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28)	psmD10 DDB_G0289189	Dictyostelium discoideum (Slime mold)	232							blue	blue	NA	NA	NA	NA
TRINITY_DN38241_c0_g1_i1	Q9Z2X3	PSD10_RAT	43.3	67	38	0	4	204	71	137	1.50E-08	59.7	PSD10_RAT	reviewed	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin)	Psmd10	Rattus norvegicus (Rat)	231	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome regulatory particle assembly [GO:0070682]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	transcription factor binding [GO:0008134]	GO:0000122; GO:0000502; GO:0005634; GO:0005737; GO:0006915; GO:0007253; GO:0008134; GO:0030307; GO:0031398; GO:0032088; GO:0032436; GO:0043066; GO:0043409; GO:0043518; GO:0045737; GO:0070682; GO:0090201	"apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome regulatory particle assembly [GO:0070682]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13546_c0_g1_i2	Q9Z2X2	PSD10_MOUSE	100	75	0	0	227	3	52	126	1.30E-37	156.4	PSD10_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin)	Psmd10	Mus musculus (Mouse)	231	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome regulatory particle assembly [GO:0070682]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	transcription factor binding [GO:0008134]	GO:0000122; GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007253; GO:0008134; GO:0008540; GO:0030307; GO:0031398; GO:0032088; GO:0032436; GO:0043066; GO:0043409; GO:0043518; GO:0045111; GO:0045737; GO:0070682; GO:0090201	"apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome regulatory particle assembly [GO:0070682]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13546_c0_g1_i1	O75832	PSD10_HUMAN	98.8	168	2	0	505	2	52	219	5.30E-92	338.2	PSD10_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK))	PSMD10	Homo sapiens (Human)	226	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	transcription factor binding [GO:0008134]	GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35483_c0_g1_i1	O75832	PSD10_HUMAN	49.3	67	34	0	10	210	42	108	5.80E-08	57.8	PSD10_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK))	PSMD10	Homo sapiens (Human)	226	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	transcription factor binding [GO:0008134]	GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29752_c0_g1_i1	O75832	PSD10_HUMAN	48	198	102	1	729	136	15	211	4.80E-48	193	PSD10_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK))	PSMD10	Homo sapiens (Human)	226	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	transcription factor binding [GO:0008134]	GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30380_c0_g1_i1	Q2KJ25	PSD12_BOVIN	100	67	0	0	202	2	256	322	4.70E-31	134.4	PSD12_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5)	PSMD12	Bos taurus (Bovine)	456	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0005737; GO:0008541; GO:0022624; GO:0031595; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN17891_c0_g1_i1	Q2KJ25	PSD12_BOVIN	100	136	0	0	410	3	108	243	3.30E-68	258.8	PSD12_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5)	PSMD12	Bos taurus (Bovine)	456	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0005737; GO:0008541; GO:0022624; GO:0031595; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN30193_c0_g1_i1	O00232	PSD12_HUMAN	100	137	0	0	1	411	320	456	6.50E-72	271.2	PSD12_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	PSMD12	Homo sapiens (Human)	456	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"		GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006521; GO:0008541; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031595; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27700_c0_g1_i1	Q9D8W5	PSD12_MOUSE	54.5	121	55	0	6	368	114	234	1.40E-28	127.1	PSD12_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	Psmd12	Mus musculus (Mouse)	456	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624; GO:0031595; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN33924_c0_g1_i1	O00232	PSD12_HUMAN	98.9	95	1	0	286	2	19	113	4.70E-45	181.4	PSD12_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	PSMD12	Homo sapiens (Human)	456	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"		GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006521; GO:0008541; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031595; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30380_c0_g1_i2	Q9D8W5	PSD12_MOUSE	100	175	0	0	526	2	148	322	3.80E-93	342	PSD12_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	Psmd12	Mus musculus (Mouse)	456	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624; GO:0031595; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN34795_c0_g1_i1	Q9D8W5	PSD12_MOUSE	100	78	0	0	25	258	1	78	6.80E-35	147.5	PSD12_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	Psmd12	Mus musculus (Mouse)	456	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624; GO:0031595; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN5383_c1_g1_i1	Q9D8W5	PSD12_MOUSE	61.4	443	166	1	1431	118	11	453	2.10E-152	540.8	PSD12_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	Psmd12	Mus musculus (Mouse)	456	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624; GO:0031595; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN27667_c0_g1_i1	Q9UNM6	PSD13_HUMAN	100	90	0	0	270	1	272	361	5.80E-45	181	PSD13_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5)	PSMD13	Homo sapiens (Human)	376	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; structural molecule activity [GO:0005198]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; meiosis I [GO:0007127]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	structural molecule activity [GO:0005198]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005198; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006511; GO:0006521; GO:0007127; GO:0008541; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043248; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; meiosis I [GO:0007127]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2425_c0_g1_i1	Q5E964	PSD13_BOVIN	58.1	129	54	0	431	45	248	376	1.20E-36	154.1	PSD13_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5)	PSMD13	Bos taurus (Bovine)	376	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	structural molecule activity [GO:0005198]	GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0007127; GO:0008541; GO:0022624; GO:0043248	meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26375_c0_g1_i1	Q9V3H2	PSDE_DROME	47.6	63	33	0	1	189	245	307	6.00E-08	57.8	PSDE_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory complex subunit p37B) (26S proteasome regulatory subunit rpn11) (Yippee-interacting protein 5)	Rpn11 yip5 CG18174	Drosophila melanogaster (Fruit fly)	308	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0004843; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008237; GO:0008541; GO:0016579; GO:0043161; GO:0046872; GO:0061578; GO:0070122; GO:0070628	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; Toll signaling pathway [GO:0008063]		red	red	NA	NA	NA	NA
TRINITY_DN16296_c0_g1_i1	O00487	PSDE_HUMAN	100	310	0	0	1006	77	1	310	5.00E-177	621.7	PSDE_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)	PSMD14 POH1	Homo sapiens (Human)	310	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000165; GO:0000209; GO:0000502; GO:0000724; GO:0002223; GO:0002479; GO:0004843; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0006521; GO:0008237; GO:0008541; GO:0010972; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031597; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0045471; GO:0046872; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0061578; GO:0070122; GO:0070498; GO:0070536; GO:0070628; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16296_c0_g1_i2	O00487	PSDE_HUMAN	100	310	0	0	1006	77	1	310	5.00E-177	621.7	PSDE_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)	PSMD14 POH1	Homo sapiens (Human)	310	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000165; GO:0000209; GO:0000502; GO:0000724; GO:0002223; GO:0002479; GO:0004843; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0006521; GO:0008237; GO:0008541; GO:0010972; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031597; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0045471; GO:0046872; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0061578; GO:0070122; GO:0070498; GO:0070536; GO:0070628; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1688_c0_g1_i1	O00487	PSDE_HUMAN	88.4	311	35	1	108	1040	1	310	8.40E-154	544.7	PSDE_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)	PSMD14 POH1	Homo sapiens (Human)	310	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000165; GO:0000209; GO:0000502; GO:0000724; GO:0002223; GO:0002479; GO:0004843; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0006521; GO:0008237; GO:0008541; GO:0010972; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031597; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0045471; GO:0046872; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0061578; GO:0070122; GO:0070498; GO:0070536; GO:0070628; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1688_c0_g1_i2	O00487	PSDE_HUMAN	88.4	311	35	1	108	1040	1	310	6.40E-154	545	PSDE_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)	PSMD14 POH1	Homo sapiens (Human)	310	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000165; GO:0000209; GO:0000502; GO:0000724; GO:0002223; GO:0002479; GO:0004843; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0006521; GO:0008237; GO:0008541; GO:0010972; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0031597; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0045471; GO:0046872; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0061578; GO:0070122; GO:0070498; GO:0070536; GO:0070628; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to ethanol [GO:0045471]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31023_c0_g1_i1	Q9LT08	PSDE_ARATH	82.5	229	39	1	687	1	4	231	2.90E-104	379.4	PSDE_ARATH	reviewed	26S proteasome non-ATPase regulatory subunit 14 homolog (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (AtRPN11)	RPN11 At5g23540 MQM1.19	Arabidopsis thaliana (Mouse-ear cress)	308	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0004843; GO:0005634; GO:0005829; GO:0008237; GO:0008541; GO:0016579; GO:0030163; GO:0043161; GO:0046872; GO:0061578; GO:0070122; GO:0070628	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN11629_c0_g1_i2	Q8VDM4	PSMD2_MOUSE	100	291	0	0	3	875	142	432	1.50E-166	586.6	PSMD2_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97)	Psmd2	Mus musculus (Mouse)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005634; GO:0005838; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN11629_c0_g1_i3	Q13200	PSMD2_HUMAN	100	323	0	0	1	969	110	432	1.60E-185	649.8	PSMD2_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Homo sapiens (Human)	908	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]"	enzyme regulator activity [GO:0030234]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034515; GO:0034774; GO:0038061; GO:0038095; GO:0042176; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11629_c0_g1_i1	P56701	PSMD2_BOVIN	100	128	0	0	3	386	305	432	5.40E-68	258.1	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN25439_c1_g1_i1	P56701	PSMD2_BOVIN	65.8	348	117	2	1045	2	92	437	1.50E-133	477.2	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		blue	blue	NA	NA	NA	NA
TRINITY_DN12773_c0_g2_i1	P56701	PSMD2_BOVIN	72.8	92	25	0	3	278	811	902	3.00E-31	135.6	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN13750_c0_g1_i1	P56701	PSMD2_BOVIN	100	247	0	0	743	3	642	888	3.70E-134	478.8	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN13750_c0_g1_i2	P56701	PSMD2_BOVIN	100	267	0	0	837	37	642	908	9.70E-147	520.8	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN10270_c0_g2_i1	P56701	PSMD2_BOVIN	75.2	326	66	1	1068	91	597	907	2.60E-128	459.9	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		blue	blue	NA	NA	NA	NA
TRINITY_DN26282_c0_g1_i1	P56701	PSMD2_BOVIN	100	125	0	0	377	3	194	318	7.60E-67	254.2	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN30545_c0_g1_i1	P56701	PSMD2_BOVIN	55.3	85	35	1	249	4	326	410	9.50E-21	100.5	PSMD2_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Bos taurus (Bovine)	908	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN21645_c0_g1_i1	Q2KJ46	PSMD3_BOVIN	57	100	43	0	316	17	224	323	4.20E-26	118.6	PSMD3_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3)	PSMD3	Bos taurus (Bovine)	534	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0006511; GO:0008541; GO:0022624; GO:0030234; GO:0042176	regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21645_c0_g2_i1	Q2KJ46	PSMD3_BOVIN	54.3	175	75	1	517	8	357	531	9.50E-44	177.9	PSMD3_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3)	PSMD3	Bos taurus (Bovine)	534	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0006511; GO:0008541; GO:0022624; GO:0030234; GO:0042176	regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN33730_c0_g1_i1	Q2KJ46	PSMD3_BOVIN	100	128	0	0	2	385	364	491	5.00E-66	251.5	PSMD3_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3)	PSMD3	Bos taurus (Bovine)	534	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0006511; GO:0008541; GO:0022624; GO:0030234; GO:0042176	regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN16690_c0_g1_i1	O43242	PSMD3_HUMAN	99.7	372	1	0	3	1118	163	534	9.50E-206	717.2	PSMD3_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58)	PSMD3	Homo sapiens (Human)	534	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	enzyme regulator activity [GO:0030234]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006521; GO:0008541; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042176; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16690_c0_g1_i2	O43242	PSMD3_HUMAN	100	218	0	0	3	656	163	380	7.30E-118	424.5	PSMD3_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58)	PSMD3	Homo sapiens (Human)	534	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	enzyme regulator activity [GO:0030234]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006521; GO:0008541; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042176; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18564_c0_g1_i1	Q58DA0	PSMD4_BOVIN	100	108	0	0	385	62	116	223	4.90E-53	208.4	PSMD4_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)	PSMD4	Bos taurus (Bovine)	382	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161; GO:0043248	proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN18564_c0_g1_i2	Q58DA0	PSMD4_BOVIN	100	108	0	0	385	62	116	223	4.90E-53	208.4	PSMD4_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)	PSMD4	Bos taurus (Bovine)	382	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161; GO:0043248	proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN3136_c0_g1_i2	Q58DA0	PSMD4_BOVIN	69	126	37	1	461	84	100	223	8.70E-41	167.9	PSMD4_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)	PSMD4	Bos taurus (Bovine)	382	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161; GO:0043248	proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN14497_c0_g1_i1	Q58DA0	PSMD4_BOVIN	75	80	20	0	40	279	1	80	5.10E-28	124.8	PSMD4_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)	PSMD4	Bos taurus (Bovine)	382	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161; GO:0043248	proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN40431_c0_g1_i1	Q58DA0	PSMD4_BOVIN	100	76	0	0	230	3	1	76	6.00E-38	157.5	PSMD4_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)	PSMD4	Bos taurus (Bovine)	382	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161; GO:0043248	proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN3136_c0_g1_i1	P55035	PSMD4_DROME	71.1	38	10	1	197	84	188	224	2.80E-06	52.4	PSMD4_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (54 kDa subunit of mu particle) (Multiubiquitin chain-binding protein) (p54)	Rpn10 PROS-54 Pros54 CG7619	Drosophila melanogaster (Fruit fly)	396	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; circadian rhythm [GO:0007623]; mitotic sister chromatid segregation [GO:0000070]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	GO:0000070; GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008270; GO:0008540; GO:0031593; GO:0031624; GO:0043161; GO:0043248	circadian rhythm [GO:0007623]; mitotic sister chromatid segregation [GO:0000070]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN35442_c0_g1_i1	P55035	PSMD4_DROME	46.4	97	42	1	120	410	296	382	1.10E-15	84.7	PSMD4_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (54 kDa subunit of mu particle) (Multiubiquitin chain-binding protein) (p54)	Rpn10 PROS-54 Pros54 CG7619	Drosophila melanogaster (Fruit fly)	396	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; circadian rhythm [GO:0007623]; mitotic sister chromatid segregation [GO:0000070]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]"	polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	GO:0000070; GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008270; GO:0008540; GO:0031593; GO:0031624; GO:0043161; GO:0043248	circadian rhythm [GO:0007623]; mitotic sister chromatid segregation [GO:0000070]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN38563_c0_g1_i1	Q8W425	PSMD6_ORYSJ	44.7	94	52	0	1	282	135	228	1.50E-19	96.7	PSMD6_ORYSJ	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory particle non-ATPase subunit 7) (OsRPN7) (26S proteasome regulatory subunit RPN7)	RPN7 Os04g0485000 LOC_Os04g40850 OJ000223_09.5 OsJ_15241 OSJNBa0081L15.15	Oryza sativa subsp. japonica (Rice)	389	proteasome complex [GO:0000502]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	proteasome complex [GO:0000502]		GO:0000502; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN40507_c0_g1_i1	Q3T0B2	PSMD6_BOVIN	100	54	0	0	43	204	1	54	8.60E-25	113.6	PSMD6_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7)	PSMD6	Bos taurus (Bovine)	389	proteasome accessory complex [GO:0022624]; enzyme regulator activity [GO:0030234]	proteasome accessory complex [GO:0022624]	enzyme regulator activity [GO:0030234]	GO:0022624; GO:0030234			NA	NA	NA	NA	NA	NA
TRINITY_DN31311_c0_g1_i1	Q3T0B2	PSMD6_BOVIN	100	122	0	0	367	2	127	248	5.80E-64	244.6	PSMD6_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7)	PSMD6	Bos taurus (Bovine)	389	proteasome accessory complex [GO:0022624]; enzyme regulator activity [GO:0030234]	proteasome accessory complex [GO:0022624]	enzyme regulator activity [GO:0030234]	GO:0022624; GO:0030234			NA	NA	NA	NA	NA	NA
TRINITY_DN25396_c0_g1_i1	Q15008	PSMD6_HUMAN	100	138	0	0	2	415	252	389	2.40E-74	279.3	PSMD6_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)	PSMD6 KIAA0107 PFAAP4	Homo sapiens (Human)	389	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0006508; GO:0006521; GO:0010972; GO:0016579; GO:0016887; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27574_c0_g1_i1	Q15008	PSMD6_HUMAN	99.5	197	1	0	592	2	52	248	6.90E-107	387.9	PSMD6_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)	PSMD6 KIAA0107 PFAAP4	Homo sapiens (Human)	389	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0006508; GO:0006521; GO:0010972; GO:0016579; GO:0016887; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26859_c0_g1_i1	Q99JI4	PSMD6_MOUSE	100	59	0	0	69	245	1	59	2.20E-27	122.5	PSMD6_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (p42A)	Psmd6	Mus musculus (Mouse)	389	proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005838; GO:0022624; GO:0030234; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN13379_c0_g1_i1	Q99JI4	PSMD6_MOUSE	100	107	0	0	3	323	283	389	8.70E-57	220.7	PSMD6_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (p42A)	Psmd6	Mus musculus (Mouse)	389	proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005838; GO:0022624; GO:0030234; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN16215_c0_g1_i1	Q9V3G7	PSMD6_DROME	71.5	389	111	0	89	1255	1	389	3.50E-159	562.8	PSMD6_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit S10) (Protein Rpn7)	Rpn7 CG5378	Drosophila melanogaster (Fruit fly)	389	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030234; GO:0043161	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN9993_c0_g1_i1	Q9V3G7	PSMD6_DROME	38.1	84	52	0	255	4	139	222	3.00E-11	68.9	PSMD6_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit S10) (Protein Rpn7)	Rpn7 CG5378	Drosophila melanogaster (Fruit fly)	389	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030234; GO:0043161	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN31188_c0_g1_i1	Q3ZBD0	PSMD7_BOVIN	42.2	83	43	2	240	1	50	130	1.40E-13	76.6	PSMD7_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8)	PSMD7	Bos taurus (Bovine)	322	proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]	GO:0000502; GO:0005838; GO:0008237; GO:0043161; GO:0070122	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN13476_c0_g1_i1	P51665	PSMD7_HUMAN	100	207	0	0	623	3	1	207	3.00E-116	419.1	PSMD7_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40)	PSMD7 MOV34L	Homo sapiens (Human)	324	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; isopeptidase activity [GO:0070122]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	isopeptidase activity [GO:0070122]; protein homodimerization activity [GO:0042803]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0010972; GO:0016020; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042803; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070122; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13476_c0_g2_i1	P51665	PSMD7_HUMAN	100	207	0	0	623	3	1	207	3.00E-116	419.1	PSMD7_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40)	PSMD7 MOV34L	Homo sapiens (Human)	324	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; isopeptidase activity [GO:0070122]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	isopeptidase activity [GO:0070122]; protein homodimerization activity [GO:0042803]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0010972; GO:0016020; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042803; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070122; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34648_c0_g1_i1	P51665	PSMD7_HUMAN	100	58	0	0	269	96	224	281	3.30E-24	112.1	PSMD7_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40)	PSMD7 MOV34L	Homo sapiens (Human)	324	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; isopeptidase activity [GO:0070122]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	isopeptidase activity [GO:0070122]; protein homodimerization activity [GO:0042803]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0010972; GO:0016020; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042803; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070122; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2393_c0_g1_i1	P26270	PSMD7_DROME	67.8	87	28	0	330	70	204	290	3.90E-27	122.1	PSMD7_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Proteasome subunit p39B) (Proteasome subunit p40) (Protein Mov34)	Rpn8 Mov34 CG3416	Drosophila melanogaster (Fruit fly)	338	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; isopeptidase activity [GO:0070122]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	isopeptidase activity [GO:0070122]	GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030425; GO:0043161; GO:0070122	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN3337_c0_g2_i1	P26270	PSMD7_DROME	50	70	34	1	207	1	141	210	1.30E-10	66.6	PSMD7_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Proteasome subunit p39B) (Proteasome subunit p40) (Protein Mov34)	Rpn8 Mov34 CG3416	Drosophila melanogaster (Fruit fly)	338	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; isopeptidase activity [GO:0070122]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	isopeptidase activity [GO:0070122]	GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030425; GO:0043161; GO:0070122	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN1589_c0_g1_i1	P26270	PSMD7_DROME	78.9	209	44	0	629	3	2	210	6.80E-92	338.2	PSMD7_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Proteasome subunit p39B) (Proteasome subunit p40) (Protein Mov34)	Rpn8 Mov34 CG3416	Drosophila melanogaster (Fruit fly)	338	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; isopeptidase activity [GO:0070122]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	isopeptidase activity [GO:0070122]	GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030425; GO:0043161; GO:0070122	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN1589_c0_g1_i2	P26270	PSMD7_DROME	81.3	182	34	0	591	46	2	183	7.80E-82	304.7	PSMD7_DROME	reviewed	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Proteasome subunit p39B) (Proteasome subunit p40) (Protein Mov34)	Rpn8 Mov34 CG3416	Drosophila melanogaster (Fruit fly)	338	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; isopeptidase activity [GO:0070122]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	isopeptidase activity [GO:0070122]	GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008541; GO:0030425; GO:0043161; GO:0070122	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN3337_c0_g1_i1	O24412	PSD7A_ARATH	54.2	83	38	0	2	250	59	141	4.80E-25	114.8	PSD7A_ARATH	reviewed	26S proteasome non-ATPase regulatory subunit 7 homolog A (26S proteasome regulatory subunit RPN8a) (AtRPN8a) (Protein ASYMMETRIC LEAVES ENHANCER 3) (Protein MOV34) (AtMOV34)	RPN8A AE3 MOV34 At5g05780 MJJ3.19	Arabidopsis thaliana (Mouse-ear cress)	308	cytosol [GO:0005829]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; innate immune response [GO:0045087]; leaf morphogenesis [GO:0009965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]	GO:0000502; GO:0005829; GO:0005838; GO:0005886; GO:0008237; GO:0009965; GO:0043161; GO:0045087; GO:0070122	innate immune response [GO:0045087]; leaf morphogenesis [GO:0009965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN15578_c0_g2_i1	Q3SYT7	PSMD8_BOVIN	100	108	0	0	325	2	106	213	7.90E-57	220.7	PSMD8_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12)	PSMD8	Bos taurus (Bovine)	287	"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0005829; GO:0008541; GO:0022624; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN18780_c0_g1_i1	Q3SYT7	PSMD8_BOVIN	54.5	99	45	0	304	8	115	213	1.20E-22	107.1	PSMD8_BOVIN	reviewed	26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12)	PSMD8	Bos taurus (Bovine)	287	"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0005829; GO:0008541; GO:0022624; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN26815_c0_g1_i1	Q9CX56	PSMD8_MOUSE	56.1	187	81	1	558	1	162	348	9.50E-58	224.6	PSMD8_MOUSE	reviewed	26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14)	Psmd8	Mus musculus (Mouse)	353	"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytosol [GO:0005829]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0000502; GO:0005829; GO:0008541; GO:0022624; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN15578_c0_g1_i1	P48556	PSMD8_HUMAN	100	145	0	0	435	1	169	313	6.90E-80	297.7	PSMD8_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31)	PSMD8	Homo sapiens (Human)	350	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"		GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006521; GO:0008541; GO:0010972; GO:0016579; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2767_c0_g1_i1	O00233	PSMD9_HUMAN	43	207	107	3	683	96	17	223	8.60E-41	168.7	PSMD9_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27)	PSMD9	Homo sapiens (Human)	223	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]; bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of insulin secretion [GO:0046676]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]	bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]	GO:0000165; GO:0000209; GO:0002223; GO:0002479; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0006521; GO:0010972; GO:0016579; GO:0031145; GO:0031146; GO:0032024; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043425; GO:0043488; GO:0043687; GO:0045893; GO:0046676; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of insulin secretion [GO:0046676]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33486_c0_g1_i1	O00233	PSMD9_HUMAN	100	94	0	0	284	3	23	116	8.50E-47	187.2	PSMD9_HUMAN	reviewed	26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27)	PSMD9	Homo sapiens (Human)	223	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]; bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of insulin secretion [GO:0046676]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]	bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]	GO:0000165; GO:0000209; GO:0002223; GO:0002479; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0006521; GO:0010972; GO:0016579; GO:0031145; GO:0031146; GO:0032024; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043425; GO:0043488; GO:0043687; GO:0045893; GO:0046676; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0070682; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of insulin secretion [GO:0046676]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30131_c0_g1_i1	Q54PJ1	PRS10_DICDI	79.4	286	59	0	3	860	108	393	8.20E-133	474.6	PRS10_DICDI	reviewed	26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6)	psmC6 DDB_G0284517	Dictyostelium discoideum (Slime mold)	393	"cytosolic proteasome complex [GO:0031597]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433]"	"cytosolic proteasome complex [GO:0031597]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0008540; GO:0016887; GO:0030433; GO:0031597; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN26564_c0_g1_i1	Q2KIW6	PRS10_BOVIN	100	198	0	0	596	3	123	320	6.00E-111	401.4	PRS10_BOVIN	reviewed	26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6)	PSMC6	Bos taurus (Bovine)	389	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ubiquitin-dependent ERAD pathway [GO:0030433]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0016887; GO:0022624; GO:0030433	ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN5129_c0_g1_i1	P62333	PRS10_HUMAN	90.8	293	27	0	885	7	97	389	1.50E-153	543.5	PRS10_HUMAN	reviewed	26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42)	PSMC6 SUG2	Homo sapiens (Human)	389	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0016887; GO:0022624; GO:0030433; GO:0030674; GO:0031145; GO:0031146; GO:0031597; GO:0033209; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0045899; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6016_c0_g2_i1	P48601	PRS4_DROME	94.6	408	22	0	1314	91	32	439	1.90E-218	759.6	PRS4_DROME	reviewed	26S proteasome regulatory subunit 4 (P26s4)	Rpt2 P26s4 Pros26.4 CG5289	Drosophila melanogaster (Fruit fly)	439	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	GO:0005524; GO:0005654; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008540; GO:0016887; GO:0017025; GO:0036402; GO:0043161	circadian rhythm [GO:0007623]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN6016_c0_g1_i3	P62191	PRS4_HUMAN	77.1	35	8	0	152	48	399	433	5.60E-07	55.5	PRS4_HUMAN	reviewed	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)	PSMC1	Homo sapiens (Human)	440	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of neuron death [GO:1901215]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0016887; GO:0017025; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0036402; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901215; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of neuron death [GO:1901215]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13081_c0_g1_i1	Q90732	PRS4_CHICK	86.7	45	4	1	35	169	398	440	1.20E-13	76.6	PRS4_CHICK	reviewed	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)	PSMC1	Gallus gallus (Chicken)	440	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; protein catabolic process [GO:0030163]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0017025; GO:0022624; GO:0030163; GO:0036402	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN12596_c0_g1_i1	P62191	PRS4_HUMAN	100	387	0	0	1246	86	54	440	1.20E-217	756.9	PRS4_HUMAN	reviewed	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)	PSMC1	Homo sapiens (Human)	440	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of neuron death [GO:1901215]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0016887; GO:0017025; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0036402; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901215; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of neuron death [GO:1901215]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12596_c0_g1_i2	P62191	PRS4_HUMAN	100	387	0	0	1246	86	54	440	1.20E-217	756.9	PRS4_HUMAN	reviewed	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)	PSMC1	Homo sapiens (Human)	440	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of neuron death [GO:1901215]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016579; GO:0016887; GO:0017025; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0036402; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901215; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of neuron death [GO:1901215]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39862_c0_g1_i1	Q8SRH0	PRS4_ENCCU	71.7	368	102	1	12	1109	57	424	2.90E-154	546.2	PRS4_ENCCU	reviewed	26S proteasome regulatory subunit 4 homolog	RPT2 ECU07_1640	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	424	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN4183_c0_g1_i1	Q9SZD4	PRS4A_ARATH	78.9	393	83	0	1208	30	51	443	3.00E-181	636	PRS4A_ARATH	reviewed	26S proteasome regulatory subunit 4 homolog A (26S proteasome AAA-ATPase subunit RPT2a) (26S proteasome subunit 4 homolog A) (Protein HALTED ROOT) (Regulatory particle triple-A ATPase subunit 2a)	RPT2A HLR At4g29040 F19B15.70 F25O24.6	Arabidopsis thaliana (Mouse-ear cress)	443	"nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; female gamete generation [GO:0007292]; innate immune response [GO:0045087]; lateral root formation [GO:0010311]; leaf morphogenesis [GO:0009965]; maintenance of root meristem identity [GO:0010078]; male gamete generation [GO:0048232]; meristem growth [GO:0035266]; meristem structural organization [GO:0009933]; phyllome development [GO:0048827]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene silencing [GO:0060968]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; root cap development [GO:0048829]; root development [GO:0048364]; root morphogenesis [GO:0010015]; seedling development [GO:0090351]; shoot system development [GO:0048367]"	"nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005886; GO:0007292; GO:0008540; GO:0009408; GO:0009933; GO:0009965; GO:0010015; GO:0010078; GO:0010311; GO:0017025; GO:0035266; GO:0036402; GO:0043161; GO:0043248; GO:0045087; GO:0046686; GO:0048232; GO:0048364; GO:0048367; GO:0048827; GO:0048829; GO:0051788; GO:0060968; GO:0090351	female gamete generation [GO:0007292]; innate immune response [GO:0045087]; lateral root formation [GO:0010311]; leaf morphogenesis [GO:0009965]; maintenance of root meristem identity [GO:0010078]; male gamete generation [GO:0048232]; meristem growth [GO:0035266]; meristem structural organization [GO:0009933]; phyllome development [GO:0048827]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene silencing [GO:0060968]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; root cap development [GO:0048829]; root development [GO:0048364]; root morphogenesis [GO:0010015]; seedling development [GO:0090351]; shoot system development [GO:0048367]		NA	NA	NA	NA	NA	NA
TRINITY_DN11316_c0_g1_i1	Q8SR13	PRS6A_ENCCU	80.8	260	50	0	23	802	142	401	2.00E-120	433.3	PRS6A_ENCCU	reviewed	26S proteasome regulatory subunit 6A	RPT5 ECU10_1420	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	401	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0030163; GO:0036402	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN6764_c0_g1_i1	P17980	PRS6A_HUMAN	89.7	261	27	0	785	3	178	438	1.10E-131	470.7	PRS6A_HUMAN	reviewed	26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)	PSMC3 TBP1	Homo sapiens (Human)	439	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0000932; GO:0001824; GO:0002223; GO:0002479; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016032; GO:0016579; GO:0016887; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0043921; GO:0045899; GO:0045944; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6764_c0_g1_i2	P17980	PRS6A_HUMAN	90.1	223	22	0	671	3	216	438	2.20E-110	399.8	PRS6A_HUMAN	reviewed	26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)	PSMC3 TBP1	Homo sapiens (Human)	439	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0000932; GO:0001824; GO:0002223; GO:0002479; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016032; GO:0016579; GO:0016887; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0043921; GO:0045899; GO:0045944; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31187_c0_g1_i1	P17980	PRS6A_HUMAN	100	194	0	0	1	582	223	416	1.30E-105	383.6	PRS6A_HUMAN	reviewed	26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)	PSMC3 TBP1	Homo sapiens (Human)	439	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0000932; GO:0001824; GO:0002223; GO:0002479; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016032; GO:0016579; GO:0016887; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0043921; GO:0045899; GO:0045944; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18053_c0_g1_i1	P17980	PRS6A_HUMAN	100	243	0	0	732	4	194	436	9.60E-135	480.7	PRS6A_HUMAN	reviewed	26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)	PSMC3 TBP1	Homo sapiens (Human)	439	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0000932; GO:0001824; GO:0002223; GO:0002479; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006521; GO:0008540; GO:0010972; GO:0016020; GO:0016032; GO:0016579; GO:0016887; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0043921; GO:0045899; GO:0045944; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; blastocyst development [GO:0001824]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; modulation by host of viral transcription [GO:0043921]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30610_c0_g1_i1	P46465	PRS6A_ORYSJ	80.8	260	48	2	5	784	157	414	1.40E-115	417.2	PRS6A_ORYSJ	reviewed	26S proteasome regulatory subunit 6A homolog (Tat-binding protein homolog 1) (TBP-1)	TBP1 OsRPT5a Os02g0803700 LOC_Os02g56000 P0689B12.30	Oryza sativa subsp. japonica (Rice)	429	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0016887; GO:0030163; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN9134_c0_g2_i1	Q3T030	PRS6B_BOVIN	100	211	0	0	2	634	51	261	7.40E-115	414.5	PRS6B_BOVIN	reviewed	26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4)	PSMC4	Bos taurus (Bovine)	418	"cytosolic proteasome complex [GO:0031597]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; blastocyst development [GO:0001824]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]"	"cytosolic proteasome complex [GO:0031597]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]"	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0001824; GO:0005524; GO:0005654; GO:0008540; GO:0022624; GO:0030163; GO:0031597; GO:0036402; GO:0045202; GO:0045899	blastocyst development [GO:0001824]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN9134_c0_g1_i1	Q3T030	PRS6B_BOVIN	100	393	0	0	1	1179	26	418	8.70E-221	767.3	PRS6B_BOVIN	reviewed	26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4)	PSMC4	Bos taurus (Bovine)	418	"cytosolic proteasome complex [GO:0031597]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; blastocyst development [GO:0001824]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]"	"cytosolic proteasome complex [GO:0031597]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]"	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0001824; GO:0005524; GO:0005654; GO:0008540; GO:0022624; GO:0030163; GO:0031597; GO:0036402; GO:0045202; GO:0045899	blastocyst development [GO:0001824]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN3668_c0_g1_i1	P46507	PRS6B_MANSE	84.1	416	65	1	1341	94	1	415	1.60E-197	690.3	PRS6B_MANSE	reviewed	26S proteasome regulatory subunit 6B (ATPase MS73)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	415	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0030163; GO:0036402	protein catabolic process [GO:0030163]		blue	blue	NA	NA	NA	NA
TRINITY_DN9695_c0_g1_i1	P85200	PRS6B_HELAN	79.3	377	78	0	1184	54	37	413	3.80E-173	609	PRS6B_HELAN	reviewed	26S proteasome regulatory subunit 6B homolog		Helianthus annuus (Common sunflower)	414	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0030163; GO:0036402	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN24736_c0_g1_i1	Q8SQI9	PRS6B_ENCCU	75.3	377	93	0	1131	1	11	387	5.60E-158	558.5	PRS6B_ENCCU	reviewed	26S proteasome regulatory subunit 6B homolog	ECU08_1970; ECU10_0130	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	387	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0030163; GO:0036402	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN26568_c0_g1_i1	O74894	PRS6B_SCHPO	92.9	70	5	0	211	2	189	258	1.80E-30	132.5	PRS6B_SCHPO	reviewed	26S proteasome regulatory subunit 6B homolog	rpt3 SPCC576.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	389	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; nuclear chromatin [GO:0000790]; nuclear periphery [GO:0034399]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; CENP-A containing chromatin organization [GO:0061641]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; nuclear chromatin [GO:0000790]; nuclear periphery [GO:0034399]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000790; GO:0005524; GO:0005737; GO:0005829; GO:0008540; GO:0031597; GO:0034399; GO:0036402; GO:0043161; GO:0045842; GO:0045899; GO:0061641	CENP-A containing chromatin organization [GO:0061641]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN12603_c0_g1_i1	Q5E9F9	PRS7_BOVIN	100	433	0	0	1368	70	1	433	1.20E-250	866.7	PRS7_BOVIN	reviewed	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)	PSMC2	Bos taurus (Bovine)	433	"cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043197; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN12603_c0_g2_i1	Q5E9F9	PRS7_BOVIN	100	382	0	0	1147	2	1	382	2.20E-221	769.2	PRS7_BOVIN	reviewed	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)	PSMC2	Bos taurus (Bovine)	433	"cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043197; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN30976_c0_g1_i1	Q5E9F9	PRS7_BOVIN	100	58	0	0	244	71	376	433	1.90E-26	119.4	PRS7_BOVIN	reviewed	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)	PSMC2	Bos taurus (Bovine)	433	"cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043197; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2100_c0_g1_i1	P46472	PRS7_XENLA	69.5	361	108	1	2	1078	73	433	1.10E-148	527.7	PRS7_XENLA	reviewed	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1) (xMSS1)	psmc2 mss1	Xenopus laevis (African clawed frog)	433	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0016887; GO:0022624; GO:0036402	ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN2290_c0_g1_i1	P46472	PRS7_XENLA	91.2	433	38	0	1356	58	1	433	1.80E-233	809.7	PRS7_XENLA	reviewed	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1) (xMSS1)	psmc2 mss1	Xenopus laevis (African clawed frog)	433	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0016887; GO:0022624; GO:0036402	ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN8215_c0_g1_i1	P0DKJ9	PRS7A_ORYSJ	78.7	375	76	2	2	1123	55	426	2.40E-175	616.3	PRS7A_ORYSJ	reviewed	26S proteasome regulatory subunit 7A (26S proteasome AAA-ATPase subunit RPT1A) (26S proteasome subunit 7A) (Regulatory particle triple-A ATPase subunit 1A)	RPT1A Os02g0784700 LOC_Os02g54340 OJ1715_H01.26	Oryza sativa subsp. japonica (Rice)	426	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]	GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0016887; GO:0017025; GO:0030163; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN15778_c1_g1_i1	O18413	PRS8_DROME	87.3	71	9	0	43	255	193	263	4.40E-26	118.2	PRS8_DROME	reviewed	26S proteasome regulatory subunit 8	Rpt6 DUG Pros45 Ug CG1489	Drosophila melanogaster (Fruit fly)	405	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; circadian rhythm [GO:0007623]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]	GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008540; GO:0016887; GO:0017025; GO:0031595; GO:0031597; GO:0043161; GO:0045899; GO:0050804; GO:0098794	circadian rhythm [GO:0007623]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN15778_c2_g1_i1	O18413	PRS8_DROME	91.5	82	7	0	1	246	180	261	3.40E-36	151.8	PRS8_DROME	reviewed	26S proteasome regulatory subunit 8	Rpt6 DUG Pros45 Ug CG1489	Drosophila melanogaster (Fruit fly)	405	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; circadian rhythm [GO:0007623]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]	GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0007623; GO:0008063; GO:0008540; GO:0016887; GO:0017025; GO:0031595; GO:0031597; GO:0043161; GO:0045899; GO:0050804; GO:0098794	circadian rhythm [GO:0007623]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN15778_c0_g1_i1	P62194	PRS8_BOVIN	100	25	0	0	3	77	267	291	6.60E-06	51.6	PRS8_BOVIN	reviewed	26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (p45/SUG)	PSMC5 SUG1	Bos taurus (Bovine)	406	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0008134; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0043161; GO:0045892; GO:0045899; GO:0050804; GO:0098794	"modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32366_c0_g1_i1	P62194	PRS8_BOVIN	85.7	70	10	0	5	214	114	183	1.90E-27	122.5	PRS8_BOVIN	reviewed	26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (p45/SUG)	PSMC5 SUG1	Bos taurus (Bovine)	406	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0008134; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0043161; GO:0045892; GO:0045899; GO:0050804; GO:0098794	"modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10126_c0_g1_i2	P62194	PRS8_BOVIN	100	358	0	0	1126	53	49	406	5.90E-200	698	PRS8_BOVIN	reviewed	26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (p45/SUG)	PSMC5 SUG1	Bos taurus (Bovine)	406	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0008134; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0043161; GO:0045892; GO:0045899; GO:0050804; GO:0098794	"modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10126_c0_g1_i3	P62194	PRS8_BOVIN	100	376	0	0	1180	53	31	406	5.60E-209	728	PRS8_BOVIN	reviewed	26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (p45/SUG)	PSMC5 SUG1	Bos taurus (Bovine)	406	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0008134; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0043161; GO:0045892; GO:0045899; GO:0050804; GO:0098794	"modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7858_c0_g1_i1	P54814	PRS8_MANSE	95.8	379	16	0	1201	65	24	402	2.70E-203	709.1	PRS8_MANSE	reviewed	26S proteasome regulatory subunit 8 (Protein 18-56)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	402	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0030163	protein catabolic process [GO:0030163]		blue	blue	NA	NA	NA	NA
TRINITY_DN5582_c0_g1_i1	Q8SQK0	PRS8_ENCCU	81.5	335	62	0	1025	21	58	392	2.20E-153	543.1	PRS8_ENCCU	reviewed	26S proteasome regulatory subunit 8 homolog	RPT6 ECU09_1840	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	392	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN25521_c0_g1_i1	Q9C5U3	PRS8A_ARATH	85.1	363	53	1	1127	39	56	417	4.50E-171	602.1	PRS8A_ARATH	reviewed	26S proteasome regulatory subunit 8 homolog A (26S proteasome AAA-ATPase subunit RPT6a) (26S proteasome subunit 8 homolog A) (Regulatory particle triple-A ATPase subunit 6a)	RPT6A SUG1 At5g19990 F28I16.140	Arabidopsis thaliana (Mouse-ear cress)	419	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein catabolic process [GO:0030163]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; proteasome complex [GO:0000502]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0000502; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0009536; GO:0016887; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN12773_c0_g1_i1	Q7S8R8	RPN1_NEUCR	61.1	131	51	0	4	396	642	772	1.10E-39	164.1	RPN1_NEUCR	reviewed	26S proteasome regulatory subunit rpn-1	rpn-1 NCU07721	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	902	"nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	"nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"	enzyme regulator activity [GO:0030234]	GO:0005634; GO:0008540; GO:0030234; GO:0034515; GO:0042176; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]		NA	NA	NA	NA	NA	NA
TRINITY_DN1369_c0_g1_i1	Q8SQY3	RPN11_ENCCU	70.1	211	60	1	651	28	16	226	3.60E-81	302.8	RPN11_ENCCU	reviewed	26S proteasome regulatory subunit RPN11	RPN11 ECU11_0570	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	294	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	GO:0000502; GO:0005634; GO:0005737; GO:0008237; GO:0046872; GO:0061578; GO:0070122			NA	NA	NA	NA	NA	NA
TRINITY_DN36433_c0_g1_i1	Q04062	RPN9_YEAST	44.1	68	38	0	209	6	310	377	7.30E-11	67.4	RPN9_YEAST	reviewed	26S proteasome regulatory subunit RPN9 (Proteasome non-ATPase subunit 7)	RPN9 NAS7 YDR427W D9461.14	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	393	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome storage granule [GO:0034515]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome storage granule [GO:0034515]"	structural molecule activity [GO:0005198]	GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0008541; GO:0034515; GO:0043248	proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN7586_c0_g1_i1	P28644	ROC1_SPIOL	29.5	95	65	2	1864	1583	135	228	7.60E-06	53.9	ROC1_SPIOL	reviewed	"28 kDa ribonucleoprotein, chloroplastic (28RNP)"		Spinacia oleracea (Spinach)	233	chloroplast [GO:0009507]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]	chloroplast [GO:0009507]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0009507	mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN8126_c0_g1_i1	Q9VFB2	RT10_DROME	53.6	151	68	2	532	86	23	173	1.20E-34	148.3	RT10_DROME	reviewed	"28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt)"	mRpS10 CG4247	Drosophila melanogaster (Fruit fly)	173	mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005763; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN8126_c0_g1_i2	Q9VFB2	RT10_DROME	53.6	151	68	2	532	86	23	173	1.10E-34	148.3	RT10_DROME	reviewed	"28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt)"	mRpS10 CG4247	Drosophila melanogaster (Fruit fly)	173	mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005763; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN37584_c0_g1_i1	P82664	RT10_HUMAN	99	103	1	0	310	2	91	193	1.50E-52	206.5	RT10_HUMAN	reviewed	"28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt) (Mitochondrial small ribosomal subunit protein uS10m)"	MRPS10 MSTP040	Homo sapiens (Human)	201	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]		GO:0005743; GO:0005763; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1020_c1_g1_i1	P82911	RT11_BOVIN	45.5	143	60	3	468	91	56	197	1.10E-21	105.1	RT11_BOVIN	reviewed	"28S ribosomal protein S11, mitochondrial (MRP-S11) (S11mt)"	MRPS11	Bos taurus (Bovine)	197	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; peptide biosynthetic process [GO:0043043]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543; GO:0043043	mitochondrial translation [GO:0032543]; peptide biosynthetic process [GO:0043043]		blue	blue	NA	NA	NA	NA
TRINITY_DN1020_c1_g1_i2	P82912	RT11_HUMAN	39.6	187	104	2	651	91	17	194	2.40E-28	127.5	RT11_HUMAN	reviewed	"28S ribosomal protein S11, mitochondrial (MRP-S11) (S11mt) (Cervical cancer proto-oncogene 2 protein) (HCC-2) (Mitochondrial small ribosomal subunit protein uS11m)"	MRPS11 RPMS11 HCC2	Homo sapiens (Human)	194	"cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; DNA damage response, detection of DNA damage [GO:0042769]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0000462; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0022627; GO:0032543; GO:0042769; GO:0048027; GO:0070125; GO:0070126; GO:0070181	"DNA damage response, detection of DNA damage [GO:0042769]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19700_c0_g1_i1	O35680	RT12_MOUSE	96.1	77	3	0	254	24	62	138	5.80E-39	161	RT12_MOUSE	reviewed	"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12)"	Mrps12 Rpms12	Mus musculus (Mouse)	139	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0005840; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19700_c0_g1_i2	O15235	RT12_HUMAN	100	108	0	0	347	24	31	138	4.80E-60	231.5	RT12_HUMAN	reviewed	"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12) (Mitochondrial small ribosomal subunit protein uS12m)"	MRPS12 RPMS12 RPSM12	Homo sapiens (Human)	138	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005743; GO:0005761; GO:0005763; GO:0005840; GO:0006412; GO:0032543; GO:0070125; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1038_c0_g1_i1	Q8WTC1	RT15_DROME	36.2	240	145	3	836	117	17	248	5.20E-32	139.8	RT15_DROME	reviewed	"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) (DmMRPS15) (Protein bonsai)"	bonsai mRpS15 CG4207	Drosophila melanogaster (Fruit fly)	280	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543; GO:0040008	mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1038_c0_g1_i4	Q8WTC1	RT15_DROME	35.9	184	114	1	668	117	69	248	1.90E-24	114.4	RT15_DROME	reviewed	"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) (DmMRPS15) (Protein bonsai)"	bonsai mRpS15 CG4207	Drosophila melanogaster (Fruit fly)	280	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543; GO:0040008	mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1038_c0_g1_i5	Q8WTC1	RT15_DROME	36.1	183	113	1	665	117	70	248	3.70E-24	113.2	RT15_DROME	reviewed	"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) (DmMRPS15) (Protein bonsai)"	bonsai mRpS15 CG4207	Drosophila melanogaster (Fruit fly)	280	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543; GO:0040008	mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1038_c0_g1_i6	Q8WTC1	RT15_DROME	36.2	240	145	3	836	117	17	248	5.50E-32	139.8	RT15_DROME	reviewed	"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) (DmMRPS15) (Protein bonsai)"	bonsai mRpS15 CG4207	Drosophila melanogaster (Fruit fly)	280	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543; GO:0040008	mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40103_c0_g1_i1	Q9Y3D3	RT16_HUMAN	100	78	0	0	235	2	28	105	4.70E-43	174.5	RT16_HUMAN	reviewed	"28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt) (Mitochondrial small ribosomal subunit protein bS16m)"	MRPS16 RPMS16 CGI-132	Homo sapiens (Human)	137	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit [GO:0015935]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0005829; GO:0006412; GO:0015935; GO:0032543; GO:0070125; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN8575_c0_g1_i1	P82916	RT17_BOVIN	41.1	95	56	0	131	415	13	107	3.20E-15	83.6	RT17_BOVIN	reviewed	"28S ribosomal protein S17, mitochondrial (MRP-S17) (S17mt)"	MRPS17 RPMS17	Bos taurus (Bovine)	130	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0019843	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN2056_c0_g1_i1	P82917	RT18C_BOVIN	45.6	90	47	1	192	461	49	136	3.50E-18	93.2	RT18C_BOVIN	reviewed	"28S ribosomal protein S18c, mitochondrial (MRP-S18-c) (Mrps18-c) (S18mt-c) (28S ribosomal protein S18-1, mitochondrial) (MRP-S18-1)"	MRPS18C	Bos taurus (Bovine)	143	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0070181	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN39919_c0_g1_i1	Q8R2L5	RT18C_MOUSE	100	80	0	0	241	2	56	135	1.10E-42	173.3	RT18C_MOUSE	reviewed	"28S ribosomal protein S18c, mitochondrial (MRP-S18-c) (Mrps18-c) (S18mt-c) (28S ribosomal protein S18-1, mitochondrial) (MRP-S18-1)"	Mrps18c	Mus musculus (Mouse)	143	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0070181	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2855_c0_g1_i3	P82923	RT02_BOVIN	60.2	211	84	0	729	97	46	256	4.20E-71	270	RT02_BOVIN	reviewed	"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt)"	MRPS2	Bos taurus (Bovine)	293	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543; GO:0061668	mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN2855_c0_g1_i6	P82923	RT02_BOVIN	60.2	211	84	0	729	97	46	256	8.40E-71	270	RT02_BOVIN	reviewed	"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt)"	MRPS2	Bos taurus (Bovine)	293	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543; GO:0061668	mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN2855_c0_g1_i2	Q9Y399	RT02_HUMAN	53.6	252	114	1	843	97	16	267	1.50E-71	271.2	RT02_HUMAN	reviewed	"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt) (Mitochondrial small ribosomal subunit protein uS2m)"	MRPS2 CGI-91	Homo sapiens (Human)	296	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0061668; GO:0070125; GO:0070126	mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		blue	blue	NA	NA	NA	NA
TRINITY_DN34258_c0_g1_i1	Q9Y399	RT02_HUMAN	100	172	0	0	518	3	101	272	1.90E-97	356.3	RT02_HUMAN	reviewed	"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt) (Mitochondrial small ribosomal subunit protein uS2m)"	MRPS2 CGI-91	Homo sapiens (Human)	296	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0061668; GO:0070125; GO:0070126	mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN7942_c0_g1_i1	P82650	RT22_HUMAN	41.7	290	166	2	999	133	68	355	5.10E-61	236.5	RT22_HUMAN	reviewed	"28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt) (Mitochondrial small ribosomal subunit protein mS22)"	MRPS22 C3orf5 RPMS22 GK002	Homo sapiens (Human)	360	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005763; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		blue	blue	NA	NA	NA	NA
TRINITY_DN7942_c0_g1_i2	P82650	RT22_HUMAN	41.7	290	166	2	992	126	68	355	5.10E-61	236.5	RT22_HUMAN	reviewed	"28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt) (Mitochondrial small ribosomal subunit protein mS22)"	MRPS22 C3orf5 RPMS22 GK002	Homo sapiens (Human)	360	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005763; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN33720_c0_g1_i1	P82650	RT22_HUMAN	100	89	0	0	268	2	137	225	4.00E-46	184.9	RT22_HUMAN	reviewed	"28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt) (Mitochondrial small ribosomal subunit protein mS22)"	MRPS22 C3orf5 RPMS22 GK002	Homo sapiens (Human)	360	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005763; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN30033_c0_g1_i1	Q9VCC3	RT24_DROME	62.5	144	54	0	156	587	22	165	3.60E-51	203	RT24_DROME	reviewed	"28S ribosomal protein S24, mitochondrial (MRP-S24) (S24mt)"	mRpS24 CG13608	Drosophila melanogaster (Fruit fly)	165	mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005763; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3282_c0_g1_i1	Q9ER88	RT29_MOUSE	37.8	362	221	3	1181	96	34	391	2.50E-72	274.2	RT29_MOUSE	reviewed	"28S ribosomal protein S29, mitochondrial (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3)"	Dap3 Mrps29	Mus musculus (Mouse)	391	mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; apoptotic mitochondrial changes [GO:0008637]	mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005654; GO:0005739; GO:0005759; GO:0005763; GO:0008637	apoptotic mitochondrial changes [GO:0008637]		blue	blue	NA	NA	NA	NA
TRINITY_DN38610_c0_g1_i1	P82925	RT31_BOVIN	47.6	145	74	2	45	479	240	382	1.40E-35	151	RT31_BOVIN	reviewed	"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt)"	MRPS31	Bos taurus (Bovine)	386	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763			NA	NA	NA	NA	NA	NA
TRINITY_DN28475_c0_g1_i1	Q92665	RT31_HUMAN	100	86	0	0	1	258	310	395	6.10E-47	187.6	RT31_HUMAN	reviewed	"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)"	MRPS31 IMOGN38	Homo sapiens (Human)	395	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN2757_c0_g1_i1	Q9Y291	RT33_HUMAN	62	100	38	0	380	81	5	104	9.30E-26	118.2	RT33_HUMAN	reviewed	"28S ribosomal protein S33, mitochondrial (MRP-S33) (S33mt) (Mitochondrial small ribosomal subunit protein mS33)"	MRPS33 CGI-139 PTD003	Homo sapiens (Human)	106	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3441_c0_g1_i18	P82929	RT34_BOVIN	33.1	133	74	6	309	698	58	178	1.50E-07	58.5	RT34_BOVIN	reviewed	"28S ribosomal protein S34, mitochondrial (MRP-S34) (S34mt)"	MRPS34	Bos taurus (Bovine)	218	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN3441_c0_g1_i9	P82929	RT34_BOVIN	33.1	133	74	6	342	731	58	178	1.60E-07	58.5	RT34_BOVIN	reviewed	"28S ribosomal protein S34, mitochondrial (MRP-S34) (S34mt)"	MRPS34	Bos taurus (Bovine)	218	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN35547_c0_g1_i1	Q2YDF6	RT35_BOVIN	96.1	77	3	0	234	4	82	158	1.90E-39	162.5	RT35_BOVIN	reviewed	"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt)"	MRPS35 MRPS28	Bos taurus (Bovine)	325	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN1722_c2_g1_i1	Q2YDF6	RT35_BOVIN	46.8	284	136	3	1020	211	42	324	1.30E-65	251.9	RT35_BOVIN	reviewed	"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt)"	MRPS35 MRPS28	Bos taurus (Bovine)	325	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN23363_c0_g1_i1	Q99N87	RT05_MOUSE	100	73	0	0	2	220	287	359	4.80E-37	154.5	RT05_MOUSE	reviewed	"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt)"	Mrps5	Mus musculus (Mouse)	432	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005763; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23363_c0_g1_i2	P82675	RT05_HUMAN	95.2	83	4	0	2	250	285	367	6.80E-40	164.1	RT05_HUMAN	reviewed	"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt) (Mitochondrial small ribosomal subunit protein uS5m)"	MRPS5	Homo sapiens (Human)	430	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5375_c0_g1_i1	P82675	RT05_HUMAN	46.7	302	153	5	4	897	106	403	2.30E-68	260.8	RT05_HUMAN	reviewed	"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt) (Mitochondrial small ribosomal subunit protein uS5m)"	MRPS5	Homo sapiens (Human)	430	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10497_c0_g1_i1	Q9VKX4	RT07_DROME	51	202	95	2	709	104	21	218	3.00E-52	206.8	RT07_DROME	reviewed	"28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt)"	mRpS7 CG5108	Drosophila melanogaster (Fruit fly)	218	mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543	mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24001_c0_g1_i2	Q80X85	RT07_MOUSE	100	55	0	0	210	46	188	242	5.60E-27	120.9	RT07_MOUSE	reviewed	"28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt)"	Mrps7	Mus musculus (Mouse)	242	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005739; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543	mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24001_c0_g1_i1	Q9Y2R9	RT07_HUMAN	100	56	0	0	213	46	187	242	1.10E-27	123.2	RT07_HUMAN	reviewed	"28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt) (Mitochondrial small ribosomal subunit protein uS7m) (bMRP-27a) (bMRP27a)"	MRPS7	Homo sapiens (Human)	242	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003729; GO:0003735; GO:0005743; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543; GO:0070125; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4613_c0_g1_i1	Q8K4F6	NSUN5_MOUSE	33.3	456	246	10	144	1343	3	456	5.40E-49	196.8	NSUN5_MOUSE	reviewed	28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein homolog)	Nsun5 Wbscr20a	Mus musculus (Mouse)	465	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0009383; GO:0014003; GO:0021987; GO:0022038; GO:0031641; GO:0045727; GO:0050890; GO:0070475	cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN4613_c0_g1_i2	Q8K4F6	NSUN5_MOUSE	36.1	463	265	9	144	1466	3	456	1.80E-61	238.4	NSUN5_MOUSE	reviewed	28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein homolog)	Nsun5 Wbscr20a	Mus musculus (Mouse)	465	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0009383; GO:0014003; GO:0021987; GO:0022038; GO:0031641; GO:0045727; GO:0050890; GO:0070475	cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN37083_c0_g1_i1	Q96P11	NSUN5_HUMAN	44.1	68	38	0	39	242	210	277	9.40E-10	63.9	NSUN5_HUMAN	reviewed	28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein)	NSUN5 NSUN5A WBSCR20 WBSCR20A	Homo sapiens (Human)	429	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0009383; GO:0014003; GO:0021987; GO:0022038; GO:0031641; GO:0045727; GO:0050890; GO:0070475	cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN33810_c0_g1_i1	Q9SLN8	DBR_TOBAC	58.5	53	22	0	12	170	207	259	1.60E-10	66.2	DBR_TOBAC	reviewed	2-alkenal reductase (NADP(+)-dependent) (EC 1.3.1.102) (Alkenal double bound reductase) (Allylic alcohol dehydrogenase 1) (allyl-ADH1) (Flavin-free double bond reductase) (NtDBR) (Pulegone reductase) (NtRed-1)	DBR	Nicotiana tabacum (Common tobacco)	343	2-alkenal reductase [NAD(P)+] activity [GO:0032440]		2-alkenal reductase [NAD(P)+] activity [GO:0032440]	GO:0032440			NA	NA	NA	NA	NA	NA
TRINITY_DN622_c0_g1_i2	D0E8I5	PHNZ_UNCHF	40.8	191	108	2	62	634	2	187	6.00E-33	142.5	PHNZ_UNCHF	reviewed	2-amino-1-hydroxyethylphosphonate dioxygenase (glycine-forming) (EC 1.13.11.78) (Di-iron oxygenase) (Nonheme iron-dependent oxygenase)	phnZ ALOHA_HF130_AEPn_1_06c	Uncultured bacterium HF130_AEPn_1	190	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]	GO:0016491; GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN40640_c0_g1_i1	Q8R519	ACMSD_MOUSE	52.4	105	46	2	3	311	167	269	7.90E-30	131	ACMSD_MOUSE	reviewed	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase)	Acmsd	Mus musculus (Mouse)	336	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; aging [GO:0007568]; negative regulation of quinolinate biosynthetic process [GO:1904985]; quinolinate metabolic process [GO:0046874]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]	GO:0001760; GO:0005737; GO:0005829; GO:0006569; GO:0007568; GO:0008270; GO:0016787; GO:0016831; GO:0019748; GO:0046874; GO:1904985	aging [GO:0007568]; negative regulation of quinolinate biosynthetic process [GO:1904985]; quinolinate metabolic process [GO:0046874]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569]		NA	NA	NA	NA	NA	NA
TRINITY_DN38978_c0_g1_i1	Q0II68	ACMSD_BOVIN	63.4	339	120	2	1095	82	1	336	9.90E-137	488	ACMSD_BOVIN	reviewed	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase)	ACMSD	Bos taurus (Bovine)	336	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; secondary metabolic process [GO:0019748]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]	GO:0001760; GO:0005737; GO:0005829; GO:0008270; GO:0016787; GO:0016831; GO:0019748; GO:1904985	negative regulation of quinolinate biosynthetic process [GO:1904985]; secondary metabolic process [GO:0019748]		NA	NA	NA	NA	NA	NA
TRINITY_DN11933_c0_g1_i1	Q6PDY2	AEDO_MOUSE	39.9	228	107	9	653	6	3	212	4.40E-28	126.3	AEDO_MOUSE	reviewed	2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase)	Ado Gm237	Mus musculus (Mouse)	256	mitochondrion [GO:0005739]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]	GO:0005739; GO:0046872; GO:0047800			NA	NA	NA	NA	NA	NA
TRINITY_DN11933_c0_g1_i2	Q6PDY2	AEDO_MOUSE	34.9	195	101	7	631	83	3	183	2.40E-15	84	AEDO_MOUSE	reviewed	2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase)	Ado Gm237	Mus musculus (Mouse)	256	mitochondrion [GO:0005739]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]	GO:0005739; GO:0046872; GO:0047800			NA	NA	NA	NA	NA	NA
TRINITY_DN17376_c0_g1_i1	A0LMC0	PHNW_SYNFM	53.5	43	20	0	60	188	329	371	4.00E-07	55.1	PHNW_SYNFM	reviewed	2-aminoethylphosphonate--pyruvate transaminase (EC 2.6.1.37) (2-aminoethylphosphonate aminotransferase) (AEP transaminase) (AEPT)	phnW Sfum_2895	Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB)	371	2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700]		2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]	GO:0019700; GO:0047304	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN17376_c0_g2_i1	A6TFW2	PHNW_KLEP7	52.3	109	51	1	6	329	217	325	7.70E-21	101.3	PHNW_KLEP7	reviewed	2-aminoethylphosphonate--pyruvate transaminase (EC 2.6.1.37) (2-aminoethylphosphonate aminotransferase) (AEP transaminase) (AEPT)	phnW KPN78578_40220 KPN_04063	Klebsiella pneumoniae subsp. pneumoniae (strain ATCC 700721 / MGH 78578)	367	2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700]		2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]	GO:0019700; GO:0047304	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN29368_c0_g1_i1	A0LMC0	PHNW_SYNFM	50	60	27	1	19	198	312	368	2.50E-10	65.9	PHNW_SYNFM	reviewed	2-aminoethylphosphonate--pyruvate transaminase (EC 2.6.1.37) (2-aminoethylphosphonate aminotransferase) (AEP transaminase) (AEPT)	phnW Sfum_2895	Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB)	371	2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700]		2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]	GO:0019700; GO:0047304	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN16857_c0_g1_i1	Q66I21	AL8A1_DANRE	39.8	83	47	1	329	81	12	91	5.40E-08	58.9	AL8A1_DANRE	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	aldh8a1	Danio rerio (Zebrafish) (Brachydanio rerio)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; L-kynurenine catabolic process [GO:0097053]; liver development [GO:0001889]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]	GO:0001889; GO:0005737; GO:0047102; GO:0097053	liver development [GO:0001889]; L-kynurenine catabolic process [GO:0097053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4878_c0_g1_i1	Q0P5F9	AL8A1_BOVIN	58.5	479	199	0	185	1621	8	486	2.40E-168	593.6	AL8A1_BOVIN	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	ALDH8A1	Bos taurus (Bovine)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005737; GO:0042573; GO:0042574; GO:0047102; GO:0097053	L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN4878_c0_g1_i2	Q0P5F9	AL8A1_BOVIN	58.5	479	199	0	779	2215	8	486	2.50E-168	594	AL8A1_BOVIN	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	ALDH8A1	Bos taurus (Bovine)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005737; GO:0042573; GO:0042574; GO:0047102; GO:0097053	L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN4878_c0_g1_i3	Q0P5F9	AL8A1_BOVIN	58.5	479	199	0	297	1733	8	486	1.90E-168	594	AL8A1_BOVIN	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	ALDH8A1	Bos taurus (Bovine)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005737; GO:0042573; GO:0042574; GO:0047102; GO:0097053	L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN4878_c0_g1_i7	Q0P5F9	AL8A1_BOVIN	58.5	479	199	0	699	2135	8	486	3.10E-168	593.6	AL8A1_BOVIN	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	ALDH8A1	Bos taurus (Bovine)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005737; GO:0042573; GO:0042574; GO:0047102; GO:0097053	L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN4878_c0_g1_i8	Q0P5F9	AL8A1_BOVIN	58.5	479	199	0	217	1653	8	486	2.40E-168	593.6	AL8A1_BOVIN	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	ALDH8A1	Bos taurus (Bovine)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005737; GO:0042573; GO:0042574; GO:0047102; GO:0097053	L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN4878_c0_g1_i9	Q0P5F9	AL8A1_BOVIN	58.5	479	199	0	508	1944	8	486	2.80E-168	593.6	AL8A1_BOVIN	reviewed	2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase family 8 member A1)	ALDH8A1	Bos taurus (Bovine)	487	cytoplasm [GO:0005737]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytoplasm [GO:0005737]	aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005737; GO:0042573; GO:0042574; GO:0047102; GO:0097053	L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN5121_c0_g1_i1	Q96291	BAS1A_ARATH	58.9	56	23	0	176	9	99	154	2.00E-12	72.8	BAS1A_ARATH	reviewed	"2-Cys peroxiredoxin BAS1, chloroplastic (2-Cys Prx A) (2-Cys peroxiredoxin A) (EC 1.11.1.24) (Thiol-specific antioxidant protein A) (Thioredoxin-dependent peroxiredoxin BAS1)"	BAS1 At3g11630 F24K9.28 T19F11.3	Arabidopsis thaliana (Mouse-ear cress)	266	apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; stromule [GO:0010319]; thylakoid [GO:0009579]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; defense response to bacterium [GO:0042742]; response to cold [GO:0009409]; response to oxidative stress [GO:0006979]	apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; stromule [GO:0010319]; thylakoid [GO:0009579]	peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]	GO:0004601; GO:0005829; GO:0006979; GO:0008379; GO:0009409; GO:0009507; GO:0009570; GO:0009579; GO:0009941; GO:0010319; GO:0042742; GO:0045454; GO:0048046; GO:0051920	cell redox homeostasis [GO:0045454]; defense response to bacterium [GO:0042742]; response to cold [GO:0009409]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN31638_c0_g1_i1	Q6ER94	BAS1_ORYSJ	43.9	82	41	2	2	244	172	249	2.10E-14	79.3	BAS1_ORYSJ	reviewed	"2-Cys peroxiredoxin BAS1, chloroplastic (EC 1.11.1.24) (Thiol-specific antioxidant protein) (Thioredoxin-dependent peroxiredoxin BAS1)"	BAS1 Os02g0537700 LOC_Os02g33450 OsJ_07037 OSJNBa0014M17.2 P0508B05.23	Oryza sativa subsp. japonica (Rice)	261	chloroplast [GO:0009507]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	chloroplast [GO:0009507]	peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]	GO:0006979; GO:0008379; GO:0009507; GO:0042744; GO:0045454; GO:0051920	cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN4135_c0_g1_i1	C1BW56	DNPH1_ESOLU	54.3	140	63	1	577	158	1	139	1.50E-33	144.4	DNPH1_ESOLU	reviewed	2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-)	dnph1	Esox lucius (Northern pike)	145	cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]	GO:0005634; GO:0005737; GO:0009116; GO:0009117; GO:0009159; GO:0070694	deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]		blue	blue	NA	NA	NA	NA
TRINITY_DN36795_c0_g1_i1	O43598	DNPH1_HUMAN	100	101	0	0	304	2	63	163	1.10E-52	206.8	DNPH1_HUMAN	reviewed	2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL)	DNPH1 C6orf108 RCL	Homo sapiens (Human)	174	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide catabolic process [GO:0006195]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005829; GO:0006195; GO:0009116; GO:0009159; GO:0030307; GO:0030855; GO:0042802; GO:0042803; GO:0070062; GO:0070694	deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide catabolic process [GO:0006195]		NA	NA	NA	NA	NA	NA
TRINITY_DN3462_c0_g1_i1	Q9UJ83	HACL1_HUMAN	42.9	105	60	0	406	92	474	578	2.40E-21	103.2	HACL1_HUMAN	reviewed	2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.n2) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	HACL1 HPCL HPCL2 PHYH2 HSPC279	Homo sapiens (Human)	578	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:1903512	fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN3462_c0_g1_i2	Q9UJ83	HACL1_HUMAN	59.8	214	86	0	733	92	365	578	3.60E-74	279.6	HACL1_HUMAN	reviewed	2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.n2) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	HACL1 HPCL HPCL2 PHYH2 HSPC279	Homo sapiens (Human)	578	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:1903512	fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN3462_c0_g1_i3	Q9UJ83	HACL1_HUMAN	59.2	569	230	1	1792	92	10	578	7.20E-203	708.4	HACL1_HUMAN	reviewed	2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.n2) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	HACL1 HPCL HPCL2 PHYH2 HSPC279	Homo sapiens (Human)	578	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:1903512	fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN34104_c0_g1_i1	Q9UJ83	HACL1_HUMAN	100	139	0	0	418	2	31	169	4.90E-75	281.6	HACL1_HUMAN	reviewed	2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.n2) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	HACL1 HPCL HPCL2 PHYH2 HSPC279	Homo sapiens (Human)	578	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:1903512	fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN31014_c0_g1_i1	Q9UJ83	HACL1_HUMAN	100	133	0	0	3	401	378	510	2.80E-75	282.3	HACL1_HUMAN	reviewed	2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.n2) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	HACL1 HPCL HPCL2 PHYH2 HSPC279	Homo sapiens (Human)	578	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:1903512	fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN39038_c0_g1_i1	Q8BU33	ILVBL_MOUSE	100	130	0	0	391	2	92	221	3.10E-63	242.3	HACL2_MOUSE	reviewed	2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)	Ilvbl Hacl2	Mus musculus (Mouse)	632	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0050660	fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]		NA	NA	NA	NA	NA	NA
TRINITY_DN968_c0_g1_i1	Q6NV04	ILVBL_DANRE	69.4	589	178	1	212	1972	33	621	1.30E-245	850.5	HACL2_DANRE	reviewed	2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)	ilvbl hacl2 zgc:66376 zgc:85697	Danio rerio (Zebrafish) (Brachydanio rerio)	621	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660	embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]		NA	NA	NA	NA	NA	NA
TRINITY_DN968_c0_g1_i2	Q8BU33	ILVBL_MOUSE	50.7	67	31	1	78	272	566	632	4.20E-14	79	HACL2_MOUSE	reviewed	2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)	Ilvbl Hacl2	Mus musculus (Mouse)	632	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0050660	fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]		NA	NA	NA	NA	NA	NA
TRINITY_DN968_c0_g1_i3	Q6NV04	ILVBL_DANRE	69.4	589	178	1	216	1976	33	621	1.30E-245	850.5	HACL2_DANRE	reviewed	2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)	ilvbl hacl2 zgc:66376 zgc:85697	Danio rerio (Zebrafish) (Brachydanio rerio)	621	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660	embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]		blue	blue	NA	NA	NA	NA
TRINITY_DN30939_c0_g1_i1	A1L0T0	ILVBL_HUMAN	100	157	0	0	474	4	445	601	1.20E-88	327	HACL2_HUMAN	reviewed	2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)	ILVBL AHAS HACL2	Homo sapiens (Human)	632	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]	acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]	GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016020; GO:0016021; GO:0016829; GO:0030976; GO:0050660	fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]		NA	NA	NA	NA	NA	NA
TRINITY_DN35954_c0_g1_i1	Q64676	CGT_MOUSE	39.1	110	67	0	331	2	346	455	2.20E-20	99.8	CGT_MOUSE	reviewed	2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase)	Ugt8 Cgt Ugt4 Ugt8a	Mus musculus (Mouse)	541	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; ceramide glucosyltransferase activity [GO:0008120]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	"2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; ceramide glucosyltransferase activity [GO:0008120]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]"	GO:0002175; GO:0003851; GO:0005783; GO:0006682; GO:0007010; GO:0008120; GO:0008489; GO:0009247; GO:0016021; GO:0030913; GO:0042552; GO:0043231; GO:0047263; GO:0048812	cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]		NA	NA	NA	NA	NA	NA
TRINITY_DN26713_c0_g1_i2	Q09426	CGT_RAT	31.1	482	324	5	1667	222	10	483	3.70E-60	234.2	CGT_RAT	reviewed	2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (CGalT) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase)	Ugt8 Cgt Ugt4	Rattus norvegicus (Rat)	541	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	"2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]"	GO:0002175; GO:0003851; GO:0005783; GO:0006682; GO:0006688; GO:0007010; GO:0008489; GO:0016021; GO:0030913; GO:0042552; GO:0043231; GO:0047263; GO:0048812	cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]		NA	NA	NA	NA	NA	NA
TRINITY_DN32901_c0_g1_i1	P80601	RIDA_CAPHI	63.4	131	48	0	73	465	2	132	1.10E-37	157.9	RIDA_CAPHI	reviewed	2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.3 kDa perchloric acid soluble protein) (Translation inhibitor L-PSP ribonuclease) (EC 3.1.-.-) (UK114 antigen)	RIDA	Capra hircus (Goat)	137	"mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 2-iminobutanoate/2-iminopropanoate deaminase [GO:0120241]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; mRNA binding [GO:0003729]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]"	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]	"2-iminobutanoate/2-iminopropanoate deaminase [GO:0120241]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; mRNA binding [GO:0003729]"	GO:0003729; GO:0005634; GO:0005759; GO:0005777; GO:0006402; GO:0016892; GO:0017148; GO:0019239; GO:0061157; GO:0120241; GO:1901565	mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]		blue	blue	NA	NA	NA	NA
TRINITY_DN29220_c0_g1_i1	P52758	RIDA_HUMAN	100	81	0	0	1	243	52	132	2.10E-38	159.1	RIDA_HUMAN	reviewed	2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.5 kDa translational inhibitor protein) (hp14.5) (p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog)	RIDA HRSP12	Homo sapiens (Human)	137	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 2-iminobutanoate/2-iminopropanoate deaminase [GO:0120241]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	"2-iminobutanoate/2-iminopropanoate deaminase [GO:0120241]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]"	GO:0001822; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0007420; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0030324; GO:0033993; GO:0036041; GO:0042802; GO:0046914; GO:0050680; GO:0061157; GO:0070062; GO:0070314; GO:0120241; GO:1901565; GO:1902074	brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN35734_c0_g1_i1	Q8P3K4	FUCDH_XANCP	64.4	87	31	0	29	289	127	213	1.90E-25	116.3	FUCDH_XANCP	reviewed	2-keto-3-deoxy-L-fuconate dehydrogenase (EC 1.1.1.-)	XCC4067	Xanthomonas campestris pv. campestris (strain ATCC 33913 / DSM 3586 / NCPPB 528 / LMG 568 / P 25)	300	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN30699_c0_g1_i1	Q8P3K4	FUCDH_XANCP	63	100	36	1	298	2	164	263	1.90E-28	126.3	FUCDH_XANCP	reviewed	2-keto-3-deoxy-L-fuconate dehydrogenase (EC 1.1.1.-)	XCC4067	Xanthomonas campestris pv. campestris (strain ATCC 33913 / DSM 3586 / NCPPB 528 / LMG 568 / P 25)	300	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN22_c0_g1_i1	Q7TMB7	PLPR4_RAT	27	174	108	6	507	16	103	267	2.10E-06	54.3	PLPR4_RAT	reviewed	2-lysophosphatidate phosphatase PLPPR4 (EC 3.1.3.106) (Brain-specific phosphatidic acid phosphatase-like protein 1) (Lipid phosphate phosphatase-related protein type 4) (Phospholipid phosphatase-related protein type 4) (Plasticity-related gene 1 protein) (PRG-1)	Plppr4 Lppr4 Php1 Prg1	Rattus norvegicus (Rat)	766	external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; axonogenesis [GO:0007409]; inner ear development [GO:0048839]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]	lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]	GO:0005887; GO:0006644; GO:0007165; GO:0007409; GO:0008195; GO:0009897; GO:0016791; GO:0042577; GO:0046839; GO:0048839; GO:0052642; GO:0098978; GO:0099061	axonogenesis [GO:0007409]; inner ear development [GO:0048839]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1784_c0_g1_i1	Q0P5A2	COQ5_BOVIN	51.9	316	146	4	1037	93	17	327	2.50E-86	320.5	COQ5_BOVIN	reviewed	"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5)"	COQ5	Bos taurus (Bovine)	330	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]"	GO:0005759; GO:0006744; GO:0008168; GO:0031314; GO:0032259; GO:0032991; GO:0043333	methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]		blue	blue	NA	NA	NA	NA
TRINITY_DN1784_c0_g1_i2	Q0P5A2	COQ5_BOVIN	51.7	211	100	2	722	93	118	327	1.70E-58	227.6	COQ5_BOVIN	reviewed	"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5)"	COQ5	Bos taurus (Bovine)	330	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]"	GO:0005759; GO:0006744; GO:0008168; GO:0031314; GO:0032259; GO:0032991; GO:0043333	methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN1784_c0_g1_i3	Q0P5A2	COQ5_BOVIN	51.7	211	100	2	722	93	118	327	1.60E-58	227.6	COQ5_BOVIN	reviewed	"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5)"	COQ5	Bos taurus (Bovine)	330	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]"	GO:0005759; GO:0006744; GO:0008168; GO:0031314; GO:0032259; GO:0032991; GO:0043333	methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN8667_c0_g1_i1	Q9FS88	MBCD_SOLTU	63.2	76	28	0	230	3	220	295	1.20E-22	106.7	MBCD_SOLTU	reviewed	"2-methylacyl-CoA dehydrogenase, mitochondrial (EC 1.3.99.12) (2-methylbutanoyl-CoA dehydrogenase) (2-methylbutyryl-CoA dehydrogenase) (2MBCD) (Isovaleryl-CoA dehydrogenase 1) (St-IVD1)"	2MBCD IVD1 PGSC0003DMG400026901	Solanum tuberosum (Potato)	412	mitochondrion [GO:0005739]; 2-methylacyl-CoA dehydrogenase activity [GO:0003853]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; 2-methylbut-2-enoyl-CoA(4-) metabolic process [GO:1902192]; 2-methylbutanoyl-CoA(4-) catabolic process [GO:1902190]	mitochondrion [GO:0005739]	2-methylacyl-CoA dehydrogenase activity [GO:0003853]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0003853; GO:0005739; GO:0008470; GO:0050660; GO:1902190; GO:1902192	2-methylbut-2-enoyl-CoA(4-) metabolic process [GO:1902192]; 2-methylbutanoyl-CoA(4-) catabolic process [GO:1902190]		NA	NA	NA	NA	NA	NA
TRINITY_DN36621_c0_g1_i1	A1L1C5	URAD_XENLA	50.9	173	85	0	669	151	3	175	1.70E-41	171	URAD_XENLA	reviewed	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase)	urad prhoxnb	Xenopus laevis (African clawed frog)	175	peroxisome [GO:0005777]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]	peroxisome [GO:0005777]	carboxy-lyase activity [GO:0016831]	GO:0005777; GO:0006144; GO:0016831; GO:0019428; GO:0019628	allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]		NA	NA	NA	NA	NA	NA
TRINITY_DN7631_c0_g1_i1	A3KGZ2	OGFD2_DANRE	48.5	332	163	5	49	1023	3	333	9.10E-84	312	OGFD2_DANRE	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-)	ogfod2 si:dkey-21k4.1 zgc:158437	Danio rerio (Zebrafish) (Brachydanio rerio)	345	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN29434_c0_g1_i1	Q6N063	OGFD2_HUMAN	99.3	151	1	0	8	460	134	284	1.40E-86	320.1	OGFD2_HUMAN	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-)	OGFOD2	Homo sapiens (Human)	350	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN5520_c0_g1_i5	Q5XGE0	OGFD3_XENTR	63.2	136	50	0	59	466	179	314	6.40E-46	185.3	OGFD3_XENTR	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3	ogfod3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	317	"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN34385_c0_g1_i1	Q6PK18	OGFD3_HUMAN	100	101	0	0	350	48	219	319	1.10E-56	220.3	OGFD3_HUMAN	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	OGFOD3 C17orf101	Homo sapiens (Human)	319	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016020; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN33651_c0_g1_i1	Q6PK18	OGFD3_HUMAN	100	71	0	0	216	4	91	161	2.80E-34	145.2	OGFD3_HUMAN	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	OGFOD3 C17orf101	Homo sapiens (Human)	319	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016020; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN36940_c0_g1_i1	Q9D136	OGFD3_MOUSE	100	86	0	0	261	4	69	154	2.80E-44	178.7	OGFD3_MOUSE	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	Ogfod3	Mus musculus (Mouse)	315	"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN5520_c0_g1_i1	Q5M843	OGFD3_RAT	57.7	253	104	2	358	1110	63	314	3.00E-77	290.4	OGFD3_RAT	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	Ogfod3	Rattus norvegicus (Rat)	315	"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN5520_c0_g1_i2	Q5M843	OGFD3_RAT	59.2	245	97	2	165	893	71	314	1.50E-77	291.2	OGFD3_RAT	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	Ogfod3	Rattus norvegicus (Rat)	315	"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN5520_c0_g1_i3	Q5M843	OGFD3_RAT	50.6	312	143	5	103	1011	5	314	3.60E-77	290	OGFD3_RAT	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	Ogfod3	Rattus norvegicus (Rat)	315	"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN5520_c0_g1_i4	Q5M843	OGFD3_RAT	57.7	253	104	2	259	1011	63	314	2.80E-77	290.4	OGFD3_RAT	reviewed	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-)	Ogfod3	Rattus norvegicus (Rat)	315	"integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	integral component of membrane [GO:0016021]	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0016021; GO:0016705; GO:0031418; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN379_c0_g1_i1	Q5ZHV5	JMJD4_CHICK	59.6	89	36	0	366	100	185	273	1.10E-30	134	JMJD4_CHICK	reviewed	2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4)	JMJD4 RCJMB04_32n10	Gallus gallus (Chicken)	425	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]	cytoplasm [GO:0005737]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]	GO:0005737; GO:0016706; GO:0018126; GO:0045905; GO:0046872	positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]		NA	NA	NA	NA	NA	NA
TRINITY_DN379_c0_g1_i2	Q5ZHV5	JMJD4_CHICK	49	384	184	6	1222	98	40	420	1.30E-108	394.8	JMJD4_CHICK	reviewed	2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4)	JMJD4 RCJMB04_32n10	Gallus gallus (Chicken)	425	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]	cytoplasm [GO:0005737]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]	GO:0005737; GO:0016706; GO:0018126; GO:0045905; GO:0046872	positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]		NA	NA	NA	NA	NA	NA
TRINITY_DN379_c0_g1_i3	Q08BY5	JMJD4_DANRE	46.7	240	119	3	793	98	180	418	3.90E-60	233.8	JMJD4_DANRE	reviewed	2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4)	jmjd4 zgc:153974	Danio rerio (Zebrafish) (Brachydanio rerio)	422	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]	cytoplasm [GO:0005737]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]	GO:0005737; GO:0016706; GO:0018126; GO:0045905; GO:0046872	positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]		NA	NA	NA	NA	NA	NA
TRINITY_DN6162_c0_g1_i2	D3DJ41	2OCL_HYDTT	46.6	73	39	0	173	391	575	647	2.00E-08	60.5	2OCL_HYDTT	reviewed	2-oxoglutarate carboxylase large subunit (EC 6.4.1.7) (2-oxoglutarate carboxylase alpha subunit)	cfiA HTH_1392 Hydth_1382	Hydrogenobacter thermophilus (strain DSM 6534 / IAM 12695 / TK-6)	652	2-oxoglutarate carboxylase activity [GO:0034029]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]		2-oxoglutarate carboxylase activity [GO:0034029]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0034029; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6162_c0_g1_i5	D3DJ41	2OCL_HYDTT	46.6	73	39	0	374	592	575	647	2.90E-08	60.5	2OCL_HYDTT	reviewed	2-oxoglutarate carboxylase large subunit (EC 6.4.1.7) (2-oxoglutarate carboxylase alpha subunit)	cfiA HTH_1392 Hydth_1382	Hydrogenobacter thermophilus (strain DSM 6534 / IAM 12695 / TK-6)	652	2-oxoglutarate carboxylase activity [GO:0034029]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]		2-oxoglutarate carboxylase activity [GO:0034029]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0034029; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27994_c0_g1_i1	P0AFG5	ODO1_ECO57	73.5	68	18	0	1	204	411	478	3.00E-25	115.2	ODO1_ECO57	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA Z0880 ECs0751	Escherichia coli O157:H7	933	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006099; GO:0030976	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN31977_c0_g1_i1	Q59106	ODO1_CUPNH	63.5	115	42	0	347	3	655	769	6.80E-38	157.9	ODO1_CUPNH	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	odhA H16_A2325	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	950	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN32401_c0_g1_i1	Q59106	ODO1_CUPNH	88.9	90	10	0	1	270	409	498	3.10E-41	168.7	ODO1_CUPNH	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	odhA H16_A2325	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	950	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN40609_c0_g1_i1	Q59106	ODO1_CUPNH	78.2	78	17	0	236	3	614	691	2.90E-32	138.7	ODO1_CUPNH	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	odhA H16_A2325	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	950	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2693_c0_g1_i1	B2S877	ODO1_BRUA1	76.8	138	32	0	14	427	712	849	1.60E-60	233.4	ODO1_BRUA1	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA odhA BAbS19_I18040	Brucella abortus (strain S19)	1004	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2693_c0_g2_i1	B2S877	ODO1_BRUA1	72.2	151	42	0	2	454	716	866	8.80E-62	237.7	ODO1_BRUA1	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA odhA BAbS19_I18040	Brucella abortus (strain S19)	1004	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6685_c0_g2_i1	B2S877	ODO1_BRUA1	77.8	90	20	0	4	273	440	529	1.30E-39	163.3	ODO1_BRUA1	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA odhA BAbS19_I18040	Brucella abortus (strain S19)	1004	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6685_c0_g1_i2	B2S877	ODO1_BRUA1	82.4	85	15	0	1	255	445	529	1.40E-37	156.4	ODO1_BRUA1	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA odhA BAbS19_I18040	Brucella abortus (strain S19)	1004	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6685_c0_g1_i3	B2S877	ODO1_BRUA1	70.3	101	30	0	1	303	445	545	1.60E-38	159.8	ODO1_BRUA1	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA odhA BAbS19_I18040	Brucella abortus (strain S19)	1004	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6685_c0_g1_i4	B2S877	ODO1_BRUA1	79.2	96	20	0	2	289	434	529	8.40E-42	170.6	ODO1_BRUA1	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	sucA odhA BAbS19_I18040	Brucella abortus (strain S19)	1004	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN35409_c0_g1_i1	Q59106	ODO1_CUPNH	92	138	11	0	3	416	667	804	8.10E-70	264.2	ODO1_CUPNH	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	odhA H16_A2325	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	950	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN15644_c0_g1_i1	Q59106	ODO1_CUPNH	76.2	80	19	0	1	240	334	413	6.80E-29	127.5	ODO1_CUPNH	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	odhA H16_A2325	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	950	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN29281_c0_g1_i1	Q59106	ODO1_CUPNH	64.5	121	43	0	27	389	354	474	4.30E-41	168.7	ODO1_CUPNH	reviewed	2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase)	odhA H16_A2325	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	950	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006096; GO:0006099; GO:0030976	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN36231_c0_g1_i1	Q8NRC3	ODO12_CORGL	80	80	16	0	242	3	947	1026	1.00E-32	140.2	ODO12_CORGL	reviewed	2-oxoglutarate dehydrogenase E1/E2 component (ODH E1/E2 component) [Includes: 2-oxoglutarate dehydrogenase E1 component (ODH E1 component) (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase E1 component) (KDH E1 component); Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex E2 component) (ODH E2 component) (OGDC-E2) (Dihydrolipoamide succinyltransferase)]	odhA Cgl1129 cg1280	Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025)	1221	dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; tricarboxylic acid cycle [GO:0006099]		dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004149; GO:0004591; GO:0006099; GO:0030976; GO:0046872	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN33583_c0_g1_i1	Q02218	ODO1_HUMAN	99.2	251	2	0	1	753	614	864	4.10E-149	528.5	ODO1_HUMAN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Homo sapiens (Human)	1023	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; lysine catabolic process [GO:0006554]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006554; GO:0030976; GO:0031966; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; lysine catabolic process [GO:0006554]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN9410_c0_g2_i1	Q54JE4	ODO1_DICDI	62.3	162	55	1	511	26	700	855	1.90E-52	206.8	ODO1_DICDI	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	ogdh DDB_G0288127	Dictyostelium discoideum (Slime mold)	1013	mitochondrial oxoglutarate dehydrogenase complex [GO:0009353]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrial oxoglutarate dehydrogenase complex [GO:0009353]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0009353; GO:0030976; GO:0045252	glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN9410_c0_g1_i1	O61199	ODO1_CAEEL	51.3	76	36	1	2	229	639	713	1.20E-14	80.1	ODO1_CAEEL	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	ogdh-1 T22B11.5	Caenorhabditis elegans	1029	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966; GO:0045252	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN35100_c0_g1_i1	Q60597	ODO1_MOUSE	100	70	0	0	1	210	738	807	3.10E-38	158.3	ODO1_MOUSE	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	Ogdh Kiaa4192	Mus musculus (Mouse)	1023	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN32310_c0_g1_i1	Q148N0	ODO1_BOVIN	100	104	0	0	2	313	333	436	5.00E-56	218	ODO1_BOVIN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Bos taurus (Bovine)	1023	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0030976; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN518_c1_g1_i1	Q148N0	ODO1_BOVIN	100	97	0	0	3	293	353	449	5.80E-51	201.1	ODO1_BOVIN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Bos taurus (Bovine)	1023	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0030976; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN518_c0_g1_i2	Q148N0	ODO1_BOVIN	67.6	775	244	5	3	2312	241	1013	0	1106.7	ODO1_BOVIN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Bos taurus (Bovine)	1023	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0030976; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN518_c0_g1_i3	Q148N0	ODO1_BOVIN	63.8	825	242	6	3	2462	241	1013	0	1084.3	ODO1_BOVIN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Bos taurus (Bovine)	1023	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0030976; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN518_c2_g1_i1	Q148N0	ODO1_BOVIN	100	87	0	0	262	2	431	517	1.30E-46	186.4	ODO1_BOVIN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Bos taurus (Bovine)	1023	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0030976; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN27324_c0_g1_i1	Q02218	ODO1_HUMAN	100	87	0	0	2	262	876	962	1.00E-46	186.8	ODO1_HUMAN	reviewed	"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)"	OGDH	Homo sapiens (Human)	1023	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; lysine catabolic process [GO:0006554]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006554; GO:0030976; GO:0031966; GO:0045252; GO:0046872; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; lysine catabolic process [GO:0006554]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN14445_c1_g1_i1	K0DZA0	HTYE_ASPRU	31.5	289	167	7	152	949	15	295	1.50E-30	135.2	HTYE_ASPRU	reviewed	2-oxoglutarate-dependent dioxygenase htyE (EC 1.14.-.-) (L-homotyrosine biosynthetic cluster protein E)	htyE	Aspergillus rugulosus (Emericella rugulosa)	329	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN14445_c1_g1_i2	K0DZA0	HTYE_ASPRU	28.6	203	88	4	53	511	100	295	5.40E-15	82.8	HTYE_ASPRU	reviewed	2-oxoglutarate-dependent dioxygenase htyE (EC 1.14.-.-) (L-homotyrosine biosynthetic cluster protein E)	htyE	Aspergillus rugulosus (Emericella rugulosa)	329	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN14445_c1_g1_i3	K0DZA0	HTYE_ASPRU	38.4	99	54	1	23	319	129	220	1.00E-12	74.3	HTYE_ASPRU	reviewed	2-oxoglutarate-dependent dioxygenase htyE (EC 1.14.-.-) (L-homotyrosine biosynthetic cluster protein E)	htyE	Aspergillus rugulosus (Emericella rugulosa)	329	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN14445_c1_g1_i8	K0DZA0	HTYE_ASPRU	32.8	256	141	7	35	733	48	295	2.00E-28	127.9	HTYE_ASPRU	reviewed	2-oxoglutarate-dependent dioxygenase htyE (EC 1.14.-.-) (L-homotyrosine biosynthetic cluster protein E)	htyE	Aspergillus rugulosus (Emericella rugulosa)	329	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN37466_c0_g1_i1	P09061	ODBB_PSEPU	77	74	17	0	1	222	26	99	3.10E-28	125.2	ODBB_PSEPU	reviewed	2-oxoisovalerate dehydrogenase subunit beta (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDH E1-beta)	bkdA2	Pseudomonas putida (Arthrobacter siderocapsulatus)	339	3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]		3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]	GO:0003863			NA	NA	NA	NA	NA	NA
TRINITY_DN1572_c0_g1_i1	P21839	ODBB_BOVIN	58.2	91	33	1	81	353	36	121	4.30E-24	112.1	ODBB_BOVIN	reviewed	"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)"	BCKDHB	Bos taurus (Bovine)	392	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]	GO:0003826; GO:0003863; GO:0005730; GO:0005739; GO:0005947; GO:0007584; GO:0009083	branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN32761_c0_g1_i1	Q8TE99	PXYP1_HUMAN	27.7	419	265	10	1385	2602	68	461	7.60E-44	180.6	PXYP1_HUMAN	reviewed	2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124)	PXYLP1 ACPL2 HEL124 XYLP UNQ370/PRO706	Homo sapiens (Human)	480	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	phosphatase activity [GO:0016791]	GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650	chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]		NA	NA	NA	NA	NA	NA
TRINITY_DN32761_c0_g1_i2	Q8TE99	PXYP1_HUMAN	27.7	419	265	10	1328	111	68	461	7.60E-44	180.6	PXYP1_HUMAN	reviewed	2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124)	PXYLP1 ACPL2 HEL124 XYLP UNQ370/PRO706	Homo sapiens (Human)	480	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	phosphatase activity [GO:0016791]	GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650	chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]		NA	NA	NA	NA	NA	NA
TRINITY_DN32296_c0_g1_i1	B7HTW3	MENE_BACC7	55.6	72	31	1	224	9	338	408	1.60E-17	89.7	MENE_BACC7	reviewed	2-succinylbenzoate--CoA ligase (EC 6.2.1.26) (o-succinylbenzoyl-CoA synthetase) (OSB-CoA synthetase)	menE BCAH187_A4993	Bacillus cereus (strain AH187)	481	ATP binding [GO:0005524]; o-succinylbenzoate-CoA ligase activity [GO:0008756]; menaquinone biosynthetic process [GO:0009234]		ATP binding [GO:0005524]; o-succinylbenzoate-CoA ligase activity [GO:0008756]	GO:0005524; GO:0008756; GO:0009234	menaquinone biosynthetic process [GO:0009234]		NA	NA	NA	NA	NA	NA
TRINITY_DN14405_c0_g1_i4	Q3ZCK3	BPNT1_BOVIN	57.7	182	74	2	641	99	127	306	6.70E-54	212.2	BPNT1_BOVIN	reviewed	"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1)"	BPNT1	Bos taurus (Bovine)	308	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]"		"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]"	GO:0008441; GO:0046854; GO:0046855; GO:0046872	inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN14405_c0_g1_i1	O95861	BPNT1_HUMAN	51.9	308	144	3	1019	99	2	306	3.70E-85	316.6	BPNT1_HUMAN	reviewed	"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)"	BPNT1	Homo sapiens (Human)	308	"cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]"	cytosol [GO:0005829]	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]"	GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046855; GO:0046872; GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN14405_c0_g1_i5	O95861	BPNT1_HUMAN	48.6	329	144	4	1082	99	2	306	3.40E-81	303.5	BPNT1_HUMAN	reviewed	"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)"	BPNT1	Homo sapiens (Human)	308	"cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]"	cytosol [GO:0005829]	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]"	GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046855; GO:0046872; GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN14405_c0_g1_i7	O95861	BPNT1_HUMAN	53.6	278	127	2	920	90	2	278	7.20E-80	298.9	BPNT1_HUMAN	reviewed	"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)"	BPNT1	Homo sapiens (Human)	308	"cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]"	cytosol [GO:0005829]	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]"	GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046855; GO:0046872; GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN37589_c0_g1_i1	Q9Z0S1	BPNT1_MOUSE	98.6	73	1	0	221	3	177	249	2.30E-36	152.1	BPNT1_MOUSE	reviewed	"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)"	Bpnt1	Mus musculus (Mouse)	308	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; magnesium ion binding [GO:0000287]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]"		"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0004441; GO:0008441; GO:0046854; GO:0046855	inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN1020_c1_g1_i3	Q7UZW5	RS11_PROMP	52.1	48	23	0	213	70	47	94	1.80E-05	49.7	RS11_PROMP	reviewed	30S ribosomal protein S11	rpsK rps11 PMM1536	Prochlorococcus marinus subsp. pastoris (strain CCMP1986 / NIES-2087 / MED4)	130	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN34919_c0_g1_i1	A0LRL5	RS12_ACIC1	94.2	69	4	0	1	207	36	104	1.60E-31	136	RS12_ACIC1	reviewed	30S ribosomal protein S12	rpsL Acel_0301	Acidothermus cellulolyticus (strain ATCC 43068 / 11B)	124	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN34974_c0_g1_i1	A0M5A2	RS12_GRAFK	98.6	72	1	0	217	2	37	108	4.80E-34	144.4	RS12_GRAFK	reviewed	30S ribosomal protein S12	rpsL GFO_2843	Gramella forsetii (strain KT0803)	124	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5517_c0_g2_i1	A5V607	RS12_SPHWW	98.6	74	1	0	224	3	43	116	7.70E-35	147.1	RS12_SPHWW	reviewed	30S ribosomal protein S12	rpsL Swit_1358	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	123	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5517_c0_g1_i1	Q2G8Y5	RS12_NOVAD	100	83	0	0	250	2	26	108	1.20E-41	169.9	RS12_NOVAD	reviewed	30S ribosomal protein S12	rpsL Saro_1244	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	123	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17927_c0_g1_i1	B2IK57	RS12_BEII9	100	86	0	0	1	258	28	113	3.60E-44	178.3	RS12_BEII9	reviewed	30S ribosomal protein S12	rpsL Bind_1349	Beijerinckia indica subsp. indica (strain ATCC 9039 / DSM 1715 / NCIB 8712)	123	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17927_c0_g1_i2	Q8KNX8	RS12_BARHE	100	70	0	0	1	210	28	97	4.20E-35	147.9	RS12_BARHE	reviewed	30S ribosomal protein S12	rpsL BH10560	Bartonella henselae (strain ATCC 49882 / DSM 28221 / Houston 1) (Rochalimaea henselae)	123	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; response to antibiotic [GO:0046677]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843; GO:0046677	response to antibiotic [GO:0046677]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23125_c0_g2_i1	Q8IV48	ERI1_HUMAN	54.3	81	36	1	69	308	128	208	2.50E-16	86.3	ERI1_HUMAN	reviewed	3'-5' exoribonuclease 1 (EC 3.1.-.-) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-end-specific exoribonuclease) (Histone mRNA 3'-exonuclease 1) (Protein 3'hExo) (HEXO)	ERI1 3'EXO THEX1	Homo sapiens (Human)	349	"cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]	GO:0000175; GO:0000467; GO:0000738; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006259; GO:0006364; GO:0008408; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10639_c0_g1_i1	B2RR83	YTDC2_MOUSE	41.2	136	75	3	103	507	1304	1435	5.00E-25	115.9	YTDC2_MOUSE	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2)	Ythdc2	Mus musculus (Mouse)	1445	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10334_c0_g1_i1	B2RR83	YTDC2_MOUSE	51.8	338	157	2	1023	19	874	1208	2.80E-92	340.1	YTDC2_MOUSE	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2)	Ythdc2	Mus musculus (Mouse)	1445	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10334_c0_g1_i2	B2RR83	YTDC2_MOUSE	51.8	338	157	2	1023	19	874	1208	2.80E-92	340.1	YTDC2_MOUSE	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2)	Ythdc2	Mus musculus (Mouse)	1445	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10334_c0_g1_i3	B2RR83	YTDC2_MOUSE	63.4	101	37	0	343	41	874	974	1.40E-32	140.2	YTDC2_MOUSE	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2)	Ythdc2	Mus musculus (Mouse)	1445	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32796_c0_g1_i1	Q9H6S0	YTDC2_HUMAN	100	98	0	0	3	296	706	803	1.00E-50	200.3	YTDC2_HUMAN	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2)	YTHDC2	Homo sapiens (Human)	1430	"endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18025_c0_g1_i1	Q9H6S0	YTDC2_HUMAN	65.6	96	33	0	289	2	199	294	5.50E-33	141.4	YTDC2_HUMAN	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2)	YTHDC2	Homo sapiens (Human)	1430	"endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15880_c0_g1_i1	Q9H6S0	YTDC2_HUMAN	66.9	160	53	0	482	3	669	828	1.40E-57	223.8	YTDC2_HUMAN	reviewed	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2)	YTHDC2	Homo sapiens (Human)	1430	"endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0005524; GO:0005634; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35972_c0_g1_i1	B2VG45	TATD_ERWT9	38.7	279	149	2	931	95	3	259	1.80E-56	221.1	TATD_ERWT9	reviewed	3'-5' ssDNA/RNA exonuclease TatD (EC 3.1.11.-) (EC 3.1.13.-) (DNase TatD)	tatD ETA_02410	Erwinia tasmaniensis (strain DSM 17950 / CIP 109463 / Et1/99)	259	"cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]"	cytoplasm [GO:0005737]	"3'-5'-exoribonuclease activity [GO:0000175]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]"	GO:0000175; GO:0000287; GO:0005737; GO:0008310; GO:0016888			NA	NA	NA	NA	NA	NA
TRINITY_DN795_c0_g1_i1	P52815	RM12_HUMAN	43.1	153	86	1	155	610	46	198	5.90E-25	115.9	RM12_HUMAN	reviewed	"39S ribosomal protein L12, mitochondrial (L12mt) (MRP-L12) (5c5-2) (Mitochondrial large ribosomal subunit protein bL12m)"	MRPL12 MRPL7 RPML12	Homo sapiens (Human)	198	"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; positive regulation of transcription, DNA-templated [GO:0045893]"	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006390; GO:0045893; GO:0070125; GO:0070126	"mitochondrial transcription [GO:0006390]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; positive regulation of transcription, DNA-templated [GO:0045893]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4388_c0_g1_i1	Q9VJ38	RM13_DROME	61.6	177	68	0	630	100	1	177	3.00E-66	253.1	RM13_DROME	reviewed	"39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13)"	mRpL13 CG10603	Drosophila melanogaster (Fruit fly)	178	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005739; GO:0005762; GO:0005840; GO:0006412; GO:0017148; GO:0032543	mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN33920_c0_g1_i1	Q9BYD1	RM13_HUMAN	100	78	0	0	235	2	87	164	3.50E-38	158.3	RM13_HUMAN	reviewed	"39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13) (Mitochondrial large ribosomal subunit protein uL13m)"	MRPL13	Homo sapiens (Human)	178	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003729; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005840; GO:0006412; GO:0017148; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5543_c0_g1_i1	Q7M0E7	RM14_RAT	51.1	131	54	2	470	78	25	145	2.70E-32	140.2	RM14_RAT	reviewed	"39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14) (39S ribosomal protein L32, mitochondrial) (L32mt) (MRP-L32)"	Mrpl14 Rpml32	Rattus norvegicus (Rat)	145	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN29212_c0_g1_i1	Q6P1L8	RM14_HUMAN	100	99	0	0	302	6	47	145	1.30E-53	209.9	RM14_HUMAN	reviewed	"39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14) (39S ribosomal protein L32, mitochondrial) (L32mt) (MRP-L32) (Mitochondrial large ribosomal subunit protein uL14m)"	MRPL14 MRPL32 RPML32	Homo sapiens (Human)	145	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN21341_c0_g2_i1	Q9CPR5	RM15_MOUSE	100	113	0	0	359	21	183	295	2.40E-62	239.2	RM15_MOUSE	reviewed	"39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15)"	Mrpl15	Mus musculus (Mouse)	295	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial genome maintenance [GO:0000002]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0000002; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial genome maintenance [GO:0000002]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5061_c0_g1_i1	Q6AZN4	RM15_XENLA	50.3	294	144	2	965	90	3	296	6.80E-80	298.9	RM15_XENLA	reviewed	"39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15)"	mrpl15	Xenopus laevis (African clawed frog)	296	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN5061_c0_g1_i2	Q6AZN4	RM15_XENLA	50	258	129	0	863	90	39	296	3.10E-72	273.5	RM15_XENLA	reviewed	"39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15)"	mrpl15	Xenopus laevis (African clawed frog)	296	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21341_c0_g1_i1	Q9P015	RM15_HUMAN	100	160	0	0	483	4	135	294	4.80E-90	331.6	RM15_HUMAN	reviewed	"39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15) (Mitochondrial large ribosomal subunit protein uL15m)"	MRPL15 HSPC145	Homo sapiens (Human)	296	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1580_c0_g2_i1	Q99N93	RM16_MOUSE	45.4	218	115	2	165	818	28	241	8.60E-48	192.2	RM16_MOUSE	reviewed	"39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16)"	Mrpl16	Mus musculus (Mouse)	251	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0019843; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN28083_c0_g1_i1	Q9NX20	RM16_HUMAN	98.9	91	1	0	273	1	107	197	4.30E-48	191.4	RM16_HUMAN	reviewed	"39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16) (Mitochondrial large ribosomal subunit protein uL16m)"	MRPL16 PNAS-111	Homo sapiens (Human)	251	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019843; GO:0032543; GO:0070125; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN35277_c0_g1_i1	Q9D8P4	RM17_MOUSE	100	75	0	0	3	227	52	126	4.40E-38	157.9	RM17_MOUSE	reviewed	"39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17)"	Mrpl17	Mus musculus (Mouse)	176	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial genome maintenance [GO:0000002]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]	GO:0000002; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0019904	mitochondrial genome maintenance [GO:0000002]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN33067_c0_g1_i1	Q9NRX2	RM17_HUMAN	45.7	138	70	4	169	576	21	155	6.20E-22	105.9	RM17_HUMAN	reviewed	"39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17) (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m)"	MRPL17 LIP2	Homo sapiens (Human)	175	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0015934; GO:0019904; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		blue	blue	NA	NA	NA	NA
TRINITY_DN226_c3_g1_i1	Q9VHN6	RM19_DROME	62.5	240	88	1	820	107	58	297	9.50E-83	308.5	RM19_DROME	reviewed	"39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19)"	mRpL19 CG8039	Drosophila melanogaster (Fruit fly)	306	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN6523_c0_g1_i1	Q498T4	RM02_RAT	54.2	227	100	2	774	103	69	294	4.60E-64	246.5	RM02_RAT	reviewed	"39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2)"	Mrpl2	Rattus norvegicus (Rat)	304	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN6249_c0_g1_i1	Q5U4Z8	RM20_XENLA	36.1	144	90	1	13	438	1	144	1.20E-22	107.8	RM20_XENLA	reviewed	"39S ribosomal protein L20, mitochondrial (L20mt) (MRP-L20)"	mrpl20	Xenopus laevis (African clawed frog)	149	mitochondrial large ribosomal subunit [GO:0005762]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0006412; GO:0019843	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN6249_c0_g1_i2	Q9CQL4	RM20_MOUSE	38.7	119	71	1	57	407	26	144	7.10E-17	88.6	RM20_MOUSE	reviewed	"39S ribosomal protein L20, mitochondrial (L20mt) (MRP-L20)"	Mrpl20	Mus musculus (Mouse)	149	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003735; GO:0005739; GO:0005761; GO:0005762; GO:0006412; GO:0019843	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN2113_c0_g1_i1	Q29IK4	RM22_DROPS	56.4	149	58	2	428	3	44	192	3.70E-44	179.1	RM22_DROPS	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	mRpL22 GA18397	Drosophila pseudoobscura pseudoobscura (Fruit fly)	233	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2113_c0_g1_i10	Q29IK4	RM22_DROPS	55.7	149	59	2	428	3	44	192	6.20E-44	178.3	RM22_DROPS	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	mRpL22 GA18397	Drosophila pseudoobscura pseudoobscura (Fruit fly)	233	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2113_c0_g1_i13	Q29IK4	RM22_DROPS	51.3	117	50	2	409	80	44	160	7.80E-28	124.8	RM22_DROPS	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	mRpL22 GA18397	Drosophila pseudoobscura pseudoobscura (Fruit fly)	233	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2113_c0_g1_i15	Q29IK4	RM22_DROPS	55.7	149	59	2	428	3	44	192	6.20E-44	178.3	RM22_DROPS	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	mRpL22 GA18397	Drosophila pseudoobscura pseudoobscura (Fruit fly)	233	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2113_c0_g1_i16	Q29IK4	RM22_DROPS	55.7	149	59	2	428	3	44	192	6.20E-44	178.3	RM22_DROPS	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	mRpL22 GA18397	Drosophila pseudoobscura pseudoobscura (Fruit fly)	233	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2113_c0_g1_i3	Q29IK4	RM22_DROPS	50.4	117	51	2	409	80	44	160	1.70E-27	123.6	RM22_DROPS	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	mRpL22 GA18397	Drosophila pseudoobscura pseudoobscura (Fruit fly)	233	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40742_c0_g1_i1	Q9NWU5	RM22_HUMAN	100	91	0	0	2	274	46	136	1.40E-46	186.4	RM22_HUMAN	reviewed	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22) (39S ribosomal protein L25, mitochondrial) (L25mt) (MRP-L25) (Mitochondrial large ribosomal subunit protein uL22m)"	MRPL22 MRPL25 RPML25 HSPC158	Homo sapiens (Human)	206	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosome assembly [GO:0042255]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0015934; GO:0042255; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN21014_c0_g1_i1	O35972	RM23_MOUSE	98.8	85	1	0	3	257	5	89	7.50E-42	170.6	RM23_MOUSE	reviewed	"39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23) (L23 mitochondrial-related protein)"	Mrpl23 L23mrp	Mus musculus (Mouse)	146	fibrillar center [GO:0001650]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	fibrillar center [GO:0001650]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0001650; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21014_c0_g1_i2	Q16540	RM23_HUMAN	97.5	80	2	0	3	242	5	84	1.50E-39	162.9	RM23_HUMAN	reviewed	"39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23) (L23 mitochondrial-related protein) (Mitochondrial large ribosomal subunit protein uL23m) (Ribosomal protein L23-like)"	MRPL23 L23MRP RPL23L	Homo sapiens (Human)	153	fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0001650; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543; GO:0070125; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN7532_c0_g1_i2	Q9VMX0	RM28_DROME	39.4	292	151	6	897	97	11	301	1.50E-50	201.4	RM28_DROME	reviewed	"39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28)"	mRpL28 CG3782	Drosophila melanogaster (Fruit fly)	302	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN7532_c0_g1_i4	Q9VMX0	RM28_DROME	39.4	292	151	6	897	97	11	301	1.80E-50	201.4	RM28_DROME	reviewed	"39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28)"	mRpL28 CG3782	Drosophila melanogaster (Fruit fly)	302	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN33084_c0_g1_i1	Q13084	RM28_HUMAN	100	71	0	0	2	214	98	168	1.60E-34	146	RM28_HUMAN	reviewed	"39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28) (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes) (Mitochondrial large ribosomal subunit protein bL28m)"	MRPL28 MAAT1	Homo sapiens (Human)	256	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005829; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4541_c6_g1_i1	Q3ZBX6	RM03_BOVIN	46.2	312	148	6	233	1141	47	347	1.00E-71	272.3	RM03_BOVIN	reviewed	"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3)"	MRPL3	Bos taurus (Bovine)	348	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN25772_c0_g1_i1	P09001	RM03_HUMAN	100	133	0	0	399	1	181	313	2.90E-77	288.9	RM03_HUMAN	reviewed	"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3) (Mitochondrial large ribosomal subunit protein uL3m)"	MRPL3 MRL3 RPML3	Homo sapiens (Human)	348	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1163_c0_g2_i1	Q9V9Z1	RM32_DROME	42	174	97	3	700	182	25	195	6.70E-26	119.4	RM32_DROME	reviewed	"39S ribosomal protein L32, mitochondrial (L32mt) (MRP-L32)"	mRpL32 CG12220	Drosophila melanogaster (Fruit fly)	195	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN15183_c0_g1_i1	Q8MS27	RM35_DROME	55.3	114	46	2	353	688	61	171	2.80E-26	120.6	RM35_DROME	reviewed	"39S ribosomal protein L35, mitochondrial (L35mt) (MRP-L35)"	mRpL35 CG13410	Drosophila melanogaster (Fruit fly)	178	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN1198_c0_g1_i1	Q9VUJ0	RM39_DROME	57	86	36	1	260	6	62	147	1.30E-22	106.7	RM39_DROME	reviewed	"39S ribosomal protein L39, mitochondrial (MRP-L39) (MRP-L5)"	mRpL39 mRpL5 CG17166	Drosophila melanogaster (Fruit fly)	333	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]	GO:0000166; GO:0003735; GO:0005739; GO:0005762; GO:0006417; GO:0031047; GO:0032543	gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1198_c0_g1_i2	Q9VUJ0	RM39_DROME	57	86	36	1	260	6	62	147	1.30E-22	106.7	RM39_DROME	reviewed	"39S ribosomal protein L39, mitochondrial (MRP-L39) (MRP-L5)"	mRpL39 mRpL5 CG17166	Drosophila melanogaster (Fruit fly)	333	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]	GO:0000166; GO:0003735; GO:0005739; GO:0005762; GO:0006417; GO:0031047; GO:0032543	gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]		blue	blue	NA	NA	NA	NA
TRINITY_DN39255_c0_g1_i1	Q32PI6	RM04_BOVIN	54.1	220	99	2	229	885	61	279	1.30E-64	248.1	RM04_BOVIN	reviewed	"39S ribosomal protein L4, mitochondrial (L4mt) (MRP-L4)"	MRPL4	Bos taurus (Bovine)	294	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN39607_c0_g1_i1	Q9BYD3	RM04_HUMAN	99.3	135	1	0	406	2	92	226	1.40E-74	280	RM04_HUMAN	reviewed	"39S ribosomal protein L4, mitochondrial (L4mt) (MRP-L4) (Mitochondrial large ribosomal subunit protein uL4m)"	MRPL4 CDABP0091 CGI-28	Homo sapiens (Human)	311	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN10006_c0_g1_i1	Q9Z2Q5	RM40_MOUSE	36.9	157	93	2	206	676	47	197	8.30E-20	99	RM40_MOUSE	reviewed	"39S ribosomal protein L40, mitochondrial (L40mt) (MRP-L40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome homolog)"	Mrpl40 Nlvcf	Mus musculus (Mouse)	206	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]		GO:0005730; GO:0005739; GO:0005761; GO:0005762			blue	blue	NA	NA	NA	NA
TRINITY_DN14869_c0_g1_i1	Q7JZM8	RM41_DROME	49.6	135	67	1	1	405	31	164	3.70E-29	129.4	RM41_DROME	reviewed	"39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41)"	mRpL41 CG12954	Drosophila melanogaster (Fruit fly)	166	mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0006412; GO:0032543; GO:1990904	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN2986_c0_g1_i2	P82927	RM42_BOVIN	37.1	97	50	3	355	89	49	142	8.70E-10	65.1	RM42_BOVIN	reviewed	"39S ribosomal protein L42, mitochondrial (L42mt) (MRP-L42) (28S ribosomal protein S32, mitochondrial) (MRP-S32) (S32mt)"	MRPL42 MRPS32	Bos taurus (Bovine)	142	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]		GO:0005743; GO:0005762			blue	blue	NA	NA	NA	NA
TRINITY_DN2986_c0_g1_i4	Q9Y6G3	RM42_HUMAN	37.5	80	41	3	270	49	49	125	2.60E-07	56.6	RM42_HUMAN	reviewed	"39S ribosomal protein L42, mitochondrial (L42mt) (MRP-L42) (39S ribosomal protein L31, mitochondrial) (L31mt) (MRP-L31) (Mitochondrial large ribosomal subunit protein mL42)"	MRPL42 MRPL31 MRPS32 RPML31 HSPC204 PTD007	Homo sapiens (Human)	142	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0005886; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN37638_c0_g1_i1	Q8N983	RM43_HUMAN	100	114	0	0	345	4	20	133	5.70E-61	234.6	RM43_HUMAN	reviewed	"39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Mitochondrial large ribosomal subunit protein mL43) (Mitochondrial ribosomal protein bMRP36a)"	MRPL43	Homo sapiens (Human)	215	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN441_c7_g1_i1	Q95KE5	RM43_BOVIN	44.4	151	83	1	592	140	8	157	1.40E-27	124.8	RM43_BOVIN	reviewed	"39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Retina-specific 15.7 kDa protein)"	MRPL43	Bos taurus (Bovine)	159	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN5621_c0_g1_i1	Q08DT6	RM47_BOVIN	44.2	206	105	4	211	819	45	243	1.10E-35	152.1	RM47_BOVIN	reviewed	"39S ribosomal protein L47, mitochondrial (L47mt) (MRP-L47)"	MRPL47	Bos taurus (Bovine)	252	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN30789_c0_g1_i1	Q9HD33	RM47_HUMAN	94.1	118	7	0	2	355	40	157	7.90E-58	224.2	RM47_HUMAN	reviewed	"39S ribosomal protein L47, mitochondrial (L47mt) (MRP-L47) (Mitochondrial large ribosomal subunit protein uL29m) (Nasopharyngeal carcinoma metastasis-related protein 1)"	MRPL47 NCM1 CGI-204	Homo sapiens (Human)	250	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543; GO:0070125; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN5970_c0_g1_i1	Q2KI49	RM50_BOVIN	28.6	105	70	2	540	238	56	159	3.40E-05	50.4	RM50_BOVIN	reviewed	"39S ribosomal protein L50, mitochondrial (L50mt) (MRP-L50)"	MRPL50	Bos taurus (Bovine)	159	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]		GO:0005743; GO:0005762			blue	blue	NA	NA	NA	NA
TRINITY_DN1196_c0_g2_i1	Q9VLJ9	RM51_DROME	52.1	165	76	2	668	177	6	168	2.90E-41	170.2	RM51_DROME	reviewed	"39S ribosomal protein L51, mitochondrial (L51mt) (MRP-L51)"	mRpL51 CG13098	Drosophila melanogaster (Fruit fly)	174	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005761; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN4140_c0_g1_i1	Q7JWG9	RM52_DROME	41.2	119	66	1	445	89	12	126	9.80E-13	75.1	RM52_DROME	reviewed	"39S ribosomal protein L52, mitochondrial (L52mt) (MRP-L52)"	mRpL52 CG1577	Drosophila melanogaster (Fruit fly)	126	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN41060_c0_g1_i1	Q6P161	RM54_HUMAN	100	67	0	0	1	201	64	130	1.80E-35	149.1	RM54_HUMAN	reviewed	"39S ribosomal protein L54, mitochondrial (L54mt) (MRP-L54) (Mitochondrial large ribosomal subunit protein mL54)"	MRPL54	Homo sapiens (Human)	138	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN8112_c0_g1_i1	Q6P161	RM54_HUMAN	42.5	120	64	4	151	504	21	137	1.60E-13	77.8	RM54_HUMAN	reviewed	"39S ribosomal protein L54, mitochondrial (L54mt) (MRP-L54) (Mitochondrial large ribosomal subunit protein mL54)"	MRPL54	Homo sapiens (Human)	138	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		blue	blue	NA	NA	NA	NA
TRINITY_DN2486_c0_g1_i1	Q9VF89	RM09_DROME	45.3	223	119	2	826	158	19	238	5.60E-48	193	RM09_DROME	reviewed	"39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9)"	mRpL9 CG4923	Drosophila melanogaster (Fruit fly)	248	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2486_c0_g1_i2	Q9VF89	RM09_DROME	44.5	218	118	2	811	158	24	238	2.00E-46	187.6	RM09_DROME	reviewed	"39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9)"	mRpL9 CG4923	Drosophila melanogaster (Fruit fly)	248	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN39738_c0_g1_i1	Q2RNK3	COQ7_RHORT	57.7	78	33	0	20	253	82	159	2.00E-18	92.8	COQ7_RHORT	reviewed	"3-demethoxyubiquinol 3-hydroxylase (DMQ hydroxylase) (EC 1.14.99.60) (2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase)"	coq7 Rru_A3498	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	212	plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; ubiquinone biosynthetic process [GO:0006744]	plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]	GO:0004497; GO:0005886; GO:0006744; GO:0046872	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN37609_c0_g1_i1	Q2RNK3	COQ7_RHORT	54.3	129	57	1	387	7	38	166	5.20E-29	128.6	COQ7_RHORT	reviewed	"3-demethoxyubiquinol 3-hydroxylase (DMQ hydroxylase) (EC 1.14.99.60) (2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase)"	coq7 Rru_A3498	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	212	plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; ubiquinone biosynthetic process [GO:0006744]	plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]	GO:0004497; GO:0005886; GO:0006744; GO:0046872	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN30671_c0_g1_i4	A8WG57	HMGC2_DANRE	65.5	220	72	1	31	678	113	332	1.80E-80	300.4	HMGC2_DANRE	reviewed	"3-hydroxy-3-methylglutaryl-CoA lyase, cytoplasmic (EC 4.1.3.4) (3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1)"	hmgcll1 zgc:172206	Danio rerio (Zebrafish) (Brachydanio rerio)	335	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]	GO:0004419; GO:0005783; GO:0005789; GO:0005829; GO:0006552; GO:0006629; GO:0016020; GO:0046872; GO:0046951; GO:0048471	ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN32681_c0_g1_i1	Q01237	HMDH_MOUSE	46.7	557	237	12	1793	258	158	699	2.90E-124	447.2	HMDH_MOUSE	reviewed	3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	Hmgcr	Mus musculus (Mouse)	887	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; bile acid signaling pathway [GO:0038183]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to cholesterol [GO:0070723]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; triglyceride homeostasis [GO:0070328]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]	coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein phosphatase 2A binding [GO:0051721]	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008284; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0016126; GO:0032874; GO:0038183; GO:0042177; GO:0042282; GO:0042632; GO:0042802; GO:0043066; GO:0043231; GO:0043407; GO:0045445; GO:0045471; GO:0048643; GO:0048661; GO:0050709; GO:0051721; GO:0061045; GO:0061179; GO:0070328; GO:0070374; GO:0070402; GO:0070723; GO:0097756; GO:0120225; GO:1900222	aging [GO:0007568]; bile acid signaling pathway [GO:0038183]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to cholesterol [GO:0070723]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; triglyceride homeostasis [GO:0070328]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN32681_c0_g1_i1	Q01237	HMDH_MOUSE	64.8	88	31	0	264	1	766	853	2.00E-24	115.5	HMDH_MOUSE	reviewed	3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	Hmgcr	Mus musculus (Mouse)	887	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; bile acid signaling pathway [GO:0038183]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to cholesterol [GO:0070723]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; triglyceride homeostasis [GO:0070328]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]	coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein phosphatase 2A binding [GO:0051721]	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008284; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0016126; GO:0032874; GO:0038183; GO:0042177; GO:0042282; GO:0042632; GO:0042802; GO:0043066; GO:0043231; GO:0043407; GO:0045445; GO:0045471; GO:0048643; GO:0048661; GO:0050709; GO:0051721; GO:0061045; GO:0061179; GO:0070328; GO:0070374; GO:0070402; GO:0070723; GO:0097756; GO:0120225; GO:1900222	aging [GO:0007568]; bile acid signaling pathway [GO:0038183]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to cholesterol [GO:0070723]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; triglyceride homeostasis [GO:0070328]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN32681_c0_g1_i2	Q01237	HMDH_MOUSE	51.5	710	284	12	1998	4	158	852	1.20E-184	647.9	HMDH_MOUSE	reviewed	3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	Hmgcr	Mus musculus (Mouse)	887	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; bile acid signaling pathway [GO:0038183]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to cholesterol [GO:0070723]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; triglyceride homeostasis [GO:0070328]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]	coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein phosphatase 2A binding [GO:0051721]	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008284; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0016126; GO:0032874; GO:0038183; GO:0042177; GO:0042282; GO:0042632; GO:0042802; GO:0043066; GO:0043231; GO:0043407; GO:0045445; GO:0045471; GO:0048643; GO:0048661; GO:0050709; GO:0051721; GO:0061045; GO:0061179; GO:0070328; GO:0070374; GO:0070402; GO:0070723; GO:0097756; GO:0120225; GO:1900222	aging [GO:0007568]; bile acid signaling pathway [GO:0038183]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to cholesterol [GO:0070723]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; triglyceride homeostasis [GO:0070328]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN36419_c0_g1_i1	A7Z064	HMDH_BOVIN	98.5	132	2	0	3	398	685	816	1.10E-68	260.4	HMDH_BOVIN	reviewed	3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	HMGCR	Bos taurus (Bovine)	888	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; NADPH binding [GO:0070402]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; NADPH binding [GO:0070402]	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0008299; GO:0008542; GO:0015936; GO:0016021; GO:0016126; GO:0042177; GO:0042282; GO:0043407; GO:0050709; GO:0070402; GO:0120225; GO:1900222	cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN3860_c0_g1_i2	Q8JZV9	BDH2_MOUSE	55.9	245	106	2	824	93	2	245	1.90E-68	260.8	BDH2_MOUSE	reviewed	3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (R-beta-hydroxybutyrate dehydrogenase)	Bdh2 Dhrs6	Mus musculus (Mouse)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016616; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0051287; GO:0055072	epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]		NA	NA	NA	NA	NA	1
TRINITY_DN3860_c0_g1_i4	Q8JZV9	BDH2_MOUSE	55	120	52	2	669	313	2	120	4.40E-26	119.8	BDH2_MOUSE	reviewed	3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (R-beta-hydroxybutyrate dehydrogenase)	Bdh2 Dhrs6	Mus musculus (Mouse)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016616; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0051287; GO:0055072	epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3860_c0_g1_i4	Q8JZV9	BDH2_MOUSE	50	74	37	0	314	93	172	245	4.30E-13	76.6	BDH2_MOUSE	reviewed	3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (R-beta-hydroxybutyrate dehydrogenase)	Bdh2 Dhrs6	Mus musculus (Mouse)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016616; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0051287; GO:0055072	epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3860_c0_g1_i3	Q3KPT7	BDH2_XENLA	61.2	49	19	0	239	93	197	245	1.20E-10	67	BDH2_XENLA	reviewed	3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase)	bdh2	Xenopus laevis (African clawed frog)	245	"cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]"	cytoplasm [GO:0005737]	"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]"	GO:0003858; GO:0005737; GO:0016628; GO:0019290; GO:0042168; GO:0055072	heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3860_c0_g1_i5	Q3KPT7	BDH2_XENLA	47.7	88	46	0	356	93	158	245	6.40E-16	85.1	BDH2_XENLA	reviewed	3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase)	bdh2	Xenopus laevis (African clawed frog)	245	"cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]"	cytoplasm [GO:0005737]	"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]"	GO:0003858; GO:0005737; GO:0016628; GO:0019290; GO:0042168; GO:0055072	heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]		NA	NA	NA	NA	NA	NA
TRINITY_DN37838_c0_g1_i1	Q45223	HBD_BRADU	56.8	139	60	0	419	3	97	235	1.10E-39	164.1	HBD_BRADU	reviewed	3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) (Beta-hydroxybutyryl-CoA dehydrogenase) (BHBD)	hbdA blr1379	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	293	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]; butyrate metabolic process [GO:0019605]		3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]	GO:0003857; GO:0008691; GO:0019605; GO:0070403	butyrate metabolic process [GO:0019605]		NA	NA	NA	NA	NA	NA
TRINITY_DN11509_c0_g1_i1	P52041	HBD_CLOAB	58.8	80	33	0	292	53	79	158	7.70E-22	104.4	HBD_CLOAB	reviewed	3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) (Beta-hydroxybutyryl-CoA dehydrogenase) (BHBD)	hbd CA_C2708	Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787)	282	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]; butyrate metabolic process [GO:0019605]		3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]	GO:0003857; GO:0008691; GO:0019605; GO:0070403	butyrate metabolic process [GO:0019605]		NA	NA	NA	NA	NA	NA
TRINITY_DN26623_c0_g1_i1	Q45223	HBD_BRADU	56.6	143	61	1	7	435	97	238	8.50E-38	157.9	HBD_BRADU	reviewed	3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) (Beta-hydroxybutyryl-CoA dehydrogenase) (BHBD)	hbdA blr1379	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	293	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]; butyrate metabolic process [GO:0019605]		3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]	GO:0003857; GO:0008691; GO:0019605; GO:0070403	butyrate metabolic process [GO:0019605]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g2_i1	P31937	3HIDH_HUMAN	70.7	58	17	0	277	104	275	332	5.10E-17	88.6	3HIDH_HUMAN	reviewed	"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	HIBADH	Homo sapiens (Human)	336	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0009083; GO:0016616; GO:0050661; GO:0051287	branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g2_i2	P31937	3HIDH_HUMAN	63.5	293	107	0	982	104	40	332	8.80E-106	385.2	3HIDH_HUMAN	reviewed	"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	HIBADH	Homo sapiens (Human)	336	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0009083; GO:0016616; GO:0050661; GO:0051287	branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g2_i4	P31937	3HIDH_HUMAN	62.6	270	101	0	928	119	40	309	5.10E-95	349.4	3HIDH_HUMAN	reviewed	"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	HIBADH	Homo sapiens (Human)	336	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0009083; GO:0016616; GO:0050661; GO:0051287	branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN37448_c0_g1_i1	Q99L13	3HIDH_MOUSE	100	88	0	0	267	4	98	185	2.50E-40	165.6	3HIDH_MOUSE	reviewed	"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	Hibadh	Mus musculus (Mouse)	335	"mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574]"	mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN21025_c0_g1_i1	P31937	3HIDH_HUMAN	99.1	112	1	0	338	3	223	334	2.00E-58	226.1	3HIDH_HUMAN	reviewed	"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	HIBADH	Homo sapiens (Human)	336	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0009083; GO:0016616; GO:0050661; GO:0051287	branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN21025_c0_g2_i1	Q99L13	3HIDH_MOUSE	98.9	87	1	0	263	3	247	333	7.40E-45	180.6	3HIDH_MOUSE	reviewed	"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	Hibadh	Mus musculus (Mouse)	335	"mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574]"	mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN65_c0_g1_i1	Q58EB4	HIBCH_DANRE	54.9	355	158	1	1328	270	21	375	9.90E-107	388.7	HIBCH_DANRE	reviewed	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)"	hibch zgc:110824	Danio rerio (Zebrafish) (Brachydanio rerio)	382	mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]	GO:0003860; GO:0005739; GO:0006574	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN65_c0_g1_i2	Q58EB4	HIBCH_DANRE	54.9	355	158	1	1328	270	21	375	1.00E-106	388.7	HIBCH_DANRE	reviewed	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)"	hibch zgc:110824	Danio rerio (Zebrafish) (Brachydanio rerio)	382	mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]	GO:0003860; GO:0005739; GO:0006574	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN37880_c0_g1_i1	Q28FR6	HIBCH_XENTR	56.6	83	36	0	252	4	133	215	6.00E-20	97.8	HIBCH_XENTR	reviewed	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)"	hibch TGas039e14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	385	mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]	GO:0003860; GO:0005739; GO:0006574	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN32952_c0_g1_i1	Q28FR6	HIBCH_XENTR	64.1	78	28	0	237	4	121	198	2.20E-24	112.5	HIBCH_XENTR	reviewed	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)"	hibch TGas039e14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	385	mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]	GO:0003860; GO:0005739; GO:0006574	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN10281_c0_g1_i2	A4YI89	HPCD_METS5	34.5	197	127	2	214	798	4	200	2.90E-28	127.5	HPCD_METS5	reviewed	3-hydroxypropionyl-coenzyme A dehydratase (3-hydroxypropionyl-CoA dehydratase) (EC 4.2.1.116)	Msed_2001	Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2)	259	3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; fatty acid metabolic process [GO:0006631]		3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]	GO:0006631; GO:0043956	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN41116_c0_g1_i1	Q8LF48	THIK1_ARATH	54.9	82	35	1	3	242	342	423	4.20E-18	91.7	THIK1_ARATH	reviewed	"3-ketoacyl-CoA thiolase 1, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase 1) (Beta-ketothiolase 1) (Peroxisomal 3-oxoacyl-CoA thiolase 1)"	KAT1 At1g04710 T1G11.4	Arabidopsis thaliana (Mouse-ear cress)	443	peroxisome [GO:0005777]; vacuole [GO:0005773]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]; oxylipin biosynthetic process [GO:0031408]; phenylacetate catabolic process [GO:0010124]	peroxisome [GO:0005777]; vacuole [GO:0005773]	acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003988; GO:0005773; GO:0005777; GO:0006635; GO:0010124; GO:0031408	fatty acid beta-oxidation [GO:0006635]; oxylipin biosynthetic process [GO:0031408]; phenylacetate catabolic process [GO:0010124]		NA	NA	NA	NA	NA	1
TRINITY_DN30727_c0_g1_i1	P21775	THIKA_RAT	58.9	112	45	1	334	2	297	408	2.50E-29	129.4	THIKA_RAT	reviewed	"3-ketoacyl-CoA thiolase A, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase A) (Beta-ketothiolase A) (Peroxisomal 3-oxoacyl-CoA thiolase A)"	Acaa1a	Rattus norvegicus (Rat)	424	cytosol [GO:0005829]; peroxisome [GO:0005777]; acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; palmitoyl-CoA oxidase activity [GO:0016401]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000038; GO:0003988; GO:0005777; GO:0005829; GO:0006635; GO:0007584; GO:0008206; GO:0008775; GO:0010124; GO:0016401; GO:0042493; GO:0048545; GO:0050633	bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN32455_c0_g1_i1	P42765	THIM_HUMAN	100	96	0	0	1	288	291	386	1.00E-47	190.3	THIM_HUMAN	reviewed	"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)"	ACAA2	Homo sapiens (Human)	397	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]	GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109	cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]		NA	NA	NA	NA	NA	NA
TRINITY_DN25702_c0_g1_i1	Q3T0R7	THIM_BOVIN	69.6	161	49	0	493	11	234	394	1.30E-58	227.3	THIM_BOVIN	reviewed	"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)"	ACAA2	Bos taurus (Bovine)	397	mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029	fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]		NA	NA	NA	NA	NA	NA
TRINITY_DN31468_c0_g1_i1	Q8BWT1	THIM_MOUSE	63.2	68	25	0	5	208	139	206	7.20E-19	94	THIM_MOUSE	reviewed	"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)"	Acaa2	Mus musculus (Mouse)	397	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acetyl-CoA metabolic process [GO:0006084]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006084; GO:0006635; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109	acetyl-CoA metabolic process [GO:0006084]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]		NA	NA	NA	NA	NA	NA
TRINITY_DN36070_c0_g1_i1	P09110	THIK_HUMAN	100	90	0	0	272	3	310	399	2.60E-45	182.2	THIK_HUMAN	reviewed	"3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase)"	ACAA1 ACAA PTHIO	Homo sapiens (Human)	424	cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; specific granule lumen [GO:0035580]; acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; palmitoyl-CoA oxidase activity [GO:0016401]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; neutrophil degranulation [GO:0043312]; phenylacetate catabolic process [GO:0010124]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; specific granule lumen [GO:0035580]	acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000038; GO:0003988; GO:0005576; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0008206; GO:0008775; GO:0010124; GO:0016020; GO:0016401; GO:0033540; GO:0035580; GO:0036109; GO:0043231; GO:0043312; GO:0050633	alpha-linolenic acid metabolic process [GO:0036109]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; neutrophil degranulation [GO:0043312]; phenylacetate catabolic process [GO:0010124]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN38552_c0_g1_i1	Q6GV12	KDSR_MOUSE	46.9	337	173	3	71	1081	1	331	7.50E-73	275.8	KDSR_MOUSE	reviewed	3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1)	Kdsr Fvt1	Mus musculus (Mouse)	332	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	3-dehydrosphinganine reductase activity [GO:0047560]	GO:0005783; GO:0005789; GO:0006666; GO:0016021; GO:0030148; GO:0047560	3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]		blue	blue	NA	NA	NA	NA
TRINITY_DN35390_c0_g1_i1	Q06136	KDSR_HUMAN	100	94	0	0	282	1	179	272	1.70E-47	189.5	KDSR_HUMAN	reviewed	3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)	KDSR FVT1 SDR35C1	Homo sapiens (Human)	332	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	3-dehydrosphinganine reductase activity [GO:0047560]	GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560	3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN31717_c0_g1_i1	Q06136	KDSR_HUMAN	47.4	95	46	1	301	29	150	244	2.20E-16	86.3	KDSR_HUMAN	reviewed	3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)	KDSR FVT1 SDR35C1	Homo sapiens (Human)	332	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	3-dehydrosphinganine reductase activity [GO:0047560]	GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560	3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN5187_c0_g1_i1	Q9KQH7	FABG_VIBCH	37.2	253	148	4	787	29	2	243	1.20E-35	151.8	FABG_VIBCH	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG VC_2021	Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)	244	"3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]"		"3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0004316; GO:0006633; GO:0016616; GO:0030497; GO:0050661; GO:0051287; GO:0055114; GO:0102131; GO:0102132	fatty acid biosynthetic process [GO:0006633]; fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN5187_c0_g1_i4	Q9X248	FABG_THEMA	36.6	254	145	5	796	38	5	243	3.90E-34	146.7	FABG_THEMA	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG TM_1724	Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)	246	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]		3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	fatty acid elongation [GO:0030497]		NA	NA	NA	NA	NA	NA
TRINITY_DN15066_c0_g1_i1	P51831	FABG_BACSU	49.3	73	37	0	221	3	57	129	3.40E-14	78.6	FABG_BACSU	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG ylpF BSU15910	Bacillus subtilis (strain 168)	246	"3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]"		"3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0004316; GO:0016616; GO:0030497; GO:0051287; GO:0055114; GO:0102131; GO:0102132	fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN11455_c1_g1_i2	Q5HGK2	FABG_STAAC	34.2	240	151	5	809	102	7	243	3.20E-29	130.6	FABG_STAAC	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG SACOL1245	Staphylococcus aureus (strain COL)	246	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]		3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	fatty acid elongation [GO:0030497]		blue	blue	NA	NA	NA	NA
TRINITY_DN1700_c0_g2_i2	Q9X248	FABG_THEMA	54.1	37	17	0	18	128	208	244	4.30E-05	48.9	FABG_THEMA	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG TM_1724	Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)	246	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]		3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	fatty acid elongation [GO:0030497]		NA	NA	NA	NA	NA	NA
TRINITY_DN2269_c0_g1_i1	Q9X248	FABG_THEMA	37.2	250	147	4	109	855	3	243	1.30E-33	145.2	FABG_THEMA	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG TM_1724	Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)	246	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]		3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	fatty acid elongation [GO:0030497]		blue	blue	NA	NA	NA	NA
TRINITY_DN2269_c0_g1_i2	Q9X248	FABG_THEMA	37.2	250	147	4	109	855	3	243	1.30E-33	145.2	FABG_THEMA	reviewed	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	fabG TM_1724	Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)	246	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]		3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	fatty acid elongation [GO:0030497]		NA	NA	NA	NA	NA	NA
TRINITY_DN23320_c0_g1_i1	Q9KQH9	FABF_VIBCH	58.2	91	38	0	275	3	187	277	2.70E-24	112.5	FABF_VIBCH	reviewed	3-oxoacyl-[acyl-carrier-protein] synthase 2 (EC 2.3.1.179) (3-oxoacyl-[acyl-carrier-protein] synthase II) (Beta-ketoacyl-ACP synthase II) (KAS II)	fabF VC_2019	Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)	414	cytosol [GO:0005829]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]; fatty acid biosynthetic process [GO:0006633]	cytosol [GO:0005829]	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]	GO:0004315; GO:0005829; GO:0006633; GO:0033817	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN6411_c0_g1_i1	P56902	FABF_RHIME	68.8	96	30	0	289	2	198	293	1.90E-33	142.9	FABF_RHIME	reviewed	3-oxoacyl-[acyl-carrier-protein] synthase 2 (EC 2.3.1.179) (3-oxoacyl-[acyl-carrier-protein] synthase II) (Beta-ketoacyl-ACP synthase II) (KAS II)	fabF R01144 SMc00574	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	421	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]; fatty acid biosynthetic process [GO:0006633]		3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]	GO:0004315; GO:0006633; GO:0033817	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN6411_c0_g1_i2	P56902	FABF_RHIME	65.8	111	38	0	333	1	198	308	5.00E-38	158.3	FABF_RHIME	reviewed	3-oxoacyl-[acyl-carrier-protein] synthase 2 (EC 2.3.1.179) (3-oxoacyl-[acyl-carrier-protein] synthase II) (Beta-ketoacyl-ACP synthase II) (KAS II)	fabF R01144 SMc00574	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	421	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]; fatty acid biosynthetic process [GO:0006633]		3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]	GO:0004315; GO:0006633; GO:0033817	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN34821_c0_g1_i1	Q83E37	FABF_COXBU	55.3	94	38	2	3	281	288	378	1.80E-20	99.8	FABF_COXBU	reviewed	3-oxoacyl-[acyl-carrier-protein] synthase 2 (EC 2.3.1.179) (3-oxoacyl-[acyl-carrier-protein] synthase II) (Beta-ketoacyl-ACP synthase II) (KAS II)	fabF CBU_0497	Coxiella burnetii (strain RSA 493 / Nine Mile phase I)	414	cytosol [GO:0005829]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]; fatty acid biosynthetic process [GO:0006633]	cytosol [GO:0005829]	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase II activity [GO:0033817]	GO:0004315; GO:0005829; GO:0006633; GO:0033817	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1558_c1_g2_i2	Q0VCA7	OXSM_BOVIN	56.6	422	179	3	87	1349	40	458	1.10E-129	464.9	OXSM_BOVIN	reviewed	"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)"	OXSM	Bos taurus (Bovine)	460	mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid biosynthetic process [GO:0006633]	mitochondrion [GO:0005739]	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]	GO:0004315; GO:0005739; GO:0006633	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1558_c1_g2_i1	Q8L3X9	KASM_ARATH	47.2	53	28	0	96	254	31	83	9.70E-05	47.4	KASM_ARATH	reviewed	"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase) (mtKAS)"	KAS At2g04540 T1O3.5	Arabidopsis thaliana (Mouse-ear cress)	461	mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid biosynthetic process [GO:0006633]; thylakoid membrane organization [GO:0010027]	mitochondrion [GO:0005739]	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]	GO:0004315; GO:0005739; GO:0006633; GO:0010027	fatty acid biosynthetic process [GO:0006633]; thylakoid membrane organization [GO:0010027]		NA	NA	NA	NA	NA	NA
TRINITY_DN28957_c0_g1_i1	Q01103	PCAI_PSEPU	76.5	85	20	0	256	2	128	212	1.90E-32	139.4	PCAI_PSEPU	reviewed	3-oxoadipate CoA-transferase subunit A (EC 2.8.3.6) (Beta-ketoadipate:succinyl-CoA transferase subunit A)	pcaI	Pseudomonas putida (Arthrobacter siderocapsulatus)	231	3-oxoadipate CoA-transferase activity [GO:0047569]; beta-ketoadipate pathway [GO:0042952]		3-oxoadipate CoA-transferase activity [GO:0047569]	GO:0042952; GO:0047569	beta-ketoadipate pathway [GO:0042952]		NA	NA	NA	NA	NA	NA
TRINITY_DN30566_c0_g1_i1	Q59091	PCAJ_ACIAD	76.4	72	17	0	218	3	57	128	8.80E-28	123.6	PCAJ_ACIAD	reviewed	3-oxoadipate CoA-transferase subunit B (EC 2.8.3.6) (Beta-ketoadipate:succinyl-CoA transferase subunit B)	pcaJ ACIAD1705; catJ ACIAD1449	Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)	217	3-oxoadipate CoA-transferase activity [GO:0047569]; beta-ketoadipate pathway [GO:0042952]		3-oxoadipate CoA-transferase activity [GO:0047569]	GO:0042952; GO:0047569	beta-ketoadipate pathway [GO:0042952]		NA	NA	NA	NA	NA	NA
TRINITY_DN13004_c0_g2_i3	Q9W0V1	PDPK1_DROME	53.5	86	35	1	194	451	240	320	7.70E-17	88.6	PDPK1_DROME	reviewed	3-phosphoinositide-dependent protein kinase 1 (dPDK-1) (EC 2.7.11.1) (Serine/threonine-protein kinase 61C) (dSTPK61)	Pdk1 Pk61C CG1210	Drosophila melanogaster (Fruit fly)	836	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004676; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007166; GO:0007283; GO:0008286; GO:0018105; GO:0018107; GO:0030154; GO:0030295; GO:0030307; GO:0031594; GO:0035556; GO:0040018; GO:0043066; GO:0045793; GO:0046622; GO:0051124; GO:0051897	apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]		brown	brown	NA	NA	NA	NA
TRINITY_DN13004_c0_g2_i2	O15530	PDPK1_HUMAN	52.1	48	23	0	54	197	157	204	2.00E-07	57.8	PDPK1_HUMAN	reviewed	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	Homo sapiens (Human)	556	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030036; GO:0030168; GO:0030512; GO:0031295; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0038095; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0046777; GO:0048041; GO:0050852; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN13004_c0_g2_i2	O15530	PDPK1_HUMAN	63.6	33	12	0	296	394	204	236	1.50E-05	51.6	PDPK1_HUMAN	reviewed	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	Homo sapiens (Human)	556	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030036; GO:0030168; GO:0030512; GO:0031295; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0038095; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0046777; GO:0048041; GO:0050852; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN13004_c0_g2_i6	O15530	PDPK1_HUMAN	52.1	48	23	0	54	197	157	204	1.20E-07	57.8	PDPK1_HUMAN	reviewed	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	Homo sapiens (Human)	556	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030036; GO:0030168; GO:0030512; GO:0031295; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0038095; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0046777; GO:0048041; GO:0050852; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN13004_c0_g2_i6	O15530	PDPK1_HUMAN	63.6	33	12	0	296	394	204	236	8.90E-06	51.6	PDPK1_HUMAN	reviewed	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	Homo sapiens (Human)	556	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030036; GO:0030168; GO:0030512; GO:0031295; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0038095; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0046777; GO:0048041; GO:0050852; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN13004_c0_g2_i9	O15530	PDPK1_HUMAN	55.4	222	86	2	194	859	76	284	1.20E-65	251.5	PDPK1_HUMAN	reviewed	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	Homo sapiens (Human)	556	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030036; GO:0030168; GO:0030512; GO:0031295; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0038095; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0046777; GO:0048041; GO:0050852; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN33064_c0_g1_i1	O15530	PDPK1_HUMAN	100	153	0	0	460	2	140	292	3.40E-85	315.5	PDPK1_HUMAN	reviewed	3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)	PDPK1 PDK1	Homo sapiens (Human)	556	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030036; GO:0030168; GO:0030512; GO:0031295; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0038095; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0046777; GO:0048041; GO:0050852; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; Fc-epsilon receptor signaling pathway [GO:0038095]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN37583_c0_g1_i1	H8ZPX2	SAPD_PSESP	69.9	143	43	0	3	431	124	266	3.30E-50	199.1	SAPD_PSESP	reviewed	3-succinoylsemialdehyde-pyridine dehydrogenase (SAPD) (EC 1.2.1.83)	ald	Pseudomonas sp.	477	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; nicotine catabolic process [GO:0019608]"		"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0016620; GO:0019608	nicotine catabolic process [GO:0019608]		NA	NA	NA	NA	NA	NA
TRINITY_DN4673_c0_g1_i1	H8ZPX2	SAPD_PSESP	66.2	71	24	0	219	7	116	186	2.70E-19	95.5	SAPD_PSESP	reviewed	3-succinoylsemialdehyde-pyridine dehydrogenase (SAPD) (EC 1.2.1.83)	ald	Pseudomonas sp.	477	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; nicotine catabolic process [GO:0019608]"		"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0016620; GO:0019608	nicotine catabolic process [GO:0019608]		NA	NA	NA	NA	NA	NA
TRINITY_DN28290_c0_g1_i1	P0DPF0	CRTNC_BACFI	62.7	67	25	0	201	1	187	253	1.00E-17	90.1	CRTNC_CYTFI	reviewed	"4,4'-diapolycopene-4,4'-dial dehydrogenase (EC 1.2.99.10) (4,4'-diapolycopene aldehyde oxidase) (4,4'-diapolycopene-4,4'-dial oxidase) (4,4'-diapolycopene-4,4'-dioate synthase)"	crtNc	Cytobacillus firmus (Bacillus firmus)	453	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; carotenoid biosynthetic process [GO:0016117]; cellular aldehyde metabolic process [GO:0006081]"		"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0006081; GO:0016117; GO:0016620	carotenoid biosynthetic process [GO:0016117]; cellular aldehyde metabolic process [GO:0006081]		NA	NA	NA	NA	NA	NA
TRINITY_DN1646_c0_g1_i4	Q00558	HAP40_MOUSE	61	41	16	0	968	846	16	56	7.20E-06	53.1	HAP40_MOUSE	reviewed	40-kDa huntingtin-associated protein (CpG island protein) (Factor VIII intron 22 protein)	F8a1 F8a Hap40	Mus musculus (Mouse)	380	cytoplasm [GO:0005737]; early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005769; GO:0016604; GO:0099518; GO:1901799	negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]		NA	NA	NA	NA	NA	NA
TRINITY_DN1646_c0_g1_i5	Q00558	HAP40_MOUSE	65.7	35	12	0	990	886	16	50	2.10E-05	51.6	HAP40_MOUSE	reviewed	40-kDa huntingtin-associated protein (CpG island protein) (Factor VIII intron 22 protein)	F8a1 F8a Hap40	Mus musculus (Mouse)	380	cytoplasm [GO:0005737]; early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005769; GO:0016604; GO:0099518; GO:1901799	negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]		NA	NA	NA	NA	NA	NA
TRINITY_DN1646_c0_g1_i1	P23610	HAP40_HUMAN	36.8	353	180	5	964	35	19	371	5.80E-48	193	HAP40_HUMAN	reviewed	40-kDa huntingtin-associated protein (HAP40) (CpG island protein) (Factor VIII intron 22 protein)	F8A1; F8A2; F8A3	Homo sapiens (Human)	371	early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]	early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]		GO:0005634; GO:0005769; GO:0016604; GO:0099518; GO:1901799	negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]		NA	NA	NA	NA	NA	NA
TRINITY_DN1646_c0_g1_i2	P23610	HAP40_HUMAN	36.8	353	180	5	964	35	19	371	5.80E-48	193	HAP40_HUMAN	reviewed	40-kDa huntingtin-associated protein (HAP40) (CpG island protein) (Factor VIII intron 22 protein)	F8A1; F8A2; F8A3	Homo sapiens (Human)	371	early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]	early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]		GO:0005634; GO:0005769; GO:0016604; GO:0099518; GO:1901799	negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]		NA	NA	NA	NA	NA	NA
TRINITY_DN8230_c0_g1_i1	Q962R9	RS10_SPOFR	72.4	76	21	0	14	241	1	76	5.70E-28	124.4	RS10_SPOFR	reviewed	40S ribosomal protein S10	RpS10	Spodoptera frugiperda (Fall armyworm)	158	cytoplasm [GO:0005737]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; ribosome [GO:0005840]		GO:0005737; GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN8230_c1_g1_i1	Q962R9	RS10_SPOFR	50.6	83	40	1	247	2	44	126	1.00E-11	70.5	RS10_SPOFR	reviewed	40S ribosomal protein S10	RpS10	Spodoptera frugiperda (Fall armyworm)	158	cytoplasm [GO:0005737]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; ribosome [GO:0005840]		GO:0005737; GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN7692_c0_g1_i1	O77302	RS10_LUMRU	52.3	65	28	1	3	188	38	102	1.50E-12	73.2	RS10_LUMRU	reviewed	40S ribosomal protein S10	RPS10	Lumbricus rubellus (Humus earthworm)	156	cytoplasm [GO:0005737]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; ribosome [GO:0005840]		GO:0005737; GO:0005840			red	red	NA	NA	NA	NA
TRINITY_DN13421_c0_g1_i1	Q3T0F4	RS10_BOVIN	100	122	0	0	367	2	7	128	1.60E-66	253.1	RS10_BOVIN	reviewed	40S ribosomal protein S10	RPS10	Bos taurus (Bovine)	165	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0005730; GO:0022627	ribosomal small subunit assembly [GO:0000028]		NA	NA	NA	NA	NA	NA
TRINITY_DN13421_c0_g1_i4	P63325	RS10_MOUSE	100	121	0	0	363	1	8	128	6.10E-66	251.1	RS10_MOUSE	reviewed	40S ribosomal protein S10	Rps10	Mus musculus (Mouse)	165	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; ribosomal small subunit assembly [GO:0000028]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000028; GO:0000049; GO:0003723; GO:0003735; GO:0005730; GO:0005829; GO:0022627	ribosomal small subunit assembly [GO:0000028]		NA	NA	NA	NA	NA	NA
TRINITY_DN13125_c1_g1_i1	Q3T0F4	RS10_BOVIN	72.6	73	18	1	3	215	23	95	2.40E-25	115.5	RS10_BOVIN	reviewed	40S ribosomal protein S10	RPS10	Bos taurus (Bovine)	165	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0005730; GO:0022627	ribosomal small subunit assembly [GO:0000028]		NA	NA	NA	NA	NA	NA
TRINITY_DN13125_c0_g1_i1	Q3T0F4	RS10_BOVIN	71.4	84	22	1	246	1	1	84	4.60E-28	124.8	RS10_BOVIN	reviewed	40S ribosomal protein S10	RPS10	Bos taurus (Bovine)	165	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0005730; GO:0022627	ribosomal small subunit assembly [GO:0000028]		NA	NA	NA	NA	NA	NA
TRINITY_DN37258_c0_g1_i1	O77302	RS10_LUMRU	55.9	68	27	1	236	42	35	102	8.80E-13	73.9	RS10_LUMRU	reviewed	40S ribosomal protein S10	RPS10	Lumbricus rubellus (Humus earthworm)	156	cytoplasm [GO:0005737]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; ribosome [GO:0005840]		GO:0005737; GO:0005840			red	red	NA	NA	NA	NA
TRINITY_DN29630_c2_g2_i1	Q3T0F4	RS10_BOVIN	61	159	53	3	513	64	1	159	2.50E-45	183.3	RS10_BOVIN	reviewed	40S ribosomal protein S10	RPS10	Bos taurus (Bovine)	165	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0005730; GO:0022627	ribosomal small subunit assembly [GO:0000028]		blue	blue	NA	NA	NA	NA
TRINITY_DN27665_c0_g1_i1	O14112	RS10A_SCHPO	53	66	29	1	5	202	39	102	7.10E-12	70.9	RS10A_SCHPO	reviewed	40S ribosomal protein S10-A	rps1001 rps10 rps10a SPAC31G5.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	144	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0022627	cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]		red	red	NA	NA	NA	NA
TRINITY_DN5679_c0_g1_i1	Q76I81	RS12_BOVIN	99.2	129	1	0	387	1	1	129	1.10E-68	260.4	RS12_BOVIN	reviewed	40S ribosomal protein S12	RPS12	Bos taurus (Bovine)	132	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5679_c0_g2_i1	Q76I81	RS12_BOVIN	100	132	0	0	416	21	1	132	3.40E-71	268.9	RS12_BOVIN	reviewed	40S ribosomal protein S12	RPS12	Bos taurus (Bovine)	132	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20297_c0_g1_i1	Q76I81	RS12_BOVIN	79.3	111	23	0	335	3	9	119	8.90E-46	184.5	RS12_BOVIN	reviewed	40S ribosomal protein S12	RPS12	Bos taurus (Bovine)	132	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN20297_c0_g1_i2	Q76I81	RS12_BOVIN	90	30	3	0	92	3	90	119	5.00E-09	61.2	RS12_BOVIN	reviewed	40S ribosomal protein S12	RPS12	Bos taurus (Bovine)	132	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN20297_c0_g1_i3	Q76I81	RS12_BOVIN	83.3	48	8	0	146	3	72	119	1.40E-17	89.7	RS12_BOVIN	reviewed	40S ribosomal protein S12	RPS12	Bos taurus (Bovine)	132	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15381_c0_g2_i1	Q9XHS0	RS12_HORVU	55.3	114	51	0	343	2	24	137	8.00E-31	134.4	RS12_HORVU	reviewed	40S ribosomal protein S12	RPS12	Hordeum vulgare (Barley)	143	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15381_c0_g4_i1	Q9XHS0	RS12_HORVU	61	77	29	1	240	10	62	137	7.30E-23	107.5	RS12_HORVU	reviewed	40S ribosomal protein S12	RPS12	Hordeum vulgare (Barley)	143	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN15381_c0_g3_i1	Q76I81	RS12_BOVIN	73	100	27	0	302	3	9	108	3.20E-35	149.1	RS12_BOVIN	reviewed	40S ribosomal protein S12	RPS12	Bos taurus (Bovine)	132	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN32955_c1_g1_i1	O13019	RS12_ORENI	73.6	87	23	0	2	262	45	131	2.90E-31	135.6	RS12_ORENI	reviewed	40S ribosomal protein S12	rps12	Oreochromis niloticus (Nile tilapia) (Tilapia nilotica)	132	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN4977_c0_g1_i1	P10735	RT12_DROME	71.3	108	31	0	359	682	31	138	2.10E-39	164.1	RT12_DROME	reviewed	"40S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12) (Protein technical knockout locus)"	tko CG7925	Drosophila melanogaster (Fruit fly)	140	mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; courtship behavior [GO:0007619]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; mitochondrial translation [GO:0032543]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0001666; GO:0003735; GO:0005763; GO:0005840; GO:0006412; GO:0007605; GO:0007619; GO:0007638; GO:0008049; GO:0009612; GO:0032543	courtship behavior [GO:0007619]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; mitochondrial translation [GO:0032543]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23366_c0_g1_i1	P48855	RS14_PROCL	92.5	67	5	0	201	1	22	88	7.40E-29	127.1	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3169_c0_g1_i1	P62265	RS14_CRIGR	100	151	0	0	507	55	1	151	1.30E-80	300.4	RS14_CRIGR	reviewed	40S ribosomal protein S14	RPS14 EMTB	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	151	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]	mRNA 5'-UTR binding [GO:0048027]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000028; GO:0000122; GO:0003735; GO:0005730; GO:0006412; GO:0014069; GO:0022627; GO:0030218; GO:0045182; GO:0048027	erythrocyte differentiation [GO:0030218]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3169_c0_g2_i1	P62265	RS14_CRIGR	100	151	0	0	503	51	1	151	7.60E-81	301.2	RS14_CRIGR	reviewed	40S ribosomal protein S14	RPS14 EMTB	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	151	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]	mRNA 5'-UTR binding [GO:0048027]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000028; GO:0000122; GO:0003735; GO:0005730; GO:0006412; GO:0014069; GO:0022627; GO:0030218; GO:0045182; GO:0048027	erythrocyte differentiation [GO:0030218]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16583_c2_g1_i1	P48855	RS14_PROCL	89	91	10	0	2	274	1	91	1.80E-39	162.9	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16583_c0_g1_i1	P48855	RS14_PROCL	96.3	82	3	0	248	3	66	147	1.70E-38	159.5	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN16583_c0_g1_i4	P48855	RS14_PROCL	95.6	113	5	0	341	3	35	147	9.20E-56	217.2	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16583_c0_g1_i7	P48855	RS14_PROCL	96.3	81	3	0	245	3	35	115	1.60E-38	159.5	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN32710_c0_g1_i1	P48855	RS14_PROCL	98.7	151	2	0	493	41	1	151	1.40E-80	300.4	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN5711_c0_g1_i1	Q8SSA6	RS14_ENCCU	59	61	25	0	191	9	13	73	1.80E-13	76.3	RS14_ENCCU	reviewed	40S ribosomal protein S14	RPS14 ECU03_0650	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	134	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19959_c0_g1_i1	P48855	RS14_PROCL	100	55	0	0	201	37	97	151	4.20E-24	111.3	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19959_c0_g1_i2	P48855	RS14_PROCL	98.2	55	1	0	206	42	97	151	2.10E-23	109	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN37249_c0_g1_i1	P48855	RS14_PROCL	93.5	77	5	0	32	262	1	77	6.90E-35	147.5	RS14_PROCL	reviewed	40S ribosomal protein S14	RPS14	Procambarus clarkii (Red swamp crayfish)	151	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10452_c0_g1_i1	Q9CAX6	RS142_ARATH	84.7	150	23	0	14	463	1	150	2.20E-67	256.5	RS142_ARATH	reviewed	40S ribosomal protein S14-2	RPS14B At3g11510 F24K9.19	Arabidopsis thaliana (Mouse-ear cress)	150	"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0000462; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0022626; GO:0022627; GO:0042788; GO:0048027; GO:0070181	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27065_c0_g1_i1	Q9CAX6	RS142_ARATH	84	150	24	0	533	84	1	150	5.00E-67	255.4	RS142_ARATH	reviewed	40S ribosomal protein S14-2	RPS14B At3g11510 F24K9.19	Arabidopsis thaliana (Mouse-ear cress)	150	"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0000462; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0022626; GO:0022627; GO:0042788; GO:0048027; GO:0070181	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"		red	red	NA	NA	NA	NA
TRINITY_DN1523_c0_g1_i1	Q9CAX6	RS142_ARATH	85.3	150	22	0	527	78	1	150	4.50E-68	258.8	RS142_ARATH	reviewed	40S ribosomal protein S14-2	RPS14B At3g11510 F24K9.19	Arabidopsis thaliana (Mouse-ear cress)	150	"cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0000462; GO:0003729; GO:0003735; GO:0005730; GO:0005829; GO:0006412; GO:0022626; GO:0022627; GO:0042788; GO:0048027; GO:0070181	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10636_c0_g1_i1	Q56K10	RS15_BOVIN	92.3	39	3	0	156	40	107	145	2.50E-16	85.5	RS15_BOVIN	reviewed	40S ribosomal protein S15	RPS15	Bos taurus (Bovine)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN771_c0_g1_i1	P31674	RS15_ORYSJ	69.3	140	40	2	470	60	15	154	1.00E-50	201.1	RS15_ORYSJ	reviewed	40S ribosomal protein S15	RPS15 Os07g0184300 LOC_Os07g08660 OJ1046_F10.119	Oryza sativa subsp. japonica (Rice)	154	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN771_c0_g2_i1	P31674	RS15_ORYSJ	69.3	140	40	2	457	47	15	154	9.80E-51	201.1	RS15_ORYSJ	reviewed	40S ribosomal protein S15	RPS15 Os07g0184300 LOC_Os07g08660 OJ1046_F10.119	Oryza sativa subsp. japonica (Rice)	154	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN38900_c0_g1_i1	P62846	RS15_CHICK	68.8	64	20	0	193	2	5	68	6.50E-17	87.4	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN10636_c0_g2_i1	P62846	RS15_CHICK	100	145	0	0	464	30	1	145	2.30E-76	286.2	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10636_c1_g1_i1	P62846	RS15_CHICK	77.9	95	21	0	286	2	18	112	3.20E-33	142.1	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10636_c0_g1_i2	P62846	RS15_CHICK	100	145	0	0	474	40	1	145	5.00E-77	288.5	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10636_c5_g1_i1	P62846	RS15_CHICK	77.5	71	16	0	215	3	63	133	1.40E-25	116.3	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10636_c2_g1_i1	P62846	RS15_CHICK	78.8	104	22	0	327	16	42	145	1.80E-40	166.4	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29809_c0_g1_i1	P62846	RS15_CHICK	72.7	66	18	0	198	1	31	96	9.40E-17	87	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29808_c0_g1_i1	P62846	RS15_CHICK	79.2	72	15	0	8	223	41	112	4.30E-25	114.8	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1811_c0_g1_i1	P62846	RS15_CHICK	84	144	23	0	472	41	2	145	6.80E-64	245	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1811_c0_g1_i2	P62846	RS15_CHICK	84	144	23	0	472	41	2	145	6.80E-64	245	RS15_CHICK	reviewed	40S ribosomal protein S15 (RIG protein)	RPS15 RIG	Gallus gallus (Chicken)	145	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627	ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN23402_c0_g1_i1	Q76I82	RS15A_BOVIN	82.2	73	13	0	222	4	1	73	1.40E-26	119.8	RS15A_BOVIN	reviewed	40S ribosomal protein S15a	RPS15A	Bos taurus (Bovine)	130	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23402_c0_g1_i2	Q76I82	RS15A_BOVIN	78.1	73	16	0	222	4	1	73	5.20E-25	114.8	RS15A_BOVIN	reviewed	40S ribosomal protein S15a	RPS15A	Bos taurus (Bovine)	130	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15798_c0_g1_i1	Q76I82	RS15A_BOVIN	100	130	0	0	54	443	1	130	5.00E-71	268.5	RS15A_BOVIN	reviewed	40S ribosomal protein S15a	RPS15A	Bos taurus (Bovine)	130	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15798_c0_g2_i1	Q76I82	RS15A_BOVIN	100	130	0	0	52	441	1	130	3.90E-71	268.9	RS15A_BOVIN	reviewed	40S ribosomal protein S15a	RPS15A	Bos taurus (Bovine)	130	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN666_c0_g1_i1	P46793	RS15A_DICDI	70	130	39	0	462	73	1	130	1.80E-50	200.3	RS15A_DICDI	reviewed	40S ribosomal protein S15a (Ribosomal protein S24)	rps15a rps24 DDB_G0276457	Dictyostelium discoideum (Slime mold)	130	cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627; GO:0031012	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN666_c0_g1_i2	P46793	RS15A_DICDI	70	130	39	0	474	85	1	130	1.70E-50	200.3	RS15A_DICDI	reviewed	40S ribosomal protein S15a (Ribosomal protein S24)	rps15a rps24 DDB_G0276457	Dictyostelium discoideum (Slime mold)	130	cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627; GO:0031012	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN666_c0_g1_i3	P46793	RS15A_DICDI	70	130	39	0	474	85	1	130	1.70E-50	200.3	RS15A_DICDI	reviewed	40S ribosomal protein S15a (Ribosomal protein S24)	rps15a rps24 DDB_G0276457	Dictyostelium discoideum (Slime mold)	130	cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; extracellular matrix [GO:0031012]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627; GO:0031012	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN22149_c0_g1_i1	P48149	RS15A_DROME	84.6	78	12	0	3	236	47	124	4.50E-33	141.4	RS15A_DROME	reviewed	40S ribosomal protein S15Aa	RpS15Aa RpS15A CG2033	Drosophila melanogaster (Fruit fly)	130	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022626; GO:0022627	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN22149_c0_g1_i2	P48149	RS15A_DROME	84.6	78	12	0	3	236	47	124	1.50E-33	142.9	RS15A_DROME	reviewed	40S ribosomal protein S15Aa	RpS15Aa RpS15A CG2033	Drosophila melanogaster (Fruit fly)	130	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022626; GO:0022627	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15646_c2_g1_i2	P48149	RS15A_DROME	89.2	130	14	0	78	467	1	130	1.30E-64	247.3	RS15A_DROME	reviewed	40S ribosomal protein S15Aa	RpS15Aa RpS15A CG2033	Drosophila melanogaster (Fruit fly)	130	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022626; GO:0022627	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN31458_c0_g1_i1	P48149	RS15A_DROME	85.3	68	10	0	1	204	48	115	3.20E-27	121.7	RS15A_DROME	reviewed	40S ribosomal protein S15Aa	RpS15Aa RpS15A CG2033	Drosophila melanogaster (Fruit fly)	130	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022626; GO:0022627	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN22149_c2_g1_i1	Q7KR04	RS15B_DROME	80.8	104	20	0	312	1	1	104	3.50E-41	168.7	RS15B_DROME	reviewed	40S ribosomal protein S15Ab	RpS15Ab RpS15A CG12324	Drosophila melanogaster (Fruit fly)	130	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022627	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15646_c3_g1_i1	Q7KR04	RS15B_DROME	79.3	92	19	0	3	278	14	105	6.60E-36	151	RS15B_DROME	reviewed	40S ribosomal protein S15Ab	RpS15Ab RpS15A CG12324	Drosophila melanogaster (Fruit fly)	130	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022627	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN17183_c0_g1_i1	A5PK63	RS17_BOVIN	80.2	81	16	0	3	245	40	120	1.40E-29	129.8	RS17_BOVIN	reviewed	40S ribosomal protein S17	RPS17	Bos taurus (Bovine)	135	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN14671_c5_g1_i1	P63273	RS17_CANLF	88.5	122	14	0	88	453	1	122	1.10E-55	217.6	RS17_CANLF	reviewed	40S ribosomal protein S17	RPS17 B179	Canis lupus familiaris (Dog) (Canis familiaris)	135	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0034101; GO:0042274	erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN14671_c0_g2_i1	P63273	RS17_CANLF	82	122	22	0	31	396	1	122	2.60E-49	196.1	RS17_CANLF	reviewed	40S ribosomal protein S17	RPS17 B179	Canis lupus familiaris (Dog) (Canis familiaris)	135	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0034101; GO:0042274	erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24789_c0_g1_i1	Q962R2	RS17_SPOFR	65.2	66	22	1	204	10	67	132	8.60E-17	87	RS17_SPOFR	reviewed	40S ribosomal protein S17	RpS17	Spodoptera frugiperda (Fall armyworm)	133	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23243_c0_g1_i1	P04644	RS17_RAT	82.4	68	12	0	6	209	40	107	4.90E-23	107.8	RS17_RAT	reviewed	40S ribosomal protein S17	Rps17	Rattus norvegicus (Rat)	135	cytosolic small ribosomal subunit [GO:0022627]; synapse [GO:0045202]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0034101; GO:0042274; GO:0045202	erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23245_c0_g1_i1	P63273	RS17_CANLF	86.6	97	13	0	7	297	1	97	1.50E-41	169.9	RS17_CANLF	reviewed	40S ribosomal protein S17	RPS17 B179	Canis lupus familiaris (Dog) (Canis familiaris)	135	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0034101; GO:0042274	erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4658_c0_g1_i1	P63273	RS17_CANLF	100	135	0	0	425	21	1	135	6.40E-71	268.1	RS17_CANLF	reviewed	40S ribosomal protein S17	RPS17 B179	Canis lupus familiaris (Dog) (Canis familiaris)	135	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0034101; GO:0042274	erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20060_c1_g1_i1	P63273	RS17_CANLF	88.5	87	10	0	54	314	1	87	2.10E-38	159.5	RS17_CANLF	reviewed	40S ribosomal protein S17	RPS17 B179	Canis lupus familiaris (Dog) (Canis familiaris)	135	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006364; GO:0006412; GO:0022627; GO:0034101; GO:0042274	erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4658_c0_g2_i1	P08708	RS17_HUMAN	100	135	0	0	431	27	1	135	2.90E-71	269.2	RS17_HUMAN	reviewed	40S ribosomal protein S17 (Small ribosomal subunit protein eS17)	RPS17 RPS17L	Homo sapiens (Human)	135	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; erythrocyte homeostasis [GO:0034101]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003735; GO:0005654; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022627; GO:0034101; GO:0042274	"erythrocyte homeostasis [GO:0034101]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32929_c0_g1_i1	Q9LZ17	RS174_ARATH	72.9	118	32	0	18	371	1	118	1.30E-42	173.7	RS174_ARATH	reviewed	40S ribosomal protein S17-4	RPS17D At5g04800 MUK11.12 T1E3_160	Arabidopsis thaliana (Mouse-ear cress)	141	plasma membrane [GO:0005886]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	plasma membrane [GO:0005886]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0005886; GO:0006412	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN1327_c0_g1_i1	Q9P7J6	RS17B_SCHPO	45.8	96	52	0	312	25	12	107	2.00E-17	89.7	RS17B_SCHPO	reviewed	40S ribosomal protein S17-B	rps1702 rps17b SPCC24B10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	132	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; cytoplasmic translational elongation [GO:0002182]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0002182; GO:0003735; GO:0005829; GO:0022627; GO:0042254	cytoplasmic translational elongation [GO:0002182]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN6969_c0_g1_i1	Q3T0R1	RS18_BOVIN	100	152	0	0	503	48	1	152	1.60E-81	303.5	RS18_BOVIN	reviewed	40S ribosomal protein S18	RPS18	Bos taurus (Bovine)	152	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005829; GO:0006412; GO:0015935; GO:0019843; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN6969_c0_g2_i1	Q3T0R1	RS18_BOVIN	100	152	0	0	503	48	1	152	2.80E-81	302.8	RS18_BOVIN	reviewed	40S ribosomal protein S18	RPS18	Bos taurus (Bovine)	152	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005829; GO:0006412; GO:0015935; GO:0019843; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23757_c0_g1_i1	Q8ISP0	RS18_BRABE	82.4	68	12	0	1	204	34	101	1.90E-27	122.5	RS18_BRABE	reviewed	40S ribosomal protein S18	RPS18	Branchiostoma belcheri (Amphioxus)	152	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13405_c0_g1_i1	Q962R1	RS18_SPOFR	85.4	82	12	0	3	248	28	109	1.10E-31	136.7	RS18_SPOFR	reviewed	40S ribosomal protein S18	RpS18	Spodoptera frugiperda (Fall armyworm)	152	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13405_c2_g1_i1	Q962R1	RS18_SPOFR	77.2	127	29	0	1	381	26	152	1.20E-46	187.2	RS18_SPOFR	reviewed	40S ribosomal protein S18	RpS18	Spodoptera frugiperda (Fall armyworm)	152	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20217_c0_g1_i1	Q962R1	RS18_SPOFR	79.1	67	14	0	10	210	14	80	7.00E-22	104	RS18_SPOFR	reviewed	40S ribosomal protein S18	RpS18	Spodoptera frugiperda (Fall armyworm)	152	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN33468_c0_g1_i1	P34788	RS18_ARATH	67.7	133	43	0	46	444	9	141	1.40E-50	200.7	RS18_ARATH	reviewed	40S ribosomal protein S18	RPS18A PFL At1g22780 T22J18.5; RPS18B At1g34030 F12G12.15 T15K4.9; RPS18C At4g09800 F17A8.150	Arabidopsis thaliana (Mouse-ear cress)	152	cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translational initiation [GO:0006413]	cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005618; GO:0005634; GO:0005730; GO:0005773; GO:0005774; GO:0005829; GO:0005840; GO:0005886; GO:0006413; GO:0009506; GO:0015935; GO:0019843; GO:0022626; GO:0022627	translational initiation [GO:0006413]		red	red	NA	NA	NA	NA
TRINITY_DN23147_c0_g1_i1	Q962R1	RS18_SPOFR	78.7	75	16	0	227	3	1	75	1.70E-26	119.8	RS18_SPOFR	reviewed	40S ribosomal protein S18	RpS18	Spodoptera frugiperda (Fall armyworm)	152	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23147_c3_g1_i1	Q962R1	RS18_SPOFR	88.8	152	17	0	522	67	1	152	3.60E-73	275.8	RS18_SPOFR	reviewed	40S ribosomal protein S18	RpS18	Spodoptera frugiperda (Fall armyworm)	152	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN13581_c1_g1_i1	Q3ZBH8	RS20_BOVIN	69.6	46	14	0	6	143	28	73	1.90E-09	62.8	RS20_BOVIN	reviewed	40S ribosomal protein S20	RPS20	Bos taurus (Bovine)	119	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022627; GO:0045202	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13581_c1_g1_i1	Q3ZBH8	RS20_BOVIN	77.1	35	8	0	124	228	67	101	2.50E-09	62.4	RS20_BOVIN	reviewed	40S ribosomal protein S20	RPS20	Bos taurus (Bovine)	119	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022627; GO:0045202	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3964_c0_g2_i1	Q3ZBH8	RS20_BOVIN	100	119	0	0	381	25	1	119	1.80E-61	236.5	RS20_BOVIN	reviewed	40S ribosomal protein S20	RPS20	Bos taurus (Bovine)	119	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022627; GO:0045202	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3964_c0_g1_i1	Q3ZBH8	RS20_BOVIN	100	119	0	0	385	29	1	119	1.40E-61	236.9	RS20_BOVIN	reviewed	40S ribosomal protein S20	RPS20	Bos taurus (Bovine)	119	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022627; GO:0045202	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16407_c0_g1_i1	P23403	RS20_XENLA	74	50	13	0	66	215	11	60	3.60E-13	75.1	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN293_c0_g1_i1	P23403	RS20_XENLA	79.2	106	22	0	46	363	13	118	2.20E-43	176.4	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN13581_c0_g1_i1	P23403	RS20_XENLA	84.3	108	17	0	330	7	11	118	2.10E-45	183	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10627_c1_g1_i1	P23403	RS20_XENLA	74.6	67	17	0	202	2	11	77	1.20E-20	100.1	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3371_c0_g1_i1	P23403	RS20_XENLA	86.1	108	15	0	378	55	11	118	4.80E-47	188.7	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3371_c0_g1_i3	P23403	RS20_XENLA	86.1	108	15	0	378	55	11	118	5.10E-47	188.7	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN39888_c0_g1_i1	P23403	RS20_XENLA	73.9	115	30	0	379	35	4	118	2.90E-43	176	RS20_XENLA	reviewed	40S ribosomal protein S20 (S22)	rps20	Xenopus laevis (African clawed frog)	119	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN25395_c1_g1_i1	Q9W6X9	RS24_ORYLA	60.8	74	29	0	222	1	58	131	5.70E-14	77.8	RS24_ORYLA	reviewed	40S ribosomal protein S24	rps24	Oryzias latipes (Japanese rice fish) (Japanese killifish)	132	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22949_c1_g1_i1	Q9W6X9	RS24_ORYLA	80.4	56	11	0	169	2	4	59	5.00E-18	91.3	RS24_ORYLA	reviewed	40S ribosomal protein S24	rps24	Oryzias latipes (Japanese rice fish) (Japanese killifish)	132	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17643_c1_g1_i1	Q90YQ0	RS24_ICTPU	70.8	65	19	0	200	6	32	96	1.50E-19	96.3	RS24_ICTPU	reviewed	40S ribosomal protein S24	rps24	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	131	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17643_c0_g1_i1	Q56JU9	RS24_BOVIN	79.4	63	13	0	191	3	4	66	4.90E-23	108.2	RS24_BOVIN	reviewed	40S ribosomal protein S24	RPS24	Bos taurus (Bovine)	131	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN17643_c0_g1_i2	Q56JU9	RS24_BOVIN	79.4	63	13	0	191	3	4	66	1.70E-23	109.8	RS24_BOVIN	reviewed	40S ribosomal protein S24	RPS24	Bos taurus (Bovine)	131	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4871_c0_g1_i1	Q56JU9	RS24_BOVIN	98.4	122	2	0	369	4	1	122	8.60E-59	227.6	RS24_BOVIN	reviewed	40S ribosomal protein S24	RPS24	Bos taurus (Bovine)	131	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4871_c0_g2_i1	Q56JU9	RS24_BOVIN	98.4	122	2	0	366	1	2	123	1.40E-58	226.9	RS24_BOVIN	reviewed	40S ribosomal protein S24	RPS24	Bos taurus (Bovine)	131	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29647_c1_g1_i1	Q56JU9	RS24_BOVIN	74.2	128	33	0	71	454	4	131	1.80E-44	180.3	RS24_BOVIN	reviewed	40S ribosomal protein S24	RPS24	Bos taurus (Bovine)	131	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN40580_c0_g1_i1	Q9SS17	RS241_ARATH	57.6	92	39	0	281	6	7	98	1.60E-24	113.2	RS241_ARATH	reviewed	40S ribosomal protein S24-1	RPS24A At3g04920 T9J14.13	Arabidopsis thaliana (Mouse-ear cress)	133	chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009507; GO:0022626; GO:0022627; GO:0042788	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN38647_c0_g1_i1	Q9SS17	RS241_ARATH	55.1	98	44	0	46	339	4	101	1.80E-25	116.7	RS241_ARATH	reviewed	40S ribosomal protein S24-1	RPS24A At3g04920 T9J14.13	Arabidopsis thaliana (Mouse-ear cress)	133	chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0006412; GO:0009507; GO:0022626; GO:0022627; GO:0042788	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN897_c0_g1_i1	P27085	RS26_OCTVU	67	94	31	0	340	59	1	94	2.70E-32	139.4	RS26_OCTVU	reviewed	40S ribosomal protein S26	RPS26	Octopus vulgaris (Common octopus)	127	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		red	red	NA	NA	NA	NA
TRINITY_DN897_c0_g1_i2	P27085	RS26_OCTVU	65.5	110	34	1	327	10	1	110	2.60E-35	149.4	RS26_OCTVU	reviewed	40S ribosomal protein S26	RPS26	Octopus vulgaris (Common octopus)	127	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		red	red	NA	NA	NA	NA
TRINITY_DN897_c0_g1_i3	P27085	RS26_OCTVU	67	94	31	0	340	59	1	94	2.70E-32	139.4	RS26_OCTVU	reviewed	40S ribosomal protein S26	RPS26	Octopus vulgaris (Common octopus)	127	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN16119_c0_g1_i1	Q56JV1	RS26_BOVIN	73.5	68	18	0	3	206	5	72	1.40E-22	106.3	RS26_BOVIN	reviewed	40S ribosomal protein S26	RPS26	Bos taurus (Bovine)	115	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN16119_c4_g1_i1	Q56JV1	RS26_BOVIN	75	100	25	0	301	2	1	100	3.30E-36	152.1	RS26_BOVIN	reviewed	40S ribosomal protein S26	RPS26	Bos taurus (Bovine)	115	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN30344_c0_g1_i1	Q56JV1	RS26_BOVIN	100	115	0	0	42	386	1	115	2.10E-59	229.6	RS26_BOVIN	reviewed	40S ribosomal protein S26	RPS26	Bos taurus (Bovine)	115	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN10514_c0_g1_i1	Q56JV1	RS26_BOVIN	100	115	0	0	370	26	1	115	1.60E-59	229.9	RS26_BOVIN	reviewed	40S ribosomal protein S26	RPS26	Bos taurus (Bovine)	115	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN31291_c0_g1_i1	Q56JV1	RS26_BOVIN	73.9	46	12	0	3	140	56	101	4.90E-12	71.2	RS26_BOVIN	reviewed	40S ribosomal protein S26	RPS26	Bos taurus (Bovine)	115	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN38703_c3_g1_i1	Q56JV1	RS26_BOVIN	82.2	101	18	0	405	103	1	101	2.60E-42	172.9	RS26_BOVIN	reviewed	40S ribosomal protein S26	RPS26	Bos taurus (Bovine)	115	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN36972_c0_g1_i1	P21772	RS26_NEUCR	92.2	116	9	0	348	1	1	116	1.40E-55	216.9	RS26_NEUCR	reviewed	40S ribosomal protein S26E (13.6 kDa ribosomal protein) (CRP5)	rps-26 crp-5 NCU04552	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	119	cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN27702_c0_g1_i1	Q8SQM3	RS3_ENCCU	48	102	53	0	17	322	114	215	1.90E-21	103.2	RS3_ENCCU	reviewed	40S ribosomal protein S3	RPS3 ECU09_1250	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	216	small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015935	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN27726_c0_g1_i1	Q3T169	RS3_BOVIN	72.7	88	24	0	1	264	144	231	2.60E-29	129	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18122_c0_g1_i1	Q3T169	RS3_BOVIN	84.8	138	21	0	1	414	85	222	6.10E-62	238	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18122_c1_g1_i1	Q3T169	RS3_BOVIN	74.4	117	30	0	355	5	106	222	2.00E-45	183	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN38556_c4_g1_i1	Q3T169	RS3_BOVIN	85.5	234	34	0	764	63	1	234	3.40E-109	396	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN24707_c0_g1_i1	Q3T169	RS3_BOVIN	74	73	19	0	1	219	137	209	5.40E-25	114.4	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19603_c0_g1_i1	Q3T169	RS3_BOVIN	74.1	58	15	0	218	45	177	234	2.20E-18	92.4	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19603_c1_g1_i1	Q3T169	RS3_BOVIN	84.7	72	11	0	231	16	126	197	2.50E-28	125.6	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22663_c0_g2_i1	E2RH47	RS3_CANLF	100	243	0	0	55	783	1	243	1.20E-133	477.2	RS3_CANLF	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Canis lupus familiaris (Dog) (Canis familiaris)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; synapse [GO:0045202]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; synapse [GO:0045202]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0031334; GO:0045202; GO:0051092; GO:0051301; GO:0140078; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22663_c3_g1_i1	P79891	RS3_AMBME	84.8	66	10	0	1	198	67	132	9.40E-24	110.2	RS3_AMBME	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Ambystoma mexicanum (Axolotl)	253	mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0015935; GO:0051301; GO:0140078	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22663_c0_g1_i1	Q3T169	RS3_BOVIN	100	243	0	0	54	782	1	243	6.90E-134	478	RS3_BOVIN	reviewed	40S ribosomal protein S3 (EC 4.2.99.18)	RPS3	Bos taurus (Bovine)	243	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2946_c0_g3_i1	P62866	RS30_BOVIN	77.6	58	13	0	248	75	1	58	4.20E-18	92	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN2946_c0_g2_i1	P62866	RS30_BOVIN	77.6	58	13	0	234	61	1	58	9.00E-18	90.9	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2946_c0_g1_i1	P62866	RS30_BOVIN	79.3	58	12	0	221	48	1	58	6.20E-18	91.3	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN13370_c0_g1_i1	P62866	RS30_BOVIN	87	46	6	0	273	410	1	46	1.40E-13	77.4	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13370_c0_g1_i3	P62866	RS30_BOVIN	84.5	58	9	0	273	446	1	58	1.70E-19	97.4	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN13370_c0_g1_i5	P62866	RS30_BOVIN	79.3	58	12	0	273	446	1	58	4.30E-18	92.8	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN4402_c0_g2_i1	P62866	RS30_BOVIN	86.4	59	8	0	227	51	1	59	3.80E-21	102.1	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4402_c0_g1_i1	P62866	RS30_BOVIN	86.4	59	8	0	231	55	1	59	2.20E-21	102.8	RS30_BOVIN	reviewed	40S ribosomal protein S30	FAU	Bos taurus (Bovine)	59	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN84_c0_g1_i1	Q9SIP7	RS31_ARATH	78.3	217	47	0	18	668	4	220	6.50E-93	341.7	RS31_ARATH	reviewed	40S ribosomal protein S3-1	RPS3A At2g31610 T9H9.13	Arabidopsis thaliana (Mouse-ear cress)	250	chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005634; GO:0005773; GO:0005774; GO:0005777; GO:0005829; GO:0006412; GO:0009506; GO:0009507; GO:0022626; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN84_c0_g2_i1	Q9M339	RS32_ARATH	76	217	52	0	18	668	4	220	3.50E-91	335.9	RS32_ARATH	reviewed	40S ribosomal protein S3-2	RPS3B At3g53870 F5K20_170	Arabidopsis thaliana (Mouse-ear cress)	249	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0009506; GO:0022626; GO:0022627; GO:0042788	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN820_c0_g1_i1	Q6EV04	RS3A_BIPLU	75.7	267	65	0	58	858	1	267	4.50E-113	409.1	RS3A_BIPLU	reviewed	40S ribosomal protein S3a		Biphyllus lunatus (Beetle)	267	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3429_c0_g1_i1	Q5CP76	RS3A_CRYHO	62.2	98	37	0	294	1	84	181	2.00E-30	132.9	RS3A_CRYHO	reviewed	40S ribosomal protein S3a	Chro.40360	Cryptosporidium hominis	262	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3429_c0_g1_i2	Q5CP76	RS3A_CRYHO	62	100	38	0	305	6	84	183	7.10E-31	134.4	RS3A_CRYHO	reviewed	40S ribosomal protein S3a	Chro.40360	Cryptosporidium hominis	262	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3429_c0_g1_i3	Q5CP76	RS3A_CRYHO	67.1	76	25	0	228	1	106	181	3.40E-22	105.1	RS3A_CRYHO	reviewed	40S ribosomal protein S3a	Chro.40360	Cryptosporidium hominis	262	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29138_c0_g1_i1	A6YPJ8	RS3A_TRIIF	79	81	17	0	245	3	13	93	2.40E-29	129	RS3A_TRIIF	reviewed	40S ribosomal protein S3a		Triatoma infestans (Assassin bug)	262	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15691_c0_g1_i1	Q1HRR3	RS3A_AEDAE	79.7	79	16	0	237	1	21	99	9.30E-31	133.7	RS3A_AEDAE	reviewed	40S ribosomal protein S3a	AAEL005901; AAEL013158	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	270	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15691_c0_g2_i1	A5JSW9	RS3A_BOMMA	78.3	83	18	0	250	2	93	175	6.90E-32	137.5	RS3A_BOMMA	reviewed	40S ribosomal protein S3a		Bombyx mandarina (Wild silk moth) (Wild silkworm)	263	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN15691_c1_g1_i1	Q5G5C4	RS3A_PERAM	79.2	72	15	0	3	218	44	115	2.70E-24	112.1	RS3A_PERAM	reviewed	40S ribosomal protein S3a	Parcxpwex01	Periplaneta americana (American cockroach) (Blatta americana)	263	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022627	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2277_c0_g2_i1	Q56JV9	RS3A_BOVIN	100	264	0	0	840	49	1	264	5.40E-148	525	RS3A_BOVIN	reviewed	40S ribosomal protein S3a	RPS3A	Bos taurus (Bovine)	264	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005829; GO:0006412; GO:0022627; GO:0030154; GO:1990904	cell differentiation [GO:0030154]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26883_c0_g1_i1	P02350	RS31_XENLA	79.2	72	15	0	218	3	59	130	1.10E-25	116.7	RS31_XENLA	reviewed	40S ribosomal protein S3-A (EC 4.2.99.18) (S1A)	rps3-a	Xenopus laevis (African clawed frog)	246	mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; spindle [GO:0005819]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003677; GO:0003723; GO:0003735; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0007049; GO:0015935; GO:0051301; GO:0140078	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; regulation of translation [GO:0006417]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2277_c0_g1_i1	P97351	RS3A_MOUSE	100	264	0	0	836	45	1	264	3.10E-148	525.8	RS3A_MOUSE	reviewed	40S ribosomal protein S3a (Protein TU-11)	Rps3a Rps3a1	Mus musculus (Mouse)	264	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation initiation factor binding [GO:0031369]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation initiation factor binding [GO:0031369]	GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0015935; GO:0022627; GO:0030154; GO:0031369; GO:0043066; GO:0045202; GO:0045727; GO:0048027; GO:0048146; GO:1990904	cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of translation [GO:0045727]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4089_c0_g1_i1	Q8SS72	RS5_ENCCU	56.2	121	53	0	363	1	29	149	1.20E-32	140.6	RS5_ENCCU	reviewed	40S ribosomal protein S5	RPS5 ECU04_0140	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	189	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0006412; GO:0015935	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN34390_c0_g1_i1	Q5E988	RS5_BOVIN	71.2	198	48	2	648	55	16	204	3.30E-73	276.2	RS5_BOVIN	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	RPS5	Bos taurus (Bovine)	204	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN4246_c1_g1_i1	Q5E988	RS5_BOVIN	91.1	192	17	0	625	50	13	204	1.90E-96	353.6	RS5_BOVIN	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	RPS5	Bos taurus (Bovine)	204	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN4246_c0_g2_i1	P97461	RS5_MOUSE	99.5	204	1	0	662	51	1	204	1.40E-111	403.7	RS5_MOUSE	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	Rps5	Mus musculus (Mouse)	204	cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627; GO:1990904	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4246_c0_g1_i1	Q5E988	RS5_BOVIN	100	204	0	0	658	47	1	204	4.90E-112	405.2	RS5_BOVIN	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	RPS5	Bos taurus (Bovine)	204	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20032_c1_g1_i1	Q5E988	RS5_BOVIN	85.7	70	10	0	3	212	69	138	3.00E-28	125.2	RS5_BOVIN	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	RPS5	Bos taurus (Bovine)	204	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20032_c2_g1_i1	Q5E988	RS5_BOVIN	82.9	82	14	0	249	4	13	94	9.60E-33	140.6	RS5_BOVIN	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	RPS5	Bos taurus (Bovine)	204	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN25015_c0_g1_i1	Q5E988	RS5_BOVIN	87.6	97	12	0	311	21	108	204	1.10E-39	163.7	RS5_BOVIN	reviewed	"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	RPS5	Bos taurus (Bovine)	204	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022627	regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN24079_c0_g1_i1	Q24186	RS5A_DROME	54.9	71	27	1	65	262	9	79	1.10E-13	77	RS5A_DROME	reviewed	40S ribosomal protein S5a	RpS5a M(1)15D RpS5 CG8922	Drosophila melanogaster (Fruit fly)	228	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0002181; GO:0003729; GO:0003735; GO:0005730; GO:0005737; GO:0005840; GO:0006412; GO:0019843; GO:0022626; GO:0022627	cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN25015_c0_g1_i2	Q24186	RS5A_DROME	87.7	73	9	0	239	21	156	228	4.00E-27	121.7	RS5A_DROME	reviewed	40S ribosomal protein S5a	RpS5a M(1)15D RpS5 CG8922	Drosophila melanogaster (Fruit fly)	228	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0002181; GO:0003729; GO:0003735; GO:0005730; GO:0005737; GO:0005840; GO:0006412; GO:0019843; GO:0022626; GO:0022627	cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18945_c0_g1_i1	A6H769	RS7_BOVIN	72	82	23	0	4	249	66	147	5.90E-25	114.8	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5127_c1_g3_i1	A6H769	RS7_BOVIN	70.3	37	11	0	122	12	153	189	6.50E-07	54.3	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5127_c0_g1_i10	A6H769	RS7_BOVIN	73.7	190	47	2	606	46	5	194	1.60E-70	267.3	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN36701_c0_g1_i1	Q10101	RS7_SCHPO	60	100	39	1	300	4	76	175	2.20E-24	112.8	RS7_SCHPO	reviewed	40S ribosomal protein S7	rps7 SPAC18G6.14c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	195	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0022627; GO:0032040; GO:0042254; GO:0042274	cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		red	red	NA	NA	NA	NA
TRINITY_DN3905_c0_g1_i1	A6H769	RS7_BOVIN	100	194	0	0	617	36	1	194	4.10E-102	372.1	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3905_c0_g2_i1	A6H769	RS7_BOVIN	100	194	0	0	626	45	1	194	5.40E-102	371.7	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3905_c1_g1_i1	A6H769	RS7_BOVIN	73.9	92	24	0	3	278	97	188	1.60E-29	129.8	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19216_c0_g1_i1	A6H769	RS7_BOVIN	84.3	70	11	0	18	227	113	182	1.60E-27	122.9	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN19307_c4_g1_i1	Q9VA91	RS7_DROME	66.7	99	33	0	300	4	94	192	2.20E-29	129.4	RS7_DROME	reviewed	40S ribosomal protein S7	RpS7 CG1883	Drosophila melanogaster (Fruit fly)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]	cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005634; GO:0006364; GO:0022627; GO:0032040; GO:0042274	cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN19307_c1_g1_i1	Q90YR7	RS7_ICTPU	66.7	78	25	1	236	6	32	109	5.10E-21	101.3	RS7_ICTPU	reviewed	40S ribosomal protein S7	rps7	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	194	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0030097; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19307_c1_g2_i1	A6H769	RS7_BOVIN	78.4	111	24	0	335	3	78	188	3.70E-41	168.7	RS7_BOVIN	reviewed	40S ribosomal protein S7	RPS7	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; microtubule organizing center [GO:0005815]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005815; GO:0006364; GO:0006412; GO:0022627; GO:0032040; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19307_c1_g2_i2	Q9VA91	RS7_DROME	79.7	69	14	0	237	31	77	145	5.10E-24	111.3	RS7_DROME	reviewed	40S ribosomal protein S7	RpS7 CG1883	Drosophila melanogaster (Fruit fly)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]	cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005634; GO:0006364; GO:0022627; GO:0032040; GO:0042274	cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN19307_c2_g1_i1	Q90YR7	RS7_ICTPU	60.2	88	32	2	37	291	5	92	2.60E-19	95.9	RS7_ICTPU	reviewed	40S ribosomal protein S7	rps7	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	194	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0030097; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19307_c2_g1_i2	Q90YR7	RS7_ICTPU	54.2	72	30	2	37	243	5	76	1.00E-11	70.5	RS7_ICTPU	reviewed	40S ribosomal protein S7	rps7	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	194	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0030097; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; hemopoiesis [GO:0030097]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19307_c3_g1_i1	P02362	RS7_XENLA	74	73	19	0	3	221	91	163	1.30E-21	103.2	RS7_XENLA	reviewed	40S ribosomal protein S7 (40S ribosomal protein S8)	rps7 rps8	Xenopus laevis (African clawed frog)	194	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN35958_c0_g1_i1	Q20228	RS9_CAEEL	43.9	57	32	0	49	219	10	66	4.00E-07	55.1	RS9_CAEEL	reviewed	40S ribosomal protein S9	rps-9 F40F8.10	Caenorhabditis elegans	189	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015935; GO:0019843; GO:0022627; GO:0045903	positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23178_c0_g1_i1	P55935	RS9_DROME	75.4	65	16	0	1	195	116	180	4.80E-20	97.8	RS9_DROME	reviewed	40S ribosomal protein S9	RpS9 CG3395	Drosophila melanogaster (Fruit fly)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0045903	cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]		NA	NA	NA	NA	NA	NA
TRINITY_DN23199_c0_g1_i1	A6QLG5	RS9_BOVIN	75.3	73	18	0	14	232	11	83	2.90E-21	102.1	RS9_BOVIN	reviewed	40S ribosomal protein S9	RPS9	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0003735; GO:0005730; GO:0006412; GO:0008284; GO:0015935; GO:0019843; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:1990904	positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2116_c0_g1_i1	A6QLG5	RS9_BOVIN	99	194	2	0	603	22	1	194	2.90E-98	359.4	RS9_BOVIN	reviewed	40S ribosomal protein S9	RPS9	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0003735; GO:0005730; GO:0006412; GO:0008284; GO:0015935; GO:0019843; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:1990904	positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2116_c0_g1_i2	A6QLG5	RS9_BOVIN	99	194	2	0	603	22	1	194	2.20E-98	359.8	RS9_BOVIN	reviewed	40S ribosomal protein S9	RPS9	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0003735; GO:0005730; GO:0006412; GO:0008284; GO:0015935; GO:0019843; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:1990904	positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2116_c1_g1_i13	A6QLG5	RS9_BOVIN	87	46	6	0	210	73	136	181	4.20E-16	85.5	RS9_BOVIN	reviewed	40S ribosomal protein S9	RPS9	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0003735; GO:0005730; GO:0006412; GO:0008284; GO:0015935; GO:0019843; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:1990904	positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN2116_c1_g1_i18	P55935	RS9_DROME	84.4	180	28	0	442	981	1	180	3.70E-79	296.6	RS9_DROME	reviewed	40S ribosomal protein S9	RpS9 CG3395	Drosophila melanogaster (Fruit fly)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0045903	cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]		blue	blue	NA	NA	NA	NA
TRINITY_DN2116_c1_g1_i18	P55935	RS9_DROME	79.7	128	26	0	386	3	8	135	8.90E-49	195.7	RS9_DROME	reviewed	40S ribosomal protein S9	RpS9 CG3395	Drosophila melanogaster (Fruit fly)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0045903	cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]		blue	blue	NA	NA	NA	NA
TRINITY_DN2116_c1_g1_i2	P55935	RS9_DROME	84.4	180	28	0	618	79	1	180	4.50E-79	296.6	RS9_DROME	reviewed	40S ribosomal protein S9	RpS9 CG3395	Drosophila melanogaster (Fruit fly)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0045903	cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]		NA	NA	NA	NA	NA	NA
TRINITY_DN2116_c1_g1_i22	P55935	RS9_DROME	82.1	173	31	0	846	1364	8	180	5.40E-73	276.6	RS9_DROME	reviewed	40S ribosomal protein S9	RpS9 CG3395	Drosophila melanogaster (Fruit fly)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0045903	cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]		blue	blue	NA	NA	NA	NA
TRINITY_DN2116_c1_g1_i22	P55935	RS9_DROME	83.2	137	23	0	790	380	1	137	7.90E-56	219.5	RS9_DROME	reviewed	40S ribosomal protein S9	RpS9 CG3395	Drosophila melanogaster (Fruit fly)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0045903	cytoplasmic translation [GO:0002181]; positive regulation of translational fidelity [GO:0045903]		blue	blue	NA	NA	NA	NA
TRINITY_DN2116_c0_g2_i1	A6QLG5	RS9_BOVIN	97.7	88	2	0	299	36	107	194	5.80E-36	151.4	RS9_BOVIN	reviewed	40S ribosomal protein S9	RPS9	Bos taurus (Bovine)	194	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0003735; GO:0005730; GO:0006412; GO:0008284; GO:0015935; GO:0019843; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:1990904	positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN39122_c0_g1_i1	Q9LXG1	RS91_ARATH	70.5	166	49	0	49	546	7	172	8.90E-65	248.1	RS91_ARATH	reviewed	40S ribosomal protein S9-1	RPS9B At5g15200 F8M21_90	Arabidopsis thaliana (Mouse-ear cress)	198	cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cell wall [GO:0005618]; chloroplast [GO:0009507]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005618; GO:0005730; GO:0005774; GO:0005829; GO:0006412; GO:0009506; GO:0009507; GO:0009536; GO:0015935; GO:0019843; GO:0022626; GO:0022627; GO:0042788; GO:0045903	positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN17215_c0_g1_i1	Q55FI1	GABT_DICDI	62	129	49	0	1	387	185	313	1.70E-42	173.3	GABT_DICDI	reviewed	4-aminobutyrate aminotransferase (EC 2.6.1.19) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase)	gabT DDB_G0268104	Dictyostelium discoideum (Slime mold)	495	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrion [GO:0005739]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; gamma-aminobutyric acid catabolic process [GO:0009450]	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrion [GO:0005739]	4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; 4-aminobutyrate transaminase activity [GO:0003867]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0003867; GO:0005739; GO:0009450; GO:0030170; GO:0032144; GO:0034386; GO:0042802	gamma-aminobutyric acid catabolic process [GO:0009450]		NA	NA	NA	NA	NA	NA
TRINITY_DN3350_c0_g1_i2	P80404	GABT_HUMAN	59.2	76	31	0	28	255	198	273	1.20E-18	94	GABT_HUMAN	reviewed	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	ABAT GABAT	Homo sapiens (Human)	500	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]	(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]	GO:0001666; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042493; GO:0042802; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]		NA	NA	NA	NA	NA	NA
TRINITY_DN3350_c0_g1_i3	P80147	GABT_PIG	55.3	190	83	1	2	571	274	461	1.40E-57	224.2	GABT_PIG	reviewed	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	ABAT GABAT	Sus scrofa (Pig)	500	"4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]"	4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]"	GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537	behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]		NA	NA	NA	NA	NA	NA
TRINITY_DN3350_c0_g1_i6	P80147	GABT_PIG	54.6	478	214	2	158	1591	22	496	8.70E-155	548.5	GABT_PIG	reviewed	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	ABAT GABAT	Sus scrofa (Pig)	500	"4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]"	4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]"	GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537	behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]		NA	NA	NA	NA	NA	NA
TRINITY_DN3350_c0_g1_i8	P80404	GABT_HUMAN	65.7	70	24	0	283	492	203	272	6.30E-21	102.1	GABT_HUMAN	reviewed	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	ABAT GABAT	Homo sapiens (Human)	500	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]	(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]	GO:0001666; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042493; GO:0042802; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]		NA	NA	NA	NA	NA	NA
TRINITY_DN3350_c0_g1_i8	P80404	GABT_HUMAN	54.7	64	28	1	93	284	140	202	3.90E-15	82.8	GABT_HUMAN	reviewed	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	ABAT GABAT	Homo sapiens (Human)	500	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]	(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]	GO:0001666; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042493; GO:0042802; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]		NA	NA	NA	NA	NA	NA
TRINITY_DN34320_c0_g1_i1	A5JTM6	CBACL_PSEUC	56.5	69	28	1	203	3	395	463	5.30E-14	77.8	CBACL_PSEUC	reviewed	4-chlorobenzoate--CoA ligase (4-CBA:CoA ligase) (EC 6.2.1.33)		Pseudomonas sp. (strain CBS-3)	528	4-chlorobenzoate-CoA ligase activity [GO:0018861]; ATP binding [GO:0005524]		4-chlorobenzoate-CoA ligase activity [GO:0018861]; ATP binding [GO:0005524]	GO:0005524; GO:0018861			yellow	yellow	NA	NA	NA	NA
TRINITY_DN7955_c0_g1_i3	P41636	4CL_PINTA	42.4	210	112	3	63	671	289	496	1.10E-40	168.3	4CL_PINTA	reviewed	4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase)	4CL	Pinus taeda (Loblolly pine)	537	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]	GO:0005524; GO:0009698; GO:0016207	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN7955_c0_g1_i6	P41636	4CL_PINTA	41.5	272	150	3	314	1108	227	496	6.00E-54	213	4CL_PINTA	reviewed	4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase)	4CL	Pinus taeda (Loblolly pine)	537	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]	GO:0005524; GO:0009698; GO:0016207	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN12205_c0_g1_i1	P14912	4CL1_PETCR	40.1	531	304	8	120	1682	8	534	7.20E-99	362.8	4CL1_PETCR	reviewed	4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1)	4CL1 4CL-1	Petroselinum crispum (Parsley) (Petroselinum hortense)	544	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]	GO:0005524; GO:0009698; GO:0016207	phenylpropanoid metabolic process [GO:0009698]		blue	blue	NA	NA	NA	NA
TRINITY_DN5873_c0_g1_i1	P14912	4CL1_PETCR	35.8	81	52	0	448	206	50	130	5.30E-07	55.8	4CL1_PETCR	reviewed	4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1)	4CL1 4CL-1	Petroselinum crispum (Parsley) (Petroselinum hortense)	544	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]	GO:0005524; GO:0009698; GO:0016207	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN2220_c0_g1_i1	O24146	4CL2_TOBAC	43.5	283	147	7	4	822	261	540	2.50E-55	217.2	4CL2_TOBAC	reviewed	4-coumarate--CoA ligase 2 (4CL 2) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 2)	4CL2	Nicotiana tabacum (Common tobacco)	542	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009698; GO:0016207; GO:0016405	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN7955_c0_g1_i1	Q9LU36	4CL4_ARATH	38.6	57	35	0	31	201	249	305	1.30E-05	50.4	4CL4_ARATH	reviewed	4-coumarate--CoA ligase 4 (4CL 4) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 5) (At4CL5) (4-coumaroyl-CoA synthase 4)	4CL4 At3g21230 MXL8_9	Arabidopsis thaliana (Mouse-ear cress)	570	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid biosynthetic process [GO:0009699]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009699; GO:0016207; GO:0016405	phenylpropanoid biosynthetic process [GO:0009699]		NA	NA	NA	NA	NA	NA
TRINITY_DN7955_c0_g1_i4	Q9LU36	4CL4_ARATH	33.9	112	74	0	31	366	249	360	7.90E-12	71.6	4CL4_ARATH	reviewed	4-coumarate--CoA ligase 4 (4CL 4) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 5) (At4CL5) (4-coumaroyl-CoA synthase 4)	4CL4 At3g21230 MXL8_9	Arabidopsis thaliana (Mouse-ear cress)	570	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid biosynthetic process [GO:0009699]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009699; GO:0016207; GO:0016405	phenylpropanoid biosynthetic process [GO:0009699]		NA	NA	NA	NA	NA	NA
TRINITY_DN7470_c0_g2_i1	Q84P24	4CLL6_ARATH	49.7	155	76	2	13	474	402	555	2.90E-42	172.9	4CLL6_ARATH	reviewed	4-coumarate--CoA ligase-like 6 (EC 6.2.1.-) (4-coumarate--CoA ligase) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 7) (At4CL7) (4-hydroxybenzoate--CoA ligase) (EC 6.2.1.27)	4CLL6 At4g19010 F13C5.180	Arabidopsis thaliana (Mouse-ear cress)	566	peroxisome [GO:0005777]; 4-coumarate-CoA ligase activity [GO:0016207]; 4-hydroxybenzoate-CoA ligase activity [GO:0018859]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; ubiquinone biosynthetic process [GO:0006744]	peroxisome [GO:0005777]	4-coumarate-CoA ligase activity [GO:0016207]; 4-hydroxybenzoate-CoA ligase activity [GO:0018859]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0005777; GO:0006744; GO:0016207; GO:0016405; GO:0018859	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN1449_c0_g1_i1	Q7YQK3	4F2_RABIT	26.5	211	140	5	132	722	15	224	1.10E-13	79.7	4F2_RABIT	reviewed	4F2 cell-surface antigen heavy chain (4F2hc) (Solute carrier family 3 member 2) (CD antigen CD98)	SLC3A2	Oryctolagus cuniculus (Rabbit)	529	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; neutral amino acid transmembrane transporter activity [GO:0015175]; carbohydrate metabolic process [GO:0005975]; L-leucine import across plasma membrane [GO:1903801]; tryptophan transport [GO:0015827]	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	catalytic activity [GO:0003824]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0003824; GO:0005765; GO:0005886; GO:0005975; GO:0015175; GO:0015827; GO:0016021; GO:0016324; GO:0030054; GO:0042470; GO:1903801	carbohydrate metabolic process [GO:0005975]; L-leucine import across plasma membrane [GO:1903801]; tryptophan transport [GO:0015827]		blue	blue	NA	NA	NA	NA
TRINITY_DN40780_c0_g1_i1	Q5M8W9	HOGA1_XENTR	49.3	67	33	1	14	214	103	168	3.90E-12	71.6	HOGA1_XENTR	reviewed	"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)"	hoga1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	328	mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	mitochondrion [GO:0005739]	4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	GO:0005739; GO:0008700			NA	NA	NA	NA	NA	NA
TRINITY_DN2377_c0_g1_i1	Q5M8W9	HOGA1_XENTR	58.1	298	123	1	958	65	31	326	8.70E-98	358.6	HOGA1_XENTR	reviewed	"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)"	hoga1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	328	mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	mitochondrion [GO:0005739]	4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	GO:0005739; GO:0008700			NA	NA	NA	NA	NA	NA
TRINITY_DN2377_c0_g1_i2	Q5M8W9	HOGA1_XENTR	61.8	152	58	0	520	65	175	326	9.60E-51	202.2	HOGA1_XENTR	reviewed	"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)"	hoga1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	328	mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	mitochondrion [GO:0005739]	4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	GO:0005739; GO:0008700			NA	NA	NA	NA	NA	NA
TRINITY_DN2377_c0_g1_i2	Q5M8W9	HOGA1_XENTR	53.4	116	52	1	873	526	31	144	4.20E-30	133.7	HOGA1_XENTR	reviewed	"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)"	hoga1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	328	mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	mitochondrion [GO:0005739]	4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]	GO:0005739; GO:0008700			NA	NA	NA	NA	NA	NA
TRINITY_DN4770_c0_g1_i1	Q16QL3	COQ2_AEDAE	64.1	281	101	0	935	93	119	399	2.20E-107	391	COQ2_AEDAE	reviewed	"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (Coenzyme Q biosynthesis protein 2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)"	coq2 AAEL011249	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	441	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; 4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; isoprenoid biosynthetic process [GO:0008299]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383]; ubiquinone biosynthetic process [GO:0006744]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]	4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]	GO:0002083; GO:0005666; GO:0005736; GO:0005743; GO:0006360; GO:0006383; GO:0006744; GO:0008299; GO:0008412; GO:0031305; GO:0047293	isoprenoid biosynthetic process [GO:0008299]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c1_g1_i1	P38942	CAT2_CLOK5	50.1	415	199	6	218	1456	13	421	1.20E-105	385.2	CAT2_CLOK5	reviewed	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	cat2 CKL_3018	Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)	429	"acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]; acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"		acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]	GO:0003986; GO:0006083; GO:0008775; GO:0019679	"acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3296_c1_g1_i3	P38942	CAT2_CLOK5	42.5	207	114	4	218	835	13	215	1.10E-37	158.7	CAT2_CLOK5	reviewed	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	cat2 CKL_3018	Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)	429	"acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]; acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"		acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]	GO:0003986; GO:0006083; GO:0008775; GO:0019679	"acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c1_g1_i8	P38942	CAT2_CLOK5	42.5	207	114	4	218	835	13	215	1.10E-37	158.7	CAT2_CLOK5	reviewed	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	cat2 CKL_3018	Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)	429	"acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]; acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"		acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]	GO:0003986; GO:0006083; GO:0008775; GO:0019679	"acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40419_c0_g1_i1	A4YDT1	HBCL1_METS5	52.7	74	35	0	227	6	425	498	1.60E-16	86.3	HBCL1_METS5	reviewed	4-hydroxybutyrate--CoA ligase 1 (EC 6.2.1.40) (Acetate--CoA ligase) (EC 6.2.1.1) (Butyrate--CoA ligase) (EC 6.2.1.2) (Propionate--CoA ligase) (EC 6.2.1.17)	Msed_0406	Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2)	564	integral component of membrane [GO:0016021]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]; fatty acid metabolic process [GO:0006631]	integral component of membrane [GO:0016021]	acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0006631; GO:0016021; GO:0047760; GO:0050218	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN976_c0_g1_i2	Q96IR7	HPDL_HUMAN	26.5	253	122	6	418	1164	73	265	7.60E-17	89.7	HPDL_HUMAN	reviewed	4-hydroxyphenylpyruvate dioxygenase-like protein (HPD-like protein) (EC 1.13.-.-) (Glyoxalase domain-containing protein 1)	HPDL GLOXD1	Homo sapiens (Human)	371	4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072]		4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]	GO:0003868; GO:0009072; GO:0046872	aromatic amino acid family metabolic process [GO:0009072]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i17	Q9NVE7	PANK4_HUMAN	50	108	54	0	541	218	595	702	1.90E-25	117.5	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i17	Q9NVE7	PANK4_HUMAN	55.8	52	23	0	194	39	703	754	8.20E-08	58.9	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i21	Q9NVE7	PANK4_HUMAN	57.8	45	17	1	199	71	548	592	1.90E-05	49.3	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i26	Q9NVE7	PANK4_HUMAN	49.1	116	56	1	435	88	595	707	5.60E-26	119	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i28	Q9NVE7	PANK4_HUMAN	52.1	242	114	1	767	48	528	769	1.50E-64	247.7	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i29	Q9NVE7	PANK4_HUMAN	51.9	162	78	0	575	90	595	756	8.20E-43	175.3	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i37	Q9NVE7	PANK4_HUMAN	51.9	162	78	0	575	90	595	756	8.40E-43	175.3	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i6	Q9NVE7	PANK4_HUMAN	58.5	53	22	0	247	89	595	647	2.10E-13	76.6	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i7	Q9NVE7	PANK4_HUMAN	70	40	11	1	247	128	19	57	2.10E-08	60.1	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i9	Q9NVE7	PANK4_HUMAN	72.2	54	15	0	306	145	318	371	5.80E-17	88.6	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN27067_c0_g1_i1	Q9NVE7	PANK4_HUMAN	100	72	0	0	218	3	312	383	2.10E-37	155.6	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN30984_c0_g1_i1	Q9NVE7	PANK4_HUMAN	100	152	0	0	3	458	89	240	4.70E-87	321.6	PANK4_HUMAN	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4)	PANK4	Homo sapiens (Human)	773	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i15	Q80YV4	PANK4_MOUSE	54.2	120	53	1	442	89	528	647	9.50E-30	131.3	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i45	Q80YV4	PANK4_MOUSE	49.7	177	87	1	712	188	528	704	9.90E-42	171.8	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN4386_c0_g1_i45	Q80YV4	PANK4_MOUSE	69.4	36	11	0	146	39	766	801	3.50E-07	57	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i10	Q80YV4	PANK4_MOUSE	64.6	175	56	1	669	145	203	371	7.80E-60	231.9	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i11	Q80YV4	PANK4_MOUSE	60.7	364	127	5	1221	145	19	371	2.30E-118	427.2	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i13	Q80YV4	PANK4_MOUSE	58.3	235	88	4	988	302	29	259	2.00E-67	257.7	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i13	Q80YV4	PANK4_MOUSE	73.6	53	14	0	303	145	319	371	2.10E-16	88.2	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i14	Q80YV4	PANK4_MOUSE	61	246	86	4	1024	302	19	259	1.10E-76	288.5	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i14	Q80YV4	PANK4_MOUSE	73.6	53	14	0	303	145	319	371	2.20E-16	88.2	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i3	Q80YV4	PANK4_MOUSE	71.7	60	17	0	481	302	200	259	1.80E-19	97.8	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i3	Q80YV4	PANK4_MOUSE	73.6	53	14	0	303	145	319	371	1.40E-16	88.2	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN3490_c0_g1_i8	Q80YV4	PANK4_MOUSE	70.1	77	23	0	339	109	203	279	7.60E-25	114.8	PANK4_MOUSE	reviewed	4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (mPanK4)	Pank4	Mus musculus (Mouse)	820	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN16857_c0_g1_i2	Q9JLJ2	AL9A1_MOUSE	45.1	142	78	0	431	6	8	149	7.30E-28	125.2	AL9A1_MOUSE	reviewed	4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3)	Aldh9a1	Mus musculus (Mouse)	494	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0004029; GO:0005739; GO:0005829; GO:0006081; GO:0009437; GO:0016620; GO:0019145; GO:0042136; GO:0042802; GO:0043176; GO:0043878; GO:0045329; GO:0047105; GO:0051287; GO:0051289; GO:0055114	carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN40449_c0_g1_i1	P49189	AL9A1_HUMAN	100	128	0	0	1	384	358	485	6.10E-72	271.2	AL9A1_HUMAN	reviewed	"4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABALDH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed]"	ALDH9A1 ALDH4 ALDH7 ALDH9	Homo sapiens (Human)	494	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0005737; GO:0005829; GO:0006081; GO:0019145; GO:0033737; GO:0042136; GO:0042445; GO:0043878; GO:0045329; GO:0047105; GO:0051289; GO:0055114; GO:0070062	carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN16857_c0_g2_i1	Q7ZVB2	A9A1A_DANRE	62.8	164	61	0	494	3	201	364	2.10E-53	209.9	A9A1A_DANRE	reviewed	4-trimethylaminobutyraldehyde dehydrogenase A (TMABA-DH) (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1-A) (EC 1.2.1.3)	aldh9a1a aldh9a1l	Danio rerio (Zebrafish) (Brachydanio rerio)	508	cytosol [GO:0005829]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]	cytosol [GO:0005829]	4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0005829; GO:0006081; GO:0019145; GO:0043878; GO:0045329; GO:0047105; GO:0051289	carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i12	Q8C7W7	DCR1B_MOUSE	45.1	324	167	3	213	1184	1	313	1.80E-77	291.2	DCR1B_MOUSE	reviewed	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	Dclre1b Snm1b	Mus musculus (Mouse)	541	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006289; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i2	Q8C7W7	DCR1B_MOUSE	45.1	324	167	3	3056	4027	1	313	6.00E-77	291.2	DCR1B_MOUSE	reviewed	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	Dclre1b Snm1b	Mus musculus (Mouse)	541	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006289; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i21	Q8C7W7	DCR1B_MOUSE	45.1	324	167	3	1347	2318	1	313	3.50E-77	291.2	DCR1B_MOUSE	reviewed	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	Dclre1b Snm1b	Mus musculus (Mouse)	541	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006289; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i22	Q8C7W7	DCR1B_MOUSE	45.1	324	167	3	3123	4094	1	313	6.10E-77	291.2	DCR1B_MOUSE	reviewed	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	Dclre1b Snm1b	Mus musculus (Mouse)	541	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006289; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i6	Q8C7W7	DCR1B_MOUSE	45.1	324	167	3	3208	4179	1	313	6.20E-77	291.2	DCR1B_MOUSE	reviewed	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	Dclre1b Snm1b	Mus musculus (Mouse)	541	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006289; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i7	Q8C7W7	DCR1B_MOUSE	45.1	324	167	3	223	1194	1	313	1.80E-77	291.2	DCR1B_MOUSE	reviewed	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	Dclre1b Snm1b	Mus musculus (Mouse)	541	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006289; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; nucleotide-excision repair [GO:0006289]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c1_g1_i2	P49544	RK1_TRICV	25.8	198	125	8	798	214	23	201	7.40E-09	63.2	RK1_TRICV	reviewed	"50S ribosomal protein L1, chloroplastic"	rpl1	Trieres chinensis (Marine centric diatom) (Odontella sinensis)	230	chloroplast [GO:0009507]; large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	chloroplast [GO:0009507]; large ribosomal subunit [GO:0015934]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0009507; GO:0015934; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c1_g1_i4	P49544	RK1_TRICV	25.8	198	125	8	797	213	23	201	5.70E-09	63.5	RK1_TRICV	reviewed	"50S ribosomal protein L1, chloroplastic"	rpl1	Trieres chinensis (Marine centric diatom) (Odontella sinensis)	230	chloroplast [GO:0009507]; large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	chloroplast [GO:0009507]; large ribosomal subunit [GO:0015934]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0009507; GO:0015934; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c1_g1_i5	P49544	RK1_TRICV	25.8	198	125	8	788	204	23	201	7.40E-09	63.2	RK1_TRICV	reviewed	"50S ribosomal protein L1, chloroplastic"	rpl1	Trieres chinensis (Marine centric diatom) (Odontella sinensis)	230	chloroplast [GO:0009507]; large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	chloroplast [GO:0009507]; large ribosomal subunit [GO:0015934]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0009507; GO:0015934; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40706_c0_g1_i1	A6GZ89	RL14_FLAPJ	82.4	74	13	0	2	223	49	122	9.90E-30	130.2	RL14_FLAPJ	reviewed	50S ribosomal protein L14	rplN FP1329	Flavobacterium psychrophilum (strain ATCC 49511 / DSM 21280 / CIP 103535 / JIP02/86)	122	large ribosomal subunit [GO:0015934]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015934; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN366_c1_g1_i1	Q21Z00	RL27_RHOFT	50	72	35	1	450	235	2	72	7.30E-11	68.9	RL27_RHOFT	reviewed	50S ribosomal protein L27	rpmA Rfer_1269	Rhodoferax ferrireducens (strain ATCC BAA-621 / DSM 15236 / T118) (Albidiferax ferrireducens)	85	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN17333_c0_g1_i11	Q9CUX1	P52K_MOUSE	29.5	193	124	5	1	558	554	741	1.30E-13	78.2	P52K_MOUSE	reviewed	52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	Thap12 Prkrir Thap0	Mus musculus (Mouse)	758	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0005634; GO:0046872; GO:0046983			NA	NA	NA	NA	NA	NA
TRINITY_DN2032_c0_g1_i1	Q6PB03	PLD3_XENLA	51.2	209	99	2	628	2	272	477	1.10E-54	214.5	PLD3_XENLA	reviewed	5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)	pld3	Xenopus laevis (African clawed frog)	493	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0016021; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015	immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN2032_c0_g1_i2	Q6PB03	PLD3_XENLA	51.2	209	99	2	628	2	272	477	1.10E-54	214.5	PLD3_XENLA	reviewed	5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)	pld3	Xenopus laevis (African clawed frog)	493	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0016021; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015	immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN2032_c0_g1_i4	Q6PB03	PLD3_XENLA	51.2	209	99	2	628	2	272	477	1.10E-54	214.5	PLD3_XENLA	reviewed	5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)	pld3	Xenopus laevis (African clawed frog)	493	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0016021; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015	immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN1962_c0_g1_i1	Q2KJJ8	PLD3_BOVIN	52.3	197	90	4	597	7	79	271	9.50E-50	198.4	PLD3_BOVIN	reviewed	5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)	PLD3	Bos taurus (Bovine)	490	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0000139; GO:0002376; GO:0005765; GO:0005789; GO:0006954; GO:0014902; GO:0016021; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015	immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN1962_c0_g1_i2	Q2KJJ8	PLD3_BOVIN	56.8	118	49	2	354	1	158	273	1.40E-31	137.1	PLD3_BOVIN	reviewed	5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)	PLD3	Bos taurus (Bovine)	490	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0000139; GO:0002376; GO:0005765; GO:0005789; GO:0006954; GO:0014902; GO:0016021; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015	immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN15118_c0_g1_i1	Q8BG07	PLD4_MOUSE	98.8	84	1	0	3	254	199	282	4.20E-45	181.4	PLD4_MOUSE	reviewed	5'-3' exonuclease PLD4 (EC 3.1.16.1) (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4) (Phospholipase D4) (PLD 4)	Pld4	Mus musculus (Mouse)	503	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0002244; GO:0005634; GO:0005769; GO:0005783; GO:0005789; GO:0006909; GO:0006954; GO:0016021; GO:0032588; GO:0045087; GO:0045145; GO:0045335; GO:1900015	hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN38743_c0_g1_i1	Q8BG07	PLD4_MOUSE	100	79	0	0	239	3	403	481	3.20E-39	161.8	PLD4_MOUSE	reviewed	5'-3' exonuclease PLD4 (EC 3.1.16.1) (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4) (Phospholipase D4) (PLD 4)	Pld4	Mus musculus (Mouse)	503	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0002244; GO:0005634; GO:0005769; GO:0005783; GO:0005789; GO:0006909; GO:0006954; GO:0016021; GO:0032588; GO:0045087; GO:0045145; GO:0045335; GO:1900015	hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015]		NA	NA	NA	NA	NA	NA
TRINITY_DN36318_c0_g1_i1	Q8IZH2	XRN1_HUMAN	100	109	0	0	3	329	164	272	1.70E-59	229.6	XRN1_HUMAN	reviewed	5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog)	XRN1 SEP1	Homo sapiens (Human)	1706	"cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0043488; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795	"cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g2_i1	Q8IZH2	XRN1_HUMAN	63.5	74	27	0	32	253	99	172	3.30E-20	99	XRN1_HUMAN	reviewed	5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog)	XRN1 SEP1	Homo sapiens (Human)	1706	"cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0043488; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795	"cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23529_c0_g1_i1	Q8IZH2	XRN1_HUMAN	100	134	0	0	47	448	1	134	9.90E-74	277.3	XRN1_HUMAN	reviewed	5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog)	XRN1 SEP1	Homo sapiens (Human)	1706	"cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0043488; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795	"cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25796_c0_g1_i1	Q8IZH2	XRN1_HUMAN	97.8	89	2	0	5	271	264	352	4.80E-47	188	XRN1_HUMAN	reviewed	5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog)	XRN1 SEP1	Homo sapiens (Human)	1706	"cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0043488; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795	"cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g1_i1	P97789	XRN1_MOUSE	38.9	416	227	10	97	1293	616	1021	1.00E-73	278.9	XRN1_MOUSE	reviewed	5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog)	Xrn1 Dhm2 Exo Sep1	Mus musculus (Mouse)	1719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]	GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503	"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g1_i2	P97789	XRN1_MOUSE	50.6	1223	562	16	37	3639	1	1203	0	1174.8	XRN1_MOUSE	reviewed	5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog)	Xrn1 Dhm2 Exo Sep1	Mus musculus (Mouse)	1719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]	GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503	"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g1_i3	P97789	XRN1_MOUSE	46.1	1058	528	16	60	3167	166	1203	7.60E-261	901.7	XRN1_MOUSE	reviewed	5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog)	Xrn1 Dhm2 Exo Sep1	Mus musculus (Mouse)	1719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]	GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503	"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g1_i4	P97789	XRN1_MOUSE	49.7	1199	561	16	64	3594	25	1203	0	1124.8	XRN1_MOUSE	reviewed	5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog)	Xrn1 Dhm2 Exo Sep1	Mus musculus (Mouse)	1719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]	GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503	"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g1_i5	P97789	XRN1_MOUSE	36.9	301	172	6	97	951	616	914	1.10E-48	195.3	XRN1_MOUSE	reviewed	5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog)	Xrn1 Dhm2 Exo Sep1	Mus musculus (Mouse)	1719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]	GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503	"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6352_c0_g1_i6	P97789	XRN1_MOUSE	38.5	600	337	12	97	1836	616	1203	3.00E-108	394	XRN1_MOUSE	reviewed	5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog)	Xrn1 Dhm2 Exo Sep1	Mus musculus (Mouse)	1719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]	GO:0000723; GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006396; GO:0007569; GO:0016075; GO:0017148; GO:0030425; GO:0043025; GO:0045202; GO:0051321; GO:0051880; GO:0071028; GO:0071044; GO:0090503	"cell aging [GO:0007569]; histone mRNA catabolic process [GO:0071044]; meiotic cell cycle [GO:0051321]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36502_c0_g1_i1	Q74ZA0	XRN2_ASHGO	62.7	67	21	1	205	5	615	677	1.60E-18	92.8	XRN2_ASHGO	reviewed	5'-3' exoribonuclease 2 (EC 3.1.13.-)	RAT1 AGR303W	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	945	"nucleus [GO:0005634]; 5'-3' exoribonuclease activity [GO:0004534]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; mRNA processing [GO:0006397]; negative regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901408]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 5'-3' [GO:0034428]; positive regulation of chromosome segregation [GO:0051984]; snoRNA processing [GO:0043144]; termination of RNA polymerase II transcription, exosome-dependent [GO:0030847]; termination of RNA polymerase II transcription, poly(A)-coupled [GO:0030846]"	nucleus [GO:0005634]	5'-3' exoribonuclease activity [GO:0004534]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000448; GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0006397; GO:0019843; GO:0030846; GO:0030847; GO:0034244; GO:0034428; GO:0043144; GO:0051984; GO:0071028; GO:0071035; GO:1901408	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; mRNA processing [GO:0006397]; negative regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901408]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 5'-3' [GO:0034428]; positive regulation of chromosome segregation [GO:0051984]; snoRNA processing [GO:0043144]; termination of RNA polymerase II transcription, exosome-dependent [GO:0030847]; termination of RNA polymerase II transcription, poly(A)-coupled [GO:0030846]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34048_c0_g1_i1	Q6C961	XRN2_YARLI	44.7	85	41	2	248	12	183	267	1.70E-11	69.7	XRN2_YARLI	reviewed	5'-3' exoribonuclease 2 (EC 3.1.13.-)	RAT1 YALI0D13750g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	1010	"nucleus [GO:0005634]; 5'-3' exoribonuclease activity [GO:0004534]; RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; rRNA processing [GO:0006364]"	nucleus [GO:0005634]	5'-3' exoribonuclease activity [GO:0004534]; RNA binding [GO:0003723]	GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0006353; GO:0006364; GO:0006397	"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12221_c0_g1_i2	Q9H0D6	XRN2_HUMAN	100	350	0	0	1052	3	18	367	8.20E-212	737.3	XRN2_HUMAN	reviewed	5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein)	XRN2	Homo sapiens (Human)	950	"aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]"	aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0000175; GO:0000738; GO:0000956; GO:0001147; GO:0003723; GO:0004518; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006353; GO:0006364; GO:0006396; GO:0006397; GO:0006401; GO:0007283; GO:0008409; GO:0016020; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0046872; GO:0060041	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12221_c0_g1_i1	Q9DBR1	XRN2_MOUSE	99.7	313	1	0	941	3	18	330	1.30E-187	656.8	XRN2_MOUSE	reviewed	5'-3' exoribonuclease 2 (EC 3.1.13.-) (Protein Dhm1)	Xrn2 Dhm1	Mus musculus (Mouse)	951	"aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-templated transcription, termination [GO:0006353]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]"	aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0000175; GO:0000738; GO:0000956; GO:0001147; GO:0003723; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006353; GO:0006397; GO:0007017; GO:0007283; GO:0008409; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0046872; GO:0060041	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-templated transcription, termination [GO:0006353]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14624_c0_g2_i1	Q9U299	XRN2_CAEEL	56	75	30	1	225	1	297	368	6.70E-18	90.9	XRN2_CAEEL	reviewed	5'-3' exoribonuclease 2 homolog (EC 3.1.13.-)	xrn-2 Y48B6A.3	Caenorhabditis elegans	975	"nucleolus [GO:0005730]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; miRNA catabolic process [GO:0010587]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of gene silencing by miRNA [GO:0060965]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of development, heterochronic [GO:0040034]; regulation of vulval development [GO:0040028]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000738; GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0005730; GO:0006353; GO:0006397; GO:0007275; GO:0008409; GO:0010587; GO:0040028; GO:0040034; GO:0046872; GO:0060965	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; miRNA catabolic process [GO:0010587]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of gene silencing by miRNA [GO:0060965]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of development, heterochronic [GO:0040034]; regulation of vulval development [GO:0040028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14624_c0_g1_i1	Q9U299	XRN2_CAEEL	67.5	83	27	0	256	8	47	129	2.30E-27	122.5	XRN2_CAEEL	reviewed	5'-3' exoribonuclease 2 homolog (EC 3.1.13.-)	xrn-2 Y48B6A.3	Caenorhabditis elegans	975	"nucleolus [GO:0005730]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; miRNA catabolic process [GO:0010587]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of gene silencing by miRNA [GO:0060965]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of development, heterochronic [GO:0040034]; regulation of vulval development [GO:0040028]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000738; GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0005730; GO:0006353; GO:0006397; GO:0007275; GO:0008409; GO:0010587; GO:0040028; GO:0040034; GO:0046872; GO:0060965	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; miRNA catabolic process [GO:0010587]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of gene silencing by miRNA [GO:0060965]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of development, heterochronic [GO:0040034]; regulation of vulval development [GO:0040028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2525_c0_g1_i1	Q9VM71	XRN2_DROME	80.4	97	19	0	329	39	17	113	1.40E-40	166.8	XRN2_DROME	reviewed	5'-3' exoribonuclease 2 homolog (EC 3.1.13.-) (Ribonucleic acid-trafficking protein 1) (dRAT1)	Rat1 CG10354	Drosophila melanogaster (Fruit fly)	908	"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]"	nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000738; GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0006353; GO:0006397; GO:0008409; GO:0046872	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2525_c0_g1_i2	Q9VM71	XRN2_DROME	76	359	81	1	1064	3	17	375	1.30E-164	580.5	XRN2_DROME	reviewed	5'-3' exoribonuclease 2 homolog (EC 3.1.13.-) (Ribonucleic acid-trafficking protein 1) (dRAT1)	Rat1 CG10354	Drosophila melanogaster (Fruit fly)	908	"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]"	nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000738; GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0006353; GO:0006397; GO:0008409; GO:0046872	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36141_c0_g1_i1	Q9VM71	XRN2_DROME	84.3	83	13	0	249	1	570	652	6.60E-35	147.5	XRN2_DROME	reviewed	5'-3' exoribonuclease 2 homolog (EC 3.1.13.-) (Ribonucleic acid-trafficking protein 1) (dRAT1)	Rat1 CG10354	Drosophila melanogaster (Fruit fly)	908	"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]"	nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000738; GO:0000956; GO:0003723; GO:0004534; GO:0005634; GO:0006353; GO:0006397; GO:0008409; GO:0046872	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14624_c0_g3_i1	Q9FQ03	XRN3_ARATH	63	108	37	2	322	2	174	279	4.60E-33	141.7	XRN3_ARATH	reviewed	5'-3' exoribonuclease 3 (AtXRN3) (EC 3.1.13.-) (Protein EXORIBONUCLEASE 3)	XRN3 At1g75660 F10A5.15	Arabidopsis thaliana (Mouse-ear cress)	1020	nucleus [GO:0005634]; 5'-3' exoribonuclease activity [GO:0004534]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; mRNA processing [GO:0006397]; negative regulation of posttranscriptional gene silencing [GO:0060149]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; rRNA 5'-end processing [GO:0000967]	nucleus [GO:0005634]	5'-3' exoribonuclease activity [GO:0004534]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000956; GO:0000967; GO:0003723; GO:0004534; GO:0005634; GO:0006397; GO:0008270; GO:0010587; GO:0060149; GO:0071035	miRNA catabolic process [GO:0010587]; mRNA processing [GO:0006397]; negative regulation of posttranscriptional gene silencing [GO:0060149]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; rRNA 5'-end processing [GO:0000967]		NA	NA	NA	NA	NA	NA
TRINITY_DN25992_c0_g1_i1	Q9FQ04	XRN4_ARATH	50	48	24	0	207	64	78	125	2.30E-08	59.3	XRN4_ARATH	reviewed	5'-3' exoribonuclease 4 (EC 3.1.13.-) (Protein ACC INSENSITIVE 1) (Protein ETHYLENE INSENSITIVE 5) (Protein EXORIBONUCLEASE 4)	XRN4 AIN1 EIN5 At1g54490 F20D21.30	Arabidopsis thaliana (Mouse-ear cress)	947	"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; 5'-3' exoribonuclease activity [GO:0004534]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular heat acclimation [GO:0070370]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; heat acclimation [GO:0010286]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; phloem or xylem histogenesis [GO:0010087]; regulation of gene expression, epigenetic [GO:0040029]; unidimensional cell growth [GO:0009826]"	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]	5'-3' exoribonuclease activity [GO:0004534]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000291; GO:0000932; GO:0000956; GO:0003723; GO:0003729; GO:0004534; GO:0005634; GO:0005829; GO:0005844; GO:0006397; GO:0006402; GO:0008270; GO:0009826; GO:0010087; GO:0010286; GO:0010494; GO:0010587; GO:0031087; GO:0040029; GO:0051301; GO:0070370	"cell division [GO:0051301]; cellular heat acclimation [GO:0070370]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; heat acclimation [GO:0010286]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; phloem or xylem histogenesis [GO:0010087]; regulation of gene expression, epigenetic [GO:0040029]; unidimensional cell growth [GO:0009826]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31640_c0_g1_i1	Q6CF20	RM04_YARLI	71.9	32	9	0	61	156	78	109	1.30E-06	53.5	RM04_YARLI	reviewed	"54S ribosomal protein L4, mitochondrial"	MRPL4 YALI0B11000g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	340	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		red	red	NA	NA	NA	NA
TRINITY_DN24161_c0_g1_i1	Q00013	EM55_HUMAN	100	244	0	0	734	3	221	464	2.70E-137	489.2	EM55_HUMAN	reviewed	"55 kDa erythrocyte membrane protein (p55) (Membrane protein, palmitoylated 1)"	MPP1 DXS552E EMP55	Homo sapiens (Human)	466	centriolar satellite [GO:0034451]; cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; guanylate kinase activity [GO:0004385]; regulation of neutrophil chemotaxis [GO:0090022]; signal transduction [GO:0007165]	centriolar satellite [GO:0034451]; cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]	guanylate kinase activity [GO:0004385]	GO:0004385; GO:0005886; GO:0007165; GO:0016020; GO:0030863; GO:0032420; GO:0034451; GO:0090022	regulation of neutrophil chemotaxis [GO:0090022]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12729_c0_g2_i1	P08262	HEM1_BRADU	63.5	85	31	0	260	6	186	270	3.40E-26	118.6	HEM1_BRADU	reviewed	5-aminolevulinate synthase (EC 2.3.1.37) (5-aminolevulinic acid synthase) (Delta-ALA synthase) (Delta-aminolevulinate synthase)	hemA bll1200	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	409	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0006782; GO:0006783; GO:0030170	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN29069_c0_g1_i1	P26505	HEM1_RHIRD	65.2	69	24	0	3	209	330	398	8.40E-21	100.5	HEM1_RHIRD	reviewed	5-aminolevulinate synthase (EC 2.3.1.37) (5-aminolevulinic acid synthase) (Delta-ALA synthase) (Delta-aminolevulinate synthase)	hemA	Rhizobium radiobacter (Agrobacterium tumefaciens) (Agrobacterium radiobacter)	405	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; protoporphyrinogen IX biosynthetic process [GO:0006782]		5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0003870; GO:0006782; GO:0030170	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN19099_c0_g1_i1	P26505	HEM1_RHIRD	71.1	97	28	0	7	297	200	296	2.50E-33	142.5	HEM1_RHIRD	reviewed	5-aminolevulinate synthase (EC 2.3.1.37) (5-aminolevulinic acid synthase) (Delta-ALA synthase) (Delta-aminolevulinate synthase)	hemA	Rhizobium radiobacter (Agrobacterium tumefaciens) (Agrobacterium radiobacter)	405	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; protoporphyrinogen IX biosynthetic process [GO:0006782]		5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0003870; GO:0006782; GO:0030170	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN19099_c0_g1_i2	P08080	HEM1_RHIME	72.7	88	24	0	1	264	208	295	1.80E-30	132.9	HEM1_RHIME	reviewed	5-aminolevulinate synthase (EC 2.3.1.37) (5-aminolevulinic acid synthase) (Delta-ALA synthase) (Delta-aminolevulinate synthase)	hemA R02989 SMc03104	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	404	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; protoporphyrinogen IX biosynthetic process [GO:0006782]		5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0003870; GO:0006782; GO:0030170	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN4455_c0_g1_i1	P43089	HEM1_PARDP	72.9	133	36	0	401	3	124	256	2.30E-53	209.5	HEM1_PARDP	reviewed	5-aminolevulinate synthase (EC 2.3.1.37) (5-aminolevulinic acid synthase) (Delta-ALA synthase) (Delta-aminolevulinate synthase)	hemA Pden_1822	Paracoccus denitrificans (strain Pd 1222)	409	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; protoporphyrinogen IX biosynthetic process [GO:0006782]		5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0003870; GO:0006782; GO:0030170	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	1
TRINITY_DN243_c0_g1_i1	Q3ZC31	HEM0_BOVIN	53.2	562	213	8	1713	175	11	571	1.60E-159	564.3	HEM0_BOVIN	reviewed	"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	ALAS2	Bos taurus (Bovine)	587	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0048821	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN243_c0_g1_i3	Q3ZC31	HEM0_BOVIN	53.1	571	234	8	1815	175	11	571	8.30E-162	572	HEM0_BOVIN	reviewed	"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	ALAS2	Bos taurus (Bovine)	587	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0048821	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN243_c0_g1_i4	Q3ZC31	HEM0_BOVIN	53.1	571	234	8	1815	175	11	571	8.30E-162	572	HEM0_BOVIN	reviewed	"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	ALAS2	Bos taurus (Bovine)	587	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0048821	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN243_c0_g1_i5	Q3ZC31	HEM0_BOVIN	53.2	562	213	8	1713	175	11	571	1.60E-159	564.3	HEM0_BOVIN	reviewed	"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	ALAS2	Bos taurus (Bovine)	587	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0048821	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		blue	blue	NA	NA	NA	NA
TRINITY_DN39022_c0_g1_i1	P08680	HEM0_MOUSE	100	404	0	0	3	1214	153	556	1.70E-237	822.8	HEM0_MOUSE	reviewed	"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	Alas2	Mus musculus (Mouse)	587	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; coenzyme A binding [GO:0120225]; pyridoxal phosphate binding [GO:0030170]; cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-aminolevulinate synthase activity [GO:0003870]; coenzyme A binding [GO:0120225]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0006879; GO:0030170; GO:0030218; GO:0042541; GO:0048821; GO:0120225	cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN12729_c0_g1_i1	Q92403	HEM1_AGABI	57.1	77	33	0	9	239	199	275	3.20E-18	92	HEM1_AGABI	reviewed	"5-aminolevulinate synthase, mitochondrial (EC 2.3.1.37) (5-aminolevulinic acid synthase) (Delta-ALA synthase) (Delta-aminolevulinate synthase)"	hem1	Agaricus bisporus (White button mushroom)	621	mitochondrial matrix [GO:0005759]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; protoporphyrinogen IX biosynthetic process [GO:0006782]	mitochondrial matrix [GO:0005759]	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0003870; GO:0005759; GO:0006782; GO:0030170	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN25731_c0_g1_i1	P13196	HEM1_HUMAN	99.4	174	1	0	523	2	451	624	3.70E-96	352.1	HEM1_HUMAN	reviewed	"5-aminolevulinate synthase, nonspecific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)"	ALAS1 ALAS3 ALASH OK/SW-cl.121	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; mitochondrion organization [GO:0007005]; protoporphyrinogen IX biosynthetic process [GO:0006782]; regulation of lipid metabolic process [GO:0019216]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0007005; GO:0019216; GO:0030170; GO:0042541; GO:0042802; GO:0048821	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; mitochondrion organization [GO:0007005]; protoporphyrinogen IX biosynthetic process [GO:0006782]; regulation of lipid metabolic process [GO:0019216]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN34042_c0_g1_i1	P13196	HEM1_HUMAN	100	128	0	0	386	3	326	453	1.80E-71	269.6	HEM1_HUMAN	reviewed	"5-aminolevulinate synthase, nonspecific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)"	ALAS1 ALAS3 ALASH OK/SW-cl.121	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; mitochondrion organization [GO:0007005]; protoporphyrinogen IX biosynthetic process [GO:0006782]; regulation of lipid metabolic process [GO:0019216]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0007005; GO:0019216; GO:0030170; GO:0042541; GO:0042802; GO:0048821	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; mitochondrion organization [GO:0007005]; protoporphyrinogen IX biosynthetic process [GO:0006782]; regulation of lipid metabolic process [GO:0019216]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN39758_c0_g1_i1	Q13131	AAPK1_HUMAN	99.1	111	1	0	336	4	22	132	1.10E-56	220.3	AAPK1_HUMAN	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26)	PRKAA1 AMPK1	Homo sapiens (Human)	559	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of MAPK activity [GO:0000187]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000187; GO:0001666; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0006468; GO:0006633; GO:0006695; GO:0007050; GO:0007165; GO:0008022; GO:0008284; GO:0008610; GO:0009411; GO:0009631; GO:0010332; GO:0010508; GO:0010628; GO:0010629; GO:0014823; GO:0015721; GO:0016055; GO:0016236; GO:0016241; GO:0016324; GO:0016607; GO:0019395; GO:0030424; GO:0030425; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0033135; GO:0034599; GO:0035174; GO:0035556; GO:0035690; GO:0038183; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045542; GO:0045821; GO:0046318; GO:0046627; GO:0046872; GO:0047322; GO:0048156; GO:0048511; GO:0048643; GO:0050321; GO:0050405; GO:0050995; GO:0055089; GO:0060627; GO:0061744; GO:0061762; GO:0062028; GO:0070050; GO:0070301; GO:0070507; GO:0071277; GO:0071333; GO:0071361; GO:0071380; GO:0071417; GO:0071456; GO:0097009; GO:0120188; GO:1901563; GO:1901796; GO:1903109; GO:1903829; GO:1903955; GO:1904428; GO:1904486; GO:2000758	activation of MAPK activity [GO:0000187]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN40286_c0_g1_i1	Q13131	AAPK1_HUMAN	100	100	0	0	302	3	144	243	7.00E-55	214.2	AAPK1_HUMAN	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26)	PRKAA1 AMPK1	Homo sapiens (Human)	559	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of MAPK activity [GO:0000187]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000187; GO:0001666; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0006468; GO:0006633; GO:0006695; GO:0007050; GO:0007165; GO:0008022; GO:0008284; GO:0008610; GO:0009411; GO:0009631; GO:0010332; GO:0010508; GO:0010628; GO:0010629; GO:0014823; GO:0015721; GO:0016055; GO:0016236; GO:0016241; GO:0016324; GO:0016607; GO:0019395; GO:0030424; GO:0030425; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0033135; GO:0034599; GO:0035174; GO:0035556; GO:0035690; GO:0038183; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045542; GO:0045821; GO:0046318; GO:0046627; GO:0046872; GO:0047322; GO:0048156; GO:0048511; GO:0048643; GO:0050321; GO:0050405; GO:0050995; GO:0055089; GO:0060627; GO:0061744; GO:0061762; GO:0062028; GO:0070050; GO:0070301; GO:0070507; GO:0071277; GO:0071333; GO:0071361; GO:0071380; GO:0071417; GO:0071456; GO:0097009; GO:0120188; GO:1901563; GO:1901796; GO:1903109; GO:1903829; GO:1903955; GO:1904428; GO:1904486; GO:2000758	activation of MAPK activity [GO:0000187]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN18609_c0_g1_i1	Q95ZQ4	AAPK2_CAEEL	60.5	114	45	0	3	344	187	300	6.00E-34	144.8	AAPK2_CAEEL	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1)	aak-2 T01C8.1	Caenorhabditis elegans	626	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008340; GO:0018105; GO:0030424; GO:0035556; GO:0043025; GO:0050709; GO:0050714; GO:0061066	determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN18024_c0_g1_i1	Q95ZQ4	AAPK2_CAEEL	60.9	92	36	0	3	278	150	241	1.30E-26	120.2	AAPK2_CAEEL	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1)	aak-2 T01C8.1	Caenorhabditis elegans	626	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008340; GO:0018105; GO:0030424; GO:0035556; GO:0043025; GO:0050709; GO:0050714; GO:0061066	determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN20422_c0_g1_i1	Q95ZQ4	AAPK2_CAEEL	62.8	113	42	0	362	24	185	297	1.90E-35	149.8	AAPK2_CAEEL	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1)	aak-2 T01C8.1	Caenorhabditis elegans	626	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008340; GO:0018105; GO:0030424; GO:0035556; GO:0043025; GO:0050709; GO:0050714; GO:0061066	determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN231_c0_g1_i1	Q5RD00	AAPK2_PONAB	66.7	369	116	2	1166	60	11	372	7.70E-141	501.9	AAPK2_PONAB	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	PRKAA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	552	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]	GO:0003682; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0031669; GO:0032007; GO:0035174; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0097009	autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN231_c0_g1_i2	Q5RD00	AAPK2_PONAB	64	491	145	7	1551	106	11	478	8.10E-175	615.1	AAPK2_PONAB	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	PRKAA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	552	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]	GO:0003682; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0031669; GO:0032007; GO:0035174; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0097009	autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN231_c0_g1_i3	Q5RD00	AAPK2_PONAB	59.2	564	161	11	1554	1	11	551	5.10E-177	622.5	AAPK2_PONAB	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	PRKAA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	552	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]	GO:0003682; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0031669; GO:0032007; GO:0035174; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0097009	autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN231_c0_g1_i4	Q5RD00	AAPK2_PONAB	65.2	477	148	4	1509	106	11	478	5.00E-177	622.5	AAPK2_PONAB	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	PRKAA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	552	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]	GO:0003682; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0031669; GO:0032007; GO:0035174; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0097009	autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN231_c0_g1_i5	Q5RD00	AAPK2_PONAB	60.2	550	164	8	1512	1	11	551	3.10E-179	629.8	AAPK2_PONAB	reviewed	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	PRKAA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	552	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]	GO:0003682; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0031669; GO:0032007; GO:0035174; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0097009	autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN902_c0_g2_i2	O43741	AAKB2_HUMAN	53	202	87	3	352	954	78	272	2.60E-56	220.7	AAKB2_HUMAN	reviewed	5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2)	PRKAB2	Homo sapiens (Human)	272	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]	GO:0004679; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0006853; GO:0007050; GO:0007165; GO:0016236; GO:0016241; GO:0019901; GO:0031588; GO:0042304; GO:0042802; GO:0050790; GO:0120162; GO:1901796	carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN902_c0_g1_i1	O43741	AAKB2_HUMAN	50.7	134	55	2	3	404	150	272	7.30E-30	131.7	AAKB2_HUMAN	reviewed	5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2)	PRKAB2	Homo sapiens (Human)	272	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]	GO:0004679; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0006853; GO:0007050; GO:0007165; GO:0016236; GO:0016241; GO:0019901; GO:0031588; GO:0042304; GO:0042802; GO:0050790; GO:0120162; GO:1901796	carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]		brown	brown	NA	NA	NA	NA
TRINITY_DN4920_c0_g1_i1	O43741	AAKB2_HUMAN	62.5	56	20	1	231	67	78	133	4.10E-16	85.5	AAKB2_HUMAN	reviewed	5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2)	PRKAB2	Homo sapiens (Human)	272	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]	GO:0004679; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0006853; GO:0007050; GO:0007165; GO:0016236; GO:0016241; GO:0019901; GO:0031588; GO:0042304; GO:0042802; GO:0050790; GO:0120162; GO:1901796	carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN22345_c0_g1_i1	O54950	AAKG1_MOUSE	99.3	136	1	0	2	409	142	277	9.30E-71	267.3	AAKG1_MOUSE	reviewed	5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg)	Prkag1 Prkaac	Mus musculus (Mouse)	330	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ADP binding [GO:0043531]; AMP-activated protein kinase activity [GO:0004679]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0004672; GO:0004679; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0010628; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0032991; GO:0042149; GO:0043531; GO:0044877; GO:0050790; GO:0051170; GO:0071900	cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]		NA	NA	NA	NA	NA	NA
TRINITY_DN29683_c0_g1_i1	P58108	AAKG1_BOVIN	100	160	0	0	3	482	158	317	2.30E-84	312.8	AAKG1_BOVIN	reviewed	5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg)	PRKAG1	Bos taurus (Bovine)	330	cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]	cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0042149; GO:0043531; GO:0050790; GO:0071900	cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]		NA	NA	NA	NA	NA	NA
TRINITY_DN33774_c0_g1_i1	P58108	AAKG1_BOVIN	100	68	0	0	204	1	39	106	1.20E-31	136.3	AAKG1_BOVIN	reviewed	5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg)	PRKAG1	Bos taurus (Bovine)	330	cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]	cytoplasm [GO:0005737]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0042149; GO:0043531; GO:0050790; GO:0071900	cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]		NA	NA	NA	NA	NA	NA
TRINITY_DN3634_c0_g1_i1	Q91WG5	AAKG2_MOUSE	59.6	314	126	1	723	1661	242	555	1.70E-104	381.7	AAKG2_MOUSE	reviewed	5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2)	Prkag2	Mus musculus (Mouse)	566	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP-activated protein kinase activity [GO:0004679]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0004679; GO:0004862; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006468; GO:0006469; GO:0006633; GO:0008603; GO:0008607; GO:0010800; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0042149; GO:0043531; GO:0045860; GO:0050790	cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3634_c0_g1_i2	Q91WG5	AAKG2_MOUSE	59.6	314	126	1	237	1175	242	555	1.30E-104	381.7	AAKG2_MOUSE	reviewed	5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2)	Prkag2	Mus musculus (Mouse)	566	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP-activated protein kinase activity [GO:0004679]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0004679; GO:0004862; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006468; GO:0006469; GO:0006633; GO:0008603; GO:0008607; GO:0010800; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0042149; GO:0043531; GO:0045860; GO:0050790	cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]		NA	NA	NA	NA	NA	NA
TRINITY_DN37488_c0_g1_i1	Q9UGJ0	AAKG2_HUMAN	100	84	0	0	2	253	443	526	9.10E-40	163.7	AAKG2_HUMAN	reviewed	5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p)	PRKAG2	Homo sapiens (Human)	569	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ATP biosynthetic process [GO:0006754]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP-activated protein kinase activity [GO:0004679]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006468; GO:0006469; GO:0006633; GO:0006754; GO:0006853; GO:0007050; GO:0008603; GO:0008607; GO:0010800; GO:0016126; GO:0016208; GO:0016236; GO:0016241; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0042149; GO:0042304; GO:0043531; GO:0045860; GO:0046320; GO:0046324; GO:0050790; GO:1901796	ATP biosynthetic process [GO:0006754]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; regulation of macroautophagy [GO:0016241]; regulation of signal transduction by p53 class mediator [GO:1901796]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN41050_c0_g1_i1	P42269	HPCC_ECOLX	84.1	69	11	0	2	208	353	421	1.60E-29	129.4	HPCC_ECOLX	reviewed	5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase (CHMS dehydrogenase) (EC 1.2.1.-)	hpcC	Escherichia coli	468	5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase activity [GO:0018480]; 4-hydroxyphenylacetate catabolic process [GO:1901023]		5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase activity [GO:0018480]	GO:0018480; GO:1901023	4-hydroxyphenylacetate catabolic process [GO:1901023]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN7118_c0_g1_i1	P42269	HPCC_ECOLX	82.9	199	33	1	2	598	120	317	6.60E-92	338.2	HPCC_ECOLX	reviewed	5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase (CHMS dehydrogenase) (EC 1.2.1.-)	hpcC	Escherichia coli	468	5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase activity [GO:0018480]; 4-hydroxyphenylacetate catabolic process [GO:1901023]		5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase activity [GO:0018480]	GO:0018480; GO:1901023	4-hydroxyphenylacetate catabolic process [GO:1901023]		NA	NA	NA	NA	NA	NA
TRINITY_DN31249_c0_g1_i1	P97478	COQ7_MOUSE	100	119	0	0	3	359	44	162	1.10E-62	240.4	COQ7_MOUSE	reviewed	"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.99.60) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)"	Coq7	Mus musculus (Mouse)	217	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; age-dependent response to oxidative stress [GO:0001306]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion morphogenesis [GO:0070584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0000122; GO:0001306; GO:0001701; GO:0001841; GO:0003682; GO:0005634; GO:0005739; GO:0005743; GO:0006744; GO:0006979; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0022008; GO:0022904; GO:0031314; GO:0034599; GO:0042775; GO:0045944; GO:0046872; GO:0070584; GO:2000377	age-dependent response to oxidative stress [GO:0001306]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion morphogenesis [GO:0070584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN766_c2_g1_i1	Q99807	COQ7_HUMAN	59.3	221	83	2	934	275	3	217	2.90E-67	256.9	COQ7_HUMAN	reviewed	"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.99.60) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)"	COQ7	Homo sapiens (Human)	217	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0000122; GO:0003682; GO:0005634; GO:0005739; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0045944; GO:0046872; GO:2000377	determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN766_c2_g1_i2	Q2TBW2	COQ7_BOVIN	64.4	194	69	0	856	275	24	217	3.10E-66	253.4	COQ7_BOVIN	reviewed	"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.99.60) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)"	COQ7	Bos taurus (Bovine)	217	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	"2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0046872; GO:2000377	determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN766_c2_g1_i3	Q2TBW2	COQ7_BOVIN	60.1	218	82	2	922	275	3	217	3.80E-67	256.5	COQ7_BOVIN	reviewed	"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.99.60) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)"	COQ7	Bos taurus (Bovine)	217	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]"	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	"2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0046872; GO:2000377	determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN12087_c3_g1_i1	Q66L17	HDDC2_XENLA	49.2	185	93	1	62	616	15	198	9.10E-47	188.3	HDDC2_XENLA	reviewed	5'-deoxynucleotidase HDDC2 (EC 3.1.3.89) (HD domain-containing protein 2)	hddc2	Xenopus laevis (African clawed frog)	201	5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872]		5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872]	GO:0002953; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7801_c0_g1_i1	P80405	MTHFS_RABIT	50	196	98	0	126	713	4	199	7.60E-53	208.8	MTHFS_RABIT	reviewed	"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)"	MTHFS	Oryctolagus cuniculus (Rabbit)	201	cytoplasm [GO:0005737]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]	5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]	GO:0005524; GO:0005542; GO:0005737; GO:0030272; GO:0046653; GO:0046872	tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN7801_c0_g1_i2	Q9D110	MTHFS_MOUSE	56.5	115	50	0	400	744	82	196	5.90E-32	139.4	MTHFS_MOUSE	reviewed	"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)"	Mthfs	Mus musculus (Mouse)	203	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]	GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009396; GO:0030272; GO:0035999; GO:0046653; GO:0046872	folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN7801_c0_g2_i1	P80405	MTHFS_RABIT	50	196	98	0	665	78	4	199	7.60E-53	208.8	MTHFS_RABIT	reviewed	"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)"	MTHFS	Oryctolagus cuniculus (Rabbit)	201	cytoplasm [GO:0005737]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]	5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]	GO:0005524; GO:0005542; GO:0005737; GO:0030272; GO:0046653; GO:0046872	tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN7801_c0_g2_i2	Q9D110	MTHFS_MOUSE	56.5	115	50	0	431	87	82	196	5.90E-32	139.4	MTHFS_MOUSE	reviewed	"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)"	Mthfs	Mus musculus (Mouse)	203	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]	GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009396; GO:0030272; GO:0035999; GO:0046653; GO:0046872	folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN29340_c0_g1_i1	Q9D110	MTHFS_MOUSE	100	92	0	0	3	278	111	202	4.70E-50	198	MTHFS_MOUSE	reviewed	"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)"	Mthfs	Mus musculus (Mouse)	203	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]	GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009396; GO:0030272; GO:0035999; GO:0046653; GO:0046872	folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN27401_c0_g1_i1	Q17239	5HTR_BOMMO	67.1	79	24	1	231	1	113	191	4.40E-25	114.8	5HTR_BOMMO	reviewed	5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor)		Bombyx mori (Silk moth)	446	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33962_c0_g1_i1	P28285	5HT2A_DROME	65.3	98	33	1	316	23	737	833	1.80E-28	127.5	5HT2A_DROME	reviewed	5-hydroxytryptamine receptor 2A (5-HT receptor 2A) (Serotonin receptor 2A)	5-HT1A 5HT-R2A CG16720	Drosophila melanogaster (Fruit fly)	834	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210]"	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	Gi/o-coupled serotonin receptor activity [GO:0001586]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]	GO:0001586; GO:0002121; GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007198; GO:0007208; GO:0007210; GO:0007268; GO:0007615; GO:0008049; GO:0008227; GO:0016021; GO:0030425; GO:0030594; GO:0045187; GO:0045202	"adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4573_c0_g1_i3	Q96CB9	NSUN4_HUMAN	46.6	262	128	6	861	91	129	383	5.40E-54	213	NSUN4_HUMAN	reviewed	5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)	NSUN4	Homo sapiens (Human)	384	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]; mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]	methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]	GO:0001510; GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0031167; GO:0042256; GO:0070131; GO:0070181	mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN4573_c0_g1_i4	Q96CB9	NSUN4_HUMAN	46.6	262	128	6	861	91	129	383	5.00E-54	213	NSUN4_HUMAN	reviewed	5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)	NSUN4	Homo sapiens (Human)	384	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]; mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]	methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]	GO:0001510; GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0031167; GO:0042256; GO:0070131; GO:0070181	mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN4573_c0_g1_i5	Q5M7E3	NSUN4_XENLA	33.8	468	206	8	1485	88	41	406	3.10E-56	221.1	NSUN4_XENLA	reviewed	5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)	nsun4	Xenopus laevis (African clawed frog)	406	mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA methylation [GO:0001510]; rRNA processing [GO:0006364]	mitochondrion [GO:0005739]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]	GO:0001510; GO:0003723; GO:0005739; GO:0006364; GO:0008168	RNA methylation [GO:0001510]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN10451_c0_g1_i1	Q61503	5NTD_MOUSE	31.3	150	82	5	422	27	31	177	1.70E-10	67.8	5NTD_MOUSE	reviewed	5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73)	Nt5e Nt5 Nte	Mus musculus (Mouse)	576	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]	5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0009986; GO:0016020; GO:0031225; GO:0046085; GO:0046086; GO:0050728; GO:0097060	adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]		NA	NA	NA	NA	NA	NA
TRINITY_DN36015_c0_g1_i1	Q9H857	NT5D2_HUMAN	100	75	0	0	3	227	232	306	4.00E-39	161.4	NT5D2_HUMAN	reviewed	5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)	NT5DC2	Homo sapiens (Human)	520	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]		5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	GO:0008253; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN37213_c0_g1_i1	Q6Q0N3	NT5D2_RAT	99.1	107	1	0	322	2	67	173	1.60E-57	223	NT5D2_RAT	reviewed	5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)	Nt5dc2	Rattus norvegicus (Rat)	553	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]		5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	GO:0008253; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17539_c3_g1_i2	Q9H857	NT5D2_HUMAN	46	446	237	3	229	1557	51	495	5.60E-119	429.5	NT5D2_HUMAN	reviewed	5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)	NT5DC2	Homo sapiens (Human)	520	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]		5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	GO:0008253; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17539_c3_g1_i5	Q9H857	NT5D2_HUMAN	42.9	289	157	4	229	1086	51	334	2.00E-67	257.7	NT5D2_HUMAN	reviewed	5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)	NT5DC2	Homo sapiens (Human)	520	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]		5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	GO:0008253; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17539_c3_g1_i1	Q6GN91	NT5D3_XENLA	53.8	160	74	0	197	676	315	474	8.40E-46	185.3	NT5D3_XENLA	reviewed	5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-)	nt5dc3	Xenopus laevis (African clawed frog)	499	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17539_c3_g1_i3	Q6GN91	NT5D3_XENLA	50.7	223	109	1	30	698	253	474	1.00E-62	241.5	NT5D3_XENLA	reviewed	5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-)	nt5dc3	Xenopus laevis (African clawed frog)	499	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17539_c3_g1_i4	Q6GN91	NT5D3_XENLA	64.5	62	22	0	57	242	413	474	1.30E-16	87	NT5D3_XENLA	reviewed	5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-)	nt5dc3	Xenopus laevis (African clawed frog)	499	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN21253_c0_g1_i1	Q9FIZ7	OPLA_ARATH	63.4	82	30	0	258	13	453	534	2.70E-24	112.5	OPLA_ARATH	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Protein OXOPROLINASE 1) (Pyroglutamase)	OXP1 At5g37830 K22F20.70	Arabidopsis thaliana (Mouse-ear cress)	1266	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasmodesma [GO:0009506]; plastid [GO:0009536]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasmodesma [GO:0009506]; plastid [GO:0009536]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005829; GO:0006749; GO:0006751; GO:0009506; GO:0009536; GO:0017168	glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN16404_c0_g1_i1	Q8K010	OPLA_MOUSE	64.1	78	28	0	3	236	186	263	1.80E-21	102.8	OPLA_MOUSE	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	Oplah	Mus musculus (Mouse)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN16404_c0_g2_i1	P97608	OPLA_RAT	60.8	186	67	1	562	5	5	184	1.20E-54	214.5	OPLA_RAT	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	Oplah	Rattus norvegicus (Rat)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN7422_c0_g2_i1	Q8K010	OPLA_MOUSE	48.6	74	38	0	20	241	606	679	5.30E-13	74.7	OPLA_MOUSE	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	Oplah	Mus musculus (Mouse)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN7422_c0_g1_i2	Q75WB5	OPLA_BOVIN	72.2	216	60	0	365	1012	822	1037	3.70E-84	313.2	OPLA_BOVIN	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	OPLAH	Bos taurus (Bovine)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006749; GO:0017168	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN7422_c0_g1_i2	Q75WB5	OPLA_BOVIN	65.1	126	44	0	9	386	682	807	7.00E-43	176	OPLA_BOVIN	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	OPLAH	Bos taurus (Bovine)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006749; GO:0017168	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN7422_c0_g1_i3	Q75WB5	OPLA_BOVIN	71.8	195	55	0	93	677	843	1037	1.80E-74	280.4	OPLA_BOVIN	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	OPLAH	Bos taurus (Bovine)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006749; GO:0017168	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN7422_c0_g1_i4	Q75WB5	OPLA_BOVIN	70.2	356	106	0	9	1076	682	1037	8.30E-143	508.1	OPLA_BOVIN	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	OPLAH	Bos taurus (Bovine)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006749; GO:0017168	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN7422_c0_g3_i1	O14841	OPLA_HUMAN	71	241	67	1	716	3	319	559	1.10E-95	350.9	OPLA_HUMAN	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	OPLAH	Homo sapiens (Human)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0006750; GO:0017168; GO:0042802	glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN15389_c0_g1_i1	O14841	OPLA_HUMAN	76.4	72	17	0	20	235	734	805	3.40E-26	118.6	OPLA_HUMAN	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	OPLAH	Homo sapiens (Human)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0006750; GO:0017168; GO:0042802	glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN18060_c0_g1_i1	Q8K010	OPLA_MOUSE	64.9	77	27	0	244	14	64	140	1.50E-21	103.2	OPLA_MOUSE	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	Oplah	Mus musculus (Mouse)	1288	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN21253_c0_g2_i1	Q54NW6	OPLA_DICDI	71.9	89	25	0	3	269	360	448	1.90E-33	142.9	OPLA_DICDI	reviewed	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	oplah DDB_G0284953	Dictyostelium discoideum (Slime mold)	1265	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006749; GO:0017168	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN30165_c0_g1_i1	Q8IUZ5	AT2L2_HUMAN	58.6	87	36	0	1	261	318	404	5.20E-22	104.8	AT2L2_HUMAN	reviewed	5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2)	PHYKPL AGXT2L2 PP9286	Homo sapiens (Human)	450	mitochondrial matrix [GO:0005759]; identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; collagen catabolic process [GO:0030574]; lysine catabolic process [GO:0006554]	mitochondrial matrix [GO:0005759]	identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005759; GO:0006554; GO:0008483; GO:0016829; GO:0030170; GO:0030574; GO:0042802	collagen catabolic process [GO:0030574]; lysine catabolic process [GO:0006554]		NA	NA	NA	NA	NA	NA
TRINITY_DN2934_c0_g1_i1	Q1LQS4	CH60_CUPMC	94.5	73	4	0	221	3	444	516	6.70E-31	134	CH60_CUPMC	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Rmet_0616	Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) (Ralstonia metallidurans)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN15524_c0_g3_i1	A6Q2B4	CH60_NITSB	66.7	159	52	1	5	478	150	308	1.30E-55	217.2	CH60_NITSB	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL NIS_0509	Nitratiruptor sp. (strain SB155-2)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN9282_c0_g1_i1	Q8Y1P8	CH60_RALSO	100	82	0	0	248	3	352	433	5.00E-35	147.9	CH60_RALSO	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL mopA RSc0642 RS01546	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN9282_c0_g1_i2	Q8Y1P8	CH60_RALSO	90.8	98	9	0	296	3	336	433	2.60E-38	159.1	CH60_RALSO	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL mopA RSc0642 RS01546	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN9282_c0_g1_i3	Q2G2Z4	CH60_NOVAD	94.4	72	4	0	217	2	336	407	1.60E-29	129.4	CH60_NOVAD	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Saro_0035	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN9282_c0_g2_i1	A5VBQ6	CH60_SPHWW	93.9	115	7	0	348	4	329	443	2.60E-53	209.1	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN9282_c0_g2_i2	A5VBQ6	CH60_SPHWW	87.4	127	16	0	384	4	329	455	1.00E-55	217.2	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	1
TRINITY_DN2856_c0_g2_i1	Q2G2Z4	CH60_NOVAD	96.1	127	5	0	381	1	165	291	7.40E-62	237.7	CH60_NOVAD	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Saro_0035	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN2856_c0_g3_i1	A5VBQ6	CH60_SPHWW	95.2	126	6	0	380	3	167	292	1.10E-60	233.8	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN2856_c0_g1_i1	B1LVA0	CH60_METRJ	97.9	97	2	0	292	2	217	313	1.40E-44	179.9	CH60_METRJ	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Mrad2831_0534	Methylobacterium radiotolerans (strain ATCC 27329 / DSM 1819 / JCM 2831 / NBRC 15690 / NCIMB 10815 / 0-1)	546	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i3	A5VBQ6	CH60_SPHWW	86.7	120	16	0	360	1	36	155	1.20E-50	200.3	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i4	A5VBQ6	CH60_SPHWW	92.6	136	10	0	410	3	1	136	1.10E-63	243.8	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i6	A5VBQ6	CH60_SPHWW	90.9	154	14	0	465	4	1	154	3.90E-71	268.9	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i7	A5VBQ6	CH60_SPHWW	91.9	136	11	0	410	3	1	136	4.60E-63	241.9	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN29038_c0_g1_i1	Q0KDR7	CH60_CUPNH	70	100	30	0	306	7	340	439	2.60E-28	125.9	CH60_CUPNH	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL H16_A0706	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN19960_c0_g1_i1	Q8Y1P8	CH60_RALSO	95.6	136	6	0	409	2	132	267	1.70E-64	246.5	CH60_RALSO	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL mopA RSc0642 RS01546	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	1
TRINITY_DN10544_c0_g1_i1	Q2G2Z4	CH60_NOVAD	79.1	67	14	0	1	201	469	535	1.50E-21	102.8	CH60_NOVAD	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Saro_0035	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN10544_c0_g1_i2	Q2G2Z4	CH60_NOVAD	82.9	82	14	0	2	247	454	535	4.90E-30	131.3	CH60_NOVAD	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Saro_0035	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN10544_c0_g1_i3	A5VBQ6	CH60_SPHWW	83.3	84	14	0	2	253	454	537	2.20E-31	136	CH60_SPHWW	reviewed	60 kDa chaperonin (GroEL protein) (Protein Cpn60)	groL groEL Swit_3376	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	549	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN28464_c0_g1_i1	P0CY97	CH601_CUTAK	100	94	0	0	2	283	23	116	9.40E-46	183.7	CH601_CUTAK	reviewed	60 kDa chaperonin 1 (GroEL protein 1) (Heat shock protein 60 1) (Protein Cpn60 1)	groL1 groEL1 hsp60 PPA0453	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	544	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i2	P35469	CH601_RHIME	94.8	77	4	0	307	77	15	91	3.10E-34	145.6	CH601_RHIME	reviewed	60 kDa chaperonin 1 (GroEL protein 1) (Protein Cpn60 1)	groL1 groEL-A groEL1 R00792 SMc00913	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	545	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i2	P35469	CH601_RHIME	88	25	3	0	77	3	91	115	2.00E-04	46.6	CH601_RHIME	reviewed	60 kDa chaperonin 1 (GroEL protein 1) (Protein Cpn60 1)	groL1 groEL-A groEL1 R00792 SMc00913	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	545	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12574_c0_g1_i5	Q1GVZ9	CH601_SPHAL	97.2	141	4	0	423	1	15	155	4.50E-68	258.5	CH601_SPHAL	reviewed	60 kDa chaperonin 1 (GroEL protein 1) (Protein Cpn60 1)	groL1 groEL1 Sala_0452	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN2934_c0_g2_i1	Q13ZW7	CH602_PARXL	88.5	78	9	0	235	2	450	527	6.40E-32	137.5	CH602_PARXL	reviewed	60 kDa chaperonin 2 (GroEL protein 2) (Protein Cpn60 2)	groL2 groEL2 Bxeno_A1804 Bxe_A4544; groL3 groEL3 Bxeno_A1834 Bxe_A2609	Paraburkholderia xenovorans (strain LB400)	540	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN15524_c0_g2_i1	Q2N5R9	CH602_ERYLH	71.4	105	30	0	5	319	9	113	3.40E-36	152.1	CH602_ERYLH	reviewed	60 kDa chaperonin 2 (GroEL protein 2) (Protein Cpn60 2)	groL2 groEL2 ELI_14400	Erythrobacter litoralis (strain HTCC2594)	550	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN29885_c0_g1_i1	A4JPD1	CH602_BURVG	91	122	11	0	369	4	333	454	1.80E-52	206.5	CH602_BURVG	reviewed	60 kDa chaperonin 2 (GroEL protein 2) (Protein Cpn60 2)	groL2 groEL2 Bcep1808_5184	Burkholderia vietnamiensis (strain G4 / LMG 22486) (Burkholderia cepacia (strain R1808))	540	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN40468_c0_g1_i1	Q6A6W2	CH602_CUTAK	100	79	0	0	1	237	346	424	1.50E-36	152.9	CH602_CUTAK	reviewed	60 kDa chaperonin 2 (GroEL protein 2) (Protein Cpn60 2)	groL2 groEL2 PPA1772	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	531	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN38727_c0_g1_i1	A4JPD1	CH602_BURVG	90.8	87	8	0	261	1	130	216	3.50E-39	161.8	CH602_BURVG	reviewed	60 kDa chaperonin 2 (GroEL protein 2) (Protein Cpn60 2)	groL2 groEL2 Bcep1808_5184	Burkholderia vietnamiensis (strain G4 / LMG 22486) (Burkholderia cepacia (strain R1808))	540	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN8385_c0_g1_i1	Q0B1N7	CH603_BURCM	97.5	119	3	0	357	1	1	119	4.90E-58	224.9	CH603_BURCM	reviewed	60 kDa chaperonin 3 (GroEL protein 3) (Protein Cpn60 3)	groL3 groEL3 Bamb_6392	Burkholderia ambifaria (strain ATCC BAA-244 / AMMD) (Burkholderia cepacia (strain AMMD))	540	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0042026; GO:0051082	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN15764_c0_g1_i1	P10809	CH60_HUMAN	100	560	0	0	1	1680	1	560	1.30E-307	1056.2	CH60_HUMAN	reviewed	"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)"	HSPD1 HSP60	Homo sapiens (Human)	573	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; insulin binding [GO:0043559]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protease binding [GO:0002020]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; chaperone-mediated protein complex assembly [GO:0051131]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]; viral process [GO:0016032]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; insulin binding [GO:0043559]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protease binding [GO:0002020]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001530; GO:0001666; GO:0002020; GO:0002039; GO:0002368; GO:0002755; GO:0002842; GO:0002931; GO:0003688; GO:0003697; GO:0003723; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005782; GO:0005791; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006457; GO:0006458; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0014823; GO:0016020; GO:0016032; GO:0016853; GO:0016887; GO:0019899; GO:0030061; GO:0030135; GO:0030141; GO:0031625; GO:0032496; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0033198; GO:0034185; GO:0034186; GO:0034514; GO:0034605; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0042220; GO:0042493; GO:0042542; GO:0042588; GO:0043032; GO:0043065; GO:0043066; GO:0043524; GO:0043559; GO:0043627; GO:0045041; GO:0045121; GO:0046696; GO:0048291; GO:0050729; GO:0050821; GO:0050870; GO:0051082; GO:0051087; GO:0051131; GO:0051384; GO:0051604; GO:0051702; GO:0070062; GO:0071866; GO:0098761; GO:0140030; GO:1903427; GO:1904469	'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; chaperone-mediated protein complex assembly [GO:0051131]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3251_c0_g1_i1	P18687	CH60_CRIGR	73.3	554	145	2	1696	41	1	553	4.00E-227	788.9	CH60_CRIGR	reviewed	"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (Mitochondrial matrix protein P1)"	HSPD1 HSP60	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	573	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lipopolysaccharide receptor complex [GO:0046696]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; apolipoprotein A-I binding [GO:0034186]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lipopolysaccharide receptor complex [GO:0046696]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]	apolipoprotein A-I binding [GO:0034186]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; ubiquitin protein ligase binding [GO:0031625]	GO:0001530; GO:0002039; GO:0002368; GO:0002755; GO:0002842; GO:0003725; GO:0005524; GO:0005737; GO:0005759; GO:0005769; GO:0005829; GO:0005905; GO:0006919; GO:0006986; GO:0008035; GO:0009409; GO:0009986; GO:0016853; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0034186; GO:0042026; GO:0042100; GO:0042110; GO:0043032; GO:0043066; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051087; GO:0051702; GO:0070062; GO:0098761	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]		blue	blue	NA	NA	NA	NA
TRINITY_DN15764_c0_g2_i1	P63038	CH60_MOUSE	99.6	485	2	0	1	1455	1	485	2.30E-265	915.6	CH60_MOUSE	reviewed	"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (HSP-65) (Heat shock protein 60) (HSP-60) (Hsp60) (Mitochondrial matrix protein P1)"	Hspd1 Hsp60	Mus musculus (Mouse)	573	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; insulin binding [GO:0043559]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; insulin binding [GO:0043559]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]	GO:0001530; GO:0001666; GO:0002020; GO:0002039; GO:0002368; GO:0002755; GO:0002842; GO:0002931; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005782; GO:0005791; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0014823; GO:0016020; GO:0016853; GO:0019899; GO:0030061; GO:0030135; GO:0030141; GO:0031625; GO:0032496; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0033198; GO:0034185; GO:0034186; GO:0034514; GO:0034605; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0042220; GO:0042493; GO:0042542; GO:0042588; GO:0043032; GO:0043065; GO:0043066; GO:0043209; GO:0043231; GO:0043524; GO:0043559; GO:0043627; GO:0044877; GO:0045041; GO:0045121; GO:0046696; GO:0048291; GO:0050729; GO:0050821; GO:0050870; GO:0051087; GO:0051384; GO:0051702; GO:0070062; GO:0071866; GO:0098761; GO:0140030; GO:1903427; GO:1904469	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN15764_c1_g1_i1	P63038	CH60_MOUSE	100	68	0	0	204	1	487	554	9.80E-29	126.7	CH60_MOUSE	reviewed	"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (HSP-65) (Heat shock protein 60) (HSP-60) (Hsp60) (Mitochondrial matrix protein P1)"	Hspd1 Hsp60	Mus musculus (Mouse)	573	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; insulin binding [GO:0043559]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; insulin binding [GO:0043559]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]	GO:0001530; GO:0001666; GO:0002020; GO:0002039; GO:0002368; GO:0002755; GO:0002842; GO:0002931; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005782; GO:0005791; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0014823; GO:0016020; GO:0016853; GO:0019899; GO:0030061; GO:0030135; GO:0030141; GO:0031625; GO:0032496; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0033198; GO:0034185; GO:0034186; GO:0034514; GO:0034605; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0042220; GO:0042493; GO:0042542; GO:0042588; GO:0043032; GO:0043065; GO:0043066; GO:0043209; GO:0043231; GO:0043524; GO:0043559; GO:0043627; GO:0044877; GO:0045041; GO:0045121; GO:0046696; GO:0048291; GO:0050729; GO:0050821; GO:0050870; GO:0051087; GO:0051384; GO:0051702; GO:0070062; GO:0071866; GO:0098761; GO:0140030; GO:1903427; GO:1904469	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN10044_c0_g1_i1	Q967Y7	RLA0_EIMTE	51.4	179	87	0	613	77	100	278	5.30E-46	185.7	RLA0_EIMTE	reviewed	60S acidic ribosomal protein P0		Eimeria tenella (Coccidian parasite)	314	ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribosome [GO:0005840]		GO:0005840; GO:0042254	ribosome biogenesis [GO:0042254]		red	red	NA	NA	NA	NA
TRINITY_DN10044_c0_g1_i3	Q967Y7	RLA0_EIMTE	51.4	179	87	0	615	79	100	278	2.00E-45	183.7	RLA0_EIMTE	reviewed	60S acidic ribosomal protein P0		Eimeria tenella (Coccidian parasite)	314	ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribosome [GO:0005840]		GO:0005840; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN19130_c1_g1_i1	Q93572	RLA0_CAEEL	72.6	73	20	0	220	2	106	178	3.50E-24	111.7	RLA0_CAEEL	reviewed	60S acidic ribosomal protein P0	rla-0 rpa-0 F25H2.10	Caenorhabditis elegans	312	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN21201_c1_g1_i1	Q93572	RLA0_CAEEL	57.1	98	42	0	3	296	181	278	9.30E-26	117.5	RLA0_CAEEL	reviewed	60S acidic ribosomal protein P0	rla-0 rpa-0 F25H2.10	Caenorhabditis elegans	312	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN22637_c0_g1_i1	P47826	RLA0_CHICK	57.1	70	30	0	1	210	181	250	6.80E-17	87.4	RLA0_CHICK	reviewed	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)	RPLP0	Gallus gallus (Chicken)	316	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN10044_c0_g2_i1	Q9DG68	RLA0_RANSY	52.5	80	36	1	25	264	13	90	8.50E-17	87.4	RLA0_LITSY	reviewed	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)	RPLP0	Lithobates sylvaticus (Wood frog) (Rana sylvatica)	315	ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribosome [GO:0005840]		GO:0005840; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN19130_c3_g1_i1	Q90YX1	RLA0_ICTPU	72.7	88	24	0	1	264	124	211	1.20E-29	130.2	RLA0_ICTPU	reviewed	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)	rplp0	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	317	ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribosome [GO:0005840]		GO:0005840; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN19130_c2_g1_i1	Q95140	RLA0_BOVIN	76.1	88	21	0	264	1	46	133	1.00E-30	133.7	RLA0_BOVIN	reviewed	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)	RPLP0	Bos taurus (Bovine)	318	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005634; GO:0005737; GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN19130_c0_g1_i1	P14869	RLA0_MOUSE	99.6	275	1	0	41	865	1	275	9.20E-153	540.8	RLA0_MOUSE	reviewed	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)	Rplp0 Arbp	Mus musculus (Mouse)	317	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0014069; GO:0016020; GO:0022625; GO:0030425; GO:0036464; GO:0042277; GO:0045202; GO:0070180; GO:0071353; GO:0098794; GO:1990904	cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN19130_c0_g2_i1	P05388	RLA0_HUMAN	100	280	0	0	41	880	1	280	2.70E-155	549.3	RLA0_HUMAN	reviewed	60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)	RPLP0	Homo sapiens (Human)	317	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; interleukin-12-mediated signaling pathway [GO:0035722]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]	large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022625; GO:0035722; GO:0036464; GO:0070062; GO:0070180; GO:1990904	"cytoplasmic translation [GO:0002181]; interleukin-12-mediated signaling pathway [GO:0035722]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32713_c2_g1_i1	P19889	RLA0_DROME	71.5	277	79	0	948	118	1	277	3.30E-112	406.4	RLA0_DROME	reviewed	60S acidic ribosomal protein P0 (Apurinic-apyrimidinic endonuclease) (EC 3.1.-.-)	RpLP0 AP3 Ape RpP0 CG7490	Drosophila melanogaster (Fruit fly)	317	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]; base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000287; GO:0002181; GO:0003735; GO:0003906; GO:0004519; GO:0005509; GO:0005654; GO:0005829; GO:0005840; GO:0006284; GO:0016363; GO:0022625; GO:0022626; GO:0052720; GO:0070180; GO:0090305	base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN21201_c0_g1_i1	P19889	RLA0_DROME	71.4	91	26	0	273	1	127	217	5.70E-32	137.9	RLA0_DROME	reviewed	60S acidic ribosomal protein P0 (Apurinic-apyrimidinic endonuclease) (EC 3.1.-.-)	RpLP0 AP3 Ape RpP0 CG7490	Drosophila melanogaster (Fruit fly)	317	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]; base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000287; GO:0002181; GO:0003735; GO:0003906; GO:0004519; GO:0005509; GO:0005654; GO:0005829; GO:0005840; GO:0006284; GO:0016363; GO:0022625; GO:0022626; GO:0052720; GO:0070180; GO:0090305	base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN21201_c2_g1_i1	P19889	RLA0_DROME	66.7	78	26	0	235	2	133	210	4.90E-24	111.3	RLA0_DROME	reviewed	60S acidic ribosomal protein P0 (Apurinic-apyrimidinic endonuclease) (EC 3.1.-.-)	RpLP0 AP3 Ape RpP0 CG7490	Drosophila melanogaster (Fruit fly)	317	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]; base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000287; GO:0002181; GO:0003735; GO:0003906; GO:0004519; GO:0005509; GO:0005654; GO:0005829; GO:0005840; GO:0006284; GO:0016363; GO:0022625; GO:0022626; GO:0052720; GO:0070180; GO:0090305	base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN21875_c1_g1_i1	P19889	RLA0_DROME	59.8	122	49	0	367	2	156	277	1.50E-35	150.2	RLA0_DROME	reviewed	60S acidic ribosomal protein P0 (Apurinic-apyrimidinic endonuclease) (EC 3.1.-.-)	RpLP0 AP3 Ape RpP0 CG7490	Drosophila melanogaster (Fruit fly)	317	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]; base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	calcium ion binding [GO:0005509]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endonuclease activity [GO:0004519]; large ribosomal subunit rRNA binding [GO:0070180]; magnesium ion binding [GO:0000287]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000287; GO:0002181; GO:0003735; GO:0003906; GO:0004519; GO:0005509; GO:0005654; GO:0005829; GO:0005840; GO:0006284; GO:0016363; GO:0022625; GO:0022626; GO:0052720; GO:0070180; GO:0090305	base-excision repair [GO:0006284]; cytoplasmic translation [GO:0002181]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN8736_c0_g1_i1	P19944	RLA1_RAT	98.6	74	1	0	262	41	1	74	8.80E-34	144.1	RLA1_RAT	reviewed	60S acidic ribosomal protein P1	Rplp1	Rattus norvegicus (Rat)	114	cytosolic large ribosomal subunit [GO:0022625]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; cytoplasmic translation [GO:0002181]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; translational elongation [GO:0006414]	cytosolic large ribosomal subunit [GO:0022625]	protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0006414; GO:0006417; GO:0022625; GO:0030295; GO:0043021; GO:0045727; GO:0071320; GO:1904401	cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; cytoplasmic translation [GO:0002181]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN8736_c0_g1_i2	P19944	RLA1_RAT	100	74	0	0	262	41	1	74	3.10E-34	145.6	RLA1_RAT	reviewed	60S acidic ribosomal protein P1	Rplp1	Rattus norvegicus (Rat)	114	cytosolic large ribosomal subunit [GO:0022625]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; cytoplasmic translation [GO:0002181]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; translational elongation [GO:0006414]	cytosolic large ribosomal subunit [GO:0022625]	protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0006414; GO:0006417; GO:0022625; GO:0030295; GO:0043021; GO:0045727; GO:0071320; GO:1904401	cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; cytoplasmic translation [GO:0002181]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15530_c0_g1_i1	P02402	RLA1_ARTSA	70.1	67	20	0	252	52	1	67	3.20E-21	102.4	RLA1_ARTSA	reviewed	60S acidic ribosomal protein P1 (eL12'/ eL12'-P)		Artemia salina (Brine shrimp)	110	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006414	translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN15530_c0_g1_i2	P02402	RLA1_ARTSA	69.7	66	20	0	422	225	1	66	1.40E-20	100.9	RLA1_ARTSA	reviewed	60S acidic ribosomal protein P1 (eL12'/ eL12'-P)		Artemia salina (Brine shrimp)	110	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006414	translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN27754_c0_g1_i1	P42899	RLA2_BOVIN	97.4	77	2	0	236	6	1	77	1.70E-32	139.4	RLA2_BOVIN	reviewed	60S acidic ribosomal protein P2	RPLP2	Bos taurus (Bovine)	115	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006414	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN7379_c0_g1_i3	P02401	RLA2_RAT	55.9	68	29	1	397	197	1	68	2.80E-13	76.6	RLA2_RAT	reviewed	60S acidic ribosomal protein P2	Rplp2 Rp2	Rattus norvegicus (Rat)	115	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005506; GO:0006414; GO:0022625; GO:0043021; GO:0045202; GO:0045727; GO:0071320; GO:1904401	cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]		NA	NA	1	NA	NA	NA
TRINITY_DN12245_c1_g2_i1	P02401	RLA2_RAT	56.5	46	19	1	139	5	1	46	4.50E-06	51.6	RLA2_RAT	reviewed	60S acidic ribosomal protein P2	Rplp2 Rp2	Rattus norvegicus (Rat)	115	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005506; GO:0006414; GO:0022625; GO:0043021; GO:0045202; GO:0045727; GO:0071320; GO:1904401	cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN12245_c1_g1_i1	P02401	RLA2_RAT	54.4	68	30	1	251	51	1	68	4.30E-13	75.1	RLA2_RAT	reviewed	60S acidic ribosomal protein P2	Rplp2 Rp2	Rattus norvegicus (Rat)	115	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005506; GO:0006414; GO:0022625; GO:0043021; GO:0045202; GO:0045727; GO:0071320; GO:1904401	cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN7379_c0_g1_i2	P02401	RLA2_RAT	55.9	68	29	1	360	160	1	68	2.60E-13	76.6	RLA2_RAT	reviewed	60S acidic ribosomal protein P2	Rplp2 Rp2	Rattus norvegicus (Rat)	115	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	iron ion binding [GO:0005506]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005506; GO:0006414; GO:0022625; GO:0043021; GO:0045202; GO:0045727; GO:0071320; GO:1904401	cellular response to cAMP [GO:0071320]; cellular response to Thyroid stimulating hormone [GO:1904401]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN39467_c0_g1_i1	P42899	RLA2_BOVIN	54.5	55	24	1	165	4	1	55	1.70E-08	59.7	RLA2_BOVIN	reviewed	60S acidic ribosomal protein P2	RPLP2	Bos taurus (Bovine)	115	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006414	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17827_c4_g1_i1	P02399	RLA2_ARTSA	53.6	69	31	1	207	4	1	69	7.70E-11	67.4	RLA2_ARTSA	reviewed	60S acidic ribosomal protein P2 (EL12)		Artemia salina (Brine shrimp)	111	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006414	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN30873_c0_g1_i1	P05387	RLA2_HUMAN	100	74	0	0	10	231	1	74	6.30E-32	137.5	RLA2_HUMAN	reviewed	60S acidic ribosomal protein P2 (Large ribosomal subunit protein P2) (Renal carcinoma antigen NY-REN-44)	RPLP2 D11S2243E RPP2	Homo sapiens (Human)	115	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational elongation [GO:0006414]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]	structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003735; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006414; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0070062	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational elongation [GO:0006414]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16579_c0_g1_i1	Q99L48	NMD3_MOUSE	97.8	182	4	0	1	546	8	189	2.10E-102	372.9	NMD3_MOUSE	reviewed	60S ribosomal export protein NMD3	Nmd3	Mus musculus (Mouse)	503	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]	GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751	positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN16579_c0_g1_i2	Q99L48	NMD3_MOUSE	100	182	0	0	1	546	8	189	5.50E-103	374.8	NMD3_MOUSE	reviewed	60S ribosomal export protein NMD3	Nmd3	Mus musculus (Mouse)	503	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]	GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751	positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN38875_c0_g1_i1	Q09817	NMD3_SCHPO	53.7	164	73	2	9	494	48	210	4.70E-48	192.2	NMD3_SCHPO	reviewed	60S ribosomal export protein nmd3	nmd3 SPAC16C9.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	498	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal subunit export from nucleus [GO:0000054]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]	GO:0000054; GO:0000055; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030674; GO:0043023	ribosomal large subunit export from nucleus [GO:0000055]; ribosomal subunit export from nucleus [GO:0000054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3056_c0_g1_i1	Q08DS5	NMD3_BOVIN	54.5	266	110	7	839	57	243	502	3.30E-68	260	NMD3_BOVIN	reviewed	60S ribosomal export protein NMD3	NMD3	Bos taurus (Bovine)	503	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosomal large subunit binding [GO:0043023]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ribosomal large subunit binding [GO:0043023]	GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043023	ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	1
TRINITY_DN3056_c0_g1_i2	Q08DS5	NMD3_BOVIN	58.9	508	196	9	1559	57	1	502	1.30E-166	587.8	NMD3_BOVIN	reviewed	60S ribosomal export protein NMD3	NMD3	Bos taurus (Bovine)	503	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosomal large subunit binding [GO:0043023]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ribosomal large subunit binding [GO:0043023]	GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043023	ribosomal large subunit export from nucleus [GO:0000055]		blue	blue	NA	NA	NA	NA
TRINITY_DN33289_c0_g1_i1	Q96D46	NMD3_HUMAN	100	82	0	0	248	3	347	428	9.50E-42	170.2	NMD3_HUMAN	reviewed	60S ribosomal export protein NMD3 (hNMD3)	NMD3 CGI-07	Homo sapiens (Human)	503	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]	GO:0000055; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016020; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751	positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3631_c0_g1_i1	Q8SR96	RL10_ENCCU	66	97	33	0	291	1	58	154	8.20E-29	127.5	RL10_ENCCU	reviewed	60S ribosomal protein L10	RPL10 ECU08_1570	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22634_c0_g2_i1	P27635	RL10_HUMAN	99.5	214	1	0	660	19	1	214	3.80E-126	452.2	RL10_HUMAN	reviewed	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10 DXS648E QM	Homo sapiens (Human)	214	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000027; GO:0000122; GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006417; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0032991; GO:0043066; GO:0045182; GO:1990403	"embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22634_c0_g2_i2	P27635	RL10_HUMAN	99	105	1	0	333	19	110	214	7.90E-57	221.1	RL10_HUMAN	reviewed	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10 DXS648E QM	Homo sapiens (Human)	214	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000027; GO:0000122; GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006417; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0032991; GO:0043066; GO:0045182; GO:1990403	"embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22634_c0_g3_i1	P27635	RL10_HUMAN	100	214	0	0	668	27	1	214	5.60E-127	454.9	RL10_HUMAN	reviewed	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10 DXS648E QM	Homo sapiens (Human)	214	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000027; GO:0000122; GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006417; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0032991; GO:0043066; GO:0045182; GO:1990403	"embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22634_c0_g3_i2	P27635	RL10_HUMAN	96.4	110	4	0	356	27	105	214	3.20E-58	225.7	RL10_HUMAN	reviewed	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10 DXS648E QM	Homo sapiens (Human)	214	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000027; GO:0000122; GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006417; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0032991; GO:0043066; GO:0045182; GO:1990403	"embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i9	Q7ZV96	RL10_DANRE	75.5	159	39	0	52	528	1	159	3.60E-67	255.8	RL10_DANRE	reviewed	60S ribosomal protein L10 (Protein QM) (Ribosomal protein L10)	rpl10 QM	Danio rerio (Zebrafish) (Brachydanio rerio)	215	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; brain development [GO:0007420]; embryonic brain development [GO:1990403]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000027; GO:0003735; GO:0006412; GO:0006417; GO:0007420; GO:0022625; GO:0045182; GO:1990403	brain development [GO:0007420]; embryonic brain development [GO:1990403]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20261_c0_g1_i1	O96647	RL10_BOMMA	63.8	69	25	0	5	211	148	216	4.00E-21	101.7	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19697_c0_g1_i1	O96647	RL10_BOMMA	85.9	78	11	0	234	1	73	150	1.70E-32	139.4	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN19678_c0_g1_i1	O96647	RL10_BOMMA	84.8	92	14	0	2	277	32	123	4.00E-41	168.3	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN19678_c0_g1_i2	O96647	RL10_BOMMA	86.2	94	13	0	2	283	32	125	4.30E-43	174.9	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21689_c1_g1_i1	O96647	RL10_BOMMA	83.3	90	15	0	2	271	74	163	1.30E-36	153.3	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN19839_c1_g1_i1	O96647	RL10_BOMMA	74.1	85	22	0	2	256	13	97	5.30E-32	137.9	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN14892_c0_g1_i1	O96647	RL10_BOMMA	88	117	14	0	24	374	1	117	5.30E-57	221.5	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN14892_c0_g1_i2	O96647	RL10_BOMMA	88	117	14	0	24	374	1	117	8.20E-58	224.2	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN14892_c0_g1_i3	O96647	RL10_BOMMA	86.3	117	16	0	24	374	1	117	1.60E-56	219.9	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1883_c4_g1_i1	O96647	RL10_BOMMA	90	70	7	0	215	6	77	146	2.90E-31	135.2	RL10_BOMMA	reviewed	60S ribosomal protein L10 (QM protein homolog)	RpL10	Bombyx mandarina (Wild silk moth) (Wild silkworm)	219	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22634_c0_g1_i1	O61231	RL10_DROME	82.2	208	37	0	716	93	9	216	9.80E-102	371.3	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN22634_c0_g1_i2	O61231	RL10_DROME	82.9	216	37	0	740	93	1	216	7.00E-107	388.3	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN22634_c0_g1_i3	O61231	RL10_DROME	82.9	216	37	0	740	93	1	216	7.00E-107	388.3	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN22634_c0_g1_i6	O61231	RL10_DROME	82.2	208	37	0	716	93	9	216	6.20E-102	371.7	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN22634_c0_g1_i8	O61231	RL10_DROME	82.2	208	37	0	716	93	9	216	1.00E-101	371.3	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN19697_c1_g1_i1	O61231	RL10_DROME	79.8	84	17	0	255	4	96	179	7.70E-31	134	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN19678_c1_g1_i1	O61231	RL10_DROME	55.1	69	31	0	234	28	148	216	4.10E-18	91.7	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c1_g1_i1	O61231	RL10_DROME	88.2	68	8	0	205	2	1	68	1.10E-28	126.7	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN29789_c0_g1_i1	O61231	RL10_DROME	77.5	40	9	0	108	227	142	181	1.20E-11	70.1	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN21689_c0_g1_i1	O61231	RL10_DROME	57.7	52	22	0	21	176	165	216	6.40E-14	77.8	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN14892_c0_g2_i1	O61231	RL10_DROME	70.9	103	30	0	1	309	114	216	2.80E-39	162.5	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN28590_c0_g1_i1	O61231	RL10_DROME	76.7	90	21	0	271	2	105	194	1.00E-33	143.7	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN39552_c0_g1_i1	O61231	RL10_DROME	82.4	68	12	0	8	211	89	156	1.40E-22	106.3	RL10_DROME	reviewed	60S ribosomal protein L10 (QM protein homolog) (dQM)	RpL10 Qm CG17521	Drosophila melanogaster (Fruit fly)	218	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i1	A2ZCQ7	RL101_ORYSI	73.3	202	54	0	26	631	1	202	9.00E-81	301.2	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i15	A2ZCQ7	RL101_ORYSI	73.3	202	54	0	31	636	1	202	1.20E-80	300.8	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i2	A2ZCQ7	RL101_ORYSI	73.3	202	54	0	31	636	1	202	1.20E-80	300.8	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i3	A2ZCQ7	RL101_ORYSI	73.3	202	54	0	31	636	1	202	1.20E-80	300.8	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i6	A2ZCQ7	RL101_ORYSI	73.3	202	54	0	52	657	1	202	9.40E-81	301.2	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i7	A2ZCQ7	RL101_ORYSI	73.7	198	52	0	26	619	1	198	4.40E-80	298.9	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22912_c0_g1_i8	A2ZCQ7	RL101_ORYSI	73.7	198	52	0	52	645	1	198	3.50E-80	299.3	RL101_ORYSI	reviewed	60S ribosomal protein L10-1 (Protein QM) (Putative tumor suppressor SC34)	SC34 OsI_034350	Oryza sativa subsp. indica (Rice)	224	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20477_c0_g1_i1	Q9P769	RL10B_SCHPO	73.5	200	53	0	604	5	1	200	1.10E-86	320.9	RL10B_SCHPO	reviewed	60S ribosomal protein L10-B	rpl1002 rpl10b SPAP7G5.05	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	221	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005829; GO:0022625; GO:0042254	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN21313_c0_g1_i1	Q2TBW8	RL10L_BOVIN	83.3	42	7	0	205	80	4	45	5.20E-14	78.2	RL10L_BOVIN	reviewed	60S ribosomal protein L10-like	RPL10L	Bos taurus (Bovine)	214	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; polysome [GO:0005844]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; polysome [GO:0005844]	structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003735; GO:0005634; GO:0005783; GO:0005844; GO:0006412; GO:0007283; GO:0022625	ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2925_c0_g1_i1	Q8SSG9	RL11_ENCCU	57.3	143	61	0	434	6	29	171	3.70E-47	189.1	RL11_ENCCU	reviewed	60S ribosomal protein L11	RPL11 ECU02_0610	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	173	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10802_c3_g1_i1	Q3T087	RL11_BOVIN	80.8	73	14	0	219	1	12	84	2.60E-25	115.5	RL11_BOVIN	reviewed	60S ribosomal protein L11	RPL11	Bos taurus (Bovine)	178	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0006412; GO:0019843; GO:0022625; GO:0032435; GO:0034504; GO:1901798	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24882_c1_g1_i1	Q3T087	RL11_BOVIN	81.5	65	12	0	196	2	12	76	2.20E-23	109	RL11_BOVIN	reviewed	60S ribosomal protein L11	RPL11	Bos taurus (Bovine)	178	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0006412; GO:0019843; GO:0022625; GO:0032435; GO:0034504; GO:1901798	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24664_c0_g1_i1	Q6FTK4	RL11_CANGA	74.4	86	22	0	2	259	51	136	2.70E-31	135.6	RL11_CANGA	reviewed	60S ribosomal protein L11	RPL11 CAGL0G01826g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	174	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5539_c0_g1_i1	Q3T087	RL11_BOVIN	100	178	0	0	558	25	1	178	1.70E-100	366.7	RL11_BOVIN	reviewed	60S ribosomal protein L11	RPL11	Bos taurus (Bovine)	178	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0006412; GO:0019843; GO:0022625; GO:0032435; GO:0034504; GO:1901798	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5539_c0_g1_i2	Q3T087	RL11_BOVIN	100	178	0	0	558	25	1	178	1.20E-100	367.1	RL11_BOVIN	reviewed	60S ribosomal protein L11	RPL11	Bos taurus (Bovine)	178	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0006412; GO:0019843; GO:0022625; GO:0032435; GO:0034504; GO:1901798	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4597_c3_g1_i1	A8WQ43	RL111_CAEBR	77.1	175	40	0	113	637	13	187	5.80E-78	292	RL111_CAEBR	reviewed	60S ribosomal protein L11-1	rpl-11.1 CBG01314	Caenorhabditis briggsae	196	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN25221_c0_g1_i1	A8WQ43	RL111_CAEBR	73.5	162	43	0	69	554	13	174	8.50E-67	254.6	RL111_CAEBR	reviewed	60S ribosomal protein L11-1	rpl-11.1 CBG01314	Caenorhabditis briggsae	196	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1287_c1_g1_i1	P42795	RL111_ARATH	71.8	170	48	0	10	519	6	175	4.80E-70	265.4	RL111_ARATH	reviewed	60S ribosomal protein L11-1 (L16A)	RPL11A RPL16A At2g42740 F7D19.26	Arabidopsis thaliana (Mouse-ear cress)	182	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; vacuole [GO:0005773]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005773; GO:0005829; GO:0006412; GO:0009506; GO:0019843; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1287_c0_g1_i2	P42795	RL111_ARATH	71.8	170	48	0	520	11	6	175	4.60E-70	265.4	RL111_ARATH	reviewed	60S ribosomal protein L11-1 (L16A)	RPL11A RPL16A At2g42740 F7D19.26	Arabidopsis thaliana (Mouse-ear cress)	182	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; vacuole [GO:0005773]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005773; GO:0005829; GO:0006412; GO:0009506; GO:0019843; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10802_c0_g1_i2	A8XJ93	RL112_CAEBR	54.7	53	24	0	204	46	115	167	4.30E-12	72	RL112_CAEBR	reviewed	60S ribosomal protein L11-2	rpl-11.2 CBG14053 CBG_14053	Caenorhabditis briggsae	196	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10802_c0_g1_i8	A8XJ93	RL112_CAEBR	54.7	53	24	0	204	46	115	167	6.00E-12	72	RL112_CAEBR	reviewed	60S ribosomal protein L11-2	rpl-11.2 CBG14053 CBG_14053	Caenorhabditis briggsae	196	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40624_c0_g1_i1	P0CT77	RL11A_SCHPO	77.7	94	21	0	284	3	6	99	5.40E-33	141.4	RL11A_SCHPO	reviewed	60S ribosomal protein L11-A	rpl1101 rpl11 rpl11a SPAC26A3.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	174	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005829; GO:0019843; GO:0022625; GO:0022627; GO:0042254	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN1287_c0_g1_i3	P0CT77	RL11A_SCHPO	73.2	164	44	0	494	3	1	164	1.00E-66	254.2	RL11A_SCHPO	reviewed	60S ribosomal protein L11-A	rpl1101 rpl11 rpl11a SPAC26A3.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	174	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005829; GO:0019843; GO:0022625; GO:0022627; GO:0042254	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN472_c0_g1_i3	Q6QMZ7	RL12_CHILA	64.3	157	56	0	500	30	7	163	9.40E-57	221.1	RL12_CHILA	reviewed	60S ribosomal protein L12	RPL12	Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera)	165	ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26867_c0_g1_i1	P61865	RL12_CAEBR	58.6	70	29	0	211	2	92	161	2.80E-18	92	RL12_CAEBR	reviewed	60S ribosomal protein L12	rpl-12 CBG01806	Caenorhabditis briggsae	165	"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]"	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000381; GO:0003735; GO:0005840; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3006_c0_g1_i1	P61284	RL12_BOVIN	99.4	163	1	0	532	44	3	165	1.30E-88	327	RL12_BOVIN	reviewed	60S ribosomal protein L12	RPL12	Bos taurus (Bovine)	165	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003735; GO:0005840; GO:0006412; GO:0014069; GO:0015934; GO:0019843; GO:0022625; GO:0070180	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3006_c1_g1_i1	P35979	RL12_MOUSE	97.3	111	3	0	51	383	1	111	6.10E-56	218	RL12_MOUSE	reviewed	60S ribosomal protein L12	Rpl12	Mus musculus (Mouse)	165	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005840; GO:0006412; GO:0014069; GO:0015934; GO:0019843; GO:0022625; GO:0070180	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3006_c1_g2_i1	P61284	RL12_BOVIN	100	60	0	0	2	181	106	165	1.90E-28	125.9	RL12_BOVIN	reviewed	60S ribosomal protein L12	RPL12	Bos taurus (Bovine)	165	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003735; GO:0005840; GO:0006412; GO:0014069; GO:0015934; GO:0019843; GO:0022625; GO:0070180	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3368_c1_g1_i1	P61284	RL12_BOVIN	71.8	163	46	0	88	576	1	163	8.70E-66	251.5	RL12_BOVIN	reviewed	60S ribosomal protein L12	RPL12	Bos taurus (Bovine)	165	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003735; GO:0005840; GO:0006412; GO:0014069; GO:0015934; GO:0019843; GO:0022625; GO:0070180	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN9834_c0_g1_i1	P61865	RL12_CAEBR	71.8	163	46	0	560	72	1	163	1.50E-64	247.3	RL12_CAEBR	reviewed	60S ribosomal protein L12	rpl-12 CBG01806	Caenorhabditis briggsae	165	"cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]"	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000381; GO:0003735; GO:0005840; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN472_c0_g1_i1	P0CT83	RL12A_SCHPO	60.4	159	63	0	514	38	7	165	1.10E-55	217.6	RL12A_SCHPO	reviewed	60S ribosomal protein L12-A	rpl1201 SPCC16C4.13c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	165	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003735; GO:0005730; GO:0005829; GO:0005840; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24201_c1_g1_i1	Q90Z10	RL13_DANRE	58.1	124	52	0	2	373	76	199	3.10E-28	125.9	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24201_c2_g1_i1	Q90Z10	RL13_DANRE	54.6	97	44	0	315	25	108	204	8.40E-19	94.4	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24201_c0_g1_i1	Q90Z10	RL13_DANRE	59.1	110	44	1	335	9	1	110	1.50E-26	120.6	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12720_c0_g1_i1	P91128	RL13_CAEEL	68.2	85	27	0	3	257	36	120	1.20E-23	110.2	RL13_CAEEL	reviewed	60S ribosomal protein L13	rpl-13 C32E8.2	Caenorhabditis elegans	207	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12720_c0_g1_i2	P91128	RL13_CAEEL	68.2	85	27	0	3	257	36	120	1.60E-23	109.8	RL13_CAEEL	reviewed	60S ribosomal protein L13	rpl-13 C32E8.2	Caenorhabditis elegans	207	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12720_c0_g1_i3	P91128	RL13_CAEEL	68.2	85	27	0	3	257	36	120	1.20E-23	110.2	RL13_CAEEL	reviewed	60S ribosomal protein L13	rpl-13 C32E8.2	Caenorhabditis elegans	207	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN28736_c0_g1_i1	Q90Z10	RL13_DANRE	59	78	32	0	2	235	77	154	7.60E-17	87.4	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17708_c0_g2_i1	Q90Z10	RL13_DANRE	62.4	93	34	1	3	278	43	135	2.10E-26	119.4	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17708_c0_g2_i2	Q90Z10	RL13_DANRE	65.3	72	24	1	3	215	43	114	3.00E-20	98.6	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17708_c0_g1_i1	Q90Z10	RL13_DANRE	52.8	72	34	0	1	216	133	204	6.60E-10	64.3	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17708_c0_g1_i2	Q90Z10	RL13_DANRE	53.8	80	37	0	23	262	125	204	5.90E-13	74.7	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17708_c0_g1_i4	Q90Z10	RL13_DANRE	48.5	66	34	0	23	220	125	190	4.00E-07	55.1	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24084_c0_g1_i1	Q90Z10	RL13_DANRE	56.2	80	35	0	299	60	125	204	3.50E-14	79	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24280_c0_g1_i1	Q90Z10	RL13_DANRE	55.8	86	38	0	6	263	91	176	1.30E-17	90.1	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24280_c1_g1_i1	Q90Z10	RL13_DANRE	59.4	101	40	1	313	14	47	147	2.00E-25	116.3	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20077_c1_g1_i1	Q90Z10	RL13_DANRE	57	79	33	1	235	2	60	138	1.30E-16	86.7	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN38625_c4_g1_i1	Q90Z10	RL13_DANRE	64.2	204	72	1	676	68	1	204	1.10E-64	248.1	RL13_DANRE	reviewed	60S ribosomal protein L13	rpl13	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726	regulation of cell cycle [GO:0051726]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN38625_c11_g1_i1	Q90YV5	RL13_ICTPU	46.9	64	34	0	193	2	140	203	7.90E-05	47.4	RL13_ICTPU	reviewed	60S ribosomal protein L13	rpl13	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	211	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN895_c0_g1_i1	P47963	RL13_MOUSE	99.5	211	1	0	639	7	1	211	2.70E-112	406	RL13_MOUSE	reviewed	60S ribosomal protein L13 (A52)	Rpl13	Mus musculus (Mouse)	211	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; bone development [GO:0060348]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0060348	bone development [GO:0060348]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN28586_c0_g1_i1	P41126	RL13_DROME	60.9	69	26	1	1	204	47	115	2.50E-16	85.5	RL13_DROME	reviewed	60S ribosomal protein L13 (BBC1 protein homolog)	RpL13 bbc1 CG4651	Drosophila melanogaster (Fruit fly)	218	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN31925_c0_g1_i1	P41125	RL13_CHICK	46.5	71	38	0	2	214	134	204	7.70E-07	54.3	RL13_CHICK	reviewed	60S ribosomal protein L13 (Breast basic conserved protein 1)	RPL13 BBC1	Gallus gallus (Chicken)	211	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; bone development [GO:0060348]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0060348	bone development [GO:0060348]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24084_c0_g2_i1	P41125	RL13_CHICK	60.6	71	28	0	220	8	86	156	5.50E-17	87.8	RL13_CHICK	reviewed	60S ribosomal protein L13 (Breast basic conserved protein 1)	RPL13 BBC1	Gallus gallus (Chicken)	211	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; bone development [GO:0060348]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0060348	bone development [GO:0060348]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN895_c0_g2_i1	P26373	RL13_HUMAN	100	207	0	0	622	2	1	207	3.30E-110	399.1	RL13_HUMAN	reviewed	60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)	RPL13 BBC1 OK/SW-cl.46	Homo sapiens (Human)	211	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; bone development [GO:0060348]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0022626; GO:0060348	"bone development [GO:0060348]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20693_c0_g2_i1	P93099	RL13A_CYAPA	64.1	78	28	0	235	2	62	139	1.20E-25	116.7	RL13A_CYAPA	reviewed	60S ribosomal protein L13a		Cyanophora paradoxa	200	large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16927_c0_g1_i1	Q3SZ90	RL13A_BOVIN	74.7	75	19	0	225	1	21	95	1.20E-24	113.2	RL13A_BOVIN	reviewed	60S ribosomal protein L13a	RPL13A	Bos taurus (Bovine)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0071346; GO:0097452; GO:1901194	cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16927_c0_g2_i1	Q3SZ90	RL13A_BOVIN	55.2	96	43	0	289	2	98	193	4.70E-24	111.7	RL13A_BOVIN	reviewed	60S ribosomal protein L13a	RPL13A	Bos taurus (Bovine)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0071346; GO:0097452; GO:1901194	cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN16927_c0_g2_i2	Q9XSU0	RL13A_CANLF	50	104	52	0	338	27	98	201	4.60E-23	108.6	RL13A_CANLF	reviewed	60S ribosomal protein L13a	RPL13A	Canis lupus familiaris (Dog) (Canis familiaris)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194	negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26529_c0_g1_i1	Q9XSU0	RL13A_CANLF	43.4	76	43	0	242	15	126	201	1.20E-12	73.6	RL13A_CANLF	reviewed	60S ribosomal protein L13a	RPL13A	Canis lupus familiaris (Dog) (Canis familiaris)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194	negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26534_c0_g1_i1	Q3SZ90	RL13A_BOVIN	67.8	118	38	0	3	356	14	131	4.10E-38	158.7	RL13A_BOVIN	reviewed	60S ribosomal protein L13a	RPL13A	Bos taurus (Bovine)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0071346; GO:0097452; GO:1901194	cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22935_c0_g1_i1	Q553M7	RL13A_DICDI	54.4	68	31	0	206	3	119	186	7.30E-11	67.4	RL13A_DICDI	reviewed	60S ribosomal protein L13a	rpl13a DDB_G0275881	Dictyostelium discoideum (Slime mold)	187	cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625	negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN7112_c0_g1_i1	Q3SZ90	RL13A_BOVIN	67.1	82	27	0	11	256	8	89	3.60E-28	125.2	RL13A_BOVIN	reviewed	60S ribosomal protein L13a	RPL13A	Bos taurus (Bovine)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0071346; GO:0097452; GO:1901194	cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23130_c0_g1_i1	Q8MUR4	RL13A_CHOPR	63.8	138	50	0	10	423	1	138	7.80E-48	191.8	RL13A_CHOPR	reviewed	60S ribosomal protein L13a	RpL13A	Choristoneura parallela (Spotted fireworm moth)	204	large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23130_c0_g1_i1	Q8MUR4	RL13A_CHOPR	50.8	65	28	2	428	616	140	202	1.60E-08	61.2	RL13A_CHOPR	reviewed	60S ribosomal protein L13a	RpL13A	Choristoneura parallela (Spotted fireworm moth)	204	large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23130_c1_g1_i1	Q962U0	RL13A_SPOFR	68.2	88	28	0	266	3	9	96	2.30E-30	132.5	RL13A_SPOFR	reviewed	60S ribosomal protein L13a	RpL13A	Spodoptera frugiperda (Fall armyworm)	204	large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29624_c4_g1_i1	Q8MUR4	RL13A_CHOPR	62.7	204	72	2	44	649	1	202	1.10E-68	261.2	RL13A_CHOPR	reviewed	60S ribosomal protein L13a	RpL13A	Choristoneura parallela (Spotted fireworm moth)	204	large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN5831_c0_g1_i2	P40429	RL13A_HUMAN	100	184	0	0	554	3	1	184	1.50E-98	360.1	RL13A_HUMAN	reviewed	60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)	RPL13A	Homo sapiens (Human)	203	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0015934; GO:0016020; GO:0017148; GO:0019083; GO:0022625; GO:0071346; GO:0097452; GO:1901194; GO:1990904	"cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23130_c0_g1_i2	P40429	RL13A_HUMAN	56.1	139	61	0	4	420	63	201	4.80E-41	168.7	RL13A_HUMAN	reviewed	60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)	RPL13A	Homo sapiens (Human)	203	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0015934; GO:0016020; GO:0017148; GO:0019083; GO:0022625; GO:0071346; GO:0097452; GO:1901194; GO:1990904	"cellular response to interferon-gamma [GO:0071346]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5831_c0_g1_i3	P19253	RL13A_MOUSE	100	173	0	0	519	1	4	176	5.10E-93	341.7	RL13A_MOUSE	reviewed	60S ribosomal protein L13a (Transplantation antigen P198) (Tum-P198 antigen)	Rpl13a P198 Tstap198-7	Mus musculus (Mouse)	203	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194; GO:1990904	cellular response to interferon-gamma [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4295_c0_g1_i1	O82712	RL15_QUESU	44.7	94	50	1	19	294	10	103	1.40E-15	83.6	RL15_QUESU	reviewed	60S ribosomal protein L15	RPL15	Quercus suber (Cork oak)	201	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i1	Q9XYC2	RL15_FAXLI	94.8	58	3	0	338	165	1	58	5.70E-25	115.5	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i1	Q9XYC2	RL15_FAXLI	98	50	1	0	151	2	1	50	5.00E-21	102.4	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i1	Q9XYC2	RL15_FAXLI	91.1	56	2	1	510	352	3	58	1.10E-20	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i10	Q9XYC2	RL15_FAXLI	94.8	58	3	0	193	20	1	58	4.00E-25	115.5	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i10	Q9XYC2	RL15_FAXLI	91.1	56	2	1	365	207	3	58	7.90E-21	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i11	Q9XYC2	RL15_FAXLI	98	50	1	0	151	2	1	50	4.60E-21	102.4	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i11	Q9XYC2	RL15_FAXLI	91.1	56	2	1	473	315	3	58	1.00E-20	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i2	Q9XYC2	RL15_FAXLI	98	50	1	0	151	2	1	50	4.30E-21	102.4	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i2	Q9XYC2	RL15_FAXLI	91.1	56	2	1	443	285	3	58	9.60E-21	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i3	Q9XYC2	RL15_FAXLI	86.7	166	17	1	532	50	39	204	2.00E-76	287	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i3	Q9XYC2	RL15_FAXLI	98.2	56	1	0	725	558	3	58	1.40E-24	114.8	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i3	Q9XYC2	RL15_FAXLI	100	23	0	0	558	490	28	50	4.90E-06	53.1	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i4	Q9XYC2	RL15_FAXLI	94.8	58	3	0	286	113	1	58	5.10E-25	115.5	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i4	Q9XYC2	RL15_FAXLI	91.1	56	2	1	458	300	3	58	9.90E-21	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i5	Q9XYC2	RL15_FAXLI	98	50	1	0	151	2	1	50	4.10E-21	102.4	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i6	Q9XYC2	RL15_FAXLI	94.8	58	3	0	263	90	1	58	4.80E-25	115.5	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i6	Q9XYC2	RL15_FAXLI	91.1	56	2	1	435	277	3	58	9.40E-21	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i6	Q9XYC2	RL15_FAXLI	92.3	26	2	0	79	2	25	50	1.30E-06	54.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i7	Q9XYC2	RL15_FAXLI	91.1	56	2	1	474	316	3	58	1.00E-20	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i7	Q9XYC2	RL15_FAXLI	79.3	58	4	1	175	2	1	50	9.00E-17	88.2	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i8	Q9XYC2	RL15_FAXLI	98	50	1	0	151	2	1	50	4.40E-21	102.4	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i8	Q9XYC2	RL15_FAXLI	91.1	56	2	1	450	292	3	58	9.80E-21	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i8	Q9XYC2	RL15_FAXLI	97.2	36	1	0	272	165	23	58	2.60E-13	76.6	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i9	Q9XYC2	RL15_FAXLI	87.3	63	3	1	353	165	1	58	5.50E-23	109	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i9	Q9XYC2	RL15_FAXLI	98	50	1	0	151	2	1	50	5.10E-21	102.4	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3464_c2_g1_i9	Q9XYC2	RL15_FAXLI	91.1	56	2	1	525	367	3	58	1.10E-20	101.3	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3464_c8_g1_i1	Q9XYC2	RL15_FAXLI	82	61	11	0	185	3	111	171	4.70E-23	107.8	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN38537_c0_g1_i1	Q9XYC2	RL15_FAXLI	89.8	49	5	0	22	168	156	204	1.40E-17	89.7	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN38537_c1_g1_i1	Q9XYC2	RL15_FAXLI	93.7	95	6	0	3	287	31	125	6.20E-45	181	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN18916_c3_g1_i1	Q9XYC2	RL15_FAXLI	76.7	103	24	0	3	311	81	183	7.10E-39	161	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18916_c0_g1_i1	Q9XYC2	RL15_FAXLI	83.8	74	12	0	249	28	131	204	7.80E-28	124	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18916_c0_g2_i1	Q9XYC2	RL15_FAXLI	82.7	75	8	2	219	1	27	98	3.40E-27	121.7	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18916_c0_g3_i1	Q9XYC2	RL15_FAXLI	90.8	120	11	0	360	1	47	166	2.00E-56	219.5	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24147_c0_g1_i1	Q9XYC2	RL15_FAXLI	85.9	78	11	0	2	235	67	144	8.40E-32	137.1	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN581_c0_g1_i11	O82528	RL15_PETHY	69.4	196	60	0	588	1	1	196	2.00E-72	273.5	RL15_PETHY	reviewed	60S ribosomal protein L15	RPL15	Petunia hybrida (Petunia)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN581_c0_g1_i7	O82528	RL15_PETHY	68.7	195	61	0	588	4	1	195	1.60E-71	270.4	RL15_PETHY	reviewed	60S ribosomal protein L15	RPL15	Petunia hybrida (Petunia)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN581_c0_g1_i8	O82528	RL15_PETHY	68.9	196	61	0	588	1	1	196	7.60E-72	271.6	RL15_PETHY	reviewed	60S ribosomal protein L15	RPL15	Petunia hybrida (Petunia)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN581_c0_g1_i9	O82528	RL15_PETHY	68.9	196	61	0	588	1	1	196	3.30E-72	272.7	RL15_PETHY	reviewed	60S ribosomal protein L15	RPL15	Petunia hybrida (Petunia)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5006_c0_g1_i1	Q5EAD6	RL15_BOVIN	100	166	0	0	500	3	1	166	5.60E-95	348.2	RL15_BOVIN	reviewed	60S ribosomal protein L15	RPL15	Bos taurus (Bovine)	204	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0016020; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN5006_c0_g1_i2	Q5EAD6	RL15_BOVIN	100	166	0	0	500	3	1	166	5.60E-95	348.2	RL15_BOVIN	reviewed	60S ribosomal protein L15	RPL15	Bos taurus (Bovine)	204	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0016020; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN39571_c0_g1_i1	Q9XYC2	RL15_FAXLI	81	58	11	0	202	29	147	204	1.20E-18	93.2	RL15_FAXLI	reviewed	60S ribosomal protein L15	RPL15	Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN8144_c0_g1_i1	P30736	RL15_CHITE	57.3	89	36	1	2	262	116	204	1.60E-26	119.8	RL15_CHITE	reviewed	60S ribosomal protein L15 (YL10)	RpL15	Chironomus tentans (Midge) (Camptochironomus tentans)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3464_c1_g1_i1	O65082	RL15B_PICMA	66.8	193	64	0	580	2	1	193	9.90E-69	261.2	RL15B_PICMA	reviewed	60S ribosomal protein L15-2	SB62	Picea mariana (Black spruce) (Abies mariana)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN581_c0_g1_i10	O65082	RL15B_PICMA	67.3	196	64	0	588	1	1	196	5.60E-72	271.9	RL15B_PICMA	reviewed	60S ribosomal protein L15-2	SB62	Picea mariana (Black spruce) (Abies mariana)	204	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN7112_c0_g2_i1	Q9P720	RL16_NEUCR	61.6	86	33	0	3	260	89	174	5.80E-26	117.9	RL16_NEUCR	reviewed	60S ribosomal protein L16 (Cytoplasmic ribosomal protein 46)	crp-46 rpl16 8D4.200 NCU01221	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	202	cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625	negative regulation of translation [GO:0017148]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20693_c0_g1_i1	O42991	RL16B_SCHPO	57.4	68	29	0	210	7	110	177	2.60E-16	85.5	RL16B_SCHPO	reviewed	60S ribosomal protein L16-B	rpl1601 rpl16b SPBC24E9.13c SPBC839.13c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	197	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; negative regulation of translation [GO:0017148]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0005829; GO:0005840; GO:0017148; GO:0022625	cytoplasmic translation [GO:0002181]; negative regulation of translation [GO:0017148]		NA	NA	NA	NA	NA	NA
TRINITY_DN28792_c0_g1_i1	P36241	RL19_DROME	75.4	69	17	0	209	3	26	94	7.80E-21	100.5	RL19_DROME	reviewed	60S ribosomal protein L19	RpL19 M(2)60E CG2746	Drosophila melanogaster (Fruit fly)	203	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN18985_c0_g1_i1	P36241	RL19_DROME	83	165	28	0	613	119	1	165	2.20E-69	263.5	RL19_DROME	reviewed	60S ribosomal protein L19	RpL19 M(2)60E CG2746	Drosophila melanogaster (Fruit fly)	203	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN3474_c0_g1_i1	Q3T0W9	RL19_BOVIN	100	159	0	0	558	82	1	159	7.90E-82	304.7	RL19_BOVIN	reviewed	60S ribosomal protein L19	RPL19	Bos taurus (Bovine)	196	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0022625; GO:0042788	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN3474_c0_g1_i2	Q3T0W9	RL19_BOVIN	100	159	0	0	558	82	1	159	7.90E-82	304.7	RL19_BOVIN	reviewed	60S ribosomal protein L19	RPL19	Bos taurus (Bovine)	196	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0022625; GO:0042788	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN25183_c0_g1_i1	P36241	RL19_DROME	74.6	63	16	0	12	200	3	65	2.90E-17	88.6	RL19_DROME	reviewed	60S ribosomal protein L19	RpL19 M(2)60E CG2746	Drosophila melanogaster (Fruit fly)	203	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1841_c2_g1_i1	P36241	RL19_DROME	73.6	53	14	0	195	37	111	163	4.50E-16	84.7	RL19_DROME	reviewed	60S ribosomal protein L19	RpL19 M(2)60E CG2746	Drosophila melanogaster (Fruit fly)	203	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN27950_c0_g1_i1	Q9SRX2	RL191_ARATH	66.5	173	58	0	521	3	1	173	1.20E-55	217.6	RL191_ARATH	reviewed	60S ribosomal protein L19-1 (Protein EMBRYO DEFECTIVE 2386)	RPL19A EMB2386 At1g02780 F22D16.23	Arabidopsis thaliana (Mouse-ear cress)	214	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003729; GO:0003735; GO:0005576; GO:0005730; GO:0005829; GO:0005886; GO:0006412; GO:0009506; GO:0022625; GO:0022626; GO:0042788	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN8763_c0_g2_i1	O09167	RL21_MOUSE	69.9	83	25	0	2	250	31	113	1.10E-29	130.2	RL21_MOUSE	reviewed	60S ribosomal protein L21	Rpl21	Mus musculus (Mouse)	160	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005783; GO:0005840; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15511_c0_g1_i1	Q6QN05	RL21_CHILA	97.3	112	3	0	336	1	30	141	1.40E-56	219.9	RL21_CHILA	reviewed	60S ribosomal protein L21	RPL21	Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera)	160	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005783; GO:0005829; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20764_c0_g1_i1	A5JSS2	RL21_CAPHI	69.2	65	20	0	197	3	49	113	7.40E-21	100.5	RL21_CAPHI	reviewed	60S ribosomal protein L21	RPL21	Capra hircus (Goat)	160	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005783; GO:0005829; GO:0005840; GO:0006412	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN24299_c1_g1_i1	A5JSS2	RL21_CAPHI	63.1	65	24	0	1	195	49	113	1.20E-18	93.2	RL21_CAPHI	reviewed	60S ribosomal protein L21	RPL21	Capra hircus (Goat)	160	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005783; GO:0005829; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24299_c0_g1_i1	Q6QN05	RL21_CHILA	58.8	51	21	0	296	144	69	119	6.00E-11	68.2	RL21_CHILA	reviewed	60S ribosomal protein L21	RPL21	Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera)	160	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005783; GO:0005829; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN8763_c0_g3_i1	P46778	RL21_HUMAN	61.4	44	17	0	76	207	1	44	1.50E-08	59.7	RL21_HUMAN	reviewed	60S ribosomal protein L21 (Large ribosomal subunit protein eL21)	RPL21	Homo sapiens (Human)	160	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003735; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15511_c1_g1_i1	P46778	RL21_HUMAN	100	141	0	0	21	443	1	141	8.00E-76	284.3	RL21_HUMAN	reviewed	60S ribosomal protein L21 (Large ribosomal subunit protein eL21)	RPL21	Homo sapiens (Human)	160	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003735; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4695_c10_g1_i1	P46778	RL21_HUMAN	62.9	70	26	0	19	228	1	70	1.60E-19	96.3	RL21_HUMAN	reviewed	60S ribosomal protein L21 (Large ribosomal subunit protein eL21)	RPL21	Homo sapiens (Human)	160	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003735; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4695_c0_g1_i1	P46778	RL21_HUMAN	61.9	160	61	0	523	44	1	160	1.50E-53	210.7	RL21_HUMAN	reviewed	60S ribosomal protein L21 (Large ribosomal subunit protein eL21)	RPL21	Homo sapiens (Human)	160	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0003723; GO:0003735; GO:0005783; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		blue	blue	NA	NA	NA	NA
TRINITY_DN35973_c0_g1_i1	Q9UUC1	RL21A_SCHPO	53.8	78	36	0	243	10	19	96	1.30E-19	96.7	RL21A_SCHPO	reviewed	60S ribosomal protein L21-A	rpl2101 rpl21 rpl21a SPBC365.03c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	160	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005829; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN17117_c1_g1_i1	Q3T057	RL23_BOVIN	85.5	83	12	0	259	11	58	140	1.90E-32	139.4	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17117_c0_g1_i4	Q3T057	RL23_BOVIN	80.6	72	14	0	217	2	7	78	8.00E-26	117.5	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26892_c0_g1_i1	Q3T057	RL23_BOVIN	79	105	22	0	317	3	20	124	4.60E-41	168.3	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21738_c0_g1_i1	Q3T057	RL23_BOVIN	75.9	58	14	0	70	243	1	58	1.00E-16	87.4	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21738_c1_g1_i1	Q3T057	RL23_BOVIN	87	108	14	0	3	326	33	140	1.60E-47	189.9	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN11846_c0_g1_i1	Q6PC14	RL23_DANRE	82.9	105	18	0	22	336	1	105	1.00E-43	177.2	RL23_DANRE	reviewed	60S ribosomal protein L23	rpl23 zgc:73149	Danio rerio (Zebrafish) (Brachydanio rerio)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0070180	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2557_c0_g1_i1	Q8SRA7	RL23_ENCCU	67.9	78	25	0	268	35	68	145	3.30E-24	112.1	RL23_ENCCU	reviewed	60S ribosomal protein L23	RPL23 ECU08_1160i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	146	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN31186_c0_g1_i1	Q3T057	RL23_BOVIN	79.5	73	15	0	1	219	29	101	7.10E-25	114	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26674_c3_g1_i1	Q3T057	RL23_BOVIN	90.7	140	13	0	479	60	1	140	4.20E-68	258.8	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN1826_c0_g1_i1	Q3T057	RL23_BOVIN	100	140	0	0	439	20	1	140	3.70E-74	278.9	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1826_c0_g1_i2	Q3T057	RL23_BOVIN	100	140	0	0	439	20	1	140	1.70E-74	280	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1826_c0_g2_i1	Q3T057	RL23_BOVIN	100	140	0	0	499	80	1	140	3.20E-74	279.3	RL23_BOVIN	reviewed	60S ribosomal protein L23	RPL23	Bos taurus (Bovine)	140	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0050821; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1990948; GO:2000059	cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17117_c0_g1_i1	P48159	RL23_DROME	79	62	13	0	575	390	7	68	2.10E-21	104	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN17117_c0_g1_i1	P48159	RL23_DROME	78.7	47	9	1	330	193	6	52	1.80E-12	74.3	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN17117_c0_g1_i3	P48159	RL23_DROME	79	62	13	0	546	361	7	68	2.00E-21	104	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN17117_c0_g1_i3	P48159	RL23_DROME	78.7	47	9	1	301	164	6	52	1.70E-12	74.3	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i14	P48159	RL23_DROME	70.2	57	17	0	523	693	1	57	7.80E-15	82.4	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i14	P48159	RL23_DROME	66.7	57	18	1	462	295	1	57	2.80E-12	73.9	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i15	P48159	RL23_DROME	68.4	57	17	1	462	295	1	57	7.00E-13	75.5	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i16	P48159	RL23_DROME	68.4	57	17	1	462	295	1	57	1.30E-12	75.5	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i16	P48159	RL23_DROME	66.7	57	18	1	523	690	1	57	3.70E-12	73.9	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i24	P48159	RL23_DROME	68.4	57	17	1	523	690	1	57	1.00E-12	75.5	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i24	P48159	RL23_DROME	66.7	57	18	1	462	295	1	57	3.00E-12	73.9	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i28	P48159	RL23_DROME	68.4	57	17	1	296	129	1	57	6.40E-13	75.1	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i29	P48159	RL23_DROME	70.2	57	17	0	465	295	1	57	5.80E-15	82.4	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i3	P48159	RL23_DROME	68.4	57	17	1	523	690	1	57	1.30E-12	75.5	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i3	P48159	RL23_DROME	66.7	57	18	1	462	295	1	57	3.70E-12	73.9	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN31479_c0_g1_i1	P48159	RL23_DROME	78.7	47	10	0	141	1	4	50	1.90E-14	79.3	RL23_DROME	reviewed	60S ribosomal protein L23 (L17A)	RpL23 RpL17A CG3661	Drosophila melanogaster (Fruit fly)	140	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c5_g1_i1	P49690	RL23_ARATH	75	36	8	1	187	83	17	52	1.00E-06	53.5	RL23_ARATH	reviewed	60S ribosomal protein L23 (Protein EMBRYO DEFECTIVE 2171)	RPL23A At1g04480 F19P19.5; RPL23B At2g33370 F4P9.14; RPL23C EMB2171 At3g04400 T27C4.4	Arabidopsis thaliana (Mouse-ear cress)	140	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleolus [GO:0005730]	large ribosomal subunit rRNA binding [GO:0070180]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005576; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0070180	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19154_c0_g1_i1	P49690	RL23_ARATH	76.1	46	11	0	8	145	26	71	6.60E-12	71.6	RL23_ARATH	reviewed	60S ribosomal protein L23 (Protein EMBRYO DEFECTIVE 2171)	RPL23A At1g04480 F19P19.5; RPL23B At2g33370 F4P9.14; RPL23C EMB2171 At3g04400 T27C4.4	Arabidopsis thaliana (Mouse-ear cress)	140	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; large ribosomal subunit rRNA binding [GO:0070180]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleolus [GO:0005730]	large ribosomal subunit rRNA binding [GO:0070180]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0005576; GO:0005730; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0070180	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN205_c0_g1_i1	P0CT60	RL23A_SCHPO	71.9	139	38	1	466	53	1	139	8.20E-50	198	RL23A_SCHPO	reviewed	60S ribosomal protein L23-A	rpl2301 rpl23 rpl23a SPAC3G9.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	139	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005634; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		red	red	NA	NA	NA	NA
TRINITY_DN205_c0_g2_i1	P0CT60	RL23A_SCHPO	71.9	139	38	1	451	38	1	139	1.40E-49	197.2	RL23A_SCHPO	reviewed	60S ribosomal protein L23-A	rpl2301 rpl23 rpl23a SPAC3G9.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	139	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005634; GO:0022625; GO:0070180	cytoplasmic translation [GO:0002181]		red	red	NA	NA	NA	NA
TRINITY_DN16924_c0_g1_i1	Q962T5	RL24_SPOFR	72.1	111	31	0	427	95	1	111	2.00E-40	166.8	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN16924_c0_g1_i3	Q8ISQ3	RL24_BRABE	62.9	62	23	0	186	1	1	62	7.10E-19	94	RL24_BRABE	reviewed	60S ribosomal protein L24	RPL24	Branchiostoma belcheri (Amphioxus)	154	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN16924_c0_g1_i5	Q962T5	RL24_SPOFR	71.2	111	32	0	427	95	1	111	2.40E-40	166.4	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN16924_c0_g1_i6	Q962T5	RL24_SPOFR	68.5	111	35	0	427	95	1	111	1.00E-36	154.5	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			blue	blue	NA	NA	NA	NA
TRINITY_DN16924_c0_g1_i7	Q962T5	RL24_SPOFR	72.2	90	25	0	364	95	22	111	3.20E-30	132.5	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN29801_c0_g1_i1	Q962T5	RL24_SPOFR	73.8	61	16	0	199	17	51	111	4.70E-15	81.3	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN21255_c0_g1_i1	Q962T5	RL24_SPOFR	74.8	111	28	0	53	385	1	111	2.50E-43	176.4	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			blue	blue	NA	NA	NA	NA
TRINITY_DN21255_c3_g1_i1	Q962T5	RL24_SPOFR	64.6	65	23	0	195	1	29	93	3.80E-18	92	RL24_SPOFR	reviewed	60S ribosomal protein L24	RpL24	Spodoptera frugiperda (Fall armyworm)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN11459_c0_g1_i1	Q862I1	RL24_BOVIN	100	63	0	0	269	81	49	111	1.20E-26	120.2	RL24_BOVIN	reviewed	60S ribosomal protein L24 (Ribosomal protein L30)	RPL24	Bos taurus (Bovine)	157	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; mitotic cell cycle checkpoint [GO:0007093]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005783; GO:0006412; GO:0007093; GO:0010458; GO:0021554; GO:0022625; GO:0031290; GO:0042788; GO:0060041; GO:1902626	assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; mitotic cell cycle checkpoint [GO:0007093]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN11459_c0_g1_i2	Q862I1	RL24_BOVIN	100	63	0	0	269	81	49	111	1.20E-26	120.2	RL24_BOVIN	reviewed	60S ribosomal protein L24 (Ribosomal protein L30)	RPL24	Bos taurus (Bovine)	157	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; mitotic cell cycle checkpoint [GO:0007093]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005783; GO:0006412; GO:0007093; GO:0010458; GO:0021554; GO:0022625; GO:0031290; GO:0042788; GO:0060041; GO:1902626	assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; mitotic cell cycle checkpoint [GO:0007093]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i12	Q95WA0	RL26_LITLI	63.2	57	21	0	1	171	63	119	4.70E-13	75.1	RL26_LITLI	reviewed	60S ribosomal protein L26	RPL26	Littorina littorea (Common periwinkle)	144	large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i5	Q95WA0	RL26_LITLI	65.3	75	26	0	3	227	53	127	1.60E-19	96.3	RL26_LITLI	reviewed	60S ribosomal protein L26	RPL26	Littorina littorea (Common periwinkle)	144	large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c1_g1_i1	P61257	RL26_BOVIN	64.3	70	25	0	31	240	2	71	1.80E-16	86.3	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6928_c0_g1_i1	P61257	RL26_BOVIN	100	145	0	0	441	7	1	145	1.40E-73	276.9	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6928_c0_g2_i1	P61257	RL26_BOVIN	100	142	0	0	426	1	1	142	5.60E-72	271.6	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22857_c0_g1_i1	P61257	RL26_BOVIN	73.5	83	22	0	249	1	1	83	1.10E-27	123.6	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11772_c0_g1_i1	P61257	RL26_BOVIN	64	100	36	0	302	3	1	100	1.50E-28	126.7	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11772_c0_g1_i2	P61257	RL26_BOVIN	68.9	103	32	0	315	7	1	103	2.20E-33	142.9	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN942_c48_g1_i1	P61257	RL26_BOVIN	71.5	137	37	1	464	54	1	135	6.30E-48	191.8	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		blue	blue	NA	NA	NA	NA
TRINITY_DN32628_c0_g1_i1	P61257	RL26_BOVIN	71.1	45	13	0	137	3	1	45	7.60E-11	67.4	RL26_BOVIN	reviewed	60S ribosomal protein L26	RPL26	Bos taurus (Bovine)	145	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0006977; GO:0022625; GO:0042273; GO:0071479; GO:1902167	"cellular response to ionizing radiation [GO:0071479]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; ribosomal large subunit biogenesis [GO:0042273]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39842_c0_g1_i1	Q95WA0	RL26_LITLI	62.7	67	20	2	1	192	80	144	1.20E-13	76.6	RL26_LITLI	reviewed	60S ribosomal protein L26	RPL26	Littorina littorea (Common periwinkle)	144	large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0015934	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN7480_c0_g1_i1	P51414	RL261_ARATH	66.1	124	42	0	18	389	1	124	1.90E-37	156.8	RL261_ARATH	reviewed	60S ribosomal protein L26-1	RPL26A At3g49910 F3A4.4 T16K5.260	Arabidopsis thaliana (Mouse-ear cress)	146	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to cold [GO:0009409]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005774; GO:0005829; GO:0005886; GO:0009409; GO:0022625; GO:0022626; GO:0042273; GO:0042788	cytoplasmic translation [GO:0002181]; response to cold [GO:0009409]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN12286_c0_g1_i1	Q9FJX2	RL262_ARATH	68.3	82	25	1	11	253	1	82	3.10E-24	112.1	RL262_ARATH	reviewed	60S ribosomal protein L26-2	RPL26B At5g67510 K9I9.7	Arabidopsis thaliana (Mouse-ear cress)	146	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; plastid [GO:0009536]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0009536; GO:0022625; GO:0022626; GO:0042273; GO:0042788	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i1	Q9UNX3	RL26L_HUMAN	68	103	31	1	3	311	35	135	1.60E-30	133.3	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i10	Q9UNX3	RL26L_HUMAN	62.5	80	28	1	2	241	58	135	3.80E-20	98.6	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		blue	blue	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i11	Q9UNX3	RL26L_HUMAN	69.4	108	31	1	6	329	30	135	5.10E-35	148.3	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i2	Q9UNX3	RL26L_HUMAN	61.3	75	27	1	1	225	63	135	2.10E-17	89.4	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		blue	blue	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i3	Q9UNX3	RL26L_HUMAN	67	103	32	1	3	311	35	135	8.00E-30	131	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i4	Q9UNX3	RL26L_HUMAN	68	103	31	1	3	311	35	135	3.60E-30	132.1	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i6	Q9UNX3	RL26L_HUMAN	61.2	85	31	1	3	257	53	135	2.80E-20	99	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i8	Q9UNX3	RL26L_HUMAN	60	75	28	1	1	225	63	135	2.80E-17	89	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2980_c0_g1_i9	Q9UNX3	RL26L_HUMAN	68	103	31	1	3	311	35	135	5.90E-31	134.8	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN35000_c0_g1_i1	Q9UNX3	RL26L_HUMAN	100	115	0	0	28	372	1	115	7.50E-59	227.6	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN11772_c2_g1_i1	Q9UNX3	RL26L_HUMAN	59.4	69	26	1	208	2	69	135	4.80E-15	81.3	RL26L_HUMAN	reviewed	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1 RPL26P1	Homo sapiens (Human)	145	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN17113_c0_g1_i1	Q9VZS5	RL28_DROME	55.2	87	39	0	263	3	4	90	1.70E-20	99.8	RL28_DROME	reviewed	60S ribosomal protein L28	RpL28 CG12740	Drosophila melanogaster (Fruit fly)	144	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15568_c0_g2_i1	Q9VZS5	RL28_DROME	56.7	60	26	0	28	207	4	63	7.20E-12	70.9	RL28_DROME	reviewed	60S ribosomal protein L28	RpL28 CG12740	Drosophila melanogaster (Fruit fly)	144	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15568_c0_g2_i2	Q9VZS5	RL28_DROME	60	60	24	0	28	207	4	63	1.10E-12	73.6	RL28_DROME	reviewed	60S ribosomal protein L28	RpL28 CG12740	Drosophila melanogaster (Fruit fly)	144	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15568_c0_g1_i1	Q9VZS5	RL28_DROME	49.3	71	35	1	2	214	73	142	9.20E-09	60.5	RL28_DROME	reviewed	60S ribosomal protein L28	RpL28 CG12740	Drosophila melanogaster (Fruit fly)	144	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN9415_c0_g1_i1	P41105	RL28_MOUSE	100	64	0	0	3	194	74	137	6.20E-26	117.5	RL28_MOUSE	reviewed	60S ribosomal protein L28	Rpl28	Mus musculus (Mouse)	137	cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0030425; GO:0036464; GO:0044297	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26512_c2_g1_i1	Q962T2	RL28_SPOFR	53.3	137	64	0	469	59	1	137	1.40E-31	137.5	RL28_SPOFR	reviewed	60S ribosomal protein L28	RpL28	Spodoptera frugiperda (Fall armyworm)	139	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN27006_c0_g1_i1	Q962T2	RL28_SPOFR	52.5	80	38	0	18	257	1	80	1.70E-17	89.7	RL28_SPOFR	reviewed	60S ribosomal protein L28	RpL28	Spodoptera frugiperda (Fall armyworm)	139	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN464_c0_g1_i10	P35684	RL3_ORYSJ	68	369	114	3	1170	73	21	388	2.30E-146	520	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN464_c0_g1_i11	P35684	RL3_ORYSJ	66.5	284	91	3	915	73	106	388	6.90E-106	385.2	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN464_c0_g1_i12	P35684	RL3_ORYSJ	67.8	369	115	3	1170	73	21	388	8.70E-146	518.1	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN464_c0_g1_i2	P35684	RL3_ORYSJ	68.3	378	116	3	1197	73	12	388	7.00E-151	535	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN464_c0_g1_i6	P35684	RL3_ORYSJ	68.5	378	115	3	1197	73	12	388	1.80E-151	537	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN858_c1_g1_i1	P49149	RL3_TOXCA	64.3	70	25	0	212	3	160	229	1.60E-21	102.8	RL3_TOXCA	reviewed	60S ribosomal protein L3	RPL3	Toxocara canis (Canine roundworm)	402	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22987_c1_g1_i1	P49149	RL3_TOXCA	71.7	106	30	0	319	2	176	281	5.50E-42	171.4	RL3_TOXCA	reviewed	60S ribosomal protein L3	RPL3	Toxocara canis (Canine roundworm)	402	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24883_c0_g1_i1	P49149	RL3_TOXCA	64.9	74	26	0	3	224	104	177	2.60E-22	105.5	RL3_TOXCA	reviewed	60S ribosomal protein L3	RPL3	Toxocara canis (Canine roundworm)	402	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN27878_c1_g1_i1	O16797	RL3_DROME	80.9	68	13	0	210	7	272	339	1.60E-29	129.4	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN24413_c1_g1_i1	P39872	RL3_BOVIN	69.2	117	36	0	2	352	20	136	5.40E-43	174.9	RL3_BOVIN	reviewed	60S ribosomal protein L3	RPL3	Bos taurus (Bovine)	403	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24417_c0_g1_i1	O16797	RL3_DROME	73.6	87	23	0	263	3	279	365	1.60E-31	136.3	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN32686_c9_g1_i1	O16797	RL3_DROME	76.3	38	9	0	244	131	265	302	1.80E-08	59.7	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN32686_c6_g1_i1	O16797	RL3_DROME	77.9	398	88	0	1283	90	1	398	4.70E-188	658.7	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN17709_c0_g1_i1	O16797	RL3_DROME	75.6	45	11	0	6	140	285	329	4.20E-15	81.6	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN2626_c0_g1_i1	Q8SQI3	RL3_ENCCU	56.1	98	43	0	3	296	9	106	2.50E-26	119.4	RL3_ENCCU	reviewed	60S ribosomal protein L3	RPL3-1 ECU03_1220; RPL3-2 ECU09_1000	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	383	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN464_c0_g1_i15	P35684	RL3_ORYSJ	68	369	114	3	1170	73	21	388	2.30E-146	520	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	1	NA	NA	NA
TRINITY_DN15642_c0_g2_i1	O16797	RL3_DROME	79.5	127	26	0	381	1	221	347	1.20E-56	220.3	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN15642_c1_g1_i1	O16797	RL3_DROME	78.2	87	19	0	1	261	253	339	1.10E-37	156.8	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN15642_c0_g1_i2	O16797	RL3_DROME	74.7	91	23	0	315	43	308	398	1.90E-34	146.4	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN15642_c0_g1_i3	O16797	RL3_DROME	74.7	91	23	0	310	38	308	398	2.40E-34	146	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN15642_c0_g1_i4	O16797	RL3_DROME	74.7	91	23	0	315	43	308	398	1.90E-34	146.4	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN5862_c0_g1_i1	Q8SQI3	RL3_ENCCU	65.7	207	69	2	648	31	173	378	1.40E-73	277.3	RL3_ENCCU	reviewed	60S ribosomal protein L3	RPL3-1 ECU03_1220; RPL3-2 ECU09_1000	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	383	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4989_c0_g1_i1	P35684	RL3_ORYSJ	79.5	44	9	0	206	75	345	388	1.70E-12	72.8	RL3_ORYSJ	reviewed	60S ribosomal protein L3	RPL3 Os12g0167900 LOC_Os12g07010	Oryza sativa subsp. japonica (Rice)	389	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN31798_c0_g1_i1	O16797	RL3_DROME	65.7	67	23	0	1	201	332	398	6.00E-17	87.8	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN20051_c1_g1_i1	O16797	RL3_DROME	75.7	189	46	0	1	567	171	359	3.30E-82	305.8	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN20051_c0_g1_i1	P39872	RL3_BOVIN	70	40	12	0	1	120	83	122	2.80E-11	69.7	RL3_BOVIN	reviewed	60S ribosomal protein L3	RPL3	Bos taurus (Bovine)	403	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22339_c0_g1_i1	O16797	RL3_DROME	72.2	72	20	0	218	3	318	389	8.50E-23	107.1	RL3_DROME	reviewed	60S ribosomal protein L3	RpL3 CG4863	Drosophila melanogaster (Fruit fly)	416	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN38737_c0_g1_i1	P59671	RL3_NEUCR	87.7	73	9	0	7	225	226	298	4.30E-33	141.4	RL3_NEUCR	reviewed	60S ribosomal protein L3	rpl-3 B17B1.040 NCU06843	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	392	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN25669_c0_g1_i1	Q8NKF4	RL3_ASPFU	92.5	67	5	0	203	3	90	156	8.80E-30	130.2	RL3_ASPFU	reviewed	60S ribosomal protein L3 (allergen Asp f 23)	rpl3 AFUA_2G11850	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	392	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0006412; GO:0022625	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN858_c0_g1_i3	P39023	RL3_HUMAN	100	403	0	0	25	1233	1	403	7.10E-234	810.8	RL3_HUMAN	reviewed	60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3)	RPL3 OK/SW-cl.32	Homo sapiens (Human)	403	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0008097; GO:0019083; GO:0022625; GO:0032991; GO:0045202; GO:0070062; GO:0071353	"cellular response to interleukin-4 [GO:0071353]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN858_c0_g1_i1	P27659	RL3_MOUSE	100	402	0	0	1	1206	2	403	3.40E-233	808.5	RL3_MOUSE	reviewed	60S ribosomal protein L3 (J1 protein)	Rpl3	Mus musculus (Mouse)	403	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0032991; GO:0045202; GO:0071353	cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN858_c0_g1_i2	P27659	RL3_MOUSE	99.3	402	3	0	1	1206	2	403	2.90E-232	805.4	RL3_MOUSE	reviewed	60S ribosomal protein L3 (J1 protein)	Rpl3	Mus musculus (Mouse)	403	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0032991; GO:0045202; GO:0071353	cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN429_c0_g1_i2	Q3T0D5	RL30_BOVIN	99.1	115	1	0	56	400	1	115	5.20E-59	228.4	RL30_BOVIN	reviewed	60S ribosomal protein L30	RPL30	Bos taurus (Bovine)	115	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			NA	NA	NA	NA	NA	NA
TRINITY_DN429_c0_g1_i3	Q3T0D5	RL30_BOVIN	100	115	0	0	62	406	1	115	1.40E-59	230.3	RL30_BOVIN	reviewed	60S ribosomal protein L30	RPL30	Bos taurus (Bovine)	115	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			NA	NA	NA	NA	NA	NA
TRINITY_DN33220_c0_g1_i1	P58374	RL30_BRABE	70.6	102	30	0	382	77	2	103	1.80E-36	153.3	RL30_BRABE	reviewed	60S ribosomal protein L30	RPL30	Branchiostoma belcheri (Amphioxus)	114	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			red	red	NA	NA	NA	NA
TRINITY_DN3435_c0_g1_i1	Q3T0D5	RL30_BOVIN	82	111	20	0	211	543	1	111	2.10E-47	190.3	RL30_BOVIN	reviewed	60S ribosomal protein L30	RPL30	Bos taurus (Bovine)	115	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			blue	blue	NA	NA	NA	NA
TRINITY_DN3435_c0_g1_i1	Q3T0D5	RL30_BOVIN	81.6	49	9	0	152	6	3	51	1.20E-13	78.2	RL30_BOVIN	reviewed	60S ribosomal protein L30	RPL30	Bos taurus (Bovine)	115	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			blue	blue	NA	NA	NA	NA
TRINITY_DN3435_c0_g1_i2	Q3T0D5	RL30_BOVIN	82	111	20	0	394	62	1	111	3.00E-47	190.3	RL30_BOVIN	reviewed	60S ribosomal protein L30	RPL30	Bos taurus (Bovine)	115	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			NA	NA	NA	NA	NA	NA
TRINITY_DN7516_c0_g1_i1	P58374	RL30_BRABE	68.2	110	35	0	18	347	2	111	2.30E-37	156.4	RL30_BRABE	reviewed	60S ribosomal protein L30	RPL30	Branchiostoma belcheri (Amphioxus)	114	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			red	red	NA	NA	NA	NA
TRINITY_DN32597_c0_g1_i1	Q3T0D5	RL30_BOVIN	68.2	66	21	0	200	3	3	68	7.80E-18	90.5	RL30_BOVIN	reviewed	60S ribosomal protein L30	RPL30	Bos taurus (Bovine)	115	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			NA	NA	NA	NA	NA	NA
TRINITY_DN10189_c1_g1_i1	P58374	RL30_BRABE	83.1	83	14	0	250	2	9	91	6.20E-33	141	RL30_BRABE	reviewed	60S ribosomal protein L30	RPL30	Branchiostoma belcheri (Amphioxus)	114	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			NA	NA	NA	NA	NA	NA
TRINITY_DN10189_c0_g1_i1	P58374	RL30_BRABE	93.6	47	3	0	92	232	54	100	4.30E-20	98.2	RL30_BRABE	reviewed	60S ribosomal protein L30	RPL30	Branchiostoma belcheri (Amphioxus)	114	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0022625			NA	NA	NA	NA	NA	NA
TRINITY_DN10819_c0_g1_i1	Q8JHJ1	RL35_DANRE	75.3	97	24	0	60	350	1	97	2.20E-28	126.3	RL35_DANRE	reviewed	60S ribosomal protein L35	rpl35	Danio rerio (Zebrafish) (Brachydanio rerio)	123	"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; erythrocyte differentiation [GO:0030218]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]"	cytosolic large ribosomal subunit [GO:0022625]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625; GO:0030218; GO:0043009; GO:0051726	"chordate embryonic development [GO:0043009]; erythrocyte differentiation [GO:0030218]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]"		blue	blue	NA	NA	NA	NA
TRINITY_DN37410_c0_g1_i1	Q9M5L0	RL35_EUPES	52.9	51	24	0	154	2	67	117	3.30E-06	52	RL35_EUPES	reviewed	60S ribosomal protein L35	RPL35	Euphorbia esula (Leafy spurge)	123	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN36237_c0_g1_i1	Q98TF7	RL35_CHICK	100	66	0	0	199	2	1	66	1.60E-25	116.3	RL35_CHICK	reviewed	60S ribosomal protein L35	RPL35	Gallus gallus (Chicken)	123	"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"	cytosolic large ribosomal subunit [GO:0022625]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33912_c0_g1_i1	Q98TF7	RL35_CHICK	100	70	0	0	212	3	1	70	1.10E-27	123.6	RL35_CHICK	reviewed	60S ribosomal protein L35	RPL35	Gallus gallus (Chicken)	123	"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"	cytosolic large ribosomal subunit [GO:0022625]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38723_c3_g1_i1	Q6ZWV7	RL35_MOUSE	71.5	123	35	0	50	418	1	123	1.00E-38	161	RL35_MOUSE	reviewed	60S ribosomal protein L35	Rpl35	Mus musculus (Mouse)	123	"cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"	cytosolic large ribosomal subunit [GO:0022625]	mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003729; GO:0003735; GO:0006412; GO:0022625; GO:0043021	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"		blue	blue	NA	NA	NA	NA
TRINITY_DN20024_c0_g1_i1	Q56JY1	RL35A_BOVIN	55.7	70	31	0	2	211	2	71	2.80E-18	92	RL35A_BOVIN	reviewed	60S ribosomal protein L35a	RPL35A	Bos taurus (Bovine)	110	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0002181; GO:0003735; GO:0022625; GO:0042273	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN20024_c2_g1_i1	Q56JY1	RL35A_BOVIN	58.2	55	23	0	83	247	3	57	5.50E-13	74.7	RL35A_BOVIN	reviewed	60S ribosomal protein L35a	RPL35A	Bos taurus (Bovine)	110	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0002181; GO:0003735; GO:0022625; GO:0042273	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN5540_c0_g1_i1	O55142	RL35A_MOUSE	100	110	0	0	51	380	1	110	1.20E-59	230.3	RL35A_MOUSE	reviewed	60S ribosomal protein L35a	Rpl35a	Mus musculus (Mouse)	110	cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]	ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005739; GO:0006364; GO:0022625; GO:0042273; GO:0043021	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN33662_c0_g1_i1	P18077	RL35A_HUMAN	100	110	0	0	364	35	1	110	4.90E-59	228.4	RL35A_HUMAN	reviewed	60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33)	RPL35A GIG33	Homo sapiens (Human)	110	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042273; GO:0070062	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35353_c0_g1_i1	P18077	RL35A_HUMAN	61.4	70	27	0	226	17	41	110	5.40E-20	97.8	RL35A_HUMAN	reviewed	60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33)	RPL35A GIG33	Homo sapiens (Human)	110	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042273; GO:0070062	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28067_c1_g1_i1	P18077	RL35A_HUMAN	58.1	74	31	0	227	6	37	110	2.20E-21	102.4	RL35A_HUMAN	reviewed	60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33)	RPL35A GIG33	Homo sapiens (Human)	110	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042273; GO:0070062	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29612_c4_g1_i1	P18077	RL35A_HUMAN	61.5	109	42	0	100	426	2	110	2.40E-35	149.8	RL35A_HUMAN	reviewed	60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33)	RPL35A GIG33	Homo sapiens (Human)	110	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042273; GO:0070062	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		blue	blue	NA	NA	NA	NA
TRINITY_DN23509_c0_g1_i1	P02434	RL35A_XENLA	60.6	66	26	0	6	203	41	106	5.00E-17	87.8	RL35A_XENLA	reviewed	60S ribosomal protein L35a (L32)	rpl35a	Xenopus laevis (African clawed frog)	110	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000049; GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20648_c0_g1_i1	P61485	RL36A_DANRE	76.8	69	16	0	208	2	1	69	9.00E-24	110.5	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20648_c1_g1_i1	P61485	RL36A_DANRE	61.2	85	31	1	38	286	1	85	7.40E-22	104.4	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24621_c0_g1_i1	P61485	RL36A_DANRE	71.4	91	24	1	3	269	1	91	1.10E-30	133.7	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17627_c0_g1_i1	P61485	RL36A_DANRE	74.5	106	25	1	317	6	1	106	6.40E-39	161.4	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29717_c3_g1_i1	P61485	RL36A_DANRE	76.4	106	23	1	103	414	1	106	1.90E-40	166.8	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN21199_c2_g1_i1	P61485	RL36A_DANRE	65.6	96	31	1	289	8	11	106	2.40E-28	125.9	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21199_c3_g1_i1	P61485	RL36A_DANRE	73.6	72	19	0	14	229	1	72	3.30E-23	108.6	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5056_c0_g1_i10	Q3SZ59	RL36A_BOVIN	100	106	0	0	396	79	1	106	1.90E-56	219.9	RL36A_BOVIN	reviewed	60S ribosomal protein L36a	RPL36A	Bos taurus (Bovine)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5056_c0_g1_i12	Q3SZ59	RL36A_BOVIN	100	106	0	0	407	90	1	106	2.00E-56	219.9	RL36A_BOVIN	reviewed	60S ribosomal protein L36a	RPL36A	Bos taurus (Bovine)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5056_c0_g1_i5	Q3SZ59	RL36A_BOVIN	100	106	0	0	407	90	1	106	2.00E-56	219.9	RL36A_BOVIN	reviewed	60S ribosomal protein L36a	RPL36A	Bos taurus (Bovine)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN30994_c0_g1_i1	P61485	RL36A_DANRE	72.3	94	24	1	278	3	5	98	2.90E-31	135.6	RL36A_DANRE	reviewed	60S ribosomal protein L36a	rpl36a	Danio rerio (Zebrafish) (Brachydanio rerio)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625; GO:0043009; GO:0051726	chordate embryonic development [GO:0043009]; regulation of cell cycle [GO:0051726]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40612_c0_g1_i1	Q22X38	RL36A_TETTS	56.5	69	30	0	3	209	10	78	5.80E-16	84.3	RL36A_TETTS	reviewed	60S ribosomal protein L36a (60S ribosomal protein L44)	RPL36A RPL42 RPL44 TTHERM_00633150	Tetrahymena thermophila (strain SB210)	109	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21837_c1_g1_i1	Q969Q0	RL36L_HUMAN	73.8	61	16	0	183	1	1	61	5.50E-18	91.3	RL36L_HUMAN	reviewed	60S ribosomal protein L36a-like (Large ribosomal subunit protein eL42-like)	RPL36AL	Homo sapiens (Human)	106	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005886; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5056_c0_g1_i2	Q969Q0	RL36L_HUMAN	100	106	0	0	407	90	1	106	2.00E-56	219.9	RL36L_HUMAN	reviewed	60S ribosomal protein L36a-like (Large ribosomal subunit protein eL42-like)	RPL36AL	Homo sapiens (Human)	106	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005886; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN5056_c0_g1_i8	Q969Q0	RL36L_HUMAN	100	106	0	0	408	91	1	106	2.00E-56	219.9	RL36L_HUMAN	reviewed	60S ribosomal protein L36a-like (Large ribosomal subunit protein eL42-like)	RPL36AL	Homo sapiens (Human)	106	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005886; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN453_c0_g2_i1	Q4R5P9	RL4_MACFA	71.6	148	40	1	450	7	11	156	3.40E-53	209.1	RL4_MACFA	reviewed	60S ribosomal protein L4	RPL4 QccE-11167	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	427	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN453_c0_g1_i1	Q58DW0	RL4_BOVIN	68.6	121	36	1	363	1	11	129	9.20E-41	167.5	RL4_BOVIN	reviewed	60S ribosomal protein L4	RPL4	Bos taurus (Bovine)	422	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN15163_c0_g1_i1	P0DJ55	RL4_TETTS	56.2	137	59	1	3	410	169	305	1.30E-40	167.2	RL4_TETTS	reviewed	60S ribosomal protein L4	RPL4 TTHERM_00333210	Tetrahymena thermophila (strain SB210)	410	cytoplasm [GO:0005737]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN12664_c0_g1_i1	Q58DW0	RL4_BOVIN	68.2	88	28	0	267	4	164	251	8.90E-30	130.6	RL4_BOVIN	reviewed	60S ribosomal protein L4	RPL4	Bos taurus (Bovine)	422	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22217_c0_g1_i1	P50878	RL4_RAT	54.6	97	44	0	5	295	156	252	7.60E-22	104.4	RL4_RAT	reviewed	60S ribosomal protein L4 (60S ribosomal protein L1)	Rpl4 Rpl1	Rattus norvegicus (Rat)	421	A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; brainstem development [GO:0003360]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; translation [GO:0006412]	A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003360; GO:0003723; GO:0003735; GO:0005634; GO:0005791; GO:0006412; GO:0007420; GO:0008097; GO:0014069; GO:0015934; GO:0022625; GO:0030154; GO:0031672; GO:0045773; GO:0050772; GO:0071417; GO:1990904	brain development [GO:0007420]; brainstem development [GO:0003360]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2857_c0_g2_i1	Q28346	RL4_CANLF	96.3	322	12	0	982	17	1	322	5.40E-176	618.2	RL4_CANLF	reviewed	60S ribosomal protein L4 (60S ribosomal protein L1)	RPL4 RPL1	Canis lupus familiaris (Dog) (Canis familiaris)	421	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2857_c0_g1_i1	Q28346	RL4_CANLF	96.6	322	11	0	981	16	1	322	1.40E-176	620.2	RL4_CANLF	reviewed	60S ribosomal protein L4 (60S ribosomal protein L1)	RPL4 RPL1	Canis lupus familiaris (Dog) (Canis familiaris)	421	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2028_c0_g1_i1	P09180	RL4_DROME	61.4	88	34	0	1	264	30	117	3.20E-22	105.5	RL4_DROME	reviewed	60S ribosomal protein L4 (L1)	RpL4 RpL1 CG5502	Drosophila melanogaster (Fruit fly)	401	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15163_c0_g2_i1	P49165	RL4_URECA	61.1	113	44	0	3	341	185	297	1.30E-36	153.7	RL4_URECA	reviewed	60S ribosomal protein L4 (L1)	RPL4 RPL1	Urechis caupo (Innkeeper worm) (Spoonworm)	386	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21350_c0_g1_i1	P49165	RL4_URECA	57.6	66	28	0	207	10	270	335	7.70E-13	73.9	RL4_URECA	reviewed	60S ribosomal protein L4 (L1)	RPL4 RPL1	Urechis caupo (Innkeeper worm) (Spoonworm)	386	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN35987_c0_g1_i1	Q9XF97	RL4_PRUAR	44	91	43	3	252	4	206	296	2.50E-13	75.9	RL4_PRUAR	reviewed	60S ribosomal protein L4 (L1)	RPL4	Prunus armeniaca (Apricot) (Armeniaca vulgaris)	408	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN844_c0_g1_i1	Q6CFS7	RL44_YARLI	71.8	103	27	1	41	343	1	103	1.80E-36	153.3	RL44_YARLI	reviewed	60S ribosomal protein L44	RPL44 YALI0B04224g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN844_c0_g1_i2	Q6CFS7	RL44_YARLI	71.8	103	27	1	26	328	1	103	1.30E-36	153.7	RL44_YARLI	reviewed	60S ribosomal protein L44	RPL44 YALI0B04224g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21837_c0_g1_i1	Q9NB33	RL44_OCHTR	77.6	67	15	0	202	2	36	102	7.50E-24	110.5	RL44_OCHTR	reviewed	60S ribosomal protein L44	RpL44	Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	104	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN30457_c0_g1_i1	Q8SR18	RL44_ENCCU	53.2	94	44	0	290	9	11	104	2.60E-19	95.9	RL44_ENCCU	reviewed	60S ribosomal protein L44	RPL44 ECU10_1300	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	104	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29717_c0_g1_i2	Q9NB33	RL44_OCHTR	70.7	58	17	0	25	198	47	104	1.40E-17	89.7	RL44_OCHTR	reviewed	60S ribosomal protein L44	RpL44	Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	104	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN576_c0_g1_i1	Q6CFS7	RL44_YARLI	72.8	103	26	1	69	371	1	103	1.20E-36	154.1	RL44_YARLI	reviewed	60S ribosomal protein L44	RPL44 YALI0B04224g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN576_c0_g1_i3	Q6CFS7	RL44_YARLI	72.8	103	26	1	35	337	1	103	8.30E-37	154.5	RL44_YARLI	reviewed	60S ribosomal protein L44	RPL44 YALI0B04224g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN576_c0_g1_i4	Q6CFS7	RL44_YARLI	72.8	103	26	1	69	371	1	103	1.20E-36	154.1	RL44_YARLI	reviewed	60S ribosomal protein L44	RPL44 YALI0B04224g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	106	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21194_c0_g1_i1	Q9NB33	RL44_OCHTR	75.8	66	16	0	22	219	37	102	8.60E-23	107.1	RL44_OCHTR	reviewed	60S ribosomal protein L44	RpL44	Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	104	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12664_c0_g2_i1	P08429	RL4A_XENLA	65.8	111	38	0	337	5	227	337	3.60E-36	152.1	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12663_c0_g2_i1	P08429	RL4A_XENLA	56.2	64	27	1	190	2	2	65	1.60E-10	66.6	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN12663_c0_g2_i2	P08429	RL4A_XENLA	55.6	63	27	1	187	2	3	65	9.90E-11	67	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12663_c0_g1_i1	P08429	RL4A_XENLA	73.7	156	40	1	466	2	7	162	8.50E-60	231.1	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN12663_c1_g1_i1	P08429	RL4A_XENLA	79.5	83	17	0	2	250	44	126	6.20E-33	141	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN24661_c0_g1_i1	P08429	RL4A_XENLA	70.1	67	20	0	4	204	221	287	1.20E-21	103.2	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21172_c0_g1_i1	P08429	RL4A_XENLA	64.8	91	32	0	275	3	109	199	8.10E-27	120.9	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21172_c1_g1_i1	P08429	RL4A_XENLA	65.9	88	30	0	266	3	220	307	2.70E-26	119	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22340_c0_g1_i1	P08429	RL4A_XENLA	66.7	93	31	0	280	2	192	284	1.80E-28	126.3	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29653_c0_g1_i1	P08429	RL4A_XENLA	70.6	357	102	2	70	1137	2	356	3.40E-140	499.6	RL4A_XENLA	reviewed	60S ribosomal protein L4-A (L1A)	rpl4-a rpl-4 rpl1a	Xenopus laevis (African clawed frog)	396	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN12139_c0_g1_i1	Q6QMZ4	RL6_CHILA	44.8	67	33	1	191	3	92	158	1.30E-09	63.5	RL6_CHILA	reviewed	60S ribosomal protein L6	RPL6	Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera)	288	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN12139_c1_g1_i1	Q6QMZ4	RL6_CHILA	50.5	91	45	0	274	2	148	238	2.20E-20	99.4	RL6_CHILA	reviewed	60S ribosomal protein L6	RPL6	Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera)	288	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN18934_c2_g1_i1	Q02878	RL6_HUMAN	46.9	64	34	0	2	193	191	254	5.30E-11	67.8	RL6_HUMAN	reviewed	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6 TXREB1	Homo sapiens (Human)	288	"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]	cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000184; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005791; GO:0005829; GO:0005925; GO:0006355; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0036464; GO:0042788; GO:0045296	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34049_c0_g1_i1	Q02878	RL6_HUMAN	100	156	0	0	470	3	86	241	2.30E-82	306.2	RL6_HUMAN	reviewed	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6 TXREB1	Homo sapiens (Human)	288	"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]	cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0000184; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005791; GO:0005829; GO:0005925; GO:0006355; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0036464; GO:0042788; GO:0045296	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9094_c0_g1_i1	P21533	RL6_RAT	49.5	200	94	2	621	34	102	298	3.30E-48	193.4	RL6_RAT	reviewed	60S ribosomal protein L6 (Neoplasm-related protein C140)	Rpl6	Rattus norvegicus (Rat)	298	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000027; GO:0000049; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005791; GO:0014069; GO:0022625; GO:0031672; GO:0036464; GO:0042788; GO:0045202; GO:1990932	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN9094_c0_g1_i2	P21533	RL6_RAT	49.5	200	94	2	621	34	102	298	3.30E-48	193.4	RL6_RAT	reviewed	60S ribosomal protein L6 (Neoplasm-related protein C140)	Rpl6	Rattus norvegicus (Rat)	298	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000027; GO:0000049; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005791; GO:0014069; GO:0022625; GO:0031672; GO:0036464; GO:0042788; GO:0045202; GO:1990932	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN9094_c0_g1_i5	P21533	RL6_RAT	49.5	200	94	2	621	34	102	298	3.40E-48	193.4	RL6_RAT	reviewed	60S ribosomal protein L6 (Neoplasm-related protein C140)	Rpl6	Rattus norvegicus (Rat)	298	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000027; GO:0000049; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005791; GO:0014069; GO:0022625; GO:0031672; GO:0036464; GO:0042788; GO:0045202; GO:1990932	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN27828_c0_g1_i1	P47911	RL6_MOUSE	100	169	0	0	7	513	96	264	1.90E-89	329.7	RL6_MOUSE	reviewed	60S ribosomal protein L6 (TAX-responsive enhancer element-binding protein 107) (TAXREB107)	Rpl6	Mus musculus (Mouse)	296	A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]	5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	GO:0000027; GO:0000049; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0022625; GO:0031672; GO:0036464; GO:0042788; GO:1990932	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN18934_c1_g1_i1	P34091	RL6_MESCR	65.1	63	22	0	14	202	86	148	8.50E-17	87	RL6_MESCR	reviewed	60S ribosomal protein L6 (YL16-like)	RPL6	Mesembryanthemum crystallinum (Common ice plant) (Cryophytum crystallinum)	234	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN36860_c0_g1_i1	P34091	RL6_MESCR	44.6	65	35	1	21	215	131	194	7.20E-06	50.8	RL6_MESCR	reviewed	60S ribosomal protein L6 (YL16-like)	RPL6	Mesembryanthemum crystallinum (Common ice plant) (Cryophytum crystallinum)	234	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN9094_c5_g1_i1	Q9FZ76	RL61_ARATH	62.9	62	21	1	180	1	74	135	1.40E-12	73.2	RL61_ARATH	reviewed	60S ribosomal protein L6-1	RPL6A At1g18540 F25I16.12	Arabidopsis thaliana (Mouse-ear cress)	233	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005886; GO:0009506; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN18926_c1_g1_i1	O01802	RL7_CAEEL	59.5	242	90	2	1	714	7	244	5.90E-79	295.4	RL7_CAEEL	reviewed	60S ribosomal protein L7	rpl-7 F53G12.10	Caenorhabditis elegans	244	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003723; GO:0003735; GO:0022625	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		blue	blue	NA	NA	NA	NA
TRINITY_DN22985_c0_g1_i1	Q58DT1	RL7_BOVIN	64.7	68	24	0	205	2	130	197	4.20E-19	94.7	RL7_BOVIN	reviewed	60S ribosomal protein L7	RPL7	Bos taurus (Bovine)	248	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003723; GO:0003735; GO:0022625	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12735_c0_g1_i1	P14148	RL7_MOUSE	100	167	0	0	504	4	90	256	1.30E-91	337	RL7_MOUSE	reviewed	60S ribosomal protein L7	Rpl7	Mus musculus (Mouse)	270	"A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]"	A band [GO:0031672]; cytosolic large ribosomal subunit [GO:0022625]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003677; GO:0003723; GO:0003729; GO:0003735; GO:0005840; GO:0005844; GO:0006364; GO:0006412; GO:0008097; GO:0014069; GO:0022625; GO:0031672; GO:0042273; GO:0042802; GO:0045202; GO:1990904	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12735_c0_g2_i1	Q58DT1	RL7_BOVIN	100	168	0	0	504	1	68	235	2.70E-92	339.3	RL7_BOVIN	reviewed	60S ribosomal protein L7	RPL7	Bos taurus (Bovine)	248	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003723; GO:0003735; GO:0022625	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN192_c0_g1_i1	P0DJ13	RL7_TETTH	59.3	118	46	1	354	1	121	236	1.20E-37	157.1	RL7_TETTH	reviewed	60S ribosomal protein L7	RPL7	Tetrahymena thermophila	239	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0003723; GO:0003735; GO:0022625	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		red	red	NA	NA	NA	NA
TRINITY_DN3806_c0_g1_i1	P0DJ14	RL7A_TETTH	66.1	62	21	0	19	204	12	73	4.80E-18	91.3	RL7A_TETTH	reviewed	60S ribosomal protein L7a	RPL7A RPL8	Tetrahymena thermophila	255	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3806_c0_g1_i2	P0DJ14	RL7A_TETTH	57.7	78	33	0	19	252	12	89	9.30E-21	100.5	RL7A_TETTH	reviewed	60S ribosomal protein L7a	RPL7A RPL8	Tetrahymena thermophila	255	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3806_c0_g1_i3	P0DJ14	RL7A_TETTH	68.3	63	19	1	5	193	12	73	1.30E-17	89.7	RL7A_TETTH	reviewed	60S ribosomal protein L7a	RPL7A RPL8	Tetrahymena thermophila	255	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3806_c0_g1_i4	P0DJ14	RL7A_TETTH	59.5	79	31	1	5	241	12	89	2.60E-20	99	RL7A_TETTH	reviewed	60S ribosomal protein L7a	RPL7A RPL8	Tetrahymena thermophila	255	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3806_c1_g1_i1	P0DJ14	RL7A_TETTH	63.8	69	25	0	210	4	15	83	1.00E-20	100.1	RL7A_TETTH	reviewed	60S ribosomal protein L7a	RPL7A RPL8	Tetrahymena thermophila	255	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN15504_c0_g1_i1	Q2TBQ5	RL7A_BOVIN	99.1	110	1	0	330	1	1	110	6.50E-54	211.1	RL7A_BOVIN	reviewed	60S ribosomal protein L7a	RPL7A	Bos taurus (Bovine)	266	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0005730; GO:0016020; GO:0022625; GO:0042788	maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN29146_c0_g1_i1	Q90YW2	RL7A_ICTPU	68.1	69	22	0	209	3	114	182	3.60E-18	91.7	RL7A_ICTPU	reviewed	60S ribosomal protein L7a	rpl7a	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	266	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]		GO:0005840; GO:0042254; GO:1990904	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN35410_c0_g1_i1	O76732	RL7A_ANOGA	64.7	102	36	0	1	306	145	246	8.90E-34	144.1	RL7A_ANOGA	reviewed	60S ribosomal protein L7a	RpL7A AGAP005960	Anopheles gambiae (African malaria mosquito)	271	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0022625	maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN7339_c0_g1_i1	Q2TBQ5	RL7A_BOVIN	73.9	69	18	0	281	75	25	93	5.60E-25	115.2	RL7A_BOVIN	reviewed	60S ribosomal protein L7a	RPL7A	Bos taurus (Bovine)	266	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0005730; GO:0016020; GO:0022625; GO:0042788	maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN7339_c0_g1_i2	P32429	RL7A_CHICK	66.2	240	81	0	750	31	25	264	1.10E-86	321.2	RL7A_CHICK	reviewed	60S ribosomal protein L7a	RPL7A SURF-3	Gallus gallus (Chicken)	266	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0022625	maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN7339_c0_g1_i3	P32429	RL7A_CHICK	66.2	240	81	0	750	31	25	264	1.10E-86	321.2	RL7A_CHICK	reviewed	60S ribosomal protein L7a	RPL7A SURF-3	Gallus gallus (Chicken)	266	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0022625	maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN17906_c0_g1_i1	O76732	RL7A_ANOGA	67.4	89	29	0	289	23	182	270	5.30E-28	124.8	RL7A_ANOGA	reviewed	60S ribosomal protein L7a	RpL7A AGAP005960	Anopheles gambiae (African malaria mosquito)	271	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0022625	maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN15504_c0_g2_i1	P62424	RL7A_HUMAN	100	142	0	0	462	37	125	266	1.90E-75	283.1	RL7A_HUMAN	reviewed	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A SURF-3 SURF3	Homo sapiens (Human)	266	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0000470; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042788; GO:0045296	"maturation of LSU-rRNA [GO:0000470]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15504_c0_g2_i2	P12970	RL7A_MOUSE	100	142	0	0	462	37	125	266	6.40E-76	284.6	RL7A_MOUSE	reviewed	60S ribosomal protein L7a (Surfeit locus protein 3)	Rpl7a Surf-3 Surf3	Mus musculus (Mouse)	266	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; synapse [GO:0045202]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; synapse [GO:0045202]	RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0005730; GO:0005840; GO:0016020; GO:0022625; GO:0042788; GO:0045202	maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN4562_c0_g1_i1	P49692	RL7A1_ARATH	68	100	32	0	1	300	104	203	1.20E-33	143.7	RL7A1_ARATH	reviewed	60S ribosomal protein L7a-1	RPL7AA At2g47610 T30B22.8	Arabidopsis thaliana (Mouse-ear cress)	257	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000470; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005774; GO:0005829; GO:0009506; GO:0022625; GO:0022626; GO:0042788	maturation of LSU-rRNA [GO:0000470]		red	red	NA	NA	NA	NA
TRINITY_DN25619_c0_g1_i1	P49692	RL7A1_ARATH	69.3	88	27	0	267	4	116	203	3.60E-31	135.2	RL7A1_ARATH	reviewed	60S ribosomal protein L7a-1	RPL7AA At2g47610 T30B22.8	Arabidopsis thaliana (Mouse-ear cress)	257	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; polysomal ribosome [GO:0042788]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000470; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005774; GO:0005829; GO:0009506; GO:0022625; GO:0022626; GO:0042788	maturation of LSU-rRNA [GO:0000470]		red	red	NA	NA	NA	NA
TRINITY_DN16449_c0_g1_i1	Q9D8M4	RL7L_MOUSE	100	110	0	0	330	1	102	211	1.20E-57	223.4	RL7L_MOUSE	reviewed	60S ribosomal protein L7-like 1	Rpl7l1	Mus musculus (Mouse)	246	"cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; blastocyst formation [GO:0001825]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0001825; GO:0003723; GO:0003735; GO:0005730; GO:0022625	"blastocyst formation [GO:0001825]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6948_c0_g2_i1	Q3T0S6	RL8_BOVIN	100	70	0	0	211	2	1	70	2.70E-34	145.6	RL8_BOVIN	reviewed	60S ribosomal protein L8	RPL8	Bos taurus (Bovine)	257	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625; GO:0042788; GO:0045202	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN6948_c0_g1_i1	Q3T0S6	RL8_BOVIN	100	148	0	0	2	445	110	257	1.80E-81	303.1	RL8_BOVIN	reviewed	60S ribosomal protein L8	RPL8	Bos taurus (Bovine)	257	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625; GO:0042788; GO:0045202	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN6948_c0_g1_i3	Q3T0S6	RL8_BOVIN	100	171	0	0	3	515	87	257	7.80E-97	354.4	RL8_BOVIN	reviewed	60S ribosomal protein L8	RPL8	Bos taurus (Bovine)	257	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625; GO:0042788; GO:0045202	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN25451_c0_g1_i1	Q9V3G1	RL8_DROME	82.3	79	14	0	239	3	133	211	1.10E-31	136.7	RL8_DROME	reviewed	60S ribosomal protein L8	RpL8 CG1263	Drosophila melanogaster (Fruit fly)	256	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN887_c0_g1_i16	P0DJ52	RL8_TETTS	72.6	146	40	0	4	441	109	254	8.20E-58	224.6	RL8_TETTS	reviewed	60S ribosomal protein L8	RPL8 RPL2 TTHERM_00716240	Tetrahymena thermophila (strain SB210)	264	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN887_c0_g1_i2	P0DJ52	RL8_TETTS	72.6	146	40	0	4	441	109	254	6.40E-58	224.9	RL8_TETTS	reviewed	60S ribosomal protein L8	RPL8 RPL2 TTHERM_00716240	Tetrahymena thermophila (strain SB210)	264	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN887_c0_g1_i20	P0DJ52	RL8_TETTS	72.6	146	40	0	4	441	109	254	8.20E-58	224.6	RL8_TETTS	reviewed	60S ribosomal protein L8	RPL8 RPL2 TTHERM_00716240	Tetrahymena thermophila (strain SB210)	264	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN887_c0_g1_i6	P0DJ52	RL8_TETTS	72.6	146	40	0	4	441	109	254	8.30E-58	224.6	RL8_TETTS	reviewed	60S ribosomal protein L8	RPL8 RPL2 TTHERM_00716240	Tetrahymena thermophila (strain SB210)	264	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN27691_c0_g1_i1	Q9U9L2	RL8_ANOGA	58.7	92	36	1	290	21	163	254	1.10E-23	110.5	RL8_ANOGA	reviewed	60S ribosomal protein L8	RpL8 AGAP005802	Anopheles gambiae (African malaria mosquito)	261	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN3173_c0_g1_i1	Q6RYS3	RL8_MAMBR	79.5	73	15	0	221	3	1	73	1.70E-29	129.8	RL8_MAMBR	reviewed	60S ribosomal protein L8	RpL8	Mamestra brassicae (Cabbage moth)	257	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3173_c0_g1_i2	Q6RYS3	RL8_MAMBR	79.5	73	15	0	221	3	1	73	2.60E-29	129	RL8_MAMBR	reviewed	60S ribosomal protein L8	RpL8	Mamestra brassicae (Cabbage moth)	257	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN19541_c0_g1_i1	P41569	RL8_AEDAL	72.1	86	24	0	264	7	87	172	4.70E-31	134.8	RL8_AEDAL	reviewed	60S ribosomal protein L8	RpL8	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	261	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytoplasm [GO:0005737]; ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN32473_c0_g1_i1	Q3T0S6	RL8_BOVIN	100	52	0	0	66	221	1	52	1.10E-22	106.7	RL8_BOVIN	reviewed	60S ribosomal protein L8	RPL8	Bos taurus (Bovine)	257	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625; GO:0042788; GO:0045202	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN14048_c0_g1_i1	Q9U9L2	RL8_ANOGA	85	173	26	0	566	48	82	254	2.30E-83	309.7	RL8_ANOGA	reviewed	60S ribosomal protein L8	RpL8 AGAP005802	Anopheles gambiae (African malaria mosquito)	261	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN54_c7_g1_i1	P50882	RL9_DROME	63.5	192	67	1	606	31	1	189	1.60E-62	240.7	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN54_c6_g1_i1	Q90YW0	RL9_ICTPU	77.1	35	8	0	97	201	157	191	5.90E-08	57.8	RL9_ICTPU	reviewed	60S ribosomal protein L9	rpl9	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	192	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4288_c0_g1_i1	P51410	RL9_MOUSE	100	174	0	0	1	522	19	192	1.70E-94	346.7	RL9_MOUSE	reviewed	60S ribosomal protein L9	Rpl9	Mus musculus (Mouse)	192	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0006412; GO:0019843; GO:0022625; GO:0045202	cytoplasmic translation [GO:0002181]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23039_c0_g1_i1	Q963B7	RL9_SPOFR	50.7	75	34	1	229	5	12	83	1.00E-13	77	RL9_SPOFR	reviewed	60S ribosomal protein L9	RpL9	Spodoptera frugiperda (Fall armyworm)	190	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23039_c1_g1_i1	P50882	RL9_DROME	53.5	101	44	1	2	304	13	110	2.70E-22	105.9	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN31621_c0_g1_i1	P50882	RL9_DROME	75.8	66	16	0	1	198	67	132	1.20E-23	109.8	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN23996_c1_g1_i1	Q90YW0	RL9_ICTPU	50.8	65	31	1	197	3	13	76	3.60E-10	65.1	RL9_ICTPU	reviewed	60S ribosomal protein L9	rpl9	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	192	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23996_c0_g1_i1	Q963B7	RL9_SPOFR	59.1	127	49	1	383	3	20	143	1.70E-37	156.8	RL9_SPOFR	reviewed	60S ribosomal protein L9	RpL9	Spodoptera frugiperda (Fall armyworm)	190	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18918_c7_g1_i1	P50882	RL9_DROME	58.7	75	31	0	227	3	106	180	1.40E-15	83.2	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN18918_c0_g2_i1	P50882	RL9_DROME	64.3	84	27	1	4	255	34	114	1.30E-22	106.7	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN18918_c0_g1_i1	P50882	RL9_DROME	65.4	78	27	0	2	235	89	166	5.40E-23	107.8	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN18918_c0_g1_i3	P50882	RL9_DROME	64.4	73	26	0	3	221	94	166	2.80E-21	102.1	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN18918_c2_g1_i1	P50882	RL9_DROME	66.7	93	31	0	1	279	97	189	4.90E-29	128.3	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN26673_c1_g1_i1	Q963B7	RL9_SPOFR	50.7	71	32	1	215	3	17	84	3.10E-09	62	RL9_SPOFR	reviewed	60S ribosomal protein L9	RpL9	Spodoptera frugiperda (Fall armyworm)	190	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN20932_c0_g1_i1	P50882	RL9_DROME	65.2	89	31	0	269	3	68	156	6.50E-28	124.4	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN35356_c0_g1_i1	Q963B7	RL9_SPOFR	67.8	59	19	0	28	204	110	168	8.10E-15	80.5	RL9_SPOFR	reviewed	60S ribosomal protein L9	RpL9	Spodoptera frugiperda (Fall armyworm)	190	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22085_c0_g2_i1	Q90YW0	RL9_ICTPU	69.6	79	24	0	243	7	113	191	1.10E-23	110.2	RL9_ICTPU	reviewed	60S ribosomal protein L9	rpl9	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	192	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	ribosome [GO:0005840]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005840; GO:0006412; GO:0019843	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN22085_c0_g1_i1	P50882	RL9_DROME	58.9	73	22	1	220	2	49	113	1.30E-13	76.6	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN30584_c0_g1_i1	P50882	RL9_DROME	72.5	69	19	0	1	207	64	132	4.90E-23	107.8	RL9_DROME	reviewed	60S ribosomal protein L9	RpL9 M(2)32D CG6141	Drosophila melanogaster (Fruit fly)	190	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0019843; GO:0022625; GO:0022626	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN4288_c0_g1_i2	P32969	RL9_HUMAN	100	174	0	0	1	522	19	192	6.00E-95	348.2	RL9_HUMAN	reviewed	60S ribosomal protein L9 (Large ribosomal subunit protein uL6)	RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9	Homo sapiens (Human)	192	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0019843; GO:0022625	"cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1366_c0_g1_i4	P49209	RL91_ARATH	60.3	136	54	0	31	438	57	192	4.00E-41	169.1	RL91_ARATH	reviewed	60S ribosomal protein L9-1	RPL9B At1g33120 T9L6.2; RPL9C At1g33140 T9L6.5	Arabidopsis thaliana (Mouse-ear cress)	194	chloroplast envelope [GO:0009941]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; adaxial/abaxial pattern specification [GO:0009955]; cytoplasmic translation [GO:0002181]	chloroplast envelope [GO:0009941]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005773; GO:0005774; GO:0005829; GO:0005886; GO:0009506; GO:0009941; GO:0009955; GO:0019843; GO:0022625; GO:0022626	adaxial/abaxial pattern specification [GO:0009955]; cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1366_c0_g2_i1	Q9SZX9	RL92_ARATH	61.3	142	54	1	11	433	50	191	1.10E-41	171	RL92_ARATH	reviewed	60S ribosomal protein L9-2	RPL9D At4g10450 F7L13.30	Arabidopsis thaliana (Mouse-ear cress)	194	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0005829; GO:0019843; GO:0022625; GO:0022626; GO:0042788	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1366_c0_g1_i1	Q9SZX9	RL92_ARATH	59.9	137	55	0	31	441	57	193	3.10E-41	169.5	RL92_ARATH	reviewed	60S ribosomal protein L9-2	RPL9D At4g10450 F7L13.30	Arabidopsis thaliana (Mouse-ear cress)	194	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003729; GO:0003735; GO:0005829; GO:0019843; GO:0022625; GO:0022626; GO:0042788	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN28690_c0_g1_i1	Q08962	NIP7_YEAST	53	66	31	0	4	201	86	151	1.70E-17	89.4	NIP7_YEAST	reviewed	60S ribosome subunit biogenesis protein NIP7 (Nuclear import protein 7)	NIP7 YPL211W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	181	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; assembly of large subunit precursor of preribosome [GO:1902626]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0000463; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0030687; GO:0042255; GO:0042273; GO:1902626	"assembly of large subunit precursor of preribosome [GO:1902626]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9510_c0_g1_i1	B0G104	NIP7_DICDI	43.7	87	48	1	3	260	59	145	1.70E-17	89.7	NIP7_DICDI	reviewed	60S ribosome subunit biogenesis protein NIP7 homolog	nip7 DDB_G0295477	Dictyostelium discoideum (Slime mold)	179	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0030687; GO:0042255; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN1185_c0_g1_i1	Q9Y221	NIP7_HUMAN	65.4	179	62	0	636	100	1	179	1.90E-66	253.8	NIP7_HUMAN	reviewed	60S ribosome subunit biogenesis protein NIP7 homolog (KD93)	NIP7 CGI-37 HSPC031 HSPC180 OK/SW-cl.76 OK/SW-cl.78	Homo sapiens (Human)	180	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0030687; GO:0042255; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]		blue	blue	NA	NA	NA	NA
TRINITY_DN40477_c0_g1_i1	Q9Y221	NIP7_HUMAN	100	75	0	0	243	19	106	180	1.40E-37	156.4	NIP7_HUMAN	reviewed	60S ribosome subunit biogenesis protein NIP7 homolog (KD93)	NIP7 CGI-37 HSPC031 HSPC180 OK/SW-cl.76 OK/SW-cl.78	Homo sapiens (Human)	180	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0030687; GO:0042255; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN30663_c0_g1_i1	Q9Y221	NIP7_HUMAN	100	155	0	0	1	465	26	180	4.30E-88	325.1	NIP7_HUMAN	reviewed	60S ribosome subunit biogenesis protein NIP7 homolog (KD93)	NIP7 CGI-37 HSPC031 HSPC180 OK/SW-cl.76 OK/SW-cl.78	Homo sapiens (Human)	180	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0030687; GO:0042255; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN13692_c0_g1_i2	Q91348	F26L_CHICK	61.2	417	161	1	23	1273	36	451	1.30E-150	534.3	F26L_CHICK	reviewed	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"		Gallus gallus (Chicken)	470	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]"	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"	GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0006094; GO:0006096; GO:0043540	"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8583_c0_g1_i1	P70266	F261_MOUSE	61.7	436	164	3	1326	22	38	471	1.90E-155	550.4	F261_MOUSE	reviewed	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (6PF-2-K/Fru-2,6-P2ase 1) (PFK/FBPase 1) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"	Pfkfb1	Mus musculus (Mouse)	471	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]"	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]"	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]"	GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0019900; GO:0031100; GO:0032868; GO:0033133; GO:0033762; GO:0042594; GO:0042802; GO:0043540; GO:0046835; GO:0051384; GO:0051591; GO:0070095	"animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13692_c0_g1_i1	P70266	F261_MOUSE	62.3	281	106	0	57	899	172	452	3.30E-103	376.3	F261_MOUSE	reviewed	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (6PF-2-K/Fru-2,6-P2ase 1) (PFK/FBPase 1) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"	Pfkfb1	Mus musculus (Mouse)	471	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]"	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]"	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]"	GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0019900; GO:0031100; GO:0032868; GO:0033133; GO:0033762; GO:0042594; GO:0042802; GO:0043540; GO:0046835; GO:0051384; GO:0051591; GO:0070095	"animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35004_c0_g1_i1	Q16875	F263_HUMAN	100	90	0	0	1	270	103	192	5.80E-45	181	F263_HUMAN	reviewed	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"	PFKFB3	Homo sapiens (Human)	520	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glycolytic process [GO:0045821]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"	GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0045821	"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glycolytic process [GO:0045821]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20432_c0_g1_i1	Q16875	F263_HUMAN	100	184	0	0	552	1	261	444	4.00E-101	368.6	F263_HUMAN	reviewed	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"	PFKFB3	Homo sapiens (Human)	520	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glycolytic process [GO:0045821]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"	GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0045821	"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glycolytic process [GO:0045821]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32822_c0_g1_i1	P52207	6PGD_BACLI	45.1	91	44	1	3	257	143	233	2.70E-15	82.4	6PGD_BACLI	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	gntZ	Bacillus licheniformis	467	NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0006098; GO:0019521; GO:0050661	D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN38259_c0_g1_i1	P41570	6PGD_CERCA	56.4	78	34	0	236	3	153	230	1.00E-21	103.6	6PGD_CERCA	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	Pgd	Ceratitis capitata (Mediterranean fruit fly) (Tephritis capitata)	481	NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0006098; GO:0019521; GO:0050661	D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN6731_c0_g1_i1	P00349	6PGD_SHEEP	75.4	480	117	1	49	1485	4	483	1.50E-219	763.5	6PGD_SHEEP	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	PGD	Ovis aries (Sheep)	483	cytoplasm [GO:0005737]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0005737; GO:0006098; GO:0019521; GO:0050661	D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN6731_c0_g1_i2	P00349	6PGD_SHEEP	71.7	237	67	0	94	804	247	483	5.70E-99	362.1	6PGD_SHEEP	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	PGD	Ovis aries (Sheep)	483	cytoplasm [GO:0005737]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0005737; GO:0006098; GO:0019521; GO:0050661	D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN21371_c0_g1_i1	Q9DCD0	6PGD_MOUSE	100	117	0	0	382	32	367	483	1.90E-65	249.6	6PGD_MOUSE	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	Pgd	Mus musculus (Mouse)	483	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; carbohydrate metabolic process [GO:0005975]; D-gluconate catabolic process [GO:0046177]; D-gluconate metabolic process [GO:0019521]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0005829; GO:0005975; GO:0006098; GO:0006739; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0043231; GO:0046177; GO:0050661; GO:0055114	"carbohydrate metabolic process [GO:0005975]; D-gluconate catabolic process [GO:0046177]; D-gluconate metabolic process [GO:0019521]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33763_c0_g1_i1	Q5HFR2	6PGD_STAAC	90.8	87	8	0	3	263	305	391	3.40E-42	171.8	6PGD_STAAC	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	gnd SACOL1554	Staphylococcus aureus (strain COL)	468	NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0006098; GO:0019521; GO:0050661	D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN28555_c0_g1_i1	Q9DCD0	6PGD_MOUSE	100	124	0	0	374	3	182	305	6.40E-66	251.1	6PGD_MOUSE	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	Pgd	Mus musculus (Mouse)	483	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; carbohydrate metabolic process [GO:0005975]; D-gluconate catabolic process [GO:0046177]; D-gluconate metabolic process [GO:0019521]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0005829; GO:0005975; GO:0006098; GO:0006739; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0043231; GO:0046177; GO:0050661; GO:0055114	"carbohydrate metabolic process [GO:0005975]; D-gluconate catabolic process [GO:0046177]; D-gluconate metabolic process [GO:0019521]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19477_c0_g1_i1	Q9DCD0	6PGD_MOUSE	99.5	200	1	0	69	668	1	200	2.10E-112	406.4	6PGD_MOUSE	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	Pgd	Mus musculus (Mouse)	483	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; carbohydrate metabolic process [GO:0005975]; D-gluconate catabolic process [GO:0046177]; D-gluconate metabolic process [GO:0019521]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0005829; GO:0005975; GO:0006098; GO:0006739; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0043231; GO:0046177; GO:0050661; GO:0055114	"carbohydrate metabolic process [GO:0005975]; D-gluconate catabolic process [GO:0046177]; D-gluconate metabolic process [GO:0019521]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26996_c0_g1_i1	P52209	6PGD_HUMAN	100	483	0	0	56	1504	1	483	9.60E-286	983.4	6PGD_HUMAN	reviewed	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	PGD PGDH	Homo sapiens (Human)	483	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate catabolic process [GO:0046177]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]	GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0055114; GO:0070062	"D-gluconate catabolic process [GO:0046177]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN620_c2_g1_i3	O95336	6PGL_HUMAN	51.9	212	95	2	711	97	37	248	1.30E-55	218.4	6PGL_HUMAN	reviewed	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	PGLS	Homo sapiens (Human)	258	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	6-phosphogluconolactonase activity [GO:0017057]	GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0070062	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		blue	blue	NA	NA	NA	NA
TRINITY_DN620_c2_g1_i6	O95336	6PGL_HUMAN	51.9	212	95	2	710	96	37	248	1.30E-55	218.4	6PGL_HUMAN	reviewed	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	PGLS	Homo sapiens (Human)	258	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	6-phosphogluconolactonase activity [GO:0017057]	GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0070062	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		blue	blue	NA	NA	NA	NA
TRINITY_DN620_c2_g1_i7	Q9CQ60	6PGL_MOUSE	48.5	237	115	3	706	17	11	247	1.20E-55	218.4	6PGL_MOUSE	reviewed	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	Pgls	Mus musculus (Mouse)	257	"cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytoplasm [GO:0005737]	6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]	GO:0005737; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0048029	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40052_c0_g1_i1	Q9CQ60	6PGL_MOUSE	100	69	0	0	1	207	118	186	4.60E-34	144.4	6PGL_MOUSE	reviewed	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	Pgls	Mus musculus (Mouse)	257	"cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"	cytoplasm [GO:0005737]	6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]	GO:0005737; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0048029	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7186_c0_g1_i1	Q90W95	PTPS_POERE	54.2	96	41	2	393	106	54	146	1.70E-20	100.5	PTPS_POERE	reviewed	6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12)	pts	Poecilia reticulata (Guppy) (Acanthophacelus reticulatus)	147	6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; metal ion binding [GO:0046872]; tetrahydrobiopterin biosynthetic process [GO:0006729]		6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; metal ion binding [GO:0046872]	GO:0003874; GO:0006729; GO:0046872	tetrahydrobiopterin biosynthetic process [GO:0006729]		blue	blue	NA	NA	NA	NA
TRINITY_DN7186_c0_g1_i2	Q03393	PTPS_HUMAN	56.9	123	50	2	474	106	25	144	2.50E-35	149.8	PTPS_HUMAN	reviewed	6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12)	PTS	Homo sapiens (Human)	145	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; tetrahydrobiopterin biosynthetic process [GO:0006729]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003874; GO:0005737; GO:0005739; GO:0005829; GO:0006520; GO:0006729; GO:0007417; GO:0042802; GO:0046872	cellular amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; tetrahydrobiopterin biosynthetic process [GO:0006729]		blue	blue	NA	NA	NA	NA
TRINITY_DN4488_c0_g1_i1	Q43207	FKB70_WHEAT	32.1	162	106	2	495	980	390	547	2.70E-13	77.8	FKB70_WHEAT	reviewed	70 kDa peptidyl-prolyl isomerase (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	FKBP70	Triticum aestivum (Wheat)	559	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005516; GO:0005737; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN7616_c0_g1_i2	Q90611	MMP2_CHICK	38.9	193	106	8	640	77	478	663	6.10E-32	139	MMP2_CHICK	reviewed	72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2)	MMP2	Gallus gallus (Chicken)	663	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cartilage condensation [GO:1904932]; negative regulation of cartilage development [GO:0061037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of MAPK cascade [GO:0043408]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001933; GO:0001955; GO:0001957; GO:0004222; GO:0005604; GO:0005615; GO:0005886; GO:0008270; GO:0030017; GO:0030198; GO:0030574; GO:0034614; GO:0035987; GO:0043408; GO:0048771; GO:0051895; GO:0060325; GO:0060346; GO:0061037; GO:0062023; GO:0071230; GO:0071492; GO:1904645; GO:1904707; GO:1904932; GO:1990314	blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cartilage condensation [GO:1904932]; negative regulation of cartilage development [GO:0061037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of MAPK cascade [GO:0043408]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]		NA	NA	NA	NA	NA	NA
TRINITY_DN7616_c0_g1_i3	Q90611	MMP2_CHICK	39	177	96	8	592	77	494	663	9.20E-28	125.2	MMP2_CHICK	reviewed	72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2)	MMP2	Gallus gallus (Chicken)	663	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cartilage condensation [GO:1904932]; negative regulation of cartilage development [GO:0061037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of MAPK cascade [GO:0043408]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001933; GO:0001955; GO:0001957; GO:0004222; GO:0005604; GO:0005615; GO:0005886; GO:0008270; GO:0030017; GO:0030198; GO:0030574; GO:0034614; GO:0035987; GO:0043408; GO:0048771; GO:0051895; GO:0060325; GO:0060346; GO:0061037; GO:0062023; GO:0071230; GO:0071492; GO:1904645; GO:1904707; GO:1904932; GO:1990314	blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cartilage condensation [GO:1904932]; negative regulation of cartilage development [GO:0061037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of MAPK cascade [GO:0043408]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; tissue remodeling [GO:0048771]		NA	NA	NA	NA	NA	NA
TRINITY_DN38819_c0_g1_i1	Q9LDU6	ST7R_ARATH	41.4	355	205	3	245	1300	78	432	3.20E-80	300.4	ST7R_ARATH	reviewed	7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Protein DWARF 5) (Sterol Delta(7)-reductase)	DWF5 ST7R At1g50430 F11F12.21	Arabidopsis thaliana (Mouse-ear cress)	432	"Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 7-dehydrocholesterol reductase activity [GO:0047598]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; sterol delta7 reductase activity [GO:0009918]; brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]"	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"7-dehydrocholesterol reductase activity [GO:0047598]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; sterol delta7 reductase activity [GO:0009918]"	GO:0005634; GO:0005794; GO:0005886; GO:0006695; GO:0009918; GO:0016126; GO:0016132; GO:0016627; GO:0030176; GO:0047598	brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN38819_c0_g2_i1	Q9LDU6	ST7R_ARATH	41.4	355	205	3	1091	36	78	432	3.20E-80	300.4	ST7R_ARATH	reviewed	7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Protein DWARF 5) (Sterol Delta(7)-reductase)	DWF5 ST7R At1g50430 F11F12.21	Arabidopsis thaliana (Mouse-ear cress)	432	"Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 7-dehydrocholesterol reductase activity [GO:0047598]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; sterol delta7 reductase activity [GO:0009918]; brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]"	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"7-dehydrocholesterol reductase activity [GO:0047598]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; sterol delta7 reductase activity [GO:0009918]"	GO:0005634; GO:0005794; GO:0005886; GO:0006695; GO:0009918; GO:0016126; GO:0016132; GO:0016627; GO:0030176; GO:0047598	brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN22839_c0_g1_i1	Q3UFY7	5NT3B_MOUSE	98.5	67	1	0	2	202	224	290	3.60E-31	134.8	5NT3B_MOUSE	reviewed	7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase)	Nt5c3b Nt5c3l	Mus musculus (Mouse)	300	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]	GO:0000166; GO:0000287; GO:0005737; GO:0009117; GO:0016791	nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN982_c0_g1_i4	Q969T7	5NT3B_HUMAN	48.4	248	128	0	490	1233	38	285	6.40E-68	259.6	5NT3B_HUMAN	reviewed	7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase)	NT5C3B NT5C3L	Homo sapiens (Human)	300	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]	GO:0000166; GO:0000287; GO:0005737; GO:0005829; GO:0008253; GO:0009117; GO:0016791; GO:0043928	exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN982_c0_g1_i4	Q969T7	5NT3B_HUMAN	31.8	85	53	2	315	566	3	83	3.40E-05	51.2	5NT3B_HUMAN	reviewed	7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase)	NT5C3B NT5C3L	Homo sapiens (Human)	300	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]	GO:0000166; GO:0000287; GO:0005737; GO:0005829; GO:0008253; GO:0009117; GO:0016791; GO:0043928	exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN16354_c0_g1_i1	A3KQ55	MEPCE_DANRE	54.3	46	21	0	147	10	530	575	3.90E-09	61.6	MEPCE_DANRE	reviewed	7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3)	mepce bcdin3 si:ch211-283h6.1	Danio rerio (Zebrafish) (Brachydanio rerio)	645	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]	GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904	positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]		red	red	NA	NA	NA	NA
TRINITY_DN2292_c0_g1_i3	A3KQ55	MEPCE_DANRE	61.6	138	53	0	58	471	508	645	3.60E-46	186.8	MEPCE_DANRE	reviewed	7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3)	mepce bcdin3 si:ch211-283h6.1	Danio rerio (Zebrafish) (Brachydanio rerio)	645	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]	GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904	positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2292_c0_g1_i4	A3KQ55	MEPCE_DANRE	34.8	601	332	9	169	1806	50	645	3.30E-77	291.2	MEPCE_DANRE	reviewed	7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3)	mepce bcdin3 si:ch211-283h6.1	Danio rerio (Zebrafish) (Brachydanio rerio)	645	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]	GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904	positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]		NA	NA	NA	NA	NA	NA
TRINITY_DN7905_c0_g1_i1	O60733	PLPL9_HUMAN	52.5	179	85	0	641	105	625	803	4.00E-50	199.5	PLPL9_HUMAN	reviewed	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	PLA2G6 PLPLA9	Homo sapiens (Human)	806	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"	GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0016787; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0036151; GO:0036152; GO:0038096; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102545; GO:0102567; GO:0102568; GO:0102991; GO:1901339; GO:2000304	"antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7905_c0_g1_i2	O60733	PLPL9_HUMAN	52.5	179	85	0	623	87	625	803	3.90E-50	199.5	PLPL9_HUMAN	reviewed	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	PLA2G6 PLPLA9	Homo sapiens (Human)	806	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"	GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0016787; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0036151; GO:0036152; GO:0038096; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102545; GO:0102567; GO:0102568; GO:0102991; GO:1901339; GO:2000304	"antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7905_c0_g2_i1	P97570	PLPL9_RAT	42.7	356	183	6	1035	4	255	601	8.50E-71	268.9	PLPL9_RAT	reviewed	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	Pla2g6 Pnpla9	Rattus norvegicus (Rat)	807	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"	GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102545; GO:0102567; GO:0102568; GO:0102991; GO:1901339; GO:2000304	"antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7905_c0_g2_i3	P97570	PLPL9_RAT	41.2	335	176	6	1064	96	255	580	7.40E-62	239.2	PLPL9_RAT	reviewed	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	Pla2g6 Pnpla9	Rattus norvegicus (Rat)	807	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"	GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102545; GO:0102567; GO:0102568; GO:0102991; GO:1901339; GO:2000304	"antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35326_c0_g1_i1	O60733	PLPL9_HUMAN	39.5	430	247	6	8	1276	383	806	7.20E-82	306.2	PLPL9_HUMAN	reviewed	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	PLA2G6 PLPLA9	Homo sapiens (Human)	806	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]"	GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0016787; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0036151; GO:0036152; GO:0038096; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102545; GO:0102567; GO:0102568; GO:0102991; GO:1901339; GO:2000304	"antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c3_g1_i3	Q568Q0	NUD18_DANRE	34.5	342	181	9	73	1053	8	321	1.50E-41	171.8	NUD18_DANRE	reviewed	"8-oxo-dGDP phosphatase NUDT18 (EC 3.6.1.58) (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (Nucleoside diphosphate-linked moiety X motif 18) (Nudix motif 18)"	nudt18 zgc:110174	Danio rerio (Zebrafish) (Brachydanio rerio)	325	8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]; dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]		8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712	dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]		NA	NA	NA	NA	NA	NA
TRINITY_DN7188_c0_g1_i1	Q94738	HSP97_MESFR	60	165	65	1	587	96	334	498	5.80E-50	198.7	HSP97_MESFR	reviewed	97 kDa heat shock protein (Heat shock protein 110)	HSP110	Mesocentrotus franciscanus (Giant red sea urchin) (Strongylocentrotus franciscanus)	886	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN8266_c0_g1_i1	Q9H324	ATS10_HUMAN	58.1	31	13	0	195	103	675	705	2.80E-05	48.9	ATS10_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 10 (ADAM-TS 10) (ADAM-TS10) (ADAMTS-10) (EC 3.4.24.-)	ADAMTS10	Homo sapiens (Human)	1103	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; microfibril [GO:0001527]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; microfibril [GO:0001527]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0001527; GO:0004222; GO:0030198; GO:0031012; GO:0046872; GO:0062023	extracellular matrix organization [GO:0030198]		brown	brown	1	NA	NA	NA
TRINITY_DN8266_c0_g1_i3	P58459	ATS10_MOUSE	39.7	58	30	2	232	68	663	718	3.60E-05	48.9	ATS10_MOUSE	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 10 (ADAM-TS 10) (ADAM-TS10) (ADAMTS-10) (EC 3.4.24.-)	Adamts10	Mus musculus (Mouse)	1104	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; microfibril [GO:0001527]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; microfibril [GO:0001527]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0001527; GO:0004222; GO:0030198; GO:0031012; GO:0046872; GO:0062023	extracellular matrix organization [GO:0030198]		brown	brown	1	NA	NA	NA
TRINITY_DN16570_c0_g1_i6	Q8WXS8	ATS14_HUMAN	46.6	176	82	2	83	610	476	639	3.20E-46	186.4	ATS14_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 14 (ADAM-TS 14) (ADAM-TS14) (ADAMTS-14) (EC 3.4.24.-)	ADAMTS14	Homo sapiens (Human)	1223	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005576; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0046872	collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN16570_c0_g1_i8	Q8WXS8	ATS14_HUMAN	46.9	175	81	2	145	669	476	638	8.00E-46	185.3	ATS14_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 14 (ADAM-TS 14) (ADAM-TS14) (ADAMTS-14) (EC 3.4.24.-)	ADAMTS14	Homo sapiens (Human)	1223	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005576; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0046872	collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN16570_c0_g1_i9	Q8WXS8	ATS14_HUMAN	45.4	185	89	2	145	699	476	648	7.20E-47	188.7	ATS14_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 14 (ADAM-TS 14) (ADAM-TS14) (ADAMTS-14) (EC 3.4.24.-)	ADAMTS14	Homo sapiens (Human)	1223	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005576; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0046872	collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN8266_c0_g1_i5	Q8C9W3	ATS2_MOUSE	40.5	79	47	0	240	4	689	767	1.70E-11	70.1	ATS2_MOUSE	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI)	Adamts2	Mus musculus (Mouse)	1213	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]	metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588; GO:0062023	collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN957_c1_g1_i1	P59511	ATS20_MOUSE	58.1	31	13	0	174	82	1875	1905	5.40E-05	48.1	ATS20_MOUSE	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-)	Adamts20	Mus musculus (Mouse)	1906	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0008270; GO:0009967; GO:0030198; GO:0031012; GO:0043066; GO:0045636; GO:0048070	extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]		NA	NA	NA	NA	NA	NA
TRINITY_DN18658_c0_g1_i1	P59510	ATS20_HUMAN	54.9	91	40	1	19	291	506	595	1.70E-26	119.8	ATS20_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-)	ADAMTS20	Homo sapiens (Human)	1910	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0008270; GO:0009967; GO:0030198; GO:0031012; GO:0043066; GO:0045636	extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]		NA	NA	NA	NA	NA	NA
TRINITY_DN16570_c0_g1_i1	O15072	ATS3_HUMAN	52.1	48	23	0	65	208	490	537	5.20E-11	68.2	ATS3_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme)	ADAMTS3 KIAA0366	Homo sapiens (Human)	1205	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748	collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]		NA	NA	NA	NA	NA	NA
TRINITY_DN16570_c0_g1_i3	O15072	ATS3_HUMAN	44.7	141	67	2	73	495	452	581	1.60E-33	144.1	ATS3_HUMAN	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme)	ADAMTS3 KIAA0366	Homo sapiens (Human)	1205	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748	collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]		NA	NA	NA	NA	NA	NA
TRINITY_DN18658_c0_g1_i2	Q19791	GON1_CAEEL	50	68	30	2	13	210	533	598	2.90E-14	79	GON1_CAEEL	reviewed	A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1)	gon-1 F25H8.3	Caenorhabditis elegans	2150	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005604; GO:0005783; GO:0005794; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607	cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]		brown	brown	1	NA	NA	NA
TRINITY_DN30090_c0_g1_i1	Q9I742	CLPV1_PSEAE	83.3	72	12	0	218	3	675	746	6.10E-29	127.5	CLPV1_PSEAE	reviewed	AAA+ ATPase ClpV1	clpV1 PA0090	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	902	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN3142_c0_g1_i1	Q6INL7	ADCK1_XENLA	52.3	128	60	1	419	36	376	502	1.30E-27	124	ADCK1_XENLA	reviewed	AarF domain-containing protein kinase 1 (EC 2.7.-.-)	adck1	Xenopus laevis (African clawed frog)	520	extracellular region [GO:0005576]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	extracellular region [GO:0005576]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN3142_c0_g1_i2	Q6INL7	ADCK1_XENLA	50	106	52	1	353	36	398	502	3.80E-19	95.9	ADCK1_XENLA	reviewed	AarF domain-containing protein kinase 1 (EC 2.7.-.-)	adck1	Xenopus laevis (African clawed frog)	520	extracellular region [GO:0005576]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	extracellular region [GO:0005576]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN38485_c0_g1_i1	Q86TW2	ADCK1_HUMAN	59.2	49	20	0	30	176	149	197	4.90E-10	64.7	ADCK1_HUMAN	reviewed	AarF domain-containing protein kinase 1 (EC 2.7.-.-)	ADCK1	Homo sapiens (Human)	530	extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]	extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005576; GO:0005743; GO:0007005; GO:0010637; GO:0032592; GO:0055088; GO:1903852	lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]		NA	NA	NA	NA	NA	NA
TRINITY_DN20006_c0_g1_i1	Q9D0L4	ADCK1_MOUSE	55.8	319	138	2	959	6	19	335	1.10E-97	358.2	ADCK1_MOUSE	reviewed	AarF domain-containing protein kinase 1 (EC 2.7.-.-)	Adck1	Mus musculus (Mouse)	525	extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]	extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005576; GO:0005739; GO:0005743; GO:0007005; GO:0010637; GO:0032592; GO:0055088; GO:1903852	lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]		NA	NA	NA	NA	NA	NA
TRINITY_DN20006_c0_g1_i2	Q9D0L4	ADCK1_MOUSE	54.2	236	106	1	744	37	19	252	2.50E-65	250.4	ADCK1_MOUSE	reviewed	AarF domain-containing protein kinase 1 (EC 2.7.-.-)	Adck1	Mus musculus (Mouse)	525	extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]	extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005576; GO:0005739; GO:0005743; GO:0007005; GO:0010637; GO:0032592; GO:0055088; GO:1903852	lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]		NA	NA	NA	NA	NA	NA
TRINITY_DN8150_c0_g1_i1	Q5XIJ1	HMCES_RAT	38.1	318	177	7	1011	64	1	300	2.80E-53	210.7	HMCES_RAT	reviewed	Abasic site processing protein HMCES (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (SRAP domain-containing protein 1)	Hmces Srapd1	Rattus norvegicus (Rat)	353	replication fork [GO:0005657]; peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking [GO:0018142]	replication fork [GO:0005657]	peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0005657; GO:0006974; GO:0008233; GO:0018142; GO:0045830; GO:0097681	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking [GO:0018142]		NA	NA	NA	NA	NA	NA
TRINITY_DN34425_c0_g1_i1	Q84M24	AB1A_ARATH	56.7	97	42	0	295	5	1587	1683	9.10E-26	117.5	AB1A_ARATH	reviewed	ABC transporter A family member 1 (ABC transporter ABCA.1) (AtABCA1) (ABC one homolog protein 1) (AtAOH1)	ABCA1 ABC1 AOH1 At2g41700 T32G6.22	Arabidopsis thaliana (Mouse-ear cress)	1882	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005774; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN38166_c0_g1_i1	Q84K47	AB2A_ARATH	60.3	78	31	0	17	250	666	743	8.30E-22	104	AB2A_ARATH	reviewed	ABC transporter A family member 2 (ABC transporter ABCA.2) (AtABCA2) (ABC2 homolog 1)	ABCA2 ATH1 At3g47730 T23J7.60	Arabidopsis thaliana (Mouse-ear cress)	983	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g2_i3	Q8T6J2	ABCA5_DICDI	30.5	128	77	2	24	407	761	876	2.90E-07	57	ABCA5_DICDI	reviewed	ABC transporter A family member 5 (ABC transporter ABCA.5)	abcA5 DDB_G0274119	Dictyostelium discoideum (Slime mold)	1662	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; sorocarp development [GO:0030587]; sorocarp morphogenesis [GO:0031288]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0016887; GO:0030587; GO:0031288; GO:0042626; GO:0043231	lipid transport [GO:0006869]; sorocarp development [GO:0030587]; sorocarp morphogenesis [GO:0031288]		NA	NA	NA	NA	NA	NA
TRINITY_DN12374_c0_g1_i1	Q2UPC0	ACLQ_ASPOR	60.8	130	51	0	391	2	663	792	5.90E-38	158.3	ACLQ_ASPOR	reviewed	ABC transporter aclQ (Aspirochlorine biosynthesis protein Q)	aclQ AO090001000032	Aspergillus oryzae (strain ATCC 42149 / RIB 40) (Yellow koji mold)	804	integral component of fungal-type vacuolar membrane [GO:0071627]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled phytochelatin transmembrane transporter activity [GO:0044604]; cadmium ion import into vacuole [GO:0036249]; cellular detoxification of cadmium ion [GO:0098849]; glutathione transmembrane import into vacuole [GO:0071996]; phytochelatin 2 import into vacuole [GO:0036246]	integral component of fungal-type vacuolar membrane [GO:0071627]	ATPase activity [GO:0016887]; ATPase-coupled phytochelatin transmembrane transporter activity [GO:0044604]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0036246; GO:0036249; GO:0044604; GO:0071627; GO:0071996; GO:0098849	cadmium ion import into vacuole [GO:0036249]; cellular detoxification of cadmium ion [GO:0098849]; glutathione transmembrane import into vacuole [GO:0071996]; phytochelatin 2 import into vacuole [GO:0036246]		NA	NA	NA	NA	NA	NA
TRINITY_DN12374_c0_g1_i2	Q2UPC0	ACLQ_ASPOR	59	234	96	0	703	2	559	792	8.80E-77	288.1	ACLQ_ASPOR	reviewed	ABC transporter aclQ (Aspirochlorine biosynthesis protein Q)	aclQ AO090001000032	Aspergillus oryzae (strain ATCC 42149 / RIB 40) (Yellow koji mold)	804	integral component of fungal-type vacuolar membrane [GO:0071627]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled phytochelatin transmembrane transporter activity [GO:0044604]; cadmium ion import into vacuole [GO:0036249]; cellular detoxification of cadmium ion [GO:0098849]; glutathione transmembrane import into vacuole [GO:0071996]; phytochelatin 2 import into vacuole [GO:0036246]	integral component of fungal-type vacuolar membrane [GO:0071627]	ATPase activity [GO:0016887]; ATPase-coupled phytochelatin transmembrane transporter activity [GO:0044604]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0036246; GO:0036249; GO:0044604; GO:0071627; GO:0071996; GO:0098849	cadmium ion import into vacuole [GO:0036249]; cellular detoxification of cadmium ion [GO:0098849]; glutathione transmembrane import into vacuole [GO:0071996]; phytochelatin 2 import into vacuole [GO:0036246]		NA	NA	NA	NA	NA	NA
TRINITY_DN4635_c0_g1_i1	P38735	VMR1_YEAST	51.4	35	17	0	169	65	1541	1575	2.60E-05	49.7	VMR1_YEAST	reviewed	ABC transporter ATP-binding protein/permease VMR1 (Vacuolar multidrug resistance protein 1)	VMR1 YHL035C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1592	fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; response to metal ion [GO:0010038]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]	GO:0000329; GO:0005524; GO:0005739; GO:0008559; GO:0010038; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085; GO:1990961	response to metal ion [GO:0010038]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]		NA	NA	NA	NA	NA	NA
TRINITY_DN4129_c1_g3_i5	Q11180	WHT1_CAEEL	35.4	99	60	1	60	344	497	595	1.50E-10	67.4	WHT1_CAEEL	reviewed	ABC transporter ATP-binding protein/permease wht-1	wht-1 C05D10.3	Caenorhabditis elegans	671	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; RNA interference [GO:0016246]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016246; GO:0042626	RNA interference [GO:0016246]		NA	NA	NA	NA	NA	NA
TRINITY_DN30631_c0_g1_i1	Q54BU4	ABCB1_DICDI	52.8	125	55	1	3	377	782	902	3.00E-31	136	ABCB1_DICDI	reviewed	ABC transporter B family member 1 (ABC transporter ABCB.1)	abcB1 mrpA DDB_G0293416	Dictyostelium discoideum (Slime mold)	909	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0006935; GO:0006972; GO:0016021; GO:0016887; GO:0031154; GO:0042626; GO:0055085	chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN33370_c0_g1_i1	Q9C7F8	AB13B_ARATH	63.7	113	39	2	5	343	1119	1229	3.80E-31	135.6	AB13B_ARATH	reviewed	ABC transporter B family member 13 (ABC transporter ABCB.13) (AtABCB13) (P-glycoprotein 13) (Putative multidrug resistance protein 15)	ABCB13 MDR15 PGP13 At1g27940 F13K9.5	Arabidopsis thaliana (Mouse-ear cress)	1245	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN33804_c0_g1_i1	Q9LHD1	AB15B_ARATH	63.3	139	46	2	414	4	455	590	9.50E-39	161	AB15B_ARATH	reviewed	ABC transporter B family member 15 (ABC transporter ABCB.15) (AtABCB15) (Multidrug resistance protein 13) (P-glycoprotein 15)	ABCB15 MDR13 PGP15 At3g28345 MZF16.16	Arabidopsis thaliana (Mouse-ear cress)	1240	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN30928_c0_g1_i1	Q8T9W2	ABCB5_DICDI	53.3	197	89	3	1	582	487	683	1.30E-54	214.2	ABCB5_DICDI	reviewed	ABC transporter B family member 5 (ABC transporter ABCB.5)	abcB5 DDB_G0292554	Dictyostelium discoideum (Slime mold)	697	ATP-binding cassette (ABC) transporter complex [GO:0043190]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cellular iron ion homeostasis [GO:0006879]; culmination involved in sorocarp development [GO:0031154]; transmembrane transport [GO:0055085]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0016887; GO:0031154; GO:0042626; GO:0043190; GO:0055085	cellular iron ion homeostasis [GO:0006879]; culmination involved in sorocarp development [GO:0031154]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN30928_c0_g1_i2	Q8T9W2	ABCB5_DICDI	53.8	197	89	2	1	585	487	683	1.40E-56	220.7	ABCB5_DICDI	reviewed	ABC transporter B family member 5 (ABC transporter ABCB.5)	abcB5 DDB_G0292554	Dictyostelium discoideum (Slime mold)	697	ATP-binding cassette (ABC) transporter complex [GO:0043190]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cellular iron ion homeostasis [GO:0006879]; culmination involved in sorocarp development [GO:0031154]; transmembrane transport [GO:0055085]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0016887; GO:0031154; GO:0042626; GO:0043190; GO:0055085	cellular iron ion homeostasis [GO:0006879]; culmination involved in sorocarp development [GO:0031154]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN27276_c0_g1_i1	Q9FHF1	AB7B_ARATH	58.3	72	30	0	216	1	1033	1104	1.10E-17	90.1	AB7B_ARATH	reviewed	ABC transporter B family member 7 (ABC transporter ABCB.7) (AtABCB7) (Multidrug resistance protein 7) (P-glycoprotein 7)	ABCB7 MDR7 PGP7 At5g46540 K11I1.13	Arabidopsis thaliana (Mouse-ear cress)	1248	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0009536; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN4768_c1_g1_i1	Q9M0M2	AB9B_ARATH	65.3	72	25	0	11	226	1114	1185	6.50E-21	100.9	AB9B_ARATH	reviewed	ABC transporter B family member 9 (ABC transporter ABCB.9) (AtABCB9) (Multidrug resistance protein 9) (P-glycoprotein 9)	ABCB9 MDR9 PGP9 At4g18050 F15J5.20	Arabidopsis thaliana (Mouse-ear cress)	1236	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN36428_c0_g1_i1	Q9C8G9	AB1C_ARATH	53.8	106	49	0	42	359	679	784	2.50E-27	122.9	AB1C_ARATH	reviewed	ABC transporter C family member 1 (ABC transporter ABCC.1) (AtABCC1) (EC 7.6.2.2) (ATP-energized glutathione S-conjugate pump 1) (Glutathione S-conjugate-transporting ATPase 1) (Multidrug resistance-associated protein 1)	ABCC1 EST1 MRP1 At1g30400 T4K22.12	Arabidopsis thaliana (Mouse-ear cress)	1622	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; (+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity [GO:1902417]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled arsenite transmembrane transporter activity [GO:0015446]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; calmodulin binding [GO:0005516]; (+)-abscisic acid D-glucopyranosyl ester transmembrane transport [GO:1902418]; arsenite transport [GO:0015700]; response to arsenic-containing substance [GO:0046685]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	(+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity [GO:1902417]; ATPase activity [GO:0016887]; ATPase-coupled arsenite transmembrane transporter activity [GO:0015446]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]	GO:0000325; GO:0005516; GO:0005524; GO:0005773; GO:0005774; GO:0008559; GO:0009506; GO:0015446; GO:0015700; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0046685; GO:0055085; GO:1902417; GO:1902418	(+)-abscisic acid D-glucopyranosyl ester transmembrane transport [GO:1902418]; arsenite transport [GO:0015700]; response to arsenic-containing substance [GO:0046685]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN1713_c0_g1_i1	Q9C8H0	AB12C_ARATH	38.1	63	39	0	307	495	223	285	1.50E-07	57.8	AB12C_ARATH	reviewed	ABC transporter C family member 12 (ABC transporter ABCC.12) (AtABCC12) (EC 7.6.2.2) (ATP-energized glutathione S-conjugate pump 13) (Glutathione S-conjugate-transporting ATPase 13) (Multidrug resistance-associated protein 13)	ABCC12 MRP12 MRP13 At1g30410 T4K22.13	Arabidopsis thaliana (Mouse-ear cress)	1495	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]	GO:0000325; GO:0005524; GO:0005774; GO:0008559; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN28502_c0_g1_i1	Q54JR2	ABCC3_DICDI	50.4	121	60	0	381	19	1122	1242	3.70E-29	129	ABCC3_DICDI	reviewed	ABC transporter C family member 3 (ABC transporter ABCC.3)	abcC3 DDB_G0287691	Dictyostelium discoideum (Slime mold)	1412	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; culmination involved in sorocarp development [GO:0031154]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0016020; GO:0016021; GO:0016887; GO:0031154; GO:0042626; GO:0055085	culmination involved in sorocarp development [GO:0031154]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8531_c0_g1_i1	Q8LPJ4	AB2E_ARATH	67.3	602	193	3	52	1854	7	605	5.00E-244	845.1	AB2E_ARATH	reviewed	ABC transporter E family member 2 (ABC transporter ABCE.2) (AtABCE2) (RNase L inhibitor-like protein 2) (AtRLI2) (AthaRLI2)	ABCE2 RLI2 At4g19210 T18B16.180	Arabidopsis thaliana (Mouse-ear cress)	605	"cytosol [GO:0005829]; membrane [GO:0016020]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]"	cytosol [GO:0005829]; membrane [GO:0016020]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]"	GO:0000054; GO:0005506; GO:0005524; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016887; GO:0043024; GO:0051539	ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN27939_c0_g1_i1	Q8LPJ4	AB2E_ARATH	61.4	127	49	0	2	382	469	595	1.40E-39	163.7	AB2E_ARATH	reviewed	ABC transporter E family member 2 (ABC transporter ABCE.2) (AtABCE2) (RNase L inhibitor-like protein 2) (AtRLI2) (AthaRLI2)	ABCE2 RLI2 At4g19210 T18B16.180	Arabidopsis thaliana (Mouse-ear cress)	605	"cytosol [GO:0005829]; membrane [GO:0016020]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]"	cytosol [GO:0005829]; membrane [GO:0016020]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]"	GO:0000054; GO:0005506; GO:0005524; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016887; GO:0043024; GO:0051539	ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN1719_c0_g2_i1	Q8T6B7	ABCF2_DICDI	67	94	31	0	1	282	487	580	6.00E-32	137.9	ABCF2_DICDI	reviewed	ABC transporter F family member 2	abcF2 DDB_G0284047	Dictyostelium discoideum (Slime mold)	593	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; aggregation involved in sorocarp development [GO:0031152]; sorocarp morphogenesis [GO:0031288]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0031152; GO:0031288	aggregation involved in sorocarp development [GO:0031152]; sorocarp morphogenesis [GO:0031288]		NA	NA	NA	NA	NA	NA
TRINITY_DN16133_c0_g1_i2	Q8H0V6	AB3F_ARATH	62.9	97	36	0	2	292	307	403	1.40E-28	126.7	AB3F_ARATH	reviewed	ABC transporter F family member 3 (ABC transporter ABCF.3) (AtABCF3) (GCN20-type ATP-binding cassette protein GCN3)	ABCF3 GCN3 At1g64550 F1N19.11	Arabidopsis thaliana (Mouse-ear cress)	715	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to bacterium [GO:0042742]; response to cadmium ion [GO:0046686]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005829; GO:0016887; GO:0042742; GO:0046686	defense response to bacterium [GO:0042742]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN32947_c0_g1_i1	Q8H0V6	AB3F_ARATH	57.7	71	30	0	2	214	620	690	5.70E-19	94.4	AB3F_ARATH	reviewed	ABC transporter F family member 3 (ABC transporter ABCF.3) (AtABCF3) (GCN20-type ATP-binding cassette protein GCN3)	ABCF3 GCN3 At1g64550 F1N19.11	Arabidopsis thaliana (Mouse-ear cress)	715	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to bacterium [GO:0042742]; response to cadmium ion [GO:0046686]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005829; GO:0016887; GO:0042742; GO:0046686	defense response to bacterium [GO:0042742]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN2125_c0_g1_i1	Q8T6B4	ABCF4_DICDI	50.5	109	46	1	13	315	1018	1126	5.20E-29	128.3	ABCF4_DICDI	reviewed	ABC transporter F family member 4	abcF4 DDB_G0267436	Dictyostelium discoideum (Slime mold)	1142	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; regulation of translational elongation [GO:0006448]; response to differentiation-inducing factor 1 [GO:1903013]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]	cytosol [GO:0005829]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006448; GO:0016887; GO:0031288; GO:0055085; GO:1903013	regulation of translational elongation [GO:0006448]; response to differentiation-inducing factor 1 [GO:1903013]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN37142_c0_g1_i1	Q9M1H3	AB4F_ARATH	61.1	113	43	1	351	13	301	412	6.50E-36	151.4	AB4F_ARATH	reviewed	ABC transporter F family member 4 (ABC transporter ABCF.4) (AtABCF4) (GCN20-type ATP-binding cassette protein GCN4)	ABCF4 GCN4 At3g54540 T14E10.110	Arabidopsis thaliana (Mouse-ear cress)	723	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytosol [GO:0005829]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN16133_c0_g1_i1	Q9M1H3	AB4F_ARATH	65.4	81	28	0	2	244	302	382	8.10E-25	114	AB4F_ARATH	reviewed	ABC transporter F family member 4 (ABC transporter ABCF.4) (AtABCF4) (GCN20-type ATP-binding cassette protein GCN4)	ABCF4 GCN4 At3g54540 T14E10.110	Arabidopsis thaliana (Mouse-ear cress)	723	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytosol [GO:0005829]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN1719_c0_g1_i1	Q9M1H3	AB4F_ARATH	57.7	78	28	1	29	247	617	694	1.10E-19	97.1	AB4F_ARATH	reviewed	ABC transporter F family member 4 (ABC transporter ABCF.4) (AtABCF4) (GCN20-type ATP-binding cassette protein GCN4)	ABCF4 GCN4 At3g54540 T14E10.110	Arabidopsis thaliana (Mouse-ear cress)	723	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytosol [GO:0005829]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN31949_c0_g1_i1	Q4WD46	FMPD_ASPFU	56.4	55	24	0	168	4	513	567	2.90E-09	62	FMPD_ASPFU	reviewed	ABC transporter fmpD (Fumipyrrole biosynthesis protein D)	fmpD AFUA_6G03470	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	1285	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN39911_c0_g1_i1	Q9C6W5	AB14G_ARATH	48.1	108	56	0	324	1	203	310	1.80E-24	113.2	AB14G_ARATH	reviewed	ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (Protein INSENSITIVE TO TEMPERATURE 211) (White-brown complex homolog protein 14) (AtWBC14)	ABCG14 INT211 WBC14 At1g31770 F27M3.2 F5M6.22	Arabidopsis thaliana (Mouse-ear cress)	648	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; cotyledon vascular tissue pattern formation [GO:0010588]; cytokinin transport [GO:0010184]; cytokinin-activated signaling pathway [GO:0009736]; defense response to bacterium [GO:0042742]; export across plasma membrane [GO:0140115]; export from cell [GO:0140352]; response to hydrogen peroxide [GO:0042542]; stem vascular tissue pattern formation [GO:0010222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]	GO:0005524; GO:0005886; GO:0009736; GO:0010184; GO:0010222; GO:0010588; GO:0015562; GO:0016021; GO:0016887; GO:0042542; GO:0042626; GO:0042742; GO:0140115; GO:0140352	cotyledon vascular tissue pattern formation [GO:0010588]; cytokinin-activated signaling pathway [GO:0009736]; cytokinin transport [GO:0010184]; defense response to bacterium [GO:0042742]; export across plasma membrane [GO:0140115]; export from cell [GO:0140352]; response to hydrogen peroxide [GO:0042542]; stem vascular tissue pattern formation [GO:0010222]		NA	NA	NA	NA	NA	NA
TRINITY_DN32931_c0_g1_i1	Q55DA0	ABCGM_DICDI	41.2	85	45	3	246	4	28	111	6.80E-08	57.8	ABCGM_DICDI	reviewed	ABC transporter G family member 22 (ABC transporter ABCG.22)	abcG22 DDB_G0270826	Dictyostelium discoideum (Slime mold)	615	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0016021; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870	aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]		NA	NA	NA	NA	NA	NA
TRINITY_DN30094_c0_g1_i1	D4AYW0	ABCG1_ARTBC	52.4	63	29	1	2	187	501	563	3.70E-10	65.1	ABCG1_ARTBC	reviewed	ABC transporter G family member ARB_01379 (ABC transporter ARB_01379)	ARB_01379	Arthroderma benhamiae (strain ATCC MYA-4681 / CBS 112371) (Trichophyton mentagrophytes)	1101	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005789; GO:0016021; GO:0016887; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN30458_c0_g1_i1	Q24093	ABHD2_DROME	46.2	173	91	1	521	3	26	196	6.10E-43	175.3	ABHD2_DROME	reviewed	Abhydrolase domain-containing protein 2 (EC 3.1.1.-)	Hydr2 anon-23D anon-23Da CG3488	Drosophila melanogaster (Fruit fly)	398	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]	acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]	GO:0006629; GO:0008126; GO:0016021; GO:0016298; GO:0034338; GO:0036126; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524	acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]		NA	NA	NA	NA	NA	NA
TRINITY_DN30458_c0_g1_i2	Q24093	ABHD2_DROME	41.1	90	53	0	293	24	26	115	4.70E-16	85.1	ABHD2_DROME	reviewed	Abhydrolase domain-containing protein 2 (EC 3.1.1.-)	Hydr2 anon-23D anon-23Da CG3488	Drosophila melanogaster (Fruit fly)	398	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]	acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]	GO:0006629; GO:0008126; GO:0016021; GO:0016298; GO:0034338; GO:0036126; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524	acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]		NA	NA	NA	NA	NA	NA
TRINITY_DN13706_c0_g1_i1	Q24093	ABHD2_DROME	49.2	118	60	0	2	355	270	387	1.90E-32	140.2	ABHD2_DROME	reviewed	Abhydrolase domain-containing protein 2 (EC 3.1.1.-)	Hydr2 anon-23D anon-23Da CG3488	Drosophila melanogaster (Fruit fly)	398	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]	acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]	GO:0006629; GO:0008126; GO:0016021; GO:0016298; GO:0034338; GO:0036126; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524	acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]		NA	NA	NA	NA	NA	NA
TRINITY_DN13706_c0_g1_i2	Q24093	ABHD2_DROME	50	68	34	0	2	205	270	337	5.90E-15	81.3	ABHD2_DROME	reviewed	Abhydrolase domain-containing protein 2 (EC 3.1.1.-)	Hydr2 anon-23D anon-23Da CG3488	Drosophila melanogaster (Fruit fly)	398	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]	integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]	acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]	GO:0006629; GO:0008126; GO:0016021; GO:0016298; GO:0034338; GO:0036126; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524	acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]		NA	NA	NA	NA	NA	NA
TRINITY_DN13530_c0_g1_i1	Q7G9P4	ALDO3_ARATH	48.1	81	37	1	280	53	88	168	1.30E-18	93.6	ALDO3_ARATH	reviewed	Abscisic-aldehyde oxidase (EC 1.2.3.14) (Aldehyde oxidase 3) (AO-3) (AtAO-3) (AtAO4) (Indole-3-acetaldehyde oxidase) (IAA oxidase) (EC 1.2.3.7)	AAO3 AO4 At2g27150 F20F1.2	Arabidopsis thaliana (Mouse-ear cress)	1332	"cytosol [GO:0005829]; 2 iron, 2 sulfur cluster binding [GO:0051537]; abscisic aldehyde oxidase activity [GO:0010293]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; indole-3-acetaldehyde oxidase activity [GO:0050302]; iron ion binding [GO:0005506]; ubiquitin protein ligase binding [GO:0031625]; abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]"	cytosol [GO:0005829]	"2 iron, 2 sulfur cluster binding [GO:0051537]; abscisic aldehyde oxidase activity [GO:0010293]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; indole-3-acetaldehyde oxidase activity [GO:0050302]; iron ion binding [GO:0005506]; ubiquitin protein ligase binding [GO:0031625]"	GO:0004031; GO:0005506; GO:0005829; GO:0009055; GO:0009688; GO:0009851; GO:0010293; GO:0031625; GO:0050302; GO:0051537; GO:0071949	abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]		NA	NA	NA	NA	NA	NA
TRINITY_DN1311_c0_g1_i1	Q9DAZ9	ANCHR_MOUSE	32.2	121	74	4	774	430	123	241	1.50E-05	52	ANCHR_MOUSE	reviewed	Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19)	Zfyve19 Anchr	Mus musculus (Mouse)	389	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0005737; GO:0005813; GO:0009838; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0046872; GO:0051301; GO:0090543	abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]		NA	NA	NA	NA	NA	NA
TRINITY_DN1311_c0_g1_i3	Q9DAZ9	ANCHR_MOUSE	32.2	121	74	4	774	430	123	241	1.50E-05	52	ANCHR_MOUSE	reviewed	Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19)	Zfyve19 Anchr	Mus musculus (Mouse)	389	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0005737; GO:0005813; GO:0009838; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0046872; GO:0051301; GO:0090543	abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]		NA	NA	NA	NA	NA	NA
TRINITY_DN577_c0_g1_i1	P46368	DHA2_CUPNH	91.8	85	7	0	256	2	122	206	3.30E-42	171.8	DHA2_CUPNH	reviewed	Acetaldehyde dehydrogenase 2 (EC 1.2.1.3) (Acetaldehyde dehydrogenase II) (ACDH-II)	acoD H16_B1960	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	506	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; acetoin catabolic process [GO:0045150]; ethanol catabolic process [GO:0006068]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0006068; GO:0043878; GO:0045150	acetoin catabolic process [GO:0045150]; ethanol catabolic process [GO:0006068]		NA	NA	NA	NA	NA	1
TRINITY_DN27077_c0_g1_i1	P50205	PHAB_RHIME	55.4	65	29	0	200	6	169	233	2.50E-16	85.5	PHAB_RHIME	reviewed	Acetoacetyl-CoA reductase (EC 1.1.1.36)	phaB R03261 SMc03878	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	241	cytoplasm [GO:0005737]; acetoacetyl-CoA reductase activity [GO:0018454]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetoacetyl-CoA reductase activity [GO:0018454]	GO:0005737; GO:0018454; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN5790_c0_g1_i1	Q5ZLG0	AACS_CHICK	61.6	620	235	2	1945	95	48	667	2.70E-236	819.7	AACS_CHICK	reviewed	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	AACS RCJMB04_6g9	Gallus gallus (Chicken)	667	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]	cytosol [GO:0005829]	acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024	fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5790_c0_g1_i3	Q5ZLG0	AACS_CHICK	64.9	350	121	1	1138	95	318	667	2.10E-136	486.9	AACS_CHICK	reviewed	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	AACS RCJMB04_6g9	Gallus gallus (Chicken)	667	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]	cytosol [GO:0005829]	acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024	fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5790_c0_g1_i4	Q5ZLG0	AACS_CHICK	56.7	291	123	2	926	63	37	327	4.30E-95	349.4	AACS_CHICK	reviewed	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	AACS RCJMB04_6g9	Gallus gallus (Chicken)	667	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]	cytosol [GO:0005829]	acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024	fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5790_c0_g1_i5	Q5ZLG0	AACS_CHICK	59.8	214	84	1	698	63	114	327	1.30E-70	267.7	AACS_CHICK	reviewed	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	AACS RCJMB04_6g9	Gallus gallus (Chicken)	667	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]	cytosol [GO:0005829]	acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024	fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5790_c0_g1_i6	Q5ZLG0	AACS_CHICK	61.5	589	224	2	1780	23	37	625	6.00E-223	775	AACS_CHICK	reviewed	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	AACS RCJMB04_6g9	Gallus gallus (Chicken)	667	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]	cytosol [GO:0005829]	acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024	fatty acid metabolic process [GO:0006631]; positive regulation of insulin secretion [GO:0032024]		NA	NA	NA	NA	NA	NA
TRINITY_DN30218_c0_g1_i1	P0A509	BCCA_MYCBO	67	91	30	0	37	309	2	92	2.40E-26	119.4	BCCA_MYCBO	reviewed	Acetyl-/propionyl-coenzyme A carboxylase alpha chain [Includes: Biotin carboxylase (EC 6.3.4.14); Biotin carboxyl carrier protein (BCCP)]	accA1 bccA BQ2027_MB2529C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	654	ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]		ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0004075; GO:0005524; GO:0006633; GO:0046872	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN40532_c0_g1_i1	P46392	BCCA_MYCLE	69.2	91	28	0	281	9	226	316	3.20E-30	132.1	BCCA_MYCLE	reviewed	Acetyl-/propionyl-coenzyme A carboxylase alpha chain [Includes: Biotin carboxylase (EC 6.3.4.14); Biotin carboxyl carrier protein (BCCP)]	bccA ML0726 B1308_C1_129	Mycobacterium leprae (strain TN)	598	ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]		ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0004075; GO:0005524; GO:0006633; GO:0046872	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN38791_c0_g1_i1	P46392	BCCA_MYCLE	72.8	103	28	0	311	3	124	226	1.40E-39	163.3	BCCA_MYCLE	reviewed	Acetyl-/propionyl-coenzyme A carboxylase alpha chain [Includes: Biotin carboxylase (EC 6.3.4.14); Biotin carboxyl carrier protein (BCCP)]	bccA ML0726 B1308_C1_129	Mycobacterium leprae (strain TN)	598	ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]		ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0004075; GO:0005524; GO:0006633; GO:0046872	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN33210_c0_g1_i1	P02708	ACHA_HUMAN	100	71	0	0	215	3	157	227	8.50E-39	160.2	ACHA_HUMAN	reviewed	Acetylcholine receptor subunit alpha	CHRNA1 ACHRA CHNRA	Homo sapiens (Human)	482	acetylcholine-gated channel complex [GO:0005892]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ion channel activity [GO:0005216]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]	acetylcholine-gated channel complex [GO:0005892]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; acetylcholine receptor activity [GO:0015464]; ion channel activity [GO:0005216]; neurotransmitter receptor activity [GO:0030594]	GO:0003009; GO:0005216; GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046716; GO:0048630; GO:0050877; GO:0050881; GO:0050905; GO:0070050; GO:0099060	chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuronal action potential [GO:0019228]; neuron cellular homeostasis [GO:0070050]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]		NA	NA	NA	NA	NA	NA
TRINITY_DN37904_c0_g1_i1	P91766	ACH1_MANSE	88.9	45	5	0	137	3	317	361	1.80E-17	89.4	ACH1_MANSE	reviewed	Acetylcholine receptor subunit alpha-like (MARA1)	ARA1	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	516	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0016021; GO:0022848; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g1_i3	P91766	ACH1_MANSE	29.3	328	223	5	1265	303	14	339	6.90E-30	133.3	ACH1_MANSE	reviewed	Acetylcholine receptor subunit alpha-like (MARA1)	ARA1	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	516	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0016021; GO:0022848; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN23565_c0_g1_i2	P09478	ACH1_DROME	26.8	299	208	6	1314	442	27	322	1.70E-26	122.1	ACH1_DROME	reviewed	Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1)	nAChRalpha1 Acr96Aa AcrB als nAcRalpha-96Aa CG5610	Drosophila melanogaster (Fruit fly)	567	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23565_c0_g1_i3	P17644	ACH2_DROME	34.8	161	103	2	801	322	47	206	1.90E-26	121.3	ACH2_DROME	reviewed	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	nAChRalpha2 Acr96Ab AcrE nAcRalpha-96Ab sad CG6844	Drosophila melanogaster (Fruit fly)	576	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		pink	pink	NA	NA	NA	NA
TRINITY_DN1603_c0_g1_i2	P49579	ACHB_XENLA	35	103	64	2	438	136	13	114	3.10E-10	66.6	ACHB_XENLA	reviewed	Acetylcholine receptor subunit beta (Fragment)	chrnb1	Xenopus laevis (African clawed frog)	489	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0016021; GO:0022848; GO:0045211			brown	brown	NA	NA	NA	NA
TRINITY_DN15491_c0_g1_i1	P04755	ACH3_DROME	76.5	85	12	3	262	8	253	329	1.90E-22	106.3	ACH3_DROME	reviewed	Acetylcholine receptor subunit beta-like 1 (Nicotinic acetylcholine receptor beta 1)	nAChRbeta1 Acr64B AcrD ard nAcRbeta-64B CG11348	Drosophila melanogaster (Fruit fly)	521	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15491_c0_g1_i2	P04755	ACH3_DROME	94.6	111	4	1	340	8	221	329	1.30E-46	186.8	ACH3_DROME	reviewed	Acetylcholine receptor subunit beta-like 1 (Nicotinic acetylcholine receptor beta 1)	nAChRbeta1 Acr64B AcrD ard nAcRbeta-64B CG11348	Drosophila melanogaster (Fruit fly)	521	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40000_c0_g1_i1	P04755	ACH3_DROME	88.9	36	4	0	176	69	83	118	1.10E-13	77	ACH3_DROME	reviewed	Acetylcholine receptor subunit beta-like 1 (Nicotinic acetylcholine receptor beta 1)	nAChRbeta1 Acr64B AcrD ard nAcRbeta-64B CG11348	Drosophila melanogaster (Fruit fly)	521	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		brown	brown	NA	NA	NA	NA
TRINITY_DN31420_c0_g1_i1	P04755	ACH3_DROME	75.5	53	11	1	154	2	14	66	1.30E-13	76.6	ACH3_DROME	reviewed	Acetylcholine receptor subunit beta-like 1 (Nicotinic acetylcholine receptor beta 1)	nAChRbeta1 Acr64B AcrD ard nAcRbeta-64B CG11348	Drosophila melanogaster (Fruit fly)	521	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38082_c0_g1_i1	P25162	ACH4_DROME	84.8	79	12	0	3	239	226	304	3.50E-30	131.7	ACH4_DROME	reviewed	Acetylcholine receptor subunit beta-like 2 (Nicotinic acetylcholine receptor beta 2)	nAChRbeta2 Acr96Ac AcrF nAcRbeta-96 SBD CG6798	Drosophila melanogaster (Fruit fly)	519	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated cation-selective channel activity [GO:0022848]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38346_c0_g1_i1	Q869C3	ACES_ANOGA	58.5	65	27	0	3	197	478	542	1.80E-17	89.4	ACES_ANOGA	reviewed	Acetylcholinesterase (AChE) (EC 3.1.1.7)	Ace ACE1 ACHE1 AGAP001356	Anopheles gambiae (African malaria mosquito)	737	synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]	synapse [GO:0045202]	acetylcholinesterase activity [GO:0003990]	GO:0003990; GO:0042135; GO:0045202	neurotransmitter catabolic process [GO:0042135]		NA	NA	NA	NA	NA	NA
TRINITY_DN33733_c0_g1_i1	Q27677	ACES_LEPDE	60.9	156	53	2	445	2	40	195	6.30E-55	214.9	ACES_LEPDE	reviewed	Acetylcholinesterase (AChE) (EC 3.1.1.7)		Leptinotarsa decemlineata (Colorado potato beetle) (Doryphora decemlineata)	629	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; acetylcholine catabolic process in synaptic cleft [GO:0001507]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]	acetylcholinesterase activity [GO:0003990]	GO:0001507; GO:0003990; GO:0005886; GO:0031225; GO:0043083	acetylcholine catabolic process in synaptic cleft [GO:0001507]		NA	NA	NA	NA	NA	NA
TRINITY_DN39924_c0_g1_i1	P23795	ACES_BOVIN	56.7	67	28	1	56	253	187	253	6.50E-14	77.8	ACES_BOVIN	reviewed	Acetylcholinesterase (AChE) (EC 3.1.1.7)	ACHE	Bos taurus (Bovine)	613	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; neurotransmitter catabolic process [GO:0042135]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]	GO:0001540; GO:0003990; GO:0005576; GO:0005886; GO:0031225; GO:0042135; GO:0045202	neurotransmitter catabolic process [GO:0042135]		NA	NA	NA	NA	NA	NA
TRINITY_DN623_c0_g1_i2	P54810	THIL_PARDE	69.7	152	46	0	3	458	168	319	3.40E-53	209.1	THIL_PARDE	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)	phaA	Paracoccus denitrificans	391	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN623_c0_g1_i3	P54810	THIL_PARDE	68.6	156	49	0	3	470	168	323	6.30E-55	214.9	THIL_PARDE	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)	phaA	Paracoccus denitrificans	391	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN37375_c0_g1_i1	Q9I2A8	ATOB_PSEAE	61.8	136	50	1	1	408	52	185	7.00E-42	171.4	ATOB_PSEAE	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)	atoB PA2001	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	393	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003985; GO:0003988; GO:0005737; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN144_c0_g1_i1	Q18AR0	THLA_CLOD6	60.1	173	69	0	570	52	219	391	9.10E-56	218	THLA_CLOD6	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)	thlA CD630_10590	Clostridioides difficile (strain 630) (Peptoclostridium difficile)	391	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN2236_c0_g1_i2	P54810	THIL_PARDE	66.4	116	39	0	348	1	13	128	1.80E-35	149.8	THIL_PARDE	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)	phaA	Paracoccus denitrificans	391	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN31576_c0_g1_i1	P14611	THIL_CUPNH	55.8	138	61	0	13	426	4	141	9.20E-37	154.5	THIL_CUPNH	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA H16_A1438	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	393	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN623_c0_g1_i1	P07097	THIL_ZOORA	68.5	146	46	0	3	440	169	314	7.50E-50	198	THIL_ZOORA	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA	Zoogloea ramigera	392	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN37723_c0_g1_i1	P45363	THIL_THIVI	84.4	77	12	0	2	232	317	393	1.90E-31	136.3	THIL_THIVI	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA	Thiocystis violacea	394	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN38155_c0_g1_i1	P07097	THIL_ZOORA	67.9	81	26	0	6	248	48	128	6.20E-25	114.4	THIL_ZOORA	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA	Zoogloea ramigera	392	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN27073_c0_g1_i1	P14611	THIL_CUPNH	89.5	153	16	0	16	474	1	153	7.80E-69	261.2	THIL_CUPNH	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA H16_A1438	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	393	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN1292_c0_g2_i1	P07097	THIL_ZOORA	64.4	90	32	0	283	14	303	392	2.40E-25	115.9	THIL_ZOORA	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA	Zoogloea ramigera	392	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	1
TRINITY_DN1292_c0_g1_i1	P07097	THIL_ZOORA	55.3	114	51	0	366	25	277	390	2.50E-27	122.9	THIL_ZOORA	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA	Zoogloea ramigera	392	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN31856_c0_g1_i1	P14611	THIL_CUPNH	86.5	52	7	0	2	157	341	392	1.30E-20	99.8	THIL_CUPNH	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA H16_A1438	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	393	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN2236_c0_g1_i1	P07097	THIL_ZOORA	65.2	158	55	0	479	6	15	172	3.30E-51	202.6	THIL_ZOORA	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA phbA	Zoogloea ramigera	392	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN2236_c0_g2_i1	P50174	THIL_RHIME	63.8	116	42	0	353	6	58	173	1.10E-35	150.6	THIL_RHIME	reviewed	Acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (Beta-ketothiolase)	phaA R03262 SMc03879	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	393	cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619]	cytoplasm [GO:0005737]	acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985; GO:0005737; GO:0042619	poly-hydroxybutyrate biosynthetic process [GO:0042619]		NA	NA	NA	NA	NA	NA
TRINITY_DN32677_c0_g1_i1	Q9BWD1	THIC_HUMAN	100	358	0	0	3	1076	40	397	1.20E-203	710.3	THIC_HUMAN	reviewed	"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)"	ACAT2 ACTL	Homo sapiens (Human)	397	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003985; GO:0003988; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006635; GO:0006695; GO:0070062	cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN10271_c0_g1_i1	Q8CAY6	THIC_MOUSE	60.2	389	155	0	1252	86	8	396	4.40E-138	492.7	THIC_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Cytosolic acetoacetyl-CoA thiolase)"	Acat2	Mus musculus (Mouse)	397	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]; positive regulation of intestinal cholesterol absorption [GO:0045797]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003985; GO:0003988; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006635; GO:0045797	fatty acid beta-oxidation [GO:0006635]; positive regulation of intestinal cholesterol absorption [GO:0045797]		NA	NA	NA	NA	NA	NA
TRINITY_DN10271_c0_g1_i2	Q5XI22	THIC_RAT	57.7	163	69	0	542	54	8	170	5.70E-48	192.2	THIC_RAT	reviewed	"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Cytosolic acetoacetyl-CoA thiolase)"	Acat2	Rattus norvegicus (Rat)	397	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; bile acid signaling pathway [GO:0038183]; brain development [GO:0007420]; cellular response to fatty acid [GO:0071398]; cellular response to nutrient [GO:0031670]; cholesterol biosynthetic process [GO:0006695]; dolichol biosynthetic process [GO:0019408]; fatty acid beta-oxidation [GO:0006635]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; positive regulation of intestinal cholesterol absorption [GO:0045797]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0001889; GO:0003985; GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005829; GO:0006635; GO:0006695; GO:0007420; GO:0019408; GO:0031670; GO:0038183; GO:0045797; GO:0046952; GO:0071398	bile acid signaling pathway [GO:0038183]; brain development [GO:0007420]; cellular response to fatty acid [GO:0071398]; cellular response to nutrient [GO:0031670]; cholesterol biosynthetic process [GO:0006695]; dolichol biosynthetic process [GO:0019408]; fatty acid beta-oxidation [GO:0006635]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; positive regulation of intestinal cholesterol absorption [GO:0045797]		NA	NA	NA	NA	NA	NA
TRINITY_DN30286_c0_g1_i1	Q8S4Y1	THIC1_ARATH	56.2	105	46	0	325	11	298	402	4.00E-24	112.1	THIC1_ARATH	reviewed	"Acetyl-CoA acetyltransferase, cytosolic 1 (EC 2.3.1.9) (Cytosolic acetoacetyl-CoA thiolase 1) (Thiolase 1) (Protein EMBRYO DEFECTIVE 1276)"	AAT1 EMB1276 At5g48230 MIF21.12	Arabidopsis thaliana (Mouse-ear cress)	403	cytosol [GO:0005829]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; plastid [GO:0009536]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]; fatty acid beta-oxidation [GO:0006635]; isoprenoid biosynthetic process [GO:0008299]; pollen germination [GO:0009846]; pollen tube growth [GO:0009860]; sterol metabolic process [GO:0016125]	cytosol [GO:0005829]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; plastid [GO:0009536]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]	GO:0003985; GO:0003988; GO:0005777; GO:0005829; GO:0005886; GO:0006635; GO:0008299; GO:0009536; GO:0009846; GO:0009860; GO:0016125; GO:0046872	fatty acid beta-oxidation [GO:0006635]; isoprenoid biosynthetic process [GO:0008299]; pollen germination [GO:0009846]; pollen tube growth [GO:0009860]; sterol metabolic process [GO:0016125]		NA	NA	NA	NA	NA	NA
TRINITY_DN12458_c0_g1_i1	Q8QZT1	THIL_MOUSE	100	179	0	0	537	1	242	420	6.70E-93	341.3	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN12652_c0_g1_i1	Q8QZT1	THIL_MOUSE	99.4	161	1	0	1	483	84	244	3.80E-87	322	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN1968_c0_g1_i10	Q8QZT1	THIL_MOUSE	65.9	393	130	3	1171	2	19	410	2.50E-137	490	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN1968_c0_g1_i11	Q8QZT1	THIL_MOUSE	66.1	407	134	3	1367	156	19	424	4.30E-144	512.7	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN1968_c0_g1_i3	Q8QZT1	THIL_MOUSE	66.1	407	134	3	1367	156	19	424	4.30E-144	512.7	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN1968_c0_g1_i7	Q8QZT1	THIL_MOUSE	66.1	407	134	3	1367	156	19	424	4.30E-144	512.7	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN32518_c0_g1_i1	Q8QZT1	THIL_MOUSE	77.4	31	7	0	1	93	394	424	2.40E-07	56.6	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN32518_c0_g1_i2	Q8QZT1	THIL_MOUSE	77.4	31	7	0	1	93	394	424	2.60E-07	56.6	THIL_MOUSE	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)"	Acat1	Mus musculus (Mouse)	424	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN12652_c0_g1_i2	P24752	THIL_HUMAN	96.9	128	4	0	1	384	87	214	5.90E-67	254.6	THIL_HUMAN	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)"	ACAT1 ACAT MAT	Homo sapiens (Human)	427	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009083; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0034435; GO:0042594; GO:0042802; GO:0046356; GO:0046951; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:1902224; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN34686_c0_g1_i1	P24752	THIL_HUMAN	100	92	0	0	276	1	241	332	6.10E-42	171	THIL_HUMAN	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)"	ACAT1 ACAT MAT	Homo sapiens (Human)	427	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009083; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0034435; GO:0042594; GO:0042802; GO:0046356; GO:0046951; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:1902224; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN34287_c0_g1_i1	P24752	THIL_HUMAN	100	81	0	0	3	245	347	427	1.40E-39	163.3	THIL_HUMAN	reviewed	"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)"	ACAT1 ACAT MAT	Homo sapiens (Human)	427	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; C-acetyltransferase activity [GO:0016453]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0003988; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009083; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0034435; GO:0042594; GO:0042802; GO:0046356; GO:0046951; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:1902224; GO:1902860	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN32832_c0_g1_i1	P11029	ACAC_CHICK	66.3	172	58	0	53	568	1604	1775	1.10E-66	254.2	ACAC_CHICK	reviewed	Acetyl-CoA carboxylase (ACC) (EC 6.4.1.2) [Includes: Biotin carboxylase (EC 6.3.4.14)]	ACAC	Gallus gallus (Chicken)	2324	"cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DNA binding domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression, epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]"	cytoplasm [GO:0005737]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DNA binding domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]	GO:0003989; GO:0004075; GO:0005102; GO:0005524; GO:0005737; GO:0006633; GO:0006810; GO:0009374; GO:0009743; GO:0010628; GO:0032810; GO:0040029; GO:0045893; GO:0046872; GO:0046966; GO:0050692; GO:0065008; GO:0070542; GO:0097066; GO:2001295	"fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression, epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32201_c0_g1_i1	Q9TTS3	ACACA_BOVIN	82.6	69	12	0	3	209	401	469	3.80E-28	124.8	ACACA_BOVIN	reviewed	Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha)	ACACA ACAC ACCA	Bos taurus (Bovine)	2346	cytosol [GO:0005829]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA metabolic process [GO:0006084]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; protein homotetramerization [GO:0051289]	cytosol [GO:0005829]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003989; GO:0005524; GO:0005829; GO:0006084; GO:0006633; GO:0046872; GO:0051289; GO:2001295	acetyl-CoA metabolic process [GO:0006084]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN4790_c0_g1_i1	B2U6V1	ACSA_RALPJ	99.2	355	3	0	1066	2	231	585	1.50E-216	753.1	ACSA_RALPJ	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Rpic_2099	Ralstonia pickettii (strain 12J)	660	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN3818_c0_g1_i1	A7HSR8	ACSA_PARL1	78.7	75	16	0	227	3	297	371	4.40E-32	138.3	ACSA_PARL1	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Plav_1331	Parvibaculum lavamentivorans (strain DS-1 / DSM 13023 / NCIMB 13966)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN3818_c0_g2_i1	Q89WV5	ACSA_BRADU	96	125	5	0	376	2	297	421	3.80E-71	268.5	ACSA_BRADU	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA blr0573	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	648	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN6925_c0_g2_i1	Q2G512	ACSA_NOVAD	92.2	116	9	0	351	4	447	562	1.40E-59	229.9	ACSA_NOVAD	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Saro_2625	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	649	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN6925_c0_g1_i1	Q9A2I0	ACSA_CAUVC	82.4	102	18	0	306	1	463	564	7.00E-47	187.6	ACSA_CAUVC	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA CC_3581	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN21065_c0_g1_i1	Q9A2I0	ACSA_CAUVC	75.6	78	19	0	1	234	492	569	3.50E-30	131.7	ACSA_CAUVC	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA CC_3581	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN27639_c0_g1_i1	Q9A2I0	ACSA_CAUVC	78.1	210	46	0	644	15	435	644	8.90E-92	337.8	ACSA_CAUVC	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA CC_3581	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN11251_c0_g1_i1	Q9A2I0	ACSA_CAUVC	68.9	148	46	0	2	445	53	200	1.40E-56	220.3	ACSA_CAUVC	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA CC_3581	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN631_c0_g1_i1	Q2G512	ACSA_NOVAD	68.5	89	28	0	3	269	95	183	8.90E-30	130.6	ACSA_NOVAD	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Saro_2625	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	649	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN631_c0_g1_i2	A7HSR8	ACSA_PARL1	78.4	102	21	1	3	308	95	195	1.60E-38	159.8	ACSA_PARL1	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Plav_1331	Parvibaculum lavamentivorans (strain DS-1 / DSM 13023 / NCIMB 13966)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN3472_c0_g1_i1	A7HSR8	ACSA_PARL1	78.9	90	19	0	280	11	115	204	1.00E-36	153.7	ACSA_PARL1	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Plav_1331	Parvibaculum lavamentivorans (strain DS-1 / DSM 13023 / NCIMB 13966)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN1935_c1_g1_i1	A1UR36	ACSA_BARBK	82.9	70	12	0	1	210	238	307	8.30E-31	133.7	ACSA_BARBK	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA BARBAKC583_0101	Bartonella bacilliformis (strain ATCC 35685 / NCTC 12138 / KC583)	652	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN1935_c0_g2_i1	A8G8G7	ACSA_SERP5	68.5	73	23	0	220	2	219	291	2.50E-25	115.5	ACSA_SERP5	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acs Spro_0297	Serratia proteamaculans (strain 568)	652	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; chemotaxis [GO:0006935]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0006935; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]; chemotaxis [GO:0006935]		NA	NA	NA	NA	NA	NA
TRINITY_DN1935_c0_g2_i2	Q4UP35	ACSA_XANC8	65.9	217	74	0	653	3	218	434	4.60E-88	325.5	ACSA_XANC8	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA XC_4149	Xanthomonas campestris pv. campestris (strain 8004)	647	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN1935_c0_g3_i1	O68040	ACSA_RHOCB	92.9	70	5	0	211	2	235	304	2.10E-34	145.6	ACSA_RHOCB	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA acs RCAP_rcc02126	Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003)	656	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN33520_c0_g1_i1	Q72J95	ACSA_THET2	58	176	72	1	35	562	236	409	1.20E-63	244.2	ACSA_THET2	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA TT_C0884	Thermus thermophilus (strain HB27 / ATCC BAA-163 / DSM 7039)	648	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN31910_c0_g1_i1	B2U6V1	ACSA_RALPJ	100	94	0	0	284	3	124	217	2.80E-45	182.2	ACSA_RALPJ	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Rpic_2099	Ralstonia pickettii (strain 12J)	660	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN35811_c0_g1_i1	Q2G512	ACSA_NOVAD	83	100	17	0	2	301	52	151	4.90E-45	181.4	ACSA_NOVAD	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Saro_2625	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	649	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN7063_c1_g1_i1	Q2G512	ACSA_NOVAD	85.9	71	10	0	214	2	564	634	1.90E-30	132.5	ACSA_NOVAD	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Saro_2625	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	649	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN7063_c0_g1_i1	B2U6V1	ACSA_RALPJ	100	75	0	0	2	226	586	660	2.00E-36	152.5	ACSA_RALPJ	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Rpic_2099	Ralstonia pickettii (strain 12J)	660	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN7063_c0_g1_i2	B2U6V1	ACSA_RALPJ	75.3	77	17	1	22	246	584	660	7.20E-24	110.9	ACSA_RALPJ	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Rpic_2099	Ralstonia pickettii (strain 12J)	660	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN19437_c0_g2_i1	Q2G512	ACSA_NOVAD	73	89	24	0	269	3	253	341	8.10E-39	160.6	ACSA_NOVAD	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA Saro_2625	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	649	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN19437_c0_g1_i1	Q82EL5	ACSA_STRAW	74.1	116	30	0	3	350	338	453	7.70E-45	181	ACSA_STRAW	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA SAV_4599	Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)	652	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN19437_c0_g1_i2	Q89WV5	ACSA_BRADU	67	109	36	0	3	329	342	450	2.60E-39	162.5	ACSA_BRADU	reviewed	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	acsA blr0573	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	648	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN21688_c0_g1_i1	Q01576	ACSA_PHYB8	65.3	95	33	0	3	287	107	201	9.60E-30	130.6	ACSA_PHYB8	reviewed	Acetyl-coenzyme A synthetase (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	facA	Phycomyces blakesleeanus (strain ATCC 8743b / DSM 1359 / FGSC 10004 / NBRC 33097 / NRRL 1555)	672	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]	GO:0003987; GO:0005524; GO:0016208; GO:0019427	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN21065_c0_g2_i1	Q9I558	ACSA1_PSEAE	65.3	75	26	0	1	225	569	643	4.20E-20	98.2	ACSA1_PSEAE	reviewed	Acetyl-coenzyme A synthetase 1 (AcCoA synthetase 1) (Acs 1) (EC 6.2.1.1) (Acetate--CoA ligase 1) (Acyl-activating enzyme 1)	acsA1 PA0887	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	651	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN1935_c0_g1_i1	Q9HV66	ACSA2_PSEAE	76.8	185	43	0	555	1	215	399	2.40E-85	316.2	ACSA2_PSEAE	reviewed	Acetyl-coenzyme A synthetase 2 (AcCoA synthetase 2) (Acs 2) (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acyl-activating enzyme 2)	acsA2 acsB PA4733	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	645	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN1935_c0_g1_i2	Q9HV66	ACSA2_PSEAE	79.3	135	28	0	405	1	265	399	1.60E-62	240	ACSA2_PSEAE	reviewed	Acetyl-coenzyme A synthetase 2 (AcCoA synthetase 2) (Acs 2) (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acyl-activating enzyme 2)	acsA2 acsB PA4733	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	645	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN21688_c0_g2_i1	Q9HV66	ACSA2_PSEAE	68.1	213	68	0	643	5	231	443	1.30E-90	334	ACSA2_PSEAE	reviewed	Acetyl-coenzyme A synthetase 2 (AcCoA synthetase 2) (Acs 2) (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acyl-activating enzyme 2)	acsA2 acsB PA4733	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	645	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]		acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0003987; GO:0005524; GO:0016208; GO:0019427; GO:0046872	acetyl-CoA biosynthetic process from acetate [GO:0019427]		NA	NA	NA	NA	NA	NA
TRINITY_DN31978_c0_g1_i1	Q9NUB1	ACS2L_HUMAN	100	136	0	0	1	408	538	673	8.70E-69	260.8	ACS2L_HUMAN	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS1 ACAS2L KIAA1846	Homo sapiens (Human)	689	mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN34334_c0_g1_i1	Q9NUB1	ACS2L_HUMAN	100	110	0	0	331	2	328	437	4.00E-64	245	ACS2L_HUMAN	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS1 ACAS2L KIAA1846	Homo sapiens (Human)	689	mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN33483_c0_g1_i1	Q99NB1	ACS2L_MOUSE	66.8	229	76	0	776	90	135	363	1.30E-84	314.3	ACS2L_MOUSE	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	Acss1 Acas2 Acas2l	Mus musculus (Mouse)	682	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN33483_c0_g1_i2	Q99NB1	ACS2L_MOUSE	64.4	160	57	0	569	90	204	363	5.80E-56	218.8	ACS2L_MOUSE	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	Acss1 Acas2 Acas2l	Mus musculus (Mouse)	682	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN40028_c0_g1_i1	Q9NUB1	ACS2L_HUMAN	97.9	95	2	0	1	285	170	264	5.00E-47	188	ACS2L_HUMAN	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS1 ACAS2L KIAA1846	Homo sapiens (Human)	689	mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN11130_c5_g1_i1	Q99NB1	ACS2L_MOUSE	63.9	310	111	1	22	951	361	669	1.80E-120	433.7	ACS2L_MOUSE	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	Acss1 Acas2 Acas2l	Mus musculus (Mouse)	682	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN20418_c0_g1_i2	Q99NB1	ACS2L_MOUSE	41.9	117	60	1	142	492	29	137	1.00E-18	94.7	ACS2L_MOUSE	reviewed	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	Acss1 Acas2 Acas2l	Mus musculus (Mouse)	682	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN34712_c0_g1_i1	Q9NR19	ACSA_HUMAN	100	93	0	0	282	4	300	392	3.50E-53	208.4	ACSA_HUMAN	reviewed	"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS2 ACAS2	Homo sapiens (Human)	701	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN20604_c0_g1_i1	Q9NR19	ACSA_HUMAN	99.5	193	1	0	2	580	444	636	7.90E-116	417.5	ACSA_HUMAN	reviewed	"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS2 ACAS2	Homo sapiens (Human)	701	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN20604_c0_g1_i2	Q9NR19	ACSA_HUMAN	72.1	219	2	1	2	481	444	662	1.30E-87	323.6	ACSA_HUMAN	reviewed	"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS2 ACAS2	Homo sapiens (Human)	701	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN37057_c0_g1_i1	Q9NR19	ACSA_HUMAN	97.8	89	2	0	269	3	130	218	7.10E-43	174.1	ACSA_HUMAN	reviewed	"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS2 ACAS2	Homo sapiens (Human)	701	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN2893_c0_g1_i1	Q9NR19	ACSA_HUMAN	64	677	237	3	2130	103	26	696	3.30E-271	935.6	ACSA_HUMAN	reviewed	"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS2 ACAS2	Homo sapiens (Human)	701	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]		blue	blue	NA	NA	NA	NA
TRINITY_DN31138_c0_g1_i1	Q9NR19	ACSA_HUMAN	97.2	141	4	0	1	423	387	527	7.90E-81	300.8	ACSA_HUMAN	reviewed	"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)"	ACSS2 ACAS2	Homo sapiens (Human)	701	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0008610; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0043231; GO:0050218	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610]; propionate biosynthetic process [GO:0019542]		NA	NA	NA	NA	NA	NA
TRINITY_DN9137_c0_g1_i1	O00400	ACATN_HUMAN	51.3	349	161	4	53	1087	200	543	3.30E-92	340.1	ACATN_HUMAN	reviewed	Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)	SLC33A1 ACATN AT1	Homo sapiens (Human)	549	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]	GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395	BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN9137_c0_g1_i2	O00400	ACATN_HUMAN	56	468	197	4	214	1605	81	543	8.30E-145	515.4	ACATN_HUMAN	reviewed	Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)	SLC33A1 ACATN AT1	Homo sapiens (Human)	549	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]	GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395	BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN40376_c0_g1_i1	O00400	ACATN_HUMAN	100	104	0	0	2	313	124	227	4.20E-55	214.9	ACATN_HUMAN	reviewed	Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)	SLC33A1 ACATN AT1	Homo sapiens (Human)	549	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]	GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395	BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN16852_c0_g1_i1	O00400	ACATN_HUMAN	64.1	64	23	0	195	4	164	227	4.30E-16	84.7	ACATN_HUMAN	reviewed	Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)	SLC33A1 ACATN AT1	Homo sapiens (Human)	549	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]	GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395	BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN16852_c0_g2_i1	O00400	ACATN_HUMAN	55.4	83	37	0	256	8	74	156	1.60E-20	99.8	ACATN_HUMAN	reviewed	Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)	SLC33A1 ACATN AT1	Homo sapiens (Human)	549	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]	GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395	BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN28649_c0_g1_i1	Q13510	ASAH1_HUMAN	100	77	0	0	2	232	319	395	5.70E-42	171	ASAH1_HUMAN	reviewed	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein) (PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	ASAH1 ASAH HSD-33 HSD33	Homo sapiens (Human)	395	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; glycosphingolipid metabolic process [GO:0006687]; keratinocyte differentiation [GO:0030216]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neutrophil degranulation [GO:0043312]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]"	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]	"ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]"	GO:0003714; GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0006687; GO:0016810; GO:0016811; GO:0016922; GO:0017040; GO:0017064; GO:0030216; GO:0043202; GO:0043312; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0070062; GO:0071356; GO:0102121; GO:1903507; GO:1904724; GO:1904813	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; glycosphingolipid metabolic process [GO:0006687]; keratinocyte differentiation [GO:0030216]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neutrophil degranulation [GO:0043312]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN2016_c0_g1_i1	A5A6P2	ASAH1_PANTR	47.6	349	177	3	1077	46	48	395	2.10E-98	360.5	ASAH1_PANTR	reviewed	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	ASAH1	Pan troglodytes (Chimpanzee)	395	"extracellular space [GO:0005615]; lysosome [GO:0005764]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]"	extracellular space [GO:0005615]; lysosome [GO:0005764]	"ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]"	GO:0005615; GO:0005764; GO:0006631; GO:0016810; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN33629_c0_g1_i1	Q9WV54	ASAH1_MOUSE	100	92	0	0	1	276	92	183	2.80E-50	198.7	ASAH1_MOUSE	reviewed	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	Asah1 Asah	Mus musculus (Mouse)	394	"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; lung development [GO:0030324]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]"	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]	"ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]"	GO:0003714; GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0010033; GO:0016810; GO:0016811; GO:0016922; GO:0017040; GO:0017064; GO:0030216; GO:0030324; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121; GO:1903507	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; lung development [GO:0030324]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN33862_c0_g1_i1	Q9WV54	ASAH1_MOUSE	100	96	0	0	3	290	215	310	5.80E-51	201.1	ASAH1_MOUSE	reviewed	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	Asah1 Asah	Mus musculus (Mouse)	394	"extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; lung development [GO:0030324]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]"	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]	"ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]"	GO:0003714; GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0010033; GO:0016810; GO:0016811; GO:0016922; GO:0017040; GO:0017064; GO:0030216; GO:0030324; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121; GO:1903507	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; lung development [GO:0030324]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN1196_c1_g1_i3	A0A0P6JG37	ASAH1_HETGA	46.1	369	190	5	1248	157	31	395	9.00E-97	355.5	ASAH1_HETGA	reviewed	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	ASAH1	Heterocephalus glaber (Naked mole rat)	395	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]	ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]	GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]		blue	blue	NA	NA	NA	NA
TRINITY_DN13768_c0_g1_i1	A0A0P6JG37	ASAH1_HETGA	57.1	42	18	0	2	127	354	395	2.90E-08	58.9	ASAH1_HETGA	reviewed	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	ASAH1	Heterocephalus glaber (Naked mole rat)	395	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleus [GO:0005634]	ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]	GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN9139_c0_g1_i1	Q8BX37	ACP7_MOUSE	52.8	89	42	0	45	311	76	164	1.60E-22	106.7	ACP7_MOUSE	reviewed	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	Acp7 Papl Papl1	Mus musculus (Mouse)	438	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	GO:0003993; GO:0005576; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3921_c0_g1_i1	A5D6U8	ACP7_DANRE	60.8	74	26	2	220	2	209	280	3.80E-18	91.7	ACP7_DANRE	reviewed	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	acp7 papl zgc:162913	Danio rerio (Zebrafish) (Brachydanio rerio)	443	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	GO:0003993; GO:0005576; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1694_c0_g1_i1	A5D6U8	ACP7_DANRE	55.4	413	175	5	1261	41	30	439	2.80E-135	483.4	ACP7_DANRE	reviewed	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	acp7 papl zgc:162913	Danio rerio (Zebrafish) (Brachydanio rerio)	443	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	GO:0003993; GO:0005576; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1694_c0_g1_i2	A5D6U8	ACP7_DANRE	55.4	413	175	5	1261	41	30	439	2.90E-135	483.4	ACP7_DANRE	reviewed	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	acp7 papl zgc:162913	Danio rerio (Zebrafish) (Brachydanio rerio)	443	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	GO:0003993; GO:0005576; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1694_c0_g1_i6	A5D6U8	ACP7_DANRE	55.4	413	175	5	1261	41	30	439	2.90E-135	483.4	ACP7_DANRE	reviewed	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	acp7 papl zgc:162913	Danio rerio (Zebrafish) (Brachydanio rerio)	443	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]	GO:0003993; GO:0005576; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN26593_c0_g1_i1	Q92485	ASM3B_HUMAN	35.7	308	189	5	212	1117	21	325	2.00E-54	214.5	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B ASMLPD	Homo sapiens (Human)	455	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]		NA	NA	NA	NA	NA	NA
TRINITY_DN5373_c0_g1_i1	Q92485	ASM3B_HUMAN	40.8	439	236	8	170	1474	16	434	9.50E-95	349	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B ASMLPD	Homo sapiens (Human)	455	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]		NA	NA	NA	NA	NA	NA
TRINITY_DN5373_c0_g1_i2	Q92485	ASM3B_HUMAN	40.8	434	233	8	86	1375	21	434	1.50E-94	348.2	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B ASMLPD	Homo sapiens (Human)	455	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]		NA	NA	NA	NA	NA	NA
TRINITY_DN5373_c0_g1_i3	Q92485	ASM3B_HUMAN	40.8	439	236	8	146	1450	16	434	9.40E-95	349	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B ASMLPD	Homo sapiens (Human)	455	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]		NA	NA	NA	NA	NA	NA
TRINITY_DN27647_c0_g1_i1	A6QM00	GADL1_BOVIN	51.2	123	60	0	389	21	84	206	1.40E-31	137.1	GADL1_BOVIN	reviewed	Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1)	GADL1	Bos taurus (Bovine)	521	aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]		aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]	GO:0004068; GO:0004782; GO:0019752; GO:0030170	carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN10699_c1_g1_i1	Q80WP8	GADL1_MOUSE	47.1	155	78	3	487	23	400	550	2.10E-37	156.8	GADL1_MOUSE	reviewed	Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1)	Gadl1	Mus musculus (Mouse)	550	aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]		aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]	GO:0004068; GO:0004782; GO:0019752; GO:0030170	carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN24448_c0_g1_i1	Q80WP8	GADL1_MOUSE	54	50	22	1	213	64	446	494	8.70E-10	64.3	GADL1_MOUSE	reviewed	Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1)	Gadl1	Mus musculus (Mouse)	550	aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]		aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]	GO:0004068; GO:0004782; GO:0019752; GO:0030170	carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN36273_c0_g1_i1	Q28D99	GADL1_XENTR	54.3	324	147	1	970	2	39	362	2.60E-101	370.2	GADL1_XENTR	reviewed	Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1) (Fragment)	gadl1 TGas121d14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	511	aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]		aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]	GO:0004068; GO:0004782; GO:0019752; GO:0030170	carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN2680_c0_g1_i1	O46431	FIBP_CHLAE	45.9	366	185	4	342	1430	1	356	2.30E-87	324.3	FIBP_CHLAE	reviewed	Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein)	FIBP	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	357	endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]	endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634]	fibroblast growth factor binding [GO:0017134]	GO:0005634; GO:0012505; GO:0016020; GO:0017134			NA	NA	NA	NA	NA	NA
TRINITY_DN2680_c0_g1_i11	O46431	FIBP_CHLAE	45.9	366	185	4	216	1304	1	356	2.10E-87	324.3	FIBP_CHLAE	reviewed	Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein)	FIBP	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	357	endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]	endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634]	fibroblast growth factor binding [GO:0017134]	GO:0005634; GO:0012505; GO:0016020; GO:0017134			NA	NA	NA	NA	NA	NA
TRINITY_DN2868_c0_g1_i1	Q28XE2	AN32A_DROPS	67.9	156	47	1	549	91	1	156	5.20E-51	202.2	AN32A_DROPS	reviewed	Acidic leucine-rich nuclear phosphoprotein 32 family member A	Anp32a Mapmodulin GA19125	Drosophila pseudoobscura pseudoobscura (Fruit fly)	263	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0005634; GO:0005737; GO:0005783; GO:0006913; GO:0048471	nucleocytoplasmic transport [GO:0006913]		NA	NA	NA	NA	NA	NA
TRINITY_DN35219_c0_g1_i1	Q9EST6	AN32B_RAT	98.9	91	1	0	274	2	37	127	2.20E-44	179.1	AN32B_RAT	reviewed	Acidic leucine-rich nuclear phosphoprotein 32 family member B (Proliferation-related acidic leucine-rich protein PAL31)	Anp32b Pal31	Rattus norvegicus (Rat)	272	cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone binding [GO:0042393]; RNA polymerase binding [GO:0070063]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein export from nucleus [GO:0046827]; regulation of apoptotic process [GO:0042981]; roof of mouth development [GO:0060021]; vasculature development [GO:0001944]; ventricular system development [GO:0021591]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	histone binding [GO:0042393]; RNA polymerase binding [GO:0070063]	GO:0001944; GO:0005634; GO:0005737; GO:0006334; GO:0006919; GO:0008284; GO:0021591; GO:0042393; GO:0042981; GO:0043066; GO:0045596; GO:0046827; GO:0048839; GO:0060021; GO:0070063; GO:1900087	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein export from nucleus [GO:0046827]; regulation of apoptotic process [GO:0042981]; roof of mouth development [GO:0060021]; vasculature development [GO:0001944]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN36400_c0_g1_i1	Q9EST6	AN32B_RAT	85.3	95	14	0	286	2	49	143	7.80E-40	164.1	AN32B_RAT	reviewed	Acidic leucine-rich nuclear phosphoprotein 32 family member B (Proliferation-related acidic leucine-rich protein PAL31)	Anp32b Pal31	Rattus norvegicus (Rat)	272	cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone binding [GO:0042393]; RNA polymerase binding [GO:0070063]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein export from nucleus [GO:0046827]; regulation of apoptotic process [GO:0042981]; roof of mouth development [GO:0060021]; vasculature development [GO:0001944]; ventricular system development [GO:0021591]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	histone binding [GO:0042393]; RNA polymerase binding [GO:0070063]	GO:0001944; GO:0005634; GO:0005737; GO:0006334; GO:0006919; GO:0008284; GO:0021591; GO:0042393; GO:0042981; GO:0043066; GO:0045596; GO:0046827; GO:0048839; GO:0060021; GO:0070063; GO:1900087	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein export from nucleus [GO:0046827]; regulation of apoptotic process [GO:0042981]; roof of mouth development [GO:0060021]; vasculature development [GO:0001944]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN39355_c0_g1_i1	Q9BTT0	AN32E_HUMAN	100	92	0	0	277	2	38	129	8.60E-44	177.2	AN32E_HUMAN	reviewed	Acidic leucine-rich nuclear phosphoprotein 32 family member E (LANP-like protein) (LANP-L)	ANP32E	Homo sapiens (Human)	268	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone binding [GO:0042393]; phosphatase inhibitor activity [GO:0019212]; histone exchange [GO:0043486]; regulation of apoptotic process [GO:0042981]	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	histone binding [GO:0042393]; phosphatase inhibitor activity [GO:0019212]	GO:0000812; GO:0005634; GO:0019212; GO:0031410; GO:0042393; GO:0042981; GO:0043486	histone exchange [GO:0043486]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN17711_c0_g1_i2	Q95M17	CHIA_BOVIN	36	172	90	7	598	116	236	398	9.00E-17	88.6	CHIA_BOVIN	reviewed	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)	CHIA	Bos taurus (Bovine)	472	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197	apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]	xx	black	black	1	NA	1	1
TRINITY_DN17711_c0_g1_i6	Q95M17	CHIA_BOVIN	37.3	169	92	6	598	116	236	398	1.30E-18	94.7	CHIA_BOVIN	reviewed	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)	CHIA	Bos taurus (Bovine)	472	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197	apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]	xx	black	black	1	NA	1	1
TRINITY_DN40540_c0_g1_i1	Q95M17	CHIA_BOVIN	61.4	44	17	0	13	144	20	63	9.40E-11	67	CHIA_BOVIN	reviewed	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)	CHIA	Bos taurus (Bovine)	472	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197	apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]		NA	NA	NA	NA	NA	NA
TRINITY_DN32655_c0_g1_i2	Q95M17	CHIA_BOVIN	50	148	73	1	808	365	241	387	2.70E-40	167.2	CHIA_BOVIN	reviewed	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)	CHIA	Bos taurus (Bovine)	472	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197	apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]		NA	NA	NA	NA	NA	NA
TRINITY_DN11288_c0_g1_i1	Q91XA9	CHIA_MOUSE	52	75	29	2	212	3	111	183	4.20E-14	78.2	CHIA_MOUSE	reviewed	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (YNL)	Chia Chia1	Mus musculus (Mouse)	473	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]; kinase binding [GO:0019900]	GO:0000272; GO:0001878; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0006955; GO:0008061; GO:0019900; GO:0052356; GO:0090197	apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]		NA	NA	NA	NA	NA	NA
TRINITY_DN22982_c0_g1_i1	Q96QF7	ACRC_HUMAN	43.5	161	91	0	1520	2002	512	672	4.60E-37	157.9	ACRC_HUMAN	reviewed	Acidic repeat-containing protein (Germ cell nuclear antigen)	GCNA ACRC	Homo sapiens (Human)	691	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12745_c0_g1_i1	Q99KI0	ACON_MOUSE	80	60	12	0	2	181	116	175	1.50E-23	109.8	ACON_MOUSE	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	Aco2	Mus musculus (Mouse)	780	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0043209; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN12274_c0_g1_i1	P16276	ACON_PIG	74.7	359	91	0	1080	4	338	696	1.40E-161	570.5	ACON_PIG	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Sus scrofa (Pig)	781	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; metal ion binding [GO:0046872]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; metal ion binding [GO:0046872]"	GO:0003994; GO:0005739; GO:0005829; GO:0006099; GO:0046872; GO:0047780; GO:0051539	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN15379_c0_g2_i1	Q99KI0	ACON_MOUSE	100	239	0	0	719	3	352	590	4.10E-138	491.9	ACON_MOUSE	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	Aco2	Mus musculus (Mouse)	780	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0043209; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN15379_c0_g1_i1	Q99798	ACON_HUMAN	100	111	0	0	335	3	540	650	5.50E-61	234.6	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN18108_c0_g1_i1	Q99798	ACON_HUMAN	99	105	1	0	317	3	145	249	6.00E-57	221.1	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN18050_c0_g1_i1	Q99798	ACON_HUMAN	100	160	0	0	482	3	347	506	2.80E-90	332.4	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c8_g1_i1	Q99798	ACON_HUMAN	100	94	0	0	282	1	229	322	2.60E-48	192.2	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i1	Q99798	ACON_HUMAN	68.9	45	14	0	67	201	133	177	6.30E-13	74.7	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i17	Q99798	ACON_HUMAN	84	187	30	0	67	627	133	319	2.80E-90	332.8	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i2	Q99798	ACON_HUMAN	67.6	37	12	0	523	633	133	169	1.60E-08	61.2	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i24	Q99798	ACON_HUMAN	51.4	70	30	1	67	276	133	198	7.50E-13	75.9	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i37	Q99798	ACON_HUMAN	67.6	37	12	0	245	355	133	169	8.90E-09	61.2	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i4	Q99798	ACON_HUMAN	67.6	37	12	0	435	545	133	169	1.40E-08	61.2	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i41	Q99798	ACON_HUMAN	67.6	37	12	0	597	707	133	169	1.80E-08	61.2	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i42	Q99798	ACON_HUMAN	67.6	37	12	0	520	630	133	169	3.50E-08	60.1	ACON_HUMAN	reviewed	"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)"	ACO2	Homo sapiens (Human)	780	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]"	GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539	citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c3_g1_i1	O17320	ACT_CRAGI	83.7	104	17	0	1	312	153	256	3.40E-41	168.7	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c4_g1_i1	O17320	ACT_CRAGI	82.2	107	19	0	324	4	193	299	5.90E-44	177.9	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN15426_c0_g4_i1	O17320	ACT_CRAGI	93.1	87	6	0	2	262	184	270	9.30E-40	163.7	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN24153_c0_g1_i1	P14235	ACT_CANAX	94.6	37	2	0	212	102	340	376	4.90E-15	81.3	ACT_CANAX	reviewed	Actin	ACT1	Candida albicans (Yeast)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN23435_c2_g1_i1	O17320	ACT_CRAGI	95.9	73	3	0	222	4	181	253	1.60E-32	139.4	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i1	P26182	ACT_ACHBI	89.4	369	39	0	30	1136	1	369	2.20E-194	679.5	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i11	P26182	ACT_ACHBI	89.7	369	38	0	62	1168	1	369	1.00E-194	680.6	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i13	P26182	ACT_ACHBI	89.9	376	38	0	62	1189	1	376	6.50E-200	698	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i21	P26182	ACT_ACHBI	89.9	376	38	0	62	1189	1	376	6.50E-200	698	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i25	P53476	ACT_TOXGO	86.3	219	30	0	2	658	158	376	3.60E-110	399.1	ACT_TOXGO	reviewed	Actin	ACT1	Toxoplasma gondii	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i27	P26182	ACT_ACHBI	89.9	376	38	0	62	1189	1	376	8.50E-200	697.6	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	1
TRINITY_DN611_c0_g1_i3	P26182	ACT_ACHBI	89.9	376	38	0	62	1189	1	376	6.50E-200	698	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i4	P26182	ACT_ACHBI	90.7	257	24	0	62	832	1	257	6.40E-135	481.5	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i5	P26182	ACT_ACHBI	90.7	257	24	0	62	832	1	257	6.40E-135	481.5	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i6	P26182	ACT_ACHBI	89.9	376	38	0	62	1189	1	376	6.50E-200	698	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN8084_c1_g1_i1	O17320	ACT_CRAGI	91.5	82	7	0	247	2	133	214	9.20E-37	153.7	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c1_g1_i7	O17320	ACT_CRAGI	90.5	95	9	0	3	287	143	237	7.00E-41	167.5	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i1	O65316	ACT_MESVI	95.5	154	7	0	3	464	18	171	1.90E-83	309.7	ACT_MESVI	reviewed	Actin		Mesostigma viride (Green alga)	377	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i12	O65316	ACT_MESVI	95.5	154	7	0	3	464	18	171	1.90E-83	309.7	ACT_MESVI	reviewed	Actin		Mesostigma viride (Green alga)	377	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c4_g1_i1	O17320	ACT_CRAGI	90	90	9	0	272	3	147	236	2.10E-39	162.5	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN29733_c3_g1_i1	O17320	ACT_CRAGI	79.1	91	19	0	3	275	190	280	2.10E-34	146	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN35371_c1_g1_i4	O17320	ACT_CRAGI	93.9	98	6	0	1	294	162	259	3.60E-47	189.5	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN35371_c1_g1_i4	O17320	ACT_CRAGI	81.6	103	19	0	291	599	259	361	1.20E-42	174.5	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN7034_c3_g1_i1	O17320	ACT_CRAGI	88.6	176	20	0	2	529	86	261	5.60E-84	311.6	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN7034_c4_g1_i1	O17320	ACT_CRAGI	86.2	80	11	0	1	240	162	241	2.50E-31	135.6	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i2	O17320	ACT_CRAGI	91.7	108	9	0	324	1	143	250	2.90E-51	202.2	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i4	O17320	ACT_CRAGI	90.5	95	9	0	285	1	143	237	1.20E-43	176.8	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i6	O17320	ACT_CRAGI	88.8	89	10	0	269	3	176	264	4.30E-40	164.9	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i7	O17320	ACT_CRAGI	89.9	89	9	0	269	3	176	264	1.90E-40	166	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN20527_c0_g2_i1	O17320	ACT_CRAGI	93	115	8	0	347	3	149	263	2.50E-56	219.2	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN20527_c0_g1_i1	O17320	ACT_CRAGI	88.6	88	10	0	266	3	214	301	1.90E-40	166	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN23473_c1_g1_i1	P48465	ACT_CRYNH	89.3	56	6	0	1	168	62	117	1.90E-23	109.4	ACT_CRYNH	reviewed	Actin	CNAG_00483	Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN23473_c1_g1_i1	P48465	ACT_CRYNH	80	30	6	0	152	241	113	142	1.40E-05	50.1	ACT_CRYNH	reviewed	Actin	CNAG_00483	Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26588_c3_g1_i1	O17320	ACT_CRAGI	93	129	9	0	388	2	143	271	6.80E-63	241.1	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26588_c3_g1_i2	O17320	ACT_CRAGI	88.9	108	12	0	325	2	143	250	5.20E-48	191.4	ACT_CRAGI	reviewed	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26588_c1_g1_i1	P26182	ACT_ACHBI	90.7	107	10	0	388	68	270	376	7.00E-52	204.5	ACT_ACHBI	reviewed	Actin		Achlya bisexualis (Water mold)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN38985_c0_g1_i1	P45521	ACT_PROCL	78.9	123	26	0	396	28	200	322	1.30E-56	220.3	ACT_PROCL	reviewed	Actin (Fragment)		Procambarus clarkii (Red swamp crayfish)	322	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i13	P45521	ACT_PROCL	95.8	72	3	0	1	216	251	322	1.10E-35	150.2	ACT_PROCL	reviewed	Actin (Fragment)		Procambarus clarkii (Red swamp crayfish)	322	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i4	P45521	ACT_PROCL	95.8	72	3	0	1	216	251	322	2.20E-35	149.4	ACT_PROCL	reviewed	Actin (Fragment)		Procambarus clarkii (Red swamp crayfish)	322	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	1	1
TRINITY_DN19513_c1_g1_i1	P45521	ACT_PROCL	90.9	77	7	0	3	233	245	321	4.40E-37	154.8	ACT_PROCL	reviewed	Actin (Fragment)		Procambarus clarkii (Red swamp crayfish)	322	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN8670_c0_g1_i1	P53491	ACT_ACEPE	56.7	120	52	0	2	361	64	183	1.60E-34	146.7	ACT_ACEPE	reviewed	Actin (Fragment)		Acetabularia peniculus (Green alga) (Polyphysa peniculus)	353	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i9	P45521	ACT_PROCL	95.8	72	3	0	1	216	251	322	1.70E-35	149.8	ACT_PROCL	reviewed	Actin (Fragment)		Procambarus clarkii (Red swamp crayfish)	322	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	1	NA	NA	1
TRINITY_DN26515_c0_g2_i1	P69002	ACT1_HELER	87.7	73	9	0	220	2	65	137	1.80E-31	136	ACT1_HELER	reviewed	"Actin CyI, cytoplasmic"		Heliocidaris erythrogramma (Sea urchin)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26910_c0_g1_i1	P41339	ACTA_LIMPO	89.1	110	12	0	331	2	1	110	4.50E-53	208.4	ACTA_LIMPO	reviewed	"Actin, acrosomal process isoform (Actin-5)"		Limulus polyphemus (Atlantic horseshoe crab)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN4435_c2_g1_i1	P41339	ACTA_LIMPO	90.5	84	8	0	2	253	186	269	3.00E-35	148.7	ACTA_LIMPO	reviewed	"Actin, acrosomal process isoform (Actin-5)"		Limulus polyphemus (Atlantic horseshoe crab)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN29733_c0_g1_i1	Q26065	ACT_PLAMG	94.9	79	4	0	1	237	266	344	1.60E-38	159.5	ACT_PLAMG	reviewed	"Actin, adductor muscle"		Placopecten magellanicus (Sea scallop)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			black	black	NA	NA	NA	1
TRINITY_DN19513_c0_g1_i3	Q26065	ACT_PLAMG	94.9	137	7	0	468	58	240	376	1.00E-73	277.3	ACT_PLAMG	reviewed	"Actin, adductor muscle"		Placopecten magellanicus (Sea scallop)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19513_c0_g1_i8	Q26065	ACT_PLAMG	94	134	8	0	402	1	240	373	4.60E-70	265	ACT_PLAMG	reviewed	"Actin, adductor muscle"		Placopecten magellanicus (Sea scallop)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN38004_c0_g1_i1	P10995	ACT2_XENLA	100	68	0	0	3	206	195	262	5.60E-32	137.5	ACT2_XENLA	reviewed	"Actin, alpha skeletal muscle 2 (Actin alpha 2) (alpha2) (alpha2p)"	act2	Xenopus laevis (African clawed frog)	377	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN37969_c0_g1_i1	P62739	ACTA_BOVIN	100	63	0	0	23	211	1	63	6.40E-31	134	ACTA_BOVIN	reviewed	"Actin, aortic smooth muscle (Alpha-actin-2) [Cleaved into: Actin, aortic smooth muscle, intermediate form]"	ACTA2 ACTSA ACTVS	Bos taurus (Bovine)	377	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; smooth muscle contractile fiber [GO:0030485]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; glomerular mesangial cell development [GO:0072144]; mesenchyme migration [GO:0090131]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; response to virus [GO:0009615]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; vascular associated smooth muscle contraction [GO:0014829]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; smooth muscle contractile fiber [GO:0030485]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]	GO:0001725; GO:0005524; GO:0005737; GO:0005865; GO:0005869; GO:0005884; GO:0008217; GO:0009615; GO:0010628; GO:0014829; GO:0015629; GO:0019901; GO:0030027; GO:0030175; GO:0030240; GO:0030485; GO:0044297; GO:0048741; GO:0072144; GO:0090131	glomerular mesangial cell development [GO:0072144]; mesenchyme migration [GO:0090131]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; response to virus [GO:0009615]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; vascular associated smooth muscle contraction [GO:0014829]		NA	NA	NA	NA	NA	NA
TRINITY_DN30542_c0_g1_i1	P62739	ACTA_BOVIN	100	121	0	0	1	363	73	193	2.10E-66	252.7	ACTA_BOVIN	reviewed	"Actin, aortic smooth muscle (Alpha-actin-2) [Cleaved into: Actin, aortic smooth muscle, intermediate form]"	ACTA2 ACTSA ACTVS	Bos taurus (Bovine)	377	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; smooth muscle contractile fiber [GO:0030485]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; glomerular mesangial cell development [GO:0072144]; mesenchyme migration [GO:0090131]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; response to virus [GO:0009615]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; vascular associated smooth muscle contraction [GO:0014829]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; smooth muscle contractile fiber [GO:0030485]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]	GO:0001725; GO:0005524; GO:0005737; GO:0005865; GO:0005869; GO:0005884; GO:0008217; GO:0009615; GO:0010628; GO:0014829; GO:0015629; GO:0019901; GO:0030027; GO:0030175; GO:0030240; GO:0030485; GO:0044297; GO:0048741; GO:0072144; GO:0090131	glomerular mesangial cell development [GO:0072144]; mesenchyme migration [GO:0090131]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; response to virus [GO:0009615]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; vascular associated smooth muscle contraction [GO:0014829]		NA	NA	NA	NA	NA	NA
TRINITY_DN9245_c0_g1_i1	P18600	ACT1_ARTSX	100	41	0	0	19	141	1	41	9.20E-18	90.5	ACT1_ARTSX	reviewed	"Actin, clone 205"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c1_g1_i3	P18600	ACT1_ARTSX	97.9	47	1	0	142	2	1	47	1.10E-20	100.1	ACT1_ARTSX	reviewed	"Actin, clone 205"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c3_g1_i1	P18600	ACT1_ARTSX	92.5	67	5	0	202	2	133	199	1.30E-28	126.3	ACT1_ARTSX	reviewed	"Actin, clone 205"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c1_g1_i1	P18600	ACT1_ARTSX	97.9	47	1	0	142	2	1	47	1.90E-20	99.4	ACT1_ARTSX	reviewed	"Actin, clone 205"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			black	black	1	NA	NA	NA
TRINITY_DN1209_c1_g1_i2	P18600	ACT1_ARTSX	97.9	47	1	0	142	2	1	47	1.50E-20	99.8	ACT1_ARTSX	reviewed	"Actin, clone 205"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			black	black	1	NA	NA	1
TRINITY_DN2014_c6_g1_i1	P18602	ACT3_ARTSX	93.3	119	8	0	358	2	33	151	9.30E-59	227.3	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c5_g1_i1	P18602	ACT3_ARTSX	75.7	74	18	0	224	3	153	226	6.20E-24	110.9	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN495_c55_g1_i2	P18602	ACT3_ARTSX	91.7	24	2	0	2	73	227	250	3.30E-06	52	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN23385_c0_g1_i1	P18602	ACT3_ARTSX	91.9	62	5	0	205	20	123	184	1.70E-25	115.9	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26515_c4_g1_i1	P18602	ACT3_ARTSX	84.8	112	17	0	1	336	80	191	1.00E-43	177.2	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c1_g1_i2	P18602	ACT3_ARTSX	89.8	127	13	0	3	383	62	188	7.20E-57	221.1	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c1_g1_i9	P18602	ACT3_ARTSX	93.8	130	8	0	2	391	26	155	2.80E-64	245.7	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN6602_c1_g1_i1	P18602	ACT3_ARTSX	88.3	103	12	0	2	310	3	105	2.20E-48	192.6	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g4_i1	P18602	ACT3_ARTSX	90.5	105	10	0	2	316	132	236	1.00E-48	193.7	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g4_i2	P18602	ACT3_ARTSX	91	111	10	0	2	334	126	236	3.50E-52	205.3	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g1_i2	P18602	ACT3_ARTSX	98.6	69	1	0	209	3	94	162	6.70E-33	140.6	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g1_i4	P18602	ACT3_ARTSX	92.5	67	5	0	1	201	112	178	9.70E-29	126.7	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c2_g1_i1	P18602	ACT3_ARTSX	88.3	111	13	0	335	3	71	181	2.10E-47	189.5	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN4435_c0_g1_i1	P18602	ACT3_ARTSX	96.4	84	3	0	1	252	91	174	1.20E-39	163.3	ACT3_ARTSX	reviewed	"Actin, clone 302 (Fragment)"		Artemia sp. (Brine shrimp)	327	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21454_c1_g1_i1	P18603	ACT4_ARTSX	87.2	94	12	0	1	282	258	351	2.40E-41	169.1	ACT4_ARTSX	reviewed	"Actin, clone 403"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21456_c0_g1_i1	P18603	ACT4_ARTSX	91.5	94	8	0	1	282	261	354	3.90E-44	178.3	ACT4_ARTSX	reviewed	"Actin, clone 403"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c1_g1_i1	P18603	ACT4_ARTSX	88.9	108	12	0	2	325	267	374	4.70E-49	194.9	ACT4_ARTSX	reviewed	"Actin, clone 403"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17980_c2_g1_i2	P18603	ACT4_ARTSX	89	82	9	0	248	3	236	317	4.10E-37	154.8	ACT4_ARTSX	reviewed	"Actin, clone 403"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN28091_c0_g1_i1	P18603	ACT4_ARTSX	87	77	10	0	4	234	237	313	9.90E-33	140.2	ACT4_ARTSX	reviewed	"Actin, clone 403"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN29646_c0_g1_i1	P18603	ACT4_ARTSX	93.9	114	7	0	3	344	263	376	1.30E-58	226.9	ACT4_ARTSX	reviewed	"Actin, clone 403"		Artemia sp. (Brine shrimp)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN11688_c6_g1_i1	Q00215	ACTC_STYPL	94.8	77	4	0	1	231	40	116	9.10E-39	160.2	ACTC_STYPL	reviewed	"Actin, cytoplasmic"		Styela plicata (Wrinkled sea squirt) (Ascidia plicata)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26490_c4_g1_i1	Q93131	ACTC_BRAFL	90.6	191	18	0	575	3	70	260	1.20E-95	350.5	ACTC_BRAFL	reviewed	"Actin, cytoplasmic (BfCA1) [Cleaved into: Actin, cytoplasmic, N-terminally processed]"		Branchiostoma floridae (Florida lancelet) (Amphioxus)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i5	Q964E1	ACTC_BIOOB	91.7	168	14	0	65	568	3	170	1.50E-87	323.6	ACTC_BIOOB	reviewed	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"		Biomphalaria obstructa (Bloodfluke planorb) (Freshwater snail)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i6	Q964E1	ACTC_BIOOB	92.3	168	13	0	65	568	3	170	2.30E-88	326.2	ACTC_BIOOB	reviewed	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"		Biomphalaria obstructa (Bloodfluke planorb) (Freshwater snail)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN22077_c0_g1_i1	Q964D9	ACTC_PLATR	90.2	92	9	0	3	278	68	159	3.30E-43	175.3	ACTC_PLATR	reviewed	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"		Planorbella trivolvis (Marsh rams-horn) (Helisoma trivolvis)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g3_i1	P68142	ACTB1_TAKRU	95.5	66	3	0	200	3	229	294	2.30E-30	132.1	ACTB1_TAKRU	reviewed	"Actin, cytoplasmic 1 (Beta-actin A) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN35908_c0_g1_i1	P68142	ACTB1_TAKRU	94.9	79	4	0	5	241	229	307	9.60E-39	160.2	ACTB1_TAKRU	reviewed	"Actin, cytoplasmic 1 (Beta-actin A) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c0_g2_i1	P68142	ACTB1_TAKRU	93	71	5	0	3	215	229	299	7.70E-32	137.1	ACTB1_TAKRU	reviewed	"Actin, cytoplasmic 1 (Beta-actin A) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN31304_c0_g1_i1	P68142	ACTB1_TAKRU	84.9	73	11	0	221	3	231	303	1.40E-29	129.8	ACTB1_TAKRU	reviewed	"Actin, cytoplasmic 1 (Beta-actin A) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c3_g1_i1	O93400	ACTB_XENLA	95.4	109	5	0	327	1	207	315	7.50E-55	214.2	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN26515_c3_g1_i1	O93400	ACTB_XENLA	83.8	111	18	0	1	333	185	295	3.80E-46	185.3	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN26490_c0_g1_i1	O93400	ACTB_XENLA	90.2	122	12	0	2	367	202	323	4.80E-58	224.9	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN25713_c1_g1_i1	O93400	ACTB_XENLA	88.2	68	8	0	3	206	212	279	1.10E-27	123.2	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN29743_c2_g1_i1	O93400	ACTB_XENLA	88.9	108	12	0	5	328	218	325	3.30E-50	198.7	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN21575_c0_g1_i1	O93400	ACTB_XENLA	91.8	110	9	0	1	330	227	336	7.80E-52	204.1	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN35371_c1_g1_i2	O93400	ACTB_XENLA	95.5	133	6	0	1	399	161	293	2.20E-69	262.7	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			blue	blue	NA	NA	NA	NA
TRINITY_DN17980_c2_g1_i1	O93400	ACTB_XENLA	89.8	98	10	0	296	3	219	316	2.40E-44	179.1	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN26588_c5_g1_i1	O93400	ACTB_XENLA	91.9	99	8	0	299	3	188	286	4.00E-47	188.3	ACTB_XENLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (Cytoplasmic beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Xenopus laevis (African clawed frog)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c2_g1_i1	P79818	ACTB_ORYLA	90.2	82	8	0	1	246	28	109	1.60E-38	159.5	ACTB_ORYLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (OlCA1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Oryzias latipes (Japanese rice fish) (Japanese killifish)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c2_g1_i2	P79818	ACTB_ORYLA	91	78	7	0	3	236	32	109	1.90E-36	152.5	ACTB_ORYLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (OlCA1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Oryzias latipes (Japanese rice fish) (Japanese killifish)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g3_i2	P79818	ACTB_ORYLA	96.4	83	3	0	2	250	27	109	2.30E-43	175.6	ACTB_ORYLA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) (OlCA1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Oryzias latipes (Japanese rice fish) (Japanese killifish)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g1_i4	P29751	ACTB_RABIT	90.2	92	9	0	278	3	32	123	6.10E-42	171	ACTB_RABIT	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Oryctolagus cuniculus (Rabbit)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0032991; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g1_i5	P29751	ACTB_RABIT	89.7	78	8	0	236	3	46	123	4.50E-33	141.4	ACTB_RABIT	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Oryctolagus cuniculus (Rabbit)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0032991; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c3_g1_i3	O42161	ACTB_SALSA	94.8	172	9	0	1	516	204	375	1.70E-91	336.7	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			blue	blue	NA	NA	NA	NA
TRINITY_DN25431_c0_g1_i1	O42161	ACTB_SALSA	83.4	145	24	0	2	436	212	356	3.70E-65	248.8	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN15426_c0_g3_i1	Q0PGG4	ACTB_BOSMU	88.4	86	10	0	1	258	42	127	5.90E-39	161	ACTB_BOSMU	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Bos mutus grunniens (Wild yak) (Bos grunniens)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0032991; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN24153_c1_g1_i1	O42161	ACTB_SALSA	85.2	122	18	0	2	367	232	353	8.40E-55	214.2	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN22555_c1_g1_i1	O42161	ACTB_SALSA	93.3	104	7	0	312	1	238	341	3.30E-52	205.3	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN21768_c1_g1_i1	O42161	ACTB_SALSA	89	82	9	0	2	247	250	331	1.20E-36	153.3	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN26515_c1_g1_i2	O42161	ACTB_SALSA	87.5	104	13	0	7	318	233	336	1.90E-47	189.5	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN34353_c0_g1_i1	O42161	ACTB_SALSA	83.3	90	15	0	5	274	244	333	2.60E-37	155.6	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c5_g1_i1	O42161	ACTB_SALSA	92.2	116	9	0	3	350	243	358	6.00E-58	224.6	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g5_i1	P84336	ACTB_CAMDR	95.1	102	5	0	308	3	30	131	2.10E-51	202.6	ACTB_CAMDR	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Camelus dromedarius (Dromedary) (Arabian camel)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0032991; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g3_i1	Q0PGG4	ACTB_BOSMU	100	111	0	0	334	2	1	111	8.20E-62	237.7	ACTB_BOSMU	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Bos mutus grunniens (Wild yak) (Bos grunniens)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0032991; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN35371_c1_g1_i1	O42161	ACTB_SALSA	87.1	116	15	0	1	348	259	374	2.30E-54	212.6	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i10	Q6NVA9	ACTB_XENTR	94.7	375	20	0	107	1231	1	375	2.40E-210	732.6	ACTB_XENTR	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb TNeu072n05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			NA	NA	NA	NA	NA	1
TRINITY_DN1209_c0_g1_i15	P60712	ACTB_BOVIN	98.9	374	4	0	81	1202	2	375	8.80E-218	757.3	ACTB_BOVIN	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Bos taurus (Bovine)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0015629; GO:0016020; GO:0019901; GO:0030424; GO:0032991; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i18	P60712	ACTB_BOVIN	98.7	374	5	0	81	1202	2	375	1.20E-217	756.9	ACTB_BOVIN	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Bos taurus (Bovine)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0015629; GO:0016020; GO:0019901; GO:0030424; GO:0032991; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i3	P60712	ACTB_BOVIN	98.9	374	4	0	81	1202	2	375	8.80E-218	757.3	ACTB_BOVIN	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Bos taurus (Bovine)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0015629; GO:0016020; GO:0019901; GO:0030424; GO:0032991; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i8	P60712	ACTB_BOVIN	98.7	374	5	0	81	1202	2	375	1.20E-217	756.9	ACTB_BOVIN	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Bos taurus (Bovine)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0015629; GO:0016020; GO:0019901; GO:0030424; GO:0032991; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c10_g1_i1	O42161	ACTB_SALSA	90.6	117	11	0	3	353	259	375	2.60E-56	219.2	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g2_i1	O42161	ACTB_SALSA	96.1	76	3	0	4	231	279	354	4.70E-35	147.9	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN7034_c0_g1_i1	O42161	ACTB_SALSA	90.8	120	11	0	361	2	235	354	6.10E-58	224.6	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g2_i1	O42161	ACTB_SALSA	94	100	6	0	332	33	276	375	1.30E-49	196.8	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN20527_c3_g1_i1	Q91ZK5	ACTB_SIGHI	84.9	86	13	0	1	258	290	375	2.00E-35	149.4	ACTB_SIGHI	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	ACTB	Sigmodon hispidus (Hispid cotton rat)	375	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005925; GO:0015629; GO:0032991; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN23771_c0_g1_i1	O42161	ACTB_SALSA	92.5	120	9	0	2	361	256	375	1.20E-61	237.3	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	1	NA	NA	NA
TRINITY_DN4435_c0_g3_i2	O42161	ACTB_SALSA	92.8	111	8	0	2	334	216	326	1.30E-54	213.4	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN4435_c0_g3_i4	O42161	ACTB_SALSA	76.4	297	62	4	9	881	32	326	2.10E-128	459.9	ACTB_SALSA	reviewed	"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actb	Salmo salar (Atlantic salmon)	375	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN24153_c1_g1_i2	Q7ZVI7	ACTB1_DANRE	92.3	52	4	0	74	229	302	353	1.90E-20	99.4	ACTB1_DANRE	reviewed	"Actin, cytoplasmic 1 (Beta-actin-1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba bact bactin1 bactzf	Danio rerio (Zebrafish) (Brachydanio rerio)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			NA	NA	NA	NA	NA	NA
TRINITY_DN22555_c2_g1_i1	Q7ZVI7	ACTB1_DANRE	87.2	78	10	0	2	235	283	360	1.70E-32	139.4	ACTB1_DANRE	reviewed	"Actin, cytoplasmic 1 (Beta-actin-1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba bact bactin1 bactzf	Danio rerio (Zebrafish) (Brachydanio rerio)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			NA	NA	NA	NA	NA	NA
TRINITY_DN26515_c1_g1_i1	Q7ZVI7	ACTB1_DANRE	92.7	82	6	0	1	246	255	336	6.30E-38	157.5	ACTB1_DANRE	reviewed	"Actin, cytoplasmic 1 (Beta-actin-1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba bact bactin1 bactzf	Danio rerio (Zebrafish) (Brachydanio rerio)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			NA	NA	NA	NA	NA	NA
TRINITY_DN9245_c7_g1_i1	Q7ZVI7	ACTB1_DANRE	92.8	69	5	0	2	208	303	371	4.10E-30	131.3	ACTB1_DANRE	reviewed	"Actin, cytoplasmic 1 (Beta-actin-1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba bact bactin1 bactzf	Danio rerio (Zebrafish) (Brachydanio rerio)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			NA	NA	NA	NA	NA	NA
TRINITY_DN22884_c0_g1_i1	Q7ZVI7	ACTB1_DANRE	90.7	75	7	0	294	70	301	375	4.30E-33	141.7	ACTB1_DANRE	reviewed	"Actin, cytoplasmic 1 (Beta-actin-1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba bact bactin1 bactzf	Danio rerio (Zebrafish) (Brachydanio rerio)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			NA	NA	NA	NA	NA	NA
TRINITY_DN29743_c0_g1_i1	Q7ZVI7	ACTB1_DANRE	95.3	85	4	0	312	58	291	375	9.10E-42	170.6	ACTB1_DANRE	reviewed	"Actin, cytoplasmic 1 (Beta-actin-1) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]"	actba bact bactin1 bactzf	Danio rerio (Zebrafish) (Brachydanio rerio)	375	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005634; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0015629; GO:0097433; GO:0098973			black	black	1	NA	NA	1
TRINITY_DN15426_c2_g1_i1	Q8JJB8	ACTG_TRISC	78.9	375	79	0	1164	40	1	375	7.70E-182	637.9	ACTG_TRISC	reviewed	"Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]"	actg1 actg	Triakis scyllium (Banded houndshark) (Hemigaleus pingi)	375	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g2_i1	P63258	ACTG_BOVIN	100	84	0	0	254	3	1	84	3.50E-44	178.7	ACTG_BOVIN	reviewed	"Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]"	ACTG1 ACTG	Bos taurus (Bovine)	375	actin filament [GO:0005884]; apical junction complex [GO:0043296]; basal body patch [GO:0120220]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; myofibril [GO:0030016]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; cellular response to interferon-gamma [GO:0071346]; morphogenesis of a polarized epithelium [GO:0001738]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of transepithelial transport [GO:0150111]; sarcomere organization [GO:0045214]; tight junction assembly [GO:0120192]	actin filament [GO:0005884]; apical junction complex [GO:0043296]; basal body patch [GO:0120220]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; myofibril [GO:0030016]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]	GO:0001525; GO:0001738; GO:0005522; GO:0005524; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0010628; GO:0030016; GO:0030335; GO:0031625; GO:0031941; GO:0042802; GO:0043296; GO:0045214; GO:0045335; GO:0051492; GO:0051893; GO:0070062; GO:0071346; GO:0090303; GO:0097433; GO:0098973; GO:0120192; GO:0120220; GO:0150111; GO:1902396	angiogenesis [GO:0001525]; cellular response to interferon-gamma [GO:0071346]; morphogenesis of a polarized epithelium [GO:0001738]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of transepithelial transport [GO:0150111]; sarcomere organization [GO:0045214]; tight junction assembly [GO:0120192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c0_g1_i3	P53486	ACTB3_TAKRU	88.8	125	14	0	2	376	180	304	8.90E-60	230.7	ACTB3_TAKRU	reviewed	"Actin, cytoplasmic 3 (Beta-actin C) [Cleaved into: Actin, cytoplasmic 3, N-terminally processed]"	actbc	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c0_g2_i1	P53505	ACT5_XENLA	97.6	85	2	0	1	255	245	329	2.30E-43	175.6	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c0_g1_i1	P53505	ACT5_XENLA	100	186	0	0	558	1	163	348	1.50E-103	376.7	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c0_g1_i3	P53505	ACT5_XENLA	100	155	0	0	468	4	193	347	7.60E-85	314.3	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c0_g1_i4	P53505	ACT5_XENLA	100	214	0	0	713	72	163	376	1.50E-121	436.8	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c0_g1_i5	P53505	ACT5_XENLA	100	184	0	0	623	72	193	376	3.70E-103	375.6	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c8_g1_i1	P53478	ACT5_CHICK	81	63	12	0	46	234	1	63	1.10E-20	100.1	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i2	P53505	ACT5_XENLA	100	285	0	0	2	856	92	376	3.40E-163	575.5	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i6	P53505	ACT5_XENLA	100	285	0	0	2	856	92	376	3.40E-163	575.5	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g1_i1	P53478	ACT5_CHICK	90.8	119	11	0	2	358	157	275	5.20E-57	221.5	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g1_i2	P53478	ACT5_CHICK	88.2	119	14	0	2	358	157	275	1.40E-54	213.4	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g1_i3	P53478	ACT5_CHICK	90	90	9	0	1	270	186	275	3.60E-39	161.8	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g1_i5	P53478	ACT5_CHICK	88.4	86	10	0	3	260	190	275	1.30E-36	153.3	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN7034_c1_g1_i1	P53478	ACT5_CHICK	100	119	0	0	3	359	92	210	4.10E-62	238.4	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN29646_c0_g3_i1	P53478	ACT5_CHICK	100	139	0	0	1	417	108	246	6.00E-73	274.6	ACT5_CHICK	reviewed	"Actin, cytoplasmic type 5"		Gallus gallus (Chicken)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005737; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0097433; GO:0098973	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN29646_c0_g2_i1	P53505	ACT5_XENLA	99.3	148	1	0	3	446	143	290	1.10E-80	300.4	ACT5_XENLA	reviewed	"Actin, cytoplasmic type 5"		Xenopus laevis (African clawed frog)	376	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]	cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]	GO:0005524; GO:0005856; GO:0005886; GO:0005925; GO:0097433			blue	blue	NA	NA	NA	NA
TRINITY_DN19985_c0_g1_i1	P53466	ACT2_LYTPI	81.8	66	7	1	722	919	68	128	4.30E-23	110.2	ACT2_LYTPI	reviewed	"Actin, cytoskeletal 2 (LPC2)"		Lytechinus pictus (Painted sea urchin)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i1	P53466	ACT2_LYTPI	94.5	55	3	0	75	239	1	55	1.00E-24	113.6	ACT2_LYTPI	reviewed	"Actin, cytoskeletal 2 (LPC2)"		Lytechinus pictus (Painted sea urchin)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i14	Q07903	ACTC_STRPU	97.4	116	3	0	75	422	1	116	1.50E-63	243.4	ACTC_STRPU	reviewed	"Actin, cytoskeletal 2A (Actin, cytoskeletal IIA) [Cleaved into: Actin, cytoskeletal 2A, intermediate form]"	CYIIA	Strongylocentrotus purpuratus (Purple sea urchin)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i7	Q07903	ACTC_STRPU	97.4	116	3	0	75	422	1	116	8.70E-64	244.2	ACTC_STRPU	reviewed	"Actin, cytoskeletal 2A (Actin, cytoskeletal IIA) [Cleaved into: Actin, cytoskeletal 2A, intermediate form]"	CYIIA	Strongylocentrotus purpuratus (Purple sea urchin)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c2_g1_i1	P83969	ACT1_BACDO	80.5	123	24	0	371	3	154	276	9.80E-51	200.7	ACT1_BACDO	reviewed	"Actin, indirect flight muscle"		Bactrocera dorsalis (Oriental fruit fly) (Dacus dorsalis)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c1_g2_i1	P02574	ACT4_DROME	83.8	68	11	0	1	204	240	307	1.20E-29	129.8	ACT4_DROME	reviewed	"Actin, larval muscle (Actin-79B)"	Act79B CG7478	Drosophila melanogaster (Fruit fly)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856	mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN20685_c0_g1_i1	O17502	ACTM_BRALA	95.5	67	3	0	201	1	34	100	2.60E-34	145.2	ACTM_BRALA	reviewed	"Actin, muscle"		Branchiostoma lanceolatum (Common lancelet) (Amphioxus lanceolatum)	380	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i11	P49871	ACT_MANSE	93.6	374	24	0	110	1231	3	376	8.20E-209	727.6	ACT_MANSE	reviewed	"Actin, muscle"		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i16	P49871	ACT_MANSE	93.6	374	24	0	110	1231	3	376	1.10E-208	727.2	ACT_MANSE	reviewed	"Actin, muscle"		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c4_g1_i1	P17304	ACTM_APLCA	97.1	68	2	0	1	204	305	372	1.90E-32	139	ACTM_APLCA	reviewed	"Actin, muscle"		Aplysia californica (California sea hare)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c0_g1_i1	P07836	ACT1_BOMMO	91.7	145	12	0	2	436	181	325	9.00E-72	270.8	ACT1_BOMMO	reviewed	"Actin, muscle-type A1"		Bombyx mori (Silk moth)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN8084_c0_g1_i1	P07836	ACT1_BOMMO	95.1	103	5	0	309	1	236	338	8.70E-53	207.2	ACT1_BOMMO	reviewed	"Actin, muscle-type A1"		Bombyx mori (Silk moth)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN8084_c0_g1_i2	P07836	ACT1_BOMMO	95	141	7	0	515	93	236	376	7.10E-76	284.6	ACT1_BOMMO	reviewed	"Actin, muscle-type A1"		Bombyx mori (Silk moth)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	1
TRINITY_DN8084_c0_g1_i3	P07836	ACT1_BOMMO	95	141	7	0	513	91	236	376	5.40E-76	285	ACT1_BOMMO	reviewed	"Actin, muscle-type A1"		Bombyx mori (Silk moth)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i5	P07836	ACT1_BOMMO	91.5	258	22	0	1	774	119	376	5.80E-136	485	ACT1_BOMMO	reviewed	"Actin, muscle-type A1"		Bombyx mori (Silk moth)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN35456_c3_g1_i1	P07836	ACT1_BOMMO	80	75	15	0	1	225	232	306	1.60E-27	122.9	ACT1_BOMMO	reviewed	"Actin, muscle-type A1"		Bombyx mori (Silk moth)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21320_c0_g1_i1	P17126	ACT_HYDVU	82.6	92	16	0	277	2	2	93	4.50E-38	158.3	ACT_HYDVU	reviewed	"Actin, non-muscle 6.2"		Hydra vulgaris (Hydra) (Hydra attenuata)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g1_i1	P0DM41	ACT1_CAEEL	94.4	72	4	0	217	2	30	101	4.80E-34	144.4	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g1_i3	P0DM41	ACT1_CAEEL	94	67	4	0	201	1	30	96	3.20E-32	138.3	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c1_g2_i1	P0DM41	ACT1_CAEEL	95.9	73	3	0	3	221	40	112	2.40E-36	152.1	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c2_g1_i1	P0DM41	ACT1_CAEEL	96.2	80	3	0	243	4	296	375	5.60E-39	161	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c2_g1_i3	P0DM41	ACT1_CAEEL	95	80	4	0	242	3	296	375	1.20E-38	159.8	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN2004_c8_g1_i1	P0DM41	ACT1_CAEEL	88.9	72	8	0	218	3	286	357	6.80E-31	134.4	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN2014_c4_g1_i1	P0DM41	ACT1_CAEEL	95.9	74	3	0	2	223	32	105	1.40E-36	152.9	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c0_g1_i2	P0DM41	ACT1_CAEEL	100	66	0	0	269	72	311	376	5.60E-32	137.9	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c3_g1_i1	O18499	ACT1_SACKO	92.3	65	5	0	3	197	312	376	4.70E-27	121.3	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c3_g1_i4	P0DM41	ACT1_CAEEL	90.5	63	6	0	3	191	314	376	3.10E-24	112.1	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c3_g1_i7	P0DM41	ACT1_CAEEL	88.1	42	5	0	1	126	335	376	1.80E-14	79.3	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c1_g1_i1	O18499	ACT1_SACKO	87.7	57	7	0	6	176	320	376	5.90E-21	100.9	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c1_g1_i2	P0DM41	ACT1_CAEEL	90.9	66	6	0	2	199	311	376	7.20E-28	124	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c5_g1_i1	P35432	ACT1_ECHGR	86.9	107	14	0	328	8	81	187	1.20E-47	190.3	ACT1_ECHGR	reviewed	Actin-1	ACTI	Echinococcus granulosus (Hydatid tapeworm)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN24573_c1_g1_i1	P0DM41	ACT1_CAEEL	92.3	78	6	0	279	46	299	376	8.70E-36	150.6	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN15426_c0_g1_i1	P0DM41	ACT1_CAEEL	93.2	73	5	0	1	219	18	90	7.50E-35	147.1	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN23771_c2_g1_i1	P0DM41	ACT1_CAEEL	87.2	78	10	0	303	70	299	376	1.50E-33	143.3	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN26910_c1_g1_i1	P0DM41	ACT1_CAEEL	90	80	8	0	1	240	10	89	2.60E-36	152.1	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN24153_c0_g2_i1	P0DM41	ACT1_CAEEL	100	41	0	0	211	89	336	376	3.70E-18	91.7	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN24153_c0_g1_i2	P0DM41	ACT1_CAEEL	100	37	0	0	210	100	340	376	1.70E-15	82.8	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i10	P53470	ACT1_SCHMA	93.6	203	13	0	30	638	1	203	5.50E-110	398.3	ACT1_SCHMA	reviewed	Actin-1		Schistosoma mansoni (Blood fluke)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i19	P53470	ACT1_SCHMA	94.1	203	12	0	62	670	1	203	2.00E-110	399.8	ACT1_SCHMA	reviewed	Actin-1		Schistosoma mansoni (Blood fluke)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i8	P53470	ACT1_SCHMA	89	310	34	0	39	968	1	310	6.50E-163	574.7	ACT1_SCHMA	reviewed	Actin-1		Schistosoma mansoni (Blood fluke)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9245_c0_g1_i3	P0DM41	ACT1_CAEEL	97	99	3	0	19	315	1	99	1.80E-53	209.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		black	black	1	NA	NA	1
TRINITY_DN26515_c2_g1_i1	P0DM41	ACT1_CAEEL	100	45	0	0	1	135	332	376	8.30E-21	100.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN26515_c0_g1_i1	P49128	ACT1_AEDAE	95.3	86	4	0	260	3	98	183	3.20E-40	165.2	ACT1_AEDAE	reviewed	Actin-1	ACT-1 AAEL001928	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26490_c5_g1_i1	P0DM41	ACT1_CAEEL	90.9	77	7	0	2	232	14	90	8.50E-37	153.7	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN24887_c0_g1_i1	P0DM41	ACT1_CAEEL	95.2	63	3	0	224	36	314	376	5.40E-28	124.4	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN24887_c1_g1_i1	O18499	ACT1_SACKO	88.9	63	7	0	226	38	313	375	2.30E-23	109	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN24879_c1_g1_i1	P0DM41	ACT1_CAEEL	93.8	80	5	0	241	2	15	94	7.80E-41	167.2	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN16130_c0_g1_i6	P0DM41	ACT1_CAEEL	85.3	34	5	0	636	737	343	376	1.00E-09	65.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN16130_c0_g1_i7	P0DM41	ACT1_CAEEL	85.3	34	5	0	636	737	343	376	1.00E-09	65.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN2663_c1_g1_i1	P0DM41	ACT1_CAEEL	100	26	0	0	80	3	313	338	1.50E-06	53.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN2663_c1_g1_i5	P0DM41	ACT1_CAEEL	96	25	1	0	76	2	351	375	7.30E-08	57.8	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN23331_c0_g1_i1	P02578	ACT1_ACACA	98.2	111	2	0	2	334	106	216	2.00E-55	216.1	ACT1_ACACA	reviewed	Actin-1		Acanthamoeba castellanii (Amoeba)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c1_g1_i3	P0DM41	ACT1_CAEEL	98.1	107	2	0	2	322	31	137	2.30E-56	219.2	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN6602_c2_g1_i3	P0DM41	ACT1_CAEEL	94.6	111	6	0	3	335	33	143	9.10E-56	217.2	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i11	O18499	ACT1_SACKO	95.6	114	5	0	1	342	57	170	8.10E-60	230.7	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i14	O18499	ACT1_SACKO	96.5	114	4	0	1	342	57	170	5.60E-61	234.6	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i2	O18499	ACT1_SACKO	95.6	114	5	0	1	342	57	170	2.10E-60	232.6	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i8	O18499	ACT1_SACKO	97.4	114	3	0	1	342	57	170	5.60E-61	234.6	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g2_i9	O18499	ACT1_SACKO	95.6	114	5	0	1	342	57	170	1.40E-59	229.9	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g3_i2	P0DM41	ACT1_CAEEL	100	103	0	0	311	3	20	122	1.30E-56	219.9	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g3_i3	P0DM41	ACT1_CAEEL	100	93	0	0	280	2	20	112	5.60E-51	201.1	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g4_i1	O18499	ACT1_SACKO	96.8	62	2	0	261	76	315	376	2.10E-28	125.9	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN138_c1_g4_i2	O18499	ACT1_SACKO	95.2	62	3	0	261	76	315	376	3.10E-27	122.1	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c0_g1_i1	P02578	ACT1_ACACA	69.3	371	110	1	45	1145	4	374	1.30E-152	540.8	ACT1_ACACA	reviewed	Actin-1		Acanthamoeba castellanii (Amoeba)	375	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i17	P0DM41	ACT1_CAEEL	100	72	0	0	1	216	305	376	3.20E-36	151.8	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN1209_c1_g2_i1	P0DM41	ACT1_CAEEL	95.5	66	3	0	201	4	20	85	2.10E-31	135.6	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c1_g2_i1	P0DM41	ACT1_CAEEL	92.2	51	4	0	1	153	326	376	8.30E-20	97.8	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN21276_c0_g1_i1	P0DM41	ACT1_CAEEL	91.5	82	7	0	1	246	294	375	9.90E-37	153.7	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c0_g1_i2	P0DM41	ACT1_CAEEL	91.6	83	7	0	1	249	294	376	8.30E-38	157.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c5_g1_i1	P0DM41	ACT1_CAEEL	88	108	13	0	326	3	28	135	2.90E-51	202.2	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN19513_c0_g1_i6	P49128	ACT1_AEDAE	93.4	76	5	0	229	2	240	315	1.30E-37	156.4	ACT1_AEDAE	reviewed	Actin-1	ACT-1 AAEL001928	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN20527_c2_g1_i1	P0DM41	ACT1_CAEEL	95.1	102	5	0	341	36	275	376	9.60E-53	207.2	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN17980_c2_g2_i1	O18499	ACT1_SACKO	92.4	66	5	0	241	44	311	376	1.70E-27	122.9	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g1_i5	P49128	ACT1_AEDAE	91.4	139	12	0	419	3	143	281	6.20E-70	264.6	ACT1_AEDAE	reviewed	Actin-1	ACT-1 AAEL001928	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			black	black	1	NA	1	1
TRINITY_DN791_c23_g1_i2	O18499	ACT1_SACKO	92.1	101	8	0	372	70	276	376	3.70E-50	198.7	ACT1_SACKO	reviewed	Actin-1		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN4435_c0_g4_i1	P0DM41	ACT1_CAEEL	92.3	26	2	0	3	80	351	376	3.60E-07	55.5	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN29646_c2_g1_i2	P0DM41	ACT1_CAEEL	90.4	52	5	0	2	157	325	376	6.10E-21	100.9	ACT1_CAEEL	reviewed	Actin-1	act-1 T04C12.6	Caenorhabditis elegans	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005524; GO:0005737; GO:0005856; GO:0009792; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN20808_c0_g1_i1	P10982	ACT1_ABSGL	100	23	0	0	2	70	21	43	1.40E-06	53.5	ACT1_ABSGL	reviewed	Actin-1 (Fragment)	ACT1	Absidia glauca (Pin mould)	140	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN20808_c0_g1_i1	P10982	ACT1_ABSGL	95.2	21	1	0	198	260	43	63	3.70E-04	45.4	ACT1_ABSGL	reviewed	Actin-1 (Fragment)	ACT1	Absidia glauca (Pin mould)	140	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN10997_c0_g1_i1	P10982	ACT1_ABSGL	95.6	68	3	0	63	266	1	68	7.30E-32	137.5	ACT1_ABSGL	reviewed	Actin-1 (Fragment)	ACT1	Absidia glauca (Pin mould)	140	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g1_i2	Q54GX7	ACT10_DICDI	89.4	85	9	0	257	3	63	147	1.10E-37	156.8	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN18931_c2_g1_i1	Q54GX7	ACT10_DICDI	94.9	78	4	0	1	234	46	123	8.60E-37	153.7	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c3_g2_i1	Q54GX7	ACT10_DICDI	95.6	68	3	0	1	204	77	144	1.60E-31	136	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c2_g1_i1	Q54GX7	ACT10_DICDI	94.7	76	4	0	229	2	29	104	1.80E-39	162.5	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		blue	blue	1	NA	NA	1
TRINITY_DN30848_c0_g1_i1	Q54GX7	ACT10_DICDI	98.9	88	1	0	1	264	64	151	1.10E-45	183.3	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i23	Q54GX7	ACT10_DICDI	96.7	120	4	0	280	639	84	203	1.10E-62	241.1	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN611_c0_g1_i23	Q54GX7	ACT10_DICDI	67.5	117	38	0	30	380	1	117	3.00E-39	163.3	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN24879_c0_g1_i1	Q54GX7	ACT10_DICDI	85.1	74	11	0	36	257	57	130	7.00E-32	137.5	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN9245_c0_g1_i2	Q54GX7	ACT10_DICDI	96.5	57	2	0	72	242	43	99	3.40E-28	125.2	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN35745_c0_g1_i1	Q54GX7	ACT10_DICDI	87.5	72	9	0	1	216	50	121	4.90E-32	137.9	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g1_i1	Q54GX7	ACT10_DICDI	85.3	68	10	0	1	204	58	125	1.20E-26	119.8	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN26588_c2_g1_i1	Q54GX7	ACT10_DICDI	89.8	88	9	0	4	267	60	147	2.50E-40	165.6	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4435_c1_g1_i1	Q54GX7	ACT10_DICDI	95.7	69	3	0	1	207	23	91	3.60E-34	144.8	ACT10_DICDI	reviewed	Actin-10	act10 DDB_G0289811	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005884; GO:0005938; GO:0006897; GO:0006909; GO:0006935; GO:0015629; GO:0016192; GO:0017022; GO:0030027; GO:0030864; GO:0031143; GO:0031252; GO:0032009; GO:0032010; GO:0042331; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; chemotaxis [GO:0006935]; endocytosis [GO:0006897]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; phototaxis [GO:0042331]; response to cAMP [GO:0051591]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g2_i1	P53496	ACT11_ARATH	97.4	78	2	0	234	1	118	195	3.30E-36	151.8	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN19759_c0_g2_i2	P53496	ACT11_ARATH	97.4	78	2	0	234	1	118	195	2.50E-36	152.1	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c1_g1_i1	P53496	ACT11_ARATH	95.7	69	3	0	1	207	124	192	2.40E-30	132.1	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN11688_c1_g1_i3	P53496	ACT11_ARATH	95.5	88	4	0	1	264	105	192	2.30E-41	169.1	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN6602_c0_g3_i1	P53496	ACT11_ARATH	94.3	88	5	0	3	266	110	197	8.60E-41	167.2	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN19985_c1_g1_i1	P53496	ACT11_ARATH	84.1	69	11	0	208	2	126	194	3.00E-25	115.2	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN35456_c2_g1_i1	P53496	ACT11_ARATH	92.1	101	8	0	304	2	92	192	3.00E-45	182.2	ACT11_ARATH	reviewed	Actin-11	ACT11 At3g12110 T21B14.7 T21B14_108 T23B7.5	Arabidopsis thaliana (Mouse-ear cress)	377	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0009506; GO:0009570; GO:0009941			NA	NA	NA	NA	NA	NA
TRINITY_DN21456_c2_g1_i1	O18500	ACT2_SACKO	77.1	83	19	0	272	24	294	376	5.50E-30	131.3	ACT2_SACKO	reviewed	Actin-2		Saccoglossus kowalevskii (Acorn worm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19985_c0_g1_i2	P23344	ACT2_DAUCA	84.9	73	11	0	9	227	59	131	1.80E-28	125.9	ACT2_DAUCA	reviewed	Actin-2		Daucus carota (Wild carrot)	381	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i19	P92176	ACT2_LUMTE	92.6	336	25	0	3	1010	41	376	6.90E-185	647.9	ACT2_LUMTE	reviewed	Actin-2	ACT2	Lumbricus terrestris (Common earthworm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c0_g1_i20	P92176	ACT2_LUMTE	92.6	336	25	0	3	1010	41	376	5.30E-185	648.3	ACT2_LUMTE	reviewed	Actin-2	ACT2	Lumbricus terrestris (Common earthworm)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c3_g1_i1	P53471	ACT2_SCHMA	90.5	137	13	0	412	2	129	265	7.80E-65	247.7	ACT2_SCHMA	reviewed	Actin-2		Schistosoma mansoni (Blood fluke)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN18709_c0_g1_i1	P42023	ACTZ_PNECA	67.1	210	66	3	629	3	2	209	1.30E-79	297.4	ACTZ_PNECA	reviewed	Actin-2 (Actin II) (Centractin-like protein)		Pneumocystis carinii	385	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN8084_c0_g2_i1	P45885	ACT2_BACDO	84.3	178	26	1	580	53	199	376	4.30E-85	315.5	ACT2_BACDO	reviewed	"Actin-2, muscle-specific"		Bactrocera dorsalis (Oriental fruit fly) (Dacus dorsalis)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i9	P41340	ACT3_LIMPO	91	89	8	0	269	3	176	264	1.90E-40	166	ACT3_LIMPO	reviewed	Actin-3		Limulus polyphemus (Atlantic horseshoe crab)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c0_g1_i1	P41340	ACT3_LIMPO	94.1	102	6	0	309	4	166	267	9.00E-50	197.2	ACT3_LIMPO	reviewed	Actin-3		Limulus polyphemus (Atlantic horseshoe crab)	376	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19513_c0_g1_i4	P07829	ACT3_DICDI	72.2	126	35	0	378	1	248	373	2.90E-50	199.1	ACT3_DICDI	reviewed	Actin-3 (Actin-3-sub 1)	act3 act3-1 DDB_G0289487	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; phagocytosis [GO:0006909]; response to cAMP [GO:0051591]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005938; GO:0006909; GO:0015629; GO:0017022; GO:0030027; GO:0030864; GO:0031252; GO:0032009; GO:0032010; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; phagocytosis [GO:0006909]; response to cAMP [GO:0051591]		NA	NA	NA	NA	NA	NA
TRINITY_DN19513_c0_g1_i5	P07829	ACT3_DICDI	78.4	134	29	0	402	1	240	373	2.80E-59	229.2	ACT3_DICDI	reviewed	Actin-3 (Actin-3-sub 1)	act3 act3-1 DDB_G0289487	Dictyostelium discoideum (Slime mold)	376	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; phagocytosis [GO:0006909]; response to cAMP [GO:0051591]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell pole [GO:0060187]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagolysosome [GO:0032010]	ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0000902; GO:0001891; GO:0005200; GO:0005524; GO:0005938; GO:0006909; GO:0015629; GO:0017022; GO:0030027; GO:0030864; GO:0031252; GO:0032009; GO:0032010; GO:0045335; GO:0051591; GO:0060187; GO:0061836	cell morphogenesis [GO:0000902]; phagocytosis [GO:0006909]; response to cAMP [GO:0051591]		NA	NA	NA	NA	NA	NA
TRINITY_DN19513_c0_g1_i2	Q03342	ACT3_ECHGR	85.3	68	10	0	205	2	181	248	4.40E-29	127.9	ACT3_ECHGR	reviewed	Actin-3 (Fragment)	ACTIII	Echinococcus granulosus (Hydatid tapeworm)	309	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN0_c53_g4_i1	P02572	ACT2_DROME	89.3	169	18	0	3	509	121	289	3.30E-81	302.4	ACT2_DROME	reviewed	Actin-42A	Act42A CG12051	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; mitotic cytokinesis [GO:0000281]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0035060	mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c3_g1_i1	P02572	ACT2_DROME	87.4	95	12	0	286	2	183	277	1.90E-41	169.5	ACT2_DROME	reviewed	Actin-42A	Act42A CG12051	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; mitotic cytokinesis [GO:0000281]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0035060	mitotic cytokinesis [GO:0000281]		NA	NA	NA	NA	NA	NA
TRINITY_DN0_c2_g4_i1	P10987	ACT1_DROME	98.4	376	6	0	96	1223	1	376	7.30E-219	761.1	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		blue	blue	NA	NA	NA	NA
TRINITY_DN18931_c0_g1_i1	P10987	ACT1_DROME	90	40	4	0	122	3	1	40	5.20E-14	77.8	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		blue	blue	NA	NA	NA	NA
TRINITY_DN18931_c1_g1_i1	P10987	ACT1_DROME	98.3	60	1	0	182	3	1	60	3.80E-29	128.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		blue	blue	NA	NA	NA	NA
TRINITY_DN2014_c4_g1_i2	P10987	ACT1_DROME	96.8	124	4	0	2	373	32	155	2.60E-64	245.7	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN2014_c4_g2_i1	P10987	ACT1_DROME	88.7	71	8	0	8	220	1	71	1.40E-28	126.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN25431_c7_g1_i1	P10987	ACT1_DROME	91	89	8	0	267	1	1	89	4.80E-42	171.4	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN23435_c0_g1_i1	P10987	ACT1_DROME	91.4	128	11	0	1	384	44	171	7.90E-64	244.2	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN38920_c1_g1_i1	P10987	ACT1_DROME	92.1	140	11	0	31	450	1	140	8.70E-70	264.2	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g1_i4	P10987	ACT1_DROME	93.5	155	10	0	465	1	143	297	7.30E-80	297.7	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	1	NA	NA	NA
TRINITY_DN26490_c2_g1_i1	P10987	ACT1_DROME	93.9	99	6	0	298	2	2	100	5.00E-51	201.4	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN26490_c3_g1_i1	P10987	ACT1_DROME	89.7	195	20	0	588	4	86	280	2.40E-96	352.8	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN9245_c0_g2_i1	P10987	ACT1_DROME	90.4	260	25	0	2	781	85	344	3.30E-133	475.7	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN9245_c0_g2_i2	P10987	ACT1_DROME	89.7	214	22	0	2	643	131	344	3.70E-106	385.6	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN23331_c0_g1_i2	P10987	ACT1_DROME	96.9	98	3	0	2	295	107	204	2.30E-47	189.1	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN14135_c1_g1_i6	P10987	ACT1_DROME	89.2	102	11	0	2	307	75	176	8.60E-45	180.6	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN29733_c1_g1_i1	P10987	ACT1_DROME	92.3	155	12	0	85	549	1	155	2.90E-78	292.7	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN29743_c1_g1_i1	P10987	ACT1_DROME	92.2	128	10	0	3	386	56	183	1.10E-62	240.4	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g1_i1	P10987	ACT1_DROME	93.5	155	10	0	465	1	143	297	2.50E-80	299.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN138_c1_g1_i3	P10987	ACT1_DROME	91.8	147	12	0	442	2	143	289	2.60E-74	279.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN35371_c4_g1_i1	P10987	ACT1_DROME	80	95	19	0	286	2	1	95	1.80E-38	159.8	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g3_i1	P10987	ACT1_DROME	92	150	12	0	7	456	43	192	4.80E-76	285	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN1209_c2_g3_i3	P10987	ACT1_DROME	95.8	165	7	0	2	496	28	192	2.40E-89	329.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN35456_c1_g1_i1	P10987	ACT1_DROME	93.2	264	18	0	85	876	1	264	1.30E-138	493.8	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		blue	blue	NA	NA	NA	NA
TRINITY_DN7034_c2_g1_i1	P10987	ACT1_DROME	91.3	104	9	0	313	2	116	219	4.20E-47	188.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i1	P10987	ACT1_DROME	94.4	126	7	0	379	2	49	174	2.10E-64	246.1	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		blue	blue	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i10	P10987	ACT1_DROME	92.6	216	16	0	650	3	49	264	1.10E-113	410.6	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i11	P10987	ACT1_DROME	90.1	202	20	0	606	1	49	250	3.40E-101	369	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i12	P10987	ACT1_DROME	92.1	202	16	0	606	1	49	250	7.30E-104	377.9	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN6166_c0_g1_i14	P10987	ACT1_DROME	94.4	126	7	0	379	2	49	174	7.10E-65	247.7	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c4_g1_i1	P10987	ACT1_DROME	89.9	139	14	0	2	418	128	266	3.90E-64	245.4	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c1_g1_i1	P10987	ACT1_DROME	92.3	182	14	0	6	551	77	258	4.00E-93	342	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN21276_c1_g1_i2	P10987	ACT1_DROME	92.6	163	12	0	3	491	96	258	1.70E-79	296.6	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN26588_c4_g1_i1	P10987	ACT1_DROME	95.7	46	2	0	31	168	1	46	5.50E-19	94.4	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN4435_c0_g2_i1	P10987	ACT1_DROME	93.9	115	7	0	2	346	69	183	6.30E-60	231.1	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN40464_c0_g1_i1	P10987	ACT1_DROME	88.6	44	5	0	86	217	1	44	3.80E-15	81.6	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN29646_c3_g1_i1	P10987	ACT1_DROME	91.7	48	4	0	146	3	1	48	1.40E-19	96.3	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		NA	NA	NA	NA	NA	NA
TRINITY_DN29646_c1_g1_i1	P10987	ACT1_DROME	98.6	70	1	0	44	253	1	70	5.60E-34	144.4	ACT1_DROME	reviewed	Actin-5C	Act5C CG4027	Drosophila melanogaster (Fruit fly)	376	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]	brahma complex [GO:0035060]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Ino80 complex [GO:0031011]	ATP binding [GO:0005524]	GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0006338; GO:0007291; GO:0031011; GO:0032507; GO:0035060; GO:0035148	chromatin remodeling [GO:0006338]; maintenance of protein location in cell [GO:0032507]; mitotic cytokinesis [GO:0000281]; sperm individualization [GO:0007291]; tube formation [GO:0035148]		blue	blue	NA	NA	NA	NA
TRINITY_DN19675_c1_g1_i1	P53459	ACT6_DIPDE	89.7	97	10	0	1	291	129	225	5.90E-43	174.5	ACT6_DIPDE	reviewed	Actin-6 (Fragment)	ACT6	Diphyllobothrium dendriticum (Tapeworm)	373	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN8670_c0_g2_i1	P53459	ACT6_DIPDE	45.7	127	59	3	363	4	215	338	3.30E-27	122.5	ACT6_DIPDE	reviewed	Actin-6 (Fragment)	ACT6	Diphyllobothrium dendriticum (Tapeworm)	373	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN15426_c0_g2_i1	P30170	ACT10_SOLTU	96.9	65	2	0	21	215	95	159	1.00E-28	126.7	ACT10_SOLTU	reviewed	Actin-85C (Fragment)	AC85C	Solanum tuberosum (Potato)	195	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN35371_c1_g2_i1	P30170	ACT10_SOLTU	88.3	77	9	0	4	234	73	149	2.90E-32	138.7	ACT10_SOLTU	reviewed	Actin-85C (Fragment)	AC85C	Solanum tuberosum (Potato)	195	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c1_g1_i1	P30170	ACT10_SOLTU	91.3	69	6	0	210	4	98	166	2.70E-29	128.6	ACT10_SOLTU	reviewed	Actin-85C (Fragment)	AC85C	Solanum tuberosum (Potato)	195	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19512_c1_g1_i2	P30170	ACT10_SOLTU	94.2	103	6	0	312	4	64	166	4.80E-51	201.4	ACT10_SOLTU	reviewed	Actin-85C (Fragment)	AC85C	Solanum tuberosum (Potato)	195	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN20526_c0_g1_i1	P30170	ACT10_SOLTU	93.4	91	6	0	47	319	74	164	2.70E-41	169.1	ACT10_SOLTU	reviewed	Actin-85C (Fragment)	AC85C	Solanum tuberosum (Potato)	195	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN38590_c0_g1_i1	Q69ZX8	ABLM3_MOUSE	53.8	65	27	1	224	39	618	682	1.30E-10	67.4	ABLM3_MOUSE	reviewed	Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3)	Ablim3 Kiaa0843	Mus musculus (Mouse)	682	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0001725; GO:0005737; GO:0006351; GO:0015629; GO:0030027; GO:0030032; GO:0030036; GO:0045944; GO:0046872; GO:0051015; GO:0060271	"actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38590_c0_g1_i3	Q69ZX8	ABLM3_MOUSE	53.8	65	27	1	224	39	618	682	1.40E-10	67.4	ABLM3_MOUSE	reviewed	Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3)	Ablim3 Kiaa0843	Mus musculus (Mouse)	682	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0001725; GO:0005737; GO:0006351; GO:0015629; GO:0030027; GO:0030032; GO:0030036; GO:0045944; GO:0046872; GO:0051015; GO:0060271	"actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5479_c0_g1_i1	Q9Y573	IPP_HUMAN	40	575	331	5	1844	150	14	584	7.00E-119	429.5	IPP_HUMAN	reviewed	Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27)	IPP KLHL27	Homo sapiens (Human)	584	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0015629			NA	NA	NA	NA	NA	1
TRINITY_DN5479_c0_g2_i1	Q9Y573	IPP_HUMAN	40	575	331	5	171	1865	14	584	7.00E-119	429.5	IPP_HUMAN	reviewed	Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27)	IPP KLHL27	Homo sapiens (Human)	584	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0015629			NA	NA	NA	NA	NA	NA
TRINITY_DN2782_c0_g1_i1	Q7SXS7	SETD3_DANRE	39.6	490	276	7	1553	114	1	480	5.90E-95	349.7	SETD3_DANRE	reviewed	Actin-histidine N-methyltransferase (EC 2.1.1.85) (SET domain-containing protein 3)	setd3 zgc:63842	Danio rerio (Zebrafish) (Brachydanio rerio)	596	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-histidine N-methyltransferase activity [GO:0018064]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription coactivator activity [GO:0003713]; actin modification [GO:0030047]; cell population proliferation [GO:0008283]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]	actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-histidine N-methyltransferase activity [GO:0018064]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001558; GO:0003713; GO:0003779; GO:0005737; GO:0008283; GO:0010452; GO:0016279; GO:0018021; GO:0018023; GO:0018026; GO:0018027; GO:0018064; GO:0030047; GO:0042800; GO:0045893; GO:0045944; GO:0046975	"actin modification [GO:0030047]; cell population proliferation [GO:0008283]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell growth [GO:0001558]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2782_c0_g1_i2	Q7SXS7	SETD3_DANRE	39.6	490	276	7	1553	114	1	480	1.30E-94	348.6	SETD3_DANRE	reviewed	Actin-histidine N-methyltransferase (EC 2.1.1.85) (SET domain-containing protein 3)	setd3 zgc:63842	Danio rerio (Zebrafish) (Brachydanio rerio)	596	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-histidine N-methyltransferase activity [GO:0018064]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription coactivator activity [GO:0003713]; actin modification [GO:0030047]; cell population proliferation [GO:0008283]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]	actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-histidine N-methyltransferase activity [GO:0018064]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001558; GO:0003713; GO:0003779; GO:0005737; GO:0008283; GO:0010452; GO:0016279; GO:0018021; GO:0018023; GO:0018026; GO:0018027; GO:0018064; GO:0030047; GO:0042800; GO:0045893; GO:0045944; GO:0046975	"actin modification [GO:0030047]; cell population proliferation [GO:0008283]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell growth [GO:0001558]"		blue	blue	NA	NA	NA	NA
TRINITY_DN32354_c0_g1_i1	Q86TU7	SETD3_HUMAN	98.7	75	1	0	226	2	197	271	8.30E-37	153.7	SETD3_HUMAN	reviewed	Actin-histidine N-methyltransferase (EC 2.1.1.85) (SET domain-containing protein 3) (hSETD3)	SETD3 C14orf154	Homo sapiens (Human)	594	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-histidine N-methyltransferase activity [GO:0018064]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coactivator activity [GO:0003713]; actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-histidine N-methyltransferase activity [GO:0018064]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001102; GO:0003713; GO:0003779; GO:0005654; GO:0005737; GO:0010452; GO:0018021; GO:0018023; GO:0018026; GO:0018027; GO:0018064; GO:0030047; GO:0042800; GO:0045893; GO:0045944; GO:0046975; GO:0051149; GO:0070472	"actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of uterine smooth muscle contraction [GO:0070472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38839_c0_g1_i1	P00785	ACTN_ACTCC	41.5	65	33	1	4	198	286	345	1.20E-10	66.6	ACTN_ACTCC	reviewed	Actinidain (Actinidin) (EC 3.4.22.14) (allergen Act c 1)	ACT1A CEY00_Acc12058	Actinidia chinensis var. chinensis (Chinese soft-hair kiwi)	380	cysteine-type endopeptidase activity [GO:0004197]		cysteine-type endopeptidase activity [GO:0004197]	GO:0004197			NA	NA	NA	NA	NA	NA
TRINITY_DN3902_c0_g1_i1	Q9VU68	WDR1_DROME	47.8	207	105	3	695	81	368	573	1.30E-51	204.5	WDR1_DROME	reviewed	Actin-interacting protein 1 (AIP1) (Protein flare)	flr CG10724	Drosophila melanogaster (Fruit fly)	608	cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]	cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]	GO:0001736; GO:0005856; GO:0007298; GO:0030042; GO:0030833; GO:0030834; GO:0030836; GO:0030864; GO:0034316; GO:0035317; GO:0040011; GO:0045214; GO:0051015	actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN3902_c0_g1_i2	Q9VU68	WDR1_DROME	48.8	240	120	3	778	65	368	606	3.30E-64	246.5	WDR1_DROME	reviewed	Actin-interacting protein 1 (AIP1) (Protein flare)	flr CG10724	Drosophila melanogaster (Fruit fly)	608	cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]	cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]	GO:0001736; GO:0005856; GO:0007298; GO:0030042; GO:0030833; GO:0030834; GO:0030836; GO:0030864; GO:0034316; GO:0035317; GO:0040011; GO:0045214; GO:0051015	actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]		blue	blue	NA	NA	NA	NA
TRINITY_DN35145_c0_g1_i1	O96019	ACL6A_HUMAN	100	74	0	0	2	223	221	294	1.50E-38	159.5	ACL6A_HUMAN	reviewed	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)	ACTL6A BAF53 BAF53A INO80K	Homo sapiens (Human)	429	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007165; GO:0007399; GO:0016514; GO:0016579; GO:0021510; GO:0031011; GO:0032991; GO:0035267; GO:0040008; GO:0043044; GO:0043967; GO:0043968; GO:0071564	ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN15336_c1_g1_i1	O96019	ACL6A_HUMAN	100	105	0	0	315	1	305	409	6.10E-54	211.1	ACL6A_HUMAN	reviewed	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)	ACTL6A BAF53 BAF53A INO80K	Homo sapiens (Human)	429	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007165; GO:0007399; GO:0016514; GO:0016579; GO:0021510; GO:0031011; GO:0032991; GO:0035267; GO:0040008; GO:0043044; GO:0043967; GO:0043968; GO:0071564	ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN15336_c0_g1_i1	O96019	ACL6A_HUMAN	100	122	0	0	440	75	308	429	1.70E-65	250	ACL6A_HUMAN	reviewed	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)	ACTL6A BAF53 BAF53A INO80K	Homo sapiens (Human)	429	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007165; GO:0007399; GO:0016514; GO:0016579; GO:0021510; GO:0031011; GO:0032991; GO:0035267; GO:0040008; GO:0043044; GO:0043967; GO:0043968; GO:0071564	ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN19979_c0_g1_i1	Q9Z2N8	ACL6A_MOUSE	100	112	0	0	336	1	106	217	2.30E-59	229.2	ACL6A_MOUSE	reviewed	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A)	Actl6a Actl6 Baf53a	Mus musculus (Mouse)	429	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]	GO:0001825; GO:0003407; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0021510; GO:0031011; GO:0035267; GO:0040008; GO:0043044; GO:0043967; GO:0043968; GO:0071564	ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN6640_c0_g1_i1	O94805	ACL6B_HUMAN	62.7	426	147	2	68	1309	1	426	3.80E-156	552.7	ACL6B_HUMAN	reviewed	Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B) (BAF53B)	ACTL6B ACTL6 BAF53B	Homo sapiens (Human)	426	nBAF complex [GO:0071565]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]	nBAF complex [GO:0071565]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0005200; GO:0005634; GO:0006325; GO:0006338; GO:0006357; GO:0007399; GO:0016358; GO:0016514; GO:0021510; GO:0035267; GO:0042551; GO:0043044; GO:0043967; GO:0071565	ATP-dependent chromatin remodeling [GO:0043044]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]		blue	blue	NA	NA	NA	NA
TRINITY_DN193_c0_g1_i10	Q3ZBD2	ARP10_BOVIN	48.6	395	195	4	97	1269	1	391	1.40E-103	378.3	ARP10_BOVIN	reviewed	Actin-related protein 10	ACTR10	Bos taurus (Bovine)	417	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]		GO:0005869; GO:0007018; GO:0098958; GO:1904115	microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	1
TRINITY_DN193_c0_g1_i2	Q3ZBD2	ARP10_BOVIN	48.6	395	195	4	97	1269	1	391	1.40E-103	378.3	ARP10_BOVIN	reviewed	Actin-related protein 10	ACTR10	Bos taurus (Bovine)	417	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]		GO:0005869; GO:0007018; GO:0098958; GO:1904115	microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	NA
TRINITY_DN193_c0_g1_i7	Q3ZBD2	ARP10_BOVIN	48.6	395	195	4	97	1269	1	391	1.40E-103	378.3	ARP10_BOVIN	reviewed	Actin-related protein 10	ACTR10	Bos taurus (Bovine)	417	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]		GO:0005869; GO:0007018; GO:0098958; GO:1904115	microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	NA
TRINITY_DN31724_c0_g1_i1	Q9QZB7	ARP10_MOUSE	100	83	0	0	1	249	75	157	1.00E-40	166.8	ARP10_MOUSE	reviewed	Actin-related protein 10 (Actin-related protein 11)	Actr10 Act11 Actr11 Arp11	Mus musculus (Mouse)	417	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; dynactin complex [GO:0005869]		GO:0005869; GO:0007018; GO:0098958; GO:1904115	microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	NA
TRINITY_DN32312_c0_g1_i1	Q9NZ32	ARP10_HUMAN	100	66	0	0	199	2	245	310	3.90E-30	131.3	ARP10_HUMAN	reviewed	Actin-related protein 10 (Actin-related protein 11) (hARP11)	ACTR10 ACTR11 ARP11	Homo sapiens (Human)	417	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; neutrophil degranulation [GO:0043312]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]		GO:0005576; GO:0005829; GO:0005869; GO:0006888; GO:0007018; GO:0019886; GO:0035578; GO:0043312; GO:0098958; GO:1904115; GO:1904813	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; neutrophil degranulation [GO:0043312]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	NA
TRINITY_DN31817_c0_g1_i1	Q9NZ32	ARP10_HUMAN	100	79	0	0	3	239	68	146	3.60E-38	158.3	ARP10_HUMAN	reviewed	Actin-related protein 10 (Actin-related protein 11) (hARP11)	ACTR10 ACTR11 ARP11	Homo sapiens (Human)	417	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; neutrophil degranulation [GO:0043312]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]		GO:0005576; GO:0005829; GO:0005869; GO:0006888; GO:0007018; GO:0019886; GO:0035578; GO:0043312; GO:0098958; GO:1904115; GO:1904813	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; neutrophil degranulation [GO:0043312]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	NA
TRINITY_DN33648_c0_g1_i1	P45888	ARP2_DROME	47.1	68	36	0	206	3	281	348	2.30E-12	72.4	ARP2_DROME	reviewed	Actin-related protein 2 (Actin-like protein 14D) (Actin-like protein 2)	Arp2 Actr14D Arp14D CG9901	Drosophila melanogaster (Fruit fly)	399	actin filament [GO:0005884]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell morphogenesis [GO:0000902]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of filopodium assembly [GO:0051489]; terminal button organization [GO:0072553]	actin filament [GO:0005884]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]	actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000902; GO:0003779; GO:0005200; GO:0005524; GO:0005737; GO:0005884; GO:0005885; GO:0007015; GO:0034314; GO:0045887; GO:0051489; GO:0072553	actin filament organization [GO:0007015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell morphogenesis [GO:0000902]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of filopodium assembly [GO:0051489]; terminal button organization [GO:0072553]		NA	NA	NA	NA	NA	NA
TRINITY_DN40660_c0_g1_i1	A7MB62	ARP2_BOVIN	99.4	158	1	0	3	476	151	308	3.20E-86	318.9	ARP2_BOVIN	reviewed	Actin-related protein 2 (Actin-like protein 2)	ACTR2 ARP2	Bos taurus (Bovine)	394	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0010592; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:1905168	Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN10225_c0_g1_i2	Q5BL41	ARP2_XENTR	82.3	390	67	2	40	1206	1	389	9.60E-194	677.6	ARP2_XENTR	reviewed	Actin-related protein 2 (Actin-like protein 2)	actr2 arp2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	394	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:1905168	Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]		blue	blue	NA	NA	NA	NA
TRINITY_DN29819_c0_g1_i1	A7MB62	ARP2_BOVIN	100	394	0	0	1196	15	1	394	2.40E-231	802.4	ARP2_BOVIN	reviewed	Actin-related protein 2 (Actin-like protein 2)	ACTR2 ARP2	Bos taurus (Bovine)	394	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0010592; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:1905168	Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN13950_c0_g1_i1	Q92747	ARC1A_HUMAN	99.5	221	1	0	665	3	1	221	3.50E-134	478.8	ARC1A_HUMAN	reviewed	Actin-related protein 2/3 complex subunit 1A (SOP2-like protein)	ARPC1A SOP2L	Homo sapiens (Human)	370	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024]	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005634; GO:0005829; GO:0005885; GO:0015629; GO:0030036; GO:0034314; GO:0035861; GO:0036195; GO:0038096; GO:0048013; GO:0051015; GO:0061024; GO:0070062	actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024]		NA	NA	NA	NA	NA	NA
TRINITY_DN13950_c0_g1_i2	Q9R0Q6	ARC1A_MOUSE	99.5	221	1	0	665	3	1	221	2.00E-134	479.6	ARC1A_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 1A (SOP2-like protein) (Sid 329)	Arpc1a Sid329	Mus musculus (Mouse)	370	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]	GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0036195; GO:0051015	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN29238_c0_g1_i1	Q9R0Q6	ARC1A_MOUSE	100	56	0	0	44	211	1	56	1.30E-28	126.3	ARC1A_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 1A (SOP2-like protein) (Sid 329)	Arpc1a Sid329	Mus musculus (Mouse)	370	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]	GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0036195; GO:0051015	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19662_c0_g1_i1	A0A1L8EXB5	AR1AB_XENLA	51.5	99	47	1	2	298	194	291	2.80E-24	112.5	AR1AB_XENLA	reviewed	Actin-related protein 2/3 complex subunit 1A-B	arpc1a-b XELAEV_18045070mg	Xenopus laevis (African clawed frog)	370	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN22778_c0_g1_i1	A0A1L8EXB5	AR1AB_XENLA	59.7	367	146	2	1194	94	5	369	1.20E-135	484.6	AR1AB_XENLA	reviewed	Actin-related protein 2/3 complex subunit 1A-B	arpc1a-b XELAEV_18045070mg	Xenopus laevis (African clawed frog)	370	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861	Arp2/3 complex-mediated actin nucleation [GO:0034314]		blue	blue	NA	NA	NA	NA
TRINITY_DN3517_c0_g2_i1	Q9WV32	ARC1B_MOUSE	100	227	0	0	50	730	1	227	1.10E-141	503.8	ARC1B_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)	Arpc1b	Mus musculus (Mouse)	372	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; tubulobulbar complex [GO:0036284]; actin filament binding [GO:0051015]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; tubulobulbar complex [GO:0036284]	actin filament binding [GO:0051015]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0032355; GO:0034314; GO:0036284; GO:0043627; GO:0044877; GO:0051015	Arp2/3 complex-mediated actin nucleation [GO:0034314]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN3517_c0_g1_i1	O15143	ARC1B_HUMAN	100	228	0	0	54	737	1	228	4.80E-142	505	ARC1B_HUMAN	reviewed	Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)	ARPC1B ARC41	Homo sapiens (Human)	372	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; tubulobulbar complex [GO:0036284]; actin binding [GO:0003779]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; tubulobulbar complex [GO:0036284]	actin binding [GO:0003779]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005885; GO:0005925; GO:0015629; GO:0032355; GO:0034314; GO:0036284; GO:0038096; GO:0043627; GO:0044877; GO:0048013; GO:0070062	Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN36714_c0_g1_i1	Q9JM76	ARPC3_MOUSE	52.4	42	19	1	189	64	15	55	6.90E-06	50.8	ARPC3_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	Arpc3	Mus musculus (Mouse)	178	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]		NA	NA	NA	NA	NA	NA
TRINITY_DN20531_c1_g1_i1	Q9JM76	ARPC3_MOUSE	58.6	87	35	1	262	2	15	100	6.00E-24	111.3	ARPC3_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	Arpc3	Mus musculus (Mouse)	178	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]		NA	NA	NA	NA	NA	NA
TRINITY_DN20531_c0_g1_i1	Q3T035	ARPC3_BOVIN	58.9	73	30	0	2	220	74	146	8.10E-21	100.5	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN11174_c0_g1_i1	Q3T035	ARPC3_BOVIN	100	178	0	0	610	77	1	178	5.10E-103	375.2	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN11174_c0_g2_i1	Q9JM76	ARPC3_MOUSE	100	178	0	0	603	70	1	178	2.40E-102	372.9	ARPC3_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	Arpc3	Mus musculus (Mouse)	178	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]		NA	NA	NA	NA	NA	NA
TRINITY_DN1780_c1_g2_i1	Q3T035	ARPC3_BOVIN	60.5	177	68	2	893	366	1	176	1.30E-62	241.5	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN1780_c1_g2_i2	Q3T035	ARPC3_BOVIN	60.5	177	68	2	812	285	1	176	1.20E-62	241.5	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		blue	blue	NA	NA	NA	NA
TRINITY_DN21610_c0_g1_i1	Q3T035	ARPC3_BOVIN	46.2	106	40	1	438	121	88	176	9.60E-21	101.3	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN21610_c0_g1_i6	Q3T035	ARPC3_BOVIN	55.9	68	30	0	324	121	109	176	9.00E-16	85.1	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		blue	blue	NA	NA	NA	NA
TRINITY_DN21610_c0_g1_i6	Q3T035	ARPC3_BOVIN	52.7	55	26	0	559	395	78	132	5.10E-11	69.3	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		blue	blue	NA	NA	NA	NA
TRINITY_DN21610_c0_g1_i7	Q3T035	ARPC3_BOVIN	55.6	99	44	0	417	121	78	176	1.70E-27	123.6	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN21610_c0_g2_i1	Q9JM76	ARPC3_MOUSE	63.8	69	24	1	212	6	15	82	5.90E-19	94.4	ARPC3_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	Arpc3	Mus musculus (Mouse)	178	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]		NA	NA	NA	NA	NA	NA
TRINITY_DN22093_c1_g1_i1	Q9JM76	ARPC3_MOUSE	57.5	80	32	2	34	270	1	79	3.20E-19	95.5	ARPC3_MOUSE	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	Arpc3	Mus musculus (Mouse)	178	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]		NA	NA	NA	NA	NA	NA
TRINITY_DN22093_c2_g1_i1	Q3T035	ARPC3_BOVIN	53.5	71	33	0	3	215	106	176	1.10E-15	83.6	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN25149_c0_g1_i1	Q3T035	ARPC3_BOVIN	56.2	80	35	0	251	12	40	119	3.40E-21	102.1	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN30521_c0_g1_i1	Q3T035	ARPC3_BOVIN	55	100	44	1	300	1	29	127	1.00E-26	120.6	ARPC3_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Bos taurus (Bovine)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN22093_c0_g1_i1	A1DPK7	ARC3A_XENLA	56.8	118	49	2	63	413	1	117	9.80E-36	151	ARC3A_XENLA	reviewed	Actin-related protein 2/3 complex subunit 3-A	arpc3-a XELAEV_18010654mg	Xenopus laevis (African clawed frog)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN22093_c0_g1_i2	A1DPK7	ARC3A_XENLA	53	83	37	2	63	308	1	82	1.80E-18	93.2	ARC3A_XENLA	reviewed	Actin-related protein 2/3 complex subunit 3-A	arpc3-a XELAEV_18010654mg	Xenopus laevis (African clawed frog)	178	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19980_c0_g1_i1	Q641G7	ARPC4_XENLA	77.4	93	21	0	281	3	2	94	3.30E-32	139	ARPC4_XENLA	reviewed	Actin-related protein 2/3 complex subunit 4	arpc4 XELAEV_18025964mg	Xenopus laevis (African clawed frog)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19980_c0_g1_i3	Q641G7	ARPC4_XENLA	77.7	94	21	0	284	3	1	94	8.50E-33	141	ARPC4_XENLA	reviewed	Actin-related protein 2/3 complex subunit 4	arpc4 XELAEV_18025964mg	Xenopus laevis (African clawed frog)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		blue	blue	NA	NA	NA	NA
TRINITY_DN1606_c0_g2_i1	Q641G7	ARPC4_XENLA	84.5	168	26	0	87	590	1	168	1.30E-74	280.8	ARPC4_XENLA	reviewed	Actin-related protein 2/3 complex subunit 4	arpc4 XELAEV_18025964mg	Xenopus laevis (African clawed frog)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		blue	blue	NA	NA	NA	NA
TRINITY_DN1606_c0_g2_i3	Q641G7	ARPC4_XENLA	75.9	54	13	0	185	346	41	94	2.20E-16	86.7	ARPC4_XENLA	reviewed	Actin-related protein 2/3 complex subunit 4	arpc4 XELAEV_18025964mg	Xenopus laevis (African clawed frog)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19980_c0_g1_i2	Q148J6	ARPC4_BOVIN	75	72	18	0	218	3	23	94	9.40E-22	103.6	ARPC4_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)	ARPC4	Bos taurus (Bovine)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005829; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19980_c1_g1_i1	Q148J6	ARPC4_BOVIN	79	105	22	0	316	2	59	163	1.30E-40	166.8	ARPC4_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)	ARPC4	Bos taurus (Bovine)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005829; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN17960_c0_g2_i1	Q148J6	ARPC4_BOVIN	100	168	0	0	554	51	1	168	1.30E-86	320.5	ARPC4_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)	ARPC4	Bos taurus (Bovine)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005829; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN17960_c0_g1_i1	Q148J6	ARPC4_BOVIN	100	168	0	0	553	50	1	168	1.00E-86	320.9	ARPC4_BOVIN	reviewed	Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)	ARPC4	Bos taurus (Bovine)	168	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005829; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN10225_c0_g1_i1	Q7ZXV3	ARP2B_XENLA	82.6	287	49	1	40	897	1	287	2.20E-142	506.5	ARP2B_XENLA	reviewed	Actin-related protein 2-B (Actin-like protein 2-B)	actr2-b arp2-b	Xenopus laevis (African clawed frog)	394	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:1905168	Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]		blue	blue	NA	NA	NA	NA
TRINITY_DN21473_c0_g1_i1	A2X6S3	ARP3_ORYSI	55.4	101	41	1	306	4	82	178	3.80E-24	112.1	ARP3_ORYSI	reviewed	Actin-related protein 3	ARP3 OsI_07915	Oryza sativa subsp. indica (Rice)	428	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; ATP binding [GO:0005524]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005737; GO:0005856; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN15889_c0_g1_i1	P61157	ARP3_BOVIN	100	418	0	0	1342	89	1	418	4.20E-248	858.2	ARP3_BOVIN	reviewed	Actin-related protein 3 (Actin-2) (Actin-like protein 3)	ACTR3 ARP3	Bos taurus (Bovine)	418	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cilium assembly [GO:0060271]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0010592; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:0060271	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cilium assembly [GO:0060271]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN15889_c0_g1_i2	P61157	ARP3_BOVIN	100	418	0	0	1326	73	1	418	4.20E-248	858.2	ARP3_BOVIN	reviewed	Actin-related protein 3 (Actin-2) (Actin-like protein 3)	ACTR3 ARP3	Bos taurus (Bovine)	418	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cilium assembly [GO:0060271]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0010592; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:0060271	Arp2/3 complex-mediated actin nucleation [GO:0034314]; cilium assembly [GO:0060271]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN1339_c0_g1_i1	P32392	ARP3_DROME	79.6	417	85	0	96	1346	1	417	8.20E-207	721.1	ARP3_DROME	reviewed	Actin-related protein 3 (Actin-2) (Actin-like protein 3) (Actin-like protein 66B)	Arp3 Actr66B Arp66B CG7558	Drosophila melanogaster (Fruit fly)	418	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament reorganization involved in cell cycle [GO:0030037]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; axonal fasciculation [GO:0007413]; cell morphogenesis [GO:0000902]; chaeta development [GO:0022416]; intracellular protein transport [GO:0006886]; myoblast fusion [GO:0007520]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; terminal button organization [GO:0072553]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]	actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000902; GO:0003779; GO:0005200; GO:0005524; GO:0005737; GO:0005885; GO:0006886; GO:0007413; GO:0007520; GO:0010592; GO:0022416; GO:0030027; GO:0030036; GO:0030037; GO:0030589; GO:0034314; GO:0045887; GO:0051491; GO:0072553; GO:0097320	actin cytoskeleton organization [GO:0030036]; actin filament reorganization involved in cell cycle [GO:0030037]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; axonal fasciculation [GO:0007413]; cell morphogenesis [GO:0000902]; chaeta development [GO:0022416]; intracellular protein transport [GO:0006886]; myoblast fusion [GO:0007520]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; terminal button organization [GO:0072553]		blue	blue	NA	NA	NA	NA
TRINITY_DN1339_c0_g1_i9	P32392	ARP3_DROME	81.9	127	23	0	96	476	1	127	3.10E-62	239.6	ARP3_DROME	reviewed	Actin-related protein 3 (Actin-2) (Actin-like protein 3) (Actin-like protein 66B)	Arp3 Actr66B Arp66B CG7558	Drosophila melanogaster (Fruit fly)	418	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament reorganization involved in cell cycle [GO:0030037]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; axonal fasciculation [GO:0007413]; cell morphogenesis [GO:0000902]; chaeta development [GO:0022416]; intracellular protein transport [GO:0006886]; myoblast fusion [GO:0007520]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; terminal button organization [GO:0072553]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]	actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000902; GO:0003779; GO:0005200; GO:0005524; GO:0005737; GO:0005885; GO:0006886; GO:0007413; GO:0007520; GO:0010592; GO:0022416; GO:0030027; GO:0030036; GO:0030037; GO:0030589; GO:0034314; GO:0045887; GO:0051491; GO:0072553; GO:0097320	actin cytoskeleton organization [GO:0030036]; actin filament reorganization involved in cell cycle [GO:0030037]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; axonal fasciculation [GO:0007413]; cell morphogenesis [GO:0000902]; chaeta development [GO:0022416]; intracellular protein transport [GO:0006886]; myoblast fusion [GO:0007520]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; terminal button organization [GO:0072553]		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i27	Q99JY9	ARP3_MOUSE	50.9	53	26	0	82	240	228	280	4.00E-12	72.8	ARP3_MOUSE	reviewed	Actin-related protein 3 (Actin-like protein 3)	Actr3 Arp3	Mus musculus (Mouse)	418	apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of myosin II filament organization [GO:0043519]; spindle localization [GO:0051653]	apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell leading edge [GO:0031252]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000139; GO:0001726; GO:0002102; GO:0003779; GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0008356; GO:0010592; GO:0010763; GO:0016344; GO:0030027; GO:0030056; GO:0030517; GO:0030838; GO:0031252; GO:0032092; GO:0033206; GO:0034314; GO:0035861; GO:0043519; GO:0045666; GO:0045944; GO:0048471; GO:0048708; GO:0048711; GO:0050775; GO:0051015; GO:0051117; GO:0051321; GO:0051491; GO:0051653; GO:0051965; GO:0060076; GO:0060271; GO:0061003; GO:0061825; GO:0061828; GO:0061830; GO:0061831; GO:0061832; GO:0061851; GO:0071346; GO:0071356; GO:0071560; GO:0090314; GO:0098794; GO:0098974; GO:0098978; GO:1903078; GO:1904171; GO:2000251	Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of myosin II filament organization [GO:0043519]; spindle localization [GO:0051653]		blue	blue	NA	NA	NA	NA
TRINITY_DN1339_c1_g1_i1	Q61WW9	ARP3_CAEBR	70.3	37	11	0	238	128	152	188	5.20E-05	48.1	ARP3_CAEBR	reviewed	Actin-related protein 3 (Actin-like protein 3)	arx-1 CBG04224	Caenorhabditis briggsae	426	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; epithelial cell migration [GO:0010631]; gastrulation [GO:0007369]; morphogenesis of embryonic epithelium [GO:0016331]	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005737; GO:0005885; GO:0007369; GO:0010631; GO:0016331; GO:0031252; GO:0034314	Arp2/3 complex-mediated actin nucleation [GO:0034314]; epithelial cell migration [GO:0010631]; gastrulation [GO:0007369]; morphogenesis of embryonic epithelium [GO:0016331]		NA	NA	NA	NA	NA	NA
TRINITY_DN15889_c0_g1_i3	Q99JY9	ARP3_MOUSE	100	418	0	0	1326	73	1	418	5.50E-248	857.8	ARP3_MOUSE	reviewed	Actin-related protein 3 (Actin-like protein 3)	Actr3 Arp3	Mus musculus (Mouse)	418	apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of myosin II filament organization [GO:0043519]; spindle localization [GO:0051653]	apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell leading edge [GO:0031252]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]	GO:0000139; GO:0001726; GO:0002102; GO:0003779; GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0008356; GO:0010592; GO:0010763; GO:0016344; GO:0030027; GO:0030056; GO:0030517; GO:0030838; GO:0031252; GO:0032092; GO:0033206; GO:0034314; GO:0035861; GO:0043519; GO:0045666; GO:0045944; GO:0048471; GO:0048708; GO:0048711; GO:0050775; GO:0051015; GO:0051117; GO:0051321; GO:0051491; GO:0051653; GO:0051965; GO:0060076; GO:0060271; GO:0061003; GO:0061825; GO:0061828; GO:0061830; GO:0061831; GO:0061832; GO:0061851; GO:0071346; GO:0071356; GO:0071560; GO:0090314; GO:0098794; GO:0098974; GO:0098978; GO:1903078; GO:1904171; GO:2000251	Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of myosin II filament organization [GO:0043519]; spindle localization [GO:0051653]		NA	NA	NA	NA	NA	NA
TRINITY_DN26827_c0_g1_i1	Q9C0K3	ARP3C_HUMAN	95.4	65	3	0	227	33	127	191	4.50E-30	131.3	ARP3C_HUMAN	reviewed	Actin-related protein 3C (Actin-related protein 11)	ACTR3C ARP11	Homo sapiens (Human)	210	Arp2/3 protein complex [GO:0005885]; extracellular exosome [GO:0070062]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]	Arp2/3 protein complex [GO:0005885]; extracellular exosome [GO:0070062]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005885; GO:0034314; GO:0070062	Arp2/3 complex-mediated actin nucleation [GO:0034314]		NA	NA	NA	NA	NA	NA
TRINITY_DN27255_c0_g1_i1	Q17GZ9	ARP5_AEDAE	46.3	244	126	3	6	731	407	647	2.10E-49	197.6	ARP5_AEDAE	reviewed	Actin-related protein 5	Arp5 AAEL002822	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	655	"nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]		GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006355	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11464_c0_g1_i1	Q17GZ9	ARP5_AEDAE	45.8	349	171	7	1025	12	41	382	5.70E-71	269.6	ARP5_AEDAE	reviewed	Actin-related protein 5	Arp5 AAEL002822	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	655	"nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]		GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006355	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11464_c0_g1_i1	Q17GZ9	ARP5_AEDAE	43.3	67	36	1	1128	934	3	69	3.60E-09	64.3	ARP5_AEDAE	reviewed	Actin-related protein 5	Arp5 AAEL002822	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	655	"nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]		GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006355	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11464_c0_g1_i2	Q17GZ9	ARP5_AEDAE	46.5	387	191	7	1145	12	3	382	1.30E-86	321.6	ARP5_AEDAE	reviewed	Actin-related protein 5	Arp5 AAEL002822	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	655	"nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]		GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006355	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30453_c0_g1_i1	Q9GZN1	ARP6_HUMAN	100	103	0	0	310	2	184	286	2.10E-54	212.6	ARP6_HUMAN	reviewed	Actin-related protein 6 (hArp6) (hARPX)	ACTR6 CDA12	Homo sapiens (Human)	396	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	nucleosome binding [GO:0031491]	GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0031491; GO:0043486	histone exchange [GO:0043486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1408_c0_g1_i1	Q9GZN1	ARP6_HUMAN	56	393	170	2	1245	73	5	396	1.30E-139	497.7	ARP6_HUMAN	reviewed	Actin-related protein 6 (hArp6) (hARPX)	ACTR6 CDA12	Homo sapiens (Human)	396	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	nucleosome binding [GO:0031491]	GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0031491; GO:0043486	histone exchange [GO:0043486]		NA	NA	NA	NA	NA	NA
TRINITY_DN26961_c0_g1_i1	Q9GZN1	ARP6_HUMAN	100	101	0	0	2	304	55	155	9.10E-55	213.8	ARP6_HUMAN	reviewed	Actin-related protein 6 (hArp6) (hARPX)	ACTR6 CDA12	Homo sapiens (Human)	396	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	nucleosome binding [GO:0031491]	GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0031491; GO:0043486	histone exchange [GO:0043486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3329_c0_g1_i3	O54967	ACK1_MOUSE	47	151	79	1	3	452	365	515	7.90E-33	143.3	ACK1_MOUSE	reviewed	Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2)	Tnk2 Ack1	Mus musculus (Mouse)	1055	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]	GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007169; GO:0007286; GO:0016310; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031234; GO:0031625; GO:0038083; GO:0042127; GO:0042802; GO:0043025; GO:0045087; GO:0046872; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:2000369	cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN14861_c0_g1_i2	O54967	ACK1_MOUSE	53.1	254	107	2	114	839	13	266	4.50E-65	249.6	ACK1_MOUSE	reviewed	Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2)	Tnk2 Ack1	Mus musculus (Mouse)	1055	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]	GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007169; GO:0007286; GO:0016310; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031234; GO:0031625; GO:0038083; GO:0042127; GO:0042802; GO:0043025; GO:0045087; GO:0046872; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:2000369	cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN14861_c0_g1_i3	O54967	ACK1_MOUSE	63.2	223	82	0	55	723	144	366	4.80E-78	292.4	ACK1_MOUSE	reviewed	Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2)	Tnk2 Ack1	Mus musculus (Mouse)	1055	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]	GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007169; GO:0007286; GO:0016310; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031234; GO:0031625; GO:0038083; GO:0042127; GO:0042802; GO:0043025; GO:0045087; GO:0046872; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:2000369	cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN14861_c0_g1_i6	O54967	ACK1_MOUSE	57.1	354	140	2	114	1139	13	366	8.80E-111	401.7	ACK1_MOUSE	reviewed	Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2)	Tnk2 Ack1	Mus musculus (Mouse)	1055	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]	GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007169; GO:0007286; GO:0016310; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031234; GO:0031625; GO:0038083; GO:0042127; GO:0042802; GO:0043025; GO:0045087; GO:0046872; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:2000369	cell differentiation [GO:0030154]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN35332_c0_g1_i2	Q9I7F7	ACKL_DROME	39.3	140	70	2	74	448	479	618	1.00E-14	81.6	ACKL_DROME	reviewed	Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)	Ack-like PR2 CG43741	Drosophila melanogaster (Fruit fly)	1337	"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0006468; GO:0007169; GO:0008258; GO:0018108; GO:0030154; GO:0031034; GO:0031234; GO:0038083; GO:0042127; GO:0045087; GO:0046664	"cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35332_c0_g1_i3	Q9I7F7	ACKL_DROME	34.3	254	101	5	11	601	438	682	5.00E-26	119.4	ACKL_DROME	reviewed	Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)	Ack-like PR2 CG43741	Drosophila melanogaster (Fruit fly)	1337	"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0006468; GO:0007169; GO:0008258; GO:0018108; GO:0030154; GO:0031034; GO:0031234; GO:0038083; GO:0042127; GO:0045087; GO:0046664	"cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35332_c0_g1_i4	Q9I7F7	ACKL_DROME	37.1	194	96	3	11	553	438	618	1.40E-21	104.8	ACKL_DROME	reviewed	Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)	Ack-like PR2 CG43741	Drosophila melanogaster (Fruit fly)	1337	"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0006468; GO:0007169; GO:0008258; GO:0018108; GO:0030154; GO:0031034; GO:0031234; GO:0038083; GO:0042127; GO:0045087; GO:0046664	"cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14468_c0_g1_i1	Q9I7F7	ACKL_DROME	81.2	64	12	0	193	2	234	297	8.50E-25	113.6	ACKL_DROME	reviewed	Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)	Ack-like PR2 CG43741	Drosophila melanogaster (Fruit fly)	1337	"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0006468; GO:0007169; GO:0008258; GO:0018108; GO:0030154; GO:0031034; GO:0031234; GO:0038083; GO:0042127; GO:0045087; GO:0046664	"cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14468_c0_g1_i2	Q9I7F7	ACKL_DROME	90	40	4	0	121	2	258	297	1.10E-13	77	ACKL_DROME	reviewed	Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)	Ack-like PR2 CG43741	Drosophila melanogaster (Fruit fly)	1337	"extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0006468; GO:0007169; GO:0008258; GO:0018108; GO:0030154; GO:0031034; GO:0031234; GO:0038083; GO:0042127; GO:0045087; GO:0046664	"cell differentiation [GO:0030154]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; innate immune response [GO:0045087]; myosin filament assembly [GO:0031034]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7839_c0_g1_i1	P11031	TCP4_MOUSE	100	76	0	0	3	230	52	127	5.60E-37	154.5	TCP4_MOUSE	reviewed	Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14)	Sub1 Pc4 Rpo2tc1	Mus musculus (Mouse)	127	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]	GO:0000978; GO:0003678; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0033613; GO:0042802; GO:0051053; GO:0051260; GO:0060261; GO:0060395	negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN7839_c0_g2_i1	P11031	TCP4_MOUSE	96.1	76	3	0	3	230	52	127	1.40E-35	149.8	TCP4_MOUSE	reviewed	Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14)	Sub1 Pc4 Rpo2tc1	Mus musculus (Mouse)	127	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]	GO:0000978; GO:0003678; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0033613; GO:0042802; GO:0051053; GO:0051260; GO:0060261; GO:0060395	negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN29833_c0_g1_i1	Q5ZK63	TCP4_CHICK	45.1	71	38	1	303	94	56	126	7.60E-13	75.1	TCP4_CHICK	reviewed	Activated RNA polymerase II transcriptional coactivator p15 (SUB1 homolog)	SUB1 RPO2TC1 RCJMB04_12p22	Gallus gallus (Chicken)	126	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0005634; GO:0005667; GO:0060261	positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]		blue	blue	NA	NA	NA	NA
TRINITY_DN24867_c0_g1_i1	E1BNG3	ASCC3_BOVIN	56.2	112	49	0	1	336	484	595	1.40E-32	140.2	ASCC3_BOVIN	reviewed	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	ascc3	Bos taurus (Bovine)	2201	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]		NA	NA	NA	NA	NA	NA
TRINITY_DN39207_c0_g1_i1	E7F8F4	ASCC3_DANRE	66.5	475	157	1	1498	74	861	1333	5.50E-193	675.2	ASCC3_DANRE	reviewed	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	ascc3	Danio rerio (Zebrafish) (Brachydanio rerio)	1534	nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; RNA catabolic process [GO:0006401]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0006307; GO:0006401; GO:0008283; GO:0016607; GO:0032508; GO:0043138	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN2458_c0_g1_i1	E9PZJ8	ASCC3_MOUSE	53.4	2172	931	22	6458	108	38	2183	0	2247.6	ASCC3_MOUSE	reviewed	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	Ascc3	Mus musculus (Mouse)	2198	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8971_c0_g1_i1	E7F8F4	ASCC3_DANRE	49.4	81	29	2	217	11	73	153	2.40E-12	72.8	ASCC3_DANRE	reviewed	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	ascc3	Danio rerio (Zebrafish) (Brachydanio rerio)	1534	nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; RNA catabolic process [GO:0006401]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0006307; GO:0006401; GO:0008283; GO:0016607; GO:0032508; GO:0043138	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN39094_c0_g1_i1	Q8N3C0	ASCC3_HUMAN	100	122	0	0	1	366	1465	1586	7.60E-64	244.2	ASCC3_HUMAN	reviewed	"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)"	ASCC3 HELIC1	Homo sapiens (Human)	2202	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0032508; GO:0043138; GO:0099053	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]		NA	NA	NA	NA	NA	NA
TRINITY_DN36546_c0_g1_i1	Q8N3C0	ASCC3_HUMAN	100	129	0	0	1	387	567	695	7.70E-67	254.2	ASCC3_HUMAN	reviewed	"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)"	ASCC3 HELIC1	Homo sapiens (Human)	2202	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0032508; GO:0043138; GO:0099053	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]		NA	NA	NA	NA	NA	NA
TRINITY_DN29355_c0_g1_i1	Q8N3C0	ASCC3_HUMAN	96.2	104	4	0	312	1	1200	1303	5.90E-57	221.1	ASCC3_HUMAN	reviewed	"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)"	ASCC3 HELIC1	Homo sapiens (Human)	2202	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0032508; GO:0043138; GO:0099053	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]		NA	NA	NA	NA	NA	NA
TRINITY_DN28605_c0_g1_i1	Q8N3C0	ASCC3_HUMAN	100	106	0	0	2	319	891	996	1.60E-54	213	ASCC3_HUMAN	reviewed	"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)"	ASCC3 HELIC1	Homo sapiens (Human)	2202	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0032508; GO:0043138; GO:0099053	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]		NA	NA	NA	NA	NA	NA
TRINITY_DN659_c0_g1_i1	Q6VMQ6	MCAF1_HUMAN	51.9	104	47	2	1917	2219	1157	1260	8.60E-20	100.5	MCAF1_HUMAN	reviewed	Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621)	ATF7IP MCAF MCAF1	Homo sapiens (Human)	1270	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016032; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309	"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN659_c0_g1_i2	Q6VMQ6	MCAF1_HUMAN	51.9	104	47	2	1698	2000	1157	1260	7.80E-20	100.5	MCAF1_HUMAN	reviewed	Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621)	ATF7IP MCAF MCAF1	Homo sapiens (Human)	1270	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016032; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309	"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN659_c0_g1_i3	Q6VMQ6	MCAF1_HUMAN	51.9	104	47	2	1602	1904	1157	1260	7.40E-20	100.5	MCAF1_HUMAN	reviewed	Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621)	ATF7IP MCAF MCAF1	Homo sapiens (Human)	1270	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016032; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309	"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN659_c0_g1_i4	Q6VMQ6	MCAF1_HUMAN	51.9	104	47	2	1569	1871	1157	1260	7.30E-20	100.5	MCAF1_HUMAN	reviewed	Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621)	ATF7IP MCAF MCAF1	Homo sapiens (Human)	1270	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016032; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309	"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN659_c0_g1_i6	Q6VMQ6	MCAF1_HUMAN	51.9	104	47	2	1950	2252	1157	1260	8.70E-20	100.5	MCAF1_HUMAN	reviewed	Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621)	ATF7IP MCAF MCAF1	Homo sapiens (Human)	1270	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0016032; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309	"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19488_c0_g2_i1	Q8BK64	AHSA1_MOUSE	100	87	0	0	1	261	232	318	1.20E-47	189.9	AHSA1_MOUSE	reviewed	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1)	Ahsa1	Mus musculus (Mouse)	338	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879	positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN25000_c0_g1_i2	Q8BK64	AHSA1_MOUSE	99	98	1	0	297	4	1	98	5.30E-54	211.5	AHSA1_MOUSE	reviewed	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1)	Ahsa1	Mus musculus (Mouse)	338	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879	positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN13128_c0_g1_i1	O95433	AHSA1_HUMAN	47.4	133	70	0	401	3	200	332	3.10E-33	143.3	AHSA1_HUMAN	reviewed	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38)	AHSA1 C14orf3 HSPC322	Homo sapiens (Human)	338	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]	ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005783; GO:0005829; GO:0006457; GO:0016032; GO:0032781; GO:0045296; GO:0051087; GO:0051879; GO:0070062	positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]		brown	brown	NA	NA	NA	NA
TRINITY_DN13128_c0_g1_i2	O95433	AHSA1_HUMAN	43.7	348	179	6	1043	3	1	332	4.00E-79	296.6	AHSA1_HUMAN	reviewed	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38)	AHSA1 C14orf3 HSPC322	Homo sapiens (Human)	338	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]	ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005783; GO:0005829; GO:0006457; GO:0016032; GO:0032781; GO:0045296; GO:0051087; GO:0051879; GO:0070062	positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN19488_c0_g1_i1	O95433	AHSA1_HUMAN	100	74	0	0	3	224	229	302	8.00E-40	163.7	AHSA1_HUMAN	reviewed	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38)	AHSA1 C14orf3 HSPC322	Homo sapiens (Human)	338	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]	ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005783; GO:0005829; GO:0006457; GO:0016032; GO:0032781; GO:0045296; GO:0051087; GO:0051879; GO:0070062	positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN25000_c0_g1_i1	O95433	AHSA1_HUMAN	100	118	0	0	355	2	1	118	9.10E-66	250.8	AHSA1_HUMAN	reviewed	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38)	AHSA1 C14orf3 HSPC322	Homo sapiens (Human)	338	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]	ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005783; GO:0005829; GO:0006457; GO:0016032; GO:0032781; GO:0045296; GO:0051087; GO:0051879; GO:0070062	positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2029_c0_g1_i4	Q28041	ACVR1_BOVIN	65.2	256	89	0	860	93	253	508	1.70E-99	364	ACVR1_BOVIN	reviewed	Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1)	ACVR1 ACVRLK2	Bos taurus (Bovine)	509	"activin receptor complex [GO:0048179]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; angiogenesis [GO:0001525]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; neural crest cell migration [GO:0001755]; protein phosphorylation [GO:0006468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]"	activin receptor complex [GO:0048179]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]"	GO:0001525; GO:0001655; GO:0001701; GO:0001755; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007507; GO:0009953; GO:0016361; GO:0030509; GO:0043235; GO:0046332; GO:0046872; GO:0048179; GO:0050431; GO:0070724; GO:0071363	angiogenesis [GO:0001525]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; neural crest cell migration [GO:0001755]; protein phosphorylation [GO:0006468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN37805_c0_g1_i1	Q28041	ACVR1_BOVIN	100	73	0	0	219	1	241	313	1.50E-35	149.4	ACVR1_BOVIN	reviewed	Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1)	ACVR1 ACVRLK2	Bos taurus (Bovine)	509	"activin receptor complex [GO:0048179]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; angiogenesis [GO:0001525]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; neural crest cell migration [GO:0001755]; protein phosphorylation [GO:0006468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]"	activin receptor complex [GO:0048179]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]"	GO:0001525; GO:0001655; GO:0001701; GO:0001755; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007507; GO:0009953; GO:0016361; GO:0030509; GO:0043235; GO:0046332; GO:0046872; GO:0048179; GO:0050431; GO:0070724; GO:0071363	angiogenesis [GO:0001525]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; neural crest cell migration [GO:0001755]; protein phosphorylation [GO:0006468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN2029_c0_g1_i2	Q90ZK6	ACVR1_CHICK	52.2	496	209	6	1538	93	22	503	6.90E-139	495.7	ACVR1_CHICK	reviewed	Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor)	ACVR1	Gallus gallus (Chicken)	504	"activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; angiogenesis [GO:0001525]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412]"	activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]"	GO:0000082; GO:0001525; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003203; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0010694; GO:0010718; GO:0010862; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0043235; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060389; GO:0060412; GO:0060923; GO:0061312; GO:0061445; GO:0070724; GO:0071363; GO:0071773; GO:1905007; GO:2000017; GO:2001237	"activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; angiogenesis [GO:0001525]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN51_c0_g1_i1	P36896	ACV1B_HUMAN	56.9	508	186	10	249	1760	26	504	6.80E-153	542.3	ACV1B_HUMAN	reviewed	Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2)	ACVR1B ACVRLK4 ALK4	Homo sapiens (Human)	505	"activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; development of primary female sexual characteristics [GO:0046545]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000082; GO:0001701; GO:0001942; GO:0004674; GO:0004675; GO:0005524; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007399; GO:0007417; GO:0009986; GO:0010629; GO:0010862; GO:0016361; GO:0018107; GO:0030308; GO:0031625; GO:0032924; GO:0032927; GO:0034711; GO:0038092; GO:0043235; GO:0045648; GO:0045944; GO:0046332; GO:0046545; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0071363; GO:0097191; GO:1901165	"activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; development of primary female sexual characteristics [GO:0046545]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"		NA	NA	NA	NA	NA	NA
TRINITY_DN51_c0_g1_i4	P36896	ACV1B_HUMAN	56	514	187	10	249	1778	26	504	2.40E-153	543.9	ACV1B_HUMAN	reviewed	Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2)	ACVR1B ACVRLK4 ALK4	Homo sapiens (Human)	505	"activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; development of primary female sexual characteristics [GO:0046545]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000082; GO:0001701; GO:0001942; GO:0004674; GO:0004675; GO:0005524; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007399; GO:0007417; GO:0009986; GO:0010629; GO:0010862; GO:0016361; GO:0018107; GO:0030308; GO:0031625; GO:0032924; GO:0032927; GO:0034711; GO:0038092; GO:0043235; GO:0045648; GO:0045944; GO:0046332; GO:0046545; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0071363; GO:0097191; GO:1901165	"activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; development of primary female sexual characteristics [GO:0046545]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"		NA	NA	NA	NA	NA	NA
TRINITY_DN51_c0_g1_i6	P36896	ACV1B_HUMAN	36.6	243	121	10	249	965	26	239	1.50E-24	115.2	ACV1B_HUMAN	reviewed	Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2)	ACVR1B ACVRLK4 ALK4	Homo sapiens (Human)	505	"activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; development of primary female sexual characteristics [GO:0046545]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000082; GO:0001701; GO:0001942; GO:0004674; GO:0004675; GO:0005524; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007399; GO:0007417; GO:0009986; GO:0010629; GO:0010862; GO:0016361; GO:0018107; GO:0030308; GO:0031625; GO:0032924; GO:0032927; GO:0034711; GO:0038092; GO:0043235; GO:0045648; GO:0045944; GO:0046332; GO:0046545; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0071363; GO:0097191; GO:1901165	"activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; development of primary female sexual characteristics [GO:0046545]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"		NA	NA	NA	NA	NA	1
TRINITY_DN38074_c0_g1_i1	Q28043	AVR2A_BOVIN	100	89	0	0	268	2	174	262	8.10E-47	187.2	AVR2A_BOVIN	reviewed	Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA)	ACVR2A ACTRII ACVR2	Bos taurus (Bovine)	513	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]	GO:0001702; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007283; GO:0007368; GO:0007498; GO:0009952; GO:0009986; GO:0010862; GO:0015026; GO:0017002; GO:0019838; GO:0030165; GO:0030501; GO:0030509; GO:0032924; GO:0032927; GO:0034673; GO:0034711; GO:0042713; GO:0043084; GO:0043235; GO:0043621; GO:0045648; GO:0045669; GO:0045944; GO:0046872; GO:0048179; GO:0048185; GO:0048706; GO:0050999; GO:0060011; GO:0071363; GO:0098821	activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; sperm ejaculation [GO:0042713]		NA	NA	NA	NA	NA	NA
TRINITY_DN30070_c0_g1_i1	Q90669	AVR2A_CHICK	54.1	471	192	4	317	1681	51	513	4.70E-143	509.6	AVR2A_CHICK	reviewed	Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA)	ACVR2A	Gallus gallus (Chicken)	513	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesodermal cell differentiation [GO:0048333]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]	GO:0001702; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007283; GO:0007368; GO:0008283; GO:0009798; GO:0009952; GO:0009986; GO:0010862; GO:0015026; GO:0016020; GO:0017002; GO:0019838; GO:0030165; GO:0030501; GO:0032924; GO:0032927; GO:0034673; GO:0034711; GO:0042713; GO:0043084; GO:0043235; GO:0043621; GO:0045648; GO:0045669; GO:0045944; GO:0046872; GO:0048179; GO:0048185; GO:0048333; GO:0048706; GO:0050999; GO:0060011; GO:0071363; GO:0098821	activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesodermal cell differentiation [GO:0048333]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; sperm ejaculation [GO:0042713]		NA	NA	NA	NA	NA	NA
TRINITY_DN4078_c0_g1_i2	P13798	ACPH_HUMAN	36.3	601	344	11	93	1823	144	729	2.10E-109	397.9	ACPH_HUMAN	reviewed	Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)	APEH D3F15S2 D3S48E DNF15S2	Homo sapiens (Human)	732	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]	identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]	GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0043312; GO:0050435; GO:0070062; GO:1904813	amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN4078_c0_g1_i3	P13798	ACPH_HUMAN	34.6	699	410	14	246	2246	46	729	1.10E-115	419.1	ACPH_HUMAN	reviewed	Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)	APEH D3F15S2 D3S48E DNF15S2	Homo sapiens (Human)	732	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]	identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]	GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0043312; GO:0050435; GO:0070062; GO:1904813	amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN4078_c0_g1_i4	P13798	ACPH_HUMAN	34.6	699	410	14	267	2267	46	729	1.10E-115	419.1	ACPH_HUMAN	reviewed	Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)	APEH D3F15S2 D3S48E DNF15S2	Homo sapiens (Human)	732	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]	identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]	GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0043312; GO:0050435; GO:0070062; GO:1904813	amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN27909_c0_g1_i1	P45867	ACDA_BACSU	42.6	54	31	0	191	30	318	371	8.90E-09	60.5	ACDA_BACSU	reviewed	Acyl-CoA dehydrogenase (EC 1.3.99.-)	acdA acd BSU37170	Bacillus subtilis (strain 168)	379	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]		acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0006635; GO:0050660	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN34372_c0_g1_i1	P45867	ACDA_BACSU	54.8	62	28	0	1	186	317	378	7.10E-15	80.9	ACDA_BACSU	reviewed	Acyl-CoA dehydrogenase (EC 1.3.99.-)	acdA acd BSU37170	Bacillus subtilis (strain 168)	379	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]		acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0006635; GO:0050660	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN35043_c0_g1_i1	P45867	ACDA_BACSU	50.7	73	36	0	220	2	110	182	2.80E-13	75.5	ACDA_BACSU	reviewed	Acyl-CoA dehydrogenase (EC 1.3.99.-)	acdA acd BSU37170	Bacillus subtilis (strain 168)	379	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]		acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0006635; GO:0050660	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN30948_c0_g1_i1	I6YCA3	CHSE4_MYCTU	56.6	76	33	0	1	228	100	175	9.30E-20	97.1	CHSE4_MYCTU	reviewed	Acyl-CoA dehydrogenase FadE26 (ACAD) (EC 1.3.99.-) (3-oxocholest-4-en-26-oyl-CoA dehydrogenase alpha subunit)	fadE26 Rv3504 LH57_19105	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	400	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]"		"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"	GO:0006707; GO:0009405; GO:0016627; GO:0050660	cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN28542_c0_g1_i1	Q14DH7	ACSS3_MOUSE	79.8	89	18	0	268	2	281	369	3.30E-40	165.2	ACSS3_MOUSE	reviewed	"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Propionate--CoA ligase) (EC 6.2.1.17)"	Acss3	Mus musculus (Mouse)	682	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0047760; GO:0050218			NA	NA	NA	NA	NA	NA
TRINITY_DN11414_c0_g1_i1	Q92604	LGAT1_HUMAN	42.6	364	187	2	137	1192	13	366	1.50E-82	308.1	LGAT1_HUMAN	reviewed	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-) (Acyl-CoA:monoacylglycerol acyltransferase LPGAT1) (EC 2.3.1.22)	LPGAT1 FAM34A KIAA0205	Homo sapiens (Human)	370	"cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; lysophospholipid acyltransferase activity [GO:0071617]; transferase activity, transferring acyl groups [GO:0016746]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]; triglyceride biosynthetic process [GO:0019432]"	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"2-acylglycerol O-acyltransferase activity [GO:0003846]; lysophospholipid acyltransferase activity [GO:0071617]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003846; GO:0005737; GO:0005783; GO:0005789; GO:0008654; GO:0012505; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0036148; GO:0036149; GO:0045723; GO:0071617	phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN4399_c0_g1_i2	Q8RWD9	ACBP5_ARATH	25	240	157	7	322	1008	211	438	4.50E-13	77.4	ACBP5_ARATH	reviewed	Acyl-CoA-binding domain-containing protein 5 (Acyl-CoA binding protein 5)	ACBP5 At5g27630 F15A18.90	Arabidopsis thaliana (Mouse-ear cress)	648	cytosol [GO:0005829]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; response to hypoxia [GO:0001666]; response to light stimulus [GO:0009416]	cytosol [GO:0005829]	fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]	GO:0000062; GO:0001666; GO:0005829; GO:0006869; GO:0008289; GO:0009416	lipid transport [GO:0006869]; response to hypoxia [GO:0001666]; response to light stimulus [GO:0009416]		NA	NA	NA	NA	NA	NA
TRINITY_DN4531_c0_g1_i1	Q4V8X4	ACBD6_DANRE	36.7	79	50	0	499	263	199	277	3.30E-06	53.9	ACBD6_DANRE	reviewed	Acyl-CoA-binding domain-containing protein 6	acbd6 wu:fc18d09	Danio rerio (Zebrafish) (Brachydanio rerio)	300	cytoplasm [GO:0005737]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]	cytoplasm [GO:0005737]	fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]	GO:0000062; GO:0005737; GO:0008289			NA	NA	NA	NA	NA	NA
TRINITY_DN10594_c1_g1_i1	A2VDR2	ACBD6_BOVIN	45.7	219	116	1	127	774	45	263	1.90E-55	217.6	ACBD6_BOVIN	reviewed	Acyl-CoA-binding domain-containing protein 6	ACBD6	Bos taurus (Bovine)	282	cytoplasm [GO:0005737]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]	cytoplasm [GO:0005737]	fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]	GO:0000062; GO:0005737; GO:0008289			blue	blue	NA	NA	NA	NA
TRINITY_DN10791_c0_g1_i6	Q5FVR5	ACNT2_RAT	50	56	28	0	69	236	356	411	2.60E-12	72.8	ACNT2_RAT	reviewed	Acyl-coenzyme A amino acid N-acyltransferase 2 (EC 2.3.1.-)	Acnat2	Rattus norvegicus (Rat)	418	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]	peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]	GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN826_c0_g1_i1	P0CZ23	ACOX3_ARATH	33.5	627	374	10	19	1782	48	670	1.90E-86	321.6	ACOX3_ARATH	reviewed	"Acyl-coenzyme A oxidase 3, peroxisomal (AOX 3) (Acyl-CoA oxidase 3) (EC 1.3.3.6) (Medium-chain acyl-CoA oxidase) (AtCX3)"	ACX3 At1g06290 F9P14.15 F9P14_11 T2D23.1	Arabidopsis thaliana (Mouse-ear cress)	675	extracellular region [GO:0005576]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; medium-chain fatty acid metabolic process [GO:0051791]	extracellular region [GO:0005576]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003997; GO:0005504; GO:0005576; GO:0005777; GO:0006635; GO:0033540; GO:0050660; GO:0051791; GO:0055088; GO:0071949	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; medium-chain fatty acid metabolic process [GO:0051791]		NA	NA	NA	NA	NA	NA
TRINITY_DN7777_c0_g1_i1	P0CZ23	ACOX3_ARATH	43.6	172	97	0	32	547	137	308	3.70E-38	159.5	ACOX3_ARATH	reviewed	"Acyl-coenzyme A oxidase 3, peroxisomal (AOX 3) (Acyl-CoA oxidase 3) (EC 1.3.3.6) (Medium-chain acyl-CoA oxidase) (AtCX3)"	ACX3 At1g06290 F9P14.15 F9P14_11 T2D23.1	Arabidopsis thaliana (Mouse-ear cress)	675	extracellular region [GO:0005576]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; medium-chain fatty acid metabolic process [GO:0051791]	extracellular region [GO:0005576]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003997; GO:0005504; GO:0005576; GO:0005777; GO:0006635; GO:0033540; GO:0050660; GO:0051791; GO:0055088; GO:0071949	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; medium-chain fatty acid metabolic process [GO:0051791]		NA	NA	NA	NA	NA	NA
TRINITY_DN18792_c0_g1_i1	O70490	ACSM2_RAT	41.4	70	41	0	10	219	214	283	2.20E-10	65.9	ACSM2_RAT	reviewed	"Acyl-coenzyme A synthetase ACSM2, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 2) (Benzoate--CoA ligase) (EC 6.2.1.25) (Butyrate--CoA ligase 2) (Butyryl-coenzyme A synthetase 2) (Kidney-specific protein KS) (Middle-chain acyl-CoA synthetase 2)"	Acsm2 Ks	Rattus norvegicus (Rat)	572	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]	GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018858; GO:0036112; GO:0046872; GO:0047760	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]		NA	NA	NA	NA	NA	NA
TRINITY_DN1270_c0_g1_i1	Q5REV5	ACSM3_PONAB	34.5	235	134	8	117	785	29	255	1.30E-29	131.7	ACSM3_PONAB	reviewed	"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)"	ACSM3 SAH	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	586	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; metal ion binding [GO:0046872]; propionate-CoA ligase activity [GO:0050218]; propionate CoA-transferase activity [GO:0018729]	GO:0005524; GO:0005759; GO:0006633; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1270_c0_g1_i2	Q3UNX5	ACSM3_MOUSE	47.2	563	276	9	117	1766	23	577	4.40E-152	539.7	ACSM3_MOUSE	reviewed	"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)"	Acsm3 Sa Sah	Mus musculus (Mouse)	580	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate-CoA ligase activity [GO:0050218]; propionate CoA-transferase activity [GO:0018729]	GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1270_c0_g1_i4	Q3UNX5	ACSM3_MOUSE	41	415	225	8	2	1210	26	432	6.40E-91	336.3	ACSM3_MOUSE	reviewed	"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)"	Acsm3 Sa Sah	Mus musculus (Mouse)	580	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate-CoA ligase activity [GO:0050218]; propionate CoA-transferase activity [GO:0018729]	GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1270_c0_g1_i4	Q3UNX5	ACSM3_MOUSE	71.4	98	27	1	1216	1506	480	577	1.50E-34	149.1	ACSM3_MOUSE	reviewed	"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)"	Acsm3 Sa Sah	Mus musculus (Mouse)	580	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate-CoA ligase activity [GO:0050218]; propionate CoA-transferase activity [GO:0018729]	GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1270_c0_g1_i3	Q6SKG1	ACSM3_RAT	68.5	143	44	1	65	490	435	577	1.10E-53	211.1	ACSM3_RAT	reviewed	"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (SA rat hypertension-associated protein) (Protein SA)"	Acsm3 Sah	Rattus norvegicus (Rat)	580	mitochondrial matrix [GO:0005759]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate-CoA ligase activity [GO:0050218]; propionate CoA-transferase activity [GO:0018729]	GO:0003996; GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN12993_c0_g1_i1	P0C7M7	ACSM4_HUMAN	70.5	78	23	0	235	2	447	524	5.80E-28	124.4	ACSM4_HUMAN	reviewed	"Acyl-coenzyme A synthetase ACSM4, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 4)"	ACSM4	Homo sapiens (Human)	580	mitochondrial matrix [GO:0005759]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]	GO:0003996; GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0047760; GO:0102391	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN8526_c0_g2_i3	Q86TX2	ACOT1_HUMAN	32.7	251	154	4	868	116	175	410	3.10E-31	137.1	ACOT1_HUMAN	reviewed	Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)	ACOT1 CTE1	Homo sapiens (Human)	421	cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN12893_c0_g2_i1	Q86TX2	ACOT1_HUMAN	53.1	147	68	1	10	447	126	272	3.60E-36	152.9	ACOT1_HUMAN	reviewed	Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)	ACOT1 CTE1	Homo sapiens (Human)	421	cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN12893_c0_g2_i2	Q86TX2	ACOT1_HUMAN	49	98	49	1	75	365	175	272	1.40E-17	90.9	ACOT1_HUMAN	reviewed	Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)	ACOT1 CTE1	Homo sapiens (Human)	421	cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN10791_c0_g1_i2	O55137	ACOT1_MOUSE	43.7	126	71	0	45	422	283	408	3.40E-27	122.9	ACOT1_MOUSE	reviewed	Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)	Acot1 Cte1	Mus musculus (Mouse)	419	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0001676; GO:0005737; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0010667; GO:0016290; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]		NA	NA	NA	NA	NA	NA
TRINITY_DN10791_c0_g1_i5	O55137	ACOT1_MOUSE	41.3	138	80	1	3	413	271	408	1.20E-27	124.4	ACOT1_MOUSE	reviewed	Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)	Acot1 Cte1	Mus musculus (Mouse)	419	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0001676; GO:0005737; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0010667; GO:0016290; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]		NA	NA	NA	NA	NA	NA
TRINITY_DN3179_c0_g1_i2	Q32MW3	ACO10_MOUSE	50	56	28	0	958	1125	247	302	1.80E-10	68.6	ACO10_MOUSE	reviewed	"Acyl-coenzyme A thioesterase 10, mitochondrial (Acyl-CoA thioesterase 10) (EC 3.1.2.-) (Mitochondrial 48 kDa acyl-CoA thioester hydrolase 2) (Mt-ACT48.2)"	Acot10	Mus musculus (Mouse)	439	mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]	mitochondrion [GO:0005739]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]	GO:0005739; GO:0006637; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]		NA	NA	NA	NA	NA	NA
TRINITY_DN3547_c0_g1_i2	Q9QYR7	ACOT3_MOUSE	39.9	321	173	7	33	977	115	421	1.40E-55	218.4	ACOT3_MOUSE	reviewed	Acyl-coenzyme A thioesterase 3 (Acyl-CoA thioesterase 3) (EC 3.1.2.2) (PTE-Ia) (Peroxisomal acyl-coenzyme A thioester hydrolase 2a) (Peroxisomal long-chain acyl-CoA thioesterase 2)	Acot3 Pte1a Pte2 Pte2a	Mus musculus (Mouse)	432	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005777; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN33430_c0_g1_i1	Q9QYR7	ACOT3_MOUSE	46.4	248	122	3	101	841	11	248	1.40E-60	234.6	ACOT3_MOUSE	reviewed	Acyl-coenzyme A thioesterase 3 (Acyl-CoA thioesterase 3) (EC 3.1.2.2) (PTE-Ia) (Peroxisomal acyl-coenzyme A thioester hydrolase 2a) (Peroxisomal long-chain acyl-CoA thioesterase 2)	Acot3 Pte1a Pte2 Pte2a	Mus musculus (Mouse)	432	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005777; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN12893_c0_g1_i3	Q9QYR7	ACOT3_MOUSE	38.3	94	55	2	157	435	24	115	2.50E-09	63.5	ACOT3_MOUSE	reviewed	Acyl-coenzyme A thioesterase 3 (Acyl-CoA thioesterase 3) (EC 3.1.2.2) (PTE-Ia) (Peroxisomal acyl-coenzyme A thioester hydrolase 2a) (Peroxisomal long-chain acyl-CoA thioesterase 2)	Acot3 Pte1a Pte2 Pte2a	Mus musculus (Mouse)	432	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005777; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN8526_c0_g2_i1	Q6Q2Z6	ACOT5_MOUSE	39.5	314	173	6	1039	101	118	415	8.90E-52	205.7	ACOT5_MOUSE	reviewed	Acyl-coenzyme A thioesterase 5 (Acyl-CoA thioesterase 5) (EC 3.1.2.2) (Peroxisomal acyl-coenzyme A thioester hydrolase Ic) (PTE-Ic) (Peroxisomal acyl-CoA thioesterase Ic)	Acot5	Mus musculus (Mouse)	421	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005777; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN10791_c0_g1_i3	Q6Q2Z6	ACOT5_MOUSE	41.6	77	42	2	3	224	271	347	7.80E-09	61.2	ACOT5_MOUSE	reviewed	Acyl-coenzyme A thioesterase 5 (Acyl-CoA thioesterase 5) (EC 3.1.2.2) (Peroxisomal acyl-coenzyme A thioester hydrolase Ic) (PTE-Ic) (Peroxisomal acyl-CoA thioesterase Ic)	Acot5	Mus musculus (Mouse)	421	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005777; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN33430_c0_g1_i4	Q6Q2Z6	ACOT5_MOUSE	49.2	195	89	2	58	642	53	237	9.90E-51	201.4	ACOT5_MOUSE	reviewed	Acyl-coenzyme A thioesterase 5 (Acyl-CoA thioesterase 5) (EC 3.1.2.2) (Peroxisomal acyl-coenzyme A thioester hydrolase Ic) (PTE-Ic) (Peroxisomal acyl-CoA thioesterase Ic)	Acot5	Mus musculus (Mouse)	421	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005777; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0047617; GO:0052689; GO:0102991	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN3179_c0_g1_i1	Q9Y305	ACOT9_HUMAN	48.2	303	149	4	249	1145	37	335	6.80E-73	276.2	ACOT9_HUMAN	reviewed	"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)"	ACOT9 CGI-16	Homo sapiens (Human)	439	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]		NA	NA	NA	NA	NA	NA
TRINITY_DN3179_c0_g1_i3	Q9Y305	ACOT9_HUMAN	48.2	303	149	4	249	1145	37	335	6.90E-73	276.2	ACOT9_HUMAN	reviewed	"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)"	ACOT9 CGI-16	Homo sapiens (Human)	439	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]		NA	NA	NA	NA	NA	NA
TRINITY_DN3179_c0_g1_i4	Q9Y305	ACOT9_HUMAN	46.7	403	204	5	249	1436	37	435	2.30E-101	370.9	ACOT9_HUMAN	reviewed	"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)"	ACOT9 CGI-16	Homo sapiens (Human)	439	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]		NA	NA	NA	NA	NA	NA
TRINITY_DN34609_c0_g1_i1	Q9Y305	ACOT9_HUMAN	100	69	0	0	3	209	261	329	7.10E-35	147.1	ACOT9_HUMAN	reviewed	"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)"	ACOT9 CGI-16	Homo sapiens (Human)	439	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]		NA	NA	NA	NA	NA	NA
TRINITY_DN39261_c0_g1_i1	Q9Y305	ACOT9_HUMAN	100	66	0	0	3	200	372	437	2.50E-32	138.7	ACOT9_HUMAN	reviewed	"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)"	ACOT9 CGI-16	Homo sapiens (Human)	439	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]		NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c1_g1_i1	Q53H12	AGK_HUMAN	32.4	438	265	7	159	1472	5	411	7.50E-52	206.5	AGK_HUMAN	reviewed	"Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase)"	AGK MULK	Homo sapiens (Human)	422	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; D-erythro-sphingosine kinase activity [GO:0017050]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid biosynthetic process [GO:0046474]; phosphorylation [GO:0016310]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]	acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; D-erythro-sphingosine kinase activity [GO:0017050]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]	GO:0001727; GO:0001729; GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0006665; GO:0016020; GO:0016310; GO:0017050; GO:0031305; GO:0031966; GO:0042721; GO:0043231; GO:0045039; GO:0046474; GO:0046512; GO:0046513; GO:0047620; GO:0102773	ceramide biosynthetic process [GO:0046513]; glycerophospholipid biosynthetic process [GO:0046474]; phosphorylation [GO:0016310]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN38649_c0_g1_i1	Q5RBR7	LYPA1_PONAB	56.8	229	95	2	761	87	1	229	1.30E-71	271.2	LYPA1_PONAB	reviewed	Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	LYPLA1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	230	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005886; GO:0006631; GO:0008474; GO:0031965	fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN31765_c0_g1_i1	O75608	LYPA1_HUMAN	100	69	0	0	38	244	1	69	8.40E-35	147.1	LYPA1_HUMAN	reviewed	Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	LYPLA1 APT1 LPL1	Homo sapiens (Human)	230	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0008474; GO:0016298; GO:0031965; GO:0042997; GO:0050999; GO:0052689; GO:0070062	fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]		NA	NA	NA	NA	NA	NA
TRINITY_DN38606_c0_g1_i1	O75608	LYPA1_HUMAN	100	91	0	0	3	275	140	230	9.40E-50	197.2	LYPA1_HUMAN	reviewed	Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	LYPLA1 APT1 LPL1	Homo sapiens (Human)	230	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0008474; GO:0016298; GO:0031965; GO:0042997; GO:0050999; GO:0052689; GO:0070062	fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]; regulation of nitric-oxide synthase activity [GO:0050999]		NA	NA	NA	NA	NA	NA
TRINITY_DN36769_c0_g1_i1	O95372	LYPA2_HUMAN	100	100	0	0	2	301	79	178	4.90E-53	208	LYPA2_HUMAN	reviewed	Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II)	LYPLA2 APT2	Homo sapiens (Human)	231	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]	cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0004622; GO:0005737; GO:0005795; GO:0005829; GO:0007411; GO:0008474; GO:0045296; GO:0046464; GO:0052689; GO:0070062; GO:1905344	acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN3975_c0_g1_i1	Q2HJ98	FAHD1_BOVIN	55.1	214	95	1	75	716	8	220	3.80E-68	259.6	FAHD1_BOVIN	reviewed	"Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112)"	FAHD1	Bos taurus (Bovine)	221	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0005654; GO:0005739; GO:0005829; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621			NA	NA	NA	NA	NA	NA
TRINITY_DN9144_c0_g1_i1	Q9VAC5	ADA17_DROME	64.1	248	87	1	1	738	414	661	1.40E-93	344	ADA17_DROME	reviewed	ADAM 17-like protease (EC 3.4.24.-)	Tace CG7908	Drosophila melanogaster (Fruit fly)	732	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0033209; GO:0040015; GO:0046872; GO:0051088; GO:1903427	membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]		NA	NA	NA	NA	NA	NA
TRINITY_DN9310_c0_g1_i1	Q8N6G6	ATL1_HUMAN	56.5	85	35	1	267	19	101	185	7.60E-21	100.9	ATL1_HUMAN	reviewed	ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1)	ADAMTSL1 ADAMTSR1 C9orf94 UNQ528/PRO1071	Homo sapiens (Human)	1762	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]	metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005788; GO:0030198; GO:0031012	extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN8266_c0_g1_i4	Q86TH1	ATL2_HUMAN	43.4	76	43	0	228	1	183	258	2.20E-11	69.7	ATL2_HUMAN	reviewed	ADAMTS-like protein 2 (ADAMTSL-2)	ADAMTSL2 KIAA0605	Homo sapiens (Human)	951	extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; microfibril binding [GO:0050436]; extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	extracellular matrix [GO:0031012]	metalloendopeptidase activity [GO:0004222]; microfibril binding [GO:0050436]	GO:0004222; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481	extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]		NA	NA	NA	NA	NA	NA
TRINITY_DN18452_c0_g1_i3	P82987	ATL3_HUMAN	42.2	90	44	5	361	104	421	506	4.80E-13	75.9	ATL3_HUMAN	reviewed	ADAMTS-like protein 3 (ADAMTSL-3) (Punctin-2)	ADAMTSL3 KIAA1233	Homo sapiens (Human)	1691	extracellular matrix [GO:0031012]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; intracellular membrane-bounded organelle [GO:0043231]	metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0030198; GO:0031012; GO:0043231	extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN654_c0_g1_i1	Q9XYM0	CRK_DROME	65.5	267	82	3	89	862	4	269	1.40E-98	360.9	CRK_DROME	reviewed	Adapter molecule Crk	Crk CG1587	Drosophila melanogaster (Fruit fly)	271	"receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		receptor tyrosine kinase binding [GO:0030971]	GO:0006911; GO:0007298; GO:0007520; GO:0030971; GO:0032956; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013	"border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN654_c0_g1_i2	Q9XYM0	CRK_DROME	64.1	273	82	4	89	880	4	269	1.30E-96	354.4	CRK_DROME	reviewed	Adapter molecule Crk	Crk CG1587	Drosophila melanogaster (Fruit fly)	271	"receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		receptor tyrosine kinase binding [GO:0030971]	GO:0006911; GO:0007298; GO:0007520; GO:0030971; GO:0032956; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013	"border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40819_c0_g1_i1	Q9NVZ3	NECP2_HUMAN	98.1	104	2	0	312	1	55	158	5.50E-55	214.5	NECP2_HUMAN	reviewed	Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2)	NECAP2	Homo sapiens (Human)	263	clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	clathrin-coated pit [GO:0005905]; clathrin vesicle coat [GO:0030125]		GO:0005905; GO:0006897; GO:0015031; GO:0016192; GO:0030125	endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN803_c0_g1_i12	P54363	APT_DROPS	48.6	181	93	0	82	624	1	181	5.10E-40	166	APT_DROPS	reviewed	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	Aprt GA14884	Drosophila pseudoobscura pseudoobscura (Fruit fly)	181	cytoplasm [GO:0005737]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]	adenine phosphoribosyltransferase activity [GO:0003999]	GO:0003999; GO:0005737; GO:0006166; GO:0006168; GO:0044209	adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN40390_c0_g1_i1	P08030	APT_MOUSE	100	86	0	0	3	260	84	169	2.20E-41	169.1	APT_MOUSE	reviewed	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	Aprt	Mus musculus (Mouse)	180	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine metabolic process [GO:0046083]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; grooming behavior [GO:0007625]; lactation [GO:0007595]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]	GO:0002055; GO:0003999; GO:0005654; GO:0005737; GO:0005829; GO:0006166; GO:0006168; GO:0007595; GO:0007625; GO:0016208; GO:0032869; GO:0044209; GO:0046083	adenine metabolic process [GO:0046083]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; grooming behavior [GO:0007625]; lactation [GO:0007595]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN803_c0_g1_i1	Q43199	APT1_WHEAT	52.1	165	77	1	397	891	4	166	9.50E-40	165.6	APT1_WHEAT	reviewed	Adenine phosphoribosyltransferase 1 (APRT 1) (EC 2.4.2.7)	APT1	Triticum aestivum (Wheat)	181	chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; circadian rhythm [GO:0007623]; cytokinin metabolic process [GO:0009690]; purine ribonucleoside salvage [GO:0006166]; response to cadmium ion [GO:0046686]	chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]	adenine phosphoribosyltransferase activity [GO:0003999]	GO:0003999; GO:0005794; GO:0005829; GO:0005886; GO:0006166; GO:0006168; GO:0007623; GO:0009505; GO:0009570; GO:0009690; GO:0044209; GO:0046686	adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; circadian rhythm [GO:0007623]; cytokinin metabolic process [GO:0009690]; purine ribonucleoside salvage [GO:0006166]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN803_c0_g1_i3	Q43199	APT1_WHEAT	52.1	165	77	1	227	721	4	166	7.90E-40	165.6	APT1_WHEAT	reviewed	Adenine phosphoribosyltransferase 1 (APRT 1) (EC 2.4.2.7)	APT1	Triticum aestivum (Wheat)	181	chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; circadian rhythm [GO:0007623]; cytokinin metabolic process [GO:0009690]; purine ribonucleoside salvage [GO:0006166]; response to cadmium ion [GO:0046686]	chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]	adenine phosphoribosyltransferase activity [GO:0003999]	GO:0003999; GO:0005794; GO:0005829; GO:0005886; GO:0006166; GO:0006168; GO:0007623; GO:0009505; GO:0009570; GO:0009690; GO:0044209; GO:0046686	adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; circadian rhythm [GO:0007623]; cytokinin metabolic process [GO:0009690]; purine ribonucleoside salvage [GO:0006166]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN803_c0_g1_i7	Q43199	APT1_WHEAT	52.1	165	77	1	134	628	4	166	1.20E-39	164.9	APT1_WHEAT	reviewed	Adenine phosphoribosyltransferase 1 (APRT 1) (EC 2.4.2.7)	APT1	Triticum aestivum (Wheat)	181	chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; circadian rhythm [GO:0007623]; cytokinin metabolic process [GO:0009690]; purine ribonucleoside salvage [GO:0006166]; response to cadmium ion [GO:0046686]	chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]	adenine phosphoribosyltransferase activity [GO:0003999]	GO:0003999; GO:0005794; GO:0005829; GO:0005886; GO:0006166; GO:0006168; GO:0007623; GO:0009505; GO:0009570; GO:0009690; GO:0044209; GO:0046686	adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; circadian rhythm [GO:0007623]; cytokinin metabolic process [GO:0009690]; purine ribonucleoside salvage [GO:0006166]; response to cadmium ion [GO:0046686]		blue	blue	NA	NA	NA	NA
TRINITY_DN19950_c0_g2_i1	Q61315	APC_MOUSE	62.8	218	74	4	1154	516	580	795	2.20E-64	247.7	APC_MOUSE	reviewed	Adenomatous polyposis coli protein (Protein APC) (mAPC)	Apc	Mus musculus (Mouse)	2845	adherens junction [GO:0005912]; axon [GO:0030424]; axonal growth cone [GO:0044295]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell body fiber [GO:0070852]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; Scrib-APC-beta-catenin complex [GO:0034750]; beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell cycle arrest [GO:0007050]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; establishment or maintenance of cell polarity [GO:0007163]; hair follicle development [GO:0001942]; insulin receptor signaling pathway [GO:0008286]; kidney development [GO:0001822]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint [GO:0007094]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of odontogenesis [GO:0042483]; negative regulation of Wnt signaling pathway [GO:0030178]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; protein-containing complex assembly [GO:0065003]; proximal/distal pattern formation [GO:0009954]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation [GO:0030856]; regulation of glutamate metabolic process [GO:2000211]; regulation of microtubule-based process [GO:0032886]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; retina development in camera-type eye [GO:0060041]; skin development [GO:0043588]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; Wnt signaling pathway [GO:0016055]	adherens junction [GO:0005912]; axon [GO:0030424]; axonal growth cone [GO:0044295]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell body fiber [GO:0070852]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; Scrib-APC-beta-catenin complex [GO:0034750]	beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625]	GO:0000281; GO:0000776; GO:0001708; GO:0001822; GO:0001942; GO:0002020; GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0005938; GO:0006974; GO:0007026; GO:0007050; GO:0007091; GO:0007094; GO:0007163; GO:0007389; GO:0007399; GO:0007409; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0009798; GO:0009952; GO:0009953; GO:0009954; GO:0010942; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019827; GO:0019887; GO:0019901; GO:0030027; GO:0030178; GO:0030334; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0030856; GO:0030877; GO:0031116; GO:0031122; GO:0031175; GO:0031253; GO:0031274; GO:0031625; GO:0031965; GO:0032587; GO:0032886; GO:0032991; GO:0033077; GO:0034750; GO:0035019; GO:0042483; GO:0042995; GO:0043025; GO:0043065; GO:0043066; GO:0043409; GO:0043588; GO:0044295; GO:0044306; GO:0044336; GO:0044337; GO:0044877; GO:0045295; GO:0045595; GO:0045597; GO:0045667; GO:0045670; GO:0045732; GO:0045736; GO:0045785; GO:0046716; GO:0048471; GO:0048538; GO:0050680; GO:0051010; GO:0051171; GO:0051276; GO:0051726; GO:0051781; GO:0051988; GO:0060041; GO:0060044; GO:0060070; GO:0060770; GO:0065003; GO:0070840; GO:0070852; GO:0090090; GO:0120162; GO:1904781; GO:2000211	anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell cycle arrest [GO:0007050]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; establishment or maintenance of cell polarity [GO:0007163]; hair follicle development [GO:0001942]; insulin receptor signaling pathway [GO:0008286]; kidney development [GO:0001822]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint [GO:0007094]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of odontogenesis [GO:0042483]; negative regulation of Wnt signaling pathway [GO:0030178]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; protein-containing complex assembly [GO:0065003]; proximal/distal pattern formation [GO:0009954]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation [GO:0030856]; regulation of glutamate metabolic process [GO:2000211]; regulation of microtubule-based process [GO:0032886]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; retina development in camera-type eye [GO:0060041]; skin development [GO:0043588]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN860_c0_g1_i1	Q9VEI3	S35B2_DROME	54.5	224	100	1	93	764	242	463	4.70E-61	236.1	S35B2_DROME	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)	sll PAPST1 CG7623	Drosophila melanogaster (Fruit fly)	465	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007310; GO:0015012; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]		NA	NA	NA	NA	NA	NA
TRINITY_DN860_c0_g1_i3	Q9VEI3	S35B2_DROME	52.6	407	184	4	132	1331	59	463	4.40E-112	406.4	S35B2_DROME	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)	sll PAPST1 CG7623	Drosophila melanogaster (Fruit fly)	465	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007310; GO:0015012; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]		NA	NA	NA	NA	NA	NA
TRINITY_DN860_c0_g1_i4	Q9VEI3	S35B2_DROME	53.3	353	156	4	132	1169	59	409	7.00E-96	352.4	S35B2_DROME	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)	sll PAPST1 CG7623	Drosophila melanogaster (Fruit fly)	465	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007310; GO:0015012; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]		NA	NA	NA	NA	NA	NA
TRINITY_DN860_c0_g1_i5	Q9VEI3	S35B2_DROME	53.3	353	156	4	134	1171	59	409	7.00E-96	352.4	S35B2_DROME	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)	sll PAPST1 CG7623	Drosophila melanogaster (Fruit fly)	465	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007310; GO:0015012; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]		NA	NA	NA	NA	NA	NA
TRINITY_DN860_c0_g1_i7	Q9VEI3	S35B2_DROME	49.1	55	28	0	88	252	409	463	2.80E-09	62.8	S35B2_DROME	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)	sll PAPST1 CG7623	Drosophila melanogaster (Fruit fly)	465	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007310; GO:0015012; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]		NA	NA	NA	NA	NA	NA
TRINITY_DN860_c0_g1_i9	Q9VEI3	S35B2_DROME	52.6	407	184	4	134	1333	59	463	5.80E-112	406	S35B2_DROME	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Protein slalom)	sll PAPST1 CG7623	Drosophila melanogaster (Fruit fly)	465	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007310; GO:0015012; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; oocyte dorsal/ventral axis specification [GO:0007310]		NA	NA	NA	NA	NA	NA
TRINITY_DN29020_c0_g1_i1	Q8TB61	S35B2_HUMAN	100	91	0	0	276	4	96	186	2.80E-47	188.7	S35B2_HUMAN	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2)	SLC35B2 PAPST1 PSEC0149	Homo sapiens (Human)	432	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0000139; GO:0005794; GO:0016020; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0043123; GO:0046963; GO:0046964; GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN22048_c0_g1_i1	Q91ZN5	S35B2_MOUSE	98.5	201	3	0	605	3	177	377	1.20E-106	387.1	S35B2_MOUSE	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Solute carrier family 35 member B2)	Slc35b2 J207 Papst1	Mus musculus (Mouse)	431	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0016020; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i2	Q9H1N7	S35B3_HUMAN	54.2	177	72	1	4	534	204	371	8.40E-46	185.3	S35B3_HUMAN	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (3'-phosphoadenosine 5'-phosphosulfate transporter) (PAPS transporter 2) (Solute carrier family 35 member B3)	SLC35B3 C6orf196 PAPST2 CGI-19	Homo sapiens (Human)	401	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0000139; GO:0022857; GO:0030173; GO:0030176; GO:0046964; GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i5	Q9H1N7	S35B3_HUMAN	57.1	168	72	0	4	507	204	371	3.30E-47	189.9	S35B3_HUMAN	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (3'-phosphoadenosine 5'-phosphosulfate transporter) (PAPS transporter 2) (Solute carrier family 35 member B3)	SLC35B3 C6orf196 PAPST2 CGI-19	Homo sapiens (Human)	401	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0000139; GO:0022857; GO:0030173; GO:0030176; GO:0046964; GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i3	Q7Q5D4	S35B3_ANOGA	52.3	149	71	0	282	728	196	344	2.30E-37	157.5	S35B3_ANOGA	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3 homolog)	Papst2 AGAP006509	Anopheles gambiae (African malaria mosquito)	377	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007275; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i3	Q7Q5D4	S35B3_ANOGA	63.2	95	35	0	1	285	47	141	2.00E-25	117.9	S35B3_ANOGA	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3 homolog)	Papst2 AGAP006509	Anopheles gambiae (African malaria mosquito)	377	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007275; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i4	Q17CE7	S35B3_AEDAE	45.9	183	88	2	282	824	202	375	2.00E-36	154.5	S35B3_AEDAE	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3 homolog)	Papst2 AAEL004594	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	382	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]	GO:0000139; GO:0005794; GO:0007275; GO:0016021; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i4	Q17CE7	S35B3_AEDAE	63.2	87	32	0	25	285	61	147	3.60E-25	117.1	S35B3_AEDAE	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3 homolog)	Papst2 AAEL004594	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	382	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]	GO:0000139; GO:0005794; GO:0007275; GO:0016021; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i7	Q7Q5D4	S35B3_ANOGA	60.7	61	24	0	61	243	260	320	6.50E-13	74.7	S35B3_ANOGA	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3 homolog)	Papst2 AGAP006509	Anopheles gambiae (African malaria mosquito)	377	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0007275; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i1	Q922Q5	S35B3_MOUSE	47.9	71	36	1	1	213	48	117	2.20E-11	69.3	S35B3_MOUSE	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3)	Slc35b3	Mus musculus (Mouse)	369	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0022857; GO:0030173; GO:0030176; GO:0046964			NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i6	Q922Q5	S35B3_MOUSE	54.4	57	26	0	1	171	48	104	1.30E-11	70.1	S35B3_MOUSE	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3)	Slc35b3	Mus musculus (Mouse)	369	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0022857; GO:0030173; GO:0030176; GO:0046964			NA	NA	NA	NA	NA	NA
TRINITY_DN3885_c0_g1_i6	Q922Q5	S35B3_MOUSE	66.7	33	8	1	165	254	131	163	0.0023	42.7	S35B3_MOUSE	reviewed	Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (PAPS transporter 2) (Solute carrier family 35 member B3)	Slc35b3	Mus musculus (Mouse)	369	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0022857; GO:0030173; GO:0030176; GO:0046964			NA	NA	NA	NA	NA	NA
TRINITY_DN36266_c0_g1_i1	P00813	ADA_HUMAN	98.9	89	1	0	269	3	201	289	1.00E-46	186.8	ADA_HUMAN	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ADA ADA1	Homo sapiens (Human)	363	"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; purine nucleoside binding [GO:0001883]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; cell adhesion [GO:0007155]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; histamine secretion [GO:0001821]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to vitamin E [GO:0033197]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]"	cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	adenosine deaminase activity [GO:0004000]; purine nucleoside binding [GO:0001883]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001821; GO:0001829; GO:0001883; GO:0001889; GO:0001890; GO:0002314; GO:0002636; GO:0002686; GO:0002906; GO:0004000; GO:0005615; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0006157; GO:0007155; GO:0007568; GO:0008270; GO:0009168; GO:0009897; GO:0009986; GO:0010460; GO:0016020; GO:0030054; GO:0030890; GO:0032261; GO:0032839; GO:0033089; GO:0033197; GO:0033632; GO:0042110; GO:0042323; GO:0042493; GO:0042542; GO:0043025; GO:0043101; GO:0043103; GO:0043278; GO:0045987; GO:0046061; GO:0046103; GO:0046111; GO:0046638; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050862; GO:0060169; GO:0060205; GO:0060407; GO:0070244; GO:0070256	"adenosine catabolic process [GO:0006154]; aging [GO:0007568]; cell adhesion [GO:0007155]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; histamine secretion [GO:0001821]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine-containing compound salvage [GO:0043101]; purine nucleotide salvage [GO:0032261]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to vitamin E [GO:0033197]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i1	Q6GP70	ADA_XENLA	39.1	169	94	2	123	629	8	167	2.60E-27	123.6	ADA_XENLA	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ada	Xenopus laevis (African clawed frog)	358	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0046103; GO:0060205	adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i10	Q6GP70	ADA_XENLA	45.6	103	55	1	123	431	8	109	2.10E-19	97.1	ADA_XENLA	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ada	Xenopus laevis (African clawed frog)	358	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0046103; GO:0060205	adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i11	Q5ZKP6	ADA_CHICK	41.4	220	118	3	17	673	144	353	8.40E-45	182.2	ADA_CHICK	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ADA RCJMB04_9m8	Gallus gallus (Chicken)	357	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i2	Q6DG22	ADA_DANRE	43.4	265	136	3	123	917	9	259	5.50E-55	216.1	ADA_DANRE	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ada	Danio rerio (Zebrafish) (Brachydanio rerio)	359	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i3	Q6DG22	ADA_DANRE	45.4	238	121	3	14	724	123	352	4.80E-54	213	ADA_DANRE	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ada	Danio rerio (Zebrafish) (Brachydanio rerio)	359	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i4	Q5ZKP6	ADA_CHICK	45.6	160	83	2	99	575	197	353	4.90E-36	152.9	ADA_CHICK	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ADA RCJMB04_9m8	Gallus gallus (Chicken)	357	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i7	P56658	ADA_BOVIN	43.7	71	39	1	279	488	282	352	5.90E-09	62.8	ADA_BOVIN	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ADA	Bos taurus (Bovine)	363	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; cell adhesion [GO:0007155]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0007155; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; cell adhesion [GO:0007155]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i8	Q6DG22	ADA_DANRE	44.2	362	181	7	123	1199	9	352	2.50E-78	294.3	ADA_DANRE	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ada	Danio rerio (Zebrafish) (Brachydanio rerio)	359	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		blue	blue	NA	NA	NA	NA
TRINITY_DN3325_c0_g1_i9	Q6DG22	ADA_DANRE	43.1	65	36	1	123	317	9	72	7.10E-07	55.1	ADA_DANRE	reviewed	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ada	Danio rerio (Zebrafish) (Brachydanio rerio)	359	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]	adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0030054; GO:0042110; GO:0043103; GO:0046103; GO:0060169; GO:0060205	adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN27597_c0_g1_i1	Q9NZK5	ADA2_HUMAN	100	147	0	0	2	442	337	483	5.20E-83	308.1	ADA2_HUMAN	reviewed	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	ADA2 ADGF CECR1 IDGFL	Homo sapiens (Human)	511	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; cellular protein metabolic process [GO:0044267]; inosine biosynthetic process [GO:0046103]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005576; GO:0005615; GO:0006154; GO:0007275; GO:0008083; GO:0008201; GO:0008270; GO:0031685; GO:0035578; GO:0042803; GO:0043312; GO:0043394; GO:0044267; GO:0046103	adenosine catabolic process [GO:0006154]; cellular protein metabolic process [GO:0044267]; inosine biosynthetic process [GO:0046103]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN13571_c0_g1_i2	Q5RC46	ADA2_PONAB	44.8	475	255	5	1608	202	32	505	5.50E-115	416.4	ADA2_PONAB	reviewed	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	ADA2 CECR1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	511	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]	extracellular space [GO:0005615]	adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394	adenosine catabolic process [GO:0006154]		NA	NA	NA	NA	NA	NA
TRINITY_DN13571_c0_g1_i3	Q5RC46	ADA2_PONAB	44.8	475	255	5	1590	184	32	505	5.40E-115	416.4	ADA2_PONAB	reviewed	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	ADA2 CECR1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	511	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]	extracellular space [GO:0005615]	adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394	adenosine catabolic process [GO:0006154]		NA	NA	NA	NA	NA	NA
TRINITY_DN13571_c0_g1_i8	P58780	ADA2_PIG	68.8	96	30	0	471	184	407	502	8.60E-31	134.8	ADA2_PIG	reviewed	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	ADA2 CECR1	Sus scrofa (Pig)	510	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]	extracellular space [GO:0005615]	adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]		NA	NA	NA	NA	NA	NA
TRINITY_DN9940_c0_g1_i1	Q4V831	ADALA_XENLA	45	338	175	4	203	1213	7	334	2.00E-74	281.2	ADALA_XENLA	reviewed	Adenosine deaminase-like protein A (EC 3.5.4.-)	adal-a	Xenopus laevis (African clawed frog)	347	deaminase activity [GO:0019239]; metal ion binding [GO:0046872]; nucleotide metabolic process [GO:0009117]		deaminase activity [GO:0019239]; metal ion binding [GO:0046872]	GO:0009117; GO:0019239; GO:0046872	nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN9940_c0_g1_i3	Q4V831	ADALA_XENLA	45	338	175	4	203	1213	7	334	2.00E-74	281.2	ADALA_XENLA	reviewed	Adenosine deaminase-like protein A (EC 3.5.4.-)	adal-a	Xenopus laevis (African clawed frog)	347	deaminase activity [GO:0019239]; metal ion binding [GO:0046872]; nucleotide metabolic process [GO:0009117]		deaminase activity [GO:0019239]; metal ion binding [GO:0046872]	GO:0009117; GO:0019239; GO:0046872	nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN1527_c0_g1_i1	O49923	ADK_PHYPA	54.9	337	150	1	1120	110	1	335	3.10E-106	386.7	ADK_PHYPA	reviewed	Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase)	ADK PHYPADRAFT_184505	Physcomitrium patens (Spreading-leaved earth moss) (Physcomitrella patens)	343	adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]		adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]	GO:0004001; GO:0005524; GO:0006166; GO:0044209	AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN1527_c0_g1_i3	O49923	ADK_PHYPA	55.2	335	148	1	1114	110	3	335	6.80E-106	385.6	ADK_PHYPA	reviewed	Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase)	ADK PHYPADRAFT_184505	Physcomitrium patens (Spreading-leaved earth moss) (Physcomitrella patens)	343	adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]		adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]	GO:0004001; GO:0005524; GO:0006166; GO:0044209	AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27058_c0_g1_i1	Q9SF85	ADK1_ARATH	54.4	79	36	0	239	3	259	337	2.10E-17	89.4	ADK1_ARATH	reviewed	Adenosine kinase 1 (AK 1) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 1)	ADK1 At3g09820 F8A24.13	Arabidopsis thaliana (Mouse-ear cress)	344	apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]	apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]	GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006169; GO:0009506; GO:0016032; GO:0044209; GO:0046686; GO:0048046; GO:0080094	adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]		red	red	NA	NA	NA	NA
TRINITY_DN27058_c0_g1_i2	Q9SF85	ADK1_ARATH	56.9	58	25	0	176	3	280	337	7.40E-13	73.9	ADK1_ARATH	reviewed	Adenosine kinase 1 (AK 1) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 1)	ADK1 At3g09820 F8A24.13	Arabidopsis thaliana (Mouse-ear cress)	344	apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]	apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]	GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006169; GO:0009506; GO:0016032; GO:0044209; GO:0046686; GO:0048046; GO:0080094	adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31670_c0_g1_i1	Q9LZG0	ADK2_ARATH	63.5	96	34	1	303	16	8	102	1.30E-27	123.6	ADK2_ARATH	reviewed	Adenosine kinase 2 (AK 2) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 2)	ADK2 At5g03300 F12E4.30 MOK16.21	Arabidopsis thaliana (Mouse-ear cress)	345	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]	GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006169; GO:0016032; GO:0019900; GO:0044209	adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN5007_c0_g1_i1	Q60613	AA2AR_MOUSE	32.2	230	99	5	1	651	103	288	3.80E-20	101.7	AA2AR_MOUSE	reviewed	Adenosine receptor A2a	Adora2a	Mus musculus (Mouse)	410	"asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; alpha-actinin binding [GO:0051393]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; astrocyte activation [GO:0048143]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inflammatory response [GO:0050728]; negative regulation of locomotion [GO:0040013]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription, DNA-templated [GO:0006355]; response to alkaloid [GO:0043279]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]"	asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]	alpha-actinin binding [GO:0051393]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802]	GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005882; GO:0005886; GO:0005887; GO:0006355; GO:0006469; GO:0007186; GO:0007189; GO:0007205; GO:0007271; GO:0007626; GO:0008285; GO:0012505; GO:0014049; GO:0014057; GO:0014061; GO:0014069; GO:0016020; GO:0019899; GO:0030424; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0035815; GO:0040013; GO:0042311; GO:0042493; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043154; GO:0043279; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0098978; GO:0099055; GO:0099056; GO:1900273; GO:2000300; GO:2001235	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; astrocyte activation [GO:0048143]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inflammatory response [GO:0050728]; negative regulation of locomotion [GO:0040013]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription, DNA-templated [GO:0006355]; response to alkaloid [GO:0043279]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5007_c0_g1_i2	P11617	AA2AR_CANLF	32.1	265	119	7	1	744	106	326	1.60E-23	112.8	AA2AR_CANLF	reviewed	Adenosine receptor A2a	ADORA2A RDC8	Canis lupus familiaris (Dog) (Canis familiaris)	412	"integral component of plasma membrane [GO:0005887]; postsynapse [GO:0098794]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; eating behavior [GO:0042755]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; synaptic transmission, dopaminergic [GO:0001963]"	integral component of plasma membrane [GO:0005887]; postsynapse [GO:0098794]	enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]	GO:0001609; GO:0001963; GO:0001975; GO:0005887; GO:0007189; GO:0007626; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0098794; GO:2001235	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; eating behavior [GO:0042755]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; synaptic transmission, dopaminergic [GO:0001963]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36241_c0_g1_i1	P50247	SAHH_MOUSE	94.8	97	5	0	293	3	70	166	2.10E-51	202.6	SAHH_MOUSE	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (CUBP) (Liver copper-binding protein) (S-adenosyl-L-homocysteine hydrolase)	Ahcy	Mus musculus (Mouse)	432	cytosol [GO:0005829]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; protein self-association [GO:0043621]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]	adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; protein self-association [GO:0043621]	GO:0002439; GO:0004013; GO:0005507; GO:0005634; GO:0005829; GO:0006730; GO:0007584; GO:0019510; GO:0030554; GO:0033353; GO:0042470; GO:0042745; GO:0042802; GO:0043005; GO:0043621; GO:0051287	chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN27061_c0_g1_i1	P68172	SAHH_NICSY	72	243	67	1	1	726	181	423	3.30E-96	352.8	SAHH_NICSY	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (Cytokinin-binding protein CBP57) (S-adenosyl-L-homocysteine hydrolase)	SAHH	Nicotiana sylvestris (Wood tobacco) (South American tobacco)	485	adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]		adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0006730	one-carbon metabolic process [GO:0006730]		red	red	NA	NA	NA	NA
TRINITY_DN20308_c0_g2_i1	Q3MHL4	SAHH_BOVIN	83.5	91	13	1	2	268	126	216	4.10E-35	148.3	SAHH_BOVIN	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)	AHCY	Bos taurus (Bovine)	432	cytosol [GO:0005829]; melanosome [GO:0042470]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; melanosome [GO:0042470]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005829; GO:0006730; GO:0033353; GO:0042470	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN20308_c0_g1_i1	P23526	SAHH_HUMAN	99.1	115	1	0	3	347	166	280	5.30E-59	228	SAHH_HUMAN	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)	AHCY SAHH	Homo sapiens (Human)	432	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]	adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]	GO:0000096; GO:0001666; GO:0002439; GO:0004013; GO:0005634; GO:0005829; GO:0006730; GO:0007584; GO:0019510; GO:0030554; GO:0032259; GO:0033353; GO:0042470; GO:0042745; GO:0042802; GO:0043005; GO:0051287; GO:0070062	chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN39748_c0_g1_i1	Q01781	SAHH_PETCR	71.9	121	33	1	364	2	15	134	7.90E-44	177.9	SAHH_PETCR	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)	SAHH SHH	Petroselinum crispum (Parsley) (Petroselinum hortense)	485	adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]		adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN2583_c0_g1_i1	O76757	SAHH_ANOGA	80.8	432	82	1	1395	100	2	432	8.60E-207	721.1	SAHH_ANOGA	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)	Ahcy13 AGAP000719	Anopheles gambiae (African malaria mosquito)	432	cytosol [GO:0005829]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005829; GO:0006730; GO:0033353	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]		blue	blue	NA	NA	NA	NA
TRINITY_DN27337_c0_g1_i1	P23526	SAHH_HUMAN	98.8	84	1	0	3	254	294	377	3.90E-43	174.9	SAHH_HUMAN	reviewed	Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)	AHCY SAHH	Homo sapiens (Human)	432	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]	adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]	GO:0000096; GO:0001666; GO:0002439; GO:0004013; GO:0005634; GO:0005829; GO:0006730; GO:0007584; GO:0019510; GO:0030554; GO:0032259; GO:0033353; GO:0042470; GO:0042745; GO:0042802; GO:0043005; GO:0051287; GO:0070062	chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN5190_c0_g1_i1	Q2G6T1	SAHH_NOVAD	88.6	88	10	0	267	4	353	440	1.50E-40	166.4	SAHH_NOVAD	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Saro_2003	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	468	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN5190_c0_g2_i1	Q1GWT5	SAHH_SPHAL	89.9	79	8	0	239	3	394	472	9.80E-36	150.2	SAHH_SPHAL	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Sala_0163	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	472	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN12045_c0_g1_i1	Q1GWT5	SAHH_SPHAL	93.6	171	11	0	4	516	192	362	1.50E-86	320.1	SAHH_SPHAL	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Sala_0163	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	472	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN12045_c0_g1_i2	Q1GWT5	SAHH_SPHAL	92.5	80	6	0	20	259	283	362	6.20E-36	151	SAHH_SPHAL	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Sala_0163	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	472	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN24002_c0_g1_i1	Q2G6T1	SAHH_NOVAD	90.4	135	13	0	426	22	334	468	3.50E-68	258.8	SAHH_NOVAD	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Saro_2003	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	468	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN974_c0_g1_i1	B2U774	SAHH_RALPJ	100	257	0	0	3	773	166	422	6.80E-147	521.2	SAHH_RALPJ	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Rpic_3656	Ralstonia pickettii (strain 12J)	474	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN974_c0_g2_i1	Q2G6T1	SAHH_NOVAD	95.3	107	5	0	1	321	230	336	3.80E-51	201.8	SAHH_NOVAD	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Saro_2003	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	468	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN16459_c0_g1_i1	A4XPF3	SAHH_PSEMY	98.7	79	1	0	3	239	188	266	9.40E-39	160.2	SAHH_PSEMY	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Pmen_0449	Pseudomonas mendocina (strain ymp)	469	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN28508_c0_g1_i1	B2U774	SAHH_RALPJ	100	58	0	0	221	48	417	474	3.40E-27	121.7	SAHH_RALPJ	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Rpic_3656	Ralstonia pickettii (strain 12J)	474	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN22267_c0_g2_i1	Q1GWT5	SAHH_SPHAL	86.3	73	10	0	221	3	29	101	1.50E-27	122.9	SAHH_SPHAL	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Sala_0163	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	472	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN22267_c0_g3_i1	Q2G6T1	SAHH_NOVAD	91.7	84	7	0	254	3	47	130	5.80E-39	161	SAHH_NOVAD	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Saro_2003	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	468	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN22267_c0_g1_i1	Q2G6T1	SAHH_NOVAD	91.3	104	9	0	312	1	13	116	2.50E-47	189.1	SAHH_NOVAD	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Saro_2003	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	468	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN22267_c0_g1_i2	B2U774	SAHH_RALPJ	96	101	4	0	303	1	16	116	1.30E-48	193.4	SAHH_RALPJ	reviewed	Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)	ahcY Rpic_3656	Ralstonia pickettii (strain 12J)	474	cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005737; GO:0006730	one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN33029_c0_g1_i1	A6QLP2	SAHH3_BOVIN	100	61	0	0	253	71	551	611	3.40E-31	135.2	SAHH3_BOVIN	reviewed	Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.3.1.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT)	AHCYL2	Bos taurus (Bovine)	611	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]	hydrolase activity [GO:0016787]	GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN37177_c0_g1_i1	A6QLP2	SAHH3_BOVIN	100	68	0	0	206	3	333	400	1.60E-34	146	SAHH3_BOVIN	reviewed	Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.3.1.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT)	AHCYL2	Bos taurus (Bovine)	611	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]	hydrolase activity [GO:0016787]	GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN2189_c0_g1_i1	Q9VZX9	SAHH2_DROME	87.4	451	56	1	1297	2646	71	521	5.60E-236	818.9	SAHH2_DROME	reviewed	Adenosylhomocysteinase-like 1 (dAhcyL1) (Inactive S-adenosyl-L-homocysteine hydrolase) (S-adenosylhomocysteine hydrolase-like protein 1)	AhcyL1 CG9977	Drosophila melanogaster (Fruit fly)	521	cytosol [GO:0005829]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]		GO:0005829; GO:0006730; GO:0019510; GO:0033353	one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN2189_c0_g1_i2	Q9VZX9	SAHH2_DROME	85.9	411	57	1	1273	44	71	481	6.10E-210	732.3	SAHH2_DROME	reviewed	Adenosylhomocysteinase-like 1 (dAhcyL1) (Inactive S-adenosyl-L-homocysteine hydrolase) (S-adenosylhomocysteine hydrolase-like protein 1)	AhcyL1 CG9977	Drosophila melanogaster (Fruit fly)	521	cytosol [GO:0005829]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]		GO:0005829; GO:0006730; GO:0019510; GO:0033353	one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN2189_c0_g1_i3	Q9VZX9	SAHH2_DROME	87.4	451	56	1	1439	90	71	521	5.60E-236	818.9	SAHH2_DROME	reviewed	Adenosylhomocysteinase-like 1 (dAhcyL1) (Inactive S-adenosyl-L-homocysteine hydrolase) (S-adenosylhomocysteine hydrolase-like protein 1)	AhcyL1 CG9977	Drosophila melanogaster (Fruit fly)	521	cytosol [GO:0005829]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]		GO:0005829; GO:0006730; GO:0019510; GO:0033353	one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g3_i1	P19754	ADCY1_BOVIN	52.7	110	44	2	1067	738	997	1098	4.20E-22	107.1	ADCY1_BOVIN	reviewed	Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (AC1) (Ca(2+)/calmodulin-activated adenylyl cyclase)	ADCY1	Bos taurus (Bovine)	1134	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0007409; GO:0007616; GO:0008294; GO:0019933; GO:0032793; GO:0042752; GO:0045121; GO:0046872; GO:0048511; GO:0071277; GO:0098686; GO:0098978; GO:0099061; GO:0150076; GO:1900273; GO:1904322; GO:2000300	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN12661_c0_g1_i2	Q08828	ADCY1_HUMAN	48.7	187	94	1	614	54	837	1021	1.00E-44	181.4	ADCY1_HUMAN	reviewed	Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase)	ADCY1	Homo sapiens (Human)	1119	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; renal water homeostasis [GO:0003091]; response to drug [GO:0042493]; response to lithium ion [GO:0010226]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0003091; GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0007409; GO:0007420; GO:0007616; GO:0007623; GO:0008294; GO:0010226; GO:0019933; GO:0032793; GO:0034199; GO:0042493; GO:0042752; GO:0045121; GO:0046872; GO:0070062; GO:0071277; GO:0071377; GO:0098686; GO:0098978; GO:0099061; GO:0150076; GO:1900273; GO:1904322; GO:2000300	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; renal water homeostasis [GO:0003091]; response to drug [GO:0042493]; response to lithium ion [GO:0010226]		NA	NA	NA	NA	NA	NA
TRINITY_DN12661_c0_g1_i1	Q80TL1	ADCY2_MOUSE	52.8	214	98	2	719	84	864	1076	3.50E-55	216.5	ADCY2_MOUSE	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)	Adcy2 Kiaa1060	Mus musculus (Mouse)	1090	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; G-protein beta/gamma-subunit complex binding [GO:0031683]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; G-protein beta/gamma-subunit complex binding [GO:0031683]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]	GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007188; GO:0007189; GO:0007190; GO:0008179; GO:0016020; GO:0019933; GO:0030145; GO:0030425; GO:0031683; GO:0032991; GO:0045121; GO:1904322	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322]		NA	NA	NA	NA	NA	NA
TRINITY_DN7725_c0_g1_i1	Q9VW60	ADCY2_DROME	68.4	269	79	3	1009	218	1037	1304	4.50E-102	372.9	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN7725_c0_g1_i4	Q9VW60	ADCY2_DROME	34.6	237	136	4	673	2	900	1130	4.10E-23	109.8	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN3347_c0_g1_i2	Q9VW60	ADCY2_DROME	80.6	186	36	0	938	381	307	492	5.60E-87	322.4	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN3347_c0_g1_i2	Q9VW60	ADCY2_DROME	54.7	53	24	0	254	96	733	785	2.10E-09	64.7	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN3347_c0_g1_i3	Q9VW60	ADCY2_DROME	54.7	53	24	0	254	96	733	785	9.60E-10	64.7	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN3347_c0_g1_i4	Q9VW60	ADCY2_DROME	80.6	186	36	0	884	327	307	492	5.30E-87	322.4	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN3347_c0_g1_i4	Q9VW60	ADCY2_DROME	52.6	38	18	0	200	87	733	770	1.90E-04	48.1	ADCY2_DROME	reviewed	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylyl cyclase 76E)	Ac76E CG7978	Drosophila melanogaster (Fruit fly)	1307	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002165; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007193; GO:0040015; GO:0042594; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; instar larval or pupal development [GO:0002165]; negative regulation of multicellular organism growth [GO:0040015]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN39150_c0_g1_i2	P84309	ADCY5_MOUSE	77.4	248	56	0	750	7	397	644	1.60E-113	410.2	ADCY5_MOUSE	reviewed	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5)	Adcy5	Mus musculus (Mouse)	1262	cilium [GO:0005929]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	cilium [GO:0005929]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]	GO:0001973; GO:0004016; GO:0005524; GO:0005768; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007626; GO:0008179; GO:0008294; GO:0016020; GO:0016021; GO:0045111; GO:0045121; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]		NA	NA	NA	NA	NA	NA
TRINITY_DN39150_c0_g1_i3	P84309	ADCY5_MOUSE	80.1	216	43	0	654	7	429	644	8.50E-101	367.9	ADCY5_MOUSE	reviewed	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5)	Adcy5	Mus musculus (Mouse)	1262	cilium [GO:0005929]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	cilium [GO:0005929]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]	GO:0001973; GO:0004016; GO:0005524; GO:0005768; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007626; GO:0008179; GO:0008294; GO:0016020; GO:0016021; GO:0045111; GO:0045121; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c0_g1_i3	P40144	ADCY5_RABIT	43	486	222	6	1472	57	778	1222	8.10E-96	352.4	ADCY5_RABIT	reviewed	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5)	ADCY5	Oryctolagus cuniculus (Rabbit)	1264	cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007204; GO:0016021; GO:0046872; GO:0061178; GO:1904322	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c0_g1_i4	P40144	ADCY5_RABIT	44.4	523	236	6	1617	91	778	1259	3.30E-111	403.7	ADCY5_RABIT	reviewed	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5)	ADCY5	Oryctolagus cuniculus (Rabbit)	1264	cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007204; GO:0016021; GO:0046872; GO:0061178; GO:1904322	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]		NA	NA	NA	NA	NA	NA
TRINITY_DN39150_c0_g1_i1	P30803	ADCY5_CANLF	74.3	74	19	0	260	39	431	504	1.20E-24	113.6	ADCY5_CANLF	reviewed	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (Ca(2+)-inhibitable adenylyl cyclase)	ADCY5	Canis lupus familiaris (Dog) (Canis familiaris)	1265	cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007193; GO:0007204; GO:0016021; GO:0046872; GO:0061178; GO:1904322	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c0_g1_i2	O43306	ADCY6_HUMAN	65.6	279	96	0	927	91	886	1164	7.20E-106	386	ADCY6_HUMAN	reviewed	Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)	ADCY6 KIAA0422	Homo sapiens (Human)	1168	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; regulation of blood vessel diameter [GO:0097746]; renal water homeostasis [GO:0003091]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]	GO:0003091; GO:0004016; GO:0005080; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0007212; GO:0010977; GO:0016020; GO:0019901; GO:0031226; GO:0032420; GO:0034199; GO:0035811; GO:0046872; GO:0071377; GO:0071380; GO:0071870; GO:0097746; GO:1904117; GO:1904322	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; regulation of blood vessel diameter [GO:0097746]; renal water homeostasis [GO:0003091]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c0_g1_i5	O43306	ADCY6_HUMAN	68.8	234	73	0	792	91	931	1164	9.40E-94	344.7	ADCY6_HUMAN	reviewed	Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)	ADCY6 KIAA0422	Homo sapiens (Human)	1168	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; regulation of blood vessel diameter [GO:0097746]; renal water homeostasis [GO:0003091]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]	GO:0003091; GO:0004016; GO:0005080; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0007212; GO:0010977; GO:0016020; GO:0019901; GO:0031226; GO:0032420; GO:0034199; GO:0035811; GO:0046872; GO:0071377; GO:0071380; GO:0071870; GO:0097746; GO:1904117; GO:1904322	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; regulation of blood vessel diameter [GO:0097746]; renal water homeostasis [GO:0003091]		NA	NA	NA	NA	NA	NA
TRINITY_DN35930_c0_g1_i1	P51828	ADCY7_HUMAN	100	118	0	0	355	2	811	928	7.10E-67	254.2	ADCY7_HUMAN	reviewed	Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7)	ADCY7 KIAA0037	Homo sapiens (Human)	1080	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to glucagon stimulus [GO:0071377]; cellular response to lithium ion [GO:0071285]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]; renal water homeostasis [GO:0003091]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002819; GO:0003091; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0016021; GO:0034199; GO:0046872; GO:0071285; GO:0071361; GO:0071377; GO:1900016	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to glucagon stimulus [GO:0071377]; cellular response to lithium ion [GO:0071285]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]; renal water homeostasis [GO:0003091]		NA	NA	NA	NA	NA	NA
TRINITY_DN36244_c0_g1_i1	P51828	ADCY7_HUMAN	100	128	0	0	3	386	268	395	2.10E-72	272.7	ADCY7_HUMAN	reviewed	Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7)	ADCY7 KIAA0037	Homo sapiens (Human)	1080	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to glucagon stimulus [GO:0071377]; cellular response to lithium ion [GO:0071285]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]; renal water homeostasis [GO:0003091]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002819; GO:0003091; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0016021; GO:0034199; GO:0046872; GO:0071285; GO:0071361; GO:0071377; GO:1900016	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to glucagon stimulus [GO:0071377]; cellular response to lithium ion [GO:0071285]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]; renal water homeostasis [GO:0003091]		NA	NA	NA	NA	NA	NA
TRINITY_DN18767_c0_g1_i1	P51828	ADCY7_HUMAN	64.7	102	33	1	444	148	966	1067	1.10E-27	124.4	ADCY7_HUMAN	reviewed	Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7)	ADCY7 KIAA0037	Homo sapiens (Human)	1080	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to glucagon stimulus [GO:0071377]; cellular response to lithium ion [GO:0071285]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]; renal water homeostasis [GO:0003091]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002819; GO:0003091; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007193; GO:0016021; GO:0034199; GO:0046872; GO:0071285; GO:0071361; GO:0071377; GO:1900016	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to glucagon stimulus [GO:0071377]; cellular response to lithium ion [GO:0071285]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]; renal water homeostasis [GO:0003091]		NA	NA	NA	NA	NA	NA
TRINITY_DN18767_c0_g1_i2	Q29450	ADCY7_BOVIN	74.7	83	21	0	396	148	983	1065	5.00E-28	125.6	ADCY7_BOVIN	reviewed	Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7)	ADCY7	Bos taurus (Bovine)	1078	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to lithium ion [GO:0071285]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0002819; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0046872; GO:0071285; GO:0071361; GO:1900016	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to lithium ion [GO:0071285]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819]		NA	NA	NA	NA	NA	NA
TRINITY_DN6362_c0_g1_i22	P97490	ADCY8_MOUSE	69.3	254	76	1	919	158	338	589	3.90E-101	369.4	ADCY8_MOUSE	reviewed	Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (Ca(2+)/calmodulin-activated adenylyl cyclase)	Adcy8	Mus musculus (Mouse)	1249	apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; opioid receptor signaling pathway [GO:0038003]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]	actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]	GO:0003779; GO:0004016; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0006171; GO:0007189; GO:0007204; GO:0007613; GO:0007616; GO:0007626; GO:0008022; GO:0008294; GO:0010255; GO:0014069; GO:0016020; GO:0016323; GO:0016324; GO:0019902; GO:0019933; GO:0030424; GO:0030425; GO:0030665; GO:0031915; GO:0032793; GO:0032809; GO:0034199; GO:0035774; GO:0038003; GO:0042593; GO:0042803; GO:0044853; GO:0045121; GO:0046872; GO:0046982; GO:0046983; GO:0047485; GO:0048786; GO:0050804; GO:0051259; GO:0051260; GO:0051480; GO:0051721; GO:0060076; GO:0071277; GO:0071315; GO:0071333; GO:0071377; GO:0080135; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0150076; GO:1900273; GO:1900454; GO:1904322	activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; opioid receptor signaling pathway [GO:0038003]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i1	P98999	ADCY9_XENLA	45	513	234	9	135	1556	64	567	5.30E-110	401	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i1	P98999	ADCY9_XENLA	39	567	315	9	2228	3874	678	1231	3.00E-97	358.6	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i3	P98999	ADCY9_XENLA	44.2	434	207	7	135	1355	64	489	1.80E-89	331.3	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i4	P98999	ADCY9_XENLA	35.6	239	124	4	135	773	64	298	1.70E-25	118.2	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i5	P98999	ADCY9_XENLA	37.2	1270	615	27	260	3898	88	1231	1.80E-195	684.9	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i6	P98999	ADCY9_XENLA	37.5	1294	626	27	135	3845	64	1231	1.60E-204	714.9	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN1225_c0_g1_i8	P98999	ADCY9_XENLA	36.7	98	62	0	135	428	64	161	6.50E-10	65.5	ADCY9_XENLA	reviewed	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (xlAC)	adcy9	Xenopus laevis (African clawed frog)	1305	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]		NA	NA	NA	NA	NA	NA
TRINITY_DN27740_c0_g1_i1	Q8UE38	KAD_AGRFC	58.2	91	38	0	3	275	26	116	4.20E-22	105.1	KAD_AGRFC	reviewed	Adenylate kinase (AK) (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)	adk Atu1926 AGR_C_3521	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	196	cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]	cytoplasm [GO:0005737]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005737; GO:0044209	AMP salvage [GO:0044209]		NA	NA	NA	NA	NA	NA
TRINITY_DN35495_c0_g1_i1	B2UB85	KAD_RALPJ	100	86	0	0	2	259	33	118	2.60E-42	172.2	KAD_RALPJ	reviewed	Adenylate kinase (AK) (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)	adk Rpic_2810	Ralstonia pickettii (strain 12J)	222	cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]	cytoplasm [GO:0005737]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005737; GO:0044209	AMP salvage [GO:0044209]		NA	NA	NA	NA	NA	NA
TRINITY_DN40331_c0_g1_i1	Q6A6Q4	KAD_CUTAK	100	68	0	0	204	1	24	91	3.90E-33	141.4	KAD_CUTAK	reviewed	Adenylate kinase (AK) (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)	adk PPA1834	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	189	cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]	cytoplasm [GO:0005737]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005737; GO:0044209	AMP salvage [GO:0044209]		NA	NA	NA	NA	NA	NA
TRINITY_DN8673_c0_g1_i1	B7L0S9	KAD_METC4	77.6	85	19	0	300	46	29	113	1.50E-30	133.3	KAD_METC4	reviewed	Adenylate kinase (AK) (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)	adk Mchl_2458	Methylorubrum extorquens (strain CM4 / NCIMB 13688) (Methylobacterium extorquens)	200	cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; AMP salvage [GO:0044209]	cytoplasm [GO:0005737]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005737; GO:0044209	AMP salvage [GO:0044209]		NA	NA	NA	NA	NA	NA
TRINITY_DN8673_c0_g2_i1	Q290A8	KAD2_DROPS	47.6	84	32	1	256	5	144	215	1.30E-14	80.1	KAD2_DROPS	reviewed	Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)	Adk2 GA16231	Drosophila pseudoobscura pseudoobscura (Fruit fly)	240	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]		red	red	NA	NA	NA	NA
TRINITY_DN767_c0_g1_i2	Q290A8	KAD2_DROPS	67.9	234	74	1	72	770	1	234	1.10E-87	324.7	KAD2_DROPS	reviewed	Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)	Adk2 GA16231	Drosophila pseudoobscura pseudoobscura (Fruit fly)	240	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]		NA	NA	NA	NA	NA	NA
TRINITY_DN24492_c0_g1_i1	Q9WTP6	KAD2_MOUSE	100	90	0	0	3	272	106	195	2.90E-44	178.7	KAD2_MOUSE	reviewed	"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)"	Ak2	Mus musculus (Mouse)	239	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; nucleoside diphosphate metabolic process [GO:0009132]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006163; GO:0006172; GO:0009132; GO:0036126; GO:0046033; GO:0046034; GO:0046060; GO:0097226	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; nucleoside diphosphate metabolic process [GO:0009132]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN25138_c0_g1_i1	Q9WTP6	KAD2_MOUSE	100	107	0	0	323	3	8	114	1.10E-55	216.9	KAD2_MOUSE	reviewed	"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)"	Ak2	Mus musculus (Mouse)	239	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; nucleoside diphosphate metabolic process [GO:0009132]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006163; GO:0006172; GO:0009132; GO:0036126; GO:0046033; GO:0046034; GO:0046060; GO:0097226	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; nucleoside diphosphate metabolic process [GO:0009132]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN767_c0_g1_i1	P29410	KAD2_RAT	68	241	75	1	72	794	1	239	1.50E-89	330.9	KAD2_RAT	reviewed	"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)"	Ak2	Rattus norvegicus (Rat)	239	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; adenine metabolic process [GO:0046083]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; dATP metabolic process [GO:0046060]; liver development [GO:0001889]; nucleoside diphosphate metabolic process [GO:0009132]; oxidative phosphorylation [GO:0006119]; purine nucleotide metabolic process [GO:0006163]; response to thyroid hormone [GO:0097066]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0001889; GO:0004017; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005829; GO:0006119; GO:0006163; GO:0006172; GO:0007420; GO:0009132; GO:0036126; GO:0046033; GO:0046034; GO:0046060; GO:0046083; GO:0097066; GO:0097226	adenine metabolic process [GO:0046083]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; dATP metabolic process [GO:0046060]; liver development [GO:0001889]; nucleoside diphosphate metabolic process [GO:0009132]; oxidative phosphorylation [GO:0006119]; purine nucleotide metabolic process [GO:0006163]; response to thyroid hormone [GO:0097066]		blue	blue	NA	NA	NA	NA
TRINITY_DN28522_c0_g1_i1	P54819	KAD2_HUMAN	100	205	0	0	46	660	1	205	4.90E-114	411.8	KAD2_HUMAN	reviewed	"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]"	AK2 ADK2	Homo sapiens (Human)	239	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate metabolic process [GO:0009132]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; sperm mitochondrial sheath [GO:0097226]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0006163; GO:0006172; GO:0009132; GO:0015949; GO:0046033; GO:0046034; GO:0070062; GO:0097226	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate metabolic process [GO:0009132]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN35848_c0_g1_i1	Q20140	KAD1_CAEEL	62.3	199	71	3	632	48	1	199	3.40E-60	233	KAD1_CAEEL	reviewed	Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)	F38B2.4	Caenorhabditis elegans	210	cytoplasm [GO:0005737]; cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006163; GO:0006165; GO:0006172; GO:0009142; GO:0046033; GO:0046034	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN27622_c0_g1_i1	Q9R0Y5	KAD1_MOUSE	30.5	187	114	4	732	1280	11	185	3.50E-16	87.8	KAD1_MOUSE	reviewed	Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)	Ak1	Mus musculus (Mouse)	194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006163; GO:0006165; GO:0006172; GO:0007050; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0043005; GO:0046033; GO:0046034; GO:0046103; GO:0048471	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN27622_c0_g1_i2	Q9R0Y5	KAD1_MOUSE	30.5	187	114	4	256	804	11	185	2.40E-16	87.8	KAD1_MOUSE	reviewed	Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)	Ak1	Mus musculus (Mouse)	194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006163; GO:0006165; GO:0006172; GO:0007050; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0043005; GO:0046033; GO:0046034; GO:0046103; GO:0048471	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; inosine biosynthetic process [GO:0046103]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of glucose transmembrane transport [GO:0010828]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN33510_c0_g1_i1	P00568	KAD1_HUMAN	100	78	0	0	234	1	1	78	1.60E-37	156.4	KAD1_HUMAN	reviewed	Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)	AK1	Homo sapiens (Human)	194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006163; GO:0006165; GO:0006172; GO:0009142; GO:0015949; GO:0046033; GO:0046034; GO:0070062	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN18387_c0_g2_i1	Q9Y3D8	KAD6_HUMAN	100	84	0	0	255	4	38	121	7.20E-45	180.6	KAD6_HUMAN	reviewed	Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Adrenal gland protein AD-004) (Coilin-interacting nuclear ATPase protein) (hCINAP) (Dual activity adenylate kinase/ATPase) (AK/ATPase)	AK6 CINAP AD-004 CGI-137	Homo sapiens (Human)	172	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nucleoside monophosphate kinase activity [GO:0050145]; nucleobase-containing small molecule interconversion [GO:0015949]	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; nucleoside monophosphate kinase activity [GO:0050145]	GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0015030; GO:0015949; GO:0016020; GO:0016607; GO:0016887; GO:0050145	nucleobase-containing small molecule interconversion [GO:0015949]		NA	NA	NA	NA	NA	NA
TRINITY_DN7601_c0_g1_i1	A5PJA1	KAD6_BOVIN	62.3	167	63	0	586	86	4	170	1.00E-61	238	KAD6_BOVIN	reviewed	Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Coilin-interacting nuclear ATPase protein) (Dual activity adenylate kinase/ATPase) (AK/ATPase)	AK6 CINAP	Bos taurus (Bovine)	172	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0015030; GO:0016887			blue	blue	NA	NA	NA	NA
TRINITY_DN18387_c0_g1_i1	Q8VCP8	KAD6_MOUSE	100	146	0	0	440	3	1	146	6.50E-82	304.7	KAD6_MOUSE	reviewed	Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Coilin-interacting nuclear ATPase protein) (Dual activity adenylate kinase/ATPase) (AK/ATPase)	Ak6 Cinap	Mus musculus (Mouse)	172	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0015030; GO:0016607; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN7444_c0_g1_i1	Q9VP76	AC78C_DROME	36.4	766	356	16	2332	68	929	1574	1.50E-112	408.7	AC78C_DROME	reviewed	Adenylyl cyclase 78C (EC 4.6.1.1)	Ac78C CG10564	Drosophila melanogaster (Fruit fly)	1718	integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; circadian rhythm [GO:0007623]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; response to caffeine [GO:0031000]; response to sucrose [GO:0009744]; response to trehalose [GO:0010353]	integral component of plasma membrane [GO:0005887]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0001582; GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0007623; GO:0009744; GO:0010353; GO:0031000; GO:0046872	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; circadian rhythm [GO:0007623]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; response to caffeine [GO:0031000]; response to sucrose [GO:0009744]; response to trehalose [GO:0010353]		NA	NA	NA	NA	NA	NA
TRINITY_DN20633_c0_g1_i1	Q3SYV4	CAP1_BOVIN	51.8	388	168	7	1222	92	90	469	6.20E-94	345.9	CAP1_BOVIN	reviewed	Adenylyl cyclase-associated protein 1 (CAP 1)	CAP1	Bos taurus (Bovine)	472	cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; regulation of adenylate cyclase activity [GO:0045761]	cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]	GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0008154; GO:0008179; GO:0030864; GO:0045761	actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; regulation of adenylate cyclase activity [GO:0045761]		blue	blue	NA	NA	NA	NA
TRINITY_DN27495_c0_g1_i1	Q01518	CAP1_HUMAN	100	106	0	0	330	13	370	475	3.40E-55	215.3	CAP1_HUMAN	reviewed	Adenylyl cyclase-associated protein 1 (CAP 1)	CAP1 CAP	Homo sapiens (Human)	475	azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165]	azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]	GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005886; GO:0005925; GO:0006898; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0030864; GO:0035578; GO:0043312; GO:0045761; GO:0070062	actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30869_c0_g1_i1	Q01518	CAP1_HUMAN	100	110	0	0	332	3	98	207	3.00E-59	228.8	CAP1_HUMAN	reviewed	Adenylyl cyclase-associated protein 1 (CAP 1)	CAP1 CAP	Homo sapiens (Human)	475	azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165]	azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]	GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005886; GO:0005925; GO:0006898; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0030864; GO:0035578; GO:0043312; GO:0045761; GO:0070062	actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN34807_c0_g1_i1	O95396	MOCS3_HUMAN	100	74	0	0	224	3	133	206	1.10E-33	143.3	MOCS3_HUMAN	reviewed	Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) (Molybdopterin synthase sulfurylase) (MPT synthase sulfurylase) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]	MOCS3 UBA4	Homo sapiens (Human)	460	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]	GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032324; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605	enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1870_c0_g1_i11	A5GFZ6	MOCS3_PIG	54.3	418	178	4	310	1524	38	455	3.80E-126	453.4	MOCS3_PIG	reviewed	Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]	MOCS3 UBA4	Sus scrofa (Pig)	455	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]	GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605	enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1870_c0_g1_i3	A5GFZ6	MOCS3_PIG	54.3	418	178	4	310	1524	38	455	3.70E-126	453.4	MOCS3_PIG	reviewed	Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]	MOCS3 UBA4	Sus scrofa (Pig)	455	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]	GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605	enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1870_c0_g1_i5	A5GFZ6	MOCS3_PIG	54.3	418	178	4	310	1524	38	455	4.20E-126	453.4	MOCS3_PIG	reviewed	Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]	MOCS3 UBA4	Sus scrofa (Pig)	455	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]	GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605	enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1870_c0_g1_i6	A5GFZ6	MOCS3_PIG	54.3	418	178	4	310	1524	38	455	4.20E-126	453.4	MOCS3_PIG	reviewed	Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]	MOCS3 UBA4	Sus scrofa (Pig)	455	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]	GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605	enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN9715_c0_g1_i1	Q9HAR2	AGRL3_HUMAN	50	78	38	1	1	231	1056	1133	8.70E-13	75.9	AGRL3_HUMAN	reviewed	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	ADGRL3 KIAA0768 LEC3 LPHN3	Homo sapiens (Human)	1447	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN34842_c0_g1_i1	Q8K3V3	AGRG1_RAT	39.4	71	43	0	84	296	361	431	4.90E-06	52	AGRG1_RAT	reviewed	Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)]	Adgrg1 Gpr56	Rattus norvegicus (Rat)	687	extracellular region [GO:0005576]; glial limiting end-foot [GO:0097451]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cerebral cortex radial glia guided migration [GO:0021801]; cerebral cortex regionalization [GO:0021796]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573]	extracellular region [GO:0005576]; glial limiting end-foot [GO:0097451]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]	GO:0001525; GO:0004930; GO:0005518; GO:0005576; GO:0005887; GO:0007155; GO:0007166; GO:0007189; GO:0007266; GO:0008201; GO:0008285; GO:0010573; GO:0016477; GO:0021796; GO:0021801; GO:0021819; GO:0035025; GO:0045121; GO:0045785; GO:0050840; GO:0070528; GO:0072520; GO:0097451; GO:2000179; GO:2001223	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cerebral cortex radial glia guided migration [GO:0021801]; cerebral cortex regionalization [GO:0021796]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573]		NA	NA	NA	NA	NA	NA
TRINITY_DN40086_c0_g1_i1	Q8CJ12	AGRG2_MOUSE	41.7	84	49	0	252	1	561	644	1.10E-11	70.5	AGRG2_MOUSE	reviewed	Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6)	Adgrg2 Gpr64 Me6	Mus musculus (Mouse)	1009	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005829; GO:0005886; GO:0005887; GO:0007166; GO:0007189; GO:0016324	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i1	Q6F3F9	AGRG6_MOUSE	29	630	370	28	2832	4649	508	1084	4.70E-41	172.2	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i10	Q6F3F9	AGRG6_MOUSE	28.2	645	388	28	2832	4700	508	1099	8.80E-46	188	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i2	Q6F3F9	AGRG6_MOUSE	29	630	370	28	2822	4639	508	1084	4.70E-41	172.2	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i3	Q6F3F9	AGRG6_MOUSE	29	630	370	28	2850	4667	508	1084	4.70E-41	172.2	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i5	Q6F3F9	AGRG6_MOUSE	28.2	645	388	28	2850	4718	508	1099	8.80E-46	188	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i6	Q6F3F9	AGRG6_MOUSE	28.2	645	388	28	2822	4690	508	1099	8.80E-46	188	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i7	Q6F3F9	AGRG6_MOUSE	28.2	645	388	28	2840	4708	508	1099	8.80E-46	188	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN1286_c0_g1_i8	Q6F3F9	AGRG6_MOUSE	29	630	370	28	2840	4657	508	1084	4.70E-41	172.2	AGRG6_MOUSE	reviewed	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	Adgrg6 Dreg Gm222 Gpr126	Mus musculus (Mouse)	1165	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]	GO:0004930; GO:0005518; GO:0005737; GO:0005886; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0009986; GO:0014037; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; Schwann cell differentiation [GO:0014037]		NA	NA	NA	NA	NA	NA
TRINITY_DN8052_c0_g1_i1	Q803F5	APMAP_DANRE	37.3	193	110	7	163	735	35	218	2.10E-21	104.4	APMAP_DANRE	reviewed	Adipocyte plasma membrane-associated protein	apmap bscv zgc:55833 zgc:85628	Danio rerio (Zebrafish) (Brachydanio rerio)	415	integral component of membrane [GO:0016021]; strictosidine synthase activity [GO:0016844]; biosynthetic process [GO:0009058]	integral component of membrane [GO:0016021]	strictosidine synthase activity [GO:0016844]	GO:0009058; GO:0016021; GO:0016844	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN8052_c0_g1_i2	Q803F5	APMAP_DANRE	31.9	420	239	12	163	1404	35	413	6.00E-47	190.3	APMAP_DANRE	reviewed	Adipocyte plasma membrane-associated protein	apmap bscv zgc:55833 zgc:85628	Danio rerio (Zebrafish) (Brachydanio rerio)	415	integral component of membrane [GO:0016021]; strictosidine synthase activity [GO:0016844]; biosynthetic process [GO:0009058]	integral component of membrane [GO:0016021]	strictosidine synthase activity [GO:0016844]	GO:0009058; GO:0016021; GO:0016844	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN3373_c0_g1_i1	Q9VCY8	ADRL_DROME	58.4	411	152	4	1326	94	45	436	9.60E-136	485	ADRL_DROME	reviewed	Adiponectin receptor protein	AdipoR CG5315	Drosophila melanogaster (Fruit fly)	444	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0016021; GO:0016500; GO:0019395; GO:0032024; GO:0033211; GO:0036099; GO:0038023; GO:0042593; GO:0046872; GO:0070328	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN30169_c0_g1_i1	Q96A54	PAQR1_HUMAN	100	84	0	0	285	34	292	375	1.80E-44	179.5	PAQR1_HUMAN	reviewed	Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I)	ADIPOR1 PAQR1 TESBP1A CGI-45	Homo sapiens (Human)	375	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN9044_c0_g2_i1	Q96A54	PAQR1_HUMAN	100	101	0	0	305	3	78	178	1.70E-56	219.5	PAQR1_HUMAN	reviewed	Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I)	ADIPOR1 PAQR1 TESBP1A CGI-45	Homo sapiens (Human)	375	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN9044_c0_g1_i1	Q96A54	PAQR1_HUMAN	100	96	0	0	289	2	85	180	4.30E-54	211.5	PAQR1_HUMAN	reviewed	Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I)	ADIPOR1 PAQR1 TESBP1A CGI-45	Homo sapiens (Human)	375	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN20220_c0_g1_i1	Q96A54	PAQR1_HUMAN	100	68	0	0	2	205	189	256	5.90E-34	144.1	PAQR1_HUMAN	reviewed	Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I)	ADIPOR1 PAQR1 TESBP1A CGI-45	Homo sapiens (Human)	375	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN20220_c0_g1_i2	Q96A54	PAQR1_HUMAN	100	79	0	0	2	238	178	256	1.30E-40	166.4	PAQR1_HUMAN	reviewed	Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I)	ADIPOR1 PAQR1 TESBP1A CGI-45	Homo sapiens (Human)	375	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN10983_c0_g1_i1	Q96A54	PAQR1_HUMAN	100	83	0	0	1	249	284	366	3.80E-43	174.9	PAQR1_HUMAN	reviewed	Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I)	ADIPOR1 PAQR1 TESBP1A CGI-45	Homo sapiens (Human)	375	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042304; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN36437_c0_g1_i1	Q8BQS5	PAQR2_MOUSE	100	69	0	0	213	7	87	155	1.30E-39	162.9	PAQR2_MOUSE	reviewed	Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II)	Adipor2 D6Ucla1e Parq2	Mus musculus (Mouse)	386	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; cellular response to fatty acid [GO:0071398]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatic stellate cell migration [GO:0061871]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; positive regulation of protein phosphorylation [GO:0001934]; response to amine [GO:0014075]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]	GO:0001934; GO:0005886; GO:0007507; GO:0007565; GO:0007584; GO:0009750; GO:0009755; GO:0010629; GO:0014075; GO:0016021; GO:0019395; GO:0030308; GO:0031226; GO:0032496; GO:0033211; GO:0038023; GO:0042493; GO:0042593; GO:0042802; GO:0045471; GO:0046326; GO:0046872; GO:0055100; GO:0061042; GO:0061871; GO:0071398; GO:0097003; GO:0120162	adiponectin-activated signaling pathway [GO:0033211]; cellular response to fatty acid [GO:0071398]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatic stellate cell migration [GO:0061871]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; positive regulation of protein phosphorylation [GO:0001934]; response to amine [GO:0014075]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]		NA	NA	NA	NA	NA	NA
TRINITY_DN27421_c0_g1_i1	Q86V24	PAQR2_HUMAN	100	73	0	0	220	2	201	273	1.20E-37	156.4	PAQR2_HUMAN	reviewed	Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II)	ADIPOR2 PAQR2	Homo sapiens (Human)	386	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; cellular response to fatty acid [GO:0071398]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatic stellate cell migration [GO:0061871]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; positive regulation of protein phosphorylation [GO:0001934]; regulation of fatty acid biosynthetic process [GO:0042304]; response to amine [GO:0014075]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]	GO:0001934; GO:0005886; GO:0007507; GO:0007565; GO:0007584; GO:0009750; GO:0009755; GO:0010629; GO:0014075; GO:0016021; GO:0019395; GO:0030308; GO:0031226; GO:0032496; GO:0033211; GO:0038023; GO:0042304; GO:0042493; GO:0042593; GO:0042802; GO:0045471; GO:0046326; GO:0046872; GO:0055100; GO:0061042; GO:0061871; GO:0071398; GO:0097003; GO:0120162	adiponectin-activated signaling pathway [GO:0033211]; cellular response to fatty acid [GO:0071398]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatic stellate cell migration [GO:0061871]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of glucose import [GO:0046326]; positive regulation of protein phosphorylation [GO:0001934]; regulation of fatty acid biosynthetic process [GO:0042304]; response to amine [GO:0014075]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; vascular wound healing [GO:0061042]		NA	NA	NA	NA	NA	NA
TRINITY_DN30733_c0_g1_i1	P31692	ADT_PARKE	72.7	110	29	1	3	329	87	196	7.30E-43	174.5	ADT_PARKE	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT)"		Parachlorella kessleri (Green alga) (Chlorella kessleri)	339	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544	mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]		NA	NA	NA	NA	NA	NA
TRINITY_DN22347_c2_g1_i1	Q26365	ADT_DROME	71.4	63	18	0	232	44	250	312	2.70E-19	95.5	ADT_DROME	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)"	sesB A/A-T CG16944	Drosophila melanogaster (Fruit fly)	312	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]	ATP:ADP antiporter activity [GO:0005471]	GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171	action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN5374_c0_g1_i1	Q26365	ADT_DROME	83	47	8	0	231	91	67	113	6.30E-16	84.7	ADT_DROME	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)"	sesB A/A-T CG16944	Drosophila melanogaster (Fruit fly)	312	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]	ATP:ADP antiporter activity [GO:0005471]	GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171	action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]		blue	blue	NA	NA	NA	NA
TRINITY_DN5374_c0_g1_i2	Q26365	ADT_DROME	84.4	45	7	0	225	91	69	113	5.50E-15	81.6	ADT_DROME	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)"	sesB A/A-T CG16944	Drosophila melanogaster (Fruit fly)	312	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]	ATP:ADP antiporter activity [GO:0005471]	GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171	action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN5374_c0_g1_i3	Q26365	ADT_DROME	83	47	8	0	231	91	67	113	6.00E-16	84.7	ADT_DROME	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)"	sesB A/A-T CG16944	Drosophila melanogaster (Fruit fly)	312	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]	ATP:ADP antiporter activity [GO:0005471]	GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171	action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN5374_c0_g2_i1	Q26365	ADT_DROME	78.6	266	56	1	984	187	48	312	3.70E-121	436	ADT_DROME	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)"	sesB A/A-T CG16944	Drosophila melanogaster (Fruit fly)	312	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]	ATP:ADP antiporter activity [GO:0005471]	GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171	action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]		blue	blue	NA	NA	NA	NA
TRINITY_DN5374_c0_g2_i2	Q26365	ADT_DROME	80.6	304	58	1	1098	187	10	312	9.90E-142	504.6	ADT_DROME	reviewed	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)"	sesB A/A-T CG16944	Drosophila melanogaster (Fruit fly)	312	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]; ATP:ADP antiporter activity [GO:0005471]; action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; synapse [GO:0045202]	ATP:ADP antiporter activity [GO:0005471]	GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171	action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]		blue	blue	NA	NA	NA	NA
TRINITY_DN12790_c2_g1_i1	Q27238	ADT1_ANOGA	67.4	89	29	0	291	25	205	293	4.80E-29	128.3	ADT1_ANOGA	reviewed	"ADP,ATP carrier protein 1 (ADP/ATP translocase 1) (Adenine nucleotide translocator 1) (ANT 1)"	AGAP006782	Anopheles gambiae (African malaria mosquito)	301	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544	mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]		NA	NA	NA	NA	NA	NA
TRINITY_DN18769_c1_g1_i1	Q27238	ADT1_ANOGA	72.1	68	19	0	292	89	233	300	4.00E-23	108.6	ADT1_ANOGA	reviewed	"ADP,ATP carrier protein 1 (ADP/ATP translocase 1) (Adenine nucleotide translocator 1) (ANT 1)"	AGAP006782	Anopheles gambiae (African malaria mosquito)	301	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544	mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]		NA	NA	NA	NA	NA	NA
TRINITY_DN12790_c0_g1_i1	P12235	ADT1_HUMAN	97.7	298	7	0	941	48	1	298	3.60E-169	595.5	ADT1_HUMAN	reviewed	"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)"	SLC25A4 ANT1	Homo sapiens (Human)	298	integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]	integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]	GO:0000002; GO:0005471; GO:0005739; GO:0005743; GO:0005887; GO:0006091; GO:0008637; GO:0015207; GO:0015866; GO:0016020; GO:0016032; GO:0032592; GO:0050796; GO:0060546; GO:0140021; GO:1990544	ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN12790_c0_g2_i1	P12235	ADT1_HUMAN	100	70	0	0	210	1	1	70	1.10E-32	140.2	ADT1_HUMAN	reviewed	"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)"	SLC25A4 ANT1	Homo sapiens (Human)	298	integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]	integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]	GO:0000002; GO:0005471; GO:0005739; GO:0005743; GO:0005887; GO:0006091; GO:0008637; GO:0015207; GO:0015866; GO:0016020; GO:0016032; GO:0032592; GO:0050796; GO:0060546; GO:0140021; GO:1990544	ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN20380_c0_g1_i1	P12235	ADT1_HUMAN	100	109	0	0	378	52	187	295	3.40E-59	228.8	ADT1_HUMAN	reviewed	"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)"	SLC25A4 ANT1	Homo sapiens (Human)	298	integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]	integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]	GO:0000002; GO:0005471; GO:0005739; GO:0005743; GO:0005887; GO:0006091; GO:0008637; GO:0015207; GO:0015866; GO:0016020; GO:0016032; GO:0032592; GO:0050796; GO:0060546; GO:0140021; GO:1990544	ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of necroptotic process [GO:0060546]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN12790_c0_g1_i2	P48962	ADT1_MOUSE	100	298	0	0	941	48	1	298	1.00E-171	604	ADT1_MOUSE	reviewed	"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4) (mANC1)"	Slc25a4 Anc1 Ant1	Mus musculus (Mouse)	298	integral component of mitochondrial membrane [GO:0032592]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; ATP:ADP antiporter activity [GO:0005471]; enzyme binding [GO:0019899]; ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of necroptotic process [GO:0060546]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]	integral component of mitochondrial membrane [GO:0032592]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	ATP:ADP antiporter activity [GO:0005471]; enzyme binding [GO:0019899]	GO:0005471; GO:0005739; GO:0005741; GO:0005743; GO:0008637; GO:0010667; GO:0015866; GO:0019899; GO:0032592; GO:0043209; GO:0045121; GO:0060546; GO:0061051; GO:0140021; GO:1902109; GO:1990544; GO:2000277	ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of necroptotic process [GO:0060546]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]		NA	NA	NA	NA	NA	NA
TRINITY_DN5162_c1_g1_i1	Q09073	ADT2_RAT	99.3	298	2	0	951	58	1	298	1.40E-170	600.1	ADT2_RAT	reviewed	"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]"	Slc25a5 Ant2	Rattus norvegicus (Rat)	298	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; MMXD complex [GO:0071817]; adenine nucleotide transmembrane transporter activity [GO:0000295]; ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]; adenine nucleotide transport [GO:0051503]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; MMXD complex [GO:0071817]	adenine nucleotide transmembrane transporter activity [GO:0000295]; ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]	GO:0000295; GO:0005471; GO:0005743; GO:0007059; GO:0008284; GO:0016021; GO:0031625; GO:0042645; GO:0045121; GO:0051503; GO:0071817; GO:0140021; GO:1901029; GO:1990544; GO:1990830	adenine nucleotide transport [GO:0051503]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN5162_c1_g1_i2	P51881	ADT2_MOUSE	100	298	0	0	943	50	1	298	9.90E-172	604	ADT2_MOUSE	reviewed	"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]"	Slc25a5 Ant2	Mus musculus (Mouse)	298	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]; adenine nucleotide transmembrane transporter activity [GO:0000295]; ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]; adenine nucleotide transport [GO:0051503]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]	adenine nucleotide transmembrane transporter activity [GO:0000295]; ATP:ADP antiporter activity [GO:0005471]; ubiquitin protein ligase binding [GO:0031625]	GO:0000295; GO:0005471; GO:0005739; GO:0005743; GO:0007059; GO:0008284; GO:0016021; GO:0031625; GO:0042645; GO:0043209; GO:0045121; GO:0051503; GO:0071817; GO:0140021; GO:1901029; GO:1990544; GO:1990830	adenine nucleotide transport [GO:0051503]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN22347_c1_g1_i1	Q8SQH5	ADT2_BOVIN	85.5	69	10	0	3	209	75	143	8.40E-28	123.6	ADT2_BOVIN	reviewed	"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]"	SLC25A5 ANT2	Bos taurus (Bovine)	298	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; MMXD complex [GO:0071817]; ATP:ADP antiporter activity [GO:0005471]; chromosome segregation [GO:0007059]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; MMXD complex [GO:0071817]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0007059; GO:0008284; GO:0016020; GO:0016021; GO:0071817; GO:0140021; GO:1901029; GO:1990544	chromosome segregation [GO:0007059]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN21475_c1_g1_i1	P32007	ADT3_BOVIN	79.2	72	15	0	218	3	34	105	2.90E-26	118.6	ADT3_BOVIN	reviewed	"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]"	SLC25A6 ANT3	Bos taurus (Bovine)	298	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0016021; GO:0140021; GO:1990544	apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]		NA	NA	NA	NA	NA	NA
TRINITY_DN5162_c2_g1_i1	P12236	ADT3_HUMAN	100	268	0	0	2	805	31	298	1.20E-155	550.4	ADT3_HUMAN	reviewed	"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]"	SLC25A6 ANT3 CDABP0051	Homo sapiens (Human)	298	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; protein targeting to mitochondrion [GO:0006626]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0006915; GO:0016020; GO:0016021; GO:0016032; GO:0050796; GO:0140021; GO:1990544	apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; protein targeting to mitochondrion [GO:0006626]; regulation of insulin secretion [GO:0050796]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN22347_c0_g1_i1	P32007	ADT3_BOVIN	78.8	165	35	0	1	495	80	244	3.20E-73	275.8	ADT3_BOVIN	reviewed	"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]"	SLC25A6 ANT3	Bos taurus (Bovine)	298	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0016021; GO:0140021; GO:1990544	apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]		NA	NA	NA	NA	NA	NA
TRINITY_DN22347_c0_g1_i2	P32007	ADT3_BOVIN	78.9	147	31	0	6	446	98	244	3.80E-65	248.8	ADT3_BOVIN	reviewed	"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]"	SLC25A6 ANT3	Bos taurus (Bovine)	298	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0016021; GO:0140021; GO:1990544	apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]		blue	blue	NA	NA	NA	NA
TRINITY_DN26227_c0_g1_i1	Q8CG72	ARHL2_MOUSE	98.5	68	1	0	1	204	126	193	1.80E-30	132.5	ADPRS_MOUSE	reviewed	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	Adprs Adprhl2 Arh3	Mus musculus (Mouse)	370	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006281; GO:0016604; GO:0061463; GO:0071451; GO:0090734; GO:0140290; GO:0140292	cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]		NA	NA	NA	NA	NA	NA
TRINITY_DN678_c0_g1_i1	Q8CG72	ARHL2_MOUSE	47.4	342	166	7	1113	112	28	363	1.10E-71	271.9	ADPRS_MOUSE	reviewed	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	Adprs Adprhl2 Arh3	Mus musculus (Mouse)	370	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006281; GO:0016604; GO:0061463; GO:0071451; GO:0090734; GO:0140290; GO:0140292	cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]		NA	NA	NA	NA	NA	NA
TRINITY_DN678_c0_g1_i2	Q5ZI51	ARHL2_CHICK	43.5	85	40	1	316	86	22	106	5.10E-11	68.9	ADPRS_CHICK	reviewed	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	ADPRS ADPRHL2 ARH3 RCJMB04_30e5	Gallus gallus (Chicken)	367	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005739; GO:0005759; GO:0006281; GO:0061463; GO:0090734; GO:0140290; GO:0140292	DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]		NA	NA	NA	NA	NA	NA
TRINITY_DN678_c0_g1_i3	Q5ZI51	ARHL2_CHICK	43.5	85	40	1	313	83	22	106	6.70E-11	68.6	ADPRS_CHICK	reviewed	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	ADPRS ADPRHL2 ARH3 RCJMB04_30e5	Gallus gallus (Chicken)	367	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005739; GO:0005759; GO:0006281; GO:0061463; GO:0090734; GO:0140290; GO:0140292	DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]		NA	NA	NA	NA	NA	NA
TRINITY_DN678_c0_g1_i4	Q66HT8	ARHL2_DANRE	40.6	101	57	1	360	58	5	102	8.20E-12	71.6	ADPRS_DANRE	reviewed	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	adprs adprhl2 arh3 zgc:92867	Danio rerio (Zebrafish) (Brachydanio rerio)	370	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005739; GO:0005759; GO:0006281; GO:0061463; GO:0090734; GO:0140290; GO:0140292	DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]		NA	NA	NA	NA	NA	NA
TRINITY_DN35331_c0_g1_i1	Q9NX46	ARHL2_HUMAN	100	99	0	0	313	17	265	363	1.10E-52	206.8	ADPRS_HUMAN	reviewed	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	ADPRS ADPRHL2 ARH3	Homo sapiens (Human)	363	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]"	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006281; GO:0016604; GO:0061463; GO:0071451; GO:0090734; GO:0140290; GO:0140292	cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]		NA	NA	NA	NA	NA	NA
TRINITY_DN808_c0_g1_i1	Q1LZ74	OARD1_BOVIN	61.1	144	56	0	522	91	9	152	4.70E-45	182.6	OARD1_BOVIN	reviewed	ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-)	OARD1	Bos taurus (Bovine)	152	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]	ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]	GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]		NA	NA	NA	NA	NA	NA
TRINITY_DN4689_c0_g1_i1	Q9BW91	NUDT9_HUMAN	54.5	154	68	2	555	97	187	339	3.80E-43	176	NUDT9_HUMAN	reviewed	"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)"	NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771	Homo sapiens (Human)	350	cell junction [GO:0030054]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656]	cell junction [GO:0030054]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]	adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]	GO:0005739; GO:0005759; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0034656; GO:0043262; GO:0046032; GO:0046709; GO:0047631; GO:0070062	ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656]		NA	NA	NA	NA	NA	NA
TRINITY_DN211_c0_g1_i4	P91924	ARF_DUGJA	79.8	183	34	1	41	589	1	180	6.50E-82	305.1	ARF_DUGJA	reviewed	ADP-ribosylation factor		Dugesia japonica (Planarian)	183	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005794; GO:0015031; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN34244_c0_g1_i1	Q8SQH8	ARF_ENCCU	46.9	96	50	1	290	6	13	108	5.90E-19	94.7	ARF_ENCCU	reviewed	ADP-ribosylation factor	ARF-1 ECU08_1930; ARF-2 ECU10_0090	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	207	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005794; GO:0015031; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4596_c0_g1_i1	P51824	ARF1_SOLTU	64.1	192	67	2	593	18	1	190	1.00E-65	251.1	ARF1_SOLTU	reviewed	ADP-ribosylation factor 1		Solanum tuberosum (Potato)	197	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4596_c0_g2_i1	P51824	ARF1_SOLTU	65.1	192	65	2	593	18	1	190	3.10E-67	256.1	ARF1_SOLTU	reviewed	ADP-ribosylation factor 1		Solanum tuberosum (Potato)	197	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN211_c0_g1_i1	P61209	ARF1_DROME	79.8	178	36	0	44	577	1	178	2.30E-81	303.1	ARF1_DROME	reviewed	ADP-ribosylation factor 1	Arf79F ARF1 CG8385	Drosophila melanogaster (Fruit fly)	182	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0007112; GO:0007269; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0098793; GO:1902036; GO:1904801; GO:1990386	ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN211_c0_g2_i1	P51824	ARF1_SOLTU	80.8	182	34	1	24	569	1	181	5.70E-83	308.5	ARF1_SOLTU	reviewed	ADP-ribosylation factor 1		Solanum tuberosum (Potato)	197	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17401_c6_g1_i1	P61209	ARF1_DROME	90	70	7	0	1	210	107	176	7.70E-29	127.1	ARF1_DROME	reviewed	ADP-ribosylation factor 1	Arf79F ARF1 CG8385	Drosophila melanogaster (Fruit fly)	182	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0007112; GO:0007269; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0098793; GO:1902036; GO:1904801; GO:1990386	ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17401_c0_g3_i1	P61209	ARF1_DROME	97.5	40	1	0	208	89	143	182	2.30E-17	89	ARF1_DROME	reviewed	ADP-ribosylation factor 1	Arf79F ARF1 CG8385	Drosophila melanogaster (Fruit fly)	182	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0007112; GO:0007269; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0098793; GO:1902036; GO:1904801; GO:1990386	ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17401_c0_g1_i1	P51643	ARF1_XENLA	93.9	99	6	0	299	3	1	99	1.50E-47	189.9	ARF1_XENLA	reviewed	ADP-ribosylation factor 1	arf1	Xenopus laevis (African clawed frog)	181	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005794; GO:0015031; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN32768_c2_g1_i1	P61209	ARF1_DROME	99.5	182	1	0	636	91	1	182	6.20E-102	371.7	ARF1_DROME	reviewed	ADP-ribosylation factor 1	Arf79F ARF1 CG8385	Drosophila melanogaster (Fruit fly)	182	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006886; GO:0006892; GO:0007112; GO:0007269; GO:0010883; GO:0016192; GO:0032011; GO:0032154; GO:0043001; GO:0045177; GO:0045807; GO:0048488; GO:0048749; GO:0098793; GO:1902036; GO:1904801; GO:1990386	ARF protein signal transduction [GO:0032011]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; mitotic cleavage furrow ingression [GO:1990386]; neurotransmitter secretion [GO:0007269]; positive regulation of endocytosis [GO:0045807]; positive regulation of neuron remodeling [GO:1904801]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of lipid storage [GO:0010883]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN33706_c0_g1_i1	Q96361	ARF1_BRARP	68.4	177	56	0	552	22	1	177	2.50E-67	256.5	ARF1_BRARP	reviewed	ADP-ribosylation factor 1	ARF1	Brassica rapa subsp. pekinensis (Chinese cabbage) (Brassica pekinensis)	182	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g1_i2	P84080	ARF1_BOVIN	100	181	0	0	280	822	1	181	1.70E-101	370.5	ARF1_BOVIN	reviewed	ADP-ribosylation factor 1	ARF1	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTP binding [GO:0005525]; dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	GTP binding [GO:0005525]	GO:0002090; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0014069; GO:0016192; GO:0034315; GO:0043005; GO:0048471; GO:0060292; GO:0097061	dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g1_i2	P84080	ARF1_BOVIN	88.1	59	7	0	177	1	59	117	1.90E-23	111.3	ARF1_BOVIN	reviewed	ADP-ribosylation factor 1	ARF1	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTP binding [GO:0005525]; dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	GTP binding [GO:0005525]	GO:0002090; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0014069; GO:0016192; GO:0034315; GO:0043005; GO:0048471; GO:0060292; GO:0097061	dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g1_i3	P84080	ARF1_BOVIN	100	181	0	0	92	634	1	181	1.80E-101	370.2	ARF1_BOVIN	reviewed	ADP-ribosylation factor 1	ARF1	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTP binding [GO:0005525]; dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	GTP binding [GO:0005525]	GO:0002090; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0014069; GO:0016192; GO:0034315; GO:0043005; GO:0048471; GO:0060292; GO:0097061	dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g1_i5	P84080	ARF1_BOVIN	100	181	0	0	92	634	1	181	1.80E-101	370.2	ARF1_BOVIN	reviewed	ADP-ribosylation factor 1	ARF1	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTP binding [GO:0005525]; dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	GTP binding [GO:0005525]	GO:0002090; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0014069; GO:0016192; GO:0034315; GO:0043005; GO:0048471; GO:0060292; GO:0097061	dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17401_c0_g2_i1	Q61LA8	ARF12_CAEBR	93.4	76	5	0	229	2	8	83	6.60E-34	144.1	ARF12_CAEBR	reviewed	ADP-ribosylation factor 1-like 2 (ADP-ribosylation factor-related protein 1.2)	arf-1.2 CBG09004	Caenorhabditis briggsae	181	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0007005; GO:0009792; GO:0016192; GO:0048259; GO:0048599; GO:1904748	embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17401_c0_g2_i2	Q61LA8	ARF12_CAEBR	95.3	43	2	0	299	171	8	50	9.10E-15	80.9	ARF12_CAEBR	reviewed	ADP-ribosylation factor 1-like 2 (ADP-ribosylation factor-related protein 1.2)	arf-1.2 CBG09004	Caenorhabditis briggsae	181	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0007005; GO:0009792; GO:0016192; GO:0048259; GO:0048599; GO:1904748	embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN21368_c0_g1_i1	Q61LA8	ARF12_CAEBR	96.7	30	1	0	1	90	68	97	1.90E-11	69.3	ARF12_CAEBR	reviewed	ADP-ribosylation factor 1-like 2 (ADP-ribosylation factor-related protein 1.2)	arf-1.2 CBG09004	Caenorhabditis briggsae	181	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0007005; GO:0009792; GO:0016192; GO:0048259; GO:0048599; GO:1904748	embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; mitochondrion organization [GO:0007005]; oocyte development [GO:0048599]; regulation of apoptotic process involved in development [GO:1904748]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN36775_c0_g1_i1	P84081	ARF2_BOVIN	75.6	156	1	1	443	87	26	181	4.10E-56	218.8	ARF2_BOVIN	reviewed	ADP-ribosylation factor 2	ARF2	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g3_i1	Q5E9I6	ARF3_BOVIN	100	143	0	0	10	438	1	143	1.80E-75	283.1	ARF3_BOVIN	reviewed	ADP-ribosylation factor 3	ARF3	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0048471	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN878_c0_g1_i1	Q3SZF2	ARF4_BOVIN	87.8	180	22	0	91	630	1	180	3.00E-88	326.2	ARF4_BOVIN	reviewed	ADP-ribosylation factor 4	ARF4	Bos taurus (Bovine)	180	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN10763_c0_g1_i2	P61750	ARF4_MOUSE	98.9	180	2	0	593	54	1	180	1.70E-98	360.1	ARF4_MOUSE	reviewed	ADP-ribosylation factor 4	Arf4	Mus musculus (Mouse)	180	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; epidermal growth factor receptor binding [GO:0005154]; GTP binding [GO:0005525]; activation of phospholipase D activity [GO:0031584]; apical protein localization [GO:0045176]; brain development [GO:0007420]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to axon injury [GO:0048678]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	epidermal growth factor receptor binding [GO:0005154]; GTP binding [GO:0005525]	GO:0005154; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006471; GO:0006886; GO:0006890; GO:0007173; GO:0007420; GO:0007612; GO:0016192; GO:0016477; GO:0031584; GO:0032587; GO:0043066; GO:0043197; GO:0045176; GO:0045197; GO:0045944; GO:0048678; GO:0060996; GO:0061512; GO:2000377	"activation of phospholipase D activity [GO:0031584]; apical protein localization [GO:0045176]; brain development [GO:0007420]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to axon injury [GO:0048678]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10763_c0_g1_i4	P18085	ARF4_HUMAN	100	180	0	0	593	54	1	180	5.70E-99	361.7	ARF4_HUMAN	reviewed	ADP-ribosylation factor 4	ARF4 ARF2	Homo sapiens (Human)	180	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; epidermal growth factor receptor binding [GO:0005154]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; activation of phospholipase D activity [GO:0031584]; apical protein localization [GO:0045176]; brain development [GO:0007420]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to axon injury [GO:0048678]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; epidermal growth factor receptor binding [GO:0005154]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005086; GO:0005154; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006471; GO:0006886; GO:0006888; GO:0006890; GO:0007173; GO:0007420; GO:0007612; GO:0016020; GO:0016192; GO:0016477; GO:0031584; GO:0032587; GO:0043066; GO:0043197; GO:0045176; GO:0045197; GO:0045944; GO:0048678; GO:0060996; GO:0061512; GO:0070062; GO:0098978; GO:0099175; GO:2000377	"activation of phospholipase D activity [GO:0031584]; apical protein localization [GO:0045176]; brain development [GO:0007420]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to axon injury [GO:0048678]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN878_c0_g2_i1	P84085	ARF5_HUMAN	100	180	0	0	28	567	1	180	2.30E-100	366.3	ARF5_HUMAN	reviewed	ADP-ribosylation factor 5	ARF5	Homo sapiens (Human)	180	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0006890; GO:0016192; GO:0048471; GO:0070062	"intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN878_c0_g2_i2	P84085	ARF5_HUMAN	100	180	0	0	28	567	1	180	2.30E-100	366.3	ARF5_HUMAN	reviewed	ADP-ribosylation factor 5	ARF5	Homo sapiens (Human)	180	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0006890; GO:0016192; GO:0048471; GO:0070062	"intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g1_i1	P62330	ARF6_HUMAN	100	175	0	0	21	545	1	175	7.80E-100	364.4	ARF6_HUMAN	reviewed	ADP-ribosylation factor 6	ARF6	Homo sapiens (Human)	175	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]	GO:0001726; GO:0001889; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006886; GO:0007049; GO:0007155; GO:0016020; GO:0016192; GO:0030139; GO:0030838; GO:0030866; GO:0031527; GO:0031901; GO:0031996; GO:0032154; GO:0032456; GO:0033028; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0048261; GO:0048488; GO:0050714; GO:0051301; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0070062; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0098793; GO:0098978; GO:0099562; GO:0120183; GO:1903078; GO:1990090; GO:2000009; GO:2000171	cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19098_c0_g2_i1	P26990	ARF6_CHICK	95.4	175	8	0	70	594	1	175	4.30E-97	355.5	ARF6_CHICK	reviewed	ADP-ribosylation factor 6	ARF6 CPS1	Gallus gallus (Chicken)	175	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; myeloid cell apoptotic process [GO:0033028]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; vesicle-mediated transport [GO:0016192]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]	GO:0001726; GO:0001889; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0016192; GO:0030139; GO:0030838; GO:0030866; GO:0031527; GO:0031996; GO:0032154; GO:0032456; GO:0032587; GO:0033028; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0050714; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0120183; GO:1903078; GO:2000009	cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; myeloid cell apoptotic process [GO:0033028]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN36404_c0_g1_i1	P26990	ARF6_CHICK	100	78	0	0	80	313	1	78	2.50E-39	162.5	ARF6_CHICK	reviewed	ADP-ribosylation factor 6	ARF6 CPS1	Gallus gallus (Chicken)	175	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; myeloid cell apoptotic process [GO:0033028]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; vesicle-mediated transport [GO:0016192]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]	GO:0001726; GO:0001889; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0016192; GO:0030139; GO:0030838; GO:0030866; GO:0031527; GO:0031996; GO:0032154; GO:0032456; GO:0032587; GO:0033028; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0050714; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0120183; GO:1903078; GO:2000009	cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; myeloid cell apoptotic process [GO:0033028]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN32299_c0_g1_i1	Q8N6T3	ARFG1_HUMAN	100	76	0	0	230	3	9	84	1.90E-41	169.1	ARFG1_HUMAN	reviewed	ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein)	ARFGAP1 ARF1GAP	Homo sapiens (Human)	406	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0005829; GO:0006888; GO:0006890; GO:0014069; GO:0015031; GO:0030100; GO:0032012; GO:0036498; GO:0045202; GO:0046872	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39971_c0_g1_i1	Q9EPJ9	ARFG1_MOUSE	73.7	76	20	0	228	1	10	85	5.30E-31	134.4	ARFG1_MOUSE	reviewed	ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein)	Arfgap1 Arf1gap	Mus musculus (Mouse)	414	Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192]	Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0014069; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202; GO:0046872	protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN6627_c0_g1_i1	Q28CM8	ARFG2_XENTR	72.5	91	25	0	342	70	12	102	4.30E-37	155.2	ARFG2_XENTR	reviewed	ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289)	arfgap2 znf289 TEgg043a17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	526	Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; protein transport [GO:0015031]	Golgi membrane [GO:0000139]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0015031; GO:0046872; GO:0048205	COPI coating of Golgi vesicle [GO:0048205]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN35884_c0_g1_i1	Q9NP61	ARFG3_HUMAN	100	92	0	0	1	276	6	97	9.50E-51	200.3	ARFG3_HUMAN	reviewed	ADP-ribosylation factor GTPase-activating protein 3 (ARF GAP 3)	ARFGAP3 ARFGAP1	Homo sapiens (Human)	516	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0009306; GO:0016020; GO:0016192; GO:0046872; GO:0048205	"COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33243_c0_g1_i1	Q9FL69	AGD5_ARATH	61.7	60	23	0	188	9	22	81	4.20E-17	88.2	AGD5_ARATH	reviewed	ADP-ribosylation factor GTPase-activating protein AGD5 (ARF GAP AGD5) (Protein ARF-GAP DOMAIN 5) (AtAGD5) (Protein MODIFIED TRANSPORT TO THE VACUOLE 4) (Protein NEVERSHED) (Protein ZIGA3)	AGD5 MTV4 NEV ZIG3 ZIGA3 At5g54310 MDK4.13	Arabidopsis thaliana (Mouse-ear cress)	483	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; clathrin-coated vesicle cargo loading [GO:0035652]; defense response to Gram-negative bacterium [GO:0050829]; floral organ abscission [GO:0010227]; leaf abscission [GO:0060866]; negative regulation of cell growth [GO:0030308]; vesicle-mediated transport involved in floral organ abscission [GO:0060858]	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]	clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005768; GO:0005802; GO:0005829; GO:0010227; GO:0030136; GO:0030276; GO:0030308; GO:0035652; GO:0046872; GO:0050829; GO:0060858; GO:0060866; GO:0090630	activation of GTPase activity [GO:0090630]; clathrin-coated vesicle cargo loading [GO:0035652]; defense response to Gram-negative bacterium [GO:0050829]; floral organ abscission [GO:0010227]; leaf abscission [GO:0060866]; negative regulation of cell growth [GO:0030308]; vesicle-mediated transport involved in floral organ abscission [GO:0060858]		NA	NA	NA	NA	NA	NA
TRINITY_DN38531_c0_g1_i1	Q9UJY5	GGA1_HUMAN	98.9	88	1	0	1	264	59	146	4.80E-44	177.9	GGA1_HUMAN	reviewed	"ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)"	GGA1	Homo sapiens (Human)	639	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ADP-ribosylation factor binding [GO:0030306]; cellular protein metabolic process [GO:0044267]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]"	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	ADP-ribosylation factor binding [GO:0030306]	GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0008104; GO:0010008; GO:0016020; GO:0030306; GO:0031901; GO:0032991; GO:0034394; GO:0042147; GO:0043001; GO:0043231; GO:0044267; GO:0045732; GO:1901998; GO:1903441	"cellular protein metabolic process [GO:0044267]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35554_c0_g1_i1	Q6P5E6	GGA2_MOUSE	98	101	2	0	305	3	121	221	4.30E-52	204.9	GGA2_MOUSE	reviewed	"ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2)"	Gga2 Kiaa1080	Mus musculus (Mouse)	603	clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394]	clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]	ADP-ribosylation factor binding [GO:0030306]	GO:0005794; GO:0005802; GO:0006886; GO:0030136; GO:0030306; GO:0031901; GO:0034394; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394]		NA	NA	NA	NA	NA	NA
TRINITY_DN9038_c0_g1_i1	A0A0G2JV04	GGA3_RAT	53.2	237	109	2	732	28	63	299	4.30E-66	252.7	GGA3_RAT	reviewed	"ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)"	Gga3	Rattus norvegicus (Rat)	727	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	ADP-ribosylation factor binding [GO:0030306]; ubiquitin binding [GO:0043130]	GO:0005769; GO:0005802; GO:0006886; GO:0030306; GO:0031647; GO:0031648; GO:0031901; GO:0032456; GO:0034394; GO:0043001; GO:0043130; GO:0045732; GO:0055037; GO:0055038; GO:0061462; GO:1902430	endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN3936_c0_g1_i1	P25160	ARL1_DROME	87.8	180	22	0	633	94	1	180	1.30E-85	317.4	ARL1_DROME	reviewed	ADP-ribosylation factor-like protein 1	Arl1 Arf72A arl CG6025	Drosophila melanogaster (Fruit fly)	180	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; dsRNA transport [GO:0033227]; endoplasmic reticulum membrane organization [GO:0090158]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; regulation of cell migration [GO:0030334]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; salivary gland development [GO:0007431]; secretory granule organization [GO:0033363]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein domain specific binding [GO:0019904]	GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0006886; GO:0007030; GO:0007269; GO:0007431; GO:0016192; GO:0019904; GO:0030334; GO:0033227; GO:0033363; GO:0034067; GO:0035220; GO:0048488; GO:0060628; GO:0070861; GO:0090158; GO:0098793; GO:1903292	dsRNA transport [GO:0033227]; endoplasmic reticulum membrane organization [GO:0090158]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; regulation of cell migration [GO:0030334]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; salivary gland development [GO:0007431]; secretory granule organization [GO:0033363]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]; wing disc development [GO:0035220]		blue	blue	NA	NA	NA	NA
TRINITY_DN17700_c0_g1_i1	Q2YDM1	ARL1_BOVIN	100	75	0	0	225	1	42	116	1.70E-37	156	ARL1_BOVIN	reviewed	ADP-ribosylation factor-like protein 1	ARL1	Bos taurus (Bovine)	181	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	enzyme activator activity [GO:0008047]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0031584; GO:0034067; GO:0042147; GO:0046872	"activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17700_c0_g2_i1	Q2YDM1	ARL1_BOVIN	100	105	0	0	317	3	8	112	5.60E-55	214.5	ARL1_BOVIN	reviewed	ADP-ribosylation factor-like protein 1	ARL1	Bos taurus (Bovine)	181	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	enzyme activator activity [GO:0008047]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0031584; GO:0034067; GO:0042147; GO:0046872	"activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34810_c0_g1_i1	P61211	ARL1_MOUSE	100	67	0	0	248	48	115	181	3.30E-31	135.2	ARL1_MOUSE	reviewed	ADP-ribosylation factor-like protein 1	Arl1	Mus musculus (Mouse)	181	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	enzyme activator activity [GO:0008047]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0031584; GO:0034067; GO:0042147; GO:0046872; GO:0048193	"activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15716_c0_g1_i1	Q8JHI3	AR13B_DANRE	46.8	141	75	0	484	62	69	209	5.40E-33	142.1	AR13B_DANRE	reviewed	ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion)	arl13b arl2l1	Danio rerio (Zebrafish) (Brachydanio rerio)	407	ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]	GTP binding [GO:0005525]	GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515	cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN15716_c0_g1_i2	Q8JHI3	AR13B_DANRE	45	120	66	0	421	62	90	209	2.60E-24	113.2	AR13B_DANRE	reviewed	ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion)	arl13b arl2l1	Danio rerio (Zebrafish) (Brachydanio rerio)	407	ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]	GTP binding [GO:0005525]	GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515	cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN32132_c0_g1_i1	Q8IVW1	ARL17_HUMAN	100	61	0	0	230	48	26	86	1.30E-30	133.3	ARL17_HUMAN	reviewed	ADP-ribosylation factor-like protein 17 (ADP-ribosylation factor 7 variant)	ARL17A ARL17P1; ARL17B ARF1P2 ARL17A PRO2667	Homo sapiens (Human)	177	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11960_c0_g1_i1	P36404	ARL2_HUMAN	74.1	174	41	1	522	1	1	170	5.90E-71	268.5	ARL2_HUMAN	reviewed	ADP-ribosylation factor-like protein 2	ARL2	Homo sapiens (Human)	184	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; GTP binding [GO:0005525]	GO:0003924; GO:0005095; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005758; GO:0005759; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0007021; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0050796; GO:0051457; GO:0070830	bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN26395_c0_g1_i1	Q9D0J4	ARL2_MOUSE	98.9	93	1	0	280	2	46	138	1.20E-48	193.4	ARL2_MOUSE	reviewed	ADP-ribosylation factor-like protein 2	Arl2	Mus musculus (Mouse)	184	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; acetylcholine transport [GO:0015870]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of microtubule polymerization [GO:0031113]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005758; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0007098; GO:0010811; GO:0015630; GO:0015870; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0051457; GO:0070830	acetylcholine transport [GO:0015870]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of microtubule polymerization [GO:0031113]		NA	NA	NA	NA	NA	NA
TRINITY_DN31254_c0_g1_i1	Q2TA37	ARL2_BOVIN	72.3	112	31	0	9	344	1	112	1.90E-45	183	ARL2_BOVIN	reviewed	ADP-ribosylation factor-like protein 2	ARL2	Bos taurus (Bovine)	184	centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005813; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031116; GO:0034260; GO:0034333; GO:0051457; GO:0070830	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]		NA	NA	NA	NA	NA	NA
TRINITY_DN20218_c0_g1_i1	P36404	ARL2_HUMAN	100	166	0	0	1	498	3	168	1.20E-91	337	ARL2_HUMAN	reviewed	ADP-ribosylation factor-like protein 2	ARL2	Homo sapiens (Human)	184	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; GTP binding [GO:0005525]	GO:0003924; GO:0005095; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005758; GO:0005759; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0007021; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0050796; GO:0051457; GO:0070830	bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN39159_c0_g1_i1	Q9WUL7	ARL3_MOUSE	100	118	0	0	357	4	65	182	5.10E-65	248.1	ARL3_MOUSE	reviewed	ADP-ribosylation factor-like protein 3	Arl3	Mus musculus (Mouse)	182	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	GDP binding [GO:0019003]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]	GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006892; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015630; GO:0019003; GO:0030496; GO:0032391; GO:0032794; GO:0035869; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:0061512; GO:1903441	cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN32701_c0_g1_i1	Q8QHI3	ARL3_XENLA	43.8	121	61	2	73	435	16	129	2.50E-21	103.2	ARL3_XENLA	reviewed	ADP-ribosylation factor-like protein 3	arl3	Xenopus laevis (African clawed frog)	182	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000139; GO:0000281; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0042461; GO:0060271	cilium assembly [GO:0060271]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5743_c0_g1_i1	B5FYQ0	ARL3_TAEGU	86.2	167	23	0	579	79	1	167	8.00E-80	298.1	ARL3_TAEGU	reviewed	ADP-ribosylation factor-like protein 3	ARL3	Taeniopygia guttata (Zebra finch) (Poephila guttata)	182	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	GDP binding [GO:0019003]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]	GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0019003; GO:0030496; GO:0032391; GO:0032794; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441	cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN5743_c0_g1_i2	B5FYQ0	ARL3_TAEGU	84.4	180	28	0	581	42	1	180	1.50E-86	320.5	ARL3_TAEGU	reviewed	ADP-ribosylation factor-like protein 3	ARL3	Taeniopygia guttata (Zebra finch) (Poephila guttata)	182	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	GDP binding [GO:0019003]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]	GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0019003; GO:0030496; GO:0032391; GO:0032794; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441	cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN33684_c0_g1_i1	Q1MTE5	ARL3_DANRE	66.7	180	59	1	40	576	1	180	4.80E-68	258.8	ARL3_DANRE	reviewed	ADP-ribosylation factor-like protein 3	arl3 sfxn2 si:ch211-208d15.4	Danio rerio (Zebrafish) (Brachydanio rerio)	182	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000139; GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0008017; GO:0015031; GO:0015630; GO:0019003; GO:0030496; GO:0032391; GO:0060271	cilium assembly [GO:0060271]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN26149_c0_g1_i1	Q3T0M9	ARL4A_BOVIN	47.2	53	28	0	196	38	146	198	3.90E-09	61.6	ARL4A_BOVIN	reviewed	ADP-ribosylation factor-like protein 4A	ARL4A	Bos taurus (Bovine)	200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873	brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN15873_c0_g1_i1	Q3T0M9	ARL4A_BOVIN	100	160	0	0	2	481	21	180	6.80E-89	327.8	ARL4A_BOVIN	reviewed	ADP-ribosylation factor-like protein 4A	ARL4A	Bos taurus (Bovine)	200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873	brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN15873_c0_g1_i2	Q3T0M9	ARL4A_BOVIN	100	160	0	0	2	481	21	180	6.80E-89	327.8	ARL4A_BOVIN	reviewed	ADP-ribosylation factor-like protein 4A	ARL4A	Bos taurus (Bovine)	200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873	brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN32910_c0_g1_i1	P56559	ARL4C_HUMAN	100	192	0	0	11	586	1	192	5.80E-106	384.8	ARL4C_HUMAN	reviewed	ADP-ribosylation factor-like protein 4C (ADP-ribosylation factor-like protein 7) (ADP-ribosylation factor-like protein LAK)	ARL4C ARL7	Homo sapiens (Human)	192	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-tubulin binding [GO:0043014]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	alpha-tubulin binding [GO:0043014]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0030175; GO:0032456; GO:0043014	endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14946_c0_g1_i1	Q99PE9	ARL4D_MOUSE	56.2	112	39	5	15	335	23	129	3.30E-24	112.5	ARL4D_MOUSE	reviewed	ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5)	Arl4d Arf4l Arl5	Mus musculus (Mouse)	201	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN29347_c0_g1_i1	Q99PE9	ARL4D_MOUSE	69.9	83	25	0	4	252	68	150	6.20E-28	124.4	ARL4D_MOUSE	reviewed	ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5)	Arl4d Arf4l Arl5	Mus musculus (Mouse)	201	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0016192	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN34281_c0_g1_i1	Q80ZU0	ARL5A_MOUSE	99.4	166	1	0	500	3	14	179	2.40E-92	339.3	ARL5A_MOUSE	reviewed	ADP-ribosylation factor-like protein 5A	Arl5a Arl5	Mus musculus (Mouse)	179	cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005802; GO:0006886; GO:0016192; GO:1903292	intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1425_c0_g1_i1	Q96KC2	ARL5B_HUMAN	76.1	176	42	0	30	557	1	176	3.50E-77	289.3	ARL5B_HUMAN	reviewed	ADP-ribosylation factor-like protein 5B (ADP-ribosylation factor-like protein 8)	ARL5B ARL8	Homo sapiens (Human)	179	cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005802; GO:0006886; GO:0016192; GO:1903292	intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN29259_c0_g1_i1	O88848	ARL6_MOUSE	98	50	1	0	1	150	137	186	1.80E-22	105.9	ARL6_MOUSE	reviewed	ADP-ribosylation factor-like protein 6	Arl6 Bbs3	Mus musculus (Mouse)	186	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane coat [GO:0030117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; Ras protein signal transduction [GO:0007265]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane coat [GO:0030117]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0003924; GO:0005525; GO:0005543; GO:0005737; GO:0005829; GO:0005879; GO:0005929; GO:0005930; GO:0006471; GO:0006612; GO:0006886; GO:0007265; GO:0007420; GO:0008589; GO:0010842; GO:0016020; GO:0016055; GO:0016192; GO:0030117; GO:0045444; GO:0046872; GO:0051258; GO:0060170; GO:0060271; GO:0061512; GO:0097499; GO:1903445	brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; Ras protein signal transduction [GO:0007265]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN5014_c0_g1_i1	O88848	ARL6_MOUSE	63.7	182	66	0	649	104	1	182	3.20E-66	253.1	ARL6_MOUSE	reviewed	ADP-ribosylation factor-like protein 6	Arl6 Bbs3	Mus musculus (Mouse)	186	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane coat [GO:0030117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; Ras protein signal transduction [GO:0007265]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane coat [GO:0030117]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0003924; GO:0005525; GO:0005543; GO:0005737; GO:0005829; GO:0005879; GO:0005929; GO:0005930; GO:0006471; GO:0006612; GO:0006886; GO:0007265; GO:0007420; GO:0008589; GO:0010842; GO:0016020; GO:0016055; GO:0016192; GO:0030117; GO:0045444; GO:0046872; GO:0051258; GO:0060170; GO:0060271; GO:0061512; GO:0097499; GO:1903445	brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; Ras protein signal transduction [GO:0007265]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN5014_c0_g1_i2	Q5M9P8	ARL6_DANRE	54.9	182	51	1	556	104	1	182	9.80E-51	201.4	ARL6_DANRE	reviewed	ADP-ribosylation factor-like protein 6	arl6 si:dkey-24h22.2 zgc:101762	Danio rerio (Zebrafish) (Brachydanio rerio)	186	axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]	axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0005737; GO:0005930; GO:0006886; GO:0007368; GO:0007369; GO:0007601; GO:0008593; GO:0016192; GO:0032402; GO:0033339; GO:0046872; GO:0050896; GO:0060170; GO:0060271; GO:0061512; GO:0070121	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN30914_c0_g1_i1	Q0IIM2	ARL6_BOVIN	53.6	166	76	1	26	520	14	179	1.40E-47	190.7	ARL6_BOVIN	reviewed	ADP-ribosylation factor-like protein 6	ARL6	Bos taurus (Bovine)	186	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane coat [GO:0030117]; BBSome binding [GO:0062063]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane coat [GO:0030117]	BBSome binding [GO:0062063]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phospholipid binding [GO:0005543]	GO:0003924; GO:0005525; GO:0005543; GO:0005737; GO:0005829; GO:0005879; GO:0005930; GO:0006612; GO:0006886; GO:0007420; GO:0008589; GO:0010842; GO:0016055; GO:0016192; GO:0030117; GO:0045444; GO:0051258; GO:0060170; GO:0060271; GO:0061512; GO:0062063; GO:0097499; GO:1903445	brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7514_c1_g1_i1	Q9JKW0	AR6P1_MOUSE	39.1	179	109	0	50	586	18	196	9.80E-31	135.2	AR6P1_MOUSE	reviewed	ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2)	Arl6ip1 Arl6ip	Mus musculus (Mouse)	203	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	identical protein binding [GO:0042802]	GO:0002038; GO:0005737; GO:0005783; GO:0005784; GO:0005789; GO:0005829; GO:0006613; GO:0006915; GO:0016021; GO:0030176; GO:0042802; GO:0043066; GO:0043154; GO:0071787; GO:1903371; GO:1990809	apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]		NA	NA	NA	NA	NA	NA
TRINITY_DN32966_c0_g1_i1	Q8VEH3	ARL8A_MOUSE	100	168	0	0	64	567	1	168	6.40E-94	344.7	ARL8A_MOUSE	reviewed	ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2)	Arl8a Arl10b Gie2	Mus musculus (Mouse)	186	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein transport [GO:0015031]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005765; GO:0005774; GO:0007049; GO:0007059; GO:0008089; GO:0015031; GO:0030496; GO:0031902; GO:0045202; GO:0051233; GO:0051301; GO:1904115	anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN39053_c0_g1_i1	Q9NVJ2	ARL8B_HUMAN	100	170	0	0	3	512	17	186	8.20E-96	350.9	ARL8B_HUMAN	reviewed	ADP-ribosylation factor-like protein 8B (ADP-ribosylation factor-like protein 10C) (Novel small G protein indispensable for equal chromosome segregation 1)	ARL8B ARL10C GIE1	Homo sapiens (Human)	186	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; protein transport [GO:0015031]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]	alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0005765; GO:0005774; GO:0007049; GO:0007059; GO:0008089; GO:0015031; GO:0016020; GO:0016197; GO:0019003; GO:0030496; GO:0031902; GO:0032418; GO:0043014; GO:0045202; GO:0048487; GO:0051233; GO:0051301; GO:0070062; GO:1904115	anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3279_c0_g1_i1	Q6NZW8	AR8BA_DANRE	94.5	183	10	0	652	104	1	183	7.90E-100	364.8	AR8BA_DANRE	reviewed	ADP-ribosylation factor-like protein 8B-A	arl8ba arl8b zgc:77187	Danio rerio (Zebrafish) (Brachydanio rerio)	186	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; spindle [GO:0005819]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; spindle [GO:0005819]; vacuolar membrane [GO:0005774]	GTP binding [GO:0005525]	GO:0005525; GO:0005765; GO:0005774; GO:0005819; GO:0007049; GO:0007059; GO:0031902; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]		blue	blue	NA	NA	NA	NA
TRINITY_DN1194_c0_g1_i1	Q32LJ2	ARFRP_BOVIN	58.9	202	82	1	88	693	1	201	2.40E-67	256.9	ARFRP_BOVIN	reviewed	ADP-ribosylation factor-related protein 1 (ARF-related protein 1)	ARFRP1	Bos taurus (Bovine)	201	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	GTP binding [GO:0005525]	GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007369; GO:0016020; GO:0033365; GO:0034067; GO:0042147; GO:0043001	"gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30460_c0_g1_i1	Q13795	ARFRP_HUMAN	100	97	0	0	16	306	1	97	7.30E-52	204.1	ARFRP_HUMAN	reviewed	ADP-ribosylation factor-related protein 1 (ARF-related protein 1) (ARP)	ARFRP1 ARP1	Homo sapiens (Human)	201	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport, endosome to Golgi [GO:0042147]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007165; GO:0007369; GO:0016020; GO:0032588; GO:0033365; GO:0034067; GO:0042147; GO:0043001	"gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport, endosome to Golgi [GO:0042147]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39070_c0_g1_i1	Q12184	ADRX_YEAST	55	60	27	0	180	1	69	128	3.80E-13	75.1	ADRX_YEAST	reviewed	"Adrenodoxin homolog, mitochondrial (Mitochondrial ferredoxin)"	YAH1 YPL252C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	172	"mitochondrial matrix [GO:0005759]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; heme A biosynthetic process [GO:0006784]; iron-sulfur cluster assembly [GO:0016226]; ubiquinone biosynthetic process [GO:0006744]"	mitochondrial matrix [GO:0005759]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]"	GO:0005759; GO:0006744; GO:0006784; GO:0009055; GO:0016226; GO:0016653; GO:0046872; GO:0051537	heme A biosynthetic process [GO:0006784]; iron-sulfur cluster assembly [GO:0016226]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN21805_c0_g1_i3	P46656	ADX_MOUSE	56.7	127	54	1	387	7	56	181	2.90E-35	149.8	ADX_MOUSE	reviewed	"Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1)"	Fdx1	Mus musculus (Mouse)	188	"mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; iron ion binding [GO:0005506]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; hormone biosynthetic process [GO:0042446]; NADPH oxidation [GO:0070995]; positive regulation of oxidoreductase activity [GO:0051353]; regulation of catalytic activity [GO:0050790]; steroid biosynthetic process [GO:0006694]"	mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005739; GO:0005759; GO:0006694; GO:0008203; GO:0009055; GO:0019899; GO:0030061; GO:0042446; GO:0050790; GO:0051353; GO:0051537; GO:0070995; GO:0071320; GO:1904322	cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; hormone biosynthetic process [GO:0042446]; NADPH oxidation [GO:0070995]; positive regulation of oxidoreductase activity [GO:0051353]; regulation of catalytic activity [GO:0050790]; steroid biosynthetic process [GO:0006694]		blue	blue	NA	NA	NA	NA
TRINITY_DN7080_c0_g1_i1	P37193	ADXH1_DROME	64.7	139	49	0	173	589	34	172	3.60E-51	203	ADXH1_DROME	reviewed	"Adrenodoxin-like protein 1, mitochondrial (Ferredoxin-1)"	Fdx1 Fdxh CG4205	Drosophila melanogaster (Fruit fly)	172	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	GO:0005739; GO:0005759; GO:0006694; GO:0009055; GO:0045998; GO:0046872; GO:0051537	positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g2_i1	Q5ZIV9	ADSV_CHICK	43.7	103	56	2	6	308	258	360	3.00E-18	92.8	ADSV_CHICK	reviewed	Adseverin (Scinderin)	SCIN RCJMB04_23d8	Gallus gallus (Chicken)	717	"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; regulation of chondrocyte differentiation [GO:0032330]"	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0005509; GO:0005546; GO:0005737; GO:0007417; GO:0008154; GO:0015629; GO:0030031; GO:0030054; GO:0032330; GO:0042995; GO:0051014; GO:0051015; GO:0051016	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; regulation of chondrocyte differentiation [GO:0032330]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g2_i2	Q5ZIV9	ADSV_CHICK	47.7	44	23	0	22	153	317	360	7.00E-07	54.3	ADSV_CHICK	reviewed	Adseverin (Scinderin)	SCIN RCJMB04_23d8	Gallus gallus (Chicken)	717	"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; regulation of chondrocyte differentiation [GO:0032330]"	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0005509; GO:0005546; GO:0005737; GO:0007417; GO:0008154; GO:0015629; GO:0030031; GO:0030054; GO:0032330; GO:0042995; GO:0051014; GO:0051015; GO:0051016	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; regulation of chondrocyte differentiation [GO:0032330]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g1_i2	O88398	AVIL_MOUSE	43.8	322	164	7	16	963	360	670	1.50E-61	238	AVIL_MOUSE	reviewed	Advillin (Actin-binding protein DOC6) (p92)	Avil Advil	Mus musculus (Mouse)	819	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480	actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g1_i3	O88398	AVIL_MOUSE	57.6	33	14	0	84	182	632	664	8.00E-05	47.8	AVIL_MOUSE	reviewed	Advillin (Actin-binding protein DOC6) (p92)	Avil Advil	Mus musculus (Mouse)	819	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480	actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g1_i5	O75366	AVIL_HUMAN	40	100	54	2	105	389	721	819	3.40E-12	72.8	AVIL_HUMAN	reviewed	Advillin (p92)	AVIL	Homo sapiens (Human)	819	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480	actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]		NA	NA	NA	NA	NA	NA
TRINITY_DN11428_c0_g1_i1	B4MUE1	AFFL_DROWI	42	119	65	1	393	49	1601	1719	7.90E-17	89	AFFL_DROWI	reviewed	AF4/FMR2 family member lilli (Protein lilliputian)	lilli GK14864	Drosophila willistoni (Fruit fly)	1837	"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; periodic partitioning by pair rule gene [GO:0007366]; regulation of cytoskeleton organization [GO:0051493]; regulation of lipid transport [GO:0032368]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0005634; GO:0006355; GO:0007366; GO:0032368; GO:0051493	"periodic partitioning by pair rule gene [GO:0007366]; regulation of cytoskeleton organization [GO:0051493]; regulation of lipid transport [GO:0032368]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11428_c0_g1_i2	Q9VQI9	AFFL_DROME	40.4	141	75	2	447	52	1414	1554	9.20E-19	94.7	AFFL_DROME	reviewed	AF4/FMR2 family member lilli (Protein lilliputian) (Suppressor of Raf at 2A) (Suppressor of sina 2-1)	lilli l(2)00632 SS2-1 Su(Raf)2A CG8817	Drosophila melanogaster (Fruit fly)	1673	"nucleus [GO:0005634]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; learning or memory [GO:0007611]; neuronal stem cell population maintenance [GO:0097150]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoskeleton organization [GO:0051493]; regulation of gene expression [GO:0010468]; regulation of lipid transport [GO:0032368]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]; super elongation complex [GO:0032783]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]	DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0005634; GO:0006355; GO:0007366; GO:0007379; GO:0007611; GO:0008023; GO:0010468; GO:0032368; GO:0032783; GO:0035327; GO:0045944; GO:0048190; GO:0051493; GO:0061629; GO:0097150	"learning or memory [GO:0007611]; neuronal stem cell population maintenance [GO:0097150]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoskeleton organization [GO:0051493]; regulation of gene expression [GO:0010468]; regulation of lipid transport [GO:0032368]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16871_c0_g1_i1	Q9QZQ1	AFAD_MOUSE	51.6	477	213	4	1486	107	505	980	3.70E-125	449.9	AFAD_MOUSE	reviewed	Afadin (Afadin adherens junction formation factor) (Protein Af-6)	Afdn Af6 Mllt4	Mus musculus (Mouse)	1820	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]; adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]	actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]	GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0017016; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0043547; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0140059; GO:1902414; GO:1903861; GO:2000049	adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN16871_c0_g1_i3	Q9QZQ1	AFAD_MOUSE	40	225	117	4	688	65	505	728	1.60E-30	134.4	AFAD_MOUSE	reviewed	Afadin (Afadin adherens junction formation factor) (Protein Af-6)	Afdn Af6 Mllt4	Mus musculus (Mouse)	1820	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]; adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]	actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]	GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0017016; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0043547; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0140059; GO:1902414; GO:1903861; GO:2000049	adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN16871_c0_g1_i5	Q9QZQ1	AFAD_MOUSE	53.2	579	244	8	1686	4	505	1074	2.10E-153	543.9	AFAD_MOUSE	reviewed	Afadin (Afadin adherens junction formation factor) (Protein Af-6)	Afdn Af6 Mllt4	Mus musculus (Mouse)	1820	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]; adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]	actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]	GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0017016; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0043547; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0140059; GO:1902414; GO:1903861; GO:2000049	adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN16871_c0_g1_i2	P55196	AFAD_HUMAN	72	82	21	2	246	4	994	1074	9.80E-23	107.5	AFAD_HUMAN	reviewed	Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor)	AFDN AF6 MLLT4	Homo sapiens (Human)	1824	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; Ras GTPase binding [GO:0017016]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]	adherens junction [GO:0005912]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; Ras GTPase binding [GO:0017016]	GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007155; GO:0007165; GO:0007267; GO:0008022; GO:0010628; GO:0016607; GO:0017016; GO:0022409; GO:0030054; GO:0030336; GO:0032880; GO:0034332; GO:0043547; GO:0044291; GO:0044331; GO:0045296; GO:0046930; GO:0046931; GO:0050839; GO:0051015; GO:0061951; GO:0070160; GO:0070830; GO:0090557; GO:2000049	adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32804_c0_g1_i1	Q920A7	AFG31_MOUSE	100	96	0	0	2	289	682	777	1.10E-46	186.8	AFG31_MOUSE	reviewed	AFG3-like protein 1 (EC 3.4.24.-)	Afg3l1	Mus musculus (Mouse)	789	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0007005; GO:0008053; GO:0008270; GO:0016485; GO:0034982; GO:0042407; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN32028_c0_g1_i1	Q920A7	AFG31_MOUSE	100	130	0	0	391	2	514	643	9.00E-71	267.3	AFG31_MOUSE	reviewed	AFG3-like protein 1 (EC 3.4.24.-)	Afg3l1	Mus musculus (Mouse)	789	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0007005; GO:0008053; GO:0008270; GO:0016485; GO:0034982; GO:0042407; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN11154_c0_g2_i1	Q920A7	AFG31_MOUSE	65.9	249	83	1	25	771	296	542	2.40E-91	336.7	AFG31_MOUSE	reviewed	AFG3-like protein 1 (EC 3.4.24.-)	Afg3l1	Mus musculus (Mouse)	789	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0007005; GO:0008053; GO:0008270; GO:0016485; GO:0034982; GO:0042407; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN676_c0_g1_i1	Q2KJI7	AFG32_BOVIN	62.7	244	88	3	734	3	164	404	1.10E-77	291.2	AFG32_BOVIN	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	AFG3L2	Bos taurus (Bovine)	805	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN676_c0_g1_i3	Q2KJI7	AFG32_BOVIN	74.7	510	125	3	1616	93	287	794	3.10E-218	759.2	AFG32_BOVIN	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	AFG3L2	Bos taurus (Bovine)	805	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN676_c0_g1_i6	Q2KJI7	AFG32_BOVIN	62.8	94	35	0	374	93	701	794	1.90E-25	116.7	AFG32_BOVIN	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	AFG3L2	Bos taurus (Bovine)	805	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN676_c0_g1_i7	Q2KJI7	AFG32_BOVIN	68.5	634	195	4	1988	93	164	794	1.20E-246	854	AFG32_BOVIN	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	AFG3L2	Bos taurus (Bovine)	805	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN676_c0_g1_i9	Q2KJI7	AFG32_BOVIN	62.7	244	88	3	734	3	164	404	1.10E-77	291.2	AFG32_BOVIN	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	AFG3L2	Bos taurus (Bovine)	805	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN37702_c0_g1_i1	Q8JZQ2	AFG32_MOUSE	100	125	0	0	377	3	392	516	2.20E-66	252.7	AFG32_MOUSE	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	Afg3l2	Mus musculus (Mouse)	802	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007005; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN11154_c0_g1_i1	Q2KJI7	AFG32_BOVIN	53.8	143	64	2	426	1	549	690	9.80E-39	161	AFG32_BOVIN	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	AFG3L2	Bos taurus (Bovine)	805	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN27022_c0_g1_i1	Q8JZQ2	AFG32_MOUSE	100	128	0	0	387	4	577	704	2.80E-69	262.3	AFG32_MOUSE	reviewed	AFG3-like protein 2 (EC 3.4.24.-)	Afg3l2	Mus musculus (Mouse)	802	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007005; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN30241_c0_g1_i1	Q9Y4W6	AFG32_HUMAN	100	70	0	0	212	3	176	245	5.50E-35	147.5	AFG32_HUMAN	reviewed	AFG3-like protein 2 (EC 3.4.24.-) (Paraplegin-like protein)	AFG3L2	Homo sapiens (Human)	797	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0006851; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051082; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN40288_c0_g1_i1	Q9Y4W6	AFG32_HUMAN	100	131	0	0	2	394	556	686	4.00E-71	268.5	AFG32_HUMAN	reviewed	AFG3-like protein 2 (EC 3.4.24.-) (Paraplegin-like protein)	AFG3L2	Homo sapiens (Human)	797	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0006851; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051082; GO:0051560; GO:0060013; GO:0065003	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein-containing complex assembly [GO:0065003]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g2_i1	Q90XD2	SPEB_CHICK	58.2	208	80	2	733	113	16	217	3.40E-65	250	SPEB_CHICK	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Gallus gallus (Chicken)	340	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872	"putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g2_i2	Q90XD2	SPEB_CHICK	67.6	176	57	0	633	106	162	337	3.70E-68	259.6	SPEB_CHICK	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Gallus gallus (Chicken)	340	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872	"putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g2_i4	Q90XD2	SPEB_CHICK	60.5	301	112	2	966	67	16	310	7.10E-105	382.1	SPEB_CHICK	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Gallus gallus (Chicken)	340	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872	"putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g2_i6	Q90XD2	SPEB_CHICK	62.5	328	116	2	1086	106	16	337	1.30E-118	427.9	SPEB_CHICK	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Gallus gallus (Chicken)	340	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872	"putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g1_i2	Q90XD2	SPEB_CHICK	58.1	277	110	3	833	21	4	280	4.30E-90	332.8	SPEB_CHICK	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Gallus gallus (Chicken)	340	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872	"putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g1_i1	Q90XD2	SPEB_CHICK	60.9	335	125	3	1092	106	4	338	1.00E-117	424.9	SPEB_CHICK	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Gallus gallus (Chicken)	340	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872	"putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	1	NA	NA	NA
TRINITY_DN27030_c0_g1_i1	Q9BSE5	SPEB_HUMAN	100	94	0	0	284	3	238	331	7.50E-51	200.7	SPEB_HUMAN	reviewed	"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)"	AGMAT	Homo sapiens (Human)	352	"mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; agmatine biosynthetic process [GO:0097055]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"	mitochondrion [GO:0005739]	agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]	GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872; GO:0097055	"agmatine biosynthetic process [GO:0097055]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23538_c0_g1_i1	Q90404	AGRIN_DIPOM	40.5	168	92	3	483	4	858	1025	1.20E-32	141	AGRIN_DIPOM	reviewed	Agrin (Fragment)	AGRN AGRIN	Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)	1328	calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		calcium ion binding [GO:0005509]	GO:0005509; GO:0007275; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN15452_c0_g2_i1	A2ASQ1	AGRIN_MOUSE	41	134	72	4	408	22	1543	1674	1.90E-18	93.6	AGRIN_MOUSE	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	Agrn Agrin	Mus musculus (Mouse)	1950	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN882_c0_g1_i10	O00468	AGRIN_HUMAN	28.9	501	252	17	1323	94	268	755	5.50E-39	163.7	AGRIN_HUMAN	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	AGRN AGRIN	Homo sapiens (Human)	2068	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]; animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; extracellular matrix organization [GO:0030198]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]	GO:0001523; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005829; GO:0005886; GO:0006024; GO:0006027; GO:0007165; GO:0007213; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0030198; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062	animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]		blue	blue	NA	NA	NA	NA
TRINITY_DN882_c0_g1_i11	A2ASQ1	AGRIN_MOUSE	29.4	480	230	17	1245	94	179	645	5.10E-37	157.1	AGRIN_MOUSE	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	Agrn Agrin	Mus musculus (Mouse)	1950	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN882_c0_g1_i2	A2ASQ1	AGRIN_MOUSE	29.6	483	231	17	1260	100	179	648	1.20E-38	162.5	AGRIN_MOUSE	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	Agrn Agrin	Mus musculus (Mouse)	1950	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]		blue	blue	NA	NA	NA	NA
TRINITY_DN22962_c0_g1_i2	P31696	AGRIN_CHICK	36.8	57	35	1	208	38	547	602	1.00E-05	50.4	AGRIN_CHICK	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	AGRN AGRIN	Gallus gallus (Chicken)	2081	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978	actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]		blue	blue	NA	NA	NA	NA
TRINITY_DN22962_c0_g1_i3	P31696	AGRIN_CHICK	36.8	57	35	1	208	38	547	602	1.00E-05	50.4	AGRIN_CHICK	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	AGRN AGRIN	Gallus gallus (Chicken)	2081	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978	actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]		blue	blue	NA	NA	NA	1
TRINITY_DN21779_c0_g1_i2	P31696	AGRIN_CHICK	34.7	219	126	7	683	36	1351	1555	2.30E-26	120.9	AGRIN_CHICK	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	AGRN AGRIN	Gallus gallus (Chicken)	2081	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978	actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]		NA	NA	NA	NA	NA	NA
TRINITY_DN12622_c0_g1_i1	P31696	AGRIN_CHICK	56.4	39	17	0	9	125	567	605	1.90E-06	53.1	AGRIN_CHICK	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	AGRN AGRIN	Gallus gallus (Chicken)	2081	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978	actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]		NA	NA	NA	NA	NA	NA
TRINITY_DN383_c0_g1_i5	A2ASQ1	AGRIN_MOUSE	27.6	388	203	15	953	3	158	538	2.20E-26	121.3	AGRIN_MOUSE	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	Agrn Agrin	Mus musculus (Mouse)	1950	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN383_c0_g1_i6	P31696	AGRIN_CHICK	29.6	260	125	8	773	138	488	737	1.20E-20	102.1	AGRIN_CHICK	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	AGRN AGRIN	Gallus gallus (Chicken)	2081	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978	actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]		NA	NA	NA	NA	NA	NA
TRINITY_DN23538_c0_g2_i1	P25304	AGRIN_RAT	34	188	118	4	571	14	1273	1456	2.80E-25	116.7	AGRIN_RAT	reviewed	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	Agrn Agrin	Rattus norvegicus (Rat)	1959	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0008582; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0030548; GO:0031012; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:1902667; GO:1903277; GO:1903407; GO:2000541	animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN35703_c0_g1_i1	Q7YRC1	AIP_BOVIN	38.4	328	196	3	9	980	4	329	2.00E-64	247.7	AIP_BOVIN	reviewed	AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein)	AIP	Bos taurus (Bovine)	330	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coregulator activity [GO:0003712]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003755; GO:0005737; GO:0006805	xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN34669_c0_g1_i1	O00170	AIP_HUMAN	98.8	84	1	0	252	1	219	302	2.30E-43	175.6	AIP_HUMAN	reviewed	AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9)	AIP XAP2	Homo sapiens (Human)	330	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]	GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0008134; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0035722; GO:0036004; GO:0051082; GO:0051344	interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN20064_c0_g1_i1	Q12802	AKP13_HUMAN	41.9	148	85	1	225	665	2079	2226	3.40E-29	130.2	AKP13_HUMAN	reviewed	A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)	AKAP13 BRX HT31 LBC	Homo sapiens (Human)	2813	actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]	actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004691; GO:0005078; GO:0005089; GO:0005634; GO:0005829; GO:0005884; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0017048; GO:0035023; GO:0035025; GO:0043065; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051056; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023; GO:1900169	adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN20064_c0_g1_i1	Q12802	AKP13_HUMAN	37.2	43	27	0	70	198	2019	2061	4.90E-04	46.6	AKP13_HUMAN	reviewed	A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)	AKAP13 BRX HT31 LBC	Homo sapiens (Human)	2813	actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]	actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004691; GO:0005078; GO:0005089; GO:0005634; GO:0005829; GO:0005884; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0017048; GO:0035023; GO:0035025; GO:0043065; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051056; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023; GO:1900169	adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN5580_c0_g3_i1	Q02040	AK17A_HUMAN	54.7	148	66	1	476	36	9	156	1.20E-42	174.5	AK17A_HUMAN	reviewed	"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)"	AKAP17A CXYorf3 DXYS155E SFRS17A XE7	Homo sapiens (Human)	695	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018	"B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"		brown	brown	NA	NA	NA	NA
TRINITY_DN5580_c0_g3_i2	Q02040	AK17A_HUMAN	52.7	275	125	4	897	76	9	279	2.90E-76	287	AK17A_HUMAN	reviewed	"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)"	AKAP17A CXYorf3 DXYS155E SFRS17A XE7	Homo sapiens (Human)	695	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018	"B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27329_c0_g1_i1	Q02040	AK17A_HUMAN	99.4	169	1	0	2	508	11	179	5.70E-94	344.7	AK17A_HUMAN	reviewed	"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)"	AKAP17A CXYorf3 DXYS155E SFRS17A XE7	Homo sapiens (Human)	695	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018	"B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c1_g1_i1	Q99996	AKAP9_HUMAN	32.3	201	121	5	949	386	3589	3787	6.70E-14	80.1	AKAP9_HUMAN	reviewed	A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao)	AKAP9 AKAP350 AKAP450 KIAA0803	Homo sapiens (Human)	3907	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; cardiac conduction [GO:0061337]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]	DNA binding [GO:0003677]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]	GO:0000086; GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0010389; GO:0015459; GO:0031116; GO:0033138; GO:0034237; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0061337; GO:0071320; GO:0086091; GO:0097060; GO:0097711; GO:0098909; GO:0098962; GO:0098978; GO:1901018; GO:1903358	cardiac conduction [GO:0061337]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c1_g1_i4	Q99996	AKAP9_HUMAN	32.3	201	121	5	889	326	3589	3787	6.40E-14	80.1	AKAP9_HUMAN	reviewed	A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao)	AKAP9 AKAP350 AKAP450 KIAA0803	Homo sapiens (Human)	3907	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; cardiac conduction [GO:0061337]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]	DNA binding [GO:0003677]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]	GO:0000086; GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0010389; GO:0015459; GO:0031116; GO:0033138; GO:0034237; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0061337; GO:0071320; GO:0086091; GO:0097060; GO:0097711; GO:0098909; GO:0098962; GO:0098978; GO:1901018; GO:1903358	cardiac conduction [GO:0061337]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN16036_c0_g1_i1	Q9H8T0	AKTIP_HUMAN	100	169	0	0	5	511	50	218	9.50E-97	354	AKTIP_HUMAN	reviewed	AKT-interacting protein (Ft1) (Fused toes protein homolog)	AKTIP FTS	Homo sapiens (Human)	292	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0001934; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0032092; GO:0045022; GO:0061631; GO:0070695	apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN16327_c0_g1_i1	Q5ZJJ5	AKTIP_CHICK	48.1	268	136	2	5	808	28	292	1.30E-71	271.2	AKTIP_CHICK	reviewed	AKT-interacting protein (Fused toes protein homolog)	AKTIP FTS RCJMB04_17k13	Gallus gallus (Chicken)	293	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0061631; GO:0070695	apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5461_c1_g1_i1	A4IFH5	ALAT1_BOVIN	53.9	89	40	1	272	6	137	224	2.20E-20	99.4	ALAT1_BOVIN	reviewed	Alanine aminotransferase 1 (ALT1) (EC 2.6.1.2) (Glutamate pyruvate transaminase 1) (GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1)	GPT GPT1	Bos taurus (Bovine)	496	cytoplasm [GO:0005737]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]	cytoplasm [GO:0005737]	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0005737; GO:0009058; GO:0030170; GO:0042853	biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]		blue	blue	NA	NA	NA	NA
TRINITY_DN7753_c0_g1_i1	Q28DB5	ALAT2_XENTR	60.6	254	99	1	857	99	270	523	1.90E-89	330.5	ALAT2_XENTR	reviewed	Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	gpt2 TEgg035f04.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	524	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		blue	blue	NA	NA	NA	NA
TRINITY_DN34933_c0_g1_i1	Q8TD30	ALAT2_HUMAN	98.9	87	1	0	2	262	399	485	1.30E-44	179.9	ALAT2_HUMAN	reviewed	Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	GPT2 AAT2 ALT2	Homo sapiens (Human)	523	mitochondrial matrix [GO:0005759]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; cellular amino acid biosynthetic process [GO:0008652]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]	mitochondrial matrix [GO:0005759]	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0005759; GO:0006103; GO:0008652; GO:0030170; GO:0042851; GO:0042853	2-oxoglutarate metabolic process [GO:0006103]; cellular amino acid biosynthetic process [GO:0008652]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		NA	NA	NA	NA	NA	NA
TRINITY_DN14126_c0_g1_i2	Q28DB5	ALAT2_XENTR	87.1	31	4	0	113	205	83	113	8.60E-09	60.5	ALAT2_XENTR	reviewed	Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	gpt2 TEgg035f04.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	524	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		blue	blue	NA	NA	NA	NA
TRINITY_DN7753_c0_g2_i1	Q6NYL5	ALAT2_DANRE	62.2	249	93	1	825	82	300	548	1.30E-87	324.3	ALAT2_DANRE	reviewed	Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	gpt2l gpt2 im:6791811 si:ch211-261f3.4	Danio rerio (Zebrafish) (Brachydanio rerio)	549	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]		blue	blue	NA	NA	NA	NA
TRINITY_DN993_c0_g2_i13	P83944	ALR_PENMO	85.7	35	5	0	200	96	86	120	1.10E-09	64.7	ALR_PENMO	reviewed	Alanine racemase (EC 5.1.1.1) (Fragments)		Penaeus monodon (Giant tiger prawn)	120	alanine racemase activity [GO:0008784]; chiral amino acid racemization [GO:0018366]		alanine racemase activity [GO:0008784]	GO:0008784; GO:0018366	chiral amino acid racemization [GO:0018366]		NA	NA	NA	NA	NA	NA
TRINITY_DN993_c0_g2_i15	P83944	ALR_PENMO	51.7	87	34	2	593	342	1	82	5.00E-16	87	ALR_PENMO	reviewed	Alanine racemase (EC 5.1.1.1) (Fragments)		Penaeus monodon (Giant tiger prawn)	120	alanine racemase activity [GO:0008784]; chiral amino acid racemization [GO:0018366]		alanine racemase activity [GO:0008784]	GO:0008784; GO:0018366	chiral amino acid racemization [GO:0018366]		blue	blue	NA	NA	NA	NA
TRINITY_DN993_c0_g2_i5	P83944	ALR_PENMO	51.7	87	34	2	593	342	1	82	5.10E-16	87	ALR_PENMO	reviewed	Alanine racemase (EC 5.1.1.1) (Fragments)		Penaeus monodon (Giant tiger prawn)	120	alanine racemase activity [GO:0008784]; chiral amino acid racemization [GO:0018366]		alanine racemase activity [GO:0008784]	GO:0008784; GO:0018366	chiral amino acid racemization [GO:0018366]		NA	NA	NA	NA	NA	NA
TRINITY_DN993_c0_g2_i6	P83944	ALR_PENMO	51.7	87	34	2	593	342	1	82	4.30E-16	87	ALR_PENMO	reviewed	Alanine racemase (EC 5.1.1.1) (Fragments)		Penaeus monodon (Giant tiger prawn)	120	alanine racemase activity [GO:0008784]; chiral amino acid racemization [GO:0018366]		alanine racemase activity [GO:0008784]	GO:0008784; GO:0018366	chiral amino acid racemization [GO:0018366]		NA	NA	NA	NA	NA	NA
TRINITY_DN993_c0_g2_i7	P83944	ALR_PENMO	85.7	35	5	0	200	96	86	120	1.20E-09	64.7	ALR_PENMO	reviewed	Alanine racemase (EC 5.1.1.1) (Fragments)		Penaeus monodon (Giant tiger prawn)	120	alanine racemase activity [GO:0008784]; chiral amino acid racemization [GO:0018366]		alanine racemase activity [GO:0008784]	GO:0008784; GO:0018366	chiral amino acid racemization [GO:0018366]		NA	NA	NA	NA	NA	NA
TRINITY_DN993_c0_g3_i1	P94494	ALR2_BACSU	48.1	77	40	0	296	66	10	86	9.90E-11	68.2	ALR2_BACSU	reviewed	Alanine racemase 2 (EC 5.1.1.1)	alr2 yncD BSU17640	Bacillus subtilis (strain 168)	394	cytosol [GO:0005829]; alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170]; D-alanine biosynthetic process [GO:0030632]; peptidoglycan biosynthetic process [GO:0009252]	cytosol [GO:0005829]	alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170]	GO:0005829; GO:0008784; GO:0009252; GO:0030170; GO:0030632	D-alanine biosynthetic process [GO:0030632]; peptidoglycan biosynthetic process [GO:0009252]		blue	blue	NA	NA	NA	NA
TRINITY_DN711_c2_g1_i1	Q17QF0	AGT2_BOVIN	52.9	482	221	4	44	1480	27	505	2.00E-153	543.9	AGT2_BOVIN	reviewed	"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)"	AGXT2	Bos taurus (Bovine)	514	"mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"	mitochondrion [GO:0005739]	(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0008453; GO:0009436; GO:0019481; GO:0030170; GO:0045429; GO:0047305	"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN711_c2_g1_i2	Q17QF0	AGT2_BOVIN	52.5	463	214	4	44	1423	27	486	2.90E-146	520	AGT2_BOVIN	reviewed	"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)"	AGXT2	Bos taurus (Bovine)	514	"mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"	mitochondrion [GO:0005739]	(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0008453; GO:0009436; GO:0019481; GO:0030170; GO:0045429; GO:0047305	"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN711_c2_g1_i3	Q17QF0	AGT2_BOVIN	53.7	374	167	4	44	1156	27	397	6.00E-118	425.6	AGT2_BOVIN	reviewed	"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)"	AGXT2	Bos taurus (Bovine)	514	"mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"	mitochondrion [GO:0005739]	(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0008453; GO:0009436; GO:0019481; GO:0030170; GO:0045429; GO:0047305	"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1113_c0_g1_i2	P36428	SYA_ARATH	70.4	206	60	1	627	10	188	392	1.70E-84	313.5	SYA_ARATH	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	ALATS ALARS At1g50200 F14I3.17	Arabidopsis thaliana (Mouse-ear cress)	1003	chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; response to cadmium ion [GO:0046686]; tRNA modification [GO:0006400]	chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0009507; GO:0016597; GO:0046686; GO:0070143	alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; response to cadmium ion [GO:0046686]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN31618_c0_g1_i1	B0UGC4	SYA_METS4	84	75	12	0	225	1	206	280	3.00E-31	135.2	SYA_METS4	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS M446_5834	Methylobacterium sp. (strain 4-46)	886	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN22584_c0_g1_i1	Q1GSD9	SYA_SPHAL	91	89	8	0	4	270	123	211	5.70E-48	191	SYA_SPHAL	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS Sala_1720	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	884	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN5247_c0_g1_i2	A0LLA3	SYA_SYNFM	29.8	178	108	4	5	535	564	725	9.30E-10	66.2	SYA_SYNFM	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS Sfum_2527	Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB)	885	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN13042_c0_g1_i1	Q9RNN8	SYA_ZYMMO	97.3	75	2	0	228	4	22	96	7.60E-38	157.1	SYA_ZYMMO	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS ZMO0845	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	890	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN31466_c0_g1_i1	Q8Y193	SYA_RALSO	95.9	74	3	0	2	223	276	349	4.10E-36	151.4	SYA_RALSO	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS RSc0797 RS05040	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	884	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN29784_c0_g1_i1	Q5A8K2	SYA_CANAL	56.6	136	51	2	402	13	24	157	7.30E-39	161.4	SYA_CANAL	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	ALA1 SYA1 CAALFM_C603720WA CaO19.13169 CaO19.5746	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	969	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143	alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN8457_c1_g1_i1	Q8Y193	SYA_RALSO	83.8	99	16	0	2	298	41	139	2.00E-46	186	SYA_RALSO	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS RSc0797 RS05040	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	884	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN8457_c1_g1_i2	Q8Y193	SYA_RALSO	97.6	126	3	0	2	379	14	139	1.80E-71	269.6	SYA_RALSO	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS RSc0797 RS05040	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	884	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN8457_c0_g1_i1	A5V3L0	SYA_SPHWW	83.7	245	39	1	4	735	1	245	2.60E-124	446	SYA_SPHWW	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS Swit_0508	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	887	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN8457_c0_g1_i2	Q1GSD9	SYA_SPHAL	87.8	131	16	0	4	396	1	131	3.30E-65	248.8	SYA_SPHAL	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS Sala_1720	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	884	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN8457_c0_g1_i3	Q1GSD9	SYA_SPHAL	84.9	199	28	1	4	594	1	199	5.10E-102	371.7	SYA_SPHAL	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS Sala_1720	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	884	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN29605_c0_g1_i1	Q2N9K5	SYA_ERYLH	83.5	79	13	0	2	238	261	339	8.60E-32	137.1	SYA_ERYLH	reviewed	Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)	alaS ELI_07720	Erythrobacter litoralis (strain HTCC2594)	887	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN1113_c0_g3_i1	Q54Y20	SYAC_DICDI	77.9	122	27	0	368	3	10	131	1.40E-54	213.4	SYAC_DICDI	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	alaS DDB_G0277823	Dictyostelium discoideum (Slime mold)	946	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597	alanyl-tRNA aminoacylation [GO:0006419]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN36812_c0_g1_i1	P21894	SYAC_BOMMO	61.3	75	27	2	233	12	163	236	3.50E-22	105.1	SYAC_BOMMO	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"		Bombyx mori (Silk moth)	967	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN1697_c0_g1_i1	P21894	SYAC_BOMMO	58	962	394	5	3688	821	9	966	0	1156.4	SYAC_BOMMO	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"		Bombyx mori (Silk moth)	967	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN1113_c0_g2_i1	Q8BGQ7	SYAC_MOUSE	91.4	245	19	2	734	3	134	377	2.70E-129	462.6	SYAC_MOUSE	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein sticky) (Sti)"	Aars1 Aars	Mus musculus (Mouse)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0050905; GO:0140018	alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN1113_c0_g2_i2	Q8BGQ7	SYAC_MOUSE	87.7	179	20	2	536	3	134	311	2.60E-89	329.3	SYAC_MOUSE	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein sticky) (Sti)"	Aars1 Aars	Mus musculus (Mouse)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0050905; GO:0140018	alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN1444_c1_g1_i1	Q8BGQ7	SYAC_MOUSE	100	80	0	0	242	3	56	135	1.90E-42	172.6	SYAC_MOUSE	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein sticky) (Sti)"	Aars1 Aars	Mus musculus (Mouse)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0050905; GO:0140018	alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN37110_c0_g1_i1	P49588	SYAC_HUMAN	98.8	83	1	0	251	3	649	731	6.90E-40	164.1	SYAC_HUMAN	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)"	AARS1 AARS	Homo sapiens (Human)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0070062	alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN20544_c0_g1_i1	P49588	SYAC_HUMAN	100	128	0	0	384	1	306	433	1.40E-68	260	SYAC_HUMAN	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)"	AARS1 AARS	Homo sapiens (Human)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0070062	alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN33539_c0_g1_i1	P49588	SYAC_HUMAN	100	70	0	0	210	1	719	788	2.40E-30	132.1	SYAC_HUMAN	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)"	AARS1 AARS	Homo sapiens (Human)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0070062	alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN27046_c0_g1_i1	P49588	SYAC_HUMAN	100	139	0	0	3	419	25	163	5.10E-80	298.1	SYAC_HUMAN	reviewed	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)"	AARS1 AARS	Homo sapiens (Human)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0070062	alanyl-tRNA aminoacylation [GO:0006419]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN1113_c0_g1_i1	P40825	SYA_YEAST	69.1	149	46	0	447	1	223	371	1.50E-57	223.8	SYA_YEAST	reviewed	"Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	ALA1 CDC64 YOR335C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	983	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143	alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN1444_c0_g1_i1	P40825	SYA_YEAST	57.8	296	119	2	872	3	39	334	2.70E-104	379.8	SYA_YEAST	reviewed	"Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	ALA1 CDC64 YOR335C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	983	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143	alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN1444_c0_g1_i2	P40825	SYA_YEAST	58.4	267	106	1	811	26	39	305	5.70E-96	352.1	SYA_YEAST	reviewed	"Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	ALA1 CDC64 YOR335C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	983	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143	alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN30251_c0_g1_i1	Q9BTE6	AASD1_HUMAN	99.2	126	1	0	1	378	44	169	5.20E-68	258.1	AASD1_HUMAN	reviewed	Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1)	AARSD1	Homo sapiens (Human)	412	cytoplasm [GO:0005737]; nucleus [GO:0005634]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; alanyl-tRNA aminoacylation [GO:0006419]; regulation of translational fidelity [GO:0006450]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]	GO:0002196; GO:0003676; GO:0004813; GO:0005524; GO:0005634; GO:0005737; GO:0006419; GO:0006450; GO:0046872	alanyl-tRNA aminoacylation [GO:0006419]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN180_c0_g1_i1	Q5XI97	AASD1_RAT	53.6	97	45	0	372	82	87	183	2.60E-22	106.3	AASD1_RAT	reviewed	Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1)	Aarsd1	Rattus norvegicus (Rat)	412	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; alanyl-tRNA aminoacylation [GO:0006419]; regulation of translational fidelity [GO:0006450]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]	GO:0002161; GO:0002196; GO:0003676; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0006450; GO:0046872	alanyl-tRNA aminoacylation [GO:0006419]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN180_c0_g2_i1	Q6DEJ5	AASD1_DANRE	51.3	78	34	1	223	2	1	78	1.20E-14	80.5	AASD1_DANRE	reviewed	Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1)	aarsd1 zgc:101066	Danio rerio (Zebrafish) (Brachydanio rerio)	412	cytoplasm [GO:0005737]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]	cytoplasm [GO:0005737]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]	GO:0002196; GO:0004812; GO:0005524; GO:0005737; GO:0006412; GO:0006450; GO:0043039; GO:0046872	regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]		NA	NA	NA	NA	NA	NA
TRINITY_DN180_c0_g1_i2	Q7ZYJ9	AASDB_XENLA	48.6	317	162	1	1076	129	81	397	2.80E-82	307	AASDB_XENLA	reviewed	Alanyl-tRNA editing protein Aarsd1-B (Alanyl-tRNA synthetase domain-containing protein 1-B)	aarsd1-b	Xenopus laevis (African clawed frog)	412	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; alanyl-tRNA aminoacylation [GO:0006419]	cytoplasm [GO:0005737]	alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0046872	alanyl-tRNA aminoacylation [GO:0006419]		NA	NA	NA	NA	NA	NA
TRINITY_DN39819_c0_g1_i1	Q00593	ALKJ_PSEOL	57.1	84	36	0	313	62	447	530	4.70E-22	105.1	ALKJ_PSEOL	reviewed	Alcohol dehydrogenase [acceptor] (EC 1.1.99.-)	alkJ alcO	Pseudomonas oleovorans	558	"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	plasma membrane [GO:0005886]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005886; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN29565_c0_g1_i1	Q9WWW2	ALKJ_PSEPU	43.5	62	35	0	196	11	365	426	1.60E-08	59.7	ALKJ_PSEPU	reviewed	Alcohol dehydrogenase [acceptor] (EC 1.1.99.-)	alkJ	Pseudomonas putida (Arthrobacter siderocapsulatus)	552	"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	plasma membrane [GO:0005886]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005886; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN33271_c0_g1_i1	P28474	ADHX_MOUSE	100	220	0	0	661	2	116	335	9.90E-123	440.7	ADHX_MOUSE	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 2) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase B2) (ADH-B2) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)	Adh5 Adh-2 Adh2	Mus musculus (Mouse)	374	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"	GO:0001523; GO:0003016; GO:0004022; GO:0004024; GO:0005504; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006068; GO:0006069; GO:0008270; GO:0010430; GO:0018119; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903	ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]		NA	NA	NA	NA	NA	NA
TRINITY_DN25580_c0_g1_i1	P11766	ADHX_HUMAN	100	176	0	0	530	3	100	275	8.10E-99	360.9	ADHX_HUMAN	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)	ADH5 ADHX FDH	Homo sapiens (Human)	374	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	"alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"	GO:0001523; GO:0003016; GO:0004024; GO:0005504; GO:0005739; GO:0005829; GO:0006069; GO:0008270; GO:0009055; GO:0010430; GO:0018119; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903; GO:0070062	ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]		NA	NA	NA	NA	NA	NA
TRINITY_DN37900_c0_g1_i1	P79896	ADHX_SPAAU	69.5	118	36	0	394	41	259	376	1.20E-46	187.2	ADHX_SPAAU	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)		Sparus aurata (Gilthead sea bream)	376	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN5462_c0_g1_i1	P79896	ADHX_SPAAU	79.5	366	75	0	1198	101	9	374	6.30E-176	618.2	ADHX_SPAAU	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)		Sparus aurata (Gilthead sea bream)	376	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		blue	blue	NA	NA	NA	NA
TRINITY_DN348_c0_g3_i1	P72324	ADHI_RHOS4	75	184	39	2	2	532	166	349	1.30E-75	283.9	ADHI_RHOS4	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)	adhI RHOS4_11650 RSP_2576	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	376	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; methanol metabolic process [GO:0015945]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0015945; GO:0051903	ethanol oxidation [GO:0006069]; methanol metabolic process [GO:0015945]		NA	NA	NA	NA	NA	NA
TRINITY_DN348_c0_g4_i1	P72324	ADHI_RHOS4	80.2	192	37	1	574	2	17	208	4.00E-88	325.5	ADHI_RHOS4	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)	adhI RHOS4_11650 RSP_2576	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	376	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; methanol metabolic process [GO:0015945]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0015945; GO:0051903	ethanol oxidation [GO:0006069]; methanol metabolic process [GO:0015945]		NA	NA	NA	NA	NA	NA
TRINITY_DN30915_c0_g1_i1	P80467	ADHX_SAAHA	70.1	97	29	0	291	1	263	359	5.70E-38	157.9	ADHX_SAAHA	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)		Saara hardwickii (Indian spiny-tailed lizard) (Uromastyx hardwickii)	373	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN13268_c0_g2_i1	P80572	ADHX_PEA	63.9	72	26	0	6	221	110	181	4.10E-20	98.2	ADHX_PEA	reviewed	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)		Pisum sativum (Garden pea)	378	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN13268_c0_g1_i1	P81601	ADHL_GADMO	74.3	74	19	0	7	228	34	107	3.80E-29	128.3	ADHL_GADMO	reviewed	Alcohol dehydrogenase class-3 chain L (EC 1.1.1.1) (Alcohol dehydrogenase class-III chain L) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)		Gadus morhua (Atlantic cod)	375	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN3535_c0_g1_i1	P08157	ALDH_EMENI	55.2	116	50	1	434	87	27	140	7.90E-28	124.8	ALDH_EMENI	reviewed	Aldehyde dehydrogenase (ALDDH) (ALDH) (EC 1.2.1.3)	aldA aspA AN0554	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	497	extracellular region [GO:0005576]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; acetaldehyde catabolic process [GO:0046187]; acetate biosynthetic process [GO:0019413]; carbon catabolite activation of transcription [GO:0045991]; cellular response to osmotic stress [GO:0071470]; ethanol catabolic process [GO:0006068]; ethanol metabolic process [GO:0006067]; threonine catabolic process [GO:0006567]	extracellular region [GO:0005576]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0004030; GO:0005576; GO:0006067; GO:0006068; GO:0006567; GO:0019413; GO:0043878; GO:0045991; GO:0046187; GO:0071470	acetaldehyde catabolic process [GO:0046187]; acetate biosynthetic process [GO:0019413]; carbon catabolite activation of transcription [GO:0045991]; cellular response to osmotic stress [GO:0071470]; ethanol catabolic process [GO:0006068]; ethanol metabolic process [GO:0006067]; threonine catabolic process [GO:0006567]		NA	NA	NA	NA	NA	NA
TRINITY_DN30513_c0_g1_i1	Q27640	ALDH_ENCBU	60.9	69	27	0	213	7	151	219	8.30E-18	90.5	ALDH_ENCBU	reviewed	Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase [NAD(+)])	ALDH	Enchytraeus buchholzi (Grindal worm)	497	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; ethanol catabolic process [GO:0006068]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0006068; GO:0043878	ethanol catabolic process [GO:0006068]		NA	NA	NA	NA	NA	NA
TRINITY_DN31489_c0_g1_i1	Q8VXQ2	ALDH_CRAPL	53.3	90	41	1	3	272	362	450	9.10E-22	104	ALDH_CRAPL	reviewed	Aldehyde dehydrogenase (EC 1.2.1.3) (Cp-ALDH)	ALDH	Craterostigma plantagineum (Blue gem) (Torenia plantagineum)	479	amyloplast [GO:0009501]; chloroplast [GO:0009507]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; cellular aldehyde metabolic process [GO:0006081]	amyloplast [GO:0009501]; chloroplast [GO:0009507]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0006081; GO:0009501; GO:0009507; GO:0043878	cellular aldehyde metabolic process [GO:0006081]		NA	NA	NA	NA	NA	NA
TRINITY_DN32395_c0_g1_i1	A6ZR27	ALDH5_YEAS7	54.5	99	45	0	1	297	231	329	4.20E-28	125.2	ALDH5_YEAS7	reviewed	"Aldehyde dehydrogenase 5, mitochondrial (EC 1.2.1.5)"	ALD5 SCY_1574	Saccharomyces cerevisiae (strain YJM789) (Baker's yeast)	520	mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; ethanol catabolic process [GO:0006068]	mitochondrial matrix [GO:0005759]	aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]	GO:0004030; GO:0005759; GO:0006068	ethanol catabolic process [GO:0006068]		NA	NA	NA	NA	NA	NA
TRINITY_DN38090_c0_g1_i1	A6ZR27	ALDH5_YEAS7	54.1	183	83	1	1	546	180	362	6.40E-49	195.3	ALDH5_YEAS7	reviewed	"Aldehyde dehydrogenase 5, mitochondrial (EC 1.2.1.5)"	ALD5 SCY_1574	Saccharomyces cerevisiae (strain YJM789) (Baker's yeast)	520	mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; ethanol catabolic process [GO:0006068]	mitochondrial matrix [GO:0005759]	aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]	GO:0004030; GO:0005759; GO:0006068	ethanol catabolic process [GO:0006068]		NA	NA	NA	NA	NA	NA
TRINITY_DN10715_c0_g1_i1	A6QR56	A16A1_BOVIN	41.4	589	314	13	1795	50	208	772	1.10E-107	392.1	A16A1_BOVIN	reviewed	Aldehyde dehydrogenase family 16 member A1	ALDH16A1	Bos taurus (Bovine)	800	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"		"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0016620			NA	NA	NA	NA	NA	NA
TRINITY_DN10715_c0_g1_i2	Q571I9	A16A1_MOUSE	43.4	611	327	8	1912	89	208	802	4.30E-126	453.4	A16A1_MOUSE	reviewed	Aldehyde dehydrogenase family 16 member A1	Aldh16a1	Mus musculus (Mouse)	802	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"		"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0016620			blue	blue	NA	NA	NA	NA
TRINITY_DN17898_c0_g2_i1	A6QR56	A16A1_BOVIN	50	170	81	3	6	506	632	800	1.80E-38	160.6	A16A1_BOVIN	reviewed	Aldehyde dehydrogenase family 16 member A1	ALDH16A1	Bos taurus (Bovine)	800	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"		"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0016620			NA	NA	NA	NA	NA	NA
TRINITY_DN39594_c0_g1_i1	Q9SU63	AL2B4_ARATH	62.8	94	35	0	284	3	413	506	2.40E-28	125.9	AL2B4_ARATH	reviewed	"Aldehyde dehydrogenase family 2 member B4, mitochondrial (ALDH2a) (EC 1.2.1.3)"	ALDH2B4 ALDH2 At3g48000 T17F15.130	Arabidopsis thaliana (Mouse-ear cress)	538	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; ATP binding [GO:0005524]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; response to cadmium ion [GO:0046686]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; ATP binding [GO:0005524]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0043878; GO:0046686	response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN31433_c0_g1_i1	P51648	AL3A2_HUMAN	100	71	0	0	3	215	204	274	3.80E-39	161.4	AL3A2_HUMAN	reviewed	Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase)	ALDH3A2 ALDH10 FALDH	Homo sapiens (Human)	485	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]; cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid alpha-oxidation [GO:0001561]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]	GO:0001561; GO:0004028; GO:0004029; GO:0005777; GO:0005778; GO:0005789; GO:0006081; GO:0006714; GO:0007417; GO:0007422; GO:0008544; GO:0016021; GO:0030148; GO:0033306; GO:0042803; GO:0043231; GO:0043878; GO:0046458; GO:0046577; GO:0050061; GO:0052814; GO:0055114	cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid alpha-oxidation [GO:0001561]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN1770_c0_g1_i1	P47740	AL3A2_MOUSE	51.5	421	199	3	1352	93	68	484	2.70E-122	440.3	AL3A2_MOUSE	reviewed	Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 3) (Fatty aldehyde dehydrogenase)	Aldh3a2 Ahd-3 Ahd3 Aldh3 Aldh4	Mus musculus (Mouse)	484	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]; cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302]; sesquiterpenoid metabolic process [GO:0006714]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]	GO:0000302; GO:0004028; GO:0004029; GO:0005634; GO:0005739; GO:0005743; GO:0005777; GO:0005783; GO:0005829; GO:0006081; GO:0006631; GO:0006714; GO:0007417; GO:0007422; GO:0008544; GO:0016021; GO:0033306; GO:0042406; GO:0042803; GO:0043231; GO:0043878; GO:0046292; GO:0046458; GO:0046577; GO:0050061; GO:0052814; GO:0055114	cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302]; sesquiterpenoid metabolic process [GO:0006714]		NA	NA	NA	NA	NA	NA
TRINITY_DN25802_c0_g1_i1	P47740	AL3A2_MOUSE	100	94	0	0	283	2	154	247	1.00E-52	206.8	AL3A2_MOUSE	reviewed	Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 3) (Fatty aldehyde dehydrogenase)	Aldh3a2 Ahd-3 Ahd3 Aldh3 Aldh4	Mus musculus (Mouse)	484	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]; cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302]; sesquiterpenoid metabolic process [GO:0006714]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]	GO:0000302; GO:0004028; GO:0004029; GO:0005634; GO:0005739; GO:0005743; GO:0005777; GO:0005783; GO:0005829; GO:0006081; GO:0006631; GO:0006714; GO:0007417; GO:0007422; GO:0008544; GO:0016021; GO:0033306; GO:0042406; GO:0042803; GO:0043231; GO:0043878; GO:0046292; GO:0046458; GO:0046577; GO:0050061; GO:0052814; GO:0055114	cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302]; sesquiterpenoid metabolic process [GO:0006714]		NA	NA	NA	NA	NA	NA
TRINITY_DN25970_c0_g1_i1	Q80VQ0	AL3B1_MOUSE	100	151	0	0	2	454	181	331	1.30E-86	320.1	AL3B1_MOUSE	reviewed	Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7) (Aldehyde dehydrogenase 7)	Aldh3b1 Aldh7	Mus musculus (Mouse)	468	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]	GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006068; GO:0006081; GO:0018477; GO:0018479; GO:0034599; GO:0046185; GO:0055114	aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN12427_c0_g1_i1	Q41247	AL7A1_BRANA	62.9	89	33	0	1	267	81	169	3.70E-28	125.2	AL7A1_BRANA	reviewed	Aldehyde dehydrogenase family 7 member A1 (EC 1.2.1.3) (Antiquitin-1) (Brassica turgor-responsive/drought-induced gene 26 protein) (Btg-26)	BTG-26	Brassica napus (Rape)	494	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0043878			NA	NA	NA	NA	NA	NA
TRINITY_DN22783_c0_g1_i1	Q9CZS1	AL1B1_MOUSE	98.8	83	1	0	3	251	181	263	1.80E-40	166	AL1B1_MOUSE	reviewed	"Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase family 1 member B1)"	Aldh1b1 Aldhx	Mus musculus (Mouse)	519	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; ethanol catabolic process [GO:0006068]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0006068; GO:0043231; GO:0043878	ethanol catabolic process [GO:0006068]		NA	NA	NA	NA	NA	NA
TRINITY_DN1463_c0_g1_i1	P30838	AL3A1_HUMAN	50.7	446	216	2	68	1399	2	445	5.80E-123	442.6	AL3A1_HUMAN	reviewed	"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (ALDHIII) (Aldehyde dehydrogenase 3) (Aldehyde dehydrogenase family 3 member A1)"	ALDH3A1 ALDH3	Homo sapiens (Human)	453	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; aging [GO:0007568]; cellular aldehyde metabolic process [GO:0006081]; oxidation-reduction process [GO:0055114]; positive regulation of cell population proliferation [GO:0008284]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]	GO:0001666; GO:0004028; GO:0004029; GO:0004030; GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006081; GO:0006805; GO:0007568; GO:0007584; GO:0008106; GO:0008284; GO:0016021; GO:0018479; GO:0042493; GO:0051384; GO:0051591; GO:0055114	aging [GO:0007568]; cellular aldehyde metabolic process [GO:0006081]; oxidation-reduction process [GO:0055114]; positive regulation of cell population proliferation [GO:0008284]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]		NA	NA	1	NA	NA	NA
TRINITY_DN1463_c0_g1_i2	P30838	AL3A1_HUMAN	50.4	446	217	2	68	1399	2	445	9.90E-123	441.8	AL3A1_HUMAN	reviewed	"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (ALDHIII) (Aldehyde dehydrogenase 3) (Aldehyde dehydrogenase family 3 member A1)"	ALDH3A1 ALDH3	Homo sapiens (Human)	453	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; aging [GO:0007568]; cellular aldehyde metabolic process [GO:0006081]; oxidation-reduction process [GO:0055114]; positive regulation of cell population proliferation [GO:0008284]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]	GO:0001666; GO:0004028; GO:0004029; GO:0004030; GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006081; GO:0006805; GO:0007568; GO:0007584; GO:0008106; GO:0008284; GO:0016021; GO:0018479; GO:0042493; GO:0051384; GO:0051591; GO:0055114	aging [GO:0007568]; cellular aldehyde metabolic process [GO:0006081]; oxidation-reduction process [GO:0055114]; positive regulation of cell population proliferation [GO:0008284]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]		NA	NA	1	NA	NA	NA
TRINITY_DN28567_c0_g1_i1	P47738	ALDH2_MOUSE	100	353	0	0	1060	2	39	391	2.70E-207	722.2	ALDH2_MOUSE	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (AHD-M1) (ALDH class 2) (ALDH-E2) (ALDHI)"	Aldh2 Ahd-1 Ahd1	Mus musculus (Mouse)	519	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NADH binding [GO:0070404]; acetaldehyde metabolic process [GO:0006117]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to organic cyclic compound [GO:0014070]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NADH binding [GO:0070404]	GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0006117; GO:0008631; GO:0014070; GO:0042802; GO:0043066; GO:0043878; GO:0048149; GO:0050727; GO:0051287; GO:0070404; GO:0110095; GO:2000377	acetaldehyde metabolic process [GO:0006117]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN32142_c0_g1_i1	P47738	ALDH2_MOUSE	99.3	148	1	0	3	446	365	512	3.10E-80	298.9	ALDH2_MOUSE	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (AHD-M1) (ALDH class 2) (ALDH-E2) (ALDHI)"	Aldh2 Ahd-1 Ahd1	Mus musculus (Mouse)	519	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NADH binding [GO:0070404]; acetaldehyde metabolic process [GO:0006117]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to organic cyclic compound [GO:0014070]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NADH binding [GO:0070404]	GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0006117; GO:0008631; GO:0014070; GO:0042802; GO:0043066; GO:0043878; GO:0048149; GO:0050727; GO:0051287; GO:0070404; GO:0110095; GO:2000377	acetaldehyde metabolic process [GO:0006117]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN3789_c0_g1_i1	P11884	ALDH2_RAT	68.3	523	161	3	72	1637	1	519	1.40E-208	727.2	ALDH2_RAT	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1)"	Aldh2	Rattus norvegicus (Rat)	519	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; acetaldehyde metabolic process [GO:0006117]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to resveratrol [GO:1904639]; ethanol catabolic process [GO:0006068]; ethanol metabolic process [GO:0006067]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to oxidative stress [GO:1902882]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]	GO:0001889; GO:0002931; GO:0004029; GO:0005739; GO:0005759; GO:0006067; GO:0006068; GO:0006117; GO:0008631; GO:0008637; GO:0009408; GO:0014070; GO:0032355; GO:0032496; GO:0032570; GO:0032870; GO:0033574; GO:0035094; GO:0042802; GO:0043066; GO:0043878; GO:0045471; GO:0048149; GO:0050727; GO:0055093; GO:0070404; GO:0071398; GO:0110095; GO:1902882; GO:1904639; GO:2000377	acetaldehyde metabolic process [GO:0006117]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to resveratrol [GO:1904639]; ethanol catabolic process [GO:0006068]; ethanol metabolic process [GO:0006067]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to oxidative stress [GO:1902882]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN8064_c0_g1_i1	P05091	ALDH2_HUMAN	66.4	125	41	1	3	374	185	309	1.80E-39	163.3	ALDH2_HUMAN	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)"	ALDH2 ALDM	Homo sapiens (Human)	517	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; alcohol metabolic process [GO:0006066]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]	GO:0004029; GO:0004030; GO:0005759; GO:0005975; GO:0006066; GO:0006068; GO:0006069; GO:0009055; GO:0043878; GO:0051287; GO:0070062	alcohol metabolic process [GO:0006066]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN8064_c0_g2_i1	P12762	ALDH2_HORSE	65.7	108	37	0	1	324	332	439	1.30E-35	150.2	ALDH2_HORSE	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)"	ALDH2	Equus caballus (Horse)	500	mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068]	mitochondrial matrix [GO:0005759]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]	GO:0004029; GO:0005759; GO:0006068; GO:0043878; GO:0051287	ethanol catabolic process [GO:0006068]		NA	NA	NA	NA	NA	NA
TRINITY_DN3535_c0_g1_i2	P05091	ALDH2_HUMAN	62.5	472	175	2	1533	121	47	517	8.70E-170	598.2	ALDH2_HUMAN	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)"	ALDH2 ALDM	Homo sapiens (Human)	517	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; alcohol metabolic process [GO:0006066]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]	GO:0004029; GO:0004030; GO:0005759; GO:0005975; GO:0006066; GO:0006068; GO:0006069; GO:0009055; GO:0043878; GO:0051287; GO:0070062	alcohol metabolic process [GO:0006066]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]		blue	blue	NA	NA	NA	NA
TRINITY_DN3535_c0_g1_i3	P05091	ALDH2_HUMAN	62.3	470	175	2	1490	84	47	515	4.20E-169	595.9	ALDH2_HUMAN	reviewed	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)"	ALDH2 ALDM	Homo sapiens (Human)	517	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; alcohol metabolic process [GO:0006066]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]	GO:0004029; GO:0004030; GO:0005759; GO:0005975; GO:0006066; GO:0006068; GO:0006069; GO:0009055; GO:0043878; GO:0051287; GO:0070062	alcohol metabolic process [GO:0006066]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN28177_c0_g1_i1	H9TB17	AOXA_CAVPO	59.6	94	38	0	284	3	1144	1237	5.00E-26	118.2	AOXA_CAVPO	reviewed	Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-)	AOX1 AO	Cavia porcellus (Guinea pig)	1332	"cytosol [GO:0005829]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]"	cytosol [GO:0005829]	"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]"	GO:0004031; GO:0005506; GO:0005829; GO:0009055; GO:0017144; GO:0042803; GO:0043546; GO:0050250; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0071949; GO:0102797; GO:0102798	drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g1_i1	Q3TYQ9	AOXD_MOUSE	29.6	487	298	16	9	1397	244	709	9.20E-39	162.9	AOXD_MOUSE	reviewed	Aldehyde oxidase 4 (EC 1.2.3.1) (Aldehyde oxidase homolog 2) (Azaheterocycle hydroxylase 4) (EC 1.17.3.-) (Retinal oxidase)	Aox4 Aoh2	Mus musculus (Mouse)	1336	"cytosol [GO:0005829]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; xanthine dehydrogenase activity [GO:0004854]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]	"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; retinal oxidase activity [GO:0050250]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004031; GO:0004854; GO:0005506; GO:0005829; GO:0009055; GO:0009115; GO:0017144; GO:0030151; GO:0042803; GO:0043546; GO:0050250; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0071949; GO:0102797; GO:0102798	drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN11932_c0_g1_i2	Q9JII6	AK1A1_MOUSE	100	192	0	0	1	576	11	202	1.00E-110	400.6	AK1A1_MOUSE	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	Akr1a1 Akr1a4	Mus musculus (Mouse)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095	aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN11932_c0_g1_i3	Q9JII6	AK1A1_MOUSE	99	192	2	0	1	576	11	202	6.50E-110	397.9	AK1A1_MOUSE	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	Akr1a1 Akr1a4	Mus musculus (Mouse)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095	aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i3	Q9JII6	AK1A1_MOUSE	38.8	273	132	4	54	770	8	279	5.70E-45	182.6	AK1A1_MOUSE	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	Akr1a1 Akr1a4	Mus musculus (Mouse)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095	aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN22410_c0_g1_i1	Q9JII6	AK1A1_MOUSE	98	98	2	0	296	3	214	311	6.00E-51	201.1	AK1A1_MOUSE	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	Akr1a1 Akr1a4	Mus musculus (Mouse)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095	aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN22410_c0_g1_i2	Q9JII6	AK1A1_MOUSE	100	101	0	0	305	3	211	311	2.00E-54	212.6	AK1A1_MOUSE	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	Akr1a1 Akr1a4	Mus musculus (Mouse)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016324; GO:0016491; GO:0019726; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0110095	aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN31147_c0_g1_i1	Q5R5D5	AK1A1_PONAB	60.4	91	35	1	280	11	6	96	2.20E-26	119.4	AK1A1_PONAB	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.33) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	AKR1A1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]; cellular detoxification of aldehyde [GO:0110095]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; mevaldate reductase (NADPH) activity [GO:0019726]	GO:0005829; GO:0008106; GO:0016324; GO:0019726; GO:0047655; GO:0047939; GO:0047941; GO:0110095	cellular detoxification of aldehyde [GO:0110095]		NA	NA	NA	NA	NA	NA
TRINITY_DN11932_c0_g1_i1	P14550	AK1A1_HUMAN	97.4	77	2	0	2	232	126	202	2.60E-38	158.7	AK1A1_HUMAN	reviewed	Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)	AKR1A1 ALDR1 ALR	Homo sapiens (Human)	325	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; oxidoreductase activity [GO:0016491]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0004033; GO:0005615; GO:0005829; GO:0006006; GO:0006081; GO:0008106; GO:0009055; GO:0016324; GO:0016491; GO:0019640; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0070062; GO:0110095; GO:1901687	aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; D-glucuronate catabolic process [GO:0042840]; doxorubicin metabolic process [GO:0044598]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN15385_c1_g1_i1	P45376	ALDR_MOUSE	99.4	175	1	0	525	1	48	222	6.50E-101	367.9	ALDR_MOUSE	reviewed	Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldo-keto reductase family 1 member B3) (Aldose reductase) (AR) (EC 1.1.1.21)	Akr1b1 Akr1b3 Aldor1 Aldr1 Alr2	Mus musculus (Mouse)	316	cytosol [GO:0005829]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; nucleoplasm [GO:0005654]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; Schmidt-Lanterman incisure [GO:0043220]; Schwann cell microvillus [GO:0097454]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glyceraldehyde oxidoreductase activity [GO:0043795]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to methylglyoxal [GO:0097238]; cellular response to peptide [GO:1901653]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; inner medullary collecting duct development [GO:0072061]; maternal process involved in female pregnancy [GO:0060135]; metanephric collecting duct development [GO:0072205]; monosaccharide metabolic process [GO:0005996]; naphthalene metabolic process [GO:0018931]; negative regulation of apoptotic process [GO:0043066]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; response to organic substance [GO:0010033]; response to thyroid hormone [GO:0097066]; response to water deprivation [GO:0009414]; retinoid metabolic process [GO:0001523]; sorbitol biosynthetic process [GO:0006061]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]	cytosol [GO:0005829]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; nucleoplasm [GO:0005654]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; Schmidt-Lanterman incisure [GO:0043220]; Schwann cell microvillus [GO:0097454]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glyceraldehyde oxidoreductase activity [GO:0043795]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0001894; GO:0002070; GO:0003091; GO:0004032; GO:0005615; GO:0005654; GO:0005829; GO:0005996; GO:0006061; GO:0008106; GO:0009414; GO:0010033; GO:0016491; GO:0018931; GO:0031098; GO:0032838; GO:0033010; GO:0035809; GO:0042415; GO:0042629; GO:0043066; GO:0043220; GO:0043795; GO:0044597; GO:0044598; GO:0046427; GO:0047655; GO:0048471; GO:0048661; GO:0052650; GO:0055114; GO:0060135; GO:0070301; GO:0071475; GO:0072061; GO:0072205; GO:0097066; GO:0097238; GO:0097454; GO:1901653	cellular hyperosmotic salinity response [GO:0071475]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to methylglyoxal [GO:0097238]; cellular response to peptide [GO:1901653]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; inner medullary collecting duct development [GO:0072061]; maternal process involved in female pregnancy [GO:0060135]; metanephric collecting duct development [GO:0072205]; monosaccharide metabolic process [GO:0005996]; naphthalene metabolic process [GO:0018931]; negative regulation of apoptotic process [GO:0043066]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; response to organic substance [GO:0010033]; response to thyroid hormone [GO:0097066]; response to water deprivation [GO:0009414]; retinoid metabolic process [GO:0001523]; sorbitol biosynthetic process [GO:0006061]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]		NA	NA	NA	NA	NA	NA
TRINITY_DN15385_c0_g1_i1	P15121	ALDR_HUMAN	100	205	0	0	617	3	31	235	9.60E-120	430.6	ALDR_HUMAN	reviewed	Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21)	AKR1B1 ALDR1 ALR2	Homo sapiens (Human)	316	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; nucleoplasm [GO:0005654]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; Schmidt-Lanterman incisure [GO:0043220]; Schwann cell microvillus [GO:0097454]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glyceraldehyde oxidoreductase activity [GO:0043795]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; C21-steroid hormone biosynthetic process [GO:0006700]; carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to methylglyoxal [GO:0097238]; cellular response to peptide [GO:1901653]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; fructose biosynthetic process [GO:0046370]; inner medullary collecting duct development [GO:0072061]; maternal process involved in female pregnancy [GO:0060135]; metanephric collecting duct development [GO:0072205]; naphthalene metabolic process [GO:0018931]; negative regulation of apoptotic process [GO:0043066]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; response to thyroid hormone [GO:0097066]; response to water deprivation [GO:0009414]; retinoid metabolic process [GO:0001523]; sorbitol biosynthetic process [GO:0006061]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; nucleoplasm [GO:0005654]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection cytoplasm [GO:0032838]; Schmidt-Lanterman incisure [GO:0043220]; Schwann cell microvillus [GO:0097454]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glyceraldehyde oxidoreductase activity [GO:0043795]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0001894; GO:0002070; GO:0003091; GO:0004032; GO:0005615; GO:0005654; GO:0005829; GO:0005975; GO:0006061; GO:0006700; GO:0008106; GO:0009055; GO:0009414; GO:0016491; GO:0018931; GO:0031098; GO:0032838; GO:0033010; GO:0035809; GO:0042415; GO:0042629; GO:0043066; GO:0043220; GO:0043795; GO:0044597; GO:0044598; GO:0046370; GO:0046427; GO:0047655; GO:0048471; GO:0048661; GO:0052650; GO:0055114; GO:0060135; GO:0070062; GO:0071475; GO:0072061; GO:0072205; GO:0097066; GO:0097238; GO:0097454; GO:1901653	C21-steroid hormone biosynthetic process [GO:0006700]; carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to methylglyoxal [GO:0097238]; cellular response to peptide [GO:1901653]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; fructose biosynthetic process [GO:0046370]; inner medullary collecting duct development [GO:0072061]; maternal process involved in female pregnancy [GO:0060135]; metanephric collecting duct development [GO:0072205]; naphthalene metabolic process [GO:0018931]; negative regulation of apoptotic process [GO:0043066]; norepinephrine metabolic process [GO:0042415]; oxidation-reduction process [GO:0055114]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; response to thyroid hormone [GO:0097066]; response to water deprivation [GO:0009414]; retinoid metabolic process [GO:0001523]; sorbitol biosynthetic process [GO:0006061]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]		NA	NA	NA	NA	NA	NA
TRINITY_DN10249_c0_g1_i3	P15122	ALDR_RABIT	60.7	308	119	1	1019	102	9	316	7.30E-107	388.7	ALDR_RABIT	reviewed	Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21)	AKR1B1	Oryctolagus cuniculus (Rabbit)	316	cytoplasm [GO:0005737]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]; retinoid metabolic process [GO:0001523]	cytoplasm [GO:0005737]	alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004032; GO:0005737; GO:0047655; GO:0052650	retinoid metabolic process [GO:0001523]		blue	blue	NA	NA	NA	NA
TRINITY_DN33391_c0_g1_i1	P80276	ALDR_PIG	59.9	142	53	2	428	9	160	299	5.10E-43	175.3	ALDR_PIG	reviewed	Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21)	AKR1B1 ALR2	Sus scrofa (Pig)	316	cytoplasm [GO:0005737]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]; retinoid metabolic process [GO:0001523]	cytoplasm [GO:0005737]	alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004032; GO:0005737; GO:0047655; GO:0052650	retinoid metabolic process [GO:0001523]		NA	NA	NA	NA	NA	NA
TRINITY_DN27851_c0_g1_i1	P42330	AK1C3_HUMAN	100	80	0	0	1	240	147	226	4.10E-42	171.4	AK1C3_HUMAN	reviewed	"Aldo-keto reductase family 1 member C3 (EC 1.-.-.-) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Indanol dehydrogenase) (EC 1.1.1.112) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20)"	AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS	Homo sapiens (Human)	323	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; prostaglandin-F synthase activity [GO:0047017]; retinal dehydrogenase activity [GO:0001758]; retinol dehydrogenase activity [GO:0004745]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; C21-steroid hormone metabolic process [GO:0008207]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; oxidation-reduction process [GO:0055114]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin-F synthase activity [GO:0047017]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758]; retinol dehydrogenase activity [GO:0004745]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0004745; GO:0005496; GO:0005634; GO:0005737; GO:0005829; GO:0006693; GO:0007186; GO:0007584; GO:0008106; GO:0008202; GO:0008207; GO:0008284; GO:0008584; GO:0009267; GO:0010942; GO:0016229; GO:0016488; GO:0016491; GO:0016655; GO:0018636; GO:0019371; GO:0030216; GO:0032052; GO:0034614; GO:0035410; GO:0036130; GO:0036131; GO:0042448; GO:0042574; GO:0043170; GO:0044597; GO:0044598; GO:0045550; GO:0045703; GO:0047017; GO:0047020; GO:0047023; GO:0047035; GO:0047045; GO:0047086; GO:0047115; GO:0047718; GO:0047787; GO:0048385; GO:0051897; GO:0052650; GO:0055114; GO:0061370; GO:0070062; GO:0070293; GO:0071276; GO:0071277; GO:0071379; GO:0071384; GO:0071395; GO:0071799; GO:1900053; GO:2000224; GO:2000353; GO:2000379	C21-steroid hormone metabolic process [GO:0008207]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; oxidation-reduction process [GO:0055114]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i4	P51857	AK1D1_HUMAN	41.7	254	142	4	28	780	40	290	3.70E-52	206.5	AK1D1_HUMAN	reviewed	Aldo-keto reductase family 1 member D1 (EC 1.3.1.3) (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase)	AKR1D1 SRD5B1	Homo sapiens (Human)	326	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]	GO:0004032; GO:0004033; GO:0005496; GO:0005829; GO:0006699; GO:0006707; GO:0007586; GO:0008106; GO:0008202; GO:0008207; GO:0008209; GO:0016229; GO:0016491; GO:0030573; GO:0047086; GO:0047787; GO:0055114	androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i6	P51857	AK1D1_HUMAN	38.5	252	118	4	133	780	40	290	2.20E-44	180.6	AK1D1_HUMAN	reviewed	Aldo-keto reductase family 1 member D1 (EC 1.3.1.3) (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase)	AKR1D1 SRD5B1	Homo sapiens (Human)	326	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]	GO:0004032; GO:0004033; GO:0005496; GO:0005829; GO:0006699; GO:0006707; GO:0007586; GO:0008106; GO:0008202; GO:0008207; GO:0008209; GO:0016229; GO:0016491; GO:0030573; GO:0047086; GO:0047787; GO:0055114	androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i7	P51857	AK1D1_HUMAN	40.9	242	138	3	210	929	66	304	2.60E-47	190.7	AK1D1_HUMAN	reviewed	Aldo-keto reductase family 1 member D1 (EC 1.3.1.3) (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase)	AKR1D1 SRD5B1	Homo sapiens (Human)	326	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]	GO:0004032; GO:0004033; GO:0005496; GO:0005829; GO:0006699; GO:0006707; GO:0007586; GO:0008106; GO:0008202; GO:0008207; GO:0008209; GO:0016229; GO:0016491; GO:0030573; GO:0047086; GO:0047787; GO:0055114	androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c1_g1_i1	Q8SSK6	ALDR_ENCCU	44.3	70	38	1	100	306	7	76	5.30E-10	65.1	ALDR_ENCCU	reviewed	Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase)	ECU01_0970	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	301	cytoplasm [GO:0005737]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]	cytoplasm [GO:0005737]	alditol:NADP+ 1-oxidoreductase activity [GO:0004032]	GO:0004032; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN40824_c0_g1_i1	P45377	ALD2_MOUSE	100	118	0	0	2	355	73	190	2.10E-66	252.7	ALD2_MOUSE	reviewed	Aldose reductase-related protein 2 (AR) (EC 1.1.1.21) (Aldehyde reductase) (Fibroblast growth factor-regulated protein) (Protein FR-1)	Akr1b8 Fgfrp	Mus musculus (Mouse)	316	cytosol [GO:0005829]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004032; GO:0005739; GO:0005829; GO:0008106; GO:0016488; GO:0016491; GO:0044597; GO:0044598; GO:0045550; GO:0047718; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523]		NA	NA	NA	NA	NA	NA
TRINITY_DN3669_c0_g1_i9	P83456	PPB_GADMO	54.4	125	52	2	41	400	350	474	7.90E-33	141.7	PPB_GADMO	reviewed	Alkaline phosphatase (AP) (EC 3.1.3.1)		Gadus morhua (Atlantic cod)	477	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]	GO:0004035; GO:0005886; GO:0031225; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN25861_c0_g1_i1	P24823	PPBN_MOUSE	53.5	71	32	1	244	32	295	364	1.10E-13	77	PPBN_MOUSE	reviewed	"Alkaline phosphatase, germ cell type (EC 3.1.3.1) (Alkaline phosphatase 5) (Alkaline phosphatase, placental-like) (Embryonic alkaline phosphatase) (EAP) (Embryonic-type alkaline phosphatase)"	Alpg Akp5 Alppl2 Eap	Mus musculus (Mouse)	529	anchored component of membrane [GO:0031225]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; myofibril [GO:0030016]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]	GO:0004035; GO:0005886; GO:0016311; GO:0030016; GO:0031225; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN38872_c0_g1_i1	P05187	PPB1_HUMAN	97	67	2	0	4	204	447	513	4.60E-32	137.9	PPB1_HUMAN	reviewed	"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)"	ALPP PLAP	Homo sapiens (Human)	535	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]	GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0016311; GO:0031225	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN38872_c0_g1_i2	P05187	PPB1_HUMAN	94.3	53	3	0	39	197	461	513	2.90E-23	108.6	PPB1_HUMAN	reviewed	"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)"	ALPP PLAP	Homo sapiens (Human)	535	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]	GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0016311; GO:0031225	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3669_c0_g1_i3	Q92058	PPBT_CHICK	53.6	194	87	3	163	738	20	212	1.90E-49	197.6	PPBT_CHICK	reviewed	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1)"	ALPL	Gallus gallus (Chicken)	519	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]	GO:0004035; GO:0005886; GO:0016311; GO:0031225; GO:0046872; GO:0065010	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3669_c0_g1_i4	Q92058	PPBT_CHICK	47.1	274	138	6	163	975	20	289	3.50E-58	226.9	PPBT_CHICK	reviewed	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1)"	ALPL	Gallus gallus (Chicken)	519	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]	GO:0004035; GO:0005886; GO:0016311; GO:0031225; GO:0046872; GO:0065010	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN911_c0_g2_i1	Q92058	PPBT_CHICK	45.4	500	243	13	179	1639	21	503	1.00E-105	385.6	PPBT_CHICK	reviewed	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1)"	ALPL	Gallus gallus (Chicken)	519	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]	GO:0004035; GO:0005886; GO:0016311; GO:0031225; GO:0046872; GO:0065010	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3669_c0_g1_i6	P08289	PPBT_RAT	47.6	229	113	3	35	706	287	513	1.50E-53	211.1	PPBT_RAT	reviewed	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)"	Alpl	Rattus norvegicus (Rat)	524	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]	GO:0001958; GO:0003006; GO:0004035; GO:0005615; GO:0005886; GO:0016311; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0071407; GO:0071529	cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]		NA	NA	NA	NA	NA	NA
TRINITY_DN3669_c0_g1_i7	P05186	PPBT_HUMAN	51.9	160	67	3	112	588	12	162	2.70E-35	150.2	PPBT_HUMAN	reviewed	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)"	ALPL	Homo sapiens (Human)	524	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; osteoblast differentiation [GO:0001649]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]	GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0005576; GO:0005886; GO:0016020; GO:0016311; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0070062; GO:0071407; GO:0071529	cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; osteoblast differentiation [GO:0001649]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN3669_c0_g1_i1	P08289	PPBT_RAT	46.5	499	253	9	163	1635	21	513	4.00E-115	416.8	PPBT_RAT	reviewed	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)"	Alpl	Rattus norvegicus (Rat)	524	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]	GO:0001958; GO:0003006; GO:0004035; GO:0005615; GO:0005886; GO:0016311; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0071407; GO:0071529	cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]		NA	NA	1	NA	NA	NA
TRINITY_DN36288_c0_g1_i1	P0A252	AHPC_SALTI	64.3	70	25	0	211	2	1	70	1.90E-22	105.9	AHPC_SALTI	reviewed	Alkyl hydroperoxide reductase C (EC 1.11.1.26) (Alkyl hydroperoxide reductase protein C22) (Peroxiredoxin) (Thioredoxin peroxidase)	ahpC STY0653 t2260	Salmonella typhi	187	cytoplasm [GO:0005737]; alkylhydroperoxide reductase activity [GO:0102039]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]	alkylhydroperoxide reductase activity [GO:0102039]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]	GO:0004601; GO:0005737; GO:0006979; GO:0051920; GO:0102039	response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN13144_c0_g1_i1	Q07G10	ALKB8_XENTR	39.7	723	321	17	2187	61	7	628	7.40E-133	476.1	ALKB8_XENTR	reviewed	Alkylated DNA repair protein alkB homolog 8 (EC 1.14.11.-) (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.-) (EC 2.1.1.229)	alkbh8 TEgg091o15.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	628	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016300; GO:0016706; GO:0030488; GO:0055114	oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN13144_c0_g1_i2	Q07G10	ALKB8_XENTR	28	157	105	5	606	148	7	159	1.60E-09	64.7	ALKB8_XENTR	reviewed	Alkylated DNA repair protein alkB homolog 8 (EC 1.14.11.-) (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.-) (EC 2.1.1.229)	alkbh8 TEgg091o15.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	628	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016300; GO:0016706; GO:0030488; GO:0055114	oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN27799_c0_g1_i1	O17554	ALKMO_CAEEL	54.2	48	22	0	22	165	239	286	1.60E-10	66.2	ALKMO_CAEEL	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195 homolog)	agmo-1 BE10.2	Caenorhabditis elegans	505	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0050479	lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN30889_c0_g1_i1	O17554	ALKMO_CAEEL	58.8	51	21	0	184	32	239	289	1.00E-13	77	ALKMO_CAEEL	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195 homolog)	agmo-1 BE10.2	Caenorhabditis elegans	505	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0050479	lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN28765_c0_g1_i1	Q5M8F9	ALKMO_XENTR	56.8	81	33	1	7	249	189	267	5.80E-23	107.8	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN8091_c0_g1_i1	Q5M8F9	ALKMO_XENTR	45.2	62	33	1	191	6	130	190	6.20E-10	64.3	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4364_c0_g1_i1	Q5M8F9	ALKMO_XENTR	38	71	35	3	66	278	170	231	6.10E-08	58.2	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4364_c0_g1_i2	Q6NYE4	ALKMO_DANRE	53.6	97	36	3	57	347	167	254	2.80E-23	109.4	ALKMO_DANRE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195 zgc:77121	Danio rerio (Zebrafish) (Brachydanio rerio)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4364_c0_g1_i4	Q6NYE4	ALKMO_DANRE	54.6	97	35	3	57	347	167	254	7.40E-24	111.3	ALKMO_DANRE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195 zgc:77121	Danio rerio (Zebrafish) (Brachydanio rerio)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4364_c0_g1_i9	Q5M8F9	ALKMO_XENTR	39.4	71	34	3	66	278	170	231	1.60E-08	60.1	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4364_c0_g1_i3	Q5M8F9	ALKMO_XENTR	41.5	65	29	3	66	260	170	225	2.10E-08	59.7	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		brown	brown	1	NA	NA	NA
TRINITY_DN4364_c0_g1_i7	Q5M8F9	ALKMO_XENTR	43.1	65	28	3	66	260	170	225	5.70E-09	61.6	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		brown	brown	1	NA	NA	NA
TRINITY_DN4851_c0_g1_i2	Q5M8F9	ALKMO_XENTR	44.5	283	154	2	90	938	121	400	3.60E-69	263.5	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4851_c0_g1_i3	Q5M8F9	ALKMO_XENTR	41.4	394	226	4	81	1256	10	400	2.60E-91	337.4	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN4851_c0_g1_i4	Q5M8F9	ALKMO_XENTR	45.6	342	181	4	81	1100	10	348	2.80E-91	337	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1665_c8_g1_i1	Q8BS35	ALKMO_MOUSE	34.7	262	156	6	831	58	168	418	2.30E-37	157.5	ALKMO_MOUSE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	Agmo Tmem195	Mus musculus (Mouse)	447	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1665_c8_g1_i10	Q8BS35	ALKMO_MOUSE	32.3	195	126	3	630	58	226	418	1.30E-24	114.8	ALKMO_MOUSE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	Agmo Tmem195	Mus musculus (Mouse)	447	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1665_c8_g1_i2	Q8BS35	ALKMO_MOUSE	29.3	181	122	3	588	58	240	418	1.50E-16	87.8	ALKMO_MOUSE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	Agmo Tmem195	Mus musculus (Mouse)	447	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1665_c8_g1_i3	Q6NYE4	ALKMO_DANRE	41.1	90	51	1	280	11	225	312	1.50E-13	77	ALKMO_DANRE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195 zgc:77121	Danio rerio (Zebrafish) (Brachydanio rerio)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1665_c8_g1_i6	Q8BS35	ALKMO_MOUSE	33.2	262	160	6	831	58	168	418	2.00E-33	144.4	ALKMO_MOUSE	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	Agmo Tmem195	Mus musculus (Mouse)	447	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1665_c8_g1_i7	Q5M8F9	ALKMO_XENTR	35.2	71	37	3	222	10	170	231	7.50E-06	51.2	ALKMO_XENTR	reviewed	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	agmo tmem195	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]		NA	NA	NA	NA	NA	NA
TRINITY_DN12006_c0_g1_i1	Q5T2R2	DPS1_HUMAN	60.2	314	124	1	992	54	102	415	3.90E-103	376.3	DPS1_HUMAN	reviewed	All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1)	PDSS1 DPS1 TPRT	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]	metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]	GO:0000010; GO:0004659; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:1990234	isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN29834_c0_g1_i1	Q86YH6	DLP1_HUMAN	100	96	0	0	1	288	35	130	7.10E-49	194.1	DLP1_HUMAN	reviewed	All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)	PDSS2 C6orf210 DLP1	Homo sapiens (Human)	399	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]	prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]	GO:0000010; GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0046982; GO:0050347; GO:0050878; GO:1990234	isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN1398_c0_g1_i2	Q5U2R1	DLP1_RAT	46.9	352	178	7	1139	99	50	397	5.80E-80	299.7	DLP1_RAT	reviewed	All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)	Pdss2 Dlp1	Rattus norvegicus (Rat)	401	cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]	prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]	GO:0000010; GO:0004659; GO:0005739; GO:0005829; GO:0006744; GO:0008299; GO:0046982; GO:0050347; GO:0050878; GO:1990234	isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]		blue	blue	NA	NA	NA	NA
TRINITY_DN9611_c1_g2_i1	Q6DGA6	ALLC_DANRE	47.2	72	36	2	3	218	146	215	3.10E-12	72.4	ALLC_DANRE	reviewed	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	allc si:ch211-284k10.3 zgc:91799	Danio rerio (Zebrafish) (Brachydanio rerio)	395	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN9611_c1_g2_i2	Q6DGA6	ALLC_DANRE	53.6	179	76	4	52	567	213	391	4.90E-49	196.1	ALLC_DANRE	reviewed	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	allc si:ch211-284k10.3 zgc:91799	Danio rerio (Zebrafish) (Brachydanio rerio)	395	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN9611_c1_g2_i3	Q6DGA6	ALLC_DANRE	51.4	247	112	5	3	722	146	391	5.10E-69	262.7	ALLC_DANRE	reviewed	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	allc si:ch211-284k10.3 zgc:91799	Danio rerio (Zebrafish) (Brachydanio rerio)	395	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN9611_c1_g2_i4	Q6DGA6	ALLC_DANRE	53.6	179	76	4	3	518	213	391	1.60E-49	197.6	ALLC_DANRE	reviewed	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	allc si:ch211-284k10.3 zgc:91799	Danio rerio (Zebrafish) (Brachydanio rerio)	395	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN27604_c0_g1_i1	Q9W6S5	ALLC_XENLA	62.6	99	37	0	299	3	14	112	3.40E-31	135.6	ALLC_XENLA	reviewed	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	allc	Xenopus laevis (African clawed frog)	389	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN7698_c0_g1_i2	Q9W6S5	ALLC_XENLA	52.9	136	63	1	94	501	14	148	8.30E-37	154.8	ALLC_XENLA	reviewed	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	allc	Xenopus laevis (African clawed frog)	389	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN3757_c0_g1_i1	Q5BLE8	RETST_DANRE	45.1	577	314	3	157	1887	23	596	2.00E-150	534.3	RETST_DANRE	reviewed	"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase A) (RetSat A) (All-trans-retinol 7,8-reductase)"	retsat retsata zgc:113107	Danio rerio (Zebrafish) (Brachydanio rerio)	607	"endoplasmic reticulum membrane [GO:0005789]; all-trans-retinol 13,14-reductase activity [GO:0051786]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]	"all-trans-retinol 13,14-reductase activity [GO:0051786]"	GO:0005789; GO:0042572; GO:0051786	retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN35766_c0_g1_i1	P83088	FUCTC_DROME	48.9	180	82	4	17	544	240	413	6.70E-42	172.2	FUCTC_DROME	reviewed	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	FucTC CG40305	Drosophila melanogaster (Fruit fly)	425	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11371_c0_g1_i4	P83088	FUCTC_DROME	48.9	139	70	1	144	560	236	373	1.50E-30	134.8	FUCTC_DROME	reviewed	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	FucTC CG40305	Drosophila melanogaster (Fruit fly)	425	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11371_c0_g1_i5	P83088	FUCTC_DROME	42	193	102	4	144	710	236	422	8.10E-36	152.1	FUCTC_DROME	reviewed	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	FucTC CG40305	Drosophila melanogaster (Fruit fly)	425	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11371_c0_g1_i6	P83088	FUCTC_DROME	37.1	143	68	5	155	517	117	259	2.10E-12	73.9	FUCTC_DROME	reviewed	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	FucTC CG40305	Drosophila melanogaster (Fruit fly)	425	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN9307_c2_g1_i1	P83088	FUCTC_DROME	41.4	186	99	5	759	205	241	417	2.60E-37	157.1	FUCTC_DROME	reviewed	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	FucTC CG40305	Drosophila melanogaster (Fruit fly)	425	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN9307_c2_g1_i2	G5EDR5	FUTA_CAEEL	46	87	44	2	317	57	234	317	3.30E-18	92.4	FUTA_CAEEL	reviewed	"Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1)"	fut-1 CEFT-1 K08F8.3	Caenorhabditis elegans	433	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872]; carbohydrate biosynthetic process [GO:0016051]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872]	GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0036065; GO:0046872; GO:0046920	carbohydrate biosynthetic process [GO:0016051]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN39856_c0_g1_i1	G5EFP5	FUTC_CAEEL	34.3	108	64	4	422	108	276	379	1.30E-11	70.9	FUTC_CAEEL	reviewed	"Alpha-(1,3)-fucosyltransferase fut-3 (EC 2.4.1.65) (Fucosyltransferase fut-3)"	fut-3 CEFT-4 F59E12.13	Caenorhabditis elegans	400	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1873_c0_g1_i4	G5EE06	FUTD_CAEEL	35.9	78	42	3	219	440	80	153	4.80E-07	56.2	FUTD_CAEEL	reviewed	"Alpha-(1,3)-fucosyltransferase fut-5 (EC 2.4.1.65) (Fucosyltransferase fut-5)"	fut-5 CEFT-2 T05A7.10	Caenorhabditis elegans	378	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; metal ion binding [GO:0046872]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; metal ion binding [GO:0046872]	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046872	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN27194_c0_g1_i1	Q9BYC5	FUT8_HUMAN	98.6	139	2	0	420	4	431	569	1.60E-78	293.1	FUT8_HUMAN	reviewed	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	FUT8	Homo sapiens (Human)	575	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001701; GO:0005794; GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0009312; GO:0010468; GO:0016020; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0042355; GO:0043112; GO:0046368; GO:0046921; GO:0070062; GO:1900407	cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN19947_c0_g1_i1	Q9BYC5	FUT8_HUMAN	100	137	0	0	412	2	279	415	5.70E-76	284.6	FUT8_HUMAN	reviewed	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	FUT8	Homo sapiens (Human)	575	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001701; GO:0005794; GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0009312; GO:0010468; GO:0016020; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0042355; GO:0043112; GO:0046368; GO:0046921; GO:0070062; GO:1900407	cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN19947_c0_g1_i2	Q9WTS2	FUT8_MOUSE	99.6	240	1	0	721	2	176	415	7.30E-143	507.7	FUT8_MOUSE	reviewed	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	Fut8	Mus musculus (Mouse)	575	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; transferase activity, transferring glycosyl groups [GO:0016757]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0010468; GO:0016021; GO:0016477; GO:0016757; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0043112; GO:0046368; GO:0046921; GO:1900407	cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN8349_c0_g1_i1	Q9VYV5	FUT8_DROME	48.8	494	233	6	12	1442	27	517	1.80E-132	474.2	FUT8_DROME	reviewed	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	FucT6 CG2448	Drosophila melanogaster (Fruit fly)	619	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]	GO:0006487; GO:0008424; GO:0016021; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046872; GO:0046921	GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN8349_c0_g1_i3	Q9VYV5	FUT8_DROME	51.3	593	269	6	12	1739	27	616	1.90E-173	610.5	FUT8_DROME	reviewed	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	FucT6 CG2448	Drosophila melanogaster (Fruit fly)	619	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; metal ion binding [GO:0046872]	GO:0006487; GO:0008424; GO:0016021; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046872; GO:0046921	GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN38051_c0_g1_i1	Q9SYM4	TPS1_ARATH	76.6	64	15	0	193	2	438	501	6.60E-20	97.4	TPS1_ARATH	reviewed	"Alpha,alpha-trehalose-phosphate synthase [UDP-forming] 1 (EC 2.4.1.15) (Trehalose-6-phosphate synthase 1) (AtTPS1)"	TPS1 At1g78580 T30F21.9	Arabidopsis thaliana (Mouse-ear cress)	942	"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; vacuole [GO:0005773]; alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; cell division [GO:0051301]; embryo development ending in seed dormancy [GO:0009793]; plant-type cell wall biogenesis [GO:0009832]; sugar mediated signaling pathway [GO:0010182]; trehalose metabolic process [GO:0005991]"	cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; vacuole [GO:0005773]	"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]"	GO:0003825; GO:0005576; GO:0005618; GO:0005737; GO:0005773; GO:0005829; GO:0005991; GO:0009793; GO:0009832; GO:0010182; GO:0051301	cell division [GO:0051301]; embryo development ending in seed dormancy [GO:0009793]; plant-type cell wall biogenesis [GO:0009832]; sugar mediated signaling pathway [GO:0010182]; trehalose metabolic process [GO:0005991]		NA	NA	NA	NA	NA	NA
TRINITY_DN30702_c0_g1_i1	Q2HJ19	AB17A_BOVIN	57.6	92	38	1	3	275	145	236	1.10E-22	107.1	AB17A_BOVIN	reviewed	Alpha/beta hydrolase domain-containing protein 17A (Abhydrolase domain-containing protein 17A) (EC 3.1.2.22)	ABHD17A	Bos taurus (Bovine)	310	dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; postsynaptic density membrane [GO:0098839]; palmitoyl-(protein) hydrolase activity [GO:0008474]	dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; postsynaptic density membrane [GO:0098839]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0008474; GO:0010008; GO:0043197; GO:0098839			NA	NA	NA	NA	NA	NA
TRINITY_DN21158_c0_g1_i1	Q99JW1	AB17A_MOUSE	100	98	0	0	294	1	107	204	1.80E-52	206.1	AB17A_MOUSE	reviewed	Alpha/beta hydrolase domain-containing protein 17A (Abhydrolase domain-containing protein 17A) (EC 3.1.2.22)	Abhd17a D10Bwg1364e	Mus musculus (Mouse)	310	anchored component of postsynaptic density membrane [GO:0099031]; anchored component of postsynaptic recycling endosome membrane [GO:0099033]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]	anchored component of postsynaptic density membrane [GO:0099031]; anchored component of postsynaptic recycling endosome membrane [GO:0099033]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0014069; GO:0018345; GO:0043197; GO:0055038; GO:0072657; GO:0098978; GO:0099031; GO:0099033; GO:0099175; GO:1902817; GO:1905668	negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]		NA	NA	NA	NA	NA	NA
TRINITY_DN707_c0_g2_i1	Q96GS6	AB17A_HUMAN	100	249	0	0	749	3	53	301	1.60E-145	516.5	AB17A_HUMAN	reviewed	Alpha/beta hydrolase domain-containing protein 17A (Abhydrolase domain-containing protein 17A) (EC 3.1.2.22)	ABHD17A C19orf27 FAM108A1	Homo sapiens (Human)	310	anchored component of postsynaptic density membrane [GO:0099031]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]	anchored component of postsynaptic density membrane [GO:0099031]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0016020; GO:0018345; GO:0043197; GO:0055038; GO:0072657; GO:0098978; GO:0099031; GO:0099175; GO:1902817; GO:1905668	negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]		NA	NA	NA	NA	NA	NA
TRINITY_DN25773_c0_g1_i1	Q96GS6	AB17A_HUMAN	100	40	0	0	35	154	1	40	1.40E-17	89.7	AB17A_HUMAN	reviewed	Alpha/beta hydrolase domain-containing protein 17A (Abhydrolase domain-containing protein 17A) (EC 3.1.2.22)	ABHD17A C19orf27 FAM108A1	Homo sapiens (Human)	310	anchored component of postsynaptic density membrane [GO:0099031]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]	anchored component of postsynaptic density membrane [GO:0099031]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0016020; GO:0018345; GO:0043197; GO:0055038; GO:0072657; GO:0098978; GO:0099031; GO:0099175; GO:1902817; GO:1905668	negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]		NA	NA	NA	NA	NA	NA
TRINITY_DN25773_c0_g1_i1	Q96GS6	AB17A_HUMAN	76.2	21	5	0	220	158	6	26	0.0027	42.4	AB17A_HUMAN	reviewed	Alpha/beta hydrolase domain-containing protein 17A (Abhydrolase domain-containing protein 17A) (EC 3.1.2.22)	ABHD17A C19orf27 FAM108A1	Homo sapiens (Human)	310	anchored component of postsynaptic density membrane [GO:0099031]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]	anchored component of postsynaptic density membrane [GO:0099031]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0016020; GO:0018345; GO:0043197; GO:0055038; GO:0072657; GO:0098978; GO:0099031; GO:0099175; GO:1902817; GO:1905668	negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein localization to membrane [GO:0072657]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]		NA	NA	NA	NA	NA	NA
TRINITY_DN26711_c0_g1_i1	Q5VST6	AB17B_HUMAN	100	122	0	0	2	367	68	189	8.10E-66	250.8	AB17B_HUMAN	reviewed	Alpha/beta hydrolase domain-containing protein 17B (Abhydrolase domain-containing protein 17B) (EC 3.1.2.22)	ABHD17B C9orf77 FAM108B1 CGI-67	Homo sapiens (Human)	288	anchored component of postsynaptic recycling endosome membrane [GO:0099033]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein palmitoylation [GO:0018345]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse organization [GO:0099175]; regulation of protein localization to synapse [GO:1902473]	anchored component of postsynaptic recycling endosome membrane [GO:0099033]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0016020; GO:0018345; GO:0043197; GO:0055038; GO:0098839; GO:0098978; GO:0099033; GO:0099175; GO:1902473; GO:1902817; GO:1902950; GO:1905668	negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein palmitoylation [GO:0018345]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse organization [GO:0099175]; regulation of protein localization to synapse [GO:1902473]		NA	NA	NA	NA	NA	NA
TRINITY_DN707_c0_g1_i1	Q5ZJ01	AB17B_CHICK	72.8	287	77	1	877	20	1	287	8.00E-129	461.5	AB17B_CHICK	reviewed	Alpha/beta hydrolase domain-containing protein 17B (Abhydrolase domain-containing protein 17B) (EC 3.1.2.22)	ABHD17B RCJMB04_22d6	Gallus gallus (Chicken)	288	dendritic spine [GO:0043197]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]	dendritic spine [GO:0043197]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0008474; GO:0043197; GO:0055038; GO:0098839			NA	NA	NA	NA	NA	NA
TRINITY_DN707_c0_g1_i2	Q5ZJ01	AB17B_CHICK	70.2	215	63	1	738	97	1	215	3.30E-91	336.3	AB17B_CHICK	reviewed	Alpha/beta hydrolase domain-containing protein 17B (Abhydrolase domain-containing protein 17B) (EC 3.1.2.22)	ABHD17B RCJMB04_22d6	Gallus gallus (Chicken)	288	dendritic spine [GO:0043197]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]	dendritic spine [GO:0043197]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0008474; GO:0043197; GO:0055038; GO:0098839			NA	NA	NA	NA	NA	NA
TRINITY_DN25509_c0_g1_i1	A5PKD9	AB17C_BOVIN	100	82	0	0	247	2	208	289	7.20E-42	170.6	AB17C_BOVIN	reviewed	Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22)	ABHD17C	Bos taurus (Bovine)	329	dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]; regulation of postsynapse organization [GO:0099175]	dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0043197; GO:0055038; GO:0098839; GO:0099175	protein depalmitoylation [GO:0002084]; regulation of postsynapse organization [GO:0099175]		NA	NA	NA	NA	NA	NA
TRINITY_DN13887_c0_g1_i1	Q9DBE8	ALG2_MOUSE	56.9	58	25	0	188	15	227	284	4.10E-09	61.6	ALG2_MOUSE	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	Alg2 MNCb-5081	Mus musculus (Mouse)	415	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN26890_c0_g1_i1	Q9H553	ALG2_HUMAN	97.4	194	5	0	582	1	91	284	3.70E-105	382.1	ALG2_HUMAN	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	ALG2 UNQ666/PRO1298	Homo sapiens (Human)	416	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN24026_c0_g1_i1	Q9H553	ALG2_HUMAN	49.5	91	44	1	270	4	109	199	2.20E-19	96.3	ALG2_HUMAN	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	ALG2 UNQ666/PRO1298	Homo sapiens (Human)	416	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN24026_c0_g1_i2	Q9H553	ALG2_HUMAN	51.8	85	39	1	252	4	115	199	1.70E-18	93.2	ALG2_HUMAN	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	ALG2 UNQ666/PRO1298	Homo sapiens (Human)	416	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN10194_c0_g1_i1	Q9DBE8	ALG2_MOUSE	51.9	405	182	6	155	1348	17	415	1.50E-102	374.8	ALG2_MOUSE	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	Alg2 MNCb-5081	Mus musculus (Mouse)	415	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN10194_c0_g1_i2	Q9DBE8	ALG2_MOUSE	51.9	405	182	6	155	1348	17	415	1.50E-102	374.8	ALG2_MOUSE	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	Alg2 MNCb-5081	Mus musculus (Mouse)	415	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		blue	blue	NA	NA	NA	NA
TRINITY_DN10194_c0_g1_i3	Q9DBE8	ALG2_MOUSE	51.9	405	182	6	155	1348	17	415	1.50E-102	374.8	ALG2_MOUSE	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	Alg2 MNCb-5081	Mus musculus (Mouse)	415	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		blue	blue	NA	NA	NA	NA
TRINITY_DN30660_c0_g1_i1	Q9H553	ALG2_HUMAN	100	93	0	0	2	280	291	383	6.20E-50	197.6	ALG2_HUMAN	reviewed	"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	ALG2 UNQ666/PRO1298	Homo sapiens (Human)	416	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0006488; GO:0006490; GO:0015629; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN39332_c0_g1_i1	P26572	MGAT1_HUMAN	100	91	0	0	2	274	258	348	9.50E-51	200.3	MGAT1_HUMAN	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GGNT1 GLCT1 GLYT1 MGAT	Homo sapiens (Human)	445	"extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0048471; GO:0070062; GO:1903561	in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN27944_c0_g1_i1	P26572	MGAT1_HUMAN	100	128	0	0	2	385	115	242	1.60E-72	273.1	MGAT1_HUMAN	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GGNT1 GLCT1 GLYT1 MGAT	Homo sapiens (Human)	445	"extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0048471; GO:0070062; GO:1903561	in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN34313_c0_g1_i1	P26572	MGAT1_HUMAN	49.3	142	68	2	432	19	188	329	5.80E-39	161.8	MGAT1_HUMAN	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GGNT1 GLCT1 GLYT1 MGAT	Homo sapiens (Human)	445	"extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0048471; GO:0070062; GO:1903561	in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN32699_c0_g1_i1	P26572	MGAT1_HUMAN	49.2	431	195	6	1256	3	18	437	6.00E-116	419.1	MGAT1_HUMAN	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GGNT1 GLCT1 GLYT1 MGAT	Homo sapiens (Human)	445	"extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0048471; GO:0070062; GO:1903561	in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		blue	blue	NA	NA	NA	NA
TRINITY_DN5804_c0_g1_i2	P27115	MGAT1_RABIT	36.5	115	63	4	929	600	205	314	6.10E-09	63.9	MGAT1_RABIT	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GNT1	Oryctolagus cuniculus (Rabbit)	447	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; in utero embryonic development [GO:0001701]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]"	GO:0000139; GO:0001701; GO:0003827; GO:0005797; GO:0006013; GO:0006049; GO:0006487; GO:0016021; GO:0016262; GO:0018279; GO:0030145; GO:0048471	in utero embryonic development [GO:0001701]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN5804_c0_g1_i3	P27115	MGAT1_RABIT	36.5	115	63	4	929	600	205	314	8.30E-09	63.9	MGAT1_RABIT	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GNT1	Oryctolagus cuniculus (Rabbit)	447	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; in utero embryonic development [GO:0001701]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]"	GO:0000139; GO:0001701; GO:0003827; GO:0005797; GO:0006013; GO:0006049; GO:0006487; GO:0016021; GO:0016262; GO:0018279; GO:0030145; GO:0048471	in utero embryonic development [GO:0001701]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN5804_c0_g1_i5	P27115	MGAT1_RABIT	36.5	115	63	4	794	465	205	314	7.80E-09	63.9	MGAT1_RABIT	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	MGAT1 GNT1	Oryctolagus cuniculus (Rabbit)	447	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; in utero embryonic development [GO:0001701]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]"	GO:0000139; GO:0001701; GO:0003827; GO:0005797; GO:0006013; GO:0006049; GO:0006487; GO:0016021; GO:0016262; GO:0018279; GO:0030145; GO:0048471	in utero embryonic development [GO:0001701]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN34012_c0_g1_i1	P27808	MGAT1_MOUSE	100	67	0	0	203	3	235	301	1.20E-37	156.4	MGAT1_MOUSE	reviewed	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	Mgat1 Gnt1	Mus musculus (Mouse)	447	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016021; GO:0018279; GO:0030145; GO:0048471	in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]		NA	NA	NA	NA	NA	NA
TRINITY_DN7898_c0_g1_i2	Q9UNA3	A4GCT_HUMAN	31.6	76	51	1	301	74	146	220	3.90E-06	52.8	A4GCT_HUMAN	reviewed	"Alpha-1,4-N-acetylglucosaminyltransferase (Alpha4GnT) (EC 2.4.1.-)"	A4GNT	Homo sapiens (Human)	340	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring hexosyl groups [GO:0016758]; carbohydrate metabolic process [GO:0005975]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005975; GO:0006493; GO:0008375; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016758; GO:0050680	carbohydrate metabolic process [GO:0005975]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN7898_c0_g1_i4	Q9UNA3	A4GCT_HUMAN	28	164	101	5	463	2	52	208	6.90E-10	65.9	A4GCT_HUMAN	reviewed	"Alpha-1,4-N-acetylglucosaminyltransferase (Alpha4GnT) (EC 2.4.1.-)"	A4GNT	Homo sapiens (Human)	340	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring hexosyl groups [GO:0016758]; carbohydrate metabolic process [GO:0005975]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005975; GO:0006493; GO:0008375; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016758; GO:0050680	carbohydrate metabolic process [GO:0005975]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN3954_c0_g1_i3	O19071	MGAT2_PIG	41.2	342	194	4	1155	139	102	439	1.80E-82	307.8	MGAT2_PIG	reviewed	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	MGAT2 GNT2	Sus scrofa (Pig)	446	"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0042803	oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN38019_c0_g1_i1	Q10469	MGAT2_HUMAN	99.1	108	1	0	1	324	124	231	1.30E-59	229.9	MGAT2_HUMAN	reviewed	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	MGAT2	Homo sapiens (Human)	447	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803	oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN21655_c0_g2_i1	Q10469	MGAT2_HUMAN	100	71	0	0	3	215	213	283	2.90E-39	161.8	MGAT2_HUMAN	reviewed	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	MGAT2	Homo sapiens (Human)	447	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803	oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN21655_c0_g1_i1	Q921V5	MGAT2_MOUSE	100	112	0	0	1	336	167	278	5.70E-66	251.1	MGAT2_MOUSE	reviewed	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	Mgat2	Mus musculus (Mouse)	442	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803	oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN38614_c0_g1_i1	O19071	MGAT2_PIG	45.8	262	140	1	31	810	123	384	2.70E-72	273.5	MGAT2_PIG	reviewed	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	MGAT2 GNT2	Sus scrofa (Pig)	446	"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0042803	oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN38614_c0_g1_i2	Q10469	MGAT2_HUMAN	37.4	388	228	4	62	1192	1	384	4.20E-74	280	MGAT2_HUMAN	reviewed	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	MGAT2	Homo sapiens (Human)	447	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803	oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN2954_c0_g1_i1	Q9DGD1	MGT4C_CHICK	35.1	393	237	9	1469	297	85	461	1.80E-57	225.3	MGT4C_CHICK	reviewed	"Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.201) (N-acetylglucosaminyltransferase VI) (GnT-VI)"	MGAT4C	Gallus gallus (Chicken)	464	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0047253]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"alpha-1,6-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0047253]; metal ion binding [GO:0046872]"	GO:0000139; GO:0006486; GO:0016021; GO:0046872; GO:0047253	protein glycosylation [GO:0006486]		blue	blue	NA	NA	NA	NA
TRINITY_DN15441_c1_g1_i1	Q63041	A1M_RAT	33.3	93	60	1	13	291	1400	1490	5.60E-10	65.5	A1M_RAT	reviewed	Alpha-1-macroglobulin (Alpha-1-M) (Alpha-1-macroglobulin 165 kDa subunit) [Cleaved into: Alpha-1-macroglobulin 45 kDa subunit]	A1m Pzp	Rattus norvegicus (Rat)	1500	extracellular space [GO:0005615]; brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]; embryo implantation [GO:0007566]	extracellular space [GO:0005615]	brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0007566; GO:0044877; GO:0048403; GO:0048406	embryo implantation [GO:0007566]		NA	NA	NA	NA	NA	NA
TRINITY_DN3629_c0_g1_i1	Q13424	SNTA1_HUMAN	52.9	157	58	4	6	428	9	165	1.20E-32	141	SNTA1_HUMAN	reviewed	Alpha-1-syntrophin (59 kDa dystrophin-associated protein A1 acidic component 1) (Pro-TGF-alpha cytoplasmic domain-interacting protein 1) (TACIP1) (Syntrophin-1)	SNTA1 SNT1	Homo sapiens (Human)	505	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; neuromuscular junction [GO:0031594]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; muscle contraction [GO:0006936]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; neuromuscular junction [GO:0031594]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]	GO:0002027; GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0006936; GO:0016010; GO:0016013; GO:0030165; GO:0031594; GO:0032991; GO:0042383; GO:0044325; GO:0045202; GO:0050998; GO:0051117; GO:0060307; GO:0086005; GO:1902083; GO:1902305	muscle contraction [GO:0006936]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN3629_c0_g1_i2	Q61234	SNTA1_MOUSE	51.6	91	40	3	77	346	409	496	1.00E-17	91.3	SNTA1_MOUSE	reviewed	Alpha-1-syntrophin (59 kDa dystrophin-associated protein A1 acidic component 1) (Syntrophin-1)	Snta1 Snt1	Mus musculus (Mouse)	503	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuromuscular junction development [GO:0007528]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of vasoconstriction by circulating norepinephrine [GO:0003117]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]	GO:0002027; GO:0003117; GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0007528; GO:0016010; GO:0030165; GO:0031594; GO:0032991; GO:0042383; GO:0044325; GO:0045202; GO:0045211; GO:0050998; GO:0051117; GO:0060307; GO:0086005; GO:1902083; GO:1902305	negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuromuscular junction development [GO:0007528]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of vasoconstriction by circulating norepinephrine [GO:0003117]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN16947_c0_g1_i1	Q7SIH1	A2MG_BOVIN	45.2	84	46	0	1	252	745	828	7.30E-15	81.3	A2MG_BOVIN	reviewed	Alpha-2-macroglobulin (Alpha-2-M)	A2M	Bos taurus (Bovine)	1510	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615			NA	NA	NA	NA	NA	NA
TRINITY_DN36095_c0_g1_i1	Q5R4N8	A2MG_PONAB	44.9	69	35	1	229	32	1196	1264	1.30E-08	60.1	A2MG_PONAB	reviewed	Alpha-2-macroglobulin (Alpha-2-M)	A2M	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	1474	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615			NA	NA	NA	NA	NA	NA
TRINITY_DN1008_c0_g1_i22	Q5R4N8	A2MG_PONAB	37.5	827	463	17	2555	177	660	1466	1.20E-137	492.3	A2MG_PONAB	reviewed	Alpha-2-macroglobulin (Alpha-2-M)	A2M	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	1474	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615			NA	NA	NA	NA	NA	NA
TRINITY_DN1008_c0_g1_i21	Q5R4N8	A2MG_PONAB	38.7	759	416	16	2354	177	724	1466	1.90E-134	481.5	A2MG_PONAB	reviewed	Alpha-2-macroglobulin (Alpha-2-M)	A2M	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	1474	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615			blue	blue	1	NA	NA	NA
TRINITY_DN14118_c0_g1_i1	P01023	A2MG_HUMAN	48.4	95	45	1	274	2	932	1026	1.30E-18	93.6	A2MG_HUMAN	reviewed	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M CPAMD5 FWP007	Homo sapiens (Human)	1474	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; negative regulation of complement activation, lectin pathway [GO:0001869]; platelet degranulation [GO:0002576]; regulation of small GTPase mediated signal transduction [GO:0051056]; stem cell differentiation [GO:0048863]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]	GO:0001869; GO:0002020; GO:0002576; GO:0004866; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0005829; GO:0007597; GO:0019838; GO:0019899; GO:0019959; GO:0019966; GO:0022617; GO:0031093; GO:0043120; GO:0048306; GO:0048863; GO:0051056; GO:0062023; GO:0070062; GO:0072562	"blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; negative regulation of complement activation, lectin pathway [GO:0001869]; platelet degranulation [GO:0002576]; regulation of small GTPase mediated signal transduction [GO:0051056]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14118_c0_g1_i2	P01023	A2MG_HUMAN	45.3	95	48	1	274	2	932	1026	1.30E-15	83.6	A2MG_HUMAN	reviewed	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M CPAMD5 FWP007	Homo sapiens (Human)	1474	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; negative regulation of complement activation, lectin pathway [GO:0001869]; platelet degranulation [GO:0002576]; regulation of small GTPase mediated signal transduction [GO:0051056]; stem cell differentiation [GO:0048863]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]	GO:0001869; GO:0002020; GO:0002576; GO:0004866; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0005829; GO:0007597; GO:0019838; GO:0019899; GO:0019959; GO:0019966; GO:0022617; GO:0031093; GO:0043120; GO:0048306; GO:0048863; GO:0051056; GO:0062023; GO:0070062; GO:0072562	"blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; negative regulation of complement activation, lectin pathway [GO:0001869]; platelet degranulation [GO:0002576]; regulation of small GTPase mediated signal transduction [GO:0051056]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14118_c0_g1_i3	P01023	A2MG_HUMAN	52.2	67	28	1	190	2	960	1026	1.50E-12	73.2	A2MG_HUMAN	reviewed	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M CPAMD5 FWP007	Homo sapiens (Human)	1474	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; negative regulation of complement activation, lectin pathway [GO:0001869]; platelet degranulation [GO:0002576]; regulation of small GTPase mediated signal transduction [GO:0051056]; stem cell differentiation [GO:0048863]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]	GO:0001869; GO:0002020; GO:0002576; GO:0004866; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0005829; GO:0007597; GO:0019838; GO:0019899; GO:0019959; GO:0019966; GO:0022617; GO:0031093; GO:0043120; GO:0048306; GO:0048863; GO:0051056; GO:0062023; GO:0070062; GO:0072562	"blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; negative regulation of complement activation, lectin pathway [GO:0001869]; platelet degranulation [GO:0002576]; regulation of small GTPase mediated signal transduction [GO:0051056]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29217_c0_g1_i1	P30533	AMRP_HUMAN	100	74	0	0	1	222	62	135	6.90E-36	150.6	AMRP_HUMAN	reviewed	Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP)	LRPAP1 A2MRAP	Homo sapiens (Human)	357	cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]	amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0007165; GO:0008201; GO:0009986; GO:0010916; GO:0012505; GO:0031904; GO:0032091; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0060548; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223	amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7740_c1_g3_i1	P30533	AMRP_HUMAN	33.3	354	208	12	1219	194	19	356	1.80E-30	135.2	AMRP_HUMAN	reviewed	Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP)	LRPAP1 A2MRAP	Homo sapiens (Human)	357	cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]	amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0007165; GO:0008201; GO:0009986; GO:0010916; GO:0012505; GO:0031904; GO:0032091; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0060548; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223	amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN16942_c0_g2_i1	A8K2U0	A2ML1_HUMAN	31.9	229	147	3	3	671	1014	1239	9.80E-26	118.6	A2ML1_HUMAN	reviewed	Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)	A2ML1 CPAMD9	Homo sapiens (Human)	1454	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of endopeptidase activity [GO:0052548]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062	regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN16942_c0_g2_i2	A8K2U0	A2ML1_HUMAN	33.9	242	151	3	3	710	1014	1252	8.20E-30	132.1	A2ML1_HUMAN	reviewed	Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)	A2ML1 CPAMD9	Homo sapiens (Human)	1454	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of endopeptidase activity [GO:0052548]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062	regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN32770_c0_g1_i1	L7UZ85	ACTN_DERFA	84.6	26	4	0	151	228	811	836	1.30E-05	50.1	ACTN_DERFA	reviewed	Alpha-actinin (F-actin cross-linking protein) (allergen Der f 24)		Dermatophagoides farinae (American house dust mite)	885	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; IgE binding [GO:0019863]; actin filament bundle assembly [GO:0051017]		actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; IgE binding [GO:0019863]	GO:0005509; GO:0019863; GO:0051015; GO:0051017	actin filament bundle assembly [GO:0051017]		blue	blue	NA	NA	NA	NA
TRINITY_DN22932_c0_g1_i1	P18091	ACTN_DROME	80.3	885	144	2	2654	87	41	924	0	1432.5	ACTN_DROME	reviewed	"Alpha-actinin, sarcomeric (F-actin cross-linking protein)"	Actn fliA l(1)2Cb CG4376	Drosophila melanogaster (Fruit fly)	924	focal adhesion [GO:0005925]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; sarcomere organization [GO:0045214]	focal adhesion [GO:0005925]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]	GO:0003779; GO:0005509; GO:0005925; GO:0030018; GO:0031532; GO:0045214; GO:0051015; GO:0051017	actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; sarcomere organization [GO:0045214]		blue	blue	NA	NA	NA	NA
TRINITY_DN22842_c0_g1_i1	Q3B7N2	ACTN1_BOVIN	100	78	0	0	1	234	674	751	1.20E-38	159.8	ACTN1_BOVIN	reviewed	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	Bos taurus (Bovine)	892	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]	GO:0001725; GO:0001726; GO:0005509; GO:0005523; GO:0005915; GO:0005923; GO:0005925; GO:0012506; GO:0016328; GO:0017166; GO:0030018; GO:0030027; GO:0030486; GO:0031252; GO:0042383; GO:0042803; GO:0043462; GO:0043495; GO:0045214; GO:0046928; GO:0048741; GO:0051015; GO:0051017; GO:0051234; GO:0051393; GO:0051764; GO:0090636; GO:0090637; GO:0097433; GO:1990357	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN9067_c0_g1_i3	P12814	ACTN1_HUMAN	95.9	513	21	0	1	1539	40	552	2.40E-289	995.3	ACTN1_HUMAN	reviewed	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	Homo sapiens (Human)	892	brush border [GO:0005903]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; vinculin binding [GO:0017166]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; negative regulation of cellular component movement [GO:0051271]; platelet degranulation [GO:0002576]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; vinculin binding [GO:0017166]	GO:0001725; GO:0001726; GO:0002576; GO:0003725; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005916; GO:0005925; GO:0007015; GO:0017166; GO:0030018; GO:0030220; GO:0030374; GO:0031093; GO:0031143; GO:0036344; GO:0042803; GO:0042981; GO:0042995; GO:0044325; GO:0048041; GO:0051015; GO:0051017; GO:0051271; GO:0051639; GO:0051764; GO:0070062; GO:0098978; GO:0099186	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; negative regulation of cellular component movement [GO:0051271]; platelet degranulation [GO:0002576]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN39623_c0_g1_i1	Q3B7N2	ACTN1_BOVIN	100	81	0	0	246	4	52	132	1.80E-37	156	ACTN1_BOVIN	reviewed	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	Bos taurus (Bovine)	892	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]	GO:0001725; GO:0001726; GO:0005509; GO:0005523; GO:0005915; GO:0005923; GO:0005925; GO:0012506; GO:0016328; GO:0017166; GO:0030018; GO:0030027; GO:0030486; GO:0031252; GO:0042383; GO:0042803; GO:0043462; GO:0043495; GO:0045214; GO:0046928; GO:0048741; GO:0051015; GO:0051017; GO:0051234; GO:0051393; GO:0051764; GO:0090636; GO:0090637; GO:0097433; GO:1990357	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN35436_c0_g1_i1	Q3B7N2	ACTN1_BOVIN	100	92	0	0	279	4	125	216	9.60E-51	200.3	ACTN1_BOVIN	reviewed	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	Bos taurus (Bovine)	892	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]	GO:0001725; GO:0001726; GO:0005509; GO:0005523; GO:0005915; GO:0005923; GO:0005925; GO:0012506; GO:0016328; GO:0017166; GO:0030018; GO:0030027; GO:0030486; GO:0031252; GO:0042383; GO:0042803; GO:0043462; GO:0043495; GO:0045214; GO:0046928; GO:0048741; GO:0051015; GO:0051017; GO:0051234; GO:0051393; GO:0051764; GO:0090636; GO:0090637; GO:0097433; GO:1990357	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN34806_c0_g1_i1	P12814	ACTN1_HUMAN	100	97	0	0	2	292	796	892	3.20E-50	198.7	ACTN1_HUMAN	reviewed	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	Homo sapiens (Human)	892	brush border [GO:0005903]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; vinculin binding [GO:0017166]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; negative regulation of cellular component movement [GO:0051271]; platelet degranulation [GO:0002576]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; vinculin binding [GO:0017166]	GO:0001725; GO:0001726; GO:0002576; GO:0003725; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005916; GO:0005925; GO:0007015; GO:0017166; GO:0030018; GO:0030220; GO:0030374; GO:0031093; GO:0031143; GO:0036344; GO:0042803; GO:0042981; GO:0042995; GO:0044325; GO:0048041; GO:0051015; GO:0051017; GO:0051271; GO:0051639; GO:0051764; GO:0070062; GO:0098978; GO:0099186	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; negative regulation of cellular component movement [GO:0051271]; platelet degranulation [GO:0002576]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN22842_c0_g1_i2	P57780	ACTN4_MOUSE	96.8	219	7	0	1	657	694	912	2.90E-120	432.6	ACTN4_MOUSE	reviewed	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	Actn4	Mus musculus (Mouse)	912	cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]	cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]	GO:0000977; GO:0001666; GO:0001725; GO:0001882; GO:0003713; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0015031; GO:0016604; GO:0030018; GO:0030050; GO:0030335; GO:0030374; GO:0030863; GO:0031143; GO:0031490; GO:0032991; GO:0033209; GO:0035257; GO:0035357; GO:0042803; GO:0042974; GO:0042981; GO:0043005; GO:0044325; GO:0044877; GO:0047485; GO:0048384; GO:0048471; GO:0048549; GO:0051015; GO:0051017; GO:0051271; GO:0051272; GO:0070830; GO:1900025; GO:1901224; GO:1902396; GO:1903506; GO:1990904	actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN22842_c0_g1_i3	O43707	ACTN4_HUMAN	96.1	181	7	0	1	543	693	873	1.30E-96	353.6	ACTN4_HUMAN	reviewed	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	ACTN4	Homo sapiens (Human)	911	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]	GO:0000977; GO:0001666; GO:0001725; GO:0001882; GO:0002576; GO:0003713; GO:0003723; GO:0003779; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005903; GO:0005911; GO:0005925; GO:0015031; GO:0016604; GO:0030018; GO:0030050; GO:0030335; GO:0030374; GO:0030863; GO:0031093; GO:0031143; GO:0031490; GO:0032417; GO:0032991; GO:0033209; GO:0035257; GO:0035357; GO:0042803; GO:0042974; GO:0042981; GO:0043005; GO:0044325; GO:0047485; GO:0048384; GO:0048471; GO:0048549; GO:0051015; GO:0051017; GO:0051271; GO:0051272; GO:0070062; GO:0070830; GO:1900025; GO:1901224; GO:1902396; GO:1903506; GO:1990904	actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN9067_c1_g1_i1	A5D7D1	ACTN4_BOVIN	100	85	0	0	258	4	172	256	1.10E-45	183.3	ACTN4_BOVIN	reviewed	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	ACTN4	Bos taurus (Bovine)	911	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; nuclear receptor transcription coactivator activity [GO:0030374]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein transport [GO:0015031]; retinoic acid receptor signaling pathway [GO:0048384]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; nuclear receptor transcription coactivator activity [GO:0030374]	GO:0003779; GO:0005509; GO:0005634; GO:0005737; GO:0005856; GO:0015031; GO:0030054; GO:0030374; GO:0035357; GO:0048384; GO:1990904	peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein transport [GO:0015031]; retinoic acid receptor signaling pathway [GO:0048384]		NA	NA	NA	NA	NA	NA
TRINITY_DN9067_c0_g1_i2	P57780	ACTN4_MOUSE	97.7	389	9	0	3	1169	260	648	1.30E-218	760	ACTN4_MOUSE	reviewed	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	Actn4	Mus musculus (Mouse)	912	cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]	cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]	GO:0000977; GO:0001666; GO:0001725; GO:0001882; GO:0003713; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0015031; GO:0016604; GO:0030018; GO:0030050; GO:0030335; GO:0030374; GO:0030863; GO:0031143; GO:0031490; GO:0032991; GO:0033209; GO:0035257; GO:0035357; GO:0042803; GO:0042974; GO:0042981; GO:0043005; GO:0044325; GO:0044877; GO:0047485; GO:0048384; GO:0048471; GO:0048549; GO:0051015; GO:0051017; GO:0051271; GO:0051272; GO:0070830; GO:1900025; GO:1901224; GO:1902396; GO:1903506; GO:1990904	actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN15155_c0_g2_i1	P35611	ADDA_HUMAN	99.6	224	1	0	672	1	121	344	2.40E-124	446	ADDA_HUMAN	reviewed	Alpha-adducin (Erythrocyte adducin subunit alpha)	ADD1 ADDA	Homo sapiens (Human)	737	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; IRE1-mediated unfolded protein response [GO:0036498]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]; transmembrane transport [GO:0055085]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transcription factor binding [GO:0008134]	GO:0000902; GO:0001701; GO:0003723; GO:0003779; GO:0005198; GO:0005200; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006884; GO:0008134; GO:0008290; GO:0014069; GO:0016604; GO:0020027; GO:0030036; GO:0030218; GO:0030507; GO:0032092; GO:0035264; GO:0036498; GO:0042803; GO:0044853; GO:0045296; GO:0046982; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0055085; GO:0071277; GO:1903142; GO:1903393	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cell volume homeostasis [GO:0006884]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; IRE1-mediated unfolded protein response [GO:0036498]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15155_c0_g2_i2	P35611	ADDA_HUMAN	99.6	239	1	0	720	4	105	343	6.80E-133	474.6	ADDA_HUMAN	reviewed	Alpha-adducin (Erythrocyte adducin subunit alpha)	ADD1 ADDA	Homo sapiens (Human)	737	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; IRE1-mediated unfolded protein response [GO:0036498]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]; transmembrane transport [GO:0055085]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transcription factor binding [GO:0008134]	GO:0000902; GO:0001701; GO:0003723; GO:0003779; GO:0005198; GO:0005200; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006884; GO:0008134; GO:0008290; GO:0014069; GO:0016604; GO:0020027; GO:0030036; GO:0030218; GO:0030507; GO:0032092; GO:0035264; GO:0036498; GO:0042803; GO:0044853; GO:0045296; GO:0046982; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0055085; GO:0071277; GO:1903142; GO:1903393	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cell volume homeostasis [GO:0006884]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; IRE1-mediated unfolded protein response [GO:0036498]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15155_c0_g1_i1	Q9QYC0	ADDA_MOUSE	100	117	0	0	353	3	201	317	1.20E-61	236.9	ADDA_MOUSE	reviewed	Alpha-adducin (Erythrocyte adducin subunit alpha)	Add1	Mus musculus (Mouse)	735	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; T cell receptor binding [GO:0042608]; transcription factor binding [GO:0008134]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; T cell receptor binding [GO:0042608]; transcription factor binding [GO:0008134]	GO:0000902; GO:0001701; GO:0005198; GO:0005200; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006884; GO:0008134; GO:0008290; GO:0014069; GO:0016020; GO:0016604; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0032092; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0044853; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0071277; GO:0071300; GO:1903142; GO:1903393	actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cell volume homeostasis [GO:0006884]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]		NA	NA	NA	NA	NA	NA
TRINITY_DN31259_c0_g1_i1	Q9DBF1	AL7A1_MOUSE	100	86	0	0	2	259	150	235	1.60E-44	179.5	AL7A1_MOUSE	reviewed	Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)	Aldh7a1 Ald7a1	Mus musculus (Mouse)	539	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]	GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0008802; GO:0019285; GO:0042802; GO:0043878	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN1760_c1_g1_i1	Q2KJC9	AL7A1_BOVIN	69.5	509	153	1	1623	97	33	539	4.80E-220	765.4	AL7A1_BOVIN	reviewed	Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)	ALDH7A1	Bos taurus (Bovine)	539	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]	GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0008802; GO:0019285; GO:0043878	glycine betaine biosynthetic process from choline [GO:0019285]		blue	blue	NA	NA	NA	NA
TRINITY_DN4369_c0_g2_i1	Q91642	PEPE_XENLA	63.9	133	47	1	109	507	6	137	2.90E-41	169.9	PEPE_XENLA	reviewed	Alpha-aspartyl dipeptidase (EC 3.4.13.21) (Asp-specific dipeptidase) (Dipeptidase E)	aad-a	Xenopus laevis (African clawed frog)	242	cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	cytoplasm [GO:0005737]	dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	GO:0005737; GO:0008236; GO:0016805			blue	blue	NA	NA	NA	NA
TRINITY_DN4369_c0_g2_i3	Q91642	PEPE_XENLA	59.8	112	44	1	109	444	6	116	3.00E-30	133.3	PEPE_XENLA	reviewed	Alpha-aspartyl dipeptidase (EC 3.4.13.21) (Asp-specific dipeptidase) (Dipeptidase E)	aad-a	Xenopus laevis (African clawed frog)	242	cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	cytoplasm [GO:0005737]	dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	GO:0005737; GO:0008236; GO:0016805			NA	NA	NA	NA	NA	NA
TRINITY_DN4369_c0_g1_i1	Q91642	PEPE_XENLA	64	89	32	0	5	271	151	239	1.70E-25	116.7	PEPE_XENLA	reviewed	Alpha-aspartyl dipeptidase (EC 3.4.13.21) (Asp-specific dipeptidase) (Dipeptidase E)	aad-a	Xenopus laevis (African clawed frog)	242	cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	cytoplasm [GO:0005737]	dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	GO:0005737; GO:0008236; GO:0016805			NA	NA	NA	NA	NA	NA
TRINITY_DN3315_c1_g1_i1	P61162	ACTZ_CANLF	100	376	0	0	31	1158	1	376	9.70E-220	763.8	ACTZ_CANLF	reviewed	Alpha-centractin (Centractin) (ARP1) (Actin-RPV) (Centrosome-associated actin homolog)	ACTR1A CTRN1	Canis lupus familiaris (Dog) (Canis familiaris)	376	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005815; GO:0005938			NA	NA	NA	NA	NA	NA
TRINITY_DN18709_c0_g2_i1	P61162	ACTZ_CANLF	67.7	164	49	1	3	494	217	376	4.80E-59	228.8	ACTZ_CANLF	reviewed	Alpha-centractin (Centractin) (ARP1) (Actin-RPV) (Centrosome-associated actin homolog)	ACTR1A CTRN1	Canis lupus familiaris (Dog) (Canis familiaris)	376	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005815; GO:0005938			NA	NA	NA	NA	NA	NA
TRINITY_DN35874_c0_g1_i1	P02504	CRYAA_CHICK	32	103	68	2	320	12	48	148	2.40E-05	51.2	CRYAA_CHICK	reviewed	Alpha-crystallin A chain	CRYAA	Gallus gallus (Chicken)	173	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]; actin filament organization [GO:0007015]; apoptotic process involved in morphogenesis [GO:0060561]; embryonic camera-type eye morphogenesis [GO:0048596]; lens fiber cell morphogenesis [GO:0070309]; microtubule-based process [GO:0007017]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; positive regulation of cell growth [GO:0030307]; positive regulation of protein phosphorylation [GO:0001934]; protein homooligomerization [GO:0051260]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to UV-A [GO:0070141]; tubulin complex assembly [GO:0007021]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0001934; GO:0005212; GO:0005634; GO:0005737; GO:0007005; GO:0007015; GO:0007017; GO:0007021; GO:0007601; GO:0010629; GO:0030307; GO:0032387; GO:0042542; GO:0042802; GO:0043066; GO:0043154; GO:0046872; GO:0048596; GO:0051082; GO:0051260; GO:0060561; GO:0070062; GO:0070141; GO:0070309	actin filament organization [GO:0007015]; apoptotic process involved in morphogenesis [GO:0060561]; embryonic camera-type eye morphogenesis [GO:0048596]; lens fiber cell morphogenesis [GO:0070309]; microtubule-based process [GO:0007017]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; positive regulation of cell growth [GO:0030307]; positive regulation of protein phosphorylation [GO:0001934]; protein homooligomerization [GO:0051260]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to UV-A [GO:0070141]; tubulin complex assembly [GO:0007021]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN19082_c0_g2_i1	P06733	ENOA_HUMAN	100	434	0	0	80	1381	1	434	4.70E-250	864.8	ENOA_HUMAN	reviewed	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)	ENO1 ENO1L1 MBPB1 MPB1	Homo sapiens (Human)	434	"cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to virus [GO:0009615]"	cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]	"cadherin binding [GO:0045296]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000015; GO:0000122; GO:0000287; GO:0000977; GO:0001227; GO:0003723; GO:0004634; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0009615; GO:0009986; GO:0010756; GO:0016020; GO:0030308; GO:0031430; GO:0032889; GO:0042803; GO:0045296; GO:0045892; GO:0045933; GO:0051020; GO:0061621; GO:0070062; GO:0099738; GO:1903298; GO:2001171	"canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to virus [GO:0009615]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19082_c0_g1_i1	P17182	ENOA_MOUSE	100	434	0	0	75	1376	1	434	3.90E-249	861.7	ENOA_MOUSE	reviewed	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 1) (Non-neural enolase) (NNE)	Eno1 Eno-1	Mus musculus (Mouse)	434	"cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; GTPase binding [GO:0051020]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; canonical glycolysis [GO:0061621]; cellular response to interleukin-7 [GO:0098761]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; positive regulation of binding [GO:0051099]; regulation of vacuole fusion, non-autophagic [GO:0032889]"	cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; GTPase binding [GO:0051020]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000015; GO:0000287; GO:0000977; GO:0001227; GO:0001701; GO:0003723; GO:0004634; GO:0005737; GO:0005829; GO:0005886; GO:0006096; GO:0009986; GO:0016020; GO:0019897; GO:0019899; GO:0030426; GO:0031072; GO:0032889; GO:0042802; GO:0042803; GO:0043005; GO:0043209; GO:0044877; GO:0045121; GO:0051020; GO:0051099; GO:0061621; GO:0097060; GO:0098761; GO:0099738	"canonical glycolysis [GO:0061621]; cellular response to interleukin-7 [GO:0098761]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; positive regulation of binding [GO:0051099]; regulation of vacuole fusion, non-autophagic [GO:0032889]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12850_c0_g1_i1	Q8RX86	AGAL2_ARATH	48.9	92	46	1	276	4	86	177	8.10E-21	100.9	AGAL2_ARATH	reviewed	Alpha-galactosidase 2 (AtAGAL2) (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase 2) (Melibiase)	AGAL2 At5g08370 F8L15.100	Arabidopsis thaliana (Mouse-ear cress)	396	apoplast [GO:0048046]; plant-type cell wall [GO:0009505]; secretory vesicle [GO:0099503]; alpha-galactosidase activity [GO:0004557]; raffinose alpha-galactosidase activity [GO:0052692]; carbohydrate metabolic process [GO:0005975]; cell wall organization [GO:0071555]; leaf morphogenesis [GO:0009965]; positive regulation of flower development [GO:0009911]; response to fungus [GO:0009620]	apoplast [GO:0048046]; plant-type cell wall [GO:0009505]; secretory vesicle [GO:0099503]	alpha-galactosidase activity [GO:0004557]; raffinose alpha-galactosidase activity [GO:0052692]	GO:0004557; GO:0005975; GO:0009505; GO:0009620; GO:0009911; GO:0009965; GO:0048046; GO:0052692; GO:0071555; GO:0099503	carbohydrate metabolic process [GO:0005975]; cell wall organization [GO:0071555]; leaf morphogenesis [GO:0009965]; positive regulation of flower development [GO:0009911]; response to fungus [GO:0009620]		NA	NA	NA	NA	NA	NA
TRINITY_DN38653_c0_g1_i1	P06280	AGAL_HUMAN	100	72	0	0	2	217	233	304	9.50E-38	156.8	AGAL_HUMAN	reviewed	Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (EC 3.2.1.47) (Melibiase) (Agalsidase)	GLA	Homo sapiens (Human)	429	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; galactosylgalactosylglucosylceramidase activity [GO:0017041]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; galactosylgalactosylglucosylceramidase activity [GO:0017041]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]	GO:0003824; GO:0004557; GO:0005102; GO:0005576; GO:0005737; GO:0005764; GO:0005794; GO:0006687; GO:0009311; GO:0016139; GO:0016787; GO:0016936; GO:0017041; GO:0035578; GO:0042803; GO:0043202; GO:0043312; GO:0045019; GO:0046477; GO:0046479; GO:0051001; GO:0052692; GO:0070062	glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN5500_c0_g1_i2	Q9ERA0	TFCP2_MOUSE	53.5	127	56	1	639	1010	67	193	4.10E-33	143.7	TFCP2_MOUSE	reviewed	Alpha-globin transcription factor CP2	Tfcp2 Tcfcp2	Mus musculus (Mouse)	502	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0000987; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008022; GO:0008134; GO:0032991; GO:0042789; GO:0043565; GO:0045893; GO:0045944; GO:1990837	"mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5500_c0_g1_i4	Q12800	TFCP2_HUMAN	58.6	210	82	2	639	1253	67	276	5.80E-66	253.1	TFCP2_HUMAN	reviewed	Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF)	TFCP2 LSF SEF	Homo sapiens (Human)	502	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008022; GO:0008134; GO:0032991; GO:0042789; GO:0043565; GO:0045944; GO:1990837	mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8237_c0_g1_i1	Q9D8F1	ALKB4_MOUSE	38.9	321	158	4	111	1073	13	295	1.70E-59	231.5	ALKB4_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-)	Alkbh4	Mus musculus (Mouse)	300	contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; actin binding [GO:0003779]; demethylase activity [GO:0032451]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; oxidative DNA demethylase activity [GO:0035516]; oxidoreductase activity [GO:0016491]; actomyosin structure organization [GO:0031032]; chromatin organization [GO:0006325]; cleavage furrow ingression [GO:0036090]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]; regulation of chromatin organization [GO:1902275]	contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]	actin binding [GO:0003779]; demethylase activity [GO:0032451]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; oxidative DNA demethylase activity [GO:0035516]; oxidoreductase activity [GO:0016491]	GO:0003779; GO:0005730; GO:0005737; GO:0006325; GO:0006482; GO:0016491; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0051213; GO:0070938; GO:0070989; GO:0080111; GO:1902275	actomyosin structure organization [GO:0031032]; chromatin organization [GO:0006325]; cleavage furrow ingression [GO:0036090]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]; regulation of chromatin organization [GO:1902275]		NA	NA	NA	NA	NA	NA
TRINITY_DN30235_c0_g1_i1	Q3KRA9	ALKB6_HUMAN	56.5	69	24	2	9	200	75	142	1.30E-12	73.2	ALKB6_HUMAN	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	ALKBH6 ABH6	Homo sapiens (Human)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN35545_c0_g1_i1	Q6IQE9	ALKB6_DANRE	49.4	87	44	0	21	281	148	234	8.30E-18	90.9	ALKB6_DANRE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	alkbh6 si:ch211-222c22.5	Danio rerio (Zebrafish) (Brachydanio rerio)	234	cytoplasm [GO:0005737]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i1	Q8K2U2	ALKB6_MOUSE	59.5	148	52	2	132	572	14	154	9.20E-49	195.3	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i10	Q8K2U2	ALKB6_MOUSE	59.5	148	52	2	138	578	14	154	9.30E-49	195.3	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i12	Q8K2U2	ALKB6_MOUSE	60.1	148	51	2	132	572	14	154	3.50E-49	196.8	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i2	Q8K2U2	ALKB6_MOUSE	60.1	148	51	2	132	572	14	154	3.40E-49	196.8	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i4	Q8K2U2	ALKB6_MOUSE	60.1	148	51	2	138	578	14	154	3.40E-49	196.8	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i6	Q8K2U2	ALKB6_MOUSE	62.9	132	49	0	138	533	14	145	2.30E-49	197.2	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i7	Q8K2U2	ALKB6_MOUSE	60.1	148	51	2	138	578	14	154	3.50E-49	196.8	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN7272_c0_g1_i8	Q8K2U2	ALKB6_MOUSE	61.4	140	53	1	90	506	14	153	2.00E-49	196.8	ALKB6_MOUSE	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	Alkbh6	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN19535_c0_g1_i1	Q3KRA9	ALKB6_HUMAN	91.9	99	8	0	33	329	52	150	3.30E-50	198.7	ALKB6_HUMAN	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	ALKBH6 ABH6	Homo sapiens (Human)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN19535_c0_g1_i1	Q3KRA9	ALKB6_HUMAN	95.5	22	1	0	1	66	21	42	9.40E-05	47.8	ALKB6_HUMAN	reviewed	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	ALKBH6 ABH6	Homo sapiens (Human)	238	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN1549_c0_g1_i1	Q9D6Z0	ALKB7_MOUSE	51.7	143	69	0	287	715	69	211	1.30E-34	148.3	ALKB7_MOUSE	reviewed	"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7)"	Alkbh7 Spata11	Mus musculus (Mouse)	221	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005739; GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445	cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]		NA	NA	NA	NA	NA	NA
TRINITY_DN1549_c0_g1_i2	Q2M2S8	ALKB7_BOVIN	51.4	173	84	0	228	746	39	211	3.30E-46	186.8	ALKB7_BOVIN	reviewed	"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7)"	ALKBH7	Bos taurus (Bovine)	221	mitochondrial matrix [GO:0005759]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]	mitochondrial matrix [GO:0005759]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445	cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]		NA	NA	NA	NA	NA	NA
TRINITY_DN26427_c0_g1_i1	P42236	KGSDH_BACSU	56.2	64	28	0	22	213	119	182	2.40E-15	82.4	KGSDH_BACSU	reviewed	"Alpha-ketoglutaric semialdehyde dehydrogenase (alphaKGSA dehydrogenase) (EC 1.2.1.26) (2,5-dioxovalerate dehydrogenase)"	gucD ycbD BSU02470	Bacillus subtilis (strain 168)	488	"2,5-dioxovalerate dehydrogenase (NADP+) activity [GO:0047533]"		"2,5-dioxovalerate dehydrogenase (NADP+) activity [GO:0047533]"	GO:0047533			NA	NA	NA	NA	NA	NA
TRINITY_DN32367_c0_g1_i1	Q1JUP4	KGSD1_AZOBR	54.1	74	34	0	6	227	135	208	1.40E-15	83.2	KGSD1_AZOBR	reviewed	"Alpha-ketoglutaric semialdehyde dehydrogenase 1 (alphaKGSA dehydrogenase 1) (EC 1.2.1.26) (2,5-dioxovalerate dehydrogenase 1) (2-oxoglutarate semialdehyde dehydrogenase 1) (KGSADH-I) (Succinate-semialdehyde dehydrogenase [NAD(+)]) (SSDH) (EC 1.2.1.24)"	araE	Azospirillum brasilense	481	"2,5-dioxovalerate dehydrogenase (NADP+) activity [GO:0047533]; NAD+ binding [GO:0070403]; NADP+ binding [GO:0070401]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; L-arabinose catabolic process to 2-oxoglutarate [GO:0019570]; protein tetramerization [GO:0051262]"		"2,5-dioxovalerate dehydrogenase (NADP+) activity [GO:0047533]; NAD+ binding [GO:0070403]; NADP+ binding [GO:0070401]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]"	GO:0004777; GO:0019570; GO:0047533; GO:0051262; GO:0070401; GO:0070403	L-arabinose catabolic process to 2-oxoglutarate [GO:0019570]; protein tetramerization [GO:0051262]		NA	NA	NA	NA	NA	NA
TRINITY_DN25522_c0_g1_i1	Q1JUP4	KGSD1_AZOBR	54.8	84	38	0	254	3	235	318	1.40E-19	96.7	KGSD1_AZOBR	reviewed	"Alpha-ketoglutaric semialdehyde dehydrogenase 1 (alphaKGSA dehydrogenase 1) (EC 1.2.1.26) (2,5-dioxovalerate dehydrogenase 1) (2-oxoglutarate semialdehyde dehydrogenase 1) (KGSADH-I) (Succinate-semialdehyde dehydrogenase [NAD(+)]) (SSDH) (EC 1.2.1.24)"	araE	Azospirillum brasilense	481	"2,5-dioxovalerate dehydrogenase (NADP+) activity [GO:0047533]; NAD+ binding [GO:0070403]; NADP+ binding [GO:0070401]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; L-arabinose catabolic process to 2-oxoglutarate [GO:0019570]; protein tetramerization [GO:0051262]"		"2,5-dioxovalerate dehydrogenase (NADP+) activity [GO:0047533]; NAD+ binding [GO:0070403]; NADP+ binding [GO:0070401]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]"	GO:0004777; GO:0019570; GO:0047533; GO:0051262; GO:0070401; GO:0070403	L-arabinose catabolic process to 2-oxoglutarate [GO:0019570]; protein tetramerization [GO:0051262]		NA	NA	NA	NA	NA	NA
TRINITY_DN2631_c0_g1_i1	C3YWU0	FUCO_BRAFL	58.7	433	172	3	1406	114	21	448	9.90E-163	574.7	FUCO_BRAFL	reviewed	Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)	BRAFLDRAFT_56888	Branchiostoma floridae (Florida lancelet) (Amphioxus)	449	extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]	extracellular region [GO:0005576]; lysosome [GO:0005764]	alpha-L-fucosidase activity [GO:0004560]	GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139	fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN2631_c0_g1_i3	C3YWU0	FUCO_BRAFL	57.1	457	185	4	1478	114	1	448	1.20E-163	577.8	FUCO_BRAFL	reviewed	Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)	BRAFLDRAFT_56888	Branchiostoma floridae (Florida lancelet) (Amphioxus)	449	extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]	extracellular region [GO:0005576]; lysosome [GO:0005764]	alpha-L-fucosidase activity [GO:0004560]	GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139	fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]		NA	NA	NA	NA	NA	NA
TRINITY_DN650_c0_g1_i2	Q24451	MAN2_DROME	48.8	203	94	3	601	2	744	939	2.40E-43	177.2	MAN2_DROME	reviewed	"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Golgi alpha-mannosidase IIa) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	alpha-Man-IIa GmII CG18802	Drosophila melanogaster (Fruit fly)	1108	"endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; encapsulation of foreign target [GO:0035010]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; rhodopsin biosynthetic process [GO:0016063]"	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0005783; GO:0005795; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016063; GO:0030246; GO:0035010; GO:0046872	encapsulation of foreign target [GO:0035010]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; rhodopsin biosynthetic process [GO:0016063]		NA	NA	NA	NA	NA	NA
TRINITY_DN650_c0_g1_i3	Q24451	MAN2_DROME	48.8	203	94	3	601	2	744	939	2.40E-43	177.2	MAN2_DROME	reviewed	"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Golgi alpha-mannosidase IIa) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	alpha-Man-IIa GmII CG18802	Drosophila melanogaster (Fruit fly)	1108	"endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; encapsulation of foreign target [GO:0035010]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; rhodopsin biosynthetic process [GO:0016063]"	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0005783; GO:0005795; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016063; GO:0030246; GO:0035010; GO:0046872	encapsulation of foreign target [GO:0035010]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; rhodopsin biosynthetic process [GO:0016063]		NA	NA	NA	NA	NA	NA
TRINITY_DN650_c0_g3_i1	Q16706	MA2A1_HUMAN	52.4	126	58	2	453	79	100	224	8.10E-34	144.8	MA2A1_HUMAN	reviewed	"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	MAN2A1 MANA2	Homo sapiens (Human)	1144	"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]"	cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0042803; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062	in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN4151_c0_g1_i3	Q9NTJ4	MA2C1_HUMAN	40.8	664	341	13	2035	80	408	1031	1.30E-125	451.8	MA2C1_HUMAN	reviewed	Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)	MAN2C1 MANA MANA1	Homo sapiens (Human)	1040	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]		NA	NA	NA	NA	NA	NA
TRINITY_DN4151_c0_g1_i6	Q9NTJ4	MA2C1_HUMAN	40.4	374	184	7	1226	129	408	750	2.00E-68	261.2	MA2C1_HUMAN	reviewed	Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)	MAN2C1 MANA MANA1	Homo sapiens (Human)	1040	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]		NA	NA	NA	NA	NA	NA
TRINITY_DN29992_c0_g1_i1	Q9NTJ4	MA2C1_HUMAN	100	70	0	0	1	210	708	777	4.20E-35	147.9	MA2C1_HUMAN	reviewed	Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)	MAN2C1 MANA MANA1	Homo sapiens (Human)	1040	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]		NA	NA	NA	NA	NA	NA
TRINITY_DN650_c0_g3_i2	Q8BRK9	MA2A2_MOUSE	52.2	624	287	6	2000	132	110	723	4.70E-195	682.6	MA2A2_MOUSE	reviewed	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	Man2a2 Mana2x	Mus musculus (Mouse)	1152	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN38499_c0_g1_i1	P49641	MA2A2_HUMAN	100	97	0	0	291	1	436	532	5.70E-54	211.1	MA2A2_HUMAN	reviewed	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	MAN2A2 MANA2X	Homo sapiens (Human)	1150	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN5388_c3_g3_i1	Q8BRK9	MA2A2_MOUSE	36.9	969	547	18	29	2863	161	1089	6.00E-170	599.7	MA2A2_MOUSE	reviewed	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	Man2a2 Mana2x	Mus musculus (Mouse)	1152	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN5388_c3_g3_i2	Q8BRK9	MA2A2_MOUSE	35.5	860	491	18	91	2598	270	1089	1.10E-133	479.2	MA2A2_MOUSE	reviewed	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	Man2a2 Mana2x	Mus musculus (Mouse)	1152	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN4151_c0_g1_i5	Q54K67	MANG_DICDI	38.1	194	109	4	640	77	895	1083	1.60E-30	134.4	MANG_DICDI	reviewed	Alpha-mannosidase G (EC 3.2.1.24)	manG DDB_G0287577	Dictyostelium discoideum (Slime mold)	1087	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]		alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]		NA	NA	NA	NA	NA	NA
TRINITY_DN4212_c0_g1_i1	P70473	AMACR_RAT	48.6	212	103	3	81	707	174	382	3.70E-49	196.4	AMACR_RAT	reviewed	Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase)	Amacr	Rattus norvegicus (Rat)	382	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008410	bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]		brown	brown	NA	NA	NA	NA
TRINITY_DN40934_c0_g1_i1	P70473	AMACR_RAT	47.6	63	33	0	13	201	106	168	7.40E-13	73.9	AMACR_RAT	reviewed	Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase)	Amacr	Rattus norvegicus (Rat)	382	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008410	bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN18995_c0_g1_i1	Q9UHK6	AMACR_HUMAN	66.7	72	24	0	223	8	65	136	1.20E-22	106.7	AMACR_HUMAN	reviewed	Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase)	AMACR	Homo sapiens (Human)	382	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; protein targeting to peroxisome [GO:0006625]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0005886; GO:0006625; GO:0006699; GO:0008111; GO:0008206; GO:0008410; GO:0033540; GO:0043231	bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN4212_c0_g1_i3	O09174	AMACR_MOUSE	57.4	385	156	4	51	1193	1	381	2.50E-119	430.3	AMACR_MOUSE	reviewed	Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase)	Amacr Macr1	Mus musculus (Mouse)	381	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008300; GO:0008410; GO:0043231	bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]		NA	NA	NA	NA	NA	NA
TRINITY_DN26919_c0_g1_i1	O09174	AMACR_MOUSE	50	86	42	1	1	258	183	267	1.10E-16	87	AMACR_MOUSE	reviewed	Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase)	Amacr Macr1	Mus musculus (Mouse)	381	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	alpha-methylacyl-CoA racemase activity [GO:0008111]; CoA-transferase activity [GO:0008410]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008300; GO:0008410; GO:0043231	bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300]		NA	NA	NA	NA	NA	NA
TRINITY_DN37495_c0_g1_i1	P17050	NAGAB_HUMAN	100	93	0	0	280	2	185	277	5.40E-54	211.1	NAGAB_HUMAN	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Homo sapiens (Human)	411	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; protein homodimerization activity [GO:0042803]; carbohydrate catabolic process [GO:0016052]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; protein homodimerization activity [GO:0042803]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016052; GO:0016139; GO:0019377; GO:0042803; GO:0046477; GO:0070062	carbohydrate catabolic process [GO:0016052]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN271_c0_g1_i1	Q90744	NAGAB_CHICK	56.3	387	161	4	1368	214	1	381	4.60E-131	469.5	NAGAB_CHICK	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN271_c0_g1_i2	Q90744	NAGAB_CHICK	57.2	187	73	3	569	15	1	182	2.20E-59	230.3	NAGAB_CHICK	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN271_c0_g1_i4	Q90744	NAGAB_CHICK	51.7	236	107	3	918	214	152	381	3.80E-65	250	NAGAB_CHICK	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN271_c0_g1_i5	Q90744	NAGAB_CHICK	59.2	201	76	3	593	3	1	199	5.80E-71	268.9	NAGAB_CHICK	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN271_c0_g1_i6	Q90744	NAGAB_CHICK	56	389	159	6	1368	214	1	381	1.30E-128	461.5	NAGAB_CHICK	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN27783_c0_g1_i1	Q90744	NAGAB_CHICK	60.3	315	119	3	977	51	1	315	2.10E-114	413.7	NAGAB_CHICK	reviewed	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	NAGA	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3418_c0_g1_i1	P54802	ANAG_HUMAN	44	150	83	1	65	511	375	524	4.50E-33	142.5	ANAG_HUMAN	reviewed	Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]	NAGLU UFHSD1	Homo sapiens (Human)	743	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	alpha-N-acetylglucosaminidase activity [GO:0004561]	GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062	cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]		NA	NA	NA	NA	NA	NA
TRINITY_DN3418_c0_g1_i2	P54802	ANAG_HUMAN	44	323	180	1	68	1033	202	524	1.80E-86	320.9	ANAG_HUMAN	reviewed	Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]	NAGLU UFHSD1	Homo sapiens (Human)	743	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	alpha-N-acetylglucosaminidase activity [GO:0004561]	GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062	cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]		NA	NA	NA	NA	NA	NA
TRINITY_DN3418_c0_g1_i3	P54802	ANAG_HUMAN	44	498	267	6	152	1621	31	524	3.40E-124	446.8	ANAG_HUMAN	reviewed	Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]	NAGLU UFHSD1	Homo sapiens (Human)	743	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	alpha-N-acetylglucosaminidase activity [GO:0004561]	GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062	cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]		NA	NA	NA	NA	NA	NA
TRINITY_DN16105_c0_g1_i2	P54802	ANAG_HUMAN	34.7	190	121	3	2	568	549	736	4.80E-22	106.3	ANAG_HUMAN	reviewed	Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]	NAGLU UFHSD1	Homo sapiens (Human)	743	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	alpha-N-acetylglucosaminidase activity [GO:0004561]	GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062	cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548]		NA	NA	NA	NA	NA	NA
TRINITY_DN39110_c0_g1_i1	Q9NVD7	PARVA_HUMAN	100	136	0	0	2	409	227	362	1.30E-72	273.5	PARVA_HUMAN	reviewed	Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2)	PARVA MXRA2	Homo sapiens (Human)	372	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	GO:0002040; GO:0003148; GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0031532; GO:0034113; GO:0034446; GO:0045296; GO:0060271; GO:0070252; GO:0071670	actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN203_c0_g1_i3	Q9D3D0	TTPAL_MOUSE	36.7	256	156	4	1011	250	32	283	2.90E-42	174.1	TTPAL_MOUSE	reviewed	Alpha-tocopherol transfer protein-like	Ttpal	Mus musculus (Mouse)	343	phosphatidylinositol bisphosphate binding [GO:1902936]		phosphatidylinositol bisphosphate binding [GO:1902936]	GO:1902936			NA	NA	NA	NA	NA	NA
TRINITY_DN203_c0_g1_i5	Q9BTX7	TTPAL_HUMAN	34.5	255	163	3	1011	250	31	282	1.90E-41	171.4	TTPAL_HUMAN	reviewed	Alpha-tocopherol transfer protein-like	TTPAL C20orf121	Homo sapiens (Human)	342	membrane [GO:0016020]; phosphatidylinositol bisphosphate binding [GO:1902936]	membrane [GO:0016020]	phosphatidylinositol bisphosphate binding [GO:1902936]	GO:0016020; GO:1902936			NA	NA	NA	NA	NA	NA
TRINITY_DN203_c0_g1_i6	Q9BTX7	TTPAL_HUMAN	28	186	130	3	770	216	31	213	7.40E-17	89.4	TTPAL_HUMAN	reviewed	Alpha-tocopherol transfer protein-like	TTPAL C20orf121	Homo sapiens (Human)	342	membrane [GO:0016020]; phosphatidylinositol bisphosphate binding [GO:1902936]	membrane [GO:0016020]	phosphatidylinositol bisphosphate binding [GO:1902936]	GO:0016020; GO:1902936			NA	NA	NA	NA	NA	NA
TRINITY_DN203_c0_g1_i7	Q9BTX7	TTPAL_HUMAN	34.1	255	164	3	1011	250	31	282	5.50E-41	169.9	TTPAL_HUMAN	reviewed	Alpha-tocopherol transfer protein-like	TTPAL C20orf121	Homo sapiens (Human)	342	membrane [GO:0016020]; phosphatidylinositol bisphosphate binding [GO:1902936]	membrane [GO:0016020]	phosphatidylinositol bisphosphate binding [GO:1902936]	GO:0016020; GO:1902936			NA	NA	NA	NA	NA	NA
TRINITY_DN4634_c0_g1_i1	Q9D3D0	TTPAL_MOUSE	33.3	273	178	3	22	837	11	280	5.10E-37	156.4	TTPAL_MOUSE	reviewed	Alpha-tocopherol transfer protein-like	Ttpal	Mus musculus (Mouse)	343	phosphatidylinositol bisphosphate binding [GO:1902936]		phosphatidylinositol bisphosphate binding [GO:1902936]	GO:1902936			NA	NA	NA	NA	NA	NA
TRINITY_DN4634_c0_g1_i2	Q9D3D0	TTPAL_MOUSE	34.5	261	167	3	69	848	23	280	1.10E-36	155.2	TTPAL_MOUSE	reviewed	Alpha-tocopherol transfer protein-like	Ttpal	Mus musculus (Mouse)	343	phosphatidylinositol bisphosphate binding [GO:1902936]		phosphatidylinositol bisphosphate binding [GO:1902936]	GO:1902936			NA	NA	NA	NA	NA	NA
TRINITY_DN4403_c2_g1_i3	Q7PNM6	ATAT_ANOGA	48.6	144	68	3	478	56	1	141	8.90E-27	121.7	ATAT_ANOGA	reviewed	Alpha-tubulin N-acetyltransferase (Alpha-TAT) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)	AGAP005828	Anopheles gambiae (African malaria mosquito)	483	microtubule [GO:0005874]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]	microtubule [GO:0005874]	tubulin N-acetyltransferase activity [GO:0019799]	GO:0005874; GO:0019799; GO:0048666; GO:0070507; GO:0071929	alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]		brown	brown	1	NA	NA	NA
TRINITY_DN4403_c2_g1_i1	Q16Y34	ATAT_AEDAE	48.7	191	94	2	656	90	1	189	3.80E-46	186.4	ATAT_AEDAE	reviewed	Alpha-tubulin N-acetyltransferase (Alpha-TAT) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)	AAEL008679	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	272	microtubule [GO:0005874]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]	microtubule [GO:0005874]	tubulin N-acetyltransferase activity [GO:0019799]	GO:0005874; GO:0019799; GO:0048666; GO:0070507; GO:0071929	alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN4403_c2_g1_i4	Q16Y34	ATAT_AEDAE	43.5	230	125	3	885	205	1	228	7.30E-45	182.6	ATAT_AEDAE	reviewed	Alpha-tubulin N-acetyltransferase (Alpha-TAT) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)	AAEL008679	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	272	microtubule [GO:0005874]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]	microtubule [GO:0005874]	tubulin N-acetyltransferase activity [GO:0019799]	GO:0005874; GO:0019799; GO:0048666; GO:0070507; GO:0071929	alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]		NA	NA	NA	NA	NA	NA
TRINITY_DN4403_c2_g1_i6	Q16Y34	ATAT_AEDAE	43.5	230	125	3	936	256	1	228	7.60E-45	182.6	ATAT_AEDAE	reviewed	Alpha-tubulin N-acetyltransferase (Alpha-TAT) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)	AAEL008679	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	272	microtubule [GO:0005874]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]	microtubule [GO:0005874]	tubulin N-acetyltransferase activity [GO:0019799]	GO:0005874; GO:0019799; GO:0048666; GO:0070507; GO:0071929	alpha-tubulin acetylation [GO:0071929]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507]		NA	NA	NA	NA	NA	NA
TRINITY_DN31852_c0_g1_i1	Q8K341	ATAT_MOUSE	97.5	79	2	0	1	237	80	158	1.90E-39	162.5	ATAT_MOUSE	reviewed	Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)	Atat1 Mec17	Mus musculus (Mouse)	421	"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]"	axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]	"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]"	GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0019799; GO:0021542; GO:0030424; GO:0045598; GO:0048666; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227	alpha-tubulin acetylation [GO:0071929]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4403_c2_g1_i5	Q5SQI0	ATAT_HUMAN	40.2	82	46	2	338	102	1	82	2.60E-07	56.6	ATAT_HUMAN	reviewed	Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)	ATAT1 C6orf134 MEC17 Nbla00487	Homo sapiens (Human)	421	"axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]"	axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]	"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]"	GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0019799; GO:0021542; GO:0030424; GO:0045598; GO:0048666; GO:0060271; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227	alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6121_c0_g1_i3	Q5AW25	AGDD_EMENI	34.8	112	59	5	463	155	588	694	2.90E-06	53.9	AGDD_EMENI	reviewed	Alpha-xylosidase (EC 3.2.1.177)	agdD axlA AN7505	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	780	"extracellular region [GO:0005576]; alpha-D-xyloside xylohydrolase [GO:0061634]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; xyloglucan metabolic process [GO:0010411]"	extracellular region [GO:0005576]	"alpha-D-xyloside xylohydrolase [GO:0061634]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005576; GO:0010411; GO:0030246; GO:0061634	xyloglucan metabolic process [GO:0010411]		NA	NA	NA	NA	NA	NA
TRINITY_DN3880_c0_g1_i4	Q96Q42	ALS2_HUMAN	59.5	42	17	0	174	49	1172	1213	7.80E-09	60.8	ALS2_HUMAN	reviewed	Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein)	ALS2 ALS2CR6 KIAA1563	Homo sapiens (Human)	1657	"centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]"	centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]	GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005096; GO:0005634; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035022; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048365; GO:0048812; GO:0051036; GO:0051260	"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3880_c0_g1_i3	Q920R0	ALS2_MOUSE	38.9	892	501	12	2669	108	765	1650	4.20E-178	626.7	ALS2_MOUSE	reviewed	Alsin (Amyotrophic lateral sclerosis 2 protein homolog)	Als2	Mus musculus (Mouse)	1651	"axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]"	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]	GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048365; GO:0048812; GO:0051036; GO:0051260	"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26423_c0_g1_i1	Q06203	PUR1_HUMAN	100	117	0	0	1	351	183	299	1.20E-63	243.4	PUR1_HUMAN	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)	PPAT GPAT	Homo sapiens (Human)	517	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0000082; GO:0001822; GO:0004044; GO:0005829; GO:0006164; GO:0006189; GO:0006543; GO:0007595; GO:0009113; GO:0009116; GO:0009168; GO:0031100; GO:0032869; GO:0035690; GO:0042802; GO:0046872; GO:0051539; GO:0060135	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN32712_c0_g1_i1	P35433	PUR1_RAT	56.7	254	86	2	787	32	109	340	6.20E-79	295.4	PUR1_RAT	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)	Ppat	Rattus norvegicus (Rat)	517	"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]; ribose phosphate metabolic process [GO:0019693]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0000082; GO:0001822; GO:0004044; GO:0006164; GO:0006189; GO:0006543; GO:0007595; GO:0009113; GO:0009116; GO:0009168; GO:0019693; GO:0031100; GO:0032869; GO:0035690; GO:0042493; GO:0042802; GO:0046872; GO:0051539; GO:0060135	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]; ribose phosphate metabolic process [GO:0019693]		NA	NA	NA	NA	NA	NA
TRINITY_DN32712_c0_g1_i3	P35433	PUR1_RAT	56.9	255	86	2	1	759	108	340	9.50E-80	298.1	PUR1_RAT	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)	Ppat	Rattus norvegicus (Rat)	517	"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]; ribose phosphate metabolic process [GO:0019693]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0000082; GO:0001822; GO:0004044; GO:0006164; GO:0006189; GO:0006543; GO:0007595; GO:0009113; GO:0009116; GO:0009168; GO:0019693; GO:0031100; GO:0032869; GO:0035690; GO:0042493; GO:0042802; GO:0046872; GO:0051539; GO:0060135	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]; ribose phosphate metabolic process [GO:0019693]		NA	NA	NA	NA	NA	NA
TRINITY_DN32712_c0_g1_i4	P28173	PUR1_CHICK	57.9	413	138	4	1	1197	108	498	1.50E-136	488.4	PUR1_CHICK	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)	PPAT GPAT	Gallus gallus (Chicken)	510	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]"	GO:0004044; GO:0005829; GO:0006189; GO:0006541; GO:0009113; GO:0009116; GO:0046872; GO:0051539	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN26310_c0_g1_i1	Q06203	PUR1_HUMAN	100	86	0	0	259	2	385	470	7.60E-42	170.6	PUR1_HUMAN	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)	PPAT GPAT	Homo sapiens (Human)	517	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0000082; GO:0001822; GO:0004044; GO:0005829; GO:0006164; GO:0006189; GO:0006543; GO:0007595; GO:0009113; GO:0009116; GO:0009168; GO:0031100; GO:0032869; GO:0035690; GO:0042802; GO:0046872; GO:0051539; GO:0060135	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; G1/S transition of mitotic cell cycle [GO:0000082]; glutamine catabolic process [GO:0006543]; kidney development [GO:0001822]; lactation [GO:0007595]; maternal process involved in female pregnancy [GO:0060135]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN30670_c0_g1_i1	Q9L6B8	PUR1_PASMU	73.9	111	29	0	5	337	327	437	2.60E-42	172.6	PUR1_PASMU	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPATase)	purF PM0701	Pasteurella multocida (strain Pm70)	504	amidophosphoribosyltransferase activity [GO:0004044]; magnesium ion binding [GO:0000287]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]		amidophosphoribosyltransferase activity [GO:0004044]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004044; GO:0006189; GO:0006541; GO:0009113; GO:0009116	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN33402_c0_g1_i1	P77935	PUR1_RHIEC	64.1	103	36	1	1	306	333	435	3.20E-31	135.6	PUR1_RHIEC	reviewed	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPATase)	purF RHE_CH01428	Rhizobium etli (strain CFN 42 / ATCC 51251)	496	amidophosphoribosyltransferase activity [GO:0004044]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]		amidophosphoribosyltransferase activity [GO:0004044]	GO:0004044; GO:0006189; GO:0006541; GO:0009113; GO:0009116	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN13744_c0_g1_i2	Q9SVG0	AVT3C_ARATH	41.2	194	100	5	869	294	250	431	3.30E-31	137.1	AVT3C_ARATH	reviewed	Amino acid transporter AVT3C (AtAvt3C) (Aromatic and neutral amino acid transporter-like protein 2)	AVT3C At4g38250 F22I13.20	Arabidopsis thaliana (Mouse-ear cress)	436	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]; neutral amino acid transport [GO:0015804]	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]	amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0003333; GO:0005774; GO:0015171; GO:0015175; GO:0015804; GO:0016021	amino acid transmembrane transport [GO:0003333]; neutral amino acid transport [GO:0015804]		NA	NA	NA	NA	NA	NA
TRINITY_DN3100_c0_g1_i1	O54873	AIMP1_CRIGR	74.7	91	23	0	275	3	197	287	3.10E-33	142.1	AIMP1_CRIGR	reviewed	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-II) (Small inducible cytokine subfamily E member 1)]	AIMP1 SCYE1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	359	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; tRNA binding [GO:0000049]	GO:0000049; GO:0001525; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0017101; GO:0070094	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3100_c0_g1_i2	O54873	AIMP1_CRIGR	74.7	91	23	0	275	3	197	287	3.10E-33	142.1	AIMP1_CRIGR	reviewed	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-II) (Small inducible cytokine subfamily E member 1)]	AIMP1 SCYE1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	359	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; tRNA binding [GO:0000049]	GO:0000049; GO:0001525; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0017101; GO:0070094	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN35248_c0_g1_i1	Q99JW2	ACY1_MOUSE	100	73	0	0	220	2	11	83	7.30E-38	157.1	ACY1_MOUSE	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	Acy1	Mus musculus (Mouse)	408	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN33627_c0_g1_i1	Q03154	ACY1_HUMAN	100	78	0	0	234	1	314	391	5.20E-42	171	ACY1_HUMAN	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	ACY1	Homo sapiens (Human)	408	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005829; GO:0006520; GO:0006805; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN28424_c0_g1_i1	Q99JW2	ACY1_MOUSE	50	68	34	0	209	6	318	385	5.80E-16	84.3	ACY1_MOUSE	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	Acy1	Mus musculus (Mouse)	408	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN4005_c0_g1_i1	Q99JW2	ACY1_MOUSE	55	300	134	1	64	963	7	305	2.50E-93	343.6	ACY1_MOUSE	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	Acy1	Mus musculus (Mouse)	408	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN4005_c0_g1_i3	Q99JW2	ACY1_MOUSE	56.1	380	165	2	64	1203	7	384	1.80E-122	440.7	ACY1_MOUSE	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	Acy1	Mus musculus (Mouse)	408	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN4005_c0_g1_i4	P37111	ACY1_PIG	54.9	113	50	1	3	341	147	258	2.20E-26	119.8	ACY1_PIG	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	ACY1	Sus scrofa (Pig)	407	cytoplasm [GO:0005737]; aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]	aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0046872	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN4005_c0_g1_i5	Q99JW2	ACY1_MOUSE	56.4	140	60	1	64	483	7	145	9.30E-42	171.4	ACY1_MOUSE	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	Acy1	Mus musculus (Mouse)	408	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN22801_c0_g1_i1	Q03154	ACY1_HUMAN	96.3	81	3	0	2	244	99	179	8.70E-40	163.7	ACY1_HUMAN	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	ACY1	Homo sapiens (Human)	408	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005829; GO:0006520; GO:0006805; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN22801_c0_g1_i2	Q99JW2	ACY1_MOUSE	100	86	0	0	2	259	99	184	2.80E-44	178.7	ACY1_MOUSE	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	Acy1	Mus musculus (Mouse)	408	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN28468_c0_g1_i1	P37111	ACY1_PIG	52.6	97	43	3	285	1	60	155	2.30E-23	109.4	ACY1_PIG	reviewed	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	ACY1	Sus scrofa (Pig)	407	cytoplasm [GO:0005737]; aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]	cytoplasm [GO:0005737]	aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]	GO:0004046; GO:0005737; GO:0006520; GO:0046872	cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN26954_c0_g1_i1	Q0I682	GCST_SYNS3	47.2	53	28	0	202	44	312	364	5.60E-06	51.6	GCST_SYNS3	reviewed	Aminomethyltransferase (EC 2.1.2.10) (Glycine cleavage system T protein)	gcvT sync_2853	Synechococcus sp. (strain CC9311)	369	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]		aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0008483; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN37414_c0_g1_i1	P48728	GCST_HUMAN	100	80	0	0	3	242	35	114	3.20E-42	171.8	GCST_HUMAN	reviewed	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)"	AMT GCST	Homo sapiens (Human)	403	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0005654; GO:0005739; GO:0005759; GO:0006546; GO:0008483; GO:0019464	glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN24178_c0_g1_i1	Q54DD3	GCST_DICDI	55.9	111	43	1	315	1	192	302	1.50E-26	120.2	GCST_DICDI	reviewed	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)"	gcvT DDB_G0292326	Dictyostelium discoideum (Slime mold)	403	mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]	mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0005739; GO:0008483; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	1
TRINITY_DN4357_c0_g1_i1	P28337	GCST_CHICK	64.9	57	20	0	39	209	336	392	1.10E-12	73.9	GCST_CHICK	reviewed	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)"	AMT	Gallus gallus (Chicken)	392	mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]	mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0005739; GO:0008483; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN4357_c0_g1_i2	P28337	GCST_CHICK	56.5	393	167	4	100	1272	2	392	1.20E-114	414.8	GCST_CHICK	reviewed	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)"	AMT	Gallus gallus (Chicken)	392	mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]	mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0005739; GO:0008483; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN4357_c0_g1_i3	P28337	GCST_CHICK	55	342	150	4	100	1119	2	341	1.10E-95	351.7	GCST_CHICK	reviewed	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)"	AMT	Gallus gallus (Chicken)	392	mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]	mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0005739; GO:0008483; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN39124_c0_g1_i1	P48015	GCST_YEAST	63.4	71	26	0	213	1	213	283	4.80E-18	91.3	GCST_YEAST	reviewed	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT) (Glycine decarboxylase complex subunit T)"	GCV1 YDR019C YD9335.05C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	400	glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; glycine metabolic process [GO:0006544]; one-carbon metabolic process [GO:0006730]; oxidation-reduction process [GO:0055114]	glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]	GO:0004047; GO:0005739; GO:0005960; GO:0006544; GO:0006546; GO:0006730; GO:0008483; GO:0019464; GO:0055114	glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; glycine metabolic process [GO:0006544]; one-carbon metabolic process [GO:0006730]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN33008_c0_g1_i1	P32454	APE2_YEAST	46.5	114	53	1	351	10	437	542	1.80E-22	106.7	APE2_YEAST	reviewed	"Aminopeptidase 2, mitochondrial (AP-II) (Aminopeptidase II) (EC 3.4.11.-) (YscII)"	APE2 LAP1 YKL157W YKL158W YKL611 YKL612	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	952	cell wall-bounded periplasmic space [GO:0030287]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cell wall-bounded periplasmic space [GO:0030287]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0006508; GO:0008270; GO:0030287; GO:0042277; GO:0043171; GO:0070006	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN36365_c0_g1_i1	Q8VZH2	APM1_ARATH	64.3	126	45	0	396	19	230	355	1.20E-46	187.2	APM1_ARATH	reviewed	Aminopeptidase M1 (EC 3.4.11.2) (Alpha-aminoacylpeptide hydrolase)	APM1 At4g33090 F4I10_20	Arabidopsis thaliana (Mouse-ear cress)	879	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; N-1-naphthylphthalamic acid binding [GO:0010013]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; auxin polar transport [GO:0009926]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; N-1-naphthylphthalamic acid binding [GO:0010013]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006508; GO:0008270; GO:0009926; GO:0010013; GO:0031090; GO:0042277; GO:0043171; GO:0070006	auxin polar transport [GO:0009926]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN31755_c0_g1_i1	Q8VZH2	APM1_ARATH	56.9	65	28	0	30	224	223	287	1.10E-15	83.6	APM1_ARATH	reviewed	Aminopeptidase M1 (EC 3.4.11.2) (Alpha-aminoacylpeptide hydrolase)	APM1 At4g33090 F4I10_20	Arabidopsis thaliana (Mouse-ear cress)	879	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; N-1-naphthylphthalamic acid binding [GO:0010013]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; auxin polar transport [GO:0009926]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; N-1-naphthylphthalamic acid binding [GO:0010013]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006508; GO:0008270; GO:0009926; GO:0010013; GO:0031090; GO:0042277; GO:0043171; GO:0070006	auxin polar transport [GO:0009926]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN2821_c0_g1_i2	P79098	AMPN_BOVIN	44	616	314	11	1873	77	72	673	9.50E-137	488.8	AMPN_BOVIN	reviewed	Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	ANPEP APN	Bos taurus (Bovine)	965	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN16652_c0_g1_i1	P79098	AMPN_BOVIN	33.9	112	72	2	337	8	853	964	2.60E-13	76.3	AMPN_BOVIN	reviewed	Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	ANPEP APN	Bos taurus (Bovine)	965	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN29896_c0_g1_i1	P91887	AMPN_PLUXY	38	92	55	1	281	12	539	630	6.10E-13	74.7	AMPN_PLUXY	reviewed	Aminopeptidase N (AP-N) (EC 3.4.11.2) (Apn1) (Microsomal aminopeptidase)	APN1	Plutella xylostella (Diamondback moth) (Plutella maculipennis)	946	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0031225			NA	NA	NA	NA	NA	NA
TRINITY_DN25698_c0_g1_i1	P91887	AMPN_PLUXY	47.9	96	50	0	20	307	548	643	7.80E-22	104.4	AMPN_PLUXY	reviewed	Aminopeptidase N (AP-N) (EC 3.4.11.2) (Apn1) (Microsomal aminopeptidase)	APN1	Plutella xylostella (Diamondback moth) (Plutella maculipennis)	946	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0031225			NA	NA	NA	NA	NA	NA
TRINITY_DN33801_c0_g1_i1	P91887	AMPN_PLUXY	52.2	69	33	0	21	227	576	644	6.50E-13	74.3	AMPN_PLUXY	reviewed	Aminopeptidase N (AP-N) (EC 3.4.11.2) (Apn1) (Microsomal aminopeptidase)	APN1	Plutella xylostella (Diamondback moth) (Plutella maculipennis)	946	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0031225			NA	NA	NA	NA	NA	NA
TRINITY_DN40420_c0_g1_i1	P79171	AMPN_FELCA	42.9	56	32	0	20	187	789	844	2.20E-10	65.9	AMPN_FELCA	reviewed	Aminopeptidase N (AP-N) (fAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	ANPEP APN	Felis catus (Cat) (Felis silvestris catus)	967	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2821_c0_g1_i1	P15144	AMPN_HUMAN	42.3	907	487	16	2746	86	75	965	4.20E-202	706.4	AMPN_HUMAN	reviewed	Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)	ANPEP APN CD13 PEPN	Homo sapiens (Human)	967	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; neutrophil degranulation [GO:0043312]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0043312; GO:0070006; GO:0070062	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; neutrophil degranulation [GO:0043312]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32904_c0_g1_i1	P15144	AMPN_HUMAN	35.8	212	127	6	620	3	702	910	4.00E-33	142.9	AMPN_HUMAN	reviewed	Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)	ANPEP APN CD13 PEPN	Homo sapiens (Human)	967	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; neutrophil degranulation [GO:0043312]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0043312; GO:0070006; GO:0070062	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; neutrophil degranulation [GO:0043312]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN39117_c0_g1_i1	P97449	AMPN_MOUSE	47.9	48	25	0	94	237	507	554	2.70E-06	52.8	AMPN_MOUSE	reviewed	Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13)	Anpep Lap-1 Lap1	Mus musculus (Mouse)	966	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0031526; GO:0035814; GO:0042277; GO:0043171; GO:0070006; GO:0070062	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4226_c2_g1_i1	P15145	AMPN_PIG	41.8	55	31	1	33	197	832	885	7.40E-06	51.2	AMPN_PIG	reviewed	Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13)	ANPEP	Sus scrofa (Pig)	963	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36331_c0_g1_i2	P15145	AMPN_PIG	47	66	34	1	34	228	202	267	2.00E-09	62.8	AMPN_PIG	reviewed	Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13)	ANPEP	Sus scrofa (Pig)	963	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN27506_c0_g1_i1	P15145	AMPN_PIG	63	46	17	0	173	36	202	247	1.50E-10	66.6	AMPN_PIG	reviewed	Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13)	ANPEP	Sus scrofa (Pig)	963	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN9195_c0_g1_i1	P15541	AMPN_RABIT	48.3	58	26	2	212	51	422	479	1.00E-06	53.9	AMPN_RABIT	reviewed	Aminopeptidase N (AP-N) (rbAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	ANPEP	Oryctolagus cuniculus (Rabbit)	966	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0001525; GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0016021; GO:0030154	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]		brown	brown	NA	NA	NA	NA
TRINITY_DN36175_c0_g1_i1	P15541	AMPN_RABIT	37.9	87	54	0	340	80	628	714	5.30E-11	68.6	AMPN_RABIT	reviewed	Aminopeptidase N (AP-N) (rbAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	ANPEP	Oryctolagus cuniculus (Rabbit)	966	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0001525; GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0016021; GO:0030154	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]		NA	NA	NA	NA	NA	NA
TRINITY_DN7278_c1_g1_i1	P15541	AMPN_RABIT	67.7	65	21	0	23	217	355	419	1.20E-20	100.1	AMPN_RABIT	reviewed	Aminopeptidase N (AP-N) (rbAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	ANPEP	Oryctolagus cuniculus (Rabbit)	966	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0001525; GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0016021; GO:0030154	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]		NA	NA	NA	NA	NA	NA
TRINITY_DN521_c0_g1_i1	Q9CIQ1	AMPN_LACLA	56.7	67	25	2	207	7	267	329	3.20E-14	78.6	AMPN_LACLA	reviewed	Aminopeptidase N (EC 3.4.11.2) (Alanine aminopeptidase) (Lysyl aminopeptidase) (Lys-AP)	pepN LL0305 L102360	Lactococcus lactis subsp. lactis (strain IL1403) (Streptococcus lactis)	846	cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005737; GO:0008237; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN10555_c0_g1_i1	Q10736	AMPN_ACEPA	66.3	95	31	1	2	286	262	355	4.10E-33	142.9	AMPN_ACEPA	reviewed	Aminopeptidase N (EC 3.4.11.2) (Alpha-aminoacylpeptide hydrolase) (Fragment)	pepN	Acetobacter pasteurianus (Acetobacter turbidans)	355	cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005737; GO:0008237; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN25440_c0_g1_i1	P69527	AMPO_RAT	40.3	303	168	6	215	1108	522	816	1.60E-54	214.9	AMPO_RAT	reviewed	Aminopeptidase O (AP-O) (EC 3.4.11.-)	Aopep Onpep	Rattus norvegicus (Rat)	816	nucleolus [GO:0005730]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	nucleolus [GO:0005730]	metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	GO:0005730; GO:0008270; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN28761_c0_g1_i1	Q8BXQ6	AMPO_MOUSE	98.6	73	1	0	221	3	733	805	8.20E-37	153.7	AMPO_MOUSE	reviewed	Aminopeptidase O (AP-O) (EC 3.4.11.-)	Aopep Onpep	Mus musculus (Mouse)	817	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005730; GO:0005737; GO:0006508; GO:0008270; GO:0070006	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN6306_c0_g1_i1	P69527	AMPO_RAT	31.3	543	276	16	1596	154	8	515	1.10E-61	239.2	AMPO_RAT	reviewed	Aminopeptidase O (AP-O) (EC 3.4.11.-)	Aopep Onpep	Rattus norvegicus (Rat)	816	nucleolus [GO:0005730]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	nucleolus [GO:0005730]	metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	GO:0005730; GO:0008270; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN6306_c0_g1_i2	P69527	AMPO_RAT	71.4	35	10	0	258	154	481	515	9.00E-10	64.3	AMPO_RAT	reviewed	Aminopeptidase O (AP-O) (EC 3.4.11.-)	Aopep Onpep	Rattus norvegicus (Rat)	816	nucleolus [GO:0005730]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	nucleolus [GO:0005730]	metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	GO:0005730; GO:0008270; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN6306_c0_g1_i3	Q8N6M6	AMPO_HUMAN	27.9	505	268	13	1410	82	11	481	5.60E-44	180.3	AMPO_HUMAN	reviewed	Aminopeptidase O (AP-O) (EC 3.4.11.-)	AOPEP C9orf3 ONPEP	Homo sapiens (Human)	819	cytosol [GO:0005829]; nucleolus [GO:0005730]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]	cytosol [GO:0005829]; nucleolus [GO:0005730]	metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	GO:0002003; GO:0005730; GO:0005829; GO:0008270; GO:0070006	angiotensin maturation [GO:0002003]		NA	NA	NA	NA	NA	NA
TRINITY_DN30232_c0_g1_i1	Q8RY11	AMPP2_ARATH	54	213	89	2	633	1	480	685	3.00E-60	233	AMPP2_ARATH	reviewed	Aminopeptidase P2 (AtAPP2) (EC 3.4.11.9)	APP2 At3g05350 T12H1.32	Arabidopsis thaliana (Mouse-ear cress)	710	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005829; GO:0009507; GO:0009570; GO:0046872; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN3777_c1_g1_i1	Q8RY11	AMPP2_ARATH	58.4	166	63	2	2	499	472	631	8.80E-47	188	AMPP2_ARATH	reviewed	Aminopeptidase P2 (AtAPP2) (EC 3.4.11.9)	APP2 At3g05350 T12H1.32	Arabidopsis thaliana (Mouse-ear cress)	710	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005829; GO:0009507; GO:0009570; GO:0046872; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g2_i1	Q8RY11	AMPP2_ARATH	60.9	87	34	0	261	1	102	188	3.80E-25	115.2	AMPP2_ARATH	reviewed	Aminopeptidase P2 (AtAPP2) (EC 3.4.11.9)	APP2 At3g05350 T12H1.32	Arabidopsis thaliana (Mouse-ear cress)	710	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005829; GO:0009507; GO:0009570; GO:0046872; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN7147_c0_g1_i4	Q9Y4X0	AMMR1_HUMAN	69.7	188	57	0	193	756	125	312	4.70E-80	299.3	AMMR1_HUMAN	reviewed	AMME syndrome candidate gene 1 protein	AMMECR1	Homo sapiens (Human)	333	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN7147_c0_g1_i3	Q6DCA0	AMERL_HUMAN	50.2	301	130	2	20	922	9	289	6.00E-82	305.8	AMERL_HUMAN	reviewed	AMMECR1-like protein	AMMECR1L	Homo sapiens (Human)	310	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN7147_c0_g1_i5	Q6DCA0	AMERL_HUMAN	52.8	288	120	2	20	856	9	289	2.70E-84	313.5	AMERL_HUMAN	reviewed	AMMECR1-like protein	AMMECR1L	Homo sapiens (Human)	310	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN34879_c0_g1_i1	Q01433	AMPD2_HUMAN	99.4	154	1	0	2	463	562	715	1.90E-88	326.2	AMPD2_HUMAN	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	AMPD2	Homo sapiens (Human)	879	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009	AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]		NA	NA	NA	NA	NA	NA
TRINITY_DN2151_c0_g1_i1	Q02356	AMPD2_RAT	49.3	406	174	8	125	1264	64	463	8.90E-96	352.1	AMPD2_RAT	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	Ampd2	Rattus norvegicus (Rat)	824	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009	AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN2151_c0_g1_i2	Q02356	AMPD2_RAT	49.3	406	174	8	96	1235	64	463	8.70E-96	352.1	AMPD2_RAT	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	Ampd2	Rattus norvegicus (Rat)	824	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009	AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN2151_c0_g1_i3	Q02356	AMPD2_RAT	49.3	406	174	8	116	1255	64	463	6.80E-96	352.4	AMPD2_RAT	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	Ampd2	Rattus norvegicus (Rat)	824	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009	AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN1590_c0_g1_i1	Q02356	AMPD2_RAT	73.8	344	90	0	2	1033	457	800	9.10E-156	551.2	AMPD2_RAT	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	Ampd2	Rattus norvegicus (Rat)	824	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009	AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; glomerular visceral epithelial cell development [GO:0072015]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN30970_c0_g1_i1	Q01433	AMPD2_HUMAN	57.9	152	62	2	9	458	685	836	1.30E-49	197.2	AMPD2_HUMAN	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	AMPD2	Homo sapiens (Human)	879	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009	AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]		NA	NA	NA	NA	NA	NA
TRINITY_DN20116_c0_g1_i1	Q01433	AMPD2_HUMAN	100	196	0	0	1	588	669	864	7.00E-112	404.4	AMPD2_HUMAN	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	AMPD2	Homo sapiens (Human)	879	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009	AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]		NA	NA	NA	NA	NA	NA
TRINITY_DN20116_c0_g1_i2	Q01433	AMPD2_HUMAN	100	95	0	0	1	285	669	763	3.10E-49	195.3	AMPD2_HUMAN	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	AMPD2	Homo sapiens (Human)	879	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009	AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]		NA	NA	NA	NA	NA	NA
TRINITY_DN31454_c0_g1_i1	Q01433	AMPD2_HUMAN	100	74	0	0	3	224	377	450	2.00E-35	149.1	AMPD2_HUMAN	reviewed	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	AMPD2	Homo sapiens (Human)	879	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009	AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]		NA	NA	NA	NA	NA	NA
TRINITY_DN23593_c0_g1_i1	Q92624	APBP2_HUMAN	100	129	0	0	389	3	314	442	5.40E-68	258.1	APBP2_HUMAN	reviewed	Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2) (Protein interacting with APP tail 1)	APPBP2 KIAA0228 PAT1	Homo sapiens (Human)	585	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]	microtubule motor activity [GO:0003777]	GO:0003777; GO:0005634; GO:0005737; GO:0005874; GO:0005875; GO:0006886; GO:0030659; GO:0046907	intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]		NA	NA	NA	NA	NA	NA
TRINITY_DN38794_c0_g1_i1	Q92624	APBP2_HUMAN	53.5	579	263	2	1825	92	2	575	4.00E-177	622.9	APBP2_HUMAN	reviewed	Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2) (Protein interacting with APP tail 1)	APPBP2 KIAA0228 PAT1	Homo sapiens (Human)	585	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]	microtubule motor activity [GO:0003777]	GO:0003777; GO:0005634; GO:0005737; GO:0005874; GO:0005875; GO:0006886; GO:0030659; GO:0046907	intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]		blue	blue	NA	NA	NA	NA
TRINITY_DN31030_c0_g1_i1	Q99767	APBA2_HUMAN	100	93	0	0	280	2	553	645	2.90E-47	188.7	APBA2_HUMAN	reviewed	Amyloid-beta A4 precursor protein-binding family A member 2 (Adapter protein X11beta) (Neuron-specific X11L protein) (Neuronal Munc18-1-interacting protein 2) (Mint-2)	APBA2 MINT2 X11L	Homo sapiens (Human)	749	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein transport [GO:0015031]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]	GO:0001540; GO:0001701; GO:0005737; GO:0005886; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0010468; GO:0015031; GO:0035264; GO:0042802; GO:0043197; GO:0045202	chemical synaptic transmission [GO:0007268]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein transport [GO:0015031]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN25295_c0_g1_i1	Q92870	APBB2_HUMAN	68.6	51	16	0	146	298	419	469	1.30E-13	77	APBB2_HUMAN	reviewed	Amyloid-beta A4 precursor protein-binding family B member 2 (Protein Fe65-like 1)	APBB2 FE65L FE65L1	Homo sapiens (Human)	758	"cytoplasm [GO:0005737]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; cell cycle arrest [GO:0007050]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202]	amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]	GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0006355; GO:0007050; GO:0007411; GO:0008134; GO:0016020; GO:0030027; GO:0030198; GO:0030308; GO:0030426; GO:0035556; GO:0043065; GO:0043066; GO:0045202	"axon guidance [GO:0007411]; cell cycle arrest [GO:0007050]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25151_c0_g1_i1	O93279	A4_TAKRU	61.1	54	21	0	96	257	289	342	2.30E-15	82.8	A4_TAKRU	reviewed	Amyloid-beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta precursor protein) [Cleaved into: Amyloid-beta protein (A-beta) (APP-beta)]	app	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	737	Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]; nervous system development [GO:0007399]	Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]	heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]	GO:0004867; GO:0005798; GO:0007399; GO:0008201; GO:0016021; GO:0046914; GO:0055037	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN26580_c0_g1_i1	Q06481	APLP2_HUMAN	100	72	0	0	217	2	304	375	9.20E-41	166.8	APLP2_HUMAN	reviewed	Amyloid-like protein 2 (APLP-2) (APPH) (Amyloid protein homolog) (CDEI box-binding protein) (CDEBP)	APLP2 APPL2	Homo sapiens (Human)	763	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]; cellular protein metabolic process [GO:0044267]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet degranulation [GO:0002576]; post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	DNA binding [GO:0003677]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]	GO:0002576; GO:0003677; GO:0004867; GO:0005634; GO:0005788; GO:0005886; GO:0007186; GO:0008201; GO:0016020; GO:0016021; GO:0031092; GO:0042802; GO:0043687; GO:0044267; GO:0046914; GO:0070062	cellular protein metabolic process [GO:0044267]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet degranulation [GO:0002576]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN12150_c0_g1_i1	Q8TCF1	ZFAN1_HUMAN	45	60	29	1	43	222	62	117	4.20E-09	61.6	ZFAN1_HUMAN	reviewed	AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1)	ZFAND1	Homo sapiens (Human)	268	cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]	cytoplasmic stress granule [GO:0010494]	proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]	GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843	cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]		NA	NA	NA	NA	NA	NA
TRINITY_DN12150_c0_g1_i2	Q8TCF1	ZFAN1_HUMAN	45	60	29	1	33	212	62	117	4.00E-09	61.6	ZFAN1_HUMAN	reviewed	AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1)	ZFAND1	Homo sapiens (Human)	268	cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]	cytoplasmic stress granule [GO:0010494]	proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]	GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843	cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]		NA	NA	NA	NA	NA	NA
TRINITY_DN6711_c0_g1_i1	Q8WV99	ZFN2B_HUMAN	43.1	276	134	5	918	103	1	257	1.20E-50	201.8	ZFN2B_HUMAN	reviewed	AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein)	ZFAND2B AIRAPL	Homo sapiens (Human)	257	"anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]	K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0031225; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047	"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6711_c0_g1_i2	Q8WV99	ZFN2B_HUMAN	51	143	64	2	728	318	1	143	3.60E-42	173.3	ZFN2B_HUMAN	reviewed	AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein)	ZFAND2B AIRAPL	Homo sapiens (Human)	257	"anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]	K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0031225; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047	"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6711_c0_g1_i2	Q8WV99	ZFN2B_HUMAN	44.3	70	32	3	312	103	195	257	8.80E-04	45.8	ZFN2B_HUMAN	reviewed	AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein)	ZFAND2B AIRAPL	Homo sapiens (Human)	257	"anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]	K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0031225; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047	"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25510_c0_g1_i1	O76080	ZFAN5_HUMAN	56.1	41	17	1	75	197	1	40	8.00E-08	57.8	ZFAN5_HUMAN	reviewed	AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216)	ZFAND5 ZA20D2 ZNF216	Homo sapiens (Human)	213	cytoplasm [GO:0005737]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; face development [GO:0060324]; fibroblast migration [GO:0010761]; in utero embryonic development [GO:0001701]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0001701; GO:0001944; GO:0003016; GO:0003677; GO:0005737; GO:0008270; GO:0010761; GO:0048008; GO:0048705; GO:0048745; GO:0060324	face development [GO:0060324]; fibroblast migration [GO:0010761]; in utero embryonic development [GO:0001701]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculature development [GO:0001944]		blue	blue	NA	NA	NA	NA
TRINITY_DN30313_c0_g1_i1	O76080	ZFAN5_HUMAN	100	72	0	0	232	17	142	213	3.80E-38	158.3	ZFAN5_HUMAN	reviewed	AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216)	ZFAND5 ZA20D2 ZNF216	Homo sapiens (Human)	213	cytoplasm [GO:0005737]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; face development [GO:0060324]; fibroblast migration [GO:0010761]; in utero embryonic development [GO:0001701]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0001701; GO:0001944; GO:0003016; GO:0003677; GO:0005737; GO:0008270; GO:0010761; GO:0048008; GO:0048705; GO:0048745; GO:0060324	face development [GO:0060324]; fibroblast migration [GO:0010761]; in utero embryonic development [GO:0001701]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN40935_c0_g1_i1	Q6FIF0	ZFAN6_HUMAN	100	56	0	0	168	1	1	56	1.20E-27	123.2	ZFAN6_HUMAN	reviewed	AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3)	ZFAND6 AWP1 ZA20D3 HT032	Homo sapiens (Human)	208	cytosol [GO:0005829]; DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]	cytosol [GO:0005829]	DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0031593; GO:0043066; GO:0043122; GO:0071356	apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]		NA	NA	NA	NA	NA	NA
TRINITY_DN32950_c0_g1_i1	Q3SZY7	ZFAN6_BOVIN	62.1	66	25	0	288	91	143	208	4.00E-20	99	ZFAN6_BOVIN	reviewed	AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3)	ZFAND6 ZA20D3	Bos taurus (Bovine)	208	DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]		DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]	GO:0003677; GO:0006625; GO:0008270; GO:0031593; GO:0043066; GO:0043122; GO:0071356	cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]		blue	blue	NA	NA	NA	NA
TRINITY_DN2078_c0_g1_i1	Q4V7N8	CPIN1_XENLA	40.1	302	142	6	968	174	11	310	8.60E-47	189.1	CPIN1_XENLA	reviewed	Anamorsin (Cytokine-induced apoptosis inhibitor 1) (Fe-S cluster assembly protein DRE2 homolog)	ciapin1	Xenopus laevis (African clawed frog)	311	"mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]"	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"	GO:0005634; GO:0005758; GO:0006915; GO:0008168; GO:0009055; GO:0016226; GO:0030097; GO:0043066; GO:0046872; GO:0051537; GO:0051539	apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]		blue	blue	NA	NA	NA	NA
TRINITY_DN8451_c0_g1_i1	Q5EAC7	CPIN1_BOVIN	53.4	73	25	1	27	218	237	309	1.00E-15	84	CPIN1_BOVIN	reviewed	Anamorsin (Cytokine-induced apoptosis inhibitor 1) (Fe-S cluster assembly protein DRE2 homolog)	CIAPIN1	Bos taurus (Bovine)	310	"cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]"	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	GO:0005654; GO:0005730; GO:0005737; GO:0005758; GO:0006915; GO:0009055; GO:0016226; GO:0030097; GO:0043066; GO:0046872; GO:0051537; GO:0051539	apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]		NA	NA	NA	NA	NA	NA
TRINITY_DN34363_c0_g1_i1	Q5CKJ0	DRE2_CRYHO	62.5	64	20	1	252	73	185	248	2.60E-18	92.4	DRE2_CRYHO	reviewed	Anamorsin homolog (Fe-S cluster assembly protein DRE2 homolog)	Chro.60473	Cryptosporidium hominis	298	"mitochondrial intermembrane space [GO:0005758]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	mitochondrial intermembrane space [GO:0005758]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	GO:0005758; GO:0009055; GO:0016226; GO:0046872; GO:0051537; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c2_g1_i1	Q9HDY1	ASE1_SCHPO	27.5	211	145	4	1158	535	247	452	2.40E-12	75.1	ASE1_SCHPO	reviewed	Anaphase spindle elongation protein 1	ase1 SPAPB1A10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	731	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]	microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]	GO:0000226; GO:0000281; GO:0000923; GO:0005634; GO:0005737; GO:0005819; GO:0005881; GO:0008017; GO:0015630; GO:0030989; GO:0044878; GO:0051256; GO:0055028; GO:0062168; GO:0099070; GO:0099609; GO:1903562; GO:1903563; GO:1905121; GO:1990023; GO:1990498	dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c2_g1_i2	Q9HDY1	ASE1_SCHPO	27.5	211	145	4	1158	535	247	452	3.10E-12	75.1	ASE1_SCHPO	reviewed	Anaphase spindle elongation protein 1	ase1 SPAPB1A10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	731	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]	microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]	GO:0000226; GO:0000281; GO:0000923; GO:0005634; GO:0005737; GO:0005819; GO:0005881; GO:0008017; GO:0015630; GO:0030989; GO:0044878; GO:0051256; GO:0055028; GO:0062168; GO:0099070; GO:0099609; GO:1903562; GO:1903563; GO:1905121; GO:1990023; GO:1990498	dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]		NA	NA	NA	NA	NA	NA
TRINITY_DN13262_c0_g1_i1	Q9HDY1	ASE1_SCHPO	23.6	444	306	10	91	1362	34	464	4.80E-19	97.4	ASE1_SCHPO	reviewed	Anaphase spindle elongation protein 1	ase1 SPAPB1A10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	731	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]	microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]	GO:0000226; GO:0000281; GO:0000923; GO:0005634; GO:0005737; GO:0005819; GO:0005881; GO:0008017; GO:0015630; GO:0030989; GO:0044878; GO:0051256; GO:0055028; GO:0062168; GO:0099070; GO:0099609; GO:1903562; GO:1903563; GO:1905121; GO:1990023; GO:1990498	dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]		NA	NA	NA	NA	NA	NA
TRINITY_DN13262_c0_g1_i2	Q9HDY1	ASE1_SCHPO	27.8	284	195	5	225	1052	183	464	4.60E-20	100.5	ASE1_SCHPO	reviewed	Anaphase spindle elongation protein 1	ase1 SPAPB1A10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	731	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]	microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]	GO:0000226; GO:0000281; GO:0000923; GO:0005634; GO:0005737; GO:0005819; GO:0005881; GO:0008017; GO:0015630; GO:0030989; GO:0044878; GO:0051256; GO:0055028; GO:0062168; GO:0099070; GO:0099609; GO:1903562; GO:1903563; GO:1905121; GO:1990023; GO:1990498	dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]		NA	NA	NA	NA	NA	NA
TRINITY_DN13262_c0_g1_i5	Q9HDY1	ASE1_SCHPO	26	334	231	7	182	1144	134	464	8.40E-20	99.8	ASE1_SCHPO	reviewed	Anaphase spindle elongation protein 1	ase1 SPAPB1A10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	731	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]	microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]	GO:0000226; GO:0000281; GO:0000923; GO:0005634; GO:0005737; GO:0005819; GO:0005881; GO:0008017; GO:0015630; GO:0030989; GO:0044878; GO:0051256; GO:0055028; GO:0062168; GO:0099070; GO:0099609; GO:1903562; GO:1903563; GO:1905121; GO:1990023; GO:1990498	dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]		NA	NA	NA	NA	NA	NA
TRINITY_DN13262_c0_g1_i8	Q9HDY1	ASE1_SCHPO	23.6	444	306	10	91	1362	34	464	4.60E-19	97.4	ASE1_SCHPO	reviewed	Anaphase spindle elongation protein 1	ase1 SPAPB1A10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	731	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; equatorial microtubule organizing center [GO:0000923]; microtubule cytoskeleton [GO:0015630]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle [GO:0005819]; static microtubule bundle [GO:0099070]	microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]	GO:0000226; GO:0000281; GO:0000923; GO:0005634; GO:0005737; GO:0005819; GO:0005881; GO:0008017; GO:0015630; GO:0030989; GO:0044878; GO:0051256; GO:0055028; GO:0062168; GO:0099070; GO:0099609; GO:1903562; GO:1903563; GO:1905121; GO:1990023; GO:1990498	dynein-driven meiotic oscillatory nuclear movement [GO:0030989]; microtubule bundle formation involved in horsetail-astral microtubule organization [GO:1903563]; microtubule bundle formation involved in mitotic spindle midzone assembly [GO:1903562]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding involved in mitotic spindle elongation [GO:1905121]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of plus-end directed microtubule sliding [GO:0062168]		NA	NA	NA	NA	NA	NA
TRINITY_DN32758_c0_g1_i1	P53995	APC1_MOUSE	41.1	1520	793	29	2	4495	462	1901	2.00E-307	1057	APC1_MOUSE	reviewed	Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)	Anapc1 Mcpr Tsg24	Mus musculus (Mouse)	1944	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]	molecular adaptor activity [GO:0060090]	GO:0005634; GO:0005680; GO:0007091; GO:0031145; GO:0051301; GO:0060090; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]		NA	NA	NA	NA	NA	NA
TRINITY_DN21671_c0_g1_i1	Q9H1A4	APC1_HUMAN	99.3	301	2	0	906	4	1027	1327	9.30E-172	604	APC1_HUMAN	reviewed	Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)	ANAPC1 TSG24	Homo sapiens (Human)	1944	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	molecular adaptor activity [GO:0060090]	GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007091; GO:0031145; GO:0051301; GO:0060090; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21671_c0_g2_i1	P53995	APC1_MOUSE	100	86	0	0	262	5	1172	1257	6.40E-41	167.5	APC1_MOUSE	reviewed	Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)	Anapc1 Mcpr Tsg24	Mus musculus (Mouse)	1944	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]	molecular adaptor activity [GO:0060090]	GO:0005634; GO:0005680; GO:0007091; GO:0031145; GO:0051301; GO:0060090; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]		NA	NA	NA	NA	NA	NA
TRINITY_DN17177_c0_g1_i1	Q9ZPW2	APC10_ARATH	53.8	65	30	0	197	3	24	88	1.30E-16	86.7	APC10_ARATH	reviewed	Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)	APC10 At2g18290 T30D6.20	Arabidopsis thaliana (Mouse-ear cress)	192	anaphase-promoting complex [GO:0005680]; nuclear body [GO:0016604]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of DNA endoreduplication [GO:0032876]; phloem or xylem histogenesis [GO:0010087]; protein K11-linked ubiquitination [GO:0070979]; regulation of DNA endoreduplication [GO:0032875]	anaphase-promoting complex [GO:0005680]; nuclear body [GO:0016604]		GO:0005680; GO:0007049; GO:0010087; GO:0016604; GO:0031145; GO:0032875; GO:0032876; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of DNA endoreduplication [GO:0032876]; phloem or xylem histogenesis [GO:0010087]; protein K11-linked ubiquitination [GO:0070979]; regulation of DNA endoreduplication [GO:0032875]		NA	NA	NA	NA	NA	NA
TRINITY_DN17325_c0_g1_i1	Q2YDH1	APC10_BOVIN	100	96	0	0	3	290	89	184	5.30E-52	204.5	APC10_BOVIN	reviewed	Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)	ANAPC10 APC10	Bos taurus (Bovine)	185	anaphase-promoting complex [GO:0005680]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]	anaphase-promoting complex [GO:0005680]		GO:0005680; GO:0007049; GO:0031145; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]		NA	NA	NA	NA	NA	NA
TRINITY_DN17325_c0_g1_i2	Q2YDH1	APC10_BOVIN	100	93	0	0	3	281	89	181	1.60E-50	199.5	APC10_BOVIN	reviewed	Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)	ANAPC10 APC10	Bos taurus (Bovine)	185	anaphase-promoting complex [GO:0005680]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]	anaphase-promoting complex [GO:0005680]		GO:0005680; GO:0007049; GO:0031145; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]		NA	NA	NA	NA	NA	NA
TRINITY_DN6473_c0_g1_i1	Q9V831	APC10_DROME	65.6	180	62	0	124	663	16	195	2.60E-66	253.4	APC10_DROME	reviewed	Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)	APC10 CG11419	Drosophila melanogaster (Fruit fly)	195	anaphase-promoting complex [GO:0005680]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; protein K11-linked ubiquitination [GO:0070979]; regulation of stem cell differentiation [GO:2000736]	anaphase-promoting complex [GO:0005680]		GO:0000278; GO:0005680; GO:0007113; GO:0031145; GO:0051301; GO:0070979; GO:2000736	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; protein K11-linked ubiquitination [GO:0070979]; regulation of stem cell differentiation [GO:2000736]		blue	blue	NA	NA	NA	NA
TRINITY_DN35622_c0_g1_i1	Q9UM13	APC10_HUMAN	100	99	0	0	298	2	1	99	1.50E-53	209.9	APC10_HUMAN	reviewed	Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)	ANAPC10 APC10	Homo sapiens (Human)	185	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0031145; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN28781_c0_g1_i1	Q9UJX5	APC4_HUMAN	100	68	0	0	206	3	300	367	2.60E-29	128.6	APC4_HUMAN	reviewed	Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)	ANAPC4 APC4	Homo sapiens (Human)	808	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2398_c0_g1_i1	Q91W96	APC4_MOUSE	32.9	773	463	18	2387	147	6	748	2.40E-92	341.7	APC4_MOUSE	reviewed	Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)	Anapc4 D5Ertd249e	Mus musculus (Mouse)	807	anaphase-promoting complex [GO:0005680]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]	anaphase-promoting complex [GO:0005680]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]		NA	NA	NA	NA	NA	NA
TRINITY_DN11484_c0_g1_i1	Q9UJX4	APC5_HUMAN	30.8	685	401	9	2125	104	129	751	2.50E-77	291.6	APC5_HUMAN	reviewed	Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5)	ANAPC5 APC5	Homo sapiens (Human)	755	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11484_c0_g1_i10	Q8BTZ4	APC5_MOUSE	29.6	759	449	12	2269	29	33	718	3.20E-73	278.1	APC5_MOUSE	reviewed	Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5)	Anapc5 MNCb-2778	Mus musculus (Mouse)	740	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]		NA	NA	NA	NA	NA	NA
TRINITY_DN11484_c0_g1_i15	Q9UJX4	APC5_HUMAN	30.6	206	138	3	706	104	546	751	5.50E-16	86.3	APC5_HUMAN	reviewed	Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5)	ANAPC5 APC5	Homo sapiens (Human)	755	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11484_c0_g1_i7	Q9UJX4	APC5_HUMAN	32	122	80	2	460	104	630	751	1.40E-10	67.8	APC5_HUMAN	reviewed	Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5)	ANAPC5 APC5	Homo sapiens (Human)	755	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11484_c0_g1_i8	Q9UJX4	APC5_HUMAN	29.7	809	473	13	2494	104	27	751	5.50E-84	313.9	APC5_HUMAN	reviewed	Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5)	ANAPC5 APC5	Homo sapiens (Human)	755	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN7236_c0_g1_i1	Q9WVM3	APC7_MOUSE	40.4	532	304	4	1644	79	1	529	1.80E-104	381.3	APC7_MOUSE	reviewed	Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7) (Prediabetic NOD sera-reactive autoantigen)	Anapc7 Apc7	Mus musculus (Mouse)	565	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN28881_c0_g1_i1	O94556	APC8_SCHPO	61.5	65	25	0	200	6	375	439	5.30E-19	94.4	APC8_SCHPO	reviewed	Anaphase-promoting complex subunit 8 (20S cyclosome/APC complex protein apc8) (Cell untimely torn protein 23)	cut23 apc8 SPAC6F12.14	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	565	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]		GO:0005634; GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0043161; GO:0044732; GO:0045842; GO:0051301	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN4096_c0_g1_i1	Q9NVV5	AIG1_HUMAN	38	208	121	4	699	97	31	237	9.40E-31	135.6	AIG1_HUMAN	reviewed	Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-)	AIG1 CGI-103	Homo sapiens (Human)	238	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; long-chain fatty acid catabolic process [GO:0042758]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	hydrolase activity [GO:0016787]	GO:0005886; GO:0016020; GO:0016021; GO:0016787; GO:0042758	long-chain fatty acid catabolic process [GO:0042758]		NA	NA	NA	NA	NA	NA
TRINITY_DN3803_c0_g1_i1	Q7YR70	AAMP_CANLF	40.5	405	218	7	1201	50	26	428	1.50E-80	301.6	AAMP_CANLF	reviewed	Angio-associated migratory cell protein	AAMP	Canis lupus familiaris (Dog) (Canis familiaris)	435	cell surface [GO:0009986]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909]	cell surface [GO:0009986]; cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0001525; GO:0005829; GO:0005886; GO:0009986; GO:0010595; GO:0014909; GO:0030154	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909]		NA	NA	NA	NA	NA	NA
TRINITY_DN3803_c0_g1_i2	Q3SZK1	AAMP_BOVIN	43.7	325	179	3	1018	50	105	427	2.00E-77	291.2	AAMP_BOVIN	reviewed	Angio-associated migratory cell protein	AAMP	Bos taurus (Bovine)	434	cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909]	cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]		GO:0001525; GO:0005829; GO:0005886; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0045171; GO:0045766	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909]		NA	NA	NA	NA	NA	NA
TRINITY_DN11118_c0_g1_i1	Q7TN31	AGGF1_MOUSE	31.1	244	140	7	768	82	418	648	8.60E-25	115.5	AGGF1_MOUSE	reviewed	Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q)	Aggf1 Vg5q	Mus musculus (Mouse)	711	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; nucleic acid binding [GO:0003676]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]	nucleic acid binding [GO:0003676]	GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0045766; GO:0048471	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]		NA	NA	NA	NA	NA	NA
TRINITY_DN11118_c0_g1_i3	Q7TN31	AGGF1_MOUSE	29.7	290	176	7	887	63	418	694	2.60E-25	117.5	AGGF1_MOUSE	reviewed	Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q)	Aggf1 Vg5q	Mus musculus (Mouse)	711	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; nucleic acid binding [GO:0003676]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]	nucleic acid binding [GO:0003676]	GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0045766; GO:0048471	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]		NA	NA	NA	NA	NA	NA
TRINITY_DN11118_c0_g1_i4	Q7TN31	AGGF1_MOUSE	29.5	217	128	5	677	63	491	694	1.50E-15	84.7	AGGF1_MOUSE	reviewed	Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q)	Aggf1 Vg5q	Mus musculus (Mouse)	711	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; nucleic acid binding [GO:0003676]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]	nucleic acid binding [GO:0003676]	GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0045766; GO:0048471	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]		NA	NA	NA	NA	NA	NA
TRINITY_DN1406_c0_g1_i1	Q8VHG2	AMOT_MOUSE	38.3	376	214	6	1246	2352	411	775	3.70E-50	202.2	AMOT_MOUSE	reviewed	Angiomotin	Amot Kiaa1071	Mus musculus (Mouse)	1126	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]		NA	NA	1	NA	NA	NA
TRINITY_DN1406_c0_g1_i3	Q8VHG2	AMOT_MOUSE	38.3	376	214	6	1246	2352	411	775	3.70E-50	202.2	AMOT_MOUSE	reviewed	Angiomotin	Amot Kiaa1071	Mus musculus (Mouse)	1126	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN1406_c0_g1_i4	Q8VHG2	AMOT_MOUSE	38.3	376	214	6	1246	2352	411	775	3.70E-50	202.2	AMOT_MOUSE	reviewed	Angiomotin	Amot Kiaa1071	Mus musculus (Mouse)	1126	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN1406_c0_g1_i5	Q8VHG2	AMOT_MOUSE	38.3	376	214	6	1246	2352	411	775	3.70E-50	202.2	AMOT_MOUSE	reviewed	Angiomotin	Amot Kiaa1071	Mus musculus (Mouse)	1126	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN18246_c0_g1_i1	Q06807	TIE2_BOVIN	31.4	299	172	7	962	123	830	1114	4.10E-32	140.2	TIE2_BOVIN	reviewed	Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b)	TEK TIE-2 TIE2	Bos taurus (Bovine)	1125	actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001725; GO:0001934; GO:0001935; GO:0002040; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005884; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007169; GO:0007275; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000251; GO:2000352	angiogenesis [GO:0001525]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN18246_c0_g1_i3	Q06807	TIE2_BOVIN	32.4	287	173	6	926	123	830	1114	2.50E-34	147.5	TIE2_BOVIN	reviewed	Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b)	TEK TIE-2 TIE2	Bos taurus (Bovine)	1125	actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001725; GO:0001934; GO:0001935; GO:0002040; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005884; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007169; GO:0007275; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000251; GO:2000352	angiogenesis [GO:0001525]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN38329_c0_g1_i1	A0A8J8	ANGP2_CANLF	37.3	75	46	1	227	3	333	406	1.80E-07	56.2	ANGP2_CANLF	reviewed	Angiopoietin-2 (ANG-2)	ANGPT2	Canis lupus familiaris (Dog) (Canis familiaris)	495	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; gene expression [GO:0010467]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; Tie signaling pathway [GO:0048014]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0005102; GO:0005615; GO:0010467; GO:0010812; GO:0016525; GO:0030154; GO:0030971; GO:0043537; GO:0046872; GO:0048014; GO:0050928; GO:0062023	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; gene expression [GO:0010467]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; Tie signaling pathway [GO:0048014]		NA	NA	NA	NA	NA	NA
TRINITY_DN4181_c0_g1_i2	O35608	ANGP2_MOUSE	42	88	49	2	306	46	407	493	1.80E-10	67	ANGP2_MOUSE	reviewed	Angiopoietin-2 (ANG-2)	Angpt2 Agpt2	Mus musculus (Mouse)	496	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor antagonist activity [GO:0048019]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; vascular endothelial growth factor receptor binding [GO:0005172]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; regulation of angiogenesis [GO:0045765]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; receptor antagonist activity [GO:0048019]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0001525; GO:0001666; GO:0001974; GO:0005102; GO:0005172; GO:0005615; GO:0005634; GO:0005886; GO:0007169; GO:0007281; GO:0007492; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030097; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045765; GO:0045766; GO:0046872; GO:0048014; GO:0048019; GO:0048514; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012	angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; regulation of angiogenesis [GO:0045765]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g1_i2	O35608	ANGP2_MOUSE	44	75	42	0	21	245	420	494	1.80E-12	73.2	ANGP2_MOUSE	reviewed	Angiopoietin-2 (ANG-2)	Angpt2 Agpt2	Mus musculus (Mouse)	496	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor antagonist activity [GO:0048019]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; vascular endothelial growth factor receptor binding [GO:0005172]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; regulation of angiogenesis [GO:0045765]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; receptor antagonist activity [GO:0048019]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0001525; GO:0001666; GO:0001974; GO:0005102; GO:0005172; GO:0005615; GO:0005634; GO:0005886; GO:0007169; GO:0007281; GO:0007492; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030097; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045765; GO:0045766; GO:0046872; GO:0048014; GO:0048019; GO:0048514; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012	angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; regulation of angiogenesis [GO:0045765]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN10175_c0_g1_i1	O15123	ANGP2_HUMAN	42.6	68	33	1	223	38	427	494	1.20E-08	60.1	ANGP2_HUMAN	reviewed	Angiopoietin-2 (ANG-2)	ANGPT2	Homo sapiens (Human)	496	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; leukocyte migration [GO:0050900]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007165; GO:0007281; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0050900; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012	angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; leukocyte migration [GO:0050900]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]		NA	NA	NA	NA	NA	NA
TRINITY_DN8029_c0_g1_i1	Q24K15	ANGP4_BOVIN	39.7	224	119	8	575	1234	285	496	3.10E-38	161	ANGP4_BOVIN	reviewed	Angiopoietin-4 (ANG-4)	ANGPT4	Bos taurus (Bovine)	498	extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525]	extracellular region [GO:0005576]	receptor tyrosine kinase binding [GO:0030971]	GO:0001525; GO:0005576; GO:0030971	angiogenesis [GO:0001525]		NA	NA	NA	NA	NA	NA
TRINITY_DN6128_c0_g1_i1	Q24K15	ANGP4_BOVIN	46.1	89	42	2	269	3	315	397	6.10E-18	91.3	ANGP4_BOVIN	reviewed	Angiopoietin-4 (ANG-4)	ANGPT4	Bos taurus (Bovine)	498	extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525]	extracellular region [GO:0005576]	receptor tyrosine kinase binding [GO:0030971]	GO:0001525; GO:0005576; GO:0030971	angiogenesis [GO:0001525]		NA	NA	NA	NA	NA	NA
TRINITY_DN29393_c0_g1_i1	Q9WVH6	ANGP4_MOUSE	65.5	55	17	2	176	12	319	371	4.70E-14	78.2	ANGP4_MOUSE	reviewed	Angiopoietin-4 (ANG-4) (Angiopoietin-3) (ANG-3)	Angpt4 Agpt4 Ang3	Mus musculus (Mouse)	509	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor binding [GO:0005172]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; endoderm development [GO:0007492]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0001525; GO:0005102; GO:0005172; GO:0005615; GO:0007165; GO:0007219; GO:0007492; GO:0010595; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0048014; GO:0050731; GO:0062023; GO:0071456	angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; endoderm development [GO:0007492]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]		NA	NA	NA	NA	NA	NA
TRINITY_DN16700_c0_g2_i1	Q9WVH6	ANGP4_MOUSE	43.6	78	32	2	298	65	304	369	9.70E-12	70.9	ANGP4_MOUSE	reviewed	Angiopoietin-4 (ANG-4) (Angiopoietin-3) (ANG-3)	Angpt4 Agpt4 Ang3	Mus musculus (Mouse)	509	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor binding [GO:0005172]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; endoderm development [GO:0007492]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0001525; GO:0005102; GO:0005172; GO:0005615; GO:0007165; GO:0007219; GO:0007492; GO:0010595; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0048014; GO:0050731; GO:0062023; GO:0071456	angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; endoderm development [GO:0007492]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]		NA	NA	NA	NA	NA	NA
TRINITY_DN16906_c0_g1_i1	O95841	ANGL1_HUMAN	39.1	92	54	1	276	1	278	367	1.90E-16	86.7	ANGL1_HUMAN	reviewed	Angiopoietin-related protein 1 (Angiopoietin-3) (ANG-3) (Angiopoietin-like protein 1)	ANGPTL1 ANG3 ANGPT3 ARP1 PSEC0154 UNQ162/PRO188	Homo sapiens (Human)	491	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	GO:0001525; GO:0005102; GO:0005615; GO:0007169; GO:0062023; GO:0070062	angiogenesis [GO:0001525]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN23415_c0_g1_i1	Q9UKU9	ANGL2_HUMAN	30.4	138	83	3	447	64	354	488	2.20E-07	57	ANGL2_HUMAN	reviewed	Angiopoietin-related protein 2 (Angiopoietin-like protein 2)	ANGPTL2 ARP2 UNQ170/PRO196	Homo sapiens (Human)	493	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	GO:0001525; GO:0005102; GO:0005615; GO:0007275; GO:0062023; GO:0070062	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN36982_c0_g1_i1	Q9UKU9	ANGL2_HUMAN	100	147	0	0	3	443	296	442	6.90E-91	334.3	ANGL2_HUMAN	reviewed	Angiopoietin-related protein 2 (Angiopoietin-like protein 2)	ANGPTL2 ARP2 UNQ170/PRO196	Homo sapiens (Human)	493	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	GO:0001525; GO:0005102; GO:0005615; GO:0007275; GO:0062023; GO:0070062	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN28055_c0_g1_i1	Q8R1Q3	ANGL7_MOUSE	100	69	0	0	3	209	133	201	1.20E-37	156.4	ANGL7_MOUSE	reviewed	Angiopoietin-related protein 7 (Angiopoietin-like protein 7)	Angptl7	Mus musculus (Mouse)	337	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0005102; GO:0005576; GO:0005615; GO:0042802; GO:0062023; GO:1901346; GO:1903053	angiogenesis [GO:0001525]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]		NA	NA	NA	NA	NA	NA
TRINITY_DN3539_c0_g1_i7	P47820	ACE_RAT	41.1	501	243	11	1820	324	779	1229	6.00E-104	379.8	ACE_RAT	reviewed	"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]"	Ace Dcp1	Rattus norvegicus (Rat)	1313	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]	actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001822; GO:0002446; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0007420; GO:0007565; GO:0007568; GO:0008144; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010815; GO:0014910; GO:0016021; GO:0019233; GO:0030324; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0031982; GO:0032091; GO:0032092; GO:0032496; GO:0034616; GO:0035814; GO:0042277; GO:0042310; GO:0042447; GO:0042493; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0046325; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0090281; GO:0097066; GO:0097225; GO:0097756; GO:1900086; GO:1902033; GO:1903597; GO:1904045; GO:2000170	aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]		NA	NA	NA	NA	NA	1
TRINITY_DN3539_c0_g1_i9	P47820	ACE_RAT	40.1	536	268	12	1925	324	745	1229	1.90E-105	384.8	ACE_RAT	reviewed	"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]"	Ace Dcp1	Rattus norvegicus (Rat)	1313	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]	actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001822; GO:0002446; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0007420; GO:0007565; GO:0007568; GO:0008144; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010815; GO:0014910; GO:0016021; GO:0019233; GO:0030324; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0031982; GO:0032091; GO:0032092; GO:0032496; GO:0034616; GO:0035814; GO:0042277; GO:0042310; GO:0042447; GO:0042493; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0046325; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0090281; GO:0097066; GO:0097225; GO:0097756; GO:1900086; GO:1902033; GO:1903597; GO:1904045; GO:2000170	aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]		NA	NA	NA	NA	NA	NA
TRINITY_DN233_c0_g2_i1	Q10751	ACE_CHICK	72.5	80	21	1	370	134	236	315	2.70E-29	129.4	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN233_c0_g1_i1	Q10751	ACE_CHICK	64.7	292	96	2	1092	220	834	1119	2.30E-116	420.2	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN36309_c0_g1_i1	Q10751	ACE_CHICK	53	132	60	1	417	28	988	1119	1.40E-37	157.1	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN35548_c0_g1_i1	Q10751	ACE_CHICK	68.6	121	38	0	68	430	906	1026	1.50E-47	190.3	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN33884_c0_g1_i1	Q10751	ACE_CHICK	56.1	264	105	2	916	125	867	1119	7.20E-90	332	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN33884_c0_g1_i2	Q10751	ACE_CHICK	63.4	71	25	1	258	46	957	1026	7.30E-22	104.4	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN6530_c0_g1_i1	Q10751	ACE_CHICK	48.1	108	55	1	328	8	146	253	3.20E-26	119.4	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN6530_c0_g1_i2	Q10751	ACE_CHICK	44.2	52	29	0	213	58	667	718	4.30E-07	55.1	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN5573_c0_g1_i1	Q10751	ACE_CHICK	51.3	152	74	0	457	2	77	228	9.20E-43	174.5	ACE_CHICK	reviewed	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	ACE DCP1	Gallus gallus (Chicken)	1193	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]	GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]		NA	NA	NA	NA	NA	NA
TRINITY_DN675_c0_g1_i1	Q58DD0	ACE2_BOVIN	64.2	67	23	1	2	199	359	425	7.40E-19	94	ACE2_BOVIN	reviewed	Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2]	ACE2	Bos taurus (Bovine)	804	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004180; GO:0005615; GO:0005737; GO:0005886; GO:0008237; GO:0008241; GO:0009986; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	1
TRINITY_DN675_c0_g1_i2	Q56H28	ACE2_FELCA	57.4	68	28	1	2	202	360	427	9.70E-16	83.6	ACE2_FELCA	reviewed	Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2]	ACE2	Felis catus (Cat) (Felis silvestris catus)	805	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004180; GO:0005615; GO:0005737; GO:0005886; GO:0008237; GO:0008241; GO:0009986; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6530_c0_g1_i4	Q5EGZ1	ACE2_RAT	29.4	272	179	4	844	35	8	268	4.60E-33	143.3	ACE2_RAT	reviewed	Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2]	Ace2	Rattus norvegicus (Rat)	805	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; angiotensin-mediated drinking behavior [GO:0003051]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; receptor biosynthetic process [GO:0032800]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]	GO:0001618; GO:0003051; GO:0003081; GO:0004175; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0008237; GO:0008241; GO:0009986; GO:0015827; GO:0016020; GO:0016021; GO:0016324; GO:0022898; GO:0031526; GO:0032800; GO:0046718; GO:0046813; GO:0046872; GO:0048662; GO:0051957; GO:0060135; GO:0060452; GO:0070373; GO:1903598; GO:1903779; GO:1905737	angiotensin-mediated drinking behavior [GO:0003051]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; receptor biosynthetic process [GO:0032800]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN9041_c0_g1_i1	Q801E2	ANLN_XENLA	36.7	455	271	9	1075	2394	656	1108	4.10E-76	287.7	ANLN_XENLA	reviewed	Anillin	anln	Xenopus laevis (African clawed frog)	1116	bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172]	bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005856; GO:0007049; GO:0032059; GO:0051301; GO:0099738; GO:1904172	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172]		NA	NA	NA	NA	NA	NA
TRINITY_DN9041_c0_g1_i2	Q801E2	ANLN_XENLA	36.7	455	271	9	262	1581	656	1108	2.80E-76	287.7	ANLN_XENLA	reviewed	Anillin	anln	Xenopus laevis (African clawed frog)	1116	bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172]	bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	actin binding [GO:0003779]	GO:0003779; GO:0005634; GO:0005856; GO:0007049; GO:0032059; GO:0051301; GO:0099738; GO:1904172	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172]		NA	NA	NA	NA	NA	NA
TRINITY_DN12450_c0_g1_i1	P23347	B3A2_RAT	36.1	122	69	3	831	1193	235	348	5.60E-07	57	B3A2_RAT	reviewed	Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein 2) (B3RP-2) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2)	Slc4a2 Ae2 B3rp2	Rattus norvegicus (Rat)	1234	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	anion:anion antiporter activity [GO:0015301]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0006821; GO:0007283; GO:0015108; GO:0015301; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0048565; GO:0050801; GO:0051453; GO:0055085	bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN5890_c0_g1_i2	P48746	B3A2_RABIT	42.2	772	373	11	2688	388	372	1075	3.20E-151	537.3	B3A2_RABIT	reviewed	Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Solute carrier family 4 member 2)	SLC4A2 AE2	Oryctolagus cuniculus (Rabbit)	1237	integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	integral component of membrane [GO:0016021]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	GO:0005452; GO:0015301; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5890_c0_g1_i3	P48746	B3A2_RABIT	44	929	447	11	2902	131	372	1232	1.90E-197	691	B3A2_RABIT	reviewed	Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Solute carrier family 4 member 2)	SLC4A2 AE2	Oryctolagus cuniculus (Rabbit)	1237	integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	integral component of membrane [GO:0016021]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	GO:0005452; GO:0015301; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN34884_c0_g1_i1	Q6SJP2	B3A2_HORSE	97.9	94	2	0	2	283	688	781	1.60E-45	183	B3A2_HORSE	reviewed	Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2)	SLC4A2 AE2	Equus caballus (Horse)	1237	integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	integral component of membrane [GO:0016021]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	GO:0005452; GO:0015301; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN28770_c0_g1_i1	P06872	TRY2_CANLF	54.7	95	32	2	308	24	164	247	6.20E-22	104.8	TRY2_CANLF	reviewed	Anionic trypsin (EC 3.4.21.4)		Canis lupus familiaris (Dog) (Canis familiaris)	247	extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0030574	collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN9363_c1_g1_i3	P07146	TRY2_MOUSE	44.7	76	39	2	57	284	47	119	9.30E-09	61.2	TRY2_MOUSE	reviewed	Anionic trypsin-2 (EC 3.4.21.4) (Anionic trypsin II) (Pretrypsinogen II) (Serine protease 2)	Prss2 Try2	Mus musculus (Mouse)	246	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]; response to caffeine [GO:0031000]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007584; GO:0007586; GO:0030574; GO:0031000; GO:0035094; GO:0062023	collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]; response to caffeine [GO:0031000]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN23669_c0_g1_i1	Q5U312	RAI14_RAT	34.1	205	126	6	608	6	24	223	9.30E-18	92.4	RAI14_RAT	reviewed	Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Retinoic acid-induced protein 14)	Rai14	Rattus norvegicus (Rat)	978	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]	GO:0001650; GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005938; GO:0007283; GO:0030054; GO:0030154	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN26808_c0_g1_i1	Q14DN9	AKD1B_MOUSE	39.7	68	41	0	212	9	101	168	1.40E-06	53.1	AKD1B_MOUSE	reviewed	Ankyrin repeat and death domain-containing protein 1B	Ankdd1b	Mus musculus (Mouse)	521	signal transduction [GO:0007165]			GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5997_c0_g1_i2	Q8N957	ANKF1_HUMAN	37	627	363	11	3496	1631	157	756	3.20E-103	378.3	ANKF1_HUMAN	reviewed	Ankyrin repeat and fibronectin type-III domain-containing protein 1	ANKFN1	Homo sapiens (Human)	763							NA	NA	NA	NA	NA	NA
TRINITY_DN5997_c0_g1_i4	Q8N957	ANKF1_HUMAN	37.7	416	231	8	2875	1631	368	756	1.90E-64	249.2	ANKF1_HUMAN	reviewed	Ankyrin repeat and fibronectin type-III domain-containing protein 1	ANKFN1	Homo sapiens (Human)	763							NA	NA	NA	NA	NA	NA
TRINITY_DN3174_c0_g1_i1	Q6ZPS6	AKIB1_MOUSE	47.6	313	148	2	915	13	1	309	1.80E-72	274.2	AKIB1_MOUSE	reviewed	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	Ankib1 Kiaa1386	Mus musculus (Mouse)	1085	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1678_c0_g1_i1	Q9P2G1	AKIB1_HUMAN	52.1	426	189	5	82	1350	331	744	4.00E-125	451.1	AKIB1_HUMAN	reviewed	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	ANKIB1 KIAA1386	Homo sapiens (Human)	1089	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1678_c0_g1_i3	Q1L8G6	AKIB1_DANRE	49	102	52	0	89	394	642	743	2.40E-18	95.9	AKIB1_DANRE	reviewed	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	ankib1 si:dkey-231l1.6	Danio rerio (Zebrafish) (Brachydanio rerio)	1060	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1678_c0_g1_i4	Q9P2G1	AKIB1_HUMAN	52.1	426	189	5	82	1350	331	744	2.20E-125	451.1	AKIB1_HUMAN	reviewed	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	ANKIB1 KIAA1386	Homo sapiens (Human)	1089	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1678_c0_g1_i5	Q9P2G1	AKIB1_HUMAN	55.1	314	131	3	82	1014	331	637	8.20E-102	373.6	AKIB1_HUMAN	reviewed	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	ANKIB1 KIAA1386	Homo sapiens (Human)	1089	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10496_c0_g1_i1	Q8IWZ3	ANKH1_HUMAN	100	495	0	0	1487	3	183	677	1.90E-283	975.7	ANKH1_HUMAN	reviewed	Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)	ANKHD1 KIAA1085 MASK VBARP PP2500	Homo sapiens (Human)	2542	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0045087	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN10496_c0_g1_i2	Q8IWZ3	ANKH1_HUMAN	96.3	514	0	1	1544	3	183	677	1.00E-279	963.4	ANKH1_HUMAN	reviewed	Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)	ANKHD1 KIAA1085 MASK VBARP PP2500	Homo sapiens (Human)	2542	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0045087	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN31510_c0_g1_i1	Q8IWZ3	ANKH1_HUMAN	41.5	65	37	1	200	9	320	384	7.80E-05	47.4	ANKH1_HUMAN	reviewed	Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)	ANKHD1 KIAA1085 MASK VBARP PP2500	Homo sapiens (Human)	2542	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0045087	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN31035_c0_g1_i1	Q8IWZ3	ANKH1_HUMAN	47.5	59	31	0	179	3	570	628	2.10E-07	55.8	ANKH1_HUMAN	reviewed	Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)	ANKHD1 KIAA1085 MASK VBARP PP2500	Homo sapiens (Human)	2542	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0045087	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN31603_c0_g1_i1	Q9VCA8	ANKHM_DROME	44.4	81	44	1	242	3	624	704	5.30E-13	74.7	ANKHM_DROME	reviewed	Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein)	mask CG33106	Drosophila melanogaster (Fruit fly)	4001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0001751; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007005; GO:0007169; GO:0019901; GO:0030018; GO:0031430; GO:0045214; GO:0045874; GO:0045944; GO:0046427; GO:0046843; GO:0060361; GO:0090212; GO:0090575; GO:1903147	compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN37762_c0_g1_i1	Q9VCA8	ANKHM_DROME	47.2	53	28	0	8	166	2315	2367	1.60E-05	49.7	ANKHM_DROME	reviewed	Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein)	mask CG33106	Drosophila melanogaster (Fruit fly)	4001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0001751; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007005; GO:0007169; GO:0019901; GO:0030018; GO:0031430; GO:0045214; GO:0045874; GO:0045944; GO:0046427; GO:0046843; GO:0060361; GO:0090212; GO:0090575; GO:1903147	compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i10	Q9VCA8	ANKHM_DROME	40.3	72	43	0	258	43	774	845	3.70E-07	55.8	ANKHM_DROME	reviewed	Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein)	mask CG33106	Drosophila melanogaster (Fruit fly)	4001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0001751; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007005; GO:0007169; GO:0019901; GO:0030018; GO:0031430; GO:0045214; GO:0045874; GO:0045944; GO:0046427; GO:0046843; GO:0060361; GO:0090212; GO:0090575; GO:1903147	compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i13	Q9VCA8	ANKHM_DROME	36.3	91	58	0	315	43	755	845	2.30E-08	60.5	ANKHM_DROME	reviewed	Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein)	mask CG33106	Drosophila melanogaster (Fruit fly)	4001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; Z disc [GO:0030018]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0001751; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007005; GO:0007169; GO:0019901; GO:0030018; GO:0031430; GO:0045214; GO:0045874; GO:0045944; GO:0046427; GO:0046843; GO:0060361; GO:0090212; GO:0090575; GO:1903147	compound eye photoreceptor cell differentiation [GO:0001751]; dorsal appendage formation [GO:0046843]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN11804_c0_g3_i5	Q8NAG6	ANKL1_HUMAN	37.3	169	96	5	212	715	339	498	7.70E-20	99	ANKL1_HUMAN	reviewed	Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3)	ANKLE1 ANKRD41 LEM3	Homo sapiens (Human)	615	cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; DNA repair [GO:0006281]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]	GO:0004519; GO:0005634; GO:0005737; GO:0006281; GO:0006611; GO:0090305; GO:2001022	DNA repair [GO:0006281]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN38569_c0_g1_i1	Q8IV38	ANKY2_HUMAN	39.9	353	197	6	1055	6	15	355	6.80E-66	252.7	ANKY2_HUMAN	reviewed	Ankyrin repeat and MYND domain-containing protein 2	ANKMY2	Homo sapiens (Human)	441	cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	cilium [GO:0005929]	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0005929; GO:0019899; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN30668_c0_g1_i1	Q8BZ25	ANKK1_MOUSE	29.3	232	159	1	394	1089	382	608	1.30E-18	95.5	ANKK1_MOUSE	reviewed	Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1)	Ankk1	Mus musculus (Mouse)	745	cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995	regulation of cell cycle process [GO:0010564]		NA	NA	NA	NA	NA	NA
TRINITY_DN40027_c0_g1_i1	Q8NFD2	ANKK1_HUMAN	36.3	91	56	2	303	34	531	620	1.70E-05	50.8	ANKK1_HUMAN	reviewed	Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase)	ANKK1 PKK2 SGK288	Homo sapiens (Human)	765	cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995	regulation of cell cycle process [GO:0010564]		NA	NA	NA	NA	NA	NA
TRINITY_DN11324_c0_g1_i1	Q92625	ANS1A_HUMAN	53.2	252	110	1	59	814	60	303	1.20E-67	258.1	ANS1A_HUMAN	reviewed	Ankyrin repeat and SAM domain-containing protein 1A (Odin)	ANKS1A ANKS1 KIAA0229 ODIN	Homo sapiens (Human)	1134	cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929]	cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]	ephrin receptor binding [GO:0046875]	GO:0005654; GO:0005829; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187	ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929]		NA	NA	NA	NA	NA	NA
TRINITY_DN6159_c0_g1_i1	Q5M9H0	ANKS3_RAT	30.8	451	236	12	203	1342	139	584	1.80E-32	142.1	ANKS3_RAT	reviewed	Ankyrin repeat and SAM domain-containing protein 3	Anks3	Rattus norvegicus (Rat)	663	cilium [GO:0005929]; cytoplasm [GO:0005737]	cilium [GO:0005929]; cytoplasm [GO:0005737]		GO:0005737; GO:0005929			NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i11	Q68DC2	ANKS6_HUMAN	39.4	406	220	6	2027	888	71	476	1.10E-65	253.1	ANKS6_HUMAN	reviewed	Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	ANKS6 ANKRD14 PKDR1 SAMD6	Homo sapiens (Human)	871	cilium [GO:0005929]; cytoplasm [GO:0005737]	cilium [GO:0005929]; cytoplasm [GO:0005737]		GO:0005737; GO:0005929			NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i2	Q5XJ13	ANKS6_DANRE	54.2	59	27	0	260	84	647	705	1.60E-08	61.6	ANKS6_DANRE	reviewed	Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	anks6 samd6 zgc:85964	Danio rerio (Zebrafish) (Brachydanio rerio)	739	cilium [GO:0005929]; cytoplasm [GO:0005737]; pronephros development [GO:0048793]	cilium [GO:0005929]; cytoplasm [GO:0005737]		GO:0005737; GO:0005929; GO:0048793	pronephros development [GO:0048793]		NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i3	Q68DC2	ANKS6_HUMAN	39.7	353	197	4	1029	19	71	423	4.30E-59	230.3	ANKS6_HUMAN	reviewed	Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	ANKS6 ANKRD14 PKDR1 SAMD6	Homo sapiens (Human)	871	cilium [GO:0005929]; cytoplasm [GO:0005737]	cilium [GO:0005929]; cytoplasm [GO:0005737]		GO:0005737; GO:0005929			NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i5	Q5XJ13	ANKS6_DANRE	40.7	231	132	2	702	25	58	288	6.40E-36	152.5	ANKS6_DANRE	reviewed	Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	anks6 samd6 zgc:85964	Danio rerio (Zebrafish) (Brachydanio rerio)	739	cilium [GO:0005929]; cytoplasm [GO:0005737]; pronephros development [GO:0048793]	cilium [GO:0005929]; cytoplasm [GO:0005737]		GO:0005737; GO:0005929; GO:0048793	pronephros development [GO:0048793]		NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i6	Q5XJ13	ANKS6_DANRE	46.1	76	41	0	286	59	162	237	1.60E-11	70.1	ANKS6_DANRE	reviewed	Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	anks6 samd6 zgc:85964	Danio rerio (Zebrafish) (Brachydanio rerio)	739	cilium [GO:0005929]; cytoplasm [GO:0005737]; pronephros development [GO:0048793]	cilium [GO:0005929]; cytoplasm [GO:0005737]		GO:0005737; GO:0005929; GO:0048793	pronephros development [GO:0048793]		NA	NA	NA	NA	NA	NA
TRINITY_DN2618_c0_g1_i7	P0C0T2	ANKS6_RAT	30.7	579	273	14	1457	84	264	835	5.20E-26	120.6	ANKS6_RAT	reviewed	Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	Anks6 Pkdr1 Samd6	Rattus norvegicus (Rat)	885	ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]	ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737]	identical protein binding [GO:0042802]	GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0042802; GO:0097543	determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]		NA	NA	NA	NA	NA	NA
TRINITY_DN680_c0_g1_i3	Q3SX45	ASB2_BOVIN	25.3	249	143	6	2710	1964	149	354	2.20E-06	56.2	ASB2_BOVIN	reviewed	Ankyrin repeat and SOCS box protein 2 (ASB-2)	ASB2	Bos taurus (Bovine)	633	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]			GO:0016567; GO:0035556	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN680_c0_g1_i6	Q3SX45	ASB2_BOVIN	25.3	249	143	6	3752	3006	149	354	3.00E-06	56.2	ASB2_BOVIN	reviewed	Ankyrin repeat and SOCS box protein 2 (ASB-2)	ASB2	Bos taurus (Bovine)	633	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]			GO:0016567; GO:0035556	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN680_c0_g1_i7	Q3SX45	ASB2_BOVIN	25.3	249	143	6	4035	3289	149	354	3.30E-06	56.2	ASB2_BOVIN	reviewed	Ankyrin repeat and SOCS box protein 2 (ASB-2)	ASB2	Bos taurus (Bovine)	633	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]			GO:0016567; GO:0035556	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1536_c0_g1_i1	P0C6S7	ANS1B_RAT	42.8	397	213	5	440	1618	813	1199	6.20E-72	273.5	ANS1B_RAT	reviewed	Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1)	Anks1b	Rattus norvegicus (Rat)	1260	"Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; receptor localization to synapse [GO:0097120]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]"	"Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]"	ephrin receptor binding [GO:0046875]	GO:0005829; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013; GO:0097120; GO:0098685; GO:0098686; GO:0098978; GO:0099092; GO:0099523; GO:1900383	ephrin receptor signaling pathway [GO:0048013]; receptor localization to synapse [GO:0097120]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]		NA	NA	NA	NA	NA	NA
TRINITY_DN1536_c0_g1_i2	P0C6S7	ANS1B_RAT	42.8	397	213	5	461	1639	813	1199	6.20E-72	273.5	ANS1B_RAT	reviewed	Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1)	Anks1b	Rattus norvegicus (Rat)	1260	"Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; receptor localization to synapse [GO:0097120]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]"	"Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]"	ephrin receptor binding [GO:0046875]	GO:0005829; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013; GO:0097120; GO:0098685; GO:0098686; GO:0098978; GO:0099092; GO:0099523; GO:1900383	ephrin receptor signaling pathway [GO:0048013]; receptor localization to synapse [GO:0097120]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]		NA	NA	NA	NA	NA	NA
TRINITY_DN11324_c0_g1_i2	Q7Z6G8	ANS1B_HUMAN	51.2	289	122	4	1	834	7	287	1.50E-70	267.7	ANS1B_HUMAN	reviewed	Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1)	ANKS1B	Homo sapiens (Human)	1248	Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]	Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ephrin receptor binding [GO:0046875]	GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0043231; GO:0046875; GO:0048013; GO:1900383	ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]		NA	NA	NA	NA	NA	NA
TRINITY_DN11324_c0_g1_i6	Q7Z6G8	ANS1B_HUMAN	53.4	118	45	2	1	324	7	124	1.20E-25	117.9	ANS1B_HUMAN	reviewed	Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1)	ANKS1B	Homo sapiens (Human)	1248	Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]	Cajal body [GO:0015030]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ephrin receptor binding [GO:0046875]	GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0043231; GO:0046875; GO:0048013; GO:1900383	ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]		NA	NA	NA	NA	NA	NA
TRINITY_DN4710_c0_g2_i1	Q58CQ5	ANKZ1_BOVIN	45.8	72	30	2	3	191	649	720	4.60E-10	65.9	ANKZ1_BOVIN	reviewed	Ankyrin repeat and zinc finger domain-containing protein 1	ANKZF1	Bos taurus (Bovine)	728	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]	metal ion binding [GO:0046872]	GO:0005737; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671	cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN4710_c0_g1_i1	Q58CQ5	ANKZ1_BOVIN	32.1	644	366	17	78	1895	4	614	2.10E-62	241.9	ANKZ1_BOVIN	reviewed	Ankyrin repeat and zinc finger domain-containing protein 1	ANKZF1	Bos taurus (Bovine)	728	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]	metal ion binding [GO:0046872]	GO:0005737; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671	cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN4710_c0_g1_i2	Q58CQ5	ANKZ1_BOVIN	30.1	581	335	17	78	1706	4	551	3.90E-44	181	ANKZ1_BOVIN	reviewed	Ankyrin repeat and zinc finger domain-containing protein 1	ANKZF1	Bos taurus (Bovine)	728	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]	metal ion binding [GO:0046872]	GO:0005737; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671	cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN29751_c0_g1_i1	Q9H8Y5	ANKZ1_HUMAN	100	85	0	0	3	257	189	273	1.20E-42	173.3	ANKZ1_HUMAN	reviewed	Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744)	ANKZF1 ZNF744	Homo sapiens (Human)	726	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; membrane [GO:0016020]	metal ion binding [GO:0046872]	GO:0005737; GO:0016020; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671	cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN2446_c0_g1_i1	Q7ZUV0	AN13C_DANRE	66.2	361	120	2	1163	84	129	488	3.30E-137	489.6	AN13C_DANRE	reviewed	Ankyrin repeat domain-containing protein 13C	ankrd13c zgc:56077	Danio rerio (Zebrafish) (Brachydanio rerio)	488	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; signaling receptor binding [GO:0005102]; protein retention in ER lumen [GO:0006621]; regulation of receptor biosynthetic process [GO:0010869]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010869	protein retention in ER lumen [GO:0006621]; regulation of receptor biosynthetic process [GO:0010869]		NA	NA	NA	NA	NA	NA
TRINITY_DN32470_c0_g1_i1	Q3UX43	AN13C_MOUSE	100	108	0	0	325	2	370	477	3.70E-54	211.8	AN13C_MOUSE	reviewed	Ankyrin repeat domain-containing protein 13C	Ankrd13c	Mus musculus (Mouse)	541	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of receptor biosynthetic process [GO:0010869]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010869; GO:0048471; GO:2000209	protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of receptor biosynthetic process [GO:0010869]		NA	NA	NA	NA	NA	NA
TRINITY_DN38659_c0_g1_i1	Q3UX43	AN13C_MOUSE	97	100	3	0	312	13	439	538	3.70E-51	201.8	AN13C_MOUSE	reviewed	Ankyrin repeat domain-containing protein 13C	Ankrd13c	Mus musculus (Mouse)	541	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of receptor biosynthetic process [GO:0010869]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010869; GO:0048471; GO:2000209	protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of receptor biosynthetic process [GO:0010869]		NA	NA	NA	NA	NA	NA
TRINITY_DN25520_c0_g1_i1	Q6NRD0	A13CA_XENLA	100	86	0	0	260	3	183	268	1.10E-45	183.3	A13CA_XENLA	reviewed	Ankyrin repeat domain-containing protein 13C-A	ankrd13c-a	Xenopus laevis (African clawed frog)	510	endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]		GO:0005789			NA	NA	NA	NA	NA	NA
TRINITY_DN27250_c0_g1_i1	Q6PD24	AN13D_MOUSE	96.4	83	3	0	250	2	67	149	1.50E-42	172.9	AN13D_MOUSE	reviewed	Ankyrin repeat domain-containing protein 13D	Ankrd13d	Mus musculus (Mouse)	605	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	negative regulation of receptor internalization [GO:0002091]		NA	NA	NA	NA	NA	NA
TRINITY_DN26299_c0_g1_i1	Q6ZTN6	AN13D_HUMAN	97.4	78	2	0	3	236	375	452	6.60E-37	154.1	AN13D_HUMAN	reviewed	Ankyrin repeat domain-containing protein 13D	ANKRD13D	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	negative regulation of receptor internalization [GO:0002091]		NA	NA	NA	NA	NA	NA
TRINITY_DN4901_c0_g1_i1	Q6ZTN6	AN13D_HUMAN	48.8	84	28	2	130	381	394	462	1.90E-10	67.4	AN13D_HUMAN	reviewed	Ankyrin repeat domain-containing protein 13D	ANKRD13D	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	negative regulation of receptor internalization [GO:0002091]		NA	NA	NA	NA	NA	NA
TRINITY_DN4901_c0_g1_i2	Q6ZTN6	AN13D_HUMAN	66	47	13	2	130	264	394	439	3.70E-07	55.8	AN13D_HUMAN	reviewed	Ankyrin repeat domain-containing protein 13D	ANKRD13D	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	negative regulation of receptor internalization [GO:0002091]		NA	NA	NA	NA	NA	NA
TRINITY_DN4901_c0_g1_i3	Q6PD24	AN13D_MOUSE	53.6	515	221	7	114	1628	5	511	5.90E-154	545.8	AN13D_MOUSE	reviewed	Ankyrin repeat domain-containing protein 13D	Ankrd13d	Mus musculus (Mouse)	605	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	negative regulation of receptor internalization [GO:0002091]		NA	NA	NA	NA	NA	NA
TRINITY_DN4901_c0_g1_i4	Q6PD24	AN13D_MOUSE	51.1	568	245	10	114	1787	5	549	6.30E-157	555.8	AN13D_MOUSE	reviewed	Ankyrin repeat domain-containing protein 13D	Ankrd13d	Mus musculus (Mouse)	605	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	negative regulation of receptor internalization [GO:0002091]		NA	NA	NA	NA	NA	NA
TRINITY_DN5559_c0_g1_i2	Q99NH0	ANR17_MOUSE	71.9	320	75	3	1160	204	455	760	6.20E-126	452.2	ANR17_MOUSE	reviewed	Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)	Ankrd17 Foe Gtar Kiaa0697	Mus musculus (Mouse)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN5559_c0_g1_i3	Q99NH0	ANR17_MOUSE	71.9	320	75	3	1047	91	455	760	4.30E-126	452.6	ANR17_MOUSE	reviewed	Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)	Ankrd17 Foe Gtar Kiaa0697	Mus musculus (Mouse)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN5559_c0_g1_i4	Q99NH0	ANR17_MOUSE	76.8	543	111	3	1829	204	232	760	6.00E-237	821.6	ANR17_MOUSE	reviewed	Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)	Ankrd17 Foe Gtar Kiaa0697	Mus musculus (Mouse)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN5559_c0_g1_i5	Q99NH0	ANR17_MOUSE	76.8	543	111	3	1716	91	232	760	5.60E-237	821.6	ANR17_MOUSE	reviewed	Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)	Ankrd17 Foe Gtar Kiaa0697	Mus musculus (Mouse)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10496_c0_g2_i1	O75179	ANR17_HUMAN	100	175	0	0	527	3	444	618	3.50E-94	345.5	ANR17_HUMAN	reviewed	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	ANKRD17 GTAR KIAA0697	Homo sapiens (Human)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN10496_c0_g2_i2	O75179	ANR17_HUMAN	63.4	175	0	1	335	3	444	618	4.10E-48	191.8	ANR17_HUMAN	reviewed	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	ANKRD17 GTAR KIAA0697	Homo sapiens (Human)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31247_c0_g1_i1	O75179	ANR17_HUMAN	100	118	0	0	354	1	224	341	5.40E-59	228	ANR17_HUMAN	reviewed	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	ANKRD17 GTAR KIAA0697	Homo sapiens (Human)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32903_c0_g1_i1	O75179	ANR17_HUMAN	85	113	17	0	341	3	1073	1185	2.30E-49	196.1	ANR17_HUMAN	reviewed	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	ANKRD17 GTAR KIAA0697	Homo sapiens (Human)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN5559_c0_g1_i1	O75179	ANR17_HUMAN	78.3	152	33	0	536	81	236	387	8.90E-62	238	ANR17_HUMAN	reviewed	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	ANKRD17 GTAR KIAA0697	Homo sapiens (Human)	2603	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32849_c0_g1_i1	Q86SG2	ANR23_HUMAN	44.6	65	36	0	200	6	184	248	4.10E-06	51.6	ANR23_HUMAN	reviewed	Ankyrin repeat domain-containing protein 23 (Diabetes-related ankyrin repeat protein) (Muscle ankyrin repeat protein 3)	ANKRD23 DARP	Homo sapiens (Human)	305	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; myofibril [GO:0030016]; nucleoplasm [GO:0005654]; titin binding [GO:0031432]; response to mechanical stimulus [GO:0009612]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; myofibril [GO:0030016]; nucleoplasm [GO:0005654]	titin binding [GO:0031432]	GO:0005654; GO:0005829; GO:0009612; GO:0014704; GO:0015629; GO:0030016; GO:0031432	response to mechanical stimulus [GO:0009612]		NA	NA	NA	NA	NA	NA
TRINITY_DN28019_c0_g1_i1	Q9ULJ7	ANR50_HUMAN	99	102	1	0	307	2	262	363	5.60E-52	204.5	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38211_c0_g1_i1	Q9ULJ7	ANR50_HUMAN	42.2	83	48	0	5	253	723	805	8.00E-12	70.9	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1988_c0_g1_i1	Q9ULJ7	ANR50_HUMAN	47.7	507	227	5	86	1531	12	505	2.50E-119	430.6	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16891_c0_g2_i1	Q9ULJ7	ANR50_HUMAN	59.2	657	244	4	2008	110	524	1180	1.90E-212	740.3	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i1	Q9ULJ7	ANR50_HUMAN	34.5	235	145	2	260	937	702	936	6.40E-28	126.3	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i10	Q9ULJ7	ANR50_HUMAN	39.1	174	101	1	260	766	702	875	1.90E-25	118.6	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i3	Q9ULJ7	ANR50_HUMAN	39.1	174	101	1	260	766	702	875	1.40E-25	118.6	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i4	Q9ULJ7	ANR50_HUMAN	33.6	301	154	6	260	1144	702	962	9.50E-31	136	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i6	Q9ULJ7	ANR50_HUMAN	31.3	319	172	8	240	1190	726	999	6.80E-26	120.2	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i7	Q9ULJ7	ANR50_HUMAN	31.9	339	183	8	260	1255	702	999	3.30E-31	137.9	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN145_c0_g1_i9	Q9ULJ7	ANR50_HUMAN	39	154	90	1	240	701	726	875	5.10E-20	100.5	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0015031; GO:1990126	"protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2564_c0_g1_i2	Q6DGX3	ANR54_DANRE	43.9	173	97	0	488	1006	127	299	1.30E-34	148.7	ANR54_DANRE	reviewed	Ankyrin repeat domain-containing protein 54	ankrd54 zgc:110569 zgc:92735	Danio rerio (Zebrafish) (Brachydanio rerio)	315	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0030496			NA	NA	NA	NA	NA	NA
TRINITY_DN2564_c0_g1_i3	Q6DGX3	ANR54_DANRE	43.9	173	97	0	503	1021	127	299	1.30E-34	148.7	ANR54_DANRE	reviewed	Ankyrin repeat domain-containing protein 54	ankrd54 zgc:110569 zgc:92735	Danio rerio (Zebrafish) (Brachydanio rerio)	315	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0030496			NA	NA	NA	NA	NA	NA
TRINITY_DN32552_c0_g1_i1	Q91WK7	ANR54_MOUSE	98.8	85	1	0	258	4	148	232	6.10E-44	177.6	ANR54_MOUSE	reviewed	Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein)	Ankrd54 Liar	Mus musculus (Mouse)	299	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	protein-containing complex binding [GO:0044877]; protein kinase regulator activity [GO:0019887]	GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531	nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]		NA	NA	NA	NA	NA	NA
TRINITY_DN6841_c0_g1_i1	E5RJM6	ANR65_HUMAN	36.1	83	49	1	124	372	236	314	3.10E-05	50.1	ANR65_HUMAN	reviewed	Ankyrin repeat domain-containing protein 65	ANKRD65	Homo sapiens (Human)	399							NA	NA	NA	NA	NA	NA
TRINITY_DN6841_c0_g1_i2	E5RJM6	ANR65_HUMAN	36.1	83	49	1	124	372	236	314	3.10E-05	50.1	ANR65_HUMAN	reviewed	Ankyrin repeat domain-containing protein 65	ANKRD65	Homo sapiens (Human)	399							NA	NA	NA	NA	NA	NA
TRINITY_DN28296_c0_g1_i1	Q54KA7	SECG_DICDI	37.2	121	74	2	432	73	336	455	1.60E-11	70.9	SECG_DICDI	reviewed	"Ankyrin repeat, PH and SEC7 domain containing protein secG"	secG DDB_G0287459	Dictyostelium discoideum (Slime mold)	986	cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]	cytosol [GO:0005829]; lysosome [GO:0005764]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327	actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i21	Q54KA7	SECG_DICDI	29.1	485	322	8	2322	874	61	525	1.90E-47	192.6	SECG_DICDI	reviewed	"Ankyrin repeat, PH and SEC7 domain containing protein secG"	secG DDB_G0287459	Dictyostelium discoideum (Slime mold)	986	cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]	cytosol [GO:0005829]; lysosome [GO:0005764]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327	actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i30	Q54KA7	SECG_DICDI	29.1	485	322	8	2280	832	61	525	1.90E-47	192.6	SECG_DICDI	reviewed	"Ankyrin repeat, PH and SEC7 domain containing protein secG"	secG DDB_G0287459	Dictyostelium discoideum (Slime mold)	986	cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]	cytosol [GO:0005829]; lysosome [GO:0005764]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327	actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN16887_c0_g1_i2	Q00PJ3	ASZ1_ATEAB	40.5	116	68	1	75	422	68	182	6.40E-18	92	ASZ1_ATEAB	reviewed	"Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)"	ASZ1 GASZ	Atelerix albiventris (Middle-African hedgehog) (Four-toed hedgehog)	475	pi-body [GO:0071546]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	pi-body [GO:0071546]		GO:0007140; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN16887_c0_g1_i3	Q00PJ3	ASZ1_ATEAB	38.5	143	83	2	496	912	41	182	2.10E-20	101.3	ASZ1_ATEAB	reviewed	"Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)"	ASZ1 GASZ	Atelerix albiventris (Middle-African hedgehog) (Four-toed hedgehog)	475	pi-body [GO:0071546]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	pi-body [GO:0071546]		GO:0007140; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN16887_c0_g1_i4	Q07DZ7	ASZ1_ORNAN	33.6	268	168	4	511	1299	48	310	6.00E-31	136.7	ASZ1_ORNAN	reviewed	"Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)"	ASZ1 GASZ	Ornithorhynchus anatinus (Duckbill platypus)	474	pi-body [GO:0071546]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	pi-body [GO:0071546]		GO:0007140; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i11	Q02357	ANK1_MOUSE	28.4	694	452	15	2264	285	73	755	4.10E-50	201.4	ANK1_MOUSE	reviewed	Ankyrin-1 (ANK-1) (Erythrocyte ankyrin)	Ank1 Ank-1	Mus musculus (Mouse)	1862	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]	GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i16	Q02357	ANK1_MOUSE	28.4	694	452	15	2222	243	73	755	4.00E-50	201.4	ANK1_MOUSE	reviewed	Ankyrin-1 (ANK-1) (Erythrocyte ankyrin)	Ank1 Ank-1	Mus musculus (Mouse)	1862	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]	GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i9	Q02357	ANK1_MOUSE	30.7	560	361	9	2159	531	73	622	3.50E-51	204.9	ANK1_MOUSE	reviewed	Ankyrin-1 (ANK-1) (Erythrocyte ankyrin)	Ank1 Ank-1	Mus musculus (Mouse)	1862	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]	GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2971_c0_g1_i2	Q8C8R3	ANK2_MOUSE	65.6	337	114	1	1127	117	1001	1335	2.70E-128	459.9	ANK2_MOUSE	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin)	Ank2 AnkB	Mus musculus (Mouse)	3898	A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-macromolecule adaptor activity [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]	A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-macromolecule adaptor activity [GO:0030674]	GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN27192_c0_g1_i1	Q8C8R3	ANK2_MOUSE	39.7	121	71	1	23	385	235	353	1.10E-16	87.8	ANK2_MOUSE	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin)	Ank2 AnkB	Mus musculus (Mouse)	3898	A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-macromolecule adaptor activity [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]	A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-macromolecule adaptor activity [GO:0030674]	GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN2438_c0_g1_i1	Q8C8R3	ANK2_MOUSE	67.9	290	93	0	1	870	478	767	7.00E-108	391.7	ANK2_MOUSE	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin)	Ank2 AnkB	Mus musculus (Mouse)	3898	A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-macromolecule adaptor activity [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]	A band [GO:0031672]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-macromolecule adaptor activity [GO:0030674]	GO:0002027; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN12310_c0_g1_i2	Q01484	ANK2_HUMAN	65.1	109	37	1	1	327	277	384	5.20E-36	151.8	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN12310_c0_g1_i3	Q01484	ANK2_HUMAN	74.3	136	35	0	1	408	277	412	1.30E-56	220.3	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN38094_c0_g1_i1	Q01484	ANK2_HUMAN	32.8	119	64	4	351	13	664	772	2.10E-07	56.6	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN2436_c0_g1_i1	Q01484	ANK2_HUMAN	32.7	156	104	1	175	642	664	818	2.60E-15	85.1	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN10537_c0_g1_i3	Q01484	ANK2_HUMAN	50.9	55	26	1	21	185	465	518	2.00E-06	52.8	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i10	Q01484	ANK2_HUMAN	33.3	306	202	1	1391	474	291	594	5.20E-34	147.9	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN1638_c0_g1_i10	Q01484	ANK2_HUMAN	29.1	285	176	7	2167	1331	367	631	5.20E-18	94.7	ANK2_HUMAN	reviewed	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	ANK2 ANKB	Homo sapiens (Human)	3957	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]		NA	NA	NA	NA	NA	NA
TRINITY_DN2971_c0_g1_i5	G5E8K5	ANK3_MOUSE	64.7	34	12	0	194	93	1111	1144	2.00E-05	49.7	ANK3_MOUSE	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	Ank3	Mus musculus (Mouse)	1961	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN2971_c0_g1_i6	O70511	ANK3_RAT	62	166	61	1	571	74	1025	1188	4.10E-56	219.2	ANK3_RAT	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	Ank3	Rattus norvegicus (Rat)	2622	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005856; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN30236_c0_g1_i1	G5E8K5	ANK3_MOUSE	74.7	79	20	0	241	5	21	99	3.20E-27	122.1	ANK3_MOUSE	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	Ank3	Mus musculus (Mouse)	1961	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN12310_c0_g1_i1	Q12955	ANK3_HUMAN	72.2	54	15	0	1	162	279	332	1.20E-16	86.7	ANK3_HUMAN	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	ANK3	Homo sapiens (Human)	4377	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38111_c0_g1_i1	Q12955	ANK3_HUMAN	96.4	83	3	0	2	250	159	241	4.20E-37	154.8	ANK3_HUMAN	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	ANK3	Homo sapiens (Human)	4377	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i12	Q12955	ANK3_HUMAN	28.5	319	195	10	247	1188	331	621	3.40E-17	91.3	ANK3_HUMAN	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	ANK3	Homo sapiens (Human)	4377	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN35367_c0_g1_i1	Q12955	ANK3_HUMAN	33.3	189	122	1	607	41	616	800	6.50E-21	102.4	ANK3_HUMAN	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	ANK3	Homo sapiens (Human)	4377	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2438_c0_g3_i1	O70511	ANK3_RAT	56.2	96	38	2	21	308	772	863	5.20E-20	98.6	ANK3_RAT	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	Ank3	Rattus norvegicus (Rat)	2622	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005856; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN15284_c0_g1_i1	P04083	ANXA1_HUMAN	96.7	92	3	0	291	16	255	346	1.30E-45	183.3	ANXA1_HUMAN	reviewed	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)	ANXA1 ANX1 LPC1	Homo sapiens (Human)	346	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; mast cell granule [GO:0042629]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; identical protein binding [GO:0042802]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gliogenesis [GO:0042063]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of protein secretion [GO:0050709]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; mast cell granule [GO:0042629]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]	cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; identical protein binding [GO:0042802]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0001533; GO:0001780; GO:0001891; GO:0002250; GO:0002548; GO:0002685; GO:0003697; GO:0003727; GO:0005102; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006909; GO:0006954; GO:0007165; GO:0007166; GO:0007186; GO:0007187; GO:0008360; GO:0009986; GO:0010165; GO:0014839; GO:0016323; GO:0016324; GO:0016328; GO:0018149; GO:0019221; GO:0019834; GO:0019898; GO:0030073; GO:0030216; GO:0030659; GO:0030850; GO:0031018; GO:0031232; GO:0031313; GO:0031340; GO:0031394; GO:0031514; GO:0031532; GO:0031901; GO:0031966; GO:0031982; GO:0032355; GO:0032508; GO:0032652; GO:0032717; GO:0032743; GO:0032991; GO:0033031; GO:0035924; GO:0036121; GO:0042063; GO:0042102; GO:0042127; GO:0042383; GO:0042493; GO:0042629; GO:0042802; GO:0043066; GO:0043434; GO:0045087; GO:0045627; GO:0045629; GO:0045920; GO:0046632; GO:0046883; GO:0048306; GO:0050482; GO:0050709; GO:0050727; GO:0062023; GO:0070062; GO:0070301; GO:0070365; GO:0070459; GO:0070555; GO:0071385; GO:0071621; GO:0090050; GO:0090303; GO:0097060; GO:0097350; GO:0098641; GO:1900087; GO:1900138; GO:1990814	"actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; gliogenesis [GO:0042063]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of protein secretion [GO:0050709]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15284_c0_g1_i2	P04083	ANXA1_HUMAN	100	92	0	0	291	16	255	346	2.30E-47	189.1	ANXA1_HUMAN	reviewed	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)	ANXA1 ANX1 LPC1	Homo sapiens (Human)	346	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; mast cell granule [GO:0042629]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; identical protein binding [GO:0042802]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gliogenesis [GO:0042063]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of protein secretion [GO:0050709]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; mast cell granule [GO:0042629]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]	cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; identical protein binding [GO:0042802]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0001533; GO:0001780; GO:0001891; GO:0002250; GO:0002548; GO:0002685; GO:0003697; GO:0003727; GO:0005102; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006909; GO:0006954; GO:0007165; GO:0007166; GO:0007186; GO:0007187; GO:0008360; GO:0009986; GO:0010165; GO:0014839; GO:0016323; GO:0016324; GO:0016328; GO:0018149; GO:0019221; GO:0019834; GO:0019898; GO:0030073; GO:0030216; GO:0030659; GO:0030850; GO:0031018; GO:0031232; GO:0031313; GO:0031340; GO:0031394; GO:0031514; GO:0031532; GO:0031901; GO:0031966; GO:0031982; GO:0032355; GO:0032508; GO:0032652; GO:0032717; GO:0032743; GO:0032991; GO:0033031; GO:0035924; GO:0036121; GO:0042063; GO:0042102; GO:0042127; GO:0042383; GO:0042493; GO:0042629; GO:0042802; GO:0043066; GO:0043434; GO:0045087; GO:0045627; GO:0045629; GO:0045920; GO:0046632; GO:0046883; GO:0048306; GO:0050482; GO:0050709; GO:0050727; GO:0062023; GO:0070062; GO:0070301; GO:0070365; GO:0070459; GO:0070555; GO:0071385; GO:0071621; GO:0090050; GO:0090303; GO:0097060; GO:0097350; GO:0098641; GO:1900087; GO:1900138; GO:1990814	"actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; gliogenesis [GO:0042063]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of protein secretion [GO:0050709]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28799_c0_g1_i1	P50995	ANX11_HUMAN	100	94	0	0	3	284	412	505	4.90E-48	191.4	ANX11_HUMAN	reviewed	Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50)	ANXA11 ANX11	Homo sapiens (Human)	505	azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592]	azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]	GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006909; GO:0008429; GO:0016020; GO:0023026; GO:0030496; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0062023; GO:0070062	cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN37309_c0_g1_i1	P33477	ANX11_RABIT	95	101	5	0	3	305	177	277	7.50E-49	194.1	ANX11_RABIT	reviewed	Annexin A11 (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50)	ANXA11 ANX11	Oryctolagus cuniculus (Rabbit)	503	melanosome [GO:0042470]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]	melanosome [GO:0042470]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; S100 protein binding [GO:0044548]	GO:0005509; GO:0005544; GO:0005635; GO:0005654; GO:0005819; GO:0030496; GO:0032506; GO:0042470; GO:0044548	cytokinetic process [GO:0032506]		NA	NA	NA	NA	NA	NA
TRINITY_DN36140_c0_g1_i1	Q6TEQ7	ANXA2_CANLF	100	79	0	0	1	237	256	334	1.60E-38	159.5	ANXA2_CANLF	reviewed	Annexin A2 (Annexin-2)	ANXA2 ANX2	Canis lupus familiaris (Dog) (Canis familiaris)	339	"basement membrane [GO:0005604]; cytoplasm [GO:0005737]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cytoskeletal protein binding [GO:0008092]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; Rab GTPase binding [GO:0017137]; virion binding [GO:0046790]"	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; Rab GTPase binding [GO:0017137]; virion binding [GO:0046790]"	GO:0001786; GO:0002020; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005604; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0008092; GO:0017137; GO:0019834; GO:0031982; GO:0046790; GO:0070382			NA	NA	NA	NA	NA	NA
TRINITY_DN33737_c0_g1_i1	Q6TEQ7	ANXA2_CANLF	100	92	0	0	277	2	246	337	3.80E-47	188.3	ANXA2_CANLF	reviewed	Annexin A2 (Annexin-2)	ANXA2 ANX2	Canis lupus familiaris (Dog) (Canis familiaris)	339	"basement membrane [GO:0005604]; cytoplasm [GO:0005737]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cytoskeletal protein binding [GO:0008092]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; Rab GTPase binding [GO:0017137]; virion binding [GO:0046790]"	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; Rab GTPase binding [GO:0017137]; virion binding [GO:0046790]"	GO:0001786; GO:0002020; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005604; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0008092; GO:0017137; GO:0019834; GO:0031982; GO:0046790; GO:0070382			NA	NA	NA	NA	NA	NA
TRINITY_DN35897_c0_g1_i1	P09525	ANXA4_HUMAN	100	73	0	0	221	3	236	308	5.80E-35	147.5	ANXA4_HUMAN	reviewed	Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)	ANXA4 ANX4	Homo sapiens (Human)	319	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phospholipase inhibitor activity [GO:0004859]; epithelial cell differentiation [GO:0030855]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phospholipase inhibitor activity [GO:0004859]	GO:0004859; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006357; GO:0007165; GO:0007219; GO:0009986; GO:0012506; GO:0030855; GO:0031965; GO:0032088; GO:0032717; GO:0042802; GO:0043066; GO:0048306; GO:0048471; GO:0051059; GO:0062023; GO:0070062	epithelial cell differentiation [GO:0030855]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33831_c0_g1_i1	P97429	ANXA4_MOUSE	100	86	0	0	2	259	232	317	1.20E-42	173.3	ANXA4_MOUSE	reviewed	Annexin A4 (Annexin IV) (Annexin-4)	Anxa4 Anx4	Mus musculus (Mouse)	319	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; epithelial cell differentiation [GO:0030855]; kidney development [GO:0001822]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]	GO:0001822; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006357; GO:0007219; GO:0009986; GO:0012506; GO:0016324; GO:0030855; GO:0031965; GO:0032088; GO:0032717; GO:0042802; GO:0048306; GO:0048471; GO:0051059; GO:0062023	epithelial cell differentiation [GO:0030855]; kidney development [GO:0001822]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32426_c0_g1_i1	P08758	ANXA5_HUMAN	100	72	0	0	217	2	247	318	7.60E-35	147.1	ANXA5_HUMAN	reviewed	Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)	ANXA5 ANX5 ENX2 PP4	Homo sapiens (Human)	320	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; platelet degranulation [GO:0002576]; response to organic substance [GO:0010033]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543]	GO:0002576; GO:0004859; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005737; GO:0005829; GO:0005925; GO:0007165; GO:0007596; GO:0009897; GO:0010033; GO:0016020; GO:0043066; GO:0050819; GO:0062023; GO:0070062; GO:0072563	blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; platelet degranulation [GO:0002576]; response to organic substance [GO:0010033]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38113_c0_g1_i1	P48036	ANXA5_MOUSE	100	77	0	0	232	2	232	308	5.50E-36	151	ANXA5_MOUSE	reviewed	Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)	Anxa5 Anx5	Mus musculus (Mouse)	319	"axon terminus [GO:0043679]; cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; receptor tyrosine kinase binding [GO:0030971]; blood coagulation [GO:0007596]; cellular response to gonadotropin-releasing hormone [GO:0097211]; negative regulation of blood coagulation [GO:0030195]; negative regulation of prolactin secretion [GO:1902721]; positive regulation of apoptotic process [GO:0043065]; regulation of flagellated sperm motility [GO:1901317]; response to calcium ion [GO:0051592]; response to organic substance [GO:0010033]"	axon terminus [GO:0043679]; cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018]	"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; receptor tyrosine kinase binding [GO:0030971]"	GO:0005388; GO:0005509; GO:0005544; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007596; GO:0008021; GO:0009897; GO:0010033; GO:0014704; GO:0017046; GO:0030018; GO:0030195; GO:0030425; GO:0030971; GO:0042383; GO:0042802; GO:0042995; GO:0043025; GO:0043065; GO:0043204; GO:0043679; GO:0051592; GO:0062023; GO:0072563; GO:0097211; GO:1901317; GO:1902721	blood coagulation [GO:0007596]; cellular response to gonadotropin-releasing hormone [GO:0097211]; negative regulation of blood coagulation [GO:0030195]; negative regulation of prolactin secretion [GO:1902721]; positive regulation of apoptotic process [GO:0043065]; regulation of flagellated sperm motility [GO:1901317]; response to calcium ion [GO:0051592]; response to organic substance [GO:0010033]		NA	NA	NA	NA	NA	NA
TRINITY_DN488_c0_g1_i1	Q4R4H7	ANXA5_MACFA	46.9	113	58	1	436	104	19	131	3.70E-17	89.7	ANXA5_MACFA	reviewed	Annexin A5 (Annexin V) (Annexin-5)	ANXA5 QnpA-14191	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	320	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544; GO:0007596; GO:0009897; GO:0010033; GO:0050819; GO:0072563	blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]		NA	NA	NA	NA	NA	NA
TRINITY_DN488_c0_g1_i3	Q4R4H7	ANXA5_MACFA	41.7	144	82	1	571	146	19	162	2.00E-20	100.9	ANXA5_MACFA	reviewed	Annexin A5 (Annexin V) (Annexin-5)	ANXA5 QnpA-14191	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	320	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544; GO:0007596; GO:0009897; GO:0010033; GO:0050819; GO:0072563	blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]		NA	NA	NA	NA	NA	NA
TRINITY_DN488_c0_g1_i6	Q4R4H7	ANXA5_MACFA	46.9	113	58	1	433	101	19	131	3.70E-17	89.7	ANXA5_MACFA	reviewed	Annexin A5 (Annexin V) (Annexin-5)	ANXA5 QnpA-14191	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	320	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544; GO:0007596; GO:0009897; GO:0010033; GO:0050819; GO:0072563	blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]		blue	blue	NA	NA	NA	NA
TRINITY_DN488_c0_g1_i7	Q4R4H7	ANXA5_MACFA	39.4	297	173	3	978	109	19	315	5.70E-46	186.4	ANXA5_MACFA	reviewed	Annexin A5 (Annexin V) (Annexin-5)	ANXA5 QnpA-14191	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	320	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]	endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544; GO:0007596; GO:0009897; GO:0010033; GO:0050819; GO:0072563	blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]		black	black	1	NA	NA	1
TRINITY_DN38853_c0_g1_i1	P14824	ANXA6_MOUSE	100	78	0	0	2	235	71	148	3.50E-38	158.3	ANXA6_MOUSE	reviewed	Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70)	Anxa6 Anx6	Mus musculus (Mouse)	673	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]	GO:0001755; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005634; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005925; GO:0006816; GO:0006937; GO:0008289; GO:0014704; GO:0015276; GO:0015485; GO:0016020; GO:0016324; GO:0031902; GO:0032991; GO:0034220; GO:0035374; GO:0042383; GO:0042470; GO:0042802; GO:0044877; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0062023; GO:0097190	apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]		NA	NA	NA	NA	NA	NA
TRINITY_DN33020_c0_g1_i1	P08133	ANXA6_HUMAN	100	76	0	0	230	3	247	322	7.10E-36	150.6	ANXA6_HUMAN	reviewed	Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70)	ANXA6 ANX6	Homo sapiens (Human)	673	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; apoptotic signaling pathway [GO:0097190]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]	actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]	GO:0001755; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005737; GO:0005739; GO:0005765; GO:0005925; GO:0006937; GO:0008289; GO:0015276; GO:0015485; GO:0016020; GO:0031902; GO:0034220; GO:0035374; GO:0042470; GO:0042802; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0062023; GO:0070062; GO:0097190	apoptotic signaling pathway [GO:0097190]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]		NA	NA	NA	NA	NA	NA
TRINITY_DN21130_c0_g1_i1	P48037	ANXA6_RAT	98.8	81	1	0	244	2	441	521	9.10E-37	153.7	ANXA6_RAT	reviewed	Annexin A6 (Annexin VI) (Annexin-6) (Calcium-binding protein 65/67) (CBP 65/67)	Anxa6 Anx6	Rattus norvegicus (Rat)	673	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]; secretion [GO:0046903]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]	GO:0001755; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005634; GO:0005737; GO:0005739; GO:0005765; GO:0005925; GO:0006816; GO:0006937; GO:0008289; GO:0014704; GO:0015276; GO:0015485; GO:0016020; GO:0016324; GO:0031902; GO:0032991; GO:0034220; GO:0035374; GO:0042383; GO:0042470; GO:0042802; GO:0044877; GO:0046903; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0097190	apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]; secretion [GO:0046903]		NA	NA	NA	NA	NA	NA
TRINITY_DN21130_c0_g1_i2	P48037	ANXA6_RAT	98.8	81	1	0	244	2	441	521	9.10E-37	153.7	ANXA6_RAT	reviewed	Annexin A6 (Annexin VI) (Annexin-6) (Calcium-binding protein 65/67) (CBP 65/67)	Anxa6 Anx6	Rattus norvegicus (Rat)	673	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]; secretion [GO:0046903]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]	GO:0001755; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005634; GO:0005737; GO:0005739; GO:0005765; GO:0005925; GO:0006816; GO:0006937; GO:0008289; GO:0014704; GO:0015276; GO:0015485; GO:0016020; GO:0016324; GO:0031902; GO:0032991; GO:0034220; GO:0035374; GO:0042383; GO:0042470; GO:0042802; GO:0044877; GO:0046903; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0097190	apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]; secretion [GO:0046903]		NA	NA	NA	NA	NA	NA
TRINITY_DN220_c0_g1_i2	P20072	ANXA7_BOVIN	49	310	157	1	75	1001	153	462	3.40E-80	300.1	ANXA7_BOVIN	reviewed	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7	Bos taurus (Bovine)	463	chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]	chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0042584			NA	NA	NA	NA	NA	NA
TRINITY_DN36260_c0_g1_i1	P20073	ANXA7_HUMAN	100	68	0	0	204	1	176	243	1.00E-30	133.3	ANXA7_HUMAN	reviewed	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	Homo sapiens (Human)	488	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; RNA binding [GO:0003723]	GO:0003723; GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0048306; GO:0051592; GO:0061025; GO:0062023; GO:0070062	autophagy [GO:0006914]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN28556_c0_g1_i1	P20073	ANXA7_HUMAN	41.2	136	79	1	30	434	176	311	8.00E-20	98.2	ANXA7_HUMAN	reviewed	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	Homo sapiens (Human)	488	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; RNA binding [GO:0003723]	GO:0003723; GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0016020; GO:0030855; GO:0048306; GO:0051592; GO:0061025; GO:0062023; GO:0070062	autophagy [GO:0006914]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN220_c0_g1_i3	Q9VXG4	ANX11_DROME	45.2	334	167	3	76	1071	187	506	2.20E-77	290.8	ANX11_DROME	reviewed	Annexin B11	AnxB11 CG9968	Drosophila melanogaster (Fruit fly)	511	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]	cytoplasm [GO:0005737]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN220_c0_g1_i1	P22464	ANXB9_DROME	47.8	335	158	3	62	1057	1	321	1.70E-77	291.2	ANXB9_DROME	reviewed	Annexin B9 (Annexin IX) (Annexin-9)	AnxB9 AnnIX CG5730	Drosophila melanogaster (Fruit fly)	324	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; spectrin binding [GO:0030507]; endosome transport via multivesicular body sorting pathway [GO:0032509]; maintenance of cell polarity [GO:0030011]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; spectrin binding [GO:0030507]	GO:0005509; GO:0005544; GO:0005737; GO:0005938; GO:0012505; GO:0030011; GO:0030507; GO:0032509; GO:0048190	endosome transport via multivesicular body sorting pathway [GO:0032509]; maintenance of cell polarity [GO:0030011]; wing disc dorsal/ventral pattern formation [GO:0048190]		blue	blue	NA	NA	NA	NA
TRINITY_DN220_c0_g1_i4	P22464	ANXB9_DROME	50.8	307	150	1	72	989	13	319	2.60E-80	300.4	ANXB9_DROME	reviewed	Annexin B9 (Annexin IX) (Annexin-9)	AnxB9 AnnIX CG5730	Drosophila melanogaster (Fruit fly)	324	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; spectrin binding [GO:0030507]; endosome transport via multivesicular body sorting pathway [GO:0032509]; maintenance of cell polarity [GO:0030011]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; spectrin binding [GO:0030507]	GO:0005509; GO:0005544; GO:0005737; GO:0005938; GO:0012505; GO:0030011; GO:0030507; GO:0032509; GO:0048190	endosome transport via multivesicular body sorting pathway [GO:0032509]; maintenance of cell polarity [GO:0030011]; wing disc dorsal/ventral pattern formation [GO:0048190]		blue	blue	NA	NA	NA	NA
TRINITY_DN17049_c0_g1_i1	P26256	ANX12_HYDVU	47	83	44	0	2	250	178	260	4.80E-17	88.2	ANX12_HYDVU	reviewed	Annexin-B12 (Annexin XII) (Annexin-12)	ANXB12	Hydra vulgaris (Hydra) (Hydra attenuata)	316	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]		calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544			NA	NA	NA	NA	NA	NA
TRINITY_DN8534_c0_g1_i2	P26256	ANX12_HYDVU	45.5	156	84	1	16	483	159	313	4.60E-31	136	ANX12_HYDVU	reviewed	Annexin-B12 (Annexin XII) (Annexin-12)	ANXB12	Hydra vulgaris (Hydra) (Hydra attenuata)	316	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]		calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005544			NA	NA	NA	NA	NA	NA
TRINITY_DN4248_c0_g1_i1	P52183	ANNU_SCHAM	47.1	741	371	8	36	2207	35	771	8.80E-206	718.4	ANNU_SCHAM	reviewed	Annulin (Protein-glutamine gamma-glutamyltransferase) (EC 2.3.2.13) (Transglutaminase)		Schistocerca americana (American grasshopper)	772	plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0005886; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		blue	blue	NA	NA	NA	NA
TRINITY_DN4248_c0_g1_i2	P52183	ANNU_SCHAM	48	712	356	7	87	2192	64	771	1.10E-205	718	ANNU_SCHAM	reviewed	Annulin (Protein-glutamine gamma-glutamyltransferase) (EC 2.3.2.13) (Transglutaminase)		Schistocerca americana (American grasshopper)	772	plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0005886; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN4248_c0_g1_i3	P52183	ANNU_SCHAM	47.9	653	327	6	30	1961	123	771	7.90E-190	665.2	ANNU_SCHAM	reviewed	Annulin (Protein-glutamine gamma-glutamyltransferase) (EC 2.3.2.13) (Transglutaminase)		Schistocerca americana (American grasshopper)	772	plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0005886; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN8474_c0_g1_i2	Q5XXA6	ANO1_HUMAN	53.8	93	38	1	1	279	283	370	7.90E-21	100.9	ANO1_HUMAN	reviewed	Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2)	ANO1 DOG1 ORAOV2 TAOS2 TMEM16A	Homo sapiens (Human)	986	apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated chloride channel activity [GO:0005247]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; cellular response to peptide [GO:1901653]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; ion transmembrane transport [GO:0034220]; multicellular organism development [GO:0007275]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated chloride channel activity [GO:0005247]	GO:0005102; GO:0005227; GO:0005229; GO:0005247; GO:0005254; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007200; GO:0007275; GO:0015111; GO:0015705; GO:0016324; GO:0034220; GO:0034605; GO:0034707; GO:0035774; GO:0042803; GO:0045121; GO:0046872; GO:0050965; GO:0055085; GO:0070062; GO:1901653; GO:1902476	cation transport [GO:0006812]; cellular response to heat [GO:0034605]; cellular response to peptide [GO:1901653]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; ion transmembrane transport [GO:0034220]; multicellular organism development [GO:0007275]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8474_c0_g1_i1	Q8BHY3	ANO1_MOUSE	58.7	75	31	0	122	346	296	370	1.80E-19	96.7	ANO1_MOUSE	reviewed	Anoctamin-1 (Transmembrane protein 16A)	Ano1 Tmem16a	Mus musculus (Mouse)	960	apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated chloride channel activity [GO:0005247]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; cellular response to peptide [GO:1901653]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of membrane potential [GO:0042391]; trachea development [GO:0060438]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated chloride channel activity [GO:0005247]	GO:0005102; GO:0005227; GO:0005229; GO:0005247; GO:0005254; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007200; GO:0009897; GO:0015111; GO:0015705; GO:0016324; GO:0034605; GO:0034707; GO:0035774; GO:0042391; GO:0042802; GO:0042803; GO:0045121; GO:0046872; GO:0050965; GO:0055085; GO:0060438; GO:1901653; GO:1902476	cation transport [GO:0006812]; cellular response to heat [GO:0034605]; cellular response to peptide [GO:1901653]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; iodide transport [GO:0015705]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of membrane potential [GO:0042391]; trachea development [GO:0060438]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i9	Q9NQ90	ANO2_HUMAN	34.8	161	94	3	1	471	830	983	2.70E-20	100.1	ANO2_HUMAN	reviewed	Anoctamin-2 (Transmembrane protein 16B)	ANO2 C12orf3 TMEM16B	Homo sapiens (Human)	1003	chloride channel complex [GO:0034707]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel complex [GO:0034707]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0034220; GO:0034707; GO:0042802; GO:0046983; GO:0055085; GO:0097730; GO:1902476	chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i7	A2AHL1	ANO3_MOUSE	50	92	43	1	67	333	886	977	3.50E-16	86.3	ANO3_MOUSE	reviewed	Anoctamin-3 (Transmembrane protein 16C)	Ano3 Tmem16c	Mus musculus (Mouse)	981	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005254; GO:0005886; GO:0016021; GO:0016048; GO:0017128; GO:0046983; GO:0050982; GO:0055085; GO:0061590; GO:0061591; GO:1902476	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i4	A6QLE6	ANO4_BOVIN	45	373	179	6	20	1075	533	900	1.70E-83	311.2	ANO4_BOVIN	reviewed	Anoctamin-4 (Transmembrane protein 16D)	ANO4 TMEM16D	Bos taurus (Bovine)	920	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005886; GO:0016021; GO:0046983; GO:0055085; GO:0061588; GO:1902476	calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i5	A6QLE6	ANO4_BOVIN	45.1	388	187	6	9	1109	518	900	3.50E-87	323.6	ANO4_BOVIN	reviewed	Anoctamin-4 (Transmembrane protein 16D)	ANO4 TMEM16D	Bos taurus (Bovine)	920	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005886; GO:0016021; GO:0046983; GO:0055085; GO:0061588; GO:1902476	calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15790_c0_g1_i3	Q75V66	ANO5_HUMAN	33.8	130	69	4	113	496	101	215	3.60E-08	59.7	ANO5_HUMAN	reviewed	Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)	ANO5 GDD1 TMEM16E	Homo sapiens (Human)	913	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983; GO:0055085; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15790_c0_g1_i6	Q75V66	ANO5_HUMAN	33.3	150	67	5	113	553	101	220	3.10E-08	60.1	ANO5_HUMAN	reviewed	Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)	ANO5 GDD1 TMEM16E	Homo sapiens (Human)	913	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983; GO:0055085; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i1	Q75V66	ANO5_HUMAN	39.5	157	89	4	14	472	735	889	6.10E-24	112.5	ANO5_HUMAN	reviewed	Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)	ANO5 GDD1 TMEM16E	Homo sapiens (Human)	913	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983; GO:0055085; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN33591_c0_g1_i1	Q4KMQ2	ANO6_HUMAN	100	89	0	0	2	268	540	628	1.00E-49	196.8	ANO6_HUMAN	reviewed	Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F)	ANO6 TMEM16F	Homo sapiens (Human)	910	"cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"	cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]	GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005254; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035630; GO:0035725; GO:0042803; GO:0043065; GO:0043312; GO:0045794; GO:0046872; GO:0046931; GO:0055085; GO:0060100; GO:0061589; GO:0061590; GO:0061591; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353	"activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21798_c0_g1_i1	Q4KMQ2	ANO6_HUMAN	99	103	1	0	1	309	662	764	2.80E-51	202.2	ANO6_HUMAN	reviewed	Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F)	ANO6 TMEM16F	Homo sapiens (Human)	910	"cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"	cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]	GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005254; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035630; GO:0035725; GO:0042803; GO:0043065; GO:0043312; GO:0045794; GO:0046872; GO:0046931; GO:0055085; GO:0060100; GO:0061589; GO:0061590; GO:0061591; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353	"activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21798_c0_g1_i2	Q4KMQ2	ANO6_HUMAN	100	102	0	0	1	306	662	763	1.00E-50	200.3	ANO6_HUMAN	reviewed	Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F)	ANO6 TMEM16F	Homo sapiens (Human)	910	"cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"	cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]	GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005254; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035630; GO:0035725; GO:0042803; GO:0043065; GO:0043312; GO:0045794; GO:0046872; GO:0046931; GO:0055085; GO:0060100; GO:0061589; GO:0061590; GO:0061591; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353	"activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; bone mineralization involved in bone maturation [GO:0035630]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; neutrophil degranulation [GO:0043312]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i3	Q14AT5	ANO7_MOUSE	53.6	69	32	0	17	223	504	572	5.50E-16	84.7	ANO7_MOUSE	reviewed	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	Ano7 Ngep Tmem16g	Mus musculus (Mouse)	859	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0055085; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c0_g1_i8	Q14AT5	ANO7_MOUSE	50.6	85	42	0	3	257	488	572	6.10E-19	94.7	ANO7_MOUSE	reviewed	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	Ano7 Ngep Tmem16g	Mus musculus (Mouse)	859	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0055085; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN14444_c0_g1_i2	Q14AT5	ANO7_MOUSE	53.4	817	350	9	2554	143	55	853	1.10E-245	851.3	ANO7_MOUSE	reviewed	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	Ano7 Ngep Tmem16g	Mus musculus (Mouse)	859	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0055085; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN14444_c0_g1_i3	Q14AT5	ANO7_MOUSE	53.4	817	350	9	2554	143	55	853	1.00E-245	851.3	ANO7_MOUSE	reviewed	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	Ano7 Ngep Tmem16g	Mus musculus (Mouse)	859	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0055085; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN14444_c0_g1_i5	Q6IFT6	ANO7_RAT	50.4	575	264	6	1833	124	55	613	2.90E-163	577	ANO7_RAT	reviewed	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	Ano7 Ngep Tmem16g	Rattus norvegicus (Rat)	860	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0055085; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN26987_c0_g1_i1	Q9HCE9	ANO8_HUMAN	72.6	73	18	1	264	52	734	806	7.40E-24	110.9	ANO8_HUMAN	reviewed	Anoctamin-8 (Transmembrane protein 16H)	ANO8 KIAA1623 TMEM16H	Homo sapiens (Human)	1232	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; cellular protein metabolic process [GO:0044267]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; post-translational protein modification [GO:0043687]; transmembrane transport [GO:0055085]	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	intracellular calcium activated chloride channel activity [GO:0005229]	GO:0005229; GO:0005788; GO:0005886; GO:0006821; GO:0016021; GO:0034220; GO:0043687; GO:0044267; GO:0055085	cellular protein metabolic process [GO:0044267]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; post-translational protein modification [GO:0043687]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN19074_c0_g1_i1	P21958	TAP1_MOUSE	100	104	0	0	312	1	560	663	1.90E-52	206.1	TAP1_MOUSE	reviewed	Antigen peptide transporter 1 (APT1) (ATP-binding cassette sub-family B member 2) (Histocompatibility antigen modifier 1) (Peptide transporter TAP1)	Tap1 Abcb2 Ham-1 Ham1	Mus musculus (Mouse)	724	"centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; nucleotide binding [GO:0000166]; peptide transmembrane transporter activity [GO:1904680]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; tapasin binding [GO:0046980]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]"	centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; MHC class Ib protein binding [GO:0023029]; MHC class I protein binding [GO:0042288]; nucleotide binding [GO:0000166]; peptide transmembrane transporter activity [GO:1904680]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; tapasin binding [GO:0046980]	GO:0000166; GO:0002250; GO:0002479; GO:0005524; GO:0005739; GO:0005783; GO:0006952; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016021; GO:0016887; GO:0019885; GO:0023029; GO:0030176; GO:0030670; GO:0034451; GO:0042270; GO:0042288; GO:0042626; GO:0042803; GO:0042824; GO:0042825; GO:0043231; GO:0043531; GO:0044877; GO:0046967; GO:0046978; GO:0046979; GO:0046980; GO:0055085; GO:1904680	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30492_c0_g1_i1	Q03518	TAP1_HUMAN	100	86	0	0	3	260	669	754	3.20E-40	165.2	TAP1_HUMAN	reviewed	Antigen peptide transporter 1 (APT1) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein)	TAP1 ABCB2 PSF1 RING4 Y3	Homo sapiens (Human)	808	"centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; peptide transmembrane transporter activity [GO:1904680]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]; vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990668]; viral process [GO:0016032]"	centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; MHC class Ib protein binding [GO:0023029]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; peptide transmembrane transporter activity [GO:1904680]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]	GO:0002250; GO:0002474; GO:0002479; GO:0005524; GO:0005783; GO:0005789; GO:0006952; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016020; GO:0016021; GO:0016032; GO:0016887; GO:0019885; GO:0023029; GO:0030176; GO:0030670; GO:0033116; GO:0034451; GO:0042288; GO:0042605; GO:0042626; GO:0042803; GO:0042824; GO:0042825; GO:0043531; GO:0046967; GO:0046978; GO:0046979; GO:0055085; GO:1904680; GO:1990668	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]; vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990668]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37453_c0_g1_i1	P36371	TAP2_MOUSE	100	77	0	0	3	233	461	537	8.30E-40	163.7	TAP2_MOUSE	reviewed	Antigen peptide transporter 2 (APT2) (ATP-binding cassette sub-family B member 3) (Histocompatibility antigen modifier 2)	Tap2 Abcb3 Ham-2 Ham2	Mus musculus (Mouse)	702	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; TAP complex [GO:0042825]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; tapasin binding [GO:0046980]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; positive regulation of antigen processing and presentation of peptide antigen via MHC class I [GO:0002591]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; response to molecule of bacterial origin [GO:0002237]; transmembrane transport [GO:0055085]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; TAP complex [GO:0042825]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MHC class Ib protein binding [GO:0023029]; MHC class I protein binding [GO:0042288]; nucleotide binding [GO:0000166]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; tapasin binding [GO:0046980]	GO:0000166; GO:0001916; GO:0002237; GO:0002250; GO:0002481; GO:0002485; GO:0002489; GO:0002591; GO:0005524; GO:0005783; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016021; GO:0016607; GO:0016887; GO:0019885; GO:0023029; GO:0030176; GO:0042270; GO:0042288; GO:0042626; GO:0042802; GO:0042803; GO:0042824; GO:0042825; GO:0043231; GO:0043531; GO:0044877; GO:0046967; GO:0046968; GO:0046978; GO:0046979; GO:0046980; GO:0055085; GO:0065003	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; positive regulation of antigen processing and presentation of peptide antigen via MHC class I [GO:0002591]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein-containing complex assembly [GO:0065003]; protein transport [GO:0015031]; response to molecule of bacterial origin [GO:0002237]; transmembrane transport [GO:0055085]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29665_c0_g1_i1	P36371	TAP2_MOUSE	100	95	0	0	2	286	573	667	2.50E-46	185.7	TAP2_MOUSE	reviewed	Antigen peptide transporter 2 (APT2) (ATP-binding cassette sub-family B member 3) (Histocompatibility antigen modifier 2)	Tap2 Abcb3 Ham-2 Ham2	Mus musculus (Mouse)	702	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; TAP complex [GO:0042825]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; tapasin binding [GO:0046980]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; positive regulation of antigen processing and presentation of peptide antigen via MHC class I [GO:0002591]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; response to molecule of bacterial origin [GO:0002237]; transmembrane transport [GO:0055085]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; TAP complex [GO:0042825]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled peptide antigen transmembrane transporter activity [GO:0015433]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MHC class Ib protein binding [GO:0023029]; MHC class I protein binding [GO:0042288]; nucleotide binding [GO:0000166]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; tapasin binding [GO:0046980]	GO:0000166; GO:0001916; GO:0002237; GO:0002250; GO:0002481; GO:0002485; GO:0002489; GO:0002591; GO:0005524; GO:0005783; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016021; GO:0016607; GO:0016887; GO:0019885; GO:0023029; GO:0030176; GO:0042270; GO:0042288; GO:0042626; GO:0042802; GO:0042803; GO:0042824; GO:0042825; GO:0043231; GO:0043531; GO:0044877; GO:0046967; GO:0046968; GO:0046978; GO:0046979; GO:0046980; GO:0055085; GO:0065003	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; positive regulation of antigen processing and presentation of peptide antigen via MHC class I [GO:0002591]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein-containing complex assembly [GO:0065003]; protein transport [GO:0015031]; response to molecule of bacterial origin [GO:0002237]; transmembrane transport [GO:0055085]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25376_c1_g1_i1	C0KJQ4	ALPS_PORTR	66.7	102	34	0	38	343	1	102	2.10E-36	152.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN25376_c0_g1_i1	C0KJQ4	ALPS_PORTR	68.5	92	29	0	358	83	32	123	4.70E-34	145.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN30151_c1_g1_i1	C0KJQ4	ALPS_PORTR	71.2	59	17	0	267	91	65	123	2.40E-19	95.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN26947_c1_g1_i1	C0KJQ4	ALPS_PORTR	66.7	66	22	0	199	2	21	86	9.00E-22	103.6	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN24187_c1_g1_i1	C0KJQ4	ALPS_PORTR	72.7	66	18	0	211	14	58	123	5.40E-22	104.4	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN24187_c0_g1_i1	C0KJQ4	ALPS_PORTR	67.5	80	26	0	241	2	1	80	1.90E-27	122.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN604_c0_g1_i1	C0KJQ4	ALPS_PORTR	33.9	112	62	4	316	5	5	112	9.80E-09	61.6	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN604_c0_g1_i10	C0KJQ4	ALPS_PORTR	33.6	125	78	4	426	55	1	121	1.40E-11	71.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN11929_c4_g1_i1	C0KJQ4	ALPS_PORTR	40.6	69	41	0	234	28	53	121	6.70E-13	74.3	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN8080_c2_g1_i1	C0KJQ4	ALPS_PORTR	70.1	77	23	0	231	1	15	91	1.00E-29	130.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN8080_c3_g1_i1	C0KJQ4	ALPS_PORTR	72.4	98	27	0	1	294	26	123	1.40E-39	163.3	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN8080_c4_g1_i1	C0KJQ4	ALPS_PORTR	75.8	66	16	0	206	9	41	106	2.50E-24	112.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN16595_c0_g2_i1	C0KJQ4	ALPS_PORTR	75	64	16	0	1	192	58	121	2.50E-23	109	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN16595_c0_g1_i2	C0KJQ4	ALPS_PORTR	68.8	77	24	0	59	289	4	80	5.70E-30	131.3	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN16595_c0_g1_i3	C0KJQ4	ALPS_PORTR	66.2	80	27	0	28	267	1	80	1.30E-28	126.7	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c2_g1_i1	C0KJQ4	ALPS_PORTR	41.1	112	64	1	7	342	12	121	7.80E-22	105.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN3711_c2_g1_i2	C0KJQ4	ALPS_PORTR	41.1	112	64	1	7	342	12	121	6.30E-22	105.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN3711_c2_g1_i3	C0KJQ4	ALPS_PORTR	41.1	112	64	1	7	342	12	121	7.70E-22	105.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN32672_c1_g1_i1	C0KJQ4	ALPS_PORTR	77.6	67	15	0	214	14	57	123	1.30E-26	119.8	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN32672_c2_g1_i1	C0KJQ4	ALPS_PORTR	60.2	83	33	0	253	5	13	95	2.00E-23	109.4	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21960_c0_g1_i1	C0KJQ4	ALPS_PORTR	76.9	65	15	0	247	53	59	123	2.10E-25	115.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN27123_c0_g1_i1	C0KJQ4	ALPS_PORTR	64.4	90	32	0	1	270	4	93	2.10E-31	136	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN27123_c1_g1_i1	C0KJQ4	ALPS_PORTR	75.4	61	15	0	3	185	63	123	8.20E-23	107.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN595_c19_g1_i1	C0KJQ4	ALPS_PORTR	80.5	41	8	0	124	2	42	82	1.10E-15	83.6	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN25469_c0_g2_i1	C0KJQ4	ALPS_PORTR	82	50	9	0	210	61	74	123	7.30E-19	94	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN25469_c0_g1_i1	C0KJQ4	ALPS_PORTR	68.8	77	24	0	232	2	4	80	2.20E-29	129	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21136_c2_g1_i1	C0KJQ4	ALPS_PORTR	68.2	110	35	0	3	332	14	123	2.60E-41	169.5	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN21226_c3_g1_i1	C0KJQ4	ALPS_PORTR	63.4	82	30	0	248	3	10	91	1.20E-27	123.6	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c0_g5_i1	C0KJQ4	ALPS_PORTR	69.5	105	32	0	60	374	1	105	1.20E-40	167.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c1_g6_i1	C0KJQ4	ALPS_PORTR	70	100	30	0	3	302	24	123	1.80E-38	159.8	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c13_g1_i1	C0KJQ4	ALPS_PORTR	65.9	123	42	0	63	431	1	123	3.50E-45	182.6	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN21226_c12_g1_i1	C0KJQ4	ALPS_PORTR	73.2	123	33	0	135	503	1	123	1.40E-51	204.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN21226_c1_g7_i1	C0KJQ4	ALPS_PORTR	67.8	121	39	0	441	79	1	121	1.70E-45	183.7	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c1_g5_i1	C0KJQ4	ALPS_PORTR	65.5	119	41	0	397	41	5	123	2.20E-40	166.4	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c1_g8_i1	C0KJQ4	ALPS_PORTR	64.5	62	22	0	139	324	42	103	9.30E-17	87.8	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN21226_c0_g2_i1	C0KJQ4	ALPS_PORTR	72.4	58	16	0	1	174	66	123	6.00E-19	94.4	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c1_g4_i1	C0KJQ4	ALPS_PORTR	68.6	121	38	0	389	27	1	121	2.70E-45	183	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c0_g1_i1	C0KJQ4	ALPS_PORTR	64	89	32	0	6	272	35	123	4.60E-28	125.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c0_g3_i1	C0KJQ4	ALPS_PORTR	67.4	89	29	0	6	272	35	123	1.70E-32	139.8	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21170_c0_g1_i1	C0KJQ4	ALPS_PORTR	74.4	78	20	0	7	240	46	123	2.00E-29	129.4	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN32658_c1_g1_i1	C0KJQ4	ALPS_PORTR	60.7	89	35	0	60	326	1	89	2.30E-27	122.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN30032_c0_g1_i1	C0KJQ4	ALPS_PORTR	77.4	62	14	0	2	187	60	121	2.70E-22	105.5	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN30029_c0_g1_i1	C0KJQ4	ALPS_PORTR	68.2	110	35	0	336	7	12	121	1.10E-40	167.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21853_c3_g1_i1	C0KJQ4	ALPS_PORTR	66.7	78	26	0	236	3	1	78	1.20E-25	117.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21853_c1_g1_i1	C0KJQ4	ALPS_PORTR	69.1	123	38	0	51	419	1	123	1.60E-47	190.3	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN21853_c2_g1_i1	C0KJQ4	ALPS_PORTR	68.8	96	30	0	311	24	28	123	8.20E-35	147.5	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN18318_c0_g1_i1	C0KJQ4	ALPS_PORTR	71.9	96	27	0	2	289	28	123	7.20E-36	151	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN10107_c1_g1_i1	C0KJQ4	ALPS_PORTR	64.6	113	40	0	365	27	11	123	3.80E-39	162.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN10107_c0_g1_i1	C0KJQ4	ALPS_PORTR	70.8	72	21	0	250	35	52	123	9.50E-26	117.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN10107_c0_g1_i3	C0KJQ4	ALPS_PORTR	70.8	72	21	0	295	80	52	123	1.10E-25	117.1	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN10107_c0_g2_i1	C0KJQ4	ALPS_PORTR	63.6	66	24	0	294	97	1	66	6.10E-20	98.2	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN10107_c0_g2_i2	C0KJQ4	ALPS_PORTR	62.1	66	25	0	294	97	1	66	3.40E-19	95.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN25013_c0_g1_i1	C0KJQ4	ALPS_PORTR	65.8	73	25	0	18	236	1	73	6.40E-24	110.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN29636_c1_g1_i1	C0KJQ4	ALPS_PORTR	65.9	91	31	0	274	2	7	97	5.80E-32	137.9	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN29636_c0_g1_i1	C0KJQ4	ALPS_PORTR	67.8	59	19	0	210	34	65	123	1.50E-16	86.3	ALPS_PORTR	reviewed	Anti-lipopolysaccharide factor (PtALF)	ALF	Portunus trituberculatus (Swimming crab) (Neptunus trituberculatus)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21960_c0_g2_i1	B5TTX7	ALPS_SCYSE	60	55	22	0	170	6	1	55	8.00E-14	77.4	ALPS_SCYSE	reviewed	Anti-lipopolysaccharide factor (SsALF)		Scylla serrata (Mud crab)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN23180_c0_g1_i1	B5TTX7	ALPS_SCYSE	60.5	76	30	0	11	238	1	76	3.30E-20	98.6	ALPS_SCYSE	reviewed	Anti-lipopolysaccharide factor (SsALF)		Scylla serrata (Mud crab)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN38786_c0_g1_i1	B5TTX7	ALPS_SCYSE	65.6	64	22	0	21	212	1	64	2.90E-20	98.6	ALPS_SCYSE	reviewed	Anti-lipopolysaccharide factor (SsALF)		Scylla serrata (Mud crab)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21136_c3_g1_i1	B5TTX7	ALPS_SCYSE	62.3	53	20	0	73	231	1	53	5.30E-13	74.7	ALPS_SCYSE	reviewed	Anti-lipopolysaccharide factor (SsALF)		Scylla serrata (Mud crab)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN21226_c0_g4_i1	B5TTX7	ALPS_SCYSE	62.5	72	27	0	63	278	1	72	3.00E-20	99	ALPS_SCYSE	reviewed	Anti-lipopolysaccharide factor (SsALF)		Scylla serrata (Mud crab)	123	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]	extracellular region [GO:0005576]		GO:0005576; GO:0042742	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN25977_c0_g1_i1	P35207	SKI2_YEAST	62.4	181	67	1	546	4	322	501	9.00E-61	234.6	SKI2_YEAST	reviewed	Antiviral helicase SKI2 (EC 3.6.4.13) (Superkiller protein 2)	SKI2 YLR398C L8084.17	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1287	"cytoplasm [GO:0005737]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; defense response to virus [GO:0051607]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; regulation of translation [GO:0006417]; RNA catabolic process [GO:0006401]"	cytoplasm [GO:0005737]; Ski complex [GO:0055087]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]	GO:0003677; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0006401; GO:0006417; GO:0034427; GO:0051607; GO:0055087; GO:0070478; GO:0070481	"defense response to virus [GO:0051607]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; regulation of translation [GO:0006417]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38927_c0_g1_i1	O14977	AZIN1_HUMAN	100	71	0	0	3	215	319	389	3.50E-37	154.8	AZIN1_HUMAN	reviewed	Antizyme inhibitor 1 (AZI) (AZI1) (Ornithine decarboxylase antizyme inhibitor)	AZIN1 OAZI OAZIN	Homo sapiens (Human)	448	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ornithine decarboxylase activator activity [GO:0042978]; ornithine decarboxylase activity [GO:0004586]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ornithine decarboxylase activator activity [GO:0042978]; ornithine decarboxylase activity [GO:0004586]	GO:0004586; GO:0005634; GO:0005737; GO:0005829; GO:0006521; GO:0033387; GO:0042177; GO:0042978; GO:1902269	negative regulation of protein catabolic process [GO:0042177]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]		NA	NA	NA	NA	NA	NA
TRINITY_DN30771_c0_g1_i1	Q10567	AP1B1_HUMAN	68.8	176	55	0	529	2	287	462	3.40E-65	249.2	AP1B1_HUMAN	reviewed	AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)	AP1B1 ADTB1 BAM22 CLAPB2	Homo sapiens (Human)	949	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0000139; GO:0001822; GO:0005765; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019886; GO:0019901; GO:0030131; GO:0030276; GO:0030659; GO:0030665; GO:0032588; GO:0043231; GO:0050690	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN21696_c0_g1_i1	Q10567	AP1B1_HUMAN	100	127	0	0	383	3	328	454	1.00E-63	243.8	AP1B1_HUMAN	reviewed	AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)	AP1B1 ADTB1 BAM22 CLAPB2	Homo sapiens (Human)	949	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0000139; GO:0001822; GO:0005765; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019886; GO:0019901; GO:0030131; GO:0030276; GO:0030659; GO:0030665; GO:0032588; GO:0043231; GO:0050690	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN32913_c0_g1_i1	Q08DS7	AP1B1_BOVIN	100	175	0	0	2	526	277	451	2.30E-90	332.8	AP1B1_BOVIN	reviewed	AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)	AP2B1	Bos taurus (Bovine)	951	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; clathrin binding [GO:0030276]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]	clathrin binding [GO:0030276]	GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030276; GO:0030665	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4428_c0_g1_i1	O35643	AP1B1_MOUSE	90.3	196	19	0	11	598	273	468	3.90E-94	345.5	AP1B1_MOUSE	reviewed	AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)	Ap1b1 Adtb1	Mus musculus (Mouse)	943	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0001822; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030131; GO:0030276; GO:0030665; GO:0043231; GO:0048268	clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN18970_c0_g1_i1	P35585	AP1M1_MOUSE	100	138	0	0	417	4	285	422	1.20E-76	287	AP1M1_MOUSE	reviewed	AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)	Ap1m1 Cltnm	Mus musculus (Mouse)	423	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; clathrin adaptor activity [GO:0035615]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]	clathrin adaptor activity [GO:0035615]	GO:0005802; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0031410; GO:0032438; GO:0035615; GO:0035646; GO:0043231	endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN18970_c0_g2_i1	P35585	AP1M1_MOUSE	99.5	213	1	0	686	48	61	273	5.50E-116	418.3	AP1M1_MOUSE	reviewed	AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)	Ap1m1 Cltnm	Mus musculus (Mouse)	423	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; clathrin adaptor activity [GO:0035615]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]	clathrin adaptor activity [GO:0035615]	GO:0005802; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0031410; GO:0032438; GO:0035615; GO:0035646; GO:0043231	endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN18970_c0_g2_i2	Q2KJ81	AP1M1_BOVIN	99.7	363	1	0	1089	1	61	423	3.30E-208	725.3	AP1M1_BOVIN	reviewed	AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)	AP1M1	Bos taurus (Bovine)	423	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0031410; GO:0035615; GO:0043231	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN26014_c0_g1_i1	Q2KJ81	AP1M1_BOVIN	70.3	276	79	2	829	2	74	346	6.40E-111	401.7	AP1M1_BOVIN	reviewed	AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)	AP1M1	Bos taurus (Bovine)	423	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0031410; GO:0035615; GO:0043231	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2418_c0_g1_i1	Q32Q06	AP1M1_RAT	83.2	423	69	2	15	1280	1	422	1.50E-204	713.4	AP1M1_RAT	reviewed	AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)	Ap1m1	Rattus norvegicus (Rat)	423	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0031410; GO:0032438; GO:0035615; GO:0035646; GO:0043231	endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2418_c0_g1_i2	Q32Q06	AP1M1_RAT	83.4	422	69	1	15	1277	1	422	6.20E-206	718	AP1M1_RAT	reviewed	AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)	Ap1m1	Rattus norvegicus (Rat)	423	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0031410; GO:0032438; GO:0035615; GO:0035646; GO:0043231	endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN33926_c0_g1_i1	Q8LEZ8	AP1S1_ARATH	65.4	127	44	0	390	10	22	148	5.80E-46	184.9	AP1S1_ARATH	reviewed	AP-1 complex subunit sigma-1 (Adaptor AP-1 19 kDa protein) (Adaptor protein complex AP-1 sigma-1 subunit) (Adaptor-related protein complex 1 sigma-1 subunit) (Clathrin assembly protein complex 1 sigma-1 small chain) (Clathrin assembly small subunit protein AP19-1) (AtAP19-1) (Sigma 1 subunit of AP-1 clathrin) (Sigma-adaptin 1) (Sigma1-adaptin)	AAP19-1 At2g17380 F5J6.14	Arabidopsis thaliana (Mouse-ear cress)	161	clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]		GO:0005794; GO:0006886; GO:0016192; GO:0030117; GO:0030665; GO:0043231	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN29016_c0_g1_i1	Q3ZBS3	AP1S2_BOVIN	100	69	0	0	3	209	49	117	2.10E-34	145.6	AP1S2_BOVIN	reviewed	AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin)	AP1S2	Bos taurus (Bovine)	160	clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]		GO:0005794; GO:0005905; GO:0006886; GO:0016192; GO:0030117; GO:0030659; GO:0043231	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3090_c0_g1_i1	Q3ZBS3	AP1S2_BOVIN	85.5	131	19	0	404	12	13	143	2.40E-58	226.1	AP1S2_BOVIN	reviewed	AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin)	AP1S2	Bos taurus (Bovine)	160	clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]		GO:0005794; GO:0005905; GO:0006886; GO:0016192; GO:0030117; GO:0030659; GO:0043231	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN34_c0_g1_i1	Q7QG73	AP2A_ANOGA	75.7	953	207	7	91	2931	1	934	0	1395.6	AP2A_ANOGA	reviewed	AP-2 complex subunit alpha (Alpha-adaptin)	alpha-Adaptin AGAP009538	Anopheles gambiae (African malaria mosquito)	934	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488]	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]	GO:0005886; GO:0005905; GO:0006886; GO:0006898; GO:0015031; GO:0030122; GO:0035615; GO:0048488; GO:0072583; GO:0098793; GO:0140312	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN34_c0_g1_i4	Q7QG73	AP2A_ANOGA	75.7	953	207	7	94	2934	1	934	0	1395.9	AP2A_ANOGA	reviewed	AP-2 complex subunit alpha (Alpha-adaptin)	alpha-Adaptin AGAP009538	Anopheles gambiae (African malaria mosquito)	934	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488]	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]	GO:0005886; GO:0005905; GO:0006886; GO:0006898; GO:0015031; GO:0030122; GO:0035615; GO:0048488; GO:0072583; GO:0098793; GO:0140312	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN28392_c0_g1_i1	O95782	AP2A1_HUMAN	100	100	0	0	301	2	406	505	6.00E-51	201.1	AP2A1_HUMAN	reviewed	AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)	AP2A1 ADTAA CLAPA1	Homo sapiens (Human)	977	"AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0006898; GO:0008022; GO:0010976; GO:0016020; GO:0016323; GO:0016324; GO:0019886; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0044877; GO:0045334; GO:0048013; GO:0048260; GO:0050690; GO:0050750; GO:0060071; GO:0061024; GO:0072583; GO:0140312; GO:1900126	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40177_c0_g1_i1	O95782	AP2A1_HUMAN	100	140	0	0	422	3	182	321	4.50E-76	285	AP2A1_HUMAN	reviewed	AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)	AP2A1 ADTAA CLAPA1	Homo sapiens (Human)	977	"AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0006898; GO:0008022; GO:0010976; GO:0016020; GO:0016323; GO:0016324; GO:0019886; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0044877; GO:0045334; GO:0048013; GO:0048260; GO:0050690; GO:0050750; GO:0060071; GO:0061024; GO:0072583; GO:0140312; GO:1900126	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34003_c0_g1_i1	O95782	AP2A1_HUMAN	100	97	0	0	291	1	75	171	1.30E-47	189.9	AP2A1_HUMAN	reviewed	AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)	AP2A1 ADTAA CLAPA1	Homo sapiens (Human)	977	"AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0006898; GO:0008022; GO:0010976; GO:0016020; GO:0016323; GO:0016324; GO:0019886; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0044877; GO:0045334; GO:0048013; GO:0048260; GO:0050690; GO:0050750; GO:0060071; GO:0061024; GO:0072583; GO:0140312; GO:1900126	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39692_c0_g1_i1	O94973	AP2A2_HUMAN	100	96	0	0	289	2	755	850	5.00E-50	198	AP2A2_HUMAN	reviewed	AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)	AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899	Homo sapiens (Human)	939	"AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0008289; GO:0019886; GO:0019901; GO:0030122; GO:0030666; GO:0030667; GO:0030669; GO:0031410; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0043312; GO:0045334; GO:0048013; GO:0050690; GO:0060071; GO:0061024; GO:0072583; GO:0097718; GO:0101003; GO:0140312	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33475_c0_g1_i1	P17427	AP2A2_MOUSE	100	100	0	0	2	301	96	195	6.70E-50	197.6	AP2A2_MOUSE	reviewed	AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)	Ap2a2 Adtab	Mus musculus (Mouse)	938	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; kinase binding [GO:0019900]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; kinase binding [GO:0019900]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0006886; GO:0006898; GO:0008021; GO:0016192; GO:0019900; GO:0019901; GO:0019904; GO:0030117; GO:0030122; GO:0030141; GO:0031410; GO:0035091; GO:0035615; GO:0044877; GO:0072583; GO:0097718; GO:0140312; GO:1902036	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN27774_c0_g1_i1	O94973	AP2A2_HUMAN	97.7	87	2	0	1	261	230	316	2.00E-42	172.6	AP2A2_HUMAN	reviewed	AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)	AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899	Homo sapiens (Human)	939	"AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0008289; GO:0019886; GO:0019901; GO:0030122; GO:0030666; GO:0030667; GO:0030669; GO:0031410; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0043312; GO:0045334; GO:0048013; GO:0050690; GO:0060071; GO:0061024; GO:0072583; GO:0097718; GO:0101003; GO:0140312	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2926_c1_g1_i1	Q3ZC13	AP2M1_BOVIN	100	435	0	0	67	1371	1	435	7.10E-251	867.5	AP2M1_BOVIN	reviewed	AP-2 complex subunit mu (AP-2 mu chain) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein)	AP2M1	Bos taurus (Bovine)	435	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]	GO:0006886; GO:0006897; GO:0008289; GO:0016192; GO:0030122; GO:0031410; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2926_c1_g1_i2	Q3ZC13	AP2M1_BOVIN	100	352	0	0	2	1057	84	435	8.10E-202	704.1	AP2M1_BOVIN	reviewed	AP-2 complex subunit mu (AP-2 mu chain) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein)	AP2M1	Bos taurus (Bovine)	435	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]	GO:0006886; GO:0006897; GO:0008289; GO:0016192; GO:0030122; GO:0031410; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2926_c0_g1_i1	Q5ZMP6	AP2M1_CHICK	87.8	433	52	1	1388	93	1	433	5.50E-222	771.5	AP2M1_CHICK	reviewed	AP-2 complex subunit mu (AP-2 mu chain) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein)	AP2M1 RCJMB04_1h23	Gallus gallus (Chicken)	433	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]	GO:0006886; GO:0006897; GO:0008289; GO:0016192; GO:0030122; GO:0031410; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN2926_c1_g1_i3	Q5ZMP6	AP2M1_CHICK	99.3	431	3	0	3	1295	3	433	3.80E-246	851.7	AP2M1_CHICK	reviewed	AP-2 complex subunit mu (AP-2 mu chain) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein)	AP2M1 RCJMB04_1h23	Gallus gallus (Chicken)	433	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]; lipid binding [GO:0008289]	GO:0006886; GO:0006897; GO:0008289; GO:0016192; GO:0030122; GO:0031410; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN39617_c0_g1_i1	P54672	AP2M_DICDI	66.7	90	28	1	1	264	348	437	1.50E-29	129.8	AP2M_DICDI	reviewed	AP-2 complex subunit mu (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (Clathrin-adaptor medium chain Apm2) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein)	apm2 apm1 apmA DDB_G0277139	Dictyostelium discoideum (Slime mold)	439	AP-2 adaptor complex [GO:0030122]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; SNARE complex [GO:0031201]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin coat of coated pit [GO:0030132]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; SNARE complex [GO:0031201]	clathrin adaptor activity [GO:0035615]	GO:0005905; GO:0006886; GO:0006897; GO:0016192; GO:0030122; GO:0030132; GO:0031201; GO:0031410; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38633_c0_g1_i1	P54672	AP2M_DICDI	56	241	101	2	2	709	85	325	2.40E-74	280	AP2M_DICDI	reviewed	AP-2 complex subunit mu (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (Clathrin-adaptor medium chain Apm2) (Mu2-adaptin) (Plasma membrane adaptor AP-2 50 kDa protein)	apm2 apm1 apmA DDB_G0277139	Dictyostelium discoideum (Slime mold)	439	AP-2 adaptor complex [GO:0030122]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; SNARE complex [GO:0031201]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin coat of coated pit [GO:0030132]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; SNARE complex [GO:0031201]	clathrin adaptor activity [GO:0035615]	GO:0005905; GO:0006886; GO:0006897; GO:0016192; GO:0030122; GO:0030132; GO:0031201; GO:0031410; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10500_c0_g1_i1	Q84WL9	AP2S_ARATH	69.5	131	40	0	77	469	1	131	9.70E-48	191	AP2S_ARATH	reviewed	AP-2 complex subunit sigma (Adaptor AP-2 17 kDa protein) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Sigma2-adaptin)	AP17 At1g47830 T2E6.6	Arabidopsis thaliana (Mouse-ear cress)	142	clathrin-coated pit [GO:0005905]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	clathrin-coated pit [GO:0005905]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]		GO:0005634; GO:0005905; GO:0006897; GO:0015031; GO:0016192; GO:0043231	endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		red	red	NA	NA	NA	NA
TRINITY_DN11087_c0_g1_i1	Q17QC5	AP2S1_BOVIN	94.7	113	6	0	64	402	1	113	2.90E-58	226.1	AP2S1_BOVIN	reviewed	AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin)	AP2S1	Bos taurus (Bovine)	142	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN11087_c0_g1_i2	Q17QC5	AP2S1_BOVIN	95.1	142	7	0	64	489	1	142	4.70E-73	275.4	AP2S1_BOVIN	reviewed	AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin)	AP2S1	Bos taurus (Bovine)	142	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN22084_c0_g1_i1	Q17QC5	AP2S1_BOVIN	100	142	0	0	459	34	1	142	5.00E-76	285	AP2S1_BOVIN	reviewed	AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin)	AP2S1	Bos taurus (Bovine)	142	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN22084_c0_g1_i2	Q17QC5	AP2S1_BOVIN	100	142	0	0	459	34	1	142	5.00E-76	285	AP2S1_BOVIN	reviewed	AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin)	AP2S1	Bos taurus (Bovine)	142	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]	clathrin adaptor activity [GO:0035615]	GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN20939_c0_g1_i1	O00203	AP3B1_HUMAN	100	153	0	0	3	461	408	560	1.40E-78	293.5	AP3B1_HUMAN	reviewed	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	Homo sapiens (Human)	1094	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]	GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]	GO:0000902; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005794; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0042789; GO:0045202; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20939_c0_g1_i2	O00203	AP3B1_HUMAN	99.3	153	1	0	3	461	408	560	2.30E-78	292.7	AP3B1_HUMAN	reviewed	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	Homo sapiens (Human)	1094	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]	GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]	GO:0000902; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005794; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0042789; GO:0045202; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9023_c0_g1_i1	Q9Z1T1	AP3B1_MOUSE	100	49	0	0	1	147	229	277	6.50E-23	107.5	AP3B1_MOUSE	reviewed	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	Ap3b1	Mus musculus (Mouse)	1105	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; mitochondrion [GO:0005739]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; membrane organization [GO:0061024]; mRNA transcription by RNA polymerase II [GO:0042789]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]; zinc ion transport [GO:0006829]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; mitochondrion [GO:0005739]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]	GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]	GO:0000902; GO:0002244; GO:0003016; GO:0005739; GO:0005802; GO:0006622; GO:0006829; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016182; GO:0016192; GO:0019882; GO:0019903; GO:0030123; GO:0030131; GO:0030324; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0042789; GO:0043473; GO:0045202; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0061024; GO:0090152; GO:0098773; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; membrane organization [GO:0061024]; mRNA transcription by RNA polymerase II [GO:0042789]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]; zinc ion transport [GO:0006829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11312_c0_g1_i1	Q32PG1	AP3B1_BOVIN	37.9	232	141	2	54	743	848	1078	1.40E-33	144.8	AP3B1_BOVIN	reviewed	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1	Bos taurus (Bovine)	1084	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; synapse [GO:0045202]	GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]	GO:0000902; GO:0002244; GO:0003016; GO:0005739; GO:0005794; GO:0006622; GO:0006882; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0042789; GO:0045202; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28085_c0_g1_i1	Q7YRF1	AP3B1_CANLF	100	71	0	0	214	2	145	215	1.40E-30	132.9	AP3B1_CANLF	reviewed	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	Canis lupus familiaris (Dog) (Canis familiaris)	1091	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]		GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030131; GO:0030665; GO:0048490; GO:1904115	anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN16769_c0_g1_i1	O00203	AP3B1_HUMAN	98.6	74	1	0	225	4	355	428	2.50E-33	142.1	AP3B1_HUMAN	reviewed	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	Homo sapiens (Human)	1094	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]	GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]	GO:0000902; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005794; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0042789; GO:0045202; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2943_c0_g1_i1	Q9JME5	AP3B2_MOUSE	67.4	402	119	3	1295	90	293	682	3.10E-144	513.1	AP3B2_MOUSE	reviewed	AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain)	Ap3b2	Mus musculus (Mouse)	1082	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:1904115	anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2943_c0_g1_i2	Q9JME5	AP3B2_MOUSE	66.1	410	119	4	1319	90	293	682	5.10E-142	505.8	AP3B2_MOUSE	reviewed	AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain)	Ap3b2	Mus musculus (Mouse)	1082	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:1904115	anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3227_c0_g1_i1	Q13367	AP3B2_HUMAN	78.3	138	28	1	440	33	133	270	1.60E-55	216.9	AP3B2_HUMAN	reviewed	AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) (Neuron-specific vesicle coat protein beta-NAP)	AP3B2	Homo sapiens (Human)	1082	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]		GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:0097708; GO:1904115	anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN33119_c0_g1_i1	Q865S1	AP3D1_BOVIN	100	178	0	0	3	536	141	318	1.60E-94	346.7	AP3D1_BOVIN	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (BLVPCP1) (Bovine leukemia virus cell receptor) (BLV-R) (Delta-adaptin)	AP3D1 BLVR	Bos taurus (Bovine)	1207	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]		GO:0000139; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0030123; GO:0043195; GO:0048490; GO:0048499; GO:0098830; GO:0098943; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"		NA	NA	NA	NA	NA	NA
TRINITY_DN560_c0_g1_i1	Q865S1	AP3D1_BOVIN	53.8	1267	493	14	91	3804	1	1204	0	1091.3	AP3D1_BOVIN	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (BLVPCP1) (Bovine leukemia virus cell receptor) (BLV-R) (Delta-adaptin)	AP3D1 BLVR	Bos taurus (Bovine)	1207	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]		GO:0000139; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0030123; GO:0043195; GO:0048490; GO:0048499; GO:0098830; GO:0098943; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"		blue	blue	NA	NA	NA	NA
TRINITY_DN560_c0_g1_i2	Q865S1	AP3D1_BOVIN	53.4	1267	492	15	91	3783	1	1204	0	1076.2	AP3D1_BOVIN	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (BLVPCP1) (Bovine leukemia virus cell receptor) (BLV-R) (Delta-adaptin)	AP3D1 BLVR	Bos taurus (Bovine)	1207	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]		GO:0000139; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0030123; GO:0043195; GO:0048490; GO:0048499; GO:0098830; GO:0098943; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26470_c0_g1_i1	O14617	AP3D1_HUMAN	100	131	0	0	396	4	515	645	2.30E-66	252.7	AP3D1_HUMAN	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin)	AP3D1 PRO0039	Homo sapiens (Human)	1153	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]		GO:0000139; GO:0005765; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0030123; GO:0032438; GO:0035646; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38122_c0_g1_i1	O14617	AP3D1_HUMAN	99.1	109	1	0	42	368	287	395	4.60E-53	208.4	AP3D1_HUMAN	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin)	AP3D1 PRO0039	Homo sapiens (Human)	1153	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]		GO:0000139; GO:0005765; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0030123; GO:0032438; GO:0035646; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27139_c0_g1_i1	O14617	AP3D1_HUMAN	100	127	0	0	31	411	1	127	4.10E-66	251.9	AP3D1_HUMAN	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin)	AP3D1 PRO0039	Homo sapiens (Human)	1153	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]		GO:0000139; GO:0005765; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0030123; GO:0032438; GO:0035646; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16452_c0_g1_i1	O54774	AP3D1_MOUSE	97.6	82	2	0	1	246	448	529	6.30E-38	157.5	AP3D1_MOUSE	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1)	Ap3d1 Ap3d	Mus musculus (Mouse)	1199	"AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829]"	AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005802; GO:0006623; GO:0006829; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0033365; GO:0035646; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0099003; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16452_c0_g1_i2	O54774	AP3D1_MOUSE	98.1	209	4	0	2	628	321	529	4.90E-111	401.7	AP3D1_MOUSE	reviewed	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1)	Ap3d1 Ap3d	Mus musculus (Mouse)	1199	"AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829]"	AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005802; GO:0006623; GO:0006829; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0033365; GO:0035646; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0099003; GO:1904115	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40697_c0_g1_i1	P53677	AP3M2_HUMAN	81.6	76	14	0	8	235	72	147	9.30E-31	133.7	AP3M2_HUMAN	reviewed	AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (P47B)	AP3M2	Homo sapiens (Human)	418	AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]		GO:0005794; GO:0006886; GO:0006897; GO:0008089; GO:0016192; GO:0030119; GO:0030131; GO:0030659; GO:0031410; GO:0043231; GO:0048490; GO:1904115	anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN1164_c0_g2_i6	Q96N21	AP4AT_HUMAN	37.2	129	79	2	41	421	39	167	7.20E-11	70.1	AP4AT_HUMAN	reviewed	AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Epsin for AP-4) (Tetra-epsin)	TEPSIN C17orf56 ENTHD2	Homo sapiens (Human)	525	coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588]	coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588]		GO:0005737; GO:0005794; GO:0005829; GO:0016607; GO:0030662; GO:0031312; GO:0031965; GO:0032588			NA	NA	NA	NA	NA	NA
TRINITY_DN1164_c0_g2_i7	Q96N21	AP4AT_HUMAN	37.2	129	79	2	41	421	39	167	7.20E-11	70.1	AP4AT_HUMAN	reviewed	AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Epsin for AP-4) (Tetra-epsin)	TEPSIN C17orf56 ENTHD2	Homo sapiens (Human)	525	coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588]	coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588]		GO:0005737; GO:0005794; GO:0005829; GO:0016607; GO:0030662; GO:0031312; GO:0031965; GO:0032588			NA	NA	NA	NA	NA	NA
TRINITY_DN1164_c0_g2_i1	Q4V832	AP4AT_XENLA	28.4	328	217	6	14	973	7	324	1.30E-23	112.5	AP4AT_XENLA	reviewed	AP-4 complex accessory subunit tepsin (Tetra-epsin)	tepsin	Xenopus laevis (African clawed frog)	559	coated vesicle membrane [GO:0030662]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	coated vesicle membrane [GO:0030662]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]		GO:0005794; GO:0005829; GO:0030662			NA	NA	NA	NA	NA	NA
TRINITY_DN1164_c0_g2_i3	Q4V832	AP4AT_XENLA	29	324	216	6	14	961	7	324	4.10E-25	117.5	AP4AT_XENLA	reviewed	AP-4 complex accessory subunit tepsin (Tetra-epsin)	tepsin	Xenopus laevis (African clawed frog)	559	coated vesicle membrane [GO:0030662]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	coated vesicle membrane [GO:0030662]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]		GO:0005794; GO:0005829; GO:0030662			NA	NA	NA	NA	NA	NA
TRINITY_DN7590_c0_g1_i1	Q9Y6B7	AP4B1_HUMAN	28.7	512	293	8	166	1677	52	499	5.10E-50	200.7	AP4B1_HUMAN	reviewed	AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin)	AP4B1	Homo sapiens (Human)	739	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	clathrin binding [GO:0030276]	GO:0005802; GO:0005829; GO:0006605; GO:0008104; GO:0016192; GO:0019898; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588	protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN7590_c0_g1_i2	Q9Y6B7	AP4B1_HUMAN	28.3	428	237	7	81	1346	136	499	1.50E-39	165.6	AP4B1_HUMAN	reviewed	AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin)	AP4B1	Homo sapiens (Human)	739	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	clathrin binding [GO:0030276]	GO:0005802; GO:0005829; GO:0006605; GO:0008104; GO:0016192; GO:0019898; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588	protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN7819_c0_g1_i1	Q80V94	AP4E1_MOUSE	27	641	411	15	278	2137	37	641	3.30E-47	191.8	AP4E1_MOUSE	reviewed	AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin)	Ap4e1	Mus musculus (Mouse)	1122	AP-4 adaptor complex [GO:0030124]; trans-Golgi network [GO:0005802]; cargo adaptor activity [GO:0140312]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; trans-Golgi network [GO:0005802]	cargo adaptor activity [GO:0140312]	GO:0005802; GO:0006886; GO:0006898; GO:0016192; GO:0030124; GO:0140312	intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN28335_c0_g1_i1	Q9SB50	AP4M_ARATH	67.1	73	24	0	3	221	72	144	1.00E-21	103.6	AP4M_ARATH	reviewed	AP-4 complex subunit mu (Adaptor protein complex AP-4 subunit mu) (Adaptor protein-4 mu-adaptin) (Adaptor-related protein complex 4 subunit mu) (At-muC-Ad) (Mu4-adaptin)	AP4M CLH At4g24550 F22K18.250	Arabidopsis thaliana (Mouse-ear cress)	451	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; Golgi to lysosome transport [GO:0090160]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0005829; GO:0005905; GO:0006605; GO:0016192; GO:0030124; GO:0030131; GO:0031410; GO:0043231; GO:0090160	Golgi to lysosome transport [GO:0090160]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4621_c0_g1_i1	Q9GPF0	AP4M_DICDI	21	499	270	15	1257	88	45	528	1.20E-13	79.3	AP4M_DICDI	reviewed	AP-4 complex subunit mu (AP-4 adaptor complex mu4 subunit) (Adaptor-related protein complex 4 subunit mu) (Clathrin-adaptor medium chain Apm4) (Mu4-adaptin)	apm4 DDB_G0276945	Dictyostelium discoideum (Slime mold)	530	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; Golgi to lysosome transport [GO:0090160]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]		GO:0005769; GO:0005802; GO:0005829; GO:0006605; GO:0016192; GO:0030124; GO:0030131; GO:0031410; GO:0043231; GO:0090160	Golgi to lysosome transport [GO:0090160]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN316_c1_g1_i1	Q9Y587	AP4S1_HUMAN	32.6	138	93	0	534	121	5	142	1.50E-19	97.8	AP4S1_HUMAN	reviewed	AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin)	AP4S1	Homo sapiens (Human)	144	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]		GO:0006605; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0043231	protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN316_c1_g1_i2	Q9Y587	AP4S1_HUMAN	32.6	138	93	0	534	121	5	142	1.20E-19	98.2	AP4S1_HUMAN	reviewed	AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin)	AP4S1	Homo sapiens (Human)	144	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]		GO:0006605; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0043231	protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN316_c1_g1_i4	Q9Y587	AP4S1_HUMAN	33.3	99	66	0	417	121	44	142	1.20E-12	75.1	AP4S1_HUMAN	reviewed	AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin)	AP4S1	Homo sapiens (Human)	144	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]		GO:0006605; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0043231	protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN40276_c0_g1_i1	A2AJA7	AEGP_MOUSE	33	97	59	2	70	342	932	1028	9.40E-08	57.8	AEGP_MOUSE	reviewed	Apical endosomal glycoprotein (MAM domain-containing protein 4)	Mamdc4 Aegp Gm995	Mus musculus (Mouse)	1228	endosome [GO:0005768]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]	endosome [GO:0005768]; integral component of membrane [GO:0016021]		GO:0005768; GO:0015031; GO:0016021	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5144_c0_g1_i1	Q9U943	APLP_LOCMI	26.2	545	336	21	1965	424	2804	3313	2.90E-44	181.8	APLP_LOCMI	reviewed	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]		Locusta migratoria (Migratory locust)	3380	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0008289; GO:0016055	Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN6730_c0_g1_i1	Q9U943	APLP_LOCMI	27.9	86	59	2	387	130	396	478	3.00E-05	49.7	APLP_LOCMI	reviewed	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]		Locusta migratoria (Migratory locust)	3380	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0008289; GO:0016055	Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN40094_c0_g1_i1	Q25490	APLP_MANSE	36.5	104	66	0	4	315	571	674	2.60E-12	72.8	APLP_MANSE	reviewed	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	3305	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0008289; GO:0016055	Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN10873_c0_g1_i1	P04114	APOB_HUMAN	27.8	162	106	5	3	464	113	271	2.20E-08	61.2	APOB_HUMAN	reviewed	Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]	APOB	Homo sapiens (Human)	4563	chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]; cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; post-translational protein modification [GO:0043687]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; retinoid metabolic process [GO:0001523]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]; very-low-density lipoprotein particle clearance [GO:0034447]	chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]	cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]	GO:0001523; GO:0001701; GO:0002224; GO:0005543; GO:0005576; GO:0005615; GO:0005737; GO:0005769; GO:0005788; GO:0005789; GO:0005790; GO:0005811; GO:0005829; GO:0005886; GO:0006642; GO:0006898; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009743; GO:0009791; GO:0010008; GO:0010269; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0019433; GO:0030301; GO:0030317; GO:0030669; GO:0031904; GO:0031983; GO:0032355; GO:0032496; GO:0033344; GO:0034359; GO:0034360; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034371; GO:0034374; GO:0034378; GO:0034379; GO:0034382; GO:0034383; GO:0034447; GO:0035473; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0043202; GO:0043231; GO:0043687; GO:0044267; GO:0045540; GO:0048844; GO:0050750; GO:0050900; GO:0061024; GO:0070062; GO:0070971; GO:0071356; GO:0071379; GO:0071682; GO:0120020	artery morphogenesis [GO:0048844]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; post-translational protein modification [GO:0043687]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; retinoid metabolic process [GO:0001523]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]; very-low-density lipoprotein particle clearance [GO:0034447]		NA	NA	NA	NA	NA	NA
TRINITY_DN8292_c0_g1_i1	P51910	APOD_MOUSE	46.4	69	36	1	234	31	26	94	1.80E-13	77	APOD_MOUSE	reviewed	Apolipoprotein D (Apo-D) (ApoD)	Apod	Mus musculus (Mouse)	189	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]	GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN12911_c0_g1_i1	O35841	API5_MOUSE	100	121	0	0	365	3	340	460	7.10E-62	237.7	API5_MOUSE	reviewed	Apoptosis inhibitor 5 (API-5) (AAC-11)	Api5	Mus musculus (Mouse)	504	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006915; GO:0016607; GO:0017134; GO:0043066; GO:2000270	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]		NA	NA	NA	NA	NA	NA
TRINITY_DN12911_c0_g1_i2	O35841	API5_MOUSE	100	121	0	0	365	3	340	460	7.10E-62	237.7	API5_MOUSE	reviewed	Apoptosis inhibitor 5 (API-5) (AAC-11)	Api5	Mus musculus (Mouse)	504	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006915; GO:0016607; GO:0017134; GO:0043066; GO:2000270	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]		NA	NA	NA	NA	NA	NA
TRINITY_DN4156_c0_g1_i2	Q6DDM4	API5A_XENLA	48.3	515	237	11	1556	45	1	497	1.20E-116	421.8	API5A_XENLA	reviewed	Apoptosis inhibitor 5-A (API-5A)	api5-a	Xenopus laevis (African clawed frog)	524	nucleus [GO:0005634]; apoptotic process [GO:0006915]	nucleus [GO:0005634]		GO:0005634; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN7201_c0_g1_i1	Q96NN9	AIFM3_HUMAN	45.9	279	146	1	935	114	66	344	1.20E-66	255	AIFM3_HUMAN	reviewed	Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)	AIFM3 AIFL	Homo sapiens (Human)	605	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194	execution phase of apoptosis [GO:0097194]		NA	NA	NA	NA	NA	NA
TRINITY_DN7201_c0_g1_i2	Q96NN9	AIFM3_HUMAN	44.6	522	281	3	1645	98	66	585	6.60E-130	466.1	AIFM3_HUMAN	reviewed	Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)	AIFM3 AIFL	Homo sapiens (Human)	605	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194	execution phase of apoptosis [GO:0097194]		NA	NA	NA	NA	NA	NA
TRINITY_DN7201_c0_g1_i5	Q96NN9	AIFM3_HUMAN	44.7	347	185	2	1118	93	66	410	4.30E-78	293.5	AIFM3_HUMAN	reviewed	Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)	AIFM3 AIFL	Homo sapiens (Human)	605	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194	execution phase of apoptosis [GO:0097194]		NA	NA	NA	NA	NA	NA
TRINITY_DN7201_c0_g1_i6	Q3TY86	AIFM3_MOUSE	42.9	261	144	4	877	98	329	585	3.80E-56	219.9	AIFM3_MOUSE	reviewed	Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)	Aifm3 Aifl	Mus musculus (Mouse)	605	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194	execution phase of apoptosis [GO:0097194]		NA	NA	NA	NA	NA	NA
TRINITY_DN27025_c0_g1_i1	Q96NN9	AIFM3_HUMAN	47.1	70	34	1	210	1	494	560	4.60E-13	74.7	AIFM3_HUMAN	reviewed	Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein)	AIFM3 AIFL	Homo sapiens (Human)	605	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016491; GO:0046872; GO:0050660; GO:0051537; GO:0097194	execution phase of apoptosis [GO:0097194]		NA	NA	NA	NA	NA	NA
TRINITY_DN10087_c0_g1_i1	Q96KQ4	ASPP1_HUMAN	74.2	31	8	0	1	93	1053	1083	2.10E-08	60.1	ASPP1_HUMAN	reviewed	Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B)	PPP1R13B ASPP1 KIAA0771	Homo sapiens (Human)	1090	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; p53 binding [GO:0002039]; transcription factor binding [GO:0008134]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of apoptotic process [GO:0042981]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	p53 binding [GO:0002039]; transcription factor binding [GO:0008134]	GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0008134; GO:0042981; GO:0045786; GO:0048471; GO:0072332; GO:1900740; GO:1901216; GO:1901796	intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of apoptotic process [GO:0042981]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN2707_c0_g1_i4	Q9UKV3	ACINU_HUMAN	36.7	90	52	3	449	180	65	149	6.40E-06	52.4	ACINU_HUMAN	reviewed	Apoptotic chromatin condensation inducer in the nucleus (Acinus)	ACIN1 ACINUS KIAA0670	Homo sapiens (Human)	1341	"ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]"	ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0019899; GO:0030218; GO:0030263; GO:0043065; GO:0045657; GO:0048025; GO:0061574	"apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN17752_c0_g1_i1	Q9NHW7	AQP_AEDAE	65	80	28	0	5	244	159	238	2.40E-26	119	AQP_AEDAE	reviewed	Aquaporin AQPAe.a	AAEL003512	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	249	integral component of membrane [GO:0016021]; channel activity [GO:0015267]	integral component of membrane [GO:0016021]	channel activity [GO:0015267]	GO:0015267; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN29410_c0_g1_i2	Q23808	AQP_CICVR	57.8	64	27	0	238	47	60	123	5.90E-15	81.6	AQP_CICVR	reviewed	Aquaporin AQPcic	AQP CIC	Cicadella viridis (Green leafhopper)	255	integral component of membrane [GO:0016021]; channel activity [GO:0015267]	integral component of membrane [GO:0016021]	channel activity [GO:0015267]	GO:0015267; GO:0016021			brown	brown	1	NA	NA	NA
TRINITY_DN33610_c0_g1_i1	G5CTG4	AQP7_MILTA	52.1	117	53	2	53	397	162	277	4.00E-31	136	AQP7_MILTA	reviewed	Aquaporin-7 (AQP-7)	AQP7	Milnesium tardigradum (Water bear) (Tardigrade)	315	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	channel activity [GO:0015267]	GO:0005886; GO:0015267; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33610_c0_g1_i2	G5CTG4	AQP7_MILTA	47.8	207	93	4	1	612	83	277	3.30E-50	199.9	AQP7_MILTA	reviewed	Aquaporin-7 (AQP-7)	AQP7	Milnesium tardigradum (Water bear) (Tardigrade)	315	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	channel activity [GO:0015267]	GO:0005886; GO:0015267; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33610_c0_g1_i4	G5CTG4	AQP7_MILTA	47.8	207	93	4	1	612	83	277	3.20E-50	199.9	AQP7_MILTA	reviewed	Aquaporin-7 (AQP-7)	AQP7	Milnesium tardigradum (Water bear) (Tardigrade)	315	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	channel activity [GO:0015267]	GO:0005886; GO:0015267; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN38683_c0_g1_i1	Q9Y2X7	GIT1_HUMAN	100	158	0	0	2	475	154	311	2.80E-87	322.4	GIT1_HUMAN	reviewed	ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1)	GIT1	Homo sapiens (Human)	761	cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ephrin receptor signaling pathway [GO:0048013]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrion [GO:0005739]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005739; GO:0005829; GO:0005925; GO:0008277; GO:0016020; GO:0032465; GO:0044877; GO:0046872; GO:0048013	ephrin receptor signaling pathway [GO:0048013]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN5115_c0_g2_i1	Q9JLQ2	GIT2_MOUSE	65.9	367	122	2	102	1199	2	366	5.20E-137	489.2	GIT2_MOUSE	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	Git2	Mus musculus (Mouse)	708	nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]	nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005654; GO:0044877; GO:0046872; GO:0048266	behavioral response to pain [GO:0048266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5115_c0_g2_i2	Q9JLQ2	GIT2_MOUSE	65.6	363	122	2	3	1088	19	379	5.40E-134	479.2	GIT2_MOUSE	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	Git2	Mus musculus (Mouse)	708	nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]	nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005654; GO:0044877; GO:0046872; GO:0048266	behavioral response to pain [GO:0048266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5115_c0_g2_i3	Q9JLQ2	GIT2_MOUSE	64.2	380	133	2	102	1238	2	379	2.90E-137	490.7	GIT2_MOUSE	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	Git2	Mus musculus (Mouse)	708	nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]	nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005654; GO:0044877; GO:0046872; GO:0048266	behavioral response to pain [GO:0048266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5115_c1_g1_i1	Q14161	GIT2_HUMAN	27.4	401	193	7	1059	55	383	751	5.20E-26	120.2	GIT2_HUMAN	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GIT2 KIAA0148	Homo sapiens (Human)	759	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN5115_c1_g1_i3	Q14161	GIT2_HUMAN	57.1	56	23	1	219	55	696	751	4.50E-07	55.5	GIT2_HUMAN	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GIT2 KIAA0148	Homo sapiens (Human)	759	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN21278_c0_g1_i1	Q14161	GIT2_HUMAN	98.8	84	1	0	253	2	169	252	5.10E-43	174.5	GIT2_HUMAN	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GIT2 KIAA0148	Homo sapiens (Human)	759	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN21278_c0_g1_i2	Q14161	GIT2_HUMAN	100	252	0	0	757	2	1	252	4.00E-150	531.9	GIT2_HUMAN	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GIT2 KIAA0148	Homo sapiens (Human)	759	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN39843_c0_g1_i1	Q14161	GIT2_HUMAN	100	114	0	0	342	1	246	359	4.40E-58	224.9	GIT2_HUMAN	reviewed	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GIT2 KIAA0148	Homo sapiens (Human)	759	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN2303_c0_g1_i1	Q3ZCL5	ARFP2_BOVIN	63.5	148	52	1	444	1	71	216	2.60E-44	179.9	ARFP2_BOVIN	reviewed	Arfaptin-2 (ADP-ribosylation factor-interacting protein 2)	ARFIP2	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]	phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]	GO:0005543; GO:0005737; GO:0006886; GO:0006914; GO:0019904; GO:0032588; GO:0034315	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		NA	NA	NA	NA	NA	NA
TRINITY_DN2303_c0_g1_i2	Q3ZCL5	ARFP2_BOVIN	59.8	164	64	1	492	1	55	216	8.60E-46	184.9	ARFP2_BOVIN	reviewed	Arfaptin-2 (ADP-ribosylation factor-interacting protein 2)	ARFIP2	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]	phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]	GO:0005543; GO:0005737; GO:0006886; GO:0006914; GO:0019904; GO:0032588; GO:0034315	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		NA	NA	NA	NA	NA	NA
TRINITY_DN9818_c0_g1_i1	Q3ZCL5	ARFP2_BOVIN	67.2	131	43	0	483	91	210	340	6.70E-44	178.3	ARFP2_BOVIN	reviewed	Arfaptin-2 (ADP-ribosylation factor-interacting protein 2)	ARFIP2	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]	phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]	GO:0005543; GO:0005737; GO:0006886; GO:0006914; GO:0019904; GO:0032588; GO:0034315	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		NA	NA	NA	NA	NA	NA
TRINITY_DN9818_c0_g1_i2	Q3ZCL5	ARFP2_BOVIN	69.2	117	36	0	442	92	210	326	4.60E-39	162.2	ARFP2_BOVIN	reviewed	Arfaptin-2 (ADP-ribosylation factor-interacting protein 2)	ARFIP2	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]	phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]	GO:0005543; GO:0005737; GO:0006886; GO:0006914; GO:0019904; GO:0032588; GO:0034315	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		NA	NA	NA	NA	NA	NA
TRINITY_DN28240_c0_g1_i1	Q3ZCL5	ARFP2_BOVIN	100	73	0	0	1	219	84	156	1.30E-34	146.4	ARFP2_BOVIN	reviewed	Arfaptin-2 (ADP-ribosylation factor-interacting protein 2)	ARFIP2	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]	phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]	GO:0005543; GO:0005737; GO:0006886; GO:0006914; GO:0019904; GO:0032588; GO:0034315	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		NA	NA	NA	NA	NA	NA
TRINITY_DN36187_c0_g1_i1	Q2TA45	AGFG1_BOVIN	58.8	85	35	0	2	256	41	125	7.60E-27	120.9	AGFG1_BOVIN	reviewed	Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP)	AGFG1 HRB RIP	Bos taurus (Bovine)	562	cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0003677; GO:0005096; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0031410; GO:0043231; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN36187_c0_g1_i2	Q2TA45	AGFG1_BOVIN	54.4	103	46	1	2	310	41	142	5.70E-29	128.3	AGFG1_BOVIN	reviewed	Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP)	AGFG1 HRB RIP	Bos taurus (Bovine)	562	cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0003677; GO:0005096; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0031410; GO:0043231; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN25408_c0_g1_i1	Q15027	ACAP1_HUMAN	100	82	0	0	3	248	260	341	6.60E-43	174.1	ACAP1_HUMAN	reviewed	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1) (Cnt-b1)"	ACAP1 CENTB1 KIAA0050	Homo sapiens (Human)	740	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031]	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0015031; GO:0016020; GO:0046872; GO:0055038	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN36686_c0_g1_i1	Q15027	ACAP1_HUMAN	100	76	0	0	231	4	606	681	7.70E-38	157.1	ACAP1_HUMAN	reviewed	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1) (Cnt-b1)"	ACAP1 CENTB1 KIAA0050	Homo sapiens (Human)	740	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031]	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0015031; GO:0016020; GO:0046872; GO:0055038	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN27019_c0_g1_i1	Q15027	ACAP1_HUMAN	100	105	0	0	6	320	394	498	4.60E-57	221.5	ACAP1_HUMAN	reviewed	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1) (Cnt-b1)"	ACAP1 CENTB1 KIAA0050	Homo sapiens (Human)	740	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031]	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0015031; GO:0016020; GO:0046872; GO:0055038	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN879_c0_g1_i1	Q6ZQK5	ACAP2_MOUSE	37.8	820	428	10	97	2517	1	751	4.00E-146	520.4	ACAP2_MOUSE	reviewed	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)"	Acap2 Centb2 Kiaa0041	Mus musculus (Mouse)	770	"endosome membrane [GO:0010008]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; Rab GTPase binding [GO:0017137]; actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]"	endosome membrane [GO:0010008]; ruffle [GO:0001726]	"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; Rab GTPase binding [GO:0017137]"	GO:0001726; GO:0005096; GO:0010008; GO:0017137; GO:0030029; GO:0032456; GO:0046872; GO:0080025; GO:1990090	actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]		NA	NA	NA	NA	NA	NA
TRINITY_DN879_c0_g1_i3	Q6ZQK5	ACAP2_MOUSE	37.8	820	428	10	97	2517	1	751	6.70E-146	519.6	ACAP2_MOUSE	reviewed	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)"	Acap2 Centb2 Kiaa0041	Mus musculus (Mouse)	770	"endosome membrane [GO:0010008]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; Rab GTPase binding [GO:0017137]; actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]"	endosome membrane [GO:0010008]; ruffle [GO:0001726]	"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; Rab GTPase binding [GO:0017137]"	GO:0001726; GO:0005096; GO:0010008; GO:0017137; GO:0030029; GO:0032456; GO:0046872; GO:0080025; GO:1990090	actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]		NA	NA	NA	NA	NA	NA
TRINITY_DN38748_c0_g1_i1	Q5VW22	AGAP6_HUMAN	96.2	80	3	0	2	241	480	559	9.60E-39	160.2	AGAP6_HUMAN	reviewed	"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6 (AGAP-6) (Centaurin-gamma-like family member 3)"	AGAP6 CTGLF3	Homo sapiens (Human)	663	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12099_c0_g1_i1	A1Z7A6	ASAP_DROME	66.7	63	21	0	283	95	1093	1155	2.90E-19	96.3	ASAP_DROME	reviewed	"ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein"	Asap Asap1 CG30372	Drosophila melanogaster (Fruit fly)	1155	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386	compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN269_c0_g1_i1	A1Z7A6	ASAP_DROME	52.4	506	232	3	3	1502	12	514	1.10E-148	528.1	ASAP_DROME	reviewed	"ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein"	Asap Asap1 CG30372	Drosophila melanogaster (Fruit fly)	1155	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386	compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN269_c0_g1_i2	A1Z7A6	ASAP_DROME	47.7	457	214	9	22	1347	298	744	3.90E-111	403.3	ASAP_DROME	reviewed	"ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein"	Asap Asap1 CG30372	Drosophila melanogaster (Fruit fly)	1155	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386	compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN269_c0_g1_i3	A1Z7A6	ASAP_DROME	50.8	445	214	3	3	1334	12	452	9.60E-123	441.8	ASAP_DROME	reviewed	"ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein"	Asap Asap1 CG30372	Drosophila melanogaster (Fruit fly)	1155	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386	compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN269_c0_g1_i4	A1Z7A6	ASAP_DROME	56.4	55	24	0	3	167	12	66	2.70E-11	68.9	ASAP_DROME	reviewed	"ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein"	Asap Asap1 CG30372	Drosophila melanogaster (Fruit fly)	1155	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386	compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN269_c0_g1_i5	A1Z7A6	ASAP_DROME	56.3	158	65	2	101	571	298	452	3.20E-44	179.9	ASAP_DROME	reviewed	"ArfGAP with SH3 domain, ANK repeat and PH domain-containing protein"	Asap Asap1 CG30372	Drosophila melanogaster (Fruit fly)	1155	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0001745; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0043087; GO:0045177; GO:0046872; GO:1901981; GO:1903358; GO:1903829; GO:1990386	compound eye morphogenesis [GO:0001745]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of cellular protein localization [GO:1903829]; regulation of Golgi organization [GO:1903358]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN40091_c0_g1_i1	Q9ULH1	ASAP1_HUMAN	100	76	0	0	228	1	444	519	3.10E-39	161.8	ASAP1_HUMAN	reviewed	"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)"	ASAP1 DDEF1 KIAA1249	Homo sapiens (Human)	1129	"cell projection membrane [GO:0031253]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; podosome [GO:0002102]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803]"	cell projection membrane [GO:0031253]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; podosome [GO:0002102]	"cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]"	GO:0001786; GO:0002102; GO:0005096; GO:0005546; GO:0005547; GO:0005829; GO:0031253; GO:0043197; GO:0045296; GO:0046872; GO:0060271; GO:0061000; GO:0071803; GO:1903527	cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803]		NA	NA	NA	NA	NA	NA
TRINITY_DN36405_c0_g1_i1	O97902	ASAP1_BOVIN	100	112	0	0	339	4	151	262	1.50E-58	226.5	ASAP1_BOVIN	reviewed	"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)"	ASAP1 DDEF1	Bos taurus (Bovine)	1129	cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; podosome [GO:0002102]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803]	cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; podosome [GO:0002102]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0002102; GO:0005096; GO:0005737; GO:0031253; GO:0046872; GO:0060271; GO:0071803; GO:1903527	cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803]		NA	NA	NA	NA	NA	NA
TRINITY_DN18980_c0_g1_i1	Q9GYX1	KARG_PACMR	87.8	74	9	0	4	225	33	106	2.60E-30	132.1	KARG_PACMR	reviewed	Arginine kinase (AK) (EC 2.7.3.3)		Pachygrapsus marmoratus (Marbled rock crab) (Cancer marmoratus)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004054; GO:0004111; GO:0005524; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		NA	NA	NA	NA	NA	NA
TRINITY_DN9639_c0_g1_i1	Q9U9J4	KARG_CARMA	85.7	98	14	0	46	339	1	98	1.90E-40	166.4	KARG_CARMA	reviewed	Arginine kinase (AK) (EC 2.7.3.3)		Carcinus maenas (Common shore crab) (Green crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004054; GO:0004111; GO:0005524; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		NA	NA	NA	NA	NA	NA
TRINITY_DN24074_c0_g1_i1	Q9NH49	KARG_CALSI	83.3	72	12	0	2	217	133	204	1.10E-30	133.3	KARG_CALSI	reviewed	Arginine kinase (AK) (EC 2.7.3.3)		Callinectes sapidus (Blue crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004054; GO:0004111; GO:0005524; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		NA	NA	NA	NA	NA	NA
TRINITY_DN35398_c5_g1_i1	Q9NH49	KARG_CALSI	95.2	357	17	0	1158	88	1	357	3.80E-200	698.7	KARG_CALSI	reviewed	Arginine kinase (AK) (EC 2.7.3.3)		Callinectes sapidus (Blue crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004054; GO:0004111; GO:0005524; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		blue	blue	NA	NA	NA	NA
TRINITY_DN15671_c0_g1_i1	Q9NH49	KARG_CALSI	93.1	202	14	0	3	608	124	325	1.80E-110	399.8	KARG_CALSI	reviewed	Arginine kinase (AK) (EC 2.7.3.3)		Callinectes sapidus (Blue crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004054; GO:0004111; GO:0005524; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		NA	NA	NA	NA	NA	NA
TRINITY_DN15671_c1_g1_i1	Q9GYX1	KARG_PACMR	92	125	10	0	1	375	7	131	1.00E-60	233.8	KARG_PACMR	reviewed	Arginine kinase (AK) (EC 2.7.3.3)		Pachygrapsus marmoratus (Marbled rock crab) (Cancer marmoratus)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004054; GO:0004111; GO:0005524; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		NA	NA	NA	NA	NA	NA
TRINITY_DN24074_c2_g1_i1	H6VGI3	KARG0_SCYPA	84.5	71	11	0	2	214	211	281	2.10E-29	129	KARG0_SCYPA	reviewed	Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)		Scylla paramamosain (Mud crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]	GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN24074_c1_g1_i1	H6VGI3	KARG0_SCYPA	75	72	18	0	217	2	90	161	1.60E-24	112.8	KARG0_SCYPA	reviewed	Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)		Scylla paramamosain (Mud crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]	GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN21670_c0_g1_i1	H6VGI3	KARG0_SCYPA	89.8	88	9	0	6	269	266	353	6.80E-38	157.5	KARG0_SCYPA	reviewed	Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)		Scylla paramamosain (Mud crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]	GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN15671_c2_g1_i1	H6VGI3	KARG0_SCYPA	86.2	109	15	0	327	1	236	344	1.30E-46	186.8	KARG0_SCYPA	reviewed	Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)		Scylla paramamosain (Mud crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]	GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN15671_c3_g1_i1	H6VGI3	KARG0_SCYPA	85.2	108	16	0	326	3	68	175	5.20E-48	191.4	KARG0_SCYPA	reviewed	Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)		Scylla paramamosain (Mud crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]	GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN22686_c0_g1_i1	H6VGI3	KARG0_SCYPA	86.7	75	10	0	3	227	73	147	3.60E-32	138.3	KARG0_SCYPA	reviewed	Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)		Scylla paramamosain (Mud crab)	357	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; IgE binding [GO:0019863]	GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN36946_c0_g1_i1	Q7ZYR8	RSRC2_XENLA	51.6	64	31	0	98	289	195	258	5.00E-10	65.5	RSRC2_XENLA	reviewed	Arginine/serine-rich coiled-coil protein 2	rsrc2	Xenopus laevis (African clawed frog)	350							blue	blue	NA	NA	NA	NA
TRINITY_DN29670_c0_g1_i1	Q9P2R6	RERE_HUMAN	61	41	16	0	3	125	513	553	4.30E-11	68.2	RERE_HUMAN	reviewed	Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein)	RERE ARG ARP ATN1L KIAA0458	Homo sapiens (Human)	1566	"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription, DNA-templated [GO:0006355]"	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000118; GO:0001085; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813	"branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27180_c0_g1_i1	Q8SRD8	SYR_ENCCU	55.7	106	47	0	326	9	96	201	2.60E-31	136	SYR_ENCCU	reviewed	Arginine--tRNA ligase (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)	ECU08_0550	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	563	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]		arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0006420	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN27184_c0_g1_i1	Q6MEP4	SYR_PARUW	59.4	69	24	1	199	5	292	360	3.20E-16	85.1	SYR_PARUW	reviewed	Arginine--tRNA ligase (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)	argS pc0231	Protochlamydia amoebophila (strain UWE25)	584	cytoplasm [GO:0005737]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]	cytoplasm [GO:0005737]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005737; GO:0006420	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN37974_c0_g1_i1	P54136	SYRC_HUMAN	100	93	0	0	1	279	325	417	9.90E-48	190.3	SYRC_HUMAN	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	RARS1 RARS	Homo sapiens (Human)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062	arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN19019_c1_g1_i1	Q9D0I9	SYRC_MOUSE	100	68	0	0	3	206	183	250	1.70E-33	142.5	SYRC_MOUSE	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	Rars1 Rars	Mus musculus (Mouse)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006420; GO:0017101; GO:0034618	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN19019_c0_g1_i1	P54136	SYRC_HUMAN	99.5	200	1	0	2	601	125	324	1.00E-113	410.6	SYRC_HUMAN	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	RARS1 RARS	Homo sapiens (Human)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062	arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN17059_c0_g1_i1	Q9D0I9	SYRC_MOUSE	99.4	162	1	0	520	35	499	660	8.70E-90	330.9	SYRC_MOUSE	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	Rars1 Rars	Mus musculus (Mouse)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006420; GO:0017101; GO:0034618	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN17059_c0_g1_i2	P54136	SYRC_HUMAN	100	162	0	0	520	35	499	660	6.70E-90	331.3	SYRC_HUMAN	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	RARS1 RARS	Homo sapiens (Human)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062	arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN1980_c0_g1_i1	Q6P1S4	SYRC_XENTR	54.3	694	267	8	2144	90	8	660	2.40E-208	726.9	SYRC_XENTR	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	rars1 rars	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN1980_c0_g1_i2	Q6P1S4	SYRC_XENTR	56.1	667	270	7	2063	90	8	660	8.40E-211	734.9	SYRC_XENTR	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	rars1 rars	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN1980_c0_g1_i4	Q6P1S4	SYRC_XENTR	63.1	149	54	1	533	90	512	660	1.40E-46	187.6	SYRC_XENTR	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	rars1 rars	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN39399_c0_g1_i1	Q9D0I9	SYRC_MOUSE	100	94	0	0	282	1	336	429	6.90E-49	194.1	SYRC_MOUSE	reviewed	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	Rars1 Rars	Mus musculus (Mouse)	660	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006420; GO:0017101; GO:0034618	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN35267_c0_g1_i1	Q3SZJ0	ARLY_BOVIN	100	71	0	0	216	4	234	304	3.70E-34	144.8	ARLY_BOVIN	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	ASL	Bos taurus (Bovine)	473	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0000050; GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN33959_c0_g1_i1	B2UA10	ARLY_RALPJ	98.6	71	1	0	213	1	90	160	4.00E-33	141.4	ARLY_RALPJ	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Rpic_2577	Ralstonia pickettii (strain 12J)	471	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN37030_c0_g1_i1	Q2G4W0	ARLY_NOVAD	89.3	75	8	0	227	3	84	158	4.80E-32	137.9	ARLY_NOVAD	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Saro_2677	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	469	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	1
TRINITY_DN34985_c0_g1_i1	P04424	ARLY_HUMAN	100	91	0	0	275	3	249	339	3.10E-46	185.3	ARLY_HUMAN	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	ASL	Homo sapiens (Human)	464	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; argininosuccinate lyase activity [GO:0004056]; identical protein binding [GO:0042802]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	argininosuccinate lyase activity [GO:0004056]; identical protein binding [GO:0042802]	GO:0000050; GO:0004056; GO:0005737; GO:0005829; GO:0042450; GO:0042802; GO:0070062	arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN524_c0_g2_i1	B2UA10	ARLY_RALPJ	100	83	0	0	2	250	245	327	3.80E-43	174.9	ARLY_RALPJ	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Rpic_2577	Ralstonia pickettii (strain 12J)	471	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN524_c0_g1_i1	Q2G4W0	ARLY_NOVAD	98.6	70	1	0	2	211	245	314	5.30E-33	141	ARLY_NOVAD	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Saro_2677	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	469	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN30899_c0_g1_i1	B1M509	ARLY_METRJ	94.9	78	4	0	2	235	86	163	6.20E-35	147.5	ARLY_METRJ	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Mrad2831_4504	Methylobacterium radiotolerans (strain ATCC 27329 / DSM 1819 / JCM 2831 / NBRC 15690 / NCIMB 10815 / 0-1)	459	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN37228_c0_g1_i1	Q2RXE3	ARLY_RHORT	82.4	68	12	0	206	3	110	177	3.90E-25	114.8	ARLY_RHORT	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Rru_A0397	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	478	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN36470_c0_g1_i1	A5VAA0	ARLY_SPHWW	77.8	117	26	0	3	353	72	188	4.20E-43	175.3	ARLY_SPHWW	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Swit_2864	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	458	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN17482_c0_g1_i1	P51464	ARLY_LITCT	59.6	446	180	0	103	1440	1	446	3.40E-160	566.2	ARLY_LITCT	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	ASL	Lithobates catesbeianus (American bullfrog) (Rana catesbeiana)	467	argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]		argininosuccinate lyase activity [GO:0004056]	GO:0000050; GO:0004056; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN17482_c0_g1_i2	P51464	ARLY_LITCT	59.6	446	180	0	127	1464	1	446	3.50E-160	566.2	ARLY_LITCT	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	ASL	Lithobates catesbeianus (American bullfrog) (Rana catesbeiana)	467	argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]		argininosuccinate lyase activity [GO:0004056]	GO:0000050; GO:0004056; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]		blue	blue	NA	NA	NA	NA
TRINITY_DN15916_c0_g1_i1	B8EPF2	ARLY_METSB	88.2	93	11	0	4	282	265	357	4.50E-40	164.9	ARLY_METSB	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Msil_1188	Methylocella silvestris (strain DSM 15510 / CIP 108128 / LMG 27833 / NCIMB 13906 / BL2)	466	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN38706_c0_g1_i1	Q2G4W0	ARLY_NOVAD	91.4	70	6	0	4	213	1	70	3.00E-28	125.2	ARLY_NOVAD	reviewed	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	argH Saro_2677	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	469	cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]	cytoplasm [GO:0005737]	argininosuccinate lyase activity [GO:0004056]	GO:0004056; GO:0005737; GO:0042450	arginine biosynthetic process via ornithine [GO:0042450]		NA	NA	NA	NA	NA	NA
TRINITY_DN1359_c0_g1_i2	Q66I24	ASSY_DANRE	59.5	299	118	2	9	899	110	407	7.50E-106	385.2	ASSY_DANRE	reviewed	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	ass1 zgc:92051	Danio rerio (Zebrafish) (Brachydanio rerio)	414	cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]	GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526	arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1359_c0_g1_i3	Q66I24	ASSY_DANRE	58	269	110	2	84	884	140	407	6.70E-91	335.5	ASSY_DANRE	reviewed	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	ass1 zgc:92051	Danio rerio (Zebrafish) (Brachydanio rerio)	414	cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]	GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526	arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1359_c0_g1_i4	Q5ZJ23	ASSY_CHICK	59.2	120	49	0	9	368	112	231	1.10E-42	174.1	ASSY_CHICK	reviewed	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	ASS1 RCJMB04_21j5	Gallus gallus (Chicken)	416	cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]	GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526	arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1359_c0_g1_i6	Q66I24	ASSY_DANRE	64	89	32	0	72	338	319	407	2.30E-27	123.2	ASSY_DANRE	reviewed	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	ass1 zgc:92051	Danio rerio (Zebrafish) (Brachydanio rerio)	414	cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]	GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526	arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1359_c0_g1_i7	Q5M8Z6	ASSY_XENTR	59.8	214	85	1	9	647	112	325	8.60E-72	271.6	ASSY_XENTR	reviewed	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	ass1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	412	cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]	GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526	arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN33_c0_g1_i1	O95260	ATE1_HUMAN	44.3	424	214	7	1	1242	5	416	7.70E-92	339	ATE1_HUMAN	reviewed	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	ATE1	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	arginyltransferase activity [GO:0004057]	GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598	proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]		NA	NA	NA	NA	NA	NA
TRINITY_DN33_c0_g1_i2	O95260	ATE1_HUMAN	40.1	424	178	9	1	1080	5	416	9.10E-73	275.4	ATE1_HUMAN	reviewed	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	ATE1	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	arginyltransferase activity [GO:0004057]	GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598	proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]		NA	NA	NA	NA	NA	NA
TRINITY_DN33_c0_g1_i3	Q2PFX0	ATE1_MACFA	37.9	280	152	7	1	810	5	272	9.00E-39	162.2	ATE1_MACFA	reviewed	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	ATE1 QflA-16011	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	518	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	arginyltransferase activity [GO:0004057]	GO:0004057; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN33_c0_g1_i4	O95260	ATE1_HUMAN	46.5	424	205	7	1	1242	5	416	9.40E-98	358.6	ATE1_HUMAN	reviewed	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	ATE1	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	arginyltransferase activity [GO:0004057]	GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598	proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]		NA	NA	NA	NA	NA	NA
TRINITY_DN33_c0_g1_i5	Q9Z2A5	ATE1_MOUSE	37	54	34	0	38	199	269	322	3.10E-05	48.9	ATE1_MOUSE	reviewed	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	Ate1	Mus musculus (Mouse)	516	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	arginyltransferase activity [GO:0004057]	GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598	proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]		NA	NA	NA	NA	NA	NA
TRINITY_DN27352_c0_g1_i1	O95260	ATE1_HUMAN	100	74	0	0	224	3	331	404	8.80E-39	160.2	ATE1_HUMAN	reviewed	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	ATE1	Homo sapiens (Human)	518	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	arginyltransferase activity [GO:0004057]	GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598	proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]		NA	NA	NA	NA	NA	NA
TRINITY_DN2520_c0_g1_i1	Q8N8R7	AL14E_HUMAN	34	144	79	4	462	70	116	256	1.40E-15	84.3	AL14E_HUMAN	reviewed	ARL14 effector protein (ARF7 effector protein)	ARL14EP ARF7EP C11orf46	Homo sapiens (Human)	260	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN2520_c0_g1_i3	Q5EA92	AL14E_BOVIN	40	120	67	2	423	70	140	256	3.70E-16	86.3	AL14E_BOVIN	reviewed	ARL14 effector protein (ARF7 effector protein)	ARL14EP ARF7EP	Bos taurus (Bovine)	260	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN2520_c0_g1_i5	Q5EA92	AL14E_BOVIN	40	120	67	2	423	70	140	256	2.70E-15	84.3	AL14E_BOVIN	reviewed	ARL14 effector protein (ARF7 effector protein)	ARL14EP ARF7EP	Bos taurus (Bovine)	260	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN764_c2_g1_i1	Q8N2F6	ARM10_HUMAN	27	259	175	4	902	135	88	335	9.90E-15	82.8	ARM10_HUMAN	reviewed	Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein)	ARMC10 SVH PSEC0198	Homo sapiens (Human)	343	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010]; regulation of growth [GO:0040008]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039]	GO:0002039; GO:0005739; GO:0005783; GO:0005789; GO:0016021; GO:0040008; GO:0040010; GO:0043066; GO:0050692; GO:1902254	negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN764_c2_g1_i2	Q8N2F6	ARM10_HUMAN	29	207	144	2	941	330	88	294	8.70E-14	79.7	ARM10_HUMAN	reviewed	Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein)	ARMC10 SVH PSEC0198	Homo sapiens (Human)	343	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010]; regulation of growth [GO:0040008]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039]	GO:0002039; GO:0005739; GO:0005783; GO:0005789; GO:0016021; GO:0040008; GO:0040010; GO:0043066; GO:0050692; GO:1902254	negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN38972_c0_g1_i1	Q8IUR7	ARMC8_HUMAN	96.4	112	4	0	167	502	497	608	1.70E-53	210.3	ARMC8_HUMAN	reviewed	Armadillo repeat-containing protein 8	ARMC8 S863-2	Homo sapiens (Human)	673	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005576; GO:0005634; GO:0005737; GO:0034657; GO:0035580; GO:0043161; GO:0043312; GO:1904724	neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN38972_c0_g1_i1	Q8IUR7	ARMC8_HUMAN	96.9	64	2	0	1	192	442	505	4.60E-27	122.5	ARMC8_HUMAN	reviewed	Armadillo repeat-containing protein 8	ARMC8 S863-2	Homo sapiens (Human)	673	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005576; GO:0005634; GO:0005737; GO:0034657; GO:0035580; GO:0043161; GO:0043312; GO:1904724	neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN4674_c0_g1_i1	Q8IUR7	ARMC8_HUMAN	69.1	230	70	1	2	691	405	633	2.30E-85	316.6	ARMC8_HUMAN	reviewed	Armadillo repeat-containing protein 8	ARMC8 S863-2	Homo sapiens (Human)	673	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005576; GO:0005634; GO:0005737; GO:0034657; GO:0035580; GO:0043161; GO:0043312; GO:1904724	neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN1690_c1_g2_i1	P18824	ARM_DROME	74.9	847	179	8	2532	79	1	842	0	1176.8	ARM_DROME	reviewed	Armadillo segment polarity protein	arm CG11579	Drosophila melanogaster (Fruit fly)	843	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; beta-catenin-TCF complex [GO:1990907]; catenin complex [GO:0016342]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate determination [GO:0001709]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; cuticle pattern formation [GO:0035017]; delamination [GO:0060232]; dorsal closure [GO:0007391]; epithelial cell type specification, open tracheal system [GO:0035153]; germ-line stem-cell niche homeostasis [GO:0060250]; heart development [GO:0007507]; heart formation [GO:0060914]; imaginal disc-derived wing expansion [GO:0048526]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; long-term memory [GO:0007616]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast development [GO:0014019]; neuroblast fate commitment [GO:0014017]; oogenesis [GO:0048477]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to adherens junction [GO:0071896]; protein localization to plasma membrane [GO:0072659]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; beta-catenin-TCF complex [GO:1990907]; catenin complex [GO:0016342]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]	alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000902; GO:0001709; GO:0001745; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005915; GO:0007155; GO:0007367; GO:0007370; GO:0007391; GO:0007399; GO:0007472; GO:0007507; GO:0007616; GO:0008134; GO:0008587; GO:0014017; GO:0014019; GO:0016028; GO:0016324; GO:0016342; GO:0019900; GO:0019903; GO:0030139; GO:0030424; GO:0035017; GO:0035019; GO:0035147; GO:0035153; GO:0035257; GO:0035293; GO:0045186; GO:0045294; GO:0045296; GO:0045893; GO:0045944; GO:0046530; GO:0046667; GO:0048477; GO:0048526; GO:0048754; GO:0060070; GO:0060232; GO:0060250; GO:0060914; GO:0071896; GO:0072659; GO:0090254; GO:0098609; GO:1990907	"branch fusion, open tracheal system [GO:0035147]; branching morphogenesis of an epithelial tube [GO:0048754]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell fate determination [GO:0001709]; cell morphogenesis [GO:0000902]; chitin-based larval cuticle pattern formation [GO:0035293]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; cuticle pattern formation [GO:0035017]; delamination [GO:0060232]; dorsal closure [GO:0007391]; epithelial cell type specification, open tracheal system [GO:0035153]; germ-line stem-cell niche homeostasis [GO:0060250]; heart development [GO:0007507]; heart formation [GO:0060914]; imaginal disc-derived wing expansion [GO:0048526]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; long-term memory [GO:0007616]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast development [GO:0014019]; neuroblast fate commitment [GO:0014017]; oogenesis [GO:0048477]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to adherens junction [GO:0071896]; protein localization to plasma membrane [GO:0072659]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21046_c0_g1_i1	Q5T2E6	ARMD3_HUMAN	50.6	237	117	0	714	4	7	243	1.00E-62	241.5	ARMD3_HUMAN	reviewed	Armadillo-like helical domain-containing protein 3	ARMH3 C10orf76	Homo sapiens (Human)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN21046_c0_g1_i2	Q6DCT2	ARMD3_XENLA	44.2	95	53	0	365	81	7	101	1.40E-18	94	ARMD3_XENLA	reviewed	Armadillo-like helical domain-containing protein 3	armh3	Xenopus laevis (African clawed frog)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN21046_c0_g1_i3	Q5T2E6	ARMD3_HUMAN	57.3	96	41	0	291	4	148	243	1.90E-24	113.2	ARMD3_HUMAN	reviewed	Armadillo-like helical domain-containing protein 3	ARMH3 C10orf76	Homo sapiens (Human)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN7211_c0_g1_i1	Q6PGW3	ARMD3_DANRE	59.7	67	27	0	1	201	594	660	9.70E-17	87.8	ARMD3_DANRE	reviewed	Armadillo-like helical domain-containing protein 3	armh3 zgc:63733	Danio rerio (Zebrafish) (Brachydanio rerio)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN7211_c0_g1_i2	Q6PGW3	ARMD3_DANRE	51.9	135	65	0	2	406	553	687	4.10E-33	142.5	ARMD3_DANRE	reviewed	Armadillo-like helical domain-containing protein 3	armh3 zgc:63733	Danio rerio (Zebrafish) (Brachydanio rerio)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN7211_c0_g2_i1	Q6DCT2	ARMD3_XENLA	58.5	82	34	0	48	293	367	448	9.90E-19	94.4	ARMD3_XENLA	reviewed	Armadillo-like helical domain-containing protein 3	armh3	Xenopus laevis (African clawed frog)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN7211_c0_g2_i2	Q6PGW3	ARMD3_DANRE	57.6	172	73	0	48	563	367	538	1.50E-50	200.7	ARMD3_DANRE	reviewed	Armadillo-like helical domain-containing protein 3	armh3 zgc:63733	Danio rerio (Zebrafish) (Brachydanio rerio)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN7211_c0_g2_i3	Q6PD19	ARMD3_MOUSE	57.4	183	78	0	48	596	356	538	1.60E-55	217.2	ARMD3_MOUSE	reviewed	Armadillo-like helical domain-containing protein 3	Armh3	Mus musculus (Mouse)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN7211_c0_g2_i4	Q6DCT2	ARMD3_XENLA	57.3	103	43	1	18	326	347	448	6.50E-24	111.7	ARMD3_XENLA	reviewed	Armadillo-like helical domain-containing protein 3	armh3	Xenopus laevis (African clawed frog)	689	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005829; GO:0016021; GO:1903358	regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN33205_c0_g1_i2	P05031	DDC_DROME	54.7	64	28	1	30	221	417	479	3.10E-11	68.9	DDC_DROME	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	Ddc CG10697	Drosophila melanogaster (Fruit fly)	510	cytoplasm [GO:0005737]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; adult chitin-containing cuticle pigmentation [GO:0048085]; anesthesia-resistant memory [GO:0007615]; catecholamine metabolic process [GO:0006584]; dopamine biosynthetic process from tyrosine [GO:0006585]; long-term memory [GO:0007616]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; serotonin biosynthetic process [GO:0042427]; serotonin biosynthetic process from tryptophan [GO:0006587]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0005737; GO:0006584; GO:0006585; GO:0006587; GO:0007615; GO:0007616; GO:0009611; GO:0016831; GO:0030170; GO:0035220; GO:0040040; GO:0042427; GO:0042542; GO:0043052; GO:0048082; GO:0048085	adult chitin-containing cuticle pigmentation [GO:0048085]; anesthesia-resistant memory [GO:0007615]; catecholamine metabolic process [GO:0006584]; dopamine biosynthetic process from tyrosine [GO:0006585]; long-term memory [GO:0007616]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; response to hydrogen peroxide [GO:0042542]; response to wounding [GO:0009611]; serotonin biosynthetic process [GO:0042427]; serotonin biosynthetic process from tryptophan [GO:0006587]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN16205_c0_g1_i1	P20711	DDC_HUMAN	66.2	77	26	0	296	66	239	315	5.20E-27	121.7	DDC_HUMAN	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	DDC AADC	Homo sapiens (Human)	480	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine biosynthetic process [GO:0042423]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to drug [GO:0035690]; cellular response to growth factor stimulus [GO:0071363]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; indolalkylamine biosynthetic process [GO:0046219]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]	amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0005737; GO:0005829; GO:0006520; GO:0006584; GO:0007623; GO:0008021; GO:0010259; GO:0015842; GO:0016597; GO:0016831; GO:0019899; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0035690; GO:0036468; GO:0042416; GO:0042423; GO:0042427; GO:0043025; GO:0046219; GO:0046684; GO:0052314; GO:0070062; GO:0071312; GO:0071363	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine biosynthetic process [GO:0042423]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to drug [GO:0035690]; cellular response to growth factor stimulus [GO:0071363]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; indolalkylamine biosynthetic process [GO:0046219]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427]		NA	NA	NA	NA	NA	NA
TRINITY_DN16205_c0_g1_i4	P22781	DDC_CAVPO	70.5	44	13	0	197	66	272	315	9.10E-13	73.9	DDC_CAVPO	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	DDC	Cavia porcellus (Guinea pig)	480	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid metabolic process [GO:0006520]; dopamine biosynthetic process [GO:0042416]		aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0006520; GO:0030170; GO:0042416	cellular amino acid metabolic process [GO:0006520]; dopamine biosynthetic process [GO:0042416]		NA	NA	NA	NA	NA	NA
TRINITY_DN16205_c0_g1_i5	P22781	DDC_CAVPO	72.7	44	12	0	174	43	272	315	5.70E-14	77.8	DDC_CAVPO	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	DDC	Cavia porcellus (Guinea pig)	480	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid metabolic process [GO:0006520]; dopamine biosynthetic process [GO:0042416]		aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0006520; GO:0030170; GO:0042416	cellular amino acid metabolic process [GO:0006520]; dopamine biosynthetic process [GO:0042416]		blue	blue	NA	NA	NA	NA
TRINITY_DN15408_c3_g1_i1	P48861	DDC_MANSE	80	40	8	0	174	55	68	107	4.50E-14	78.2	DDC_MANSE	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	Ddc	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	508	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0006520; GO:0030170; GO:0042423	catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN17096_c0_g1_i1	O96571	DDC_DROLE	64.6	48	17	0	188	45	116	163	1.50E-09	63.2	DDC_DROLE	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC) (Fragment)	Ddc	Drosophila lebanonensis (Fruit fly) (Scaptodrosophila lebanonensis)	403	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0006520; GO:0030170; GO:0042423	catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		red	red	NA	NA	NA	NA
TRINITY_DN33205_c0_g1_i1	O96571	DDC_DROLE	74.2	31	8	0	91	183	341	371	3.70E-05	48.5	DDC_DROLE	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC) (Fragment)	Ddc	Drosophila lebanonensis (Fruit fly) (Scaptodrosophila lebanonensis)	403	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0006520; GO:0030170; GO:0042423	catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN16205_c0_g1_i3	O96571	DDC_DROLE	65.6	125	43	0	417	43	117	241	2.60E-44	179.5	DDC_DROLE	reviewed	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC) (Fragment)	Ddc	Drosophila lebanonensis (Fruit fly) (Scaptodrosophila lebanonensis)	403	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0006520; GO:0030170; GO:0042423	catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN36956_c0_g1_i1	P51484	ARRH_LIMPO	44	75	35	2	18	221	317	391	5.90E-06	52	ARRH_LIMPO	reviewed	"Arrestin, lateral eye"		Limulus polyphemus (Atlantic horseshoe crab)	400	signal transduction [GO:0007165]; visual perception [GO:0007601]			GO:0007165; GO:0007601	signal transduction [GO:0007165]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN32717_c0_g1_i1	P27540	ARNT_HUMAN	100	321	0	0	2	964	118	438	2.30E-189	662.5	ARNT_HUMAN	reviewed	"Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta)"	ARNT BHLHE2	Homo sapiens (Human)	789	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001666; GO:0001892; GO:0001938; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006805; GO:0008134; GO:0010575; GO:0016604; GO:0017162; GO:0030154; GO:0030949; GO:0033235; GO:0042803; GO:0043565; GO:0043619; GO:0045648; GO:0045821; GO:0045944; GO:0046886; GO:0046982; GO:0061418; GO:0090575; GO:1990837	cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN4666_c0_g1_i1	O15945	ARNT_DROME	68.6	446	111	8	1950	634	9	432	2.30E-167	590.5	ARNT_DROME	reviewed	Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango)	tgo ARNT HIF-1-beta CG11987	Drosophila melanogaster (Fruit fly)	642	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575	"appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4666_c0_g1_i2	O15945	ARNT_DROME	70.2	436	111	7	1920	634	9	432	3.70E-170	599.7	ARNT_DROME	reviewed	Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango)	tgo ARNT HIF-1-beta CG11987	Drosophila melanogaster (Fruit fly)	642	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575	"appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36126_c0_g1_i1	Q91YA9	BMAL1_NANGA	51.8	421	187	5	2	1261	116	521	2.20E-114	414.1	BMAL1_NANGA	reviewed	Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1)	Arntl BMAL1 MOP3	Nannospalax galili (Northern Israeli blind subterranean mole rat) (Spalax galili)	626	"chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"	chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007283; GO:0016605; GO:0032007; GO:0032922; GO:0033391; GO:0042634; GO:0042753; GO:0043161; GO:0045599; GO:0045893; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0070888; GO:0090263; GO:0090403; GO:1901985; GO:2000074; GO:2000772; GO:2001016	"circadian regulation of gene expression [GO:0032922]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25805_c0_g1_i1	Q9I8T7	BMAL1_CHICK	56.5	62	23	1	69	242	572	633	2.70E-10	65.9	BMAL1_CHICK	reviewed	Aryl hydrocarbon receptor nuclear translocator-like protein 1 (BMAL1b') (Brain and muscle ARNT-like 1) (cBMAL1)	ARNTL BMAL1	Gallus gallus (Chicken)	633	"chromatoid body [GO:0033391]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein heterodimerization activity [GO:0046982]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; maternal process involved in parturition [GO:0060137]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of protein catabolic process [GO:0042176]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"	chromatoid body [GO:0033391]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]	"aryl hydrocarbon receptor binding [GO:0017162]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein heterodimerization activity [GO:0046982]"	GO:0001228; GO:0003677; GO:0005667; GO:0006606; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0042176; GO:0042634; GO:0042753; GO:0043161; GO:0043425; GO:0045599; GO:0045892; GO:0045893; GO:0046982; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0060137; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:1901985; GO:2000074; GO:2000323; GO:2000772; GO:2001016	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; maternal process involved in parturition [GO:0060137]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of protein catabolic process [GO:0042176]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29470_c0_g1_i1	A0MLS5	BMAL1_HORSE	98.9	95	1	0	285	1	127	221	2.70E-48	192.2	BMAL1_HORSE	reviewed	Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Brain and muscle ARNT-like 1)	ARNTL BMAL1	Equus caballus (Horse)	626	"chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; maternal process involved in parturition [GO:0060137]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"	chromatoid body [GO:0033391]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]	"aryl hydrocarbon receptor binding [GO:0017162]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0005667; GO:0006355; GO:0006606; GO:0007283; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0042176; GO:0042634; GO:0042753; GO:0043161; GO:0043425; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0046982; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0060137; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:1901985; GO:2000074; GO:2000323; GO:2000772; GO:2001016	"circadian regulation of gene expression [GO:0032922]; maternal process involved in parturition [GO:0060137]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6768_c0_g1_i6	P14000	ARS_HEMPU	32.4	111	58	3	153	443	411	518	4.30E-06	52.8	ARS_HEMPU	reviewed	Arylsulfatase (AS) (EC 3.1.6.1) (Aryl-sulfate sulphohydrolase) (ARS)		Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)	551	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6768_c0_g1_i1	Q08DD1	ARSA_BOVIN	51.8	257	120	3	234	995	28	283	5.40E-67	256.1	ARSA_BOVIN	reviewed	Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase)	ARSA	Bos taurus (Bovine)	507	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; binding of sperm to zona pellucida [GO:0007339]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]	GO:0004065; GO:0004098; GO:0005509; GO:0005764; GO:0005783; GO:0005886; GO:0007339; GO:0016021	binding of sperm to zona pellucida [GO:0007339]		NA	NA	NA	NA	NA	NA
TRINITY_DN6768_c0_g1_i3	P50428	ARSA_MOUSE	49.2	480	231	8	234	1646	27	502	1.80E-120	434.5	ARSA_MOUSE	reviewed	Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase)	Arsa As2	Mus musculus (Mouse)	506	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]	GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0007339; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0016021; GO:0031232; GO:0043627; GO:0045471; GO:0051597	autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN6768_c0_g1_i4	P50428	ARSA_MOUSE	48.4	436	212	8	26	1306	71	502	6.40E-105	382.5	ARSA_MOUSE	reviewed	Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase)	Arsa As2	Mus musculus (Mouse)	506	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]	GO:0001669; GO:0004065; GO:0004098; GO:0005509; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0006914; GO:0007339; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0016021; GO:0031232; GO:0043627; GO:0045471; GO:0051597	autophagy [GO:0006914]; binding of sperm to zona pellucida [GO:0007339]; central nervous system development [GO:0007417]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN6768_c0_g1_i5	Q08DD1	ARSA_BOVIN	49.4	170	82	3	32	532	114	282	2.30E-37	156.8	ARSA_BOVIN	reviewed	Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase)	ARSA	Bos taurus (Bovine)	507	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; binding of sperm to zona pellucida [GO:0007339]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]	GO:0004065; GO:0004098; GO:0005509; GO:0005764; GO:0005783; GO:0005886; GO:0007339; GO:0016021	binding of sperm to zona pellucida [GO:0007339]		NA	NA	NA	NA	NA	NA
TRINITY_DN28204_c0_g1_i1	Q08DD1	ARSA_BOVIN	63.2	57	18	2	4	168	100	155	3.60E-14	78.6	ARSA_BOVIN	reviewed	Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase)	ARSA	Bos taurus (Bovine)	507	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; binding of sperm to zona pellucida [GO:0007339]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]	GO:0004065; GO:0004098; GO:0005509; GO:0005764; GO:0005783; GO:0005886; GO:0007339; GO:0016021	binding of sperm to zona pellucida [GO:0007339]		NA	NA	NA	NA	NA	NA
TRINITY_DN31758_c0_g1_i1	P15289	ARSA_HUMAN	100	84	0	0	3	254	44	127	1.50E-42	172.9	ARSA_HUMAN	reviewed	Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B; Arylsulfatase A component C]	ARSA	Homo sapiens (Human)	507	azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; glycosphingolipid metabolic process [GO:0006687]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004065; GO:0004098; GO:0005509; GO:0005576; GO:0005764; GO:0005788; GO:0006687; GO:0008484; GO:0035578; GO:0043202; GO:0043312; GO:0070062	glycosphingolipid metabolic process [GO:0006687]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN14629_c0_g1_i1	P15848	ARSB_HUMAN	46.5	86	46	0	260	3	62	147	8.20E-20	97.4	ARSB_HUMAN	reviewed	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	ARSB	Homo sapiens (Human)	533	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]	GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813	autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN14629_c0_g1_i2	P15848	ARSB_HUMAN	46.7	60	30	1	201	22	62	119	2.20E-09	62.4	ARSB_HUMAN	reviewed	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	ARSB	Homo sapiens (Human)	533	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]	GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813	autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN4382_c0_g1_i1	P50430	ARSB_RAT	33.2	337	144	7	1009	5	41	298	3.90E-41	170.2	ARSB_RAT	reviewed	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	Arsb	Rattus norvegicus (Rat)	528	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g2_i1	P50430	ARSB_RAT	43.4	212	111	2	1187	552	190	392	3.50E-49	197.2	ARSB_RAT	reviewed	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	Arsb	Rattus norvegicus (Rat)	528	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN13097_c0_g3_i1	Q5FYA8	ARSH_HUMAN	39.9	561	304	10	1940	279	7	541	2.40E-98	361.3	ARSH_HUMAN	reviewed	Arylsulfatase H (ASH) (EC 3.1.6.-)	ARSH	Homo sapiens (Human)	562	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005788; GO:0016021; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN13097_c0_g3_i2	Q5FYA8	ARSH_HUMAN	39.9	561	304	10	1911	250	7	541	2.30E-98	361.3	ARSH_HUMAN	reviewed	Arylsulfatase H (ASH) (EC 3.1.6.-)	ARSH	Homo sapiens (Human)	562	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005788; GO:0016021; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN38304_c0_g1_i1	Q5FYB1	ARSI_HUMAN	47.9	71	37	0	6	218	69	139	3.10E-12	72	ARSI_HUMAN	reviewed	Arylsulfatase I (ASI) (EC 3.1.6.-)	ARSI	Homo sapiens (Human)	569	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g1_i4	Q5FYB1	ARSI_HUMAN	39.2	525	243	8	1697	177	57	523	3.70E-100	367.1	ARSI_HUMAN	reviewed	Arylsulfatase I (ASI) (EC 3.1.6.-)	ARSI	Homo sapiens (Human)	569	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g1_i5	Q5FYB1	ARSI_HUMAN	39.9	541	249	8	1745	177	41	523	8.40E-106	386	ARSI_HUMAN	reviewed	Arylsulfatase I (ASI) (EC 3.1.6.-)	ARSI	Homo sapiens (Human)	569	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g1_i6	Q32KH7	ARSI_CANLF	35.2	471	230	7	1535	177	111	524	6.50E-75	283.5	ARSI_CANLF	reviewed	Arylsulfatase I (ASI) (EC 3.1.6.-)	ARSI	Canis lupus familiaris (Dog) (Canis familiaris)	573	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005576; GO:0005783; GO:0008484; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g1_i6	Q32KH7	ARSI_CANLF	54.1	133	58	2	1921	1529	59	190	9.50E-34	146.7	ARSI_CANLF	reviewed	Arylsulfatase I (ASI) (EC 3.1.6.-)	ARSI	Canis lupus familiaris (Dog) (Canis familiaris)	573	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005576; GO:0005783; GO:0008484; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g1_i2	Q5FYB0	ARSJ_HUMAN	35.1	373	191	7	1307	210	215	543	2.30E-53	211.5	ARSJ_HUMAN	reviewed	Arylsulfatase J (ASJ) (EC 3.1.6.-)	ARSJ UNQ372/PRO708	Homo sapiens (Human)	599	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g1_i2	Q5FYB0	ARSJ_HUMAN	64.8	54	18	1	1470	1309	86	138	6.70E-13	77	ARSJ_HUMAN	reviewed	Arylsulfatase J (ASJ) (EC 3.1.6.-)	ARSJ UNQ372/PRO708	Homo sapiens (Human)	599	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g2_i4	Q5FYB0	ARSJ_HUMAN	42.8	138	69	3	652	242	215	343	8.80E-23	108.6	ARSJ_HUMAN	reviewed	Arylsulfatase J (ASJ) (EC 3.1.6.-)	ARSJ UNQ372/PRO708	Homo sapiens (Human)	599	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3434_c0_g2_i5	Q8BM89	ARSJ_MOUSE	29.5	349	203	9	1069	107	213	546	5.70E-27	123.2	ARSJ_MOUSE	reviewed	Arylsulfatase J (ASJ) (EC 3.1.6.-)	Arsj	Mus musculus (Mouse)	598	actin cytoskeleton [GO:0015629]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]	actin cytoskeleton [GO:0015629]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005576; GO:0008484; GO:0015629; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN9621_c0_g6_i1	P51690	ARSE_HUMAN	55.8	138	58	1	414	1	37	171	1.10E-40	167.5	ARSL_HUMAN	reviewed	Arylsulfatase L (EC 3.1.6.-) (Arylsulfatase E) (ASE)	ARSL ARSE	Homo sapiens (Human)	589	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; skeletal system development [GO:0001501]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0001501; GO:0004065; GO:0005788; GO:0005794; GO:0005795; GO:0046872; GO:0070062	skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN9621_c0_g8_i1	P51690	ARSE_HUMAN	40.9	242	119	5	737	63	28	262	3.70E-41	169.9	ARSL_HUMAN	reviewed	Arylsulfatase L (EC 3.1.6.-) (Arylsulfatase E) (ASE)	ARSL ARSE	Homo sapiens (Human)	589	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; skeletal system development [GO:0001501]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0001501; GO:0004065; GO:0005788; GO:0005794; GO:0005795; GO:0046872; GO:0070062	skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN25482_c0_g1_i1	Q0V8E4	ASND1_BOVIN	42.1	634	313	16	40	1797	1	628	9.90E-120	432.2	ASND1_BOVIN	reviewed	Asparagine synthetase domain-containing protein 1	ASNSD1	Bos taurus (Bovine)	640	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]	GO:0004066; GO:0006529; GO:0006541	asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN30647_c0_g1_i1	Q8BFS9	ASND1_MOUSE	100	114	0	0	2	343	387	500	1.10E-59	230.3	ASND1_MOUSE	reviewed	Asparagine synthetase domain-containing protein 1	Asnsd1	Mus musculus (Mouse)	627	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]	GO:0004066; GO:0006529; GO:0006541	asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN26799_c0_g1_i1	Q9NWL6	ASND1_HUMAN	100	105	0	0	315	1	502	606	1.40E-53	209.9	ASND1_HUMAN	reviewed	Asparagine synthetase domain-containing protein 1 (HCV NS3-transactivated protein 1)	ASNSD1 NS3TP1 Nbla00058	Homo sapiens (Human)	643	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]	GO:0004066; GO:0006529; GO:0006541	asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN8537_c0_g1_i1	P32770	NRP1_YEAST	62.5	32	12	0	221	126	355	386	2.10E-06	53.1	NRP1_YEAST	reviewed	Asparagine-rich protein (Protein ARP)	NRP1 ARP ARP1 YDL167C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	719	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0010494; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN2783_c0_g2_i1	P41696	AZF1_YEAST	44.3	79	44	0	17	253	593	671	4.40E-17	89	AZF1_YEAST	reviewed	Asparagine-rich zinc finger protein AZF1	AZF1 YOR113W O3244 YOR3244W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	914	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0043565; GO:0046872; GO:0060237; GO:0071322	cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN36201_c0_g1_i1	P72173	AAT_PSEAE	63.9	97	35	0	2	292	152	248	3.60E-32	138.7	AAT_PSEAE	reviewed	Aspartate aminotransferase (AspAT) (EC 2.6.1.1) (Transaminase A)	aspC PA3139	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	398	cytosol [GO:0005829]; identical protein binding [GO:0042802]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; L-phenylalanine biosynthetic process from chorismate via phenylpyruvate [GO:0033585]	cytosol [GO:0005829]	identical protein binding [GO:0042802]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0004069; GO:0004838; GO:0005829; GO:0008483; GO:0030170; GO:0033585; GO:0042802	L-phenylalanine biosynthetic process from chorismate via phenylpyruvate [GO:0033585]		NA	NA	NA	NA	NA	NA
TRINITY_DN35396_c0_g1_i1	P72173	AAT_PSEAE	85.3	68	10	0	1	204	246	313	1.20E-26	119.8	AAT_PSEAE	reviewed	Aspartate aminotransferase (AspAT) (EC 2.6.1.1) (Transaminase A)	aspC PA3139	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	398	cytosol [GO:0005829]; identical protein binding [GO:0042802]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; L-phenylalanine biosynthetic process from chorismate via phenylpyruvate [GO:0033585]	cytosol [GO:0005829]	identical protein binding [GO:0042802]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0004069; GO:0004838; GO:0005829; GO:0008483; GO:0030170; GO:0033585; GO:0042802	L-phenylalanine biosynthetic process from chorismate via phenylpyruvate [GO:0033585]		NA	NA	NA	NA	NA	NA
TRINITY_DN26187_c0_g1_i1	P17174	AATC_HUMAN	100	117	0	0	352	2	156	272	5.40E-67	254.6	AATC_HUMAN	reviewed	"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)"	GOT1	Homo sapiens (Human)	413	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0004609; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006094; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0008652; GO:0009743; GO:0019550; GO:0019551; GO:0030170; GO:0030511; GO:0031406; GO:0032869; GO:0032966; GO:0035902; GO:0043679; GO:0046686; GO:0047801; GO:0051384; GO:0051481; GO:0051902; GO:0055089; GO:0060290; GO:0070062; GO:0071260; GO:1990267	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]		NA	NA	NA	NA	NA	NA
TRINITY_DN9162_c2_g1_i1	P05201	AATC_MOUSE	58.6	406	163	2	1324	122	7	412	2.60E-141	503.4	AATC_MOUSE	reviewed	"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)"	Got1	Mus musculus (Mouse)	413	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0004609; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0009743; GO:0019550; GO:0019551; GO:0030170; GO:0030511; GO:0031406; GO:0032869; GO:0032966; GO:0035902; GO:0043648; GO:0043679; GO:0046686; GO:0047801; GO:0051384; GO:0051481; GO:0051902; GO:0055089; GO:0060290; GO:0071260; GO:1990267	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]		blue	blue	NA	NA	NA	NA
TRINITY_DN35856_c0_g1_i1	P00504	AATC_CHICK	49.2	297	147	2	888	10	103	399	1.90E-84	313.9	AATC_CHICK	reviewed	"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)"	GOT1	Gallus gallus (Chicken)	412	cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]	cytosol [GO:0005829]	L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005829; GO:0006094; GO:0006103; GO:0006114; GO:0006520; GO:0006531; GO:0006532; GO:0006536; GO:0030170; GO:0047801	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]		NA	NA	NA	NA	NA	NA
TRINITY_DN4850_c0_g2_i1	P17174	AATC_HUMAN	52.8	106	49	1	1	315	151	256	1.80E-29	129.8	AATC_HUMAN	reviewed	"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)"	GOT1	Homo sapiens (Human)	413	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0004609; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006094; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0008652; GO:0009743; GO:0019550; GO:0019551; GO:0030170; GO:0030511; GO:0031406; GO:0032869; GO:0032966; GO:0035902; GO:0043679; GO:0046686; GO:0047801; GO:0051384; GO:0051481; GO:0051902; GO:0055089; GO:0060290; GO:0070062; GO:0071260; GO:1990267	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]		NA	NA	NA	NA	NA	NA
TRINITY_DN37236_c0_g1_i1	P17174	AATC_HUMAN	100	61	0	0	216	34	353	413	8.00E-29	127.1	AATC_HUMAN	reviewed	"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)"	GOT1	Homo sapiens (Human)	413	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0004609; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006094; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0008652; GO:0009743; GO:0019550; GO:0019551; GO:0030170; GO:0030511; GO:0031406; GO:0032869; GO:0032966; GO:0035902; GO:0043679; GO:0046686; GO:0047801; GO:0051384; GO:0051481; GO:0051902; GO:0055089; GO:0060290; GO:0070062; GO:0071260; GO:1990267	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]		NA	NA	NA	NA	NA	NA
TRINITY_DN4850_c0_g1_i1	P28734	AATC_DAUCA	53.1	145	68	0	445	11	253	397	5.10E-41	168.7	AATC_DAUCA	reviewed	"Aspartate aminotransferase, cytoplasmic (EC 2.6.1.1) (Transaminase A)"		Daucus carota (Wild carrot)	405	peroxisome [GO:0005777]; plastid [GO:0009536]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; leaf senescence [GO:0010150]	peroxisome [GO:0005777]; plastid [GO:0009536]	L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005777; GO:0006103; GO:0006531; GO:0006536; GO:0009058; GO:0009536; GO:0010150; GO:0030170	2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; leaf senescence [GO:0010150]		NA	NA	NA	NA	NA	NA
TRINITY_DN39001_c0_g1_i1	P00505	AATM_HUMAN	100	77	0	0	3	233	36	112	1.60E-38	159.5	AATM_HUMAN	reviewed	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	GOT2	Homo sapiens (Human)	430	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; amino acid binding [GO:0016597]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glyoxylate metabolic process [GO:0046487]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]	amino acid binding [GO:0016597]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]	GO:0003723; GO:0004069; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006094; GO:0006103; GO:0006107; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007565; GO:0007595; GO:0008652; GO:0009986; GO:0014850; GO:0015908; GO:0016212; GO:0016597; GO:0019470; GO:0019550; GO:0019551; GO:0019899; GO:0030170; GO:0030315; GO:0032868; GO:0032991; GO:0042802; GO:0043204; GO:0043278; GO:0045471; GO:0046487; GO:0070062	2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glyoxylate metabolic process [GO:0046487]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]		NA	NA	NA	NA	NA	NA
TRINITY_DN4042_c1_g1_i1	P05202	AATM_MOUSE	69.8	404	122	0	1305	94	27	430	2.70E-173	609.8	AATM_MOUSE	reviewed	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	Got2 Got-2	Mus musculus (Mouse)	430	cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]	cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]	amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006520; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007565; GO:0007595; GO:0009986; GO:0014850; GO:0015908; GO:0016212; GO:0016597; GO:0019550; GO:0019551; GO:0019899; GO:0030170; GO:0030315; GO:0031406; GO:0032868; GO:0032991; GO:0042383; GO:0042802; GO:0043204; GO:0043209; GO:0043278; GO:0043648; GO:0045471	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]		blue	blue	NA	NA	NA	NA
TRINITY_DN25636_c0_g1_i1	P00507	AATM_RAT	49.3	71	33	1	11	223	29	96	9.80E-14	77	AATM_RAT	reviewed	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	Got2 Maat	Rattus norvegicus (Rat)	430	cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]	cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]	amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006520; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007565; GO:0007595; GO:0009986; GO:0014850; GO:0015908; GO:0016212; GO:0016597; GO:0019550; GO:0019551; GO:0019899; GO:0030170; GO:0030315; GO:0031406; GO:0032868; GO:0032991; GO:0042383; GO:0042802; GO:0043204; GO:0043278; GO:0043648; GO:0045471	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]		NA	NA	NA	NA	NA	NA
TRINITY_DN12311_c0_g1_i1	Q4R559	AATM_MACFA	99.6	231	1	0	1	693	120	350	1.70E-136	486.5	AATM_MACFA	reviewed	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	GOT2 QccE-17876	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	430	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; fatty acid transport [GO:0015908]; glutamate metabolic process [GO:0006536]; response to ethanol [GO:0045471]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006531; GO:0006533; GO:0006536; GO:0009058; GO:0015908; GO:0016212; GO:0030170; GO:0045471	2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; fatty acid transport [GO:0015908]; glutamate metabolic process [GO:0006536]; response to ethanol [GO:0045471]		NA	NA	NA	NA	NA	NA
TRINITY_DN12311_c1_g1_i1	P05202	AATM_MOUSE	100	153	0	0	461	3	268	420	1.70E-84	313.2	AATM_MOUSE	reviewed	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	Got2 Got-2	Mus musculus (Mouse)	430	cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]	cell surface [GO:0009986]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]	amino acid binding [GO:0016597]; carboxylic acid binding [GO:0031406]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; phospholipid binding [GO:0005543]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006520; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007565; GO:0007595; GO:0009986; GO:0014850; GO:0015908; GO:0016212; GO:0016597; GO:0019550; GO:0019551; GO:0019899; GO:0030170; GO:0030315; GO:0031406; GO:0032868; GO:0032991; GO:0042383; GO:0042802; GO:0043204; GO:0043209; GO:0043278; GO:0043648; GO:0045471	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid transport [GO:0015908]; female pregnancy [GO:0007565]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to muscle activity [GO:0014850]		NA	NA	NA	NA	NA	NA
TRINITY_DN36998_c0_g1_i1	Q5REB0	AATM_PONAB	100	92	0	0	3	278	339	430	2.40E-48	192.6	AATM_PONAB	reviewed	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	GOT2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	430	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; fatty acid transport [GO:0015908]; glutamate metabolic process [GO:0006536]; response to ethanol [GO:0045471]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006531; GO:0006533; GO:0006536; GO:0009058; GO:0015908; GO:0016212; GO:0030170; GO:0045471	2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; fatty acid transport [GO:0015908]; glutamate metabolic process [GO:0006536]; response to ethanol [GO:0045471]		NA	NA	NA	NA	NA	NA
TRINITY_DN27984_c0_g1_i1	A0JMH0	ASPH2_DANRE	40.8	103	54	2	312	13	263	361	1.60E-17	90.1	ASPH2_DANRE	reviewed	Aspartate beta-hydroxylase domain-containing protein 2 (EC 1.14.11.-)	asphd2 si:ch211-286e11.9 zgc:153516	Danio rerio (Zebrafish) (Brachydanio rerio)	371	integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; peptidyl-amino acid modification [GO:0018193]	integral component of membrane [GO:0016021]	dioxygenase activity [GO:0051213]	GO:0016021; GO:0018193; GO:0051213	peptidyl-amino acid modification [GO:0018193]		NA	NA	NA	NA	NA	NA
TRINITY_DN5917_c0_g1_i1	Q6ICH7	ASPH2_HUMAN	44.8	210	109	5	723	100	163	367	7.50E-46	186.4	ASPH2_HUMAN	reviewed	Aspartate beta-hydroxylase domain-containing protein 2 (EC 1.14.11.-)	ASPHD2	Homo sapiens (Human)	369	integral component of membrane [GO:0016021]; membrane [GO:0016020]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; peptidyl-amino acid modification [GO:0018193]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0016020; GO:0016021; GO:0018193; GO:0046872; GO:0051213	peptidyl-amino acid modification [GO:0018193]		NA	NA	NA	NA	NA	NA
TRINITY_DN5917_c0_g1_i2	A0JMH0	ASPH2_DANRE	45.3	75	38	1	324	100	298	369	3.00E-12	72.8	ASPH2_DANRE	reviewed	Aspartate beta-hydroxylase domain-containing protein 2 (EC 1.14.11.-)	asphd2 si:ch211-286e11.9 zgc:153516	Danio rerio (Zebrafish) (Brachydanio rerio)	371	integral component of membrane [GO:0016021]; dioxygenase activity [GO:0051213]; peptidyl-amino acid modification [GO:0018193]	integral component of membrane [GO:0016021]	dioxygenase activity [GO:0051213]	GO:0016021; GO:0018193; GO:0051213	peptidyl-amino acid modification [GO:0018193]		NA	NA	NA	NA	NA	NA
TRINITY_DN22194_c0_g1_i1	A5V3V4	PYRB_SPHWW	84.2	76	12	0	3	230	95	170	2.60E-30	132.1	PYRB_SPHWW	reviewed	Aspartate carbamoyltransferase (EC 2.1.3.2) (Aspartate transcarbamylase) (ATCase)	pyrB Swit_0602	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	316	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]		amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]	GO:0004070; GO:0006207; GO:0006520; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN39347_c0_g1_i1	P04802	SYDC_YEAST	61.4	189	71	2	2	565	195	382	8.10E-57	221.5	SYDC_YEAST	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	DPS1 APS APS1 YLL018C L1295	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	557	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004815; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006422; GO:0017101	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN14526_c0_g1_i1	Q922B2	SYDC_MOUSE	98.7	388	5	0	1	1164	114	501	4.30E-225	781.6	SYDC_MOUSE	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	Dars1 Dars	Mus musculus (Mouse)	501	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN14526_c0_g1_i3	Q922B2	SYDC_MOUSE	91.9	372	6	1	1	1044	114	485	6.90E-195	681	SYDC_MOUSE	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	Dars1 Dars	Mus musculus (Mouse)	501	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN2426_c1_g1_i1	P15178	SYDC_RAT	64.1	499	174	1	196	1677	3	501	2.00E-186	653.7	SYDC_RAT	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	Dars1 Dars Drs1	Rattus norvegicus (Rat)	501	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202	aspartyl-tRNA aminoacylation [GO:0006422]		blue	blue	NA	NA	NA	NA
TRINITY_DN2426_c1_g1_i6	P15178	SYDC_RAT	61.4	404	151	1	196	1392	3	406	1.20E-139	498	SYDC_RAT	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	Dars1 Dars Drs1	Rattus norvegicus (Rat)	501	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202	aspartyl-tRNA aminoacylation [GO:0006422]		blue	blue	NA	NA	NA	NA
TRINITY_DN39475_c0_g1_i1	Q922B2	SYDC_MOUSE	65.9	138	47	0	468	55	364	501	2.30E-50	199.9	SYDC_MOUSE	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	Dars1 Dars	Mus musculus (Mouse)	501	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN14526_c0_g1_i2	P14868	SYDC_HUMAN	100	388	0	0	1	1164	114	501	7.90E-227	787.3	SYDC_HUMAN	reviewed	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)"	DARS1 DARS PIG40	Homo sapiens (Human)	501	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; synapse [GO:0045202]; aminoacylase activity [GO:0004046]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; synapse [GO:0045202]	aminoacylase activity [GO:0004046]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004046; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006422; GO:0016020; GO:0017101; GO:0045202; GO:0065003; GO:0070062	aspartyl-tRNA aminoacylation [GO:0006422]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN7223_c0_g1_i1	Q6PI48	SYDM_HUMAN	45	369	200	3	2	1102	268	635	1.40E-87	324.7	SYDM_HUMAN	reviewed	"Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	DARS2	Homo sapiens (Human)	645	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	aspartate-tRNA(Asn) ligase activity [GO:0050560]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006418; GO:0042803; GO:0043039; GO:0050560; GO:0070145	mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN37281_c0_g1_i1	Q8Y270	SYDND_RALSO	96.8	93	3	0	279	1	415	507	8.70E-52	203.8	SYDND_RALSO	reviewed	Aspartate--tRNA(Asp/Asn) ligase (EC 6.1.1.23) (Aspartyl-tRNA synthetase) (AspRS) (Non-discriminating aspartyl-tRNA synthetase) (ND-AspRS)	aspS RSc0466 RS04431	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	605	cytoplasm [GO:0005737]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; aspartyl-tRNA aminoacylation [GO:0006422]	cytoplasm [GO:0005737]	aspartate-tRNA(Asn) ligase activity [GO:0050560]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004815; GO:0005524; GO:0005737; GO:0006422; GO:0050560	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN11005_c3_g1_i1	B3CV53	SYDND_ORITI	41.3	150	82	3	515	78	5	152	3.90E-20	100.1	SYDND_ORITI	reviewed	Aspartate--tRNA(Asp/Asn) ligase (EC 6.1.1.23) (Aspartyl-tRNA synthetase) (AspRS) (Non-discriminating aspartyl-tRNA synthetase) (ND-AspRS)	aspS OTT_1792	Orientia tsutsugamushi (strain Ikeda) (Rickettsia tsutsugamushi)	597	cytoplasm [GO:0005737]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; aspartyl-tRNA aminoacylation [GO:0006422]	cytoplasm [GO:0005737]	aspartate-tRNA(Asn) ligase activity [GO:0050560]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004815; GO:0005524; GO:0005737; GO:0006422; GO:0050560	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN29409_c0_g1_i1	P55956	ASP3_CAEEL	63	46	17	0	5	142	351	396	7.00E-11	67.4	ASP3_CAEEL	reviewed	Aspartic protease 3 (EC 3.4.23.-)	asp-3 H22K11.1	Caenorhabditis elegans	398	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]; cell death [GO:0008219]; necrotic cell death [GO:0070265]; programmed cell death [GO:0012501]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosome [GO:0005764]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0005576; GO:0005737; GO:0005764; GO:0008219; GO:0012501; GO:0070265	cell death [GO:0008219]; necrotic cell death [GO:0070265]; programmed cell death [GO:0012501]		NA	NA	NA	NA	NA	NA
TRINITY_DN39190_c0_g1_i1	Q8BSY0	ASPH_MOUSE	49.1	407	198	5	39	1256	343	741	6.30E-109	396.7	ASPH_MOUSE	reviewed	Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)	Asph Bah	Mus musculus (Mouse)	741	"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]"	cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]	calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]	GO:0004597; GO:0005509; GO:0005737; GO:0005783; GO:0005886; GO:0007389; GO:0008285; GO:0010524; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033198; GO:0035108; GO:0042264; GO:0045862; GO:0045893; GO:0051480; GO:0055074; GO:0060021; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879	"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39190_c0_g1_i3	Q8BSY0	ASPH_MOUSE	49.1	407	198	5	1304	87	343	741	3.30E-109	396.7	ASPH_MOUSE	reviewed	Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)	Asph Bah	Mus musculus (Mouse)	741	"cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]"	cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]	calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]	GO:0004597; GO:0005509; GO:0005737; GO:0005783; GO:0005886; GO:0007389; GO:0008285; GO:0010524; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033198; GO:0035108; GO:0042264; GO:0045862; GO:0045893; GO:0051480; GO:0055074; GO:0060021; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879	"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17407_c0_g1_i1	Q2G4F6	GATB_NOVAD	90.9	66	6	0	2	199	52	117	1.00E-30	133.3	GATB_NOVAD	reviewed	Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B (Asp/Glu-ADT subunit B) (EC 6.3.5.-)	gatB Saro_2831	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	497	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; translation [GO:0006412]		ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0006412; GO:0050567	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN298_c0_g1_i1	P07584	ASTA_ASTAS	54.2	236	106	2	798	94	10	244	1.40E-71	271.2	ASTA_ASTAS	reviewed	Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	251	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]		black	black	NA	NA	1	1
TRINITY_DN298_c0_g1_i2	P07584	ASTA_ASTAS	54	235	106	2	798	97	10	243	7.10E-71	268.9	ASTA_ASTAS	reviewed	Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	251	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]		NA	NA	NA	NA	NA	NA
TRINITY_DN298_c0_g2_i2	P07584	ASTA_ASTAS	55.4	251	110	2	943	194	1	250	5.30E-75	282.7	ASTA_ASTAS	reviewed	Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	251	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]		black	black	NA	NA	NA	NA
TRINITY_DN38925_c0_g1_i1	P07584	ASTA_ASTAS	47.8	69	35	1	208	5	137	205	9.70E-14	77	ASTA_ASTAS	reviewed	Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	251	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23677_c0_g1_i1	P07584	ASTA_ASTAS	54.4	57	25	1	49	216	175	231	1.10E-09	63.5	ASTA_ASTAS	reviewed	Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	251	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2118_c0_g1_i2	P07584	ASTA_ASTAS	36.4	77	46	2	309	85	31	106	3.30E-08	59.3	ASTA_ASTAS	reviewed	Astacin (EC 3.4.24.21) (Crayfish small molecule proteinase)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	251	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1018_c0_g1_i7	Q56R10	ASTA_PENMO	39.8	113	63	3	15	347	7	116	1.60E-16	87.4	ASTA_PENMO	reviewed	Astakine		Penaeus monodon (Giant tiger prawn)	124	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN4950_c0_g1_i14	C9STX5	ASA1_VERA1	23.1	386	221	12	252	1211	29	404	1.10E-16	89.4	ASA1_VERA1	reviewed	ASTRA-associated protein 1	asa1 VDBG_08396	Verticillium alfalfae (strain VaMs.102 / ATCC MYA-4576 / FGSC 10136) (Verticillium wilt of alfalfa) (Verticillium albo-atrum)	404	nucleus [GO:0005634]; chromatin organization [GO:0006325]	nucleus [GO:0005634]		GO:0005634; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN4950_c0_g1_i4	C9STX5	ASA1_VERA1	23.1	386	221	12	685	1644	29	404	1.40E-16	89.4	ASA1_VERA1	reviewed	ASTRA-associated protein 1	asa1 VDBG_08396	Verticillium alfalfae (strain VaMs.102 / ATCC MYA-4576 / FGSC 10136) (Verticillium wilt of alfalfa) (Verticillium albo-atrum)	404	nucleus [GO:0005634]; chromatin organization [GO:0006325]	nucleus [GO:0005634]		GO:0005634; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN20344_c0_g1_i1	Q99700	ATX2_HUMAN	40.7	231	129	5	87	767	244	470	9.30E-38	158.7	ATX2_HUMAN	reviewed	Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein)	ATXN2 ATX2 SCA2 TNRC13	Homo sapiens (Human)	1313	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]	epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0002091; GO:0003723; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005844; GO:0006417; GO:0008022; GO:0010494; GO:0010603; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904	negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN20344_c0_g1_i2	Q99700	ATX2_HUMAN	38.1	294	164	7	87	935	244	530	4.30E-39	163.3	ATX2_HUMAN	reviewed	Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein)	ATXN2 ATX2 SCA2 TNRC13	Homo sapiens (Human)	1313	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]	epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0002091; GO:0003723; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005844; GO:0006417; GO:0008022; GO:0010494; GO:0010603; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904	negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN758_c0_g1_i1	Q9W689	ATX3_CHICK	63.5	96	35	0	41	328	1	96	1.20E-30	134	ATX3_CHICK	reviewed	Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog)	ATXN3 MDJ1 MJD	Gallus gallus (Chicken)	363	nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; cellular response to misfolded protein [GO:0071218]; monoubiquitinated protein deubiquitination [GO:0035520]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005634; GO:0006515; GO:0008234; GO:0016579; GO:0031625; GO:0035520; GO:0043161; GO:0071218	cellular response to misfolded protein [GO:0071218]; monoubiquitinated protein deubiquitination [GO:0035520]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN758_c0_g1_i2	Q9W689	ATX3_CHICK	61.4	88	34	0	160	423	9	96	4.90E-26	119	ATX3_CHICK	reviewed	Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog)	ATXN3 MDJ1 MJD	Gallus gallus (Chicken)	363	nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; cellular response to misfolded protein [GO:0071218]; monoubiquitinated protein deubiquitination [GO:0035520]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005634; GO:0006515; GO:0008234; GO:0016579; GO:0031625; GO:0035520; GO:0043161; GO:0071218	cellular response to misfolded protein [GO:0071218]; monoubiquitinated protein deubiquitination [GO:0035520]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN758_c0_g1_i3	Q9W689	ATX3_CHICK	60.7	89	35	0	96	362	8	96	1.90E-26	120.2	ATX3_CHICK	reviewed	Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog)	ATXN3 MDJ1 MJD	Gallus gallus (Chicken)	363	nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; cellular response to misfolded protein [GO:0071218]; monoubiquitinated protein deubiquitination [GO:0035520]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005634; GO:0006515; GO:0008234; GO:0016579; GO:0031625; GO:0035520; GO:0043161; GO:0071218	cellular response to misfolded protein [GO:0071218]; monoubiquitinated protein deubiquitination [GO:0035520]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN35942_c0_g1_i1	Q9ULK2	AT7L1_HUMAN	52.9	87	38	1	349	98	265	351	3.20E-14	79.3	AT7L1_HUMAN	reviewed	Ataxin-7-like protein 1 (Ataxin-7-like protein 4)	ATXN7L1 ATXN7L4 KIAA1218	Homo sapiens (Human)	861							NA	NA	NA	NA	NA	NA
TRINITY_DN4768_c0_g1_i1	Q2G506	ATM1_NOVAD	89	118	13	0	1	354	476	593	2.20E-52	206.1	ATM1_NOVAD	reviewed	ATM1-type heavy metal exporter (ATP-binding cassette transporter Atm1) (NaAtm1)	atm1 Saro_2631	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	608	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; response to mercury ion [GO:0046689]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0006811; GO:0016021; GO:0016887; GO:0042626; GO:0046689	ion transport [GO:0006811]; response to mercury ion [GO:0046689]		NA	NA	NA	NA	NA	NA
TRINITY_DN4768_c0_g1_i2	Q2G506	ATM1_NOVAD	84.5	226	35	0	2	679	368	593	5.90E-102	371.7	ATM1_NOVAD	reviewed	ATM1-type heavy metal exporter (ATP-binding cassette transporter Atm1) (NaAtm1)	atm1 Saro_2631	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	608	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; response to mercury ion [GO:0046689]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0006811; GO:0016021; GO:0016887; GO:0042626; GO:0046689	ion transport [GO:0006811]; response to mercury ion [GO:0046689]		NA	NA	NA	NA	NA	NA
TRINITY_DN4296_c0_g1_i1	Q2G506	ATM1_NOVAD	73.1	93	25	0	279	1	379	471	6.90E-33	141	ATM1_NOVAD	reviewed	ATM1-type heavy metal exporter (ATP-binding cassette transporter Atm1) (NaAtm1)	atm1 Saro_2631	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	608	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; response to mercury ion [GO:0046689]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0006811; GO:0016021; GO:0016887; GO:0042626; GO:0046689	ion transport [GO:0006811]; response to mercury ion [GO:0046689]		NA	NA	NA	NA	NA	NA
TRINITY_DN4296_c0_g1_i2	Q2G506	ATM1_NOVAD	73.1	108	29	0	327	4	363	470	1.50E-39	163.3	ATM1_NOVAD	reviewed	ATM1-type heavy metal exporter (ATP-binding cassette transporter Atm1) (NaAtm1)	atm1 Saro_2631	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	608	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; response to mercury ion [GO:0046689]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0006811; GO:0016021; GO:0016887; GO:0042626; GO:0046689	ion transport [GO:0006811]; response to mercury ion [GO:0046689]		NA	NA	NA	NA	NA	NA
TRINITY_DN31066_c0_g1_i1	Q2G506	ATM1_NOVAD	57.4	68	29	0	206	3	535	602	7.00E-14	77.4	ATM1_NOVAD	reviewed	ATM1-type heavy metal exporter (ATP-binding cassette transporter Atm1) (NaAtm1)	atm1 Saro_2631	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	608	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; response to mercury ion [GO:0046689]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0006811; GO:0016021; GO:0016887; GO:0042626; GO:0046689	ion transport [GO:0006811]; response to mercury ion [GO:0046689]		NA	NA	NA	NA	NA	NA
TRINITY_DN32113_c0_g1_i1	Q2G506	ATM1_NOVAD	74.3	109	28	0	327	1	491	599	6.40E-38	157.9	ATM1_NOVAD	reviewed	ATM1-type heavy metal exporter (ATP-binding cassette transporter Atm1) (NaAtm1)	atm1 Saro_2631	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	608	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; response to mercury ion [GO:0046689]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0006811; GO:0016021; GO:0016887; GO:0042626; GO:0046689	ion transport [GO:0006811]; response to mercury ion [GO:0046689]		NA	NA	NA	NA	NA	NA
TRINITY_DN19228_c0_g1_i1	Q9S7D8	APS4_ARATH	56.7	60	26	0	25	204	387	446	1.20E-13	76.6	APS4_ARATH	reviewed	"ATP sulfurylase 4, chloroplastic (EC 2.7.7.4)"	APS4 At5g43780 MQD19.13	Arabidopsis thaliana (Mouse-ear cress)	469	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]; plastid [GO:0009536]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation [GO:0000103]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]; plastid [GO:0009536]	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; sulfate adenylyltransferase (ATP) activity [GO:0004781]	GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0005739; GO:0009507; GO:0009536; GO:0009570; GO:0070814	hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation [GO:0000103]		NA	NA	NA	NA	NA	NA
TRINITY_DN1158_c0_g2_i1	Q5TC12	ATPF1_HUMAN	35.2	264	164	3	184	957	53	315	1.60E-37	158.3	ATPF1_HUMAN	reviewed	ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog)	ATPAF1 ATP11	Homo sapiens (Human)	328	mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	mitochondrion [GO:0005739]		GO:0005739; GO:0033615	mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]		NA	NA	NA	NA	NA	NA
TRINITY_DN1158_c0_g2_i4	Q5TC12	ATPF1_HUMAN	35.2	264	164	3	242	1015	53	315	1.70E-37	158.3	ATPF1_HUMAN	reviewed	ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog)	ATPAF1 ATP11	Homo sapiens (Human)	328	mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	mitochondrion [GO:0005739]		GO:0005739; GO:0033615	mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]		blue	blue	NA	NA	NA	NA
TRINITY_DN1158_c0_g2_i6	Q5TC12	ATPF1_HUMAN	35.5	231	142	3	102	776	86	315	1.30E-32	141.7	ATPF1_HUMAN	reviewed	ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog)	ATPAF1 ATP11	Homo sapiens (Human)	328	mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	mitochondrion [GO:0005739]		GO:0005739; GO:0033615	mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]		NA	NA	NA	NA	NA	NA
TRINITY_DN24825_c0_g1_i1	Q5TC12	ATPF1_HUMAN	32.2	87	41	1	2	262	242	310	5.30E-06	51.6	ATPF1_HUMAN	reviewed	ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog)	ATPAF1 ATP11	Homo sapiens (Human)	328	mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	mitochondrion [GO:0005739]		GO:0005739; GO:0033615	mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]		NA	NA	NA	NA	NA	NA
TRINITY_DN17047_c0_g1_i1	Q2G5N7	ATPA_NOVAD	89.3	112	12	0	2	337	9	120	1.50E-50	199.9	ATPA_NOVAD	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Saro_2400	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	1
TRINITY_DN17047_c0_g1_i2	Q1GQS7	ATPA_SPHAL	89.2	111	12	0	2	334	9	119	7.40E-50	197.6	ATPA_SPHAL	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Sala_2286	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN36341_c0_g1_i1	Q6A8C5	ATPA_CUTAK	100	105	0	0	316	2	362	466	2.60E-52	205.7	ATPA_CUTAK	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA PPA1241	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	545	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN40186_c0_g1_i1	A5CQ58	ATPA_CLAM3	94.5	73	4	0	221	3	180	252	1.20E-32	139.8	ATPA_CLAM3	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA CMM_1167	Clavibacter michiganensis subsp. michiganensis (strain NCPPB 382)	545	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g3_i1	Q2J3I2	ATPA_RHOP2	85.7	84	12	0	3	254	118	201	3.90E-35	148.3	ATPA_RHOP2	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA RPB_0267	Rhodopseudomonas palustris (strain HaA2)	510	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g2_i2	Q2N8Z5	ATPA_ERYLH	97.5	81	2	0	1	243	254	334	3.00E-40	165.2	ATPA_ERYLH	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA ELI_08770	Erythrobacter litoralis (strain HTCC2594)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g2_i3	Q2N8Z5	ATPA_ERYLH	93.6	187	12	0	1	561	254	440	8.20E-94	344.4	ATPA_ERYLH	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA ELI_08770	Erythrobacter litoralis (strain HTCC2594)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g2_i4	A5V3X3	ATPA_SPHWW	91.8	233	19	0	1	699	102	334	4.10E-119	428.7	ATPA_SPHWW	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Swit_0621	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g2_i5	Q2N8Z5	ATPA_ERYLH	97.5	81	2	0	1	243	254	334	3.00E-40	165.2	ATPA_ERYLH	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA ELI_08770	Erythrobacter litoralis (strain HTCC2594)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g2_i6	A5V3X3	ATPA_SPHWW	92	339	27	0	1	1017	102	440	1.70E-174	613.2	ATPA_SPHWW	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Swit_0621	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN7296_c0_g1_i1	A5V3X3	ATPA_SPHWW	94.8	77	4	0	1	231	162	238	8.80E-34	143.7	ATPA_SPHWW	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Swit_0621	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN26701_c0_g1_i1	Q11DD7	ATPA_CHESB	75.8	450	108	1	7	1356	3	451	5.80E-194	678.3	ATPA_CHESB	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Meso_3216	Chelativorans sp. (strain BNC1)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c3_g1_i1	Q6A8C5	ATPA_CUTAK	100	79	0	0	3	239	273	351	2.50E-39	162.2	ATPA_CUTAK	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA PPA1241	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	545	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN9317_c1_g1_i1	B2UGV1	ATPA_RALPJ	99.7	344	1	0	1034	3	119	462	4.30E-189	661.8	ATPA_RALPJ	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Rpic_3514	Ralstonia pickettii (strain 12J)	513	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN30588_c0_g1_i1	Q2G5N7	ATPA_NOVAD	97.9	97	2	0	294	4	357	453	1.20E-46	186.8	ATPA_NOVAD	reviewed	ATP synthase subunit alpha (EC 7.1.2.2) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha)	atpA Saro_2400	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	509	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN28671_c0_g1_i1	Q03265	ATPA_MOUSE	100	128	0	0	385	2	33	160	3.60E-64	245.4	ATPA_MOUSE	reviewed	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	Atp5f1a Atp5a1	Mus musculus (Mouse)	553	"cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]"	"cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0001937; GO:0002020; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006629; GO:0006754; GO:0008180; GO:0009986; GO:0015986; GO:0016020; GO:0042288; GO:0042776; GO:0043209; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0046034; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]		NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c1_g3_i1	P19483	ATPA_BOVIN	100	67	0	0	204	4	178	244	9.50E-32	136.7	ATPA_BOVIN	reviewed	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	ATP5F1A ATP5A1 ATP5A2	Bos taurus (Bovine)	553	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005753; GO:0005886; GO:0015986; GO:0043531; GO:0045261; GO:0046933	ATP synthesis coupled proton transport [GO:0015986]		NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c1_g1_i1	Q03265	ATPA_MOUSE	97.5	159	4	0	7	483	236	394	1.30E-82	307	ATPA_MOUSE	reviewed	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	Atp5f1a Atp5a1	Mus musculus (Mouse)	553	"cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]"	"cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0001937; GO:0002020; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006629; GO:0006754; GO:0008180; GO:0009986; GO:0015986; GO:0016020; GO:0042288; GO:0042776; GO:0043209; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0046034; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]		NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c1_g2_i1	P25705	ATPA_HUMAN	99.4	161	1	0	483	1	382	542	1.10E-81	303.9	ATPA_HUMAN	reviewed	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM	Homo sapiens (Human)	553	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]"	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0001937; GO:0003723; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0015986; GO:0016020; GO:0042288; GO:0042407; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0070062	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]		NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c1_g2_i2	P25705	ATPA_HUMAN	99.4	161	1	0	483	1	382	542	1.10E-81	303.9	ATPA_HUMAN	reviewed	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM	Homo sapiens (Human)	553	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]"	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0001937; GO:0003723; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0015986; GO:0016020; GO:0042288; GO:0042407; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0070062	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]		NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c1_g4_i1	P25705	ATPA_HUMAN	100	366	0	0	3	1100	29	394	2.30E-204	712.6	ATPA_HUMAN	reviewed	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM	Homo sapiens (Human)	553	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]"	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0001937; GO:0003723; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0015986; GO:0016020; GO:0042288; GO:0042407; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0070062	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]		NA	NA	NA	NA	NA	NA
TRINITY_DN5747_c0_g1_i1	P35381	ATPA_DROME	84.8	552	82	1	58	1707	1	552	3.60E-260	898.7	ATPA_DROME	reviewed	"ATP synthase subunit alpha, mitochondrial (Protein bellwether)"	blw ATPSYN-ALPHA CG3612	Drosophila melanogaster (Fruit fly)	552	"mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]"	"mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005524; GO:0005739; GO:0005754; GO:0005886; GO:0015986; GO:0019915; GO:0022900; GO:0043531; GO:0045261; GO:0046933; GO:1902769	ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; lipid storage [GO:0019915]; regulation of choline O-acetyltransferase activity [GO:1902769]		blue	blue	NA	NA	NA	NA
TRINITY_DN624_c0_g1_i5	B3CN17	ATPB_WOLPP	75.5	94	23	0	363	82	383	476	3.10E-33	142.5	ATPB_WOLPP	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD WP1157	Wolbachia pipientis subsp. Culex pipiens (strain wPip)	478	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			blue	blue	NA	NA	NA	NA
TRINITY_DN26365_c0_g1_i1	Q0BQE8	ATPB_GRABC	94	84	5	0	2	253	294	377	3.80E-38	158.3	ATPB_GRABC	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD GbCGDNIH1_2056	Granulibacter bethesdensis (strain ATCC BAA-1260 / CGDNIH1)	476	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g3_i1	Q1GQS5	ATPB_SPHAL	89.9	474	48	0	12	1433	40	513	3.10E-241	835.5	ATPB_SPHAL	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Sala_2288	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	513	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g3_i2	A5V3X5	ATPB_SPHWW	89.8	343	35	0	5	1033	82	424	4.80E-172	605.1	ATPB_SPHWW	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Swit_0623	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	484	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g3_i3	A5V3X5	ATPB_SPHWW	89.3	402	43	0	5	1210	82	483	1.40E-202	706.8	ATPB_SPHWW	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Swit_0623	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	484	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g3_i4	C3M9S1	ATPB_SINFN	83.2	101	17	0	5	307	109	209	1.40E-42	173.3	ATPB_SINFN	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD NGR_c31110	Sinorhizobium fredii (strain NBRC 101917 / NGR234)	505	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g2_i1	A5V3X5	ATPB_SPHWW	96.4	168	6	0	3	506	167	334	2.30E-87	322.8	ATPB_SPHWW	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Swit_0623	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	484	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g1_i1	Q2G5N5	ATPB_NOVAD	96.4	306	11	0	3	920	158	463	3.30E-164	578.9	ATPB_NOVAD	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Saro_2402	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	481	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN6542_c0_g1_i2	Q2G5N5	ATPB_NOVAD	94.8	306	16	0	3	920	158	463	4.00E-162	572	ATPB_NOVAD	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Saro_2402	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	481	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN2378_c0_g1_i1	Q6A8C7	ATPB_CUTAK	100	124	0	0	2	373	323	446	1.50E-62	240	ATPB_CUTAK	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD PPA1239	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	484	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN9726_c0_g1_i1	Q2G5N5	ATPB_NOVAD	98.8	80	1	0	2	241	163	242	3.30E-39	161.8	ATPB_NOVAD	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Saro_2402	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	481	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN33757_c0_g1_i1	P63678	ATPB_MYCBO	97.2	71	2	0	216	4	372	442	4.50E-32	137.9	ATPB_MYCBO	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD BQ2027_MB1342	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	486	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN17821_c0_g1_i1	Q46VY0	ATPB_CUPPJ	96.6	88	3	0	264	1	84	171	1.40E-43	176.4	ATPB_CUPPJ	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Reut_A3346	Cupriavidus pinatubonensis (strain JMP 134 / LMG 1197) (Cupriavidus necator (strain JMP 134))	467	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN32482_c0_g1_i1	Q2G5N5	ATPB_NOVAD	86.4	66	9	0	3	200	61	126	5.30E-27	120.9	ATPB_NOVAD	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Saro_2402	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	481	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN32155_c0_g1_i1	Q6A8C7	ATPB_CUTAK	100	71	0	0	1	213	133	203	9.60E-35	146.7	ATPB_CUTAK	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD PPA1239	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	484	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN1686_c0_g2_i1	Q1LHL0	ATPB_CUPMC	100	137	0	0	411	1	179	315	4.50E-73	275	ATPB_CUPMC	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD Rmet_3494	Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) (Ralstonia metallidurans)	467	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN1686_c1_g1_i1	A4GAG9	ATPB_HERAR	98.9	88	1	0	2	265	250	337	1.70E-41	169.5	ATPB_HERAR	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD HEAR3405	Herminiimonas arsenicoxydans	466	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN1686_c0_g1_i1	Q8XU76	ATPB_RALSO	94.6	93	5	0	280	2	310	402	7.30E-43	174.1	ATPB_RALSO	reviewed	ATP synthase subunit beta (EC 7.1.2.2) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta)	atpD RSc3317	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	467	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005886; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN19373_c1_g1_i1	Q05825	ATPB_DROME	89.2	74	8	0	222	1	334	407	7.40E-30	130.6	ATPB_DROME	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2)"	ATPsynbeta ATPsyn-beta CG11154	Drosophila melanogaster (Fruit fly)	505	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005524; GO:0005739; GO:0005753; GO:0005754; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:0046961; GO:1902600	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN624_c0_g1_i2	Q05825	ATPB_DROME	85	500	74	1	1596	97	3	501	2.70E-233	809.3	ATPB_DROME	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2)"	ATPsynbeta ATPsyn-beta CG11154	Drosophila melanogaster (Fruit fly)	505	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005524; GO:0005739; GO:0005753; GO:0005754; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:0046961; GO:1902600	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		blue	blue	NA	NA	NA	NA
TRINITY_DN624_c2_g1_i1	Q25117	ATPB_HEMPU	93.3	135	9	0	3	407	247	381	5.80E-65	248.1	ATPB_HEMPU	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2)"		Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)	523	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005743; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN9146_c0_g1_i1	P56480	ATPB_MOUSE	100	124	0	0	375	4	33	156	5.60E-62	238	ATPB_MOUSE	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	Atp5f1b Atp5b	Mus musculus (Mouse)	529	"cell surface [GO:0009986]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; cellular response to interleukin-7 [GO:0098761]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]"	"cell surface [GO:0009986]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; MHC class I protein binding [GO:0042288]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0001525; GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006629; GO:0006754; GO:0006898; GO:0006933; GO:0009986; GO:0016020; GO:0016887; GO:0030228; GO:0031966; GO:0042288; GO:0042645; GO:0042776; GO:0043209; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:0046961; GO:0051453; GO:0098761; GO:1902600	angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; cellular response to interleukin-7 [GO:0098761]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN624_c0_g1_i1	Q5ZLC5	ATPB_CHICK	88.9	126	14	0	380	3	381	506	1.20E-56	220.3	ATPB_CHICK	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B RCJMB04_6l18	Gallus gallus (Chicken)	533	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0001525; GO:0005524; GO:0005753; GO:0042776; GO:0045261; GO:0046933; GO:0046961	angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN624_c0_g1_i3	P06576	ATPB_HUMAN	100	478	0	0	1434	1	37	514	6.90E-270	930.6	ATPB_HUMAN	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B ATPMB ATPSB	Homo sapiens (Human)	529	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]"	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0001525; GO:0001649; GO:0005524; GO:0005634; GO:0005739; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0007005; GO:0009986; GO:0016020; GO:0031966; GO:0042288; GO:0042407; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:0098761; GO:1902600	angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN624_c0_g1_i4	P06576	ATPB_HUMAN	100	478	0	0	1434	1	37	514	6.90E-270	930.6	ATPB_HUMAN	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B ATPMB ATPSB	Homo sapiens (Human)	529	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]"	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0001525; GO:0001649; GO:0005524; GO:0005634; GO:0005739; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0007005; GO:0009986; GO:0016020; GO:0031966; GO:0042288; GO:0042407; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:0098761; GO:1902600	angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN21020_c0_g1_i1	Q5ZLC5	ATPB_CHICK	78.4	111	24	0	335	3	62	172	8.40E-41	167.5	ATPB_CHICK	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B RCJMB04_6l18	Gallus gallus (Chicken)	533	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0001525; GO:0005524; GO:0005753; GO:0042776; GO:0045261; GO:0046933; GO:0046961	angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN25680_c0_g1_i1	Q5ZLC5	ATPB_CHICK	85.8	162	23	0	487	2	94	255	3.40E-72	272.3	ATPB_CHICK	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B RCJMB04_6l18	Gallus gallus (Chicken)	533	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0001525; GO:0005524; GO:0005753; GO:0042776; GO:0045261; GO:0046933; GO:0046961	angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN2819_c0_g1_i1	Q9PTY0	ATPB_CYPCA	79.7	458	92	1	1377	4	45	501	6.30E-204	711.4	ATPB_CYPCA	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B atp5b	Cyprinus carpio (Common carp)	518	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005743; GO:0045261; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN3270_c0_g1_i1	P56480	ATPB_MOUSE	100	152	0	0	458	3	357	508	5.00E-81	301.6	ATPB_MOUSE	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	Atp5f1b Atp5b	Mus musculus (Mouse)	529	"cell surface [GO:0009986]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; cellular response to interleukin-7 [GO:0098761]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]"	"cell surface [GO:0009986]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228]; MHC class I protein binding [GO:0042288]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0001525; GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006629; GO:0006754; GO:0006898; GO:0006933; GO:0009986; GO:0016020; GO:0016887; GO:0030228; GO:0031966; GO:0042288; GO:0042645; GO:0042776; GO:0043209; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:0046961; GO:0051453; GO:0098761; GO:1902600	angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; cellular response to interleukin-7 [GO:0098761]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; receptor-mediated endocytosis [GO:0006898]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN7040_c0_g1_i1	Q5ZLC5	ATPB_CHICK	81.5	173	32	0	1	519	358	530	3.30E-76	285.8	ATPB_CHICK	reviewed	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B RCJMB04_6l18	Gallus gallus (Chicken)	533	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0001525; GO:0005524; GO:0005753; GO:0042776; GO:0045261; GO:0046933; GO:0046961	angiogenesis [GO:0001525]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN3292_c0_g1_i1	Q9D1Z3	ACKMT_MOUSE	49.8	233	106	3	1141	470	16	246	1.20E-55	218.8	ACKMT_MOUSE	reviewed	ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (mFam173b)	Atpsckmt Fam173b	Mus musculus (Mouse)	247	"integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"	integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005739; GO:0016021; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706	"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3292_c0_g1_i3	Q9D1Z3	ACKMT_MOUSE	50	234	106	3	1144	470	15	246	2.90E-56	220.7	ACKMT_MOUSE	reviewed	ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (mFam173b)	Atpsckmt Fam173b	Mus musculus (Mouse)	247	"integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"	integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005739; GO:0016021; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706	"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3292_c0_g1_i7	Q9D1Z3	ACKMT_MOUSE	49.8	233	106	3	1128	457	16	246	1.20E-55	218.8	ACKMT_MOUSE	reviewed	ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (mFam173b)	Atpsckmt Fam173b	Mus musculus (Mouse)	247	"integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"	integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005739; GO:0016021; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706	"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38736_c1_g1_i1	Q24251	ATP5H_DROME	45.9	172	92	1	82	594	1	172	2.90E-35	150.2	ATP5H_DROME	reviewed	"ATP synthase subunit d, mitochondrial (ATPase subunit d)"	ATPsynD ATPsyn-d CG6030	Drosophila melanogaster (Fruit fly)	178	"mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of TOR signaling [GO:0032007]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]"	"mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]"	proton transmembrane transporter activity [GO:0015078]	GO:0000274; GO:0005739; GO:0006979; GO:0008340; GO:0015078; GO:0015986; GO:0032007; GO:0046034; GO:0051881; GO:0070373; GO:1902600	ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of TOR signaling [GO:0032007]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN14326_c0_g1_i1	P13620	ATP5H_BOVIN	39.1	110	67	0	386	57	50	159	8.90E-18	91.3	ATP5H_BOVIN	reviewed	"ATP synthase subunit d, mitochondrial (ATPase subunit d) (ATP synthase peripheral stalk subunit d)"	ATP5PD ATP5H	Bos taurus (Bovine)	161	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000274; GO:0005753; GO:0015986; GO:0042776; GO:0046933	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN39059_c0_g1_i1	P30049	ATPD_HUMAN	100	111	0	0	335	3	33	143	8.50E-54	210.7	ATPD_HUMAN	reviewed	"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)"	ATP5F1D ATP5D	Homo sapiens (Human)	168	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; ATPase activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; oxidative phosphorylation [GO:0006119]; response to copper ion [GO:0046688]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"ATPase activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006119; GO:0006754; GO:0009060; GO:0015986; GO:0016887; GO:0033615; GO:0042407; GO:0042776; GO:0046688; GO:0046933	aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; oxidative phosphorylation [GO:0006119]; response to copper ion [GO:0046688]		NA	NA	NA	NA	NA	NA
TRINITY_DN33147_c0_g1_i1	P35434	ATPD_RAT	60.3	131	52	0	477	85	38	168	1.00E-33	144.8	ATPD_RAT	reviewed	"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)"	Atp5f1d Atp5d	Rattus norvegicus (Rat)	168	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to resveratrol [GO:1904638]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"protein-containing complex binding [GO:0044877]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005743; GO:0005753; GO:0006754; GO:0009060; GO:0015986; GO:0033615; GO:0042776; GO:0044877; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:1904638	aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to resveratrol [GO:1904638]		blue	blue	NA	NA	NA	NA
TRINITY_DN33147_c0_g1_i2	P35434	ATPD_RAT	60.3	131	52	0	477	85	38	168	1.10E-33	144.8	ATPD_RAT	reviewed	"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)"	Atp5f1d Atp5d	Rattus norvegicus (Rat)	168	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to resveratrol [GO:1904638]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"protein-containing complex binding [GO:0044877]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005743; GO:0005753; GO:0006754; GO:0009060; GO:0015986; GO:0033615; GO:0042776; GO:0044877; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:1904638	aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to resveratrol [GO:1904638]		blue	blue	NA	NA	NA	NA
TRINITY_DN31498_c0_g1_i1	Q9D3D9	ATPD_MOUSE	99	97	1	0	2	292	39	135	1.60E-45	183	ATPD_MOUSE	reviewed	"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)"	Atp5f1d Atp5d	Mus musculus (Mouse)	168	"mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton transmembrane transport [GO:1902600]"	"mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005740; GO:0005743; GO:0005753; GO:0009060; GO:0015078; GO:0015986; GO:0033615; GO:0042776; GO:0044877; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:1902600	aerobic respiration [GO:0009060]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN7649_c0_g1_i1	Q5RFH0	ATP5L_PONAB	52.1	96	46	0	383	96	8	103	5.10E-21	102.4	ATP5L_PONAB	reviewed	"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)"	ATP5MG ATP5L	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	103	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005753; GO:0015078; GO:0015986	ATP synthesis coupled proton transport [GO:0015986]		blue	blue	NA	NA	NA	NA
TRINITY_DN7649_c0_g1_i2	Q5RFH0	ATP5L_PONAB	52.1	96	46	0	383	96	8	103	5.10E-21	102.4	ATP5L_PONAB	reviewed	"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)"	ATP5MG ATP5L	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	103	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005753; GO:0015078; GO:0015986	ATP synthesis coupled proton transport [GO:0015986]		blue	blue	NA	NA	NA	NA
TRINITY_DN31184_c0_g1_i1	O75964	ATP5L_HUMAN	100	103	0	0	16	324	1	103	1.40E-51	203.4	ATP5L_HUMAN	reviewed	"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)"	ATP5MG ATP5L	Homo sapiens (Human)	103	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0006754; GO:0015078; GO:0015986; GO:0042407; GO:0042776	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN27838_c0_g1_i1	Q5RFH0	ATP5L_PONAB	50	66	33	0	3	200	38	103	1.10E-10	67	ATP5L_PONAB	reviewed	"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)"	ATP5MG ATP5L	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	103	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005753; GO:0015078; GO:0015986	ATP synthesis coupled proton transport [GO:0015986]		NA	NA	NA	NA	NA	NA
TRINITY_DN28235_c0_g1_i1	Q5RFH0	ATP5L_PONAB	45	80	44	0	7	246	8	87	2.20E-11	69.3	ATP5L_PONAB	reviewed	"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)"	ATP5MG ATP5L	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	103	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005753; GO:0015078; GO:0015986	ATP synthesis coupled proton transport [GO:0015986]		NA	NA	NA	NA	NA	NA
TRINITY_DN40737_c0_g1_i1	Q91VR2	ATPG_MOUSE	100	73	0	0	264	46	226	298	2.10E-31	136	ATPG_MOUSE	reviewed	"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)"	Atp5f1c Atp5c1	Mus musculus (Mouse)	298	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005743; GO:0005753; GO:0006754; GO:0015986; GO:0042776; GO:0043209; GO:0045261; GO:0046034; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN11356_c0_g2_i1	Q91VR2	ATPG_MOUSE	100	128	0	0	2	385	6	133	5.20E-63	241.5	ATPG_MOUSE	reviewed	"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)"	Atp5f1c Atp5c1	Mus musculus (Mouse)	298	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005743; GO:0005753; GO:0006754; GO:0015986; GO:0042776; GO:0043209; GO:0045261; GO:0046034; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN11356_c0_g1_i1	P36542	ATPG_HUMAN	100	144	0	0	2	433	2	145	3.30E-74	278.9	ATPG_HUMAN	reviewed	"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)"	ATP5F1C ATP5C ATP5C1 ATP5CL1	Homo sapiens (Human)	298	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]"	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0000275; GO:0003723; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006119; GO:0006754; GO:0015986; GO:0016020; GO:0042407; GO:0042776; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]		NA	NA	NA	NA	NA	NA
TRINITY_DN15295_c0_g1_i1	Q91VR2	ATPG_MOUSE	100	74	0	0	2	223	142	215	1.20E-35	149.8	ATPG_MOUSE	reviewed	"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)"	Atp5f1c Atp5c1	Mus musculus (Mouse)	298	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005743; GO:0005753; GO:0006754; GO:0015986; GO:0042776; GO:0043209; GO:0045261; GO:0046034; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN15295_c0_g2_i1	P36542	ATPG_HUMAN	100	93	0	0	3	281	141	233	8.40E-47	187.2	ATPG_HUMAN	reviewed	"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)"	ATP5F1C ATP5C ATP5C1 ATP5CL1	Homo sapiens (Human)	298	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]"	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0000275; GO:0003723; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006119; GO:0006754; GO:0015986; GO:0016020; GO:0042407; GO:0042776; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]		NA	NA	NA	NA	NA	NA
TRINITY_DN18527_c0_g1_i1	O01666	ATPG_DROME	62	295	106	2	950	84	2	296	3.60E-95	349.7	ATPG_DROME	reviewed	"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)"	ATPsyngamma ATPsyn-gamma CG7610	Drosophila melanogaster (Fruit fly)	297	"mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005756; GO:0006754; GO:0015986; GO:0046933; GO:1902600	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]		blue	blue	NA	NA	NA	NA
TRINITY_DN28305_c0_g1_i1	Q96250	ATPG3_ARATH	59.7	67	27	0	2	202	255	321	1.20E-15	83.6	ATPG3_ARATH	reviewed	"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)"	ATPC At2g33040 F25I18.22	Arabidopsis thaliana (Mouse-ear cress)	325	"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; zinc ion binding [GO:0008270]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]"	"cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; zinc ion binding [GO:0008270]"	GO:0000275; GO:0005618; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005753; GO:0005783; GO:0006754; GO:0008270; GO:0009507; GO:0015986; GO:0046933	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]		red	red	NA	NA	NA	NA
TRINITY_DN9580_c1_g1_i1	O01666	ATPG_DROME	77.8	81	18	0	291	49	216	296	3.80E-26	118.6	ATPG_DROME	reviewed	"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)"	ATPsyngamma ATPsyn-gamma CG7610	Drosophila melanogaster (Fruit fly)	297	"mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005756; GO:0006754; GO:0015986; GO:0046933; GO:1902600	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN9580_c2_g1_i1	O01666	ATPG_DROME	50	76	38	0	7	234	129	204	4.30E-15	81.6	ATPG_DROME	reviewed	"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)"	ATPsyngamma ATPsyn-gamma CG7610	Drosophila melanogaster (Fruit fly)	297	"mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005756; GO:0006754; GO:0015986; GO:0046933; GO:1902600	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN29106_c0_g1_i1	Q9DB20	ATPO_MOUSE	100	66	0	0	223	26	148	213	1.80E-28	125.9	ATPO_MOUSE	reviewed	"ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein) (OSCP)"	Atp5po Atp5o D12Wsu28e	Mus musculus (Mouse)	213	"cell surface [GO:0009986]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATPase activity [GO:0016887]; drug binding [GO:0008144]; estradiol binding [GO:1903924]; protein-containing complex binding [GO:0044877]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	"cell surface [GO:0009986]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"ATPase activity [GO:0016887]; drug binding [GO:0008144]; estradiol binding [GO:1903924]; protein-containing complex binding [GO:0044877]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000274; GO:0000276; GO:0005739; GO:0005753; GO:0005886; GO:0006754; GO:0008144; GO:0009986; GO:0015986; GO:0016887; GO:0042776; GO:0043209; GO:0044877; GO:0045261; GO:0046034; GO:0046933; GO:0071320; GO:0071345; GO:1903924	ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]		NA	NA	NA	NA	NA	NA
TRINITY_DN37210_c0_g1_i1	P48047	ATPO_HUMAN	100	93	0	0	293	15	121	213	1.60E-43	176.4	ATPO_HUMAN	reviewed	"ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein) (OSCP)"	ATP5PO ATP5O ATPO	Homo sapiens (Human)	213	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000274; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006754; GO:0015986; GO:0042407; GO:0042776; GO:0045261; GO:0046933; GO:1902600	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN2485_c0_g1_i1	Q24439	ATPO_DROME	48	204	105	1	40	651	6	208	3.60E-44	179.9	ATPO_DROME	reviewed	"ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)"	ATPsynO Oscp CG4307	Drosophila melanogaster (Fruit fly)	209	"mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000274; GO:0005739; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		blue	blue	NA	NA	NA	NA
TRINITY_DN1948_c0_g1_i1	Q99766	ATP5S_HUMAN	52.7	110	52	0	43	372	39	148	1.10E-30	134	ATP5S_HUMAN	reviewed	"ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B)"	DMAC2L ATP5S ATPW	Homo sapiens (Human)	215	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]"	metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078]	GO:0005743; GO:0006754; GO:0015078; GO:0042407; GO:0042776; GO:0045263; GO:0046872; GO:1902600	ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN4512_c0_g1_i1	Q16MG9	ASNA_AEDAE	68.2	85	27	0	294	40	6	90	3.80E-27	122.1	ASNA_AEDAE	reviewed	ATPase ASNA1 homolog (EC 3.6.-.-) (Arsenical pump-driving ATPase homolog) (Arsenite-stimulated ATPase)	AAEL011136; AAEL012316	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	341	endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048]	endoplasmic reticulum [GO:0005783]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005783; GO:0016887; GO:0045048; GO:0046872	protein insertion into ER membrane [GO:0045048]		NA	NA	NA	NA	NA	NA
TRINITY_DN2149_c0_g1_i1	B0WEV5	ASNA_CULQU	73.5	328	86	1	1080	97	4	330	1.00E-141	504.6	ASNA_CULQU	reviewed	ATPase ASNA1 homolog (EC 3.6.-.-) (Arsenical pump-driving ATPase homolog) (Arsenite-stimulated ATPase)	CPIJ005690	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	348	endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048]	endoplasmic reticulum [GO:0005783]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005783; GO:0016887; GO:0045048; GO:0046872	protein insertion into ER membrane [GO:0045048]		blue	blue	NA	NA	NA	NA
TRINITY_DN13902_c0_g1_i2	Q8NBU5	ATAD1_HUMAN	53.7	354	154	3	1156	95	4	347	4.40E-103	376.3	ATAD1_HUMAN	reviewed	ATPase family AAA domain-containing protein 1 (EC 3.6.1.-) (Thorase)	ATAD1 FNP001	Homo sapiens (Human)	361	"glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"	glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0002092; GO:0005524; GO:0005778; GO:0007612; GO:0007613; GO:0016020; GO:0016887; GO:0045211; GO:0051967; GO:0098978; GO:0099149	"learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13902_c0_g1_i3	Q8NBU5	ATAD1_HUMAN	53.7	354	154	3	1156	95	4	347	3.30E-103	376.7	ATAD1_HUMAN	reviewed	ATPase family AAA domain-containing protein 1 (EC 3.6.1.-) (Thorase)	ATAD1 FNP001	Homo sapiens (Human)	361	"glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"	glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0002092; GO:0005524; GO:0005778; GO:0007612; GO:0007613; GO:0016020; GO:0016887; GO:0045211; GO:0051967; GO:0098978; GO:0099149	"learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34321_c0_g1_i1	F6QV99	ATAD1_BOVIN	100	71	0	0	215	3	147	217	1.10E-33	143.3	ATAD1_BOVIN	reviewed	ATPase family AAA domain-containing protein 1 (EC 3.6.1.-) (Thorase)	ATAD1	Bos taurus (Bovine)	361	"glutamatergic synapse [GO:0098978]; peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"	glutamatergic synapse [GO:0098978]; peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0002092; GO:0005524; GO:0005777; GO:0007612; GO:0007613; GO:0016887; GO:0045211; GO:0051967; GO:0098978; GO:0099149	"learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37189_c0_g1_i1	F6QV99	ATAD1_BOVIN	100	165	0	0	497	3	157	321	2.40E-89	329.3	ATAD1_BOVIN	reviewed	ATPase family AAA domain-containing protein 1 (EC 3.6.1.-) (Thorase)	ATAD1	Bos taurus (Bovine)	361	"glutamatergic synapse [GO:0098978]; peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"	glutamatergic synapse [GO:0098978]; peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0002092; GO:0005524; GO:0005777; GO:0007612; GO:0007613; GO:0016887; GO:0045211; GO:0051967; GO:0098978; GO:0099149	"learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26191_c0_g1_i1	Q7ZZ25	ATD1A_DANRE	54	87	40	0	263	3	137	223	6.00E-23	107.8	ATD1A_DANRE	reviewed	ATPase family AAA domain-containing protein 1-A (EC 3.6.1.-)	atad1a si:zc156n3.1 zgc:101570	Danio rerio (Zebrafish) (Brachydanio rerio)	380	peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005777; GO:0016887; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN13902_c0_g1_i1	Q7ZZ25	ATD1A_DANRE	55.6	351	150	2	1132	95	14	363	4.30E-103	376.3	ATD1A_DANRE	reviewed	ATPase family AAA domain-containing protein 1-A (EC 3.6.1.-)	atad1a si:zc156n3.1 zgc:101570	Danio rerio (Zebrafish) (Brachydanio rerio)	380	peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	peroxisome [GO:0005777]; postsynaptic membrane [GO:0045211]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005777; GO:0016887; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN25862_c0_g1_i1	Q6PL18	ATAD2_HUMAN	91.9	86	7	0	1	258	1038	1123	1.90E-37	156	ATAD2_HUMAN	reviewed	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	Homo sapiens (Human)	1390	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0016887; GO:0031936; GO:0042393; GO:0045893; GO:0045944; GO:0070062	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32575_c0_g1_i1	Q6PL18	ATAD2_HUMAN	98.8	85	1	0	255	1	942	1026	2.20E-38	159.1	ATAD2_HUMAN	reviewed	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	Homo sapiens (Human)	1390	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0016887; GO:0031936; GO:0042393; GO:0045893; GO:0045944; GO:0070062	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40880_c0_g1_i1	Q6PL18	ATAD2_HUMAN	100	89	0	0	3	269	796	884	5.30E-46	184.5	ATAD2_HUMAN	reviewed	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	Homo sapiens (Human)	1390	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0016887; GO:0031936; GO:0042393; GO:0045893; GO:0045944; GO:0070062	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18368_c0_g1_i2	Q6PL18	ATAD2_HUMAN	54	785	290	10	2	2188	435	1204	6.00E-216	752.3	ATAD2_HUMAN	reviewed	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	Homo sapiens (Human)	1390	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0016887; GO:0031936; GO:0042393; GO:0045893; GO:0045944; GO:0070062	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18368_c0_g1_i6	Q6PL18	ATAD2_HUMAN	56.3	723	255	8	2	2002	435	1152	1.40E-215	750.7	ATAD2_HUMAN	reviewed	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	Homo sapiens (Human)	1390	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0016887; GO:0031936; GO:0042393; GO:0045893; GO:0045944; GO:0070062	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39507_c0_g1_i1	Q6PL18	ATAD2_HUMAN	98.8	80	1	0	241	2	612	691	1.10E-39	163.3	ATAD2_HUMAN	reviewed	ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA)	ATAD2 L16 PRO2000	Homo sapiens (Human)	1390	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0016887; GO:0031936; GO:0042393; GO:0045893; GO:0045944; GO:0070062	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34070_c0_g1_i1	Q20748	ATAD3_CAEEL	50.3	155	75	1	467	3	321	473	1.90E-38	160.2	ATAD3_CAEEL	reviewed	ATPase family AAA domain-containing protein 3	atad-3 F54B3.3	Caenorhabditis elegans	595	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0008270; GO:0016021; GO:0016887; GO:0042645	mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN35014_c0_g1_i1	Q925I1	ATAD3_MOUSE	100	82	0	0	247	2	462	543	5.10E-40	164.5	ATAD3_MOUSE	reviewed	ATPase family AAA domain-containing protein 3 (AAA-ATPase TOB3)	Atad3 Atad3a Kiaa1273	Mus musculus (Mouse)	591	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0001558; GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0008270; GO:0016021; GO:0016887; GO:0042645; GO:0042802; GO:0043066; GO:0140374	antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN18618_c0_g1_i2	Q9NVI7	ATD3A_HUMAN	92.1	101	8	0	307	5	383	483	3.70E-48	191.8	ATD3A_HUMAN	reviewed	ATPase family AAA domain-containing protein 3A	ATAD3A	Homo sapiens (Human)	634	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0001558; GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0008270; GO:0016021; GO:0016887; GO:0042645; GO:0042802; GO:0043066; GO:0140374	antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN9276_c0_g1_i1	Q6PAX2	ATD3B_XENLA	57.7	409	160	3	643	1866	179	575	1.10E-124	448.7	ATD3B_XENLA	reviewed	ATPase family AAA domain-containing protein 3-B	atad3-b	Xenopus laevis (African clawed frog)	593	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrion organization [GO:0007005]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0007005; GO:0016021; GO:0016887; GO:0042645	mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN18618_c0_g1_i1	Q5T9A4	ATD3B_HUMAN	97.5	122	3	0	370	5	314	435	2.10E-61	236.1	ATD3B_HUMAN	reviewed	ATPase family AAA domain-containing protein 3B (AAA-TOB3)	ATAD3B KIAA1273 TOB3	Homo sapiens (Human)	648	ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005]; neutrophil degranulation [GO:0043312]	ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005739; GO:0005743; GO:0005886; GO:0007005; GO:0008270; GO:0016887; GO:0030667; GO:0043312; GO:0101003	mitochondrion organization [GO:0007005]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN13671_c0_g1_i1	Q4QY64	ATAD5_MOUSE	33.1	308	128	7	66	776	1095	1395	6.50E-26	119.4	ATAD5_MOUSE	reviewed	ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein)	Atad5 Frag1	Mus musculus (Mouse)	1826	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]	GO:0002377; GO:0003677; GO:0005524; GO:0005634; GO:0006974; GO:0008630; GO:0030890; GO:0031391; GO:0042770; GO:0042771; GO:0045740; GO:0048304; GO:0061860; GO:0090618; GO:1901990; GO:1902166; GO:1902230; GO:1902751	cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]		NA	NA	NA	NA	NA	NA
TRINITY_DN13671_c0_g1_i2	Q4QY64	ATAD5_MOUSE	33.1	308	128	7	32	742	1095	1395	6.30E-26	119.4	ATAD5_MOUSE	reviewed	ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein)	Atad5 Frag1	Mus musculus (Mouse)	1826	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]	GO:0002377; GO:0003677; GO:0005524; GO:0005634; GO:0006974; GO:0008630; GO:0030890; GO:0031391; GO:0042770; GO:0042771; GO:0045740; GO:0048304; GO:0061860; GO:0090618; GO:1901990; GO:1902166; GO:1902230; GO:1902751	cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]		NA	NA	NA	NA	NA	NA
TRINITY_DN17805_c0_g1_i1	Q8NB90	AFG2H_HUMAN	35.3	329	190	4	77	994	493	821	1.50E-53	211.5	AFG2H_HUMAN	reviewed	ATPase family protein 2 homolog (EC 3.6.4.10) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)	SPATA5 AFG2 SPAF	Homo sapiens (Human)	893	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0007283; GO:0007420; GO:0016887; GO:0030154	brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6397_c0_g1_i1	Q3UMC0	AFG2H_MOUSE	58.5	176	67	2	551	33	643	815	3.10E-53	209.5	AFG2H_MOUSE	reviewed	ATPase family protein 2 homolog (EC 3.6.4.10) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)	Spata5 Spaf	Mus musculus (Mouse)	893	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0007283; GO:0007420; GO:0016887; GO:0030154	brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1097_c0_g1_i1	Q3UMC0	AFG2H_MOUSE	35.8	520	305	6	1713	232	330	846	4.00E-81	304.3	AFG2H_MOUSE	reviewed	ATPase family protein 2 homolog (EC 3.6.4.10) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)	Spata5 Spaf	Mus musculus (Mouse)	893	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0007283; GO:0007420; GO:0016887; GO:0030154	brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1097_c0_g1_i5	Q3UMC0	AFG2H_MOUSE	35.6	365	218	1	1275	232	482	846	2.00E-58	228	AFG2H_MOUSE	reviewed	ATPase family protein 2 homolog (EC 3.6.4.10) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)	Spata5 Spaf	Mus musculus (Mouse)	893	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0007283; GO:0007420; GO:0016887; GO:0030154	brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4512_c0_g2_i1	P0CM25	GET3_CRYNB	57.3	185	77	1	16	570	106	288	8.50E-54	211.5	GET3_CRYNB	reviewed	ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Golgi to ER traffic protein 3) (Guided entry of tail-anchored proteins 3)	GET3 CNBK0900	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	325	endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048]	endoplasmic reticulum [GO:0005783]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005783; GO:0016887; GO:0045048; GO:0046872	protein insertion into ER membrane [GO:0045048]		red	red	NA	NA	NA	NA
TRINITY_DN32039_c0_g1_i1	A5PJI5	ASNA_BOVIN	100	80	0	0	241	2	204	283	1.90E-39	162.5	GET3_BOVIN	reviewed	"ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase)"	GET3 ASNA1	Bos taurus (Bovine)	348	GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005654; GO:0005730; GO:0006620; GO:0016887; GO:0043529; GO:0046872; GO:0071816	posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		NA	NA	NA	NA	NA	NA
TRINITY_DN35555_c0_g1_i1	A5PJI5	ASNA_BOVIN	100	339	0	0	1020	4	10	348	8.80E-195	680.6	GET3_BOVIN	reviewed	"ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase)"	GET3 ASNA1	Bos taurus (Bovine)	348	GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005654; GO:0005730; GO:0006620; GO:0016887; GO:0043529; GO:0046872; GO:0071816	posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		NA	NA	NA	NA	NA	NA
TRINITY_DN39331_c0_g1_i1	A5PJI5	ASNA_BOVIN	100	104	0	0	3	314	102	205	5.20E-53	208	GET3_BOVIN	reviewed	"ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase)"	GET3 ASNA1	Bos taurus (Bovine)	348	GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005654; GO:0005730; GO:0006620; GO:0016887; GO:0043529; GO:0046872; GO:0071816	posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		NA	NA	NA	NA	NA	NA
TRINITY_DN40275_c0_g1_i1	Q86UK0	ABCAC_HUMAN	40.7	86	37	3	226	2	2256	2338	8.10E-08	57.4	ABCAC_HUMAN	reviewed	ATP-binding cassette sub-family A member 12 (ATP-binding cassette transporter 12) (ATP-binding cassette 12)	ABCA12 ABC12	Homo sapiens (Human)	2595	cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cellular homeostasis [GO:0019725]; ceramide transport [GO:0035627]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]; transmembrane transport [GO:0055085]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	apolipoprotein A-I receptor binding [GO:0034191]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006869; GO:0010875; GO:0016021; GO:0016887; GO:0019725; GO:0031424; GO:0032940; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0048286; GO:0055085; GO:0055088; GO:0061436; GO:0072659; GO:0097209; GO:2000010	cellular homeostasis [GO:0019725]; ceramide transport [GO:0035627]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN28891_c0_g1_i1	E9PX95	ABCAH_MOUSE	52.7	93	43	1	4	282	652	743	8.80E-20	97.4	ABCAH_MOUSE	reviewed	ATP-binding cassette sub-family A member 17	Abca17	Mus musculus (Mouse)	1733	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; neutral lipid metabolic process [GO:0006638]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005783; GO:0005789; GO:0006638; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231	lipid transport [GO:0006869]; neutral lipid metabolic process [GO:0006638]		NA	NA	NA	NA	NA	NA
TRINITY_DN37522_c0_g1_i1	Q9BZC7	ABCA2_HUMAN	100	79	0	0	1	237	2165	2243	3.80E-40	164.9	ABCA2_HUMAN	reviewed	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	ABCA2 ABC2 KIAA1062	Homo sapiens (Human)	2435	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150104; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN17389_c0_g1_i1	Q9BZC7	ABCA2_HUMAN	57	86	37	0	2	259	1120	1205	6.50E-25	114.4	ABCA2_HUMAN	reviewed	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	ABCA2 ABC2 KIAA1062	Homo sapiens (Human)	2435	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150104; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN36572_c0_g1_i1	Q9BZC7	ABCA2_HUMAN	55.4	65	23	1	5	199	2063	2121	2.20E-12	72.4	ABCA2_HUMAN	reviewed	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	ABCA2 ABC2 KIAA1062	Homo sapiens (Human)	2435	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150104; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN2222_c0_g1_i1	Q9BZC7	ABCA2_HUMAN	38.1	464	264	10	1	1356	1945	2397	7.40E-72	273.1	ABCA2_HUMAN	reviewed	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	ABCA2 ABC2 KIAA1062	Homo sapiens (Human)	2435	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150104; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN2222_c0_g1_i2	Q9BZC7	ABCA2_HUMAN	38.6	184	110	3	66	611	2215	2397	8.60E-28	125.9	ABCA2_HUMAN	reviewed	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	ABCA2 ABC2 KIAA1062	Homo sapiens (Human)	2435	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150104; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN30536_c0_g1_i1	Q9BZC7	ABCA2_HUMAN	53.7	134	61	1	402	1	2154	2286	7.60E-33	141.4	ABCA2_HUMAN	reviewed	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	ABCA2 ABC2 KIAA1062	Homo sapiens (Human)	2435	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150104; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN4278_c0_g1_i2	Q8R420	ABCA3_MOUSE	34	702	404	17	10	2076	1019	1674	9.70E-98	359.4	ABCA3_MOUSE	reviewed	ATP-binding cassette sub-family A member 3	Abca3	Mus musculus (Mouse)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233	lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]		NA	NA	NA	NA	NA	NA
TRINITY_DN4278_c0_g1_i6	Q8R420	ABCA3_MOUSE	44	332	172	6	132	1121	1355	1674	5.70E-71	269.6	ABCA3_MOUSE	reviewed	ATP-binding cassette sub-family A member 3	Abca3	Mus musculus (Mouse)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233	lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i12	Q8R420	ABCA3_MOUSE	45	525	235	7	253	1809	491	967	7.70E-117	422.5	ABCA3_MOUSE	reviewed	ATP-binding cassette sub-family A member 3	Abca3	Mus musculus (Mouse)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233	lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i6	Q8R420	ABCA3_MOUSE	45.1	525	234	7	200	1756	491	967	2.00E-117	424.5	ABCA3_MOUSE	reviewed	ATP-binding cassette sub-family A member 3	Abca3	Mus musculus (Mouse)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233	lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i9	Q8R420	ABCA3_MOUSE	45	525	235	7	287	1843	491	967	7.90E-117	422.5	ABCA3_MOUSE	reviewed	ATP-binding cassette sub-family A member 3	Abca3	Mus musculus (Mouse)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233	lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]		NA	NA	NA	NA	NA	NA
TRINITY_DN26992_c0_g1_i1	Q8R420	ABCA3_MOUSE	48.2	193	97	3	770	198	652	843	1.10E-43	178.3	ABCA3_MOUSE	reviewed	ATP-binding cassette sub-family A member 3	Abca3	Mus musculus (Mouse)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231; GO:0051384; GO:0097208; GO:0097233	lipid transport [GO:0006869]; response to glucocorticoid [GO:0051384]		NA	NA	NA	NA	NA	NA
TRINITY_DN4278_c0_g1_i5	Q99758	ABCA3_HUMAN	44.3	174	91	1	17	520	1484	1657	6.00E-38	158.7	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN23429_c0_g1_i1	Q99758	ABCA3_HUMAN	59.7	67	27	0	1	201	1517	1583	1.30E-17	89.7	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8363_c0_g1_i1	Q99758	ABCA3_HUMAN	37.5	403	234	6	1198	8	205	595	5.00E-64	246.5	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8363_c0_g1_i3	Q99758	ABCA3_HUMAN	56.7	60	25	1	187	8	537	595	1.60E-12	73.2	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i11	Q99758	ABCA3_HUMAN	46.2	779	363	8	9	2327	239	967	3.50E-186	653.3	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i13	Q99758	ABCA3_HUMAN	49.4	253	126	1	205	963	239	489	4.40E-63	243	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i15	Q99758	ABCA3_HUMAN	52.1	94	39	3	200	463	491	584	6.10E-17	89	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i2	Q99758	ABCA3_HUMAN	44.3	255	136	3	83	835	291	543	6.70E-55	215.7	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i7	Q99758	ABCA3_HUMAN	40.8	483	262	10	194	1594	69	543	9.90E-92	339	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN546_c0_g1_i1	Q99758	ABCA3_HUMAN	47	413	177	7	1292	60	1250	1622	5.70E-98	359.4	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN546_c0_g1_i2	Q99758	ABCA3_HUMAN	49.1	395	177	6	1238	60	1250	1622	1.80E-101	370.9	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN32962_c0_g1_i1	Q99758	ABCA3_HUMAN	36.5	181	111	3	65	601	1019	1197	7.10E-27	122.1	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN28076_c0_g1_i1	Q99758	ABCA3_HUMAN	53.1	98	46	0	3	296	1509	1606	1.50E-25	116.7	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN29662_c0_g1_i1	Q99758	ABCA3_HUMAN	59.1	88	36	0	265	2	665	752	2.50E-24	112.5	ABCA3_HUMAN	reviewed	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	ABCA3 ABC3	Homo sapiens (Human)	1704	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g1_i2	Q8WWZ7	ABCA5_HUMAN	30.2	602	358	16	214	1971	13	568	3.60E-67	257.7	ABCA5_HUMAN	reviewed	ATP-binding cassette sub-family A member 5	ABCA5 KIAA1888	Homo sapiens (Human)	1642	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0006869; GO:0010745; GO:0016021; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0043231; GO:0043691; GO:0055085	cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g1_i3	Q8WWZ7	ABCA5_HUMAN	31.5	485	282	11	119	1534	121	568	1.40E-58	228.8	ABCA5_HUMAN	reviewed	ATP-binding cassette sub-family A member 5	ABCA5 KIAA1888	Homo sapiens (Human)	1642	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0006869; GO:0010745; GO:0016021; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0043231; GO:0043691; GO:0055085	cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g1_i4	Q8K441	ABCA6_MOUSE	60	70	28	0	79	288	499	568	6.00E-19	94.7	ABCA6_MOUSE	reviewed	ATP-binding cassette sub-family A member 6	Abca6	Mus musculus (Mouse)	1624	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005654; GO:0005886; GO:0006869; GO:0016021; GO:0042626; GO:0043231	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN2222_c2_g1_i1	O94911	ABCA8_HUMAN	39	146	82	3	499	62	1213	1351	3.10E-20	100.1	ABCA8_HUMAN	reviewed	ATP-binding cassette sub-family A member 8	ABCA8 KIAA0822	Homo sapiens (Human)	1581	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0055085	lipid transport [GO:0006869]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2222_c2_g1_i2	O94911	ABCA8_HUMAN	39.4	378	197	6	1321	191	1213	1559	3.90E-71	270.4	ABCA8_HUMAN	reviewed	ATP-binding cassette sub-family A member 8	ABCA8 KIAA0822	Homo sapiens (Human)	1581	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0055085	lipid transport [GO:0006869]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g2_i1	Q8K442	ABC8A_MOUSE	33.8	452	263	9	2	1324	566	992	2.30E-60	234.6	ABC8A_MOUSE	reviewed	ATP-binding cassette sub-family A member 8-A	Abca8a	Mus musculus (Mouse)	1620	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g2_i2	Q8K442	ABC8A_MOUSE	24.8	307	195	9	17	904	711	992	9.10E-10	65.9	ABC8A_MOUSE	reviewed	ATP-binding cassette sub-family A member 8-A	Abca8a	Mus musculus (Mouse)	1620	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN3937_c0_g2_i4	Q8K442	ABC8A_MOUSE	31.1	550	341	10	2	1618	566	1088	2.80E-62	241.1	ABC8A_MOUSE	reviewed	ATP-binding cassette sub-family A member 8-A	Abca8a	Mus musculus (Mouse)	1620	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042626; GO:0043231	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN25741_c0_g1_i1	Q9JI39	ABCBA_MOUSE	52.3	86	41	0	263	6	456	541	4.50E-21	101.7	ABCBA_MOUSE	reviewed	"ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein)"	Abcb10	Mus musculus (Mouse)	715	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0032592; GO:0042626; GO:0042802			NA	NA	NA	NA	NA	NA
TRINITY_DN5580_c0_g1_i1	Q9JI39	ABCBA_MOUSE	85.7	63	9	0	250	62	599	661	6.40E-22	104.4	ABCBA_MOUSE	reviewed	"ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein)"	Abcb10	Mus musculus (Mouse)	715	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0032592; GO:0042626; GO:0042802			brown	brown	1	NA	NA	NA
TRINITY_DN35162_c0_g1_i1	Q9NRK6	ABCBA_HUMAN	100	91	0	0	275	3	597	687	3.60E-42	171.8	ABCBA_HUMAN	reviewed	"ATP-binding cassette sub-family B member 10, mitochondrial (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)"	ABCB10	Homo sapiens (Human)	738	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; mitochondrial transport [GO:0006839]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005743; GO:0006839; GO:0016887; GO:0032592; GO:0042626; GO:0042802	mitochondrial transport [GO:0006839]		NA	NA	NA	NA	NA	NA
TRINITY_DN5580_c0_g1_i2	Q9NRK6	ABCBA_HUMAN	71.7	92	26	0	279	4	634	725	1.10E-30	133.7	ABCBA_HUMAN	reviewed	"ATP-binding cassette sub-family B member 10, mitochondrial (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)"	ABCB10	Homo sapiens (Human)	738	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; mitochondrial transport [GO:0006839]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005743; GO:0006839; GO:0016887; GO:0032592; GO:0042626; GO:0042802	mitochondrial transport [GO:0006839]		NA	NA	NA	NA	NA	NA
TRINITY_DN26897_c0_g1_i1	Q08D64	ABCB6_XENTR	56	84	36	1	435	184	256	338	9.10E-16	84.7	ABCB6_XENTR	reviewed	"ATP-binding cassette sub-family B member 6, mitochondrial"	abcb6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	849	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme binding [GO:0020037]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme binding [GO:0020037]	GO:0005524; GO:0005741; GO:0005774; GO:0005783; GO:0005794; GO:0005886; GO:0015439; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0042626; GO:0055085	heme transport [GO:0015886]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN26897_c0_g1_i2	Q08D64	ABCB6_XENTR	63.1	111	40	1	333	1	256	365	1.30E-30	133.7	ABCB6_XENTR	reviewed	"ATP-binding cassette sub-family B member 6, mitochondrial"	abcb6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	849	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme binding [GO:0020037]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme binding [GO:0020037]	GO:0005524; GO:0005741; GO:0005774; GO:0005783; GO:0005794; GO:0005886; GO:0015439; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0042626; GO:0055085	heme transport [GO:0015886]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN26897_c0_g1_i3	Q08D64	ABCB6_XENTR	69	42	13	0	309	184	297	338	4.30E-10	65.9	ABCB6_XENTR	reviewed	"ATP-binding cassette sub-family B member 6, mitochondrial"	abcb6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	849	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme binding [GO:0020037]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme binding [GO:0020037]	GO:0005524; GO:0005741; GO:0005774; GO:0005783; GO:0005794; GO:0005886; GO:0015439; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0042626; GO:0055085	heme transport [GO:0015886]; transmembrane transport [GO:0055085]		brown	brown	NA	NA	NA	NA
TRINITY_DN10696_c0_g1_i1	Q08D64	ABCB6_XENTR	67.3	220	72	0	663	4	597	816	2.30E-79	296.6	ABCB6_XENTR	reviewed	"ATP-binding cassette sub-family B member 6, mitochondrial"	abcb6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	849	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme binding [GO:0020037]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme binding [GO:0020037]	GO:0005524; GO:0005741; GO:0005774; GO:0005783; GO:0005794; GO:0005886; GO:0015439; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0042626; GO:0055085	heme transport [GO:0015886]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN40004_c0_g1_i1	O75027	ABCB7_HUMAN	47.4	76	40	0	16	243	576	651	3.10E-14	79	ABCB7_HUMAN	reviewed	"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)"	ABCB7 ABC7	Homo sapiens (Human)	752	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme transmembrane transporter activity [GO:0015232]	GO:0005524; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016887; GO:0042626; GO:0055085	cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i25	O75027	ABCB7_HUMAN	62.9	237	87	1	4	711	472	708	1.20E-81	305.1	ABCB7_HUMAN	reviewed	"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)"	ABCB7 ABC7	Homo sapiens (Human)	752	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme transmembrane transporter activity [GO:0015232]	GO:0005524; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016887; GO:0042626; GO:0055085	cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i7	O75027	ABCB7_HUMAN	62.9	237	87	1	4	711	472	708	1.40E-81	305.1	ABCB7_HUMAN	reviewed	"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)"	ABCB7 ABC7	Homo sapiens (Human)	752	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme transmembrane transporter activity [GO:0015232]	GO:0005524; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016887; GO:0042626; GO:0055085	cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i8	O75027	ABCB7_HUMAN	62.9	237	87	1	4	711	472	708	1.00E-81	305.1	ABCB7_HUMAN	reviewed	"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)"	ABCB7 ABC7	Homo sapiens (Human)	752	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; heme transmembrane transporter activity [GO:0015232]	GO:0005524; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016887; GO:0042626; GO:0055085	cellular iron ion homeostasis [GO:0006879]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN18496_c0_g1_i1	O60706	ABCC9_HUMAN	57.4	47	20	0	148	8	1341	1387	5.10E-09	61.2	ABCC9_HUMAN	reviewed	ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2)	ABCC9 SUR2	Homo sapiens (Human)	1549	inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; sulfonylurea receptor activity [GO:0008281]; cardiac conduction [GO:0061337]; cation transmembrane transport [GO:0098655]; defense response to virus [GO:0051607]; inorganic cation transmembrane transport [GO:0098662]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac conduction [GO:1903779]; response to ATP [GO:0033198]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcomere [GO:0030017]	ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ion channel binding [GO:0044325]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; sulfonylurea receptor activity [GO:0008281]	GO:0005267; GO:0005524; GO:0005886; GO:0008281; GO:0008282; GO:0015459; GO:0016020; GO:0016887; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0042626; GO:0044325; GO:0051607; GO:0055085; GO:0061337; GO:0071805; GO:0098655; GO:0098662; GO:0150104; GO:1903779; GO:1990573	cardiac conduction [GO:0061337]; cation transmembrane transport [GO:0098655]; defense response to virus [GO:0051607]; inorganic cation transmembrane transport [GO:0098662]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac conduction [GO:1903779]; response to ATP [GO:0033198]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN36586_c0_g1_i1	Q9VL32	SUR_DROME	68.9	45	14	0	13	147	1715	1759	6.30E-11	67.8	SUR_DROME	reviewed	ATP-binding cassette sub-family C member Sur (Sulfonylurea receptor) (Dsur)	Sur CG5772	Drosophila melanogaster (Fruit fly)	2171	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; response to hypoxia [GO:0001666]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0001666; GO:0005524; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	response to hypoxia [GO:0001666]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN34593_c0_g1_i1	Q7JUN3	ABCD_DROME	71.2	80	23	0	3	242	184	263	2.80E-25	115.5	ABCD_DROME	reviewed	ATP-binding cassette sub-family D member (EC 7.6.2.4)	ABCD CG2316	Drosophila melanogaster (Fruit fly)	730	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; long-chain fatty acid metabolic process [GO:0001676]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760]	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]	GO:0001676; GO:0005324; GO:0005524; GO:0005778; GO:0006635; GO:0007031; GO:0015910; GO:0016021; GO:0016887; GO:0042626; GO:0042760	fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; long-chain fatty acid metabolic process [GO:0001676]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN33100_c0_g1_i2	D3ZHR2	ABCD1_RAT	73.4	207	55	0	16	636	475	681	7.40E-91	334.7	ABCD1_RAT	reviewed	ATP-binding cassette sub-family D member 1 (EC 7.6.2.4) (Adrenoleukodystrophy protein) (ALDP)	Abcd1	Rattus norvegicus (Rat)	737	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled fatty-acyl-CoA transmembrane transporter activity [GO:0015607]; ATPase-coupled transmembrane transporter activity [GO:0042626]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; fatty acid homeostasis [GO:0055089]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of mitochondrial depolarization [GO:0051900]; regulation of oxidative phosphorylation [GO:0002082]; sterol homeostasis [GO:0055092]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA catabolic process [GO:0036113]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled fatty-acyl-CoA transmembrane transporter activity [GO:0015607]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]	GO:0000038; GO:0002082; GO:0005324; GO:0005524; GO:0005737; GO:0005765; GO:0005777; GO:0005778; GO:0005779; GO:0005789; GO:0006635; GO:0007031; GO:0015607; GO:0015910; GO:0016887; GO:0019899; GO:0030497; GO:0031966; GO:0031998; GO:0032000; GO:0036113; GO:0042626; GO:0042758; GO:0042760; GO:0042802; GO:0042803; GO:0043217; GO:0043531; GO:0048471; GO:0051900; GO:0055089; GO:0055092; GO:1900016; GO:1900407; GO:1903427; GO:1990535; GO:2001280	fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; fatty acid homeostasis [GO:0055089]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of mitochondrial depolarization [GO:0051900]; regulation of oxidative phosphorylation [GO:0002082]; sterol homeostasis [GO:0055092]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA catabolic process [GO:0036113]		NA	NA	NA	NA	NA	NA
TRINITY_DN35010_c0_g1_i1	Q9UBJ2	ABCD2_HUMAN	98.9	95	1	0	2	286	542	636	2.70E-53	208.8	ABCD2_HUMAN	reviewed	ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR)	ABCD2 ALD1 ALDL1 ALDR ALDRP	Homo sapiens (Human)	740	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]	GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0007031; GO:0015910; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:0055085; GO:1900016; GO:1903427; GO:1990535; GO:2001280	fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN33100_c0_g1_i1	Q9QY44	ABCD2_RAT	70.3	155	46	0	7	471	476	630	4.50E-59	228.8	ABCD2_RAT	reviewed	ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-related protein)	Abcd2 Aldr Aldrp	Rattus norvegicus (Rat)	741	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]	GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0006635; GO:0007031; GO:0009617; GO:0015910; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:1900016; GO:1903427; GO:1990535; GO:2001280	fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN31430_c0_g1_i1	P55096	ABCD3_MOUSE	100	75	0	0	225	1	560	634	6.10E-40	164.1	ABCD3_MOUSE	reviewed	ATP-binding cassette sub-family D member 3 (68 kDa peroxisomal membrane protein) (PMP68) (70 kDa peroxisomal membrane protein) (PMP70)	Abcd3 Pmp70 Pxmp1	Mus musculus (Mouse)	659	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0005324; GO:0005524; GO:0005739; GO:0005743; GO:0005777; GO:0005778; GO:0005782; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621	fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN36204_c0_g1_i1	P28288	ABCD3_HUMAN	100	124	0	0	374	3	192	315	2.00E-64	246.1	ABCD3_HUMAN	reviewed	ATP-binding cassette sub-family D member 3 (70 kDa peroxisomal membrane protein) (PMP70)	ABCD3 PMP70 PXMP1	Homo sapiens (Human)	659	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621; GO:0055085	fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN31013_c0_g1_i1	P28288	ABCD3_HUMAN	100	94	0	0	3	284	77	170	1.00E-47	190.3	ABCD3_HUMAN	reviewed	ATP-binding cassette sub-family D member 3 (70 kDa peroxisomal membrane protein) (PMP70)	ABCD3 PMP70 PXMP1	Homo sapiens (Human)	659	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621; GO:0055085	fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN8994_c0_g1_i2	P28288	ABCD3_HUMAN	65.2	606	207	3	244	2049	54	659	5.30E-234	812	ABCD3_HUMAN	reviewed	ATP-binding cassette sub-family D member 3 (70 kDa peroxisomal membrane protein) (PMP70)	ABCD3 PMP70 PXMP1	Homo sapiens (Human)	659	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621; GO:0055085	fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN31984_c0_g1_i1	P61221	ABCE1_HUMAN	100	63	0	0	190	2	1	63	6.80E-32	137.5	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30081_c0_g1_i1	P61221	ABCE1_HUMAN	52.9	153	71	1	475	17	184	335	2.60E-40	166.4	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6717_c0_g1_i1	P61221	ABCE1_HUMAN	75.9	597	143	1	1906	116	3	598	3.00E-271	935.6	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6717_c0_g1_i2	P61221	ABCE1_HUMAN	75.9	597	143	1	1906	116	3	598	3.00E-271	935.6	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30820_c0_g1_i1	P61221	ABCE1_HUMAN	100	82	0	0	3	248	9	90	7.00E-45	180.6	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN26478_c0_g1_i1	P61221	ABCE1_HUMAN	100	335	0	0	1006	2	92	426	4.80E-193	674.9	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN14590_c0_g1_i1	P61221	ABCE1_HUMAN	100	189	0	0	3	569	411	599	3.60E-103	375.6	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN14590_c0_g1_i2	P61221	ABCE1_HUMAN	100	108	0	0	2	325	492	599	8.10E-55	214.2	ABCE1_HUMAN	reviewed	ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40	Homo sapiens (Human)	599	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016032; GO:0016887; GO:0043024; GO:0051607; GO:0060338; GO:0060698; GO:0060702	defense response to virus [GO:0051607]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN38085_c0_g1_i1	Q6P542	ABCF1_MOUSE	100	125	0	0	2	376	408	532	6.10E-69	261.2	ABCF1_MOUSE	reviewed	ATP-binding cassette sub-family F member 1	Abcf1	Mus musculus (Mouse)	837	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]	GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0006413; GO:0008494; GO:0016887; GO:0042788; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN22479_c0_g1_i1	Q767L0	ABCF1_PIG	69.9	103	31	0	3	311	696	798	8.80E-37	154.1	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]	GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0006413; GO:0008494; GO:0016887; GO:0042788; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN31954_c0_g1_i1	Q8NE71	ABCF1_HUMAN	64	75	27	0	228	4	433	507	1.40E-23	109.8	ABCF1_HUMAN	reviewed	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein)	ABCF1 ABC50	Homo sapiens (Human)	845	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0016887; GO:0042788; GO:0043022; GO:0045727; GO:0055085	inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN22777_c0_g1_i1	Q8NE71	ABCF1_HUMAN	79.3	135	28	0	413	9	415	549	5.90E-57	221.5	ABCF1_HUMAN	reviewed	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein)	ABCF1 ABC50	Homo sapiens (Human)	845	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0016887; GO:0042788; GO:0043022; GO:0045727; GO:0055085	inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN22777_c0_g1_i2	Q8NE71	ABCF1_HUMAN	84.7	85	12	1	308	54	415	498	1.20E-33	143.7	ABCF1_HUMAN	reviewed	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein)	ABCF1 ABC50	Homo sapiens (Human)	845	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0016887; GO:0042788; GO:0043022; GO:0045727; GO:0055085	inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN22479_c0_g2_i1	Q8NE71	ABCF1_HUMAN	65.4	81	28	0	8	250	630	710	1.10E-24	113.6	ABCF1_HUMAN	reviewed	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein)	ABCF1 ABC50	Homo sapiens (Human)	845	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0016887; GO:0042788; GO:0043022; GO:0045727; GO:0055085	inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN9150_c0_g1_i1	Q99LE6	ABCF2_MOUSE	54.4	90	41	0	272	3	59	148	8.10E-23	108.2	ABCF2_MOUSE	reviewed	ATP-binding cassette sub-family F member 2	Abcf2	Mus musculus (Mouse)	628	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0016887			blue	blue	NA	NA	NA	NA
TRINITY_DN37505_c0_g1_i1	Q99LE6	ABCF2_MOUSE	100	82	0	0	247	2	83	164	4.60E-41	167.9	ABCF2_MOUSE	reviewed	ATP-binding cassette sub-family F member 2	Abcf2	Mus musculus (Mouse)	628	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN4034_c0_g1_i1	Q2KJA2	ABCF2_BOVIN	77.9	113	25	0	350	12	500	612	2.30E-49	196.1	ABCF2_BOVIN	reviewed	ATP-binding cassette sub-family F member 2	ABCF2	Bos taurus (Bovine)	625	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			blue	blue	NA	NA	NA	NA
TRINITY_DN38787_c0_g1_i1	Q2KJA2	ABCF2_BOVIN	76.7	86	20	0	3	260	400	485	1.90E-32	139.4	ABCF2_BOVIN	reviewed	ATP-binding cassette sub-family F member 2	ABCF2	Bos taurus (Bovine)	625	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			blue	blue	NA	NA	NA	NA
TRINITY_DN22660_c0_g1_i1	Q2KJA2	ABCF2_BOVIN	100	151	0	0	455	3	206	356	2.80E-84	312.4	ABCF2_BOVIN	reviewed	ATP-binding cassette sub-family F member 2	ABCF2	Bos taurus (Bovine)	625	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN22660_c0_g1_i2	Q2KJA2	ABCF2_BOVIN	100	142	0	0	428	3	215	356	8.80E-80	297.4	ABCF2_BOVIN	reviewed	ATP-binding cassette sub-family F member 2	ABCF2	Bos taurus (Bovine)	625	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN22660_c0_g1_i3	Q2KJA2	ABCF2_BOVIN	100	78	0	0	236	3	279	356	1.10E-39	163.3	ABCF2_BOVIN	reviewed	ATP-binding cassette sub-family F member 2	ABCF2	Bos taurus (Bovine)	625	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN28124_c0_g1_i1	Q2KJA2	ABCF2_BOVIN	100	75	0	0	3	227	412	486	4.40E-38	157.9	ABCF2_BOVIN	reviewed	ATP-binding cassette sub-family F member 2	ABCF2	Bos taurus (Bovine)	625	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN9150_c0_g2_i1	Q9UG63	ABCF2_HUMAN	71.6	208	57	1	3	626	165	370	3.10E-81	302.8	ABCF2_HUMAN	reviewed	ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2)	ABCF2 HUSSY-18	Homo sapiens (Human)	623	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016020; GO:0016887			blue	blue	NA	NA	NA	NA
TRINITY_DN33146_c0_g1_i1	Q9UG63	ABCF2_HUMAN	98.6	69	1	0	211	5	503	571	1.50E-35	149.4	ABCF2_HUMAN	reviewed	ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2)	ABCF2 HUSSY-18	Homo sapiens (Human)	623	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016020; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN25449_c0_g1_i1	Q8K268	ABCF3_MOUSE	99.6	250	1	0	750	1	314	563	4.60E-140	498.4	ABCF3_MOUSE	reviewed	ATP-binding cassette sub-family F member 3	Abcf3	Mus musculus (Mouse)	709	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN804_c0_g1_i1	Q9NUQ8	ABCF3_HUMAN	56	707	302	6	32	2134	1	704	6.20E-225	781.9	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		blue	blue	NA	NA	NA	NA
TRINITY_DN804_c0_g1_i2	Q9NUQ8	ABCF3_HUMAN	56	707	302	6	32	2134	1	704	8.00E-225	781.6	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		blue	blue	NA	NA	NA	NA
TRINITY_DN28458_c0_g1_i1	Q9NUQ8	ABCF3_HUMAN	100	96	0	0	289	2	149	244	2.20E-45	182.6	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN37764_c0_g1_i1	Q9NUQ8	ABCF3_HUMAN	98.9	93	1	0	1	279	163	255	3.00E-44	178.7	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN37812_c0_g1_i1	Q9NUQ8	ABCF3_HUMAN	100	164	0	0	2	493	499	662	1.50E-91	336.7	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN29118_c0_g1_i1	Q8K268	ABCF3_MOUSE	100	70	0	0	1	210	423	492	2.80E-31	135.2	ABCF3_MOUSE	reviewed	ATP-binding cassette sub-family F member 3	Abcf3	Mus musculus (Mouse)	709	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN35799_c0_g1_i1	Q8K268	ABCF3_MOUSE	100	114	0	0	3	344	560	673	4.30E-61	235	ABCF3_MOUSE	reviewed	ATP-binding cassette sub-family F member 3	Abcf3	Mus musculus (Mouse)	709	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN29303_c0_g1_i1	Q9NUQ8	ABCF3_HUMAN	100	71	0	0	215	3	240	310	1.30E-28	126.3	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN30878_c0_g1_i1	Q9NUQ8	ABCF3_HUMAN	63.5	96	35	0	5	292	300	395	3.40E-30	132.1	ABCF3_HUMAN	reviewed	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	709	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0016887; GO:0045296; GO:0051607	defense response to virus [GO:0051607]		NA	NA	NA	NA	NA	NA
TRINITY_DN2744_c0_g1_i1	Q64343	ABCG1_MOUSE	63.3	221	79	2	3	659	446	666	8.60E-74	278.1	ABCG1_MOUSE	reviewed	ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog)	Abcg1 Abc8 Wht1	Mus musculus (Mouse)	666	endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]; amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; reverse cholesterol transport [GO:0043691]	endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; ATP binding [GO:0005524]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]	GO:0000139; GO:0005524; GO:0005739; GO:0005768; GO:0005789; GO:0005886; GO:0008203; GO:0009897; GO:0010745; GO:0010872; GO:0010875; GO:0010888; GO:0016021; GO:0016887; GO:0019534; GO:0030301; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0050714; GO:0055037; GO:0055091; GO:0071403; GO:0090554; GO:0120020; GO:0140328; GO:1902004	amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; reverse cholesterol transport [GO:0043691]		NA	NA	NA	NA	NA	NA
TRINITY_DN33212_c0_g1_i1	P45844	ABCG1_HUMAN	100	126	0	0	3	380	184	309	4.50E-67	255	ABCG1_HUMAN	reviewed	ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog)	ABCG1 ABC8 WHT1	Homo sapiens (Human)	678	endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]; amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; ATP binding [GO:0005524]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]	GO:0000139; GO:0005524; GO:0005543; GO:0005739; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0008203; GO:0009897; GO:0010033; GO:0010745; GO:0010872; GO:0010875; GO:0010887; GO:0015485; GO:0016021; GO:0016887; GO:0019534; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0090554; GO:0120020; GO:0140328; GO:1902004	amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2744_c0_g2_i1	Q9H172	ABCG4_HUMAN	61.9	147	51	2	53	484	38	182	5.20E-39	162.2	ABCG4_HUMAN	reviewed	ATP-binding cassette sub-family G member 4	ABCG4 WHITE2	Homo sapiens (Human)	646	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0033344; GO:0042626; GO:0042803; GO:0046982; GO:0055085; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN2744_c0_g2_i2	Q9H172	ABCG4_HUMAN	57.1	417	147	4	53	1291	38	426	1.10E-122	441.4	ABCG4_HUMAN	reviewed	ATP-binding cassette sub-family G member 4	ABCG4 WHITE2	Homo sapiens (Human)	646	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0033344; GO:0042626; GO:0042803; GO:0046982; GO:0055085; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN37877_c0_g1_i1	P43672	UUP_ECOLI	59.2	71	29	0	3	215	146	216	3.70E-18	91.7	UUP_ECOLI	reviewed	ATP-binding protein Uup (EC 3.6.1.-)	uup ycbH ycbI b0949 JW0932	Escherichia coli (strain K12)	635	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; DNA repair [GO:0006281]; regulation of transposon integration [GO:0070894]; response to radiation [GO:0009314]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]	GO:0003677; GO:0005524; GO:0005737; GO:0005886; GO:0006281; GO:0009314; GO:0016887; GO:0043022; GO:0070894	DNA repair [GO:0006281]; regulation of transposon integration [GO:0070894]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN21594_c0_g1_i1	Q45978	HFAC_CAUVC	60.8	74	29	0	237	16	111	184	9.20E-18	90.5	UUP_CAUVC	reviewed	ATP-binding protein Uup (EC 3.6.1.-) (Holdfast attachment protein C)	uup hfaC CC_2631	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	608	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; DNA repair [GO:0006281]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]	GO:0003677; GO:0005524; GO:0005737; GO:0006281; GO:0016887; GO:0043022	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN34495_c0_g1_i1	Q45978	HFAC_CAUVC	54.5	66	30	0	207	10	291	356	1.20E-13	76.6	UUP_CAUVC	reviewed	ATP-binding protein Uup (EC 3.6.1.-) (Holdfast attachment protein C)	uup hfaC CC_2631	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	608	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; DNA repair [GO:0006281]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]	GO:0003677; GO:0005524; GO:0005737; GO:0006281; GO:0016887; GO:0043022	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN23796_c0_g1_i1	P53396	ACLY_HUMAN	93.8	210	11	1	631	2	475	682	6.10E-109	394.8	ACLY_HUMAN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)	ACLY	Homo sapiens (Human)	1101	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0070062; GO:1904813	acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]		NA	NA	NA	NA	NA	NA
TRINITY_DN23796_c0_g1_i2	P53396	ACLY_HUMAN	96.3	328	10	1	986	3	475	800	8.40E-182	637.5	ACLY_HUMAN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)	ACLY	Homo sapiens (Human)	1101	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0070062; GO:1904813	acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]		NA	NA	NA	NA	NA	NA
TRINITY_DN31613_c0_g1_i1	P53396	ACLY_HUMAN	100	148	0	0	515	72	954	1101	1.00E-82	307.4	ACLY_HUMAN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)	ACLY	Homo sapiens (Human)	1101	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0070062; GO:1904813	acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]		NA	NA	NA	NA	NA	NA
TRINITY_DN30982_c0_g1_i1	P53396	ACLY_HUMAN	100	181	0	0	543	1	116	296	2.10E-102	372.9	ACLY_HUMAN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)	ACLY	Homo sapiens (Human)	1101	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0070062; GO:1904813	acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]		NA	NA	NA	NA	NA	NA
TRINITY_DN35615_c0_g1_i1	P53396	ACLY_HUMAN	100	188	0	0	566	3	785	972	4.70E-105	381.7	ACLY_HUMAN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)	ACLY	Homo sapiens (Human)	1101	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0070062; GO:1904813	acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]		NA	NA	NA	NA	NA	NA
TRINITY_DN23796_c0_g1_i3	Q91V92	ACLY_MOUSE	100	67	0	0	203	3	724	790	2.50E-32	138.7	ACLY_MOUSE	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	Acly	Mus musculus (Mouse)	1091	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN12100_c0_g1_i1	Q91V92	ACLY_MOUSE	62	529	186	4	4	1584	569	1084	9.90E-196	684.5	ACLY_MOUSE	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	Acly	Mus musculus (Mouse)	1091	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN36285_c0_g1_i1	P16638	ACLY_RAT	62.6	182	68	0	5	550	192	373	1.30E-64	247.3	ACLY_RAT	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	Acly	Rattus norvegicus (Rat)	1100	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; oxaloacetate metabolic process [GO:0006107]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006629; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN1281_c0_g1_i1	Q91V92	ACLY_MOUSE	76.3	532	125	1	1692	97	558	1088	3.20E-242	839	ACLY_MOUSE	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	Acly	Mus musculus (Mouse)	1091	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN1281_c0_g1_i2	Q32PF2	ACLY_BOVIN	67	582	178	4	1766	60	1	581	3.40E-226	785.8	ACLY_BOVIN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	ACLY	Bos taurus (Bovine)	1091	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]		NA	NA	NA	NA	NA	NA
TRINITY_DN1281_c0_g1_i3	Q91V92	ACLY_MOUSE	72.5	1089	285	4	3324	97	1	1088	0	1615.9	ACLY_MOUSE	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	Acly	Mus musculus (Mouse)	1091	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN1281_c0_g2_i1	Q32PF2	ACLY_BOVIN	69.4	85	25	1	876	622	558	641	2.60E-22	107.5	ACLY_BOVIN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	ACLY	Bos taurus (Bovine)	1091	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]		NA	NA	NA	NA	NA	NA
TRINITY_DN18634_c0_g1_i1	Q91V92	ACLY_MOUSE	100	80	0	0	241	2	310	389	2.90E-40	165.2	ACLY_MOUSE	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	Acly	Mus musculus (Mouse)	1091	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN18634_c0_g2_i1	Q32PF2	ACLY_BOVIN	100	96	0	0	289	2	294	389	2.20E-50	199.1	ACLY_BOVIN	reviewed	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	ACLY	Bos taurus (Bovine)	1091	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872	acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]		NA	NA	NA	NA	NA	NA
TRINITY_DN26550_c0_g1_i1	D4AAT7	NNRD_RAT	49.5	293	144	3	35	910	52	341	4.30E-74	279.6	NNRD_RAT	reviewed	ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase)	Naxd Carkd	Rattus norvegicus (Rat)	343	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; metabolite repair [GO:0110051]; nicotinamide nucleotide metabolic process [GO:0046496]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]	GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0046496; GO:0047453; GO:0052855; GO:0110051	metabolite repair [GO:0110051]; nicotinamide nucleotide metabolic process [GO:0046496]		NA	NA	NA	NA	NA	NA
TRINITY_DN35840_c0_g1_i1	Q8IW45	NNRD_HUMAN	100	73	0	0	220	2	231	303	2.20E-34	145.6	NNRD_HUMAN	reviewed	ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase)	NAXD CARKD	Homo sapiens (Human)	347	mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; metabolite repair [GO:0110051]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]	mitochondrial matrix [GO:0005759]	ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]	GO:0005524; GO:0005759; GO:0034356; GO:0047453; GO:0052855; GO:0110051	metabolite repair [GO:0110051]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]		NA	NA	NA	NA	NA	NA
TRINITY_DN33053_c0_g1_i1	Q9CZ42	NNRD_MOUSE	100	86	0	0	259	2	38	123	1.20E-44	179.9	NNRD_MOUSE	reviewed	ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase)	Naxd Carkd	Mus musculus (Mouse)	343	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; metabolite repair [GO:0110051]; nicotinamide nucleotide metabolic process [GO:0046496]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]	GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0046496; GO:0047453; GO:0052855; GO:0110051	metabolite repair [GO:0110051]; nicotinamide nucleotide metabolic process [GO:0046496]		NA	NA	NA	NA	NA	NA
TRINITY_DN26584_c0_g1_i1	Q8IW45	NNRD_HUMAN	100	120	0	0	362	3	43	162	4.40E-64	245	NNRD_HUMAN	reviewed	ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase)	NAXD CARKD	Homo sapiens (Human)	347	mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; metabolite repair [GO:0110051]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]	mitochondrial matrix [GO:0005759]	ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]	GO:0005524; GO:0005759; GO:0034356; GO:0047453; GO:0052855; GO:0110051	metabolite repair [GO:0110051]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]		NA	NA	NA	NA	NA	NA
TRINITY_DN17930_c0_g1_i1	P52034	PFKA_DROME	70.8	373	109	0	1172	54	409	781	7.90E-161	568.2	PFKA_DROME	reviewed	ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase)	Pfk CG4001	Drosophila melanogaster (Fruit fly)	788	"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]"	6-phosphofructokinase complex [GO:0005945]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009744; GO:0016208; GO:0030388; GO:0042593; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17930_c0_g1_i2	P52034	PFKA_DROME	70.9	774	221	2	2363	54	8	781	0	1138.6	PFKA_DROME	reviewed	ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase)	Pfk CG4001	Drosophila melanogaster (Fruit fly)	788	"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]"	6-phosphofructokinase complex [GO:0005945]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009744; GO:0016208; GO:0030388; GO:0042593; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37927_c0_g1_i1	P12382	PFKAL_MOUSE	100	91	0	0	3	275	611	701	3.90E-49	194.9	PFKAL_MOUSE	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	Pfkl Pfk-l Pfkb	Mus musculus (Mouse)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005829; GO:0005945; GO:0005975; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061615; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15208_c0_g1_i1	P17858	PFKAL_HUMAN	100	236	0	0	2	709	171	406	1.10E-132	473.8	PFKAL_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Homo sapiens (Human)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005576; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0034774; GO:0042802; GO:0043312; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070062; GO:0070095; GO:1904813	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15208_c1_g1_i1	P12382	PFKAL_MOUSE	100	89	0	0	2	268	283	371	3.20E-43	175.3	PFKAL_MOUSE	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	Pfkl Pfk-l Pfkb	Mus musculus (Mouse)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005829; GO:0005945; GO:0005975; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061615; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38951_c0_g1_i1	A1A4J1	PFKAL_BOVIN	100	77	0	0	232	2	519	595	4.30E-36	151.4	PFKAL_BOVIN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Bos taurus (Bovine)	780	"6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24068_c0_g2_i1	P17858	PFKAL_HUMAN	100	77	0	0	233	3	415	491	1.90E-39	162.5	PFKAL_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Homo sapiens (Human)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005576; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0034774; GO:0042802; GO:0043312; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070062; GO:0070095; GO:1904813	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24068_c0_g1_i1	P17858	PFKAL_HUMAN	100	196	0	0	3	590	488	683	4.60E-111	401.7	PFKAL_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Homo sapiens (Human)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005576; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0034774; GO:0042802; GO:0043312; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070062; GO:0070095; GO:1904813	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29841_c0_g1_i1	P17858	PFKAL_HUMAN	100	83	0	0	252	4	2	84	1.30E-38	159.8	PFKAL_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Homo sapiens (Human)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005576; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0034774; GO:0042802; GO:0043312; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070062; GO:0070095; GO:1904813	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17930_c1_g1_i1	A1A4J1	PFKAL_BOVIN	100	82	0	0	249	4	163	244	1.30E-43	176.4	PFKAL_BOVIN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Bos taurus (Bovine)	780	"6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17930_c1_g2_i1	P12382	PFKAL_MOUSE	100	105	0	0	2	316	65	169	4.20E-55	214.9	PFKAL_MOUSE	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	Pfkl Pfk-l Pfkb	Mus musculus (Mouse)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005829; GO:0005945; GO:0005975; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061615; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17930_c0_g2_i1	P17858	PFKAL_HUMAN	100	129	0	0	387	1	83	211	2.40E-68	259.2	PFKAL_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	PFKL	Homo sapiens (Human)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005576; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0034774; GO:0042802; GO:0043312; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070061; GO:0070062; GO:0070095; GO:1904813	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28189_c0_g1_i1	P12382	PFKAL_MOUSE	61.8	131	50	0	394	2	98	228	2.20E-40	166.4	PFKAL_MOUSE	reviewed	"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)"	Pfkl Pfk-l Pfkb	Mus musculus (Mouse)	780	"6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"	6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; membrane [GO:0016020]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]	GO:0003872; GO:0005524; GO:0005829; GO:0005945; GO:0005975; GO:0006002; GO:0006007; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0051289; GO:0061615; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; negative regulation of insulin secretion [GO:0046676]; protein homotetramerization [GO:0051289]; response to glucose [GO:0009749]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15208_c2_g1_i1	P08237	PFKAM_HUMAN	100	75	0	0	272	48	12	86	2.50E-35	149.1	PFKAM_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)"	PFKM PFKX	Homo sapiens (Human)	780	"6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]"	6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022]	GO:0003872; GO:0005524; GO:0005634; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0008022; GO:0016020; GO:0016208; GO:0016324; GO:0019900; GO:0030388; GO:0042802; GO:0045944; GO:0046716; GO:0046872; GO:0048029; GO:0051289; GO:0061615; GO:0061621; GO:0070061; GO:0070095	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6798_c0_g1_i1	Q01813	PFKAP_HUMAN	100	233	0	0	701	3	16	248	2.10E-131	469.5	PFKAP_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)"	PFKP PFKF	Homo sapiens (Human)	784	"6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"	6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]	GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070062; GO:0070095; GO:1990830	"canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29112_c0_g1_i1	Q01813	PFKAP_HUMAN	100	101	0	0	1	303	609	709	7.80E-54	210.7	PFKAP_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)"	PFKP PFKF	Homo sapiens (Human)	784	"6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"	6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]	GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070062; GO:0070095; GO:1990830	"canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35837_c0_g1_i1	Q01813	PFKAP_HUMAN	100	159	0	0	477	1	268	426	2.30E-84	312.8	PFKAP_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)"	PFKP PFKF	Homo sapiens (Human)	784	"6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"	6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]	GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070062; GO:0070095; GO:1990830	"canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35635_c0_g1_i1	Q01813	PFKAP_HUMAN	100	120	0	0	3	362	496	615	2.20E-63	242.7	PFKAP_HUMAN	reviewed	"ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)"	PFKP PFKF	Homo sapiens (Human)	784	"6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"	6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]	GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070062; GO:0070095; GO:1990830	"canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6163_c2_g2_i1	A0R574	CLPC1_MYCS2	83.6	116	19	0	350	3	552	667	3.70E-52	205.3	CLPC1_MYCS2	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpC1	clpC1 MSMEG_6091 MSMEI_5933	Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium smegmatis)	848	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN27830_c0_g1_i1	Q9CI09	CLPE_LACLA	59	78	32	0	234	1	448	525	3.70E-19	95.1	CLPE_LACLA	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpE	clpE LL0557 L0221	Lactococcus lactis subsp. lactis (strain IL1403) (Streptococcus lactis)	748	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0016887; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17779_c0_g1_i1	Q2G3T4	CLPX_NOVAD	89.3	75	8	0	227	3	332	406	5.80E-30	131	CLPX_NOVAD	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Saro_3054	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	418	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g1_i1	A5V3U4	CLPX_SPHWW	93.7	205	13	0	615	1	51	255	4.60E-106	385.2	CLPX_SPHWW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Swit_0592	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g1_i3	Q2G3T4	CLPX_NOVAD	99.5	182	1	0	546	1	74	255	1.10E-98	360.5	CLPX_NOVAD	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Saro_3054	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	418	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g1_i4	Q2G3T4	CLPX_NOVAD	96.4	166	6	0	500	3	74	239	3.60E-85	315.5	CLPX_NOVAD	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Saro_3054	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	418	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g1_i5	A5V3U4	CLPX_SPHWW	93.6	188	12	0	566	3	52	239	2.60E-95	349.4	CLPX_SPHWW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Swit_0592	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g1_i7	A5V3U4	CLPX_SPHWW	96.2	132	5	0	398	3	108	239	1.20E-65	250.4	CLPX_SPHWW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Swit_0592	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g1_i8	A5V3U4	CLPX_SPHWW	96.2	132	5	0	398	3	108	239	1.20E-65	250.4	CLPX_SPHWW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Swit_0592	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11975_c0_g2_i1	B2UFQ3	CLPX_RALPJ	100	202	0	0	608	3	76	277	1.00E-110	400.6	CLPX_RALPJ	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Rpic_1868	Ralstonia pickettii (strain 12J)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2305_c0_g1_i1	A5V3U4	CLPX_SPHWW	80.8	151	29	0	2	454	264	414	1.10E-64	247.3	CLPX_SPHWW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Swit_0592	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2305_c0_g1_i2	A5V3U4	CLPX_SPHWW	80.5	149	29	0	1	447	266	414	2.70E-63	242.7	CLPX_SPHWW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Swit_0592	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	424	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2305_c0_g1_i3	Q1GPH4	CLPX_SPHAL	84	75	12	0	2	226	264	338	9.90E-30	130.2	CLPX_SPHAL	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX Sala_2743	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	423	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN6108_c0_g1_i1	Q820F8	CLPX_STRAW	97.1	69	2	0	1	207	113	181	2.00E-29	129	CLPX_STRAW	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX SAV_5449	Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)	428	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN13288_c0_g1_i1	Q6A7F1	CLPX_CUTAK	95.2	84	4	0	2	253	315	398	1.10E-37	156.8	CLPX_CUTAK	reviewed	ATP-dependent Clp protease ATP-binding subunit ClpX	clpX PPA1571	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	429	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0006457; GO:0008270; GO:0016887; GO:0046983; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN30438_c0_g1_i1	O76031	CLPX_HUMAN	100	80	0	0	3	242	525	604	2.80E-38	158.7	CLPX_HUMAN	reviewed	"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial"	CLPX	Homo sapiens (Human)	633	cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006457; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0030163; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603	ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN27517_c0_g1_i1	O76031	CLPX_HUMAN	100	184	0	0	1	552	263	446	7.60E-100	364.4	CLPX_HUMAN	reviewed	"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial"	CLPX	Homo sapiens (Human)	633	cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006457; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0030163; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603	ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN20416_c0_g1_i1	O76031	CLPX_HUMAN	62.8	537	158	8	348	1901	101	614	1.50E-161	571.2	CLPX_HUMAN	reviewed	"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial"	CLPX	Homo sapiens (Human)	633	cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006457; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0030163; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603	ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN31533_c0_g1_i1	Q8XYP7	CLPP_RALSO	98.4	125	2	0	1	375	2	126	1.90E-62	239.6	CLPP_RALSO	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP RSc1711 RS02901	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	217	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN31533_c0_g1_i2	Q8XYP7	CLPP_RALSO	96.6	118	4	0	1	354	2	119	4.30E-57	221.9	CLPP_RALSO	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP RSc1711 RS02901	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	217	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	1
TRINITY_DN1642_c0_g2_i1	Q2G3T3	CLPP_NOVAD	87.4	103	13	0	311	3	23	125	7.20E-47	187.6	CLPP_NOVAD	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP Saro_3055	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	235	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN1642_c0_g1_i1	Q1GPH5	CLPP_SPHAL	88.8	179	20	0	539	3	6	184	8.20E-87	321.2	CLPP_SPHAL	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP Sala_2742	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	216	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN1642_c0_g1_i2	Q1GPH5	CLPP_SPHAL	87	154	20	0	463	2	28	181	4.30E-72	271.9	CLPP_SPHAL	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP Sala_2742	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	216	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN1642_c0_g1_i4	Q1GPH5	CLPP_SPHAL	85.8	176	25	0	529	2	6	181	5.40E-83	308.5	CLPP_SPHAL	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP Sala_2742	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	216	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN1642_c0_g3_i1	Q2G3T3	CLPP_NOVAD	89.4	160	17	0	480	1	17	176	7.10E-78	291.2	CLPP_NOVAD	reviewed	ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92) (Endopeptidase Clp)	clpP Saro_3055	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	235	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN29379_c0_g1_i1	Q5FUR3	CLPP1_GLUOX	65.8	73	24	1	2	217	4	76	1.10E-22	106.7	CLPP1_GLUOX	reviewed	ATP-dependent Clp protease proteolytic subunit 1 (EC 3.4.21.92) (Endopeptidase Clp 1)	clpP1 GOX0087	Gluconobacter oxydans (strain 621H) (Gluconobacter suboxydans)	215	cytoplasm [GO:0005737]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]	ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN39769_c0_g1_i1	Q16740	CLPP_HUMAN	100	70	0	0	213	4	167	236	2.60E-32	138.7	CLPP_HUMAN	reviewed	"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)"	CLPP	Homo sapiens (Human)	277	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase binding [GO:0051117]; ATP-dependent peptidase activity [GO:0004176]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006515; GO:0008233; GO:0009368; GO:0033619; GO:0042802; GO:0051117; GO:0051603	membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN27068_c0_g1_i1	Q16740	CLPP_HUMAN	100	187	0	0	3	563	29	215	1.70E-102	373.2	CLPP_HUMAN	reviewed	"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)"	CLPP	Homo sapiens (Human)	277	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase binding [GO:0051117]; ATP-dependent peptidase activity [GO:0004176]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006515; GO:0008233; GO:0009368; GO:0033619; GO:0042802; GO:0051117; GO:0051603	membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN6471_c0_g1_i1	Q2KHU4	CLPP_BOVIN	63.2	231	79	1	717	25	46	270	2.10E-80	300.4	CLPP_BOVIN	reviewed	"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)"	CLPP	Bos taurus (Bovine)	272	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]	ATPase binding [GO:0051117]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005759; GO:0006515; GO:0009368; GO:0033619; GO:0051117; GO:0051603	membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN24286_c0_g1_i1	O88696	CLPP_MOUSE	100	115	0	0	347	3	34	148	3.30E-61	235.3	CLPP_MOUSE	reviewed	"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)"	Clpp	Mus musculus (Mouse)	272	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase binding [GO:0051117]; ATP-dependent peptidase activity [GO:0004176]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006515; GO:0009368; GO:0033619; GO:0042802; GO:0051117; GO:0051603	membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN199_c0_g1_i4	Q26228	KU70_RHIAP	30.4	431	281	7	1380	112	175	594	1.30E-47	192.2	KU70_RHIAP	reviewed	ATP-dependent DNA helicase 2 subunit 1 (EC 3.6.4.12) (ATP-dependent DNA helicase II 70 kDa subunit) (ATP-dependent DNA helicase II subunit Ku70) (Ku autoantigen protein p70 homolog)	ku70	Rhipicephalus appendiculatus (Brown ear tick)	600	chromosome [GO:0005694]; Ku70:Ku80 complex [GO:0043564]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; telomeric DNA binding [GO:0042162]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723]	chromosome [GO:0005694]; Ku70:Ku80 complex [GO:0043564]	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; telomeric DNA binding [GO:0042162]	GO:0000723; GO:0003678; GO:0003684; GO:0005524; GO:0005694; GO:0006303; GO:0006310; GO:0042162; GO:0043564	DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723]		brown	brown	1	NA	NA	NA
TRINITY_DN39438_c0_g1_i1	Q21489	CHL1_CAEEL	44.4	108	49	4	321	31	701	808	1.40E-16	87	CHL1_CAEEL	reviewed	ATP-dependent DNA helicase chl-1 (EC 3.6.4.12) (Chromosome loss protein homolog)	chl-1 M03C11.2	Caenorhabditis elegans	830	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; positive regulation of cell population proliferation [GO:0008284]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0008284; GO:0032508; GO:0034085	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN6702_c0_g1_i2	Q6AXC6	DDX11_MOUSE	49.4	158	79	1	88	561	282	438	9.00E-40	164.9	DDX11_MOUSE	reviewed	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	Ddx11	Mus musculus (Mouse)	906	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; midbody [GO:0030496]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism development [GO:0007275]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; midbody [GO:0030496]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]"	GO:0000790; GO:0000922; GO:0001650; GO:0003677; GO:0003678; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003727; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0007062; GO:0007275; GO:0008094; GO:0008186; GO:0030496; GO:0031297; GO:0032079; GO:0032091; GO:0032508; GO:0034085; GO:0035563; GO:0044806; GO:0045142; GO:0045876; GO:0046872; GO:0051539; GO:0051880; GO:0070062; GO:0072711; GO:0072719; GO:1901838; GO:1904976; GO:1990700; GO:2000781	cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism development [GO:0007275]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN6702_c0_g1_i3	F1R345	DDX11_DANRE	44.4	426	208	5	109	1332	6	420	1.80E-86	321.2	DDX11_DANRE	reviewed	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	ddx11 zgc:92172	Danio rerio (Zebrafish) (Brachydanio rerio)	890	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]"	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"	GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007275; GO:0009303; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN6702_c0_g1_i4	F1R345	DDX11_DANRE	40.1	317	161	5	109	1005	6	311	4.10E-49	196.8	DDX11_DANRE	reviewed	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	ddx11 zgc:92172	Danio rerio (Zebrafish) (Brachydanio rerio)	890	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]"	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"	GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007275; GO:0009303; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN29825_c0_g1_i1	F1R345	DDX11_DANRE	56.6	274	116	2	823	8	597	869	4.30E-92	339.3	DDX11_DANRE	reviewed	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	ddx11 zgc:92172	Danio rerio (Zebrafish) (Brachydanio rerio)	890	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]"	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"	GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007275; GO:0009303; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN29825_c0_g1_i2	F1R345	DDX11_DANRE	56.2	283	121	2	850	8	588	869	1.80E-95	350.5	DDX11_DANRE	reviewed	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	ddx11 zgc:92172	Danio rerio (Zebrafish) (Brachydanio rerio)	890	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]"	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"	GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007275; GO:0009303; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN8397_c0_g1_i1	Q0P9V4	PIF1_CAMJE	48.1	52	26	1	62	217	356	406	6.20E-06	51.2	PIF1_CAMJE	reviewed	ATP-dependent DNA helicase pif1 (EC 3.6.4.12)	pif1 Cj0945c	Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168)	447	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]		ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]		brown	brown	1	NA	NA	NA
TRINITY_DN3161_c1_g1_i1	Q7ZV90	PIF1_DANRE	36.5	137	84	2	92	496	10	145	2.60E-15	84	PIF1_DANRE	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	pif1 zgc:56161	Danio rerio (Zebrafish) (Brachydanio rerio)	639	mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0032508; GO:0043139	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN3161_c1_g1_i4	Q7ZV90	PIF1_DANRE	33.5	233	121	7	92	721	10	231	1.70E-19	97.8	PIF1_DANRE	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	pif1 zgc:56161	Danio rerio (Zebrafish) (Brachydanio rerio)	639	mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0032508; GO:0043139	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7336_c0_g1_i2	Q0R4F1	PIF1_XENLA	61.7	128	49	0	91	474	319	446	2.20E-42	173.3	PIF1_XENLA	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	pif1	Xenopus laevis (African clawed frog)	635	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0043139	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7336_c0_g1_i3	Q0R4F1	PIF1_XENLA	61.2	381	148	0	3	1145	237	617	9.20E-135	481.5	PIF1_XENLA	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	pif1	Xenopus laevis (African clawed frog)	635	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0043139	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7336_c0_g1_i5	Q0R4F1	PIF1_XENLA	52.1	48	23	0	34	177	399	446	7.30E-08	57.4	PIF1_XENLA	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	pif1	Xenopus laevis (African clawed frog)	635	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0043139	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7336_c0_g1_i7	Q0R4F1	PIF1_XENLA	59.1	352	144	0	8	1063	266	617	2.10E-120	433.7	PIF1_XENLA	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	pif1	Xenopus laevis (African clawed frog)	635	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0043139	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN36173_c0_g1_i1	Q9H611	PIF1_HUMAN	56.7	60	26	0	23	202	529	588	6.50E-12	70.9	PIF1_HUMAN	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein)	PIF1 C15orf20	Homo sapiens (Human)	641	"mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]"	"mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]"	5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]	GO:0000002; GO:0000287; GO:0000723; GO:0000784; GO:0005524; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0010521; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7336_c0_g1_i6	Q9H611	PIF1_HUMAN	57	107	46	0	34	354	398	504	1.80E-24	113.6	PIF1_HUMAN	reviewed	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein)	PIF1 C15orf20	Homo sapiens (Human)	641	"mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]"	"mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]"	5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]	GO:0000002; GO:0000287; GO:0000723; GO:0000784; GO:0005524; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0010521; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN39103_c0_g1_i1	P46063	RECQ1_HUMAN	98	98	2	0	1	294	159	256	6.50E-50	197.6	RECQ1_HUMAN	reviewed	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	649	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN32008_c0_g1_i1	P46063	RECQ1_HUMAN	100	81	0	0	243	1	333	413	2.70E-41	168.7	RECQ1_HUMAN	reviewed	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	649	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i17	P46063	RECQ1_HUMAN	37.3	59	37	0	265	89	453	511	1.70E-07	57	RECQ1_HUMAN	reviewed	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	649	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i2	P46063	RECQ1_HUMAN	49.4	567	277	3	2348	666	16	578	2.20E-162	574.3	RECQ1_HUMAN	reviewed	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	649	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i20	P46063	RECQ1_HUMAN	49.6	562	273	3	2442	775	16	573	6.50E-162	572.8	RECQ1_HUMAN	reviewed	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	649	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i23	P46063	RECQ1_HUMAN	50.4	500	238	3	1570	89	16	511	6.70E-147	522.3	RECQ1_HUMAN	reviewed	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	649	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i11	Q9Z129	RECQ1_MOUSE	33.3	135	69	4	525	166	514	642	3.30E-07	56.6	RECQ1_MOUSE	reviewed	ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA-dependent ATPase Q1) (RecQ protein-like 1)	Recql Recql1	Mus musculus (Mouse)	648	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i14	Q5RF63	RECQ1_PONAB	49.5	281	142	0	931	89	231	511	8.10E-82	305.4	RECQ1_PONAB	reviewed	ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA-dependent ATPase Q1) (RecQ protein-like 1)	RECQL RECQL1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	649	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006310	DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i22	Q9Z129	RECQ1_MOUSE	34.1	135	68	4	525	166	514	642	3.40E-08	60.1	RECQ1_MOUSE	reviewed	ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA-dependent ATPase Q1) (RecQ protein-like 1)	Recql Recql1	Mus musculus (Mouse)	648	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i4	Q6AYJ1	RECQ1_RAT	47.8	588	292	4	2091	337	1	576	2.70E-161	570.5	RECQ1_RAT	reviewed	ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA-dependent ATPase Q1) (RecQ protein-like 1)	Recql Recql1	Rattus norvegicus (Rat)	621	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i5	Q5RF63	RECQ1_PONAB	48.4	343	177	0	1803	775	231	573	1.20E-96	355.5	RECQ1_PONAB	reviewed	ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA-dependent ATPase Q1) (RecQ protein-like 1)	RECQL RECQL1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	649	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006310	DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i9	Q9Z129	RECQ1_MOUSE	46.7	60	32	0	683	504	514	573	1.90E-08	61.2	RECQ1_MOUSE	reviewed	ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA-dependent ATPase Q1) (RecQ protein-like 1)	Recql Recql1	Mus musculus (Mouse)	648	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN3466_c0_g1_i1	O94761	RECQ4_HUMAN	57.4	47	20	0	232	92	1159	1205	6.80E-11	67.8	RECQ4_HUMAN	reviewed	"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)"	RECQL4 RECQ4	Homo sapiens (Human)	1208	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]"	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]	GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0007275; GO:0009378; GO:0016020; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0061820; GO:0061821	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]		NA	NA	NA	NA	NA	NA
TRINITY_DN3466_c0_g1_i2	O94761	RECQ4_HUMAN	45.6	809	407	16	2494	92	422	1205	8.80E-188	658.7	RECQ4_HUMAN	reviewed	"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)"	RECQL4 RECQ4	Homo sapiens (Human)	1208	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]"	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]	GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0007275; GO:0009378; GO:0016020; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0061820; GO:0061821	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]		NA	NA	NA	NA	NA	NA
TRINITY_DN21902_c0_g1_i1	Q8VID5	RECQ5_MOUSE	53.7	352	154	4	1118	66	135	478	5.10E-104	379.4	RECQ5_MOUSE	reviewed	"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RECQL5beta) (RecQ protein-like 5)"	Recql5	Mus musculus (Mouse)	982	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]"	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]	GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0035690; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042	cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]		NA	NA	NA	NA	NA	NA
TRINITY_DN21902_c0_g1_i2	Q8VID5	RECQ5_MOUSE	54.6	476	206	5	1490	66	12	478	2.60E-145	516.9	RECQ5_MOUSE	reviewed	"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RECQL5beta) (RecQ protein-like 5)"	Recql5	Mus musculus (Mouse)	982	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]"	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]	GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0035690; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042	cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]		NA	NA	NA	NA	NA	NA
TRINITY_DN21902_c0_g1_i3	Q8VID5	RECQ5_MOUSE	53.3	403	179	4	1271	66	84	478	9.60E-120	431.8	RECQ5_MOUSE	reviewed	"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RECQL5beta) (RecQ protein-like 5)"	Recql5	Mus musculus (Mouse)	982	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]"	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]	GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0035690; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042	cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to drug [GO:0035690]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]		NA	NA	NA	NA	NA	NA
TRINITY_DN24577_c0_g1_i1	Q9FT74	RQL1_ARATH	37.3	51	29	1	181	38	556	606	5.70E-05	47.8	RQL1_ARATH	reviewed	ATP-dependent DNA helicase Q-like 1 (EC 3.6.4.12) (RecQ-like protein 1) (AtRecQ1) (AtRecQl1)	RECQL1 RECQ1 RQL1 At3g05740 F10A16.2	Arabidopsis thaliana (Mouse-ear cress)	606	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to cold [GO:0070417]; cellular response to water deprivation [GO:0042631]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0000724; GO:0003676; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0042631; GO:0043138; GO:0046872; GO:0070417	cellular response to cold [GO:0070417]; cellular response to water deprivation [GO:0042631]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i3	Q9FT73	MED34_ARATH	43.4	113	62	1	427	89	398	508	9.70E-25	114.8	RECQ2_ARATH	reviewed	ATP-dependent DNA helicase Q-like 2 (EC 3.6.4.12) (RecQ-like protein 2) (AtRQ2) (AtRecQ2) (AtRecQl2)	RECQL2 MED34 MED34_1 RECQ2 RQL2 At1g31360 T19E23.16	Arabidopsis thaliana (Mouse-ear cress)	705	chromosome [GO:0005694]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]	GO:0000724; GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016592; GO:0032508; GO:0043138; GO:0046872	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN31945_c0_g1_i1	Q8L840	RQL4A_ARATH	61.2	80	31	0	248	9	446	525	3.80E-20	98.6	RQL4A_ARATH	reviewed	ATP-dependent DNA helicase Q-like 4A (EC 3.6.4.12) (RecQ-like protein 4A) (AtRecQ4A) (AtRecQl4A) (SGS1-like protein) (AtSGS1)	RECQL4A RECQ4A RQL4A SGS1 At1g10930 T19D16.15	Arabidopsis thaliana (Mouse-ear cress)	1188	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to abscisic acid stimulus [GO:0071215]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0000724; GO:0003676; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0009378; GO:0009506; GO:0032508; GO:0043138; GO:0046872; GO:0051276; GO:0070417; GO:0071215	cellular response to abscisic acid stimulus [GO:0071215]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN28034_c0_g1_i1	Q9FT70	RQL4B_ARATH	62.7	67	25	0	1	201	739	805	2.30E-19	95.9	RQL4B_ARATH	reviewed	ATP-dependent DNA helicase Q-like 4B (EC 3.6.4.12) (RecQ-like protein 4B) (AtRecQ4B) (AtRecQl4B)	RECQL4B RECQ4B RQL4B At1g60930 T7P1.7	Arabidopsis thaliana (Mouse-ear cress)	1150	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to cold [GO:0070417]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0000724; GO:0003676; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0043138; GO:0046872; GO:0070417	cellular response to cold [GO:0070417]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN7831_c1_g1_i1	P71359	RECQ_HAEIN	53.7	67	31	0	2	202	122	188	6.50E-17	87.4	RECQ_HAEIN	reviewed	ATP-dependent DNA helicase RecQ (EC 3.6.4.12)	recQ HI_0728	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	619	bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]	bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]	GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0030894; GO:0032508; GO:0043138; GO:0043590	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]		NA	NA	NA	NA	NA	NA
TRINITY_DN24577_c0_g2_i1	P15043	RECQ_ECOLI	52.9	85	40	0	259	5	261	345	2.40E-19	95.9	RECQ_ECOLI	reviewed	ATP-dependent DNA helicase RecQ (EC 3.6.4.12)	recQ b3822 JW5855	Escherichia coli (strain K12)	609	bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]	bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003678; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0008270; GO:0009378; GO:0009432; GO:0016887; GO:0017116; GO:0017117; GO:0030894; GO:0032508; GO:0043138; GO:0043590; GO:0046914	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]		NA	NA	NA	NA	NA	NA
TRINITY_DN35222_c0_g1_i1	Q9H2U1	DHX36_HUMAN	98.6	71	1	0	215	3	257	327	1.80E-33	142.5	DHX36_HUMAN	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)	DHX36 DDX36 KIAA1488 MLEL1 RHAU	Homo sapiens (Human)	1008	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of type I interferon production [GO:0032481]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032481; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070062; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of type I interferon production [GO:0032481]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39056_c0_g1_i1	Q9H2U1	DHX36_HUMAN	54.1	85	39	0	1	255	201	285	4.00E-22	105.1	DHX36_HUMAN	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)	DHX36 DDX36 KIAA1488 MLEL1 RHAU	Homo sapiens (Human)	1008	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of type I interferon production [GO:0032481]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032481; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070062; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of type I interferon production [GO:0032481]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32203_c0_g1_i1	Q05B79	DHX36_BOVIN	98.6	71	1	0	214	2	223	293	8.10E-34	143.7	DHX36_BOVIN	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)	DHX36	Bos taurus (Bovine)	1010	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]	GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26535_c0_g1_i1	Q8VHK9	DHX36_MOUSE	48.2	562	275	7	19	1662	442	1001	2.00E-146	520.8	DHX36_MOUSE	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)	Dhx36 Ddx36 Kiaa1488 Mlel1	Mus musculus (Mouse)	1001	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13109_c0_g1_i1	Q8VHK9	DHX36_MOUSE	58.4	257	97	2	28	768	173	429	1.20E-77	291.2	DHX36_MOUSE	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)	Dhx36 Ddx36 Kiaa1488 Mlel1	Mus musculus (Mouse)	1001	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32715_c0_g1_i1	Q8VHK9	DHX36_MOUSE	100	89	0	0	1	267	300	388	9.80E-45	180.3	DHX36_MOUSE	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)	Dhx36 Ddx36 Kiaa1488 Mlel1	Mus musculus (Mouse)	1001	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26317_c0_g1_i1	Q8VHK9	DHX36_MOUSE	100	56	0	0	2	169	494	549	1.10E-23	110.5	DHX36_MOUSE	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)	Dhx36 Ddx36 Kiaa1488 Mlel1	Mus musculus (Mouse)	1001	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26317_c0_g1_i1	Q8VHK9	DHX36_MOUSE	97.9	47	1	0	168	308	560	606	2.30E-21	102.8	DHX36_MOUSE	reviewed	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)	Dhx36 Ddx36 Kiaa1488 Mlel1	Mus musculus (Mouse)	1001	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10472_c0_g1_i1	P25439	BRM_DROME	71.1	235	68	0	92	796	389	623	9.70E-72	271.6	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10362_c0_g1_i1	P25439	BRM_DROME	64.1	92	32	1	282	7	1423	1513	4.40E-27	121.7	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4827_c0_g1_i1	P25439	BRM_DROME	89.5	105	11	0	317	3	863	967	3.70E-51	201.8	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13666_c0_g1_i3	P25439	BRM_DROME	79.8	119	24	0	359	3	750	868	2.30E-49	196.1	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13666_c0_g1_i4	P25439	BRM_DROME	81.1	90	17	0	272	3	779	868	1.20E-36	153.7	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13666_c0_g1_i5	P25439	BRM_DROME	79.8	119	24	0	359	3	750	868	2.30E-49	196.1	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33997_c0_g1_i1	P25439	BRM_DROME	35.1	114	30	1	100	441	135	204	7.90E-09	62	BRM_DROME	reviewed	ATP-dependent helicase brm (EC 3.6.4.12) (Homeotic gene regulator) (Protein brahma)	brm CG5942	Drosophila melanogaster (Fruit fly)	1638	"brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"	brahma complex [GO:0035060]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0006357; GO:0007406; GO:0007409; GO:0007419; GO:0007474; GO:0007480; GO:0008094; GO:0008134; GO:0008586; GO:0008587; GO:0016514; GO:0016586; GO:0016887; GO:0035060; GO:0035172; GO:0036335; GO:0042393; GO:0043044; GO:0043697; GO:0043974; GO:0045088; GO:0045893; GO:0045944; GO:0048477; GO:0048813; GO:0070983; GO:1902692; GO:2000134; GO:2000648	"ATP-dependent chromatin remodeling [GO:0043044]; axonogenesis [GO:0007409]; cell dedifferentiation [GO:0043697]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemocyte proliferation [GO:0035172]; histone H3-K27 acetylation [GO:0043974]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuroblast proliferation [GO:0007406]; oogenesis [GO:0048477]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29649_c0_g1_i1	P35187	SGS1_YEAST	56.7	97	42	0	25	315	922	1018	3.70E-28	125.6	SGS1_YEAST	reviewed	ATP-dependent helicase SGS1 (EC 3.6.4.12) (Helicase TPS1)	SGS1 TPS1 YMR190C YM9646.02C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1447	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; nucleic acid binding [GO:0003676]; chromosome organization [GO:0051276]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; gene conversion at mating-type locus, DNA double-strand break processing [GO:0031292]; intra-S DNA damage checkpoint [GO:0031573]; meiotic chromosome segregation [GO:0045132]; meiotic DNA double-strand break processing [GO:0000706]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of meiotic joint molecule formation [GO:0010947]; regulation of reciprocal meiotic recombination [GO:0010520]; replicative cell aging [GO:0001302]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomeric 3' overhang formation [GO:0031860]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; nucleic acid binding [GO:0003676]	GO:0000070; GO:0000706; GO:0000722; GO:0000723; GO:0000724; GO:0000729; GO:0001302; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0006265; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0010520; GO:0010947; GO:0031292; GO:0031422; GO:0031573; GO:0031860; GO:0032508; GO:0043138; GO:0044818; GO:0045132; GO:0051276	"chromosome organization [GO:0051276]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; gene conversion at mating-type locus, DNA double-strand break processing [GO:0031292]; intra-S DNA damage checkpoint [GO:0031573]; meiotic chromosome segregation [GO:0045132]; meiotic DNA double-strand break processing [GO:0000706]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of meiotic joint molecule formation [GO:0010947]; regulation of reciprocal meiotic recombination [GO:0010520]; replicative cell aging [GO:0001302]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomeric 3' overhang formation [GO:0031860]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15197_c0_g1_i1	Q09820	RENT1_SCHPO	54.9	113	44	2	339	19	383	494	2.20E-23	109.8	RENT1_SCHPO	reviewed	ATP-dependent helicase upf1 (EC 3.6.4.-) (Nonsense-mediated mRNA decay protein upf1) (Regulator of nonsense transcripts 1 homolog) (Up-frameshift suppressor 1)	upf1 SPAC16C9.06c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	925	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005829; GO:0008270; GO:0070478; GO:2000815	"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17039_c0_g1_i1	Q2LVL0	MSBA_SYNAS	65.8	117	40	0	352	2	457	573	9.90E-37	154.1	MSBA_SYNAS	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA SYNAS_22440 SYN_01564	Syntrophus aciditrophicus (strain SB)	601	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN32409_c0_g1_i1	Q2LVL0	MSBA_SYNAS	60	65	26	0	6	200	366	430	2.70E-15	82	MSBA_SYNAS	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA SYNAS_22440 SYN_01564	Syntrophus aciditrophicus (strain SB)	601	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN25673_c0_g1_i1	Q6LPK6	MSBA_PHOPR	47.8	69	36	0	208	2	354	422	2.00E-13	75.9	MSBA_PHOPR	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA PBPRA2385	Photobacterium profundum (strain SS9)	585	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN33548_c0_g1_i1	Q8XXB6	MSBA_RALSO	85.4	82	12	0	2	247	357	438	3.20E-34	145.2	MSBA_RALSO	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA RSc2200 RS01399	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	592	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN33817_c0_g1_i1	Q14JW6	MSBA_FRAT1	44.4	63	35	0	190	2	499	561	8.00E-08	57.4	MSBA_FRAT1	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA FTF0109	Francisella tularensis subsp. tularensis (strain FSC 198)	609	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN3382_c0_g2_i1	Q8XXB6	MSBA_RALSO	91.3	127	11	0	2	382	466	592	3.70E-61	235.3	MSBA_RALSO	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA RSc2200 RS01399	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	592	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	1
TRINITY_DN3333_c0_g2_i1	Q3SFZ6	MSBA_THIDA	61.2	152	58	1	458	6	421	572	8.40E-44	177.9	MSBA_THIDA	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA Tbd_2507	Thiobacillus denitrificans (strain ATCC 25259)	579	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN3333_c0_g1_i1	Q5F4X8	MSBA_NEIG1	74.1	81	21	0	246	4	521	601	5.50E-26	117.9	MSBA_NEIG1	reviewed	ATP-dependent lipid A-core flippase (EC 7.5.2.6) (Lipid A export ATP-binding/permease protein MsbA)	msbA NGO2165	Neisseria gonorrhoeae (strain ATCC 700825 / FA 1090)	622	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040			NA	NA	NA	NA	NA	NA
TRINITY_DN10826_c0_g1_i1	Q08211	DHX9_HUMAN	56.7	164	71	0	493	2	382	545	3.10E-52	206.1	DHX9_HUMAN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9 DDX9 LKP NDH2	Homo sapiens (Human)	1270	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000398; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032481; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032991; GO:0033679; GO:0034458; GO:0034622; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39120_c0_g1_i1	Q08211	DHX9_HUMAN	100	188	0	0	1	564	381	568	8.30E-102	370.9	DHX9_HUMAN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9 DDX9 LKP NDH2	Homo sapiens (Human)	1270	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000398; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032481; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032991; GO:0033679; GO:0034458; GO:0034622; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40769_c0_g1_i1	Q08211	DHX9_HUMAN	100	72	0	0	2	217	681	752	1.30E-34	146.4	DHX9_HUMAN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9 DDX9 LKP NDH2	Homo sapiens (Human)	1270	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000398; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032481; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032991; GO:0033679; GO:0034458; GO:0034622; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32553_c0_g1_i1	Q08211	DHX9_HUMAN	100	86	0	0	259	2	999	1084	3.00E-43	175.3	DHX9_HUMAN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9 DDX9 LKP NDH2	Homo sapiens (Human)	1270	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000398; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032481; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032991; GO:0033679; GO:0034458; GO:0034622; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27935_c0_g1_i1	O70133	DHX9_MOUSE	72.4	58	16	0	43	216	686	743	2.80E-17	89	DHX9_MOUSE	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (mHEL-5) (Nuclear DNA helicase II) (NDH II) (RNA helicase A) (RHA)	Dhx9 Ddx9	Mus musculus (Mouse)	1380	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005844; GO:0006353; GO:0006357; GO:0006954; GO:0007623; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032991; GO:0033679; GO:0034458; GO:0034605; GO:0034622; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular protein-containing complex assembly [GO:0034622]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5732_c0_g1_i2	Q28141	DHX9_BOVIN	40	105	55	3	28	318	102	206	7.10E-14	78.2	DHX9_BOVIN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)	DHX9 DDX9 NDH2	Bos taurus (Bovine)	1287	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005844; GO:0006260; GO:0006353; GO:0006954; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032755; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5732_c0_g1_i3	Q28141	DHX9_BOVIN	40	105	55	3	28	318	102	206	2.40E-14	79.7	DHX9_BOVIN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)	DHX9 DDX9 NDH2	Bos taurus (Bovine)	1287	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005844; GO:0006260; GO:0006353; GO:0006954; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032755; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26341_c0_g1_i1	Q28141	DHX9_BOVIN	100	76	0	0	229	2	140	215	7.70E-38	157.1	DHX9_BOVIN	reviewed	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)	DHX9 DDX9 NDH2	Bos taurus (Bovine)	1287	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005844; GO:0006260; GO:0006353; GO:0006954; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032755; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22975_c1_g1_i2	Q68FK8	DHX9_XENLA	60.8	79	31	0	59	295	3	81	1.80E-25	116.7	DHX9_XENLA	reviewed	ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)	dhx9	Xenopus laevis (African clawed frog)	1262	"actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005815; GO:0005844; GO:0006260; GO:0006353; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0033679; GO:0034458; GO:0035613; GO:0036464; GO:0042788; GO:0043138; GO:0044806; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071356; GO:0097165; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26861_c0_g1_i1	Q68FK8	DHX9_XENLA	71.2	184	53	0	554	3	397	580	3.20E-74	279.3	DHX9_XENLA	reviewed	ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)	dhx9	Xenopus laevis (African clawed frog)	1262	"actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005815; GO:0005844; GO:0006260; GO:0006353; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0033679; GO:0034458; GO:0035613; GO:0036464; GO:0042788; GO:0043138; GO:0044806; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071356; GO:0097165; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29727_c0_g1_i1	Q9V3C0	DDX41_DROME	63.7	625	204	6	83	1915	4	619	7.70E-219	761.5	DDX41_DROME	reviewed	ATP-dependent RNA helicase abstrakt (DEAD box protein abstrakt) (EC 3.6.4.13)	abs CG14637	Drosophila melanogaster (Fruit fly)	619	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005681; GO:0008270; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN14898_c0_g1_i1	Q9VHP0	DDX3_DROME	68.5	73	19	1	2	208	303	375	2.80E-21	102.1	DDX3_DROME	reviewed	ATP-dependent RNA helicase bel (EC 3.6.4.13) (Protein belle)	bel CG9748	Drosophila melanogaster (Fruit fly)	798	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P granule [GO:0043186]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; gamete generation [GO:0007276]; instar larval development [GO:0002168]; male germ-line stem cell population maintenance [GO:0036098]; mitotic sister chromatid segregation [GO:0000070]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]; RNA interference [GO:0016246]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P granule [GO:0043186]; RISC complex [GO:0016442]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000070; GO:0002168; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007276; GO:0007283; GO:0010468; GO:0016246; GO:0016442; GO:0030154; GO:0035072; GO:0036098; GO:0043025; GO:0043186; GO:0048477	cell differentiation [GO:0030154]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; gamete generation [GO:0007276]; instar larval development [GO:0002168]; male germ-line stem cell population maintenance [GO:0036098]; mitotic sister chromatid segregation [GO:0000070]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]; RNA interference [GO:0016246]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN40500_c0_g1_i1	Q6FNA2	DBP10_CANGA	57.3	82	34	1	9	251	437	518	8.40E-22	104	DBP10_CANGA	reviewed	ATP-dependent RNA helicase DBP10 (EC 3.6.4.13)	DBP10 CAGL0K01551g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	969	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; assembly of large subunit precursor of preribosome [GO:1902626]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0000466; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030687; GO:0042802; GO:1902626	"assembly of large subunit precursor of preribosome [GO:1902626]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16368_c0_g2_i1	Q1DP69	DBP2_COCIM	60.4	91	34	1	4	276	236	324	7.60E-25	114.4	DBP2_COCIM	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 CIMG_07894	Coccidioides immitis (strain RS) (Valley fever fungus)	545	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24166_c0_g7_i1	Q755N4	DBP2_ASHGO	71.7	191	53	1	573	1	133	322	1.30E-78	293.9	DBP2_ASHGO	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 AFL221C	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	557	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; snoRNA binding [GO:0030515]; messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; snoRNA binding [GO:0030515]	GO:0000184; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:0006369; GO:0008186; GO:0030515; GO:0071042; GO:1990120; GO:1990904	"messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24033_c0_g2_i1	A3LQW7	DBP2_PICST	57.4	230	95	2	698	9	98	324	1.50E-68	260.8	DBP2_PICST	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 PICST_82821	Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) (Yeast) (Pichia stipitis)	530	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; snoRNA binding [GO:0030515]; messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; snoRNA binding [GO:0030515]	GO:0000184; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:0006369; GO:0008186; GO:0030515; GO:0071042; GO:1990120	"messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28689_c0_g1_i1	Q8SRB2	DBP2_ENCCU	58.3	115	46	2	3	344	336	449	5.00E-33	141.7	DBP2_ENCCU	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 ECU08_1080	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	495	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5974_c0_g2_i2	A6RGE3	DBP2_AJECN	55.3	85	38	0	2	256	242	326	6.00E-23	107.8	DBP2_AJECN	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 HCAG_08709	Ajellomyces capsulatus (strain NAm1 / WU24) (Darling's disease fungus) (Histoplasma capsulatum)	542	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11776_c0_g2_i1	Q755N4	DBP2_ASHGO	73.1	197	52	1	591	1	128	323	3.50E-79	295.8	DBP2_ASHGO	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 AFL221C	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	557	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; snoRNA binding [GO:0030515]; messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; snoRNA binding [GO:0030515]	GO:0000184; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:0006369; GO:0008186; GO:0030515; GO:0071042; GO:1990120; GO:1990904	"messenger ribonucleoprotein complex assembly [GO:1990120]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35299_c0_g1_i1	A4QSS5	DBP2_MAGO7	54.3	92	42	0	21	296	399	490	8.70E-26	117.5	DBP2_MAGO7	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 MGG_12894	Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) (Rice blast fungus) (Pyricularia oryzae)	548	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4685_c0_g1_i1	Q8SRB2	DBP2_ENCCU	69.1	110	33	1	334	5	189	297	2.00E-39	162.9	DBP2_ENCCU	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 ECU08_1080	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	495	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35598_c0_g1_i1	Q8SRB2	DBP2_ENCCU	62.5	104	39	0	322	11	79	182	6.10E-33	141.4	DBP2_ENCCU	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13)	DBP2 ECU08_1080	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	495	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24166_c0_g6_i1	G0SFM2	DBP2_CHATD	74.8	214	54	0	669	28	114	327	1.80E-93	343.6	DBP2_CHATD	reviewed	ATP-dependent RNA helicase DBP2 (EC 3.6.4.13) (DEAD box protein 2)	DBP2 CTHT_0071350	Chaetomium thermophilum (strain DSM 1495 / CBS 144.50 / IMI 039719)	556	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25386_c0_g1_i1	P24782	DBP2_SCHPO	54.2	72	33	0	19	234	245	316	1.30E-16	86.7	DBP2_SCHPO	reviewed	ATP-dependent RNA helicase dbp2 (EC 3.6.4.13) (p68-like protein)	dbp2 SPBP8B7.16c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	550	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36047_c0_g1_i1	P0CQ79	DBP3_CRYNB	72.2	79	22	0	15	251	463	541	1.50E-26	119.8	DBP3_CRYNB	reviewed	ATP-dependent RNA helicase DBP3 (EC 3.6.4.13)	DBP3 CNBE0530	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	605	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000464]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]	GO:0000464; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0008186; GO:0030687	"endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000464]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23460_c0_g1_i1	A5DAC8	DBP3_PICGU	52.8	72	32	1	3	212	250	321	4.60E-13	74.7	DBP3_PICGU	reviewed	ATP-dependent RNA helicase DBP3 (EC 3.6.4.13)	DBP3 PGUG_00233	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	534	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000464]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]	GO:0000464; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0008186; GO:0030687	"endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000464]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28095_c0_g1_i1	A6QXC1	DBP3_AJECN	57.4	68	29	0	5	208	358	425	4.10E-14	78.2	DBP3_AJECN	reviewed	ATP-dependent RNA helicase DBP3 (EC 3.6.4.13)	DBP3 HCAG_02028	Ajellomyces capsulatus (strain NAm1 / WU24) (Darling's disease fungus) (Histoplasma capsulatum)	487	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN27312_c0_g1_i1	Q0CL13	DBP3_ASPTN	53.5	71	33	0	2	214	207	277	1.20E-11	70.1	DBP3_ASPTN	reviewed	ATP-dependent RNA helicase dbp3 (EC 3.6.4.13)	dbp3 ATEG_05621	Aspergillus terreus (strain NIH 2624 / FGSC A1156)	493	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN8391_c0_g1_i1	Q1EB31	DBP4_COCIM	58.3	103	43	0	3	311	60	162	1.50E-31	136.7	DBP4_COCIM	reviewed	ATP-dependent RNA helicase DBP4 (EC 3.6.4.13)	DBP4 CIMG_00232	Coccidioides immitis (strain RS) (Valley fever fungus)	806	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN39912_c0_g1_i1	Q9UTP9	DBP4_SCHPO	55.7	106	46	1	320	3	312	416	5.00E-27	121.7	DBP4_SCHPO	reviewed	ATP-dependent RNA helicase dbp4 (EC 3.6.4.13)	dbp4 SPAC1093.05	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	735	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0032040	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2770_c0_g1_i1	Q6C835	DBP7_YARLI	61	77	30	0	2	232	333	409	1.40E-23	109.8	DBP7_YARLI	reviewed	ATP-dependent RNA helicase DBP7 (EC 3.6.4.13)	DBP7 YALI0D23133g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	799	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0042254	ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN40659_c0_g1_i1	A5AA68	DBP8_ASPNC	54.7	106	48	0	1	318	366	471	5.40E-26	118.2	DBP8_ASPNC	reviewed	ATP-dependent RNA helicase dbp8 (EC 3.6.4.13)	dbp8 An02g06750	Aspergillus niger (strain CBS 513.88 / FGSC A1513)	522	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31031_c0_g1_i1	Q9HGM5	DBP8_SCHPO	53.8	173	80	0	2	520	25	197	6.60E-45	181.8	DBP8_SCHPO	reviewed	ATP-dependent RNA helicase dbp8 (EC 3.6.4.13)	dbp8 SPBC543.06c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	453	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31715_c0_g1_i1	Q7S6F3	DBP9_NEUCR	54.9	71	27	2	29	226	114	184	2.40E-12	72.4	DBP9_NEUCR	reviewed	ATP-dependent RNA helicase dbp-9 (EC 3.6.4.13)	dbp-9 NCU07070	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	676	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN36716_c0_g1_i1	P21693	DBPA_ECOLI	64.1	64	23	0	3	194	123	186	8.50E-17	87	DBPA_ECOLI	reviewed	ATP-dependent RNA helicase DbpA (EC 3.6.4.13)	dbpA b1343 JW1337	Escherichia coli (strain K12)	457	cytoplasm [GO:0005737]; 3'-5' RNA helicase activity [GO:0034458]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA/RNA helicase activity [GO:0033677]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]	3'-5' RNA helicase activity [GO:0034458]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA/RNA helicase activity [GO:0033677]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]	GO:0000027; GO:0003724; GO:0005524; GO:0005737; GO:0016887; GO:0019843; GO:0033677; GO:0034458; GO:0043531	ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN3327_c0_g1_i1	Q9VNV3	DDX1_DROME	66.2	733	233	5	63	2243	1	724	2.50E-293	1009.2	DDX1_DROME	reviewed	ATP-dependent RNA helicase Ddx1 (DEAD box protein 1) (EC 3.6.4.13)	Ddx1 CG9054	Drosophila melanogaster (Fruit fly)	727	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; ribosome biogenesis [GO:0042254]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0001700; GO:0003682; GO:0003712; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0007283; GO:0008143; GO:0032508; GO:0033677; GO:0042254; GO:0048477	DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; ribosome biogenesis [GO:0042254]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN3327_c0_g1_i2	Q9VNV3	DDX1_DROME	68.2	233	72	1	63	755	1	233	3.60E-90	332.8	DDX1_DROME	reviewed	ATP-dependent RNA helicase Ddx1 (DEAD box protein 1) (EC 3.6.4.13)	Ddx1 CG9054	Drosophila melanogaster (Fruit fly)	727	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; ribosome biogenesis [GO:0042254]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0001700; GO:0003682; GO:0003712; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0007283; GO:0008143; GO:0032508; GO:0033677; GO:0042254; GO:0048477	DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; ribosome biogenesis [GO:0042254]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN29251_c0_g1_i1	Q0IIK5	DDX1_BOVIN	100	71	0	0	216	4	1	71	8.50E-33	140.6	DDX1_BOVIN	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	DDX1	Bos taurus (Bovine)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; rRNA processing [GO:0006364]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006364; GO:0006388; GO:0006397; GO:0008143; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0045087; GO:0051607; GO:0071920; GO:0072669	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; rRNA processing [GO:0006364]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37547_c0_g1_i1	Q91VR5	DDX1_MOUSE	100	85	0	0	258	4	643	727	8.00E-44	177.2	DDX1_MOUSE	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	Ddx1	Mus musculus (Mouse)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0007275; GO:0008143; GO:0009615; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12657_c1_g1_i1	Q91VR5	DDX1_MOUSE	100	76	0	0	230	3	571	646	2.80E-40	165.2	DDX1_MOUSE	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	Ddx1	Mus musculus (Mouse)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0007275; GO:0008143; GO:0009615; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12657_c0_g1_i1	Q4R7L5	DDX1_MACFA	99.4	319	2	0	2	958	389	707	1.00E-192	673.7	DDX1_MACFA	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	DDX1 QtsA-14927	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0007275; GO:0008143; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29805_c0_g1_i1	Q91VR5	DDX1_MOUSE	100	96	0	0	290	3	410	505	1.80E-52	206.1	DDX1_MOUSE	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	Ddx1	Mus musculus (Mouse)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0007275; GO:0008143; GO:0009615; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10141_c0_g1_i1	Q0IIK5	DDX1_BOVIN	57.8	154	58	1	5	466	492	638	3.80E-47	189.1	DDX1_BOVIN	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	DDX1	Bos taurus (Bovine)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; rRNA processing [GO:0006364]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006364; GO:0006388; GO:0006397; GO:0008143; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0045087; GO:0051607; GO:0071920; GO:0072669	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; rRNA processing [GO:0006364]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36975_c0_g1_i1	Q92499	DDX1_HUMAN	100	106	0	0	2	319	271	376	6.80E-53	207.6	DDX1_HUMAN	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB)	DDX1	Homo sapiens (Human)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0000245; GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006446; GO:0007275; GO:0008143; GO:0010494; GO:0016020; GO:0016032; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29810_c0_g1_i1	Q92499	DDX1_HUMAN	100	84	0	0	254	3	14	97	4.30E-42	171.4	DDX1_HUMAN	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB)	DDX1	Homo sapiens (Human)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0000245; GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006446; GO:0007275; GO:0008143; GO:0010494; GO:0016020; GO:0016032; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30983_c0_g1_i1	Q92499	DDX1_HUMAN	98.7	75	1	0	225	1	125	199	2.70E-40	165.2	DDX1_HUMAN	reviewed	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB)	DDX1	Homo sapiens (Human)	740	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0000245; GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006446; GO:0007275; GO:0008143; GO:0010494; GO:0016020; GO:0016032; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2077_c0_g2_i1	Q8K363	DDX18_MOUSE	72.2	158	44	0	477	4	384	541	4.50E-64	245.4	DDX18_MOUSE	reviewed	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18)	Ddx18	Mus musculus (Mouse)	660	"chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0071392	"cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15335_c0_g2_i1	Q8K363	DDX18_MOUSE	95.3	213	0	1	611	3	292	504	8.70E-113	407.5	DDX18_MOUSE	reviewed	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18)	Ddx18	Mus musculus (Mouse)	660	"chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0071392	"cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3255_c0_g1_i1	Q8K363	DDX18_MOUSE	65.9	490	163	3	122	1585	168	655	4.40E-188	659.1	DDX18_MOUSE	reviewed	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18)	Ddx18	Mus musculus (Mouse)	660	"chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0071392	"cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39726_c0_g1_i1	Q9NVP1	DDX18_HUMAN	100	149	0	0	448	2	196	344	8.30E-81	300.8	DDX18_HUMAN	reviewed	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb)	DDX18 cPERP-D	Homo sapiens (Human)	670	"chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0071392	"cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15335_c0_g1_i1	Q9NVP1	DDX18_HUMAN	100	272	0	0	818	3	357	628	3.20E-155	548.9	DDX18_HUMAN	reviewed	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb)	DDX18 cPERP-D	Homo sapiens (Human)	670	"chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0071392	"cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29253_c0_g1_i1	Q9NUU7	DD19A_HUMAN	100	69	0	0	209	3	354	422	5.70E-32	137.5	DD19A_HUMAN	reviewed	ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A)	DDX19A DDX19L	Homo sapiens (Human)	478	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016020; GO:0016973	poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN26538_c0_g1_i1	Q9NUU7	DD19A_HUMAN	100	125	0	0	1	375	201	325	6.80E-68	257.7	DD19A_HUMAN	reviewed	ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A)	DDX19A DDX19L	Homo sapiens (Human)	478	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016020; GO:0016973	poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN31106_c0_g1_i1	Q9NUU7	DD19A_HUMAN	98.6	71	1	0	215	3	106	176	6.20E-34	144.1	DD19A_HUMAN	reviewed	ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A)	DDX19A DDX19L	Homo sapiens (Human)	478	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016020; GO:0016973	poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN37743_c0_g1_i1	Q9UMR2	DD19B_HUMAN	52.6	76	34	1	2	223	93	168	1.20E-14	80.1	DD19B_HUMAN	reviewed	ATP-dependent RNA helicase DDX19B (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B)	DDX19B DBP5 DDX19 TDBP	Homo sapiens (Human)	479	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0010494; GO:0016020; GO:0016973; GO:0070062	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN37686_c0_g1_i1	Q9UMR2	DD19B_HUMAN	100	93	0	0	1	279	75	167	8.40E-47	187.2	DD19B_HUMAN	reviewed	ATP-dependent RNA helicase DDX19B (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B)	DDX19B DBP5 DDX19 TDBP	Homo sapiens (Human)	479	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0010494; GO:0016020; GO:0016973; GO:0070062	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN34745_c0_g1_i1	Q9GZR7	DDX24_HUMAN	100	80	0	0	2	241	193	272	2.10E-39	162.5	DDX24_HUMAN	reviewed	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)	DDX24	Homo sapiens (Human)	859	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070	RNA metabolic process [GO:0016070]		NA	NA	NA	NA	NA	NA
TRINITY_DN4196_c0_g1_i1	Q9GZR7	DDX24_HUMAN	45.2	126	67	1	462	91	141	266	1.50E-19	97.4	DDX24_HUMAN	reviewed	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)	DDX24	Homo sapiens (Human)	859	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070	RNA metabolic process [GO:0016070]		NA	NA	NA	NA	NA	NA
TRINITY_DN38142_c0_g1_i1	Q9GZR7	DDX24_HUMAN	100	61	0	0	3	185	604	664	2.40E-28	125.6	DDX24_HUMAN	reviewed	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)	DDX24	Homo sapiens (Human)	859	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070	RNA metabolic process [GO:0016070]		NA	NA	NA	NA	NA	NA
TRINITY_DN27100_c0_g1_i1	Q9ESV0	DDX24_MOUSE	54.4	68	31	0	222	19	628	695	4.30E-17	88.2	DDX24_MOUSE	reviewed	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)	Ddx24	Mus musculus (Mouse)	857	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN5071_c0_g1_i1	Q9GZR7	DDX24_HUMAN	67.4	86	28	0	268	11	606	691	7.80E-26	117.5	DDX24_HUMAN	reviewed	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)	DDX24	Homo sapiens (Human)	859	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070	RNA metabolic process [GO:0016070]		blue	blue	NA	NA	NA	NA
TRINITY_DN11881_c0_g1_i1	Q8VDW0	DX39A_MOUSE	100	154	0	0	463	2	217	370	4.10E-83	308.5	DX39A_MOUSE	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39)	Ddx39a Ddx39	Mus musculus (Mouse)	427	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0016887; GO:0042802	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36497_c0_g1_i1	Q8VDW0	DX39A_MOUSE	100	67	0	0	3	203	361	427	3.90E-32	138.3	DX39A_MOUSE	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39)	Ddx39a Ddx39	Mus musculus (Mouse)	427	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0016887; GO:0042802	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25937_c0_g1_i1	Q8VDW0	DX39A_MOUSE	100	100	0	0	3	302	153	252	1.90E-52	206.1	DX39A_MOUSE	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39)	Ddx39a Ddx39	Mus musculus (Mouse)	427	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0016887; GO:0042802	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30919_c0_g1_i1	Q8VDW0	DX39A_MOUSE	100	93	0	0	279	1	16	108	5.80E-48	191	DX39A_MOUSE	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39)	Ddx39a Ddx39	Mus musculus (Mouse)	427	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0016887; GO:0042802	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g2_i1	O00148	DX39A_HUMAN	100	241	0	0	809	87	4	244	3.30E-136	485.7	DX39A_HUMAN	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)	DDX39A DDX39	Homo sapiens (Human)	427	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0031124; GO:0042802	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g2_i2	O00148	DX39A_HUMAN	100	322	0	0	1413	448	4	325	1.40E-182	640.6	DX39A_HUMAN	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)	DDX39A DDX39	Homo sapiens (Human)	427	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0031124; GO:0042802	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g2_i2	O00148	DX39A_HUMAN	100	102	0	0	359	54	326	427	6.80E-52	206.5	DX39A_HUMAN	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)	DDX39A DDX39	Homo sapiens (Human)	427	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0031124; GO:0042802	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g2_i3	O00148	DX39A_HUMAN	100	424	0	0	1325	54	4	427	2.30E-243	842.4	DX39A_HUMAN	reviewed	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)	DDX39A DDX39	Homo sapiens (Human)	427	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0031124; GO:0042802	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15908_c0_g1_i2	O00571	DDX3X_HUMAN	99.7	302	0	1	905	3	293	594	7.10E-172	604.4	DDX3X_HUMAN	reviewed	"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)"	DDX3X DBX DDX3	Homo sapiens (Human)	662	cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]	GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016032; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0031954; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043312; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1901985; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243	cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2019_c0_g1_i1	Q62095	DDX3Y_MOUSE	29.1	371	238	7	1355	276	179	535	4.20E-38	161	DDX3Y_MOUSE	reviewed	"ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (D1Pas1-related sequence 1) (DEAD box protein 3, Y-chromosomal) (DEAD-box RNA helicase DEAD2) (mDEAD2)"	Ddx3y D1Pas1-rs1 Dead2	Mus musculus (Mouse)	658	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007276; GO:0030154; GO:0043186	cell differentiation [GO:0030154]; gamete generation [GO:0007276]		NA	NA	NA	NA	NA	NA
TRINITY_DN14141_c0_g1_i1	O15523	DDX3Y_HUMAN	100	149	0	0	449	3	430	578	2.90E-81	302.4	DDX3Y_HUMAN	reviewed	"ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal)"	DDX3Y DBY	Homo sapiens (Human)	660	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007276; GO:0016020; GO:0030154; GO:0043186	cell differentiation [GO:0030154]; gamete generation [GO:0007276]		NA	NA	NA	NA	NA	NA
TRINITY_DN15908_c0_g1_i1	O15523	DDX3Y_HUMAN	98.3	302	4	1	905	3	291	592	1.80E-170	599.7	DDX3Y_HUMAN	reviewed	"ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal)"	DDX3Y DBY	Homo sapiens (Human)	660	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007276; GO:0016020; GO:0030154; GO:0043186	cell differentiation [GO:0030154]; gamete generation [GO:0007276]		NA	NA	NA	NA	NA	NA
TRINITY_DN17969_c0_g3_i1	Q5F485	DDX42_CHICK	60.4	101	40	0	305	3	522	622	6.30E-27	121.3	DDX42_CHICK	reviewed	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42)	DDX42 RCJMB04_2e15	Gallus gallus (Chicken)	944	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008104; GO:0042981	protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN3735_c0_g1_i1	Q86XP3	DDX42_HUMAN	71.9	231	65	0	2	694	249	479	4.70E-99	362.1	DDX42_HUMAN	reviewed	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125)	DDX42	Homo sapiens (Human)	938	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0042981	"mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19239_c0_g1_i1	Q86XP3	DDX42_HUMAN	100	114	0	0	344	3	249	362	3.20E-64	245.4	DDX42_HUMAN	reviewed	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125)	DDX42	Homo sapiens (Human)	938	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0042981	"mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11059_c0_g1_i1	Q86XP3	DDX42_HUMAN	81	100	19	0	301	2	527	626	2.30E-40	166	DDX42_HUMAN	reviewed	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125)	DDX42	Homo sapiens (Human)	938	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0042981	"mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37635_c0_g1_i1	Q86XP3	DDX42_HUMAN	100	71	0	0	215	3	548	618	8.20E-34	143.7	DDX42_HUMAN	reviewed	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125)	DDX42	Homo sapiens (Human)	938	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0042981	"mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17969_c0_g2_i1	Q86XP3	DDX42_HUMAN	61.3	75	29	0	232	8	264	338	4.50E-22	104.8	DDX42_HUMAN	reviewed	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125)	DDX42	Homo sapiens (Human)	938	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0042981	"mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11669_c0_g1_i1	Q6P9R1	DDX51_MOUSE	52.2	90	43	0	294	25	508	597	1.60E-19	96.7	DDX51_MOUSE	reviewed	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)	Ddx51	Mus musculus (Mouse)	639	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c28_g1_i2	Q8N8A6	DDX51_HUMAN	42.9	487	247	10	111	1493	173	654	4.50E-85	317	DDX51_HUMAN	reviewed	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)	DDX51	Homo sapiens (Human)	666	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c28_g1_i3	Q8N8A6	DDX51_HUMAN	42.8	400	200	8	111	1238	173	567	1.70E-67	258.1	DDX51_HUMAN	reviewed	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)	DDX51	Homo sapiens (Human)	666	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c28_g1_i4	Q8N8A6	DDX51_HUMAN	39.8	364	192	8	70	1095	296	654	1.30E-52	208.8	DDX51_HUMAN	reviewed	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)	DDX51	Homo sapiens (Human)	666	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN41072_c0_g1_i1	Q8N8A6	DDX51_HUMAN	98.7	77	1	0	1	231	530	606	8.50E-37	153.7	DDX51_HUMAN	reviewed	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)	DDX51	Homo sapiens (Human)	666	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN35238_c0_g1_i1	Q8TDD1	DDX54_HUMAN	100	138	0	0	2	415	68	205	6.40E-73	274.6	DDX54_HUMAN	reviewed	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)	DDX54	Homo sapiens (Human)	881	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016020; GO:0016070; GO:0030331; GO:0030520	intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31995_c0_g1_i1	Q8TDD1	DDX54_HUMAN	100	102	0	0	308	3	379	480	3.30E-52	205.3	DDX54_HUMAN	reviewed	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)	DDX54	Homo sapiens (Human)	881	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016020; GO:0016070; GO:0030331; GO:0030520	intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN4131_c0_g1_i3	Q8TDD1	DDX54_HUMAN	50.3	739	329	8	2455	269	69	779	3.60E-184	646.7	DDX54_HUMAN	reviewed	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)	DDX54	Homo sapiens (Human)	881	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016020; GO:0016070; GO:0030331; GO:0030520	intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN39734_c0_g1_i1	Q54CD8	DDX54_DICDI	60.2	181	71	1	3	545	235	414	1.90E-55	216.9	DDX54_DICDI	reviewed	ATP-dependent RNA helicase ddx54 (EC 3.6.4.13) (ATP-dependent RNA helicase helA) (DEAD box protein 54)	helA ddx54 DDB_G0292992	Dictyostelium discoideum (Slime mold)	1091	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN33226_c0_g1_i1	Q8K4L0	DDX54_MOUSE	100	69	0	0	3	209	389	457	8.70E-33	140.2	DDX54_MOUSE	reviewed	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54)	Ddx54	Mus musculus (Mouse)	874	Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016070; GO:0030331	RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5156_c0_g1_i1	Q8JHJ2	DDX55_DANRE	59.4	207	83	1	686	66	6	211	2.50E-64	246.9	DDX55_DANRE	reviewed	ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55)	ddx55	Danio rerio (Zebrafish) (Brachydanio rerio)	593	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; multicellular organism development [GO:0007275]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN5156_c0_g1_i2	Q8JHJ2	DDX55_DANRE	56.3	469	202	2	1401	1	6	473	1.20E-150	534.6	DDX55_DANRE	reviewed	ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55)	ddx55	Danio rerio (Zebrafish) (Brachydanio rerio)	593	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; multicellular organism development [GO:0007275]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN34562_c0_g1_i1	Q6ZPL9	DDX55_MOUSE	98.6	73	1	0	222	4	105	177	8.20E-37	153.7	DDX55_MOUSE	reviewed	ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55)	Ddx55 Kiaa1595	Mus musculus (Mouse)	600	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN26638_c0_g1_i1	P44586	DEAD_HAEIN	52.6	76	36	0	232	5	102	177	1.50E-15	83.2	DEAD_HAEIN	reviewed	ATP-dependent RNA helicase DeaD (EC 3.6.4.13) (Cold-shock DEAD box protein A)	deaD csdA HI_0231	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	613	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA strand annealing activity [GO:0033592]; cellular response to cold [GO:0070417]; ribosomal large subunit assembly [GO:0000027]; RNA catabolic process [GO:0006401]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA strand annealing activity [GO:0033592]	GO:0000027; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0006401; GO:0033592; GO:0070417	cellular response to cold [GO:0070417]; ribosomal large subunit assembly [GO:0000027]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN16355_c0_g1_i1	P0CE10	DEAHB_ARATH	57.9	126	52	1	27	404	551	675	9.00E-34	144.4	DEAHB_ARATH	reviewed	"ATP-dependent RNA helicase DEAH11, chloroplastic (EC 3.6.4.13)"	At4g01020 F3I3.40	Arabidopsis thaliana (Mouse-ear cress)	1787	chloroplast [GO:0009507]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transferase activity [GO:0016740]	chloroplast [GO:0009507]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transferase activity [GO:0016740]	GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4024_c0_g1_i2	F4KGU4	DEAHC_ARATH	51.6	64	31	0	14	205	298	361	1.60E-12	73.2	DEAHC_ARATH	reviewed	"ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)"	At5g10370 F12B17_280	Arabidopsis thaliana (Mouse-ear cress)	1775	chloroplast [GO:0009507]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transferase activity [GO:0016740]	chloroplast [GO:0009507]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transferase activity [GO:0016740]	GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17660_c0_g1_i1	Q9C813	DEAHD_ARATH	53.1	81	34	1	243	1	322	398	5.30E-19	94.7	DEAHD_ARATH	reviewed	ATP-dependent RNA helicase DEAH13 (EC 3.6.4.13) (Protein FASCIATED STEM 4) (AtFAS4)	FAS4 At1g33390 F10C21.6 T16O9.12	Arabidopsis thaliana (Mouse-ear cress)	1237	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24166_c0_g4_i1	A7EJY3	DED1_SCLS1	57.9	261	109	1	785	3	317	576	2.90E-76	286.6	DED1_SCLS1	reviewed	ATP-dependent RNA helicase ded1 (EC 3.6.4.13)	ded1 SS1G_05629	Sclerotinia sclerotiorum (strain ATCC 18683 / 1980 / Ss-1) (White mold) (Whetzelinia sclerotiorum)	678	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN24166_c0_g3_i1	Q0UWA6	DED1_PHANO	56.2	64	24	1	204	13	212	271	2.80E-14	79	DED1_PHANO	reviewed	ATP-dependent RNA helicase DED1 (EC 3.6.4.13)	DED1 SNOG_03958	Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) (Glume blotch fungus) (Parastagonospora nodorum)	696	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN19233_c0_g1_i1	Q8TFK8	DED1_CANGA	64.5	107	37	1	11	331	284	389	1.30E-33	143.7	DED1_CANGA	reviewed	ATP-dependent RNA helicase DED1 (EC 3.6.4.13)	DED1 CAGL0L02915g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	617	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003724; GO:0003743; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN19233_c0_g1_i2	A1CH78	DED1_ASPCL	73.4	79	21	0	11	247	332	410	1.60E-26	119.8	DED1_ASPCL	reviewed	ATP-dependent RNA helicase ded1 (EC 3.6.4.13)	ded1 ACLA_046980	Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1)	681	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003724; GO:0003743; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN18097_c0_g1_i1	Q6BU54	DED1_DEBHA	61.5	117	43	1	354	4	284	398	1.80E-33	143.3	DED1_DEBHA	reviewed	ATP-dependent RNA helicase DED1 (EC 3.6.4.13)	DED1 DEHA2C13486g	Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii)	630	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003724; GO:0003743; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN18097_c0_g2_i1	A7TKR8	DED1_VANPO	65.1	106	36	1	332	15	440	544	1.90E-29	129.8	DED1_VANPO	reviewed	ATP-dependent RNA helicase DED1 (EC 3.6.4.13)	DED1 Kpol_1072p50	Vanderwaltozyma polyspora (strain ATCC 22028 / DSM 70294) (Kluyveromyces polysporus)	650	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ATP binding [GO:0005524]; eukaryotic initiation factor 4G binding [GO:0031370]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; RNA strand annealing activity [GO:0033592]; translation initiation factor activity [GO:0003743]; positive regulation of formation of translation preinitiation complex [GO:1901195]; spliceosomal complex disassembly [GO:0000390]	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	ATP binding [GO:0005524]; eukaryotic initiation factor 4G binding [GO:0031370]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; RNA strand annealing activity [GO:0033592]; translation initiation factor activity [GO:0003743]	GO:0000390; GO:0003724; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0010494; GO:0031370; GO:0033592; GO:1901195	positive regulation of formation of translation preinitiation complex [GO:1901195]; spliceosomal complex disassembly [GO:0000390]		NA	NA	NA	NA	NA	NA
TRINITY_DN34729_c0_g1_i1	Q9P6U9	DED1_NEUCR	55.1	78	35	0	244	11	492	569	7.00E-21	100.9	DED1_NEUCR	reviewed	ATP-dependent RNA helicase ded1 (EC 3.6.4.13) (DEAD box RNA helicase 9)	drh-9 ded1 15E6.040 NCU01369	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	688	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN35406_c0_g1_i1	Q8SQK9	DHH1_ENCCU	45.9	159	81	3	485	12	111	265	2.20E-31	136.7	DHH1_ENCCU	reviewed	ATP-dependent RNA helicase DHH1 (EC 3.6.4.13)	DHH1 ECU09_1640	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	487	P-body [GO:0000932]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]	P-body [GO:0000932]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000932; GO:0003723; GO:0003724; GO:0005524; GO:0006397; GO:0006417; GO:0051028	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN34090_c0_g1_i1	Q8SQK9	DHH1_ENCCU	57.8	90	38	0	2	271	362	451	5.00E-24	111.7	DHH1_ENCCU	reviewed	ATP-dependent RNA helicase DHH1 (EC 3.6.4.13)	DHH1 ECU09_1640	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	487	P-body [GO:0000932]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]	P-body [GO:0000932]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000932; GO:0003723; GO:0003724; GO:0005524; GO:0006397; GO:0006417; GO:0051028	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN26344_c0_g1_i1	Q99PU8	DHX30_MOUSE	100	65	0	0	195	1	726	790	2.70E-30	132.1	DHX30_MOUSE	reviewed	ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)	Dhx30 Helg	Mus musculus (Mouse)	1217	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003682; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0007417; GO:0035770; GO:0042645; GO:1902775	central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]		NA	NA	NA	NA	NA	NA
TRINITY_DN34500_c0_g1_i1	Q7L2E3	DHX30_HUMAN	100	146	0	0	439	2	448	593	5.50E-77	288.1	DHX30_HUMAN	reviewed	ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)	DHX30 DDX30 KIAA0890	Homo sapiens (Human)	1194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003682; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0007417; GO:0035770; GO:0042645; GO:1902775	central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]		NA	NA	NA	NA	NA	NA
TRINITY_DN31434_c0_g1_i1	Q7L2E3	DHX30_HUMAN	97.3	74	2	0	1	222	691	764	5.50E-34	144.4	DHX30_HUMAN	reviewed	ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)	DHX30 DDX30 KIAA0890	Homo sapiens (Human)	1194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003682; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0007417; GO:0035770; GO:0042645; GO:1902775	central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i1	Q9H6R0	DHX33_HUMAN	55.4	574	252	3	2034	316	70	640	7.20E-176	619	DHX33_HUMAN	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	DHX33 DDX33	Homo sapiens (Human)	707	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i1	Q9H6R0	DHX33_HUMAN	55	80	36	0	340	101	622	701	4.30E-19	98.2	DHX33_HUMAN	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	DHX33 DDX33	Homo sapiens (Human)	707	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i2	Q9H6R0	DHX33_HUMAN	56.5	556	238	3	2312	648	70	622	8.90E-175	615.5	DHX33_HUMAN	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	DHX33 DDX33	Homo sapiens (Human)	707	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i2	Q9H6R0	DHX33_HUMAN	55	80	36	0	340	101	622	701	4.80E-19	98.2	DHX33_HUMAN	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	DHX33 DDX33	Homo sapiens (Human)	707	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i3	Q80VY9	DHX33_MOUSE	49.2	181	92	0	643	101	512	692	9.70E-47	188.3	DHX33_MOUSE	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	Dhx33	Mus musculus (Mouse)	698	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i4	Q9H6R0	DHX33_HUMAN	56.2	635	274	3	2002	101	70	701	9.80E-202	704.9	DHX33_HUMAN	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	DHX33 DDX33	Homo sapiens (Human)	707	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN871_c0_g1_i5	Q80VY9	DHX33_MOUSE	55	80	36	0	340	101	613	692	9.10E-20	99	DHX33_MOUSE	reviewed	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	Dhx33	Mus musculus (Mouse)	698	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN39379_c0_g1_i1	Q54F05	DHX8_DICDI	59.6	89	36	0	2	268	1054	1142	5.80E-29	127.9	DHX8_DICDI	reviewed	ATP-dependent RNA helicase dhx8 (EC 3.6.4.13) (DEAH box protein 8)	dhx8 prp22 DDB_G0291183	Dictyostelium discoideum (Slime mold)	1160	catalytic step 2 spliceosome [GO:0071013]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; spliceosomal complex disassembly [GO:0000390]	catalytic step 2 spliceosome [GO:0071013]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000390; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0071013	spliceosomal complex disassembly [GO:0000390]		NA	NA	NA	NA	NA	NA
TRINITY_DN39205_c0_g1_i1	Q14562	DHX8_HUMAN	71.9	565	157	2	3	1697	550	1112	6.10E-241	834.7	DHX8_HUMAN	reviewed	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1)	DHX8 DDX8	Homo sapiens (Human)	1220	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0016604; GO:0042802; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39918_c0_g1_i1	Q14562	DHX8_HUMAN	62.2	74	27	1	1	222	631	703	9.20E-20	97.1	DHX8_HUMAN	reviewed	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1)	DHX8 DDX8	Homo sapiens (Human)	1220	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0016604; GO:0042802; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31793_c0_g1_i1	Q14562	DHX8_HUMAN	100	84	0	0	254	3	561	644	2.20E-41	169.1	DHX8_HUMAN	reviewed	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1)	DHX8 DDX8	Homo sapiens (Human)	1220	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0016604; GO:0042802; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29911_c0_g1_i1	A1Z9L3	DHX8_DROME	87.1	559	72	0	1679	3	568	1126	1.80E-285	982.6	DHX8_DROME	reviewed	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (Peanuts)	pea Prp22 CG8241	Drosophila melanogaster (Fruit fly)	1242	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000381; GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006325; GO:0007419; GO:0030261; GO:0048477; GO:0071011; GO:0071013	"chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26528_c0_g1_i1	A1Z9L3	DHX8_DROME	94.6	92	5	0	278	3	1132	1223	2.90E-47	188.7	DHX8_DROME	reviewed	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (Peanuts)	pea Prp22 CG8241	Drosophila melanogaster (Fruit fly)	1242	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000381; GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006325; GO:0007419; GO:0030261; GO:0048477; GO:0071011; GO:0071013	"chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28016_c0_g1_i1	P0CQ71	IF4A_CRYNB	43	79	43	2	241	5	138	214	1.30E-11	70.1	IF4A_CRYNB	reviewed	ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1)	TIF1 TIF41 CNBA7450	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	401	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003724; GO:0003743; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6994_c0_g1_i1	Q8SQM5	IF4A_ENCCU	47.5	120	63	0	361	2	306	425	1.70E-28	126.7	IF4A_ENCCU	reviewed	ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1)	TIF1 TIF41 ECU09_1200	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003724; GO:0003743; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23263_c0_g1_i1	P47943	IF4A_SCHPO	90.1	81	8	0	3	245	312	392	9.90E-36	150.2	IF4A_SCHPO	reviewed	ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1)	tif1 tif41 SPAC1006.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	392	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003724; GO:0003743; GO:0005524; GO:0005829; GO:0010494; GO:0016281	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN38841_c0_g1_i1	P47943	IF4A_SCHPO	73.1	383	103	0	1	1149	10	392	1.60E-166	587	IF4A_SCHPO	reviewed	ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1)	tif1 tif41 SPAC1006.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	392	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003724; GO:0003743; GO:0005524; GO:0005829; GO:0010494; GO:0016281	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN34591_c0_g1_i1	Q8SQM5	IF4A_ENCCU	62.2	90	34	0	279	10	40	129	1.60E-22	106.7	IF4A_ENCCU	reviewed	ATP-dependent RNA helicase eIF4A (EC 3.6.4.13) (Eukaryotic initiation factor 4A) (eIF-4A) (Translation initiation factor 1)	TIF1 TIF41 ECU09_1200	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003724; GO:0003743; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN27746_c0_g1_i1	A5DE68	FAL1_PICGU	51	104	38	1	313	2	302	392	8.20E-20	97.8	FAL1_PICGU	reviewed	ATP-dependent RNA helicase FAL1 (EC 3.6.4.13)	FAL1 PGUG_01569	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	397	"FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"FAL1-SGD1 complex [GO:0097078]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030688; GO:0097078	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40530_c0_g1_i1	Q5A9Z6	FAL1_CANAL	46.2	78	42	0	21	254	304	381	1.00E-15	84	FAL1_CANAL	reviewed	ATP-dependent RNA helicase FAL1 (EC 3.6.4.13)	FAL1 CAALFM_C105640CA CaO19.10024 CaO19.2488	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	399	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005730; GO:0006364; GO:0071013	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2077_c0_g1_i1	Q09916	HAS1_SCHPO	72.9	181	48	1	1	540	98	278	3.40E-68	259.2	HAS1_SCHPO	reviewed	ATP-dependent RNA helicase has1 (EC 3.6.4.13)	has1 SPAC1F7.02c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	578	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; rRNA processing [GO:0006364]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24165_c0_g1_i1	P0CQ85	HAS1_CRYNB	64.2	81	28	1	244	5	418	498	4.40E-23	108.2	HAS1_CRYNB	reviewed	ATP-dependent RNA helicase HAS1 (EC 3.6.4.13)	HAS1 CNBB4650	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	607	"nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; snoRNA release from pre-rRNA [GO:1990417]"	"nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005635; GO:0005730; GO:0008186; GO:0030687; GO:0042802; GO:1990417	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; snoRNA release from pre-rRNA [GO:1990417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38437_c0_g1_i1	P43329	HRPA_ECOLI	72.3	65	18	0	7	201	331	395	1.40E-19	96.3	HRPA_ECOLI	reviewed	ATP-dependent RNA helicase HrpA (EC 3.6.4.13)	hrpA b1413 JW5905	Escherichia coli (strain K12)	1300	"ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mRNA processing [GO:0006397]; RNA modification [GO:0009451]"		ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0006397; GO:0009451	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mRNA processing [GO:0006397]; RNA modification [GO:0009451]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34027_c0_g1_i1	P43329	HRPA_ECOLI	68.2	110	35	0	3	332	139	248	4.70E-36	151.8	HRPA_ECOLI	reviewed	ATP-dependent RNA helicase HrpA (EC 3.6.4.13)	hrpA b1413 JW5905	Escherichia coli (strain K12)	1300	"ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mRNA processing [GO:0006397]; RNA modification [GO:0009451]"		ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0006397; GO:0009451	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mRNA processing [GO:0006397]; RNA modification [GO:0009451]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39348_c0_g1_i1	P37024	HRPB_ECOLI	53.2	79	37	0	19	255	239	317	2.10E-15	82.8	HRPB_ECOLI	reviewed	ATP-dependent RNA helicase HrpB (EC 3.6.4.13)	hrpB yadO b0148 JW0144	Escherichia coli (strain K12)	809	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]		ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN39181_c0_g1_i1	P23128	DDX6_DROME	79	438	71	2	202	1476	30	459	5.30E-199	695.3	DDX6_DROME	reviewed	ATP-dependent RNA helicase me31b (EC 3.6.4.13) (Maternal expression at 31B)	me31B CG4916	Drosophila melanogaster (Fruit fly)	459	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; P-body assembly [GO:0033962]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P-body [GO:0000932]; P granule [GO:0043186]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000290; GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005783; GO:0007279; GO:0010494; GO:0030707; GO:0033962; GO:0034063; GO:0035195; GO:0036464; GO:0043025; GO:0043186; GO:0046959; GO:0050688; GO:0060148; GO:0071598; GO:0071683; GO:0090328; GO:0098794; GO:0150011; GO:1905618; GO:1990120; GO:1990124; GO:2000766	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; P-body assembly [GO:0033962]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]		blue	blue	NA	NA	NA	NA
TRINITY_DN39513_c0_g1_i1	Q8PFZ3	RHLB_XANAC	50.7	73	36	0	9	227	276	348	2.80E-16	85.5	RHLB_XANAC	reviewed	ATP-dependent RNA helicase RhlB (EC 3.6.4.13)	rhlB XAC3829	Xanthomonas axonopodis pv. citri (strain 306)	571	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0006401	RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN30120_c0_g1_i1	P25888	RHLE_ECOLI	57.7	104	44	0	335	24	109	212	8.30E-25	114.4	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	1
TRINITY_DN35879_c0_g1_i1	P25888	RHLE_ECOLI	67.6	105	34	0	316	2	98	202	6.40E-35	147.9	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN40603_c0_g1_i1	P25888	RHLE_ECOLI	75.2	109	27	0	328	2	269	377	6.00E-44	177.9	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN38525_c0_g1_i1	P25888	RHLE_ECOLI	60.6	99	39	0	297	1	268	366	1.20E-27	123.6	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN5869_c0_g2_i1	P25888	RHLE_ECOLI	57.5	87	37	0	265	5	109	195	3.70E-21	102.1	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN5869_c0_g1_i1	P25888	RHLE_ECOLI	54.7	95	43	0	294	10	95	189	2.60E-22	105.9	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN30888_c0_g1_i1	P25888	RHLE_ECOLI	57.7	104	44	0	3	314	267	370	2.70E-28	125.9	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN38725_c0_g1_i1	P25888	RHLE_ECOLI	64.2	134	48	0	1	402	78	211	3.80E-40	165.6	RHLE_ECOLI	reviewed	ATP-dependent RNA helicase RhlE (EC 3.6.4.13)	rhlE b0797 JW0781	Escherichia coli (strain K12)	454	cytosol [GO:0005829]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; response to heat [GO:0009408]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0009408; GO:0042255	response to heat [GO:0009408]; ribosome assembly [GO:0042255]		NA	NA	NA	NA	NA	NA
TRINITY_DN36362_c0_g1_i1	Q75AE1	ROK1_ASHGO	60.2	171	68	0	513	1	342	512	1.80E-58	226.9	ROK1_ASHGO	reviewed	ATP-dependent RNA helicase ROK1 (EC 3.6.4.13)	ROK1 ADL024C	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	569	"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; snoRNA localization [GO:0048254]"	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]	GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0008186; GO:0030490; GO:0048254	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; snoRNA localization [GO:0048254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37103_c0_g1_i1	Q0CGJ9	SUB2_ASPTN	43.4	76	30	2	2	208	236	305	4.70E-10	64.7	SUB2_ASPTN	reviewed	ATP-dependent RNA helicase sub2 (EC 3.6.4.13)	sub2 ATEG_07193	Aspergillus terreus (strain NIH 2624 / FGSC A1156)	438	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0051028	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN34427_c0_g1_i1	Q80YD1	SUV3_MOUSE	100	76	0	0	3	230	172	247	2.40E-39	162.2	SUV3_MOUSE	reviewed	"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)"	Supv3l1 Suv3l1	Mus musculus (Mouse)	779	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA helicase activity [GO:0003724]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN40550_c0_g1_i1	Q5EBA1	SUV3_RAT	98.3	121	2	0	2	364	364	484	5.80E-64	244.6	SUV3_RAT	reviewed	"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)"	Supv3l1	Rattus norvegicus (Rat)	776	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA helicase activity [GO:0003724]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN557_c1_g1_i2	Q8IYB8	SUV3_HUMAN	59	39	16	0	165	49	645	683	7.60E-07	54.3	SUV3_HUMAN	reviewed	"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)"	SUPV3L1 SUV3	Homo sapiens (Human)	786	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN557_c1_g1_i8	A4IG62	SUV3_DANRE	48.1	54	27	1	226	68	62	115	2.00E-07	57	SUV3_DANRE	reviewed	"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)"	supv3l1	Danio rerio (Zebrafish) (Brachydanio rerio)	763	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; liver development [GO:0001889]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0001889; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; liver development [GO:0001889]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN28152_c0_g1_i1	Q8IYB8	SUV3_HUMAN	100	69	0	0	209	3	187	255	2.90E-36	151.8	SUV3_HUMAN	reviewed	"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)"	SUPV3L1 SUV3	Homo sapiens (Human)	786	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN27385_c0_g1_i1	Q8IYB8	SUV3_HUMAN	100	185	0	0	558	4	483	667	2.70E-105	382.5	SUV3_HUMAN	reviewed	"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)"	SUPV3L1 SUV3	Homo sapiens (Human)	786	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN557_c1_g1_i4	Q9VN03	SUV3_DROME	62.3	726	239	4	2273	102	48	740	4.50E-266	918.7	SUV3_DROME	reviewed	"ATP-dependent RNA helicase SUV3 homolog, mitochondrial (EC 3.6.4.13)"	Suv3 CG9791	Drosophila melanogaster (Fruit fly)	763	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]	GO:0000963; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005739; GO:0005759; GO:0006401; GO:0032508; GO:0044528; GO:0045025; GO:0070131; GO:0090646; GO:0097222	DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN557_c1_g1_i5	Q9VN03	SUV3_DROME	62.3	726	239	4	2273	102	48	740	4.70E-266	918.7	SUV3_DROME	reviewed	"ATP-dependent RNA helicase SUV3 homolog, mitochondrial (EC 3.6.4.13)"	Suv3 CG9791	Drosophila melanogaster (Fruit fly)	763	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]	GO:0000963; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005739; GO:0005759; GO:0006401; GO:0032508; GO:0044528; GO:0045025; GO:0070131; GO:0090646; GO:0097222	DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN557_c1_g1_i6	Q9VN03	SUV3_DROME	63.8	640	197	4	2015	102	134	740	8.80E-239	827.8	SUV3_DROME	reviewed	"ATP-dependent RNA helicase SUV3 homolog, mitochondrial (EC 3.6.4.13)"	Suv3 CG9791	Drosophila melanogaster (Fruit fly)	763	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]	GO:0000963; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005739; GO:0005759; GO:0006401; GO:0032508; GO:0044528; GO:0045025; GO:0070131; GO:0090646; GO:0097222	DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i3	Q8NDG6	TDRD9_HUMAN	31.1	705	412	22	2077	35	640	1294	3.40E-76	287.7	TDRD9_HUMAN	reviewed	ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)	TDRD9 C14orf75	Homo sapiens (Human)	1382	cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071547	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i5	Q8NDG6	TDRD9_HUMAN	30.9	698	408	22	2057	36	640	1287	4.80E-75	283.9	TDRD9_HUMAN	reviewed	ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)	TDRD9 C14orf75	Homo sapiens (Human)	1382	cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071547	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i6	B8A4F4	TDRD9_DANRE	32.5	431	257	11	1271	36	833	1248	2.60E-48	194.9	TDRD9_DANRE	reviewed	ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)	tdrd9 si:dkey-15f17.9	Danio rerio (Zebrafish) (Brachydanio rerio)	1342	nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]; piP-body [GO:0071547]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071547	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i8	B8A4F4	TDRD9_DANRE	32.5	431	257	11	1271	36	833	1248	2.10E-48	194.9	TDRD9_DANRE	reviewed	ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)	tdrd9 si:dkey-15f17.9	Danio rerio (Zebrafish) (Brachydanio rerio)	1342	nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]; piP-body [GO:0071547]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071547	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i9	B8A4F4	TDRD9_DANRE	32.6	438	261	11	1291	35	833	1255	1.90E-49	198.4	TDRD9_DANRE	reviewed	ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)	tdrd9 si:dkey-15f17.9	Danio rerio (Zebrafish) (Brachydanio rerio)	1342	nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]; piP-body [GO:0071547]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071547	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN30906_c0_g1_i1	O13792	SUB2_SCHPO	52.3	88	37	1	2	265	56	138	5.20E-14	78.2	SUB2_SCHPO	reviewed	ATP-dependent RNA helicase uap56 (EC 3.6.4.13)	uap56 sub2 SPAC17G6.14c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	434	"nucleus [GO:0005634]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; transcription export complex [GO:0000346]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006406; GO:0031124	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1484_c0_g2_i1	Q27268	DX39B_DROME	68.3	388	116	2	1180	17	32	412	1.20E-153	544.3	DX39B_DROME	reviewed	ATP-dependent RNA helicase WM6 (DEAD box protein UAP56) (Dmrnahel) (EC 3.6.4.13) (HEL/UAP56)	Hel25E Dbp25F hel WM6 CG7269	Drosophila melanogaster (Fruit fly)	424	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin remodeling [GO:0006338]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000346; GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006338; GO:0006406; GO:0016607	"chromatin remodeling [GO:0006338]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14377_c0_g1_i1	Q4IFI0	RRP3_GIBZE	50.6	79	27	1	203	3	363	441	2.80E-12	72	RRP3_GIBZE	reviewed	ATP-dependent rRNA helicase RRP3 (EC 3.6.4.13)	RRP3 FGRRES_04028 FGSG_04028	Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)	486	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN39639_c0_g1_i1	Q8SR63	RRP3_ENCCU	47.8	92	44	2	4	276	267	355	2.60E-16	85.9	RRP3_ENCCU	reviewed	ATP-dependent rRNA helicase RRP3 (EC 3.6.4.13)	RRP3 ECU10_0440	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	400	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN33722_c0_g1_i1	Q4WJE9	RRP3_ASPFU	58.5	65	27	0	235	41	53	117	3.50E-15	82	RRP3_ASPFU	reviewed	ATP-dependent rRNA helicase rrp3 (EC 3.6.4.13)	rrp3 AFUA_1G06220	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	472	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31826_c0_g1_i1	Q4P9E5	SPB4_USTMA	52.7	91	43	0	299	27	210	300	1.30E-19	97.1	SPB4_USTMA	reviewed	ATP-dependent rRNA helicase SPB4 (EC 3.6.4.13)	SPB4 UMAG_03268	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	767	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN38574_c0_g1_i1	P43245	MDR1_RAT	64.7	133	45	2	400	8	486	618	1.50E-36	153.7	MDR1_RAT	reviewed	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	Abcb1 Mdr1 Mdr1b Pgy1	Rattus norvegicus (Rat)	1277	apical plasma membrane [GO:0016324]; external side of apical plasma membrane [GO:0098591]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; brain development [GO:0007420]; cellular response to external biotic stimulus [GO:0071217]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; lactation [GO:0007595]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to genistein [GO:0033595]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]; response to vitamin A [GO:0033189]; Sertoli cell barrier remodeling [GO:0061843]	apical plasma membrane [GO:0016324]; external side of apical plasma membrane [GO:0098591]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]	GO:0000139; GO:0001666; GO:0001890; GO:0005524; GO:0005886; GO:0007420; GO:0007595; GO:0008559; GO:0010046; GO:0010212; GO:0014045; GO:0014070; GO:0016021; GO:0016324; GO:0016887; GO:0032496; GO:0033189; GO:0033595; GO:0042493; GO:0042626; GO:0045332; GO:0046581; GO:0046685; GO:0048545; GO:0061843; GO:0071217; GO:0071356; GO:0090554; GO:0090555; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140328; GO:1903416	brain development [GO:0007420]; cellular response to external biotic stimulus [GO:0071217]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; lactation [GO:0007595]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to genistein [GO:0033595]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]; response to vitamin A [GO:0033189]; Sertoli cell barrier remodeling [GO:0061843]		NA	NA	NA	NA	NA	NA
TRINITY_DN4652_c0_g1_i2	P43245	MDR1_RAT	75.5	110	27	0	27	356	1162	1271	3.80E-37	155.6	MDR1_RAT	reviewed	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	Abcb1 Mdr1 Mdr1b Pgy1	Rattus norvegicus (Rat)	1277	apical plasma membrane [GO:0016324]; external side of apical plasma membrane [GO:0098591]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; brain development [GO:0007420]; cellular response to external biotic stimulus [GO:0071217]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; lactation [GO:0007595]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to genistein [GO:0033595]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]; response to vitamin A [GO:0033189]; Sertoli cell barrier remodeling [GO:0061843]	apical plasma membrane [GO:0016324]; external side of apical plasma membrane [GO:0098591]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]	GO:0000139; GO:0001666; GO:0001890; GO:0005524; GO:0005886; GO:0007420; GO:0007595; GO:0008559; GO:0010046; GO:0010212; GO:0014045; GO:0014070; GO:0016021; GO:0016324; GO:0016887; GO:0032496; GO:0033189; GO:0033595; GO:0042493; GO:0042626; GO:0045332; GO:0046581; GO:0046685; GO:0048545; GO:0061843; GO:0071217; GO:0071356; GO:0090554; GO:0090555; GO:0097327; GO:0098591; GO:0099038; GO:0099040; GO:0140328; GO:1903416	brain development [GO:0007420]; cellular response to external biotic stimulus [GO:0071217]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; lactation [GO:0007595]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to genistein [GO:0033595]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]; response to vitamin A [GO:0033189]; Sertoli cell barrier remodeling [GO:0061843]		NA	NA	NA	NA	NA	NA
TRINITY_DN4652_c0_g2_i1	P08183	MDR1_HUMAN	59.6	319	128	1	14	970	330	647	1.70E-103	377.5	MDR1_HUMAN	reviewed	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	ABCB1 MDR1 PGY1	Homo sapiens (Human)	1280	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transporter activity [GO:0005215]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transporter activity [GO:0005215]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000086; GO:0005215; GO:0005524; GO:0005886; GO:0008559; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0031625; GO:0042493; GO:0042626; GO:0042910; GO:0045332; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0150104; GO:1901529; GO:1990962; GO:2001225	ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN27126_c0_g1_i1	P21447	MDR1A_MOUSE	100	111	0	0	1	333	491	601	5.00E-54	211.5	MDR1A_MOUSE	reviewed	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)	Abcb1a Abcb4 Mdr1a Mdr3 Pgy-3 Pgy3	Mus musculus (Mouse)	1276	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; carbohydrate export [GO:0033231]; ceramide translocation [GO:0099040]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000086; GO:0005524; GO:0005886; GO:0008559; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0031526; GO:0031625; GO:0033231; GO:0035633; GO:0042626; GO:0042910; GO:0043215; GO:0045177; GO:0045332; GO:0046581; GO:0047484; GO:0050892; GO:0055085; GO:0060548; GO:0060856; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1904446; GO:1904478; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225	carbohydrate export [GO:0033231]; ceramide translocation [GO:0099040]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN4652_c0_g1_i1	P21447	MDR1A_MOUSE	69.9	236	71	0	29	736	1031	1266	1.50E-88	327.4	MDR1A_MOUSE	reviewed	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1)	Abcb1a Abcb4 Mdr1a Mdr3 Pgy-3 Pgy3	Mus musculus (Mouse)	1276	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; carbohydrate export [GO:0033231]; ceramide translocation [GO:0099040]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000086; GO:0005524; GO:0005886; GO:0008559; GO:0009914; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0031526; GO:0031625; GO:0033231; GO:0035633; GO:0042626; GO:0042910; GO:0043215; GO:0045177; GO:0045332; GO:0046581; GO:0047484; GO:0050892; GO:0055085; GO:0060548; GO:0060856; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1902396; GO:1904446; GO:1904478; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225	carbohydrate export [GO:0033231]; ceramide translocation [GO:0099040]; daunorubicin transport [GO:0043215]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; regulation of response to osmotic stress [GO:0047484]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN38678_c0_g1_i1	P06795	MDR1B_MOUSE	51.3	76	37	0	228	1	1042	1117	1.80E-15	82.8	MDR1B_MOUSE	reviewed	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	Abcb1b Abcb1 Mdr1 Mdr1b Pgy1 Pgy1-1	Mus musculus (Mouse)	1276	apical plasma membrane [GO:0016324]; external side of apical plasma membrane [GO:0098591]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; phospholipid translocation [GO:0045332]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843]	apical plasma membrane [GO:0016324]; external side of apical plasma membrane [GO:0098591]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; ceramide floppase activity [GO:0099038]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]	GO:0000139; GO:0005524; GO:0005739; GO:0005886; GO:0008559; GO:0014045; GO:0016021; GO:0016324; GO:0016887; GO:0042493; GO:0042626; GO:0045332; GO:0046581; GO:0061843; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140328	ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; phospholipid translocation [GO:0045332]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843]		NA	NA	NA	NA	NA	NA
TRINITY_DN25734_c0_g1_i1	B2UE66	FTSH_RALPJ	89.5	229	24	0	689	3	264	492	3.10E-111	402.5	FTSH_RALPJ	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Rpic_1702	Ralstonia pickettii (strain 12J)	714	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN31225_c0_g1_i1	O83746	FTSH_TREPA	76.9	65	15	0	197	3	255	319	2.20E-23	109	FTSH_TREPA	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH TP_0765	Treponema pallidum (strain Nichols)	609	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN37073_c0_g1_i1	D1CDT8	FTSH_THET1	62.9	70	25	1	218	9	309	377	1.60E-16	86.3	FTSH_THET1	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Tter_0172	Thermobaculum terrenum (strain ATCC BAA-798 / YNP1)	646	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN13782_c0_g1_i1	C1F8X6	FTSH_ACIC5	91.4	70	6	0	2	211	251	320	1.50E-32	139.4	FTSH_ACIC5	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH ACP_2036	Acidobacterium capsulatum (strain ATCC 51196 / DSM 11244 / JCM 7670 / NBRC 15755 / NCIMB 13165 / 161)	639	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN29852_c0_g1_i1	B2UE66	FTSH_RALPJ	100	285	0	0	2	856	255	539	4.30E-158	558.5	FTSH_RALPJ	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Rpic_1702	Ralstonia pickettii (strain 12J)	714	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN987_c0_g1_i1	C8WEG0	FTSH_ZYMMN	90.7	247	23	0	744	4	174	420	8.30E-126	451.1	FTSH_ZYMMN	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Za10_1558	Zymomonas mobilis subsp. mobilis (strain NCIMB 11163 / B70)	662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN987_c0_g1_i2	C8WEG0	FTSH_ZYMMN	90.7	247	23	0	744	4	174	420	4.10E-125	448.7	FTSH_ZYMMN	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Za10_1558	Zymomonas mobilis subsp. mobilis (strain NCIMB 11163 / B70)	662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN987_c0_g1_i4	C8WEG0	FTSH_ZYMMN	89.5	105	11	0	315	1	317	421	1.50E-47	189.9	FTSH_ZYMMN	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Za10_1558	Zymomonas mobilis subsp. mobilis (strain NCIMB 11163 / B70)	662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN987_c0_g2_i1	C8WEG0	FTSH_ZYMMN	93.3	135	9	0	408	4	230	364	2.40E-67	256.1	FTSH_ZYMMN	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Za10_1558	Zymomonas mobilis subsp. mobilis (strain NCIMB 11163 / B70)	662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN38778_c0_g1_i1	Q1LLA9	FTSH_CUPMC	96.9	318	10	0	957	4	155	472	1.30E-176	620.2	FTSH_CUPMC	reviewed	ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)	ftsH Rmet_2188	Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) (Ralstonia metallidurans)	649	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein catabolic process [GO:0030163]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0008270; GO:0016021; GO:0030163	protein catabolic process [GO:0030163]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN17251_c0_g1_i1	O80983	FTSH4_ARATH	59.1	88	36	0	280	17	245	332	6.50E-23	107.8	FTSH4_ARATH	reviewed	"ATP-dependent zinc metalloprotease FTSH 4, mitochondrial (AtFTSH4) (EC 3.4.24.-)"	FTSH4 At2g26140 T19L18.5	Arabidopsis thaliana (Mouse-ear cress)	717	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plastid [GO:0009536]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; meristem maintenance [GO:0010073]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plastid [GO:0009536]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0009536; GO:0010073; GO:0016021; GO:0046872	meristem maintenance [GO:0010073]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN30301_c0_g1_i1	Q8LQJ8	FTSH5_ORYSJ	65.9	167	57	0	3	503	241	407	1.30E-61	237.3	FTSH5_ORYSJ	reviewed	"ATP-dependent zinc metalloprotease FTSH 5, mitochondrial (OsFTSH5) (EC 3.4.24.-)"	FTSH5 Os01g0574500 LOC_Os01g39260 B1151A10.26-1 OsJ_002241	Oryza sativa subsp. japonica (Rice)	715	membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]	membrane [GO:0016020]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0006508; GO:0016020; GO:0046872	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN21963_c0_g1_i1	Q67WJ2	FTSH6_ORYSJ	61.3	119	45	1	3	356	235	353	4.20E-36	152.1	FTSH6_ORYSJ	reviewed	"ATP-dependent zinc metalloprotease FTSH 6, chloroplastic (OsFTSH6) (EC 3.4.24.-)"	FTSH6 Os06g0229066 LOC_Os06g12370 OsJ_019841 P0425F05.40 P0525F01.10	Oryza sativa subsp. japonica (Rice)	686	chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]	chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0006508; GO:0009535; GO:0016021; GO:0046872	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN7731_c0_g1_i1	F3YDF1	YMEL1_DROME	69.6	115	33	1	1	345	583	695	2.10E-40	166.4	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN7731_c0_g1_i2	F3YDF1	YMEL1_DROME	77	61	14	0	1	183	583	643	3.80E-22	105.1	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		blue	blue	NA	NA	NA	NA
TRINITY_DN7731_c0_g1_i3	F3YDF1	YMEL1_DROME	67.7	133	41	1	1	399	583	713	2.00E-46	186.4	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN5771_c0_g1_i1	F3YDF1	YMEL1_DROME	62.4	330	110	6	972	7	165	488	9.00E-101	368.6	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN5771_c0_g1_i2	F3YDF1	YMEL1_DROME	63	311	101	6	959	51	165	469	2.90E-94	347.1	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN5771_c0_g1_i3	F3YDF1	YMEL1_DROME	62.4	330	110	6	972	7	165	488	9.30E-101	368.6	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN5771_c0_g1_i4	F3YDF1	YMEL1_DROME	63	311	101	6	959	51	165	469	2.80E-94	347.1	YMEL1_DROME	reviewed	ATP-dependent zinc metalloprotease YME1L (EC 3.4.24.-) (YME1-like ATPase)	YME1L CG3499	Drosophila melanogaster (Fruit fly)	740	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0008053; GO:0016021; GO:0034982; GO:0042407; GO:0046872; GO:0065003	cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN28775_c0_g1_i1	Q96TA2	YMEL1_HUMAN	98.7	78	1	0	236	3	461	538	4.90E-40	164.5	YMEL1_HUMAN	reviewed	ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1)	YME1L1 FTSH1 YME1L UNQ1868/PRO4304	Homo sapiens (Human)	773	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0006851; GO:0007005; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872	cell population proliferation [GO:0008283]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN31802_c0_g1_i1	Q96TA2	YMEL1_HUMAN	99.3	146	1	0	1	438	316	461	1.10E-77	290.4	YMEL1_HUMAN	reviewed	ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1)	YME1L1 FTSH1 YME1L UNQ1868/PRO4304	Homo sapiens (Human)	773	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0006851; GO:0007005; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872	cell population proliferation [GO:0008283]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN32129_c0_g1_i1	Q96TA2	YMEL1_HUMAN	100	78	0	0	3	236	628	705	2.70E-38	158.7	YMEL1_HUMAN	reviewed	ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1)	YME1L1 FTSH1 YME1L UNQ1868/PRO4304	Homo sapiens (Human)	773	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0006851; GO:0007005; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872	cell population proliferation [GO:0008283]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN34921_c0_g1_i1	F1NHE9	KCJ12_CHICK	60.9	69	27	0	1	207	213	281	4.20E-19	94.7	KCJ12_CHICK	reviewed	"ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12)"	KCNJ12	Gallus gallus (Chicken)	429	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]	inward rectifier potassium channel activity [GO:0005242]	GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573	potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN39581_c0_g1_i1	Q4LE39	ARI4B_HUMAN	100	66	0	0	60	257	1	66	3.50E-31	135.2	ARI4B_HUMAN	reviewed	AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)	ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180	Homo sapiens (Human)	1312	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005654; GO:0005737; GO:0006349; GO:0006357; GO:0007283; GO:0034773; GO:0036124; GO:0045944; GO:0097368	establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN30534_c0_g1_i1	Q4LE39	ARI4B_HUMAN	98.7	79	1	0	2	238	73	151	5.60E-40	164.5	ARI4B_HUMAN	reviewed	AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)	ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180	Homo sapiens (Human)	1312	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005654; GO:0005737; GO:0006349; GO:0006357; GO:0007283; GO:0034773; GO:0036124; GO:0045944; GO:0097368	establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN22571_c0_g1_i1	Q9JKB5	ARI4B_RAT	49.2	244	117	4	727	2	2	240	7.90E-56	218.8	ARI4B_RAT	reviewed	AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)	Arid4b Rbbp1l1 Sap180	Rattus norvegicus (Rat)	1228	nucleus [GO:0005634]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0006349; GO:0006357; GO:0007283; GO:0034773; GO:0036124; GO:0045944; GO:0097368	establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN22571_c0_g1_i2	Q9JKB5	ARI4B_RAT	49.4	241	115	4	718	2	5	240	7.50E-56	218.8	ARI4B_RAT	reviewed	AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)	Arid4b Rbbp1l1 Sap180	Rattus norvegicus (Rat)	1228	nucleus [GO:0005634]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0006349; GO:0006357; GO:0007283; GO:0034773; GO:0036124; GO:0045944; GO:0097368	establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN34896_c0_g1_i1	Q3U108	ARI5A_MOUSE	100	69	0	0	1	207	53	121	9.30E-35	146.7	ARI5A_MOUSE	reviewed	AT-rich interactive domain-containing protein 5A (ARID domain-containing protein 5A)	Arid5a	Mus musculus (Mouse)	590	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; retinoid X receptor binding [GO:0046965]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; retinoid X receptor binding [GO:0046965]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000976; GO:0002062; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0008134; GO:0030331; GO:0032729; GO:0032740; GO:0032755; GO:0035066; GO:0035613; GO:0042802; GO:0043565; GO:0045087; GO:0045944; GO:0046965; GO:0046966; GO:0050681; GO:0071222; GO:0071391; GO:1904469; GO:2000318; GO:2000556	cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14914_c0_g2_i1	E1BLP6	ARI5B_BOVIN	40	70	36	1	112	321	354	417	1.20E-09	63.9	ARI5B_BOVIN	reviewed	AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B)	ARID5B	Bos taurus (Bovine)	1173	nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; adipose tissue development [GO:0060612]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003713; GO:0005634; GO:0006357; GO:0051091; GO:0060612	adipose tissue development [GO:0060612]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14914_c0_g1_i1	Q8BM75	ARI5B_MOUSE	36.7	240	138	4	3	707	184	414	1.10E-39	164.9	ARI5B_MOUSE	reviewed	AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2)	Arid5b Desrt Mrf2	Mus musculus (Mouse)	1188	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000977; GO:0001227; GO:0001822; GO:0003677; GO:0003713; GO:0005634; GO:0006357; GO:0006807; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0051091; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830	adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]		NA	NA	NA	NA	NA	NA
TRINITY_DN8538_c0_g1_i1	O75882	ATRN_HUMAN	37.4	238	139	5	695	3	537	771	8.80E-45	181.8	ATRN_HUMAN	reviewed	Attractin (DPPT-L) (Mahogany homolog)	ATRN KIAA0548 MGCA	Homo sapiens (Human)	1429	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]	GO:0005604; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0006979; GO:0009887; GO:0009888; GO:0016477; GO:0021549; GO:0030246; GO:0034446; GO:0038023; GO:0040014; GO:0042552; GO:0043473; GO:0070062	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN7878_c0_g1_i2	Q9WU60	ATRN_MOUSE	64	86	30	1	15	272	117	201	2.10E-28	126.3	ATRN_MOUSE	reviewed	Attractin (Protein mahogany)	Atrn Mg Mgca	Mus musculus (Mouse)	1428	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]	GO:0005604; GO:0005615; GO:0005737; GO:0005886; GO:0006954; GO:0006979; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0021549; GO:0030246; GO:0034446; GO:0038023; GO:0040014; GO:0042552; GO:0043473	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN7878_c0_g1_i1	Q5VV63	ATRN1_HUMAN	42.4	311	148	9	3	893	75	368	7.00E-64	245.7	ATRN1_HUMAN	reviewed	Attractin-like protein 1	ATRNL1 KIAA0534	Homo sapiens (Human)	1379	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]	GO:0005604; GO:0007186; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0030246; GO:0034446	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN7878_c0_g1_i4	Q5VV63	ATRN1_HUMAN	43.5	329	153	10	3	941	75	386	3.70E-70	266.5	ATRN1_HUMAN	reviewed	Attractin-like protein 1	ATRNL1 KIAA0534	Homo sapiens (Human)	1379	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]	GO:0005604; GO:0007186; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0030246; GO:0034446	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN15494_c0_g2_i1	Q29RI0	COQ8A_BOVIN	60.7	428	168	0	1300	17	213	640	9.00E-152	538.1	COQ8A_BOVIN	reviewed	"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)"	COQ8A ADCK3 CABC1	Bos taurus (Bovine)	648	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]	GO:0005524; GO:0005739; GO:0006468; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531	phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN15494_c0_g2_i2	Q5BJQ0	COQ8A_RAT	59.7	139	56	0	433	17	503	641	3.00E-45	183	COQ8A_RAT	reviewed	"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)"	Coq8a Adck3 Cabc1	Rattus norvegicus (Rat)	649	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]	GO:0005524; GO:0005739; GO:0006468; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531	phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN26467_c0_g1_i1	Q8NI60	COQ8A_HUMAN	100	140	0	0	422	3	453	592	5.30E-77	288.1	COQ8A_HUMAN	reviewed	"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)"	COQ8A ADCK3 CABC1 PP265	Homo sapiens (Human)	647	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]	GO:0005524; GO:0005739; GO:0006468; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531	phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN26170_c0_g1_i1	Q96D53	COQ8B_HUMAN	98.9	91	1	0	275	3	170	260	8.60E-44	177.2	COQ8B_HUMAN	reviewed	"Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B)"	COQ8B ADCK4	Homo sapiens (Human)	544	cytosol [GO:0005829]; extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]	cytosol [GO:0005829]; extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; kinase activity [GO:0016301]	GO:0005524; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0006744; GO:0016021; GO:0016301; GO:0021692; GO:0031314	cerebellar Purkinje cell layer morphogenesis [GO:0021692]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN2252_c0_g2_i1	A1Z9X0	APKC_DROME	76.3	38	9	0	213	100	540	577	1.10E-10	67.4	APKC_DROME	reviewed	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475	Drosophila melanogaster (Fruit fly)	606	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005938; GO:0006468; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0018105; GO:0030011; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0046872; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:1904580	"adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2252_c0_g2_i3	A1Z9X0	APKC_DROME	76.2	105	25	0	410	96	502	606	1.00E-45	184.1	APKC_DROME	reviewed	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475	Drosophila melanogaster (Fruit fly)	606	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005938; GO:0006468; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0018105; GO:0030011; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0046872; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:1904580	"adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2252_c0_g1_i1	A1Z9X0	APKC_DROME	70	487	102	5	1397	3	31	495	1.80E-194	680.2	APKC_DROME	reviewed	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475	Drosophila melanogaster (Fruit fly)	606	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005938; GO:0006468; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0018105; GO:0030011; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0046872; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:1904580	"adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2252_c0_g1_i3	A1Z9X0	APKC_DROME	70.4	490	106	4	1421	3	28	495	4.50E-198	692.2	APKC_DROME	reviewed	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475	Drosophila melanogaster (Fruit fly)	606	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; subapical complex [GO:0035003]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005938; GO:0006468; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0018105; GO:0030011; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0046872; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:1904580	"adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; oocyte anterior/posterior axis specification [GO:0007314]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5545_c0_g1_i1	Q54WX4	AURK_DICDI	52.3	128	56	1	3	386	186	308	8.40E-35	147.9	AURK_DICDI	reviewed	Aurora kinase (EC 2.7.11.1)	aurK AurB Aurora DDB_G0279343	Dictyostelium discoideum (Slime mold)	384	"centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cleavage furrow [GO:0032154]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; regulation of cytokinesis [GO:0032465]"	"centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cleavage furrow [GO:0032154]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]"	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]	GO:0000278; GO:0000780; GO:0000922; GO:0004672; GO:0005524; GO:0005737; GO:0005813; GO:0005876; GO:0007052; GO:0031616; GO:0032133; GO:0032154; GO:0032465; GO:0035174; GO:0043005; GO:0051233	mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN35193_c0_g1_i1	D7UQM5	AURK_PATPE	88.1	84	10	0	254	3	256	339	1.30E-41	169.9	AURK_PATPE	reviewed	Aurora kinase (EC 2.7.11.1) (ApAurora)	aur	Patiria pectinifera (Starfish) (Asterina pectinifera)	407	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0007275; GO:0030496; GO:0051301; GO:0051321	cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN40900_c0_g1_i1	Q91820	AURAA_XENLA	59.1	181	74	0	552	10	176	356	7.20E-58	224.9	AURAA_XENLA	reviewed	Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265)	aurka-a aurka eg2 stk6	Xenopus laevis (African clawed frog)	407	centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]	GO:0000212; GO:0000922; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005876; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0046777; GO:0051301; GO:0090307	cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN28757_c0_g1_i1	Q96GD4	AURKB_HUMAN	99.2	122	1	0	366	1	181	302	4.10E-70	265	AURKB_HUMAN	reviewed	Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B)	AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5	Homo sapiens (Human)	344	"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; abscission [GO:0009838]; aging [GO:0007568]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; histone modification [GO:0016570]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore [GO:1905116]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]"	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0000122; GO:0000776; GO:0000779; GO:0000780; GO:0002903; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005876; GO:0006468; GO:0006511; GO:0007051; GO:0007052; GO:0007094; GO:0007568; GO:0008283; GO:0008608; GO:0009838; GO:0010369; GO:0016570; GO:0019900; GO:0030496; GO:0031145; GO:0031616; GO:0032091; GO:0032133; GO:0032212; GO:0032465; GO:0032466; GO:0032467; GO:0034501; GO:0034644; GO:0035174; GO:0036089; GO:0043988; GO:0044878; GO:0046777; GO:0046872; GO:0051233; GO:0051256; GO:0051973; GO:0051983; GO:0097431; GO:1901796; GO:1904355; GO:1905116; GO:1990023	abscission [GO:0009838]; aging [GO:0007568]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; histone modification [GO:0016570]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore [GO:1905116]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN27512_c0_g1_i1	Q6NW76	AURKB_DANRE	46.4	112	53	2	3	338	153	257	9.80E-26	117.5	AURKB_DANRE	reviewed	Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B)	aurkb stka	Danio rerio (Zebrafish) (Brachydanio rerio)	320	"chromosome passenger complex [GO:0032133]; condensed nuclear chromosome, centromeric region [GO:0000780]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; abscission [GO:0009838]; cellular response to UV [GO:0034644]; chromosome segregation [GO:0007059]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]"	"chromosome passenger complex [GO:0032133]; condensed nuclear chromosome, centromeric region [GO:0000780]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]"	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000122; GO:0000226; GO:0000281; GO:0000780; GO:0002903; GO:0004674; GO:0005524; GO:0005634; GO:0005876; GO:0006468; GO:0007052; GO:0007059; GO:0007094; GO:0009838; GO:0030496; GO:0031616; GO:0032133; GO:0032465; GO:0032466; GO:0032467; GO:0034501; GO:0034644; GO:0035174; GO:0036089; GO:0043988; GO:0044878; GO:0046872; GO:0051233; GO:0051256	abscission [GO:0009838]; cellular response to UV [GO:0034644]; chromosome segregation [GO:0007059]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN4436_c0_g1_i1	Q99J83	ATG5_MOUSE	56	273	111	6	881	84	1	271	1.50E-87	324.3	ATG5_MOUSE	reviewed	Autophagy protein 5 (APG5-like)	Atg5 Apg5l	Mus musculus (Mouse)	275	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]		GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009267; GO:0009620; GO:0016020; GO:0016236; GO:0019883; GO:0031397; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0042493; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0048840; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061739; GO:0070257; GO:0071500; GO:0075044; GO:1902017; GO:2000377; GO:2000378; GO:2000619	aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; C-terminal protein lipidation [GO:0006501]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]		blue	blue	NA	NA	NA	NA
TRINITY_DN26817_c0_g1_i1	Q9H1Y0	ATG5_HUMAN	100	150	0	0	450	1	5	154	1.70E-86	319.7	ATG5_HUMAN	reviewed	Autophagy protein 5 (APG5-like) (Apoptosis-specific protein)	ATG5 APG5L ASP	Homo sapiens (Human)	275	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]		GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009620; GO:0016020; GO:0016236; GO:0019883; GO:0030670; GO:0031397; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0042493; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0048840; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061739; GO:0070257; GO:0071500; GO:0075044; GO:1902017; GO:2000378; GO:2000619	aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; C-terminal protein lipidation [GO:0006501]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]		NA	NA	NA	NA	NA	NA
TRINITY_DN27316_c0_g1_i1	Q9H1Y0	ATG5_HUMAN	100	61	0	0	3	185	215	275	6.20E-31	134	ATG5_HUMAN	reviewed	Autophagy protein 5 (APG5-like) (Apoptosis-specific protein)	ATG5 APG5L ASP	Homo sapiens (Human)	275	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]		GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009620; GO:0016020; GO:0016236; GO:0019883; GO:0030670; GO:0031397; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0042493; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0048840; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061739; GO:0070257; GO:0071500; GO:0075044; GO:1902017; GO:2000378; GO:2000619	aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; C-terminal protein lipidation [GO:0006501]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; post-translational protein modification [GO:0043687]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]		NA	NA	NA	NA	NA	NA
TRINITY_DN2228_c0_g1_i1	Q9VHR6	ATG13_DROME	30.9	444	239	11	1411	218	11	432	1.60E-36	155.6	ATG13_DROME	reviewed	Autophagy-related protein 13 homolog	Atg13 CG7331	Drosophila melanogaster (Fruit fly)	523	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005829; GO:0006914; GO:0010506; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0035096; GO:0044804; GO:0045850; GO:0060729; GO:1990316	activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN2228_c0_g1_i2	Q9VHR6	ATG13_DROME	30.9	444	239	11	1411	218	11	432	1.60E-36	155.6	ATG13_DROME	reviewed	Autophagy-related protein 13 homolog	Atg13 CG7331	Drosophila melanogaster (Fruit fly)	523	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005829; GO:0006914; GO:0010506; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0035096; GO:0044804; GO:0045850; GO:0060729; GO:1990316	activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN2228_c0_g1_i3	Q9VHR6	ATG13_DROME	30.9	444	239	11	1411	218	11	432	1.60E-36	155.6	ATG13_DROME	reviewed	Autophagy-related protein 13 homolog	Atg13 CG7331	Drosophila melanogaster (Fruit fly)	523	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005829; GO:0006914; GO:0010506; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0035096; GO:0044804; GO:0045850; GO:0060729; GO:1990316	activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN2228_c0_g1_i6	Q9VHR6	ATG13_DROME	45.5	99	54	0	978	682	134	232	6.80E-19	96.3	ATG13_DROME	reviewed	Autophagy-related protein 13 homolog	Atg13 CG7331	Drosophila melanogaster (Fruit fly)	523	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005829; GO:0006914; GO:0010506; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0035096; GO:0044804; GO:0045850; GO:0060729; GO:1990316	activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN2228_c0_g1_i7	Q9VHR6	ATG13_DROME	30.9	444	239	11	1262	69	11	432	1.40E-36	155.6	ATG13_DROME	reviewed	Autophagy-related protein 13 homolog	Atg13 CG7331	Drosophila melanogaster (Fruit fly)	523	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005829; GO:0006914; GO:0010506; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0035096; GO:0044804; GO:0045850; GO:0060729; GO:1990316	activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; intestinal epithelial structure maintenance [GO:0060729]; larval midgut cell programmed cell death [GO:0035096]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of nurse cell apoptotic process [GO:0045850]; protein localization to phagophore assembly site [GO:0034497]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN5898_c0_g1_i1	Q5I0B9	ATG16_XENTR	41.4	524	223	5	118	1470	13	525	3.90E-103	376.7	ATG16_XENTR	reviewed	Autophagy-related protein 16 (APG16-like 1)	atg16 apg16l TEgg115a02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	622	autophagosome membrane [GO:0000421]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]	autophagosome membrane [GO:0000421]; phagophore assembly site membrane [GO:0034045]		GO:0000045; GO:0000421; GO:0015031; GO:0034045; GO:0039689	autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN10259_c0_g1_i1	Q8C0J2	A16L1_MOUSE	96.9	97	3	0	294	4	300	396	1.90E-49	196.1	A16L1_MOUSE	reviewed	Autophagy-related protein 16-1 (APG16-like 1)	Atg16l1 Apg16l	Mus musculus (Mouse)	607	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]	GTPase binding [GO:0051020]; identical protein binding [GO:0042802]	GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0010508; GO:0015031; GO:0034045; GO:0034497; GO:0039689; GO:0042802; GO:0051020; GO:0061739; GO:0098792	autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]		NA	NA	NA	NA	NA	NA
TRINITY_DN10259_c0_g1_i2	Q8C0J2	A16L1_MOUSE	99	97	1	0	294	4	300	396	2.90E-50	198.7	A16L1_MOUSE	reviewed	Autophagy-related protein 16-1 (APG16-like 1)	Atg16l1 Apg16l	Mus musculus (Mouse)	607	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]	GTPase binding [GO:0051020]; identical protein binding [GO:0042802]	GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0010508; GO:0015031; GO:0034045; GO:0034497; GO:0039689; GO:0042802; GO:0051020; GO:0061739; GO:0098792	autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]		NA	NA	NA	NA	NA	NA
TRINITY_DN31112_c0_g1_i1	Q676U5	A16L1_HUMAN	100	82	0	0	246	1	398	479	2.90E-43	175.3	A16L1_HUMAN	reviewed	Autophagy-related protein 16-1 (APG16-like 1)	ATG16L1 APG16L UNQ9393/PRO34307	Homo sapiens (Human)	607	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]	GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]	GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0015031; GO:0016236; GO:0019787; GO:0034045; GO:0039689; GO:0042802; GO:0051020	autophagosome assembly [GO:0000045]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN37244_c0_g1_i1	Q2TAZ0	ATG2A_HUMAN	100	72	0	0	1	216	147	218	7.40E-35	147.1	ATG2A_HUMAN	reviewed	Autophagy-related protein 2 homolog A	ATG2A KIAA0404	Homo sapiens (Human)	1938	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005789; GO:0005811; GO:0005829; GO:0019898; GO:0032266; GO:0034045; GO:0034727; GO:0043231; GO:0044805; GO:0061709	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN7488_c0_g1_i1	Q96BY7	ATG2B_HUMAN	33.5	2245	1223	59	131	6577	1	2072	1.70E-302	1041.2	ATG2B_HUMAN	reviewed	Autophagy-related protein 2 homolog B	ATG2B C14orf103	Homo sapiens (Human)	2078	endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]	endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005789; GO:0005811; GO:0019898; GO:0032266; GO:0034045; GO:0034727; GO:0044805; GO:0061709; GO:0120013	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN34229_c0_g1_i1	P0CM35	ATG3_CRYNB	51.9	81	33	1	226	2	9	89	2.80E-16	85.5	ATG3_CRYNB	reviewed	Autophagy-related protein 3 (Autophagy-related E2-like conjugation enzyme ATG3)	ATG3 CNBK3080	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	385	cytoplasm [GO:0005737]; autophagy [GO:0006914]; protein transport [GO:0015031]	cytoplasm [GO:0005737]		GO:0005737; GO:0006914; GO:0015031	autophagy [GO:0006914]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN40631_c0_g1_i1	Q0WWQ1	ATG3_ARATH	48.2	83	39	3	258	16	166	246	2.30E-14	79.3	ATG3_ARATH	reviewed	Autophagy-related protein 3 (Autophagy-related E2-like conjugation enzyme ATG3) (AtAPG3) (Protein autophagy 3)	ATG3 APG3 At5g61500 K11J9.3	Arabidopsis thaliana (Mouse-ear cress)	313	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; protein transport [GO:0015031]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg8 ligase activity [GO:0019776]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0019776; GO:0044804	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; protein transport [GO:0015031]		red	red	NA	NA	NA	NA
TRINITY_DN34229_c0_g1_i2	Q0WWQ1	ATG3_ARATH	52.6	78	37	0	250	17	6	83	1.10E-16	87	ATG3_ARATH	reviewed	Autophagy-related protein 3 (Autophagy-related E2-like conjugation enzyme ATG3) (AtAPG3) (Protein autophagy 3)	ATG3 APG3 At5g61500 K11J9.3	Arabidopsis thaliana (Mouse-ear cress)	313	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; protein transport [GO:0015031]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg8 ligase activity [GO:0019776]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0019776; GO:0044804	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN39196_c0_g1_i1	A1CQS1	ATG8_ASPCL	97.1	68	2	0	205	2	29	96	3.60E-29	128.3	ATG8_ASPCL	reviewed	Autophagy-related protein 8 (Autophagy-related ubiquitin-like modifier atg8)	atg8 ACLA_027140	Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1)	118	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; autophagy [GO:0006914]; protein transport [GO:0015031]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]		GO:0000421; GO:0006914; GO:0015031; GO:0031410	autophagy [GO:0006914]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3519_c0_g1_i1	Q3T904	ATG9A_BOVIN	47.7	725	337	10	2392	263	18	715	3.20E-180	633.6	ATG9A_BOVIN	reviewed	Autophagy-related protein 9A (APG9-like 1) (Autophagy protein 9)	ATG9A ATG9	Bos taurus (Bovine)	839	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; phagophore assembly site [GO:0000407]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; phagophore assembly site [GO:0000407]		GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0005776; GO:0005794; GO:0015031; GO:0016021; GO:0031902; GO:0034497; GO:0044805	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN27614_c0_g1_i1	Q7Z3C6	ATG9A_HUMAN	100	113	0	0	3	341	298	410	9.00E-59	227.3	ATG9A_HUMAN	reviewed	Autophagy-related protein 9A (APG9-like 1) (mATG9)	ATG9A APG9L1	Homo sapiens (Human)	839	autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]	autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]		GO:0000045; GO:0000407; GO:0000422; GO:0005768; GO:0005770; GO:0005776; GO:0005789; GO:0005802; GO:0015031; GO:0016020; GO:0016021; GO:0031902; GO:0034497; GO:0043231; GO:0044805; GO:0055037	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN35934_c0_g1_i1	Q7Z3C6	ATG9A_HUMAN	100	133	0	0	400	2	449	581	6.80E-74	277.7	ATG9A_HUMAN	reviewed	Autophagy-related protein 9A (APG9-like 1) (mATG9)	ATG9A APG9L1	Homo sapiens (Human)	839	autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]	autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]		GO:0000045; GO:0000407; GO:0000422; GO:0005768; GO:0005770; GO:0005776; GO:0005789; GO:0005802; GO:0015031; GO:0016020; GO:0016021; GO:0031902; GO:0034497; GO:0043231; GO:0044805; GO:0055037	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1224_c1_g2_i1	Q9V407	AXN_DROME	39.8	88	51	1	219	476	658	745	4.20E-13	76.3	AXN_DROME	reviewed	Axin (Axis inhibition protein) (d-Axin) (dAxin)	Axn CG7926	Drosophila melanogaster (Fruit fly)	745	"beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; chitin-based larval cuticle pattern formation [GO:0035293]; circadian rhythm [GO:0007623]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; eye-antennal disc morphogenesis [GO:0007455]; heart development [GO:0007507]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of cell death [GO:0010941]; response to starvation [GO:0042594]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway [GO:0016055]"	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007367; GO:0007450; GO:0007455; GO:0007507; GO:0007623; GO:0008013; GO:0008587; GO:0010941; GO:0016055; GO:0019901; GO:0030707; GO:0030877; GO:0032436; GO:0035019; GO:0035293; GO:0042594; GO:0048477; GO:0060090; GO:0090090	"chitin-based larval cuticle pattern formation [GO:0035293]; circadian rhythm [GO:0007623]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; eye-antennal disc morphogenesis [GO:0007455]; heart development [GO:0007507]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of cell death [GO:0010941]; response to starvation [GO:0042594]; segment polarity determination [GO:0007367]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4959_c0_g1_i19	O42400	AXIN1_CHICK	32.1	558	274	23	91	1620	4	504	6.50E-44	180.3	AXIN1_CHICK	reviewed	Axin-1 (Axis inhibition protein 1)	AXIN1 AXIN AXN	Gallus gallus (Chicken)	841	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005886; GO:0007275; GO:0008013; GO:0016055; GO:0030877; GO:0031410; GO:0042803; GO:0046330; GO:0090090	multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4959_c0_g1_i26	O42400	AXIN1_CHICK	32.1	558	274	23	246	1775	4	504	9.20E-44	179.9	AXIN1_CHICK	reviewed	Axin-1 (Axis inhibition protein 1)	AXIN1 AXIN AXN	Gallus gallus (Chicken)	841	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005886; GO:0007275; GO:0008013; GO:0016055; GO:0030877; GO:0031410; GO:0042803; GO:0046330; GO:0090090	multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4959_c0_g1_i29	O42400	AXIN1_CHICK	32.1	558	274	23	197	1726	4	504	8.90E-44	179.9	AXIN1_CHICK	reviewed	Axin-1 (Axis inhibition protein 1)	AXIN1 AXIN AXN	Gallus gallus (Chicken)	841	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005886; GO:0007275; GO:0008013; GO:0016055; GO:0030877; GO:0031410; GO:0042803; GO:0046330; GO:0090090	multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4959_c0_g1_i3	O42400	AXIN1_CHICK	32.1	558	274	23	65	1594	4	504	4.90E-44	180.6	AXIN1_CHICK	reviewed	Axin-1 (Axis inhibition protein 1)	AXIN1 AXIN AXN	Gallus gallus (Chicken)	841	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005886; GO:0007275; GO:0008013; GO:0016055; GO:0030877; GO:0031410; GO:0042803; GO:0046330; GO:0090090	multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4959_c0_g1_i8	O42400	AXIN1_CHICK	30.7	316	159	13	663	1538	225	504	5.20E-19	97.4	AXIN1_CHICK	reviewed	Axin-1 (Axis inhibition protein 1)	AXIN1 AXIN AXN	Gallus gallus (Chicken)	841	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005886; GO:0007275; GO:0008013; GO:0016055; GO:0030877; GO:0031410; GO:0042803; GO:0046330; GO:0090090	multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4959_c0_g1_i9	O42400	AXIN1_CHICK	31.3	566	276	23	246	1799	4	504	1.90E-41	172.2	AXIN1_CHICK	reviewed	Axin-1 (Axis inhibition protein 1)	AXIN1 AXIN AXN	Gallus gallus (Chicken)	841	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005886; GO:0007275; GO:0008013; GO:0016055; GO:0030877; GO:0031410; GO:0042803; GO:0046330; GO:0090090	multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN17326_c0_g1_i1	Q00436	YB3_XENLA	77.6	98	22	0	418	125	22	119	1.60E-36	154.1	YB3_XENLA	reviewed	B box-binding protein (Protein YB3)		Xenopus laevis (African clawed frog)	305	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN13760_c0_g1_i1	Q93560	BLMP1_CAEEL	62.5	32	12	0	406	311	622	653	2.30E-05	50.1	BLMP1_CAEEL	reviewed	B lymphocyte-induced maturation protein 1 homolog	blmp-1 F25D7.3	Caenorhabditis elegans	817	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000122; GO:0000978; GO:0000987; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0008340; GO:0010468; GO:0040035; GO:0042826; GO:0043053; GO:0045165; GO:0045684; GO:0045944; GO:0046872; GO:0110039; GO:1903355	cell fate commitment [GO:0045165]; dauer entry [GO:0043053]; determination of adult lifespan [GO:0008340]; hermaphrodite genitalia development [GO:0040035]; negative regulation of distal tip cell migration [GO:1903355]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epidermis development [GO:0045684]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5734_c0_g1_i1	Q9QXA6	BAT1_MOUSE	52.8	477	209	4	1514	90	25	487	2.10E-134	480.7	BAT1_MOUSE	reviewed	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	Slc7a9 Bat1	Mus musculus (Mouse)	487	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]	GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016021; GO:0016324; GO:0031526; GO:0042605	amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]		NA	NA	NA	NA	NA	NA
TRINITY_DN12809_c0_g1_i1	Q9R1S0	B9D1_MOUSE	60.4	144	57	0	75	506	1	144	4.30E-49	195.7	B9D1_MOUSE	reviewed	B9 domain-containing protein 1 (Endothelial precursor cells protein B9)	B9d1 Eppb9	Mus musculus (Mouse)	204	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]; hedgehog receptor activity [GO:0008158]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]	hedgehog receptor activity [GO:0008158]	GO:0001701; GO:0001944; GO:0005737; GO:0005813; GO:0007224; GO:0008158; GO:0016020; GO:0032880; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0043010; GO:0060271; GO:0060563	camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN12809_c0_g1_i2	Q9R1S0	B9D1_MOUSE	60.7	117	46	0	75	425	1	117	1.10E-38	161	B9D1_MOUSE	reviewed	B9 domain-containing protein 1 (Endothelial precursor cells protein B9)	B9d1 Eppb9	Mus musculus (Mouse)	204	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]; hedgehog receptor activity [GO:0008158]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]	hedgehog receptor activity [GO:0008158]	GO:0001701; GO:0001944; GO:0005737; GO:0005813; GO:0007224; GO:0008158; GO:0016020; GO:0032880; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0043010; GO:0060271; GO:0060563	camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN12809_c0_g1_i3	P0C5J2	B9D1_RAT	59.3	81	33	0	75	317	1	81	2.00E-22	106.7	B9D1_RAT	reviewed	B9 domain-containing protein 1 (Endothelial precursor cells protein B9)	B9d1 Eppb9	Rattus norvegicus (Rat)	204	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]; hedgehog receptor activity [GO:0008158]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]	hedgehog receptor activity [GO:0008158]	GO:0001701; GO:0001944; GO:0005737; GO:0005813; GO:0007224; GO:0008158; GO:0016020; GO:0032880; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0043010; GO:0060271; GO:0060563	camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN9340_c0_g1_i1	Q56JY9	B9D2_BOVIN	55.4	112	50	0	338	3	1	112	4.60E-36	152.1	B9D2_BOVIN	reviewed	B9 domain-containing protein 2	B9D2	Bos taurus (Bovine)	175	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; nucleus [GO:0005634]; gamma-tubulin binding [GO:0043015]; cilium assembly [GO:0060271]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; nucleus [GO:0005634]	gamma-tubulin binding [GO:0043015]	GO:0005634; GO:0005737; GO:0005813; GO:0036038; GO:0036064; GO:0043015; GO:0060271	cilium assembly [GO:0060271]		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i3	O68008	BACC_BACLI	34.8	66	43	0	280	83	3116	3181	1.40E-06	53.9	BACC_BACLI	reviewed	Bacitracin synthase 3 (BA3) [Includes: ATP-dependent isoleucine adenylase (IleA) (Isoleucine activase); ATP-dependent D-phenylalanine adenylase (D-PheA) (D-phenylalanine activase); ATP-dependent histidine adenylase (HisA) (Histidine activase); ATP-dependent D-aspartate adenylase (D-AspA) (D-aspartate activase); ATP-dependent asparagine adenylase (AsnA) (Asparagine activase); Aspartate racemase (EC 5.1.1.13); Phenylalanine racemase [ATP hydrolyzing] (EC 5.1.1.11)]	bacC	Bacillus licheniformis	6359	"aspartate racemase activity [GO:0047689]; ATP binding [GO:0005524]; hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phenylalanine racemase (ATP-hydrolyzing) activity [GO:0047462]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000]"		"aspartate racemase activity [GO:0047689]; ATP binding [GO:0005524]; hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phenylalanine racemase (ATP-hydrolyzing) activity [GO:0047462]; phosphopantetheine binding [GO:0031177]"	GO:0005524; GO:0016788; GO:0016874; GO:0017000; GO:0031177; GO:0047462; GO:0047689	antibiotic biosynthetic process [GO:0017000]		NA	NA	NA	NA	NA	NA
TRINITY_DN30946_c0_g1_i1	Q62210	BIRC2_MOUSE	48.1	52	27	0	237	82	552	603	6.90E-08	58.5	BIRC2_MOUSE	reviewed	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (Inhibitor of apoptosis protein 2) (mIAP2) (RING-type E3 ubiquitin transferase BIRC2)	Birc2	Mus musculus (Mouse)	612	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]	chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0032991; GO:0035631; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0044877; GO:0045121; GO:0045471; GO:0047485; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1902916; GO:1990001; GO:2000377	cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN29660_c0_g1_i1	Q62210	BIRC2_MOUSE	98.5	68	1	0	205	2	290	357	1.10E-38	159.8	BIRC2_MOUSE	reviewed	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (Inhibitor of apoptosis protein 2) (mIAP2) (RING-type E3 ubiquitin transferase BIRC2)	Birc2	Mus musculus (Mouse)	612	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]	chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0032991; GO:0035631; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0044877; GO:0045121; GO:0045471; GO:0047485; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1902916; GO:1990001; GO:2000377	cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN3957_c0_g1_i2	O08863	BIRC3_MOUSE	29	224	106	7	691	179	27	250	1.60E-18	94.7	BIRC3_MOUSE	reviewed	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 2) (C-IAP2) (Inhibitor of apoptosis protein 1) (mIAP1) (RING-type E3 ubiquitin transferase BIRC3)	Birc3	Mus musculus (Mouse)	600	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016740; GO:0031398; GO:0032991; GO:0042326; GO:0042981; GO:0043027; GO:0043154; GO:0044877; GO:0045121; GO:0046872; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:1901222; GO:1902916; GO:1990001; GO:2000378	cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]		NA	NA	NA	NA	NA	NA
TRINITY_DN31266_c0_g1_i1	O08863	BIRC3_MOUSE	39.3	89	47	2	122	367	512	600	2.60E-12	73.2	BIRC3_MOUSE	reviewed	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 2) (C-IAP2) (Inhibitor of apoptosis protein 1) (mIAP1) (RING-type E3 ubiquitin transferase BIRC3)	Birc3	Mus musculus (Mouse)	600	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016740; GO:0031398; GO:0032991; GO:0042326; GO:0042981; GO:0043027; GO:0043154; GO:0044877; GO:0045121; GO:0046872; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:1901222; GO:1902916; GO:1990001; GO:2000378	cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]		blue	blue	NA	NA	NA	NA
TRINITY_DN25152_c0_g1_i1	A1E2V0	BIRC3_CANLF	38.6	88	54	0	310	47	150	237	5.70E-11	68.6	BIRC3_CANLF	reviewed	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BIRC3)	BIRC3	Canis lupus familiaris (Dog) (Canis familiaris)	604	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0031398; GO:0043027; GO:0043154; GO:0046872; GO:0060546; GO:0061630; GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]		NA	NA	NA	NA	NA	NA
TRINITY_DN6494_c0_g1_i1	Q6J1J1	BIRC5_BOVIN	41	122	72	0	124	489	17	138	6.30E-22	105.5	BIRC5_BOVIN	reviewed	Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor survivin)	BIRC5	Bos taurus (Bovine)	142	"centriole [GO:0005814]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; protein-containing complex localization [GO:0031503]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of type B pancreatic cell proliferation [GO:0061469]"	"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]"	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0000086; GO:0000281; GO:0000775; GO:0000777; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0005876; GO:0005881; GO:0006468; GO:0007059; GO:0007094; GO:0008017; GO:0008270; GO:0015631; GO:0030496; GO:0031021; GO:0031503; GO:0031536; GO:0032133; GO:0042803; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0045892; GO:0045931; GO:0051301; GO:0051303; GO:0061178; GO:0061469; GO:0090307	"cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; protein-containing complex localization [GO:0031503]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of type B pancreatic cell proliferation [GO:0061469]"		blue	blue	NA	NA	NA	NA
TRINITY_DN32850_c0_g1_i1	Q9NR09	BIRC6_HUMAN	30.3	221	149	2	649	2	1281	1501	7.90E-26	119	BIRC6_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	BIRC6 KIAA1289	Homo sapiens (Human)	4857	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10632_c0_g2_i2	Q9NR09	BIRC6_HUMAN	34.5	255	161	4	89	847	52	302	3.60E-31	137.1	BIRC6_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	BIRC6 KIAA1289	Homo sapiens (Human)	4857	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10632_c0_g2_i3	Q9NR09	BIRC6_HUMAN	45.2	330	175	4	89	1072	52	377	7.10E-73	275.8	BIRC6_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	BIRC6 KIAA1289	Homo sapiens (Human)	4857	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9975_c0_g1_i1	Q9NR09	BIRC6_HUMAN	84.5	97	15	0	53	343	4652	4748	3.30E-45	182.2	BIRC6_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	BIRC6 KIAA1289	Homo sapiens (Human)	4857	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9975_c0_g1_i2	Q9NR09	BIRC6_HUMAN	82.2	129	23	0	3	389	4620	4748	2.20E-61	236.1	BIRC6_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	BIRC6 KIAA1289	Homo sapiens (Human)	4857	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN25892_c0_g1_i1	Q9NR09	BIRC6_HUMAN	100	107	0	0	2	322	264	370	1.50E-63	243	BIRC6_HUMAN	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	BIRC6 KIAA1289	Homo sapiens (Human)	4857	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11282_c0_g1_i1	A9JTP3	BIRC7_XENTR	28.9	419	230	14	1278	52	4	364	1.60E-37	158.7	BIRC7_XENTR	reviewed	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	birc7	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	365	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN11282_c0_g1_i2	A9JTP3	BIRC7_XENTR	28.9	419	230	14	1278	52	4	364	1.60E-37	158.7	BIRC7_XENTR	reviewed	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	birc7	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	365	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN11282_c0_g1_i3	A9JTP3	BIRC7_XENTR	28.9	419	230	14	1278	52	4	364	1.70E-37	158.7	BIRC7_XENTR	reviewed	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	birc7	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	365	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN11282_c0_g1_i4	A9JTP3	BIRC7_XENTR	28.2	280	167	8	879	52	115	364	2.30E-22	107.8	BIRC7_XENTR	reviewed	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	birc7	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	365	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN4342_c0_g2_i1	Q9JLV1	BAG3_MOUSE	37.2	78	49	0	79	312	423	500	1.40E-09	64.3	BAG3_MOUSE	reviewed	BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis)	Bag3 Bis MNCb-2243	Mus musculus (Mouse)	577	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein-containing complex binding [GO:0044877]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein stabilization [GO:0050821]; spinal cord development [GO:0021510]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]	adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein-containing complex binding [GO:0044877]	GO:0000045; GO:0000774; GO:0001725; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007420; GO:0008625; GO:0010664; GO:0016020; GO:0021510; GO:0030018; GO:0031072; GO:0034605; GO:0034620; GO:0042307; GO:0043005; GO:0043066; GO:0044877; GO:0046716; GO:0046827; GO:0050821; GO:0051087; GO:0061684; GO:0071260; GO:0097192; GO:0097201; GO:0101031; GO:1903215; GO:1905337	autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein stabilization [GO:0050821]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN5444_c0_g1_i1	Q9P281	BAHC1_HUMAN	55.7	70	26	1	1235	1026	2571	2635	1.50E-13	79	BAHC1_HUMAN	reviewed	BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)	BAHCC1 BAHD2 KIAA1447	Homo sapiens (Human)	2639	chromatin binding [GO:0003682]		chromatin binding [GO:0003682]	GO:0003682			NA	NA	NA	NA	NA	NA
TRINITY_DN5444_c0_g1_i2	Q9P281	BAHC1_HUMAN	55.7	70	26	1	1085	876	2571	2635	1.30E-13	79	BAHC1_HUMAN	reviewed	BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)	BAHCC1 BAHD2 KIAA1447	Homo sapiens (Human)	2639	chromatin binding [GO:0003682]		chromatin binding [GO:0003682]	GO:0003682			NA	NA	NA	NA	NA	NA
TRINITY_DN5444_c0_g1_i5	Q9P281	BAHC1_HUMAN	55.7	70	26	1	766	557	2571	2635	9.20E-14	79	BAHC1_HUMAN	reviewed	BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)	BAHCC1 BAHD2 KIAA1447	Homo sapiens (Human)	2639	chromatin binding [GO:0003682]		chromatin binding [GO:0003682]	GO:0003682			NA	NA	NA	NA	NA	NA
TRINITY_DN5444_c0_g1_i6	Q9P281	BAHC1_HUMAN	55.7	70	26	1	471	262	2571	2635	5.80E-14	79	BAHC1_HUMAN	reviewed	BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)	BAHCC1 BAHD2 KIAA1447	Homo sapiens (Human)	2639	chromatin binding [GO:0003682]		chromatin binding [GO:0003682]	GO:0003682			NA	NA	NA	NA	NA	NA
TRINITY_DN5890_c0_g1_i1	P02730	B3AT_HUMAN	51.3	316	153	1	1075	131	591	906	2.70E-88	327	B3AT_HUMAN	reviewed	Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233)	SLC4A1 AE1 DI EPB3	Homo sapiens (Human)	911	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0006873; GO:0007596; GO:0008509; GO:0009898; GO:0015106; GO:0015108; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0017121; GO:0022857; GO:0030018; GO:0030492; GO:0030506; GO:0030863; GO:0035811; GO:0042803; GO:0043495; GO:0045852; GO:0048821; GO:0050801; GO:0051354; GO:0051453; GO:0055085; GO:0070062; GO:0072562; GO:0072659; GO:1904539	anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN26320_c0_g1_i1	Q9WTP0	E41L1_RAT	96.5	85	3	0	255	1	151	235	4.60E-44	177.9	E41L1_RAT	reviewed	Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1) (4.1N)	Epb41l1 Epb4.1l1	Rattus norvegicus (Rat)	879	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]	actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005102; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0014069; GO:0030866; GO:0031032; GO:0032991; GO:0097060	actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]		NA	NA	NA	NA	NA	NA
TRINITY_DN28365_c0_g1_i1	O70318	E41L2_MOUSE	100	71	0	0	214	2	345	415	9.60E-35	146.7	E41L2_MOUSE	reviewed	Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G)	Epb41l2 Epb4.1l2	Mus musculus (Mouse)	988	actin cytoskeleton [GO:0015629]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cell shape [GO:0008360]	actin cytoskeleton [GO:0015629]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005654; GO:0005856; GO:0005886; GO:0007049; GO:0008180; GO:0008360; GO:0015629; GO:0030036; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0099738; GO:1904778	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN39742_c0_g1_i1	O70318	E41L2_MOUSE	99.1	117	1	0	3	353	410	526	8.00E-63	240.7	E41L2_MOUSE	reviewed	Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G)	Epb41l2 Epb4.1l2	Mus musculus (Mouse)	988	actin cytoskeleton [GO:0015629]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cell shape [GO:0008360]	actin cytoskeleton [GO:0015629]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005654; GO:0005856; GO:0005886; GO:0007049; GO:0008180; GO:0008360; GO:0015629; GO:0030036; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0099738; GO:1904778	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN35709_c0_g1_i1	Q58CU2	E41L5_BOVIN	61.2	67	26	0	203	3	113	179	5.10E-17	87.8	E41L5_BOVIN	reviewed	Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5)	EPB41L5	Bos taurus (Bovine)	502	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoskeletal protein binding [GO:0008092]	GO:0005737; GO:0005856; GO:0005912; GO:0008092; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN10859_c1_g1_i1	Q3V3N7	BBS1_MOUSE	53.4	178	83	0	2	535	217	394	2.00E-49	197.2	BBS1_MOUSE	reviewed	Bardet-Biedl syndrome 1 protein homolog	Bbs1	Mus musculus (Mouse)	593	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]	patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]	GO:0000226; GO:0001103; GO:0001764; GO:0001895; GO:0005102; GO:0005113; GO:0005119; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0007608; GO:0008104; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0035721; GO:0036064; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:1905515	adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN13322_c0_g1_i1	Q3V3N7	BBS1_MOUSE	52.7	146	69	0	462	25	448	593	1.00E-32	141.4	BBS1_MOUSE	reviewed	Bardet-Biedl syndrome 1 protein homolog	Bbs1	Mus musculus (Mouse)	593	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]	patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]	GO:0000226; GO:0001103; GO:0001764; GO:0001895; GO:0005102; GO:0005113; GO:0005119; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0007608; GO:0008104; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0035721; GO:0036064; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:1905515	adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN13322_c0_g1_i2	Q3V3N7	BBS1_MOUSE	53.2	158	74	0	498	25	436	593	4.10E-36	152.5	BBS1_MOUSE	reviewed	Bardet-Biedl syndrome 1 protein homolog	Bbs1	Mus musculus (Mouse)	593	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]	patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]	GO:0000226; GO:0001103; GO:0001764; GO:0001895; GO:0005102; GO:0005113; GO:0005119; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0007608; GO:0008104; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0035721; GO:0036064; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:1905515	adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN35057_c0_g1_i1	Q9BXC9	BBS2_HUMAN	100	87	0	0	1	261	407	493	1.10E-43	176.8	BBS2_HUMAN	reviewed	Bardet-Biedl syndrome 2 protein	BBS2	Homo sapiens (Human)	721	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]	RNA polymerase II repressing transcription factor binding [GO:0001103]	GO:0001103; GO:0005829; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032402; GO:0032420; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:1905515	adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7140_c0_g1_i1	Q98SP7	BBS2_DANRE	66.6	317	105	1	89	1036	1	317	3.50E-120	433	BBS2_DANRE	reviewed	Bardet-Biedl syndrome 2 protein homolog	bbs2	Danio rerio (Zebrafish) (Brachydanio rerio)	715	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]		GO:0005737; GO:0007368; GO:0007369; GO:0016020; GO:0031514; GO:0032402; GO:0034464; GO:0036064; GO:0043005; GO:0046907; GO:0051877; GO:0060170; GO:0060271; GO:0070121; GO:1905515	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877]		NA	NA	NA	NA	NA	NA
TRINITY_DN7140_c0_g1_i2	Q98SP7	BBS2_DANRE	66	285	96	1	89	940	1	285	4.40E-106	386	BBS2_DANRE	reviewed	Bardet-Biedl syndrome 2 protein homolog	bbs2	Danio rerio (Zebrafish) (Brachydanio rerio)	715	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]		GO:0005737; GO:0007368; GO:0007369; GO:0016020; GO:0031514; GO:0032402; GO:0034464; GO:0036064; GO:0043005; GO:0046907; GO:0051877; GO:0060170; GO:0060271; GO:0070121; GO:1905515	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877]		NA	NA	NA	NA	NA	NA
TRINITY_DN7140_c0_g1_i3	Q9CWF6	BBS2_MOUSE	58.8	656	260	5	89	2050	1	648	7.10E-220	765	BBS2_MOUSE	reviewed	Bardet-Biedl syndrome 2 protein homolog	Bbs2	Mus musculus (Mouse)	721	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to ciliary membrane [GO:1903441]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]	RNA polymerase II repressing transcription factor binding [GO:0001103]	GO:0001103; GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:1903441; GO:1905515	adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to ciliary membrane [GO:1903441]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN4468_c0_g1_i3	Q8N3I7	BBS5_HUMAN	62.5	64	24	0	244	53	209	272	1.70E-18	93.2	BBS5_HUMAN	reviewed	Bardet-Biedl syndrome 5 protein	BBS5	Homo sapiens (Human)	341	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]	phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]	GO:0001103; GO:0001947; GO:0005829; GO:0007601; GO:0015031; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0044458; GO:0046907; GO:0050896; GO:0060170; GO:0060271	cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN10480_c0_g1_i1	Q66IS6	BBS5_XENLA	65	117	41	0	373	23	121	237	1.50E-38	160.2	BBS5_XENLA	reviewed	Bardet-Biedl syndrome 5 protein homolog	bbs5	Xenopus laevis (African clawed frog)	365	BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]		GO:0005737; GO:0005815; GO:0034464; GO:0060170			NA	NA	NA	NA	NA	NA
TRINITY_DN10480_c0_g1_i2	Q7ZWB7	BBS5_DANRE	59.6	151	61	0	456	4	121	271	1.90E-48	193.4	BBS5_DANRE	reviewed	Bardet-Biedl syndrome 5 protein homolog	bbs5 zgc:56578	Danio rerio (Zebrafish) (Brachydanio rerio)	342	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]	phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0001947; GO:0005737; GO:0007369; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0043010; GO:0046907; GO:0051877; GO:0060170; GO:0060271; GO:0062139; GO:0070121; GO:0072116	camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]		NA	NA	NA	NA	NA	NA
TRINITY_DN4468_c0_g1_i2	Q7ZWB7	BBS5_DANRE	65.1	261	88	2	848	69	83	341	3.50E-96	352.8	BBS5_DANRE	reviewed	Bardet-Biedl syndrome 5 protein homolog	bbs5 zgc:56578	Danio rerio (Zebrafish) (Brachydanio rerio)	342	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]	phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0001947; GO:0005737; GO:0007369; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0043010; GO:0046907; GO:0051877; GO:0060170; GO:0060271; GO:0062139; GO:0070121; GO:0072116	camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]		NA	NA	NA	NA	NA	NA
TRINITY_DN4468_c0_g1_i4	Q7ZWB7	BBS5_DANRE	73.2	41	11	0	123	1	169	209	3.30E-10	65.1	BBS5_DANRE	reviewed	Bardet-Biedl syndrome 5 protein homolog	bbs5 zgc:56578	Danio rerio (Zebrafish) (Brachydanio rerio)	342	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]	phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0001947; GO:0005737; GO:0007369; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0043010; GO:0046907; GO:0051877; GO:0060170; GO:0060271; GO:0062139; GO:0070121; GO:0072116	camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]		NA	NA	NA	NA	NA	NA
TRINITY_DN15452_c0_g1_i1	Q06561	UNC52_CAEEL	46.5	99	53	0	1	297	3236	3334	3.00E-21	102.4	UNC52_CAEEL	reviewed	Basement membrane proteoglycan (Perlecan homolog) (Uncoordinated protein 52) (Protein unc-52)	unc-52 ZC101.2	Caenorhabditis elegans	3375	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemidesmosome assembly [GO:0031581]; locomotion [GO:0040011]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; myofibril assembly [GO:0030239]; nematode larval development [GO:0002119]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; positive regulation of locomotion [GO:0040017]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; tissue development [GO:0009888]	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; M band [GO:0031430]; striated muscle dense body [GO:0055120]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0002119; GO:0005201; GO:0005509; GO:0005604; GO:0007005; GO:0007517; GO:0008543; GO:0009792; GO:0009887; GO:0009888; GO:0016477; GO:0030239; GO:0031012; GO:0031430; GO:0031581; GO:0040011; GO:0040017; GO:0046716; GO:0048644; GO:0055120; GO:0060279; GO:0060298; GO:0060465; GO:1905905	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemidesmosome assembly [GO:0031581]; locomotion [GO:0040011]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; myofibril assembly [GO:0030239]; nematode larval development [GO:0002119]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; positive regulation of locomotion [GO:0040017]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN39086_c0_g1_i1	Q06561	UNC52_CAEEL	42.9	56	32	0	61	228	156	211	1.50E-09	63.2	UNC52_CAEEL	reviewed	Basement membrane proteoglycan (Perlecan homolog) (Uncoordinated protein 52) (Protein unc-52)	unc-52 ZC101.2	Caenorhabditis elegans	3375	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemidesmosome assembly [GO:0031581]; locomotion [GO:0040011]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; myofibril assembly [GO:0030239]; nematode larval development [GO:0002119]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; positive regulation of locomotion [GO:0040017]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; tissue development [GO:0009888]	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; M band [GO:0031430]; striated muscle dense body [GO:0055120]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0002119; GO:0005201; GO:0005509; GO:0005604; GO:0007005; GO:0007517; GO:0008543; GO:0009792; GO:0009887; GO:0009888; GO:0016477; GO:0030239; GO:0031012; GO:0031430; GO:0031581; GO:0040011; GO:0040017; GO:0046716; GO:0048644; GO:0055120; GO:0060279; GO:0060298; GO:0060465; GO:1905905	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemidesmosome assembly [GO:0031581]; locomotion [GO:0040011]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; myofibril assembly [GO:0030239]; nematode larval development [GO:0002119]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; positive regulation of locomotion [GO:0040017]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; tissue development [GO:0009888]		blue	blue	NA	NA	NA	NA
TRINITY_DN9841_c0_g1_i1	Q05793	PGBM_MOUSE	35.4	288	164	9	941	99	1396	1668	8.80E-39	162.5	PGBM_MOUSE	reviewed	Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide]	Hspg2	Mus musculus (Mouse)	3707	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; calcium ion binding [GO:0005509]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]	calcium ion binding [GO:0005509]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]	GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008022; GO:0008104; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0060548; GO:0062023; GO:1905907	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN26231_c0_g1_i1	Q7L1Q6	BZW1_HUMAN	100	99	0	0	3	299	295	393	1.70E-50	199.5	BZW1_HUMAN	reviewed	Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf)	BZW1 BZAP45 KIAA0005	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0016020; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN26231_c0_g1_i2	Q7L1Q6	BZW1_HUMAN	99.2	126	1	0	3	380	268	393	4.90E-66	251.5	BZW1_HUMAN	reviewed	Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf)	BZW1 BZAP45 KIAA0005	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0016020; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN24015_c0_g1_i1	Q7L1Q6	BZW1_HUMAN	100	88	0	0	265	2	83	170	2.20E-41	169.1	BZW1_HUMAN	reviewed	Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf)	BZW1 BZAP45 KIAA0005	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0016020; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN24015_c0_g1_i2	Q7L1Q6	BZW1_HUMAN	100	88	0	0	265	2	83	170	2.20E-41	169.1	BZW1_HUMAN	reviewed	Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf)	BZW1 BZAP45 KIAA0005	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0016020; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN17535_c0_g1_i1	Q91VK1	BZW2_MOUSE	100	117	0	0	353	3	267	383	1.50E-61	236.5	BZW2_MOUSE	reviewed	Basic leucine zipper and W2 domain-containing protein 2	Bzw2	Mus musculus (Mouse)	419	cytoplasm [GO:0005737]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]		GO:0005737; GO:0007399; GO:0030154	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN32248_c0_g1_i1	Q9Y6E2	BZW2_HUMAN	100	117	0	0	353	3	267	383	1.50E-61	236.5	BZW2_HUMAN	reviewed	Basic leucine zipper and W2 domain-containing protein 2	BZW2 HSPC028 MSTP017	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cadherin binding [GO:0045296]	GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0045296	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN28409_c0_g1_i1	P35613	BASI_HUMAN	100	76	0	0	2	229	292	367	1.40E-36	152.9	BASI_HUMAN	reviewed	Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)	BSG UNQ6505/PRO21383	Homo sapiens (Human)	385	acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]	acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]	GO:0000139; GO:0001525; GO:0001618; GO:0001750; GO:0001917; GO:0002080; GO:0003407; GO:0005537; GO:0005739; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006090; GO:0007156; GO:0007166; GO:0007411; GO:0007566; GO:0010575; GO:0010595; GO:0016020; GO:0016323; GO:0022617; GO:0030198; GO:0030424; GO:0030593; GO:0032755; GO:0038023; GO:0042383; GO:0042470; GO:0042475; GO:0043231; GO:0043434; GO:0045121; GO:0045296; GO:0045494; GO:0046598; GO:0046689; GO:0046697; GO:0050900; GO:0051591; GO:0061154; GO:0070062; GO:0070593; GO:0072659; GO:0098632; GO:1904466	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]		NA	NA	NA	NA	NA	NA
TRINITY_DN27650_c0_g1_i1	P18572	BASI_MOUSE	100	81	0	0	1	243	295	375	5.10E-40	164.5	BASI_MOUSE	reviewed	Basigin (Basic immunoglobulin superfamily) (HT7 antigen) (Membrane glycoprotein gp42) (CD antigen CD147)	Bsg	Mus musculus (Mouse)	389	acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]	acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]	GO:0001525; GO:0001618; GO:0001750; GO:0001917; GO:0002080; GO:0003407; GO:0005537; GO:0005739; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0007156; GO:0007283; GO:0007411; GO:0007566; GO:0010575; GO:0010595; GO:0016323; GO:0030424; GO:0030593; GO:0032755; GO:0038023; GO:0042383; GO:0042475; GO:0043231; GO:0043434; GO:0045121; GO:0045494; GO:0046598; GO:0046689; GO:0046697; GO:0051591; GO:0061154; GO:0070593; GO:0072659; GO:0098632; GO:1904466	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN35726_c0_g1_i1	P18572	BASI_MOUSE	45.9	74	38	1	27	248	291	362	4.70E-08	58.5	BASI_MOUSE	reviewed	Basigin (Basic immunoglobulin superfamily) (HT7 antigen) (Membrane glycoprotein gp42) (CD antigen CD147)	Bsg	Mus musculus (Mouse)	389	acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]	acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]	GO:0001525; GO:0001618; GO:0001750; GO:0001917; GO:0002080; GO:0003407; GO:0005537; GO:0005739; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0007156; GO:0007283; GO:0007411; GO:0007566; GO:0010575; GO:0010595; GO:0016323; GO:0030424; GO:0030593; GO:0032755; GO:0038023; GO:0042383; GO:0042475; GO:0043231; GO:0043434; GO:0045121; GO:0045494; GO:0046598; GO:0046689; GO:0046697; GO:0051591; GO:0061154; GO:0070593; GO:0072659; GO:0098632; GO:1904466	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN1013_c0_g1_i1	Q28740	BASI_RABIT	28.6	217	145	5	166	813	38	245	1.10E-10	68.9	BASI_RABIT	reviewed	Basigin (CD antigen CD147)	BSG	Oryctolagus cuniculus (Rabbit)	270	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005537; GO:0005789; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010575; GO:0010595; GO:0016323; GO:0038023; GO:0061154; GO:0072659	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1013_c0_g1_i2	Q28740	BASI_RABIT	27.3	238	159	5	166	861	38	267	5.50E-10	66.6	BASI_RABIT	reviewed	Basigin (CD antigen CD147)	BSG	Oryctolagus cuniculus (Rabbit)	270	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005537; GO:0005789; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010575; GO:0010595; GO:0016323; GO:0038023; GO:0061154; GO:0072659	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1013_c0_g1_i3	Q28740	BASI_RABIT	28.6	217	145	5	166	813	38	245	1.40E-10	68.6	BASI_RABIT	reviewed	Basigin (CD antigen CD147)	BSG	Oryctolagus cuniculus (Rabbit)	270	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005537; GO:0005789; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010575; GO:0010595; GO:0016323; GO:0038023; GO:0061154; GO:0072659	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1013_c0_g1_i4	Q28740	BASI_RABIT	28.6	217	145	5	451	1098	38	245	1.40E-10	68.9	BASI_RABIT	reviewed	Basigin (CD antigen CD147)	BSG	Oryctolagus cuniculus (Rabbit)	270	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005537; GO:0005789; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010575; GO:0010595; GO:0016323; GO:0038023; GO:0061154; GO:0072659	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1013_c0_g1_i6	Q28740	BASI_RABIT	28.6	217	145	5	451	1098	38	245	1.80E-10	68.6	BASI_RABIT	reviewed	Basigin (CD antigen CD147)	BSG	Oryctolagus cuniculus (Rabbit)	270	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005537; GO:0005789; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010575; GO:0010595; GO:0016323; GO:0038023; GO:0061154; GO:0072659	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1013_c0_g1_i7	Q28740	BASI_RABIT	27.3	238	159	5	451	1146	38	267	7.20E-10	66.6	BASI_RABIT	reviewed	Basigin (CD antigen CD147)	BSG	Oryctolagus cuniculus (Rabbit)	270	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005537; GO:0005789; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010575; GO:0010595; GO:0016323; GO:0038023; GO:0061154; GO:0072659	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; endothelial tube morphogenesis [GO:0061154]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN7648_c0_g1_i1	Q60HH0	CLN3_MACFA	42.8	425	209	8	177	1403	31	437	2.30E-82	307.8	CLN3_MACFA	reviewed	Battenin (Protein CLN3)	CLN3 QccE-16380	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	438	"autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; autophagosome-lysosome fusion [GO:0061909]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"	autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]	glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]	GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0015809; GO:0016021; GO:0030176; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1905146; GO:1905162; GO:1905244; GO:2001288	"amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; autophagosome-lysosome fusion [GO:0061909]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7648_c0_g1_i2	Q60HH0	CLN3_MACFA	45.6	136	72	1	72	479	304	437	1.70E-30	134	CLN3_MACFA	reviewed	Battenin (Protein CLN3)	CLN3 QccE-16380	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	438	"autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; autophagosome-lysosome fusion [GO:0061909]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"	autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]	glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]	GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0015809; GO:0016021; GO:0030176; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1905146; GO:1905162; GO:1905244; GO:2001288	"amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; autophagosome-lysosome fusion [GO:0061909]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32630_c0_g1_i1	Q61124	CLN3_MOUSE	100	61	0	0	212	30	378	438	3.50E-29	128.3	CLN3_MOUSE	reviewed	Battenin (Protein CLN3)	Cln3	Mus musculus (Mouse)	438	"autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]; actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amino acid transport [GO:0006865]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cell migration [GO:0016477]; cellular water homeostasis [GO:0009992]; endocytosis [GO:0006897]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of autophagy [GO:0010506]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"	autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]	calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]	GO:0000139; GO:0001508; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006865; GO:0006897; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0008306; GO:0009992; GO:0010468; GO:0010506; GO:0010762; GO:0015809; GO:0016021; GO:0016236; GO:0016243; GO:0016477; GO:0016485; GO:0030036; GO:0030176; GO:0031410; GO:0031901; GO:0031902; GO:0032228; GO:0035235; GO:0035752; GO:0036359; GO:0042133; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0043086; GO:0043524; GO:0044754; GO:0044857; GO:0045121; GO:0045861; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048306; GO:0048549; GO:0050885; GO:0051453; GO:0051480; GO:0051489; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061024; GO:0061909; GO:0070613; GO:0072657; GO:0072659; GO:0090160; GO:0090384; GO:0090385; GO:0097352; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1905146; GO:1905162; GO:1905244; GO:2001288	"actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amino acid transport [GO:0006865]; amyloid precursor protein catabolic process [GO:0042987]; arginine transport [GO:0015809]; associative learning [GO:0008306]; autophagosome-lysosome fusion [GO:0061909]; autophagosome maturation [GO:0097352]; cell migration [GO:0016477]; cellular water homeostasis [GO:0009992]; endocytosis [GO:0006897]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of autophagy [GO:0010506]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37649_c0_g1_i1	P55061	BI1_HUMAN	100	114	0	0	374	33	124	237	1.40E-57	223.4	BI1_HUMAN	reviewed	Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6)	TMBIM6 BI1 TEGT	Homo sapiens (Human)	237	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; endoribonuclease inhibitor activity [GO:0060698]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoribonuclease activity [GO:0060702]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of immunoglobulin secretion [GO:0051025]; negative regulation of protein binding [GO:0032091]; negative regulation of RNA splicing [GO:0033119]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; response to L-glutamate [GO:1902065]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]	endoribonuclease inhibitor activity [GO:0060698]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005887; GO:0006914; GO:0010523; GO:0016020; GO:0016021; GO:0019899; GO:0031625; GO:0031966; GO:0032091; GO:0032469; GO:0033119; GO:0034620; GO:0043066; GO:0051025; GO:0060698; GO:0060702; GO:0070059; GO:1902065; GO:1902236; GO:1903298; GO:1990441; GO:2001234	autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoribonuclease activity [GO:0060702]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of immunoglobulin secretion [GO:0051025]; negative regulation of protein binding [GO:0032091]; negative regulation of RNA splicing [GO:0033119]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; response to L-glutamate [GO:1902065]		NA	NA	NA	NA	NA	NA
TRINITY_DN15207_c1_g1_i1	Q5ZM39	BCL6_CHICK	98.8	81	1	0	3	245	613	693	1.30E-43	176.4	BCL6_CHICK	reviewed	B-cell lymphoma 6 protein homolog	BCL6 RCJMB04_3d20	Gallus gallus (Chicken)	708	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000902; GO:0000978; GO:0001227; GO:0001817; GO:0001953; GO:0002467; GO:0002682; GO:0002829; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0043065; GO:0043066; GO:0043087; GO:0043380; GO:0043565; GO:0045595; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0051272	"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; protein localization [GO:0008104]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1483_c0_g1_i1	Q9UHQ4	BAP29_HUMAN	32.2	236	141	3	132	785	1	235	2.10E-22	107.8	BAP29_HUMAN	reviewed	B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29)	BCAP29 BAP29	Homo sapiens (Human)	241	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001649; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0016021; GO:0070973	apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973]		NA	NA	NA	NA	NA	NA
TRINITY_DN1483_c0_g1_i2	Q9UHQ4	BAP29_HUMAN	32.2	236	141	3	109	762	1	235	1.20E-22	108.6	BAP29_HUMAN	reviewed	B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29)	BCAP29 BAP29	Homo sapiens (Human)	241	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001649; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0016021; GO:0070973	apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973]		blue	blue	NA	NA	NA	NA
TRINITY_DN36238_c0_g1_i1	Q12982	BNIP2_HUMAN	100	122	0	0	2	367	181	302	8.90E-65	247.3	BNIP2_HUMAN	reviewed	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	BNIP2 NIP2	Homo sapiens (Human)	314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; exopolyphosphatase activity [GO:0004309]; GTPase activator activity [GO:0005096]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; polyphosphate catabolic process [GO:0006798]; positive regulation of muscle cell differentiation [GO:0051149]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	calcium ion binding [GO:0005509]; exopolyphosphatase activity [GO:0004309]; GTPase activator activity [GO:0005096]	GO:0004309; GO:0005096; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0006798; GO:0006915; GO:0043066; GO:0043231; GO:0048471; GO:0051149	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; polyphosphate catabolic process [GO:0006798]; positive regulation of muscle cell differentiation [GO:0051149]		NA	NA	NA	NA	NA	NA
TRINITY_DN31325_c0_g1_i1	O54940	BNIP2_MOUSE	100	88	0	0	1	264	158	245	8.80E-46	183.7	BNIP2_MOUSE	reviewed	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	Bnip2 Nip2l	Mus musculus (Mouse)	326	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; spindle pole centrosome [GO:0031616]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; centrosome cycle [GO:0007098]; polyphosphate catabolic process [GO:0006798]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to oxygen-glucose deprivation [GO:0090649]; striated muscle cell differentiation [GO:0051146]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; spindle pole centrosome [GO:0031616]	exopolyphosphatase activity [GO:0004309]	GO:0001824; GO:0004309; GO:0005635; GO:0005737; GO:0005814; GO:0005829; GO:0006798; GO:0006915; GO:0007098; GO:0031616; GO:0043231; GO:0043410; GO:0045666; GO:0048471; GO:0051057; GO:0051146; GO:0090649	apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; centrosome cycle [GO:0007098]; polyphosphate catabolic process [GO:0006798]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to oxygen-glucose deprivation [GO:0090649]; striated muscle cell differentiation [GO:0051146]		NA	NA	NA	NA	NA	NA
TRINITY_DN16084_c0_g1_i3	O55003	BNIP3_MOUSE	29.2	185	108	3	663	127	12	179	2.00E-10	67.8	BNIP3_MOUSE	reviewed	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	Bnip3 Nip3	Mus musculus (Mouse)	187	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cell death [GO:0008219]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrion organization [GO:0010821]; regulation of programmed cell death [GO:0043067]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0006915; GO:0008219; GO:0008626; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010821; GO:0010917; GO:0010940; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031307; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0043068; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0060548; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:1901998; GO:1902109; GO:1903599; GO:1903715; GO:1990144; GO:2000378	apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cell death [GO:0008219]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrion organization [GO:0010821]; regulation of programmed cell death [GO:0043067]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; toxin transport [GO:1901998]		blue	blue	NA	NA	NA	NA
TRINITY_DN16084_c0_g1_i4	O55003	BNIP3_MOUSE	29.2	185	108	3	663	127	12	179	1.50E-10	68.2	BNIP3_MOUSE	reviewed	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	Bnip3 Nip3	Mus musculus (Mouse)	187	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cell death [GO:0008219]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrion organization [GO:0010821]; regulation of programmed cell death [GO:0043067]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0006915; GO:0008219; GO:0008626; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010821; GO:0010917; GO:0010940; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031307; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0043068; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0060548; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:1901998; GO:1902109; GO:1903599; GO:1903715; GO:1990144; GO:2000378	apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cell death [GO:0008219]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrion organization [GO:0010821]; regulation of programmed cell death [GO:0043067]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1657_c0_g1_i1	Q7T381	BOKB_DANRE	38.4	99	49	4	462	740	106	198	1.70E-09	64.7	BOKB_DANRE	reviewed	Bcl-2-related ovarian killer protein homolog B (zBok2)	bokb bok zgc:64041	Danio rerio (Zebrafish) (Brachydanio rerio)	211	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of apoptotic process [GO:0042981]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005741; GO:0008630; GO:0016021; GO:0042803; GO:0042981; GO:0046982; GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN1657_c0_g1_i2	Q7T381	BOKB_DANRE	40	80	45	1	462	701	106	182	6.30E-10	66.2	BOKB_DANRE	reviewed	Bcl-2-related ovarian killer protein homolog B (zBok2)	bokb bok zgc:64041	Danio rerio (Zebrafish) (Brachydanio rerio)	211	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of apoptotic process [GO:0042981]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005741; GO:0008630; GO:0016021; GO:0042803; GO:0042981; GO:0046982; GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN8883_c0_g1_i2	Q55DM1	LVSA_DICDI	28.7	122	78	2	7	360	3390	3506	3.40E-09	62.8	LVSA_DICDI	reviewed	BEACH domain-containing protein lvsA (Large volume sphere mutant protein A)	lvsA DDB_G0269150	Dictyostelium discoideum (Slime mold)	3619	contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; actomyosin contractile ring assembly [GO:0000915]; bleb assembly [GO:0032060]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; contractile vacuole dissociation from plasma membrane [GO:0140026]; contractile vacuole organization [GO:0033298]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; pinocytosis [GO:0006907]; protein localization [GO:0008104]	contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]	GO:0000281; GO:0000331; GO:0000915; GO:0005737; GO:0005829; GO:0006874; GO:0006907; GO:0006909; GO:0007032; GO:0007155; GO:0008104; GO:0008289; GO:0016020; GO:0019901; GO:0031164; GO:0032060; GO:0033298; GO:0044877; GO:0140026	actomyosin contractile ring assembly [GO:0000915]; bleb assembly [GO:0032060]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; contractile vacuole dissociation from plasma membrane [GO:0140026]; contractile vacuole organization [GO:0033298]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; pinocytosis [GO:0006907]; protein localization [GO:0008104]		NA	NA	NA	NA	NA	NA
TRINITY_DN31190_c0_g1_i1	Q5ZKS6	BECN1_CHICK	98.3	118	2	0	25	378	232	349	3.90E-63	241.9	BECN1_CHICK	reviewed	Beclin-1	BECN1 RCJMB04_9f22	Gallus gallus (Chicken)	447	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; autophagosome assembly [GO:0000045]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"		GO:0000045; GO:0000407; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006897; GO:0006995; GO:0007049; GO:0010008; GO:0019898; GO:0031966; GO:0032465; GO:0034271; GO:0034272; GO:0045022; GO:0045324; GO:0051301; GO:0051607	autophagosome assembly [GO:0000045]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN33830_c0_g1_i1	Q5ZKS6	BECN1_CHICK	98.3	118	2	0	37	390	232	349	2.60E-62	239.2	BECN1_CHICK	reviewed	Beclin-1	BECN1 RCJMB04_9f22	Gallus gallus (Chicken)	447	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; autophagosome assembly [GO:0000045]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"		GO:0000045; GO:0000407; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006897; GO:0006995; GO:0007049; GO:0010008; GO:0019898; GO:0031966; GO:0032465; GO:0034271; GO:0034272; GO:0045022; GO:0045324; GO:0051301; GO:0051607	autophagosome assembly [GO:0000045]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN559_c0_g1_i1	Q9VCE1	BECN1_DROME	78.1	32	7	0	91	186	388	419	9.80E-09	60.8	BECN1_DROME	reviewed	Beclin-1-like protein (Autophagy protein 6-like) (APG6-like)	Atg6 CG5429	Drosophila melanogaster (Fruit fly)	422	"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]"	"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"		GO:0000045; GO:0000407; GO:0006897; GO:0006914; GO:0006979; GO:0006995; GO:0009267; GO:0009306; GO:0016322; GO:0019898; GO:0030097; GO:0032465; GO:0034271; GO:0034272; GO:0035096; GO:0045324; GO:0045824; GO:0050829; GO:0061723	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN559_c0_g1_i2	Q9VCE1	BECN1_DROME	40.5	158	88	5	114	572	9	165	2.30E-23	110.5	BECN1_DROME	reviewed	Beclin-1-like protein (Autophagy protein 6-like) (APG6-like)	Atg6 CG5429	Drosophila melanogaster (Fruit fly)	422	"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]"	"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"		GO:0000045; GO:0000407; GO:0006897; GO:0006914; GO:0006979; GO:0006995; GO:0009267; GO:0009306; GO:0016322; GO:0019898; GO:0030097; GO:0032465; GO:0034271; GO:0034272; GO:0035096; GO:0045324; GO:0045824; GO:0050829; GO:0061723	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN559_c0_g1_i3	Q9VCE1	BECN1_DROME	58.3	415	164	6	114	1343	9	419	7.80E-112	405.6	BECN1_DROME	reviewed	Beclin-1-like protein (Autophagy protein 6-like) (APG6-like)	Atg6 CG5429	Drosophila melanogaster (Fruit fly)	422	"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]"	"extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"		GO:0000045; GO:0000407; GO:0006897; GO:0006914; GO:0006979; GO:0006995; GO:0009267; GO:0009306; GO:0016322; GO:0019898; GO:0030097; GO:0032465; GO:0034271; GO:0034272; GO:0035096; GO:0045324; GO:0045824; GO:0050829; GO:0061723	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to Gram-negative bacterium [GO:0050829]; endocytosis [GO:0006897]; glycophagy [GO:0061723]; hemopoiesis [GO:0030097]; larval midgut cell programmed cell death [GO:0035096]; late endosome to vacuole transport [GO:0045324]; negative regulation of innate immune response [GO:0045824]; neuron remodeling [GO:0016322]; protein secretion [GO:0009306]; regulation of cytokinesis [GO:0032465]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN6015_c0_g1_i1	O76090	BEST1_HUMAN	43.4	159	89	1	49	525	1	158	3.20E-31	136.3	BEST1_HUMAN	reviewed	Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2)	BEST1 VMD2	Homo sapiens (Human)	585	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]	GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0009925; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924	chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN3119_c0_g1_i2	Q8BGM5	BEST2_MOUSE	46	174	92	1	772	251	161	332	9.50E-38	159.5	BEST2_MOUSE	reviewed	Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1)	Best2 Vmd2l1	Mus musculus (Mouse)	508	chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]	chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN3119_c0_g1_i2	Q8BGM5	BEST2_MOUSE	41	161	94	1	1338	859	1	161	4.40E-27	124	BEST2_MOUSE	reviewed	Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1)	Best2 Vmd2l1	Mus musculus (Mouse)	508	chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]	chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN12837_c0_g1_i1	Q8BGM5	BEST2_MOUSE	69	84	26	0	1	252	234	317	1.00E-28	127.1	BEST2_MOUSE	reviewed	Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1)	Best2 Vmd2l1	Mus musculus (Mouse)	508	chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]	chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0005929; GO:0006821; GO:0007608; GO:0034707; GO:0051899; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN3119_c0_g1_i3	Q8N1M1	BEST3_HUMAN	43.4	334	186	2	1249	251	1	332	2.00E-74	281.2	BEST3_HUMAN	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	BEST3 VMD2L3	Homo sapiens (Human)	668	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0034707; GO:0043271	negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN3119_c0_g1_i4	Q6H1V1	BEST3_MOUSE	38.5	182	101	2	566	24	1	172	5.70E-30	132.5	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN6871_c0_g1_i1	Q6H1V1	BEST3_MOUSE	54.6	370	164	3	34	1143	1	366	4.90E-120	432.6	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN3303_c0_g1_i1	Q8N1M1	BEST3_HUMAN	48.9	137	69	1	452	45	194	330	4.20E-32	139	BEST3_HUMAN	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	BEST3 VMD2L3	Homo sapiens (Human)	668	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0034707; GO:0043271	negative regulation of ion transport [GO:0043271]		blue	blue	NA	NA	NA	NA
TRINITY_DN7179_c0_g1_i1	Q6H1V1	BEST3_MOUSE	53.7	164	75	1	5	496	1	163	1.50E-50	200.7	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN7179_c0_g1_i2	Q6H1V1	BEST3_MOUSE	55	373	164	3	5	1123	1	369	1.40E-124	448.7	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN7179_c0_g1_i4	Q6H1V1	BEST3_MOUSE	55.2	181	79	1	1	543	60	238	2.70E-61	238.4	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN7179_c0_g1_i4	Q6H1V1	BEST3_MOUSE	58.2	134	55	1	558	959	237	369	3.80E-39	164.9	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN7179_c0_g1_i5	Q8N1M1	BEST3_HUMAN	54.8	376	166	3	5	1132	1	372	7.10E-125	448.7	BEST3_HUMAN	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	BEST3 VMD2L3	Homo sapiens (Human)	668	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0034707; GO:0043271	negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN7179_c0_g1_i9	Q6H1V1	BEST3_MOUSE	59.8	102	41	0	77	382	60	161	7.70E-35	147.9	BEST3_MOUSE	reviewed	Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3)	Best3 Vmd2l3	Mus musculus (Mouse)	669	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]	GO:0005254; GO:0005886; GO:0015698; GO:0034707; GO:0043271	inorganic anion transport [GO:0015698]; negative regulation of ion transport [GO:0043271]		NA	NA	NA	NA	NA	NA
TRINITY_DN3119_c0_g1_i5	Q17851	BEST6_CAEEL	47.1	51	27	0	266	114	1	51	1.40E-06	53.9	BEST6_CAEEL	reviewed	Bestrophin-6	best-6 C09B9.3	Caenorhabditis elegans	382	integral component of membrane [GO:0016021]; chloride channel activity [GO:0005254]	integral component of membrane [GO:0016021]	chloride channel activity [GO:0005254]	GO:0005254; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33056_c0_g1_i1	Q22460	BCA1_CAEEL	46.1	258	131	5	837	76	1	254	9.10E-61	235.3	BCA1_CAEEL	reviewed	Beta carbonic anhydrase 1 (EC 4.2.1.1)	bca-1 T13C5.5	Caenorhabditis elegans	270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]		carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN7974_c0_g1_i6	Q7JK24	B3GT1_GORGO	32.1	190	124	4	797	234	91	277	1.00E-22	109	B3GT1_GORGO	reviewed	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	B3GALT1	Gorilla gorilla gorilla (Western lowland gorilla)	326	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030259; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN32894_c0_g1_i1	Q7JK24	B3GT1_GORGO	35.5	301	155	8	1057	164	58	322	1.10E-46	189.1	B3GT1_GORGO	reviewed	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	B3GALT1	Gorilla gorilla gorilla (Western lowland gorilla)	326	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030259; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i1	O54905	B3GT2_MOUSE	28.8	219	135	4	916	266	145	344	7.10E-19	96.7	B3GT2_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)"	B3galt2	Mus musculus (Mouse)	422	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i3	O54905	B3GT2_MOUSE	28.8	219	135	4	916	266	145	344	9.30E-19	96.7	B3GT2_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)"	B3galt2	Mus musculus (Mouse)	422	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i5	O54905	B3GT2_MOUSE	28.8	219	135	4	916	266	145	344	7.30E-19	96.7	B3GT2_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)"	B3galt2	Mus musculus (Mouse)	422	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i7	O54905	B3GT2_MOUSE	28.8	219	135	4	916	266	145	344	7.90E-19	96.7	B3GT2_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)"	B3galt2	Mus musculus (Mouse)	422	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i8	O54905	B3GT2_MOUSE	28.8	219	135	4	916	266	145	344	1.00E-18	96.7	B3GT2_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)"	B3galt2	Mus musculus (Mouse)	422	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005794; GO:0006486; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0008532; GO:0009312; GO:0016021; GO:0016758; GO:0030311; GO:0047275	galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN26448_c0_g1_i1	Q9Z0F0	B3GT4_MOUSE	53.2	62	29	0	237	52	120	181	3.30E-12	72	B3GT4_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 4 (Beta-1,3-GalTase 4) (Beta3Gal-T4) (Beta3GalT4) (b3Gal-T4) (EC 2.4.1.62) (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase)"	B3galt4	Mus musculus (Mouse)	371	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; ganglioside galactosyltransferase activity [GO:0047915]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; ganglioside biosynthetic process [GO:0001574]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; ganglioside galactosyltransferase activity [GO:0047915]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0001574; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008499; GO:0016021; GO:0016758; GO:0047915	ganglioside biosynthetic process [GO:0001574]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2572_c0_g1_i1	Q9Z0F0	B3GT4_MOUSE	33.8	228	126	8	876	226	122	335	3.00E-21	104	B3GT4_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 4 (Beta-1,3-GalTase 4) (Beta3Gal-T4) (Beta3GalT4) (b3Gal-T4) (EC 2.4.1.62) (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase)"	B3galt4	Mus musculus (Mouse)	371	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; ganglioside galactosyltransferase activity [GO:0047915]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; ganglioside biosynthetic process [GO:0001574]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; ganglioside galactosyltransferase activity [GO:0047915]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0001574; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008499; GO:0016021; GO:0016758; GO:0047915	ganglioside biosynthetic process [GO:0001574]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN27167_c0_g1_i1	Q9JI67	B3GT5_MOUSE	28.9	180	119	3	538	2	50	221	1.60E-17	90.9	B3GT5_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (Stage-specific embryonic antigen 3 synthase) (SSEA-3 synthase) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)"	B3galt5 B3gt5	Mus musculus (Mouse)	308	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]; response to bacterium [GO:0009617]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008532; GO:0009617; GO:0016021; GO:0016758; GO:0030311	poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN3849_c0_g1_i1	Q91Z92	B3GT6_MOUSE	47.6	273	137	2	322	1122	52	324	1.20E-70	268.5	B3GT6_MOUSE	reviewed	"Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)"	B3galt6	Mus musculus (Mouse)	325	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]"	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"galactosyltransferase activity [GO:0008378]; galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]"	GO:0000139; GO:0005797; GO:0006024; GO:0006486; GO:0008378; GO:0008499; GO:0015012; GO:0016021; GO:0030206; GO:0035250; GO:0047220	chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i13	Q6Y288	B3GLT_HUMAN	42.7	227	122	5	287	949	156	380	3.00E-43	177.2	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i15	Q6Y288	B3GLT_HUMAN	35.5	346	188	10	149	1153	59	380	1.30E-48	195.3	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i2	Q6Y288	B3GLT_HUMAN	26.3	357	191	12	149	1186	59	354	2.00E-23	111.7	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i24	Q6Y288	B3GLT_HUMAN	28.7	383	201	12	149	1264	59	380	2.40E-32	141.4	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i3	Q6Y288	B3GLT_HUMAN	42.7	227	122	5	450	1112	156	380	3.50E-43	177.2	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i31	Q6Y288	B3GLT_HUMAN	37.5	296	158	6	121	990	106	380	1.90E-48	194.5	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i6	Q6Y288	B3GLT_HUMAN	33.4	320	178	10	149	1075	59	354	1.10E-39	165.6	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i7	Q6Y288	B3GLT_HUMAN	43.8	169	89	4	613	1101	212	380	4.00E-31	137.1	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3673_c0_g1_i9	Q6Y288	B3GLT_HUMAN	40.3	201	112	5	450	1034	156	354	3.00E-34	147.5	B3GLT_HUMAN	reviewed	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	B3GLCT B3GALTL B3GTL	Homo sapiens (Human)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN29186_c0_g1_i1	P15291	B4GT1_HUMAN	95.2	63	3	0	1	189	220	282	4.00E-30	131.3	B4GT1_HUMAN	reviewed	"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]"	B4GALT1 GGTB2	Homo sapiens (Human)	398	"azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; alpha-tubulin binding [GO:0043014]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; beta-tubulin binding [GO:0048487]; galactosyltransferase activity [GO:0008378]; identical protein binding [GO:0042802]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]; acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; keratan sulfate biosynthetic process [GO:0018146]; lactose biosynthetic process [GO:0005989]; leukocyte migration [GO:0050900]; negative regulation of cell population proliferation [GO:0008285]; neutrophil degranulation [GO:0043312]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]"	azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	"alpha-tubulin binding [GO:0043014]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; beta-tubulin binding [GO:0048487]; galactosyltransferase activity [GO:0008378]; identical protein binding [GO:0042802]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]"	GO:0000138; GO:0000139; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005615; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006487; GO:0007155; GO:0007339; GO:0007341; GO:0008285; GO:0008378; GO:0009312; GO:0009897; GO:0016020; GO:0016021; GO:0016323; GO:0018146; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0030667; GO:0031526; GO:0032580; GO:0035250; GO:0035577; GO:0042802; GO:0043014; GO:0043065; GO:0043312; GO:0045136; GO:0048487; GO:0050900; GO:0060046; GO:0060054; GO:0060055; GO:0070062	acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; keratan sulfate biosynthetic process [GO:0018146]; lactose biosynthetic process [GO:0005989]; leukocyte migration [GO:0050900]; negative regulation of cell population proliferation [GO:0008285]; neutrophil degranulation [GO:0043312]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]		NA	NA	NA	NA	NA	NA
TRINITY_DN36651_c0_g1_i1	Q5EA87	B4GT3_BOVIN	98.8	86	1	0	3	260	162	247	1.60E-47	189.5	B4GT3_BOVIN	reviewed	"Beta-1,4-galactosyltransferase 3 (Beta-1,4-GalTase 3) (Beta4Gal-T3) (b4Gal-T3) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3)"	B4GALT3	Bos taurus (Bovine)	396	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]"	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]"	GO:0003831; GO:0003945; GO:0005975; GO:0006486; GO:0016021; GO:0032580; GO:0046872	carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN16714_c0_g1_i1	Q5EA87	B4GT3_BOVIN	100	124	0	0	2	373	172	295	1.40E-73	276.6	B4GT3_BOVIN	reviewed	"Beta-1,4-galactosyltransferase 3 (Beta-1,4-GalTase 3) (Beta4Gal-T3) (b4Gal-T3) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3)"	B4GALT3	Bos taurus (Bovine)	396	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]"	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]"	GO:0003831; GO:0003945; GO:0005975; GO:0006486; GO:0016021; GO:0032580; GO:0046872	carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN9537_c0_g1_i1	Q80WN7	B4GT4_CRIGR	43.4	265	147	2	891	97	77	338	1.10E-59	231.9	B4GT4_CRIGR	reviewed	"Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)"	B4GALT4	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	344	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]	GO:0003945; GO:0005975; GO:0006486; GO:0016021; GO:0032580; GO:0046872	carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i10	Q8R087	B4GT7_MOUSE	48.4	184	81	3	143	652	25	208	1.60E-41	171.8	B4GT7_MOUSE	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4galt7 Xgalt1	Mus musculus (Mouse)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i10	Q8R087	B4GT7_MOUSE	41.6	149	85	2	616	1062	178	324	1.40E-29	132.1	B4GT7_MOUSE	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4galt7 Xgalt1	Mus musculus (Mouse)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i11	Q8R087	B4GT7_MOUSE	48.2	301	141	4	132	992	25	324	5.50E-79	296.2	B4GT7_MOUSE	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4galt7 Xgalt1	Mus musculus (Mouse)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		blue	blue	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i3	Q8R087	B4GT7_MOUSE	48.2	301	141	4	143	1003	25	324	4.20E-79	296.6	B4GT7_MOUSE	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4galt7 Xgalt1	Mus musculus (Mouse)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i6	Q8R087	B4GT7_MOUSE	48.4	184	81	3	132	641	25	208	1.60E-41	171.8	B4GT7_MOUSE	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4galt7 Xgalt1	Mus musculus (Mouse)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i6	Q8R087	B4GT7_MOUSE	41.6	149	85	2	605	1051	178	324	1.40E-29	132.1	B4GT7_MOUSE	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4galt7 Xgalt1	Mus musculus (Mouse)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i8	Q9UBV7	B4GT7_HUMAN	49.2	118	59	1	84	437	208	324	5.60E-30	132.5	B4GT7_HUMAN	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4GALT7 XGALT1 UNQ748/PRO1478	Homo sapiens (Human)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN14496_c0_g1_i9	Q9UBV7	B4GT7_HUMAN	48.8	295	132	4	135	974	34	324	2.70E-78	293.9	B4GT7_HUMAN	reviewed	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4GALT7 XGALT1 UNQ748/PRO1478	Homo sapiens (Human)	327	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0097435	carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN29934_c0_g1_i1	L7YAI7	B4GA1_DANRE	40.3	370	194	9	364	1428	74	431	4.50E-70	266.9	B4GA1_DANRE	reviewed	"Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)"	b4gat1 b3gnt1	Danio rerio (Zebrafish) (Brachydanio rerio)	431	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]	GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0035269; GO:0046872; GO:0048747	muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN3306_c0_g1_i1	O01346	EGH_DROME	61.9	454	167	2	140	1483	4	457	2.40E-167	590.1	EGH_DROME	reviewed	"Beta-1,4-mannosyltransferase egh (EC 2.4.1.-) (Protein egghead) (Protein zeste-white 4)"	egh l(1)3Ae zw4 CG9659	Drosophila melanogaster (Fruit fly)	457	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; beta-1,4-mannosyltransferase activity [GO:0019187]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; dsRNA transport [GO:0033227]; germ cell development [GO:0007281]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; peripheral nervous system neuron development [GO:0048935]; regulation of oviposition [GO:0046662]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	"beta-1,4-mannosyltransferase activity [GO:0019187]"	GO:0001744; GO:0005737; GO:0006688; GO:0007281; GO:0007293; GO:0007298; GO:0007299; GO:0007411; GO:0008049; GO:0016021; GO:0016325; GO:0016333; GO:0019187; GO:0030707; GO:0030720; GO:0033227; GO:0042248; GO:0045165; GO:0045434; GO:0046662; GO:0048935	"axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; dsRNA transport [GO:0033227]; germarium-derived egg chamber formation [GO:0007293]; germ cell development [GO:0007281]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; optic lobe placode formation [GO:0001744]; ovarian follicle cell-cell adhesion [GO:0007299]; ovarian follicle cell development [GO:0030707]; peripheral nervous system neuron development [GO:0048935]; regulation of oviposition [GO:0046662]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9557_c0_g1_i1	A8Y1P7	BRE4_CAEBR	46.7	334	157	4	1033	77	46	373	1.20E-80	301.6	BRE4_CAEBR	reviewed	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	bre-4 CBG22165	Caenorhabditis briggsae	384	"integral component of membrane [GO:0016021]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"	integral component of membrane [GO:0016021]	"beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]"	GO:0005975; GO:0006486; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN27452_c0_g1_i1	A8Y1P7	BRE4_CAEBR	46.1	204	102	2	160	771	102	297	1.50E-50	201.1	BRE4_CAEBR	reviewed	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	bre-4 CBG22165	Caenorhabditis briggsae	384	"integral component of membrane [GO:0016021]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"	integral component of membrane [GO:0016021]	"beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]"	GO:0005975; GO:0006486; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN3629_c0_g1_i3	Q13884	SNTB1_HUMAN	43.8	448	227	9	153	1466	99	531	9.40E-103	375.6	SNTB1_HUMAN	reviewed	Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43)	SNTB1 SNT2B1	Homo sapiens (Human)	538	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; muscle contraction [GO:0006936]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202	muscle contraction [GO:0006936]		NA	NA	NA	NA	NA	NA
TRINITY_DN24153_c1_g2_i1	Q562R1	ACTBL_HUMAN	91.1	56	5	0	5	172	321	376	4.40E-24	111.3	ACTBL_HUMAN	reviewed	Beta-actin-like protein 2 (Kappa-actin)	ACTBL2	Homo sapiens (Human)	376	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005615; GO:0005737; GO:0005884; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0070062; GO:0098973; GO:0098978	axonogenesis [GO:0007409]; cell motility [GO:0048870]		NA	NA	NA	NA	NA	NA
TRINITY_DN30347_c0_g1_i1	Q9SUS3	APBLB_ARATH	63.9	169	61	0	512	6	292	460	2.20E-61	236.5	APBLB_ARATH	reviewed	Beta-adaptin-like protein B (At-bB-Ad) (At-betaB-Ad) (AP complex subunit beta-B) (Adaptor protein complex AP subunit beta-B) (Beta-adaptin B) (Clathrin assembly protein complex beta large chain B)	BETAB-AD At4g11380 F8L21.170	Arabidopsis thaliana (Mouse-ear cress)	894	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; clathrin binding [GO:0030276]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]	clathrin binding [GO:0030276]	GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030276; GO:0030665	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN23101_c0_g1_i2	P25098	ARBK1_HUMAN	100	379	0	0	1	1137	173	551	6.30E-226	784.3	ARBK1_HUMAN	reviewed	Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2)	GRK2 ADRBK1 BARK BARK1	Homo sapiens (Human)	689	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; receptor internalization [GO:0031623]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]	alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0002029; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0016020; GO:0018105; GO:0018107; GO:0019079; GO:0031623; GO:0031694; GO:0031755; GO:0033605; GO:0045202; GO:0045988; GO:0046718; GO:0047696; GO:0060048; GO:1901081	cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; receptor internalization [GO:0031623]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]		NA	NA	NA	NA	NA	NA
TRINITY_DN23101_c0_g1_i1	P21146	ARBK1_BOVIN	100	172	0	0	1	516	173	344	7.10E-100	364.4	ARBK1_BOVIN	reviewed	Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein-coupled receptor kinase 2)	GRK2 ADRBK1	Bos taurus (Bovine)	689	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]	alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0002029; GO:0002031; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006886; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0009966; GO:0016020; GO:0018105; GO:0018107; GO:0019079; GO:0031694; GO:0031755; GO:0045202; GO:0045880; GO:0045988; GO:0046718; GO:0047696; GO:0060048; GO:1901081; GO:1903566	cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]		NA	NA	NA	NA	NA	NA
TRINITY_DN28059_c0_g1_i1	Q961J5	BALAT_DROME	43	86	49	0	342	85	230	315	6.70E-14	78.2	BALAT_DROME	reviewed	Beta-alanine transporter (BalaT)	Balat CG3790	Drosophila melanogaster (Fruit fly)	604	integral component of plasma membrane [GO:0005887]; beta-alanine transmembrane transporter activity [GO:0001761]; beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]	integral component of plasma membrane [GO:0005887]	beta-alanine transmembrane transporter activity [GO:0001761]	GO:0001694; GO:0001761; GO:0001762; GO:0005887	beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]		NA	NA	NA	NA	NA	NA
TRINITY_DN1701_c0_g1_i2	Q961J5	BALAT_DROME	31	187	120	2	731	171	349	526	1.60E-12	74.7	BALAT_DROME	reviewed	Beta-alanine transporter (BalaT)	Balat CG3790	Drosophila melanogaster (Fruit fly)	604	integral component of plasma membrane [GO:0005887]; beta-alanine transmembrane transporter activity [GO:0001761]; beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]	integral component of plasma membrane [GO:0005887]	beta-alanine transmembrane transporter activity [GO:0001761]	GO:0001694; GO:0001761; GO:0001762; GO:0005887	beta-alanine transport [GO:0001762]; histamine biosynthetic process [GO:0001694]		NA	NA	NA	NA	NA	NA
TRINITY_DN10447_c0_g1_i1	Q5RG49	ACSF4_DANRE	35.5	341	183	8	3	956	819	1145	3.90E-52	206.8	ACSF4_DANRE	reviewed	Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4)	aasdh acsf4 si:dkeyp-117h8.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1149	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]		acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]	GO:0005524; GO:0006631; GO:0016878	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4877_c0_g1_i1	O62703	CTBL1_BOVIN	52.4	191	83	1	3	551	373	563	7.20E-48	191.8	CTBL1_BOVIN	reviewed	Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (p14)	CTNNBL1	Bos taurus (Bovine)	563	nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]		GO:0000974; GO:0005634; GO:0005681; GO:0006397; GO:0006915; GO:0008380	apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN25851_c0_g1_i1	Q8WYA6	CTBL1_HUMAN	100	71	0	0	213	1	399	469	1.10E-33	143.3	CTBL1_HUMAN	reviewed	Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19)	CTNNBL1 C20orf33 PP8304	Homo sapiens (Human)	563	"centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]"	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]	enzyme binding [GO:0019899]	GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016020; GO:0016445; GO:0019899; GO:0043065	"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32012_c0_g1_i1	A4IFE3	ACTY_BOVIN	98.6	71	1	0	3	215	306	376	1.40E-34	146.4	ACTY_BOVIN	reviewed	Beta-centractin (Actin-related protein 1B) (ARP1B)	ACTR1B	Bos taurus (Bovine)	376	centrosome [GO:0005813]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]	centrosome [GO:0005813]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005813			NA	NA	NA	NA	NA	NA
TRINITY_DN3315_c0_g1_i1	Q8R5C5	ACTY_MOUSE	84.3	376	59	0	74	1201	1	376	1.60E-193	676.8	ACTY_MOUSE	reviewed	Beta-centractin (Actin-related protein 1B) (ARP1B)	Actr1b	Mus musculus (Mouse)	376	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005813; GO:0015630			NA	NA	NA	NA	NA	NA
TRINITY_DN3315_c0_g1_i2	Q8R5C5	ACTY_MOUSE	78.4	185	40	0	65	619	192	376	7.40E-84	311.6	ACTY_MOUSE	reviewed	Beta-centractin (Actin-related protein 1B) (ARP1B)	Actr1b	Mus musculus (Mouse)	376	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005813; GO:0015630			NA	NA	NA	NA	NA	NA
TRINITY_DN28153_c0_g1_i1	P42025	ACTY_HUMAN	100	139	0	0	419	3	55	193	5.20E-77	288.1	ACTY_HUMAN	reviewed	Beta-centractin (Actin-related protein 1B) (ARP1B)	ACTR1B CTRN2	Homo sapiens (Human)	376	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; neutrophil degranulation [GO:0043312]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]	ATP binding [GO:0005524]	GO:0005524; GO:0005576; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0015630; GO:0016020; GO:0019886; GO:0034774; GO:0043312; GO:0070062; GO:1904813	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN34017_c0_g1_i1	Q8R5C5	ACTY_MOUSE	100	139	0	0	3	419	156	294	4.90E-75	281.6	ACTY_MOUSE	reviewed	Beta-centractin (Actin-related protein 1B) (ARP1B)	Actr1b	Mus musculus (Mouse)	376	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005813; GO:0015630			NA	NA	NA	NA	NA	NA
TRINITY_DN1040_c0_g1_i1	P52757	CHIO_HUMAN	39.4	452	243	7	70	1392	30	461	6.90E-87	322.8	CHIO_HUMAN	reviewed	Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)	CHN2 ARHGAP3 BCH	Homo sapiens (Human)	468	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0045202; GO:0046872; GO:0051056	intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN1040_c0_g1_i2	P52757	CHIO_HUMAN	39.1	455	252	7	70	1428	30	461	2.70E-86	320.9	CHIO_HUMAN	reviewed	Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)	CHN2 ARHGAP3 BCH	Homo sapiens (Human)	468	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0045202; GO:0046872; GO:0051056	intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN1040_c0_g1_i3	P52757	CHIO_HUMAN	40	457	243	7	118	1455	25	461	1.40E-90	335.1	CHIO_HUMAN	reviewed	Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)	CHN2 ARHGAP3 BCH	Homo sapiens (Human)	468	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0045202; GO:0046872; GO:0051056	intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN1040_c0_g1_i4	P52757	CHIO_HUMAN	39.4	452	243	7	98	1420	30	461	7.00E-87	322.8	CHIO_HUMAN	reviewed	Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)	CHN2 ARHGAP3 BCH	Homo sapiens (Human)	468	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0045202; GO:0046872; GO:0051056	intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN1040_c0_g1_i5	P52757	CHIO_HUMAN	39.8	460	252	7	118	1491	25	461	7.10E-90	332.8	CHIO_HUMAN	reviewed	Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)	CHN2 ARHGAP3 BCH	Homo sapiens (Human)	468	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0045202; GO:0046872; GO:0051056	intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN1040_c0_g1_i6	P52757	CHIO_HUMAN	39.1	455	252	7	98	1456	30	461	3.60E-86	320.5	CHIO_HUMAN	reviewed	Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3)	CHN2 ARHGAP3 BCH	Homo sapiens (Human)	468	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0045202; GO:0046872; GO:0051056	intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN34819_c0_g1_i1	P21550	ENOB_MOUSE	100	84	0	0	253	2	83	166	2.10E-41	169.1	ENOB_MOUSE	reviewed	Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)	Eno3 Eno-3	Mus musculus (Mouse)	434	"cytosol [GO:0005829]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to drug [GO:0042493]; skeletal muscle tissue regeneration [GO:0043403]"	cytosol [GO:0005829]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]	GO:0000015; GO:0000287; GO:0004634; GO:0005829; GO:0005886; GO:0006096; GO:0007568; GO:0016020; GO:0032889; GO:0042493; GO:0042802; GO:0043403; GO:0044877	"aging [GO:0007568]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to drug [GO:0042493]; skeletal muscle tissue regeneration [GO:0043403]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32246_c0_g1_i1	P21550	ENOB_MOUSE	100	83	0	0	249	1	1	83	3.80E-40	165.2	ENOB_MOUSE	reviewed	Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)	Eno3 Eno-3	Mus musculus (Mouse)	434	"cytosol [GO:0005829]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to drug [GO:0042493]; skeletal muscle tissue regeneration [GO:0043403]"	cytosol [GO:0005829]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]	GO:0000015; GO:0000287; GO:0004634; GO:0005829; GO:0005886; GO:0006096; GO:0007568; GO:0016020; GO:0032889; GO:0042493; GO:0042802; GO:0043403; GO:0044877	"aging [GO:0007568]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to drug [GO:0042493]; skeletal muscle tissue regeneration [GO:0043403]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39462_c0_g1_i1	P21550	ENOB_MOUSE	100	292	0	0	1	876	143	434	9.50E-169	594	ENOB_MOUSE	reviewed	Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)	Eno3 Eno-3	Mus musculus (Mouse)	434	"cytosol [GO:0005829]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to drug [GO:0042493]; skeletal muscle tissue regeneration [GO:0043403]"	cytosol [GO:0005829]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]	GO:0000015; GO:0000287; GO:0004634; GO:0005829; GO:0005886; GO:0006096; GO:0007568; GO:0016020; GO:0032889; GO:0042493; GO:0042802; GO:0043403; GO:0044877	"aging [GO:0007568]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; response to drug [GO:0042493]; skeletal muscle tissue regeneration [GO:0043403]"		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i10	Q9TRY9	BGAL_CANLF	48.2	629	304	11	478	2328	30	648	3.20E-166	587	BGAL_CANLF	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Canis lupus familiaris (Dog) (Canis familiaris)	668	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i13	Q9TRY9	BGAL_CANLF	48.2	629	304	11	445	2295	30	648	3.10E-166	587	BGAL_CANLF	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Canis lupus familiaris (Dog) (Canis familiaris)	668	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i2	Q5R7P4	BGAL_PONAB	47.4	679	323	15	385	2364	3	666	8.30E-167	589	BGAL_PONAB	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	677	lysosome [GO:0005764]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i3	O19015	BGAL_FELCA	60.6	104	41	0	447	758	30	133	5.90E-32	139.4	BGAL_FELCA	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1 BGAL	Felis catus (Cat) (Felis silvestris catus)	669	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i5	Q9TRY9	BGAL_CANLF	51.5	460	213	6	174	1538	30	484	2.10E-131	470.7	BGAL_CANLF	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Canis lupus familiaris (Dog) (Canis familiaris)	668	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i6	Q9TRY9	BGAL_CANLF	48.2	629	304	11	445	2295	30	648	3.10E-166	587	BGAL_CANLF	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Canis lupus familiaris (Dog) (Canis familiaris)	668	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i8	Q5R7P4	BGAL_PONAB	47.4	679	323	15	352	2331	3	666	8.20E-167	589	BGAL_PONAB	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	677	lysosome [GO:0005764]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i9	Q5R7P4	BGAL_PONAB	47.4	679	323	15	352	2331	3	666	8.20E-167	589	BGAL_PONAB	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	677	lysosome [GO:0005764]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2209_c0_g2_i1	Q9TRY9	BGAL_CANLF	46	100	50	3	47	334	552	651	6.30E-20	98.2	BGAL_CANLF	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1	Canis lupus familiaris (Dog) (Canis familiaris)	668	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2209_c0_g1_i3	O19015	BGAL_FELCA	50	486	232	7	93	1535	31	510	8.20E-131	468.8	BGAL_FELCA	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1 BGAL	Felis catus (Cat) (Felis silvestris catus)	669	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2209_c0_g1_i4	O19015	BGAL_FELCA	52.3	216	99	3	3	650	151	362	3.50E-59	229.6	BGAL_FELCA	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GLB1 BGAL	Felis catus (Cat) (Felis silvestris catus)	669	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	lysosome [GO:0005764]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005764; GO:0005773; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN35951_c0_g1_i1	P16278	BGAL_HUMAN	100	83	0	0	1	249	9	91	1.70E-43	176	BGAL_HUMAN	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)	GLB1 ELNR1	Homo sapiens (Human)	677	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]	GO:0004565; GO:0005576; GO:0005737; GO:0005773; GO:0005794; GO:0006027; GO:0006687; GO:0016936; GO:0019388; GO:0035578; GO:0042340; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0044262; GO:0048471; GO:0051413; GO:0070062; GO:1904016; GO:1904813	cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]		NA	NA	NA	NA	NA	NA
TRINITY_DN296_c0_g1_i4	P16278	BGAL_HUMAN	49.6	361	171	6	1	1068	129	483	1.20E-93	344.7	BGAL_HUMAN	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)	GLB1 ELNR1	Homo sapiens (Human)	677	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]	GO:0004565; GO:0005576; GO:0005737; GO:0005773; GO:0005794; GO:0006027; GO:0006687; GO:0016936; GO:0019388; GO:0035578; GO:0042340; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0044262; GO:0048471; GO:0051413; GO:0070062; GO:1904016; GO:1904813	cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]		NA	NA	NA	NA	NA	NA
TRINITY_DN33964_c0_g1_i1	P16278	BGAL_HUMAN	100	69	0	0	209	3	144	212	3.20E-35	148.3	BGAL_HUMAN	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)	GLB1 ELNR1	Homo sapiens (Human)	677	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]	GO:0004565; GO:0005576; GO:0005737; GO:0005773; GO:0005794; GO:0006027; GO:0006687; GO:0016936; GO:0019388; GO:0035578; GO:0042340; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0044262; GO:0048471; GO:0051413; GO:0070062; GO:1904016; GO:1904813	cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]		NA	NA	NA	NA	NA	NA
TRINITY_DN40810_c0_g1_i1	P16278	BGAL_HUMAN	100	103	0	0	2	310	260	362	1.30E-56	219.9	BGAL_HUMAN	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)	GLB1 ELNR1	Homo sapiens (Human)	677	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]	GO:0004565; GO:0005576; GO:0005737; GO:0005773; GO:0005794; GO:0006027; GO:0006687; GO:0016936; GO:0019388; GO:0035578; GO:0042340; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0044262; GO:0048471; GO:0051413; GO:0070062; GO:1904016; GO:1904813	cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]		NA	NA	NA	NA	NA	NA
TRINITY_DN2209_c0_g1_i2	P16278	BGAL_HUMAN	46.5	368	185	7	3	1088	150	511	5.80E-86	319.3	BGAL_HUMAN	reviewed	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)	GLB1 ELNR1	Homo sapiens (Human)	677	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]	beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]	GO:0004565; GO:0005576; GO:0005737; GO:0005773; GO:0005794; GO:0006027; GO:0006687; GO:0016936; GO:0019388; GO:0035578; GO:0042340; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0044262; GO:0048471; GO:0051413; GO:0070062; GO:1904016; GO:1904813	cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]		NA	NA	NA	NA	NA	NA
TRINITY_DN806_c0_g1_i4	P06760	BGLR_RAT	48.3	478	230	6	3	1421	125	590	2.80E-130	466.8	BGLR_RAT	reviewed	Beta-glucuronidase (EC 3.2.1.31)	Gusb Gus	Rattus norvegicus (Rat)	648	extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]	extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]	GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0016787; GO:0019391; GO:0019904; GO:0030246	carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN806_c0_g1_i7	O97524	BGLR_FELCA	49.7	513	245	5	3	1526	125	629	2.70E-141	503.8	BGLR_FELCA	reviewed	Beta-glucuronidase (EC 3.2.1.31)	GUSB	Felis catus (Cat) (Felis silvestris catus)	651	extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]; glucuronoside catabolic process [GO:0019391]	extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]	GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0030246	glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN806_c0_g1_i8	P06760	BGLR_RAT	48.3	515	250	5	3	1532	125	628	5.40E-141	502.7	BGLR_RAT	reviewed	Beta-glucuronidase (EC 3.2.1.31)	Gusb Gus	Rattus norvegicus (Rat)	648	extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]	extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]	GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0016787; GO:0019391; GO:0019904; GO:0030246	carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN806_c0_g1_i9	O97524	BGLR_FELCA	49.9	513	243	6	3	1523	125	629	4.10E-142	506.5	BGLR_FELCA	reviewed	Beta-glucuronidase (EC 3.2.1.31)	GUSB	Felis catus (Cat) (Felis silvestris catus)	651	extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]; glucuronoside catabolic process [GO:0019391]	extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]	GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0030246	glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN36328_c0_g1_i1	P08236	BGLR_HUMAN	69.5	167	0	1	1	348	291	457	1.80E-59	229.6	BGLR_HUMAN	reviewed	Beta-glucuronidase (EC 3.2.1.31) (Beta-G1)	GUSB	Homo sapiens (Human)	651	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]	beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]	GO:0004566; GO:0005102; GO:0005576; GO:0005615; GO:0005975; GO:0006027; GO:0016020; GO:0019391; GO:0019904; GO:0030214; GO:0030246; GO:0035578; GO:0043202; GO:0043231; GO:0043312; GO:0070062; GO:1904813	carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN9605_c0_g1_i1	P06865	HEXA_HUMAN	98.4	253	4	0	759	1	116	368	9.30E-149	527.3	HEXA_HUMAN	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	HEXA	Homo sapiens (Human)	529	azurophil granule [GO:0042582]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]	azurophil granule [GO:0042582]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0004563; GO:0005975; GO:0006024; GO:0006687; GO:0006689; GO:0008375; GO:0016020; GO:0030207; GO:0030214; GO:0042340; GO:0042582; GO:0043202; GO:0046982; GO:0070062; GO:0102148	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]		NA	NA	NA	NA	NA	NA
TRINITY_DN9605_c0_g1_i2	P06865	HEXA_HUMAN	100	253	0	0	759	1	116	368	1.50E-151	536.6	HEXA_HUMAN	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	HEXA	Homo sapiens (Human)	529	azurophil granule [GO:0042582]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]	azurophil granule [GO:0042582]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0004563; GO:0005975; GO:0006024; GO:0006687; GO:0006689; GO:0008375; GO:0016020; GO:0030207; GO:0030214; GO:0042340; GO:0042582; GO:0043202; GO:0046982; GO:0070062; GO:0102148	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]		NA	NA	NA	NA	NA	NA
TRINITY_DN39063_c0_g1_i3	Q641X3	HEXA_RAT	46.7	398	195	5	618	1808	127	508	1.30E-111	405.2	HEXA_RAT	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Rattus norvegicus (Rat)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		brown	brown	1	NA	NA	NA
TRINITY_DN39063_c0_g1_i3	Q641X3	HEXA_RAT	47	151	71	2	38	487	182	324	3.60E-37	157.9	HEXA_RAT	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Rattus norvegicus (Rat)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		brown	brown	1	NA	NA	NA
TRINITY_DN39063_c0_g1_i1	Q641X3	HEXA_RAT	47.7	411	198	5	103	1332	127	521	7.10E-118	425.6	HEXA_RAT	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Rattus norvegicus (Rat)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN39063_c0_g1_i2	Q641X3	HEXA_RAT	46.7	398	195	5	103	1293	127	508	9.30E-112	405.2	HEXA_RAT	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Rattus norvegicus (Rat)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN39063_c0_g1_i7	Q641X3	HEXA_RAT	47.7	411	198	5	618	1847	127	521	9.70E-118	425.6	HEXA_RAT	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Rattus norvegicus (Rat)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN39063_c0_g1_i7	Q641X3	HEXA_RAT	47	151	71	2	38	487	182	324	3.80E-37	157.9	HEXA_RAT	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Rattus norvegicus (Rat)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN3260_c0_g1_i1	Q0V8R6	HEXA_BOVIN	48	512	245	10	1619	111	23	522	6.70E-142	505.8	HEXA_BOVIN	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	HEXA	Bos taurus (Bovine)	529	lysosome [GO:0005764]; membrane [GO:0016020]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	lysosome [GO:0005764]; membrane [GO:0016020]	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006689; GO:0007040; GO:0007605; GO:0007628; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		blue	blue	NA	NA	NA	NA
TRINITY_DN39627_c0_g1_i1	P29416	HEXA_MOUSE	100	94	0	0	1	282	409	502	2.70E-53	208.8	HEXA_MOUSE	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Mus musculus (Mouse)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN40522_c0_g1_i1	Q5RC84	HEXA_PONAB	98.9	95	1	0	288	4	419	513	3.90E-54	211.8	HEXA_PONAB	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	HEXA	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	529	lysosome [GO:0005764]; membrane [GO:0016020]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	lysosome [GO:0005764]; membrane [GO:0016020]	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006689; GO:0007040; GO:0007605; GO:0007628; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN28244_c0_g1_i1	P29416	HEXA_MOUSE	94.6	93	5	0	1	279	271	363	3.20E-46	185.3	HEXA_MOUSE	reviewed	Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)	Hexa	Mus musculus (Mouse)	528	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	azurophil granule [GO:0042582]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]	GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148	adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN14969_c0_g1_i1	P07686	HEXB_HUMAN	97.1	136	4	0	1	408	136	271	2.90E-72	272.3	HEXB_HUMAN	reviewed	Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]	HEXB HCC7	Homo sapiens (Human)	556	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0001501; GO:0001669; GO:0004563; GO:0005576; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0016020; GO:0019915; GO:0030207; GO:0030214; GO:0035578; GO:0042340; GO:0042552; GO:0042582; GO:0042802; GO:0043202; GO:0043312; GO:0043615; GO:0044267; GO:0045944; GO:0048477; GO:0050885; GO:0070062; GO:0102148	astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN34105_c0_g1_i1	P07686	HEXB_HUMAN	100	119	0	0	379	23	438	556	7.30E-70	264.2	HEXB_HUMAN	reviewed	Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]	HEXB HCC7	Homo sapiens (Human)	556	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0001501; GO:0001669; GO:0004563; GO:0005576; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0016020; GO:0019915; GO:0030207; GO:0030214; GO:0035578; GO:0042340; GO:0042552; GO:0042582; GO:0042802; GO:0043202; GO:0043312; GO:0043615; GO:0044267; GO:0045944; GO:0048477; GO:0050885; GO:0070062; GO:0102148	astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN14969_c0_g2_i1	P20060	HEXB_MOUSE	100	405	0	0	1	1215	132	536	2.00E-246	852.4	HEXB_MOUSE	reviewed	Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)	Hexb	Mus musculus (Mouse)	536	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein-containing complex binding [GO:0044877]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of cellular metabolic process [GO:0031323]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]	acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein-containing complex binding [GO:0044877]	GO:0001501; GO:0001669; GO:0004563; GO:0005615; GO:0005764; GO:0006044; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0015929; GO:0016020; GO:0016231; GO:0016787; GO:0019915; GO:0019953; GO:0030203; GO:0030246; GO:0031323; GO:0042552; GO:0042582; GO:0042802; GO:0043615; GO:0044267; GO:0044877; GO:0045944; GO:0048477; GO:0050885; GO:0050905; GO:0102148	astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of cellular metabolic process [GO:0031323]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN6413_c0_g1_i1	Q5M8Z0	BHMT1_XENTR	69.5	400	118	2	1267	80	1	400	2.80E-164	579.7	BHMT1_XENTR	reviewed	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	bhmt	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	403	cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]	cytoplasm [GO:0005737]	betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0032259; GO:0047150	amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]		NA	NA	NA	NA	NA	1
TRINITY_DN4486_c0_g1_i1	O35490	BHMT1_MOUSE	57	365	145	5	44	1123	9	366	1.40E-114	414.5	BHMT1_MOUSE	reviewed	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	Bhmt	Mus musculus (Mouse)	407	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]	betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]	GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267	amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]		NA	NA	NA	NA	NA	NA
TRINITY_DN4486_c0_g1_i2	O09171	BHMT1_RAT	51.7	58	28	0	82	255	213	270	4.40E-12	72	BHMT1_RAT	reviewed	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	Bhmt	Rattus norvegicus (Rat)	407	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]; response to organonitrogen compound [GO:0010243]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]	betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]	GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0010243; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267	amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]; response to organonitrogen compound [GO:0010243]		NA	NA	NA	NA	NA	NA
TRINITY_DN4486_c0_g1_i4	Q5XGM3	BHMT1_XENLA	56.4	211	92	0	545	1177	153	363	8.10E-68	259.2	BHMT1_XENLA	reviewed	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	bhmt	Xenopus laevis (African clawed frog)	403	cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]	cytoplasm [GO:0005737]	betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0032259; GO:0047150	amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4486_c0_g1_i4	Q5XGM3	BHMT1_XENLA	61.2	139	53	1	15	431	19	156	6.50E-41	169.9	BHMT1_XENLA	reviewed	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	bhmt	Xenopus laevis (African clawed frog)	403	cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]	cytoplasm [GO:0005737]	betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0032259; GO:0047150	amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4486_c0_g1_i5	Q5XGM3	BHMT1_XENLA	57.3	213	90	1	46	681	151	363	5.60E-67	255.8	BHMT1_XENLA	reviewed	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	bhmt	Xenopus laevis (African clawed frog)	403	cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]	cytoplasm [GO:0005737]	betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006579; GO:0008270; GO:0009086; GO:0032259; GO:0047150	amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN623_c0_g2_i1	Q9I6R0	PCAF_PSEAE	67.9	84	25	2	4	252	214	296	9.30E-21	100.5	PCAF_PSEAE	reviewed	Beta-ketoadipyl-CoA thiolase (EC 2.3.1.174) (3-oxoadipyl-CoA thiolase)	pcaF PA0228	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	401	"3-oxoadipyl-CoA thiolase activity [GO:0033812]; acetyl-CoA C-acyltransferase activity [GO:0003988]; 3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]"		3-oxoadipyl-CoA thiolase activity [GO:0033812]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003988; GO:0006635; GO:0010124; GO:0019619; GO:0033812; GO:0042952	"3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32345_c0_g1_i1	Q9I6R0	PCAF_PSEAE	65.6	90	29	2	271	5	214	302	1.30E-23	110.2	PCAF_PSEAE	reviewed	Beta-ketoadipyl-CoA thiolase (EC 2.3.1.174) (3-oxoadipyl-CoA thiolase)	pcaF PA0228	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	401	"3-oxoadipyl-CoA thiolase activity [GO:0033812]; acetyl-CoA C-acyltransferase activity [GO:0003988]; 3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]"		3-oxoadipyl-CoA thiolase activity [GO:0033812]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003988; GO:0006635; GO:0010124; GO:0019619; GO:0033812; GO:0042952	"3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38877_c0_g1_i1	Q51956	PCAF_PSEPU	69.7	142	43	0	7	432	243	384	8.70E-51	201.1	PCAF_PSEPU	reviewed	Beta-ketoadipyl-CoA thiolase (EC 2.3.1.174) (3-oxoadipyl-CoA thiolase)	pcaF	Pseudomonas putida (Arthrobacter siderocapsulatus)	400	"3-oxoadipyl-CoA thiolase activity [GO:0033812]; 3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]"		3-oxoadipyl-CoA thiolase activity [GO:0033812]	GO:0019619; GO:0033812; GO:0042952	"3,4-dihydroxybenzoate catabolic process [GO:0019619]; beta-ketoadipate pathway [GO:0042952]"		NA	NA	NA	NA	NA	1
TRINITY_DN40996_c0_g1_i1	Q0KBP1	BKTB_CUPNH	74	73	19	0	226	8	295	367	1.50E-25	116.3	BKTB_CUPNH	reviewed	Beta-ketothiolase BktB (EC 2.3.1.16) (EC 2.3.1.9) (Acetyl-CoA acetyltransferase) (Acetyl-CoA acyltransferase)	bktB H16_A1445	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	394	acetyl-CoA C-acetyltransferase activity [GO:0003985]		acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985			NA	NA	NA	NA	NA	NA
TRINITY_DN18448_c0_g1_i1	Q0KBP1	BKTB_CUPNH	93.6	78	5	0	3	236	309	386	1.10E-34	146.7	BKTB_CUPNH	reviewed	Beta-ketothiolase BktB (EC 2.3.1.16) (EC 2.3.1.9) (Acetyl-CoA acetyltransferase) (Acetyl-CoA acyltransferase)	bktB H16_A1445	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	394	acetyl-CoA C-acetyltransferase activity [GO:0003985]		acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985			NA	NA	NA	NA	NA	1
TRINITY_DN18448_c0_g2_i1	Q0KBP1	BKTB_CUPNH	84.1	82	13	0	2	247	228	309	1.40E-32	139.8	BKTB_CUPNH	reviewed	Beta-ketothiolase BktB (EC 2.3.1.16) (EC 2.3.1.9) (Acetyl-CoA acetyltransferase) (Acetyl-CoA acyltransferase)	bktB H16_A1445	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	394	acetyl-CoA C-acetyltransferase activity [GO:0003985]		acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985			NA	NA	NA	NA	NA	NA
TRINITY_DN27845_c0_g1_i1	Q0KBP1	BKTB_CUPNH	87.9	66	8	0	26	223	1	66	5.50E-25	114.4	BKTB_CUPNH	reviewed	Beta-ketothiolase BktB (EC 2.3.1.16) (EC 2.3.1.9) (Acetyl-CoA acetyltransferase) (Acetyl-CoA acyltransferase)	bktB H16_A1445	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	394	acetyl-CoA C-acetyltransferase activity [GO:0003985]		acetyl-CoA C-acetyltransferase activity [GO:0003985]	GO:0003985			NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c6_g1_i1	Q29444	MANBA_BOVIN	40	145	83	2	436	2	23	163	1.60E-25	117.9	MANBA_BOVIN	reviewed	Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)	MANBA	Bos taurus (Bovine)	879	lysosome [GO:0005764]; beta-mannosidase activity [GO:0004567]; carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]	lysosome [GO:0005764]	beta-mannosidase activity [GO:0004567]	GO:0004567; GO:0005764; GO:0005975; GO:0006516	carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c6_g1_i3	Q29444	MANBA_BOVIN	40	145	83	2	436	2	23	163	1.40E-25	117.9	MANBA_BOVIN	reviewed	Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)	MANBA	Bos taurus (Bovine)	879	lysosome [GO:0005764]; beta-mannosidase activity [GO:0004567]; carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]	lysosome [GO:0005764]	beta-mannosidase activity [GO:0004567]	GO:0004567; GO:0005764; GO:0005975; GO:0006516	carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]		NA	NA	NA	NA	NA	NA
TRINITY_DN1626_c0_g1_i1	Q4FZV0	MANBA_RAT	42.7	579	309	11	3	1724	321	881	1.30E-130	468.4	MANBA_RAT	reviewed	Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)	Manba	Rattus norvegicus (Rat)	881	extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-mannosidase activity [GO:0004567]; hydrolase activity [GO:0016787]; mannose binding [GO:0005537]; carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]	extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-mannosidase activity [GO:0004567]; hydrolase activity [GO:0016787]; mannose binding [GO:0005537]	GO:0004567; GO:0005537; GO:0005615; GO:0005764; GO:0005975; GO:0006516; GO:0016787	carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]		NA	NA	NA	NA	NA	NA
TRINITY_DN14471_c0_g1_i1	Q9ES46	PARVB_MOUSE	52	75	32	2	8	229	7	78	3.00E-10	65.5	PARVB_MOUSE	reviewed	Beta-parvin	Parvb	Mus musculus (Mouse)	365	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0031532; GO:0034446; GO:0071963	actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN11935_c0_g1_i1	Q9HBI1	PARVB_HUMAN	64.6	302	106	1	152	1057	62	362	4.10E-108	392.9	PARVB_HUMAN	reviewed	Beta-parvin (Affixin)	PARVB CGI-56	Homo sapiens (Human)	364	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0031532; GO:0034446; GO:0071963	actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN11935_c0_g1_i2	Q9HBI1	PARVB_HUMAN	62	363	135	3	98	1183	2	362	4.30E-122	439.5	PARVB_HUMAN	reviewed	Beta-parvin (Affixin)	PARVB CGI-56	Homo sapiens (Human)	364	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0031532; GO:0034446; GO:0071963	actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN10455_c0_g1_i1	Q5RBM6	BUP1_PONAB	67.6	380	122	1	103	1239	5	384	9.90E-154	544.7	BUP1_PONAB	reviewed	Beta-ureidopropionase (EC 3.5.1.6) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase)	UPB1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	384	cytoplasm [GO:0005737]; beta-ureidopropionase activity [GO:0003837]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; protein homooligomerization [GO:0051260]; pyrimidine nucleoside catabolic process [GO:0046135]	cytoplasm [GO:0005737]	beta-ureidopropionase activity [GO:0003837]	GO:0003837; GO:0005737; GO:0033396; GO:0046135; GO:0051260	beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; protein homooligomerization [GO:0051260]; pyrimidine nucleoside catabolic process [GO:0046135]		blue	blue	NA	NA	NA	NA
TRINITY_DN36480_c0_g1_i1	Q55108	CMPD_SYNE7	48.1	77	40	0	1	231	23	99	6.30E-16	84.3	CMPD_SYNE7	reviewed	Bicarbonate transport ATP-binding protein CmpD (EC 7.6.2.-)	cmpD Synpcc7942_1491	Synechococcus elongatus (strain PCC 7942 / FACHB-805) (Anacystis nidulans R2)	278	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nitrate transmembrane transporter activity [GO:0015112]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; nitrate transmembrane transporter activity [GO:0015112]	GO:0005524; GO:0005886; GO:0015112; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN24929_c0_g1_i1	Q60967	PAPS1_MOUSE	99.1	109	1	0	3	329	452	560	4.90E-62	238	PAPS1_MOUSE	reviewed	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]	Papss1 Asapk Atpsk1 Papss	Mus musculus (Mouse)	624	sulfate adenylyltransferase complex (ATP) [GO:0009336]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103]	sulfate adenylyltransferase complex (ATP) [GO:0009336]	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]	GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0009336; GO:0016779; GO:0042803; GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103]		NA	NA	NA	NA	NA	NA
TRINITY_DN24929_c0_g1_i2	Q60967	PAPS1_MOUSE	99.2	133	1	0	3	401	452	584	1.10E-76	287	PAPS1_MOUSE	reviewed	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]	Papss1 Asapk Atpsk1 Papss	Mus musculus (Mouse)	624	sulfate adenylyltransferase complex (ATP) [GO:0009336]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103]	sulfate adenylyltransferase complex (ATP) [GO:0009336]	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]	GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0009336; GO:0016779; GO:0042803; GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103]		NA	NA	NA	NA	NA	NA
TRINITY_DN34885_c0_g1_i1	O43252	PAPS1_HUMAN	100	71	0	0	215	3	360	430	1.40E-38	159.5	PAPS1_HUMAN	reviewed	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]	PAPSS1 ATPSK1 PAPSS	Homo sapiens (Human)	624	cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]	cytosol [GO:0005829]	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]	GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]		NA	NA	NA	NA	NA	NA
TRINITY_DN33350_c0_g1_i1	O95340	PAPS2_HUMAN	74.4	285	73	0	928	74	329	613	9.70E-132	471.1	PAPS2_HUMAN	reviewed	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]	PAPSS2 ATPSK2	Homo sapiens (Human)	614	cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; blood coagulation [GO:0007596]; bone development [GO:0060348]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]	cytosol [GO:0005829]	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]	GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0007596; GO:0016779; GO:0050428; GO:0060348	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; blood coagulation [GO:0007596]; bone development [GO:0060348]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]		NA	NA	NA	NA	NA	NA
TRINITY_DN22767_c0_g1_i1	Q58DS6	JMJD6_BOVIN	100	81	0	0	243	1	80	160	3.20E-42	171.8	JMJD6_BOVIN	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR)	JMJD6 PTDSR	Bos taurus (Bovine)	403	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]	GO:0002040; GO:0003713; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0035513; GO:0035515; GO:0045893; GO:0045944; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3094_c0_g1_i2	Q6PFM0	JMJD6_DANRE	71	93	27	0	68	346	250	342	3.50E-36	152.5	JMJD6_DANRE	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr)	jmjd6 psr ptdsr zgc:66264	Danio rerio (Zebrafish) (Brachydanio rerio)	403	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]	GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3094_c0_g1_i3	Q6PFM0	JMJD6_DANRE	67.1	343	112	1	91	1119	1	342	3.60E-147	522.7	JMJD6_DANRE	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr)	jmjd6 psr ptdsr zgc:66264	Danio rerio (Zebrafish) (Brachydanio rerio)	403	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]	GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3094_c0_g1_i5	Q6PFM0	JMJD6_DANRE	64.3	213	73	2	91	729	1	210	2.00E-80	300.8	JMJD6_DANRE	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr)	jmjd6 psr ptdsr zgc:66264	Danio rerio (Zebrafish) (Brachydanio rerio)	403	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]	GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3094_c0_g1_i5	Q6PFM0	JMJD6_DANRE	72.7	88	24	0	708	971	255	342	2.50E-35	151	JMJD6_DANRE	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr)	jmjd6 psr ptdsr zgc:66264	Danio rerio (Zebrafish) (Brachydanio rerio)	403	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]	GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15255_c0_g1_i1	Q6NYC1	JMJD6_HUMAN	100	258	0	0	2	775	13	270	8.00E-156	551.2	JMJD6_HUMAN	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR)	JMJD6 KIAA0585 PSR PTDSR	Homo sapiens (Human)	403	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; P-TEFb complex binding [GO:0106140]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]	GO:0001822; GO:0002040; GO:0003713; GO:0003723; GO:0003727; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006397; GO:0006482; GO:0007166; GO:0007507; GO:0008380; GO:0018395; GO:0030324; GO:0032451; GO:0032452; GO:0033077; GO:0033746; GO:0033749; GO:0035513; GO:0035515; GO:0038023; GO:0042116; GO:0042802; GO:0043654; GO:0045893; GO:0045944; GO:0048024; GO:0048821; GO:0051260; GO:0060041; GO:0070078; GO:0070079; GO:0070815; GO:0106140; GO:1990904	"cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15255_c0_g1_i1	Q6NYC1	JMJD6_HUMAN	100	75	0	0	771	995	269	343	7.50E-37	156	JMJD6_HUMAN	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR)	JMJD6 KIAA0585 PSR PTDSR	Homo sapiens (Human)	403	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; P-TEFb complex binding [GO:0106140]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]	GO:0001822; GO:0002040; GO:0003713; GO:0003723; GO:0003727; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006397; GO:0006482; GO:0007166; GO:0007507; GO:0008380; GO:0018395; GO:0030324; GO:0032451; GO:0032452; GO:0033077; GO:0033746; GO:0033749; GO:0035513; GO:0035515; GO:0038023; GO:0042116; GO:0042802; GO:0043654; GO:0045893; GO:0045944; GO:0048024; GO:0048821; GO:0051260; GO:0060041; GO:0070078; GO:0070079; GO:0070815; GO:0106140; GO:1990904	"cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7869_c0_g1_i1	Q6GND3	JMD6A_XENLA	44.2	147	82	0	5	445	85	231	7.30E-37	154.8	JMD6A_XENLA	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6-A (EC 1.14.11.-) (Histone arginine demethylase JMJD6-A) (JmjC domain-containing protein 6-A) (Jumonji domain-containing protein 6-A) (Lysyl-hydroxylase JMJD6-A) (Peptide-lysine 5-dioxygenase JMJD6-A) (Phosphatidylserine receptor-A) (Protein PTDSR-A)	jmjd6-a ptdsr-a	Xenopus laevis (African clawed frog)	403	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]	GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3094_c0_g1_i4	Q9VD28	JMJD6_DROME	71.6	320	90	1	111	1070	29	347	5.70E-142	505.4	JMJD6_DROME	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-)	PSR CG5383	Drosophila melanogaster (Fruit fly)	408	nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]	GO:0005634; GO:0006325; GO:0018395; GO:0035212; GO:0043066; GO:0046329; GO:0046872; GO:0070815	cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]		NA	NA	NA	NA	NA	NA
TRINITY_DN3094_c0_g1_i8	Q9VD28	JMJD6_DROME	71.6	320	90	1	137	1096	29	347	5.90E-142	505.4	JMJD6_DROME	reviewed	Bifunctional arginine demethylase and lysyl-hydroxylase PSR (EC 1.14.11.-)	PSR CG5383	Drosophila melanogaster (Fruit fly)	408	nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]	GO:0005634; GO:0006325; GO:0018395; GO:0035212; GO:0043066; GO:0046329; GO:0046872; GO:0070815	cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]		NA	NA	NA	NA	NA	NA
TRINITY_DN10601_c0_g1_i1	Q13057	COASY_HUMAN	44.5	382	207	3	117	1250	176	556	1.30E-78	295	COASY_HUMAN	reviewed	Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)]	COASY PSEC0106	Homo sapiens (Human)	564	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]	GO:0004140; GO:0004595; GO:0005524; GO:0005741; GO:0005759; GO:0015937; GO:0070062	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN24105_c0_g1_i1	G9M9M3	F6H22_IPOBA	25.6	308	196	9	6	878	46	337	5.80E-13	76.6	F6H22_IPOBA	reviewed	Bi-functional coumaroyl CoA and feruloyl CoA ortho-hydroxylase F6H2-2-1 (IbF6H2-2-1) (EC 1.14.11.61) (EC 1.14.11.62) (2-oxoglutarate-dependent dioxygenase F6H2-2-1) (2OGD F6H2-2-1)	F6H2-2-1	Ipomoea batatas (Sweet potato) (Convolvulus batatas)	358	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; coumarin biosynthetic process [GO:0009805]; phenylpropanoid biosynthetic process [GO:0009699]; response to fungus [GO:0009620]; response to molecule of fungal origin [GO:0002238]		2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]	GO:0002238; GO:0009620; GO:0009699; GO:0009805; GO:0016706; GO:0046872	coumarin biosynthetic process [GO:0009805]; phenylpropanoid biosynthetic process [GO:0009699]; response to fungus [GO:0009620]; response to molecule of fungal origin [GO:0002238]		NA	NA	NA	NA	NA	NA
TRINITY_DN24105_c0_g1_i2	G9M9M3	F6H22_IPOBA	24	217	146	4	6	635	46	250	1.60E-06	54.7	F6H22_IPOBA	reviewed	Bi-functional coumaroyl CoA and feruloyl CoA ortho-hydroxylase F6H2-2-1 (IbF6H2-2-1) (EC 1.14.11.61) (EC 1.14.11.62) (2-oxoglutarate-dependent dioxygenase F6H2-2-1) (2OGD F6H2-2-1)	F6H2-2-1	Ipomoea batatas (Sweet potato) (Convolvulus batatas)	358	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; coumarin biosynthetic process [GO:0009805]; phenylpropanoid biosynthetic process [GO:0009699]; response to fungus [GO:0009620]; response to molecule of fungal origin [GO:0002238]		2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]	GO:0002238; GO:0009620; GO:0009699; GO:0009805; GO:0016706; GO:0046872	coumarin biosynthetic process [GO:0009805]; phenylpropanoid biosynthetic process [GO:0009699]; response to fungus [GO:0009620]; response to molecule of fungal origin [GO:0002238]		NA	NA	NA	NA	NA	NA
TRINITY_DN6492_c0_g2_i1	Q05762	DRTS1_ARATH	72	157	44	0	474	4	233	389	1.40E-65	250.4	DRTS1_ARATH	reviewed	Bifunctional dihydrofolate reductase-thymidylate synthase 1 (DHFR-TS 1) [Includes: Dihydrofolate reductase (EC 1.5.1.3); Thymidylate synthase (EC 2.1.1.45)]	THY-1 At2g16370 F16F14.13	Arabidopsis thaliana (Mouse-ear cress)	519	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; thymidylate synthase activity [GO:0004799]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; dTMP biosynthetic process [GO:0006231]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	dihydrofolate reductase activity [GO:0004146]; thymidylate synthase activity [GO:0004799]	GO:0004146; GO:0004799; GO:0005737; GO:0005739; GO:0005829; GO:0006231; GO:0006730; GO:0009257; GO:0032259	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; dTMP biosynthetic process [GO:0006231]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN37412_c0_g1_i1	Q7SIA2	SYEP_CRIGR	100	79	0	0	2	238	389	467	2.10E-43	175.6	SYEP_CRIGR	reviewed	Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]	EPRS1 EPRS QPRS	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1511	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]	GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904	cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]		NA	NA	NA	NA	NA	NA
TRINITY_DN39330_c0_g1_i1	Q7SIA2	SYEP_CRIGR	100	80	0	0	242	3	390	469	9.90E-44	176.8	SYEP_CRIGR	reviewed	Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]	EPRS1 EPRS QPRS	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1511	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]	GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904	cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]		NA	NA	NA	NA	NA	NA
TRINITY_DN8360_c0_g1_i1	Q9V3L1	NDST_DROME	55.1	263	98	2	3	731	289	551	8.20E-78	291.6	NDST_DROME	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]	sfl CG8339	Drosophila melanogaster (Fruit fly)	1048	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; sulfotransferase activity [GO:0008146]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; sulfotransferase activity [GO:0008146]	GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140	"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8360_c0_g1_i4	Q9V3L1	NDST_DROME	57.8	263	104	1	3	770	289	551	3.30E-85	316.2	NDST_DROME	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]	sfl CG8339	Drosophila melanogaster (Fruit fly)	1048	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; sulfotransferase activity [GO:0008146]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; sulfotransferase activity [GO:0008146]	GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140	"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8360_c0_g1_i5	Q9V3L1	NDST_DROME	55.5	200	82	1	62	640	352	551	1.10E-57	224.6	NDST_DROME	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]	sfl CG8339	Drosophila melanogaster (Fruit fly)	1048	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; sulfotransferase activity [GO:0008146]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; sulfotransferase activity [GO:0008146]	GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140	"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11380_c0_g1_i1	O97583	NDST2_BOVIN	63.1	485	178	1	1	1452	395	879	2.30E-199	696.4	NDST2_BOVIN	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (CCL44) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)]	NDST2	Bos taurus (Bovine)	884	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]	GO:0000139; GO:0005794; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210	"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26608_c0_g1_i1	O97583	NDST2_BOVIN	100	106	0	0	320	3	398	503	6.90E-61	234.2	NDST2_BOVIN	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (CCL44) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)]	NDST2	Bos taurus (Bovine)	884	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]	GO:0000139; GO:0005794; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210	"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33898_c0_g1_i1	P52849	NDST2_HUMAN	100	71	0	0	1	213	497	567	1.10E-35	149.8	NDST2_HUMAN	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) (N-heparan sulfate sulfotransferase 2) (N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)]	NDST2 HSST2	Homo sapiens (Human)	883	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]	GO:0000139; GO:0005794; GO:0006024; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37759_c0_g1_i1	P52849	NDST2_HUMAN	100	94	0	0	3	284	617	710	1.80E-49	196.1	NDST2_HUMAN	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) (N-heparan sulfate sulfotransferase 2) (N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)]	NDST2 HSST2	Homo sapiens (Human)	883	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]	GO:0000139; GO:0005794; GO:0006024; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34502_c0_g1_i1	P52849	NDST2_HUMAN	100	72	0	0	1	216	719	790	2.30E-36	152.1	NDST2_HUMAN	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) (N-heparan sulfate sulfotransferase 2) (N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)]	NDST2 HSST2	Homo sapiens (Human)	883	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]	GO:0000139; GO:0005794; GO:0006024; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11380_c0_g1_i2	O95803	NDST3_HUMAN	48.2	485	136	4	1	1110	386	870	4.10E-132	472.6	NDST3_HUMAN	reviewed	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 3) (NDST-3) (hNDST-3) (N-heparan sulfate sulfotransferase 3) (N-HSST 3) [Includes: Heparan sulfate N-deacetylase 3 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 3 (EC 2.8.2.-)]	NDST3 HSST3 UNQ2544/PRO4998	Homo sapiens (Human)	873	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]	GO:0000139; GO:0005794; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0102140	"heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28720_c0_g1_i1	C3XRY1	NO66_BRAFL	47.9	73	37	1	243	28	357	429	2.80E-14	79	NO66_BRAFL	reviewed	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66)	BRAFLDRAFT_123918	Branchiostoma floridae (Florida lancelet) (Amphioxus)	607	"nucleolus [GO:0005730]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]	GO:0005506; GO:0005634; GO:0005730; GO:0016706; GO:0032453; GO:0034720; GO:0045892; GO:0051864; GO:0070544	"histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33900_c0_g1_i1	P18155	MTDC_MOUSE	99	102	1	0	1	306	133	234	9.80E-57	220.3	MTDC_MOUSE	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	Mthfd2 Nmdmc	Mus musculus (Mouse)	350	mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0006730; GO:0035999; GO:0042301; GO:0046653	one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g1_i1	Q0P5C2	MTDC_BOVIN	52.1	140	67	0	15	434	25	164	2.10E-34	147.1	MTDC_BOVIN	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	MTHFD2	Bos taurus (Bovine)	350	mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0006730; GO:0035999; GO:0042301	one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g1_i1	Q0P5C2	MTDC_BOVIN	62.2	45	15	1	433	561	188	232	2.50E-06	53.9	MTDC_BOVIN	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	MTHFD2	Bos taurus (Bovine)	350	mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0006730; GO:0035999; GO:0042301	one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g1_i2	Q0P5C2	MTDC_BOVIN	52.1	140	67	0	15	434	25	164	2.20E-34	146.7	MTDC_BOVIN	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	MTHFD2	Bos taurus (Bovine)	350	mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0006730; GO:0035999; GO:0042301	one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g1_i3	Q0P5C2	MTDC_BOVIN	67.8	149	45	1	433	879	188	333	4.40E-52	206.5	MTDC_BOVIN	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	MTHFD2	Bos taurus (Bovine)	350	mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0006730; GO:0035999; GO:0042301	one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g1_i3	Q0P5C2	MTDC_BOVIN	52.1	140	67	0	15	434	25	164	3.20E-34	147.1	MTDC_BOVIN	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	MTHFD2	Bos taurus (Bovine)	350	mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0006730; GO:0035999; GO:0042301	one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN35358_c0_g1_i1	P13995	MTDC_HUMAN	100	294	0	0	3	884	57	350	2.60E-166	585.9	MTDC_HUMAN	reviewed	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	MTHFD2 NMDMC	Homo sapiens (Human)	350	extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005615; GO:0005739; GO:0005759; GO:0006730; GO:0035999; GO:0042301; GO:0046653; GO:0046655	folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN11116_c0_g1_i1	P0C870	JMJD7_HUMAN	54	302	138	1	143	1045	9	310	2.30E-98	360.5	JMJD7_HUMAN	reviewed	Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase JMJD7)	JMJD7	Homo sapiens (Human)	316	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; protein hydroxylation [GO:0018126]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]	GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0035064; GO:0046872	protein hydroxylation [GO:0018126]		NA	NA	NA	NA	NA	NA
TRINITY_DN11116_c0_g1_i3	P0C872	JMJD7_MOUSE	52.5	242	114	1	143	865	9	250	7.00E-71	268.9	JMJD7_MOUSE	reviewed	Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7)	Jmjd7	Mus musculus (Mouse)	316	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; protein hydroxylation [GO:0018126]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]	GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0035064; GO:0046872	protein hydroxylation [GO:0018126]		NA	NA	NA	NA	NA	NA
TRINITY_DN11116_c0_g1_i8	P0C870	JMJD7_HUMAN	55.4	289	128	1	90	953	22	310	8.70E-97	355.1	JMJD7_HUMAN	reviewed	Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase JMJD7)	JMJD7	Homo sapiens (Human)	316	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; protein hydroxylation [GO:0018126]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]	GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0035064; GO:0046872	protein hydroxylation [GO:0018126]		NA	NA	NA	NA	NA	NA
TRINITY_DN35769_c0_g1_i1	Q497B8	KDM8_RAT	42.3	376	183	9	1176	91	59	414	3.50E-81	303.5	KDM8_RAT	reviewed	Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.-) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)	Kdm8 Jmjd5	Rattus norvegicus (Rat)	414	"chromosome [GO:0005694]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]"	chromosome [GO:0005694]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000086; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005694; GO:0016706; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0051864; GO:0070544	"circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9153_c0_g1_i1	Q2VYZ7	FOLD_MAGSA	76.8	82	14	2	4	234	201	282	1.80E-26	119.4	FOLD_MAGSA	reviewed	Bifunctional protein FolD [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]	folD amb4374	Magnetospirillum magneticum (strain AMB-1 / ATCC 700264)	295	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004477; GO:0004488; GO:0006164; GO:0009086; GO:0035999	histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN31661_c0_g1_i1	B2UFY4	FOLD_RALPJ	100	77	0	0	233	3	64	140	3.20E-39	161.8	FOLD_RALPJ	reviewed	Bifunctional protein FolD [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]	folD Rpic_1950	Ralstonia pickettii (strain 12J)	289	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004477; GO:0004488; GO:0006164; GO:0009086; GO:0035999	histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g1_i4	C4XLR8	FOLD_DESMR	50.8	59	29	0	54	230	2	60	9.40E-11	67.4	FOLD_DESMR	reviewed	Bifunctional protein FolD [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]	folD DMR_11650	Desulfovibrio magneticus (strain ATCC 700980 / DSM 13731 / RS-1)	292	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004477; GO:0004488; GO:0006164; GO:0009086; GO:0035999	histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN34037_c0_g1_i1	B2UFY4	FOLD_RALPJ	99	96	1	0	2	289	188	283	3.90E-47	188.3	FOLD_RALPJ	reviewed	Bifunctional protein FolD [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]	folD Rpic_1950	Ralstonia pickettii (strain 12J)	289	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004477; GO:0004488; GO:0006164; GO:0009086; GO:0035999	histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN12639_c0_g1_i1	Q9LHH7	FOLD2_ARATH	64	86	31	0	280	23	210	295	1.30E-26	120.2	FOLD2_ARATH	reviewed	Bifunctional protein FolD 2 (Tetrahydrofolate dehydrogenase/cyclohydrolase 2) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]	FOLD2 DHC2 At3g12290 F28J15.8	Arabidopsis thaliana (Mouse-ear cress)	299	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; regulation of DNA methylation [GO:0044030]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0004477; GO:0004488; GO:0005737; GO:0005829; GO:0006730; GO:0009507; GO:0009853; GO:0035999; GO:0044030; GO:0046653	one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; regulation of DNA methylation [GO:0044030]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN15422_c0_g1_i1	O65271	FOLD4_ARATH	75.4	61	15	0	3	185	295	355	2.30E-18	92.4	FOLD4_ARATH	reviewed	"Bifunctional protein FolD 4, chloroplastic (Protein EMBRYO DEFECTIVE 3127) (Tetrahydrofolate dehydrogenase/cyclohydrolase 4) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"	FOLD4 DHC4 EMB3127 At4g00620 F6N23.26	Arabidopsis thaliana (Mouse-ear cress)	360	chloroplast [GO:0009507]; cytosol [GO:0005829]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; tetrahydrofolate interconversion [GO:0035999]	chloroplast [GO:0009507]; cytosol [GO:0005829]	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0004477; GO:0004488; GO:0005829; GO:0006730; GO:0009507; GO:0009853; GO:0035999	one-carbon metabolic process [GO:0006730]; photorespiration [GO:0009853]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN37115_c0_g1_i1	P04397	GAL10_YEAST	97.1	69	2	0	240	34	201	269	4.50E-33	141.4	GAL10_YEAST	reviewed	Bifunctional protein GAL10 [Includes: UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase); Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)]	GAL10 YBR019C YBR0301	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	699	cytosol [GO:0005829]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; UDP-glucose 4-epimerase activity [GO:0003978]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; UDP-glucose 4-epimerase activity [GO:0003978]	GO:0003978; GO:0004034; GO:0005829; GO:0030246; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN31105_c0_g1_i1	P54113	PUR91_YEAST	63.7	102	36	1	307	5	205	306	3.40E-28	125.6	PUR91_YEAST	reviewed	Bifunctional purine biosynthesis protein ADE16 [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	ADE16 YLR028C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	591	cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]	GO:0003937; GO:0004643; GO:0005829; GO:0006164; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN30659_c0_g1_i1	P31939	PUR9_HUMAN	100	249	0	0	1	747	95	343	8.00E-137	487.6	PUR9_HUMAN	reviewed	"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase (IMP cyclohydrolase) (EC 3.5.4.10) (IMP synthase) (Inosinicase)]"	ATIC PURH OK/SW-cl.86	Homo sapiens (Human)	592	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]	GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006139; GO:0006189; GO:0009116; GO:0009168; GO:0010035; GO:0016020; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0045296; GO:0046452; GO:0046654; GO:0070062; GO:0098761	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN13480_c0_g1_i1	O35567	PUR9_RAT	72.3	329	87	3	1	978	35	362	7.30E-130	464.9	PUR9_RAT	reviewed	Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]	Atic Purh	Rattus norvegicus (Rat)	592	cytosol [GO:0005829]; plasma membrane [GO:0005886]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cobalamin metabolic process [GO:0009235]; dihydrofolate metabolic process [GO:0046452]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]	GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006189; GO:0009116; GO:0009235; GO:0009259; GO:0010035; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0046452; GO:0046654; GO:0098761	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cobalamin metabolic process [GO:0009235]; dihydrofolate metabolic process [GO:0046452]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN13480_c0_g1_i2	P31335	PUR9_CHICK	80.5	133	25	1	74	469	231	363	1.20E-53	210.7	PUR9_CHICK	reviewed	Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]	ATIC PURH	Gallus gallus (Chicken)	593	cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]	cytosol [GO:0005829]	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]	GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN13480_c0_g1_i3	O35567	PUR9_RAT	74.3	272	67	2	53	859	91	362	1.30E-109	397.5	PUR9_RAT	reviewed	Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]	Atic Purh	Rattus norvegicus (Rat)	592	cytosol [GO:0005829]; plasma membrane [GO:0005886]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cobalamin metabolic process [GO:0009235]; dihydrofolate metabolic process [GO:0046452]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]	GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006189; GO:0009116; GO:0009235; GO:0009259; GO:0010035; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0046452; GO:0046654; GO:0098761	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cobalamin metabolic process [GO:0009235]; dihydrofolate metabolic process [GO:0046452]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN28627_c0_g1_i1	Q9CWJ9	PUR9_MOUSE	100	77	0	0	233	3	49	125	1.80E-37	156	PUR9_MOUSE	reviewed	Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]	Atic Purh	Mus musculus (Mouse)	592	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]	GO:0003360; GO:0003937; GO:0004643; GO:0005739; GO:0005829; GO:0005886; GO:0006189; GO:0009116; GO:0009259; GO:0010035; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0046452; GO:0046654; GO:0098761	'de novo' IMP biosynthetic process [GO:0006189]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN37518_c0_g1_i1	B2UFL5	PUR9_RALPJ	98.6	70	1	0	3	212	92	161	3.40E-32	138.3	PUR9_RALPJ	reviewed	Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	purH Rpic_0380	Ralstonia pickettii (strain 12J)	524	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]		IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]	GO:0003937; GO:0004643; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN37048_c0_g1_i1	Q5LN38	PUR9_RUEPO	65.6	96	33	0	295	8	50	145	2.00E-30	132.9	PUR9_RUEPO	reviewed	Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	purH SPO3374	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	529	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]		IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]	GO:0003937; GO:0004643; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN8909_c0_g1_i1	Q8Y232	PUR9_RALSO	82.1	67	12	0	2	202	26	92	2.00E-26	119	PUR9_RALSO	reviewed	Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	purH RSc0504 RS05018	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	524	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]		IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]	GO:0003937; GO:0004643; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN8909_c0_g2_i1	A8LMD0	PUR9_DINSH	80.4	102	20	0	18	323	5	106	9.80E-39	160.6	PUR9_DINSH	reviewed	Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	purH Dshi_0358	Dinoroseobacter shibae (strain DSM 16493 / NCIMB 14021 / DFL 12)	529	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]		IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]	GO:0003937; GO:0004643; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN8909_c0_g3_i1	Q5LN38	PUR9_RUEPO	77.6	98	22	0	1	294	11	108	1.70E-37	156.4	PUR9_RUEPO	reviewed	Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	purH SPO3374	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	529	IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]		IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]	GO:0003937; GO:0004643; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c1_g1_i2	Q54GJ2	PUR2_DICDI	58	69	28	1	289	83	313	380	1.90E-17	89.7	PUR2_DICDI	reviewed	Bifunctional purine biosynthetic protein purD [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)]	purD DDB_G0290121	Dictyostelium discoideum (Slime mold)	815	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004637; GO:0004641; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0046084; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN32683_c0_g1_i1	G4RK44	TPSP_THETK	35	748	412	20	99	2258	3	704	1.70E-112	408.7	TPSP_THETK	reviewed	"Bifunctional trehalose-6-phosphate synthase/phosphatase [Includes: Alpha,alpha-trehalose-phosphate synthase [UDP-forming] (EC 2.4.1.15) (Trehalose-6-phosphate synthase); Trehalose-6-phosphate phosphatase (EC 3.1.3.12)]"	tpsp TTX_1304	Thermoproteus tenax (strain ATCC 35583 / DSM 2078 / JCM 9277 / NBRC 100435 / Kra 1)	731	"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]; trehalose biosynthetic process [GO:0005992]"		"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; metal ion binding [GO:0046872]; trehalose-phosphatase activity [GO:0004805]"	GO:0003825; GO:0004805; GO:0005992; GO:0046872	trehalose biosynthetic process [GO:0005992]		NA	NA	NA	NA	NA	NA
TRINITY_DN12893_c0_g1_i1	Q91X34	BAAT_MOUSE	42.2	135	78	0	202	606	44	178	9.90E-24	111.7	BAAT_MOUSE	reviewed	Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2)	Baat	Mus musculus (Mouse)	420	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]	GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817; GO:0102991	acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]		NA	NA	NA	NA	NA	NA
TRINITY_DN12893_c0_g1_i4	Q91X34	BAAT_MOUSE	40.4	171	102	0	148	660	8	178	5.50E-28	125.9	BAAT_MOUSE	reviewed	Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2)	Baat	Mus musculus (Mouse)	420	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]	cytosol [GO:0005829]; peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]	GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817; GO:0102991	acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]		NA	NA	NA	NA	NA	NA
TRINITY_DN13937_c0_g1_i2	O95342	ABCBB_HUMAN	43.3	60	34	0	182	3	733	792	2.20E-09	62.4	ABCBB_HUMAN	reviewed	Bile salt export pump (EC 7.6.2.-) (ATP-binding cassette sub-family B member 11)	ABCB11 BSEP	Homo sapiens (Human)	1321	"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium transmembrane transporter activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; drug export [GO:0046618]; drug metabolic process [GO:0017144]; drug transmembrane transport [GO:0006855]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; transmembrane transport [GO:0055085]"	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	"ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium transmembrane transporter activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]"	GO:0005215; GO:0005524; GO:0005768; GO:0005886; GO:0005887; GO:0006631; GO:0006699; GO:0006855; GO:0008206; GO:0008554; GO:0008559; GO:0009986; GO:0015125; GO:0015126; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016324; GO:0016567; GO:0016887; GO:0017144; GO:0031998; GO:0042626; GO:0042632; GO:0046581; GO:0046618; GO:0046691; GO:0055037; GO:0055038; GO:0055085; GO:0055088; GO:0055091; GO:0070062; GO:0120189; GO:1904251	bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; drug export [GO:0046618]; drug metabolic process [GO:0017144]; drug transmembrane transport [GO:0006855]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN13937_c0_g1_i4	O95342	ABCBB_HUMAN	44.9	49	27	0	384	238	733	781	3.20E-07	56.2	ABCBB_HUMAN	reviewed	Bile salt export pump (EC 7.6.2.-) (ATP-binding cassette sub-family B member 11)	ABCB11 BSEP	Homo sapiens (Human)	1321	"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium transmembrane transporter activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; drug export [GO:0046618]; drug metabolic process [GO:0017144]; drug transmembrane transport [GO:0006855]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; transmembrane transport [GO:0055085]"	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	"ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium transmembrane transporter activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]"	GO:0005215; GO:0005524; GO:0005768; GO:0005886; GO:0005887; GO:0006631; GO:0006699; GO:0006855; GO:0008206; GO:0008554; GO:0008559; GO:0009986; GO:0015125; GO:0015126; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016324; GO:0016567; GO:0016887; GO:0017144; GO:0031998; GO:0042626; GO:0042632; GO:0046581; GO:0046618; GO:0046691; GO:0055037; GO:0055038; GO:0055085; GO:0055088; GO:0055091; GO:0070062; GO:0120189; GO:1904251	bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; drug export [GO:0046618]; drug metabolic process [GO:0017144]; drug transmembrane transport [GO:0006855]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN7225_c2_g1_i3	P30122	CEL_BOVIN	68.8	64	20	0	82	273	166	229	9.40E-20	97.4	CEL_BOVIN	reviewed	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	CEL	Bos taurus (Bovine)	597	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; acetylesterase activity [GO:0008126]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	acetylesterase activity [GO:0008126]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0008126; GO:0016042	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5767_c0_g1_i1	P09464	BBP_PIEBR	26.9	156	105	4	334	792	1	150	3.30E-07	57.4	BBP_PIEBR	reviewed	Bilin-binding protein (BBP)		Pieris brassicae (White butterfly) (Large white butterfly)	189	extracellular region [GO:0005576]; pigment binding [GO:0031409]; protein-chromophore linkage [GO:0018298]	extracellular region [GO:0005576]	pigment binding [GO:0031409]	GO:0005576; GO:0018298; GO:0031409	protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN29867_c0_g1_i2	O55102	BL1S1_MOUSE	100	105	0	0	2	316	21	125	4.00E-53	208.4	BL1S1_MOUSE	reviewed	Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (GCN5-like protein 1)	Bloc1s1 Gcn5l1	Mus musculus (Mouse)	125	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]		GO:0005739; GO:0005758; GO:0005759; GO:0005765; GO:0005769; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0048490; GO:0099078; GO:1904115	aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]		NA	NA	NA	NA	NA	NA
TRINITY_DN26765_c0_g1_i1	P78537	BL1S1_HUMAN	54	124	57	0	526	155	27	150	1.40E-30	134.4	BL1S1_HUMAN	reviewed	Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (GCN5-like protein 1) (Protein RT14)	BLOC1S1 BLOS1 GCN5L1 RT14	Homo sapiens (Human)	153	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]		GO:0005615; GO:0005739; GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0032438; GO:0048490; GO:0060155; GO:0099078; GO:1904115	aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]		blue	blue	NA	NA	NA	NA
TRINITY_DN29867_c0_g1_i1	P78537	BL1S1_HUMAN	100	126	0	0	3	380	28	153	7.90E-64	244.2	BL1S1_HUMAN	reviewed	Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (GCN5-like protein 1) (Protein RT14)	BLOC1S1 BLOS1 GCN5L1 RT14	Homo sapiens (Human)	153	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]		GO:0005615; GO:0005739; GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0032438; GO:0048490; GO:0060155; GO:0099078; GO:1904115	aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]		NA	NA	NA	NA	NA	NA
TRINITY_DN5896_c0_g1_i1	Q9VTE0	BL1S2_DROME	60.3	126	49	1	481	104	21	145	7.50E-33	142.1	BL1S2_DROME	reviewed	Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2)	Blos2 CG14145	Drosophila melanogaster (Fruit fly)	159	BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; gamma-tubulin binding [GO:0043015]; protein homodimerization activity [GO:0042803]; autophagosome-lysosome fusion [GO:0061909]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]	BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]	gamma-tubulin binding [GO:0043015]; protein homodimerization activity [GO:0042803]	GO:0000930; GO:0016197; GO:0031083; GO:0032418; GO:0042803; GO:0043015; GO:0061909; GO:0099078	autophagosome-lysosome fusion [GO:0061909]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]		NA	NA	NA	NA	NA	NA
TRINITY_DN35327_c0_g1_i1	Q96IK1	BOD1_HUMAN	53.4	118	55	0	528	175	44	161	3.40E-32	139.8	BOD1_HUMAN	reviewed	Biorientation of chromosomes in cell division protein 1 (Biorientation defective protein 1) (Protein FAM44B)	BOD1 FAM44B	Homo sapiens (Human)	185	"centrosome [GO:0005813]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; protein localization to chromosome, centromeric region [GO:0071459]"	centrosome [GO:0005813]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]	GO:0000922; GO:0000940; GO:0004864; GO:0005737; GO:0005813; GO:0005876; GO:0007080; GO:0032515; GO:0051301; GO:0051721; GO:0071459; GO:0071962; GO:1990758	"cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; protein localization to chromosome, centromeric region [GO:0071459]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5663_c0_g4_i1	P24182	ACCC_ECOLI	64.3	210	74	1	629	3	131	340	3.70E-74	279.3	ACCC_ECOLI	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC fabG b3256 JW3224	Escherichia coli (strain K12)	449	cytoplasm [GO:0005737]; cytosol [GO:0005829]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of fatty acid biosynthetic process [GO:0045717]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0005737; GO:0005829; GO:0006633; GO:0045717; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of fatty acid biosynthetic process [GO:0045717]		NA	NA	NA	NA	NA	NA
TRINITY_DN8254_c0_g2_i1	P43873	ACCC_HAEIN	77.4	146	33	0	2	439	198	343	1.70E-62	240	ACCC_HAEIN	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC HI_0972	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	448	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN8254_c0_g1_i1	Q8X9B6	ACCC_ECO57	73.6	87	23	0	1	261	257	343	1.30E-33	143.3	ACCC_ECO57	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC Z4616 ECs4128	Escherichia coli O157:H7	449	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN30798_c0_g1_i1	P43873	ACCC_HAEIN	73.5	83	22	0	6	254	23	105	1.10E-27	123.6	ACCC_HAEIN	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC HI_0972	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	448	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN38067_c0_g1_i1	P43873	ACCC_HAEIN	55.6	72	32	0	218	3	44	115	2.90E-16	85.5	ACCC_HAEIN	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC HI_0972	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	448	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN29021_c0_g1_i1	P43873	ACCC_HAEIN	51.4	74	35	1	10	228	126	199	5.00E-13	74.7	ACCC_HAEIN	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC HI_0972	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	448	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN13292_c0_g1_i1	O52058	ACCC_ALLVD	82.6	109	19	0	329	3	13	121	1.00E-44	181.4	ACCC_ALLVD	reviewed	Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) (ACC) (EC 6.4.1.2)	accC Alvin_1906	Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) (Chromatium vinosum)	449	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN37967_c0_g1_i1	P49787	ACCC1_BACSU	71.6	95	27	0	12	296	2	96	3.40E-33	142.1	ACCC1_BACSU	reviewed	Biotin carboxylase 1 (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A 1) (ACC 1) (EC 6.4.1.2)	accC1 accC yqhX BSU24340	Bacillus subtilis (strain 168)	450	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN39231_c0_g1_i1	P49787	ACCC1_BACSU	51.4	140	67	1	417	1	175	314	4.20E-37	155.6	ACCC1_BACSU	reviewed	Biotin carboxylase 1 (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A 1) (ACC 1) (EC 6.4.1.2)	accC1 accC yqhX BSU24340	Bacillus subtilis (strain 168)	450	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	NA
TRINITY_DN36536_c0_g1_i1	B9N843	ACCC2_POPTR	61.5	65	25	0	197	3	193	257	2.00E-16	85.9	ACCC2_POPTR	reviewed	"Biotin carboxylase 2, chloroplastic (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A 2) (ACC) (EC 6.4.1.2)"	POPTR_0018s14250g	Populus trichocarpa (Western balsam poplar) (Populus balsamifera subsp. trichocarpa)	526	chloroplast [GO:0009507]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]	chloroplast [GO:0009507]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0006633; GO:0009507; GO:0046872; GO:2001295	fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]		NA	NA	NA	NA	NA	1
TRINITY_DN10628_c0_g1_i1	Q0VA77	ENPP4_XENTR	35.9	410	243	7	1271	45	28	418	2.30E-68	261.2	ENPP4_XENTR	reviewed	Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4)	enpp4	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	452	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]	GO:0005886; GO:0007596; GO:0016021; GO:0030194; GO:0046872; GO:0047710	blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]		NA	NA	NA	NA	NA	NA
TRINITY_DN10628_c0_g1_i2	Q6AX80	ENPP4_XENLA	36.7	226	125	6	722	45	211	418	8.70E-30	132.1	ENPP4_XENLA	reviewed	Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4)	enpp4	Xenopus laevis (African clawed frog)	452	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]	GO:0005886; GO:0007596; GO:0016021; GO:0030194; GO:0046872; GO:0047710	blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]		NA	NA	NA	NA	NA	NA
TRINITY_DN1475_c0_g1_i1	P56380	AP4A_MOUSE	50	140	64	1	101	502	3	142	4.30E-32	139.4	AP4A_MOUSE	reviewed	"Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.17) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (Nudix motif 2)"	Nudt2 Apah1	Mus musculus (Mouse)	147	mitochondrion [GO:0005739]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]; AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]	mitochondrion [GO:0005739]	bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]	GO:0004081; GO:0005525; GO:0005739; GO:0006167; GO:0006754; GO:0006915	AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]		blue	blue	NA	NA	NA	NA
TRINITY_DN20556_c0_g1_i1	P07738	PMGE_HUMAN	99	99	1	0	298	2	58	156	5.30E-55	214.5	PMGE_HUMAN	reviewed	"Bisphosphoglycerate mutase (BPGM) (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (EC 5.4.2.11) (2,3-diphosphoglycerate mutase) (DPGM) (BPG-dependent PGAM)"	BPGM	Homo sapiens (Human)	259	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; erythrocyte development [GO:0048821]; respiratory gaseous exchange by respiratory system [GO:0007585]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0005829; GO:0005975; GO:0007585; GO:0016787; GO:0048821; GO:0061621; GO:0070062	canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; erythrocyte development [GO:0048821]; respiratory gaseous exchange by respiratory system [GO:0007585]		NA	NA	NA	NA	NA	NA
TRINITY_DN20556_c0_g2_i1	P15327	PMGE_MOUSE	100	99	0	0	298	2	58	156	2.40E-55	215.7	PMGE_MOUSE	reviewed	"Bisphosphoglycerate mutase (BPGM) (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (EC 5.4.2.11) (BPG-dependent PGAM)"	Bpgm	Mus musculus (Mouse)	259	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; erythrocyte development [GO:0048821]; glycolytic process [GO:0006096]		bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0006096; GO:0016787; GO:0048821	erythrocyte development [GO:0048821]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN38065_c0_g1_i1	P15327	PMGE_MOUSE	100	99	0	0	1	297	161	259	1.90E-49	196.1	PMGE_MOUSE	reviewed	"Bisphosphoglycerate mutase (BPGM) (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (EC 5.4.2.11) (BPG-dependent PGAM)"	Bpgm	Mus musculus (Mouse)	259	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; erythrocyte development [GO:0048821]; glycolytic process [GO:0006096]		bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0006096; GO:0016787; GO:0048821	erythrocyte development [GO:0048821]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN36438_c0_g1_i1	P62954	BLCAP_BOVIN	57	86	32	1	90	332	1	86	1.70E-19	97.1	BLCAP_BOVIN	reviewed	Bladder cancer-associated protein	BLCAP	Bos taurus (Bovine)	87	integral component of membrane [GO:0016021]; apoptotic nuclear changes [GO:0030262]; cell cycle [GO:0007049]	integral component of membrane [GO:0016021]		GO:0007049; GO:0016021; GO:0030262	apoptotic nuclear changes [GO:0030262]; cell cycle [GO:0007049]		NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i27	P42674	BP10_PARLI	30.6	98	60	2	49	342	358	447	5.20E-06	52.4	BP10_PARLI	reviewed	Blastula protease 10 (EC 3.4.24.-)	BP10	Paracentrotus lividus (Common sea urchin)	597	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i7	P42674	BP10_PARLI	33.3	99	58	2	3	299	357	447	1.70E-08	60.5	BP10_PARLI	reviewed	Blastula protease 10 (EC 3.4.24.-)	BP10	Paracentrotus lividus (Common sea urchin)	597	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN19578_c0_g1_i3	P42674	BP10_PARLI	61.5	65	25	0	75	269	186	250	5.20E-17	88.2	BP10_PARLI	reviewed	Blastula protease 10 (EC 3.4.24.-)	BP10	Paracentrotus lividus (Common sea urchin)	597	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN19578_c0_g1_i4	P42674	BP10_PARLI	63.2	57	21	0	75	245	186	242	1.20E-15	83.6	BP10_PARLI	reviewed	Blastula protease 10 (EC 3.4.24.-)	BP10	Paracentrotus lividus (Common sea urchin)	597	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN22948_c0_g1_i1	Q8R016	BLMH_MOUSE	100	74	0	0	224	3	190	263	8.00E-40	163.7	BLMH_MOUSE	reviewed	Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40)	Blmh	Mus musculus (Mouse)	455	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; homocysteine catabolic process [GO:0043418]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0004197; GO:0005737; GO:0008233; GO:0008234; GO:0009636; GO:0042493; GO:0042802; GO:0043418	homocysteine catabolic process [GO:0043418]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN29736_c0_g1_i1	Q8R016	BLMH_MOUSE	55.5	411	180	2	34	1260	6	415	8.20E-142	505	BLMH_MOUSE	reviewed	Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40)	Blmh	Mus musculus (Mouse)	455	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; homocysteine catabolic process [GO:0043418]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0004197; GO:0005737; GO:0008233; GO:0008234; GO:0009636; GO:0042493; GO:0042802; GO:0043418	homocysteine catabolic process [GO:0043418]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]		blue	blue	NA	NA	NA	NA
TRINITY_DN39435_c1_g1_i1	Q13867	BLMH_HUMAN	98.6	69	1	0	210	4	37	105	2.50E-35	148.7	BLMH_HUMAN	reviewed	Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40)	BLMH	Homo sapiens (Human)	455	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]	GO:0000209; GO:0004177; GO:0004180; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008234; GO:0009636; GO:0042493; GO:0042802; GO:0043418; GO:0070062	homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN28264_c0_g1_i1	P54132	BLM_HUMAN	56.4	78	33	1	14	247	776	852	4.20E-19	95.1	BLM_HUMAN	reviewed	"Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)"	BLM RECQ2 RECQL3	Homo sapiens (Human)	1417	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]	3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]	GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0032508; GO:0032991; GO:0036310; GO:0042802; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1901796; GO:1905773	"cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35421_c0_g1_i1	P54132	BLM_HUMAN	100	85	0	0	2	256	909	993	2.50E-45	182.2	BLM_HUMAN	reviewed	"Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)"	BLM RECQ2 RECQL3	Homo sapiens (Human)	1417	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]	3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]	GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0032508; GO:0032991; GO:0036310; GO:0042802; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1901796; GO:1905773	"cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6965_c0_g1_i1	Q9VGI8	BLM_DROME	61.9	155	58	1	523	59	830	983	3.90E-51	202.6	BLM_DROME	reviewed	Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog)	Blm mus309 CG6920	Drosophila melanogaster (Fruit fly)	1487	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]	GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0000733; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0008094; GO:0009378; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990918	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]		NA	NA	NA	NA	NA	NA
TRINITY_DN6965_c0_g1_i3	Q9VGI8	BLM_DROME	50.3	551	261	8	1792	161	819	1363	3.80E-156	553.1	BLM_DROME	reviewed	Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog)	Blm mus309 CG6920	Drosophila melanogaster (Fruit fly)	1487	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]	GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0000733; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0008094; GO:0009378; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990918	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]		NA	NA	NA	NA	NA	NA
TRINITY_DN6965_c0_g1_i4	Q9VGI8	BLM_DROME	54.1	61	28	0	241	59	923	983	1.30E-12	73.6	BLM_DROME	reviewed	Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog)	Blm mus309 CG6920	Drosophila melanogaster (Fruit fly)	1487	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]	GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0000733; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0008094; GO:0009378; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990918	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]		NA	NA	NA	NA	NA	NA
TRINITY_DN35947_c0_g1_i1	Q9VGI8	BLM_DROME	53.9	76	33	1	12	233	832	907	4.50E-17	88.2	BLM_DROME	reviewed	Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog)	Blm mus309 CG6920	Drosophila melanogaster (Fruit fly)	1487	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]	GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0000733; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0008094; GO:0009378; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990918	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]		NA	NA	NA	NA	NA	NA
TRINITY_DN11458_c0_g1_i1	Q9VGI8	BLM_DROME	64.4	90	32	0	28	297	829	918	2.30E-26	119.4	BLM_DROME	reviewed	Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog)	Blm mus309 CG6920	Drosophila melanogaster (Fruit fly)	1487	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; Y-form DNA binding [GO:0000403]	GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0000733; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0008094; GO:0009378; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990918	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]		NA	NA	NA	NA	NA	NA
TRINITY_DN33881_c0_g1_i1	O18017	BLM_CAEEL	61.6	73	28	0	254	36	515	587	1.50E-18	93.2	BLM_CAEEL	reviewed	Bloom syndrome protein homolog (EC 3.6.4.12) (High incidence of males protein 6) (RecQ helicase homolog)	him-6 T04A11.6	Caenorhabditis elegans	988	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; meiotic chromosome separation [GO:0051307]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; mitotic cell cycle [GO:0000278]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]	GO:0000077; GO:0000278; GO:0000712; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0007059; GO:0007131; GO:0008094; GO:0008340; GO:0009378; GO:0010165; GO:0010705; GO:0019899; GO:0032508; GO:0043066; GO:0043138; GO:0046872; GO:0051276; GO:0051307; GO:0051321; GO:0071139	chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; meiotic chromosome separation [GO:0051307]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; mitotic cell cycle [GO:0000278]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38571_c0_g1_i1	Q8HYZ0	BAMBI_SHEEP	46.7	105	39	5	124	387	92	196	4.00E-13	76.6	BAMBI_SHEEP	reviewed	BMP and activin membrane-bound inhibitor homolog	BAMBI	Ovis aries (Sheep)	260	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; cell migration [GO:0016477]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	frizzled binding [GO:0005109]	GO:0005109; GO:0005737; GO:0005886; GO:0008284; GO:0008360; GO:0010718; GO:0016021; GO:0016477; GO:0030512; GO:0032092; GO:0045668; GO:0045893; GO:0090263	"cell migration [GO:0016477]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38549_c0_g1_i1	Q8N8U9	BMPER_HUMAN	38.3	541	309	10	1731	115	165	682	8.80E-105	382.5	BMPER_HUMAN	reviewed	BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2)	BMPER KIAA1965	Homo sapiens (Human)	685	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0001568; GO:0001657; GO:0002043; GO:0005615; GO:0010594; GO:0030514; GO:0031012; GO:0042118; GO:0045765; GO:0048839; GO:0060393; GO:0070374; GO:1903672	blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN38549_c0_g1_i2	Q8N8U9	BMPER_HUMAN	38	571	328	11	1821	115	136	682	4.10E-110	400.2	BMPER_HUMAN	reviewed	BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2)	BMPER KIAA1965	Homo sapiens (Human)	685	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0001568; GO:0001657; GO:0002043; GO:0005615; GO:0010594; GO:0030514; GO:0031012; GO:0042118; GO:0045765; GO:0048839; GO:0060393; GO:0070374; GO:1903672	blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN9559_c0_g1_i1	Q9H3K6	BOLA2_HUMAN	62.7	75	27	1	318	97	6	80	6.10E-18	91.7	BOLA2_HUMAN	reviewed	BolA-like protein 2	BOLA2 BOLA2A My016; BOLA2B	Homo sapiens (Human)	86	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; iron-sulfur cluster binding [GO:0051536]; [2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	iron-sulfur cluster binding [GO:0051536]	GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0035722; GO:0044571; GO:0051536; GO:0097428	[2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN24264_c0_g1_i1	Q9H3K6	BOLA2_HUMAN	98.6	71	1	0	249	37	16	86	2.90E-35	148.7	BOLA2_HUMAN	reviewed	BolA-like protein 2	BOLA2 BOLA2A My016; BOLA2B	Homo sapiens (Human)	86	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; iron-sulfur cluster binding [GO:0051536]; [2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	iron-sulfur cluster binding [GO:0051536]	GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0035722; GO:0044571; GO:0051536; GO:0097428	[2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN24264_c0_g1_i2	Q9H3K6	BOLA2_HUMAN	100	71	0	0	249	37	16	86	5.90E-36	151	BOLA2_HUMAN	reviewed	BolA-like protein 2	BOLA2 BOLA2A My016; BOLA2B	Homo sapiens (Human)	86	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; iron-sulfur cluster binding [GO:0051536]; [2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	iron-sulfur cluster binding [GO:0051536]	GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0035722; GO:0044571; GO:0051536; GO:0097428	[2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; interleukin-12-mediated signaling pathway [GO:0035722]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN2991_c0_g1_i2	Q53S33	BOLA3_HUMAN	48.1	79	41	0	335	99	27	105	3.70E-17	89.4	BOLA3_HUMAN	reviewed	BolA-like protein 3	BOLA3	Homo sapiens (Human)	107	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]		GO:0005739; GO:0005829; GO:0016604			blue	blue	NA	NA	NA	NA
TRINITY_DN26195_c0_g1_i1	P98063	BMP1_MOUSE	51.5	66	29	1	278	90	212	277	1.70E-11	70.1	BMP1_MOUSE	reviewed	Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP)	Bmp1	Mus musculus (Mouse)	991	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]	calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023	cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN15047_c0_g1_i2	P36898	BMR1B_MOUSE	54.9	494	192	12	1545	94	30	502	1.90E-146	520.8	BMR1B_MOUSE	reviewed	Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (Activin receptor-like kinase 6) (ALK-6) (Serine/threonine-protein kinase receptor R6) (SKR6) (CD antigen CDw293)	Bmpr1b Acvrlk6	Mus musculus (Mouse)	502	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]"	GO:0001501; GO:0001502; GO:0001550; GO:0001654; GO:0002062; GO:0002063; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0006703; GO:0006954; GO:0007178; GO:0007179; GO:0009953; GO:0016021; GO:0030154; GO:0030166; GO:0030425; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0035108; GO:0042698; GO:0043010; GO:0043025; GO:0043235; GO:0045597; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:1902043; GO:1902731	BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]		NA	NA	NA	NA	NA	NA
TRINITY_DN15047_c0_g1_i3	P36898	BMR1B_MOUSE	58.1	437	160	8	1374	94	79	502	6.10E-141	502.3	BMR1B_MOUSE	reviewed	Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (Activin receptor-like kinase 6) (ALK-6) (Serine/threonine-protein kinase receptor R6) (SKR6) (CD antigen CDw293)	Bmpr1b Acvrlk6	Mus musculus (Mouse)	502	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]"	GO:0001501; GO:0001502; GO:0001550; GO:0001654; GO:0002062; GO:0002063; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0006703; GO:0006954; GO:0007178; GO:0007179; GO:0009953; GO:0016021; GO:0030154; GO:0030166; GO:0030425; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0035108; GO:0042698; GO:0043010; GO:0043025; GO:0043235; GO:0045597; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:1902043; GO:1902731	BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; limb morphogenesis [GO:0035108]; negative regulation of chondrocyte proliferation [GO:1902731]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]		NA	NA	NA	NA	NA	NA
TRINITY_DN159_c0_g1_i1	O35607	BMPR2_MOUSE	49	349	169	2	146	1192	190	529	1.90E-97	358.2	BMPR2_MOUSE	reviewed	Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (BRK-3) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)	Bmpr2	Mus musculus (Mouse)	1038	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta-activated receptor activity [GO:0005024]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; vasculature development [GO:0001944]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta-activated receptor activity [GO:0005024]	GO:0001568; GO:0001707; GO:0001893; GO:0001935; GO:0001938; GO:0001944; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003148; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0004674; GO:0005024; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0005912; GO:0006468; GO:0007178; GO:0007420; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010595; GO:0010634; GO:0010862; GO:0014069; GO:0014916; GO:0016324; GO:0019838; GO:0030166; GO:0030308; GO:0030425; GO:0030501; GO:0030509; GO:0030513; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048842; GO:0060173; GO:0060350; GO:0060412; GO:0060413; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0061626; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782; GO:2000279	anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; vasculature development [GO:0001944]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN6881_c0_g1_i1	P86733	KCP_HALAI	56.1	57	25	0	238	68	65	121	1.50E-12	73.2	KCP_HALAI	reviewed	BPTI/Kunitz domain-containing protein (Fragment)		Haliotis asinina (Donkey's ear abalone) (Ass's ear abalone)	126	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576			blue	blue	NA	NA	NA	NA
TRINITY_DN4852_c0_g1_i1	P00771	COGS_LEPPG	65.3	98	32	1	347	54	131	226	3.60E-31	135.6	COGS_LEPPG	reviewed	Brachyurin (EC 3.4.21.32) (Collagenolytic protease)		Leptuca pugilator (Atlantic sand fiddler crab) (Uca pugilator)	226	serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]		serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0030574	collagen catabolic process [GO:0030574]		black	black	1	NA	1	1
TRINITY_DN4358_c0_g1_i1	P00771	COGS_LEPPG	76.7	90	21	0	272	3	135	224	5.00E-36	151.4	COGS_LEPPG	reviewed	Brachyurin (EC 3.4.21.32) (Collagenolytic protease)		Leptuca pugilator (Atlantic sand fiddler crab) (Uca pugilator)	226	serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]		serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN21380_c0_g1_i1	P00771	COGS_LEPPG	83.6	73	12	0	222	4	139	211	4.10E-28	124.8	COGS_LEPPG	reviewed	Brachyurin (EC 3.4.21.32) (Collagenolytic protease)		Leptuca pugilator (Atlantic sand fiddler crab) (Uca pugilator)	226	serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]		serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN643_c0_g1_i1	Q9VYG2	BAP60_DROME	85.7	189	23	1	3	569	133	317	3.40E-87	322.4	BAP60_DROME	reviewed	Brahma-associated protein of 60 kDa (BRM-associated protein 60)	Bap60 CG4303	Drosophila melanogaster (Fruit fly)	515	"brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]	GO:0001085; GO:0003677; GO:0005634; GO:0005719; GO:0006337; GO:0006357; GO:0007406; GO:0008134; GO:0010628; GO:0016514; GO:0016586; GO:0017022; GO:0019904; GO:0031453; GO:0035060; GO:0045893; GO:0045944; GO:0071564; GO:0071565	"negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN643_c0_g1_i3	Q9VYG2	BAP60_DROME	88.1	185	21	1	3	554	133	317	1.30E-88	327	BAP60_DROME	reviewed	Brahma-associated protein of 60 kDa (BRM-associated protein 60)	Bap60 CG4303	Drosophila melanogaster (Fruit fly)	515	"brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]	GO:0001085; GO:0003677; GO:0005634; GO:0005719; GO:0006337; GO:0006357; GO:0007406; GO:0008134; GO:0010628; GO:0016514; GO:0016586; GO:0017022; GO:0019904; GO:0031453; GO:0035060; GO:0045893; GO:0045944; GO:0071564; GO:0071565	"negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN643_c0_g1_i5	Q9VYG2	BAP60_DROME	96.1	77	3	0	2	232	241	317	6.00E-38	157.5	BAP60_DROME	reviewed	Brahma-associated protein of 60 kDa (BRM-associated protein 60)	Bap60 CG4303	Drosophila melanogaster (Fruit fly)	515	"brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]	GO:0001085; GO:0003677; GO:0005634; GO:0005719; GO:0006337; GO:0006357; GO:0007406; GO:0008134; GO:0010628; GO:0016514; GO:0016586; GO:0017022; GO:0019904; GO:0031453; GO:0035060; GO:0045893; GO:0045944; GO:0071564; GO:0071565	"negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1615_c0_g1_i1	Q9VYG2	BAP60_DROME	77.1	201	45	1	1	603	315	514	5.80E-89	328.6	BAP60_DROME	reviewed	Brahma-associated protein of 60 kDa (BRM-associated protein 60)	Bap60 CG4303	Drosophila melanogaster (Fruit fly)	515	"brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]	GO:0001085; GO:0003677; GO:0005634; GO:0005719; GO:0006337; GO:0006357; GO:0007406; GO:0008134; GO:0010628; GO:0016514; GO:0016586; GO:0017022; GO:0019904; GO:0031453; GO:0035060; GO:0045893; GO:0045944; GO:0071564; GO:0071565	"negative regulation of neuroblast proliferation [GO:0007406]; nucleosome disassembly [GO:0006337]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN38487_c0_g1_i1	Q32L83	BRI3_BOVIN	56.5	46	20	0	6	143	76	121	1.00E-10	67	BRI3_BOVIN	reviewed	Brain protein I3	BRI3	Bos taurus (Bovine)	124	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]		GO:0005765; GO:0016021; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c1_g1_i1	Q32L83	BRI3_BOVIN	56.1	57	25	0	261	91	68	124	7.20E-13	75.5	BRI3_BOVIN	reviewed	Brain protein I3	BRI3	Bos taurus (Bovine)	124	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]		GO:0005765; GO:0016021; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c1_g1_i2	Q32L83	BRI3_BOVIN	56.1	57	25	0	261	91	68	124	7.50E-13	75.5	BRI3_BOVIN	reviewed	Brain protein I3	BRI3	Bos taurus (Bovine)	124	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]		GO:0005765; GO:0016021; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN27869_c0_g1_i1	Q8MQJ9	BRAT_DROME	87.5	304	38	0	15	926	734	1037	1.10E-157	557.4	BRAT_DROME	reviewed	Brain tumor protein	brat CG10719	Drosophila melanogaster (Fruit fly)	1037	apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]	apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]	mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]	GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0099738; GO:1900242; GO:1902692	asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN35463_c0_g1_i1	Q8MQJ9	BRAT_DROME	36.3	248	135	4	721	32	328	570	4.90E-33	143.7	BRAT_DROME	reviewed	Brain tumor protein	brat CG10719	Drosophila melanogaster (Fruit fly)	1037	apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]	apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]	mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]	GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0099738; GO:1900242; GO:1902692	asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN31652_c0_g1_i1	Q9GKM4	BCAT1_SHEEP	66.2	65	21	1	225	34	169	233	1.80E-18	92.8	BCAT1_SHEEP	reviewed	"Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42)"	BCAT1	Ovis aries (Sheep)	385	cytoplasm [GO:0005737]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid biosynthetic process [GO:0009082]	cytoplasm [GO:0005737]	L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]	GO:0005737; GO:0009082; GO:0052654; GO:0052655; GO:0052656	branched-chain amino acid biosynthetic process [GO:0009082]		NA	NA	NA	NA	NA	NA
TRINITY_DN26120_c0_g1_i1	P54687	BCAT1_HUMAN	100	128	0	0	389	6	218	345	3.80E-74	278.5	BCAT1_HUMAN	reviewed	"Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)"	BCAT1 BCT1 ECA39	Homo sapiens (Human)	386	cytosol [GO:0005829]; mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid biosynthetic process [GO:0009082]; branched-chain amino acid catabolic process [GO:0009083]; G1/S transition of mitotic cell cycle [GO:0000082]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]	GO:0000082; GO:0004084; GO:0005739; GO:0005829; GO:0009082; GO:0009083; GO:0009098; GO:0009099; GO:0042802; GO:0052654; GO:0052655; GO:0052656	branched-chain amino acid biosynthetic process [GO:0009082]; branched-chain amino acid catabolic process [GO:0009083]; G1/S transition of mitotic cell cycle [GO:0000082]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]		NA	NA	NA	NA	NA	NA
TRINITY_DN34325_c0_g1_i1	O35855	BCAT2_MOUSE	100	141	0	0	425	3	173	313	1.00E-80	300.4	BCAT2_MOUSE	reviewed	"Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42)"	Bcat2 Bcatm Eca40	Mus musculus (Mouse)	393	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid metabolic process [GO:0009081]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; isoleucine metabolic process [GO:0006549]; leucine biosynthetic process [GO:0009098]; leucine metabolic process [GO:0006551]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099]; valine metabolic process [GO:0006573]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]	GO:0004084; GO:0005634; GO:0005737; GO:0005739; GO:0006549; GO:0006550; GO:0006551; GO:0006573; GO:0009081; GO:0009083; GO:0009098; GO:0009099; GO:0010817; GO:0052654; GO:0052655; GO:0052656; GO:1990830	branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid metabolic process [GO:0009081]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; isoleucine metabolic process [GO:0006549]; leucine biosynthetic process [GO:0009098]; leucine metabolic process [GO:0006551]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN35234_c0_g1_i1	O31461	ILVE1_BACSU	50	58	26	2	195	28	294	350	1.40E-08	60.1	ILVE1_BACSU	reviewed	Branched-chain-amino-acid transaminase 1 (BCAT 1) (EC 2.6.1.42)	ilvE ybgE BSU02390	Bacillus subtilis (strain 168)	356	L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; isoleucine biosynthetic process [GO:0009097]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]		L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]	GO:0009097; GO:0009098; GO:0009099; GO:0052654; GO:0052655; GO:0052656	isoleucine biosynthetic process [GO:0009097]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]		NA	NA	NA	NA	NA	NA
TRINITY_DN4136_c0_g1_i2	Q7Z569	BRAP_HUMAN	51	157	69	2	48	518	299	447	1.60E-41	170.6	BRAP_HUMAN	reviewed	BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)	BRAP RNF52	Homo sapiens (Human)	592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630	MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN4136_c0_g1_i3	Q7Z569	BRAP_HUMAN	45.9	109	51	2	97	423	347	447	6.10E-18	92	BRAP_HUMAN	reviewed	BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)	BRAP RNF52	Homo sapiens (Human)	592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630	MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN4136_c0_g1_i4	Q7Z569	BRAP_HUMAN	46.6	494	207	8	87	1538	1	447	6.70E-117	422.5	BRAP_HUMAN	reviewed	BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)	BRAP RNF52	Homo sapiens (Human)	592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630	MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN17619_c0_g1_i1	Q7Z569	BRAP_HUMAN	100	155	0	0	465	1	103	257	8.40E-84	310.8	BRAP_HUMAN	reviewed	BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)	BRAP RNF52	Homo sapiens (Human)	592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630	MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN36088_c0_g1_i1	Q7Z569	BRAP_HUMAN	100	69	0	0	3	209	288	356	1.50E-40	166	BRAP_HUMAN	reviewed	BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)	BRAP RNF52	Homo sapiens (Human)	592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630	MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN6048_c0_g1_i1	Q7ZUV7	EMSY_DANRE	59.4	138	56	0	489	76	1	138	2.80E-41	169.9	EMSY_DANRE	reviewed	BRCA2-interacting transcriptional repressor EMSY	emsy zgc:56039	Danio rerio (Zebrafish) (Brachydanio rerio)	1173	"nucleoplasm [GO:0005654]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]		GO:0005654; GO:0006281; GO:0006325; GO:0006355	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6048_c0_g1_i2	Q7ZUV7	EMSY_DANRE	59.4	138	56	0	691	278	1	138	6.40E-41	169.1	EMSY_DANRE	reviewed	BRCA2-interacting transcriptional repressor EMSY	emsy zgc:56039	Danio rerio (Zebrafish) (Brachydanio rerio)	1173	"nucleoplasm [GO:0005654]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]		GO:0005654; GO:0006281; GO:0006325; GO:0006355	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40958_c0_g1_i1	Q8BMB0	EMSY_MOUSE	100	92	0	0	3	278	8	99	1.50E-43	176.4	EMSY_MOUSE	reviewed	BRCA2-interacting transcriptional repressor EMSY	Emsy	Mus musculus (Mouse)	1264	"nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]	GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40958_c0_g1_i2	Q8BMB0	EMSY_MOUSE	100	92	0	0	3	278	8	99	1.50E-43	176.4	EMSY_MOUSE	reviewed	BRCA2-interacting transcriptional repressor EMSY	Emsy	Mus musculus (Mouse)	1264	"nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]	GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26667_c0_g1_i1	Q61140	BCAR1_MOUSE	30.1	468	297	8	519	1862	411	868	4.30E-49	197.6	BCAR1_MOUSE	reviewed	Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (p130cas)	Bcar1 Cas Crkas	Mus musculus (Mouse)	874	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to endothelin [GO:1990859]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to nitric oxide [GO:0071732]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]	GO:0001726; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007015; GO:0007155; GO:0007169; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016477; GO:0017124; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0035729; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050853; GO:0060326; GO:0071732; GO:0086100; GO:0090527; GO:1900025; GO:1990859	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to endothelin [GO:1990859]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to nitric oxide [GO:0071732]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i1	Q6INP9	BCAR3_XENLA	35.3	170	99	4	713	207	645	804	9.10E-21	102.1	BCAR3_XENLA	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog	bcar3	Xenopus laevis (African clawed frog)	806	guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase mediated signal transduction [GO:0007264]		guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0007264	small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i2	Q58DL5	BCAR3_BOVIN	47.7	44	23	0	332	201	777	820	1.90E-06	54.7	BCAR3_BOVIN	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog	BCAR3	Bos taurus (Bovine)	826	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i2	Q58DL5	BCAR3_BOVIN	50	52	23	1	772	626	551	602	6.30E-05	49.7	BCAR3_BOVIN	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog	BCAR3	Bos taurus (Bovine)	826	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i2	Q58DL5	BCAR3_BOVIN	41.7	60	34	1	531	355	602	661	0.002	44.7	BCAR3_BOVIN	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog	BCAR3	Bos taurus (Bovine)	826	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i3	Q58DL5	BCAR3_BOVIN	29.8	299	191	7	1061	201	529	820	7.80E-24	112.8	BCAR3_BOVIN	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog	BCAR3	Bos taurus (Bovine)	826	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i5	Q58DL5	BCAR3_BOVIN	28.5	277	179	7	995	201	551	820	9.60E-19	95.9	BCAR3_BOVIN	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog	BCAR3	Bos taurus (Bovine)	826	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i4	Q9QZK2	BCAR3_MOUSE	48.1	52	24	1	435	289	545	596	9.90E-06	51.6	BCAR3_MOUSE	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog (p130Cas-binding protein AND-34)	Bcar3 And34	Mus musculus (Mouse)	820	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0019900; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3137_c0_g1_i6	Q9QZK2	BCAR3_MOUSE	47.3	74	36	1	838	626	523	596	1.80E-10	68.2	BCAR3_MOUSE	reviewed	Breast cancer anti-estrogen resistance protein 3 homolog (p130Cas-binding protein AND-34)	Bcar3 And34	Mus musculus (Mouse)	820	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007264; GO:0008286; GO:0019900; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0086100	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN38837_c0_g1_i3	P51587	BRCA2_HUMAN	34.6	387	222	9	1075	2	2491	2875	3.60E-56	221.1	BRCA2_HUMAN	reviewed	Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)	BRCA2 FACD FANCD1	Homo sapiens (Human)	3418	"BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; gamma-tubulin binding [GO:0043015]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697]; brain development [GO:0007420]; cell aging [GO:0007569]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokinesis [GO:0032465]; regulation of transcription, DNA-templated [GO:0006355]; replication fork protection [GO:0048478]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]"	"BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]"	gamma-tubulin binding [GO:0043015]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697]	GO:0000722; GO:0000724; GO:0000784; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0006978; GO:0007141; GO:0007283; GO:0007420; GO:0007569; GO:0008022; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030097; GO:0030141; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0043966; GO:0043967; GO:0045893; GO:0045931; GO:0048478; GO:0051298; GO:0070200; GO:1990426	"brain development [GO:0007420]; cell aging [GO:0007569]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokinesis [GO:0032465]; regulation of transcription, DNA-templated [GO:0006355]; replication fork protection [GO:0048478]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]"		NA	NA	NA	NA	NA	NA
TRINITY_DN790_c0_g1_i1	Q8SY41	BCAS3_DROME	47.7	455	178	10	6	1220	295	739	7.30E-79	295.8	BCAS3_DROME	reviewed	Breast carcinoma-amplified sequence 3 homolog (Protein rudhira) (DRudh)	rudhira CG43154	Drosophila melanogaster (Fruit fly)	1122	cytoplasm [GO:0005737]; cytosol [GO:0005829]; macropinocytosis [GO:0044351]; response to starvation [GO:0042594]	cytoplasm [GO:0005737]; cytosol [GO:0005829]		GO:0005737; GO:0005829; GO:0042594; GO:0044351	macropinocytosis [GO:0044351]; response to starvation [GO:0042594]		blue	blue	NA	NA	NA	NA
TRINITY_DN39492_c0_g1_i1	F4JSZ5	BIG1_ARATH	60.2	103	40	1	3	311	1009	1110	1.60E-28	126.7	BIG1_ARATH	reviewed	Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (ARF guanine-nucleotide exchange factor BIG1)	BIG1 At4g38200 F20D10.320	Arabidopsis thaliana (Mouse-ear cress)	1687	chloroplast [GO:0009507]; cytosol [GO:0005829]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]	chloroplast [GO:0009507]; cytosol [GO:0005829]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0005802; GO:0005829; GO:0009507; GO:0015031; GO:0016020; GO:0032012	protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN32753_c0_g1_i1	G3X9K3	BIG1_MOUSE	71.2	330	94	1	989	3	1104	1433	2.90E-142	506.1	BIG1_MOUSE	reviewed	Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1)	Arfgef1	Mus musculus (Mouse)	1846	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0000139; GO:0005085; GO:0005086; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0007030; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0051897; GO:0090284; GO:0090303; GO:2000114	endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]		NA	NA	NA	NA	NA	NA
TRINITY_DN4761_c0_g1_i1	Q9Y6D6	BIG1_HUMAN	62.2	553	188	5	1	1611	518	1065	5.10E-189	662.1	BIG1_HUMAN	reviewed	Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1)	ARFGEF1 ARFGEP1 BIG1	Homo sapiens (Human)	1849	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0000139; GO:0005085; GO:0005086; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0006887; GO:0007030; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0043547; GO:0048471; GO:0051897; GO:0090284; GO:0090303; GO:2000114	endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]		NA	NA	NA	NA	NA	NA
TRINITY_DN3924_c11_g1_i1	Q5TH69	BIG3_HUMAN	53.3	60	28	0	265	86	323	382	2.40E-11	69.3	BIG3_HUMAN	reviewed	Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3)	ARFGEF3 BIG3 C6orf92 KIAA1244	Homo sapiens (Human)	2177	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012]	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0010923; GO:0016021; GO:0030036; GO:0030658; GO:0032012	actin cytoskeleton organization [GO:0030036]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN33464_c0_g1_i1	Q9LPC5	BIG3_ARATH	60	65	26	0	3	197	728	792	6.80E-17	87.4	BIG3_ARATH	reviewed	Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) (ARF guanine-nucleotide exchange factor BIG3) (Protein EMBRYO SAC DEVELOPMENT ARREST 10)	BIG3 EDA10 At1g01960 F22M8.9	Arabidopsis thaliana (Mouse-ear cress)	1750	cytosol [GO:0005829]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; megagametogenesis [GO:0009561]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0005634; GO:0005802; GO:0005829; GO:0009561; GO:0015031; GO:0016192; GO:0032012; GO:0032588	megagametogenesis [GO:0009561]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1847_c0_g1_i1	Q5ZKL7	BIN2_CHICK	35.7	199	120	3	978	400	105	301	1.20E-20	102.1	BIN2_CHICK	reviewed	Bridging integrator 2	BIN2 RCJMB04_10b19	Gallus gallus (Chicken)	476	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; podosome [GO:0002102]; phospholipid binding [GO:0005543]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; podosome [GO:0002102]	phospholipid binding [GO:0005543]	GO:0002102; GO:0005543; GO:0005737; GO:0005886; GO:0006911; GO:0071800; GO:0097320	"phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1847_c0_g1_i2	Q5ZKL7	BIN2_CHICK	35.7	199	120	3	983	405	105	301	1.20E-20	102.1	BIN2_CHICK	reviewed	Bridging integrator 2	BIN2 RCJMB04_10b19	Gallus gallus (Chicken)	476	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; podosome [GO:0002102]; phospholipid binding [GO:0005543]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; podosome [GO:0002102]	phospholipid binding [GO:0005543]	GO:0002102; GO:0005543; GO:0005737; GO:0005886; GO:0006911; GO:0071800; GO:0097320	"phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3318_c0_g1_i1	Q9NWV8	BABA1_HUMAN	36.2	240	145	5	172	873	82	319	6.00E-36	152.9	BABA1_HUMAN	reviewed	BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex)	BABAM1 C19orf62 MERIT40 NBA1 HSPC142	Homo sapiens (Human)	329	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA repair [GO:0045739]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006325; GO:0007049; GO:0010212; GO:0016579; GO:0016604; GO:0045739; GO:0051301; GO:0070531; GO:0070536; GO:0070552; GO:0072425	cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA repair [GO:0045739]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN3318_c0_g1_i2	Q9NWV8	BABA1_HUMAN	36.2	240	145	5	159	860	82	319	5.90E-36	152.9	BABA1_HUMAN	reviewed	BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex)	BABAM1 C19orf62 MERIT40 NBA1 HSPC142	Homo sapiens (Human)	329	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA repair [GO:0045739]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006325; GO:0007049; GO:0010212; GO:0016579; GO:0016604; GO:0045739; GO:0051301; GO:0070531; GO:0070536; GO:0070552; GO:0072425	cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA repair [GO:0045739]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		blue	blue	NA	NA	NA	NA
TRINITY_DN5726_c0_g1_i1	P54073	YUY1_CAEEL	56.1	171	73	2	532	23	215	384	3.10E-53	209.5	YUY1_CAEEL	reviewed	Brix domain-containing protein F44G4.1	F44G4.1	Caenorhabditis elegans	384	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0006364; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c0_g1_i14	Q4V8K5	BROX_RAT	46.6	421	214	3	1303	41	1	410	9.10E-101	369	BROX_RAT	reviewed	BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)	Brox	Rattus norvegicus (Rat)	411	membrane [GO:0016020]	membrane [GO:0016020]		GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN14402_c0_g1_i1	A4IIL4	BROX_XENTR	52.5	80	38	0	241	2	132	211	1.80E-13	76.3	BROX_XENTR	reviewed	BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)	brox	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	411	membrane [GO:0016020]	membrane [GO:0016020]		GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN11133_c0_g2_i1	Q24206	BRC4_DROME	46.8	47	25	0	193	333	712	758	7.90E-05	48.9	BRC4_DROME	reviewed	Broad-complex core protein isoform 6	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	880	"neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription repressor activity [GO:0001217]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription repressor activity [GO:0001217]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000122; GO:0000977; GO:0001217; GO:0001752; GO:0005634; GO:0005700; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0043025; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11133_c0_g2_i2	Q24206	BRC4_DROME	46.8	47	25	0	193	333	712	758	6.90E-05	48.9	BRC4_DROME	reviewed	Broad-complex core protein isoform 6	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	880	"neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription repressor activity [GO:0001217]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription repressor activity [GO:0001217]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000122; GO:0000977; GO:0001217; GO:0001752; GO:0005634; GO:0005700; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0043025; GO:0045944; GO:0046843; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c0_g2_i1	Q01295	BRC1_DROME	49.5	107	54	0	781	461	9	115	6.80E-26	119.4	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c0_g2_i2	Q01295	BRC1_DROME	49.5	107	54	0	781	461	9	115	6.90E-26	119.4	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7405_c0_g1_i1	Q01295	BRC1_DROME	62.3	114	42	1	107	448	5	117	7.50E-36	152.1	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6860_c0_g1_i1	Q01295	BRC1_DROME	49.3	148	66	3	73	492	3	149	5.90E-35	148.7	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2621_c0_g1_i2	Q01295	BRC1_DROME	50	110	55	0	125	454	6	115	3.60E-27	123.2	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN599_c0_g1_i1	Q01295	BRC1_DROME	62.8	121	45	0	372	10	1	121	1.20E-41	170.6	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32896_c0_g1_i1	Q01295	BRC1_DROME	55.3	141	63	0	428	6	1	141	2.20E-40	166.8	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39474_c0_g1_i1	Q01295	BRC1_DROME	37.3	67	42	0	10	210	9	75	3.70E-07	55.1	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40460_c0_g1_i1	Q01295	BRC1_DROME	52.9	104	49	0	17	328	9	112	1.90E-26	119.8	BRC1_DROME	reviewed	Broad-complex core protein isoforms 1/2/3/4/5	br Br-C CG11491	Drosophila melanogaster (Fruit fly)	727	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0001752; GO:0003677; GO:0005634; GO:0006357; GO:0006914; GO:0007458; GO:0007562; GO:0009608; GO:0010629; GO:0030707; GO:0035070; GO:0035075; GO:0040034; GO:0042332; GO:0045944; GO:0046872; GO:0048477; GO:0048747; GO:0048808; GO:0048813; GO:0071390	"autophagy [GO:0006914]; cellular response to ecdysone [GO:0071390]; compound eye photoreceptor fate commitment [GO:0001752]; dendrite morphogenesis [GO:0048813]; eclosion [GO:0007562]; gravitaxis [GO:0042332]; male genitalia morphogenesis [GO:0048808]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to symbiont [GO:0009608]; salivary gland histolysis [GO:0035070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39724_c0_g1_i1	Q8TBE0	BAHD1_HUMAN	45.3	192	100	3	608	45	589	779	2.60E-44	180.3	BAHD1_HUMAN	reviewed	Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1)	BAHD1 KIAA0945	Homo sapiens (Human)	780	"chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892	"heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26620_c0_g1_i1	Q9UIF8	BAZ2B_HUMAN	37	135	61	4	18	350	766	900	1.60E-14	80.5	BAZ2B_HUMAN	reviewed	Bromodomain adjacent to zinc finger domain protein 2B (hWALp4)	BAZ2B KIAA1476	Homo sapiens (Human)	2168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872	chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38542_c0_g1_i1	Q921C3	BRWD1_MOUSE	47.2	197	104	0	592	2	37	233	7.20E-40	165.2	BRWD1_MOUSE	reviewed	Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9)	Brwd1 Wdr9	Mus musculus (Mouse)	2304	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007010; GO:0008360	cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN32638_c0_g1_i1	O95696	BRD1_HUMAN	97	67	2	0	203	3	961	1027	1.90E-32	139	BRD1_HUMAN	reviewed	Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2)	BRD1 BRL BRPF2	Homo sapiens (Human)	1058	chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of erythrocyte differentiation [GO:0045648]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902]	chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]	histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0005634; GO:0005694; GO:0016607; GO:0030425; GO:0035902; GO:0036409; GO:0042393; GO:0043204; GO:0043249; GO:0043966; GO:0043972; GO:0044154; GO:0045648; GO:0046872; GO:0051602; GO:0070776	erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of erythrocyte differentiation [GO:0045648]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902]		NA	NA	NA	NA	NA	NA
TRINITY_DN28862_c0_g1_i1	Q32S26	BRD2_BOVIN	100	125	0	0	375	1	83	207	2.10E-69	262.7	BRD2_BOVIN	reviewed	Bromodomain-containing protein 2	BRD2	Bos taurus (Bovine)	803	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]	GO:0003682; GO:0005737; GO:0006334; GO:0006357; GO:0016607; GO:0070577	nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30828_c0_g1_i1	Q32S26	BRD2_BOVIN	100	109	0	0	1	327	357	465	1.20E-60	233.4	BRD2_BOVIN	reviewed	Bromodomain-containing protein 2	BRD2	Bos taurus (Bovine)	803	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]	GO:0003682; GO:0005737; GO:0006334; GO:0006357; GO:0016607; GO:0070577	nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31799_c0_g1_i1	Q8K2F0	BRD3_MOUSE	98.7	78	1	0	2	235	87	164	2.80E-38	158.7	BRD3_MOUSE	reviewed	Bromodomain-containing protein 3 (Bromodomain-containing FSH-like protein FSRG2)	Brd3 Fsrg2	Mus musculus (Mouse)	726	nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]	GO:0003682; GO:0005634; GO:0006325; GO:0006357; GO:0070577	chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34957_c0_g1_i1	Q15059	BRD3_HUMAN	100	82	0	0	248	3	335	416	1.00E-43	176.8	BRD3_HUMAN	reviewed	Bromodomain-containing protein 3 (RING3-like protein)	BRD3 KIAA0043 RING3L	Homo sapiens (Human)	726	nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]	GO:0003682; GO:0005634; GO:0006325; GO:0006357; GO:0070577	chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23010_c0_g1_i2	Q9ESU6	BRD4_MOUSE	100	128	0	0	27	410	52	179	2.00E-71	269.6	BRD4_MOUSE	reviewed	Bromodomain-containing protein 4 (Mitotic chromosome-associated protein) (MCAP)	Brd4 Mcap	Mus musculus (Mouse)	1400	"condensed nuclear chromosome [GO:0000794]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; GTP-dependent protein kinase activity [GO:0034211]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coregulator activity [GO:0003712]; chromosome segregation [GO:0007059]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA binding [GO:0043388]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	condensed nuclear chromosome [GO:0000794]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; GTP-dependent protein kinase activity [GO:0034211]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II C-terminal domain binding [GO:0099122]; transcription coregulator activity [GO:0003712]	GO:0000083; GO:0000790; GO:0000794; GO:0001833; GO:0002039; GO:0003677; GO:0003682; GO:0003712; GO:0005634; GO:0006468; GO:0007059; GO:0008024; GO:0008353; GO:0010971; GO:0032968; GO:0034211; GO:0043123; GO:0043388; GO:0043983; GO:0044154; GO:0045893; GO:0045944; GO:0046777; GO:0050727; GO:0070577; GO:0099122; GO:1901407; GO:2001255	"chromosome segregation [GO:0007059]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA binding [GO:0043388]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27033_c0_g1_i1	Q9ESU6	BRD4_MOUSE	100	75	0	0	1	225	360	434	1.00E-39	163.3	BRD4_MOUSE	reviewed	Bromodomain-containing protein 4 (Mitotic chromosome-associated protein) (MCAP)	Brd4 Mcap	Mus musculus (Mouse)	1400	"condensed nuclear chromosome [GO:0000794]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; GTP-dependent protein kinase activity [GO:0034211]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coregulator activity [GO:0003712]; chromosome segregation [GO:0007059]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA binding [GO:0043388]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	condensed nuclear chromosome [GO:0000794]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; GTP-dependent protein kinase activity [GO:0034211]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II C-terminal domain binding [GO:0099122]; transcription coregulator activity [GO:0003712]	GO:0000083; GO:0000790; GO:0000794; GO:0001833; GO:0002039; GO:0003677; GO:0003682; GO:0003712; GO:0005634; GO:0006468; GO:0007059; GO:0008024; GO:0008353; GO:0010971; GO:0032968; GO:0034211; GO:0043123; GO:0043388; GO:0043983; GO:0044154; GO:0045893; GO:0045944; GO:0046777; GO:0050727; GO:0070577; GO:0099122; GO:1901407; GO:2001255	"chromosome segregation [GO:0007059]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA binding [GO:0043388]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23010_c0_g1_i1	O60885	BRD4_HUMAN	100	123	0	0	27	395	52	174	2.50E-68	259.2	BRD4_HUMAN	reviewed	Bromodomain-containing protein 4 (Protein HUNK1)	BRD4 HUNK1	Homo sapiens (Human)	1362	"chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coregulator activity [GO:0003712]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]"	chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; P-TEFb complex binding [GO:0106140]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II C-terminal domain binding [GO:0099122]; transcription coregulator activity [GO:0003712]	GO:0000083; GO:0000794; GO:0002039; GO:0003682; GO:0003712; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006338; GO:0006974; GO:0008353; GO:0010971; GO:0016032; GO:0019899; GO:0032968; GO:0043123; GO:0045893; GO:0045944; GO:0050727; GO:0070577; GO:0099122; GO:0106140; GO:1901407; GO:2000002; GO:2001255	"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4807_c0_g2_i4	Q8R3B7	BRD8_MOUSE	46.8	124	65	1	40	411	17	139	7.60E-25	115.9	BRD8_MOUSE	reviewed	Bromodomain-containing protein 8	Brd8	Mus musculus (Mouse)	951	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000812; GO:0005654; GO:0005739; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944; GO:0046966; GO:0097067	cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4807_c0_g2_i6	Q8R3B7	BRD8_MOUSE	43.7	142	78	2	40	462	17	157	2.00E-25	117.1	BRD8_MOUSE	reviewed	Bromodomain-containing protein 8	Brd8	Mus musculus (Mouse)	951	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000812; GO:0005654; GO:0005739; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944; GO:0046966; GO:0097067	cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4807_c0_g2_i1	Q9H0E9	BRD8_HUMAN	46.8	124	65	1	40	411	17	139	7.80E-25	115.9	BRD8_HUMAN	reviewed	Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120)	BRD8 SMAP SMAP2	Homo sapiens (Human)	1235	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000812; GO:0005654; GO:0005739; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944; GO:0046966; GO:0097067	cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4807_c0_g2_i5	Q9H0E9	BRD8_HUMAN	46.8	124	65	1	40	411	17	139	7.70E-25	115.9	BRD8_HUMAN	reviewed	Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120)	BRD8 SMAP SMAP2	Homo sapiens (Human)	1235	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000812; GO:0005654; GO:0005739; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944; GO:0046966; GO:0097067	cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4807_c0_g2_i7	Q9H0E9	BRD8_HUMAN	46.8	124	65	1	40	411	17	139	7.90E-25	115.9	BRD8_HUMAN	reviewed	Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120)	BRD8 SMAP SMAP2	Homo sapiens (Human)	1235	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000812; GO:0005654; GO:0005739; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944; GO:0046966; GO:0097067	cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN9309_c0_g2_i1	Q9H0E9	BRD8_HUMAN	47.4	156	79	1	3	461	684	839	6.40E-36	151.8	BRD8_HUMAN	reviewed	Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120)	BRD8 SMAP SMAP2	Homo sapiens (Human)	1235	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000812; GO:0005654; GO:0005739; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944; GO:0046966; GO:0097067	cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4463_c0_g1_i1	Q7ZUF2	BRD9_DANRE	60.8	102	31	1	308	3	169	261	5.80E-29	128.6	BRD9_DANRE	reviewed	Bromodomain-containing protein 9	brd9	Danio rerio (Zebrafish) (Brachydanio rerio)	631	nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	lysine-acetylated histone binding [GO:0070577]	GO:0005634; GO:0006325; GO:0006357; GO:0070577	chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4463_c0_g1_i2	Q7ZUF2	BRD9_DANRE	51.3	78	29	1	293	60	169	237	1.50E-13	77.4	BRD9_DANRE	reviewed	Bromodomain-containing protein 9	brd9	Danio rerio (Zebrafish) (Brachydanio rerio)	631	nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	lysine-acetylated histone binding [GO:0070577]	GO:0005634; GO:0006325; GO:0006357; GO:0070577	chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24266_c1_g1_i1	Q2T9W0	BACD1_BOVIN	98.6	69	1	0	2	208	176	244	1.00E-33	143.3	BACD1_BOVIN	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 (BTB/POZ domain-containing protein KCTD13)	KCTD13	Bos taurus (Bovine)	329	Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]; GTP-Rho binding [GO:0017049]; cell migration [GO:0016477]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of synaptic transmission [GO:0050806]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleus [GO:0005634]	GTP-Rho binding [GO:0017049]	GO:0005634; GO:0016477; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0043149; GO:0043161; GO:0050806; GO:0051260	cell migration [GO:0016477]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of synaptic transmission [GO:0050806]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN24266_c0_g1_i1	Q8WZ19	BACD1_HUMAN	100	64	0	0	242	51	122	185	1.80E-29	129.4	BACD1_HUMAN	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 (hBACURD1) (BTB/POZ domain-containing protein KCTD13) (Polymerase delta-interacting protein 1) (TNFAIP1-like protein)	KCTD13 BACURD1 PDIP1 POLDIP1 FKSG86 PP6832	Homo sapiens (Human)	329	Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cell migration [GO:0016477]; DNA replication [GO:0006260]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; positive regulation of synaptic transmission [GO:0050806]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005654; GO:0006260; GO:0016477; GO:0016567; GO:0016604; GO:0017049; GO:0019904; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0050806; GO:0051260	cell migration [GO:0016477]; DNA replication [GO:0006260]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; positive regulation of synaptic transmission [GO:0050806]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN21121_c0_g1_i1	O70479	BACD2_MOUSE	98.2	111	2	0	333	1	15	125	1.90E-58	226.1	BACD2_MOUSE	reviewed	"BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (BTB/POZ domain-containing protein TNFAIP1) (Tumor necrosis factor, alpha-induced protein 1, endothelial)"	Tnfaip1 Edp1	Mus musculus (Mouse)	316	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; cell migration [GO:0016477]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005768; GO:0006260; GO:0006955; GO:0016477; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260	cell migration [GO:0016477]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN30369_c0_g1_i1	O70479	BACD2_MOUSE	100	108	0	0	325	2	180	287	1.50E-55	216.5	BACD2_MOUSE	reviewed	"BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (BTB/POZ domain-containing protein TNFAIP1) (Tumor necrosis factor, alpha-induced protein 1, endothelial)"	Tnfaip1 Edp1	Mus musculus (Mouse)	316	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; cell migration [GO:0016477]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005768; GO:0006260; GO:0006955; GO:0016477; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260	cell migration [GO:0016477]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN4573_c1_g1_i1	Q7TNY1	BACD2_RAT	68.9	257	78	2	1053	286	24	279	1.20E-100	368.2	BACD2_RAT	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (BTB/POZ domain-containing protein TNFAIP1) (Tumor necrosis factor-induced protein 1)	Tnfaip1	Rattus norvegicus (Rat)	316	"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; stress fiber assembly [GO:0043149]"	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005768; GO:0006260; GO:0006281; GO:0006355; GO:0006955; GO:0016477; GO:0016567; GO:0017049; GO:0030036; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260	"actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; stress fiber assembly [GO:0043149]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21121_c0_g1_i2	Q13829	BACD2_HUMAN	100	130	0	0	391	2	15	144	1.80E-71	269.6	BACD2_HUMAN	reviewed	"BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (hBACURD2) (BTB/POZ domain-containing protein TNFAIP1) (Protein B12) (Tumor necrosis factor, alpha-induced protein 1, endothelial)"	TNFAIP1 BACURD2 EDP1	Homo sapiens (Human)	316	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]	GO:0005634; GO:0005737; GO:0005768; GO:0006260; GO:0006915; GO:0006955; GO:0016477; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260	apoptotic process [GO:0006915]; cell migration [GO:0016477]; DNA replication [GO:0006260]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN31667_c0_g1_i1	Q9H3F6	BACD3_HUMAN	100	120	0	0	362	3	87	206	2.70E-61	235.7	BACD3_HUMAN	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)	KCTD10 ULR061 MSTP028	Homo sapiens (Human)	313	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]	GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260	negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN39895_c0_g1_i1	Q9H3F6	BACD3_HUMAN	100	111	0	0	336	4	173	283	6.70E-59	227.6	BACD3_HUMAN	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)	KCTD10 ULR061 MSTP028	Homo sapiens (Human)	313	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]	GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260	negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36343_c0_g1_i1	Q922M3	BACD3_MOUSE	100	106	0	0	320	3	42	147	3.00E-56	218.8	BACD3_MOUSE	reviewed	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (mBACURD3) (BTB/POZ domain-containing protein KCTD10)	Kctd10	Mus musculus (Mouse)	315	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleoplasm [GO:0005654]; GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; heart development [GO:0007507]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleoplasm [GO:0005654]	GTP-Rho binding [GO:0017049]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]	GO:0001525; GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0007507; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0036038; GO:0042802; GO:0043161; GO:0045746; GO:0051260	angiogenesis [GO:0001525]; heart development [GO:0007507]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN33646_c0_g1_i1	Q9H0C5	BTBD1_HUMAN	100	67	0	0	201	1	158	224	4.60E-31	134.4	BTBD1_HUMAN	reviewed	BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8)	BTBD1 C15orf1 NS5ATP8	Homo sapiens (Human)	482	cytosol [GO:0005829]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]	cytosol [GO:0005829]; P-body [GO:0000932]; protein-containing complex [GO:0032991]	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]	GO:0000932; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0042802; GO:0043393; GO:0043687; GO:0097602	muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]		NA	NA	NA	NA	NA	NA
TRINITY_DN7533_c0_g1_i1	Q9BSF8	BTBDA_HUMAN	73.2	228	59	1	71	748	165	392	3.90E-99	362.5	BTBDA_HUMAN	reviewed	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	BTBD10 GMRP1	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]		GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN7533_c0_g1_i3	Q9BSF8	BTBDA_HUMAN	66.7	105	33	1	71	379	165	269	1.50E-37	157.1	BTBDA_HUMAN	reviewed	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	BTBD10 GMRP1	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]		GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN7533_c0_g1_i4	Q9BSF8	BTBDA_HUMAN	72.2	212	57	1	71	700	165	376	1.30E-90	334.3	BTBDA_HUMAN	reviewed	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	BTBD10 GMRP1	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]		GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN7533_c0_g1_i5	Q9BSF8	BTBDA_HUMAN	63.6	173	61	1	71	583	165	337	2.40E-64	246.9	BTBDA_HUMAN	reviewed	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	BTBD10 GMRP1	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]		GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN7533_c0_g1_i5	Q9BSF8	BTBDA_HUMAN	87.5	40	5	0	576	695	337	376	7.40E-13	75.9	BTBDA_HUMAN	reviewed	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	BTBD10 GMRP1	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]		GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN24679_c0_g1_i1	Q9BSF8	BTBDA_HUMAN	98.7	75	1	0	3	227	171	245	1.30E-37	156.4	BTBDA_HUMAN	reviewed	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	BTBD10 GMRP1	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]		GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN9693_c0_g1_i1	Q9BX70	BTBD2_HUMAN	74.8	127	32	0	3	383	306	432	3.80E-53	208.8	BTBD2_HUMAN	reviewed	BTB/POZ domain-containing protein 2	BTBD2	Homo sapiens (Human)	525	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]	cytosol [GO:0005829]; P-body [GO:0000932]		GO:0000932; GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3061_c0_g1_i1	Q9BX70	BTBD2_HUMAN	29.7	232	118	4	838	1533	110	296	1.40E-18	95.9	BTBD2_HUMAN	reviewed	BTB/POZ domain-containing protein 2	BTBD2	Homo sapiens (Human)	525	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]	cytosol [GO:0005829]; P-body [GO:0000932]		GO:0000932; GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3061_c0_g1_i2	Q9BX70	BTBD2_HUMAN	29.7	232	118	4	704	9	110	296	4.00E-19	96.7	BTBD2_HUMAN	reviewed	BTB/POZ domain-containing protein 2	BTBD2	Homo sapiens (Human)	525	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]	cytosol [GO:0005829]; P-body [GO:0000932]		GO:0000932; GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN33846_c0_g1_i1	Q9BX70	BTBD2_HUMAN	83.3	84	14	0	8	259	102	185	7.50E-34	144.1	BTBD2_HUMAN	reviewed	BTB/POZ domain-containing protein 2	BTBD2	Homo sapiens (Human)	525	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]	cytosol [GO:0005829]; P-body [GO:0000932]		GO:0000932; GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3713_c0_g1_i1	F7ASZ0	BTBD3_CALJA	69.3	417	127	1	1358	111	105	521	1.70E-170	600.5	BTBD3_CALJA	reviewed	BTB/POZ domain-containing protein 3	BTBD3	Callithrix jacchus (White-tufted-ear marmoset)	522	cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]	cytosol [GO:0005829]; nucleus [GO:0005634]	identical protein binding [GO:0042802]	GO:0005634; GO:0005829; GO:0021987; GO:0042802; GO:0048813	cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]		NA	NA	NA	NA	NA	NA
TRINITY_DN3297_c0_g1_i2	Q0V9W6	BTBD6_XENTR	42.3	156	86	3	102	566	102	254	6.10E-25	116.3	BTBD6_XENTR	reviewed	BTB/POZ domain-containing protein 6	btbd6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	529	cytosol [GO:0005829]; neurogenesis [GO:0022008]	cytosol [GO:0005829]		GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3297_c0_g1_i3	Q0V9W6	BTBD6_XENTR	41.7	259	147	3	102	875	102	357	2.60E-49	197.2	BTBD6_XENTR	reviewed	BTB/POZ domain-containing protein 6	btbd6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	529	cytosol [GO:0005829]; neurogenesis [GO:0022008]	cytosol [GO:0005829]		GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3297_c0_g1_i4	Q0V9W6	BTBD6_XENTR	41.7	259	147	3	92	865	102	357	1.90E-49	197.6	BTBD6_XENTR	reviewed	BTB/POZ domain-containing protein 6	btbd6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	529	cytosol [GO:0005829]; neurogenesis [GO:0022008]	cytosol [GO:0005829]		GO:0005829; GO:0022008	neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN26336_c0_g1_i1	Q96KE9	BTBD6_HUMAN	100	86	0	0	259	2	190	275	5.30E-43	174.5	BTBD6_HUMAN	reviewed	BTB/POZ domain-containing protein 6 (Lens BTB domain protein)	BTBD6 BDPL	Homo sapiens (Human)	485	cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]	cytosol [GO:0005829]		GO:0005829; GO:0022008; GO:0043687	neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN1722_c0_g1_i1	Q9P203	BTBD7_HUMAN	58.8	131	48	2	80	472	118	242	5.60E-38	159.1	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		blue	blue	NA	NA	NA	NA
TRINITY_DN1722_c0_g1_i2	Q9P203	BTBD7_HUMAN	56.6	143	56	2	69	497	118	254	7.10E-39	161.8	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1722_c0_g1_i4	Q9P203	BTBD7_HUMAN	56.6	143	56	2	80	508	118	254	5.60E-39	162.2	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1722_c0_g1_i6	Q9P203	BTBD7_HUMAN	58.8	131	48	2	69	461	118	242	9.30E-38	158.3	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1722_c0_g1_i7	Q9P203	BTBD7_HUMAN	58.5	135	50	2	60	464	114	242	8.50E-39	161.8	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2187_c0_g2_i1	Q9P203	BTBD7_HUMAN	56.1	66	29	0	203	6	379	444	1.10E-16	86.7	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2187_c0_g1_i1	Q9P203	BTBD7_HUMAN	48.9	45	23	0	222	88	388	432	4.70E-08	58.2	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2187_c0_g1_i2	Q9P203	BTBD7_HUMAN	49.2	59	30	0	260	84	374	432	8.20E-12	70.9	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2187_c0_g1_i3	Q9P203	BTBD7_HUMAN	51.1	45	22	0	218	84	388	432	7.00E-09	60.8	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2187_c0_g1_i4	Q9P203	BTBD7_HUMAN	51.1	45	22	0	222	88	388	432	9.40E-09	60.5	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2187_c0_g1_i5	Q9P203	BTBD7_HUMAN	47.9	48	25	0	227	84	385	432	7.50E-09	61.2	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		blue	blue	NA	NA	NA	NA
TRINITY_DN2187_c0_g1_i6	Q9P203	BTBD7_HUMAN	48.9	45	23	0	218	84	388	432	8.20E-08	57.8	BTBD7_HUMAN	reviewed	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	1132	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0060693; GO:0061138	morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		blue	blue	NA	NA	NA	NA
TRINITY_DN10393_c0_g1_i1	Q96Q07	BTBD9_HUMAN	59	393	158	1	1180	2	157	546	5.50E-140	498.8	BTBD9_HUMAN	reviewed	BTB/POZ domain-containing protein 9	BTBD9 KIAA1880	Homo sapiens (Human)	612	"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]"			GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050804; GO:0050951; GO:0060586; GO:1900242	"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35405_c0_g1_i1	A4IFG2	BTBD9_BOVIN	59.7	77	30	1	11	238	22	98	3.20E-18	92	BTBD9_BOVIN	reviewed	BTB/POZ domain-containing protein 9	BTBD9	Bos taurus (Bovine)	611	adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; modulation of chemical synaptic transmission [GO:0050804]			GO:0008344; GO:0048512; GO:0050804	adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; modulation of chemical synaptic transmission [GO:0050804]		NA	NA	NA	NA	NA	NA
TRINITY_DN32861_c0_g1_i1	Q8N5Z5	KCD17_HUMAN	100	81	0	0	244	2	37	117	2.10E-41	169.1	KCD17_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD17	KCTD17	Homo sapiens (Human)	321	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0030030; GO:0031463; GO:0032469; GO:0042802; GO:0043161; GO:0045724; GO:0051260; GO:0097602	cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN26414_c0_g1_i1	Q8N5Z5	KCD17_HUMAN	100	109	0	0	328	2	78	186	8.60E-59	227.3	KCD17_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD17	KCTD17	Homo sapiens (Human)	321	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0030030; GO:0031463; GO:0032469; GO:0042802; GO:0043161; GO:0045724; GO:0051260; GO:0097602	cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN34880_c0_g1_i1	Q7Z5Y7	KCD20_HUMAN	100	76	0	0	3	230	105	180	4.00E-39	161.4	KCD20_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD20 (Potassium channel tetramerization domain containing 20)	KCTD20 C6orf69	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; positive regulation of phosphorylation [GO:0042327]	cytoplasm [GO:0005737]	identical protein binding [GO:0042802]	GO:0005737; GO:0042327; GO:0042802	positive regulation of phosphorylation [GO:0042327]		NA	NA	NA	NA	NA	NA
TRINITY_DN2370_c0_g2_i1	Q9Y597	KCTD3_HUMAN	71.1	121	35	0	100	462	15	135	1.20E-45	184.9	KCTD3_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45)	KCTD3	Homo sapiens (Human)	815	plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]	plasma membrane [GO:0005886]		GO:0005886; GO:0051260	protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN2370_c0_g2_i2	Q9Y597	KCTD3_HUMAN	71.2	118	34	0	100	453	15	132	2.20E-44	180.6	KCTD3_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45)	KCTD3	Homo sapiens (Human)	815	plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]	plasma membrane [GO:0005886]		GO:0005886; GO:0051260	protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN2370_c0_g1_i1	Q9Y597	KCTD3_HUMAN	69.3	437	130	2	246	1556	182	614	4.60E-181	636	KCTD3_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45)	KCTD3	Homo sapiens (Human)	815	plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]	plasma membrane [GO:0005886]		GO:0005886; GO:0051260	protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN2370_c0_g1_i2	Q9Y597	KCTD3_HUMAN	69.3	437	130	2	99	1409	182	614	3.30E-181	636.3	KCTD3_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45)	KCTD3	Homo sapiens (Human)	815	plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]	plasma membrane [GO:0005886]		GO:0005886; GO:0051260	protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN28545_c0_g1_i1	Q9Y597	KCTD3_HUMAN	100	84	0	0	1	252	367	450	4.30E-42	171.4	KCTD3_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45)	KCTD3	Homo sapiens (Human)	815	plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]	plasma membrane [GO:0005886]		GO:0005886; GO:0051260	protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN30703_c0_g1_i1	Q8VC57	KCTD5_MOUSE	99.2	120	1	0	362	3	84	203	6.40E-64	244.6	KCTD5_MOUSE	reviewed	BTB/POZ domain-containing protein KCTD5	Kctd5	Mus musculus (Mouse)	234	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN35670_c0_g1_i1	A5PKG7	KCTD5_BOVIN	68.2	192	59	1	115	690	44	233	3.40E-72	273.1	KCTD5_BOVIN	reviewed	BTB/POZ domain-containing protein KCTD5	KCTD5	Bos taurus (Bovine)	234	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cullin family protein binding [GO:0097602]	GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0043161; GO:0051260; GO:0097602	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]		blue	blue	NA	NA	NA	NA
TRINITY_DN34289_c0_g1_i1	Q80UN1	KCTD9_MOUSE	99	98	1	0	294	1	42	139	2.60E-54	212.2	KCTD9_MOUSE	reviewed	BTB/POZ domain-containing protein KCTD9	Kctd9	Mus musculus (Mouse)	339	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]		cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]	GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602	intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN7290_c0_g1_i1	Q7L273	KCTD9_HUMAN	47.3	262	112	2	873	88	1	236	1.20E-55	218.4	KCTD9_HUMAN	reviewed	BTB/POZ domain-containing protein KCTD9	KCTD9	Homo sapiens (Human)	389	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]		cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]	GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602	intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN18876_c0_g1_i1	Q7ZXV8	ZN207_XENLA	96.6	59	2	0	217	41	43	101	8.80E-28	123.6	ZN207_XENLA	reviewed	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (xBuGZ) (Zinc finger protein 207)	znf207 bugz	Xenopus laevis (African clawed frog)	452	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]	metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0000070; GO:0000776; GO:0000777; GO:0001578; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]		NA	NA	NA	NA	NA	NA
TRINITY_DN18876_c0_g1_i2	Q7ZXV8	ZN207_XENLA	96.9	64	2	0	232	41	38	101	1.80E-31	136	ZN207_XENLA	reviewed	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (xBuGZ) (Zinc finger protein 207)	znf207 bugz	Xenopus laevis (African clawed frog)	452	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]	metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0000070; GO:0000776; GO:0000777; GO:0001578; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]		NA	NA	NA	NA	NA	NA
TRINITY_DN30047_c0_g1_i1	Q7ZXV8	ZN207_XENLA	82.9	70	12	0	3	212	26	95	2.20E-30	132.9	ZN207_XENLA	reviewed	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (xBuGZ) (Zinc finger protein 207)	znf207 bugz	Xenopus laevis (African clawed frog)	452	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]	metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0000070; GO:0000776; GO:0000777; GO:0001578; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]		blue	blue	NA	NA	NA	NA
TRINITY_DN4052_c0_g1_i1	Q5ZIJ0	BUD13_CHICK	40	155	90	3	132	590	406	559	2.10E-22	107.5	BUD13_CHICK	reviewed	BUD13 homolog	BUD13 RCJMB04_25m15	Gallus gallus (Chicken)	559	"nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]		GO:0000398; GO:0005634; GO:0005684; GO:0070274; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6911_c0_g1_i1	Q25479	NKCL_MANSE	49.2	313	152	3	983	54	87	395	5.90E-82	305.8	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6911_c0_g1_i10	Q25479	NKCL_MANSE	45.8	991	507	7	3023	90	87	1060	9.90E-250	864.8	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	1
TRINITY_DN6911_c0_g1_i2	Q25479	NKCL_MANSE	45.7	993	507	8	3029	90	87	1060	3.20E-248	859.8	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6911_c0_g1_i5	Q25479	NKCL_MANSE	61.7	81	28	2	329	90	982	1060	1.10E-17	90.9	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6911_c0_g1_i6	Q25479	NKCL_MANSE	42.4	396	212	3	1247	90	671	1060	1.90E-80	301.2	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6911_c0_g1_i9	Q25479	NKCL_MANSE	65.6	61	20	1	269	90	1000	1060	9.80E-14	77.4	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN5055_c0_g1_i1	Q25479	NKCL_MANSE	54	50	23	0	159	308	881	930	3.60E-12	72.4	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN5055_c0_g1_i2	Q25479	NKCL_MANSE	47.9	96	50	0	159	446	881	976	2.00E-22	107.1	NKCL_MANSE	reviewed	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter (Na-K-CL symporter)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	1060	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	cation:chloride symporter activity [GO:0015377]	GO:0006813; GO:0006814; GO:0015377; GO:0016021	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN29144_c0_g1_i1	P0DMT5	PIN1B_THEAN	53.7	54	21	1	215	54	93	142	7.80E-08	57.4	PIN1B_THEAN	reviewed	Buparvaquone-resistant peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)	PIN1	Theileria annulata	142	extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005576; GO:0009405; GO:0030430; GO:0042025	pathogenesis [GO:0009405]		red	red	NA	NA	NA	NA
TRINITY_DN33764_c0_g1_i1	A9UNU6	BYST_MONBE	55.1	185	81	2	16	567	150	333	4.10E-56	219.2	BYST_MONBE	reviewed	Bystin	bysl 17006	Monosiga brevicollis (Choanoflagellate)	414	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	snoRNA binding [GO:0030515]	GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0030515; GO:0030688	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1885_c0_g1_i1	Q13895	BYST_HUMAN	46.7	458	221	6	1460	93	1	437	1.10E-103	378.6	BYST_HUMAN	reviewed	Bystin	BYSL ENP1	Homo sapiens (Human)	437	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; cell population proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]"	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0000462; GO:0001829; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0008283; GO:0016020; GO:0030515; GO:0030688; GO:0042254; GO:0043231; GO:0045177; GO:1904749	"cell population proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30934_c0_g1_i1	Q13895	BYST_HUMAN	100	97	0	0	3	293	307	403	1.00E-47	190.3	BYST_HUMAN	reviewed	Bystin	BYSL ENP1	Homo sapiens (Human)	437	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; cell population proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]"	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0000462; GO:0001829; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0008283; GO:0016020; GO:0030515; GO:0030688; GO:0042254; GO:0043231; GO:0045177; GO:1904749	"cell population proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17799_c0_g1_i1	P11586	C1TC_HUMAN	68	153	49	0	464	6	779	931	1.60E-58	226.9	C1TC_HUMAN	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	MTHFD1 MTHFC MTHFD	Homo sapiens (Human)	935	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN39716_c0_g1_i1	P11586	C1TC_HUMAN	100	273	0	0	819	1	18	290	3.20E-155	548.9	C1TC_HUMAN	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	MTHFD1 MTHFC MTHFD	Homo sapiens (Human)	935	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN29907_c0_g1_i1	Q922D8	C1TC_MOUSE	68.2	107	34	0	322	2	561	667	5.80E-39	161.4	C1TC_MOUSE	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	Mthfd1	Mus musculus (Mouse)	935	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0019346; GO:0035999; GO:0061053	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346]		NA	NA	NA	NA	NA	NA
TRINITY_DN19272_c0_g1_i1	Q922D8	C1TC_MOUSE	100	76	0	0	2	229	549	624	1.70E-34	146	C1TC_MOUSE	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	Mthfd1	Mus musculus (Mouse)	935	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0019346; GO:0035999; GO:0061053	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346]		NA	NA	NA	NA	NA	NA
TRINITY_DN19272_c0_g1_i2	P11586	C1TC_HUMAN	96.5	57	2	0	2	172	549	605	2.60E-22	105.5	C1TC_HUMAN	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	MTHFD1 MTHFC MTHFD	Homo sapiens (Human)	935	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN33158_c0_g1_i1	P11586	C1TC_HUMAN	99.4	168	1	0	507	4	761	928	2.80E-93	342.4	C1TC_HUMAN	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	MTHFD1 MTHFC MTHFD	Homo sapiens (Human)	935	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN39531_c0_g1_i1	P11586	C1TC_HUMAN	100	167	0	0	6	506	419	585	5.50E-89	328.2	C1TC_HUMAN	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	MTHFD1 MTHFC MTHFD	Homo sapiens (Human)	935	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]	GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN12639_c0_g2_i1	O96553	C1TC_DROME	59.3	86	32	2	262	5	150	232	1.70E-20	99.8	C1TC_DROME	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	pug CG4067	Drosophila melanogaster (Fruit fly)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0006730; GO:0008652; GO:0009086; GO:0035999	cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3705_c0_g2_i2	O96553	C1TC_DROME	60.3	317	125	1	106	1056	37	352	7.40E-104	378.6	C1TC_DROME	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"	pug CG4067	Drosophila melanogaster (Fruit fly)	968	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0006730; GO:0008652; GO:0009086; GO:0035999	cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN39982_c0_g1_i1	Q27772	C1TC_SPOFR	57.3	117	49	1	394	47	817	933	1.50E-33	143.7	C1TC_SPOFR	reviewed	"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"		Spodoptera frugiperda (Fall armyworm)	933	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0006164; GO:0009086; GO:0035999	histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN13899_c0_g1_i1	Q8IZJ3	CPMD8_HUMAN	51.5	103	50	0	342	34	1118	1220	3.00E-25	115.9	CPMD8_HUMAN	reviewed	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8	CPAMD8 KIAA1283	Homo sapiens (Human)	1885	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0001654; GO:0004867; GO:0005615; GO:0005886	eye development [GO:0001654]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g1_i3	P32870	CYA1_DROME	53.9	102	34	3	430	735	2087	2175	1.50E-18	95.1	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g1_i4	P32870	CYA1_DROME	53.9	102	34	3	1270	1575	2087	2175	2.80E-18	95.1	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g1_i5	P32870	CYA1_DROME	53.9	102	34	3	797	1102	2087	2175	2.00E-18	95.1	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g2_i1	P32870	CYA1_DROME	52.4	798	246	9	40	2061	310	1097	6.50E-213	741.9	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g2_i3	P32870	CYA1_DROME	36.6	164	100	2	50	535	77	238	2.80E-20	100.1	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g2_i4	P32870	CYA1_DROME	46.8	583	176	9	40	1416	310	882	1.90E-121	437.6	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g2_i5	P32870	CYA1_DROME	52.7	1033	359	10	50	2794	77	1097	2.10E-283	976.5	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16725_c0_g1_i1	P32870	CYA1_DROME	47.9	71	30	1	49	261	1	64	6.90E-06	51.2	CYA1_DROME	reviewed	Ca(2+)/calmodulin-responsive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Protein rutabaga)	rut CG9533	Drosophila melanogaster (Fruit fly)	2248	"integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0001661; GO:0004016; GO:0005516; GO:0005524; GO:0005887; GO:0006171; GO:0006979; GO:0007189; GO:0007268; GO:0007274; GO:0007528; GO:0007591; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008294; GO:0008306; GO:0008340; GO:0008355; GO:0009190; GO:0009408; GO:0010738; GO:0016020; GO:0030431; GO:0045202; GO:0046872; GO:0048149; GO:0048675; GO:0072375; GO:0090328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP biosynthetic process [GO:0006171]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; cyclic nucleotide biosynthetic process [GO:0009190]; determination of adult lifespan [GO:0008340]; learning [GO:0007612]; learning or memory [GO:0007611]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; molting cycle, chitin-based cuticle [GO:0007591]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of protein kinase A signaling [GO:0010738]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; sleep [GO:0030431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6260_c0_g1_i1	P47154	STE24_YEAST	59.6	89	34	2	1	264	215	302	6.10E-23	107.8	STE24_YEAST	reviewed	CAAX prenyl protease 1 (EC 3.4.24.84) (A-factor-converting enzyme) (Prenyl protein-specific endoprotease 1) (PPSEP 1)	STE24 AFC1 YJR117W J2032	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	453	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial outer membrane [GO:0005741]; nuclear inner membrane [GO:0005637]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]; ER-associated misfolded protein catabolic process [GO:0071712]; peptide mating pheromone maturation involved in positive regulation of conjugation with cellular fusion [GO:0071432]; protein processing [GO:0016485]; response to pheromone [GO:0019236]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial outer membrane [GO:0005741]; nuclear inner membrane [GO:0005637]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005637; GO:0005741; GO:0005783; GO:0016485; GO:0019236; GO:0030176; GO:0046872; GO:0071432; GO:0071586; GO:0071712	CAAX-box protein processing [GO:0071586]; ER-associated misfolded protein catabolic process [GO:0071712]; peptide mating pheromone maturation involved in positive regulation of conjugation with cellular fusion [GO:0071432]; protein processing [GO:0016485]; response to pheromone [GO:0019236]		NA	NA	NA	NA	NA	NA
TRINITY_DN9297_c0_g1_i1	Q8RX88	FACE1_ARATH	59.5	126	49	1	8	379	170	295	2.60E-38	159.5	FACE1_ARATH	reviewed	CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (AtFACE-1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) (AtSTE24)	FACE1 STE24 At4g01320 A_IG002N01.21 F2N1.21	Arabidopsis thaliana (Mouse-ear cress)	424	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; vacuole [GO:0005773]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein maturation [GO:0080120]; CAAX-box protein processing [GO:0071586]; proteolysis [GO:0006508]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; vacuole [GO:0005773]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004175; GO:0004222; GO:0005773; GO:0005783; GO:0005829; GO:0006508; GO:0030176; GO:0046872; GO:0071586; GO:0080120	CAAX-box protein maturation [GO:0080120]; CAAX-box protein processing [GO:0071586]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN4302_c0_g1_i1	O75844	FACE1_HUMAN	55.6	455	188	1	1430	108	16	470	3.50E-142	506.5	FACE1_HUMAN	reviewed	CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)	ZMPSTE24 FACE1 STE24	Homo sapiens (Human)	475	"extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"	extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]	double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]	GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004222; GO:0005637; GO:0006281; GO:0006508; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030176; GO:0030282; GO:0030327; GO:0030500; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0043979; GO:0044029; GO:0044255; GO:0046872; GO:0048145; GO:0048538; GO:0048739; GO:0050688; GO:0050905; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903025; GO:1903463; GO:1903799; GO:1990036; GO:1990164; GO:2000618; GO:2000730; GO:2000772	"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"		blue	blue	NA	NA	NA	NA
TRINITY_DN35806_c0_g1_i1	O75844	FACE1_HUMAN	100	67	0	0	211	11	409	475	3.00E-33	141.7	FACE1_HUMAN	reviewed	CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)	ZMPSTE24 FACE1 STE24	Homo sapiens (Human)	475	"extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"	extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]	double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]	GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004222; GO:0005637; GO:0006281; GO:0006508; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030176; GO:0030282; GO:0030327; GO:0030500; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0043979; GO:0044029; GO:0044255; GO:0046872; GO:0048145; GO:0048538; GO:0048739; GO:0050688; GO:0050905; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903025; GO:1903463; GO:1903799; GO:1990036; GO:1990164; GO:2000618; GO:2000730; GO:2000772	"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32921_c0_g1_i1	O75844	FACE1_HUMAN	100	167	0	0	1	501	143	309	2.10E-88	326.2	FACE1_HUMAN	reviewed	CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)	ZMPSTE24 FACE1 STE24	Homo sapiens (Human)	475	"extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"	extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]	double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]	GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004222; GO:0005637; GO:0006281; GO:0006508; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030176; GO:0030282; GO:0030327; GO:0030500; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0043979; GO:0044029; GO:0044255; GO:0046872; GO:0048145; GO:0048538; GO:0048739; GO:0050688; GO:0050905; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903025; GO:1903463; GO:1903799; GO:1990036; GO:1990164; GO:2000618; GO:2000730; GO:2000772	"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15913_c0_g1_i1	Q9U1H8	FACE2_DROME	44	243	131	2	830	105	58	296	1.20E-53	211.5	FACE2_DROME	reviewed	CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (Protein severas)	Sras CG4852	Drosophila melanogaster (Fruit fly)	302	integral component of endoplasmic reticulum membrane [GO:0030176]; cysteine-type endopeptidase activity [GO:0004197]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]	integral component of endoplasmic reticulum membrane [GO:0030176]	cysteine-type endopeptidase activity [GO:0004197]; metalloendopeptidase activity [GO:0004222]	GO:0004197; GO:0004222; GO:0030176; GO:0071586	CAAX-box protein processing [GO:0071586]		NA	NA	NA	NA	NA	NA
TRINITY_DN36227_c0_g1_i1	B6KG46	CATIN_TOXGV	58.7	155	60	2	480	16	538	688	3.70E-50	199.1	CATIN_TOXGV	reviewed	Cactin	CACTIN TGVEG_244380	Toxoplasma gondii (strain ATCC 50861 / VEG)	688	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein homooligomerization [GO:0051260]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]		GO:0005634; GO:0007049; GO:0010468; GO:0010971; GO:0030154; GO:0045595; GO:0051260	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein homooligomerization [GO:0051260]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN31759_c0_g1_i1	Q9CS00	CATIN_MOUSE	100	85	0	0	1	255	637	721	2.40E-48	192.2	CATIN_MOUSE	reviewed	Cactin	Cactin	Mus musculus (Mouse)	772	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of gene expression [GO:0010468]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]		GO:0001933; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0007275; GO:0010468; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356	"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of gene expression [GO:0010468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13699_c0_g1_i3	Q9VR99	CATIN_DROME	85.2	142	21	0	467	42	579	720	2.50E-71	269.6	CATIN_DROME	reviewed	Cactin (Cactus-interacting protein)	cactin CG1676	Drosophila melanogaster (Fruit fly)	720	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; dorsal/ventral axis specification [GO:0009950]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of gene expression [GO:0010468]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005681; GO:0005737; GO:0009950; GO:0010468; GO:0045292; GO:0045752; GO:0071013	"dorsal/ventral axis specification [GO:0009950]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of gene expression [GO:0010468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13699_c0_g1_i1	F1Q8W0	CATIN_DANRE	68.5	216	64	1	689	42	624	835	1.00E-81	304.7	CATIN_DANRE	reviewed	Cactin (zCactin)	cactin si:dkey-158a20.4 zgc:158620	Danio rerio (Zebrafish) (Brachydanio rerio)	835	"cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; anterior/posterior axis specification, embryo [GO:0008595]; eye development [GO:0001654]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of innate immune response [GO:0045824]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of embryonic development [GO:0040019]; regulation of gene expression [GO:0010468]"	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]		GO:0001654; GO:0003407; GO:0005681; GO:0005737; GO:0007399; GO:0008595; GO:0010468; GO:0040019; GO:0045087; GO:0045292; GO:0045824	"anterior/posterior axis specification, embryo [GO:0008595]; eye development [GO:0001654]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of innate immune response [GO:0045824]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of embryonic development [GO:0040019]; regulation of gene expression [GO:0010468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24878_c0_g1_i2	P05990	PYR1_DROME	74.4	508	130	0	1537	14	874	1381	1.40E-221	770.4	PYR1_DROME	reviewed	CAD protein (Protein rudimentary) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	r CG18572	Drosophila melanogaster (Fruit fly)	2224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0019240; GO:0044205; GO:0046872; GO:0070406	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN2610_c0_g1_i1	P05990	PYR1_DROME	70.3	165	49	0	573	79	1958	2122	1.60E-60	233.8	PYR1_DROME	reviewed	CAD protein (Protein rudimentary) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	r CG18572	Drosophila melanogaster (Fruit fly)	2224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0019240; GO:0044205; GO:0046872; GO:0070406	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN2610_c0_g1_i2	P05990	PYR1_DROME	67.1	307	101	0	984	64	1912	2218	3.90E-115	416.4	PYR1_DROME	reviewed	CAD protein (Protein rudimentary) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	r CG18572	Drosophila melanogaster (Fruit fly)	2224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0019240; GO:0044205; GO:0046872; GO:0070406	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN2610_c0_g1_i8	P05990	PYR1_DROME	66.4	244	82	0	845	114	1912	2155	2.40E-87	323.9	PYR1_DROME	reviewed	CAD protein (Protein rudimentary) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	r CG18572	Drosophila melanogaster (Fruit fly)	2224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutamine binding [GO:0070406]; metal ion binding [GO:0046872]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0019240; GO:0044205; GO:0046872; GO:0070406	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN21077_c0_g1_i1	P08955	PYR1_MESAU	74.6	67	17	0	7	207	13	79	3.70E-23	108.2	PYR1_MESAU	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Mesocricetus auratus (Golden hamster)	2225	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; protein kinase activity [GO:0004672]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; protein kinase activity [GO:0004672]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]	GO:0002134; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006207; GO:0006541; GO:0008270; GO:0016363; GO:0018107; GO:0044205; GO:0046777; GO:0070335	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN27179_c0_g1_i1	P27708	PYR1_HUMAN	100	87	0	0	262	2	1454	1540	8.10E-44	177.2	PYR1_HUMAN	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Homo sapiens (Human)	2225	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0001889; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN24878_c0_g1_i11	Q91437	PYR1_SQUAC	75.9	203	49	0	694	86	643	845	2.60E-82	306.6	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN24878_c0_g1_i3	Q91437	PYR1_SQUAC	62.1	340	125	3	1095	85	128	466	2.50E-126	453.4	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN24878_c0_g1_i5	B2RQC6	PYR1_MOUSE	64.7	116	40	1	361	14	22	136	4.60E-37	155.2	PYR1_MOUSE	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	Cad	Mus musculus (Mouse)	2225	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]	GO:0001889; GO:0002134; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016363; GO:0016597; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046777; GO:0051414; GO:0071364	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN24878_c0_g1_i6	Q91437	PYR1_SQUAC	60.3	204	79	1	695	90	128	331	1.70E-77	290.4	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN24878_c0_g1_i8	Q91437	PYR1_SQUAC	68.7	1356	420	4	4069	11	20	1373	0	1906.3	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN2610_c0_g1_i11	P27708	PYR1_HUMAN	55.6	592	225	12	1780	32	1399	1961	6.30E-180	632.1	PYR1_HUMAN	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Homo sapiens (Human)	2225	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0001889; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN2610_c0_g1_i4	Q91437	PYR1_SQUAC	71.8	216	61	0	708	61	2026	2241	3.10E-86	319.7	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN2610_c0_g1_i6	Q91437	PYR1_SQUAC	68	150	48	0	510	61	2092	2241	3.60E-55	216.1	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		brown	brown	NA	NA	NA	NA
TRINITY_DN6673_c0_g1_i1	Q91437	PYR1_SQUAC	64.4	160	57	0	11	490	195	354	5.00E-58	225.3	PYR1_SQUAC	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Squalus acanthias (Spiny dogfish)	2242	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN6673_c0_g3_i1	Q18990	PYR1_CAEEL	70	260	78	0	6	785	529	788	3.70E-103	375.9	PYR1_CAEEL	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	pyr-1 D2085.1	Caenorhabditis elegans	2198	cytoplasm [GO:0005737]; cytosol [GO:0005829]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nematode larval development [GO:0002119]; nitrogen compound metabolic process [GO:0006807]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]	GO:0002119; GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0016597; GO:0019240; GO:0019856; GO:0044205; GO:0046872; GO:0060465; GO:1905905	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nematode larval development [GO:0002119]; nitrogen compound metabolic process [GO:0006807]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN38410_c0_g1_i1	P27708	PYR1_HUMAN	100	76	0	0	230	3	629	704	5.40E-36	151	PYR1_HUMAN	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Homo sapiens (Human)	2225	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0001889; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN37655_c0_g1_i1	P27708	PYR1_HUMAN	100	108	0	0	3	326	238	345	6.30E-62	237.7	PYR1_HUMAN	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Homo sapiens (Human)	2225	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0001889; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN40874_c0_g1_i1	P27708	PYR1_HUMAN	100	79	0	0	238	2	1014	1092	7.60E-41	167.2	PYR1_HUMAN	reviewed	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	CAD	Homo sapiens (Human)	2225	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0001889; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN11694_c0_g1_i1	O35161	CELR1_MOUSE	33.9	230	125	6	1000	329	400	608	4.90E-20	100.1	CELR1_MOUSE	reviewed	Cadherin EGF LAG seven-pass G-type receptor 1	Celsr1	Mus musculus (Mouse)	3034	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0016021; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0098609	anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN14513_c1_g1_i4	O35161	CELR1_MOUSE	24.6	138	83	2	56	469	1557	1673	9.70E-07	55.1	CELR1_MOUSE	reviewed	Cadherin EGF LAG seven-pass G-type receptor 1	Celsr1	Mus musculus (Mouse)	3034	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0016021; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0098609	anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN28033_c0_g1_i1	Q9NYQ6	CELR1_HUMAN	39.3	84	46	2	4	240	364	447	2.20E-06	52.8	CELR1_HUMAN	reviewed	Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)	CELSR1 CDHF9 FMI2	Homo sapiens (Human)	3014	"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0007626; GO:0009952; GO:0016021; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0098609	"anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21811_c0_g1_i1	Q9NYQ6	CELR1_HUMAN	31.9	119	71	4	163	507	1407	1519	1.60E-05	52	CELR1_HUMAN	reviewed	Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)	CELSR1 CDHF9 FMI2	Homo sapiens (Human)	3014	"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0007626; GO:0009952; GO:0016021; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0098609	"anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32223_c0_g1_i1	Q9R0M0	CELR2_MOUSE	60.8	51	20	0	155	3	1394	1444	2.70E-11	68.9	CELR2_MOUSE	reviewed	Cadherin EGF LAG seven-pass G-type receptor 2 (Flamingo homolog)	Celsr2	Mus musculus (Mouse)	2919	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001764; GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0016021; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060271; GO:0098609	"cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39152_c0_g1_i1	Q9NYQ7	CELR3_HUMAN	27.3	176	91	8	62	574	819	962	7.50E-06	52.4	CELR3_HUMAN	reviewed	Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2)	CELSR3 CDHF11 EGFL1 FMI1 KIAA0812 MEGF2	Homo sapiens (Human)	3312	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060071; GO:0060271; GO:0098609; GO:1904938	"axonal fasciculation [GO:0007413]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12005_c0_g1_i2	Q99PF4	CAD23_MOUSE	39.2	130	70	5	97	483	2090	2211	2.80E-13	76.6	CAD23_MOUSE	reviewed	Cadherin-23 (Otocadherin)	Cdh23	Mus musculus (Mouse)	3354	apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]	apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]	GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0047485; GO:0048563; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0098742	auditory receptor cell stereocilium organization [GO:0060088]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transport [GO:0006816]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]		blue	blue	NA	NA	NA	NA
TRINITY_DN10384_c0_g2_i2	Q9VGG5	CAD87_DROME	49.1	114	43	4	6	341	1791	1891	2.30E-16	87.4	CAD87_DROME	reviewed	Cadherin-87A	Cad87A CG6977	Drosophila melanogaster (Fruit fly)	1975	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016339; GO:0044331	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]		NA	NA	NA	NA	NA	NA
TRINITY_DN12005_c0_g1_i1	Q91XU7	CDHR1_RAT	33.5	209	120	7	20	631	81	275	1.30E-16	88.2	CDHR1_RAT	reviewed	Cadherin-related family member 1 (MT-protocadherin) (Photoreceptor cadherin) (prCAD) (Protocadherin-21)	Cdhr1 Kiaa1775 Pcdh21 Prcad	Rattus norvegicus (Rat)	859	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cellular process [GO:0009987]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0008594; GO:0009987; GO:0035845; GO:0042622; GO:0045494	cell adhesion [GO:0007155]; cellular process [GO:0009987]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]		NA	NA	NA	NA	NA	NA
TRINITY_DN9119_c0_g1_i1	Q967F4	HMR1_CAEEL	59	39	15	1	78	194	2008	2045	5.30E-06	51.2	HMR1_CAEEL	reviewed	Cadherin-related hmr-1 (Protein Hammerhead)	hmr-1 W02B9.1	Caenorhabditis elegans	2920	adherens junction [GO:0005912]; catenin complex [GO:0016342]; spanning component of plasma membrane [GO:0044214]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; apical constriction involved in gastrulation [GO:0003384]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; spanning component of plasma membrane [GO:0044214]	beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]	GO:0000132; GO:0003384; GO:0005509; GO:0005912; GO:0007156; GO:0007369; GO:0007399; GO:0008013; GO:0009792; GO:0016342; GO:0016477; GO:0030866; GO:0042074; GO:0044214; GO:0070097; GO:0098609	apical constriction involved in gastrulation [GO:0003384]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN17372_c0_g1_i1	P33450	FAT_DROME	57.5	40	16	1	241	125	4089	4128	1.10E-07	57	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33874_c0_g1_i1	P33450	FAT_DROME	46	150	77	2	514	77	3729	3878	1.10E-28	127.9	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN41099_c0_g1_i1	P33450	FAT_DROME	43.7	135	58	4	358	2	4927	5059	4.50E-13	75.5	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25297_c0_g1_i1	P33450	FAT_DROME	64.5	121	43	0	2	364	3451	3571	2.20E-36	153.3	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30756_c0_g1_i1	P33450	FAT_DROME	55.5	164	73	0	78	569	3179	3342	1.70E-46	187.2	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20869_c0_g2_i1	P33450	FAT_DROME	50.9	53	23	2	197	42	4078	4128	2.60E-08	58.9	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32617_c0_g1_i1	P33450	FAT_DROME	61.4	88	33	1	6	266	4037	4124	1.20E-29	130.2	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090175; GO:0090176; GO:0090251; GO:0098609	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36609_c0_g1_i1	H6LGM6	CARC_ACEWD	53	66	31	0	2	199	314	379	8.60E-15	80.5	CARC_ACEWD	reviewed	Caffeyl-CoA reductase-Etf complex subunit CarC (EC 1.3.1.108) (Caffeoyl-CoA reductase CarC) (NADH-dependent caffeyl-CoA reduction)	carC Awo_c15720	Acetobacterium woodii (strain ATCC 29683 / DSM 1030 / JCM 2381 / KCTC 1655 / WB1)	379	"cytoplasm [GO:0005737]; acyl-CoA dehydrogenase activity [GO:0003995]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]"	cytoplasm [GO:0005737]	"acyl-CoA dehydrogenase activity [GO:0003995]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]"	GO:0003995; GO:0005737; GO:0016628; GO:0071949			NA	NA	NA	NA	NA	1
TRINITY_DN40960_c0_g1_i1	Q55CV9	Y9880_DICDI	56.2	73	31	1	220	2	134	205	7.70E-19	94	Y9880_DICDI	reviewed	CaiB/baiF CoA-transferase family protein DDB_G0269880 (EC 2.-.-.-)	DDB_G0269880	Dictyostelium discoideum (Slime mold)	471	CoA-transferase activity [GO:0008410]		CoA-transferase activity [GO:0008410]	GO:0008410			NA	NA	NA	NA	NA	NA
TRINITY_DN32447_c0_g1_i1	P41044	CAB32_DROME	56.6	53	23	0	18	176	257	309	1.50E-08	59.7	CAB32_DROME	reviewed	Calbindin-32	Cbp53E cbn CG6702	Drosophila melanogaster (Fruit fly)	310	cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]	cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; type III terminal bouton [GO:0097467]; type II terminal bouton [GO:0061175]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0061175; GO:0097467; GO:0099509; GO:1900271; GO:1903035	negative regulation of response to wounding [GO:1903035]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]		NA	NA	NA	NA	NA	NA
TRINITY_DN45_c0_g1_i1	Q99653	CHP1_HUMAN	65.1	195	60	2	89	652	1	194	6.30E-65	248.8	CHP1_HUMAN	reviewed	Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22)	CHP1 CHP	Homo sapiens (Human)	195	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; hyaluronan catabolic process [GO:0030214]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860]	GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0005925; GO:0006469; GO:0006611; GO:0006813; GO:0007264; GO:0008017; GO:0010923; GO:0015459; GO:0015630; GO:0017156; GO:0019900; GO:0022406; GO:0030133; GO:0030214; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070062; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1901214	calcium-ion regulated exocytosis [GO:0017156]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; hyaluronan catabolic process [GO:0030214]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264]		blue	blue	NA	NA	NA	NA
TRINITY_DN41041_c0_g1_i1	P63099	CANB1_BOVIN	100	68	0	0	2	205	15	82	5.60E-32	137.5	CANB1_BOVIN	reviewed	Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)	PPP3R1 CNA2 CNB	Bos taurus (Bovine)	170	calcineurin complex [GO:0005955]; cytosol [GO:0005829]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; myelination in peripheral nervous system [GO:0022011]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein import into nucleus [GO:0006606]	calcineurin complex [GO:0005955]; cytosol [GO:0005829]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]	calcium ion binding [GO:0005509]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]	GO:0001569; GO:0001837; GO:0004721; GO:0005509; GO:0005829; GO:0005955; GO:0006606; GO:0007507; GO:0019902; GO:0022011; GO:0033173; GO:0042383; GO:0060487; GO:0098685; GO:0098794; GO:0099170	branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; myelination in peripheral nervous system [GO:0022011]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN28258_c0_g1_i1	P63099	CANB1_BOVIN	100	91	0	0	1	273	80	170	7.70E-46	184.1	CANB1_BOVIN	reviewed	Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)	PPP3R1 CNA2 CNB	Bos taurus (Bovine)	170	calcineurin complex [GO:0005955]; cytosol [GO:0005829]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; myelination in peripheral nervous system [GO:0022011]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein import into nucleus [GO:0006606]	calcineurin complex [GO:0005955]; cytosol [GO:0005829]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]	calcium ion binding [GO:0005509]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]	GO:0001569; GO:0001837; GO:0004721; GO:0005509; GO:0005829; GO:0005955; GO:0006606; GO:0007507; GO:0019902; GO:0022011; GO:0033173; GO:0042383; GO:0060487; GO:0098685; GO:0098794; GO:0099170	branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; myelination in peripheral nervous system [GO:0022011]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN24044_c0_g1_i1	Q96LZ3	CANB2_HUMAN	64.6	79	28	0	21	257	88	166	7.70E-24	110.9	CANB2_HUMAN	reviewed	Calcineurin subunit B type 2 (Calcineurin B-like protein) (CBLP) (Calcineurin BII) (CNBII) (PPP3R1-like) (Protein phosphatase 2B regulatory subunit 2) (Protein phosphatase 3 regulatory subunit B beta isoform)	PPP3R2 CBLP PPP3RL	Homo sapiens (Human)	170	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			NA	NA	NA	NA	NA	NA
TRINITY_DN6520_c0_g1_i1	Q24214	CANB2_DROME	94.9	156	8	0	555	88	15	170	1.80E-80	300.1	CANB2_DROME	reviewed	Calcineurin subunit B type 2 (Protein phosphatase 2B regulatory subunit 2) (dCNB2)	CanB2 CNB2 CG11217	Drosophila melanogaster (Fruit fly)	170	calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calmodulin binding [GO:0005516]; meiotic cell cycle [GO:0051321]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192]	calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021]	calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005955; GO:0006470; GO:0007269; GO:0008021; GO:0008597; GO:0016192; GO:0030241; GO:0030431; GO:0045214; GO:0051321	meiotic cell cycle [GO:0051321]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN12542_c0_g1_i1	Q9Y6J0	CABIN_HUMAN	42.6	169	89	2	89	592	1510	1671	2.00E-34	148.3	CABIN_HUMAN	reviewed	Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)	CABIN1 KIAA0330	Homo sapiens (Human)	2220	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235	cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]		NA	NA	NA	NA	NA	NA
TRINITY_DN2199_c0_g1_i3	Q9Y6J0	CABIN_HUMAN	31	814	453	19	74	2407	588	1328	1.10E-95	352.8	CABIN_HUMAN	reviewed	Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)	CABIN1 KIAA0330	Homo sapiens (Human)	2220	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235	cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]		NA	NA	NA	NA	NA	NA
TRINITY_DN2199_c0_g1_i5	Q9Y6J0	CABIN_HUMAN	30.3	943	524	24	72	2741	466	1328	2.50E-101	371.7	CABIN_HUMAN	reviewed	Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)	CABIN1 KIAA0330	Homo sapiens (Human)	2220	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235	cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]		NA	NA	NA	NA	NA	NA
TRINITY_DN19094_c0_g2_i1	O88480	CABIN_RAT	34	188	122	1	1689	1132	115	302	1.90E-24	115.5	CABIN_RAT	reviewed	Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)	Cabin1	Rattus norvegicus (Rat)	2182	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase inhibitor activity [GO:0004864]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005634; GO:0005737; GO:0006336; GO:0014823; GO:0019904; GO:0030346; GO:0060548	DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]		NA	NA	NA	NA	NA	NA
TRINITY_DN2066_c0_g1_i1	Q3ZC15	RCAN2_BOVIN	46.6	189	92	3	237	794	7	189	1.10E-42	175.3	RCAN2_BOVIN	reviewed	Calcipressin-2 (Down syndrome candidate region 1-like 1) (Regulator of calcineurin 2)	RCAN2 DSCR1L1	Bos taurus (Bovine)	197	cytoplasm [GO:0005737]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; nucleic acid binding [GO:0003676]; calcium-mediated signaling [GO:0019722]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]	cytoplasm [GO:0005737]	calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0005737; GO:0008597; GO:0019722; GO:0070884	calcium-mediated signaling [GO:0019722]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]		blue	blue	NA	NA	NA	NA
TRINITY_DN29614_c0_g1_i1	Q9UKA8	RCAN3_HUMAN	97.4	76	2	0	228	1	111	186	9.90E-38	156.8	RCAN3_HUMAN	reviewed	Calcipressin-3 (Down syndrome candidate region 1-like protein 2) (Myocyte-enriched calcineurin-interacting protein 3) (MCIP3) (Regulator of calcineurin 3)	RCAN3 DSCR1L2	Homo sapiens (Human)	241	cytoplasm [GO:0005737]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902]; RNA binding [GO:0003723]; troponin I binding [GO:0031013]; anatomical structure morphogenesis [GO:0009653]; calcium-mediated signaling [GO:0019722]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]	cytoplasm [GO:0005737]	calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902]; RNA binding [GO:0003723]; troponin I binding [GO:0031013]	GO:0003723; GO:0005737; GO:0008597; GO:0009653; GO:0019722; GO:0019902; GO:0031013; GO:0070884	anatomical structure morphogenesis [GO:0009653]; calcium-mediated signaling [GO:0019722]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]		NA	NA	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i10	Q96Q77	CIB3_HUMAN	36.1	72	42	1	268	65	1	72	7.30E-05	48.1	CIB3_HUMAN	reviewed	Calcium and integrin-binding family member 3 (Kinase-interacting protein 3) (KIP 3)	CIB3 KIP3	Homo sapiens (Human)	187	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]		calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005509			NA	NA	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i7	Q96Q77	CIB3_HUMAN	36.1	72	42	1	268	65	1	72	9.10E-05	48.1	CIB3_HUMAN	reviewed	Calcium and integrin-binding family member 3 (Kinase-interacting protein 3) (KIP 3)	CIB3 KIP3	Homo sapiens (Human)	187	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]		calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005509			yellow	yellow	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i9	Q96Q77	CIB3_HUMAN	36.1	72	42	1	268	65	1	72	8.80E-05	48.1	CIB3_HUMAN	reviewed	Calcium and integrin-binding family member 3 (Kinase-interacting protein 3) (KIP 3)	CIB3 KIP3	Homo sapiens (Human)	187	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]		calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005509			blue	blue	NA	NA	NA	NA
TRINITY_DN1181_c0_g1_i1	Q17QE5	CIB1_BOVIN	47.5	177	86	3	581	72	15	191	3.20E-40	166.8	CIB1_BOVIN	reviewed	Calcium and integrin-binding protein 1 (Calmyrin)	CIB1	Bos taurus (Bovine)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]	calcium ion binding [GO:0005509]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005737; GO:0005813; GO:0005886; GO:0006915; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008284; GO:0008285; GO:0010977; GO:0016324; GO:0030027; GO:0030220; GO:0030307; GO:0030335; GO:0030426; GO:0031122; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070374; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:1900026; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN1181_c0_g1_i2	Q17QE5	CIB1_BOVIN	46.6	191	95	3	623	72	1	191	7.10E-42	172.2	CIB1_BOVIN	reviewed	Calcium and integrin-binding protein 1 (Calmyrin)	CIB1	Bos taurus (Bovine)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]	calcium ion binding [GO:0005509]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005737; GO:0005813; GO:0005886; GO:0006915; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008284; GO:0008285; GO:0010977; GO:0016324; GO:0030027; GO:0030220; GO:0030307; GO:0030335; GO:0030426; GO:0031122; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070374; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:1900026; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		blue	blue	NA	NA	NA	NA
TRINITY_DN25444_c0_g1_i1	Q99828	CIB1_HUMAN	100	131	0	0	1	393	28	158	1.90E-68	259.6	CIB1_HUMAN	reviewed	Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)	CIB1 CIB KIP PRKDCIP	Homo sapiens (Human)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0031122; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i1	Q99828	CIB1_HUMAN	42.6	188	100	4	541	2	1	188	1.20E-32	141.4	CIB1_HUMAN	reviewed	Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)	CIB1 CIB KIP PRKDCIP	Homo sapiens (Human)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0031122; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i12	Q99828	CIB1_HUMAN	42.8	159	84	3	538	83	1	159	8.80E-25	115.2	CIB1_HUMAN	reviewed	Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)	CIB1 CIB KIP PRKDCIP	Homo sapiens (Human)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0031122; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i3	Q99828	CIB1_HUMAN	42.8	159	84	3	538	83	1	159	1.00E-24	115.2	CIB1_HUMAN	reviewed	Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)	CIB1 CIB KIP PRKDCIP	Homo sapiens (Human)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0031122; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN1016_c0_g1_i4	Q99828	CIB1_HUMAN	42.6	188	100	4	541	2	1	188	1.30E-32	141.4	CIB1_HUMAN	reviewed	Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)	CIB1 CIB KIP PRKDCIP	Homo sapiens (Human)	191	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0031122; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN27963_c0_g1_i1	Q9Z0F4	CIB1_MOUSE	100	93	0	0	280	2	45	137	3.80E-47	188.3	CIB1_MOUSE	reviewed	Calcium and integrin-binding protein 1 (CIB) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP)	Cib1 Cib Kip Prkdcip	Mus musculus (Mouse)	191	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; Ras GTPase binding [GO:0017016]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]	calcium-dependent protein kinase inhibitor activity [GO:0008427]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; protein serine/threonine kinase inhibitor activity [GO:0030291]; Ras GTPase binding [GO:0017016]	GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005813; GO:0005886; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008022; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0017016; GO:0019901; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031122; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:1900026; GO:1903078; GO:1990090; GO:2000256	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; endomitotic cell cycle [GO:0007113]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163]		NA	NA	NA	NA	NA	NA
TRINITY_DN35437_c0_g1_i1	B3M9W1	FLOWR_DROAN	50.7	138	65	1	440	36	23	160	3.20E-28	126.3	FLOWR_DROAN	reviewed	Calcium channel flower	flower GF10375	Drosophila ananassae (Fruit fly)	195	integral component of synaptic vesicle membrane [GO:0030285]; spanning component of plasma membrane [GO:0044214]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; bulk synaptic vesicle endocytosis [GO:0150008]; cell competition in a multicellular organism [GO:0035212]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; photoreceptor cell differentiation [GO:0046530]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; synaptic vesicle endocytosis [GO:0048488]	integral component of synaptic vesicle membrane [GO:0030285]; spanning component of plasma membrane [GO:0044214]	calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]	GO:0005262; GO:0030285; GO:0035212; GO:0042802; GO:0043525; GO:0044214; GO:0046530; GO:0048488; GO:0099533; GO:0150007; GO:0150008	bulk synaptic vesicle endocytosis [GO:0150008]; cell competition in a multicellular organism [GO:0035212]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; photoreceptor cell differentiation [GO:0046530]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2536_c0_g1_i1	Q8IWX8	CHERP_HUMAN	40.1	142	85	0	41	466	105	246	1.30E-23	110.9	CHERP_HUMAN	reviewed	Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6)	CHERP DAN26 SCAF6	Homo sapiens (Human)	916	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]	ion channel binding [GO:0044325]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886	"cellular calcium ion homeostasis [GO:0006874]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2536_c0_g1_i2	Q8IWX8	CHERP_HUMAN	34.4	93	61	0	41	319	105	197	1.50E-07	57.4	CHERP_HUMAN	reviewed	Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6)	CHERP DAN26 SCAF6	Homo sapiens (Human)	916	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]	ion channel binding [GO:0044325]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886	"cellular calcium ion homeostasis [GO:0006874]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5012_c0_g1_i1	Q8IWX8	CHERP_HUMAN	60	40	16	0	606	487	687	726	3.40E-08	60.1	CHERP_HUMAN	reviewed	Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6)	CHERP DAN26 SCAF6	Homo sapiens (Human)	916	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]	ion channel binding [GO:0044325]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886	"cellular calcium ion homeostasis [GO:0006874]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39352_c0_g1_i1	Q8CGZ0	CHERP_MOUSE	75	64	16	0	22	213	1	64	3.80E-23	108.2	CHERP_MOUSE	reviewed	Calcium homeostasis endoplasmic reticulum protein (SR-related CTD-associated factor 6)	Cherp Scaf6	Mus musculus (Mouse)	936	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]	ion channel binding [GO:0044325]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006396; GO:0006874; GO:0008285; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886	cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN4229_c0_g1_i1	Q6DGW9	TMCO1_DANRE	67.6	182	59	0	73	618	2	183	4.40E-63	242.7	TMCO1_DANRE	reviewed	Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1)	tmco1	Danio rerio (Zebrafish) (Brachydanio rerio)	188	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]	calcium channel activity [GO:0005262]	GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0006874; GO:0006983; GO:0030176; GO:0032469; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]		blue	blue	NA	NA	NA	NA
TRINITY_DN20609_c0_g1_i1	Q9UM00	TMCO1_HUMAN	100	193	0	0	599	21	47	239	2.50E-88	326.2	TMCO1_HUMAN	reviewed	Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3)	TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177	Homo sapiens (Human)	239	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]	calcium channel activity [GO:0005262]	GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0006874; GO:0006983; GO:0030176; GO:0032469; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]		NA	NA	NA	NA	NA	NA
TRINITY_DN20609_c0_g1_i2	Q9UM00	TMCO1_HUMAN	100	157	0	0	472	2	47	203	3.20E-67	255.8	TMCO1_HUMAN	reviewed	Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3)	TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177	Homo sapiens (Human)	239	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]	calcium channel activity [GO:0005262]	GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0006874; GO:0006983; GO:0030176; GO:0032469; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]		NA	NA	NA	NA	NA	NA
TRINITY_DN25528_c0_g1_i1	Q96D31	CRCM1_HUMAN	100	144	0	0	1	432	52	195	2.50E-74	279.3	CRCM1_HUMAN	reviewed	Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A)	ORAI1 CRACM1 TMEM142A	Homo sapiens (Human)	301	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279]; adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]	calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0002250; GO:0005262; GO:0005516; GO:0005829; GO:0005886; GO:0005887; GO:0015279; GO:0016020; GO:0016323; GO:0034704; GO:0042802; GO:0044853; GO:0045121; GO:0045762; GO:0051924; GO:0051928; GO:0061180; GO:0070509; GO:0070588	adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]		NA	NA	NA	NA	NA	NA
TRINITY_DN4315_c0_g1_i1	Q08BI9	MCU_DANRE	56.9	225	97	0	1	675	143	367	1.10E-68	261.5	MCU_DANRE	reviewed	"Calcium uniporter protein, mitochondrial"	mcu zgc:153607	Danio rerio (Zebrafish) (Brachydanio rerio)	376	calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016]	calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]	calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]	GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0031305; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0051259; GO:0051560; GO:0051561; GO:0060027; GO:1990246	actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016]		NA	NA	NA	NA	NA	NA
TRINITY_DN37161_c0_g1_i1	Q9NWR8	MCUB_HUMAN	100	70	0	0	212	3	205	274	6.20E-34	144.1	MCUB_HUMAN	reviewed	"Calcium uniporter regulatory subunit MCUb, mitochondrial (MCUb) (Coiled-coil domain-containing protein 109B)"	MCUB CCDC109B	Homo sapiens (Human)	336	calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]; calcium channel inhibitor activity [GO:0019855]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]	calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]	calcium channel inhibitor activity [GO:0019855]	GO:0005654; GO:0005739; GO:0005743; GO:0006851; GO:0019855; GO:0031224; GO:0031305; GO:0034704; GO:0036444; GO:0043231; GO:0051560; GO:1990246	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]		NA	NA	NA	NA	NA	NA
TRINITY_DN17810_c0_g1_i1	A2VEI2	MICU1_DROME	40.3	216	113	6	169	792	13	220	1.30E-25	118.6	MICU1_DROME	reviewed	"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)"	MICU1 CG4495	Drosophila melanogaster (Fruit fly)	525	mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246	anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		NA	NA	NA	NA	NA	NA
TRINITY_DN17810_c0_g1_i3	A2VEI2	MICU1_DROME	74.5	368	89	2	88	1191	163	525	3.30E-154	546.2	MICU1_DROME	reviewed	"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)"	MICU1 CG4495	Drosophila melanogaster (Fruit fly)	525	mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246	anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		NA	NA	NA	NA	NA	NA
TRINITY_DN17810_c0_g1_i6	A2VEI2	MICU1_DROME	61.7	522	183	7	169	1710	13	525	1.70E-164	580.9	MICU1_DROME	reviewed	"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)"	MICU1 CG4495	Drosophila melanogaster (Fruit fly)	525	mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246	anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		NA	NA	NA	NA	NA	NA
TRINITY_DN38989_c0_g1_i1	D2HZB0	MICU1_AILME	100	128	0	0	401	18	354	481	1.70E-69	263.1	MICU1_AILME	reviewed	"Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog)"	MICU1 CBARA1 PANDA_018142	Ailuropoda melanoleuca (Giant panda)	481	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0036444; GO:0051560; GO:0051561; GO:0070509; GO:1900069; GO:1990246	calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]		NA	NA	NA	NA	NA	NA
TRINITY_DN3916_c1_g1_i1	A4IG32	MICU1_DANRE	67.2	61	20	0	415	233	114	174	1.20E-19	97.8	MICU1_DANRE	reviewed	"Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog)"	micu1 cbara1 si:ch211-199i24.4 zgc:162148	Danio rerio (Zebrafish) (Brachydanio rerio)	489	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0036444; GO:0051560; GO:0051561; GO:0070509; GO:1990246	calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		NA	NA	NA	NA	NA	NA
TRINITY_DN27444_c0_g1_i1	Q8VCX5	MICU1_MOUSE	100	72	0	0	1	216	196	267	1.30E-34	146.4	MICU1_MOUSE	reviewed	"Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog)"	Micu1 Cbara1	Mus musculus (Mouse)	477	calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]	calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]	GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0034704; GO:0036444; GO:0042802; GO:0046982; GO:0051260; GO:0051560; GO:0051561; GO:0070509; GO:1900069; GO:1990246	calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]		NA	NA	NA	NA	NA	NA
TRINITY_DN33178_c0_g1_i1	Q8IYU8	MICU2_HUMAN	100	113	0	0	341	3	295	407	4.30E-61	235	MICU2_HUMAN	reviewed	"Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1)"	MICU2 EFHA1	Homo sapiens (Human)	434	calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]	GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0051562; GO:1990246	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		NA	NA	NA	NA	NA	NA
TRINITY_DN28641_c0_g1_i1	Q8CD10	MICU2_MOUSE	100	71	0	0	1	213	332	402	7.30E-35	147.1	MICU2_MOUSE	reviewed	"Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1)"	Micu2 Efha1	Mus musculus (Mouse)	432	calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]	GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0051562; GO:1990246	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		NA	NA	NA	NA	NA	NA
TRINITY_DN1167_c0_g1_i1	Q9CTY5	MICU3_MOUSE	71.7	53	15	0	75	233	449	501	9.30E-16	84.3	MICU3_MOUSE	reviewed	"Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)"	Micu3 Efha2	Mus musculus (Mouse)	523	uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]	uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0036444; GO:0051560; GO:1990246	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]		NA	NA	NA	NA	NA	NA
TRINITY_DN1167_c0_g1_i2	Q86XE3	MICU3_HUMAN	48.6	333	141	3	7	972	214	527	1.70E-79	297.7	MICU3_HUMAN	reviewed	"Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)"	MICU3 EFHA2	Homo sapiens (Human)	530	mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]	mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005743; GO:0006851; GO:0036444; GO:0051560; GO:1990246	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]		NA	NA	NA	NA	NA	NA
TRINITY_DN1167_c0_g1_i3	Q86XE3	MICU3_HUMAN	49.6	341	142	5	7	1020	214	527	3.60E-80	300.1	MICU3_HUMAN	reviewed	"Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)"	MICU3 EFHA2	Homo sapiens (Human)	530	mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]	mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005743; GO:0006851; GO:0036444; GO:0051560; GO:1990246	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]		NA	NA	NA	NA	NA	NA
TRINITY_DN30114_c0_g1_i1	B7YZV4	PDE1_DROME	72.6	95	26	0	1	285	591	685	5.20E-36	151.4	PDE1_DROME	reviewed	"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1) (EC 3.1.4.17)"	Pde1c CG44007	Drosophila melanogaster (Fruit fly)	834	"extracellular space [GO:0005615]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165]"	extracellular space [GO:0005615]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005516; GO:0005615; GO:0007165; GO:0032504; GO:0046058; GO:0046068; GO:0046872; GO:0047555; GO:0048101; GO:0060179	cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8685_c0_g1_i1	Q8N5S9	KKCC1_HUMAN	54	396	127	4	2	1135	142	500	1.30E-112	407.9	KKCC1_HUMAN	reviewed	Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha)	CAMKK1 CAMKKA	Homo sapiens (Human)	505	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0035556; GO:0045860	intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]		NA	NA	NA	NA	NA	NA
TRINITY_DN31353_c0_g1_i1	Q96RR4	KKCC2_HUMAN	100	86	0	0	260	3	306	391	2.10E-44	179.1	KKCC2_HUMAN	reviewed	Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta)	CAMKK2 CAMKKB KIAA0787	Homo sapiens (Human)	588	"cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein tyrosine kinase activity [GO:0004713]; calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]"	cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0001934; GO:0004683; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0019722; GO:0034614; GO:0043005; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:1903599	"calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12059_c0_g1_i1	Q91YS8	KCC1A_MOUSE	100	297	0	0	893	3	26	322	5.40E-172	604.7	KCC1A_MOUSE	reviewed	Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha)	Camk1	Mus musculus (Mouse)	374	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; negative regulation of protein binding [GO:0032091]; nucleocytoplasmic transport [GO:0006913]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of muscle cell differentiation [GO:0051147]; regulation of protein binding [GO:0043393]; regulation of protein localization [GO:0032880]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006913; GO:0007049; GO:0007165; GO:0010976; GO:0014069; GO:0018105; GO:0032091; GO:0032880; GO:0033138; GO:0043393; GO:0045944; GO:0046827; GO:0050807; GO:0051147; GO:0051149; GO:0051835; GO:0060143; GO:0060999; GO:0071902; GO:0098978; GO:1901985	cell cycle [GO:0007049]; negative regulation of protein binding [GO:0032091]; nucleocytoplasmic transport [GO:0006913]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of muscle cell differentiation [GO:0051147]; regulation of protein binding [GO:0043393]; regulation of protein localization [GO:0032880]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN527_c0_g1_i1	W0LYS5	CAMKI_MACNP	91	321	28	1	3	962	11	331	2.20E-167	589.7	CAMKI_MACNP	reviewed	Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI)	CaMKI	Macrobrachium nipponense (Oriental river shrimp) (Palaemon nipponensis)	345	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404	molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		blue	blue	NA	NA	NA	NA
TRINITY_DN527_c0_g1_i3	W0LYS5	CAMKI_MACNP	90	321	31	1	3	962	11	331	1.20E-165	583.9	CAMKI_MACNP	reviewed	Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI)	CaMKI	Macrobrachium nipponense (Oriental river shrimp) (Palaemon nipponensis)	345	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404	molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN527_c0_g1_i4	W0LYS5	CAMKI_MACNP	87.9	321	38	1	3	962	11	331	7.20E-162	571.6	CAMKI_MACNP	reviewed	Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI)	CaMKI	Macrobrachium nipponense (Oriental river shrimp) (Palaemon nipponensis)	345	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404	molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN527_c0_g1_i5	W0LYS5	CAMKI_MACNP	90.8	305	27	1	3	914	11	315	2.60E-159	562.8	CAMKI_MACNP	reviewed	Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI)	CaMKI	Macrobrachium nipponense (Oriental river shrimp) (Palaemon nipponensis)	345	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404	molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN7995_c0_g1_i1	Q8IU85	KCC1D_HUMAN	55.6	72	32	0	3	218	100	171	2.60E-18	92.4	KCC1D_HUMAN	reviewed	Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK)	CAMK1D CAMKID	Homo sapiens (Human)	385	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0010976; GO:0018105; GO:0032793; GO:0043065; GO:0043066; GO:0050766; GO:0050773; GO:0060267; GO:0071622; GO:0090023	inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622]		NA	NA	NA	NA	NA	NA
TRINITY_DN1165_c0_g1_i1	Q00168	KCC2A_DROME	62.6	195	40	2	3	488	321	515	8.20E-63	241.5	KCC2A_DROME	reviewed	Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)	CaMKII CaM CG18069	Drosophila melanogaster (Fruit fly)	530	"axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0005954; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0050710; GO:0051489; GO:0060278; GO:1990443	"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1165_c0_g1_i2	Q00168	KCC2A_DROME	67.5	166	41	1	5	463	350	515	2.80E-60	233	KCC2A_DROME	reviewed	Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)	CaMKII CaM CG18069	Drosophila melanogaster (Fruit fly)	530	"axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0005954; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0050710; GO:0051489; GO:0060278; GO:1990443	"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1165_c0_g1_i3	Q00168	KCC2A_DROME	62.6	195	31	2	3	461	321	515	1.10E-61	237.7	KCC2A_DROME	reviewed	Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)	CaMKII CaM CG18069	Drosophila melanogaster (Fruit fly)	530	"axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0005954; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0050710; GO:0051489; GO:0060278; GO:1990443	"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30057_c0_g1_i1	Q00168	KCC2A_DROME	95.2	209	10	0	629	3	42	250	2.30E-116	419.5	KCC2A_DROME	reviewed	Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)	CaMKII CaM CG18069	Drosophila melanogaster (Fruit fly)	530	"axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0005954; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0050710; GO:0051489; GO:0060278; GO:1990443	"cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19181_c0_g1_i1	Q2HJF7	KCC2D_BOVIN	99.1	108	1	0	3	326	183	290	8.30E-62	237.3	KCC2D_BOVIN	reviewed	Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17)	CAMK2D	Bos taurus (Bovine)	488	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0010613; GO:0033017; GO:0042383; GO:0043005; GO:0060341	positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]		NA	NA	NA	NA	NA	NA
TRINITY_DN15277_c0_g1_i1	Q2HJF7	KCC2D_BOVIN	100	123	0	0	370	2	350	472	1.80E-68	259.6	KCC2D_BOVIN	reviewed	Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17)	CAMK2D	Bos taurus (Bovine)	488	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0010613; GO:0033017; GO:0042383; GO:0043005; GO:0060341	positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]		NA	NA	NA	NA	NA	NA
TRINITY_DN15277_c0_g1_i2	Q2HJF7	KCC2D_BOVIN	100	96	0	0	289	2	350	445	1.30E-50	199.9	KCC2D_BOVIN	reviewed	Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17)	CAMK2D	Bos taurus (Bovine)	488	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0010613; GO:0033017; GO:0042383; GO:0043005; GO:0060341	positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]		NA	NA	NA	NA	NA	NA
TRINITY_DN33634_c0_g1_i1	Q16566	KCC4_HUMAN	100	96	0	0	3	290	112	207	1.40E-49	196.4	KCC4_HUMAN	reviewed	Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR)	CAMK4 CAMK CAMK-GR CAMKIV	Homo sapiens (Human)	473	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0018105; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0046777; GO:0070062	"adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21366_c0_g1_i1	Q16566	KCC4_HUMAN	52.5	80	35	2	11	250	96	172	3.40E-15	82	KCC4_HUMAN	reviewed	Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR)	CAMK4 CAMK CAMK-GR CAMKIV	Homo sapiens (Human)	473	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]	GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0018105; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0046777; GO:0070062	"adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2286_c0_g1_i1	Q9QX15	CA3A1_MOUSE	33.5	316	171	10	892	14	28	327	2.20E-40	167.5	CA3A1_MOUSE	reviewed	Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-)	Clca3a1 Clca1	Mus musculus (Mouse)	902	integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; chloride transport [GO:0006821]	integral component of plasma membrane [GO:0005887]	intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	GO:0005229; GO:0005887; GO:0006821; GO:0008237; GO:0046872	chloride transport [GO:0006821]		blue	blue	NA	NA	NA	NA
TRINITY_DN9407_c0_g1_i1	Q14CN2	CLCA4_HUMAN	31.9	166	104	3	503	6	221	377	1.00E-18	94.7	CLCA4_HUMAN	reviewed	"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]"	CLCA4 CaCC2 UNQ562/PRO1124	Homo sapiens (Human)	919	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872	ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN34521_c0_g1_i1	Q03720	SLO_DROME	81.4	70	11	1	55	258	761	830	7.50E-26	117.5	SLO_DROME	reviewed	Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK)	slo CG10693	Drosophila melanogaster (Fruit fly)	1200	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; voltage-gated ion channel activity [GO:0005244]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0016020; GO:0016021; GO:0034765; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074	"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34521_c0_g1_i2	Q03720	SLO_DROME	81.7	71	11	1	26	232	760	830	3.10E-26	118.6	SLO_DROME	reviewed	Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK)	slo CG10693	Drosophila melanogaster (Fruit fly)	1200	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; voltage-gated ion channel activity [GO:0005244]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0015269; GO:0016020; GO:0016021; GO:0034765; GO:0042493; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074	"circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to drug [GO:0042493]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10807_c0_g1_i1	Q9VA73	CMC_DROME	70.6	51	15	0	205	53	492	542	1.50E-14	80.1	CMC_DROME	reviewed	Calcium-binding mitochondrial carrier protein Aralar1	aralar1 CG2139	Drosophila melanogaster (Fruit fly)	695	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]	GO:0005313; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490	aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN10807_c0_g1_i2	Q9VA73	CMC_DROME	74.7	340	85	1	1022	3	279	617	1.10E-141	504.2	CMC_DROME	reviewed	Calcium-binding mitochondrial carrier protein Aralar1	aralar1 CG2139	Drosophila melanogaster (Fruit fly)	695	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]	GO:0005313; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490	aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN10807_c0_g1_i3	Q9VA73	CMC_DROME	80.1	267	53	0	803	3	351	617	2.30E-120	433.3	CMC_DROME	reviewed	Calcium-binding mitochondrial carrier protein Aralar1	aralar1 CG2139	Drosophila melanogaster (Fruit fly)	695	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]	GO:0005313; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490	aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN10807_c0_g1_i4	Q9VA73	CMC_DROME	79.6	225	46	0	677	3	393	617	2.40E-98	359.8	CMC_DROME	reviewed	Calcium-binding mitochondrial carrier protein Aralar1	aralar1 CG2139	Drosophila melanogaster (Fruit fly)	695	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]	GO:0005313; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0042060; GO:0042802; GO:0043490	aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN11534_c0_g1_i1	Q8ICR0	CDPK2_PLAF7	61.9	126	44	2	6	383	164	285	1.00E-39	164.1	CDPK2_PLAF7	reviewed	Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2)	CPK2 CDPK2 MAL6P1.108 PFF0520w	Plasmodium falciparum (isolate 3D7)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN18468_c0_g2_i1	Q8ICR0	CDPK2_PLAF7	66.3	104	35	0	2	313	114	217	7.20E-34	144.4	CDPK2_PLAF7	reviewed	Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2)	CPK2 CDPK2 MAL6P1.108 PFF0520w	Plasmodium falciparum (isolate 3D7)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN18468_c0_g1_i1	Q8ICR0	CDPK2_PLAF7	62.1	87	33	0	1	261	216	302	8.10E-28	124	CDPK2_PLAF7	reviewed	Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2)	CPK2 CDPK2 MAL6P1.108 PFF0520w	Plasmodium falciparum (isolate 3D7)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN10372_c0_g2_i1	Q8ICR0	CDPK2_PLAF7	59	100	41	0	302	3	108	207	3.80E-29	128.6	CDPK2_PLAF7	reviewed	Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2)	CPK2 CDPK2 MAL6P1.108 PFF0520w	Plasmodium falciparum (isolate 3D7)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN32086_c0_g1_i1	Q8ICR0	CDPK2_PLAF7	58.6	87	36	0	6	266	113	199	1.30E-25	116.7	CDPK2_PLAF7	reviewed	Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2)	CPK2 CDPK2 MAL6P1.108 PFF0520w	Plasmodium falciparum (isolate 3D7)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN10842_c0_g1_i1	Q6ZIU9	CDPKL_ORYSJ	48.9	94	45	2	9	287	267	358	2.00E-19	96.3	CDPKL_ORYSJ	reviewed	Calcium-dependent protein kinase 21 (OsCDPK21) (OsCPK21) (EC 2.7.11.1)	CPK21 Os08g0540400 LOC_Os08g42750 OJ1211_G06.4	Oryza sativa subsp. japonica (Rice)	565	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; intracellular signal transduction [GO:0035556]; negative regulation of response to salt stress [GO:1901001]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to abscisic acid [GO:0009737]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0009737; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:1901001	intracellular signal transduction [GO:0035556]; negative regulation of response to salt stress [GO:1901001]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to abscisic acid [GO:0009737]		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i11	Q8RWL2	CDPKT_ARATH	41.3	63	36	1	97	282	281	343	3.20E-07	56.2	CDPKT_ARATH	reviewed	Calcium-dependent protein kinase 29 (EC 2.7.11.1)	CPK29 At1g76040 T4O12.25	Arabidopsis thaliana (Mouse-ear cress)	534	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of response to salt stress [GO:1901002]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0050832; GO:1901002	defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of response to salt stress [GO:1901002]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i4	Q8RWL2	CDPKT_ARATH	41.5	65	37	1	97	288	281	345	1.90E-07	57.4	CDPKT_ARATH	reviewed	Calcium-dependent protein kinase 29 (EC 2.7.11.1)	CPK29 At1g76040 T4O12.25	Arabidopsis thaliana (Mouse-ear cress)	534	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of response to salt stress [GO:1901002]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0050832; GO:1901002	defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of response to salt stress [GO:1901002]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i6	Q8RWL2	CDPKT_ARATH	41.5	65	37	1	97	288	281	345	1.90E-07	57.4	CDPKT_ARATH	reviewed	Calcium-dependent protein kinase 29 (EC 2.7.11.1)	CPK29 At1g76040 T4O12.25	Arabidopsis thaliana (Mouse-ear cress)	534	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of response to salt stress [GO:1901002]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0005509; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0050832; GO:1901002	defense response to fungus [GO:0050832]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of response to salt stress [GO:1901002]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN10372_c0_g1_i1	Q7RAV5	CDPK3_PLAYO	72.7	66	18	0	3	200	270	335	3.80E-25	114.8	CDPK3_PLAYO	reviewed	Calcium-dependent protein kinase 3 (EC 2.7.11.1)	CPK3 CDPK3 PY06394	Plasmodium yoelii yoelii	538	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005509; GO:0005524; GO:0007275; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN33325_c0_g1_i1	Q7RAV5	CDPK3_PLAYO	47.2	127	66	1	379	2	215	341	6.70E-34	144.8	CDPK3_PLAYO	reviewed	Calcium-dependent protein kinase 3 (EC 2.7.11.1)	CPK3 CDPK3 PY06394	Plasmodium yoelii yoelii	538	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005509; GO:0005524; GO:0007275; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN15976_c0_g1_i1	Q7RAV5	CDPK3_PLAYO	53.2	79	35	1	2	238	274	350	4.00E-21	101.7	CDPK3_PLAYO	reviewed	Calcium-dependent protein kinase 3 (EC 2.7.11.1)	CPK3 CDPK3 PY06394	Plasmodium yoelii yoelii	538	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005509; GO:0005524; GO:0007275; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN994_c0_g1_i2	Q9NHE5	CAPS_DROME	67.2	485	91	2	3	1274	845	1322	1.20E-188	660.6	CAPS_DROME	reviewed	Calcium-dependent secretion activator (Calcium-activated protein for secretion)	Cadps Caps CG33653	Drosophila melanogaster (Fruit fly)	1447	"cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"	cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504	"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN994_c0_g1_i4	Q9NHE5	CAPS_DROME	69	478	92	1	3	1268	845	1322	1.50E-194	680.2	CAPS_DROME	reviewed	Calcium-dependent secretion activator (Calcium-activated protein for secretion)	Cadps Caps CG33653	Drosophila melanogaster (Fruit fly)	1447	"cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"	cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504	"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN994_c0_g1_i5	Q9NHE5	CAPS_DROME	69.7	478	110	2	3	1331	845	1322	4.70E-196	685.3	CAPS_DROME	reviewed	Calcium-dependent secretion activator (Calcium-activated protein for secretion)	Cadps Caps CG33653	Drosophila melanogaster (Fruit fly)	1447	"cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"	cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504	"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN994_c0_g1_i6	Q9NHE5	CAPS_DROME	68.2	478	91	1	3	1253	845	1322	7.40E-191	667.9	CAPS_DROME	reviewed	Calcium-dependent secretion activator (Calcium-activated protein for secretion)	Cadps Caps CG33653	Drosophila melanogaster (Fruit fly)	1447	"cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"	cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504	"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6451_c0_g1_i1	Q9NHE5	CAPS_DROME	77.4	159	35	1	83	556	167	325	1.20E-65	250.8	CAPS_DROME	reviewed	Calcium-dependent secretion activator (Calcium-activated protein for secretion)	Cadps Caps CG33653	Drosophila melanogaster (Fruit fly)	1447	"cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"	cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504	"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6451_c0_g1_i2	Q9NHE5	CAPS_DROME	74.8	103	26	0	83	391	167	269	1.10E-38	161	CAPS_DROME	reviewed	Calcium-dependent secretion activator (Calcium-activated protein for secretion)	Cadps Caps CG33653	Drosophila melanogaster (Fruit fly)	1447	"cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"	cytoplasmic vesicle membrane [GO:0030659]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	GO:0005509; GO:0006887; GO:0007269; GO:0008021; GO:0008289; GO:0015031; GO:0016079; GO:0016192; GO:0030659; GO:0035249; GO:0045202; GO:0045956; GO:1990504	"dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; protein transport [GO:0015031]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36904_c0_g1_i1	Q5XTS1	PLPL8_RABIT	42.9	168	93	1	508	5	334	498	1.20E-30	134.4	PLPL8_RABIT	reviewed	Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8)	PNPLA8	Oryctolagus cuniculus (Rabbit)	786	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]	GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0016021; GO:0016042; GO:0031966; GO:0047499; GO:0055088; GO:0070328; GO:0102545	lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN2153_c0_g1_i2	Q5XTS1	PLPL8_RABIT	41.4	232	135	1	1	693	546	777	3.10E-48	193.4	PLPL8_RABIT	reviewed	Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8)	PNPLA8	Oryctolagus cuniculus (Rabbit)	786	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]	GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0016021; GO:0016042; GO:0031966; GO:0047499; GO:0055088; GO:0070328; GO:0102545	lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN29416_c0_g1_i1	Q9NP80	PLPL8_HUMAN	100	88	0	0	264	1	582	669	4.50E-50	198	PLPL8_HUMAN	reviewed	Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2)	PNPLA8 IPLA22 IPLA2G BM-043	Homo sapiens (Human)	782	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase activity [GO:0004620]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cell death [GO:0008219]; fatty acid metabolic process [GO:0006631]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; triglyceride homeostasis [GO:0070328]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase activity [GO:0004620]	GO:0001516; GO:0004620; GO:0004622; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0006631; GO:0008219; GO:0016020; GO:0016021; GO:0019369; GO:0031966; GO:0034638; GO:0036151; GO:0036152; GO:0043651; GO:0046338; GO:0047499; GO:0050482; GO:0055088; GO:0070328; GO:0102545	arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cell death [GO:0008219]; fatty acid metabolic process [GO:0006631]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN1005_c0_g1_i2	Q08853	ATC_PLAFK	68	153	47	1	1	453	241	393	7.00E-51	201.4	ATC_PLAFK	reviewed	Calcium-transporting ATPase (EC 7.2.2.10) (Calcium pump)	ATP6	Plasmodium falciparum (isolate K1 / Thailand)	1228	"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	GO:0005388; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1005_c0_g1_i3	Q08853	ATC_PLAFK	75.8	128	31	0	1	384	241	368	1.60E-49	196.8	ATC_PLAFK	reviewed	Calcium-transporting ATPase (EC 7.2.2.10) (Calcium pump)	ATP6	Plasmodium falciparum (isolate K1 / Thailand)	1228	"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	GO:0005388; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2811_c0_g1_i1	P92939	ECA1_ARATH	64.4	90	31	1	7	273	103	192	6.10E-26	117.9	ECA1_ARATH	reviewed	"Calcium-transporting ATPase 1, endoplasmic reticulum-type (EC 7.2.2.10)"	ECA1 ACA3 At1g07810 F24B9.9	Arabidopsis thaliana (Mouse-ear cress)	1061	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005576; GO:0005774; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0006874; GO:0008553; GO:0010042; GO:0016887; GO:0030176; GO:0046686; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]		NA	NA	NA	NA	NA	NA
TRINITY_DN361_c0_g1_i1	P92939	ECA1_ARATH	76.1	205	44	1	11	610	701	905	4.50E-85	315.5	ECA1_ARATH	reviewed	"Calcium-transporting ATPase 1, endoplasmic reticulum-type (EC 7.2.2.10)"	ECA1 ACA3 At1g07810 F24B9.9	Arabidopsis thaliana (Mouse-ear cress)	1061	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005576; GO:0005774; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0006874; GO:0008553; GO:0010042; GO:0016887; GO:0030176; GO:0046686; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]		NA	NA	NA	NA	NA	NA
TRINITY_DN361_c0_g1_i2	P92939	ECA1_ARATH	76.1	205	44	1	11	610	701	905	2.20E-84	313.2	ECA1_ARATH	reviewed	"Calcium-transporting ATPase 1, endoplasmic reticulum-type (EC 7.2.2.10)"	ECA1 ACA3 At1g07810 F24B9.9	Arabidopsis thaliana (Mouse-ear cress)	1061	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005576; GO:0005774; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0006874; GO:0008553; GO:0010042; GO:0016887; GO:0030176; GO:0046686; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; response to cadmium ion [GO:0046686]; response to manganese ion [GO:0010042]		NA	NA	NA	NA	NA	NA
TRINITY_DN37516_c0_g1_i1	Q9XES1	ECA4_ARATH	67.6	74	24	0	20	241	701	774	3.80E-19	95.1	ECA4_ARATH	reviewed	"Calcium-transporting ATPase 4, endoplasmic reticulum-type (EC 7.2.2.10)"	ECA4 At1g07670 F24B9.24	Arabidopsis thaliana (Mouse-ear cress)	1061	"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005576; GO:0005783; GO:0005886; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	1
TRINITY_DN447_c0_g1_i1	P22700	ATC1_DROME	82.4	737	130	0	2	2212	210	946	0	1214.9	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN447_c0_g1_i11	P22700	ATC1_DROME	82.1	716	128	0	2	2149	210	925	0	1172.5	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN447_c0_g1_i12	P22700	ATC1_DROME	83.1	563	95	0	2	1690	210	772	1.90E-269	929.5	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		brown	brown	NA	NA	NA	NA
TRINITY_DN447_c0_g1_i2	P22700	ATC1_DROME	83.1	563	95	0	2	1690	210	772	1.50E-269	929.9	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		brown	brown	NA	NA	NA	NA
TRINITY_DN447_c0_g1_i3	P22700	ATC1_DROME	81.3	731	137	0	2	2194	210	940	0	1184.9	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN447_c0_g1_i7	P22700	ATC1_DROME	73.6	401	106	0	64	1266	371	771	1.30E-168	594	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN447_c0_g1_i9	P22700	ATC1_DROME	83.1	562	95	0	2	1687	210	771	6.90E-269	927.5	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6973_c0_g1_i1	P22700	ATC1_DROME	95.5	66	3	0	340	143	274	339	3.30E-29	129	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6973_c0_g1_i1	P22700	ATC1_DROME	79.6	49	8	2	147	1	337	383	2.40E-11	69.7	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6973_c0_g1_i2	P22700	ATC1_DROME	95.5	66	3	0	382	185	274	339	3.70E-29	129	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6973_c0_g1_i2	P22700	ATC1_DROME	86.8	38	3	2	189	76	337	372	4.70E-08	58.9	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6890_c0_g1_i2	P22700	ATC1_DROME	62.9	89	33	0	40	306	371	459	1.60E-27	123.2	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6335_c0_g1_i2	P22700	ATC1_DROME	92.6	136	10	0	2	409	697	832	1.30E-64	246.9	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN6335_c0_g1_i3	P22700	ATC1_DROME	91.8	61	5	0	67	249	772	832	2.80E-25	115.5	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN14015_c0_g1_i1	P22700	ATC1_DROME	76.4	72	17	0	30	245	602	673	4.30E-23	108.2	ATC1_DROME	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium ATPase at 60A) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A CG3725	Drosophila melanogaster (Fruit fly)	1020	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006635; GO:0006874; GO:0007274; GO:0007629; GO:0008553; GO:0008610; GO:0010884; GO:0012505; GO:0016021; GO:0016529; GO:0016887; GO:0030322; GO:0030707; GO:0033017; GO:0036335; GO:0045202; GO:0046872; GO:0048863; GO:0051282; GO:0060047; GO:0070588; GO:1901896; GO:1903515; GO:1990845	adaptive thermogenesis [GO:1990845]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; fatty acid beta-oxidation [GO:0006635]; flight behavior [GO:0007629]; heart contraction [GO:0060047]; intestinal stem cell homeostasis [GO:0036335]; lipid biosynthetic process [GO:0008610]; neuromuscular synaptic transmission [GO:0007274]; ovarian follicle cell development [GO:0030707]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of lipid storage [GO:0010884]; regulation of sequestering of calcium ion [GO:0051282]; stabilization of membrane potential [GO:0030322]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN1965_c1_g1_i1	Q292Q0	ATC1_DROPS	76.7	103	24	0	2	310	351	453	6.50E-40	164.5	ATC1_DROPS	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A GA17643	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1002	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]"	GO:0005388; GO:0005524; GO:0005783; GO:0016021; GO:0016529; GO:0033017; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7740_c0_g1_i1	Q7PPA5	ATC1_ANOGA	86.2	130	18	0	2	391	64	193	4.00E-55	215.3	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN7740_c0_g1_i2	Q7PPA5	ATC1_ANOGA	80.3	193	38	0	12	590	1	193	6.00E-79	295	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		blue	blue	NA	NA	NA	NA
TRINITY_DN7740_c0_g1_i3	Q7PPA5	ATC1_ANOGA	77.7	193	43	0	87	665	1	193	1.10E-76	287.7	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN7740_c0_g1_i5	Q7PPA5	ATC1_ANOGA	79.3	193	40	0	12	590	1	193	1.90E-77	290	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN6890_c0_g1_i1	Q7PPA5	ATC1_ANOGA	65.2	89	31	0	40	306	370	458	1.10E-28	127.1	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN6890_c0_g1_i3	Q7PPA5	ATC1_ANOGA	65.2	89	31	0	40	306	370	458	5.10E-29	128.3	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN6890_c0_g1_i4	Q7PPA5	ATC1_ANOGA	65.2	89	31	0	40	306	370	458	5.10E-29	128.3	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN6335_c1_g1_i1	Q7PPA5	ATC1_ANOGA	83.7	123	20	0	369	1	632	754	1.30E-50	200.3	ATC1_ANOGA	reviewed	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	SERCA Ca-P60A AGAP006186	Anopheles gambiae (African malaria mosquito)	1018	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN3683_c1_g1_i1	P98194	AT2C1_HUMAN	51.5	689	331	2	1	2058	226	914	5.20E-189	662.5	AT2C1_HUMAN	reviewed	Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1)	ATP2C1 KIAA1347 PMR1L HUSSY-28	Homo sapiens (Human)	919	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0034220; GO:0043123; GO:0046872; GO:0070588	actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN3683_c1_g1_i5	P98194	AT2C1_HUMAN	51.1	436	213	0	108	1415	479	914	1.50E-118	427.9	AT2C1_HUMAN	reviewed	Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1)	ATP2C1 KIAA1347 PMR1L HUSSY-28	Homo sapiens (Human)	919	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0034220; GO:0043123; GO:0046872; GO:0070588	actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN3683_c1_g2_i1	Q64566	AT2C1_RAT	57.9	197	83	0	591	1	34	230	8.80E-54	211.5	AT2C1_RAT	reviewed	Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1)	Atp2c1	Rattus norvegicus (Rat)	919	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030133; GO:0030141; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0043123; GO:0043231; GO:0070509; GO:0070588	actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN26495_c0_g1_i1	Q80XR2	AT2C1_MOUSE	96.8	93	3	0	281	3	41	133	3.60E-42	171.8	AT2C1_MOUSE	reviewed	Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1)	Atp2c1 Pmr1	Mus musculus (Mouse)	918	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030133; GO:0030141; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0032580; GO:0043123; GO:0043231; GO:0070588	actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN3683_c1_g1_i4	P57709	AT2C1_BOVIN	51.6	62	30	0	30	215	767	828	1.20E-13	77	AT2C1_BOVIN	reviewed	Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (Secretory pathway Ca(2+)-transporting ATPase)	ATP2C1 SPCA	Bos taurus (Bovine)	953	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0043123; GO:0070588	actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN2811_c0_g1_i2	Q42883	ECAP_SOLLC	61.4	153	57	2	1	453	22	174	2.80E-44	179.5	ECAP_SOLLC	reviewed	"Calcium-transporting ATPase, endoplasmic reticulum-type (EC 7.2.2.10)"	LCA1	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	1048	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0006816; GO:0006874; GO:0008553; GO:0016887; GO:0030176; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN39425_c0_g1_i1	Q42883	ECAP_SOLLC	75.4	167	41	0	4	504	698	864	1.70E-69	263.5	ECAP_SOLLC	reviewed	"Calcium-transporting ATPase, endoplasmic reticulum-type (EC 7.2.2.10)"	LCA1	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	1048	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0006816; GO:0006874; GO:0008553; GO:0016887; GO:0030176; GO:0046872; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN30220_c0_g1_i1	Q3T168	CYBP_BOVIN	39.6	227	132	4	773	108	1	227	1.70E-37	157.9	CYBP_BOVIN	reviewed	Calcyclin-binding protein (CacyBP)	CACYBP	Bos taurus (Bovine)	230	beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]	beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005641; GO:0005654; GO:0005829; GO:0007507; GO:0015631; GO:0019005; GO:0019904; GO:0030877; GO:0031625; GO:0042803; GO:0044548; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]		blue	blue	NA	NA	NA	NA
TRINITY_DN29089_c0_g1_i1	Q8WWF8	CAPSL_HUMAN	43.3	60	34	0	209	30	46	105	7.80E-10	64.3	CAPSL_HUMAN	reviewed	Calcyphosin-like protein	CAPSL	Homo sapiens (Human)	208	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]	cytoplasm [GO:0005737]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7840_c0_g1_i1	Q3SYT6	CLGN_BOVIN	54.8	442	195	3	1421	96	44	480	4.00E-120	433.3	CLGN_BOVIN	reviewed	Calmegin	CLGN	Bos taurus (Bovine)	606	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein folding [GO:0006457]; protein-containing complex assembly [GO:0065003]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]	calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005635; GO:0005789; GO:0006457; GO:0007339; GO:0016021; GO:0030968; GO:0044183; GO:0051082; GO:0065003	binding of sperm to zona pellucida [GO:0007339]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN17085_c0_g2_i1	P21251	CALM_STIJA	71	69	20	0	100	306	81	149	1.90E-22	106.7	CALM_STIJA	reviewed	Calmodulin (CaM)		Stichopus japonicus (Sea cucumber)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN37174_c0_g1_i1	A4UHC0	CALM_ALEFU	75.2	141	35	0	3	425	9	149	8.00E-57	221.1	CALM_ALEFU	reviewed	Calmodulin (CaM)		Alexandrium fundyense (Dinoflagellate)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN24876_c0_g2_i1	Q9HFY6	CALM_BLAEM	60.6	66	26	0	8	205	81	146	8.10E-17	87.4	CALM_BLAEM	reviewed	Calmodulin (CaM)	CMD1	Blastocladiella emersonii (Aquatic fungus)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		blue	blue	NA	NA	NA	NA
TRINITY_DN24876_c0_g1_i1	P41041	CALM_PNECA	60	60	24	0	38	217	5	64	2.10E-13	75.9	CALM_PNECA	reviewed	Calmodulin (CaM)		Pneumocystis carinii	151	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		blue	blue	NA	NA	NA	NA
TRINITY_DN28274_c0_g1_i1	A8I1Q0	CALM_HETTR	76.3	93	22	0	289	11	57	149	6.80E-34	144.4	CALM_HETTR	reviewed	Calmodulin (CaM)		Heterocapsa triquetra (Dinoflagellate) (Glenodinium triquetrum)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN25891_c0_g1_i1	P41041	CALM_PNECA	52.7	74	35	0	11	232	68	141	2.50E-15	82.4	CALM_PNECA	reviewed	Calmodulin (CaM)		Pneumocystis carinii	151	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN21734_c0_g1_i1	Q95NR9	CALM_METSE	74.7	99	25	0	303	7	51	149	7.50E-33	141	CALM_METSE	reviewed	Calmodulin (CaM)		Metridium senile (Brown sea anemone) (Frilled sea anemone)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN540_c0_g1_i1	A4UHC0	CALM_ALEFU	98.6	145	2	0	2	436	5	149	1.10E-75	283.9	CALM_ALEFU	reviewed	Calmodulin (CaM)		Alexandrium fundyense (Dinoflagellate)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN32964_c0_g1_i1	A4UHC0	CALM_ALEFU	95.9	145	6	0	2	436	5	149	3.80E-74	278.9	CALM_ALEFU	reviewed	Calmodulin (CaM)		Alexandrium fundyense (Dinoflagellate)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN4629_c2_g1_i1	Q95NR9	CALM_METSE	98.7	149	2	0	511	65	1	149	2.30E-78	293.1	CALM_METSE	reviewed	Calmodulin (CaM)		Metridium senile (Brown sea anemone) (Frilled sea anemone)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		blue	blue	NA	NA	NA	NA
TRINITY_DN32173_c0_g1_i1	P18061	CALM_TRYCR	64.5	141	50	0	1	423	9	149	2.40E-48	193	CALM_TRYCR	reviewed	Calmodulin (CaM)	CALA2	Trypanosoma cruzi	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN8427_c0_g1_i1	A4UHC0	CALM_ALEFU	100	145	0	0	2	436	5	149	1.00E-76	287.3	CALM_ALEFU	reviewed	Calmodulin (CaM)		Alexandrium fundyense (Dinoflagellate)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN4090_c0_g1_i1	P02597	CALMS_CHICK	36.2	149	91	2	93	527	1	149	1.00E-23	111.7	CALMS_CHICK	reviewed	"Calmodulin, striated muscle"	CCM1	Gallus gallus (Chicken)	149	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]	GO:0000226; GO:0005509; GO:0019722; GO:0030234	calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		NA	NA	NA	NA	NA	NA
TRINITY_DN3281_c0_g1_i2	P0DP23	CALM1_HUMAN	99.3	148	1	0	1	444	2	149	1.30E-77	290.4	CALM1_HUMAN	reviewed	Calmodulin-1	CALM1 CALM CAM CAM1	Homo sapiens (Human)	149	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0000086; GO:0000165; GO:0000226; GO:0000922; GO:0001975; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007190; GO:0007223; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0016032; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0043647; GO:0044325; GO:0048306; GO:0050998; GO:0050999; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:2000300	"activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3281_c0_g1_i4	P0DP23	CALM1_HUMAN	100	143	0	0	1	429	7	149	2.00E-75	283.1	CALM1_HUMAN	reviewed	Calmodulin-1	CALM1 CALM CAM CAM1	Homo sapiens (Human)	149	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0000086; GO:0000165; GO:0000226; GO:0000922; GO:0001975; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007190; GO:0007223; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0016032; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0043647; GO:0044325; GO:0048306; GO:0050998; GO:0050999; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:2000300	"activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8427_c0_g1_i3	P0DP23	CALM1_HUMAN	100	149	0	0	20	466	1	149	5.40E-79	295	CALM1_HUMAN	reviewed	Calmodulin-1	CALM1 CALM CAM CAM1	Homo sapiens (Human)	149	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0000086; GO:0000165; GO:0000226; GO:0000922; GO:0001975; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007190; GO:0007223; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0016032; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0043647; GO:0044325; GO:0048306; GO:0050998; GO:0050999; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:2000300	"activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8427_c0_g1_i4	P0DP23	CALM1_HUMAN	100	149	0	0	20	466	1	149	5.40E-79	295	CALM1_HUMAN	reviewed	Calmodulin-1	CALM1 CALM CAM CAM1	Homo sapiens (Human)	149	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0000086; GO:0000165; GO:0000226; GO:0000922; GO:0001975; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007190; GO:0007223; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0016032; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0043647; GO:0044325; GO:0048306; GO:0050998; GO:0050999; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:2000300	"activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30469_c0_g1_i1	P0DP23	CALM1_HUMAN	100	144	0	0	3	434	6	149	3.90E-76	285.4	CALM1_HUMAN	reviewed	Calmodulin-1	CALM1 CALM CAM CAM1	Homo sapiens (Human)	149	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0000086; GO:0000165; GO:0000226; GO:0000922; GO:0001975; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007190; GO:0007223; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0016032; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0043647; GO:0044325; GO:0048306; GO:0050998; GO:0050999; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:2000300	"activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; glycogen catabolic process [GO:0005980]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; muscle contraction [GO:0006936]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; viral process [GO:0016032]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32982_c0_g1_i1	P62147	CALM1_BRAFL	87.3	71	9	0	213	1	67	137	2.50E-27	122.1	CALM1_BRAFL	reviewed	Calmodulin-1 (CaM 1)		Branchiostoma floridae (Florida lancelet) (Amphioxus)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN21879_c0_g1_i1	P62147	CALM1_BRAFL	97	100	3	0	2	301	43	142	6.20E-48	191	CALM1_BRAFL	reviewed	Calmodulin-1 (CaM 1)		Branchiostoma floridae (Florida lancelet) (Amphioxus)	149	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN17085_c0_g1_i1	P13868	CALM1_SOLTU	40	70	38	3	262	65	1	70	3.90E-05	48.9	CALM1_SOLTU	reviewed	Calmodulin-1 (CaM-1)	PCM1	Solanum tuberosum (Potato)	149	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]	GO:0000226; GO:0005509; GO:0019722; GO:0030234	calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		NA	NA	NA	NA	NA	NA
TRINITY_DN21879_c0_g1_i2	P05932	CALMB_ARBPU	94	100	6	0	2	301	32	131	3.40E-46	185.3	CALMB_ARBPU	reviewed	Calmodulin-beta (Cam B) (Fragment)		Arbacia punctulata (Punctuate sea urchin)	138	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN21879_c0_g1_i3	P05932	CALMB_ARBPU	81	79	15	0	1	237	38	116	6.70E-29	127.5	CALMB_ARBPU	reviewed	Calmodulin-beta (Cam B) (Fragment)		Arbacia punctulata (Punctuate sea urchin)	138	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN4118_c0_g1_i1	Q9Y6Y1	CMTA1_HUMAN	62.4	178	61	3	3	524	77	252	8.90E-58	225.3	CMTA1_HUMAN	reviewed	Calmodulin-binding transcription activator 1	CAMTA1 KIAA0833 MSTP023	Homo sapiens (Human)	1673	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]	GO:0003690; GO:0003712; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0035307; GO:0043565; GO:0045944; GO:0050885; GO:0070886	neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN16073_c0_g1_i1	Q9Y6Y1	CMTA1_HUMAN	42	307	152	6	1227	370	873	1174	5.30E-56	220.7	CMTA1_HUMAN	reviewed	Calmodulin-binding transcription activator 1	CAMTA1 KIAA0833 MSTP023	Homo sapiens (Human)	1673	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]	GO:0003690; GO:0003712; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0035307; GO:0043565; GO:0045944; GO:0050885; GO:0070886	neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11671_c0_g1_i1	Q3T0E8	CALL4_BOVIN	44.2	154	79	3	48	491	1	153	1.10E-26	121.3	CALL4_BOVIN	reviewed	Calmodulin-like protein 4	CALML4	Bos taurus (Bovine)	153	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]	GO:0000226; GO:0005509; GO:0019722; GO:0030234	calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		blue	blue	NA	NA	NA	NA
TRINITY_DN11671_c0_g1_i3	Q3T0E8	CALL4_BOVIN	41.8	122	64	3	48	395	1	121	5.70E-16	85.5	CALL4_BOVIN	reviewed	Calmodulin-like protein 4	CALML4	Bos taurus (Bovine)	153	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]	GO:0000226; GO:0005509; GO:0019722; GO:0030234	calcium-mediated signaling [GO:0019722]; microtubule cytoskeleton organization [GO:0000226]		NA	NA	NA	NA	NA	NA
TRINITY_DN32279_c0_g1_i1	Q7Z624	CMKMT_HUMAN	100	84	0	0	254	3	89	172	1.00E-43	176.8	CMKMT_HUMAN	reviewed	Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60)	CAMKMT C2orf34 CLNMT	Homo sapiens (Human)	323	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072]; mitochondrion organization [GO:0007005]; protein methylation [GO:0006479]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006479; GO:0007005; GO:0018025; GO:0022400; GO:0031072; GO:0032991	mitochondrion organization [GO:0007005]; protein methylation [GO:0006479]; regulation of rhodopsin mediated signaling pathway [GO:0022400]		NA	NA	NA	NA	NA	NA
TRINITY_DN6233_c0_g1_i3	Q6GQ33	CMKMT_XENLA	39.6	154	78	4	104	529	32	182	2.30E-21	104	CMKMT_XENLA	reviewed	Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60)	camkmt clnmt	Xenopus laevis (African clawed frog)	318	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin-lysine N-methyltransferase activity [GO:0018025]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calmodulin-lysine N-methyltransferase activity [GO:0018025]	GO:0005634; GO:0005737; GO:0018025			NA	NA	NA	NA	NA	NA
TRINITY_DN6233_c0_g1_i4	Q6GQ33	CMKMT_XENLA	39.6	154	78	4	104	529	32	182	2.30E-21	104	CMKMT_XENLA	reviewed	Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60)	camkmt clnmt	Xenopus laevis (African clawed frog)	318	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin-lysine N-methyltransferase activity [GO:0018025]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calmodulin-lysine N-methyltransferase activity [GO:0018025]	GO:0005634; GO:0005737; GO:0018025			NA	NA	NA	NA	NA	NA
TRINITY_DN6233_c0_g1_i5	Q6GQ33	CMKMT_XENLA	33.2	265	130	8	104	766	32	293	4.90E-26	119.8	CMKMT_XENLA	reviewed	Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60)	camkmt clnmt	Xenopus laevis (African clawed frog)	318	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin-lysine N-methyltransferase activity [GO:0018025]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calmodulin-lysine N-methyltransferase activity [GO:0018025]	GO:0005634; GO:0005737; GO:0018025			NA	NA	NA	NA	NA	NA
TRINITY_DN10095_c0_g1_i1	P27824	CALX_HUMAN	99.7	348	1	0	1044	1	111	458	6.70E-182	637.9	CALX_HUMAN	reviewed	Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90)	CANX	Homo sapiens (Human)	592	axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum unfolded protein response [GO:0030968]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]	axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002474; GO:0003723; GO:0005509; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005791; GO:0005840; GO:0006457; GO:0007568; GO:0009306; GO:0016020; GO:0016032; GO:0019886; GO:0030246; GO:0030424; GO:0030968; GO:0032839; GO:0032991; GO:0034185; GO:0034975; GO:0035255; GO:0042470; GO:0043025; GO:0043197; GO:0044233; GO:0044322; GO:0048488; GO:0051082; GO:0070062; GO:0070106; GO:0070757; GO:0071556; GO:0072583; GO:0098978; GO:0099059	aging [GO:0007568]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum unfolded protein response [GO:0030968]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN10095_c0_g1_i2	P27824	CALX_HUMAN	92	348	28	0	1044	1	111	458	2.80E-164	579.3	CALX_HUMAN	reviewed	Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90)	CANX	Homo sapiens (Human)	592	axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum unfolded protein response [GO:0030968]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]	axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002474; GO:0003723; GO:0005509; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005791; GO:0005840; GO:0006457; GO:0007568; GO:0009306; GO:0016020; GO:0016032; GO:0019886; GO:0030246; GO:0030424; GO:0030968; GO:0032839; GO:0032991; GO:0034185; GO:0034975; GO:0035255; GO:0042470; GO:0043025; GO:0043197; GO:0044233; GO:0044322; GO:0048488; GO:0051082; GO:0070062; GO:0070106; GO:0070757; GO:0071556; GO:0072583; GO:0098978; GO:0099059	aging [GO:0007568]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum unfolded protein response [GO:0030968]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30484_c0_g1_i1	P27730	CAN_SCHMA	43.3	67	33	2	77	274	294	356	2.40E-09	62.8	CAN_SCHMA	reviewed	Calpain (EC 3.4.22.-) (Calcium-activated neutral proteinase) (CANP)		Schistosoma mansoni (Blood fluke)	758	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]		calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509			NA	NA	NA	NA	NA	NA
TRINITY_DN30064_c0_g1_i1	P34308	CAN_CAEEL	53.8	78	36	0	55	288	540	617	7.40E-24	111.3	CAN_CAEEL	reviewed	Calpain clp-1 (EC 3.4.22.-)	clp-1 C06G4.2	Caenorhabditis elegans	780	cytoplasm [GO:0005737]; M band [GO:0031430]; sarcomere [GO:0030017]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cellular response to calcium ion [GO:0071277]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of sarcomere organization [GO:0060298]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; M band [GO:0031430]; sarcomere [GO:0030017]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0006508; GO:0007005; GO:0010940; GO:0030017; GO:0031430; GO:0046716; GO:0060298; GO:0071277	cellular response to calcium ion [GO:0071277]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of sarcomere organization [GO:0060298]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN31677_c0_g1_i1	P04632	CPNS1_HUMAN	100	71	0	0	215	3	112	182	3.00E-36	151.8	CPNS1_HUMAN	reviewed	Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit)	CAPNS1 CAPN4 CAPNS	Homo sapiens (Human)	268	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cornification [GO:0070268]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell population proliferation [GO:0008284]; regulation of macroautophagy [GO:0016241]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005829; GO:0005886; GO:0008284; GO:0016020; GO:0016241; GO:0022617; GO:0070062; GO:0070268	cornification [GO:0070268]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell population proliferation [GO:0008284]; regulation of macroautophagy [GO:0016241]		NA	NA	NA	NA	NA	NA
TRINITY_DN39684_c0_g1_i1	P07384	CAN1_HUMAN	100	207	0	0	624	4	75	281	8.20E-119	427.6	CAN1_HUMAN	reviewed	Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP)	CAPN1 CANPL1 PIG30	Homo sapiens (Human)	714	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cornification [GO:0070268]; extracellular matrix disassembly [GO:0022617]; mammary gland involution [GO:0060056]; neutrophil degranulation [GO:0043312]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005576; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0008284; GO:0016020; GO:0016241; GO:0022617; GO:0032801; GO:0043312; GO:0050790; GO:0060056; GO:0070062; GO:0070268; GO:0097264; GO:1904813; GO:2000310	cornification [GO:0070268]; extracellular matrix disassembly [GO:0022617]; mammary gland involution [GO:0060056]; neutrophil degranulation [GO:0043312]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]		NA	NA	NA	NA	NA	NA
TRINITY_DN39494_c0_g1_i1	P07384	CAN1_HUMAN	100	114	0	0	345	4	294	407	1.80E-67	256.1	CAN1_HUMAN	reviewed	Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP)	CAPN1 CANPL1 PIG30	Homo sapiens (Human)	714	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cornification [GO:0070268]; extracellular matrix disassembly [GO:0022617]; mammary gland involution [GO:0060056]; neutrophil degranulation [GO:0043312]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005576; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0008284; GO:0016020; GO:0016241; GO:0022617; GO:0032801; GO:0043312; GO:0050790; GO:0060056; GO:0070062; GO:0070268; GO:0097264; GO:1904813; GO:2000310	cornification [GO:0070268]; extracellular matrix disassembly [GO:0022617]; mammary gland involution [GO:0060056]; neutrophil degranulation [GO:0043312]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]		NA	NA	NA	NA	NA	NA
TRINITY_DN38285_c0_g1_i1	Q9ESK3	CAN10_MOUSE	44.2	86	46	2	282	25	106	189	6.30E-14	78.2	CAN10_MOUSE	reviewed	Calpain-10 (EC 3.4.22.-) (Calcium-activated neutral proteinase 10) (CANP 10)	Capn10 Capn8	Mus musculus (Mouse)	666	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]; actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; autophagy of mitochondrion [GO:0000422]; cellular response to insulin stimulus [GO:0032869]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; response to nutrient levels [GO:0031667]; type B pancreatic cell apoptotic process [GO:0097050]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]	GO:0000149; GO:0000422; GO:0004198; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006508; GO:0007005; GO:0007568; GO:0008092; GO:0031532; GO:0031667; GO:0032024; GO:0032388; GO:0032869; GO:0043065; GO:0043231; GO:0046326; GO:0097050; GO:2000676	actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; autophagy of mitochondrion [GO:0000422]; cellular response to insulin stimulus [GO:0032869]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; response to nutrient levels [GO:0031667]; type B pancreatic cell apoptotic process [GO:0097050]		NA	NA	NA	NA	NA	NA
TRINITY_DN34627_c0_g1_i1	Q9HC96	CAN10_HUMAN	100	79	0	0	238	2	90	168	4.60E-46	184.5	CAN10_HUMAN	reviewed	Calpain-10 (EC 3.4.22.-) (Calcium-activated neutral proteinase 10) (CANP 10)	CAPN10 KIAA1845	Homo sapiens (Human)	672	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]; actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]	GO:0000149; GO:0004198; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006921; GO:0008092; GO:0031532; GO:0032024; GO:0032388; GO:0032869; GO:0046326; GO:0097050; GO:2000676	actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050]		NA	NA	NA	NA	NA	NA
TRINITY_DN22703_c0_g1_i2	O08529	CAN2_MOUSE	98.7	150	2	0	2	451	97	246	7.40E-85	314.3	CAN2_MOUSE	reviewed	Calpain-2 catalytic subunit (EC 3.4.22.53) (80 kDa M-calpain subunit) (CALP80) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)	Capn2	Mus musculus (Mouse)	700	cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008233; GO:0009897; GO:0010666; GO:0016020; GO:0016540; GO:0019899; GO:0030425; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0042995; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0071222; GO:0071230; GO:0097038; GO:1901216; GO:1901741; GO:2001247	behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN33480_c0_g1_i1	P17655	CAN2_HUMAN	100	74	0	0	224	3	292	365	2.20E-42	172.2	CAN2_HUMAN	reviewed	Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)	CAPN2 CANPL2	Homo sapiens (Human)	700	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009897; GO:0010666; GO:0019899; GO:0022617; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:1901216; GO:1901741; GO:2001247	behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN38825_c0_g1_i1	P17655	CAN2_HUMAN	100	81	0	0	245	3	444	524	1.30E-40	166.4	CAN2_HUMAN	reviewed	Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)	CAPN2 CANPL2	Homo sapiens (Human)	700	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009897; GO:0010666; GO:0019899; GO:0022617; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:1901216; GO:1901741; GO:2001247	behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN22703_c0_g1_i1	P17655	CAN2_HUMAN	100	190	0	0	1	570	57	246	9.90E-111	400.6	CAN2_HUMAN	reviewed	Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)	CAPN2 CANPL2	Homo sapiens (Human)	700	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009897; GO:0010666; GO:0019899; GO:0022617; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:1901216; GO:1901741; GO:2001247	behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN8486_c0_g1_i1	O15484	CAN5_HUMAN	51.3	265	125	1	92	874	1	265	1.30E-77	291.2	CAN5_HUMAN	reviewed	Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3)	CAPN5 NCL3	Homo sapiens (Human)	640	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062	proteolysis [GO:0006508]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8486_c0_g1_i2	O15484	CAN5_HUMAN	52.7	239	109	1	106	810	27	265	9.80E-72	271.6	CAN5_HUMAN	reviewed	Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3)	CAPN5 NCL3	Homo sapiens (Human)	640	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062	proteolysis [GO:0006508]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8486_c0_g1_i3	O15484	CAN5_HUMAN	52.7	239	109	1	108	812	27	265	1.30E-71	271.2	CAN5_HUMAN	reviewed	Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3)	CAPN5 NCL3	Homo sapiens (Human)	640	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062	proteolysis [GO:0006508]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN34873_c0_g1_i1	O08688	CAN5_MOUSE	64.1	78	28	0	247	14	280	357	3.30E-26	118.6	CAN5_MOUSE	reviewed	Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3)	Capn5 Ncl3	Mus musculus (Mouse)	640	cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0006508; GO:0009986; GO:0045202	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN12630_c0_g1_i1	Q11002	CANA_DROME	61.9	181	69	0	548	6	83	263	3.20E-66	252.7	CANA_DROME	reviewed	Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]	CalpA CG7563	Drosophila melanogaster (Fruit fly)	828	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832	cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN19858_c0_g1_i1	Q11002	CANA_DROME	54.3	46	21	0	216	79	508	553	8.90E-08	57.8	CANA_DROME	reviewed	Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]	CalpA CG7563	Drosophila melanogaster (Fruit fly)	828	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832	cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN19858_c0_g1_i2	Q11002	CANA_DROME	54.3	46	21	0	216	79	508	553	6.60E-08	58.2	CANA_DROME	reviewed	Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]	CalpA CG7563	Drosophila melanogaster (Fruit fly)	828	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832	cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i1	Q9VT65	CANB_DROME	60.8	658	243	4	142	2085	245	897	1.20E-249	864	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i10	Q9VT65	CANB_DROME	56.2	728	271	5	154	2334	245	925	3.40E-250	865.9	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i13	Q9VT65	CANB_DROME	59.8	686	261	4	142	2169	245	925	2.00E-257	889.8	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i16	Q9VT65	CANB_DROME	59.8	686	261	4	154	2181	245	925	2.70E-257	889.4	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i2	Q9VT65	CANB_DROME	60.8	658	243	4	154	2097	245	897	1.60E-249	863.6	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i3	Q9VT65	CANB_DROME	60.3	665	249	4	154	2118	245	904	1.30E-249	864	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i4	Q9VT65	CANB_DROME	56.7	721	262	5	142	2274	245	925	1.00E-251	870.9	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i5	Q9VT65	CANB_DROME	60.2	665	252	4	142	2133	245	897	3.80E-248	859	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN669_c0_g1_i6	Q9VT65	CANB_DROME	56.7	721	262	5	154	2286	245	925	1.40E-251	870.5	CANB_DROME	reviewed	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	CalpB CG8107	Drosophila melanogaster (Fruit fly)	925	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; membrane [GO:0016020]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; calcium ion binding [GO:0005509]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN31971_c0_g1_i1	Q9VXH6	CANC_DROME	72.9	48	13	0	186	43	118	165	2.10E-16	85.9	CANC_DROME	reviewed	Calpain-C (Calcium-activated neutral proteinase homolog C) (CANP C)	CalpC CG3692	Drosophila melanogaster (Fruit fly)	681	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005737; GO:0006508	proteolysis [GO:0006508]		pink	pink	NA	NA	NA	NA
TRINITY_DN40608_c0_g1_i1	P27398	CAND_DROME	51.5	66	31	1	199	5	1117	1182	1.90E-11	69.3	CAND_DROME	reviewed	Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein)	sol CalpD CG1391	Drosophila melanogaster (Fruit fly)	1594	cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cytoplasm [GO:0005737]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]	GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0046872; GO:0050896	nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11859_c0_g1_i1	P27398	CAND_DROME	74	281	68	2	858	22	1085	1362	2.50E-126	453	CAND_DROME	reviewed	Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein)	sol CalpD CG1391	Drosophila melanogaster (Fruit fly)	1594	cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cytoplasm [GO:0005737]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]	GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0046872; GO:0050896	nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11859_c0_g1_i2	P27398	CAND_DROME	73.7	513	129	3	1632	100	1085	1593	9.40E-231	800.8	CAND_DROME	reviewed	Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein)	sol CalpD CG1391	Drosophila melanogaster (Fruit fly)	1594	cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cytoplasm [GO:0005737]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]	GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0046872; GO:0050896	nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11859_c0_g1_i3	P27398	CAND_DROME	71.3	122	35	0	368	3	1085	1206	1.30E-47	190.3	CAND_DROME	reviewed	Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein)	sol CalpD CG1391	Drosophila melanogaster (Fruit fly)	1594	cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cytoplasm [GO:0005737]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]	GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0046872; GO:0050896	nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN40029_c0_g1_i1	Q08093	CNN2_MOUSE	100	81	0	0	2	244	24	104	1.10E-42	173.3	CNN2_MOUSE	reviewed	"Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin)"	Cnn2	Mus musculus (Mouse)	305	stress fiber [GO:0001725]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]; cellular response to mechanical stimulus [GO:0071260]; hemopoiesis [GO:0030097]; negative regulation of cell migration [GO:0030336]; negative regulation of phagocytosis [GO:0050765]; positive regulation of gene expression [GO:0010628]; regulation of actin filament-based process [GO:0032970]; regulation of cell population proliferation [GO:0042127]; wound healing [GO:0042060]	stress fiber [GO:0001725]	actin binding [GO:0003779]; calmodulin binding [GO:0005516]	GO:0001725; GO:0003779; GO:0005516; GO:0010628; GO:0030097; GO:0030336; GO:0031032; GO:0032970; GO:0042060; GO:0042127; GO:0050765; GO:0071260	actomyosin structure organization [GO:0031032]; cellular response to mechanical stimulus [GO:0071260]; hemopoiesis [GO:0030097]; negative regulation of cell migration [GO:0030336]; negative regulation of phagocytosis [GO:0050765]; positive regulation of gene expression [GO:0010628]; regulation of actin filament-based process [GO:0032970]; regulation of cell population proliferation [GO:0042127]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN37223_c0_g1_i1	Q9DAW9	CNN3_MOUSE	100	83	0	0	251	3	23	105	1.30E-43	176.4	CNN3_MOUSE	reviewed	"Calponin-3 (Calponin, acidic isoform)"	Cnn3	Mus musculus (Mouse)	330	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]	actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]	GO:0003779; GO:0005516; GO:0005829; GO:0008017; GO:0014069; GO:0015629; GO:0030425; GO:0030855; GO:0031032; GO:0032780; GO:0043025; GO:0043197	actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]		NA	NA	NA	NA	NA	NA
TRINITY_DN11699_c1_g1_i1	Q7Z1E6	CALR_BOMMO	70.8	144	42	0	1	432	83	226	2.80E-58	226.1	CALR_BOMMO	reviewed	Calreticulin	crt	Bombyx mori (Silk moth)	398	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11699_c0_g1_i1	Q7Z1E6	CALR_BOMMO	73.9	92	24	0	3	278	63	154	4.20E-38	158.3	CALR_BOMMO	reviewed	Calreticulin	crt	Bombyx mori (Silk moth)	398	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN6004_c0_g1_i1	Q4VIT5	CALR_CHLAE	100	215	0	0	3	647	23	237	1.40E-126	453.8	CALR_CHLAE	reviewed	Calreticulin	CALR	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	417	sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0006457; GO:0030246; GO:0033018; GO:0050821; GO:0051082	protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN20312_c0_g1_i1	P29413	CALR_DROME	75.9	83	20	0	249	1	43	125	1.40E-32	139.8	CALR_DROME	reviewed	Calreticulin	Calr Crc CG9429	Drosophila melanogaster (Fruit fly)	406	endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; fusome [GO:0045169]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]	endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; fusome [GO:0045169]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005615; GO:0005788; GO:0005789; GO:0006457; GO:0012505; GO:0030246; GO:0030431; GO:0030968; GO:0042048; GO:0045169; GO:0051082	endoplasmic reticulum unfolded protein response [GO:0030968]; olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN16578_c0_g1_i1	Q7Z1E6	CALR_BOMMO	80	315	63	0	1089	145	30	344	3.00E-103	376.7	CALR_BOMMO	reviewed	Calreticulin	crt	Bombyx mori (Silk moth)	398	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN16578_c0_g1_i2	Q7Z1E6	CALR_BOMMO	77.8	334	74	0	1146	145	11	344	7.70E-108	392.1	CALR_BOMMO	reviewed	Calreticulin	crt	Bombyx mori (Silk moth)	398	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN7501_c0_g1_i1	P27798	CALR_CAEEL	57.1	56	23	1	53	217	297	352	1.40E-10	66.6	CALR_CAEEL	reviewed	Calreticulin	crt-1 Y38A10A.5	Caenorhabditis elegans	395	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; defecation [GO:0030421]; endoplasmic reticulum unfolded protein response [GO:0030968]; hemidesmosome assembly [GO:0031581]; multicellular organismal reproductive process [GO:0048609]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; programmed cell death [GO:0012501]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]	GO:0005509; GO:0005737; GO:0005788; GO:0005789; GO:0006457; GO:0009408; GO:0010468; GO:0012501; GO:0030246; GO:0030421; GO:0030968; GO:0031581; GO:0045471; GO:0048609; GO:0051082; GO:1903204	defecation [GO:0030421]; endoplasmic reticulum unfolded protein response [GO:0030968]; hemidesmosome assembly [GO:0031581]; multicellular organismal reproductive process [GO:0048609]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; programmed cell death [GO:0012501]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; response to heat [GO:0009408]		red	red	NA	NA	NA	NA
TRINITY_DN6004_c0_g2_i1	P14211	CALR_MOUSE	100	337	0	0	1	1011	25	361	6.30E-156	551.6	CALR_MOUSE	reviewed	Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP)	Calr	Mus musculus (Mouse)	416	"acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; androgen receptor binding [GO:0050681]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; peptide binding [GO:0042277]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cardiac muscle cell differentiation [GO:0055007]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]"	acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]	androgen receptor binding [GO:0050681]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; peptide binding [GO:0042277]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0001669; GO:0002502; GO:0003729; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005794; GO:0005829; GO:0005844; GO:0006457; GO:0006611; GO:0007283; GO:0008284; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0016020; GO:0016529; GO:0017148; GO:0030246; GO:0030866; GO:0030968; GO:0031625; GO:0032355; GO:0032991; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042493; GO:0042562; GO:0042824; GO:0043231; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0045892; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0062023; GO:0071157; GO:0071285; GO:0090398; GO:1900026; GO:1901164; GO:1901224; GO:2000510	"cardiac muscle cell differentiation [GO:0055007]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40074_c0_g1_i1	Q9EPL2	CSTN1_MOUSE	28.4	194	116	6	541	23	588	779	1.90E-18	94	CSTN1_MOUSE	reviewed	Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)]	Clstn1 Cs1 Cstn1 Kiaa0911	Mus musculus (Mouse)	979	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]	GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0006874; GO:0007156; GO:0007268; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0042988; GO:0045211; GO:0050806; GO:0051965; GO:0090128; GO:0098969; GO:0098978; GO:0098982; GO:0099003; GO:0099061; GO:0099065	cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003]		NA	NA	NA	NA	NA	NA
TRINITY_DN2935_c0_g1_i1	P05434	CATR_CHLRE	41.7	84	45	1	654	403	10	89	6.70E-10	65.9	CATR_CHLRE	reviewed	Caltractin (20 kDa calcium-binding protein) (Centrin)		Chlamydomonas reinhardtii (Chlamydomonas smithii)	169	inner dynein arm [GO:0036156]; calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]; cell cycle [GO:0007049]; cell division [GO:0051301]	inner dynein arm [GO:0036156]	calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]	GO:0005509; GO:0007049; GO:0036156; GO:0045504; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN23026_c0_g1_i1	P05434	CATR_CHLRE	69.8	96	28	1	22	309	13	107	2.60E-28	125.9	CATR_CHLRE	reviewed	Caltractin (20 kDa calcium-binding protein) (Centrin)		Chlamydomonas reinhardtii (Chlamydomonas smithii)	169	inner dynein arm [GO:0036156]; calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]; cell cycle [GO:0007049]; cell division [GO:0051301]	inner dynein arm [GO:0036156]	calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]	GO:0005509; GO:0007049; GO:0036156; GO:0045504; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN35912_c0_g1_i1	Q06827	CATR_SCHDU	79.2	168	31	1	523	32	1	168	1.10E-66	254.2	CATR_SCHDU	reviewed	Caltractin (Centrin)		Scherffelia dubia (Green alga) (Chlamydomonas dubia)	168	calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]		calcium ion binding [GO:0005509]	GO:0005509; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN2324_c0_g1_i1	Q06827	CATR_SCHDU	64.5	93	33	0	346	68	72	164	6.80E-30	131.3	CATR_SCHDU	reviewed	Caltractin (Centrin)		Scherffelia dubia (Green alga) (Chlamydomonas dubia)	168	calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]		calcium ion binding [GO:0005509]	GO:0005509; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN2324_c0_g2_i1	Q06827	CATR_SCHDU	67.5	77	25	0	303	73	88	164	4.40E-25	115.2	CATR_SCHDU	reviewed	Caltractin (Centrin)		Scherffelia dubia (Green alga) (Chlamydomonas dubia)	168	calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]		calcium ion binding [GO:0005509]	GO:0005509; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN33138_c0_g1_i1	Q06827	CATR_SCHDU	83.1	59	10	0	21	197	110	168	5.40E-21	101.3	CATR_SCHDU	reviewed	Caltractin (Centrin)		Scherffelia dubia (Green alga) (Chlamydomonas dubia)	168	calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]		calcium ion binding [GO:0005509]	GO:0005509; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN35778_c0_g1_i1	P43646	CATR_TETST	85.1	148	22	0	41	484	1	148	2.50E-65	249.6	CATR_TETST	reviewed	Caltractin (Centrin) (Fragment)		Tetraselmis striata (Green microalga)	148	calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]		calcium ion binding [GO:0005509]	GO:0005509; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN36180_c0_g1_i1	Q3SEK0	CATR5_PARTE	68.5	146	44	2	441	4	26	169	1.70E-50	200.3	CATR5_PARTE	reviewed	Caltractin ICL1e (Centrin-5)	Icl1e GSPATT00007681001	Paramecium tetraurelia	174	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calcium ion binding [GO:0005509]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16941_c0_g1_i1	Q3T0K1	CALU_BOVIN	100	119	0	0	3	359	197	315	2.00E-64	246.1	CALU_BOVIN	reviewed	Calumenin	CALU	Bos taurus (Bovine)	315	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN23117_c0_g1_i1	Q4U471	CALU_MESAU	98.9	95	1	0	3	287	21	115	1.40E-49	196.4	CALU_MESAU	reviewed	Calumenin	CALU	Mesocricetus auratus (Golden hamster)	315	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN23117_c0_g1_i2	Q4U471	CALU_MESAU	100	89	0	0	3	269	27	115	8.10E-47	187.2	CALU_MESAU	reviewed	Calumenin	CALU	Mesocricetus auratus (Golden hamster)	315	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN16941_c0_g1_i2	O43852	CALU_HUMAN	99.1	115	1	0	1	345	201	315	6.90E-62	237.7	CALU_HUMAN	reviewed	Calumenin (Crocalbin) (IEF SSP 9302)	CALU	Homo sapiens (Human)	315	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016020; GO:0033018; GO:0042470; GO:0043687; GO:0044267	cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN3181_c0_g1_i3	Q6IQP3	CALUA_DANRE	59.9	304	109	4	1002	94	24	315	4.40E-96	352.8	CALUA_DANRE	reviewed	Calumenin-A	calua si:ch211-266a5.5	Danio rerio (Zebrafish) (Brachydanio rerio)	315	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN2540_c0_g4_i1	B5X186	CALUA_SALSA	36.3	328	185	7	1272	310	5	315	1.00E-47	192.6	CALUA_SALSA	reviewed	Calumenin-A	calua	Salmo salar (Atlantic salmon)	315	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470			blue	blue	NA	NA	NA	NA
TRINITY_DN3181_c0_g1_i1	B5X4E0	CALUB_SALSA	56.7	210	80	4	631	5	93	292	1.10E-59	231.1	CALUB_SALSA	reviewed	Calumenin-B	calub	Salmo salar (Atlantic salmon)	316	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN3181_c0_g1_i2	Q7SXV9	CALUB_DANRE	56.7	270	106	4	815	6	24	282	1.10E-79	298.1	CALUB_DANRE	reviewed	Calumenin-B	calub	Danio rerio (Zebrafish) (Brachydanio rerio)	315	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN4983_c0_g1_i1	Q8CA95	PDE10_MOUSE	29.7	185	129	1	145	696	99	283	1.90E-18	94.4	PDE10_MOUSE	reviewed	"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35)"	Pde10a	Mus musculus (Mouse)	790	"cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"	GO:0004112; GO:0004114; GO:0004118; GO:0005737; GO:0006198; GO:0007165; GO:0010738; GO:0010754; GO:0016020; GO:0030552; GO:0030553; GO:0043025; GO:0043204; GO:0043949; GO:0043951; GO:0046069; GO:0046872; GO:0047555	cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN39123_c0_g1_i1	P34099	KAPC_DICDI	66.9	239	79	0	2	718	374	612	1.80E-96	353.6	KAPC_DICDI	reviewed	cAMP-dependent protein kinase catalytic subunit (EC 2.7.11.11) (Dd GPK2) (DdPK3)	pkaC PK2 PK3 DDB_G0283907	Dictyostelium discoideum (Slime mold)	648	"cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005813; GO:0005829; GO:0005952; GO:0006355; GO:0006468; GO:0006469; GO:0007165; GO:0010628; GO:0010629; GO:0010737; GO:0018105; GO:0030435; GO:0031154; GO:0031285; GO:0031288; GO:0034237; GO:0034260; GO:0042173; GO:0043327; GO:0043405; GO:0044671; GO:0061939; GO:0090630; GO:1901261; GO:1903669; GO:1904643; GO:1905301	"activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30234_c0_g1_i1	P34099	KAPC_DICDI	56.7	120	50	1	10	369	436	553	1.20E-37	157.1	KAPC_DICDI	reviewed	cAMP-dependent protein kinase catalytic subunit (EC 2.7.11.11) (Dd GPK2) (DdPK3)	pkaC PK2 PK3 DDB_G0283907	Dictyostelium discoideum (Slime mold)	648	"cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005813; GO:0005829; GO:0005952; GO:0006355; GO:0006468; GO:0006469; GO:0007165; GO:0010628; GO:0010629; GO:0010737; GO:0018105; GO:0030435; GO:0031154; GO:0031285; GO:0031288; GO:0034237; GO:0034260; GO:0042173; GO:0043327; GO:0043405; GO:0044671; GO:0061939; GO:0090630; GO:1901261; GO:1903669; GO:1904643; GO:1905301	"activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39708_c0_g1_i1	P34099	KAPC_DICDI	54.8	250	113	0	3	752	367	616	3.60E-84	312.8	KAPC_DICDI	reviewed	cAMP-dependent protein kinase catalytic subunit (EC 2.7.11.11) (Dd GPK2) (DdPK3)	pkaC PK2 PK3 DDB_G0283907	Dictyostelium discoideum (Slime mold)	648	"cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005813; GO:0005829; GO:0005952; GO:0006355; GO:0006468; GO:0006469; GO:0007165; GO:0010628; GO:0010629; GO:0010737; GO:0018105; GO:0030435; GO:0031154; GO:0031285; GO:0031288; GO:0034237; GO:0034260; GO:0042173; GO:0043327; GO:0043405; GO:0044671; GO:0061939; GO:0090630; GO:1901261; GO:1903669; GO:1904643; GO:1905301	"activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39060_c0_g1_i1	P34099	KAPC_DICDI	57.7	163	69	0	11	499	393	555	3.70E-56	219.2	KAPC_DICDI	reviewed	cAMP-dependent protein kinase catalytic subunit (EC 2.7.11.11) (Dd GPK2) (DdPK3)	pkaC PK2 PK3 DDB_G0283907	Dictyostelium discoideum (Slime mold)	648	"cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005813; GO:0005829; GO:0005952; GO:0006355; GO:0006468; GO:0006469; GO:0007165; GO:0010628; GO:0010629; GO:0010737; GO:0018105; GO:0030435; GO:0031154; GO:0031285; GO:0031288; GO:0034237; GO:0034260; GO:0042173; GO:0043327; GO:0043405; GO:0044671; GO:0061939; GO:0090630; GO:1901261; GO:1903669; GO:1904643; GO:1905301	"activation of GTPase activity [GO:0090630]; c-di-GMP signaling [GO:0061939]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of chemorepellent activity [GO:1903669]; positive regulation of gene expression [GO:0010628]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of macropinocytosis [GO:1905301]; regulation of MAP kinase activity [GO:0043405]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]; regulation of sporulation resulting in formation of a cellular spore [GO:0042173]; regulation of transcription, DNA-templated [GO:0006355]; response to curcumin [GO:1904643]; signal transduction [GO:0007165]; sorocarp morphogenesis [GO:0031288]; sorocarp spore cell differentiation [GO:0044671]; sporulation resulting in formation of a cellular spore [GO:0030435]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4214_c0_g1_i1	P21137	KAPC1_CAEEL	55	111	50	0	334	2	181	291	4.40E-34	145.2	KAPC1_CAEEL	reviewed	cAMP-dependent protein kinase catalytic subunit (PKA C) (EC 2.7.11.11)	kin-1 ZK909.2	Caenorhabditis elegans	404	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005952; GO:0006468; GO:0007186; GO:0010737; GO:0034237; GO:1900195	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN29702_c0_g1_i1	P21137	KAPC1_CAEEL	55.3	170	74	1	512	3	181	348	4.00E-55	215.7	KAPC1_CAEEL	reviewed	cAMP-dependent protein kinase catalytic subunit (PKA C) (EC 2.7.11.11)	kin-1 ZK909.2	Caenorhabditis elegans	404	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005952; GO:0006468; GO:0007186; GO:0010737; GO:0034237; GO:1900195	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN9733_c0_g1_i1	P21137	KAPC1_CAEEL	56.9	109	47	0	332	6	181	289	1.50E-34	146.7	KAPC1_CAEEL	reviewed	cAMP-dependent protein kinase catalytic subunit (PKA C) (EC 2.7.11.11)	kin-1 ZK909.2	Caenorhabditis elegans	404	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005952; GO:0006468; GO:0007186; GO:0010737; GO:0034237; GO:1900195	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN36462_c0_g1_i1	P21137	KAPC1_CAEEL	53.2	111	52	0	333	1	180	290	2.20E-33	142.9	KAPC1_CAEEL	reviewed	cAMP-dependent protein kinase catalytic subunit (PKA C) (EC 2.7.11.11)	kin-1 ZK909.2	Caenorhabditis elegans	404	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]	cAMP-dependent protein kinase complex [GO:0005952]; nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005952; GO:0006468; GO:0007186; GO:0010737; GO:0034237; GO:1900195	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of oocyte maturation [GO:1900195]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN33992_c0_g1_i1	A8XW88	KAPC1_CAEBR	51.9	104	49	1	320	12	153	256	3.50E-28	125.6	KAPC1_CAEBR	reviewed	cAMP-dependent protein kinase catalytic subunit (PKA C) (EC 2.7.11.11)	kin-1 CBG19814	Caenorhabditis briggsae	374	nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; G protein-coupled receptor signaling pathway [GO:0007186]; protein kinase A signaling [GO:0010737]	nucleus [GO:0005634]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0007186; GO:0010737; GO:0034237	G protein-coupled receptor signaling pathway [GO:0007186]; protein kinase A signaling [GO:0010737]		NA	NA	NA	NA	NA	NA
TRINITY_DN15_c0_g2_i1	P12370	KAPC1_DROME	94.2	241	14	0	13	735	113	353	1.00E-137	490.7	KAPC1_DROME	reviewed	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379	Drosophila melanogaster (Fruit fly)	353	"cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"	cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007186; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0010737; GO:0019933; GO:0030425; GO:0032436; GO:0034237; GO:0035332; GO:0040040; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:2000249	"anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15_c0_g2_i2	P12370	KAPC1_DROME	93.8	272	17	0	2	817	82	353	2.60E-153	542.7	KAPC1_DROME	reviewed	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379	Drosophila melanogaster (Fruit fly)	353	"cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"	cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007186; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0010737; GO:0019933; GO:0030425; GO:0032436; GO:0034237; GO:0035332; GO:0040040; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:2000249	"anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11378_c0_g1_i1	P12370	KAPC1_DROME	61.2	160	60	2	2	481	105	262	1.90E-54	213.4	KAPC1_DROME	reviewed	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379	Drosophila melanogaster (Fruit fly)	353	"cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"	cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007186; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0010737; GO:0019933; GO:0030425; GO:0032436; GO:0034237; GO:0035332; GO:0040040; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:2000249	"anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27298_c0_g1_i1	P12370	KAPC1_DROME	51.5	103	49	1	320	12	132	233	6.50E-27	121.3	KAPC1_DROME	reviewed	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379	Drosophila melanogaster (Fruit fly)	353	"cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"	cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007186; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0010737; GO:0019933; GO:0030425; GO:0032436; GO:0034237; GO:0035332; GO:0040040; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:2000249	"anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30846_c0_g1_i1	P16912	KAPC3_DROME	57.5	113	46	1	356	18	376	486	6.80E-33	141.4	KAPC3_DROME	reviewed	cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2)	Pka-C3 DC2 CG6117	Drosophila melanogaster (Fruit fly)	583	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105	imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38645_c0_g1_i2	P16912	KAPC3_DROME	73.1	297	79	1	959	69	288	583	1.80E-133	476.9	KAPC3_DROME	reviewed	cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2)	Pka-C3 DC2 CG6117	Drosophila melanogaster (Fruit fly)	583	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0006468; GO:0007165; GO:0007476; GO:0018105	imaginal disc-derived wing morphogenesis [GO:0007476]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN27535_c0_g1_i1	P05131	KAPCB_BOVIN	100	199	0	0	599	3	95	293	5.30E-115	414.8	KAPCB_BOVIN	reviewed	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB	Bos taurus (Bovine)	351	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; G protein-coupled receptor signaling pathway [GO:0007186]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0007186; GO:0010737; GO:0034237	G protein-coupled receptor signaling pathway [GO:0007186]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN40122_c0_g1_i1	Q922R0	PRKX_MOUSE	60.7	117	46	0	17	367	146	262	2.50E-43	176	PRKX_MOUSE	reviewed	cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (PKA-related protein kinase)	Prkx Pkare	Mus musculus (Mouse)	355	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]	GO:0001525; GO:0001935; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:2000696	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33183_c0_g1_i1	P51817	PRKX_HUMAN	58.8	204	84	0	614	3	85	288	6.00E-69	261.9	PRKX_HUMAN	reviewed	cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1)	PRKX PKX1	Homo sapiens (Human)	358	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:2000696	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN40337_c0_g1_i1	P51817	PRKX_HUMAN	100	208	0	0	2	625	94	301	6.50E-124	444.5	PRKX_HUMAN	reviewed	cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1)	PRKX PKX1	Homo sapiens (Human)	358	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:2000696	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31950_c0_g1_i1	P56212	ARP19_MOUSE	100	83	0	0	1	249	20	102	2.80E-41	168.7	ARP19_MOUSE	reviewed	cAMP-regulated phosphoprotein 19 (ARPP-19)	Arpp19	Mus musculus (Mouse)	112	cytoplasm [GO:0005737]; phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of Ras protein signal transduction [GO:0046579]	cytoplasm [GO:0005737]	phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]	GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005737; GO:0015459; GO:0019212; GO:0019888; GO:0035308; GO:0045722; GO:0046579; GO:0051301; GO:0051721	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of Ras protein signal transduction [GO:0046579]		NA	NA	NA	NA	NA	NA
TRINITY_DN2135_c0_g1_i1	Q6GQG3	AR19B_XENLA	53.2	79	34	2	330	103	37	115	1.60E-12	73.9	AR19B_XENLA	reviewed	cAMP-regulated phosphoprotein 19-B (ARPP-19-B)	arpp19-b	Xenopus laevis (African clawed frog)	117	cytoplasm [GO:0005737]; phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]	phosphatase inhibitor activity [GO:0019212]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]	GO:0000086; GO:0000278; GO:0004864; GO:0005737; GO:0019212; GO:0019888; GO:0051301; GO:0051721	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]		blue	blue	NA	NA	NA	NA
TRINITY_DN2527_c0_g1_i7	Q03060	CREM_HUMAN	43.3	60	28	1	232	71	75	134	7.50E-05	47.8	CREM_HUMAN	reviewed	cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER)	CREM	Homo sapiens (Human)	345	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; cAMP response element binding protein binding [GO:0008140]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; glycosphingolipid metabolic process [GO:0006687]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"cAMP response element binding protein binding [GO:0008140]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006006; GO:0006355; GO:0006631; GO:0006687; GO:0007165; GO:0007275; GO:0007283; GO:0008140; GO:0030154; GO:0042752; GO:0045944; GO:0048384; GO:0048511; GO:1990837	"cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; glycosphingolipid metabolic process [GO:0006687]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15458_c0_g1_i1	Q0VD32	CRBL2_BOVIN	57.5	73	31	0	1	219	30	102	3.10E-17	89	CRBL2_BOVIN	reviewed	cAMP-responsive element-binding protein-like 2	CREBL2	Bos taurus (Bovine)	120	"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; viral process [GO:0016032]"	nuclear body [GO:0016604]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0016032; GO:0016604; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821	"cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32925_c0_g1_i1	Q0VD32	CRBL2_BOVIN	58.3	72	30	0	307	92	31	102	5.70E-17	89	CRBL2_BOVIN	reviewed	cAMP-responsive element-binding protein-like 2	CREBL2	Bos taurus (Bovine)	120	"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; viral process [GO:0016032]"	nuclear body [GO:0016604]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0016032; GO:0016604; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821	"cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28952_c0_g1_i1	O89084	PDE4A_MOUSE	47.3	74	37	1	2	223	453	524	2.20E-10	65.9	PDE4A_MOUSE	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53)"	Pde4a	Mus musculus (Mouse)	844	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; modulation of chemical synaptic transmission [GO:0050804]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006198; GO:0007165; GO:0007608; GO:0010738; GO:0016020; GO:0030552; GO:0035690; GO:0043949; GO:0046872; GO:0048471; GO:0050804; GO:0098685	cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; modulation of chemical synaptic transmission [GO:0050804]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN40594_c0_g1_i1	P27815	PDE4A_HUMAN	100	149	0	0	449	3	488	636	1.20E-79	297	PDE4A_HUMAN	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46)"	PDE4A DPDE2	Homo sapiens (Human)	886	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006198; GO:0007165; GO:0007186; GO:0007608; GO:0010738; GO:0016020; GO:0030552; GO:0032587; GO:0035690; GO:0043949; GO:0046872; GO:0048471	cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN28981_c0_g1_i1	Q07343	PDE4B_HUMAN	96.3	81	3	0	245	3	565	645	3.90E-40	164.9	PDE4B_HUMAN	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32)"	PDE4B DPDE4	Homo sapiens (Human)	736	"centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; leukocyte migration [GO:0050900]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]"	centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]"	GO:0000930; GO:0001780; GO:0004114; GO:0004115; GO:0005634; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0007165; GO:0007186; GO:0008021; GO:0014069; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0035690; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0048471; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071872; GO:0086004; GO:1901841; GO:1901898	cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; leukocyte migration [GO:0050900]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN36053_c0_g1_i1	Q07343	PDE4B_HUMAN	100	161	0	0	3	485	446	606	6.50E-87	321.2	PDE4B_HUMAN	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32)"	PDE4B DPDE4	Homo sapiens (Human)	736	"centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; leukocyte migration [GO:0050900]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]"	centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]"	GO:0000930; GO:0001780; GO:0004114; GO:0004115; GO:0005634; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0007165; GO:0007186; GO:0008021; GO:0014069; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0035690; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0048471; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071872; GO:0086004; GO:1901841; GO:1901898	cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; leukocyte migration [GO:0050900]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN31709_c0_g1_i1	Q07343	PDE4B_HUMAN	98.9	87	1	0	3	263	356	442	1.50E-42	172.9	PDE4B_HUMAN	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32)"	PDE4B DPDE4	Homo sapiens (Human)	736	"centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; leukocyte migration [GO:0050900]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]"	centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]"	GO:0000930; GO:0001780; GO:0004114; GO:0004115; GO:0005634; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0007165; GO:0007186; GO:0008021; GO:0014069; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0035690; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0048471; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071872; GO:0086004; GO:1901841; GO:1901898	cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; leukocyte migration [GO:0050900]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN40382_c0_g1_i1	Q08499	PDE4D_HUMAN	100	86	0	0	261	4	442	527	3.40E-42	171.8	PDE4D_HUMAN	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)"	PDE4D DPDE3	Homo sapiens (Human)	809	"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]"	apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]"	GO:0002027; GO:0004114; GO:0004115; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005891; GO:0006198; GO:0006939; GO:0007165; GO:0007186; GO:0007568; GO:0008144; GO:0010469; GO:0010880; GO:0016020; GO:0016324; GO:0019899; GO:0019933; GO:0030552; GO:0030593; GO:0031625; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0035264; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0048471; GO:0050852; GO:0051117; GO:0060314; GO:0061028; GO:0071222; GO:0071320; GO:0071872; GO:0071875; GO:0086004; GO:0086024; GO:0097110; GO:1901844; GO:1901898	adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN30409_c0_g1_i1	Q08499	PDE4D_HUMAN	100	108	0	0	2	325	602	709	5.30E-61	234.6	PDE4D_HUMAN	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)"	PDE4D DPDE3	Homo sapiens (Human)	809	"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]"	apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]"	GO:0002027; GO:0004114; GO:0004115; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005891; GO:0006198; GO:0006939; GO:0007165; GO:0007186; GO:0007568; GO:0008144; GO:0010469; GO:0010880; GO:0016020; GO:0016324; GO:0019899; GO:0019933; GO:0030552; GO:0030593; GO:0031625; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0035264; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0048471; GO:0050852; GO:0051117; GO:0060314; GO:0061028; GO:0071222; GO:0071320; GO:0071872; GO:0071875; GO:0086004; GO:0086024; GO:0097110; GO:1901844; GO:1901898	adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN4720_c0_g1_i1	Q9QXQ1	PDE7B_MOUSE	48.2	340	170	2	2698	1697	96	435	5.60E-93	344	PDE7B_MOUSE	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase 7B (EC 3.1.4.53)"	Pde7b	Mus musculus (Mouse)	446	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; signal transduction [GO:0007165]"		"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0006198; GO:0007165; GO:0019933; GO:0046872	cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN34170_c0_g1_i1	Q9W4T4	PDE4A_DROME	56.4	55	24	0	202	38	901	955	2.00E-10	65.9	PDE4A_DROME	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase, isoform I (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce)"	dnc CG32498	Drosophila melanogaster (Fruit fly)	1209	"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]"	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0001661; GO:0004114; GO:0004115; GO:0005634; GO:0005829; GO:0006198; GO:0007165; GO:0007268; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0010738; GO:0019933; GO:0040040; GO:0043951; GO:0045202; GO:0046872; GO:0046958; GO:0048149; GO:0048471; GO:0048675; GO:0072375	anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]		NA	NA	NA	NA	NA	NA
TRINITY_DN1605_c0_g1_i1	Q9W4T4	PDE4A_DROME	69.7	466	120	1	1635	238	693	1137	5.30E-184	645.6	PDE4A_DROME	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase, isoform I (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce)"	dnc CG32498	Drosophila melanogaster (Fruit fly)	1209	"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]"	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0001661; GO:0004114; GO:0004115; GO:0005634; GO:0005829; GO:0006198; GO:0007165; GO:0007268; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0010738; GO:0019933; GO:0040040; GO:0043951; GO:0045202; GO:0046872; GO:0046958; GO:0048149; GO:0048471; GO:0048675; GO:0072375	anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]		NA	NA	NA	NA	NA	NA
TRINITY_DN1605_c0_g1_i2	Q9W4T4	PDE4A_DROME	71.2	493	121	1	1716	238	666	1137	4.50E-199	695.7	PDE4A_DROME	reviewed	"cAMP-specific 3',5'-cyclic phosphodiesterase, isoform I (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce)"	dnc CG32498	Drosophila melanogaster (Fruit fly)	1209	"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]"	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0001661; GO:0004114; GO:0004115; GO:0005634; GO:0005829; GO:0006198; GO:0007165; GO:0007268; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0010738; GO:0019933; GO:0040040; GO:0043951; GO:0045202; GO:0046872; GO:0046958; GO:0048149; GO:0048471; GO:0048675; GO:0072375	anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; medium-term memory [GO:0072375]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]		blue	blue	NA	NA	NA	NA
TRINITY_DN5422_c0_g1_i1	Q28689	MRP2_RABIT	38.1	155	88	2	461	21	953	1107	3.60E-26	119.4	MRP2_RABIT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Epithelial basolateral chloride conductance regulator) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 EBCR MRP2	Oryctolagus cuniculus (Rabbit)	1564	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; bile acid and bile salt transport [GO:0015721]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0005887; GO:0008514; GO:0008559; GO:0015721; GO:0016324; GO:0016887; GO:0042626	bile acid and bile salt transport [GO:0015721]		NA	NA	NA	NA	NA	NA
TRINITY_DN15260_c0_g1_i1	Q28689	MRP2_RABIT	30.7	163	98	4	581	105	98	249	1.60E-13	77.8	MRP2_RABIT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Epithelial basolateral chloride conductance regulator) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 EBCR MRP2	Oryctolagus cuniculus (Rabbit)	1564	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; bile acid and bile salt transport [GO:0015721]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0005887; GO:0008514; GO:0008559; GO:0015721; GO:0016324; GO:0016887; GO:0042626	bile acid and bile salt transport [GO:0015721]		NA	NA	1	NA	NA	NA
TRINITY_DN24295_c0_g2_i1	Q28689	MRP2_RABIT	65.1	86	30	0	258	1	763	848	1.20E-28	126.7	MRP2_RABIT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Epithelial basolateral chloride conductance regulator) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 EBCR MRP2	Oryctolagus cuniculus (Rabbit)	1564	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; bile acid and bile salt transport [GO:0015721]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0005887; GO:0008514; GO:0008559; GO:0015721; GO:0016324; GO:0016887; GO:0042626	bile acid and bile salt transport [GO:0015721]		NA	NA	NA	NA	NA	NA
TRINITY_DN28144_c0_g1_i2	Q28689	MRP2_RABIT	60.4	106	42	0	3	320	671	776	1.60E-32	140.2	MRP2_RABIT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Epithelial basolateral chloride conductance regulator) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 EBCR MRP2	Oryctolagus cuniculus (Rabbit)	1564	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; bile acid and bile salt transport [GO:0015721]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0005887; GO:0008514; GO:0008559; GO:0015721; GO:0016324; GO:0016887; GO:0042626	bile acid and bile salt transport [GO:0015721]		NA	NA	NA	NA	NA	NA
TRINITY_DN21526_c0_g1_i1	Q92887	MRP2_HUMAN	53.1	49	22	1	248	102	1277	1324	1.40E-08	60.5	MRP2_HUMAN	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 CMOAT CMOAT1 CMRP MRP2	Homo sapiens (Human)	1545	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015127; GO:0015694; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:0150104; GO:1901086; GO:1904486; GO:1990961; GO:1990962	benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN21526_c0_g2_i1	Q92887	MRP2_HUMAN	63.6	99	36	0	1	297	1332	1430	1.80E-31	136.3	MRP2_HUMAN	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 CMOAT CMOAT1 CMRP MRP2	Homo sapiens (Human)	1545	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015127; GO:0015694; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:0150104; GO:1901086; GO:1904486; GO:1990961; GO:1990962	benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN4316_c0_g1_i1	Q63120	MRP2_RAT	57.1	240	103	0	4	723	1286	1525	6.90E-75	282	MRP2_RAT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2 Cmoat Cmrp Mrp2	Rattus norvegicus (Rat)	1541	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010468; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0032496; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0048545; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		blue	blue	NA	NA	NA	NA
TRINITY_DN28347_c0_g1_i1	Q63120	MRP2_RAT	60.3	141	56	0	425	3	698	838	2.20E-46	186.4	MRP2_RAT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2 Cmoat Cmrp Mrp2	Rattus norvegicus (Rat)	1541	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010468; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0032496; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0048545; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN35061_c0_g1_i1	Q92887	MRP2_HUMAN	60.3	63	25	0	9	197	1050	1112	1.50E-16	86.3	MRP2_HUMAN	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 CMOAT CMOAT1 CMRP MRP2	Homo sapiens (Human)	1545	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015127; GO:0015694; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:0150104; GO:1901086; GO:1904486; GO:1990961; GO:1990962	benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN34059_c0_g1_i1	Q63120	MRP2_RAT	50.8	118	58	0	362	9	1294	1411	6.50E-31	134.8	MRP2_RAT	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2 Cmoat Cmrp Mrp2	Rattus norvegicus (Rat)	1541	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010468; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0032496; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0048545; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN5422_c0_g1_i2	Q8VI47	MRP2_MOUSE	39.6	53	32	0	2	160	1026	1078	6.00E-05	48.9	MRP2_MOUSE	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2	Mus musculus (Mouse)	1543	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN5422_c0_g1_i3	Q8VI47	MRP2_MOUSE	37.6	93	58	0	2	280	1026	1118	3.00E-12	72.4	MRP2_MOUSE	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2	Mus musculus (Mouse)	1543	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN5422_c0_g1_i4	Q8VI47	MRP2_MOUSE	35.2	142	84	2	425	24	953	1094	4.60E-20	99	MRP2_MOUSE	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2	Mus musculus (Mouse)	1543	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN35818_c0_g1_i1	Q8VI47	MRP2_MOUSE	49.1	110	56	0	1	330	1357	1466	4.90E-25	115.2	MRP2_MOUSE	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2	Mus musculus (Mouse)	1543	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN24295_c0_g1_i1	Q8VI47	MRP2_MOUSE	54.2	59	27	0	178	2	695	753	5.50E-16	84.7	MRP2_MOUSE	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2	Mus musculus (Mouse)	1543	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN31835_c0_g1_i1	Q8VI47	MRP2_MOUSE	49.3	69	35	0	3	209	1035	1103	6.00E-15	81.3	MRP2_MOUSE	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	Abcc2	Mus musculus (Mouse)	1543	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0006855; GO:0006954; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015694; GO:0015711; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016999; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0032355; GO:0033762; GO:0035690; GO:0038183; GO:0042178; GO:0042493; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046618; GO:0046685; GO:0050787; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:0071716; GO:0097327; GO:0120188; GO:1901086; GO:1904486; GO:1990961; GO:1990962	antibiotic metabolic process [GO:0016999]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; detoxification of mercury ion [GO:0050787]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; leukotriene transport [GO:0071716]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; organic anion transport [GO:0015711]; prostaglandin transport [GO:0015732]; regulation of bile acid secretion [GO:0120188]; response to 17alpha-ethynylestradiol [GO:1904486]; response to antineoplastic agent [GO:0097327]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic catabolic process [GO:0042178]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN2837_c0_g1_i1	O88563	MRP3_RAT	66.1	221	75	0	727	65	640	860	1.70E-78	293.9	MRP3_RAT	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (MRP-like protein 2) (MLP-2) (Multidrug resistance-associated protein 3)	Abcc3 Cmoat2 Mlp2 Mrp3	Rattus norvegicus (Rat)	1522	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0010033; GO:0010243; GO:0014070; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0032355; GO:0032496; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN10075_c0_g1_i1	B2RX12	MRP3_MOUSE	40	70	42	0	3	212	468	537	4.20E-09	61.6	MRP3_MOUSE	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	Abcc3 Cmoat2 Mrp3	Mus musculus (Mouse)	1523	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		blue	blue	NA	NA	NA	NA
TRINITY_DN36649_c0_g1_i1	B2RX12	MRP3_MOUSE	98.9	90	1	0	3	272	1206	1295	8.50E-44	177.2	MRP3_MOUSE	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	Abcc3 Cmoat2 Mrp3	Mus musculus (Mouse)	1523	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4856_c0_g1_i3	B2RX12	MRP3_MOUSE	80.3	66	13	0	422	225	1423	1488	3.90E-22	105.9	MRP3_MOUSE	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	Abcc3 Cmoat2 Mrp3	Mus musculus (Mouse)	1523	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN21140_c0_g2_i1	B2RX12	MRP3_MOUSE	54.9	51	23	0	171	19	497	547	2.80E-09	62.4	MRP3_MOUSE	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	Abcc3 Cmoat2 Mrp3	Mus musculus (Mouse)	1523	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN27572_c0_g1_i1	O15438	MRP3_HUMAN	62	326	122	2	5	979	1202	1526	4.80E-108	392.5	MRP3_HUMAN	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)	ABCC3 CMOAT2 MLP2 MRP3	Homo sapiens (Human)	1527	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0006855; GO:0008559; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0150104	bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN25694_c0_g1_i1	O15438	MRP3_HUMAN	61	100	39	0	309	10	440	539	3.90E-29	128.6	MRP3_HUMAN	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)	ABCC3 CMOAT2 MLP2 MRP3	Homo sapiens (Human)	1527	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0006855; GO:0008559; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0150104	bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN28669_c0_g1_i1	O15438	MRP3_HUMAN	67.2	67	21	1	202	2	722	787	1.70E-17	89.4	MRP3_HUMAN	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)	ABCC3 CMOAT2 MLP2 MRP3	Homo sapiens (Human)	1527	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0006855; GO:0008559; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0150104	bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN2837_c0_g1_i3	O15438	MRP3_HUMAN	68.1	160	45	1	527	66	658	817	1.40E-55	217.2	MRP3_HUMAN	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)	ABCC3 CMOAT2 MLP2 MRP3	Homo sapiens (Human)	1527	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled bile acid transmembrane transporter activity [GO:0015432]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0006855; GO:0008559; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0150104	bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN34537_c0_g1_i1	P30622	CLIP1_HUMAN	100	76	0	0	1	228	44	119	9.60E-41	166.8	CLIP1_HUMAN	reviewed	CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)	CLIP1 CYLN1 RSN	Homo sapiens (Human)	1438	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ruffle [GO:0001726]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005881; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0035371; GO:0042802; GO:0044861; GO:0051010	cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]		NA	NA	NA	NA	NA	NA
TRINITY_DN28945_c0_g1_i1	Q96DZ5	CLIP3_HUMAN	61.9	42	16	0	165	40	101	142	6.30E-09	61.2	CLIP3_HUMAN	reviewed	CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein) (CLIP-170-related 59 kDa protein) (CLIPR-59)	CLIP3 CLIPR59	Homo sapiens (Human)	547	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; chaperone-mediated protein transport [GO:0072321]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0001934; GO:0005634; GO:0005737; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0008017; GO:0010803; GO:0010828; GO:0018230; GO:0031115; GO:0031122; GO:0031901; GO:0032588; GO:0035371; GO:0035594; GO:0043065; GO:0044091; GO:0045121; GO:0045444; GO:0045807; GO:0051010; GO:0055038; GO:0072321; GO:1903078	chaperone-mediated protein transport [GO:0072321]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]		NA	NA	NA	NA	NA	NA
TRINITY_DN37421_c0_g1_i1	Q96DZ5	CLIP3_HUMAN	47.8	67	35	0	261	61	294	360	1.20E-13	77	CLIP3_HUMAN	reviewed	CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein) (CLIP-170-related 59 kDa protein) (CLIPR-59)	CLIP3 CLIPR59	Homo sapiens (Human)	547	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; chaperone-mediated protein transport [GO:0072321]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0001934; GO:0005634; GO:0005737; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0008017; GO:0010803; GO:0010828; GO:0018230; GO:0031115; GO:0031122; GO:0031901; GO:0032588; GO:0035371; GO:0035594; GO:0043065; GO:0044091; GO:0045121; GO:0045444; GO:0045807; GO:0051010; GO:0055038; GO:0072321; GO:1903078	chaperone-mediated protein transport [GO:0072321]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]		NA	NA	NA	NA	NA	NA
TRINITY_DN1295_c0_g1_i1	Q1LZB6	CAPR1_BOVIN	35	197	125	1	128	718	50	243	5.30E-24	113.6	CAPR1_BOVIN	reviewed	Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (RNA granule protein 105)	CAPRIN1 RNG105	Bos taurus (Bovine)	708	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; P-body [GO:0000932]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; P-body [GO:0000932]	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0050775; GO:0061003	negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]		blue	blue	NA	NA	NA	NA
TRINITY_DN1295_c0_g1_i3	Q1LZB6	CAPR1_BOVIN	37	146	92	0	128	565	50	195	2.40E-18	94	CAPR1_BOVIN	reviewed	Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (RNA granule protein 105)	CAPRIN1 RNG105	Bos taurus (Bovine)	708	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; P-body [GO:0000932]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; P-body [GO:0000932]	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0050775; GO:0061003	negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]		blue	blue	NA	NA	NA	1
TRINITY_DN1775_c0_g1_i1	Q7ZVS8	CMTR2_DANRE	43.6	385	196	3	1624	473	48	412	8.00E-82	306.2	CMTR2_DANRE	reviewed	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (MTr2) (FtsJ methyltransferase domain-containing protein 1)	cmtr2 ftsjd1 zgc:55686	Danio rerio (Zebrafish) (Brachydanio rerio)	743	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]	GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097309; GO:0097310	7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]		NA	NA	NA	NA	NA	NA
TRINITY_DN33286_c0_g1_i1	Q8IV04	TB10C_HUMAN	84	150	19	1	210	659	170	314	2.90E-66	253.1	TB10C_HUMAN	reviewed	Carabin (TBC1 domain family member 10C)	TBC1D10C	Homo sapiens (Human)	446	"cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; neutrophil degranulation [GO:0043312]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0017137; GO:0031527; GO:0042147; GO:0043312; GO:0050869; GO:0070373; GO:0070885; GO:0090630; GO:0101003	"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; neutrophil degranulation [GO:0043312]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33286_c0_g1_i1	Q8IV04	TB10C_HUMAN	99	101	1	0	1	303	57	157	2.10E-56	220.3	TB10C_HUMAN	reviewed	Carabin (TBC1 domain family member 10C)	TBC1D10C	Homo sapiens (Human)	446	"cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; neutrophil degranulation [GO:0043312]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0017137; GO:0031527; GO:0042147; GO:0043312; GO:0050869; GO:0070373; GO:0070885; GO:0090630; GO:0101003	"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; neutrophil degranulation [GO:0043312]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33286_c0_g1_i2	Q8IV04	TB10C_HUMAN	100	258	0	0	1	774	57	314	2.80E-153	542.3	TB10C_HUMAN	reviewed	Carabin (TBC1 domain family member 10C)	TBC1D10C	Homo sapiens (Human)	446	"cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; neutrophil degranulation [GO:0043312]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0017137; GO:0031527; GO:0042147; GO:0043312; GO:0050869; GO:0070373; GO:0070885; GO:0090630; GO:0101003	"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; neutrophil degranulation [GO:0043312]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN482_c0_g1_i1	Q8XZ83	CARB_RALSO	98.4	186	3	0	2	559	206	391	1.70E-99	363.2	CARB_RALSO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB RSc1521 RS03783	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	1081	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN482_c1_g2_i1	Q8YIC2	CARB_BRUME	89	146	15	1	437	3	318	463	5.70E-66	251.5	CARB_BRUME	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB BMEI0522	Brucella melitensis biotype 1 (strain 16M / ATCC 23456 / NCTC 10094)	1162	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN482_c1_g2_i2	Q98I87	CARB_RHILO	88.4	146	16	1	440	6	317	462	8.30E-65	247.7	CARB_RHILO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB mlr2517	Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))	1167	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN482_c1_g1_i1	Q8UDE9	CARB_AGRFC	97.2	72	2	0	217	2	313	384	1.30E-31	136.3	CARB_AGRFC	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB Atu2178 AGR_C_3955	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	1162	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN482_c1_g3_i1	Q8UDE9	CARB_AGRFC	96	100	4	0	300	1	309	408	3.70E-48	191.8	CARB_AGRFC	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB Atu2178 AGR_C_3955	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	1162	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN33754_c0_g1_i1	Q8XZ83	CARB_RALSO	96.5	85	3	0	1	255	54	138	9.70E-42	170.2	CARB_RALSO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB RSc1521 RS03783	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	1081	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN24693_c0_g1_i1	Q8YIC2	CARB_BRUME	90.9	77	7	0	3	233	21	97	6.70E-34	144.1	CARB_BRUME	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB BMEI0522	Brucella melitensis biotype 1 (strain 16M / ATCC 23456 / NCTC 10094)	1162	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN34269_c0_g1_i1	Q98I87	CARB_RHILO	93.2	73	4	1	2	217	327	399	8.10E-29	127.1	CARB_RHILO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB mlr2517	Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))	1167	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN30014_c0_g1_i1	Q8UDE9	CARB_AGRFC	77.1	70	16	0	212	3	638	707	2.30E-28	125.6	CARB_AGRFC	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB Atu2178 AGR_C_3955	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	1162	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN32120_c0_g1_i1	O50236	CARB_ZYMMO	82.6	69	12	0	3	209	796	864	6.80E-25	114	CARB_ZYMMO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB ZMO1617	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	1112	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN1692_c0_g1_i1	Q8XZ83	CARB_RALSO	100	98	0	0	296	3	564	661	2.40E-52	205.7	CARB_RALSO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB RSc1521 RS03783	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	1081	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN1692_c0_g1_i2	Q98I87	CARB_RHILO	81.9	94	17	0	282	1	625	718	4.80E-42	171.4	CARB_RHILO	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB mlr2517	Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))	1167	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN31418_c0_g1_i1	A6WCC6	CARB_KINRD	88.9	72	8	0	2	217	216	287	1.00E-31	136.7	CARB_KINRD	reviewed	Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain)	carB Krad_3001	Kineococcus radiotolerans (strain ATCC BAA-149 / DSM 14245 / SRS30216)	1104	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]	GO:0004088; GO:0005524; GO:0006526; GO:0044205; GO:0046872	'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]		NA	NA	NA	NA	NA	NA
TRINITY_DN30133_c0_g1_i1	O50235	CARA_ZYMMO	79.8	104	21	0	2	313	192	295	1.30E-43	176.8	CARA_ZYMMO	reviewed	Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase glutamine chain)	carA ZMO1618	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	374	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]	GO:0004088; GO:0005524; GO:0006207; GO:0006526; GO:0006541; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN38039_c0_g1_i1	Q8XZ85	CARA_RALSO	91.3	115	10	0	346	2	200	314	2.80E-60	232.3	CARA_RALSO	reviewed	Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase glutamine chain)	carA RSc1519 RS03785	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	378	ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]	GO:0004088; GO:0005524; GO:0006207; GO:0006526; GO:0006541; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN7523_c0_g1_i3	Q6AXM1	CHSTA_DANRE	30.1	123	80	3	426	67	184	303	4.10E-08	59.3	CHSTA_DANRE	reviewed	Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST)	chst10 zgc:100964	Danio rerio (Zebrafish) (Brachydanio rerio)	365	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0030166	carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN39854_c0_g1_i1	Q9JME2	CHSTB_MOUSE	44.6	168	87	3	63	557	107	271	4.50E-37	156	CHSTB_MOUSE	reviewed	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	Chst11	Mus musculus (Mouse)	352	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216	carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]		NA	NA	NA	NA	NA	NA
TRINITY_DN39854_c0_g1_i2	Q9JME2	CHSTB_MOUSE	41.9	246	135	4	63	785	107	349	2.70E-53	210.3	CHSTB_MOUSE	reviewed	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	Chst11	Mus musculus (Mouse)	352	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216	carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]		NA	NA	NA	NA	NA	NA
TRINITY_DN38600_c0_g1_i1	Q9NPF2	CHSTB_HUMAN	100	66	0	0	201	4	83	148	1.00E-33	143.3	CHSTB_HUMAN	reviewed	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	CHST11	Homo sapiens (Human)	352	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659	carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]		NA	NA	NA	NA	NA	NA
TRINITY_DN1131_c0_g1_i4	Q9NRB3	CHSTC_HUMAN	24.5	261	169	6	821	102	152	405	4.30E-13	77.4	CHSTC_HUMAN	reviewed	Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo)	CHST12 UNQ500/PRO1017	Homo sapiens (Human)	414	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030173; GO:0030206; GO:0030208; GO:0047756; GO:0050656	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN1131_c0_g1_i5	Q9NRB3	CHSTC_HUMAN	32.6	89	53	2	359	102	321	405	1.50E-07	57.8	CHSTC_HUMAN	reviewed	Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo)	CHST12 UNQ500/PRO1017	Homo sapiens (Human)	414	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030173; GO:0030206; GO:0030208; GO:0047756; GO:0050656	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN1131_c0_g1_i6	Q9NRB3	CHSTC_HUMAN	23.3	258	176	5	821	102	152	405	1.30E-12	75.9	CHSTC_HUMAN	reviewed	Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo)	CHST12 UNQ500/PRO1017	Homo sapiens (Human)	414	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030173; GO:0030206; GO:0030208; GO:0047756; GO:0050656	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN1131_c0_g1_i7	Q9NRB3	CHSTC_HUMAN	32.6	89	53	2	359	102	321	405	1.50E-07	57.8	CHSTC_HUMAN	reviewed	Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo)	CHST12 UNQ500/PRO1017	Homo sapiens (Human)	414	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030173; GO:0030206; GO:0030208; GO:0047756; GO:0050656	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN30223_c0_g1_i1	Q9R1I1	CHST4_MOUSE	26.7	344	211	10	164	1072	41	384	1.80E-23	111.7	CHST4_MOUSE	reviewed	Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2)	Chst4 Gst3	Mus musculus (Mouse)	388	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; leukocyte tethering or rolling [GO:0050901]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0006954; GO:0016021; GO:0050901	carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; leukocyte tethering or rolling [GO:0050901]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN26139_c0_g1_i1	Q9NS84	CHST7_HUMAN	44	50	27	1	186	37	94	142	2.00E-05	49.3	CHST7_HUMAN	reviewed	Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4)	CHST7	Homo sapiens (Human)	486	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]	GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206	chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN26962_c0_g1_i1	Q92051	CAHZ_DANRE	37.6	205	118	6	594	1	51	252	2.30E-33	143.7	CAHZ_DANRE	reviewed	Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)	cahz cah-z	Danio rerio (Zebrafish) (Brachydanio rerio)	260	cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]	cytoplasm [GO:0005737]	carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0042539	carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]		black	black	NA	NA	NA	1
TRINITY_DN15598_c0_g1_i2	Q8UWA5	CAH2_TRIHK	42.5	219	116	7	27	668	45	258	4.90E-39	162.9	CAH2_TRIHK	reviewed	Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)	ca2	Tribolodon hakonensis (Big-scaled redfin) (Leuciscus hakonensis)	260	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005737; GO:0005886; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN13329_c1_g1_i1	Q8UWA5	CAH2_TRIHK	44.1	261	135	5	905	129	4	255	8.00E-57	222.2	CAH2_TRIHK	reviewed	Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)	ca2	Tribolodon hakonensis (Big-scaled redfin) (Leuciscus hakonensis)	260	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005737; GO:0005886; GO:0008270			blue	blue	NA	NA	NA	NA
TRINITY_DN30318_c0_g1_i1	Q8UWA5	CAH2_TRIHK	40.8	76	44	1	2	229	154	228	5.00E-08	58.2	CAH2_TRIHK	reviewed	Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)	ca2	Tribolodon hakonensis (Big-scaled redfin) (Leuciscus hakonensis)	260	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005737; GO:0005886; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN5594_c0_g1_i2	P00919	CAH2_RABIT	53.8	80	36	1	241	2	86	164	1.00E-18	94	CAH2_RABIT	reviewed	Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)	CA2	Oryctolagus cuniculus (Rabbit)	260	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; positive regulation of dipeptide transmembrane transport [GO:2001150]; regulation of anion transport [GO:0044070]; regulation of intracellular pH [GO:0051453]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005737; GO:0005886; GO:0008270; GO:0038166; GO:0044070; GO:0051453; GO:2001150	angiotensin-activated signaling pathway [GO:0038166]; positive regulation of dipeptide transmembrane transport [GO:2001150]; regulation of anion transport [GO:0044070]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN31515_c0_g1_i1	P16152	CBR1_HUMAN	100	96	0	0	9	296	1	96	3.10E-47	188.7	CBR1_HUMAN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)	CBR1 CBR CRN SDR21C1	Homo sapiens (Human)	277	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"	GO:0004090; GO:0005829; GO:0016655; GO:0017144; GO:0019371; GO:0030855; GO:0042373; GO:0047020; GO:0047021; GO:0050221; GO:0055114; GO:0070062; GO:1903561	cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN27149_c0_g1_i1	P16152	CBR1_HUMAN	100	80	0	0	2	241	127	206	1.20E-38	159.8	CBR1_HUMAN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)	CBR1 CBR CRN SDR21C1	Homo sapiens (Human)	277	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"	GO:0004090; GO:0005829; GO:0016655; GO:0017144; GO:0019371; GO:0030855; GO:0042373; GO:0047020; GO:0047021; GO:0050221; GO:0055114; GO:0070062; GO:1903561	cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN18106_c0_g1_i2	P47727	CBR1_RAT	42.6	61	35	0	64	246	153	213	1.00E-08	60.5	CBR1_RAT	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	Cbr1 Cbr	Rattus norvegicus (Rat)	277	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"	GO:0001542; GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0016655; GO:0017144; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0043231; GO:0047020; GO:0047021; GO:0050221; GO:0055114; GO:1905344	drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i1	Q3SZD7	CBR1_BOVIN	48.2	276	137	3	33	857	7	277	2.70E-65	250.4	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		brown	brown	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i2	Q3SZD7	CBR1_BOVIN	48.6	276	136	3	82	906	7	277	7.60E-66	252.3	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i3	Q3SZD7	CBR1_BOVIN	58.3	72	30	0	52	267	51	122	1.10E-14	80.5	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i4	Q3SZD7	CBR1_BOVIN	57.6	85	36	0	52	306	51	135	1.30E-19	97.1	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i6	Q3SZD7	CBR1_BOVIN	59.4	69	28	0	81	287	54	122	1.50E-14	80.1	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i7	Q3SZD7	CBR1_BOVIN	57.4	129	55	0	33	419	7	135	8.50E-35	147.9	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN14838_c0_g1_i8	Q3SZD7	CBR1_BOVIN	57.8	116	49	0	33	380	7	122	9.80E-30	131	CBR1_BOVIN	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1	Bos taurus (Bovine)	277	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i14	P47727	CBR1_RAT	37.2	180	103	4	635	1159	65	239	2.00E-23	111.7	CBR1_RAT	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	Cbr1 Cbr	Rattus norvegicus (Rat)	277	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"	GO:0001542; GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0016655; GO:0017144; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0043231; GO:0047020; GO:0047021; GO:0050221; GO:0055114; GO:1905344	drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i23	P47727	CBR1_RAT	37.2	180	103	4	647	1171	65	239	3.50E-23	110.9	CBR1_RAT	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	Cbr1 Cbr	Rattus norvegicus (Rat)	277	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"	GO:0001542; GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0016655; GO:0017144; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0043231; GO:0047020; GO:0047021; GO:0050221; GO:0055114; GO:1905344	drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i25	Q28960	CBR1_PIG	39.4	142	81	2	737	1159	102	239	2.70E-20	101.3	CBR1_PIG	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1 CBR CRN	Sus scrofa (Pig)	289	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i26	Q28960	CBR1_PIG	39.4	142	81	2	728	1150	102	239	2.70E-20	101.3	CBR1_PIG	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1 CBR CRN	Sus scrofa (Pig)	289	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i32	Q28960	CBR1_PIG	39.4	142	81	2	749	1171	102	239	2.70E-20	101.3	CBR1_PIG	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1 CBR CRN	Sus scrofa (Pig)	289	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i40	P47727	CBR1_RAT	37.2	180	103	4	626	1150	65	239	2.00E-23	111.7	CBR1_RAT	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	Cbr1 Cbr	Rattus norvegicus (Rat)	277	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]"	GO:0001542; GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0016655; GO:0017144; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0043231; GO:0047020; GO:0047021; GO:0050221; GO:0055114; GO:1905344	drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN309_c0_g1_i9	Q28960	CBR1_PIG	39.4	142	81	2	740	1162	102	239	2.70E-20	101.3	CBR1_PIG	reviewed	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	CBR1 CBR CRN	Sus scrofa (Pig)	289	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]	cytoplasm [GO:0005737]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047020; GO:0047021; GO:0050221	drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN26443_c0_g1_i1	P86325	EST1_THEFU	61.9	63	24	0	53	241	152	214	9.70E-15	80.5	EST1_THEFU	reviewed	Carboxylesterase (EC 3.1.1.1)		Thermobifida fusca (Thermomonospora fusca)	497	extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0052689; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN34988_c0_g1_i1	P86325	EST1_THEFU	69	58	18	0	4	177	156	213	9.70E-16	83.6	EST1_THEFU	reviewed	Carboxylesterase (EC 3.1.1.1)		Thermobifida fusca (Thermomonospora fusca)	497	extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0052689; GO:0080030			NA	NA	NA	NA	NA	1
TRINITY_DN25841_c0_g1_i1	P86325	EST1_THEFU	68.7	67	21	0	13	213	148	214	1.00E-18	93.6	EST1_THEFU	reviewed	Carboxylesterase (EC 3.1.1.1)		Thermobifida fusca (Thermomonospora fusca)	497	extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0052689; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN28992_c0_g1_i1	P23953	EST1C_MOUSE	54.5	44	20	0	81	212	133	176	7.80E-06	50.8	EST1C_MOUSE	reviewed	Carboxylesterase 1C (EC 3.1.1.1) (Liver carboxylesterase N) (Lung surfactant convertase) (PES-N)	Ces1c Es1	Mus musculus (Mouse)	554	"endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617]"	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]	"carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]"	GO:0004771; GO:0004806; GO:0005615; GO:0005788; GO:0009617; GO:0016042; GO:0016788; GO:0052689; GO:0080030	lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN10613_c0_g1_i3	Q8R0W5	EST4A_MOUSE	31.8	544	306	18	370	1941	50	548	3.00E-59	231.5	EST4A_MOUSE	reviewed	Carboxylesterase 4A (EC 3.1.1.-)	Ces4a Ces8	Mus musculus (Mouse)	563	extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005615; GO:0016042; GO:0052689	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN10613_c0_g1_i4	Q8R0W5	EST4A_MOUSE	38.1	331	177	7	370	1314	50	368	4.50E-50	200.7	EST4A_MOUSE	reviewed	Carboxylesterase 4A (EC 3.1.1.-)	Ces4a Ces8	Mus musculus (Mouse)	563	extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005615; GO:0016042; GO:0052689	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN39662_c0_g1_i1	Q5XG92	EST4A_HUMAN	100	72	0	0	218	3	188	259	3.70E-34	144.8	EST4A_HUMAN	reviewed	Carboxylesterase 4A (EC 3.1.1.-)	CES4A CES8 UNQ440/PRO873	Homo sapiens (Human)	561	extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005615; GO:0016042; GO:0052689	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN40125_c0_g1_i1	Q8R0W5	EST4A_MOUSE	39.5	124	66	1	20	391	179	293	4.00E-18	92.4	EST4A_MOUSE	reviewed	Carboxylesterase 4A (EC 3.1.1.-)	Ces4a Ces8	Mus musculus (Mouse)	563	extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005615; GO:0016042; GO:0052689	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN13698_c0_g1_i1	O75052	CAPON_HUMAN	44.4	252	120	3	2	712	123	369	8.00E-40	165.6	CAPON_HUMAN	reviewed	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein)	NOS1AP CAPON KIAA0464	Homo sapiens (Human)	506	caveola [GO:0005901]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]; nitric-oxide synthase binding [GO:0050998]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]	caveola [GO:0005901]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]	nitric-oxide synthase binding [GO:0050998]	GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0005901; GO:0010628; GO:0010750; GO:0030018; GO:0030315; GO:0033017; GO:0042383; GO:0045428; GO:0045429; GO:0048471; GO:0050998; GO:0050999; GO:0051000; GO:0060307; GO:0098901; GO:1901381; GO:1901841; GO:1902261; GO:1902514; GO:1903762; GO:2000170	positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]		NA	NA	NA	NA	NA	NA
TRINITY_DN5980_c0_g1_i1	P04069	CBPB_ASTAS	50.4	256	119	4	824	81	36	291	2.70E-69	263.5	CBPB_ASTAS	reviewed	Carboxypeptidase B (EC 3.4.17.2)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	303	extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN1284_c0_g1_i1	P04069	CBPB_ASTAS	38.8	309	177	7	1119	205	1	301	6.20E-56	219.9	CBPB_ASTAS	reviewed	Carboxypeptidase B (EC 3.4.17.2)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	303	extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN53_c0_g1_i1	P04069	CBPB_ASTAS	73.2	302	78	2	990	94	1	302	1.80E-134	480.7	CBPB_ASTAS	reviewed	Carboxypeptidase B (EC 3.4.17.2)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	303	extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005576; GO:0008270			black	black	1	NA	1	1
TRINITY_DN14272_c0_g1_i3	O89001	CBPD_MOUSE	58.8	279	110	3	218	1048	502	777	1.40E-99	364.4	CBPD_MOUSE	reviewed	Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)	Cpd	Mus musculus (Mouse)	1377	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	metallocarboxypeptidase activity [GO:0004181]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006518; GO:0008270; GO:0016021; GO:0016485; GO:0043231; GO:0044877; GO:0048471; GO:0051721	peptide metabolic process [GO:0006518]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN33785_c0_g1_i1	O75976	CBPD_HUMAN	100	80	0	0	2	241	560	639	1.20E-41	169.9	CBPD_HUMAN	reviewed	Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)	CPD	Homo sapiens (Human)	1380	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]	GO:0004181; GO:0004185; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016020; GO:0016021; GO:0016485; GO:0070062	peptide metabolic process [GO:0006518]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN15979_c0_g1_i1	P42787	CBPD_DROME	49.6	242	118	4	721	2	66	305	1.20E-65	251.1	CBPD_DROME	reviewed	Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (Protein silver)	svr CPD CpepE CG4122	Drosophila melanogaster (Fruit fly)	1406	endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]	endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; structural constituent of cuticle [GO:0042302]; zinc ion binding [GO:0008270]	GO:0001933; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0006518; GO:0007476; GO:0007616; GO:0008270; GO:0012505; GO:0016021; GO:0016485; GO:0030838; GO:0042302; GO:0048471; GO:0061837	imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; negative regulation of protein phosphorylation [GO:0001933]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of actin filament polymerization [GO:0030838]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN4677_c0_g2_i1	P37892	CBPE_LOPAM	54.3	116	52	1	403	56	36	150	1.00E-29	131	CBPE_LOPAM	reviewed	Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)	cpe	Lophius americanus (American angler) (Anglerfish)	454	extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005576; GO:0008270; GO:0030658			NA	NA	NA	NA	NA	NA
TRINITY_DN4677_c0_g1_i1	Q4R4M3	CBPE_MACFA	49.5	295	128	5	44	919	173	449	3.20E-79	297	CBPE_MACFA	reviewed	Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)	CPE QflA-11442	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	476	extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005576; GO:0008270; GO:0030658			NA	NA	NA	NA	NA	NA
TRINITY_DN35653_c0_g1_i1	Q00493	CBPE_MOUSE	100	265	0	0	3	797	66	330	2.30E-158	559.3	CBPE_MOUSE	reviewed	Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)	Cpe	Mus musculus (Mouse)	476	dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]; carboxypeptidase activity [GO:0004180]; cell adhesion molecule binding [GO:0050839]; cobalt ion binding [GO:0050897]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; peptidase activity [GO:0008233]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270]; cardiac left ventricle morphogenesis [GO:0003214]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; peptide catabolic process [GO:0043171]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]	dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]	carboxypeptidase activity [GO:0004180]; cell adhesion molecule binding [GO:0050839]; cobalt ion binding [GO:0050897]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; peptidase activity [GO:0008233]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270]	GO:0003214; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005794; GO:0006518; GO:0008233; GO:0008270; GO:0016055; GO:0016485; GO:0019904; GO:0030070; GO:0030072; GO:0030141; GO:0030425; GO:0030658; GO:0030667; GO:0031045; GO:0033366; GO:0034230; GO:0042043; GO:0043025; GO:0043171; GO:0043204; GO:0045121; GO:0050839; GO:0050897; GO:0072657; GO:0097060; GO:2000173	cardiac left ventricle morphogenesis [GO:0003214]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; peptide catabolic process [GO:0043171]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7216_c1_g1_i2	Q80V42	CBPM_MOUSE	53.9	128	59	0	174	557	11	138	7.80E-36	151.8	CBPM_MOUSE	reviewed	Carboxypeptidase M (CPM) (EC 3.4.17.12)	Cpm	Mus musculus (Mouse)	443	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016485; GO:0031225	peptide metabolic process [GO:0006518]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN16473_c0_g1_i1	P14384	CBPM_HUMAN	61.1	54	21	0	29	190	248	301	8.60E-18	90.5	CBPM_HUMAN	reviewed	Carboxypeptidase M (CPM) (EC 3.4.17.12)	CPM	Homo sapiens (Human)	443	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0009653; GO:0009986; GO:0016485; GO:0031225; GO:0070062	anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN16473_c0_g1_i2	P14384	CBPM_HUMAN	48.7	117	58	1	29	373	248	364	6.20E-32	138.3	CBPM_HUMAN	reviewed	Carboxypeptidase M (CPM) (EC 3.4.17.12)	CPM	Homo sapiens (Human)	443	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0009653; GO:0009986; GO:0016485; GO:0031225; GO:0070062	anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN24884_c0_g2_i4	Q9DBB9	CPN2_MOUSE	38	137	82	2	490	80	147	280	1.30E-10	67.8	CPN2_MOUSE	reviewed	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	Cpn2	Mus musculus (Mouse)	547	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0005615; GO:0031012; GO:0062023			NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i1	P22792	CPN2_HUMAN	37.8	135	84	0	35	439	126	260	3.00E-15	83.2	CPN2_HUMAN	reviewed	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	CPN2 ACBP	Homo sapiens (Human)	545	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme regulator activity [GO:0030234]; protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	enzyme regulator activity [GO:0030234]	GO:0005576; GO:0005615; GO:0030234; GO:0030449; GO:0031012; GO:0050821; GO:0070062; GO:0072562	protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i10	P22792	CPN2_HUMAN	34.9	295	178	7	784	1662	126	408	7.70E-29	130.2	CPN2_HUMAN	reviewed	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	CPN2 ACBP	Homo sapiens (Human)	545	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme regulator activity [GO:0030234]; protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	enzyme regulator activity [GO:0030234]	GO:0005576; GO:0005615; GO:0030234; GO:0030449; GO:0031012; GO:0050821; GO:0070062; GO:0072562	protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i2	P22792	CPN2_HUMAN	34.1	314	193	7	8	943	107	408	5.90E-29	129.8	CPN2_HUMAN	reviewed	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	CPN2 ACBP	Homo sapiens (Human)	545	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme regulator activity [GO:0030234]; protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	enzyme regulator activity [GO:0030234]	GO:0005576; GO:0005615; GO:0030234; GO:0030449; GO:0031012; GO:0050821; GO:0070062; GO:0072562	protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i6	P22792	CPN2_HUMAN	33.2	340	207	9	8	1009	107	432	5.20E-30	133.3	CPN2_HUMAN	reviewed	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	CPN2 ACBP	Homo sapiens (Human)	545	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme regulator activity [GO:0030234]; protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	enzyme regulator activity [GO:0030234]	GO:0005576; GO:0005615; GO:0030234; GO:0030449; GO:0031012; GO:0050821; GO:0070062; GO:0072562	protein stabilization [GO:0050821]; regulation of complement activation [GO:0030449]		NA	NA	NA	NA	NA	NA
TRINITY_DN8456_c0_g1_i6	Q6IRK9	CBPQ_RAT	55.3	188	81	2	4	564	64	249	4.80E-52	205.7	CBPQ_RAT	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Hematopoietic lineage switch 2 related protein) (Hls2-rp) (Liver annexin-like protein 1) (LAL-1) (Plasma glutamate carboxypeptidase)	Cpq Pgcp	Rattus norvegicus (Rat)	472	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0046872; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN34213_c0_g1_i1	Q9WVJ3	CBPQ_MOUSE	100	89	0	0	1	267	97	185	4.40E-45	181.4	CBPQ_MOUSE	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Hematopoietic lineage switch 2) (Plasma glutamate carboxypeptidase)	Cpq Hls2 Pgcp	Mus musculus (Mouse)	470	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0043231; GO:0046872; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN8456_c0_g1_i1	Q9Y646	CBPQ_HUMAN	56.4	55	24	0	70	234	115	169	7.20E-11	67.8	CBPQ_HUMAN	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase)	CPQ LCH1 PGCP	Homo sapiens (Human)	472	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0043231; GO:0046872; GO:0070062; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]		brown	brown	NA	NA	NA	NA
TRINITY_DN8456_c0_g1_i2	Q6GQ29	CBPQ_XENLA	59.4	64	26	0	107	298	406	469	9.70E-17	87.8	CBPQ_XENLA	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase)	cpq pgcp	Xenopus laevis (African clawed frog)	469	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8456_c0_g1_i3	Q6GQ29	CBPQ_XENLA	56.9	195	79	2	77	661	163	352	1.10E-55	218.8	CBPQ_XENLA	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase)	cpq pgcp	Xenopus laevis (African clawed frog)	469	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8456_c0_g1_i3	Q6GQ29	CBPQ_XENLA	53.9	128	58	1	657	1040	343	469	2.50E-33	144.4	CBPQ_XENLA	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase)	cpq pgcp	Xenopus laevis (African clawed frog)	469	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8456_c0_g1_i5	Q6GQ29	CBPQ_XENLA	57.3	309	130	2	77	1003	163	469	3.10E-97	356.7	CBPQ_XENLA	reviewed	Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase)	cpq pgcp	Xenopus laevis (African clawed frog)	469	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN19198_c0_g2_i1	E5A7I6	CBPYA_LEPMJ	55.4	65	29	0	29	223	153	217	3.80E-18	91.7	CBPYA_LEPMJ	reviewed	Carboxypeptidase Y homolog A (EC 3.4.16.5)	CPYA Lema_P088200	Leptosphaeria maculans (strain JN3 / isolate v23.1.3 / race Av1-4-5-6-7-8) (Blackleg fungus) (Phoma lingam)	543	vacuole [GO:0005773]; serine-type carboxypeptidase activity [GO:0004185]	vacuole [GO:0005773]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005773			NA	NA	NA	NA	NA	NA
TRINITY_DN2792_c0_g1_i1	P79955	CTK2_XENLA	70.1	67	18	1	54	254	574	638	8.20E-20	97.4	CTK2_XENLA	reviewed	Carboxy-terminal kinesin 2 (XCTK2)		Xenopus laevis (African clawed frog)	643	cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017	microtubule-based movement [GO:0007018]		blue	blue	NA	NA	NA	NA
TRINITY_DN1932_c0_g1_i1	Q9VIK2	CART_DROME	34.1	549	339	13	1895	291	35	574	2.50E-68	261.5	CART_DROME	reviewed	Carcinine transporter	CarT CG9317	Drosophila melanogaster (Fruit fly)	674	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]; carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]	GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0016021; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131	carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN17228_c0_g2_i2	Q9VIK2	CART_DROME	57.6	33	14	0	90	188	312	344	1.20E-05	50.4	CART_DROME	reviewed	Carcinine transporter	CarT CG9317	Drosophila melanogaster (Fruit fly)	674	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]; carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]	GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0016021; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131	carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN17228_c0_g2_i3	Q9VIK2	CART_DROME	57.6	33	14	0	106	204	312	344	1.60E-05	50.1	CART_DROME	reviewed	Carcinine transporter	CarT CG9317	Drosophila melanogaster (Fruit fly)	674	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]; carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]	GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0016021; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131	carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN4529_c0_g1_i6	Q5TYM7	CAIAP_DANRE	33.3	126	76	2	54	431	418	535	5.30E-08	58.9	CAIAP_DANRE	reviewed	CARD- and ANK-domain containing inflammasome adapter protein	caiap si:dkey-86e18.2	Danio rerio (Zebrafish) (Brachydanio rerio)	744	cytoplasm [GO:0005737]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]	cytoplasm [GO:0005737]		GO:0005737; GO:0006954; GO:0042981; GO:0045087	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN24545_c0_g1_i1	P43155	CACP_HUMAN	30.5	128	83	3	378	1	63	186	9.40E-09	61.2	CACP_HUMAN	reviewed	Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)	CRAT CAT1	Homo sapiens (Human)	626	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625]; short-chain fatty acid metabolic process [GO:0046459]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]	GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006625; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625]; short-chain fatty acid metabolic process [GO:0046459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2143_c0_g1_i13	P52826	CACP_COLLI	47.4	570	286	4	193	1896	31	588	9.40E-150	531.9	CACP_COLLI	reviewed	Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)	CRAT	Columba livia (Rock dove)	627	"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]	GO:0003997; GO:0004092; GO:0005743; GO:0005777; GO:0005783; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2143_c0_g1_i7	P52826	CACP_COLLI	47.4	563	285	3	199	1881	35	588	1.60E-149	531.2	CACP_COLLI	reviewed	Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)	CRAT	Columba livia (Rock dove)	627	"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]	GO:0003997; GO:0004092; GO:0005743; GO:0005777; GO:0005783; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2143_c0_g1_i9	P52826	CACP_COLLI	47.4	563	285	3	161	1843	35	588	1.60E-149	531.2	CACP_COLLI	reviewed	Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)	CRAT	Columba livia (Rock dove)	627	"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]	GO:0003997; GO:0004092; GO:0005743; GO:0005777; GO:0005783; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34015_c0_g1_i1	P43155	CACP_HUMAN	100	88	0	0	266	3	93	180	3.60E-47	188.3	CACP_HUMAN	reviewed	Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)	CRAT CAT1	Homo sapiens (Human)	626	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625]; short-chain fatty acid metabolic process [GO:0046459]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]	GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006625; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625]; short-chain fatty acid metabolic process [GO:0046459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11003_c0_g1_i2	P32198	CPT1A_RAT	43	744	395	9	2289	88	41	765	2.30E-164	580.9	CPT1A_RAT	reviewed	"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)"	Cpt1a Cpt-1 Cpt1	Rattus norvegicus (Rat)	773	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; lipid localization [GO:0010876]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; triglyceride metabolic process [GO:0006641]	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0009437; GO:0010876; GO:0010883; GO:0014070; GO:0016021; GO:0030855; GO:0031307; GO:0031667; GO:0031998; GO:0032000; GO:0042493; GO:0042755; GO:0042802; GO:0043231; GO:0043279; GO:0045471; GO:0046320; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698	carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; lipid localization [GO:0010876]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN11003_c0_g1_i3	P32198	CPT1A_RAT	45.5	244	125	4	819	91	183	419	6.60E-58	225.7	CPT1A_RAT	reviewed	"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)"	Cpt1a Cpt-1 Cpt1	Rattus norvegicus (Rat)	773	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; lipid localization [GO:0010876]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; triglyceride metabolic process [GO:0006641]	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0009437; GO:0010876; GO:0010883; GO:0014070; GO:0016021; GO:0030855; GO:0031307; GO:0031667; GO:0031998; GO:0032000; GO:0042493; GO:0042755; GO:0042802; GO:0043231; GO:0043279; GO:0045471; GO:0046320; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698	carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; lipid localization [GO:0010876]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN11003_c0_g1_i4	P50416	CPT1A_HUMAN	58.7	63	26	0	264	76	707	769	3.20E-12	72.4	CPT1A_HUMAN	reviewed	"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)"	CPT1A CPT1	Homo sapiens (Human)	773	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid storage [GO:0010883]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007623; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0019216; GO:0030855; GO:0031307; GO:0032000; GO:0042493; GO:0042755; GO:0042802; GO:0045471; GO:0050796; GO:0071398; GO:1990698	carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid storage [GO:0010883]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN37476_c0_g1_i1	Q8HY46	CPT1B_PIG	72.7	66	18	0	201	4	554	619	1.20E-21	103.2	CPT1B_PIG	reviewed	"Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1-M) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, muscle isoform) (CPT I) (CPTI-M) (Carnitine palmitoyltransferase 1B)"	CPT1B	Sus scrofa (Pig)	772	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005741; GO:0006631; GO:0006635; GO:0009437; GO:0015909; GO:0016021	carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]		NA	NA	NA	NA	NA	NA
TRINITY_DN11003_c0_g1_i1	Q63704	CPT1B_RAT	46.8	346	176	2	1104	67	435	772	6.30E-83	309.3	CPT1B_RAT	reviewed	"Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1-M) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, muscle isoform) (CPT I) (CPTI-M) (Carnitine palmitoyltransferase 1B) (Carnitine palmitoyltransferase I-like protein)"	Cpt1b	Rattus norvegicus (Rat)	772	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; response to blue light [GO:0009637]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005741; GO:0006631; GO:0006635; GO:0009437; GO:0009637; GO:0015909; GO:0016021; GO:0043231	carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; response to blue light [GO:0009637]		NA	NA	NA	NA	NA	NA
TRINITY_DN26270_c0_g1_i1	Q63704	CPT1B_RAT	65.8	76	26	0	230	3	195	270	1.20E-25	116.7	CPT1B_RAT	reviewed	"Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1-M) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, muscle isoform) (CPT I) (CPTI-M) (Carnitine palmitoyltransferase 1B) (Carnitine palmitoyltransferase I-like protein)"	Cpt1b	Rattus norvegicus (Rat)	772	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; response to blue light [GO:0009637]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005741; GO:0006631; GO:0006635; GO:0009437; GO:0009637; GO:0015909; GO:0016021; GO:0043231	carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; response to blue light [GO:0009637]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i10	Q5U3U3	CPT2_DANRE	51.1	442	215	1	1437	112	45	485	1.10E-135	485	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i3	Q5U3U3	CPT2_DANRE	53.2	622	286	4	1959	100	45	663	2.40E-194	680.2	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i4	Q5U3U3	CPT2_DANRE	52.8	595	276	4	1878	100	72	663	5.00E-184	646	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i5	Q5U3U3	CPT2_DANRE	51.8	521	247	3	1621	65	45	563	8.00E-159	562	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i6	Q5U3U3	CPT2_DANRE	53.2	622	286	4	1959	100	45	663	2.50E-194	680.2	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i7	Q6P4X5	CPT2_XENTR	50.7	136	64	2	466	65	418	552	1.60E-30	134	CPT2_XENTR	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	658	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i8	Q5U3U3	CPT2_DANRE	55	238	103	3	807	100	428	663	5.60E-65	249.2	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN164_c0_g1_i9	Q5U3U3	CPT2_DANRE	55	229	103	0	765	79	45	273	4.80E-75	282.7	CPT2_DANRE	reviewed	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	cpt2 si:ch211-216k22.1 zgc:101627	Danio rerio (Zebrafish) (Brachydanio rerio)	669	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	carnitine O-palmitoyltransferase activity [GO:0004095]	GO:0004095; GO:0005739; GO:0005743; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN4714_c0_g1_i1	Q80UY1	CARME_MOUSE	48.5	367	183	2	66	1160	37	399	7.90E-98	359	CARME_MOUSE	reviewed	Carnosine N-methyltransferase (EC 2.1.1.22)	Carnmt1	Mus musculus (Mouse)	400	cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498]; methylation [GO:0032259]	cytosol [GO:0005829]; nucleus [GO:0005634]	carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005634; GO:0005829; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803	carnosine metabolic process [GO:0035498]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4714_c0_g1_i9	Q80UY1	CARME_MOUSE	48.5	367	183	2	66	1160	37	399	7.90E-98	359	CARME_MOUSE	reviewed	Carnosine N-methyltransferase (EC 2.1.1.22)	Carnmt1	Mus musculus (Mouse)	400	cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498]; methylation [GO:0032259]	cytosol [GO:0005829]; nucleus [GO:0005634]	carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005634; GO:0005829; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803	carnosine metabolic process [GO:0035498]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN39925_c0_g1_i1	Q8N4J0	CARME_HUMAN	100	78	0	0	3	236	180	257	6.20E-43	174.1	CARME_HUMAN	reviewed	Carnosine N-methyltransferase (EC 2.1.1.22)	CARNMT1 C9orf41	Homo sapiens (Human)	409	cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498]; histidine catabolic process [GO:0006548]; methylation [GO:0032259]	cytosol [GO:0005829]; nucleus [GO:0005634]	carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005634; GO:0005829; GO:0006548; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803	carnosine metabolic process [GO:0035498]; histidine catabolic process [GO:0006548]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN35199_c0_g1_i1	Q9VFS2	NINAB_DROME	43.6	39	22	0	219	103	331	369	1.70E-05	49.7	NINAB_DROME	reviewed	"Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B)"	ninaB beta-diox CG9347	Drosophila melanogaster (Fruit fly)	620	"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; retinal isomerase activity [GO:0004744]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; oxidation-reduction process [GO:0055114]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; rhodopsin biosynthetic process [GO:0016063]; vitamin A biosynthetic process [GO:0035238]; vitamin biosynthetic process [GO:0009110]"		"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; retinal isomerase activity [GO:0004744]"	GO:0003834; GO:0004497; GO:0004744; GO:0007602; GO:0007603; GO:0007604; GO:0009110; GO:0010436; GO:0016063; GO:0016119; GO:0016121; GO:0035238; GO:0042572; GO:0042574; GO:0046872; GO:0055114	"carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; oxidation-reduction process [GO:0055114]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; rhodopsin biosynthetic process [GO:0016063]; vitamin A biosynthetic process [GO:0035238]; vitamin biosynthetic process [GO:0009110]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5279_c0_g1_i1	A8Y9I2	NINAB_GALME	36.2	520	296	13	128	1651	13	508	1.90E-86	321.6	NINAB_GALME	reviewed	"Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B)"	ninaB	Galleria mellonella (Greater wax moth)	513	"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinol metabolic process [GO:0042572]"		"metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"	GO:0004497; GO:0016702; GO:0042572; GO:0046872	retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN7659_c0_g2_i1	Q5XF24	CKL13_ARATH	37.9	58	36	0	10	183	101	158	4.60E-05	48.1	CKL13_ARATH	reviewed	Casein kinase 1-like protein 13 (EC 2.7.11.1) (Protein CASEIN KINASE I-LIKE 13)	CKL13 At1g04440 F19P19.10	Arabidopsis thaliana (Mouse-ear cress)	468	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006897; GO:0009506; GO:0018105	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN7659_c0_g1_i5	Q5XF24	CKL13_ARATH	29	100	67	2	91	378	51	150	1.10E-06	54.3	CKL13_ARATH	reviewed	Casein kinase 1-like protein 13 (EC 2.7.11.1) (Protein CASEIN KINASE I-LIKE 13)	CKL13 At1g04440 F19P19.10	Arabidopsis thaliana (Mouse-ear cress)	468	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006897; GO:0009506; GO:0018105	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN40739_c0_g1_i1	Q9ZUP4	CKL5_ARATH	51.6	64	31	0	5	196	154	217	3.30E-11	68.6	CKL5_ARATH	reviewed	Casein kinase 1-like protein 5 (EC 2.7.11.1) (Protein CASEIN KINASE I-LIKE 5)	CKL5 At2g19470	Arabidopsis thaliana (Mouse-ear cress)	433	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006897; GO:0018105	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN5562_c0_g1_i2	Q9LSX4	CKL8_ARATH	35.8	67	43	0	244	44	92	158	7.70E-07	54.3	CKL8_ARATH	reviewed	Casein kinase 1-like protein 8 (EC 2.7.11.1) (Protein CASEIN KINASE I-LIKE 8)	CKL8 CKI3 At5g43320 MWF20.1	Arabidopsis thaliana (Mouse-ear cress)	480	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006897; GO:0009506; GO:0018105	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN33254_c0_g1_i1	Q6QNM1	KC1_TOXGO	62.2	230	83	1	1	690	54	279	2.40E-79	296.6	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN285_c0_g1_i3	Q6QNM1	KC1_TOXGO	84.9	312	46	1	938	3	1	311	2.00E-156	553.1	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN285_c0_g1_i4	Q6QNM1	KC1_TOXGO	87.8	222	27	0	669	4	1	222	1.40E-114	413.7	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN285_c0_g1_i5	Q6QNM1	KC1_TOXGO	83.4	314	52	0	946	5	1	314	6.90E-157	554.7	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN11530_c0_g1_i1	Q6QNM1	KC1_TOXGO	62.7	75	28	0	2	226	19	93	4.80E-22	104.8	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN32306_c0_g1_i1	O15726	KC1_PLAF4	55.1	78	31	2	1	234	65	138	1.80E-17	89.7	KC1_PLAF4	reviewed	Casein kinase I (EC 2.7.11.1)	CK1	Plasmodium falciparum (isolate Dd2)	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN39964_c0_g1_i1	Q6QNM1	KC1_TOXGO	59.6	230	92	1	727	38	56	284	6.70E-80	298.5	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN8436_c0_g1_i1	Q6QNM1	KC1_TOXGO	64.3	258	92	0	776	3	9	266	9.80E-99	361.3	KC1_TOXGO	reviewed	Casein kinase I (EC 2.7.11.1)		Toxoplasma gondii	324	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN7659_c0_g1_i1	P54367	KC1A_DROME	32.1	109	70	2	88	402	61	169	1.30E-08	61.2	KC1A_DROME	reviewed	Casein kinase I isoform alpha (CKI-alpha) (DmCK1) (EC 2.7.11.1)	CkIalpha CKI CG2028	Drosophila melanogaster (Fruit fly)	337	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell morphogenesis [GO:0000902]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; glucose homeostasis [GO:0042593]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000902; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0007623; GO:0016055; GO:0018105; GO:0030877; GO:0032436; GO:0035331; GO:0042593; GO:0045879; GO:0045880; GO:0090090; GO:1901800	cell morphogenesis [GO:0000902]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; glucose homeostasis [GO:0042593]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7659_c0_g1_i3	P54367	KC1A_DROME	28.5	144	99	2	88	507	61	204	1.80E-08	60.8	KC1A_DROME	reviewed	Casein kinase I isoform alpha (CKI-alpha) (DmCK1) (EC 2.7.11.1)	CkIalpha CKI CG2028	Drosophila melanogaster (Fruit fly)	337	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell morphogenesis [GO:0000902]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; glucose homeostasis [GO:0042593]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000902; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0007623; GO:0016055; GO:0018105; GO:0030877; GO:0032436; GO:0035331; GO:0042593; GO:0045879; GO:0045880; GO:0090090; GO:1901800	cell morphogenesis [GO:0000902]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; glucose homeostasis [GO:0042593]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN12318_c0_g1_i2	P54367	KC1A_DROME	85.7	49	7	0	179	33	259	307	1.10E-19	97.1	KC1A_DROME	reviewed	Casein kinase I isoform alpha (CKI-alpha) (DmCK1) (EC 2.7.11.1)	CkIalpha CKI CG2028	Drosophila melanogaster (Fruit fly)	337	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell morphogenesis [GO:0000902]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; glucose homeostasis [GO:0042593]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000902; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0007623; GO:0016055; GO:0018105; GO:0030877; GO:0032436; GO:0035331; GO:0042593; GO:0045879; GO:0045880; GO:0090090; GO:1901800	cell morphogenesis [GO:0000902]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; glucose homeostasis [GO:0042593]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN8000_c0_g1_i1	P67827	KC1A_BOVIN	100	284	0	0	52	903	1	284	1.20E-164	580.5	KC1A_BOVIN	reviewed	Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)	CSNK1A1	Bos taurus (Bovine)	325	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0000777; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007049; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090	cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN12318_c0_g1_i1	P67827	KC1A_BOVIN	92.7	275	20	0	917	93	10	284	7.20E-152	538.1	KC1A_BOVIN	reviewed	Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)	CSNK1A1	Bos taurus (Bovine)	325	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0000777; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007049; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090	cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN11530_c0_g2_i1	P67827	KC1A_BOVIN	62.3	175	66	0	543	19	108	282	5.10E-64	245.4	KC1A_BOVIN	reviewed	Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)	CSNK1A1	Bos taurus (Bovine)	325	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0000777; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007049; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090	cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN33971_c0_g1_i1	P35508	KC1D_BOVIN	100	157	0	0	63	533	1	157	6.40E-88	324.7	KC1D_BOVIN	reviewed	Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)	CSNK1D HCKID	Bos taurus (Bovine)	415	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; circadian regulation of gene expression [GO:0032922]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005876; GO:0005886; GO:0006468; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0042752; GO:0048471; GO:0050321; GO:0051225; GO:0090263; GO:1905515	circadian regulation of gene expression [GO:0032922]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15775_c0_g1_i1	P35508	KC1D_BOVIN	100	300	0	0	901	2	26	325	8.10E-176	617.5	KC1D_BOVIN	reviewed	Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)	CSNK1D HCKID	Bos taurus (Bovine)	415	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; circadian regulation of gene expression [GO:0032922]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005876; GO:0005886; GO:0006468; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0042752; GO:0048471; GO:0050321; GO:0051225; GO:0090263; GO:1905515	circadian regulation of gene expression [GO:0032922]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15775_c0_g2_i1	P35508	KC1D_BOVIN	100	185	0	0	555	1	144	328	6.00E-105	381.3	KC1D_BOVIN	reviewed	Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)	CSNK1D HCKID	Bos taurus (Bovine)	415	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; circadian regulation of gene expression [GO:0032922]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005876; GO:0005886; GO:0006468; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0042752; GO:0048471; GO:0050321; GO:0051225; GO:0090263; GO:1905515	circadian regulation of gene expression [GO:0032922]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24108_c0_g1_i1	Q5RC72	KC1D_PONAB	57.8	64	27	0	21	212	64	127	2.10E-18	92.4	KC1D_PONAB	reviewed	Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)	CSNK1D HCKID	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	415	Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; circadian regulation of gene expression [GO:0032922]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; Wnt signaling pathway [GO:0016055]	Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005794; GO:0005815; GO:0005819; GO:0005886; GO:0006468; GO:0016055; GO:0032436; GO:0032922; GO:0042752; GO:0048471; GO:0050321	circadian regulation of gene expression [GO:0032922]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15775_c0_g3_i1	Q5ZLL1	KC1E_CHICK	94.6	222	12	0	728	63	1	222	2.80E-124	446	KC1E_CHICK	reviewed	Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1)	CSNK1E DBT RCJMB04_5k10	Gallus gallus (Chicken)	416	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular protein localization [GO:0034613]; circadian regulation of gene expression [GO:0032922]; endocytosis [GO:0006897]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of cellular protein localization [GO:1903827]; regulation of circadian rhythm [GO:0042752]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0016055; GO:0018105; GO:0030178; GO:0032436; GO:0032922; GO:0034613; GO:0042752; GO:0090263; GO:1903827; GO:1990904; GO:2000052	cellular protein localization [GO:0034613]; circadian regulation of gene expression [GO:0032922]; endocytosis [GO:0006897]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of cellular protein localization [GO:1903827]; regulation of circadian rhythm [GO:0042752]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15775_c0_g3_i2	Q5ZLL1	KC1E_CHICK	84.3	343	43	3	1106	87	1	335	5.60E-169	595.1	KC1E_CHICK	reviewed	Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1)	CSNK1E DBT RCJMB04_5k10	Gallus gallus (Chicken)	416	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular protein localization [GO:0034613]; circadian regulation of gene expression [GO:0032922]; endocytosis [GO:0006897]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of cellular protein localization [GO:1903827]; regulation of circadian rhythm [GO:0042752]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0016055; GO:0018105; GO:0030178; GO:0032436; GO:0032922; GO:0034613; GO:0042752; GO:0090263; GO:1903827; GO:1990904; GO:2000052	cellular protein localization [GO:0034613]; circadian regulation of gene expression [GO:0032922]; endocytosis [GO:0006897]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of cellular protein localization [GO:1903827]; regulation of circadian rhythm [GO:0042752]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN16724_c0_g1_i1	P49674	KC1E_HUMAN	100	241	0	0	1	723	23	263	1.20E-140	500.4	KC1E_HUMAN	reviewed	Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1)	CSNK1E	Homo sapiens (Human)	416	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; canonical Wnt signaling pathway [GO:0060070]; ciliary basal body-plasma membrane docking [GO:0097711]; circadian regulation of gene expression [GO:0032922]; DNA repair [GO:0006281]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein phosphorylation [GO:0006468]; regulation of cellular protein localization [GO:1903827]; regulation of circadian rhythm [GO:0042752]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000086; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0006897; GO:0007165; GO:0010389; GO:0016055; GO:0018105; GO:0032091; GO:0032436; GO:0032922; GO:0042752; GO:0060070; GO:0090263; GO:0097711; GO:1903827; GO:1905426; GO:2000052	canonical Wnt signaling pathway [GO:0060070]; ciliary basal body-plasma membrane docking [GO:0097711]; circadian regulation of gene expression [GO:0032922]; DNA repair [GO:0006281]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein phosphorylation [GO:0006468]; regulation of cellular protein localization [GO:1903827]; regulation of circadian rhythm [GO:0042752]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN30159_c0_g1_i1	A7E3X2	KC1G1_BOVIN	100	155	0	0	467	3	48	202	2.80E-87	322.4	KC1G1_BOVIN	reviewed	Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1)	CSNK1G1	Bos taurus (Bovine)	457	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006897; GO:0016055; GO:0018105; GO:0090263	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN16081_c0_g1_i1	P78368	KC1G2_HUMAN	100	283	0	0	3	851	57	339	5.90E-168	591.3	KC1G2_HUMAN	reviewed	Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1)	CSNK1G2 CK1G2	Homo sapiens (Human)	415	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006897; GO:0007165; GO:0016020; GO:0016055; GO:0018105; GO:0030148; GO:0046777; GO:0090263	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1187_c0_g1_i1	Q8C4X2	KC1G3_MOUSE	75.7	374	77	4	9	1118	37	400	1.80E-162	573.5	KC1G3_MOUSE	reviewed	Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1)	Csnk1g3	Mus musculus (Mouse)	424	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006897; GO:0016055; GO:0018105; GO:0046777; GO:0090263	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1187_c0_g1_i2	Q62763	KC1G3_RAT	72.8	408	95	7	9	1220	37	432	1.90E-165	583.6	KC1G3_RAT	reviewed	Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1)	Csnk1g3	Rattus norvegicus (Rat)	448	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006897; GO:0016055; GO:0018105; GO:0046777; GO:0090263	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN27658_c0_g1_i1	P68399	CSK21_BOVIN	100	152	0	0	456	1	105	256	5.00E-89	328.2	CSK21_BOVIN	reviewed	Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)	CSNK2A1 CK2A1	Bos taurus (Bovine)	391	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]	ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0006468; GO:0006915; GO:0007049; GO:0008284; GO:0016055; GO:0018105; GO:0018107; GO:0030177; GO:0030307; GO:0043154; GO:0045732; GO:0047485; GO:0048511; GO:0051726; GO:1905818	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN36239_c0_g1_i1	P68399	CSK21_BOVIN	100	91	0	0	3	275	252	342	2.00E-48	192.6	CSK21_BOVIN	reviewed	Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)	CSNK2A1 CK2A1	Bos taurus (Bovine)	391	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]	ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0006468; GO:0006915; GO:0007049; GO:0008284; GO:0016055; GO:0018105; GO:0018107; GO:0030177; GO:0030307; GO:0043154; GO:0045732; GO:0047485; GO:0048511; GO:0051726; GO:1905818	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN31492_c0_g1_i1	P68399	CSK21_BOVIN	100	106	0	0	321	4	1	106	5.20E-55	214.9	CSK21_BOVIN	reviewed	Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)	CSNK2A1 CK2A1	Bos taurus (Bovine)	391	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]	ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0006468; GO:0006915; GO:0007049; GO:0008284; GO:0016055; GO:0018105; GO:0018107; GO:0030177; GO:0030307; GO:0043154; GO:0045732; GO:0047485; GO:0048511; GO:0051726; GO:1905818	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4086_c0_g2_i1	O76484	CSK2A_SPOFR	89	345	38	0	1128	94	3	347	2.60E-185	649.4	CSK2A_SPOFR	reviewed	Casein kinase II subunit alpha (CK II subunit alpha) (EC 2.7.11.1)		Spodoptera frugiperda (Fall armyworm)	353	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016055	Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN4086_c0_g2_i2	O76484	CSK2A_SPOFR	89	345	38	0	1128	94	3	347	3.50E-185	649	CSK2A_SPOFR	reviewed	Casein kinase II subunit alpha (CK II subunit alpha) (EC 2.7.11.1)		Spodoptera frugiperda (Fall armyworm)	353	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016055	Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4086_c0_g1_i1	O76484	CSK2A_SPOFR	89.8	206	21	0	130	747	3	208	3.80E-108	392.5	CSK2A_SPOFR	reviewed	Casein kinase II subunit alpha (CK II subunit alpha) (EC 2.7.11.1)		Spodoptera frugiperda (Fall armyworm)	353	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016055	Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN35650_c0_g1_i1	P28523	CSK2A_MAIZE	75.6	270	66	0	7	816	5	274	3.50E-125	449.1	CSK2A_MAIZE	reviewed	Casein kinase II subunit alpha (EC 2.7.11.1) (CK II) (CK2-alpha)	ACK2	Zea mays (Maize)	332	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of cell cycle [GO:0051726]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0018105; GO:0018107; GO:0051726	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of cell cycle [GO:0051726]		NA	NA	NA	NA	NA	NA
TRINITY_DN7626_c0_g1_i1	Q5E9N5	CLPB_BOVIN	58.2	411	169	2	17	1246	100	508	1.50E-131	471.5	CLPB_BOVIN	reviewed	Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)	CLPB SKD3	Bos taurus (Bovine)	677	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005758; GO:0006986; GO:0016887; GO:0034605; GO:0039529; GO:0140374	antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]		NA	NA	NA	NA	NA	NA
TRINITY_DN7626_c0_g1_i1	Q5E9N5	CLPB_BOVIN	54.5	154	62	3	1284	1727	508	659	2.70E-37	158.3	CLPB_BOVIN	reviewed	Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)	CLPB SKD3	Bos taurus (Bovine)	677	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005758; GO:0006986; GO:0016887; GO:0034605; GO:0039529; GO:0140374	antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]		NA	NA	NA	NA	NA	NA
TRINITY_DN7626_c0_g1_i3	Q5E9N5	CLPB_BOVIN	57.3	564	230	5	17	1687	100	659	2.90E-177	623.2	CLPB_BOVIN	reviewed	Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)	CLPB SKD3	Bos taurus (Bovine)	677	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005758; GO:0006986; GO:0016887; GO:0034605; GO:0039529; GO:0140374	antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]		NA	NA	NA	NA	NA	NA
TRINITY_DN20741_c0_g1_i1	Q9H078	CLPB_HUMAN	100	92	0	0	278	3	418	509	3.40E-48	191.8	CLPB_HUMAN	reviewed	Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)	CLPB HSP78 SKD3	Homo sapiens (Human)	707	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005758; GO:0006986; GO:0016887; GO:0034605; GO:0039529; GO:0140374	antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]		NA	NA	NA	NA	NA	NA
TRINITY_DN20741_c0_g1_i2	Q5E9N5	CLPB_BOVIN	100	67	0	0	203	3	413	479	3.20E-32	138.3	CLPB_BOVIN	reviewed	Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)	CLPB SKD3	Bos taurus (Bovine)	677	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005758; GO:0006986; GO:0016887; GO:0034605; GO:0039529; GO:0140374	antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; response to unfolded protein [GO:0006986]; RIG-I signaling pathway [GO:0039529]		NA	NA	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i16	O01382	DRICE_DROME	38.3	227	127	4	182	862	75	288	3.80E-37	156.8	DRICE_DROME	reviewed	Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]	Drice ICE CG7788	Drosophila melanogaster (Fruit fly)	339	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]	GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0043066; GO:0045476; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]		NA	NA	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i3	O01382	DRICE_DROME	36.6	268	156	5	182	985	75	328	3.70E-42	173.7	DRICE_DROME	reviewed	Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]	Drice ICE CG7788	Drosophila melanogaster (Fruit fly)	339	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]	GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0043066; GO:0045476; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]		NA	NA	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i4	O01382	DRICE_DROME	36.7	267	156	4	182	982	75	328	2.60E-43	177.6	DRICE_DROME	reviewed	Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]	Drice ICE CG7788	Drosophila melanogaster (Fruit fly)	339	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]	GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0043066; GO:0045476; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]		blue	blue	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i5	O01382	DRICE_DROME	37.4	227	129	4	182	862	75	288	3.20E-36	153.7	DRICE_DROME	reviewed	Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]	Drice ICE CG7788	Drosophila melanogaster (Fruit fly)	339	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]	GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0043066; GO:0045476; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]		NA	NA	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i8	O01382	DRICE_DROME	36.7	267	156	4	182	982	75	328	1.50E-43	178.3	DRICE_DROME	reviewed	Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]	Drice ICE CG7788	Drosophila melanogaster (Fruit fly)	339	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]	GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0043066; GO:0045476; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]		NA	NA	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i9	O01382	DRICE_DROME	37.6	271	152	6	98	910	75	328	1.20E-42	175.3	DRICE_DROME	reviewed	Caspase (EC 3.4.22.-) (drICE) [Cleaved into: Caspase subunit p21; Caspase subunit p12]	Drice ICE CG7788	Drosophila melanogaster (Fruit fly)	339	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	BIR domain binding [GO:1990525]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]	GO:0004197; GO:0005634; GO:0005737; GO:0005886; GO:0006508; GO:0006915; GO:0010165; GO:0010623; GO:0012501; GO:0016322; GO:0035070; GO:0035103; GO:0043066; GO:0045476; GO:0046672; GO:0048515; GO:0097153; GO:0097200; GO:1990525; GO:2001269	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; neuron remodeling [GO:0016322]; nurse cell apoptotic process [GO:0045476]; positive regulation of compound eye retinal cell programmed cell death [GO:0046672]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; programmed cell death [GO:0012501]; programmed cell death involved in cell development [GO:0010623]; proteolysis [GO:0006508]; response to X-ray [GO:0010165]; salivary gland histolysis [GO:0035070]; spermatid differentiation [GO:0048515]; sterol regulatory element binding protein cleavage [GO:0035103]		blue	blue	NA	NA	NA	NA
TRINITY_DN1705_c0_g1_i1	P89116	CASP1_SPOFR	41.4	278	154	4	297	1118	24	296	2.60E-54	214.2	CASP1_SPOFR	reviewed	Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]		Spodoptera frugiperda (Fall armyworm)	299	cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]		cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0006915	apoptotic process [GO:0006915]		blue	blue	NA	NA	NA	NA
TRINITY_DN1705_c0_g1_i3	P89116	CASP1_SPOFR	41.4	278	154	4	292	1113	24	296	2.60E-54	214.2	CASP1_SPOFR	reviewed	Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]		Spodoptera frugiperda (Fall armyworm)	299	cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]		cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN1705_c0_g1_i4	P89116	CASP1_SPOFR	41.4	278	154	4	291	1112	24	296	2.60E-54	214.2	CASP1_SPOFR	reviewed	Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]		Spodoptera frugiperda (Fall armyworm)	299	cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]		cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN720_c0_g1_i1	P89116	CASP1_SPOFR	37.9	219	116	5	35	667	13	219	5.10E-34	146	CASP1_SPOFR	reviewed	Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]		Spodoptera frugiperda (Fall armyworm)	299	cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]		cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN36832_c0_g1_i1	Q920D5	CASPC_RAT	27.9	111	70	2	335	24	198	305	9.50E-05	47.8	CASPC_RAT	reviewed	Caspase-12 (CASP-12) (EC 3.4.22.-)	Casp12	Rattus norvegicus (Rat)	420	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; IPAF inflammasome complex [GO:0072557]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; protease binding [GO:0002020]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to manganese ion [GO:0071287]; endoplasmic reticulum unfolded protein response [GO:0030968]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; luteolysis [GO:0001554]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of striated muscle cell apoptotic process [GO:0010663]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727]; response to anoxia [GO:0034059]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to ethanol [GO:0045471]; response to inorganic substance [GO:0010035]; response to iron(III) ion [GO:0010041]; response to nicotine [GO:0035094]; response to organonitrogen compound [GO:0010243]; self proteolysis [GO:0097264]	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; IPAF inflammasome complex [GO:0072557]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; protease binding [GO:0002020]	GO:0001554; GO:0002020; GO:0004175; GO:0004197; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006508; GO:0006915; GO:0007568; GO:0008234; GO:0009409; GO:0010035; GO:0010041; GO:0010243; GO:0010663; GO:0016540; GO:0030968; GO:0034059; GO:0034976; GO:0035094; GO:0042493; GO:0043065; GO:0043231; GO:0043280; GO:0045471; GO:0050727; GO:0070059; GO:0070301; GO:0071287; GO:0072557; GO:0072559; GO:0097169; GO:0097193; GO:0097194; GO:0097199; GO:0097264	aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to manganese ion [GO:0071287]; endoplasmic reticulum unfolded protein response [GO:0030968]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; luteolysis [GO:0001554]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of striated muscle cell apoptotic process [GO:0010663]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727]; response to anoxia [GO:0034059]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to ethanol [GO:0045471]; response to inorganic substance [GO:0010035]; response to iron(III) ion [GO:0010041]; response to nicotine [GO:0035094]; response to organonitrogen compound [GO:0010243]; self proteolysis [GO:0097264]		NA	NA	NA	NA	NA	NA
TRINITY_DN1143_c0_g1_i1	O89094	CASPE_MOUSE	27.6	181	127	4	825	1361	33	211	8.70E-15	84	CASPE_MOUSE	reviewed	"Caspase-14 (CASP-14) (EC 3.4.22.-) (Mini-ICE) (MICE) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]"	Casp14	Mus musculus (Mouse)	257	cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]; cornification [GO:0070268]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]	GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0008233; GO:0045095; GO:0070268; GO:0097200	cornification [GO:0070268]		NA	NA	NA	NA	NA	NA
TRINITY_DN1143_c0_g1_i4	O89094	CASPE_MOUSE	27.6	181	127	4	825	1361	33	211	5.70E-15	84	CASPE_MOUSE	reviewed	"Caspase-14 (CASP-14) (EC 3.4.22.-) (Mini-ICE) (MICE) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]"	Casp14	Mus musculus (Mouse)	257	cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]; cornification [GO:0070268]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]	GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0008233; GO:0045095; GO:0070268; GO:0097200	cornification [GO:0070268]		NA	NA	NA	NA	NA	NA
TRINITY_DN1143_c0_g1_i5	O89094	CASPE_MOUSE	30	110	76	1	27	356	103	211	8.50E-10	66.6	CASPE_MOUSE	reviewed	"Caspase-14 (CASP-14) (EC 3.4.22.-) (Mini-ICE) (MICE) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]"	Casp14	Mus musculus (Mouse)	257	cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]; cornification [GO:0070268]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; peptidase activity [GO:0008233]	GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0008233; GO:0045095; GO:0070268; GO:0097200	cornification [GO:0070268]		NA	NA	NA	NA	NA	NA
TRINITY_DN2436_c0_g1_i2	P70343	CASP4_MOUSE	22.2	230	143	4	849	1451	146	368	2.00E-12	75.5	CASP4_MOUSE	reviewed	Caspase-4 (CASP-4) (EC 3.4.22.64) (Caspase-11) (CASP-11) (Protease ICH-3) [Cleaved into: Caspase-4 subunit p10; Caspase-4 subunit p20]	Casp4 Casp11 Caspl Ich3	Mus musculus (Mouse)	373	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; scaffold protein binding [GO:0097110]; actin filament organization [GO:0007015]; cellular response to amyloid-beta [GO:1904646]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; scaffold protein binding [GO:0097110]	GO:0004197; GO:0005576; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006954; GO:0007015; GO:0032731; GO:0032991; GO:0035234; GO:0042981; GO:0043005; GO:0043025; GO:0045087; GO:0050700; GO:0050727; GO:0070059; GO:0070269; GO:0072557; GO:0072559; GO:0097110; GO:0097169; GO:0097193; GO:0097194; GO:0097199; GO:1903265; GO:1904646	actin filament organization [GO:0007015]; cellular response to amyloid-beta [GO:1904646]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]	x	NA	NA	1	NA	NA	NA
TRINITY_DN2436_c0_g1_i3	P70343	CASP4_MOUSE	22.2	230	143	4	1022	1624	146	368	2.20E-12	75.5	CASP4_MOUSE	reviewed	Caspase-4 (CASP-4) (EC 3.4.22.64) (Caspase-11) (CASP-11) (Protease ICH-3) [Cleaved into: Caspase-4 subunit p10; Caspase-4 subunit p20]	Casp4 Casp11 Caspl Ich3	Mus musculus (Mouse)	373	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; scaffold protein binding [GO:0097110]; actin filament organization [GO:0007015]; cellular response to amyloid-beta [GO:1904646]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; scaffold protein binding [GO:0097110]	GO:0004197; GO:0005576; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006954; GO:0007015; GO:0032731; GO:0032991; GO:0035234; GO:0042981; GO:0043005; GO:0043025; GO:0045087; GO:0050700; GO:0050727; GO:0070059; GO:0070269; GO:0072557; GO:0072559; GO:0097110; GO:0097169; GO:0097193; GO:0097194; GO:0097199; GO:1903265; GO:1904646	actin filament organization [GO:0007015]; cellular response to amyloid-beta [GO:1904646]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]		NA	NA	NA	NA	NA	NA
TRINITY_DN7265_c0_g1_i5	P97864	CASP7_MOUSE	28.4	109	69	2	446	147	153	261	1.20E-08	61.2	CASP7_MOUSE	reviewed	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	Casp7 Lice2 Mch3	Mus musculus (Mouse)	303	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0043231; GO:0051146; GO:0051402; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097200	aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]		NA	NA	NA	NA	NA	NA
TRINITY_DN2506_c0_g1_i1	P55214	CASP7_MESAU	31.8	211	114	7	795	1379	68	264	2.30E-19	98.6	CASP7_MESAU	reviewed	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (ICE-like apoptotic protease 3) (ICE-LAP3) (SREBP cleavage activity 2) (SCA-2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	CASP7 MCH3	Mesocricetus auratus (Golden hamster)	303	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005737; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN37947_c0_g1_i1	Q14790	CASP8_HUMAN	100	77	0	0	3	233	310	386	2.00E-41	169.1	CASP8_HUMAN	reviewed	Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]	CASP8 MCH5	Homo sapiens (Human)	479	CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; toll-like receptor 3 signaling pathway [GO:0034138]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]	CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]	GO:0004197; GO:0005123; GO:0005164; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0006508; GO:0006915; GO:0006919; GO:0007166; GO:0008233; GO:0008234; GO:0008625; GO:0009409; GO:0010803; GO:0030101; GO:0030225; GO:0031264; GO:0031265; GO:0031625; GO:0032025; GO:0032355; GO:0032496; GO:0032731; GO:0032991; GO:0034138; GO:0034612; GO:0035666; GO:0035877; GO:0036462; GO:0039650; GO:0042110; GO:0042113; GO:0042802; GO:0043005; GO:0043065; GO:0043123; GO:0043124; GO:0044297; GO:0044877; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0046677; GO:0051603; GO:0060544; GO:0060546; GO:0060715; GO:0070423; GO:0071260; GO:0071407; GO:0071550; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097200; GO:0097202; GO:0097264; GO:0097296; GO:0097342; GO:1900740; GO:1901216; GO:1902041; GO:1902042	activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; toll-like receptor 3 signaling pathway [GO:0034138]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]		NA	NA	NA	NA	NA	NA
TRINITY_DN700_c0_g1_i1	Q9BXF3	CECR2_HUMAN	42.9	170	67	4	529	110	135	304	5.80E-13	75.9	CECR2_HUMAN	reviewed	Cat eye syndrome critical region protein 2	CECR2 KIAA1740	Homo sapiens (Human)	1484	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]		GO:0005634; GO:0005719; GO:0006309; GO:0007010; GO:0007338; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194	apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton-dependent cytokinesis [GO:0061640]; cytoskeleton organization [GO:0007010]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN700_c0_g1_i2	Q9BXF3	CECR2_HUMAN	50.3	163	76	1	1022	534	11	168	8.00E-42	173.3	CECR2_HUMAN	reviewed	Cat eye syndrome critical region protein 2	CECR2 KIAA1740	Homo sapiens (Human)	1484	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]		GO:0005634; GO:0005719; GO:0006309; GO:0007010; GO:0007338; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194	apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton-dependent cytokinesis [GO:0061640]; cytoskeleton organization [GO:0007010]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN700_c0_g1_i2	Q9BXF3	CECR2_HUMAN	44.8	183	74	2	1702	1154	13	168	1.60E-37	159.1	CECR2_HUMAN	reviewed	Cat eye syndrome critical region protein 2	CECR2 KIAA1740	Homo sapiens (Human)	1484	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]		GO:0005634; GO:0005719; GO:0006309; GO:0007010; GO:0007338; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194	apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton-dependent cytokinesis [GO:0061640]; cytoskeleton organization [GO:0007010]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN700_c0_g1_i2	Q9BXF3	CECR2_HUMAN	44	134	70	1	402	1	11	139	4.70E-26	120.9	CECR2_HUMAN	reviewed	Cat eye syndrome critical region protein 2	CECR2 KIAA1740	Homo sapiens (Human)	1484	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]	CERF complex [GO:0090537]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]		GO:0005634; GO:0005719; GO:0006309; GO:0007010; GO:0007338; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194	apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton-dependent cytokinesis [GO:0061640]; cytoskeleton organization [GO:0007010]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN30210_c0_g1_i1	P04040	CATA_HUMAN	100	225	0	0	3	677	15	239	2.00E-134	479.6	CATA_HUMAN	reviewed	Catalase (EC 1.11.1.6)	CAT	Homo sapiens (Human)	527	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein targeting to peroxisome [GO:0006625]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]	"aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]"	GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006625; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034599; GO:0034774; GO:0042493; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0043312; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813	aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein targeting to peroxisome [GO:0006625]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]		NA	NA	NA	NA	NA	NA
TRINITY_DN33253_c0_g1_i1	P04040	CATA_HUMAN	94.1	236	14	0	2	709	203	438	3.80E-136	485.3	CATA_HUMAN	reviewed	Catalase (EC 1.11.1.6)	CAT	Homo sapiens (Human)	527	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein targeting to peroxisome [GO:0006625]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]	"aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]"	GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006625; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034599; GO:0034774; GO:0042493; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0043312; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813	aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein targeting to peroxisome [GO:0006625]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]		NA	NA	NA	NA	NA	NA
TRINITY_DN30464_c0_g1_i1	O52762	CATA_PSEAE	73.7	95	25	0	1	285	259	353	1.50E-38	159.8	CATA_PSEAE	reviewed	Catalase (EC 1.11.1.6)	katA PA4236	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	482	cytoplasm [GO:0005737]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0005737; GO:0020037; GO:0042542; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN33482_c0_g1_i1	P24270	CATA_MOUSE	97.3	149	4	0	2	448	359	507	2.40E-83	309.3	CATA_MOUSE	reviewed	Catalase (EC 1.11.1.6)	Cat Cas-1 Cas1	Mus musculus (Mouse)	527	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to oxidative stress [GO:0006979]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]"	GO:0000268; GO:0000302; GO:0001657; GO:0001666; GO:0001822; GO:0004046; GO:0004096; GO:0005615; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006641; GO:0006979; GO:0007568; GO:0008203; GO:0009060; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0042493; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0070542; GO:0071363; GO:0080184	aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to oxidative stress [GO:0006979]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]		NA	NA	NA	NA	NA	NA
TRINITY_DN1242_c0_g1_i1	O62839	CATA_PIG	70	516	150	3	1627	89	5	518	6.20E-217	755	CATA_PIG	reviewed	Catalase (EC 1.11.1.6)	CAT	Sus scrofa (Pig)	527	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0005737; GO:0005739; GO:0005777; GO:0020037; GO:0042542; GO:0042744; GO:0046872; GO:0051781	hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]		blue	blue	NA	NA	NA	NA
TRINITY_DN1242_c0_g1_i2	Q9PWF7	CATA_RUGRU	57.4	54	22	1	241	80	398	450	4.70E-09	62	CATA_GLARU	reviewed	Catalase (EC 1.11.1.6)	cat	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	528	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	peroxisome [GO:0005777]	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN33690_c0_g1_i1	P04040	CATA_HUMAN	98.7	77	1	0	233	3	236	312	1.30E-40	166.4	CATA_HUMAN	reviewed	Catalase (EC 1.11.1.6)	CAT	Homo sapiens (Human)	527	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein targeting to peroxisome [GO:0006625]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]	"aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]"	GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006625; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034599; GO:0034774; GO:0042493; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0043312; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813	aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein targeting to peroxisome [GO:0006625]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]		NA	NA	NA	NA	NA	NA
TRINITY_DN33770_c0_g1_i1	P00432	CATA_BOVIN	99.4	172	1	0	3	518	47	218	4.90E-101	368.2	CATA_BOVIN	reviewed	Catalase (EC 1.11.1.6)	CAT	Bos taurus (Bovine)	527	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0005737; GO:0005739; GO:0005777; GO:0019899; GO:0020037; GO:0042542; GO:0042744; GO:0046872; GO:0051781; GO:0055114	hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN32633_c0_g1_i1	Q9Z598	CATA_STRCO	68.6	70	22	0	210	1	248	317	7.10E-25	114	CATA_STRCO	reviewed	Catalase (EC 1.11.1.6)	katA SCO6204 SC2G5.25c	Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)	487	cytoplasm [GO:0005737]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0005737; GO:0020037; GO:0042542; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN39950_c0_g1_i1	P0A324	CATA_BORBR	84.5	71	11	0	5	217	22	92	1.90E-30	132.5	CATA_BORBR	reviewed	Catalase (EC 1.11.1.6)	katA BB4994	Bordetella bronchiseptica (strain ATCC BAA-588 / NCTC 13252 / RB50) (Alcaligenes bronchisepticus)	482	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN40220_c0_g1_i1	Q9X576	CATE_RHIME	70.7	147	43	0	444	4	51	197	3.70E-57	222.2	CATE_RHIME	reviewed	Catalase C (EC 1.11.1.6) (KAT2)	katE catC katC RB0010 SMb20007	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	705	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN11497_c0_g1_i1	Q9X576	CATE_RHIME	74.4	223	57	0	2	670	52	274	1.40E-100	367.1	CATE_RHIME	reviewed	Catalase C (EC 1.11.1.6) (KAT2)	katE catC katC RB0010 SMb20007	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	705	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN11497_c0_g1_i2	Q9X576	CATE_RHIME	78.8	198	42	0	3	596	77	274	6.70E-94	344.7	CATE_RHIME	reviewed	Catalase C (EC 1.11.1.6) (KAT2)	katE catC katC RB0010 SMb20007	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	705	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0006979; GO:0020037; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN31111_c0_g1_i1	Q9I1W8	CATE_PSEAE	70.6	68	20	0	206	3	309	376	8.30E-23	107.1	CATE_PSEAE	reviewed	Catalase HPII (EC 1.11.1.6)	katE PA2147	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	709	cytosol [GO:0005829]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]	catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004096; GO:0005829; GO:0006979; GO:0020037; GO:0042744; GO:0046872	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN1956_c0_g1_i1	P35220	CTNA_DROME	75.9	381	90	2	1205	66	16	395	4.20E-152	539.3	CTNA_DROME	reviewed	Catenin alpha	alpha-Cat CG17947	Drosophila melanogaster (Fruit fly)	917	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; dorsal closure, amnioserosa morphology change [GO:0046664]; head morphogenesis [GO:0060323]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; dorsal closure, amnioserosa morphology change [GO:0046664]; head morphogenesis [GO:0060323]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1956_c0_g1_i2	P35220	CTNA_DROME	73.6	933	212	5	2864	75	16	917	0	1277.7	CTNA_DROME	reviewed	Catenin alpha	alpha-Cat CG17947	Drosophila melanogaster (Fruit fly)	917	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; dorsal closure, amnioserosa morphology change [GO:0046664]; head morphogenesis [GO:0060323]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; dorsal closure, amnioserosa morphology change [GO:0046664]; head morphogenesis [GO:0060323]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1956_c0_g1_i3	P35220	CTNA_DROME	76	905	211	5	2780	75	16	917	0	1291.9	CTNA_DROME	reviewed	Catenin alpha	alpha-Cat CG17947	Drosophila melanogaster (Fruit fly)	917	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; dorsal closure, amnioserosa morphology change [GO:0046664]; head morphogenesis [GO:0060323]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0003383; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0016342; GO:0034332; GO:0034333; GO:0042802; GO:0045296; GO:0046664; GO:0051015; GO:0060323	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; apical constriction [GO:0003383]; cell adhesion [GO:0007155]; dorsal closure, amnioserosa morphology change [GO:0046664]; head morphogenesis [GO:0060323]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33954_c0_g1_i1	Q3MHM6	CTNA1_BOVIN	100	112	0	0	336	1	428	539	1.70E-54	213	CTNA1_BOVIN	reviewed	Catenin alpha-1	CTNNA1	Bos taurus (Bovine)	906	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0045296; GO:0051015	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN32286_c0_g1_i1	Q3MHM6	CTNA1_BOVIN	100	117	0	0	353	3	538	654	2.10E-58	226.1	CTNA1_BOVIN	reviewed	Catenin alpha-1	CTNNA1	Bos taurus (Bovine)	906	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0045296; GO:0051015	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN39585_c0_g1_i1	Q3MHM6	CTNA1_BOVIN	100	132	0	0	3	398	685	816	5.00E-69	261.5	CTNA1_BOVIN	reviewed	Catenin alpha-1	CTNNA1	Bos taurus (Bovine)	906	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0045296; GO:0051015	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN34548_c0_g1_i1	Q3MHM6	CTNA1_BOVIN	98.6	72	1	0	216	1	817	888	2.10E-29	129	CTNA1_BOVIN	reviewed	Catenin alpha-1	CTNNA1	Bos taurus (Bovine)	906	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0045296; GO:0051015	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN18250_c0_g1_i1	Q3MHM6	CTNA1_BOVIN	100	122	0	0	3	368	713	834	9.30E-62	237.3	CTNA1_BOVIN	reviewed	Catenin alpha-1	CTNNA1	Bos taurus (Bovine)	906	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0045296; GO:0051015	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN20608_c0_g1_i1	P35221	CTNA1_HUMAN	100	190	0	0	572	3	277	466	3.00E-99	362.5	CTNA1_HUMAN	reviewed	Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13)	CTNNA1	Homo sapiens (Human)	906	acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166]; adherens junction organization [GO:0034332]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; gap junction assembly [GO:0016264]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of smoothened signaling pathway [GO:0045880]; response to estrogen [GO:0043627]	acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166]	GO:0001541; GO:0001669; GO:0003723; GO:0005198; GO:0005829; GO:0005886; GO:0005911; GO:0005915; GO:0005925; GO:0007155; GO:0007163; GO:0007406; GO:0007568; GO:0008013; GO:0008584; GO:0014704; GO:0015629; GO:0016264; GO:0016342; GO:0016600; GO:0017166; GO:0030027; GO:0030054; GO:0031103; GO:0034332; GO:0034613; GO:0042475; GO:0042802; GO:0043231; GO:0043297; GO:0043627; GO:0045295; GO:0045296; GO:0045880; GO:0051015; GO:0051149; GO:0071681; GO:0090136; GO:2000146; GO:2001045; GO:2001240; GO:2001241	adherens junction organization [GO:0034332]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; gap junction assembly [GO:0016264]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of smoothened signaling pathway [GO:0045880]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20608_c0_g1_i2	P35221	CTNA1_HUMAN	98.9	190	2	0	572	3	277	466	1.60E-97	356.7	CTNA1_HUMAN	reviewed	Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13)	CTNNA1	Homo sapiens (Human)	906	acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166]; adherens junction organization [GO:0034332]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; gap junction assembly [GO:0016264]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of smoothened signaling pathway [GO:0045880]; response to estrogen [GO:0043627]	acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166]	GO:0001541; GO:0001669; GO:0003723; GO:0005198; GO:0005829; GO:0005886; GO:0005911; GO:0005915; GO:0005925; GO:0007155; GO:0007163; GO:0007406; GO:0007568; GO:0008013; GO:0008584; GO:0014704; GO:0015629; GO:0016264; GO:0016342; GO:0016600; GO:0017166; GO:0030027; GO:0030054; GO:0031103; GO:0034332; GO:0034613; GO:0042475; GO:0042802; GO:0043231; GO:0043297; GO:0043627; GO:0045295; GO:0045296; GO:0045880; GO:0051015; GO:0051149; GO:0071681; GO:0090136; GO:2000146; GO:2001045; GO:2001240; GO:2001241	adherens junction organization [GO:0034332]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; gap junction assembly [GO:0016264]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of smoothened signaling pathway [GO:0045880]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN22955_c0_g1_i1	P35222	CTNB1_HUMAN	100	196	0	0	590	3	9	204	2.40E-104	379.4	CTNB1_HUMAN	reviewed	Catenin beta-1 (Beta-catenin)	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	Homo sapiens (Human)	781	"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; ion channel binding [GO:0044325]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007223; GO:0007268; GO:0007398; GO:0007403; GO:0008013; GO:0008022; GO:0008134; GO:0008285; GO:0009948; GO:0009950; GO:0009954; GO:0010718; GO:0010909; GO:0016020; GO:0016032; GO:0016055; GO:0016323; GO:0016327; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032481; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035257; GO:0035315; GO:0035635; GO:0035995; GO:0036023; GO:0036520; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0044338; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048096; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051149; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060828; GO:0060916; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070062; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1903204; GO:1904501; GO:1904793; GO:1904798; GO:1904837; GO:1904886; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2001234	"adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal/ventral axis specification [GO:0009950]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of type I interferon production [GO:0032481]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22955_c1_g1_i1	Q0VCX4	CTNB1_BOVIN	100	150	0	0	451	2	117	266	2.50E-77	289.3	CTNB1_BOVIN	reviewed	Catenin beta-1 (Beta-catenin)	CTNNB1	Bos taurus (Bovine)	781	"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]"	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; ion channel binding [GO:0044325]; I-SMAD binding [GO:0070411]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005938; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0008013; GO:0008022; GO:0008285; GO:0009948; GO:0009950; GO:0009954; GO:0010909; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035257; GO:0036023; GO:0036520; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0043065; GO:0043123; GO:0043161; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044338; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0048096; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050808; GO:0051091; GO:0051145; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1903204; GO:1904501; GO:1904793; GO:1904798; GO:1904888; GO:1904948; GO:1990138; GO:1990403; GO:1990791; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2001234	"adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12672_c0_g1_i1	Q02248	CTNB1_MOUSE	99.3	445	3	0	1337	3	267	711	4.00E-248	858.2	CTNB1_MOUSE	reviewed	Catenin beta-1 (Beta-catenin)	Ctnnb1 Catnb	Mus musculus (Mouse)	781	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endoderm formation [GO:0001706]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001501; GO:0001569; GO:0001570; GO:0001658; GO:0001701; GO:0001702; GO:0001706; GO:0001708; GO:0001709; GO:0001711; GO:0001764; GO:0001822; GO:0001840; GO:0001894; GO:0001944; GO:0002052; GO:0002053; GO:0002089; GO:0003223; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005938; GO:0006357; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0007507; GO:0008013; GO:0008022; GO:0008134; GO:0008283; GO:0008284; GO:0008285; GO:0009948; GO:0009950; GO:0009953; GO:0009954; GO:0009987; GO:0010468; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0014010; GO:0014704; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0022405; GO:0030018; GO:0030027; GO:0030054; GO:0030097; GO:0030154; GO:0030182; GO:0030217; GO:0030316; GO:0030324; GO:0030331; GO:0030539; GO:0030856; GO:0030858; GO:0030877; GO:0030900; GO:0030901; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031253; GO:0031528; GO:0031641; GO:0031965; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034097; GO:0034332; GO:0034333; GO:0034394; GO:0034613; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035255; GO:0035257; GO:0036023; GO:0036520; GO:0042127; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0042981; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043198; GO:0043296; GO:0043410; GO:0043525; GO:0043588; GO:0043627; GO:0044325; GO:0044334; GO:0044338; GO:0044877; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045595; GO:0045596; GO:0045603; GO:0045667; GO:0045669; GO:0045670; GO:0045671; GO:0045743; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048096; GO:0048469; GO:0048471; GO:0048489; GO:0048513; GO:0048538; GO:0048568; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050768; GO:0050808; GO:0050998; GO:0051091; GO:0051145; GO:0051569; GO:0051884; GO:0051973; GO:0060038; GO:0060066; GO:0060070; GO:0060173; GO:0060439; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060485; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0060947; GO:0060982; GO:0060983; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071260; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072132; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1901215; GO:1903204; GO:1904173; GO:1904499; GO:1904501; GO:1904793; GO:1904796; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990314; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2000179; GO:2001234	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endoderm formation [GO:0001706]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12672_c0_g1_i2	Q02248	CTNB1_MOUSE	99.8	493	1	0	1481	3	219	711	3.40E-280	964.9	CTNB1_MOUSE	reviewed	Catenin beta-1 (Beta-catenin)	Ctnnb1 Catnb	Mus musculus (Mouse)	781	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endoderm formation [GO:0001706]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001501; GO:0001569; GO:0001570; GO:0001658; GO:0001701; GO:0001702; GO:0001706; GO:0001708; GO:0001709; GO:0001711; GO:0001764; GO:0001822; GO:0001840; GO:0001894; GO:0001944; GO:0002052; GO:0002053; GO:0002089; GO:0003223; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005938; GO:0006357; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0007507; GO:0008013; GO:0008022; GO:0008134; GO:0008283; GO:0008284; GO:0008285; GO:0009948; GO:0009950; GO:0009953; GO:0009954; GO:0009987; GO:0010468; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0014010; GO:0014704; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0022405; GO:0030018; GO:0030027; GO:0030054; GO:0030097; GO:0030154; GO:0030182; GO:0030217; GO:0030316; GO:0030324; GO:0030331; GO:0030539; GO:0030856; GO:0030858; GO:0030877; GO:0030900; GO:0030901; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031253; GO:0031528; GO:0031641; GO:0031965; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034097; GO:0034332; GO:0034333; GO:0034394; GO:0034613; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035255; GO:0035257; GO:0036023; GO:0036520; GO:0042127; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0042981; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043198; GO:0043296; GO:0043410; GO:0043525; GO:0043588; GO:0043627; GO:0044325; GO:0044334; GO:0044338; GO:0044877; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045595; GO:0045596; GO:0045603; GO:0045667; GO:0045669; GO:0045670; GO:0045671; GO:0045743; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048096; GO:0048469; GO:0048471; GO:0048489; GO:0048513; GO:0048538; GO:0048568; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050768; GO:0050808; GO:0050998; GO:0051091; GO:0051145; GO:0051569; GO:0051884; GO:0051973; GO:0060038; GO:0060066; GO:0060070; GO:0060173; GO:0060439; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060485; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0060947; GO:0060982; GO:0060983; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071260; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072132; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1901215; GO:1903204; GO:1904173; GO:1904499; GO:1904501; GO:1904793; GO:1904796; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990314; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2000179; GO:2001234	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endoderm formation [GO:0001706]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12672_c0_g1_i3	Q02248	CTNB1_MOUSE	99.4	493	3	0	1481	3	219	711	5.40E-278	957.6	CTNB1_MOUSE	reviewed	Catenin beta-1 (Beta-catenin)	Ctnnb1 Catnb	Mus musculus (Mouse)	781	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endoderm formation [GO:0001706]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001501; GO:0001569; GO:0001570; GO:0001658; GO:0001701; GO:0001702; GO:0001706; GO:0001708; GO:0001709; GO:0001711; GO:0001764; GO:0001822; GO:0001840; GO:0001894; GO:0001944; GO:0002052; GO:0002053; GO:0002089; GO:0003223; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005938; GO:0006357; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0007507; GO:0008013; GO:0008022; GO:0008134; GO:0008283; GO:0008284; GO:0008285; GO:0009948; GO:0009950; GO:0009953; GO:0009954; GO:0009987; GO:0010468; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0014010; GO:0014704; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0022405; GO:0030018; GO:0030027; GO:0030054; GO:0030097; GO:0030154; GO:0030182; GO:0030217; GO:0030316; GO:0030324; GO:0030331; GO:0030539; GO:0030856; GO:0030858; GO:0030877; GO:0030900; GO:0030901; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031253; GO:0031528; GO:0031641; GO:0031965; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034097; GO:0034332; GO:0034333; GO:0034394; GO:0034613; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035255; GO:0035257; GO:0036023; GO:0036520; GO:0042127; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0042981; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043198; GO:0043296; GO:0043410; GO:0043525; GO:0043588; GO:0043627; GO:0044325; GO:0044334; GO:0044338; GO:0044877; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045595; GO:0045596; GO:0045603; GO:0045667; GO:0045669; GO:0045670; GO:0045671; GO:0045743; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048096; GO:0048469; GO:0048471; GO:0048489; GO:0048513; GO:0048538; GO:0048568; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050768; GO:0050808; GO:0050998; GO:0051091; GO:0051145; GO:0051569; GO:0051884; GO:0051973; GO:0060038; GO:0060066; GO:0060070; GO:0060173; GO:0060439; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060485; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0060947; GO:0060982; GO:0060983; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071260; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072132; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1901215; GO:1903204; GO:1904173; GO:1904499; GO:1904501; GO:1904793; GO:1904796; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990314; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2000179; GO:2001234	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endoderm formation [GO:0001706]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12672_c0_g1_i4	Q02248	CTNB1_MOUSE	99.8	445	1	0	1337	3	267	711	2.50E-250	865.5	CTNB1_MOUSE	reviewed	Catenin beta-1 (Beta-catenin)	Ctnnb1 Catnb	Mus musculus (Mouse)	781	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endoderm formation [GO:0001706]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001501; GO:0001569; GO:0001570; GO:0001658; GO:0001701; GO:0001702; GO:0001706; GO:0001708; GO:0001709; GO:0001711; GO:0001764; GO:0001822; GO:0001840; GO:0001894; GO:0001944; GO:0002052; GO:0002053; GO:0002089; GO:0003223; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005938; GO:0006357; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0007507; GO:0008013; GO:0008022; GO:0008134; GO:0008283; GO:0008284; GO:0008285; GO:0009948; GO:0009950; GO:0009953; GO:0009954; GO:0009987; GO:0010468; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0014010; GO:0014704; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0022405; GO:0030018; GO:0030027; GO:0030054; GO:0030097; GO:0030154; GO:0030182; GO:0030217; GO:0030316; GO:0030324; GO:0030331; GO:0030539; GO:0030856; GO:0030858; GO:0030877; GO:0030900; GO:0030901; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031253; GO:0031528; GO:0031641; GO:0031965; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034097; GO:0034332; GO:0034333; GO:0034394; GO:0034613; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035255; GO:0035257; GO:0036023; GO:0036520; GO:0042127; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0042981; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043198; GO:0043296; GO:0043410; GO:0043525; GO:0043588; GO:0043627; GO:0044325; GO:0044334; GO:0044338; GO:0044877; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045595; GO:0045596; GO:0045603; GO:0045667; GO:0045669; GO:0045670; GO:0045671; GO:0045743; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048096; GO:0048469; GO:0048471; GO:0048489; GO:0048513; GO:0048538; GO:0048568; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050768; GO:0050808; GO:0050998; GO:0051091; GO:0051145; GO:0051569; GO:0051884; GO:0051973; GO:0060038; GO:0060066; GO:0060070; GO:0060173; GO:0060439; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060485; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0060947; GO:0060982; GO:0060983; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071260; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072132; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1901215; GO:1903204; GO:1904173; GO:1904499; GO:1904501; GO:1904793; GO:1904796; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990314; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2000179; GO:2001234	"adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endoderm formation [GO:0001706]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of euchromatin binding [GO:1904793]; regulation of gene expression [GO:0010468]; regulation of histone demethylase activity (H3-K4 specific) [GO:1904173]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31855_c0_g1_i1	P35222	CTNB1_HUMAN	99	104	1	0	312	1	29	132	2.50E-52	205.7	CTNB1_HUMAN	reviewed	Catenin beta-1 (Beta-catenin)	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	Homo sapiens (Human)	781	"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; ion channel binding [GO:0044325]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000209; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007223; GO:0007268; GO:0007398; GO:0007403; GO:0008013; GO:0008022; GO:0008134; GO:0008285; GO:0009948; GO:0009950; GO:0009954; GO:0010718; GO:0010909; GO:0016020; GO:0016032; GO:0016055; GO:0016323; GO:0016327; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032481; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035257; GO:0035315; GO:0035635; GO:0035995; GO:0036023; GO:0036520; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0044338; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048096; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051149; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060828; GO:0060916; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070062; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:1903204; GO:1904501; GO:1904793; GO:1904798; GO:1904837; GO:1904886; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2001234	"adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal/ventral axis specification [GO:0009950]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of type I interferon production [GO:0032481]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24052_c1_g1_i1	P07858	CATB_HUMAN	53.2	47	20	2	10	147	293	338	2.30E-06	52.4	CATB_HUMAN	reviewed	Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB CPSB	Homo sapiens (Human)	339	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0002224; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904813	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c26_g1_i1	P07858	CATB_HUMAN	51.5	68	27	4	256	56	276	338	1.60E-10	66.6	CATB_HUMAN	reviewed	Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB CPSB	Homo sapiens (Human)	339	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0002224; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904813	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c0_g1_i1	P07858	CATB_HUMAN	100	60	0	0	2	181	280	339	5.30E-33	141	CATB_HUMAN	reviewed	Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB CPSB	Homo sapiens (Human)	339	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0002224; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904813	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c0_g2_i1	P07858	CATB_HUMAN	100	71	0	0	213	1	216	286	5.10E-36	151	CATB_HUMAN	reviewed	Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB CPSB	Homo sapiens (Human)	339	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0002224; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904813	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN20903_c0_g2_i1	P07858	CATB_HUMAN	98.1	104	2	0	312	1	56	159	6.30E-59	227.6	CATB_HUMAN	reviewed	Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB CPSB	Homo sapiens (Human)	339	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0002224; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0062023; GO:0070062; GO:0097067; GO:1904813	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c4_g1_i1	P10605	CATB_MOUSE	100	124	0	0	2	373	216	339	3.70E-72	271.9	CATB_MOUSE	reviewed	Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	Ctsb	Mus musculus (Mouse)	339	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; negative regulation of cell death [GO:0060548]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; protein self-association [GO:0043621]; proteoglycan binding [GO:0043394]	GO:0004175; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0005739; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0009986; GO:0016324; GO:0030574; GO:0030855; GO:0030984; GO:0042277; GO:0042383; GO:0042470; GO:0043231; GO:0043394; GO:0043621; GO:0044877; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0060548; GO:0062023; GO:0097067	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; negative regulation of cell death [GO:0060548]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN20903_c0_g1_i1	P10605	CATB_MOUSE	100	98	0	0	294	1	62	159	1.20E-56	219.9	CATB_MOUSE	reviewed	Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	Ctsb	Mus musculus (Mouse)	339	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; negative regulation of cell death [GO:0060548]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; protein self-association [GO:0043621]; proteoglycan binding [GO:0043394]	GO:0004175; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0005739; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0009986; GO:0016324; GO:0030574; GO:0030855; GO:0030984; GO:0042277; GO:0042383; GO:0042470; GO:0043231; GO:0043394; GO:0043621; GO:0044877; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0060548; GO:0062023; GO:0097067	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; negative regulation of cell death [GO:0060548]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN3396_c0_g1_i1	Q4R5M2	CATB_MACFA	64.9	251	87	1	19	768	80	330	4.20E-99	362.5	CATB_MACFA	reviewed	Cathepsin B (EC 3.4.22.1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	CTSB QccE-13673	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	339	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394]	GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005730; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0097067	cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN5571_c0_g1_i5	P25792	CYSP_SCHMA	57.9	57	24	0	17	187	283	339	9.50E-15	80.5	CYSP_SCHMA	reviewed	Cathepsin B-like cysteine proteinase (EC 3.4.22.-) (Antigen Sm31)		Schistosoma mansoni (Blood fluke)	340	cysteine-type endopeptidase activity [GO:0004197]; regulation of catalytic activity [GO:0050790]		cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0050790	regulation of catalytic activity [GO:0050790]		NA	NA	NA	NA	NA	NA
TRINITY_DN21115_c0_g2_i1	P25802	CYSP1_OSTOS	38.2	76	38	3	50	277	239	305	8.40E-07	54.3	CYSP1_OSTOS	reviewed	Cathepsin B-like cysteine proteinase 1 (EC 3.4.22.-)	CP-1	Ostertagia ostertagi (Brown stomach worm) (Strongylus ostertagi)	341	cysteine-type peptidase activity [GO:0008234]		cysteine-type peptidase activity [GO:0008234]	GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN5571_c0_g1_i1	P43509	CPR5_CAEEL	58.2	55	23	0	17	181	282	336	1.40E-13	76.6	CPR5_CAEEL	reviewed	Cathepsin B-like cysteine proteinase 5 (EC 3.4.22.-) (Cysteine protease-related 5)	cpr-5 W07B8.5	Caenorhabditis elegans	344	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN5571_c0_g1_i2	P43509	CPR5_CAEEL	60.8	51	20	0	4	156	286	336	3.50E-13	75.1	CPR5_CAEEL	reviewed	Cathepsin B-like cysteine proteinase 5 (EC 3.4.22.-) (Cysteine protease-related 5)	cpr-5 W07B8.5	Caenorhabditis elegans	344	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN5571_c0_g1_i3	P43509	CPR5_CAEEL	62.7	51	19	0	4	156	286	336	2.50E-14	79	CPR5_CAEEL	reviewed	Cathepsin B-like cysteine proteinase 5 (EC 3.4.22.-) (Cysteine protease-related 5)	cpr-5 W07B8.5	Caenorhabditis elegans	344	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN5571_c0_g1_i4	P43509	CPR5_CAEEL	60	55	22	0	17	181	282	336	9.50E-15	80.5	CPR5_CAEEL	reviewed	Cathepsin B-like cysteine proteinase 5 (EC 3.4.22.-) (Cysteine protease-related 5)	cpr-5 W07B8.5	Caenorhabditis elegans	344	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN40421_c0_g1_i1	Q26563	CATC_SCHMA	55.9	59	24	1	10	180	393	451	7.20E-12	70.9	CATC_SCHMA	reviewed	Cathepsin C (EC 3.4.22.-)		Schistosoma mansoni (Blood fluke)	454	lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN26524_c0_g1_i1	P18242	CATD_MOUSE	100	298	0	0	896	3	42	339	6.80E-175	614.4	CATD_MOUSE	reviewed	Cathepsin D (EC 3.4.23.5)	Ctsd	Mus musculus (Mouse)	410	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; endopeptidase activity [GO:0004175]; hydrolase activity [GO:0016787]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; autophagosome assembly [GO:0000045]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]	aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; endopeptidase activity [GO:0004175]; hydrolase activity [GO:0016787]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]	GO:0000045; GO:0004175; GO:0004190; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0016787; GO:0042159; GO:0042277; GO:0042470; GO:0043065; GO:0043280; GO:0045121; GO:0062023; GO:0070001; GO:0070201	autophagosome assembly [GO:0000045]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]		NA	NA	NA	NA	NA	NA
TRINITY_DN1062_c0_g1_i1	P18242	CATD_MOUSE	100	75	0	0	3	227	336	410	5.80E-40	164.5	CATD_MOUSE	reviewed	Cathepsin D (EC 3.4.23.5)	Ctsd	Mus musculus (Mouse)	410	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; endopeptidase activity [GO:0004175]; hydrolase activity [GO:0016787]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; autophagosome assembly [GO:0000045]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]	aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; endopeptidase activity [GO:0004175]; hydrolase activity [GO:0016787]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]	GO:0000045; GO:0004175; GO:0004190; GO:0005615; GO:0005739; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0016787; GO:0042159; GO:0042277; GO:0042470; GO:0043065; GO:0043280; GO:0045121; GO:0062023; GO:0070001; GO:0070201	autophagosome assembly [GO:0000045]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]		NA	NA	NA	NA	NA	NA
TRINITY_DN26560_c0_g1_i1	P07339	CATD_HUMAN	100	67	0	0	234	34	346	412	6.20E-35	147.5	CATD_HUMAN	reviewed	Cathepsin D (EC 3.4.23.5) [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain]	CTSD CPSD	Homo sapiens (Human)	412	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; peptidase activity [GO:0008233]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; collagen catabolic process [GO:0030574]; lipoprotein catabolic process [GO:0042159]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; peptidase activity [GO:0008233]	GO:0004190; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0019886; GO:0030574; GO:0035580; GO:0042159; GO:0042470; GO:0043065; GO:0043202; GO:0043280; GO:0043312; GO:0045121; GO:0062023; GO:0070001; GO:0070062; GO:0070201; GO:1904724; GO:1904813	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; collagen catabolic process [GO:0030574]; lipoprotein catabolic process [GO:0042159]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]		NA	NA	NA	NA	NA	NA
TRINITY_DN27414_c0_g1_i1	P07339	CATD_HUMAN	100	282	0	0	3	848	53	334	8.80E-164	577.4	CATD_HUMAN	reviewed	Cathepsin D (EC 3.4.23.5) [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain]	CTSD CPSD	Homo sapiens (Human)	412	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; peptidase activity [GO:0008233]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; collagen catabolic process [GO:0030574]; lipoprotein catabolic process [GO:0042159]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; peptidase activity [GO:0008233]	GO:0004190; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0019886; GO:0030574; GO:0035580; GO:0042159; GO:0042470; GO:0043065; GO:0043202; GO:0043280; GO:0043312; GO:0045121; GO:0062023; GO:0070001; GO:0070062; GO:0070201; GO:1904724; GO:1904813	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; collagen catabolic process [GO:0030574]; lipoprotein catabolic process [GO:0042159]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]		NA	NA	NA	NA	NA	NA
TRINITY_DN3503_c0_g1_i1	Q9R013	CATF_MOUSE	55.9	177	77	1	2	532	205	380	2.20E-51	203.4	CATF_MOUSE	reviewed	Cathepsin F (EC 3.4.22.41)	Ctsf	Mus musculus (Mouse)	462	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN30175_c0_g1_i1	Q95029	CATL_DROME	60.6	160	53	3	460	2	104	260	1.50E-48	193.7	CATL_DROME	reviewed	Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]	Cp1 fs(2)50Ca CG6692	Drosophila melanogaster (Fruit fly)	371	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; digestion [GO:0007586]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007275; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603	digestion [GO:0007586]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN9394_c0_g1_i1	Q95029	CATL_DROME	63.4	216	78	1	66	713	31	245	3.20E-75	283.1	CATL_DROME	reviewed	Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]	Cp1 fs(2)50Ca CG6692	Drosophila melanogaster (Fruit fly)	371	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; digestion [GO:0007586]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007275; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603	digestion [GO:0007586]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN9394_c0_g1_i2	Q95029	CATL_DROME	64	342	122	1	66	1091	31	371	4.80E-128	459.1	CATL_DROME	reviewed	Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]	Cp1 fs(2)50Ca CG6692	Drosophila melanogaster (Fruit fly)	371	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; digestion [GO:0007586]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007275; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603	digestion [GO:0007586]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN24918_c0_g1_i1	O60911	CATL2_HUMAN	56.4	172	69	2	5	502	160	331	1.20E-51	204.1	CATL2_HUMAN	reviewed	Cathepsin L2 (EC 3.4.22.43) (Cathepsin U) (Cathepsin V)	CTSV CATL2 CTSL2 CTSU UNQ268/PRO305	Homo sapiens (Human)	334	apical part of cell [GO:0045177]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagic cell death [GO:0048102]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of keratinocyte differentiation [GO:0045616]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]	apical part of cell [GO:0045177]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; secretory granule [GO:0030141]	aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]	GO:0004177; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005902; GO:0006955; GO:0007283; GO:0008234; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0019886; GO:0021675; GO:0022617; GO:0030141; GO:0030984; GO:0034698; GO:0042277; GO:0043005; GO:0043202; GO:0043204; GO:0044877; GO:0045177; GO:0045616; GO:0046697; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:1990834	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagic cell death [GO:0048102]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of keratinocyte differentiation [GO:0045616]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3050_c0_g1_i1	O45734	CPL1_CAEEL	58.9	90	33	3	22	282	120	208	1.00E-23	110.5	CPL1_CAEEL	reviewed	Cathepsin L-like (EC 3.4.22.15)	cpl-1 T03E6.7	Caenorhabditis elegans	337	cytoplasm [GO:0005737]; endolysosome [GO:0036019]; extracellular space [GO:0005615]; lysosome [GO:0005764]; phagolysosome [GO:0032010]; vesicle lumen [GO:0031983]; yolk granule [GO:0042718]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic cell clearance [GO:0043277]; immune response [GO:0006955]; lipid droplet disassembly [GO:1905691]; positive regulation of vitellogenesis [GO:1903188]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of protein processing [GO:0070613]	cytoplasm [GO:0005737]; endolysosome [GO:0036019]; extracellular space [GO:0005615]; lysosome [GO:0005764]; phagolysosome [GO:0032010]; vesicle lumen [GO:0031983]; yolk granule [GO:0042718]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005737; GO:0005764; GO:0006955; GO:0031983; GO:0032010; GO:0036019; GO:0042718; GO:0043277; GO:0051603; GO:0060785; GO:0070613; GO:1903188; GO:1905691	apoptotic cell clearance [GO:0043277]; immune response [GO:0006955]; lipid droplet disassembly [GO:1905691]; positive regulation of vitellogenesis [GO:1903188]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of protein processing [GO:0070613]		NA	NA	NA	NA	NA	NA
TRINITY_DN31660_c0_g1_i1	P43234	CATO_HUMAN	98.5	68	1	0	206	3	99	166	2.70E-34	145.2	CATO_HUMAN	reviewed	Cathepsin O (EC 3.4.22.42)	CTSO CTSO1	Homo sapiens (Human)	321	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0051603	proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN24378_c0_g1_i1	P25774	CATS_HUMAN	100	89	0	0	1	267	120	208	1.20E-47	189.9	CATS_HUMAN	reviewed	Cathepsin S (EC 3.4.22.27)	CTSS	Homo sapiens (Human)	331	collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; tertiary granule lumen [GO:1904724]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]; toll-like receptor signaling pathway [GO:0002224]	collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; tertiary granule lumen [GO:1904724]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]	GO:0001968; GO:0002224; GO:0002250; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0010447; GO:0016485; GO:0019882; GO:0019886; GO:0022617; GO:0030574; GO:0034769; GO:0036021; GO:0043202; GO:0043231; GO:0043236; GO:0043312; GO:0043394; GO:0045335; GO:0048002; GO:0051603; GO:0062023; GO:0097067; GO:1904724; GO:1904813; GO:2001259	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN24378_c0_g1_i2	O70370	CATS_MOUSE	100	86	0	0	1	258	128	213	5.00E-46	184.5	CATS_MOUSE	reviewed	Cathepsin S (EC 3.4.22.27)	Ctss Cats	Mus musculus (Mouse)	340	cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]	cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0008233; GO:0008234; GO:0009986; GO:0010447; GO:0016020; GO:0016485; GO:0019886; GO:0030574; GO:0031905; GO:0034769; GO:0043231; GO:0043236; GO:0043394; GO:0045335; GO:0045453; GO:0048002; GO:0050729; GO:0051603; GO:0051930; GO:2001259	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]		NA	NA	NA	NA	NA	NA
TRINITY_DN31476_c0_g1_i1	P25774	CATS_HUMAN	100	77	0	0	232	2	245	321	6.20E-43	174.1	CATS_HUMAN	reviewed	Cathepsin S (EC 3.4.22.27)	CTSS	Homo sapiens (Human)	331	collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; tertiary granule lumen [GO:1904724]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]; toll-like receptor signaling pathway [GO:0002224]	collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; tertiary granule lumen [GO:1904724]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]	GO:0001968; GO:0002224; GO:0002250; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0010447; GO:0016485; GO:0019882; GO:0019886; GO:0022617; GO:0030574; GO:0034769; GO:0036021; GO:0043202; GO:0043231; GO:0043236; GO:0043312; GO:0043394; GO:0045335; GO:0048002; GO:0051603; GO:0062023; GO:0097067; GO:1904724; GO:1904813; GO:2001259	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN36840_c0_g1_i1	O70370	CATS_MOUSE	100	108	0	0	2	325	233	340	6.60E-62	237.7	CATS_MOUSE	reviewed	Cathepsin S (EC 3.4.22.27)	Ctss Cats	Mus musculus (Mouse)	340	cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]	cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0008233; GO:0008234; GO:0009986; GO:0010447; GO:0016020; GO:0016485; GO:0019886; GO:0030574; GO:0031905; GO:0034769; GO:0043231; GO:0043236; GO:0043394; GO:0045335; GO:0045453; GO:0048002; GO:0050729; GO:0051603; GO:0051930; GO:2001259	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]		NA	NA	NA	NA	NA	NA
TRINITY_DN34964_c0_g1_i1	P56202	CATW_HUMAN	100	76	0	0	2	229	301	376	4.00E-42	171.4	CATW_HUMAN	reviewed	Cathepsin W (EC 3.4.22.-) (Lymphopain)	CTSW	Homo sapiens (Human)	376	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; immune response [GO:0006955]; platelet degranulation [GO:0002576]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0002576; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0006955; GO:0008234; GO:0016020; GO:0031089; GO:0051603	immune response [GO:0006955]; platelet degranulation [GO:0002576]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN30290_c0_g1_i1	Q9WUU7	CATZ_MOUSE	45.1	71	31	2	7	195	234	304	3.80E-11	68.6	CATZ_MOUSE	reviewed	Cathepsin Z (EC 3.4.18.1)	Ctsz	Mus musculus (Mouse)	306	cell cortex region [GO:0099738]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of neuron projection development [GO:0010977]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of protein binding [GO:0032091]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of neuron death [GO:1901214]	cell cortex region [GO:0099738]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]	GO:0004180; GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0006508; GO:0009986; GO:0010757; GO:0010977; GO:0030426; GO:0031410; GO:0032091; GO:0043231; GO:0043525; GO:0051603; GO:0060441; GO:0062023; GO:0099738; GO:1901214; GO:2000179	epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of neuron projection development [GO:0010977]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of protein binding [GO:0032091]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of neuron death [GO:1901214]		red	red	NA	NA	NA	NA
TRINITY_DN8737_c0_g1_i1	P94178	CZCD_ALCSC	44.9	89	49	0	271	5	29	117	4.10E-14	78.6	CZCD_ALCSC	reviewed	Cation efflux system protein CzcD	czcD	Alcaligenes sp. (strain CT14)	316	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation transmembrane transporter activity [GO:0008324]	GO:0005886; GO:0006829; GO:0008324; GO:0016021	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN38712_c0_g1_i1	Q6AY20	MPRD_RAT	27.7	242	157	6	788	87	41	272	1.10E-19	98.6	MPRD_RAT	reviewed	Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR)	M6pr	Rattus norvegicus (Rat)	278	endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299]	endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]	protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]	GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0007041; GO:0016021; GO:0019904; GO:0033299; GO:0048471; GO:1905394	lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN35078_c0_g1_i1	P20645	MPRD_HUMAN	100	79	0	0	239	3	188	266	1.50E-39	162.9	MPRD_HUMAN	reviewed	Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46)	M6PR MPR46 MPRD	Homo sapiens (Human)	277	clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]; endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299]	clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]	protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0005886; GO:0005887; GO:0006622; GO:0006898; GO:0007041; GO:0008333; GO:0016020; GO:0019904; GO:0030133; GO:0030665; GO:0032588; GO:0033299; GO:0048471; GO:0061024; GO:1905394	endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN3804_c0_g2_i1	P52569	CTR2_HUMAN	39.2	232	123	5	851	180	385	606	1.60E-27	124.8	CTR2_HUMAN	reviewed	Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	SLC7A2 ATRC2 CAT2	Homo sapiens (Human)	658	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; macrophage activation [GO:0042116]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]; transport across blood-brain barrier [GO:0150104]	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0002537; GO:0005886; GO:0005887; GO:0006809; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015181; GO:0015189; GO:0015807; GO:0030054; GO:0042116; GO:0043030; GO:0050727; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; macrophage activation [GO:0042116]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN3804_c0_g2_i2	Q5PR34	CTR2_DANRE	38.5	122	75	0	542	177	482	603	7.40E-18	92.4	CTR2_DANRE	reviewed	Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	slc7a2 zgc:103686	Danio rerio (Zebrafish) (Brachydanio rerio)	640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016021; GO:0097638; GO:1903352	amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]		NA	NA	NA	NA	NA	NA
TRINITY_DN3804_c0_g2_i3	Q5PR34	CTR2_DANRE	38.5	122	75	0	542	177	482	603	7.90E-18	92.4	CTR2_DANRE	reviewed	Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	slc7a2 zgc:103686	Danio rerio (Zebrafish) (Brachydanio rerio)	640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016021; GO:0097638; GO:1903352	amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]		NA	NA	NA	NA	NA	NA
TRINITY_DN3804_c0_g2_i3	Q5PR34	CTR2_DANRE	61.4	44	17	0	790	659	547	590	1.00E-09	65.5	CTR2_DANRE	reviewed	Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	slc7a2 zgc:103686	Danio rerio (Zebrafish) (Brachydanio rerio)	640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016021; GO:0097638; GO:1903352	amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]		NA	NA	NA	NA	NA	NA
TRINITY_DN3804_c0_g1_i1	Q5PR34	CTR2_DANRE	50	76	34	1	914	687	547	618	1.10E-15	85.5	CTR2_DANRE	reviewed	Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	slc7a2 zgc:103686	Danio rerio (Zebrafish) (Brachydanio rerio)	640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016021; GO:0097638; GO:1903352	amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]		NA	NA	NA	NA	NA	NA
TRINITY_DN3804_c0_g1_i3	Q5PR34	CTR2_DANRE	50	76	34	1	920	693	547	618	1.10E-15	85.5	CTR2_DANRE	reviewed	Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	slc7a2 zgc:103686	Danio rerio (Zebrafish) (Brachydanio rerio)	640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016021; GO:0097638; GO:1903352	amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]		NA	NA	NA	NA	NA	NA
TRINITY_DN36852_c0_g1_i1	P54209	ATC1_DUNBI	49.4	79	30	1	4	210	598	676	5.50E-17	87.8	ATC1_DUNBI	reviewed	Cation-transporting ATPase CA1 (EC 7.2.2.-)	CA1	Dunaliella bioculata (Green alga)	1037	"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	GO:0005388; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN36852_c0_g1_i2	P54209	ATC1_DUNBI	50	82	31	1	7	222	595	676	1.80E-18	92.8	ATC1_DUNBI	reviewed	Cation-transporting ATPase CA1 (EC 7.2.2.-)	CA1	Dunaliella bioculata (Green alga)	1037	"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	GO:0005388; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN29328_c0_g1_i1	A0A0P0X004	HMA9_ORYSJ	52.8	72	30	1	3	206	857	928	3.20E-11	68.6	HMA9_ORYSJ	reviewed	Cation-transporting ATPase HMA5 (EC 7.2.2.-) (Protein HEAVY METAL ATPASE 5) (OsHMA5)	HMA9 Os06g0665800 LOC_Os06g45500 P0473H04.28	Oryza sativa subsp. japonica (Rice)	1003	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; nucleotide binding [GO:0000166]; response to toxic substance [GO:0009636]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"copper ion binding [GO:0005507]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0005507; GO:0005886; GO:0009636; GO:0016021; GO:0043682	response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN2007_c0_g1_i1	Q9USK6	CBP3_SCHPO	30.7	150	99	4	467	904	126	274	9.60E-11	69.3	CBP3_SCHPO	reviewed	CBP3-like protein	cbp3 SPCC4B3.17	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	283	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0034551; GO:0070131	mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]		NA	NA	NA	NA	NA	NA
TRINITY_DN2379_c0_g1_i1	P28033	CEBPB_MOUSE	100	63	0	0	189	1	218	280	6.80E-25	114	CEBPB_MOUSE	reviewed	CCAAT/enhancer-binding protein beta (C/EBP beta) (AGP/EBP) (Interleukin-6-dependent-binding protein) (IL-6DBP) (Liver-enriched transcriptional activator) (LAP)	Cebpb	Mus musculus (Mouse)	296	"CHOP-C/EBP complex [GO:0036488]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor binding [GO:0035259]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]; brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; fat cell differentiation [GO:0045444]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; memory [GO:0007613]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription involved in cell fate commitment [GO:0060850]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; T-helper 1 cell activation [GO:0035711]"	"CHOP-C/EBP complex [GO:0036488]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor binding [GO:0035259]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]"	GO:0000122; GO:0000779; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001541; GO:0001892; GO:0002432; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007613; GO:0008134; GO:0010628; GO:0016363; GO:0019900; GO:0030182; GO:0032496; GO:0032675; GO:0032753; GO:0033598; GO:0034976; GO:0035035; GO:0035259; GO:0035711; GO:0036488; GO:0042130; GO:0042742; GO:0042802; GO:0042803; GO:0042826; GO:0043524; GO:0043565; GO:0044389; GO:0045444; GO:0045600; GO:0045669; GO:0045670; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050729; GO:0050873; GO:0060644; GO:0060850; GO:0070059; GO:0070169; GO:0071222; GO:0071230; GO:0071347; GO:0071407; GO:0072574; GO:0090575; GO:0097421; GO:0120162; GO:1901329; GO:1990440; GO:1990837; GO:2000120; GO:2001198	"brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; fat cell differentiation [GO:0045444]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; memory [GO:0007613]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; T-helper 1 cell activation [GO:0035711]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2379_c0_g1_i2	Q05826	CEBPB_CHICK	90.5	74	7	0	222	1	239	312	1.10E-26	120.2	CEBPB_CHICK	reviewed	CCAAT/enhancer-binding protein beta (C/EBP beta) (Transcription factor NF-M) (CCR protein)	CEBPB	Gallus gallus (Chicken)	328	"condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; ubiquitin-like protein ligase binding [GO:0044389]; cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; fat cell differentiation [GO:0045444]; hepatocyte proliferation [GO:0072574]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to lipopolysaccharide [GO:0032496]"	"condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]"	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; ubiquitin-like protein ligase binding [GO:0044389]"	GO:0000779; GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0000987; GO:0001046; GO:0001228; GO:0001541; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0010628; GO:0016363; GO:0019900; GO:0030182; GO:0032496; GO:0032675; GO:0032753; GO:0035035; GO:0042130; GO:0042742; GO:0042802; GO:0042826; GO:0043524; GO:0044389; GO:0045444; GO:0045600; GO:0045669; GO:0045670; GO:0045892; GO:0050729; GO:0060850; GO:0070059; GO:0070169; GO:0071230; GO:0072574; GO:0090575; GO:0097421; GO:0120162; GO:1990440; GO:2000120; GO:2000144; GO:2000617; GO:2001198	"cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; fat cell differentiation [GO:0045444]; hepatocyte proliferation [GO:0072574]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to lipopolysaccharide [GO:0032496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38617_c1_g1_i1	Q05826	CEBPB_CHICK	57.7	78	31	1	374	141	239	314	7.30E-13	76.3	CEBPB_CHICK	reviewed	CCAAT/enhancer-binding protein beta (C/EBP beta) (Transcription factor NF-M) (CCR protein)	CEBPB	Gallus gallus (Chicken)	328	"condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; ubiquitin-like protein ligase binding [GO:0044389]; cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; fat cell differentiation [GO:0045444]; hepatocyte proliferation [GO:0072574]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to lipopolysaccharide [GO:0032496]"	"condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]"	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; ubiquitin-like protein ligase binding [GO:0044389]"	GO:0000779; GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0000987; GO:0001046; GO:0001228; GO:0001541; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0010628; GO:0016363; GO:0019900; GO:0030182; GO:0032496; GO:0032675; GO:0032753; GO:0035035; GO:0042130; GO:0042742; GO:0042802; GO:0042826; GO:0043524; GO:0044389; GO:0045444; GO:0045600; GO:0045669; GO:0045670; GO:0045892; GO:0050729; GO:0060850; GO:0070059; GO:0070169; GO:0071230; GO:0072574; GO:0090575; GO:0097421; GO:0120162; GO:1990440; GO:2000120; GO:2000144; GO:2000617; GO:2001198	"cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; fat cell differentiation [GO:0045444]; hepatocyte proliferation [GO:0072574]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to lipopolysaccharide [GO:0032496]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4870_c0_g1_i1	Q03701	CEBPZ_HUMAN	47.9	142	72	1	507	82	689	828	2.00E-33	143.7	CEBPZ_HUMAN	reviewed	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)	CEBPZ CBF2	Homo sapiens (Human)	1054	nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0003723; GO:0005634; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN5593_c0_g1_i2	Q03701	CEBPZ_HUMAN	36.2	508	308	10	1661	156	126	623	2.00E-79	298.1	CEBPZ_HUMAN	reviewed	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)	CEBPZ CBF2	Homo sapiens (Human)	1054	nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0003723; GO:0005634; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN852_c0_g1_i1	Q8T8R1	Y3800_DROME	41.8	182	59	4	614	126	7	160	1.60E-36	154.5	Y3800_DROME	reviewed	CCHC-type zinc finger protein CG3800	CG3800	Drosophila melanogaster (Fruit fly)	165	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]		blue	blue	NA	NA	NA	NA
TRINITY_DN852_c0_g1_i2	Q8T8R1	Y3800_DROME	47.5	158	51	5	956	561	7	158	1.90E-35	151.4	Y3800_DROME	reviewed	CCHC-type zinc finger protein CG3800	CG3800	Drosophila melanogaster (Fruit fly)	165	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]		blue	blue	NA	NA	NA	NA
TRINITY_DN852_c0_g1_i3	Q8T8R1	Y3800_DROME	41.8	182	59	4	968	480	7	160	3.00E-36	154.1	Y3800_DROME	reviewed	CCHC-type zinc finger protein CG3800	CG3800	Drosophila melanogaster (Fruit fly)	165	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]		blue	blue	NA	NA	NA	NA
TRINITY_DN852_c0_g1_i4	Q8T8R1	Y3800_DROME	54.5	110	37	4	418	110	55	158	2.70E-29	129.8	Y3800_DROME	reviewed	CCHC-type zinc finger protein CG3800	CG3800	Drosophila melanogaster (Fruit fly)	165	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]		NA	NA	NA	NA	NA	NA
TRINITY_DN852_c0_g1_i5	Q8T8R1	Y3800_DROME	47.5	158	51	5	602	207	7	158	1.30E-35	151.4	Y3800_DROME	reviewed	CCHC-type zinc finger protein CG3800	CG3800	Drosophila melanogaster (Fruit fly)	165	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]		blue	blue	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i14	P18406	CCN1_MOUSE	34.1	317	142	7	1235	453	30	335	3.90E-49	197.2	CCN1_MOUSE	reviewed	CCN family member 1 (3CH61) (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61)	Ccn1 Cyr61 Igfbp10	Mus musculus (Mouse)	379	"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005520; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043065; GO:0043066; GO:0043280; GO:0044319; GO:0045597; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:0098609; GO:2000304	"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i16	P18406	CCN1_MOUSE	37	243	96	5	662	99	30	270	3.80E-41	169.9	CCN1_MOUSE	reviewed	CCN family member 1 (3CH61) (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61)	Ccn1 Cyr61 Igfbp10	Mus musculus (Mouse)	379	"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005520; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043065; GO:0043066; GO:0043280; GO:0044319; GO:0045597; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:0098609; GO:2000304	"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i4	P18406	CCN1_MOUSE	34.1	317	142	7	1216	434	30	335	3.70E-49	197.2	CCN1_MOUSE	reviewed	CCN family member 1 (3CH61) (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61)	Ccn1 Cyr61 Igfbp10	Mus musculus (Mouse)	379	"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005520; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043065; GO:0043066; GO:0043280; GO:0044319; GO:0045597; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:0098609; GO:2000304	"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i3	O00622	CCN1_HUMAN	47.7	65	32	2	280	92	30	94	2.30E-10	66.6	CCN1_HUMAN	reviewed	CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)	CCN1 CYR61 GIG1 IGFBP10	Homo sapiens (Human)	381	"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005520; GO:0005788; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043066; GO:0043280; GO:0043687; GO:0044267; GO:0044319; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:2000304	"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"		NA	NA	1	NA	NA	NA
TRINITY_DN12880_c0_g1_i12	O00622	CCN1_HUMAN	49.3	73	34	3	440	228	30	101	4.60E-12	72.8	CCN1_HUMAN	reviewed	CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)	CCN1 CYR61 GIG1 IGFBP10	Homo sapiens (Human)	381	"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005520; GO:0005788; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043066; GO:0043280; GO:0043687; GO:0044267; GO:0044319; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:2000304	"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i6	O00622	CCN1_HUMAN	47.7	65	32	2	280	92	30	94	1.60E-10	67	CCN1_HUMAN	reviewed	CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)	CCN1 CYR61 GIG1 IGFBP10	Homo sapiens (Human)	381	"collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005520; GO:0005788; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043066; GO:0043280; GO:0043687; GO:0044267; GO:0044319; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:2000304	"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i8	Q9QZQ5	CCN3_RAT	50	46	22	1	233	96	200	244	2.50E-06	52.8	CCN3_RAT	reviewed	CCN family member 3 (Cellular communication network factor 3) (Nephroblastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH)	Ccn3 Nov	Rattus norvegicus (Rat)	351	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]	GO:0001525; GO:0002062; GO:0005112; GO:0005178; GO:0005520; GO:0005576; GO:0005737; GO:0005921; GO:0007155; GO:0007165; GO:0008083; GO:0008201; GO:0010468; GO:0010761; GO:0010832; GO:0014909; GO:0030308; GO:0030424; GO:0030425; GO:0031012; GO:0033627; GO:0035767; GO:0043025; GO:0043231; GO:0044342; GO:0045747; GO:0046676; GO:0048659; GO:0050728; GO:0060326; GO:0060392; GO:0060548; GO:0061484; GO:0062023; GO:0071603; GO:0090027; GO:1901223; GO:1902731; GO:1904057; GO:1990523	angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell chemotaxis [GO:0035767]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	1	NA	NA	NA
TRINITY_DN12880_c0_g1_i17	P42642	CCN3_COTJA	25.7	288	104	7	1016	450	36	312	3.50E-19	97.4	CCN3_COTJA	reviewed	CCN family member 3 (Cellular communication network factor 3) (Nephroblastoma-overexpressed gene protein) (Protein NOV)	CCN3 NOV	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	353	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; growth factor activity [GO:0008083]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion mediated by integrin [GO:0033627]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]	growth factor activity [GO:0008083]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]	GO:0001525; GO:0002062; GO:0005112; GO:0005178; GO:0005520; GO:0005576; GO:0005737; GO:0005921; GO:0008083; GO:0010761; GO:0010832; GO:0014909; GO:0030308; GO:0033627; GO:0035767; GO:0043231; GO:0044342; GO:0045747; GO:0046676; GO:0048659; GO:0050728; GO:0060392; GO:0061484; GO:0071603; GO:0090027; GO:1901223; GO:1902731; GO:1990523	angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion mediated by integrin [GO:0033627]; chondrocyte differentiation [GO:0002062]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell chemotaxis [GO:0035767]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN12880_c0_g1_i18	P42642	CCN3_COTJA	25.7	288	104	7	997	431	36	312	2.60E-19	97.8	CCN3_COTJA	reviewed	CCN family member 3 (Cellular communication network factor 3) (Nephroblastoma-overexpressed gene protein) (Protein NOV)	CCN3 NOV	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	353	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; growth factor activity [GO:0008083]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion mediated by integrin [GO:0033627]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]	growth factor activity [GO:0008083]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]	GO:0001525; GO:0002062; GO:0005112; GO:0005178; GO:0005520; GO:0005576; GO:0005737; GO:0005921; GO:0008083; GO:0010761; GO:0010832; GO:0014909; GO:0030308; GO:0033627; GO:0035767; GO:0043231; GO:0044342; GO:0045747; GO:0046676; GO:0048659; GO:0050728; GO:0060392; GO:0061484; GO:0071603; GO:0090027; GO:1901223; GO:1902731; GO:1990523	angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion mediated by integrin [GO:0033627]; chondrocyte differentiation [GO:0002062]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell chemotaxis [GO:0035767]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN3834_c0_g1_i1	A1A5H6	CNOT1_DANRE	59.5	111	41	3	11	334	793	902	1.30E-28	127.1	CNOT1_DANRE	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1 zgc:152902	Danio rerio (Zebrafish) (Brachydanio rerio)	2374	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0048589; GO:0060090; GO:0060213; GO:1900153	"developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3834_c0_g1_i2	A1A5H6	CNOT1_DANRE	63.8	213	73	3	11	640	793	1004	2.50E-71	270	CNOT1_DANRE	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1 zgc:152902	Danio rerio (Zebrafish) (Brachydanio rerio)	2374	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0048589; GO:0060090; GO:0060213; GO:1900153	"developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13033_c0_g1_i1	A1A5H6	CNOT1_DANRE	53.8	78	28	2	18	242	1046	1118	9.70E-15	80.5	CNOT1_DANRE	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1 zgc:152902	Danio rerio (Zebrafish) (Brachydanio rerio)	2374	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0048589; GO:0060090; GO:0060213; GO:1900153	"developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13033_c0_g1_i2	A1A5H6	CNOT1_DANRE	56.7	67	21	2	18	209	1046	1107	1.60E-11	69.7	CNOT1_DANRE	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1 zgc:152902	Danio rerio (Zebrafish) (Brachydanio rerio)	2374	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0048589; GO:0060090; GO:0060213; GO:1900153	"developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35828_c0_g1_i1	A0JP85	CNOT1_XENTR	52	252	103	5	24	767	1767	2004	3.20E-64	246.5	CNOT1_XENTR	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2388	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:1900153	"gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29734_c0_g1_i1	A1A5H6	CNOT1_DANRE	45	111	50	4	331	20	617	723	1.70E-14	80.1	CNOT1_DANRE	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1 zgc:152902	Danio rerio (Zebrafish) (Brachydanio rerio)	2374	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0048589; GO:0060090; GO:0060213; GO:1900153	"developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29840_c0_g1_i1	A1A5H6	CNOT1_DANRE	99.1	106	1	0	320	3	820	925	2.10E-57	222.6	CNOT1_DANRE	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	cnot1 zgc:152902	Danio rerio (Zebrafish) (Brachydanio rerio)	2374	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]; developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; retinoic acid receptor binding [GO:0042974]	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0048589; GO:0060090; GO:0060213; GO:1900153	"developmental growth [GO:0048589]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4391_c0_g1_i1	A5YKK6	CNOT1_HUMAN	80.5	365	69	2	1	1095	1989	2351	3.80E-173	609	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4391_c0_g1_i2	A5YKK6	CNOT1_HUMAN	80.2	378	73	2	1	1134	1989	2364	3.10E-178	625.9	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12369_c0_g1_i1	A5YKK6	CNOT1_HUMAN	52.7	129	60	1	490	104	1354	1481	1.50E-28	127.5	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12369_c0_g1_i3	A5YKK6	CNOT1_HUMAN	53.8	132	60	1	409	14	1354	1484	1.80E-30	133.7	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26759_c0_g1_i1	A5YKK6	CNOT1_HUMAN	58.7	109	44	1	335	9	2080	2187	4.40E-34	145.2	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21692_c0_g1_i1	A5YKK6	CNOT1_HUMAN	100	144	0	0	432	1	2021	2164	3.30E-82	305.4	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21692_c0_g1_i2	A5YKK6	CNOT1_HUMAN	100	356	0	0	1108	41	2021	2376	7.30E-211	734.2	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37664_c0_g1_i1	A5YKK6	CNOT1_HUMAN	74.5	102	26	0	328	23	2261	2362	1.30E-41	170.2	CNOT1_HUMAN	reviewed	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	2376	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0006977; GO:0007275; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by miRNA [GO:0035195]; multicellular organism development [GO:0007275]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6606_c0_g1_i1	Q08CL8	CNO10_DANRE	40.1	464	218	11	2	1255	136	585	3.60E-71	270.4	CNO10_DANRE	reviewed	CCR4-NOT transcription complex subunit 10	cnot10 im:7139356 zgc:152939	Danio rerio (Zebrafish) (Brachydanio rerio)	624	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006402; GO:0017148; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]		NA	NA	NA	NA	NA	NA
TRINITY_DN27710_c0_g1_i1	Q9UKZ1	CNO11_HUMAN	98.6	69	1	0	3	209	86	154	5.20E-33	141	CNO11_HUMAN	reviewed	CCR4-NOT transcription complex subunit 11	CNOT11 C2orf29 C40	Homo sapiens (Human)	510	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0000289; GO:0005634; GO:0005829; GO:0006417; GO:0006977; GO:0030014; GO:0031047	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27168_c0_g1_i1	A4QP78	CNO11_DANRE	83.9	137	22	0	6	416	297	433	4.80E-57	221.9	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN27168_c0_g1_i2	A4QP78	CNO11_DANRE	67.3	98	32	0	6	299	297	394	7.20E-29	128.3	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN27168_c0_g1_i2	A4QP78	CNO11_DANRE	88.1	59	7	0	239	415	375	433	2.70E-20	99.8	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1912_c0_g1_i6	Q9UKZ1	CNO11_HUMAN	81.5	168	31	0	533	30	343	510	2.90E-70	266.9	CNO11_HUMAN	reviewed	CCR4-NOT transcription complex subunit 11	CNOT11 C2orf29 C40	Homo sapiens (Human)	510	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0000289; GO:0005634; GO:0005829; GO:0006417; GO:0006977; GO:0030014; GO:0031047	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"		NA	NA	1	NA	NA	NA
TRINITY_DN1912_c0_g1_i8	Q9UKZ1	CNO11_HUMAN	81.5	168	31	0	411	914	343	510	2.20E-70	267.3	CNO11_HUMAN	reviewed	CCR4-NOT transcription complex subunit 11	CNOT11 C2orf29 C40	Homo sapiens (Human)	510	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0000289; GO:0005634; GO:0005829; GO:0006417; GO:0006977; GO:0030014; GO:0031047	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"		NA	NA	1	NA	NA	NA
TRINITY_DN1912_c0_g1_i2	A4QP78	CNO11_DANRE	43.4	189	101	5	628	65	1	184	8.90E-31	135.2	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1912_c0_g1_i4	A4QP78	CNO11_DANRE	57.4	455	182	9	1388	30	1	445	1.90E-126	454.1	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1912_c0_g1_i7	A4QP78	CNO11_DANRE	57.4	455	182	9	30	1388	1	445	1.90E-126	454.1	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1912_c0_g1_i9	A4QP78	CNO11_DANRE	72	50	13	1	179	30	397	445	6.10E-11	67.8	CNO11_DANRE	reviewed	CCR4-NOT transcription complex subunit 11	cnot11 zgc:163002	Danio rerio (Zebrafish) (Brachydanio rerio)	445	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0031047	gene silencing by RNA [GO:0031047]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN32930_c0_g1_i1	Q9UKZ1	CNO11_HUMAN	100	164	0	0	1	492	337	500	5.50E-86	318.2	CNO11_HUMAN	reviewed	CCR4-NOT transcription complex subunit 11	CNOT11 C2orf29 C40	Homo sapiens (Human)	510	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0000289; GO:0005634; GO:0005829; GO:0006417; GO:0006977; GO:0030014; GO:0031047	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24078_c0_g1_i1	Q9NZN8	CNOT2_HUMAN	100	203	0	0	610	2	334	536	7.20E-121	434.5	CNOT2_HUMAN	reviewed	CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2)	CNOT2 CDC36 NOT2 HSPC131 MSTP046	Homo sapiens (Human)	540	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]	RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0000289; GO:0000932; GO:0001226; GO:0001829; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24078_c0_g1_i2	Q9NZN8	CNOT2_HUMAN	99.2	132	1	0	410	15	334	465	3.30E-72	272.3	CNOT2_HUMAN	reviewed	CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2)	CNOT2 CDC36 NOT2 HSPC131 MSTP046	Homo sapiens (Human)	540	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]	RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0000289; GO:0000932; GO:0001226; GO:0001829; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3080_c0_g1_i1	Q9NZN8	CNOT2_HUMAN	61.6	315	96	5	1001	102	225	529	1.00E-103	378.6	CNOT2_HUMAN	reviewed	CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2)	CNOT2 CDC36 NOT2 HSPC131 MSTP046	Homo sapiens (Human)	540	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]	RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0000289; GO:0000932; GO:0001226; GO:0001829; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7851_c0_g1_i1	O95628	CNOT4_HUMAN	77.1	175	40	0	525	1	9	183	5.50E-73	275.4	CNOT4_HUMAN	reviewed	CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4)	CNOT4 NOT4	Homo sapiens (Human)	575	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]"	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0006977; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7851_c0_g1_i2	O95628	CNOT4_HUMAN	75	180	40	1	540	1	9	183	4.00E-71	269.2	CNOT4_HUMAN	reviewed	CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4)	CNOT4 NOT4	Homo sapiens (Human)	575	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]"	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0006977; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28942_c0_g1_i1	Q8K3P5	CNOT6_MOUSE	100	104	0	0	313	2	284	387	5.70E-52	204.5	CNOT6_MOUSE	reviewed	CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase)	Cnot6 Ccr4 Kiaa1194	Mus musculus (Mouse)	557	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of translation [GO:0006417]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0043928; GO:0046872; GO:0070966; GO:2000327	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13157_c0_g1_i1	Q8VEG6	CNO6L_MOUSE	60.5	362	133	4	91	1176	189	540	6.20E-126	452.2	CNO6L_MOUSE	reviewed	CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4)	Cnot6l	Mus musculus (Mouse)	555	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000288; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872; GO:0061157	"gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13157_c0_g1_i2	Q8VEG6	CNO6L_MOUSE	59.9	419	158	4	2	1258	132	540	1.10E-144	514.6	CNO6L_MOUSE	reviewed	CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4)	Cnot6l	Mus musculus (Mouse)	555	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000288; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872; GO:0061157	"gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33853_c0_g1_i1	Q8VEG6	CNO6L_MOUSE	99.2	121	1	0	3	365	368	488	5.70E-65	248.1	CNO6L_MOUSE	reviewed	CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4)	Cnot6l	Mus musculus (Mouse)	555	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000288; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872; GO:0061157	"gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18306_c0_g1_i1	Q3ZC01	CNOT7_BOVIN	100	263	0	0	1	789	15	277	1.20E-154	547	CNOT7_BOVIN	reviewed	CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1)	CNOT7 CAF1	Bos taurus (Bovine)	285	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0008134; GO:0008284; GO:0008285; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:1900153	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25831_c0_g1_i1	Q3ZC01	CNOT7_BOVIN	51.7	205	99	0	49	663	12	216	1.10E-60	234.6	CNOT7_BOVIN	reviewed	CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1)	CNOT7 CAF1	Bos taurus (Bovine)	285	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0008134; GO:0008284; GO:0008285; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:1900153	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38654_c0_g1_i1	Q3ZC01	CNOT7_BOVIN	79.6	265	52	1	913	125	12	276	2.90E-122	439.9	CNOT7_BOVIN	reviewed	CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1)	CNOT7 CAF1	Bos taurus (Bovine)	285	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0008134; GO:0008284; GO:0008285; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:1900153	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40587_c0_g1_i1	Q9UFF9	CNOT8_HUMAN	100	74	0	0	224	3	199	272	6.30E-37	154.1	CNOT8_HUMAN	reviewed	CCR4-NOT transcription complex subunit 8 (EC 3.1.13.4) (CAF1-like protein) (CALIFp) (CAF2) (CCR4-associated factor 8) (Caf1b)	CNOT8 CALIF POP2	Homo sapiens (Human)	292	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005829; GO:0006351; GO:0006977; GO:0008284; GO:0017148; GO:0030014; GO:0030015; GO:0035195; GO:0043928; GO:0046872; GO:0061014	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14588_c0_g1_i1	Q9UFF9	CNOT8_HUMAN	100	275	0	0	8	832	1	275	3.40E-160	565.5	CNOT8_HUMAN	reviewed	CCR4-NOT transcription complex subunit 8 (EC 3.1.13.4) (CAF1-like protein) (CALIFp) (CAF2) (CCR4-associated factor 8) (Caf1b)	CNOT8 CALIF POP2	Homo sapiens (Human)	292	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005829; GO:0006351; GO:0006977; GO:0008284; GO:0017148; GO:0030014; GO:0030015; GO:0035195; GO:0043928; GO:0046872; GO:0061014	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14588_c0_g1_i2	Q9UFF9	CNOT8_HUMAN	99.5	189	1	0	8	574	1	189	3.30E-106	385.6	CNOT8_HUMAN	reviewed	CCR4-NOT transcription complex subunit 8 (EC 3.1.13.4) (CAF1-like protein) (CALIFp) (CAF2) (CCR4-associated factor 8) (Caf1b)	CNOT8 CALIF POP2	Homo sapiens (Human)	292	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005829; GO:0006351; GO:0006977; GO:0008284; GO:0017148; GO:0030014; GO:0030015; GO:0035195; GO:0043928; GO:0046872; GO:0061014	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11229_c0_g1_i1	A7MB47	CNOT9_BOVIN	85.3	285	41	1	949	98	14	298	1.10E-134	481.1	CNOT9_BOVIN	reviewed	CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1)	CNOT9 RCD1 RQCD1	Bos taurus (Bovine)	299	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	GO:0000932; GO:0005154; GO:0005634; GO:0006402; GO:0017148; GO:0019221; GO:0019900; GO:0019904; GO:0030014; GO:0030015; GO:0031047; GO:0033138; GO:0033147; GO:0042803; GO:0045742; GO:2000327	cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]		NA	NA	NA	NA	NA	NA
TRINITY_DN26781_c0_g1_i1	A7MB47	CNOT9_BOVIN	74.6	252	63	1	762	7	26	276	4.20E-101	369	CNOT9_BOVIN	reviewed	CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1)	CNOT9 RCD1 RQCD1	Bos taurus (Bovine)	299	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]	epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	GO:0000932; GO:0005154; GO:0005634; GO:0006402; GO:0017148; GO:0019221; GO:0019900; GO:0019904; GO:0030014; GO:0030015; GO:0031047; GO:0033138; GO:0033147; GO:0042803; GO:0045742; GO:2000327	cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]		NA	NA	NA	NA	NA	NA
TRINITY_DN24317_c0_g1_i1	Q92600	CNOT9_HUMAN	99.2	241	2	0	3	725	4	244	3.10E-131	469.2	CNOT9_HUMAN	reviewed	CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1)	CNOT9 RCD1 RQCD1	Homo sapiens (Human)	299	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; sex differentiation [GO:0007548]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]	epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	GO:0000289; GO:0000932; GO:0005154; GO:0005634; GO:0005829; GO:0006977; GO:0007548; GO:0016020; GO:0017148; GO:0019221; GO:0019900; GO:0019904; GO:0030014; GO:0030015; GO:0031047; GO:0032991; GO:0033138; GO:0033147; GO:0042803; GO:0045742; GO:2000327	"cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24317_c0_g1_i2	Q92600	CNOT9_HUMAN	99.2	252	2	0	3	758	4	255	9.60E-138	490.7	CNOT9_HUMAN	reviewed	CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1)	CNOT9 RCD1 RQCD1	Homo sapiens (Human)	299	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; sex differentiation [GO:0007548]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]	epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	GO:0000289; GO:0000932; GO:0005154; GO:0005634; GO:0005829; GO:0006977; GO:0007548; GO:0016020; GO:0017148; GO:0019221; GO:0019900; GO:0019904; GO:0030014; GO:0030015; GO:0031047; GO:0032991; GO:0033138; GO:0033147; GO:0042803; GO:0045742; GO:2000327	"cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16942_c0_g1_i1	Q6YHK3	CD109_HUMAN	40.9	132	76	1	422	33	854	985	6.80E-24	111.7	CD109_HUMAN	reviewed	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	CD109 CPAMD7	Homo sapiens (Human)	1445	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]		NA	NA	NA	NA	NA	NA
TRINITY_DN9935_c0_g1_i1	Q6YHK3	CD109_HUMAN	43.9	66	37	0	88	285	202	267	6.80E-09	62	CD109_HUMAN	reviewed	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	CD109 CPAMD7	Homo sapiens (Human)	1445	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]		NA	NA	NA	NA	NA	NA
TRINITY_DN40438_c0_g1_i1	Q6YHK3	CD109_HUMAN	68.1	47	15	0	146	6	960	1006	6.50E-12	70.9	CD109_HUMAN	reviewed	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	CD109 CPAMD7	Homo sapiens (Human)	1445	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]		NA	NA	NA	NA	NA	NA
TRINITY_DN6986_c0_g1_i12	Q8R422	CD109_MOUSE	26.5	268	183	2	1247	483	131	397	6.00E-20	100.1	CD109_MOUSE	reviewed	CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109)	Cd109	Mus musculus (Mouse)	1442	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	GO:0001933; GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]		NA	NA	NA	NA	NA	NA
TRINITY_DN6986_c0_g1_i5	Q8R422	CD109_MOUSE	26.5	268	183	2	2379	1615	131	397	1.10E-19	100.1	CD109_MOUSE	reviewed	CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109)	Cd109	Mus musculus (Mouse)	1442	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	GO:0001933; GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]		NA	NA	NA	NA	NA	NA
TRINITY_DN12840_c0_g2_i3	Q9CWK3	CD2B2_MOUSE	38.3	345	184	10	1097	93	17	342	3.70E-46	187.2	CD2B2_MOUSE	reviewed	CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2)	Cd2bp2	Mus musculus (Mouse)	342	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]	ribonucleoprotein complex binding [GO:0043021]	GO:0001650; GO:0005634; GO:0005654; GO:0005682; GO:0005829; GO:0006397; GO:0008380; GO:0010923; GO:0016607; GO:0043021	mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]		NA	NA	1	NA	NA	NA
TRINITY_DN12840_c0_g2_i1	Q9CWK3	CD2B2_MOUSE	44.8	172	83	6	642	133	17	178	2.40E-22	107.5	CD2B2_MOUSE	reviewed	CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2)	Cd2bp2	Mus musculus (Mouse)	342	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]	ribonucleoprotein complex binding [GO:0043021]	GO:0001650; GO:0005634; GO:0005654; GO:0005682; GO:0005829; GO:0006397; GO:0008380; GO:0010923; GO:0016607; GO:0043021	mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12840_c0_g2_i2	Q9CWK3	CD2B2_MOUSE	38.3	345	184	10	1097	93	17	342	4.90E-46	186.8	CD2B2_MOUSE	reviewed	CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2)	Cd2bp2	Mus musculus (Mouse)	342	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]	ribonucleoprotein complex binding [GO:0043021]	GO:0001650; GO:0005634; GO:0005654; GO:0005682; GO:0005829; GO:0006397; GO:0008380; GO:0010923; GO:0016607; GO:0043021	mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12840_c0_g2_i6	Q9CWK3	CD2B2_MOUSE	44.8	172	83	6	642	133	17	178	1.80E-22	107.8	CD2B2_MOUSE	reviewed	CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2)	Cd2bp2	Mus musculus (Mouse)	342	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]	ribonucleoprotein complex binding [GO:0043021]	GO:0001650; GO:0005634; GO:0005654; GO:0005682; GO:0005829; GO:0006397; GO:0008380; GO:0010923; GO:0016607; GO:0043021	mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12840_c0_g2_i7	Q9CWK3	CD2B2_MOUSE	42.5	167	84	6	592	98	17	173	2.30E-19	97.4	CD2B2_MOUSE	reviewed	CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2)	Cd2bp2	Mus musculus (Mouse)	342	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]	ribonucleoprotein complex binding [GO:0043021]	GO:0001650; GO:0005634; GO:0005654; GO:0005682; GO:0005829; GO:0006397; GO:0008380; GO:0010923; GO:0016607; GO:0043021	mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN15042_c0_g1_i2	P40239	CD9_FELCA	45.2	93	42	1	367	89	6	89	2.90E-13	76.3	CD9_FELCA	reviewed	CD9 antigen (CD antigen CD9)	CD9	Felis catus (Cat) (Felis silvestris catus)	226	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]	GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007338; GO:0007342; GO:0014905; GO:0016020; GO:0030913; GO:0031623; GO:0035036; GO:0051271; GO:0071404; GO:0090331	cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]		NA	NA	NA	NA	NA	NA
TRINITY_DN34114_c0_g1_i1	P40240	CD9_MOUSE	100	121	0	0	34	396	1	121	2.80E-64	245.7	CD9_MOUSE	reviewed	CD9 antigen (CD antigen CD9)	Cd9	Mus musculus (Mouse)	226	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; oligodendrocyte development [GO:0014003]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; response to water deprivation [GO:0009414]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	integrin binding [GO:0005178]	GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007338; GO:0007342; GO:0007420; GO:0008285; GO:0008347; GO:0009414; GO:0009897; GO:0009986; GO:0014003; GO:0014905; GO:0016020; GO:0016324; GO:0030913; GO:0031623; GO:0032991; GO:0035036; GO:0051271; GO:0070062; GO:0071404; GO:0090331; GO:1905521	brain development [GO:0007420]; cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; oligodendrocyte development [GO:0014003]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; response to water deprivation [GO:0009414]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]		NA	NA	NA	NA	NA	NA
TRINITY_DN7389_c0_g1_i1	Q6NRW5	CO041_XENLA	50	244	121	1	129	860	28	270	4.50E-67	256.1	CDIN1_XENLA	reviewed	CDAN1-interacting nuclease 1		Xenopus laevis (African clawed frog)	303	cytoplasm [GO:0005737]; nucleus [GO:0005634]; erythrocyte differentiation [GO:0030218]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0030218	erythrocyte differentiation [GO:0030218]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i11	Q16YG0	CDC42_AEDAE	57.7	104	44	0	396	85	2	105	4.30E-28	125.9	CDC42_AEDAE	reviewed	Cdc42 homolog	Cdc42 AAEL008543	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	191	adherens junction [GO:0005912]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]	adherens junction [GO:0005912]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0005912; GO:0007264; GO:0007275; GO:0045185; GO:0045860	maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	1
TRINITY_DN222_c0_g1_i21	Q16YG0	CDC42_AEDAE	57.7	104	44	0	396	85	2	105	4.20E-28	125.9	CDC42_AEDAE	reviewed	Cdc42 homolog	Cdc42 AAEL008543	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	191	adherens junction [GO:0005912]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]	adherens junction [GO:0005912]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0005912; GO:0007264; GO:0007275; GO:0045185; GO:0045860	maintenance of protein location [GO:0045185]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; small GTPase mediated signal transduction [GO:0007264]		blue	blue	NA	NA	NA	NA
TRINITY_DN6773_c0_g1_i1	Q17031	CDC42_ANOGA	93.7	191	12	0	696	124	1	191	1.50E-101	370.5	CDC42_ANOGA	reviewed	Cdc42 homolog (25 kDa GTP-binding protein)	Cdc42 AGAP002440	Anopheles gambiae (African malaria mosquito)	191	adherens junction [GO:0005912]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Cdc42 protein signal transduction [GO:0032488]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; multicellular organism development [GO:0007275]	adherens junction [GO:0005912]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0005912; GO:0006897; GO:0007275; GO:0016477; GO:0030031; GO:0032488	Cdc42 protein signal transduction [GO:0032488]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN6697_c0_g1_i1	Q3ZBU2	CISD1_BOVIN	53.1	96	42	1	137	415	10	105	1.30E-23	110.9	CISD1_BOVIN	reviewed	CDGSH iron-sulfur domain-containing protein 1 (MitoNEET)	CISD1 ZCD1	Bos taurus (Bovine)	106	"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"	GO:0005741; GO:0016021; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN6697_c0_g1_i2	Q3ZBU2	CISD1_BOVIN	53.1	96	42	1	87	365	10	105	5.30E-24	112.1	CISD1_BOVIN	reviewed	CDGSH iron-sulfur domain-containing protein 1 (MitoNEET)	CISD1 ZCD1	Bos taurus (Bovine)	106	"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"	GO:0005741; GO:0016021; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN30351_c0_g1_i1	Q8R0X2	CACL1_MOUSE	39.4	231	136	2	212	904	135	361	3.20E-40	167.2	CACL1_MOUSE	reviewed	CDK2-associated and cullin domain-containing protein 1	Cacul1	Mus musculus (Mouse)	377	protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]		protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0006511; GO:0008284; GO:0019901; GO:0031625; GO:0045860	G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10412_c0_g1_i1	Q8TDN4	CABL1_HUMAN	40.6	360	163	7	1147	83	320	633	2.10E-58	228.4	CABL1_HUMAN	reviewed	CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1)	CABLES1 CABLES	Homo sapiens (Human)	633	cytosol [GO:0005829]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell cycle [GO:0051726]	cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0007049; GO:0051301; GO:0051726	cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell cycle [GO:0051726]		NA	NA	NA	NA	NA	NA
TRINITY_DN32559_c0_g1_i1	Q9BTV7	CABL2_HUMAN	100	105	0	0	316	2	292	396	2.50E-55	215.7	CABL2_HUMAN	reviewed	CDK5 and ABL1 enzyme substrate 2 (Interactor with CDK3 2) (Ik3-2)	CABLES2 C20orf150	Homo sapiens (Human)	478	cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell cycle [GO:0051726]			GO:0007049; GO:0051301; GO:0051726	cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell cycle [GO:0051726]		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i16	Q8K389	CK5P2_MOUSE	61.4	44	17	0	23	154	47	90	9.50E-07	55.1	CK5P2_MOUSE	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48)	Cdk5rap2 Kiaa1633	Mus musculus (Mouse)	1822	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0008274; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044877; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i1	Q96SN8	CK5P2_HUMAN	66.7	39	13	0	171	287	53	91	1.50E-06	54.7	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i12	Q96SN8	CK5P2_HUMAN	44.5	128	66	2	38	409	53	179	1.50E-15	84.3	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i2	Q96SN8	CK5P2_HUMAN	66.7	39	13	0	171	287	53	91	1.60E-06	54.7	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i3	Q96SN8	CK5P2_HUMAN	66.7	39	13	0	171	287	53	91	1.50E-06	54.7	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i4	Q96SN8	CK5P2_HUMAN	66.7	39	13	0	171	287	53	91	1.80E-06	54.7	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i5	Q96SN8	CK5P2_HUMAN	44.5	128	66	2	171	542	53	179	1.40E-15	84.7	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4331_c0_g1_i8	Q96SN8	CK5P2_HUMAN	66.7	39	13	0	171	287	53	91	1.80E-06	54.7	CK5P2_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	1893	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8928_c0_g1_i1	Q99LM2	CK5P3_MOUSE	48.4	275	136	3	95	916	1	270	5.20E-69	262.7	CK5P3_MOUSE	reviewed	CDK5 regulatory subunit-associated protein 3	Cdk5rap3	Mus musculus (Mouse)	503	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007095; GO:0007346; GO:0008283; GO:0010921; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032991; GO:0034976; GO:0043231; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0044877; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0097371; GO:1900182; GO:1901798; GO:1903363	apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN8928_c0_g1_i6	Q99LM2	CK5P3_MOUSE	48.4	275	136	3	95	916	1	270	5.20E-69	262.7	CK5P3_MOUSE	reviewed	CDK5 regulatory subunit-associated protein 3	Cdk5rap3	Mus musculus (Mouse)	503	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007095; GO:0007346; GO:0008283; GO:0010921; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032991; GO:0034976; GO:0043231; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0044877; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0097371; GO:1900182; GO:1901798; GO:1903363	apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN41004_c0_g1_i1	Q96JB5	CK5P3_HUMAN	98.7	76	1	0	230	3	49	124	5.00E-37	154.5	CK5P3_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27)	CDK5RAP3 IC53 LZAP MSTP016 OK/SW-cl.114 PP1553	Homo sapiens (Human)	506	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; viral process [GO:0016032]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007095; GO:0007346; GO:0007420; GO:0008283; GO:0010921; GO:0016020; GO:0016032; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032991; GO:0034976; GO:0043231; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0045664; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0097371; GO:1900182; GO:1901798; GO:1903363	apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN8928_c0_g1_i7	Q96JB5	CK5P3_HUMAN	52.2	161	76	1	95	574	1	161	6.20E-44	178.7	CK5P3_HUMAN	reviewed	CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27)	CDK5RAP3 IC53 LZAP MSTP016 OK/SW-cl.114 PP1553	Homo sapiens (Human)	506	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; viral process [GO:0016032]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007095; GO:0007346; GO:0007420; GO:0008283; GO:0010921; GO:0016020; GO:0016032; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032991; GO:0034976; GO:0043231; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0045664; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0097371; GO:1900182; GO:1901798; GO:1903363	apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN13897_c0_g1_i2	Q32NB8	PGPS1_HUMAN	46.4	392	188	8	88	1209	68	455	4.20E-87	323.2	PGPS1_HUMAN	reviewed	"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)"	PGS1	Homo sapiens (Human)	556	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]	GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005783; GO:0006655; GO:0008444; GO:0032049; GO:0046339	cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN13897_c0_g1_i3	Q32NB8	PGPS1_HUMAN	46.7	392	187	8	88	1209	68	455	6.50E-88	325.9	PGPS1_HUMAN	reviewed	"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)"	PGS1	Homo sapiens (Human)	556	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]	GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005783; GO:0006655; GO:0008444; GO:0032049; GO:0046339	cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN13897_c0_g1_i5	Q32NB8	PGPS1_HUMAN	47.6	372	176	7	7	1077	88	455	5.50E-86	319.3	PGPS1_HUMAN	reviewed	"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)"	PGS1	Homo sapiens (Human)	556	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]	GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005783; GO:0006655; GO:0008444; GO:0032049; GO:0046339	cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN12708_c0_g2_i1	Q9Z2Z7	PGPS1_CRIGR	57.5	106	45	0	407	90	448	553	2.10E-30	133.3	PGPS1_CRIGR	reviewed	"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)"	PGS1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	553	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]	GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005783; GO:0006655; GO:0008444; GO:0008654; GO:0032049; GO:0046339	cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]		NA	NA	NA	NA	NA	NA
TRINITY_DN34601_c0_g1_i1	Q8SX37	CDIPT_DROME	50.8	63	31	0	30	218	42	104	2.00E-08	59.3	CDIPT_DROME	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (CDIPT) (EC 2.7.8.11) (Phosphatidylinositol synthase)	Pis CG9245	Drosophila melanogaster (Fruit fly)	224	apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872]; basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]	apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]	CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872]	GO:0003881; GO:0005794; GO:0006661; GO:0007602; GO:0016021; GO:0016324; GO:0016328; GO:0046872; GO:0071711	basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]		NA	NA	NA	NA	NA	NA
TRINITY_DN12349_c0_g1_i2	O14735	CDIPT_HUMAN	37.8	82	51	0	671	426	2	83	3.60E-10	67	CDIPT_HUMAN	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	CDIPT PIS PIS1	Homo sapiens (Human)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN147_c0_g2_i2	O14735	CDIPT_HUMAN	57.6	210	89	0	122	751	4	213	2.90E-66	253.4	CDIPT_HUMAN	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	CDIPT PIS PIS1	Homo sapiens (Human)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		blue	blue	NA	NA	NA	NA
TRINITY_DN147_c0_g1_i1	O14735	CDIPT_HUMAN	74.1	27	7	0	416	336	4	30	5.20E-05	49.3	CDIPT_HUMAN	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	CDIPT PIS PIS1	Homo sapiens (Human)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN147_c0_g1_i5	O14735	CDIPT_HUMAN	74.1	27	7	0	409	329	4	30	5.20E-05	49.3	CDIPT_HUMAN	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	CDIPT PIS PIS1	Homo sapiens (Human)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		blue	blue	NA	NA	NA	NA
TRINITY_DN147_c0_g1_i8	O14735	CDIPT_HUMAN	74.1	27	7	0	416	336	4	30	5.20E-05	49.3	CDIPT_HUMAN	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	CDIPT PIS PIS1	Homo sapiens (Human)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN12826_c0_g1_i1	Q8VDP6	CDIPT_MOUSE	98.5	202	3	0	608	3	1	202	6.30E-109	394.8	CDIPT_MOUSE	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	Cdipt Pis1	Mus musculus (Mouse)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN12826_c0_g1_i2	O14735	CDIPT_HUMAN	100	202	0	0	608	3	1	202	3.00E-111	402.5	CDIPT_HUMAN	reviewed	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	CDIPT PIS PIS1	Homo sapiens (Human)	213	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN3686_c0_g1_i1	O60671	RAD1_HUMAN	53	266	125	0	18	815	11	276	2.90E-80	300.1	RAD1_HUMAN	reviewed	Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)	RAD1 REC1	Homo sapiens (Human)	282	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]	GO:0000077; GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0021762; GO:0030896; GO:0043231; GO:0051598; GO:0071479; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN3686_c0_g1_i3	O60671	RAD1_HUMAN	52	125	60	0	355	729	152	276	1.70E-34	147.9	RAD1_HUMAN	reviewed	Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)	RAD1 REC1	Homo sapiens (Human)	282	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]	GO:0000077; GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0021762; GO:0030896; GO:0043231; GO:0051598; GO:0071479; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN3686_c0_g1_i3	O60671	RAD1_HUMAN	47.9	117	61	0	18	368	11	127	1.20E-24	115.2	RAD1_HUMAN	reviewed	Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)	RAD1 REC1	Homo sapiens (Human)	282	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]	GO:0000077; GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0021762; GO:0030896; GO:0043231; GO:0051598; GO:0071479; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN40896_c0_g1_i1	O60671	RAD1_HUMAN	100	68	0	0	205	2	122	189	6.60E-33	140.6	RAD1_HUMAN	reviewed	Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)	RAD1 REC1	Homo sapiens (Human)	282	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]	GO:0000077; GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0021762; GO:0030896; GO:0043231; GO:0051598; GO:0071479; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; meiotic recombination checkpoint [GO:0051598]; regulation of signal transduction by p53 class mediator [GO:1901796]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN3686_c0_g1_i2	Q9QWZ1	RAD1_MOUSE	50.5	103	51	0	42	350	19	121	8.40E-25	114.8	RAD1_MOUSE	reviewed	Cell cycle checkpoint protein RAD1 (mRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)	Rad1 Rec1	Mus musculus (Mouse)	280	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598]	checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]	GO:0000077; GO:0005654; GO:0005694; GO:0006281; GO:0008408; GO:0008853; GO:0030896; GO:0043231; GO:0051598; GO:0071479	cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598]		NA	NA	NA	NA	NA	NA
TRINITY_DN9829_c1_g2_i2	Q6NXW6	RAD17_MOUSE	34.1	610	357	14	122	1843	3	603	1.10E-84	315.8	RAD17_MOUSE	reviewed	Cell cycle checkpoint protein RAD17	Rad17	Mus musculus (Mouse)	688	"chromosome, telomeric region [GO:0000781]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]"	"chromosome, telomeric region [GO:0000781]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rad17 RFC-like complex [GO:0031389]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]	GO:0000077; GO:0000781; GO:0000790; GO:0003682; GO:0003689; GO:0005524; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0007093; GO:0007275; GO:0008156; GO:0031389; GO:0033314; GO:0042325	cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]		NA	NA	NA	NA	NA	NA
TRINITY_DN9829_c1_g2_i1	O75943	RAD17_HUMAN	36.4	519	310	11	320	1828	91	605	1.30E-85	318.9	RAD17_HUMAN	reviewed	Cell cycle checkpoint protein RAD17 (hRad17) (RF-C/activator 1 homolog)	RAD17 R24L	Homo sapiens (Human)	681	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]	GO:0000076; GO:0000077; GO:0000790; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006974; GO:0007093; GO:0008156; GO:0031389; GO:0033314; GO:0042325; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN13559_c0_g1_i1	Q5R6C0	CC50A_PONAB	95.1	103	5	0	1	309	93	195	2.30E-53	209.1	CC50A_PONAB	reviewed	Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A)	TMEM30A CDC50A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	361	apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; phospholipid transport [GO:0015914]	apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]		GO:0005794; GO:0015914; GO:0016021; GO:0016324; GO:0030658	phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN13559_c0_g1_i2	Q8VEK0	CC50A_MOUSE	100	85	0	0	1	255	93	177	3.20E-45	181.8	CC50A_MOUSE	reviewed	Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A)	Tmem30a Cdc50a D9Wsu20e	Mus musculus (Mouse)	364	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; aminophospholipid flippase activity [GO:0015247]; aminophospholipid transport [GO:0015917]; drug transmembrane transport [GO:0006855]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]	aminophospholipid flippase activity [GO:0015247]	GO:0005783; GO:0005794; GO:0005886; GO:0006855; GO:0010976; GO:0015247; GO:0015917; GO:0016020; GO:0016021; GO:0016324; GO:0030658; GO:0036010; GO:0045332; GO:0070863	aminophospholipid transport [GO:0015917]; drug transmembrane transport [GO:0006855]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]		NA	NA	NA	NA	NA	NA
TRINITY_DN11880_c0_g1_i1	Q9NV96	CC50A_HUMAN	100	138	0	0	415	2	221	358	6.10E-78	291.2	CC50A_HUMAN	reviewed	Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A)	TMEM30A C6orf67 CDC50A	Homo sapiens (Human)	361	apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; transport vesicle membrane [GO:0030658]; aminophospholipid flippase activity [GO:0015247]; aminophospholipid transport [GO:0015917]; drug transmembrane transport [GO:0006855]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]	apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; transport vesicle membrane [GO:0030658]	aminophospholipid flippase activity [GO:0015247]	GO:0005783; GO:0005794; GO:0005886; GO:0006855; GO:0010976; GO:0015247; GO:0015917; GO:0016020; GO:0016021; GO:0016324; GO:0030658; GO:0035577; GO:0035579; GO:0036010; GO:0043312; GO:0045332; GO:0070863	aminophospholipid transport [GO:0015917]; drug transmembrane transport [GO:0006855]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]		NA	NA	NA	NA	NA	NA
TRINITY_DN11880_c0_g1_i2	Q8VEK0	CC50A_MOUSE	100	120	0	0	361	2	242	361	8.00E-66	250.8	CC50A_MOUSE	reviewed	Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A)	Tmem30a Cdc50a D9Wsu20e	Mus musculus (Mouse)	364	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; aminophospholipid flippase activity [GO:0015247]; aminophospholipid transport [GO:0015917]; drug transmembrane transport [GO:0006855]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]	aminophospholipid flippase activity [GO:0015247]	GO:0005783; GO:0005794; GO:0005886; GO:0006855; GO:0010976; GO:0015247; GO:0015917; GO:0016020; GO:0016021; GO:0016324; GO:0030658; GO:0036010; GO:0045332; GO:0070863	aminophospholipid transport [GO:0015917]; drug transmembrane transport [GO:0006855]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]		NA	NA	NA	NA	NA	NA
TRINITY_DN15697_c0_g1_i1	Q5F362	CC50A_CHICK	53.8	333	142	5	1123	140	39	364	3.70E-94	346.7	CC50A_CHICK	reviewed	Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A)	TMEM30A CDC50A RCJMB04_32j24	Gallus gallus (Chicken)	372	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; phospholipid translocation [GO:0045332]	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]		GO:0005783; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0016324; GO:0030658; GO:0045332	phospholipid translocation [GO:0045332]		blue	blue	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i9	Q9NHC3	CED2_CAEEL	33.9	56	37	0	88	255	102	157	8.40E-05	47.8	CED2_CAEEL	reviewed	Cell death abnormality protein 2 (Cell-corpse engulfment protein CED-2)	ced-2 Y41D4B.13	Caenorhabditis elegans	279	plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cell migration [GO:0016477]; engulfment of apoptotic cell [GO:0043652]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; programmed cell death [GO:0012501]; signal transduction [GO:0007165]	plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]	GO:0005886; GO:0006915; GO:0007165; GO:0012501; GO:0016477; GO:0031532; GO:0043652; GO:0044877; GO:1901076; GO:1902742; GO:1903356	actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cell migration [GO:0016477]; engulfment of apoptotic cell [GO:0043652]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; programmed cell death [GO:0012501]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN38729_c0_g1_i1	Q9UHD4	CIDEB_HUMAN	38.1	84	49	2	101	349	36	117	9.10E-05	48.9	CIDEB_HUMAN	reviewed	Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B)	CIDEB	Homo sapiens (Human)	219	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; bile acid signaling pathway [GO:0038183]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of cell death [GO:0010942]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; response to nutrient levels [GO:0031667]; viral process [GO:0016032]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	identical protein binding [GO:0042802]	GO:0005829; GO:0006915; GO:0008630; GO:0010942; GO:0016032; GO:0031667; GO:0038183; GO:0042802; GO:0042981; GO:0048471; GO:0090200; GO:0097194; GO:0097202	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; bile acid signaling pathway [GO:0038183]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of cell death [GO:0010942]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; response to nutrient levels [GO:0031667]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN7265_c0_g1_i2	P45436	CED3_CAERE	29.6	277	142	9	812	111	233	499	1.40E-21	105.1	CED3_CAERE	reviewed	Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]	ced-3 CRE_10123	Caenorhabditis remanei (Caenorhabditis vulgaris)	508	"caspase complex [GO:0008303]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]"	caspase complex [GO:0008303]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]	GO:0005739; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0016540; GO:0030042; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050829; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845	"actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7265_c0_g1_i3	P45436	CED3_CAERE	30	277	141	9	761	60	233	499	7.70E-22	105.9	CED3_CAERE	reviewed	Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]	ced-3 CRE_10123	Caenorhabditis remanei (Caenorhabditis vulgaris)	508	"caspase complex [GO:0008303]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]"	caspase complex [GO:0008303]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]	GO:0005739; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0016540; GO:0030042; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050829; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845	"actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1852_c0_g1_i1	Q38772	CDC2A_ANTMA	69.2	39	12	0	52	168	1	39	1.40E-08	60.1	CDC2A_ANTMA	reviewed	Cell division control protein 2 homolog A (EC 2.7.11.22) (EC 2.7.11.23)	CDC2A	Antirrhinum majus (Garden snapdragon)	294	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]		ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0007049; GO:0008353; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i6	Q2KJ93	CDC42_BOVIN	50.6	178	78	3	650	144	2	178	8.90E-38	158.7	CDC42_BOVIN	reviewed	Cell division control protein 42 homolog (EC 3.6.5.2)	CDC42	Bos taurus (Bovine)	191	"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"	apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]	apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]	GO:0000322; GO:0003161; GO:0003924; GO:0005525; GO:0005813; GO:0005829; GO:0005911; GO:0006897; GO:0006911; GO:0007015; GO:0007088; GO:0007097; GO:0007229; GO:0010592; GO:0016020; GO:0016477; GO:0017119; GO:0019901; GO:0030031; GO:0030175; GO:0030307; GO:0030496; GO:0030742; GO:0031258; GO:0031274; GO:0031333; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0034191; GO:0034329; GO:0034332; GO:0034613; GO:0036336; GO:0036464; GO:0038189; GO:0039694; GO:0042802; GO:0043025; GO:0043197; GO:0043393; GO:0043410; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051496; GO:0051988; GO:0060047; GO:0060501; GO:0060997; GO:0061630; GO:0071346; GO:0072686; GO:0099563; GO:1900026; GO:2000251	"actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"	x	NA	NA	1	NA	NA	NA
TRINITY_DN222_c0_g1_i8	Q2KJ93	CDC42_BOVIN	50.6	178	78	3	650	144	2	178	8.70E-38	158.7	CDC42_BOVIN	reviewed	Cell division control protein 42 homolog (EC 3.6.5.2)	CDC42	Bos taurus (Bovine)	191	"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"	apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]	apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]	GO:0000322; GO:0003161; GO:0003924; GO:0005525; GO:0005813; GO:0005829; GO:0005911; GO:0006897; GO:0006911; GO:0007015; GO:0007088; GO:0007097; GO:0007229; GO:0010592; GO:0016020; GO:0016477; GO:0017119; GO:0019901; GO:0030031; GO:0030175; GO:0030307; GO:0030496; GO:0030742; GO:0031258; GO:0031274; GO:0031333; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0034191; GO:0034329; GO:0034332; GO:0034613; GO:0036336; GO:0036464; GO:0038189; GO:0039694; GO:0042802; GO:0043025; GO:0043197; GO:0043393; GO:0043410; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051496; GO:0051988; GO:0060047; GO:0060501; GO:0060997; GO:0061630; GO:0071346; GO:0072686; GO:0099563; GO:1900026; GO:2000251	"actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"	x	brown	brown	NA	NA	NA	NA
TRINITY_DN6833_c0_g1_i1	Q2KJ93	CDC42_BOVIN	100	191	0	0	57	629	1	191	4.10E-108	392.1	CDC42_BOVIN	reviewed	Cell division control protein 42 homolog (EC 3.6.5.2)	CDC42	Bos taurus (Bovine)	191	"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"	apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]	apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]	GO:0000322; GO:0003161; GO:0003924; GO:0005525; GO:0005813; GO:0005829; GO:0005911; GO:0006897; GO:0006911; GO:0007015; GO:0007088; GO:0007097; GO:0007229; GO:0010592; GO:0016020; GO:0016477; GO:0017119; GO:0019901; GO:0030031; GO:0030175; GO:0030307; GO:0030496; GO:0030742; GO:0031258; GO:0031274; GO:0031333; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0034191; GO:0034329; GO:0034332; GO:0034613; GO:0036336; GO:0036464; GO:0038189; GO:0039694; GO:0042802; GO:0043025; GO:0043197; GO:0043393; GO:0043410; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051496; GO:0051988; GO:0060047; GO:0060501; GO:0060997; GO:0061630; GO:0071346; GO:0072686; GO:0099563; GO:1900026; GO:2000251	"actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6833_c0_g1_i3	Q2KJ93	CDC42_BOVIN	100	191	0	0	57	629	1	191	4.10E-108	392.1	CDC42_BOVIN	reviewed	Cell division control protein 42 homolog (EC 3.6.5.2)	CDC42	Bos taurus (Bovine)	191	"apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"	apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; Golgi transport complex [GO:0017119]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]	apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]	GO:0000322; GO:0003161; GO:0003924; GO:0005525; GO:0005813; GO:0005829; GO:0005911; GO:0006897; GO:0006911; GO:0007015; GO:0007088; GO:0007097; GO:0007229; GO:0010592; GO:0016020; GO:0016477; GO:0017119; GO:0019901; GO:0030031; GO:0030175; GO:0030307; GO:0030496; GO:0030742; GO:0031258; GO:0031274; GO:0031333; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0034191; GO:0034329; GO:0034332; GO:0034613; GO:0036336; GO:0036464; GO:0038189; GO:0039694; GO:0042802; GO:0043025; GO:0043197; GO:0043393; GO:0043410; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051496; GO:0051988; GO:0060047; GO:0060501; GO:0060997; GO:0061630; GO:0071346; GO:0072686; GO:0099563; GO:1900026; GO:2000251	"actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; modification of synaptic structure [GO:0099563]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; viral RNA genome replication [GO:0039694]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4127_c0_g1_i1	Q9YHZ6	CDC45_XENLA	53.8	52	24	0	3	158	269	320	7.40E-10	64.3	CDC45_XENLA	reviewed	Cell division control protein 45 homolog	cdc45 cdc45l	Xenopus laevis (African clawed frog)	567	CMG complex [GO:0071162]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	GO:0003682; GO:0005654; GO:0006270; GO:0007049; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN4127_c0_g1_i3	Q9YHZ6	CDC45_XENLA	41.5	301	173	2	3	902	269	567	4.70E-60	233	CDC45_XENLA	reviewed	Cell division control protein 45 homolog	cdc45 cdc45l	Xenopus laevis (African clawed frog)	567	CMG complex [GO:0071162]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	GO:0003682; GO:0005654; GO:0006270; GO:0007049; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g2_i1	Q5AWS6	CDC48_EMENI	37.9	87	54	0	3	263	321	407	1.40E-12	73.6	CDC48_EMENI	reviewed	Cell division control protein 48	cdc48 AN7254	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	823	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0071712; GO:0097352	"autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1097_c0_g1_i3	Q8SSJ5	CDC48_ENCCU	29.5	572	343	8	1686	97	205	758	1.10E-67	259.6	CDC48_ENCCU	reviewed	Cell division control protein 48	CDC48 ECU01_1230	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	780	endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cell cycle [GO:0007049]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005783; GO:0007049; GO:0015031; GO:0016887	cell cycle [GO:0007049]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN27370_c0_g1_i1	Q5AWS6	CDC48_EMENI	70.7	225	66	0	13	687	207	431	1.10E-92	340.9	CDC48_EMENI	reviewed	Cell division control protein 48	cdc48 AN7254	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	823	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0071712; GO:0097352	"autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13256_c0_g1_i1	Q8SSJ5	CDC48_ENCCU	74	200	52	0	3	602	476	675	5.20E-86	318.5	CDC48_ENCCU	reviewed	Cell division control protein 48	CDC48 ECU01_1230	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	780	endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cell cycle [GO:0007049]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005783; GO:0007049; GO:0015031; GO:0016887	cell cycle [GO:0007049]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3111_c0_g1_i3	Q9SCN8	CD48D_ARATH	83.8	130	21	0	3	392	190	319	3.20E-60	232.3	CD48D_ARATH	reviewed	Cell division control protein 48 homolog D (AtCDC48d) (Transitional endoplasmic reticulum ATPase D)	CDC48D At3g53230 T4D2.160	Arabidopsis thaliana (Mouse-ear cress)	815	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; positive regulation of protein catabolic process [GO:0045732]; response to cadmium ion [GO:0046686]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0009524; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0045732; GO:0046686; GO:0051228; GO:0051301; GO:0071712; GO:0097352	"autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; positive regulation of protein catabolic process [GO:0045732]; response to cadmium ion [GO:0046686]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4211_c0_g1_i1	Q9LZF6	CD48E_ARATH	77	204	47	0	612	1	459	662	9.00E-94	344.4	CD48E_ARATH	reviewed	Cell division control protein 48 homolog E (AtCDC48e) (Transitional endoplasmic reticulum ATPase E)	CDC48E At5g03340 F12E4_70	Arabidopsis thaliana (Mouse-ear cress)	810	"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005618; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0009524; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0051301; GO:0071712; GO:0097352	"autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3111_c0_g1_i2	Q9LZF6	CD48E_ARATH	84.3	127	20	0	1	381	192	318	6.90E-60	231.1	CD48E_ARATH	reviewed	Cell division control protein 48 homolog E (AtCDC48e) (Transitional endoplasmic reticulum ATPase E)	CDC48E At5g03340 F12E4_70	Arabidopsis thaliana (Mouse-ear cress)	810	"cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005618; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0009524; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0051301; GO:0071712; GO:0097352	"autophagosome maturation [GO:0097352]; cell division [GO:0051301]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3991_c0_g3_i2	Q99741	CDC6_HUMAN	48.1	420	210	5	113	1357	139	555	3.60E-96	353.6	CDC6_HUMAN	reviewed	Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6)	CDC6 CDC18L	Homo sapiens (Human)	560	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]; cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]	GO:0000076; GO:0000079; GO:0000082; GO:0000083; GO:0000166; GO:0000278; GO:0000922; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:1904117; GO:1904385	cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]		NA	NA	NA	NA	NA	NA
TRINITY_DN34685_c0_g1_i1	Q99741	CDC6_HUMAN	100	71	0	0	216	4	298	368	2.60E-35	148.7	CDC6_HUMAN	reviewed	Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6)	CDC6 CDC18L	Homo sapiens (Human)	560	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]; cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]	GO:0000076; GO:0000079; GO:0000082; GO:0000083; GO:0000166; GO:0000278; GO:0000922; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:1904117; GO:1904385	cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]		NA	NA	NA	NA	NA	NA
TRINITY_DN37627_c0_g1_i1	Q4PSE4	CDC24_ARATH	53.1	96	44	1	289	2	297	391	1.40E-27	123.6	CDC24_ARATH	reviewed	"Cell division cycle 20.4, cofactor of APC complex (AtCDC20.4)"	CDC20-4 CDC20_3 At5g26900 F2P16.8	Arabidopsis thaliana (Mouse-ear cress)	444	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005680; GO:0005737; GO:0007049; GO:0010997; GO:0016567; GO:0031145; GO:0051301; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN26250_c0_g1_i1	Q6A068	CDC5L_MOUSE	98.7	79	1	0	237	1	32	110	2.90E-40	165.2	CDC5L_MOUSE	reviewed	Cell division cycle 5-like protein (Cdc5-like protein)	Cdc5l Kiaa0432	Mus musculus (Mouse)	802	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in DNA damage checkpoint [GO:0072422]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]"	GO:0000278; GO:0000398; GO:0000974; GO:0000977; GO:0001222; GO:0001228; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008157; GO:0016607; GO:0019901; GO:0032993; GO:0043522; GO:0045944; GO:0048471; GO:0071007; GO:0071013; GO:0071987; GO:0072422; GO:1904568; GO:1990090	"cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in DNA damage checkpoint [GO:0072422]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39114_c0_g1_i1	Q6A068	CDC5L_MOUSE	99.2	128	1	0	434	51	10	137	1.90E-69	263.1	CDC5L_MOUSE	reviewed	Cell division cycle 5-like protein (Cdc5-like protein)	Cdc5l Kiaa0432	Mus musculus (Mouse)	802	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in DNA damage checkpoint [GO:0072422]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]"	GO:0000278; GO:0000398; GO:0000974; GO:0000977; GO:0001222; GO:0001228; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008157; GO:0016607; GO:0019901; GO:0032993; GO:0043522; GO:0045944; GO:0048471; GO:0071007; GO:0071013; GO:0071987; GO:0072422; GO:1904568; GO:1990090	"cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in DNA damage checkpoint [GO:0072422]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4000_c0_g1_i1	Q2KJC1	CDC5L_BOVIN	60.5	190	75	0	30	599	610	799	7.50E-53	208.8	CDC5L_BOVIN	reviewed	Cell division cycle 5-like protein (Cdc5-like protein)	CDC5L	Bos taurus (Bovine)	802	"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"	cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]"	GO:0000398; GO:0000974; GO:0000977; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0007049; GO:0016607; GO:0071007; GO:0071987; GO:0072422	"cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4000_c0_g1_i2	Q2KJC1	CDC5L_BOVIN	60.5	190	75	0	30	599	610	799	7.50E-53	208.8	CDC5L_BOVIN	reviewed	Cell division cycle 5-like protein (Cdc5-like protein)	CDC5L	Bos taurus (Bovine)	802	"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"	cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]"	GO:0000398; GO:0000974; GO:0000977; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0007049; GO:0016607; GO:0071007; GO:0071987; GO:0072422	"cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4000_c0_g1_i3	Q2KJC1	CDC5L_BOVIN	61.9	118	45	0	12	365	682	799	3.20E-26	119.8	CDC5L_BOVIN	reviewed	Cell division cycle 5-like protein (Cdc5-like protein)	CDC5L	Bos taurus (Bovine)	802	"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"	cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]"	GO:0000398; GO:0000974; GO:0000977; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0007049; GO:0016607; GO:0071007; GO:0071987; GO:0072422	"cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4000_c0_g1_i4	Q2KJC1	CDC5L_BOVIN	60.5	190	75	0	30	599	610	799	7.50E-53	208.8	CDC5L_BOVIN	reviewed	Cell division cycle 5-like protein (Cdc5-like protein)	CDC5L	Bos taurus (Bovine)	802	"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"	cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]"	GO:0000398; GO:0000974; GO:0000977; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0007049; GO:0016607; GO:0071007; GO:0071987; GO:0072422	"cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1814_c0_g1_i1	A7SD85	CDC5L_NEMVE	89.8	167	16	1	588	91	1	167	9.10E-79	294.7	CDC5L_NEMVE	reviewed	Cell division cycle 5-related protein (Cdc5-like protein)	cdc5l v1g169217	Nematostella vectensis (Starlet sea anemone)	805	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005681; GO:0005737; GO:0006281; GO:0006397; GO:0007049; GO:0008380	cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1814_c0_g1_i2	A7SD85	CDC5L_NEMVE	89.2	167	17	1	593	96	1	167	6.40E-80	298.5	CDC5L_NEMVE	reviewed	Cell division cycle 5-related protein (Cdc5-like protein)	cdc5l v1g169217	Nematostella vectensis (Starlet sea anemone)	805	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005681; GO:0005737; GO:0006281; GO:0006397; GO:0007049; GO:0008380	cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i10	O00311	CDC7_HUMAN	44.9	176	89	1	832	1335	299	474	1.10E-35	152.5	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i11	O00311	CDC7_HUMAN	44.9	176	89	1	264	767	299	474	6.70E-36	152.5	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i13	O00311	CDC7_HUMAN	36.3	306	151	4	829	1722	299	568	3.20E-38	161.4	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i3	O00311	CDC7_HUMAN	62.2	37	14	0	3	113	152	188	2.00E-08	59.3	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i4	O00311	CDC7_HUMAN	29.4	579	247	11	6	1718	144	568	6.50E-47	190.3	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i5	O00311	CDC7_HUMAN	29.1	581	245	12	6	1715	144	568	1.60E-45	185.7	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i9	O00311	CDC7_HUMAN	49.1	55	27	1	6	170	144	197	2.00E-09	62.8	CDC7_HUMAN	reviewed	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	CDC7 CDC7L1	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]		NA	NA	NA	NA	NA	NA
TRINITY_DN10593_c0_g1_i1	Q641G3	CCAR1_XENLA	23.6	212	123	4	723	88	984	1156	3.20E-05	50.4	CCAR1_XENLA	reviewed	Cell division cycle and apoptosis regulator protein 1	ccar1	Xenopus laevis (African clawed frog)	1157	"perinuclear region of cytoplasm [GO:0048471]; cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]"	perinuclear region of cytoplasm [GO:0048471]		GO:0006355; GO:0006417; GO:0007049; GO:0048471	"cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26916_c0_g1_i1	Q8CH18	CCAR1_MOUSE	55.6	63	28	0	278	90	608	670	6.30E-10	64.7	CCAR1_MOUSE	reviewed	Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1)	Ccar1 Carp1	Mus musculus (Mouse)	1146	"nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000978; GO:0003713; GO:0003714; GO:0005634; GO:0005641; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0043065; GO:0048471	"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3305_c0_g1_i1	Q8IX12	CCAR1_HUMAN	80	70	14	0	107	316	718	787	5.40E-26	118.2	CCAR1_HUMAN	reviewed	Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain)	CCAR1 CARP1 DIS	Homo sapiens (Human)	1150	"nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000398; GO:0000978; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005641; GO:0005654; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0043065; GO:0048471	"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28727_c0_g1_i1	A5E3J7	CD123_LODEL	53.2	62	29	0	189	4	114	175	2.20E-15	82.4	CD123_LODEL	reviewed	Cell division cycle protein 123	CDC123 LELG_04184	Lodderomyces elongisporus (strain ATCC 11503 / CBS 2605 / JCM 1781 / NBRC 1676 / NRRL YB-4239) (Yeast) (Saccharomyces elongisporus)	387	cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]; eukaryotic translation initiation factor 2 complex assembly [GO:1905143]; positive regulation of translational initiation [GO:0045948]	cytoplasm [GO:0005737]		GO:0005737; GO:0007049; GO:0045948; GO:0051301; GO:1905143	cell cycle [GO:0007049]; cell division [GO:0051301]; eukaryotic translation initiation factor 2 complex assembly [GO:1905143]; positive regulation of translational initiation [GO:0045948]		NA	NA	NA	NA	NA	NA
TRINITY_DN25683_c0_g1_i1	Q5BKN5	CD123_XENTR	42.1	378	170	7	96	1211	1	335	2.50E-77	290.8	CD123_XENTR	reviewed	Cell division cycle protein 123 homolog	cdc123	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	335	cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]		GO:0005737; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN34956_c0_g1_i1	Q8CII2	CD123_MOUSE	96.3	82	3	0	2	247	70	151	1.80E-40	166	CD123_MOUSE	reviewed	Cell division cycle protein 123 homolog	Cdc123	Mus musculus (Mouse)	336	cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]		GO:0005737; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN34996_c0_g1_i1	O75794	CD123_HUMAN	100	163	0	0	2	490	62	224	1.60E-93	343.2	CD123_HUMAN	reviewed	Cell division cycle protein 123 homolog (Protein D123) (HT-1080) (PZ32)	CDC123 C10orf7 D123	Homo sapiens (Human)	336	cytoplasm [GO:0005737]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; eukaryotic translation initiation factor 2 complex assembly [GO:1905143]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational initiation [GO:0045948]	cytoplasm [GO:0005737]		GO:0005737; GO:0007050; GO:0008284; GO:0045948; GO:0051301; GO:1905143	cell cycle arrest [GO:0007050]; cell division [GO:0051301]; eukaryotic translation initiation factor 2 complex assembly [GO:1905143]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational initiation [GO:0045948]		NA	NA	NA	NA	NA	NA
TRINITY_DN6999_c0_g1_i1	Q13042	CDC16_HUMAN	41.1	146	79	4	81	497	1	146	1.40E-20	100.9	CDC16_HUMAN	reviewed	Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)	CDC16 ANAPC6	Homo sapiens (Human)	620	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN23176_c0_g1_i1	Q13042	CDC16_HUMAN	100	104	0	0	2	313	285	388	1.60E-57	223	CDC16_HUMAN	reviewed	Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)	CDC16 ANAPC6	Homo sapiens (Human)	620	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN23176_c0_g1_i2	Q13042	CDC16_HUMAN	100	112	0	0	2	337	285	396	8.50E-62	237.3	CDC16_HUMAN	reviewed	Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)	CDC16 ANAPC6	Homo sapiens (Human)	620	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6625_c0_g1_i1	Q13042	CDC16_HUMAN	57.2	320	134	2	6	962	220	537	3.70E-105	383.3	CDC16_HUMAN	reviewed	Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)	CDC16 ANAPC6	Homo sapiens (Human)	620	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40111_c0_g1_i1	Q9JJ66	CDC20_MOUSE	100	75	0	0	2	226	160	234	1.20E-38	159.8	CDC20_MOUSE	reviewed	Cell division cycle protein 20 homolog (mmCdc20) (p55CDC)	Cdc20	Mus musculus (Mouse)	499	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]	GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]		NA	NA	NA	NA	NA	NA
TRINITY_DN36005_c0_g1_i1	Q12834	CDC20_HUMAN	74.2	62	16	0	14	199	400	461	3.30E-21	101.7	CDC20_HUMAN	reviewed	Cell division cycle protein 20 homolog (p55CDC)	CDC20	Homo sapiens (Human)	499	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]	anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]	GO:0000922; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007064; GO:0007094; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0016579; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1901990; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN32139_c0_g1_i1	Q12834	CDC20_HUMAN	100	71	0	0	3	215	160	230	4.30E-35	147.9	CDC20_HUMAN	reviewed	Cell division cycle protein 20 homolog (p55CDC)	CDC20	Homo sapiens (Human)	499	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]	anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]	GO:0000922; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007064; GO:0007094; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0016579; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1901990; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6998_c0_g1_i1	A1A4R8	CDC23_BOVIN	50.2	281	121	3	16	852	75	338	1.40E-74	281.2	CDC23_BOVIN	reviewed	Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8)	CDC23 ANAPC8	Bos taurus (Bovine)	597	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007080; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN6998_c0_g1_i2	Q8BGZ4	CDC23_MOUSE	52.6	540	230	4	16	1620	75	593	3.80E-158	559.7	CDC23_MOUSE	reviewed	Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8)	Cdc23 Anapc8	Mus musculus (Mouse)	597	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic metaphase/anaphase transition [GO:0030071]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0000278; GO:0005680; GO:0005737; GO:0007080; GO:0007091; GO:0016567; GO:0030071; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of mitotic metaphase/anaphase transition [GO:0030071]		NA	NA	NA	NA	NA	NA
TRINITY_DN29915_c0_g1_i1	A1A4R8	CDC23_BOVIN	100	69	0	0	209	3	422	490	1.00E-33	143.3	CDC23_BOVIN	reviewed	Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8)	CDC23 ANAPC8	Bos taurus (Bovine)	597	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007080; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN41007_c0_g1_i1	A7Z061	CDC27_BOVIN	100	67	0	0	39	239	1	67	2.90E-32	138.7	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN39052_c0_g1_i1	A7Z061	CDC27_BOVIN	60.6	99	39	0	18	314	564	662	6.40E-35	147.9	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5233_c0_g1_i1	A7Z061	CDC27_BOVIN	46.4	597	273	8	1817	105	241	816	2.40E-134	480.7	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN37864_c0_g1_i1	A7Z061	CDC27_BOVIN	84.2	38	6	0	88	201	568	605	5.20E-14	77.8	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN37864_c0_g1_i1	A7Z061	CDC27_BOVIN	85.7	28	4	0	3	86	541	568	1.80E-06	52.8	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN35860_c0_g1_i1	A7Z061	CDC27_BOVIN	100	76	0	0	228	1	723	798	3.20E-36	151.8	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1275_c2_g1_i1	A2A6Q5	CDC27_MOUSE	53.7	188	87	0	52	615	3	190	2.10E-55	217.2	CDC27_MOUSE	reviewed	Cell division cycle protein 27 homolog	Cdc27	Mus musculus (Mouse)	825	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005876; GO:0007091; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN38661_c0_g1_i1	A7Z061	CDC27_BOVIN	100	138	0	0	1	414	604	741	1.10E-74	280.4	CDC27_BOVIN	reviewed	Cell division cycle protein 27 homolog	CDC27	Bos taurus (Bovine)	825	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]		GO:0005680; GO:0005737; GO:0007091; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN6506_c0_g1_i1	P54774	CDC48_SOYBN	75.9	83	20	0	252	4	326	408	1.10E-29	130.2	CDC48_SOYBN	reviewed	Cell division cycle protein 48 homolog (Valosin-containing protein homolog) (VCP)	CDC48	Glycine max (Soybean) (Glycine hispida)	807	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016236; GO:0016887; GO:0030433; GO:0030970; GO:0031593; GO:0034098; GO:0051228; GO:0071712; GO:0097352	"autophagosome maturation [GO:0097352]; ER-associated misfolded protein catabolic process [GO:0071712]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g1_i14	O28972	Y1297_ARCFU	36	100	64	0	145	444	459	558	2.10E-11	70.5	Y1297_ARCFU	reviewed	Cell division cycle protein 48 homolog AF_1297	AF_1297	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	733	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN7653_c0_g1_i1	O28972	Y1297_ARCFU	61.7	81	30	1	244	2	521	600	2.10E-22	105.9	Y1297_ARCFU	reviewed	Cell division cycle protein 48 homolog AF_1297	AF_1297	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	733	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN7653_c1_g2_i1	O28972	Y1297_ARCFU	56.2	137	59	1	411	1	517	652	6.60E-40	164.9	Y1297_ARCFU	reviewed	Cell division cycle protein 48 homolog AF_1297	AF_1297	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	733	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN7653_c1_g1_i1	O28972	Y1297_ARCFU	66	97	32	1	294	4	525	620	1.40E-31	136.7	Y1297_ARCFU	reviewed	Cell division cycle protein 48 homolog AF_1297	AF_1297	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	733	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN3187_c0_g1_i1	O28972	Y1297_ARCFU	75.4	114	28	0	347	6	194	307	2.20E-44	179.5	Y1297_ARCFU	reviewed	Cell division cycle protein 48 homolog AF_1297	AF_1297	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	733	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN3187_c1_g1_i1	Q58556	Y1156_METJA	69.7	76	23	0	16	243	175	250	1.80E-27	122.9	Y1156_METJA	reviewed	Cell division cycle protein 48 homolog MJ1156	MJ1156	Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)	903	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN16217_c0_g1_i1	Q96GN5	CDA7L_HUMAN	53.1	130	61	0	509	120	316	445	2.00E-36	154.1	CDA7L_HUMAN	reviewed	Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2)	CDCA7L HR1 JPO2 R1	Homo sapiens (Human)	454	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284	"positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN37361_c0_g1_i1	Q922M5	CDA7L_MOUSE	100	90	0	0	2	271	346	435	1.70E-52	206.1	CDA7L_MOUSE	reviewed	Cell division cycle-associated 7-like protein (Transcription factor RAM2)	Cdca7l	Mus musculus (Mouse)	438	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284	"positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31648_c0_g1_i1	Q9D0M2	CDCA7_MOUSE	100	110	0	0	1	330	248	357	5.60E-66	251.1	CDCA7_MOUSE	reviewed	Cell division cycle-associated protein 7	Cdca7	Mus musculus (Mouse)	382	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006915; GO:0042127	"apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1718_c0_g1_i1	Q08288	LYAR_MOUSE	46.9	143	75	1	563	135	1	142	1.70E-35	151	LYAR_MOUSE	reviewed	Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264)	Lyar	Mus musculus (Mouse)	388	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0042802; GO:0045087; GO:0046872; GO:0048821; GO:0050766	erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN21314_c0_g2_i3	P43121	MUC18_HUMAN	23.4	192	132	5	341	898	201	383	7.90E-05	50.1	MUC18_HUMAN	reviewed	Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146)	MCAM MUC18	Homo sapiens (Human)	646	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; positive regulation of cell migration [GO:0030335]; vascular wound healing [GO:0061042]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		GO:0001525; GO:0003094; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0005925; GO:0007155; GO:0009653; GO:0009897; GO:0016021; GO:0030335; GO:0061042	anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; positive regulation of cell migration [GO:0030335]; vascular wound healing [GO:0061042]		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i5	Q5FWI3	CEIP2_MOUSE	27.8	169	84	7	528	85	469	620	8.20E-06	52	CEIP2_MOUSE	reviewed	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	Cemip2 Kiaa1412 Tmem2	Mus musculus (Mouse)	1383	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]	GO:0001525; GO:0004415; GO:0005509; GO:0005886; GO:0005887; GO:0030214; GO:0043231; GO:1903670	angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i9	Q5FWI3	CEIP2_MOUSE	28.7	150	76	6	451	44	469	601	2.70E-05	50.1	CEIP2_MOUSE	reviewed	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	Cemip2 Kiaa1412 Tmem2	Mus musculus (Mouse)	1383	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]	GO:0001525; GO:0004415; GO:0005509; GO:0005886; GO:0005887; GO:0030214; GO:0043231; GO:1903670	angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]		NA	NA	NA	NA	NA	NA
TRINITY_DN5214_c3_g1_i10	B2RD01	CENP1_HUMAN	42.9	77	43	1	77	307	1	76	2.90E-08	59.7	CENP1_HUMAN	reviewed	CENPB DNA-binding domain-containing protein 1	CENPBD1	Homo sapiens (Human)	187	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN5214_c3_g1_i12	B2RD01	CENP1_HUMAN	37.1	197	107	6	77	667	1	180	3.50E-22	106.7	CENP1_HUMAN	reviewed	CENPB DNA-binding domain-containing protein 1	CENPBD1	Homo sapiens (Human)	187	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN570_c0_g1_i1	Q9NGC3	CEG1A_DROME	54.9	344	114	6	38	967	427	763	7.70E-93	342	CEG1A_DROME	reviewed	Centaurin-gamma-1A	CenG1A CG31811	Drosophila melanogaster (Fruit fly)	995	membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]	membrane [GO:0016020]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375	medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN570_c0_g1_i2	Q9NGC3	CEG1A_DROME	55.3	398	137	6	38	1129	427	817	2.20E-112	407.1	CEG1A_DROME	reviewed	Centaurin-gamma-1A	CenG1A CG31811	Drosophila melanogaster (Fruit fly)	995	membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]	membrane [GO:0016020]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375	medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN570_c0_g1_i3	Q9NGC3	CEG1A_DROME	51.3	491	192	7	38	1390	427	910	3.90E-128	459.9	CEG1A_DROME	reviewed	Centaurin-gamma-1A	CenG1A CG31811	Drosophila melanogaster (Fruit fly)	995	membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]	membrane [GO:0016020]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375	medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN33138_c0_g1_i2	Q2TBN3	CETN2_BOVIN	72.7	172	46	1	66	578	1	172	2.50E-62	240	CETN2_BOVIN	reviewed	Centrin-2	CETN2	Bos taurus (Bovine)	172	9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]	9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]	calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]	GO:0000278; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0045177; GO:0051028; GO:0051301; GO:0070390; GO:0071942; GO:0097729	cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN33245_c0_g1_i1	Q9R1K9	CETN2_MOUSE	100	166	0	0	503	6	7	172	4.80E-85	315.1	CETN2_MOUSE	reviewed	Centrin-2 (Caltractin isoform 1)	Cetn2 Calt	Mus musculus (Mouse)	172	9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]	9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]	calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]	GO:0000278; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0045177; GO:0051028; GO:0051301; GO:0070390; GO:0071942; GO:0097729	cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN20717_c0_g1_i1	O15182	CETN3_HUMAN	100	148	0	0	444	1	10	157	8.00E-76	284.3	CETN3_HUMAN	reviewed	Centrin-3	CETN3 CEN3	Homo sapiens (Human)	167	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; mRNA transport [GO:0051028]; protein transport [GO:0015031]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; transcription export complex 2 [GO:0070390]	calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]	GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0044615; GO:0051028; GO:0051301; GO:0070390	cell division [GO:0051301]; centrosome cycle [GO:0007098]; mRNA transport [GO:0051028]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6189_c0_g1_i7	Q7Z7K6	CENPV_HUMAN	64.4	90	32	0	291	22	146	235	5.50E-33	141.4	CENPV_HUMAN	reviewed	Centromere protein V (CENP-V) (Nuclear protein p30) (Proline-rich protein 6)	CENPV PRR6	Homo sapiens (Human)	275	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]	GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301	ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]		NA	NA	NA	NA	NA	NA
TRINITY_DN6189_c0_g1_i1	Q9CXS4	CENPV_MOUSE	60.8	130	49	2	421	38	123	252	4.50E-44	178.7	CENPV_MOUSE	reviewed	Centromere protein V (CENP-V) (Proline-rich protein 6)	Cenpv Prr6	Mus musculus (Mouse)	252	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]	GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301	ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]		NA	NA	NA	NA	NA	NA
TRINITY_DN6189_c0_g1_i2	Q9CXS4	CENPV_MOUSE	62.6	115	43	0	436	92	123	237	6.30E-41	168.3	CENPV_MOUSE	reviewed	Centromere protein V (CENP-V) (Proline-rich protein 6)	Cenpv Prr6	Mus musculus (Mouse)	252	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]	GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301	ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]		brown	brown	NA	NA	NA	NA
TRINITY_DN6189_c0_g1_i3	Q9CXS4	CENPV_MOUSE	63.2	117	43	0	420	70	121	237	6.40E-42	171.8	CENPV_MOUSE	reviewed	Centromere protein V (CENP-V) (Proline-rich protein 6)	Cenpv Prr6	Mus musculus (Mouse)	252	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]	GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301	ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]		NA	NA	NA	NA	NA	NA
TRINITY_DN11982_c0_g1_i1	Q6RT24	CENPE_MOUSE	53.3	120	54	1	418	65	286	405	6.90E-21	101.7	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c0_g3_i1	Q6RT24	CENPE_MOUSE	60.4	96	36	1	79	360	228	323	5.40E-26	119.8	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c0_g3_i1	Q6RT24	CENPE_MOUSE	39.5	129	70	3	354	716	305	433	7.10E-10	66.2	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i1	Q6RT24	CENPE_MOUSE	57.6	151	62	1	728	282	223	373	3.20E-40	167.2	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i1	Q6RT24	CENPE_MOUSE	51.6	95	45	1	1005	721	125	218	7.80E-18	92.8	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i10	Q6RT24	CENPE_MOUSE	57.6	151	62	1	734	288	223	373	3.10E-40	167.2	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i10	Q6RT24	CENPE_MOUSE	49.3	71	36	0	939	727	148	218	2.50E-10	67.8	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i2	Q6RT24	CENPE_MOUSE	57.6	151	62	1	546	100	223	373	2.90E-40	167.2	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i2	Q6RT24	CENPE_MOUSE	49.3	71	36	0	751	539	148	218	1.80E-10	68.2	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i6	Q6RT24	CENPE_MOUSE	58.9	151	60	1	546	100	223	373	4.10E-41	169.9	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN17268_c0_g1_i6	Q6RT24	CENPE_MOUSE	51.6	95	45	1	823	539	125	218	6.40E-18	92.8	CENPE_MOUSE	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	Cenpe	Mus musculus (Mouse)	2474	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN20324_c0_g1_i1	Q02224	CENPE_HUMAN	58.3	84	35	0	265	14	62	145	5.00E-25	114.8	CENPE_HUMAN	reviewed	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE)	CENPE	Homo sapiens (Human)	2701	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0006890; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007275; GO:0008017; GO:0015630; GO:0016020; GO:0019886; GO:0030071; GO:0030496; GO:0043515; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0099606; GO:0099607; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8165_c0_g1_i1	Q9QZX9	CEP19_RAT	40	155	89	3	234	686	7	161	3.00E-25	117.1	CEP19_RAT	reviewed	Centrosomal protein of 19 kDa (Cep19)	Cep19	Rattus norvegicus (Rat)	163	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]		GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712	"cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8165_c0_g1_i3	Q9CQA8	CEP19_MOUSE	39.7	121	70	2	234	587	7	127	1.40E-17	91.3	CEP19_MOUSE	reviewed	Centrosomal protein of 19 kDa (Cep19)	Cep19	Mus musculus (Mouse)	163	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]		GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712	"cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28111_c0_g1_i1	A2RRS8	CEP78_XENTR	28.4	388	238	6	126	1178	18	402	9.30E-37	156	CEP78_XENTR	reviewed	Centrosomal protein of 78 kDa (Cep78)	cep78	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	727	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium organization [GO:0044782]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]		GO:0005737; GO:0005813; GO:0005814; GO:0036064; GO:0044782	cilium organization [GO:0044782]		NA	NA	NA	NA	NA	NA
TRINITY_DN3553_c0_g1_i2	Q8TCT0	CERK1_HUMAN	35.9	440	239	3	1313	120	97	535	2.10E-76	288.1	CERK1_HUMAN	reviewed	Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)	CERK KIAA1646	Homo sapiens (Human)	537	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]	GO:0000287; GO:0001727; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016021; GO:0016310; GO:0102773	ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3553_c0_g1_i3	Q8TCT0	CERK1_HUMAN	35.9	440	239	3	1313	120	97	535	2.10E-76	288.1	CERK1_HUMAN	reviewed	Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)	CERK KIAA1646	Homo sapiens (Human)	537	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]	GO:0000287; GO:0001727; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016021; GO:0016310; GO:0102773	ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN31286_c0_g1_i1	Q8TCT0	CERK1_HUMAN	98.8	83	1	0	3	251	245	327	7.30E-42	170.6	CERK1_HUMAN	reviewed	Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)	CERK KIAA1646	Homo sapiens (Human)	537	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]	GO:0000287; GO:0001727; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016021; GO:0016310; GO:0102773	ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN36442_c0_g1_i1	Q71RH2	TLC3B_HUMAN	34.7	216	121	6	15	611	56	268	4.70E-22	106.3	TLC3B_HUMAN	reviewed	Ceramide synthase (EC 2.3.1.-) (Protein FAM57B) (TLC domain-containing protein 3B)	TLCD3B FAM57B FP1188	Homo sapiens (Human)	274	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of fat cell differentiation [GO:0045599]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sphingosine N-acyltransferase activity [GO:0050291]	GO:0000139; GO:0005783; GO:0005789; GO:0016021; GO:0045599; GO:0046513; GO:0050291	ceramide biosynthetic process [GO:0046513]; negative regulation of fat cell differentiation [GO:0045599]		NA	NA	NA	NA	NA	NA
TRINITY_DN31545_c0_g1_i1	Q924Z4	CERS2_MOUSE	94.8	77	4	0	2	232	148	224	1.90E-39	162.5	CERS2_MOUSE	reviewed	Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3)	Cers2 Lass2 Trh3	Mus musculus (Mouse)	380	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045	ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN36129_c0_g1_i1	Q8N5B7	CERS5_HUMAN	36.5	370	212	5	46	1116	1	360	1.40E-58	228.4	CERS5_HUMAN	reviewed	Ceramide synthase 5 (CerS5) (EC 2.3.1.-) (LAG1 longevity assurance homolog 5) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24)	CERS5 LASS5	Homo sapiens (Human)	392	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291	ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN31707_c0_g1_i1	Q8N5B7	CERS5_HUMAN	100	74	0	0	223	2	174	247	1.60E-37	156	CERS5_HUMAN	reviewed	Ceramide synthase 5 (CerS5) (EC 2.3.1.-) (LAG1 longevity assurance homolog 5) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24)	CERS5 LASS5	Homo sapiens (Human)	392	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291	ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN32816_c0_g1_i1	Q8C172	CERS6_MOUSE	40.7	317	183	4	1063	119	28	341	8.40E-64	245.7	CERS6_MOUSE	reviewed	Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6)	Cers6 Lass6	Mus musculus (Mouse)	384	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0003677; GO:0005783; GO:0005789; GO:0006954; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291	ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN9805_c0_g1_i1	Q6ZMG9	CERS6_HUMAN	54.9	51	23	0	162	10	207	257	2.50E-08	58.9	CERS6_HUMAN	reviewed	Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6)	CERS6 LASS6	Homo sapiens (Human)	384	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0003677; GO:0005783; GO:0005789; GO:0006954; GO:0016020; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291	ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN3560_c0_g1_i1	Q9GKI7	CERT_BOVIN	45.9	534	216	13	98	1588	127	624	4.30E-117	423.3	CERT_BOVIN	reviewed	Ceramide transfer protein (CERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11)	CERT1 CERT COL4A3BP STARD11	Bos taurus (Bovine)	624	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0000902; GO:0001701; GO:0003007; GO:0005654; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006672; GO:0006936; GO:0007029; GO:0007165; GO:0008283; GO:0008289; GO:0016020; GO:0016301; GO:0034976; GO:0035621; GO:0035627; GO:0048471; GO:0055088; GO:0070273; GO:0070584; GO:0120009; GO:0120012; GO:1902387; GO:1902388	cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; in utero embryonic development [GO:0001701]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3560_c0_g1_i2	Q9GKI7	CERT_BOVIN	81	42	8	0	59	184	583	624	5.30E-13	75.1	CERT_BOVIN	reviewed	Ceramide transfer protein (CERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11)	CERT1 CERT COL4A3BP STARD11	Bos taurus (Bovine)	624	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0000902; GO:0001701; GO:0003007; GO:0005654; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006672; GO:0006936; GO:0007029; GO:0007165; GO:0008283; GO:0008289; GO:0016020; GO:0016301; GO:0034976; GO:0035621; GO:0035627; GO:0048471; GO:0055088; GO:0070273; GO:0070584; GO:0120009; GO:0120012; GO:1902387; GO:1902388	cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; in utero embryonic development [GO:0001701]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3560_c0_g1_i3	Q9GKI7	CERT_BOVIN	46.2	660	275	15	91	1944	3	624	6.30E-155	549.3	CERT_BOVIN	reviewed	Ceramide transfer protein (CERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11)	CERT1 CERT COL4A3BP STARD11	Bos taurus (Bovine)	624	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0000902; GO:0001701; GO:0003007; GO:0005654; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006672; GO:0006936; GO:0007029; GO:0007165; GO:0008283; GO:0008289; GO:0016020; GO:0016301; GO:0034976; GO:0035621; GO:0035627; GO:0048471; GO:0055088; GO:0070273; GO:0070584; GO:0120009; GO:0120012; GO:1902387; GO:1902388	cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; in utero embryonic development [GO:0001701]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN14489_c0_g1_i1	Q6DBQ8	CPTP_DANRE	34.9	212	127	3	646	29	5	211	7.30E-33	142.5	CPTP_DANRE	reviewed	Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP)	cptp gltpd1 zgc:92000	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0008289; GO:0010008; GO:0010507; GO:0016020; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389	ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]		NA	NA	NA	NA	NA	NA
TRINITY_DN14489_c0_g1_i2	Q5XIS2	CPTP_RAT	27.4	106	70	2	340	29	116	216	3.30E-06	52.8	CPTP_RAT	reviewed	Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP)	Cptp Gltpd1	Rattus norvegicus (Rat)	216	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0008289; GO:0010008; GO:0010507; GO:0016020; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389	ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]		NA	NA	NA	NA	NA	NA
TRINITY_DN14489_c0_g1_i3	Q6DBQ8	CPTP_DANRE	34.9	212	127	3	646	29	5	211	7.20E-33	142.5	CPTP_DANRE	reviewed	Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP)	cptp gltpd1 zgc:92000	Danio rerio (Zebrafish) (Brachydanio rerio)	211	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0008289; GO:0010008; GO:0010507; GO:0016020; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389	ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]		NA	NA	NA	NA	NA	NA
TRINITY_DN39292_c0_g1_i1	P21158	CSGA_MYXXA	37.4	115	61	2	347	3	54	157	2.20E-14	80.1	CSGA_MYXXA	reviewed	C-factor (C signal)	csgA spoC	Myxococcus xanthus	166	extracellular region [GO:0005576]; oxidation-reduction process [GO:0055114]; sporulation resulting in formation of a cellular spore [GO:0030435]	extracellular region [GO:0005576]		GO:0005576; GO:0030435; GO:0055114	oxidation-reduction process [GO:0055114]; sporulation resulting in formation of a cellular spore [GO:0030435]		NA	NA	NA	NA	NA	NA
TRINITY_DN109_c0_g1_i1	P21158	CSGA_MYXXA	32.4	170	99	3	600	91	13	166	1.20E-15	85.5	CSGA_MYXXA	reviewed	C-factor (C signal)	csgA spoC	Myxococcus xanthus	166	extracellular region [GO:0005576]; oxidation-reduction process [GO:0055114]; sporulation resulting in formation of a cellular spore [GO:0030435]	extracellular region [GO:0005576]		GO:0005576; GO:0030435; GO:0055114	oxidation-reduction process [GO:0055114]; sporulation resulting in formation of a cellular spore [GO:0030435]		NA	NA	NA	NA	NA	NA
TRINITY_DN34725_c0_g1_i1	P00516	KGP1_BOVIN	71.4	84	24	0	258	7	388	471	1.70E-30	132.9	KGP1_BOVIN	reviewed	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	PRKG1 PRKG1B PRKGR1A PRKGR1B	Bos taurus (Bovine)	671	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0001764; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0016358; GO:0019934; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:1904706; GO:1904753	cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]		NA	NA	NA	NA	NA	NA
TRINITY_DN27669_c0_g1_i1	Q13237	KGP2_HUMAN	48.4	128	63	2	1	381	538	663	1.30E-29	130.6	KGP2_HUMAN	reviewed	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2	Homo sapiens (Human)	762	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; negative regulation of chloride transport [GO:2001226]; peptidyl-serine autophosphorylation [GO:0036289]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004692; GO:0005524; GO:0005829; GO:0006468; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0036289; GO:0042802; GO:0072659; GO:2001226	negative regulation of chloride transport [GO:2001226]; peptidyl-serine autophosphorylation [GO:0036289]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4214_c1_g1_i1	Q03042	KGP1_DROME	56.1	66	29	0	2	199	613	678	2.40E-18	92.4	KGP1_DROME	reviewed	"cGMP-dependent protein kinase, isozyme 1 (cGK) (EC 2.7.11.12)"	Pkg21D DG1 CG3324	Drosophila melanogaster (Fruit fly)	768	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; larval somatic muscle development [GO:0007526]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005737; GO:0006468; GO:0007526; GO:0030553	larval somatic muscle development [GO:0007526]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN4214_c0_g2_i1	Q03042	KGP1_DROME	55.9	68	30	0	237	34	610	677	2.10E-17	89.4	KGP1_DROME	reviewed	"cGMP-dependent protein kinase, isozyme 1 (cGK) (EC 2.7.11.12)"	Pkg21D DG1 CG3324	Drosophila melanogaster (Fruit fly)	768	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; larval somatic muscle development [GO:0007526]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005737; GO:0006468; GO:0007526; GO:0030553	larval somatic muscle development [GO:0007526]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN33673_c0_g1_i1	Q03042	KGP1_DROME	65	40	14	0	131	12	323	362	1.60E-08	59.7	KGP1_DROME	reviewed	"cGMP-dependent protein kinase, isozyme 1 (cGK) (EC 2.7.11.12)"	Pkg21D DG1 CG3324	Drosophila melanogaster (Fruit fly)	768	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; larval somatic muscle development [GO:0007526]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005737; GO:0006468; GO:0007526; GO:0030553	larval somatic muscle development [GO:0007526]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN27654_c0_g1_i1	Q03043	KGP24_DROME	52.7	91	42	1	271	2	876	966	1.70E-23	109.8	KGP24_DROME	reviewed	"cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)"	for DG2 PGK2 Pkg24A CG10033	Drosophila melanogaster (Fruit fly)	1088	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN4592_c0_g1_i1	Q03043	KGP24_DROME	76.6	586	135	1	72	1823	503	1088	2.40E-270	932.6	KGP24_DROME	reviewed	"cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)"	for DG2 PGK2 Pkg24A CG10033	Drosophila melanogaster (Fruit fly)	1088	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]		blue	blue	NA	NA	NA	NA
TRINITY_DN36999_c0_g1_i1	Q03043	KGP24_DROME	53	117	54	1	349	2	855	971	2.90E-28	125.9	KGP24_DROME	reviewed	"cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)"	for DG2 PGK2 Pkg24A CG10033	Drosophila melanogaster (Fruit fly)	1088	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN16245_c0_g1_i1	Q8EBE6	CLPB_SHEON	80	65	13	0	228	34	662	726	1.10E-23	110.2	CLPB_SHEON	reviewed	Chaperone protein ClpB	clpB SO_3577	Shewanella oneidensis (strain MR-1)	857	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0006986; GO:0016887; GO:0034605; GO:0042026	cellular response to heat [GO:0034605]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN36741_c0_g1_i1	Q8XZR0	CLPB_RALSO	100	98	0	0	296	3	577	674	3.50E-51	201.8	CLPB_RALSO	reviewed	Chaperone protein ClpB	clpB RSc1335 RS02857	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	862	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0009408; GO:0016887; GO:0042026	protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN36573_c0_g1_i1	Q7WSY8	CLPB_PROFC	89.8	88	9	0	265	2	573	660	3.30E-40	165.2	CLPB_PROFC	reviewed	Chaperone protein ClpB	clpB PFREUD_19250	Propionibacterium freudenreichii subsp. shermanii (strain ATCC 9614 / DSM 4902 / CIP 103027 / NCIMB 8099 / CIRM-BIA1)	866	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0009408; GO:0016887; GO:0042026	protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN1211_c0_g1_i1	Q98G96	CLPB_RHILO	88.7	124	14	0	3	374	612	735	1.40E-57	223.4	CLPB_RHILO	reviewed	Chaperone protein ClpB	clpB mll3429	Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))	868	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0009408; GO:0016887; GO:0042026	protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN6163_c2_g1_i2	Q7WSY8	CLPB_PROFC	88.5	78	9	0	236	3	631	708	9.50E-36	150.2	CLPB_PROFC	reviewed	Chaperone protein ClpB	clpB PFREUD_19250	Propionibacterium freudenreichii subsp. shermanii (strain ATCC 9614 / DSM 4902 / CIP 103027 / NCIMB 8099 / CIRM-BIA1)	866	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0009408; GO:0016887; GO:0042026	protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN36766_c0_g1_i1	A1WX30	DNAJ_HALHL	44.6	74	40	1	250	468	5	78	2.60E-11	70.9	DNAJ_HALHL	reviewed	Chaperone protein DnaJ	dnaJ Hhal_1475	Halorhodospira halophila (strain DSM 244 / SL1) (Ectothiorhodospira halophila (strain DSM 244 / SL1))	385	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN27737_c0_g1_i1	B7J7X8	DNAJ_ACIF2	55.2	67	30	0	55	255	4	70	1.60E-15	83.2	DNAJ_ACIF2	reviewed	Chaperone protein DnaJ	dnaJ AFE_2664	Acidithiobacillus ferrooxidans (strain ATCC 23270 / DSM 14882 / CIP 104768 / NCIMB 8455) (Ferrobacillus ferrooxidans (strain ATCC 23270))	375	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		red	red	NA	NA	NA	NA
TRINITY_DN25985_c0_g1_i1	Q253T6	DNAJ_CHLFF	57.5	73	28	1	221	12	2	74	8.70E-16	84	DNAJ_CHLFF	reviewed	Chaperone protein DnaJ	dnaJ CF0680	Chlamydia felis (strain Fe/C-56) (Chlamydophila felis)	391	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN14937_c0_g1_i1	Q607A6	DNAJ_METCA	65.5	55	19	0	43	207	5	59	3.10E-14	78.6	DNAJ_METCA	reviewed	Chaperone protein DnaJ	dnaJ MCA1855	Methylococcus capsulatus (strain ATCC 33009 / NCIMB 11132 / Bath)	377	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN37798_c0_g1_i1	Q8DWH2	DNAJ_STRMU	56.5	62	27	0	42	227	6	67	1.30E-13	76.6	DNAJ_STRMU	reviewed	Chaperone protein DnaJ	dnaJ SMU_83	Streptococcus mutans serotype c (strain ATCC 700610 / UA159)	377	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN28666_c0_g1_i1	Q8TQR1	DNAJ_METAC	65.2	69	24	0	12	218	5	73	2.50E-19	95.9	DNAJ_METAC	reviewed	Chaperone protein DnaJ	dnaJ MA_1479	Methanosarcina acetivorans (strain ATCC 35395 / DSM 2834 / JCM 12185 / C2A)	382	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA replication [GO:0006260]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0008270; GO:0009408; GO:0031072; GO:0042026; GO:0051082; GO:0051085	chaperone cofactor-dependent protein refolding [GO:0051085]; DNA replication [GO:0006260]; protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN36992_c0_g1_i1	A6Q486	DNAJ_NITSB	52.9	51	24	0	164	12	7	57	5.00E-09	61.2	DNAJ_NITSB	reviewed	Chaperone protein DnaJ	dnaJ NIS_1186	Nitratiruptor sp. (strain SB155-2)	373	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i3	Q8CP18	DNAJ_STAES	69.6	69	21	0	244	38	4	72	4.20E-20	98.6	DNAJ_STAES	reviewed	Chaperone protein DnaJ	dnaJ SE_1266	Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200)	373	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN38438_c0_g1_i1	Q6ME07	DNAJ_PARUW	59.4	69	27	1	205	2	2	70	5.40E-15	81.3	DNAJ_PARUW	reviewed	Chaperone protein DnaJ	dnaJ pc0468	Protochlamydia amoebophila (strain UWE25)	386	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN30357_c0_g1_i1	Q3J7D9	DNAJ_NITOC	55.4	65	26	1	186	1	3	67	2.20E-12	72.4	DNAJ_NITOC	reviewed	Chaperone protein DnaJ	dnaJ Noc_2810	Nitrosococcus oceani (strain ATCC 19707 / BCRC 17464 / NCIMB 11848 / C-107)	380	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN5505_c0_g1_i5	Q3AF07	DNAJ_CARHZ	58.5	65	26	1	320	126	4	67	8.40E-14	78.2	DNAJ_CARHZ	reviewed	Chaperone protein DnaJ	dnaJ CHY_0416	Carboxydothermus hydrogenoformans (strain ATCC BAA-161 / DSM 6008 / Z-2901)	381	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN30936_c0_g1_i1	Q75VW3	DNAJ_HYDTT	46	87	45	1	502	248	7	93	3.40E-13	76.6	DNAJ_HYDTT	reviewed	Chaperone protein DnaJ	dnaJ HTH_1895 Hydth_1877	Hydrogenobacter thermophilus (strain DSM 6534 / IAM 12695 / TK-6)	356	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN5505_c0_g1_i2	Q5SLW9	DNAJ1_THET8	60	65	25	1	320	126	3	66	1.40E-13	77.4	DNAJ1_THET8	reviewed	Chaperone protein DnaJ 1	dnaJ1 TTHA0174	Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)	350	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN5505_c0_g1_i3	Q5SLW9	DNAJ1_THET8	61.5	65	24	1	320	126	3	66	3.60E-14	79.3	DNAJ1_THET8	reviewed	Chaperone protein DnaJ 1	dnaJ1 TTHA0174	Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)	350	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN5505_c0_g1_i4	Q5SLW9	DNAJ1_THET8	59.4	69	27	1	320	114	3	70	4.40E-14	79	DNAJ1_THET8	reviewed	Chaperone protein DnaJ 1	dnaJ1 TTHA0174	Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)	350	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN38066_c0_g1_i1	Q8GYX8	DNJ10_ARATH	67.6	74	24	0	232	11	2	75	5.30E-21	101.3	DNJ10_ARATH	reviewed	Chaperone protein dnaJ 10 (AtDjC10) (AtJ10)	ATJ10 C10 J10 At1g76700 F28O16.7	Arabidopsis thaliana (Mouse-ear cress)	398							NA	NA	NA	NA	NA	NA
TRINITY_DN40328_c0_g1_i1	Q56237	DNAJ2_THET8	54.1	61	28	0	22	204	7	67	3.60E-13	75.1	DNAJ2_THET8	reviewed	Chaperone protein DnaJ 2	dnaJ2 TTHA1489	Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)	280	cytoplasm [GO:0005737]; unfolded protein binding [GO:0051082]; DNA replication [GO:0006260]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	unfolded protein binding [GO:0051082]	GO:0005737; GO:0006260; GO:0006457; GO:0051082	DNA replication [GO:0006260]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN39197_c0_g1_i1	P42825	DNAJ2_ARATH	58.7	75	31	0	14	238	236	310	2.00E-20	99.4	DNAJ2_ARATH	reviewed	Chaperone protein dnaJ 2 (AtDjA2)	ATJ2 A2 ATJ At5g22060 T6G21.11 T6G21_170	Arabidopsis thaliana (Mouse-ear cress)	419	cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; plastid [GO:0009536]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; plastid [GO:0009536]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; unfolded protein binding [GO:0051082]	GO:0003729; GO:0005524; GO:0005829; GO:0005886; GO:0006457; GO:0009408; GO:0009506; GO:0009536; GO:0031072; GO:0046872; GO:0051082	protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN40730_c0_g1_i1	Q6XL73	DNJ39_ARATH	46.9	64	34	0	212	21	14	77	3.70E-13	75.1	DNJ39_ARATH	reviewed	Chaperone protein dnaJ 39 (AtDjC39) (AtJ39) (Protein ARG1-LIKE 2) (AtARL2)	ATJ39 ARL2 C39 At1g59980 T2K10.3	Arabidopsis thaliana (Mouse-ear cress)	414	membrane [GO:0016020]	membrane [GO:0016020]		GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN33181_c0_g1_i1	Q9FH28	DNJ49_ARATH	57	79	34	0	17	253	83	161	1.20E-20	100.1	DNJ49_ARATH	reviewed	Chaperone protein dnaJ 49 (AtDjC49) (AtJ49)	ATJ49 C49 At5g49060 K19E20.16 K20J1_3	Arabidopsis thaliana (Mouse-ear cress)	354	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	Hsp70 protein binding [GO:0030544]	GO:0005789; GO:0016021; GO:0030433; GO:0030544; GO:0051085; GO:0071218	cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN10407_c0_g1_i1	A1WAR6	DNAK_ACISJ	84.6	78	12	0	2	235	306	383	2.10E-30	132.5	DNAK_ACISJ	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Ajs_3218	Acidovorax sp. (strain JS42)	646	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN10407_c1_g1_i1	A5V5P9	DNAK_SPHWW	100	75	0	0	2	226	353	427	3.50E-35	148.3	DNAK_SPHWW	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Swit_1250	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	630	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN35552_c0_g1_i1	B2UBP3	DNAK_RALPJ	100	71	0	0	215	3	318	388	8.20E-34	143.7	DNAK_RALPJ	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Rpic_2870	Ralstonia pickettii (strain 12J)	650	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN26384_c0_g1_i1	A1SPX5	DNAK_NOCSJ	81.2	85	16	0	256	2	127	211	1.30E-33	143.3	DNAK_NOCSJ	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Noca_4363	Nocardioides sp. (strain ATCC BAA-499 / JS614)	621	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN30461_c0_g1_i1	B2UBP3	DNAK_RALPJ	100	94	0	0	1	282	227	320	4.60E-45	181.4	DNAK_RALPJ	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Rpic_2870	Ralstonia pickettii (strain 12J)	650	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN12956_c0_g1_i1	Q57AD7	DNAK_BRUAB	74.8	433	109	0	1299	1	101	533	1.20E-183	644	DNAK_BRUAB	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK BruAb1_2100	Brucella abortus biovar 1 (strain 9-941)	637	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN1596_c0_g1_i1	B2UBP3	DNAK_RALPJ	99.2	127	1	0	382	2	433	559	1.60E-64	246.5	DNAK_RALPJ	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Rpic_2870	Ralstonia pickettii (strain 12J)	650	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN31694_c0_g1_i1	C3P8M0	DNAK_BACAA	68.6	70	22	0	3	212	109	178	2.40E-22	105.5	DNAK_BACAA	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK BAA_4558	Bacillus anthracis (strain A0248)	611	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN794_c0_g1_i1	Q2RNE6	DNAK_RHORT	83.2	386	65	0	1160	3	110	495	3.70E-181	635.6	DNAK_RHORT	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Rru_A3555	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	639	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN794_c0_g1_i2	Q11KJ6	DNAK_CHESB	80.3	289	57	0	867	1	129	417	8.40E-130	464.5	DNAK_CHESB	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Meso_0679	Chelativorans sp. (strain BNC1)	636	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN794_c0_g1_i3	B8EIP9	DNAK_METSB	81	422	80	0	1268	3	110	531	3.30E-191	669.1	DNAK_METSB	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Msil_2955	Methylocella silvestris (strain DSM 15510 / CIP 108128 / LMG 27833 / NCIMB 13906 / BL2)	634	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN794_c0_g2_i1	Q2G6N0	DNAK_NOVAD	98.7	77	1	0	233	3	129	205	3.30E-36	151.8	DNAK_NOVAD	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK Saro_2054	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	635	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN12818_c0_g1_i1	Q5NPS6	DNAK_ZYMMO	94.1	68	4	0	2	205	416	483	1.80E-30	132.5	DNAK_ZYMMO	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK ZMO0660	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	635	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN26562_c0_g1_i1	Q9ZEJ0	DNAK_MYCHO	54.2	83	38	0	3	251	411	493	3.00E-19	95.5	DNAK_MYCHO	reviewed	Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70)	dnaK	Mycoplasma hominis	595	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN28966_c0_g1_i1	Q82EX9	DNAK1_STRAW	94.2	86	5	0	260	3	368	453	3.50E-39	161.8	DNAK1_STRAW	reviewed	Chaperone protein dnaK1 (HSP70-1) (Heat shock 70 kDa protein 1) (Heat shock protein 70-1)	dnaK1 SAV_4484	Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)	622	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN30377_c0_g1_i1	Q7U3C4	DNAK2_SYNPX	60.6	66	26	0	202	5	171	236	7.70E-18	90.5	DNAK2_SYNPX	reviewed	Chaperone protein dnaK2 (HSP70-2) (Heat shock 70 kDa protein 2) (Heat shock protein 70-2)	dnaK2 SYNW2508	Synechococcus sp. (strain WH8102)	637	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN39701_c0_g1_i1	B2U8U5	HSCA_RALPJ	100	88	0	0	265	2	334	421	4.10E-43	174.9	HSCA_RALPJ	reviewed	Chaperone protein HscA homolog	hscA Rpic_0889	Ralstonia pickettii (strain 12J)	621	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; iron-sulfur cluster assembly [GO:0016226]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0016226; GO:0016887; GO:0051082	iron-sulfur cluster assembly [GO:0016226]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN29323_c0_g1_i1	B2U8U5	HSCA_RALPJ	97.1	103	3	0	2	310	149	251	1.30E-51	203.4	HSCA_RALPJ	reviewed	Chaperone protein HscA homolog	hscA Rpic_0889	Ralstonia pickettii (strain 12J)	621	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; iron-sulfur cluster assembly [GO:0016226]; protein folding [GO:0006457]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0016226; GO:0016887; GO:0051082	iron-sulfur cluster assembly [GO:0016226]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	1
TRINITY_DN16397_c0_g1_i1	B1LZG0	HTPG_METRJ	81.1	95	18	0	286	2	50	144	1.70E-34	146.4	HTPG_METRJ	reviewed	Chaperone protein HtpG (Heat shock protein HtpG) (High temperature protein G)	htpG Mrad2831_5467	Methylobacterium radiotolerans (strain ATCC 27329 / DSM 1819 / JCM 2831 / NBRC 15690 / NCIMB 10815 / 0-1)	610	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN36969_c0_g1_i1	Q8Y0Q3	HTPG_RALSO	97.2	106	3	0	3	320	28	133	2.20E-51	202.6	HTPG_RALSO	reviewed	Chaperone protein HtpG (Heat shock protein HtpG) (High temperature protein G)	htpG RSc0990 RS04302	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	640	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN12505_c0_g1_i1	Q5QWR2	HTPG_IDILO	53.7	95	43	1	286	2	70	163	6.20E-21	101.3	HTPG_IDILO	reviewed	Chaperone protein HtpG (Heat shock protein HtpG) (High temperature protein G)	htpG IL1846	Idiomarina loihiensis (strain ATCC BAA-735 / DSM 15497 / L2-TR)	637	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN27339_c0_g1_i1	Q5P1C5	HTPG_AROAE	89.8	88	9	0	1	264	281	368	1.20E-42	173.3	HTPG_AROAE	reviewed	Chaperone protein HtpG (Heat shock protein HtpG) (High temperature protein G)	htpG AZOSEA27640 ebA4865	Aromatoleum aromaticum (strain EbN1) (Azoarcus sp. (strain EbN1))	648	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN15524_c0_g1_i1	Q05046	CH62_CUCMA	64.7	116	41	0	348	1	373	488	8.40E-36	151	CH62_CUCMA	reviewed	"Chaperonin CPN60-2, mitochondrial (HSP60-2)"	CPN60-2	Cucurbita maxima (Pumpkin) (Winter squash)	575	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein refolding [GO:0042026]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0042026	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN572_c0_g2_i1	Q6PHF0	CHM1A_DANRE	63.5	200	68	2	710	120	1	198	2.60E-59	230.3	CHM1A_DANRE	reviewed	Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a)	chmp1a km0004 pcoln3 zgc:65914 zgc:85863	Danio rerio (Zebrafish) (Brachydanio rerio)	198	ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]		GO:0000815; GO:0005771; GO:0007076; GO:0015031; GO:0016363; GO:0021549; GO:0032509; GO:0045324	cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN572_c0_g2_i2	Q6PHF0	CHM1A_DANRE	63.5	200	68	2	847	257	1	198	2.30E-59	230.7	CHM1A_DANRE	reviewed	Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a)	chmp1a km0004 pcoln3 zgc:65914 zgc:85863	Danio rerio (Zebrafish) (Brachydanio rerio)	198	ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]		GO:0000815; GO:0005771; GO:0007076; GO:0015031; GO:0016363; GO:0021549; GO:0032509; GO:0045324	cerebellum development [GO:0021549]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; mitotic chromosome condensation [GO:0007076]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN31800_c0_g1_i1	Q921W0	CHM1A_MOUSE	100	111	0	0	334	2	83	193	5.70E-50	198	CHM1A_MOUSE	reviewed	Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a)	Chmp1a Chmp1 Pcoln3	Mus musculus (Mouse)	196	"condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; gene silencing [GO:0016458]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vesicle-mediated transport [GO:0016192]"	condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0000815; GO:0005769; GO:0005771; GO:0005815; GO:0006997; GO:0007076; GO:0007080; GO:0010824; GO:0012505; GO:0015031; GO:0016192; GO:0016363; GO:0016458; GO:0019904; GO:0032509; GO:0042802; GO:0042803; GO:0045324; GO:0045786; GO:0045892; GO:0051301; GO:0061952; GO:1901673	"cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; gene silencing [GO:0016458]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31265_c0_g1_i1	Q9HD42	CHM1A_HUMAN	100	135	0	0	2	406	26	160	8.40E-64	244.2	CHM1A_HUMAN	reviewed	Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a) (Vacuolar protein sorting-associated protein 46-1) (Vps46-1) (hVps46-1)	CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1	Homo sapiens (Human)	196	"condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; gene silencing [GO:0016458]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]"	condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nuclear matrix [GO:0016363]	identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0000794; GO:0000815; GO:0005769; GO:0005771; GO:0005815; GO:0006997; GO:0007076; GO:0007080; GO:0008237; GO:0008270; GO:0010824; GO:0012505; GO:0015031; GO:0016192; GO:0016363; GO:0016458; GO:0019904; GO:0032509; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0045324; GO:0045786; GO:0045892; GO:0051301; GO:0061952; GO:0070062; GO:1901673; GO:1904903	"cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; gene silencing [GO:0016458]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28735_c0_g1_i1	Q7LBR1	CHM1B_HUMAN	98.6	142	2	0	428	3	2	143	1.70E-54	213.4	CHM1B_HUMAN	reviewed	Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2)	CHMP1B C18orf2	Homo sapiens (Human)	199	cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; viral budding via host ESCRT complex [GO:0039702]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000815; GO:0005654; GO:0005771; GO:0005829; GO:0006997; GO:0007080; GO:0010008; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0030496; GO:0031902; GO:0032509; GO:0036258; GO:0039702; GO:0042802; GO:0045184; GO:0045324; GO:0051301; GO:0061952; GO:0070062; GO:1901673; GO:1904903	cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; viral budding via host ESCRT complex [GO:0039702]		NA	NA	NA	NA	NA	NA
TRINITY_DN4888_c0_g1_i1	Q7ZVB1	CHM1B_DANRE	59.8	199	78	1	678	82	1	197	1.00E-53	211.5	CHM1B_DANRE	reviewed	Charged multivesicular body protein 1b (Chromatin-modifying protein 1b) (CHMP1b)	chmp1b zgc:56134	Danio rerio (Zebrafish) (Brachydanio rerio)	199	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]		GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]		brown	brown	NA	NA	NA	NA
TRINITY_DN30924_c0_g1_i1	Q99LU0	CH1B1_MOUSE	99.1	111	1	0	2	334	57	167	1.80E-40	166.4	CH1B1_MOUSE	reviewed	Charged multivesicular body protein 1b-1 (Chromatin-modifying protein 1b-1) (CHMP1b-1)	Chmp1b1 Chmp1b	Mus musculus (Mouse)	199	cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment of protein localization [GO:0045184]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; viral budding via host ESCRT complex [GO:0039702]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000815; GO:0005654; GO:0005771; GO:0005829; GO:0006997; GO:0007080; GO:0010008; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0030496; GO:0031902; GO:0032509; GO:0039702; GO:0042802; GO:0045184; GO:0045324; GO:0051301; GO:0061952; GO:1901673	cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment of protein localization [GO:0045184]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; viral budding via host ESCRT complex [GO:0039702]		NA	NA	NA	NA	NA	NA
TRINITY_DN40791_c0_g1_i1	Q9CQD4	CH1B2_MOUSE	100	64	0	0	214	23	26	89	1.20E-24	113.2	CH1B2_MOUSE	reviewed	Charged multivesicular body protein 1b-2 (Chromatin-modifying protein 1b-2) (CHMP1b-2)	Chmp1b2	Mus musculus (Mouse)	199	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]		GO:0000815; GO:0005771; GO:0005829; GO:0007049; GO:0015031; GO:0031902; GO:0032509; GO:0045324; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN13778_c0_g1_i1	Q6DFS6	CHM2A_XENTR	65.2	89	31	0	273	7	19	107	9.80E-24	110.5	CHM2A_XENTR	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a)	chmp2a TNeu078g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	220	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]		GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3321_c0_g1_i12	Q6DFS6	CHM2A_XENTR	74.1	220	57	0	72	731	1	220	4.00E-65	249.6	CHM2A_XENTR	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a)	chmp2a TNeu078g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	220	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]		GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN3321_c0_g1_i14	Q6DFS6	CHM2A_XENTR	74.1	220	57	0	245	904	1	220	4.90E-65	249.6	CHM2A_XENTR	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a)	chmp2a TNeu078g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	220	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]		GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN3321_c0_g1_i7	Q6DFS6	CHM2A_XENTR	74.1	220	57	0	318	977	1	220	5.20E-65	249.6	CHM2A_XENTR	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a)	chmp2a TNeu078g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	220	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]		GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3321_c0_g1_i8	Q6DFS6	CHM2A_XENTR	74.1	220	57	0	297	956	1	220	5.10E-65	249.6	CHM2A_XENTR	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a)	chmp2a TNeu078g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	220	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]		GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN12249_c0_g1_i1	Q9DB34	CHM2A_MOUSE	100	191	0	0	59	631	1	191	1.70E-80	300.4	CHM2A_MOUSE	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Vacuolar protein sorting-associated protein 2) (mVps2)	Chmp2a	Mus musculus (Mouse)	222	chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]; endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell death [GO:0060548]; negative regulation of centriole elongation [GO:1903723]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral release from host cell [GO:1902188]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; viral budding via host ESCRT complex [GO:0039702]	chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]	phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]	GO:0000785; GO:0000815; GO:0005635; GO:0005771; GO:0005829; GO:0006997; GO:0007080; GO:0010324; GO:0010458; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0031210; GO:0031468; GO:0031902; GO:0032509; GO:0039702; GO:0045184; GO:0045324; GO:0050792; GO:0051258; GO:0051260; GO:0060548; GO:0061952; GO:1901673; GO:1902188; GO:1903543; GO:1903723	endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell death [GO:0060548]; negative regulation of centriole elongation [GO:1903723]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral release from host cell [GO:1902188]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; viral budding via host ESCRT complex [GO:0039702]		NA	NA	NA	NA	NA	NA
TRINITY_DN12249_c0_g1_i2	Q9DB34	CHM2A_MOUSE	100	191	0	0	12	584	1	191	2.70E-80	299.7	CHM2A_MOUSE	reviewed	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Vacuolar protein sorting-associated protein 2) (mVps2)	Chmp2a	Mus musculus (Mouse)	222	chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]; endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell death [GO:0060548]; negative regulation of centriole elongation [GO:1903723]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral release from host cell [GO:1902188]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; viral budding via host ESCRT complex [GO:0039702]	chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]	phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]	GO:0000785; GO:0000815; GO:0005635; GO:0005771; GO:0005829; GO:0006997; GO:0007080; GO:0010324; GO:0010458; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0031210; GO:0031468; GO:0031902; GO:0032509; GO:0039702; GO:0045184; GO:0045324; GO:0050792; GO:0051258; GO:0051260; GO:0060548; GO:0061952; GO:1901673; GO:1902188; GO:1903543; GO:1903723	endosome transport via multivesicular body sorting pathway [GO:0032509]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell death [GO:0060548]; negative regulation of centriole elongation [GO:1903723]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral release from host cell [GO:1902188]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; viral budding via host ESCRT complex [GO:0039702]		NA	NA	NA	NA	NA	NA
TRINITY_DN3618_c0_g1_i1	Q6NXD2	CHM2B_DANRE	44	209	115	2	52	675	4	211	8.20E-28	125.6	CHM2B_DANRE	reviewed	Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b)	chmp2b si:ch211-106g5.3 zgc:77025	Danio rerio (Zebrafish) (Brachydanio rerio)	214	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]		GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN28969_c0_g1_i1	Q5F3A2	CHM2B_CHICK	92.5	67	5	0	203	3	38	104	1.60E-23	109.4	CHM2B_CHICK	reviewed	Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b)	CHMP2B RCJMB04_25h19	Gallus gallus (Chicken)	214	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]		GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324	endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN36823_c0_g1_i1	Q9BY43	CHM4A_HUMAN	97.4	191	5	0	2	574	5	195	5.50E-85	315.1	CHM4A_HUMAN	reviewed	Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1)	CHMP4A C14orf123 SHAX2 CDA04 HSPC134	Homo sapiens (Human)	222	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of neuron death [GO:1901215]; nucleus organization [GO:0006997]; plasma membrane tubulation [GO:0097320]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; vesicle budding from membrane [GO:0006900]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleus [GO:0005634]	ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]	GO:0000815; GO:0005634; GO:0005737; GO:0005771; GO:0005829; GO:0006620; GO:0006900; GO:0006997; GO:0007080; GO:0008289; GO:0009898; GO:0010324; GO:0016197; GO:0016236; GO:0019058; GO:0030117; GO:0030496; GO:0030659; GO:0031902; GO:0032511; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0051117; GO:0051258; GO:0061952; GO:0097320; GO:1901215; GO:1902902	endosomal transport [GO:0016197]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of neuron death [GO:1901215]; nucleus organization [GO:0006997]; plasma membrane tubulation [GO:0097320]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; vesicle budding from membrane [GO:0006900]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN1299_c0_g1_i1	Q6IQ73	CHM4C_DANRE	69.1	194	59	1	93	671	1	194	4.70E-58	226.1	CHM4C_DANRE	reviewed	Charged multivesicular body protein 4c (Chromatin-modifying protein 4c) (CHMP4c)	chmp4c chmp4b zgc:55566	Danio rerio (Zebrafish) (Brachydanio rerio)	224	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; abscission [GO:0009838]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]		GO:0000815; GO:0005771; GO:0005829; GO:0006900; GO:0009838; GO:0009898; GO:0015031; GO:0031902; GO:0032466; GO:0032511; GO:0044878	abscission [GO:0009838]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]		blue	blue	NA	NA	NA	NA
TRINITY_DN1299_c0_g1_i2	Q6IQ73	CHM4C_DANRE	69.1	194	59	1	93	671	1	194	4.70E-58	226.1	CHM4C_DANRE	reviewed	Charged multivesicular body protein 4c (Chromatin-modifying protein 4c) (CHMP4c)	chmp4c chmp4b zgc:55566	Danio rerio (Zebrafish) (Brachydanio rerio)	224	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; abscission [GO:0009838]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]		GO:0000815; GO:0005771; GO:0005829; GO:0006900; GO:0009838; GO:0009898; GO:0015031; GO:0031902; GO:0032466; GO:0032511; GO:0044878	abscission [GO:0009838]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN3221_c0_g1_i1	Q7T339	CHMP5_DANRE	77	217	49	1	89	736	1	217	6.10E-77	288.9	CHMP5_DANRE	reviewed	Charged multivesicular body protein 5 (Chromatin-modifying protein 5)	chmp5	Danio rerio (Zebrafish) (Brachydanio rerio)	220	cytosol [GO:0005829]; endosome membrane [GO:0010008]; multivesicular body [GO:0005771]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; multivesicular body [GO:0005771]		GO:0005771; GO:0005829; GO:0006900; GO:0010008; GO:0015031; GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]		blue	blue	NA	NA	NA	NA
TRINITY_DN19296_c0_g1_i1	Q7T339	CHMP5_DANRE	56	125	55	0	25	399	5	129	1.10E-29	131	CHMP5_DANRE	reviewed	Charged multivesicular body protein 5 (Chromatin-modifying protein 5)	chmp5	Danio rerio (Zebrafish) (Brachydanio rerio)	220	cytosol [GO:0005829]; endosome membrane [GO:0010008]; multivesicular body [GO:0005771]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; multivesicular body [GO:0005771]		GO:0005771; GO:0005829; GO:0006900; GO:0010008; GO:0015031; GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN19296_c0_g1_i2	Q7T339	CHMP5_DANRE	60.6	104	41	0	2	313	26	129	1.90E-24	113.2	CHMP5_DANRE	reviewed	Charged multivesicular body protein 5 (Chromatin-modifying protein 5)	chmp5	Danio rerio (Zebrafish) (Brachydanio rerio)	220	cytosol [GO:0005829]; endosome membrane [GO:0010008]; multivesicular body [GO:0005771]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; multivesicular body [GO:0005771]		GO:0005771; GO:0005829; GO:0006900; GO:0010008; GO:0015031; GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN4675_c0_g1_i1	Q5ZL55	CHMP6_CHICK	45.1	164	89	1	672	181	1	163	4.20E-29	129.8	CHMP6_CHICK	reviewed	Charged multivesicular body protein 6 (Chromatin-modifying protein 6)	CHMP6 RCJMB04_7k13	Gallus gallus (Chicken)	200	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of protein catabolic process [GO:0042176]; vesicle budding from membrane [GO:0006900]; viral budding via host ESCRT complex [GO:0039702]	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]	protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]	GO:0000815; GO:0005771; GO:0006900; GO:0006997; GO:0007080; GO:0007175; GO:0015031; GO:0031902; GO:0032511; GO:0039702; GO:0042176; GO:0044877; GO:0047485; GO:0061952	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of protein catabolic process [GO:0042176]; vesicle budding from membrane [GO:0006900]; viral budding via host ESCRT complex [GO:0039702]		NA	NA	NA	NA	NA	NA
TRINITY_DN7484_c0_g1_i3	O60921	HUS1_HUMAN	42.4	158	91	0	522	49	121	278	2.20E-33	143.7	HUS1_HUMAN	reviewed	Checkpoint protein HUS1 (hHUS1)	HUS1	Homo sapiens (Human)	280	checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]	checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]		GO:0000077; GO:0000723; GO:0000724; GO:0001932; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0006468; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7484_c0_g1_i4	O60921	HUS1_HUMAN	40.4	267	154	2	849	49	17	278	3.00E-53	210.3	HUS1_HUMAN	reviewed	Checkpoint protein HUS1 (hHUS1)	HUS1	Homo sapiens (Human)	280	checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]	checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]		GO:0000077; GO:0000723; GO:0000724; GO:0001932; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0006468; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN7484_c0_g1_i2	Q8BQY8	HUS1_MOUSE	40.6	283	163	2	897	49	1	278	7.90E-57	222.2	HUS1_MOUSE	reviewed	Checkpoint protein HUS1 (mHUS1)	Hus1	Mus musculus (Mouse)	280	checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]	checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]		GO:0000077; GO:0000723; GO:0000724; GO:0001932; GO:0005634; GO:0005730; GO:0005737; GO:0006289; GO:0006468; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN11279_c0_g1_i1	Q8T5G8	CHS_MELAT	57.6	224	95	0	678	7	1010	1233	3.70E-72	272.7	CHS_MELAT	reviewed	Chitin synthase (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase)		Meloidogyne artiellia (British root-knot nematode)	1851	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; embryo development ending in birth or egg hatching [GO:0009792]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0009792; GO:0016021	embryo development ending in birth or egg hatching [GO:0009792]		NA	NA	NA	NA	NA	NA
TRINITY_DN11279_c0_g1_i2	G5EBQ8	CHS2_CAEEL	52.4	273	130	0	876	58	931	1203	6.90E-79	295.4	CHS2_CAEEL	reviewed	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063; GO:0071944	chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]		NA	NA	NA	NA	NA	NA
TRINITY_DN14921_c0_g1_i1	G5EBQ8	CHS2_CAEEL	34.2	415	240	10	1381	197	1227	1628	1.10E-49	199.1	CHS2_CAEEL	reviewed	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063; GO:0071944	chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]		NA	NA	NA	NA	NA	NA
TRINITY_DN14921_c0_g1_i2	G5EBQ8	CHS2_CAEEL	41.9	203	100	6	781	197	1436	1628	1.60E-27	124.8	CHS2_CAEEL	reviewed	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063; GO:0071944	chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]		NA	NA	NA	NA	NA	NA
TRINITY_DN14921_c0_g1_i4	G5EBQ8	CHS2_CAEEL	35.2	369	218	7	1431	373	1227	1590	9.00E-50	199.5	CHS2_CAEEL	reviewed	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063; GO:0071944	chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]		NA	NA	NA	NA	NA	NA
TRINITY_DN21263_c0_g1_i1	G5EBQ8	CHS2_CAEEL	50.2	285	121	5	2	811	550	828	3.40E-72	273.1	CHS2_CAEEL	reviewed	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063; GO:0071944	chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]		NA	NA	NA	NA	NA	NA
TRINITY_DN30814_c0_g1_i1	A0JPQ9	CHID1_RAT	43.6	165	86	4	38	517	20	182	3.80E-30	132.9	CHID1_RAT	reviewed	Chitinase domain-containing protein 1	Chid1	Rattus norvegicus (Rat)	393	extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]	GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0045087; GO:0070492; GO:1900016	carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]		NA	NA	NA	NA	NA	NA
TRINITY_DN30814_c0_g1_i2	A0JPQ9	CHID1_RAT	44.6	184	95	4	38	574	20	201	4.30E-37	156	CHID1_RAT	reviewed	Chitinase domain-containing protein 1	Chid1	Rattus norvegicus (Rat)	393	extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]	GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0045087; GO:0070492; GO:1900016	carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]		NA	NA	NA	NA	NA	NA
TRINITY_DN8842_c0_g2_i1	Q66IL0	CHID1_XENTR	56	100	41	2	395	105	295	394	4.40E-26	119	CHID1_XENTR	reviewed	Chitinase domain-containing protein 1	chid1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	394	extracellular region [GO:0005576]; lysosome [GO:0005764]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]; lysosome [GO:0005764]	chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]	GO:0005576; GO:0005764; GO:0005975; GO:0008061; GO:0070492	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN8842_c0_g2_i2	Q66IL0	CHID1_XENTR	54.3	173	73	4	611	105	224	394	8.30E-47	188.3	CHID1_XENTR	reviewed	Chitinase domain-containing protein 1	chid1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	394	extracellular region [GO:0005576]; lysosome [GO:0005764]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]; lysosome [GO:0005764]	chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]	GO:0005576; GO:0005764; GO:0005975; GO:0008061; GO:0070492	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN18568_c0_g1_i1	P30922	CH3L1_BOVIN	45.5	66	35	1	2	196	317	382	1.20E-08	61.6	CH3L1_BOVIN	reviewed	Chitinase-3-like protein 1 (39 kDa whey protein) (Cartilage glycoprotein 39) (CGP-39) (GP-39) (Chitinase-like protein 1) (CLP-1) (SPC-40) (Signal-processing protein)	CHI3L1	Bos taurus (Bovine)	383	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; interleukin-8 production [GO:0032637]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]	GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005975; GO:0006032; GO:0006915; GO:0006954; GO:0007250; GO:0008061; GO:0009612; GO:0010800; GO:0030246; GO:0030324; GO:0032637; GO:0034612; GO:0045766; GO:0048471; GO:0051897; GO:0070374; GO:0070555; GO:0070741; GO:0071356	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; interleukin-8 production [GO:0032637]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]		NA	NA	NA	NA	NA	NA
TRINITY_DN32655_c0_g1_i1	O35744	CHIL3_MOUSE	51.9	54	26	0	196	35	23	76	7.90E-11	68.2	CHIL3_MOUSE	reviewed	Chitinase-like protein 3 (EC 3.2.1.52) (Beta-N-acetylhexosaminidase Ym1) (Chitinase-3-like protein 3) (ECF-L) (Eosinophil chemotactic cytokine) (Secreted protein Ym1)	Chil3 Chi3l3 Ym1	Mus musculus (Mouse)	398	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum lumen [GO:0048237]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; polysaccharide catabolic process [GO:0000272]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum lumen [GO:0048237]	beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0005576; GO:0005635; GO:0005737; GO:0006032; GO:0006954; GO:0008061; GO:0030246; GO:0031410; GO:0048237; GO:0102148	chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN32194_c0_g1_i1	O35744	CHIL3_MOUSE	52.7	74	34	1	222	1	265	337	1.20E-16	86.7	CHIL3_MOUSE	reviewed	Chitinase-like protein 3 (EC 3.2.1.52) (Beta-N-acetylhexosaminidase Ym1) (Chitinase-3-like protein 3) (ECF-L) (Eosinophil chemotactic cytokine) (Secreted protein Ym1)	Chil3 Chi3l3 Ym1	Mus musculus (Mouse)	398	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum lumen [GO:0048237]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; polysaccharide catabolic process [GO:0000272]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum lumen [GO:0048237]	beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0005576; GO:0005635; GO:0005737; GO:0006032; GO:0006954; GO:0008061; GO:0030246; GO:0031410; GO:0048237; GO:0102148	chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN3822_c0_g1_i1	Q5R7A2	ALG1_PONAB	48.5	433	208	7	1398	124	35	460	2.30E-106	387.5	ALG1_PONAB	reviewed	"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase)"	ALG1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	464	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; protein glycosylation [GO:0006486]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]	GO:0004578; GO:0005789; GO:0006486; GO:0016021	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN18543_c0_g1_i1	Q9BT22	ALG1_HUMAN	100	104	0	0	314	3	299	402	2.80E-59	228.8	ALG1_HUMAN	reviewed	"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)"	ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870	Homo sapiens (Human)	464	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016020; GO:0016021	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN9421_c1_g3_i1	P49010	HEXC_BOMMO	47.1	592	283	11	1844	90	27	595	5.70E-155	549.3	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN9421_c1_g3_i2	P49010	HEXC_BOMMO	47.1	592	283	11	1844	90	27	595	7.90E-155	548.9	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN9421_c1_g3_i3	P49010	HEXC_BOMMO	51.1	280	131	2	929	90	322	595	4.60E-87	322.8	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		brown	brown	NA	NA	NA	NA
TRINITY_DN9421_c1_g1_i3	P49010	HEXC_BOMMO	46.4	293	149	3	887	12	146	431	3.00E-74	280.4	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN9421_c1_g2_i1	P49010	HEXC_BOMMO	55.1	98	39	1	383	90	503	595	2.40E-28	126.3	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN20957_c0_g1_i1	P49010	HEXC_BOMMO	59.7	124	45	1	445	74	421	539	5.10E-38	158.7	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN7935_c0_g1_i1	P49010	HEXC_BOMMO	55.7	79	35	0	322	86	517	595	8.60E-25	114.4	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN7935_c0_g1_i2	P49010	HEXC_BOMMO	55.7	79	35	0	290	54	517	595	7.80E-25	114.4	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN7935_c0_g1_i3	P49010	HEXC_BOMMO	52.1	142	63	1	511	86	459	595	9.10E-39	161.4	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN37854_c0_g1_i1	P49010	HEXC_BOMMO	58.8	51	21	0	170	18	322	372	1.30E-12	73.6	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN16863_c0_g1_i1	P49010	HEXC_BOMMO	50.8	124	60	1	375	4	381	503	1.80E-28	126.7	HEXC_BOMMO	reviewed	Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)		Bombyx mori (Silk moth)	596	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0000272; GO:0004563; GO:0006032; GO:0102148	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN14381_c0_g1_i1	Q13231	CHIT1_HUMAN	37	468	256	12	116	1477	24	466	1.30E-83	312	CHIT1_HUMAN	reviewed	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	CHIT1	Homo sapiens (Human)	466	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	"chitinase activity [GO:0004568]; chitin binding [GO:0008061]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]	x	brown	brown	NA	NA	NA	NA
TRINITY_DN33233_c0_g1_i1	Q9VGH7	CLCN2_DROME	82.4	188	33	0	565	2	213	400	4.60E-84	312	CLCN2_DROME	reviewed	Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a)	ClC-a CG31116	Drosophila melanogaster (Fruit fly)	1193	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]	chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]	GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]		NA	NA	NA	NA	NA	NA
TRINITY_DN33233_c0_g1_i2	Q9VGH7	CLCN2_DROME	85.1	74	11	0	249	28	213	286	1.40E-29	129.8	CLCN2_DROME	reviewed	Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a)	ClC-a CG31116	Drosophila melanogaster (Fruit fly)	1193	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]	chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]	GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]		NA	NA	NA	NA	NA	NA
TRINITY_DN25909_c0_g1_i1	Q9VGH7	CLCN2_DROME	58.2	55	21	1	244	86	1010	1064	4.30E-10	65.1	CLCN2_DROME	reviewed	Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a)	ClC-a CG31116	Drosophila melanogaster (Fruit fly)	1193	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]	chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]	GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]		NA	NA	NA	NA	NA	NA
TRINITY_DN23483_c0_g1_i1	Q9VGH7	CLCN2_DROME	53.3	289	129	3	77	937	103	387	9.00E-77	288.5	CLCN2_DROME	reviewed	Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a)	ClC-a CG31116	Drosophila melanogaster (Fruit fly)	1193	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]	chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]	GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]		NA	NA	NA	NA	NA	NA
TRINITY_DN23483_c0_g1_i3	Q9VGH7	CLCN2_DROME	47.3	184	84	4	77	601	103	282	1.70E-34	147.5	CLCN2_DROME	reviewed	Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a)	ClC-a CG31116	Drosophila melanogaster (Fruit fly)	1193	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]	chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]	GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]		NA	NA	NA	NA	NA	NA
TRINITY_DN39446_c0_g1_i1	P92941	CLCA_ARATH	46.4	84	44	1	1	252	148	230	5.00E-15	81.6	CLCA_ARATH	reviewed	Chloride channel protein CLC-a (AtCLC-a) (CBS domain-containing protein CBSCLC5)	CLC-A CBSCLC5 At5g40890 MHK7.12	Arabidopsis thaliana (Mouse-ear cress)	775	chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; plant-type vacuole membrane [GO:0009705]; nitrate transmembrane transporter activity [GO:0015112]; nitrate:proton symporter activity [GO:0009671]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; nitrate transport [GO:0015706]; regulation of ion transmembrane transport [GO:0034765]; response to nitrate [GO:0010167]	chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; plant-type vacuole membrane [GO:0009705]	nitrate:proton symporter activity [GO:0009671]; nitrate transmembrane transporter activity [GO:0015112]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0006821; GO:0009671; GO:0009705; GO:0010167; GO:0015112; GO:0015706; GO:0022857; GO:0034707; GO:0034765; GO:0043231	chloride transport [GO:0006821]; nitrate transport [GO:0015706]; regulation of ion transmembrane transport [GO:0034765]; response to nitrate [GO:0010167]		NA	NA	NA	NA	NA	NA
TRINITY_DN811_c0_g1_i2	P70031	CCKAR_XENLA	32.8	323	159	5	1228	266	150	416	2.20E-33	145.6	CCKAR_XENLA	reviewed	Cholecystokinin receptor (CCK-XLR)	cckar	Xenopus laevis (African clawed frog)	453	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN811_c0_g1_i2	P70031	CCKAR_XENLA	45.7	81	44	0	1538	1296	69	149	3.60E-12	75.1	CCKAR_XENLA	reviewed	Cholecystokinin receptor (CCK-XLR)	cckar	Xenopus laevis (African clawed frog)	453	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN811_c0_g1_i3	P70031	CCKAR_XENLA	45.5	198	106	1	726	139	69	266	4.40E-40	167.2	CCKAR_XENLA	reviewed	Cholecystokinin receptor (CCK-XLR)	cckar	Xenopus laevis (African clawed frog)	453	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN27197_c0_g1_i1	Q8NE62	CHDH_HUMAN	49.3	150	66	3	516	76	437	579	3.30E-28	126.3	CHDH_HUMAN	reviewed	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	CHDH	Homo sapiens (Human)	594	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660	choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN33887_c0_g1_i1	Q6UPE0	CHDH_RAT	55.7	79	35	0	271	35	499	577	1.10E-16	87.4	CHDH_RAT	reviewed	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	Chdh	Rattus norvegicus (Rat)	599	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0050660	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN39672_c0_g1_i1	Q8NE62	CHDH_HUMAN	56.8	74	25	2	202	2	511	584	2.60E-13	75.5	CHDH_HUMAN	reviewed	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	CHDH	Homo sapiens (Human)	594	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660	choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN34547_c0_g1_i1	Q8NE62	CHDH_HUMAN	100	75	0	0	3	227	271	345	1.80E-36	152.5	CHDH_HUMAN	reviewed	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	CHDH	Homo sapiens (Human)	594	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660	choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN26605_c0_g1_i1	Q8NE62	CHDH_HUMAN	100	71	0	0	2	214	499	569	1.10E-33	143.3	CHDH_HUMAN	reviewed	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	CHDH	Homo sapiens (Human)	594	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660	choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN15904_c0_g1_i1	Q8NE62	CHDH_HUMAN	71.4	42	12	0	48	173	533	574	2.60E-09	62.4	CHDH_HUMAN	reviewed	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	CHDH	Homo sapiens (Human)	594	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660	choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN9349_c0_g1_i4	O54804	CHKA_MOUSE	38.5	244	112	5	815	93	243	451	6.80E-39	162.5	CHKA_MOUSE	reviewed	Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82)	Chka Chk	Mus musculus (Mouse)	453	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; identical protein binding [GO:0042802]; choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; identical protein binding [GO:0042802]	GO:0004103; GO:0004104; GO:0004305; GO:0005524; GO:0005737; GO:0006580; GO:0006646; GO:0006656; GO:0008144; GO:0009636; GO:0019695; GO:0033265; GO:0042802; GO:1904681	choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN2143_c0_g1_i5	Q90YJ9	CLAT_CHICK	50	54	27	0	205	366	19	72	1.10E-07	57.8	CLAT_CHICK	reviewed	Choline O-acetyltransferase (CHOACTase) (ChAT) (Choline acetylase) (EC 2.3.1.6)	CHAT	Gallus gallus (Chicken)	640	choline O-acetyltransferase activity [GO:0004102]; neurotransmitter biosynthetic process [GO:0042136]; response to growth hormone [GO:0060416]		choline O-acetyltransferase activity [GO:0004102]	GO:0004102; GO:0042136; GO:0060416	neurotransmitter biosynthetic process [GO:0042136]; response to growth hormone [GO:0060416]		blue	blue	NA	NA	NA	NA
TRINITY_DN38685_c0_g1_i1	Q8WWI5	CTL1_HUMAN	51.6	161	78	0	241	723	384	544	7.20E-42	172.2	CTL1_HUMAN	reviewed	Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92)	SLC44A1 CD92 CDW92 CTL1	Homo sapiens (Human)	657	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0042426; GO:0055085; GO:0070062; GO:0150104	choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN20616_c0_g1_i2	Q810F1	CTL2_CAVPO	100	81	0	0	2	244	563	643	3.60E-38	158.3	CTL2_CAVPO	reviewed	Choline transporter-like protein 2 (Inner ear supporting cell antigen) (IESCA) (Solute carrier family 44 member 2)	SLC44A2 CTL2	Cavia porcellus (Guinea pig)	705	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN20616_c0_g1_i1	Q8IWA5	CTL2_HUMAN	100	143	0	0	2	430	564	706	1.50E-74	280	CTL2_HUMAN	reviewed	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	SLC44A2 CTL2 PSEC0210	Homo sapiens (Human)	706	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline transport [GO:0015871]; neutrophil degranulation [GO:0043312]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0005765; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0035579; GO:0043123; GO:0043312; GO:0055085; GO:0070062	choline transport [GO:0015871]; neutrophil degranulation [GO:0043312]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN5330_c0_g1_i2	Q5R5L9	CTL2_PONAB	36.6	224	129	4	4	663	218	432	2.60E-21	104	CTL2_PONAB	reviewed	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	SLC44A2 CTL2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	711	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5330_c0_g1_i1	Q7T2B0	CTL4_DANRE	46.2	496	250	7	1	1458	230	718	4.10E-105	383.6	CTL4_DANRE	reviewed	Choline transporter-like protein 4 (Solute carrier family 44 member 4)	slc44a4 ctl4	Danio rerio (Zebrafish) (Brachydanio rerio)	723	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0008292; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0048840; GO:0055085; GO:0061526; GO:0090422	acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN5330_c0_g1_i4	Q7T2B0	CTL4_DANRE	46.2	496	250	7	1	1458	230	718	3.60E-105	383.6	CTL4_DANRE	reviewed	Choline transporter-like protein 4 (Solute carrier family 44 member 4)	slc44a4 ctl4	Danio rerio (Zebrafish) (Brachydanio rerio)	723	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0008292; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0048840; GO:0055085; GO:0061526; GO:0090422	acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN37510_c0_g1_i1	Q9Y259	CHKB_HUMAN	100	87	0	0	1	261	117	203	1.60E-44	179.5	CHKB_HUMAN	reviewed	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	CHKB CHETK CHKL	Homo sapiens (Human)	395	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN23474_c0_g2_i1	Q9Y259	CHKB_HUMAN	100	112	0	0	2	337	208	319	2.00E-63	242.7	CHKB_HUMAN	reviewed	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	CHKB CHETK CHKL	Homo sapiens (Human)	395	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN9349_c0_g1_i1	Q9Y259	CHKB_HUMAN	43.8	345	146	7	1127	93	92	388	2.10E-72	274.2	CHKB_HUMAN	reviewed	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	CHKB CHETK CHKL	Homo sapiens (Human)	395	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN9349_c0_g1_i2	Q9Y259	CHKB_HUMAN	58.3	60	23	1	239	60	92	149	2.60E-12	72.4	CHKB_HUMAN	reviewed	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	CHKB CHETK CHKL	Homo sapiens (Human)	395	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN9349_c0_g1_i3	Q9Y259	CHKB_HUMAN	40.8	287	124	6	953	93	148	388	2.10E-52	207.6	CHKB_HUMAN	reviewed	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	CHKB CHETK CHKL	Homo sapiens (Human)	395	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN23474_c0_g1_i1	O55229	CHKB_MOUSE	100	68	0	0	2	205	204	271	8.60E-33	140.2	CHKB_MOUSE	reviewed	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (choline/ethanolamine kinase beta) (CKEKB)	Chkb Chetk Chkl	Mus musculus (Mouse)	394	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0006646; GO:0006656; GO:0007517	muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN9794_c0_g1_i4	Q5ZKD1	CEPT1_CHICK	59.3	241	97	1	94	816	43	282	6.60E-77	288.9	CEPT1_CHICK	reviewed	Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2)	CEPT1 RCJMB04_11l7	Gallus gallus (Chicken)	416	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; phosphatidylethanolamine biosynthetic process [GO:0006646]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0004142; GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0016021; GO:0016780; GO:0031965; GO:0046872	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN21152_c0_g1_i1	Q9Y6K0	CEPT1_HUMAN	100	159	0	0	2	478	57	215	5.00E-92	338.2	CEPT1_HUMAN	reviewed	Choline/ethanolaminephosphotransferase 1 (hCEPT1) (EC 2.7.8.1) (EC 2.7.8.2)	CEPT1 PRO1101	Homo sapiens (Human)	416	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0004142; GO:0004307; GO:0005789; GO:0005794; GO:0006629; GO:0006646; GO:0006656; GO:0016021; GO:0016780; GO:0031965; GO:0046872	lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN9794_c0_g1_i2	Q8BGS7	CEPT1_MOUSE	55.1	365	163	1	94	1188	43	406	1.10E-110	401.7	CEPT1_MOUSE	reviewed	Choline/ethanolaminephosphotransferase 1 (mCEPT1) (EC 2.7.8.1) (EC 2.7.8.2)	Cept1	Mus musculus (Mouse)	416	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0004142; GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0006656; GO:0016021; GO:0016780; GO:0031965; GO:0046872	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN27611_c0_g1_i1	P49585	PCY1A_HUMAN	99.5	201	1	0	635	33	56	256	4.70E-114	411.8	PCY1A_HUMAN	reviewed	Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A)	PCYT1A CTPCT PCYT1	Homo sapiens (Human)	367	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]	GO:0004105; GO:0005516; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006656; GO:0006657; GO:0031210; GO:0042587; GO:0042802; GO:0042803	CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656]		NA	NA	NA	NA	NA	NA
TRINITY_DN3527_c0_g1_i1	P19836	PCY1A_RAT	53	313	129	5	161	1075	43	345	1.00E-80	302	PCY1A_RAT	reviewed	Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A)	Pcyt1a Ctpct Pcyt1	Rattus norvegicus (Rat)	367	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]	GO:0004105; GO:0005516; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006656; GO:0006657; GO:0008289; GO:0019898; GO:0031210; GO:0042587; GO:0042802; GO:0042803	CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656]		NA	NA	NA	NA	NA	NA
TRINITY_DN33707_c0_g1_i1	Q8WUD6	CHPT1_HUMAN	99.4	164	1	0	494	3	7	170	9.80E-91	334	CHPT1_HUMAN	reviewed	Cholinephosphotransferase 1 (hCPT1) (EC 2.7.8.2) (AAPT1-like protein) (Diacylglycerol cholinephosphotransferase 1)	CHPT1 CPT1 MSTP022	Homo sapiens (Human)	406	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; diacylglycerol binding [GO:0019992]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; CDP-choline pathway [GO:0006657]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; platelet activating factor biosynthetic process [GO:0006663]; regulation of cell growth [GO:0001558]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"diacylglycerol binding [GO:0019992]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0000139; GO:0001558; GO:0004142; GO:0005789; GO:0005794; GO:0006629; GO:0006656; GO:0006657; GO:0006663; GO:0016020; GO:0016021; GO:0016780; GO:0019992; GO:0043231; GO:0046872	CDP-choline pathway [GO:0006657]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; platelet activating factor biosynthetic process [GO:0006663]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN34932_c0_g1_i1	Q8C025	CHPT1_MOUSE	98.9	91	1	0	275	3	82	172	3.00E-49	195.3	CHPT1_MOUSE	reviewed	Cholinephosphotransferase 1 (mCHPT1) (EC 2.7.8.2) (Diabetic nephropathy-associated gene transcript 1) (Diacylglycerol cholinephosphotransferase 1)	Chpt1 Cpt1 Dn4	Mus musculus (Mouse)	398	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; phosphatidylcholine biosynthetic process [GO:0006656]; platelet activating factor biosynthetic process [GO:0006663]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0000139; GO:0004142; GO:0005789; GO:0005794; GO:0006656; GO:0006663; GO:0016021; GO:0016780; GO:0046872	phosphatidylcholine biosynthetic process [GO:0006656]; platelet activating factor biosynthetic process [GO:0006663]		NA	NA	NA	NA	NA	NA
TRINITY_DN7225_c2_g1_i1	Q95001	CHLE2_BRALA	42.5	186	97	3	696	145	52	229	1.40E-35	151.4	CHLE2_BRALA	reviewed	Cholinesterase 2 (EC 3.1.1.8) (Fragment)	CHE2	Branchiostoma lanceolatum (Common lancelet) (Amphioxus lanceolatum)	337	cholinesterase activity [GO:0004104]		cholinesterase activity [GO:0004104]	GO:0004104			NA	NA	NA	NA	NA	NA
TRINITY_DN7225_c2_g1_i4	Q95001	CHLE2_BRALA	42.5	186	97	3	1183	632	52	229	2.30E-35	151.4	CHLE2_BRALA	reviewed	Cholinesterase 2 (EC 3.1.1.8) (Fragment)	CHE2	Branchiostoma lanceolatum (Common lancelet) (Amphioxus lanceolatum)	337	cholinesterase activity [GO:0004104]		cholinesterase activity [GO:0004104]	GO:0004104			NA	NA	NA	NA	NA	NA
TRINITY_DN5998_c0_g1_i1	Q8TDX6	CGAT1_HUMAN	48.6	107	53	2	335	18	353	458	8.80E-27	120.9	CGAT1_HUMAN	reviewed	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CsGalNAcT-1) (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1)"	CSGALNACT1 CHGN GALNACT1 UNQ656/PRO1287	Homo sapiens (Human)	532	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]	GO:0000139; GO:0001958; GO:0008376; GO:0008955; GO:0015014; GO:0015020; GO:0019276; GO:0030166; GO:0030173; GO:0030198; GO:0030206; GO:0030210; GO:0032580; GO:0046398; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050653; GO:0051216	"cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21148_c0_g1_i1	Q8TDX6	CGAT1_HUMAN	100	113	0	0	339	1	358	470	3.40E-66	251.9	CGAT1_HUMAN	reviewed	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CsGalNAcT-1) (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1)"	CSGALNACT1 CHGN GALNACT1 UNQ656/PRO1287	Homo sapiens (Human)	532	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]	GO:0000139; GO:0001958; GO:0008376; GO:0008955; GO:0015014; GO:0015020; GO:0019276; GO:0030166; GO:0030173; GO:0030198; GO:0030206; GO:0030210; GO:0032580; GO:0046398; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050653; GO:0051216	"cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21148_c0_g1_i2	Q8TDX6	CGAT1_HUMAN	100	97	0	0	291	1	358	454	1.60E-56	219.5	CGAT1_HUMAN	reviewed	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CsGalNAcT-1) (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1)"	CSGALNACT1 CHGN GALNACT1 UNQ656/PRO1287	Homo sapiens (Human)	532	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]	GO:0000139; GO:0001958; GO:0008376; GO:0008955; GO:0015014; GO:0015020; GO:0019276; GO:0030166; GO:0030173; GO:0030198; GO:0030206; GO:0030210; GO:0032580; GO:0046398; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050653; GO:0051216	"cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12261_c0_g1_i1	Q8N6G5	CGAT2_HUMAN	47.3	410	195	5	1316	135	124	528	1.30E-108	394.8	CGAT2_HUMAN	reviewed	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2)"	CSGALNACT2 CHGN2 GALNACT2 PRO0082	Homo sapiens (Human)	542	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]	GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030173; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050652; GO:0050653	"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26346_c0_g1_i1	Q8N6G5	CGAT2_HUMAN	100	75	0	0	228	4	467	541	3.10E-39	161.8	CGAT2_HUMAN	reviewed	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2)"	CSGALNACT2 CHGN2 GALNACT2 PRO0082	Homo sapiens (Human)	542	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]	GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030173; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050652; GO:0050653	"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10250_c0_g1_i1	Q6ZQ11	CHSS1_MOUSE	64.7	190	67	0	409	978	83	272	1.70E-71	271.2	CHSS1_MOUSE	reviewed	Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1)	Chsy1 Kiaa0990	Mus musculus (Mouse)	800	"extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]; bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]"	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0002063; GO:0005576; GO:0008376; GO:0009954; GO:0016021; GO:0016757; GO:0030206; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0051216; GO:0051923; GO:0060349	bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN10250_c0_g1_i2	Q6ZQ11	CHSS1_MOUSE	46.8	553	270	9	409	2046	83	618	1.70E-136	488	CHSS1_MOUSE	reviewed	Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1)	Chsy1 Kiaa0990	Mus musculus (Mouse)	800	"extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]; bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]"	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0002063; GO:0005576; GO:0008376; GO:0009954; GO:0016021; GO:0016757; GO:0030206; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0051216; GO:0051923; GO:0060349	bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN4893_c0_g1_i1	Q6IQX7	CHSS2_MOUSE	31.9	788	482	17	2345	63	11	770	4.70E-93	344	CHSS2_MOUSE	reviewed	Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2)	Chpf Css2 D1Bwg1363e	Mus musculus (Mouse)	774	"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206]"	cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]	"acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005759; GO:0005829; GO:0008376; GO:0016021; GO:0016757; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510	chondroitin sulfate biosynthetic process [GO:0030206]		NA	NA	NA	NA	NA	NA
TRINITY_DN4893_c0_g1_i2	Q8IZ52	CHSS2_HUMAN	30.8	286	171	5	883	92	11	291	7.50E-29	129.4	CHSS2_HUMAN	reviewed	Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2)	CHPF CSS2 UNQ651/PRO1281	Homo sapiens (Human)	775	cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206]	cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]	GO:0000139; GO:0005759; GO:0005829; GO:0008376; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510	chondroitin sulfate biosynthetic process [GO:0030206]		NA	NA	NA	NA	NA	NA
TRINITY_DN25817_c0_g1_i1	Q5DTK1	CHSS3_MOUSE	55.6	81	36	0	4	246	771	851	2.20E-22	105.9	CHSS3_MOUSE	reviewed	Chondroitin sulfate synthase 3 (EC 2.4.1.175) (EC 2.4.1.226) (Carbohydrate synthase 2) (Chondroitin glucuronyltransferase 3) (Chondroitin synthase 2) (ChSy-2) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3) (N-acetylgalactosaminyltransferase 3)	Chsy3 Chsy2 Css3 Kiaa4168	Mus musculus (Mouse)	884	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]	GO:0008376; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510	chondroitin sulfate biosynthetic process [GO:0030206]		blue	blue	NA	NA	NA	NA
TRINITY_DN17119_c0_g1_i1	P82600	PERC_AEDAE	43.2	192	93	4	559	5	337	519	1.30E-38	161	PERC_AEDAE	reviewed	Chorion peroxidase (EC 1.11.1.7)	pxt AAEL004386	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	790	extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]	extracellular region [GO:0005576]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0020037; GO:0042743; GO:0042744; GO:0046872	eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN29035_c0_g1_i1	Q9VEG6	PERC_DROME	55.9	59	26	0	216	40	469	527	8.40E-10	63.9	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	x	brown	brown	1	NA	NA	NA
TRINITY_DN35959_c0_g1_i1	Q9VEG6	PERC_DROME	58.8	68	28	0	30	233	460	527	9.80E-17	87	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN3992_c1_g1_i1	Q9VEG6	PERC_DROME	33.6	658	382	16	1907	3	66	691	1.50E-92	342	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN34616_c0_g1_i1	Q9VEG6	PERC_DROME	45.2	73	39	1	219	1	483	554	6.90E-12	70.9	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN28127_c0_g1_i1	Q9VEG6	PERC_DROME	45.7	129	66	1	7	393	615	739	1.30E-24	114	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN38632_c0_g1_i1	Q9VEG6	PERC_DROME	39.9	313	183	3	933	10	272	584	1.30E-62	241.5	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN9424_c0_g1_i1	P20385	CF2_DROME	50	82	41	0	269	24	425	506	1.10E-17	90.9	CF2_DROME	reviewed	Chorion transcription factor Cf2	Cf2 CG11924	Drosophila melanogaster (Fruit fly)	510	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872	"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27176_c0_g1_i1	P20385	CF2_DROME	43.4	76	43	0	33	260	431	506	2.70E-13	75.9	CF2_DROME	reviewed	Chorion transcription factor Cf2	Cf2 CG11924	Drosophila melanogaster (Fruit fly)	510	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872	"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40099_c0_g1_i1	P20385	CF2_DROME	48.2	85	44	0	3	257	406	490	1.40E-19	96.7	CF2_DROME	reviewed	Chorion transcription factor Cf2	Cf2 CG11924	Drosophila melanogaster (Fruit fly)	510	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872	"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40100_c0_g1_i1	P20385	CF2_DROME	50	106	53	0	6	323	401	506	8.10E-26	117.9	CF2_DROME	reviewed	Chorion transcription factor Cf2	Cf2 CG11924	Drosophila melanogaster (Fruit fly)	510	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872	"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28102_c0_g1_i1	P20385	CF2_DROME	46.3	54	29	0	18	179	424	477	2.40E-09	62.4	CF2_DROME	reviewed	Chorion transcription factor Cf2	Cf2 CG11924	Drosophila melanogaster (Fruit fly)	510	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872	"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c1_g1_i1	P20385	CF2_DROME	44.5	110	61	0	429	100	394	503	3.10E-22	106.7	CF2_DROME	reviewed	Chorion transcription factor Cf2	Cf2 CG11924	Drosophila melanogaster (Fruit fly)	510	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; adult somatic muscle development [GO:0007527]; dorsal appendage formation [GO:0046843]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005829; GO:0006355; GO:0007527; GO:0009953; GO:0032968; GO:0043565; GO:0046843; GO:0046872	"adult somatic muscle development [GO:0007527]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28852_c0_g1_i1	Q8R090	VMAT1_MOUSE	75.8	62	15	0	48	233	380	441	2.60E-20	99	VMAT1_MOUSE	reviewed	Chromaffin granule amine transporter (Solute carrier family 18 member 1) (Vesicular amine transporter 1) (VAT1)	Slc18a1 Vmat1	Mus musculus (Mouse)	521	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; enzyme binding [GO:0019899]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter transport [GO:0006836]; positive regulation of dopamine secretion [GO:0033603]; serotonin uptake [GO:0051610]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	enzyme binding [GO:0019899]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005335; GO:0005737; GO:0006836; GO:0008504; GO:0015842; GO:0016021; GO:0019899; GO:0022857; GO:0030672; GO:0033603; GO:0042910; GO:0043195; GO:0051610; GO:0051612	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter transport [GO:0006836]; positive regulation of dopamine secretion [GO:0033603]; serotonin uptake [GO:0051610]		NA	NA	NA	NA	NA	NA
TRINITY_DN1093_c0_g1_i1	Q9JKP8	CHRC1_MOUSE	46.2	80	41	1	383	150	19	98	3.30E-10	66.6	CHRC1_MOUSE	reviewed	Chromatin accessibility complex protein 1 (CHRAC-1) (DNA polymerase epsilon subunit p15) (NF-YC-like protein) (YC-like protein 1) (YCL1)	Chrac1	Mus musculus (Mouse)	129	CHRAC [GO:0008623]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]	CHRAC [GO:0008623]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0003887; GO:0005634; GO:0008623; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN1093_c0_g1_i2	Q9JKP8	CHRC1_MOUSE	46.2	80	41	1	383	150	19	98	3.30E-10	66.6	CHRC1_MOUSE	reviewed	Chromatin accessibility complex protein 1 (CHRAC-1) (DNA polymerase epsilon subunit p15) (NF-YC-like protein) (YC-like protein 1) (YCL1)	Chrac1	Mus musculus (Mouse)	129	CHRAC [GO:0008623]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]	CHRAC [GO:0008623]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0003887; GO:0005634; GO:0008623; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN800_c0_g1_i3	Q24572	CAF1_DROME	92.5	427	32	0	187	1467	4	430	5.40E-244	844.7	CAF1_DROME	reviewed	Chromatin assembly factor 1 p55 subunit (CAF-1 p55 subunit) (CAF-1) (Nucleosome-remodeling factor 55 kDa subunit) (NURF-55)	Caf1-55 Caf1 CG4236	Drosophila melanogaster (Fruit fly)	430	"CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; histone acetylation [GO:0016573]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; mitotic cytokinesis [GO:0000281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; segment specification [GO:0007379]"	CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]	histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000281; GO:0000976; GO:0005634; GO:0005667; GO:0005700; GO:0006281; GO:0006334; GO:0006338; GO:0006342; GO:0007307; GO:0007346; GO:0007379; GO:0008284; GO:0010468; GO:0016571; GO:0016573; GO:0016581; GO:0016584; GO:0016589; GO:0031497; GO:0031523; GO:0033186; GO:0034968; GO:0035097; GO:0035098; GO:0042393; GO:0042766; GO:0042803; GO:0042826; GO:0045893; GO:0051567; GO:0070734; GO:0070822	"chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; histone acetylation [GO:0016573]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; mitotic cytokinesis [GO:0000281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; segment specification [GO:0007379]"		blue	blue	NA	NA	NA	NA
TRINITY_DN800_c0_g1_i4	Q24572	CAF1_DROME	92.5	427	32	0	187	1467	4	430	5.40E-244	844.7	CAF1_DROME	reviewed	Chromatin assembly factor 1 p55 subunit (CAF-1 p55 subunit) (CAF-1) (Nucleosome-remodeling factor 55 kDa subunit) (NURF-55)	Caf1-55 Caf1 CG4236	Drosophila melanogaster (Fruit fly)	430	"CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; histone acetylation [GO:0016573]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; mitotic cytokinesis [GO:0000281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; segment specification [GO:0007379]"	CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]	histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000281; GO:0000976; GO:0005634; GO:0005667; GO:0005700; GO:0006281; GO:0006334; GO:0006338; GO:0006342; GO:0007307; GO:0007346; GO:0007379; GO:0008284; GO:0010468; GO:0016571; GO:0016573; GO:0016581; GO:0016584; GO:0016589; GO:0031497; GO:0031523; GO:0033186; GO:0034968; GO:0035097; GO:0035098; GO:0042393; GO:0042766; GO:0042803; GO:0042826; GO:0045893; GO:0051567; GO:0070734; GO:0070822	"chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; histone acetylation [GO:0016573]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; mitotic cytokinesis [GO:0000281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; segment specification [GO:0007379]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2360_c0_g1_i2	Q9D0N7	CAF1B_MOUSE	50.2	436	189	7	1317	55	1	423	1.20E-114	414.8	CAF1B_MOUSE	reviewed	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)	Chaf1b	Mus musculus (Mouse)	572	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0000790; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN2360_c0_g1_i4	Q9D0N7	CAF1B_MOUSE	53.4	208	77	4	648	55	226	423	8.20E-51	201.8	CAF1B_MOUSE	reviewed	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)	Chaf1b	Mus musculus (Mouse)	572	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0000790; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN2360_c0_g1_i5	Q9D0N7	CAF1B_MOUSE	50	162	76	2	498	28	32	193	3.50E-43	176	CAF1B_MOUSE	reviewed	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)	Chaf1b	Mus musculus (Mouse)	572	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0000790; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN2360_c0_g1_i1	Q13112	CAF1B_HUMAN	50.2	211	100	2	765	148	1	211	9.30E-59	228.4	CAF1B_HUMAN	reviewed	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7)	CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7	Homo sapiens (Human)	559	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]	GO:0000790; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393; GO:0051082	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN2360_c0_g1_i7	Q13112	CAF1B_HUMAN	52.3	193	87	2	591	28	1	193	2.90E-55	216.5	CAF1B_HUMAN	reviewed	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7)	CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7	Homo sapiens (Human)	559	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]	GO:0000790; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393; GO:0051082	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN1911_c0_g1_i1	Q32LD1	BAP18_BOVIN	56.5	46	18	1	2	139	12	55	6.60E-05	49.7	BAP18_BOVIN	reviewed	Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa)	BAP18	Bos taurus (Bovine)	172	MLL1 complex [GO:0071339]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; chromatin organization [GO:0006325]	MLL1 complex [GO:0071339]; NURF complex [GO:0016589]	DNA binding [GO:0003677]	GO:0003677; GO:0006325; GO:0016589; GO:0071339	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN40543_c0_g1_i1	Q58CU0	EAF6_BOVIN	100	98	0	0	294	1	16	113	1.30E-45	183.3	EAF6_BOVIN	reviewed	Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog)	MEAF6	Bos taurus (Bovine)	191	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]		GO:0000776; GO:0000777; GO:0005730; GO:0035267; GO:0043968; GO:0043972; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0070776; GO:1990467; GO:1990468	histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		NA	NA	NA	NA	NA	NA
TRINITY_DN773_c11_g1_i1	Q58CU0	EAF6_BOVIN	65.8	120	34	2	531	193	14	133	1.30E-34	147.9	EAF6_BOVIN	reviewed	Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog)	MEAF6	Bos taurus (Bovine)	191	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]		GO:0000776; GO:0000777; GO:0005730; GO:0035267; GO:0043968; GO:0043972; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0070776; GO:1990467; GO:1990468	histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		NA	NA	NA	NA	NA	NA
TRINITY_DN1488_c0_g1_i1	Q498T2	CHTOP_RAT	52.7	74	31	2	300	82	5	75	9.50E-08	57.8	CHTOP_RAT	reviewed	Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG)	Chtop Fop	Rattus norvegicus (Rat)	248	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; transcription export complex [GO:0000346]; methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; transcription export complex [GO:0000346]	methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723]	GO:0000346; GO:0003723; GO:0005730; GO:0006406; GO:0008284; GO:0008327; GO:0016607; GO:0031062; GO:0032781; GO:0051096	mRNA export from nucleus [GO:0006406]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062]		blue	blue	NA	NA	NA	NA
TRINITY_DN7965_c0_g1_i1	Q9VDY1	INO80_DROME	39.5	185	107	2	230	784	313	492	9.30E-22	105.5	INO80_DROME	reviewed	Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-)	Ino80 CG31212	Drosophila melanogaster (Fruit fly)	1638	"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"	Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000790; GO:0000976; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0032508; GO:0040034; GO:0042393; GO:0042766; GO:0043044; GO:0043618; GO:0045892	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10217_c0_g1_i1	Q9VDY1	INO80_DROME	46.7	150	57	1	146	595	1078	1204	2.80E-31	136.7	INO80_DROME	reviewed	Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-)	Ino80 CG31212	Drosophila melanogaster (Fruit fly)	1638	"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"	Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000790; GO:0000976; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0032508; GO:0040034; GO:0042393; GO:0042766; GO:0043044; GO:0043618; GO:0045892	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10217_c0_g1_i2	Q9VDY1	INO80_DROME	73.3	75	20	0	90	314	1130	1204	2.40E-26	119.4	INO80_DROME	reviewed	Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-)	Ino80 CG31212	Drosophila melanogaster (Fruit fly)	1638	"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"	Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000790; GO:0000976; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0032508; GO:0040034; GO:0042393; GO:0042766; GO:0043044; GO:0043618; GO:0045892	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10217_c0_g2_i1	Q9VDY1	INO80_DROME	95.9	74	3	0	224	3	1214	1287	4.50E-35	147.9	INO80_DROME	reviewed	Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-)	Ino80 CG31212	Drosophila melanogaster (Fruit fly)	1638	"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"	Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000790; GO:0000976; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0032508; GO:0040034; GO:0042393; GO:0042766; GO:0043044; GO:0043618; GO:0045892	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6607_c0_g1_i2	Q9VDY1	INO80_DROME	65	389	133	2	62	1225	527	913	2.80E-147	523.1	INO80_DROME	reviewed	Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-)	Ino80 CG31212	Drosophila melanogaster (Fruit fly)	1638	"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"	Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000790; GO:0000976; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0032508; GO:0040034; GO:0042393; GO:0042766; GO:0043044; GO:0043618; GO:0045892	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3366_c0_g1_i1	O14148	INO80_SCHPO	64.2	165	59	0	507	13	1415	1579	9.00E-58	224.6	INO80_SCHPO	reviewed	Chromatin-remodeling ATPase INO80 (EC 3.6.4.-)	ino80 SPAC29B12.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1604	"Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of cellular response to phosphate starvation [GO:0080040]; regulation of CENP-A containing nucleosome assembly [GO:1903097]; regulation of nucleosome density [GO:0060303]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"	Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone binding [GO:0042393]	GO:0000790; GO:0003677; GO:0005524; GO:0006281; GO:0006338; GO:0006351; GO:0006357; GO:0016887; GO:0031011; GO:0042393; GO:0042766; GO:0043044; GO:0043138; GO:0043618; GO:0060303; GO:0080040; GO:1903097	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of cellular response to phosphate starvation [GO:0080040]; regulation of CENP-A containing nucleosome assembly [GO:1903097]; regulation of nucleosome density [GO:0060303]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7965_c0_g1_i2	Q9ULG1	INO80_HUMAN	37.8	135	71	3	74	451	339	469	5.60E-11	68.9	INO80_HUMAN	reviewed	Chromatin-remodeling ATPase INO80 (hINO80) (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A)	INO80 INO80A INOC1 KIAA1259	Homo sapiens (Human)	1556	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]	GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016579; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0032508; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045	"ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6607_c0_g1_i4	Q9ULG1	INO80_HUMAN	49.3	138	69	1	78	491	760	896	2.60E-27	123.2	INO80_HUMAN	reviewed	Chromatin-remodeling ATPase INO80 (hINO80) (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A)	INO80 INO80A INOC1 KIAA1259	Homo sapiens (Human)	1556	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]	GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016579; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0032508; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045	"ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31471_c0_g1_i1	Q24368	ISWI_DROME	82.3	96	17	0	290	3	483	578	1.50E-38	159.8	ISWI_DROME	reviewed	Chromatin-remodeling complex ATPase chain Iswi (EC 3.6.4.-) (CHRAC 140 kDa subunit) (Nucleosome-remodeling factor 140 kDa subunit) (NURF-140) (Protein imitation swi)	Iswi CG8625	Drosophila melanogaster (Fruit fly)	1027	"ACF complex [GO:0016590]; CHRAC [GO:0008623]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; nucleotide binding [GO:0000166]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sperm chromatin condensation [GO:0035092]; sperm chromatin decondensation [GO:0035041]; spermatogenesis [GO:0007283]"	ACF complex [GO:0016590]; CHRAC [GO:0008623]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription regulator complex [GO:0005667]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; nucleotide binding [GO:0000166]; transcription factor binding [GO:0008134]	GO:0000166; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005667; GO:0005700; GO:0006325; GO:0006333; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0008094; GO:0008134; GO:0008623; GO:0016584; GO:0016589; GO:0016590; GO:0031010; GO:0031213; GO:0031491; GO:0035041; GO:0035063; GO:0035076; GO:0035092; GO:0042752; GO:0042766; GO:0043044; GO:0045892; GO:0045893; GO:0045944; GO:0070615	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; sperm chromatin condensation [GO:0035092]; sperm chromatin decondensation [GO:0035041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39866_c0_g1_i1	Q24368	ISWI_DROME	65	60	20	1	179	3	112	171	2.30E-15	82.4	ISWI_DROME	reviewed	Chromatin-remodeling complex ATPase chain Iswi (EC 3.6.4.-) (CHRAC 140 kDa subunit) (Nucleosome-remodeling factor 140 kDa subunit) (NURF-140) (Protein imitation swi)	Iswi CG8625	Drosophila melanogaster (Fruit fly)	1027	"ACF complex [GO:0016590]; CHRAC [GO:0008623]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; nucleotide binding [GO:0000166]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sperm chromatin condensation [GO:0035092]; sperm chromatin decondensation [GO:0035041]; spermatogenesis [GO:0007283]"	ACF complex [GO:0016590]; CHRAC [GO:0008623]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; RSF complex [GO:0031213]; transcription regulator complex [GO:0005667]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; nucleotide binding [GO:0000166]; transcription factor binding [GO:0008134]	GO:0000166; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005667; GO:0005700; GO:0006325; GO:0006333; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0008094; GO:0008134; GO:0008623; GO:0016584; GO:0016589; GO:0016590; GO:0031010; GO:0031213; GO:0031491; GO:0035041; GO:0035063; GO:0035076; GO:0035092; GO:0042752; GO:0042766; GO:0043044; GO:0045892; GO:0045893; GO:0045944; GO:0070615	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear speck organization [GO:0035063]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; sperm chromatin condensation [GO:0035092]; sperm chromatin decondensation [GO:0035041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8188_c1_g1_i4	P83916	CBX1_HUMAN	59.7	159	61	1	115	582	21	179	3.80E-45	183	CBX1_HUMAN	reviewed	Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta)	CBX1 CBX	Homo sapiens (Human)	185	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; cellular response to DNA damage stimulus [GO:0006974]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]	GO:0000775; GO:0000784; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005819; GO:0006974; GO:0019899; GO:0090734; GO:1990226	cellular response to DNA damage stimulus [GO:0006974]		blue	blue	NA	NA	NA	NA
TRINITY_DN171_c0_g1_i1	P83916	CBX1_HUMAN	42.3	52	27	1	93	248	21	69	4.10E-05	50.4	CBX1_HUMAN	reviewed	Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta)	CBX1 CBX	Homo sapiens (Human)	185	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; cellular response to DNA damage stimulus [GO:0006974]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]	GO:0000775; GO:0000784; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005819; GO:0006974; GO:0019899; GO:0090734; GO:1990226	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN31754_c0_g1_i1	Q13185	CBX3_HUMAN	100	76	0	0	2	229	108	183	1.20E-39	163.3	CBX3_HUMAN	reviewed	Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein)	CBX3	Homo sapiens (Human)	183	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"	enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000775; GO:0000779; GO:0000784; GO:0000785; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005719; GO:0005720; GO:0005819; GO:0006338; GO:0006974; GO:0019899; GO:0019904; GO:0031618; GO:0042802; GO:0045892; GO:0048511; GO:0070317; GO:0090734; GO:1990226	"cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30637_c0_g1_i1	Q13185	CBX3_HUMAN	100	93	0	0	2	280	91	183	3.30E-47	188.7	CBX3_HUMAN	reviewed	Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein)	CBX3	Homo sapiens (Human)	183	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"	enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000775; GO:0000779; GO:0000784; GO:0000785; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005719; GO:0005720; GO:0005819; GO:0006338; GO:0006974; GO:0019899; GO:0019904; GO:0031618; GO:0042802; GO:0045892; GO:0048511; GO:0070317; GO:0090734; GO:1990226	"cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8188_c1_g1_i1	P23198	CBX3_MOUSE	42.4	125	70	1	58	432	11	133	6.00E-20	99	CBX3_MOUSE	reviewed	Chromobox protein homolog 3 (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (M32) (Modifier 2 protein)	Cbx3	Mus musculus (Mouse)	183	"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"	enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000775; GO:0000779; GO:0000785; GO:0000976; GO:0005634; GO:0005635; GO:0005654; GO:0005719; GO:0005720; GO:0005819; GO:0006325; GO:0006974; GO:0010369; GO:0019899; GO:0019904; GO:0031618; GO:0035985; GO:0042802; GO:0045892; GO:0048511; GO:0090734; GO:1990226	"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30130_c0_g1_i1	Q61686	CBX5_MOUSE	98.9	95	1	0	293	9	97	191	2.30E-48	192.6	CBX5_MOUSE	reviewed	Chromobox protein homolog 5 (Heterochromatin protein 1 homolog alpha) (HP1 alpha)	Cbx5 Hp1a	Mus musculus (Mouse)	191	"chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"	"chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]"	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]	GO:0000118; GO:0000122; GO:0000776; GO:0000784; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005730; GO:0006974; GO:0010369; GO:0016605; GO:0017053; GO:0030674; GO:0032991; GO:0035064; GO:0035097; GO:0042802; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0070491; GO:0090734; GO:1990904	"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]"		NA	NA	NA	NA	NA	NA
TRINITY_DN171_c0_g1_i5	Q61686	CBX5_MOUSE	41.7	60	35	0	486	665	7	66	2.80E-08	61.2	CBX5_MOUSE	reviewed	Chromobox protein homolog 5 (Heterochromatin protein 1 homolog alpha) (HP1 alpha)	Cbx5 Hp1a	Mus musculus (Mouse)	191	"chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"	"chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]"	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]	GO:0000118; GO:0000122; GO:0000776; GO:0000784; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0005730; GO:0006974; GO:0010369; GO:0016605; GO:0017053; GO:0030674; GO:0032991; GO:0035064; GO:0035097; GO:0042802; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0070491; GO:0090734; GO:1990904	"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11964_c0_g1_i1	Q8N8U2	CDYL2_HUMAN	42.2	237	134	3	123	830	237	471	1.50E-43	177.9	CDYL2_HUMAN	reviewed	Chromodomain Y-like protein 2 (CDY-like 2)	CDYL2	Homo sapiens (Human)	506	nucleus [GO:0005634]; catalytic activity [GO:0003824]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]	nucleus [GO:0005634]	catalytic activity [GO:0003824]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003824; GO:0005634; GO:0035064			NA	NA	NA	NA	NA	NA
TRINITY_DN35923_c0_g1_i1	A9X4T1	CHD1_BOMMO	71.1	90	25	1	30	299	332	420	4.80E-32	138.3	CHD1_BOMMO	reviewed	Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)	CHD1	Bombyx mori (Silk moth)	1365	chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]	chromosome [GO:0005694]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN3940_c0_g1_i1	P40201	CHD1_MOUSE	60.5	38	15	0	1	114	1461	1498	1.80E-06	55.1	CHD1_MOUSE	reviewed	Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)	Chd1 Chd-1	Mus musculus (Mouse)	1711	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; methylated histone binding [GO:0035064]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; positive regulation by host of viral transcription [GO:0043923]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; methylated histone binding [GO:0035064]	GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006333; GO:0006338; GO:0016569; GO:0035064; GO:0043923	chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; positive regulation by host of viral transcription [GO:0043923]		NA	NA	NA	NA	NA	NA
TRINITY_DN3940_c0_g1_i2	P40201	CHD1_MOUSE	60.5	38	15	0	1	114	1461	1498	1.80E-06	55.1	CHD1_MOUSE	reviewed	Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)	Chd1 Chd-1	Mus musculus (Mouse)	1711	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; methylated histone binding [GO:0035064]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; positive regulation by host of viral transcription [GO:0043923]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; methylated histone binding [GO:0035064]	GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006333; GO:0006338; GO:0016569; GO:0035064; GO:0043923	chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; positive regulation by host of viral transcription [GO:0043923]		NA	NA	NA	NA	NA	NA
TRINITY_DN15629_c0_g1_i1	A9X4T1	CHD1_BOMMO	72.5	320	81	3	6	944	488	807	1.50E-125	450.7	CHD1_BOMMO	reviewed	Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)	CHD1	Bombyx mori (Silk moth)	1365	chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]	chromosome [GO:0005694]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN15629_c0_g1_i2	A9X4T1	CHD1_BOMMO	72.5	320	81	3	6	944	488	807	7.40E-126	451.8	CHD1_BOMMO	reviewed	Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)	CHD1	Bombyx mori (Silk moth)	1365	chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]	chromosome [GO:0005694]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN31467_c0_g1_i1	O14647	CHD2_HUMAN	75.3	81	18	1	4	246	470	548	3.90E-32	138.3	CHD2_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2)	CHD2	Homo sapiens (Human)	1828	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin organization [GO:0006325]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357]	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0007517; GO:0042393; GO:0043231	chromatin organization [GO:0006325]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN39978_c0_g1_i1	E9PZM4	CHD2_MOUSE	100	75	0	0	225	1	771	845	6.60E-34	144.1	CHD2_MOUSE	reviewed	Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2)	Chd2	Mus musculus (Mouse)	1827	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006974; GO:0007517; GO:0042393; GO:0043231; GO:0060218	cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]		NA	NA	NA	NA	NA	NA
TRINITY_DN29366_c0_g1_i1	Q14839	CHD4_HUMAN	100	72	0	0	217	2	1118	1189	4.40E-35	147.9	CHD4_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)	CHD4	Homo sapiens (Human)	1912	centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]	GO:0000790; GO:0001103; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0006357; GO:0008270; GO:0016020; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:1901796	ATP-dependent chromatin remodeling [GO:0043044]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32181_c0_g1_i1	Q14839	CHD4_HUMAN	100	86	0	0	258	1	725	810	3.50E-47	188.3	CHD4_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)	CHD4	Homo sapiens (Human)	1912	centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; zinc ion binding [GO:0008270]	GO:0000790; GO:0001103; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0006357; GO:0008270; GO:0016020; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:1901796	ATP-dependent chromatin remodeling [GO:0043044]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN36144_c0_g1_i1	Q8TDI0	CHD5_HUMAN	84.5	58	4	1	178	5	336	388	8.90E-25	113.6	CHD5_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.12) (ATP-dependent helicase CHD5)	CHD5 KIAA0444	Homo sapiens (Human)	1954	"cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; metal ion binding [GO:0046872]	GO:0000792; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008285; GO:0016020; GO:0016581; GO:0016607; GO:0021895; GO:0035093; GO:0043967; GO:0046872; GO:0060850; GO:0061628; GO:0098532; GO:1901798	"cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34419_c0_g1_i1	Q8TD26	CHD6_HUMAN	77.2	136	27	1	412	5	837	968	8.80E-56	217.6	CHD6_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.12) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein)	CHD6 CHD5 KIAA1335 RIGB	Homo sapiens (Human)	2715	nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; transcription cofactor binding [GO:0001221]; chromatin organization [GO:0006325]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; viral process [GO:0016032]	nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; transcription cofactor binding [GO:0001221]	GO:0001221; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0006325; GO:0008094; GO:0016032; GO:0036091	chromatin organization [GO:0006325]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN5435_c0_g1_i1	Q06A37	CHD7_CHICK	46.5	114	61	0	5	346	2013	2126	6.20E-26	118.2	CHD7_CHICK	reviewed	Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)	CHD7	Gallus gallus (Chicken)	3011	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006325; GO:0006364	chromatin organization [GO:0006325]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5051_c0_g1_i1	Q9P2D1	CHD7_HUMAN	71.1	387	110	1	2	1162	970	1354	8.60E-162	571.2	CHD7_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)	CHD7 KIAA1416	Homo sapiens (Human)	2997	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001501; GO:0001701; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0006364; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010880; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042472; GO:0043584; GO:0045944; GO:0048752; GO:0048806; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060173; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:1990841	"adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28660_c0_g1_i1	B5DE69	CHD8_XENTR	49.3	69	33	1	205	5	760	828	3.20E-11	68.6	CHD8_XENTR	reviewed	Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8)	chd8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2184	"MLL1 complex [GO:0071339]; nucleus [GO:0005634]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; p53 binding [GO:0002039]; ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleus [GO:0005634]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; p53 binding [GO:0002039]	GO:0002039; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0008013; GO:0016055; GO:0030178; GO:0042393; GO:0043044; GO:0043066; GO:0045892; GO:0045893; GO:0071339	"ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5051_c0_g1_i2	B5DE69	CHD8_XENTR	70.8	144	42	0	2	433	757	900	9.40E-59	227.6	CHD8_XENTR	reviewed	Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8)	chd8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2184	"MLL1 complex [GO:0071339]; nucleus [GO:0005634]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; p53 binding [GO:0002039]; ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleus [GO:0005634]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; p53 binding [GO:0002039]	GO:0002039; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0008013; GO:0016055; GO:0030178; GO:0042393; GO:0043044; GO:0043066; GO:0045892; GO:0045893; GO:0071339	"ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33993_c0_g1_i1	B5DE69	CHD8_XENTR	56.2	105	42	2	340	29	962	1063	1.60E-26	120.2	CHD8_XENTR	reviewed	Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8)	chd8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2184	"MLL1 complex [GO:0071339]; nucleus [GO:0005634]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; p53 binding [GO:0002039]; ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleus [GO:0005634]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; p53 binding [GO:0002039]	GO:0002039; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0008013; GO:0016055; GO:0030178; GO:0042393; GO:0043044; GO:0043066; GO:0045892; GO:0045893; GO:0071339	"ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29780_c0_g1_i1	Q9HCK8	CHD8_HUMAN	99.1	116	1	0	349	2	853	968	1.50E-64	246.5	CHD8_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1)	CHD8 HELSNF1 KIAA1564	Homo sapiens (Human)	2581	"MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]	GO:0000122; GO:0001701; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0007420; GO:0008013; GO:0008094; GO:0016055; GO:0032991; GO:0035064; GO:0035176; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:2000270	"ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5051_c0_g1_i5	Q9HCK8	CHD8_HUMAN	79.2	53	11	0	54	212	1051	1103	3.20E-19	95.5	CHD8_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1)	CHD8 HELSNF1 KIAA1564	Homo sapiens (Human)	2581	"MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]	GO:0000122; GO:0001701; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0007420; GO:0008013; GO:0008094; GO:0016055; GO:0032991; GO:0035064; GO:0035176; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:2000270	"ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13696_c0_g1_i1	Q9HCK8	CHD8_HUMAN	37.2	78	49	0	13	246	941	1018	4.30E-10	65.1	CHD8_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1)	CHD8 HELSNF1 KIAA1564	Homo sapiens (Human)	2581	"MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]	GO:0000122; GO:0001701; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0007420; GO:0008013; GO:0008094; GO:0016055; GO:0032991; GO:0035064; GO:0035176; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:2000270	"ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5021_c0_g1_i1	Q3L8U1	CHD9_HUMAN	69.4	134	37	2	2	391	1229	1362	2.00E-46	186.4	CHD9_HUMAN	reviewed	Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein)	CHD9 KIAA0308 KISH2 PRIC320 AD-013 x0008	Homo sapiens (Human)	2897	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]; regulation of lipid metabolic process [GO:0019216]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005737; GO:0006325; GO:0019216	chromatin organization [GO:0006325]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN18531_c0_g1_i1	O97159	CHDM_DROME	81.7	164	30	0	492	1	1031	1194	8.60E-71	267.7	CHDM_DROME	reviewed	Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2)	Mi-2 CG8103	Drosophila melanogaster (Fruit fly)	1982	"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0035327; GO:0042766; GO:0043044; GO:0045892; GO:0051276; GO:0051312; GO:0070615; GO:0071923	"ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9016_c0_g1_i1	O97159	CHDM_DROME	76.8	112	26	0	4	339	722	833	2.80E-52	205.7	CHDM_DROME	reviewed	Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2)	Mi-2 CG8103	Drosophila melanogaster (Fruit fly)	1982	"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0035327; GO:0042766; GO:0043044; GO:0045892; GO:0051276; GO:0051312; GO:0070615; GO:0071923	"ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29791_c0_g1_i1	O97159	CHDM_DROME	76.5	196	46	0	3	590	839	1034	4.60E-87	322	CHDM_DROME	reviewed	Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2)	Mi-2 CG8103	Drosophila melanogaster (Fruit fly)	1982	"cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; polytene chromosome [GO:0005700]; transcriptionally active chromatin [GO:0035327]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0035327; GO:0042766; GO:0043044; GO:0045892; GO:0051276; GO:0051312; GO:0070615; GO:0071923	"ATP-dependent chromatin remodeling [GO:0043044]; chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30283_c0_g1_i1	Q3JR19	SMC_BURP1	91.3	69	6	0	208	2	1055	1123	4.00E-30	131.3	SMC_BURP1	reviewed	Chromosome partition protein Smc	smc BURPS1710b_2592	Burkholderia pseudomallei (strain 1710b)	1170	chromosome [GO:0005694]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; DNA replication [GO:0006260]; sister chromatid cohesion [GO:0007062]	chromosome [GO:0005694]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0007062; GO:0030261	chromosome condensation [GO:0030261]; DNA replication [GO:0006260]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN35430_c0_g1_i1	Q90640	KIF4_CHICK	70.1	187	55	1	578	21	182	368	2.20E-65	250	KIF4_CHICK	reviewed	Chromosome-associated kinesin KIF4 (Chromokinesin)	KIF4 KIF4A	Gallus gallus (Chicken)	1225	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0046872; GO:0051536	microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN37625_c0_g1_i1	Q91784	KIF4_XENLA	54.3	70	32	0	1	210	186	255	4.60E-13	74.7	KIF4_XENLA	reviewed	Chromosome-associated kinesin KIF4 (Chromokinesin) (Chromosome-associated kinesin KLP1)	kif4 kif4a klp1	Xenopus laevis (African clawed frog)	1226	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0046872; GO:0051536	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN39743_c0_g1_i2	Q2VIQ3	KIF4B_HUMAN	54.2	144	65	1	2	430	200	343	2.50E-29	129.8	KIF4B_HUMAN	reviewed	Chromosome-associated kinesin KIF4B (Chromokinesin-B)	KIF4B	Homo sapiens (Human)	1234	"cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005829; GO:0005874; GO:0006890; GO:0007018; GO:0007052; GO:0008017; GO:0016363; GO:0019886; GO:0046872; GO:0051256; GO:0051536	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3443_c0_g5_i1	Q00871	CTRB1_PENVA	61.4	140	54	0	424	5	26	165	1.40E-45	183.7	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		black	black	1	NA	1	1
TRINITY_DN3443_c0_g3_i1	Q00871	CTRB1_PENVA	73.7	270	70	1	846	40	1	270	8.00E-115	414.8	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		black	black	1	NA	1	1
TRINITY_DN3443_c0_g1_i1	Q00871	CTRB1_PENVA	73.6	53	14	0	248	90	38	90	2.10E-18	93.2	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN3443_c0_g1_i2	Q00871	CTRB1_PENVA	65	40	8	1	209	90	57	90	2.00E-08	59.3	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN3443_c0_g1_i3	Q00871	CTRB1_PENVA	73.6	53	14	0	248	90	38	90	2.10E-18	93.2	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN3443_c0_g1_i4	Q00871	CTRB1_PENVA	64.6	65	21	1	284	90	28	90	1.10E-18	94	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN9065_c0_g1_i1	Q00871	CTRB1_PENVA	79.5	44	9	0	220	89	43	86	2.00E-15	83.2	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN9065_c0_g1_i3	Q00871	CTRB1_PENVA	79.5	44	9	0	220	89	43	86	3.90E-15	83.2	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN12524_c0_g1_i1	Q00871	CTRB1_PENVA	41.7	96	50	2	135	404	56	151	2.30E-11	70.1	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN12524_c0_g1_i3	Q00871	CTRB1_PENVA	43.3	97	47	3	316	47	56	151	1.60E-12	73.9	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN6186_c0_g1_i2	Q00871	CTRB1_PENVA	78.4	74	15	1	295	77	17	90	1.20E-30	133.7	CTRB1_PENVA	reviewed	Chymotrypsin BI (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN9065_c0_g2_i1	P36178	CTRB2_PENVA	55.2	67	29	1	257	60	81	147	3.70E-14	79	CTRB2_PENVA	reviewed	Chymotrypsin BII (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN12524_c0_g1_i6	P36178	CTRB2_PENVA	53.8	65	26	2	219	37	87	151	6.20E-11	67.8	CTRB2_PENVA	reviewed	Chymotrypsin BII (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN12524_c0_g1_i7	P36178	CTRB2_PENVA	53.8	65	26	2	46	228	87	151	3.80E-11	68.6	CTRB2_PENVA	reviewed	Chymotrypsin BII (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN36139_c0_g1_i1	P36178	CTRB2_PENVA	77.5	80	18	0	241	2	78	157	2.10E-30	132.5	CTRB2_PENVA	reviewed	Chymotrypsin BII (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN6186_c0_g1_i1	P36178	CTRB2_PENVA	70.9	141	39	2	418	2	17	157	3.10E-53	209.1	CTRB2_PENVA	reviewed	Chymotrypsin BII (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN12877_c0_g2_i1	P36178	CTRB2_PENVA	70.7	58	17	0	1	174	214	271	1.80E-18	92.8	CTRB2_PENVA	reviewed	Chymotrypsin BII (EC 3.4.21.1)		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	271	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; collagen catabolic process [GO:0030574]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0030574	collagen catabolic process [GO:0030574]		NA	NA	NA	NA	NA	NA
TRINITY_DN12877_c0_g1_i3	P00769	CTR2_VESCR	56.8	44	17	1	18	149	173	214	1.10E-05	50.4	CTR2_VESCR	reviewed	Chymotrypsin-2 (EC 3.4.21.1) (Chymotrypsin II)		Vespa crabro (European hornet)	218	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615			NA	NA	NA	NA	NA	NA
TRINITY_DN32452_c0_g1_i1	O46644	CELA1_MACFA	42.5	73	40	1	236	18	26	96	6.00E-09	61.2	CELA1_MACFA	reviewed	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1)	CELA1 ELA1	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	266	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i13	Q5R1M5	CELA1_FELCA	33.5	155	97	4	478	20	26	176	1.70E-13	77.4	CELA1_FELCA	reviewed	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1)	CELA1 ELA1 ELS1	Felis catus (Cat) (Felis silvestris catus)	266	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508; GO:0046872	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i15	Q5R1M5	CELA1_FELCA	33.1	166	105	4	504	13	26	187	9.30E-15	81.6	CELA1_FELCA	reviewed	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1)	CELA1 ELA1 ELS1	Felis catus (Cat) (Felis silvestris catus)	266	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508; GO:0046872	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN7005_c0_g1_i1	Q6GNL4	CPLN2_XENLA	35.5	217	127	3	698	87	28	244	2.80E-36	153.7	CPLN2_XENLA	reviewed	Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1)	cplane2 rsg1	Xenopus laevis (African clawed frog)	249	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of vesicle fusion [GO:0031338]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001843; GO:0003924; GO:0005525; GO:0005737; GO:0006887; GO:0015031; GO:0017157; GO:0031338; GO:0034613; GO:0036064; GO:0060271	cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of vesicle fusion [GO:0031338]		NA	NA	NA	NA	NA	NA
TRINITY_DN9002_c0_g1_i1	Q8N0X4	CLYBL_HUMAN	51.8	334	155	2	1091	102	3	334	2.00E-89	330.9	CLYBL_HUMAN	reviewed	"Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)"	CLYBL CLB	Homo sapiens (Human)	340	mitochondrion [GO:0005739]; (S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]	mitochondrion [GO:0005739]	(S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]	GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121	positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]		NA	NA	NA	NA	NA	NA
TRINITY_DN37944_c0_g1_i1	P49025	CTRO_MOUSE	50.6	79	39	0	5	241	69	147	2.50E-15	82.4	CTRO_MOUSE	reviewed	"Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21)"	Cit Crik	Mus musculus (Mouse)	2055	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuole [GO:0005773]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuole [GO:0005773]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]	GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001726; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005773; GO:0005829; GO:0005856; GO:0005886; GO:0007030; GO:0007091; GO:0007283; GO:0008064; GO:0015629; GO:0016358; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0045665; GO:0046872; GO:0048699; GO:0050774; GO:0051402; GO:0097110	actomyosin structure organization [GO:0031032]; dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN36384_c0_g1_i1	O14578	CTRO_HUMAN	59.1	137	56	0	412	2	156	292	2.10E-46	186.4	CTRO_HUMAN	reviewed	Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21)	CIT CRIK KIAA0949 STK21	Homo sapiens (Human)	2027	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; generation of neurons [GO:0048699]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]	GO:0000278; GO:0000281; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0016020; GO:0017124; GO:0018107; GO:0030165; GO:0031032; GO:0032467; GO:0035556; GO:0046872; GO:0048699; GO:0051402; GO:0097110	actomyosin structure organization [GO:0031032]; generation of neurons [GO:0048699]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]		NA	NA	NA	NA	NA	NA
TRINITY_DN15537_c0_g1_i1	Q9UPT6	JIP3_HUMAN	60	100	30	1	5	274	475	574	8.30E-23	107.8	JIP3_HUMAN	reviewed	C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)	MAPK8IP3 JIP3 KIAA1066	Homo sapiens (Human)	1336	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0044297; GO:0046328; GO:0048471; GO:0061564; GO:0099641; GO:1904115	activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i30	Q9UPT6	JIP3_HUMAN	59.7	72	29	0	159	374	6	77	3.90E-15	82.8	JIP3_HUMAN	reviewed	C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)	MAPK8IP3 JIP3 KIAA1066	Homo sapiens (Human)	1336	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0044297; GO:0046328; GO:0048471; GO:0061564; GO:0099641; GO:1904115	activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i35	Q9UPT6	JIP3_HUMAN	56.9	72	30	1	159	371	6	77	4.90E-12	73.2	JIP3_HUMAN	reviewed	C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)	MAPK8IP3 JIP3 KIAA1066	Homo sapiens (Human)	1336	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0044297; GO:0046328; GO:0048471; GO:0061564; GO:0099641; GO:1904115	activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i7	Q9UPT6	JIP3_HUMAN	73.3	30	8	0	269	358	48	77	2.60E-05	50.8	JIP3_HUMAN	reviewed	C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)	MAPK8IP3 JIP3 KIAA1066	Homo sapiens (Human)	1336	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0044297; GO:0046328; GO:0048471; GO:0061564; GO:0099641; GO:1904115	activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38231_c0_g1_i1	O60271	JIP4_HUMAN	100	96	0	0	290	3	5	100	1.30E-45	183.3	JIP4_HUMAN	reviewed	C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)	SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6	Homo sapiens (Human)	1321	"acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; lysosome localization [GO:0032418]; positive regulation of cell migration [GO:0030335]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]"	acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]	identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001669; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0007257; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0045666; GO:0048471; GO:0051146; GO:0051149; GO:0070062	"activation of JUN kinase activity [GO:0007257]; lysosome localization [GO:0032418]; positive regulation of cell migration [GO:0030335]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19178_c0_g2_i1	Q9HAW4	CLSPN_HUMAN	27.5	273	134	10	800	78	747	987	9.10E-07	55.8	CLSPN_HUMAN	reviewed	Claspin (hClaspin)	CLSPN	Homo sapiens (Human)	1339	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]; activation of protein kinase activity [GO:0032147]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]; protein deubiquitination [GO:0016579]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]	GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006260; GO:0006281; GO:0007095; GO:0010997; GO:0016579; GO:0018105; GO:0032147; GO:0033314	activation of protein kinase activity [GO:0032147]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]; protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN19178_c0_g2_i2	Q9HAW4	CLSPN_HUMAN	27.5	251	124	9	716	78	757	987	8.10E-07	55.8	CLSPN_HUMAN	reviewed	Claspin (hClaspin)	CLSPN	Homo sapiens (Human)	1339	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]; activation of protein kinase activity [GO:0032147]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]; protein deubiquitination [GO:0016579]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]	GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006260; GO:0006281; GO:0007095; GO:0010997; GO:0016579; GO:0018105; GO:0032147; GO:0033314	activation of protein kinase activity [GO:0032147]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]; protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN19178_c0_g1_i1	Q9HAW4	CLSPN_HUMAN	42.5	146	79	3	580	158	1055	1200	5.40E-14	79.7	CLSPN_HUMAN	reviewed	Claspin (hClaspin)	CLSPN	Homo sapiens (Human)	1339	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]; activation of protein kinase activity [GO:0032147]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]; protein deubiquitination [GO:0016579]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]	GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006260; GO:0006281; GO:0007095; GO:0010997; GO:0016579; GO:0018105; GO:0032147; GO:0033314	activation of protein kinase activity [GO:0032147]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]; protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN5228_c1_g1_i1	Q7RTS1	BHA15_HUMAN	69.2	65	20	0	289	95	76	140	1.60E-16	87	BHA15_HUMAN	reviewed	"Class A basic helix-loop-helix protein 15 (bHLHa15) (Class B basic helix-loop-helix protein 8) (bHLHb8) (Muscle, intestine and stomach expression 1) (MIST-1)"	BHLHA15 BHLHB8 MIST1	Homo sapiens (Human)	189	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to glucose starvation [GO:0042149]; endoplasmic reticulum unfolded protein response [GO:0030968]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of myotube differentiation [GO:0010832]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006851; GO:0007030; GO:0007186; GO:0007267; GO:0010832; GO:0019722; GO:0030182; GO:0030968; GO:0042149; GO:0042593; GO:0042802; GO:0046983; GO:0048312; GO:0048469; GO:1990837	calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cell maturation [GO:0048469]; cellular response to glucose starvation [GO:0042149]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of myotube differentiation [GO:0010832]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38187_c0_g1_i1	P25870	CLH_DICDI	66.7	69	23	0	209	3	420	488	2.50E-19	95.5	CLH_DICDI	reviewed	Clathrin heavy chain	chcA DDB_G0277221	Dictyostelium discoideum (Slime mold)	1694	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; actomyosin contractile ring assembly [GO:0000915]; aggregation involved in sorocarp development [GO:0031152]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; mitotic cytokinesis [GO:0000281]; pinocytosis [GO:0006907]; receptor-mediated endocytosis [GO:0006898]; response to osmotic stress [GO:0006970]; sporulation resulting in formation of a cellular spore [GO:0030435]; vacuole organization [GO:0007033]	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]	clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]	GO:0000281; GO:0000915; GO:0005198; GO:0006886; GO:0006898; GO:0006907; GO:0006970; GO:0007033; GO:0007041; GO:0030118; GO:0030130; GO:0030132; GO:0030435; GO:0031152; GO:0032051; GO:0048268; GO:0071439; GO:0072583	actomyosin contractile ring assembly [GO:0000915]; aggregation involved in sorocarp development [GO:0031152]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; mitotic cytokinesis [GO:0000281]; pinocytosis [GO:0006907]; receptor-mediated endocytosis [GO:0006898]; response to osmotic stress [GO:0006970]; sporulation resulting in formation of a cellular spore [GO:0030435]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN32772_c0_g1_i1	P49951	CLH1_BOVIN	100	165	0	0	497	3	1468	1632	2.20E-90	332.8	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN32772_c0_g1_i2	P49951	CLH1_BOVIN	100	165	0	0	497	3	1468	1632	2.20E-90	332.8	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN23837_c0_g1_i1	P49951	CLH1_BOVIN	100	238	0	0	31	744	1	238	1.10E-133	477.2	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN22960_c0_g1_i1	P49951	CLH1_BOVIN	62.2	82	31	0	251	6	557	638	6.90E-24	110.9	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN37534_c0_g1_i1	Q2RBN7	CLH1_ORYSJ	59	134	53	1	402	1	976	1107	1.10E-37	157.5	CLH1_ORYSJ	reviewed	Clathrin heavy chain 1	Os11g0104900 LOC_Os11g01380	Oryza sativa subsp. japonica (Rice)	1708	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0009506; GO:0009507; GO:0030130; GO:0030132; GO:0032051; GO:0071439	intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN34327_c0_g1_i1	Q2RBN7	CLH1_ORYSJ	56.9	116	50	0	348	1	1304	1419	3.00E-33	142.5	CLH1_ORYSJ	reviewed	Clathrin heavy chain 1	Os11g0104900 LOC_Os11g01380	Oryza sativa subsp. japonica (Rice)	1708	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0009506; GO:0009507; GO:0030130; GO:0030132; GO:0032051; GO:0071439	intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN18436_c0_g1_i1	P49951	CLH1_BOVIN	99.9	726	1	0	1	2178	743	1468	0	1449.1	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN18436_c0_g1_i2	Q68FD5	CLH1_MOUSE	100	130	0	0	2	391	1339	1468	2.00E-70	266.2	CLH1_MOUSE	reviewed	Clathrin heavy chain 1	Cltc	Mus musculus (Mouse)	1675	"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]; ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]"	clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]	ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]	GO:0000278; GO:0003725; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0006914; GO:0007030; GO:0008022; GO:0016020; GO:0019901; GO:0030117; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030315; GO:0030506; GO:0031072; GO:0031523; GO:0031623; GO:0032051; GO:0032991; GO:0033572; GO:0042147; GO:0042277; GO:0042383; GO:0042470; GO:0043209; GO:0045334; GO:0048268; GO:0048488; GO:0050750; GO:0051301; GO:0060236; GO:0071439; GO:0072583; GO:0072686; GO:0090307; GO:0097718; GO:0098850; GO:0150093; GO:1900126; GO:1903077; GO:1990381; GO:1990498	"amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15887_c0_g2_i1	P49951	CLH1_BOVIN	100	103	0	0	311	3	335	437	1.90E-52	206.1	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN15887_c0_g1_i1	P49951	CLH1_BOVIN	99.8	539	1	0	1617	1	240	778	0	1076.2	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN15887_c0_g1_i2	P49951	CLH1_BOVIN	99.8	539	1	0	1617	1	240	778	0	1076.2	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN15987_c0_g1_i1	Q2RBN7	CLH1_ORYSJ	61.7	107	41	0	4	324	1443	1549	3.10E-29	129	CLH1_ORYSJ	reviewed	Clathrin heavy chain 1	Os11g0104900 LOC_Os11g01380	Oryza sativa subsp. japonica (Rice)	1708	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0009506; GO:0009507; GO:0030130; GO:0030132; GO:0032051; GO:0071439	intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN1659_c0_g1_i1	P49951	CLH1_BOVIN	85.4	820	120	0	2461	2	1	820	0	1432.2	CLH1_BOVIN	reviewed	Clathrin heavy chain 1	CLTC	Bos taurus (Bovine)	1675	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; endosome [GO:0005768]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; spindle [GO:0005819]	arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000278; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0006886; GO:0006898; GO:0006914; GO:0019901; GO:0019904; GO:0030117; GO:0030130; GO:0030132; GO:0032051; GO:0042470; GO:0042802; GO:0045334; GO:0048268; GO:0051301; GO:0071439; GO:0072686; GO:0097718; GO:1900126; GO:1990763	autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN1659_c0_g1_i2	Q68FD5	CLH1_MOUSE	83.1	1614	273	0	5127	286	1	1614	0	2754.5	CLH1_MOUSE	reviewed	Clathrin heavy chain 1	Cltc	Mus musculus (Mouse)	1675	"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]; ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]"	clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]	ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]	GO:0000278; GO:0003725; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0006914; GO:0007030; GO:0008022; GO:0016020; GO:0019901; GO:0030117; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030315; GO:0030506; GO:0031072; GO:0031523; GO:0031623; GO:0032051; GO:0032991; GO:0033572; GO:0042147; GO:0042277; GO:0042383; GO:0042470; GO:0043209; GO:0045334; GO:0048268; GO:0048488; GO:0050750; GO:0051301; GO:0060236; GO:0071439; GO:0072583; GO:0072686; GO:0090307; GO:0097718; GO:0098850; GO:0150093; GO:1900126; GO:1903077; GO:1990381; GO:1990498	"amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1659_c0_g1_i5	Q68FD5	CLH1_MOUSE	83.1	1614	273	0	5127	286	1	1614	0	2754.5	CLH1_MOUSE	reviewed	Clathrin heavy chain 1	Cltc	Mus musculus (Mouse)	1675	"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]; ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]"	clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]	ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]	GO:0000278; GO:0003725; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0006914; GO:0007030; GO:0008022; GO:0016020; GO:0019901; GO:0030117; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030315; GO:0030506; GO:0031072; GO:0031523; GO:0031623; GO:0032051; GO:0032991; GO:0033572; GO:0042147; GO:0042277; GO:0042383; GO:0042470; GO:0043209; GO:0045334; GO:0048268; GO:0048488; GO:0050750; GO:0051301; GO:0060236; GO:0071439; GO:0072583; GO:0072686; GO:0090307; GO:0097718; GO:0098850; GO:0150093; GO:1900126; GO:1903077; GO:1990381; GO:1990498	"amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15987_c0_g2_i1	Q0WLB5	CLAH2_ARATH	57.9	76	32	0	244	17	1552	1627	9.90E-20	97.1	CLAH2_ARATH	reviewed	Clathrin heavy chain 2	CHC2 CHC1 At3g08530 F17O14.1 T8G24.1	Arabidopsis thaliana (Mouse-ear cress)	1703	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	chloroplast [GO:0009507]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0003729; GO:0005198; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0009506; GO:0009507; GO:0016192; GO:0030130; GO:0030132; GO:0032051; GO:0042802; GO:0071439	endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN25927_c0_g1_i1	A7Z035	EPN4_BOVIN	77.2	123	28	0	369	1	46	168	4.30E-51	201.8	EPN4_BOVIN	reviewed	Clathrin interactor 1 (Epsin-4)	CLINT1 EPN4	Bos taurus (Bovine)	643	clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897]	clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0043231; GO:0048471	endocytosis [GO:0006897]		blue	blue	NA	NA	NA	NA
TRINITY_DN33151_c0_g1_i1	A7Z035	EPN4_BOVIN	98.9	95	1	0	287	3	5	99	9.20E-49	193.7	EPN4_BOVIN	reviewed	Clathrin interactor 1 (Epsin-4)	CLINT1 EPN4	Bos taurus (Bovine)	643	clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897]	clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0043231; GO:0048471	endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN12863_c0_g1_i1	O08585	CLCA_MOUSE	42.4	144	63	2	472	101	89	232	1.10E-22	109	CLCA_MOUSE	reviewed	Clathrin light chain A (Lca)	Clta	Mus musculus (Mouse)	235	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]	clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]	clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631	cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN12863_c0_g1_i2	O08585	CLCA_MOUSE	34.4	256	113	6	775	101	1	232	3.90E-26	120.2	CLCA_MOUSE	reviewed	Clathrin light chain A (Lca)	Clta	Mus musculus (Mouse)	235	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]	clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]	clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631	cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]		blue	blue	NA	NA	NA	NA
TRINITY_DN23104_c0_g1_i1	O08585	CLCA_MOUSE	80.6	93	0	1	265	41	143	235	2.50E-32	139	CLCA_MOUSE	reviewed	Clathrin light chain A (Lca)	Clta	Mus musculus (Mouse)	235	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]	clathrin coat [GO:0030118]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]	clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0007049; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978; GO:0099631	cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN23104_c0_g1_i2	P09496	CLCA_HUMAN	100	54	0	0	202	41	195	248	7.20E-24	110.5	CLCA_HUMAN	reviewed	Clathrin light chain A (Lca)	CLTA	Homo sapiens (Human)	248	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network membrane [GO:0032588]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]	clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network membrane [GO:0032588]	clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0007049; GO:0016020; GO:0019886; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030672; GO:0031410; GO:0032050; GO:0032588; GO:0032802; GO:0034383; GO:0036020; GO:0042277; GO:0044877; GO:0045334; GO:0048268; GO:0051020; GO:0051301; GO:0061024; GO:0071439; GO:0072583; GO:0098835; GO:0099631	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]		NA	NA	NA	NA	NA	NA
TRINITY_DN27991_c0_g1_i1	P04975	CLCB_BOVIN	78.8	85	0	1	209	9	144	228	1.60E-26	119.4	CLCB_BOVIN	reviewed	Clathrin light chain B (Lcb)	CLTB CLTLB	Bos taurus (Bovine)	228	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin vesicle coat [GO:0030125]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; structural molecule activity [GO:0005198]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]	clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin vesicle coat [GO:0030125]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; synaptic vesicle membrane [GO:0030672]	clathrin heavy chain binding [GO:0032050]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005886; GO:0006886; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030672; GO:0032050; GO:0048268; GO:0072583; GO:0099631	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN10955_c0_g1_i3	Q05582	CAS2_STRC2	44.8	58	32	0	511	684	247	304	1.10E-06	55.5	CAS2_STRCL	reviewed	Clavaminate synthase 2 (EC 1.14.11.21) (Clavaminic acid synthase 2) (CAS2) (CS2)	cs2	Streptomyces clavuligerus	325	clavaminate synthase activity [GO:0033758]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; clavulanic acid biosynthetic process [GO:0033050]		clavaminate synthase activity [GO:0033758]; iron ion binding [GO:0005506]	GO:0005506; GO:0017000; GO:0033050; GO:0033758	antibiotic biosynthetic process [GO:0017000]; clavulanic acid biosynthetic process [GO:0033050]		NA	NA	NA	NA	NA	NA
TRINITY_DN27587_c0_g1_i1	Q10570	CPSF1_HUMAN	100	68	0	0	205	2	101	168	1.60E-34	146	CPSF1_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Homo sapiens (Human)	1443	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN657_c0_g1_i1	Q10569	CPSF1_BOVIN	50.9	1453	673	13	88	4350	1	1444	0	1424.5	CPSF1_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Bos taurus (Bovine)	1444	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005847; GO:0006378	mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN37053_c0_g1_i1	Q10570	CPSF1_HUMAN	100	87	0	0	3	263	948	1034	2.90E-49	195.3	CPSF1_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Homo sapiens (Human)	1443	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37053_c0_g1_i2	Q10570	CPSF1_HUMAN	99	99	1	0	3	299	948	1046	1.40E-55	216.5	CPSF1_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Homo sapiens (Human)	1443	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37074_c0_g1_i1	Q10570	CPSF1_HUMAN	100	76	0	0	3	230	300	375	4.70E-35	147.9	CPSF1_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Homo sapiens (Human)	1443	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34882_c0_g1_i1	Q10570	CPSF1_HUMAN	100	79	0	0	1	237	179	257	2.20E-40	165.6	CPSF1_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Homo sapiens (Human)	1443	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27815_c0_g1_i1	Q10569	CPSF1_BOVIN	100	123	0	0	1	369	1163	1285	1.00E-63	243.8	CPSF1_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Bos taurus (Bovine)	1444	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005847; GO:0006378	mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN32469_c0_g1_i1	Q10569	CPSF1_BOVIN	100	106	0	0	1	318	1097	1202	3.50E-57	221.9	CPSF1_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Bos taurus (Bovine)	1444	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005847; GO:0006378	mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN27458_c0_g1_i1	Q10570	CPSF1_HUMAN	99.1	117	1	0	3	353	433	549	8.10E-63	240.7	CPSF1_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	CPSF1 CPSF160	Homo sapiens (Human)	1443	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000398; GO:0005634; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0006406; GO:0019899; GO:0031124; GO:0035925; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20164_c0_g1_i1	Q10568	CPSF2_BOVIN	99.6	260	1	0	32	811	1	260	3.40E-149	528.9	CPSF2_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit)	CPSF2 CPSF100	Bos taurus (Bovine)	782	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]	GO:0003723; GO:0005847; GO:0006378; GO:0006398; GO:0098789	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN20164_c0_g1_i2	Q10568	CPSF2_BOVIN	99.2	260	2	0	32	811	1	260	7.60E-149	527.7	CPSF2_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit)	CPSF2 CPSF100	Bos taurus (Bovine)	782	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]	GO:0003723; GO:0005847; GO:0006378; GO:0006398; GO:0098789	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN2111_c0_g1_i1	Q9W799	CPSF2_XENLA	44.1	93	51	1	362	84	692	783	4.30E-16	85.9	CPSF2_XENLA	reviewed	Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit)	cpsf2	Xenopus laevis (African clawed frog)	783	cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]	cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005847; GO:0006378; GO:0006379	mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN6930_c0_g2_i1	Q86A79	CPSF3_DICDI	64.2	151	54	0	461	9	165	315	5.60E-56	218.4	CPSF3_DICDI	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (Cleavage and polyadenylation specificity factor 3) (EC 3.1.27.-)	cpsf3 DDB_G0274799	Dictyostelium discoideum (Slime mold)	774	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0035925; GO:0046872; GO:0098789	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN12715_c0_g1_i1	Q86A79	CPSF3_DICDI	61.4	280	108	0	847	8	176	455	5.60E-102	372.1	CPSF3_DICDI	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (Cleavage and polyadenylation specificity factor 3) (EC 3.1.27.-)	cpsf3 DDB_G0274799	Dictyostelium discoideum (Slime mold)	774	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0035925; GO:0046872; GO:0098789	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN36532_c0_g1_i1	P79101	CPSF3_BOVIN	100	307	0	0	923	3	109	415	3.30E-180	632.1	CPSF3_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)	CPSF3 CPSF73	Bos taurus (Bovine)	684	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN26736_c0_g1_i1	P79101	CPSF3_BOVIN	49.2	124	63	0	379	8	312	435	7.30E-33	141.4	CPSF3_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)	CPSF3 CPSF73	Bos taurus (Bovine)	684	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN10913_c0_g1_i2	P79101	CPSF3_BOVIN	62.3	658	234	6	3	1952	32	683	7.20E-241	834.7	CPSF3_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)	CPSF3 CPSF73	Bos taurus (Bovine)	684	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN39976_c0_g1_i1	Q9QXK7	CPSF3_MOUSE	100	96	0	0	3	290	239	334	4.40E-51	201.4	CPSF3_MOUSE	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)	Cpsf3 Cpsf73	Mus musculus (Mouse)	684	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN32084_c0_g1_i1	P79101	CPSF3_BOVIN	100	143	0	0	3	431	28	170	1.80E-80	299.7	CPSF3_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)	CPSF3 CPSF73	Bos taurus (Bovine)	684	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN6930_c0_g1_i1	Q9C952	CPSF3_ARATH	58.9	73	30	0	2	220	54	126	5.60E-22	104.4	CPSF3_ARATH	reviewed	Cleavage and polyadenylation specificity factor subunit 3-I (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit I) (AtCPSF73-I) (CPSF 73 kDa subunit I)	CPSF73-I At1g61010 T7P1.15	Arabidopsis thaliana (Mouse-ear cress)	693	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; snRNA processing [GO:0016180]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005634; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0016180	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN13711_c0_g1_i1	Q6DJP7	CPSF4_XENLA	48.9	133	66	2	8	400	38	170	4.50E-42	172.2	CPSF4_XENLA	reviewed	Cleavage and polyadenylation specificity factor subunit 4	cpsf4	Xenopus laevis (African clawed frog)	269	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005847; GO:0006397; GO:0008270	mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN29892_c0_g1_i1	O19137	CPSF4_BOVIN	56	50	22	0	152	3	65	114	3.60E-14	78.6	CPSF4_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit)	CPSF4 CPSF30	Bos taurus (Bovine)	243	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005847; GO:0008270; GO:0098789	pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN35403_c0_g1_i1	O19137	CPSF4_BOVIN	100	99	0	0	298	2	52	150	2.00E-62	239.2	CPSF4_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit)	CPSF4 CPSF30	Bos taurus (Bovine)	243	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005847; GO:0008270; GO:0098789	pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN29459_c0_g1_i1	O95639	CPSF4_HUMAN	100	51	0	0	205	53	219	269	1.10E-24	113.2	CPSF4_HUMAN	reviewed	Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog)	CPSF4 CPSF30 NAR NEB1	Homo sapiens (Human)	269	"intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; modification by virus of host mRNA processing [GO:0046778]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0005654; GO:0005847; GO:0006369; GO:0006388; GO:0006406; GO:0008270; GO:0031124; GO:0043231; GO:0046778; GO:0098789; GO:1990837	"modification by virus of host mRNA processing [GO:0046778]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2580_c0_g1_i1	Q9VPT8	CPSF4_DROME	57	291	104	5	70	882	1	290	1.70E-94	347.4	CPSF4_DROME	reviewed	Cleavage and polyadenylation specificity factor subunit 4 (EC 3.1.-.-) (Cleavage and polyadenylation specificity factor 30 kDa subunit) (Protein clipper)	Clp CPSF30 Ssb-c6a CG3642	Drosophila melanogaster (Fruit fly)	296	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0004521; GO:0005847; GO:0007275; GO:0008270; GO:0098789	multicellular organism development [GO:0007275]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN30600_c0_g1_i1	Q55E68	CPSF5_DICDI	43.3	141	74	2	422	3	35	170	8.10E-31	134.8	CPSF5_DICDI	reviewed	Cleavage and polyadenylation specificity factor subunit 5	nudt21 cpsf5 DDB_G0269370	Dictyostelium discoideum (Slime mold)	200	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]	AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005737; GO:0005849; GO:0006378; GO:0006397; GO:0016787; GO:0017091; GO:0030154; GO:0031439; GO:0035925; GO:0051290; GO:0110104; GO:1900365; GO:1990120	cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN2367_c0_g1_i1	Q3ZCA2	CPSF5_BOVIN	73.9	238	41	3	788	78	9	226	7.70E-96	351.7	CPSF5_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21)	NUDT21 CPSF5	Bos taurus (Bovine)	227	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]		blue	blue	NA	NA	NA	NA
TRINITY_DN2367_c0_g1_i3	Q3ZCA2	CPSF5_BOVIN	80	220	41	2	734	78	9	226	1.80E-99	363.6	CPSF5_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21)	NUDT21 CPSF5	Bos taurus (Bovine)	227	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]		blue	blue	NA	NA	NA	NA
TRINITY_DN2367_c0_g1_i4	Q3ZCA2	CPSF5_BOVIN	72	100	25	2	386	90	9	106	3.70E-33	142.5	CPSF5_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21)	NUDT21 CPSF5	Bos taurus (Bovine)	227	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN2367_c0_g1_i5	Q3ZCA2	CPSF5_BOVIN	70.7	249	41	3	821	78	9	226	1.20E-94	347.8	CPSF5_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21)	NUDT21 CPSF5	Bos taurus (Bovine)	227	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN18627_c0_g1_i1	Q3ZCA2	CPSF5_BOVIN	100	220	0	0	3	662	8	227	3.30E-129	462.2	CPSF5_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21)	NUDT21 CPSF5	Bos taurus (Bovine)	227	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN18627_c0_g1_i2	Q3ZCA2	CPSF5_BOVIN	100	220	0	0	3	662	8	227	3.30E-129	462.2	CPSF5_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21)	NUDT21 CPSF5	Bos taurus (Bovine)	227	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	AU-rich element binding [GO:0017091]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016787; GO:0017091; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN6958_c0_g1_i1	Q9VSH4	CPSF6_DROME	65.9	41	14	0	1	123	152	192	7.00E-08	58.5	CPSF6_DROME	reviewed	Cleavage and polyadenylation specificity factor subunit 6	Cpsf6 CG7185	Drosophila melanogaster (Fruit fly)	652	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of autophagy [GO:0010508]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0010508; GO:0043484	"mRNA processing [GO:0006397]; positive regulation of autophagy [GO:0010508]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2552_c0_g1_i2	Q9VSH4	CPSF6_DROME	73.3	45	12	0	132	266	91	135	3.00E-14	79	CPSF6_DROME	reviewed	Cleavage and polyadenylation specificity factor subunit 6	Cpsf6 CG7185	Drosophila melanogaster (Fruit fly)	652	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of autophagy [GO:0010508]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0010508; GO:0043484	"mRNA processing [GO:0006397]; positive regulation of autophagy [GO:0010508]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2552_c0_g1_i5	Q0P5D2	CPSF6_BOVIN	58.7	46	18	1	129	263	78	123	2.70E-07	55.8	CPSF6_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 6	CPSF6	Bos taurus (Bovine)	551	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051290; GO:0110104; GO:1990120; GO:1990448	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN33363_c0_g1_i1	Q0P5D2	CPSF6_BOVIN	100	99	0	0	29	325	396	494	3.90E-46	185.3	CPSF6_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 6	CPSF6	Bos taurus (Bovine)	551	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051290; GO:0110104; GO:1990120; GO:1990448	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN704_c0_g1_i1	Q0P5D2	CPSF6_BOVIN	75.5	94	16	1	369	88	408	494	8.60E-29	129	CPSF6_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 6	CPSF6	Bos taurus (Bovine)	551	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051290; GO:0110104; GO:1990120; GO:1990448	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN704_c0_g1_i2	Q0P5D2	CPSF6_BOVIN	75.5	94	16	1	369	88	408	494	5.90E-29	129	CPSF6_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 6	CPSF6	Bos taurus (Bovine)	551	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051290; GO:0110104; GO:1990120; GO:1990448	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN704_c0_g1_i3	Q0P5D2	CPSF6_BOVIN	81.6	87	16	0	348	88	408	494	2.80E-31	136.7	CPSF6_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 6	CPSF6	Bos taurus (Bovine)	551	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051290; GO:0110104; GO:1990120; GO:1990448	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN704_c0_g1_i4	Q0P5D2	CPSF6_BOVIN	81.6	87	16	0	348	88	408	494	4.00E-31	136.7	CPSF6_BOVIN	reviewed	Cleavage and polyadenylation specificity factor subunit 6	CPSF6	Bos taurus (Bovine)	551	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051290; GO:0110104; GO:1990120; GO:1990448	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN14819_c0_g1_i1	Q8BIQ5	CSTF2_MOUSE	75.3	182	44	1	605	63	11	192	9.90E-75	281.2	CSTF2_MOUSE	reviewed	Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64)	Cstf2	Mus musculus (Mouse)	580	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0006378; GO:0016604; GO:0071920; GO:0098789; GO:1990090	cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN14819_c0_g1_i2	Q8BIQ5	CSTF2_MOUSE	75.3	182	44	1	605	63	11	192	9.90E-75	281.2	CSTF2_MOUSE	reviewed	Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64)	Cstf2	Mus musculus (Mouse)	580	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0006378; GO:0016604; GO:0071920; GO:0098789; GO:1990090	cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN29454_c0_g1_i1	P33240	CSTF2_HUMAN	100	103	0	0	2	310	114	216	1.40E-50	199.9	CSTF2_HUMAN	reviewed	Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64)	CSTF2	Homo sapiens (Human)	577	"cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006388; GO:0016604; GO:0031124; GO:0071920; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9593_c0_g1_i1	Q8HXM1	CSTF2_BOVIN	69.9	83	25	0	20	268	18	100	7.80E-27	120.9	CSTF2_BOVIN	reviewed	Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64)	CSTF2	Bos taurus (Bovine)	572	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005847; GO:0006378; GO:0071920; GO:0098789	mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN22986_c0_g1_i2	O96005	CLPT1_HUMAN	100	213	0	0	1	639	159	371	8.70E-124	444.1	CLPT1_HUMAN	reviewed	Cleft lip and palate transmembrane protein 1	CLPTM1	Homo sapiens (Human)	669	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]		GO:0005887; GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN22986_c0_g1_i3	O96005	CLPT1_HUMAN	100	132	0	0	3	398	463	594	2.60E-73	275.8	CLPT1_HUMAN	reviewed	Cleft lip and palate transmembrane protein 1	CLPTM1	Homo sapiens (Human)	669	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]		GO:0005887; GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN2114_c0_g2_i1	Q2NL17	CLPT1_BOVIN	58.9	584	226	6	1929	184	37	608	4.70E-192	672.5	CLPT1_BOVIN	reviewed	Cleft lip and palate transmembrane protein 1 homolog	CLPTM1	Bos taurus (Bovine)	670	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0016021; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN2114_c0_g2_i2	Q2NL17	CLPT1_BOVIN	58.9	584	226	6	1944	199	37	608	4.80E-192	672.5	CLPT1_BOVIN	reviewed	Cleft lip and palate transmembrane protein 1 homolog	CLPTM1	Bos taurus (Bovine)	670	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0016021; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN2114_c0_g1_i1	Q2NL17	CLPT1_BOVIN	58.9	584	226	6	74	1819	37	608	4.80E-192	672.5	CLPT1_BOVIN	reviewed	Cleft lip and palate transmembrane protein 1 homolog	CLPTM1	Bos taurus (Bovine)	670	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0016021; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN2114_c0_g1_i2	Q2NL17	CLPT1_BOVIN	58.9	584	226	6	74	1819	37	608	4.70E-192	672.5	CLPT1_BOVIN	reviewed	Cleft lip and palate transmembrane protein 1 homolog	CLPTM1	Bos taurus (Bovine)	670	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0016021; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN22986_c0_g1_i1	Q8VBZ3	CLPT1_MOUSE	100	436	0	0	1	1308	159	594	2.50E-258	892.1	CLPT1_MOUSE	reviewed	Cleft lip and palate transmembrane protein 1 homolog (Thymic epithelial cell surface antigen)	Clptm1 N14	Mus musculus (Mouse)	664	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0007275; GO:0009897; GO:0012505; GO:0016020; GO:0016021; GO:0030154; GO:0033081	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]		NA	NA	NA	NA	NA	NA
TRINITY_DN38246_c0_g1_i1	A2VE61	CLP1L_BOVIN	100	74	0	0	2	223	251	324	7.00E-36	150.6	CLP1L_BOVIN	reviewed	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein)	CLPTM1L	Bos taurus (Bovine)	538	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0006915; GO:0012505; GO:0016020; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN27676_c0_g1_i1	Q8BXA5	CLP1L_MOUSE	100	105	0	0	3	317	414	518	4.50E-57	221.5	CLP1L_MOUSE	reviewed	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein)	Clptm1l	Mus musculus (Mouse)	539	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0006915; GO:0012505; GO:0016020; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN29704_c0_g1_i1	Q8BXA5	CLP1L_MOUSE	60.6	94	36	1	14	295	439	531	2.40E-29	129.4	CLP1L_MOUSE	reviewed	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein)	Clptm1l	Mus musculus (Mouse)	539	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0006915; GO:0012505; GO:0016020; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN36117_c0_g1_i1	Q6DHU1	CLP1L_DANRE	52	98	47	0	337	44	416	513	1.10E-24	114	CLP1L_DANRE	reviewed	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein)	clptm1l zgc:92063	Danio rerio (Zebrafish) (Brachydanio rerio)	538	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0006915; GO:0012505; GO:0016020; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN8867_c0_g1_i1	Q6DHU1	CLP1L_DANRE	46.8	545	262	10	1614	10	6	532	6.90E-136	485.7	CLP1L_DANRE	reviewed	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein)	clptm1l zgc:92063	Danio rerio (Zebrafish) (Brachydanio rerio)	538	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0006915; GO:0012505; GO:0016020; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN20452_c0_g1_i1	Q96KA5	CLP1L_HUMAN	100	108	0	0	325	2	417	524	5.00E-59	228	CLP1L_HUMAN	reviewed	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein) (Cisplatin resistance-related protein 9) (CRR9p)	CLPTM1L CRR9	Homo sapiens (Human)	538	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0006915; GO:0012505; GO:0016020; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN2325_c0_g1_i1	Q7PEV7	CL14D_ANOGA	39.4	104	58	3	3	305	258	359	2.70E-13	76.3	CL14D_ANOGA	reviewed	CLIP domain-containing serine protease 14D (AgSp14D1) (EC 3.4.21.-)	CLIPB4 SP14D1 AGAP003250	Anopheles gambiae (African malaria mosquito)	360	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]	extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576			pink	pink	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i1	A1A5G0	CLAP1_XENTR	40.9	1232	611	31	270	3863	296	1444	4.90E-209	729.9	CLAP1_XENTR	reviewed	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	clasp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1452	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000226; GO:0000776; GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051010; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i12	A1A5G0	CLAP1_XENTR	39.6	1189	593	28	270	3581	296	1444	1.10E-199	698.7	CLAP1_XENTR	reviewed	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	clasp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1452	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000226; GO:0000776; GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051010; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i5	A1A5G0	CLAP1_XENTR	39.5	1194	597	28	165	3491	291	1444	1.40E-199	698.4	CLAP1_XENTR	reviewed	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	clasp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1452	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000226; GO:0000776; GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051010; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i7	A1A5G0	CLAP1_XENTR	40.9	1229	616	30	165	3746	291	1444	1.30E-209	731.9	CLAP1_XENTR	reviewed	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	clasp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1452	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000226; GO:0000776; GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051010; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i9	A1A5G0	CLAP1_XENTR	41	1224	612	30	270	3836	296	1444	9.90E-210	732.3	CLAP1_XENTR	reviewed	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	clasp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1452	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]	basal cortex [GO:0045180]; condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000226; GO:0000776; GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051010; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN29268_c0_g1_i1	Q7Z460	CLAP1_HUMAN	100	73	0	0	1	219	1466	1538	1.50E-33	142.9	CLAP1_HUMAN	reviewed	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1)	CLASP1 KIAA0622 MAST1	Homo sapiens (Human)	1538	"basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization or depolymerization [GO:0031110]; vesicle targeting [GO:0006903]"	basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000086; GO:0000226; GO:0000776; GO:0000777; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005815; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010389; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031110; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0072686; GO:0090091; GO:0090162; GO:0090307; GO:0097711; GO:1903690; GO:1904261	"astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization or depolymerization [GO:0031110]; vesicle targeting [GO:0006903]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i2	A1A5K2	CLA1B_XENLA	38.5	1248	613	27	57	3464	244	1448	1.30E-200	701.8	CLA1B_XENLA	reviewed	CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP)	clasp1b clasp1	Xenopus laevis (African clawed frog)	1456	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]	kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]	GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005881; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0043515; GO:0051010; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i4	A1A5K2	CLA1B_XENLA	40.7	734	390	17	86	2221	738	1448	2.10E-127	458	CLA1B_XENLA	reviewed	CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP)	clasp1b clasp1	Xenopus laevis (African clawed frog)	1456	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]	kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]	GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005881; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0043515; GO:0051010; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]		NA	NA	NA	NA	NA	NA
TRINITY_DN1320_c0_g1_i6	A1A5K2	CLA1B_XENLA	38.8	1215	600	25	213	3554	277	1448	7.80E-201	702.6	CLA1B_XENLA	reviewed	CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP)	clasp1b clasp1	Xenopus laevis (African clawed frog)	1456	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]	kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]	GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005881; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0043515; GO:0051010; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]		NA	NA	NA	NA	NA	NA
TRINITY_DN41020_c0_g1_i1	O75122	CLAP2_HUMAN	100	79	0	0	1	237	136	214	1.00E-37	156.8	CLAP2_HUMAN	reviewed	CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2)	CLASP2 KIAA0627	Homo sapiens (Human)	1294	"axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]"	axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]	GO:0000226; GO:0000777; GO:0002162; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:0090307; GO:1903690; GO:1903754; GO:1904261; GO:1990782	"cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; vesicle targeting [GO:0006903]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9552_c0_g1_i1	A0JNI5	CLASR_BOVIN	56.5	62	22	2	217	41	67	126	7.70E-13	74.3	CLASR_BOVIN	reviewed	"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)"	CLASRP SFRS16	Bos taurus (Bovine)	670	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]		GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN9552_c0_g1_i2	A0JNI5	CLASR_BOVIN	60.5	172	62	3	532	26	1	169	2.80E-53	209.9	CLASR_BOVIN	reviewed	"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)"	CLASRP SFRS16	Bos taurus (Bovine)	670	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]		GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN32595_c0_g1_i1	A0JNI5	CLASR_BOVIN	100	88	0	0	264	1	1	88	3.30E-46	185.3	CLASR_BOVIN	reviewed	"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)"	CLASRP SFRS16	Bos taurus (Bovine)	670	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]		GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN28785_c0_g1_i1	Q27081	CFB_TACTR	59.2	49	20	0	35	181	341	389	6.70E-14	77.4	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN21704_c0_g1_i6	Q27081	CFB_TACTR	44.9	89	44	3	326	60	307	390	1.10E-13	77.4	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i2	Q27081	CFB_TACTR	31.2	160	107	2	480	1	219	375	1.00E-16	88.2	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i10	Q27081	CFB_TACTR	35.3	252	146	5	832	95	150	390	8.30E-37	155.6	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i11	Q27081	CFB_TACTR	33.9	254	151	5	838	95	148	390	2.60E-38	160.6	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i12	Q27081	CFB_TACTR	35.7	252	145	5	832	95	150	390	2.00E-38	161	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i2	Q27081	CFB_TACTR	35.3	252	146	5	832	95	150	390	3.70E-37	156.8	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i4	Q27081	CFB_TACTR	34.1	252	149	5	832	95	150	390	7.80E-35	149.1	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i5	Q27081	CFB_TACTR	36.9	160	96	3	574	95	236	390	2.10E-23	110.5	CFB_TACTR	reviewed	Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	400	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0016485; GO:0042381	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN6163_c1_g2_i1	P05444	CLPA_RHOBL	80	80	16	0	242	3	566	645	8.40E-35	147.1	CLPA_RHOBL	reviewed	ClpA homolog protein		Rhodobacter blasticus (Rhodopseudomonas blastica)	793	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein unfolding [GO:0043335]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0043335	protein unfolding [GO:0043335]		NA	NA	NA	NA	NA	NA
TRINITY_DN6163_c1_g1_i1	P05444	CLPA_RHOBL	78.8	66	14	0	200	3	576	641	5.90E-26	117.5	CLPA_RHOBL	reviewed	ClpA homolog protein		Rhodobacter blasticus (Rhodopseudomonas blastica)	793	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein unfolding [GO:0043335]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0043335	protein unfolding [GO:0043335]		NA	NA	NA	NA	NA	NA
TRINITY_DN15003_c0_g1_i1	Q54RJ1	CNRB_DICDI	64.5	110	39	0	3	332	452	561	4.60E-37	155.2	CNRB_DICDI	reviewed	CLPTM1-like membrane protein cnrB	cnrB DDB_G0283115	Dictyostelium discoideum (Slime mold)	619	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0012505; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN28072_c0_g1_i1	Q54RJ1	CNRB_DICDI	63.6	110	40	0	367	38	452	561	2.70E-37	156	CNRB_DICDI	reviewed	CLPTM1-like membrane protein cnrB	cnrB DDB_G0283115	Dictyostelium discoideum (Slime mold)	619	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0012505; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4525_c0_g1_i1	A1L3F5	CMIP_XENLA	50	158	78	1	61	531	452	609	8.50E-40	164.9	CMIP_XENLA	reviewed	C-Maf-inducing protein (c-Mip)	cmip	Xenopus laevis (African clawed frog)	772	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN31318_c0_g1_i1	Q54I57	MYCBP_DICDI	56.5	46	20	0	417	280	5	50	2.20E-07	57	MYCBP_DICDI	reviewed	c-Myc-binding protein homolog	mycbp DDB_G0288991	Dictyostelium discoideum (Slime mold)	90	"nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1141_c0_g1_i1	A8WJ42	COA8_CAEBR	42	112	59	2	484	152	15	121	2.60E-17	90.5	COA8_CAEBR	reviewed	"COA8 family protein CBG23705, mitochondrial (COA8) (APOPT family protein CBG23705, mitochondrial)"	CBG23705	Caenorhabditis briggsae	142	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; intrinsic apoptotic signaling pathway [GO:0097193]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0097193	intrinsic apoptotic signaling pathway [GO:0097193]		NA	NA	NA	NA	NA	NA
TRINITY_DN1141_c0_g1_i2	A8WJ42	COA8_CAEBR	42.5	113	59	2	487	152	14	121	4.10E-18	93.2	COA8_CAEBR	reviewed	"COA8 family protein CBG23705, mitochondrial (COA8) (APOPT family protein CBG23705, mitochondrial)"	CBG23705	Caenorhabditis briggsae	142	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; intrinsic apoptotic signaling pathway [GO:0097193]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0097193	intrinsic apoptotic signaling pathway [GO:0097193]		NA	NA	NA	NA	NA	NA
TRINITY_DN1141_c0_g1_i3	A8WJ42	COA8_CAEBR	42.5	113	59	2	487	152	14	121	4.30E-18	93.2	COA8_CAEBR	reviewed	"COA8 family protein CBG23705, mitochondrial (COA8) (APOPT family protein CBG23705, mitochondrial)"	CBG23705	Caenorhabditis briggsae	142	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; intrinsic apoptotic signaling pathway [GO:0097193]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0097193	intrinsic apoptotic signaling pathway [GO:0097193]		NA	NA	NA	NA	NA	NA
TRINITY_DN1141_c0_g1_i4	A8WJ42	COA8_CAEBR	42.5	113	59	2	487	152	14	121	3.30E-18	93.6	COA8_CAEBR	reviewed	"COA8 family protein CBG23705, mitochondrial (COA8) (APOPT family protein CBG23705, mitochondrial)"	CBG23705	Caenorhabditis briggsae	142	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; intrinsic apoptotic signaling pathway [GO:0097193]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0097193	intrinsic apoptotic signaling pathway [GO:0097193]		NA	NA	NA	NA	NA	NA
TRINITY_DN19689_c1_g1_i1	P34121	COAA_DICDI	30	90	60	3	262	2	1	90	2.40E-05	49.7	COAA_DICDI	reviewed	Coactosin (Cyclic AMP-regulated protein p16) (Cytoskeletal protein p17)	coaA p17 DDB_G0293898	Dictyostelium discoideum (Slime mold)	146	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]	GO:0005886; GO:0009617; GO:0015629; GO:0030833; GO:0030864; GO:0045335; GO:0051015	regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN19689_c1_g2_i1	P34121	COAA_DICDI	37.8	82	51	0	339	94	58	139	8.70E-09	61.2	COAA_DICDI	reviewed	Coactosin (Cyclic AMP-regulated protein p16) (Cytoskeletal protein p17)	coaA p17 DDB_G0293898	Dictyostelium discoideum (Slime mold)	146	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]	GO:0005886; GO:0009617; GO:0015629; GO:0030833; GO:0030864; GO:0045335; GO:0051015	regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN19689_c1_g2_i4	P34121	COAA_DICDI	37	81	51	0	307	65	58	138	5.10E-08	58.5	COAA_DICDI	reviewed	Coactosin (Cyclic AMP-regulated protein p16) (Cytoskeletal protein p17)	coaA p17 DDB_G0293898	Dictyostelium discoideum (Slime mold)	146	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]	GO:0005886; GO:0009617; GO:0015629; GO:0030833; GO:0030864; GO:0045335; GO:0051015	regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN21428_c1_g1_i1	Q2HJ57	COTL1_BOVIN	43.8	64	36	0	45	236	20	83	1.90E-10	66.2	COTL1_BOVIN	reviewed	Coactosin-like protein	COTL1	Bos taurus (Bovine)	142	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; enzyme binding [GO:0019899]	GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0050832; GO:0051015	defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]		blue	blue	NA	NA	NA	NA
TRINITY_DN21428_c0_g1_i1	Q2HJ57	COTL1_BOVIN	45.9	135	73	0	170	574	3	137	2.00E-30	134.4	COTL1_BOVIN	reviewed	Coactosin-like protein	COTL1	Bos taurus (Bovine)	142	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; enzyme binding [GO:0019899]	GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0050832; GO:0051015	defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]		blue	blue	NA	NA	NA	NA
TRINITY_DN32305_c0_g1_i1	Q14019	COTL1_HUMAN	100	84	0	0	253	2	34	117	4.30E-42	171.4	COTL1_HUMAN	reviewed	Coactosin-like protein	COTL1 CLP	Homo sapiens (Human)	142	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; neutrophil degranulation [GO:0043312]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]	GO:0003779; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0034774; GO:0043312; GO:0050832; GO:0051015; GO:0070062; GO:1904813	defense response to fungus [GO:0050832]; neutrophil degranulation [GO:0043312]; regulation of actin filament polymerization [GO:0030833]		NA	NA	NA	NA	NA	NA
TRINITY_DN29999_c0_g1_i1	Q2HJ57	COTL1_BOVIN	46.6	58	31	0	182	9	66	123	6.10E-08	57.8	COTL1_BOVIN	reviewed	Coactosin-like protein	COTL1	Bos taurus (Bovine)	142	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; enzyme binding [GO:0019899]	GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0050832; GO:0051015	defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]		blue	blue	NA	NA	NA	NA
TRINITY_DN20047_c0_g1_i1	Q2HJ57	COTL1_BOVIN	46.8	79	42	0	238	2	3	81	1.20E-15	83.6	COTL1_BOVIN	reviewed	Coactosin-like protein	COTL1	Bos taurus (Bovine)	142	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; enzyme binding [GO:0019899]	GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0050832; GO:0051015	defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]		NA	NA	NA	NA	NA	NA
TRINITY_DN21305_c0_g1_i1	P00743	FA10_BOVIN	49.1	57	24	2	114	275	260	314	1.20E-05	50.8	FA10_BOVIN	reviewed	Coagulation factor X (EC 3.4.21.6) (Stuart factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]	F10	Bos taurus (Bovine)	492	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005509; GO:0005615; GO:0007596	blood coagulation [GO:0007596]		NA	NA	NA	NA	NA	NA
TRINITY_DN39088_c0_g1_i1	Q8BH61	F13A_MOUSE	100	80	0	0	242	3	164	243	1.50E-44	179.5	F13A_MOUSE	reviewed	Coagulation factor XIII A chain (Coagulation factor XIIIa) (EC 2.3.2.13) (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)	F13a1 F13a	Mus musculus (Mouse)	732	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0005737; GO:0007596; GO:0018149; GO:0046872; GO:0062023; GO:0072378	"blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]"		NA	NA	NA	NA	NA	NA
TRINITY_DN193_c20_g1_i1	P00488	F13A_HUMAN	69.2	39	12	0	192	76	368	406	4.10E-12	71.6	F13A_HUMAN	reviewed	Coagulation factor XIII A chain (Coagulation factor XIIIa) (EC 2.3.2.13) (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)	F13A1 F13A	Homo sapiens (Human)	732	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; cytokine-mediated signaling pathway [GO:0019221]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0002576; GO:0003810; GO:0005576; GO:0007596; GO:0018149; GO:0019221; GO:0031093; GO:0046872; GO:0062023; GO:0072378; GO:0072562	"blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; cytokine-mediated signaling pathway [GO:0019221]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9670_c0_g1_i1	Q55FR9	COPA_DICDI	44.2	95	53	0	18	302	49	143	4.60E-22	105.1	COPA_DICDI	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP)	copa DDB_G0267982	Dictyostelium discoideum (Slime mold)	1221	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1835_c0_g1_i2	Q55FR9	COPA_DICDI	50.7	71	35	0	142	354	1150	1220	8.30E-20	98.2	COPA_DICDI	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP)	copa DDB_G0267982	Dictyostelium discoideum (Slime mold)	1221	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		blue	blue	NA	NA	NA	NA
TRINITY_DN15523_c0_g1_i1	P53621	COPA_HUMAN	99.9	695	1	0	2085	1	60	754	0	1437.9	COPA_HUMAN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Homo sapiens (Human)	1224	"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40688_c0_g1_i1	Q27954	COPA_BOVIN	81.9	72	13	0	219	4	654	725	2.40E-28	125.6	COPA_BOVIN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Bos taurus (Bovine)	1224	"COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]	hormone activity [GO:0005179]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005179; GO:0005198; GO:0005576; GO:0006886; GO:0006890; GO:0006891; GO:0030126	"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27232_c0_g1_i1	Q27954	COPA_BOVIN	99.4	169	1	0	507	1	54	222	3.70E-101	368.6	COPA_BOVIN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Bos taurus (Bovine)	1224	"COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]	hormone activity [GO:0005179]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005179; GO:0005198; GO:0005576; GO:0006886; GO:0006890; GO:0006891; GO:0030126	"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20586_c0_g3_i1	Q27954	COPA_BOVIN	69.6	293	86	2	2	877	68	358	3.40E-126	452.6	COPA_BOVIN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Bos taurus (Bovine)	1224	"COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]	hormone activity [GO:0005179]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005179; GO:0005198; GO:0005576; GO:0006886; GO:0006890; GO:0006891; GO:0030126	"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17946_c0_g1_i3	P53621	COPA_HUMAN	100	153	0	0	1	459	1032	1184	1.30E-81	303.5	COPA_HUMAN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Homo sapiens (Human)	1224	"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31366_c0_g1_i1	P53621	COPA_HUMAN	100	91	0	0	2	274	893	983	1.40E-49	196.4	COPA_HUMAN	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	Homo sapiens (Human)	1224	"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26085_c0_g1_i1	Q8CIE6	COPA_MOUSE	99.2	127	1	0	382	2	893	1019	6.70E-71	267.7	COPA_MOUSE	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	Copa	Mus musculus (Mouse)	1224	"axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15523_c0_g2_i1	Q8CIE6	COPA_MOUSE	100	121	0	0	363	1	667	787	1.20E-64	246.9	COPA_MOUSE	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	Copa	Mus musculus (Mouse)	1224	"axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15523_c0_g1_i2	Q8CIE6	COPA_MOUSE	99.7	329	1	0	987	1	426	754	3.10E-189	662.1	COPA_MOUSE	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	Copa	Mus musculus (Mouse)	1224	"axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17946_c0_g1_i1	Q8CIE6	COPA_MOUSE	100	129	0	0	1	387	1032	1160	1.70E-66	253.1	COPA_MOUSE	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	Copa	Mus musculus (Mouse)	1224	"axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1835_c0_g1_i1	Q8CIE6	COPA_MOUSE	66.2	1188	383	5	3	3539	47	1224	0	1638.6	COPA_MOUSE	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	Copa	Mus musculus (Mouse)	1224	"axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1835_c0_g1_i3	Q8CIE6	COPA_MOUSE	66.6	1181	383	4	3	3518	47	1224	0	1645.9	COPA_MOUSE	reviewed	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	Copa	Mus musculus (Mouse)	1224	"axon [GO:0030424]; cell body [GO:0044297]; COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20586_c0_g2_i1	Q9AUR8	COPA1_ORYSJ	60.6	71	28	0	3	215	597	667	1.30E-18	93.2	COPA1_ORYSJ	reviewed	Coatomer subunit alpha-1 (Alpha-coat protein 1) (Alpha-COP 1)	Os03g0711400 LOC_Os03g50340 OsJ_011822 OSJNBb0033N16.10	Oryza sativa subsp. japonica (Rice)	1218	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20586_c0_g1_i1	Q94A40	COPA1_ARATH	57.9	76	32	0	1	228	501	576	4.30E-20	98.2	COPA1_ARATH	reviewed	Coatomer subunit alpha-1 (Alpha-coat protein 1) (Alpha-COP 1)	At1g62020 F8K4.21	Arabidopsis thaliana (Mouse-ear cress)	1216	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005634; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13923_c0_g1_i1	Q5ZIA5	COPB_CHICK	84.8	230	35	0	692	3	33	262	1.40E-111	403.7	COPB_CHICK	reviewed	Coatomer subunit beta (Beta-coat protein) (Beta-COP)	COPB1 COPB RCJMB04_28l17	Gallus gallus (Chicken)	953	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]		NA	NA	NA	NA	NA	NA
TRINITY_DN24856_c0_g1_i1	A0JN39	COPB_BOVIN	100	215	0	0	645	1	37	251	7.00E-121	434.5	COPB_BOVIN	reviewed	Coatomer subunit beta (Beta-coat protein) (Beta-COP)	COPB1	Bos taurus (Bovine)	953	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005793; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006891; GO:0030126	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]		NA	NA	NA	NA	NA	NA
TRINITY_DN34976_c0_g1_i1	Q9U4N3	COPB_TOXGO	72.6	73	20	0	3	221	93	165	8.50E-26	117.1	COPB_TOXGO	reviewed	Coatomer subunit beta (Beta-coat protein) (Beta-COP)		Toxoplasma gondii	1103	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0006886; GO:0016192; GO:0030126	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN35885_c0_g1_i1	O62621	COPB2_DROME	53.7	67	31	0	29	229	742	808	2.00E-14	79.3	COPB2_DROME	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)	beta'COP CG6699	Drosophila melanogaster (Fruit fly)	914	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005795; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0010883; GO:0030126	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; regulation of lipid storage [GO:0010883]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17287_c0_g1_i1	Q4R4I8	COPB2_MACFA	100	135	0	0	1	405	502	636	3.80E-72	271.9	COPB2_MACFA	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)	COPB2 QtrA-12583	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	906	COPI-coated vesicle membrane [GO:0030663]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane coat [GO:0030117]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	COPI-coated vesicle membrane [GO:0030663]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane coat [GO:0030117]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0016192; GO:0030117; GO:0030663	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN20987_c0_g1_i1	P35605	COPB2_BOVIN	78.8	33	7	0	1	99	333	365	6.50E-10	64.3	COPB2_BOVIN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Bos taurus (Bovine)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		blue	blue	NA	NA	NA	NA
TRINITY_DN24828_c0_g1_i1	O55029	COPB2_MOUSE	98.4	185	3	0	556	2	320	504	9.70E-103	374	COPB2_MOUSE	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	Copb2	Mus musculus (Mouse)	905	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20535_c0_g2_i1	P35605	COPB2_BOVIN	71.4	91	26	0	2	274	56	146	1.80E-36	152.9	COPB2_BOVIN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Bos taurus (Bovine)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37044_c0_g1_i1	P35606	COPB2_HUMAN	100	293	0	0	880	2	500	792	6.90E-164	577.8	COPB2_HUMAN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Homo sapiens (Human)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN115_c0_g1_i1	P35605	COPB2_BOVIN	79.1	440	91	1	3	1322	53	491	1.70E-225	783.1	COPB2_BOVIN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Bos taurus (Bovine)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN115_c0_g1_i3	O55029	COPB2_MOUSE	71.1	805	228	3	3	2405	53	856	0	1228.4	COPB2_MOUSE	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	Copb2	Mus musculus (Mouse)	905	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		blue	blue	NA	NA	NA	NA
TRINITY_DN115_c0_g1_i4	O55029	COPB2_MOUSE	71.1	805	228	3	3	2405	53	856	0	1228.4	COPB2_MOUSE	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	Copb2	Mus musculus (Mouse)	905	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN115_c0_g1_i5	O35142	COPB2_RAT	61.8	364	135	2	8	1087	493	856	1.30E-126	454.5	COPB2_RAT	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	Copb2	Rattus norvegicus (Rat)	905	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10903_c0_g1_i1	P35605	COPB2_BOVIN	99.7	313	1	0	942	4	69	381	2.70E-190	665.6	COPB2_BOVIN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Bos taurus (Bovine)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10903_c0_g1_i2	P35605	COPB2_BOVIN	99.7	313	1	0	942	4	69	381	2.70E-190	665.6	COPB2_BOVIN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Bos taurus (Bovine)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10903_c0_g1_i3	P35605	COPB2_BOVIN	99.2	127	1	0	383	3	69	195	1.90E-73	276.2	COPB2_BOVIN	reviewed	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	COPB2	Bos taurus (Bovine)	906	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20535_c0_g1_i1	Q5VQ78	COB21_ORYSJ	67.2	128	42	0	389	6	197	324	1.30E-48	193.7	COB21_ORYSJ	reviewed	Coatomer subunit beta'-1 (Beta'-coat protein 1) (Beta'-COP 1)	Os06g0143900 LOC_Os06g05180 OSJNBa0007O20.8-1	Oryza sativa subsp. japonica (Rice)	907	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33130_c0_g1_i1	O14579	COPE_HUMAN	100	107	0	0	322	2	1	107	3.60E-55	215.3	COPE_HUMAN	reviewed	Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)	COPE	Homo sapiens (Human)	308	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11762_c0_g1_i1	O89079	COPE_MOUSE	100	66	0	0	200	3	1	66	1.90E-31	136	COPE_MOUSE	reviewed	Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)	Cope Cope1	Mus musculus (Mouse)	308	"COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0005794; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030137; GO:0099612	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN593_c2_g1_i1	Q28104	COPE_BOVIN	58.8	291	120	0	985	113	15	305	3.90E-97	356.3	COPE_BOVIN	reviewed	Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)	COPE COPE1	Bos taurus (Bovine)	308	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		blue	blue	NA	NA	NA	NA
TRINITY_DN39249_c0_g1_i1	O14579	COPE_HUMAN	100	107	0	0	321	1	138	244	5.60E-55	214.5	COPE_HUMAN	reviewed	Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)	COPE	Homo sapiens (Human)	308	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39249_c0_g1_i2	O14579	COPE_HUMAN	95.3	107	0	1	306	1	138	244	8.00E-51	200.7	COPE_HUMAN	reviewed	Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)	COPE	Homo sapiens (Human)	308	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30557_c0_g1_i1	O89079	COPE_MOUSE	100	104	0	0	313	2	134	237	1.00E-53	210.3	COPE_MOUSE	reviewed	Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)	Cope Cope1	Mus musculus (Mouse)	308	"COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0005794; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030137; GO:0099612	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5397_c0_g1_i1	Q29AE5	COPG_DROPS	69.4	121	37	0	78	440	1	121	1.20E-42	174.1	COPG_DROPS	reviewed	Coatomer subunit gamma (Gamma-coat protein) (Gamma-COP)	gammaCop GA13624	Drosophila pseudoobscura pseudoobscura (Fruit fly)	878	COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005783; GO:0006886; GO:0016192; GO:0030126	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN28026_c0_g1_i1	P53620	COPG1_BOVIN	100	100	0	0	35	334	1	100	1.60E-52	206.5	COPG1_BOVIN	reviewed	Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP)	COPG1 COPG	Bos taurus (Bovine)	874	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0030126	"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN485_c0_g1_i2	Q8VEH6	CBWD1_MOUSE	51.8	367	164	3	1177	110	12	376	6.90E-107	389	CBWD1_MOUSE	reviewed	COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1)	Cbwd1	Mus musculus (Mouse)	393	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN485_c0_g1_i4	Q99MB4	CBWD1_RAT	46.9	271	141	2	919	110	109	377	8.50E-70	265.4	CBWD1_RAT	reviewed	COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1)	Cbwd1	Rattus norvegicus (Rat)	394	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN485_c0_g1_i6	Q8VEH6	CBWD1_MOUSE	51.8	367	164	3	1177	110	12	376	1.50E-106	389	CBWD1_MOUSE	reviewed	COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1)	Cbwd1	Mus musculus (Mouse)	393	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN8834_c0_g1_i1	Q9BRT8	CBWD1_HUMAN	100	94	0	0	3	284	20	113	2.20E-47	189.5	CBWD1_HUMAN	reviewed	COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1) (COBP) (NPC-A-6 COBW domain-containing protein 1) (NPC-A-6)	CBWD1	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN485_c0_g1_i1	Q8IUF1	CBWD2_HUMAN	67	97	28	1	380	90	21	113	3.40E-30	132.9	CBWD2_HUMAN	reviewed	COBW domain-containing protein 2 (Cobalamin synthase W domain-containing protein 2)	CBWD2	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			yellow	yellow	NA	NA	NA	NA
TRINITY_DN8834_c0_g1_i2	Q8IUF1	CBWD2_HUMAN	99.6	232	1	0	3	698	20	251	2.40E-127	456.1	CBWD2_HUMAN	reviewed	COBW domain-containing protein 2 (Cobalamin synthase W domain-containing protein 2)	CBWD2	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN35341_c0_g1_i1	Q8IUF1	CBWD2_HUMAN	53.3	75	35	0	228	4	94	168	5.70E-17	87.8	CBWD2_HUMAN	reviewed	COBW domain-containing protein 2 (Cobalamin synthase W domain-containing protein 2)	CBWD2	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN38800_c0_g1_i1	Q23280	DAF41_CAEEL	39.1	69	42	0	300	94	41	109	2.20E-08	59.7	DAF41_CAEEL	reviewed	Co-chaperone protein daf-41 (Abnormal dauer formation protein daf-41) (p23/cytosolic prostaglandin E synthase 3 homolog)	daf-41 p23 ZC395.10	Caenorhabditis elegans	175	cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0030016; GO:0051087; GO:0051131; GO:0051879	chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN29626_c0_g1_i1	A9M033	HSCB_NEIM0	31.1	161	107	2	347	817	4	164	2.00E-12	74.7	HSCB_NEIM0	reviewed	Co-chaperone protein HscB homolog	hscB NMCC_1297	Neisseria meningitidis serogroup C (strain 053442)	166	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; protein complex oligomerization [GO:0051259]; protein folding [GO:0006457]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]	GO:0001671; GO:0006457; GO:0051087; GO:0051259; GO:0097428	protein complex oligomerization [GO:0051259]; protein folding [GO:0006457]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN2603_c0_g1_i3	Q96MF6	CQ10A_HUMAN	57.1	42	18	0	173	48	90	131	2.30E-07	55.8	CQ10A_HUMAN	reviewed	"Coenzyme Q-binding protein COQ10 homolog A, mitochondrial"	COQ10A UNQ6192/PRO20219	Homo sapiens (Human)	247	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN17748_c0_g1_i1	Q3THF9	CQ10B_MOUSE	100	84	0	0	1	252	146	229	1.90E-45	182.6	CQ10B_MOUSE	reviewed	"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial"	Coq10b	Mus musculus (Mouse)	240	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN2603_c0_g1_i1	Q3THF9	CQ10B_MOUSE	63	162	60	0	604	119	69	230	2.20E-55	217.2	CQ10B_MOUSE	reviewed	"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial"	Coq10b	Mus musculus (Mouse)	240	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN2603_c0_g1_i2	Q3THF9	CQ10B_MOUSE	63	162	60	0	604	119	69	230	2.20E-55	217.2	CQ10B_MOUSE	reviewed	"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial"	Coq10b	Mus musculus (Mouse)	240	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN2603_c0_g1_i4	Q3THF9	CQ10B_MOUSE	63	162	60	0	604	119	69	230	2.30E-55	217.2	CQ10B_MOUSE	reviewed	"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial"	Coq10b	Mus musculus (Mouse)	240	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN38021_c0_g1_i1	Q3THF9	CQ10B_MOUSE	100	86	0	0	3	260	58	143	1.10E-45	183.3	CQ10B_MOUSE	reviewed	"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial"	Coq10b	Mus musculus (Mouse)	240	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN21438_c0_g1_i1	P45594	CADF_DROME	60.5	114	44	1	19	357	1	114	1.00E-33	144.1	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN21438_c1_g1_i1	P45594	CADF_DROME	50	72	36	0	225	10	1	72	5.90E-14	77.8	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN39170_c0_g1_i1	P45594	CADF_DROME	63.2	106	38	1	3	317	41	146	5.60E-31	134.8	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN35889_c0_g1_i1	P45594	CADF_DROME	58.2	122	50	1	363	1	15	136	4.80E-37	155.2	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c3_g1_i1	P45594	CADF_DROME	61.7	120	45	1	358	2	27	146	2.50E-35	149.4	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c2_g1_i1	P45594	CADF_DROME	58.9	90	36	1	3	269	26	115	7.80E-26	117.5	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i1	P45594	CADF_DROME	73.9	88	22	1	317	57	60	147	2.20E-30	132.9	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i2	P45594	CADF_DROME	68.4	79	24	1	240	7	63	141	9.60E-23	107.1	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i3	P45594	CADF_DROME	76.5	68	15	1	350	150	60	127	2.20E-23	109.8	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		blue	blue	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i4	P45594	CADF_DROME	73.8	84	21	1	448	200	60	143	3.70E-28	125.9	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		blue	blue	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i5	P45594	CADF_DROME	66.3	95	31	1	283	2	49	143	4.70E-29	128.3	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i6	P45594	CADF_DROME	76.3	59	13	1	177	4	60	118	5.60E-20	97.4	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c0_g1_i7	P45594	CADF_DROME	71.6	88	24	1	317	57	60	147	4.10E-29	128.6	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14396_c0_g2_i1	P45594	CADF_DROME	50.7	67	33	0	203	3	1	67	5.50E-13	74.7	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN31644_c0_g1_i1	P45594	CADF_DROME	70	70	20	1	213	7	65	134	5.10E-20	97.8	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN29941_c0_g1_i1	P45594	CADF_DROME	64.6	99	34	1	1	294	45	143	3.70E-29	128.6	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN35487_c1_g1_i1	P45594	CADF_DROME	59.7	67	26	1	5	202	49	115	1.70E-17	89.4	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN24778_c0_g1_i1	P45594	CADF_DROME	60.2	118	46	1	22	372	17	134	2.60E-35	149.4	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN24778_c0_g1_i2	P45594	CADF_DROME	61.5	96	36	1	3	287	39	134	4.10E-28	125.2	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN24778_c1_g1_i1	P45594	CADF_DROME	62.8	94	34	1	1	279	22	115	1.60E-29	129.8	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN23304_c0_g1_i1	P45594	CADF_DROME	61.5	52	19	1	155	3	44	95	1.10E-13	77	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN23304_c0_g1_i3	P45594	CADF_DROME	57.9	95	39	1	284	3	1	95	1.00E-27	124	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN29730_c2_g1_i1	P45594	CADF_DROME	62.6	147	54	1	724	287	1	147	5.40E-46	186	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		blue	blue	NA	NA	NA	NA
TRINITY_DN35423_c3_g1_i1	P45594	CADF_DROME	66.7	147	48	1	826	389	1	147	4.60E-51	203	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		blue	blue	NA	NA	NA	NA
TRINITY_DN35423_c3_g1_i1	P45594	CADF_DROME	77.6	85	18	1	2	253	63	147	5.30E-31	136.3	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		blue	blue	NA	NA	NA	NA
TRINITY_DN35423_c4_g1_i1	P45594	CADF_DROME	64.7	85	29	1	334	83	44	128	4.40E-26	118.6	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN20459_c0_g1_i1	P45594	CADF_DROME	58.5	41	17	0	191	69	44	84	2.40E-09	62.8	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN20459_c0_g1_i2	P45594	CADF_DROME	61.1	54	20	1	161	3	44	97	3.10E-13	75.5	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN18664_c1_g1_i1	P45594	CADF_DROME	60.9	69	26	1	2	205	31	99	3.70E-20	98.2	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN18738_c0_g1_i1	P45594	CADF_DROME	58.1	74	30	1	220	2	27	100	2.80E-21	102.1	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN28068_c0_g1_i1	P45594	CADF_DROME	60.4	101	39	1	11	310	15	115	3.90E-29	128.6	CADF_DROME	reviewed	Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)	tsr Cadf CG4254	Drosophila melanogaster (Fruit fly)	148	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0030864; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN40674_c0_g1_i1	P23528	COF1_HUMAN	100	75	0	0	2	226	69	143	4.90E-37	154.5	COF1_HUMAN	reviewed	"Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)"	CFL1 CFL	Homo sapiens (Human)	166	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; establishment of cell polarity [GO:0030010]; interleukin-12-mediated signaling pathway [GO:0035722]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation by host of viral process [GO:0044794]; positive regulation of actin filament depolymerization [GO:0030836]; protein phosphorylation [GO:0006468]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to amino acid [GO:0043200]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]	actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]	GO:0000281; GO:0001755; GO:0001842; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0005925; GO:0006468; GO:0007010; GO:0007266; GO:0009615; GO:0015629; GO:0016020; GO:0016363; GO:0022604; GO:0030010; GO:0030027; GO:0030036; GO:0030042; GO:0030043; GO:0030836; GO:0030864; GO:0031258; GO:0031982; GO:0032587; GO:0035722; GO:0043066; GO:0043200; GO:0044794; GO:0048870; GO:0051014; GO:0051015; GO:0061001; GO:0070062	actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; establishment of cell polarity [GO:0030010]; interleukin-12-mediated signaling pathway [GO:0035722]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation by host of viral process [GO:0044794]; positive regulation of actin filament depolymerization [GO:0030836]; protein phosphorylation [GO:0006468]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to amino acid [GO:0043200]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN25948_c0_g1_i1	Q8WVM7	STAG1_HUMAN	100	83	0	0	1	249	854	936	8.90E-40	163.7	STAG1_HUMAN	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	STAG1 SA1 SCC3	Homo sapiens (Human)	1258	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0090307; GO:0097431	cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN20737_c0_g1_i1	Q8WVM7	STAG1_HUMAN	100	189	0	0	570	4	79	267	2.40E-104	379.4	STAG1_HUMAN	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	STAG1 SA1 SCC3	Homo sapiens (Human)	1258	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0090307; GO:0097431	cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN3313_c0_g1_i1	Q8WVM7	STAG1_HUMAN	52.9	1001	449	11	181	3150	86	1075	2.90E-293	1009.6	STAG1_HUMAN	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	STAG1 SA1 SCC3	Homo sapiens (Human)	1258	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0090307; GO:0097431	cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN3313_c0_g1_i2	Q8WVM7	STAG1_HUMAN	53.6	924	408	10	181	2919	86	999	6.80E-274	945.3	STAG1_HUMAN	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	STAG1 SA1 SCC3	Homo sapiens (Human)	1258	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0090307; GO:0097431	cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN3313_c0_g1_i2	Q8WVM7	STAG1_HUMAN	45.6	79	43	0	2915	3151	997	1075	7.80E-12	74.7	STAG1_HUMAN	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	STAG1 SA1 SCC3	Homo sapiens (Human)	1258	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0090307; GO:0097431	cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN38436_c0_g1_i1	Q8WVM7	STAG1_HUMAN	100	70	0	0	3	212	290	359	1.50E-35	149.4	STAG1_HUMAN	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	STAG1 SA1 SCC3	Homo sapiens (Human)	1258	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0090307; GO:0097431	cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN30330_c0_g1_i1	Q8N3U4	STAG2_HUMAN	100	91	0	0	273	1	843	933	5.00E-44	177.9	STAG2_HUMAN	reviewed	Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2)	STAG2 SA2	Homo sapiens (Human)	1231	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0051301; GO:0051321; GO:0090307; GO:0097431	cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN33384_c0_g1_i1	Q8N3U4	STAG2_HUMAN	96.1	77	3	0	1	231	437	513	1.70E-37	156	STAG2_HUMAN	reviewed	Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2)	STAG2 SA2	Homo sapiens (Human)	1231	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0051301; GO:0051321; GO:0090307; GO:0097431	cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN27434_c0_g1_i1	Q8N3U4	STAG2_HUMAN	100	192	0	0	3	578	246	437	5.80E-103	374.8	STAG2_HUMAN	reviewed	Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2)	STAG2 SA2	Homo sapiens (Human)	1231	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0051301; GO:0051321; GO:0090307; GO:0097431	cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN39472_c0_g1_i1	Q8K1A6	C2D1A_MOUSE	37.6	109	66	1	56	376	118	226	7.10E-09	61.6	C2D1A_MOUSE	reviewed	Coiled-coil and C2 domain-containing protein 1A (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1)	Cc2d1a	Mus musculus (Mouse)	943	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886	negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN5225_c1_g1_i1	Q8BRN9	C2D1B_MOUSE	51.4	72	35	0	28	243	376	447	1.30E-12	73.9	C2D1B_MOUSE	reviewed	Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2) (FRE under dual repression-binding protein 2) (Freud-2)	Cc2d1b Kiaa1836	Mus musculus (Mouse)	848	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0043231	negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN5225_c1_g1_i2	Q29M42	C2D1_DROPS	56.2	48	21	0	52	195	370	417	2.00E-08	60.1	C2D1_DROPS	reviewed	Coiled-coil and C2 domain-containing protein 1-like	GA18377	Drosophila pseudoobscura pseudoobscura (Fruit fly)	814	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]"		"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]"	GO:0001227			brown	brown	NA	NA	NA	NA
TRINITY_DN2340_c0_g1_i2	Q29M42	C2D1_DROPS	51.8	328	150	3	84	1067	492	811	9.90E-94	345.1	C2D1_DROPS	reviewed	Coiled-coil and C2 domain-containing protein 1-like	GA18377	Drosophila pseudoobscura pseudoobscura (Fruit fly)	814	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]"		"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]"	GO:0001227			NA	NA	NA	NA	NA	NA
TRINITY_DN2340_c0_g1_i3	Q29M42	C2D1_DROPS	52.2	205	91	2	84	698	492	689	4.70E-55	216.1	C2D1_DROPS	reviewed	Coiled-coil and C2 domain-containing protein 1-like	GA18377	Drosophila pseudoobscura pseudoobscura (Fruit fly)	814	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]"		"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]"	GO:0001227			NA	NA	NA	NA	NA	NA
TRINITY_DN7469_c0_g1_i1	Q9VKJ9	C2D1_DROME	45.8	59	32	0	77	253	500	558	5.20E-07	55.1	C2D1_DROME	reviewed	Coiled-coil and C2 domain-containing protein 1-like (Lethal giant disks protein)	l(2)gd1 lgd CG4713	Drosophila melanogaster (Fruit fly)	816	"cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phospholipid binding [GO:0005543]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472]"	cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phospholipid binding [GO:0005543]"	GO:0000122; GO:0000281; GO:0000981; GO:0001227; GO:0005543; GO:0005634; GO:0005737; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0016197; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592	compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN11002_c1_g1_i2	Q3TMW1	C102A_MOUSE	51.8	114	44	2	380	72	68	181	6.90E-23	108.2	C102A_MOUSE	reviewed	Coiled-coil domain-containing protein 102A	Ccdc102a	Mus musculus (Mouse)	549	myosin complex [GO:0016459]; motor activity [GO:0003774]	myosin complex [GO:0016459]	motor activity [GO:0003774]	GO:0003774; GO:0016459			NA	NA	NA	NA	NA	NA
TRINITY_DN11002_c1_g1_i3	Q3TMW1	C102A_MOUSE	42.8	159	71	2	519	43	68	206	7.10E-23	108.6	C102A_MOUSE	reviewed	Coiled-coil domain-containing protein 102A	Ccdc102a	Mus musculus (Mouse)	549	myosin complex [GO:0016459]; motor activity [GO:0003774]	myosin complex [GO:0016459]	motor activity [GO:0003774]	GO:0003774; GO:0016459			NA	NA	NA	NA	NA	NA
TRINITY_DN9599_c0_g1_i1	Q68D86	C102B_HUMAN	42.7	178	102	0	5	538	333	510	6.00E-27	122.5	C102B_HUMAN	reviewed	Coiled-coil domain-containing protein 102B	CCDC102B C18orf14	Homo sapiens (Human)	513							NA	NA	NA	NA	NA	NA
TRINITY_DN32880_c0_g1_i1	Q6DGB6	CC103_DANRE	32.5	209	126	7	118	732	7	204	3.90E-13	77	CC103_DANRE	reviewed	Coiled-coil domain-containing protein 103 (Protein schmalhans)	ccdc103 smh zgc:100838	Danio rerio (Zebrafish) (Brachydanio rerio)	247	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]		GO:0001947; GO:0003143; GO:0003146; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036159; GO:0070286	axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]		NA	NA	NA	NA	NA	NA
TRINITY_DN32880_c0_g1_i2	Q6DGB6	CC103_DANRE	32.5	209	126	7	90	704	7	204	4.90E-13	76.6	CC103_DANRE	reviewed	Coiled-coil domain-containing protein 103 (Protein schmalhans)	ccdc103 smh zgc:100838	Danio rerio (Zebrafish) (Brachydanio rerio)	247	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]		GO:0001947; GO:0003143; GO:0003146; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036159; GO:0070286	axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]		NA	NA	NA	NA	NA	NA
TRINITY_DN997_c0_g1_i1	Q8R344	CCD12_MOUSE	41.9	124	70	2	501	133	34	156	3.90E-13	76.3	CCD12_MOUSE	reviewed	Coiled-coil domain-containing protein 12	Ccdc12	Mus musculus (Mouse)	166	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]		GO:0005684; GO:0071014			NA	NA	NA	NA	NA	NA
TRINITY_DN36366_c0_g1_i1	Q96CT7	CC124_HUMAN	100	74	0	0	2	223	150	223	5.60E-34	144.4	CC124_HUMAN	reviewed	Coiled-coil domain-containing protein 124	CCDC124	Homo sapiens (Human)	223	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005815; GO:0005829; GO:0005886; GO:0007049; GO:0030496; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN5369_c0_g1_i1	Q28HN4	CC124_XENTR	46.5	213	100	5	71	679	1	209	2.10E-26	120.9	CC124_XENTR	reviewed	Coiled-coil domain-containing protein 124	ccdc124 TTpA004i15.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	217	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]		GO:0005737; GO:0005815; GO:0007049; GO:0030496; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		blue	blue	NA	NA	NA	NA
TRINITY_DN5369_c0_g1_i2	Q28HN4	CC124_XENTR	46.5	213	100	5	87	695	1	209	2.10E-26	120.9	CC124_XENTR	reviewed	Coiled-coil domain-containing protein 124	ccdc124 TTpA004i15.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	217	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]		GO:0005737; GO:0005815; GO:0007049; GO:0030496; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		blue	blue	NA	NA	NA	NA
TRINITY_DN22743_c0_g1_i1	Q5EA37	CC130_BOVIN	100	124	0	0	30	401	1	124	2.00E-73	276.2	CC130_BOVIN	reviewed	Coiled-coil domain-containing protein 130	CCDC130	Bos taurus (Bovine)	400	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; response to virus [GO:0009615]; RNA splicing [GO:0008380]	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]		GO:0005684; GO:0008380; GO:0009615; GO:0071014	response to virus [GO:0009615]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN22743_c0_g1_i2	Q5EA37	CC130_BOVIN	99.2	124	1	0	30	401	1	124	2.60E-73	275.8	CC130_BOVIN	reviewed	Coiled-coil domain-containing protein 130	CCDC130	Bos taurus (Bovine)	400	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; response to virus [GO:0009615]; RNA splicing [GO:0008380]	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]		GO:0005684; GO:0008380; GO:0009615; GO:0071014	response to virus [GO:0009615]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN2836_c0_g1_i1	Q7K0F0	CC130_DROME	62.3	247	88	2	88	816	1	246	3.80E-84	313.5	CC130_DROME	reviewed	Coiled-coil domain-containing protein 130 homolog	CG15084	Drosophila melanogaster (Fruit fly)	316	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; RNA splicing [GO:0008380]	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]		GO:0005684; GO:0008380; GO:0071014	RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN15978_c0_g3_i1	Q6PII3	CC174_HUMAN	33.9	274	158	8	834	46	13	274	2.30E-24	114.4	CC174_HUMAN	reviewed	Coiled-coil domain-containing protein 174	CCDC174 C3orf19	Homo sapiens (Human)	467	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4544_c0_g1_i1	O60826	CCD22_HUMAN	44.8	145	80	0	443	9	465	609	4.30E-29	129	CCD22_HUMAN	reviewed	Coiled-coil domain-containing protein 22	CCDC22 CXorf37 JM1	Homo sapiens (Human)	627	"cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; cullin family protein binding [GO:0097602]; cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-translational protein modification [GO:0043687]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; retrograde transport, endosome to plasma membrane [GO:1990126]"	cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]	cullin family protein binding [GO:0097602]	GO:0005654; GO:0005768; GO:0005829; GO:0006878; GO:0006893; GO:0007253; GO:0015031; GO:0016567; GO:0032456; GO:0043123; GO:0043124; GO:0043687; GO:0097602; GO:1990126; GO:2000060	"cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-translational protein modification [GO:0043687]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2155_c0_g1_i2	Q28G12	CCD22_XENTR	27.1	457	289	8	1327	68	1	450	6.20E-37	156.8	CCD22_XENTR	reviewed	Coiled-coil domain-containing protein 22	ccdc22 tgas103k19.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	632	cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031]		cullin family protein binding [GO:0097602]	GO:0015031; GO:0097602; GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2155_c0_g1_i4	Q4V909	CCD22_DANRE	46.6	148	77	1	639	202	1	148	2.30E-32	140.6	CCD22_DANRE	reviewed	Coiled-coil domain-containing protein 22	ccdc22 zgc:114058	Danio rerio (Zebrafish) (Brachydanio rerio)	639	cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031]		cullin family protein binding [GO:0097602]	GO:0015031; GO:0097602; GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2155_c0_g1_i1	A7RNG8	CCD22_NEMVE	26.2	485	318	5	1335	1	1	485	1.30E-39	165.6	CCD22_NEMVE	reviewed	Coiled-coil domain-containing protein 22 homolog	v1g180167	Nematostella vectensis (Starlet sea anemone)	644	cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]		cullin family protein binding [GO:0097602]	GO:0097602; GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]		NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i1	Q6GLE1	CCD25_XENTR	43.1	137	77	1	518	108	2	137	2.00E-25	117.5	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i10	Q78PG9	CCD25_MOUSE	44.6	121	67	0	476	114	17	137	2.20E-23	110.2	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i12	Q7T312	CCD25_DANRE	44.5	137	76	0	518	108	2	138	3.90E-26	119.8	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i13	Q7T312	CCD25_DANRE	43.1	137	78	0	476	66	2	138	3.10E-25	116.7	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i14	Q6GLE1	CCD25_XENTR	43.1	137	77	1	518	108	2	137	1.50E-25	117.9	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i16	Q7T312	CCD25_DANRE	42.3	137	79	0	518	108	2	138	4.70E-25	115.9	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i18	Q78PG9	CCD25_MOUSE	50.6	83	41	0	251	3	40	122	7.60E-16	84.3	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i2	Q78PG9	CCD25_MOUSE	44.6	121	67	0	476	114	17	137	1.30E-23	110.9	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i20	Q78PG9	CCD25_MOUSE	40	140	80	1	434	27	17	156	1.70E-22	107.1	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i21	Q78PG9	CCD25_MOUSE	56.9	65	28	0	201	7	40	104	8.30E-13	73.9	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i22	Q7T312	CCD25_DANRE	44.5	137	76	0	518	108	2	138	3.30E-26	119.8	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i25	Q7T312	CCD25_DANRE	41.6	137	80	0	449	39	2	138	1.60E-24	114.4	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i26	Q6GLE1	CCD25_XENTR	42.3	137	78	1	518	108	2	137	2.80E-25	116.7	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i3	Q6GLE1	CCD25_XENTR	49.5	99	50	0	299	3	2	100	1.60E-20	100.1	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i4	Q7T312	CCD25_DANRE	44.5	137	76	0	518	108	2	138	4.10E-26	119.8	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i6	Q78PG9	CCD25_MOUSE	49.4	85	43	0	255	1	40	124	1.20E-16	87	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN2567_c0_g1_i9	Q78PG9	CCD25_MOUSE	40.4	109	61	1	317	3	47	155	7.40E-15	81.3	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN13121_c0_g1_i1	Q7T312	CCD25_DANRE	68.4	209	64	1	80	706	1	207	5.40E-59	229.2	CCD25_DANRE	reviewed	Coiled-coil domain-containing protein 25	ccdc25 zgc:64173	Danio rerio (Zebrafish) (Brachydanio rerio)	207							blue	blue	NA	NA	NA	NA
TRINITY_DN37217_c0_g1_i1	Q86WR0	CCD25_HUMAN	100	100	0	0	301	2	59	158	6.00E-51	201.1	CCD25_HUMAN	reviewed	Coiled-coil domain-containing protein 25	CCDC25	Homo sapiens (Human)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN15961_c2_g1_i1	Q78PG9	CCD25_MOUSE	43.1	72	40	1	217	5	1	72	4.30E-09	62	CCD25_MOUSE	reviewed	Coiled-coil domain-containing protein 25	Ccdc25	Mus musculus (Mouse)	208							NA	NA	NA	NA	NA	NA
TRINITY_DN15961_c0_g1_i1	Q6GLE1	CCD25_XENTR	45.8	59	32	0	226	50	23	81	1.10E-07	57	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN15961_c0_g2_i1	Q6GLE1	CCD25_XENTR	43.7	71	40	0	215	3	1	71	1.80E-11	70.1	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN15961_c0_g2_i2	Q6GLE1	CCD25_XENTR	45.7	70	38	0	212	3	2	71	1.50E-12	73.2	CCD25_XENTR	reviewed	Coiled-coil domain-containing protein 25	ccdc25	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN11676_c0_g1_i1	Q55D55	CCD25_DICDI	53.3	60	27	1	9	185	1	60	3.10E-12	72	CCD25_DICDI	reviewed	Coiled-coil domain-containing protein 25 homolog	ccdc25 DDB_G0269786	Dictyostelium discoideum (Slime mold)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN11676_c0_g2_i1	Q55D55	CCD25_DICDI	47.6	63	33	0	190	2	60	122	1.80E-11	69.3	CCD25_DICDI	reviewed	Coiled-coil domain-containing protein 25 homolog	ccdc25 DDB_G0269786	Dictyostelium discoideum (Slime mold)	206							NA	NA	NA	NA	NA	NA
TRINITY_DN3442_c0_g1_i1	Q6AZI2	CCD47_XENLA	48.9	319	155	6	117	1055	119	435	7.50E-88	325.5	CCD47_XENLA	reviewed	Coiled-coil domain-containing protein 47	ccdc47	Xenopus laevis (African clawed frog)	489	integral component of membrane [GO:0016021]; rough endoplasmic reticulum membrane [GO:0030867]	integral component of membrane [GO:0016021]; rough endoplasmic reticulum membrane [GO:0030867]		GO:0016021; GO:0030867			NA	NA	NA	NA	NA	NA
TRINITY_DN20843_c0_g1_i1	Q9D024	CCD47_MOUSE	100	92	0	0	2	277	203	294	9.80E-48	190.3	CCD47_MOUSE	reviewed	Coiled-coil domain-containing protein 47 (Adipocyte-specific protein 4) (Calumin)	Ccdc47 Asp4	Mus musculus (Mouse)	483	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; calcium ion binding [GO:0005509]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005783; GO:0005791; GO:0006983; GO:0007029; GO:0009791; GO:0016021; GO:0030433; GO:0030867; GO:0032469; GO:0036503; GO:0055074	calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN20843_c0_g1_i2	Q96A33	CCD47_HUMAN	100	92	0	0	2	277	203	294	9.80E-48	190.3	CCD47_HUMAN	reviewed	Coiled-coil domain-containing protein 47 (Calumin)	CCDC47 GK001 MSTP041 PSEC0077	Homo sapiens (Human)	483	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum membrane [GO:0030867]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; osteoblast differentiation [GO:0001649]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum membrane [GO:0030867]	calcium ion binding [GO:0005509]; RNA binding [GO:0003723]	GO:0001649; GO:0003723; GO:0005509; GO:0005783; GO:0006983; GO:0007029; GO:0009791; GO:0016020; GO:0016021; GO:0030433; GO:0030867; GO:0032469; GO:0036503	endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; ER overload response [GO:0006983]; osteoblast differentiation [GO:0001649]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN23061_c0_g1_i1	Q16204	CCDC6_HUMAN	45.6	169	91	1	506	3	126	294	1.40E-23	110.9	CCDC6_HUMAN	reviewed	Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4)	CCDC6 D10S170 TST1	Homo sapiens (Human)	474	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]	identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802			NA	NA	NA	NA	NA	NA
TRINITY_DN23061_c0_g1_i2	Q16204	CCDC6_HUMAN	46.5	155	82	1	582	121	126	280	5.10E-22	105.9	CCDC6_HUMAN	reviewed	Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4)	CCDC6 D10S170 TST1	Homo sapiens (Human)	474	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]	identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802			NA	NA	NA	NA	NA	NA
TRINITY_DN13845_c0_g1_i1	Q9CZH8	CCD77_MOUSE	24.8	206	146	2	2	619	247	443	9.70E-14	79	CCD77_MOUSE	reviewed	Coiled-coil domain-containing protein 77	Ccdc77	Mus musculus (Mouse)	489	centrosome [GO:0005813]	centrosome [GO:0005813]		GO:0005813			NA	NA	NA	NA	NA	NA
TRINITY_DN36968_c0_g1_i1	Q15834	CC85B_HUMAN	100	66	0	0	200	3	57	122	6.10E-31	134	CC85B_HUMAN	reviewed	Coiled-coil domain-containing protein 85B (Hepatitis delta antigen-interacting protein A) (Delta-interacting protein A)	CCDC85B DIPA	Homo sapiens (Human)	202	"adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; delta-catenin binding [GO:0070097]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; viral process [GO:0016032]"	adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	delta-catenin binding [GO:0070097]	GO:0005634; GO:0005737; GO:0005813; GO:0005912; GO:0016032; GO:0030154; GO:0030308; GO:0045599; GO:0045892; GO:0070097	"cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN41010_c0_g1_i1	Q0V989	CC85C_XENTR	74.1	81	21	0	243	1	73	153	5.80E-28	124.4	CC85C_XENTR	reviewed	Coiled-coil domain-containing protein 85C	ccdc85c	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	391	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; multicellular organism development [GO:0007275]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]		GO:0005912; GO:0005923; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN6784_c0_g1_i2	Q6GQI5	CCD93_XENLA	63.6	187	68	0	164	724	9	195	2.60E-63	243.4	CCD93_XENLA	reviewed	Coiled-coil domain-containing protein 93	ccdc93	Xenopus laevis (African clawed frog)	609	early endosome [GO:0005769]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6784_c0_g1_i3	Q6GQI5	CCD93_XENLA	63.6	187	68	0	161	721	9	195	2.60E-63	243.4	CCD93_XENLA	reviewed	Coiled-coil domain-containing protein 93	ccdc93	Xenopus laevis (African clawed frog)	609	early endosome [GO:0005769]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6784_c0_g1_i4	Q6GQI5	CCD93_XENLA	83.3	108	18	0	164	487	9	116	4.10E-47	189.1	CCD93_XENLA	reviewed	Coiled-coil domain-containing protein 93	ccdc93	Xenopus laevis (African clawed frog)	609	early endosome [GO:0005769]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i1	Q5ZKI4	CCD93_CHICK	43.3	231	129	1	5	691	384	614	1.60E-41	171	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i11	Q5ZKI4	CCD93_CHICK	36.5	389	237	5	3	1148	229	614	2.80E-46	187.6	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i18	Q5ZKI4	CCD93_CHICK	36.5	389	237	5	3	1148	229	614	3.70E-46	187.2	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i2	Q5ZKI4	CCD93_CHICK	36.5	389	237	5	3	1148	229	614	3.80E-46	187.2	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i4	Q5ZKI4	CCD93_CHICK	43.3	231	129	1	5	691	384	614	1.30E-41	171.4	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i7	Q5ZKI4	CCD93_CHICK	36.2	392	234	5	3	1148	229	614	2.90E-46	187.6	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4008_c0_g1_i8	Q5ZKI4	CCD93_CHICK	36.5	389	237	5	3	1148	229	614	3.80E-46	187.2	CCD93_CHICK	reviewed	Coiled-coil domain-containing protein 93	CCDC93 RCJMB04_10i21	Gallus gallus (Chicken)	617	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]		GO:0005769; GO:0006893; GO:0015031	Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN33731_c0_g1_i1	Q567U6	CCD93_HUMAN	100	76	0	0	3	230	67	142	3.50E-38	158.3	CCD93_HUMAN	reviewed	Coiled-coil domain-containing protein 93	CCDC93	Homo sapiens (Human)	631	"early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]		GO:0005769; GO:0006893; GO:0015031; GO:0032456; GO:0043231; GO:1990126	"endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1682_c0_g1_i1	Q96F63	CCD97_HUMAN	50.5	275	120	2	844	68	66	340	3.20E-30	134	CCD97_HUMAN	reviewed	Coiled-coil domain-containing protein 97	CCDC97	Homo sapiens (Human)	343							NA	NA	NA	NA	NA	NA
TRINITY_DN1682_c0_g1_i2	Q96F63	CCD97_HUMAN	45.5	132	70	1	751	362	66	197	7.30E-21	102.8	CCD97_HUMAN	reviewed	Coiled-coil domain-containing protein 97	CCDC97	Homo sapiens (Human)	343							NA	NA	NA	NA	NA	NA
TRINITY_DN1682_c0_g1_i3	Q96F63	CCD97_HUMAN	45.5	132	70	1	863	474	66	197	8.10E-21	102.8	CCD97_HUMAN	reviewed	Coiled-coil domain-containing protein 97	CCDC97	Homo sapiens (Human)	343							NA	NA	NA	NA	NA	NA
TRINITY_DN13741_c0_g1_i1	Q8BJM3	R3HCL_MOUSE	45.4	185	99	2	121	672	570	753	1.70E-41	171	R3HCL_MOUSE	reviewed	Coiled-coil domain-containing protein R3HCC1L (Growth inhibition and differentiation-related protein 88 homolog) (R3H and coiled-coil domain-containing protein 1-like)	R3hcc1l D19Ertd386e Gidrp88	Mus musculus (Mouse)	775	exon-exon junction complex [GO:0035145]	exon-exon junction complex [GO:0035145]		GO:0035145			NA	NA	NA	NA	NA	NA
TRINITY_DN13741_c0_g1_i2	Q8BJM3	R3HCL_MOUSE	48.3	201	102	2	121	720	570	769	4.50E-48	193	R3HCL_MOUSE	reviewed	Coiled-coil domain-containing protein R3HCC1L (Growth inhibition and differentiation-related protein 88 homolog) (R3H and coiled-coil domain-containing protein 1-like)	R3hcc1l D19Ertd386e Gidrp88	Mus musculus (Mouse)	775	exon-exon junction complex [GO:0035145]	exon-exon junction complex [GO:0035145]		GO:0035145			NA	NA	NA	NA	NA	NA
TRINITY_DN1251_c0_g1_i1	Q9VVA0	Y9705_DROME	56.2	130	53	1	502	113	7	132	2.30E-35	150.2	Y9705_DROME	reviewed	Cold shock domain-containing protein CG9705	CG9705	Drosophila melanogaster (Fruit fly)	143	cytoplasm [GO:0005737]; mRNA 3'-UTR binding [GO:0003730]; dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]	cytoplasm [GO:0005737]	mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0005737; GO:0043488; GO:0048813	dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]		NA	NA	NA	NA	NA	NA
TRINITY_DN1251_c0_g1_i2	Q9VVA0	Y9705_DROME	65.5	110	37	1	442	113	24	132	3.60E-35	149.4	Y9705_DROME	reviewed	Cold shock domain-containing protein CG9705	CG9705	Drosophila melanogaster (Fruit fly)	143	cytoplasm [GO:0005737]; mRNA 3'-UTR binding [GO:0003730]; dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]	cytoplasm [GO:0005737]	mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0005737; GO:0043488; GO:0048813	dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]		NA	NA	NA	NA	NA	NA
TRINITY_DN1251_c0_g1_i4	Q9VVA0	Y9705_DROME	65.5	110	37	1	442	113	24	132	2.90E-35	149.8	Y9705_DROME	reviewed	Cold shock domain-containing protein CG9705	CG9705	Drosophila melanogaster (Fruit fly)	143	cytoplasm [GO:0005737]; mRNA 3'-UTR binding [GO:0003730]; dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]	cytoplasm [GO:0005737]	mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0005737; GO:0043488; GO:0048813	dendrite morphogenesis [GO:0048813]; regulation of mRNA stability [GO:0043488]		blue	blue	NA	NA	NA	NA
TRINITY_DN1738_c1_g1_i1	Q6P4Z2	CO2A1_XENTR	39.5	276	151	3	52	849	1222	1491	2.60E-57	223.8	CO2A1_XENTR	reviewed	Collagen alpha-1(II) chain (Alpha-1 type II collagen)	col2a1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1492	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; notochord development [GO:0030903]; skeletal system development [GO:0001501]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]	GO:0001501; GO:0005201; GO:0005581; GO:0005615; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0046872	collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; notochord development [GO:0030903]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN10577_c0_g1_i2	Q9JI03	CO5A1_RAT	43.3	245	126	5	784	71	1600	1838	1.10E-53	211.8	CO5A1_RAT	reviewed	Collagen alpha-1(V) chain	Col5a1	Rattus norvegicus (Rat)	1840	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]"	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; collagen type V trimer [GO:0005588]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]	GO:0001568; GO:0003007; GO:0005201; GO:0005581; GO:0005588; GO:0005604; GO:0005615; GO:0007155; GO:0008201; GO:0016477; GO:0030198; GO:0030199; GO:0031012; GO:0032964; GO:0035313; GO:0035989; GO:0043394; GO:0043588; GO:0045112; GO:0048407; GO:0048592; GO:0051128; GO:0062023; GO:0097435; GO:1903225	"blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10577_c0_g1_i3	Q9JI03	CO5A1_RAT	43.3	245	126	5	784	71	1600	1838	1.30E-53	211.5	CO5A1_RAT	reviewed	Collagen alpha-1(V) chain	Col5a1	Rattus norvegicus (Rat)	1840	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]"	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; collagen type V trimer [GO:0005588]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]	GO:0001568; GO:0003007; GO:0005201; GO:0005581; GO:0005588; GO:0005604; GO:0005615; GO:0007155; GO:0008201; GO:0016477; GO:0030198; GO:0030199; GO:0031012; GO:0032964; GO:0035313; GO:0035989; GO:0043394; GO:0043588; GO:0045112; GO:0048407; GO:0048592; GO:0051128; GO:0062023; GO:0097435; GO:1903225	"blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27508_c0_g1_i1	Q61245	COBA1_MOUSE	43.8	89	49	1	266	3	94	182	2.30E-17	89.4	COBA1_MOUSE	reviewed	Collagen alpha-1(XI) chain	Col11a1	Mus musculus (Mouse)	1804	collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]	GO:0001502; GO:0001503; GO:0002063; GO:0003007; GO:0005201; GO:0005581; GO:0005592; GO:0005615; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0048705; GO:0050910; GO:0051216; GO:0055010; GO:0062023; GO:1904399	cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN31837_c0_g1_i1	P39059	COFA1_HUMAN	38.1	155	88	3	103	564	1138	1285	3.80E-22	106.3	COFA1_HUMAN	reviewed	Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)]	COL15A1	Homo sapiens (Human)	1388	collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; collagen type XV trimer [GO:0005582]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005582; GO:0005615; GO:0005788; GO:0007155; GO:0007165; GO:0016021; GO:0030020; GO:0030198; GO:0030574; GO:0031012; GO:0062023; GO:0070062	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31392_c0_g1_i1	P39059	COFA1_HUMAN	44	75	42	0	2	226	1314	1388	1.90E-13	76.6	COFA1_HUMAN	reviewed	Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)]	COL15A1	Homo sapiens (Human)	1388	collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; collagen type XV trimer [GO:0005582]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005582; GO:0005615; GO:0005788; GO:0007155; GO:0007165; GO:0016021; GO:0030020; GO:0030198; GO:0030574; GO:0031012; GO:0062023; GO:0070062	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN25622_c0_g1_i1	O35206	COFA1_MOUSE	50.5	99	48	1	5	298	1269	1367	7.40E-20	99	COFA1_MOUSE	reviewed	Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV)]	Col15a1	Mus musculus (Mouse)	1367	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]	GO:0001525; GO:0001886; GO:0005201; GO:0005581; GO:0005604; GO:0005615; GO:0007155; GO:0030198; GO:0031012; GO:0062023	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN33260_c0_g1_i1	P27393	CO4A2_ASCSU	82.6	144	25	0	433	2	1576	1719	7.50E-72	271.2	CO4A2_ASCSU	reviewed	Collagen alpha-2(IV) chain		Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	1763	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005581; GO:0005604			NA	NA	NA	NA	NA	NA
TRINITY_DN33260_c0_g1_i2	P27393	CO4A2_ASCSU	77.9	190	42	0	571	2	1530	1719	3.50E-91	335.9	CO4A2_ASCSU	reviewed	Collagen alpha-2(IV) chain		Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	1763	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005581; GO:0005604			NA	NA	NA	NA	NA	NA
TRINITY_DN33574_c0_g1_i1	Q32S24	COBA2_BOVIN	35.6	59	38	0	3	179	163	221	2.60E-07	57	COBA2_BOVIN	reviewed	Collagen alpha-2(XI) chain	COL11A2	Bos taurus (Bovine)	1736	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]	GO:0005201; GO:0005576; GO:0005581; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27431_c0_g1_i1	P29400	CO4A5_HUMAN	64.9	191	67	0	673	101	1494	1684	9.70E-81	301.2	CO4A5_HUMAN	reviewed	Collagen alpha-5(IV) chain	COL4A5	Homo sapiens (Human)	1685	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen type IV trimer [GO:0005587]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0031594; GO:0038063; GO:0062023	collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]		NA	NA	NA	NA	NA	NA
TRINITY_DN27431_c0_g1_i2	P29400	CO4A5_HUMAN	70.4	108	32	0	390	67	1494	1601	1.00E-45	184.1	CO4A5_HUMAN	reviewed	Collagen alpha-5(IV) chain	COL4A5	Homo sapiens (Human)	1685	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen type IV trimer [GO:0005587]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0031594; GO:0038063; GO:0062023	collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]		NA	NA	NA	NA	NA	NA
TRINITY_DN40223_c0_g1_i1	A8WGB1	CCBE1_DANRE	48	50	26	0	59	208	76	125	6.10E-11	67.8	CCBE1_DANRE	reviewed	Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein)	ccbe1 fof	Danio rerio (Zebrafish) (Brachydanio rerio)	401	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; blood vessel morphogenesis [GO:0048514]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor signaling pathway [GO:0038084]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell migration involved in lymph vessel development [GO:0060855]	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0001945; GO:0001946; GO:0002040; GO:0005509; GO:0005576; GO:0005581; GO:0038084; GO:0048514; GO:0048845; GO:0060855	blood vessel morphogenesis [GO:0048514]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor signaling pathway [GO:0038084]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell migration involved in lymph vessel development [GO:0060855]		NA	NA	NA	NA	NA	NA
TRINITY_DN26522_c0_g1_i1	P23508	CRCM_HUMAN	46.4	69	35	1	227	21	57	123	2.90E-05	48.9	CRCM_HUMAN	reviewed	Colorectal mutant cancer protein (Protein MCC)	MCC	Homo sapiens (Human)	829	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090	establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN29361_c0_g1_i1	P23508	CRCM_HUMAN	47.6	84	43	1	252	1	376	458	1.50E-15	83.2	CRCM_HUMAN	reviewed	Colorectal mutant cancer protein (Protein MCC)	MCC	Homo sapiens (Human)	829	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090	establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN19382_c0_g1_i1	Q9H0A8	COMD4_HUMAN	41.2	148	69	2	3	413	20	160	3.50E-17	89.4	COMD4_HUMAN	reviewed	COMM domain-containing protein 4	COMMD4	Homo sapiens (Human)	199	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN2909_c0_g1_i1	Q86IW8	COMD5_DICDI	31.7	139	91	2	496	80	67	201	4.50E-12	74.3	COMD5_DICDI	reviewed	COMM domain-containing protein 5	commd5 DDB_G0274791	Dictyostelium discoideum (Slime mold)	205							NA	NA	NA	NA	NA	NA
TRINITY_DN2909_c0_g1_i2	Q86IW8	COMD5_DICDI	31.7	139	91	2	1089	1505	67	201	4.50E-12	74.3	COMD5_DICDI	reviewed	COMM domain-containing protein 5	commd5 DDB_G0274791	Dictyostelium discoideum (Slime mold)	205							NA	NA	NA	NA	NA	NA
TRINITY_DN2909_c0_g1_i4	Q86IW8	COMD5_DICDI	31.7	139	91	2	1062	1478	67	201	4.40E-12	74.3	COMD5_DICDI	reviewed	COMM domain-containing protein 5	commd5 DDB_G0274791	Dictyostelium discoideum (Slime mold)	205							NA	NA	NA	NA	NA	NA
TRINITY_DN2909_c0_g1_i5	Q86IW8	COMD5_DICDI	31.7	139	91	2	496	80	67	201	4.50E-12	74.3	COMD5_DICDI	reviewed	COMM domain-containing protein 5	commd5 DDB_G0274791	Dictyostelium discoideum (Slime mold)	205							NA	NA	NA	NA	NA	NA
TRINITY_DN6986_c0_g1_i11	P0C0L5	CO4B_HUMAN	22.4	876	545	34	2549	147	781	1596	1.10E-26	124.4	CO4B_HUMAN	reviewed	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B CO4 CPAMD3; C4B_2	Homo sapiens (Human)	1744	"axon [GO:0030424]; blood microparticle [GO:0072562]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; other organism cell [GO:0044216]; plasma membrane [GO:0005886]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; complement binding [GO:0001848]; endopeptidase inhibitor activity [GO:0004866]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; detection of molecule of bacterial origin [GO:0032490]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; opsonization [GO:0008228]; positive regulation of apoptotic cell clearance [GO:2000427]; regulation of complement activation [GO:0030449]"	axon [GO:0030424]; blood microparticle [GO:0072562]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; other organism cell [GO:0044216]; plasma membrane [GO:0005886]; synapse [GO:0045202]	carbohydrate binding [GO:0030246]; complement binding [GO:0001848]; endopeptidase inhibitor activity [GO:0004866]	GO:0001848; GO:0004866; GO:0005576; GO:0005615; GO:0005886; GO:0006954; GO:0006956; GO:0006958; GO:0008228; GO:0030246; GO:0030424; GO:0030425; GO:0030449; GO:0032490; GO:0044216; GO:0045087; GO:0045202; GO:0070062; GO:0072562; GO:2000427	"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; detection of molecule of bacterial origin [GO:0032490]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; opsonization [GO:0008228]; positive regulation of apoptotic cell clearance [GO:2000427]; regulation of complement activation [GO:0030449]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36282_c0_g1_i1	Q9H845	ACAD9_HUMAN	100	104	0	0	1	312	74	177	1.70E-51	203	ACAD9_HUMAN	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	621	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN37724_c0_g1_i1	Q9H845	ACAD9_HUMAN	58.2	67	26	1	198	4	148	214	5.40E-15	81.3	ACAD9_HUMAN	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	621	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN1471_c0_g1_i12	Q9H845	ACAD9_HUMAN	23.2	207	152	5	851	246	88	292	1.30E-06	55.5	ACAD9_HUMAN	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	621	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN1471_c0_g1_i13	Q9H845	ACAD9_HUMAN	22.8	215	159	5	665	36	88	300	2.10E-07	57.8	ACAD9_HUMAN	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	621	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN7001_c0_g1_i2	Q9H845	ACAD9_HUMAN	55.7	122	52	2	456	94	31	151	9.00E-29	128.6	ACAD9_HUMAN	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	621	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	1	NA	NA	NA
TRINITY_DN7001_c0_g1_i1	B1WC61	ACAD9_RAT	57.9	587	237	6	1847	99	43	623	1.80E-178	627.5	ACAD9_RAT	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	Acad9	Rattus norvegicus (Rat)	625	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN36783_c0_g1_i1	Q8JZN5	ACAD9_MOUSE	98.8	80	1	0	242	3	104	183	8.00E-38	157.1	ACAD9_MOUSE	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	Acad9	Mus musculus (Mouse)	625	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN28077_c0_g1_i1	Q9H845	ACAD9_HUMAN	100	98	0	0	295	2	359	456	7.80E-51	200.7	ACAD9_HUMAN	reviewed	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	621	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN4520_c0_g1_i1	Q9NPL8	TIDC1_HUMAN	25.8	233	146	6	766	89	53	265	1.30E-12	75.5	TIDC1_HUMAN	reviewed	"Complex I assembly factor TIMMDC1, mitochondrial (Protein M5-14) (Translocase of inner mitochondrial membrane domain-containing protein 1) (TIMM domain containing-protein 1)"	TIMMDC1 C3orf1 UNQ247/PRO284	Homo sapiens (Human)	285	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005739; GO:0005743; GO:0016021; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN25654_c0_g1_i1	Q9YHY6	CND1_XENLA	34.3	204	130	3	3	608	60	261	1.00E-28	128.3	CND1_XENLA	reviewed	Condensin complex subunit 1 (Chromosome assembly protein XCAP-D2) (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (Eg7) (Non-SMC condensin I complex subunit D2)	ncapd2 capd2 cnap1 eg7	Xenopus laevis (African clawed frog)	1364	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0051301	cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c3_g1_i2	Q15003	CND2_HUMAN	44.2	165	81	4	100	585	28	184	6.50E-25	115.5	CND2_HUMAN	reviewed	Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)	NCAPH BRRN BRRN1 CAPH KIAA0074	Homo sapiens (Human)	741	"condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]"	condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nucleoplasm [GO:0005654]	"chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]"	GO:0000796; GO:0000799; GO:0003682; GO:0005654; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0044547; GO:0051301; GO:0051309; GO:0072587	cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c3_g1_i4	Q15003	CND2_HUMAN	42.6	176	90	4	79	597	17	184	6.60E-25	115.5	CND2_HUMAN	reviewed	Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)	NCAPH BRRN BRRN1 CAPH KIAA0074	Homo sapiens (Human)	741	"condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]"	condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nucleoplasm [GO:0005654]	"chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]"	GO:0000796; GO:0000799; GO:0003682; GO:0005654; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0044547; GO:0051301; GO:0051309; GO:0072587	cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN9320_c0_g1_i1	Q8C156	CND2_MOUSE	35.2	244	121	7	865	209	499	730	6.70E-26	119.4	CND2_MOUSE	reviewed	Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (mCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)	Ncaph Brrn Brrn1 Caph	Mus musculus (Mouse)	731	"chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]"	chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]"	GO:0000796; GO:0000799; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007076; GO:0007143; GO:0010032; GO:0044547; GO:0045132; GO:0051301; GO:0051309; GO:0072587	cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2473_c0_g1_i1	P42695	CNDD3_HUMAN	30.2	1184	707	17	3479	51	22	1127	2.40E-146	521.5	CNDD3_HUMAN	reviewed	Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3)	NCAPD3 CAPD3 KIAA0056	Homo sapiens (Human)	1498	"condensed chromosome, centromeric region [GO:0000779]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; chromosome separation [GO:0051304]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]"	"condensed chromosome, centromeric region [GO:0000779]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]	GO:0000779; GO:0000799; GO:0003682; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0031618; GO:0035064; GO:0042393; GO:0051301; GO:0051304	cell division [GO:0051301]; chromosome separation [GO:0051304]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2473_c0_g1_i2	P42695	CNDD3_HUMAN	30.4	1282	768	20	3714	1	22	1223	1.20E-159	565.8	CNDD3_HUMAN	reviewed	Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3)	NCAPD3 CAPD3 KIAA0056	Homo sapiens (Human)	1498	"condensed chromosome, centromeric region [GO:0000779]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; chromosome separation [GO:0051304]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]"	"condensed chromosome, centromeric region [GO:0000779]; membrane [GO:0016020]; nuclear condensin complex [GO:0000799]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]	GO:0000779; GO:0000799; GO:0003682; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0031618; GO:0035064; GO:0042393; GO:0051301; GO:0051304	cell division [GO:0051301]; chromosome separation [GO:0051304]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN15962_c0_g1_i1	Q2TAW0	CNDG2_XENLA	41.2	148	87	0	2	445	331	478	2.10E-23	110.2	CNDG2_XENLA	reviewed	Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (Non-SMC condensin II complex subunit G2) (XCAP-G2)	ncapg2	Xenopus laevis (African clawed frog)	1156	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]	nucleus [GO:0005634]		GO:0005634; GO:0007049; GO:0030261; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]		NA	NA	NA	NA	NA	NA
TRINITY_DN38265_c0_g1_i1	Q8BSP2	CNDH2_MOUSE	100	71	0	0	234	22	1	71	1.90E-34	146	CNDH2_MOUSE	reviewed	Condensin-2 complex subunit H2 (Kleisin-beta) (Non-SMC condensin II complex subunit H2)	Ncaph2 D15Ertd785e	Mus musculus (Mouse)	607	cell junction [GO:0030054]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromosome organization [GO:0051276]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; T cell differentiation in thymus [GO:0033077]	cell junction [GO:0030054]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0000793; GO:0000796; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0007076; GO:0007143; GO:0010032; GO:0030054; GO:0033077; GO:0045171; GO:0051276; GO:0051306; GO:0051309	chromosome organization [GO:0051276]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; T cell differentiation in thymus [GO:0033077]		NA	NA	NA	NA	NA	NA
TRINITY_DN27826_c0_g1_i1	Q641G4	CNDH2_XENLA	56.7	90	39	0	302	33	3	92	8.90E-24	111.3	CNDH2_XENLA	reviewed	Condensin-2 complex subunit H2 (Non-SMC condensin II complex subunit H2)	ncaph2	Xenopus laevis (African clawed frog)	624	nucleus [GO:0005634]; chromosome condensation [GO:0030261]	nucleus [GO:0005634]		GO:0005634; GO:0030261	chromosome condensation [GO:0030261]		NA	NA	NA	NA	NA	NA
TRINITY_DN5924_c0_g1_i2	Q01819	CONN_DROME	26.1	222	157	5	55	708	199	417	2.20E-11	71.2	CONN_DROME	reviewed	Connectin	Con CG7503	Drosophila melanogaster (Fruit fly)	682	anchored component of membrane [GO:0031225]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; axonal fasciculation [GO:0007413]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic target attraction [GO:0016200]	anchored component of membrane [GO:0031225]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]		GO:0005886; GO:0007156; GO:0007413; GO:0009986; GO:0016200; GO:0031225; GO:0031594; GO:0044295	axonal fasciculation [GO:0007413]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic target attraction [GO:0016200]		NA	NA	NA	NA	NA	NA
TRINITY_DN15166_c0_g1_i4	Q8WTW3	COG1_HUMAN	29.6	226	141	5	889	251	702	922	1.70E-18	95.1	COG1_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1)	COG1 KIAA1381 LDLB	Homo sapiens (Human)	980	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005794; GO:0006888; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15166_c0_g1_i5	Q9VGC3	COG1_DROME	43.6	55	31	0	259	95	46	100	2.70E-07	56.2	COG1_DROME	reviewed	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1)	Cog1 CG4848	Drosophila melanogaster (Fruit fly)	886	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0017119	Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15166_c0_g1_i6	Q9VGC3	COG1_DROME	45.1	91	50	0	367	95	10	100	1.50E-16	87.4	COG1_DROME	reviewed	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1)	Cog1 CG4848	Drosophila melanogaster (Fruit fly)	886	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0017119	Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15166_c0_g1_i1	Q9Z160	COG1_MOUSE	27.1	943	599	19	2908	251	9	920	1.40E-78	296.2	COG1_MOUSE	reviewed	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)	Cog1 Ldlb	Mus musculus (Mouse)	980	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0005794; GO:0006891; GO:0015031; GO:0017119	intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15166_c0_g1_i2	Q9Z160	COG1_MOUSE	35.8	95	56	3	535	251	831	920	8.00E-07	55.5	COG1_MOUSE	reviewed	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)	Cog1 Ldlb	Mus musculus (Mouse)	980	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0005794; GO:0006891; GO:0015031; GO:0017119	intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15166_c0_g1_i3	Q9Z160	COG1_MOUSE	32.7	153	84	6	667	251	773	920	6.10E-10	66.2	COG1_MOUSE	reviewed	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)	Cog1 Ldlb	Mus musculus (Mouse)	980	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0005794; GO:0006891; GO:0015031; GO:0017119	intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6701_c0_g1_i1	Q9VF78	COG2_DROME	30.5	233	146	4	806	114	260	478	1.40E-20	101.7	COG2_DROME	reviewed	Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (LdlCp-related protein)	Cog2 ldlCp CG6177	Drosophila melanogaster (Fruit fly)	710	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; dsRNA transport [GO:0033227]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0033227	dsRNA transport [GO:0033227]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6701_c0_g1_i2	Q9VF78	COG2_DROME	29.5	193	122	3	686	114	298	478	2.10E-15	84.3	COG2_DROME	reviewed	Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (LdlCp-related protein)	Cog2 ldlCp CG6177	Drosophila melanogaster (Fruit fly)	710	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; dsRNA transport [GO:0033227]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0033227	dsRNA transport [GO:0033227]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN30107_c0_g1_i1	Q96JB2	COG3_HUMAN	55.3	206	85	2	4	612	406	607	3.70E-55	216.1	COG3_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94)	COG3 SEC34	Homo sapiens (Human)	828	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0032588; GO:0033365; GO:0050821	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2604_c0_g1_i1	Q29RB1	COG4_DANRE	43.3	759	412	6	108	2345	28	781	5.10E-172	606.3	COG4_DANRE	reviewed	Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4)	cog4 zgc:136860	Danio rerio (Zebrafish) (Brachydanio rerio)	781	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; proteoglycan metabolic process [GO:0006029]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal system development [GO:0001501]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0001501; GO:0005829; GO:0006029; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0048213	"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; proteoglycan metabolic process [GO:0006029]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2604_c0_g1_i4	Q3MHG0	COG4_BOVIN	50.9	108	53	0	30	353	188	295	1.30E-25	117.5	COG4_BOVIN	reviewed	Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4)	COG4	Bos taurus (Bovine)	785	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0048213	"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28513_c0_g1_i1	Q8R1U1	COG4_MOUSE	100	106	0	0	1	318	671	776	1.80E-53	209.5	COG4_MOUSE	reviewed	Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4)	Cog4	Mus musculus (Mouse)	785	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; identical protein binding [GO:0042802]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]	identical protein binding [GO:0042802]	GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0042802; GO:0048213	"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38756_c0_g1_i1	Q9H9E3	COG4_HUMAN	100	65	0	0	1	195	721	785	4.00E-32	138.3	COG4_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4)	COG4	Homo sapiens (Human)	785	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]	identical protein binding [GO:0042802]	GO:0000139; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0042802; GO:0048213	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7477_c0_g1_i1	Q9UP83	COG5_HUMAN	49.4	508	225	6	1807	305	354	836	2.00E-131	471.1	COG5_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1)	COG5 GOLTC1 GTC90	Homo sapiens (Human)	839	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN7477_c0_g1_i2	Q9UP83	COG5_HUMAN	48	816	389	7	2731	305	49	836	1.10E-210	734.9	COG5_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1)	COG5 GOLTC1 GTC90	Homo sapiens (Human)	839	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2215_c0_g1_i1	Q9VAD6	COG7_DROME	41.2	194	89	3	148	708	563	738	3.40E-29	130.2	COG7_DROME	reviewed	Conserved oligomeric Golgi complex subunit 7 (COG complex subunit 7) (Component of oligomeric Golgi complex 7)	Cog7 CG31040	Drosophila melanogaster (Fruit fly)	742	"acroblast [GO:0036063]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; actomyosin contractile ring contraction [GO:0000916]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; protein localization to Golgi membrane [GO:1903292]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	acroblast [GO:0036063]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0000916; GO:0005794; GO:0006886; GO:0006890; GO:0006891; GO:0007030; GO:0007112; GO:0017119; GO:0036063; GO:1903292	"actomyosin contractile ring contraction [GO:0000916]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; protein localization to Golgi membrane [GO:1903292]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1939_c0_g1_i3	Q2TBH9	COG8_BOVIN	49.2	429	211	4	76	1341	138	566	1.30E-116	421.8	COG8_BOVIN	reviewed	Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8)	COG8	Bos taurus (Bovine)	626	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; protein transport [GO:0015031]	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0015031; GO:0017119	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1939_c0_g1_i4	Q96MW5	COG8_HUMAN	62.6	179	65	1	88	618	194	372	7.80E-61	235	COG8_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8)	COG8	Homo sapiens (Human)	612	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005794; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1939_c0_g1_i6	Q2TBH9	COG8_BOVIN	47.7	541	275	5	100	1698	26	566	5.30E-141	503.1	COG8_BOVIN	reviewed	Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8)	COG8	Bos taurus (Bovine)	626	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; protein transport [GO:0015031]	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]		GO:0000139; GO:0015031; GO:0017119	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1939_c0_g1_i7	Q96MW5	COG8_HUMAN	62.7	177	64	1	2	526	196	372	8.50E-60	231.5	COG8_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8)	COG8	Homo sapiens (Human)	612	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005794; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN28150_c0_g1_i1	Q96MW5	COG8_HUMAN	100	133	0	0	399	1	265	397	1.70E-72	273.1	COG8_HUMAN	reviewed	Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8)	COG8	Homo sapiens (Human)	612	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]		GO:0000139; GO:0005794; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2219_c0_g1_i2	Q9NZB2	F120A_HUMAN	36	809	332	16	2548	662	62	864	9.50E-132	472.6	F120A_HUMAN	reviewed	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)	FAM120A C9orf10 KIAA0183 OSSA	Homo sapiens (Human)	1118	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN2219_c0_g1_i5	A6H7H1	F120A_BOVIN	42.5	334	171	5	1596	640	1	328	5.20E-72	273.5	F120A_BOVIN	reviewed	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)	FAM120A OSSA	Bos taurus (Bovine)	1114	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN2219_c0_g1_i8	A6H7H1	F120A_BOVIN	48.1	212	104	2	691	56	1	206	3.10E-56	219.9	F120A_BOVIN	reviewed	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)	FAM120A OSSA	Bos taurus (Bovine)	1114	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN2219_c0_g1_i9	Q9NZB2	F120A_HUMAN	36.4	876	365	18	2749	662	1	864	5.50E-146	520	F120A_HUMAN	reviewed	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)	FAM120A C9orf10 KIAA0183 OSSA	Homo sapiens (Human)	1118	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN2219_c0_g1_i4	Q6DEZ2	F120A_XENTR	40.9	208	108	3	812	234	121	328	1.40E-39	164.9	F120A_XENTR	reviewed	Constitutive coactivator of PPAR-gamma-like protein 1 homolog (Protein FAM120A)	fam120a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1043	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN2182_c0_g1_i1	Q9VN14	CONT_DROME	40.1	409	196	6	29	1252	711	1071	1.20E-82	308.5	CONT_DROME	reviewed	Contactin	Cont CG1084	Drosophila melanogaster (Fruit fly)	1390	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]		NA	NA	NA	NA	NA	NA
TRINITY_DN2182_c0_g1_i3	Q9VN14	CONT_DROME	45.4	725	340	10	29	2200	711	1380	1.80E-179	630.9	CONT_DROME	reviewed	Contactin	Cont CG1084	Drosophila melanogaster (Fruit fly)	1390	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]		NA	NA	NA	NA	NA	NA
TRINITY_DN2182_c0_g1_i4	Q9VN14	CONT_DROME	36.6	432	209	5	193	1305	139	566	2.50E-83	310.8	CONT_DROME	reviewed	Contactin	Cont CG1084	Drosophila melanogaster (Fruit fly)	1390	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]		NA	NA	NA	NA	NA	NA
TRINITY_DN2182_c0_g1_i5	Q9VN14	CONT_DROME	32.9	362	178	5	193	1095	139	496	3.40E-57	223.8	CONT_DROME	reviewed	Contactin	Cont CG1084	Drosophila melanogaster (Fruit fly)	1390	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]		NA	NA	NA	NA	NA	NA
TRINITY_DN2182_c0_g1_i6	Q9VN14	CONT_DROME	42.6	1304	624	16	193	3918	139	1380	0	1082.8	CONT_DROME	reviewed	Contactin	Cont CG1084	Drosophila melanogaster (Fruit fly)	1390	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]		NA	NA	NA	NA	NA	NA
TRINITY_DN17921_c0_g1_i1	Q99LD4	CSN1_MOUSE	100	247	0	0	3	743	101	347	5.00E-139	495	CSN1_MOUSE	reviewed	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1)	Gps1 Cops1 Csn1	Mus musculus (Mouse)	471	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0005654; GO:0005829; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN17921_c0_g1_i3	Q99LD4	CSN1_MOUSE	100	108	0	0	3	326	101	208	1.20E-57	223.4	CSN1_MOUSE	reviewed	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1)	Gps1 Cops1 Csn1	Mus musculus (Mouse)	471	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0005654; GO:0005829; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN37221_c0_g1_i1	Q99LD4	CSN1_MOUSE	98.5	131	2	0	395	3	3	133	1.60E-67	256.5	CSN1_MOUSE	reviewed	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1)	Gps1 Cops1 Csn1	Mus musculus (Mouse)	471	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0005654; GO:0005829; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN20185_c0_g1_i1	Q13098	CSN1_HUMAN	100	247	0	0	3	743	232	478	4.10E-133	475.3	CSN1_HUMAN	reviewed	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)	GPS1 COPS1 CSN1	Homo sapiens (Human)	491	"COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTPase inhibitor activity [GO:0005095]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	GTPase inhibitor activity [GO:0005095]	GO:0000188; GO:0000338; GO:0000715; GO:0005095; GO:0005654; GO:0005829; GO:0006283; GO:0007254; GO:0008180; GO:0043687	"inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17921_c0_g1_i4	Q13098	CSN1_HUMAN	100	104	0	0	1	312	125	228	1.60E-54	213	CSN1_HUMAN	reviewed	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)	GPS1 COPS1 CSN1	Homo sapiens (Human)	491	"COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTPase inhibitor activity [GO:0005095]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	GTPase inhibitor activity [GO:0005095]	GO:0000188; GO:0000338; GO:0000715; GO:0005095; GO:0005654; GO:0005829; GO:0006283; GO:0007254; GO:0008180; GO:0043687	"inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3331_c0_g1_i1	Q6NRT5	CSN1_XENLA	67.6	472	142	3	1665	253	7	468	1.70E-174	614	CSN1_XENLA	reviewed	COP9 signalosome complex subunit 1 (Signalosome subunit 1)	csn1	Xenopus laevis (African clawed frog)	487	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]		GO:0000338; GO:0005737; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN3331_c0_g1_i2	Q6NRT5	CSN1_XENLA	67.6	478	144	3	1683	253	1	468	1.20E-175	617.8	CSN1_XENLA	reviewed	COP9 signalosome complex subunit 1 (Signalosome subunit 1)	csn1	Xenopus laevis (African clawed frog)	487	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]		GO:0000338; GO:0005737; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN15446_c0_g1_i1	O88543	CSN3_MOUSE	100	164	0	0	525	34	260	423	3.70E-88	325.5	CSN3_MOUSE	reviewed	COP9 signalosome complex subunit 3 (SGN3) (Signalosome subunit 3) (JAB1-containing signalosome subunit 3)	Cops3 Csn3	Mus musculus (Mouse)	423	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; in utero embryonic development [GO:0001701]; protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0001701; GO:0005654; GO:0005829; GO:0006511; GO:0008180	in utero embryonic development [GO:0001701]; protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN15446_c0_g1_i2	Q9UNS2	CSN3_HUMAN	100	161	0	0	516	34	263	423	4.50E-86	318.5	CSN3_HUMAN	reviewed	COP9 signalosome complex subunit 3 (SGN3) (Signalosome subunit 3) (JAB1-containing signalosome subunit 3)	COPS3 CSN3	Homo sapiens (Human)	423	"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; in utero embryonic development [GO:0001701]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]"	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0000715; GO:0001701; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006511; GO:0007165; GO:0008180; GO:0009416; GO:0043687	"in utero embryonic development [GO:0001701]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11122_c0_g1_i1	Q5ZJF1	CSN3_CHICK	65.9	226	77	0	712	35	159	384	8.90E-85	314.7	CSN3_CHICK	reviewed	COP9 signalosome complex subunit 3 (Signalosome subunit 3)	COPS3 CSN3 RCJMB04_18l12	Gallus gallus (Chicken)	423	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0005654; GO:0005829; GO:0006511; GO:0008180	protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11122_c0_g1_i2	Q5ZJF1	CSN3_CHICK	64.1	270	92	1	858	49	159	423	6.00E-96	352.1	CSN3_CHICK	reviewed	COP9 signalosome complex subunit 3 (Signalosome subunit 3)	COPS3 CSN3 RCJMB04_18l12	Gallus gallus (Chicken)	423	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0005654; GO:0005829; GO:0006511; GO:0008180	protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36017_c0_g1_i1	Q5ZJF1	CSN3_CHICK	100	80	0	0	3	242	160	239	3.00E-40	165.2	CSN3_CHICK	reviewed	COP9 signalosome complex subunit 3 (Signalosome subunit 3)	COPS3 CSN3 RCJMB04_18l12	Gallus gallus (Chicken)	423	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0005654; GO:0005829; GO:0006511; GO:0008180	protein deneddylation [GO:0000338]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8764_c0_g1_i1	Q3SZA0	CSN4_BOVIN	76.3	232	55	0	54	749	175	406	1.10E-97	357.8	CSN4_BOVIN	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4)	COPS4	Bos taurus (Bovine)	406	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; synaptic vesicle [GO:0008021]		GO:0000338; GO:0005829; GO:0008021; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN13438_c0_g1_i1	Q3SZA0	CSN4_BOVIN	99.1	108	1	0	1	324	299	406	8.20E-55	214.2	CSN4_BOVIN	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4)	COPS4	Bos taurus (Bovine)	406	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; synaptic vesicle [GO:0008021]		GO:0000338; GO:0005829; GO:0008021; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN13438_c0_g1_i2	Q3SZA0	CSN4_BOVIN	98.3	118	2	0	28	381	289	406	4.40E-60	231.9	CSN4_BOVIN	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4)	COPS4	Bos taurus (Bovine)	406	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; synaptic vesicle [GO:0008021]		GO:0000338; GO:0005829; GO:0008021; GO:0008180	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN8764_c0_g1_i2	Q9BT78	CSN4_HUMAN	74.7	383	96	1	1	1149	25	406	2.30E-160	566.6	CSN4_HUMAN	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4)	COPS4 CSN4	Homo sapiens (Human)	406	"cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; NEDD8-specific protease activity [GO:0019784]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	NEDD8-specific protease activity [GO:0019784]	GO:0000338; GO:0000715; GO:0005634; GO:0005654; GO:0005829; GO:0006283; GO:0008021; GO:0008180; GO:0016607; GO:0019784; GO:0030054; GO:0043687	"nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12215_c1_g1_i1	Q9BT78	CSN4_HUMAN	98.9	89	1	0	267	1	39	127	9.20E-43	173.7	CSN4_HUMAN	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4)	COPS4 CSN4	Homo sapiens (Human)	406	"cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; NEDD8-specific protease activity [GO:0019784]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	NEDD8-specific protease activity [GO:0019784]	GO:0000338; GO:0000715; GO:0005634; GO:0005654; GO:0005829; GO:0006283; GO:0008021; GO:0008180; GO:0016607; GO:0019784; GO:0030054; GO:0043687	"nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12215_c0_g1_i1	O88544	CSN4_MOUSE	100	236	0	0	3	710	60	295	1.10E-130	467.2	CSN4_MOUSE	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4)	Cops4 Csn4	Mus musculus (Mouse)	406	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]		GO:0000338; GO:0005829; GO:0008021; GO:0008180; GO:0016607; GO:0030054	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN12215_c0_g1_i2	O88544	CSN4_MOUSE	100	211	0	0	3	635	60	270	3.00E-116	419.1	CSN4_MOUSE	reviewed	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4)	Cops4 Csn4	Mus musculus (Mouse)	406	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]		GO:0000338; GO:0005829; GO:0008021; GO:0008180; GO:0016607; GO:0030054	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN28893_c0_g1_i1	Q92905	CSN5_HUMAN	100	71	0	0	213	1	259	329	2.40E-33	142.1	CSN5_HUMAN	reviewed	COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1)	COPS5 CSN5 JAB1	Homo sapiens (Human)	334	"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]; exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; transcription-coupled nucleotide-excision repair [GO:0006283]; translation [GO:0006412]"	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]	GO:0000338; GO:0000715; GO:0003713; GO:0003743; GO:0004222; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006283; GO:0006412; GO:0008021; GO:0008180; GO:0008237; GO:0016579; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0070122; GO:1903894; GO:1990182	"exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; transcription-coupled nucleotide-excision repair [GO:0006283]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36303_c0_g1_i1	Q92905	CSN5_HUMAN	100	327	0	0	1051	71	8	334	1.70E-188	659.8	CSN5_HUMAN	reviewed	COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1)	COPS5 CSN5 JAB1	Homo sapiens (Human)	334	"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]; exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; transcription-coupled nucleotide-excision repair [GO:0006283]; translation [GO:0006412]"	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]	GO:0000338; GO:0000715; GO:0003713; GO:0003743; GO:0004222; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006283; GO:0006412; GO:0008021; GO:0008180; GO:0008237; GO:0016579; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0070122; GO:1903894; GO:1990182	"exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; transcription-coupled nucleotide-excision repair [GO:0006283]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17286_c0_g1_i1	Q92905	CSN5_HUMAN	100	99	0	0	300	4	16	114	6.70E-50	197.6	CSN5_HUMAN	reviewed	COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1)	COPS5 CSN5 JAB1	Homo sapiens (Human)	334	"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]; exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; transcription-coupled nucleotide-excision repair [GO:0006283]; translation [GO:0006412]"	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]	GO:0000338; GO:0000715; GO:0003713; GO:0003743; GO:0004222; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006283; GO:0006412; GO:0008021; GO:0008180; GO:0008237; GO:0016579; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0070122; GO:1903894; GO:1990182	"exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; transcription-coupled nucleotide-excision repair [GO:0006283]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33440_c0_g1_i1	Q6GLM9	CSN5_XENLA	78.4	329	70	1	1117	134	1	329	2.70E-153	543.1	CSN5_XENLA	reviewed	COP9 signalosome complex subunit 5 (Signalosome subunit 5) (EC 3.4.-.-)	cops5 csn5	Xenopus laevis (African clawed frog)	332	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005634; GO:0005829; GO:0008021; GO:0008180; GO:0043066; GO:0046872; GO:0048471; GO:0051091; GO:0070122	negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]		blue	blue	NA	NA	NA	NA
TRINITY_DN33292_c0_g1_i1	Q8LAZ7	CSN5A_ARATH	63.8	254	91	1	793	32	32	284	1.40E-91	337.4	CSN5A_ARATH	reviewed	COP9 signalosome complex subunit 5a (Signalosome subunit 5a) (EC 3.4.-.-) (Jun activation domain-binding homolog 1)	CSN5A AJH1 CSN5B At1g22920 F19G10.12	Arabidopsis thaliana (Mouse-ear cress)	357	"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; COP9 signalosome assembly [GO:0010387]; negative regulation of photomorphogenesis [GO:0010100]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein deneddylation [GO:0000338]; red, far-red light phototransduction [GO:0009585]; regulation of defense response [GO:0031347]; response to auxin [GO:0009733]; specification of floral organ identity [GO:0010093]"	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]	isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]	GO:0000338; GO:0004222; GO:0005737; GO:0008180; GO:0008237; GO:0009585; GO:0009733; GO:0010093; GO:0010100; GO:0010387; GO:0010971; GO:0019784; GO:0031347; GO:0046872; GO:0070122	"COP9 signalosome assembly [GO:0010387]; negative regulation of photomorphogenesis [GO:0010100]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein deneddylation [GO:0000338]; red, far-red light phototransduction [GO:0009585]; regulation of defense response [GO:0031347]; response to auxin [GO:0009733]; specification of floral organ identity [GO:0010093]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7166_c0_g1_i1	O88545	CSN6_MOUSE	100	306	0	0	986	69	19	324	9.80E-175	614	CSN6_MOUSE	reviewed	COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) (JAB1-containing signalosome subunit 6)	Cops6 Csn6	Mus musculus (Mouse)	324	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]	GO:0000338; GO:0005654; GO:0005737; GO:0008180; GO:0008237; GO:0070122	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN7166_c0_g1_i2	O88545	CSN6_MOUSE	100	306	0	0	986	69	19	324	9.80E-175	614	CSN6_MOUSE	reviewed	COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) (JAB1-containing signalosome subunit 6)	Cops6 Csn6	Mus musculus (Mouse)	324	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]	GO:0000338; GO:0005654; GO:0005737; GO:0008180; GO:0008237; GO:0070122	protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN9186_c0_g1_i1	Q6NUC2	CSN6_XENLA	69.7	300	90	1	86	985	20	318	1.30E-119	431	CSN6_XENLA	reviewed	COP9 signalosome complex subunit 6 (Signalosome subunit 6)	cops6 csn6	Xenopus laevis (African clawed frog)	318	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]	GO:0000338; GO:0005737; GO:0008180; GO:0008237; GO:0070122	protein deneddylation [GO:0000338]		blue	blue	NA	NA	NA	NA
TRINITY_DN7578_c0_g1_i1	Q9UBW8	CSN7A_HUMAN	44.3	264	130	3	128	871	13	275	6.40E-54	212.6	CSN7A_HUMAN	reviewed	COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a)	COPS7A CSN7A DERP10	Homo sapiens (Human)	275	"COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; COP9 signalosome assembly [GO:0010387]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0000715; GO:0005654; GO:0005829; GO:0006283; GO:0008180; GO:0010387; GO:0016032; GO:0043687	"COP9 signalosome assembly [GO:0010387]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7578_c0_g1_i2	Q9UBW8	CSN7A_HUMAN	44.3	264	130	3	165	908	13	275	8.70E-54	212.2	CSN7A_HUMAN	reviewed	COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a)	COPS7A CSN7A DERP10	Homo sapiens (Human)	275	"COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; COP9 signalosome assembly [GO:0010387]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000338; GO:0000715; GO:0005654; GO:0005829; GO:0006283; GO:0008180; GO:0010387; GO:0016032; GO:0043687	"COP9 signalosome assembly [GO:0010387]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3427_c0_g1_i1	Q6GQA6	CSN8_XENLA	51.4	183	88	1	632	87	13	195	4.10E-47	189.5	CSN8_XENLA	reviewed	COP9 signalosome complex subunit 8 (Signalosome subunit 8)	csn8	Xenopus laevis (African clawed frog)	195	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]		GO:0000338; GO:0005737; GO:0008180; GO:0010387	COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]		NA	NA	NA	NA	NA	NA
TRINITY_DN5902_c0_g1_i1	Q9DC53	CPNE8_MOUSE	51	239	113	3	49	759	31	267	1.20E-66	254.6	CPNE8_MOUSE	reviewed	Copine-8 (Copine VIII)	Cpne8	Mus musculus (Mouse)	577	plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277]	plasma membrane [GO:0005886]	calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]	GO:0005544; GO:0005886; GO:0046872; GO:0071277	cellular response to calcium ion [GO:0071277]		NA	NA	NA	NA	NA	NA
TRINITY_DN28196_c0_g1_i1	Q92SZ1	CUTC_RHIME	60.7	56	18	1	168	1	4	55	7.60E-08	57.4	CUTC_RHIME	reviewed	Copper homeostasis protein CutC	cutC R00204 SMc02879	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	245	cytoplasm [GO:0005737]; copper ion binding [GO:0005507]; cellular copper ion homeostasis [GO:0006878]	cytoplasm [GO:0005737]	copper ion binding [GO:0005507]	GO:0005507; GO:0005737; GO:0006878	cellular copper ion homeostasis [GO:0006878]		NA	NA	NA	NA	NA	NA
TRINITY_DN4759_c1_g1_i1	Q9NTM9	CUTC_HUMAN	49.5	204	101	1	904	293	28	229	1.00E-49	198.7	CUTC_HUMAN	reviewed	Copper homeostasis protein cutC homolog	CUTC CGI-32	Homo sapiens (Human)	273	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	copper ion binding [GO:0005507]	GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070	copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]		NA	NA	NA	NA	NA	NA
TRINITY_DN4759_c1_g1_i2	Q9NTM9	CUTC_HUMAN	45.9	246	126	3	808	86	28	271	6.60E-53	209.1	CUTC_HUMAN	reviewed	Copper homeostasis protein cutC homolog	CUTC CGI-32	Homo sapiens (Human)	273	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	copper ion binding [GO:0005507]	GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070	copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]		NA	NA	NA	NA	NA	NA
TRINITY_DN37949_c0_g1_i1	Q5ZWR1	COPA_LEGPH	68.1	72	23	0	218	3	600	671	1.40E-20	99.8	COPA_LEGPH	reviewed	Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA)	copA lpg1024	Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)	736	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN34904_c0_g1_i1	Q5ZWR1	COPA_LEGPH	67.9	81	26	0	16	258	599	679	3.20E-24	112.1	COPA_LEGPH	reviewed	Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA)	copA lpg1024	Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)	736	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN3063_c0_g1_i1	Q5ZWR1	COPA_LEGPH	68.1	72	23	0	6	221	233	304	1.80E-20	99.4	COPA_LEGPH	reviewed	Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA)	copA lpg1024	Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)	736	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN3063_c0_g1_i2	Q5ZWR1	COPA_LEGPH	67.1	79	26	0	3	239	226	304	3.60E-22	105.1	COPA_LEGPH	reviewed	Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA)	copA lpg1024	Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)	736	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN31364_c0_g1_i1	Q5ZWR1	COPA_LEGPH	63.4	112	41	0	339	4	303	414	6.00E-31	134.8	COPA_LEGPH	reviewed	Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Copper-transporting PIB-type ATPase) (Cu(+)-ATPase LpCopA)	copA lpg1024	Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)	736	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN30945_c0_g1_i1	Q2FDV0	COPA_STAA3	61.3	111	43	0	346	14	317	427	2.50E-32	139.4	COPA_STAA3	reviewed	Copper-exporting P-type ATPase (EC 7.2.2.8) (Copper-exporting P-type ATPase A) (Cu(+)-exporting ATPase)	copA SAUSA300_2494	Staphylococcus aureus (strain USA300)	802	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; copper ion binding [GO:0005507]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]	GO:0005507; GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN4836_c0_g1_i2	P70705	ATP7A_RAT	47.6	1390	595	15	4150	209	102	1434	0	1142.1	ATP7A_RAT	reviewed	Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein homolog)	Atp7a Mnk	Rattus norvegicus (Rat)	1492	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]	"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]"	GO:0001568; GO:0001701; GO:0001836; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007565; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010288; GO:0010468; GO:0010592; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0031069; GO:0031252; GO:0031410; GO:0031526; GO:0032767; GO:0034760; GO:0035137; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043204; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0045914; GO:0046034; GO:0046688; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0048813; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:1901671; GO:1903036; GO:1903136; GO:1904754; GO:1904959; GO:1904960	ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN4836_c0_g1_i3	P70705	ATP7A_RAT	47.6	1390	595	15	4077	136	102	1434	0	1142.1	ATP7A_RAT	reviewed	Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein homolog)	Atp7a Mnk	Rattus norvegicus (Rat)	1492	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]	"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]"	GO:0001568; GO:0001701; GO:0001836; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007565; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010288; GO:0010468; GO:0010592; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0031069; GO:0031252; GO:0031410; GO:0031526; GO:0032767; GO:0034760; GO:0035137; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043204; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0045914; GO:0046034; GO:0046688; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0048813; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:1901671; GO:1903036; GO:1903136; GO:1904754; GO:1904959; GO:1904960	ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN4836_c0_g1_i6	P70705	ATP7A_RAT	33.5	558	292	7	1507	2	102	636	1.20E-73	278.9	ATP7A_RAT	reviewed	Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein homolog)	Atp7a Mnk	Rattus norvegicus (Rat)	1492	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]	"ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]"	GO:0001568; GO:0001701; GO:0001836; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007565; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010288; GO:0010468; GO:0010592; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0031069; GO:0031252; GO:0031410; GO:0031526; GO:0032767; GO:0034760; GO:0035137; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043204; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0045914; GO:0046034; GO:0046688; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0048813; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:1901671; GO:1903036; GO:1903136; GO:1904754; GO:1904959; GO:1904960	ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN25393_c0_g1_i1	Q9XT50	ATP7B_SHEEP	68	75	24	0	229	5	1281	1355	8.50E-21	100.5	ATP7B_SHEEP	reviewed	Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein homolog)	ATP7B WND	Ovis aries (Sheep)	1505	"integral component of membrane [GO:0016021]; late endosome [GO:0005770]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper ion transport [GO:0006825]"	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; trans-Golgi network membrane [GO:0032588]	"ATP binding [GO:0005524]; copper ion binding [GO:0005507]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]"	GO:0005507; GO:0005524; GO:0005770; GO:0006825; GO:0016021; GO:0032588; GO:0043682	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN37269_c0_g1_i1	Q64446	ATP7B_MOUSE	71.2	73	21	0	223	5	1236	1308	2.80E-21	102.1	ATP7B_MOUSE	reviewed	Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein homolog)	Atp7b Wnd	Mus musculus (Mouse)	1462	"apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; zinc ion binding [GO:0008270]; cellular copper ion homeostasis [GO:0006878]; cellular response to copper ion [GO:0071280]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]"	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	"ATP binding [GO:0005524]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; zinc ion binding [GO:0008270]"	GO:0005375; GO:0005507; GO:0005524; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0008270; GO:0015677; GO:0015680; GO:0016020; GO:0016021; GO:0016323; GO:0032588; GO:0043682; GO:0045177; GO:0046688; GO:0048471; GO:0051208; GO:0060003; GO:0070160; GO:0071280	cellular copper ion homeostasis [GO:0006878]; cellular response to copper ion [GO:0071280]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]		NA	NA	NA	NA	NA	NA
TRINITY_DN40671_c0_g1_i1	Q9X5V3	ATCU_RHILV	70.1	77	23	0	3	233	698	774	5.40E-23	107.8	ATCU_RHILV	reviewed	Copper-transporting P-type ATPase (EC 7.2.2.9)	actP	Rhizobium leguminosarum bv. viciae	841	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005524; GO:0005886; GO:0016021; GO:0016491; GO:0043682; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN25838_c0_g1_i1	Q9X5V3	ATCU_RHILV	66.2	68	23	0	3	206	332	399	1.90E-19	95.9	ATCU_RHILV	reviewed	Copper-transporting P-type ATPase (EC 7.2.2.9)	actP	Rhizobium leguminosarum bv. viciae	841	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0005524; GO:0005886; GO:0016021; GO:0016491; GO:0043682; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2877_c0_g1_i1	Q02874	H2AY_RAT	54.1	403	149	6	1290	91	1	370	1.30E-89	331.6	H2AY_RAT	reviewed	Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y)	Macroh2a1 H2afy	Rattus norvegicus (Rat)	371	"Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"	Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000790; GO:0000793; GO:0000976; GO:0000977; GO:0000979; GO:0001740; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006325; GO:0006334; GO:0006342; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0031490; GO:0031492; GO:0033128; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0071169; GO:0071901; GO:1901837; GO:1902750; GO:1902882; GO:1902883; GO:1902884; GO:1903226; GO:1904815; GO:1990841	"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20915_c0_g1_i1	O93327	H2AY_CHICK	100	68	0	0	206	3	21	88	1.90E-32	139	H2AY_CHICK	reviewed	Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y)	MACROH2A1	Gallus gallus (Chicken)	372	"condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"	condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]	DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]	GO:0000122; GO:0000182; GO:0000786; GO:0000790; GO:0000793; GO:0000979; GO:0003677; GO:0005654; GO:0005721; GO:0005730; GO:0006325; GO:0006334; GO:0006342; GO:0007549; GO:0010385; GO:0019216; GO:0019901; GO:0030291; GO:0031492; GO:0033128; GO:0034184; GO:0045618; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0071169; GO:1901837; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841	"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20915_c0_g2_i1	O93327	H2AY_CHICK	100	131	0	0	411	19	6	136	2.80E-67	255.8	H2AY_CHICK	reviewed	Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y)	MACROH2A1	Gallus gallus (Chicken)	372	"condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"	condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]	DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]	GO:0000122; GO:0000182; GO:0000786; GO:0000790; GO:0000793; GO:0000979; GO:0003677; GO:0005654; GO:0005721; GO:0005730; GO:0006325; GO:0006334; GO:0006342; GO:0007549; GO:0010385; GO:0019216; GO:0019901; GO:0030291; GO:0031492; GO:0033128; GO:0034184; GO:0045618; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0071169; GO:1901837; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841	"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36755_c0_g1_i1	O75367	H2AY_HUMAN	100	78	0	0	235	2	286	363	2.10E-35	149.1	H2AY_HUMAN	reviewed	Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205)	MACROH2A1 H2AFY	Homo sapiens (Human)	372	"Barr body [GO:0001740]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"	"Barr body [GO:0001740]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]"	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000182; GO:0000228; GO:0000784; GO:0000786; GO:0000790; GO:0000793; GO:0000976; GO:0000977; GO:0000979; GO:0001739; GO:0001740; GO:0003677; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006325; GO:0006334; GO:0006342; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0031490; GO:0031492; GO:0033128; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0070062; GO:0071169; GO:0071901; GO:1901837; GO:1902750; GO:1902882; GO:1902883; GO:1902884; GO:1903226; GO:1904815; GO:1990841	"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13137_c0_g1_i1	Q92176	COR1A_BOVIN	59.2	130	51	1	385	2	52	181	2.70E-43	176	COR1A_BOVIN	reviewed	Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)	CORO1A CORO1	Bos taurus (Bovine)	461	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0001772; GO:0001845; GO:0001891; GO:0003785; GO:0005769; GO:0005829; GO:0005884; GO:0005911; GO:0006816; GO:0007015; GO:0008022; GO:0008360; GO:0016477; GO:0030027; GO:0030335; GO:0030424; GO:0030595; GO:0030670; GO:0030864; GO:0031339; GO:0031589; GO:0032036; GO:0032796; GO:0032991; GO:0038180; GO:0042102; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0048873; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0061502; GO:0071353; GO:0098978	actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]		NA	NA	NA	NA	NA	NA
TRINITY_DN38459_c0_g1_i1	Q92176	COR1A_BOVIN	43.3	60	34	0	216	37	245	304	3.40E-09	62	COR1A_BOVIN	reviewed	Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)	CORO1A CORO1	Bos taurus (Bovine)	461	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0001772; GO:0001845; GO:0001891; GO:0003785; GO:0005769; GO:0005829; GO:0005884; GO:0005911; GO:0006816; GO:0007015; GO:0008022; GO:0008360; GO:0016477; GO:0030027; GO:0030335; GO:0030424; GO:0030595; GO:0030670; GO:0030864; GO:0031339; GO:0031589; GO:0032036; GO:0032796; GO:0032991; GO:0038180; GO:0042102; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0048873; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0061502; GO:0071353; GO:0098978	actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]		NA	NA	NA	NA	NA	NA
TRINITY_DN8938_c0_g1_i1	O89053	COR1A_MOUSE	100	343	0	0	1029	1	55	397	5.90E-207	721.1	COR1A_MOUSE	reviewed	Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)	Coro1a Coro1	Mus musculus (Mouse)	461	actin filament [GO:0005884]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to cytokine [GO:0034097]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell leading edge [GO:0031252]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; stereocilium tip [GO:0032426]; synapse [GO:0045202]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0001772; GO:0001845; GO:0001891; GO:0003779; GO:0003785; GO:0005737; GO:0005769; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006816; GO:0006909; GO:0007015; GO:0008022; GO:0008064; GO:0008092; GO:0008360; GO:0016477; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0030595; GO:0030670; GO:0030833; GO:0030864; GO:0031252; GO:0031339; GO:0031589; GO:0032036; GO:0032426; GO:0032796; GO:0032956; GO:0032991; GO:0034097; GO:0038180; GO:0042102; GO:0042802; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0045202; GO:0045335; GO:0048873; GO:0050870; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0061502; GO:0071353; GO:0098978	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to cytokine [GO:0034097]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]		NA	NA	NA	NA	NA	NA
TRINITY_DN8938_c0_g2_i1	P31146	COR1A_HUMAN	100	358	0	0	1076	3	54	411	7.30E-216	750.7	COR1A_HUMAN	reviewed	Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)	CORO1A CORO1	Homo sapiens (Human)	461	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0001772; GO:0001845; GO:0001891; GO:0003723; GO:0003779; GO:0003785; GO:0005737; GO:0005769; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006816; GO:0006909; GO:0007015; GO:0008022; GO:0008092; GO:0008360; GO:0016020; GO:0016477; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0030595; GO:0030670; GO:0030864; GO:0031339; GO:0031589; GO:0032036; GO:0032796; GO:0032956; GO:0032991; GO:0038180; GO:0042102; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0045087; GO:0045335; GO:0048873; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0061502; GO:0070062; GO:0071353; GO:0098978	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]		NA	NA	NA	NA	NA	NA
TRINITY_DN30164_c0_g1_i1	Q9WUM3	COR1B_MOUSE	100	171	0	0	2	514	66	236	2.90E-101	369	COR1B_MOUSE	reviewed	Coronin-1B (Coronin-2)	Coro1b	Mus musculus (Mouse)	484	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]	GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0007015; GO:0008092; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0044877; GO:0048471; GO:0051015; GO:0051017; GO:0070528; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000393; GO:2000394	actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN23294_c0_g2_i1	Q9WUM3	COR1B_MOUSE	100	131	0	0	1	393	262	392	6.60E-74	277.7	COR1B_MOUSE	reviewed	Coronin-1B (Coronin-2)	Coro1b	Mus musculus (Mouse)	484	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]	GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0007015; GO:0008092; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0044877; GO:0048471; GO:0051015; GO:0051017; GO:0070528; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000393; GO:2000394	actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN23294_c0_g1_i1	Q9BR76	COR1B_HUMAN	100	83	0	0	2	250	308	390	3.80E-43	174.9	COR1B_HUMAN	reviewed	Coronin-1B (Coronin-2)	CORO1B	Homo sapiens (Human)	489	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060]	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]	GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007015; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034315; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000394	actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN5069_c0_g1_i1	Q9XS70	COR1B_RABIT	56.1	221	93	3	1241	582	197	414	1.80E-64	248.1	COR1B_RABIT	reviewed	Coronin-1B (Coronin-like protein pp66) (Coroninse)	CORO1B	Oryctolagus cuniculus (Rabbit)	486	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN29207_c0_g1_i1	Q9ULV4	COR1C_HUMAN	100	76	0	0	230	3	213	288	4.80E-40	164.5	COR1C_HUMAN	reviewed	Coronin-1C (Coronin-3) (hCRNN4)	CORO1C CRN2 CRNN4	Homo sapiens (Human)	474	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]	actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]	GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016477; GO:0016600; GO:0030017; GO:0030027; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0048365; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394	actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38127_c0_g1_i1	Q9ULV4	COR1C_HUMAN	100	93	0	0	281	3	76	168	1.90E-51	202.6	COR1C_HUMAN	reviewed	Coronin-1C (Coronin-3) (hCRNN4)	CORO1C CRN2 CRNN4	Homo sapiens (Human)	474	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]	actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]	GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016477; GO:0016600; GO:0030017; GO:0030027; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0048365; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394	actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN26604_c0_g1_i1	B0R0D7	COR1C_DANRE	54.7	75	33	1	6	227	106	180	4.40E-17	88.2	COR1C_DANRE	reviewed	Coronin-1C-A	coro1ca	Danio rerio (Zebrafish) (Brachydanio rerio)	474	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]	GO:0001755; GO:0005938; GO:0007015; GO:0010008; GO:0015629; GO:0016197; GO:0016477; GO:0030027; GO:0032587; GO:0051015; GO:0090148; GO:0097750; GO:0140285	actin filament organization [GO:0007015]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755]		NA	NA	NA	NA	NA	NA
TRINITY_DN15945_c0_g1_i1	B0R0D7	COR1C_DANRE	54	463	184	7	3	1385	37	472	1.80E-138	494.2	COR1C_DANRE	reviewed	Coronin-1C-A	coro1ca	Danio rerio (Zebrafish) (Brachydanio rerio)	474	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]	GO:0001755; GO:0005938; GO:0007015; GO:0010008; GO:0015629; GO:0016197; GO:0016477; GO:0030027; GO:0032587; GO:0051015; GO:0090148; GO:0097750; GO:0140285	actin filament organization [GO:0007015]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755]		blue	blue	NA	NA	NA	NA
TRINITY_DN15945_c0_g1_i2	B0R0D7	COR1C_DANRE	55.1	454	184	7	3	1358	37	472	1.60E-139	497.7	COR1C_DANRE	reviewed	Coronin-1C-A	coro1ca	Danio rerio (Zebrafish) (Brachydanio rerio)	474	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]	GO:0001755; GO:0005938; GO:0007015; GO:0010008; GO:0015629; GO:0016197; GO:0016477; GO:0030027; GO:0032587; GO:0051015; GO:0090148; GO:0097750; GO:0140285	actin filament organization [GO:0007015]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]; neural crest cell migration [GO:0001755]		blue	blue	NA	NA	NA	NA
TRINITY_DN38216_c0_g1_i1	Q92828	COR2A_HUMAN	100	85	0	0	255	1	311	395	6.10E-44	177.6	COR2A_HUMAN	reviewed	Coronin-2A (IR10) (WD repeat-containing protein 2)	CORO2A IR10 WDR2	Homo sapiens (Human)	525	transcription repressor complex [GO:0017053]; actin filament binding [GO:0051015]; intracellular signal transduction [GO:0035556]	transcription repressor complex [GO:0017053]	actin filament binding [GO:0051015]	GO:0017053; GO:0035556; GO:0051015	intracellular signal transduction [GO:0035556]		NA	NA	NA	NA	NA	NA
TRINITY_DN36794_c0_g1_i1	Q6QEF8	CORO6_HUMAN	88.1	67	8	0	28	228	139	205	2.40E-28	125.6	CORO6_HUMAN	reviewed	Coronin-6 (Coronin-like protein E) (Clipin-E)	CORO6 PP1009 PP1782 PP1881	Homo sapiens (Human)	472	actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cell migration [GO:0016477]		actin filament binding [GO:0051015]	GO:0007015; GO:0016477; GO:0051015	actin filament organization [GO:0007015]; cell migration [GO:0016477]		NA	NA	NA	NA	NA	NA
TRINITY_DN27846_c0_g1_i1	P27133	COROA_DICDI	48.8	125	64	0	31	405	252	376	2.10E-33	143.3	COROA_DICDI	reviewed	Coronin-A (Coronin) (p55)	corA DDB_G0267382	Dictyostelium discoideum (Slime mold)	445	actin cytoskeleton [GO:0015629]; anterior cell cortex [GO:0061802]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; plasma membrane [GO:0005886]; posterior cell cortex [GO:0061803]; actin filament binding [GO:0051015]; protein self-association [GO:0043621]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; gene expression [GO:0010467]; hyperosmotic response [GO:0006972]; intranuclear rod assembly [GO:1905861]; mitotic cleavage furrow formation [GO:1903673]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; regulation of myosin II filament disassembly [GO:0043521]; response to bacterium [GO:0009617]; response to curcumin [GO:1904643]; response to extracellular stimulus [GO:0009991]; response to other organism [GO:0051707]	actin cytoskeleton [GO:0015629]; anterior cell cortex [GO:0061802]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; plasma membrane [GO:0005886]; posterior cell cortex [GO:0061803]	actin filament binding [GO:0051015]; protein self-association [GO:0043621]	GO:0000281; GO:0005886; GO:0005938; GO:0006897; GO:0006909; GO:0006972; GO:0007015; GO:0009617; GO:0009986; GO:0009991; GO:0010467; GO:0015629; GO:0030036; GO:0030042; GO:0030863; GO:0031152; GO:0042742; GO:0043521; GO:0043621; GO:0048870; GO:0051015; GO:0051707; GO:0061802; GO:0061803; GO:1903673; GO:1904643; GO:1905861	actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; gene expression [GO:0010467]; hyperosmotic response [GO:0006972]; intranuclear rod assembly [GO:1905861]; mitotic cleavage furrow formation [GO:1903673]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; regulation of myosin II filament disassembly [GO:0043521]; response to bacterium [GO:0009617]; response to curcumin [GO:1904643]; response to extracellular stimulus [GO:0009991]; response to other organism [GO:0051707]		NA	NA	NA	NA	NA	NA
TRINITY_DN19372_c0_g1_i1	Q21624	CORO_CAEEL	55.4	65	29	0	5	199	209	273	2.00E-13	75.9	CORO_CAEEL	reviewed	Coronin-like protein cor-1	cor-1 R01H10.3	Caenorhabditis elegans	607	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]	GO:0005737; GO:0005856; GO:0007015; GO:0051015	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i16	Q2QLB3	CTTB2_PLEMO	31.1	132	83	4	420	25	745	868	1.70E-07	57.4	CTTB2_PLEMO	reviewed	Cortactin-binding protein 2 (CortBP2)	CTTNBP2 CORTBP2	Plecturocebus moloch (Dusky titi monkey) (Callicebus moloch)	1663	cell cortex [GO:0005938]; dendritic spine [GO:0043197]	cell cortex [GO:0005938]; dendritic spine [GO:0043197]		GO:0005938; GO:0043197			NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i8	Q2QLB3	CTTB2_PLEMO	31.1	132	83	4	420	25	745	868	1.80E-07	57.4	CTTB2_PLEMO	reviewed	Cortactin-binding protein 2 (CortBP2)	CTTNBP2 CORTBP2	Plecturocebus moloch (Dusky titi monkey) (Callicebus moloch)	1663	cell cortex [GO:0005938]; dendritic spine [GO:0043197]	cell cortex [GO:0005938]; dendritic spine [GO:0043197]		GO:0005938; GO:0043197			NA	NA	NA	NA	NA	NA
TRINITY_DN7392_c0_g1_i1	A1X157	CTTB2_ECHTE	24.6	391	236	10	556	1554	1046	1435	1.60E-21	105.9	CTTB2_ECHTE	reviewed	Cortactin-binding protein 2 (CortBP2)	CTTNBP2 CORTBP2	Echinops telfairi (Lesser hedgehog tenrec)	1666	cell cortex [GO:0005938]; dendritic spine [GO:0043197]	cell cortex [GO:0005938]; dendritic spine [GO:0043197]		GO:0005938; GO:0043197			NA	NA	NA	NA	NA	NA
TRINITY_DN3621_c0_g1_i1	Q3SZM6	COXM1_BOVIN	60	70	27	1	213	4	5	73	6.10E-17	88.2	COXM1_BOVIN	reviewed	COX assembly mitochondrial protein homolog (Cmc1p)	CMC1	Bos taurus (Bovine)	106	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]	GO:0005739; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3621_c0_g1_i2	Q3SZM6	COXM1_BOVIN	55.8	95	41	1	406	122	5	98	9.10E-23	108.2	COXM1_BOVIN	reviewed	COX assembly mitochondrial protein homolog (Cmc1p)	CMC1	Bos taurus (Bovine)	106	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]	GO:0005739; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN3621_c0_g1_i4	Q3SZM6	COXM1_BOVIN	55.8	43	19	0	226	98	31	73	9.40E-08	57.4	COXM1_BOVIN	reviewed	COX assembly mitochondrial protein homolog (Cmc1p)	CMC1	Bos taurus (Bovine)	106	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]	GO:0005739; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3621_c0_g1_i6	Q3SZM6	COXM1_BOVIN	55.8	95	41	1	392	108	5	98	8.90E-23	108.2	COXM1_BOVIN	reviewed	COX assembly mitochondrial protein homolog (Cmc1p)	CMC1	Bos taurus (Bovine)	106	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]	GO:0005739; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN3621_c0_g1_i8	Q3SZM6	COXM1_BOVIN	60	70	27	1	213	4	5	73	6.20E-17	88.2	COXM1_BOVIN	reviewed	COX assembly mitochondrial protein homolog (Cmc1p)	CMC1	Bos taurus (Bovine)	106	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]	GO:0005739; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN29861_c0_g1_i1	Q75QI0	CFDP1_CHICK	49.2	132	64	1	86	481	159	287	6.50E-25	115.5	CFDP1_CHICK	reviewed	Craniofacial development protein 1 (Bucentaur)	CFDP1 BCNT	Gallus gallus (Chicken)	290	condensed chromosome kinetochore [GO:0000777]; multicellular organism development [GO:0007275]	condensed chromosome kinetochore [GO:0000777]		GO:0000777; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c213_g1_i3	O02751	CFDP2_BOVIN	25.2	119	87	2	379	23	233	349	1.80E-07	57	CFDP2_BOVIN	reviewed	Craniofacial development protein 2 (p97 bucentaur protein)	CFDP2 BCNT	Bos taurus (Bovine)	592	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN40371_c0_g1_i1	P48199	CRP_RAT	37.1	70	42	1	14	217	122	191	2.40E-05	49.3	CRP_RAT	reviewed	C-reactive protein	Crp Ptx1	Rattus norvegicus (Rat)	230	"extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; acute-phase response [GO:0006953]; aging [GO:0007568]; cellular response to calcium ion [GO:0071277]; cellular response to interleukin-6 [GO:0071354]; cellular response to nitric oxide [GO:0071732]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation by host of viral process [GO:0044793]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of dendrite development [GO:1900006]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of superoxide anion generation [GO:0032930]; protein polymerization [GO:0051258]; regulation of interleukin-8 production [GO:0032677]; regulation of low-density lipoprotein particle clearance [GO:0010988]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to testosterone [GO:0033574]; wound healing [GO:0042060]"	extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]	calcium ion binding [GO:0005509]; cholesterol binding [GO:0015485]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001666; GO:0001849; GO:0005509; GO:0005615; GO:0006953; GO:0006958; GO:0007568; GO:0009314; GO:0010288; GO:0010628; GO:0010745; GO:0010888; GO:0010988; GO:0015485; GO:0030169; GO:0030175; GO:0030426; GO:0031667; GO:0032355; GO:0032677; GO:0032929; GO:0032930; GO:0032945; GO:0033574; GO:0042060; GO:0042802; GO:0044793; GO:0045087; GO:0045429; GO:0045471; GO:0050750; GO:0051258; GO:0071277; GO:0071354; GO:0071732; GO:0097756; GO:1900006	"acute-phase response [GO:0006953]; aging [GO:0007568]; cellular response to calcium ion [GO:0071277]; cellular response to interleukin-6 [GO:0071354]; cellular response to nitric oxide [GO:0071732]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation by host of viral process [GO:0044793]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of dendrite development [GO:1900006]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of superoxide anion generation [GO:0032930]; protein polymerization [GO:0051258]; regulation of interleukin-8 production [GO:0032677]; regulation of low-density lipoprotein particle clearance [GO:0010988]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to testosterone [GO:0033574]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35566_c0_g1_i1	P38487	CREA_BACB0	57.7	52	22	0	159	4	175	226	3.10E-09	62	CREA_BACB0	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Bacillus sp. (strain B-0618)	411	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g2_i2	P19213	CREA_FLASU	72.4	185	50	1	623	69	219	402	2.70E-83	309.7	CREA_FLASU	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Flavobacterium sp. (strain U-188)	403	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g2_i4	P38487	CREA_BACB0	63.1	404	143	4	1271	69	10	410	3.30E-146	519.6	CREA_BACB0	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Bacillus sp. (strain B-0618)	411	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g2_i5	P19213	CREA_FLASU	64.4	87	31	0	292	32	252	338	3.40E-31	135.6	CREA_FLASU	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Flavobacterium sp. (strain U-188)	403	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g2_i6	P19213	CREA_FLASU	67.4	86	28	0	313	56	252	337	4.30E-32	138.7	CREA_FLASU	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Flavobacterium sp. (strain U-188)	403	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g2_i7	P19213	CREA_FLASU	67.8	152	48	1	524	69	252	402	9.80E-63	241.1	CREA_FLASU	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Flavobacterium sp. (strain U-188)	403	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g2_i9	P19213	CREA_FLASU	74.8	119	30	0	412	56	219	337	1.30E-52	207.2	CREA_FLASU	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Flavobacterium sp. (strain U-188)	403	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN2634_c0_g1_i1	P19213	CREA_FLASU	73.7	38	10	0	114	1	219	256	1.50E-11	69.7	CREA_FLASU	reviewed	Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)		Flavobacterium sp. (strain U-188)	403	creatinase activity [GO:0016980]		creatinase activity [GO:0016980]	GO:0016980			NA	NA	NA	NA	NA	NA
TRINITY_DN25847_c0_g1_i1	Q9XSC6	KCRM_BOVIN	57.4	68	29	0	211	8	205	272	5.60E-19	94.4	KCRM_BOVIN	reviewed	Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)	CKM	Bos taurus (Bovine)	381	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]	GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0016301; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN18434_c0_g1_i1	P11009	KCRS_CHICK	53.9	152	70	0	463	8	240	391	1.50E-45	183.7	KCRS_CHICK	reviewed	"Creatine kinase S-type, mitochondrial (EC 2.7.3.2) (Basic-type mitochondrial creatine kinase) (Mib-CK) (Sarcomeric mitochondrial creatine kinase) (S-MtCK)"	CKMT2	Gallus gallus (Chicken)	419	mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]	mitochondrial inner membrane [GO:0005743]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]	GO:0004111; GO:0005524; GO:0005743; GO:0046314	phosphocreatine biosynthetic process [GO:0046314]		NA	NA	NA	NA	NA	NA
TRINITY_DN15319_c0_g1_i2	Q8IUR6	CRERF_HUMAN	35.7	112	54	2	493	158	536	629	1.80E-11	70.9	CRERF_HUMAN	reviewed	CREB3 regulatory factor (Luman recruitment factor) (LRF)	CREBRF C5orf41	Homo sapiens (Human)	639	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; endoplasmic reticulum unfolded protein response [GO:0030968]; maternal behavior [GO:0042711]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of glucocorticoid mediated signaling pathway [GO:1900170]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of intracellular transport [GO:0032388]; positive regulation of prolactin signaling pathway [GO:1902213]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein transport [GO:0051222]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to endoplasmic reticulum stress [GO:0034976]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0001228; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0030968; GO:0032388; GO:0034976; GO:0042711; GO:0045732; GO:0045944; GO:0051222; GO:1900102; GO:1900170; GO:1902213	endoplasmic reticulum unfolded protein response [GO:0030968]; maternal behavior [GO:0042711]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of glucocorticoid mediated signaling pathway [GO:1900170]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of intracellular transport [GO:0032388]; positive regulation of prolactin signaling pathway [GO:1902213]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein transport [GO:0051222]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN37125_c0_g1_i1	Q92793	CBP_HUMAN	85.7	77	11	0	4	234	1094	1170	1.50E-36	152.9	CBP_HUMAN	reviewed	CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-)	CREBBP CBP	Homo sapiens (Human)	2442	"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000123; GO:0000790; GO:0001085; GO:0001102; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006367; GO:0006473; GO:0007165; GO:0007219; GO:0007221; GO:0008134; GO:0008270; GO:0008589; GO:0016032; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0019216; GO:0030511; GO:0031490; GO:0031648; GO:0032481; GO:0034644; GO:0042592; GO:0042733; GO:0042981; GO:0043426; GO:0045637; GO:0045747; GO:0045893; GO:0045944; GO:0048511; GO:0061418; GO:0061733; GO:0065003; GO:1900034; GO:1904837; GO:1990258	"beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein-containing complex assembly [GO:0065003]; protein destabilization [GO:0031648]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21443_c0_g1_i1	Q9BZJ0	CRNL1_HUMAN	59.7	72	29	0	3	218	495	566	6.90E-20	97.4	CRNL1_HUMAN	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	848	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35202_c0_g1_i1	Q9BZJ0	CRNL1_HUMAN	100	69	0	0	209	3	487	555	8.40E-36	150.2	CRNL1_HUMAN	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	848	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35919_c0_g1_i1	Q9BZJ0	CRNL1_HUMAN	100	111	0	0	334	2	240	350	2.20E-62	239.2	CRNL1_HUMAN	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	848	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23322_c0_g1_i1	Q9BZJ0	CRNL1_HUMAN	47.6	84	44	0	258	7	642	725	5.40E-19	94.7	CRNL1_HUMAN	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	848	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32900_c0_g1_i1	Q9BZJ0	CRNL1_HUMAN	100	133	0	0	3	401	579	711	3.10E-71	268.9	CRNL1_HUMAN	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	848	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8641_c0_g1_i1	Q9BZJ0	CRNL1_HUMAN	59.7	119	48	0	358	2	220	338	2.40E-38	159.5	CRNL1_HUMAN	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	848	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5478_c0_g1_i1	P80363	CCB23_FAXLI	78.3	184	40	0	601	50	17	200	9.70E-80	297.7	CCB23_FAXLI	reviewed	Crustacean calcium-binding protein 23 (CCBP-23)		Faxonius limosus (Spinycheek crayfish) (Orconectes limosus)	202	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			blue	blue	NA	NA	NA	NA
TRINITY_DN39739_c0_g1_i1	Q4KML2	CRYD_DANRE	65.8	228	73	2	2	682	275	498	1.00E-90	334.3	CRYD_DANRE	reviewed	Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH)	cry-dash	Danio rerio (Zebrafish) (Brachydanio rerio)	520	damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0000719; GO:0003677; GO:0003684; GO:0003904; GO:0018298; GO:0050660; GO:0071949	photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN39739_c0_g1_i2	Q4KML2	CRYD_DANRE	63.8	240	78	1	2	694	275	514	8.90E-94	344.7	CRYD_DANRE	reviewed	Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH)	cry-dash	Danio rerio (Zebrafish) (Brachydanio rerio)	520	damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0000719; GO:0003677; GO:0003684; GO:0003904; GO:0018298; GO:0050660; GO:0071949	photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN39739_c0_g1_i3	Q4KML2	CRYD_DANRE	66.1	180	52	1	78	590	335	514	4.70E-67	255.8	CRYD_DANRE	reviewed	Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH)	cry-dash	Danio rerio (Zebrafish) (Brachydanio rerio)	520	damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0000719; GO:0003677; GO:0003684; GO:0003904; GO:0018298; GO:0050660; GO:0071949	photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN39739_c0_g1_i3	Q4KML2	CRYD_DANRE	73.1	26	7	0	2	79	275	300	1.80E-05	51.2	CRYD_DANRE	reviewed	Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH)	cry-dash	Danio rerio (Zebrafish) (Brachydanio rerio)	520	damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0000719; GO:0003677; GO:0003684; GO:0003904; GO:0018298; GO:0050660; GO:0071949	photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN40319_c0_g1_i1	Q17DK5	CRY1_AEDAE	54.2	142	61	1	467	54	398	539	2.20E-42	173.3	CRY1_AEDAE	reviewed	Cryptochrome-1	cry AAEL004146	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	545	"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"	cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]	GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0042752; GO:0045892; GO:0048471; GO:0048511; GO:0050660	"negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40319_c0_g1_i2	Q17DK5	CRY1_AEDAE	54.9	173	74	1	560	54	367	539	3.10E-56	219.9	CRY1_AEDAE	reviewed	Cryptochrome-1	cry AAEL004146	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	545	"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"	cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]	GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0042752; GO:0045892; GO:0048471; GO:0048511; GO:0050660	"negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24531_c0_g1_i1	Q8QG61	CRY1_CHICK	72	493	137	1	136	1611	4	496	7.10E-227	788.1	CRY1_CHICK	reviewed	Cryptochrome-1	CRY1	Gallus gallus (Chicken)	621	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; photoreceptor activity [GO:0009881]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]	DNA binding [GO:0003677]; FAD binding [GO:0071949]; photoreceptor activity [GO:0009881]	GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0031398; GO:0032922; GO:0042622; GO:0043153; GO:0045721; GO:0045892; GO:0071949; GO:0097381	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23718_c1_g1_i2	Q17DK5	CRY1_AEDAE	54.2	48	16	1	201	76	1	48	1.70E-07	56.6	CRY1_AEDAE	reviewed	Cryptochrome-1	cry AAEL004146	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	545	"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"	cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]	GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0042752; GO:0045892; GO:0048471; GO:0048511; GO:0050660	"negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN752_c0_g1_i3	P97784	CRY1_MOUSE	54	378	158	3	1124	39	3	380	6.50E-120	432.2	CRY1_MOUSE	reviewed	Cryptochrome-1	Cry1	Mus musculus (Mouse)	606	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]	GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006094; GO:0006975; GO:0007623; GO:0008134; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:0071949; GO:2000001; GO:2000323; GO:2000850	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN752_c0_g1_i5	P97784	CRY1_MOUSE	56.3	378	163	2	1639	512	3	380	3.70E-129	463.4	CRY1_MOUSE	reviewed	Cryptochrome-1	Cry1	Mus musculus (Mouse)	606	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]	GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006094; GO:0006975; GO:0007623; GO:0008134; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:0071949; GO:2000001; GO:2000323; GO:2000850	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN752_c0_g1_i5	P97784	CRY1_MOUSE	54.7	117	53	0	492	142	373	489	3.10E-35	151.4	CRY1_MOUSE	reviewed	Cryptochrome-1	Cry1	Mus musculus (Mouse)	606	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]	GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006094; GO:0006975; GO:0007623; GO:0008134; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:0071949; GO:2000001; GO:2000323; GO:2000850	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23718_c1_g1_i1	Q7PYI7	CRY1_ANOGA	48.2	363	172	4	1132	92	5	367	3.90E-104	379.8	CRY1_ANOGA	reviewed	Cryptochrome-1 (agCRY1)	Cry1 AGAP001958	Anopheles gambiae (African malaria mosquito)	545	"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]"	cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003677; GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0032922; GO:0042752; GO:0043153; GO:0045892; GO:0048471; GO:0050660; GO:0071949	"circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23718_c1_g1_i4	Q7PYI7	CRY1_ANOGA	47.7	375	180	4	1110	34	5	379	5.80E-105	382.5	CRY1_ANOGA	reviewed	Cryptochrome-1 (agCRY1)	Cry1 AGAP001958	Anopheles gambiae (African malaria mosquito)	545	"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]"	cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003677; GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0032922; GO:0042752; GO:0043153; GO:0045892; GO:0048471; GO:0050660; GO:0071949	"circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37853_c0_g1_i1	Q49AN0	CRY2_HUMAN	100	84	0	0	254	3	450	533	2.70E-44	178.7	CRY2_HUMAN	reviewed	Cryptochrome-2	CRY2 KIAA0658	Homo sapiens (Human)	593	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0016607; GO:0018298; GO:0019902; GO:0032515; GO:0032922; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323	"blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22099_c0_g1_i1	Q49AN0	CRY2_HUMAN	100	115	0	0	2	346	304	418	7.40E-69	260.8	CRY2_HUMAN	reviewed	Cryptochrome-2	CRY2 KIAA0658	Homo sapiens (Human)	593	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0016607; GO:0018298; GO:0019902; GO:0032515; GO:0032922; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323	"blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN752_c0_g1_i1	Q923I8	CRY2_RAT	53.2	62	29	0	327	142	446	507	4.40E-15	82.4	CRY2_RAT	reviewed	Cryptochrome-2	Cry2	Rattus norvegicus (Rat)	594	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein import into nucleus [GO:0006606]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0006606; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0032515; GO:0032868; GO:0032922; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323; GO:2000850	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-chromophore linkage [GO:0018298]; protein import into nucleus [GO:0006606]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN752_c0_g1_i2	Q923I8	CRY2_RAT	59.1	110	45	0	471	142	398	507	9.90E-36	151.4	CRY2_RAT	reviewed	Cryptochrome-2	Cry2	Rattus norvegicus (Rat)	594	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein import into nucleus [GO:0006606]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0006606; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0032515; GO:0032868; GO:0032922; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323; GO:2000850	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-chromophore linkage [GO:0018298]; protein import into nucleus [GO:0006606]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN752_c0_g1_i4	Q49AN0	CRY2_HUMAN	56.1	488	212	2	1599	142	21	508	7.70E-172	605.1	CRY2_HUMAN	reviewed	Cryptochrome-2	CRY2 KIAA0658	Homo sapiens (Human)	593	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; phosphatase binding [GO:0019902]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0016607; GO:0018298; GO:0019902; GO:0032515; GO:0032922; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323	"blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37171_c0_g1_i1	O94886	CSCL1_HUMAN	100	73	0	0	1	219	421	493	5.80E-35	147.5	CSCL1_HUMAN	reviewed	CSC1-like protein 1 (Transmembrane protein 63A)	TMEM63A KIAA0489 KIAA0792	Homo sapiens (Human)	807	centriolar satellite [GO:0034451]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; nucleic acid binding [GO:0003676]; osmolarity-sensing cation channel activity [GO:1990760]; neutrophil degranulation [GO:0043312]	centriolar satellite [GO:0034451]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; nucleic acid binding [GO:0003676]; osmolarity-sensing cation channel activity [GO:1990760]	GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:0008381; GO:0016021; GO:0034451; GO:0035579; GO:0043231; GO:0043312; GO:0070062; GO:0070821; GO:1990760	neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN4291_c0_g1_i4	Q3TWI9	CSCL2_MOUSE	40.7	751	415	12	2826	637	38	779	2.70E-154	547.7	CSCL2_MOUSE	reviewed	CSC1-like protein 2 (Transmembrane protein 63B)	Tmem63b	Mus musculus (Mouse)	832	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	GO:0005227; GO:0005886; GO:0008381; GO:0015629; GO:0016021; GO:1990760			NA	NA	NA	NA	NA	NA
TRINITY_DN4291_c0_g1_i8	Q3TWI9	CSCL2_MOUSE	40.7	751	415	12	2705	516	38	779	2.60E-154	547.7	CSCL2_MOUSE	reviewed	CSC1-like protein 2 (Transmembrane protein 63B)	Tmem63b	Mus musculus (Mouse)	832	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	GO:0005227; GO:0005886; GO:0008381; GO:0015629; GO:0016021; GO:1990760			NA	NA	NA	NA	NA	NA
TRINITY_DN4291_c0_g1_i1	Q3TWI9	CSCL2_MOUSE	40.7	751	415	12	2661	472	38	779	2.50E-154	547.7	CSCL2_MOUSE	reviewed	CSC1-like protein 2 (Transmembrane protein 63B)	Tmem63b	Mus musculus (Mouse)	832	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	GO:0005227; GO:0005886; GO:0008381; GO:0015629; GO:0016021; GO:1990760			NA	NA	1	NA	NA	NA
TRINITY_DN36429_c0_g1_i1	O14098	CTK1_SCHPO	61.1	90	35	0	3	272	387	476	2.60E-27	122.5	CTK1_SCHPO	reviewed	CTD kinase subunit alpha (CTDK-I subunit alpha) (EC 2.7.11.23) (CTD kinase subunit 1) (Latrunculin sensitive kinase 1)	lsk1 ctk1 SPAC2F3.15	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	593	chromosome [GO:0005694]; CTDK-1 complex [GO:0070692]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; mRNA processing [GO:0006397]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:0071619]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic actomyosin contractile ring maintenance [GO:1904789]; signaling [GO:0023052]; transcription elongation from RNA polymerase II promoter [GO:0006368]	chromosome [GO:0005694]; CTDK-1 complex [GO:0070692]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0005730; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008353; GO:0019908; GO:0023052; GO:0030332; GO:0032968; GO:0045944; GO:0070692; GO:0070816; GO:0071619; GO:1904789	mRNA processing [GO:0006397]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:0071619]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic actomyosin contractile ring maintenance [GO:1904789]; signaling [GO:0023052]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN24304_c0_g1_i1	Q1RMV9	CNEP1_BOVIN	100	148	0	0	1	444	85	232	3.70E-81	302	CNEP1_BOVIN	reviewed	CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard)	CTDNEP1 DULLARD	Bos taurus (Bovine)	244	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006470; GO:0006998; GO:0007276; GO:0007498; GO:0010867; GO:0016021; GO:0031965; GO:0034504; GO:0071595; GO:0090263	gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN24304_c0_g1_i2	Q1RMV9	CNEP1_BOVIN	100	113	0	0	1	339	85	197	1.20E-60	233.4	CNEP1_BOVIN	reviewed	CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard)	CTDNEP1 DULLARD	Bos taurus (Bovine)	244	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006470; GO:0006998; GO:0007276; GO:0007498; GO:0010867; GO:0016021; GO:0031965; GO:0034504; GO:0071595; GO:0090263	gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN10157_c0_g1_i1	Q5U395	CNEPA_DANRE	81.6	174	32	0	525	4	61	234	7.20E-84	311.2	CNEPA_DANRE	reviewed	CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A)	ctdnep1a dullard	Danio rerio (Zebrafish) (Brachydanio rerio)	245	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; nuclear envelope organization [GO:0006998]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0006470; GO:0006998; GO:0010867; GO:0016021; GO:0031965; GO:0071595	nuclear envelope organization [GO:0006998]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN957_c0_g1_i1	O46036	CTBP_DROME	85.9	354	45	3	206	1267	9	357	1.40E-174	614	CTBP_DROME	reviewed	C-terminal-binding protein (CtBP protein) (dCtBP)	CtBP CG7583	Drosophila melanogaster (Fruit fly)	476	"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"	ISWI-type complex [GO:0031010]; nucleus [GO:0005634]	"identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0016360; GO:0016616; GO:0022416; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0045944; GO:0051287; GO:0070491; GO:0090090; GO:0090263	"ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN957_c0_g1_i3	O46036	CTBP_DROME	85.9	354	45	3	136	1197	9	357	1.40E-174	614	CTBP_DROME	reviewed	C-terminal-binding protein (CtBP protein) (dCtBP)	CtBP CG7583	Drosophila melanogaster (Fruit fly)	476	"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"	ISWI-type complex [GO:0031010]; nucleus [GO:0005634]	"identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0016360; GO:0016616; GO:0022416; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0045944; GO:0051287; GO:0070491; GO:0090090; GO:0090263	"ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN957_c0_g1_i4	O46036	CTBP_DROME	84.9	358	45	4	136	1209	9	357	7.50E-173	608.2	CTBP_DROME	reviewed	C-terminal-binding protein (CtBP protein) (dCtBP)	CtBP CG7583	Drosophila melanogaster (Fruit fly)	476	"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"	ISWI-type complex [GO:0031010]; nucleus [GO:0005634]	"identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0016360; GO:0016616; GO:0022416; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0045944; GO:0051287; GO:0070491; GO:0090090; GO:0090263	"ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN957_c0_g1_i5	O46036	CTBP_DROME	84.9	358	45	4	206	1279	9	357	7.90E-173	608.2	CTBP_DROME	reviewed	C-terminal-binding protein (CtBP protein) (dCtBP)	CtBP CG7583	Drosophila melanogaster (Fruit fly)	476	"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"	ISWI-type complex [GO:0031010]; nucleus [GO:0005634]	"identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0016360; GO:0016616; GO:0022416; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0045944; GO:0051287; GO:0070491; GO:0090090; GO:0090263	"ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28428_c0_g1_i1	Q13363	CTBP1_HUMAN	100	78	0	0	2	235	243	320	8.40E-40	163.7	CTBP1_HUMAN	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-)	CTBP1 CTBP	Homo sapiens (Human)	440	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006342; GO:0006468; GO:0008022; GO:0008134; GO:0008285; GO:0016616; GO:0017053; GO:0019079; GO:0019904; GO:0031065; GO:0035067; GO:0042802; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0070491; GO:0090241	"chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31525_c0_g1_i1	Q13363	CTBP1_HUMAN	100	126	0	0	378	1	120	245	7.60E-67	254.2	CTBP1_HUMAN	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-)	CTBP1 CTBP	Homo sapiens (Human)	440	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006342; GO:0006468; GO:0008022; GO:0008134; GO:0008285; GO:0016616; GO:0017053; GO:0019079; GO:0019904; GO:0031065; GO:0035067; GO:0042802; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0070491; GO:0090241	"chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27330_c0_g1_i1	Q13363	CTBP1_HUMAN	100	133	0	0	402	4	247	379	2.20E-72	272.7	CTBP1_HUMAN	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-)	CTBP1 CTBP	Homo sapiens (Human)	440	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006342; GO:0006468; GO:0008022; GO:0008134; GO:0008285; GO:0016616; GO:0017053; GO:0019079; GO:0019904; GO:0031065; GO:0035067; GO:0042802; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0070491; GO:0090241	"chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27450_c0_g1_i1	O88712	CTBP1_MOUSE	100	78	0	0	235	2	174	251	8.40E-40	163.7	CTBP1_MOUSE	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-)	Ctbp1	Mus musculus (Mouse)	441	"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin silencing [GO:0006342]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006342; GO:0008134; GO:0016616; GO:0017053; GO:0019904; GO:0030165; GO:0031065; GO:0035067; GO:0042802; GO:0042803; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0070491; GO:0090241; GO:0098793; GO:0098978; GO:0099526	"chromatin silencing [GO:0006342]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN957_c0_g1_i2	Q9Z2F5	CTBP1_RAT	82.1	56	9	1	117	284	1	55	1.30E-19	97.1	CTBP1_RAT	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-) (50 kDa BFA-dependent ADP-ribosylation substrate) (BARS-50) (C-terminal-binding protein 3) (CtBP3)	Ctbp1 Bars Ctbp3	Rattus norvegicus (Rat)	430	"cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; chromatin silencing [GO:0006342]; membrane fusion [GO:0061025]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005737; GO:0006342; GO:0008134; GO:0016616; GO:0016746; GO:0017053; GO:0019904; GO:0030165; GO:0031065; GO:0035067; GO:0042802; GO:0042803; GO:0043005; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0061025; GO:0070491; GO:0090241; GO:0098793; GO:0098831; GO:0098978; GO:0098982; GO:0099526	"chromatin silencing [GO:0006342]; membrane fusion [GO:0061025]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20460_c0_g1_i1	Q9Z2F5	CTBP1_RAT	100	119	0	0	358	2	1	119	4.40E-62	238.4	CTBP1_RAT	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-) (50 kDa BFA-dependent ADP-ribosylation substrate) (BARS-50) (C-terminal-binding protein 3) (CtBP3)	Ctbp1 Bars Ctbp3	Rattus norvegicus (Rat)	430	"cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; chromatin silencing [GO:0006342]; membrane fusion [GO:0061025]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005737; GO:0006342; GO:0008134; GO:0016616; GO:0016746; GO:0017053; GO:0019904; GO:0030165; GO:0031065; GO:0035067; GO:0042802; GO:0042803; GO:0043005; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0061025; GO:0070491; GO:0090241; GO:0098793; GO:0098831; GO:0098978; GO:0098982; GO:0099526	"chromatin silencing [GO:0006342]; membrane fusion [GO:0061025]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20460_c0_g1_i2	Q9Z2F5	CTBP1_RAT	100	114	0	0	343	2	1	114	2.50E-59	229.2	CTBP1_RAT	reviewed	C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-) (50 kDa BFA-dependent ADP-ribosylation substrate) (BARS-50) (C-terminal-binding protein 3) (CtBP3)	Ctbp1 Bars Ctbp3	Rattus norvegicus (Rat)	430	"cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; chromatin silencing [GO:0006342]; membrane fusion [GO:0061025]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005737; GO:0006342; GO:0008134; GO:0016616; GO:0016746; GO:0017053; GO:0019904; GO:0030165; GO:0031065; GO:0035067; GO:0042802; GO:0042803; GO:0043005; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0061025; GO:0070491; GO:0090241; GO:0098793; GO:0098831; GO:0098978; GO:0098982; GO:0099526	"chromatin silencing [GO:0006342]; membrane fusion [GO:0061025]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; presynapse to nucleus signaling pathway [GO:0099526]; regulation of cell cycle [GO:0051726]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31344_c0_g1_i1	P56546	CTBP2_MOUSE	100	137	0	0	412	2	82	218	5.00E-72	271.6	CTBP2_MOUSE	reviewed	C-terminal-binding protein 2 (CtBP2)	Ctbp2	Mus musculus (Mouse)	445	"GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; synaptic vesicle docking [GO:0016081]; white fat cell differentiation [GO:0050872]"	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"	GO:0001226; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0016081; GO:0016616; GO:0017053; GO:0019901; GO:0035563; GO:0042802; GO:0042974; GO:0044877; GO:0045202; GO:0045892; GO:0045944; GO:0048386; GO:0050872; GO:0051287; GO:0097470; GO:0098684; GO:0098831; GO:0098978; GO:0098982; GO:0099523; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; synaptic vesicle docking [GO:0016081]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25603_c0_g1_i1	Q6FUD0	PYRG_CANGA	62	171	65	0	516	4	15	185	5.90E-62	238.4	PYRG_CANGA	reviewed	CTP synthase (EC 6.3.4.2) (CTP synthetase) (UTP--ammonia ligase)	URA7 CAGL0F04433g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	578	cytoophidium [GO:0097268]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]; phospholipid biosynthetic process [GO:0008654]; pyrimidine nucleobase biosynthetic process [GO:0019856]	cytoophidium [GO:0097268]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]	GO:0003883; GO:0005524; GO:0006541; GO:0008654; GO:0019856; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]; phospholipid biosynthetic process [GO:0008654]; pyrimidine nucleobase biosynthetic process [GO:0019856]		NA	NA	NA	NA	NA	NA
TRINITY_DN2989_c0_g1_i1	A0LUA5	PYRG_ACIC1	90.8	87	8	0	3	263	29	115	1.70E-41	169.5	PYRG_ACIC1	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG Acel_1243	Acidothermus cellulolyticus (strain ATCC 43068 / 11B)	558	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN26198_c0_g1_i1	B2U9C0	PYRG_RALPJ	100	146	0	0	439	2	28	173	3.80E-78	292	PYRG_RALPJ	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG Rpic_0969	Ralstonia pickettii (strain 12J)	553	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN27879_c0_g1_i1	Q6A7X4	PYRG_CUTAK	100	67	0	0	2	202	189	255	4.20E-32	137.9	PYRG_CUTAK	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG PPA1390	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	562	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN34298_c0_g1_i1	Q89KU5	PYRG_BRADU	99	103	1	0	310	2	18	120	3.50E-54	211.8	PYRG_BRADU	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG bll4805	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	543	cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]	cytosol [GO:0005829]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0005829; GO:0006241; GO:0006541; GO:0019856; GO:0042802; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]		NA	NA	NA	NA	NA	NA
TRINITY_DN3247_c0_g1_i1	Q6A7X4	PYRG_CUTAK	98.9	89	1	0	1	267	5	93	2.60E-45	182.2	PYRG_CUTAK	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG PPA1390	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	562	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN2271_c0_g2_i1	Q1GTY6	PYRG_SPHAL	94.3	174	10	0	2	523	4	177	5.10E-90	331.6	PYRG_SPHAL	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG Sala_1170	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	543	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN2271_c0_g1_i1	A5V8U1	PYRG_SPHWW	87.2	94	12	0	2	283	85	178	8.30E-42	170.6	PYRG_SPHWW	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG Swit_2348	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	544	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN2271_c0_g3_i1	Q2G6R7	PYRG_NOVAD	97.3	112	3	0	1	336	67	178	1.10E-58	226.9	PYRG_NOVAD	reviewed	CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase)	pyrG Saro_2017	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	543	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]	GO:0003883; GO:0005524; GO:0006541; GO:0044210; GO:0046872	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN18928_c0_g1_i1	P17812	PYRG1_HUMAN	100	271	0	0	814	2	4	274	2.10E-154	546.2	PYRG1_HUMAN	reviewed	CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)	CTPS1 CTPS	Homo sapiens (Human)	591	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to drug [GO:0042493]; T cell proliferation [GO:0042098]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006139; GO:0006241; GO:0006541; GO:0015949; GO:0016020; GO:0019856; GO:0042098; GO:0042100; GO:0042493; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to drug [GO:0042493]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN21744_c0_g1_i1	P70698	PYRG1_MOUSE	60.9	192	75	0	637	62	291	482	1.20E-67	257.7	PYRG1_MOUSE	reviewed	CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)	Ctps1 Ctps	Mus musculus (Mouse)	591	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; T cell proliferation [GO:0042098]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006241; GO:0006541; GO:0019856; GO:0042098; GO:0042100; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN21744_c0_g1_i2	P70698	PYRG1_MOUSE	66.8	587	185	2	1928	195	1	586	1.60E-235	817	PYRG1_MOUSE	reviewed	CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)	Ctps1 Ctps	Mus musculus (Mouse)	591	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; T cell proliferation [GO:0042098]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006241; GO:0006541; GO:0019856; GO:0042098; GO:0042100; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN24279_c0_g1_i1	P17812	PYRG1_HUMAN	100	213	0	0	2	640	344	556	2.40E-126	452.6	PYRG1_HUMAN	reviewed	CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)	CTPS1 CTPS	Homo sapiens (Human)	591	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to drug [GO:0042493]; T cell proliferation [GO:0042098]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006139; GO:0006241; GO:0006541; GO:0015949; GO:0016020; GO:0019856; GO:0042098; GO:0042100; GO:0042493; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to drug [GO:0042493]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN38364_c0_g1_i1	Q5XHA8	PYG1A_XENLA	60	120	47	1	358	2	26	145	7.40E-40	164.5	PYG1A_XENLA	reviewed	CTP synthase 1-A (EC 6.3.4.2) (CTP synthetase 1-A) (UTP--ammonia ligase 1-A)	ctps1-a	Xenopus laevis (African clawed frog)	591	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]	GO:0003883; GO:0005524; GO:0006241; GO:0006541; GO:0044210	'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN38990_c0_g1_i1	P70303	PYRG2_MOUSE	100	136	0	0	1	408	428	563	1.00E-77	290.4	PYRG2_MOUSE	reviewed	CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (CTPsH) (UTP--ammonia ligase 2)	Ctps2	Mus musculus (Mouse)	586	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005739; GO:0006241; GO:0006541; GO:0019856; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]		NA	NA	NA	NA	NA	NA
TRINITY_DN22830_c0_g1_i1	Q1RMS2	PYRG2_BOVIN	100	103	0	0	1	309	4	106	6.60E-53	207.6	PYRG2_BOVIN	reviewed	CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2)	CTPS2	Bos taurus (Bovine)	586	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0006241; GO:0006541; GO:0019856; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]		NA	NA	NA	NA	NA	NA
TRINITY_DN38099_c0_g1_i1	A6ZQ59	URA8_YEAS7	61.2	80	31	0	243	4	1	80	2.30E-22	105.9	URA8_YEAS7	reviewed	CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2)	URA8 SCY_3020	Saccharomyces cerevisiae (strain YJM789) (Baker's yeast)	578	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]	GO:0003883; GO:0005524; GO:0005737; GO:0006541; GO:0044210	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN25837_c0_g1_i1	Q6GME1	PYRG2_XENLA	57.3	89	33	1	3	269	453	536	1.80E-22	106.3	PYRG2_XENLA	reviewed	CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2)	ctps2	Xenopus laevis (African clawed frog)	578	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]	GO:0003883; GO:0005524; GO:0006541; GO:0044210	'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN25821_c0_g1_i1	Q9NRF8	PYRG2_HUMAN	95.9	74	3	0	1	222	114	187	6.30E-37	154.1	PYRG2_HUMAN	reviewed	CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2)	CTPS2	Homo sapiens (Human)	586	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006220; GO:0006241; GO:0006541; GO:0015949; GO:0019856; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN25821_c0_g1_i2	Q9NRF8	PYRG2_HUMAN	98.6	74	1	0	1	222	114	187	3.30E-38	158.3	PYRG2_HUMAN	reviewed	CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2)	CTPS2	Homo sapiens (Human)	586	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220]	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]	GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006220; GO:0006241; GO:0006541; GO:0015949; GO:0019856; GO:0042802; GO:0044210; GO:0097268	'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN27753_c0_g1_i1	Q8SX68	Y0915_DROME	34.3	137	78	4	28	402	60	196	9.00E-10	64.7	CT2NL_DROME	reviewed	CTTNBP2 N-terminal-like protein (Protein Nausicaa)	Naus CG10915	Drosophila melanogaster (Fruit fly)	609	cytoplasm [GO:0005737]; FAR/SIN/STRIPAK complex [GO:0090443]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin filament bundle retrograde transport [GO:0061573]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of neuron projection arborization [GO:0150012]; protein localization to actin cytoskeleton [GO:1903119]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	cytoplasm [GO:0005737]; FAR/SIN/STRIPAK complex [GO:0090443]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]		GO:0001725; GO:0005737; GO:0030027; GO:0034315; GO:0061573; GO:0090443; GO:0150012; GO:1903119; GO:2000394	actin filament bundle retrograde transport [GO:0061573]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of neuron projection arborization [GO:0150012]; protein localization to actin cytoskeleton [GO:1903119]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i10	A3FM55	LECM1_HYDHA	31.7	161	95	5	139	597	1	154	7.60E-14	79.7	LECM1_HYDHA	reviewed	C-type lectin 1 (CTL)		Hydrophis hardwickii (Hardwick's spine-bellied seasnake) (Lapemis hardwickii)	164	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i2	A3FM55	LECM1_HYDHA	31.7	161	95	5	139	597	1	154	2.90E-13	77.8	LECM1_HYDHA	reviewed	C-type lectin 1 (CTL)		Hydrophis hardwickii (Hardwick's spine-bellied seasnake) (Lapemis hardwickii)	164	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN10015_c0_g1_i1	Q6ZS10	CL17A_HUMAN	27.3	121	65	6	428	75	275	375	4.50E-05	49.7	CL17A_HUMAN	reviewed	"C-type lectin domain family 17, member A (Prolectin)"	CLEC17A	Homo sapiens (Human)	378	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]	fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0005537; GO:0009986; GO:0016021; GO:0042802; GO:0042806; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN273_c0_g1_i11	Q9R0Q8	CLC4E_MOUSE	33.3	75	45	2	220	444	96	165	3.80E-05	50.1	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	x	NA	NA	1	NA	NA	1
TRINITY_DN273_c0_g1_i4	Q9R0Q8	CLC4E_MOUSE	33.8	71	42	2	232	444	100	165	6.60E-05	49.3	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	x	NA	NA	1	NA	NA	NA
TRINITY_DN5548_c0_g1_i1	Q9R0Q8	CLC4E_MOUSE	28.9	97	58	4	540	256	68	155	2.70E-05	50.4	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	xx	black	black	1	NA	NA	1
TRINITY_DN273_c0_g1_i1	Q9R0Q8	CLC4E_MOUSE	30.4	112	66	4	220	549	96	197	5.90E-07	55.8	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]		NA	NA	NA	NA	NA	NA
TRINITY_DN273_c0_g1_i12	Q9R0Q8	CLC4E_MOUSE	33.8	71	42	2	4	216	100	165	3.30E-05	49.7	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]		NA	NA	NA	NA	NA	NA
TRINITY_DN273_c0_g1_i13	Q9R0Q8	CLC4E_MOUSE	30.9	110	64	4	232	555	100	199	2.20E-06	53.9	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]		NA	NA	NA	NA	NA	NA
TRINITY_DN273_c0_g1_i3	Q9R0Q8	CLC4E_MOUSE	34.6	78	45	3	232	465	100	171	4.40E-05	49.7	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]		NA	NA	NA	NA	NA	NA
TRINITY_DN273_c0_g1_i6	Q9R0Q8	CLC4E_MOUSE	29.6	108	64	5	232	549	100	197	8.50E-05	48.9	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]		NA	NA	NA	NA	NA	NA
TRINITY_DN273_c0_g1_i9	Q9R0Q8	CLC4E_MOUSE	29.5	112	67	5	220	549	96	197	4.50E-05	49.7	CLC4E_MOUSE	reviewed	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	Clec4e Clecsf9 Mincle	Mus musculus (Mouse)	214	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]		NA	NA	NA	NA	NA	NA
TRINITY_DN1416_c0_g2_i1	Q8R3V6	CUED1_MOUSE	48.7	150	69	2	525	94	45	192	3.00E-14	80.1	CUED1_MOUSE	reviewed	CUE domain-containing protein 1	Cuedc1	Mus musculus (Mouse)	388							NA	NA	NA	NA	NA	NA
TRINITY_DN25429_c0_g1_i1	Q9H467	CUED2_HUMAN	32.2	295	183	6	49	921	6	287	1.50E-31	138.7	CUED2_HUMAN	reviewed	CUE domain-containing protein 2	CUEDC2 C10orf66 HOYS6	Homo sapiens (Human)	287	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of macrophage cytokine production [GO:0010936]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829; GO:0010936; GO:0031965; GO:1900016	negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of macrophage cytokine production [GO:0010936]		NA	NA	NA	NA	NA	NA
TRINITY_DN28676_c0_g1_i1	Q92879	CELF1_HUMAN	100	118	0	0	2	355	369	486	2.20E-62	239.6	CELF1_HUMAN	reviewed	CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2)	CELF1 BRUNOL2 CUGBP CUGBP1 NAB50	Homo sapiens (Human)	486	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinucleolar compartment [GO:0097356]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; negative regulation of gene expression [GO:0010629]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; posttranscriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of inflammatory response [GO:0050727]; regulation of RNA splicing [GO:0043484]; RNA interference [GO:0016246]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinucleolar compartment [GO:0097356]; ribonucleoprotein complex [GO:1990904]	"BRE binding [GO:0042835]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000381; GO:0000900; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0007281; GO:0009792; GO:0010494; GO:0010628; GO:0010629; GO:0010942; GO:0016020; GO:0016246; GO:0016441; GO:0036002; GO:0042835; GO:0043484; GO:0050727; GO:0061157; GO:0097356; GO:1990904	"embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; negative regulation of gene expression [GO:0010629]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; posttranscriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of inflammatory response [GO:0050727]; regulation of RNA splicing [GO:0043484]; RNA interference [GO:0016246]"		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c1_g1_i2	Q9IBD0	CELF1_DANRE	64.4	132	47	0	243	638	370	501	2.20E-38	160.6	CELF1_DANRE	reviewed	CUGBP Elav-like family member 1 (CELF-1) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (EDEN-BP/Bruno-like protein) (RNA-binding protein BRUNOL-2)	celf1 brul cugbp1	Danio rerio (Zebrafish) (Brachydanio rerio)	501	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; pole plasm [GO:0045495]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell migration [GO:0016477]; determination of left/right symmetry [GO:0007368]; developmental cell growth [GO:0048588]; digestive tract development [GO:0048565]; embryonic liver development [GO:1990402]; endodermal digestive tract morphogenesis [GO:0061031]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mRNA splice site selection [GO:0006376]; pancreas development [GO:0031016]; pancreas morphogenesis [GO:0061113]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; pole plasm [GO:0045495]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0001889; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006376; GO:0007368; GO:0016477; GO:0031016; GO:0045495; GO:0048565; GO:0048588; GO:0061014; GO:0061031; GO:0061113; GO:0070306; GO:1990402; GO:1990904	"cell migration [GO:0016477]; determination of left/right symmetry [GO:0007368]; developmental cell growth [GO:0048588]; digestive tract development [GO:0048565]; embryonic liver development [GO:1990402]; endodermal digestive tract morphogenesis [GO:0061031]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mRNA splice site selection [GO:0006376]; pancreas development [GO:0031016]; pancreas morphogenesis [GO:0061113]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19253_c0_g1_i1	Q5R995	CELF1_PONAB	97.3	224	6	0	672	1	19	242	1.70E-122	439.9	CELF1_PONAB	reviewed	CUGBP Elav-like family member 1 (CELF-1) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (RNA-binding protein BRUNOL-2)	CELF1 CUGBP1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	513	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0043484	mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c1_g1_i1	Q28HE9	CELF1_XENTR	70.4	115	28	1	321	665	382	490	3.90E-38	159.8	CELF1_XENTR	reviewed	CUGBP Elav-like family member 1 (CELF-1) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (RNA-binding protein BRUNOL-2)	celf1 cugbp1 TEgg064f02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	490	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c1_g1_i3	Q28HE9	CELF1_XENTR	70.4	115	28	1	348	692	382	490	6.80E-38	159.1	CELF1_XENTR	reviewed	CUGBP Elav-like family member 1 (CELF-1) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (RNA-binding protein BRUNOL-2)	celf1 cugbp1 TEgg064f02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	490	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22215_c0_g1_i1	O95319	CELF2_HUMAN	100	234	0	0	703	2	18	251	2.80E-134	479.2	CELF2_HUMAN	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3)	CELF2 BRUNOL3 CUGBP2 ETR3 NAPOR	Homo sapiens (Human)	508	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0006396; GO:0008016; GO:0036002; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c0_g1_i2	O95319	CELF2_HUMAN	58.6	266	79	7	771	1	34	277	2.40E-73	276.9	CELF2_HUMAN	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3)	CELF2 BRUNOL3 CUGBP2 ETR3 NAPOR	Homo sapiens (Human)	508	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0006396; GO:0008016; GO:0036002; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c0_g1_i3	O95319	CELF2_HUMAN	58.2	268	79	7	777	1	34	277	5.60E-73	275.8	CELF2_HUMAN	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3)	CELF2 BRUNOL3 CUGBP2 ETR3 NAPOR	Homo sapiens (Human)	508	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0006396; GO:0008016; GO:0036002; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c0_g1_i4	O95319	CELF2_HUMAN	62.9	248	79	6	717	1	34	277	1.30E-76	287.7	CELF2_HUMAN	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3)	CELF2 BRUNOL3 CUGBP2 ETR3 NAPOR	Homo sapiens (Human)	508	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0006396; GO:0008016; GO:0036002; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN908_c0_g1_i5	O95319	CELF2_HUMAN	58.6	266	79	7	771	1	34	277	3.20E-73	276.6	CELF2_HUMAN	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3)	CELF2 BRUNOL3 CUGBP2 ETR3 NAPOR	Homo sapiens (Human)	508	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0006396; GO:0008016; GO:0036002; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1924_c0_g1_i1	Q6P0B1	CELF2_DANRE	27.4	197	95	4	825	244	43	194	2.20E-08	61.2	CELF2_DANRE	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (RNA-binding protein BRUNOL-3)	celf2 cugbp2 etr3	Danio rerio (Zebrafish) (Brachydanio rerio)	514	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34640_c0_g1_i1	Q7T2T1	CELF2_CHICK	100	121	0	0	411	49	364	484	4.20E-63	241.9	CELF2_CHICK	reviewed	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (RNA-binding protein BRUNOL-3)	CELF2 CUGBP2	Gallus gallus (Chicken)	484	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"BRE binding [GO:0042835]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000166; GO:0000380; GO:0000381; GO:0000900; GO:0003676; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0042835; GO:1990904	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16392_c0_g1_i1	Q13616	CUL1_HUMAN	100	280	0	0	2	841	53	332	4.90E-159	561.6	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15129_c0_g1_i1	Q13616	CUL1_HUMAN	99.7	382	1	0	1147	2	262	643	1.80E-212	739.6	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15129_c0_g1_i2	Q13616	CUL1_HUMAN	99.4	163	1	0	492	4	262	424	9.50E-86	317.4	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN25718_c0_g1_i1	Q13616	CUL1_HUMAN	100	76	0	0	1	228	514	589	5.80E-38	157.5	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN123_c0_g1_i1	Q13616	CUL1_HUMAN	74.1	796	173	5	69	2438	8	776	0	1142.9	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN123_c0_g1_i2	Q13616	CUL1_HUMAN	73.5	770	170	5	69	2360	8	749	0	1088.9	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN123_c0_g1_i3	Q13616	CUL1_HUMAN	85.2	27	4	0	89	169	750	776	2.70E-07	55.8	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN123_c0_g2_i1	Q13616	CUL1_HUMAN	74.1	796	173	5	2397	28	8	776	0	1143.3	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN31678_c0_g1_i1	Q13616	CUL1_HUMAN	99	100	1	0	327	28	677	776	5.90E-48	191.4	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN35616_c0_g1_i1	Q13616	CUL1_HUMAN	100	71	0	0	214	2	1	71	1.00E-35	150.2	CUL1_HUMAN	reviewed	Cullin-1 (CUL-1)	CUL1	Homo sapiens (Human)	776	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000086; GO:0000209; GO:0002223; GO:0004842; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006879; GO:0008283; GO:0009887; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031625; GO:0038061; GO:0038095; GO:0043161; GO:0043687; GO:0050852; GO:0051403; GO:0070498; GO:0070936; GO:0097193; GO:1901990; GO:1990452	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN40356_c0_g1_i1	Q9D4H8	CUL2_MOUSE	100	87	0	0	263	3	5	91	1.50E-45	183	CUL2_MOUSE	reviewed	Cullin-2 (CUL-2)	Cul2	Mus musculus (Mouse)	745	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005730; GO:0006511; GO:0016567; GO:0019005; GO:0030163; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0043161; GO:0044877	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN37366_c0_g1_i1	Q9D4H8	CUL2_MOUSE	100	117	0	0	3	353	443	559	6.80E-62	237.7	CUL2_MOUSE	reviewed	Cullin-2 (CUL-2)	Cul2	Mus musculus (Mouse)	745	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005730; GO:0006511; GO:0016567; GO:0019005; GO:0030163; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0043161; GO:0044877	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2217_c0_g1_i1	Q9D4H8	CUL2_MOUSE	56.9	749	315	5	2330	96	1	745	7.30E-240	831.6	CUL2_MOUSE	reviewed	Cullin-2 (CUL-2)	Cul2	Mus musculus (Mouse)	745	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005730; GO:0006511; GO:0016567; GO:0019005; GO:0030163; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0043161; GO:0044877	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN2217_c0_g1_i2	Q13617	CUL2_HUMAN	77.3	44	10	0	227	96	702	745	4.20E-12	72	CUL2_HUMAN	reviewed	Cullin-2 (CUL-2)	CUL2	Homo sapiens (Human)	745	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0004842; GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0016032; GO:0016567; GO:0019005; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0043161; GO:0043687; GO:0044877; GO:0061418; GO:0097193	G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3298_c0_g1_i1	B5DF89	CUL3_RAT	71.4	823	172	5	2533	68	8	768	0	1116.3	CUL3_RAT	reviewed	Cullin-3	Cul3	Rattus norvegicus (Rat)	768	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]	cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000139; GO:0000209; GO:0000278; GO:0000902; GO:0000922; GO:0001701; GO:0001831; GO:0004842; GO:0005112; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005886; GO:0006357; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0071630; GO:0072576; GO:0072686; GO:1901992	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN27206_c0_g1_i1	Q13618	CUL3_HUMAN	100	174	0	0	522	1	6	179	1.80E-95	349.7	CUL3_HUMAN	reviewed	Cullin-3 (CUL-3)	CUL3 KIAA0617	Homo sapiens (Human)	768	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; MAPK cascade [GO:0000165]; mitotic metaphase plate congression [GO:0007080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]	cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0000122; GO:0000139; GO:0000165; GO:0000209; GO:0000922; GO:0001831; GO:0005112; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005827; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0008284; GO:0016020; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0043149; GO:0043161; GO:0043687; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070062; GO:0071630; GO:0072576; GO:0072686; GO:0090090; GO:0097193; GO:1901992	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; MAPK cascade [GO:0000165]; mitotic metaphase plate congression [GO:0007080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN29971_c0_g1_i1	Q13618	CUL3_HUMAN	100	241	0	0	724	2	264	504	2.80E-134	479.2	CUL3_HUMAN	reviewed	Cullin-3 (CUL-3)	CUL3 KIAA0617	Homo sapiens (Human)	768	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; MAPK cascade [GO:0000165]; mitotic metaphase plate congression [GO:0007080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]	cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0000122; GO:0000139; GO:0000165; GO:0000209; GO:0000922; GO:0001831; GO:0005112; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005827; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0008284; GO:0016020; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0043149; GO:0043161; GO:0043687; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070062; GO:0071630; GO:0072576; GO:0072686; GO:0090090; GO:0097193; GO:1901992	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; MAPK cascade [GO:0000165]; mitotic metaphase plate congression [GO:0007080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN38663_c0_g1_i1	Q9ZVH4	CUL3A_ARATH	53.5	127	58	1	2	382	378	503	2.10E-32	139.8	CUL3A_ARATH	reviewed	Cullin-3A (AtCUL3a)	CUL3A CUL3 At1g26830 T2P11.2	Arabidopsis thaliana (Mouse-ear cress)	732	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of flower development [GO:0009911]; protein ubiquitination [GO:0016567]; response to red or far red light [GO:0009639]; ubiquitin-dependent protein catabolic process [GO:0006511]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005829; GO:0006511; GO:0009639; GO:0009911; GO:0016567; GO:0031461; GO:0031625	positive regulation of flower development [GO:0009911]; protein ubiquitination [GO:0016567]; response to red or far red light [GO:0009639]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40335_c0_g1_i1	Q6DE95	CUL3A_XENLA	100	84	0	0	252	1	503	586	3.50E-44	178.3	CUL3A_XENLA	reviewed	Cullin-3-A (CUL-3-A)	cul3a	Xenopus laevis (African clawed frog)	768	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; spindle pole [GO:0000922]; ubiquitin protein ligase binding [GO:0031625]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; spindle pole [GO:0000922]	ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000922; GO:0005634; GO:0005813; GO:0005827; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0016477; GO:0016567; GO:0017145; GO:0031463; GO:0031625; GO:0035024; GO:0040016; GO:0043149; GO:0043161; GO:0045842; GO:0048208; GO:0072686; GO:1901992	cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN40990_c0_g1_i1	Q13619	CUL4A_HUMAN	100	125	0	0	377	3	322	446	9.90E-67	253.8	CUL4A_HUMAN	reviewed	Cullin-4A (CUL-4A)	CUL4A	Homo sapiens (Human)	759	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0001701; GO:0004842; GO:0005654; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0033683; GO:0035019; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0048511; GO:0051246; GO:0070911; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; intrinsic apoptotic signaling pathway [GO:0097193]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40767_c0_g1_i1	Q3TCH7	CUL4A_MOUSE	100	79	0	0	3	239	194	272	1.10E-36	153.3	CUL4A_MOUSE	reviewed	Cullin-4A (CUL-4A)	Cul4a	Mus musculus (Mouse)	759	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001701; GO:0004842; GO:0006281; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0035019; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0051246; GO:0080008; GO:1900087; GO:2000001; GO:2000819	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31571_c0_g1_i1	Q13619	CUL4A_HUMAN	100	101	0	0	1	303	550	650	3.60E-51	201.8	CUL4A_HUMAN	reviewed	Cullin-4A (CUL-4A)	CUL4A	Homo sapiens (Human)	759	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0001701; GO:0004842; GO:0005654; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0033683; GO:0035019; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0048511; GO:0051246; GO:0070911; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; intrinsic apoptotic signaling pathway [GO:0097193]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33885_c0_g1_i1	Q3TCH7	CUL4A_MOUSE	100	81	0	0	245	3	554	634	1.30E-40	166.4	CUL4A_MOUSE	reviewed	Cullin-4A (CUL-4A)	Cul4a	Mus musculus (Mouse)	759	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001701; GO:0004842; GO:0006281; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0035019; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0051246; GO:0080008; GO:1900087; GO:2000001; GO:2000819	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN24784_c0_g1_i1	Q3TCH7	CUL4A_MOUSE	87.7	73	9	0	2	220	403	475	2.00E-27	122.5	CUL4A_MOUSE	reviewed	Cullin-4A (CUL-4A)	Cul4a	Mus musculus (Mouse)	759	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001701; GO:0004842; GO:0006281; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0035019; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0051246; GO:0080008; GO:1900087; GO:2000001; GO:2000819	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN36048_c0_g1_i1	Q13619	CUL4A_HUMAN	100	112	0	0	410	75	648	759	4.10E-58	225.3	CUL4A_HUMAN	reviewed	Cullin-4A (CUL-4A)	CUL4A	Homo sapiens (Human)	759	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0001701; GO:0004842; GO:0005654; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0033683; GO:0035019; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0048511; GO:0051246; GO:0070911; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; intrinsic apoptotic signaling pathway [GO:0097193]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31679_c0_g1_i1	Q3TCH7	CUL4A_MOUSE	47.3	91	48	0	285	13	669	759	3.50E-16	85.5	CUL4A_MOUSE	reviewed	Cullin-4A (CUL-4A)	Cul4a	Mus musculus (Mouse)	759	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001701; GO:0004842; GO:0006281; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0035019; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0051246; GO:0080008; GO:1900087; GO:2000001; GO:2000819	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		red	red	NA	NA	NA	NA
TRINITY_DN30962_c0_g1_i1	Q13619	CUL4A_HUMAN	100	89	0	0	268	2	140	228	2.40E-43	175.6	CUL4A_HUMAN	reviewed	Cullin-4A (CUL-4A)	CUL4A	Homo sapiens (Human)	759	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0001701; GO:0004842; GO:0005654; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0033683; GO:0035019; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0048511; GO:0051246; GO:0070911; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; intrinsic apoptotic signaling pathway [GO:0097193]; in utero embryonic development [GO:0001701]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38014_c0_g1_i1	Q13620	CUL4B_HUMAN	100	46	0	0	211	74	868	913	1.50E-19	96.3	CUL4B_HUMAN	reviewed	Cullin-4B (CUL-4B)	CUL4B KIAA0695	Homo sapiens (Human)	913	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"	Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0004842; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0010498; GO:0016567; GO:0019005; GO:0031146; GO:0031175; GO:0031461; GO:0031465; GO:0031625; GO:0033683; GO:0035518; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0045732; GO:0070062; GO:0070911; GO:0070914; GO:0080008; GO:1900087	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN324_c0_g1_i1	Q13620	CUL4B_HUMAN	77.6	192	43	0	663	88	722	913	1.60E-78	293.9	CUL4B_HUMAN	reviewed	Cullin-4B (CUL-4B)	CUL4B KIAA0695	Homo sapiens (Human)	913	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"	Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0004842; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0010498; GO:0016567; GO:0019005; GO:0031146; GO:0031175; GO:0031461; GO:0031465; GO:0031625; GO:0033683; GO:0035518; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0045732; GO:0070062; GO:0070911; GO:0070914; GO:0080008; GO:1900087	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN324_c0_g1_i2	Q13620	CUL4B_HUMAN	65.3	741	252	3	2304	88	176	913	5.80E-272	938.3	CUL4B_HUMAN	reviewed	Cullin-4B (CUL-4B)	CUL4B KIAA0695	Homo sapiens (Human)	913	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"	Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0004842; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0010498; GO:0016567; GO:0019005; GO:0031146; GO:0031175; GO:0031461; GO:0031465; GO:0031625; GO:0033683; GO:0035518; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0045732; GO:0070062; GO:0070911; GO:0070914; GO:0080008; GO:1900087	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN324_c0_g1_i3	Q13620	CUL4B_HUMAN	87.5	32	4	0	183	88	882	913	4.50E-10	65.1	CUL4B_HUMAN	reviewed	Cullin-4B (CUL-4B)	CUL4B KIAA0695	Homo sapiens (Human)	913	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"	Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0004842; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0010498; GO:0016567; GO:0019005; GO:0031146; GO:0031175; GO:0031461; GO:0031465; GO:0031625; GO:0033683; GO:0035518; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0045732; GO:0070062; GO:0070911; GO:0070914; GO:0080008; GO:1900087	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN324_c0_g1_i4	Q13620	CUL4B_HUMAN	63.8	759	252	4	2358	88	176	913	1.40E-268	927.2	CUL4B_HUMAN	reviewed	Cullin-4B (CUL-4B)	CUL4B KIAA0695	Homo sapiens (Human)	913	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"	Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000715; GO:0000717; GO:0004842; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006974; GO:0010498; GO:0016567; GO:0019005; GO:0031146; GO:0031175; GO:0031461; GO:0031465; GO:0031625; GO:0033683; GO:0035518; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0045732; GO:0070062; GO:0070911; GO:0070914; GO:0080008; GO:1900087	"cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27386_c0_g1_i1	Q93034	CUL5_HUMAN	91.2	80	7	0	241	2	402	481	3.70E-35	148.3	CUL5_HUMAN	reviewed	Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1)	CUL5 VACM1	Homo sapiens (Human)	780	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]	calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0004842; GO:0005262; GO:0005829; GO:0006511; GO:0016032; GO:0016567; GO:0019005; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0038023; GO:0038128; GO:0043161; GO:0043687; GO:0090734; GO:0097193	ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN5641_c0_g1_i1	A7MBJ5	CAND1_BOVIN	72.9	388	100	2	3	1166	848	1230	8.00E-155	548.1	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN39694_c0_g1_i1	A7MBJ5	CAND1_BOVIN	100	167	0	0	2	502	458	624	4.50E-91	335.1	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN39688_c0_g1_i1	A7MBJ5	CAND1_BOVIN	100	139	0	0	52	468	344	482	7.20E-75	281.2	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN40908_c0_g1_i1	Q86KD1	CAND1_DICDI	44.3	61	34	0	10	192	1045	1105	1.60E-08	59.7	CAND1_DICDI	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	cand1 DDB_G0274167	Dictyostelium discoideum (Slime mold)	1238	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005634; GO:0010265; GO:0016567; GO:0043086	negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN27463_c0_g1_i1	A7MBJ5	CAND1_BOVIN	100	112	0	0	1	336	61	172	2.20E-54	212.6	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN35792_c0_g1_i1	A7MBJ5	CAND1_BOVIN	100	66	0	0	3	200	173	238	3.00E-30	131.7	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN7551_c0_g1_i1	A7MBJ5	CAND1_BOVIN	68.3	807	252	2	27	2435	1	807	2.30E-297	1022.7	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN7551_c0_g1_i8	A7MBJ5	CAND1_BOVIN	59.6	339	135	1	24	1034	469	807	2.40E-107	390.2	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN7551_c0_g1_i9	A7MBJ5	CAND1_BOVIN	59.6	339	135	1	24	1034	469	807	2.40E-107	390.2	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN14863_c0_g1_i2	A7MBJ5	CAND1_BOVIN	99.7	350	1	0	1	1050	867	1216	2.40E-195	682.6	CAND1_BOVIN	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1)	CAND1	Bos taurus (Bovine)	1230	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0030154; GO:0031461; GO:0043086	cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]		NA	NA	NA	NA	NA	NA
TRINITY_DN14863_c0_g1_i1	Q6ZQ38	CAND1_MOUSE	100	280	0	0	2	841	937	1216	6.70E-156	551.2	CAND1_MOUSE	reviewed	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1)	Cand1 D10Ertd516e Kiaa0829	Mus musculus (Mouse)	1230	"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]"	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	TBP-class protein binding [GO:0017025]	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0043086; GO:0045893; GO:0045899	"cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38702_c0_g1_i1	P81575	CUPA1_CANPG	77.8	90	20	0	3	272	5	94	1.60E-34	146.4	CUPA1_CANPG	reviewed	Cuticle protein AM/CP1114 (CPAM/CPAM1114)		Cancer pagurus (Rock crab)	102	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN36737_c0_g1_i1	P81576	CUPA2_CANPG	50	56	24	1	257	90	48	99	1.70E-06	53.5	CUPA2_CANPG	reviewed	Cuticle protein AM1159 (CPAM1159)		Cancer pagurus (Rock crab)	105	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN23395_c0_g1_i1	P81576	CUPA2_CANPG	67.3	55	18	0	166	2	51	105	4.70E-15	81.3	CUPA2_CANPG	reviewed	Cuticle protein AM1159 (CPAM1159)		Cancer pagurus (Rock crab)	105	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN38864_c0_g1_i1	P81577	CUPA3_CANPG	84.3	51	8	0	1	153	10	60	1.10E-19	96.7	CUPA3_CANPG	reviewed	Cuticle protein AM1199 (CPAM1199)		Cancer pagurus (Rock crab)	108	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN35311_c0_g1_i1	P81577	CUPA3_CANPG	81.2	48	9	0	195	52	61	108	4.20E-15	81.6	CUPA3_CANPG	reviewed	Cuticle protein AM1199 (CPAM1199)		Cancer pagurus (Rock crab)	108	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN1571_c0_g1_i1	P81577	CUPA3_CANPG	49.5	93	45	2	366	88	14	104	5.50E-16	86.3	CUPA3_CANPG	reviewed	Cuticle protein AM1199 (CPAM1199)		Cancer pagurus (Rock crab)	108	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN1571_c0_g1_i5	P81577	CUPA3_CANPG	51.2	82	39	1	333	88	24	104	5.90E-15	82.4	CUPA3_CANPG	reviewed	Cuticle protein AM1199 (CPAM1199)		Cancer pagurus (Rock crab)	108	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN1571_c0_g1_i7	P81577	CUPA3_CANPG	48.5	101	45	3	390	88	11	104	2.00E-16	87	CUPA3_CANPG	reviewed	Cuticle protein AM1199 (CPAM1199)		Cancer pagurus (Rock crab)	108	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN1571_c0_g1_i8	P81577	CUPA3_CANPG	49.5	93	45	2	366	88	14	104	4.90E-17	89.4	CUPA3_CANPG	reviewed	Cuticle protein AM1199 (CPAM1199)		Cancer pagurus (Rock crab)	108	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN3367_c0_g1_i1	Q8CI33	C19L1_MOUSE	57.8	173	71	1	1	513	365	537	8.40E-52	204.9	C19L1_MOUSE	reviewed	CWF19-like protein 1	Cwf19l1	Mus musculus (Mouse)	537	"post-mRNA release spliceosomal complex [GO:0071014]; RNA lariat debranching enzyme activator activity [GO:0061632]; mRNA splicing, via spliceosome [GO:0000398]"	post-mRNA release spliceosomal complex [GO:0071014]	RNA lariat debranching enzyme activator activity [GO:0061632]	GO:0000398; GO:0061632; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13495_c0_g1_i1	Q9P0U4	CXXC1_HUMAN	43.8	112	61	1	332	3	368	479	4.50E-21	102.8	CXXC1_HUMAN	reviewed	CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1)	CXXC1 CFP1 CGBP PCCX1 PHF18	Homo sapiens (Human)	656	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; histone H3-K4 methylation [GO:0051568]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0000987; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008270; GO:0016363; GO:0016607; GO:0035064; GO:0035097; GO:0036498; GO:0045322; GO:0045893; GO:0048188; GO:0051568	"histone H3-K4 methylation [GO:0051568]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN470_c0_g1_i1	Q9W352	CXXC1_DROME	52.8	89	38	1	39	305	35	119	6.90E-26	118.2	CXXC1_DROME	reviewed	CXXC-type zinc finger protein 1 (PHD finger and CXXC domain-containing protein 1)	Cfp1 CG17446	Drosophila melanogaster (Fruit fly)	663	"Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; histone H3-K4 methylation [GO:0051568]; positive regulation of transcription, DNA-templated [GO:0045893]"	Set1C/COMPASS complex [GO:0048188]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0008270; GO:0045893; GO:0048188; GO:0051568	"histone H3-K4 methylation [GO:0051568]; positive regulation of transcription, DNA-templated [GO:0045893]"		blue	blue	NA	NA	NA	NA
TRINITY_DN40999_c0_g1_i1	P15336	ATF2_HUMAN	100	48	0	0	145	2	357	404	5.00E-18	91.3	ATF2_HUMAN	reviewed	Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1)	ATF2 CREB2 CREBP1	Homo sapiens (Human)	505	"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]"	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001102; GO:0001228; GO:0003151; GO:0003682; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006970; GO:0006974; GO:0008140; GO:0009414; GO:0010628; GO:0016525; GO:0019901; GO:0031573; GO:0032915; GO:0035497; GO:0035861; GO:0043525; GO:0044877; GO:0045444; GO:0045944; GO:0046872; GO:0050680; GO:0051090; GO:0051091; GO:0060612; GO:0097186; GO:0110024; GO:1902110; GO:1990837	"adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7074_c0_g1_i1	P15336	ATF2_HUMAN	33	497	250	13	59	1534	6	424	8.60E-30	133.3	ATF2_HUMAN	reviewed	Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1)	ATF2 CREB2 CREBP1	Homo sapiens (Human)	505	"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]"	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001102; GO:0001228; GO:0003151; GO:0003682; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006970; GO:0006974; GO:0008140; GO:0009414; GO:0010628; GO:0016525; GO:0019901; GO:0031573; GO:0032915; GO:0035497; GO:0035861; GO:0043525; GO:0044877; GO:0045444; GO:0045944; GO:0046872; GO:0050680; GO:0051090; GO:0051091; GO:0060612; GO:0097186; GO:0110024; GO:1902110; GO:1990837	"adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1226_c0_g1_i2	G3V909	ATF6A_RAT	29	362	193	12	26	1057	331	646	1.80E-24	115.2	ATF6A_RAT	reviewed	Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha]	Atf6	Rattus norvegicus (Rat)	656	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]	"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000139; GO:0000976; GO:0000977; GO:0000978; GO:0001228; GO:0001654; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0007601; GO:0016020; GO:0030176; GO:0030968; GO:0031625; GO:0035497; GO:0042802; GO:0043065; GO:0043565; GO:0045944; GO:0046982; GO:1903893; GO:1990440; GO:1990837	endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN2527_c0_g1_i1	P16220	CREB1_HUMAN	42.5	259	94	10	633	1	71	322	4.80E-29	129.4	CREB1_HUMAN	reviewed	Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)	CREB1	Homo sapiens (Human)	327	"ATF4-CREB1 transcription factor complex [GO:1990589]; axon [GO:0030424]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; arrestin family protein binding [GO:1990763]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; axonogenesis [GO:0007409]; cellular response to fatty acid [GO:0071398]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to zinc ion [GO:0071294]; chemotaxis to arachidonic acid [GO:0034670]; circadian rhythm [GO:0007623]; lactation [GO:0007595]; lung saccule development [GO:0060430]; memory [GO:0007613]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by competitive promoter binding [GO:0010944]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell size [GO:0008361]; regulation of circadian rhythm [GO:0042752]; regulation of fibroblast proliferation [GO:0048145]; regulation of glial cell proliferation [GO:0060251]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucagon [GO:0033762]; response to hypoxia [GO:0001666]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; secretory granule organization [GO:0033363]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type I pneumocyte differentiation [GO:0060509]; viral process [GO:0016032]; visual learning [GO:0008542]"	ATF4-CREB1 transcription factor complex [GO:1990589]; axon [GO:0030424]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"arrestin family protein binding [GO:1990763]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001102; GO:0001225; GO:0001228; GO:0001666; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005759; GO:0006366; GO:0006468; GO:0007165; GO:0007179; GO:0007409; GO:0007568; GO:0007595; GO:0007613; GO:0007623; GO:0008361; GO:0008542; GO:0010033; GO:0010944; GO:0014823; GO:0016032; GO:0019899; GO:0021983; GO:0030424; GO:0030544; GO:0032916; GO:0033363; GO:0033762; GO:0034670; GO:0035035; GO:0035094; GO:0035497; GO:0035729; GO:0036120; GO:0040018; GO:0042493; GO:0042752; GO:0042802; GO:0043065; GO:0045600; GO:0045672; GO:0045893; GO:0045899; GO:0045944; GO:0046887; GO:0046889; GO:0048145; GO:0050821; GO:0055025; GO:0060251; GO:0060430; GO:0060509; GO:0071294; GO:0071300; GO:0071398; GO:1900273; GO:1901215; GO:1902065; GO:1990090; GO:1990314; GO:1990589; GO:1990763; GO:1990830; GO:1990837	"aging [GO:0007568]; axonogenesis [GO:0007409]; cellular response to fatty acid [GO:0071398]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to zinc ion [GO:0071294]; chemotaxis to arachidonic acid [GO:0034670]; circadian rhythm [GO:0007623]; lactation [GO:0007595]; lung saccule development [GO:0060430]; memory [GO:0007613]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by competitive promoter binding [GO:0010944]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell size [GO:0008361]; regulation of circadian rhythm [GO:0042752]; regulation of fibroblast proliferation [GO:0048145]; regulation of glial cell proliferation [GO:0060251]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucagon [GO:0033762]; response to hypoxia [GO:0001666]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; secretory granule organization [GO:0033363]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type I pneumocyte differentiation [GO:0060509]; viral process [GO:0016032]; visual learning [GO:0008542]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2527_c0_g1_i4	P16220	CREB1_HUMAN	42.1	259	99	10	645	1	71	322	2.20E-29	130.6	CREB1_HUMAN	reviewed	Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)	CREB1	Homo sapiens (Human)	327	"ATF4-CREB1 transcription factor complex [GO:1990589]; axon [GO:0030424]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; arrestin family protein binding [GO:1990763]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; axonogenesis [GO:0007409]; cellular response to fatty acid [GO:0071398]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to zinc ion [GO:0071294]; chemotaxis to arachidonic acid [GO:0034670]; circadian rhythm [GO:0007623]; lactation [GO:0007595]; lung saccule development [GO:0060430]; memory [GO:0007613]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by competitive promoter binding [GO:0010944]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell size [GO:0008361]; regulation of circadian rhythm [GO:0042752]; regulation of fibroblast proliferation [GO:0048145]; regulation of glial cell proliferation [GO:0060251]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucagon [GO:0033762]; response to hypoxia [GO:0001666]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; secretory granule organization [GO:0033363]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type I pneumocyte differentiation [GO:0060509]; viral process [GO:0016032]; visual learning [GO:0008542]"	ATF4-CREB1 transcription factor complex [GO:1990589]; axon [GO:0030424]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"arrestin family protein binding [GO:1990763]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001102; GO:0001225; GO:0001228; GO:0001666; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005759; GO:0006366; GO:0006468; GO:0007165; GO:0007179; GO:0007409; GO:0007568; GO:0007595; GO:0007613; GO:0007623; GO:0008361; GO:0008542; GO:0010033; GO:0010944; GO:0014823; GO:0016032; GO:0019899; GO:0021983; GO:0030424; GO:0030544; GO:0032916; GO:0033363; GO:0033762; GO:0034670; GO:0035035; GO:0035094; GO:0035497; GO:0035729; GO:0036120; GO:0040018; GO:0042493; GO:0042752; GO:0042802; GO:0043065; GO:0045600; GO:0045672; GO:0045893; GO:0045899; GO:0045944; GO:0046887; GO:0046889; GO:0048145; GO:0050821; GO:0055025; GO:0060251; GO:0060430; GO:0060509; GO:0071294; GO:0071300; GO:0071398; GO:1900273; GO:1901215; GO:1902065; GO:1990090; GO:1990314; GO:1990589; GO:1990763; GO:1990830; GO:1990837	"aging [GO:0007568]; axonogenesis [GO:0007409]; cellular response to fatty acid [GO:0071398]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to zinc ion [GO:0071294]; chemotaxis to arachidonic acid [GO:0034670]; circadian rhythm [GO:0007623]; lactation [GO:0007595]; lung saccule development [GO:0060430]; memory [GO:0007613]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by competitive promoter binding [GO:0010944]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell size [GO:0008361]; regulation of circadian rhythm [GO:0042752]; regulation of fibroblast proliferation [GO:0048145]; regulation of glial cell proliferation [GO:0060251]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucagon [GO:0033762]; response to hypoxia [GO:0001666]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; secretory granule organization [GO:0033363]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type I pneumocyte differentiation [GO:0060509]; viral process [GO:0016032]; visual learning [GO:0008542]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2527_c0_g1_i5	P16220	CREB1_HUMAN	40.9	259	86	11	597	1	71	322	4.00E-25	116.3	CREB1_HUMAN	reviewed	Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)	CREB1	Homo sapiens (Human)	327	"ATF4-CREB1 transcription factor complex [GO:1990589]; axon [GO:0030424]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; arrestin family protein binding [GO:1990763]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; axonogenesis [GO:0007409]; cellular response to fatty acid [GO:0071398]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to zinc ion [GO:0071294]; chemotaxis to arachidonic acid [GO:0034670]; circadian rhythm [GO:0007623]; lactation [GO:0007595]; lung saccule development [GO:0060430]; memory [GO:0007613]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by competitive promoter binding [GO:0010944]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell size [GO:0008361]; regulation of circadian rhythm [GO:0042752]; regulation of fibroblast proliferation [GO:0048145]; regulation of glial cell proliferation [GO:0060251]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucagon [GO:0033762]; response to hypoxia [GO:0001666]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; secretory granule organization [GO:0033363]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type I pneumocyte differentiation [GO:0060509]; viral process [GO:0016032]; visual learning [GO:0008542]"	ATF4-CREB1 transcription factor complex [GO:1990589]; axon [GO:0030424]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"arrestin family protein binding [GO:1990763]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001102; GO:0001225; GO:0001228; GO:0001666; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005759; GO:0006366; GO:0006468; GO:0007165; GO:0007179; GO:0007409; GO:0007568; GO:0007595; GO:0007613; GO:0007623; GO:0008361; GO:0008542; GO:0010033; GO:0010944; GO:0014823; GO:0016032; GO:0019899; GO:0021983; GO:0030424; GO:0030544; GO:0032916; GO:0033363; GO:0033762; GO:0034670; GO:0035035; GO:0035094; GO:0035497; GO:0035729; GO:0036120; GO:0040018; GO:0042493; GO:0042752; GO:0042802; GO:0043065; GO:0045600; GO:0045672; GO:0045893; GO:0045899; GO:0045944; GO:0046887; GO:0046889; GO:0048145; GO:0050821; GO:0055025; GO:0060251; GO:0060430; GO:0060509; GO:0071294; GO:0071300; GO:0071398; GO:1900273; GO:1901215; GO:1902065; GO:1990090; GO:1990314; GO:1990589; GO:1990763; GO:1990830; GO:1990837	"aging [GO:0007568]; axonogenesis [GO:0007409]; cellular response to fatty acid [GO:0071398]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to zinc ion [GO:0071294]; chemotaxis to arachidonic acid [GO:0034670]; circadian rhythm [GO:0007623]; lactation [GO:0007595]; lung saccule development [GO:0060430]; memory [GO:0007613]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by competitive promoter binding [GO:0010944]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell size [GO:0008361]; regulation of circadian rhythm [GO:0042752]; regulation of fibroblast proliferation [GO:0048145]; regulation of glial cell proliferation [GO:0060251]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucagon [GO:0033762]; response to hypoxia [GO:0001666]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; secretory granule organization [GO:0033363]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type I pneumocyte differentiation [GO:0060509]; viral process [GO:0016032]; visual learning [GO:0008542]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24027_c0_g1_i1	P55934	CNG_ICTPU	53	66	31	0	221	24	412	477	6.60E-15	80.9	CNG_ICTPU	reviewed	Cyclic nucleotide-gated cation channel		Ictalurus punctatus (Channel catfish) (Silurus punctatus)	682	integral component of membrane [GO:0016021]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]	cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; ion channel activity [GO:0005216]	GO:0005216; GO:0007608; GO:0016021; GO:0030552; GO:0030553; GO:0050896	response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN37752_c0_g1_i1	Q16281	CNGA3_HUMAN	67.9	84	27	0	2	253	448	531	1.00E-27	123.6	CNGA3_HUMAN	reviewed	Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3)	CNGA3 CNCG3	Homo sapiens (Human)	694	axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]	axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]	cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]	GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0008022; GO:0015276; GO:0030425; GO:0030553; GO:0031960; GO:0032026; GO:0043194; GO:0043204; GO:0051591; GO:0097386; GO:0098659; GO:1902495	cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN26319_c0_g1_i1	Q8MJD7	CNGB3_CANLF	44.8	87	48	0	1	261	404	490	6.90E-17	87.8	CNGB3_CANLF	reviewed	Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3) (CNG channel beta-3)	CNGB3	Canis lupus familiaris (Dog) (Canis familiaris)	782	photoreceptor outer segment [GO:0001750]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	photoreceptor outer segment [GO:0001750]; transmembrane transporter complex [GO:1902495]	cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]	GO:0001750; GO:0005222; GO:0005223; GO:0007601; GO:0030553; GO:0050896; GO:1902495	response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7958_c0_g1_i1	Q24278	CNGA_DROME	59.6	589	224	3	162	1892	28	614	1.00E-198	694.9	CNGA_DROME	reviewed	Cyclic nucleotide-gated cation channel subunit A (Cyclic nucleotide-gated ion channel subunit A) (CNG channel)	CngA Cng CG7779	Drosophila melanogaster (Fruit fly)	665	intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]	intracellular cyclic nucleotide activated cation channel complex [GO:0017071]	cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]	GO:0001666; GO:0005221; GO:0005222; GO:0005223; GO:0006812; GO:0017071; GO:0019934; GO:0030553; GO:0098655	cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN7958_c0_g1_i2	Q24278	CNGA_DROME	51.5	406	176	4	162	1322	28	431	9.40E-112	405.2	CNGA_DROME	reviewed	Cyclic nucleotide-gated cation channel subunit A (Cyclic nucleotide-gated ion channel subunit A) (CNG channel)	CngA Cng CG7779	Drosophila melanogaster (Fruit fly)	665	intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]	intracellular cyclic nucleotide activated cation channel complex [GO:0017071]	cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]	GO:0001666; GO:0005221; GO:0005222; GO:0005223; GO:0006812; GO:0017071; GO:0019934; GO:0030553; GO:0098655	cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; cGMP-mediated signaling [GO:0019934]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN1661_c0_g1_i1	Q95TJ9	CYCG_DROME	34.9	327	187	6	68	1018	239	549	2.50E-41	171	CYCG_DROME	reviewed	Cyclin G	CycG CG11525	Drosophila melanogaster (Fruit fly)	566	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein phosphatase inhibitor activity [GO:0004864]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; epithelium development [GO:0060429]; female meiotic nuclear division [GO:0007143]; meiotic DNA repair synthesis [GO:0000711]; mitotic cell cycle phase transition [GO:0044772]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of growth [GO:0045927]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein phosphatase inhibitor activity [GO:0004864]	GO:0000079; GO:0000307; GO:0000711; GO:0003677; GO:0004864; GO:0005634; GO:0005700; GO:0005737; GO:0006302; GO:0007143; GO:0007275; GO:0016538; GO:0044772; GO:0045746; GO:0045927; GO:0046628; GO:0051301; GO:0051897; GO:0060429; GO:2000134	cell division [GO:0051301]; double-strand break repair [GO:0006302]; epithelium development [GO:0060429]; female meiotic nuclear division [GO:0007143]; meiotic DNA repair synthesis [GO:0000711]; mitotic cell cycle phase transition [GO:0044772]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of growth [GO:0045927]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN9050_c0_g1_i3	P47827	CCNA2_XENLA	56.5	232	101	0	89	784	176	407	8.20E-72	271.9	CCNA2_XENLA	reviewed	Cyclin-A2 (Cyclin-A)	ccna2	Xenopus laevis (African clawed frog)	415	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0000086; GO:0000307; GO:0005634; GO:0005737; GO:0044843; GO:0051301	cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]		NA	NA	NA	NA	NA	NA
TRINITY_DN34078_c0_g1_i1	P30274	CCNA2_BOVIN	99	103	1	0	2	310	182	284	1.50E-52	206.5	CCNA2_BOVIN	reviewed	Cyclin-A2 (Cyclin-A)	CCNA2	Bos taurus (Bovine)	430	cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA replication [GO:0006275]	cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000086; GO:0000307; GO:0005634; GO:0005737; GO:0006275; GO:0016538; GO:0044772; GO:0044843; GO:0051301; GO:0097124	cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN4176_c0_g1_i1	Q3ECW2	CCA34_ARATH	35.5	110	71	0	1552	1223	123	232	3.10E-09	65.5	CCA34_ARATH	reviewed	Cyclin-A3-4 (G2/mitotic-specific cyclin-A3-4) (CycA3;4)	CYCA3-4 At1g47230 F8G22.5	Arabidopsis thaliana (Mouse-ear cress)	370	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0016538; GO:0044772; GO:0051301	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN2260_c0_g1_i1	Q7QB13	CCNC_ANOGA	75.1	229	57	0	689	3	1	229	2.90E-102	372.9	CCNC_ANOGA	reviewed	Cyclin-C	CycC AGAP004240	Anopheles gambiae (African malaria mosquito)	266	mediator complex [GO:0016592]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006357; GO:0016538; GO:0016592; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN27083_c0_g1_i1	P24863	CCNC_HUMAN	99.4	168	1	0	3	506	47	214	1.40E-92	340.1	CCNC_HUMAN	reviewed	Cyclin-C (SRB11 homolog) (hSRB11)	CCNC	Homo sapiens (Human)	283	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; identical protein binding [GO:0042802]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; identical protein binding [GO:0042802]	GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0016538; GO:0016592; GO:0042802; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN5779_c0_g2_i1	Q5U4I3	CCDB1_XENLA	29.9	107	75	0	2	322	218	324	4.10E-09	62.4	CCDB1_XENLA	reviewed	Cyclin-D1-binding protein 1 homolog	ccndbp1	Xenopus laevis (African clawed frog)	331	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007049; GO:0051726	cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]		blue	blue	NA	NA	NA	NA
TRINITY_DN2616_c0_g1_i1	Q6DG03	DMTF1_DANRE	48.6	346	165	2	1862	864	40	385	7.00E-95	350.1	DMTF1_DANRE	reviewed	Cyclin-D-binding Myb-like transcription factor 1	dmtf1 si:dkey-153k10.8 zgc:92448	Danio rerio (Zebrafish) (Brachydanio rerio)	645	nucleoplasm [GO:0005654]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]	nucleoplasm [GO:0005654]	RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005654; GO:0007049	cell cycle [GO:0007049]		NA	NA	NA	NA	NA	NA
TRINITY_DN31612_c0_g1_i1	Q9Y222	DMTF1_HUMAN	98.8	83	1	0	286	38	155	237	3.70E-42	171.8	DMTF1_HUMAN	reviewed	Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1)	DMTF1 DMP1	Homo sapiens (Human)	760	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007049	"cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6068_c0_g1_i1	Q8SR86	CDK1_ENCCU	58.8	131	54	0	3	395	107	237	3.40E-41	169.1	CDK1_ENCCU	reviewed	Cyclin-dependent kinase 1 (CDK1) (Cell division control protein 28 homolog) (EC 2.7.11.22) (Cell division protein kinase 1)	CDC28 CDK1 ECU08_1920	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	296	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]	nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0004693; GO:0005524; GO:0005634; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN9848_c0_g1_i1	P04551	CDK1_SCHPO	58.3	132	50	1	397	2	110	236	1.40E-42	173.7	CDK1_SCHPO	reviewed	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 2) (Cell division protein kinase 1) (p34 protein kinase)	cdc2 cdk1 swo2 pi002 SPBC11B10.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	297	"chromosome, centromeric region [GO:0000775]; chromosome, telomeric repeat region [GO:0140445]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; meiotic spindle pole body [GO:0035974]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of anaphase-promoting complex-dependent catabolic process [GO:1905785]; negative regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902424]; negative regulation of cell cycle switching, mitotic to meiotic cell cycle [GO:0110045]; negative regulation of conjugation with cellular fusion [GO:0031138]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of exit from mitosis [GO:0001100]; negative regulation of mitotic actomyosin contractile ring assembly [GO:1903500]; negative regulation of mitotic DNA replication initiation [GO:1903467]; negative regulation of mitotic spindle elongation [GO:1902845]; negative regulation of mitotic telomere tethering at nuclear periphery [GO:1904537]; negative regulation of primary cell septum biogenesis [GO:1905757]; negative regulation of protein binding [GO:0032091]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of initiation of premeiotic DNA replication [GO:1904514]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:1905263]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of mitotic chromosome condensation [GO:1903380]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of mitotic sister chromatid biorientation [GO:0140429]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of septation initiation signaling [GO:0031031]; protein phosphorylation [GO:0006468]; regulation of cell cycle switching, mitotic to meiotic cell cycle [GO:0110044]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of linear element maturation [GO:0062123]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; response to meiotic DNA replication checkpoint signaling [GO:0072441]; response to mitotic DNA integrity checkpoint signaling [GO:1990820]; response to mitotic G2 DNA damage checkpoint signaling [GO:0072435]; signal transduction [GO:0007165]"	"chromosome, centromeric region [GO:0000775]; chromosome, telomeric repeat region [GO:0140445]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; meiotic spindle pole body [GO:0035974]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000307; GO:0000775; GO:0000790; GO:0001100; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007165; GO:0010389; GO:0010468; GO:0030332; GO:0031031; GO:0031138; GO:0031536; GO:0032091; GO:0035974; GO:0042307; GO:0044732; GO:0045842; GO:0051446; GO:0062123; GO:0072429; GO:0072435; GO:0072441; GO:0072686; GO:0097472; GO:0110044; GO:0110045; GO:0140429; GO:0140445; GO:1902424; GO:1902845; GO:1903364; GO:1903380; GO:1903465; GO:1903467; GO:1903500; GO:1904514; GO:1904537; GO:1905168; GO:1905263; GO:1905757; GO:1905785; GO:1990023; GO:1990820; GO:2001033	"G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of anaphase-promoting complex-dependent catabolic process [GO:1905785]; negative regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902424]; negative regulation of cell cycle switching, mitotic to meiotic cell cycle [GO:0110045]; negative regulation of conjugation with cellular fusion [GO:0031138]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of exit from mitosis [GO:0001100]; negative regulation of mitotic actomyosin contractile ring assembly [GO:1903500]; negative regulation of mitotic DNA replication initiation [GO:1903467]; negative regulation of mitotic spindle elongation [GO:1902845]; negative regulation of mitotic telomere tethering at nuclear periphery [GO:1904537]; negative regulation of primary cell septum biogenesis [GO:1905757]; negative regulation of protein binding [GO:0032091]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of initiation of premeiotic DNA replication [GO:1904514]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:1905263]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of mitotic chromosome condensation [GO:1903380]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of mitotic sister chromatid biorientation [GO:0140429]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of septation initiation signaling [GO:0031031]; protein phosphorylation [GO:0006468]; regulation of cell cycle switching, mitotic to meiotic cell cycle [GO:0110044]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of linear element maturation [GO:0062123]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; response to meiotic DNA replication checkpoint signaling [GO:0072441]; response to mitotic DNA integrity checkpoint signaling [GO:1990820]; response to mitotic G2 DNA damage checkpoint signaling [GO:0072435]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28433_c0_g1_i1	A8XA58	CDK1_CAEBR	56.4	117	49	2	15	362	121	236	2.90E-29	129.4	CDK1_CAEBR	reviewed	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1)	cdk-1 CBG10007	Caenorhabditis briggsae	326	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of meiotic cell cycle [GO:0051446]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000086; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0006468; GO:0007095; GO:0008353; GO:0019901; GO:0051301; GO:0051446	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of meiotic cell cycle [GO:0051446]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN35784_c0_g1_i1	P23572	CDK1_DROME	61.6	73	28	0	243	25	1	73	2.00E-19	96.3	CDK1_DROME	reviewed	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)	Cdk1 cdc2 CG5363	Drosophila melanogaster (Fruit fly)	297	fusome [GO:0045169]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; asymmetric neuroblast division [GO:0055059]; embryonic development via the syncytial blastoderm [GO:0001700]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; germarium-derived cystoblast division [GO:0048142]; male meiotic nuclear division [GO:0007140]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; ovarian follicle cell development [GO:0030707]; protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of protein localization [GO:0032880]; spermatogonial cell division [GO:0007284]	fusome [GO:0045169]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000086; GO:0001700; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0007095; GO:0007140; GO:0007284; GO:0008353; GO:0030174; GO:0030707; GO:0032880; GO:0044818; GO:0045169; GO:0048142; GO:0055059; GO:1901987	asymmetric neuroblast division [GO:0055059]; embryonic development via the syncytial blastoderm [GO:0001700]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; germarium-derived cystoblast division [GO:0048142]; male meiotic nuclear division [GO:0007140]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic G2 DNA damage checkpoint [GO:0007095]; ovarian follicle cell development [GO:0030707]; protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of protein localization [GO:0032880]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN27113_c0_g1_i1	P06493	CDK1_HUMAN	100	295	0	0	38	922	1	295	4.70E-171	601.7	CDK1_HUMAN	reviewed	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)	CDK1 CDC2 CDC28A CDKN1 P34CDC2	Homo sapiens (Human)	297	"centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618]; activation of MAPK activity [GO:0000187]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; ciliary basal body-plasma membrane docking [GO:0097711]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic nuclear envelope disassembly [GO:0007077]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]"	"centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618]	GO:0000086; GO:0000187; GO:0000226; GO:0000307; GO:0000784; GO:0001618; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005789; GO:0005813; GO:0005829; GO:0005876; GO:0006260; GO:0006281; GO:0006367; GO:0006468; GO:0006915; GO:0006977; GO:0007077; GO:0007095; GO:0007098; GO:0007344; GO:0007569; GO:0008283; GO:0008353; GO:0009636; GO:0010389; GO:0010628; GO:0010971; GO:0014038; GO:0014070; GO:0014075; GO:0014823; GO:0016020; GO:0016477; GO:0016579; GO:0018105; GO:0018107; GO:0030261; GO:0030332; GO:0030496; GO:0030544; GO:0030855; GO:0031100; GO:0031145; GO:0034501; GO:0035173; GO:0042307; GO:0042493; GO:0042752; GO:0043066; GO:0045471; GO:0045740; GO:0045995; GO:0046686; GO:0046688; GO:0048511; GO:0048678; GO:0051301; GO:0055015; GO:0060045; GO:0065003; GO:0070062; GO:0070301; GO:0072686; GO:0090166; GO:0097125; GO:0097472; GO:0097711; GO:1900182; GO:1901990; GO:1905448	"activation of MAPK activity [GO:0000187]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; ciliary basal body-plasma membrane docking [GO:0097711]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic nuclear envelope disassembly [GO:0007077]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein-containing complex assembly [GO:0065003]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33742_c0_g1_i1	P11440	CDK1_MOUSE	100	166	0	0	500	3	23	188	2.90E-90	332.4	CDK1_MOUSE	reviewed	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)	Cdk1 Cdc2 Cdc2a Cdkn1	Mus musculus (Mouse)	297	centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; chromosome condensation [GO:0030261]; epithelial cell differentiation [GO:0030855]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]	centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000086; GO:0000307; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005876; GO:0006468; GO:0006915; GO:0007095; GO:0007569; GO:0008283; GO:0008353; GO:0009636; GO:0010243; GO:0010628; GO:0010971; GO:0014070; GO:0014075; GO:0014823; GO:0016301; GO:0018105; GO:0018107; GO:0030261; GO:0030332; GO:0030496; GO:0030544; GO:0030855; GO:0031100; GO:0034501; GO:0035173; GO:0042307; GO:0042493; GO:0042752; GO:0043066; GO:0044772; GO:0045471; GO:0045740; GO:0045931; GO:0046686; GO:0046688; GO:0048511; GO:0048678; GO:0051301; GO:0055015; GO:0060045; GO:0065003; GO:0070301; GO:0072686; GO:0090166; GO:0097125; GO:0097472; GO:1900182; GO:1905448	animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; chromosome condensation [GO:0030261]; epithelial cell differentiation [GO:0030855]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]		NA	NA	NA	NA	NA	NA
TRINITY_DN27024_c0_g1_i1	P51958	CDK1_CARAU	75.5	298	73	0	987	94	1	298	2.60E-133	476.5	CDK1_CARAU	reviewed	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)	cdk1 cdc2	Carassius auratus (Goldfish)	302	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0007049; GO:0008353; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN2897_c1_g1_i1	Q3UMM4	CDK10_MOUSE	72.1	244	68	0	149	880	24	267	8.40E-101	368.2	CDK10_MOUSE	reviewed	Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10)	Cdk10	Mus musculus (Mouse)	360	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007346; GO:0010468; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:1902018	cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN2897_c1_g1_i2	Q3UMM4	CDK10_MOUSE	71.6	155	44	0	149	613	24	178	8.20E-59	228.4	CDK10_MOUSE	reviewed	Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10)	Cdk10	Mus musculus (Mouse)	360	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007346; GO:0010468; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:1902018	cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN18315_c0_g1_i1	Q15131	CDK10_HUMAN	100	209	0	0	1	627	20	228	1.60E-117	423.3	CDK10_HUMAN	reviewed	Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10) (Serine/threonine-protein kinase PISSLRE)	CDK10	Homo sapiens (Human)	360	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; cell projection organization [GO:0030030]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; traversing start control point of mitotic cell cycle [GO:0007089]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007089; GO:0007346; GO:0008285; GO:0010468; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:1902018	cell projection organization [GO:0030030]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; traversing start control point of mitotic cell cycle [GO:0007089]		NA	NA	NA	NA	NA	NA
TRINITY_DN32018_c0_g1_i1	Q9UQ88	CD11A_HUMAN	100	93	0	0	2	280	407	499	1.90E-46	186	CD11A_HUMAN	reviewed	Cyclin-dependent kinase 11A (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2)	CDK11A CDC2L2 CDC2L3 PITSLREB	Homo sapiens (Human)	783	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0001558; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0007346; GO:0010468; GO:0050684	"apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3152_c0_g1_i1	P24788	CD11B_MOUSE	81.7	153	28	0	459	1	523	675	3.90E-73	275.4	CD11B_MOUSE	reviewed	Cyclin-dependent kinase 11B (Cell division cycle 2-like protein kinase 1) (Cell division protein kinase 11) (Cyclin-dependent kinase 11) (EC 2.7.11.22) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1)	Cdk11b Cdc2l1 Cdk11	Mus musculus (Mouse)	784	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; blastocyst development [GO:0001824]; cell cycle [GO:0007049]; negative regulation of apoptotic signaling pathway [GO:2001234]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mRNA processing [GO:0050684]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0001824; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0007049; GO:0007088; GO:0007346; GO:0010468; GO:0050684; GO:2001234	blastocyst development [GO:0001824]; cell cycle [GO:0007049]; negative regulation of apoptotic signaling pathway [GO:2001234]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mRNA processing [GO:0050684]		NA	NA	NA	NA	NA	NA
TRINITY_DN3792_c0_g1_i1	Q9VP22	CDK12_DROME	68.1	332	85	7	1235	294	687	1015	8.40E-122	438.7	CDK12_DROME	reviewed	Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) (dCdk12)	Cdk12 CG7597	Drosophila melanogaster (Fruit fly)	1157	chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000228; GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0006366; GO:0006368; GO:0006468; GO:0008024; GO:0008353; GO:0019908; GO:0030332; GO:0032968; GO:0045944; GO:0070816	phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN3792_c0_g1_i2	Q9VP22	CDK12_DROME	66	453	132	8	1777	473	687	1135	1.40E-167	591.3	CDK12_DROME	reviewed	Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) (dCdk12)	Cdk12 CG7597	Drosophila melanogaster (Fruit fly)	1157	chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000228; GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0006366; GO:0006368; GO:0006468; GO:0008024; GO:0008353; GO:0019908; GO:0030332; GO:0032968; GO:0045944; GO:0070816	phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN3792_c0_g1_i3	Q9VP22	CDK12_DROME	66	453	132	8	2175	871	687	1135	1.70E-167	591.3	CDK12_DROME	reviewed	Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) (dCdk12)	Cdk12 CG7597	Drosophila melanogaster (Fruit fly)	1157	chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000228; GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005703; GO:0006366; GO:0006368; GO:0006468; GO:0008024; GO:0008353; GO:0019908; GO:0030332; GO:0032968; GO:0045944; GO:0070816	phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN35239_c0_g1_i1	Q14004	CDK13_HUMAN	100	75	0	0	227	3	682	756	6.80E-39	160.6	CDK13_HUMAN	reviewed	Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller)	CDK13 CDC2L CDC2L5 CHED KIAA1791	Homo sapiens (Human)	1512	"chromosome [GO:0005694]; cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of stem cell differentiation [GO:2000737]; neutrophil degranulation [GO:0043312]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	chromosome [GO:0005694]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin K-CDK13 complex [GO:0002945]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000307; GO:0000380; GO:0000790; GO:0002945; GO:0003723; GO:0004672; GO:0004693; GO:0005524; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0006368; GO:0006468; GO:0007088; GO:0007275; GO:0008024; GO:0008284; GO:0008353; GO:0016032; GO:0016607; GO:0019901; GO:0019908; GO:0030097; GO:0030332; GO:0032968; GO:0043312; GO:0045944; GO:0070816; GO:1904813; GO:2000737	"alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of stem cell differentiation [GO:2000737]; neutrophil degranulation [GO:0043312]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21410_c0_g1_i1	C0RW22	CDK14_DASNO	73.4	259	69	0	780	4	128	386	1.40E-110	400.6	CDK14_DASNO	reviewed	Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14)	CDK14 PFTK1	Dasypus novemcinctus (Nine-banded armadillo)	468	cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005886; GO:0016055; GO:0051301; GO:0060828	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN36577_c0_g1_i1	Q00536	CDK16_HUMAN	96.1	77	3	0	231	1	113	189	6.10E-35	147.5	CDK16_HUMAN	reviewed	Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)	CDK16 PCTAIRE1 PCTK1	Homo sapiens (Human)	496	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0015630; GO:0030252; GO:0031175; GO:0031234; GO:0043005; GO:0061178	exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN21887_c0_g1_i1	Q00536	CDK16_HUMAN	98.9	88	1	0	265	2	296	383	2.80E-47	188.7	CDK16_HUMAN	reviewed	Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)	CDK16 PCTAIRE1 PCTK1	Homo sapiens (Human)	496	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0015630; GO:0030252; GO:0031175; GO:0031234; GO:0043005; GO:0061178	exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN30254_c0_g1_i1	Q00537	CDK17_HUMAN	100	173	0	0	521	3	203	375	2.80E-96	352.4	CDK17_HUMAN	reviewed	Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)	CDK17 PCTAIRE2 PCTK2	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN34324_c0_g1_i1	Q00537	CDK17_HUMAN	100	130	0	0	1	390	352	481	3.00E-74	278.9	CDK17_HUMAN	reviewed	Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)	CDK17 PCTAIRE2 PCTK2	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN2477_c0_g1_i1	Q00537	CDK17_HUMAN	64.6	198	66	2	76	660	327	523	1.60E-68	260.8	CDK17_HUMAN	reviewed	Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)	CDK17 PCTAIRE2 PCTK2	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN2477_c0_g1_i2	Q00537	CDK17_HUMAN	71.1	432	117	4	83	1357	93	523	6.00E-173	608.6	CDK17_HUMAN	reviewed	Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)	CDK17 PCTAIRE2 PCTK2	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN2477_c0_g1_i3	Q00537	CDK17_HUMAN	71.3	429	115	4	90	1355	96	523	2.30E-172	606.7	CDK17_HUMAN	reviewed	Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)	CDK17 PCTAIRE2 PCTK2	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000083; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN6054_c1_g1_i5	P48963	CDK2_MESAU	27	293	169	7	1171	377	18	293	1.00E-15	86.3	CDK2_MESAU	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	CDK2 CDKN2	Mesocricetus auratus (Golden hamster)	298	Cajal body [GO:0015030]; endosome [GO:0005768]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468]	Cajal body [GO:0015030]; endosome [GO:0005768]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]	GO:0004693; GO:0005524; GO:0005768; GO:0005815; GO:0006281; GO:0006468; GO:0015030; GO:0046872; GO:0051301; GO:0051321; GO:0097472	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN6054_c1_g1_i8	P48963	CDK2_MESAU	27	293	169	7	1171	377	18	293	1.00E-15	86.3	CDK2_MESAU	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	CDK2 CDKN2	Mesocricetus auratus (Golden hamster)	298	Cajal body [GO:0015030]; endosome [GO:0005768]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468]	Cajal body [GO:0015030]; endosome [GO:0005768]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]	GO:0004693; GO:0005524; GO:0005768; GO:0005815; GO:0006281; GO:0006468; GO:0015030; GO:0046872; GO:0051301; GO:0051321; GO:0097472	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1852_c0_g1_i2	P43450	CDK2_CARAU	65.4	298	99	2	52	942	1	295	2.80E-111	403.3	CDK2_CARAU	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	cdk2	Carassius auratus (Goldfish)	298	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0004693; GO:0005524; GO:0006468; GO:0007049; GO:0051301; GO:0097472	cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1852_c0_g1_i3	P43450	CDK2_CARAU	65.4	214	70	2	165	803	85	295	1.30E-77	291.2	CDK2_CARAU	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	cdk2	Carassius auratus (Goldfish)	298	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0004693; GO:0005524; GO:0006468; GO:0007049; GO:0051301; GO:0097472	cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1852_c0_g1_i3	P43450	CDK2_CARAU	63.2	38	14	0	52	165	1	38	4.70E-06	53.5	CDK2_CARAU	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	cdk2	Carassius auratus (Goldfish)	298	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0004693; GO:0005524; GO:0006468; GO:0007049; GO:0051301; GO:0097472	cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1852_c0_g1_i4	P43450	CDK2_CARAU	64.1	298	96	3	52	921	1	295	7.70E-106	385.2	CDK2_CARAU	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	cdk2	Carassius auratus (Goldfish)	298	ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0004693; GO:0005524; GO:0006468; GO:0007049; GO:0051301; GO:0097472	cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN17036_c0_g1_i1	P24941	CDK2_HUMAN	100	187	0	0	3	563	69	255	2.00E-108	392.9	CDK2_HUMAN	reviewed	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase)	CDK2 CDKN2	Homo sapiens (Human)	298	"Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; X chromosome [GO:0000805]; Y chromosome [GO:0000806]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to nitric oxide [GO:0071732]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; histone phosphorylation [GO:0016572]; meiotic cell cycle [GO:0051321]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion transport [GO:0006813]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of gene silencing [GO:0060968]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]"	"Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; X chromosome [GO:0000805]; Y chromosome [GO:0000806]"	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000122; GO:0000287; GO:0000307; GO:0000781; GO:0000793; GO:0000805; GO:0000806; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006260; GO:0006281; GO:0006468; GO:0006813; GO:0006977; GO:0007099; GO:0007165; GO:0007265; GO:0008284; GO:0010389; GO:0010468; GO:0015030; GO:0016572; GO:0018105; GO:0019904; GO:0030332; GO:0031145; GO:0031571; GO:0032298; GO:0045893; GO:0051298; GO:0051301; GO:0051321; GO:0060968; GO:0071732; GO:0097123; GO:0097124; GO:0097134; GO:0097135; GO:0097472; GO:1901796	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to nitric oxide [GO:0071732]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; histone phosphorylation [GO:0016572]; meiotic cell cycle [GO:0051321]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion transport [GO:0006813]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of gene silencing [GO:0060968]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37212_c0_g1_i1	Q8IZL9	CDK20_HUMAN	52.1	119	56	1	6	362	105	222	1.50E-27	123.6	CDK20_HUMAN	reviewed	Cyclin-dependent kinase 20 (EC 2.7.11.22) (CDK-activating kinase p42) (CAK-kinase p42) (Cell cycle-related kinase) (Cell division protein kinase 20) (Cyclin-dependent protein kinase H) (Cyclin-kinase-activating kinase p42)	CDK20 CCRK CDCH	Homo sapiens (Human)	346	cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic skeletal system development [GO:0048706]; floor plate formation [GO:0021508]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; protein phosphorylation [GO:0006468]; regulation of protein maturation [GO:1903317]; roof of mouth development [GO:0060021]	cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0001843; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005929; GO:0006468; GO:0007049; GO:0021508; GO:0031076; GO:0048706; GO:0051301; GO:0060021; GO:0061512; GO:1901621; GO:1903317; GO:1990403	cell cycle [GO:0007049]; cell division [GO:0051301]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic skeletal system development [GO:0048706]; floor plate formation [GO:0021508]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; protein phosphorylation [GO:0006468]; regulation of protein maturation [GO:1903317]; roof of mouth development [GO:0060021]		NA	NA	NA	NA	NA	NA
TRINITY_DN10198_c0_g2_i1	P11802	CDK4_HUMAN	100	197	0	0	592	2	54	250	1.70E-113	409.8	CDK4_HUMAN	reviewed	Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3)	CDK4	Homo sapiens (Human)	303	bicellular tight junction [GO:0005923]; chromatin [GO:0000785]; cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein-containing complex binding [GO:0044877]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; adipose tissue development [GO:0060612]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; circadian rhythm [GO:0007623]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; response to drug [GO:0042493]; response to hyperoxia [GO:0055093]; response to lead ion [GO:0010288]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; transcription initiation from RNA polymerase II promoter [GO:0006367]	bicellular tight junction [GO:0005923]; chromatin [GO:0000785]; cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein-containing complex binding [GO:0044877]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000307; GO:0000785; GO:0002088; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005923; GO:0006367; GO:0006468; GO:0007165; GO:0007623; GO:0008284; GO:0008353; GO:0009636; GO:0010288; GO:0010468; GO:0010971; GO:0016538; GO:0016592; GO:0030332; GO:0031100; GO:0031965; GO:0032869; GO:0033574; GO:0040014; GO:0042493; GO:0043065; GO:0044877; GO:0045727; GO:0045787; GO:0045793; GO:0046626; GO:0046890; GO:0048146; GO:0048471; GO:0050994; GO:0051301; GO:0051726; GO:0055093; GO:0060612; GO:0071157; GO:0071222; GO:0071353; GO:0097129; GO:1904628; GO:1904637; GO:2000134	adipose tissue development [GO:0060612]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; circadian rhythm [GO:0007623]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; response to drug [GO:0042493]; response to hyperoxia [GO:0055093]; response to lead ion [GO:0010288]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN10198_c0_g1_i1	P30285	CDK4_MOUSE	100	156	0	0	470	3	97	252	1.00E-89	330.5	CDK4_MOUSE	reviewed	Cyclin-dependent kinase 4 (EC 2.7.11.22) (CRK3) (Cell division protein kinase 4) (PSK-J3)	Cdk4 Crk3	Mus musculus (Mouse)	303	chromatin [GO:0000785]; cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; adipose tissue development [GO:0060612]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; circadian rhythm [GO:0007623]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; response to drug [GO:0042493]; response to hyperoxia [GO:0055093]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]	chromatin [GO:0000785]; cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000307; GO:0000785; GO:0002088; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007623; GO:0008284; GO:0008353; GO:0009636; GO:0010033; GO:0010288; GO:0010468; GO:0010971; GO:0016301; GO:0016592; GO:0030332; GO:0031100; GO:0031965; GO:0032869; GO:0032991; GO:0033574; GO:0040014; GO:0042127; GO:0042493; GO:0043065; GO:0044877; GO:0045727; GO:0045793; GO:0046626; GO:0046890; GO:0048146; GO:0048471; GO:0050994; GO:0051301; GO:0051726; GO:0055093; GO:0060612; GO:0071157; GO:0071222; GO:0071353; GO:0097129; GO:1904628; GO:1904637	adipose tissue development [GO:0060612]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; circadian rhythm [GO:0007623]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; response to drug [GO:0042493]; response to hyperoxia [GO:0055093]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12795_c0_g1_i1	P42773	CDN2C_HUMAN	37	73	46	0	234	16	74	146	6.00E-06	51.2	CDN2C_HUMAN	reviewed	Cyclin-dependent kinase 4 inhibitor C (Cyclin-dependent kinase 6 inhibitor) (p18-INK4c) (p18-INK6)	CDKN2C CDKN6	Homo sapiens (Human)	168	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphorylation [GO:0042326]; oligodendrocyte differentiation [GO:0048709]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000082; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0007050; GO:0008285; GO:0019901; GO:0030308; GO:0042326; GO:0048709; GO:2000134	cell cycle arrest [GO:0007050]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphorylation [GO:0042326]; oligodendrocyte differentiation [GO:0048709]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	1	NA	NA	NA
TRINITY_DN26360_c0_g1_i1	P55273	CDN2D_HUMAN	100	75	0	0	3	227	57	131	5.40E-36	151	CDN2D_HUMAN	reviewed	Cyclin-dependent kinase 4 inhibitor D (p19-INK4d)	CDKN2D	Homo sapiens (Human)	166	cyclin D2-CDK4 complex [GO:0097129]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]; autophagic cell death [GO:0048102]; cell cycle arrest [GO:0007050]; DNA synthesis involved in DNA repair [GO:0000731]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of phosphorylation [GO:0042326]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to retinoic acid [GO:0032526]; response to UV [GO:0009411]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605]	cyclin D2-CDK4 complex [GO:0097129]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000082; GO:0000731; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0007605; GO:0008285; GO:0009411; GO:0019901; GO:0030308; GO:0032526; GO:0033280; GO:0042326; GO:0043154; GO:0048102; GO:0097129; GO:1902230; GO:2000134	autophagic cell death [GO:0048102]; cell cycle arrest [GO:0007050]; DNA synthesis involved in DNA repair [GO:0000731]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of phosphorylation [GO:0042326]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to retinoic acid [GO:0032526]; response to UV [GO:0009411]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN32959_c0_g1_i1	P34117	CDK5_DICDI	77.9	240	52	1	719	3	1	240	1.10E-109	397.5	CDK5_DICDI	reviewed	Cyclin-dependent kinase 5 homolog (EC 2.7.11.22) (CDC2-like serine/threonine-protein kinase CRP) (Cell division protein kinase 5)	cdk5 crp crpA DDB_G0288677	Dictyostelium discoideum (Slime mold)	292	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; aggregation involved in sorocarp development [GO:0031152]; asexual reproduction [GO:0019954]; phagocytosis [GO:0006909]; pinocytosis [GO:0006907]; protein phosphorylation [GO:0006468]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; sporulation resulting in formation of a cellular spore [GO:0030435]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0000083; GO:0004693; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006907; GO:0006909; GO:0016192; GO:0019954; GO:0030435; GO:0031152; GO:0031157; GO:0072686	aggregation involved in sorocarp development [GO:0031152]; asexual reproduction [GO:0019954]; phagocytosis [GO:0006909]; pinocytosis [GO:0006907]; protein phosphorylation [GO:0006468]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; sporulation resulting in formation of a cellular spore [GO:0030435]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN9848_c0_g2_i1	P34117	CDK5_DICDI	56	75	33	0	13	237	10	84	2.40E-18	92.4	CDK5_DICDI	reviewed	Cyclin-dependent kinase 5 homolog (EC 2.7.11.22) (CDC2-like serine/threonine-protein kinase CRP) (Cell division protein kinase 5)	cdk5 crp crpA DDB_G0288677	Dictyostelium discoideum (Slime mold)	292	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; aggregation involved in sorocarp development [GO:0031152]; asexual reproduction [GO:0019954]; phagocytosis [GO:0006909]; pinocytosis [GO:0006907]; protein phosphorylation [GO:0006468]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; sporulation resulting in formation of a cellular spore [GO:0030435]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0000083; GO:0004693; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006907; GO:0006909; GO:0016192; GO:0019954; GO:0030435; GO:0031152; GO:0031157; GO:0072686	aggregation involved in sorocarp development [GO:0031152]; asexual reproduction [GO:0019954]; phagocytosis [GO:0006909]; pinocytosis [GO:0006907]; protein phosphorylation [GO:0006468]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; sporulation resulting in formation of a cellular spore [GO:0030435]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38157_c0_g1_i1	Q00534	CDK6_HUMAN	68.1	69	22	0	209	3	156	224	8.90E-25	113.6	CDK6_HUMAN	reviewed	Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	CDK6 CDKN6	Homo sapiens (Human)	326	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007050; GO:0007219; GO:0008285; GO:0008353; GO:0009615; GO:0010468; GO:0010628; GO:0014002; GO:0016592; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000134; GO:2000145; GO:2000773	astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN37628_c0_g1_i1	Q00534	CDK6_HUMAN	99.3	141	1	0	424	2	101	241	2.60E-76	285.8	CDK6_HUMAN	reviewed	Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	CDK6 CDKN6	Homo sapiens (Human)	326	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007050; GO:0007219; GO:0008285; GO:0008353; GO:0009615; GO:0010468; GO:0010628; GO:0014002; GO:0016592; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000134; GO:2000145; GO:2000773	astrocyte development [GO:0014002]; cell cycle arrest [GO:0007050]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN32812_c0_g1_i1	Q64261	CDK6_MOUSE	100	70	0	0	212	3	176	245	1.50E-35	149.4	CDK6_MOUSE	reviewed	Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	Cdk6 Cdkn6 Crk2	Mus musculus (Mouse)	326	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0007219; GO:0008353; GO:0009615; GO:0010468; GO:0010628; GO:0016301; GO:0016592; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000773	cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN26376_c0_g1_i1	Q64261	CDK6_MOUSE	54.8	62	28	0	197	12	22	83	1.80E-14	79.3	CDK6_MOUSE	reviewed	Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	Cdk6 Cdkn6 Crk2	Mus musculus (Mouse)	326	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0007219; GO:0008353; GO:0009615; GO:0010468; GO:0010628; GO:0016301; GO:0016592; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000773	cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]		NA	NA	NA	NA	NA	NA
TRINITY_DN980_c0_g1_i1	P50613	CDK7_HUMAN	67.2	323	101	4	3	962	26	346	1.00E-121	438	CDK7_HUMAN	reviewed	Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)	CDK7 CAK CAK1 CDKN7 MO15 STK1	Homo sapiens (Human)	346	"CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; 7-methylguanosine mRNA capping [GO:0006370]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"	CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0000082; GO:0000086; GO:0000439; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0006283; GO:0006294; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006468; GO:0007050; GO:0008022; GO:0008094; GO:0008353; GO:0016301; GO:0019907; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0070516; GO:0070816; GO:0070985	"7-methylguanosine mRNA capping [GO:0006370]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		blue	blue	NA	NA	NA	NA
TRINITY_DN980_c0_g1_i4	P50613	CDK7_HUMAN	65.8	322	103	4	3	950	26	346	1.40E-120	434.1	CDK7_HUMAN	reviewed	Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)	CDK7 CAK CAK1 CDKN7 MO15 STK1	Homo sapiens (Human)	346	"CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; 7-methylguanosine mRNA capping [GO:0006370]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"	CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0000082; GO:0000086; GO:0000439; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0006283; GO:0006294; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006468; GO:0007050; GO:0008022; GO:0008094; GO:0008353; GO:0016301; GO:0019907; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0070516; GO:0070816; GO:0070985	"7-methylguanosine mRNA capping [GO:0006370]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20085_c0_g1_i1	P50613	CDK7_HUMAN	100	133	0	0	3	401	112	244	9.50E-76	283.9	CDK7_HUMAN	reviewed	Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)	CDK7 CAK CAK1 CDKN7 MO15 STK1	Homo sapiens (Human)	346	"CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; 7-methylguanosine mRNA capping [GO:0006370]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"	CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0000082; GO:0000086; GO:0000439; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0006283; GO:0006294; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006468; GO:0007050; GO:0008022; GO:0008094; GO:0008353; GO:0016301; GO:0019907; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0070516; GO:0070816; GO:0070985	"7-methylguanosine mRNA capping [GO:0006370]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; snRNA transcription by RNA polymerase II [GO:0042795]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12539_c0_g1_i1	P49336	CDK8_HUMAN	88.6	333	38	0	1	999	31	363	4.50E-178	625.5	CDK8_HUMAN	reviewed	Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35)	CDK8	Homo sapiens (Human)	464	mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; transcription initiation from RNA polymerase II promoter [GO:0006367]	mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006367; GO:0006468; GO:0008353; GO:0016592; GO:0032991; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN1404_c0_g1_i1	P50750	CDK9_HUMAN	70.9	371	93	3	1130	27	2	360	2.00E-153	543.5	CDK9_HUMAN	reviewed	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit)	CDK9 CDC2L4 TAK	Homo sapiens (Human)	372	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]	GO:0000978; GO:0001223; GO:0003677; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006282; GO:0006366; GO:0006367; GO:0006368; GO:0006468; GO:0008023; GO:0008024; GO:0008283; GO:0008353; GO:0010613; GO:0016020; GO:0016301; GO:0016592; GO:0016605; GO:0019901; GO:0031056; GO:0031297; GO:0033129; GO:0036464; GO:0042493; GO:0042795; GO:0045944; GO:0050434; GO:0051147; GO:0070816; GO:0071157; GO:0071345; GO:0097322; GO:1900364; GO:1903839; GO:2001168	cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		blue	blue	NA	NA	NA	NA
TRINITY_DN17865_c0_g1_i1	P50750	CDK9_HUMAN	100	319	0	0	959	3	7	325	2.40E-186	652.5	CDK9_HUMAN	reviewed	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit)	CDK9 CDC2L4 TAK	Homo sapiens (Human)	372	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]	GO:0000978; GO:0001223; GO:0003677; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006282; GO:0006366; GO:0006367; GO:0006368; GO:0006468; GO:0008023; GO:0008024; GO:0008283; GO:0008353; GO:0010613; GO:0016020; GO:0016301; GO:0016592; GO:0016605; GO:0019901; GO:0031056; GO:0031297; GO:0033129; GO:0036464; GO:0042493; GO:0042795; GO:0045944; GO:0050434; GO:0051147; GO:0070816; GO:0071157; GO:0071345; GO:0097322; GO:1900364; GO:1903839; GO:2001168	cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN5986_c0_g1_i2	Q5ZKN1	CDK9_CHICK	76.2	324	74	2	1048	86	30	353	3.80E-143	509.2	CDK9_CHICK	reviewed	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9)	CDK9 RCJMB04_9p8	Gallus gallus (Chicken)	372	mediator complex [GO:0016592]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]	mediator complex [GO:0016592]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0008353; GO:0016592; GO:0045944; GO:0070816	phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN38662_c0_g1_i1	Q99J95	CDK9_MOUSE	99.5	219	1	0	3	659	34	252	1.50E-123	443.4	CDK9_MOUSE	reviewed	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9)	Cdk9	Mus musculus (Mouse)	372	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; snRNA binding [GO:0017069]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; snRNA binding [GO:0017069]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0000978; GO:0001223; GO:0003677; GO:0003682; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006282; GO:0006468; GO:0008023; GO:0008024; GO:0008134; GO:0008353; GO:0010613; GO:0016592; GO:0016605; GO:0017069; GO:0019901; GO:0031056; GO:0031297; GO:0033129; GO:0036464; GO:0042493; GO:0045944; GO:0051147; GO:0070816; GO:0071157; GO:0071345; GO:0097322; GO:1900364; GO:1903839; GO:2001168	cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN5986_c0_g1_i1	Q4V862	CDK9A_XENLA	75.8	355	79	3	1129	86	3	357	1.90E-156	553.5	CDK9A_XENLA	reviewed	Cyclin-dependent kinase 9-A (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9-A)	cdk9-a	Xenopus laevis (African clawed frog)	376	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0005634; GO:0008353			NA	NA	NA	NA	NA	NA
TRINITY_DN5986_c0_g1_i3	Q4V862	CDK9A_XENLA	72.7	355	77	4	1090	86	3	357	1.30E-146	520.8	CDK9A_XENLA	reviewed	Cyclin-dependent kinase 9-A (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9-A)	cdk9-a	Xenopus laevis (African clawed frog)	376	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0005634; GO:0008353			NA	NA	NA	NA	NA	NA
TRINITY_DN1404_c0_g1_i2	Q4V862	CDK9A_XENLA	73.3	30	8	0	173	84	2	31	3.20E-07	55.5	CDK9A_XENLA	reviewed	Cyclin-dependent kinase 9-A (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9-A)	cdk9-a	Xenopus laevis (African clawed frog)	376	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0005634; GO:0008353			NA	NA	NA	NA	NA	NA
TRINITY_DN14715_c0_g1_i1	P29618	CDKA1_ORYSJ	58.7	126	49	1	21	398	102	224	3.30E-36	152.5	CDKA1_ORYSJ	reviewed	Cyclin-dependent kinase A-1 (CDKA;1) (EC 2.7.11.22) (EC 2.7.11.23) (CDC2Os-1) (Cell division control protein 2 homolog 1)	CDKA-1 CDC2-1 Os03g0118400 LOC_Os03g02680	Oryza sativa subsp. japonica (Rice)	294	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of meiotic cell cycle [GO:0051445]; signal transduction [GO:0007165]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000307; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007165; GO:0008284; GO:0008353; GO:0010389; GO:0010468; GO:0030332; GO:0051445	G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of meiotic cell cycle [GO:0051445]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37915_c0_g1_i1	A2X6X1	CDKG1_ORYSI	56.2	48	21	0	198	55	449	496	2.30E-10	65.9	CDKG1_ORYSI	reviewed	Cyclin-dependent kinase G-1 (CDKG;1) (EC 2.7.11.22) (EC 2.7.11.23)	CDKG-1 OsI_007814	Oryza sativa subsp. indica (Rice)	693	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]		ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0008353			NA	NA	NA	NA	NA	NA
TRINITY_DN38988_c0_g1_i1	A2XUW1	CDKG2_ORYSI	55.1	247	109	2	751	11	355	599	1.10E-80	301.2	CDKG2_ORYSI	reviewed	Cyclin-dependent kinase G-2 (CDKG;2) (EC 2.7.11.22) (EC 2.7.11.23)	CDKG-2 OsI_015854	Oryza sativa subsp. indica (Rice)	710	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]		ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0005524; GO:0008353			NA	NA	NA	NA	NA	NA
TRINITY_DN27706_c0_g1_i1	Q16667	CDKN3_HUMAN	100	87	0	0	261	1	126	212	2.40E-43	175.6	CDKN3_HUMAN	reviewed	Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase)	CDKN3 CDI1 CIP2 KAP	Homo sapiens (Human)	212	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle arrest [GO:0007050]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell population proliferation [GO:0008285]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000079; GO:0000082; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0007050; GO:0008138; GO:0008285; GO:0048471	cell cycle arrest [GO:0007050]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell population proliferation [GO:0008285]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN255_c0_g1_i3	B2RZ50	CDKN3_RAT	41.9	215	115	3	671	42	3	212	8.60E-45	181.8	CDKN3_RAT	reviewed	Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Kinase-associated phosphatase)	Cdkn3 Kap	Rattus norvegicus (Rat)	212	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cell cycle arrest [GO:0007050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0007050; GO:0048471	cell cycle arrest [GO:0007050]		NA	NA	NA	NA	NA	NA
TRINITY_DN255_c0_g1_i4	Q9MYN5	CDKN3_PIG	42.1	209	112	3	641	42	4	212	2.20E-43	177.2	CDKN3_PIG	reviewed	Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Kinase-associated phosphatase)	CDKN3 KAP	Sus scrofa (Pig)	212	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; protein tyrosine phosphatase activity [GO:0004725]; cell cycle arrest [GO:0007050]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0007050; GO:0048471	cell cycle arrest [GO:0007050]		NA	NA	NA	NA	NA	NA
TRINITY_DN28451_c0_g1_i1	O76039	CDKL5_HUMAN	59.1	93	37	1	281	3	112	203	4.30E-27	121.7	CDKL5_HUMAN	reviewed	Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9)	CDKL5 STK9	Homo sapiens (Human)	960	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; synapse [GO:0045202]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]	GO:0001764; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005813; GO:0006468; GO:0016301; GO:0032587; GO:0032839; GO:0036064; GO:0043547; GO:0044294; GO:0045202; GO:0045773; GO:0046777; GO:0048365; GO:0048471; GO:0050773; GO:0050775; GO:0060999; GO:0097542; GO:1902017	neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]		NA	NA	NA	NA	NA	NA
TRINITY_DN12057_c0_g1_i1	Q02399	CDK5_BOVIN	82.5	285	50	0	128	982	7	291	2.00E-139	496.9	CDK5_BOVIN	reviewed	Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Proline-directed protein kinase 33 kDa subunit) (PDPK) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)	CDK5 CDKN5	Bos taurus (Bovine)	292	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000083; GO:0001764; GO:0001963; GO:0002039; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006886; GO:0007160; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016301; GO:0016477; GO:0018107; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0035173; GO:0035249; GO:0035418; GO:0042501; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048167; GO:0048489; GO:0048511; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:1901215; GO:1903076	"axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12057_c0_g1_i2	Q02399	CDK5_BOVIN	84.5	291	45	0	67	939	1	291	4.80E-146	518.8	CDK5_BOVIN	reviewed	Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Proline-directed protein kinase 33 kDa subunit) (PDPK) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)	CDK5 CDKN5	Bos taurus (Bovine)	292	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000083; GO:0001764; GO:0001963; GO:0002039; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006886; GO:0007160; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016301; GO:0016477; GO:0018107; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0035173; GO:0035249; GO:0035418; GO:0042501; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048167; GO:0048489; GO:0048511; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:1901215; GO:1903076	"axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34907_c0_g1_i1	Q02399	CDK5_BOVIN	98.3	115	2	0	346	2	7	121	4.30E-61	235	CDK5_BOVIN	reviewed	Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Proline-directed protein kinase 33 kDa subunit) (PDPK) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)	CDK5 CDKN5	Bos taurus (Bovine)	292	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000083; GO:0001764; GO:0001963; GO:0002039; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006886; GO:0007160; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016301; GO:0016477; GO:0018107; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0035173; GO:0035249; GO:0035418; GO:0042501; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048167; GO:0048489; GO:0048511; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:1901215; GO:1903076	"axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30497_c0_g1_i1	Q00535	CDK5_HUMAN	99	101	1	0	305	3	150	250	2.20E-56	219.2	CDK5_HUMAN	reviewed	Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)	CDK5 CDKN5	Homo sapiens (Human)	292	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle arrest [GO:0071156]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]	acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]	GO:0000083; GO:0000226; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006468; GO:0006886; GO:0006913; GO:0007005; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0009611; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016310; GO:0016533; GO:0016572; GO:0018105; GO:0018107; GO:0019233; GO:0019901; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0030866; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0034352; GO:0035249; GO:0035418; GO:0042501; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046777; GO:0046826; GO:0046875; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0071156; GO:0090314; GO:0098793; GO:0099635; GO:1901215; GO:1901387; GO:1901796; GO:1903076; GO:1903421; GO:1904646; GO:2000251	"axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle arrest [GO:0071156]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33689_c0_g1_i1	O14976	GAK_HUMAN	100	86	0	0	300	43	1226	1311	1.00E-45	183.7	GAK_HUMAN	reviewed	Cyclin-G-associated kinase (EC 2.7.11.1)	GAK	Homo sapiens (Human)	1311	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0061024; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:1905224	cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]		NA	NA	NA	NA	NA	NA
TRINITY_DN35656_c0_g1_i1	O14976	GAK_HUMAN	48.4	159	81	1	3	479	378	535	2.20E-39	163.3	GAK_HUMAN	reviewed	Cyclin-G-associated kinase (EC 2.7.11.1)	GAK	Homo sapiens (Human)	1311	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0061024; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:1905224	cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]		NA	NA	NA	NA	NA	NA
TRINITY_DN29936_c0_g1_i1	O75909	CCNK_HUMAN	100	105	0	0	1	315	63	167	1.00E-56	220.3	CCNK_HUMAN	reviewed	Cyclin-K	CCNK CPR4	Homo sapiens (Human)	580	"cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0016538; GO:0019901; GO:0032786; GO:0042795; GO:0044828; GO:0045944; GO:0051301; GO:0061575; GO:2001165	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7555_c0_g1_i1	O75909	CCNK_HUMAN	64.6	229	80	1	761	75	24	251	1.00E-90	334.7	CCNK_HUMAN	reviewed	Cyclin-K	CCNK CPR4	Homo sapiens (Human)	580	"cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0016538; GO:0019901; GO:0032786; GO:0042795; GO:0044828; GO:0045944; GO:0051301; GO:0061575; GO:2001165	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7555_c0_g1_i2	O75909	CCNK_HUMAN	65.4	240	82	1	818	99	24	262	2.60E-97	356.7	CCNK_HUMAN	reviewed	Cyclin-K	CCNK CPR4	Homo sapiens (Human)	580	"cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0016538; GO:0019901; GO:0032786; GO:0042795; GO:0044828; GO:0045944; GO:0051301; GO:0061575; GO:2001165	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3876_c0_g1_i1	Q9UK58	CCNL1_HUMAN	50.9	114	54	1	480	145	226	339	2.30E-23	110.5	CCNL1_HUMAN	reviewed	Cyclin-L1 (Cyclin-L)	CCNL1 BM-001 UNQ530/PRO1073	Homo sapiens (Human)	526	nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006357; GO:0006396; GO:0016538; GO:0016607	regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN3876_c0_g1_i2	Q9UK58	CCNL1_HUMAN	53.1	145	66	1	573	145	195	339	5.50E-37	155.6	CCNL1_HUMAN	reviewed	Cyclin-L1 (Cyclin-L)	CCNL1 BM-001 UNQ530/PRO1073	Homo sapiens (Human)	526	nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006357; GO:0006396; GO:0016538; GO:0016607	regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN24412_c0_g1_i1	Q9UK58	CCNL1_HUMAN	100	64	0	0	194	3	226	289	7.60E-32	137.5	CCNL1_HUMAN	reviewed	Cyclin-L1 (Cyclin-L)	CCNL1 BM-001 UNQ530/PRO1073	Homo sapiens (Human)	526	nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006357; GO:0006396; GO:0016538; GO:0016607	regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN34613_c0_g1_i1	Q9JJA7	CCNL2_MOUSE	100	68	0	0	3	206	202	269	2.50E-35	148.7	CCNL2_MOUSE	reviewed	Cyclin-L2 (Cyclin Ania-6b) (Paneth cell-enhanced expression protein) (PCEE)	Ccnl2 Ania6b MNCb-5160	Mus musculus (Mouse)	518	intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]	intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0005654; GO:0006357; GO:0016538; GO:0016607; GO:0043231	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3870_c0_g1_i1	Q8N1B3	CCNQ_HUMAN	43.5	216	120	2	754	110	27	241	3.20E-45	183.7	CCNQ_HUMAN	reviewed	Cyclin-Q (CDK10-activating cyclin) (Cyclin-M) (Cyclin-related protein FAM58A)	CCNQ FAM58A	Homo sapiens (Human)	248	nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006357; GO:0016538	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1726_c0_g2_i1	Q9XT26	CCNT1_HORSE	71.2	156	45	0	1367	900	10	165	6.20E-61	236.5	CCNT1_HORSE	reviewed	Cyclin-T1 (CycT1) (Cyclin-T)	CCNT1	Equus caballus (Horse)	727	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006351; GO:0006357; GO:0007049; GO:0008024; GO:0016032; GO:0016538; GO:0032786; GO:0051301; GO:0061575; GO:0097322	"cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1726_c0_g2_i1	Q9XT26	CCNT1_HORSE	64.5	76	27	0	897	670	182	257	2.80E-21	104.8	CCNT1_HORSE	reviewed	Cyclin-T1 (CycT1) (Cyclin-T)	CCNT1	Equus caballus (Horse)	727	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006351; GO:0006357; GO:0007049; GO:0008024; GO:0016032; GO:0016538; GO:0032786; GO:0051301; GO:0061575; GO:0097322	"cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1726_c0_g2_i2	Q9XT26	CCNT1_HORSE	70.2	248	74	0	1413	670	10	257	1.70E-98	361.3	CCNT1_HORSE	reviewed	Cyclin-T1 (CycT1) (Cyclin-T)	CCNT1	Equus caballus (Horse)	727	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0005634; GO:0006351; GO:0006357; GO:0007049; GO:0008024; GO:0016032; GO:0016538; GO:0032786; GO:0051301; GO:0061575; GO:0097322	"cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN22711_c0_g1_i1	O60563	CCNT1_HUMAN	100	91	0	0	3	275	62	152	7.80E-45	180.6	CCNT1_HUMAN	reviewed	Cyclin-T1 (CycT1) (Cyclin-T)	CCNT1	Homo sapiens (Human)	726	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000079; GO:0000976; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006468; GO:0007049; GO:0008024; GO:0008134; GO:0016032; GO:0016538; GO:0019901; GO:0032786; GO:0042795; GO:0043923; GO:0045944; GO:0050434; GO:0051301; GO:0061575; GO:0070063; GO:0097322; GO:1900364	"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22711_c0_g2_i1	Q9QWV9	CCNT1_MOUSE	100	118	0	0	2	355	64	181	9.90E-61	233.8	CCNT1_MOUSE	reviewed	Cyclin-T1 (CycT1) (Cyclin-T)	Ccnt1	Mus musculus (Mouse)	724	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; snRNA binding [GO:0017069]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; snRNA binding [GO:0017069]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0006468; GO:0007049; GO:0008024; GO:0008134; GO:0016538; GO:0017069; GO:0019901; GO:0032786; GO:0045944; GO:0051301; GO:0061575; GO:0070063; GO:0097322; GO:1900364	"cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29231_c0_g1_i1	O60583	CCNT2_HUMAN	100	95	0	0	286	2	119	213	3.70E-50	198.4	CCNT2_HUMAN	reviewed	Cyclin-T2 (CycT2)	CCNT2	Homo sapiens (Human)	730	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]	GO:0000079; GO:0001223; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0006368; GO:0007049; GO:0007519; GO:0008024; GO:0016538; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0042795; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322	"cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40363_c0_g1_i1	Q8ND76	CCNY_HUMAN	100	151	0	0	454	2	178	328	4.60E-79	295	CCNY_HUMAN	reviewed	Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X)	CCNY C10orf9 CBCP1 CFP1	Homo sapiens (Human)	341	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000086; GO:0000308; GO:0005634; GO:0005737; GO:0005886; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0051301; GO:0060828	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7428_c0_g1_i3	Q8ND76	CCNY_HUMAN	73.4	259	61	5	40	810	89	341	9.30E-100	364.8	CCNY_HUMAN	reviewed	Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X)	CCNY C10orf9 CBCP1 CFP1	Homo sapiens (Human)	341	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000086; GO:0000308; GO:0005634; GO:0005737; GO:0005886; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0051301; GO:0060828	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7428_c0_g1_i4	Q8ND76	CCNY_HUMAN	66	94	30	2	52	333	250	341	2.90E-24	112.8	CCNY_HUMAN	reviewed	Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X)	CCNY C10orf9 CBCP1 CFP1	Homo sapiens (Human)	341	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000086; GO:0000308; GO:0005634; GO:0005737; GO:0005886; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0051301; GO:0060828	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7428_c0_g1_i1	Q6NRF4	CCY1B_XENLA	67.6	68	22	0	37	240	88	155	3.80E-20	98.6	CCY1B_XENLA	reviewed	Cyclin-Y-like protein 1-B	ccnyl1-b	Xenopus laevis (African clawed frog)	343	protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		protein kinase binding [GO:0019901]	GO:0000079; GO:0019901	regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN31915_c0_g1_i1	P0DKX6	CYAB_BORP1	66.7	129	43	0	395	9	575	703	4.80E-40	165.2	CYAB_BORP1	reviewed	Cyclolysin secretion/processing ATP-binding protein CyaB (EC 3.4.22.-) (EC 7.6.2.-)	cyaB BN118_0469	Bordetella pertussis (strain ATCC 9797 / DSM 5571 / NCTC 10739 / 18323)	712	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; type I protein secretion system complex [GO:0030256]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cysteine-type peptidase activity [GO:0008234]; hemolysis in other organism [GO:0044179]; protein secretion by the type I secretion system [GO:0030253]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; type I protein secretion system complex [GO:0030256]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cysteine-type peptidase activity [GO:0008234]	GO:0005524; GO:0005886; GO:0008234; GO:0016021; GO:0016887; GO:0030253; GO:0030256; GO:0042626; GO:0044179	hemolysis in other organism [GO:0044179]; protein secretion by the type I secretion system [GO:0030253]		NA	NA	NA	NA	NA	1
TRINITY_DN12053_c0_g1_i2	P0A9H8	CFA_ECOL6	46.6	58	31	0	252	79	160	217	1.10E-06	54.7	CFA_ECOL6	reviewed	Cyclopropane-fatty-acyl-phospholipid synthase (CFA synthase) (Cyclopropane fatty acid synthase) (EC 2.1.1.79)	cfa c2055	Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC)	382	cytoplasm [GO:0005737]; cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]; fatty acid biosynthetic process [GO:0006633]; methylation [GO:0032259]	cytoplasm [GO:0005737]	cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]	GO:0005737; GO:0006633; GO:0008825; GO:0032259	fatty acid biosynthetic process [GO:0006633]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN16372_c0_g1_i1	Q921M7	FA49B_MOUSE	100	312	0	0	3	938	13	324	6.10E-177	621.3	CYRIB_MOUSE	reviewed	CYFIP-related Rac1 interactor B (Protein FAM49B)	Cyrib Cyri Fam49b	Mus musculus (Mouse)	324	"cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]"	cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]"	GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0048365; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568	cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]		NA	NA	NA	NA	NA	NA
TRINITY_DN16372_c0_g1_i2	Q2KJI3	FA49B_BOVIN	100	312	0	0	3	938	13	324	4.70E-177	621.7	CYRIB_BOVIN	reviewed	CYFIP-related Rac1 interactor B (Protein FAM49B)	CYRIB FAM49B	Bos taurus (Bovine)	324	"cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]"	cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]"	GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0032729; GO:0048365; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568	cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]		NA	NA	NA	NA	NA	NA
TRINITY_DN16118_c0_g1_i1	Q2KJI3	FA49B_BOVIN	100	98	0	0	3	296	100	197	1.90E-49	196.1	CYRIB_BOVIN	reviewed	CYFIP-related Rac1 interactor B (Protein FAM49B)	CYRIB FAM49B	Bos taurus (Bovine)	324	"cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]"	cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]"	GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0032729; GO:0048365; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568	cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]		NA	NA	NA	NA	NA	NA
TRINITY_DN4487_c0_g1_i1	Q921M7	FA49B_MOUSE	58.6	331	128	4	110	1099	1	323	4.30E-100	366.3	CYRIB_MOUSE	reviewed	CYFIP-related Rac1 interactor B (Protein FAM49B)	Cyrib Cyri Fam49b	Mus musculus (Mouse)	324	"cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]"	cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]"	GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0048365; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568	cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]		blue	blue	NA	NA	NA	NA
TRINITY_DN4487_c0_g1_i2	Q921M7	FA49B_MOUSE	58.3	333	128	5	110	1105	1	323	1.40E-98	361.3	CYRIB_MOUSE	reviewed	CYFIP-related Rac1 interactor B (Protein FAM49B)	Cyrib Cyri Fam49b	Mus musculus (Mouse)	324	"cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]"	cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]"	GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0048365; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568	cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]		NA	NA	NA	NA	NA	NA
TRINITY_DN4967_c0_g1_i1	P32232	CBS_RAT	67	94	31	0	1	282	85	178	1.00E-31	137.1	CBS_RAT	reviewed	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Hemoprotein H-450) (Serine sulfhydrase)	Cbs	Rattus norvegicus (Rat)	561	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel diameter [GO:0097746]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; response to nutrient levels [GO:0031667]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]	GO:0001958; GO:0001974; GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0006801; GO:0010749; GO:0019343; GO:0019344; GO:0019346; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0021587; GO:0030170; GO:0031625; GO:0031667; GO:0042262; GO:0042802; GO:0042803; GO:0043066; GO:0043418; GO:0043506; GO:0046872; GO:0050421; GO:0050667; GO:0051593; GO:0060135; GO:0060351; GO:0070025; GO:0070026; GO:0070814; GO:0071456; GO:0072341; GO:0097746; GO:1904047	blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel diameter [GO:0097746]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; response to nutrient levels [GO:0031667]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346]		NA	NA	NA	NA	NA	NA
TRINITY_DN36747_c0_g1_i1	Q91WT9	CBS_MOUSE	88.7	53	6	0	173	15	170	222	3.60E-21	101.7	CBS_MOUSE	reviewed	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	Cbs	Mus musculus (Mouse)	561	cytoplasm [GO:0005737]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel diameter [GO:0097746]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]	GO:0001958; GO:0001974; GO:0004122; GO:0005634; GO:0005737; GO:0006535; GO:0006563; GO:0006801; GO:0010749; GO:0019343; GO:0019344; GO:0019346; GO:0019825; GO:0019899; GO:0020037; GO:0021587; GO:0030170; GO:0031625; GO:0042802; GO:0042803; GO:0043066; GO:0043418; GO:0043506; GO:0046872; GO:0050421; GO:0050667; GO:0051593; GO:0060135; GO:0060351; GO:0070025; GO:0070026; GO:0070814; GO:0071456; GO:0072341; GO:0097746; GO:1904047	blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel diameter [GO:0097746]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346]		NA	NA	NA	NA	NA	NA
TRINITY_DN4967_c0_g3_i1	Q9N0V7	CBS_RABIT	61.4	277	100	1	1	831	76	345	6.90E-97	355.1	CBS_RABIT	reviewed	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Oryctolagus cuniculus (Rabbit)	551	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cystathionine beta-synthase activity [GO:0004122]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cystathionine beta-synthase activity [GO:0004122]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0004122; GO:0005634; GO:0005737; GO:0006535; GO:0006563; GO:0019343; GO:0030170; GO:0042803; GO:0043418; GO:0046872; GO:0050667; GO:0070814	cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]		NA	NA	NA	NA	NA	NA
TRINITY_DN1092_c0_g1_i1	P0DN79	CBSL_HUMAN	60.5	476	186	2	1530	106	77	551	2.50E-170	600.1	CBSL_HUMAN	reviewed	Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBSL	Homo sapiens (Human)	551	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cystathionine beta-synthase activity [GO:0004122]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cystathionine beta-synthase activity [GO:0004122]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0004122; GO:0005634; GO:0005737; GO:0006535; GO:0019343; GO:0019346; GO:0020037; GO:0030170; GO:0046872; GO:0050667; GO:0070814	cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]		blue	blue	NA	NA	NA	NA
TRINITY_DN1092_c0_g1_i2	P0DN79	CBSL_HUMAN	60.2	480	186	3	1545	106	77	551	2.10E-169	597	CBSL_HUMAN	reviewed	Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBSL	Homo sapiens (Human)	551	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cystathionine beta-synthase activity [GO:0004122]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cystathionine beta-synthase activity [GO:0004122]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0004122; GO:0005634; GO:0005737; GO:0006535; GO:0019343; GO:0019346; GO:0020037; GO:0030170; GO:0046872; GO:0050667; GO:0070814	cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]		blue	blue	NA	NA	NA	NA
TRINITY_DN4967_c0_g2_i1	P0DN79	CBSL_HUMAN	61.2	147	50	1	3	443	206	345	8.60E-46	184.5	CBSL_HUMAN	reviewed	Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBSL	Homo sapiens (Human)	551	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cystathionine beta-synthase activity [GO:0004122]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cystathionine beta-synthase activity [GO:0004122]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0004122; GO:0005634; GO:0005737; GO:0006535; GO:0019343; GO:0019346; GO:0020037; GO:0030170; GO:0046872; GO:0050667; GO:0070814	cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]		NA	NA	NA	NA	NA	NA
TRINITY_DN1499_c0_g1_i1	Q58DW2	CGL_BOVIN	63.5	392	142	1	81	1256	6	396	2.60E-146	520	CGL_BOVIN	reviewed	Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase)	CTH	Bos taurus (Bovine)	405	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]	GO:0004123; GO:0005516; GO:0005737; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0051092; GO:0070814; GO:0080146	cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; protein sulfhydration [GO:0044524]; transsulfuration [GO:0019346]		NA	NA	NA	NA	NA	NA
TRINITY_DN1325_c0_g1_i1	E3P6P1	CYT_CRYNI	33.3	123	77	3	2292	1936	19	140	8.90E-11	70.9	CYT_CRYNI	reviewed	Cystatin		Cryptophis nigrescens (Eastern small-eyed snake) (Rhinoplocephalus nigrescens)	141	extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	extracellular region [GO:0005576]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN1325_c0_g1_i2	E3P6P1	CYT_CRYNI	33.3	123	77	3	1850	1494	19	140	7.50E-11	70.9	CYT_CRYNI	reviewed	Cystatin		Cryptophis nigrescens (Eastern small-eyed snake) (Rhinoplocephalus nigrescens)	141	extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	extracellular region [GO:0005576]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN1325_c0_g1_i4	E3P6P1	CYT_CRYNI	33.3	123	77	3	1776	1420	19	140	9.90E-11	70.9	CYT_CRYNI	reviewed	Cystatin		Cryptophis nigrescens (Eastern small-eyed snake) (Rhinoplocephalus nigrescens)	141	extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	extracellular region [GO:0005576]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN479_c0_g3_i2	Q8WNR9	CYTA_FELCA	49.2	59	30	0	116	292	1	59	1.30E-09	64.7	CYTA_FELCA	reviewed	Cystatin-A (allergen Fel d 3)	CSTA	Felis catus (Cat) (Felis silvestris catus)	98	cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	cytosol [GO:0005829]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005829			blue	blue	NA	NA	NA	NA
TRINITY_DN33277_c0_g1_i1	Q8WNR9	CYTA_FELCA	41.8	67	38	1	205	5	2	67	7.90E-09	60.8	CYTA_FELCA	reviewed	Cystatin-A (allergen Fel d 3)	CSTA	Felis catus (Cat) (Felis silvestris catus)	98	cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	cytosol [GO:0005829]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN19075_c0_g1_i1	Q8WNR9	CYTA_FELCA	48.6	70	36	0	20	229	4	73	4.50E-13	75.1	CYTA_FELCA	reviewed	Cystatin-A (allergen Fel d 3)	CSTA	Felis catus (Cat) (Felis silvestris catus)	98	cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	cytosol [GO:0005829]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005829			blue	blue	NA	NA	NA	NA
TRINITY_DN30563_c0_g1_i1	Q8WNR9	CYTA_FELCA	44.3	61	34	0	201	19	1	61	1.80E-09	62.8	CYTA_FELCA	reviewed	Cystatin-A (allergen Fel d 3)	CSTA	Felis catus (Cat) (Felis silvestris catus)	98	cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	cytosol [GO:0005829]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN479_c0_g3_i3	P56567	CYTA_MOUSE	40.8	98	55	2	116	403	1	97	2.00E-14	80.5	CYTA_MOUSE	reviewed	Cystatin-A (Cystatin-A1) (Stefin-A)	Csta Csta1	Mus musculus (Mouse)	97	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829			blue	blue	NA	NA	NA	NA
TRINITY_DN14259_c0_g1_i1	P56567	CYTA_MOUSE	43.3	60	34	0	190	11	1	60	4.80E-08	58.5	CYTA_MOUSE	reviewed	Cystatin-A (Cystatin-A1) (Stefin-A)	Csta Csta1	Mus musculus (Mouse)	97	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN14259_c0_g1_i2	P56567	CYTA_MOUSE	45	60	33	0	190	11	1	60	1.70E-08	59.7	CYTA_MOUSE	reviewed	Cystatin-A (Cystatin-A1) (Stefin-A)	Csta Csta1	Mus musculus (Mouse)	97	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN14259_c2_g1_i1	P56567	CYTA_MOUSE	46.6	58	28	2	223	56	41	97	1.60E-07	56.6	CYTA_MOUSE	reviewed	Cystatin-A (Cystatin-A1) (Stefin-A)	Csta Csta1	Mus musculus (Mouse)	97	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN23109_c0_g1_i1	P01040	CYTA_HUMAN	49	49	25	0	3	149	5	53	1.60E-05	49.7	CYTA_HUMAN	reviewed	"Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed]"	CSTA STF1 STFA	Homo sapiens (Human)	98	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]	GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0010466; GO:0018149; GO:0030216; GO:0045861; GO:0070268; GO:0098609	cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN479_c0_g3_i1	P25417	CYTB_BOVIN	38.2	110	53	3	116	436	1	98	3.40E-12	73.2	CYTB_BOVIN	reviewed	Cystatin-B (Stefin-B)	CSTB CST6	Bos taurus (Bovine)	98	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cell surface receptor signaling pathway [GO:0007166]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005737; GO:0005886; GO:0007166	cell surface receptor signaling pathway [GO:0007166]		blue	blue	NA	NA	NA	NA
TRINITY_DN479_c0_g3_i4	P25417	CYTB_BOVIN	39.8	98	56	1	116	400	1	98	1.50E-14	80.9	CYTB_BOVIN	reviewed	Cystatin-B (Stefin-B)	CSTB CST6	Bos taurus (Bovine)	98	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cell surface receptor signaling pathway [GO:0007166]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005737; GO:0005886; GO:0007166	cell surface receptor signaling pathway [GO:0007166]		blue	blue	NA	NA	NA	NA
TRINITY_DN35946_c0_g1_i1	P25417	CYTB_BOVIN	42.4	66	34	2	207	19	26	90	5.30E-06	51.2	CYTB_BOVIN	reviewed	Cystatin-B (Stefin-B)	CSTB CST6	Bos taurus (Bovine)	98	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cell surface receptor signaling pathway [GO:0007166]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005737; GO:0005886; GO:0007166	cell surface receptor signaling pathway [GO:0007166]		blue	blue	NA	NA	NA	NA
TRINITY_DN8206_c1_g2_i2	P67966	CSRP1_CHICK	45.4	185	83	3	198	740	9	179	1.60E-43	177.9	CSRP1_CHICK	reviewed	Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1)	CSRP1 CSRP	Gallus gallus (Chicken)	192	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actinin binding [GO:0042805]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actinin binding [GO:0042805]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; structural constituent of muscle [GO:0008307]	GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0008307; GO:0030018; GO:0030036; GO:0031252; GO:0042805; GO:0045214; GO:0046872; GO:0051219; GO:0051393; GO:0060537	actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]		blue	blue	NA	NA	NA	NA
TRINITY_DN40254_c0_g1_i1	P21291	CSRP1_HUMAN	100	56	0	0	204	37	138	193	2.60E-29	128.6	CSRP1_HUMAN	reviewed	Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141)	CSRP1 CSRP CYRP	Homo sapiens (Human)	193	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]	actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527	actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN12470_c0_g1_i1	Q9VCC0	CHRD1_DROME	50.5	333	142	6	101	1081	1	316	5.40E-90	332.8	CHRD1_DROME	reviewed	Cysteine and histidine-rich domain-containing protein (Morgana)	CHORD mora CG6198	Drosophila melanogaster (Fruit fly)	354	zinc ion binding [GO:0008270]; centrosome duplication [GO:0051298]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]		zinc ion binding [GO:0008270]	GO:0008270; GO:0008361; GO:0050773; GO:0051298	centrosome duplication [GO:0051298]; regulation of cell size [GO:0008361]; regulation of dendrite development [GO:0050773]		NA	NA	NA	NA	NA	NA
TRINITY_DN38585_c0_g1_i1	Q9UHD1	CHRD1_HUMAN	97.3	74	2	0	224	3	158	231	1.30E-39	162.9	CHRD1_HUMAN	reviewed	Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1) (CHORD-containing protein 1) (CHP-1) (Protein morgana)	CHORDC1 CHP1	Homo sapiens (Human)	332	ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; zinc ion binding [GO:0008270]; centrosome duplication [GO:0051298]; chaperone-mediated protein folding [GO:0061077]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]		ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; zinc ion binding [GO:0008270]	GO:0005524; GO:0008270; GO:0010824; GO:0043531; GO:0051298; GO:0051879; GO:0061077; GO:1900034; GO:2000299	centrosome duplication [GO:0051298]; chaperone-mediated protein folding [GO:0061077]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]		NA	NA	NA	NA	NA	NA
TRINITY_DN905_c0_g1_i1	Q9VZV5	CYHR1_DROME	52.2	207	93	1	661	59	206	412	2.00E-63	243.8	CYHR1_DROME	reviewed	Cysteine and histidine-rich protein 1 homolog	CG32486	Drosophila melanogaster (Fruit fly)	412	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN905_c0_g1_i2	Q9VZV5	CYHR1_DROME	52.2	247	106	2	781	59	172	412	8.30E-76	285	CYHR1_DROME	reviewed	Cysteine and histidine-rich protein 1 homolog	CG32486	Drosophila melanogaster (Fruit fly)	412	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN905_c0_g1_i3	Q9VZV5	CYHR1_DROME	50	258	106	3	814	59	172	412	5.20E-73	275.8	CYHR1_DROME	reviewed	Cysteine and histidine-rich protein 1 homolog	CG32486	Drosophila melanogaster (Fruit fly)	412	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN905_c0_g1_i4	Q9VZV5	CYHR1_DROME	53.5	241	106	1	763	59	172	412	8.60E-78	291.6	CYHR1_DROME	reviewed	Cysteine and histidine-rich protein 1 homolog	CG32486	Drosophila melanogaster (Fruit fly)	412	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN905_c0_g1_i5	Q9VZV5	CYHR1_DROME	51.2	252	106	2	796	59	172	412	5.50E-75	282.3	CYHR1_DROME	reviewed	Cysteine and histidine-rich protein 1 homolog	CG32486	Drosophila melanogaster (Fruit fly)	412	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN26159_c0_g1_i1	B8DZS1	ISCS_DICTD	50.7	67	31	1	206	6	172	236	3.40E-14	78.6	ISCS_DICTD	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS Dtur_0719	Dictyoglomus turgidum (strain Z-1310 / DSM 6724)	394	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; cellular amino acid metabolic process [GO:0006520]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0006520; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]; cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN30204_c0_g1_i1	B7H3H0	ISCS_ACIB3	65.2	69	23	1	3	206	41	109	9.70E-16	83.6	ISCS_ACIB3	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS ABBFA_001865	Acinetobacter baumannii (strain AB307-0294)	405	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN40332_c0_g1_i1	A7FWJ9	ISCS_CLOB1	55.6	81	36	0	244	2	55	135	7.80E-20	97.4	ISCS_CLOB1	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS CLB_2509	Clostridium botulinum (strain ATCC 19397 / Type A)	397	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; cellular amino acid metabolic process [GO:0006520]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0006520; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]; cellular amino acid metabolic process [GO:0006520]		NA	NA	NA	NA	NA	NA
TRINITY_DN37787_c0_g1_i1	Q47EN5	ISCS_DECAR	84	119	18	1	357	4	2	120	3.60E-51	202.2	ISCS_DECAR	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS Daro_1950	Dechloromonas aromatica (strain RCB)	405	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN31478_c0_g1_i1	Q1H361	ISCS_METFK	90.4	125	12	0	1	375	139	263	3.10E-60	232.3	ISCS_METFK	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS Mfla_0808	Methylobacillus flagellatus (strain KT / ATCC 51484 / DSM 6875)	405	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN7057_c0_g1_i1	A8GWB2	ISCS_RICB8	61	272	105	1	814	2	13	284	2.20E-93	343.6	ISCS_RICB8	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS A1I_03930	Rickettsia bellii (strain OSU 85-389)	410	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN33058_c0_g1_i1	A8GWB2	ISCS_RICB8	57.7	111	45	2	330	1	13	122	1.70E-29	130.2	ISCS_RICB8	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS A1I_03930	Rickettsia bellii (strain OSU 85-389)	410	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN26993_c0_g1_i1	Q9ZD60	ISCS_RICPR	54.2	107	49	0	321	1	151	257	1.40E-26	120.2	ISCS_RICPR	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS RP486	Rickettsia prowazekii (strain Madrid E)	410	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN33315_c0_g1_i1	C1DE68	ISCS_AZOVD	60.2	161	64	0	13	495	114	274	3.00E-47	189.5	ISCS_AZOVD	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS Avin_40400	Azotobacter vinelandii (strain DJ / ATCC BAA-1303)	404	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN8944_c0_g1_i1	Q6LU62	ISCS_PHOPR	65.7	108	36	1	342	19	287	393	6.50E-33	141.4	ISCS_PHOPR	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS PBPRA0750	Photobacterium profundum (strain SS9)	404	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN27439_c0_g1_i1	Q1H361	ISCS_METFK	82.2	118	21	0	427	74	288	405	5.40E-53	208.4	ISCS_METFK	reviewed	Cysteine desulfurase IscS (EC 2.8.1.7)	iscS Mfla_0808	Methylobacillus flagellatus (strain KT / ATCC 51484 / DSM 6875)	405	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; cysteine desulfurase activity [GO:0031071]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]"	GO:0005737; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051537	[2Fe-2S] cluster assembly [GO:0044571]		NA	NA	NA	NA	NA	NA
TRINITY_DN2754_c0_g1_i1	Q5RDE7	NFS1_PONAB	77.5	414	93	0	206	1447	44	457	2.40E-191	669.8	NFS1_PONAB	reviewed	"Cysteine desulfurase, mitochondrial (EC 2.8.1.7)"	NFS1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	457	mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0005634; GO:0005739; GO:0006777; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN2754_c0_g1_i2	Q5RDE7	NFS1_PONAB	77.5	414	93	0	206	1447	44	457	2.40E-191	669.8	NFS1_PONAB	reviewed	"Cysteine desulfurase, mitochondrial (EC 2.8.1.7)"	NFS1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	457	mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0005634; GO:0005739; GO:0006777; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN27762_c0_g1_i1	Q9Y697	NFS1_HUMAN	100	85	0	0	257	3	338	422	6.80E-43	174.1	NFS1_HUMAN	reviewed	"Cysteine desulfurase, mitochondrial (EC 2.8.1.7)"	NFS1 NIFS HUSSY-08	Homo sapiens (Human)	457	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; small molecule metabolic process [GO:0044281]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0032324; GO:0042803; GO:0044281; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; small molecule metabolic process [GO:0044281]		NA	NA	NA	NA	NA	NA
TRINITY_DN36634_c0_g1_i1	Q9Z1J3	NFS1_MOUSE	98.6	74	1	0	244	23	78	151	2.90E-35	148.7	NFS1_MOUSE	reviewed	"Cysteine desulfurase, mitochondrial (m-Nfs1) (EC 2.8.1.7)"	Nfs1 Nifs	Mus musculus (Mouse)	459	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN36584_c0_g1_i1	Q9Z1J3	NFS1_MOUSE	97	67	2	0	201	1	362	428	2.00E-29	129	NFS1_MOUSE	reviewed	"Cysteine desulfurase, mitochondrial (m-Nfs1) (EC 2.8.1.7)"	Nfs1 Nifs	Mus musculus (Mouse)	459	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN33573_c0_g1_i1	B0YLW6	NFS1_TRAHO	75.3	89	22	0	39	305	336	424	3.10E-31	135.6	NFS1_TRAHO	reviewed	"Cysteine desulfurase, mitosomal (EC 2.8.1.7)"	NFS1 THOM_0306	Trachipleistophora hominis (Microsporidian parasite)	441	mitosome [GO:0032047]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; tRNA wobble position uridine thiolation [GO:0002143]	mitosome [GO:0032047]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0002143; GO:0030170; GO:0031071; GO:0032047; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; tRNA wobble position uridine thiolation [GO:0002143]		NA	NA	NA	NA	NA	NA
TRINITY_DN13085_c0_g1_i1	Q60TI7	CDO_CAEBR	51.7	145	59	1	492	58	49	182	6.70E-43	175.3	CDO_CAEBR	reviewed	Cysteine dioxygenase (CDO) (EC 1.13.11.20)	cdo-1 CBG20456	Caenorhabditis briggsae	190	"cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]"		"cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"	GO:0008198; GO:0016702; GO:0017172; GO:0019448; GO:0042412	L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13085_c0_g1_i2	Q6NWZ9	CDO1_DANRE	52.3	199	85	1	660	64	1	189	3.30E-58	226.5	CDO1_DANRE	reviewed	Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I)	cdo1	Danio rerio (Zebrafish) (Brachydanio rerio)	201	"cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]"		"cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"	GO:0008198; GO:0016702; GO:0017172; GO:0019448; GO:0042412	L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]		NA	NA	NA	NA	NA	NA
TRINITY_DN28571_c0_g1_i1	Q8WYN0	ATG4A_HUMAN	100	67	0	0	2	202	125	191	3.80E-33	141.4	ATG4A_HUMAN	reviewed	Cysteine protease ATG4A (EC 3.4.22.-) (AUT-like 2 cysteine endopeptidase) (Autophagin-2) (Autophagy-related cysteine endopeptidase 2) (Autophagy-related protein 4 homolog A) (hAPG4A)	ATG4A APG4A AUTL2	Homo sapiens (Human)	398	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031	autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN33983_c0_g1_i1	Q8BGE6	ATG4B_MOUSE	98.7	77	1	0	2	232	214	290	1.10E-39	163.3	ATG4B_MOUSE	reviewed	Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B)	Atg4b Apg4b Autl1 Kiaa0943	Mus musculus (Mouse)	393	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]	GO:0000045; GO:0004175; GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008233; GO:0008234; GO:0009267; GO:0015031; GO:0045732; GO:0051697	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN24212_c0_g1_i1	Q9Y4P1	ATG4B_HUMAN	100	136	0	0	3	410	44	179	2.70E-78	292.4	ATG4B_HUMAN	reviewed	Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B)	ATG4B APG4B AUTL1 KIAA0943	Homo sapiens (Human)	393	cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]	cytosol [GO:0005829]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]	GO:0004175; GO:0004197; GO:0005829; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016236; GO:0045732; GO:0051697	autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN34479_c0_g1_i1	Q9Y4P1	ATG4B_HUMAN	100	70	0	0	212	3	221	290	1.50E-35	149.4	ATG4B_HUMAN	reviewed	Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B)	ATG4B APG4B AUTL1 KIAA0943	Homo sapiens (Human)	393	cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]	cytosol [GO:0005829]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]	GO:0004175; GO:0004197; GO:0005829; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016236; GO:0045732; GO:0051697	autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN209_c0_g1_i1	Q640G7	ATG4B_XENLA	45.5	385	181	7	1172	90	3	382	1.70E-96	354.4	ATG4B_XENLA	reviewed	Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related protein 4 homolog B)	atg4b apg4b	Xenopus laevis (African clawed frog)	384	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; autophagy [GO:0006914]; protein transport [GO:0015031]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005737; GO:0006914; GO:0015031	autophagy [GO:0006914]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN209_c0_g1_i2	Q640G7	ATG4B_XENLA	46	374	174	6	1142	90	14	382	4.30E-96	353.2	ATG4B_XENLA	reviewed	Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related protein 4 homolog B)	atg4b apg4b	Xenopus laevis (African clawed frog)	384	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; autophagy [GO:0006914]; protein transport [GO:0015031]	cytoplasm [GO:0005737]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005737; GO:0006914; GO:0015031	autophagy [GO:0006914]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN41062_c0_g1_i1	Q8BGV9	ATG4D_MOUSE	97.5	81	2	0	1	243	283	363	2.90E-43	175.3	ATG4D_MOUSE	reviewed	"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagin-4) (Autophagy-related cysteine endopeptidase 4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]"	Atg4d Apg4d Autl4	Mus musculus (Mouse)	474	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cysteine-type peptidase activity [GO:0008234]	GO:0005654; GO:0005739; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031	apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN6348_c0_g1_i1	Q8BGV9	ATG4D_MOUSE	47	181	88	3	77	604	297	474	6.60E-44	178.7	ATG4D_MOUSE	reviewed	"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagin-4) (Autophagy-related cysteine endopeptidase 4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]"	Atg4d Apg4d Autl4	Mus musculus (Mouse)	474	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cysteine-type peptidase activity [GO:0008234]	GO:0005654; GO:0005739; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031	apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN31078_c0_g1_i1	Q8BGV9	ATG4D_MOUSE	59.3	59	24	0	21	197	109	167	2.10E-15	82.8	ATG4D_MOUSE	reviewed	"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagin-4) (Autophagy-related cysteine endopeptidase 4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]"	Atg4d Apg4d Autl4	Mus musculus (Mouse)	474	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cysteine-type peptidase activity [GO:0008234]	GO:0005654; GO:0005739; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031	apoptotic process [GO:0006915]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN27390_c0_g1_i1	P25804	CYSP_PEA	70	60	18	0	22	201	128	187	9.80E-19	93.6	CYSP_PEA	reviewed	Cysteine proteinase 15A (EC 3.4.22.-) (Turgor-responsive protein 15A)		Pisum sativum (Garden pea)	363	cysteine-type peptidase activity [GO:0008234]		cysteine-type peptidase activity [GO:0008234]	GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN13149_c0_g1_i1	Q05094	CYSP2_LEIPI	55.7	70	31	0	46	255	124	193	7.70E-18	90.9	CYSP2_LEIPI	reviewed	Cysteine proteinase 2 (EC 3.4.22.-) (Amastigote cysteine proteinase A-2)	CYS2	Leishmania pifanoi	444	lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; pathogenesis [GO:0009405]	lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005764; GO:0009405	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN37613_c0_g1_i1	P25250	CYSP2_HORVU	63.2	68	23	2	8	208	285	351	2.10E-18	92.4	CYSP2_HORVU	reviewed	Cysteine proteinase EP-B 2 (EC 3.4.22.-)	EPB2	Hordeum vulgare (Barley)	373	cysteine-type peptidase activity [GO:0008234]		cysteine-type peptidase activity [GO:0008234]	GO:0008234			red	red	NA	NA	NA	NA
TRINITY_DN30740_c0_g1_i1	P43297	RD21A_ARATH	60	65	26	0	201	7	140	204	5.40E-17	87.8	RD21A_ARATH	reviewed	Cysteine proteinase RD21A (EC 3.4.22.-) (Protein RESPONSIVE TO DEHYDRATION 21) (RD21)	RD21A At1g47128 F2G19.31	Arabidopsis thaliana (Mouse-ear cress)	462	apoplast [GO:0048046]; cytoplasmic stress granule [GO:0010494]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleus [GO:0005634]; P-body [GO:0000932]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; defense response to fungus [GO:0050832]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	apoplast [GO:0048046]; cytoplasmic stress granule [GO:0010494]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleus [GO:0005634]; P-body [GO:0000932]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuole [GO:0005773]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0000932; GO:0004197; GO:0005615; GO:0005634; GO:0005764; GO:0005773; GO:0005794; GO:0006508; GO:0008233; GO:0008234; GO:0009506; GO:0010494; GO:0048046; GO:0050832; GO:0051603; GO:0099503	defense response to fungus [GO:0050832]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN38101_c0_g1_i1	Q54CN7	CYSK_DICDI	54.7	64	29	0	3	194	166	229	2.40E-12	72.4	CYSK_DICDI	reviewed	Cysteine synthase (CSase) (EC 2.5.1.47) (O-acetylserine (thiol)-lyase) (OAS-TL) (O-acetylserine sulfhydrylase)	cysK DDB_G0292840	Dictyostelium discoideum (Slime mold)	378	cytoplasm [GO:0005737]; cysteine synthase activity [GO:0004124]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]	cytoplasm [GO:0005737]	cysteine synthase activity [GO:0004124]; pyridoxal phosphate binding [GO:0030170]	GO:0004124; GO:0005737; GO:0006535; GO:0019344; GO:0030170	cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]		NA	NA	NA	NA	NA	NA
TRINITY_DN37662_c0_g1_i1	Q59447	CYSK_FLAS3	74.4	90	22	1	268	2	7	96	1.90E-30	132.9	CYSK_FLAS3	reviewed	Cysteine synthase (CSase) (EC 2.5.1.47) (O-acetylserine (thiol)-lyase) (OAS-TL) (O-acetylserine sulfhydrylase)	cysK	Flavobacterium sp. (strain K3-15 / DSM ID92-509)	307	cysteine synthase activity [GO:0004124]; cysteine biosynthetic process from serine [GO:0006535]		cysteine synthase activity [GO:0004124]	GO:0004124; GO:0006535	cysteine biosynthetic process from serine [GO:0006535]		NA	NA	NA	NA	NA	NA
TRINITY_DN6046_c0_g1_i1	Q7RYW6	CYSK_NEUCR	62.6	91	34	0	275	3	74	164	1.80E-25	116.3	CYSK_NEUCR	reviewed	Cysteine synthase 1 (CS 1) (EC 2.5.1.-) (EC 2.5.1.47) (O-acetylserine (thiol)-lyase 1) (OAS-TL 1) (O-acetylserine sulfhydrylase 1) (O-succinylserine sulfhydrylase)	cys-17 NCU06452	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	376	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine synthase activity [GO:0004124]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cysteine synthase activity [GO:0004124]; pyridoxal phosphate binding [GO:0030170]	GO:0004124; GO:0005737; GO:0005739; GO:0006535; GO:0030170	cysteine biosynthetic process from serine [GO:0006535]		NA	NA	NA	NA	NA	1
TRINITY_DN31252_c0_g1_i1	Q9I526	CYSM_PSEAE	78.9	76	16	0	229	2	38	113	1.60E-27	122.9	CYSM_PSEAE	reviewed	Cysteine synthase B (CSase B) (EC 2.5.1.47) (O-acetylserine (thiol)-lyase B) (OAS-TL B) (O-acetylserine sulfhydrylase B)	cysM PA0932	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	299	cytoplasm [GO:0005737]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]	cytoplasm [GO:0005737]	cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]	GO:0004124; GO:0005737; GO:0006535; GO:0030170; GO:0080146	cysteine biosynthetic process from serine [GO:0006535]		NA	NA	NA	NA	NA	NA
TRINITY_DN6256_c0_g1_i1	Q8WYN3	CSRN3_HUMAN	47.8	180	77	2	1150	1656	63	236	4.50E-34	147.5	CSRN3_HUMAN	reviewed	Cysteine/serine-rich nuclear protein 3 (CSRNP-3) (Protein FAM130A2) (TGF-beta-induced apoptosis protein 2) (TAIP-2)	CSRNP3 FAM130A2 TAIP2	Homo sapiens (Human)	585	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006915; GO:0010923; GO:0043065; GO:0043565; GO:0045944	apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN6256_c0_g1_i3	Q8WYN3	CSRN3_HUMAN	53.1	228	90	2	1150	1800	63	284	3.70E-58	227.6	CSRN3_HUMAN	reviewed	Cysteine/serine-rich nuclear protein 3 (CSRNP-3) (Protein FAM130A2) (TGF-beta-induced apoptosis protein 2) (TAIP-2)	CSRNP3 FAM130A2 TAIP2	Homo sapiens (Human)	585	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006915; GO:0010923; GO:0043065; GO:0043565; GO:0045944	apoptotic process [GO:0006915]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN29745_c0_g1_i1	Q8R3A2	CDPF1_MOUSE	40.4	104	61	1	168	479	11	113	6.20E-20	99	CDPF1_MOUSE	reviewed	Cysteine-rich DPF motif domain-containing protein 1	Cdpf1	Mus musculus (Mouse)	119							blue	blue	NA	NA	NA	NA
TRINITY_DN32988_c0_g1_i1	Q9D9G3	CHIC2_MOUSE	55.7	167	72	1	507	7	1	165	4.20E-52	205.7	CHIC2_MOUSE	reviewed	Cysteine-rich hydrophobic domain-containing protein 2	Chic2	Mus musculus (Mouse)	165	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Golgi to plasma membrane transport [GO:0006893]	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0005794; GO:0005798; GO:0005886; GO:0006893; GO:0043231	Golgi to plasma membrane transport [GO:0006893]		NA	NA	NA	NA	NA	NA
TRINITY_DN18772_c0_g1_i2	Q9D9G3	CHIC2_MOUSE	100	148	0	0	446	3	1	148	7.30E-80	297.7	CHIC2_MOUSE	reviewed	Cysteine-rich hydrophobic domain-containing protein 2	Chic2	Mus musculus (Mouse)	165	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Golgi to plasma membrane transport [GO:0006893]	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0005794; GO:0005798; GO:0005886; GO:0006893; GO:0043231	Golgi to plasma membrane transport [GO:0006893]		NA	NA	NA	NA	NA	NA
TRINITY_DN18772_c0_g1_i1	Q9UKJ5	CHIC2_HUMAN	98	100	2	0	301	2	1	100	2.30E-48	192.6	CHIC2_HUMAN	reviewed	Cysteine-rich hydrophobic domain-containing protein 2 (BrX-like translocated in leukemia)	CHIC2 BTL	Homo sapiens (Human)	165	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0005794; GO:0005798; GO:0005886; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN12315_c0_g1_i1	Q56K04	CRIP1_BOVIN	60.9	69	9	1	64	216	1	69	4.80E-18	91.3	CRIP1_BOVIN	reviewed	Cysteine-rich protein 1 (CRP-1)	CRIP1	Bos taurus (Bovine)	77	cytoplasm [GO:0005737]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]	cytoplasm [GO:0005737]	peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0071236; GO:0071493	cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN12315_c0_g1_i2	Q56K04	CRIP1_BOVIN	78.3	69	15	0	64	270	1	69	1.50E-29	129.8	CRIP1_BOVIN	reviewed	Cysteine-rich protein 1 (CRP-1)	CRIP1	Bos taurus (Bovine)	77	cytoplasm [GO:0005737]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]	cytoplasm [GO:0005737]	peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0071236; GO:0071493	cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]		blue	blue	NA	NA	NA	NA
TRINITY_DN16925_c0_g1_i1	P16562	CRIS2_HUMAN	42.1	221	113	6	246	902	35	242	7.00E-45	182.6	CRIS2_HUMAN	reviewed	Cysteine-rich secretory protein 2 (CRISP-2) (Cancer/testis antigen 36) (CT36) (Testis-specific protein TPX-1)	CRISP2 GAPDL5 TPX1	Homo sapiens (Human)	243	extracellular space [GO:0005615]; cell-cell adhesion [GO:0098609]	extracellular space [GO:0005615]		GO:0005615; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN16925_c0_g1_i2	P16562	CRIS2_HUMAN	43.3	141	74	3	246	662	35	171	8.00E-28	125.6	CRIS2_HUMAN	reviewed	Cysteine-rich secretory protein 2 (CRISP-2) (Cancer/testis antigen 36) (CT36) (Testis-specific protein TPX-1)	CRISP2 GAPDL5 TPX1	Homo sapiens (Human)	243	extracellular space [GO:0005615]; cell-cell adhesion [GO:0098609]	extracellular space [GO:0005615]		GO:0005615; GO:0098609	cell-cell adhesion [GO:0098609]		brown	brown	1	NA	NA	NA
TRINITY_DN37391_c0_g1_i1	B2U9P8	SYC_RALPJ	98.9	95	1	0	286	2	165	259	8.00E-53	207.2	SYC_RALPJ	reviewed	Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)	cysS Rpic_1008	Ralstonia pickettii (strain 12J)	463	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; zinc ion binding [GO:0008270]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; zinc ion binding [GO:0008270]	GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0008270	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN31633_c0_g1_i1	P53852	SYC_YEAST	69.5	82	25	0	248	3	322	403	2.00E-31	136	SYC_YEAST	reviewed	Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)	YNL247W N0885	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	767	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN36941_c0_g1_i1	Q8SRE0	SYC_ENCCU	71.3	94	26	1	280	2	176	269	1.80E-36	152.9	SYC_ENCCU	reviewed	Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)	ECU08_0490	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	480	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]		ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	1	NA	NA	NA
TRINITY_DN15865_c0_g1_i1	Q8SRE0	SYC_ENCCU	59.4	69	28	0	2	208	5	73	8.60E-20	97.1	SYC_ENCCU	reviewed	Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)	ECU08_0490	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	480	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]		ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN39731_c0_g1_i2	Q7KN90	SYCC_DROME	72	82	22	1	4	246	7	88	2.60E-31	135.6	SYCC_DROME	reviewed	"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase)"	CysRS Aats-cys CG8431	Drosophila melanogaster (Fruit fly)	741	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]	GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		blue	blue	NA	NA	NA	NA
TRINITY_DN39731_c0_g1_i1	P49589	SYCC_HUMAN	59.7	67	26	1	4	201	16	82	3.90E-18	91.7	SYCC_HUMAN	reviewed	"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	CARS1 CARS	Homo sapiens (Human)	748	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006423; GO:0042802; GO:0042803; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN30355_c0_g1_i1	Q54KR1	SYCC_DICDI	52.2	67	32	0	1	201	86	152	1.90E-11	69.3	SYCC_DICDI	reviewed	"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	cysS DDB_G0287159	Dictyostelium discoideum (Slime mold)	660	cytoplasm [GO:0005737]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; phagocytic vesicle [GO:0045335]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]	GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0045335; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN33428_c0_g1_i1	Q7ZWR2	SYCC_XENLA	78.6	112	22	1	331	2	296	407	2.80E-49	195.7	SYCC_XENLA	reviewed	"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	cars1 cars	Xenopus laevis (African clawed frog)	747	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]	GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN30221_c0_g1_i1	Q2QL83	CFTR_MICMU	45.7	46	25	0	197	60	163	208	2.00E-06	52.8	CFTR_MICMU	reviewed	Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel)	CFTR ABCC7	Microcebus murinus (Gray mouse lemur) (Lemur murinus)	1481	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; vesicle docking involved in exocytosis [GO:0006904]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138]	GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006695; GO:0006904; GO:0009986; GO:0015106; GO:0015108; GO:0015701; GO:0016021; GO:0016324; GO:0016853; GO:0016887; GO:0019869; GO:0019899; GO:0030165; GO:0030301; GO:0031901; GO:0034707; GO:0034976; GO:0035377; GO:0035774; GO:0042626; GO:0045921; GO:0048240; GO:0050891; GO:0051087; GO:0051454; GO:0055038; GO:0060081; GO:0071320; GO:0106138; GO:1902161; GO:1902476; GO:1902943; GO:1904322	bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN25866_c0_g1_i1	P57757	CTNS_MOUSE	39.8	103	61	1	82	390	183	284	3.40E-15	82.8	CTNS_MOUSE	reviewed	Cystinosin	Ctns	Mus musculus (Mouse)	367	integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; L-cystine transmembrane transporter activity [GO:0015184]; adult walking behavior [GO:0007628]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; cognition [GO:0050890]; glutathione metabolic process [GO:0006749]; grooming behavior [GO:0007625]; L-cystine transport [GO:0015811]; lens development in camera-type eye [GO:0002088]; long-term memory [GO:0007616]; melanin biosynthetic process [GO:0042438]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of mitochondrial membrane potential [GO:0010918]; visual learning [GO:0008542]	integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	L-cystine transmembrane transporter activity [GO:0015184]	GO:0002088; GO:0005764; GO:0005765; GO:0005770; GO:0005774; GO:0005886; GO:0006749; GO:0007420; GO:0007616; GO:0007625; GO:0007628; GO:0008542; GO:0010730; GO:0010918; GO:0015184; GO:0015811; GO:0016021; GO:0042438; GO:0042470; GO:0043231; GO:0045111; GO:0046034; GO:0050890; GO:1903427	adult walking behavior [GO:0007628]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; cognition [GO:0050890]; glutathione metabolic process [GO:0006749]; grooming behavior [GO:0007625]; L-cystine transport [GO:0015811]; lens development in camera-type eye [GO:0002088]; long-term memory [GO:0007616]; melanin biosynthetic process [GO:0042438]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of mitochondrial membrane potential [GO:0010918]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN22527_c0_g2_i1	P57757	CTNS_MOUSE	52.3	44	21	0	237	106	283	326	6.10E-05	48.1	CTNS_MOUSE	reviewed	Cystinosin	Ctns	Mus musculus (Mouse)	367	integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; L-cystine transmembrane transporter activity [GO:0015184]; adult walking behavior [GO:0007628]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; cognition [GO:0050890]; glutathione metabolic process [GO:0006749]; grooming behavior [GO:0007625]; L-cystine transport [GO:0015811]; lens development in camera-type eye [GO:0002088]; long-term memory [GO:0007616]; melanin biosynthetic process [GO:0042438]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of mitochondrial membrane potential [GO:0010918]; visual learning [GO:0008542]	integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	L-cystine transmembrane transporter activity [GO:0015184]	GO:0002088; GO:0005764; GO:0005765; GO:0005770; GO:0005774; GO:0005886; GO:0006749; GO:0007420; GO:0007616; GO:0007625; GO:0007628; GO:0008542; GO:0010730; GO:0010918; GO:0015184; GO:0015811; GO:0016021; GO:0042438; GO:0042470; GO:0043231; GO:0045111; GO:0046034; GO:0050890; GO:1903427	adult walking behavior [GO:0007628]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; cognition [GO:0050890]; glutathione metabolic process [GO:0006749]; grooming behavior [GO:0007625]; L-cystine transport [GO:0015811]; lens development in camera-type eye [GO:0002088]; long-term memory [GO:0007616]; melanin biosynthetic process [GO:0042438]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of mitochondrial membrane potential [GO:0010918]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN9632_c0_g1_i1	Q9VCR7	CTNS_DROME	62.5	192	72	0	3	578	178	369	1.20E-63	244.6	CTNS_DROME	reviewed	Cystinosin homolog	CG17119	Drosophila melanogaster (Fruit fly)	397	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; L-cystine transmembrane transporter activity [GO:0015184]; amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]	amino acid transmembrane transporter activity [GO:0015171]; L-cystine transmembrane transporter activity [GO:0015184]	GO:0003333; GO:0005765; GO:0005774; GO:0015171; GO:0015184; GO:0015811; GO:0016021	amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]		NA	NA	NA	NA	NA	NA
TRINITY_DN34908_c0_g1_i1	Q54WT7	CTNS_DICDI	50	68	34	0	3	206	156	223	6.00E-13	74.3	CTNS_DICDI	reviewed	Cystinosin homolog	ctns DDB_G0279445	Dictyostelium discoideum (Slime mold)	284	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; L-cystine transmembrane transporter activity [GO:0015184]; L-cystine transport [GO:0015811]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]	L-cystine transmembrane transporter activity [GO:0015184]	GO:0005765; GO:0005774; GO:0015184; GO:0015811; GO:0016021	L-cystine transport [GO:0015811]		NA	NA	NA	NA	NA	NA
TRINITY_DN13605_c0_g1_i1	P56389	CDD_MOUSE	53.1	128	60	0	159	542	13	140	7.00E-37	155.6	CDD_MOUSE	reviewed	Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)	Cda Cdd	Mus musculus (Mouse)	146	cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]	cytosol [GO:0005829]	cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0001882; GO:0004126; GO:0005829; GO:0008270; GO:0009972; GO:0030308; GO:0042802; GO:0042803; GO:0045980	cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]		blue	blue	NA	NA	NA	NA
TRINITY_DN13605_c0_g1_i2	P56389	CDD_MOUSE	51.9	133	64	0	59	457	8	140	5.50E-38	159.1	CDD_MOUSE	reviewed	Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)	Cda Cdd	Mus musculus (Mouse)	146	cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]	cytosol [GO:0005829]	cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0001882; GO:0004126; GO:0005829; GO:0008270; GO:0009972; GO:0030308; GO:0042802; GO:0042803; GO:0045980	cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]		NA	NA	NA	NA	NA	NA
TRINITY_DN26755_c0_g1_i2	Q53TN4	CYBR1_HUMAN	38.5	208	113	5	8	625	44	238	2.00E-25	117.5	CYBR1_HUMAN	reviewed	Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3)	CYBRD1 DCYTB FRRS3	Homo sapiens (Human)	286	brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; response to iron ion [GO:0010039]	brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]	GO:0000293; GO:0005765; GO:0005886; GO:0006879; GO:0010039; GO:0016021; GO:0016491; GO:0031526; GO:0046872; GO:0070062	cellular iron ion homeostasis [GO:0006879]; response to iron ion [GO:0010039]		NA	NA	NA	NA	NA	NA
TRINITY_DN38335_c0_g1_i1	Q9BQA9	CYBC1_HUMAN	100	72	0	0	217	2	1	72	7.70E-36	150.6	CYBC1_HUMAN	reviewed	Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros)	CYBC1 C17orf62 EROS	Homo sapiens (Human)	187	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021; GO:0045087; GO:0045728	innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728]		NA	NA	NA	NA	NA	NA
TRINITY_DN13937_c1_g1_i1	Q6DGA7	CYBC1_DANRE	36.9	157	95	4	117	578	13	168	3.30E-20	100.5	CYBC1_DANRE	reviewed	Cytochrome b-245 chaperone 1 homolog (Essential for reactive oxygen species protein) (Eros)	cybc1 eros zgc:91940	Danio rerio (Zebrafish) (Brachydanio rerio)	206	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021; GO:0045087; GO:0045728	innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728]		blue	blue	NA	NA	NA	NA
TRINITY_DN7436_c0_g1_i1	P49098	CYB5_TOBAC	47.4	95	44	2	294	560	8	102	1.50E-17	91.3	CYB5_TOBAC	reviewed	Cytochrome b5		Nicotiana tabacum (Common tobacco)	136	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005789; GO:0009055; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34167_c0_g1_i1	Q874I5	CYB5_CANTR	42.9	77	44	0	231	1	7	83	1.40E-11	70.1	CYB5_CANTR	reviewed	Cytochrome b5	Cytb5	Candida tropicalis (Yeast)	129	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005789; GO:0016021; GO:0020037; GO:0046872; GO:0055114	oxidation-reduction process [GO:0055114]		red	red	NA	NA	NA	NA
TRINITY_DN40395_c0_g1_i1	P56395	CYB5_MOUSE	100	84	0	0	4	255	1	84	6.70E-43	174.1	CYB5_MOUSE	reviewed	Cytochrome b5	Cyb5a Cyb5	Mus musculus (Mouse)	134	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]	GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0009055; GO:0016020; GO:0016021; GO:0019899; GO:0020037; GO:0043231; GO:0046686; GO:0046872	fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN5201_c0_g1_i1	P49096	CYB5_MUSDO	46.5	127	68	0	439	59	2	128	5.10E-32	139	CYB5_MUSDO	reviewed	Cytochrome b5 (CYTB5)	Cyt-b5	Musca domestica (House fly)	134	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005789; GO:0016021; GO:0020037; GO:0046872; GO:0055114	oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN12544_c1_g1_i1	Q28CZ9	NB5R4_XENTR	40.9	526	276	10	1624	71	23	521	2.10E-108	394.4	NB5R4_XENTR	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R)	cyb5r4 TGas070l21.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	523	"endoplasmic reticulum [GO:0005783]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0004128; GO:0005783; GO:0006091; GO:0006801; GO:0020037; GO:0046872; GO:0055114	generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN12544_c1_g1_i2	Q502I6	NB5R4_DANRE	42.2	249	131	6	796	71	283	525	5.90E-43	176	NB5R4_DANRE	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R)	cyb5r4 zgc:112177	Danio rerio (Zebrafish) (Brachydanio rerio)	527	"endoplasmic reticulum [GO:0005783]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0004128; GO:0005783; GO:0006091; GO:0006801; GO:0020037; GO:0046872; GO:0055114	generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN12544_c1_g1_i3	Q502I6	NB5R4_DANRE	40.4	203	110	5	664	71	329	525	3.90E-32	139.8	NB5R4_DANRE	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R)	cyb5r4 zgc:112177	Danio rerio (Zebrafish) (Brachydanio rerio)	527	"endoplasmic reticulum [GO:0005783]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0004128; GO:0005783; GO:0006091; GO:0006801; GO:0020037; GO:0046872; GO:0055114	generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN12544_c1_g1_i4	Q28CZ9	NB5R4_XENTR	58.9	56	22	1	215	48	23	77	5.50E-13	74.7	NB5R4_XENTR	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R)	cyb5r4 TGas070l21.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	523	"endoplasmic reticulum [GO:0005783]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0004128; GO:0005783; GO:0006091; GO:0006801; GO:0020037; GO:0046872; GO:0055114	generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; superoxide metabolic process [GO:0006801]		pink	pink	NA	NA	NA	NA
TRINITY_DN12544_c1_g1_i5	Q32LH7	NB5R4_BOVIN	42	250	132	5	796	71	274	518	6.60E-43	176.4	NB5R4_BOVIN	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R)	CYB5R4	Bos taurus (Bovine)	520	"endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; cell development [GO:0048468]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]"	GO:0004128; GO:0005783; GO:0006091; GO:0006801; GO:0016174; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0071949	cell development [GO:0048468]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN12544_c1_g1_i5	Q32LH7	NB5R4_BOVIN	62	108	40	1	1205	882	23	129	2.40E-37	157.9	NB5R4_BOVIN	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R)	CYB5R4	Bos taurus (Bovine)	520	"endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; cell development [GO:0048468]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]"	GO:0004128; GO:0005783; GO:0006091; GO:0006801; GO:0016174; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0071949	cell development [GO:0048468]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN28626_c0_g1_i1	Q7L1T6	NB5R4_HUMAN	100	99	0	0	298	2	43	141	1.10E-55	216.9	NB5R4_HUMAN	reviewed	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R)	CYB5R4 NCB5OR	Homo sapiens (Human)	521	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]"	GO:0003032; GO:0004128; GO:0005783; GO:0005789; GO:0006091; GO:0006801; GO:0015701; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0055114	bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN29236_c0_g1_i1	O43169	CYB5B_HUMAN	100	97	0	0	299	9	15	111	1.70E-50	199.5	CYB5B_HUMAN	reviewed	Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform)	CYB5B CYB5M OMB5	Homo sapiens (Human)	150	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; electron transfer activity [GO:0009055]; enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; xenobiotic metabolic process [GO:0006805]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]	electron transfer activity [GO:0009055]; enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005741; GO:0006805; GO:0008047; GO:0009055; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872	xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN35749_c0_g1_i1	O22704	CYP5F_ARATH	41.7	72	41	1	218	3	46	116	2.50E-12	72.4	CYP5F_ARATH	reviewed	Cytochrome B5-like protein (AtCb5LP) (Cytochrome b5 isoform F) (AtCb5-F)	CB5LP CB5-F At1g60660 F8A5.18	Arabidopsis thaliana (Mouse-ear cress)	121	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0009055; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17163_c0_g1_i1	P23004	QCR2_BOVIN	46.3	54	28	1	3	164	175	227	2.50E-06	52.4	QCR2_BOVIN	reviewed	"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)"	UQCRC2	Bos taurus (Bovine)	453	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]	metal ion binding [GO:0046872]	GO:0005739; GO:0005743; GO:0006508; GO:0046872; GO:0055114; GO:0070469	oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN6594_c0_g1_i2	P23004	QCR2_BOVIN	39.1	425	246	8	1332	91	31	453	7.30E-70	266.2	QCR2_BOVIN	reviewed	"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)"	UQCRC2	Bos taurus (Bovine)	453	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]	metal ion binding [GO:0046872]	GO:0005739; GO:0005743; GO:0006508; GO:0046872; GO:0055114; GO:0070469	oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN6594_c0_g1_i5	P23004	QCR2_BOVIN	37.8	452	268	8	1413	91	4	453	6.80E-71	269.6	QCR2_BOVIN	reviewed	"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)"	UQCRC2	Bos taurus (Bovine)	453	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; metal ion binding [GO:0046872]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]	metal ion binding [GO:0046872]	GO:0005739; GO:0005743; GO:0006508; GO:0046872; GO:0055114; GO:0070469	oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN12907_c0_g1_i1	P00129	QCR7_BOVIN	52	98	44	1	253	546	17	111	3.50E-24	113.2	QCR7_BOVIN	reviewed	Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)	UQCRB	Bos taurus (Bovine)	111	"mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]"	mitochondrial respiratory chain complex III [GO:0005750]		GO:0005750; GO:0006122; GO:0009060; GO:0034551	"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38830_c0_g1_i1	P14927	QCR7_HUMAN	100	97	0	0	332	42	15	111	1.00E-51	203.8	QCR7_HUMAN	reviewed	Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)	UQCRB UQBP	Homo sapiens (Human)	111	"mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]		GO:0005743; GO:0005746; GO:0005750; GO:0006119; GO:0006122; GO:0009060; GO:0034551; GO:0055114	"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36354_c0_g1_i1	Q9D855	QCR7_MOUSE	94.6	74	4	0	1	222	38	111	2.60E-34	145.6	QCR7_MOUSE	reviewed	Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)	Uqcrb	Mus musculus (Mouse)	111	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0009060; GO:0034551	"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12907_c0_g1_i4	Q5RC24	QCR7_PONAB	51	104	48	1	85	396	11	111	2.00E-24	113.6	QCR7_PONAB	reviewed	Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)	UQCRB	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	111	"mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	mitochondrial respiratory chain complex III [GO:0005750]		GO:0005750; GO:0006122	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2874_c0_g1_i1	Q9CQ69	QCR8_MOUSE	57.7	52	22	0	69	224	1	52	3.60E-11	68.9	QCR8_MOUSE	reviewed	Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C)	Uqcrq	Mus musculus (Mouse)	82	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]"	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	ubiquinol-cytochrome-c reductase activity [GO:0008121]	GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0016021; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901	"cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2874_c0_g1_i2	Q9CQ69	QCR8_MOUSE	51.2	80	39	0	69	308	1	80	1.40E-18	93.6	QCR8_MOUSE	reviewed	Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C)	Uqcrq	Mus musculus (Mouse)	82	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]"	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	ubiquinol-cytochrome-c reductase activity [GO:0008121]	GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0016021; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901	"cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]"		blue	blue	NA	NA	NA	NA
TRINITY_DN36021_c0_g1_i1	P07056	UCRI_NEUCR	82.5	57	9	1	1	171	176	231	7.20E-25	114	UCRI_NEUCR	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Complex III subunit V) (Rieske iron-sulfur protein) (RISP) (Ubiquinol-cytochrome c oxidoreductase iron-sulfur subunit) (Ubiquinol-cytochrome c reductase complex 25 kDa protein)"	fes-1 NCU06606	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	231	"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005750; GO:0006122; GO:0008121; GO:0016021; GO:0016491; GO:0046872; GO:0051537	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29193_c0_g1_i1	Q9CR68	UCRI_MOUSE	100	73	0	0	220	2	54	126	1.00E-31	136.7	UCRI_MOUSE	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]"	Uqcrfs1	Mus musculus (Mouse)	274	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to hormone [GO:0009725]"	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0009725; GO:0016021; GO:0016491; GO:0031966; GO:0042493; GO:0043209; GO:0044877; GO:0046677; GO:0046872; GO:0051537	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to hormone [GO:0009725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33072_c0_g1_i1	Q69BK4	UCRI_GORGO	100	230	0	0	10	699	45	274	8.20E-129	461.1	UCRI_GORGO	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]"	UQCRFS1	Gorilla gorilla gorilla (Western lowland gorilla)	274	"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0016021; GO:0016491; GO:0046872; GO:0051537	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"		NA	NA	NA	NA	NA	NA
TRINITY_DN503_c0_g1_i1	Q9CR68	UCRI_MOUSE	55.1	274	123	0	74	895	1	274	6.70E-83	308.9	UCRI_MOUSE	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]"	Uqcrfs1	Mus musculus (Mouse)	274	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to hormone [GO:0009725]"	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0009725; GO:0016021; GO:0016491; GO:0031966; GO:0042493; GO:0043209; GO:0044877; GO:0046677; GO:0046872; GO:0051537	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to hormone [GO:0009725]"		blue	blue	NA	NA	NA	NA
TRINITY_DN503_c0_g1_i2	Q69BJ9	UCRI_AOTAZ	65	203	71	0	167	775	72	274	4.10E-76	286.2	UCRI_AOTAZ	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]"	UQCRFS1	Aotus azarae (Southern owl monkey) (Aotus azarai)	274	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005743; GO:0008121; GO:0016021; GO:0046872; GO:0051537; GO:0070469			blue	blue	NA	NA	NA	NA
TRINITY_DN20524_c0_g1_i1	Q9CR68	UCRI_MOUSE	100	154	0	0	535	74	121	274	1.80E-85	316.6	UCRI_MOUSE	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]"	Uqcrfs1	Mus musculus (Mouse)	274	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to hormone [GO:0009725]"	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0009725; GO:0016021; GO:0016491; GO:0031966; GO:0042493; GO:0043209; GO:0044877; GO:0046677; GO:0046872; GO:0051537	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; response to hormone [GO:0009725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31834_c0_g1_i1	P49727	UCRI_MAIZE	68.7	99	29	1	2	298	177	273	2.60E-36	152.5	UCRI_MAIZE	reviewed	"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Rieske iron-sulfur protein) (RISP) (Ubiquinol-cytochrome c reductase iron-sulfur subunit)"		Zea mays (Maize)	273	"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to heat [GO:0009408]"	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005750; GO:0006122; GO:0008121; GO:0009060; GO:0009408; GO:0016021; GO:0016491; GO:0046872; GO:0051537	"aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to heat [GO:0009408]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36021_c0_g1_i2	P51133	UCRI3_TOBAC	85.4	48	6	1	21	164	222	268	7.40E-19	94	UCRI3_TOBAC	reviewed	"Cytochrome b-c1 complex subunit Rieske-3, mitochondrial (EC 7.1.1.8) (Complex III subunit 5-3) (Rieske iron-sulfur protein 3) (RISP3) (Ubiquinol-cytochrome c reductase iron-sulfur subunit 3)"		Nicotiana tabacum (Common tobacco)	268	"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005750; GO:0006122; GO:0008121; GO:0016021; GO:0016491; GO:0046872; GO:0051537	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39096_c0_g1_i1	Q6WUX8	CYC_GORGO	100	105	0	0	91	405	1	105	1.30E-57	223.8	CYC_GORGO	reviewed	Cytochrome c	CYCS CYC	Gorilla gorilla gorilla (Western lowland gorilla)	105	"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; respirasome [GO:0070469]; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]"	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; respirasome [GO:0070469]	"electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0005634; GO:0005758; GO:0005829; GO:0006122; GO:0006123; GO:0006915; GO:0020037; GO:0043280; GO:0045155; GO:0046872; GO:0070469	"apoptotic process [GO:0006915]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3729_c0_g2_i1	Q4UEA0	CYC_THEAN	77.4	93	21	0	3	281	21	113	1.10E-39	163.7	CYC_THEAN	reviewed	Cytochrome c	TA12950	Theileria annulata	115	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			NA	NA	NA	NA	NA	NA
TRINITY_DN3729_c0_g1_i1	Q4UEA0	CYC_THEAN	71.4	63	18	0	2	190	48	110	1.80E-22	106.3	CYC_THEAN	reviewed	Cytochrome c	TA12950	Theileria annulata	115	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			NA	NA	NA	NA	NA	NA
TRINITY_DN8632_c0_g1_i1	P00031	CYC_MACMA	82.4	85	15	0	257	3	1	85	3.90E-38	158.7	CYC_MACMA	reviewed	Cytochrome c		Macrobrachium malcolmsonii (Monsoon river-prawn) (Palaemon malcolmsonii)	105	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			NA	NA	NA	NA	NA	NA
TRINITY_DN8632_c0_g1_i2	Q6QLW4	CYC_PECGU	82.5	103	18	0	64	372	7	109	6.00E-47	188.3	CYC_PECGU	reviewed	Cytochrome c		Pectinaria gouldii (Trumpet worm) (Ice-cream cone worm)	109	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			NA	NA	NA	NA	NA	NA
TRINITY_DN8632_c0_g1_i3	P00022	CYC_CHESE	79.6	103	21	0	402	94	1	103	2.50E-44	180.6	CYC_CHESE	reviewed	Cytochrome c		Chelydra serpentina (Snapping turtle) (Testudo serpentina)	105	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			blue	blue	NA	NA	NA	NA
TRINITY_DN8632_c0_g1_i5	P00022	CYC_CHESE	79.6	103	21	0	402	94	1	103	2.60E-44	180.6	CYC_CHESE	reviewed	Cytochrome c		Chelydra serpentina (Snapping turtle) (Testudo serpentina)	105	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			blue	blue	NA	NA	NA	NA
TRINITY_DN8632_c0_g1_i7	P00031	CYC_MACMA	83.5	103	17	0	382	74	1	103	2.00E-46	187.6	CYC_MACMA	reviewed	Cytochrome c		Macrobrachium malcolmsonii (Monsoon river-prawn) (Palaemon malcolmsonii)	105	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005758; GO:0009055; GO:0020037; GO:0046872; GO:0070469			NA	NA	NA	NA	NA	NA
TRINITY_DN3999_c0_g1_i1	Q9W5N0	COA7_DROME	73	37	10	0	89	199	1	37	2.80E-10	65.9	COA7_DROME	reviewed	Cytochrome c oxidase assembly factor 7 homolog (Beta-lactamase hcp-like protein CG13865) (Sel1 repeat-containing protein 1 homolog)	Coa7 CG13865	Drosophila melanogaster (Fruit fly)	266	mitochondrial intermembrane space [GO:0005758]	mitochondrial intermembrane space [GO:0005758]		GO:0005758			NA	NA	NA	NA	NA	NA
TRINITY_DN3999_c0_g1_i2	Q9W5N0	COA7_DROME	53	264	85	5	89	772	1	261	3.20E-73	276.6	COA7_DROME	reviewed	Cytochrome c oxidase assembly factor 7 homolog (Beta-lactamase hcp-like protein CG13865) (Sel1 repeat-containing protein 1 homolog)	Coa7 CG13865	Drosophila melanogaster (Fruit fly)	266	mitochondrial intermembrane space [GO:0005758]	mitochondrial intermembrane space [GO:0005758]		GO:0005758			NA	NA	NA	NA	NA	NA
TRINITY_DN4102_c0_g1_i1	Q7KZN9	COX15_HUMAN	58.1	246	87	4	735	1	55	285	5.70E-76	285.8	COX15_HUMAN	reviewed	Cytochrome c oxidase assembly protein COX15 homolog	COX15	Homo sapiens (Human)	410	"cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; oxidation-reduction process [GO:0055114]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]"	cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"	GO:0004129; GO:0005654; GO:0005739; GO:0005743; GO:0005746; GO:0006123; GO:0006783; GO:0006784; GO:0007585; GO:0008535; GO:0016021; GO:0016627; GO:0016653; GO:0020037; GO:0045333; GO:0055114; GO:0060090; GO:0070069; GO:1902600	"cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; oxidation-reduction process [GO:0055114]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35770_c0_g1_i1	Q7KZN9	COX15_HUMAN	100	84	0	0	255	4	150	233	7.20E-45	180.6	COX15_HUMAN	reviewed	Cytochrome c oxidase assembly protein COX15 homolog	COX15	Homo sapiens (Human)	410	"cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; oxidation-reduction process [GO:0055114]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]"	cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"	GO:0004129; GO:0005654; GO:0005739; GO:0005743; GO:0005746; GO:0006123; GO:0006783; GO:0006784; GO:0007585; GO:0008535; GO:0016021; GO:0016627; GO:0016653; GO:0020037; GO:0045333; GO:0055114; GO:0060090; GO:0070069; GO:1902600	"cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; oxidation-reduction process [GO:0055114]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7153_c0_g1_i1	Q9CR63	COX16_MOUSE	51.2	84	35	2	393	142	12	89	2.90E-16	86.7	COX16_MOUSE	reviewed	"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial"	Cox16	Mus musculus (Mouse)	106	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]		GO:0005739; GO:0031305; GO:0033617	mitochondrial cytochrome c oxidase assembly [GO:0033617]		blue	blue	NA	NA	NA	NA
TRINITY_DN7153_c0_g1_i2	Q9CR63	COX16_MOUSE	62.1	29	11	0	139	53	12	40	5.90E-05	48.1	COX16_MOUSE	reviewed	"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial"	Cox16	Mus musculus (Mouse)	106	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]		GO:0005739; GO:0031305; GO:0033617	mitochondrial cytochrome c oxidase assembly [GO:0033617]		NA	NA	NA	NA	NA	NA
TRINITY_DN17102_c0_g1_i1	P12787	COX5A_MOUSE	58.5	130	49	3	608	231	1	129	4.60E-28	126.3	COX5A_MOUSE	reviewed	"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)"	Cox5a	Mus musculus (Mouse)	146	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006123; GO:0043209; GO:0046872	"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13377_c0_g1_i1	P20674	COX5A_HUMAN	98.9	92	1	0	277	2	44	135	2.00E-48	192.6	COX5A_HUMAN	reviewed	"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)"	COX5A	Homo sapiens (Human)	150	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]	cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]	GO:0004129; GO:0005743; GO:0005751; GO:0006123; GO:0009055; GO:0046872	"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13377_c0_g1_i2	P00426	COX5A_BOVIN	98.9	92	1	0	277	2	46	137	1.20E-48	193.4	COX5A_BOVIN	reviewed	"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)"	COX5A	Bos taurus (Bovine)	152	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006123; GO:0045277; GO:0046872	"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19887_c0_g1_i2	P10606	COX5B_HUMAN	57.9	38	16	0	21	134	68	105	3.20E-07	55.5	COX5B_HUMAN	reviewed	"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)"	COX5B	Homo sapiens (Human)	129	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005739; GO:0005743; GO:0006123; GO:0007585; GO:0042776; GO:0046872	"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19565_c0_g1_i1	P10606	COX5B_HUMAN	100	75	0	0	1	225	55	129	3.50E-41	168.3	COX5B_HUMAN	reviewed	"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)"	COX5B	Homo sapiens (Human)	129	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005739; GO:0005743; GO:0006123; GO:0007585; GO:0042776; GO:0046872	"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19565_c0_g1_i2	P19536	COX5B_MOUSE	93.3	75	5	0	1	225	54	128	1.90E-39	162.5	COX5B_MOUSE	reviewed	"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)"	Cox5b	Mus musculus (Mouse)	128	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005739; GO:0005743; GO:0006123; GO:0042776; GO:0043209; GO:0046872	"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19887_c0_g1_i3	P00428	COX5B_BOVIN	48.9	47	24	0	317	457	59	105	4.00E-08	59.7	COX5B_BOVIN	reviewed	"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide VIa) (Cytochrome c oxidase polypeptide Vb)"	COX5B	Bos taurus (Bovine)	129	"mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005743; GO:0006123; GO:0042776; GO:0045277; GO:0046872	"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26983_c2_g1_i1	P00428	COX5B_BOVIN	41.5	123	62	4	465	124	1	122	1.90E-15	84	COX5B_BOVIN	reviewed	"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide VIa) (Cytochrome c oxidase polypeptide Vb)"	COX5B	Bos taurus (Bovine)	129	"mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277]	cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]	GO:0004129; GO:0005743; GO:0006123; GO:0042776; GO:0045277; GO:0046872	"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"		blue	blue	NA	NA	NA	NA
TRINITY_DN16450_c0_g1_i1	P56392	CX7A1_MOUSE	42.9	63	36	0	223	411	18	80	1.80E-07	57.4	CX7A1_MOUSE	reviewed	"Cytochrome c oxidase subunit 7A1, mitochondrial (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase subunit VIIa-muscle) (Cytochrome c oxidase subunit VIIa-M)"	Cox7a1 Cox7a Cox7ah	Mus musculus (Mouse)	80	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial respirasome assembly [GO:0097250]; oxidative phosphorylation [GO:0006119]; regulation of oxidative phosphorylation [GO:0002082]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	cytochrome-c oxidase activity [GO:0004129]	GO:0002082; GO:0004129; GO:0005739; GO:0005746; GO:0006119; GO:0016021; GO:0097250	mitochondrial respirasome assembly [GO:0097250]; oxidative phosphorylation [GO:0006119]; regulation of oxidative phosphorylation [GO:0002082]		blue	blue	NA	NA	NA	NA
TRINITY_DN5267_c0_g1_i1	P13184	CX7A2_BOVIN	32.9	70	46	1	12	218	14	83	4.90E-05	48.5	CX7A2_BOVIN	reviewed	"Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart) (Cytochrome c oxidase subunit VIIa-L)"	COX7A2 COX7AL	Bos taurus (Bovine)	83	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial respirasome assembly [GO:0097250]; oxidative phosphorylation [GO:0006119]; regulation of oxidative phosphorylation [GO:0002082]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]	cytochrome-c oxidase activity [GO:0004129]	GO:0002082; GO:0004129; GO:0005746; GO:0006119; GO:0016021; GO:0097250	mitochondrial respirasome assembly [GO:0097250]; oxidative phosphorylation [GO:0006119]; regulation of oxidative phosphorylation [GO:0002082]		blue	blue	NA	NA	NA	NA
TRINITY_DN9027_c0_g1_i1	P62897	CYC_MOUSE	100	105	0	0	89	403	1	105	1.20E-57	223.8	CYC_MOUSE	reviewed	"Cytochrome c, somatic"	Cycs	Mus musculus (Mouse)	105	"cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; respirasome [GO:0070469]; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; hydrogen peroxide metabolic process [GO:0042743]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; regulation of protein binding [GO:0043393]"	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; respirasome [GO:0070469]	"electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0006122; GO:0006123; GO:0006915; GO:0008635; GO:0019899; GO:0020037; GO:0042743; GO:0043209; GO:0043280; GO:0043393; GO:0045155; GO:0046872; GO:0070469	"activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; hydrogen peroxide metabolic process [GO:0042743]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; regulation of protein binding [GO:0043393]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26364_c0_g1_i1	A5PJG7	CCHL_BOVIN	42.9	84	38	4	5	232	90	171	2.40E-10	65.9	CCHL_BOVIN	reviewed	Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase)	HCCS	Bos taurus (Bovine)	275	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	cytochrome c-heme linkage [GO:0018063]		NA	NA	NA	NA	NA	NA
TRINITY_DN31148_c0_g1_i1	A5PJG7	CCHL_BOVIN	50.7	69	33	1	216	10	189	256	3.50E-14	78.6	CCHL_BOVIN	reviewed	Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase)	HCCS	Bos taurus (Bovine)	275	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	cytochrome c-heme linkage [GO:0018063]		red	red	NA	NA	NA	NA
TRINITY_DN4607_c0_g1_i1	Q5F339	CCHL_CHICK	76.8	69	15	1	87	293	205	272	2.50E-28	126.3	CCHL_CHICK	reviewed	Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase)	HCCS RCJMB04_37l21	Gallus gallus (Chicken)	273	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	cytochrome c-heme linkage [GO:0018063]		NA	NA	NA	NA	NA	NA
TRINITY_DN4607_c0_g1_i2	P53702	CCHL_MOUSE	70.2	191	54	3	439	1008	83	271	1.40E-81	304.7	CCHL_MOUSE	reviewed	Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase)	Hccs Cchl	Mus musculus (Mouse)	272	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	cytochrome c-heme linkage [GO:0018063]		blue	blue	NA	NA	NA	NA
TRINITY_DN34122_c0_g1_i1	P53701	CCHL_HUMAN	100	96	0	0	1	288	173	268	9.20E-56	217.2	CCHL_HUMAN	reviewed	Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase)	HCCS CCHL	Homo sapiens (Human)	268	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cytochrome c-heme linkage [GO:0018063]; oxidation-reduction process [GO:0055114]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0009887; GO:0018063; GO:0046872; GO:0055114	animal organ morphogenesis [GO:0009887]; cytochrome c-heme linkage [GO:0018063]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN25840_c0_g1_i1	Q16678	CP1B1_HUMAN	100	77	0	0	1	231	317	393	2.60E-38	158.7	CP1B1_HUMAN	reviewed	Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	CYP1B1	Homo sapiens (Human)	543	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to toxic substance [GO:0009636]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]"	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	"aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]"	GO:0001525; GO:0002930; GO:0004497; GO:0005506; GO:0005739; GO:0005789; GO:0006725; GO:0006805; GO:0006809; GO:0007155; GO:0007601; GO:0008202; GO:0008210; GO:0008285; GO:0008631; GO:0009404; GO:0009636; GO:0010575; GO:0016125; GO:0016712; GO:0019369; GO:0019373; GO:0019825; GO:0020037; GO:0030199; GO:0030336; GO:0032088; GO:0033629; GO:0042572; GO:0042574; GO:0043065; GO:0043231; GO:0043542; GO:0045766; GO:0046427; GO:0046466; GO:0048514; GO:0055114; GO:0061304; GO:0070301; GO:0070330; GO:0071407; GO:0071603; GO:0097267; GO:0101020; GO:0106256; GO:2000377	angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; collagen fibril organization [GO:0030199]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell migration [GO:0043542]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to toxic substance [GO:0009636]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i18	P00178	CP2B4_RABIT	55	40	18	0	179	60	345	384	6.30E-08	57.8	CP2B4_RABIT	reviewed	Cytochrome P450 2B4 (EC 1.14.14.1) (CYPIIB4) (Cytochrome P450 isozyme 2) (Cytochrome P450 LM2) (Cytochrome P450 type B0) (Cytochrome P450 type B1)	CYP2B4	Oryctolagus cuniculus (Rabbit)	491	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN23075_c0_g1_i1	P12789	CP2B5_RABIT	46.7	137	71	2	37	444	340	475	4.30E-29	129	CP2B5_RABIT	reviewed	Cytochrome P450 2B5 (EC 1.14.14.1) (CYPIIB5) (Cytochrome P450 form HP1) (Cytochrome P450 type B2)	CYP2B5	Oryctolagus cuniculus (Rabbit)	491	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN15288_c0_g1_i1	P20814	CP2CD_RAT	47.5	61	32	0	1	183	281	341	6.70E-10	64.3	CP2CD_RAT	reviewed	"Cytochrome P450 2C13, male-specific (EC 1.14.14.1) (CYPIIC13) (Cytochrome P-450g) (Cytochrome P450-G) (Cytochrome P450-UT-5)"	Cyp2c13 Cyp2c-13	Rattus norvegicus (Rat)	490	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN18008_c0_g1_i1	P10632	CP2C8_HUMAN	41.8	55	28	1	52	204	429	483	5.80E-06	51.6	CP2C8_HUMAN	reviewed	Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase)	CYP2C8	Homo sapiens (Human)	490	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; icosanoid biosynthetic process [GO:0046456]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]"	GO:0002933; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008210; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0017144; GO:0019373; GO:0020037; GO:0034875; GO:0042572; GO:0042573; GO:0042738; GO:0042759; GO:0043231; GO:0046456; GO:0055114; GO:0070330; GO:0070989; GO:0097267; GO:0101020	drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; icosanoid biosynthetic process [GO:0046456]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c1_g1_i3	Q01361	CP2DE_BOVIN	47	66	35	0	46	243	435	500	7.40E-10	64.7	CP2DE_BOVIN	reviewed	Cytochrome P450 2D14 (EC 1.14.14.1) (CYPIID14)	CYP2D14	Bos taurus (Bovine)	500	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016712; GO:0019369; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN8362_c0_g1_i8	Q9QUJ1	CP2DS_MESAU	46.7	60	32	0	69	248	296	355	1.70E-09	64.3	CP2DS_MESAU	reviewed	Cytochrome P450 2D28 (EC 1.14.14.-) (CYPIID28)	CYP2D28A; CYP2D28B	Mesocricetus auratus (Golden hamster)	500	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"	GO:0005506; GO:0005789; GO:0016712; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i27	Q64680	CP2D4_RAT	47.8	115	60	0	534	190	355	469	1.10E-29	131.3	CP2D4_RAT	reviewed	Cytochrome P450 2D4 (EC 1.14.14.1) (CYPIID18) (CYPIID4) (Cytochrome P450 2D-29) (Cytochrome P450 2D-35) (Cytochrome P450 2D18) (Cytochrome P450-CMF3) (Cytochrome P450-DB4) (Debrisoquine 4-hydroxylase)	Cyp2d4 Cyp2d-18 Cyp2d-4 Cyp2d18	Rattus norvegicus (Rat)	500	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; drug binding [GO:0008144]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; C21-steroid hormone metabolic process [GO:0008207]; coumarin metabolic process [GO:0009804]; dopamine biosynthetic process [GO:0042416]; dopamine metabolic process [GO:0042417]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; heterocycle metabolic process [GO:0046483]; isoquinoline alkaloid metabolic process [GO:0033076]; monoterpenoid metabolic process [GO:0016098]; negative regulation of binding [GO:0051100]; negative regulation of cellular organofluorine metabolic process [GO:0090350]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; response to organic substance [GO:0010033]; retinol metabolic process [GO:0042572]; serotonin biosynthetic process from tryptophan [GO:0006587]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	"anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; drug binding [GO:0008144]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005789; GO:0006082; GO:0006587; GO:0006805; GO:0007565; GO:0008144; GO:0008202; GO:0008207; GO:0008210; GO:0008391; GO:0008395; GO:0009804; GO:0009820; GO:0009822; GO:0010033; GO:0016098; GO:0016491; GO:0016712; GO:0017144; GO:0019369; GO:0020037; GO:0033076; GO:0042416; GO:0042417; GO:0042572; GO:0042737; GO:0042738; GO:0043231; GO:0046483; GO:0051100; GO:0055114; GO:0062187; GO:0062188; GO:0062189; GO:0070330; GO:0070989; GO:0090350	alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; C21-steroid hormone metabolic process [GO:0008207]; coumarin metabolic process [GO:0009804]; dopamine biosynthetic process [GO:0042416]; dopamine metabolic process [GO:0042417]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; heterocycle metabolic process [GO:0046483]; isoquinoline alkaloid metabolic process [GO:0033076]; monoterpenoid metabolic process [GO:0016098]; negative regulation of binding [GO:0051100]; negative regulation of cellular organofluorine metabolic process [GO:0090350]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; response to organic substance [GO:0010033]; retinol metabolic process [GO:0042572]; serotonin biosynthetic process from tryptophan [GO:0006587]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]		NA	NA	1	NA	NA	1
TRINITY_DN2283_c0_g1_i3	P51589	CP2J2_HUMAN	46.7	60	32	0	288	109	291	350	1.90E-09	63.2	CP2J2_HUMAN	reviewed	Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	CYP2J2	Homo sapiens (Human)	502	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070062; GO:0071614; GO:0106255	epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN2283_c0_g1_i7	P51589	CP2J2_HUMAN	57.8	45	19	0	243	109	306	350	1.10E-08	60.8	CP2J2_HUMAN	reviewed	Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	CYP2J2	Homo sapiens (Human)	502	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070062; GO:0071614; GO:0106255	epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i19	O54750	CP2J6_MOUSE	33.3	450	280	7	1527	190	37	470	1.60E-76	288.5	CP2J6_MOUSE	reviewed	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	Cyp2j6	Mus musculus (Mouse)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i21	O54750	CP2J6_MOUSE	33.1	450	281	7	1527	190	37	470	1.60E-76	288.5	CP2J6_MOUSE	reviewed	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	Cyp2j6	Mus musculus (Mouse)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i29	O54750	CP2J6_MOUSE	30.3	122	84	1	384	19	125	245	7.80E-15	81.6	CP2J6_MOUSE	reviewed	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	Cyp2j6	Mus musculus (Mouse)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i3	O54750	CP2J6_MOUSE	30.5	128	87	1	492	115	114	241	1.00E-15	84.7	CP2J6_MOUSE	reviewed	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	Cyp2j6	Mus musculus (Mouse)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i34	O54750	CP2J6_MOUSE	31.9	429	272	7	1277	3	37	449	5.80E-69	263.1	CP2J6_MOUSE	reviewed	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	Cyp2j6	Mus musculus (Mouse)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i5	O54750	CP2J6_MOUSE	32.4	429	270	7	1277	3	37	449	4.30E-70	266.9	CP2J6_MOUSE	reviewed	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	Cyp2j6	Mus musculus (Mouse)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN10867_c0_g1_i1	Q27712	CP2L1_PANAR	38.9	167	101	1	1	498	38	204	1.40E-31	137.5	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN276_c0_g1_i11	Q27712	CP2L1_PANAR	38.9	226	126	5	882	226	62	282	1.80E-40	167.9	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN276_c0_g1_i17	Q27712	CP2L1_PANAR	38.3	230	130	5	701	33	62	286	2.50E-40	167.2	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN276_c0_g1_i2	Q27712	CP2L1_PANAR	37.5	291	170	5	884	33	1	286	3.50E-51	203.8	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN276_c0_g1_i4	Q27712	CP2L1_PANAR	38	287	166	5	1065	226	1	282	2.40E-51	204.5	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN276_c0_g1_i7	Q27712	CP2L1_PANAR	32.4	74	45	1	223	2	232	300	2.00E-06	52.8	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN276_c0_g1_i9	Q27712	CP2L1_PANAR	40.9	164	94	2	616	134	62	225	1.20E-30	134.8	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN29931_c0_g1_i1	Q27712	CP2L1_PANAR	51	98	47	1	5	298	395	491	5.90E-22	105.1	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN35527_c0_g1_i1	Q27712	CP2L1_PANAR	46.7	150	78	2	472	26	48	196	1.20E-32	141	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN8362_c0_g1_i3	Q27712	CP2L1_PANAR	55.6	234	101	2	110	802	249	482	1.60E-74	280.8	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN8362_c0_g1_i5	Q27712	CP2L1_PANAR	63	138	51	0	42	455	345	482	5.90E-50	198.4	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN8362_c0_g1_i7	Q27712	CP2L1_PANAR	50.5	311	150	3	3	923	172	482	7.70E-89	328.6	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN30385_c0_g1_i1	Q27712	CP2L1_PANAR	43.2	148	82	2	31	471	345	491	5.40E-31	135.6	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN12356_c0_g1_i1	Q27712	CP2L1_PANAR	41.6	209	118	2	90	704	18	226	2.10E-42	174.1	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN12356_c0_g1_i3	Q27712	CP2L1_PANAR	46	161	85	1	90	566	18	178	4.00E-36	152.9	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN11135_c0_g1_i1	Q27712	CP2L1_PANAR	41.2	497	281	5	61	1533	1	492	1.60E-110	401.4	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN11135_c0_g1_i4	Q27712	CP2L1_PANAR	40	295	167	4	61	927	1	291	4.30E-58	226.5	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN11135_c0_g1_i5	Q27712	CP2L1_PANAR	43.1	225	125	2	61	726	1	225	2.30E-47	190.7	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN32888_c0_g1_i1	Q27712	CP2L1_PANAR	45.1	164	85	2	493	5	240	399	1.10E-33	144.4	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN37196_c0_g1_i1	Q27712	CP2L1_PANAR	50	52	26	0	92	247	292	343	2.00E-08	59.7	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN2283_c0_g1_i1	Q27712	CP2L1_PANAR	41.6	202	117	1	691	86	291	491	9.80E-45	181.8	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN2283_c0_g1_i4	Q27712	CP2L1_PANAR	40.9	215	126	1	730	86	278	491	2.20E-46	187.2	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN2283_c0_g1_i6	Q27712	CP2L1_PANAR	40.7	108	63	1	409	86	385	491	2.80E-20	99.8	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN23075_c0_g1_i2	Q27712	CP2L1_PANAR	42.7	260	145	3	5	778	215	472	1.30E-57	224.6	CP2L1_PANAR	reviewed	Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)	CYP2L1	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	492	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i1	Q9CX98	CP2U1_MOUSE	47.2	53	25	1	179	21	385	434	2.40E-07	55.8	CP2U1_MOUSE	reviewed	Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)	Cyp2u1	Mus musculus (Mouse)	530	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]	"arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0052869; GO:0055114; GO:0097267	exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12272_c0_g1_i23	Q4V8D1	CP2U1_RAT	39.2	250	139	5	918	178	264	503	2.20E-46	187.6	CP2U1_RAT	reviewed	Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)	Cyp2u1	Rattus norvegicus (Rat)	530	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]	"arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0052869; GO:0055114; GO:0097267	exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c3_g1_i1	Q9NGX9	CP302_DROME	39.9	484	262	8	248	1675	18	480	1.80E-94	348.2	CP302_DROME	reviewed	"Cytochrome P450 302a1, mitochondrial (EC 1.14.99.-) (Protein disembodied)"	dib CYP302A1 CG12028	Drosophila melanogaster (Fruit fly)	489	"mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ecdysteroid 22-hydroxylase activity [GO:0042767]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; central nervous system development [GO:0007417]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; head involution [GO:0008258]; midgut development [GO:0007494]"	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	"ecdysteroid 22-hydroxylase activity [GO:0042767]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0005506; GO:0005739; GO:0006697; GO:0007391; GO:0007417; GO:0007494; GO:0008258; GO:0008362; GO:0016705; GO:0020037; GO:0031966; GO:0042767	central nervous system development [GO:0007417]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; dorsal closure [GO:0007391]; ecdysone biosynthetic process [GO:0006697]; head involution [GO:0008258]; midgut development [GO:0007494]		NA	NA	NA	NA	NA	NA
TRINITY_DN18477_c0_g1_i1	Q64417	CP3AE_CAVPO	33.9	171	106	5	1	495	147	316	2.50E-17	90.1	CP3AE_CAVPO	reviewed	Cytochrome P450 3A14 (EC 1.14.14.1) (CYPIIIA14)	CYP3A14	Cavia porcellus (Guinea pig)	503	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN25932_c0_g1_i1	Q64481	CP3AG_MOUSE	60.3	68	27	0	2	205	408	475	3.20E-19	95.1	CP3AG_MOUSE	reviewed	Cytochrome P450 3A16 (EC 1.14.14.1) (CYPIIIA16)	Cyp3a16 Cyp3a-16	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i12	P05183	CP3A2_RAT	43.5	69	39	0	270	64	293	361	1.40E-10	67.8	CP3A2_RAT	reviewed	Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase)	Cyp3a2 Cyp3a-2 Cyp3a11	Rattus norvegicus (Rat)	504	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; drug metabolic process [GO:0017144]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0017144; GO:0020037; GO:0032451; GO:0050649; GO:0070330; GO:0070989	drug metabolic process [GO:0017144]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i12	P05183	CP3A2_RAT	40.4	52	31	0	458	303	5	56	1.50E-04	47.8	CP3A2_RAT	reviewed	Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase)	Cyp3a2 Cyp3a-2 Cyp3a11	Rattus norvegicus (Rat)	504	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; drug metabolic process [GO:0017144]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0017144; GO:0020037; GO:0032451; GO:0050649; GO:0070330; GO:0070989	drug metabolic process [GO:0017144]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i16	P05183	CP3A2_RAT	35.5	228	141	4	732	64	135	361	2.40E-32	140.6	CP3A2_RAT	reviewed	Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase)	Cyp3a2 Cyp3a-2 Cyp3a11	Rattus norvegicus (Rat)	504	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; drug metabolic process [GO:0017144]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0017144; GO:0020037; GO:0032451; GO:0050649; GO:0070330; GO:0070989	drug metabolic process [GO:0017144]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN13411_c0_g1_i1	Q29496	CP3AO_SHEEP	48.9	88	43	2	2	262	398	484	2.10E-15	82.8	CP3AO_SHEEP	reviewed	Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)	CYP3A24	Ovis aries (Sheep)	503	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i18	Q9JMA7	CP341_MOUSE	35.2	406	248	7	1257	61	99	496	1.60E-65	251.5	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	x	NA	NA	1	NA	NA	NA
TRINITY_DN6808_c0_g1_i15	Q9JMA7	CP341_MOUSE	50.5	103	49	1	486	178	361	461	3.50E-24	112.8	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i17	Q9JMA7	CP341_MOUSE	37.4	465	277	8	1570	194	5	461	1.50E-87	325.1	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i3	Q9JMA7	CP341_MOUSE	37.9	377	223	7	1290	178	90	461	1.00E-70	268.9	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i4	Q9JMA7	CP341_MOUSE	37.9	330	197	5	1168	194	135	461	2.30E-61	237.7	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN6808_c0_g1_i6	Q9JMA7	CP341_MOUSE	38.5	330	195	5	1168	194	135	461	8.30E-64	245.7	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN31907_c0_g1_i1	Q9JMA7	CP341_MOUSE	42.9	91	52	0	27	299	291	381	6.20E-14	78.2	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i1	Q9JMA7	CP341_MOUSE	35.9	473	279	9	1545	148	6	461	1.90E-82	308.1	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i12	Q9JMA7	CP341_MOUSE	37	368	223	6	1167	85	131	496	3.70E-64	246.9	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i13	Q9JMA7	CP341_MOUSE	35.7	504	304	9	1585	95	6	496	4.50E-87	323.6	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i14	Q9JMA7	CP341_MOUSE	36.5	364	224	4	1171	95	135	496	5.80E-65	249.6	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i17	Q9JMA7	CP341_MOUSE	37.2	470	277	8	1545	148	6	461	3.10E-85	317.4	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i3	Q9JMA7	CP341_MOUSE	36	469	282	8	1542	148	7	461	2.30E-80	301.2	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i9	Q9JMA7	CP341_MOUSE	34.5	507	306	10	1585	95	6	496	2.10E-84	314.7	CP341_MOUSE	reviewed	Cytochrome P450 3A41 (EC 1.14.14.1)	Cyp3a41a Cyp3a41; Cyp3a41b	Mus musculus (Mouse)	504	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0008401; GO:0009617; GO:0010468; GO:0016491; GO:0020037; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020	oxidative demethylation [GO:0070989]; regulation of gene expression [GO:0010468]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN28029_c0_g1_i1	P51538	CP3A9_RAT	42.6	94	50	1	9	278	342	435	1.40E-17	90.1	CP3A9_RAT	reviewed	Cytochrome P450 3A9 (EC 1.14.14.1) (3AH15) (CYPIIIA9) (Cytochrome P450 olfactive 3) (Cytochrome P450-OLF3)	Cyp3a9 Cyp3a13	Rattus norvegicus (Rat)	503	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; alkaloid catabolic process [GO:0009822]; drug catabolic process [GO:0042737]; estrogen metabolic process [GO:0008210]; female pregnancy [GO:0007565]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; retinoic acid metabolic process [GO:0042573]; sensory perception of smell [GO:0007608]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0007565; GO:0007608; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0010043; GO:0010628; GO:0016491; GO:0020037; GO:0032355; GO:0042573; GO:0042737; GO:0043627; GO:0045471; GO:0050649; GO:0070330; GO:0070989; GO:0071548; GO:0101020	alkaloid catabolic process [GO:0009822]; drug catabolic process [GO:0042737]; estrogen metabolic process [GO:0008210]; female pregnancy [GO:0007565]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; retinoic acid metabolic process [GO:0042573]; sensory perception of smell [GO:0007608]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN14365_c0_g1_i1	P29981	CP4C1_BLADI	55.8	156	69	0	3	470	181	336	9.50E-43	174.5	CP4C1_BLADI	reviewed	Cytochrome P450 4C1 (EC 1.14.14.1) (CYPIVC1)	CYP4C1	Blaberus discoidalis (Tropical cockroach)	511	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN14365_c0_g1_i2	P29981	CP4C1_BLADI	52	127	61	0	58	438	210	336	6.60E-30	131.7	CP4C1_BLADI	reviewed	Cytochrome P450 4C1 (EC 1.14.14.1) (CYPIVC1)	CYP4C1	Blaberus discoidalis (Tropical cockroach)	511	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN39658_c0_g1_i1	A2RRT9	CP4V2_RAT	63.6	77	28	0	236	6	402	478	4.50E-25	114.8	CP4V2_RAT	reviewed	Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)	Cyp4v2 Cyp4v3	Rattus norvegicus (Rat)	525	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; fatty acid omega-oxidation [GO:0010430]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0010430; GO:0016021; GO:0016705; GO:0020037	fatty acid omega-oxidation [GO:0010430]		NA	NA	NA	NA	NA	NA
TRINITY_DN27585_c0_g1_i1	Q04552	CP6B1_PAPPO	61.1	72	28	0	33	248	288	359	1.30E-17	90.1	CP6B1_PAPPO	reviewed	Cytochrome P450 6B1 (EC 1.14.14.1) (CYP6B1v1/CYP6B1v2/CYP6B1v3) (CYPVIB1)	CYP6B1	Papilio polyxenes (Black swallowtail butterfly)	498	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN39432_c0_g1_i1	Q27902	CP6B4_PAPGL	47.7	44	23	0	28	159	59	102	2.30E-07	55.8	CP6B4_PAPGL	reviewed	Cytochrome P450 6B4 (EC 1.14.14.1) (CYP6B4v1/CYP6B4v2) (CYPVIB4)	CYP6B4	Papilio glaucus (Eastern tiger swallowtail butterfly) (Pterourus glaucus)	500	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	endoplasmic reticulum membrane [GO:0005789]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0005506; GO:0005789; GO:0020037; GO:0070330			NA	NA	NA	NA	NA	NA
TRINITY_DN39085_c0_g1_i1	Q964R0	CP6K1_BLAGE	41.7	120	64	2	22	381	77	190	4.20E-17	89	CP6K1_BLAGE	reviewed	Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1)	CYP6K1	Blattella germanica (German cockroach) (Blatta germanica)	524	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN14172_c0_g1_i1	Q964R0	CP6K1_BLAGE	37.2	145	86	2	1	435	16	155	1.80E-19	97.1	CP6K1_BLAGE	reviewed	Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1)	CYP6K1	Blattella germanica (German cockroach) (Blatta germanica)	524	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN20414_c0_g1_i1	Q964R0	CP6K1_BLAGE	41.1	90	49	1	36	305	70	155	1.80E-13	76.6	CP6K1_BLAGE	reviewed	Cytochrome P450 6k1 (EC 1.14.-.-) (CYPVIK1)	CYP6K1	Blattella germanica (German cockroach) (Blatta germanica)	524	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN4495_c1_g1_i1	Q0WTF4	C81F3_ARATH	45.5	77	40	1	3	227	355	431	8.70E-14	77.4	C81F3_ARATH	reviewed	Cytochrome P450 81F3 (EC 1.14.-.-)	CYP81F3 At4g37400 F6G17.50	Arabidopsis thaliana (Mouse-ear cress)	501	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; indole glucosinolate metabolic process [GO:0042343]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0004497; GO:0005506; GO:0016020; GO:0016021; GO:0016709; GO:0020037; GO:0042343	indole glucosinolate metabolic process [GO:0042343]		NA	NA	NA	NA	NA	NA
TRINITY_DN14172_c0_g1_i2	Q9V4I0	CP9B1_DROME	35.8	95	55	2	49	333	62	150	2.50E-13	76.3	CP9B1_DROME	reviewed	Cytochrome P450 9b1 (EC 1.14.-.-) (CYPIXB1)	Cyp9b1 CG4485	Drosophila melanogaster (Fruit fly)	505	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN16993_c0_g1_i1	Q964T2	CP9E2_BLAGE	54.2	72	32	1	215	3	386	457	1.30E-17	90.5	CP9E2_BLAGE	reviewed	Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)	CYP9E2	Blattella germanica (German cockroach) (Blatta germanica)	533	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN16993_c0_g1_i2	Q964T2	CP9E2_BLAGE	51.8	85	40	1	254	3	373	457	1.20E-20	100.1	CP9E2_BLAGE	reviewed	Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)	CYP9E2	Blattella germanica (German cockroach) (Blatta germanica)	533	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i11	Q964T2	CP9E2_BLAGE	52	152	70	3	625	179	349	500	4.20E-38	159.5	CP9E2_BLAGE	reviewed	Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)	CYP9E2	Blattella germanica (German cockroach) (Blatta germanica)	533	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i4	Q964T2	CP9E2_BLAGE	49.4	172	74	3	615	139	349	520	6.80E-41	168.7	CP9E2_BLAGE	reviewed	Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)	CYP9E2	Blattella germanica (German cockroach) (Blatta germanica)	533	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN118_c0_g1_i6	Q964T2	CP9E2_BLAGE	52	152	71	2	618	169	349	500	1.10E-38	161.4	CP9E2_BLAGE	reviewed	Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)	CYP9E2	Blattella germanica (German cockroach) (Blatta germanica)	533	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN18230_c0_g1_i1	Q964T2	CP9E2_BLAGE	40.7	108	60	2	16	330	345	451	1.70E-17	90.1	CP9E2_BLAGE	reviewed	Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)	CYP9E2	Blattella germanica (German cockroach) (Blatta germanica)	533	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i12	O18635	C12A2_MUSDO	25.6	320	222	7	1027	86	36	345	6.30E-22	106.7	C12A2_MUSDO	reviewed	Cytochrome P450 CYP12A2 (EC 1.14.-.-) (CYPXIIA2)	CYP12A2	Musca domestica (House fly)	537	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN24898_c0_g1_i1	Q76MZ1	CYH1_CHLAE	100	336	0	0	3	1010	41	376	2.40E-200	699.1	CYH1_CHLAE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1)"	CYTH1 PSCD1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN1521_c0_g1_i1	Q76MZ1	CYH1_CHLAE	74.2	356	89	2	1093	35	37	392	7.10E-156	551.6	CYH1_CHLAE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1)"	CYTH1 PSCD1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN1521_c0_g1_i2	Q76MZ1	CYH1_CHLAE	73	381	100	2	1168	35	12	392	3.90E-162	572.4	CYH1_CHLAE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1)"	CYTH1 PSCD1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		blue	blue	NA	NA	NA	NA
TRINITY_DN1521_c0_g1_i3	Q76MZ1	CYH1_CHLAE	73.4	361	93	2	1108	35	32	392	1.90E-156	553.5	CYH1_CHLAE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1)"	CYTH1 PSCD1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN1521_c0_g1_i4	Q76MZ1	CYH1_CHLAE	73.6	201	52	1	682	80	37	236	2.40E-79	296.6	CYH1_CHLAE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1)"	CYTH1 PSCD1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN1521_c0_g1_i5	Q76MZ1	CYH1_CHLAE	74.2	356	89	2	1093	35	37	392	3.10E-156	552.7	CYH1_CHLAE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1)"	CYTH1 PSCD1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN28036_c0_g1_i1	Q9QX11	CYH1_MOUSE	100	109	0	0	327	1	275	383	1.10E-61	236.9	CYH1_MOUSE	reviewed	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (CLM1) (SEC7 homolog A) (mSec7-1)"	Cyth1 Pscd1	Mus musculus (Mouse)	398	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of synaptic vesicle exocytosis [GO:2000300]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0031234; GO:0031594; GO:0032012; GO:0090162; GO:0098888; GO:2000300	establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of synaptic vesicle exocytosis [GO:2000300]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c1_g1_i1	P63035	CYH2_RAT	100	140	0	0	1	420	132	271	2.80E-80	299.3	CYH2_RAT	reviewed	"Cytohesin-2 (ARF nucleotide-binding site opener) (Protein ARNO) (PH, SEC7 and coiled-coil domain-containing protein 2) (CLM2) (SEC7 homolog B)"	Cyth2 Pscd2 Sec7b	Rattus norvegicus (Rat)	400	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; negative regulation of dendrite development [GO:2000171]; regulation of ARF protein signal transduction [GO:0032012]"	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"	GO:0001726; GO:0005086; GO:0005737; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0030426; GO:0032012; GO:0070679; GO:2000171	negative regulation of dendrite development [GO:2000171]; regulation of ARF protein signal transduction [GO:0032012]		blue	blue	NA	NA	NA	NA
TRINITY_DN33609_c0_g1_i1	Q2KI41	CYH2_BOVIN	100	78	0	0	234	1	287	364	2.80E-43	175.3	CYH2_BOVIN	reviewed	"Cytohesin-2 (PH, SEC7 and coiled-coil domain-containing protein 2)"	CYTH2 PSCD2	Bos taurus (Bovine)	410	"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]"	cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]	"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"	GO:0005086; GO:0005737; GO:0005886; GO:0008289; GO:0030426; GO:0032012; GO:0070679	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c1_g2_i1	Q76MY7	CYH2_CHLAE	99.7	324	1	0	2	973	68	391	2.70E-193	675.6	CYH2_CHLAE	reviewed	"Cytohesin-2 (PH, SEC7 and coiled-coil domain-containing protein 2)"	CYTH2 PSCD2	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	399	"cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]"	cytoplasm [GO:0005737]; growth cone [GO:0030426]; plasma membrane [GO:0005886]	"ARF guanyl-nucleotide exchange factor activity [GO:0005086]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"	GO:0005086; GO:0005737; GO:0005886; GO:0008289; GO:0030426; GO:0032012; GO:0070679	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c1_g3_i1	Q9UIA0	CYH4_HUMAN	100	69	0	0	2	208	50	118	6.00E-34	144.4	CYH4_HUMAN	reviewed	"Cytohesin-4 (PH, SEC7 and coiled-coil domain-containing protein 4)"	CYTH4 CYT4 PSCD4	Homo sapiens (Human)	394	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0000139; GO:0005086; GO:0005829; GO:0005886; GO:0008289; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c1_g3_i2	Q9UIA0	CYH4_HUMAN	99.5	219	1	0	2	658	50	268	1.00E-127	457.2	CYH4_HUMAN	reviewed	"Cytohesin-4 (PH, SEC7 and coiled-coil domain-containing protein 4)"	CYTH4 CYT4 PSCD4	Homo sapiens (Human)	394	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0000139; GO:0005086; GO:0005829; GO:0005886; GO:0008289; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c1_g3_i3	Q80YW0	CYH4_MOUSE	97.5	322	8	0	2	967	50	371	1.40E-189	663.3	CYH4_MOUSE	reviewed	"Cytohesin-4 (PH, SEC7 and coiled-coil domain-containing protein 4)"	Cyth4 Pscd4	Mus musculus (Mouse)	393	plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]	plasma membrane [GO:0005886]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005886; GO:0008289; GO:0032012	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN6989_c0_g1_i1	Q568M3	CRLF3_DANRE	32.5	320	185	6	114	1016	136	443	6.30E-34	146.4	CRLF3_DANRE	reviewed	Cytokine receptor-like factor 3 (Clf-3 protein)	crlf3 clf-3 zgc:110212	Danio rerio (Zebrafish) (Brachydanio rerio)	444	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN38276_c0_g1_i1	Q14204	DYHC1_HUMAN	99.1	107	1	0	323	3	2186	2292	2.50E-58	225.7	DYHC1_HUMAN	reviewed	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	4646	"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"	GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN40322_c0_g1_i1	Q14204	DYHC1_HUMAN	100	74	0	0	224	3	4309	4382	1.20E-35	149.8	DYHC1_HUMAN	reviewed	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	4646	"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"	GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN37726_c0_g1_i1	Q14204	DYHC1_HUMAN	100	93	0	0	281	3	2527	2619	1.40E-49	196.4	DYHC1_HUMAN	reviewed	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	4646	"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"	GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN37682_c0_g1_i1	Q14204	DYHC1_HUMAN	100	71	0	0	214	2	284	354	3.60E-34	144.8	DYHC1_HUMAN	reviewed	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	4646	"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"	GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN29793_c0_g1_i1	Q14204	DYHC1_HUMAN	100	104	0	0	2	313	119	222	6.70E-53	207.6	DYHC1_HUMAN	reviewed	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	4646	"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"	GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN29432_c0_g1_i1	Q14204	DYHC1_HUMAN	60.5	76	30	0	1	228	4089	4164	4.10E-23	108.2	DYHC1_HUMAN	reviewed	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	4646	"axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]"	GO:0000086; GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0006888; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1904115; GO:1905832	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i11	Q24246	DYIN_DROME	62.8	43	16	0	91	219	593	635	3.20E-09	62.4	DYIN_DROME	reviewed	"Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)"	sw Cdic Dic19B CG18000	Drosophila melanogaster (Fruit fly)	663	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]	dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642	axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i15	Q24246	DYIN_DROME	57.3	489	180	4	1	1401	111	592	9.10E-166	584.7	DYIN_DROME	reviewed	"Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)"	sw Cdic Dic19B CG18000	Drosophila melanogaster (Fruit fly)	663	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]	dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642	axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i5	Q24246	DYIN_DROME	57.8	559	210	5	1	1620	111	662	2.10E-191	670.2	DYIN_DROME	reviewed	"Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)"	sw Cdic Dic19B CG18000	Drosophila melanogaster (Fruit fly)	663	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]	dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642	axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i6	Q24246	DYIN_DROME	56.7	559	205	4	1	1587	111	662	5.50E-189	662.1	DYIN_DROME	reviewed	"Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)"	sw Cdic Dic19B CG18000	Drosophila melanogaster (Fruit fly)	663	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]	dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642	axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i8	Q24246	DYIN_DROME	62.8	471	167	3	21	1433	173	635	5.40E-182	638.6	DYIN_DROME	reviewed	"Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)"	sw Cdic Dic19B CG18000	Drosophila melanogaster (Fruit fly)	663	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]	dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642	axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN27367_c0_g1_i1	Q24246	DYIN_DROME	55.1	78	34	1	231	1	407	484	6.80E-18	90.9	DYIN_DROME	reviewed	"Cytoplasmic dynein 1 intermediate chain (DH IC) (Dynein intermediate chain, cytosolic) (Protein short wing)"	sw Cdic Dic19B CG18000	Drosophila melanogaster (Fruit fly)	663	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]; dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]	cytoplasmic dynein complex [GO:0005868]; lysosomal membrane [GO:0005765]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; protein-containing complex [GO:0032991]	dynactin binding [GO:0034452]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0000226; GO:0001754; GO:0003774; GO:0005765; GO:0005868; GO:0005874; GO:0007018; GO:0007051; GO:0007291; GO:0007349; GO:0008088; GO:0010970; GO:0031965; GO:0032991; GO:0034452; GO:0034501; GO:0043005; GO:0045503; GO:0045504; GO:0051642	axo-dendritic transport [GO:0008088]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; eye photoreceptor cell differentiation [GO:0001754]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein localization to kinetochore [GO:0034501]; sperm individualization [GO:0007291]; spindle organization [GO:0007051]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i12	Q63100	DC1I1_RAT	72.5	367	101	0	277	1377	198	564	3.70E-164	579.3	DC1I1_RAT	reviewed	"Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic) (DH IC-1)"	Dync1i1 Dnci1 Dncic1	Rattus norvegicus (Rat)	643	axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; spectrin binding [GO:0030507]; brain development [GO:0007420]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; spectrin binding [GO:0030507]	GO:0000776; GO:0000777; GO:0000922; GO:0003777; GO:0005634; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0007420; GO:0008017; GO:0010970; GO:0030507; GO:0031982; GO:0036464; GO:0045503; GO:0045504; GO:0047496; GO:0048471; GO:0055037; GO:1904115	brain development [GO:0007420]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i3	Q63100	DC1I1_RAT	61.7	522	165	6	4	1569	148	634	1.20E-188	661	DC1I1_RAT	reviewed	"Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic) (DH IC-1)"	Dync1i1 Dnci1 Dncic1	Rattus norvegicus (Rat)	643	axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; spectrin binding [GO:0030507]; brain development [GO:0007420]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; spectrin binding [GO:0030507]	GO:0000776; GO:0000777; GO:0000922; GO:0003777; GO:0005634; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0007420; GO:0008017; GO:0010970; GO:0030507; GO:0031982; GO:0036464; GO:0045503; GO:0045504; GO:0047496; GO:0048471; GO:0055037; GO:1904115	brain development [GO:0007420]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]; vesicle transport along microtubule [GO:0047496]		blue	blue	NA	NA	NA	NA
TRINITY_DN875_c0_g1_i10	Q0III3	DC1I2_BOVIN	71.7	424	118	1	337	1602	186	609	1.20E-188	661	DC1I2_BOVIN	reviewed	"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)"	DYNC1I2	Bos taurus (Bovine)	612	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0010970; GO:0031982; GO:0045503; GO:0045504	microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN27642_c0_g1_i1	Q13409	DC1I2_HUMAN	99.1	113	1	0	339	1	382	494	1.90E-61	236.1	DC1I2_HUMAN	reviewed	"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)"	DYNC1I2 DNCI2 DNCIC2	Homo sapiens (Human)	638	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; transport along microtubule [GO:0010970]; viral process [GO:0016032]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; microtubule [GO:0005874]; vesicle [GO:0031982]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]	GO:0000086; GO:0003777; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0010389; GO:0010970; GO:0016032; GO:0019886; GO:0031982; GO:0045503; GO:0045504; GO:0097711	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; transport along microtubule [GO:0010970]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN35901_c0_g1_i1	Q13409	DC1I2_HUMAN	100	101	0	0	2	304	488	588	2.60E-57	222.2	DC1I2_HUMAN	reviewed	"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)"	DYNC1I2 DNCI2 DNCIC2	Homo sapiens (Human)	638	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; transport along microtubule [GO:0010970]; viral process [GO:0016032]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; microtubule [GO:0005874]; vesicle [GO:0031982]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]	GO:0000086; GO:0003777; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0010389; GO:0010970; GO:0016032; GO:0019886; GO:0031982; GO:0045503; GO:0045504; GO:0097711	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; transport along microtubule [GO:0010970]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN26272_c0_g1_i1	Q0III3	DC1I2_BOVIN	100	99	0	0	299	3	215	313	1.50E-54	213	DC1I2_BOVIN	reviewed	"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)"	DYNC1I2	Bos taurus (Bovine)	612	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0010970; GO:0031982; GO:0045503; GO:0045504	microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN2890_c1_g1_i2	Q6PDL0	DC1L2_MOUSE	48.5	482	228	8	41	1468	10	477	1.30E-112	408.3	DC1L2_MOUSE	reviewed	"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)"	Dync1li2 Dncli2 Dnclic2	Mus musculus (Mouse)	492	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]	ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; motor activity [GO:0003774]	GO:0000226; GO:0000776; GO:0003774; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0042802; GO:0045504; GO:0051642; GO:1990090	cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]		NA	NA	NA	NA	NA	NA
TRINITY_DN2890_c1_g1_i3	Q6PDL0	DC1L2_MOUSE	48.8	168	85	1	41	544	10	176	4.80E-39	162.5	DC1L2_MOUSE	reviewed	"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)"	Dync1li2 Dncli2 Dnclic2	Mus musculus (Mouse)	492	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]	ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; motor activity [GO:0003774]	GO:0000226; GO:0000776; GO:0003774; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0042802; GO:0045504; GO:0051642; GO:1990090	cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]		blue	blue	NA	NA	NA	NA
TRINITY_DN2890_c1_g1_i1	Q62698	DC1L2_RAT	48	490	216	9	41	1489	10	467	3.20E-111	403.7	DC1L2_RAT	reviewed	"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)"	Dync1li2 Dncli2	Rattus norvegicus (Rat)	497	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; microtubule [GO:0005874]	ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; motor activity [GO:0003774]	GO:0000226; GO:0000776; GO:0003774; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0042802; GO:0045504; GO:0051642; GO:1990090	cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]		NA	NA	NA	NA	NA	NA
TRINITY_DN30182_c0_g1_i1	Q27802	DYHC2_TRIGR	69.1	68	21	0	3	206	3853	3920	1.30E-23	109.8	DYHC2_TRIGR	reviewed	Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B)	DYH1B	Tripneustes gratilla (Hawaian sea urchin) (Echinus gratilla)	4318	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]"	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0007275; GO:0008569; GO:0030030; GO:0030286	cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN855_c0_g1_i1	Q9VF87	CYFIP_DROME	76.9	684	134	2	1985	3	3	685	5.80E-307	1055.4	CYFIP_DROME	reviewed	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	Sra-1 Cyfip CG4931	Drosophila melanogaster (Fruit fly)	1291	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0048365; GO:0050807; GO:0051491; GO:0060269	axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN855_c0_g1_i2	Q9VF87	CYFIP_DROME	78.5	642	137	1	1926	1	3	643	1.30E-298	1027.7	CYFIP_DROME	reviewed	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	Sra-1 Cyfip CG4931	Drosophila melanogaster (Fruit fly)	1291	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0048365; GO:0050807; GO:0051491; GO:0060269	axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN855_c0_g1_i7	Q9VF87	CYFIP_DROME	78.9	630	132	1	1893	4	3	631	1.60E-293	1010.7	CYFIP_DROME	reviewed	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	Sra-1 Cyfip CG4931	Drosophila melanogaster (Fruit fly)	1291	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0048365; GO:0050807; GO:0051491; GO:0060269	axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN2733_c0_g1_i1	Q9VF87	CYFIP_DROME	70.2	497	144	3	1569	91	790	1286	1.00E-210	734.2	CYFIP_DROME	reviewed	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	Sra-1 Cyfip CG4931	Drosophila melanogaster (Fruit fly)	1291	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0048365; GO:0050807; GO:0051491; GO:0060269	axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN2733_c0_g1_i3	Q9VF87	CYFIP_DROME	70.2	497	144	3	1569	91	790	1286	1.00E-210	734.2	CYFIP_DROME	reviewed	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	Sra-1 Cyfip CG4931	Drosophila melanogaster (Fruit fly)	1291	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0048365; GO:0050807; GO:0051491; GO:0060269	axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN2733_c0_g1_i4	Q9VF87	CYFIP_DROME	70.2	497	144	3	1569	91	790	1286	1.00E-210	734.2	CYFIP_DROME	reviewed	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	Sra-1 Cyfip CG4931	Drosophila melanogaster (Fruit fly)	1291	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030833; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0048365; GO:0050807; GO:0051491; GO:0060269	axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN8170_c0_g1_i1	Q7TMB8	CYFP1_MOUSE	100	217	0	0	709	59	1037	1253	2.50E-127	456.1	CYFP1_MOUSE	reviewed	Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1)	Cyfip1 Kiaa0068 Shyc Sra1	Mus musculus (Mouse)	1253	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; terminal bouton [GO:0043195]; actin filament binding [GO:0051015]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuron projection development [GO:0031175]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; terminal bouton [GO:0043195]	actin filament binding [GO:0051015]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001726; GO:0005522; GO:0005737; GO:0005845; GO:0006417; GO:0007411; GO:0008360; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0031175; GO:0031209; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0044294; GO:0044295; GO:0045202; GO:0045773; GO:0048365; GO:0048471; GO:0048675; GO:0050772; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0090724; GO:0090725; GO:0097484; GO:0098794; GO:0099563; GO:1900006; GO:1900029; GO:1903422; GO:1905274; GO:2000601	axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuron projection development [GO:0031175]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]		NA	NA	NA	NA	NA	NA
TRINITY_DN31527_c0_g1_i1	Q7TMB8	CYFP1_MOUSE	100	100	0	0	1	300	789	888	1.30E-53	209.9	CYFP1_MOUSE	reviewed	Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1)	Cyfip1 Kiaa0068 Shyc Sra1	Mus musculus (Mouse)	1253	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; terminal bouton [GO:0043195]; actin filament binding [GO:0051015]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuron projection development [GO:0031175]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; terminal bouton [GO:0043195]	actin filament binding [GO:0051015]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001726; GO:0005522; GO:0005737; GO:0005845; GO:0006417; GO:0007411; GO:0008360; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0031175; GO:0031209; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0044294; GO:0044295; GO:0045202; GO:0045773; GO:0048365; GO:0048471; GO:0048675; GO:0050772; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0090724; GO:0090725; GO:0097484; GO:0098794; GO:0099563; GO:1900006; GO:1900029; GO:1903422; GO:1905274; GO:2000601	axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuron projection development [GO:0031175]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]		NA	NA	NA	NA	NA	NA
TRINITY_DN20225_c0_g1_i1	Q7L576	CYFP1_HUMAN	95.5	154	7	0	464	3	883	1036	5.60E-80	298.1	CYFP1_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1)	CYFIP1 KIAA0068	Homo sapiens (Human)	1253	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]	actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0031209; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0038096; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043312; GO:0044294; GO:0044295; GO:0045202; GO:0045773; GO:0048010; GO:0048365; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601	axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN32304_c0_g1_i1	Q7L576	CYFP1_HUMAN	100	113	0	0	1	339	331	443	8.60E-62	237.3	CYFP1_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1)	CYFIP1 KIAA0068	Homo sapiens (Human)	1253	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]	actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0031209; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0038096; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043312; GO:0044294; GO:0044295; GO:0045202; GO:0045773; GO:0048010; GO:0048365; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601	axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN30967_c0_g1_i1	Q7L576	CYFP1_HUMAN	100	180	0	0	542	3	484	663	5.70E-100	364.8	CYFP1_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1)	CYFIP1 KIAA0068	Homo sapiens (Human)	1253	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]	actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0031209; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0038096; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043312; GO:0044294; GO:0044295; GO:0045202; GO:0045773; GO:0048010; GO:0048365; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601	axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN31320_c0_g1_i1	Q7L576	CYFP1_HUMAN	100	209	0	0	3	629	31	239	3.00E-116	419.1	CYFP1_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1)	CYFIP1 KIAA0068	Homo sapiens (Human)	1253	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]	actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0031209; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0038096; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043312; GO:0044294; GO:0044295; GO:0045202; GO:0045773; GO:0048010; GO:0048365; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601	axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; neutrophil degranulation [GO:0043312]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN8170_c0_g2_i1	Q96F07	CYFP2_HUMAN	99.1	216	2	0	706	59	1062	1277	3.00E-125	449.1	CYFP2_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	CYFIP2 KIAA1168 PIR121	Homo sapiens (Human)	1278	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]	GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0038096; GO:0043005; GO:0045202; GO:0045862; GO:0048010; GO:0048365; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN20225_c0_g1_i2	Q96F07	CYFP2_HUMAN	100	244	0	0	734	3	817	1060	1.10E-141	503.8	CYFP2_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	CYFIP2 KIAA1168 PIR121	Homo sapiens (Human)	1278	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]	GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0038096; GO:0043005; GO:0045202; GO:0045862; GO:0048010; GO:0048365; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN33102_c0_g1_i1	Q96F07	CYFP2_HUMAN	100	273	0	0	821	3	1	273	6.60E-156	551.2	CYFP2_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	CYFIP2 KIAA1168 PIR121	Homo sapiens (Human)	1278	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]	GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0038096; GO:0043005; GO:0045202; GO:0045862; GO:0048010; GO:0048365; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN15673_c0_g1_i1	Q5SQX6	CYFP2_MOUSE	100	393	0	0	2	1180	272	664	5.40E-228	791.2	CYFP2_MOUSE	reviewed	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	Cyfip2 Kiaa1168 Pir121	Mus musculus (Mouse)	1253	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]	GO:0000902; GO:0005634; GO:0005737; GO:0006915; GO:0030833; GO:0031175; GO:0043005; GO:0045202; GO:0045862; GO:0048365; GO:0048471; GO:0051388; GO:0097202; GO:0097484; GO:0098609	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]		NA	NA	NA	NA	NA	NA
TRINITY_DN15673_c0_g1_i2	Q96F07	CYFP2_HUMAN	98.2	217	4	0	2	652	272	488	2.00E-120	433	CYFP2_HUMAN	reviewed	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	CYFIP2 KIAA1168 PIR121	Homo sapiens (Human)	1278	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Rac GTPase binding [GO:0048365]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	Rac GTPase binding [GO:0048365]	GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0038096; GO:0043005; GO:0045202; GO:0045862; GO:0048010; GO:0048365; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN27526_c0_g1_i1	Q9U9P7	PITC1_DROME	71.4	56	16	0	43	210	3	58	5.20E-17	87.8	PITC1_DROME	reviewed	Cytoplasmic phosphatidylinositol transfer protein 1 (Retinal degeneration B homolog beta) (RdgBbeta)	rdgBbeta CG17818	Drosophila melanogaster (Fruit fly)	273	cytoplasm [GO:0005737]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0007165; GO:0008526; GO:0035091	signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN2641_c0_g1_i1	Q9U9P7	PITC1_DROME	58.2	146	56	1	640	203	129	269	7.10E-41	168.7	PITC1_DROME	reviewed	Cytoplasmic phosphatidylinositol transfer protein 1 (Retinal degeneration B homolog beta) (RdgBbeta)	rdgBbeta CG17818	Drosophila melanogaster (Fruit fly)	273	cytoplasm [GO:0005737]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0007165; GO:0008526; GO:0035091	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN9359_c0_g1_i1	Q99M51	NCK1_MOUSE	41.9	203	89	5	590	45	53	247	8.30E-36	151.8	NCK1_MOUSE	reviewed	Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1)	Nck1	Mus musculus (Mouse)	377	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]	ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0036493; GO:0042102; GO:0042110; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0051707; GO:0060548; GO:0070262; GO:0071074; GO:1902237; GO:1903676; GO:1903679; GO:1903898; GO:1903912; GO:1990441	"actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22313_c0_g1_i1	P16333	NCK1_HUMAN	100	98	0	0	2	295	280	377	3.60E-52	205.3	NCK1_HUMAN	reviewed	Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) (SH2/SH3 adaptor protein NCK-alpha)	NCK1 NCK	Homo sapiens (Human)	377	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]; actin filament organization [GO:0007015]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0038096; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048010; GO:0048013; GO:0050852; GO:0051707; GO:0060548; GO:0070262; GO:0071074; GO:1902237; GO:1903676; GO:1903679; GO:1903898; GO:1903912; GO:1990441	"actin filament organization [GO:0007015]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22313_c0_g1_i2	P16333	NCK1_HUMAN	100	98	0	0	2	295	280	377	3.30E-52	205.3	NCK1_HUMAN	reviewed	Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) (SH2/SH3 adaptor protein NCK-alpha)	NCK1 NCK	Homo sapiens (Human)	377	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]; actin filament organization [GO:0007015]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0038096; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048010; GO:0048013; GO:0050852; GO:0051707; GO:0060548; GO:0070262; GO:0071074; GO:1902237; GO:1903676; GO:1903679; GO:1903898; GO:1903912; GO:1990441	"actin filament organization [GO:0007015]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27510_c0_g1_i1	O55033	NCK2_MOUSE	60.8	102	40	0	137	442	278	379	2.90E-34	146.4	NCK2_MOUSE	reviewed	Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta)	Nck2 Grb4	Mus musculus (Mouse)	380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]	GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030838; GO:0033137; GO:0036493; GO:0042102; GO:0044877; GO:0045202; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441	actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]		NA	NA	NA	NA	NA	NA
TRINITY_DN9359_c0_g1_i2	O55033	NCK2_MOUSE	45.5	123	53	1	356	30	135	257	3.50E-26	119.4	NCK2_MOUSE	reviewed	Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta)	Nck2 Grb4	Mus musculus (Mouse)	380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]	GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030838; GO:0033137; GO:0036493; GO:0042102; GO:0044877; GO:0045202; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441	actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]		NA	NA	NA	NA	NA	NA
TRINITY_DN5972_c0_g1_i1	B0DK66	CTU1_LACBS	79	195	41	0	587	3	30	224	6.00E-87	321.6	CTU1_LACBS	reviewed	Cytoplasmic tRNA 2-thiolation protein 1 (EC 2.7.7.-) (Cytoplasmic tRNA adenylyltransferase 1)	NCS6 CTU1 LACBIDRAFT_330073	Laccaria bicolor (strain S238N-H82 / ATCC MYA-4686) (Bicoloured deceiver) (Laccaria laccata var. bicolor)	354	cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]	nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]	GO:0000049; GO:0002098; GO:0002143; GO:0002144; GO:0005829; GO:0016779; GO:0032447; GO:0034227	protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5972_c0_g1_i2	B0DK66	CTU1_LACBS	79.2	168	35	0	587	84	30	197	2.00E-74	280	CTU1_LACBS	reviewed	Cytoplasmic tRNA 2-thiolation protein 1 (EC 2.7.7.-) (Cytoplasmic tRNA adenylyltransferase 1)	NCS6 CTU1 LACBIDRAFT_330073	Laccaria bicolor (strain S238N-H82 / ATCC MYA-4686) (Bicoloured deceiver) (Laccaria laccata var. bicolor)	354	cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]	nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]	GO:0000049; GO:0002098; GO:0002143; GO:0002144; GO:0005829; GO:0016779; GO:0032447; GO:0034227	protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN306_c1_g2_i23	Q3B7U4	CTU2_RAT	37	181	102	4	591	73	28	204	6.00E-24	113.2	CTU2_RAT	reviewed	Cytoplasmic tRNA 2-thiolation protein 2	Ctu2 Ncs2	Rattus norvegicus (Rat)	528	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]	GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0032991; GO:0034227	protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN306_c1_g2_i3	Q3B7U4	CTU2_RAT	37	181	102	4	591	73	28	204	3.00E-24	114.4	CTU2_RAT	reviewed	Cytoplasmic tRNA 2-thiolation protein 2	Ctu2 Ncs2	Rattus norvegicus (Rat)	528	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]	GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0032991; GO:0034227	protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN306_c1_g2_i6	Q3B7U4	CTU2_RAT	37	181	102	4	591	73	28	204	6.00E-24	113.2	CTU2_RAT	reviewed	Cytoplasmic tRNA 2-thiolation protein 2	Ctu2 Ncs2	Rattus norvegicus (Rat)	528	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]	GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0032991; GO:0034227	protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN13516_c0_g1_i1	Q08B12	CTU2A_XENLA	33.8	275	148	6	891	79	261	505	8.10E-27	122.5	CTU2A_XENLA	reviewed	Cytoplasmic tRNA 2-thiolation protein 2-A	ctu2-a ncs2-a	Xenopus laevis (African clawed frog)	512	cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]	nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]	GO:0000049; GO:0002098; GO:0005829; GO:0016779; GO:0032447; GO:0034227	protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN9242_c0_g1_i1	A2AGT5	CKAP5_MOUSE	46.3	510	268	3	1570	44	580	1084	7.20E-127	455.7	CKAP5_MOUSE	reviewed	Cytoskeleton-associated protein 5	Ckap5	Mus musculus (Mouse)	2032	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; central nervous system myelin formation [GO:0032289]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; locomotory behavior [GO:0007626]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]	GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005886; GO:0007051; GO:0007052; GO:0007098; GO:0007626; GO:0008017; GO:0010609; GO:0030951; GO:0032289; GO:0032991; GO:0043021; GO:0046785; GO:0050658; GO:0051298; GO:0051301; GO:0061863; GO:0090063	cell division [GO:0051301]; central nervous system myelin formation [GO:0032289]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; locomotory behavior [GO:0007626]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN6220_c0_g1_i1	A2AGT5	CKAP5_MOUSE	38.3	969	495	20	19	2808	1126	2030	1.40E-165	585.1	CKAP5_MOUSE	reviewed	Cytoskeleton-associated protein 5	Ckap5	Mus musculus (Mouse)	2032	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; central nervous system myelin formation [GO:0032289]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; locomotory behavior [GO:0007626]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]	GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005886; GO:0007051; GO:0007052; GO:0007098; GO:0007626; GO:0008017; GO:0010609; GO:0030951; GO:0032289; GO:0032991; GO:0043021; GO:0046785; GO:0050658; GO:0051298; GO:0051301; GO:0061863; GO:0090063	cell division [GO:0051301]; central nervous system myelin formation [GO:0032289]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; locomotory behavior [GO:0007626]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN37008_c0_g1_i1	Q14008	CKAP5_HUMAN	100	135	0	0	407	3	268	402	3.70E-67	255.4	CKAP5_HUMAN	reviewed	Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG)	CKAP5 KIAA0097	Homo sapiens (Human)	2032	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]	GO:0000086; GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0010389; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051298; GO:0051301; GO:0061863; GO:0090063; GO:0097711	cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN37992_c0_g1_i1	Q14008	CKAP5_HUMAN	100	80	0	0	1	240	1312	1391	1.00E-40	166.8	CKAP5_HUMAN	reviewed	Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG)	CKAP5 KIAA0097	Homo sapiens (Human)	2032	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]	GO:0000086; GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0010389; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051298; GO:0051301; GO:0061863; GO:0090063; GO:0097711	cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN38449_c0_g1_i1	Q14008	CKAP5_HUMAN	100	90	0	0	272	3	1631	1720	5.60E-40	164.5	CKAP5_HUMAN	reviewed	Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG)	CKAP5 KIAA0097	Homo sapiens (Human)	2032	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]	GO:0000086; GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0010389; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051298; GO:0051301; GO:0061863; GO:0090063; GO:0097711	cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN15815_c0_g1_i2	P00727	AMPL_BOVIN	55.9	465	194	5	1498	125	47	507	1.30E-138	494.6	AMPL_BOVIN	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (LAP) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	LAP3	Bos taurus (Bovine)	519	cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	dipeptidase activity [GO:0016805]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0008233; GO:0016805; GO:0030145; GO:0030496; GO:0070006; GO:0097718			NA	NA	NA	NA	NA	NA
TRINITY_DN12660_c0_g2_i1	P28838	AMPL_HUMAN	100	184	0	0	552	1	326	509	2.10E-105	382.9	AMPL_HUMAN	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	LAP3 LAPEP PEPS	Homo sapiens (Human)	519	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; proteolysis [GO:0006508]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]	GO:0004177; GO:0005634; GO:0005654; GO:0005802; GO:0005829; GO:0005925; GO:0006508; GO:0008235; GO:0030145; GO:0030496; GO:0070006; GO:0070062	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN12660_c0_g1_i1	Q9CPY7	AMPL_MOUSE	100	151	0	0	457	5	369	519	2.20E-84	312.8	AMPL_MOUSE	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	Lap3 Lapep	Mus musculus (Mouse)	519	cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	GO:0005654; GO:0005739; GO:0005802; GO:0005829; GO:0008233; GO:0030145; GO:0030496; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN19072_c0_g1_i1	P28838	AMPL_HUMAN	100	101	0	0	304	2	229	329	3.60E-51	201.8	AMPL_HUMAN	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	LAP3 LAPEP PEPS	Homo sapiens (Human)	519	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; proteolysis [GO:0006508]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]	GO:0004177; GO:0005634; GO:0005654; GO:0005802; GO:0005829; GO:0005925; GO:0006508; GO:0008235; GO:0030145; GO:0030496; GO:0070006; GO:0070062	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN19072_c0_g1_i2	Q9CPY7	AMPL_MOUSE	100	107	0	0	322	2	223	329	6.90E-53	207.6	AMPL_MOUSE	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	Lap3 Lapep	Mus musculus (Mouse)	519	cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	GO:0005654; GO:0005739; GO:0005802; GO:0005829; GO:0008233; GO:0030145; GO:0030496; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN15815_c0_g1_i1	Q5XGB9	AMPL_XENTR	76.9	39	9	0	241	125	468	506	3.10E-11	69.3	AMPL_XENTR	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	lap3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	520	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i2	Q8SQZ7	AMPL_ENCCU	58	162	61	3	484	2	213	368	1.40E-41	170.6	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i4	Q8SQZ7	AMPL_ENCCU	60.4	134	53	0	425	24	213	346	1.50E-37	157.1	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i5	Q8SQZ7	AMPL_ENCCU	59.7	134	54	0	425	24	213	346	7.20E-37	154.8	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i6	Q8SQZ7	AMPL_ENCCU	58.4	161	62	1	484	2	213	368	9.10E-44	177.9	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i7	Q8SQZ7	AMPL_ENCCU	58.4	161	62	1	484	2	213	368	1.50E-43	177.2	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g2_i1	Q8SQZ7	AMPL_ENCCU	59.3	167	62	1	502	2	213	373	9.60E-49	194.5	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g2_i2	Q8SQZ7	AMPL_ENCCU	59.9	167	61	1	502	2	213	373	1.30E-48	194.1	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g2_i4	Q8SQZ7	AMPL_ENCCU	59.3	167	62	1	502	2	213	373	3.70E-48	192.6	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g2_i6	Q8SQZ7	AMPL_ENCCU	58.7	167	63	1	502	2	213	373	2.80E-48	193	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN1625_c0_g1_i1	Q8SQZ7	AMPL_ENCCU	67.1	70	18	1	214	5	307	371	1.10E-17	90.1	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN1625_c0_g1_i2	Q8SQZ7	AMPL_ENCCU	60.5	86	29	1	262	5	291	371	4.10E-22	105.1	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN1625_c0_g1_i3	Q8SQZ7	AMPL_ENCCU	60.5	86	29	1	262	5	291	371	4.10E-22	105.1	AMPL_ENCCU	reviewed	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	ECU10_1770i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	486	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN7545_c0_g1_i1	Q6GNL7	AL1L1_XENLA	66.5	904	296	6	121	2817	1	902	0	1246.1	AL1L1_XENLA	reviewed	Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)	aldh1l1	Xenopus laevis (African clawed frog)	902	"cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]"	cytoplasm [GO:0005737]	"formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]"	GO:0005737; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016620; GO:0016742	10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN17898_c0_g3_i1	Q63ZT8	AL1L1_XENTR	47.4	57	30	0	198	28	838	894	4.20E-08	58.2	AL1L1_XENTR	reviewed	Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)	aldh1l1 TNeu011l01.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	902	"cytoplasm [GO:0005737]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]"	cytoplasm [GO:0005737]	"aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]"	GO:0004029; GO:0005737; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016742	10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]		NA	NA	NA	NA	NA	NA
TRINITY_DN982_c0_g1_i2	Q7SYN4	5NT3_DANRE	48	273	142	0	345	1163	10	282	3.60E-73	276.9	5NT3_DANRE	reviewed	Cytosolic 5'-nucleotidase 3 (EC 3.1.3.5) (Cytosolic 5'-nucleotidase III) (cN-III)	nt5c3 zgc:66117	Danio rerio (Zebrafish) (Brachydanio rerio)	286	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; transferase activity [GO:0016740]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; transferase activity [GO:0016740]	GO:0000166; GO:0000287; GO:0005737; GO:0008253; GO:0009117; GO:0016740; GO:0016791	nucleotide metabolic process [GO:0009117]		blue	blue	NA	NA	NA	NA
TRINITY_DN982_c0_g1_i3	Q7SYN4	5NT3_DANRE	49.1	273	139	0	345	1163	10	282	6.60E-75	282.7	5NT3_DANRE	reviewed	Cytosolic 5'-nucleotidase 3 (EC 3.1.3.5) (Cytosolic 5'-nucleotidase III) (cN-III)	nt5c3 zgc:66117	Danio rerio (Zebrafish) (Brachydanio rerio)	286	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; transferase activity [GO:0016740]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; transferase activity [GO:0016740]	GO:0000166; GO:0000287; GO:0005737; GO:0008253; GO:0009117; GO:0016740; GO:0016791	nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN982_c0_g1_i1	Q9D020	5NT3A_MOUSE	51.1	45	22	0	342	476	54	98	5.70E-07	55.8	5NT3A_MOUSE	reviewed	Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Lupin) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I)	Nt5c3a Nt5c3	Mus musculus (Mouse)	331	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; transferase activity [GO:0016740]; adenosine metabolic process [GO:0046085]; defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; transferase activity [GO:0016740]	GO:0000166; GO:0000287; GO:0005737; GO:0005739; GO:0005783; GO:0008253; GO:0009117; GO:0016740; GO:0016791; GO:0046085; GO:0051607	adenosine metabolic process [GO:0046085]; defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN40755_c0_g1_i1	Q9H0P0	5NT3A_HUMAN	98.7	76	1	0	228	1	259	334	4.60E-35	147.9	5NT3A_HUMAN	reviewed	Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I) (Uridine 5'-monophosphate hydrolase 1) (p36)	NT5C3A NT5C3 P5N1 UMPH1 HSPC233	Homo sapiens (Human)	336	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; tRNA 2'-phosphotransferase activity [GO:0000215]; defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside metabolic process [GO:0006213]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; tRNA 2'-phosphotransferase activity [GO:0000215]	GO:0000166; GO:0000215; GO:0000287; GO:0005737; GO:0005783; GO:0005829; GO:0006213; GO:0008253; GO:0009117; GO:0016791; GO:0046135; GO:0051607	defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside metabolic process [GO:0006213]		NA	NA	NA	NA	NA	NA
TRINITY_DN911_c2_g1_i1	Q6DD21	CBPC1_XENLA	46.7	540	239	6	1414	2991	624	1128	9.40E-142	506.1	CBPC1_XENLA	reviewed	Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1)	agtpbp1 ccp1	Xenopus laevis (African clawed frog)	1225	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905	cerebellar Purkinje cell differentiation [GO:0021702]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]		NA	NA	NA	NA	NA	NA
TRINITY_DN911_c2_g1_i2	Q6DD21	CBPC1_XENLA	46.7	540	239	6	1161	2738	624	1128	8.70E-142	506.1	CBPC1_XENLA	reviewed	Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1)	agtpbp1 ccp1	Xenopus laevis (African clawed frog)	1225	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905	cerebellar Purkinje cell differentiation [GO:0021702]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]		NA	NA	NA	NA	NA	NA
TRINITY_DN911_c2_g1_i4	E1C3P4	CBPC1_CHICK	42.6	61	29	2	57	224	995	1054	5.20E-08	58.2	CBPC1_CHICK	reviewed	Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1)	AGTPBP1 CCP1K	Gallus gallus (Chicken)	1224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905	cerebellar Purkinje cell differentiation [GO:0021702]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]		NA	NA	NA	NA	NA	NA
TRINITY_DN911_c2_g1_i5	Q6DD21	CBPC1_XENLA	46.7	540	239	6	580	2157	624	1128	7.00E-142	506.1	CBPC1_XENLA	reviewed	Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1)	agtpbp1 ccp1	Xenopus laevis (African clawed frog)	1225	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905	cerebellar Purkinje cell differentiation [GO:0021702]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]		NA	NA	NA	NA	NA	NA
TRINITY_DN34483_c0_g1_i1	Q641K1	CBPC1_MOUSE	61.8	89	34	0	1	267	905	993	2.20E-28	125.9	CBPC1_MOUSE	reviewed	Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1)	Agtpbp1 Ccp1 Nna1	Mus musculus (Mouse)	1218	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; axonal transport [GO:0098930]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0001754; GO:0004181; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0007628; GO:0008233; GO:0008270; GO:0008285; GO:0015631; GO:0021549; GO:0021680; GO:0021702; GO:0021772; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0042133; GO:0043231; GO:0050905; GO:0060041; GO:0098930; GO:0098957; GO:0098958; GO:1904115; GO:2000060	adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; axonal transport [GO:0098930]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958]		NA	NA	NA	NA	NA	NA
TRINITY_DN38_c0_g1_i1	P0C7A1	ENASE_CHICK	43.8	448	210	7	1465	149	85	499	7.70E-97	355.9	ENASE_CHICK	reviewed	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	ENGASE	Gallus gallus (Chicken)	728	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN38_c0_g1_i2	P0C7A1	ENASE_CHICK	43.8	249	123	4	889	149	266	499	1.80E-50	201.8	ENASE_CHICK	reviewed	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	ENGASE	Gallus gallus (Chicken)	728	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN38_c0_g1_i2	P0C7A1	ENASE_CHICK	49.4	180	73	3	1400	882	85	253	3.70E-40	167.5	ENASE_CHICK	reviewed	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	ENGASE	Gallus gallus (Chicken)	728	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN38_c0_g1_i3	P0C7A1	ENASE_CHICK	43.8	448	210	7	1465	149	85	499	7.80E-97	355.9	ENASE_CHICK	reviewed	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	ENGASE	Gallus gallus (Chicken)	728	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	1
TRINITY_DN38_c0_g1_i4	P0C7A1	ENASE_CHICK	43.8	249	123	4	889	149	266	499	1.80E-50	201.8	ENASE_CHICK	reviewed	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	ENGASE	Gallus gallus (Chicken)	728	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN38_c0_g1_i4	P0C7A1	ENASE_CHICK	49.4	180	73	3	1400	882	85	253	3.80E-40	167.5	ENASE_CHICK	reviewed	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	ENGASE	Gallus gallus (Chicken)	728	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]	beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c3_g1_i1	A8WH18	NARFL_XENTR	58.1	477	187	5	1448	48	3	476	1.30E-157	557.8	NARFL_XENTR	reviewed	Cytosolic Fe-S cluster assembly factor narfl (Nuclear prelamin A recognition factor-like protein)	narfl	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	476	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	CIA complex [GO:0097361]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"	GO:0016226; GO:0046872; GO:0051539; GO:0097361	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c3_g1_i2	A2RRV9	NARFL_DANRE	57.6	158	67	0	587	114	254	411	9.80E-49	194.9	NARFL_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor narfl (Nuclear prelamin A recognition factor-like protein)	narfl zgc:158422	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]"	CIA complex [GO:0097361]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"	GO:0002040; GO:0016226; GO:0046872; GO:0051539; GO:0097361	iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]		brown	brown	NA	NA	NA	NA
TRINITY_DN2650_c3_g1_i7	A2RRV9	NARFL_DANRE	58.7	167	69	0	586	86	245	411	3.90E-54	212.6	NARFL_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor narfl (Nuclear prelamin A recognition factor-like protein)	narfl zgc:158422	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]"	CIA complex [GO:0097361]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"	GO:0002040; GO:0016226; GO:0046872; GO:0051539; GO:0097361	iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c3_g1_i9	A2RRV9	NARFL_DANRE	57.7	156	66	0	581	114	256	411	1.20E-48	194.5	NARFL_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor narfl (Nuclear prelamin A recognition factor-like protein)	narfl zgc:158422	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]"	CIA complex [GO:0097361]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"	GO:0002040; GO:0016226; GO:0046872; GO:0051539; GO:0097361	iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]		brown	brown	NA	NA	NA	NA
TRINITY_DN24610_c0_g1_i1	P53384	NUBP1_HUMAN	100	144	0	0	432	1	28	171	4.00E-80	298.5	NUBP1_HUMAN	reviewed	Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1) (NBP 1)	NUBP1 NBP NBP1	Homo sapiens (Human)	320	"centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]"	centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0001558; GO:0005524; GO:0005634; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006879; GO:0010826; GO:0016226; GO:0030030; GO:0046872; GO:0051536; GO:0051539; GO:0051642; GO:0072697	cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN6724_c0_g1_i1	Q6P298	NUBP1_DANRE	65.8	310	106	0	114	1043	6	315	4.20E-121	436	NUBP1_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1)	nubp1 zgc:92138	Danio rerio (Zebrafish) (Brachydanio rerio)	321	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		blue	blue	NA	NA	NA	NA
TRINITY_DN39308_c0_g1_i1	Q6P298	NUBP1_DANRE	44.1	111	55	3	318	4	130	239	1.30E-19	97.1	NUBP1_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1)	nubp1 zgc:92138	Danio rerio (Zebrafish) (Brachydanio rerio)	321	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN40263_c0_g1_i1	P53384	NUBP1_HUMAN	100	75	0	0	226	2	197	271	2.00E-38	159.1	NUBP1_HUMAN	reviewed	Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1) (NBP 1)	NUBP1 NBP NBP1	Homo sapiens (Human)	320	"centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]"	centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0001558; GO:0005524; GO:0005634; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006879; GO:0010826; GO:0016226; GO:0030030; GO:0046872; GO:0051536; GO:0051539; GO:0051642; GO:0072697	cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN33472_c0_g1_i1	Q9R060	NUBP1_MOUSE	100	188	0	0	565	2	85	272	1.40E-109	396.7	NUBP1_MOUSE	reviewed	Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1) (NBP 1)	Nubp1	Mus musculus (Mouse)	320	"centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]"	centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0001558; GO:0005524; GO:0005634; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006879; GO:0010826; GO:0016226; GO:0030030; GO:0046872; GO:0051536; GO:0051539; GO:0051642; GO:0072697	cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i1	Q6P298	NUBP1_DANRE	44.1	295	155	5	169	1026	16	309	1.50E-68	261.9	NUBP1_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1)	nubp1 zgc:92138	Danio rerio (Zebrafish) (Brachydanio rerio)	321	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i17	Q6P298	NUBP1_DANRE	44.1	304	159	6	126	1007	7	309	1.20E-69	265.8	NUBP1_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1)	nubp1 zgc:92138	Danio rerio (Zebrafish) (Brachydanio rerio)	321	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i4	Q6P298	NUBP1_DANRE	44.1	304	159	6	126	1007	7	309	1.40E-69	265.8	NUBP1_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1)	nubp1 zgc:92138	Danio rerio (Zebrafish) (Brachydanio rerio)	321	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i7	Q6P298	NUBP1_DANRE	44.1	304	159	6	126	1007	7	309	1.10E-69	265.8	NUBP1_DANRE	reviewed	Cytosolic Fe-S cluster assembly factor nubp1 (Nucleotide-binding protein 1) (NBP 1)	nubp1 zgc:92138	Danio rerio (Zebrafish) (Brachydanio rerio)	321	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		blue	blue	NA	NA	NA	NA
TRINITY_DN7528_c0_g1_i1	Q3KQF0	NUP1A_XENLA	66.1	251	83	1	2	748	5	255	2.00E-95	350.1	NUP1A_XENLA	reviewed	Cytosolic Fe-S cluster assembly factor nubp1-A (Nucleotide-binding protein 1-A) (NBP 1-A)	nubp1-A	Xenopus laevis (African clawed frog)	315	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN17444_c0_g1_i1	Q9Y5Y2	NUBP2_HUMAN	100	245	0	0	31	765	1	245	3.20E-141	502.3	NUBP2_HUMAN	reviewed	Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2)	NUBP2	Homo sapiens (Human)	271	"centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cell projection organization [GO:0030030]; iron-sulfur cluster assembly [GO:0016226]"	centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0005524; GO:0005634; GO:0005814; GO:0005829; GO:0005929; GO:0016226; GO:0030030; GO:0031616; GO:0046872; GO:0051536; GO:0051539	cell projection organization [GO:0030030]; iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN36767_c0_g1_i1	A7SE07	NUBP2_NEMVE	46	63	31	1	6	185	137	199	3.10E-12	72	NUBP2_NEMVE	reviewed	Cytosolic Fe-S cluster assembly factor NUBP2 homolog	v1g229988	Nematostella vectensis (Starlet sea anemone)	270	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN26997_c0_g1_i1	A7SE07	NUBP2_NEMVE	58.8	260	105	2	881	105	9	267	1.50E-82	307.8	NUBP2_NEMVE	reviewed	Cytosolic Fe-S cluster assembly factor NUBP2 homolog	v1g229988	Nematostella vectensis (Starlet sea anemone)	270	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		blue	blue	NA	NA	NA	NA
TRINITY_DN39372_c0_g1_i1	Q9H5X1	CIA2A_HUMAN	39.3	145	71	3	474	43	28	156	2.50E-22	106.7	CIA2A_HUMAN	reviewed	Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A)	CIAO2A CIA2A FAM96A	Homo sapiens (Human)	160	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005829; GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN1913_c0_g1_i1	Q9DCL2	CIA2A_MOUSE	60.6	137	50	1	1526	1116	28	160	1.60E-41	172.2	CIA2A_MOUSE	reviewed	Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A)	Ciao2a Fam96a	Mus musculus (Mouse)	160	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005829; GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN1913_c0_g1_i2	Q9DCL2	CIA2A_MOUSE	60.6	137	50	1	1599	1189	28	160	2.20E-41	171.8	CIA2A_MOUSE	reviewed	Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A)	Ciao2a Fam96a	Mus musculus (Mouse)	160	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005829; GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN1913_c0_g1_i3	Q9DCL2	CIA2A_MOUSE	60.6	137	50	1	1599	1189	28	160	2.10E-41	171.8	CIA2A_MOUSE	reviewed	Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A)	Ciao2a Fam96a	Mus musculus (Mouse)	160	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005829; GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN14542_c0_g1_i1	Q9H5X1	CIA2A_HUMAN	100	145	0	0	470	36	16	160	1.20E-77	290.4	CIA2A_HUMAN	reviewed	Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A)	CIAO2A CIA2A FAM96A	Homo sapiens (Human)	160	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005829; GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN14542_c0_g1_i2	Q3T0U7	CIA2A_BOVIN	99.3	145	1	0	467	33	16	160	1.50E-77	290	CIA2A_BOVIN	reviewed	Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A)	CIAO2A FAM96A	Bos taurus (Bovine)	160	CIA complex [GO:0097361]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]	metal ion binding [GO:0046872]	GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN2722_c0_g1_i1	Q9D187	CIA2B_MOUSE	62.3	151	57	0	627	1079	9	159	2.80E-48	194.1	CIA2B_MOUSE	reviewed	Cytosolic iron-sulfur assembly component 2B (Mitotic spindle-associated MMXD complex subunit MIP18)	Ciao2b Fam96b Mip18	Mus musculus (Mouse)	163	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0016226; GO:0071817; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN2722_c0_g1_i2	Q9D187	CIA2B_MOUSE	62.3	151	57	0	402	854	9	159	2.20E-48	194.1	CIA2B_MOUSE	reviewed	Cytosolic iron-sulfur assembly component 2B (Mitotic spindle-associated MMXD complex subunit MIP18)	Ciao2b Fam96b Mip18	Mus musculus (Mouse)	163	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0016226; GO:0071817; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN31441_c0_g1_i1	Q9D187	CIA2B_MOUSE	100	143	0	0	1	429	11	153	3.30E-74	278.9	CIA2B_MOUSE	reviewed	Cytosolic iron-sulfur assembly component 2B (Mitotic spindle-associated MMXD complex subunit MIP18)	Ciao2b Fam96b Mip18	Mus musculus (Mouse)	163	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0016226; GO:0071817; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN28870_c0_g1_i1	Q9Y3D0	CIA2B_HUMAN	100	159	0	0	533	57	5	163	5.60E-84	311.6	CIA2B_HUMAN	reviewed	Cytosolic iron-sulfur assembly component 2B (MSS19-interacting protein of 18 kDa) (Mitotic spindle-associated MMXD complex subunit MIP18) (Protein FAM96B)	CIAO2B CIAB FAM96B MIP18 CGI-128 HSPC118	Homo sapiens (Human)	163	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0016226; GO:0030496; GO:0071817; GO:0097361; GO:0097428; GO:0106035	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN34859_c0_g1_i1	Q9H6Q4	CIAO3_HUMAN	100	74	0	0	225	4	355	428	4.00E-39	161.4	CIAO3_HUMAN	reviewed	Cytosolic iron-sulfur assembly component 3 (Cytosolic Fe-S cluster assembly factor NARFL) (Iron-only hydrogenase-like protein 1) (IOP1) (Nuclear prelamin A recognition factor-like protein) (Protein related to Narf)	CIAO3 NARFL PRN	Homo sapiens (Human)	476	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; iron-sulfur cluster assembly [GO:0016226]; oxygen homeostasis [GO:0032364]; regulation of gene expression [GO:0010468]; response to hypoxia [GO:0001666]"	CIA complex [GO:0097361]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"	GO:0001666; GO:0002244; GO:0010468; GO:0016226; GO:0032364; GO:0046872; GO:0051539; GO:0097361	hematopoietic progenitor cell differentiation [GO:0002244]; iron-sulfur cluster assembly [GO:0016226]; oxygen homeostasis [GO:0032364]; regulation of gene expression [GO:0010468]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN13316_c0_g1_i5	Q3ZC84	CNDP2_BOVIN	66.7	42	14	0	100	225	425	466	7.70E-11	67.8	CNDP2_BOVIN	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2)	CNDP2	Bos taurus (Bovine)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN15586_c0_g1_i1	Q96KP4	CNDP2_HUMAN	100	424	0	0	3	1274	52	475	4.40E-255	881.3	CNDP2_HUMAN	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Carnosine dipeptidase II) (Epididymis secretory protein Li 13) (Glutamate carboxypeptidase-like protein 1) (Peptidase A)	CNDP2 CN2 CPGL HEL-S-13 PEPA	Homo sapiens (Human)	475	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; glutathione biosynthetic process [GO:0006750]; proteolysis [GO:0006508]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0006750; GO:0008233; GO:0016805; GO:0046872; GO:0070062; GO:0070573; GO:0102008; GO:0103046	glutathione biosynthetic process [GO:0006750]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN13316_c0_g1_i1	Q96KP4	CNDP2_HUMAN	66.5	472	156	2	101	1516	3	472	2.10E-190	666.8	CNDP2_HUMAN	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Carnosine dipeptidase II) (Epididymis secretory protein Li 13) (Glutamate carboxypeptidase-like protein 1) (Peptidase A)	CNDP2 CN2 CPGL HEL-S-13 PEPA	Homo sapiens (Human)	475	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; glutathione biosynthetic process [GO:0006750]; proteolysis [GO:0006508]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0006750; GO:0008233; GO:0016805; GO:0046872; GO:0070062; GO:0070573; GO:0102008; GO:0103046	glutathione biosynthetic process [GO:0006750]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN20642_c0_g1_i1	Q9D1A2	CNDP2_MOUSE	100	115	0	0	2	346	263	377	5.70E-61	234.6	CNDP2_MOUSE	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)	Cndp2 Cn2	Mus musculus (Mouse)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN13316_c0_g1_i3	Q9D1A2	CNDP2_MOUSE	66	471	159	1	101	1513	3	472	2.40E-191	669.8	CNDP2_MOUSE	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)	Cndp2 Cn2	Mus musculus (Mouse)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN13316_c0_g1_i6	Q9D1A2	CNDP2_MOUSE	67.3	471	153	1	101	1513	3	472	1.20E-193	677.6	CNDP2_MOUSE	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)	Cndp2 Cn2	Mus musculus (Mouse)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN13316_c0_g1_i7	Q9D1A2	CNDP2_MOUSE	69.3	218	67	0	101	754	3	220	4.00E-92	339.3	CNDP2_MOUSE	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)	Cndp2 Cn2	Mus musculus (Mouse)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN40134_c0_g1_i1	Q9D1A2	CNDP2_MOUSE	100	113	0	0	2	340	126	238	2.20E-65	249.2	CNDP2_MOUSE	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)	Cndp2 Cn2	Mus musculus (Mouse)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN29292_c0_g1_i1	Q9D1A2	CNDP2_MOUSE	98.8	81	1	0	243	1	388	468	7.80E-41	167.2	CNDP2_MOUSE	reviewed	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)	Cndp2 Cn2	Mus musculus (Mouse)	475	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0102008; GO:0103046	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN2899_c0_g1_i1	A4IFJ5	PA24A_BOVIN	38.5	892	362	15	2981	342	5	721	7.50E-157	556.2	PA24A_BOVIN	reviewed	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	PLA2G4A CPLA2 PLA2G4	Bos taurus (Bovine)	749	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	"calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; calcium ion binding [GO:0005509]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"	GO:0000139; GO:0001516; GO:0002827; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0006071; GO:0006640; GO:0006663; GO:0008374; GO:0010314; GO:0010572; GO:0019369; GO:0019370; GO:0032266; GO:0032308; GO:0034478; GO:0034638; GO:0042127; GO:0043032; GO:0046475; GO:0047498; GO:0047499; GO:0050482; GO:0070273; GO:0071236; GO:0102545; GO:0102567; GO:0102568; GO:1902387	arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]		NA	NA	NA	NA	NA	NA
TRINITY_DN9168_c0_g1_i1	Q5EBF1	5NTC_XENTR	56.2	459	187	6	1478	123	99	550	3.80E-147	523.1	5NTC_XENTR	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	nt5c2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	568	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0008253; GO:0046040; GO:0046085; GO:0046872	adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]		NA	NA	NA	NA	NA	NA
TRINITY_DN9168_c0_g1_i2	Q5EBF1	5NTC_XENTR	57.4	524	209	6	1673	123	34	550	1.60E-175	617.5	5NTC_XENTR	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	nt5c2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	568	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0008253; GO:0046040; GO:0046085; GO:0046872	adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]		NA	NA	NA	NA	NA	NA
TRINITY_DN9168_c0_g2_i1	Q6DKB0	5NTC_XENLA	57.1	42	18	0	194	69	60	101	1.60E-08	60.1	5NTC_XENLA	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	nt5c2	Xenopus laevis (African clawed frog)	569	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0008253; GO:0009117; GO:0046872	nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN33813_c0_g1_i1	P49902	5NTC_HUMAN	100	131	0	0	3	395	321	451	1.40E-71	270	5NTC_HUMAN	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	NT5C2 NT5B NT5CP PNT5	Homo sapiens (Human)	561	cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]	cytosol [GO:0005829]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005829; GO:0006195; GO:0008253; GO:0017144; GO:0046040; GO:0046085; GO:0046872	adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]		NA	NA	NA	NA	NA	NA
TRINITY_DN37232_c0_g1_i1	O46411	5NTC_BOVIN	100	94	0	0	283	2	122	215	1.00E-52	206.8	5NTC_BOVIN	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II) (Cytosolic IMP/GMP-specific 5'-nucleotidase)	NT5C2	Bos taurus (Bovine)	560	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0008253; GO:0042802; GO:0046040; GO:0046085; GO:0046872	adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]		NA	NA	NA	NA	NA	NA
TRINITY_DN39514_c0_g1_i1	O46411	5NTC_BOVIN	100	68	0	0	3	206	453	520	2.50E-32	138.7	5NTC_BOVIN	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II) (Cytosolic IMP/GMP-specific 5'-nucleotidase)	NT5C2	Bos taurus (Bovine)	560	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0008253; GO:0042802; GO:0046040; GO:0046085; GO:0046872	adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]		NA	NA	NA	NA	NA	NA
TRINITY_DN38673_c0_g1_i1	O46411	5NTC_BOVIN	96.3	81	3	0	2	244	52	132	8.60E-40	163.7	5NTC_BOVIN	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II) (Cytosolic IMP/GMP-specific 5'-nucleotidase)	NT5C2	Bos taurus (Bovine)	560	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]	cytoplasm [GO:0005737]	5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0008253; GO:0042802; GO:0046040; GO:0046085; GO:0046872	adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]		NA	NA	NA	NA	NA	NA
TRINITY_DN3912_c0_g1_i1	Q2KN99	CYTSA_RAT	54.8	73	33	0	223	5	385	457	1.10E-11	71.2	CYTSA_RAT	reviewed	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	Specc1l Cytsa	Rattus norvegicus (Rat)	1118	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of protein kinase B signaling [GO:0051897]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]	beta-catenin binding [GO:0008013]	GO:0005737; GO:0005815; GO:0005819; GO:0005911; GO:0005921; GO:0007026; GO:0007049; GO:0007155; GO:0008013; GO:0015629; GO:0015630; GO:0016477; GO:0030036; GO:0030835; GO:0031941; GO:0034332; GO:0036032; GO:0051301; GO:0051897; GO:0061713	actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of protein kinase B signaling [GO:0051897]		NA	NA	NA	NA	NA	NA
TRINITY_DN1495_c0_g1_i1	Q2KN93	CYTSA_DANRE	42.9	231	129	2	456	1145	904	1132	3.20E-37	157.5	CYTSA_DANRE	reviewed	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	specc1la cytsa cytsaa specc1l im:7159316 si:dkey-118g10.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1132	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]; face morphogenesis [GO:0060325]	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]		GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0030036; GO:0031941; GO:0051301; GO:0060325	actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]; face morphogenesis [GO:0060325]		NA	NA	NA	NA	NA	NA
TRINITY_DN1495_c0_g1_i2	Q2KN96	CYTSA_XENTR	26	646	406	10	11	1777	471	1101	1.10E-41	172.9	CYTSA_XENTR	reviewed	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	specc1l cytsa	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1101	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]		GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0030036; GO:0031941; GO:0051301	actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN1495_c0_g1_i3	Q2KN98	CYTSA_MOUSE	31.6	453	288	6	590	1945	687	1118	7.50E-44	180.3	CYTSA_MOUSE	reviewed	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	Specc1l Cytsa Kiaa0376	Mus musculus (Mouse)	1118	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; face morphogenesis [GO:0060325]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of protein kinase B signaling [GO:0051897]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]	beta-catenin binding [GO:0008013]	GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0005911; GO:0005921; GO:0007026; GO:0007049; GO:0007155; GO:0008013; GO:0015629; GO:0015630; GO:0016477; GO:0030036; GO:0030835; GO:0031941; GO:0034332; GO:0036032; GO:0051301; GO:0051897; GO:0060325; GO:0061713	actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; face morphogenesis [GO:0060325]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of protein kinase B signaling [GO:0051897]		NA	NA	NA	NA	NA	NA
TRINITY_DN1495_c0_g1_i4	Q2KN96	CYTSA_XENTR	30.9	669	405	12	11	1960	471	1101	4.90E-43	177.6	CYTSA_XENTR	reviewed	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	specc1l cytsa	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1101	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]		GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0030036; GO:0031941; GO:0051301	actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN1495_c0_g1_i5	Q2KN98	CYTSA_MOUSE	31.4	433	254	8	590	1762	687	1118	1.10E-41	172.9	CYTSA_MOUSE	reviewed	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	Specc1l Cytsa Kiaa0376	Mus musculus (Mouse)	1118	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; face morphogenesis [GO:0060325]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of protein kinase B signaling [GO:0051897]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]	beta-catenin binding [GO:0008013]	GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0005911; GO:0005921; GO:0007026; GO:0007049; GO:0007155; GO:0008013; GO:0015629; GO:0015630; GO:0016477; GO:0030036; GO:0030835; GO:0031941; GO:0034332; GO:0036032; GO:0051301; GO:0051897; GO:0060325; GO:0061713	actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; face morphogenesis [GO:0060325]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of protein kinase B signaling [GO:0051897]		NA	NA	NA	NA	NA	NA
TRINITY_DN19465_c0_g1_i2	O43175	SERA_HUMAN	100	167	0	0	503	3	37	203	1.10E-89	330.5	SERA_HUMAN	reviewed	D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37)	PHGDH PGDH3	Homo sapiens (Human)	533	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0005829; GO:0006520; GO:0006541; GO:0006544; GO:0006564; GO:0006566; GO:0007420; GO:0009055; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0030060; GO:0031175; GO:0051287; GO:0070062; GO:0070314	brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]		NA	NA	NA	NA	NA	NA
TRINITY_DN5099_c0_g1_i1	A5GFY8	SERA_PIG	48.6	529	259	8	143	1717	4	523	1.90E-123	444.5	SERA_PIG	reviewed	D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37)	PHGDH	Sus scrofa (Pig)	533	L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; L-serine biosynthetic process [GO:0006564]		L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006520; GO:0006564; GO:0030060; GO:0051287	cellular amino acid metabolic process [GO:0006520]; L-serine biosynthetic process [GO:0006564]		blue	blue	NA	NA	NA	NA
TRINITY_DN36189_c0_g1_i1	Q61753	SERA_MOUSE	98.5	68	1	0	206	3	205	272	7.30E-32	137.1	SERA_MOUSE	reviewed	D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)	Phgdh	Mus musculus (Mouse)	533	myelin sheath [GO:0043209]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	myelin sheath [GO:0043209]	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006520; GO:0006541; GO:0006544; GO:0006563; GO:0006564; GO:0006566; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0022008; GO:0031175; GO:0043209; GO:0051287; GO:0070314	cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]		NA	NA	NA	NA	NA	NA
TRINITY_DN19465_c0_g1_i1	Q61753	SERA_MOUSE	100	167	0	0	503	3	37	203	8.50E-90	330.9	SERA_MOUSE	reviewed	D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)	Phgdh	Mus musculus (Mouse)	533	myelin sheath [GO:0043209]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	myelin sheath [GO:0043209]	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006520; GO:0006541; GO:0006544; GO:0006563; GO:0006564; GO:0006566; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0022008; GO:0031175; GO:0043209; GO:0051287; GO:0070314	cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]		NA	NA	NA	NA	NA	NA
TRINITY_DN6968_c0_g1_i1	O29445	SERA_ARCFU	59.5	79	32	0	3	239	45	123	6.80E-21	100.9	SERA_ARCFU	reviewed	D-3-phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95)	serA AF_0813	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	527	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; L-serine biosynthetic process [GO:0006564]		NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006564; GO:0051287	L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN6968_c0_g1_i2	O29445	SERA_ARCFU	58.2	79	33	0	3	239	45	123	2.00E-20	99.4	SERA_ARCFU	reviewed	D-3-phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95)	serA AF_0813	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	527	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; L-serine biosynthetic process [GO:0006564]		NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006564; GO:0051287	L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN6968_c0_g1_i3	O29445	SERA_ARCFU	59.8	82	33	0	2	247	42	123	7.50E-23	107.5	SERA_ARCFU	reviewed	D-3-phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95)	serA AF_0813	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126)	527	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; L-serine biosynthetic process [GO:0006564]		NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006564; GO:0051287	L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN30768_c0_g1_i1	P35136	SERA_BACSU	60	65	26	0	4	198	205	269	1.60E-15	82.8	SERA_BACSU	reviewed	D-3-phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399)	serA BSU23070	Bacillus subtilis (strain 168)	525	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; L-serine biosynthetic process [GO:0006564]		NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0006520; GO:0006564; GO:0051287	cellular amino acid metabolic process [GO:0006520]; L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN2571_c0_g1_i1	A3KMX8	ARMT1_BOVIN	41.4	353	198	3	1125	94	84	436	1.10E-76	288.9	ARMT1_BOVIN	reviewed	Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)	ARMT1	Bos taurus (Bovine)	441	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0006974; GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:2001020	cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		NA	NA	NA	NA	NA	NA
TRINITY_DN2571_c0_g1_i1	A3KMX8	ARMT1_BOVIN	46.5	71	38	0	1387	1175	5	75	1.00E-10	69.7	ARMT1_BOVIN	reviewed	Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)	ARMT1	Bos taurus (Bovine)	441	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0006974; GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:2001020	cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		NA	NA	NA	NA	NA	NA
TRINITY_DN2571_c0_g1_i2	Q9H993	ARMT1_HUMAN	41.1	438	243	5	1377	94	4	436	2.00E-94	347.8	ARMT1_HUMAN	reviewed	Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)	ARMT1 C6orf211	Homo sapiens (Human)	441	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0006974; GO:0008757; GO:0016791; GO:0019899; GO:0032259; GO:0046872; GO:0051998; GO:2001020	cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		NA	NA	NA	NA	NA	NA
TRINITY_DN2571_c0_g1_i3	A3KMX8	ARMT1_BOVIN	41.4	353	198	3	1125	94	84	436	1.20E-76	288.5	ARMT1_BOVIN	reviewed	Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)	ARMT1	Bos taurus (Bovine)	441	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0006974; GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:2001020	cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		NA	NA	NA	NA	NA	NA
TRINITY_DN2571_c0_g1_i4	Q9H993	ARMT1_HUMAN	50	70	35	0	327	118	4	73	3.20E-13	76.3	ARMT1_HUMAN	reviewed	Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)	ARMT1 C6orf211	Homo sapiens (Human)	441	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0006974; GO:0008757; GO:0016791; GO:0019899; GO:0032259; GO:0046872; GO:0051998; GO:2001020	cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]		NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c2_g1_i1	Q95XG9	OXDA_CAEEL	56.1	41	18	0	83	205	1	41	1.00E-07	57.4	OXDA_CAEEL	reviewed	D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)	daao-1 Y69A2AR.5	Caenorhabditis elegans	322	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid catabolic process [GO:0019478]; multicellular organism development [GO:0007275]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0007275; GO:0019478; GO:0055114; GO:0071949	D-amino acid catabolic process [GO:0019478]; multicellular organism development [GO:0007275]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c2_g1_i2	Q95XG9	OXDA_CAEEL	56.1	41	18	0	84	206	1	41	1.30E-07	57	OXDA_CAEEL	reviewed	D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)	daao-1 Y69A2AR.5	Caenorhabditis elegans	322	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid catabolic process [GO:0019478]; multicellular organism development [GO:0007275]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0007275; GO:0019478; GO:0055114; GO:0071949	D-amino acid catabolic process [GO:0019478]; multicellular organism development [GO:0007275]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i18	A2V9Y8	OXDA_MACFA	36	211	126	4	41	658	28	234	1.60E-24	115.2	OXDA_MACFA	reviewed	D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)	DAO Qlv-U252A-C12	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	347	peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid metabolic process [GO:0046416]	peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]	GO:0003884; GO:0005777; GO:0046416; GO:0071949	D-amino acid metabolic process [GO:0046416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i18	A2V9Y8	OXDA_MACFA	46.5	101	53	1	655	957	235	334	7.60E-22	106.3	OXDA_MACFA	reviewed	D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)	DAO Qlv-U252A-C12	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	347	peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid metabolic process [GO:0046416]	peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]	GO:0003884; GO:0005777; GO:0046416; GO:0071949	D-amino acid metabolic process [GO:0046416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i22	A2V9Y8	OXDA_MACFA	39.3	298	171	5	79	957	42	334	1.90E-52	208	OXDA_MACFA	reviewed	D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)	DAO Qlv-U252A-C12	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	347	peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid metabolic process [GO:0046416]	peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]	GO:0003884; GO:0005777; GO:0046416; GO:0071949	D-amino acid metabolic process [GO:0046416]		blue	blue	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i7	A2V9Y8	OXDA_MACFA	40.3	144	71	3	44	463	202	334	4.20E-25	116.3	OXDA_MACFA	reviewed	D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)	DAO Qlv-U252A-C12	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	347	peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid metabolic process [GO:0046416]	peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]	GO:0003884; GO:0005777; GO:0046416; GO:0071949	D-amino acid metabolic process [GO:0046416]		NA	NA	NA	NA	NA	NA
TRINITY_DN2248_c0_g1_i4	Q9VGP0	DTD_DROME	61.4	158	60	1	271	744	1	157	1.00E-49	198.4	DTD_DROME	reviewed	D-aminoacyl-tRNA deacylase (EC 3.1.1.96) (Gly-tRNA(Ala) deacylase) (Gly-tRNA(Gly) deacylase)	Dtd CG18643	Drosophila melanogaster (Fruit fly)	158	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; Gly-tRNA(Ala) hydrolase activity [GO:0106026]; tRNA binding [GO:0000049]; tRNA metabolic process [GO:0006399]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; Gly-tRNA(Ala) hydrolase activity [GO:0106026]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0005737; GO:0006399; GO:0051500; GO:0106026	tRNA metabolic process [GO:0006399]		blue	blue	NA	NA	NA	NA
TRINITY_DN2248_c0_g1_i5	Q9VGP0	DTD_DROME	71.4	35	10	0	93	197	123	157	5.30E-08	58.2	DTD_DROME	reviewed	D-aminoacyl-tRNA deacylase (EC 3.1.1.96) (Gly-tRNA(Ala) deacylase) (Gly-tRNA(Gly) deacylase)	Dtd CG18643	Drosophila melanogaster (Fruit fly)	158	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; Gly-tRNA(Ala) hydrolase activity [GO:0106026]; tRNA binding [GO:0000049]; tRNA metabolic process [GO:0006399]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; Gly-tRNA(Ala) hydrolase activity [GO:0106026]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0005737; GO:0006399; GO:0051500; GO:0106026	tRNA metabolic process [GO:0006399]		NA	NA	NA	NA	NA	NA
TRINITY_DN2248_c0_g1_i6	Q9VGP0	DTD_DROME	52.4	185	60	2	271	825	1	157	2.20E-45	184.1	DTD_DROME	reviewed	D-aminoacyl-tRNA deacylase (EC 3.1.1.96) (Gly-tRNA(Ala) deacylase) (Gly-tRNA(Gly) deacylase)	Dtd CG18643	Drosophila melanogaster (Fruit fly)	158	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; Gly-tRNA(Ala) hydrolase activity [GO:0106026]; tRNA binding [GO:0000049]; tRNA metabolic process [GO:0006399]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; Gly-tRNA(Ala) hydrolase activity [GO:0106026]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0005737; GO:0006399; GO:0051500; GO:0106026	tRNA metabolic process [GO:0006399]		NA	NA	NA	NA	NA	NA
TRINITY_DN8107_c0_g1_i2	P60924	DELE1_RAT	36.7	90	55	1	662	399	269	358	4.10E-05	51.2	DELE1_RAT	reviewed	"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)]"	Dele1 Dele	Rattus norvegicus (Rat)	509	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0005739; GO:0005743; GO:0005829; GO:0008625; GO:0019901; GO:0043281; GO:0043539; GO:0140467; GO:0140468	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]		NA	NA	NA	NA	NA	NA
TRINITY_DN8107_c0_g1_i4	P60924	DELE1_RAT	36.7	90	55	1	685	422	269	358	5.70E-05	51.2	DELE1_RAT	reviewed	"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)]"	Dele1 Dele	Rattus norvegicus (Rat)	509	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0005739; GO:0005743; GO:0005829; GO:0008625; GO:0019901; GO:0043281; GO:0043539; GO:0140467; GO:0140468	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i1	Q922Z0	OXDD_MOUSE	36.6	186	113	3	85	636	43	225	2.00E-24	114.8	OXDD_MOUSE	reviewed	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	Ddo	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i10	Q922Z0	OXDD_MOUSE	39.9	313	180	5	63	995	31	337	1.70E-53	211.5	OXDD_MOUSE	reviewed	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	Ddo	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]		blue	blue	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i12	Q922Z0	OXDD_MOUSE	39.6	285	156	5	1066	1914	67	337	6.60E-48	193.7	OXDD_MOUSE	reviewed	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	Ddo	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i15	Q922Z0	OXDD_MOUSE	41.1	275	156	4	1066	1884	67	337	5.30E-50	200.7	OXDD_MOUSE	reviewed	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	Ddo	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i3	Q922Z0	OXDD_MOUSE	37.5	160	97	2	1066	1539	67	225	3.50E-22	108.2	OXDD_MOUSE	reviewed	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	Ddo	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]		NA	NA	NA	NA	NA	NA
TRINITY_DN1651_c0_g1_i36	Q922Z0	OXDD_MOUSE	36.6	186	113	3	89	640	43	225	1.60E-24	115.2	OXDD_MOUSE	reviewed	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	Ddo	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005829; GO:0006531; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]		NA	NA	NA	NA	NA	NA
TRINITY_DN1629_c0_g1_i1	Q96EP5	DAZP1_HUMAN	53.8	39	18	0	169	53	11	49	3.70E-06	52	DAZP1_HUMAN	reviewed	DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1)	DAZAP1	Homo sapiens (Human)	407	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]	GO:0001893; GO:0003723; GO:0003730; GO:0005654; GO:0005829; GO:0007283; GO:0008266; GO:0008283; GO:0030154; GO:0032991; GO:0034046; GO:0035613; GO:0048026; GO:1990904	"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1629_c0_g1_i2	Q96EP5	DAZP1_HUMAN	55	40	18	0	183	64	11	50	3.90E-06	52	DAZP1_HUMAN	reviewed	DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1)	DAZAP1	Homo sapiens (Human)	407	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]	GO:0001893; GO:0003723; GO:0003730; GO:0005654; GO:0005829; GO:0007283; GO:0008266; GO:0008283; GO:0030154; GO:0032991; GO:0034046; GO:0035613; GO:0048026; GO:1990904	"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1629_c0_g1_i3	Q96EP5	DAZP1_HUMAN	52.4	42	20	0	214	89	11	52	2.00E-06	53.1	DAZP1_HUMAN	reviewed	DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1)	DAZAP1	Homo sapiens (Human)	407	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]	GO:0001893; GO:0003723; GO:0003730; GO:0005654; GO:0005829; GO:0007283; GO:0008266; GO:0008283; GO:0030154; GO:0032991; GO:0034046; GO:0035613; GO:0048026; GO:1990904	"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38301_c0_g1_i1	Q02338	BDH_HUMAN	100	99	0	0	299	3	153	251	2.70E-51	202.2	BDH_HUMAN	reviewed	"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1)"	BDH1 BDH SDR9C1	Homo sapiens (Human)	343	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-hydroxybutyrate dehydrogenase activity [GO:0003858]	GO:0003858; GO:0005654; GO:0005739; GO:0005759; GO:0046951; GO:0046952; GO:0099617	ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]		NA	NA	NA	NA	NA	NA
TRINITY_DN2705_c0_g1_i2	Q02338	BDH_HUMAN	36	289	177	5	1072	224	56	342	3.30E-45	184.1	BDH_HUMAN	reviewed	"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1)"	BDH1 BDH SDR9C1	Homo sapiens (Human)	343	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-hydroxybutyrate dehydrogenase activity [GO:0003858]	GO:0003858; GO:0005654; GO:0005739; GO:0005759; GO:0046951; GO:0046952; GO:0099617	ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]		NA	NA	NA	NA	NA	NA
TRINITY_DN11456_c0_g1_i1	Q5TZ24	MOXD1_DANRE	42.3	130	75	0	5	394	27	156	5.80E-23	108.6	MOXD1_DANRE	reviewed	DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)	moxd1 si:ch211-193l17.1 si:dkey-266k12.5 si:dkeyp-119b4.5	Danio rerio (Zebrafish) (Brachydanio rerio)	614	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN12825_c0_g1_i1	Q08CS6	MOXD2_DANRE	40.9	93	54	1	15	290	301	393	9.40E-17	87.4	MOXD2_DANRE	reviewed	DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)	moxd2 moxd1l si:ch211-203k16.5	Danio rerio (Zebrafish) (Brachydanio rerio)	572	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN12825_c0_g1_i2	Q08CS6	MOXD2_DANRE	47	66	35	0	15	212	301	366	9.70E-14	77.4	MOXD2_DANRE	reviewed	DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)	moxd2 moxd1l si:ch211-203k16.5	Danio rerio (Zebrafish) (Brachydanio rerio)	572	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		brown	brown	NA	NA	NA	NA
TRINITY_DN3005_c0_g1_i1	Q9UKG1	DP13A_HUMAN	32.3	705	429	13	2022	13	5	696	2.00E-92	341.7	DP13A_HUMAN	reviewed	"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)"	APPL1 APPL DIP13A KIAA1428	Homo sapiens (Human)	709	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]	beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]	GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0070062; GO:0097192; GO:0097708; GO:1900017; GO:1903076; GO:1905303; GO:1905450; GO:2000045	adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signaling [GO:0023052]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN3005_c0_g1_i5	Q9UKG1	DP13A_HUMAN	32.6	699	429	12	2004	13	5	696	2.80E-94	347.8	DP13A_HUMAN	reviewed	"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)"	APPL1 APPL DIP13A KIAA1428	Homo sapiens (Human)	709	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]	beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]	GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0070062; GO:0097192; GO:0097708; GO:1900017; GO:1903076; GO:1905303; GO:1905450; GO:2000045	adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signaling [GO:0023052]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN3005_c0_g1_i7	Q9UKG1	DP13A_HUMAN	31.6	586	354	12	1665	13	123	696	7.60E-66	253.1	DP13A_HUMAN	reviewed	"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)"	APPL1 APPL DIP13A KIAA1428	Homo sapiens (Human)	709	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]	beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]	GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0070062; GO:0097192; GO:0097708; GO:1900017; GO:1903076; GO:1905303; GO:1905450; GO:2000045	adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signaling [GO:0023052]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN3005_c0_g1_i9	Q9UKG1	DP13A_HUMAN	31.9	580	354	11	1647	13	123	696	8.10E-68	259.6	DP13A_HUMAN	reviewed	"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)"	APPL1 APPL DIP13A KIAA1428	Homo sapiens (Human)	709	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]	beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]	GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0070062; GO:0097192; GO:0097708; GO:1900017; GO:1903076; GO:1905303; GO:1905450; GO:2000045	adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signaling [GO:0023052]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN25072_c0_g1_i1	Q96GG9	DCNL1_HUMAN	99.2	133	1	0	400	2	1	133	4.60E-71	268.5	DCNL1_HUMAN	reviewed	DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene)	DCUN1D1 DCN1 DCUN1L1 RP42 SCCRO	Homo sapiens (Human)	259	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0031396; GO:0031624; GO:0032182; GO:0043687; GO:0045116; GO:0051443; GO:0097602; GO:2000434; GO:2000436	positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396]		NA	NA	NA	NA	NA	NA
TRINITY_DN32061_c0_g1_i1	Q5ZKU1	DCNL1_CHICK	49.1	55	28	0	10	174	196	250	4.90E-11	68.2	DCNL1_CHICK	reviewed	DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1)	DCUN1D1 DCUN1L1 RCJMB04_9c8	Gallus gallus (Chicken)	259	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]	cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]	GO:0000151; GO:0005654; GO:0005829; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000436	positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN25820_c0_g1_i1	Q5ZKU1	DCNL1_CHICK	100	126	0	0	430	53	134	259	9.90E-71	267.3	DCNL1_CHICK	reviewed	DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1)	DCUN1D1 DCUN1L1 RCJMB04_9c8	Gallus gallus (Chicken)	259	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]	cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]	GO:0000151; GO:0005654; GO:0005829; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000436	positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN3455_c0_g1_i1	Q6PH85	DCNL2_HUMAN	70.4	253	74	1	86	841	1	253	4.60E-105	382.5	DCNL2_HUMAN	reviewed	DCN1-like protein 2 (DCNL2) (DCUN1 domain-containing protein 2) (Defective in cullin neddylation protein 1-like protein 2)	DCUN1D2 C13orf17 DCUN1L2	Homo sapiens (Human)	259	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]	GO:0000151; GO:0005634; GO:0005737; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000434; GO:2000436	positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]		blue	blue	NA	NA	NA	NA
TRINITY_DN8914_c0_g1_i1	Q8K0V2	DCNL3_MOUSE	46.6	268	136	3	891	97	22	285	1.30E-62	241.5	DCNL3_MOUSE	reviewed	DCN1-like protein 3 (DCNL3) (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3)	Dcun1d3	Mus musculus (Mouse)	304	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]	GO:0000151; GO:0005634; GO:0005737; GO:0005886; GO:0010225; GO:0010332; GO:0010564; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0051443; GO:0097602; GO:2000134; GO:2000434; GO:2000435; GO:2000436	negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]		NA	NA	NA	NA	NA	NA
TRINITY_DN32493_c0_g1_i1	Q9BTE7	DCNL5_HUMAN	100	55	0	0	1	165	183	237	6.10E-27	120.9	DCNL5_HUMAN	reviewed	DCN1-like protein 5 (DCNL5) (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5) (Squamous cell carcinoma-related oncogene 5)	DCUN1D5 SCCRO5	Homo sapiens (Human)	237	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell growth [GO:0001558]; regulation of protein neddylation [GO:2000434]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]	GO:0000151; GO:0001558; GO:0005634; GO:0006974; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000434; GO:2000436	cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell growth [GO:0001558]; regulation of protein neddylation [GO:2000434]		NA	NA	NA	NA	NA	NA
TRINITY_DN19329_c0_g2_i1	Q80TR8	DCAF1_MOUSE	38	589	315	13	81	1781	9	569	1.30E-100	368.6	DCAF1_MOUSE	reviewed	DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1)	Dcaf1 Kiaa0800 Vprbp	Mus musculus (Mouse)	1506	COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]	COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]	GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0016032; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0080008; GO:1990244; GO:1990245	B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN37423_c0_g1_i1	Q5QP82	DCA10_HUMAN	98.6	74	1	0	224	3	269	342	1.30E-37	156.4	DCA10_HUMAN	reviewed	DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32)	DCAF10 WDR32	Homo sapiens (Human)	559	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]		GO:0005654; GO:0016567; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN14598_c0_g1_i1	Q9VAT2	DCA10_DROME	48.8	80	41	0	257	18	166	245	4.70E-16	85.5	DCA10_DROME	reviewed	DDB1- and CUL4-associated factor 10 homolog (WD repeat-containing protein 32 homolog)	CG1523	Drosophila melanogaster (Fruit fly)	621	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]		GO:0080008			NA	NA	NA	NA	NA	NA
TRINITY_DN14598_c0_g1_i2	Q9VAT2	DCA10_DROME	54.3	197	90	0	608	18	49	245	4.00E-63	242.7	DCA10_DROME	reviewed	DDB1- and CUL4-associated factor 10 homolog (WD repeat-containing protein 32 homolog)	CG1523	Drosophila melanogaster (Fruit fly)	621	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]		GO:0080008			NA	NA	NA	NA	NA	NA
TRINITY_DN21365_c0_g1_i1	Q5T6F0	DCA12_HUMAN	43.8	176	87	4	534	43	277	452	4.30E-39	162.5	DCA12_HUMAN	reviewed	DDB1- and CUL4-associated factor 12 (Centrosome-related protein TCC52) (Testis cancer centrosome-related protein) (WD repeat-containing protein 40A)	DCAF12 KIAA1892 TCC52 WDR40A	Homo sapiens (Human)	453	centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]	centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]		GO:0005737; GO:0005813; GO:0016567; GO:0080008	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN30110_c0_g1_i1	Q6PAC3	DCA13_MOUSE	100	95	0	0	2	286	65	159	5.60E-54	211.1	DCA13_MOUSE	reviewed	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	Dcaf13 Gm83 Wdsof1	Mus musculus (Mouse)	445	"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"	cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	estrogen receptor binding [GO:0030331]	GO:0000462; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0080008	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18871_c0_g1_i1	Q7ZYQ6	DCA13_XENLA	54.1	74	34	0	223	2	352	425	5.20E-15	81.3	DCA13_XENLA	reviewed	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	dcaf13 wdsof1	Xenopus laevis (African clawed frog)	445	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]		GO:0005730; GO:0006364; GO:0016567; GO:0080008	protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN18871_c0_g2_i1	Q9NV06	DCA13_HUMAN	60.3	73	29	0	220	2	266	338	1.80E-20	99.4	DCA13_HUMAN	reviewed	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	DCAF13 WDSOF1 HSPC064	Homo sapiens (Human)	445	"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]"	cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006364; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0043687; GO:0080008	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40116_c0_g1_i1	Q9NV06	DCA13_HUMAN	100	215	0	0	646	2	209	423	2.70E-120	432.6	DCA13_HUMAN	reviewed	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	DCAF13 WDSOF1 HSPC064	Homo sapiens (Human)	445	"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]"	cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006364; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0043687; GO:0080008	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1568_c1_g1_i1	Q6NVS5	DCA13_XENTR	51	451	210	4	1647	301	2	443	6.70E-134	479.2	DCA13_XENTR	reviewed	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	dcaf13 wdsof1 TEgg103a13.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	445	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005730; GO:0016567; GO:0032040; GO:0080008	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37260_c0_g1_i1	Q6PAC3	DCA13_MOUSE	100	103	0	0	309	1	274	376	2.10E-54	212.6	DCA13_MOUSE	reviewed	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	Dcaf13 Gm83 Wdsof1	Mus musculus (Mouse)	445	"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"	cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	estrogen receptor binding [GO:0030331]	GO:0000462; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0080008	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6945_c0_g1_i1	Q66K64	DCA15_HUMAN	31.2	205	116	4	2807	2214	78	264	2.20E-25	119.4	DCA15_HUMAN	reviewed	DDB1- and CUL4-associated factor 15	DCAF15 C19orf72	Homo sapiens (Human)	600	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; metal ion binding [GO:0046872]; small molecule binding [GO:0036094]; immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]	metal ion binding [GO:0046872]; small molecule binding [GO:0036094]	GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0036094; GO:0046872; GO:0080008	immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6945_c0_g1_i2	Q66K64	DCA15_HUMAN	31.2	205	116	4	2765	2172	78	264	2.10E-25	119.4	DCA15_HUMAN	reviewed	DDB1- and CUL4-associated factor 15	DCAF15 C19orf72	Homo sapiens (Human)	600	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; metal ion binding [GO:0046872]; small molecule binding [GO:0036094]; immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]	metal ion binding [GO:0046872]; small molecule binding [GO:0036094]	GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0036094; GO:0046872; GO:0080008	immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6945_c0_g1_i3	Q66K64	DCA15_HUMAN	31.2	205	116	4	1998	1405	78	264	1.50E-25	119.4	DCA15_HUMAN	reviewed	DDB1- and CUL4-associated factor 15	DCAF15 C19orf72	Homo sapiens (Human)	600	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; metal ion binding [GO:0046872]; small molecule binding [GO:0036094]; immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]	metal ion binding [GO:0046872]; small molecule binding [GO:0036094]	GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0036094; GO:0046872; GO:0080008	immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814]		NA	NA	NA	NA	NA	NA
TRINITY_DN39998_c0_g1_i1	Q96JK2	DCAF5_HUMAN	100	77	0	0	234	4	383	459	3.00E-37	155.2	DCAF5_HUMAN	reviewed	DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22)	DCAF5 BCRG2 KIAA1824 WDR22	Homo sapiens (Human)	942	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005737; GO:0016567; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN23487_c0_g2_i1	Q96JK2	DCAF5_HUMAN	100	173	0	0	521	3	212	384	3.40E-102	372.1	DCAF5_HUMAN	reviewed	DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22)	DCAF5 BCRG2 KIAA1824 WDR22	Homo sapiens (Human)	942	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005737; GO:0016567; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN23487_c0_g1_i1	Q96JK2	DCAF5_HUMAN	100	76	0	0	230	3	327	402	7.40E-41	167.2	DCAF5_HUMAN	reviewed	DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22)	DCAF5 BCRG2 KIAA1824 WDR22	Homo sapiens (Human)	942	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005737; GO:0016567; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN39546_c0_g1_i1	Q96JK2	DCAF5_HUMAN	99.1	117	0	1	348	1	26	142	3.20E-64	245.4	DCAF5_HUMAN	reviewed	DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22)	DCAF5 BCRG2 KIAA1824 WDR22	Homo sapiens (Human)	942	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005737; GO:0016567; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5727_c0_g1_i1	Q80T85	DCAF5_MOUSE	59.6	411	157	4	1342	122	30	435	7.40E-145	515.4	DCAF5_MOUSE	reviewed	DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22)	Dcaf5 Kiaa1824 Wdr22	Mus musculus (Mouse)	946	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]		GO:0005737; GO:0005739; GO:0016567; GO:0080008	protein ubiquitination [GO:0016567]		blue	blue	NA	NA	NA	NA
TRINITY_DN11709_c0_g2_i1	Q58WW2	DCAF6_HUMAN	51.8	83	39	1	23	268	124	206	5.20E-22	104.8	DCAF6_HUMAN	reviewed	DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP)	DCAF6 IQWD1 MSTP055	Homo sapiens (Human)	860	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0016567; GO:0030374; GO:0043687; GO:0045944; GO:0080008	positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		blue	blue	NA	NA	NA	NA
TRINITY_DN11674_c0_g1_i1	P61962	DCAF7_HUMAN	100	317	0	0	998	48	26	342	6.60E-195	681	DCAF7_HUMAN	reviewed	DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)	DCAF7 HAN11 WDR68	Homo sapiens (Human)	342	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0043687; GO:0080008	multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN21164_c0_g1_i1	P61962	DCAF7_HUMAN	100	77	0	0	231	1	264	340	8.70E-43	173.7	DCAF7_HUMAN	reviewed	DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)	DCAF7 HAN11 WDR68	Homo sapiens (Human)	342	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0043687; GO:0080008	multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5075_c0_g1_i1	P61962	DCAF7_HUMAN	86.8	280	36	1	868	29	7	285	9.60E-150	530.8	DCAF7_HUMAN	reviewed	DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)	DCAF7 HAN11 WDR68	Homo sapiens (Human)	342	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0043687; GO:0080008	multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5075_c0_g1_i2	P61962	DCAF7_HUMAN	86.7	338	43	2	1076	63	7	342	8.20E-183	641	DCAF7_HUMAN	reviewed	DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)	DCAF7 HAN11 WDR68	Homo sapiens (Human)	342	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0043687; GO:0080008	multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN30430_c0_g1_i1	Q68FI3	DOPDA_XENLA	38.3	115	70	1	350	9	1	115	2.70E-14	79.7	DOPDA_XENLA	reviewed	D-dopachrome decarboxylase-A (EC 4.1.1.84) (D-dopachrome tautomerase-A)	ddt-a	Xenopus laevis (African clawed frog)	118	cytoplasm [GO:0005737]; D-dopachrome decarboxylase activity [GO:0033981]; melanin biosynthetic process [GO:0042438]	cytoplasm [GO:0005737]	D-dopachrome decarboxylase activity [GO:0033981]	GO:0005737; GO:0033981; GO:0042438	melanin biosynthetic process [GO:0042438]		NA	NA	NA	NA	NA	NA
TRINITY_DN29345_c0_g1_i1	A2XVF7	RH13_ORYSI	49	100	29	3	2	238	205	303	2.10E-14	79.3	RH13_ORYSI	reviewed	DEAD-box ATP-dependent RNA helicase 13 (EC 3.6.4.13)	OsI_016050 OSIGBa0157K09-H0214G12.9	Oryza sativa subsp. indica (Rice)	832	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN5974_c0_g1_i1	Q5VQL1	RH14_ORYSJ	53.8	104	47	1	315	4	190	292	9.70E-26	117.5	RH14_ORYSJ	reviewed	DEAD-box ATP-dependent RNA helicase 14 (EC 3.6.4.13)	Os01g0172200 LOC_Os01g07740 P0583G08.30-1 P0583G08.30-2	Oryza sativa subsp. japonica (Rice)	708	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16781_c0_g1_i1	Q8H136	RH14_ARATH	49.6	121	60	1	1	360	416	536	1.20E-27	124	RH14_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 14 (EC 3.6.4.13)	RH14 DRH1 At3g01540 F4P13.9	Arabidopsis thaliana (Mouse-ear cress)	619	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0016887; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		red	red	NA	NA	NA	NA
TRINITY_DN1484_c0_g1_i1	Q56XG6	RH15_ARATH	68.9	392	119	1	1231	56	37	425	8.40E-155	548.1	RH15_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 15 (EC 3.6.4.13) (UAP56 homolog A)	RH15 UAP56A At5g11170 F2I11.60	Arabidopsis thaliana (Mouse-ear cress)	427	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; response to cadmium ion [GO:0046686]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]	GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005829; GO:0006397; GO:0008380; GO:0009506; GO:0016887; GO:0046686; GO:0051028	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; response to cadmium ion [GO:0046686]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN30056_c0_g1_i1	Q56XG6	RH15_ARATH	64.8	392	134	3	2	1174	37	425	5.50E-140	498.8	RH15_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 15 (EC 3.6.4.13) (UAP56 homolog A)	RH15 UAP56A At5g11170 F2I11.60	Arabidopsis thaliana (Mouse-ear cress)	427	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; response to cadmium ion [GO:0046686]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]	GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005829; GO:0006397; GO:0008380; GO:0009506; GO:0016887; GO:0046686; GO:0051028	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; response to cadmium ion [GO:0046686]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24166_c0_g2_i1	Q5QMN3	RH20_ORYSJ	66	159	54	0	6	482	308	466	1.10E-57	224.2	RH20_ORYSJ	reviewed	DEAD-box ATP-dependent RNA helicase 20 (EC 3.6.4.13)	Os01g0197200 LOC_Os01g10050 P0419B01.12	Oryza sativa subsp. japonica (Rice)	494	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		red	red	NA	NA	NA	NA
TRINITY_DN24033_c0_g1_i1	Q9C718	RH20_ARATH	54.4	103	43	1	314	6	373	471	5.10E-25	115.2	RH20_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 20 (EC 3.6.4.13)	RH20 At1g55150 T7N22.9	Arabidopsis thaliana (Mouse-ear cress)	501	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28528_c0_g1_i1	Q9C718	RH20_ARATH	59.5	111	40	1	340	8	360	465	7.10E-32	137.9	RH20_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 20 (EC 3.6.4.13)	RH20 At1g55150 T7N22.9	Arabidopsis thaliana (Mouse-ear cress)	501	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31730_c0_g1_i1	Q9C718	RH20_ARATH	64.1	153	55	0	9	467	318	470	7.00E-54	211.5	RH20_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 20 (EC 3.6.4.13)	RH20 At1g55150 T7N22.9	Arabidopsis thaliana (Mouse-ear cress)	501	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13598_c0_g1_i1	P93008	RH21_ARATH	53.9	154	70	1	44	505	278	430	2.20E-45	183.3	RH21_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 21 (EC 3.6.4.13)	RH21 At2g33730 T1B8.4	Arabidopsis thaliana (Mouse-ear cress)	733	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of primary miRNA processing [GO:2000636]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0071013; GO:1903800; GO:2000636	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of primary miRNA processing [GO:2000636]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13598_c0_g3_i1	P93008	RH21_ARATH	57.7	111	40	1	3	335	442	545	8.70E-30	131	RH21_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 21 (EC 3.6.4.13)	RH21 At2g33730 T1B8.4	Arabidopsis thaliana (Mouse-ear cress)	733	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of primary miRNA processing [GO:2000636]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0071013; GO:1903800; GO:2000636	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of primary miRNA processing [GO:2000636]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17969_c0_g1_i1	O22907	RH24_ARATH	56.1	132	57	1	393	1	329	460	7.70E-38	157.9	RH24_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 24 (EC 3.6.4.13)	RH24 At2g47330 T8I13.17	Arabidopsis thaliana (Mouse-ear cress)	760	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN24035_c0_g2_i1	Q9ZRZ8	RH28_ARATH	47.8	115	60	0	1	345	426	540	2.40E-27	122.9	RH28_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 28 (EC 3.6.4.13)	RH28 At4g16630 dl4340c FCAALL.424	Arabidopsis thaliana (Mouse-ear cress)	789	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN16368_c0_g1_i1	Q8W4R3	RH30_ARATH	50	98	49	0	299	6	440	537	1.70E-24	113.2	RH30_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 30 (EC 3.6.4.13)	RH30 At5g63120 MDC12.8	Arabidopsis thaliana (Mouse-ear cress)	591	"nucleus [GO:0005634]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	nucleus [GO:0005634]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0006364	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12434_c0_g1_i1	Q9C8J1	RH34_ARATH	60.3	68	27	0	34	237	298	365	4.60E-16	85.1	RH34_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 34 (AtRH34) (EC 3.6.4.13)	RH34 At1g51380 F11M15.24 F5D21.11	Arabidopsis thaliana (Mouse-ear cress)	392	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005730; GO:0006364; GO:0071013	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN29966_c0_g1_i1	Q9LU46	RH35_ARATH	45.6	68	37	0	230	27	440	507	1.10E-13	77	RH35_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 35 (EC 3.6.4.13)	RH35 At5g51280 MWD22.23	Arabidopsis thaliana (Mouse-ear cress)	591	"spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0008270	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6211_c0_g1_i1	Q9LU46	RH35_ARATH	64.6	178	59	2	539	18	413	590	8.90E-61	234.6	RH35_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 35 (EC 3.6.4.13)	RH35 At5g51280 MWD22.23	Arabidopsis thaliana (Mouse-ear cress)	591	"spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0008270	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19233_c0_g2_i1	Q75HJ0	RH37_ORYSJ	70.5	78	23	0	268	35	464	541	1.90E-24	112.8	RH37_ORYSJ	reviewed	DEAD-box ATP-dependent RNA helicase 37 (EC 3.6.4.13) (OsPL10a)	PL10A Os03g0805200 LOC_Os03g59050 OsJ_13017 OSJNBb0015I02.14	Oryza sativa subsp. japonica (Rice)	637	nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0043186			NA	NA	NA	NA	NA	NA
TRINITY_DN39476_c0_g1_i1	Q5JKF2	RH40_ORYSJ	55.2	181	81	0	551	9	168	348	1.30E-54	214.2	RH40_ORYSJ	reviewed	DEAD-box ATP-dependent RNA helicase 40 (EC 3.6.4.13)	Os01g0549400 LOC_Os01g36860 B1156H12.12-1 B1156H12.12-2 OsJ_02174	Oryza sativa subsp. japonica (Rice)	792	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24604_c0_g1_i1	Q8H0U8	RH42_ARATH	53.5	172	80	0	6	521	724	895	4.90E-48	192.2	RH42_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 42 (EC 3.6.4.13) (DEAD-box RNA helicase RCF1) (REGULATOR OF CBF GENE EXPRESSION 1)	RH42 RCF1 At1g20920 F9H16.10	Arabidopsis thaliana (Mouse-ear cress)	1166	"nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25456_c0_g1_i1	Q9C551	RH5_ARATH	55.2	96	40	1	40	327	396	488	2.50E-21	102.8	RH5_ARATH	reviewed	DEAD-box ATP-dependent RNA helicase 5 (EC 3.6.4.13)	RH5 At1g31970 F5M6.3 T12O21.12	Arabidopsis thaliana (Mouse-ear cress)	537	cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005829; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN35153_c0_g1_i1	Q0ILZ4	RH9_ORYSJ	50.7	71	34	1	216	4	226	295	5.60E-14	77.8	RH9_ORYSJ	reviewed	DEAD-box ATP-dependent RNA helicase 9 (EC 3.6.4.13)	Os12g0611200 LOC_Os12g41715	Oryza sativa subsp. japonica (Rice)	628	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; Group II intron splicing [GO:0000373]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000373; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364	Group II intron splicing [GO:0000373]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5252_c0_g1_i1	Q65N62	CSHA_BACLD	60.2	83	33	0	252	4	268	350	6.90E-24	110.9	CSHA_BACLD	reviewed	DEAD-box ATP-dependent RNA helicase CshA (EC 3.6.4.13)	cshA BLi00546 BL02197	Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / NBRC 12200 / NCIMB 9375 / NRRL NRS-1264 / Gibson 46)	487	bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA catabolic process [GO:0006401]; RNA secondary structure unwinding [GO:0010501]	bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0006401; GO:0010501; GO:0043590	RNA catabolic process [GO:0006401]; RNA secondary structure unwinding [GO:0010501]		NA	NA	NA	NA	NA	NA
TRINITY_DN7385_c0_g1_i1	Q5L3G9	CSHA_GEOKA	57.9	95	40	0	1	285	270	364	9.80E-27	120.6	CSHA_GEOKA	reviewed	DEAD-box ATP-dependent RNA helicase CshA (EC 3.6.4.13)	cshA GK0226	Geobacillus kaustophilus (strain HTA426)	467	bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA catabolic process [GO:0006401]; RNA secondary structure unwinding [GO:0010501]	bacterial nucleoid [GO:0043590]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0006401; GO:0010501; GO:0043590	RNA catabolic process [GO:0006401]; RNA secondary structure unwinding [GO:0010501]		NA	NA	NA	NA	NA	NA
TRINITY_DN29027_c0_g1_i1	B9XXL6	RHPA_HELP8	57.6	66	28	0	200	3	22	87	2.30E-14	79	RHPA_HELP8	reviewed	DEAD-box ATP-dependent RNA helicase RhpA (EC 3.6.4.13)	rhpA HPB128_21g22	Helicobacter pylori (strain B128)	492	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN4895_c0_g1_i1	O61305	DDX19_DROME	55.1	432	192	2	1388	96	29	459	1.70E-134	481.1	DDX19_DROME	reviewed	DEAD-box helicase Dbp80 (EC 3.6.4.13)	Dbp80 Hel40 HEL80 CG17023	Drosophila melanogaster (Fruit fly)	460	cytoplasmic stress granule [GO:0010494]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasmic stress granule [GO:0010494]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016973; GO:0044614	poly(A)+ mRNA export from nucleus [GO:0016973]		blue	blue	NA	NA	NA	NA
TRINITY_DN33987_c0_g1_i1	O61305	DDX19_DROME	51.5	101	48	1	39	338	350	450	1.80E-22	106.7	DDX19_DROME	reviewed	DEAD-box helicase Dbp80 (EC 3.6.4.13)	Dbp80 Hel40 HEL80 CG17023	Drosophila melanogaster (Fruit fly)	460	cytoplasmic stress granule [GO:0010494]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasmic stress granule [GO:0010494]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016973; GO:0044614	poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN35204_c0_g1_i1	Q86X76	NIT1_HUMAN	100	80	0	0	242	3	209	288	3.50E-41	168.3	NIT1_HUMAN	reviewed	Deaminated glutathione amidase (dGSH amidase) (EC 3.5.1.128) (Nitrilase homolog 1)	NIT1	Homo sapiens (Human)	327	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; nitrilase activity [GO:0000257]; nitrogen compound metabolic process [GO:0006807]"	mitochondrion [GO:0005739]; nucleus [GO:0005634]	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; nitrilase activity [GO:0000257]"	GO:0000257; GO:0005634; GO:0005739; GO:0006807; GO:0016811	nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN34927_c0_g1_i1	Q32LH4	NIT1_BOVIN	50	76	38	0	228	1	234	309	3.20E-15	82	NIT1_BOVIN	reviewed	Deaminated glutathione amidase (dGSH amidase) (EC 3.5.1.128) (Nitrilase homolog 1)	NIT1	Bos taurus (Bovine)	328	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]; nitrogen compound metabolic process [GO:0006807]	mitochondrion [GO:0005739]	hydrolase activity [GO:0016787]	GO:0005739; GO:0006807; GO:0016787	nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN3957_c0_g1_i1	Q24306	DIAP1_DROME	34.1	276	127	5	1063	374	39	305	2.40E-44	181.4	DIAP1_DROME	reviewed	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	Diap1 Iap1 th CG12284	Drosophila melanogaster (Fruit fly)	438	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle microtubule [GO:0005876]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of JNK cascade [GO:0046329]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle microtubule [GO:0005876]	caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0005876; GO:0006915; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046329; GO:0046673; GO:0048471; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0090307; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of JNK cascade [GO:0046329]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN30734_c0_g1_i1	Q9QX67	DAP1_RAT	35	117	55	4	15	347	1	102	4.50E-07	55.8	DAP1_RAT	reviewed	Death-associated protein 1 (DAP-1) (Rap7a)	Dap Rap7a	Rattus norvegicus (Rat)	102	"death domain binding [GO:0070513]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]"		death domain binding [GO:0070513]	GO:0006914; GO:0006915; GO:0006919; GO:0010507; GO:0032088; GO:0034198; GO:0045892; GO:0070513; GO:0097190	"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]"		blue	blue	NA	NA	NA	NA
TRINITY_DN29257_c0_g1_i1	P53355	DAPK1_HUMAN	100	72	0	0	1	216	200	271	1.10E-33	143.3	DAPK1_HUMAN	reviewed	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	DAPK1 DAPK	Homo sapiens (Human)	1430	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]		NA	NA	NA	NA	NA	NA
TRINITY_DN249_c0_g1_i1	P53355	DAPK1_HUMAN	40.8	1354	744	18	3982	41	10	1346	2.20E-284	980.3	DAPK1_HUMAN	reviewed	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	DAPK1 DAPK	Homo sapiens (Human)	1430	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]		NA	NA	NA	NA	NA	NA
TRINITY_DN249_c0_g1_i5	P53355	DAPK1_HUMAN	39.2	1354	700	19	3784	41	10	1346	1.90E-266	920.6	DAPK1_HUMAN	reviewed	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	DAPK1 DAPK	Homo sapiens (Human)	1430	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]		NA	NA	NA	NA	NA	NA
TRINITY_DN249_c0_g1_i2	O44997	DAPK_CAEEL	36.8	299	168	7	907	38	1057	1343	2.60E-45	184.1	DAPK_CAEEL	reviewed	Death-associated protein kinase dapk-1 (EC 2.7.11.1)	dapk-1 mor-3 tag-119 K12C11.4	Caenorhabditis elegans	1425	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005634; GO:0005829; GO:0005856; GO:0007275; GO:0035556; GO:0043065; GO:0045087; GO:0046872	innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN3613_c0_g1_i1	Q0KHT7	DAPKR_DROME	49.1	283	140	1	55	891	32	314	8.90E-73	276.2	DAPKR_DROME	reviewed	Death-associated protein kinase related (EC 2.7.11.1)	Drak CG32666	Drosophila melanogaster (Fruit fly)	674	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; morphogenesis of an epithelium [GO:0002009]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002009; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0007476; GO:0007480; GO:0035556; GO:0043065	imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; morphogenesis of an epithelium [GO:0002009]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]		blue	blue	NA	NA	NA	NA
TRINITY_DN26702_c0_g2_i1	Q0KHT7	DAPKR_DROME	60.9	179	70	0	30	566	117	295	3.40E-58	226.1	DAPKR_DROME	reviewed	Death-associated protein kinase related (EC 2.7.11.1)	Drak CG32666	Drosophila melanogaster (Fruit fly)	674	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; morphogenesis of an epithelium [GO:0002009]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002009; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0007476; GO:0007480; GO:0035556; GO:0043065	imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; morphogenesis of an epithelium [GO:0002009]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN34834_c0_g1_i1	Q0KHT7	DAPKR_DROME	54.6	97	44	0	2	292	27	123	5.90E-19	94.7	DAPKR_DROME	reviewed	Death-associated protein kinase related (EC 2.7.11.1)	Drak CG32666	Drosophila melanogaster (Fruit fly)	674	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; morphogenesis of an epithelium [GO:0002009]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002009; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0007476; GO:0007480; GO:0035556; GO:0043065	imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular signal transduction [GO:0035556]; morphogenesis of an epithelium [GO:0002009]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN36068_c0_g1_i1	Q9BTC0	DIDO1_HUMAN	60	60	24	0	206	27	260	319	2.30E-20	99	DIDO1_HUMAN	reviewed	Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1)	DIDO1 C20orf158 DATF1 KIAA0333	Homo sapiens (Human)	2240	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190	"apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11421_c0_g1_i1	Q24298	CADE_DROME	54.3	46	21	0	327	190	849	894	1.50E-08	60.5	CADE_DROME	reviewed	DE-cadherin (Protein shotgun)	shg E-cadherin CG3722	Drosophila melanogaster (Fruit fly)	1507	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; spot adherens junction [GO:0005914]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; brain development [GO:0007420]; branch fusion, open tracheal system [GO:0035147]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; determination of digestive tract left/right asymmetry [GO:0071907]; female germ-line stem cell population maintenance [GO:0036099]; gastrulation involving germ band extension [GO:0010004]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; head involution [GO:0008258]; heart development [GO:0007507]; hemocyte migration [GO:0035099]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; male germline stem cell symmetric division [GO:0098730]; morphogenesis of a polarized epithelium [GO:0001738]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; optic lobe placode development [GO:0001748]; outflow tract morphogenesis [GO:0003151]; positive regulation of border follicle cell migration [GO:1903688]; salivary gland morphogenesis [GO:0007435]; segment specification [GO:0007379]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wound healing [GO:0042060]; zonula adherens assembly [GO:0045186]"	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; spot adherens junction [GO:0005914]	beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; protein homodimerization activity [GO:0042803]	GO:0000902; GO:0001738; GO:0001745; GO:0001748; GO:0003151; GO:0005509; GO:0005886; GO:0005887; GO:0005912; GO:0005914; GO:0005938; GO:0007155; GO:0007156; GO:0007281; GO:0007298; GO:0007370; GO:0007379; GO:0007399; GO:0007409; GO:0007420; GO:0007424; GO:0007435; GO:0007506; GO:0007507; GO:0008013; GO:0008258; GO:0008354; GO:0008356; GO:0008406; GO:0010004; GO:0016318; GO:0016324; GO:0016339; GO:0016342; GO:0017022; GO:0030031; GO:0030175; GO:0030720; GO:0035019; GO:0035099; GO:0035147; GO:0035160; GO:0035212; GO:0035262; GO:0036099; GO:0042060; GO:0042803; GO:0043296; GO:0044331; GO:0045176; GO:0045186; GO:0048477; GO:0050832; GO:0055037; GO:0071907; GO:0090254; GO:0098609; GO:0098730; GO:1903688	"apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; brain development [GO:0007420]; branch fusion, open tracheal system [GO:0035147]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell competition in a multicellular organism [GO:0035212]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; determination of digestive tract left/right asymmetry [GO:0071907]; female germ-line stem cell population maintenance [GO:0036099]; gastrulation involving germ band extension [GO:0010004]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; head involution [GO:0008258]; heart development [GO:0007507]; hemocyte migration [GO:0035099]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; male germline stem cell symmetric division [GO:0098730]; morphogenesis of a polarized epithelium [GO:0001738]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; optic lobe placode development [GO:0001748]; outflow tract morphogenesis [GO:0003151]; positive regulation of border follicle cell migration [GO:1903688]; salivary gland morphogenesis [GO:0007435]; segment specification [GO:0007379]; somatic stem cell population maintenance [GO:0035019]; ventral furrow formation [GO:0007370]; wound healing [GO:0042060]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29901_c0_g1_i1	O70348	DXO_MOUSE	40.8	223	119	6	3	644	160	378	7.80E-39	162.2	DXO_MOUSE	reviewed	Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-)	Dxo Dom3z Ng6	Mus musculus (Mouse)	397	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]	GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090305; GO:0110152; GO:0110155	mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]		NA	NA	NA	NA	NA	NA
TRINITY_DN314_c0_g1_i1	Q4WDK5	DXO_ASPFU	26.8	112	76	3	510	190	228	338	8.10E-06	53.1	DXO_ASPFU	reviewed	Decapping nuclease RAI1 (EC 3.6.1.-) (NAD-capped RNA hydrolase rai1) (DeNADding enzyme rai1) (EC 3.6.1.-)	rai1 AFUA_6G05060	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	365	"cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]	GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0006353; GO:0006364; GO:0006397; GO:0034353; GO:0046872; GO:0090305; GO:0110155	"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"		blue	blue	NA	NA	NA	NA
TRINITY_DN314_c0_g1_i2	Q4WDK5	DXO_ASPFU	27.8	97	65	2	541	263	228	323	2.50E-05	51.6	DXO_ASPFU	reviewed	Decapping nuclease RAI1 (EC 3.6.1.-) (NAD-capped RNA hydrolase rai1) (DeNADding enzyme rai1) (EC 3.6.1.-)	rai1 AFUA_6G05060	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	365	"cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]	GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0006353; GO:0006364; GO:0006397; GO:0034353; GO:0046872; GO:0090305; GO:0110155	"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN314_c0_g1_i3	Q4WDK5	DXO_ASPFU	27.8	97	65	2	541	263	228	323	2.40E-05	51.6	DXO_ASPFU	reviewed	Decapping nuclease RAI1 (EC 3.6.1.-) (NAD-capped RNA hydrolase rai1) (DeNADding enzyme rai1) (EC 3.6.1.-)	rai1 AFUA_6G05060	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	365	"cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]	GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0006353; GO:0006364; GO:0006397; GO:0034353; GO:0046872; GO:0090305; GO:0110155	"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"		blue	blue	NA	NA	NA	NA
TRINITY_DN314_c0_g1_i4	Q4WDK5	DXO_ASPFU	26.8	112	76	3	510	190	228	338	8.40E-06	53.1	DXO_ASPFU	reviewed	Decapping nuclease RAI1 (EC 3.6.1.-) (NAD-capped RNA hydrolase rai1) (DeNADding enzyme rai1) (EC 3.6.1.-)	rai1 AFUA_6G05060	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	365	"cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA pyrophosphohydrolase activity [GO:0034353]	GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0006353; GO:0006364; GO:0006397; GO:0034353; GO:0046872; GO:0090305; GO:0110155	"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13964_c0_g1_i1	Q14185	DOCK1_HUMAN	43.8	352	178	5	14	1060	918	1252	4.50E-80	299.7	DOCK1_HUMAN	reviewed	Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180)	DOCK1	Homo sapiens (Human)	1865	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]	GO:0005089; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0006911; GO:0006915; GO:0007165; GO:0007229; GO:0007264; GO:0007596; GO:0010634; GO:0016020; GO:0016477; GO:0016607; GO:0017124; GO:0032045; GO:0038096; GO:0048010; GO:1900026	"apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35474_c0_g1_i1	Q14185	DOCK1_HUMAN	47.3	91	47	1	275	6	379	469	1.60E-18	93.2	DOCK1_HUMAN	reviewed	Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180)	DOCK1	Homo sapiens (Human)	1865	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]	GO:0005089; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0006911; GO:0006915; GO:0007165; GO:0007229; GO:0007264; GO:0007596; GO:0010634; GO:0016020; GO:0016477; GO:0016607; GO:0017124; GO:0032045; GO:0038096; GO:0048010; GO:1900026	"apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33585_c0_g1_i1	Q96BY6	DOC10_HUMAN	50.5	91	45	0	411	139	2059	2149	5.80E-20	98.6	DOC10_HUMAN	reviewed	Dedicator of cytokinesis protein 10 (Zizimin-3)	DOCK10 KIAA0694 ZIZ3	Homo sapiens (Human)	2186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001782; GO:0002315; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0030334; GO:0043197; GO:0043547; GO:0060997; GO:0070062	B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN29554_c0_g1_i1	Q96BY6	DOC10_HUMAN	100	85	0	0	1	255	1669	1753	6.70E-43	174.1	DOC10_HUMAN	reviewed	Dedicator of cytokinesis protein 10 (Zizimin-3)	DOCK10 KIAA0694 ZIZ3	Homo sapiens (Human)	2186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001782; GO:0002315; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0030334; GO:0043197; GO:0043547; GO:0060997; GO:0070062	B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN26854_c0_g1_i1	Q5JSL3	DOC11_HUMAN	100	95	0	0	285	1	1455	1549	5.00E-47	188	DOC11_HUMAN	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	DOCK11 ZIZ2	Homo sapiens (Human)	2073	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0005829; GO:0007264; GO:0007596; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN6557_c0_g1_i1	A2AF47	DOC11_MOUSE	37.7	154	94	2	543	88	1	154	4.50E-24	112.8	DOC11_MOUSE	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	Dock11 Ziz2	Mus musculus (Mouse)	2073	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0007264; GO:0017048; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5996_c0_g1_i7	Q5JSL3	DOC11_HUMAN	50.9	468	226	3	1398	1	1371	1836	2.50E-131	470.3	DOC11_HUMAN	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	DOCK11 ZIZ2	Homo sapiens (Human)	2073	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0005829; GO:0007264; GO:0007596; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5996_c0_g1_i8	Q5JSL3	DOC11_HUMAN	50.4	454	221	3	1441	86	1371	1822	3.30E-126	453.4	DOC11_HUMAN	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	DOCK11 ZIZ2	Homo sapiens (Human)	2073	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0005829; GO:0007264; GO:0007596; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN12142_c0_g1_i1	A2AF47	DOC11_MOUSE	46.7	167	86	3	2	496	443	608	8.20E-37	154.8	DOC11_MOUSE	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	Dock11 Ziz2	Mus musculus (Mouse)	2073	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0007264; GO:0017048; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN12142_c0_g1_i2	A2AF47	DOC11_MOUSE	47.5	158	80	3	2	469	443	599	2.20E-35	150.2	DOC11_MOUSE	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	Dock11 Ziz2	Mus musculus (Mouse)	2073	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0007264; GO:0017048; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN27021_c0_g1_i1	Q5JSL3	DOC11_HUMAN	100	106	0	0	1	318	462	567	1.00E-56	220.3	DOC11_HUMAN	reviewed	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	DOCK11 ZIZ2	Homo sapiens (Human)	2073	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0005829; GO:0007264; GO:0007596; GO:0043547; GO:0051491	B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN35167_c0_g1_i1	Q92608	DOCK2_HUMAN	100	91	0	0	1	273	1168	1258	2.00E-48	192.6	DOCK2_HUMAN	reviewed	Dedicator of cytokinesis protein 2	DOCK2 KIAA0209	Homo sapiens (Human)	1830	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of defense response to virus by virus [GO:0050690]; small GTPase mediated signal transduction [GO:0007264]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]	GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]	GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005096; GO:0005576; GO:0005829; GO:0005856; GO:0006935; GO:0007264; GO:0016020; GO:0030036; GO:0030676; GO:0035580; GO:0042608; GO:0043312; GO:0044351; GO:0045059; GO:0045060; GO:0046633; GO:0050690; GO:0050766; GO:0070062	actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of defense response to virus by virus [GO:0050690]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN37372_c0_g1_i1	Q92608	DOCK2_HUMAN	100	75	0	0	226	2	1529	1603	1.40E-39	162.9	DOCK2_HUMAN	reviewed	Dedicator of cytokinesis protein 2	DOCK2 KIAA0209	Homo sapiens (Human)	1830	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of defense response to virus by virus [GO:0050690]; small GTPase mediated signal transduction [GO:0007264]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]	GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]	GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005096; GO:0005576; GO:0005829; GO:0005856; GO:0006935; GO:0007264; GO:0016020; GO:0030036; GO:0030676; GO:0035580; GO:0042608; GO:0043312; GO:0044351; GO:0045059; GO:0045060; GO:0046633; GO:0050690; GO:0050766; GO:0070062	actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of defense response to virus by virus [GO:0050690]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN35801_c0_g1_i1	Q92608	DOCK2_HUMAN	100	153	0	0	462	4	1001	1153	6.80E-86	317.8	DOCK2_HUMAN	reviewed	Dedicator of cytokinesis protein 2	DOCK2 KIAA0209	Homo sapiens (Human)	1830	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of defense response to virus by virus [GO:0050690]; small GTPase mediated signal transduction [GO:0007264]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]	GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]	GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005096; GO:0005576; GO:0005829; GO:0005856; GO:0006935; GO:0007264; GO:0016020; GO:0030036; GO:0030676; GO:0035580; GO:0042608; GO:0043312; GO:0044351; GO:0045059; GO:0045060; GO:0046633; GO:0050690; GO:0050766; GO:0070062	actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of defense response to virus by virus [GO:0050690]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5556_c0_g1_i2	Q8IZD9	DOCK3_HUMAN	46.9	618	310	10	57	1883	1	609	1.50E-159	564.7	DOCK3_HUMAN	reviewed	Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)	DOCK3 KIAA0299 MOCA	Homo sapiens (Human)	2030	cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997	positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5556_c0_g1_i4	Q8IZD9	DOCK3_HUMAN	43.7	920	485	14	57	2774	1	901	1.90E-215	750.7	DOCK3_HUMAN	reviewed	Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)	DOCK3 KIAA0299 MOCA	Homo sapiens (Human)	2030	cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997	positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5556_c0_g2_i3	Q8CIQ7	DOCK3_MOUSE	49.7	600	289	4	75	1844	1027	1623	2.00E-172	607.4	DOCK3_MOUSE	reviewed	Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)	Dock3 Moca	Mus musculus (Mouse)	2027	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]	GO:0005085; GO:0005737; GO:0005829; GO:0007264; GO:0017124	small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN13964_c0_g1_i2	P59764	DOCK4_MOUSE	34.6	107	69	1	47	364	913	1019	3.60E-12	72.8	DOCK4_MOUSE	reviewed	Dedicator of cytokinesis protein 4	Dock4 Kiaa0716	Mus musculus (Mouse)	1978	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]	GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017124; GO:0030165; GO:0030676; GO:0030971; GO:0032420; GO:0032421; GO:0048365; GO:0060326; GO:1904694; GO:1904754	cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5556_c0_g2_i1	Q8N1I0	DOCK4_HUMAN	47.1	682	355	4	40	2085	912	1587	3.30E-184	646.7	DOCK4_HUMAN	reviewed	Dedicator of cytokinesis protein 4	DOCK4 KIAA0716	Homo sapiens (Human)	1966	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]	GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017124; GO:0030165; GO:0030676; GO:0030971; GO:0032420; GO:0032421; GO:0048365; GO:0060326; GO:1904694; GO:1904754	cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN4231_c0_g1_i2	B2RY04	DOCK5_MOUSE	48.9	356	180	1	1799	732	1293	1646	8.10E-98	359.4	DOCK5_MOUSE	reviewed	Dedicator of cytokinesis protein 5 (Lens rupture protein 2) (Rupture of lens cataract protein)	Dock5 Lr2 Rlc	Mus musculus (Mouse)	1868	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0010634; GO:0016477; GO:1900026; GO:1904694; GO:1904754	cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN4231_c0_g1_i6	B2RY04	DOCK5_MOUSE	48.9	356	180	1	1181	114	1293	1646	5.30E-98	359.4	DOCK5_MOUSE	reviewed	Dedicator of cytokinesis protein 5 (Lens rupture protein 2) (Rupture of lens cataract protein)	Dock5 Lr2 Rlc	Mus musculus (Mouse)	1868	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0010634; GO:0016477; GO:1900026; GO:1904694; GO:1904754	cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN4231_c0_g1_i8	B2RY04	DOCK5_MOUSE	48.9	356	180	1	1524	457	1293	1646	6.80E-98	359.4	DOCK5_MOUSE	reviewed	Dedicator of cytokinesis protein 5 (Lens rupture protein 2) (Rupture of lens cataract protein)	Dock5 Lr2 Rlc	Mus musculus (Mouse)	1868	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0010634; GO:0016477; GO:1900026; GO:1904694; GO:1904754	cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN4375_c0_g1_i1	Q8VDR9	DOCK6_MOUSE	38	137	79	2	611	201	3	133	4.40E-14	79.7	DOCK6_MOUSE	reviewed	Dedicator of cytokinesis protein 6	Dock6 Kiaa1395	Mus musculus (Mouse)	2080	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0048471	small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3123_c0_g1_i1	Q96N67	DOCK7_HUMAN	45.9	701	306	13	1984	44	518	1199	1.10E-164	581.6	DOCK7_HUMAN	reviewed	Dedicator of cytokinesis protein 7	DOCK7 KIAA1771	Homo sapiens (Human)	2140	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]	GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0033138; GO:0043005; GO:0045178; GO:0045200; GO:0048365; GO:0050767; GO:0090630; GO:0120163; GO:1904754	activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN4375_c0_g1_i2	Q96N67	DOCK7_HUMAN	42.7	524	262	11	1539	4	4	501	6.80E-101	369.4	DOCK7_HUMAN	reviewed	Dedicator of cytokinesis protein 7	DOCK7 KIAA1771	Homo sapiens (Human)	2140	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]	GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0033138; GO:0043005; GO:0045178; GO:0045200; GO:0048365; GO:0050767; GO:0090630; GO:0120163; GO:1904754	activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN32192_c0_g1_i1	Q96N67	DOCK7_HUMAN	100	87	0	0	262	2	662	748	7.80E-47	187.2	DOCK7_HUMAN	reviewed	Dedicator of cytokinesis protein 7	DOCK7 KIAA1771	Homo sapiens (Human)	2140	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]	GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0033138; GO:0043005; GO:0045178; GO:0045200; GO:0048365; GO:0050767; GO:0090630; GO:0120163; GO:1904754	activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN37034_c0_g1_i1	Q8NF50	DOCK8_HUMAN	100	117	0	0	3	353	583	699	8.70E-65	247.3	DOCK8_HUMAN	reviewed	Dedicator of cytokinesis protein 8	DOCK8	Homo sapiens (Human)	2099	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001771; GO:0005085; GO:0005737; GO:0005829; GO:0007264; GO:0007596; GO:0016020; GO:0031256; GO:0031258; GO:0036336; GO:0043547; GO:0061485; GO:0070233; GO:1903905; GO:1990869; GO:2000406	blood coagulation [GO:0007596]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN27491_c0_g1_i1	Q8NF50	DOCK8_HUMAN	100	154	0	0	3	464	982	1135	1.00E-81	303.9	DOCK8_HUMAN	reviewed	Dedicator of cytokinesis protein 8	DOCK8	Homo sapiens (Human)	2099	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001771; GO:0005085; GO:0005737; GO:0005829; GO:0007264; GO:0007596; GO:0016020; GO:0031256; GO:0031258; GO:0036336; GO:0043547; GO:0061485; GO:0070233; GO:1903905; GO:1990869; GO:2000406	blood coagulation [GO:0007596]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN28499_c0_g1_i1	Q8C147	DOCK8_MOUSE	74.3	70	18	0	215	6	1789	1858	3.60E-24	111.7	DOCK8_MOUSE	reviewed	Dedicator of cytokinesis protein 8	Dock8	Mus musculus (Mouse)	2100	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; small GTPase mediated signal transduction [GO:0007264]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001771; GO:0005085; GO:0005737; GO:0007264; GO:0031252; GO:0031256; GO:0031258; GO:0036336; GO:0043547; GO:0061485; GO:0070233; GO:1903905; GO:1990869; GO:2000406	cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN6743_c0_g1_i10	Q9BZ29	DOCK9_HUMAN	34.9	407	227	11	1207	5	981	1355	6.90E-56	219.5	DOCK9_HUMAN	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	2069	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN6743_c0_g1_i2	Q9BZ29	DOCK9_HUMAN	40.1	785	408	20	2317	5	619	1355	1.40E-147	525	DOCK9_HUMAN	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	2069	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN6743_c0_g1_i5	Q9BZ29	DOCK9_HUMAN	42.6	136	73	3	397	2	847	981	8.80E-21	101.3	DOCK9_HUMAN	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	2069	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN6743_c0_g1_i7	Q9BZ29	DOCK9_HUMAN	37.1	603	324	15	1783	5	798	1355	1.40E-97	358.6	DOCK9_HUMAN	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	2069	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN6743_c0_g1_i9	Q9BZ29	DOCK9_HUMAN	34.5	357	196	11	1057	5	1031	1355	3.10E-44	180.6	DOCK9_HUMAN	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	2069	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN34698_c0_g1_i1	Q8BIK4	DOCK9_MOUSE	98.1	106	2	0	3	320	1560	1665	1.40E-53	209.9	DOCK9_MOUSE	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	Dock9 D14Wsu89e Kiaa1058 Ziz1	Mus musculus (Mouse)	2055	endomembrane system [GO:0012505]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	endomembrane system [GO:0012505]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0007264; GO:0012505; GO:0016020; GO:0017048; GO:0043547	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5996_c0_g1_i10	Q8BIK4	DOCK9_MOUSE	52.3	331	143	2	954	4	1525	1854	7.00E-93	342.4	DOCK9_MOUSE	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	Dock9 D14Wsu89e Kiaa1058 Ziz1	Mus musculus (Mouse)	2055	endomembrane system [GO:0012505]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	endomembrane system [GO:0012505]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0007264; GO:0012505; GO:0016020; GO:0017048; GO:0043547	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5996_c0_g1_i3	Q8BIK4	DOCK9_MOUSE	57.1	212	90	1	687	52	1479	1689	9.50E-68	258.1	DOCK9_MOUSE	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	Dock9 D14Wsu89e Kiaa1058 Ziz1	Mus musculus (Mouse)	2055	endomembrane system [GO:0012505]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	endomembrane system [GO:0012505]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0007264; GO:0012505; GO:0016020; GO:0017048; GO:0043547	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5996_c0_g1_i5	Q8BIK4	DOCK9_MOUSE	60.2	171	67	1	548	36	1479	1648	6.70E-56	218.4	DOCK9_MOUSE	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	Dock9 D14Wsu89e Kiaa1058 Ziz1	Mus musculus (Mouse)	2055	endomembrane system [GO:0012505]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	endomembrane system [GO:0012505]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0007264; GO:0012505; GO:0016020; GO:0017048; GO:0043547	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5996_c0_g1_i9	Q8BIK4	DOCK9_MOUSE	52.4	319	137	2	997	83	1525	1842	2.20E-89	330.9	DOCK9_MOUSE	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	Dock9 D14Wsu89e Kiaa1058 Ziz1	Mus musculus (Mouse)	2055	endomembrane system [GO:0012505]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	endomembrane system [GO:0012505]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0007264; GO:0012505; GO:0016020; GO:0017048; GO:0043547	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN32251_c0_g1_i1	Q9BZ29	DOCK9_HUMAN	86.9	122	2	1	325	2	1722	1843	1.10E-53	210.3	DOCK9_HUMAN	reviewed	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	2069	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN1823_c0_g1_i2	Q24180	DEAF1_DROME	55.4	83	37	0	260	12	220	302	1.10E-23	111.7	DEAF1_DROME	reviewed	Deformed epidermal autoregulatory factor 1 (Protein DEAF-1)	Deaf1 CG8567	Drosophila melanogaster (Fruit fly)	576	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0009792; GO:0043565; GO:0045893; GO:0046872; GO:0050776	"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1823_c0_g1_i3	Q24180	DEAF1_DROME	55.4	83	37	0	260	12	220	302	9.60E-24	111.7	DEAF1_DROME	reviewed	Deformed epidermal autoregulatory factor 1 (Protein DEAF-1)	Deaf1 CG8567	Drosophila melanogaster (Fruit fly)	576	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0009792; GO:0043565; GO:0045893; GO:0046872; GO:0050776	"embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN588_c3_g1_i1	Q86SQ9	DHDDS_HUMAN	49.4	314	150	2	1098	184	1	314	2.20E-79	297.7	DHDDS_HUMAN	reviewed	Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)	DHDDS HDS	Homo sapiens (Human)	333	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	dehydrodolichyl diphosphate synthase activity [GO:0045547]	GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0045547; GO:1904423	dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]		NA	NA	NA	NA	NA	NA
TRINITY_DN29426_c0_g1_i1	Q86SQ9	DHDDS_HUMAN	98.5	130	2	0	391	2	10	139	4.40E-70	265	DHDDS_HUMAN	reviewed	Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)	DHDDS HDS	Homo sapiens (Human)	333	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	dehydrodolichyl diphosphate synthase activity [GO:0045547]	GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0045547; GO:1904423	dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i10	Q71R50	DHR11_CHICK	58.6	145	58	1	246	674	1	145	1.20E-42	174.9	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i12	Q6UWP2	DHR11_HUMAN	40.8	76	44	1	4	228	173	248	2.30E-08	59.7	DHR11_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1 UNQ836/PRO1774	Homo sapiens (Human)	260	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006694; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i13	Q71R50	DHR11_CHICK	57.1	42	18	0	87	212	104	145	3.20E-10	65.5	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i14	Q71R50	DHR11_CHICK	54.3	92	42	0	114	389	54	145	1.90E-25	117.1	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i15	Q71R50	DHR11_CHICK	51.6	250	118	2	246	986	1	250	4.00E-65	250	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i16	Q71R50	DHR11_CHICK	54.3	92	42	0	70	345	54	145	1.90E-25	116.7	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i22	Q71R50	DHR11_CHICK	59.5	37	15	0	60	170	109	145	1.00E-08	60.5	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i23	Q71R50	DHR11_CHICK	57.1	42	18	0	212	337	104	145	5.70E-10	65.5	DHR11_CHICK	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Gallus gallus (Chicken)	255	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i25	Q3ZBV9	DHR11_BOVIN	49	147	74	1	33	470	104	250	7.20E-34	145.2	DHR11_BOVIN	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Bos taurus (Bovine)	255	extracellular region [GO:0005576]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i27	Q3ZBV9	DHR11_BOVIN	46.4	207	108	2	90	701	44	250	1.10E-48	194.9	DHR11_BOVIN	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Bos taurus (Bovine)	255	extracellular region [GO:0005576]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i4	Q3ZBV9	DHR11_BOVIN	49.3	142	71	1	5	427	109	250	1.30E-32	141	DHR11_BOVIN	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Bos taurus (Bovine)	255	extracellular region [GO:0005576]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN3630_c0_g1_i9	Q3ZBV9	DHR11_BOVIN	46.4	207	108	2	46	657	44	250	1.10E-48	194.9	DHR11_BOVIN	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	DHRS11 SDR24C1	Bos taurus (Bovine)	255	extracellular region [GO:0005576]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]	extracellular region [GO:0005576]	3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703	estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN40981_c0_g1_i1	Q3U0B3	DHR11_MOUSE	100	72	0	0	217	2	66	137	5.20E-36	151	DHR11_MOUSE	reviewed	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	Dhrs11 Sdr24c1	Mus musculus (Mouse)	260	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]	extracellular region [GO:0005576]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006694; GO:0006703; GO:0072555; GO:0072582	estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN7494_c0_g1_i1	A0PJE2	DHR12_HUMAN	52.6	266	124	2	945	148	47	310	9.00E-77	288.5	DHR12_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1)	DHRS12 SDR40C1	Homo sapiens (Human)	317	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN7494_c0_g1_i2	A0PJE2	DHR12_HUMAN	49.4	158	78	2	718	245	47	202	9.70E-39	161.8	DHR12_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1)	DHRS12 SDR40C1	Homo sapiens (Human)	317	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN2383_c0_g1_i1	A0PJE2	DHR12_HUMAN	58.9	319	129	2	99	1055	1	317	5.50E-105	382.5	DHR12_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1)	DHRS12 SDR40C1	Homo sapiens (Human)	317	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			blue	blue	NA	NA	NA	NA
TRINITY_DN38883_c0_g1_i1	Q5SS80	DHR13_MOUSE	42.6	54	31	0	168	7	261	314	8.90E-07	53.9	DHR13_MOUSE	reviewed	Dehydrogenase/reductase SDR family member 13 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 7C member 5)	Dhrs13 Sdr7c5	Mus musculus (Mouse)	376	extracellular region [GO:0005576]; mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal metabolic process [GO:0042574]	extracellular region [GO:0005576]; mitochondrial inner membrane [GO:0005743]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005576; GO:0005743; GO:0042574; GO:0052650	retinal metabolic process [GO:0042574]		NA	NA	NA	NA	NA	NA
TRINITY_DN19908_c0_g1_i1	Q8SPU8	DHRS4_BOVIN	52.9	272	128	0	213	1028	8	279	1.70E-72	274.6	DHRS4_BOVIN	reviewed	Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NDRD) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD)	DHRS4 NDRD	Bos taurus (Bovine)	279	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090]	mitochondrion [GO:0005739]; peroxisome [GO:0005777]	carbonyl reductase (NADPH) activity [GO:0004090]	GO:0004090; GO:0005739; GO:0005777			blue	blue	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i1	Q9Y394	DHRS7_HUMAN	38.5	91	54	2	178	444	212	302	3.10E-10	66.6	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i1	Q9Y394	DHRS7_HUMAN	54.5	55	24	1	15	176	41	95	7.20E-07	55.5	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i2	Q9Y394	DHRS7_HUMAN	38.2	136	81	3	1	402	168	302	4.20E-19	95.9	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i3	Q9Y394	DHRS7_HUMAN	40.2	92	53	2	87	356	211	302	1.30E-11	70.9	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i4	Q9Y394	DHRS7_HUMAN	26.3	262	89	6	15	488	41	302	2.10E-12	73.9	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i6	Q9Y394	DHRS7_HUMAN	53.8	39	18	0	228	344	264	302	7.20E-05	48.5	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1434_c0_g1_i7	Q9Y394	DHRS7_HUMAN	38	92	55	2	87	356	211	302	2.60E-10	66.6	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN38624_c0_g1_i1	Q9Y394	DHRS7_HUMAN	100	69	0	0	209	3	253	321	3.80E-36	151.4	DHRS7_HUMAN	reviewed	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448	Homo sapiens (Human)	339	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]	membrane [GO:0016020]	oxidoreductase activity [GO:0016491]	GO:0016020; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN34820_c0_g1_i1	Q99J47	DRS7B_MOUSE	100	77	0	0	3	233	101	177	1.00E-37	156.8	DRS7B_MOUSE	reviewed	Dehydrogenase/reductase SDR family member 7B (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 32C member 1)	Dhrs7b Sdr32c1	Mus musculus (Mouse)	323	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	oxidoreductase activity [GO:0016491]	GO:0005789; GO:0016021; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN9486_c0_g1_i1	Q8N5I4	DHRSX_HUMAN	41.8	79	44	1	21	251	176	254	8.10E-10	64.3	DHRSX_HUMAN	reviewed	Dehydrogenase/reductase SDR family member on chromosome X (EC 1.1.-.-) (DHRSXY) (Short chain dehydrogenase/reductase family 46C member 1) (Short chain dehydrogenase/reductase family 7C member 6)	DHRSX CXorf11 DHRS5X SDR46C1 SDR7C6 UNQ6508/PRO21433	Homo sapiens (Human)	330	extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]; positive regulation of autophagy [GO:0010508]	extracellular region [GO:0005576]	oxidoreductase activity [GO:0016491]	GO:0005576; GO:0010508; GO:0016491	positive regulation of autophagy [GO:0010508]		blue	blue	NA	NA	NA	NA
TRINITY_DN17383_c1_g1_i1	Q8VBZ0	DHRSX_MOUSE	51.5	99	47	1	297	1	74	171	2.10E-18	93.2	DHRSX_MOUSE	reviewed	Dehydrogenase/reductase SDR family member on chromosome X homolog (EC 1.1.-.-) (DHRSXY) (SCAD family protein)	Dhrsx Pscad	Mus musculus (Mouse)	335	extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]; positive regulation of autophagy [GO:0010508]	extracellular region [GO:0005576]	oxidoreductase activity [GO:0016491]	GO:0005576; GO:0010508; GO:0016491	positive regulation of autophagy [GO:0010508]		blue	blue	NA	NA	NA	NA
TRINITY_DN1548_c0_g1_i1	Q9Y140	DHRS7_DROME	49.7	316	152	2	1048	101	13	321	8.10E-77	288.9	DHRS7_DROME	reviewed	Dehydrogenase/reductase SDR family protein 7-like (EC 1.1.-.-)	CG7601	Drosophila melanogaster (Fruit fly)	326	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; oxidoreductase activity [GO:0016491]	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	oxidoreductase activity [GO:0016491]	GO:0005778; GO:0016021; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN1548_c0_g1_i2	Q9Y140	DHRS7_DROME	49.7	316	152	2	1059	112	13	321	1.80E-76	287.7	DHRS7_DROME	reviewed	Dehydrogenase/reductase SDR family protein 7-like (EC 1.1.-.-)	CG7601	Drosophila melanogaster (Fruit fly)	326	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; oxidoreductase activity [GO:0016491]	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	oxidoreductase activity [GO:0016491]	GO:0005778; GO:0016021; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN3845_c1_g1_i1	Q14739	LBR_HUMAN	34.2	400	250	8	1258	92	218	615	3.10E-59	230.7	LBR_HUMAN	reviewed	Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase)	LBR	Homo sapiens (Human)	615	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	"chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]"	GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005639; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0016021; GO:0016126; GO:0016627; GO:0030223; GO:0031965; GO:0050613; GO:0070087; GO:0070402	cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]		blue	blue	NA	NA	NA	NA
TRINITY_DN40414_c0_g1_i1	O76062	ERG24_HUMAN	100	86	0	0	4	261	300	385	1.50E-45	183	ERG24_HUMAN	reviewed	Delta(14)-sterol reductase TM7SF2 (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (Another new gene 1 protein) (C-14 sterol reductase) (C14SR) (Putative sterol reductase SR-1) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2)	TM7SF2 ANG1	Homo sapiens (Human)	418	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; receptor complex [GO:0043235]; delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol biosynthetic process [GO:0006695]; regulation of cholesterol biosynthetic process [GO:0045540]; sterol biosynthetic process [GO:0016126]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; receptor complex [GO:0043235]	"delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"	GO:0005637; GO:0005783; GO:0005789; GO:0005887; GO:0006695; GO:0016126; GO:0016627; GO:0030176; GO:0043231; GO:0043235; GO:0045540; GO:0050613; GO:0050661	cholesterol biosynthetic process [GO:0006695]; regulation of cholesterol biosynthetic process [GO:0045540]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN33336_c0_g1_i1	Q8VCH6	DHC24_MOUSE	45.6	318	161	6	958	8	31	337	1.10E-67	258.5	DHC24_MOUSE	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase)	Dhcr24 Kiaa0018	Mus musculus (Mouse)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006979; GO:0007265; GO:0008104; GO:0008202; GO:0008203; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016125; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949	amyloid precursor protein catabolic process [GO:0042987]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN26505_c0_g1_i1	Q15392	DHC24_HUMAN	100	121	0	0	363	1	116	236	4.40E-64	245	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16596_c0_g1_i1	Q15392	DHC24_HUMAN	52.8	108	48	1	389	75	23	130	8.60E-29	128.3	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16596_c0_g1_i2	Q15392	DHC24_HUMAN	57.2	360	153	1	1136	57	157	515	2.10E-128	460.3	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16596_c0_g1_i3	Q15392	DHC24_HUMAN	58.4	351	145	1	1109	57	166	515	1.30E-128	461.1	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16596_c0_g1_i4	Q15392	DHC24_HUMAN	58.4	351	145	1	1109	57	166	515	1.30E-128	461.1	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16596_c0_g1_i5	Q15392	DHC24_HUMAN	57.9	494	204	2	1529	57	23	515	1.00E-179	631.3	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16596_c0_g1_i6	Q15392	DHC24_HUMAN	58.5	352	145	1	1112	57	165	515	3.30E-129	463	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN35130_c0_g1_i1	Q15392	DHC24_HUMAN	100	90	0	0	2	271	299	388	2.10E-50	199.1	DHC24_HUMAN	reviewed	Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)	DHCR24 KIAA0018	Homo sapiens (Human)	516	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]"	GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007050; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0055114; GO:0061024; GO:0071949; GO:1901214	amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; oxidation-reduction process [GO:0055114]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN6176_c0_g1_i1	P30038	AL4A1_HUMAN	61.7	399	150	2	1287	94	166	562	8.60E-147	521.5	AL4A1_HUMAN	reviewed	"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)"	ALDH4A1 ALDH4 P5CDH	Homo sapiens (Human)	563	mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; 4-hydroxyproline catabolic process [GO:0019470]; glyoxylate metabolic process [GO:0046487]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]	mitochondrial matrix [GO:0005759]	1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]	GO:0003842; GO:0004029; GO:0005759; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802; GO:0046487	4-hydroxyproline catabolic process [GO:0019470]; glyoxylate metabolic process [GO:0046487]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]		NA	NA	NA	NA	NA	NA
TRINITY_DN9682_c0_g2_i1	Q59643	HEM2_PSEAE	66.9	118	38	1	351	1	132	249	2.50E-40	166	HEM2_PSEAE	reviewed	Delta-aminolevulinic acid dehydratase (ALAD) (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	hemB PA5243	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	337	cytosol [GO:0005829]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0005829; GO:0006779; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN9682_c0_g1_i1	P45622	HEM2_BRADU	74.7	91	23	0	274	2	165	255	1.40E-30	133.3	HEM2_BRADU	reviewed	Delta-aminolevulinic acid dehydratase (ALAD) (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	hemB blr5037	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	353	cytosol [GO:0005829]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN9682_c0_g1_i2	Q59643	HEM2_PSEAE	64.6	113	39	1	337	2	128	240	1.80E-35	149.8	HEM2_PSEAE	reviewed	Delta-aminolevulinic acid dehydratase (ALAD) (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	hemB PA5243	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	337	cytosol [GO:0005829]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0005829; GO:0006779; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	1
TRINITY_DN31611_c0_g1_i1	Q58DK5	HEM2_BOVIN	60.6	66	25	1	204	10	150	215	1.40E-14	79.7	HEM2_BOVIN	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Bos taurus (Bovine)	329	cytosol [GO:0005829]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]	identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270; GO:0042802; GO:0051260; GO:0071353; GO:1901799	cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN34962_c0_g1_i1	P13716	HEM2_HUMAN	98.9	87	1	0	264	4	69	155	2.20E-44	179.1	HEM2_HUMAN	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Homo sapiens (Human)	330	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]	GO:0001666; GO:0003824; GO:0004655; GO:0005576; GO:0005634; GO:0005829; GO:0006782; GO:0006783; GO:0006979; GO:0008270; GO:0009635; GO:0010039; GO:0010043; GO:0010044; GO:0010212; GO:0010266; GO:0010269; GO:0014823; GO:0032025; GO:0032496; GO:0033197; GO:0034774; GO:0042493; GO:0042802; GO:0043200; GO:0043312; GO:0045471; GO:0046685; GO:0046686; GO:0046689; GO:0051260; GO:0051384; GO:0051597; GO:0070062; GO:0070541; GO:0070542; GO:0071284; GO:0071353; GO:1901799; GO:1904813; GO:1904854	cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN1241_c0_g1_i1	Q5R971	HEM2_PONAB	64.3	325	116	0	1061	87	6	330	3.90E-125	449.5	HEM2_PONAB	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	330	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN1241_c0_g1_i2	Q5R971	HEM2_PONAB	64.3	325	116	0	1061	87	6	330	2.30E-125	450.3	HEM2_PONAB	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	330	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN1241_c0_g1_i3	Q5R971	HEM2_PONAB	64.3	325	116	0	1061	87	6	330	2.90E-125	449.9	HEM2_PONAB	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	330	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN1241_c0_g1_i4	Q5R971	HEM2_PONAB	64.3	325	116	0	1061	87	6	330	2.90E-125	449.9	HEM2_PONAB	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	330	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]	GO:0004655; GO:0006782; GO:0006783; GO:0008270	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN39264_c0_g1_i1	P13716	HEM2_HUMAN	100	140	0	0	3	422	180	319	4.50E-76	285	HEM2_HUMAN	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Homo sapiens (Human)	330	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]	GO:0001666; GO:0003824; GO:0004655; GO:0005576; GO:0005634; GO:0005829; GO:0006782; GO:0006783; GO:0006979; GO:0008270; GO:0009635; GO:0010039; GO:0010043; GO:0010044; GO:0010212; GO:0010266; GO:0010269; GO:0014823; GO:0032025; GO:0032496; GO:0033197; GO:0034774; GO:0042493; GO:0042802; GO:0043200; GO:0043312; GO:0045471; GO:0046685; GO:0046686; GO:0046689; GO:0051260; GO:0051384; GO:0051597; GO:0070062; GO:0070541; GO:0070542; GO:0071284; GO:0071353; GO:1901799; GO:1904813; GO:1904854	cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN30323_c0_g1_i1	P10518	HEM2_MOUSE	100	235	0	0	3	707	2	236	1.50E-132	473.4	HEM2_MOUSE	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	Alad Lv	Mus musculus (Mouse)	330	cytosol [GO:0005829]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]	cytosol [GO:0005829]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]	GO:0001666; GO:0004655; GO:0005615; GO:0005829; GO:0006782; GO:0006783; GO:0006979; GO:0007584; GO:0008270; GO:0009635; GO:0010033; GO:0010038; GO:0010039; GO:0010043; GO:0010044; GO:0010212; GO:0010266; GO:0010269; GO:0014823; GO:0032025; GO:0032496; GO:0033197; GO:0042493; GO:0042802; GO:0043200; GO:0045471; GO:0046685; GO:0046686; GO:0046689; GO:0051260; GO:0051384; GO:0051597; GO:0070541; GO:0070542; GO:0071284; GO:0071353; GO:1901799; GO:1904854	cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN23512_c0_g1_i1	P13716	HEM2_HUMAN	100	104	0	0	314	3	1	104	1.20E-53	210.3	HEM2_HUMAN	reviewed	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	ALAD	Homo sapiens (Human)	330	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]	GO:0001666; GO:0003824; GO:0004655; GO:0005576; GO:0005634; GO:0005829; GO:0006782; GO:0006783; GO:0006979; GO:0008270; GO:0009635; GO:0010039; GO:0010043; GO:0010044; GO:0010212; GO:0010266; GO:0010269; GO:0014823; GO:0032025; GO:0032496; GO:0033197; GO:0034774; GO:0042493; GO:0042802; GO:0043200; GO:0043312; GO:0045471; GO:0046685; GO:0046686; GO:0046689; GO:0051260; GO:0051384; GO:0051597; GO:0070062; GO:0070541; GO:0070542; GO:0071284; GO:0071353; GO:1901799; GO:1904813; GO:1904854	cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN11260_c0_g1_i5	D3ZHH1	DLL4_RAT	30.6	193	105	8	7	504	329	519	2.30E-18	94	DLL4_RAT	reviewed	Delta-like protein 4 (Drosophila Delta homolog 4) (Delta4)	Dll4	Rattus norvegicus (Rat)	686	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0000122; GO:0001525; GO:0001569; GO:0001974; GO:0003208; GO:0003209; GO:0003222; GO:0003344; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0008285; GO:0010596; GO:0010628; GO:0010629; GO:0016021; GO:0030217; GO:0035912; GO:0035924; GO:0043537; GO:0044344; GO:0045746; GO:0045747; GO:0050767; GO:0060579; GO:0061074; GO:0061314; GO:0072554; GO:0090051; GO:1903588; GO:2000179	angiogenesis [GO:0001525]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]		NA	NA	NA	NA	NA	NA
TRINITY_DN30394_c0_g1_i1	Q9IAT6	DLLC_DANRE	35.3	119	58	4	36	344	329	444	4.10E-11	68.9	DLLC_DANRE	reviewed	Delta-like protein C (DeltaC) (delC)	dlc	Danio rerio (Zebrafish) (Brachydanio rerio)	664	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; arterial endothelial cell differentiation [GO:0060842]; blood vessel morphogenesis [GO:0048514]; dorsal aorta development [GO:0035907]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of Notch signaling pathway [GO:0045746]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; sclerotome development [GO:0061056]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; ventral spinal cord interneuron differentiation [GO:0021514]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]	GO:0001756; GO:0001757; GO:0002244; GO:0005112; GO:0005509; GO:0005737; GO:0005886; GO:0007219; GO:0016021; GO:0021514; GO:0030165; GO:0035907; GO:0042802; GO:0045746; GO:0048471; GO:0048514; GO:0048666; GO:0060218; GO:0060842; GO:0061056	arterial endothelial cell differentiation [GO:0060842]; blood vessel morphogenesis [GO:0048514]; dorsal aorta development [GO:0035907]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of Notch signaling pathway [GO:0045746]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; sclerotome development [GO:0061056]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; ventral spinal cord interneuron differentiation [GO:0021514]		NA	NA	NA	NA	NA	NA
TRINITY_DN29438_c0_g1_i1	P33533	OPRD_RAT	40.9	66	38	1	7	204	139	203	4.80E-08	58.2	OPRD_RAT	reviewed	Delta-type opioid receptor (D-OR-1) (DOR-1) (Opioid receptor A)	Oprd1 Ror-a	Rattus norvegicus (Rat)	372	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; vesicle [GO:0031982]; enkephalin receptor activity [GO:0038046]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; opioid receptor activity [GO:0004985]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; opioid receptor signaling pathway [GO:0038003]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; vesicle [GO:0031982]	enkephalin receptor activity [GO:0038046]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; opioid receptor activity [GO:0004985]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]	GO:0004930; GO:0004985; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007200; GO:0007218; GO:0008344; GO:0010629; GO:0016020; GO:0016021; GO:0030285; GO:0031226; GO:0031333; GO:0031982; GO:0032590; GO:0033138; GO:0033612; GO:0038003; GO:0038046; GO:0042277; GO:0042755; GO:0042923; GO:0043005; GO:0043679; GO:0045121; GO:0045211; GO:0051881; GO:0051924; GO:0051930; GO:0071363; GO:0071456; GO:0097237; GO:0099061	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; opioid receptor signaling pathway [GO:0038003]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930]		NA	NA	NA	NA	NA	NA
TRINITY_DN35215_c0_g1_i1	Q6IQ26	DEN5A_HUMAN	100	75	0	0	1	225	1088	1162	9.80E-38	156.8	DEN5A_HUMAN	reviewed	DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1)	DENND5A KIAA1091 RAB6IP1	Homo sapiens (Human)	1287	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000139; GO:0005802; GO:0005829; GO:0010977; GO:0017112; GO:0042147	"negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4056_c0_g1_i5	Q6IQ26	DEN5A_HUMAN	46.6	921	404	20	2	2689	429	1286	7.20E-215	748.8	DEN5A_HUMAN	reviewed	DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1)	DENND5A KIAA1091 RAB6IP1	Homo sapiens (Human)	1287	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000139; GO:0005802; GO:0005829; GO:0010977; GO:0017112; GO:0042147	"negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6368_c0_g1_i3	Q6IQ26	DEN5A_HUMAN	47.5	122	64	0	136	501	194	315	1.90E-26	120.6	DEN5A_HUMAN	reviewed	DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1)	DENND5A KIAA1091 RAB6IP1	Homo sapiens (Human)	1287	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000139; GO:0005802; GO:0005829; GO:0010977; GO:0017112; GO:0042147	"negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4056_c0_g1_i2	A2RSQ0	DEN5B_MOUSE	47.9	405	178	10	65	1213	435	828	3.10E-88	327	DEN5B_MOUSE	reviewed	DENN domain-containing protein 5B (Rab6IP1-like protein)	Dennd5b	Mus musculus (Mouse)	1274	integral component of membrane [GO:0016021]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; positive regulation of triglyceride transport [GO:1905885]	integral component of membrane [GO:0016021]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0016021; GO:0017112; GO:1905885	positive regulation of triglyceride transport [GO:1905885]		NA	NA	NA	NA	NA	NA
TRINITY_DN6368_c0_g1_i4	Q6ZUT9	DEN5B_HUMAN	48.6	393	184	4	8	1162	24	406	8.20E-102	372.1	DEN5B_HUMAN	reviewed	DENN domain-containing protein 5B (Rab6IP1-like protein)	DENND5B	Homo sapiens (Human)	1274	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005829; GO:0016021; GO:0017112			NA	NA	NA	NA	NA	NA
TRINITY_DN6368_c0_g1_i5	Q6ZUT9	DEN5B_HUMAN	44.9	287	141	3	8	847	24	300	1.90E-62	240.7	DEN5B_HUMAN	reviewed	DENN domain-containing protein 5B (Rab6IP1-like protein)	DENND5B	Homo sapiens (Human)	1274	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005829; GO:0016021; GO:0017112			NA	NA	NA	NA	NA	NA
TRINITY_DN13642_c0_g1_i2	Q9W3D3	CRAG_DROME	39.5	243	98	6	779	54	1371	1565	4.00E-38	159.8	CRAG_DROME	reviewed	DENN domain-containing protein Crag (Calmodulin-binding protein related to a Rab3 GDP/GTP exchange protein)	Crag CG12737	Drosophila melanogaster (Fruit fly)	1671	apical cortex [GO:0045179]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; lateral cell cortex [GO:0097575]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calmodulin binding [GO:0005516]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of GTPase activity [GO:0090630]; basal protein localization [GO:0045175]; basement membrane assembly [GO:0070831]; basement membrane constituent secretion [GO:0061864]; basolateral protein secretion [GO:0110010]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of innate immune response [GO:0045089]; regulation of basement membrane organization [GO:0110011]; regulation of Rab protein signal transduction [GO:0032483]	apical cortex [GO:0045179]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; lateral cell cortex [GO:0097575]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	calmodulin binding [GO:0005516]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005516; GO:0005769; GO:0005886; GO:0017112; GO:0017137; GO:0031410; GO:0032483; GO:0042998; GO:0045089; GO:0045175; GO:0045179; GO:0050829; GO:0055037; GO:0061864; GO:0070831; GO:0090630; GO:0097575; GO:0110010; GO:0110011	activation of GTPase activity [GO:0090630]; basal protein localization [GO:0045175]; basement membrane assembly [GO:0070831]; basement membrane constituent secretion [GO:0061864]; basolateral protein secretion [GO:0110010]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of innate immune response [GO:0045089]; regulation of basement membrane organization [GO:0110011]; regulation of Rab protein signal transduction [GO:0032483]		NA	NA	NA	NA	NA	NA
TRINITY_DN13642_c0_g1_i4	Q9W3D3	CRAG_DROME	36.8	348	170	7	1111	74	1371	1670	5.70E-54	213	CRAG_DROME	reviewed	DENN domain-containing protein Crag (Calmodulin-binding protein related to a Rab3 GDP/GTP exchange protein)	Crag CG12737	Drosophila melanogaster (Fruit fly)	1671	apical cortex [GO:0045179]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; lateral cell cortex [GO:0097575]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calmodulin binding [GO:0005516]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of GTPase activity [GO:0090630]; basal protein localization [GO:0045175]; basement membrane assembly [GO:0070831]; basement membrane constituent secretion [GO:0061864]; basolateral protein secretion [GO:0110010]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of innate immune response [GO:0045089]; regulation of basement membrane organization [GO:0110011]; regulation of Rab protein signal transduction [GO:0032483]	apical cortex [GO:0045179]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; lateral cell cortex [GO:0097575]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	calmodulin binding [GO:0005516]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005516; GO:0005769; GO:0005886; GO:0017112; GO:0017137; GO:0031410; GO:0032483; GO:0042998; GO:0045089; GO:0045175; GO:0045179; GO:0050829; GO:0055037; GO:0061864; GO:0070831; GO:0090630; GO:0097575; GO:0110010; GO:0110011	activation of GTPase activity [GO:0090630]; basal protein localization [GO:0045175]; basement membrane assembly [GO:0070831]; basement membrane constituent secretion [GO:0061864]; basolateral protein secretion [GO:0110010]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of innate immune response [GO:0045089]; regulation of basement membrane organization [GO:0110011]; regulation of Rab protein signal transduction [GO:0032483]		NA	NA	NA	NA	NA	NA
TRINITY_DN18126_c0_g1_i1	Q9VX98	DENR_DROME	65.5	177	53	2	576	49	19	188	1.60E-49	197.6	DENR_DROME	reviewed	Density-regulated protein homolog	DENR CG9099	Drosophila melanogaster (Fruit fly)	189	protein-containing complex [GO:0032991]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188]	protein-containing complex [GO:0032991]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]	GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0008284; GO:0032991; GO:0046628; GO:0048027; GO:0120142	formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188]		blue	blue	NA	NA	NA	NA
TRINITY_DN10524_c0_g1_i1	Q6P1W0	DTL_XENTR	32.5	163	99	3	499	44	138	300	3.40E-20	99.8	DTL_XENTR	reviewed	Denticleless protein homolog	dtl cdt2 l2dtl TEgg011o17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	713	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]	GO:0000209; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0009411; GO:0019985; GO:0031464; GO:0031465; GO:0031490; GO:0048511; GO:0051726; GO:0072425; GO:2000060	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10524_c0_g1_i4	Q6P1W0	DTL_XENTR	33.7	104	61	2	361	74	138	241	2.20E-08	60.1	DTL_XENTR	reviewed	Denticleless protein homolog	dtl cdt2 l2dtl TEgg011o17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	713	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]	GO:0000209; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0009411; GO:0019985; GO:0031464; GO:0031465; GO:0031490; GO:0048511; GO:0051726; GO:0072425; GO:2000060	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN193_c0_g1_i1	Q5RC69	DCTD_PONAB	68.9	74	23	0	202	423	8	81	3.60E-25	116.3	DCTD_PONAB	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		blue	blue	NA	NA	NA	NA
TRINITY_DN193_c0_g1_i4	Q5RC69	DCTD_PONAB	69.2	146	45	0	202	639	8	153	2.50E-57	223.8	DCTD_PONAB	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN193_c0_g1_i8	Q5RC69	DCTD_PONAB	69.4	72	22	0	39	254	82	153	3.30E-24	112.8	DCTD_PONAB	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN3344_c0_g1_i1	Q5RC69	DCTD_PONAB	70.3	74	22	0	640	419	8	81	1.60E-25	117.9	DCTD_PONAB	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN3344_c0_g1_i1	Q5RC69	DCTD_PONAB	57.3	89	38	0	414	148	82	170	3.30E-23	110.2	DCTD_PONAB	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN32524_c0_g1_i1	Q8K2D6	DCTD_MOUSE	100	73	0	0	221	3	2	74	5.10E-39	161	DCTD_MOUSE	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	Dctd	Mus musculus (Mouse)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006226; GO:0006231; GO:0008270; GO:0042802	dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]		NA	NA	NA	NA	NA	NA
TRINITY_DN39917_c0_g1_i1	P32321	DCTD_HUMAN	97.6	84	2	0	254	3	1	84	3.80E-45	181.8	DCTD_HUMAN	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Homo sapiens (Human)	178	cytosol [GO:0005829]; dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleotide metabolic process [GO:0006220]	cytosol [GO:0005829]	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0005829; GO:0006220; GO:0006226; GO:0006231; GO:0008270; GO:0015949; GO:0042802	dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN2234_c0_g2_i1	Q8K2D6	DCTD_MOUSE	59.7	67	25	1	197	3	76	142	5.50E-19	94.4	DCTD_MOUSE	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	Dctd	Mus musculus (Mouse)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006226; GO:0006231; GO:0008270; GO:0042802	dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]		NA	NA	NA	NA	NA	NA
TRINITY_DN32128_c0_g1_i1	Q5RC69	DCTD_PONAB	58.3	84	28	1	252	1	7	83	8.30E-23	107.5	DCTD_PONAB	reviewed	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	DCTD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	178	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]		NA	NA	NA	NA	NA	NA
TRINITY_DN36176_c0_g1_i1	Q99LN9	DOHH_MOUSE	100	114	0	0	343	2	1	114	6.80E-60	231.1	DOHH_MOUSE	reviewed	Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase)	Dohh	Mus musculus (Mouse)	302	deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0005506; GO:0008612; GO:0016491; GO:0019135	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		NA	NA	NA	NA	NA	NA
TRINITY_DN8_c0_g1_i1	Q9BU89	DOHH_HUMAN	62.2	299	106	3	94	990	1	292	3.60E-96	353.2	DOHH_HUMAN	reviewed	Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1)	DOHH HLRC1	Homo sapiens (Human)	302	cytosol [GO:0005829]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]	cytosol [GO:0005829]	deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0005506; GO:0005829; GO:0008612; GO:0016491; GO:0019135	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		blue	blue	NA	NA	NA	NA
TRINITY_DN8_c0_g1_i2	Q9BU89	DOHH_HUMAN	62.2	299	106	3	72	968	1	292	3.50E-96	353.2	DOHH_HUMAN	reviewed	Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1)	DOHH HLRC1	Homo sapiens (Human)	302	cytosol [GO:0005829]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]	cytosol [GO:0005829]	deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0005506; GO:0005829; GO:0008612; GO:0016491; GO:0019135	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		NA	NA	NA	NA	NA	NA
TRINITY_DN34530_c0_g1_i1	Q9BU89	DOHH_HUMAN	100	85	0	0	257	3	197	281	1.10E-42	173.3	DOHH_HUMAN	reviewed	Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1)	DOHH HLRC1	Homo sapiens (Human)	302	cytosol [GO:0005829]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]	cytosol [GO:0005829]	deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0005506; GO:0005829; GO:0008612; GO:0016491; GO:0019135	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		NA	NA	NA	NA	NA	NA
TRINITY_DN38474_c0_g1_i1	Q9BU89	DOHH_HUMAN	100	105	0	0	316	2	40	144	1.50E-55	216.5	DOHH_HUMAN	reviewed	Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1)	DOHH HLRC1	Homo sapiens (Human)	302	cytosol [GO:0005829]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]	cytosol [GO:0005829]	deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0005506; GO:0005829; GO:0008612; GO:0016491; GO:0019135	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		NA	NA	NA	NA	NA	NA
TRINITY_DN30139_c0_g1_i1	P49366	DHYS_HUMAN	100	124	0	0	1	372	145	268	1.40E-70	266.5	DHYS_HUMAN	reviewed	Deoxyhypusine synthase (DHS) (EC 2.5.1.46)	DHPS DS	Homo sapiens (Human)	369	cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]	GO:0005737; GO:0005829; GO:0006412; GO:0008216; GO:0008284; GO:0008612; GO:0034038; GO:0042102; GO:0042593; GO:0042802; GO:0046203	glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN14429_c0_g1_i1	Q6AY53	DHYS_RAT	69.6	148	44	1	3	446	131	277	1.40E-59	230.3	DHYS_RAT	reviewed	Deoxyhypusine synthase (DHS) (EC 2.5.1.46)	Dhps	Rattus norvegicus (Rat)	369	cytoplasm [GO:0005737]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]	cytoplasm [GO:0005737]	deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]	GO:0005737; GO:0008216; GO:0008612; GO:0034038; GO:0042102; GO:0042593; GO:0042802; GO:0046203	glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]		NA	NA	NA	NA	NA	NA
TRINITY_DN4202_c0_g1_i1	Q9XZT6	DNK_DROME	46.3	203	107	2	656	51	18	219	3.10E-49	197.2	DNK_DROME	reviewed	Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase)	dnk CG5452	Drosophila melanogaster (Fruit fly)	250	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]	GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897	DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN4202_c0_g1_i2	Q9XZT6	DNK_DROME	46.3	203	107	2	656	51	18	219	3.00E-49	197.2	DNK_DROME	reviewed	Deoxynucleoside kinase (EC 2.7.1.145) (Deoxyribonucleoside kinase) (Dm-dNK) (Multispecific deoxynucleoside kinase)	dnk CG5452	Drosophila melanogaster (Fruit fly)	250	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]; DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; deoxynucleoside kinase activity [GO:0019136]; kinase activity [GO:0016301]; thymidine kinase activity [GO:0004797]	GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006230; GO:0016301; GO:0016310; GO:0019136; GO:0046939; GO:0071897	DNA biosynthetic process [GO:0071897]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleotide phosphorylation [GO:0046939]; phosphorylation [GO:0016310]; TMP biosynthetic process [GO:0006230]		NA	NA	NA	NA	NA	NA
TRINITY_DN71_c0_g1_i1	Q502K2	SAMH1_DANRE	48.4	469	226	9	1506	139	95	560	3.40E-124	446.8	SAMH1_DANRE	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	samhd1	Danio rerio (Zebrafish) (Brachydanio rerio)	622	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN71_c0_g1_i2	Q502K2	SAMH1_DANRE	48.4	469	226	9	1506	139	95	560	3.40E-124	446.8	SAMH1_DANRE	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	samhd1	Danio rerio (Zebrafish) (Brachydanio rerio)	622	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN71_c0_g1_i3	Q502K2	SAMH1_DANRE	48.4	469	226	9	1506	139	95	560	3.40E-124	446.8	SAMH1_DANRE	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	samhd1	Danio rerio (Zebrafish) (Brachydanio rerio)	622	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]		blue	blue	NA	NA	NA	NA
TRINITY_DN32032_c0_g1_i1	Q5ZJL9	SAMH1_CHICK	60.4	53	21	0	160	2	274	326	1.40E-14	79.7	SAMH1_CHICK	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	SAMHD1 RCJMB04_17d8	Gallus gallus (Chicken)	614	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0005654; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0097197; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN19842_c0_g1_i1	Q502K2	SAMH1_DANRE	48.7	78	38	1	238	5	353	428	3.00E-13	75.5	SAMH1_DANRE	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	samhd1	Danio rerio (Zebrafish) (Brachydanio rerio)	622	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN31296_c0_g1_i1	Q9Y3Z3	SAMH1_HUMAN	100	67	0	0	201	1	287	353	1.10E-35	149.8	SAMH1_HUMAN	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1)	SAMHD1 MOP5	Homo sapiens (Human)	626	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016032; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060337; GO:0060339; GO:0097197; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29585_c0_g1_i1	Q9Y3Z3	SAMH1_HUMAN	100	77	0	0	3	233	169	245	5.20E-42	171	SAMH1_HUMAN	reviewed	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1)	SAMHD1 MOP5	Homo sapiens (Human)	626	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]	dGTPase activity [GO:0008832]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016032; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060337; GO:0060339; GO:0097197; GO:0110025	cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN13170_c0_g1_i2	Q8R2M2	TDIF2_MOUSE	47.5	181	83	5	611	84	585	758	7.60E-35	149.4	TDIF2_MOUSE	reviewed	Deoxynucleotidyltransferase terminal-interacting protein 2	Dnttip2	Mus musculus (Mouse)	758	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN13170_c0_g1_i3	Q8R2M2	TDIF2_MOUSE	47.5	181	83	5	611	84	585	758	1.40E-34	149.4	TDIF2_MOUSE	reviewed	Deoxynucleotidyltransferase terminal-interacting protein 2	Dnttip2	Mus musculus (Mouse)	758	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN13170_c0_g1_i4	Q8R2M2	TDIF2_MOUSE	47.5	181	83	5	611	84	585	758	1.20E-34	149.4	TDIF2_MOUSE	reviewed	Deoxynucleotidyltransferase terminal-interacting protein 2	Dnttip2	Mus musculus (Mouse)	758	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN13170_c0_g1_i5	Q8R2M2	TDIF2_MOUSE	47.5	181	83	5	611	84	585	758	1.30E-34	149.4	TDIF2_MOUSE	reviewed	Deoxynucleotidyltransferase terminal-interacting protein 2	Dnttip2	Mus musculus (Mouse)	758	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN6635_c1_g1_i4	Q9SB00	PHR_ARATH	55.9	68	30	0	335	132	398	465	2.90E-17	89.4	PHR_ARATH	reviewed	Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (AtCPDII) (DNA photolyase) (Photoreactivating enzyme 1) (Protein UV RESISTANCE 2)	PHR1 UVR2 At1g12370 F5O11.9	Arabidopsis thaliana (Mouse-ear cress)	496	nucleus [GO:0005634]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA photolyase activity [GO:0003913]; FAD binding [GO:0071949]; photoreactive repair [GO:0000719]; UV protection [GO:0009650]	nucleus [GO:0005634]	deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA photolyase activity [GO:0003913]; FAD binding [GO:0071949]	GO:0000719; GO:0003677; GO:0003904; GO:0003913; GO:0005634; GO:0009650; GO:0071949	photoreactive repair [GO:0000719]; UV protection [GO:0009650]		NA	NA	NA	NA	NA	NA
TRINITY_DN6635_c1_g1_i1	Q28811	PHR_POTTR	63.8	459	165	1	1466	93	70	528	4.00E-180	632.5	PHR_POTTR	reviewed	Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (DNA photolyase) (Photoreactivating enzyme)	PHR	Potorous tridactylus (Potoroo)	532	deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]		deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]	GO:0003677; GO:0003904; GO:0006281; GO:0018298	DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN6635_c1_g1_i2	Q28811	PHR_POTTR	68.3	145	46	0	435	1	340	484	9.10E-57	221.1	PHR_POTTR	reviewed	Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (DNA photolyase) (Photoreactivating enzyme)	PHR	Potorous tridactylus (Potoroo)	532	deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]		deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]	GO:0003677; GO:0003904; GO:0006281; GO:0018298	DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN6635_c1_g1_i3	Q28811	PHR_POTTR	64.8	452	158	1	1499	147	70	521	1.60E-179	630.6	PHR_POTTR	reviewed	Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (DNA photolyase) (Photoreactivating enzyme)	PHR	Potorous tridactylus (Potoroo)	532	deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]		deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]	GO:0003677; GO:0003904; GO:0006281; GO:0018298	DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN3483_c0_g1_i2	Q17778	NUC1_CAEEL	36.7	362	208	10	182	1234	23	374	2.10E-58	228	NUC1_CAEEL	reviewed	Deoxyribonuclease-2 (EC 3.1.22.1) (Deoxyribonuclease II) (DNase II)	nuc-1 C07B5.5	Caenorhabditis elegans	375	"lysosome [GO:0005764]; nucleus [GO:0005634]; deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]"	lysosome [GO:0005764]; nucleus [GO:0005634]	deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]	GO:0000737; GO:0004520; GO:0004531; GO:0005634; GO:0005764; GO:0006309	"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3483_c0_g1_i3	Q17778	NUC1_CAEEL	36.4	349	201	10	63	1076	36	374	3.50E-54	213.8	NUC1_CAEEL	reviewed	Deoxyribonuclease-2 (EC 3.1.22.1) (Deoxyribonuclease II) (DNase II)	nuc-1 C07B5.5	Caenorhabditis elegans	375	"lysosome [GO:0005764]; nucleus [GO:0005634]; deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]"	lysosome [GO:0005764]; nucleus [GO:0005634]	deoxyribonuclease II activity [GO:0004531]; endodeoxyribonuclease activity [GO:0004520]	GO:0000737; GO:0004520; GO:0004531; GO:0005634; GO:0005764; GO:0006309	"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27163_c0_g1_i1	Q5TB30	DEP1A_HUMAN	44.4	81	41	2	278	36	210	286	2.30E-14	79.7	DEP1A_HUMAN	reviewed	DEP domain-containing protein 1A	DEPDC1 DEPDC1A	Homo sapiens (Human)	811	"nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0017053; GO:0035556; GO:0045892	"intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34277_c0_g1_i1	Q6A9M5	COAE_CUTAK	97.1	69	2	0	1	207	53	121	5.80E-29	127.5	COAE_CUTAK	reviewed	Dephospho-CoA kinase (EC 2.7.1.24) (Dephosphocoenzyme A kinase)	coaE PPA0785	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	231	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]	GO:0004140; GO:0005524; GO:0005737; GO:0015937	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN24261_c0_g1_i1	Q6AF53	COAE_LEIXX	47.4	76	39	1	231	4	3	77	2.30E-13	75.9	COAE_LEIXX	reviewed	Dephospho-CoA kinase (EC 2.7.1.24) (Dephosphocoenzyme A kinase)	coaE Lxx11440	Leifsonia xyli subsp. xyli (strain CTCB07)	198	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]	GO:0004140; GO:0005524; GO:0005737; GO:0015937	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN11831_c0_g1_i1	Q6AY55	DCAKD_RAT	44.5	227	126	0	748	68	1	227	2.40E-49	197.2	DCAKD_RAT	reviewed	Dephospho-CoA kinase domain-containing protein	Dcakd	Rattus norvegicus (Rat)	240	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937]		ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]	GO:0004140; GO:0005524; GO:0015937	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN21411_c0_g1_i1	Q9GZP9	DERL2_HUMAN	100	170	0	0	511	2	1	170	4.90E-91	335.1	DERL2_HUMAN	reviewed	Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	239	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0016032; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044322; GO:0051787; GO:1904153; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21411_c0_g1_i2	Q9GZP9	DERL2_HUMAN	100	177	0	0	532	2	1	177	2.20E-94	346.3	DERL2_HUMAN	reviewed	Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	239	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0016032; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044322; GO:0051787; GO:1904153; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4146_c0_g1_i1	Q9GZP9	DERL2_HUMAN	76.1	92	22	0	276	1	88	179	1.70E-34	146.4	DERL2_HUMAN	reviewed	Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	239	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0016032; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044322; GO:0051787; GO:1904153; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4146_c0_g1_i2	Q9GZP9	DERL2_HUMAN	73.7	57	15	0	202	32	94	150	2.50E-16	85.5	DERL2_HUMAN	reviewed	Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	239	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0016032; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044322; GO:0051787; GO:1904153; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4146_c0_g1_i3	Q9GZP9	DERL2_HUMAN	73.7	179	47	0	537	1	1	179	1.20E-72	274.2	DERL2_HUMAN	reviewed	Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	239	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0016032; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044322; GO:0051787; GO:1904153; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31844_c0_g1_i1	Q9GZP9	DERL2_HUMAN	100	98	0	0	296	3	1	98	1.00E-50	200.3	DERL2_HUMAN	reviewed	Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	239	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	misfolded protein binding [GO:0051787]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0016032; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044322; GO:0051787; GO:1904153; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31530_c0_g1_i1	Q8JIS3	DER_CHICK	61.9	113	43	0	389	51	131	243	7.80E-35	147.9	DER_CHICK	reviewed	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	DER	Gallus gallus (Chicken)	246	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; xylulose metabolic process [GO:0005997]"	cytoplasmic microtubule [GO:0005881]	"carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038	D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN4409_c0_g1_i1	Q5U550	DDA1_XENLA	65.3	72	25	0	223	8	2	73	1.90E-20	99.8	DDA1_XENLA	reviewed	DET1- and DDB1-associated protein 1	dda1	Xenopus laevis (African clawed frog)	101	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]		GO:0000209; GO:0032434; GO:0080008	protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]		blue	blue	NA	NA	NA	NA
TRINITY_DN4409_c0_g1_i2	Q5U550	DDA1_XENLA	56.8	44	19	0	262	131	2	45	1.20E-07	57.4	DDA1_XENLA	reviewed	DET1- and DDB1-associated protein 1	dda1	Xenopus laevis (African clawed frog)	101	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]		GO:0000209; GO:0032434; GO:0080008	protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]		blue	blue	NA	NA	NA	1
TRINITY_DN20475_c0_g2_i1	Q7L5Y6	DET1_HUMAN	57.3	75	31	1	162	383	8	82	3.60E-16	85.9	DET1_HUMAN	reviewed	DET1 homolog (De-etiolated-1 homolog)	DET1	Homo sapiens (Human)	550	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]	protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0016567; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein-containing complex assembly [GO:0065003]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN20475_c0_g2_i2	Q7L5Y6	DET1_HUMAN	50.7	75	36	1	162	383	8	82	3.00E-11	69.7	DET1_HUMAN	reviewed	DET1 homolog (De-etiolated-1 homolog)	DET1	Homo sapiens (Human)	550	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]	protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0016567; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein-containing complex assembly [GO:0065003]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN20475_c0_g1_i1	Q7L5Y6	DET1_HUMAN	57.2	278	110	3	2	820	80	353	4.80E-82	305.8	DET1_HUMAN	reviewed	DET1 homolog (De-etiolated-1 homolog)	DET1	Homo sapiens (Human)	550	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]	protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0016567; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein-containing complex assembly [GO:0065003]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN2138_c0_g1_i15	Q5M8L0	OTU6B_XENTR	44.8	259	116	7	303	1055	48	287	1.70E-40	168.3	OTU6B_XENTR	reviewed	Deubiquitinase OTUD6B (EC 3.4.19.12)	otud6b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	294	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]		cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN2138_c0_g1_i18	Q5M8L0	OTU6B_XENTR	44.8	259	116	7	413	1165	48	287	2.00E-40	168.3	OTU6B_XENTR	reviewed	Deubiquitinase OTUD6B (EC 3.4.19.12)	otud6b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	294	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]		cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN2138_c0_g1_i9	Q5M8L0	OTU6B_XENTR	44.8	259	116	7	236	988	48	287	1.70E-40	168.3	OTU6B_XENTR	reviewed	Deubiquitinase OTUD6B (EC 3.4.19.12)	otud6b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	294	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]		cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN4284_c0_g2_i1	Q9LQK0	DRG1_ARATH	71.7	145	40	1	436	2	13	156	3.50E-55	215.7	DRG1_ARATH	reviewed	Developmentally-regulated G-protein 1 (AtDRG1) (Developmentally-regulated G-protein 2A) (AtDRG2a)	DRG1 DRG2A At1g17470 F1L3.17 F28G4.4	Arabidopsis thaliana (Mouse-ear cress)	399	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mRNA binding [GO:0003729]; phosphatidic acid binding [GO:0070300]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; mRNA binding [GO:0003729]; phosphatidic acid binding [GO:0070300]	GO:0002181; GO:0003729; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0019003; GO:0031410; GO:0070300	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN4284_c0_g1_i1	Q9LQK0	DRG1_ARATH	54.4	149	66	1	451	5	174	320	7.60E-45	181.4	DRG1_ARATH	reviewed	Developmentally-regulated G-protein 1 (AtDRG1) (Developmentally-regulated G-protein 2A) (AtDRG2a)	DRG1 DRG2A At1g17470 F1L3.17 F28G4.4	Arabidopsis thaliana (Mouse-ear cress)	399	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mRNA binding [GO:0003729]; phosphatidic acid binding [GO:0070300]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; mRNA binding [GO:0003729]; phosphatidic acid binding [GO:0070300]	GO:0002181; GO:0003729; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0019003; GO:0031410; GO:0070300	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN9193_c0_g1_i1	Q9SVA6	DRG3_ARATH	67.4	46	15	0	85	222	3	48	7.40E-09	60.8	DRG3_ARATH	reviewed	Developmentally-regulated G-protein 3 (AtDRG3) (Developmentally-regulated G-protein 1) (AtDRG1)	DRG3 DRG1 At4g39520 F23K16.150	Arabidopsis thaliana (Mouse-ear cress)	369	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002181; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0019003	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN9193_c0_g2_i1	Q3MHP5	DRG1_BOVIN	59.2	169	69	0	5	511	199	367	1.50E-61	237.3	DRG1_BOVIN	reviewed	Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	DRG1	Bos taurus (Bovine)	367	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0002181; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872; GO:1901673	cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]		NA	NA	NA	NA	NA	NA
TRINITY_DN10380_c0_g2_i1	Q3MHP5	DRG1_BOVIN	99.4	176	1	0	529	2	1	176	1.70E-89	330.1	DRG1_BOVIN	reviewed	Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	DRG1	Bos taurus (Bovine)	367	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0002181; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872; GO:1901673	cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]		NA	NA	NA	NA	NA	NA
TRINITY_DN10380_c0_g1_i1	P32233	DRG1_MOUSE	100	156	0	0	470	3	1	156	6.00E-78	291.6	DRG1_MOUSE	reviewed	Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	Drg1 Drg Nedd-3 Nedd3	Mus musculus (Mouse)	367	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; polysome [GO:0005844]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; potassium ion binding [GO:0030955]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; polysome [GO:0005844]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; potassium ion binding [GO:0030955]	GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0008017; GO:0016604; GO:0030955; GO:0031116; GO:0042802; GO:1901673	cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]		NA	NA	NA	NA	NA	NA
TRINITY_DN29394_c0_g1_i1	Q3MHP5	DRG1_BOVIN	100	97	0	0	2	292	174	270	8.40E-50	197.2	DRG1_BOVIN	reviewed	Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	DRG1	Bos taurus (Bovine)	367	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0002181; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872; GO:1901673	cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]		NA	NA	NA	NA	NA	NA
TRINITY_DN12158_c0_g1_i1	Q3MHP5	DRG1_BOVIN	100	141	0	0	424	2	179	319	1.70E-78	293.1	DRG1_BOVIN	reviewed	Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	DRG1	Bos taurus (Bovine)	367	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0002181; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872; GO:1901673	cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]		NA	NA	NA	NA	NA	NA
TRINITY_DN12158_c0_g1_i2	Q3MHP5	DRG1_BOVIN	100	189	0	0	580	14	179	367	9.40E-109	394	DRG1_BOVIN	reviewed	Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	DRG1	Bos taurus (Bovine)	367	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0002181; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872; GO:1901673	cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673]		NA	NA	NA	NA	NA	NA
TRINITY_DN9193_c0_g3_i1	Q54HP3	DRG1_DICDI	76.9	130	30	0	393	4	50	179	3.30E-52	205.7	DRG1_DICDI	reviewed	Developmentally-regulated GTP-binding protein 1 homolog (DRG-1)	drg1 DDB_G0289317	Dictyostelium discoideum (Slime mold)	370	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]	GO:0002181; GO:0005525; GO:0005737	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN24485_c0_g1_i1	Q9QXB9	DRG2_MOUSE	100	156	0	0	3	470	199	354	5.70E-88	324.7	DRG2_MOUSE	reviewed	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)	Drg2	Mus musculus (Mouse)	364	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0043231; GO:0046872	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN24485_c0_g1_i2	Q9QXB9	DRG2_MOUSE	100	87	0	0	3	263	199	285	4.30E-45	181.4	DRG2_MOUSE	reviewed	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)	Drg2	Mus musculus (Mouse)	364	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0043231; GO:0046872	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN1487_c0_g1_i1	Q58D56	DRG2_BOVIN	77.2	364	83	0	83	1174	1	364	1.50E-159	563.9	DRG2_BOVIN	reviewed	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)	DRG2	Bos taurus (Bovine)	364	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0046872	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN17267_c0_g1_i1	P55039	DRG2_HUMAN	99.3	153	1	0	460	2	24	176	2.00E-77	289.7	DRG2_HUMAN	reviewed	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)	DRG2	Homo sapiens (Human)	364	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872	cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN17267_c0_g1_i4	Q9QXB9	DRG2_MOUSE	100	153	0	0	460	2	24	176	1.20E-77	290.4	DRG2_MOUSE	reviewed	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)	Drg2	Mus musculus (Mouse)	364	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0043231; GO:0046872	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN30790_c0_g1_i1	F4ILR7	DEXH1_ARATH	53.8	78	30	1	7	222	234	311	1.60E-16	86.3	DEXH1_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH1 (EC 3.6.4.13)	At2g35920 F11F19.17	Arabidopsis thaliana (Mouse-ear cress)	995	nucleus [GO:0005634]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleus [GO:0005634]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN22315_c0_g2_i1	F4ILR7	DEXH1_ARATH	43.2	74	40	1	1	222	325	396	9.10E-12	70.5	DEXH1_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH1 (EC 3.6.4.13)	At2g35920 F11F19.17	Arabidopsis thaliana (Mouse-ear cress)	995	nucleus [GO:0005634]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleus [GO:0005634]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN35425_c0_g1_i1	F4JAA5	SKI2_ARATH	77.4	93	21	0	311	33	710	802	3.00E-37	155.6	SKI2_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH11 (EC 3.6.4.13) (AtHELPS) (Protein SKI2 homolog) (AtSKI2)	SKI2 HELPS At3g46960 F13I12.10 T6H20.10	Arabidopsis thaliana (Mouse-ear cress)	1347	"cytoplasm [GO:0005737]; Ski complex [GO:0055087]; vacuole [GO:0005773]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; positive regulation of wax biosynthetic process [GO:1904278]; posttranscriptional gene silencing [GO:0016441]; potassium ion transport [GO:0006813]; regulation of production of siRNA involved in RNA interference [GO:0090065]; response to potassium ion [GO:0035864]; RNA catabolic process [GO:0006401]; RNA fragment catabolic process [GO:0000292]"	cytoplasm [GO:0005737]; Ski complex [GO:0055087]; vacuole [GO:0005773]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000292; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005773; GO:0006401; GO:0006813; GO:0016441; GO:0035864; GO:0055087; GO:0070478; GO:0090065; GO:1904278	"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; positive regulation of wax biosynthetic process [GO:1904278]; posttranscriptional gene silencing [GO:0016441]; potassium ion transport [GO:0006813]; regulation of production of siRNA involved in RNA interference [GO:0090065]; response to potassium ion [GO:0035864]; RNA catabolic process [GO:0006401]; RNA fragment catabolic process [GO:0000292]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33727_c0_g1_i1	Q9SYP1	DEXHC_ARATH	65.9	220	73	2	1	660	503	720	7.80E-75	281.6	DEXHC_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH12 (EC 3.6.4.13) (BRR2 homolog A) (AtBRR2A) (Pre-mRNA-splicing helicase BRR2A) (Protein EMBRYO DEFECTIVE 1507)	BRR2A EMB1507 At1g20960 F9H16.5	Arabidopsis thaliana (Mouse-ear cress)	2171	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; vegetative to reproductive phase transition of meristem [GO:0010228]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005829; GO:0006397; GO:0010228	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; vegetative to reproductive phase transition of meristem [GO:0010228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40185_c0_g1_i1	Q9SYP1	DEXHC_ARATH	81.5	65	12	0	215	21	1273	1337	1.20E-25	116.7	DEXHC_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH12 (EC 3.6.4.13) (BRR2 homolog A) (AtBRR2A) (Pre-mRNA-splicing helicase BRR2A) (Protein EMBRYO DEFECTIVE 1507)	BRR2A EMB1507 At1g20960 F9H16.5	Arabidopsis thaliana (Mouse-ear cress)	2171	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; vegetative to reproductive phase transition of meristem [GO:0010228]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005829; GO:0006397; GO:0010228	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; vegetative to reproductive phase transition of meristem [GO:0010228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24032_c0_g1_i1	O48534	DEXHD_ARATH	62.5	72	27	0	3	218	1413	1484	3.90E-23	108.2	DEXHD_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH13 (EC 3.6.4.13) (BRR2 homolog B) (AtBRR2B) (Pre-mRNA-splicing helicase BRR2B)	BRR2B At2g42270 T24P15.18	Arabidopsis thaliana (Mouse-ear cress)	2172	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0009506	"mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22754_c0_g1_i1	Q9FNQ1	DEXHE_ARATH	64.5	110	39	0	6	335	791	900	3.00E-38	159.1	DEXHE_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH14 (EC 3.6.4.13) (BRR2 homolog C) (AtBRR2C) (Pre-mRNA-splicing helicase BRR2C)	BRR2C At5g61140 MAF19.14	Arabidopsis thaliana (Mouse-ear cress)	2157	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0043138	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN28635_c0_g1_i1	F4IDQ6	NIH_ARATH	52.7	131	62	0	421	29	604	734	8.20E-36	151.4	NIH_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH2 (EC 3.6.4.13) (DEIH-box RNA/DNA helicase) (EC 3.6.4.12)	NIH At1g06670 F12K11.4	Arabidopsis thaliana (Mouse-ear cress)	1576	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA metabolic process [GO:0006259]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006259	DNA metabolic process [GO:0006259]		NA	NA	NA	NA	NA	NA
TRINITY_DN16881_c0_g1_i1	F4HYJ7	DEXH3_ARATH	59.1	66	27	0	201	4	416	481	1.30E-17	89.7	DEXH3_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH3 (EC 3.6.4.13)	At1g48650 F11I4_16	Arabidopsis thaliana (Mouse-ear cress)	1197	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN17907_c0_g1_i1	F4HYJ7	DEXH3_ARATH	60.2	93	36	1	3	281	397	488	1.00E-23	110.5	DEXH3_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH3 (EC 3.6.4.13)	At1g48650 F11I4_16	Arabidopsis thaliana (Mouse-ear cress)	1197	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN22315_c0_g1_i1	F4HYJ7	DEXH3_ARATH	44.9	89	47	1	14	274	297	385	2.40E-17	89.4	DEXH3_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH3 (EC 3.6.4.13)	At1g48650 F11I4_16	Arabidopsis thaliana (Mouse-ear cress)	1197	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN40676_c0_g1_i1	F4INY4	HVT1_ARATH	55.3	94	42	0	48	329	585	678	1.30E-22	107.1	HVT1_ARATH	reviewed	DExH-box ATP-dependent RNA helicase DExH6 (EC 3.6.4.13) (Protein HELICASE IN VASCULAR TISSUE AND TAPETUM) (EC 3.6.4.12)	HVT1 At2g30800 F7F1.1 T11J7.19	Arabidopsis thaliana (Mouse-ear cress)	1299	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003678; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9493_c0_g1_i11	Q9EPS3	GLCE_MOUSE	47.9	526	258	10	1680	121	103	618	2.70E-133	477.2	GLCE_MOUSE	reviewed	D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)	Glce	Mus musculus (Mouse)	618	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]"	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464; GO:0050379	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]		NA	NA	NA	NA	NA	NA
TRINITY_DN9493_c0_g1_i12	Q9EPS3	GLCE_MOUSE	47.9	526	258	10	1662	103	103	618	2.70E-133	477.2	GLCE_MOUSE	reviewed	D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)	Glce	Mus musculus (Mouse)	618	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]"	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464; GO:0050379	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]		NA	NA	NA	NA	NA	NA
TRINITY_DN9493_c0_g1_i5	Q9EPS3	GLCE_MOUSE	48.2	490	238	10	1572	121	139	618	1.10E-122	441.8	GLCE_MOUSE	reviewed	D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)	Glce	Mus musculus (Mouse)	618	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]"	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464; GO:0050379	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]		NA	NA	NA	NA	NA	NA
TRINITY_DN9493_c0_g1_i8	Q9EPS3	GLCE_MOUSE	48.2	490	238	10	1572	121	139	618	1.10E-122	441.8	GLCE_MOUSE	reviewed	D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)	Glce	Mus musculus (Mouse)	618	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]"	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464; GO:0050379	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]		NA	NA	NA	NA	NA	NA
TRINITY_DN9493_c0_g1_i13	O18756	GLCE_BOVIN	60.3	73	29	0	339	121	545	617	5.00E-22	105.5	GLCE_BOVIN	reviewed	D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)	GLCE	Bos taurus (Bovine)	617	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]"	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]		NA	NA	NA	NA	NA	NA
TRINITY_DN32782_c0_g1_i1	Q1PDI2	DGK4_ARATH	61	59	20	1	218	42	155	210	1.10E-14	80.1	DGK4_ARATH	reviewed	Diacylglycerol kinase 4 (AtDGK4) (DAG kinase 4) (EC 2.7.1.107) (Diglyceride kinase 4) (DGK 4)	DGK4 At5g57690 MRI1.5	Arabidopsis thaliana (Mouse-ear cress)	487	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; NAD+ kinase activity [GO:0003951]; defense response [GO:0006952]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005886; GO:0006952; GO:0007205	defense response [GO:0006952]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN40326_c0_g1_i1	P23743	DGKA_HUMAN	100	105	0	0	3	317	404	508	7.00E-58	224.2	DGKA_HUMAN	reviewed	Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha)	DGKA DAGK DAGK1	Homo sapiens (Human)	735	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN29015_c0_g1_i1	O88673	DGKA_MOUSE	99.1	115	1	0	347	3	363	477	1.00E-65	250.4	DGKA_MOUSE	reviewed	Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha)	Dgka Dagk1	Mus musculus (Mouse)	730	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016301; GO:0035556; GO:0046339; GO:0046486; GO:0046834	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN6066_c0_g1_i1	Q16760	DGKD_HUMAN	76.5	162	36	2	1	483	202	362	8.90E-74	277.7	DGKD_HUMAN	reviewed	Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta)	DGKD KIAA0145	Homo sapiens (Human)	1214	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0007275; GO:0010033; GO:0015031; GO:0019900; GO:0019932; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370	diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN6066_c0_g1_i2	Q16760	DGKD_HUMAN	59.9	474	169	6	1	1413	202	657	1.50E-143	511.1	DGKD_HUMAN	reviewed	Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta)	DGKD KIAA0145	Homo sapiens (Human)	1214	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0007275; GO:0010033; GO:0015031; GO:0019900; GO:0019932; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370	diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15001_c0_g1_i1	P52429	DGKE_HUMAN	49	157	78	1	77	541	303	459	9.10E-38	158.3	DGKE_HUMAN	reviewed	Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon)	DGKE DAGK5	Homo sapiens (Human)	567	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0006661; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN33399_c0_g1_i1	P52429	DGKE_HUMAN	45.1	82	39	1	229	2	273	354	3.70E-14	78.6	DGKE_HUMAN	reviewed	Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon)	DGKE DAGK5	Homo sapiens (Human)	567	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0006661; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN13468_c0_g1_i2	A8JQ65	DGKH_DROME	50.9	499	212	7	1434	28	1400	1895	9.00E-131	468.8	DGKH_DROME	reviewed	Diacylglycerol kinase eta (DAG kinase eta) (EC 2.7.1.107)	CG34384	Drosophila melanogaster (Fruit fly)	1895	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0007205; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN13468_c0_g1_i3	A8JQ65	DGKH_DROME	56	373	146	4	1259	186	1400	1769	1.70E-112	407.9	DGKH_DROME	reviewed	Diacylglycerol kinase eta (DAG kinase eta) (EC 2.7.1.107)	CG34384	Drosophila melanogaster (Fruit fly)	1895	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0007205; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]		NA	NA	NA	NA	NA	NA
TRINITY_DN15001_c0_g1_i3	P49619	DGKG_HUMAN	31.9	521	289	17	180	1604	272	772	1.70E-62	241.9	DGKG_HUMAN	reviewed	Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (Diglyceride kinase gamma) (DGK-gamma)	DGKG DAGK3	Homo sapiens (Human)	791	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005829; GO:0005856; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0048666; GO:0050773; GO:0090038	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773]		NA	NA	NA	NA	NA	NA
TRINITY_DN15001_c0_g1_i9	P49619	DGKG_HUMAN	31.9	521	289	17	182	1606	272	772	1.70E-62	241.9	DGKG_HUMAN	reviewed	Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (Diglyceride kinase gamma) (DGK-gamma)	DGKG DAGK3	Homo sapiens (Human)	791	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005829; GO:0005856; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0048666; GO:0050773; GO:0090038	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773]		NA	NA	NA	NA	NA	NA
TRINITY_DN32182_c0_g1_i1	P52824	DGKQ_HUMAN	100	75	0	0	228	4	628	702	4.30E-41	167.9	DGKQ_HUMAN	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (DGKtheta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	DGKQ DAGK4	Homo sapiens (Human)	942	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030168; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN6689_c0_g1_i1	Q6P5E8	DGKQ_MOUSE	45.6	136	70	2	3	410	114	245	3.90E-30	132.9	DGKQ_MOUSE	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	Dgkq	Mus musculus (Mouse)	934	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		blue	blue	NA	NA	NA	NA
TRINITY_DN6689_c0_g1_i2	Q6P5E8	DGKQ_MOUSE	43.9	114	61	1	19	360	135	245	7.10E-23	108.6	DGKQ_MOUSE	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	Dgkq	Mus musculus (Mouse)	934	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN29429_c0_g1_i1	Q6P5E8	DGKQ_MOUSE	80	80	16	0	2	241	158	237	3.50E-33	141.7	DGKQ_MOUSE	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	Dgkq	Mus musculus (Mouse)	934	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN356_c0_g1_i1	Q6P5E8	DGKQ_MOUSE	53.9	373	161	5	21	1139	544	905	1.90E-111	404.1	DGKQ_MOUSE	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	Dgkq	Mus musculus (Mouse)	934	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		blue	blue	NA	NA	NA	NA
TRINITY_DN356_c0_g1_i2	Q6P5E8	DGKQ_MOUSE	53.9	380	165	4	21	1160	544	913	1.20E-113	411.4	DGKQ_MOUSE	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	Dgkq	Mus musculus (Mouse)	934	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN356_c0_g1_i3	Q6P5E8	DGKQ_MOUSE	51.9	401	182	5	21	1223	544	933	1.80E-112	407.5	DGKQ_MOUSE	reviewed	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	Dgkq	Mus musculus (Mouse)	934	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0045202; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:1903432; GO:2000064; GO:2000182	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C signaling [GO:0070528]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN25925_c0_g1_i1	Q13574	DGKZ_HUMAN	100	130	0	0	1	390	483	612	2.70E-75	282.3	DGKZ_HUMAN	reviewed	Diacylglycerol kinase zeta (DAG kinase zeta) (EC 2.7.1.107) (Diglyceride kinase zeta) (DGK-zeta)	DGKZ DAGK6	Homo sapiens (Human)	928	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid kinase activity [GO:0001727]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein C-terminus binding [GO:0008022]; cell migration [GO:0016477]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid kinase activity [GO:0001727]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein C-terminus binding [GO:0008022]	GO:0001727; GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008022; GO:0016301; GO:0016477; GO:0016607; GO:0030027; GO:0030168; GO:0031571; GO:0035556; GO:0045930; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050860; GO:0051966; GO:0090216	"cell migration [GO:0016477]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6924_c0_g1_i1	Q6WQJ1	DGLA_MOUSE	44.3	253	136	2	744	1	181	433	4.50E-61	236.1	DGLA_MOUSE	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	Dagla Kiaa0659 Nsddr	Mus musculus (Mouse)	1044	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN6924_c0_g1_i2	Q6WQJ1	DGLA_MOUSE	39.3	150	90	1	530	81	181	329	1.40E-30	134.4	DGLA_MOUSE	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	Dagla Kiaa0659 Nsddr	Mus musculus (Mouse)	1044	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN6924_c0_g1_i3	Q6WQJ1	DGLA_MOUSE	49.1	112	49	2	312	1	322	433	3.40E-23	109	DGLA_MOUSE	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	Dagla Kiaa0659 Nsddr	Mus musculus (Mouse)	1044	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i19	Q9Y4D2	DGLA_HUMAN	59.7	67	27	0	9	209	439	505	1.20E-16	87.8	DGLA_HUMAN	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	DAGLA C11orf11 KIAA0659 NSDDR	Homo sapiens (Human)	1042	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i2	Q6WQJ1	DGLA_MOUSE	51.4	179	84	2	173	709	439	614	7.60E-45	182.2	DGLA_MOUSE	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	Dagla Kiaa0659 Nsddr	Mus musculus (Mouse)	1044	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i22	Q6WQJ1	DGLA_MOUSE	51.4	179	84	2	166	702	439	614	7.50E-45	182.2	DGLA_MOUSE	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	Dagla Kiaa0659 Nsddr	Mus musculus (Mouse)	1044	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN16825_c0_g1_i1	Q9Y4D2	DGLA_HUMAN	50	80	40	0	18	257	584	663	7.40E-19	94.7	DGLA_HUMAN	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	DAGLA C11orf11 KIAA0659 NSDDR	Homo sapiens (Human)	1042	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN39829_c0_g1_i1	Q9Y4D2	DGLA_HUMAN	49.3	73	37	0	6	224	49	121	5.40E-12	71.2	DGLA_HUMAN	reviewed	Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)	DAGLA C11orf11 KIAA0659 NSDDR	Homo sapiens (Human)	1042	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i11	Q91WC9	DGLB_MOUSE	44.8	67	32	1	367	567	415	476	1.10E-07	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i14	Q91WC9	DGLB_MOUSE	44.8	67	32	1	166	366	415	476	8.00E-08	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i15	Q91WC9	DGLB_MOUSE	44.8	67	32	1	367	567	415	476	1.10E-07	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i18	Q91WC9	DGLB_MOUSE	44.8	67	32	1	173	373	415	476	8.00E-08	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i3	Q91WC9	DGLB_MOUSE	44.8	67	32	1	173	373	415	476	8.10E-08	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i4	Q91WC9	DGLB_MOUSE	44.8	67	32	1	367	567	415	476	1.00E-07	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN11033_c0_g1_i6	Q91WC9	DGLB_MOUSE	44.8	67	32	1	166	366	415	476	7.90E-08	58.9	DGLB_MOUSE	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.-) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	Daglb	Mus musculus (Mouse)	669	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006690; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; icosanoid metabolic process [GO:0006690]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN3314_c0_g1_i1	Q8NCG7	DGLB_HUMAN	39	282	150	7	869	48	403	670	5.90E-44	179.5	DGLB_HUMAN	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.-) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	DAGLB	Homo sapiens (Human)	672	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN3314_c0_g1_i10	Q8NCG7	DGLB_HUMAN	38.8	330	180	7	1013	48	355	670	6.30E-55	216.1	DGLB_HUMAN	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.-) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	DAGLB	Homo sapiens (Human)	672	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN3314_c0_g1_i2	Q8NCG7	DGLB_HUMAN	34.3	720	401	19	2141	48	1	670	1.70E-105	385.2	DGLB_HUMAN	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.-) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	DAGLB	Homo sapiens (Human)	672	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN3314_c0_g1_i4	Q8NCG7	DGLB_HUMAN	34.7	715	398	20	2120	48	1	670	3.40E-106	387.5	DGLB_HUMAN	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.-) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	DAGLB	Homo sapiens (Human)	672	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN3314_c0_g1_i5	Q8NCG7	DGLB_HUMAN	46.2	169	91	0	591	85	355	523	9.30E-38	158.3	DGLB_HUMAN	reviewed	Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.-) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	DAGLB	Homo sapiens (Human)	672	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046872; GO:0050727; GO:0071926; GO:0098921	arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]		NA	NA	NA	NA	NA	NA
TRINITY_DN5170_c0_g1_i1	Q9ERM3	DGAT1_RAT	60	80	32	0	1	240	327	406	1.90E-26	119.4	DGAT1_RAT	reviewed	Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase)	Dgat1 Dgat	Rattus norvegicus (Rat)	498	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; response to human chorionic gonadotropin [GO:0044752]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0005886; GO:0006640; GO:0008374; GO:0010867; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0043231; GO:0044752; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491	diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; response to human chorionic gonadotropin [GO:0044752]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]		blue	blue	NA	NA	NA	NA
TRINITY_DN25090_c0_g1_i2	Q54GC1	DGAT2_DICDI	54.7	139	62	1	182	598	156	293	2.80E-39	163.3	DGAT2_DICDI	reviewed	Diacylglycerol O-acyltransferase 2 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase 2)	dgat2 DDB_G0290279	Dictyostelium discoideum (Slime mold)	330	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum membrane [GO:1990578]; diacylglycerol O-acyltransferase activity [GO:0004144]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum membrane [GO:1990578]	diacylglycerol O-acyltransferase activity [GO:0004144]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]	GO:0004144; GO:0005783; GO:0005789; GO:0005811; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0008374; GO:0016021; GO:0019432; GO:0050252; GO:1990578	diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN25090_c0_g1_i2	Q54GC1	DGAT2_DICDI	52.6	57	27	0	12	182	71	127	7.60E-13	75.5	DGAT2_DICDI	reviewed	Diacylglycerol O-acyltransferase 2 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase 2)	dgat2 DDB_G0290279	Dictyostelium discoideum (Slime mold)	330	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum membrane [GO:1990578]; diacylglycerol O-acyltransferase activity [GO:0004144]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum membrane [GO:1990578]	diacylglycerol O-acyltransferase activity [GO:0004144]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]	GO:0004144; GO:0005783; GO:0005789; GO:0005811; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0008374; GO:0016021; GO:0019432; GO:0050252; GO:1990578	diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN25090_c0_g1_i1	Q96UY1	DGT2B_UMBRA	63.3	60	22	0	3	182	82	141	8.10E-18	90.5	DGT2B_UMBRA	reviewed	Diacylglycerol O-acyltransferase 2B (EC 2.3.1.20) (Diglyceride acyltransferase 2B) (MrDGAT2B)	DGAT2B	Umbelopsis ramanniana (Oleaginous fungus) (Mortierella ramanniana)	349	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	diacylglycerol O-acyltransferase activity [GO:0004144]	GO:0004144; GO:0005789; GO:0006071; GO:0016021; GO:0019432	glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN4530_c0_g1_i1	Q4V8I4	DEFI8_RAT	45.5	396	198	3	39	1226	62	439	1.00E-97	358.6	DEFI8_RAT	reviewed	Differentially expressed in FDCP 8 homolog (DEF-8)	Def8	Rattus norvegicus (Rat)	451	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		NA	NA	NA	NA	NA	NA
TRINITY_DN4530_c0_g1_i10	Q4V8I4	DEFI8_RAT	46.9	382	199	2	39	1184	62	439	2.80E-100	367.1	DEFI8_RAT	reviewed	Differentially expressed in FDCP 8 homolog (DEF-8)	Def8	Rattus norvegicus (Rat)	451	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		NA	NA	NA	NA	NA	NA
TRINITY_DN4530_c0_g1_i12	Q4V8I4	DEFI8_RAT	46.9	382	199	2	39	1184	62	439	4.00E-100	366.7	DEFI8_RAT	reviewed	Differentially expressed in FDCP 8 homolog (DEF-8)	Def8	Rattus norvegicus (Rat)	451	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		NA	NA	NA	NA	NA	NA
TRINITY_DN4530_c0_g1_i2	Q4V8I4	DEFI8_RAT	45.3	397	198	3	39	1229	62	439	2.20E-98	360.9	DEFI8_RAT	reviewed	Differentially expressed in FDCP 8 homolog (DEF-8)	Def8	Rattus norvegicus (Rat)	451	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		NA	NA	NA	NA	NA	NA
TRINITY_DN4530_c0_g1_i6	Q4V8I4	DEFI8_RAT	45.5	396	198	3	39	1226	62	439	1.10E-97	358.6	DEFI8_RAT	reviewed	Differentially expressed in FDCP 8 homolog (DEF-8)	Def8	Rattus norvegicus (Rat)	451	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		NA	NA	NA	NA	NA	NA
TRINITY_DN4530_c0_g1_i8	Q4V8I4	DEFI8_RAT	45.3	397	198	3	39	1229	62	439	2.00E-98	360.9	DEFI8_RAT	reviewed	Differentially expressed in FDCP 8 homolog (DEF-8)	Def8	Rattus norvegicus (Rat)	451	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		NA	NA	NA	NA	NA	NA
TRINITY_DN36196_c0_g1_i1	Q642T7	DIEXF_XENTR	40.3	236	129	5	3	698	536	763	2.70E-42	173.7	DIEXF_XENTR	reviewed	Digestive organ expansion factor homolog	diexf def	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	765	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism development [GO:0007275]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0005730; GO:0007275; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism development [GO:0007275]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i9	P52898	DDBX_BOVIN	44.3	210	112	3	2	625	80	286	1.50E-38	161	DDBX_BOVIN	reviewed	Dihydrodiol dehydrogenase 3 (EC 1.-.-.-) (Prostaglandin F synthase)		Bos taurus (Bovine)	323	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; C21-steroid hormone metabolic process [GO:0008207]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]	GO:0004032; GO:0005496; GO:0005829; GO:0006693; GO:0008106; GO:0008202; GO:0008207; GO:0016229; GO:0016491; GO:0032052; GO:0042448; GO:0044597; GO:0044598; GO:0047023; GO:0047086	C21-steroid hormone metabolic process [GO:0008207]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN4965_c0_g1_i1	P28019	DYR_AEDAL	57.8	45	19	0	241	107	109	153	3.70E-11	68.6	DYR_AEDAL	reviewed	Dihydrofolate reductase (EC 1.5.1.3)	DHFR	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	186	dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]	GO:0004146; GO:0006545; GO:0006730; GO:0046654; GO:0050661	glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4965_c0_g1_i2	P28019	DYR_AEDAL	55.9	34	15	0	208	107	120	153	5.40E-05	48.1	DYR_AEDAL	reviewed	Dihydrofolate reductase (EC 1.5.1.3)	DHFR	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	186	dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]	GO:0004146; GO:0006545; GO:0006730; GO:0046654; GO:0050661	glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4965_c0_g1_i3	P28019	DYR_AEDAL	50	74	37	0	224	3	109	182	5.60E-17	87.8	DYR_AEDAL	reviewed	Dihydrofolate reductase (EC 1.5.1.3)	DHFR	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	186	dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]	GO:0004146; GO:0006545; GO:0006730; GO:0046654; GO:0050661	glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN28223_c0_g1_i1	P52992	DLDH_CUPNH	90.3	93	9	0	281	3	302	394	1.30E-47	189.9	DLDH_CUPNH	reviewed	Dihydrolipoyl dehydrogenase (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (E3 component of 2-oxoglutarate dehydrogenase complex)	odhL H16_A2323	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	474	cytoplasm [GO:0005737]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0004148; GO:0005737; GO:0006096; GO:0045454; GO:0050660	cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN5238_c0_g1_i1	O18480	DLDH_MANSE	55.8	52	23	0	56	211	7	58	1.70E-07	56.6	DLDH_MANSE	reviewed	Dihydrolipoyl dehydrogenase (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (E3)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	497	cytoplasm [GO:0005737]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0004148; GO:0005737; GO:0006096; GO:0045454; GO:0050660	cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN7487_c0_g1_i1	Q9M5K2	DLDH2_ARATH	77.3	75	17	0	1	225	355	429	7.90E-27	120.6	DLDH2_ARATH	reviewed	"Dihydrolipoyl dehydrogenase 2, mitochondrial (AtmLPD2) (mtLPD2) (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase 2) (Glycine cleavage system L protein 2) (Pyruvate dehydrogenase complex E3 subunit 2) (E3-2) (PDC-E3 2)"	LPD2 At3g17240 MGD8.7	Arabidopsis thaliana (Mouse-ear cress)	507	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; copper ion binding [GO:0005507]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; zinc ion binding [GO:0008270]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]; response to cadmium ion [GO:0046686]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]	ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; copper ion binding [GO:0005507]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; zinc ion binding [GO:0008270]	GO:0004148; GO:0005507; GO:0005524; GO:0005739; GO:0005747; GO:0005759; GO:0005829; GO:0008270; GO:0045252; GO:0045454; GO:0046686; GO:0050660; GO:0050897; GO:0055114	cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN5371_c0_g1_i1	P31046	DLDH3_PSEPU	58.5	118	44	1	2	340	106	223	1.60E-31	136.7	DLDH3_PSEPU	reviewed	Dihydrolipoyl dehydrogenase 3 (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase 3) (LPD-3)	lpd3	Pseudomonas putida (Arthrobacter siderocapsulatus)	466	cytoplasm [GO:0005737]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0004148; GO:0005737; GO:0006096; GO:0045454; GO:0050660	cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN30136_c0_g1_i1	P09623	DLDH_PIG	60.8	222	85	2	705	40	289	508	3.10E-69	263.1	DLDH_PIG	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)"	DLD LAD	Sus scrofa (Pig)	509	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]; oxidation-reduction process [GO:0055114]	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0055114; GO:0106077	cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN30136_c0_g1_i2	P09623	DLDH_PIG	59.3	221	80	2	675	40	289	508	2.40E-66	253.4	DLDH_PIG	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)"	DLD LAD	Sus scrofa (Pig)	509	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]; oxidation-reduction process [GO:0055114]	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0055114; GO:0106077	cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN5238_c0_g1_i2	P09623	DLDH_PIG	72.9	469	126	1	125	1528	41	509	1.00E-205	717.6	DLDH_PIG	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)"	DLD LAD	Sus scrofa (Pig)	509	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]; oxidation-reduction process [GO:0055114]	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0055114; GO:0106077	cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]; oxidation-reduction process [GO:0055114]		blue	blue	NA	NA	NA	NA
TRINITY_DN9924_c0_g1_i1	Q60HG3	DLDH_MACFA	65.6	93	32	0	284	6	182	274	9.70E-27	120.6	DLDH_MACFA	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)"	DLD QflA-16416 QtsA-11266	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	509	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]	acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077	cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]		NA	NA	NA	NA	NA	NA
TRINITY_DN36413_c0_g1_i1	O17953	DLDH_CAEEL	69.5	59	16	1	178	2	19	75	7.30E-16	84	DLDH_CAEEL	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)"	dld-1 LLC1.3	Caenorhabditis elegans	495	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0004148; GO:0005739; GO:0005759; GO:0006633; GO:0045252; GO:0045454; GO:0050660; GO:0055114	cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN38894_c0_g1_i1	P09622	DLDH_HUMAN	100	232	0	0	716	21	278	509	4.80E-131	468.4	DLDH_HUMAN	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)"	DLD GCSL LAD PHE3	Homo sapiens (Human)	509	"acrosomal matrix [GO:0043159]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; lipoamide binding [GO:0043544]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; aging [GO:0007568]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; dihydrolipoamide metabolic process [GO:0051068]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; lipoate metabolic process [GO:0009106]; lysine catabolic process [GO:0006554]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]; tricarboxylic acid cycle [GO:0006099]"	acrosomal matrix [GO:0043159]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; lipoamide binding [GO:0043544]; NAD binding [GO:0051287]	GO:0004148; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006103; GO:0006120; GO:0006508; GO:0006554; GO:0007369; GO:0007568; GO:0009083; GO:0009106; GO:0031514; GO:0042391; GO:0043159; GO:0043544; GO:0045252; GO:0045254; GO:0045454; GO:0048240; GO:0050660; GO:0051068; GO:0051287; GO:0055114; GO:0061732; GO:0106077	"2-oxoglutarate metabolic process [GO:0006103]; aging [GO:0007568]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; dihydrolipoamide metabolic process [GO:0051068]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; lipoate metabolic process [GO:0009106]; lysine catabolic process [GO:0006554]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]; tricarboxylic acid cycle [GO:0006099]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37124_c0_g1_i1	P09622	DLDH_HUMAN	100	111	0	0	334	2	167	277	2.00E-55	216.1	DLDH_HUMAN	reviewed	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)"	DLD GCSL LAD PHE3	Homo sapiens (Human)	509	"acrosomal matrix [GO:0043159]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; lipoamide binding [GO:0043544]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; aging [GO:0007568]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; dihydrolipoamide metabolic process [GO:0051068]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; lipoate metabolic process [GO:0009106]; lysine catabolic process [GO:0006554]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]; tricarboxylic acid cycle [GO:0006099]"	acrosomal matrix [GO:0043159]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; lipoamide binding [GO:0043544]; NAD binding [GO:0051287]	GO:0004148; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006103; GO:0006120; GO:0006508; GO:0006554; GO:0007369; GO:0007568; GO:0009083; GO:0009106; GO:0031514; GO:0042391; GO:0043159; GO:0043544; GO:0045252; GO:0045254; GO:0045454; GO:0048240; GO:0050660; GO:0051068; GO:0051287; GO:0055114; GO:0061732; GO:0106077	"2-oxoglutarate metabolic process [GO:0006103]; aging [GO:0007568]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; dihydrolipoamide metabolic process [GO:0051068]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; lipoate metabolic process [GO:0009106]; lysine catabolic process [GO:0006554]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; oxidation-reduction process [GO:0055114]; proteolysis [GO:0006508]; pyruvate metabolic process [GO:0006090]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]; tricarboxylic acid cycle [GO:0006099]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36974_c0_g1_i1	P10515	ODP2_HUMAN	100	103	0	0	309	1	474	576	5.60E-52	204.5	ODP2_HUMAN	reviewed	"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)"	DLAT DLTA	Homo sapiens (Human)	647	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]	dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]	GO:0004742; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0030431; GO:0042802; GO:0045254	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN28441_c0_g1_i1	Q8BMF4	ODP2_MOUSE	100	102	0	0	1	306	480	581	1.90E-52	206.1	ODP2_MOUSE	reviewed	"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)"	Dlat	Mus musculus (Mouse)	642	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pyruvate dehydrogenase complex [GO:0045254]	dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004742; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0030431; GO:0034604; GO:0042802; GO:0043209; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN35065_c0_g1_i1	Q8BMF4	ODP2_MOUSE	100	66	0	0	2	199	226	291	2.70E-31	135.2	ODP2_MOUSE	reviewed	"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)"	Dlat	Mus musculus (Mouse)	642	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pyruvate dehydrogenase complex [GO:0045254]	dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004742; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0030431; GO:0034604; GO:0042802; GO:0043209; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2263_c0_g1_i3	Q19749	ODP2_CAEEL	60.4	379	113	6	169	1200	70	446	1.70E-96	354.4	ODP2_CAEEL	reviewed	"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)"	dlat-1 F23B12.5	Caenorhabditis elegans	507	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]	dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]	GO:0004742; GO:0005967; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN2263_c0_g1_i4	Q8BMF4	ODP2_MOUSE	59.2	380	135	6	184	1305	215	580	1.20E-100	368.2	ODP2_MOUSE	reviewed	"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)"	Dlat	Mus musculus (Mouse)	642	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pyruvate dehydrogenase complex [GO:0045254]	dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004742; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0030431; GO:0034604; GO:0042802; GO:0043209; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN7441_c0_g2_i1	P52993	ODO2_CUPNH	91.8	231	19	0	701	9	186	416	1.00E-117	424.1	ODO2_CUPNH	reviewed	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex)	sucB odhB H16_A2324	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	416	oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099]	oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]	GO:0004149; GO:0006099; GO:0033512; GO:0045252	L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN7441_c0_g1_i1	P52993	ODO2_CUPNH	91.9	74	6	0	224	3	319	392	1.90E-33	142.5	ODO2_CUPNH	reviewed	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex)	sucB odhB H16_A2324	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	416	oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099]	oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]	GO:0004149; GO:0006099; GO:0033512; GO:0045252	L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN7799_c1_g1_i1	P20708	ODO2_AZOVI	67.5	154	50	0	515	54	246	399	4.30E-57	222.2	ODO2_AZOVI	reviewed	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex)	sucB odhB	Azotobacter vinelandii	399	oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099]	oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]	GO:0004149; GO:0006099; GO:0033512; GO:0045252	L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN25382_c0_g1_i1	P11179	ODO2_BOVIN	65	234	82	0	40	741	222	455	1.90E-83	310.5	ODO2_BOVIN	reviewed	"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)"	DLST	Bos taurus (Bovine)	455	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; transferase activity, transferring acyl groups [GO:0016746]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	"dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0004149; GO:0005634; GO:0005739; GO:0005759; GO:0006099; GO:0006103; GO:0006104; GO:0016746; GO:0033512; GO:0045252; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2263_c0_g1_i1	Q90512	ODO2_TAKRU	66.4	411	105	2	40	1266	26	405	9.00E-118	425.2	ODO2_TAKRU	reviewed	"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment)"	dlst	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	409	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]	GO:0004149; GO:0005634; GO:0005739; GO:0005759; GO:0006099; GO:0006103; GO:0006104; GO:0033512; GO:0045252; GO:0106077	2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN29497_c0_g1_i1	Q8XYY7	PYRD_RALSO	95.7	69	3	0	210	4	68	136	4.00E-33	141.4	PYRD_RALSO	reviewed	Dihydroorotate dehydrogenase (quinone) (EC 1.3.5.2) (DHOdehase) (DHOD) (DHODase) (Dihydroorotate oxidase)	pyrD RSc1619 RS03940	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	344	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	dihydroorotate dehydrogenase activity [GO:0004152]	GO:0004152; GO:0005737; GO:0005886; GO:0006207; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN31072_c0_g1_i1	Q2GBY1	PYRD_NOVAD	62.3	69	26	0	210	4	279	347	1.80E-17	89.4	PYRD_NOVAD	reviewed	Dihydroorotate dehydrogenase (quinone) (EC 1.3.5.2) (DHOdehase) (DHOD) (DHODase) (Dihydroorotate oxidase)	pyrD Saro_0193	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	349	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	dihydroorotate dehydrogenase activity [GO:0004152]	GO:0004152; GO:0005737; GO:0005886; GO:0006207; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]		NA	NA	NA	NA	NA	NA
TRINITY_DN6979_c0_g1_i3	Q02127	PYRD_HUMAN	58.5	386	156	2	126	1271	7	392	3.10E-118	426.8	PYRD_HUMAN	reviewed	"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)"	DHODH	Homo sapiens (Human)	395	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]	dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]	GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0007565; GO:0007595; GO:0008144; GO:0009220; GO:0010181; GO:0016021; GO:0031000; GO:0042493; GO:0042594; GO:0043025; GO:0043065; GO:0044205; GO:0046134; GO:0048039; GO:0090140; GO:1903576	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN26041_c0_g1_i1	Q02127	PYRD_HUMAN	100	100	0	0	2	301	293	392	3.00E-50	198.7	PYRD_HUMAN	reviewed	"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)"	DHODH	Homo sapiens (Human)	395	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]	dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]	GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0007565; GO:0007595; GO:0008144; GO:0009220; GO:0010181; GO:0016021; GO:0031000; GO:0042493; GO:0042594; GO:0043025; GO:0043065; GO:0044205; GO:0046134; GO:0048039; GO:0090140; GO:1903576	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN1884_c0_g1_i1	P11348	DHPR_RAT	57.8	230	97	0	699	10	7	236	2.80E-71	270	DHPR_RAT	reviewed	Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase)	Qdpr Dhpr	Rattus norvegicus (Rat)	241	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; 6,7-dihydropteridine reductase activity [GO:0004155]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; cellular response to drug [GO:0035690]; L-phenylalanine catabolic process [GO:0006559]; liver development [GO:0001889]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]	"6,7-dihydropteridine reductase activity [GO:0004155]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]"	GO:0001889; GO:0004155; GO:0005737; GO:0005829; GO:0006559; GO:0006729; GO:0010044; GO:0010288; GO:0033762; GO:0035690; GO:0042802; GO:0043005; GO:0070402; GO:0070404	cellular response to drug [GO:0035690]; liver development [GO:0001889]; L-phenylalanine catabolic process [GO:0006559]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]		NA	NA	NA	NA	NA	NA
TRINITY_DN1884_c0_g1_i2	P11348	DHPR_RAT	57.8	230	97	0	699	10	7	236	2.80E-71	270	DHPR_RAT	reviewed	Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase)	Qdpr Dhpr	Rattus norvegicus (Rat)	241	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; 6,7-dihydropteridine reductase activity [GO:0004155]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; cellular response to drug [GO:0035690]; L-phenylalanine catabolic process [GO:0006559]; liver development [GO:0001889]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]	"6,7-dihydropteridine reductase activity [GO:0004155]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]"	GO:0001889; GO:0004155; GO:0005737; GO:0005829; GO:0006559; GO:0006729; GO:0010044; GO:0010288; GO:0033762; GO:0035690; GO:0042802; GO:0043005; GO:0070402; GO:0070404	cellular response to drug [GO:0035690]; liver development [GO:0001889]; L-phenylalanine catabolic process [GO:0006559]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]		NA	NA	NA	NA	NA	NA
TRINITY_DN40576_c0_g1_i1	P09417	DHPR_HUMAN	100	79	0	0	237	1	128	206	9.30E-39	160.2	DHPR_HUMAN	reviewed	Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)	QDPR DHPR SDR33C1	Homo sapiens (Human)	244	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; 6,7-dihydropteridine reductase activity [GO:0004155]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; cellular amino acid metabolic process [GO:0006520]; cellular response to drug [GO:0035690]; dihydrobiopterin metabolic process [GO:0051066]; L-phenylalanine catabolic process [GO:0006559]; liver development [GO:0001889]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]	"6,7-dihydropteridine reductase activity [GO:0004155]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]"	GO:0001889; GO:0004155; GO:0005737; GO:0005829; GO:0006520; GO:0006559; GO:0006729; GO:0009055; GO:0010044; GO:0010288; GO:0033762; GO:0035690; GO:0042802; GO:0043005; GO:0051066; GO:0070062; GO:0070402; GO:0070404	cellular amino acid metabolic process [GO:0006520]; cellular response to drug [GO:0035690]; dihydrobiopterin metabolic process [GO:0051066]; liver development [GO:0001889]; L-phenylalanine catabolic process [GO:0006559]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]		NA	NA	NA	NA	NA	NA
TRINITY_DN7562_c0_g1_i1	Q63150	DPYS_RAT	68.2	494	153	1	1735	266	4	497	1.10E-203	711.1	DPYS_RAT	reviewed	Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase)	Dpys	Rattus norvegicus (Rat)	519	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]	GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0032991; GO:0042802; GO:0051219	beta-alanine metabolic process [GO:0019482]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]		NA	NA	NA	NA	NA	NA
TRINITY_DN7562_c0_g1_i3	Q63150	DPYS_RAT	68.2	494	153	1	1794	325	4	497	1.10E-203	711.1	DPYS_RAT	reviewed	Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase)	Dpys	Rattus norvegicus (Rat)	519	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]	GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0032991; GO:0042802; GO:0051219	beta-alanine metabolic process [GO:0019482]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]		NA	NA	NA	NA	NA	NA
TRINITY_DN3843_c0_g1_i2	Q28007	DPYD_BOVIN	70.5	492	143	1	4	1473	528	1019	6.90E-210	731.5	DPYD_BOVIN	reviewed	Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)	DPYD	Bos taurus (Bovine)	1025	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; uracil catabolic process [GO:0006212]"	cytoplasm [GO:0005737]	"4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]"	GO:0005737; GO:0006212; GO:0006214; GO:0017113; GO:0019483; GO:0042803; GO:0046872; GO:0050661; GO:0051539	beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; uracil catabolic process [GO:0006212]		blue	blue	NA	NA	NA	NA
TRINITY_DN26680_c0_g1_i1	Q12882	DPYD_HUMAN	100	78	0	0	3	236	636	713	2.00E-41	169.1	DPYD_HUMAN	reviewed	Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)	DPYD	Homo sapiens (Human)	1025	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; beta-alanine biosynthetic process [GO:0019483]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]"	GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0017113; GO:0019483; GO:0042803; GO:0046135; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539	beta-alanine biosynthetic process [GO:0019483]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]		NA	NA	NA	NA	NA	NA
TRINITY_DN16415_c0_g1_i1	P98192	GNPAT_MOUSE	97.9	146	3	0	2	439	147	292	4.20E-77	288.5	GNPAT_MOUSE	reviewed	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	Gnpat Dhapat	Mus musculus (Mouse)	678	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003824; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0006631; GO:0006650; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0016287; GO:0016290; GO:0021587; GO:0030913; GO:0031966; GO:0042493; GO:0042552; GO:0042594; GO:0061024; GO:0070542	cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN16415_c0_g2_i1	A4IF87	GNPAT_BOVIN	100	81	0	0	3	245	156	236	5.10E-40	164.5	GNPAT_BOVIN	reviewed	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	GNPAT	Bos taurus (Bovine)	680	peroxisomal membrane [GO:0005778]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]	peroxisomal membrane [GO:0005778]	glycerone-phosphate O-acyltransferase activity [GO:0016287]	GO:0005778; GO:0006650; GO:0008611; GO:0016287	ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]		NA	NA	NA	NA	NA	NA
TRINITY_DN1493_c0_g1_i1	P98192	GNPAT_MOUSE	39.1	629	349	12	144	1997	34	639	1.20E-102	375.6	GNPAT_MOUSE	reviewed	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	Gnpat Dhapat	Mus musculus (Mouse)	678	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003824; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0006631; GO:0006650; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0016287; GO:0016290; GO:0021587; GO:0030913; GO:0031966; GO:0042493; GO:0042552; GO:0042594; GO:0061024; GO:0070542	cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1493_c0_g1_i4	P98192	GNPAT_MOUSE	39.1	629	349	12	144	1997	34	639	1.20E-102	375.6	GNPAT_MOUSE	reviewed	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	Gnpat Dhapat	Mus musculus (Mouse)	678	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003824; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0006631; GO:0006650; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0016287; GO:0016290; GO:0021587; GO:0030913; GO:0031966; GO:0042493; GO:0042552; GO:0042594; GO:0061024; GO:0070542	cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1493_c0_g1_i5	P98192	GNPAT_MOUSE	39.1	629	349	12	144	1997	34	639	1.20E-102	375.6	GNPAT_MOUSE	reviewed	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	Gnpat Dhapat	Mus musculus (Mouse)	678	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]	mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003824; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0006631; GO:0006650; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0016287; GO:0016290; GO:0021587; GO:0030913; GO:0031966; GO:0042493; GO:0042552; GO:0042594; GO:0061024; GO:0070542	cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN0_c467_g1_i1	Q63342	M2GD_RAT	49	204	102	1	37	642	503	706	1.30E-50	201.1	M2GD_RAT	reviewed	"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)"	Dmgdh	Rattus norvegicus (Rat)	857	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0016491; GO:0019695; GO:0035999; GO:0042426; GO:0047865; GO:0050660	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN28366_c0_g1_i1	Q9DBT9	M2GD_MOUSE	70.2	84	25	0	22	273	242	325	8.20E-30	131	M2GD_MOUSE	reviewed	"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)"	Dmgdh	Mus musculus (Mouse)	869	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0016491; GO:0035999; GO:0042426; GO:0047865; GO:0050660	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]		brown	brown	NA	NA	NA	NA
TRINITY_DN28366_c0_g1_i2	Q9DBT9	M2GD_MOUSE	66	150	50	1	22	468	242	391	1.50E-54	213.8	M2GD_MOUSE	reviewed	"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)"	Dmgdh	Mus musculus (Mouse)	869	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0016491; GO:0035999; GO:0042426; GO:0047865; GO:0050660	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN12323_c0_g1_i1	Q9UI17	M2GD_HUMAN	67.2	67	22	0	226	26	399	465	1.90E-23	109.8	M2GD_HUMAN	reviewed	"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)"	DMGDH	Homo sapiens (Human)	866	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]		NA	NA	NA	NA	NA	NA
TRINITY_DN12323_c0_g1_i2	Q63342	M2GD_RAT	59	134	54	1	404	3	392	524	6.90E-44	178.3	M2GD_RAT	reviewed	"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)"	Dmgdh	Rattus norvegicus (Rat)	857	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dimethylglycine dehydrogenase activity [GO:0047865]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0016491; GO:0019695; GO:0035999; GO:0042426; GO:0047865; GO:0050660	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN33821_c0_g1_i1	Q9UI17	M2GD_HUMAN	59.2	71	29	0	3	215	53	123	1.20E-16	86.7	M2GD_HUMAN	reviewed	"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)"	DMGDH	Homo sapiens (Human)	866	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]		NA	NA	NA	NA	NA	NA
TRINITY_DN11580_c0_g1_i1	Q01460	DIAC_RAT	43.7	355	194	3	1	1056	12	363	2.70E-83	310.5	DIAC_RAT	reviewed	Di-N-acetylchitobiase (EC 3.2.1.-)	Ctbs Ctb	Rattus norvegicus (Rat)	367	"lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]"	lysosome [GO:0005764]	"chitinase activity [GO:0004568]; chitin binding [GO:0008061]; hydrolase activity, acting on glycosyl bonds [GO:0016798]"	GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798	chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]		blue	blue	NA	NA	NA	NA
TRINITY_DN5658_c1_g1_i1	P31428	DPEP1_MOUSE	63.5	52	19	0	65	220	123	174	1.10E-13	77	DPEP1_MOUSE	reviewed	Dipeptidase 1 (DPEP-1) (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Membrane-bound dipeptidase 1) (MBD-1) (Microsomal dipeptidase) (Renal dipeptidase)	Dpep1 Mbd1 Rdp	Mus musculus (Mouse)	410	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neutrophil chemotaxis [GO:0030593]	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]	GO:0005615; GO:0005654; GO:0005886; GO:0006629; GO:0006691; GO:0006751; GO:0006954; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031225; GO:0031528; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070573; GO:0071277; GO:0071732; GO:0072341	antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neutrophil chemotaxis [GO:0030593]		NA	NA	NA	NA	NA	NA
TRINITY_DN10441_c0_g1_i1	P31430	DPEP1_RAT	52.9	70	32	1	212	3	286	354	8.20E-14	77.4	DPEP1_RAT	reviewed	Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Microsomal dipeptidase) (Renal dipeptidase)	Dpep1 Rdp	Rattus norvegicus (Rat)	410	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neutrophil chemotaxis [GO:0030593]	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]	GO:0005615; GO:0005654; GO:0005886; GO:0006629; GO:0006691; GO:0006751; GO:0006954; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031225; GO:0031528; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070573; GO:0071277; GO:0071732; GO:0072341	antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neutrophil chemotaxis [GO:0030593]		NA	NA	NA	NA	NA	NA
TRINITY_DN29860_c0_g1_i1	Q5M872	DPEP2_RAT	54.4	90	36	1	274	20	212	301	2.80E-18	92.4	DPEP2_RAT	reviewed	Dipeptidase 2 (EC 3.4.13.19)	Dpep2	Rattus norvegicus (Rat)	481	anchored component of membrane [GO:0031225]; dipeptidase activity [GO:0016805]; exopeptidase activity [GO:0008238]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]	anchored component of membrane [GO:0031225]	dipeptidase activity [GO:0016805]; exopeptidase activity [GO:0008238]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]	GO:0006629; GO:0006691; GO:0008238; GO:0016805; GO:0031225; GO:0046872; GO:0070573	leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN11065_c0_g1_i1	Q4R7M2	DPEP3_MACFA	59.7	62	25	0	104	289	250	311	9.40E-13	74.3	DPEP3_MACFA	reviewed	Dipeptidase 3 (EC 3.4.13.19)	DPEP3 QtsA-14814	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	488	acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; meiotic cell cycle [GO:0051321]	acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]	GO:0001669; GO:0005886; GO:0016805; GO:0031225; GO:0046872; GO:0051321; GO:0070573	meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN28517_c0_g1_i1	Q9Z218	DPP6_MOUSE	51.9	52	24	1	90	242	234	285	3.10E-06	52.4	DPP6_MOUSE	reviewed	Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI)	Dpp6 Dpp-6	Mus musculus (Mouse)	804	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]	GO:0005886; GO:0008076; GO:0008236; GO:0009986; GO:0015459; GO:0016020; GO:0016021; GO:0019228; GO:0042391; GO:0043025; GO:0043266; GO:0043268; GO:0072659; GO:1901379; GO:1901381; GO:1903078	neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN35925_c0_g1_i1	P53634	CATC_HUMAN	100	247	0	0	3	743	217	463	9.50E-152	537.3	CATC_HUMAN	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	CTSC CPPI	Homo sapiens (Human)	463	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006888; GO:0006955; GO:0007568; GO:0008234; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043312; GO:0043621; GO:0048208; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN3762_c0_g1_i1	P53634	CATC_HUMAN	50	456	218	4	1422	82	7	461	4.30E-137	489.6	CATC_HUMAN	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	CTSC CPPI	Homo sapiens (Human)	463	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006888; GO:0006955; GO:0007568; GO:0008234; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043312; GO:0043621; GO:0048208; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		blue	blue	NA	NA	NA	NA
TRINITY_DN35087_c0_g1_i1	P97821	CATC_MOUSE	94.8	97	5	0	1	291	287	383	4.80E-53	208	CATC_MOUSE	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	Ctsc	Mus musculus (Mouse)	462	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN5738_c0_g1_i1	P53634	CATC_HUMAN	37.3	142	89	0	449	24	5	146	8.70E-23	108.2	CATC_HUMAN	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	CTSC CPPI	Homo sapiens (Human)	463	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006888; GO:0006955; GO:0007568; GO:0008234; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043312; GO:0043621; GO:0048208; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN5738_c0_g1_i2	P53634	CATC_HUMAN	38	137	85	0	480	70	5	141	1.20E-22	107.8	CATC_HUMAN	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	CTSC CPPI	Homo sapiens (Human)	463	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006888; GO:0006955; GO:0007568; GO:0008234; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043312; GO:0043621; GO:0048208; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN710_c0_g1_i2	Q3ZCJ8	CATC_BOVIN	59.3	253	103	0	9	767	209	461	1.20E-88	327.8	CATC_BOVIN	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	CTSC	Bos taurus (Bovine)	463	lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; zymogen activation [GO:0031638]	lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005764; GO:0008234; GO:0031638	zymogen activation [GO:0031638]		black	black	1	NA	1	1
TRINITY_DN33344_c0_g1_i1	P97821	CATC_MOUSE	100	83	0	0	1	249	380	462	1.20E-45	183.3	CATC_MOUSE	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	Ctsc	Mus musculus (Mouse)	462	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN710_c0_g1_i1	P97821	CATC_MOUSE	59.7	253	102	0	9	767	208	460	3.70E-87	322.8	CATC_MOUSE	reviewed	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	Ctsc	Mus musculus (Mouse)	462	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235	aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	1
TRINITY_DN38494_c0_g1_i1	Q9UHL4	DPP2_HUMAN	98.5	67	1	0	43	243	63	129	4.60E-33	141.4	DPP2_HUMAN	reviewed	Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)	DPP7 DPP2 QPP	Homo sapiens (Human)	492	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]	dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]	GO:0005576; GO:0005794; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0043312; GO:0070062	neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN2090_c0_g1_i1	Q9VHR8	DPP3_DROME	44.5	728	394	8	2286	115	52	773	3.60E-181	636.7	DPP3_DROME	reviewed	Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III)	DppIII CG7415	Drosophila melanogaster (Fruit fly)	786	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0008239; GO:0016020; GO:0016021; GO:0046872; GO:0070006	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN2090_c0_g1_i2	Q9VHR8	DPP3_DROME	44.7	723	390	8	2271	115	57	773	3.70E-181	636.7	DPP3_DROME	reviewed	Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III)	DppIII CG7415	Drosophila melanogaster (Fruit fly)	786	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0008239; GO:0016020; GO:0016021; GO:0046872; GO:0070006	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN30865_c0_g1_i1	P27487	DPP4_HUMAN	100	209	0	0	3	629	548	756	5.20E-121	434.9	DPP4_HUMAN	reviewed	Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)]	DPP4 ADCP2 CD26	Homo sapiens (Human)	766	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; locomotory exploration behavior [GO:0035641]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of neutrophil chemotaxis [GO:0090024]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	chemorepellent activity [GO:0045499]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001662; GO:0001666; GO:0002020; GO:0004252; GO:0005102; GO:0005576; GO:0005765; GO:0005886; GO:0005925; GO:0006508; GO:0007155; GO:0008236; GO:0008239; GO:0008284; GO:0009986; GO:0010716; GO:0016020; GO:0016021; GO:0016324; GO:0030027; GO:0030139; GO:0031258; GO:0031295; GO:0033632; GO:0035641; GO:0036343; GO:0042110; GO:0042802; GO:0042803; GO:0043542; GO:0045121; GO:0045499; GO:0046581; GO:0050796; GO:0070062; GO:0071438; GO:0090024	behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; locomotory exploration behavior [GO:0035641]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of neutrophil chemotaxis [GO:0090024]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]		NA	NA	NA	NA	NA	NA
TRINITY_DN2833_c0_g1_i1	Q80YA7	DPP8_MOUSE	40.1	868	454	17	160	2670	50	882	4.90E-179	629.8	DPP8_MOUSE	reviewed	Dipeptidyl peptidase 8 (DP8) (EC 3.4.14.5) (Dipeptidyl peptidase VIII) (DPP VIII)	Dpp8	Mus musculus (Mouse)	892	cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	cytosol [GO:0005829]	aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005829; GO:0008236			NA	NA	NA	NA	NA	NA
TRINITY_DN26546_c0_g1_i1	P53602	MVD1_HUMAN	100	176	0	0	528	1	121	296	2.40E-95	349.4	MVD1_HUMAN	reviewed	Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase)	MVD MPD	Homo sapiens (Human)	400	"cytosol [GO:0005829]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; dolichyl diphosphate biosynthetic process [GO:0006489]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]; regulation of cholesterol biosynthetic process [GO:0045540]"	cytosol [GO:0005829]	ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]	GO:0004163; GO:0005524; GO:0005829; GO:0006489; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803; GO:0045540	"cholesterol biosynthetic process [GO:0006695]; dolichyl diphosphate biosynthetic process [GO:0006489]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]; regulation of cholesterol biosynthetic process [GO:0045540]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29695_c0_g1_i1	Q99JF5	MVD1_MOUSE	53.2	395	174	5	100	1275	11	397	3.80E-108	393.3	MVD1_MOUSE	reviewed	Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase)	Mvd	Mus musculus (Mouse)	401	"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]"	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]	GO:0004163; GO:0005524; GO:0005777; GO:0005782; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803	"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31911_c0_g1_i1	O74898	DPH5_SCHPO	50.9	110	50	2	324	7	13	122	1.70E-22	106.7	DPH5_SCHPO	reviewed	Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase)	dph5 SPCC576.14	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	283	cytosol [GO:0005829]; nucleus [GO:0005634]; diphthine synthase activity [GO:0004164]; methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytosol [GO:0005829]; nucleus [GO:0005634]	diphthine synthase activity [GO:0004164]	GO:0004164; GO:0005634; GO:0005829; GO:0017183; GO:0032259	methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN29059_c0_g1_i1	Q9CWQ0	DPH5_MOUSE	100	103	0	0	2	310	74	176	2.50E-55	215.7	DPH5_MOUSE	reviewed	Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase)	Dph5	Mus musculus (Mouse)	281	diphthine synthase activity [GO:0004164]; methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		diphthine synthase activity [GO:0004164]	GO:0004164; GO:0017183; GO:0032259	methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN1079_c0_g1_i1	Q9CWQ0	DPH5_MOUSE	62.8	269	95	3	89	892	1	265	9.50E-94	345.9	DPH5_MOUSE	reviewed	Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase)	Dph5	Mus musculus (Mouse)	281	diphthine synthase activity [GO:0004164]; methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		diphthine synthase activity [GO:0004164]	GO:0004164; GO:0017183; GO:0032259	methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		blue	blue	NA	NA	NA	NA
TRINITY_DN33396_c0_g1_i1	Q9H2P9	DPH5_HUMAN	55.7	185	72	2	9	533	45	229	4.40E-52	205.7	DPH5_HUMAN	reviewed	Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase)	DPH5 AD-018 CGI-30 HSPC143 NPD015	Homo sapiens (Human)	285	cytosol [GO:0005829]; diphthine synthase activity [GO:0004164]; methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytosol [GO:0005829]	diphthine synthase activity [GO:0004164]	GO:0004164; GO:0005829; GO:0017183; GO:0032259	methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN32814_c0_g1_i1	Q9CYU6	DPH7_MOUSE	44.2	337	170	10	29	997	9	341	4.40E-67	256.5	DPH7_MOUSE	reviewed	Diphthine methyltransferase (EC 3.1.1.97) (Diphthamide biosynthesis protein 7) (DPH7) (WD repeat-containing protein 85)	Dph7 Wdr85	Mus musculus (Mouse)	477	diphthine methylesterase activity [GO:0061685]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		diphthine methylesterase activity [GO:0061685]	GO:0017183; GO:0061685	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN35106_c0_g1_i1	Q9CQ28	DPH6_MOUSE	100	90	0	0	270	1	22	111	5.80E-45	181	DPH6_MOUSE	reviewed	Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)	Dph6 Atpbd4	Mus musculus (Mouse)	267	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]	GO:0005524; GO:0005654; GO:0005730; GO:0017178; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN28344_c0_g1_i1	Q7L8W6	DPH6_HUMAN	100	80	0	0	240	1	10	89	2.70E-41	168.7	DPH6_HUMAN	reviewed	Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)	DPH6 ATPBD4	Homo sapiens (Human)	267	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]	GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0017178; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN38070_c0_g1_i1	A2RV01	DPH6_DANRE	59.5	79	32	0	8	244	81	159	1.60E-17	89.7	DPH6_DANRE	reviewed	Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)	dph6 atpbd4 zgc:110758	Danio rerio (Zebrafish) (Brachydanio rerio)	255	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]	GO:0005524; GO:0017178; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN1502_c0_g1_i1	A2RV01	DPH6_DANRE	62.4	255	89	3	92	838	1	254	1.70E-85	317.4	DPH6_DANRE	reviewed	Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)	dph6 atpbd4 zgc:110758	Danio rerio (Zebrafish) (Brachydanio rerio)	255	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]	GO:0005524; GO:0017178; GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN1502_c0_g1_i3	Q9USQ7	DPH6_SCHPO	39.7	557	296	13	92	1732	1	527	4.30E-90	334	DPH6_SCHPO	reviewed	Diphthine--ammonia ligase (EC 6.3.1.14) (Diphthamide synthase) (Diphthamide synthetase)	mug71 SPBC577.12	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	606	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; meiotic cell cycle [GO:0051321]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]	GO:0005524; GO:0005634; GO:0005829; GO:0017178; GO:0017183; GO:0051321	meiotic cell cycle [GO:0051321]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		NA	NA	NA	NA	NA	NA
TRINITY_DN37513_c0_g1_i1	O14040	DI3L2_SCHPO	53.6	56	22	1	207	40	738	789	1.60E-08	59.7	DI3L2_SCHPO	reviewed	DIS3-like exonuclease 2 (EC 3.1.13.-)	dis32 dis3l2 SPAC2C4.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	927	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(U) RNA binding [GO:0008266]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(U) RNA binding [GO:0008266]	GO:0000175; GO:0000178; GO:0000291; GO:0000932; GO:0005737; GO:0005829; GO:0006402; GO:0008266; GO:0034427; GO:0046872; GO:1990074	"mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26519_c0_g1_i1	O14040	DI3L2_SCHPO	54.5	88	40	0	267	4	451	538	1.20E-21	103.6	DI3L2_SCHPO	reviewed	DIS3-like exonuclease 2 (EC 3.1.13.-)	dis32 dis3l2 SPAC2C4.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	927	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(U) RNA binding [GO:0008266]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(U) RNA binding [GO:0008266]	GO:0000175; GO:0000178; GO:0000291; GO:0000932; GO:0005737; GO:0005829; GO:0006402; GO:0008266; GO:0034427; GO:0046872; GO:1990074	"mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11182_c0_g1_i1	Q0V9R3	DI3L2_XENTR	40.5	242	126	6	742	44	599	831	3.50E-39	163.3	DI3L2_XENTR	reviewed	DIS3-like exonuclease 2 (EC 3.1.13.-)	dis3l2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	834	"cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0000178; GO:0000291; GO:0000932; GO:0003723; GO:0005737; GO:0006402; GO:0007049; GO:0010587; GO:0019827; GO:0034427; GO:0046872; GO:0051301; GO:1990074	"cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7722_c0_g1_i1	Q8IYB7	DI3L2_HUMAN	50	332	157	4	973	2	302	632	7.60E-87	322	DI3L2_HUMAN	reviewed	DIS3-like exonuclease 2 (hDIS3L2) (EC 3.1.13.-)	DIS3L2 FAM6A	Homo sapiens (Human)	885	"cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; polysome [GO:0005844]; 3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; ribonuclease activity [GO:0004540]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; polysome [GO:0005844]	3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; ribonuclease activity [GO:0004540]	GO:0000175; GO:0000178; GO:0000278; GO:0000287; GO:0000291; GO:0000932; GO:0004540; GO:0005737; GO:0005844; GO:0006402; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0034427; GO:0051301; GO:0051306; GO:1990074	"cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8865_c0_g1_i1	Q5VWQ8	DAB2P_HUMAN	44.1	68	35	1	329	135	1091	1158	8.60E-05	48.1	DAB2P_HUMAN	reviewed	Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)	DAB2IP AF9Q34 AIP1 KIAA1743	Homo sapiens (Human)	1189	"AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"	AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]	14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0000122; GO:0000165; GO:0000185; GO:0001525; GO:0001933; GO:0005096; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007049; GO:0007252; GO:0007257; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0014067; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032088; GO:0032266; GO:0032809; GO:0034144; GO:0034260; GO:0034620; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0038026; GO:0040008; GO:0042059; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043124; GO:0043184; GO:0043254; GO:0043407; GO:0043410; GO:0043507; GO:0043548; GO:0043553; GO:0044257; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045296; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050680; GO:0051721; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071158; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0071901; GO:0071902; GO:0072577; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1903363; GO:1903896; GO:1990032; GO:1990597; GO:2001224; GO:2001235	"activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23157_c0_g1_i1	Q18163	DDRA_CAEEL	50	58	29	0	1	174	132	189	9.50E-09	60.5	DDRA_CAEEL	reviewed	Discoidin domain-containing receptor A	ddr-1 C25F6.4	Caenorhabditis elegans	766	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; motor neuron axon guidance [GO:0008045]; multicellular organism development [GO:0007275]; positive regulation of axon regeneration [GO:0048680]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005518; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0008045; GO:0030424; GO:0033674; GO:0038062; GO:0043204; GO:0043235; GO:0048680	motor neuron axon guidance [GO:0008045]; multicellular organism development [GO:0007275]; positive regulation of axon regeneration [GO:0048680]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN32546_c0_g1_i1	Q18163	DDRA_CAEEL	46	50	27	0	71	220	136	185	4.20E-07	55.1	DDRA_CAEEL	reviewed	Discoidin domain-containing receptor A	ddr-1 C25F6.4	Caenorhabditis elegans	766	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; motor neuron axon guidance [GO:0008045]; multicellular organism development [GO:0007275]; positive regulation of axon regeneration [GO:0048680]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005518; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0008045; GO:0030424; GO:0033674; GO:0038062; GO:0043204; GO:0043235; GO:0048680	motor neuron axon guidance [GO:0008045]; multicellular organism development [GO:0007275]; positive regulation of axon regeneration [GO:0048680]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN254_c0_g1_i2	Q91ZV2	DCBD2_RAT	35.7	182	95	4	767	1273	289	461	3.20E-18	96.3	DCBD2_RAT	reviewed	"Discoidin, CUB and LCCL domain-containing protein 2 (Endothelial and smooth muscle cell-derived neuropilin-like protein)"	Dcbld2 Esdn	Rattus norvegicus (Rat)	769	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0009986; GO:0030308; GO:0042060	negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN254_c0_g1_i3	Q91ZV2	DCBD2_RAT	35.7	182	95	4	767	1273	289	461	3.40E-18	96.3	DCBD2_RAT	reviewed	"Discoidin, CUB and LCCL domain-containing protein 2 (Endothelial and smooth muscle cell-derived neuropilin-like protein)"	Dcbld2 Esdn	Rattus norvegicus (Rat)	769	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0009986; GO:0030308; GO:0042060	negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN254_c0_g1_i5	Q91ZV2	DCBD2_RAT	35.7	182	95	4	373	879	289	461	3.00E-18	96.3	DCBD2_RAT	reviewed	"Discoidin, CUB and LCCL domain-containing protein 2 (Endothelial and smooth muscle cell-derived neuropilin-like protein)"	Dcbld2 Esdn	Rattus norvegicus (Rat)	769	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0009986; GO:0030308; GO:0042060	negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN2731_c0_g1_i1	Q9W0S9	DIP2_DROME	71.6	109	30	1	366	40	378	485	1.20E-38	161	DIP2_DROME	reviewed	Disco-interacting protein 2	DIP2 CG7020	Drosophila melanogaster (Fruit fly)	1773	nucleus [GO:0005634]; multicellular organism development [GO:0007275]	nucleus [GO:0005634]		GO:0005634; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN2731_c0_g1_i3	Q9W0S9	DIP2_DROME	58.9	151	52	3	492	40	345	485	1.90E-40	167.2	DIP2_DROME	reviewed	Disco-interacting protein 2	DIP2 CG7020	Drosophila melanogaster (Fruit fly)	1773	nucleus [GO:0005634]; multicellular organism development [GO:0007275]	nucleus [GO:0005634]		GO:0005634; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN2731_c0_g1_i4	Q9W0S9	DIP2_DROME	65.2	1456	387	13	4176	88	345	1773	0	1891.3	DIP2_DROME	reviewed	Disco-interacting protein 2	DIP2 CG7020	Drosophila melanogaster (Fruit fly)	1773	nucleus [GO:0005634]; multicellular organism development [GO:0007275]	nucleus [GO:0005634]		GO:0005634; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN38283_c0_g1_i1	Q14689	DIP2A_HUMAN	100	101	0	0	1	303	859	959	1.20E-54	213.4	DIP2A_HUMAN	reviewed	Disco-interacting protein 2 homolog A (DIP2 homolog A)	DIP2A C21orf106 DIP2 KIAA0184	Homo sapiens (Human)	1571	cell surface [GO:0009986]; nucleus [GO:0005634]; multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]	cell surface [GO:0009986]; nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0009986; GO:0010629; GO:0042981	multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN40314_c0_g1_i1	Q14689	DIP2A_HUMAN	100	108	0	0	2	325	393	500	1.50E-60	233	DIP2A_HUMAN	reviewed	Disco-interacting protein 2 homolog A (DIP2 homolog A)	DIP2A C21orf106 DIP2 KIAA0184	Homo sapiens (Human)	1571	cell surface [GO:0009986]; nucleus [GO:0005634]; multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]	cell surface [GO:0009986]; nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0009986; GO:0010629; GO:0042981	multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN39412_c0_g1_i1	Q14689	DIP2A_HUMAN	100	166	0	0	1	498	615	780	4.90E-90	331.6	DIP2A_HUMAN	reviewed	Disco-interacting protein 2 homolog A (DIP2 homolog A)	DIP2A C21orf106 DIP2 KIAA0184	Homo sapiens (Human)	1571	cell surface [GO:0009986]; nucleus [GO:0005634]; multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]	cell surface [GO:0009986]; nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0009986; GO:0010629; GO:0042981	multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN27016_c0_g1_i1	Q9Y2E4	DIP2C_HUMAN	100	85	0	0	256	2	1313	1397	7.20E-45	180.6	DIP2C_HUMAN	reviewed	Disco-interacting protein 2 homolog C (DIP2 homolog C)	DIP2C KIAA0934	Homo sapiens (Human)	1556							NA	NA	NA	NA	NA	NA
TRINITY_DN7438_c0_g1_i1	Q9Y4D1	DAAM1_HUMAN	43	263	139	6	28	801	5	261	4.60E-45	183	DAAM1_HUMAN	reviewed	Disheveled-associated activator of morphogenesis 1	DAAM1 KIAA0666	Homo sapiens (Human)	1078	"ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin binding [GO:0003779]; identical protein binding [GO:0042802]; Rho GTPase binding [GO:0017048]	GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0017048; GO:0030036; GO:0031514; GO:0036064; GO:0042802; GO:0060071	"actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14685_c0_g1_i1	Q86T65	DAAM2_HUMAN	67.8	90	29	0	274	5	246	335	1.30E-28	126.7	DAAM2_HUMAN	reviewed	Disheveled-associated activator of morphogenesis 2	DAAM2 KIAA0381	Homo sapiens (Human)	1068	extracellular exosome [GO:0070062]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; determination of left/right symmetry [GO:0007368]; dorsal spinal cord development [GO:0021516]; negative regulation of oligodendrocyte differentiation [GO:0048715]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; Wnt signaling pathway [GO:0016055]	extracellular exosome [GO:0070062]	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]	GO:0003779; GO:0007368; GO:0016055; GO:0017048; GO:0021516; GO:0030036; GO:0048715; GO:0060828; GO:0070062; GO:0090263; GO:2000050	actin cytoskeleton organization [GO:0030036]; determination of left/right symmetry [GO:0007368]; dorsal spinal cord development [GO:0021516]; negative regulation of oligodendrocyte differentiation [GO:0048715]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN13945_c0_g1_i1	O14672	ADA10_HUMAN	55.6	315	116	11	914	6	249	551	2.00E-89	330.5	ADA10_HUMAN	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)	ADAM10 KUZ MADM	Homo sapiens (Human)	748	"adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cell-cell signaling [GO:0007267]; cellular protein metabolic process [GO:0044267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of gene expression [GO:0010629]; neutrophil degranulation [GO:0043312]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; post-translational protein modification [GO:0043687]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]	endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0034205; GO:0034332; GO:0034612; GO:0035333; GO:0035579; GO:0042117; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043066; GO:0043197; GO:0043231; GO:0043312; GO:0043687; GO:0044267; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0061001; GO:0070062; GO:0070821; GO:0071157; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	"adherens junction organization [GO:0034332]; amyloid-beta formation [GO:0034205]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cellular protein metabolic process [GO:0044267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of gene expression [GO:0010629]; neutrophil degranulation [GO:0043312]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15720_c0_g1_i1	O35598	ADA10_MOUSE	100	144	0	0	3	434	342	485	3.30E-82	305.4	ADA10_MOUSE	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)	Adam10 Kuz Madm	Mus musculus (Mouse)	749	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016020; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034205; GO:0034332; GO:0034612; GO:0042117; GO:0042169; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043197; GO:0043231; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0061001; GO:0062023; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	adherens junction organization [GO:0034332]; amyloid-beta formation [GO:0034205]; amyloid precursor protein catabolic process [GO:0042987]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN28907_c0_g1_i1	Q10741	ADA10_BOVIN	100	72	0	0	1	216	261	332	1.20E-37	156.4	ADA10_BOVIN	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c)	ADAM10 MADM	Bos taurus (Bovine)	748	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN15720_c0_g2_i1	Q10741	ADA10_BOVIN	100	124	0	0	2	373	357	480	1.20E-69	263.5	ADA10_BOVIN	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c)	ADAM10 MADM	Bos taurus (Bovine)	748	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1518_c0_g1_i1	G5EFD9	ADA10_CAEEL	32.7	150	89	3	581	159	558	704	3.70E-20	99.8	ADA10_CAEEL	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 homolog (ADAM 10 homolog) (EC 3.4.24.81)	sup-17 DY3.7	Caenorhabditis elegans	922	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0001708; GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0008237; GO:0009792; GO:0016021; GO:0016323; GO:0030511; GO:0030659; GO:0040025; GO:0042661; GO:0045138; GO:0046872; GO:1902667	cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]		blue	blue	NA	NA	NA	NA
TRINITY_DN1518_c0_g1_i2	G5EFD9	ADA10_CAEEL	40.9	181	95	3	521	6	558	735	3.80E-37	156	ADA10_CAEEL	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 homolog (ADAM 10 homolog) (EC 3.4.24.81)	sup-17 DY3.7	Caenorhabditis elegans	922	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0001708; GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0008237; GO:0009792; GO:0016021; GO:0016323; GO:0030511; GO:0030659; GO:0040025; GO:0042661; GO:0045138; GO:0046872; GO:1902667	cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]		blue	blue	NA	NA	NA	NA
TRINITY_DN5029_c0_g1_i1	G5EFD9	ADA10_CAEEL	55.8	233	82	4	4	648	315	544	1.00E-69	264.6	ADA10_CAEEL	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 homolog (ADAM 10 homolog) (EC 3.4.24.81)	sup-17 DY3.7	Caenorhabditis elegans	922	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0001708; GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0008237; GO:0009792; GO:0016021; GO:0016323; GO:0030511; GO:0030659; GO:0040025; GO:0042661; GO:0045138; GO:0046872; GO:1902667	cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]		blue	blue	NA	NA	NA	NA
TRINITY_DN25628_c0_g1_i1	O35674	ADA19_MOUSE	41.2	148	83	2	17	454	385	530	3.40E-29	129.4	ADA19_MOUSE	reviewed	Disintegrin and metalloproteinase domain-containing protein 19 (ADAM 19) (EC 3.4.24.-) (Meltrin-beta)	Adam19 Mltnb	Mus musculus (Mouse)	920	collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; heart development [GO:0007507]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]	collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]	GO:0001890; GO:0004222; GO:0005634; GO:0005794; GO:0006509; GO:0007507; GO:0010628; GO:0016021; GO:0017124; GO:0046872; GO:0062023; GO:2000049	heart development [GO:0007507]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]		blue	blue	NA	NA	NA	NA
TRINITY_DN2579_c0_g1_i4	Q60813	ADM1A_MOUSE	32.9	173	100	5	1491	1006	554	721	1.30E-14	82.8	ADM1A_MOUSE	reviewed	Disintegrin and metalloproteinase domain-containing protein 1a (ADAM 1a) (EC 3.4.24.-) (Fertilin subunit alpha-a)	Adam1a Adam1 Ftna	Mus musculus (Mouse)	791	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; male gonad development [GO:0008584]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005886; GO:0006508; GO:0007339; GO:0007342; GO:0008237; GO:0008584; GO:0016021; GO:0045121; GO:0046872	binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; male gonad development [GO:0008584]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN37829_c0_g1_i1	O75077	ADA23_HUMAN	45.7	92	49	1	6	278	550	641	8.30E-21	100.9	ADA23_HUMAN	reviewed	"Disintegrin and metalloproteinase domain-containing protein 23 (ADAM 23) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3) (MDC-3)"	ADAM23 MDC3	Homo sapiens (Human)	832	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007417; GO:0008237; GO:0099056; GO:1990830	cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN2579_c0_g1_i2	Q923W9	ADA33_MOUSE	32.7	508	320	11	3076	1595	208	707	1.20E-66	256.9	ADA33_MOUSE	reviewed	Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-)	Adam33	Mus musculus (Mouse)	797	integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine biosynthetic process [GO:0042035]	integral component of membrane [GO:0016021]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0006508; GO:0008270; GO:0016021; GO:0042035; GO:0042127	proteolysis [GO:0006508]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine biosynthetic process [GO:0042035]		blue	blue	NA	NA	NA	NA
TRINITY_DN2579_c0_g1_i5	Q923W9	ADA33_MOUSE	32.7	508	320	11	2974	1493	208	707	1.10E-66	256.9	ADA33_MOUSE	reviewed	Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-)	Adam33	Mus musculus (Mouse)	797	integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine biosynthetic process [GO:0042035]	integral component of membrane [GO:0016021]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0006508; GO:0008270; GO:0016021; GO:0042035; GO:0042127	proteolysis [GO:0006508]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine biosynthetic process [GO:0042035]		NA	NA	NA	NA	NA	NA
TRINITY_DN30780_c0_g1_i1	P78325	ADAM8_HUMAN	100	74	0	0	224	3	380	453	2.10E-40	165.6	ADAM8_HUMAN	reviewed	Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a)	ADAM8 MS2	Homo sapiens (Human)	824	alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dense core granule membrane [GO:0032127]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; podosome [GO:0002102]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule [GO:0070820]; tertiary granule membrane [GO:0070821]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; neutrophil degranulation [GO:0043312]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein processing [GO:0010954]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; regulation of cell-cell adhesion [GO:0022407]	alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dense core granule membrane [GO:0032127]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; podosome [GO:0002102]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule [GO:0070820]; tertiary granule membrane [GO:0070821]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0000902; GO:0001525; GO:0002102; GO:0002523; GO:0002675; GO:0002693; GO:0004222; GO:0004252; GO:0005509; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0008237; GO:0008270; GO:0009986; GO:0010954; GO:0022407; GO:0022617; GO:0032010; GO:0032127; GO:0033089; GO:0035579; GO:0042581; GO:0043312; GO:0043406; GO:0043524; GO:0043621; GO:0045089; GO:0045780; GO:0045785; GO:0048247; GO:0050714; GO:0050839; GO:0051044; GO:0051092; GO:0051897; GO:0070245; GO:0070820; GO:0070821; GO:0071133; GO:0071456; GO:0098609; GO:0101003; GO:2000309; GO:2000391; GO:2000415; GO:2000418	angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; cellular response to hypoxia [GO:0071456]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; neutrophil degranulation [GO:0043312]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein processing [GO:0010954]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; regulation of cell-cell adhesion [GO:0022407]		NA	NA	NA	NA	NA	NA
TRINITY_DN14189_c0_g1_i1	P78325	ADAM8_HUMAN	34.4	215	102	7	625	2	199	381	2.80E-22	107.1	ADAM8_HUMAN	reviewed	Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a)	ADAM8 MS2	Homo sapiens (Human)	824	alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dense core granule membrane [GO:0032127]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; podosome [GO:0002102]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule [GO:0070820]; tertiary granule membrane [GO:0070821]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; neutrophil degranulation [GO:0043312]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein processing [GO:0010954]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; regulation of cell-cell adhesion [GO:0022407]	alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dense core granule membrane [GO:0032127]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; podosome [GO:0002102]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule [GO:0070820]; tertiary granule membrane [GO:0070821]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0000902; GO:0001525; GO:0002102; GO:0002523; GO:0002675; GO:0002693; GO:0004222; GO:0004252; GO:0005509; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0008237; GO:0008270; GO:0009986; GO:0010954; GO:0022407; GO:0022617; GO:0032010; GO:0032127; GO:0033089; GO:0035579; GO:0042581; GO:0043312; GO:0043406; GO:0043524; GO:0043621; GO:0045089; GO:0045780; GO:0045785; GO:0048247; GO:0050714; GO:0050839; GO:0051044; GO:0051092; GO:0051897; GO:0070245; GO:0070820; GO:0070821; GO:0071133; GO:0071456; GO:0098609; GO:0101003; GO:2000309; GO:2000391; GO:2000415; GO:2000418	angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cell morphogenesis [GO:0000902]; cellular response to hypoxia [GO:0071456]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; neutrophil degranulation [GO:0043312]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein processing [GO:0010954]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; regulation of cell-cell adhesion [GO:0022407]		NA	NA	NA	NA	NA	NA
TRINITY_DN25709_c0_g1_i1	P31007	DLG1_DROME	88.3	137	16	0	412	2	778	914	5.10E-69	261.5	DLG1_DROME	reviewed	Disks large 1 tumor suppressor protein	dlg1 l(1)dlg1 CG1725	Drosophila melanogaster (Fruit fly)	970	"apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; lateral plasma membrane [GO:0016328]; leading edge membrane [GO:0031256]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; subsynaptic reticulum [GO:0071212]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tricellular tight junction [GO:0061689]; type I terminal bouton [GO:0061174]; type Ib terminal bouton [GO:0061176]; guanylate kinase activity [GO:0004385]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; behavioral response to ethanol [GO:0048149]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; dorsal closure [GO:0007391]; establishment of mitotic spindle orientation [GO:0000132]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; positive phototaxis [GO:0046956]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein localization [GO:0008104]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]; synaptic growth at neuromuscular junction [GO:0051124]"	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; lateral plasma membrane [GO:0016328]; leading edge membrane [GO:0031256]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; subsynaptic reticulum [GO:0071212]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tricellular tight junction [GO:0061689]; type Ib terminal bouton [GO:0061176]; type I terminal bouton [GO:0061174]	guanylate kinase activity [GO:0004385]	GO:0000132; GO:0001708; GO:0001738; GO:0004385; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0005938; GO:0007165; GO:0007268; GO:0007318; GO:0007391; GO:0007399; GO:0007617; GO:0008049; GO:0008104; GO:0016323; GO:0016327; GO:0016328; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030707; GO:0030714; GO:0031256; GO:0031594; GO:0042058; GO:0042332; GO:0043005; GO:0043113; GO:0043195; GO:0045167; GO:0045175; GO:0045179; GO:0045197; GO:0045202; GO:0045211; GO:0045475; GO:0045571; GO:0045887; GO:0046956; GO:0048149; GO:0048471; GO:0051124; GO:0051294; GO:0060581; GO:0061060; GO:0061174; GO:0061176; GO:0061689; GO:0071212; GO:0097120; GO:0098609; GO:0098839	"anterior/posterior axis specification, follicular epithelium [GO:0030714]; asymmetric protein localization involved in cell fate determination [GO:0045167]; basal protein localization [GO:0045175]; behavioral response to ethanol [GO:0048149]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; chemical synaptic transmission [GO:0007268]; dorsal closure [GO:0007391]; establishment of mitotic spindle orientation [GO:0000132]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; male courtship behavior [GO:0008049]; mating behavior [GO:0007617]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; nervous system development [GO:0007399]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; positive phototaxis [GO:0046956]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein localization [GO:0008104]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165]; synaptic growth at neuromuscular junction [GO:0051124]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4574_c0_g1_i1	Q5PYH6	DLG1_DANRE	58.9	353	131	5	1051	2	220	561	1.80E-103	377.5	DLG1_DANRE	reviewed	Disks large homolog 1 (Synapse-associated protein 97A) (SAP-97A) (SAP97A)	dlg1	Danio rerio (Zebrafish) (Brachydanio rerio)	873	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; endothelial cell proliferation [GO:0001935]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of mitotic cell cycle [GO:0045930]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; synapse organization [GO:0050808]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0001935; GO:0005789; GO:0007015; GO:0007268; GO:0016323; GO:0016324; GO:0019901; GO:0019902; GO:0030054; GO:0030866; GO:0031594; GO:0043005; GO:0043113; GO:0045197; GO:0045930; GO:0050808; GO:0097120; GO:0098609; GO:0098839; GO:0099645	actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; endothelial cell proliferation [GO:0001935]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of mitotic cell cycle [GO:0045930]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN4574_c0_g1_i2	Q5PYH6	DLG1_DANRE	57.5	318	125	4	946	2	251	561	3.60E-89	329.7	DLG1_DANRE	reviewed	Disks large homolog 1 (Synapse-associated protein 97A) (SAP-97A) (SAP97A)	dlg1	Danio rerio (Zebrafish) (Brachydanio rerio)	873	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; endothelial cell proliferation [GO:0001935]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of mitotic cell cycle [GO:0045930]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; synapse organization [GO:0050808]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0001935; GO:0005789; GO:0007015; GO:0007268; GO:0016323; GO:0016324; GO:0019901; GO:0019902; GO:0030054; GO:0030866; GO:0031594; GO:0043005; GO:0043113; GO:0045197; GO:0045930; GO:0050808; GO:0097120; GO:0098609; GO:0098839; GO:0099645	actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; endothelial cell proliferation [GO:0001935]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of mitotic cell cycle [GO:0045930]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN4574_c0_g1_i4	Q5PYH6	DLG1_DANRE	59.6	349	131	4	1039	2	220	561	5.50E-105	382.5	DLG1_DANRE	reviewed	Disks large homolog 1 (Synapse-associated protein 97A) (SAP-97A) (SAP97A)	dlg1	Danio rerio (Zebrafish) (Brachydanio rerio)	873	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; endothelial cell proliferation [GO:0001935]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of mitotic cell cycle [GO:0045930]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; synapse organization [GO:0050808]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0001935; GO:0005789; GO:0007015; GO:0007268; GO:0016323; GO:0016324; GO:0019901; GO:0019902; GO:0030054; GO:0030866; GO:0031594; GO:0043005; GO:0043113; GO:0045197; GO:0045930; GO:0050808; GO:0097120; GO:0098609; GO:0098839; GO:0099645	actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; endothelial cell proliferation [GO:0001935]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of mitotic cell cycle [GO:0045930]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN12725_c0_g1_i1	E9Q9R9	DLG5_MOUSE	34.8	198	118	2	573	1	152	345	1.30E-21	105.1	DLG5_MOUSE	reviewed	Disks large homolog 5	Dlg5	Mus musculus (Mouse)	1921	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]	GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205	apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]		NA	NA	NA	NA	NA	NA
TRINITY_DN12725_c0_g1_i2	E9Q9R9	DLG5_MOUSE	35	197	117	2	573	4	152	344	1.00E-21	105.5	DLG5_MOUSE	reviewed	Disks large homolog 5	Dlg5	Mus musculus (Mouse)	1921	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]	GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205	apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g1_i1	E9Q9R9	DLG5_MOUSE	39.4	264	137	9	7	765	563	814	8.50E-34	146.7	DLG5_MOUSE	reviewed	Disks large homolog 5	Dlg5	Mus musculus (Mouse)	1921	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]	GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205	apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g1_i4	E9Q9R9	DLG5_MOUSE	40.5	205	110	6	7	594	563	764	4.10E-31	136.3	DLG5_MOUSE	reviewed	Disks large homolog 5	Dlg5	Mus musculus (Mouse)	1921	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]	GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205	apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g1_i2	Q8TDM6	DLG5_HUMAN	37.7	154	84	4	35	487	670	814	4.00E-16	87.8	DLG5_HUMAN	reviewed	Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)	DLG5 KIAA0583 PDLG	Homo sapiens (Human)	1919	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609	apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]		NA	NA	NA	NA	NA	NA
TRINITY_DN3579_c0_g1_i1	Q9Y2H0	DLGP4_HUMAN	43.9	114	60	2	1199	1540	802	911	1.70E-20	102.4	DLGP4_HUMAN	reviewed	Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4)	DLGAP4 DAP4 KIAA0964 SAPAP4	Homo sapiens (Human)	992	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]	molecular adaptor activity [GO:0060090]	GO:0005886; GO:0023052; GO:0060090; GO:0098962; GO:0098978; GO:0099572	regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052]		NA	NA	NA	NA	NA	NA
TRINITY_DN29293_c0_g1_i1	Q96II8	LRCH3_HUMAN	99	98	1	0	294	1	665	762	5.90E-51	201.1	LRCH3_HUMAN	reviewed	DISP complex protein LRCH3 (Leucine-rich repeat and calponin homology domain-containing protein 3)	LRCH3	Homo sapiens (Human)	777	cytoplasm [GO:0005737]; cytosol [GO:0005829]; septin cytoskeleton organization [GO:0032185]	cytoplasm [GO:0005737]; cytosol [GO:0005829]		GO:0005737; GO:0005829; GO:0032185	septin cytoskeleton organization [GO:0032185]		NA	NA	NA	NA	NA	NA
TRINITY_DN32718_c0_g1_i1	Q8BQT2	DIK1C_MOUSE	25.7	257	170	7	67	810	141	385	1.10E-15	85.5	DIK1C_MOUSE	reviewed	Divergent protein kinase domain 1C (Protein FAM69C)	Dipk1c Fam69c	Mus musculus (Mouse)	410	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3185_c0_g1_i1	Q6PNC0	DMXL1_MOUSE	38.6	678	337	12	2094	85	2391	2997	4.50E-124	446.8	DMXL1_MOUSE	reviewed	DmX-like protein 1 (X-like 1 protein)	Dmxl1	Mus musculus (Mouse)	3013	RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]	RAVE complex [GO:0043291]		GO:0007035; GO:0043291	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN3185_c0_g1_i2	Q6PNC0	DMXL1_MOUSE	38.3	681	338	13	2103	85	2391	2997	2.50E-122	441	DMXL1_MOUSE	reviewed	DmX-like protein 1 (X-like 1 protein)	Dmxl1	Mus musculus (Mouse)	3013	RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]	RAVE complex [GO:0043291]		GO:0007035; GO:0043291	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN3185_c0_g1_i4	Q6PNC0	DMXL1_MOUSE	30.9	256	106	9	760	8	2551	2740	4.10E-19	96.7	DMXL1_MOUSE	reviewed	DmX-like protein 1 (X-like 1 protein)	Dmxl1	Mus musculus (Mouse)	3013	RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]	RAVE complex [GO:0043291]		GO:0007035; GO:0043291	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN28080_c0_g1_i1	Q9Y485	DMXL1_HUMAN	46	87	24	1	6	266	756	819	8.30E-13	74.3	DMXL1_HUMAN	reviewed	DmX-like protein 1 (X-like 1 protein)	DMXL1 XL1	Homo sapiens (Human)	3027	RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]	RAVE complex [GO:0043291]		GO:0007035; GO:0043291	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN25798_c0_g1_i1	Q9Y485	DMXL1_HUMAN	39.3	168	78	4	555	61	525	671	3.20E-21	103.2	DMXL1_HUMAN	reviewed	DmX-like protein 1 (X-like 1 protein)	DMXL1 XL1	Homo sapiens (Human)	3027	RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]	RAVE complex [GO:0043291]		GO:0007035; GO:0043291	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN14832_c0_g1_i1	Q8BPN8	DMXL2_MOUSE	57.8	64	27	0	297	106	2022	2085	1.10E-15	84	DMXL2_MOUSE	reviewed	DmX-like protein 2 (Rabconnectin-3)	Dmxl2 Kiaa0856	Mus musculus (Mouse)	3032	neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035]	neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	Rab GTPase binding [GO:0017137]	GO:0007035; GO:0008021; GO:0017137; GO:0030672; GO:0043291; GO:0098992	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN28080_c0_g1_i2	Q8TDJ6	DMXL2_HUMAN	42.3	130	48	3	6	389	776	880	7.60E-17	88.2	DMXL2_HUMAN	reviewed	DmX-like protein 2 (Rabconnectin-3)	DMXL2 KIAA0856	Homo sapiens (Human)	3036	extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035]	extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	Rab GTPase binding [GO:0017137]	GO:0005615; GO:0007035; GO:0008021; GO:0017137; GO:0030672; GO:0043291; GO:0098992	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN39863_c0_g1_i1	Q92072	DNMT1_CHICK	81.2	144	27	0	510	79	1367	1510	3.60E-72	272.3	DNMT1_CHICK	reviewed	DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT)	DNMT1 AIM DNMT	Gallus gallus (Chicken)	1537	nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]	nucleus [GO:0005634]	DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0090309; GO:1990841	positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN31597_c0_g1_i1	Q27746	DNMT1_PARLI	67.3	55	18	0	184	20	629	683	3.10E-19	95.1	DNMT1_PARLI	reviewed	DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT)	DNMT PLIMCIM	Paracentrotus lividus (Common sea urchin)	1612	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN18685_c0_g1_i2	Q27746	DNMT1_PARLI	46.1	462	222	6	1	1338	448	898	1.10E-120	434.9	DNMT1_PARLI	reviewed	DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT)	DNMT PLIMCIM	Paracentrotus lividus (Common sea urchin)	1612	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN28788_c0_g1_i1	Q5FWF4	ZRAB3_HUMAN	62.8	86	32	0	4	261	365	450	1.00E-22	107.1	ZRAB3_HUMAN	reviewed	DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)]	ZRANB3	Homo sapiens (Human)	1079	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]	GO:0004386; GO:0004520; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008094; GO:0009411; GO:0031297; GO:0032508; GO:0036292; GO:0036310; GO:0043596; GO:0045910; GO:0046872; GO:0048478; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN27525_c0_g1_i1	Q6NZP1	ZRAB3_MOUSE	62.5	96	36	0	2	289	366	461	1.30E-26	120.2	ZRAB3_MOUSE	reviewed	DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)]	Zranb3	Mus musculus (Mouse)	1069	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]	GO:0003678; GO:0004520; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008094; GO:0009411; GO:0031297; GO:0036292; GO:0036310; GO:0043596; GO:0045910; GO:0046872; GO:0048478; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN14460_c0_g1_i1	Q6NZP1	ZRAB3_MOUSE	60.6	71	27	1	42	254	392	461	7.00E-16	84.3	ZRAB3_MOUSE	reviewed	DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)]	Zranb3	Mus musculus (Mouse)	1069	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]	GO:0003678; GO:0004520; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008094; GO:0009411; GO:0031297; GO:0036292; GO:0036310; GO:0043596; GO:0045910; GO:0046872; GO:0048478; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN17249_c0_g2_i2	Q5QJC4	DCR1A_CHICK	43.6	188	105	1	563	3	698	885	2.20E-38	160.2	DCR1A_CHICK	reviewed	DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A)	DCLRE1A SNM1A	Gallus gallus (Chicken)	972	"nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; protection from non-homologous end joining at telomere [GO:0031848]"	"nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]	GO:0000715; GO:0000784; GO:0003684; GO:0005654; GO:0006281; GO:0006303; GO:0031848; GO:0035312; GO:0036297; GO:0046872	"DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; protection from non-homologous end joining at telomere [GO:0031848]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17249_c0_g2_i1	Q6PJP8	DCR1A_HUMAN	55.6	72	32	0	263	48	769	840	3.60E-15	82	DCR1A_HUMAN	reviewed	DNA cross-link repair 1A protein (SNM1 homolog A) (hSNM1) (hSNM1A)	DCLRE1A KIAA0086 SNM1 SNM1A	Homo sapiens (Human)	1040	"fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]"	"fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]	GO:0000784; GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0031848; GO:0035312; GO:0036297; GO:0046872; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]		NA	NA	NA	NA	NA	NA
TRINITY_DN17249_c0_g1_i1	Q38961	SNM1_ARATH	50.6	77	36	2	326	96	408	482	1.70E-14	80.1	SNM1_ARATH	reviewed	DNA cross-link repair protein SNM1 (AtSNM1)	SNM1 At3g26680 MLJ15.8	Arabidopsis thaliana (Mouse-ear cress)	484	"nuclear chromosome, telomeric region [GO:0000784]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]"	"nuclear chromosome, telomeric region [GO:0000784]"	5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]	GO:0000784; GO:0003684; GO:0006281; GO:0006303; GO:0031848; GO:0035312; GO:0036297	DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]		NA	NA	NA	NA	NA	NA
TRINITY_DN18610_c0_g1_i1	A1A4K3	DDB1_BOVIN	100	415	0	0	2	1246	67	481	5.60E-244	844.3	DDB1_BOVIN	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	DDB1	Bos taurus (Bovine)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN18610_c0_g1_i2	A1A4K3	DDB1_BOVIN	100	415	0	0	2	1246	67	481	5.60E-244	844.3	DDB1_BOVIN	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	DDB1	Bos taurus (Bovine)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN33186_c0_g1_i1	A1A4K3	DDB1_BOVIN	100	92	0	0	278	3	781	872	4.90E-47	188	DDB1_BOVIN	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	DDB1	Bos taurus (Bovine)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN28748_c0_g1_i1	A1A4K3	DDB1_BOVIN	98.8	81	1	0	2	244	1059	1139	2.10E-40	166	DDB1_BOVIN	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	DDB1	Bos taurus (Bovine)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26264_c0_g1_i1	A1A4K3	DDB1_BOVIN	100	73	0	0	3	221	1068	1140	1.10E-36	153.3	DDB1_BOVIN	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	DDB1	Bos taurus (Bovine)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN782_c0_g1_i1	Q6P6Z0	DDB1_XENLA	61	287	108	1	928	80	21	307	7.70E-103	375.2	DDB1_XENLA	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	ddb1	Xenopus laevis (African clawed frog)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008	DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN782_c0_g1_i2	Q6P6Z0	DDB1_XENLA	62.4	93	35	0	353	75	21	113	1.20E-28	127.5	DDB1_XENLA	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	ddb1	Xenopus laevis (African clawed frog)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008	DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN782_c0_g1_i3	Q6P6Z0	DDB1_XENLA	63.6	870	309	5	2590	2	21	889	0	1105.1	DDB1_XENLA	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	ddb1	Xenopus laevis (African clawed frog)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008	DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2241_c0_g1_i2	A1A4K3	DDB1_BOVIN	73.8	61	16	0	241	59	920	980	5.30E-21	101.3	DDB1_BOVIN	reviewed	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	DDB1	Bos taurus (Bovine)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	nucleotide-excision repair [GO:0006289]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN782_c0_g1_i4	Q805F9	DDB1_CHICK	57.8	204	78	3	601	2	690	889	2.20E-56	220.3	DDB1_CHICK	reviewed	DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)	DDB1 RCJMB04_6h2	Gallus gallus (Chicken)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0016567; GO:0031461; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0048511; GO:0080008	DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2241_c0_g1_i1	Q3U1J4	DDB1_MOUSE	71.4	196	56	0	678	91	945	1140	1.00E-75	284.6	DDB1_MOUSE	reviewed	DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)	Ddb1	Mus musculus (Mouse)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]; cellular response to DNA damage stimulus [GO:0006974]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0006974; GO:0010498; GO:0016055; GO:0016567; GO:0030674; GO:0031461; GO:0031464; GO:0031465; GO:0032991; GO:0035518; GO:0042752; GO:0043066; GO:0043161; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051702; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:1901990; GO:1902188	cellular response to DNA damage stimulus [GO:0006974]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2241_c0_g1_i3	Q3U1J4	DDB1_MOUSE	71.9	221	62	0	753	91	920	1140	1.00E-86	321.2	DDB1_MOUSE	reviewed	DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)	Ddb1	Mus musculus (Mouse)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]; cellular response to DNA damage stimulus [GO:0006974]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006511; GO:0006974; GO:0010498; GO:0016055; GO:0016567; GO:0030674; GO:0031461; GO:0031464; GO:0031465; GO:0032991; GO:0035518; GO:0042752; GO:0043066; GO:0043161; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051702; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:1901990; GO:1902188	cellular response to DNA damage stimulus [GO:0006974]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN19113_c0_g1_i1	P33194	DDB1_CHLAE	100	197	0	0	3	593	541	737	1.70E-110	399.8	DDB1_CHLAE	reviewed	DNA damage-binding protein 1 (DDB p127 subunit) (DDBa) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding protein 1) (UV-DDB 1)	DDB1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0043161; GO:0080008	DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN17492_c0_g1_i1	P33194	DDB1_CHLAE	100	149	0	0	1	447	509	657	6.40E-81	301.2	DDB1_CHLAE	reviewed	DNA damage-binding protein 1 (DDB p127 subunit) (DDBa) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding protein 1) (UV-DDB 1)	DDB1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	1140	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0016567; GO:0031464; GO:0031465; GO:0043161; GO:0080008	DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5316_c0_g1_i5	A1DNV8	CMR1_NEOFI	27.7	285	178	5	775	2	7	290	3.40E-11	70.9	CMR1_NEOFI	reviewed	DNA damage-binding protein cmr1	NFIA_058290	Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) (Aspergillus fischerianus)	527	DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]		DNA binding [GO:0003677]	GO:0003677; GO:0006974	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN5338_c0_g1_i1	A2VDT9	DDT4L_BOVIN	38.1	139	74	4	156	542	46	182	3.00E-14	80.1	DDT4L_BOVIN	reviewed	DNA damage-inducible transcript 4-like protein	DDIT4L	Bos taurus (Bovine)	193	cytoplasm [GO:0005737]; negative regulation of signal transduction [GO:0009968]	cytoplasm [GO:0005737]		GO:0005737; GO:0009968	negative regulation of signal transduction [GO:0009968]		NA	NA	NA	NA	NA	NA
TRINITY_DN35858_c0_g1_i1	Q7F2E4	CSB_ORYSJ	58.7	104	43	0	13	324	750	853	4.40E-31	135.2	CSB_ORYSJ	reviewed	DNA excision repair protein CSB (EC 3.6.4.-) (Cockayne syndrome protein CSB) (OsCSB)	CSB Os01g0102800 LOC_Os01g01312 P0402A09.26 P0455C04.20 P0672D08.47	Oryza sativa subsp. japonica (Rice)	1187	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription-coupled nucleotide-excision repair [GO:0006283]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006283; GO:0008094	transcription-coupled nucleotide-excision repair [GO:0006283]		NA	NA	NA	NA	NA	NA
TRINITY_DN29895_c1_g1_i1	P07903	ERCC1_MOUSE	58.3	187	78	0	259	819	80	266	1.50E-59	231.1	ERCC1_MOUSE	reviewed	DNA excision repair protein ERCC-1	Ercc1 Ercc-1	Mus musculus (Mouse)	298	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; germ cell development [GO:0007281]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000109; GO:0000110; GO:0000710; GO:0000720; GO:0000784; GO:0001094; GO:0001302; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006302; GO:0006303; GO:0006310; GO:0006312; GO:0006949; GO:0006974; GO:0006979; GO:0007281; GO:0007283; GO:0007584; GO:0008022; GO:0008283; GO:0008584; GO:0009650; GO:0009744; GO:0010165; GO:0010259; GO:0019904; GO:0032205; GO:0035166; GO:0035264; GO:0035902; GO:0036297; GO:0045190; GO:0046686; GO:0048468; GO:0048477; GO:0048568; GO:0051276; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090656; GO:1904431; GO:1905765; GO:1990599; GO:1990841	"cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; germ cell development [GO:0007281]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV-damage excision repair [GO:0070914]; UV protection [GO:0009650]"		blue	blue	NA	NA	NA	NA
TRINITY_DN23255_c0_g1_i1	P07903	ERCC1_MOUSE	98.3	115	2	0	347	3	109	223	2.30E-62	239.2	ERCC1_MOUSE	reviewed	DNA excision repair protein ERCC-1	Ercc1 Ercc-1	Mus musculus (Mouse)	298	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; germ cell development [GO:0007281]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000109; GO:0000110; GO:0000710; GO:0000720; GO:0000784; GO:0001094; GO:0001302; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006302; GO:0006303; GO:0006310; GO:0006312; GO:0006949; GO:0006974; GO:0006979; GO:0007281; GO:0007283; GO:0007584; GO:0008022; GO:0008283; GO:0008584; GO:0009650; GO:0009744; GO:0010165; GO:0010259; GO:0019904; GO:0032205; GO:0035166; GO:0035264; GO:0035902; GO:0036297; GO:0045190; GO:0046686; GO:0048468; GO:0048477; GO:0048568; GO:0051276; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090656; GO:1904431; GO:1905765; GO:1990599; GO:1990841	"cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; germ cell development [GO:0007281]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV-damage excision repair [GO:0070914]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23255_c0_g1_i2	P07903	ERCC1_MOUSE	100	115	0	0	347	3	109	223	8.00E-63	240.7	ERCC1_MOUSE	reviewed	DNA excision repair protein ERCC-1	Ercc1 Ercc-1	Mus musculus (Mouse)	298	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; germ cell development [GO:0007281]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000109; GO:0000110; GO:0000710; GO:0000720; GO:0000784; GO:0001094; GO:0001302; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006302; GO:0006303; GO:0006310; GO:0006312; GO:0006949; GO:0006974; GO:0006979; GO:0007281; GO:0007283; GO:0007584; GO:0008022; GO:0008283; GO:0008584; GO:0009650; GO:0009744; GO:0010165; GO:0010259; GO:0019904; GO:0032205; GO:0035166; GO:0035264; GO:0035902; GO:0036297; GO:0045190; GO:0046686; GO:0048468; GO:0048477; GO:0048568; GO:0051276; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090656; GO:1904431; GO:1905765; GO:1990599; GO:1990841	"cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; germ cell development [GO:0007281]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV-damage excision repair [GO:0070914]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20729_c2_g1_i1	Q03468	ERCC6_HUMAN	72.4	58	16	0	181	8	674	731	1.30E-20	99.8	ERCC6_HUMAN	reviewed	DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)	ERCC6 CSB	Homo sapiens (Human)	1493	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063]	GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006366; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032508; GO:0032784; GO:0032786; GO:0035264; GO:0043044; GO:0044877; GO:0045494; GO:0045739; GO:0045815; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:1905168; GO:2001033	"activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20729_c2_g1_i2	Q03468	ERCC6_HUMAN	57.5	285	113	2	856	8	453	731	4.00E-96	352.8	ERCC6_HUMAN	reviewed	DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)	ERCC6 CSB	Homo sapiens (Human)	1493	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063]	GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006366; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032508; GO:0032784; GO:0032786; GO:0035264; GO:0043044; GO:0044877; GO:0045494; GO:0045739; GO:0045815; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:1905168; GO:2001033	"activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20729_c2_g1_i3	Q03468	ERCC6_HUMAN	69	113	35	0	346	8	619	731	4.80E-45	181.8	ERCC6_HUMAN	reviewed	DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)	ERCC6 CSB	Homo sapiens (Human)	1493	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063]	GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006366; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032508; GO:0032784; GO:0032786; GO:0035264; GO:0043044; GO:0044877; GO:0045494; GO:0045739; GO:0045815; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:1905168; GO:2001033	"activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20729_c2_g2_i1	F8VPZ5	ERCC6_MOUSE	71.8	188	52	1	1	564	801	987	7.30E-74	278.1	ERCC6_MOUSE	reviewed	DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)	Ercc6 Csb	Mus musculus (Mouse)	1481	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; sequence-specific DNA binding [GO:0043565]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063]; sequence-specific DNA binding [GO:0043565]	GO:0000012; GO:0000077; GO:0000303; GO:0002230; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006974; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0010628; GO:0016604; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0033141; GO:0035264; GO:0043044; GO:0043565; GO:0044877; GO:0045494; GO:0045739; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:1905168; GO:2001033	"activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33268_c0_g1_i1	Q03468	ERCC6_HUMAN	62.1	87	33	0	263	3	622	708	2.20E-25	115.9	ERCC6_HUMAN	reviewed	DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)	ERCC6 CSB	Homo sapiens (Human)	1493	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063]	GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006366; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032508; GO:0032784; GO:0032786; GO:0035264; GO:0043044; GO:0044877; GO:0045494; GO:0045739; GO:0045815; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:1905168; GO:2001033	"activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]"		NA	NA	NA	NA	NA	NA
TRINITY_DN893_c4_g1_i1	Q5BIM8	ERCC8_BOVIN	35.3	365	225	3	1751	663	39	394	5.40E-66	253.8	ERCC8_BOVIN	reviewed	DNA excision repair protein ERCC-8	ERCC8	Bos taurus (Bovine)	397	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; protein-containing complex [GO:0032991]	protein-containing complex binding [GO:0044877]	GO:0000012; GO:0000109; GO:0000209; GO:0006283; GO:0006289; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0044877; GO:0045739; GO:0051865; GO:0097680	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2947_c0_g1_i1	O76075	DFFB_HUMAN	35.7	325	185	7	123	1082	17	322	3.10E-46	187.6	DFFB_HUMAN	reviewed	DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40)	DFFB CAD DFF2 DFF40	Homo sapiens (Human)	338	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718	apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]		NA	NA	NA	NA	NA	NA
TRINITY_DN2947_c0_g1_i2	O76075	DFFB_HUMAN	50	108	43	1	22	345	226	322	2.30E-25	117.1	DFFB_HUMAN	reviewed	DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40)	DFFB CAD DFF2 DFF40	Homo sapiens (Human)	338	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718	apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]		NA	NA	NA	NA	NA	NA
TRINITY_DN25430_c0_g1_i1	D3ZVK1	MCM8_RAT	60.3	189	70	3	560	6	215	402	1.50E-58	227.3	MCM8_RAT	reviewed	DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)	Mcm8	Rattus norvegicus (Rat)	830	chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]	chromosome [GO:0005694]; MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003678; GO:0003682; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007049; GO:0007292; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0071168; GO:0097362	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]		NA	NA	NA	NA	NA	NA
TRINITY_DN2574_c0_g1_i1	Q9CWV1	MCM8_MOUSE	50.5	208	99	2	620	9	389	596	2.80E-53	209.9	MCM8_MOUSE	reviewed	DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)	Mcm8	Mus musculus (Mouse)	833	chromosome [GO:0005694]; cytosol [GO:0005829]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]	chromosome [GO:0005694]; cytosol [GO:0005829]; MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003678; GO:0003682; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006974; GO:0007049; GO:0007292; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0071168; GO:0097362	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]		NA	NA	NA	NA	NA	NA
TRINITY_DN21634_c0_g1_i1	Q0V9Q6	MCM8_XENTR	50	124	59	2	421	53	591	712	3.10E-22	106.3	MCM8_XENTR	reviewed	DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)	mcm8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	843	MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]	MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006974; GO:0007049; GO:0042555; GO:0097362	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN21634_c0_g1_i2	I0IUP3	MCM8_CHICK	61.5	231	85	2	727	38	489	716	1.80E-69	263.8	MCM8_CHICK	reviewed	DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)	MCM8 RCJMB04_5o15	Gallus gallus (Chicken)	830	MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]	MCM8-MCM9 complex [GO:0097362]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006974; GO:0007292; GO:0042555; GO:0048232; GO:0097362	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]		NA	NA	NA	NA	NA	NA
TRINITY_DN34534_c0_g1_i1	Q6NRM6	MCM9_XENLA	73.1	67	18	0	201	1	348	414	1.40E-22	106.3	MCM9_XENLA	reviewed	DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9)	mcm9	Xenopus laevis (African clawed frog)	1143	MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]	MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0000724; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006974; GO:0097362	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN13356_c0_g1_i1	Q9W1H4	DNLI1_DROME	73	111	30	0	2	334	513	623	2.70E-45	182.6	DNLI1_DROME	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (DmDNA Lig I)	DNAlig1 DNA-ligI CG5602	Drosophila melanogaster (Fruit fly)	747	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]	GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006281; GO:0006310; GO:0051301; GO:0071897; GO:1903461	cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]		NA	NA	NA	NA	NA	NA
TRINITY_DN13356_c0_g1_i3	Q9W1H4	DNLI1_DROME	70	210	63	0	2	631	513	722	2.80E-88	326.2	DNLI1_DROME	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (DmDNA Lig I)	DNAlig1 DNA-ligI CG5602	Drosophila melanogaster (Fruit fly)	747	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]	GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006281; GO:0006310; GO:0051301; GO:0071897; GO:1903461	cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]		NA	NA	NA	NA	NA	NA
TRINITY_DN33872_c0_g1_i1	P18858	DNLI1_HUMAN	100	152	0	0	2	457	746	897	3.30E-85	315.5	DNLI1_HUMAN	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)	LIG1	Homo sapiens (Human)	919	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]; transcription-coupled nucleotide-excision repair [GO:0006283]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; metal ion binding [GO:0046872]	GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006281; GO:0006283; GO:0006284; GO:0006297; GO:0006298; GO:0006310; GO:0009653; GO:0043231; GO:0046872; GO:0051301; GO:0071897; GO:1903461	"anatomical structure morphogenesis [GO:0009653]; base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36924_c0_g1_i1	Q869E1	DNLI1_DICDI	58.1	198	83	0	18	611	981	1178	4.40E-70	265.8	DNLI1_DICDI	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)	lig1 DDB_G0274493	Dictyostelium discoideum (Slime mold)	1192	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006310; GO:0046872; GO:0051103; GO:0051301; GO:0071897; GO:1903461	cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]		NA	NA	NA	NA	NA	NA
TRINITY_DN33515_c0_g1_i1	P04819	DNLI1_YEAST	60.8	79	28	1	9	236	564	642	1.30E-21	103.2	DNLI1_YEAST	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)	CDC9 YDL164C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	755	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273]; maintenance of DNA trinucleotide repeats [GO:0035753]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0000278; GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006284; GO:0006289; GO:0006310; GO:0035753; GO:0046872; GO:0051103; GO:0051301; GO:0071897; GO:1903461	base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273]; maintenance of DNA trinucleotide repeats [GO:0035753]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]		NA	NA	NA	NA	NA	NA
TRINITY_DN13356_c0_g1_i2	P51892	DNLI1_XENLA	68.2	233	73	1	2	700	839	1070	1.40E-93	344	DNLI1_XENLA	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)	lig1	Xenopus laevis (African clawed frog)	1070	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0007049; GO:0046872; GO:0051103; GO:0051301; GO:0071897	cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN2181_c0_g1_i1	P04819	DNLI1_YEAST	61.2	67	25	1	237	40	684	750	3.90E-16	85.1	DNLI1_YEAST	reviewed	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)	CDC9 YDL164C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	755	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273]; maintenance of DNA trinucleotide repeats [GO:0035753]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0000278; GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006284; GO:0006289; GO:0006310; GO:0035753; GO:0046872; GO:0051103; GO:0051301; GO:0071897; GO:1903461	base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273]; maintenance of DNA trinucleotide repeats [GO:0035753]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]		NA	NA	NA	NA	NA	NA
TRINITY_DN10013_c0_g1_i1	P97386	DNLI3_MOUSE	56.9	288	114	2	841	5	329	615	1.90E-94	347.1	DNLI3_MOUSE	reviewed	DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3)	Lig3	Mus musculus (Mouse)	1015	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair, DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of DNA recombination [GO:0045910]; negative regulation of mitochondrial DNA replication [GO:0090298]"	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]	GO:0000794; GO:0000795; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006288; GO:0006302; GO:0006303; GO:0006310; GO:0007005; GO:0007049; GO:0008270; GO:0043504; GO:0045910; GO:0051103; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681	"base-excision repair, DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of DNA recombination [GO:0045910]; negative regulation of mitochondrial DNA replication [GO:0090298]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3675_c0_g1_i1	Q90YB1	DNLI4_CHICK	40.7	744	411	9	2217	61	172	910	1.60E-156	554.7	DNLI4_CHICK	reviewed	DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)	LIG4 RCJMB04_10b2	Gallus gallus (Chicken)	912	"DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0003677; GO:0003910; GO:0005524; GO:0005654; GO:0005958; GO:0006260; GO:0006297; GO:0006303; GO:0007049; GO:0032807; GO:0033152; GO:0046872; GO:0051103; GO:0051301; GO:0070419; GO:0071897	"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3675_c0_g1_i2	P49917	DNLI4_HUMAN	46.1	597	314	5	1818	40	10	602	1.50E-158	561.2	DNLI4_HUMAN	reviewed	DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)	LIG4	Homo sapiens (Human)	911	"condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]"	"condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]	GO:0000012; GO:0000784; GO:0000793; GO:0001701; GO:0002328; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005958; GO:0006260; GO:0006266; GO:0006297; GO:0006302; GO:0006303; GO:0007049; GO:0007417; GO:0008022; GO:0008283; GO:0010165; GO:0010332; GO:0016874; GO:0032807; GO:0033077; GO:0033151; GO:0033152; GO:0033153; GO:0035019; GO:0036464; GO:0043524; GO:0045190; GO:0046872; GO:0048146; GO:0050769; GO:0051102; GO:0051103; GO:0051276; GO:0051301; GO:0051402; GO:0070419; GO:0071285; GO:0071479; GO:0071897; GO:0075713; GO:0097680; GO:2001252	"cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3675_c0_g1_i4	Q2U6A1	DNLI4_ASPOR	30.9	81	46	1	282	40	81	151	1.20E-05	51.2	DNLI4_ASPOR	reviewed	DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)	lig4 AO090120000322	Aspergillus oryzae (strain ATCC 42149 / RIB 40) (Yellow koji mold)	1006	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0046872; GO:0051103; GO:0071897	DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN3675_c0_g1_i5	Q90YB1	DNLI4_CHICK	40.9	903	502	11	2689	56	15	910	7.80E-193	675.6	DNLI4_CHICK	reviewed	DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)	LIG4 RCJMB04_10b2	Gallus gallus (Chicken)	912	"DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0003677; GO:0003910; GO:0005524; GO:0005654; GO:0005958; GO:0006260; GO:0006297; GO:0006303; GO:0007049; GO:0032807; GO:0033152; GO:0046872; GO:0051103; GO:0051301; GO:0070419; GO:0071897	"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3675_c0_g1_i7	Q90YB1	DNLI4_CHICK	40.7	744	411	9	2212	56	172	910	1.40E-156	555.1	DNLI4_CHICK	reviewed	DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)	LIG4 RCJMB04_10b2	Gallus gallus (Chicken)	912	"DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]	GO:0003677; GO:0003910; GO:0005524; GO:0005654; GO:0005958; GO:0006260; GO:0006297; GO:0006303; GO:0007049; GO:0032807; GO:0033152; GO:0046872; GO:0051103; GO:0051301; GO:0070419; GO:0071897	"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35561_c0_g1_i1	Q9NPF5	DMAP1_HUMAN	100	143	0	0	430	2	29	171	2.10E-81	302.8	DMAP1_HUMAN	reviewed	DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1)	DMAP1 KIAA1425	Homo sapiens (Human)	467	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]	RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000812; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0035267; GO:0040008; GO:0042307; GO:0043486; GO:0043967; GO:0043968; GO:0045471; GO:0045892	"DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27505_c0_g1_i1	Q9NPF5	DMAP1_HUMAN	100	86	0	0	2	259	50	135	1.60E-47	189.5	DMAP1_HUMAN	reviewed	DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1)	DMAP1 KIAA1425	Homo sapiens (Human)	467	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]	RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000812; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0035267; GO:0040008; GO:0042307; GO:0043486; GO:0043967; GO:0043968; GO:0045471; GO:0045892	"DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29431_c0_g1_i1	Q9NPF5	DMAP1_HUMAN	100	85	0	0	2	256	323	407	8.20E-41	167.2	DMAP1_HUMAN	reviewed	DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1)	DMAP1 KIAA1425	Homo sapiens (Human)	467	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]	RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000812; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0035267; GO:0040008; GO:0042307; GO:0043486; GO:0043967; GO:0043968; GO:0045471; GO:0045892	"DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32094_c0_g1_i1	Q9NPF5	DMAP1_HUMAN	100	48	0	0	2	145	209	256	2.30E-19	95.9	DMAP1_HUMAN	reviewed	DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1)	DMAP1 KIAA1425	Homo sapiens (Human)	467	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]	RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000812; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0035267; GO:0040008; GO:0042307; GO:0043486; GO:0043967; GO:0043968; GO:0045471; GO:0045892	"DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2508_c0_g1_i1	Q9JI44	DMAP1_MOUSE	47.9	468	221	6	96	1448	5	466	2.30E-101	370.9	DMAP1_MOUSE	reviewed	DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1) (MAT1-mediated transcriptional repressor)	Dmap1 Mmtr	Mus musculus (Mouse)	468	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]	RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000812; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0035267; GO:0040008; GO:0042307; GO:0043486; GO:0043967; GO:0043968; GO:0045471	DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]		blue	blue	NA	NA	NA	NA
TRINITY_DN153_c0_g1_i1	P40692	MLH1_HUMAN	52.1	760	280	12	193	2253	8	756	1.20E-210	734.6	MLH1_HUMAN	reviewed	DNA mismatch repair protein Mlh1 (MutL protein homolog 1)	MLH1 COCA2	Homo sapiens (Human)	756	chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]	chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]	GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257	double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN33783_c0_g1_i1	P40692	MLH1_HUMAN	100	117	0	0	352	2	73	189	6.80E-62	237.7	MLH1_HUMAN	reviewed	DNA mismatch repair protein Mlh1 (MutL protein homolog 1)	MLH1 COCA2	Homo sapiens (Human)	756	chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]	chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]	GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257	double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN33065_c0_g1_i1	P40692	MLH1_HUMAN	100	133	0	0	1	399	212	344	1.20E-70	266.9	MLH1_HUMAN	reviewed	DNA mismatch repair protein Mlh1 (MutL protein homolog 1)	MLH1 COCA2	Homo sapiens (Human)	756	chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]	chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]	GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257	double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN26176_c0_g1_i1	P43246	MSH2_HUMAN	100	71	0	0	213	1	500	570	6.20E-34	144.1	MSH2_HUMAN	reviewed	DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)	MSH2	Homo sapiens (Human)	934	"membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]"	"membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]	GO:0000406; GO:0000784; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006310; GO:0007050; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032300; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168	B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]		NA	NA	NA	NA	NA	NA
TRINITY_DN35786_c0_g1_i1	P43246	MSH2_HUMAN	100	106	0	0	2	319	570	675	3.30E-55	215.3	MSH2_HUMAN	reviewed	DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)	MSH2	Homo sapiens (Human)	934	"membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]"	"membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]	GO:0000406; GO:0000784; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006310; GO:0007050; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032300; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168	B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]		NA	NA	NA	NA	NA	NA
TRINITY_DN11599_c0_g1_i1	P25847	MSH2_YEAST	64.5	93	33	0	282	4	719	811	2.70E-29	129	MSH2_YEAST	reviewed	DNA mismatch repair protein MSH2 (MutS protein homolog 2)	MSH2 YOL090W O0935	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	964	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; DNA recombination [GO:0006310]; interstrand cross-link repair [GO:0036297]; maintenance of DNA repeat elements [GO:0043570]; meiotic gene conversion [GO:0006311]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; postreplication repair [GO:0006301]; removal of nonhomologous ends [GO:0000735]; replication fork arrest [GO:0043111]; silent mating-type cassette heterochromatin assembly [GO:0030466]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000228; GO:0000400; GO:0000406; GO:0000710; GO:0000735; GO:0005524; GO:0005634; GO:0006298; GO:0006301; GO:0006310; GO:0006311; GO:0006312; GO:0008094; GO:0016887; GO:0030466; GO:0030983; GO:0032300; GO:0032301; GO:0032302; GO:0036297; GO:0043111; GO:0043570; GO:0045910	DNA recombination [GO:0006310]; interstrand cross-link repair [GO:0036297]; maintenance of DNA repeat elements [GO:0043570]; meiotic gene conversion [GO:0006311]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; postreplication repair [GO:0006301]; removal of nonhomologous ends [GO:0000735]; replication fork arrest [GO:0043111]; silent mating-type cassette heterochromatin assembly [GO:0030466]		NA	NA	NA	NA	NA	NA
TRINITY_DN34301_c0_g1_i1	Q3MHE4	MSH2_BOVIN	100	84	0	0	252	1	708	791	6.90E-40	164.1	MSH2_BOVIN	reviewed	DNA mismatch repair protein Msh2 (MutS protein homolog 2)	MSH2	Bos taurus (Bovine)	934	chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; dinucleotide repeat insertion binding [GO:0032181]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; single-stranded DNA binding [GO:0003697]; B cell differentiation [GO:0030183]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]	chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleus [GO:0005634]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; dinucleotide repeat insertion binding [GO:0032181]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single-stranded DNA binding [GO:0003697]; single thymine insertion binding [GO:0032143]	GO:0000287; GO:0000400; GO:0000406; GO:0001701; GO:0002204; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006119; GO:0006298; GO:0006301; GO:0006302; GO:0006310; GO:0007050; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016446; GO:0019237; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032300; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168	B cell differentiation [GO:0030183]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]		NA	NA	NA	NA	NA	NA
TRINITY_DN3078_c0_g1_i1	Q3MHE4	MSH2_BOVIN	53.6	472	213	2	1492	92	459	929	6.50E-138	492.3	MSH2_BOVIN	reviewed	DNA mismatch repair protein Msh2 (MutS protein homolog 2)	MSH2	Bos taurus (Bovine)	934	chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; dinucleotide repeat insertion binding [GO:0032181]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; single-stranded DNA binding [GO:0003697]; B cell differentiation [GO:0030183]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]	chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleus [GO:0005634]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; dinucleotide repeat insertion binding [GO:0032181]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single-stranded DNA binding [GO:0003697]; single thymine insertion binding [GO:0032143]	GO:0000287; GO:0000400; GO:0000406; GO:0001701; GO:0002204; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006119; GO:0006298; GO:0006301; GO:0006302; GO:0006310; GO:0007050; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016446; GO:0019237; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032300; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168	B cell differentiation [GO:0030183]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]		NA	NA	NA	NA	NA	NA
TRINITY_DN18688_c0_g1_i1	P20585	MSH3_HUMAN	37.5	200	125	0	688	89	574	773	2.70E-31	137.1	MSH3_HUMAN	reviewed	DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1)	MSH3 DUC1 DUG	Homo sapiens (Human)	1137	membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA insertion or deletion binding [GO:0032135]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; reciprocal meiotic recombination [GO:0007131]; removal of nonhomologous ends [GO:0000735]; replication fork arrest [GO:0043111]; somatic recombination of immunoglobulin gene segments [GO:0016447]	membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA insertion or deletion binding [GO:0032135]; enzyme binding [GO:0019899]	GO:0000710; GO:0000735; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0007131; GO:0008094; GO:0016020; GO:0016447; GO:0019899; GO:0032135; GO:0032300; GO:0032302; GO:0043111; GO:0043570; GO:0045910; GO:0051096	DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; reciprocal meiotic recombination [GO:0007131]; removal of nonhomologous ends [GO:0000735]; replication fork arrest [GO:0043111]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN18688_c0_g1_i2	P20585	MSH3_HUMAN	46.8	896	454	6	2763	133	230	1121	3.20E-217	756.9	MSH3_HUMAN	reviewed	DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1)	MSH3 DUC1 DUG	Homo sapiens (Human)	1137	membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA insertion or deletion binding [GO:0032135]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; reciprocal meiotic recombination [GO:0007131]; removal of nonhomologous ends [GO:0000735]; replication fork arrest [GO:0043111]; somatic recombination of immunoglobulin gene segments [GO:0016447]	membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA insertion or deletion binding [GO:0032135]; enzyme binding [GO:0019899]	GO:0000710; GO:0000735; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0007131; GO:0008094; GO:0016020; GO:0016447; GO:0019899; GO:0032135; GO:0032300; GO:0032302; GO:0043111; GO:0043570; GO:0045910; GO:0051096	DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; reciprocal meiotic recombination [GO:0007131]; removal of nonhomologous ends [GO:0000735]; replication fork arrest [GO:0043111]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN3132_c0_g1_i1	E1BYJ2	MSH6_CHICK	52.4	105	48	2	4	312	937	1041	2.50E-24	112.8	MSH6_CHICK	reviewed	DNA mismatch repair protein Msh6	MSH6	Gallus gallus (Chicken)	1337	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0007095; GO:0008094; GO:0008630; GO:0016446; GO:0016447; GO:0030890; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910	interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN3132_c0_g1_i10	E1BYJ2	MSH6_CHICK	55.5	564	238	10	17	1672	710	1272	1.70E-174	614	MSH6_CHICK	reviewed	DNA mismatch repair protein Msh6	MSH6	Gallus gallus (Chicken)	1337	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0007095; GO:0008094; GO:0008630; GO:0016446; GO:0016447; GO:0030890; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910	interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN3132_c0_g1_i14	E1BYJ2	MSH6_CHICK	54.5	525	227	9	262	1803	749	1272	3.60E-159	563.1	MSH6_CHICK	reviewed	DNA mismatch repair protein Msh6	MSH6	Gallus gallus (Chicken)	1337	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0007095; GO:0008094; GO:0008630; GO:0016446; GO:0016447; GO:0030890; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910	interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN3132_c0_g1_i16	E1BYJ2	MSH6_CHICK	48.5	233	116	3	17	703	710	942	6.60E-57	222.2	MSH6_CHICK	reviewed	DNA mismatch repair protein Msh6	MSH6	Gallus gallus (Chicken)	1337	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0007095; GO:0008094; GO:0008630; GO:0016446; GO:0016447; GO:0030890; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910	interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN3132_c0_g1_i4	E1BYJ2	MSH6_CHICK	75	140	33	2	73	489	1134	1272	6.20E-53	208.4	MSH6_CHICK	reviewed	DNA mismatch repair protein Msh6	MSH6	Gallus gallus (Chicken)	1337	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006290; GO:0006298; GO:0007095; GO:0008094; GO:0008630; GO:0016446; GO:0016447; GO:0030890; GO:0030983; GO:0032300; GO:0032301; GO:0032876; GO:0036297; GO:0043570; GO:0045910	interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of DNA recombination [GO:0045910]; positive regulation of B cell proliferation [GO:0030890]; pyrimidine dimer repair [GO:0006290]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		blue	blue	NA	NA	NA	NA
TRINITY_DN32668_c0_g1_i1	Q55GU9	MSH6_DICDI	55.8	154	66	2	484	29	992	1145	7.40E-43	174.9	MSH6_DICDI	reviewed	DNA mismatch repair protein Msh6	msh6 DDB_G0268614	Dictyostelium discoideum (Slime mold)	1260	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; interstrand cross-link repair [GO:0036297]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0005634; GO:0006290; GO:0006298; GO:0008094; GO:0016887; GO:0030983; GO:0032300; GO:0032301; GO:0036297; GO:0043570; GO:0045910	interstrand cross-link repair [GO:0036297]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3132_c0_g1_i3	P54276	MSH6_MOUSE	42.6	101	53	1	262	549	769	869	8.50E-14	78.6	MSH6_MOUSE	reviewed	DNA mismatch repair protein Msh6 (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	Msh6 Gtmbp	Mus musculus (Mouse)	1358	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]	GO:0000287; GO:0000400; GO:0000710; GO:0000790; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032142; GO:0032143; GO:0032300; GO:0032301; GO:0032357; GO:0032405; GO:0035064; GO:0036297; GO:0043231; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0051096; GO:0097193	determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN37796_c0_g1_i1	P54276	MSH6_MOUSE	94.6	74	4	0	223	2	1097	1170	1.10E-36	153.3	MSH6_MOUSE	reviewed	DNA mismatch repair protein Msh6 (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	Msh6 Gtmbp	Mus musculus (Mouse)	1358	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]	GO:0000287; GO:0000400; GO:0000710; GO:0000790; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032142; GO:0032143; GO:0032300; GO:0032301; GO:0032357; GO:0032405; GO:0035064; GO:0036297; GO:0043231; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0051096; GO:0097193	determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]		NA	NA	NA	NA	NA	NA
TRINITY_DN28562_c0_g1_i1	P52701	MSH6_HUMAN	100	72	0	0	218	3	1263	1334	1.80E-36	152.5	MSH6_HUMAN	reviewed	DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	MSH6 GTBP	Homo sapiens (Human)	1360	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]	GO:0000710; GO:0000790; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016032; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032300; GO:0032301; GO:0035064; GO:0036297; GO:0043231; GO:0045190; GO:0045910; GO:0051096; GO:0097193	determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32263_c0_g1_i1	P52701	MSH6_HUMAN	100	77	0	0	231	1	1173	1249	2.10E-35	149.1	MSH6_HUMAN	reviewed	DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	MSH6 GTBP	Homo sapiens (Human)	1360	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]	GO:0000710; GO:0000790; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016032; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032300; GO:0032301; GO:0035064; GO:0036297; GO:0043231; GO:0045190; GO:0045910; GO:0051096; GO:0097193	determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN14022_c0_g1_i1	P52701	MSH6_HUMAN	74.2	31	8	0	338	246	1269	1299	6.60E-07	55.1	MSH6_HUMAN	reviewed	DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	MSH6 GTBP	Homo sapiens (Human)	1360	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]	GO:0000710; GO:0000790; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016032; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032300; GO:0032301; GO:0035064; GO:0036297; GO:0043231; GO:0045190; GO:0045910; GO:0051096; GO:0097193	determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN28825_c0_g1_i1	B2U9E4	MUTS_RALPJ	98.8	166	2	0	500	3	593	758	3.30E-86	318.9	MUTS_RALPJ	reviewed	DNA mismatch repair protein MutS	mutS Rpic_0993	Ralstonia pickettii (strain 12J)	882	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]		ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]	GO:0003684; GO:0005524; GO:0006298; GO:0030983	mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	NA
TRINITY_DN8506_c0_g1_i1	Q5WFY3	MUTS_BACSK	53.3	137	61	2	7	408	587	723	2.90E-33	142.9	MUTS_BACSK	reviewed	DNA mismatch repair protein MutS	mutS ABC2187	Bacillus clausii (strain KSM-K16)	871	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]		ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]	GO:0003684; GO:0005524; GO:0006298; GO:0030983	mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	NA
TRINITY_DN3451_c0_g1_i1	A5VA00	MUTS_SPHWW	87.4	119	15	0	2	358	666	784	4.20E-51	201.8	MUTS_SPHWW	reviewed	DNA mismatch repair protein MutS	mutS Swit_2761	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	904	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]		ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]	GO:0003684; GO:0005524; GO:0006298; GO:0030983	mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	NA
TRINITY_DN3451_c0_g1_i3	A5VA00	MUTS_SPHWW	85.1	168	25	0	3	506	617	784	7.00E-76	284.6	MUTS_SPHWW	reviewed	DNA mismatch repair protein MutS	mutS Swit_2761	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	904	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]		ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]	GO:0003684; GO:0005524; GO:0006298; GO:0030983	mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	NA
TRINITY_DN3451_c1_g1_i1	Q0BV38	MUTS_GRABC	84.7	72	11	0	1	216	673	744	5.70E-27	120.9	MUTS_GRABC	reviewed	DNA mismatch repair protein MutS	mutS GbCGDNIH1_0416	Granulibacter bethesdensis (strain ATCC BAA-1260 / CGDNIH1)	926	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]		ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]	GO:0003684; GO:0005524; GO:0006298; GO:0030983	mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	1
TRINITY_DN9351_c0_g1_i1	B9K800	MUTS_THENN	52.4	124	58	1	384	16	586	709	4.40E-26	119	MUTS_THENN	reviewed	DNA mismatch repair protein MutS	mutS CTN_0907	Thermotoga neapolitana (strain ATCC 49049 / DSM 4359 / NS-E)	801	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]		ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; mismatched DNA binding [GO:0030983]	GO:0003684; GO:0005524; GO:0006298; GO:0030983	mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	NA
TRINITY_DN4700_c0_g1_i11	Q941I6	PMS1_ARATH	49	51	26	0	34	186	102	152	1.30E-06	54.7	PMS1_ARATH	reviewed	DNA mismatch repair protein PMS1 (Postmeiotic segregation protein 1) (Protein POSTMEIOTIC SEGREGATION 1)	PMS1 At4g02460 T14P8.6	Arabidopsis thaliana (Mouse-ear cress)	923	mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mismatched DNA binding [GO:0030983]; DNA recombination [GO:0006310]; fruit development [GO:0010154]; mismatch repair [GO:0006298]; pollen development [GO:0009555]; seed development [GO:0048316]	mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]	GO:0005524; GO:0005634; GO:0006298; GO:0006310; GO:0009555; GO:0010154; GO:0016887; GO:0030983; GO:0032300; GO:0032389; GO:0048316	DNA recombination [GO:0006310]; fruit development [GO:0010154]; mismatch repair [GO:0006298]; pollen development [GO:0009555]; seed development [GO:0048316]		NA	NA	NA	NA	NA	NA
TRINITY_DN5798_c0_g1_i1	Q58DM4	ALKB2_BOVIN	49.2	256	120	3	853	95	14	262	3.60E-65	250	ALKB2_BOVIN	reviewed	DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2)	ALKBH2 ABH2	Bos taurus (Bovine)	278	nucleoplasm [GO:0005654]; 1-ethyladenine demethylase activity [GO:0103053]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; DNA dealkylation involved in DNA repair [GO:0006307]; oxidative DNA demethylation [GO:0035511]	nucleoplasm [GO:0005654]	1-ethyladenine demethylase activity [GO:0103053]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]	GO:0005654; GO:0006307; GO:0008198; GO:0035511; GO:0043734; GO:0051747; GO:0103053	DNA dealkylation involved in DNA repair [GO:0006307]; oxidative DNA demethylation [GO:0035511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4464_c0_g1_i3	P26019	DPOLA_DROME	37	138	72	5	390	4	19	150	8.30E-11	68.2	DPOLA_DROME	reviewed	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-alpha180 DNApol-alpha DNApolA1 POLA CG6349	Drosophila melanogaster (Fruit fly)	1488	"alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016895]; metal ion binding [GO:0046872]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]"	alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication origin binding [GO:0003688]; exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016895]; metal ion binding [GO:0046872]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]"	GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005658; GO:0006261; GO:0006272; GO:0006273; GO:0008296; GO:0016895; GO:0017076; GO:0019103; GO:0045004; GO:0046872; GO:0051539; GO:1902975	DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]		NA	NA	NA	NA	NA	NA
TRINITY_DN4464_c0_g1_i7	P26019	DPOLA_DROME	36.9	130	69	4	386	24	19	144	2.00E-09	63.5	DPOLA_DROME	reviewed	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-alpha180 DNApol-alpha DNApolA1 POLA CG6349	Drosophila melanogaster (Fruit fly)	1488	"alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016895]; metal ion binding [GO:0046872]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]"	alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication origin binding [GO:0003688]; exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016895]; metal ion binding [GO:0046872]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]"	GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005658; GO:0006261; GO:0006272; GO:0006273; GO:0008296; GO:0016895; GO:0017076; GO:0019103; GO:0045004; GO:0046872; GO:0051539; GO:1902975	DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]		NA	NA	NA	NA	NA	NA
TRINITY_DN4464_c0_g1_i1	P13382	DPOA_YEAST	48.6	70	26	3	305	126	37	106	2.40E-05	49.7	DPOA_YEAST	reviewed	DNA polymerase alpha catalytic subunit A (EC 2.7.7.7) (DNA polymerase I subunit A) (DNA polymerase alpha:primase complex p180 subunit) (DNA polymerase-primase complex p180 subunit) (Pol alpha-primase complex p180 subunit)	POL1 CDC17 YNL102W N2181	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1468	"alpha DNA polymerase:primase complex [GO:0005658]; mitochondrion [GO:0005739]; replication fork [GO:0005657]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; premeiotic DNA replication [GO:0006279]; RNA-dependent DNA biosynthetic process [GO:0006278]"	alpha DNA polymerase:primase complex [GO:0005658]; mitochondrion [GO:0005739]; replication fork [GO:0005657]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]"	GO:0000731; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005657; GO:0005658; GO:0005739; GO:0006260; GO:0006270; GO:0006272; GO:0006273; GO:0006278; GO:0006279; GO:0006302; GO:0017076; GO:0019103; GO:0046872; GO:0051539; GO:1902975	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; premeiotic DNA replication [GO:0006279]; RNA-dependent DNA biosynthetic process [GO:0006278]		NA	NA	NA	NA	NA	NA
TRINITY_DN9108_c0_g1_i1	O89043	DPOA2_RAT	45.5	246	128	2	803	84	342	587	1.30E-56	221.5	DPOA2_RAT	reviewed	DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit) (DNA polymerase subunit II)	Pola2	Rattus norvegicus (Rat)	600	alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; protein import into nucleus [GO:0006606]	alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0003677; GO:0003887; GO:0005634; GO:0005658; GO:0006260; GO:0006270; GO:0006606	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN9108_c0_g1_i2	O89043	DPOA2_RAT	38.4	464	264	8	1442	84	135	587	3.40E-81	303.9	DPOA2_RAT	reviewed	DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit) (DNA polymerase subunit II)	Pola2	Rattus norvegicus (Rat)	600	alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; protein import into nucleus [GO:0006606]	alpha DNA polymerase:primase complex [GO:0005658]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0003677; GO:0003887; GO:0005634; GO:0005658; GO:0006260; GO:0006270; GO:0006606	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN3172_c0_g1_i1	P34243	HCS1_YEAST	48.5	68	35	0	13	216	582	649	4.30E-13	75.1	HCS1_YEAST	reviewed	DNA polymerase alpha-associated DNA helicase A (EC 3.6.4.12)	HCS1 DIP1 YKL017C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	683	cytoplasm [GO:0005737]; DNA helicase A complex [GO:0033203]; nuclear replisome [GO:0043601]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	cytoplasm [GO:0005737]; DNA helicase A complex [GO:0033203]; nuclear replisome [GO:0043601]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0003677; GO:0005524; GO:0005737; GO:0033203; GO:0043139; GO:0043601			NA	NA	NA	NA	NA	NA
TRINITY_DN21225_c0_g1_i1	P06746	DPOLB_HUMAN	100	196	0	0	589	2	122	317	3.50E-111	402.1	DPOLB_HUMAN	reviewed	DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-)	POLB	Homo sapiens (Human)	335	"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, base-free sugar-phosphate removal [GO:0006286]; base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; protein deubiquitination [GO:0016579]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]"	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]	damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0003684; GO:0003887; GO:0003906; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005876; GO:0006261; GO:0006281; GO:0006284; GO:0006286; GO:0006287; GO:0006288; GO:0006290; GO:0006303; GO:0006954; GO:0006974; GO:0007435; GO:0007568; GO:0008017; GO:0008630; GO:0010332; GO:0016446; GO:0016579; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0055093; GO:0071707	"aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, base-free sugar-phosphate removal [GO:0006286]; base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; protein deubiquitination [GO:0016579]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35869_c0_g1_i1	P52431	DPOD1_MOUSE	100	71	0	0	215	3	187	257	3.90E-36	151.4	DPOD1_MOUSE	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	Pold1	Mus musculus (Mouse)	1105	"aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000109; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0008408; GO:0016235; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29047_c0_g1_i1	P28339	DPOD1_BOVIN	100	105	0	0	1	315	751	855	1.10E-55	216.9	DPOD1_BOVIN	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	POLD1	Bos taurus (Bovine)	1106	"delta DNA polymerase complex [GO:0043625]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0000731; GO:0003682; GO:0003684; GO:0003887; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i1	P54358	DPOD1_DROME	74.3	668	165	4	56	2047	308	972	2.80E-281	969.1	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i1	P54358	DPOD1_DROME	56.2	73	32	0	2040	2258	1020	1092	3.30E-19	98.6	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i10	P54358	DPOD1_DROME	68	906	278	7	307	3000	71	972	0	1237.6	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i10	P54358	DPOD1_DROME	56.2	73	32	0	2993	3211	1020	1092	4.60E-19	98.6	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i3	P54358	DPOD1_DROME	66.5	1025	330	7	307	3351	71	1092	0	1382.9	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i6	P54358	DPOD1_DROME	71.4	787	217	4	56	2398	308	1092	0	1114.4	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i8	P54358	DPOD1_DROME	65.8	1035	331	8	307	3381	71	1092	0	1370.5	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i9	P54358	DPOD1_DROME	71.4	56	16	0	56	223	308	363	4.10E-17	88.6	DPOD1_DROME	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	DNApol-delta DNApolD1 PolD CG5949	Drosophila melanogaster (Fruit fly)	1092	"delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30904_c0_g1_i1	P52431	DPOD1_MOUSE	99.2	118	1	0	355	2	905	1022	1.10E-62	240.4	DPOD1_MOUSE	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	Pold1	Mus musculus (Mouse)	1105	"aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000109; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0008408; GO:0016235; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31015_c0_g1_i1	P97283	DPOD1_MESAU	98.6	71	1	0	215	3	831	901	1.60E-32	139.4	DPOD1_MESAU	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	POLD1	Mesocricetus auratus (Golden hamster)	1103	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0000731; GO:0003682; GO:0003684; GO:0003887; GO:0004527; GO:0005634; GO:0006260; GO:0034644; GO:0046872; GO:0051539; GO:0055089; GO:0070987	cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]		NA	NA	NA	NA	NA	NA
TRINITY_DN24772_c0_g1_i1	P28340	DPOD1_HUMAN	97.1	69	2	0	209	3	1032	1100	7.90E-34	143.7	DPOD1_HUMAN	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125)	POLD1 POLD	Homo sapiens (Human)	1107	"aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000109; GO:0000166; GO:0000723; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0006298; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019985; GO:0032201; GO:0033683; GO:0034644; GO:0042769; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN300_c0_g1_i7	P28340	DPOD1_HUMAN	54.6	238	105	2	307	1014	89	325	2.90E-74	280.4	DPOD1_HUMAN	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125)	POLD1 POLD	Homo sapiens (Human)	1107	"aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000109; GO:0000166; GO:0000723; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0006298; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019985; GO:0032201; GO:0033683; GO:0034644; GO:0042769; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31824_c0_g1_i1	P28340	DPOD1_HUMAN	99.1	110	1	0	330	1	606	715	3.40E-55	215.3	DPOD1_HUMAN	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125)	POLD1 POLD	Homo sapiens (Human)	1107	"aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000109; GO:0000166; GO:0000723; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0006298; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019985; GO:0032201; GO:0033683; GO:0034644; GO:0042769; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25765_c0_g1_i1	P28340	DPOD1_HUMAN	100	92	0	0	3	278	384	475	7.10E-46	184.1	DPOD1_HUMAN	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125)	POLD1 POLD	Homo sapiens (Human)	1107	"aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000109; GO:0000166; GO:0000723; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0006298; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019985; GO:0032201; GO:0033683; GO:0034644; GO:0042769; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6388_c0_g1_i1	P46588	DPOD_CANAX	66	288	96	1	3	860	504	791	1.90E-105	383.6	DPOD_CANAX	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (DNA polymerase III)	POL3 Ca35A5.06c	Candida albicans (Yeast)	1038	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0004527; GO:0005634; GO:0006260; GO:0046872; GO:0051539	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN6388_c0_g2_i1	Q9LVN7	DPOD1_ARATH	69.4	121	37	0	363	1	442	562	3.20E-41	169.1	DPOD1_ARATH	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (Protein EMBRYO DEFECTIVE 2780)	POLD1 EMB2780 At5g63960 MBM17.6	Arabidopsis thaliana (Mouse-ear cress)	1095	"delta DNA polymerase complex [GO:0043625]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	delta DNA polymerase complex [GO:0043625]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0003677; GO:0003887; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0043625; GO:0045004; GO:0046872; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27105_c0_g1_i1	P49005	DPOD2_HUMAN	100	127	0	0	382	2	34	160	5.30E-68	258.1	DPOD2_HUMAN	reviewed	DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50)	POLD2	Homo sapiens (Human)	469	"delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	DNA binding [GO:0003677]	GO:0000723; GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006271; GO:0006283; GO:0006296; GO:0006297; GO:0006298; GO:0016035; GO:0019985; GO:0032201; GO:0033683; GO:0042575; GO:0042769; GO:0043625; GO:0071897	"DNA biosynthetic process [GO:0071897]; DNA damage response, detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36054_c0_g1_i1	P49004	DPOD2_BOVIN	98.9	94	1	0	282	1	273	366	2.20E-47	189.1	DPOD2_BOVIN	reviewed	DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50)	POLD2	Bos taurus (Bovine)	469	delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; DNA binding [GO:0003677]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]	delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]	DNA binding [GO:0003677]	GO:0003677; GO:0006271; GO:0006281; GO:0042575; GO:0043625; GO:0071897	DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]		NA	NA	NA	NA	NA	NA
TRINITY_DN2542_c0_g1_i1	O93610	DPOD2_XENLA	46.1	445	222	6	1417	125	13	453	3.80E-109	396.7	DPOD2_XENLA	reviewed	DNA polymerase delta subunit 2 (XlCdc1)	pold2 cdc1	Xenopus laevis (African clawed frog)	463	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006260; GO:0006281	DNA repair [GO:0006281]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN25443_c0_g1_i1	Q07864	DPOE1_HUMAN	100	100	0	0	302	3	734	833	8.50E-53	207.2	DPOE1_HUMAN	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	POLE POLE1	Homo sapiens (Human)	2286	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27741_c0_g1_i1	Q07864	DPOE1_HUMAN	60.7	89	35	0	271	5	256	344	1.10E-25	117.1	DPOE1_HUMAN	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	POLE POLE1	Homo sapiens (Human)	2286	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28739_c0_g1_i1	Q07864	DPOE1_HUMAN	100	118	0	0	1	354	1799	1916	7.30E-64	244.2	DPOE1_HUMAN	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	POLE POLE1	Homo sapiens (Human)	2286	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31555_c0_g1_i1	Q07864	DPOE1_HUMAN	100	101	0	0	304	2	1345	1445	1.70E-53	209.5	DPOE1_HUMAN	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	POLE POLE1	Homo sapiens (Human)	2286	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4885_c0_g1_i3	Q9WVF7	DPOE1_MOUSE	57.7	2280	911	20	6854	111	16	2274	0	2635.9	DPOE1_MOUSE	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	Pole Pole1	Mus musculus (Mouse)	2283	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25458_c0_g1_i1	Q07864	DPOE1_HUMAN	99.1	106	1	0	320	3	955	1060	1.70E-51	203	DPOE1_HUMAN	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	POLE POLE1	Homo sapiens (Human)	2286	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32569_c0_g1_i1	Q9WVF7	DPOE1_MOUSE	61.9	63	24	0	38	226	620	682	9.80E-17	87	DPOE1_MOUSE	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	Pole Pole1	Mus musculus (Mouse)	2283	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7998_c0_g1_i1	Q4PFV5	DPOE_USTMA	68.7	99	31	0	23	319	834	932	6.90E-37	154.5	DPOE_USTMA	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A)	POL2 UMAG_01008	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	2305	"epsilon DNA polymerase complex [GO:0008622]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	epsilon DNA polymerase complex [GO:0008622]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000166; GO:0000278; GO:0003677; GO:0003887; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39291_c0_g1_i1	Q4PFV5	DPOE_USTMA	63.8	80	27	1	6	239	944	1023	1.10E-23	110.2	DPOE_USTMA	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A)	POL2 UMAG_01008	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	2305	"epsilon DNA polymerase complex [GO:0008622]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	epsilon DNA polymerase complex [GO:0008622]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000166; GO:0000278; GO:0003677; GO:0003887; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35732_c0_g1_i1	Q4PFV5	DPOE_USTMA	66.9	133	43	1	1	396	434	566	2.30E-48	193	DPOE_USTMA	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A)	POL2 UMAG_01008	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	2305	"epsilon DNA polymerase complex [GO:0008622]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	epsilon DNA polymerase complex [GO:0008622]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000166; GO:0000278; GO:0003677; GO:0003887; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0051539	"base-excision repair, gap-filling [GO:0006287]; DNA replication proofreading [GO:0045004]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12670_c0_g1_i2	A7YWS7	DPOE2_BOVIN	36.9	206	123	3	7	603	11	216	6.60E-34	145.6	DPOE2_BOVIN	reviewed	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2	Bos taurus (Bovine)	527	epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	epsilon DNA polymerase complex [GO:0008622]	DNA binding [GO:0003677]	GO:0003677; GO:0006261; GO:0008622; GO:0042276	DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]		NA	NA	NA	NA	NA	NA
TRINITY_DN12670_c0_g1_i3	Q5ZKQ6	DPOE2_CHICK	48.1	52	26	1	52	204	165	216	1.00E-06	53.9	DPOE2_CHICK	reviewed	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2 RCJMB04_9k18	Gallus gallus (Chicken)	527	epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	epsilon DNA polymerase complex [GO:0008622]	DNA binding [GO:0003677]	GO:0003677; GO:0006261; GO:0008622; GO:0042276	DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]		brown	brown	NA	NA	NA	NA
TRINITY_DN12670_c0_g1_i4	A7YWS7	DPOE2_BOVIN	47.8	138	69	2	52	462	165	300	1.40E-29	131	DPOE2_BOVIN	reviewed	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2	Bos taurus (Bovine)	527	epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	epsilon DNA polymerase complex [GO:0008622]	DNA binding [GO:0003677]	GO:0003677; GO:0006261; GO:0008622; GO:0042276	DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]		NA	NA	NA	NA	NA	NA
TRINITY_DN12670_c0_g1_i6	P56282	DPOE2_HUMAN	45.8	192	100	3	52	621	165	354	3.70E-42	172.9	DPOE2_HUMAN	reviewed	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2 DPE2	Homo sapiens (Human)	527	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0000082; GO:0003677; GO:0003887; GO:0005654; GO:0006260; GO:0006261; GO:0006270; GO:0006281; GO:0008622; GO:0016604; GO:0032201; GO:0042276; GO:0043231	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]		NA	NA	NA	NA	NA	NA
TRINITY_DN35412_c0_g1_i1	Q5ZKQ6	DPOE2_CHICK	50.3	191	94	1	619	50	334	524	5.80E-56	218.8	DPOE2_CHICK	reviewed	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2 RCJMB04_9k18	Gallus gallus (Chicken)	527	epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	epsilon DNA polymerase complex [GO:0008622]	DNA binding [GO:0003677]	GO:0003677; GO:0006261; GO:0008622; GO:0042276	DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]		NA	NA	NA	NA	NA	NA
TRINITY_DN35412_c0_g1_i2	P56282	DPOE2_HUMAN	51.2	82	40	0	295	50	443	524	5.20E-20	98.6	DPOE2_HUMAN	reviewed	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2 DPE2	Homo sapiens (Human)	527	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0000082; GO:0003677; GO:0003887; GO:0005654; GO:0006260; GO:0006261; GO:0006270; GO:0006281; GO:0008622; GO:0016604; GO:0032201; GO:0042276; GO:0043231	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]		NA	NA	NA	NA	NA	NA
TRINITY_DN6835_c0_g1_i1	A6QQ14	DPOE4_BOVIN	49	104	50	1	94	405	16	116	1.10E-20	101.3	DPOE4_BOVIN	reviewed	DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4)	POLE4	Bos taurus (Bovine)	116	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0005634; GO:0005671; GO:0008622; GO:0046982			blue	blue	NA	NA	NA	NA
TRINITY_DN2778_c0_g1_i1	Q9VHV1	POLI_DROME	51.1	223	102	2	660	1	13	231	1.70E-55	217.6	POLI_DROME	reviewed	DNA polymerase iota (EC 2.7.7.7)	DNApol-iota DNApolI drad30B CG7602	Drosophila melanogaster (Fruit fly)	737	nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985]	nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872	DNA replication [GO:0006260]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN2778_c0_g1_i2	Q9VHV1	POLI_DROME	50.9	222	102	2	660	4	13	230	6.30E-55	215.7	POLI_DROME	reviewed	DNA polymerase iota (EC 2.7.7.7)	DNApol-iota DNApolI drad30B CG7602	Drosophila melanogaster (Fruit fly)	737	nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985]	nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872	DNA replication [GO:0006260]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i1	Q9QUG2	POLK_MOUSE	37.2	850	385	19	339	2480	15	851	1.10E-118	429.1	POLK_MOUSE	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	Polk Dinb1	Mus musculus (Mouse)	852	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0046872; GO:0090734	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i11	Q9UBT6	POLK_HUMAN	51.6	95	46	0	50	334	30	124	2.50E-20	99.8	POLK_HUMAN	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	POLK DINB1	Homo sapiens (Human)	870	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0033683; GO:0034644; GO:0042276; GO:0046872	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i2	Q9UBT6	POLK_HUMAN	48.6	327	106	3	50	844	30	356	1.20E-73	278.1	POLK_HUMAN	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	POLK DINB1	Homo sapiens (Human)	870	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0033683; GO:0034644; GO:0042276; GO:0046872	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i3	Q9QUG2	POLK_MOUSE	57.3	96	41	0	1	288	312	407	1.30E-23	110.5	POLK_MOUSE	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	Polk Dinb1	Mus musculus (Mouse)	852	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0046872; GO:0090734	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i4	Q9QUG2	POLK_MOUSE	37	836	378	19	50	2149	29	851	5.00E-115	416.8	POLK_MOUSE	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	Polk Dinb1	Mus musculus (Mouse)	852	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0046872; GO:0090734	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i5	Q9QUG2	POLK_MOUSE	29.7	576	306	17	61	1530	289	851	3.20E-39	164.5	POLK_MOUSE	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	Polk Dinb1	Mus musculus (Mouse)	852	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0046872; GO:0090734	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i6	Q9QUG2	POLK_MOUSE	47.1	427	158	5	339	1418	15	440	9.40E-94	345.5	POLK_MOUSE	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	Polk Dinb1	Mus musculus (Mouse)	852	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0046872; GO:0090734	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i7	Q9UBT6	POLK_HUMAN	48.7	341	113	3	339	1175	16	356	3.20E-77	290.4	POLK_HUMAN	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	POLK DINB1	Homo sapiens (Human)	870	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0033683; GO:0034644; GO:0042276; GO:0046872	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5595_c0_g1_i8	Q9QUG2	POLK_MOUSE	47	413	151	5	50	1087	29	440	2.80E-90	333.6	POLK_MOUSE	reviewed	DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)	Polk Dinb1	Mus musculus (Mouse)	852	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0019985; GO:0034644; GO:0042276; GO:0046872; GO:0090734	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c0_g2_i2	Q9UGP5	DPOLL_HUMAN	62.5	280	102	2	929	93	297	574	6.00E-95	349	DPOLL_HUMAN	reviewed	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase beta-2) (Pol beta2) (DNA polymerase kappa)	POLL	Homo sapiens (Human)	575	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0016446; GO:0046872; GO:0051575; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40482_c0_g1_i1	Q9UGP5	DPOLL_HUMAN	100	59	0	0	179	3	455	513	1.90E-29	129.4	DPOLL_HUMAN	reviewed	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase beta-2) (Pol beta2) (DNA polymerase kappa)	POLL	Homo sapiens (Human)	575	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0016446; GO:0046872; GO:0051575; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c0_g2_i1	Q9QXE2	DPOLL_MOUSE	25.6	316	172	8	946	5	39	293	5.40E-18	93.6	DPOLL_MOUSE	reviewed	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase kappa)	Poll Polk	Mus musculus (Mouse)	573	"nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]"	nucleus [GO:0005634]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0046872; GO:0051575; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c0_g2_i3	Q9QXE2	DPOLL_MOUSE	42.5	597	277	10	1874	93	39	572	8.70E-120	432.6	DPOLL_MOUSE	reviewed	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase kappa)	Poll Polk	Mus musculus (Mouse)	573	"nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]"	nucleus [GO:0005634]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0046872; GO:0051575; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3711_c0_g2_i4	Q9QXE2	DPOLL_MOUSE	42.5	597	277	10	1874	93	39	572	9.10E-120	432.6	DPOLL_MOUSE	reviewed	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase kappa)	Poll Polk	Mus musculus (Mouse)	573	"nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]"	nucleus [GO:0005634]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0046872; GO:0051575; GO:0071897	"base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18705_c0_g2_i1	Q91684	DPOG1_XENLA	40.1	951	433	16	2588	111	44	982	5.40E-196	686.4	DPOG1_XENLA	reviewed	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit)	polg	Xenopus laevis (African clawed frog)	1200	gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]	gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0003677; GO:0003682; GO:0003887; GO:0005760; GO:0006260; GO:0042645	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN38192_c0_g1_i1	P54098	DPOG1_HUMAN	100	77	0	0	1	231	353	429	1.30E-40	166.4	DPOG1_HUMAN	reviewed	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)	POLG MDP1 POLG1 POLGA	Homo sapiens (Human)	1239	"gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"	gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0007568; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0055093; GO:0071333	"aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA-dependent DNA replication [GO:0006261]; DNA metabolic process [GO:0006259]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21176_c0_g1_i1	P54098	DPOG1_HUMAN	100	171	0	0	514	2	819	989	9.00E-95	347.4	DPOG1_HUMAN	reviewed	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)	POLG MDP1 POLG1 POLGA	Homo sapiens (Human)	1239	"gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"	gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0007568; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0055093; GO:0071333	"aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA-dependent DNA replication [GO:0006261]; DNA metabolic process [GO:0006259]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32090_c0_g1_i1	P54098	DPOG1_HUMAN	100	82	0	0	246	1	246	327	2.10E-41	169.1	DPOG1_HUMAN	reviewed	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)	POLG MDP1 POLG1 POLGA	Homo sapiens (Human)	1239	"gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"	gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0007568; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0055093; GO:0071333	"aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA-dependent DNA replication [GO:0006261]; DNA metabolic process [GO:0006259]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12503_c1_g1_i1	Q9GSR1	DPOZ_DROME	42	162	93	1	503	18	1392	1552	1.60E-27	124	DPOZ_DROME	reviewed	DNA polymerase zeta catalytic subunit (EC 2.7.7.7)	DNApol-zeta Dmpolzeta DNApolZ1 mus205 rev3 CG1925	Drosophila melanogaster (Fruit fly)	2130	nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; translesion synthesis [GO:0019985]	nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0016035; GO:0019985; GO:0043150; GO:0046872; GO:0051536; GO:0071897; GO:0090305	DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN12503_c1_g1_i3	Q9GSR1	DPOZ_DROME	44.3	149	82	1	464	18	1405	1552	2.90E-26	120.2	DPOZ_DROME	reviewed	DNA polymerase zeta catalytic subunit (EC 2.7.7.7)	DNApol-zeta Dmpolzeta DNApolZ1 mus205 rev3 CG1925	Drosophila melanogaster (Fruit fly)	2130	nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; translesion synthesis [GO:0019985]	nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0016035; GO:0019985; GO:0043150; GO:0046872; GO:0051536; GO:0071897; GO:0090305	DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN5648_c0_g1_i1	Q61493	REV3L_MOUSE	61.8	497	182	5	81	1568	2552	3041	6.20E-171	602.1	REV3L_MOUSE	reviewed	DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4)	Rev3l Polz Sez4	Mus musculus (Mouse)	3122	"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]"	nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005730; GO:0006260; GO:0006281; GO:0016035; GO:0042276; GO:0046872; GO:0051539; GO:0090305	DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]		NA	NA	NA	NA	NA	NA
TRINITY_DN12503_c1_g1_i2	Q61493	REV3L_MOUSE	42.9	196	110	1	599	18	2357	2552	3.80E-42	172.9	REV3L_MOUSE	reviewed	DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4)	Rev3l Polz Sez4	Mus musculus (Mouse)	3122	"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]"	nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005730; GO:0006260; GO:0006281; GO:0016035; GO:0042276; GO:0046872; GO:0051539; GO:0090305	DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]		NA	NA	NA	NA	NA	NA
TRINITY_DN31253_c0_g1_i1	Q61493	REV3L_MOUSE	50.9	55	26	1	31	195	2233	2286	1.70E-06	53.1	REV3L_MOUSE	reviewed	DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4)	Rev3l Polz Sez4	Mus musculus (Mouse)	3122	"nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]"	nucleolus [GO:0005730]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005730; GO:0006260; GO:0006281; GO:0016035; GO:0042276; GO:0046872; GO:0051539; GO:0090305	DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]		NA	NA	NA	NA	NA	NA
TRINITY_DN21446_c0_g1_i2	O89044	PRI2_RAT	30.2	222	142	5	728	69	176	386	7.10E-18	93.2	PRI2_RAT	reviewed	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	Prim2	Rattus norvegicus (Rat)	507	"alpha DNA polymerase:primase complex [GO:0005658]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]"	alpha DNA polymerase:primase complex [GO:0005658]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"	GO:0003677; GO:0005658; GO:0006260; GO:0006269; GO:0046872; GO:0051539	"DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21446_c0_g1_i4	O89044	PRI2_RAT	30.2	222	142	5	728	69	176	386	6.20E-18	93.2	PRI2_RAT	reviewed	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	Prim2	Rattus norvegicus (Rat)	507	"alpha DNA polymerase:primase complex [GO:0005658]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]"	alpha DNA polymerase:primase complex [GO:0005658]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"	GO:0003677; GO:0005658; GO:0006260; GO:0006269; GO:0046872; GO:0051539	"DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c0_g1_i14	P49643	PRI2_HUMAN	46.8	470	231	9	1945	554	1	457	1.30E-117	425.2	PRI2_HUMAN	reviewed	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	PRIM2 PRIM2A	Homo sapiens (Human)	509	"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"	alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"	GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539	"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c0_g1_i5	P49643	PRI2_HUMAN	46.8	470	231	9	1906	515	1	457	1.30E-117	425.2	PRI2_HUMAN	reviewed	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	PRIM2 PRIM2A	Homo sapiens (Human)	509	"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"	alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"	GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539	"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c0_g1_i8	P49643	PRI2_HUMAN	46.8	470	231	9	1945	554	1	457	1.30E-117	425.2	PRI2_HUMAN	reviewed	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	PRIM2 PRIM2A	Homo sapiens (Human)	509	"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"	alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"	GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539	"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c0_g1_i9	P49643	PRI2_HUMAN	46.8	470	231	9	1945	554	1	457	1.30E-117	425.2	PRI2_HUMAN	reviewed	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	PRIM2 PRIM2A	Homo sapiens (Human)	509	"alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"	alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"	GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539	"DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26991_c0_g1_i1	P40352	RAD26_YEAST	55.6	63	28	0	28	216	468	530	1.60E-15	83.2	RAD26_YEAST	reviewed	DNA repair and recombination protein RAD26 (EC 3.6.4.12) (ATP-dependent helicase RAD26)	RAD26 GTA1085 YJR035W J1606	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1085	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone H2A-H2B dimer displacement [GO:0001208]; nucleotide-excision repair [GO:0006289]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; transcription-coupled nucleotide-excision repair [GO:0006283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0001208; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005737; GO:0006283; GO:0006289; GO:0008094; GO:0010767	histone H2A-H2B dimer displacement [GO:0001208]; nucleotide-excision repair [GO:0006289]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; transcription-coupled nucleotide-excision repair [GO:0006283]		NA	NA	1	NA	NA	NA
TRINITY_DN39550_c0_g1_i1	P40352	RAD26_YEAST	50	74	36	1	16	234	288	361	3.60E-14	78.6	RAD26_YEAST	reviewed	DNA repair and recombination protein RAD26 (EC 3.6.4.12) (ATP-dependent helicase RAD26)	RAD26 GTA1085 YJR035W J1606	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1085	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; histone H2A-H2B dimer displacement [GO:0001208]; nucleotide-excision repair [GO:0006289]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; transcription-coupled nucleotide-excision repair [GO:0006283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0001208; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005737; GO:0006283; GO:0006289; GO:0008094; GO:0010767	histone H2A-H2B dimer displacement [GO:0001208]; nucleotide-excision repair [GO:0006289]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; transcription-coupled nucleotide-excision repair [GO:0006283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4933_c0_g1_i1	Q9DG67	RA54B_CHICK	39.7	406	186	8	1293	94	1	353	4.30E-64	246.9	RA54B_CHICK	reviewed	DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B)	RAD54B	Gallus gallus (Chicken)	918	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; DNA repair [GO:0006281]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN4933_c0_g1_i2	Q9DG67	RA54B_CHICK	46.4	968	444	17	2978	123	1	909	2.50E-229	797	RA54B_CHICK	reviewed	DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B)	RAD54B	Gallus gallus (Chicken)	918	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; DNA repair [GO:0006281]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN39567_c0_g1_i1	O12944	RAD54_CHICK	69.5	82	24	1	2	247	551	631	1.10E-29	130.2	RAD54_CHICK	reviewed	DNA repair and recombination protein RAD54-like (EC 3.6.4.-) (Putative recombination factor GdRad54) (RAD54 homolog) (Fragment)	RAD54L RAD54	Gallus gallus (Chicken)	733	nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131]	nucleus [GO:0005634]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0015616; GO:0036310; GO:0045003	double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131]		NA	NA	NA	NA	NA	NA
TRINITY_DN8620_c0_g1_i1	Q92698	RAD54_HUMAN	71.3	209	60	0	94	720	439	647	9.00E-85	314.7	RAD54_HUMAN	reviewed	DNA repair and recombination protein RAD54-like (EC 3.6.4.12) (RAD54 homolog) (hHR54) (hRAD54)	RAD54L RAD54A	Homo sapiens (Human)	747	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic cell cycle [GO:0051321]; reciprocal meiotic recombination [GO:0007131]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0007131; GO:0008340; GO:0010212; GO:0015616; GO:0032991; GO:0036310; GO:0042493; GO:0045003; GO:0051321	determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic cell cycle [GO:0051321]; reciprocal meiotic recombination [GO:0007131]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN8620_c0_g1_i2	P70270	RAD54_MOUSE	68	531	168	1	1	1593	119	647	9.80E-217	754.2	RAD54_MOUSE	reviewed	DNA repair and recombination protein RAD54-like (EC 3.6.4.12) (RAD54 homolog) (mHR54) (mRAD54)	Rad54l Rad54	Mus musculus (Mouse)	747	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]	GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006302; GO:0006974; GO:0007131; GO:0008340; GO:0010212; GO:0015616; GO:0032991; GO:0036310; GO:0042493; GO:0045003; GO:0051276	cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN9175_c0_g1_i2	Q9QZD4	XPF_MOUSE	44.3	70	38	1	127	333	551	620	2.10E-12	73.2	XPF_MOUSE	reviewed	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)	Ercc4	Mus musculus (Mouse)	917	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0000784; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841	"cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15986_c0_g1_i2	Q9QZD4	XPF_MOUSE	56.2	185	79	1	1	555	721	903	5.90E-52	205.7	XPF_MOUSE	reviewed	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)	Ercc4	Mus musculus (Mouse)	917	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0000784; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841	"cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9381_c0_g1_i1	Q9QYM7	XPF_CRIGR	45.5	143	71	4	43	450	294	436	5.50E-22	105.5	XPF_CRIGR	reviewed	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)	ERCC4	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	913	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; response to UV [GO:0009411]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000110; GO:0000724; GO:0000784; GO:0001094; GO:0003684; GO:0003697; GO:0005634; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841	"cellular response to UV [GO:0034644]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; response to UV [GO:0009411]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9381_c0_g1_i3	Q92889	XPF_HUMAN	49.6	425	204	3	74	1318	15	439	2.20E-113	410.6	XPF_HUMAN	reviewed	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)	ERCC4 ERCC11 XPF	Homo sapiens (Human)	916	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; global genome nucleotide-excision repair [GO:0070911]; interstrand cross-link repair [GO:0036297]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0000784; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0036297; GO:0042802; GO:0047485; GO:0051974; GO:0061819; GO:0070522; GO:0070911; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841	"cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; global genome nucleotide-excision repair [GO:0070911]; interstrand cross-link repair [GO:0036297]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN297_c0_g1_i1	P14629	ERCC5_XENLA	41.4	314	170	7	1577	663	1	309	1.20E-52	209.1	ERCC5_XENLA	reviewed	DNA repair protein complementing XP-G cells homolog (EC 3.1.-.-) (Xeroderma pigmentosum group G-complementing protein homolog)	ercc5 xpg xpgc	Xenopus laevis (African clawed frog)	1196	nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; nucleotide-excision repair [GO:0006289]	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004519; GO:0005634; GO:0006289; GO:0046872	nucleotide-excision repair [GO:0006289]		NA	NA	NA	NA	NA	NA
TRINITY_DN30116_c0_g1_i1	P70388	RAD50_MOUSE	32.1	212	144	0	13	648	140	351	1.10E-22	108.2	RAD50_MOUSE	reviewed	DNA repair protein RAD50 (mRad50) (EC 3.6.-.-)	Rad50	Mus musculus (Mouse)	1312	"condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere capping [GO:0016233]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]"	"condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]"	adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000019; GO:0000722; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003690; GO:0003691; GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007346; GO:0016233; GO:0016234; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042802; GO:0043047; GO:0044877; GO:0045120; GO:0046597; GO:0046872; GO:0048471; GO:0051276; GO:0051880; GO:0070192; GO:0090305; GO:1904354	cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere capping [GO:0016233]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]		NA	NA	NA	NA	NA	NA
TRINITY_DN10422_c0_g1_i1	P37383	RAD51_CHICK	72.4	323	88	1	988	20	18	339	8.20E-129	461.5	RAD51_CHICK	reviewed	DNA repair protein RAD51 homolog 1	RAD51A RAD51	Gallus gallus (Chicken)	339	"condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to ionizing radiation [GO:0010212]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]"	"condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA-dependent ATPase activity [GO:0008094]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000790; GO:0000793; GO:0000794; GO:0000800; GO:0001932; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006268; GO:0006281; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0010212; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0032991; GO:0035861; GO:0036297; GO:0042148; GO:0042802; GO:0048471; GO:0051106; GO:0051321; GO:0070182; GO:0070192; GO:0071479; GO:0072711; GO:0072757; GO:1990414; GO:1990426	cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to ionizing radiation [GO:0010212]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]		NA	NA	NA	NA	NA	NA
TRINITY_DN37308_c0_g1_i1	Q2KJ94	RAD51_BOVIN	98	98	2	0	296	3	123	220	3.80E-50	198.4	RAD51_BOVIN	reviewed	DNA repair protein RAD51 homolog 1	RAD51	Bos taurus (Bovine)	339	"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein phosphatase binding [GO:0019903]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic recombination-dependent replication fork processing [GO:1990426]; natural killer cell inhibitory signaling pathway [GO:0002769]; negative regulation of signaling receptor activity [GO:2000272]; positive regulation of DNA ligation [GO:0051106]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]"	"cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein phosphatase binding [GO:0019903]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000790; GO:0000800; GO:0001932; GO:0002769; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0005759; GO:0005815; GO:0006268; GO:0006974; GO:0008022; GO:0009897; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019903; GO:0032991; GO:0035861; GO:0036297; GO:0042802; GO:0048471; GO:0051106; GO:0070182; GO:0070192; GO:0071479; GO:0072711; GO:0072757; GO:1990414; GO:1990426; GO:2000272	cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic recombination-dependent replication fork processing [GO:1990426]; natural killer cell inhibitory signaling pathway [GO:0002769]; negative regulation of signaling receptor activity [GO:2000272]; positive regulation of DNA ligation [GO:0051106]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]		NA	NA	NA	NA	NA	NA
TRINITY_DN27663_c0_g1_i1	Q06609	RAD51_HUMAN	100	288	0	0	865	2	48	335	7.80E-160	564.3	RAD51_HUMAN	reviewed	DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A)	RAD51 RAD51A RECA	Homo sapiens (Human)	339	"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]"	"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA-dependent ATPase activity [GO:0008094]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000785; GO:0000790; GO:0000793; GO:0000794; GO:0000800; GO:0001932; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005815; GO:0006268; GO:0006281; GO:0006310; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0009636; GO:0010165; GO:0010212; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032991; GO:0035861; GO:0036297; GO:0042148; GO:0042493; GO:0042802; GO:0048471; GO:0051106; GO:0051321; GO:0070182; GO:0070192; GO:0070317; GO:0071479; GO:0071480; GO:0072711; GO:0072719; GO:0072757; GO:1904631; GO:1990414; GO:1990426	cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]		NA	NA	NA	NA	NA	NA
TRINITY_DN38623_c0_g1_i1	Q08297	RAD51_MOUSE	78.6	262	53	2	83	865	1	260	2.30E-109	396.7	RAD51_MOUSE	reviewed	DNA repair protein RAD51 homolog 1 (RAD51 homolog A)	Rad51 Rad51a Reca	Mus musculus (Mouse)	339	"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to alkaloid [GO:0071312]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]; telomere organization [GO:0032200]"	"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; synaptonemal complex [GO:0000795]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA-dependent ATPase activity [GO:0008094]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000785; GO:0000790; GO:0000793; GO:0000794; GO:0000795; GO:0000800; GO:0001932; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005815; GO:0006268; GO:0006281; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0009636; GO:0010165; GO:0010212; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032200; GO:0032991; GO:0035861; GO:0036297; GO:0042148; GO:0042493; GO:0042802; GO:0048471; GO:0051106; GO:0051321; GO:0070182; GO:0070192; GO:0071312; GO:0071479; GO:0071480; GO:0072711; GO:0072719; GO:0072757; GO:1904631; GO:1990414; GO:1990426	cellular response to alkaloid [GO:0071312]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]; telomere organization [GO:0032200]		NA	NA	NA	NA	NA	NA
TRINITY_DN38623_c0_g1_i2	Q08297	RAD51_MOUSE	80.9	341	62	2	83	1102	1	339	7.00E-151	535	RAD51_MOUSE	reviewed	DNA repair protein RAD51 homolog 1 (RAD51 homolog A)	Rad51 Rad51a Reca	Mus musculus (Mouse)	339	"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to alkaloid [GO:0071312]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]; telomere organization [GO:0032200]"	"chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; synaptonemal complex [GO:0000795]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA-dependent ATPase activity [GO:0008094]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000785; GO:0000790; GO:0000793; GO:0000794; GO:0000795; GO:0000800; GO:0001932; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005815; GO:0006268; GO:0006281; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0009636; GO:0010165; GO:0010212; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032200; GO:0032991; GO:0035861; GO:0036297; GO:0042148; GO:0042493; GO:0042802; GO:0048471; GO:0051106; GO:0051321; GO:0070182; GO:0070192; GO:0071312; GO:0071479; GO:0071480; GO:0072711; GO:0072719; GO:0072757; GO:1904631; GO:1990414; GO:1990426	cellular response to alkaloid [GO:0071312]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]; telomere organization [GO:0032200]		NA	NA	NA	NA	NA	NA
TRINITY_DN33649_c0_g1_i1	O43502	RA51C_HUMAN	100	100	0	0	301	2	91	190	5.00E-53	208	RA51C_HUMAN	reviewed	DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2)	RAD51C RAD51L2	Homo sapiens (Human)	376	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; blood coagulation [GO:0007596]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]	ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]	GO:0000707; GO:0000722; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0007596; GO:0008094; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0043231; GO:0048471	blood coagulation [GO:0007596]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]		NA	NA	NA	NA	NA	NA
TRINITY_DN7759_c0_g1_i1	Q924H5	RA51C_MOUSE	41.4	348	179	5	136	1107	6	352	2.30E-69	264.2	RA51C_MOUSE	reviewed	DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2)	Rad51c Rad51l2	Mus musculus (Mouse)	366	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Holliday junction resolvase complex [GO:0048476]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Holliday junction resolvase complex [GO:0048476]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]	ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]	GO:0000400; GO:0000707; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008094; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0043231; GO:0048471; GO:0048476	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]		NA	NA	NA	NA	NA	NA
TRINITY_DN23548_c0_g1_i1	Q91918	RA51A_XENLA	99	96	1	0	288	1	218	313	1.50E-46	186.4	RA51A_XENLA	reviewed	DNA repair protein RAD51 homolog A (xRAD51.1)	rad51-a rad51-1 rad51.1	Xenopus laevis (African clawed frog)	336	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombinase assembly [GO:0000730]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination-dependent replication fork processing [GO:1990426]	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]	ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000150; GO:0000228; GO:0000724; GO:0000730; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0017116; GO:1990426	cellular response to DNA damage stimulus [GO:0006974]; DNA recombinase assembly [GO:0000730]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination-dependent replication fork processing [GO:1990426]		NA	NA	NA	NA	NA	NA
TRINITY_DN27787_c0_g1_i1	Q9XED7	R51A2_MAIZE	62.6	257	95	1	2	772	84	339	9.00E-89	328.2	R51A2_MAIZE	reviewed	DNA repair protein RAD51 homolog B (Rad51-like protein B) (RAD51B) (ZmRAD51b)	RAD51B	Zea mays (Maize)	340	condensed nuclear chromosome [GO:0000794]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; strand invasion [GO:0042148]	condensed nuclear chromosome [GO:0000794]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]	GO:0000150; GO:0000730; GO:0000794; GO:0003690; GO:0003697; GO:0005524; GO:0006312; GO:0007131; GO:0008094; GO:0010212; GO:0042148; GO:0070192; GO:1990426	chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; strand invasion [GO:0042148]		NA	NA	NA	NA	NA	NA
TRINITY_DN7712_c0_g1_i1	O54935	XRCC1_CRIGR	45.3	95	51	1	23	304	298	392	2.10E-19	96.3	XRCC1_CRIGR	reviewed	DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)	XRCC1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	633	nucleolus [GO:0005730]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; single strand break repair [GO:0000012]	nucleolus [GO:0005730]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]	GO:0000012; GO:0003684; GO:0005634; GO:0005730	single strand break repair [GO:0000012]		NA	NA	NA	NA	NA	NA
TRINITY_DN31522_c0_g1_i1	Q60596	XRCC1_MOUSE	58.8	68	28	0	1	204	562	629	4.00E-20	98.6	XRCC1_MOUSE	reviewed	DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)	Xrcc1 Xrcc-1	Mus musculus (Mouse)	631	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882]"	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]	GO:0000012; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414	base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882]		NA	NA	NA	NA	NA	NA
TRINITY_DN36039_c0_g1_i1	P18887	XRCC1_HUMAN	58.9	56	23	0	1	168	92	147	4.70E-15	81.3	XRCC1_HUMAN	reviewed	DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)	XRCC1	Homo sapiens (Human)	633	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]"	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]	GO:0000012; GO:0000724; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006283; GO:0006284; GO:0006288; GO:0006297; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599	"base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]"		blue	blue	NA	NA	NA	NA
TRINITY_DN11609_c0_g1_i1	Q9CXE6	XRCC3_MOUSE	37.9	277	140	5	77	859	80	340	4.40E-41	169.9	XRCC3_MOUSE	reviewed	DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3)	Xrcc3	Mus musculus (Mouse)	349	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]	ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]	GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0008094; GO:0008821; GO:0010033; GO:0010824; GO:0033065; GO:0036297; GO:0045003; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0090737	DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]		NA	NA	NA	NA	NA	NA
TRINITY_DN11609_c0_g1_i2	Q9CXE6	XRCC3_MOUSE	38	295	148	6	21	848	62	340	4.00E-42	173.3	XRCC3_MOUSE	reviewed	DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3)	Xrcc3	Mus musculus (Mouse)	349	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]	ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]	GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0008094; GO:0008821; GO:0010033; GO:0010824; GO:0033065; GO:0036297; GO:0045003; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0090737	DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]		NA	NA	NA	NA	NA	NA
TRINITY_DN28768_c0_g1_i1	Q9Y248	PSF2_HUMAN	98.7	75	1	0	3	227	11	85	5.80E-38	157.5	PSF2_HUMAN	reviewed	DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	GINS2 PSF2 CGI-122 DC5 HSPC037	Homo sapiens (Human)	185	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; DNA duplex unwinding [GO:0032508]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]		GO:0000727; GO:0000811; GO:0005654; GO:0006271; GO:0031298; GO:0032508; GO:0071162	DNA duplex unwinding [GO:0032508]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]		NA	NA	NA	NA	NA	NA
TRINITY_DN26825_c0_g1_i1	Q8R4E9	CDT1_MOUSE	98.8	86	1	0	22	279	469	554	3.10E-41	168.7	CDT1_MOUSE	reviewed	DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein)	Cdt1 Ris2	Mus musculus (Mouse)	557	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of protein localization to kinetochore [GO:1905342]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]	GO:0000076; GO:0000278; GO:0000776; GO:0000777; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000105	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of DNA replication [GO:0045740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA replication origin binding [GO:1902595]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]		NA	NA	NA	NA	NA	NA
TRINITY_DN4602_c0_g1_i3	Q8R4E9	CDT1_MOUSE	40.4	47	28	0	221	81	502	548	1.20E-05	50.4	CDT1_MOUSE	reviewed	DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein)	Cdt1 Ris2	Mus musculus (Mouse)	557	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of protein localization to kinetochore [GO:1905342]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]	GO:0000076; GO:0000278; GO:0000776; GO:0000777; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000105	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of DNA replication [GO:0045740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA replication origin binding [GO:1902595]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]		NA	NA	NA	NA	NA	NA
TRINITY_DN4602_c0_g1_i8	Q8R4E9	CDT1_MOUSE	39.5	124	72	1	443	72	179	299	8.30E-19	96.3	CDT1_MOUSE	reviewed	DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein)	Cdt1 Ris2	Mus musculus (Mouse)	557	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of protein localization to kinetochore [GO:1905342]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]	GO:0000076; GO:0000278; GO:0000776; GO:0000777; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000105	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of DNA replication [GO:0045740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA replication origin binding [GO:1902595]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]		NA	NA	NA	NA	NA	NA
TRINITY_DN28137_c0_g1_i1	Q8R4E9	CDT1_MOUSE	100	85	0	0	2	256	175	259	3.30E-42	171.8	CDT1_MOUSE	reviewed	DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein)	Cdt1 Ris2	Mus musculus (Mouse)	557	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of protein localization to kinetochore [GO:1905342]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]	GO:0000076; GO:0000278; GO:0000776; GO:0000777; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000105	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA-dependent DNA replication [GO:2000105]; positive regulation of DNA replication [GO:0045740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of chromosome organization [GO:0033044]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA replication origin binding [GO:1902595]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708]		NA	NA	NA	NA	NA	NA
TRINITY_DN4602_c0_g1_i2	Q9I9A7	CDT1_XENLA	33.8	476	277	8	1457	57	169	615	3.30E-60	234.6	CDT1_XENLA	reviewed	DNA replication factor Cdt1 (XCDT1)	cdt1	Xenopus laevis (African clawed frog)	617	nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cell cycle [GO:0007049]; DNA replication [GO:0006260]	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]	GO:0005634; GO:0006260; GO:0007049; GO:0031490	cell cycle [GO:0007049]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN4602_c0_g1_i7	Q9I9A7	CDT1_XENLA	33.8	423	242	8	1246	5	169	562	1.70E-47	192.2	CDT1_XENLA	reviewed	DNA replication factor Cdt1 (XCDT1)	cdt1	Xenopus laevis (African clawed frog)	617	nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cell cycle [GO:0007049]; DNA replication [GO:0006260]	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]	GO:0005634; GO:0006260; GO:0007049; GO:0031490	cell cycle [GO:0007049]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN4602_c0_g1_i9	Q9I9A7	CDT1_XENLA	33.8	476	277	8	1457	57	169	615	2.50E-60	235	CDT1_XENLA	reviewed	DNA replication factor Cdt1 (XCDT1)	cdt1	Xenopus laevis (African clawed frog)	617	nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cell cycle [GO:0007049]; DNA replication [GO:0006260]	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]	GO:0005634; GO:0006260; GO:0007049; GO:0031490	cell cycle [GO:0007049]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN32855_c0_g1_i1	P55861	MCM2_XENLA	76.5	455	94	2	12	1364	441	886	7.80E-197	688	MCM2_XENLA	reviewed	DNA replication licensing factor mcm2 (EC 3.6.4.12) (BM28-homolog) (Minichromosome maintenance protein 2) (xMCM2) (p112)	mcm2	Xenopus laevis (African clawed frog)	886	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]	GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872; GO:0071162; GO:1905775	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN17083_c0_g1_i1	P49736	MCM2_HUMAN	100	139	0	0	1	417	553	691	3.20E-74	278.9	MCM2_HUMAN	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	MCM2 BM28 CCNL1 CDCL1 KIAA0030	Homo sapiens (Human)	904	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0015630; GO:0019899; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN17083_c1_g1_i1	P97310	MCM2_MOUSE	100	72	0	0	3	218	617	688	2.00E-35	149.1	MCM2_MOUSE	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	Mcm2 Bm28 Cdcl1 Kiaa0030 Mcmd2	Mus musculus (Mouse)	904	chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006267; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0015630; GO:0019899; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN33203_c0_g1_i1	P49736	MCM2_HUMAN	99.2	122	1	0	1	366	725	846	3.90E-60	231.9	MCM2_HUMAN	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	MCM2 BM28 CCNL1 CDCL1 KIAA0030	Homo sapiens (Human)	904	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0015630; GO:0019899; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN40209_c0_g1_i1	P49736	MCM2_HUMAN	100	70	0	0	211	2	467	536	1.50E-35	149.4	MCM2_HUMAN	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	MCM2 BM28 CCNL1 CDCL1 KIAA0030	Homo sapiens (Human)	904	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0015630; GO:0019899; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN27102_c0_g1_i1	P49736	MCM2_HUMAN	97.2	142	4	0	3	428	763	904	9.30E-72	270.8	MCM2_HUMAN	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	MCM2 BM28 CCNL1 CDCL1 KIAA0030	Homo sapiens (Human)	904	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0015630; GO:0019899; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN37227_c0_g1_i1	P49736	MCM2_HUMAN	49.3	67	34	0	3	203	733	799	1.40E-11	69.7	MCM2_HUMAN	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	MCM2 BM28 CCNL1 CDCL1 KIAA0030	Homo sapiens (Human)	904	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; microtubule cytoskeleton [GO:0015630]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0015630; GO:0019899; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN29957_c0_g1_i1	Q9LPD9	MCM2_ARATH	76.8	190	44	0	5	574	525	714	2.50E-77	289.7	MCM2_ARATH	reviewed	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2) (AtMCM2)	MCM2 At1g44900 T12C22.19	Arabidopsis thaliana (Mouse-ear cress)	936	cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; THO complex [GO:0000347]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; embryo development ending in seed dormancy [GO:0009793]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of cell population proliferation [GO:0042127]; regulation of root meristem growth [GO:0010082]; root development [GO:0048364]; viral process [GO:0016032]	cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; THO complex [GO:0000347]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000347; GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005829; GO:0006267; GO:0006268; GO:0009793; GO:0010082; GO:0016032; GO:0042127; GO:0042555; GO:0046872; GO:0048364; GO:1902975; GO:1905775	DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; embryo development ending in seed dormancy [GO:0009793]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of cell population proliferation [GO:0042127]; regulation of root meristem growth [GO:0010082]; root development [GO:0048364]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30693_c0_g1_i1	A4FUD9	MCM3_BOVIN	100	182	0	0	2	547	335	516	2.40E-98	359.4	MCM3_BOVIN	reviewed	DNA replication licensing factor MCM3 (EC 3.6.4.12)	MCM3	Bos taurus (Bovine)	808	centrosome [GO:0005813]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	centrosome [GO:0005813]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005813; GO:0006267; GO:0006271; GO:0042555; GO:0048471; GO:0071162; GO:1902975	DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19199_c0_g1_i1	P30666	MCM3_SCHPO	84.2	76	12	0	1	228	392	467	1.00E-29	130.2	MCM3_SCHPO	reviewed	DNA replication licensing factor mcm3 (EC 3.6.4.12) (Minichromosome maintenance protein 3)	mcm3 SPCC1682.02c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	879	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of helicase activity [GO:0051097]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000790; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005656; GO:0005829; GO:0006267; GO:0006271; GO:0031261; GO:0042555; GO:0043596; GO:0051097; GO:1902975	DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of helicase activity [GO:0051097]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN4885_c1_g1_i1	P30666	MCM3_SCHPO	72	168	47	0	515	12	332	499	3.00E-66	252.7	MCM3_SCHPO	reviewed	DNA replication licensing factor mcm3 (EC 3.6.4.12) (Minichromosome maintenance protein 3)	mcm3 SPCC1682.02c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	879	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of helicase activity [GO:0051097]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000790; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005656; GO:0005829; GO:0006267; GO:0006271; GO:0031261; GO:0042555; GO:0043596; GO:0051097; GO:1902975	DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of helicase activity [GO:0051097]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN41086_c0_g1_i1	P33991	MCM4_HUMAN	100	82	0	0	2	247	202	283	1.10E-42	173.3	MCM4_HUMAN	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)	MCM4 CDC21	Homo sapiens (Human)	863	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0016020; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN33207_c0_g1_i1	P49717	MCM4_MOUSE	63.4	213	78	0	51	689	457	669	8.20E-75	281.6	MCM4_MOUSE	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)	Mcm4 Cdc21 Mcmd4	Mus musculus (Mouse)	862	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006267; GO:0006268; GO:0006271; GO:0042555; GO:0071162; GO:1902975	DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN14918_c0_g1_i1	P33991	MCM4_HUMAN	99.7	376	1	0	2	1129	412	787	4.10E-209	728.4	MCM4_HUMAN	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)	MCM4 CDC21	Homo sapiens (Human)	863	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0016020; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN14918_c0_g1_i2	P33991	MCM4_HUMAN	99.6	248	1	0	2	745	412	659	1.50E-138	493.4	MCM4_HUMAN	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)	MCM4 CDC21	Homo sapiens (Human)	863	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0016020; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN30412_c0_g1_i1	P33991	MCM4_HUMAN	100	91	0	0	276	4	480	570	1.10E-46	186.8	MCM4_HUMAN	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)	MCM4 CDC21	Homo sapiens (Human)	863	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0016020; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN29048_c0_g1_i1	P33991	MCM4_HUMAN	100	135	0	0	406	2	270	404	1.80E-74	279.6	MCM4_HUMAN	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)	MCM4 CDC21	Homo sapiens (Human)	863	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0016020; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN6507_c0_g1_i1	P30665	MCM4_YEAST	51.1	88	38	1	250	2	761	848	1.20E-15	83.6	MCM4_YEAST	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Cell division control protein 54)	MCM4 CDC54 HCD21 YPR019W YP9531.13	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	933	CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; nuclear DNA replication [GO:0033260]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; protein hexamerization [GO:0034214]	CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0031261; GO:0031298; GO:0033260; GO:0034214; GO:0042555; GO:0043596; GO:0071162; GO:0097373; GO:1902975	DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; nuclear DNA replication [GO:0033260]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; protein hexamerization [GO:0034214]		NA	NA	NA	NA	NA	NA
TRINITY_DN8853_c1_g1_i1	Q0WVF5	MCM4_ARATH	58.6	244	101	0	736	5	419	662	1.10E-77	291.2	MCM4_ARATH	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Minichromosome maintenance protein 4) (AtMCM4)	MCM4 At2g16440 F16F14.6	Arabidopsis thaliana (Mouse-ear cress)	847	chloroplast [GO:0009507]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; THO complex [GO:0000347]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pollen development [GO:0009555]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	chloroplast [GO:0009507]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; THO complex [GO:0000347]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000347; GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005829; GO:0006267; GO:0006268; GO:0006271; GO:0009507; GO:0009555; GO:0042555; GO:0046872; GO:1902975	DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pollen development [GO:0009555]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19658_c0_g2_i1	Q26454	MCM4_DROME	65.7	35	12	0	68	172	202	236	3.50E-09	62	MCM4_DROME	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)	dpa CG1616	Drosophila melanogaster (Fruit fly)	866	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		brown	brown	NA	NA	NA	NA
TRINITY_DN19658_c0_g1_i10	Q26454	MCM4_DROME	68.2	623	191	3	38	1903	74	690	3.00E-255	882.5	MCM4_DROME	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)	dpa CG1616	Drosophila melanogaster (Fruit fly)	866	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19658_c0_g1_i2	Q26454	MCM4_DROME	68.3	764	235	3	38	2326	74	831	3.9e-312	1071.6	MCM4_DROME	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)	dpa CG1616	Drosophila melanogaster (Fruit fly)	866	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19658_c0_g1_i4	Q26454	MCM4_DROME	59.7	67	27	0	85	285	765	831	4.60E-16	85.1	MCM4_DROME	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)	dpa CG1616	Drosophila melanogaster (Fruit fly)	866	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19658_c0_g1_i8	Q26454	MCM4_DROME	66.3	526	170	3	38	1612	74	593	4.60E-209	728.8	MCM4_DROME	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)	dpa CG1616	Drosophila melanogaster (Fruit fly)	866	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19658_c0_g1_i9	Q26454	MCM4_DROME	66.9	519	165	3	38	1591	74	586	3.70E-208	725.7	MCM4_DROME	reviewed	DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)	dpa CG1616	Drosophila melanogaster (Fruit fly)	866	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006267; GO:0006268; GO:0006271; GO:0007052; GO:0042555; GO:0071162; GO:1902975	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN9786_c0_g1_i1	Q0V8B7	MCM5_BOVIN	100	181	0	0	1	543	341	521	3.70E-99	362.1	MCM5_BOVIN	reviewed	DNA replication licensing factor MCM5 (EC 3.6.4.12)	MCM5	Bos taurus (Bovine)	734	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]	GO:0003678; GO:0003688; GO:0005524; GO:0005829; GO:0006270; GO:0007049; GO:0042555; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN33229_c0_g1_i1	P33992	MCM5_HUMAN	100	266	0	0	1	798	29	294	1.90E-152	539.7	MCM5_HUMAN	reviewed	DNA replication licensing factor MCM5 (EC 3.6.4.12) (CDC46 homolog) (P1-CDC46)	MCM5 CDC46	Homo sapiens (Human)	734	"CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006267; GO:0006270; GO:0016020; GO:0042555; GO:0071162	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN35625_c0_g1_i1	Q9VGW6	MCM5_DROME	69.9	534	160	1	1599	1	1	534	5.00E-219	761.9	MCM5_DROME	reviewed	DNA replication licensing factor Mcm5 (EC 3.6.4.12) (Minichromosome maintenance 5 protein) (DmMCM5)	Mcm5 CG4082	Drosophila melanogaster (Fruit fly)	733	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; chromosome condensation [GO:0030261]; DNA endoreduplication [GO:0042023]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; resolution of meiotic recombination intermediates [GO:0000712]	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000712; GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005829; GO:0006267; GO:0006270; GO:0030261; GO:0042023; GO:0042555; GO:0051321; GO:0071162	chromosome condensation [GO:0030261]; DNA endoreduplication [GO:0042023]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; resolution of meiotic recombination intermediates [GO:0000712]		NA	NA	NA	NA	NA	NA
TRINITY_DN33933_c0_g1_i1	B8AEH3	MCM5_ORYSI	75.3	170	42	0	511	2	349	518	2.10E-67	256.5	MCM5_ORYSI	reviewed	DNA replication licensing factor MCM5 (EC 3.6.4.12) (Minichromosome maintenance protein 5)	MCM5 OsI_09290	Oryza sativa subsp. indica (Rice)	729	cytoplasm [GO:0005737]; MCM complex [GO:0042555]; THO complex [GO:0000347]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	cytoplasm [GO:0005737]; MCM complex [GO:0042555]; THO complex [GO:0000347]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]	GO:0000347; GO:0003678; GO:0003688; GO:0005524; GO:0005737; GO:0006270; GO:0007049; GO:0042555	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN635_c0_g1_i1	Q2KIZ8	MCM6_BOVIN	62.6	792	283	5	2457	97	37	820	2.10E-287	989.6	MCM6_BOVIN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12)	MCM6	Bos taurus (Bovine)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0042555; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN635_c0_g1_i2	Q7Q0Q1	MCM6_ANOGA	50.7	73	36	0	306	88	742	814	1.80E-13	77.8	MCM6_ANOGA	reviewed	DNA replication licensing factor Mcm6 (EC 3.6.4.12)	Mcm6 AGAP010219	Anopheles gambiae (African malaria mosquito)	814	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:0051301; GO:1902969	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN635_c0_g1_i4	Q2KIZ8	MCM6_BOVIN	62.6	792	283	5	2457	97	37	820	1.70E-287	989.9	MCM6_BOVIN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12)	MCM6	Bos taurus (Bovine)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0042555; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN635_c0_g1_i6	Q7Q0Q1	MCM6_ANOGA	46.6	73	39	0	312	94	742	814	6.50E-11	69.3	MCM6_ANOGA	reviewed	DNA replication licensing factor Mcm6 (EC 3.6.4.12)	Mcm6 AGAP010219	Anopheles gambiae (African malaria mosquito)	814	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:0051301; GO:1902969	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN635_c1_g1_i1	Q7Q0Q1	MCM6_ANOGA	41.9	62	35	1	236	54	717	778	1.90E-07	56.2	MCM6_ANOGA	reviewed	DNA replication licensing factor Mcm6 (EC 3.6.4.12)	Mcm6 AGAP010219	Anopheles gambiae (African malaria mosquito)	814	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:0051301; GO:1902969	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN14168_c0_g2_i1	Q2KIZ8	MCM6_BOVIN	69.2	39	12	0	20	136	615	653	5.20E-08	58.5	MCM6_BOVIN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12)	MCM6	Bos taurus (Bovine)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0042555; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN14168_c0_g2_i5	Q2KIZ8	MCM6_BOVIN	69.2	39	12	0	20	136	615	653	3.80E-08	58.5	MCM6_BOVIN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12)	MCM6	Bos taurus (Bovine)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]	CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0042555; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN19458_c0_g1_i1	Q7Q0Q1	MCM6_ANOGA	36.8	76	48	0	10	237	703	778	3.10E-11	68.9	MCM6_ANOGA	reviewed	DNA replication licensing factor Mcm6 (EC 3.6.4.12)	Mcm6 AGAP010219	Anopheles gambiae (African malaria mosquito)	814	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:0051301; GO:1902969	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN19458_c0_g1_i2	Q7Q0Q1	MCM6_ANOGA	36.8	76	48	0	10	237	703	778	3.10E-11	68.9	MCM6_ANOGA	reviewed	DNA replication licensing factor Mcm6 (EC 3.6.4.12)	Mcm6 AGAP010219	Anopheles gambiae (African malaria mosquito)	814	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:0051301; GO:1902969	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN37202_c0_g1_i1	Q7Q0Q1	MCM6_ANOGA	43.8	89	48	1	264	4	576	664	4.50E-13	75.1	MCM6_ANOGA	reviewed	DNA replication licensing factor Mcm6 (EC 3.6.4.12)	Mcm6 AGAP010219	Anopheles gambiae (African malaria mosquito)	814	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:0051301; GO:1902969	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN37857_c0_g1_i1	P49731	MCM6_SCHPO	41	83	49	0	251	3	256	338	4.10E-16	85.1	MCM6_SCHPO	reviewed	DNA replication licensing factor mcm6 (EC 3.6.4.12) (Minichromosome maintenance protein 6)	mcm6 mis5 SPBC211.04c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	892	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; double-strand break repair via homologous recombination [GO:0000724]; mitotic DNA replication [GO:1902969]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; premeiotic DNA replication [GO:0006279]	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]	GO:0000724; GO:0000727; GO:0000790; GO:0003678; GO:0003688; GO:0005524; GO:0005634; GO:0005656; GO:0005829; GO:0006267; GO:0006268; GO:0006279; GO:0031261; GO:0042555; GO:0043596; GO:0097373; GO:1902969; GO:1902975	DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; double-strand break repair via homologous recombination [GO:0000724]; mitotic DNA replication [GO:1902969]; mitotic DNA replication initiation [GO:1902975]; premeiotic DNA replication [GO:0006279]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN38843_c0_g1_i1	P53091	MCM6_YEAST	59.1	193	78	1	599	21	553	744	1.70E-57	223.8	MCM6_YEAST	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (Minichromosome maintenance protein 6)	MCM6 YGL201C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1017	CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	GO:0000727; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0017116; GO:0031261; GO:0031298; GO:0042555; GO:0071162; GO:0097373; GO:1902969	DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN27394_c0_g1_i1	P49731	MCM6_SCHPO	48.4	62	32	0	9	194	271	332	6.30E-12	70.9	MCM6_SCHPO	reviewed	DNA replication licensing factor mcm6 (EC 3.6.4.12) (Minichromosome maintenance protein 6)	mcm6 mis5 SPBC211.04c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	892	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; double-strand break repair via homologous recombination [GO:0000724]; mitotic DNA replication [GO:1902969]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; premeiotic DNA replication [GO:0006279]	cytosol [GO:0005829]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear chromatin [GO:0000790]; nuclear pre-replicative complex [GO:0005656]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]	GO:0000724; GO:0000727; GO:0000790; GO:0003678; GO:0003688; GO:0005524; GO:0005634; GO:0005656; GO:0005829; GO:0006267; GO:0006268; GO:0006279; GO:0031261; GO:0042555; GO:0043596; GO:0097373; GO:1902969; GO:1902975	DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; double-strand break repair via homologous recombination [GO:0000724]; mitotic DNA replication [GO:1902969]; mitotic DNA replication initiation [GO:1902975]; premeiotic DNA replication [GO:0006279]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN8853_c0_g1_i1	F4KAB8	MCM6_ARATH	67.3	199	63	1	611	21	357	555	3.30E-67	256.1	MCM6_ARATH	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (Minichromosome maintenance protein 6) (AtMCM6)	MCM6 At5g44635 K15C23	Arabidopsis thaliana (Mouse-ear cress)	831	MCM complex [GO:0042555]; nucleus [GO:0005634]; THO complex [GO:0000347]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]; THO complex [GO:0000347]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000347; GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:1902969	DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN17479_c0_g1_i1	P97311	MCM6_MOUSE	99.3	143	1	0	432	4	510	652	5.10E-75	281.6	MCM6_MOUSE	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (Mis5 homolog)	Mcm6 Mcmd6 Mis5	Mus musculus (Mouse)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:0071162; GO:1902969	DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN16793_c0_g1_i1	P97311	MCM6_MOUSE	98.2	223	4	0	3	671	34	256	1.60E-123	443.4	MCM6_MOUSE	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (Mis5 homolog)	Mcm6 Mcmd6 Mis5	Mus musculus (Mouse)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:0071162; GO:1902969	DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN16793_c0_g1_i2	P97311	MCM6_MOUSE	100	140	0	0	3	422	34	173	7.60E-76	284.3	MCM6_MOUSE	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (Mis5 homolog)	Mcm6 Mcmd6 Mis5	Mus musculus (Mouse)	821	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:0071162; GO:1902969	DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN13498_c0_g1_i1	Q14566	MCM6_HUMAN	100	412	0	0	1237	2	266	677	3.10E-234	812	MCM6_HUMAN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM)	MCM6	Homo sapiens (Human)	821	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:0071162; GO:1902969	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN13498_c0_g1_i2	Q14566	MCM6_HUMAN	100	412	0	0	1237	2	266	677	3.10E-234	812	MCM6_HUMAN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM)	MCM6	Homo sapiens (Human)	821	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:0071162; GO:1902969	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN14168_c0_g1_i1	Q14566	MCM6_HUMAN	50	64	27	3	20	196	615	678	3.70E-06	52.4	MCM6_HUMAN	reviewed	DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM)	MCM6	Homo sapiens (Human)	821	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"	"CMG complex [GO:0071162]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0042802; GO:0071162; GO:1902969	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN33970_c0_g1_i1	Q3ZBH9	MCM7_BOVIN	100	133	0	0	401	3	406	538	1.90E-68	259.6	MCM7_BOVIN	reviewed	DNA replication licensing factor MCM7 (EC 3.6.4.12)	MCM7	Bos taurus (Bovine)	719	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005829; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0006974; GO:0008283; GO:0042325; GO:0042555; GO:0071162; GO:0071466	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]		NA	NA	NA	NA	NA	NA
TRINITY_DN30493_c0_g1_i1	Q61881	MCM7_MOUSE	98.5	68	1	0	205	2	362	429	1.60E-31	136	MCM7_MOUSE	reviewed	DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog)	Mcm7 Cdc47 Mcmd7	Mus musculus (Mouse)	719	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]; response to drug [GO:0042493]	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0006974; GO:0008283; GO:0042325; GO:0042493; GO:0042555; GO:0071162; GO:0071364; GO:0071466	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN19658_c0_g3_i1	Q6NX31	MCM7_XENTR	88.8	232	26	0	9	704	317	548	1.90E-116	419.9	MCM7_XENTR	reviewed	DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7)	mcm7 TGas137h09.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	720	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0030174; GO:0042555; GO:0046872; GO:0071162	DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN26975_c0_g1_i1	P33993	MCM7_HUMAN	100	98	0	0	295	2	314	411	3.20E-49	195.3	MCM7_HUMAN	reviewed	DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3)	MCM7 CDC47 MCM2	Homo sapiens (Human)	719	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]; response to drug [GO:0042493]"	"chromatin [GO:0000785]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000082; GO:0000727; GO:0000784; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0006974; GO:0008283; GO:0016020; GO:0042325; GO:0042493; GO:0042555; GO:0071162; GO:0071364; GO:0071466	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN13119_c0_g1_i1	P38132	MCM7_YEAST	73.2	205	55	0	2	616	398	602	6.70E-81	301.6	MCM7_YEAST	reviewed	DNA replication licensing factor MCM7 (EC 3.6.4.12) (Cell division control protein 47) (Minichromosome maintenance protein 7)	MCM7 CDC47 YBR202W YBR1441	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	845	"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; MCM complex binding [GO:1904931]; single-stranded DNA helicase activity [GO:0017116]; chromatin silencing at telomere [GO:0006348]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; nuclear DNA replication [GO:0033260]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; silent mating-type cassette heterochromatin assembly [GO:0030466]"	"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; MCM core complex [GO:0097373]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; MCM complex binding [GO:1904931]; single-stranded DNA helicase activity [GO:0017116]	GO:0000727; GO:0000781; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0006348; GO:0017116; GO:0030466; GO:0031261; GO:0031298; GO:0033260; GO:0042555; GO:0071162; GO:0097373; GO:1904931	chromatin silencing at telomere [GO:0006348]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; nuclear DNA replication [GO:0033260]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; silent mating-type cassette heterochromatin assembly [GO:0030466]		NA	NA	NA	NA	NA	NA
TRINITY_DN6734_c0_g1_i1	Q91876	MCM7A_XENLA	68.6	191	59	1	6	578	340	529	7.50E-66	251.5	MCM7A_XENLA	reviewed	DNA replication licensing factor mcm7-A (EC 3.6.4.12) (CDC47 homolog A) (CDC47p) (Minichromosome maintenance protein 7-A) (xMCM7-A) (p90)	mcm7-a cdc47	Xenopus laevis (African clawed frog)	720	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]	GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN11036_c0_g1_i1	Q7YR26	TOP1_CHLAE	47.9	94	49	0	299	18	521	614	3.30E-20	99	TOP1_CHLAE	reviewed	DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)	TOP1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	767	"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA topological change [GO:0006265]"	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0003677; GO:0003682; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006265; GO:0006338; GO:0032922	chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN2617_c0_g1_i1	P30189	TOP1_DROME	53.8	130	58	1	112	501	433	560	4.10E-34	146	TOP1_DROME	reviewed	DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)	Top1 CG6146	Drosophila melanogaster (Fruit fly)	972	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; chromatin remodeling [GO:0006338]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; instar larval development [GO:0002168]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; regulation of embryonic development [GO:0045995]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; replication fork protection complex [GO:0031298]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]"	GO:0002168; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005700; GO:0005703; GO:0005719; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007275; GO:0030261; GO:0031298; GO:0045995; GO:0048477	chromatin remodeling [GO:0006338]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; instar larval development [GO:0002168]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; regulation of embryonic development [GO:0045995]		blue	blue	NA	NA	NA	NA
TRINITY_DN2617_c0_g1_i2	P30189	TOP1_DROME	65.9	555	174	2	112	1776	433	972	5.90E-213	741.9	TOP1_DROME	reviewed	DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)	Top1 CG6146	Drosophila melanogaster (Fruit fly)	972	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; chromatin remodeling [GO:0006338]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; instar larval development [GO:0002168]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; regulation of embryonic development [GO:0045995]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; replication fork protection complex [GO:0031298]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]"	GO:0002168; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005700; GO:0005703; GO:0005719; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007275; GO:0030261; GO:0031298; GO:0045995; GO:0048477	chromatin remodeling [GO:0006338]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; instar larval development [GO:0002168]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; regulation of embryonic development [GO:0045995]		NA	NA	NA	NA	NA	NA
TRINITY_DN36822_c0_g1_i1	Q7YR26	TOP1_CHLAE	100	113	0	0	1	339	512	624	1.00E-59	230.3	TOP1_CHLAE	reviewed	DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)	TOP1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	767	"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA topological change [GO:0006265]"	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0003677; GO:0003682; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006265; GO:0006338; GO:0032922	chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN9408_c0_g1_i1	P08096	TOP2_SCHPO	60.7	122	46	2	368	6	115	235	2.20E-39	162.9	TOP2_SCHPO	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II)	top2 SPBC1A4.03c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1485	"chromosome, centromeric core domain [GO:0034506]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; DNA topological change [GO:0006265]; mitotic chromosome condensation [GO:0007076]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic sister chromatid separation [GO:0051306]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]"	"chromosome, centromeric core domain [GO:0034506]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]"	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0000712; GO:0000790; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0006265; GO:0006325; GO:0007076; GO:0034506; GO:0035327; GO:0044774; GO:0046872; GO:0051306	chromatin organization [GO:0006325]; DNA topological change [GO:0006265]; mitotic chromosome condensation [GO:0007076]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic sister chromatid separation [GO:0051306]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN8354_c0_g1_i1	Q9Y8G8	TOP2_PENCH	58.3	168	70	0	507	4	60	227	7.70E-54	211.5	TOP2_PENCH	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II)	TOP2	Penicillium chrysogenum (Penicillium notatum)	1587	"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN27960_c0_g1_i1	P06786	TOP2_YEAST	65.7	99	31	2	304	17	116	214	7.60E-31	134.4	TOP2_YEAST	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II)	TOP2 TOR3 YNL088W N2244	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1428	"DNA replication termination region [GO:0097047]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling at centromere [GO:0031055]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA topological change [GO:0006265]; gene looping [GO:0090202]; mitotic DNA integrity checkpoint [GO:0044774]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; replication fork progression beyond termination site [GO:0097046]; resolution of meiotic recombination intermediates [GO:0000712]; rRNA transcription [GO:0009303]; sister chromatid segregation [GO:0000819]"	DNA replication termination region [GO:0097047]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0000019; GO:0000712; GO:0000795; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0005739; GO:0006265; GO:0006271; GO:0006333; GO:0007131; GO:0009303; GO:0031055; GO:0042802; GO:0044774; GO:0046872; GO:0090202; GO:0097046; GO:0097047	chromatin assembly or disassembly [GO:0006333]; chromatin remodeling at centromere [GO:0031055]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA topological change [GO:0006265]; gene looping [GO:0090202]; mitotic DNA integrity checkpoint [GO:0044774]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; replication fork progression beyond termination site [GO:0097046]; resolution of meiotic recombination intermediates [GO:0000712]; rRNA transcription [GO:0009303]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN14535_c0_g1_i1	P08096	TOP2_SCHPO	61	77	30	0	232	2	161	237	5.40E-23	107.8	TOP2_SCHPO	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II)	top2 SPBC1A4.03c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1485	"chromosome, centromeric core domain [GO:0034506]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; DNA topological change [GO:0006265]; mitotic chromosome condensation [GO:0007076]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic sister chromatid separation [GO:0051306]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]"	"chromosome, centromeric core domain [GO:0034506]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]"	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0000712; GO:0000790; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0006265; GO:0006325; GO:0007076; GO:0034506; GO:0035327; GO:0044774; GO:0046872; GO:0051306	chromatin organization [GO:0006325]; DNA topological change [GO:0006265]; mitotic chromosome condensation [GO:0007076]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic sister chromatid separation [GO:0051306]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN8408_c0_g2_i1	P15348	TOP2_DROME	62	100	36	2	297	1	3	101	3.40E-28	125.6	TOP2_DROME	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II)	Top2 CG10223	Drosophila melanogaster (Fruit fly)	1447	"CHRAC [GO:0008623]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; satellite DNA binding [GO:0003696]; chromatin silencing [GO:0006342]; chromosome condensation [GO:0030261]; DNA topological change [GO:0006265]; male meiosis chromosome segregation [GO:0007060]; meiotic cell cycle [GO:0051321]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic sister chromatid segregation [GO:0000070]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]"	CHRAC [GO:0008623]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; satellite DNA binding [GO:0003696]"	GO:0000070; GO:0000182; GO:0000278; GO:0000400; GO:0000712; GO:0000819; GO:0003677; GO:0003682; GO:0003696; GO:0003729; GO:0003918; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006265; GO:0006342; GO:0007060; GO:0007076; GO:0008623; GO:0030261; GO:0044774; GO:0046872; GO:0051310; GO:0051321	chromatin silencing [GO:0006342]; chromosome condensation [GO:0030261]; DNA topological change [GO:0006265]; male meiosis chromosome segregation [GO:0007060]; meiotic cell cycle [GO:0051321]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic sister chromatid segregation [GO:0000070]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN14535_c0_g2_i1	O24308	TOP2_PEA	61.4	88	31	2	268	5	11	95	3.50E-21	102.1	TOP2_PEA	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II) (PsTopII)	TOP2 TOPII	Pisum sativum (Garden pea)	1462	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]"		"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0003677; GO:0003918; GO:0005524; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN36529_c0_g1_i1	O24308	TOP2_PEA	61	105	37	2	311	3	17	119	1.80E-30	133.3	TOP2_PEA	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II) (PsTopII)	TOP2 TOPII	Pisum sativum (Garden pea)	1462	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]"		"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0003677; GO:0003918; GO:0005524; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN8408_c0_g1_i1	O24308	TOP2_PEA	71	62	18	0	8	193	113	174	3.40E-21	101.7	TOP2_PEA	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II) (PsTopII)	TOP2 TOPII	Pisum sativum (Garden pea)	1462	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]"		"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0003677; GO:0003918; GO:0005524; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN3967_c0_g1_i1	O16140	TOP2_BOMMO	70.5	560	153	4	95	1756	14	567	5.90E-231	801.6	TOP2_BOMMO	reviewed	DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II) (TOPOII)	TOP2	Bombyx mori (Silk moth)	1547	"nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN26957_c0_g1_i1	P11388	TOP2A_HUMAN	73.7	118	28	1	345	1	434	551	2.50E-43	176	TOP2A_HUMAN	reviewed	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	TOP2A TOP2	Homo sapiens (Human)	1531	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]"	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-dependent ATPase activity [GO:0008094]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]"	GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0044774; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904	apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN23356_c0_g1_i1	P41515	TOP2A_CRIGR	62.5	144	51	1	2	424	410	553	1.00E-43	177.6	TOP2A_CRIGR	reviewed	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	TOP2A TOP-2 TOP2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1526	"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"	"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]"	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]"	GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008301; GO:0009330; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904	apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN20573_c0_g2_i1	O42130	TOP2A_CHICK	68.2	88	26	1	278	15	412	497	4.80E-26	118.2	TOP2A_CHICK	reviewed	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	TOP2A	Gallus gallus (Chicken)	1553	"chromosome [GO:0005694]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; magnesium ion binding [GO:0000287]; apoptotic chromosome condensation [GO:0030263]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"	"chromosome [GO:0005694]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]"	"ATP binding [GO:0005524]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-dependent ATPase activity [GO:0008094]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000712; GO:0000792; GO:0000793; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006260; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0008094; GO:0008301; GO:0009330; GO:0030263; GO:0030332; GO:0043065; GO:0044774; GO:0048511; GO:0051301; GO:1905463; GO:1990904	apoptotic chromosome condensation [GO:0030263]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN36160_c0_g1_i1	P11388	TOP2A_HUMAN	100	203	0	0	610	2	30	232	8.90E-118	424.1	TOP2A_HUMAN	reviewed	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	TOP2A TOP2	Homo sapiens (Human)	1531	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]"	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-dependent ATPase activity [GO:0008094]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]"	GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0044774; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904	apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN27793_c0_g1_i1	P11388	TOP2A_HUMAN	99.4	159	1	0	1	477	408	566	4.10E-86	318.5	TOP2A_HUMAN	reviewed	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	TOP2A TOP2	Homo sapiens (Human)	1531	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]"	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-dependent ATPase activity [GO:0008094]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]"	GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0044774; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904	apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN27294_c0_g1_i1	P11388	TOP2A_HUMAN	100	170	0	0	512	3	237	406	2.60E-94	345.9	TOP2A_HUMAN	reviewed	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	TOP2A TOP2	Homo sapiens (Human)	1531	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]"	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-dependent ATPase activity [GO:0008094]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]"	GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0044774; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904	apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN26513_c0_g1_i1	Q64399	TOP2B_CRILO	93	57	4	0	2	172	14	70	3.20E-22	105.1	TOP2B_CRILO	reviewed	"DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)"	TOP2B	Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)	1612	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; DNA topological change [GO:0006265]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]"	GO:0003677; GO:0003916; GO:0003918; GO:0005524; GO:0005634; GO:0005730; GO:0006265; GO:0043021; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN37289_c0_g1_i1	Q64399	TOP2B_CRILO	96.1	76	3	0	231	4	433	508	6.70E-34	144.1	TOP2B_CRILO	reviewed	"DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)"	TOP2B	Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)	1612	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; DNA topological change [GO:0006265]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]"	GO:0003677; GO:0003916; GO:0003918; GO:0005524; GO:0005634; GO:0005730; GO:0006265; GO:0043021; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN28996_c0_g1_i1	Q64399	TOP2B_CRILO	100	151	0	0	456	4	418	568	2.90E-81	302.4	TOP2B_CRILO	reviewed	"DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)"	TOP2B	Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)	1612	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; DNA topological change [GO:0006265]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]"	GO:0003677; GO:0003916; GO:0003918; GO:0005524; GO:0005634; GO:0005730; GO:0006265; GO:0043021; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN33451_c0_g1_i1	Q02880	TOP2B_HUMAN	99.2	252	2	0	758	3	99	350	2.50E-146	519.2	TOP2B_HUMAN	reviewed	"DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)"	TOP2B	Homo sapiens (Human)	1626	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]"	GO:0000712; GO:0000819; GO:0001764; GO:0003677; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006265; GO:0007409; GO:0008022; GO:0019899; GO:0030900; GO:0042826; GO:0044774; GO:0045870; GO:0046872; GO:0046982; GO:1990904	axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i1	Q92547	TOPB1_HUMAN	32.6	282	181	4	841	14	19	297	1.10E-45	185.3	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i11	Q92547	TOPB1_HUMAN	26.9	1173	739	23	3276	22	19	1161	2.00E-110	402.1	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i2	Q92547	TOPB1_HUMAN	24.9	755	483	17	2061	22	416	1161	5.70E-42	174.1	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i4	Q92547	TOPB1_HUMAN	27.3	1162	745	22	3264	22	19	1161	2.40E-111	405.2	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i5	Q92547	TOPB1_HUMAN	27	1173	735	24	3267	22	19	1161	8.20E-109	396.7	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i7	Q92547	TOPB1_HUMAN	25.7	618	413	11	1761	22	552	1161	3.60E-41	171.4	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i9	Q92547	TOPB1_HUMAN	27.4	1162	741	23	3255	22	19	1161	7.40E-110	400.2	TOPB1_HUMAN	reviewed	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	TOPBP1 KIAA0259	Homo sapiens (Human)	1522	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN30105_c0_g1_i1	Q800K6	TOB1A_XENLA	50	52	26	0	218	63	675	726	3.80E-10	65.1	TOB1A_XENLA	reviewed	DNA topoisomerase 2-binding protein 1-A (Cut5 protein) (DNA topoisomerase II-binding protein 1-A) (TopBP1-A) (XtopBP)	topbp1-A cut5	Xenopus laevis (African clawed frog)	1513	chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]	GO:0000076; GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0005815; GO:0006270; GO:0006281; GO:0006974; GO:0019900; GO:0030174; GO:0033138; GO:0035563; GO:0045860; GO:0071163; GO:0071165; GO:0071168	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN3421_c0_g1_i3	Q800K6	TOB1A_XENLA	43.7	71	40	0	342	130	658	728	6.00E-12	72	TOB1A_XENLA	reviewed	DNA topoisomerase 2-binding protein 1-A (Cut5 protein) (DNA topoisomerase II-binding protein 1-A) (TopBP1-A) (XtopBP)	topbp1-A cut5	Xenopus laevis (African clawed frog)	1513	chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; kinase binding [GO:0019900]	GO:0000076; GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0005815; GO:0006270; GO:0006281; GO:0006974; GO:0019900; GO:0030174; GO:0033138; GO:0035563; GO:0045860; GO:0071163; GO:0071165; GO:0071168	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; GINS complex assembly [GO:0071165]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN26849_c0_g1_i1	O61660	TOP3_CAEEL	51.9	77	37	0	234	4	375	451	2.00E-17	89.4	TOP3_CAEEL	reviewed	DNA topoisomerase 3 (EC 5.6.2.1) (DNA topoisomerase III)	top-3 Y56A3A.27	Caenorhabditis elegans	759	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0008270	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN26327_c0_g1_i1	O61660	TOP3_CAEEL	48.8	82	41	1	244	2	467	548	8.00E-15	80.9	TOP3_CAEEL	reviewed	DNA topoisomerase 3 (EC 5.6.2.1) (DNA topoisomerase III)	top-3 Y56A3A.27	Caenorhabditis elegans	759	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0008270	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i1	Q9NG98	TOP3A_DROME	67.9	159	51	0	4	480	105	263	3.50E-59	229.2	TOP3A_DROME	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	Top3alpha CG10123	Drosophila melanogaster (Fruit fly)	1250	"chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]"	chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]"	GO:0000002; GO:0000724; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005694; GO:0005739; GO:0006265; GO:0008270; GO:0042246; GO:0048589	developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i2	Q13472	TOP3A_HUMAN	65.6	375	128	1	4	1125	113	487	1.70E-143	510.4	TOP3A_HUMAN	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	TOP3A TOP3	Homo sapiens (Human)	1001	"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796	chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i4	Q13472	TOP3A_HUMAN	67.5	157	50	1	593	1060	331	487	2.10E-58	227.6	TOP3A_HUMAN	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	TOP3A TOP3	Homo sapiens (Human)	1001	"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796	chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i4	Q13472	TOP3A_HUMAN	61.4	158	61	0	76	549	173	330	4.30E-51	203.4	TOP3A_HUMAN	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	TOP3A TOP3	Homo sapiens (Human)	1001	"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796	chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i5	Q9NG98	TOP3A_DROME	64.1	220	77	1	4	657	105	324	5.90E-78	292.7	TOP3A_DROME	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	Top3alpha CG10123	Drosophila melanogaster (Fruit fly)	1250	"chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]"	chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]"	GO:0000002; GO:0000724; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005694; GO:0005739; GO:0006265; GO:0008270; GO:0042246; GO:0048589	developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i5	Q9NG98	TOP3A_DROME	67.3	156	51	0	701	1168	325	480	5.40E-55	216.5	TOP3A_DROME	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	Top3alpha CG10123	Drosophila melanogaster (Fruit fly)	1250	"chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]"	chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; zinc ion binding [GO:0008270]"	GO:0000002; GO:0000724; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005694; GO:0005739; GO:0006265; GO:0008270; GO:0042246; GO:0048589	developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN14452_c0_g1_i7	Q13472	TOP3A_HUMAN	64.4	315	111	1	76	1017	173	487	8.70E-118	424.9	TOP3A_HUMAN	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	TOP3A TOP3	Homo sapiens (Human)	1001	"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796	chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN34793_c0_g1_i1	Q13472	TOP3A_HUMAN	98.6	74	1	0	224	3	178	251	2.00E-35	149.1	TOP3A_HUMAN	reviewed	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	TOP3A TOP3	Homo sapiens (Human)	1001	"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796	chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN40152_c0_g1_i1	F4ISQ7	TOP3B_ARATH	63.9	36	13	0	49	156	94	129	2.70E-07	55.5	TOP3B_ARATH	reviewed	DNA topoisomerase 3-beta (EC 5.6.2.1)	At2g32000 F22D22.25	Arabidopsis thaliana (Mouse-ear cress)	865	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"	GO:0003677; GO:0003729; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN36810_c0_g1_i1	F4ISQ7	TOP3B_ARATH	52.5	61	28	1	29	208	89	149	1.80E-09	62.8	TOP3B_ARATH	reviewed	DNA topoisomerase 3-beta (EC 5.6.2.1)	At2g32000 F22D22.25	Arabidopsis thaliana (Mouse-ear cress)	865	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"	GO:0003677; GO:0003729; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN11377_c0_g1_i1	F4ISQ7	TOP3B_ARATH	70.6	34	10	0	161	60	490	523	6.70E-07	54.3	TOP3B_ARATH	reviewed	DNA topoisomerase 3-beta (EC 5.6.2.1)	At2g32000 F22D22.25	Arabidopsis thaliana (Mouse-ear cress)	865	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; DNA topological change [GO:0006265]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]"	GO:0003677; GO:0003729; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0046872	DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN39722_c0_g1_i1	Q9Z321	TOP3B_MOUSE	54.4	103	46	1	10	315	353	455	3.30E-31	135.6	TOP3B_MOUSE	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	Top3b Top3b1	Mus musculus (Mouse)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]"	GO:0000793; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN24913_c0_g1_i1	O95985	TOP3B_HUMAN	71.8	78	22	0	1	234	170	247	1.80E-29	129.4	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN29104_c0_g1_i1	O95985	TOP3B_HUMAN	100	169	0	0	509	3	232	400	3.70E-93	342	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN32505_c0_g1_i1	O95985	TOP3B_HUMAN	100	84	0	0	2	253	467	550	1.20E-44	179.9	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN40844_c0_g1_i1	O95985	TOP3B_HUMAN	62.5	80	29	1	18	257	487	565	2.40E-22	105.9	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1609_c0_g1_i3	O95985	TOP3B_HUMAN	70	287	85	1	1510	653	1	287	1.30E-115	418.3	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1609_c0_g1_i3	O95985	TOP3B_HUMAN	64.3	210	75	0	632	3	291	500	1.50E-76	288.5	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1609_c0_g1_i4	O95985	TOP3B_HUMAN	67.9	514	164	1	1540	2	1	514	1.20E-206	720.7	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1609_c0_g1_i6	O95985	TOP3B_HUMAN	69.6	276	83	1	1477	653	12	287	1.10E-110	401.7	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1609_c0_g1_i6	O95985	TOP3B_HUMAN	64.3	210	75	0	632	3	291	500	1.40E-76	288.5	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1609_c0_g1_i7	O95985	TOP3B_HUMAN	68.7	635	198	1	1904	3	1	635	1.60E-261	903.3	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN32212_c0_g1_i1	O95985	TOP3B_HUMAN	100	105	0	0	3	317	22	126	4.90E-59	228	TOP3B_HUMAN	reviewed	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)	TOP3B TOP3B1	Homo sapiens (Human)	862	"condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]		NA	NA	NA	NA	NA	NA
TRINITY_DN35105_c0_g1_i1	Q9UBZ4	APEX2_HUMAN	100	101	0	0	3	305	56	156	3.80E-53	208.4	APEX2_HUMAN	reviewed	DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.-.-) (AP endonuclease XTH2) (APEX nuclease 2) (APEX nuclease-like 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2)	APEX2 APE2 APEXL2 XTH2	Homo sapiens (Human)	518	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]	GO:0001650; GO:0003677; GO:0003906; GO:0004519; GO:0004528; GO:0005634; GO:0005654; GO:0005739; GO:0006284; GO:0006310; GO:0007049; GO:0008270; GO:0008311; GO:0043231	base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN12297_c0_g1_i1	Q68G58	APEX2_MOUSE	39.3	600	254	14	1817	81	2	512	4.60E-104	380.2	APEX2_MOUSE	reviewed	DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.-.-) (APEX nuclease 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2)	Apex2 Ape2	Mus musculus (Mouse)	516	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]	GO:0001650; GO:0003677; GO:0003906; GO:0004519; GO:0004528; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006284; GO:0006310; GO:0007049; GO:0008270; GO:0008311; GO:0043231	base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN2301_c0_g1_i1	Q8K339	KIN17_MOUSE	36.4	261	158	4	860	96	133	391	7.30E-33	142.5	KIN17_MOUSE	reviewed	"DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein)"	Kin Btcd Kin17	Mus musculus (Mouse)	391	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0016363; GO:0032991; GO:0043231; GO:0046872	cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN10033_c0_g1_i1	P29372	3MG_HUMAN	100	129	0	0	2	388	130	258	1.70E-69	263.1	3MG_HUMAN	reviewed	DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)	MPG AAG ANPG MID1	Homo sapiens (Human)	298	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]	alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA N-glycosylase activity [GO:0019104]	GO:0003684; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822	base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]		NA	NA	NA	NA	NA	NA
TRINITY_DN1222_c0_g1_i1	P29372	3MG_HUMAN	50.2	243	102	6	296	1000	64	295	9.00E-54	212.2	3MG_HUMAN	reviewed	DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)	MPG AAG ANPG MID1	Homo sapiens (Human)	298	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]	alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA N-glycosylase activity [GO:0019104]	GO:0003684; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822	base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]		NA	NA	NA	NA	NA	NA
TRINITY_DN1222_c0_g1_i2	P29372	3MG_HUMAN	50.8	238	103	6	296	985	64	295	4.00E-54	213.4	3MG_HUMAN	reviewed	DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)	MPG AAG ANPG MID1	Homo sapiens (Human)	298	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]	alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA N-glycosylase activity [GO:0019104]	GO:0003684; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822	base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]		NA	NA	NA	NA	NA	NA
TRINITY_DN1222_c0_g1_i3	P29372	3MG_HUMAN	50	118	52	2	296	628	64	181	1.80E-23	110.9	3MG_HUMAN	reviewed	DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)	MPG AAG ANPG MID1	Homo sapiens (Human)	298	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]	alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA N-glycosylase activity [GO:0019104]	GO:0003684; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822	base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]		NA	NA	NA	NA	NA	NA
TRINITY_DN36672_c0_g1_i1	Q01981	CREA_EMENI	43.5	69	36	2	208	8	62	129	2.10E-06	52.8	CREA_EMENI	reviewed	DNA-binding protein creA (Carbon catabolite repressor A)	creA AN6195	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	416	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; carbon catabolite repression of transcription from RNA polymerase II promoter by glucose [GO:0000433]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of carbon utilization [GO:0043609]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000433; GO:0000976; GO:0000978; GO:0005634; GO:0005737; GO:0006338; GO:0009051; GO:0016584; GO:0043609; GO:0045892; GO:0046872	"carbon catabolite repression of transcription from RNA polymerase II promoter by glucose [GO:0000433]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of carbon utilization [GO:0043609]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2471_c0_g1_i1	P29775	ETS4_DROME	45.3	86	46	1	1182	1436	427	512	6.40E-15	84	ETS4_DROME	reviewed	DNA-binding protein D-ETS-4	Ets98B ETS-4 CG5583	Drosophila melanogaster (Fruit fly)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2471_c0_g1_i3	P29775	ETS4_DROME	45.3	86	46	1	1260	1514	427	512	6.70E-15	84	ETS4_DROME	reviewed	DNA-binding protein D-ETS-4	Ets98B ETS-4 CG5583	Drosophila melanogaster (Fruit fly)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33444_c0_g1_i1	P29775	ETS4_DROME	86.8	91	12	0	282	10	427	517	5.70E-43	174.5	ETS4_DROME	reviewed	DNA-binding protein D-ETS-4	Ets98B ETS-4 CG5583	Drosophila melanogaster (Fruit fly)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1946_c0_g1_i4	P29776	ETS6_DROME	52.8	214	85	4	779	1408	153	354	5.90E-52	206.8	ETS6_DROME	reviewed	DNA-binding protein D-ETS-6	Ets21C ETS-6 CG2914	Drosophila melanogaster (Fruit fly)	475	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; defense response to bacterium [GO:0042742]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0042742; GO:0043565	cell differentiation [GO:0030154]; defense response to bacterium [GO:0042742]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4588_c0_g1_i11	Q04688	ELG_DROME	30	416	228	11	1382	291	42	446	3.50E-41	171	ELG_DROME	reviewed	DNA-binding protein Ets97D (D-elg)	Ets97D elg CG6338	Drosophila melanogaster (Fruit fly)	464	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000820; GO:0000981; GO:0005634; GO:0006357; GO:0009267; GO:0010821; GO:0030154; GO:0043565; GO:0045944; GO:1903862	cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4588_c0_g1_i14	Q04688	ELG_DROME	30	416	228	11	1389	298	42	446	3.50E-41	171	ELG_DROME	reviewed	DNA-binding protein Ets97D (D-elg)	Ets97D elg CG6338	Drosophila melanogaster (Fruit fly)	464	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000820; GO:0000981; GO:0005634; GO:0006357; GO:0009267; GO:0010821; GO:0030154; GO:0043565; GO:0045944; GO:1903862	cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4588_c0_g1_i3	Q04688	ELG_DROME	30	416	228	11	1211	120	42	446	3.10E-41	171	ELG_DROME	reviewed	DNA-binding protein Ets97D (D-elg)	Ets97D elg CG6338	Drosophila melanogaster (Fruit fly)	464	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000820; GO:0000981; GO:0005634; GO:0006357; GO:0009267; GO:0010821; GO:0030154; GO:0043565; GO:0045944; GO:1903862	cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of mitochondrion organization [GO:0010821]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3581_c0_g1_i1	Q24312	EWG_DROME	38.9	463	84	9	3	830	202	652	6.90E-72	272.3	EWG_DROME	reviewed	DNA-binding protein Ewg (Protein erect wing)	ewg CG3114	Drosophila melanogaster (Fruit fly)	733	nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult somatic muscle development [GO:0007527]; central nervous system development [GO:0007417]; imaginal disc morphogenesis [GO:0007560]; muscle organ development [GO:0007517]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001046; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007417; GO:0007517; GO:0007527; GO:0007560; GO:0045886; GO:0090263	adult somatic muscle development [GO:0007527]; central nervous system development [GO:0007417]; imaginal disc morphogenesis [GO:0007560]; muscle organ development [GO:0007517]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3581_c0_g1_i2	Q24312	EWG_DROME	80.5	118	23	0	3	356	202	319	3.80E-54	212.2	EWG_DROME	reviewed	DNA-binding protein Ewg (Protein erect wing)	ewg CG3114	Drosophila melanogaster (Fruit fly)	733	nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult somatic muscle development [GO:0007527]; central nervous system development [GO:0007417]; imaginal disc morphogenesis [GO:0007560]; muscle organ development [GO:0007517]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001046; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007417; GO:0007517; GO:0007527; GO:0007560; GO:0045886; GO:0090263	adult somatic muscle development [GO:0007527]; central nervous system development [GO:0007417]; imaginal disc morphogenesis [GO:0007560]; muscle organ development [GO:0007517]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3581_c0_g1_i3	Q24312	EWG_DROME	38.4	463	90	8	3	842	202	652	7.00E-72	272.3	EWG_DROME	reviewed	DNA-binding protein Ewg (Protein erect wing)	ewg CG3114	Drosophila melanogaster (Fruit fly)	733	nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult somatic muscle development [GO:0007527]; central nervous system development [GO:0007417]; imaginal disc morphogenesis [GO:0007560]; muscle organ development [GO:0007517]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001046; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007417; GO:0007517; GO:0007527; GO:0007560; GO:0045886; GO:0090263	adult somatic muscle development [GO:0007527]; central nervous system development [GO:0007417]; imaginal disc morphogenesis [GO:0007560]; muscle organ development [GO:0007517]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35657_c0_g1_i1	Q13422	IKZF1_HUMAN	100	77	0	0	2	232	117	193	1.20E-43	176.4	IKZF1_HUMAN	reviewed	DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1)	IKZF1 IK1 IKAROS LYF1 ZNFN1A1	Homo sapiens (Human)	519	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; lymphocyte differentiation [GO:0030098]; mesoderm development [GO:0007498]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006325; GO:0006357; GO:0007049; GO:0007498; GO:0019904; GO:0030098; GO:0030218; GO:0031618; GO:0032991; GO:0042802; GO:0045892; GO:0046872	"cell cycle [GO:0007049]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; lymphocyte differentiation [GO:0030098]; mesoderm development [GO:0007498]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32442_c0_g1_i1	Q02363	ID2_HUMAN	100	78	0	0	2	235	23	100	2.70E-38	158.7	ID2_HUMAN	reviewed	DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2)	ID2 BHLHB26	Homo sapiens (Human)	134	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor inhibitor activity [GO:0140416]; ion channel binding [GO:0044325]; protein dimerization activity [GO:0046983]; RNA polymerase II activating transcription factor binding [GO:0001102]; adipose tissue development [GO:0060612]; adult locomotory behavior [GO:0008344]; bundle of His development [GO:0003166]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal digestive tract morphogenesis [GO:0061031]; entrainment of circadian clock by photoperiod [GO:0043153]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; locomotor rhythm [GO:0045475]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; membranous septum morphogenesis [GO:0003149]; metanephros development [GO:0001656]; natural killer cell differentiation [GO:0001779]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of core promoter binding [GO:1904797]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate commitment [GO:0048663]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; Peyer's patch development [GO:0048541]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid metabolic process [GO:0019216]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron differentiation [GO:0045664]; thigmotaxis [GO:0001966]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA-binding transcription factor inhibitor activity [GO:0140416]; ion channel binding [GO:0044325]; protein dimerization activity [GO:0046983]; RNA polymerase II activating transcription factor binding [GO:0001102]	GO:0000122; GO:0001102; GO:0001656; GO:0001779; GO:0001966; GO:0003149; GO:0003166; GO:0005634; GO:0005719; GO:0005737; GO:0005829; GO:0008344; GO:0010628; GO:0010629; GO:0014003; GO:0019216; GO:0021772; GO:0030154; GO:0032922; GO:0032991; GO:0033598; GO:0042752; GO:0043153; GO:0043353; GO:0043433; GO:0044325; GO:0045475; GO:0045578; GO:0045600; GO:0045648; GO:0045651; GO:0045664; GO:0045665; GO:0045668; GO:0045777; GO:0045892; GO:0045893; GO:0046983; GO:0048469; GO:0048541; GO:0048557; GO:0048661; GO:0048663; GO:0048667; GO:0048711; GO:0048715; GO:0051148; GO:0060612; GO:0060749; GO:0061030; GO:0061031; GO:0071158; GO:0071285; GO:0071931; GO:0090398; GO:0140416; GO:1904797; GO:2000045; GO:2000177	"adipose tissue development [GO:0060612]; adult locomotory behavior [GO:0008344]; bundle of His development [GO:0003166]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal digestive tract morphogenesis [GO:0061031]; entrainment of circadian clock by photoperiod [GO:0043153]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; locomotor rhythm [GO:0045475]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; membranous septum morphogenesis [GO:0003149]; metanephros development [GO:0001656]; natural killer cell differentiation [GO:0001779]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of core promoter binding [GO:1904797]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; Peyer's patch development [GO:0048541]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; regulation of circadian rhythm [GO:0042752]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid metabolic process [GO:0019216]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron differentiation [GO:0045664]; thigmotaxis [GO:0001966]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4614_c0_g1_i1	P48382	RFX5_HUMAN	36.4	77	48	1	1706	1933	91	167	7.60E-08	60.8	RFX5_HUMAN	reviewed	DNA-binding protein RFX5 (Regulatory factor X 5)	RFX5	Homo sapiens (Human)	616	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0043565; GO:0045944; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c2_g1_i1	O14335	SCR1_SCHPO	48.3	58	25	2	29	196	22	76	3.20E-08	58.5	SCR1_SCHPO	reviewed	DNA-binding protein scr1	scr1 SPBC1D7.02c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	565	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; carbon catabolite repression of transcription from RNA polymerase II promoter by glucose [GO:0000433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000433; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0005829; GO:0046872; GO:0061987	carbon catabolite repression of transcription from RNA polymerase II promoter by glucose [GO:0000433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]		NA	NA	NA	NA	NA	NA
TRINITY_DN37459_c0_g1_i1	P38935	SMBP2_HUMAN	47.3	74	38	1	221	3	526	599	9.60E-14	77	SMBP2_HUMAN	reviewed	DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2)	IGHMBP2 SMBP2 SMUBP2	Homo sapiens (Human)	993	axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; translation [GO:0006412]	axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0000122; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0016020; GO:0030424; GO:0030426; GO:0032574; GO:0042802; GO:0043022; GO:0043139; GO:1990904	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29689_c0_g1_i1	P38935	SMBP2_HUMAN	64.6	79	28	0	243	7	545	623	3.30E-23	108.6	SMBP2_HUMAN	reviewed	DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2)	IGHMBP2 SMBP2 SMUBP2	Homo sapiens (Human)	993	axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; translation [GO:0006412]	axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0000122; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0016020; GO:0030424; GO:0030426; GO:0032574; GO:0042802; GO:0043022; GO:0043139; GO:1990904	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN32232_c0_g1_i1	P38935	SMBP2_HUMAN	53.5	71	33	0	213	1	559	629	1.70E-15	82.8	SMBP2_HUMAN	reviewed	DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2)	IGHMBP2 SMBP2 SMUBP2	Homo sapiens (Human)	993	axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; translation [GO:0006412]	axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0000122; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0016020; GO:0030424; GO:0030426; GO:0032574; GO:0042802; GO:0043022; GO:0043139; GO:1990904	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN10173_c0_g2_i1	Q22557	SPRTN_CAEEL	39.3	84	41	2	115	336	23	106	1.90E-06	53.5	SPRTN_CAEEL	reviewed	DNA-dependent metalloprotease dvc-1 (EC 3.4.24.-) (DNA damage protein targeting VCP) (DVC1) (Protein with SprT-like domain at the N terminus) (Spartan)	dvc-1 T19B10.6	Caenorhabditis elegans	368	chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]	chromosome [GO:0005694]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0003677; GO:0005634; GO:0005694; GO:0006281; GO:0006974; GO:0031593; GO:0046872	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]		pink	pink	NA	NA	NA	NA
TRINITY_DN2035_c0_g1_i1	G3X912	SPRTN_MOUSE	74.5	145	37	0	3	437	73	217	5.50E-66	251.9	SPRTN_MOUSE	reviewed	DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan)	Sprtn Gm505	Mus musculus (Mouse)	497	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]	GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0005654; GO:0006508; GO:0006974; GO:0009411; GO:0016540; GO:0016607; GO:0019985; GO:0031398; GO:0031593; GO:0043130; GO:0046872; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN2035_c0_g1_i2	G3X912	SPRTN_MOUSE	60	200	70	3	3	572	73	272	7.50E-66	253.1	SPRTN_MOUSE	reviewed	DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan)	Sprtn Gm505	Mus musculus (Mouse)	497	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]	GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0005654; GO:0006508; GO:0006974; GO:0009411; GO:0016540; GO:0016607; GO:0019985; GO:0031398; GO:0031593; GO:0043130; GO:0046872; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN10173_c0_g2_i2	F6UH96	SPRTN_XENTR	50	66	33	0	195	392	125	190	9.80E-17	88.6	SPRTN_XENTR	reviewed	DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan)	sprtn	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	436	chromatin [GO:0000785]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	chromatin [GO:0000785]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]	GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0009411; GO:0016540; GO:0019985; GO:0031398; GO:0031593; GO:0043130; GO:0046872; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN10173_c0_g2_i3	F6UH96	SPRTN_XENTR	50	66	33	0	62	259	125	190	1.00E-16	88.2	SPRTN_XENTR	reviewed	DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan)	sprtn	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	436	chromatin [GO:0000785]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	chromatin [GO:0000785]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]	GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0009411; GO:0016540; GO:0019985; GO:0031398; GO:0031593; GO:0043130; GO:0046872; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN10173_c0_g2_i4	D3ZVU1	SPRTN_RAT	53.2	171	78	1	115	627	48	216	2.80E-51	203.8	SPRTN_RAT	reviewed	DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan)	Sprtn	Rattus norvegicus (Rat)	496	chromatin [GO:0000785]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	chromatin [GO:0000785]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]	GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0009411; GO:0016540; GO:0019985; GO:0031398; GO:0031593; GO:0043130; GO:0046872; GO:0070530	cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]		NA	NA	NA	NA	NA	NA
TRINITY_DN11572_c0_g1_i1	Q9DEI1	PRKDC_XENLA	38.4	99	61	0	346	50	2408	2506	1.80E-14	80.1	PRKDC_XENLA	reviewed	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	prkdc	Xenopus laevis (African clawed frog)	4146	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]	GO:0003677; GO:0004677; GO:0005524; GO:0005730; GO:0006303; GO:0042254; GO:0070419; GO:0072431	double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN11572_c0_g1_i2	Q9DEI1	PRKDC_XENLA	37.4	398	222	11	1156	11	2448	2834	1.80E-53	211.5	PRKDC_XENLA	reviewed	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	prkdc	Xenopus laevis (African clawed frog)	4146	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]	GO:0003677; GO:0004677; GO:0005524; GO:0005730; GO:0006303; GO:0042254; GO:0070419; GO:0072431	double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN11572_c0_g1_i6	Q9DEI1	PRKDC_XENLA	38.5	286	166	6	1263	427	2408	2690	9.70E-42	172.6	PRKDC_XENLA	reviewed	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	prkdc	Xenopus laevis (African clawed frog)	4146	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]	GO:0003677; GO:0004677; GO:0005524; GO:0005730; GO:0006303; GO:0042254; GO:0070419; GO:0072431	double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN11572_c0_g1_i6	Q9DEI1	PRKDC_XENLA	42.6	108	58	2	334	11	2731	2834	5.50E-13	77	PRKDC_XENLA	reviewed	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	prkdc	Xenopus laevis (African clawed frog)	4146	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]	GO:0003677; GO:0004677; GO:0005524; GO:0005730; GO:0006303; GO:0042254; GO:0070419; GO:0072431	double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN11572_c0_g1_i7	Q9DEI1	PRKDC_XENLA	36.3	438	252	11	1276	11	2408	2834	3.00E-59	230.7	PRKDC_XENLA	reviewed	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	prkdc	Xenopus laevis (African clawed frog)	4146	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]	GO:0003677; GO:0004677; GO:0005524; GO:0005730; GO:0006303; GO:0042254; GO:0070419; GO:0072431	double-strand break repair via nonhomologous end joining [GO:0006303]; ribosome biogenesis [GO:0042254]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN40764_c0_g1_i1	Q9SVY0	NRPA1_ARATH	70.4	81	24	0	28	270	552	632	1.70E-28	126.3	NRPA1_ARATH	reviewed	DNA-directed RNA polymerase I subunit 1 (DNA-directed RNA polymerase I subunit RPA1) (DNA polymerase I subunit A1) (EC 2.7.7.6) (Nuclear RNA polymerase A1)	NRPA1 RPA1 At3g57660 F15B8.150	Arabidopsis thaliana (Mouse-ear cress)	1670	"nucleus [GO:0005634]; plasmodesma [GO:0009506]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]; plasmodesma [GO:0009506]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003899; GO:0005634; GO:0005736; GO:0006351; GO:0008270; GO:0009506; GO:0042254	"ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27075_c0_g1_i1	Q9SVY0	NRPA1_ARATH	41.9	222	46	2	456	40	991	1212	9.30E-36	151.4	NRPA1_ARATH	reviewed	DNA-directed RNA polymerase I subunit 1 (DNA-directed RNA polymerase I subunit RPA1) (DNA polymerase I subunit A1) (EC 2.7.7.6) (Nuclear RNA polymerase A1)	NRPA1 RPA1 At3g57660 F15B8.150	Arabidopsis thaliana (Mouse-ear cress)	1670	"nucleus [GO:0005634]; plasmodesma [GO:0009506]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]; plasmodesma [GO:0009506]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003899; GO:0005634; GO:0005736; GO:0006351; GO:0008270; GO:0009506; GO:0042254	"ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12057_c1_g1_i1	P15398	RPA1_SCHPO	33.6	256	162	3	880	125	1432	1683	4.70E-30	133.3	RPA1_SCHPO	reviewed	DNA-directed RNA polymerase I subunit rpa1 (EC 2.7.7.6) (DNA-directed RNA polymerase I 190 kDa polypeptide) (DNA-directed RNA polymerase I largest subunit)	rpa1 nuc1 SPBC4C3.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1689	cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; transcription by RNA polymerase I [GO:0006360]	cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003899; GO:0005730; GO:0005736; GO:0005829; GO:0006360; GO:0008270	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN29558_c0_g1_i1	Q86H36	RPA1_DICDI	58.9	73	30	0	220	2	406	478	8.60E-18	90.5	RPA1_DICDI	reviewed	DNA-directed RNA polymerase I subunit rpa1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A)	polr1a rpa1 DDB_G0275759	Dictyostelium discoideum (Slime mold)	1615	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0008270	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN6184_c0_g1_i1	P91875	RPA1_DROME	38.4	1400	769	22	4316	171	1	1325	7.40E-267	922.2	RPA1_DROME	reviewed	DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A)	RpI1 RPA1 CG10122	Drosophila melanogaster (Fruit fly)	1642	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0008270	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN6184_c0_g1_i5	P91875	RPA1_DROME	41.3	1103	599	16	3428	171	254	1325	1.90E-236	820.8	RPA1_DROME	reviewed	DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A)	RpI1 RPA1 CG10122	Drosophila melanogaster (Fruit fly)	1642	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0008270	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN36203_c0_g1_i1	O35134	RPA1_MOUSE	76.2	105	24	1	1	315	936	1039	8.40E-43	174.1	RPA1_MOUSE	reviewed	DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194)	Polr1a Rpa1 Rpo1-4	Mus musculus (Mouse)	1717	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]	GO:0001054; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005736; GO:0008270; GO:0009303; GO:1904750	negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN80_c0_g1_i1	Q1RMP0	RPA12_BOVIN	39.2	130	72	2	467	78	1	123	1.90E-18	94	RPA12_BOVIN	reviewed	DNA-directed RNA polymerase I subunit RPA12 (DNA-directed RNA polymerase I subunit H)	POLR1H	Bos taurus (Bovine)	123	RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363]	RNA polymerase I complex [GO:0005736]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003899; GO:0005736; GO:0006363; GO:0006379; GO:0008270	mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363]		blue	blue	NA	NA	NA	NA
TRINITY_DN6184_c0_g1_i9	P10964	RPA1_YEAST	27.1	118	83	1	370	26	1218	1335	3.60E-06	52.8	RPA1_YEAST	reviewed	DNA-directed RNA polymerase I subunit RPA190 (EC 2.7.7.6) (DNA-directed RNA polymerase I 190 kDa polypeptide) (A190) (DNA-directed RNA polymerase I largest subunit)	RPA190 RPA1 RRN1 YOR341W O6276	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1664	nucleolus [GO:0005730]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; ribosome biogenesis [GO:0042254]; transcription by RNA polymerase I [GO:0006360]	nucleolus [GO:0005730]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]	GO:0001054; GO:0003677; GO:0005730; GO:0005736; GO:0006360; GO:0008270; GO:0042254; GO:0042790; GO:1990841	nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; ribosome biogenesis [GO:0042254]; transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN30053_c0_g1_i1	P10964	RPA1_YEAST	73.9	69	18	0	9	215	1170	1238	1.90E-22	105.9	RPA1_YEAST	reviewed	DNA-directed RNA polymerase I subunit RPA190 (EC 2.7.7.6) (DNA-directed RNA polymerase I 190 kDa polypeptide) (A190) (DNA-directed RNA polymerase I largest subunit)	RPA190 RPA1 RRN1 YOR341W O6276	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1664	nucleolus [GO:0005730]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; ribosome biogenesis [GO:0042254]; transcription by RNA polymerase I [GO:0006360]	nucleolus [GO:0005730]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]	GO:0001054; GO:0003677; GO:0005730; GO:0005736; GO:0006360; GO:0008270; GO:0042254; GO:0042790; GO:1990841	nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; ribosome biogenesis [GO:0042254]; transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN10757_c0_g2_i1	O74633	RPA2_NEUCR	62.4	125	47	0	397	23	688	812	2.40E-39	162.9	RPA2_NEUCR	reviewed	DNA-directed RNA polymerase I subunit RPA2 (EC 2.7.7.6) (DNA-directed RNA polymerase I polypeptide 2) (RNA polymerase I subunit 2)	acr-2 NCU08616	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	1234	"RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005736; GO:0006351; GO:0032549; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6326_c0_g1_i1	O74633	RPA2_NEUCR	65.2	115	40	0	20	364	1012	1126	3.00E-39	162.5	RPA2_NEUCR	reviewed	DNA-directed RNA polymerase I subunit RPA2 (EC 2.7.7.6) (DNA-directed RNA polymerase I polypeptide 2) (RNA polymerase I subunit 2)	acr-2 NCU08616	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	1234	"RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005736; GO:0006351; GO:0032549; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10757_c0_g1_i1	O54888	RPA2_RAT	63.6	110	40	0	17	346	961	1070	1.70E-36	153.3	RPA2_RAT	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (A127) (RPA135)	Polr1b Rpa2 Rpo1-2	Rattus norvegicus (Rat)	1135	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0005730; GO:0005736; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0046872	embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN3770_c0_g1_i5	P70700	RPA2_MOUSE	46	1091	572	9	3297	34	5	1081	6.30E-282	971.8	RPA2_MOUSE	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135)	Polr1b Rpa2 Rpo1-2	Mus musculus (Mouse)	1135	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005730; GO:0005736; GO:0005829; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0046872	embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN10757_c0_g3_i1	P70700	RPA2_MOUSE	69	84	25	1	302	54	859	942	1.50E-28	126.7	RPA2_MOUSE	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135)	Polr1b Rpa2 Rpo1-2	Mus musculus (Mouse)	1135	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005730; GO:0005736; GO:0005829; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0046872	embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN27072_c0_g1_i1	Q9H9Y6	RPA2_HUMAN	100	72	0	0	219	4	997	1068	5.20E-36	151	RPA2_HUMAN	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135)	POLR1B	Homo sapiens (Human)	1135	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression, epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005730; GO:0005736; GO:0005829; GO:0006361; GO:0006362; GO:0006363; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0045815; GO:0046872	"embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression, epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27032_c0_g1_i1	Q9H9Y6	RPA2_HUMAN	100	111	0	0	2	334	665	775	3.20E-61	235.3	RPA2_HUMAN	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135)	POLR1B	Homo sapiens (Human)	1135	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression, epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005730; GO:0005736; GO:0005829; GO:0006361; GO:0006362; GO:0006363; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0045815; GO:0046872	"embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression, epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28155_c0_g1_i1	P70700	RPA2_MOUSE	55.2	125	45	2	364	23	840	964	5.30E-33	141.7	RPA2_MOUSE	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135)	Polr1b Rpa2 Rpo1-2	Mus musculus (Mouse)	1135	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005730; GO:0005736; GO:0005829; GO:0007566; GO:0009303; GO:0017126; GO:0032549; GO:0046872	embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN3770_c0_g1_i2	P20028	RPA2_DROME	57	235	100	1	744	40	837	1070	4.20E-78	292.7	RPA2_DROME	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (RPA135)	RpI135 CG4033	Drosophila melanogaster (Fruit fly)	1129	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0032549; GO:0046872	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN3770_c0_g1_i4	P20028	RPA2_DROME	46.9	870	441	8	2643	40	220	1070	5.20E-234	812.4	RPA2_DROME	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (RPA135)	RpI135 CG4033	Drosophila melanogaster (Fruit fly)	1129	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0032549; GO:0046872	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN3770_c0_g1_i7	P20028	RPA2_DROME	57.7	227	95	1	727	47	837	1062	1.60E-74	280.8	RPA2_DROME	reviewed	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (RPA135)	RpI135 CG4033	Drosophila melanogaster (Fruit fly)	1129	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0032549; GO:0046872	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN5524_c0_g2_i1	P38420	NRPB2_ARATH	61.6	138	53	0	414	1	261	398	3.60E-46	185.7	NRPB2_ARATH	reviewed	DNA-directed RNA polymerase II subunit 2 (DNA-directed RNA polymerase II 135 kDa polypeptide) (DNA-directed RNA polymerase II subunit RPB2) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (Protein EMBRYO DEFECTIVE 1989)	NRPB2 EMB1989 RP140 RPB135 RPB2 At4g21710 F17L22.170	Arabidopsis thaliana (Mouse-ear cress)	1188	"cytosol [GO:0005829]; plasmodesma [GO:0009506]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; transcription, DNA-templated [GO:0006351]"	"cytosol [GO:0005829]; plasmodesma [GO:0009506]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005665; GO:0005829; GO:0006351; GO:0009506; GO:0032549; GO:0035196; GO:0046872	"production of miRNAs involved in gene silencing by miRNA [GO:0035196]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37017_c0_g1_i1	Q8SSC4	RPB1_ENCCU	66.7	75	25	0	2	226	34	108	6.70E-25	114.4	RPB1_ENCCU	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit 1) (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RPB1 ECU03_0290	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1599	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN28281_c0_g1_i1	P36594	RPB1_SCHPO	71.9	89	25	0	270	4	1364	1452	7.10E-35	147.5	RPB1_SCHPO	reviewed	DNA-directed RNA polymerase II subunit rpb1 (RNA polymerase II subunit 1) (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	rpb1 SPBC28F2.12	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1752	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0000790; GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN29277_c0_g1_i1	Q8SSC4	RPB1_ENCCU	70.6	68	20	0	206	3	234	301	7.50E-21	100.5	RPB1_ENCCU	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit 1) (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RPB1 ECU03_0290	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1599	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN27011_c0_g1_i1	Q8SSC4	RPB1_ENCCU	72.7	77	18	1	8	229	1040	1116	1.70E-21	102.8	RPB1_ENCCU	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit 1) (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RPB1 ECU03_0290	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1599	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN29246_c0_g1_i1	A5DCV3	RPB1_PICGU	68.7	115	36	0	2	346	861	975	9.40E-40	164.1	RPB1_PICGU	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit 1) (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (Fragments)	RPB1 PGUG_01108/01105	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	1579	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN38288_c0_g1_i1	P11414	RPB1_CRIGR	66.7	69	21	1	3	203	1432	1500	9.30E-17	87	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN36754_c0_g1_i1	P11414	RPB1_CRIGR	100	216	0	0	649	2	396	611	3.80E-127	455.3	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN26949_c0_g1_i1	P11414	RPB1_CRIGR	99.4	329	2	0	989	3	612	940	4.00E-184	645.2	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN25666_c0_g1_i1	P11414	RPB1_CRIGR	100	374	0	0	11	1132	1	374	8.00E-221	767.3	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN30445_c0_g1_i1	P11414	RPB1_CRIGR	99.1	113	1	0	1	339	652	764	1.30E-57	223.4	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN40491_c0_g1_i1	P11414	RPB1_CRIGR	100	86	0	0	2	259	942	1027	1.40E-43	176.4	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN38871_c0_g1_i1	P11414	RPB1_CRIGR	100	255	0	0	767	3	1055	1309	3.80E-142	505.4	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN21621_c0_g1_i1	P11414	RPB1_CRIGR	100	186	0	0	2	559	1301	1486	2.30E-104	379.4	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001046; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN35146_c0_g1_i1	P04052	RPB1_DROME	85	80	12	0	3	242	1341	1420	7.30E-34	144.1	RPB1_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RpII215 CG1554	Drosophila melanogaster (Fruit fly)	1887	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN15346_c0_g1_i1	P14248	RPB1_PLAFD	70.4	270	79	1	6	815	347	615	2.30E-111	403.3	RPB1_PLAFD	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RPII	Plasmodium falciparum (isolate CDC / Honduras)	2452	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN29152_c0_g1_i1	P14248	RPB1_PLAFD	76.8	142	33	0	428	3	894	1035	5.00E-59	228.4	RPB1_PLAFD	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RPII	Plasmodium falciparum (isolate CDC / Honduras)	2452	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1699_c0_g1_i1	P35074	RPB1_CAEBR	76	25	6	0	63	137	554	578	1.60E-05	49.7	RPB1_CAEBR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	rpb-1 ama-1 CBG05355	Caenorhabditis briggsae	1853	"chromosome [GO:0005694]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"chromosome [GO:0005694]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005665; GO:0005694; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1699_c0_g1_i3	P04052	RPB1_DROME	68.3	41	13	0	82	204	6	46	1.20E-08	60.5	RPB1_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RpII215 CG1554	Drosophila melanogaster (Fruit fly)	1887	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1699_c0_g1_i4	P04052	RPB1_DROME	80.5	1489	288	2	82	4545	6	1493	0	2496.1	RPB1_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RpII215 CG1554	Drosophila melanogaster (Fruit fly)	1887	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN39401_c0_g1_i1	P04052	RPB1_DROME	81.3	75	14	0	1	225	241	315	6.40E-29	127.5	RPB1_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RpII215 CG1554	Drosophila melanogaster (Fruit fly)	1887	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN39458_c0_g1_i1	P04052	RPB1_DROME	58	88	32	1	6	254	736	823	9.50E-21	100.5	RPB1_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RpII215 CG1554	Drosophila melanogaster (Fruit fly)	1887	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN17029_c0_g2_i1	Q32P79	RPB11_BOVIN	100	117	0	0	385	35	1	117	6.10E-62	238	RPB11_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB11 (RNA polymerase II subunit B11) (DNA-directed RNA polymerase II subunit J)	POLR2J	Bos taurus (Bovine)	117	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]	GO:0001055; GO:0003677; GO:0005634; GO:0005665; GO:0006366; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN17029_c0_g1_i1	Q32P79	RPB11_BOVIN	100	117	0	0	400	50	1	117	2.20E-62	239.6	RPB11_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB11 (RNA polymerase II subunit B11) (DNA-directed RNA polymerase II subunit J)	POLR2J	Bos taurus (Bovine)	117	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]	GO:0001055; GO:0003677; GO:0005634; GO:0005665; GO:0006366; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN5018_c0_g1_i1	Q7PVQ9	RPB11_ANOGA	82.2	118	20	1	93	446	1	117	1.30E-51	204.1	RPB11_ANOGA	reviewed	DNA-directed RNA polymerase II subunit RPB11 (RNA polymerase II subunit B11) (DNA-directed RNA polymerase II subunit J)	Rpb11 AGAP009209	Anopheles gambiae (African malaria mosquito)	117	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]"	"RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]	GO:0001055; GO:0003677; GO:0005665; GO:0046983			blue	blue	NA	NA	NA	NA
TRINITY_DN22972_c1_g1_i1	P30876	RPB2_HUMAN	100	67	0	0	2	202	777	843	2.10E-31	135.6	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22972_c0_g1_i1	P30876	RPB2_HUMAN	100	277	0	0	831	1	520	796	2.70E-157	555.8	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28378_c0_g1_i1	P30876	RPB2_HUMAN	100	135	0	0	2	406	216	350	9.20E-71	267.3	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20268_c0_g1_i1	P30876	RPB2_HUMAN	99.5	210	1	0	632	3	9	218	1.70E-119	429.9	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20268_c0_g1_i2	P30876	RPB2_HUMAN	99	210	2	0	632	3	9	218	1.40E-118	426.8	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20268_c0_g1_i4	P30876	RPB2_HUMAN	100	218	0	0	656	3	1	218	1.80E-125	449.9	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26551_c0_g1_i1	P30876	RPB2_HUMAN	100	170	0	0	513	4	351	520	6.20E-96	351.3	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4309_c0_g2_i1	P30876	RPB2_HUMAN	61.2	345	130	3	1031	3	661	1003	2.90E-121	436.4	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36903_c0_g1_i1	P30876	RPB2_HUMAN	100	76	0	0	232	5	1099	1174	2.70E-38	158.7	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16915_c0_g1_i1	P30876	RPB2_HUMAN	100	364	0	0	1094	3	787	1150	2.00E-216	752.7	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16915_c0_g1_i2	P30876	RPB2_HUMAN	100	130	0	0	392	3	1021	1150	1.90E-73	276.2	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29782_c0_g1_i1	P30876	RPB2_HUMAN	97.6	126	3	0	2	379	356	481	5.40E-65	248.1	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36789_c0_g1_i1	P30876	RPB2_HUMAN	98.8	82	1	0	247	2	487	568	2.10E-41	169.1	RPB2_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	POLR2B	Homo sapiens (Human)	1174	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0035019; GO:0042795; GO:0046872; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7892_c0_g1_i1	Q8SR75	RPB2_ENCCU	70	60	18	0	24	203	1049	1108	9.20E-19	93.6	RPB2_ENCCU	reviewed	DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6)	RPB2 ECU10_0250	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1141	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0006351; GO:0032549; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24642_c0_g1_i1	Q8SR75	RPB2_ENCCU	73.5	166	37	1	3	479	620	785	4.80E-66	251.9	RPB2_ENCCU	reviewed	DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6)	RPB2 ECU10_0250	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1141	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0006351; GO:0032549; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4309_c0_g1_i1	Q54J75	RPB2_DICDI	72.7	172	47	0	3	518	995	1166	1.40E-72	273.9	RPB2_DICDI	reviewed	DNA-directed RNA polymerase II subunit rpb2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6)	polr2b rpb2 DDB_G0288257	Dictyostelium discoideum (Slime mold)	1170	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase II [GO:0006366]"	"RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0032549; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN25823_c0_g1_i1	Q8SR75	RPB2_ENCCU	73.4	128	33	1	5	385	857	984	1.70E-50	199.9	RPB2_ENCCU	reviewed	DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6)	RPB2 ECU10_0250	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1141	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005634; GO:0006351; GO:0032549; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	1	NA	NA	NA
TRINITY_DN5524_c0_g1_i1	Q02061	RPB2_SCHPO	64.9	151	53	0	459	7	436	586	8.10E-55	214.5	RPB2_SCHPO	reviewed	DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (DNA-directed RNA polymerase II 138 kDa polypeptide)	rpb2 SPAC23G3.01 SPAC521.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1210	"cytosol [GO:0005829]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; heterochromatin assembly by small RNA [GO:0031048]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0031048; GO:0031618; GO:0032549; GO:0046872	heterochromatin assembly by small RNA [GO:0031048]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1410_c0_g1_i1	P08266	RPB2_DROME	85	1172	176	0	114	3629	5	1176	0	2062.3	RPB2_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide)	RpII140 CG3180	Drosophila melanogaster (Fruit fly)	1176	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase II [GO:0006366]"	"RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0032549; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1410_c0_g1_i2	P08266	RPB2_DROME	85.8	614	87	0	87	1928	563	1176	0	1091.6	RPB2_DROME	reviewed	DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide)	RpII140 CG3180	Drosophila melanogaster (Fruit fly)	1176	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase II [GO:0006366]"	"RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0032549; GO:0046872	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN39037_c0_g1_i1	P19387	RPB3_HUMAN	99.6	264	1	0	35	826	1	264	8.30E-151	534.3	RPB3_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II 33 kDa polypeptide) (RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31)	POLR2C A-152E5.7	Homo sapiens (Human)	275	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0000398; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0015630; GO:0016070; GO:0035019; GO:0042795; GO:0046983; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6855_c1_g2_i1	P97760	RPB3_MOUSE	68	275	88	0	923	99	1	275	2.70E-111	403.3	RPB3_MOUSE	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II 33 kDa polypeptide) (RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31)	Polr2c Rpo2-3	Mus musculus (Mouse)	275	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005737; GO:0005829; GO:0006366; GO:0015630; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN37899_c0_g1_i1	Q3T0Q3	RPB3_BOVIN	55.1	49	22	0	85	231	212	260	2.00E-09	62.8	RPB3_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)	POLR2C	Bos taurus (Bovine)	275	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0015630; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN34466_c0_g1_i1	Q3T0Q3	RPB3_BOVIN	100	80	0	0	266	27	196	275	1.20E-39	163.3	RPB3_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)	POLR2C	Bos taurus (Bovine)	275	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0015630; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN20267_c0_g1_i1	Q3T0Q3	RPB3_BOVIN	100	123	0	0	1	369	75	197	1.80E-68	259.6	RPB3_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)	POLR2C	Bos taurus (Bovine)	275	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0015630; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN8027_c0_g1_i1	Q3T0Q3	RPB3_BOVIN	45.3	86	45	2	254	3	9	94	4.90E-15	81.6	RPB3_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)	POLR2C	Bos taurus (Bovine)	275	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0015630; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN6855_c1_g2_i2	Q3T0Q3	RPB3_BOVIN	60	60	24	0	278	99	216	275	1.50E-14	80.5	RPB3_BOVIN	reviewed	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)	POLR2C	Bos taurus (Bovine)	275	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0015630; GO:0046983	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN652_c0_g1_i1	O15514	RPB4_HUMAN	73	141	36	1	87	509	4	142	2.70E-47	189.9	RPB4_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16)	POLR2D	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]"	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]	GO:0000166; GO:0000288; GO:0000398; GO:0000932; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0035019; GO:0042795; GO:0045948; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN652_c0_g1_i2	O15514	RPB4_HUMAN	73	141	36	1	87	509	4	142	2.70E-47	189.9	RPB4_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16)	POLR2D	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]"	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]	GO:0000166; GO:0000288; GO:0000398; GO:0000932; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0035019; GO:0042795; GO:0045948; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN652_c0_g1_i4	O15514	RPB4_HUMAN	73	141	36	1	87	509	4	142	2.70E-47	189.9	RPB4_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16)	POLR2D	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]"	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]	GO:0000166; GO:0000288; GO:0000398; GO:0000932; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0035019; GO:0042795; GO:0045948; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN652_c0_g1_i5	O15514	RPB4_HUMAN	73	141	36	1	87	509	4	142	2.70E-47	189.9	RPB4_HUMAN	reviewed	DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16)	POLR2D	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]"	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]	GO:0000166; GO:0000288; GO:0000398; GO:0000932; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006283; GO:0006351; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0035019; GO:0042795; GO:0045948; GO:0050434; GO:0060964	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA export from nucleus in response to heat stress [GO:0031990]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral transcription [GO:0050434]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33006_c0_g1_i1	F4JXF9	NRPC1_ARATH	66.7	93	31	0	38	316	436	528	3.90E-32	138.7	NRPC1_ARATH	reviewed	DNA-directed RNA polymerase III subunit 1 (DNA-directed RNA polymerase III subunit RPC1) (DNA polymerase I subunit C1) (EC 2.7.7.6) (Nuclear RNA polymerase C1)	NRPC1 RPC1 At5g60040 MGO3.2	Arabidopsis thaliana (Mouse-ear cress)	1376	"RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription, DNA-templated [GO:0006351]"	RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005666; GO:0006351; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32328_c0_g1_i1	Q6BI69	RPC1_DEBHA	59.6	99	40	0	2	298	1332	1430	3.70E-27	122.1	RPC1_DEBHA	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	RPC1 DEHA2G12980g	Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii)	1457	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription, DNA-templated [GO:0006351]"	nuclear chromatin [GO:0000790]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0000790; GO:0003677; GO:0003899; GO:0006351; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8224_c0_g1_i12	O14802	RPC1_HUMAN	61.5	218	78	5	644	3	172	387	7.70E-67	255	RPC1_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160)	POLR3A	Homo sapiens (Human)	1390	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032481; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5361_c0_g1_i1	O14802	RPC1_HUMAN	60.7	476	179	3	1426	2	616	1084	5.30E-161	568.9	RPC1_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160)	POLR3A	Homo sapiens (Human)	1390	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032481; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2671_c0_g1_i2	P04051	RPC1_YEAST	55.7	79	34	1	262	29	1353	1431	1.80E-17	89.7	RPC1_YEAST	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RNA polymerase III subunit C160)	RPO31 RPC1 RPC160 YOR116C O3254 YOR3254C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1460	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; termination of RNA polymerase III transcription [GO:0006386]; tRNA transcription by RNA polymerase III [GO:0042797]	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0006386; GO:0042797; GO:0046872	termination of RNA polymerase III transcription [GO:0006386]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN2671_c0_g1_i1	O94666	RPC1_SCHPO	62	108	41	0	352	29	1270	1377	9.50E-33	141	RPC1_SCHPO	reviewed	DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RPC158)	rpc1 SPBC651.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1405	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0000790; GO:0003677; GO:0003899; GO:0005666; GO:0005737; GO:0006383; GO:0046872	transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN27287_c0_g1_i1	O94666	RPC1_SCHPO	61	77	30	0	2	232	751	827	2.90E-21	102.1	RPC1_SCHPO	reviewed	DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RPC158)	rpc1 SPBC651.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1405	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0000790; GO:0003677; GO:0003899; GO:0005666; GO:0005737; GO:0006383; GO:0046872	transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN8224_c0_g1_i4	Q5ZL98	RPC1_CHICK	47.5	59	30	1	179	3	379	436	4.20E-10	65.1	RPC1_CHICK	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A RCJMB04_7b9	Gallus gallus (Chicken)	1390	"RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription, DNA-templated [GO:0006351]"	RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005666; GO:0006351; GO:0046872	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8224_c0_g1_i5	A4IF62	RPC1_BOVIN	56.4	110	47	1	417	88	2	110	3.00E-30	132.9	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8224_c0_g1_i6	A4IF62	RPC1_BOVIN	54.4	439	191	8	1304	3	2	436	2.40E-131	470.3	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8224_c0_g1_i8	A4IF62	RPC1_BOVIN	51.4	142	67	2	577	155	2	142	1.40E-35	151	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8224_c0_g1_i9	A4IF62	RPC1_BOVIN	68.6	159	46	3	470	3	230	387	1.40E-53	210.7	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4005_c1_g1_i1	A4IF62	RPC1_BOVIN	58.8	34	14	0	266	165	1314	1347	8.30E-05	47.8	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4005_c1_g1_i2	A4IF62	RPC1_BOVIN	75	36	9	0	408	301	1312	1347	1.00E-08	61.2	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8074_c0_g1_i1	Q86AQ5	RPC1_DICDI	78.9	90	19	0	272	3	428	517	2.40E-38	159.1	RPC1_DICDI	reviewed	DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	polr3a rpc1 DDB_G0277199	Dictyostelium discoideum (Slime mold)	1450	RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]	RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872	transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN25658_c0_g1_i1	Q86AQ5	RPC1_DICDI	72.5	80	22	0	241	2	1091	1170	1.10E-23	110.2	RPC1_DICDI	reviewed	DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	polr3a rpc1 DDB_G0277199	Dictyostelium discoideum (Slime mold)	1450	RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]	RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872	transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN3289_c0_g1_i1	Q86AQ5	RPC1_DICDI	73.7	95	25	0	3	287	809	903	1.40E-33	143.3	RPC1_DICDI	reviewed	DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	polr3a rpc1 DDB_G0277199	Dictyostelium discoideum (Slime mold)	1450	RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]	RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872	transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN9001_c0_g1_i1	A4IF62	RPC1_BOVIN	65.9	138	47	0	456	43	1251	1388	2.40E-46	186.8	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9001_c0_g1_i2	A4IF62	RPC1_BOVIN	72.2	169	47	0	549	43	1220	1388	1.40E-64	247.3	RPC1_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	POLR3A	Bos taurus (Bovine)	1390	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29468_c0_g1_i1	Q9Y2Y1	RPC10_HUMAN	100	77	0	0	2	232	32	108	6.60E-43	174.1	RPC10_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11)	POLR3K RPC11 My010	Homo sapiens (Human)	108	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of type I interferon production [GO:0032481]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005730; GO:0005829; GO:0006383; GO:0006386; GO:0008270; GO:0032481; GO:0042779; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of type I interferon production [GO:0032481]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779]		NA	NA	NA	NA	NA	NA
TRINITY_DN35763_c0_g1_i1	Q9CQZ7	RPC10_MOUSE	71.3	108	31	0	337	14	1	108	5.70E-43	174.9	RPC10_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III subunit C11) (RPC11)	Polr3k	Mus musculus (Mouse)	108	nucleolus [GO:0005730]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; tRNA 3'-trailer cleavage [GO:0042779]	nucleolus [GO:0005730]; RNA polymerase III complex [GO:0005666]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003899; GO:0005666; GO:0005730; GO:0006386; GO:0008270; GO:0042779; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; tRNA 3'-trailer cleavage [GO:0042779]		blue	blue	NA	NA	NA	NA
TRINITY_DN11670_c0_g1_i1	Q10233	RPC2_SCHPO	64	89	32	0	272	6	647	735	5.50E-30	131.3	RPC2_SCHPO	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit 2) (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 130 kDa polypeptide) (RPC130)	rpc2 SPAC4G9.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1165	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; termination of RNA polymerase III transcription [GO:0006386]	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0000790; GO:0003677; GO:0003899; GO:0005666; GO:0005829; GO:0006386; GO:0032549; GO:0046872	termination of RNA polymerase III transcription [GO:0006386]		NA	NA	NA	NA	NA	NA
TRINITY_DN33526_c0_g1_i1	Q10233	RPC2_SCHPO	47.4	97	50	1	290	3	43	139	6.90E-20	97.8	RPC2_SCHPO	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit 2) (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 130 kDa polypeptide) (RPC130)	rpc2 SPAC4G9.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1165	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; termination of RNA polymerase III transcription [GO:0006386]	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0000790; GO:0003677; GO:0003899; GO:0005666; GO:0005829; GO:0006386; GO:0032549; GO:0046872	termination of RNA polymerase III transcription [GO:0006386]		NA	NA	NA	NA	NA	NA
TRINITY_DN36973_c0_g1_i1	Q9NW08	RPC2_HUMAN	53.8	65	29	1	41	232	160	224	2.10E-11	69.3	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	x	NA	NA	1	NA	NA	NA
TRINITY_DN25381_c0_g1_i1	Q9NW08	RPC2_HUMAN	59.9	269	103	1	6	812	866	1129	1.40E-92	340.9	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3660_c0_g1_i1	Q9NW08	RPC2_HUMAN	61.6	279	104	3	836	9	852	1130	7.10E-97	355.1	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40778_c0_g1_i1	Q9NW08	RPC2_HUMAN	99.2	129	1	0	3	389	989	1117	3.10E-71	268.9	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40756_c0_g1_i1	P59470	RPC2_MOUSE	100	64	0	0	213	22	1070	1133	6.90E-33	140.6	RPC2_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	Polr3b	Mus musculus (Mouse)	1133	"RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005666; GO:0006351; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13403_c0_g2_i1	Q9NW08	RPC2_HUMAN	69.4	1139	337	7	86	3502	4	1131	0	1635.9	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13403_c0_g2_i4	Q9NW08	RPC2_HUMAN	61.8	131	50	0	86	478	4	134	2.80E-46	186.4	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27317_c0_g1_i1	Q9NW08	RPC2_HUMAN	99	101	1	0	303	1	593	693	1.10E-55	216.9	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34787_c0_g1_i1	Q9NW08	RPC2_HUMAN	59.4	69	28	0	211	5	146	214	2.90E-15	82	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15981_c0_g1_i1	Q9NW08	RPC2_HUMAN	65.6	125	40	1	386	12	410	531	3.30E-44	179.1	RPC2_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	POLR3B	Homo sapiens (Human)	1133	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032481; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36692_c0_g1_i1	P22276	RPC2_YEAST	60	130	52	0	404	15	671	800	2.00E-41	169.9	RPC2_YEAST	reviewed	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 130 kDa polypeptide)	RET1 RPC128 RPC2 YOR207C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1149	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; termination of RNA polymerase III transcription [GO:0006386]; tRNA transcription by RNA polymerase III [GO:0042797]	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0006386; GO:0032549; GO:0042797; GO:0046872	termination of RNA polymerase III transcription [GO:0006386]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN40980_c0_g1_i1	Q91WD1	RPC4_MOUSE	100	53	0	0	3	161	346	398	1.90E-24	112.5	RPC4_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D)	Polr3d Bn51t	Mus musculus (Mouse)	398	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0000790; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0016607; GO:0032728; GO:0045087; GO:0045089; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN507_c0_g3_i1	P05423	RPC4_HUMAN	29.7	454	239	17	1414	110	1	393	2.00E-27	125.2	RPC4_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)	POLR3D BN51 BN51T	Homo sapiens (Human)	398	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0000790; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0016607; GO:0032481; GO:0032728; GO:0045087; GO:0045089; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN26839_c0_g1_i1	Q9CZT4	RPC5_MOUSE	42.7	457	248	7	1549	194	5	452	1.10E-90	335.5	RPC5_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC5 (RNA polymerase III subunit 5) (RNA polymerase III subunit C5) (Sex-lethal interactor homolog) (Sxl interactor)	Polr3e Sin	Mus musculus (Mouse)	710	"nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0045087; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN376_c0_g1_i26	Q921X6	RPC6_MOUSE	49.5	311	149	3	1003	92	5	314	1.10E-86	322	RPC6_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F)	Polr3f	Mus musculus (Mouse)	316	RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]	RNA polymerase III complex [GO:0005666]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]	GO:0003690; GO:0003899; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN376_c0_g1_i7	Q921X6	RPC6_MOUSE	49.5	311	149	3	1003	92	5	314	1.10E-86	322	RPC6_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F)	Polr3f	Mus musculus (Mouse)	316	RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]	RNA polymerase III complex [GO:0005666]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]	GO:0003690; GO:0003899; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN14634_c0_g1_i2	Q9D2C6	RPC8_MOUSE	60.1	143	57	0	741	313	1	143	7.80E-48	192.2	RPC8_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC8 (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit C7)	Polr3h	Mus musculus (Mouse)	204	centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]	centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0006139; GO:0006383; GO:0006384; GO:0043231; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN14634_c0_g1_i3	Q9D2C6	RPC8_MOUSE	56.9	202	87	0	707	102	1	202	9.40E-67	255	RPC8_MOUSE	reviewed	DNA-directed RNA polymerase III subunit RPC8 (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit C7)	Polr3h	Mus musculus (Mouse)	204	centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]	centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0006139; GO:0006383; GO:0006384; GO:0043231; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN14634_c0_g1_i1	Q2T9X1	RPC8_BOVIN	46.7	60	32	0	275	96	145	204	1.60E-10	67	RPC8_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit 22.9 kDa polypeptide) (DNA-directed RNA polymerase III subunit H)	POLR3H	Bos taurus (Bovine)	204	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006351; GO:0045087; GO:0051607	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25113_c0_g1_i1	Q9Y535	RPC8_HUMAN	100	74	0	0	223	2	101	174	4.10E-36	151.4	RPC8_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9)	POLR3H KIAA1665 RPC8	Homo sapiens (Human)	204	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0032481; GO:0043231; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN25113_c0_g1_i2	Q9Y535	RPC8_HUMAN	100	148	0	0	445	2	27	174	2.30E-83	309.3	RPC8_HUMAN	reviewed	DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9)	POLR3H KIAA1665 RPC8	Homo sapiens (Human)	204	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0032481; GO:0043231; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN12245_c0_g1_i1	A0JN61	RPC9_BOVIN	54.4	125	56	1	513	142	1	125	7.40E-29	128.6	RPC9_BOVIN	reviewed	DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9)	CRCP	Bos taurus (Bovine)	148	DNA polymerase III complex [GO:0009360]; plasma membrane [GO:0005886]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]	DNA polymerase III complex [GO:0009360]; plasma membrane [GO:0005886]; RNA polymerase III complex [GO:0005666]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003899; GO:0005666; GO:0005886; GO:0006383; GO:0006384; GO:0009360; GO:0045087; GO:0051607	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]		blue	blue	NA	NA	NA	NA
TRINITY_DN32545_c0_g1_i1	A5GVF3	RPOB_SYNR3	94.5	73	4	0	222	4	798	870	9.00E-36	150.2	RPOB_SYNR3	reviewed	DNA-directed RNA polymerase subunit beta (RNAP subunit beta) (EC 2.7.7.6) (RNA polymerase subunit beta) (Transcriptase subunit beta)	rpoB SynRCC307_1959	Synechococcus sp. (strain RCC307)	1097	"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"		DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0006351; GO:0032549	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20859_c0_g1_i1	B1YRC3	RPOC_BURA4	98.6	71	1	0	214	2	427	497	2.80E-34	145.2	RPOC_BURA4	reviewed	DNA-directed RNA polymerase subunit beta' (RNAP subunit beta') (EC 2.7.7.6) (RNA polymerase subunit beta') (Transcriptase subunit beta')	rpoC BamMC406_0269	Burkholderia ambifaria (strain MC40-6)	1413	"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"		DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]	GO:0000287; GO:0003677; GO:0003899; GO:0006351; GO:0008270	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30516_c0_g1_i1	Q6A6K7	RPOC_CUTAK	100	71	0	0	214	2	957	1027	4.40E-35	147.9	RPOC_CUTAK	reviewed	DNA-directed RNA polymerase subunit beta' (RNAP subunit beta') (EC 2.7.7.6) (RNA polymerase subunit beta') (Transcriptase subunit beta')	rpoC PPA1883	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	1293	"DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"		DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]	GO:0000287; GO:0003677; GO:0003899; GO:0006351; GO:0008270	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37889_c0_g1_i1	O15160	RPAC1_HUMAN	100	87	0	0	3	263	53	139	1.20E-42	173.3	RPAC1_HUMAN	reviewed	DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPA39) (RPC40)	POLR1C POLR1E	Homo sapiens (Human)	346	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005736; GO:0005829; GO:0006360; GO:0006361; GO:0006362; GO:0006363; GO:0006383; GO:0032481; GO:0045815; GO:0046983	"positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29835_c0_g1_i1	P52432	RPAC1_MOUSE	51	100	46	1	302	12	50	149	6.80E-26	117.9	RPAC1_MOUSE	reviewed	DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPC40)	Polr1c Rpo1-1	Mus musculus (Mouse)	346	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383; GO:0046983	transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN3093_c0_g1_i1	P52432	RPAC1_MOUSE	49.8	293	145	2	180	1055	50	341	4.40E-81	303.1	RPAC1_MOUSE	reviewed	DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPC40)	Polr1c Rpo1-1	Mus musculus (Mouse)	346	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383; GO:0046983	transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN38046_c0_g1_i1	P28000	RPAC2_YEAST	45.2	73	40	0	52	270	56	128	3.10E-14	79	RPAC2_YEAST	reviewed	DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerases I and III 16 kDa polypeptide) (RPA19)	RPC19 YNL113W N1937	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	142	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase I activity [GO:0001054]; ribosome biogenesis [GO:0042254]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase I [GO:0006360]; tRNA transcription by RNA polymerase III [GO:0042797]	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase I activity [GO:0001054]	GO:0001054; GO:0003677; GO:0005654; GO:0005666; GO:0005736; GO:0006360; GO:0006386; GO:0042254; GO:0042797; GO:0046983	ribosome biogenesis [GO:0042254]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase I [GO:0006360]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN5409_c0_g1_i1	Q1RMG8	RPAC2_BOVIN	44.2	104	57	1	410	102	20	123	2.70E-19	96.7	RPAC2_BOVIN	reviewed	DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (DNA-directed RNA polymerase I subunit D)	POLR1D	Bos taurus (Bovine)	133	"RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription, DNA-templated [GO:0006351]"	RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0003899; GO:0005666; GO:0005736; GO:0006351; GO:0046983	"transcription, DNA-templated [GO:0006351]"		blue	blue	NA	NA	NA	NA
TRINITY_DN29126_c0_g1_i1	Q80UW8	RPAB1_MOUSE	100	106	0	0	1	318	59	164	4.00E-53	208.4	RPAB1_MOUSE	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog)"	Polr2e	Mus musculus (Mouse)	210	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1611_c4_g1_i1	Q5R587	RPAB1_PONAB	84.2	209	33	0	718	92	1	209	1.90E-99	363.6	RPAB1_PONAB	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog)"	POLR2E	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	210	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1611_c0_g1_i1	Q5R587	RPAB1_PONAB	99.5	197	1	0	640	50	14	210	6.70E-108	391.3	RPAB1_PONAB	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog)"	POLR2E	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	210	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1611_c2_g1_i1	Q80UW8	RPAB1_MOUSE	100	67	0	0	201	1	1	67	1.80E-33	142.9	RPAB1_MOUSE	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog)"	Polr2e	Mus musculus (Mouse)	210	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN26276_c0_g1_i1	Q54EH2	RPAB1_DICDI	70.1	67	20	0	277	77	131	197	1.00E-20	100.5	RPAB1_DICDI	reviewed	"DNA-directed RNA polymerases I, II, and III subunit rpabc1 (RNA polymerases I, II, and III subunit ABC1) (RPB5 homolog)"	polr2e rpb5 DDB_G0291636	Dictyostelium discoideum (Slime mold)	197	"RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]"	"RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005665; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383	transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN2795_c0_g1_i1	P20435	RPAB2_YEAST	53.8	78	36	0	291	58	77	154	3.40E-20	99	RPAB2_YEAST	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (ABC23) (DNA-directed RNA polymerases I, II, and III 23 kDa polypeptide)"	RPO26 RPB6 YPR187W P9677.8	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	155	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; ribosome biogenesis [GO:0042254]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription, RNA-templated [GO:0001172]; tRNA transcription by RNA polymerase III [GO:0042797]"	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]"	DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]	GO:0001054; GO:0001172; GO:0003677; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005737; GO:0006360; GO:0006366; GO:0006383; GO:0006386; GO:0042254; GO:0042797	"ribosome biogenesis [GO:0042254]; termination of RNA polymerase III transcription [GO:0006386]; transcription, RNA-templated [GO:0001172]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8300_c0_g1_i1	P20435	RPAB2_YEAST	74	77	20	0	69	299	76	152	1.40E-26	120.2	RPAB2_YEAST	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (ABC23) (DNA-directed RNA polymerases I, II, and III 23 kDa polypeptide)"	RPO26 RPB6 YPR187W P9677.8	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	155	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; ribosome biogenesis [GO:0042254]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription, RNA-templated [GO:0001172]; tRNA transcription by RNA polymerase III [GO:0042797]"	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]"	DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]	GO:0001054; GO:0001172; GO:0003677; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005737; GO:0006360; GO:0006366; GO:0006383; GO:0006386; GO:0042254; GO:0042797	"ribosome biogenesis [GO:0042254]; termination of RNA polymerase III transcription [GO:0006386]; transcription, RNA-templated [GO:0001172]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11453_c0_g1_i1	P61219	RPAB2_MOUSE	78.7	94	19	1	381	100	35	127	9.30E-35	147.9	RPAB2_MOUSE	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)"	Polr2f	Mus musculus (Mouse)	127	"fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0001650; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0006366	transcription by RNA polymerase II [GO:0006366]		blue	blue	NA	NA	NA	NA
TRINITY_DN12870_c0_g1_i1	Q32PE0	RPAB2_BOVIN	98	99	2	0	371	75	29	127	1.20E-48	193.7	RPAB2_BOVIN	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)"	POLR2F	Bos taurus (Bovine)	127	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN12870_c0_g2_i1	Q32PE0	RPAB2_BOVIN	98.9	93	1	0	354	76	35	127	3.10E-46	185.7	RPAB2_BOVIN	reviewed	"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)"	POLR2F	Bos taurus (Bovine)	127	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN37566_c0_g1_i1	Q39211	NRPB3_ARATH	60	70	28	0	224	15	10	79	1.10E-15	83.6	NRPB3_ARATH	reviewed	"DNA-directed RNA polymerases II, IV and V subunit 3 (DNA-directed RNA polymerase II 36 kDa polypeptide A) (DNA-directed RNA polymerase II subunit RPB3-A) (RNA polymerase II subunit 3-A) (RNA polymerase II subunit B3-A)"	NRPB3 NRPD3 NRPE3A RPB36A At2g15430 F26H6.5	Arabidopsis thaliana (Mouse-ear cress)	319	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase IV complex [GO:0000418]; RNA polymerase V complex [GO:0000419]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; stomatal complex development [GO:0010374]; stomatal complex patterning [GO:0010375]; transcription, DNA-templated [GO:0006351]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase IV complex [GO:0000418]; RNA polymerase V complex [GO:0000419]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	GO:0000418; GO:0000419; GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005730; GO:0005737; GO:0006351; GO:0010374; GO:0010375; GO:0046983	"stomatal complex development [GO:0010374]; stomatal complex patterning [GO:0010375]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35918_c0_g1_i1	Q9VPQ2	DJSHV_DROME	62.7	110	38	2	360	40	6	115	9.50E-31	134.4	DJSHV_DROME	reviewed	DnaJ homolog shv (Protein shriveled)	shv CG4164	Drosophila melanogaster (Fruit fly)	354	extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; unfolded protein binding [GO:0051082]; cell adhesion [GO:0007155]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell population maintenance [GO:0036098]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of synapse maturation [GO:0090129]; protein folding [GO:0006457]	extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; unfolded protein binding [GO:0051082]	GO:0005178; GO:0005615; GO:0005634; GO:0005886; GO:0006457; GO:0007155; GO:0031594; GO:0036098; GO:0051082; GO:0060250; GO:0090129; GO:2001046	cell adhesion [GO:0007155]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell population maintenance [GO:0036098]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of synapse maturation [GO:0090129]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN38980_c0_g1_i1	Q9VPQ2	DJSHV_DROME	71.5	239	68	0	748	32	116	354	9.30E-101	367.9	DJSHV_DROME	reviewed	DnaJ homolog shv (Protein shriveled)	shv CG4164	Drosophila melanogaster (Fruit fly)	354	extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; unfolded protein binding [GO:0051082]; cell adhesion [GO:0007155]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell population maintenance [GO:0036098]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of synapse maturation [GO:0090129]; protein folding [GO:0006457]	extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; unfolded protein binding [GO:0051082]	GO:0005178; GO:0005615; GO:0005634; GO:0005886; GO:0006457; GO:0007155; GO:0031594; GO:0036098; GO:0051082; GO:0060250; GO:0090129; GO:2001046	cell adhesion [GO:0007155]; germ-line stem-cell niche homeostasis [GO:0060250]; male germ-line stem cell population maintenance [GO:0036098]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of synapse maturation [GO:0090129]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11897_c0_g1_i3	Q5NVI9	DNJA1_PONAB	66	400	128	6	95	1282	1	396	2.00E-146	520.4	DNJA1_PONAB	reviewed	DnaJ homolog subfamily A member 1	DNAJA1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	396	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585	negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN19257_c0_g1_i1	Q5E954	DNJA1_BOVIN	44.9	69	38	0	37	243	262	330	1.20E-12	73.6	DNJA1_BOVIN	reviewed	DnaJ homolog subfamily A member 1	DNAJA1	Bos taurus (Bovine)	397	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0006457; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0070585	androgen receptor signaling pathway [GO:0030521]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11897_c0_g1_i2	Q95JF4	DNAJ1_CHLAE	76.5	51	12	0	95	247	1	51	1.70E-16	86.7	DNAJ1_CHLAE	reviewed	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (DJ-2) (Mydj2)	DNAJA1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	397	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585	negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN6299_c0_g1_i1	P63037	DNJA1_MOUSE	100	358	0	0	1079	6	1	358	2.60E-208	725.7	DNJA1_MOUSE	reviewed	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2)	Dnaja1 Dnaj2 Hsj2 Hspf4	Mus musculus (Mouse)	397	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0006457; GO:0007283; GO:0009408; GO:0015630; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070585; GO:1901998; GO:1903748; GO:1905259	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6299_c0_g1_i2	P31689	DNJA1_HUMAN	100	358	0	0	1079	6	1	358	3.40E-208	725.3	DNJA1_HUMAN	reviewed	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	Homo sapiens (Human)	397	"cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0015630; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259	"androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2965_c0_g1_i1	Q2HJ94	DNJA2_BOVIN	55.3	421	169	4	33	1274	4	412	9.40E-128	458.4	DNJA2_BOVIN	reviewed	DnaJ homolog subfamily A member 2	DNAJA2	Bos taurus (Bovine)	412	cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytosol [GO:0005829]; membrane [GO:0016020]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005829; GO:0006457; GO:0009408; GO:0016020; GO:0031072; GO:0046872; GO:0051082	protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN28269_c0_g1_i1	Q2HJ94	DNJA2_BOVIN	97.6	84	2	0	253	2	1	84	2.10E-40	166	DNJA2_BOVIN	reviewed	DnaJ homolog subfamily A member 2	DNAJA2	Bos taurus (Bovine)	412	cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to heat [GO:0009408]	cytosol [GO:0005829]; membrane [GO:0016020]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005829; GO:0006457; GO:0009408; GO:0016020; GO:0031072; GO:0046872; GO:0051082	protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN11144_c0_g1_i1	O60884	DNJA2_HUMAN	100	199	0	0	3	599	92	290	2.50E-112	406	DNJA2_HUMAN	reviewed	DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)	DNAJA2 CPR3 HIRIP4	Homo sapiens (Human)	412	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005829; GO:0008284; GO:0009408; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0070062	positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN11144_c0_g1_i2	O60884	DNJA2_HUMAN	100	112	0	0	3	338	92	203	6.80E-59	227.6	DNJA2_HUMAN	reviewed	DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)	DNAJA2 CPR3 HIRIP4	Homo sapiens (Human)	412	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005829; GO:0008284; GO:0009408; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0070062	positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN35904_c0_g1_i1	Q9QYJ0	DNJA2_MOUSE	100	87	0	0	1	261	286	372	1.30E-46	186.4	DNJA2_MOUSE	reviewed	DnaJ homolog subfamily A member 2 (mDj3)	Dnaja2	Mus musculus (Mouse)	412	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activator activity [GO:0001671]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005634; GO:0005829; GO:0009408; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087	protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN39883_c0_g1_i1	Q8WW22	DNJA4_HUMAN	56	50	21	1	79	228	210	258	1.50E-08	60.1	DNJA4_HUMAN	reviewed	DnaJ homolog subfamily A member 4	DNAJA4	Homo sapiens (Human)	397	cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0009408; GO:0010596; GO:0010628; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0090084	negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN11897_c0_g1_i1	Q9JMC3	DNJA4_MOUSE	83.6	67	11	0	95	295	1	67	2.50E-25	116.3	DNJA4_MOUSE	reviewed	DnaJ homolog subfamily A member 4 (MmDjA4)	Dnaja4	Mus musculus (Mouse)	397	cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0009408; GO:0010596; GO:0010628; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0090084	negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i1	Q3MI00	DNJB1_BOVIN	66	47	16	0	257	117	3	49	4.40E-12	72	DNJB1_BOVIN	reviewed	DnaJ homolog subfamily B member 1	DNAJB1	Bos taurus (Bovine)	340	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0001671; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0030544; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0097201	chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]		NA	NA	NA	NA	NA	NA
TRINITY_DN17255_c0_g1_i1	Q3MI00	DNJB1_BOVIN	97.5	79	2	0	59	295	1	79	3.30E-37	155.6	DNJB1_BOVIN	reviewed	DnaJ homolog subfamily B member 1	DNAJB1	Bos taurus (Bovine)	340	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0001671; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0030544; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0097201	chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]		NA	NA	NA	NA	NA	NA
TRINITY_DN17503_c0_g1_i1	Q3MI00	DNJB1_BOVIN	99.1	116	1	0	349	2	168	283	4.00E-62	238.4	DNJB1_BOVIN	reviewed	DnaJ homolog subfamily B member 1	DNAJB1	Bos taurus (Bovine)	340	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0001671; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0030544; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0090084; GO:0097201	chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]		NA	NA	NA	NA	NA	NA
TRINITY_DN17255_c0_g1_i2	P25685	DNJB1_HUMAN	94.3	106	6	0	59	376	1	106	1.00E-47	190.7	DNJB1_HUMAN	reviewed	DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1)	DNAJB1 DNAJ1 HDJ1 HSPF1	Homo sapiens (Human)	340	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm head [GO:0061827]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm head [GO:0061827]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0001671; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006986; GO:0030544; GO:0030900; GO:0032781; GO:0043025; GO:0043197; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0061827; GO:0070062; GO:0090084; GO:0097201; GO:0098978; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN39913_c0_g1_i1	P25685	DNJB1_HUMAN	100	160	0	0	3	482	172	331	3.60E-90	332	DNJB1_HUMAN	reviewed	DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1)	DNAJB1 DNAJ1 HDJ1 HSPF1	Homo sapiens (Human)	340	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm head [GO:0061827]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm head [GO:0061827]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0001671; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006986; GO:0030544; GO:0030900; GO:0032781; GO:0043025; GO:0043197; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0061827; GO:0070062; GO:0090084; GO:0097201; GO:0098978; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN27627_c0_g1_i1	Q9UBS4	DJB11_HUMAN	100	249	0	0	3	749	110	358	1.60E-145	516.5	DJB11_HUMAN	reviewed	DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4)	DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080	Homo sapiens (Human)	358	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	unfolded protein binding [GO:0051082]	GO:0005783; GO:0005788; GO:0006457; GO:0016020; GO:0032781; GO:0036498; GO:0051082; GO:0051604	IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN10554_c0_g1_i4	Q9UBS4	DJB11_HUMAN	100	103	0	0	310	2	1	103	4.40E-52	204.9	DJB11_HUMAN	reviewed	DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4)	DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080	Homo sapiens (Human)	358	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	unfolded protein binding [GO:0051082]	GO:0005783; GO:0005788; GO:0006457; GO:0016020; GO:0032781; GO:0036498; GO:0051082; GO:0051604	IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN38477_c0_g1_i1	Q99KV1	DJB11_MOUSE	100	91	0	0	275	3	225	315	4.00E-49	194.9	DJB11_MOUSE	reviewed	DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p)	Dnajb11	Mus musculus (Mouse)	358	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]	signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]	GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0016556; GO:0032781; GO:0034663; GO:0050768; GO:0051082; GO:0051604	mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN10554_c0_g1_i2	Q99KV1	DJB11_MOUSE	100	111	0	0	334	2	1	111	7.80E-58	224.2	DJB11_MOUSE	reviewed	DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p)	Dnajb11	Mus musculus (Mouse)	358	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]	signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]	GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0016556; GO:0032781; GO:0034663; GO:0050768; GO:0051082; GO:0051604	mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN31609_c0_g1_i1	Q3ZBA6	DJB11_BOVIN	100	97	0	0	292	2	132	228	1.30E-50	199.9	DJB11_BOVIN	reviewed	DnaJ homolog subfamily B member 11 (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p)	DNAJB11	Bos taurus (Bovine)	358	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]	signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]	GO:0005102; GO:0005615; GO:0005634; GO:0005788; GO:0006457; GO:0016556; GO:0050768; GO:0051082; GO:0051604	mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN10622_c0_g2_i2	Q9NXW2	DJB12_HUMAN	38.5	182	100	3	96	632	197	369	1.70E-27	124.4	DJB12_HUMAN	reviewed	DnaJ homolog subfamily B member 12	DNAJB12	Homo sapiens (Human)	375	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	Hsp70 protein binding [GO:0030544]	GO:0005783; GO:0005789; GO:0016020; GO:0016032; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218	cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN39680_c0_g1_i1	Q9NXW2	DJB12_HUMAN	100	99	0	0	299	3	101	199	2.40E-52	205.7	DJB12_HUMAN	reviewed	DnaJ homolog subfamily B member 12	DNAJB12	Homo sapiens (Human)	375	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	Hsp70 protein binding [GO:0030544]	GO:0005783; GO:0005789; GO:0016020; GO:0016032; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218	cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN10622_c0_g2_i1	Q9QYI4	DJB12_MOUSE	44.3	307	156	4	59	970	76	370	1.40E-65	251.5	DJB12_MOUSE	reviewed	DnaJ homolog subfamily B member 12 (mDj10)	Dnajb12	Mus musculus (Mouse)	376	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]	Hsp70 protein binding [GO:0030544]	GO:0005783; GO:0005789; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218	cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN10622_c0_g1_i1	Q0IIE8	DJB14_BOVIN	40.3	72	43	0	223	8	2	73	1.30E-07	57	DJB14_BOVIN	reviewed	DnaJ homolog subfamily B member 14	DNAJB14	Bos taurus (Bovine)	379	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	Hsp70 protein binding [GO:0030544]	GO:0005783; GO:0005789; GO:0016021; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0051085; GO:0071218	cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN35364_c0_g1_i1	Q9QYI5	DNJB2_MOUSE	41.1	265	98	5	891	103	1	209	1.80E-27	124.8	DNJB2_MOUSE	reviewed	DnaJ homolog subfamily B member 2 (DnaJ homolog subfamily B member 10) (mDj8)	Dnajb2 Dnajb10	Mus musculus (Mouse)	324	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; positive regulation of ATPase activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016234; GO:0030308; GO:0030433; GO:0030544; GO:0031227; GO:0031396; GO:0031398; GO:0031593; GO:0031625; GO:0031965; GO:0032091; GO:0032436; GO:0032781; GO:0032880; GO:0042026; GO:0043130; GO:0043161; GO:0048471; GO:0051082; GO:0051087; GO:0061077; GO:0070628; GO:0090084; GO:0090086; GO:0140036; GO:1903644	chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; positive regulation of ATPase activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN34796_c0_g1_i1	Q9QYI5	DNJB2_MOUSE	64.3	70	25	0	216	7	4	73	5.40E-22	104.8	DNJB2_MOUSE	reviewed	DnaJ homolog subfamily B member 2 (DnaJ homolog subfamily B member 10) (mDj8)	Dnajb2 Dnajb10	Mus musculus (Mouse)	324	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; positive regulation of ATPase activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016234; GO:0030308; GO:0030433; GO:0030544; GO:0031227; GO:0031396; GO:0031398; GO:0031593; GO:0031625; GO:0031965; GO:0032091; GO:0032436; GO:0032781; GO:0032880; GO:0042026; GO:0043130; GO:0043161; GO:0048471; GO:0051082; GO:0051087; GO:0061077; GO:0070628; GO:0090084; GO:0090086; GO:0140036; GO:1903644	chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; positive regulation of ATPase activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN40529_c0_g1_i1	Q8WWF6	DNJB3_HUMAN	57.1	77	33	0	231	1	4	80	6.50E-19	94.4	DNJB3_HUMAN	reviewed	DnaJ homolog subfamily B member 3	DNAJB3 HCG3	Homo sapiens (Human)	145							NA	NA	NA	NA	NA	NA
TRINITY_DN28401_c0_g1_i1	Q862Z4	DNJB3_MACFU	63.3	60	22	0	198	19	11	70	4.90E-15	81.3	DNJB3_MACFU	reviewed	DnaJ homolog subfamily B member 3 (Spermatogenic cell-specific DNAJ homolog)	DNAJB3 MFSJ1	Macaca fuscata fuscata (Japanese macaque)	242							NA	NA	NA	NA	NA	NA
TRINITY_DN7593_c0_g1_i1	Q9UDY4	DNJB4_HUMAN	53.4	358	143	5	88	1158	1	335	8.10E-102	372.1	DNJB4_HUMAN	reviewed	DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein)	DNAJB4 DNAJW HLJ1	Homo sapiens (Human)	337	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0051082; GO:0051085; GO:0051087	chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]		blue	blue	NA	NA	NA	NA
TRINITY_DN30973_c0_g1_i1	O89114	DNJB5_MOUSE	45.7	70	38	0	212	3	1	70	5.00E-14	78.2	DNJB5_MOUSE	reviewed	DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40)	Dnajb5 Hsc40	Mus musculus (Mouse)	348	cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0005634; GO:0005829; GO:0006986; GO:0051082; GO:0051085; GO:0051087	chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN27242_c0_g1_i1	Q0III6	DNJB6_BOVIN	97.2	72	2	0	237	22	1	72	1.20E-33	143.7	DNJB6_BOVIN	reviewed	DnaJ homolog subfamily B member 6 (MRJ)	DNAJB6 MRJ	Bos taurus (Bovine)	242	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]		GO:0005634; GO:0030018; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN30352_c0_g1_i1	Q5FWN8	DNJ6A_XENLA	56.2	73	32	0	18	236	3	75	1.10E-18	93.6	DNJ6A_XENLA	reviewed	DnaJ homolog subfamily B member 6-A	dnajb6-a	Xenopus laevis (African clawed frog)	250	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0005634; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN33449_c0_g1_i1	Q5FWN8	DNJ6A_XENLA	52.2	67	32	0	211	11	1	67	3.00E-14	79	DNJ6A_XENLA	reviewed	DnaJ homolog subfamily B member 6-A	dnajb6-a	Xenopus laevis (African clawed frog)	250	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0005634; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN31620_c0_g1_i1	Q9QYI7	DNJB8_MOUSE	73.1	67	18	0	213	13	160	226	8.10E-21	100.5	DNJB8_MOUSE	reviewed	DnaJ homolog subfamily B member 8 (mDj6)	Dnajb8	Mus musculus (Mouse)	227	cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084]	cytosol [GO:0005829]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005829; GO:0044183; GO:0051082; GO:0051087; GO:0061077; GO:0090084	chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084]		NA	NA	NA	NA	NA	NA
TRINITY_DN27416_c0_g1_i1	Q9QYI7	DNJB8_MOUSE	57.8	64	26	1	31	219	3	66	1.30E-14	80.1	DNJB8_MOUSE	reviewed	DnaJ homolog subfamily B member 8 (mDj6)	Dnajb8	Mus musculus (Mouse)	227	cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084]	cytosol [GO:0005829]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005829; GO:0044183; GO:0051082; GO:0051087; GO:0061077; GO:0090084	chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084]		NA	NA	NA	NA	NA	NA
TRINITY_DN40064_c0_g1_i1	Q9UBS3	DNJB9_HUMAN	98.7	75	1	0	227	3	30	104	1.70E-34	146	DNJB9_HUMAN	reviewed	DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1)	DNAJB9 MDG1 UNQ743/PRO1471	Homo sapiens (Human)	223	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]	GO:0002377; GO:0005730; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0030183; GO:0030433; GO:0030544; GO:0034976; GO:0036498; GO:0051087; GO:0051787; GO:0070062; GO:1903895	B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN2021_c0_g1_i2	Q61712	DNJC1_MOUSE	32.8	519	247	10	24	1304	38	546	1.90E-62	241.5	DNJC1_MOUSE	reviewed	DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1)	Dnajc1 Dnajl1 Mtj1	Mus musculus (Mouse)	552	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chaperone binding [GO:0051087]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]	GO:0003677; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0016021; GO:0031965; GO:0043022; GO:0050708; GO:0051087	protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN2021_c0_g1_i3	Q61712	DNJC1_MOUSE	56.4	55	24	0	24	188	38	92	1.30E-12	73.9	DNJC1_MOUSE	reviewed	DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1)	Dnajc1 Dnajl1 Mtj1	Mus musculus (Mouse)	552	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chaperone binding [GO:0051087]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]	GO:0003677; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0016021; GO:0031965; GO:0043022; GO:0050708; GO:0051087	protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]		blue	blue	NA	NA	NA	NA
TRINITY_DN27490_c0_g1_i1	Q96KC8	DNJC1_HUMAN	100	94	0	0	1	282	73	166	2.90E-47	188.7	DNJC1_HUMAN	reviewed	DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1)	DNAJC1 HTJ1	Homo sapiens (Human)	554	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]	GO:0001671; GO:0003677; GO:0005783; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0016020; GO:0016021; GO:0031965; GO:0045861; GO:0050708; GO:0051087	negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN25385_c0_g1_i1	Q8IXB1	DJC10_HUMAN	100	105	0	0	3	317	27	131	5.10E-56	218	DJC10_HUMAN	reviewed	DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr)	DNAJC10 ERDJ5 UNQ495/PRO1012	Homo sapiens (Human)	793	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0051087; GO:0051117; GO:0051787; GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN2779_c0_g1_i1	Q8IXB1	DJC10_HUMAN	40.1	799	430	22	2408	99	15	793	2.80E-173	610.5	DJC10_HUMAN	reviewed	DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr)	DNAJC10 ERDJ5 UNQ495/PRO1012	Homo sapiens (Human)	793	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0051087; GO:0051117; GO:0051787; GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN2779_c0_g1_i2	Q8IXB1	DJC10_HUMAN	40.1	799	430	22	2408	99	15	793	2.70E-173	610.5	DJC10_HUMAN	reviewed	DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr)	DNAJC10 ERDJ5 UNQ495/PRO1012	Homo sapiens (Human)	793	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0051087; GO:0051117; GO:0051787; GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN2779_c0_g1_i3	Q8IXB1	DJC10_HUMAN	40.1	799	430	22	2408	99	15	793	3.60E-173	610.1	DJC10_HUMAN	reviewed	DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr)	DNAJC10 ERDJ5 UNQ495/PRO1012	Homo sapiens (Human)	793	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0051087; GO:0051117; GO:0051787; GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN39075_c0_g1_i1	Q5U458	DJC11_MOUSE	99.3	150	1	0	450	1	79	228	6.00E-79	294.7	DJC11_MOUSE	reviewed	DnaJ homolog subfamily C member 11	Dnajc11	Mus musculus (Mouse)	559	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cristae formation [GO:0042407]	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]		GO:0001401; GO:0005739; GO:0005741; GO:0005743; GO:0042407; GO:0061617	cristae formation [GO:0042407]		NA	NA	NA	NA	NA	NA
TRINITY_DN40259_c0_g1_i1	Q2NL21	DJC11_BOVIN	96.8	126	4	0	379	2	425	550	1.10E-62	240.4	DJC11_BOVIN	reviewed	DnaJ homolog subfamily C member 11	DNAJC11	Bos taurus (Bovine)	559	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cristae formation [GO:0042407]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0005739; GO:0005741; GO:0042407	cristae formation [GO:0042407]		NA	NA	NA	NA	NA	NA
TRINITY_DN4927_c0_g1_i2	Q5U458	DJC11_MOUSE	54	565	249	6	85	1770	1	557	2.30E-164	580.5	DJC11_MOUSE	reviewed	DnaJ homolog subfamily C member 11	Dnajc11	Mus musculus (Mouse)	559	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cristae formation [GO:0042407]	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]		GO:0001401; GO:0005739; GO:0005741; GO:0005743; GO:0042407; GO:0061617	cristae formation [GO:0042407]		NA	NA	NA	NA	NA	NA
TRINITY_DN4927_c0_g2_i1	Q5U458	DJC11_MOUSE	56.6	53	23	0	35	193	499	551	1.70E-10	67	DJC11_MOUSE	reviewed	DnaJ homolog subfamily C member 11	Dnajc11	Mus musculus (Mouse)	559	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cristae formation [GO:0042407]	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]		GO:0001401; GO:0005739; GO:0005741; GO:0005743; GO:0042407; GO:0061617	cristae formation [GO:0042407]		NA	NA	NA	NA	NA	NA
TRINITY_DN38406_c0_g1_i1	O75165	DJC13_HUMAN	100	124	0	0	372	1	1833	1956	5.30E-65	248.1	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i19	O75165	DJC13_HUMAN	52.5	2435	937	22	101	7372	7	2232	0	2451	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i2	O75165	DJC13_HUMAN	52.4	2440	937	23	101	7387	7	2232	0	2444.5	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i23	O75165	DJC13_HUMAN	50.4	224	106	3	105	773	7	226	9.60E-60	231.9	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i25	O75165	DJC13_HUMAN	52.5	2435	937	22	108	7379	7	2232	0	2451.4	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i26	O75165	DJC13_HUMAN	52.2	2448	937	23	105	7415	7	2232	0	2442.2	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i42	O75165	DJC13_HUMAN	52.5	2435	937	22	105	7376	7	2232	0	2451.8	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i46	O75165	DJC13_HUMAN	52.3	2443	937	22	101	7396	7	2232	0	2448.3	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i47	O75165	DJC13_HUMAN	52.2	2448	937	23	101	7411	7	2232	0	2441.8	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i5	O75165	DJC13_HUMAN	52.3	2443	937	22	105	7400	7	2232	0	2449.1	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i53	O75165	DJC13_HUMAN	55.5	1770	583	14	105	5405	7	1574	0	1902.5	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i53	O75165	DJC13_HUMAN	44.5	668	356	8	5420	7399	1572	2232	2.80E-157	558.9	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c0_g1_i57	O75165	DJC13_HUMAN	52.4	2440	937	23	105	7391	7	2232	0	2444.8	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		NA	NA	NA	NA	NA	NA
TRINITY_DN27252_c0_g1_i1	Q921R4	DJC14_MOUSE	41.8	232	122	4	390	1064	426	651	1.40E-45	185.3	DJC14_MOUSE	reviewed	DnaJ homolog subfamily C member 14	Dnajc14	Mus musculus (Mouse)	703	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dopamine receptor binding [GO:0050780]; G protein-coupled receptor binding [GO:0001664]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dopamine receptor binding [GO:0050780]; G protein-coupled receptor binding [GO:0001664]	GO:0001664; GO:0005789; GO:0015031; GO:0016021; GO:0050780	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN28421_c0_g1_i1	Q9Y5T4	DJC15_HUMAN	97	66	2	0	3	200	58	123	3.00E-30	131.7	DJC15_HUMAN	reviewed	DnaJ homolog subfamily C member 15 (Cell growth-inhibiting gene 22 protein) (Methylation-controlled J protein) (MCJ)	DNAJC15 DNAJD1 GIG22 HSD18	Homo sapiens (Human)	150	"integral component of membrane [GO:0016021]; PAM complex, Tim23 associated import motor [GO:0001405]; ATPase activator activity [GO:0001671]; cellular response to starvation [GO:0009267]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import into mitochondrial matrix [GO:0030150]; regulation of lipid metabolic process [GO:0019216]"	"integral component of membrane [GO:0016021]; PAM complex, Tim23 associated import motor [GO:0001405]"	ATPase activator activity [GO:0001671]	GO:0001405; GO:0001671; GO:0009267; GO:0016021; GO:0019216; GO:0030150; GO:0031333; GO:1902957	"cellular response to starvation [GO:0009267]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import into mitochondrial matrix [GO:0030150]; regulation of lipid metabolic process [GO:0019216]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38308_c0_g1_i1	Q5RCM7	DJC16_PONAB	56.9	65	28	0	199	5	29	93	1.30E-16	86.7	DJC16_PONAB	reviewed	DnaJ homolog subfamily C member 16	DNAJC16	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	782	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2788_c0_g1_i1	Q9NVM6	DJC17_HUMAN	47.1	308	150	6	1027	128	1	303	2.00E-30	134.8	DJC17_HUMAN	reviewed	DnaJ homolog subfamily C member 17	DNAJC17	Homo sapiens (Human)	304	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005737; GO:1901998	negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN19396_c0_g1_i1	Q6NWJ4	DNJC2_DANRE	51	155	72	2	459	1	463	615	3.50E-35	149.4	DNJC2_DANRE	reviewed	DnaJ homolog subfamily C member 2	dnajc2 zgc:85671	Danio rerio (Zebrafish) (Brachydanio rerio)	618	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19396_c0_g1_i3	Q6NWJ4	DNJC2_DANRE	51.7	269	121	4	792	1	351	615	7.40E-57	222.2	DNJC2_DANRE	reviewed	DnaJ homolog subfamily C member 2	dnajc2 zgc:85671	Danio rerio (Zebrafish) (Brachydanio rerio)	618	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19396_c0_g1_i4	Q6NWJ4	DNJC2_DANRE	51.5	270	122	4	795	1	350	615	1.30E-56	221.5	DNJC2_DANRE	reviewed	DnaJ homolog subfamily C member 2	dnajc2 zgc:85671	Danio rerio (Zebrafish) (Brachydanio rerio)	618	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19396_c0_g1_i5	Q6P2Y3	DNJC2_XENTR	39.8	128	71	2	456	85	349	474	9.10E-18	91.7	DNJC2_XENTR	reviewed	DnaJ homolog subfamily C member 2	dnajc2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	620	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11954_c0_g1_i1	Q6NWJ4	DNJC2_DANRE	53.8	279	124	4	926	99	12	288	3.70E-71	270	DNJC2_DANRE	reviewed	DnaJ homolog subfamily C member 2	dnajc2 zgc:85671	Danio rerio (Zebrafish) (Brachydanio rerio)	618	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31273_c0_g1_i1	Q1RMH9	DNJC2_BOVIN	99.1	116	1	0	1	348	67	182	3.60E-63	241.9	DNJC2_BOVIN	reviewed	DnaJ homolog subfamily C member 2 (Zuotin-related factor 1)	DNAJC2 ZRF1	Bos taurus (Bovine)	621	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35374_c0_g1_i1	Q0II91	DJC21_BOVIN	37.5	562	285	11	1669	5	1	503	9.20E-59	229.6	DJC21_BOVIN	reviewed	DnaJ homolog subfamily C member 21	DNAJC21	Bos taurus (Bovine)	533	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005730; GO:0005737; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN8743_c0_g2_i1	Q9VXT2	DJC25_DROME	43.6	328	185	0	104	1087	6	333	1.50E-78	294.7	DJC25_DROME	reviewed	DnaJ homolog subfamily C member 25 homolog	CG7872	Drosophila melanogaster (Fruit fly)	333	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein folding [GO:0006457]	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0006457; GO:0012505; GO:0016021	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN6484_c0_g1_i2	Q6IMM1	DJC27_CHICK	36.2	188	107	5	150	704	93	270	1.20E-21	105.1	DJC27_CHICK	reviewed	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	DNAJC27 RBJ	Gallus gallus (Chicken)	273	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]	nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0070374; GO:0071701	intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]		NA	NA	NA	NA	NA	NA
TRINITY_DN6484_c0_g1_i2	Q6IMM1	DJC27_CHICK	60.5	43	17	0	85	213	80	122	5.40E-09	63.2	DJC27_CHICK	reviewed	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	DNAJC27 RBJ	Gallus gallus (Chicken)	273	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]	nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0070374; GO:0071701	intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]		NA	NA	NA	NA	NA	NA
TRINITY_DN6484_c0_g1_i3	A5D7F5	DJC27_BOVIN	55	120	54	0	45	404	3	122	9.10E-35	149.1	DJC27_BOVIN	reviewed	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	DNAJC27 RBJ	Bos taurus (Bovine)	273	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0006886	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN6484_c0_g1_i3	A5D7F5	DJC27_BOVIN	39.7	146	82	4	467	895	128	270	1.60E-18	95.1	DJC27_BOVIN	reviewed	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	DNAJC27 RBJ	Bos taurus (Bovine)	273	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0006886	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN6484_c0_g1_i4	Q6IMM1	DJC27_CHICK	60.5	43	17	0	85	213	80	122	3.30E-09	63.2	DJC27_CHICK	reviewed	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	DNAJC27 RBJ	Gallus gallus (Chicken)	273	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]	nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0070374; GO:0071701	intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]		NA	NA	NA	NA	NA	NA
TRINITY_DN773_c0_g1_i1	Q8VCE1	DJC28_MOUSE	41.1	319	173	5	1162	209	33	337	9.80E-60	232.3	DJC28_MOUSE	reviewed	DnaJ homolog subfamily C member 28	Dnajc28 ORF28	Mus musculus (Mouse)	385	"Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Golgi transport complex [GO:0017119]		GO:0006890; GO:0007030; GO:0017119; GO:0048213	"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN773_c0_g1_i2	Q8VCE1	DJC28_MOUSE	41.1	319	173	5	1150	197	33	337	9.70E-60	232.3	DJC28_MOUSE	reviewed	DnaJ homolog subfamily C member 28	Dnajc28 ORF28	Mus musculus (Mouse)	385	"Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Golgi transport complex [GO:0017119]		GO:0006890; GO:0007030; GO:0017119; GO:0048213	"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN773_c0_g1_i3	Q8VCE1	DJC28_MOUSE	40.4	324	173	6	982	14	33	337	1.60E-58	228	DJC28_MOUSE	reviewed	DnaJ homolog subfamily C member 28	Dnajc28 ORF28	Mus musculus (Mouse)	385	"Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Golgi transport complex [GO:0017119]		GO:0006890; GO:0007030; GO:0017119; GO:0048213	"Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6079_c0_g1_i1	Q13217	DNJC3_HUMAN	46.4	466	244	4	1473	94	5	470	2.40E-111	404.1	DNJC3_HUMAN	reviewed	"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK PRKRI	Homo sapiens (Human)	504	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular protein metabolic process [GO:0044267]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; neutrophil degranulation [GO:0043312]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]	chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0036498; GO:0043066; GO:0043312; GO:0043687; GO:0044267; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912	cellular protein metabolic process [GO:0044267]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; neutrophil degranulation [GO:0043312]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN40950_c0_g1_i1	Q13217	DNJC3_HUMAN	100	68	0	0	206	3	217	284	3.00E-33	141.7	DNJC3_HUMAN	reviewed	"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK PRKRI	Homo sapiens (Human)	504	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular protein metabolic process [GO:0044267]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; neutrophil degranulation [GO:0043312]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]	chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0036498; GO:0043066; GO:0043312; GO:0043687; GO:0044267; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912	cellular protein metabolic process [GO:0044267]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; neutrophil degranulation [GO:0043312]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN33422_c0_g1_i1	Q13217	DNJC3_HUMAN	100	100	0	0	301	2	20	119	2.30E-50	199.1	DNJC3_HUMAN	reviewed	"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	DNAJC3 P58IPK PRKRI	Homo sapiens (Human)	504	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular protein metabolic process [GO:0044267]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; neutrophil degranulation [GO:0043312]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]	chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0036498; GO:0043066; GO:0043312; GO:0043687; GO:0044267; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912	cellular protein metabolic process [GO:0044267]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; neutrophil degranulation [GO:0043312]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN35853_c0_g1_i1	Q29455	DNJC5_BOVIN	100	94	0	0	1	282	7	100	3.40E-48	191.8	DNJC5_BOVIN	reviewed	DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP)	DNAJC5	Bos taurus (Bovine)	198	anchored component of membrane [GO:0031225]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; chaperone-mediated protein folding [GO:0061077]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of synaptic vesicle cycle [GO:0098693]	anchored component of membrane [GO:0031225]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]		GO:0005829; GO:0005886; GO:0008021; GO:0031225; GO:0031594; GO:0042470; GO:0042584; GO:0043524; GO:0061077; GO:0098693	chaperone-mediated protein folding [GO:0061077]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of synaptic vesicle cycle [GO:0098693]		NA	NA	NA	NA	NA	NA
TRINITY_DN6516_c0_g1_i1	O42196	DNJC5_XENLA	56.3	190	72	1	795	259	6	195	2.70E-51	203.8	DNJC5_XENLA	reviewed	DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP) (Xcsp)	dnajc5	Xenopus laevis (African clawed frog)	197	anchored component of membrane [GO:0031225]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; plasma membrane [GO:0005886]		GO:0005829; GO:0005886; GO:0031225; GO:0042470; GO:0042584			NA	NA	NA	NA	NA	NA
TRINITY_DN6516_c0_g1_i2	O42196	DNJC5_XENLA	56.3	190	72	1	845	309	6	195	2.80E-51	203.8	DNJC5_XENLA	reviewed	DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP) (Xcsp)	dnajc5	Xenopus laevis (African clawed frog)	197	anchored component of membrane [GO:0031225]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; plasma membrane [GO:0005886]		GO:0005829; GO:0005886; GO:0031225; GO:0042470; GO:0042584			NA	NA	NA	NA	NA	NA
TRINITY_DN11284_c0_g2_i1	Q99615	DNJC7_HUMAN	57.1	112	46	1	336	1	362	471	3.60E-30	132.5	DNJC7_HUMAN	reviewed	DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2)	DNAJC7 TPR2 TTC2	Homo sapiens (Human)	494	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	heat shock protein binding [GO:0031072]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]		NA	NA	NA	NA	NA	NA
TRINITY_DN11284_c0_g2_i2	Q99615	DNJC7_HUMAN	54	341	155	1	1023	1	133	471	2.80E-98	360.1	DNJC7_HUMAN	reviewed	DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2)	DNAJC7 TPR2 TTC2	Homo sapiens (Human)	494	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	heat shock protein binding [GO:0031072]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]		NA	NA	NA	NA	NA	NA
TRINITY_DN11284_c0_g1_i1	Q99615	DNJC7_HUMAN	51.9	79	38	0	4	240	44	122	2.60E-17	89.4	DNJC7_HUMAN	reviewed	DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2)	DNAJC7 TPR2 TTC2	Homo sapiens (Human)	494	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	heat shock protein binding [GO:0031072]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]		blue	blue	NA	NA	NA	NA
TRINITY_DN39302_c0_g1_i1	Q99615	DNJC7_HUMAN	100	169	0	0	3	509	290	458	5.60E-89	328.2	DNJC7_HUMAN	reviewed	DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2)	DNAJC7 TPR2 TTC2	Homo sapiens (Human)	494	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	heat shock protein binding [GO:0031072]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]		NA	NA	NA	NA	NA	NA
TRINITY_DN24433_c0_g1_i1	Q91WN1	DNJC9_MOUSE	98.6	146	2	0	439	2	15	160	6.50E-78	291.2	DNJC9_MOUSE	reviewed	DnaJ homolog subfamily C member 9	Dnajc9	Mus musculus (Mouse)	259	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	heat shock protein binding [GO:0031072]	GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031072; GO:0032781	positive regulation of ATPase activity [GO:0032781]		NA	NA	NA	NA	NA	NA
TRINITY_DN24433_c0_g1_i2	Q8WXX5	DNJC9_HUMAN	100	84	0	0	253	2	77	160	8.70E-43	173.7	DNJC9_HUMAN	reviewed	DnaJ homolog subfamily C member 9 (HDJC9) (DnaJ protein SB73)	DNAJC9	Homo sapiens (Human)	260	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	heat shock protein binding [GO:0031072]	GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031072; GO:0032781	positive regulation of ATPase activity [GO:0032781]		NA	NA	NA	NA	NA	NA
TRINITY_DN40051_c0_g1_i1	Q8WXX5	DNJC9_HUMAN	51.2	256	119	2	850	86	2	252	1.40E-66	254.6	DNJC9_HUMAN	reviewed	DnaJ homolog subfamily C member 9 (HDJC9) (DnaJ protein SB73)	DNAJC9	Homo sapiens (Human)	260	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	heat shock protein binding [GO:0031072]	GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031072; GO:0032781	positive regulation of ATPase activity [GO:0032781]		NA	NA	NA	NA	NA	NA
TRINITY_DN35018_c0_g1_i1	P42824	DNJH2_ALLPO	72.5	69	19	0	26	232	10	78	4.20E-23	108.2	DNJH2_ALLPO	reviewed	DnaJ protein homolog 2	LDJ2	Allium porrum (Leek) (Allium ampeloprasum var. porrum)	418	membrane [GO:0016020]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to heat [GO:0009408]	membrane [GO:0016020]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0009408; GO:0016020; GO:0031072; GO:0046872; GO:0051082	protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN26361_c0_g1_i1	P43644	DNJH_ATRNU	54.9	82	36	1	248	3	14	94	3.40E-18	92	DNJH_ATRNU	reviewed	DnaJ protein homolog ANJ1		Atriplex nummularia (Old man saltbush) (Atriplex johnstonii)	417	membrane [GO:0016020]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to heat [GO:0009408]	membrane [GO:0016020]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0009408; GO:0016020; GO:0031072; GO:0046872; GO:0051082	protein folding [GO:0006457]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN4846_c0_g1_i1	P92029	DNJ60_DROME	30.6	193	120	5	203	775	25	205	2.30E-15	84.3	DNJ60_DROME	reviewed	DnaJ-like protein 60	DnaJ-60 DmJ60 DnaJ60 CG12240	Drosophila melanogaster (Fruit fly)	217	integral component of membrane [GO:0016021]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	unfolded protein binding [GO:0051082]	GO:0007275; GO:0007283; GO:0009408; GO:0016020; GO:0016021; GO:0030154; GO:0042026; GO:0051082	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4846_c0_g1_i11	P92029	DNJ60_DROME	30.6	193	120	5	197	769	25	205	2.30E-15	84.3	DNJ60_DROME	reviewed	DnaJ-like protein 60	DnaJ-60 DmJ60 DnaJ60 CG12240	Drosophila melanogaster (Fruit fly)	217	integral component of membrane [GO:0016021]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	unfolded protein binding [GO:0051082]	GO:0007275; GO:0007283; GO:0009408; GO:0016020; GO:0016021; GO:0030154; GO:0042026; GO:0051082	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN9907_c0_g1_i1	O94625	SPJ1_SCHPO	43.3	67	36	2	1093	1293	10	74	1.60E-05	52.4	SPJ1_SCHPO	reviewed	DnaJ-related protein spj1	spj1 SPBC1347.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	381	endoplasmic reticulum lumen [GO:0005788]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum lumen [GO:0005788]	Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005788; GO:0015031; GO:0030433; GO:0030544; GO:0034620; GO:0034975; GO:0046872; GO:0051082	cellular response to unfolded protein [GO:0034620]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN9907_c0_g1_i2	O94625	SPJ1_SCHPO	43.3	67	36	2	933	1133	10	74	1.40E-05	52.4	SPJ1_SCHPO	reviewed	DnaJ-related protein spj1	spj1 SPBC1347.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	381	endoplasmic reticulum lumen [GO:0005788]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum lumen [GO:0005788]	Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0005788; GO:0015031; GO:0030433; GO:0030544; GO:0034620; GO:0034975; GO:0046872; GO:0051082	cellular response to unfolded protein [GO:0034620]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN10300_c0_g1_i2	P97465	DOK1_MOUSE	26.8	179	112	6	629	132	69	241	4.30E-06	53.1	DOK1_MOUSE	reviewed	Docking protein 1 (Downstream of tyrosine kinase 1) (p62(dok))	Dok1 Dok	Mus musculus (Mouse)	482	cytosol [GO:0005829]; nucleus [GO:0005634]; intracellular signal transduction [GO:0035556]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; negative regulation of MAPK cascade [GO:0043409]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0007169; GO:0007265; GO:0035556; GO:0038145; GO:0043409	intracellular signal transduction [GO:0035556]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; negative regulation of MAPK cascade [GO:0043409]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1196_c69_g1_i1	Q6PKX4	DOK6_HUMAN	55.6	45	20	0	319	453	179	223	3.90E-06	53.5	DOK6_HUMAN	reviewed	Docking protein 6 (Downstream of tyrosine kinase 6)	DOK6 DOK5L	Homo sapiens (Human)	331	cytosol [GO:0005829]; axon guidance [GO:0007411]	cytosol [GO:0005829]		GO:0005829; GO:0007411	axon guidance [GO:0007411]		blue	blue	NA	NA	NA	NA
TRINITY_DN1196_c69_g1_i2	Q6PKX4	DOK6_HUMAN	55.6	45	20	0	340	474	179	223	4.00E-06	53.5	DOK6_HUMAN	reviewed	Docking protein 6 (Downstream of tyrosine kinase 6)	DOK6 DOK5L	Homo sapiens (Human)	331	cytosol [GO:0005829]; axon guidance [GO:0007411]	cytosol [GO:0005829]		GO:0005829; GO:0007411	axon guidance [GO:0007411]		blue	blue	NA	NA	NA	NA
TRINITY_DN22008_c0_g2_i1	Q6PKX4	DOK6_HUMAN	51.1	45	22	0	199	65	179	223	8.10E-05	47.4	DOK6_HUMAN	reviewed	Docking protein 6 (Downstream of tyrosine kinase 6)	DOK6 DOK5L	Homo sapiens (Human)	331	cytosol [GO:0005829]; axon guidance [GO:0007411]	cytosol [GO:0005829]		GO:0005829; GO:0007411	axon guidance [GO:0007411]		NA	NA	NA	NA	NA	NA
TRINITY_DN491_c0_g1_i1	Q58CR4	DOLK_BOVIN	37.4	257	149	5	816	70	285	537	2.90E-36	154.8	DOLK_BOVIN	reviewed	Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15)	DOLK TMEM15	Bos taurus (Bovine)	538	integral component of endoplasmic reticulum membrane [GO:0030176]; dolichol kinase activity [GO:0004168]; dolichyl monophosphate biosynthetic process [GO:0043048]	integral component of endoplasmic reticulum membrane [GO:0030176]	dolichol kinase activity [GO:0004168]	GO:0004168; GO:0030176; GO:0043048	dolichyl monophosphate biosynthetic process [GO:0043048]		NA	NA	NA	NA	NA	NA
TRINITY_DN36372_c0_g1_i1	Q9UPQ8	DOLK_HUMAN	100	94	0	0	282	1	401	494	2.50E-46	185.7	DOLK_HUMAN	reviewed	Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15)	DOLK KIAA1094 TMEM15 UNQ2422/PRO4980	Homo sapiens (Human)	538	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; dolichol kinase activity [GO:0004168]; dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	dolichol kinase activity [GO:0004168]	GO:0004168; GO:0005789; GO:0006489; GO:0030176; GO:0043048	dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]		NA	NA	NA	NA	NA	NA
TRINITY_DN33167_c0_g1_i1	Q9Y7T6	SEC59_SCHPO	33.3	66	43	1	198	4	334	399	2.10E-07	55.8	SEC59_SCHPO	reviewed	Dolichol kinase sec59 (EC 2.7.1.108)	sec59 SPCC63.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	504	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; dolichol kinase activity [GO:0004168]; dolichyl monophosphate biosynthetic process [GO:0043048]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	dolichol kinase activity [GO:0004168]	GO:0004168; GO:0005783; GO:0006487; GO:0030176; GO:0043048	dolichyl monophosphate biosynthetic process [GO:0043048]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN22182_c0_g1_i1	O60762	DPM1_HUMAN	99.2	125	1	0	376	2	64	188	1.10E-68	260.4	DPM1_HUMAN	reviewed	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1)	DPM1	Homo sapiens (Human)	260	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]	dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0004582; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0018279; GO:0019348; GO:0033185; GO:0035268; GO:0035269	dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN22182_c0_g1_i2	O60762	DPM1_HUMAN	100	121	0	0	363	1	64	184	1.60E-66	253.1	DPM1_HUMAN	reviewed	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1)	DPM1	Homo sapiens (Human)	260	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]	dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0004582; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0018279; GO:0019348; GO:0033185; GO:0035268; GO:0035269	dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN31003_c0_g1_i1	O60762	DPM1_HUMAN	100	83	0	0	286	38	178	260	9.30E-41	167.2	DPM1_HUMAN	reviewed	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1)	DPM1	Homo sapiens (Human)	260	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]	dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0004582; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0018279; GO:0019348; GO:0033185; GO:0035268; GO:0035269	dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN1328_c0_g2_i1	Q9WU83	DPM1_CRIGR	82.6	236	41	0	795	88	31	266	1.20E-113	411	DPM1_CRIGR	reviewed	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1)	DPM1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	266	endoplasmic reticulum [GO:0005783]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]	dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]	GO:0004582; GO:0005783; GO:0006486	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN35033_c0_g1_i1	O70152	DPM1_MOUSE	100	67	0	0	3	203	64	130	1.30E-33	142.9	DPM1_MOUSE	reviewed	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase)	Dpm1	Mus musculus (Mouse)	260	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]; dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]	GO:0004169; GO:0004582; GO:0005537; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0019348; GO:0019673; GO:0033185; GO:0035268; GO:0035269; GO:0043178; GO:0043231	dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN38191_c0_g1_i1	Q9LM93	DPM1_ARATH	73.4	64	17	0	6	197	71	134	5.10E-22	104.4	DPM1_ARATH	reviewed	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dol-P-Man synthase1) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1)	DPMS1 At1g20575 F2D10.6	Arabidopsis thaliana (Mouse-ear cress)	246	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein O-linked mannosylation [GO:0035269]; response to ammonium ion [GO:0060359]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]	GO:0004582; GO:0005783; GO:0005789; GO:0006506; GO:0019348; GO:0033185; GO:0035269; GO:0060359	dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein O-linked mannosylation [GO:0035269]; response to ammonium ion [GO:0060359]		NA	NA	NA	NA	NA	NA
TRINITY_DN8535_c0_g1_i3	Q802T2	ALG6_CHICK	49.8	490	227	5	1440	28	1	490	1.10E-129	464.9	ALG6_CHICK	reviewed	"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	ALG6 RCJMB04_6f21	Gallus gallus (Chicken)	507	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]"	GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0042281	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN40602_c0_g1_i1	Q9Y672	ALG6_HUMAN	100	68	0	0	206	3	57	124	4.20E-35	147.9	ALG6_HUMAN	reviewed	"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	ALG6 My046	Homo sapiens (Human)	507	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; glucosyltransferase activity [GO:0046527]"	GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0042281; GO:0046527	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN6757_c0_g2_i1	P39656	OST48_HUMAN	100	223	0	0	671	3	211	433	3.00E-127	455.7	OST48_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit)	DDOST KIAA0115 OST48 OK/SW-cl.45	Homo sapiens (Human)	456	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; neutrophil degranulation [GO:0043312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110]	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]	enzyme activator activity [GO:0008047]	GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0031647; GO:0034097; GO:0035577; GO:0042110; GO:0043231; GO:0043312	neutrophil degranulation [GO:0043312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN6757_c0_g1_i1	O54734	OST48_MOUSE	99.6	229	1	0	689	3	190	418	1.60E-131	469.9	OST48_MOUSE	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit)	Ddost	Mus musculus (Mouse)	441	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; oligosaccharyltransferase complex [GO:0008250]; enzyme activator activity [GO:0008047]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; oligosaccharyltransferase complex [GO:0008250]	enzyme activator activity [GO:0008047]	GO:0005783; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016021; GO:0018279; GO:0031647; GO:0034097; GO:0042110; GO:0043231	protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN29638_c0_g1_i1	P39656	OST48_HUMAN	100	105	0	0	317	3	29	133	1.20E-52	206.8	OST48_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit)	DDOST KIAA0115 OST48 OK/SW-cl.45	Homo sapiens (Human)	456	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; neutrophil degranulation [GO:0043312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110]	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]	enzyme activator activity [GO:0008047]	GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0031647; GO:0034097; GO:0035577; GO:0042110; GO:0043231; GO:0043312	neutrophil degranulation [GO:0043312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN16580_c1_g1_i1	Q24319	OST48_DROME	71.9	57	16	0	265	95	25	81	9.30E-17	87.8	OST48_DROME	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)	Ost48 OST50 CG9022	Drosophila melanogaster (Fruit fly)	449	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation via asparagine [GO:0018279]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0005783; GO:0008250; GO:0012505; GO:0016021; GO:0018279	protein N-linked glycosylation via asparagine [GO:0018279]		blue	blue	NA	NA	NA	NA
TRINITY_DN16580_c1_g1_i2	Q24319	OST48_DROME	60.8	395	149	3	1169	3	25	419	3.70E-134	479.6	OST48_DROME	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)	Ost48 OST50 CG9022	Drosophila melanogaster (Fruit fly)	449	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation via asparagine [GO:0018279]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0005783; GO:0008250; GO:0012505; GO:0016021; GO:0018279	protein N-linked glycosylation via asparagine [GO:0018279]		blue	blue	NA	NA	NA	NA
TRINITY_DN40938_c0_g1_i1	Q24319	OST48_DROME	62.9	62	23	0	22	207	14	75	2.60E-13	75.5	OST48_DROME	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)	Ost48 OST50 CG9022	Drosophila melanogaster (Fruit fly)	449	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation via asparagine [GO:0018279]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0005783; GO:0008250; GO:0012505; GO:0016021; GO:0018279	protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5536_c0_g2_i1	P04843	RPN1_HUMAN	99.7	313	1	0	939	1	189	501	3.30E-180	632.1	RPN1_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)	RPN1	Homo sapiens (Human)	607	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]	RNA binding [GO:0003723]	GO:0003723; GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006464; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0042470	cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5536_c0_g1_i1	Q91YQ5	RPN1_MOUSE	100	285	0	0	855	1	210	494	2.20E-162	572.8	RPN1_MOUSE	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)	Rpn1	Mus musculus (Mouse)	608	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]		GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006487; GO:0008250; GO:0016021; GO:0018279; GO:0042470	protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5787_c0_g1_i1	E2RQ08	RPN1_CANLF	47.5	598	301	5	1856	99	8	604	5.20E-148	526.2	RPN1_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1)	RPN1	Canis lupus familiaris (Dog) (Canis familiaris)	607	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]		GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0016021; GO:0018279	protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5787_c0_g1_i3	E2RQ08	RPN1_CANLF	47.5	598	301	5	1856	99	8	604	5.20E-148	526.2	RPN1_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1)	RPN1	Canis lupus familiaris (Dog) (Canis familiaris)	607	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]		GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0016021; GO:0018279	protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5787_c0_g1_i5	E2RQ08	RPN1_CANLF	47.5	598	301	5	1856	99	8	604	5.20E-148	526.2	RPN1_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1)	RPN1	Canis lupus familiaris (Dog) (Canis familiaris)	607	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]		GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0016021; GO:0018279	protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5787_c0_g1_i6	E2RQ08	RPN1_CANLF	47.5	598	301	5	1856	99	8	604	5.20E-148	526.2	RPN1_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1)	RPN1	Canis lupus familiaris (Dog) (Canis familiaris)	607	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]		GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0016021; GO:0018279	protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN3118_c0_g2_i1	Q9VLM5	DAD1_DROME	75.7	111	27	0	398	66	2	112	1.40E-44	180.6	DAD1_DROME	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (DAD-1) (Oligosaccharyl transferase subunit DAD1) (Defender against apoptotic cell death 1) (Defender against cell death 1)	Dad1 l(2)k12914 CG13393	Drosophila melanogaster (Fruit fly)	112	endomembrane system [GO:0012505]; integral component of endoplasmic reticulum membrane [GO:0030176]; oligosaccharyltransferase complex [GO:0008250]; apoptotic process [GO:0006915]; protein N-linked glycosylation [GO:0006487]	endomembrane system [GO:0012505]; integral component of endoplasmic reticulum membrane [GO:0030176]; oligosaccharyltransferase complex [GO:0008250]		GO:0006487; GO:0006915; GO:0008250; GO:0012505; GO:0030176	apoptotic process [GO:0006915]; protein N-linked glycosylation [GO:0006487]		blue	blue	NA	NA	NA	NA
TRINITY_DN15229_c0_g1_i1	P61803	DAD1_HUMAN	100	91	0	0	273	1	1	91	4.10E-44	178.3	DAD1_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (Defender against cell death 1) (DAD-1)	DAD1	Homo sapiens (Human)	113	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; enzyme activator activity [GO:0008047]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; response to nutrient [GO:0007584]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]	enzyme activator activity [GO:0008047]	GO:0001824; GO:0005789; GO:0006486; GO:0006487; GO:0006915; GO:0007584; GO:0008047; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0031647; GO:0042493; GO:0043066	apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN15229_c0_g1_i2	P61803	DAD1_HUMAN	100	91	0	0	273	1	1	91	4.10E-44	178.3	DAD1_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (Defender against cell death 1) (DAD-1)	DAD1	Homo sapiens (Human)	113	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; enzyme activator activity [GO:0008047]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; response to nutrient [GO:0007584]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]	enzyme activator activity [GO:0008047]	GO:0001824; GO:0005789; GO:0006486; GO:0006487; GO:0006915; GO:0007584; GO:0008047; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0031647; GO:0042493; GO:0043066	apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN11786_c0_g2_i1	P46975	STT3_CAEEL	53.7	147	67	1	2	442	125	270	6.00E-39	161.8	STT3_CAEEL	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit stt-3 (Oligosaccharyl transferase subunit stt-3) (EC 2.4.99.18)	stt-3 T12A2.2	Caenorhabditis elegans	757	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005789; GO:0016021; GO:0018279; GO:0043687; GO:0046872	post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN662_c0_g1_i1	F1PJP5	STT3A_CANLF	81.5	697	128	1	2180	93	5	701	0	1169.1	STT3A_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)	STT3A	Canis lupus familiaris (Dog) (Canis familiaris)	705	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043687; GO:0046872	post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]		blue	blue	NA	NA	NA	NA
TRINITY_DN662_c0_g1_i3	Q2KJI2	STT3A_BOVIN	90.3	62	6	0	272	87	592	653	2.30E-30	132.9	STT3A_BOVIN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)	STT3A	Bos taurus (Bovine)	705	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]		blue	blue	NA	NA	NA	NA
TRINITY_DN662_c0_g1_i4	Q2KJI2	STT3A_BOVIN	92.6	136	10	0	494	87	518	653	1.40E-73	277.3	STT3A_BOVIN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)	STT3A	Bos taurus (Bovine)	705	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN662_c0_g1_i6	F1PJP5	STT3A_CANLF	73.8	61	13	1	266	93	641	701	1.00E-19	97.4	STT3A_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)	STT3A	Canis lupus familiaris (Dog) (Canis familiaris)	705	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043687; GO:0046872	post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]		blue	blue	NA	NA	NA	NA
TRINITY_DN9882_c0_g1_i2	P46978	STT3A_MOUSE	100	705	0	0	2169	55	1	705	0	1411.4	STT3A_MOUSE	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1)	Stt3a Itm1	Mus musculus (Mouse)	705	integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN9882_c0_g1_i1	P46977	STT3A_HUMAN	99.9	705	1	0	2169	55	1	705	0	1411	STT3A_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1) (Transmembrane protein TMC)	STT3A ITM1 TMC	Homo sapiens (Human)	705	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN39886_c0_g1_i1	Q93ZY3	STT3A_ARATH	64.3	98	35	0	40	333	334	431	1.30E-28	127.1	STT3A_ARATH	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (Integral membrane protein 1) (Protein STAUROSPORIN AND TEMPERATURE SENSITIVE 3-LIKE A)	STT3A At5g19690 T29J13_110	Arabidopsis thaliana (Mouse-ear cress)	779	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]; regulation of response to osmotic stress [GO:0047484]; response to salt stress [GO:0009651]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0009536; GO:0009651; GO:0016021; GO:0046872; GO:0047484	protein glycosylation [GO:0006486]; regulation of response to osmotic stress [GO:0047484]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN38724_c0_g1_i1	Q93ZY3	STT3A_ARATH	59.6	94	38	0	284	3	334	427	2.90E-27	122.5	STT3A_ARATH	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (Integral membrane protein 1) (Protein STAUROSPORIN AND TEMPERATURE SENSITIVE 3-LIKE A)	STT3A At5g19690 T29J13_110	Arabidopsis thaliana (Mouse-ear cress)	779	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]; regulation of response to osmotic stress [GO:0047484]; response to salt stress [GO:0009651]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plastid [GO:0009536]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0009536; GO:0009651; GO:0016021; GO:0046872; GO:0047484	protein glycosylation [GO:0006486]; regulation of response to osmotic stress [GO:0047484]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN26797_c0_g1_i1	E2RG47	STT3B_CANLF	61.4	145	56	0	5	439	555	699	3.90E-49	195.7	STT3B_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18)	STT3B	Canis lupus familiaris (Dog) (Canis familiaris)	826	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0006516; GO:0006986; GO:0016021; GO:0018279; GO:0030433; GO:0034998; GO:0034999; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN14858_c0_g1_i1	E2RG47	STT3B_CANLF	100	148	0	0	444	1	353	500	6.80E-81	302	STT3B_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18)	STT3B	Canis lupus familiaris (Dog) (Canis familiaris)	826	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0006516; GO:0006986; GO:0016021; GO:0018279; GO:0030433; GO:0034998; GO:0034999; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN14858_c0_g1_i1	E2RG47	STT3B_CANLF	98.4	125	2	0	808	434	232	356	3.40E-64	246.5	STT3B_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18)	STT3B	Canis lupus familiaris (Dog) (Canis familiaris)	826	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0006516; GO:0006986; GO:0016021; GO:0018279; GO:0030433; GO:0034998; GO:0034999; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN14858_c0_g1_i2	E2RG47	STT3B_CANLF	100	444	0	0	1332	1	57	500	1.90E-258	892.5	STT3B_CANLF	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18)	STT3B	Canis lupus familiaris (Dog) (Canis familiaris)	826	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; oligosaccharyltransferase II complex [GO:0034999]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0006516; GO:0006986; GO:0016021; GO:0018279; GO:0030433; GO:0034998; GO:0034999; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN14858_c0_g2_i1	Q3TDQ1	STT3B_MOUSE	100	120	0	0	3	362	643	762	2.90E-68	258.8	STT3B_MOUSE	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (B6dom1 antigen) (Source of immunodominant MHC-associated peptides)	Stt3b Simp	Mus musculus (Mouse)	823	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005783; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN40289_c0_g1_i1	Q7XQ88	STT3B_ORYSJ	53.2	62	23	1	208	41	659	720	7.20E-11	67.4	STT3B_ORYSJ	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Protein STAUROSPORIN AND TEMPERATURE SENSITIVE 3-LIKE B)	STT3B Os04g0675500 LOC_Os04g57890 OsJ_16609 OSJNBa0018M05.20	Oryza sativa subsp. japonica (Rice)	721	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005789; GO:0005886; GO:0006486; GO:0016021; GO:0046872	protein glycosylation [GO:0006486]		red	red	NA	NA	NA	NA
TRINITY_DN38564_c0_g1_i1	Q9FX21	STT3B_ARATH	55.8	251	110	1	2	754	48	297	2.10E-76	287	STT3B_ARATH	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Protein STAUROSPORIN AND TEMPERATURE SENSITIVE 3-LIKE B)	STT3B At1g34130 F12G12.5	Arabidopsis thaliana (Mouse-ear cress)	735	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005634; GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0016021; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN37033_c0_g1_i1	Q7XQ88	STT3B_ORYSJ	57.8	166	69	1	6	503	497	661	8.30E-53	208	STT3B_ORYSJ	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Protein STAUROSPORIN AND TEMPERATURE SENSITIVE 3-LIKE B)	STT3B Os04g0675500 LOC_Os04g57890 OsJ_16609 OSJNBa0018M05.20	Oryza sativa subsp. japonica (Rice)	721	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005789; GO:0005886; GO:0006486; GO:0016021; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11786_c0_g1_i1	Q9FX21	STT3B_ARATH	59	100	41	0	307	8	41	140	2.30E-29	129.4	STT3B_ARATH	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Protein STAUROSPORIN AND TEMPERATURE SENSITIVE 3-LIKE B)	STT3B At1g34130 F12G12.5	Arabidopsis thaliana (Mouse-ear cress)	735	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005634; GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0016021; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN10783_c0_g1_i1	Q8TCJ2	STT3B_HUMAN	71.5	771	215	3	2316	13	56	824	0	1102.8	STT3B_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog)	STT3B SIMP	Homo sapiens (Human)	826	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005783; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN14858_c0_g3_i1	Q8TCJ2	STT3B_HUMAN	100	265	0	0	2	796	520	784	5.70E-157	554.7	STT3B_HUMAN	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog)	STT3B SIMP	Homo sapiens (Human)	826	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005783; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN33522_c0_g1_i1	Q54J42	ALG5_DICDI	50.6	83	41	0	251	3	228	310	7.90E-20	97.4	ALG5_DICDI	reviewed	Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog)	alg5 dgtA DDB_G0288321	Dictyostelium discoideum (Slime mold)	327	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]	GO:0004581; GO:0005789; GO:0006487; GO:0016021	protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN18721_c0_g1_i1	Q9Y673	ALG5_HUMAN	99.6	264	1	0	3	794	59	322	3.30E-152	538.9	ALG5_HUMAN	reviewed	Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog)	ALG5 HSPC149	Homo sapiens (Human)	324	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]; determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]	GO:0004576; GO:0004581; GO:0005789; GO:0006486; GO:0006487; GO:0007368; GO:0016020; GO:0016021; GO:0018279	determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN18721_c0_g1_i2	Q9DB25	ALG5_MOUSE	100	131	0	0	3	395	194	324	2.60E-73	275.8	ALG5_MOUSE	reviewed	Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog)	Alg5	Mus musculus (Mouse)	324	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; determination of left/right symmetry [GO:0007368]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]	GO:0004581; GO:0005789; GO:0006487; GO:0007368; GO:0016021	determination of left/right symmetry [GO:0007368]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN18721_c0_g1_i3	Q9Y673	ALG5_HUMAN	97.8	185	4	0	1	555	138	322	1.80E-104	379.8	ALG5_HUMAN	reviewed	Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog)	ALG5 HSPC149	Homo sapiens (Human)	324	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]; determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]	GO:0004576; GO:0004581; GO:0005789; GO:0006486; GO:0006487; GO:0007368; GO:0016020; GO:0016021; GO:0018279	determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN9986_c0_g1_i1	Q9VLQ1	ALG5_DROME	56	318	136	1	1043	90	11	324	3.20E-100	366.7	ALG5_DROME	reviewed	Dolichyl-phosphate beta-glucosyltransferase (EC 2.4.1.117) (Wollknaeuel)	wol alg5 CG7870	Drosophila melanogaster (Fruit fly)	326	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]	GO:0004581; GO:0005783; GO:0005789; GO:0006487; GO:0006493; GO:0007009; GO:0007029; GO:0007379; GO:0007509; GO:0009953; GO:0010004; GO:0016021; GO:0019991; GO:0040003	chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]		blue	blue	NA	NA	NA	NA
TRINITY_DN26347_c0_g1_i1	Q5A688	PMT6_CANAL	53.5	71	33	0	2	214	106	176	5.40E-17	87.8	PMT6_CANAL	reviewed	Dolichyl-phosphate-mannose--protein mannosyltransferase 6 (Protein mannosyltransferase 6) (EC 2.4.1.109)	PMT6 PMT3 CAALFM_C404780WA CaO19.11283 CaO19.3802	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	832	dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex [GO:0097582]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; cellular response to drug [GO:0035690]; cellular response to neutral pH [GO:0036244]; cellular response to starvation [GO:0009267]; ER-associated misfolded protein catabolic process [GO:0071712]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; filamentous growth of a population of unicellular organisms in response to neutral pH [GO:0036178]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; pathogenesis [GO:0009405]; protein O-linked mannosylation [GO:0035269]; single-species biofilm formation on inanimate substrate [GO:0044011]	dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex [GO:0097582]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005789; GO:0009267; GO:0009405; GO:0016021; GO:0030447; GO:0035269; GO:0035690; GO:0036170; GO:0036178; GO:0036244; GO:0044011; GO:0044182; GO:0071712; GO:0097582	cellular response to drug [GO:0035690]; cellular response to neutral pH [GO:0036244]; cellular response to starvation [GO:0009267]; ER-associated misfolded protein catabolic process [GO:0071712]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; filamentous growth of a population of unicellular organisms in response to neutral pH [GO:0036178]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; pathogenesis [GO:0009405]; protein O-linked mannosylation [GO:0035269]; single-species biofilm formation on inanimate substrate [GO:0044011]		NA	NA	NA	NA	NA	NA
TRINITY_DN89_c0_g1_i1	Q92685	ALG3_HUMAN	56.1	82	34	1	322	83	22	103	1.60E-17	90.5	ALG3_HUMAN	reviewed	"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)"	ALG3 NOT NOT56L	Homo sapiens (Human)	438	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]"	GO:0000033; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016021; GO:0052925	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN13116_c0_g1_i1	Q92685	ALG3_HUMAN	100	115	0	0	345	1	319	433	7.10E-64	244.2	ALG3_HUMAN	reviewed	"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)"	ALG3 NOT NOT56L	Homo sapiens (Human)	438	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]"	GO:0000033; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016021; GO:0052925	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN32994_c0_g1_i1	Q6CMF1	ALG3_KLULA	40.6	69	39	1	227	21	253	319	1.80E-07	56.2	ALG3_KLULA	reviewed	"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 6) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase)"	ALG3 KLLA0E20823g	Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica)	462	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation [GO:0006486]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]"	GO:0005789; GO:0006486; GO:0006490; GO:0016021; GO:0052925	oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN28637_c0_g1_i1	Q9BV10	ALG12_HUMAN	100	84	0	0	254	3	17	100	4.80E-41	167.9	ALG12_HUMAN	reviewed	"Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87)"	ALG12 PP14673	Homo sapiens (Human)	488	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006487; GO:0006488; GO:0016020; GO:0016021; GO:0052824; GO:0052917	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN30630_c0_g1_i1	Q05754	DOPO_RAT	65.9	44	15	0	133	2	461	504	1.30E-10	66.6	DOPO_RAT	reviewed	Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase]	Dbh	Rattus norvegicus (Rat)	620	"apical part of cell [GO:0045177]; axon [GO:0030424]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; varicosity [GO:0043196]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; catecholamine metabolic process [GO:0006584]; cellular response to manganese ion [GO:0071287]; cellular response to nicotine [GO:0071316]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organism aging [GO:0010259]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine metabolic process [GO:0046333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to iron ion [GO:0010039]; response to isolation stress [GO:0035900]; response to organic cyclic compound [GO:0014070]; response to ozone [GO:0010193]; response to pain [GO:0048265]; response to peptide hormone [GO:0043434]; sensory perception of taste [GO:0050909]; social behavior [GO:0035176]; visual learning [GO:0008542]"	apical part of cell [GO:0045177]; axon [GO:0030424]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; varicosity [GO:0043196]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0001816; GO:0001974; GO:0001975; GO:0002443; GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006584; GO:0006589; GO:0007613; GO:0007626; GO:0008306; GO:0008542; GO:0010039; GO:0010193; GO:0010259; GO:0014070; GO:0016021; GO:0016715; GO:0030424; GO:0030425; GO:0030658; GO:0030667; GO:0031410; GO:0031418; GO:0032355; GO:0034466; GO:0034774; GO:0035176; GO:0035900; GO:0035902; GO:0042127; GO:0042309; GO:0042420; GO:0042421; GO:0042493; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0043025; GO:0043195; GO:0043196; GO:0043434; GO:0045177; GO:0045202; GO:0045471; GO:0045907; GO:0046333; GO:0046688; GO:0048149; GO:0048265; GO:0050900; GO:0050909; GO:0060348; GO:0071287; GO:0071316; GO:0120162; GO:2001236	associative learning [GO:0008306]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; catecholamine metabolic process [GO:0006584]; cellular response to manganese ion [GO:0071287]; cellular response to nicotine [GO:0071316]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organism aging [GO:0010259]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine metabolic process [GO:0046333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to iron ion [GO:0010039]; response to isolation stress [GO:0035900]; response to organic cyclic compound [GO:0014070]; response to ozone [GO:0010193]; response to pain [GO:0048265]; response to peptide hormone [GO:0043434]; sensory perception of taste [GO:0050909]; social behavior [GO:0035176]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN20333_c0_g1_i1	Q8IS44	DRD2L_DROME	69.6	79	23	1	251	15	825	902	3.10E-26	119	DRD2L_DROME	reviewed	Dopamine D2-like receptor (DD2R)	Dop2R D2R CG17004	Drosophila melanogaster (Fruit fly)	905	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	"dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]"	GO:0001591; GO:0004930; GO:0005887; GO:0007186; GO:0007212; GO:0007615; GO:0008227; GO:0016021; GO:0045202; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN22979_c0_g1_i1	Q24025	SOG_DROME	33.3	153	92	3	519	67	364	508	4.00E-13	76.3	SOG_DROME	reviewed	Dorsal-ventral patterning protein Sog (Short gastrulation protein)	sog CG9224	Drosophila melanogaster (Fruit fly)	1038	"extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; amnioserosa formation [GO:0007378]; establishment of protein localization to extracellular region [GO:0035592]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of BMP signaling pathway [GO:0030513]; posterior Malpighian tubule development [GO:0061328]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing vein specification [GO:0110107]; ring gland development [GO:0035271]; sequestering of BMP from receptor via BMP binding [GO:0038098]"	extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	BMP binding [GO:0036122]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]	GO:0000139; GO:0005518; GO:0005615; GO:0005886; GO:0007313; GO:0007378; GO:0008083; GO:0008586; GO:0016021; GO:0030513; GO:0030514; GO:0035271; GO:0035592; GO:0036122; GO:0038098; GO:0040008; GO:0061328; GO:0110107	"amnioserosa formation [GO:0007378]; establishment of protein localization to extracellular region [GO:0035592]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of BMP signaling pathway [GO:0030513]; posterior Malpighian tubule development [GO:0061328]; regulation of growth [GO:0040008]; regulation of imaginal disc-derived wing vein specification [GO:0110107]; ring gland development [GO:0035271]; sequestering of BMP from receptor via BMP binding [GO:0038098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16888_c0_g1_i4	P24785	MLE_DROME	57.1	189	75	3	750	202	950	1138	1.00E-54	214.9	MLE_DROME	reviewed	Dosage compensation regulator (EC 3.6.4.13) (ATP-dependent RNA helicase mle) (Protein male-less) (Protein maleless) (Protein no action potential)	mle nap CG11680	Drosophila melanogaster (Fruit fly)	1293	"chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]"	3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000228; GO:0000785; GO:0000805; GO:0001069; GO:0003678; GO:0003682; GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005730; GO:0005737; GO:0005829; GO:0007549; GO:0008340; GO:0009047; GO:0016456; GO:0016457; GO:0031453; GO:0032508; GO:0034458; GO:0043138; GO:0045433; GO:0045944; GO:0048675; GO:0050684; GO:0072487; GO:1990904; GO:2000373; GO:2000765	"axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16888_c0_g1_i5	P24785	MLE_DROME	49.8	233	109	4	741	58	950	1179	6.20E-57	222.2	MLE_DROME	reviewed	Dosage compensation regulator (EC 3.6.4.13) (ATP-dependent RNA helicase mle) (Protein male-less) (Protein maleless) (Protein no action potential)	mle nap CG11680	Drosophila melanogaster (Fruit fly)	1293	"chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]"	3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000228; GO:0000785; GO:0000805; GO:0001069; GO:0003678; GO:0003682; GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005730; GO:0005737; GO:0005829; GO:0007549; GO:0008340; GO:0009047; GO:0016456; GO:0016457; GO:0031453; GO:0032508; GO:0034458; GO:0043138; GO:0045433; GO:0045944; GO:0048675; GO:0050684; GO:0072487; GO:1990904; GO:2000373; GO:2000765	"axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5732_c0_g1_i1	P24785	MLE_DROME	41.6	125	65	2	13	363	89	213	1.00E-20	100.9	MLE_DROME	reviewed	Dosage compensation regulator (EC 3.6.4.13) (ATP-dependent RNA helicase mle) (Protein male-less) (Protein maleless) (Protein no action potential)	mle nap CG11680	Drosophila melanogaster (Fruit fly)	1293	"chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ribonucleoprotein complex [GO:1990904]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]"	3'-5' DNA helicase activity [GO:0043138]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000228; GO:0000785; GO:0000805; GO:0001069; GO:0003678; GO:0003682; GO:0003690; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005730; GO:0005737; GO:0005829; GO:0007549; GO:0008340; GO:0009047; GO:0016456; GO:0016457; GO:0031453; GO:0032508; GO:0034458; GO:0043138; GO:0045433; GO:0045944; GO:0048675; GO:0050684; GO:0072487; GO:1990904; GO:2000373; GO:2000765	"axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome [GO:0016457]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36505_c0_g1_i1	Q8SRV0	MRE11_ENCCU	48.1	108	53	2	2	319	114	220	1.20E-25	117.1	MRE11_ENCCU	reviewed	Double-strand break repair protein MRE11	MRE11 ECU05_1280	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	567	Mre11 complex [GO:0030870]; 3'-5' exonuclease activity [GO:0008408]; endonuclease activity [GO:0004519]; manganese ion binding [GO:0030145]; double-strand break repair [GO:0006302]; meiotic cell cycle [GO:0051321]	Mre11 complex [GO:0030870]	3'-5' exonuclease activity [GO:0008408]; endonuclease activity [GO:0004519]; manganese ion binding [GO:0030145]	GO:0004519; GO:0006302; GO:0008408; GO:0030145; GO:0030870; GO:0051321	double-strand break repair [GO:0006302]; meiotic cell cycle [GO:0051321]		NA	NA	1	NA	NA	NA
TRINITY_DN5880_c0_g1_i4	Q9JIM0	MRE11_RAT	59.4	266	103	3	858	70	11	274	1.90E-92	340.5	MRE11_RAT	reviewed	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)	Mre11 Mre11a	Rattus norvegicus (Rat)	706	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; heart development [GO:0007507]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]"	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000723; GO:0000724; GO:0000784; GO:0000790; GO:0000794; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006302; GO:0006303; GO:0006974; GO:0007062; GO:0007095; GO:0007129; GO:0007507; GO:0008022; GO:0008283; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0046597; GO:0048471; GO:0051276; GO:0097552; GO:0110025	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; heart development [GO:0007507]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]		NA	NA	NA	NA	NA	NA
TRINITY_DN26875_c0_g1_i1	Q61216	MRE11_MOUSE	60.7	61	24	0	204	22	36	96	6.20E-15	80.9	MRE11_MOUSE	reviewed	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (MmMRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)	Mre11 Mre11a	Mus musculus (Mouse)	706	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]"	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000723; GO:0000724; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003678; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006302; GO:0006303; GO:0006974; GO:0007062; GO:0007095; GO:0007129; GO:0008022; GO:0008283; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0046597; GO:0048471; GO:0051276; GO:0097552; GO:0110025	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]		NA	NA	NA	NA	NA	NA
TRINITY_DN30613_c0_g1_i1	Q61216	MRE11_MOUSE	56.5	69	30	0	22	228	14	82	2.70E-17	89	MRE11_MOUSE	reviewed	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (MmMRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)	Mre11 Mre11a	Mus musculus (Mouse)	706	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]"	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000723; GO:0000724; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003678; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006302; GO:0006303; GO:0006974; GO:0007062; GO:0007095; GO:0007129; GO:0008022; GO:0008283; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0046597; GO:0048471; GO:0051276; GO:0097552; GO:0110025	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]		NA	NA	1	NA	NA	NA
TRINITY_DN5880_c0_g1_i1	Q61216	MRE11_MOUSE	59	307	122	3	1031	120	11	316	4.20E-105	382.9	MRE11_MOUSE	reviewed	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (MmMRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)	Mre11 Mre11a	Mus musculus (Mouse)	706	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]"	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000723; GO:0000724; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003678; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006302; GO:0006303; GO:0006974; GO:0007062; GO:0007095; GO:0007129; GO:0008022; GO:0008283; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0046597; GO:0048471; GO:0051276; GO:0097552; GO:0110025	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]		NA	NA	NA	NA	NA	NA
TRINITY_DN5880_c0_g1_i5	Q61216	MRE11_MOUSE	58.8	301	120	3	964	71	11	310	3.70E-103	376.3	MRE11_MOUSE	reviewed	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (MmMRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)	Mre11 Mre11a	Mus musculus (Mouse)	706	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]"	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000723; GO:0000724; GO:0000784; GO:0000790; GO:0000794; GO:0003677; GO:0003678; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006302; GO:0006303; GO:0006974; GO:0007062; GO:0007095; GO:0007129; GO:0008022; GO:0008283; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0046597; GO:0048471; GO:0051276; GO:0097552; GO:0110025	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]		NA	NA	NA	NA	NA	NA
TRINITY_DN5880_c0_g1_i3	Q9C291	MRE11_NEUCR	51.5	66	27	2	308	123	246	310	1.50E-08	60.5	MRE11_NEUCR	reviewed	Double-strand break repair protein mus-23 (Recombinational repair protein mus-23)	mus-23 B11O9.50 NCU08730	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	739	"chromosome, telomeric repeat region [GO:0140445]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; manganese ion binding [GO:0030145]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break clipping [GO:1990898]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; telomere maintenance [GO:0000723]"	"chromosome, telomeric repeat region [GO:0140445]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]"	3'-5' exonuclease activity [GO:0008408]; manganese ion binding [GO:0030145]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000723; GO:0000724; GO:0006303; GO:0007095; GO:0008408; GO:0030145; GO:0030870; GO:0031573; GO:0035861; GO:0042138; GO:0097552; GO:0140445; GO:1990898; GO:1990918	double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break clipping [GO:1990898]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN29726_c0_g1_i1	Q61550	RAD21_MOUSE	61.9	239	77	5	836	123	1	226	1.00E-72	275	RAD21_MOUSE	reviewed	Double-strand-break repair protein rad21 homolog (mHR21) (Pokeweed agglutinin-binding protein 29) (PW29) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]	Rad21 Hr21 Scc1	Mus musculus (Mouse)	635	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000780; GO:0000785; GO:0000790; GO:0000794; GO:0000795; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0007064; GO:0007130; GO:0007275; GO:0008278; GO:0010972; GO:0016363; GO:0034990; GO:0034991; GO:0045841; GO:0045876; GO:0051177; GO:0051301; GO:0071168; GO:1990414	apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]		blue	blue	NA	NA	NA	NA
TRINITY_DN36052_c0_g1_i1	Q61550	RAD21_MOUSE	100	185	0	0	555	1	1	185	3.20E-102	372.5	RAD21_MOUSE	reviewed	Double-strand-break repair protein rad21 homolog (mHR21) (Pokeweed agglutinin-binding protein 29) (PW29) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]	Rad21 Hr21 Scc1	Mus musculus (Mouse)	635	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000780; GO:0000785; GO:0000790; GO:0000794; GO:0000795; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0007064; GO:0007130; GO:0007275; GO:0008278; GO:0010972; GO:0016363; GO:0034990; GO:0034991; GO:0045841; GO:0045876; GO:0051177; GO:0051301; GO:0071168; GO:1990414	apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]		NA	NA	NA	NA	NA	NA
TRINITY_DN29953_c0_g1_i1	Q3SWX9	RAD21_BOVIN	100	111	0	0	334	2	292	402	2.50E-56	219.2	RAD21_BOVIN	reviewed	Double-strand-break repair protein rad21 homolog [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]	RAD21 SCC1	Bos taurus (Bovine)	630	"condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]"	"condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]"	chromatin binding [GO:0003682]	GO:0000780; GO:0000790; GO:0000795; GO:0000922; GO:0003682; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0007064; GO:0007130; GO:0007275; GO:0010972; GO:0016363; GO:0034990; GO:0034991; GO:0045841; GO:0045876; GO:0051177; GO:0051301; GO:0071168; GO:1990414	apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]		NA	NA	NA	NA	NA	NA
TRINITY_DN40191_c0_g1_i1	Q3SWX9	RAD21_BOVIN	43.1	72	38	1	316	110	556	627	6.10E-09	62	RAD21_BOVIN	reviewed	Double-strand-break repair protein rad21 homolog [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]	RAD21 SCC1	Bos taurus (Bovine)	630	"condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]"	"condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]"	chromatin binding [GO:0003682]	GO:0000780; GO:0000790; GO:0000795; GO:0000922; GO:0003682; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0007064; GO:0007130; GO:0007275; GO:0010972; GO:0016363; GO:0034990; GO:0034991; GO:0045841; GO:0045876; GO:0051177; GO:0051301; GO:0071168; GO:1990414	apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]		NA	NA	NA	NA	NA	NA
TRINITY_DN25787_c0_g1_i1	Q3SWX9	RAD21_BOVIN	50.7	138	63	2	539	126	292	424	2.20E-27	124	RAD21_BOVIN	reviewed	Double-strand-break repair protein rad21 homolog [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]	RAD21 SCC1	Bos taurus (Bovine)	630	"condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]"	"condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]"	chromatin binding [GO:0003682]	GO:0000780; GO:0000790; GO:0000795; GO:0000922; GO:0003682; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0007064; GO:0007130; GO:0007275; GO:0010972; GO:0016363; GO:0034990; GO:0034991; GO:0045841; GO:0045876; GO:0051177; GO:0051301; GO:0071168; GO:1990414	apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]		blue	blue	NA	NA	NA	NA
TRINITY_DN4624_c0_g1_i2	Q3L1C9	STAUH_APLCA	52.3	308	108	7	816	1	338	642	1.20E-75	284.6	STAUH_APLCA	reviewed	Double-stranded RNA-binding protein Staufen homolog		Aplysia californica (California sea hare)	950	neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880]	neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	mRNA binding [GO:0003729]	GO:0003729; GO:0032880; GO:0043005; GO:0043025; GO:0043204	regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN4624_c0_g1_i3	Q3L1C9	STAUH_APLCA	51.4	317	112	8	861	1	338	642	2.20E-75	283.9	STAUH_APLCA	reviewed	Double-stranded RNA-binding protein Staufen homolog		Aplysia californica (California sea hare)	950	neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880]	neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	mRNA binding [GO:0003729]	GO:0003729; GO:0032880; GO:0043005; GO:0043025; GO:0043204	regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN40795_c0_g1_i1	P55265	DSRAD_HUMAN	100	95	0	0	286	2	1002	1096	1.30E-50	199.9	DSRAD_HUMAN	reviewed	Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP)	ADAR ADAR1 DSRAD G1P1 IFI4	Homo sapiens (Human)	1226	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]	DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035280; GO:0035455; GO:0043066; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060337; GO:0060339; GO:0061484; GO:0098586; GO:1900369	adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566]; type I interferon signaling pathway [GO:0060337]		NA	NA	NA	NA	NA	NA
TRINITY_DN1481_c0_g1_i1	P78563	RED1_HUMAN	53.5	86	40	0	333	76	86	171	5.80E-18	91.7	RED1_HUMAN	reviewed	Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)	ADARB1 ADAR2 DRADA2 RED1	Homo sapiens (Human)	741	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045087; GO:0045202; GO:0046872; GO:0050884; GO:0051607; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049	adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]		NA	NA	NA	NA	NA	NA
TRINITY_DN1481_c0_g1_i2	P51400	RED1_RAT	49	563	249	10	1618	17	86	639	1.10E-133	478.4	RED1_RAT	reviewed	Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)	Adarb1 Red1	Rattus norvegicus (Rat)	711	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049	adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]		NA	NA	NA	NA	NA	NA
TRINITY_DN1481_c0_g1_i3	P51400	RED1_RAT	48.5	563	257	10	1633	17	86	639	6.90E-133	475.7	RED1_RAT	reviewed	Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)	Adarb1 Red1	Rattus norvegicus (Rat)	711	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049	adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]		NA	NA	NA	NA	NA	NA
TRINITY_DN1736_c0_g1_i1	Q9NS39	RED2_HUMAN	26.6	282	142	8	928	107	119	343	1.30E-10	68.9	RED2_HUMAN	reviewed	Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2)	ADARB2 ADAR3 RED2	Homo sapiens (Human)	739	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0003727; GO:0004000; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0008251; GO:0046872	adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN1736_c0_g1_i2	Q9NS39	RED2_HUMAN	27.9	297	160	9	973	107	93	343	4.60E-13	77	RED2_HUMAN	reviewed	Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2)	ADARB2 ADAR3 RED2	Homo sapiens (Human)	739	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0003727; GO:0004000; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0008251; GO:0046872	adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN1736_c0_g1_i5	Q9NS39	RED2_HUMAN	26.7	311	160	9	1015	107	93	343	2.00E-11	71.6	RED2_HUMAN	reviewed	Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2)	ADARB2 ADAR3 RED2	Homo sapiens (Human)	739	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0003727; GO:0004000; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0008251; GO:0046872	adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]		blue	blue	NA	NA	NA	NA
TRINITY_DN34405_c0_g1_i1	Q9VS29	DSCL_DROME	54.2	142	65	0	62	487	468	609	4.10E-41	169.1	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN25975_c0_g1_i1	Q9VS29	DSCL_DROME	34.8	132	85	1	4	396	761	892	1.30E-21	104	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN9431_c0_g1_i1	Q9VS29	DSCL_DROME	42.5	160	91	1	481	5	1156	1315	7.00E-33	141.7	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN37783_c0_g1_i1	Q9VS29	DSCL_DROME	56.1	57	25	0	221	51	463	519	5.50E-12	71.2	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN2810_c0_g1_i10	Q9VS29	DSCL_DROME	23.3	344	218	10	1304	390	968	1304	1.90E-09	65.9	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN2810_c0_g1_i3	Q9VS29	DSCL_DROME	23.3	344	218	10	1561	647	968	1304	2.20E-09	65.9	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN14516_c0_g1_i2	Q9VS29	DSCL_DROME	43.8	192	98	5	35	586	285	474	5.30E-35	149.1	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN32534_c0_g1_i1	Q9VS29	DSCL_DROME	79.2	48	10	0	63	206	421	468	4.80E-16	84.7	DSCL_DROME	reviewed	Down syndrome cell adhesion molecule-like protein Dscam2	Dscam2 CG42256	Drosophila melanogaster (Fruit fly)	2074	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN32858_c0_g1_i1	P9WQL8	DRRA_MYCTO	52.2	67	31	1	199	2	15	81	8.40E-12	70.5	DRRA_MYCTO	reviewed	Doxorubicin resistance ATP-binding protein DrrA (EC 7.6.2.-)	drrA MT3006	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	331	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; response to antibiotic [GO:0046677]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016887; GO:0043215; GO:0046677; GO:1900753	daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; response to antibiotic [GO:0046677]		NA	NA	NA	NA	NA	1
TRINITY_DN4430_c0_g1_i2	Q28CZ7	ISPD_XENTR	34.8	224	95	3	147	665	19	242	1.60E-26	122.1	ISPD_XENTR	reviewed	D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein)	crppa ispd TEgg020n22.1 TGas037c08.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	411	cytosol [GO:0005829]; cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]; brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle fiber development [GO:0048747]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]	cytosol [GO:0005829]	cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]	GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048747; GO:0048854; GO:0060049; GO:0070567	brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle fiber development [GO:0048747]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]		NA	NA	NA	NA	NA	NA
TRINITY_DN4430_c0_g1_i5	E1BCH6	ISPD_BOVIN	40.3	278	147	5	4	780	11	288	9.00E-52	206.1	ISPD_BOVIN	reviewed	D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein)	CRPPA ISPD	Bos taurus (Bovine)	445	cytosol [GO:0005829]; cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]; isoprenoid biosynthetic process [GO:0008299]; protein O-linked mannosylation [GO:0035269]	cytosol [GO:0005829]	cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]	GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0070567	isoprenoid biosynthetic process [GO:0008299]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN4430_c0_g1_i7	Q28CZ7	ISPD_XENTR	41.5	224	123	2	147	794	19	242	1.00E-42	176	ISPD_XENTR	reviewed	D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein)	crppa ispd TEgg020n22.1 TGas037c08.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	411	cytosol [GO:0005829]; cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]; brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle fiber development [GO:0048747]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]	cytosol [GO:0005829]	cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]	GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048747; GO:0048854; GO:0060049; GO:0070567	brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle fiber development [GO:0048747]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]		NA	NA	NA	NA	NA	NA
TRINITY_DN6741_c0_g1_i1	Q9US35	DSD1_SCHPO	28.9	391	252	10	1140	37	28	415	2.30E-43	177.9	DSD1_SCHPO	reviewed	D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase) (DSD)	SPAC1039.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	415	cytosol [GO:0005829]; nucleus [GO:0005634]; D-serine ammonia-lyase activity [GO:0008721]; D-serine catabolic process [GO:0036088]	cytosol [GO:0005829]; nucleus [GO:0005634]	D-serine ammonia-lyase activity [GO:0008721]	GO:0005634; GO:0005829; GO:0008721; GO:0036088	D-serine catabolic process [GO:0036088]		NA	NA	NA	NA	NA	NA
TRINITY_DN6741_c0_g1_i2	Q9US35	DSD1_SCHPO	32.1	184	116	4	648	124	28	211	1.70E-20	101.3	DSD1_SCHPO	reviewed	D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase) (DSD)	SPAC1039.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	415	cytosol [GO:0005829]; nucleus [GO:0005634]; D-serine ammonia-lyase activity [GO:0008721]; D-serine catabolic process [GO:0036088]	cytosol [GO:0005829]; nucleus [GO:0005634]	D-serine ammonia-lyase activity [GO:0008721]	GO:0005634; GO:0005829; GO:0008721; GO:0036088	D-serine catabolic process [GO:0036088]		NA	NA	NA	NA	NA	NA
TRINITY_DN1239_c0_g1_i2	A4XKL5	NTPPA_CALS8	44.1	102	52	2	378	73	2	98	1.60E-15	84.3	NTPPA_CALS8	reviewed	dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase)	Csac_1865	Caldicellulosiruptor saccharolyticus (strain ATCC 43494 / DSM 8903 / Tp8T 6331)	199	cytoplasm [GO:0005737]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]	GO:0005737; GO:0009117; GO:0035529; GO:0036218	nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN3511_c0_g1_i1	Q9VJ79	PDE11_DROME	71.1	457	132	0	1373	3	636	1092	1.50E-197	690.3	PDE11_DROME	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11)"	Pde11 CG34341	Drosophila melanogaster (Fruit fly)	1451	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555	cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3511_c0_g1_i3	Q9VJ79	PDE11_DROME	71.1	457	132	0	1373	3	636	1092	1.50E-197	690.3	PDE11_DROME	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11)"	Pde11 CG34341	Drosophila melanogaster (Fruit fly)	1451	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555	cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15126_c0_g1_i1	Q9HCR9	PDE11_HUMAN	51	202	52	1	466	2	680	881	1.60E-48	193.7	PDE11_HUMAN	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)"	PDE11A	Homo sapiens (Human)	933	"cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"	GO:0004112; GO:0004114; GO:0004118; GO:0005829; GO:0007165; GO:0007186; GO:0008152; GO:0010754; GO:0030553; GO:0043951; GO:0046872; GO:0047555	G protein-coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15126_c0_g1_i2	P0C1Q2	PDE11_MOUSE	55.3	76	34	0	356	129	826	901	2.20E-18	93.2	PDE11_MOUSE	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)"	Pde11a	Mus musculus (Mouse)	933	"cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; perikaryon [GO:0043204]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"	GO:0004112; GO:0004114; GO:0004118; GO:0005829; GO:0007165; GO:0008152; GO:0010754; GO:0030553; GO:0043204; GO:0043951; GO:0046872; GO:0047555	metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15126_c0_g1_i5	Q9HCR9	PDE11_HUMAN	61.7	222	85	0	794	129	680	901	3.60E-77	289.7	PDE11_HUMAN	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)"	PDE11A	Homo sapiens (Human)	933	"cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"	GO:0004112; GO:0004114; GO:0004118; GO:0005829; GO:0007165; GO:0007186; GO:0008152; GO:0010754; GO:0030553; GO:0043951; GO:0046872; GO:0047555	G protein-coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15126_c0_g1_i7	Q8VID6	PDE11_RAT	61.9	134	51	0	403	2	748	881	5.10E-44	178.7	PDE11_RAT	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)"	Pde11a	Rattus norvegicus (Rat)	935	"cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; perikaryon [GO:0043204]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"	GO:0004112; GO:0004114; GO:0004118; GO:0005829; GO:0007165; GO:0008152; GO:0010754; GO:0030553; GO:0043204; GO:0043951; GO:0046872; GO:0047555	metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8942_c0_g1_i4	Q1KKS3	PDE11_TAKRU	50.9	57	23	3	95	253	733	788	1.50E-06	53.5	PDE11_TAKRU	reviewed	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)"	pde11a	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	903	"cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; metabolic process [GO:0008152]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]"	GO:0005829; GO:0007165; GO:0008152; GO:0046872; GO:0047555	metabolic process [GO:0008152]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8140_c0_g1_i1	Q9VQH2	DUOX_DROME	36.5	178	113	0	208	741	1011	1188	1.90E-29	131	DUOX_DROME	reviewed	Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1)	Duox CG3131	Drosophila melanogaster (Fruit fly)	1537	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593	adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN33750_c0_g1_i1	Q9VQH2	DUOX_DROME	59.8	82	32	1	1	243	741	822	3.80E-19	95.1	DUOX_DROME	reviewed	Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1)	Duox CG3131	Drosophila melanogaster (Fruit fly)	1537	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593	adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN4952_c0_g1_i1	Q9VQH2	DUOX_DROME	34.4	369	180	9	11	1036	397	730	1.90E-48	194.5	DUOX_DROME	reviewed	Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1)	Duox CG3131	Drosophila melanogaster (Fruit fly)	1537	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593	adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN6318_c0_g1_i1	Q9NRD9	DUOX1_HUMAN	50.5	190	92	2	645	79	1363	1551	7.50E-50	198.7	DUOX1_HUMAN	reviewed	Dual oxidase 1 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1)	DUOX1 DUOX LNOX1 THOX1	Homo sapiens (Human)	1551	apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; NADP binding [GO:0050661]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]	apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; NADP binding [GO:0050661]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0004601; GO:0005509; GO:0005783; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0009986; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0031252; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0050661; GO:0050665; GO:0051591; GO:0055114; GO:0090303; GO:2000147	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]		NA	NA	NA	NA	NA	NA
TRINITY_DN6318_c0_g1_i2	Q8HZK2	DUOX2_PIG	49.3	280	138	3	909	79	1267	1545	6.00E-78	292.4	DUOX2_PIG	reviewed	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	Sus scrofa (Pig)	1545	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0004601; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0045177; GO:0050665; GO:0051591; GO:0055114	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]		NA	NA	NA	NA	NA	NA
TRINITY_DN11465_c0_g1_i1	Q1HG43	DOXA1_HUMAN	35.4	285	172	6	179	1018	21	298	7.50E-32	140.2	DOXA1_HUMAN	reviewed	Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein)	DUOXA1 NIP NUMBIP	Homo sapiens (Human)	343	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	enzyme binding [GO:0019899]	GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0016021; GO:0019899; GO:0031252; GO:0034613; GO:0042743; GO:0045666; GO:0050727; GO:2000609	cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]		NA	NA	NA	NA	NA	NA
TRINITY_DN11465_c0_g1_i2	Q1HG43	DOXA1_HUMAN	36.1	166	104	2	179	673	21	185	1.20E-20	101.7	DOXA1_HUMAN	reviewed	Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein)	DUOXA1 NIP NUMBIP	Homo sapiens (Human)	343	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	enzyme binding [GO:0019899]	GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0016021; GO:0019899; GO:0031252; GO:0034613; GO:0042743; GO:0045666; GO:0050727; GO:2000609	cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]		NA	NA	NA	NA	NA	NA
TRINITY_DN25865_c0_g1_i1	Q1L6Q1	DUSTY_APIME	32.4	210	122	4	7	636	33	222	1.80E-23	110.9	DUSTY_APIME	reviewed	Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)	DSTYK RIPK5	Apis mellifera (Honeybee)	969	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324			NA	NA	NA	NA	NA	NA
TRINITY_DN9861_c0_g1_i2	Q4VSN3	DUSTY_TETNG	60.9	578	225	1	1940	210	325	902	6.30E-208	725.3	DUSTY_TETNG	reviewed	Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)	dstyk ripk5	Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis)	922	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; embryonic organ development [GO:0048568]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0030054; GO:0048568	embryonic organ development [GO:0048568]		NA	NA	NA	NA	NA	NA
TRINITY_DN9861_c0_g1_i1	Q6XUX3	DUSTY_HUMAN	71.7	223	63	0	833	165	702	924	1.10E-92	341.3	DUSTY_HUMAN	reviewed	Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496) (SgK496)	DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P	Homo sapiens (Human)	929	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0030054; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070374	cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]		NA	NA	NA	NA	NA	NA
TRINITY_DN9861_c0_g1_i3	Q6XUX3	DUSTY_HUMAN	72.1	140	39	0	584	165	785	924	3.00E-58	226.5	DUSTY_HUMAN	reviewed	Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496) (SgK496)	DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P	Homo sapiens (Human)	929	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0030054; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070374	cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]		NA	NA	NA	NA	NA	NA
TRINITY_DN27415_c0_g1_i1	Q55CL6	MP2K1_DICDI	59.6	94	38	0	2	283	394	487	4.00E-28	125.2	MP2K1_DICDI	reviewed	Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (DdMEK1) (MEK1) (MAPK/ERK kinase A) (MEKA)	mekA MEK1 DDB_G0269152	Dictyostelium discoideum (Slime mold)	660	cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin binding [GO:0043130]; activation of MAPK activity [GO:0000187]; aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; MAPK cascade [GO:0000165]; protein localization to cell cortex [GO:0072697]; protein phosphorylation [GO:0006468]; sorocarp development [GO:0030587]	cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin binding [GO:0043130]	GO:0000165; GO:0000187; GO:0004674; GO:0004708; GO:0005524; GO:0005634; GO:0005829; GO:0005938; GO:0006468; GO:0030587; GO:0031152; GO:0031252; GO:0043130; GO:0043327; GO:0046872; GO:0072697	activation of MAPK activity [GO:0000187]; aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; MAPK cascade [GO:0000165]; protein localization to cell cortex [GO:0072697]; protein phosphorylation [GO:0006468]; sorocarp development [GO:0030587]		NA	NA	NA	NA	NA	NA
TRINITY_DN37478_c0_g1_i1	Q63980	MP2K1_CRIGR	100	101	0	0	1	303	133	233	3.20E-52	205.3	MP2K1_CRIGR	reviewed	Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1)	MAP2K1 MEK1 PRKMK1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	393	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN30710_c0_g1_i1	Q05116	MP2K1_XENLA	98.9	93	1	0	3	281	180	272	4.50E-48	191.4	MP2K1_XENLA	reviewed	Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK1)	map2k1	Xenopus laevis (African clawed frog)	395	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005815			NA	NA	NA	NA	NA	NA
TRINITY_DN9613_c0_g1_i4	Q02750	MP2K1_HUMAN	68.3	60	18	1	58	237	301	359	1.10E-15	84	MP2K1_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1)	MAP2K1 MEK1 PRKMK1	Homo sapiens (Human)	393	"cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; neuron differentiation [GO:0030182]; peptidyl-threonine phosphorylation [GO:0018107]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]"	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006935; GO:0007050; GO:0007165; GO:0007507; GO:0008022; GO:0008285; GO:0010628; GO:0010629; GO:0018107; GO:0021697; GO:0030182; GO:0030216; GO:0030878; GO:0032872; GO:0043539; GO:0045893; GO:0047485; GO:0048538; GO:0048679; GO:0048870; GO:0050772; GO:0060020; GO:0060324; GO:0060440; GO:0060502; GO:0060674; GO:0060711; GO:0070371; GO:0070374; GO:0071902; GO:0090170; GO:0090398; GO:0097110; GO:1903800; GO:2000641	"activation of MAPK activity [GO:0000187]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; neuron differentiation [GO:0030182]; peptidyl-threonine phosphorylation [GO:0018107]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]"	x	NA	NA	1	NA	NA	NA
TRINITY_DN9613_c0_g1_i6	Q1HG70	MP2K2_CANLF	82.1	84	15	0	2	253	154	237	8.80E-32	137.5	MP2K2_CANLF	reviewed	Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2)	MAP2K2 MEK2	Canis lupus familiaris (Dog) (Canis familiaris)	400	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]	cytoplasm [GO:0005737]; membrane [GO:0016020]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005737; GO:0016020; GO:0046872	activation of MAPK activity [GO:0000187]		NA	NA	NA	NA	NA	NA
TRINITY_DN33237_c0_g1_i1	P36507	MP2K2_HUMAN	100	99	0	0	299	3	148	246	2.30E-50	199.1	MP2K2_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2)	MAP2K2 MEK2 MKK2 PRKMK2	Homo sapiens (Human)	400	"cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]"	cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0000187; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005576; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005911; GO:0005925; GO:0009898; GO:0010629; GO:0030165; GO:0032872; GO:0036289; GO:0043539; GO:0045893; GO:0046872; GO:0048471; GO:0070371; GO:0071902; GO:0090170; GO:0097110; GO:1903800; GO:2000641	"activation of MAPK activity [GO:0000187]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40556_c0_g1_i1	P36507	MP2K2_HUMAN	100	90	0	0	2	271	311	400	1.30E-48	193.4	MP2K2_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2)	MAP2K2 MEK2 MKK2 PRKMK2	Homo sapiens (Human)	400	"cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]"	cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0000187; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005576; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005911; GO:0005925; GO:0009898; GO:0010629; GO:0030165; GO:0032872; GO:0036289; GO:0043539; GO:0045893; GO:0046872; GO:0048471; GO:0070371; GO:0071902; GO:0090170; GO:0097110; GO:1903800; GO:2000641	"activation of MAPK activity [GO:0000187]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23329_c0_g1_i1	O09110	MP2K3_MOUSE	100	137	0	0	1	411	153	289	4.80E-75	281.6	MP2K3_MOUSE	reviewed	Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3)	Map2k3 Mkk3 Prkmk3	Mus musculus (Mouse)	347	"cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; cardiac muscle contraction [GO:0060048]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]"	cytosol [GO:0005829]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0000187; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005829; GO:0006954; GO:0019901; GO:0035331; GO:0035924; GO:0038066; GO:0042035; GO:0043536; GO:0045860; GO:0045893; GO:0060048	"activation of MAPK activity [GO:0000187]; cardiac muscle contraction [GO:0060048]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18806_c0_g1_i1	O09110	MP2K3_MOUSE	100	92	0	0	3	278	52	143	1.40E-46	186.4	MP2K3_MOUSE	reviewed	Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3)	Map2k3 Mkk3 Prkmk3	Mus musculus (Mouse)	347	"cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; cardiac muscle contraction [GO:0060048]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]"	cytosol [GO:0005829]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0000187; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005829; GO:0006954; GO:0019901; GO:0035331; GO:0035924; GO:0038066; GO:0042035; GO:0043536; GO:0045860; GO:0045893; GO:0060048	"activation of MAPK activity [GO:0000187]; cardiac muscle contraction [GO:0060048]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18806_c0_g1_i3	P46734	MP2K3_HUMAN	100	238	0	0	3	716	52	289	1.90E-135	483	MP2K3_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2)	MAP2K3 MEK3 MKK3 PRKMK3 SKK2	Homo sapiens (Human)	347	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; cardiac muscle contraction [GO:0060048]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0006954; GO:0007165; GO:0016020; GO:0019901; GO:0035331; GO:0035924; GO:0038066; GO:0042035; GO:0043536; GO:0045860; GO:0045893; GO:0060048	"activation of MAPK activity [GO:0000187]; cardiac muscle contraction [GO:0060048]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18499_c0_g1_i2	P45985	MP2K4_HUMAN	100	189	0	0	1	567	130	318	3.00E-107	389	MP2K4_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	Homo sapiens (Human)	399	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0006915; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0030424; GO:0031435; GO:0032839; GO:0034393; GO:0038095; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN18499_c0_g1_i3	P45985	MP2K4_HUMAN	100	189	0	0	1	567	130	318	3.00E-107	389	MP2K4_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	Homo sapiens (Human)	399	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0006915; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0030424; GO:0031435; GO:0032839; GO:0034393; GO:0038095; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN786_c0_g1_i1	P45985	MP2K4_HUMAN	65.5	365	109	4	1208	132	35	388	1.90E-132	474.2	MP2K4_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	Homo sapiens (Human)	399	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0006915; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0030424; GO:0031435; GO:0032839; GO:0034393; GO:0038095; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN786_c0_g1_i4	P45985	MP2K4_HUMAN	72.2	317	86	2	1079	132	73	388	9.20E-132	472.2	MP2K4_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	Homo sapiens (Human)	399	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0006915; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0030424; GO:0031435; GO:0032839; GO:0034393; GO:0038095; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN786_c0_g1_i5	P45985	MP2K4_HUMAN	72.2	317	86	2	1079	132	73	388	5.80E-132	472.6	MP2K4_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	Homo sapiens (Human)	399	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0006915; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0030424; GO:0031435; GO:0032839; GO:0034393; GO:0038095; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32073_c0_g1_i1	P45985	MP2K4_HUMAN	98.9	93	1	0	1	279	68	160	1.90E-46	186	MP2K4_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	Homo sapiens (Human)	399	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0006915; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0030424; GO:0031435; GO:0032839; GO:0034393; GO:0038095; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; response to wounding [GO:0009611]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN18806_c0_g1_i2	Q5E9X2	MP2K6_BOVIN	95.7	116	5	0	1	348	163	278	4.40E-61	235	MP2K6_BOVIN	reviewed	Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6)	MAP2K6	Bos taurus (Bovine)	334	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; negative regulation of cold-induced thermogenesis [GO:0120163]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0019901; GO:0060048; GO:0120163	apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; negative regulation of cold-induced thermogenesis [GO:0120163]		NA	NA	NA	NA	NA	NA
TRINITY_DN12334_c0_g1_i1	P70236	MP2K6_MOUSE	66.1	254	86	0	765	4	40	293	6.40E-97	355.1	MP2K6_MOUSE	reviewed	Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (SAPKK3)	Map2k6 Prkmk6 Sapkk3	Mus musculus (Mouse)	334	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to drug [GO:0042493]; response to ischemia [GO:0002931]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0000187; GO:0001934; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006468; GO:0006915; GO:0019901; GO:0022602; GO:0032308; GO:0042493; GO:0042802; GO:0043065; GO:0051770; GO:0060048; GO:0072709; GO:0120163	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to drug [GO:0042493]; response to ischemia [GO:0002931]		blue	blue	NA	NA	NA	NA
TRINITY_DN34056_c0_g1_i1	P70236	MP2K6_MOUSE	100	72	0	0	217	2	59	130	1.10E-35	149.8	MP2K6_MOUSE	reviewed	Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (SAPKK3)	Map2k6 Prkmk6 Sapkk3	Mus musculus (Mouse)	334	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to drug [GO:0042493]; response to ischemia [GO:0002931]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0000187; GO:0001934; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006468; GO:0006915; GO:0019901; GO:0022602; GO:0032308; GO:0042493; GO:0042802; GO:0043065; GO:0051770; GO:0060048; GO:0072709; GO:0120163	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to drug [GO:0042493]; response to ischemia [GO:0002931]		NA	NA	NA	NA	NA	NA
TRINITY_DN5612_c0_g1_i1	O14733	MP2K7_HUMAN	59.1	367	128	8	1068	1	4	359	3.40E-107	389.8	MP2K7_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)	MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4	Homo sapiens (Human)	419	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0032212; GO:0034612; GO:0038095; GO:0045893; GO:0051403; GO:0051973; GO:0070374; GO:1904355	"activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11558_c0_g1_i1	O14733	MP2K7_HUMAN	46.6	58	26	1	4	177	363	415	2.10E-06	52.8	MP2K7_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)	MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4	Homo sapiens (Human)	419	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0032212; GO:0034612; GO:0038095; GO:0045893; GO:0051403; GO:0051973; GO:0070374; GO:1904355	"activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11558_c0_g1_i2	O14733	MP2K7_HUMAN	55	40	18	0	4	123	363	402	1.60E-05	49.7	MP2K7_HUMAN	reviewed	Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)	MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4	Homo sapiens (Human)	419	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0032212; GO:0034612; GO:0038095; GO:0045893; GO:0051403; GO:0051973; GO:0070374; GO:1904355	"activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9613_c0_g1_i3	Q24324	DSOR1_DROME	70.9	234	57	2	2	703	169	391	2.90E-87	323.2	DSOR1_DROME	reviewed	Dual specificity mitogen-activated protein kinase kinase dSOR1 (Downstream of RAF) (MAPKK) (EC 2.7.12.2)	Dsor1 CG15793	Drosophila melanogaster (Fruit fly)	396	"condensed chromosome [GO:0000793]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	condensed chromosome [GO:0000793]; cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0000793; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005829; GO:0006468; GO:0007095; GO:0007173; GO:0007298; GO:0007362; GO:0007430; GO:0007465; GO:0007623; GO:0008286; GO:0008293; GO:0008340; GO:0008543; GO:0009953; GO:0019900; GO:0033314; GO:0042386; GO:0042461; GO:0045500; GO:0048010; GO:0051607; GO:0070371; GO:0071481	"activation of MAPK activity [GO:0000187]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9613_c0_g1_i5	Q24324	DSOR1_DROME	62.5	32	12	0	87	182	360	391	1.60E-06	53.1	DSOR1_DROME	reviewed	Dual specificity mitogen-activated protein kinase kinase dSOR1 (Downstream of RAF) (MAPKK) (EC 2.7.12.2)	Dsor1 CG15793	Drosophila melanogaster (Fruit fly)	396	"condensed chromosome [GO:0000793]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	condensed chromosome [GO:0000793]; cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0000793; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005829; GO:0006468; GO:0007095; GO:0007173; GO:0007298; GO:0007362; GO:0007430; GO:0007465; GO:0007623; GO:0008286; GO:0008293; GO:0008340; GO:0008543; GO:0009953; GO:0019900; GO:0033314; GO:0042386; GO:0042461; GO:0045500; GO:0048010; GO:0051607; GO:0070371; GO:0071481	"activation of MAPK activity [GO:0000187]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9613_c0_g1_i7	Q24324	DSOR1_DROME	70.9	234	57	2	2	703	169	391	3.20E-87	323.2	DSOR1_DROME	reviewed	Dual specificity mitogen-activated protein kinase kinase dSOR1 (Downstream of RAF) (MAPKK) (EC 2.7.12.2)	Dsor1 CG15793	Drosophila melanogaster (Fruit fly)	396	"condensed chromosome [GO:0000793]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	condensed chromosome [GO:0000793]; cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000187; GO:0000793; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005829; GO:0006468; GO:0007095; GO:0007173; GO:0007298; GO:0007362; GO:0007430; GO:0007465; GO:0007623; GO:0008286; GO:0008293; GO:0008340; GO:0008543; GO:0009953; GO:0019900; GO:0033314; GO:0042386; GO:0042461; GO:0045500; GO:0048010; GO:0051607; GO:0070371; GO:0071481	"activation of MAPK activity [GO:0000187]; border follicle cell migration [GO:0007298]; cellular response to X-ray [GO:0071481]; circadian rhythm [GO:0007623]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte differentiation [GO:0042386]; insulin receptor signaling pathway [GO:0008286]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; photoreceptor cell development [GO:0042461]; protein phosphorylation [GO:0006468]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17620_c0_g1_i2	P49759	CLK1_HUMAN	100	90	0	0	3	272	330	419	5.50E-51	201.1	CLK1_HUMAN	reviewed	Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1)	CLK1 CLK	Homo sapiens (Human)	484	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004712; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0018107; GO:0043484; GO:0046777	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN32885_c0_g1_i1	P49759	CLK1_HUMAN	100	84	0	0	253	2	188	271	9.40E-45	180.3	CLK1_HUMAN	reviewed	Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1)	CLK1 CLK	Homo sapiens (Human)	484	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004712; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0018107; GO:0043484; GO:0046777	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN20679_c0_g1_i1	P22518	CLK1_MOUSE	100	82	0	0	3	248	341	422	4.80E-46	184.5	CLK1_MOUSE	reviewed	Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) (Protein kinase STY)	Clk1 Clk Sty	Mus musculus (Mouse)	483	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0018107; GO:0018108; GO:0043484; GO:0046777	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN17620_c0_g1_i1	P22518	CLK1_MOUSE	94.6	148	8	0	13	456	271	418	7.70E-82	304.3	CLK1_MOUSE	reviewed	Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) (Protein kinase STY)	Clk1 Clk Sty	Mus musculus (Mouse)	483	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0018107; GO:0018108; GO:0043484; GO:0046777	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN33217_c0_g1_i1	P49760	CLK2_HUMAN	95.3	129	6	0	389	3	261	389	3.70E-69	261.9	CLK2_HUMAN	reviewed	Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2)	CLK2	Homo sapiens (Human)	499	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777	negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]		NA	NA	NA	NA	NA	NA
TRINITY_DN25897_c0_g1_i1	P49760	CLK2_HUMAN	98.3	119	2	0	357	1	201	319	1.30E-65	250	CLK2_HUMAN	reviewed	Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2)	CLK2	Homo sapiens (Human)	499	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777	negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]		NA	NA	NA	NA	NA	NA
TRINITY_DN17837_c0_g1_i1	Q3SX21	CLK3_BOVIN	100	86	0	0	1	258	333	418	6.30E-49	194.1	CLK3_BOVIN	reviewed	Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3)	CLK3	Bos taurus (Bovine)	490	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0001669; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0042802; GO:0043484; GO:0045111; GO:0046777	protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN17837_c0_g2_i1	Q3SX21	CLK3_BOVIN	100	224	0	0	1	672	170	393	1.80E-132	473	CLK3_BOVIN	reviewed	Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3)	CLK3	Bos taurus (Bovine)	490	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0001669; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0042802; GO:0043484; GO:0045111; GO:0046777	protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN34572_c0_g1_i1	O35493	CLK4_MOUSE	100	82	0	0	248	3	336	417	2.40E-45	182.2	CLK4_MOUSE	reviewed	Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4)	Clk4	Mus musculus (Mouse)	481	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0018108; GO:0043484; GO:0046777	peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN24281_c0_g1_i1	O35493	CLK4_MOUSE	100	165	0	0	496	2	183	347	2.80E-93	342.4	CLK4_MOUSE	reviewed	Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4)	Clk4	Mus musculus (Mouse)	481	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0018108; GO:0043484; GO:0046777	peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]		NA	NA	NA	NA	NA	NA
TRINITY_DN34979_c0_g1_i1	P28562	DUS1_HUMAN	100	85	0	0	257	3	220	304	2.30E-43	175.6	DUS1_HUMAN	reviewed	Dual specificity protein phosphatase 1 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH1) (Mitogen-activated protein kinase phosphatase 1) (MAP kinase phosphatase 1) (MKP-1) (Protein-tyrosine phosphatase CL100)	DUSP1 CL100 MKP1 PTPN10 VH1	Homo sapiens (Human)	367	cytoplasm [GO:0005737]; nucleus [GO:0005634]; growth factor binding [GO:0019838]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; cellular response to chemokine [GO:1990869]; cellular response to hormone stimulus [GO:0032870]; endoderm formation [GO:0001706]; inactivation of MAPK activity [GO:0000188]; intracellular signal transduction [GO:0035556]; mitotic cell cycle arrest [GO:0071850]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of p38MAPK cascade [GO:1903753]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to light stimulus [GO:0009416]; response to retinoic acid [GO:0032526]; response to testosterone [GO:0033574]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	growth factor binding [GO:0019838]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0001706; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0007162; GO:0008138; GO:0008285; GO:0008330; GO:0009416; GO:0017017; GO:0019838; GO:0032355; GO:0032526; GO:0032870; GO:0033574; GO:0035335; GO:0035556; GO:0035970; GO:0042542; GO:0043065; GO:0043066; GO:0043407; GO:0043409; GO:0051019; GO:0051384; GO:0051447; GO:0051591; GO:0051592; GO:0070262; GO:0070373; GO:0071850; GO:0090027; GO:0090266; GO:1903753; GO:1990869; GO:2000279	cellular response to chemokine [GO:1990869]; cellular response to hormone stimulus [GO:0032870]; endoderm formation [GO:0001706]; inactivation of MAPK activity [GO:0000188]; intracellular signal transduction [GO:0035556]; mitotic cell cycle arrest [GO:0071850]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of p38MAPK cascade [GO:1903753]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to light stimulus [GO:0009416]; response to retinoic acid [GO:0032526]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN35691_c0_g1_i1	Q0IID7	DUS10_BOVIN	70.8	72	21	0	864	649	396	467	4.00E-21	103.6	DUS10_BOVIN	reviewed	Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP10	Bos taurus (Bovine)	482	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]	JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0002819; GO:0004721; GO:0004725; GO:0005737; GO:0005794; GO:0005829; GO:0006470; GO:0008330; GO:0008432; GO:0010633; GO:0016607; GO:0017017; GO:0032496; GO:0033549; GO:0035335; GO:0035970; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051019; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264	inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN35691_c0_g1_i2	Q0IID7	DUS10_BOVIN	44.9	341	165	4	1653	649	144	467	4.40E-78	293.9	DUS10_BOVIN	reviewed	Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP10	Bos taurus (Bovine)	482	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]	JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0002819; GO:0004721; GO:0004725; GO:0005737; GO:0005794; GO:0005829; GO:0006470; GO:0008330; GO:0008432; GO:0010633; GO:0016607; GO:0017017; GO:0032496; GO:0033549; GO:0035335; GO:0035970; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051019; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264	inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN35841_c0_g1_i1	Q0IID7	DUS10_BOVIN	43.4	76	43	0	9	236	377	452	5.70E-12	71.2	DUS10_BOVIN	reviewed	Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP10	Bos taurus (Bovine)	482	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]	JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0002819; GO:0004721; GO:0004725; GO:0005737; GO:0005794; GO:0005829; GO:0006470; GO:0008330; GO:0008432; GO:0010633; GO:0016607; GO:0017017; GO:0032496; GO:0033549; GO:0035335; GO:0035970; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051019; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264	inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN29085_c0_g1_i1	Q17QM8	DUS14_BOVIN	100	87	0	0	2	262	100	186	2.30E-46	185.7	DUS14_BOVIN	reviewed	Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP14	Bos taurus (Bovine)	198	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]		MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0017017			NA	NA	NA	NA	NA	NA
TRINITY_DN8439_c0_g1_i1	Q17QM8	DUS14_BOVIN	34.7	173	103	5	640	128	26	190	8.10E-14	79.3	DUS14_BOVIN	reviewed	Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP14	Bos taurus (Bovine)	198	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]		MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0017017			NA	NA	NA	NA	NA	NA
TRINITY_DN5940_c0_g1_i1	Q9BY84	DUS16_HUMAN	51.9	79	38	0	1	237	221	299	3.70E-20	98.6	DUS16_HUMAN	reviewed	Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7)	DUSP16 KIAA1700 MKP7	Homo sapiens (Human)	665	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; MAPK export from nucleus [GO:0045204]; MAPK phosphatase export from nucleus, leptomycin B sensitive [GO:0045209]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0031410; GO:0035335; GO:0035970; GO:0045204; GO:0045209; GO:0051019	"dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; MAPK export from nucleus [GO:0045204]; MAPK phosphatase export from nucleus, leptomycin B sensitive [GO:0045209]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40762_c0_g1_i1	Q05923	DUS2_HUMAN	98.7	79	1	0	237	1	224	302	1.90E-39	162.5	DUS2_HUMAN	reviewed	Dual specificity protein phosphatase 2 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PAC-1)	DUSP2 PAC1	Homo sapiens (Human)	314	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; endoderm formation [GO:0001706]; inactivation of MAPK activity [GO:0000188]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008330; GO:0017017; GO:0031965; GO:0035335; GO:0035970; GO:0051019	endoderm formation [GO:0001706]; inactivation of MAPK activity [GO:0000188]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1132_c3_g1_i2	P51452	DUS3_HUMAN	46.9	98	51	1	401	111	80	177	1.30E-17	91.7	DUS3_HUMAN	reviewed	Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR)	DUSP3 VHR	Homo sapiens (Human)	185	cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]	cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]	GO:0000188; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782	cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]		NA	NA	NA	NA	NA	NA
TRINITY_DN7252_c0_g1_i1	Q9D7X3	DUS3_MOUSE	46.7	150	79	1	540	94	31	180	1.70E-33	144.4	DUS3_MOUSE	reviewed	Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (T-DSP11) (Vaccinia H1-related phosphatase) (VHR)	Dusp3	Mus musculus (Mouse)	185	cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]	cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]	GO:0000188; GO:0001701; GO:0001772; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030336; GO:0030971; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990264; GO:1990782	cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; in utero embryonic development [GO:0001701]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; protein dephosphorylation [GO:0006470]; regulation of focal adhesion assembly [GO:0051893]		blue	blue	NA	NA	NA	NA
TRINITY_DN28162_c0_g1_i1	Q16690	DUS5_HUMAN	100	75	0	0	2	226	238	312	5.70E-38	157.5	DUS5_HUMAN	reviewed	Dual specificity protein phosphatase 5 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH3)	DUSP5 VH3	Homo sapiens (Human)	384	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; activation of MAPK activity [GO:0000187]; dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000165; GO:0000187; GO:0000188; GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008138; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0035335; GO:0035970; GO:0051019	activation of MAPK activity [GO:0000187]; dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN17306_c0_g1_i2	Q2KJ36	DUS6_BOVIN	98.7	76	1	0	561	334	193	268	5.80E-39	162.2	DUS6_BOVIN	reviewed	Dual specificity protein phosphatase 6 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP6	Bos taurus (Bovine)	381	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420]; response to nitrosative stress [GO:0051409]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0004721; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0017017; GO:0035335; GO:0035970; GO:0043065; GO:0051019; GO:0051409; GO:0060420; GO:0070373	inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420]; response to nitrosative stress [GO:0051409]		NA	NA	NA	NA	NA	NA
TRINITY_DN17306_c0_g1_i2	Q2KJ36	DUS6_BOVIN	75.9	87	18	1	341	81	285	368	4.60E-28	125.9	DUS6_BOVIN	reviewed	Dual specificity protein phosphatase 6 (EC 3.1.3.16) (EC 3.1.3.48)	DUSP6	Bos taurus (Bovine)	381	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420]; response to nitrosative stress [GO:0051409]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0004721; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0017017; GO:0035335; GO:0035970; GO:0043065; GO:0051019; GO:0051409; GO:0060420; GO:0070373	inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420]; response to nitrosative stress [GO:0051409]		NA	NA	NA	NA	NA	NA
TRINITY_DN17306_c0_g1_i1	Q16828	DUS6_HUMAN	100	184	0	0	554	3	193	376	3.00E-104	379	DUS6_HUMAN	reviewed	Dual specificity protein phosphatase 6 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3) (MAP kinase phosphatase 3) (MKP-3)	DUSP6 MKP3 PYST1	Homo sapiens (Human)	381	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; activation of MAPK activity [GO:0000187]; cell differentiation [GO:0030154]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420]; response to drug [GO:0042493]; response to growth factor [GO:0070848]; response to nitrosative stress [GO:0051409]; response to organic cyclic compound [GO:0014070]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000165; GO:0000187; GO:0000188; GO:0004721; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0014070; GO:0017017; GO:0030154; GO:0035335; GO:0035970; GO:0042493; GO:0043065; GO:0051019; GO:0051409; GO:0060420; GO:0070373; GO:0070848	activation of MAPK activity [GO:0000187]; cell differentiation [GO:0030154]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420]; response to drug [GO:0042493]; response to growth factor [GO:0070848]; response to nitrosative stress [GO:0051409]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN17306_c0_g1_i3	Q16829	DUS7_HUMAN	44	359	180	9	1115	84	53	405	2.00E-76	287.7	DUS7_HUMAN	reviewed	Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2)	DUSP7 PYST2	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; activation of MAPK activity [GO:0000187]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000165; GO:0000187; GO:0000188; GO:0004721; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0017017; GO:0035335; GO:0035970; GO:0043407; GO:0051019	activation of MAPK activity [GO:0000187]; inactivation of MAPK activity [GO:0000188]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN16241_c0_g1_i1	Q9UNH5	CC14A_HUMAN	44.7	76	42	0	2	229	147	222	4.30E-17	88.2	CC14A_HUMAN	reviewed	Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A)	CDC14A	Homo sapiens (Human)	594	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]	protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000226; GO:0000278; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0008138; GO:0016604; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0071850; GO:0072686; GO:1902636	cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN36489_c0_g1_i1	Q9UNH5	CC14A_HUMAN	100	109	0	0	329	3	7	115	2.90E-59	228.8	CC14A_HUMAN	reviewed	Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A)	CDC14A	Homo sapiens (Human)	594	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]	protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000226; GO:0000278; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0008138; GO:0016604; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0071850; GO:0072686; GO:1902636	cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN24064_c0_g1_i2	Q9UNH5	CC14A_HUMAN	100	93	0	0	2	280	240	332	6.60E-52	204.1	CC14A_HUMAN	reviewed	Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A)	CDC14A	Homo sapiens (Human)	594	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]	protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000226; GO:0000278; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0008138; GO:0016604; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0071850; GO:0072686; GO:1902636	cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN29758_c0_g1_i1	Q9UNH5	CC14A_HUMAN	56.5	462	145	3	50	1435	1	406	2.10E-152	540.4	CC14A_HUMAN	reviewed	Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A)	CDC14A	Homo sapiens (Human)	594	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]	protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000226; GO:0000278; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0008138; GO:0016604; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0071850; GO:0072686; GO:1902636	cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN15122_c0_g1_i1	Q9VWF4	DUSK4_DROME	45.2	93	50	1	108	383	30	122	2.60E-14	79.7	DUSK4_DROME	reviewed	Dual specificity protein phosphatase MPK-4 (EC 3.1.3.16) (EC 3.1.3.48)	MKP-4 CG14211	Drosophila melanogaster (Fruit fly)	387	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; negative regulation of JUN kinase activity [GO:0043508]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	phosphatase activity [GO:0016791]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0008138; GO:0016311; GO:0016791; GO:0043508	dephosphorylation [GO:0016311]; negative regulation of JUN kinase activity [GO:0043508]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN25779_c0_g1_i1	Q15569	TESK1_HUMAN	66.7	51	16	1	153	4	37	87	3.00E-11	69.3	TESK1_HUMAN	reviewed	Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1)	TESK1	Homo sapiens (Human)	626	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of stress fiber assembly [GO:0051496]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0008022; GO:0019901; GO:0030036; GO:0031410; GO:0031953; GO:0032880; GO:0046872; GO:0051496; GO:0071901	actin cytoskeleton organization [GO:0030036]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of stress fiber assembly [GO:0051496]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4723_c0_g1_i1	Q924U5	TESK2_RAT	39.9	223	103	5	1763	1155	192	403	2.10E-34	148.7	TESK2_RAT	reviewed	Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2)	Tesk2	Rattus norvegicus (Rat)	570	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006915; GO:0007283; GO:0016604; GO:0030036; GO:0035556; GO:0046872; GO:0048041	actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN32208_c0_g1_i1	Q13627	DYR1A_HUMAN	92.9	112	8	0	338	3	269	380	1.30E-57	223.4	DYR1A_HUMAN	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB)	DYRK1A DYRK MNB MNBH	Homo sapiens (Human)	763	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]	GO:0000381; GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0015631; GO:0016032; GO:0016607; GO:0018105; GO:0018107; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0033120; GO:0034205; GO:0036289; GO:0038083; GO:0042802; GO:0043518; GO:0043621; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0090312; GO:1990904	"amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36781_c0_g1_i1	Q9Z188	DYR1B_MOUSE	100	80	0	0	242	3	244	323	1.20E-41	169.9	DYR1B_MOUSE	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (EC 2.7.12.1)	Dyrk1b	Mus musculus (Mouse)	629	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription coactivator activity [GO:0003713]; adipose tissue development [GO:0060612]; myoblast fusion [GO:0007520]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0007520; GO:0018105; GO:0018107; GO:0045893; GO:0046777; GO:0060612	"adipose tissue development [GO:0060612]; myoblast fusion [GO:0007520]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35533_c0_g1_i1	Q5ZIU3	DYRK2_CHICK	100	92	0	0	277	2	234	325	9.00E-49	193.7	DYRK2_CHICK	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1)	DYRK2 RCJMB04_23i19	Gallus gallus (Chicken)	526	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0018105; GO:0018107; GO:0030145; GO:0042771; GO:0045725	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN11426_c0_g2_i1	Q5ZIU3	DYRK2_CHICK	83.1	177	30	0	1	531	223	399	6.60E-85	314.7	DYRK2_CHICK	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1)	DYRK2 RCJMB04_23i19	Gallus gallus (Chicken)	526	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0018105; GO:0018107; GO:0030145; GO:0042771; GO:0045725	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN21021_c0_g1_i1	Q9V3D5	DYRK2_DROME	80.6	103	20	0	2	310	284	386	4.60E-46	184.9	DYRK2_DROME	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) (Protein smell impaired at 35A) (dDyrk2)	Dyrk2 smi35A CG4551	Drosophila melanogaster (Fruit fly)	722	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; olfactory behavior [GO:0042048]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007608; GO:0009416; GO:0018105; GO:0018107; GO:0030177; GO:0042048	olfactory behavior [GO:0042048]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN21021_c0_g1_i2	Q9V3D5	DYRK2_DROME	83.1	59	10	0	38	214	328	386	3.40E-24	111.7	DYRK2_DROME	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) (Protein smell impaired at 35A) (dDyrk2)	Dyrk2 smi35A CG4551	Drosophila melanogaster (Fruit fly)	722	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; olfactory behavior [GO:0042048]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007608; GO:0009416; GO:0018105; GO:0018107; GO:0030177; GO:0042048	olfactory behavior [GO:0042048]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN30055_c0_g1_i1	Q9V3D5	DYRK2_DROME	39.3	191	99	5	1548	1003	312	494	3.50E-25	117.9	DYRK2_DROME	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) (Protein smell impaired at 35A) (dDyrk2)	Dyrk2 smi35A CG4551	Drosophila melanogaster (Fruit fly)	722	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; olfactory behavior [GO:0042048]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007608; GO:0009416; GO:0018105; GO:0018107; GO:0030177; GO:0042048	olfactory behavior [GO:0042048]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN29993_c0_g1_i1	Q9NR20	DYRK4_HUMAN	63.9	191	68	1	575	3	194	383	4.50E-71	268.9	DYRK4_HUMAN	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1)	DYRK4	Homo sapiens (Human)	520	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0018105; GO:0018107; GO:0043231; GO:0046872	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]		NA	NA	NA	NA	NA	NA
TRINITY_DN37253_c0_g1_i1	A8WJR8	MBK2_CAEBR	55.5	110	49	0	6	335	563	672	9.50E-29	127.5	MBK2_CAEBR	reviewed	Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 (EC 2.7.12.1) (Dual specificity Yak1-related kinase mbk-2) (Minibrain Kinase 2)	mbk-2 CBG23998	Caenorhabditis briggsae	815	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0005938; GO:0007275; GO:0007608; GO:0018105; GO:0018107; GO:0050896	multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN31784_c0_g1_i1	P0AGF5	XYLE_ECO57	38.2	55	33	1	9	173	190	243	7.70E-06	50.8	XYLE_ECO57	reviewed	D-xylose-proton symporter (D-xylose transporter)	xylE Z5629 ECs5014	Escherichia coli O157:H7	491	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	symporter activity [GO:0015293]	GO:0005886; GO:0008643; GO:0015293; GO:0016021	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i14	Q8L6Z8	XYLL1_ARATH	34.3	99	58	2	79	369	294	387	7.60E-05	48.5	XYLL1_ARATH	reviewed	D-xylose-proton symporter-like 1	At3g03090 T17B22.22	Arabidopsis thaliana (Mouse-ear cress)	503	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; fructose transmembrane transport [GO:0015755]; positive regulation of flower development [GO:0009911]; response to nematode [GO:0009624]; seed germination [GO:0009845]	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; vacuolar membrane [GO:0005774]	fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]	GO:0005353; GO:0005355; GO:0005774; GO:0009624; GO:0009705; GO:0009845; GO:0009911; GO:0015755; GO:0016021	fructose transmembrane transport [GO:0015755]; positive regulation of flower development [GO:0009911]; response to nematode [GO:0009624]; seed germination [GO:0009845]		NA	NA	NA	NA	NA	NA
TRINITY_DN9832_c0_g2_i1	Q6PCJ1	DCTN1_XENLA	37.8	640	392	4	1909	2	310	947	5.20E-82	307	DCTN1_XENLA	reviewed	Dynactin subunit 1	dctn1	Xenopus laevis (African clawed frog)	1232	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; spindle [GO:0005819]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236]; transport along microtubule [GO:0010970]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; spindle [GO:0005819]	microtubule binding [GO:0008017]; motor activity [GO:0003774]	GO:0000132; GO:0000776; GO:0003774; GO:0005813; GO:0005814; GO:0005819; GO:0005874; GO:0005938; GO:0008017; GO:0010970; GO:0030286; GO:0031122; GO:0035371; GO:0051301; GO:0060236; GO:0090316; GO:0099738	cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN9832_c0_g1_i1	P13496	DCTN1_DROME	64.4	73	26	0	803	585	1	73	9.20E-23	109	DCTN1_DROME	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (Dynactin 1 subunit p150) (Protein glued)	DCTN1-p150 Gl CG9206	Drosophila melanogaster (Fruit fly)	1265	"aster [GO:0005818]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; type Ib terminal bouton [GO:0061176]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; axon extension [GO:0048675]; axonal transport of mitochondrion [GO:0019896]; cell fate determination [GO:0001709]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of mitotic spindle orientation [GO:0000132]; evoked neurotransmitter secretion [GO:0061670]; eye photoreceptor cell differentiation [GO:0001754]; intracellular protein transport [GO:0006886]; kinetochore organization [GO:0051383]; lumen formation, open tracheal system [GO:0035149]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle [GO:0000278]; mitotic spindle midzone assembly [GO:0051256]; mRNA transport [GO:0051028]; nuclear migration [GO:0007097]; positive regulation of axonogenesis [GO:0050772]; protein localization to kinetochore [GO:0034501]; retrograde axonal transport [GO:0008090]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde synaptic vesicle transport [GO:0048491]; rhabdomere development [GO:0042052]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; spindle assembly [GO:0051225]; synaptic vesicle transport [GO:0048489]"	aster [GO:0005818]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; type Ib terminal bouton [GO:0061176]	dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]	GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0001709; GO:0001751; GO:0001754; GO:0003774; GO:0005634; GO:0005737; GO:0005813; GO:0005818; GO:0005828; GO:0005875; GO:0005876; GO:0006886; GO:0007097; GO:0007349; GO:0008017; GO:0008090; GO:0016330; GO:0019896; GO:0030286; GO:0030424; GO:0030496; GO:0031122; GO:0031616; GO:0034501; GO:0035011; GO:0035149; GO:0035371; GO:0042051; GO:0042052; GO:0045198; GO:0045505; GO:0048489; GO:0048491; GO:0048675; GO:0050772; GO:0051010; GO:0051028; GO:0051225; GO:0051256; GO:0051299; GO:0051383; GO:0051642; GO:0061176; GO:0061670; GO:0070840; GO:1904115; GO:1990049	"axonal transport of mitochondrion [GO:0019896]; axon extension [GO:0048675]; cell fate determination [GO:0001709]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of mitotic spindle orientation [GO:0000132]; evoked neurotransmitter secretion [GO:0061670]; eye photoreceptor cell differentiation [GO:0001754]; intracellular protein transport [GO:0006886]; kinetochore organization [GO:0051383]; lumen formation, open tracheal system [GO:0035149]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle [GO:0000278]; mitotic spindle midzone assembly [GO:0051256]; mRNA transport [GO:0051028]; nuclear migration [GO:0007097]; positive regulation of axonogenesis [GO:0050772]; protein localization to kinetochore [GO:0034501]; retrograde axonal transport [GO:0008090]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde synaptic vesicle transport [GO:0048491]; rhabdomere development [GO:0042052]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; spindle assembly [GO:0051225]; synaptic vesicle transport [GO:0048489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9832_c0_g1_i3	P13496	DCTN1_DROME	64.4	73	26	0	749	531	1	73	8.60E-23	109	DCTN1_DROME	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (Dynactin 1 subunit p150) (Protein glued)	DCTN1-p150 Gl CG9206	Drosophila melanogaster (Fruit fly)	1265	"aster [GO:0005818]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; type Ib terminal bouton [GO:0061176]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; axon extension [GO:0048675]; axonal transport of mitochondrion [GO:0019896]; cell fate determination [GO:0001709]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of mitotic spindle orientation [GO:0000132]; evoked neurotransmitter secretion [GO:0061670]; eye photoreceptor cell differentiation [GO:0001754]; intracellular protein transport [GO:0006886]; kinetochore organization [GO:0051383]; lumen formation, open tracheal system [GO:0035149]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle [GO:0000278]; mitotic spindle midzone assembly [GO:0051256]; mRNA transport [GO:0051028]; nuclear migration [GO:0007097]; positive regulation of axonogenesis [GO:0050772]; protein localization to kinetochore [GO:0034501]; retrograde axonal transport [GO:0008090]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde synaptic vesicle transport [GO:0048491]; rhabdomere development [GO:0042052]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; spindle assembly [GO:0051225]; synaptic vesicle transport [GO:0048489]"	aster [GO:0005818]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; type Ib terminal bouton [GO:0061176]	dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]	GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0001709; GO:0001751; GO:0001754; GO:0003774; GO:0005634; GO:0005737; GO:0005813; GO:0005818; GO:0005828; GO:0005875; GO:0005876; GO:0006886; GO:0007097; GO:0007349; GO:0008017; GO:0008090; GO:0016330; GO:0019896; GO:0030286; GO:0030424; GO:0030496; GO:0031122; GO:0031616; GO:0034501; GO:0035011; GO:0035149; GO:0035371; GO:0042051; GO:0042052; GO:0045198; GO:0045505; GO:0048489; GO:0048491; GO:0048675; GO:0050772; GO:0051010; GO:0051028; GO:0051225; GO:0051256; GO:0051299; GO:0051383; GO:0051642; GO:0061176; GO:0061670; GO:0070840; GO:1904115; GO:1990049	"axonal transport of mitochondrion [GO:0019896]; axon extension [GO:0048675]; cell fate determination [GO:0001709]; cellularization [GO:0007349]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of mitotic spindle orientation [GO:0000132]; evoked neurotransmitter secretion [GO:0061670]; eye photoreceptor cell differentiation [GO:0001754]; intracellular protein transport [GO:0006886]; kinetochore organization [GO:0051383]; lumen formation, open tracheal system [GO:0035149]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle [GO:0000278]; mitotic spindle midzone assembly [GO:0051256]; mRNA transport [GO:0051028]; nuclear migration [GO:0007097]; positive regulation of axonogenesis [GO:0050772]; protein localization to kinetochore [GO:0034501]; retrograde axonal transport [GO:0008090]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde synaptic vesicle transport [GO:0048491]; rhabdomere development [GO:0042052]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; spindle assembly [GO:0051225]; synaptic vesicle transport [GO:0048489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39630_c0_g1_i1	Q14203	DCTN1_HUMAN	100	98	0	0	296	3	645	742	6.60E-50	197.6	DCTN1_HUMAN	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued)	DCTN1	Homo sapiens (Human)	1278	"axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0003774; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0005938; GO:0006888; GO:0007097; GO:0007399; GO:0007528; GO:0008017; GO:0010389; GO:0010457; GO:0010970; GO:0015630; GO:0015631; GO:0016020; GO:0019886; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0031122; GO:0031252; GO:0032402; GO:0034454; GO:0035371; GO:0036064; GO:0036498; GO:0042147; GO:0043005; GO:0043025; GO:0045171; GO:0048156; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0097711; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30476_c0_g1_i1	Q14203	DCTN1_HUMAN	100	67	0	0	202	2	24	90	2.30E-33	142.1	DCTN1_HUMAN	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued)	DCTN1	Homo sapiens (Human)	1278	"axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]	GO:0000086; GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0003774; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0005938; GO:0006888; GO:0007097; GO:0007399; GO:0007528; GO:0008017; GO:0010389; GO:0010457; GO:0010970; GO:0015630; GO:0015631; GO:0016020; GO:0019886; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0031122; GO:0031252; GO:0032402; GO:0034454; GO:0035371; GO:0036064; GO:0036498; GO:0042147; GO:0043005; GO:0043025; GO:0045171; GO:0048156; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0097711; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9832_c2_g1_i1	P35458	DCTN1_CHICK	29.6	230	142	4	3	677	984	1198	9.00E-14	79.3	DCTN1_CHICK	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p150-glued)	DCTN1	Gallus gallus (Chicken)	1224	axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236]; transport along microtubule [GO:0010970]	axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]	GO:0000132; GO:0000776; GO:0000922; GO:0003774; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0008017; GO:0010970; GO:0030286; GO:0030424; GO:0031122; GO:0035371; GO:0051010; GO:0051301; GO:0060236; GO:0090316; GO:0099738	cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN9832_c0_g1_i2	O08788	DCTN1_MOUSE	64.9	77	27	0	1184	954	20	96	7.70E-23	109.8	DCTN1_MOUSE	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p150-glued)	Dctn1	Mus musculus (Mouse)	1281	"axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; motor behavior [GO:0061744]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; spindle [GO:0005819]; spindle pole [GO:0000922]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]	GO:0000132; GO:0000776; GO:0000922; GO:0003774; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005868; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0007528; GO:0008017; GO:0010457; GO:0010970; GO:0015630; GO:0015631; GO:0019901; GO:0021517; GO:0030424; GO:0030904; GO:0031116; GO:0031122; GO:0031252; GO:0032402; GO:0032991; GO:0034454; GO:0035371; GO:0036064; GO:0042147; GO:0042802; GO:0043005; GO:0043025; GO:0045171; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0090316; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535	"cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; motor behavior [GO:0061744]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39616_c0_g1_i1	Q99KJ8	DCTN2_MOUSE	97.3	73	2	0	219	1	301	373	2.10E-32	139	DCTN2_MOUSE	reviewed	Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (Growth cone membrane protein 23-48K) (GMP23-48K) (p50 dynamitin)	Dctn2	Mus musculus (Mouse)	402	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]	identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]	GO:0000278; GO:0000776; GO:0003774; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005874; GO:0007052; GO:0007080; GO:0016020; GO:0019901; GO:0030286; GO:0030426; GO:0030507; GO:0031982; GO:0032402; GO:0042802; GO:0071539	melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539]		NA	NA	NA	NA	NA	NA
TRINITY_DN6649_c0_g1_i1	Q66J30	DCT2A_XENLA	38.2	419	238	6	1335	94	1	403	1.50E-67	258.5	DCT2A_XENLA	reviewed	Dynactin subunit 2-A	dctn2-a	Xenopus laevis (African clawed frog)	403	cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; vesicle [GO:0031982]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; vesicle [GO:0031982]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005815; GO:0005869; GO:0005874; GO:0007017; GO:0016020; GO:0030286; GO:0031982	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN37692_c0_g1_i1	Q9UJW0	DCTN4_HUMAN	46.7	60	32	0	209	30	24	83	1.30E-11	70.1	DCTN4_HUMAN	reviewed	Dynactin subunit 4 (Dyn4) (Dynactin subunit p62)	DCTN4	Homo sapiens (Human)	460	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]	protein N-terminus binding [GO:0047485]	GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0006888; GO:0019886; GO:0030017; GO:0047485	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN11090_c0_g1_i1	Q9UJW0	DCTN4_HUMAN	45.3	464	210	6	1521	160	1	430	8.10E-107	389	DCTN4_HUMAN	reviewed	Dynactin subunit 4 (Dyn4) (Dynactin subunit p62)	DCTN4	Homo sapiens (Human)	460	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]	protein N-terminus binding [GO:0047485]	GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0006888; GO:0019886; GO:0030017; GO:0047485	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c1_g1_i1	Q148G7	DCTN6_BOVIN	62	166	60	2	491	3	8	173	2.20E-54	213.4	DCTN6_BOVIN	reviewed	Dynactin subunit 6	DCTN6	Bos taurus (Bovine)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex binding [GO:0070840]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]	dynein complex binding [GO:0070840]	GO:0000777; GO:0005737; GO:0005813; GO:0005869; GO:0007052; GO:0070840	mitotic spindle organization [GO:0007052]		blue	blue	NA	NA	NA	NA
TRINITY_DN16612_c1_g1_i3	Q148G7	DCTN6_BOVIN	64.2	106	35	2	339	31	8	113	3.50E-32	139.4	DCTN6_BOVIN	reviewed	Dynactin subunit 6	DCTN6	Bos taurus (Bovine)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex binding [GO:0070840]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]	dynein complex binding [GO:0070840]	GO:0000777; GO:0005737; GO:0005813; GO:0005869; GO:0007052; GO:0070840	mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c1_g1_i4	Q148G7	DCTN6_BOVIN	52.3	44	19	1	162	31	72	113	2.70E-07	55.8	DCTN6_BOVIN	reviewed	Dynactin subunit 6	DCTN6	Bos taurus (Bovine)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex binding [GO:0070840]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]	dynein complex binding [GO:0070840]	GO:0000777; GO:0005737; GO:0005813; GO:0005869; GO:0007052; GO:0070840	mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c1_g1_i5	Q148G7	DCTN6_BOVIN	62	166	60	2	491	3	8	173	2.50E-54	213.4	DCTN6_BOVIN	reviewed	Dynactin subunit 6	DCTN6	Bos taurus (Bovine)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex binding [GO:0070840]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]	dynein complex binding [GO:0070840]	GO:0000777; GO:0005737; GO:0005813; GO:0005869; GO:0007052; GO:0070840	mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c1_g1_i7	Q148G7	DCTN6_BOVIN	55.8	104	44	1	314	3	72	173	2.30E-29	129.8	DCTN6_BOVIN	reviewed	Dynactin subunit 6	DCTN6	Bos taurus (Bovine)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex binding [GO:0070840]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]	dynein complex binding [GO:0070840]	GO:0000777; GO:0005737; GO:0005813; GO:0005869; GO:0007052; GO:0070840	mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN34711_c0_g1_i1	Q9WUB4	DCTN6_MOUSE	100	89	0	0	3	269	6	94	4.50E-45	181.4	DCTN6_MOUSE	reviewed	Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3)	Dctn6 Ws3	Mus musculus (Mouse)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; dynactin complex [GO:0005869]; mitochondrion [GO:0005739]; catalytic activity [GO:0003824]; dynein complex binding [GO:0070840]; lipid biosynthetic process [GO:0008610]; mitochondrion organization [GO:0007005]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; dynactin complex [GO:0005869]; mitochondrion [GO:0005739]	catalytic activity [GO:0003824]; dynein complex binding [GO:0070840]	GO:0000777; GO:0003824; GO:0005739; GO:0005813; GO:0005869; GO:0007005; GO:0007052; GO:0008610; GO:0070840	lipid biosynthetic process [GO:0008610]; mitochondrion organization [GO:0007005]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN33528_c0_g1_i1	O00399	DCTN6_HUMAN	91.1	90	8	0	271	2	2	91	3.60E-39	161.8	DCTN6_HUMAN	reviewed	Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3)	DCTN6 WS3	Homo sapiens (Human)	190	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex binding [GO:0070840]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]	dynein complex binding [GO:0070840]	GO:0000777; GO:0005813; GO:0005829; GO:0005869; GO:0006888; GO:0007052; GO:0019886; GO:0070840	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN10877_c0_g1_i1	P27619	DYN_DROME	61.3	235	80	3	701	6	21	247	1.10E-76	287.7	DYN_DROME	reviewed	Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn)	shi CG18102	Drosophila melanogaster (Fruit fly)	877	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000266; GO:0001661; GO:0001738; GO:0001933; GO:0003374; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0031966; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048285; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061025; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475	"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2575_c0_g1_i1	P27619	DYN_DROME	80.1	396	78	1	3	1187	125	520	2.10E-179	629.8	DYN_DROME	reviewed	Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn)	shi CG18102	Drosophila melanogaster (Fruit fly)	877	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000266; GO:0001661; GO:0001738; GO:0001933; GO:0003374; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0031966; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048285; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061025; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475	"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2575_c0_g1_i4	P27619	DYN_DROME	84.6	123	19	0	36	404	1	123	1.50E-53	210.3	DYN_DROME	reviewed	Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn)	shi CG18102	Drosophila melanogaster (Fruit fly)	877	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000266; GO:0001661; GO:0001738; GO:0001933; GO:0003374; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0031966; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048285; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061025; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475	"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2575_c0_g1_i5	P27619	DYN_DROME	81.2	520	97	1	36	1592	1	520	2.00E-241	836.3	DYN_DROME	reviewed	Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn)	shi CG18102	Drosophila melanogaster (Fruit fly)	877	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000266; GO:0001661; GO:0001738; GO:0001933; GO:0003374; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0031966; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048285; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061025; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475	"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2575_c0_g1_i7	P27619	DYN_DROME	80.6	350	68	0	3	1052	125	474	4.30E-160	565.5	DYN_DROME	reviewed	Dynamin (EC 3.6.5.5) (Protein shibire) (dDyn)	shi CG18102	Drosophila melanogaster (Fruit fly)	877	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sperm individualization complex [GO:0070864]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]	GO:0000266; GO:0001661; GO:0001738; GO:0001933; GO:0003374; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0007268; GO:0007291; GO:0007298; GO:0007349; GO:0007424; GO:0007427; GO:0007435; GO:0007612; GO:0007613; GO:0007614; GO:0007637; GO:0008017; GO:0008355; GO:0010508; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030198; GO:0030424; GO:0030536; GO:0030707; GO:0030838; GO:0030866; GO:0031410; GO:0031623; GO:0031966; GO:0032956; GO:0032970; GO:0034334; GO:0035152; GO:0035186; GO:0036465; GO:0040008; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046667; GO:0046843; GO:0048172; GO:0048285; GO:0048488; GO:0048489; GO:0048499; GO:0050803; GO:0061025; GO:0061883; GO:0070864; GO:0072583; GO:0072659; GO:0072686; GO:0090148; GO:0098793; GO:0098844; GO:0098884; GO:0150007; GO:0150008; GO:1903475	"adherens junction maintenance [GO:0034334]; border follicle cell migration [GO:0007298]; bulk synaptic vesicle endocytosis [GO:0150008]; cellularization [GO:0007349]; chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent endocytosis involved in vitellogenesis [GO:0061883]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; compound eye retinal cell programmed cell death [GO:0046667]; conditioned taste aversion [GO:0001661]; cortical actin cytoskeleton organization [GO:0030866]; dorsal appendage formation [GO:0046843]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; epithelial cell migration, open tracheal system [GO:0007427]; extracellular matrix organization [GO:0030198]; larval feeding behavior [GO:0030536]; learning [GO:0007612]; membrane fission [GO:0090148]; membrane fusion [GO:0061025]; memory [GO:0007613]; mitochondrial fission [GO:0000266]; mitotic actomyosin contractile ring assembly [GO:1903475]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of protein phosphorylation [GO:0001933]; olfactory learning [GO:0008355]; open tracheal system development [GO:0007424]; organelle fission [GO:0048285]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of autophagy [GO:0010508]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; proboscis extension reflex [GO:0007637]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of growth [GO:0040008]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synapse structure or activity [GO:0050803]; regulation of tube architecture, open tracheal system [GO:0035152]; salivary gland morphogenesis [GO:0007435]; short-term memory [GO:0007614]; sperm individualization [GO:0007291]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37390_c0_g1_i1	Q2KIA5	DNM1L_BOVIN	100	106	0	0	2	319	405	510	2.30E-53	209.1	DNM1L_BOVIN	reviewed	Dynamin-1-like protein (EC 3.6.5.5)	DNM1L	Bos taurus (Bovine)	749	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0099073; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26488_c0_g1_i1	Q2KIA5	DNM1L_BOVIN	99.2	125	1	0	3	377	625	749	2.00E-62	239.6	DNM1L_BOVIN	reviewed	Dynamin-1-like protein (EC 3.6.5.5)	DNM1L	Bos taurus (Bovine)	749	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0099073; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38153_c0_g1_i1	Q2KIA5	DNM1L_BOVIN	100	83	0	0	1	249	184	266	1.40E-37	156.4	DNM1L_BOVIN	reviewed	Dynamin-1-like protein (EC 3.6.5.5)	DNM1L	Bos taurus (Bovine)	749	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0099073; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN19193_c0_g1_i1	Q2KIA5	DNM1L_BOVIN	99.4	164	1	0	493	2	264	427	8.30E-90	330.9	DNM1L_BOVIN	reviewed	Dynamin-1-like protein (EC 3.6.5.5)	DNM1L	Bos taurus (Bovine)	749	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0099073; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN28228_c0_g1_i1	Q2KIA5	DNM1L_BOVIN	100	69	0	0	1	207	457	525	1.60E-34	146	DNM1L_BOVIN	reviewed	Dynamin-1-like protein (EC 3.6.5.5)	DNM1L	Bos taurus (Bovine)	749	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0099073; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; necroptotic process [GO:0070266]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN55_c0_g1_i1	O00429	DNM1L_HUMAN	64.1	738	257	3	93	2288	1	736	2.00E-258	893.3	DNM1L_HUMAN	reviewed	Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	Homo sapiens (Human)	736	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein-containing complex assembly [GO:0065003]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN55_c0_g1_i2	O00429	DNM1L_HUMAN	63.2	752	260	6	93	2345	1	736	3.00E-257	889.4	DNM1L_HUMAN	reviewed	Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	Homo sapiens (Human)	736	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein-containing complex assembly [GO:0065003]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN55_c0_g1_i3	O00429	DNM1L_HUMAN	64	737	258	2	93	2285	1	736	6.90E-259	894.8	DNM1L_HUMAN	reviewed	Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	Homo sapiens (Human)	736	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein-containing complex assembly [GO:0065003]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN55_c0_g1_i4	O00429	DNM1L_HUMAN	62.8	771	250	7	93	2399	1	736	2.30E-257	889.8	DNM1L_HUMAN	reviewed	Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	Homo sapiens (Human)	736	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein-containing complex assembly [GO:0065003]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN55_c0_g1_i5	O00429	DNM1L_HUMAN	63.1	756	253	7	93	2342	1	736	1.10E-256	887.5	DNM1L_HUMAN	reviewed	Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	Homo sapiens (Human)	736	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein-containing complex assembly [GO:0065003]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN35599_c0_g1_i1	O00429	DNM1L_HUMAN	100	85	0	0	1	255	7	91	4.10E-40	164.9	DNM1L_HUMAN	reviewed	Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	Homo sapiens (Human)	736	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0008637; GO:0010468; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0031966; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048285; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0051433; GO:0060047; GO:0061003; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098835; GO:1900063; GO:1900244; GO:1903146; GO:1903578; GO:1904579; GO:1904666; GO:1905395; GO:1990910; GO:2000302; GO:2001244	apoptotic mitochondrial changes [GO:0008637]; calcium ion transport [GO:0006816]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; organelle fission [GO:0048285]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein-containing complex assembly [GO:0065003]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; rhythmic process [GO:0048511]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN13556_c0_g1_i2	P50570	DYN2_HUMAN	100	185	0	0	557	3	333	517	4.50E-100	365.2	DYN2_HUMAN	reviewed	Dynamin-2 (EC 3.6.5.5)	DNM2 DYN2	Homo sapiens (Human)	870	"axon [GO:0030424]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]"	"axon [GO:0030424]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]"	D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0000086; GO:0000139; GO:0000266; GO:0001891; GO:0001917; GO:0002031; GO:0003281; GO:0003374; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0005925; GO:0006355; GO:0006893; GO:0006897; GO:0006898; GO:0006909; GO:0007165; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0017124; GO:0019886; GO:0019899; GO:0019901; GO:0030027; GO:0030424; GO:0030426; GO:0030496; GO:0030512; GO:0030516; GO:0030666; GO:0030670; GO:0031410; GO:0031623; GO:0031749; GO:0031966; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0035904; GO:0036312; GO:0042220; GO:0043065; GO:0043197; GO:0044327; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045893; GO:0048285; GO:0048471; GO:0048489; GO:0048812; GO:0050699; GO:0050766; GO:0050803; GO:0050998; GO:0050999; GO:0060976; GO:0061024; GO:0061025; GO:0070062; GO:0071245; GO:0071481; GO:0071732; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099092; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903408; GO:1903526; GO:2000370	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; G protein-coupled receptor internalization [GO:0002031]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24100_c0_g1_i1	P50570	DYN2_HUMAN	100	304	0	0	1	912	28	331	1.50E-169	596.7	DYN2_HUMAN	reviewed	Dynamin-2 (EC 3.6.5.5)	DNM2 DYN2	Homo sapiens (Human)	870	"axon [GO:0030424]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]"	"axon [GO:0030424]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]"	D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0000086; GO:0000139; GO:0000266; GO:0001891; GO:0001917; GO:0002031; GO:0003281; GO:0003374; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0005925; GO:0006355; GO:0006893; GO:0006897; GO:0006898; GO:0006909; GO:0007165; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0017124; GO:0019886; GO:0019899; GO:0019901; GO:0030027; GO:0030424; GO:0030426; GO:0030496; GO:0030512; GO:0030516; GO:0030666; GO:0030670; GO:0031410; GO:0031623; GO:0031749; GO:0031966; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0035904; GO:0036312; GO:0042220; GO:0043065; GO:0043197; GO:0044327; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045893; GO:0048285; GO:0048471; GO:0048489; GO:0048812; GO:0050699; GO:0050766; GO:0050803; GO:0050998; GO:0050999; GO:0060976; GO:0061024; GO:0061025; GO:0070062; GO:0071245; GO:0071481; GO:0071732; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099092; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903408; GO:1903526; GO:2000370	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; G protein-coupled receptor internalization [GO:0002031]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13556_c0_g1_i1	P39054	DYN2_MOUSE	99.5	185	1	0	557	3	333	517	4.90E-99	361.7	DYN2_MOUSE	reviewed	Dynamin-2 (EC 3.6.5.5) (Dynamin UDNM)	Dnm2 Dyn2	Mus musculus (Mouse)	870	"axon [GO:0030424]; cell junction [GO:0030054]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; G protein-coupled receptor internalization [GO:0002031]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of endocytosis [GO:0045807]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]"	"axon [GO:0030424]; cell junction [GO:0030054]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]"	D2 dopamine receptor binding [GO:0031749]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0000139; GO:0000266; GO:0001891; GO:0001917; GO:0002031; GO:0003281; GO:0003374; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0006893; GO:0006898; GO:0006909; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0017124; GO:0019901; GO:0030027; GO:0030054; GO:0030424; GO:0030426; GO:0030496; GO:0030512; GO:0030516; GO:0030670; GO:0031410; GO:0031623; GO:0031749; GO:0031966; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0035904; GO:0036312; GO:0042220; GO:0043197; GO:0044327; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045807; GO:0048285; GO:0048471; GO:0048812; GO:0050699; GO:0050766; GO:0050803; GO:0050998; GO:0060976; GO:0061025; GO:0071245; GO:0071481; GO:0071732; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099092; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903408; GO:1903526; GO:2000370	aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; Golgi to plasma membrane transport [GO:0006893]; G protein-coupled receptor internalization [GO:0002031]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of endocytosis [GO:0045807]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN13556_c0_g1_i3	P39054	DYN2_MOUSE	93	185	13	0	557	3	333	517	4.80E-94	345.1	DYN2_MOUSE	reviewed	Dynamin-2 (EC 3.6.5.5) (Dynamin UDNM)	Dnm2 Dyn2	Mus musculus (Mouse)	870	"axon [GO:0030424]; cell junction [GO:0030054]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; G protein-coupled receptor internalization [GO:0002031]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of endocytosis [GO:0045807]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]"	"axon [GO:0030424]; cell junction [GO:0030054]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]"	D2 dopamine receptor binding [GO:0031749]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0000139; GO:0000266; GO:0001891; GO:0001917; GO:0002031; GO:0003281; GO:0003374; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0006893; GO:0006898; GO:0006909; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0017124; GO:0019901; GO:0030027; GO:0030054; GO:0030424; GO:0030426; GO:0030496; GO:0030512; GO:0030516; GO:0030670; GO:0031410; GO:0031623; GO:0031749; GO:0031966; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0035904; GO:0036312; GO:0042220; GO:0043197; GO:0044327; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045807; GO:0048285; GO:0048471; GO:0048812; GO:0050699; GO:0050766; GO:0050803; GO:0050998; GO:0060976; GO:0061025; GO:0071245; GO:0071481; GO:0071732; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099092; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903408; GO:1903526; GO:2000370	aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; Golgi to plasma membrane transport [GO:0006893]; G protein-coupled receptor internalization [GO:0002031]; macropinocytosis [GO:0044351]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of endocytosis [GO:0045807]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN36707_c0_g1_i1	Q8BZ98	DYN3_MOUSE	61.5	122	47	0	388	23	95	216	8.10E-32	137.9	DYN3_MOUSE	reviewed	Dynamin-3 (EC 3.6.5.5)	Dnm3 Kiaa0820	Mus musculus (Mouse)	863	apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of dendritic spine morphogenesis [GO:0061002]; organelle fission [GO:0048285]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse structure or activity [GO:0050803]; synapse assembly [GO:0007416]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]	apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]	GO:0000266; GO:0001917; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0007416; GO:0008017; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030424; GO:0031410; GO:0031623; GO:0031798; GO:0031802; GO:0031966; GO:0042802; GO:0043083; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0046847; GO:0048285; GO:0048471; GO:0048488; GO:0050803; GO:0050998; GO:0051491; GO:0061001; GO:0061002; GO:0061025; GO:0061828; GO:0061829; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099186; GO:1903423	dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of dendritic spine morphogenesis [GO:0061002]; organelle fission [GO:0048285]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse structure or activity [GO:0050803]; synapse assembly [GO:0007416]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN12914_c0_g1_i1	Q94464	DYNA_DICDI	54.5	77	35	0	234	4	364	440	1.60E-19	96.3	DYNA_DICDI	reviewed	Dynamin-A	dymA DDB_G0277849	Dictyostelium discoideum (Slime mold)	853	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]	GO:0000266; GO:0003374; GO:0003924; GO:0005522; GO:0005525; GO:0005543; GO:0005737; GO:0006907; GO:0006909; GO:0006997; GO:0007005; GO:0007015; GO:0007032; GO:0007163; GO:0008017; GO:0016020; GO:0031288; GO:0031966; GO:0032154; GO:0042802; GO:0044656; GO:0045335; GO:0048285; GO:0048312; GO:0061025; GO:0061952; GO:0090383; GO:0097204; GO:1900756; GO:1905345	actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]		NA	NA	NA	NA	NA	NA
TRINITY_DN23231_c0_g1_i1	Q94464	DYNA_DICDI	61.6	73	28	0	221	3	176	248	5.90E-19	94.4	DYNA_DICDI	reviewed	Dynamin-A	dymA DDB_G0277849	Dictyostelium discoideum (Slime mold)	853	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; phagocytic cup base [GO:0097204]; phagocytic vesicle [GO:0045335]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; profilin binding [GO:0005522]	GO:0000266; GO:0003374; GO:0003924; GO:0005522; GO:0005525; GO:0005543; GO:0005737; GO:0006907; GO:0006909; GO:0006997; GO:0007005; GO:0007015; GO:0007032; GO:0007163; GO:0008017; GO:0016020; GO:0031288; GO:0031966; GO:0032154; GO:0042802; GO:0044656; GO:0045335; GO:0048285; GO:0048312; GO:0061025; GO:0061952; GO:0090383; GO:0097204; GO:1900756; GO:1905345	actin filament organization [GO:0007015]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endosome organization [GO:0007032]; establishment or maintenance of cell polarity [GO:0007163]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; midbody abscission [GO:0061952]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; nucleus organization [GO:0006997]; organelle fission [GO:0048285]; phagocytosis [GO:0006909]; phagosome acidification [GO:0090383]; pinocytosis [GO:0006907]; protein localization to cleavage furrow [GO:1905345]; protein processing in phagocytic vesicle [GO:1900756]; regulation of post-lysosomal vacuole size [GO:0044656]; sorocarp morphogenesis [GO:0031288]		NA	NA	NA	NA	NA	NA
TRINITY_DN17741_c0_g1_i1	E7F1U2	DNMBP_DANRE	30.8	182	115	3	553	41	24	205	1.70E-22	107.5	DNMBP_DANRE	reviewed	Dynamin-binding protein (Scaffold protein Tuba)	dnmbp	Danio rerio (Zebrafish) (Brachydanio rerio)	1673	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001822; GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793	cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g1_i1	E7F1U2	DNMBP_DANRE	31.7	410	254	7	1206	7	839	1232	5.20E-51	203.4	DNMBP_DANRE	reviewed	Dynamin-binding protein (Scaffold protein Tuba)	dnmbp	Danio rerio (Zebrafish) (Brachydanio rerio)	1673	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001822; GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793	cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g1_i11	E7F1U2	DNMBP_DANRE	32.3	406	249	7	1194	7	843	1232	9.80E-51	202.6	DNMBP_DANRE	reviewed	Dynamin-binding protein (Scaffold protein Tuba)	dnmbp	Danio rerio (Zebrafish) (Brachydanio rerio)	1673	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001822; GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793	cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g1_i3	E7F1U2	DNMBP_DANRE	34.1	252	152	4	806	66	843	1085	1.40E-33	145.2	DNMBP_DANRE	reviewed	Dynamin-binding protein (Scaffold protein Tuba)	dnmbp	Danio rerio (Zebrafish) (Brachydanio rerio)	1673	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001822; GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793	cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g1_i8	E7F1U2	DNMBP_DANRE	29.3	157	99	3	462	7	1083	1232	2.50E-10	67	DNMBP_DANRE	reviewed	Dynamin-binding protein (Scaffold protein Tuba)	dnmbp	Danio rerio (Zebrafish) (Brachydanio rerio)	1673	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001822; GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793	cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]		NA	NA	NA	NA	NA	NA
TRINITY_DN2022_c0_g1_i2	Q5F499	OPA1_CHICK	76.1	113	27	0	339	1	243	355	1.50E-41	171.4	OPA1_CHICK	reviewed	"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1]"	OPA1 RCJMB04_1m16	Gallus gallus (Chicken)	977	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; organelle fission [GO:0048285]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]	cardiolipin binding [GO:1901612]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]	GO:0000266; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0006915; GO:0008017; GO:0008053; GO:0016020; GO:0016021; GO:0031966; GO:0046039; GO:0048285; GO:0061025; GO:0070300; GO:0097749; GO:1901612	apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; organelle fission [GO:0048285]		NA	NA	NA	NA	NA	NA
TRINITY_DN2022_c0_g1_i3	Q5F499	OPA1_CHICK	75.2	109	27	0	327	1	247	355	2.00E-39	164.1	OPA1_CHICK	reviewed	"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1]"	OPA1 RCJMB04_1m16	Gallus gallus (Chicken)	977	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; organelle fission [GO:0048285]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]	cardiolipin binding [GO:1901612]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]	GO:0000266; GO:0003374; GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0006915; GO:0008017; GO:0008053; GO:0016020; GO:0016021; GO:0031966; GO:0046039; GO:0048285; GO:0061025; GO:0070300; GO:0097749; GO:1901612	apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; organelle fission [GO:0048285]		NA	NA	NA	NA	NA	NA
TRINITY_DN2022_c0_g1_i4	O60313	OPA1_HUMAN	52.2	180	84	2	537	1	160	338	3.20E-39	163.3	OPA1_HUMAN	reviewed	"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1) [Cleaved into: Dynamin-like 120 kDa protein, form S1]"	OPA1 KIAA0567	Homo sapiens (Human)	960	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; axonal transport of mitochondrion [GO:0019896]; calcium import into the mitochondrion [GO:0036444]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-glutamate [GO:1905232]; cellular senescence [GO:0090398]; cochlea development [GO:0090102]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; inner mitochondrial membrane organization [GO:0007007]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial genome maintenance [GO:0000002]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; organelle fission [GO:0048285]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of neuron maturation [GO:0014042]; protein complex oligomerization [GO:0051259]; response to curcumin [GO:1904643]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cardiolipin binding [GO:1901612]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; protein-containing complex binding [GO:0044877]	GO:0000002; GO:0000266; GO:0000287; GO:0003374; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0007005; GO:0007007; GO:0007601; GO:0008017; GO:0008053; GO:0010636; GO:0014042; GO:0014850; GO:0016020; GO:0016021; GO:0019896; GO:0019900; GO:0030061; GO:0030425; GO:0031314; GO:0031667; GO:0031966; GO:0036444; GO:0043066; GO:0044877; GO:0046039; GO:0046628; GO:0048285; GO:0048312; GO:0051259; GO:0051602; GO:0060041; GO:0061003; GO:0061025; GO:0070300; GO:0070584; GO:0071333; GO:0071456; GO:0090102; GO:0090201; GO:0090398; GO:0097749; GO:1901612; GO:1902236; GO:1904115; GO:1904643; GO:1905232	apoptotic process [GO:0006915]; axonal transport of mitochondrion [GO:0019896]; calcium import into the mitochondrion [GO:0036444]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-glutamate [GO:1905232]; cellular senescence [GO:0090398]; cochlea development [GO:0090102]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; inner mitochondrial membrane organization [GO:0007007]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial genome maintenance [GO:0000002]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; organelle fission [GO:0048285]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of neuron maturation [GO:0014042]; protein complex oligomerization [GO:0051259]; response to curcumin [GO:1904643]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN39848_c0_g1_i1	Q39610	DYHA_CHLRE	85.7	63	9	0	209	21	2104	2166	6.80E-25	114	DYHA_CHLRE	reviewed	"Dynein alpha chain, flagellar outer arm (DHC alpha)"	ODA11 ODA-11	Chlamydomonas reinhardtii (Chlamydomonas smithii)	4499	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514	cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN36258_c0_g1_i1	Q39565	DYHB_CHLRE	63.3	79	29	0	238	2	2973	3051	1.30E-24	113.2	DYHB_CHLRE	reviewed	"Dynein beta chain, flagellar outer arm"	ODA4 ODA-4 SUP1	Chlamydomonas reinhardtii (Chlamydomonas smithii)	4568	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514	cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i15	Q39575	DYHG_CHLRE	32.5	212	140	3	646	17	450	660	4.10E-26	120.2	DYHG_CHLRE	reviewed	"Dynein gamma chain, flagellar outer arm"	ODA2 ODA-2	Chlamydomonas reinhardtii (Chlamydomonas smithii)	4485	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]"	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0060294	cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i2	Q39575	DYHG_CHLRE	33.2	214	140	3	652	17	448	660	1.90E-27	124.4	DYHG_CHLRE	reviewed	"Dynein gamma chain, flagellar outer arm"	ODA2 ODA-2	Chlamydomonas reinhardtii (Chlamydomonas smithii)	4485	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]"	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0060294	cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i4	Q39575	DYHG_CHLRE	33.2	214	140	3	652	17	448	660	1.90E-27	124.4	DYHG_CHLRE	reviewed	"Dynein gamma chain, flagellar outer arm"	ODA2 ODA-2	Chlamydomonas reinhardtii (Chlamydomonas smithii)	4485	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]"	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0060294	cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN40831_c0_g1_i1	Q3V0Q1	DYH12_MOUSE	63.4	82	30	0	252	7	1254	1335	2.10E-25	115.9	DYH12_MOUSE	reviewed	"Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12)"	Dnah12 Dnah12l Dnah7l Dnahc12 Dnahc7l	Mus musculus (Mouse)	3086	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; protein ubiquitination [GO:0016567]"	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0016567; GO:0030286; GO:0036156; GO:0045505; GO:0051959	cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN32869_c0_g1_i1	Q6ZR08	DYH12_HUMAN	41.4	239	134	2	703	2	1343	1580	1.40E-45	184.5	DYH12_HUMAN	reviewed	"Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2)"	DNAH12 DHC3 DLP12 DNAH12L DNAH7L DNAHC3 DNHD2 HDHC3 HL19	Homo sapiens (Human)	3092	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule-based movement [GO:0007018]"	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN30109_c0_g1_i1	Q6ZR08	DYH12_HUMAN	33.9	174	114	1	11	532	2116	2288	1.70E-20	100.9	DYH12_HUMAN	reviewed	"Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2)"	DNAH12 DHC3 DLP12 DNAH12L DNAH7L DNAHC3 DNHD2 HDHC3 HL19	Homo sapiens (Human)	3092	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule-based movement [GO:0007018]"	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN11406_c0_g1_i1	Q6ZR08	DYH12_HUMAN	78	91	20	0	1	273	1239	1329	1.00E-33	143.7	DYH12_HUMAN	reviewed	"Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2)"	DNAH12 DHC3 DLP12 DNAH12L DNAH7L DNAHC3 DNHD2 HDHC3 HL19	Homo sapiens (Human)	3092	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule-based movement [GO:0007018]"	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN37316_c0_g1_i1	Q923J6	DYH12_RAT	83.1	118	20	0	12	365	1204	1321	3.50E-53	208.8	DYH12_RAT	reviewed	"Dynein heavy chain 12, axonemal (Bm259)"	Dnah12	Rattus norvegicus (Rat)	3092	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]"	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959	cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN17373_c0_g1_i1	Q8BW94	DYH3_MOUSE	38.1	236	137	3	2	685	1718	1952	1.60E-41	171	DYH3_MOUSE	reviewed	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)"	Dnah3 Dnahc3	Mus musculus (Mouse)	4083	"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"	dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN15740_c0_g2_i2	Q8BW94	DYH3_MOUSE	39.7	340	193	1	1024	5	2792	3119	1.00E-65	251.9	DYH3_MOUSE	reviewed	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)"	Dnah3 Dnahc3	Mus musculus (Mouse)	4083	"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"	dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN15740_c0_g1_i1	Q8TD57	DYH3_HUMAN	43.9	180	99	1	58	591	2649	2828	6.60E-33	142.1	DYH3_HUMAN	reviewed	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)"	DNAH3 DNAHC3B	Homo sapiens (Human)	4116	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]"	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN26502_c0_g1_i2	Q8TE73	DYH5_HUMAN	83.3	114	19	0	342	1	1961	2074	1.40E-52	206.8	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN36674_c0_g1_i1	Q8TE73	DYH5_HUMAN	87.3	63	8	0	202	14	2333	2395	4.80E-28	124.4	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11151_c0_g1_i3	Q8TE73	DYH5_HUMAN	65.9	41	14	0	160	38	4283	4323	4.30E-11	68.2	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN6164_c1_g1_i1	Q8TE73	DYH5_HUMAN	58.1	155	65	0	25	489	3766	3920	1.40E-43	177.6	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN6164_c1_g1_i4	Q8TE73	DYH5_HUMAN	58.1	155	65	0	25	489	3766	3920	9.70E-44	177.9	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN6164_c1_g1_i5	Q8TE73	DYH5_HUMAN	66.3	95	32	0	25	309	3766	3860	1.70E-26	120.2	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN32160_c0_g1_i1	Q8TE73	DYH5_HUMAN	89.6	77	8	0	232	2	2105	2181	1.10E-33	143.3	DYH5_HUMAN	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	4624	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN5473_c1_g1_i1	M0R8U1	DYH5_RAT	61.1	54	21	0	94	255	2873	2926	7.20E-13	74.3	DYH5_RAT	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment)"	Dnah5	Rattus norvegicus (Rat)	3470	"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN10482_c0_g1_i4	M0R8U1	DYH5_RAT	65.8	76	26	0	29	256	3088	3163	3.90E-24	112.1	DYH5_RAT	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment)"	Dnah5	Rattus norvegicus (Rat)	3470	"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN26502_c0_g1_i1	M0R8U1	DYH5_RAT	82.6	144	25	0	432	1	1928	2071	6.60E-67	254.6	DYH5_RAT	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) (Fragment)"	Dnah5	Rattus norvegicus (Rat)	3470	"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN10482_c0_g1_i1	Q8VHE6	DYH5_MOUSE	66.6	302	101	0	94	999	2937	3238	3.90E-113	409.5	DYH5_MOUSE	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5)"	Dnah5 Dnahc5	Mus musculus (Mouse)	4621	"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN10482_c0_g1_i3	Q8VHE6	DYH5_MOUSE	70.9	227	66	0	94	774	2937	3163	2.30E-92	340.1	DYH5_MOUSE	reviewed	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5)"	Dnah5 Dnahc5	Mus musculus (Mouse)	4621	"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN41121_c0_g1_i1	Q63170	DYH7_RAT	64.4	45	16	0	109	243	2222	2266	7.10E-11	67.8	DYH7_RAT	reviewed	"Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7)"	Dnah7 Axob Dlp7	Rattus norvegicus (Rat)	4057	"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]"	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959	cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN39496_c0_g1_i1	Q63170	DYH7_RAT	38.1	155	96	0	468	4	3093	3247	5.30E-23	109	DYH7_RAT	reviewed	"Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7)"	Dnah7 Axob Dlp7	Rattus norvegicus (Rat)	4057	"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]"	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0003341; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959	cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN30724_c0_g1_i1	Q8WXX0	DYH7_HUMAN	57.4	61	26	0	6	188	1279	1339	2.20E-14	79.3	DYH7_HUMAN	reviewed	"Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)"	DNAH7 KIAA0944	Homo sapiens (Human)	4024	"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]"	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN10482_c0_g1_i2	Q91XQ0	DYH8_MOUSE	58.9	151	62	0	29	481	3196	3346	4.60E-46	185.7	DYH8_MOUSE	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	Dnah8 Dnahc8	Mus musculus (Mouse)	4731	"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0097228	microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11437_c0_g1_i1	Q96JB1	DYH8_HUMAN	64.8	54	19	0	232	71	3171	3224	1.20E-14	80.5	DYH8_HUMAN	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	DNAH8	Homo sapiens (Human)	4490	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11437_c0_g1_i2	Q96JB1	DYH8_HUMAN	69.4	108	33	0	343	20	3171	3278	1.10E-39	164.1	DYH8_HUMAN	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	DNAH8	Homo sapiens (Human)	4490	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11151_c0_g1_i2	Q96JB1	DYH8_HUMAN	58.7	46	19	0	238	101	4267	4312	2.20E-08	59.7	DYH8_HUMAN	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	DNAH8	Homo sapiens (Human)	4490	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11151_c0_g1_i4	Q96JB1	DYH8_HUMAN	61.8	165	63	0	601	107	4148	4312	2.30E-55	216.9	DYH8_HUMAN	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	DNAH8	Homo sapiens (Human)	4490	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11151_c0_g1_i6	Q96JB1	DYH8_HUMAN	62.9	97	36	0	324	34	4148	4244	3.90E-31	135.6	DYH8_HUMAN	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	DNAH8	Homo sapiens (Human)	4490	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN11151_c0_g1_i9	Q96JB1	DYH8_HUMAN	58.7	46	19	0	244	107	4267	4312	1.70E-08	60.1	DYH8_HUMAN	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	DNAH8	Homo sapiens (Human)	4490	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN6164_c1_g1_i2	Q91XQ0	DYH8_MOUSE	47	66	35	0	31	228	3961	4026	7.20E-11	67.8	DYH8_MOUSE	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	Dnah8 Dnahc8	Mus musculus (Mouse)	4731	"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0097228	microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN6164_c1_g1_i3	Q91XQ0	DYH8_MOUSE	47	66	35	0	31	228	3961	4026	1.10E-10	67.4	DYH8_MOUSE	reviewed	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	Dnah8 Dnahc8	Mus musculus (Mouse)	4731	"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"	axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0097228	microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		blue	blue	NA	NA	NA	NA
TRINITY_DN15855_c0_g1_i1	Q27171	DYHC_PARTE	75.4	69	17	0	10	216	1915	1983	2.70E-24	112.1	DYHC_PARTE	reviewed	"Dynein heavy chain, cytoplasmic (DHC08) (Dynein heavy chain, cytosolic) (DYHC)"	DHC-8	Paramecium tetraurelia	4540	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule-based movement [GO:0007018]"	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]"	GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030286	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN33489_c0_g1_i1	P37276	DYHC_DROME	62.5	160	60	0	1	480	2570	2729	7.40E-59	228	DYHC_DROME	reviewed	"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)"	Dhc64C cDhc CG7507	Drosophila melanogaster (Fruit fly)	4639	"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0016887; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904	"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1871_c0_g1_i1	P37276	DYHC_DROME	71.8	1296	358	6	4183	314	3244	4537	0	1860.5	DYHC_DROME	reviewed	"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)"	Dhc64C cDhc CG7507	Drosophila melanogaster (Fruit fly)	4639	"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0016887; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904	"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1871_c0_g1_i1	P37276	DYHC_DROME	56.8	74	27	3	297	91	4566	4639	1.30E-10	70.9	DYHC_DROME	reviewed	"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)"	Dhc64C cDhc CG7507	Drosophila melanogaster (Fruit fly)	4639	"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0016887; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904	"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1871_c0_g1_i3	P37276	DYHC_DROME	70.3	1398	405	8	4260	91	3244	4639	0	1943.3	DYHC_DROME	reviewed	"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)"	Dhc64C cDhc CG7507	Drosophila melanogaster (Fruit fly)	4639	"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0016887; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904	"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1825_c0_g1_i1	P37276	DYHC_DROME	79.2	2968	602	8	59	8953	258	3212	0	4792.6	DYHC_DROME	reviewed	"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)"	Dhc64C cDhc CG7507	Drosophila melanogaster (Fruit fly)	4639	"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0016887; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904	"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1825_c0_g1_i4	P37276	DYHC_DROME	77.5	3208	705	10	112	9720	18	3212	0	5055.7	DYHC_DROME	reviewed	"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)"	Dhc64C cDhc CG7507	Drosophila melanogaster (Fruit fly)	4639	"axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; ribonucleoprotein complex [GO:1990904]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0016887; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904	"axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25768_c0_g1_i1	Q8IBG1	DYHC1_PLAF7	67.8	121	39	0	367	5	3809	3929	2.70E-45	182.6	DYHC1_PLAF7	reviewed	Dynein heavy chain-like protein MAL7P1.162	MAL7P1.162	Plasmodium falciparum (isolate 3D7)	4985	"cell cortex [GO:0005938]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]"	cell cortex [GO:0005938]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; microtubule associated complex [GO:0005875]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]"	GO:0000278; GO:0003777; GO:0005524; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008569; GO:0030286; GO:0031122; GO:0045505; GO:0051293; GO:0051959; GO:0072382	cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]		NA	NA	NA	NA	NA	NA
TRINITY_DN36224_c0_g1_i1	Q8C0M8	DNAI1_MOUSE	39	118	72	0	82	435	574	691	6.50E-23	108.6	DNAI1_MOUSE	reviewed	"Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1)"	Dnai1 Dnaic1	Mus musculus (Mouse)	701	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005737; GO:0005813; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN36224_c0_g1_i3	Q8C0M8	DNAI1_MOUSE	38	221	136	1	2	664	472	691	4.50E-44	179.5	DNAI1_MOUSE	reviewed	"Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1)"	Dnai1 Dnaic1	Mus musculus (Mouse)	701	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005737; GO:0005813; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN8464_c0_g1_i11	Q8C0M8	DNAI1_MOUSE	36.8	182	115	0	129	674	514	695	3.20E-34	146.7	DNAI1_MOUSE	reviewed	"Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1)"	Dnai1 Dnaic1	Mus musculus (Mouse)	701	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005737; GO:0005813; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN8464_c0_g1_i7	Q8C0M8	DNAI1_MOUSE	34.5	139	91	0	129	545	514	652	8.60E-24	112.5	DNAI1_MOUSE	reviewed	"Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1)"	Dnai1 Dnaic1	Mus musculus (Mouse)	701	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005737; GO:0005813; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN8464_c0_g1_i8	Q32KS2	DNAI1_BOVIN	33.8	74	48	1	123	344	513	585	4.50E-08	60.1	DNAI1_BOVIN	reviewed	"Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1)"	DNAI1	Bos taurus (Bovine)	702	centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	centrosome [GO:0005813]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]	GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005874; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0036157; GO:0036158; GO:0045503; GO:0045504	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]		NA	NA	NA	NA	NA	NA
TRINITY_DN8464_c0_g2_i4	Q16959	DYI2_HELCR	48.5	99	51	0	706	410	295	393	4.70E-22	106.3	DYI2_HELCR	reviewed	"Dynein intermediate chain 2, ciliary"		Heliocidaris crassispina (Sea urchin) (Anthocidaris crassispina)	702	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286			NA	NA	NA	NA	NA	NA
TRINITY_DN38946_c0_g1_i1	Q24117	DYL1_DROME	95.5	88	4	0	342	79	2	89	2.80E-44	179.5	DYL1_DROME	reviewed	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	ctp Cdlc1 ddlc1 CG6998	Drosophila melanogaster (Fruit fly)	89	"centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; cilium assembly [GO:0060271]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]	GO:0000132; GO:0003774; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0060271; GO:0097718; GO:1904801; GO:2000582	"actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; cilium assembly [GO:0060271]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]; wing disc development [GO:0035220]"		blue	blue	NA	NA	NA	NA
TRINITY_DN27331_c0_g1_i1	Q24117	DYL1_DROME	91	89	8	0	322	56	1	89	1.20E-42	173.7	DYL1_DROME	reviewed	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	ctp Cdlc1 ddlc1 CG6998	Drosophila melanogaster (Fruit fly)	89	"centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; cilium assembly [GO:0060271]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]	GO:0000132; GO:0003774; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0060271; GO:0097718; GO:1904801; GO:2000582	"actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; cilium assembly [GO:0060271]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; sperm individualization [GO:0007291]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4731_c0_g1_i1	P61285	DYL1_BOVIN	100	89	0	0	79	345	1	89	9.90E-47	187.6	DYL1_BOVIN	reviewed	"Dynein light chain 1, cytoplasmic (Dynein light chain LC8-type 1)"	DYNLL1 DNCL1	Bos taurus (Bovine)	89	"cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; viral process [GO:0016032]"	cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]	GO:0000776; GO:0003774; GO:0005634; GO:0005739; GO:0005868; GO:0005874; GO:0006915; GO:0007017; GO:0016032; GO:0030286; GO:0045505; GO:0051959; GO:0060271; GO:0072686; GO:2000582	"apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4731_c0_g1_i2	P61285	DYL1_BOVIN	100	89	0	0	76	342	1	89	9.80E-47	187.6	DYL1_BOVIN	reviewed	"Dynein light chain 1, cytoplasmic (Dynein light chain LC8-type 1)"	DYNLL1 DNCL1	Bos taurus (Bovine)	89	"cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; viral process [GO:0016032]"	cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]	GO:0000776; GO:0003774; GO:0005634; GO:0005739; GO:0005868; GO:0005874; GO:0006915; GO:0007017; GO:0016032; GO:0030286; GO:0045505; GO:0051959; GO:0060271; GO:0072686; GO:2000582	"apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36322_c0_g1_i1	Q32KN5	DNAL4_BOVIN	61	100	37	1	384	85	7	104	7.80E-32	138.3	DNAL4_BOVIN	reviewed	"Dynein light chain 4, axonemal"	DNAL4	Bos taurus (Bovine)	105	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0042802; GO:0045505; GO:0051959; GO:2000582	"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8344_c0_g1_i2	Q9NP97	DLRB1_HUMAN	100	96	0	0	59	346	1	96	2.50E-47	189.5	DLRB1_HUMAN	reviewed	"Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)"	DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162	Homo sapiens (Human)	96	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; membrane [GO:0016020]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; membrane [GO:0016020]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0007632; GO:0016020; GO:0035735; GO:0045505; GO:0097542	intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632]		NA	NA	NA	NA	NA	NA
TRINITY_DN8344_c0_g1_i1	Q3T140	DLRB1_BOVIN	100	96	0	0	52	339	1	96	1.10E-47	190.7	DLRB1_BOVIN	reviewed	"Dynein light chain roadblock-type 1 (Dynein light chain 2A, cytoplasmic)"	DYNLRB1 DNLC2A	Bos taurus (Bovine)	96	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN33201_c0_g1_i1	Q32P85	DLRB2_BOVIN	69.1	94	29	0	361	80	1	94	5.10E-32	138.7	DLRB2_BOVIN	reviewed	"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)"	DYNLRB2 DNLC2B	Bos taurus (Bovine)	96	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN24364_c1_g1_i1	Q32P85	DLRB2_BOVIN	61.3	62	24	0	27	212	27	88	2.60E-16	85.5	DLRB2_BOVIN	reviewed	"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)"	DYNLRB2 DNLC2B	Bos taurus (Bovine)	96	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN24118_c0_g1_i1	Q32P85	DLRB2_BOVIN	75.8	95	23	0	369	85	2	96	3.50E-36	152.5	DLRB2_BOVIN	reviewed	"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)"	DYNLRB2 DNLC2B	Bos taurus (Bovine)	96	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505	microtubule-based movement [GO:0007018]		blue	blue	NA	NA	NA	NA
TRINITY_DN21568_c0_g1_i1	Q32P85	DLRB2_BOVIN	65.8	76	26	0	5	232	21	96	4.90E-22	104.8	DLRB2_BOVIN	reviewed	"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)"	DYNLRB2 DNLC2B	Bos taurus (Bovine)	96	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN1072_c0_g1_i1	Q9Z336	DYLT1_RAT	73.5	113	30	0	91	429	1	113	2.40E-43	176.4	DYLT1_RAT	reviewed	Dynein light chain Tctex-type 1 (Activator of G-protein signaling 2) (AGS2) (T-complex testis-specific protein 1 homolog)	Dynlt1 Tctel1 Tctex-1 Tctex1	Rattus norvegicus (Rat)	113	axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]	axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]	identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]	GO:0000132; GO:0003774; GO:0005739; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0006886; GO:0008022; GO:0008277; GO:0010976; GO:0016358; GO:0019060; GO:0030027; GO:0035022; GO:0035795; GO:0042802; GO:0043025; GO:0043087; GO:0043657; GO:0044295; GO:0048812; GO:0050768; GO:0051301; GO:0051493; GO:0060548; GO:0061564; GO:0099503	axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN18723_c0_g1_i2	P51807	DYLT1_MOUSE	100	113	0	0	9	347	1	113	5.20E-60	231.5	DYLT1_MOUSE	reviewed	Dynein light chain Tctex-type 1 (Activator of G-protein signaling 2) (AGS2) (T-complex testis-specific protein 1) (TCTEX-1)	Dynlt1 Tctel1 Tctex-1 Tctex1	Mus musculus (Mouse)	113	axonal growth cone [GO:0044295]; cell body [GO:0044297]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; G-protein beta-subunit binding [GO:0031681]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neurogenesis [GO:0050768]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	axonal growth cone [GO:0044295]; cell body [GO:0044297]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; secretory vesicle [GO:0099503]; spindle [GO:0005819]	G-protein beta-subunit binding [GO:0031681]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]	GO:0000132; GO:0001917; GO:0003774; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0008022; GO:0008277; GO:0010976; GO:0030027; GO:0030426; GO:0030742; GO:0031681; GO:0042802; GO:0043025; GO:0044295; GO:0044297; GO:0050768; GO:0051301; GO:0070373; GO:0099503	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neurogenesis [GO:0050768]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN32334_c0_g1_i1	P63171	DYLT1_BOVIN	49.3	73	37	0	9	227	34	106	1.30E-18	93.2	DYLT1_BOVIN	reviewed	Dynein light chain Tctex-type 1 (T-complex testis-specific protein 1 homolog)	DYNLT1 TCTEL TCTEX-1 TCTEX1	Bos taurus (Bovine)	113	cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819]; motor activity [GO:0003774]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of neurogenesis [GO:0050768]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819]	motor activity [GO:0003774]	GO:0000132; GO:0003774; GO:0005794; GO:0005819; GO:0005868; GO:0005874; GO:0006886; GO:0008277; GO:0043001; GO:0050768; GO:0051301	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of neurogenesis [GO:0050768]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN18723_c0_g1_i1	P63171	DYLT1_BOVIN	99.1	113	1	0	27	365	1	113	5.40E-60	231.5	DYLT1_BOVIN	reviewed	Dynein light chain Tctex-type 1 (T-complex testis-specific protein 1 homolog)	DYNLT1 TCTEL TCTEX-1 TCTEX1	Bos taurus (Bovine)	113	cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819]; motor activity [GO:0003774]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of neurogenesis [GO:0050768]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819]	motor activity [GO:0003774]	GO:0000132; GO:0003774; GO:0005794; GO:0005819; GO:0005868; GO:0005874; GO:0006886; GO:0008277; GO:0043001; GO:0050768; GO:0051301	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of neurogenesis [GO:0050768]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN730_c0_g1_i1	P63171	DYLT1_BOVIN	44.6	83	38	1	252	4	33	107	2.10E-15	82.8	DYLT1_BOVIN	reviewed	Dynein light chain Tctex-type 1 (T-complex testis-specific protein 1 homolog)	DYNLT1 TCTEL TCTEX-1 TCTEX1	Bos taurus (Bovine)	113	cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819]; motor activity [GO:0003774]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of neurogenesis [GO:0050768]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819]	motor activity [GO:0003774]	GO:0000132; GO:0003774; GO:0005794; GO:0005819; GO:0005868; GO:0005874; GO:0006886; GO:0008277; GO:0043001; GO:0050768; GO:0051301	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of neurogenesis [GO:0050768]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		red	red	NA	NA	NA	NA
TRINITY_DN34984_c0_g1_i1	P51808	DYLT3_HUMAN	100	68	0	0	3	206	48	115	1.80E-33	142.5	DYLT3_HUMAN	reviewed	Dynein light chain Tctex-type 3 (Protein 91/23) (T-complex-associated testis-expressed 1-like)	DYNLT3 TCTE1L TCTE1XL	Homo sapiens (Human)	116	condensed chromosome kinetochore [GO:0000777]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle astral microtubule [GO:0061673]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of mitotic cell cycle [GO:0007346]	condensed chromosome kinetochore [GO:0000777]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle astral microtubule [GO:0061673]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; motor activity [GO:0003774]	GO:0000777; GO:0003774; GO:0005634; GO:0005868; GO:0007049; GO:0007346; GO:0042802; GO:0045931; GO:0051301; GO:0061673	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN25946_c0_g1_i1	Q9CQ66	TC1D2_MOUSE	40.8	103	56	1	298	5	5	107	1.50E-16	87	DYT2B_MOUSE	reviewed	Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2)	Dynlt2b Tctex1d2	Mus musculus (Mouse)	144	cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799]	cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]	dynein intermediate chain binding [GO:0045505]	GO:0005868; GO:0005929; GO:0035721; GO:0045505; GO:0060271; GO:1902017; GO:1905799	cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799]		NA	NA	NA	NA	NA	NA
TRINITY_DN37976_c0_g1_i1	Q86A88	DYL_DICDI	49.3	67	34	0	7	207	25	91	6.00E-16	84.3	DYL_DICDI	reviewed	"Dynein light chain, cytoplasmic (Dynein light chain LC8-type 2)"	dlcB DDB_G0274815	Dictyostelium discoideum (Slime mold)	91	"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]	dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005868; GO:0005874; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582	"microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2673_c0_g1_i1	Q8CDU4	DRC6_MOUSE	25.4	185	133	4	735	184	543	723	5.10E-12	73.6	DRC6_MOUSE	reviewed	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	Fbxl13 Drc6	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005856; GO:0006511; GO:0019005; GO:0031146; GO:0031514	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2673_c0_g1_i2	Q8CDU4	DRC6_MOUSE	25.4	185	133	4	755	204	543	723	5.00E-12	73.6	DRC6_MOUSE	reviewed	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	Fbxl13 Drc6	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005856; GO:0006511; GO:0019005; GO:0031146; GO:0031514	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2673_c0_g1_i3	Q8CDU4	DRC6_MOUSE	25.4	185	133	4	755	204	543	723	5.20E-12	73.6	DRC6_MOUSE	reviewed	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	Fbxl13 Drc6	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005856; GO:0006511; GO:0019005; GO:0031146; GO:0031514	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2673_c0_g1_i6	Q8CDU4	DRC6_MOUSE	25.4	185	133	4	755	204	543	723	5.00E-12	73.6	DRC6_MOUSE	reviewed	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	Fbxl13 Drc6	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005856; GO:0006511; GO:0019005; GO:0031146; GO:0031514	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2673_c0_g1_i8	Q8CDU4	DRC6_MOUSE	25.4	185	133	4	735	184	543	723	4.90E-12	73.6	DRC6_MOUSE	reviewed	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	Fbxl13 Drc6	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005856; GO:0006511; GO:0019005; GO:0031146; GO:0031514	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2673_c0_g1_i9	Q8CDU4	DRC6_MOUSE	25.4	185	133	4	735	184	543	723	4.90E-12	73.6	DRC6_MOUSE	reviewed	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	Fbxl13 Drc6	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005856; GO:0006511; GO:0019005; GO:0031146; GO:0031514	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN19226_c3_g1_i1	Q39578	DYI2_CHLRE	56.6	53	23	0	205	47	277	329	7.50E-15	80.9	DYI2_CHLRE	reviewed	"Dynein, 78 kDa intermediate chain, flagellar outer arm (IC78)"	ODA9 ODA-9	Chlamydomonas reinhardtii (Chlamydomonas smithii)	683	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514			NA	NA	NA	NA	NA	NA
TRINITY_DN40803_c0_g1_i1	E7F6H7	DCI2A_DANRE	53.5	43	20	0	206	78	547	589	1.50E-06	53.1	DCI2A_DANRE	reviewed	"Dynein, cytoplasmic 1, intermediate chain 2a"	dync1i2a	Danio rerio (Zebrafish) (Brachydanio rerio)	626	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; transport along microtubule [GO:0010970]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]	GO:0005737; GO:0005868; GO:0007018; GO:0007052; GO:0010970; GO:0045503; GO:0045504	microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; transport along microtubule [GO:0010970]		NA	NA	NA	NA	NA	NA
TRINITY_DN4285_c0_g1_i1	Q5VV43	K0319_HUMAN	37.1	394	230	5	729	1880	279	664	6.60E-58	226.9	K0319_HUMAN	reviewed	Dyslexia-associated protein KIAA0319	KIAA0319	Homo sapiens (Human)	1072	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030665; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:0061024; GO:2000171	membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]		NA	NA	NA	NA	NA	NA
TRINITY_DN4285_c0_g1_i4	Q5VV43	K0319_HUMAN	34.8	773	473	11	495	2768	279	1035	4.00E-115	417.5	K0319_HUMAN	reviewed	Dyslexia-associated protein KIAA0319	KIAA0319	Homo sapiens (Human)	1072	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030665; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:0061024; GO:2000171	membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]		NA	NA	NA	NA	NA	NA
TRINITY_DN4285_c0_g1_i5	Q5VV43	K0319_HUMAN	34.7	749	461	10	729	2939	279	1011	1.60E-111	405.6	K0319_HUMAN	reviewed	Dyslexia-associated protein KIAA0319	KIAA0319	Homo sapiens (Human)	1072	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030665; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:0061024; GO:2000171	membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]		NA	NA	NA	NA	NA	NA
TRINITY_DN4285_c0_g1_i6	Q5VV43	K0319_HUMAN	34.8	773	473	11	729	3002	279	1035	4.30E-115	417.5	K0319_HUMAN	reviewed	Dyslexia-associated protein KIAA0319	KIAA0319	Homo sapiens (Human)	1072	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030665; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:0061024; GO:2000171	membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]		NA	NA	NA	NA	NA	NA
TRINITY_DN25539_c0_g1_i1	Q9D2N4	DTNA_MOUSE	43.6	78	28	3	86	304	616	682	8.00E-05	48.5	DTNA_MOUSE	reviewed	Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin)	Dtna Dtn	Mus musculus (Mouse)	746	axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dystrobrevin complex [GO:0016014]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536]	axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dystrobrevin complex [GO:0016014]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]	PDZ domain binding [GO:0030165]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005886; GO:0008270; GO:0016014; GO:0030165; GO:0030424; GO:0031234; GO:0032991; GO:0042383; GO:0042995; GO:0045202; GO:0099536	synaptic signaling [GO:0099536]		NA	NA	NA	NA	NA	NA
TRINITY_DN9378_c0_g1_i1	P84060	DTNB_RAT	43.2	271	120	6	720	7	249	518	1.70E-46	187.6	DTNB_RAT	reviewed	Dystrobrevin beta (DTN-B) (Beta-dystrobrevin)	Dtnb	Rattus norvegicus (Rat)	654	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202]	zinc ion binding [GO:0008270]	GO:0005737; GO:0005886; GO:0008270; GO:0045202; GO:0099536	synaptic signaling [GO:0099536]		NA	NA	NA	NA	NA	NA
TRINITY_DN8581_c0_g1_i8	Q5GN48	DMD_PIG	37.5	331	204	3	66	1052	3064	3393	1.30E-59	232.6	DMD_PIG	reviewed	Dystrophin	DMD	Sus scrofa (Pig)	3674	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]	actin binding [GO:0003779]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0008270; GO:0042383; GO:0045211; GO:0099536	synaptic signaling [GO:0099536]		NA	NA	NA	NA	NA	NA
TRINITY_DN27093_c0_g1_i1	P11532	DMD_HUMAN	100	99	0	0	1	297	37	135	5.10E-50	198	DMD_HUMAN	reviewed	Dystrophin	DMD	Homo sapiens (Human)	3685	cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]; actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein localization [GO:0034613]; cellular protein-containing complex assembly [GO:0034622]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle fiber development [GO:0048747]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]	cell-substrate junction [GO:0030055]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]	actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]	GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030049; GO:0030055; GO:0030175; GO:0031527; GO:0032991; GO:0033137; GO:0034613; GO:0034622; GO:0035633; GO:0035994; GO:0042383; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048747; GO:0050998; GO:0060048; GO:0060314; GO:0086001; GO:0090287; GO:1901385; GO:1902083; GO:2000651	cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein-containing complex assembly [GO:0034622]; cellular protein localization [GO:0034613]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle fiber development [GO:0048747]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]		NA	NA	NA	NA	NA	NA
TRINITY_DN16010_c0_g1_i1	O97592	DMD_CANLF	44.2	113	63	0	2	340	504	616	2.20E-20	99.8	DMD_CANLF	reviewed	Dystrophin	DMD	Canis lupus familiaris (Dog) (Canis familiaris)	3680	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]	actin binding [GO:0003779]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0008270; GO:0042383; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN17079_c0_g1_i1	Q9VDW3	DMDB_DROME	61.7	120	42	3	3	353	1377	1495	4.90E-29	129.8	DMDB_DROME	reviewed	"Dystrophin, isoform B (Protein detached)"	Dys det CG34157	Drosophila melanogaster (Fruit fly)	1669	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0007517; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN5116_c0_g1_i1	Q9VDW6	DMDA_DROME	67.6	247	68	2	4	720	2895	3137	3.70E-94	345.9	DMDA_DROME	reviewed	"Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached)"	Dys det CG34157	Drosophila melanogaster (Fruit fly)	3598	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN8581_c0_g1_i1	Q9VDW6	DMDA_DROME	40.6	133	78	1	1	396	3072	3204	1.80E-25	118.6	DMDA_DROME	reviewed	"Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached)"	Dys det CG34157	Drosophila melanogaster (Fruit fly)	3598	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN8581_c0_g1_i3	Q9VDW6	DMDA_DROME	39.5	354	200	5	79	1110	2855	3204	2.20E-70	268.5	DMDA_DROME	reviewed	"Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached)"	Dys det CG34157	Drosophila melanogaster (Fruit fly)	3598	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN8581_c0_g1_i4	Q9VDW6	DMDA_DROME	39.5	354	200	5	79	1110	2855	3204	1.80E-70	268.5	DMDA_DROME	reviewed	"Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached)"	Dys det CG34157	Drosophila melanogaster (Fruit fly)	3598	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN8581_c0_g1_i7	Q9VDW6	DMDA_DROME	40.6	133	78	1	64	459	3072	3204	1.50E-25	119	DMDA_DROME	reviewed	"Dystrophin, isoforms A/C/F/G/H (DmDYS) (Protein detached)"	Dys det CG34157	Drosophila melanogaster (Fruit fly)	3598	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]	GO:0003779; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		brown	brown	1	NA	NA	NA
TRINITY_DN10471_c0_g2_i1	Q56P03	EAPP_HUMAN	38.5	218	70	6	739	89	130	284	1.00E-31	139	EAPP_HUMAN	reviewed	E2F-associated phosphoprotein (EAPP)	EAPP C14orf11 BM-036	Homo sapiens (Human)	285	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]		NA	NA	NA	NA	NA	NA
TRINITY_DN27172_c0_g1_i1	Q56P03	EAPP_HUMAN	100	43	0	0	3	131	243	285	1.60E-18	92.8	EAPP_HUMAN	reviewed	E2F-associated phosphoprotein (EAPP)	EAPP C14orf11 BM-036	Homo sapiens (Human)	285	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]		NA	NA	NA	NA	NA	NA
TRINITY_DN25661_c0_g1_i1	Q5BU09	EAPP_MOUSE	100	74	0	0	224	3	147	220	2.30E-39	162.2	EAPP_MOUSE	reviewed	E2F-associated phosphoprotein (EAPP)	Eapp	Mus musculus (Mouse)	281	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]		NA	NA	NA	NA	NA	NA
TRINITY_DN27101_c0_g1_i1	Q56P03	EAPP_HUMAN	100	73	0	0	3	221	161	233	2.30E-36	152.1	EAPP_HUMAN	reviewed	E2F-associated phosphoprotein (EAPP)	EAPP C14orf11 BM-036	Homo sapiens (Human)	285	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]		NA	NA	NA	NA	NA	NA
TRINITY_DN35667_c0_g1_i1	Q56P03	EAPP_HUMAN	32.9	85	28	1	227	60	201	285	5.30E-07	54.7	EAPP_HUMAN	reviewed	E2F-associated phosphoprotein (EAPP)	EAPP C14orf11 BM-036	Homo sapiens (Human)	285	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]		red	red	NA	NA	NA	NA
TRINITY_DN39140_c0_g1_i1	A0A0B4K7J2	RBP2_DROME	56.2	96	42	0	288	1	2019	2114	5.50E-28	124.8	RBP2_DROME	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358)	Nup358 RanBP2 CG11856	Drosophila melanogaster (Fruit fly)	2718	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; SUMO transferase activity [GO:0019789]; germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; piRNA metabolic process [GO:0034587]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of cellular protein localization [GO:1903827]; regulation of transposition [GO:0010528]; ventral cord development [GO:0007419]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; SUMO transferase activity [GO:0019789]	GO:0005634; GO:0005642; GO:0005643; GO:0005737; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008284; GO:0008536; GO:0010528; GO:0010628; GO:0019789; GO:0034587; GO:0035626; GO:0043547; GO:0046833; GO:0046872; GO:0051028; GO:0051292; GO:1900182; GO:1903827	germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; piRNA metabolic process [GO:0034587]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of cellular protein localization [GO:1903827]; regulation of transposition [GO:0010528]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN12862_c0_g1_i1	A0A0B4K7J2	RBP2_DROME	54.8	166	69	2	645	160	1302	1465	1.00E-41	171.8	RBP2_DROME	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358)	Nup358 RanBP2 CG11856	Drosophila melanogaster (Fruit fly)	2718	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; SUMO transferase activity [GO:0019789]; germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; piRNA metabolic process [GO:0034587]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of cellular protein localization [GO:1903827]; regulation of transposition [GO:0010528]; ventral cord development [GO:0007419]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; SUMO transferase activity [GO:0019789]	GO:0005634; GO:0005642; GO:0005643; GO:0005737; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008284; GO:0008536; GO:0010528; GO:0010628; GO:0019789; GO:0034587; GO:0035626; GO:0043547; GO:0046833; GO:0046872; GO:0051028; GO:0051292; GO:1900182; GO:1903827	germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; piRNA metabolic process [GO:0034587]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of cellular protein localization [GO:1903827]; regulation of transposition [GO:0010528]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN12862_c0_g1_i3	A0A0B4K7J2	RBP2_DROME	54.8	166	69	2	645	160	1302	1465	1.50E-41	171.8	RBP2_DROME	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358)	Nup358 RanBP2 CG11856	Drosophila melanogaster (Fruit fly)	2718	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; SUMO transferase activity [GO:0019789]; germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; piRNA metabolic process [GO:0034587]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of cellular protein localization [GO:1903827]; regulation of transposition [GO:0010528]; ventral cord development [GO:0007419]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; SUMO transferase activity [GO:0019789]	GO:0005634; GO:0005642; GO:0005643; GO:0005737; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008284; GO:0008536; GO:0010528; GO:0010628; GO:0019789; GO:0034587; GO:0035626; GO:0043547; GO:0046833; GO:0046872; GO:0051028; GO:0051292; GO:1900182; GO:1903827	germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; piRNA metabolic process [GO:0034587]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of cellular protein localization [GO:1903827]; regulation of transposition [GO:0010528]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN25061_c0_g1_i1	P49792	RBP2_HUMAN	47.7	65	33	1	219	28	1242	1306	2.90E-10	65.5	RBP2_HUMAN	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270)	RANBP2 NUP358	Homo sapiens (Human)	3224	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; centrosome localization [GO:0051642]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; response to amphetamine [GO:0001975]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]	GO:0000413; GO:0001975; GO:0003723; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005739; GO:0005829; GO:0006110; GO:0006111; GO:0006406; GO:0006409; GO:0006457; GO:0006607; GO:0008536; GO:0016020; GO:0016032; GO:0016925; GO:0019083; GO:0019789; GO:0031965; GO:0033133; GO:0042405; GO:0043231; GO:0043547; GO:0043657; GO:0044614; GO:0044615; GO:0044877; GO:0046872; GO:0051642; GO:0060964; GO:0075733; GO:1900034; GO:1990723	centrosome localization [GO:0051642]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; response to amphetamine [GO:0001975]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN29981_c0_g1_i1	P49792	RBP2_HUMAN	100	111	0	0	336	4	2297	2407	1.20E-60	233.4	RBP2_HUMAN	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270)	RANBP2 NUP358	Homo sapiens (Human)	3224	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; centrosome localization [GO:0051642]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; response to amphetamine [GO:0001975]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]	GO:0000413; GO:0001975; GO:0003723; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005739; GO:0005829; GO:0006110; GO:0006111; GO:0006406; GO:0006409; GO:0006457; GO:0006607; GO:0008536; GO:0016020; GO:0016032; GO:0016925; GO:0019083; GO:0019789; GO:0031965; GO:0033133; GO:0042405; GO:0043231; GO:0043547; GO:0043657; GO:0044614; GO:0044615; GO:0044877; GO:0046872; GO:0051642; GO:0060964; GO:0075733; GO:1900034; GO:1990723	centrosome localization [GO:0051642]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; response to amphetamine [GO:0001975]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN11442_c0_g1_i1	P48820	RBP2_BOVIN	45.4	205	107	4	678	67	714	914	1.20E-40	168.3	RBP2_BOVIN	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) (Fragment)	RANBP2	Bos taurus (Bovine)	1085	annulate lamellae [GO:0005642]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; intracellular transport [GO:0046907]; mRNA transport [GO:0051028]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; protein transport [GO:0015031]	annulate lamellae [GO:0005642]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; transferase activity [GO:0016740]	GO:0003723; GO:0003755; GO:0005635; GO:0005642; GO:0005643; GO:0006457; GO:0015031; GO:0016740; GO:0016925; GO:0031965; GO:0042405; GO:0044615; GO:0046907; GO:0051028	intracellular transport [GO:0046907]; mRNA transport [GO:0051028]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN25061_c0_g2_i1	Q9ERU9	RBP2_MOUSE	59.3	91	37	0	18	290	1147	1237	2.70E-24	112.5	RBP2_MOUSE	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2)	Ranbp2	Mus musculus (Mouse)	3053	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]	GO:0001975; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005739; GO:0006111; GO:0006457; GO:0006607; GO:0008536; GO:0016925; GO:0019789; GO:0031965; GO:0033133; GO:0042405; GO:0043547; GO:0044614; GO:0044615; GO:0044877; GO:0046872; GO:0051028; GO:0051642; GO:1990723	centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]		NA	NA	NA	NA	NA	NA
TRINITY_DN26779_c0_g1_i1	C5FHU9	SKP1_ARTOC	69.2	78	24	0	34	267	87	164	2.20E-26	119.4	SKP1_ARTOC	reviewed	E3 ubiquitin ligase complex SCF subunit sconC (Sulfur controller C) (Sulfur metabolite repression control protein C)	sconC skpA MCYG_01748	Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) (Microsporum canis)	165	nuclear SCF ubiquitin ligase complex [GO:0043224]; RAVE complex [GO:0043291]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; nuclear membrane biogenesis involved in mitotic nuclear division [GO:0101026]; regulation of strand invasion [GO:0060542]; resolution of meiotic recombination intermediates [GO:0000712]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	nuclear SCF ubiquitin ligase complex [GO:0043224]; RAVE complex [GO:0043291]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]	ubiquitin protein ligase activity [GO:0061630]	GO:0000712; GO:0017117; GO:0031146; GO:0043224; GO:0043291; GO:0045841; GO:0060542; GO:0061630; GO:0101026	negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; nuclear membrane biogenesis involved in mitotic nuclear division [GO:0101026]; regulation of strand invasion [GO:0060542]; resolution of meiotic recombination intermediates [GO:0000712]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN32697_c0_g1_i1	Q6INH1	RN157_XENLA	58.5	330	128	5	1	972	7	333	3.30E-106	386.3	RN157_XENLA	reviewed	E3 ubiquitin ligase Rnf157 (EC 2.3.2.27) (RING finger protein 157) (RING-type E3 ubiquitin transferase Rnf157)	rnf157	Xenopus laevis (African clawed frog)	674	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; transferase activity [GO:0016740]	GO:0005737; GO:0016740; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8653_c0_g1_i2	Q6INH1	RN157_XENLA	48.1	52	24	3	217	71	265	316	4.10E-05	48.5	RN157_XENLA	reviewed	E3 ubiquitin ligase Rnf157 (EC 2.3.2.27) (RING finger protein 157) (RING-type E3 ubiquitin transferase Rnf157)	rnf157	Xenopus laevis (African clawed frog)	674	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; transferase activity [GO:0016740]	GO:0005737; GO:0016740; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24764_c0_g1_i1	Q9UKV5	AMFR_HUMAN	98.6	71	1	0	1	213	74	144	1.40E-33	142.9	AMFR_HUMAN	reviewed	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78)	AMFR RNF45	Homo sapiens (Human)	643	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006457; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381; GO:2000638	aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24764_c0_g1_i2	Q9UKV5	AMFR_HUMAN	100	71	0	0	1	213	74	144	6.20E-34	144.1	AMFR_HUMAN	reviewed	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78)	AMFR RNF45	Homo sapiens (Human)	643	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006457; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381; GO:2000638	aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1516_c0_g1_i3	Q9UKV5	AMFR_HUMAN	44.1	245	116	5	395	1117	1	228	1.10E-44	182.2	AMFR_HUMAN	reviewed	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78)	AMFR RNF45	Homo sapiens (Human)	643	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006457; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381; GO:2000638	aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1516_c0_g1_i7	Q9UKV5	AMFR_HUMAN	45.5	189	83	4	395	949	1	173	3.70E-36	153.7	AMFR_HUMAN	reviewed	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78)	AMFR RNF45	Homo sapiens (Human)	643	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006457; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381; GO:2000638	aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21299_c0_g1_i1	Q9UKV5	AMFR_HUMAN	100	91	0	0	274	2	230	320	4.90E-47	188	AMFR_HUMAN	reviewed	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78)	AMFR RNF45	Homo sapiens (Human)	643	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006457; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381; GO:2000638	aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1516_c0_g1_i5	Q9R049	AMFR_MOUSE	44.8	522	247	8	395	1936	1	489	2.60E-110	401	AMFR_MOUSE	reviewed	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING-type E3 ubiquitin transferase AMFR)	Amfr	Mus musculus (Mouse)	643	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; cellular process [GO:0009987]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000166; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005887; GO:0006511; GO:0007568; GO:0007611; GO:0009987; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1990381; GO:2000638	aging [GO:0007568]; cellular process [GO:0009987]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN35826_c0_g1_i1	A2VEA3	ARI1_BOVIN	100	85	0	0	2	256	471	555	9.50E-43	173.7	ARI1_BOVIN	reviewed	E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase ARIH1)	ARIH1	Bos taurus (Bovine)	555	Cajal body [GO:0015030]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cajal body [GO:0015030]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2212_c0_g1_i1	Q6PFJ9	ARI1_DANRE	68.9	527	141	4	1616	102	1	526	8.00E-225	781.2	ARI1_DANRE	reviewed	E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase arih1)	arih1 si:dkey-151p17.4 si:dkey-73n10.2	Danio rerio (Zebrafish) (Brachydanio rerio)	527	cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0016604; GO:0031624; GO:0032436; GO:0061630; GO:0097413	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN25858_c0_g1_i1	Q6NW85	ARI1L_DANRE	100	67	0	0	2	202	303	369	1.90E-40	165.6	ARI1L_DANRE	reviewed	E3 ubiquitin-protein ligase arih1l (EC 2.3.2.31) (RING-type E3 ubiquitin transferase arih1l)	arih1l zgc:85905	Danio rerio (Zebrafish) (Brachydanio rerio)	533	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0032436; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN27214_c0_g1_i1	O95376	ARI2_HUMAN	100	102	0	0	1	306	267	368	3.30E-60	231.9	ARI2_HUMAN	reviewed	E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein)	ARIH2 ARI2 TRIAD1 HT005	Homo sapiens (Human)	493	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism development [GO:0007275]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0031624; GO:0032436; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425; GO:1903955	developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism development [GO:0007275]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN16539_c0_g1_i1	Q9Z1K6	ARI2_MOUSE	100	194	0	0	2	583	299	492	4.00E-115	415.2	ARI2_MOUSE	reviewed	E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein) (UbcM4-interacting protein 48)	Arih2 Ari2 Triad1 Uip48	Mus musculus (Mouse)	492	Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031466; GO:0031624; GO:0032436; GO:0046872; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425	developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN33113_c0_g1_i1	Q9VRP9	BRE1_DROME	54.9	224	73	1	7	594	36	259	9.40E-56	218	BRE1_DROME	reviewed	E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1)	Bre1 CG10542	Drosophila melanogaster (Fruit fly)	1044	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574; GO:0061630	histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]		blue	blue	NA	NA	NA	NA
TRINITY_DN8844_c0_g1_i1	Q9VRP9	BRE1_DROME	54.2	286	126	2	893	45	278	561	2.70E-67	256.9	BRE1_DROME	reviewed	E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1)	Bre1 CG10542	Drosophila melanogaster (Fruit fly)	1044	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574; GO:0061630	histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]		blue	blue	NA	NA	NA	NA
TRINITY_DN7379_c1_g2_i1	Q9VRP9	BRE1_DROME	72.6	124	33	1	78	446	920	1043	3.00E-44	179.5	BRE1_DROME	reviewed	E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1)	Bre1 CG10542	Drosophila melanogaster (Fruit fly)	1044	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574; GO:0061630	histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN7379_c1_g2_i6	Q9VRP9	BRE1_DROME	74.9	171	42	1	3	512	873	1043	5.60E-63	241.9	BRE1_DROME	reviewed	E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1)	Bre1 CG10542	Drosophila melanogaster (Fruit fly)	1044	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574; GO:0061630	histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN7379_c1_g1_i1	Q9VRP9	BRE1_DROME	60.3	209	67	1	580	2	667	875	2.70E-38	160.2	BRE1_DROME	reviewed	E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1)	Bre1 CG10542	Drosophila melanogaster (Fruit fly)	1044	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574; GO:0061630	histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN7379_c1_g1_i2	Q9VRP9	BRE1_DROME	58.9	209	63	1	559	2	667	875	1.10E-36	154.8	BRE1_DROME	reviewed	E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1)	Bre1 CG10542	Drosophila melanogaster (Fruit fly)	1044	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006513; GO:0007219; GO:0008270; GO:0010390; GO:0016570; GO:0016574; GO:0061630	histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN37804_c0_g1_i1	Q5VTR2	BRE1A_HUMAN	100	75	0	0	228	4	353	427	7.90E-35	147.1	BRE1A_HUMAN	reviewed	E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A)	RNF20 BRE1A	Homo sapiens (Human)	975	"HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0002039; GO:0003682; GO:0003713; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006511; GO:0010390; GO:0016567; GO:0030336; GO:0031062; GO:0031625; GO:0033503; GO:0033523; GO:0042393; GO:0042802; GO:0045893; GO:0046872; GO:1900364; GO:2001168	"histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26134_c0_g1_i1	Q13191	CBLB_HUMAN	99.5	183	1	0	2	550	259	441	3.50E-113	408.7	CBLB_HUMAN	reviewed	E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)	CBLB RNF56 Nbla00127	Homo sapiens (Human)	982	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0001784; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006607; GO:0007165; GO:0007166; GO:0007175; GO:0008270; GO:0017124; GO:0030971; GO:0045121; GO:0061630; GO:2000583	cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33408_c0_g1_i1	Q13191	CBLB_HUMAN	100	130	0	0	3	392	132	261	1.10E-73	276.9	CBLB_HUMAN	reviewed	E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)	CBLB RNF56 Nbla00127	Homo sapiens (Human)	982	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0001784; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006607; GO:0007165; GO:0007166; GO:0007175; GO:0008270; GO:0017124; GO:0030971; GO:0045121; GO:0061630; GO:2000583	cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2717_c0_g1_i1	Q6DFR2	CBLB_XENTR	70.2	443	124	4	1365	55	23	463	3.80E-191	669.1	CBLB_XENTR	reviewed	E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)	cblb	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	982	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; unfolded protein binding [GO:0051082]; cell surface receptor signaling pathway [GO:0007166]; heart contraction [GO:0060047]; locomotory behavior [GO:0007626]; myofibril assembly [GO:0030239]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; unfolded protein binding [GO:0051082]	GO:0001784; GO:0005509; GO:0005737; GO:0005886; GO:0007165; GO:0007166; GO:0007175; GO:0007519; GO:0007626; GO:0017124; GO:0030239; GO:0030971; GO:0045121; GO:0051082; GO:0060047; GO:0061630; GO:2000583	cell surface receptor signaling pathway [GO:0007166]; heart contraction [GO:0060047]; locomotory behavior [GO:0007626]; myofibril assembly [GO:0030239]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN2717_c0_g1_i2	Q6DFR2	CBLB_XENTR	70.2	443	124	4	1401	91	23	463	1.10E-190	667.5	CBLB_XENTR	reviewed	E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)	cblb	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	982	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; unfolded protein binding [GO:0051082]; cell surface receptor signaling pathway [GO:0007166]; heart contraction [GO:0060047]; locomotory behavior [GO:0007626]; myofibril assembly [GO:0030239]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; unfolded protein binding [GO:0051082]	GO:0001784; GO:0005509; GO:0005737; GO:0005886; GO:0007165; GO:0007166; GO:0007175; GO:0007519; GO:0007626; GO:0017124; GO:0030239; GO:0030971; GO:0045121; GO:0051082; GO:0060047; GO:0061630; GO:2000583	cell surface receptor signaling pathway [GO:0007166]; heart contraction [GO:0060047]; locomotory behavior [GO:0007626]; myofibril assembly [GO:0030239]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN30104_c0_g1_i1	Q9UNE7	CHIP_HUMAN	57.6	276	115	1	939	118	28	303	6.50E-91	335.5	CHIP_HUMAN	reviewed	E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)	STUB1 CHIP PP1131	Homo sapiens (Human)	303	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		blue	blue	NA	NA	NA	NA
TRINITY_DN9149_c0_g2_i1	Q9UNE7	CHIP_HUMAN	81.6	147	0	1	1	441	183	302	1.10E-61	237.3	CHIP_HUMAN	reviewed	E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)	STUB1 CHIP PP1131	Homo sapiens (Human)	303	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN9149_c0_g2_i2	Q9UNE7	CHIP_HUMAN	100	120	0	0	1	360	183	302	4.70E-66	251.5	CHIP_HUMAN	reviewed	E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)	STUB1 CHIP PP1131	Homo sapiens (Human)	303	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN9149_c0_g1_i1	Q9UNE7	CHIP_HUMAN	100	106	0	0	1	318	198	303	2.30E-58	226.1	CHIP_HUMAN	reviewed	E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)	STUB1 CHIP PP1131	Homo sapiens (Human)	303	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN29946_c0_g1_i1	Q8NHY2	COP1_HUMAN	100	158	0	0	2	475	370	527	1.80E-89	329.7	COP1_HUMAN	reviewed	E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2)	COP1 RFWD2 RNF200	Homo sapiens (Human)	731	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0004842; GO:0005654; GO:0005829; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0043687; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN30762_c0_g1_i1	Q8NHY2	COP1_HUMAN	100	121	0	0	1	363	611	731	5.40E-65	248.1	COP1_HUMAN	reviewed	E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2)	COP1 RFWD2 RNF200	Homo sapiens (Human)	731	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0004842; GO:0005654; GO:0005829; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0043687; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN27131_c0_g1_i1	Q8NHY2	COP1_HUMAN	100	130	0	0	392	3	544	673	4.30E-73	275	COP1_HUMAN	reviewed	E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2)	COP1 RFWD2 RNF200	Homo sapiens (Human)	731	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0004842; GO:0005654; GO:0005829; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0043687; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN38560_c0_g1_i1	Q9R1A8	COP1_MOUSE	51.3	641	280	8	1962	76	113	733	5.70E-188	659.1	COP1_MOUSE	reviewed	E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2)	Cop1 Rfwd2 RNF200	Mus musculus (Mouse)	733	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000139; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN9285_c0_g1_i4	Q9CR14	FANCL_MOUSE	26.9	268	189	3	95	898	8	268	3.20E-24	114	FANCL_MOUSE	reviewed	E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein homolog) (Proliferation of germ cells protein) (RING-type E3 ubiquitin transferase FANCL)	Fancl Phf9 Pog	Mus musculus (Mouse)	375	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]		NA	NA	NA	NA	NA	NA
TRINITY_DN9285_c0_g1_i5	Q9CR14	FANCL_MOUSE	27.1	321	218	5	95	1051	8	314	7.60E-32	139.4	FANCL_MOUSE	reviewed	E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein homolog) (Proliferation of germ cells protein) (RING-type E3 ubiquitin transferase FANCL)	Fancl Phf9 Pog	Mus musculus (Mouse)	375	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]		NA	NA	NA	NA	NA	NA
TRINITY_DN9285_c0_g1_i2	Q9NW38	FANCL_HUMAN	31.8	132	90	0	61	456	142	273	4.00E-18	92.8	FANCL_HUMAN	reviewed	E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL)	FANCL PHF9	Homo sapiens (Human)	375	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]		brown	brown	1	NA	NA	NA
TRINITY_DN9285_c0_g1_i6	Q9NW38	FANCL_HUMAN	30.7	176	117	1	61	588	142	312	1.50E-24	114.4	FANCL_HUMAN	reviewed	E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL)	FANCL PHF9	Homo sapiens (Human)	375	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]		NA	NA	NA	NA	NA	NA
TRINITY_DN32957_c0_g1_i1	M9PBE2	HAKAI_DROME	66.7	138	43	1	877	473	128	265	7.80E-51	202.6	HAKAI_DROME	reviewed	E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27)	Hakai CG10263	Drosophila melanogaster (Fruit fly)	473	"cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; segmentation [GO:0035282]"	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005886; GO:0007015; GO:0007391; GO:0007427; GO:0007494; GO:0008258; GO:0008270; GO:0016567; GO:0030155; GO:0031410; GO:0035282; GO:0036396; GO:0040003; GO:0045296; GO:0048471; GO:0060429; GO:0061630	"actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; segmentation [GO:0035282]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32957_c0_g1_i2	M9PBE2	HAKAI_DROME	64.2	134	45	1	454	62	128	261	4.30E-47	189.5	HAKAI_DROME	reviewed	E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27)	Hakai CG10263	Drosophila melanogaster (Fruit fly)	473	"cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; segmentation [GO:0035282]"	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005886; GO:0007015; GO:0007391; GO:0007427; GO:0007494; GO:0008258; GO:0008270; GO:0016567; GO:0030155; GO:0031410; GO:0035282; GO:0036396; GO:0040003; GO:0045296; GO:0048471; GO:0060429; GO:0061630	"actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; segmentation [GO:0035282]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1834_c0_g1_i2	Q9ULT8	HECD1_HUMAN	48.7	2096	798	31	70	5934	652	2610	0	1728.4	HECD1_HUMAN	reviewed	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)	HECTD1 KIAA1131	Homo sapiens (Human)	2610	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003170; GO:0003281; GO:0004842; GO:0035904; GO:0046872; GO:0048856; GO:0070534	anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN1834_c0_g1_i3	Q9ULT8	HECD1_HUMAN	47.8	2150	785	34	70	6078	652	2610	0	1711.4	HECD1_HUMAN	reviewed	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)	HECTD1 KIAA1131	Homo sapiens (Human)	2610	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003170; GO:0003281; GO:0004842; GO:0035904; GO:0046872; GO:0048856; GO:0070534	anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN1834_c0_g1_i4	Q9ULT8	HECD1_HUMAN	47.4	2135	791	35	70	6003	652	2610	0	1711	HECD1_HUMAN	reviewed	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)	HECTD1 KIAA1131	Homo sapiens (Human)	2610	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003170; GO:0003281; GO:0004842; GO:0035904; GO:0046872; GO:0048856; GO:0070534	anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN35649_c0_g1_i1	Q9ULT8	HECD1_HUMAN	64.7	184	61	1	3	542	100	283	2.80E-59	229.6	HECD1_HUMAN	reviewed	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)	HECTD1 KIAA1131	Homo sapiens (Human)	2610	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003170; GO:0003281; GO:0004842; GO:0035904; GO:0046872; GO:0048856; GO:0070534	anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN32164_c0_g1_i1	Q9ULT8	HECD1_HUMAN	98.9	92	1	0	278	3	1074	1165	1.10E-49	196.8	HECD1_HUMAN	reviewed	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)	HECTD1 KIAA1131	Homo sapiens (Human)	2610	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003170; GO:0003281; GO:0004842; GO:0035904; GO:0046872; GO:0048856; GO:0070534	anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN16418_c0_g1_i1	Q8K4P8	HECW1_MOUSE	34.9	261	149	6	4	768	98	343	6.60E-39	163.3	HECW1_MOUSE	reviewed	"E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (mNEDL1)"	Hecw1 Kiaa0322 Nedl1	Mus musculus (Mouse)	1604	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:2000650	negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21057_c0_g1_i1	Q6I6G8	HECW2_MOUSE	48.6	185	79	5	24	545	1008	1187	1.60E-33	144.1	HECW2_MOUSE	reviewed	"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)"	Hecw2 Kiaa1301 Nedl2	Mus musculus (Mouse)	1578	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:0072686; GO:2000650	negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN39563_c0_g1_i1	Q9P2P5	HECW2_HUMAN	80.4	397	78	0	1207	17	1176	1572	3.00E-194	679.1	HECW2_HUMAN	reviewed	"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)"	HECW2 KIAA1301 NEDL2	Homo sapiens (Human)	1572	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:0072686; GO:2000650	negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g1_i1	O95714	HERC2_HUMAN	63.2	1509	457	10	4568	75	3404	4825	0	1882.5	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i10	O95714	HERC2_HUMAN	58	467	184	7	1470	88	2608	3068	2.40E-151	537	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i11	O95714	HERC2_HUMAN	85.7	77	11	0	233	3	3226	3302	3.00E-37	155.6	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i12	O95714	HERC2_HUMAN	66.4	718	229	7	2138	3	2591	3302	4.10E-287	988.4	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i15	O95714	HERC2_HUMAN	66.6	701	222	7	2087	3	2608	3302	1.70E-280	966.5	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i17	O95714	HERC2_HUMAN	58.1	484	191	7	1521	88	2591	3068	4.40E-158	559.3	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i18	O95714	HERC2_HUMAN	58	483	191	7	1870	440	2591	3067	9.30E-158	558.5	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i18	O95714	HERC2_HUMAN	70.2	191	51	2	575	3	3118	3302	4.10E-73	277.3	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i3	O95714	HERC2_HUMAN	85.6	146	21	0	440	3	3157	3302	4.90E-74	279.3	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i3	O95714	HERC2_HUMAN	55.4	83	37	0	783	535	2817	2899	1.30E-18	95.1	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i7	O95714	HERC2_HUMAN	55.4	83	37	0	595	347	2817	2899	1.00E-18	95.1	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8577_c0_g2_i7	O95714	HERC2_HUMAN	74.5	47	11	1	225	88	3022	3068	7.80E-11	68.9	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN17409_c0_g2_i1	O95714	HERC2_HUMAN	40.1	309	167	5	913	2	1018	1313	8.80E-53	208.8	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN17409_c0_g1_i1	Q4U2R1	HERC2_MOUSE	55.8	52	22	1	302	150	1498	1549	1.50E-09	63.5	HERC2_MOUSE	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	Herc2 Jdf2 Kiaa0393 Rjs	Mus musculus (Mouse)	4836	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN17409_c0_g1_i2	Q4U2R1	HERC2_MOUSE	38.7	93	48	2	730	455	1498	1582	6.90E-08	59.3	HERC2_MOUSE	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	Herc2 Jdf2 Kiaa0393 Rjs	Mus musculus (Mouse)	4836	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN39328_c0_g1_i1	O95714	HERC2_HUMAN	65.3	236	78	1	753	58	477	712	8.80E-91	334.7	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN39328_c0_g1_i2	Q4U2R1	HERC2_MOUSE	62.8	296	106	1	916	41	478	773	3.90E-109	396	HERC2_MOUSE	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	Herc2 Jdf2 Kiaa0393 Rjs	Mus musculus (Mouse)	4836	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN39328_c0_g1_i3	Q4U2R1	HERC2_MOUSE	60.1	373	143	2	1114	14	478	850	8.90E-132	471.5	HERC2_MOUSE	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	Herc2 Jdf2 Kiaa0393 Rjs	Mus musculus (Mouse)	4836	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN20860_c0_g1_i1	O95714	HERC2_HUMAN	36	150	89	2	438	10	2187	2336	3.00E-12	73.2	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN20860_c0_g1_i2	O95714	HERC2_HUMAN	33.3	135	83	2	506	123	2187	2321	8.70E-08	58.5	HERC2_HUMAN	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2	Homo sapiens (Human)	4834	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN32484_c0_g1_i1	Q4U2R1	HERC2_MOUSE	82.6	69	12	0	41	247	1870	1938	1.30E-30	133.3	HERC2_MOUSE	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	Herc2 Jdf2 Kiaa0393 Rjs	Mus musculus (Mouse)	4836	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN32484_c0_g1_i2	Q4U2R1	HERC2_MOUSE	82.3	79	14	0	3	239	1860	1938	1.30E-35	149.8	HERC2_MOUSE	reviewed	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	Herc2 Jdf2 Kiaa0393 Rjs	Mus musculus (Mouse)	4836	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3890_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	71.4	84	23	1	60	311	497	579	2.30E-25	116.3	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3890_c0_g1_i2	Q7Z6Z7	HUWE1_HUMAN	81.7	126	23	0	154	531	497	622	3.50E-54	212.6	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3890_c0_g1_i3	Q7Z6Z7	HUWE1_HUMAN	71.4	84	23	1	154	405	497	579	2.90E-25	116.3	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3890_c0_g1_i4	Q7Z6Z7	HUWE1_HUMAN	79.6	98	20	0	154	447	497	594	6.60E-39	161.8	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4307_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	49.6	270	121	1	810	1	29	283	2.20E-71	270.4	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4307_c0_g1_i2	Q7Z6Z7	HUWE1_HUMAN	47.1	242	113	1	811	86	29	255	1.70E-60	234.2	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5977_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	48.8	129	56	2	147	503	1745	1873	1.30E-26	120.9	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i2	Q7Z6Z7	HUWE1_HUMAN	75	36	9	0	272	165	426	461	2.70E-07	56.2	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i5	Q7Z6Z7	HUWE1_HUMAN	68.2	157	44	2	624	154	325	475	5.10E-52	205.7	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i6	Q7Z6Z7	HUWE1_HUMAN	67.8	143	40	2	565	137	325	461	1.30E-46	187.6	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i7	Q7Z6Z7	HUWE1_HUMAN	75	36	9	0	244	137	426	461	2.40E-07	56.2	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8132_c0_g1_i8	Q7Z6Z7	HUWE1_HUMAN	74	50	13	0	303	154	426	475	1.00E-12	74.3	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN29774_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	86.1	165	23	0	519	25	4210	4374	1.60E-80	300.1	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN34559_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	100	91	0	0	2	274	516	606	5.90E-45	181	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6107_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	54	341	142	3	101	1078	834	1174	1.30E-90	334.7	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6107_c0_g1_i3	Q7Z6Z7	HUWE1_HUMAN	57.8	415	160	3	6	1205	760	1174	3.20E-127	456.4	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6107_c0_g1_i4	Q7Z6Z7	HUWE1_HUMAN	66.1	224	76	0	6	677	760	983	1.70E-83	310.5	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10566_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	87.5	80	10	0	3	242	4027	4106	5.20E-37	154.5	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN26609_c0_g1_i1	Q7Z6Z7	HUWE1_HUMAN	100	70	0	0	211	2	71	140	4.20E-30	131.3	HUWE1_HUMAN	reviewed	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	4374	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0043312; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; neutrophil degranulation [GO:0043312]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2375_c0_g1_i2	P51592	HYD_DROME	89.7	29	3	0	1	87	152	180	2.70E-06	52.4	HYD_DROME	reviewed	E3 ubiquitin-protein ligase hyd (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase hyd) (Protein hyperplastic discs)	hyd l(3)C43 CG9484	Drosophila melanogaster (Fruit fly)	2885	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; eye-antennal disc morphogenesis [GO:0007455]; female gonad development [GO:0008585]; imaginal disc development [GO:0007444]; imaginal disc growth [GO:0007446]; male meiosis cytokinesis [GO:0007112]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003723; GO:0005634; GO:0005737; GO:0006974; GO:0007112; GO:0007283; GO:0007289; GO:0007444; GO:0007446; GO:0007455; GO:0008270; GO:0008585; GO:0034450; GO:0035220; GO:0043130; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779	cellular response to DNA damage stimulus [GO:0006974]; eye-antennal disc morphogenesis [GO:0007455]; female gonad development [GO:0008585]; imaginal disc development [GO:0007444]; imaginal disc growth [GO:0007446]; male meiosis cytokinesis [GO:0007112]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN2375_c0_g1_i3	P51592	HYD_DROME	46.5	256	100	10	696	4	189	432	1.60E-38	161	HYD_DROME	reviewed	E3 ubiquitin-protein ligase hyd (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase hyd) (Protein hyperplastic discs)	hyd l(3)C43 CG9484	Drosophila melanogaster (Fruit fly)	2885	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; eye-antennal disc morphogenesis [GO:0007455]; female gonad development [GO:0008585]; imaginal disc development [GO:0007444]; imaginal disc growth [GO:0007446]; male meiosis cytokinesis [GO:0007112]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003723; GO:0005634; GO:0005737; GO:0006974; GO:0007112; GO:0007283; GO:0007289; GO:0007444; GO:0007446; GO:0007455; GO:0008270; GO:0008585; GO:0034450; GO:0035220; GO:0043130; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779	cellular response to DNA damage stimulus [GO:0006974]; eye-antennal disc morphogenesis [GO:0007455]; female gonad development [GO:0008585]; imaginal disc development [GO:0007444]; imaginal disc growth [GO:0007446]; male meiosis cytokinesis [GO:0007112]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN35755_c0_g1_i1	Q1LZE1	KCMF1_BOVIN	100	117	0	0	352	2	6	122	5.70E-69	261.2	KCMF1_BOVIN	reviewed	E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase KCMF1)	KCMF1	Bos taurus (Bovine)	381	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]		ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0008270; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN4934_c0_g1_i1	Q1LZE1	KCMF1_BOVIN	81.3	155	27	1	470	6	1	153	7.70E-76	284.6	KCMF1_BOVIN	reviewed	E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase KCMF1)	KCMF1	Bos taurus (Bovine)	381	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]		ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0008270; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN4934_c0_g2_i1	Q6GPB6	KCMF1_XENLA	57.6	66	20	2	8	181	152	217	3.10E-08	58.9	KCMF1_XENLA	reviewed	E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase KCMF1)	kcmf1	Xenopus laevis (African clawed frog)	381	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]		ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0008270; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN28479_c0_g1_i1	O94822	LTN1_HUMAN	100	82	0	0	274	29	1685	1766	2.40E-46	185.7	LTN1_HUMAN	reviewed	E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294)	LTN1 C21orf10 C21orf98 KIAA0714 RNF160 ZNF294 HSPC087	Homo sapiens (Human)	1766	cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	cytosol [GO:0005829]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0043023; GO:0043161; GO:0051865; GO:0061630; GO:0072344; GO:1990112; GO:1990116	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN4241_c0_g1_i1	Q6A009	LTN1_MOUSE	48.3	145	68	3	46	459	4	148	3.20E-27	122.9	LTN1_MOUSE	reviewed	E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294) (Zfp-294)	Ltn1 Kiaa0714 Lister Rnf160 Zfp294 Znf294	Mus musculus (Mouse)	1767	cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	cytosol [GO:0005829]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005829; GO:0008270; GO:0043023; GO:0043161; GO:0051865; GO:0061630; GO:0072344; GO:1990112; GO:1990116	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN988_c1_g1_i1	A0JM49	LTN1_XENTR	43.1	350	190	4	1083	55	1348	1695	4.20E-78	293.1	LTN1_XENTR	reviewed	E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (Zfp-294) (RING-type E3 ubiquitin transferase listerin)	ltn1 rnf160	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1696	cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	cytosol [GO:0005829]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0043023; GO:0043161; GO:0061630; GO:0072344; GO:1990112; GO:1990116	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		blue	blue	NA	NA	NA	NA
TRINITY_DN31669_c0_g1_i1	Q9FGI1	LTN1_ARATH	55.9	68	30	0	248	45	1805	1872	3.90E-19	95.1	LTN1_ARATH	reviewed	E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase listerin)	At5g58410 MCK7.28	Arabidopsis thaliana (Mouse-ear cress)	1873	cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	cytosol [GO:0005829]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0043023; GO:0043161; GO:0061630; GO:0072344; GO:1990112; GO:1990116	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN35717_c0_g1_i1	Q8TBB1	LNX1_HUMAN	38.7	225	123	1	719	90	504	728	5.80E-39	162.5	LNX1_HUMAN	reviewed	E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX)	LNX1 LNX PDZRN2 UNQ574/PRO1136	Homo sapiens (Human)	728	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0006511; GO:0030165; GO:0042802; GO:0046872	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10770_c0_g1_i1	Q80ZI6	LRSM1_MOUSE	23.6	788	519	12	2378	51	5	721	6.50E-34	147.5	LRSM1_MOUSE	reviewed	E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase)	Lrsam1	Mus musculus (Mouse)	727	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786	autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]		NA	NA	NA	NA	NA	NA
TRINITY_DN10770_c0_g1_i2	Q80ZI6	LRSM1_MOUSE	32.7	266	162	3	845	51	472	721	3.30E-28	127.1	LRSM1_MOUSE	reviewed	E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase)	Lrsam1	Mus musculus (Mouse)	727	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786	autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]		NA	NA	NA	NA	NA	NA
TRINITY_DN25721_c0_g1_i1	Q8IPJ3	LUBEL_DROME	65.1	43	15	0	167	39	2694	2736	6.30E-12	70.9	LUBEL_DROME	reviewed	E3 ubiquitin-protein ligase lubel (EC 2.3.2.31) (Linear Ubiquitin E3 ligase)	LUBEL CG11321	Drosophila melanogaster (Fruit fly)	2892	LUBAC complex [GO:0071797]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to Gram-negative bacterium [GO:0050829]; heat acclimation [GO:0010286]; immune system process [GO:0002376]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]	LUBAC complex [GO:0071797]	K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002376; GO:0004842; GO:0008270; GO:0010286; GO:0036435; GO:0050829; GO:0061059; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1990450	defense response to Gram-negative bacterium [GO:0050829]; heat acclimation [GO:0010286]; immune system process [GO:0002376]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN38579_c0_g1_i1	Q8IPJ3	LUBEL_DROME	63.6	44	16	0	10	141	2579	2622	1.40E-10	66.6	LUBEL_DROME	reviewed	E3 ubiquitin-protein ligase lubel (EC 2.3.2.31) (Linear Ubiquitin E3 ligase)	LUBEL CG11321	Drosophila melanogaster (Fruit fly)	2892	LUBAC complex [GO:0071797]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to Gram-negative bacterium [GO:0050829]; heat acclimation [GO:0010286]; immune system process [GO:0002376]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]	LUBAC complex [GO:0071797]	K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002376; GO:0004842; GO:0008270; GO:0010286; GO:0036435; GO:0050829; GO:0061059; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1990450	defense response to Gram-negative bacterium [GO:0050829]; heat acclimation [GO:0010286]; immune system process [GO:0002376]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN39343_c0_g1_i1	Q9QXP6	MKRN1_MOUSE	98.1	159	3	0	478	2	239	397	5.60E-91	334.7	MKRN1_MOUSE	reviewed	E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-1)	Mkrn1	Mus musculus (Mouse)	481	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cellular response to leukemia inhibitory factor [GO:1990830]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0003682; GO:0016567; GO:0046872; GO:0061630; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN39343_c0_g1_i2	Q9QXP6	MKRN1_MOUSE	98	148	3	0	445	2	250	397	1.00E-83	310.5	MKRN1_MOUSE	reviewed	E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-1)	Mkrn1	Mus musculus (Mouse)	481	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cellular response to leukemia inhibitory factor [GO:1990830]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0003682; GO:0016567; GO:0046872; GO:0061630; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN36526_c0_g1_i1	Q6NZQ8	MARH1_MOUSE	100	94	0	0	282	1	82	175	1.00E-52	206.8	MARH1_MOUSE	reviewed	E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING-type E3 ubiquitin transferase MARCHF1)	Marchf1 March1	Mus musculus (Mouse)	289	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0005886; GO:0006955; GO:0008270; GO:0016021; GO:0030659; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0061630	antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN18056_c1_g1_i2	Q6NZQ8	MARH1_MOUSE	27.7	206	138	7	604	2	28	227	1.40E-12	74.7	MARH1_MOUSE	reviewed	E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING-type E3 ubiquitin transferase MARCHF1)	Marchf1 March1	Mus musculus (Mouse)	289	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0005886; GO:0006955; GO:0008270; GO:0016021; GO:0030659; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0061630	antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN18056_c1_g1_i3	Q6NZQ8	MARH1_MOUSE	27.7	206	138	7	604	2	28	227	1.60E-12	74.7	MARH1_MOUSE	reviewed	E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING-type E3 ubiquitin transferase MARCHF1)	Marchf1 March1	Mus musculus (Mouse)	289	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0005886; GO:0006955; GO:0008270; GO:0016021; GO:0030659; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0061630	antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN30146_c0_g1_i1	Q9H992	MARH7_HUMAN	100	71	0	0	2	214	540	610	2.00E-35	149.1	MARH7_HUMAN	reviewed	E3 ubiquitin-protein ligase MARCHF7 (EC 2.3.2.27) (Axotrophin) (Membrane-associated RING finger protein 7) (Membrane-associated RING-CH protein VII) (MARCH-VII) (RING finger protein 177) (RING-type E3 ubiquitin transferase MARCHF7)	MARCHF7 AXOT MARCH7 RNF177	Homo sapiens (Human)	704	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]"	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	GO:0002643; GO:0005634; GO:0005829; GO:0005886; GO:0006513; GO:0008270; GO:0008284; GO:0016740; GO:0031624; GO:0042130; GO:0043130; GO:0043518; GO:0050821; GO:0051865; GO:0097371; GO:1901799; GO:1902166; GO:1902916; GO:1905524	"negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5553_c0_g1_i1	Q5T0T0	MARH8_HUMAN	68.7	201	51	2	25	591	57	257	1.70E-76	287	MARH8_HUMAN	reviewed	E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8)	MARCHF8 MARCH8 MIR RNF178	Homo sapiens (Human)	291	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002250; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0006955; GO:0008270; GO:0016021; GO:0030659; GO:0031901; GO:0031902; GO:0042287; GO:0061630	adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN5553_c0_g1_i3	Q5T0T0	MARH8_HUMAN	71.7	187	49	1	25	573	57	243	3.10E-76	287	MARH8_HUMAN	reviewed	E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8)	MARCHF8 MARCH8 MIR RNF178	Homo sapiens (Human)	291	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002250; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0006955; GO:0008270; GO:0016021; GO:0030659; GO:0031901; GO:0031902; GO:0042287; GO:0061630	adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN28880_c0_g1_i1	Q86YT6	MIB1_HUMAN	100	227	0	0	1	681	70	296	3.00E-138	492.3	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5234_c0_g1_i1	Q86YT6	MIB1_HUMAN	26.7	273	165	5	851	42	466	706	3.20E-16	87.8	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5234_c0_g1_i3	Q86YT6	MIB1_HUMAN	26.7	273	165	5	851	42	466	706	3.40E-16	87.8	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38826_c0_g1_i1	Q86YT6	MIB1_HUMAN	100	76	0	0	230	3	295	370	3.10E-39	161.8	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1234_c0_g1_i2	Q86YT6	MIB1_HUMAN	76.1	117	28	0	417	67	493	609	9.40E-49	194.5	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1234_c0_g1_i3	Q86YT6	MIB1_HUMAN	78.8	491	100	2	1468	5	2	491	1.60E-235	816.6	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1234_c0_g1_i4	Q86YT6	MIB1_HUMAN	78.4	495	101	3	1537	62	2	493	1.80E-234	813.1	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1234_c0_g1_i6	Q86YT6	MIB1_HUMAN	78.1	611	128	3	1890	67	2	609	4.40E-291	1001.5	MIB1_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	1006	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1234_c0_g1_i1	Q804S5	MIB1_DANRE	89.5	76	8	0	307	80	2	77	1.90E-36	153.3	MIB1_DANRE	reviewed	E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Protein mind bomb) (RING-type E3 ubiquitin transferase mib1)	mib1 mib	Danio rerio (Zebrafish) (Brachydanio rerio)	1030	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0001568; GO:0001570; GO:0001756; GO:0001885; GO:0002040; GO:0002064; GO:0002090; GO:0002244; GO:0003407; GO:0003408; GO:0004842; GO:0005737; GO:0005815; GO:0005886; GO:0006897; GO:0007219; GO:0007368; GO:0007417; GO:0007420; GO:0007507; GO:0008270; GO:0008284; GO:0008593; GO:0009880; GO:0010001; GO:0016567; GO:0021508; GO:0021510; GO:0021514; GO:0021519; GO:0021520; GO:0021521; GO:0021536; GO:0021546; GO:0021654; GO:0021986; GO:0022008; GO:0030097; GO:0030139; GO:0030182; GO:0030318; GO:0030902; GO:0030903; GO:0031076; GO:0031398; GO:0031410; GO:0032991; GO:0035315; GO:0039022; GO:0042802; GO:0045664; GO:0045685; GO:0045747; GO:0048066; GO:0048259; GO:0048471; GO:0048514; GO:0048546; GO:0048663; GO:0048665; GO:0048666; GO:0048699; GO:0048793; GO:0048859; GO:0048892; GO:0048899; GO:0048916; GO:0050931; GO:0051865; GO:0060035; GO:0060113; GO:0060216; GO:0060218; GO:0061195; GO:0061551; GO:0070086; GO:0071599	anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]		NA	NA	NA	NA	NA	NA
TRINITY_DN1706_c0_g1_i7	Q96AX9	MIB2_HUMAN	75.5	53	13	0	20	178	89	141	1.10E-16	87	MIB2_HUMAN	reviewed	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)	MIB2 SKD ZZANK1	Homo sapiens (Human)	1013	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]	actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0043123; GO:0061630	Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		blue	blue	NA	NA	NA	NA
TRINITY_DN1706_c0_g1_i1	Q5ZIJ9	MIB2_CHICK	38.5	501	244	8	64	1530	458	906	3.80E-93	343.6	MIB2_CHICK	reviewed	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	MIB2 RCJMB04_25j24	Gallus gallus (Chicken)	954	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1706_c0_g1_i2	Q5ZIJ9	MIB2_CHICK	45.8	943	431	11	20	2809	31	906	6.80E-237	822	MIB2_CHICK	reviewed	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	MIB2 RCJMB04_25j24	Gallus gallus (Chicken)	954	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1706_c0_g1_i3	Q5ZIJ9	MIB2_CHICK	39.4	469	223	7	64	1443	458	874	1.70E-90	334.7	MIB2_CHICK	reviewed	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	MIB2 RCJMB04_25j24	Gallus gallus (Chicken)	954	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1706_c0_g1_i5	Q5ZIJ9	MIB2_CHICK	65.6	212	73	0	20	655	31	242	5.60E-82	305.4	MIB2_CHICK	reviewed	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	MIB2 RCJMB04_25j24	Gallus gallus (Chicken)	954	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1706_c0_g1_i6	Q5ZIJ9	MIB2_CHICK	51.2	611	282	3	20	1849	31	626	1.50E-182	641	MIB2_CHICK	reviewed	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	MIB2 RCJMB04_25j24	Gallus gallus (Chicken)	954	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i8	Q8VZK0	MIEL1_ARATH	37	100	63	0	176	475	158	257	3.70E-19	96.7	MIEL1_ARATH	reviewed	E3 ubiquitin-protein ligase MIEL1 (EC 2.3.2.27) (MYB30-interacting E3 ligase 1) (Pirh2-like protein 1) (AtPILP1) (RING-type E3 ubiquitin transferase MIEL1)	MIEL1 PILP1 At5g18650 T1A4.30	Arabidopsis thaliana (Mouse-ear cress)	267	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response [GO:0006952]; negative regulation of defense response to bacterium [GO:1900425]; positive regulation of transcription factor catabolic process [GO:1901485]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0006952; GO:0008134; GO:0008270; GO:0016567; GO:0061630; GO:1900425; GO:1901485	defense response [GO:0006952]; negative regulation of defense response to bacterium [GO:1900425]; positive regulation of transcription factor catabolic process [GO:1901485]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36818_c0_g1_i1	Q9HCI7	MSL2_HUMAN	50.9	112	55	0	591	256	4	115	6.00E-30	132.5	MSL2_HUMAN	reviewed	E3 ubiquitin-protein ligase MSL2 (EC 2.3.2.-) (E3 ubiquitin-protein transferase MSL2) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184)	MSL2 KIAA1585 MSL2L1 RNF184	Homo sapiens (Human)	577	MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]	MSL complex [GO:0072487]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005654; GO:0016567; GO:0043984; GO:0046872; GO:0061630; GO:0072487	histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN39892_c0_g1_i1	Q9HCI7	MSL2_HUMAN	56.8	44	19	0	358	489	465	508	1.30E-08	61.6	MSL2_HUMAN	reviewed	E3 ubiquitin-protein ligase MSL2 (EC 2.3.2.-) (E3 ubiquitin-protein transferase MSL2) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184)	MSL2 KIAA1585 MSL2L1 RNF184	Homo sapiens (Human)	577	MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]	MSL complex [GO:0072487]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005654; GO:0016567; GO:0043984; GO:0046872; GO:0061630; GO:0072487	histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN8317_c0_g1_i1	Q7TPH6	MYCB2_MOUSE	52.8	492	213	9	1	1467	3933	4408	3.10E-124	446.8	MYCB2_MOUSE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein Magellan) (Protein associated with Myc)	Mycbp2 Pam Phr1	Mus musculus (Mouse)	4749	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008045; GO:0008270; GO:0008536; GO:0015630; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0048667; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN22900_c0_g1_i1	Q7TPH6	MYCB2_MOUSE	59.3	140	56	1	477	58	1305	1443	3.30E-43	176	MYCB2_MOUSE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein Magellan) (Protein associated with Myc)	Mycbp2 Pam Phr1	Mus musculus (Mouse)	4749	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008045; GO:0008270; GO:0008536; GO:0015630; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0048667; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN20858_c0_g2_i2	Q7TPH6	MYCB2_MOUSE	26.1	257	155	9	856	1572	3312	3551	3.50E-07	58.2	MYCB2_MOUSE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein Magellan) (Protein associated with Myc)	Mycbp2 Pam Phr1	Mus musculus (Mouse)	4749	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008045; GO:0008270; GO:0008536; GO:0015630; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0048667; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN27245_c0_g1_i1	O75592	MYCB2_HUMAN	66.4	119	39	1	360	7	4373	4491	4.00E-44	178.7	MYCB2_HUMAN	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc)	MYCBP2 KIAA0916 PAM	Homo sapiens (Human)	4678	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008536; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN27245_c0_g1_i2	O75592	MYCB2_HUMAN	65.8	114	38	1	339	1	4380	4493	9.40E-42	171	MYCB2_HUMAN	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc)	MYCBP2 KIAA0916 PAM	Homo sapiens (Human)	4678	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008536; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN22900_c0_g1_i2	O75592	MYCB2_HUMAN	63.5	52	19	0	236	81	1305	1356	1.10E-15	83.6	MYCB2_HUMAN	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc)	MYCBP2 KIAA0916 PAM	Homo sapiens (Human)	4678	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008536; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN20858_c0_g1_i1	O75592	MYCB2_HUMAN	35.8	260	134	10	1475	720	2967	3201	1.20E-27	125.9	MYCB2_HUMAN	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc)	MYCBP2 KIAA0916 PAM	Homo sapiens (Human)	4678	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008536; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667	branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN39156_c0_g1_i1	F1RD40	MYCB2_DANRE	81	63	12	0	262	74	4512	4574	1.60E-28	126.3	MYCB2_DANRE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom)	mycbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	4574	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8269_c0_g1_i2	F1RD40	MYCB2_DANRE	43.7	199	94	3	649	68	1626	1811	4.70E-38	159.5	MYCB2_DANRE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom)	mycbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	4574	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8269_c0_g1_i4	F1RD40	MYCB2_DANRE	45.2	208	95	4	676	68	1618	1811	9.10E-42	171.8	MYCB2_DANRE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom)	mycbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	4574	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN33200_c0_g1_i1	F1RD40	MYCB2_DANRE	40	115	68	1	370	714	127	240	1.20E-19	98.6	MYCB2_DANRE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom)	mycbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	4574	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8317_c0_g1_i2	F1RD40	MYCB2_DANRE	64.4	160	50	3	91	570	4081	4233	1.40E-51	204.1	MYCB2_DANRE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom)	mycbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	4574	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN30473_c0_g1_i1	F1RD40	MYCB2_DANRE	50	122	61	0	369	4	3621	3742	1.50E-30	133.7	MYCB2_DANRE	reviewed	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom)	mycbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	4574	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN87_c1_g1_i2	Q9VVI3	NEDD4_DROME	73.1	484	126	1	1546	95	528	1007	1.00E-224	780.8	NEDD4_DROME	reviewed	E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4)	Nedd4 CG7555	Drosophila melanogaster (Fruit fly)	1007	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]	myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019871; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:0071212; GO:1905062; GO:1905306; GO:2000650	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN87_c1_g1_i4	Q9VVI3	NEDD4_DROME	73.1	484	126	1	1546	95	528	1007	1.10E-224	780.8	NEDD4_DROME	reviewed	E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4)	Nedd4 CG7555	Drosophila melanogaster (Fruit fly)	1007	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]	myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019871; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:0071212; GO:1905062; GO:1905306; GO:2000650	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN13961_c0_g1_i1	Q9VVI3	NEDD4_DROME	52.6	253	101	5	783	34	72	308	1.90E-60	234.2	NEDD4_DROME	reviewed	E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4)	Nedd4 CG7555	Drosophila melanogaster (Fruit fly)	1007	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; subsynaptic reticulum [GO:0071212]	myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019871; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:0071212; GO:1905062; GO:1905306; GO:2000650	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN32788_c0_g1_i1	P46935	NEDD4_MOUSE	99.6	493	2	0	2	1480	395	887	1.60E-301	1035.8	NEDD4_MOUSE	reviewed	E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4)	Nedd4 Kiaa0093 Nedd-4 Nedd4-1 Nedd4a	Mus musculus (Mouse)	887	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; endocardial cushion development [GO:0003197]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]	ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0002250; GO:0003151; GO:0003197; GO:0004842; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006511; GO:0006513; GO:0006622; GO:0007528; GO:0008022; GO:0010766; GO:0016020; GO:0016567; GO:0019871; GO:0030948; GO:0031175; GO:0031623; GO:0032801; GO:0035255; GO:0042110; GO:0043161; GO:0043197; GO:0045121; GO:0045732; GO:0048514; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0061630; GO:0070064; GO:0070534; GO:0098978; GO:0099149; GO:0099524; GO:0099576; GO:2000650	"adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; endocardial cushion development [GO:0003197]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29265_c0_g1_i1	P46935	NEDD4_MOUSE	44.4	54	30	0	4	165	534	587	2.70E-07	55.5	NEDD4_MOUSE	reviewed	E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4)	Nedd4 Kiaa0093 Nedd-4 Nedd4-1 Nedd4a	Mus musculus (Mouse)	887	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; endocardial cushion development [GO:0003197]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]	ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0002250; GO:0003151; GO:0003197; GO:0004842; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006511; GO:0006513; GO:0006622; GO:0007528; GO:0008022; GO:0010766; GO:0016020; GO:0016567; GO:0019871; GO:0030948; GO:0031175; GO:0031623; GO:0032801; GO:0035255; GO:0042110; GO:0043161; GO:0043197; GO:0045121; GO:0045732; GO:0048514; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0061630; GO:0070064; GO:0070534; GO:0098978; GO:0099149; GO:0099524; GO:0099576; GO:2000650	"adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; endocardial cushion development [GO:0003197]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN87_c1_g1_i3	Q96PU5	NED4L_HUMAN	62.2	45	17	0	224	90	765	809	1.30E-08	60.5	NED4L_HUMAN	reviewed	E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2)	NEDD4L KIAA0439 NEDL3	Homo sapiens (Human)	975	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; ion channel binding [GO:0044325]; potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular sodium ion homeostasis [GO:0006883]; excretion [GO:0007588]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process [GO:0042176]; regulation of protein stability [GO:0031647]; response to metal ion [GO:0010038]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005]; viral life cycle [GO:0019058]; water homeostasis [GO:0030104]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]	ion channel binding [GO:0044325]; potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000209; GO:0003254; GO:0004842; GO:0005654; GO:0005737; GO:0005771; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006814; GO:0006883; GO:0007588; GO:0010038; GO:0015459; GO:0016567; GO:0017080; GO:0019058; GO:0019870; GO:0019871; GO:0030104; GO:0031647; GO:0034220; GO:0034765; GO:0042176; GO:0042391; GO:0043161; GO:0044325; GO:0045732; GO:0045807; GO:0048814; GO:0060306; GO:0061630; GO:0070062; GO:0070936; GO:0086005; GO:1901016; GO:1901017; GO:1901380; GO:1902306; GO:1903861; GO:2000009; GO:2000650; GO:2001288	cellular sodium ion homeostasis [GO:0006883]; excretion [GO:0007588]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process [GO:0042176]; regulation of protein stability [GO:0031647]; response to metal ion [GO:0010038]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005]; viral life cycle [GO:0019058]; water homeostasis [GO:0030104]		NA	NA	NA	NA	NA	NA
TRINITY_DN26315_c0_g1_i1	Q9H4P4	RNF41_HUMAN	67.1	73	24	0	229	11	13	85	1.10E-25	116.7	RNF41_HUMAN	reviewed	E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)	RNF41 FLRF NRDP1 SBBI03	Homo sapiens (Human)	317	cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; identical protein binding [GO:0042802]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]	cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]	erythropoietin receptor binding [GO:0005128]; identical protein binding [GO:0042802]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0005829; GO:0006914; GO:0008270; GO:0008285; GO:0010498; GO:0016567; GO:0017160; GO:0019904; GO:0030336; GO:0030971; GO:0042802; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051091; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000114; GO:2000377; GO:2000379	autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN9755_c0_g1_i1	Q9WVS6	PRKN_MOUSE	38.6	518	252	8	1616	87	3	462	3.50E-109	397.1	PRKN_MOUSE	reviewed	E3 ubiquitin-protein ligase parkin (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase)	Prkn Park2	Mus musculus (Mouse)	464	"aggresome [GO:0016235]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein metabolic process [GO:0019538]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of gene expression [GO:0010468]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein stability [GO:0031647]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"	aggresome [GO:0016235]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]	actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]	GO:0000122; GO:0000139; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001963; GO:0001964; GO:0003714; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007612; GO:0007626; GO:0008013; GO:0008021; GO:0008344; GO:0010468; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010918; GO:0010994; GO:0014069; GO:0015631; GO:0016235; GO:0016567; GO:0016607; GO:0019538; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030424; GO:0030425; GO:0030544; GO:0030672; GO:0031072; GO:0031396; GO:0031410; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032436; GO:0032991; GO:0033132; GO:0034976; GO:0035249; GO:0035774; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043025; GO:0043065; GO:0043123; GO:0043130; GO:0043161; GO:0043195; GO:0043274; GO:0043388; GO:0043524; GO:0043653; GO:0044257; GO:0044828; GO:0044877; GO:0045121; GO:0045202; GO:0045944; GO:0046329; GO:0046676; GO:0046872; GO:0046928; GO:0048471; GO:0050804; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051646; GO:0051865; GO:0051881; GO:0051967; GO:0055069; GO:0060548; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0090258; GO:0090394; GO:0097237; GO:0097602; GO:0097708; GO:0098779; GO:0098793; GO:0099073; GO:0099074; GO:1900407; GO:1901215; GO:1901526; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1903204; GO:1903265; GO:1903377; GO:1903382; GO:1903427; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1904881; GO:1905232; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378; GO:2001171	"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein localization to mitochondrion [GO:0070585]; protein metabolic process [GO:0019538]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of gene expression [GO:0010468]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein stability [GO:0031647]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9755_c0_g1_i2	Q9WVS6	PRKN_MOUSE	38.2	68	42	0	664	461	3	70	1.50E-06	55.1	PRKN_MOUSE	reviewed	E3 ubiquitin-protein ligase parkin (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase)	Prkn Park2	Mus musculus (Mouse)	464	"aggresome [GO:0016235]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein metabolic process [GO:0019538]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of gene expression [GO:0010468]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein stability [GO:0031647]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"	aggresome [GO:0016235]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]	actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]	GO:0000122; GO:0000139; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001963; GO:0001964; GO:0003714; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007612; GO:0007626; GO:0008013; GO:0008021; GO:0008344; GO:0010468; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010918; GO:0010994; GO:0014069; GO:0015631; GO:0016235; GO:0016567; GO:0016607; GO:0019538; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030424; GO:0030425; GO:0030544; GO:0030672; GO:0031072; GO:0031396; GO:0031410; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032436; GO:0032991; GO:0033132; GO:0034976; GO:0035249; GO:0035774; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043025; GO:0043065; GO:0043123; GO:0043130; GO:0043161; GO:0043195; GO:0043274; GO:0043388; GO:0043524; GO:0043653; GO:0044257; GO:0044828; GO:0044877; GO:0045121; GO:0045202; GO:0045944; GO:0046329; GO:0046676; GO:0046872; GO:0046928; GO:0048471; GO:0050804; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051646; GO:0051865; GO:0051881; GO:0051967; GO:0055069; GO:0060548; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0090258; GO:0090394; GO:0097237; GO:0097602; GO:0097708; GO:0098779; GO:0098793; GO:0099073; GO:0099074; GO:1900407; GO:1901215; GO:1901526; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1903204; GO:1903265; GO:1903377; GO:1903382; GO:1903427; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1904881; GO:1905232; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378; GO:2001171	"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein localization to mitochondrion [GO:0070585]; protein metabolic process [GO:0019538]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of gene expression [GO:0010468]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein stability [GO:0031647]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2309_c0_g1_i2	P97868	RBBP6_MOUSE	48.1	106	47	2	103	420	4	101	1.20E-16	87.8	RBBP6_MOUSE	reviewed	E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)	Rbbp6 P2pr Pact	Mus musculus (Mouse)	1790	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; nucleic acid binding [GO:0003676]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]	nucleic acid binding [GO:0003676]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001701; GO:0003676; GO:0004842; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2309_c0_g1_i3	Q7Z6E9	RBBP6_HUMAN	60	75	29	1	103	327	4	77	2.10E-16	87	RBBP6_HUMAN	reviewed	E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)	RBBP6 P2PR PACT RBQ1 My038	Homo sapiens (Human)	1792	chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0001701; GO:0003723; GO:0004842; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein polyubiquitination [GO:0000209]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5468_c0_g1_i1	P62877	RBX1_HUMAN	100	108	0	0	35	358	1	108	3.40E-63	242.3	RBX1_HUMAN	reviewed	"E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (E3 ubiquitin-protein transferase RBX1) (Protein ZYP) (RING finger protein 75) (RING-box protein 1) (Rbx1) (Regulator of cullins 1) (ROC1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed (E3 ubiquitin-protein transferase RBX1, N-terminally processed)]"	RBX1 RNF75 ROC1	Homo sapiens (Human)	108	"Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA damage response, detection of DNA damage [GO:0042769]; global genome nucleotide-excision repair [GO:0070911]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000165; GO:0000209; GO:0000715; GO:0000717; GO:0005634; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006513; GO:0008134; GO:0008270; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0019788; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031465; GO:0031466; GO:0031467; GO:0031625; GO:0032436; GO:0033683; GO:0034450; GO:0042769; GO:0043161; GO:0043687; GO:0044877; GO:0045116; GO:0061418; GO:0061630; GO:0061663; GO:0070498; GO:0070911; GO:0070936; GO:0090090; GO:0097602; GO:1902499	"DNA damage response, detection of DNA damage [GO:0042769]; global genome nucleotide-excision repair [GO:0070911]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5468_c0_g2_i1	P62877	RBX1_HUMAN	100	108	0	0	44	367	1	108	2.60E-63	242.7	RBX1_HUMAN	reviewed	"E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (E3 ubiquitin-protein transferase RBX1) (Protein ZYP) (RING finger protein 75) (RING-box protein 1) (Rbx1) (Regulator of cullins 1) (ROC1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed (E3 ubiquitin-protein transferase RBX1, N-terminally processed)]"	RBX1 RNF75 ROC1	Homo sapiens (Human)	108	"Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA damage response, detection of DNA damage [GO:0042769]; global genome nucleotide-excision repair [GO:0070911]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000165; GO:0000209; GO:0000715; GO:0000717; GO:0005634; GO:0005654; GO:0005829; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0006513; GO:0008134; GO:0008270; GO:0010265; GO:0010972; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0019788; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031465; GO:0031466; GO:0031467; GO:0031625; GO:0032436; GO:0033683; GO:0034450; GO:0042769; GO:0043161; GO:0043687; GO:0044877; GO:0045116; GO:0061418; GO:0061630; GO:0061663; GO:0070498; GO:0070911; GO:0070936; GO:0090090; GO:0097602; GO:1902499	"DNA damage response, detection of DNA damage [GO:0042769]; global genome nucleotide-excision repair [GO:0070911]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6442_c0_g1_i1	Q8CIK8	RFWD3_MOUSE	33.9	534	325	9	5	1573	257	773	1.00E-80	302.4	RFWD3_MOUSE	reviewed	E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)	Rfwd3 Rnf201	Mus musculus (Mouse)	774	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]	MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630]	GO:0000724; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031052; GO:0031297; GO:0031571; GO:0035861; GO:0036297; GO:0046872; GO:0061630; GO:0090734; GO:0097371; GO:2000001	cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN29140_c0_g1_i1	Q5TJF3	RING1_CANLF	97.3	74	2	0	231	10	81	154	4.20E-34	146	RING1_CANLF	reviewed	E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (RING1a)	RING1	Canis lupus familiaris (Dog) (Canis familiaris)	406	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activator activity [GO:0097027]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription, DNA-templated [GO:0045892]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activator activity [GO:0097027]	GO:0000151; GO:0001739; GO:0003682; GO:0005829; GO:0009952; GO:0016607; GO:0031519; GO:0035102; GO:0035518; GO:0045892; GO:0046872; GO:0048593; GO:0061630; GO:0097027	"anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29140_c0_g1_i1	Q5TJF3	RING1_CANLF	100	55	0	0	524	360	26	80	3.20E-26	119.8	RING1_CANLF	reviewed	E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (RING1a)	RING1	Canis lupus familiaris (Dog) (Canis familiaris)	406	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activator activity [GO:0097027]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription, DNA-templated [GO:0045892]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activator activity [GO:0097027]	GO:0000151; GO:0001739; GO:0003682; GO:0005829; GO:0009952; GO:0016607; GO:0031519; GO:0035102; GO:0035518; GO:0045892; GO:0046872; GO:0048593; GO:0061630; GO:0097027	"anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5841_c0_g1_i1	Q9VB08	RING1_DROME	64	114	34	2	50	385	326	434	5.80E-38	158.3	RING1_DROME	reviewed	E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RING1) (Sex comb extra protein) (dRING protein) (dRING1)	Sce CG5595	Drosophila melanogaster (Fruit fly)	435	nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; histone H2A monoubiquitination [GO:0035518]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; neurogenesis [GO:0022008]; ovarian follicle cell stalk formation [GO:0030713]; sex comb development [GO:0045498]; ventral cord development [GO:0007419]	nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000790; GO:0003682; GO:0005634; GO:0005635; GO:0005730; GO:0006342; GO:0007275; GO:0007419; GO:0008270; GO:0022008; GO:0030708; GO:0030713; GO:0031519; GO:0035102; GO:0035518; GO:0045498; GO:0051321; GO:0061630	chromatin silencing [GO:0006342]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; histone H2A monoubiquitination [GO:0035518]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; neurogenesis [GO:0022008]; ovarian follicle cell stalk formation [GO:0030713]; sex comb development [GO:0045498]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN39054_c0_g1_i1	Q99496	RING2_HUMAN	100	145	0	0	2	436	7	151	2.60E-79	295.8	RING2_HUMAN	reviewed	E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2)	RNF2 BAP1 DING HIPI3 RING1B	Homo sapiens (Human)	336	euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]	euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0000278; GO:0000791; GO:0001702; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0007281; GO:0008270; GO:0009948; GO:0010467; GO:0016604; GO:0031519; GO:0035102; GO:0035518; GO:0036353; GO:0043433; GO:0061630; GO:0070317; GO:0071339; GO:0071535	anterior/posterior axis specification [GO:0009948]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN5250_c0_g1_i1	Q66J69	RNG2A_XENLA	76.8	164	37	1	593	105	3	166	2.40E-66	253.4	RNG2A_XENLA	reviewed	E3 ubiquitin-protein ligase RING2-A (EC 2.3.2.27) (RING finger protein 1B-A) (RING1b-A) (RING finger protein 2-A) (RING-type E3 ubiquitin transferase RING2-A)	rnf2-a ring1b-a	Xenopus laevis (African clawed frog)	344	chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]	chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]	metal ion binding [GO:0046872]; transferase activity [GO:0016740]	GO:0000122; GO:0005694; GO:0016740; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0071339	histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN2200_c0_g1_i1	Q640V2	RMD5A_XENTR	54.6	392	175	2	1267	98	1	391	3.30E-125	449.9	RMD5A_XENTR	reviewed	E3 ubiquitin-protein ligase RMND5A (EC 2.3.2.27) (Protein RMD5 homolog A)	rmnd5a TGas140j12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	391	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0034657; GO:0043161; GO:0046872	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN2200_c0_g1_i2	Q640V2	RMD5A_XENTR	53.1	403	177	2	1306	98	1	391	3.70E-124	446.4	RMD5A_XENTR	reviewed	E3 ubiquitin-protein ligase RMND5A (EC 2.3.2.27) (Protein RMD5 homolog A)	rmnd5a TGas140j12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	391	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0034657; GO:0043161; GO:0046872	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38772_c0_g1_i1	Q9EPZ8	RN103_RAT	31	316	170	7	32	973	398	667	4.90E-26	120.2	RN103_RAT	reviewed	E3 ubiquitin-protein ligase RNF103 (EC 2.3.2.27) (Protein ADRG34) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103) (Zfp-103)	Rnf103 Zfp103	Rattus norvegicus (Rat)	682	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005783; GO:0005789; GO:0016021; GO:0016567; GO:0030433; GO:0046872	protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN8759_c0_g1_i1	O15541	R113A_HUMAN	45.6	68	33	1	206	3	253	316	3.10E-12	72	R113A_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183)	RNF113A RNF113 ZNF183	Homo sapiens (Human)	343	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0061630; GO:0070100; GO:0071005	"DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37644_c0_g1_i1	O15541	R113A_HUMAN	100	151	0	0	454	2	183	333	2.40E-91	335.9	R113A_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183)	RNF113A RNF113 ZNF183	Homo sapiens (Human)	343	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0061630; GO:0070100; GO:0071005	"DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2441_c0_g1_i1	Q67ER4	R113A_BOVIN	52.2	322	132	4	987	88	15	336	3.60E-93	343.2	R113A_BOVIN	reviewed	E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (RING finger protein 113A) (Zinc finger protein 183)	RNF113A ZNF183	Bos taurus (Bovine)	343	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000398; GO:0005634; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0061630; GO:0070100; GO:0071005	"DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i27	Q6J1I8	RN114_PIG	38.2	68	26	2	81	248	5	68	1.80E-05	50.4	RN114_PIG	reviewed	E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 313)	RNF114 ZNF313	Sus scrofa (Pig)	228	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005829; GO:0005886; GO:0006511; GO:0007275; GO:0007283; GO:0030154; GO:0046872; GO:0061630	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i9	Q6J1I8	RN114_PIG	38.2	68	26	2	54	221	5	68	1.60E-05	50.4	RN114_PIG	reviewed	E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 313)	RNF114 ZNF313	Sus scrofa (Pig)	228	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005829; GO:0005886; GO:0006511; GO:0007275; GO:0007283; GO:0030154; GO:0046872; GO:0061630	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24197_c0_g1_i1	Q5XPI4	RN123_HUMAN	100	153	0	0	3	461	1011	1163	8.00E-79	294.3	RN123_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	RNF123 KPC1 FP1477	Homo sapiens (Human)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN24197_c0_g1_i2	Q5XPI3	RN123_MOUSE	98.3	175	3	0	3	527	1011	1185	2.30E-90	332.8	RN123_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	Rnf123 Kpc1	Mus musculus (Mouse)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN7004_c0_g1_i12	Q5XPI4	RN123_HUMAN	59.2	98	40	0	1	294	892	989	1.40E-28	127.9	RN123_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	RNF123 KPC1 FP1477	Homo sapiens (Human)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]		brown	brown	1	NA	NA	NA
TRINITY_DN7004_c0_g1_i1	Q5XPI4	RN123_HUMAN	54.4	114	50	1	3	338	876	989	1.20E-29	131.3	RN123_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	RNF123 KPC1 FP1477	Homo sapiens (Human)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN7004_c0_g1_i11	D3ZXK7	RN123_RAT	53.4	307	131	4	3	917	880	1176	1.40E-87	324.3	RN123_RAT	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	Rnf123 Kpc1	Rattus norvegicus (Rat)	1318	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN7004_c0_g1_i5	Q5XPI4	RN123_HUMAN	54.4	114	50	1	3	338	876	989	9.10E-30	131.3	RN123_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	RNF123 KPC1 FP1477	Homo sapiens (Human)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN7004_c0_g1_i6	Q5XPI4	RN123_HUMAN	54.4	114	50	1	3	338	876	989	9.00E-30	131.3	RN123_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	RNF123 KPC1 FP1477	Homo sapiens (Human)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN7004_c0_g1_i8	D3ZXK7	RN123_RAT	55	291	121	3	1	873	896	1176	1.50E-86	320.9	RN123_RAT	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	Rnf123 Kpc1	Rattus norvegicus (Rat)	1318	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN7004_c0_g1_i9	D3ZXK7	RN123_RAT	53.4	307	131	4	3	917	880	1176	1.40E-87	324.3	RN123_RAT	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	Rnf123 Kpc1	Rattus norvegicus (Rat)	1318	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN13243_c0_g1_i1	Q5XPI3	RN123_MOUSE	51.1	92	45	0	411	136	1209	1300	5.00E-22	105.5	RN123_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	Rnf123 Kpc1	Mus musculus (Mouse)	1314	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN25047_c0_g1_i1	Q90972	RNF13_CHICK	97.5	121	3	0	363	1	189	309	1.10E-62	240.4	RNF13_CHICK	reviewed	E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (C-RZF) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13)	RNF13 RZF	Gallus gallus (Chicken)	381	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]	JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008432; GO:0016021; GO:0031902; GO:0046872; GO:0051865; GO:0061630; GO:0070304	positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5922_c0_g1_i1	Q66HG0	RNF13_RAT	50.4	256	121	3	200	961	34	285	1.20E-68	262.3	RNF13_RAT	reviewed	E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13)	Rnf13	Rattus norvegicus (Rat)	380	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]	JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0004842; GO:0005637; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008432; GO:0016021; GO:0031902; GO:0046872; GO:0051865; GO:0061630; GO:0070304	positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN25047_c0_g1_i3	O54965	RNF13_MOUSE	100	81	0	0	246	4	212	292	5.90E-44	177.6	RNF13_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13)	Rnf13 Rzf	Mus musculus (Mouse)	381	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]	JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005637; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008432; GO:0016021; GO:0031902; GO:0043231; GO:0046872; GO:0051865; GO:0061630; GO:0070304	positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN37049_c0_g1_i1	Q7TMV1	RN139_MOUSE	96.2	106	4	0	2	319	509	614	2.40E-58	225.7	RN139_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein)	Rnf139	Mus musculus (Mouse)	668	Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; protease binding [GO:0002020]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613]	Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	protease binding [GO:0002020]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002020; GO:0004842; GO:0005783; GO:0008270; GO:0008285; GO:0012505; GO:0016021; GO:0016567; GO:0017148; GO:0019787; GO:0031648; GO:0036503; GO:0036513; GO:0060628; GO:0061630; GO:0070613; GO:2000060	ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613]		NA	NA	NA	NA	NA	NA
TRINITY_DN28214_c0_g1_i1	Q8WU17	RN139_HUMAN	100	75	0	0	1	225	487	561	5.70E-38	157.5	RN139_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein)	RNF139 TRC8	Homo sapiens (Human)	664	Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613]	Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]	protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002020; GO:0004842; GO:0005783; GO:0005789; GO:0008270; GO:0008285; GO:0012505; GO:0016021; GO:0016567; GO:0017148; GO:0019787; GO:0031648; GO:0036503; GO:0036513; GO:0038023; GO:0044322; GO:0060628; GO:0061630; GO:0070613; GO:1904380; GO:2000060	endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613]		NA	NA	NA	NA	NA	NA
TRINITY_DN13525_c0_g1_i1	Q9UBS8	RNF14_HUMAN	54.5	33	15	0	162	64	402	434	2.50E-06	52.4	RNF14_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)	RNF14 ARA54 HRIHFB2038	Homo sapiens (Human)	474	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	"androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13525_c0_g1_i2	Q9UBS8	RNF14_HUMAN	54.5	33	15	0	153	55	402	434	2.40E-06	52.4	RNF14_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)	RNF14 ARA54 HRIHFB2038	Homo sapiens (Human)	474	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	"androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26532_c0_g1_i1	Q9UBS8	RNF14_HUMAN	40.2	508	259	7	1613	99	3	468	5.70E-106	386.3	RNF14_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)	RNF14 ARA54 HRIHFB2038	Homo sapiens (Human)	474	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	"androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39579_c0_g1_i1	Q9JI90	RNF14_MOUSE	100	86	0	0	1	258	241	326	3.50E-47	188.3	RNF14_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (Protein Triad2) (RING finger protein 14)	Rnf14 Ara54 Triad2	Mus musculus (Mouse)	485	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006511; GO:0019787; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	"positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN166_c0_g1_i1	C0HBT3	RN146_SALSA	56.1	187	62	3	178	720	19	191	4.10E-55	216.5	RN146_SALSA	reviewed	E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146)	rnf146	Salmo salar (Atlantic salmon)	349	cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]	poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263	positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN166_c0_g1_i2	C0HBT3	RN146_SALSA	51.6	182	68	3	178	705	19	186	6.90E-45	183	RN146_SALSA	reviewed	E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146)	rnf146	Salmo salar (Atlantic salmon)	349	cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]	poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263	positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN166_c0_g1_i2	C0HBT3	RN146_SALSA	55.2	87	38	1	788	1045	105	191	5.30E-21	103.6	RN146_SALSA	reviewed	E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146)	rnf146	Salmo salar (Atlantic salmon)	349	cytosol [GO:0005829]; nucleus [GO:0005634]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]	poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263	positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2067_c0_g1_i1	Q7T308	RN168_DANRE	43.4	122	69	0	1148	783	19	140	1.40E-24	115.5	RN168_DANRE	reviewed	E3 ubiquitin-protein ligase rnf168 (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase rnf168)	rnf168 zgc:64185	Danio rerio (Zebrafish) (Brachydanio rerio)	474	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006511; GO:0006974; GO:0010212; GO:0016567; GO:0034244; GO:0035518; GO:0035861; GO:0036351; GO:0036352; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0046872; GO:0070530; GO:0070534; GO:0070535	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN7511_c0_g1_i1	Q5PPX5	RN170_XENLA	40	180	100	2	163	702	83	254	3.40E-34	146.7	RN170_XENLA	reviewed	E3 ubiquitin-protein ligase RNF170 (EC 2.3.2.27) (RING finger protein 170) (RING-type E3 ubiquitin transferase RNF170)	rnf170	Xenopus laevis (African clawed frog)	257	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005789; GO:0016021; GO:0046872; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN3639_c0_g1_i1	Q96GF1	RN185_HUMAN	66.9	121	39	1	41	400	1	121	1.10E-34	147.5	RN185_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185)	RNF185	Homo sapiens (Human)	192	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]	GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0043130; GO:0044322; GO:0044390; GO:0044877; GO:0046872; GO:0051865; GO:0055085; GO:0061630; GO:0071712; GO:1904294; GO:1904380	autophagy [GO:0006914]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN3639_c0_g1_i2	Q96GF1	RN185_HUMAN	72.4	123	33	1	41	406	1	123	4.50E-41	169.1	RN185_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185)	RNF185	Homo sapiens (Human)	192	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]	GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0043130; GO:0044322; GO:0044390; GO:0044877; GO:0046872; GO:0051865; GO:0055085; GO:0061630; GO:0071712; GO:1904294; GO:1904380	autophagy [GO:0006914]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN3639_c0_g2_i1	Q96GF1	RN185_HUMAN	72.4	123	33	1	490	125	1	123	4.50E-41	169.1	RN185_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185)	RNF185	Homo sapiens (Human)	192	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]	GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0043130; GO:0044322; GO:0044390; GO:0044877; GO:0046872; GO:0051865; GO:0055085; GO:0061630; GO:0071712; GO:1904294; GO:1904380	autophagy [GO:0006914]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN39020_c0_g1_i1	Q9NV58	RN19A_HUMAN	100	67	0	0	202	2	130	196	1.10E-35	149.8	RN19A_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38)	RNF19A RNF19	Homo sapiens (Human)	838	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008134; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630	microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10913_c1_g1_i2	Q9NV58	RN19A_HUMAN	54.4	526	201	13	127	1644	131	637	2.60E-147	523.9	RN19A_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38)	RNF19A RNF19	Homo sapiens (Human)	838	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008134; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630	microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10913_c1_g1_i4	Q9NV58	RN19A_HUMAN	60.3	426	149	8	127	1347	131	555	1.10E-142	508.1	RN19A_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38)	RNF19A RNF19	Homo sapiens (Human)	838	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008134; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630	microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10913_c1_g1_i5	Q9NV58	RN19A_HUMAN	52.2	67	32	0	127	327	131	197	1.40E-14	80.5	RN19A_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38)	RNF19A RNF19	Homo sapiens (Human)	838	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008134; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630	microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN37019_c0_g1_i1	Q6ZMZ0	RN19B_HUMAN	99.1	106	0	1	315	1	270	375	1.10E-58	226.9	RN19B_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF19B (EC 2.3.2.31) (IBR domain-containing protein 3) (Natural killer lytic-associated molecule) (RING finger protein 19B)	RNF19B IBRDC3 NKLAM	Homo sapiens (Human)	732	cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; adaptive immune response [GO:0002250]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0002250; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0043130; GO:0044194; GO:0046872; GO:0051865; GO:0061630	adaptive immune response [GO:0002250]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN37631_c0_g1_i1	Q9QZR0	RNF25_MOUSE	33.7	300	183	4	45	938	19	304	5.30E-37	156.4	RNF25_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) (RING-type E3 ubiquitin transferase RNF25)	Rnf25	Mus musculus (Mouse)	456	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN37631_c0_g1_i2	Q9QZR0	RNF25_MOUSE	36.7	248	150	2	45	782	19	261	5.60E-38	159.5	RNF25_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) (RING-type E3 ubiquitin transferase RNF25)	Rnf25	Mus musculus (Mouse)	456	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5819_c0_g1_i1	Q8BUH7	RNF26_MOUSE	43.1	116	51	5	1004	1333	318	424	4.70E-13	77.4	RNF26_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF26 (EC 2.3.2.27) (RING finger protein 26)	Rnf26	Mus musculus (Mouse)	424	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005789; GO:0007032; GO:0016021; GO:0016567; GO:0032479; GO:0046872; GO:0050687; GO:0061630; GO:0070979; GO:1905719	endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN5819_c0_g1_i2	Q8BUH7	RNF26_MOUSE	43.1	116	51	5	1007	1336	318	424	4.70E-13	77.4	RNF26_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF26 (EC 2.3.2.27) (RING finger protein 26)	Rnf26	Mus musculus (Mouse)	424	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005789; GO:0007032; GO:0016021; GO:0016567; GO:0032479; GO:0046872; GO:0050687; GO:0061630; GO:0070979; GO:1905719	endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN32436_c0_g1_i1	Q99KR6	RNF34_MOUSE	53.8	119	49	1	369	707	258	376	3.70E-31	136.7	RNF34_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF34 (EC 2.3.2.27) (Phafin-1) (RING finger protein 34) (RING-type E3 ubiquitin transferase RNF34)	Rnf34	Mus musculus (Mouse)	376	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0012505; GO:0016567; GO:0016604; GO:0016607; GO:0031625; GO:0035872; GO:0043161; GO:0046872; GO:0061630; GO:0070417; GO:0070936; GO:1901797; GO:1901981; GO:1902042; GO:2000374; GO:2001271	"apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33855_c0_g1_i1	Q5E9J6	RNF34_BOVIN	100	73	0	0	249	31	303	375	4.10E-37	154.8	RNF34_BOVIN	reviewed	E3 ubiquitin-protein ligase RNF34 (EC 2.3.2.27) (RING finger protein 34) (RING-type E3 ubiquitin transferase RNF34)	RNF34	Bos taurus (Bovine)	375	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]	GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0012505; GO:0016567; GO:0016607; GO:0031625; GO:0035872; GO:0043161; GO:0046872; GO:0061630; GO:0070417; GO:0070936; GO:1901797; GO:1901981; GO:1902042; GO:2000374; GO:2001271	"apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31174_c0_g1_i1	Q99942	RNF5_HUMAN	100	87	0	0	264	4	19	105	7.20E-48	190.7	RNF5_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF5 (EC 2.3.2.27) (Protein G16) (RING finger protein 5) (RING-type E3 ubiquitin transferase RNF5) (Ram1 homolog) (HsRma1)	RNF5 G16 NG2 RMA1	Homo sapiens (Human)	180	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular protein catabolic process [GO:0044257]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; negative regulation of autophagy [GO:0010507]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005783; GO:0005789; GO:0006511; GO:0008270; GO:0009617; GO:0010507; GO:0016021; GO:0030433; GO:0031648; GO:0031966; GO:0036503; GO:0042802; GO:0044257; GO:0044322; GO:0044390; GO:0044877; GO:0055085; GO:0061630; GO:0070534; GO:0070936; GO:0071712; GO:1904380; GO:2000785	cellular protein catabolic process [GO:0044257]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of autophagy [GO:0010507]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN20699_c0_g1_i1	O35445	RNF5_MOUSE	100	83	0	0	1	249	30	112	1.10E-45	183.3	RNF5_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF5 (EC 2.3.2.27) (RING finger protein 5) (RING-type E3 ubiquitin transferase RNF5)	Rnf5 Ng2	Mus musculus (Mouse)	180	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; negative regulation of autophagy [GO:0010507]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005783; GO:0005789; GO:0006511; GO:0009617; GO:0010507; GO:0016020; GO:0016021; GO:0016567; GO:0030433; GO:0031648; GO:0031966; GO:0036503; GO:0042802; GO:0044257; GO:0044390; GO:0044877; GO:0046872; GO:0061630; GO:0070534; GO:0070936; GO:0071712; GO:2000785	cellular protein catabolic process [GO:0044257]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of autophagy [GO:0010507]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN30224_c0_g1_i1	O35445	RNF5_MOUSE	54.3	94	35	3	30	302	20	108	1.80E-23	109.8	RNF5_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF5 (EC 2.3.2.27) (RING finger protein 5) (RING-type E3 ubiquitin transferase RNF5)	Rnf5 Ng2	Mus musculus (Mouse)	180	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; negative regulation of autophagy [GO:0010507]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005783; GO:0005789; GO:0006511; GO:0009617; GO:0010507; GO:0016020; GO:0016021; GO:0016567; GO:0030433; GO:0031648; GO:0031966; GO:0036503; GO:0042802; GO:0044257; GO:0044390; GO:0044877; GO:0046872; GO:0061630; GO:0070534; GO:0070936; GO:0071712; GO:2000785	cellular protein catabolic process [GO:0044257]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of autophagy [GO:0010507]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN25956_c0_g1_i1	Q7ZX20	RNF8A_XENLA	52.1	96	46	0	431	144	369	464	6.00E-23	109	RNF8A_XENLA	reviewed	E3 ubiquitin-protein ligase rnf8-A (EC 2.3.2.27) (RING finger protein 8-A) (RING-type E3 ubiquitin transferase rnf8-A)	rnf8-A	Xenopus laevis (African clawed frog)	540	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007286; GO:0008270; GO:0010212; GO:0033522; GO:0033523; GO:0034244; GO:0035861; GO:0042393; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0070534; GO:0070535; GO:0070936	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2127_c0_g1_i3	Q9DCN7	RNFT1_MOUSE	47.4	78	40	1	320	90	318	395	1.50E-19	97.1	RNFT1_MOUSE	reviewed	E3 ubiquitin-protein ligase RNFT1 (EC 2.3.2.27) (RING finger and transmembrane domain-containing protein 1)	Rnft1	Mus musculus (Mouse)	395	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]	GO:0005783; GO:0016021; GO:0031901; GO:0043130; GO:0046872; GO:0051865; GO:0061630; GO:1904294	positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN2127_c0_g1_i4	Q9DCN7	RNFT1_MOUSE	28.8	132	94	0	476	81	117	248	5.60E-09	62.4	RNFT1_MOUSE	reviewed	E3 ubiquitin-protein ligase RNFT1 (EC 2.3.2.27) (RING finger and transmembrane domain-containing protein 1)	Rnft1	Mus musculus (Mouse)	395	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]	GO:0005783; GO:0016021; GO:0031901; GO:0043130; GO:0046872; GO:0051865; GO:0061630; GO:1904294	positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN13972_c0_g3_i1	A5D8S5	SH3R1_DANRE	72.7	55	15	0	191	27	812	866	6.60E-20	97.8	SH3R1_DANRE	reviewed	E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1)	sh3rf1 posh si:dkey-15j16.4	Danio rerio (Zebrafish) (Brachydanio rerio)	867	"Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"	Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]	MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0001764; GO:0005078; GO:0005794; GO:0006915; GO:0030027; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564	"apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30017_c0_g1_i1	A5D8S5	SH3R1_DANRE	61.3	137	52	1	472	65	135	271	2.30E-47	190.3	SH3R1_DANRE	reviewed	E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1)	sh3rf1 posh si:dkey-15j16.4	Danio rerio (Zebrafish) (Brachydanio rerio)	867	"Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"	Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]	MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0001764; GO:0005078; GO:0005794; GO:0006915; GO:0030027; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564	"apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12702_c0_g1_i2	Q6NRD3	SH3R1_XENLA	63	81	30	0	485	243	1	81	2.20E-23	110.5	SH3R1_XENLA	reviewed	E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (xPOSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1)	sh3rf1 posh	Xenopus laevis (African clawed frog)	826	"Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"	Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]	MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0001764; GO:0005078; GO:0005794; GO:0006915; GO:0030027; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564	"apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13972_c0_g3_i2	Q8TEJ3	SH3R3_HUMAN	43.2	146	71	4	428	27	736	881	5.80E-21	102.1	SH3R3_HUMAN	reviewed	E3 ubiquitin-protein ligase SH3RF3 (EC 2.3.2.27) (Plenty of SH3s 2) (SH3 domain-containing RING finger protein 3) (SH3 multiple domains protein 4)	SH3RF3 POSH2 SH3MD4	Homo sapiens (Human)	882	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]		metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0006915; GO:0046330; GO:0046872; GO:0051865; GO:0061630	apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN12702_c0_g1_i1	Q8TEJ3	SH3R3_HUMAN	60.4	48	18	1	228	88	46	93	7.80E-10	64.7	SH3R3_HUMAN	reviewed	E3 ubiquitin-protein ligase SH3RF3 (EC 2.3.2.27) (Plenty of SH3s 2) (SH3 domain-containing RING finger protein 3) (SH3 multiple domains protein 4)	SH3RF3 POSH2 SH3MD4	Homo sapiens (Human)	882	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]		metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0006915; GO:0046330; GO:0046872; GO:0051865; GO:0061630	apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN9865_c0_g1_i12	Q149N8	SHPRH_HUMAN	43.6	472	254	5	16	1407	825	1292	1.00E-100	368.6	SHPRH_HUMAN	reviewed	"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	SHPRH KIAA2023	Homo sapiens (Human)	1683	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9865_c0_g1_i4	Q149N8	SHPRH_HUMAN	58.1	365	152	1	1179	88	745	1109	8.80E-122	438.3	SHPRH_HUMAN	reviewed	"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	SHPRH KIAA2023	Homo sapiens (Human)	1683	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9865_c0_g1_i6	Q149N8	SHPRH_HUMAN	66.3	86	29	0	3	260	745	830	2.20E-28	125.9	SHPRH_HUMAN	reviewed	"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	SHPRH KIAA2023	Homo sapiens (Human)	1683	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9865_c0_g1_i9	Q149N8	SHPRH_HUMAN	43.6	472	254	5	995	2386	825	1292	1.30E-100	369	SHPRH_HUMAN	reviewed	"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	SHPRH KIAA2023	Homo sapiens (Human)	1683	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9865_c0_g1_i9	Q149N8	SHPRH_HUMAN	53.3	334	137	2	1032	88	776	1109	3.70E-95	350.9	SHPRH_HUMAN	reviewed	"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	SHPRH KIAA2023	Homo sapiens (Human)	1683	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN17387_c0_g1_i1	P61092	SIA1A_MOUSE	100	75	0	0	1	225	208	282	6.90E-37	154.1	SIA1A_MOUSE	reviewed	E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a)	Siah1a	Mus musculus (Mouse)	282	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244	cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1876_c0_g2_i1	P61092	SIA1A_MOUSE	85	266	34	1	875	96	17	282	3.20E-135	483	SIA1A_MOUSE	reviewed	E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a)	Siah1a	Mus musculus (Mouse)	282	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244	cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1876_c0_g2_i3	P61092	SIA1A_MOUSE	83.2	208	29	1	677	72	17	224	6.50E-103	375.2	SIA1A_MOUSE	reviewed	E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a)	Siah1a	Mus musculus (Mouse)	282	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244	cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1876_c0_g2_i6	P61092	SIA1A_MOUSE	85	266	34	1	875	96	17	282	2.70E-135	483	SIA1A_MOUSE	reviewed	E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a)	Siah1a	Mus musculus (Mouse)	282	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0051402; GO:0061630; GO:0097718; GO:2001244	cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40266_c0_g1_i1	O43255	SIAH2_HUMAN	100	120	0	0	3	362	205	324	2.80E-66	252.3	SIAH2_HUMAN	reviewed	E3 ubiquitin-protein ligase SIAH2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2) (Siah-2) (hSiah2)	SIAH2	Homo sapiens (Human)	324	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; transcription corepressor activity [GO:0003714]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of netrin-activated signaling pathway [GO:1902842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of circadian rhythm [GO:0042752]; regulation of protein ubiquitination [GO:0031396]; rhythmic process [GO:0048511]; small GTPase mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]	transcription corepressor activity [GO:0003714]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003714; GO:0004842; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006915; GO:0007049; GO:0007264; GO:0007275; GO:0008270; GO:0016579; GO:0031396; GO:0031624; GO:0042752; GO:0043005; GO:0043025; GO:0043066; GO:0043154; GO:0043161; GO:0043231; GO:0044257; GO:0044267; GO:0048511; GO:0061630; GO:0090090; GO:1902842; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of netrin-activated signaling pathway [GO:1902842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of circadian rhythm [GO:0042752]; regulation of protein ubiquitination [GO:0031396]; rhythmic process [GO:0048511]; small GTPase mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31546_c0_g1_i1	O43255	SIAH2_HUMAN	100	100	0	0	302	3	100	199	5.60E-57	221.1	SIAH2_HUMAN	reviewed	E3 ubiquitin-protein ligase SIAH2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2) (Siah-2) (hSiah2)	SIAH2	Homo sapiens (Human)	324	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; transcription corepressor activity [GO:0003714]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of netrin-activated signaling pathway [GO:1902842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of circadian rhythm [GO:0042752]; regulation of protein ubiquitination [GO:0031396]; rhythmic process [GO:0048511]; small GTPase mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]	transcription corepressor activity [GO:0003714]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003714; GO:0004842; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006915; GO:0007049; GO:0007264; GO:0007275; GO:0008270; GO:0016579; GO:0031396; GO:0031624; GO:0042752; GO:0043005; GO:0043025; GO:0043066; GO:0043154; GO:0043161; GO:0043231; GO:0044257; GO:0044267; GO:0048511; GO:0061630; GO:0090090; GO:1902842; GO:2001237	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of netrin-activated signaling pathway [GO:1902842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of circadian rhythm [GO:0042752]; regulation of protein ubiquitination [GO:0031396]; rhythmic process [GO:0048511]; small GTPase mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40732_c0_g1_i1	Q9CUN6	SMUF1_MOUSE	98.6	74	1	0	222	1	230	303	7.10E-41	167.2	SMUF1_MOUSE	reviewed	E3 ubiquitin-protein ligase SMURF1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF1) (SMAD ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-protein ligase 1)	Smurf1	Mus musculus (Mouse)	731	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; I-SMAD binding [GO:0070411]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of ossification [GO:0030279]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	I-SMAD binding [GO:0070411]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006511; GO:0006611; GO:0016567; GO:0030154; GO:0030279; GO:0030424; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0032801; GO:0034394; GO:0043025; GO:0043161; GO:0045732; GO:0061630; GO:0061734; GO:0061736; GO:0061753; GO:0070411; GO:0070412; GO:0071211; GO:1903861; GO:2000060	BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of ossification [GO:0030279]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN365_c0_g1_i1	Q9HCE7	SMUF1_HUMAN	76.1	134	32	0	486	85	624	757	1.90E-57	223.4	SMUF1_HUMAN	reviewed	E3 ubiquitin-protein ligase SMURF1 (hSMURF1) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF1) (SMAD ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-protein ligase 1)	SMURF1 KIAA1625	Homo sapiens (Human)	757	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of ossification [GO:0030279]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006611; GO:0007179; GO:0007398; GO:0016567; GO:0030154; GO:0030279; GO:0030424; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0032801; GO:0034394; GO:0043025; GO:0043161; GO:0045732; GO:0048185; GO:0060071; GO:0061630; GO:0061734; GO:0061736; GO:0061753; GO:0070062; GO:0070411; GO:0070412; GO:0071211; GO:0072659; GO:1903861; GO:2000060	"BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of ossification [GO:0030279]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN158_c0_g1_i1	A9JRZ0	SMUF2_DANRE	47.7	310	103	8	1079	150	107	357	6.90E-65	249.2	SMUF2_DANRE	reviewed	E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	smurf2	Danio rerio (Zebrafish) (Brachydanio rerio)	765	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005737; GO:0005886; GO:0006511; GO:0016567; GO:0030514; GO:0030579; GO:0043161; GO:0045121; GO:0045732; GO:0061630	negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		blue	blue	NA	NA	NA	NA
TRINITY_DN1627_c0_g1_i1	A9JRZ0	SMUF2_DANRE	73.1	134	34	1	494	99	370	503	2.50E-52	206.8	SMUF2_DANRE	reviewed	E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	smurf2	Danio rerio (Zebrafish) (Brachydanio rerio)	765	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005737; GO:0005886; GO:0006511; GO:0016567; GO:0030514; GO:0030579; GO:0043161; GO:0045121; GO:0045732; GO:0061630	negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN1627_c0_g1_i2	A9JRZ0	SMUF2_DANRE	76	183	42	1	543	1	370	552	2.80E-81	303.1	SMUF2_DANRE	reviewed	E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	smurf2	Danio rerio (Zebrafish) (Brachydanio rerio)	765	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005737; GO:0005886; GO:0006511; GO:0016567; GO:0030514; GO:0030579; GO:0043161; GO:0045121; GO:0045732; GO:0061630	negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		blue	blue	NA	NA	NA	NA
TRINITY_DN158_c0_g1_i2	Q9HAU4	SMUF2_HUMAN	58.9	90	33	1	378	109	107	192	2.50E-22	106.3	SMUF2_HUMAN	reviewed	E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	SMURF2	Homo sapiens (Human)	748	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016579; GO:0016607; GO:0017015; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0042802; GO:0043161; GO:0045121; GO:0045732; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165	"BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN158_c0_g1_i3	Q9HAU4	SMUF2_HUMAN	55.6	99	40	1	359	63	107	201	3.20E-22	105.9	SMUF2_HUMAN	reviewed	E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	SMURF2	Homo sapiens (Human)	748	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016579; GO:0016607; GO:0017015; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0042802; GO:0043161; GO:0045121; GO:0045732; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165	"BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN158_c0_g1_i4	Q9HAU4	SMUF2_HUMAN	52.5	61	29	0	269	87	107	167	2.50E-08	59.3	SMUF2_HUMAN	reviewed	E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	SMURF2	Homo sapiens (Human)	748	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016579; GO:0016607; GO:0017015; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0042802; GO:0043161; GO:0045121; GO:0045732; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165	"BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34115_c0_g1_i1	Q9Y0H4	SUDX_DROME	93.1	102	7	0	328	23	848	949	8.40E-54	210.7	SUDX_DROME	reviewed	E3 ubiquitin-protein ligase Su(dx) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Su(dx)) (Protein suppressor of deltex)	Su(dx) CG4244	Drosophila melanogaster (Fruit fly)	949	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]	Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005112; GO:0005737; GO:0005938; GO:0006511; GO:0006622; GO:0007219; GO:0008586; GO:0008587; GO:0016348; GO:0016567; GO:0019915; GO:0031623; GO:0032880; GO:0035209; GO:0043161; GO:0045732; GO:0045746; GO:0045879; GO:0048190; GO:0061630	imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN18334_c0_g1_i1	Q9Y0H4	SUDX_DROME	73.3	120	32	0	3	362	695	814	1.90E-46	186.4	SUDX_DROME	reviewed	E3 ubiquitin-protein ligase Su(dx) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Su(dx)) (Protein suppressor of deltex)	Su(dx) CG4244	Drosophila melanogaster (Fruit fly)	949	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]	Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005112; GO:0005737; GO:0005938; GO:0006511; GO:0006622; GO:0007219; GO:0008586; GO:0008587; GO:0016348; GO:0016567; GO:0019915; GO:0031623; GO:0032880; GO:0035209; GO:0043161; GO:0045732; GO:0045746; GO:0045879; GO:0048190; GO:0061630	imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN18334_c0_g2_i1	Q9Y0H4	SUDX_DROME	86.9	99	13	0	299	3	587	685	5.30E-47	188	SUDX_DROME	reviewed	E3 ubiquitin-protein ligase Su(dx) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Su(dx)) (Protein suppressor of deltex)	Su(dx) CG4244	Drosophila melanogaster (Fruit fly)	949	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]	Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005112; GO:0005737; GO:0005938; GO:0006511; GO:0006622; GO:0007219; GO:0008586; GO:0008587; GO:0016348; GO:0016567; GO:0019915; GO:0031623; GO:0032880; GO:0035209; GO:0043161; GO:0045732; GO:0045746; GO:0045879; GO:0048190; GO:0061630	imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN13303_c0_g1_i1	Q9Y0H4	SUDX_DROME	59.6	171	56	2	56	529	362	532	1.10E-58	227.6	SUDX_DROME	reviewed	E3 ubiquitin-protein ligase Su(dx) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Su(dx)) (Protein suppressor of deltex)	Su(dx) CG4244	Drosophila melanogaster (Fruit fly)	949	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]	Notch binding [GO:0005112]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005112; GO:0005737; GO:0005938; GO:0006511; GO:0006622; GO:0007219; GO:0008586; GO:0008587; GO:0016348; GO:0016567; GO:0019915; GO:0031623; GO:0032880; GO:0035209; GO:0043161; GO:0045732; GO:0045746; GO:0045879; GO:0048190; GO:0061630	imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; lipid storage [GO:0019915]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; pupal development [GO:0035209]; receptor internalization [GO:0031623]; regulation of protein localization [GO:0032880]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc dorsal/ventral pattern formation [GO:0048190]		blue	blue	NA	NA	NA	NA
TRINITY_DN4283_c0_g1_i1	Q86TM6	SYVN1_HUMAN	52.4	63	30	0	121	309	481	543	3.30E-09	62.8	SYVN1_HUMAN	reviewed	E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1)	SYVN1 HRD1 KIAA1810	Homo sapiens (Human)	617	"cytoplasm [GO:0005737]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]	ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]	GO:0000836; GO:0000839; GO:0002327; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005790; GO:0006511; GO:0016020; GO:0016567; GO:0030176; GO:0030433; GO:0030970; GO:0036498; GO:0036503; GO:0036513; GO:0044322; GO:0046872; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:1902236; GO:1904380; GO:1990381	"endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8489_c0_g1_i1	Q9DBY1	SYVN1_MOUSE	76.2	151	36	0	515	63	185	335	5.10E-66	251.9	SYVN1_MOUSE	reviewed	E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1)	Syvn1 Hrd1 Kiaa1810	Mus musculus (Mouse)	612	"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]; ubiquitin ligase complex [GO:0000151]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; in utero embryonic development [GO:0001701]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein catabolic process [GO:0030163]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]; ubiquitin ligase complex [GO:0000151]	ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]	GO:0000151; GO:0000839; GO:0001701; GO:0002327; GO:0005654; GO:0005783; GO:0005790; GO:0006511; GO:0006986; GO:0016021; GO:0016567; GO:0030163; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0046872; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:1902236; GO:1990381	"ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; in utero embryonic development [GO:0001701]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein catabolic process [GO:0030163]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38887_c0_g1_i1	Q8K304	TM129_MOUSE	100	61	0	0	207	25	302	362	9.30E-35	146.7	TM129_MOUSE	reviewed	E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129)	Tmem129	Mus musculus (Mouse)	362	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0030970; GO:0046872; GO:0061630	"protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8515_c0_g1_i1	Q9NS56	TOPRS_HUMAN	34.2	357	179	12	256	1200	103	445	1.10E-35	153.3	TOPRS_HUMAN	reviewed	E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3)	TOPORS LUN TP53BPL	Homo sapiens (Human)	1045	"centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]"	centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]	antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006351; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0010842; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0030496; GO:0032391; GO:0034504; GO:0035845; GO:0036064; GO:0042127; GO:0042771; GO:0043066; GO:0043161; GO:0044547; GO:0045893; GO:0046548; GO:0046549; GO:0046872; GO:0051443; GO:0051457; GO:0061630; GO:0070936	"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15661_c0_g1_i1	P36406	TRI23_HUMAN	55.9	553	222	6	179	1792	29	574	2.30E-177	623.6	TRI23_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23)	TRIM23 ARD1 ARFD1 RNF46	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005886; GO:0006886; GO:0008047; GO:0008270; GO:0016032; GO:0016192; GO:0016567; GO:0019003; GO:0042802; GO:0045087	innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN15661_c0_g1_i2	P36406	TRI23_HUMAN	61.6	146	45	2	179	598	29	169	1.40E-46	187.6	TRI23_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23)	TRIM23 ARD1 ARFD1 RNF46	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005886; GO:0006886; GO:0008047; GO:0008270; GO:0016032; GO:0016192; GO:0016567; GO:0019003; GO:0042802; GO:0045087	innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN15661_c0_g1_i3	P36406	TRI23_HUMAN	71.7	53	15	0	179	337	29	81	3.90E-17	89.4	TRI23_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23)	TRIM23 ARD1 ARFD1 RNF46	Homo sapiens (Human)	574	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005886; GO:0006886; GO:0008047; GO:0008270; GO:0016032; GO:0016192; GO:0016567; GO:0019003; GO:0042802; GO:0045087	innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3395_c0_g1_i1	O94972	TRI37_HUMAN	71.4	269	76	1	908	102	1	268	7.90E-108	391.7	TRI37_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)	TRIM37 KIAA0898 MUL POB1	Homo sapiens (Human)	964	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842	aggresome assembly [GO:0070842]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN38760_c0_g1_i1	O94972	TRI37_HUMAN	99.1	114	1	0	344	3	286	399	1.10E-64	246.9	TRI37_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)	TRIM37 KIAA0898 MUL POB1	Homo sapiens (Human)	964	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842	aggresome assembly [GO:0070842]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN3395_c0_g1_i2	Q6PCX9	TRI37_MOUSE	73.4	459	119	2	1467	91	1	456	2.90E-197	689.5	TRI37_MOUSE	reviewed	E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)	Trim37 Kiaa0898	Mus musculus (Mouse)	961	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035098; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842	aggresome assembly [GO:0070842]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN9316_c0_g1_i1	Q810I1	TRI50_RAT	24.3	206	111	8	790	176	9	170	3.70E-08	60.5	TRI50_RAT	reviewed	E3 ubiquitin-protein ligase TRIM50 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM50) (Tripartite motif-containing protein 50)	Trim50	Rattus norvegicus (Rat)	483	aggresome [GO:0016235]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; regulation of establishment of protein localization [GO:0070201]	aggresome [GO:0016235]; cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0016235; GO:0016567; GO:0042802; GO:0061630; GO:0070201	protein ubiquitination [GO:0016567]; regulation of establishment of protein localization [GO:0070201]		NA	NA	NA	NA	NA	NA
TRINITY_DN9316_c0_g1_i2	Q86XT4	TRI50_HUMAN	26.9	201	125	8	715	149	7	197	3.90E-12	73.6	TRI50_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM50 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM50) (Tripartite motif-containing protein 50)	TRIM50 TRIM50A	Homo sapiens (Human)	487	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; regulation of establishment of protein localization [GO:0070201]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0016235; GO:0016567; GO:0042802; GO:0061630; GO:0070201	protein ubiquitination [GO:0016567]; regulation of establishment of protein localization [GO:0070201]		NA	NA	NA	NA	NA	NA
TRINITY_DN9316_c0_g1_i3	Q865W2	TRI50_PIG	24	221	129	7	790	149	9	197	3.40E-09	63.9	TRI50_PIG	reviewed	E3 ubiquitin-protein ligase TRIM50 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM50) (Tripartite motif-containing protein 50)	TRIM50	Sus scrofa (Pig)	486	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0016567; GO:0061630	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN12852_c0_g1_i1	Q80VI1	TRI56_MOUSE	33.8	80	47	2	284	51	12	87	4.10E-07	55.8	TRI56_MOUSE	reviewed	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	Trim56	Mus musculus (Mouse)	734	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0045087; GO:0045893; GO:0046597; GO:0051607; GO:0061630; GO:0070534; GO:1902187	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32845_c0_g1_i1	E1B7Q7	TRIPC_BOVIN	95.5	88	4	0	300	37	402	489	1.60E-40	166.4	TRIPC_BOVIN	reviewed	E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12)	TRIP12	Bos taurus (Bovine)	1992	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0045995; GO:0046966; GO:0061630; GO:1901315; GO:2000779; GO:2000780	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN29918_c0_g1_i1	E1B7Q7	TRIPC_BOVIN	73.9	119	30	1	358	2	393	510	6.60E-44	177.9	TRIPC_BOVIN	reviewed	E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12)	TRIP12	Bos taurus (Bovine)	1992	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0045995; GO:0046966; GO:0061630; GO:1901315; GO:2000779; GO:2000780	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2025_c0_g1_i2	Q9VX91	UBR1_DROME	34.9	146	82	2	476	78	5	150	2.10E-22	107.1	UBR1_DROME	reviewed	E3 ubiquitin-protein ligase UBR1 (EC 2.3.2.27) (N-recognin) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha)	Ubr1 CG9086	Drosophila melanogaster (Fruit fly)	1824	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0061630; GO:0071596	protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN28672_c0_g1_i1	Q8IWV7	UBR1_HUMAN	100	69	0	0	209	3	114	182	3.50E-40	164.9	UBR1_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR1 (EC 2.3.2.27) (N-recognin-1) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I)	UBR1	Homo sapiens (Human)	1749	cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000502; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0032007; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN37636_c0_g1_i1	Q8IWV7	UBR1_HUMAN	100	71	0	0	3	215	741	811	2.80E-34	145.2	UBR1_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR1 (EC 2.3.2.27) (N-recognin-1) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I)	UBR1	Homo sapiens (Human)	1749	cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000502; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0032007; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN35266_c0_g1_i1	Q8IWV8	UBR2_HUMAN	100	82	0	0	248	3	203	284	3.20E-42	171.8	UBR2_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	UBR2 C6orf133 KIAA0349	Homo sapiens (Human)	1755	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN2025_c0_g1_i3	Q8IWV8	UBR2_HUMAN	39.8	352	190	5	1136	84	8	338	7.60E-73	275.8	UBR2_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	UBR2 C6orf133 KIAA0349	Homo sapiens (Human)	1755	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN2025_c0_g1_i4	Q8IWV8	UBR2_HUMAN	39.4	1822	995	34	5451	94	8	1755	0	1236.5	UBR2_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	UBR2 C6orf133 KIAA0349	Homo sapiens (Human)	1755	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN2025_c0_g1_i5	Q8IWV8	UBR2_HUMAN	39.8	1320	721	19	3972	118	8	1289	2.40E-267	923.7	UBR2_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	UBR2 C6orf133 KIAA0349	Homo sapiens (Human)	1755	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN32881_c0_g1_i1	Q6WKZ8	UBR2_MOUSE	98.6	74	1	0	224	3	80	153	8.40E-42	170.2	UBR2_MOUSE	reviewed	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	Ubr2 Kiaa0349	Mus musculus (Mouse)	1755	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0005634; GO:0005737; GO:0006342; GO:0006511; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN39859_c0_g1_i1	Q8IWV8	UBR2_HUMAN	100	73	0	0	221	3	1675	1747	3.10E-39	161.8	UBR2_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	UBR2 C6orf133 KIAA0349	Homo sapiens (Human)	1755	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN8977_c0_g1_i2	Q9W3M3	UBR3_DROME	48.9	262	133	1	784	2	227	488	5.60E-72	272.3	UBR3_DROME	reviewed	E3 ubiquitin-protein ligase Ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase Ubr3)	Ubr3 CG42593	Drosophila melanogaster (Fruit fly)	2219	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0043066; GO:0045880; GO:0051865; GO:0061630; GO:0070936; GO:0071596	negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN8977_c0_g1_i3	Q9W3M3	UBR3_DROME	44.1	143	79	1	427	2	346	488	3.80E-29	129.4	UBR3_DROME	reviewed	E3 ubiquitin-protein ligase Ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase Ubr3)	Ubr3 CG42593	Drosophila melanogaster (Fruit fly)	2219	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0043066; GO:0045880; GO:0051865; GO:0061630; GO:0070936; GO:0071596	negative regulation of apoptotic process [GO:0043066]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN8977_c0_g1_i1	Q6ZT12	UBR3_HUMAN	78.1	32	7	0	137	42	151	182	3.40E-09	62	UBR3_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)	UBR3 KIAA2024 ZNF650	Homo sapiens (Human)	1888	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016021; GO:0016567; GO:0042048; GO:0061630; GO:0071596	embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]		NA	NA	NA	NA	NA	NA
TRINITY_DN38915_c0_g1_i1	Q5T4S7	UBR4_HUMAN	100	78	0	0	234	1	1848	1925	1.00E-37	156.8	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4006_c0_g1_i1	Q5T4S7	UBR4_HUMAN	53.9	438	168	8	1255	2	1550	1973	1.80E-120	434.1	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4006_c0_g1_i2	Q5T4S7	UBR4_HUMAN	63.8	345	115	4	1103	87	1633	1973	8.00E-117	421.8	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4006_c0_g1_i4	Q5T4S7	UBR4_HUMAN	56.9	390	146	6	1144	2	1597	1973	9.20E-116	418.3	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4006_c0_g1_i5	Q5T4S7	UBR4_HUMAN	56.2	625	238	9	1885	71	1550	2158	5.20E-193	675.6	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4006_c0_g1_i7	Q5T4S7	UBR4_HUMAN	56.2	625	238	9	1885	71	1550	2158	5.20E-193	675.6	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29326_c0_g1_i1	Q5T4S7	UBR4_HUMAN	100	104	0	0	315	4	2160	2263	5.50E-55	214.5	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29633_c0_g1_i1	Q5T4S7	UBR4_HUMAN	100	79	0	0	237	1	1625	1703	9.00E-42	170.2	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0061630; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1334_c0_g1_i1	Q2TL32	UBR4_RAT	50.9	450	196	9	82	1395	2157	2593	3.10E-124	446.8	UBR4_RAT	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Zinc finger UBR1-type protein 1)	Ubr4 Rbaf600 Zubr1	Rattus norvegicus (Rat)	5194	centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016021; GO:0061630	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2375_c0_g1_i1	Q62671	UBR5_RAT	46.7	285	133	9	837	1	200	471	5.70E-55	216.1	UBR5_RAT	reviewed	"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (100 kDa protein) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog)"	Ubr5 Dd5 Edd Edd1 Hyd	Rattus norvegicus (Rat)	2788	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 production [GO:0032700]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of double-strand break repair [GO:2000779]; regulation of protein stability [GO:0031647]	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003723; GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016567; GO:0019904; GO:0031647; GO:0032700; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779; GO:2000780	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 production [GO:0032700]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of double-strand break repair [GO:2000779]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN7584_c0_g1_i1	Q80TP3	UBR5_MOUSE	62.4	242	91	0	3	728	1086	1327	1.30E-86	320.9	UBR5_MOUSE	reviewed	"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog)"	Ubr5 Edd Edd1 Kiaa0896	Mus musculus (Mouse)	2792	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 production [GO:0032700]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of protein stability [GO:0031647]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032700; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779; GO:2000780	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 production [GO:0032700]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN3949_c0_g1_i1	O95071	UBR5_HUMAN	47.3	74	39	0	701	480	2008	2081	2.80E-12	73.9	UBR5_HUMAN	reviewed	"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)"	UBR5 EDD EDD1 HYD KIAA0896	Homo sapiens (Human)	2799	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; viral process [GO:0016032]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0016032; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779; GO:2000780	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3469_c0_g1_i1	F6UA42	UHRF1_XENTR	64.4	59	21	0	239	63	300	358	1.10E-20	100.1	UHRF1_XENTR	reviewed	E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1)	uhrf1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	775	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; replication fork [GO:0005657]	hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000791; GO:0000792; GO:0004842; GO:0005657; GO:0005720; GO:0006511; GO:0007049; GO:0008270; GO:0010216; GO:0010390; GO:0016567; GO:0016574; GO:0035064; GO:0042393; GO:0044729; GO:0051865; GO:0061630	cell cycle [GO:0007049]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3469_c0_g1_i2	F6UA42	UHRF1_XENTR	64.2	81	29	0	243	1	300	380	6.20E-30	131	UHRF1_XENTR	reviewed	E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1)	uhrf1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	775	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; replication fork [GO:0005657]	hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000791; GO:0000792; GO:0004842; GO:0005657; GO:0005720; GO:0006511; GO:0007049; GO:0008270; GO:0010216; GO:0010390; GO:0016567; GO:0016574; GO:0035064; GO:0042393; GO:0044729; GO:0051865; GO:0061630	cell cycle [GO:0007049]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40239_c0_g1_i1	Q8H0T4	UPL2_ARATH	61.5	109	42	0	349	23	3549	3657	1.60E-34	146.7	UPL2_ARATH	reviewed	E3 ubiquitin-protein ligase UPL2 (Ubiquitin-protein ligase 2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase UPL2)	UPL2 At1g70320 F17O7.14/F17O7.15	Arabidopsis thaliana (Mouse-ear cress)	3658	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0016567; GO:0043161; GO:0045732; GO:0061630	positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35719_c0_g1_i1	Q6PFK1	ZN598_DANRE	36.9	84	53	0	315	64	20	103	9.50E-14	77.8	ZN598_DANRE	reviewed	E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598)	znf598 zfp598	Danio rerio (Zebrafish) (Brachydanio rerio)	953	metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]		metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]	GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344	protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN35719_c0_g1_i2	Q6PFK1	ZN598_DANRE	38.8	188	115	0	565	2	20	207	4.90E-39	162.5	ZN598_DANRE	reviewed	E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598)	znf598 zfp598	Danio rerio (Zebrafish) (Brachydanio rerio)	953	metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]		metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]	GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344	protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN40614_c0_g1_i1	F1MM41	ZNRF1_BOVIN	100	66	0	0	3	200	162	227	1.80E-35	149.4	ZNRF1_BOVIN	reviewed	E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1)	ZNRF1	Bos taurus (Bovine)	227	endosome [GO:0005768]; lysosome [GO:0005764]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]	endosome [GO:0005768]; lysosome [GO:0005764]; synaptic vesicle membrane [GO:0030672]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005764; GO:0005768; GO:0030672; GO:0043161; GO:0046872; GO:0070936	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]		NA	NA	NA	NA	NA	NA
TRINITY_DN7048_c0_g1_i1	F1MM41	ZNRF1_BOVIN	76.7	86	20	0	91	348	142	227	1.20E-38	160.6	ZNRF1_BOVIN	reviewed	E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1)	ZNRF1	Bos taurus (Bovine)	227	endosome [GO:0005768]; lysosome [GO:0005764]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]	endosome [GO:0005768]; lysosome [GO:0005764]; synaptic vesicle membrane [GO:0030672]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005764; GO:0005768; GO:0030672; GO:0043161; GO:0046872; GO:0070936	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]		NA	NA	NA	NA	NA	NA
TRINITY_DN38488_c0_g1_i1	Q8NHG8	ZNRF2_HUMAN	100	67	0	0	1	201	176	242	9.90E-37	153.3	ZNRF2_HUMAN	reviewed	E3 ubiquitin-protein ligase ZNRF2 (EC 2.3.2.27) (Protein Ells2) (RING finger protein 202) (RING-type E3 ubiquitin transferase ZNRF2) (Zinc/RING finger protein 2)	ZNRF2 RNF202	Homo sapiens (Human)	242	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0010008; GO:0030659; GO:0032991; GO:0042734; GO:0042995; GO:0046872; GO:0061630	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN7048_c0_g1_i2	Q8NHG8	ZNRF2_HUMAN	67.5	114	35	1	21	356	129	242	1.20E-41	170.6	ZNRF2_HUMAN	reviewed	E3 ubiquitin-protein ligase ZNRF2 (EC 2.3.2.27) (Protein Ells2) (RING finger protein 202) (RING-type E3 ubiquitin transferase ZNRF2) (Zinc/RING finger protein 2)	ZNRF2 RNF202	Homo sapiens (Human)	242	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0010008; GO:0030659; GO:0032991; GO:0042734; GO:0042995; GO:0046872; GO:0061630	protein polyubiquitination [GO:0000209]		blue	blue	NA	NA	NA	NA
TRINITY_DN40009_c0_g1_i1	Q96G75	RMD5B_HUMAN	100	79	0	0	2	238	291	369	1.10E-42	173.3	RMD5B_HUMAN	reviewed	E3 ubiquitin-protein transferase RMND5B (EC 2.3.2.27) (Protein RMD5 homolog B)	RMND5B UNQ2508/PRO5996	Homo sapiens (Human)	393	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0034657; GO:0043161; GO:0046872	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN32340_c0_g1_i1	Q96G75	RMD5B_HUMAN	100	87	0	0	2	262	204	290	8.10E-44	177.2	RMD5B_HUMAN	reviewed	E3 ubiquitin-protein transferase RMND5B (EC 2.3.2.27) (Protein RMD5 homolog B)	RMND5B UNQ2508/PRO5996	Homo sapiens (Human)	393	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0034657; GO:0043161; GO:0046872	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26967_c0_g1_i1	Q91YQ7	RMD5B_MOUSE	100	86	0	0	309	52	308	393	5.30E-50	198	RMD5B_MOUSE	reviewed	E3 ubiquitin-protein transferase RMND5B (EC 2.3.2.27) (Protein RMD5 homolog B)	Rmnd5b	Mus musculus (Mouse)	393	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0034657; GO:0043161; GO:0046872	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26669_c0_g1_i1	A1A4I9	UFL1_BOVIN	50.5	386	187	2	1310	153	5	386	3.00E-108	393.7	UFL1_BOVIN	reviewed	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1)	UFL1	Bos taurus (Bovine)	792	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of autophagy [GO:0010508]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]	GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0010508; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of autophagy [GO:0010508]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN39024_c0_g1_i1	O94874	UFL1_HUMAN	100	102	0	0	308	3	1	102	4.70E-50	198.4	UFL1_HUMAN	reviewed	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)	UFL1 KIAA0776 MAXER NLBP RCAD	Homo sapiens (Human)	794	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]	GO:0001649; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0008284; GO:0010508; GO:0016020; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043066; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN31469_c0_g1_i1	O94874	UFL1_HUMAN	100	92	0	0	277	2	147	238	9.30E-46	183.7	UFL1_HUMAN	reviewed	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)	UFL1 KIAA0776 MAXER NLBP RCAD	Homo sapiens (Human)	794	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]	GO:0001649; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0008284; GO:0010508; GO:0016020; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043066; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN10227_c0_g1_i1	Q8CCJ3	UFL1_MOUSE	37.8	304	172	1	164	1024	490	793	1.80E-55	218	UFL1_MOUSE	reviewed	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Regulator of C53/LZAP and DDRGK1)	Ufl1 Kiaa0776 Maxer Rcad	Mus musculus (Mouse)	793	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of protein binding [GO:0032092]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of gene expression [GO:0010468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]	GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0008284; GO:0010468; GO:0010508; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032092; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043066; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of protein binding [GO:0032092]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of gene expression [GO:0010468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN10303_c0_g1_i1	Q8BL66	EEA1_MOUSE	32.5	166	88	3	478	14	41	193	4.70E-15	82.8	EEA1_MOUSE	reviewed	Early endosome antigen 1	Eea1	Mus musculus (Mouse)	1411	axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]	axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]	1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]	GO:0005545; GO:0005768; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0019897; GO:0030742; GO:0031410; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0046872; GO:0055037	endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN13973_c0_g1_i1	Q15075	EEA1_HUMAN	56	125	55	0	415	41	1285	1409	3.40E-36	152.5	EEA1_HUMAN	reviewed	Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2)	EEA1 ZFYVE2	Homo sapiens (Human)	1411	axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]	axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]	1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005516; GO:0005545; GO:0005737; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0008270; GO:0016020; GO:0016189; GO:0019897; GO:0030742; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0045022; GO:0055037; GO:0070062	early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN11700_c0_g1_i1	Q6GQH4	EGR1A_XENLA	47	83	42	1	49	291	304	386	2.70E-17	89.4	EGR1A_XENLA	reviewed	Early growth response protein 1-A (EGR-1-A) (Xegr-1)	egr1-a egr1	Xenopus laevis (African clawed frog)	497	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841	"circadian regulation of gene expression [GO:0032922]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32058_c0_g1_i1	Q6GQH4	EGR1A_XENLA	66.7	36	12	0	66	173	334	369	1.50E-08	60.1	EGR1A_XENLA	reviewed	Early growth response protein 1-A (EGR-1-A) (Xegr-1)	egr1-a egr1	Xenopus laevis (African clawed frog)	497	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841	"circadian regulation of gene expression [GO:0032922]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18158_c0_g1_i1	Q6NTY6	EGR1B_XENLA	100	73	0	0	221	3	283	355	2.70E-40	165.2	EGR1B_XENLA	reviewed	Early growth response protein 1-B (EGR-1-B)	egr1-b	Xenopus laevis (African clawed frog)	475	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841	"circadian regulation of gene expression [GO:0032922]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5119_c0_g1_i2	Q08427	EGR2_XENLA	32.3	226	128	8	651	10	184	396	9.30E-15	82	EGR2_XENLA	reviewed	Early growth response protein 2 (EGR-2) (Zinc finger protein Krox-20)	egr2 krox20	Xenopus laevis (African clawed frog)	421	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5119_c0_g1_i1	Q9GL32	EGR4_BOVIN	44.6	92	48	1	360	85	371	459	8.10E-15	82	EGR4_BOVIN	reviewed	Early growth response protein 4 (EGR-4)	EGR4	Bos taurus (Bovine)	482	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5119_c0_g1_i3	Q9GL32	EGR4_BOVIN	44.6	92	48	1	360	85	371	459	9.20E-15	82	EGR4_BOVIN	reviewed	Early growth response protein 4 (EGR-4)	EGR4	Bos taurus (Bovine)	482	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9714_c0_g1_i1	Q5M8I4	EIPR1_XENTR	51.4	397	168	7	97	1260	3	383	3.30E-112	406.8	EIPR1_XENTR	reviewed	EARP-interacting protein homolog	eipr1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	387	Golgi apparatus [GO:0005794]; endocytic recycling [GO:0032456]; protein ubiquitination [GO:0016567]	Golgi apparatus [GO:0005794]		GO:0005794; GO:0016567; GO:0032456	endocytic recycling [GO:0032456]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9714_c0_g1_i2	Q5M8I4	EIPR1_XENTR	42.1	178	85	5	97	621	3	165	2.20E-30	134	EIPR1_XENTR	reviewed	EARP-interacting protein homolog	eipr1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	387	Golgi apparatus [GO:0005794]; endocytic recycling [GO:0032456]; protein ubiquitination [GO:0016567]	Golgi apparatus [GO:0005794]		GO:0005794; GO:0016567; GO:0032456	endocytic recycling [GO:0032456]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i15	O18473	ECR_HELVI	56	273	110	4	844	32	127	391	2.20E-75	283.9	ECR_HELVI	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (HvEcR) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Heliothis virescens (Tobacco budworm moth)	576	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i23	O18473	ECR_HELVI	57.2	269	109	5	832	32	127	391	1.50E-76	287.7	ECR_HELVI	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (HvEcR) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Heliothis virescens (Tobacco budworm moth)	576	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i9	O18473	ECR_HELVI	56.4	218	89	5	878	231	127	340	5.90E-60	232.6	ECR_HELVI	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (HvEcR) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Heliothis virescens (Tobacco budworm moth)	576	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i9	O18473	ECR_HELVI	68.9	45	14	0	166	32	347	391	3.60E-09	63.9	ECR_HELVI	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (HvEcR) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Heliothis virescens (Tobacco budworm moth)	576	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i1	O18531	ECR_LUCCU	55.7	451	179	7	1380	43	263	697	1.20E-128	461.5	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i11	O18531	ECR_LUCCU	77.7	130	27	2	616	233	263	392	1.00E-53	211.5	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i12	O18531	ECR_LUCCU	60.2	206	69	5	582	4	263	468	2.70E-59	229.9	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i17	O18531	ECR_LUCCU	55.4	446	184	5	1368	43	263	697	1.10E-129	464.9	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i18	O18531	ECR_LUCCU	56.3	451	176	7	1380	43	263	697	4.90E-130	466.1	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i19	O18531	ECR_LUCCU	57.4	223	93	1	705	43	475	697	9.70E-65	249.2	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i19	O18531	ECR_LUCCU	54.8	217	86	3	1433	786	263	468	1.00E-58	229.2	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i20	O18531	ECR_LUCCU	57.9	435	163	6	1287	43	263	697	1.40E-131	471.1	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i21	O18531	ECR_LUCCU	58	224	92	1	708	43	474	697	7.80E-66	251.9	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i3	O18531	ECR_LUCCU	56.1	446	181	5	1368	43	263	697	3.30E-131	469.9	ECR_LUCCU	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	757	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]	nucleus [GO:0005634]	ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	ecdysone receptor-mediated signaling pathway [GO:0035076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2492_c0_g1_i5	P34021	ECR_DROME	80.3	61	11	1	261	82	226	286	4.30E-21	102.1	ECR_DROME	reviewed	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	EcR NR1H1 CG1765	Drosophila melanogaster (Fruit fly)	878	"activator ecdysone receptor complex [GO:0008232]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; ecdysone receptor holocomplex [GO:0008230]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; repressor ecdysone receptor complex [GO:0008231]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; border follicle cell migration [GO:0007298]; cardiac muscle tissue development [GO:0048738]; cardioblast differentiation [GO:0010002]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; dorsal vessel heart proper cell fate commitment [GO:0035053]; ecdysis, chitin-based cuticle [GO:0018990]; ecdysone receptor-mediated signaling pathway [GO:0035076]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; epidermis development [GO:0008544]; germ cell development [GO:0007281]; germ-band shortening [GO:0007390]; hatching [GO:0035188]; head involution [GO:0008258]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived wing morphogenesis [GO:0007476]; larval central nervous system remodeling [GO:0035193]; larval development [GO:0002164]; larval wandering behavior [GO:0035180]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-term memory [GO:0007616]; Malpighian tubule morphogenesis [GO:0007443]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron remodeling [GO:0016322]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; phagocytosis, engulfment [GO:0006911]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of Malpighian tubule diameter [GO:0035297]; regulation of neuron remodeling [GO:1904799]; regulation of rhodopsin gene expression [GO:0007468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to ecdysone [GO:0035075]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]"	activator ecdysone receptor complex [GO:0008232]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; ecdysone receptor holocomplex [GO:0008230]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; repressor ecdysone receptor complex [GO:0008231]	"core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator binding [GO:0001225]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001225; GO:0001228; GO:0002164; GO:0003677; GO:0004879; GO:0005102; GO:0005496; GO:0005634; GO:0005700; GO:0005737; GO:0006357; GO:0006629; GO:0006911; GO:0006914; GO:0007155; GO:0007281; GO:0007291; GO:0007298; GO:0007390; GO:0007422; GO:0007443; GO:0007468; GO:0007476; GO:0007488; GO:0007552; GO:0007616; GO:0008230; GO:0008231; GO:0008232; GO:0008258; GO:0008270; GO:0008340; GO:0008362; GO:0008544; GO:0010002; GO:0010506; GO:0016319; GO:0016322; GO:0018990; GO:0030154; GO:0030425; GO:0035053; GO:0035071; GO:0035072; GO:0035073; GO:0035075; GO:0035076; GO:0035100; GO:0035180; GO:0035188; GO:0035193; GO:0035206; GO:0035297; GO:0040003; GO:0040034; GO:0042220; GO:0042632; GO:0042803; GO:0043065; GO:0043457; GO:0045892; GO:0045893; GO:0045938; GO:0045944; GO:0046982; GO:0048477; GO:0048738; GO:0048813; GO:0055088; GO:0070491; GO:1904799; GO:1904801	"autophagy [GO:0006914]; border follicle cell migration [GO:0007298]; cardiac muscle tissue development [GO:0048738]; cardioblast differentiation [GO:0010002]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; dorsal vessel heart proper cell fate commitment [GO:0035053]; ecdysis, chitin-based cuticle [GO:0018990]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; ecdysone receptor-mediated signaling pathway [GO:0035076]; epidermis development [GO:0008544]; germ-band shortening [GO:0007390]; germ cell development [GO:0007281]; hatching [GO:0035188]; head involution [GO:0008258]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived wing morphogenesis [GO:0007476]; larval central nervous system remodeling [GO:0035193]; larval development [GO:0002164]; larval wandering behavior [GO:0035180]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-term memory [GO:0007616]; Malpighian tubule morphogenesis [GO:0007443]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron remodeling [GO:0016322]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; phagocytosis, engulfment [GO:0006911]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457]; regulation of development, heterochronic [GO:0040034]; regulation of hemocyte proliferation [GO:0035206]; regulation of Malpighian tubule diameter [GO:0035297]; regulation of neuron remodeling [GO:1904799]; regulation of rhodopsin gene expression [GO:0007468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to ecdysone [GO:0035075]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39146_c0_g1_i1	P20105	E74EA_DROME	83.7	129	16	1	314	700	705	828	5.10E-57	222.6	E74EA_DROME	reviewed	Ecdysone-induced protein 74EF isoform A (ETS-related protein E74A)	Eip74EF E74 CG32180	Drosophila melanogaster (Fruit fly)	829	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0008219; GO:0030154; GO:0035071; GO:0040034; GO:0043565; GO:0045944; GO:0048477	"autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37159_c0_g1_i1	P13055	E75BB_DROME	100	82	0	0	248	3	445	526	9.10E-45	180.3	E75BB_DROME	reviewed	"Ecdysone-induced protein 75B, isoform B (E75-C) (Nuclear receptor subfamily 1 group D member 3, isoform B)"	Eip75B NR1D3 CG8127	Drosophila melanogaster (Fruit fly)	1412	"nucleus [GO:0005634]; DNA binding [GO:0003677]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0007275; GO:0007553; GO:0007591; GO:0008270; GO:0009755; GO:0010468; GO:0018990; GO:0020037; GO:0030154; GO:0035075; GO:0045944; GO:0048477; GO:0061060	"cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2401_c0_g1_i1	Q4V8C3	EMAL1_RAT	54	648	291	4	150	2084	170	813	2.70E-225	783.1	EMAL1_RAT	reviewed	Echinoderm microtubule-associated protein-like 1 (EMAP-1)	Eml1	Rattus norvegicus (Rat)	814	cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405]	cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]	microtubule binding [GO:0008017]; tubulin binding [GO:0015631]	GO:0000226; GO:0002244; GO:0005829; GO:0005874; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015631; GO:0048471	brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405]		NA	NA	NA	NA	NA	NA
TRINITY_DN33604_c0_g1_i1	Q7TNG5	EMAL2_MOUSE	100	116	0	0	2	349	72	187	3.60E-63	241.9	EMAL2_MOUSE	reviewed	Echinoderm microtubule-associated protein-like 2 (EMAP-2)	Eml2	Mus musculus (Mouse)	649	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]	microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]	GO:0000226; GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115	microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]		NA	NA	NA	NA	NA	NA
TRINITY_DN37878_c0_g1_i1	Q7TNG5	EMAL2_MOUSE	100	81	0	0	1	243	465	545	7.60E-44	177.2	EMAL2_MOUSE	reviewed	Echinoderm microtubule-associated protein-like 2 (EMAP-2)	Eml2	Mus musculus (Mouse)	649	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]	microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]	GO:0000226; GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115	microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]		NA	NA	NA	NA	NA	NA
TRINITY_DN28982_c0_g1_i1	O95834	EMAL2_HUMAN	100	95	0	0	286	2	23	117	3.00E-52	205.3	EMAL2_HUMAN	reviewed	Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2)	EML2 EMAP2 EMAPL2	Homo sapiens (Human)	649	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]	microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]	GO:0000226; GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0005875; GO:0007601; GO:0007605; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115	microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN26677_c0_g1_i1	Q9HC35	EMAL4_HUMAN	100	129	0	0	1	387	630	758	1.60E-75	283.1	EMAL4_HUMAN	reviewed	Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)	EML4 C2orf2 EMAPL4	Homo sapiens (Human)	981	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]	microtubule binding [GO:0008017]	GO:0000226; GO:0000278; GO:0005737; GO:0005874; GO:0007017; GO:0008017; GO:0016020	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN31853_c0_g1_i1	Q9HC35	EMAL4_HUMAN	98.9	93	1	0	3	281	264	356	1.60E-50	199.5	EMAL4_HUMAN	reviewed	Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)	EML4 C2orf2 EMAPL4	Homo sapiens (Human)	981	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]	microtubule binding [GO:0008017]	GO:0000226; GO:0000278; GO:0005737; GO:0005874; GO:0007017; GO:0008017; GO:0016020	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN37149_c0_g1_i1	Q9VUI3	EMAL_DROME	79.2	48	10	0	168	25	483	530	2.40E-17	89	EMAL_DROME	reviewed	Echinoderm microtubule-associated protein-like CG42247	DCX-EMAP CG42247	Drosophila melanogaster (Fruit fly)	1076	cytoplasm [GO:0005737]; microtubule [GO:0005874]; sensory dendrite [GO:0071683]; microtubule binding [GO:0008017]; adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; sensory dendrite [GO:0071683]	microtubule binding [GO:0008017]	GO:0000226; GO:0005737; GO:0005874; GO:0007605; GO:0008017; GO:0008344; GO:0035011; GO:0035556; GO:0071683	adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN11913_c0_g1_i2	Q9VYY9	EVI5_DROME	56.7	372	155	1	1098	1	207	578	2.60E-94	347.1	EVI5_DROME	reviewed	Ecotropic viral integration site 5 ortholog	Evi5 CG11727	Drosophila melanogaster (Fruit fly)	807	cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0017137; GO:0030334; GO:0031982; GO:0032880; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN11913_c0_g1_i4	Q9VYY9	EVI5_DROME	52	706	314	6	2554	464	68	757	4.60E-168	593.2	EVI5_DROME	reviewed	Ecotropic viral integration site 5 ortholog	Evi5 CG11727	Drosophila melanogaster (Fruit fly)	807	cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0017137; GO:0030334; GO:0031982; GO:0032880; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN24988_c0_g1_i1	O60447	EVI5_HUMAN	100	69	0	0	209	3	222	290	2.30E-33	142.1	EVI5_HUMAN	reviewed	Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein)	EVI5 NB4S	Homo sapiens (Human)	810	"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0042147; GO:0043547; GO:0051301; GO:0090630	"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8792_c0_g1_i13	Q8TC92	ENOX1_HUMAN	61.2	49	19	0	357	503	149	197	4.60E-10	66.2	ENOX1_HUMAN	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	ENOX1 PIG38	Homo sapiens (Human)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN8792_c0_g1_i15	Q8TC92	ENOX1_HUMAN	61.2	49	19	0	70	216	149	197	2.30E-10	66.2	ENOX1_HUMAN	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	ENOX1 PIG38	Homo sapiens (Human)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		brown	brown	NA	NA	NA	NA
TRINITY_DN8792_c0_g1_i8	Q8TC92	ENOX1_HUMAN	64.3	140	50	0	140	559	111	250	3.60E-49	196.1	ENOX1_HUMAN	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	ENOX1 PIG38	Homo sapiens (Human)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN3021_c0_g1_i1	Q8BHR2	ENOX1_MOUSE	32.5	464	205	7	1376	96	246	638	1.10E-54	215.7	ENOX1_MOUSE	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	Enox1	Mus musculus (Mouse)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN3021_c0_g1_i2	Q8BHR2	ENOX1_MOUSE	36.2	207	61	1	774	154	246	381	1.60E-31	137.9	ENOX1_MOUSE	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	Enox1	Mus musculus (Mouse)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN3021_c0_g1_i3	Q8BHR2	ENOX1_MOUSE	31.6	174	48	1	1269	748	246	348	3.40E-18	94.4	ENOX1_MOUSE	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	Enox1	Mus musculus (Mouse)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN3021_c0_g1_i3	Q8BHR2	ENOX1_MOUSE	34.1	214	112	5	650	96	425	638	7.50E-18	93.2	ENOX1_MOUSE	reviewed	Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	Enox1	Mus musculus (Mouse)	643	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]	GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491	ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN25513_c0_g1_i1	Q16206	ENOX2_HUMAN	100	80	0	0	240	1	172	251	6.10E-30	131	ENOX2_HUMAN	reviewed	Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	ENOX2 COVA1	Homo sapiens (Human)	610	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; protein disulfide oxidoreductase activity [GO:0015035]; oxidation-reduction process [GO:0055114]; regulation of growth [GO:0040008]; ultradian rhythm [GO:0007624]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	nucleic acid binding [GO:0003676]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0003676; GO:0005615; GO:0005829; GO:0005886; GO:0007624; GO:0009897; GO:0015035; GO:0040008; GO:0055114	oxidation-reduction process [GO:0055114]; regulation of growth [GO:0040008]; ultradian rhythm [GO:0007624]		NA	NA	NA	NA	NA	NA
TRINITY_DN4838_c0_g1_i2	O75355	ENTP3_HUMAN	38	121	73	2	352	711	27	146	4.00E-16	86.7	ENTP3_HUMAN	reviewed	Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6)	ENTPD3 CD39L3	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]	GO:0005524; GO:0005886; GO:0009134; GO:0009143; GO:0016021; GO:0017110; GO:0017111; GO:0034656; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491	nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g2_i1	E1BPW0	ENTP5_BOVIN	41.6	397	203	7	226	1383	49	427	2.30E-82	307.8	ENTP5_BOVIN	reviewed	Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)	ENTPD5	Bos taurus (Bovine)	432	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]; 'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]	guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]	GO:0004382; GO:0005576; GO:0005783; GO:0006487; GO:0014066; GO:0045134; GO:0045821; GO:0046034; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g2_i2	E1BPW0	ENTP5_BOVIN	41.6	397	203	7	350	1507	49	427	2.40E-82	307.8	ENTP5_BOVIN	reviewed	Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)	ENTPD5	Bos taurus (Bovine)	432	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]; 'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]	guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]	GO:0004382; GO:0005576; GO:0005783; GO:0006487; GO:0014066; GO:0045134; GO:0045821; GO:0046034; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g2_i3	E1BPW0	ENTP5_BOVIN	41.6	397	203	7	304	1461	49	427	2.40E-82	307.8	ENTP5_BOVIN	reviewed	Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)	ENTPD5	Bos taurus (Bovine)	432	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]; 'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]	guanosine-diphosphatase activity [GO:0004382]; uridine-diphosphatase activity [GO:0045134]	GO:0004382; GO:0005576; GO:0005783; GO:0006487; GO:0014066; GO:0045134; GO:0045821; GO:0046034; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; ATP metabolic process [GO:0046034]; positive regulation of glycolytic process [GO:0045821]; protein N-linked glycosylation [GO:0006487]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]		NA	NA	NA	NA	NA	NA
TRINITY_DN38896_c0_g1_i2	P22413	ENPP1_HUMAN	43.9	98	53	1	291	4	498	595	1.10E-17	90.9	ENPP1_HUMAN	reviewed	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]"	ENPP1 M6S1 NPPS PC1 PDNP1	Homo sapiens (Human)	925	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006771; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0016021; GO:0016323; GO:0030247; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031214; GO:0031953; GO:0032869; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0090305; GO:0106177; GO:1990787	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN11983_c0_g1_i1	P22413	ENPP1_HUMAN	36.9	670	384	16	168	2096	211	868	3.20E-107	391	ENPP1_HUMAN	reviewed	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]"	ENPP1 M6S1 NPPS PC1 PDNP1	Homo sapiens (Human)	925	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006771; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0016021; GO:0016323; GO:0030247; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031214; GO:0031953; GO:0032869; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0090305; GO:0106177; GO:1990787	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN11983_c0_g1_i2	P22413	ENPP1_HUMAN	49.3	140	65	2	168	569	211	350	2.20E-33	144.1	ENPP1_HUMAN	reviewed	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]"	ENPP1 M6S1 NPPS PC1 PDNP1	Homo sapiens (Human)	925	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006771; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0016021; GO:0016323; GO:0030247; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031214; GO:0031953; GO:0032869; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0090305; GO:0106177; GO:1990787	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN31232_c0_g1_i1	P22413	ENPP1_HUMAN	63	54	20	0	43	204	542	595	2.10E-14	79.3	ENPP1_HUMAN	reviewed	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]"	ENPP1 M6S1 NPPS PC1 PDNP1	Homo sapiens (Human)	925	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006771; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0016021; GO:0016323; GO:0030247; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031214; GO:0031953; GO:0032869; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0090305; GO:0106177; GO:1990787	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN28653_c0_g1_i1	P22413	ENPP1_HUMAN	46.9	81	43	0	7	249	533	613	4.00E-16	85.1	ENPP1_HUMAN	reviewed	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]"	ENPP1 M6S1 NPPS PC1 PDNP1	Homo sapiens (Human)	925	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006771; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0016021; GO:0016323; GO:0030247; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031214; GO:0031953; GO:0032869; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0090305; GO:0106177; GO:1990787	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; riboflavin metabolic process [GO:0006771]; sequestering of triglyceride [GO:0030730]		blue	blue	NA	NA	NA	NA
TRINITY_DN10717_c0_g2_i1	Q80TA9	EPG5_MOUSE	42	169	96	2	504	1	755	922	4.80E-29	129.4	EPG5_MOUSE	reviewed	Ectopic P granules protein 5 homolog	Epg5 Kiaa1632	Mus musculus (Mouse)	2572	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]		GO:0005737; GO:0005764; GO:0006862; GO:0006914; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]		NA	NA	NA	NA	NA	NA
TRINITY_DN19557_c0_g1_i3	A5WUT8	EPG5_DANRE	28.6	370	241	7	1054	2	1078	1443	4.10E-34	147.1	EPG5_DANRE	reviewed	Ectopic P granules protein 5 homolog	epg5 si:dkey-165i4.3	Danio rerio (Zebrafish) (Brachydanio rerio)	2532	cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; intestinal epithelial cell development [GO:0060576]; intestinal stem cell homeostasis [GO:0036335]	cytoplasm [GO:0005737]		GO:0005737; GO:0006914; GO:0036335; GO:0060576; GO:0061909; GO:0097352	autophagosome-lysosome fusion [GO:0061909]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; intestinal epithelial cell development [GO:0060576]; intestinal stem cell homeostasis [GO:0036335]		NA	NA	NA	NA	NA	NA
TRINITY_DN8956_c0_g1_i3	Q0IEK6	EPG5_AEDAE	25.1	247	161	3	751	14	1649	1872	2.90E-25	117.1	EPG5_AEDAE	reviewed	Ectopic P granules protein 5 homolog	AAEL009648	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2282	autophagy [GO:0006914]			GO:0006914	autophagy [GO:0006914]		NA	NA	NA	NA	NA	NA
TRINITY_DN8956_c0_g1_i5	Q0IEK6	EPG5_AEDAE	25.6	215	135	4	652	14	1681	1872	8.80E-18	92	EPG5_AEDAE	reviewed	Ectopic P granules protein 5 homolog	AAEL009648	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2282	autophagy [GO:0006914]			GO:0006914	autophagy [GO:0006914]		NA	NA	NA	NA	NA	NA
TRINITY_DN18371_c0_g1_i1	Q9VE34	EPG5_DROME	26	146	101	2	493	62	1666	1806	4.60E-08	59.3	EPG5_DROME	reviewed	Ectopic P granules protein 5 homolog	Epg5 CG14299	Drosophila melanogaster (Fruit fly)	2455	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]		GO:0005737; GO:0005764; GO:0006914; GO:0048471; GO:0097352	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]		NA	NA	NA	NA	NA	NA
TRINITY_DN13259_c0_g1_i3	Q9HCE0	EPG5_HUMAN	31.3	179	111	5	6	536	1600	1768	2.90E-15	83.6	EPG5_HUMAN	reviewed	Ectopic P granules protein 5 homolog	EPG5 KIAA1632	Homo sapiens (Human)	2579	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]		GO:0005737; GO:0005764; GO:0006862; GO:0006914; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]		NA	NA	NA	NA	NA	NA
TRINITY_DN11448_c0_g1_i1	A5PK19	EFNMT_BOVIN	46.6	444	231	5	1331	12	1	442	6.30E-106	386	EFNMT_BOVIN	reviewed	eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)]	EEF1AKNMT	Bos taurus (Bovine)	699	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN10719_c0_g1_i1	Q6NTR1	EFNMT_XENLA	46.6	116	61	1	393	49	543	658	1.90E-20	100.1	EFNMT_XENLA	reviewed	eEF1A lysine and N-terminal methyltransferase (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)]	eef1aknmt mettl13	Xenopus laevis (African clawed frog)	693	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN9887_c0_g1_i1	Q9D853	EFMT2_MOUSE	43.1	211	114	4	633	7	30	236	2.50E-45	183.7	EFMT2_MOUSE	reviewed	EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase Mettl10)	Eef1akmt2 Mettl10	Mus musculus (Mouse)	244	cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005634; GO:0005737; GO:0008168; GO:0016279; GO:0018022; GO:0018026; GO:0018027	peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]		blue	blue	NA	NA	NA	NA
TRINITY_DN9887_c0_g1_i2	Q5D013	EFMT2_DANRE	41.7	216	118	5	645	10	20	231	8.70E-44	178.7	EFMT2_DANRE	reviewed	EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase mettl10)	eef1akmt2 mettl10 zgc:110805	Danio rerio (Zebrafish) (Brachydanio rerio)	233	cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005634; GO:0005737; GO:0008168; GO:0016279; GO:0018022; GO:0018026; GO:0018027	peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]		NA	NA	NA	NA	NA	NA
TRINITY_DN9887_c0_g1_i3	Q9D853	EFMT2_MOUSE	43.9	180	95	4	626	93	30	205	6.40E-38	159.1	EFMT2_MOUSE	reviewed	EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase Mettl10)	Eef1akmt2 Mettl10	Mus musculus (Mouse)	244	cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005634; GO:0005737; GO:0008168; GO:0016279; GO:0018022; GO:0018026; GO:0018027	peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]		NA	NA	NA	NA	NA	NA
TRINITY_DN2108_c0_g1_i1	Q8VDY4	EFCB7_MOUSE	27	585	372	9	144	1742	41	622	4.00E-65	250.8	EFCB7_MOUSE	reviewed	EF-hand calcium-binding domain-containing protein 7	Efcab7 Kiaa1799	Mus musculus (Mouse)	628	ciliary membrane [GO:0060170]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]; calcium ion binding [GO:0005509]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]	ciliary membrane [GO:0060170]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]	calcium ion binding [GO:0005509]	GO:0005509; GO:0019898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:1903569	positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN2108_c0_g1_i2	Q8VDY4	EFCB7_MOUSE	27.5	590	373	9	144	1757	41	627	7.40E-67	256.5	EFCB7_MOUSE	reviewed	EF-hand calcium-binding domain-containing protein 7	Efcab7 Kiaa1799	Mus musculus (Mouse)	628	ciliary membrane [GO:0060170]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]; calcium ion binding [GO:0005509]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]	ciliary membrane [GO:0060170]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]	calcium ion binding [GO:0005509]	GO:0005509; GO:0019898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:1903569	positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN8226_c0_g1_i1	Q9VJ26	EFHD2_DROME	35.7	115	67	4	100	435	64	174	4.30E-08	59.7	EFHD2_DROME	reviewed	EF-hand domain-containing protein D2 homolog (Swiprosin-1 homolog)	Swip-1 CG10641	Drosophila melanogaster (Fruit fly)	217	muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]	muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0005927; GO:0007498	mesoderm development [GO:0007498]		blue	blue	NA	NA	NA	NA
TRINITY_DN5745_c0_g1_i1	Q17902	EGAL1_CAEEL	40.1	262	138	7	110	862	2	255	2.10E-41	171	EGAL1_CAEEL	reviewed	Egalitarian protein homolog	egal-1 C10G6.1	Caenorhabditis elegans	574	nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]	nuclear envelope [GO:0005635]	3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0005635; GO:0008408			NA	NA	NA	NA	NA	NA
TRINITY_DN23045_c0_g1_i1	B8UU78	ELP_ACRMI	36.2	80	46	2	5	244	757	831	2.60E-07	55.8	ELP_ACRMI	reviewed	EGF and laminin G domain-containing protein (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	1124	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4408_c0_g1_i1	Q9VQB7	EOGT_DROME	54.8	447	195	4	1475	138	62	502	5.10E-146	519.2	EOGT_DROME	reviewed	EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)	Eogt CG9867	Drosophila melanogaster (Fruit fly)	520	"endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transferase activity, transferring glycosyl groups [GO:0016757]; larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]"	endoplasmic reticulum lumen [GO:0005788]	"protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005788; GO:0006493; GO:0008363; GO:0016262; GO:0016757; GO:0097363; GO:0097370	larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN4408_c0_g1_i2	Q9VQB7	EOGT_DROME	52.6	483	219	5	1583	138	29	502	3.10E-147	523.5	EOGT_DROME	reviewed	EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)	Eogt CG9867	Drosophila melanogaster (Fruit fly)	520	"endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transferase activity, transferring glycosyl groups [GO:0016757]; larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]"	endoplasmic reticulum lumen [GO:0005788]	"protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005788; GO:0006493; GO:0008363; GO:0016262; GO:0016757; GO:0097363; GO:0097370	larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN11284_c2_g1_i1	Q8NDI1	EHBP1_HUMAN	58	193	79	2	93	668	1	192	1.10E-59	231.5	EHBP1_HUMAN	reviewed	EH domain-binding protein 1	EHBP1 KIAA0903 NACSIN	Homo sapiens (Human)	1231	cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941	actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN11284_c2_g1_i2	Q8N3D4	EH1L1_HUMAN	65.7	35	12	0	93	197	1	35	8.80E-07	53.9	EH1L1_HUMAN	reviewed	EH domain-binding protein 1-like protein 1	EHBP1L1	Homo sapiens (Human)	1523	endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; actin cytoskeleton organization [GO:0030036]	endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]		GO:0005768; GO:0005815; GO:0016020; GO:0030036; GO:0031941	actin cytoskeleton organization [GO:0030036]		NA	NA	NA	NA	NA	NA
TRINITY_DN29479_c0_g1_i1	Q5E9R3	EHD1_BOVIN	100	68	0	0	206	3	259	326	2.80E-31	135.2	EHD1_BOVIN	reviewed	EH domain-containing protein 1	EHD1	Bos taurus (Bovine)	534	ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]	ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0016197; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0043231; GO:0048471; GO:0055038; GO:0060271; GO:0061512; GO:0072659; GO:1901741; GO:1990090; GO:2001137	cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c0_g2_i4	Q9H4M9	EHD1_HUMAN	68.8	170	51	1	622	113	252	419	1.30E-60	234.2	EHD1_HUMAN	reviewed	EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin)	EHD1 PAST PAST1 CDABP0131	Homo sapiens (Human)	534	ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]	ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0007596; GO:0010008; GO:0010886; GO:0016020; GO:0016197; GO:0017137; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043231; GO:0045296; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:0070062; GO:0072659; GO:1901741; GO:1990090; GO:2001137	blood coagulation [GO:0007596]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]		blue	blue	NA	NA	NA	NA
TRINITY_DN27151_c0_g1_i1	Q9H4M9	EHD1_HUMAN	98.9	88	1	0	2	265	322	409	6.60E-41	167.5	EHD1_HUMAN	reviewed	EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin)	EHD1 PAST PAST1 CDABP0131	Homo sapiens (Human)	534	ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]	ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; Rab GTPase binding [GO:0017137]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0007596; GO:0010008; GO:0010886; GO:0016020; GO:0016197; GO:0017137; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043231; GO:0045296; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:0070062; GO:0072659; GO:1901741; GO:1990090; GO:2001137	blood coagulation [GO:0007596]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1364_c0_g1_i13	Q8BH64	EHD2_MOUSE	27.9	172	100	8	585	112	61	222	3.00E-07	57	EHD2_MOUSE	reviewed	EH domain-containing protein 2	Ehd2	Mus musculus (Mouse)	543	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0015630; GO:0016020; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0072659; GO:0097320; GO:1901741; GO:2001137	cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]		blue	blue	NA	NA	NA	NA
TRINITY_DN1364_c0_g1_i14	Q8BH64	EHD2_MOUSE	27.9	172	100	8	2366	1893	61	222	1.50E-06	56.6	EHD2_MOUSE	reviewed	EH domain-containing protein 2	Ehd2	Mus musculus (Mouse)	543	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0015630; GO:0016020; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0072659; GO:0097320; GO:1901741; GO:2001137	cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1364_c0_g1_i15	Q8BH64	EHD2_MOUSE	27.9	172	100	8	1257	784	61	222	8.00E-07	56.6	EHD2_MOUSE	reviewed	EH domain-containing protein 2	Ehd2	Mus musculus (Mouse)	543	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0015630; GO:0016020; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0072659; GO:0097320; GO:1901741; GO:2001137	cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]		blue	blue	NA	NA	NA	NA
TRINITY_DN1364_c0_g1_i4	Q8BH64	EHD2_MOUSE	27.9	172	100	8	2341	1868	61	222	1.50E-06	56.6	EHD2_MOUSE	reviewed	EH domain-containing protein 2	Ehd2	Mus musculus (Mouse)	543	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0015630; GO:0016020; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0072659; GO:0097320; GO:1901741; GO:2001137	cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c0_g2_i1	Q9NZN3	EHD3_HUMAN	67	194	60	2	677	96	247	436	1.80E-63	243.8	EHD3_HUMAN	reviewed	EH domain-containing protein 3 (PAST homolog 3)	EHD3 EHD2 PAST3	Homo sapiens (Human)	535	ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of Golgi organization [GO:1903358]	ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]	GO:0001881; GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005925; GO:0006897; GO:0007596; GO:0010008; GO:0015031; GO:0016197; GO:0020018; GO:0030139; GO:0032456; GO:0034498; GO:0043231; GO:0048471; GO:0051260; GO:0055038; GO:0055117; GO:0060271; GO:0072659; GO:0086036; GO:0090160; GO:1901387; GO:1903358; GO:1903779	blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of Golgi organization [GO:1903358]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c0_g2_i2	Q9NZN3	EHD3_HUMAN	66.8	289	92	2	969	103	247	531	8.60E-107	388.3	EHD3_HUMAN	reviewed	EH domain-containing protein 3 (PAST homolog 3)	EHD3 EHD2 PAST3	Homo sapiens (Human)	535	ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of Golgi organization [GO:1903358]	ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]	GO:0001881; GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005925; GO:0006897; GO:0007596; GO:0010008; GO:0015031; GO:0016197; GO:0020018; GO:0030139; GO:0032456; GO:0034498; GO:0043231; GO:0048471; GO:0051260; GO:0055038; GO:0055117; GO:0060271; GO:0072659; GO:0086036; GO:0090160; GO:1901387; GO:1903358; GO:1903779	blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of Golgi organization [GO:1903358]		blue	blue	NA	NA	NA	NA
TRINITY_DN25301_c0_g1_i1	Q9EQP2	EHD4_MOUSE	100	86	0	0	259	2	285	370	3.70E-41	168.3	EHD4_MOUSE	reviewed	EH domain-containing protein 4 (PAST homolog 2) (mPAST2)	Ehd4 Past2	Mus musculus (Mouse)	541	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to growth factor stimulus [GO:0071363]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; pinocytosis [GO:0006907]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of endocytosis [GO:0030100]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]	GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005783; GO:0005886; GO:0006897; GO:0006907; GO:0016197; GO:0030100; GO:0030139; GO:0031901; GO:0032456; GO:0043231; GO:0048471; GO:0050731; GO:0051260; GO:0055038; GO:0060271; GO:0071363; GO:0072659	cellular response to growth factor stimulus [GO:0071363]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; pinocytosis [GO:0006907]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN38834_c0_g1_i1	E9PVA8	GCN1_MOUSE	42.4	172	98	1	3	515	1132	1303	2.30E-29	130.2	GCN1_MOUSE	reviewed	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	Gcn1 Gcn1l1	Mus musculus (Mouse)	2671	cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	cytosol [GO:0005829]; polysome [GO:0005844]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]	GO:0005829; GO:0005844; GO:0006417; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN37123_c0_g1_i1	Q92616	GCN1_HUMAN	100	112	0	0	337	2	1816	1927	8.20E-57	220.7	GCN1_HUMAN	reviewed	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1)	GCN1 GCN1L1 KIAA0219	Homo sapiens (Human)	2671	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]	"cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]		NA	NA	NA	NA	NA	NA
TRINITY_DN10932_c0_g1_i1	Q92616	GCN1_HUMAN	76.5	506	118	1	2	1519	1608	2112	6.30E-221	768.1	GCN1_HUMAN	reviewed	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1)	GCN1 GCN1L1 KIAA0219	Homo sapiens (Human)	2671	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]	"cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]		NA	NA	NA	NA	NA	NA
TRINITY_DN40418_c0_g1_i1	Q92616	GCN1_HUMAN	96.5	114	4	0	8	349	1966	2079	1.50E-53	209.9	GCN1_HUMAN	reviewed	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1)	GCN1 GCN1L1 KIAA0219	Homo sapiens (Human)	2671	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]	"cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]		NA	NA	NA	NA	NA	NA
TRINITY_DN25899_c0_g1_i1	D4A7V9	E2AK4_RAT	38.7	155	91	2	2	460	1075	1227	2.20E-24	113.6	E2AK4_RAT	reviewed	eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein)	Eif2ak4 Gcn2	Rattus norvegicus (Rat)	1649	cytosolic ribosome [GO:0022626]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endoplasmic reticulum unfolded protein response [GO:0030968]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]	cytosolic ribosome [GO:0022626]; polysome [GO:0005844]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]	GO:0000049; GO:0000077; GO:0002230; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005844; GO:0006468; GO:0007050; GO:0007612; GO:0007616; GO:0009267; GO:0010628; GO:0010998; GO:0017148; GO:0019081; GO:0022626; GO:0030968; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0034976; GO:0036492; GO:0039520; GO:0043558; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0060259; GO:0060733; GO:0070417; GO:0071264; GO:1900273; GO:1990138; GO:1990253	cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endoplasmic reticulum unfolded protein response [GO:0030968]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]		NA	NA	NA	NA	NA	NA
TRINITY_DN25899_c0_g1_i2	Q9QZ05	E2AK4_MOUSE	31.7	243	160	3	2	724	1074	1312	7.30E-29	129	E2AK4_MOUSE	reviewed	eIF-2-alpha kinase GCN2 (Eukaryotic translation initiation factor 2-alpha kinase 4) (EC 2.7.11.1) (GCN2-like protein) (mGCN2)	Eif2ak4 Gcn2 Kiaa1338	Mus musculus (Mouse)	1648	cytosolic ribosome [GO:0022626]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic initiation factor eIF2 binding [GO:0071074]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]; adaptive immune response [GO:0002250]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endoplasmic reticulum unfolded protein response [GO:0030968]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]	cytosolic ribosome [GO:0022626]; polysome [GO:0005844]	ATP binding [GO:0005524]; eukaryotic initiation factor eIF2 binding [GO:0071074]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]	GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005844; GO:0006446; GO:0006468; GO:0007050; GO:0007612; GO:0007616; GO:0009267; GO:0010628; GO:0010998; GO:0017148; GO:0019081; GO:0022626; GO:0030968; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0034976; GO:0036492; GO:0039520; GO:0043558; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0060733; GO:0070417; GO:0071074; GO:0071264; GO:1900273; GO:1990138; GO:1990253	adaptive immune response [GO:0002250]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endoplasmic reticulum unfolded protein response [GO:0030968]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]		NA	NA	NA	NA	NA	NA
TRINITY_DN7401_c0_g1_i1	Q9HGN1	GCN2_SCHPO	47.2	89	44	2	386	129	535	623	1.60E-14	80.9	GCN2_SCHPO	reviewed	eIF-2-alpha kinase GCN2 (Serine/threonine-protein kinase gcn2) (EC 2.7.11.1) (Serine/threonine-protein kinase ppk28)	gcn2 ppk28 SPBC36B7.09 SPBP18G5.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1576	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]	GO:0000049; GO:0004672; GO:0004694; GO:0005524; GO:0005829; GO:0022626; GO:0031571; GO:0034198; GO:0070301; GO:0071849; GO:0072431; GO:0072755; GO:1904803; GO:1990451; GO:1990625	cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN7401_c0_g1_i2	Q9HGN1	GCN2_SCHPO	47.2	89	44	2	386	129	535	623	4.70E-14	79.3	GCN2_SCHPO	reviewed	eIF-2-alpha kinase GCN2 (Serine/threonine-protein kinase gcn2) (EC 2.7.11.1) (Serine/threonine-protein kinase ppk28)	gcn2 ppk28 SPBC36B7.09 SPBP18G5.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1576	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]	GO:0000049; GO:0004672; GO:0004694; GO:0005524; GO:0005829; GO:0022626; GO:0031571; GO:0034198; GO:0070301; GO:0071849; GO:0072431; GO:0072755; GO:1904803; GO:1990451; GO:1990625	cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]		NA	NA	NA	NA	NA	NA
TRINITY_DN28049_c0_g1_i1	Q8QZZ7	TPRKB_MOUSE	100	72	0	0	1	216	38	109	5.30E-33	141	TPRKB_MOUSE	reviewed	EKC/KEOPS complex subunit Tprkb (PRPK-binding protein) (TP53RK-binding protein)	Tprkb	Mus musculus (Mouse)	175	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]	GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0005829; GO:0019901	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN5359_c0_g1_i1	Q8QZZ7	TPRKB_MOUSE	39.4	160	96	1	577	98	17	175	2.80E-27	123.6	TPRKB_MOUSE	reviewed	EKC/KEOPS complex subunit Tprkb (PRPK-binding protein) (TP53RK-binding protein)	Tprkb	Mus musculus (Mouse)	175	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]	GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0005829; GO:0019901	tRNA threonylcarbamoyladenosine modification [GO:0002949]		brown	brown	NA	NA	NA	NA
TRINITY_DN18955_c0_g1_i1	Q15717	ELAV1_HUMAN	100	144	0	0	433	2	57	200	1.00E-75	283.9	ELAV1_HUMAN	reviewed	ELAV-like protein 1 (Hu-antigen R) (HuR)	ELAVL1 HUR	Homo sapiens (Human)	326	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; regulation of stem cell population maintenance [GO:2000036]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]	AU-rich element binding [GO:0017091]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006606; GO:0010494; GO:0016020; GO:0017091; GO:0019901; GO:0035198; GO:0035925; GO:0042803; GO:0043488; GO:0045727; GO:0048255; GO:0051260; GO:0060965; GO:0070935; GO:0098794; GO:0098978; GO:1990904; GO:2000036	"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; regulation of stem cell population maintenance [GO:2000036]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18955_c0_g1_i2	Q15717	ELAV1_HUMAN	100	77	0	0	232	2	124	200	6.60E-37	154.1	ELAV1_HUMAN	reviewed	ELAV-like protein 1 (Hu-antigen R) (HuR)	ELAVL1 HUR	Homo sapiens (Human)	326	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; regulation of stem cell population maintenance [GO:2000036]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]	AU-rich element binding [GO:0017091]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006606; GO:0010494; GO:0016020; GO:0017091; GO:0019901; GO:0035198; GO:0035925; GO:0042803; GO:0043488; GO:0045727; GO:0048255; GO:0051260; GO:0060965; GO:0070935; GO:0098794; GO:0098978; GO:1990904; GO:2000036	"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; regulation of stem cell population maintenance [GO:2000036]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4805_c0_g1_i1	Q4V7W8	ETKMT_XENLA	48.3	209	107	1	227	850	36	244	8.40E-51	202.2	ETKMT_XENLA	reviewed	Electron transfer flavoprotein beta subunit lysine methyltransferase (EC 2.1.1.-) (ETFB lysine methyltransferase) (ETFB-KMT) (Protein N-lysine methyltransferase METTL20)	etfbkmt mettl20	Xenopus laevis (African clawed frog)	246	mitochondrial matrix [GO:0005759]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine trimethylation [GO:0018023]	mitochondrial matrix [GO:0005759]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005759; GO:0016279; GO:0018023; GO:1904733; GO:1904736	negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN4805_c0_g1_i2	A3KP85	ETKMT_DANRE	48.6	70	35	1	182	388	28	97	1.70E-12	73.9	ETKMT_DANRE	reviewed	Electron transfer flavoprotein beta subunit lysine methyltransferase (EC 2.1.1.-) (ETFB lysine methyltransferase) (ETFB-KMT) (Protein N-lysine methyltransferase METTL20)	etfbkmt mettl20	Danio rerio (Zebrafish) (Brachydanio rerio)	258	mitochondrial matrix [GO:0005759]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine trimethylation [GO:0018023]	mitochondrial matrix [GO:0005759]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005759; GO:0016279; GO:0018023; GO:1904733; GO:1904736	negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN4805_c0_g1_i3	Q4V7W8	ETKMT_XENLA	48.3	209	107	1	227	850	36	244	1.10E-50	201.8	ETKMT_XENLA	reviewed	Electron transfer flavoprotein beta subunit lysine methyltransferase (EC 2.1.1.-) (ETFB lysine methyltransferase) (ETFB-KMT) (Protein N-lysine methyltransferase METTL20)	etfbkmt mettl20	Xenopus laevis (African clawed frog)	246	mitochondrial matrix [GO:0005759]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine trimethylation [GO:0018023]	mitochondrial matrix [GO:0005759]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005759; GO:0016279; GO:0018023; GO:1904733; GO:1904736	negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN15566_c0_g1_i1	P53573	ETFA_BRADU	77.1	105	24	0	342	28	205	309	1.20E-39	163.7	ETFA_BRADU	reviewed	Electron transfer flavoprotein subunit alpha (Alpha-ETF) (Electron transfer flavoprotein large subunit) (ETFLS)	etfA etfL blr1378	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	314	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]	GO:0009055; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN13958_c0_g1_i1	P53573	ETFA_BRADU	81.2	69	13	0	3	209	197	265	8.70E-25	113.6	ETFA_BRADU	reviewed	Electron transfer flavoprotein subunit alpha (Alpha-ETF) (Electron transfer flavoprotein large subunit) (ETFLS)	etfA etfL blr1378	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	314	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]	GO:0009055; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN13958_c0_g2_i1	Q9HZP7	ETFA_PSEAE	89.4	94	10	0	10	291	211	304	3.90E-39	161.8	ETFA_PSEAE	reviewed	Electron transfer flavoprotein subunit alpha (Alpha-ETF) (Electron transfer flavoprotein large subunit) (ETFLS)	etfA PA2951	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	309	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]	GO:0009055; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN13958_c1_g1_i1	P38974	ETFA_PARDE	87.9	66	8	0	203	6	243	308	1.50E-26	119.4	ETFA_PARDE	reviewed	Electron transfer flavoprotein subunit alpha (Alpha-ETF) (Electron transfer flavoprotein large subunit) (ETFLS)	etfA	Paracoccus denitrificans	308	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]		electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]	GO:0009055; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN2588_c0_g1_i1	P53573	ETFA_BRADU	79.4	107	22	0	333	13	203	309	5.70E-42	171.4	ETFA_BRADU	reviewed	Electron transfer flavoprotein subunit alpha (Alpha-ETF) (Electron transfer flavoprotein large subunit) (ETFLS)	etfA etfL blr1378	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	314	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]	GO:0009055; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN13838_c0_g1_i1	P13804	ETFA_HUMAN	100	235	0	0	716	12	99	333	5.50E-127	454.9	ETFA_HUMAN	reviewed	"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)"	ETFA	Homo sapiens (Human)	333	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005759; GO:0009055; GO:0016491; GO:0022904; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN29688_c0_g1_i1	Q99LC5	ETFA_MOUSE	100	71	0	0	213	1	14	84	4.50E-32	137.9	ETFA_MOUSE	reviewed	"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)"	Etfa	Mus musculus (Mouse)	333	mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005739; GO:0009055; GO:0016491; GO:0017133; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN9531_c0_g1_i1	P13804	ETFA_HUMAN	71.2	312	89	1	103	1038	18	328	8.80E-122	438.3	ETFA_HUMAN	reviewed	"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)"	ETFA	Homo sapiens (Human)	333	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005759; GO:0009055; GO:0016491; GO:0022904; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN9531_c0_g1_i2	P13804	ETFA_HUMAN	71.2	312	89	1	120	1055	18	328	1.50E-121	437.6	ETFA_HUMAN	reviewed	"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)"	ETFA	Homo sapiens (Human)	333	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005759; GO:0009055; GO:0016491; GO:0022904; GO:0033539; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]		blue	blue	NA	NA	NA	NA
TRINITY_DN2736_c0_g1_i1	P38117	ETFB_HUMAN	71	252	73	0	111	866	4	255	3.30E-95	349.7	ETFB_HUMAN	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF)	ETFB FP585	Homo sapiens (Human)	255	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]	GO:0005739; GO:0005759; GO:0009055; GO:0022904; GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]		blue	blue	NA	NA	NA	NA
TRINITY_DN2736_c0_g2_i1	P38117	ETFB_HUMAN	71	252	73	0	842	87	4	255	3.30E-95	349.7	ETFB_HUMAN	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF)	ETFB FP585	Homo sapiens (Human)	255	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]	GO:0005739; GO:0005759; GO:0009055; GO:0022904; GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]		blue	blue	NA	NA	NA	NA
TRINITY_DN14984_c0_g1_i1	Q9DCW4	ETFB_MOUSE	100	137	0	0	2	412	4	140	7.90E-70	264.2	ETFB_MOUSE	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF)	Etfb	Mus musculus (Mouse)	255	mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; nucleotide binding [GO:0000166]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005739; GO:0005759; GO:0009055; GO:0017133; GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN14984_c0_g2_i1	P38117	ETFB_HUMAN	100	225	0	0	59	733	1	225	1.30E-120	433.7	ETFB_HUMAN	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF)	ETFB FP585	Homo sapiens (Human)	255	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]	GO:0005739; GO:0005759; GO:0009055; GO:0022904; GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN30642_c0_g1_i1	Q2TBV3	ETFB_BOVIN	53.8	80	36	1	239	3	157	236	1.20E-17	90.1	ETFB_BOVIN	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF)	ETFB	Bos taurus (Bovine)	255	mitochondrial matrix [GO:0005759]; electron transfer activity [GO:0009055]; nucleotide binding [GO:0000166]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	mitochondrial matrix [GO:0005759]	electron transfer activity [GO:0009055]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005759; GO:0009055; GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN35191_c0_g1_i1	Q9HZP6	ETFB_PSEAE	58.7	75	27	1	228	4	35	105	6.30E-16	84.3	ETFB_PSEAE	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB PA2952	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	249	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN13805_c0_g1_i1	P53575	ETFB_BRADU	75	108	27	0	35	358	1	108	4.50E-37	155.2	ETFB_BRADU	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB etfS blr1377	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	249	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN13805_c0_g1_i2	P53575	ETFB_BRADU	74.1	108	28	0	3	326	1	108	6.00E-36	151.4	ETFB_BRADU	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB etfS blr1377	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	249	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN216_c0_g1_i1	P38975	ETFB_PARDE	68.6	86	27	0	3	260	135	220	2.00E-26	119.4	ETFB_PARDE	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB	Paracoccus denitrificans	252	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN216_c0_g1_i2	P53575	ETFB_BRADU	71	124	36	0	1	372	56	179	5.40E-41	168.3	ETFB_BRADU	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB etfS blr1377	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	249	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN216_c0_g1_i3	P53575	ETFB_BRADU	72	161	45	0	1	483	56	216	4.50E-56	218.8	ETFB_BRADU	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB etfS blr1377	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	249	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN216_c1_g1_i1	Q9HZP6	ETFB_PSEAE	71.8	142	40	0	1	426	75	216	4.20E-50	198.7	ETFB_PSEAE	reviewed	Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS)	etfB PA2952	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	249	electron transfer activity [GO:0009055]		electron transfer activity [GO:0009055]	GO:0009055			NA	NA	NA	NA	NA	NA
TRINITY_DN39005_c0_g1_i1	Q9HZP5	ETFD_PSEAE	69.7	89	26	1	25	291	2	89	1.00E-26	120.6	ETFD_PSEAE	reviewed	Electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	PA2953	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	551	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN24920_c0_g1_i1	Q9HZP5	ETFD_PSEAE	67.5	77	25	0	231	1	426	502	3.50E-25	115.2	ETFD_PSEAE	reviewed	Electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	PA2953	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	551	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN24920_c0_g1_i2	Q9HZP5	ETFD_PSEAE	75.6	78	19	0	234	1	425	502	1.10E-29	130.2	ETFD_PSEAE	reviewed	Electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	PA2953	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	551	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN31123_c0_g1_i1	Q9HZP5	ETFD_PSEAE	71.1	121	35	0	2	364	431	551	2.60E-49	196.1	ETFD_PSEAE	reviewed	Electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	PA2953	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	551	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN6423_c0_g1_i1	Q9HZP5	ETFD_PSEAE	60.9	69	27	0	21	227	30	98	3.20E-20	98.6	ETFD_PSEAE	reviewed	Electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	PA2953	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	551	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN12478_c0_g1_i1	Q2KIG0	ETFD_BOVIN	65.5	119	39	1	360	10	293	411	3.00E-41	169.1	ETFD_BOVIN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Bos taurus (Bovine)	617	"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"	integral component of mitochondrial inner membrane [GO:0031305]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	1
TRINITY_DN1119_c0_g1_i2	Q2KIG0	ETFD_BOVIN	71.7	583	163	2	136	1881	36	617	4.70E-261	901.7	ETFD_BOVIN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Bos taurus (Bovine)	617	"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"	integral component of mitochondrial inner membrane [GO:0031305]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN1119_c0_g1_i4	Q2KIG0	ETFD_BOVIN	72.5	189	52	0	75	641	429	617	2.90E-83	309.7	ETFD_BOVIN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Bos taurus (Bovine)	617	"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"	integral component of mitochondrial inner membrane [GO:0031305]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN37545_c0_g1_i1	Q16134	ETFD_HUMAN	100	78	0	0	264	31	540	617	4.80E-44	177.9	ETFD_HUMAN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Homo sapiens (Human)	617	"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]"	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0005759; GO:0006979; GO:0009055; GO:0016491; GO:0022900; GO:0022904; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0050660; GO:0051539	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN29506_c0_g1_i1	Q921G7	ETFD_MOUSE	98.2	109	2	0	327	1	113	221	3.80E-59	228.4	ETFD_MOUSE	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	Etfdh	Mus musculus (Mouse)	616	"integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]"	integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0022904; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0051536; GO:0051539	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN6423_c0_g2_i1	Q54XM6	ETFD_DICDI	62.3	138	52	0	3	416	261	398	2.00E-50	199.9	ETFD_DICDI	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	etfdh DDB_G0278849	Dictyostelium discoideum (Slime mold)	606	"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"	integral component of mitochondrial inner membrane [GO:0031305]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN14455_c0_g1_i1	Q2KIG0	ETFD_BOVIN	98	102	2	0	308	3	266	367	2.10E-59	229.2	ETFD_BOVIN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Bos taurus (Bovine)	617	"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"	integral component of mitochondrial inner membrane [GO:0031305]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN14455_c0_g1_i2	Q16134	ETFD_HUMAN	100	96	0	0	290	3	266	361	5.50E-57	221.1	ETFD_HUMAN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Homo sapiens (Human)	617	"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]"	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0005759; GO:0006979; GO:0009055; GO:0016491; GO:0022900; GO:0022904; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0050660; GO:0051539	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN28089_c0_g1_i1	Q16134	ETFD_HUMAN	99	105	1	0	3	317	428	532	5.20E-61	234.6	ETFD_HUMAN	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Homo sapiens (Human)	617	"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]"	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0005759; GO:0006979; GO:0009055; GO:0016491; GO:0022900; GO:0022904; GO:0031305; GO:0031966; GO:0033539; GO:0043783; GO:0046872; GO:0048038; GO:0048039; GO:0050660; GO:0051539	electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN17592_c0_g1_i1	P55931	ETFD_PIG	62	92	35	0	277	2	313	404	5.50E-30	131.3	ETFD_PIG	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	ETFDH	Sus scrofa (Pig)	617	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; response to oxidative stress [GO:0006979]"	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0022900; GO:0043783; GO:0046872; GO:0048039; GO:0050660; GO:0051536; GO:0051539	electron transport chain [GO:0022900]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN27528_c0_g1_i1	Q11190	ETFD_CAEEL	70.7	58	17	0	2	175	348	405	8.10E-18	90.5	ETFD_CAEEL	reviewed	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase) (Lethal protein 721)"	let-721 C05D11.12	Caenorhabditis elegans	597	"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity, oxidizing metal ions with flavin as acceptor [GO:0043783]; ubiquinone binding [GO:0048039]"	GO:0004174; GO:0005739; GO:0009055; GO:0022904; GO:0031305; GO:0043783; GO:0046872; GO:0048039; GO:0051539	respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN28393_c0_g1_i1	Q8IZ81	ELMD2_HUMAN	64.8	71	25	0	1	213	131	201	9.30E-22	103.6	ELMD2_HUMAN	reviewed	ELMO domain-containing protein 2	ELMOD2	Homo sapiens (Human)	293	membrane [GO:0016020]; GTPase activator activity [GO:0005096]; defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]	membrane [GO:0016020]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0016020; GO:0050688; GO:0051607	defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]		NA	NA	NA	NA	NA	NA
TRINITY_DN7992_c0_g1_i1	Q96FG2	ELMD3_HUMAN	42.4	243	140	0	68	796	104	346	4.70E-59	229.6	ELMD3_HUMAN	reviewed	ELMO domain-containing protein 3 (RNA-binding motif and ELMO domain-containing protein 1) (RNA-binding motif protein 29) (RNA-binding protein 29)	ELMOD3 RBED1 RBM29 PP4068	Homo sapiens (Human)	381	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]		GO:0005737; GO:0005856; GO:0005886; GO:0032420; GO:0043547; GO:0060091	positive regulation of GTPase activity [GO:0043547]		NA	NA	NA	NA	NA	NA
TRINITY_DN26181_c0_g1_i1	P51554	EF1A_HYDVU	73.8	84	22	0	253	2	110	193	1.20E-28	126.7	EF1A_HYDVU	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Hydra vulgaris (Hydra) (Hydra attenuata)	468	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c7_g1_i1	P14963	EF1A_EUGGR	80.2	101	20	0	3	305	2	102	1.50E-41	169.9	EF1A_EUGGR	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF	Euglena gracilis	445	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g3_i1	P25698	EF1A_SOYBN	78.8	85	18	0	2	256	257	341	1.40E-32	139.8	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g3_i2	P25698	EF1A_SOYBN	77.9	131	29	0	8	400	211	341	3.00E-53	209.1	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g3_i3	P02993	EF1A_ARTSA	70.6	163	48	0	3	491	157	319	1.60E-61	236.9	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g3_i4	P02993	EF1A_ARTSA	65.2	132	46	0	3	398	157	288	1.30E-45	183.7	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c3_g1_i1	P02993	EF1A_ARTSA	71.4	84	24	0	257	6	105	188	4.00E-27	121.7	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c5_g1_i1	O42820	EF1A_SCHCO	72.1	122	34	0	4	369	304	425	3.80E-47	188.7	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g2_i1	A5DPE3	EF1A_PICGU	75.7	103	25	0	3	311	356	458	1.20E-38	160.2	EF1A_PICGU	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1 PGUG_05144	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	458	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g2_i2	A5DPE3	EF1A_PICGU	75.7	103	25	0	3	311	356	458	9.70E-39	160.6	EF1A_PICGU	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1 PGUG_05144	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	458	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN24179_c0_g1_i1	P02993	EF1A_ARTSA	61.8	110	42	0	1	330	146	255	1.30E-30	133.7	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21432_c0_g1_i1	A5DPE3	EF1A_PICGU	75.7	70	17	0	210	1	389	458	9.20E-22	103.6	EF1A_PICGU	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1 PGUG_05144	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	458	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21432_c2_g1_i1	P0CN31	EF1A_CRYNB	65.6	61	21	0	201	19	399	459	1.40E-15	83.2	EF1A_CRYNB	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1 CNBM1160	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	459	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN24482_c0_g1_i1	O59949	EF1A_YARLI	54.1	61	28	0	21	203	1	61	2.30E-14	79	EF1A_YARLI	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF YALI0C09141g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN24482_c0_g2_i1	P90519	EF1A_CRYPV	56.2	73	23	2	25	243	72	135	1.80E-13	76.3	EF1A_CRYPV	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Cryptosporidium parvum	435	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN5951_c0_g1_i1	O59949	EF1A_YARLI	60.4	53	21	0	176	18	1	53	7.40E-13	73.9	EF1A_YARLI	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF YALI0C09141g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN5951_c0_g1_i2	O59949	EF1A_YARLI	60.4	53	21	0	176	18	1	53	8.40E-13	73.9	EF1A_YARLI	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF YALI0C09141g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g1_i1	O42820	EF1A_SCHCO	67	103	33	1	1	306	358	460	3.60E-33	142.1	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g1_i3	O42820	EF1A_SCHCO	69.1	136	41	1	1	405	325	460	3.60E-49	195.7	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g1_i4	O42820	EF1A_SCHCO	67	103	33	1	1	306	358	460	4.20E-34	145.2	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g1_i6	O42820	EF1A_SCHCO	68	103	32	1	1	306	358	460	3.20E-34	145.6	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i1	P25698	EF1A_SOYBN	79.7	138	28	0	31	444	215	352	7.30E-61	234.6	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i10	P25698	EF1A_SOYBN	80.4	138	27	0	31	444	215	352	7.30E-61	234.6	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i2	P02993	EF1A_ARTSA	71.2	208	60	0	2	625	157	364	7.30E-83	308.1	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i5	P25698	EF1A_SOYBN	79.7	138	28	0	31	444	215	352	2.10E-60	233	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i7	P02993	EF1A_ARTSA	68.9	135	42	0	2	406	157	291	2.20E-48	193	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i8	P25698	EF1A_SOYBN	81.2	138	26	0	5	418	215	352	1.40E-61	236.9	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i9	P25698	EF1A_SOYBN	85.9	85	12	0	5	259	215	299	1.60E-36	152.9	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c1_g1_i2	Q92005	EF1A_DANRE	86.2	94	13	0	283	2	24	117	1.40E-41	169.9	EF1A_DANRE	reviewed	Elongation factor 1-alpha (EF-1-alpha)	eef1a ef1a	Danio rerio (Zebrafish) (Brachydanio rerio)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c1_g1_i3	Q92005	EF1A_DANRE	90.3	72	7	0	218	3	24	95	3.10E-33	141.7	EF1A_DANRE	reviewed	Elongation factor 1-alpha (EF-1-alpha)	eef1a ef1a	Danio rerio (Zebrafish) (Brachydanio rerio)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN22878_c0_g1_i1	P14963	EF1A_EUGGR	82.8	64	11	0	41	232	1	64	1.70E-24	112.8	EF1A_EUGGR	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF	Euglena gracilis	445	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21980_c1_g1_i1	P29520	EF1A_BOMMO	69.3	88	26	1	1	261	373	460	3.70E-26	118.6	EF1A_BOMMO	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Bombyx mori (Silk moth)	463	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21980_c0_g1_i1	P29520	EF1A_BOMMO	70.4	169	49	1	543	40	294	462	1.60E-62	240.4	EF1A_BOMMO	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Bombyx mori (Silk moth)	463	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21980_c0_g1_i3	O42820	EF1A_SCHCO	72.2	169	46	1	543	40	292	460	6.00E-65	248.4	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN36670_c0_g1_i1	Q9HDF6	EF1A_SERIN	90.7	86	8	0	260	3	282	367	7.00E-40	164.1	EF1A_SERIN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1 TEF	Serendipita indica (Root endophyte fungus) (Piriformospora indica)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN27552_c0_g1_i1	P31018	EF1A_ENTHI	77	87	20	0	1	261	39	125	5.50E-32	137.9	EF1A_ENTHI	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Entamoeba histolytica	430	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17245_c0_g1_i1	P14865	EF1A3_MUCCL	65.3	170	59	0	25	534	4	173	7.20E-63	241.5	EF1A3_MUCCL	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF-3	Mucor circinelloides f. lusitanicus (Mucor racemosus var. lusitanicus)	457	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c3_g1_i1	P27592	EF1A_ONCVO	58.4	77	32	0	2	232	185	261	1.10E-20	100.1	EF1A_ONCVO	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Onchocerca volvulus	464	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g2_i1	O42820	EF1A_SCHCO	75.5	102	25	0	2	307	345	446	1.40E-42	173.3	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g2_i2	O42820	EF1A_SCHCO	74.5	102	26	0	2	307	345	446	4.60E-41	168.3	EF1A_SCHCO	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEF1	Schizophyllum commune (Split gill fungus)	460	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i1	P02993	EF1A_ARTSA	66	147	50	0	1	441	136	282	3.70E-49	195.7	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i2	P02993	EF1A_ARTSA	64.9	131	46	0	1	393	136	266	1.00E-42	174.1	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i3	P02993	EF1A_ARTSA	69.8	212	64	0	1	636	136	347	5.90E-80	298.5	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i4	P25698	EF1A_SOYBN	72	125	35	0	50	424	211	335	4.10E-45	182.2	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i5	P25698	EF1A_SOYBN	74.4	125	32	0	50	424	211	335	4.40E-47	188.7	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i7	P02993	EF1A_ARTSA	69.2	133	41	0	1	399	136	268	7.00E-47	188	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g1_i8	P02993	EF1A_ARTSA	68.4	133	42	0	1	399	136	268	2.70E-46	186	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN31120_c0_g1_i1	P02993	EF1A_ARTSA	69	71	22	0	3	215	200	270	2.10E-21	102.4	EF1A_ARTSA	reviewed	Elongation factor 1-alpha (EF-1-alpha)		Artemia salina (Brine shrimp)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21329_c0_g1_i1	P25166	EF1A_STYLE	76.1	67	16	0	2	202	282	348	1.40E-24	112.8	EF1A_STYLE	reviewed	Elongation factor 1-alpha (EF-1-alpha)	EFAA	Stylonychia lemnae (Ciliate)	446	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23467_c0_g1_i1	P25698	EF1A_SOYBN	75.3	77	19	0	1	231	260	336	6.10E-27	120.9	EF1A_SOYBN	reviewed	Elongation factor 1-alpha (EF-1-alpha)	TEFS1	Glycine max (Soybean) (Glycine hispida)	447	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN2036_c0_g1_i1	Q08046	EF1A_GIAIN	52.4	166	67	3	6	500	40	194	2.10E-41	170.2	EF1A_GIAIN	reviewed	Elongation factor 1-alpha (EF-1-alpha) (14 nm filament-associated protein) (Fragment)	TEF1	Giardia intestinalis (Giardia lamblia)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			red	red	NA	NA	NA	NA
TRINITY_DN32293_c0_g1_i1	Q08046	EF1A_GIAIN	48.3	87	42	1	23	283	111	194	1.70E-19	96.7	EF1A_GIAIN	reviewed	Elongation factor 1-alpha (EF-1-alpha) (14 nm filament-associated protein) (Fragment)	TEF1	Giardia intestinalis (Giardia lamblia)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN28216_c0_g1_i1	O27132	EF1A_METTH	40.9	115	61	2	346	2	239	346	1.10E-16	87.4	EF1A_METTH	reviewed	Elongation factor 1-alpha (EF-1-alpha) (Elongation factor Tu) (EF-Tu)	tuf MTH_1058	Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) (Methanobacterium thermoautotrophicum)	413	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			red	red	NA	NA	NA	NA
TRINITY_DN40391_c0_g1_i1	Q8SS29	EF1A_ENCCU	56.1	82	35	1	244	2	58	139	2.00E-20	99.4	EF1A_ENCCU	reviewed	Elongation factor 1-alpha (EF-1-alpha) (Eukaryotic elongation factor 1A) (eEF1A) (Translation elongation factor 1A)	TEF1 ECU04_1100	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	471	cytoplasm [GO:0005737]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003779; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c13_g1_i1	P27634	EF1A_RHYAM	85.3	68	10	0	4	207	46	113	5.10E-25	114.4	EF1A_RHYAM	reviewed	Elongation factor 1-alpha (EF-1-alpha) (Fragment)		Rhynchosciara americana (Fungus gnat)	412	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g1_i2	P0CY35	EF1A1_CANAL	69.7	119	36	0	2	358	340	458	1.40E-41	170.2	EF1A1_CANAL	reviewed	Elongation factor 1-alpha 1 (EF-1-alpha 1)	TEF1 CAALFM_C208370CA CaO19.12585 CaO19.5119	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	458	cell surface [GO:0009986]; cytoplasm [GO:0005737]; fungal-type cell wall [GO:0009277]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; interaction with host [GO:0051701]; translation [GO:0006412]; translational elongation [GO:0006414]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; fungal-type cell wall [GO:0009277]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414; GO:0009277; GO:0009986; GO:0030445; GO:0030446; GO:0051701	interaction with host [GO:0051701]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN24425_c0_g1_i1	P08736	EF1A1_DROME	91.2	68	6	0	205	2	14	81	4.70E-31	134.4	EF1A1_DROME	reviewed	Elongation factor 1-alpha 1 (EF-1-alpha-1) (50 kDa female-specific protein)	eEF1alpha1 Ef1alpha48D EF1B F1 CG8280	Drosophila melanogaster (Fruit fly)	463	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN319_c0_g1_i1	P68103	EF1A1_BOVIN	100	462	0	0	1427	42	1	462	8.60E-271	933.7	EF1A1_BOVIN	reviewed	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1)	EEF1A1 EEF1A EF1A	Bos taurus (Bovine)	462	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006412; GO:0006414; GO:0071364; GO:1900022	cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN319_c0_g1_i2	P62629	EF1A1_CRIGR	100	462	0	0	1427	42	1	462	1.50E-270	932.9	EF1A1_CRIGR	reviewed	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1)	EEF1A1 EEF1A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	462	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0071364; GO:1900022	cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]		NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g1_i1	P05303	EF1A2_DROME	89.2	157	17	0	78	548	1	157	2.80E-78	292.7	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c0_g1_i2	P05303	EF1A2_DROME	87.6	129	16	0	3	389	29	157	1.40E-60	233.4	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17050_c1_g1_i1	P05303	EF1A2_DROME	76.4	178	42	0	538	5	1	178	1.20E-73	277.3	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN26895_c0_g1_i1	P05303	EF1A2_DROME	82.4	68	12	0	204	1	55	122	3.50E-26	118.2	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN24179_c1_g1_i1	P05303	EF1A2_DROME	79.7	69	14	0	44	250	107	175	8.90E-24	110.5	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		brown	brown	NA	NA	NA	NA
TRINITY_DN15341_c1_g1_i1	P05303	EF1A2_DROME	86.5	148	20	0	446	3	1	148	1.00E-71	270.8	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c1_g1_i4	P05303	EF1A2_DROME	83.8	117	19	0	352	2	1	117	5.70E-52	204.9	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN32702_c12_g1_i1	P05303	EF1A2_DROME	79.2	462	95	1	1470	88	1	462	1.80E-215	750	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN21580_c0_g1_i1	P05303	EF1A2_DROME	86.2	87	12	0	269	9	5	91	4.00E-38	158.3	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15712_c0_g3_i1	P05303	EF1A2_DROME	90.7	86	8	0	3	260	65	150	1.00E-38	160.2	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN319_c0_g2_i1	P05303	EF1A2_DROME	81.3	75	14	0	227	3	59	133	1.00E-26	120.2	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN319_c1_g1_i1	P05303	EF1A2_DROME	84	125	20	0	377	3	5	129	1.50E-54	213.4	EF1A2_DROME	reviewed	Elongation factor 1-alpha 2 (EF-1-alpha-2)	eEF1alpha2 EF1a Ef1alpha100E F2 CG1873	Drosophila melanogaster (Fruit fly)	462	eukaryotic translation elongation factor 1 complex [GO:0005853]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]	eukaryotic translation elongation factor 1 complex [GO:0005853]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005853; GO:0006412; GO:0006414	translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN31337_c0_g1_i1	P50257	EF1AS_PORPU	60.6	66	26	0	199	2	88	153	2.00E-17	89.4	EF1AS_PORPU	reviewed	Elongation factor 1-alpha S (EF-1-alpha S) (Sporophyte-specific EF-1-alpha)	TEF-S	Porphyra purpurea (Red seaweed) (Ulva purpurea)	515	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN30676_c0_g1_i1	P17507	EF1A2_XENLA	79.3	87	18	0	4	264	1	87	5.30E-35	147.9	EF1A2_XENLA	reviewed	"Elongation factor 1-alpha, oocyte form (EF-1-alpha-O) (EF-1AO) (42S p48)"	eef1ao	Xenopus laevis (African clawed frog)	461	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN30546_c1_g1_i1	P17507	EF1A2_XENLA	61.5	91	35	0	274	2	196	286	3.10E-25	115.5	EF1A2_XENLA	reviewed	"Elongation factor 1-alpha, oocyte form (EF-1-alpha-O) (EF-1AO) (42S p48)"	eef1ao	Xenopus laevis (African clawed frog)	461	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c3_g1_i1	P13549	EF1A0_XENLA	75.9	116	28	0	3	350	260	375	6.40E-44	177.9	EF1A0_XENLA	reviewed	"Elongation factor 1-alpha, somatic form (EF-1-alpha-S)"	eef1as	Xenopus laevis (African clawed frog)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g2_i6	P13549	EF1A0_XENLA	76.9	147	34	0	4	444	218	364	1.40E-59	230.3	EF1A0_XENLA	reviewed	"Elongation factor 1-alpha, somatic form (EF-1-alpha-S)"	eef1as	Xenopus laevis (African clawed frog)	462	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN21432_c1_g1_i1	P0CT53	EF1A1_SCHPO	79.3	82	17	0	2	247	355	436	6.70E-32	137.5	EF1A1_SCHPO	reviewed	Elongation factor 1-alpha-A (EF-1-alpha-A)	tef101 ef1a-a tef1a tef1e SPCC794.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	460	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0002182; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005829; GO:0005853; GO:0006412; GO:0006414	cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c0_g1_i7	P0CT53	EF1A1_SCHPO	74.2	89	23	0	2	268	340	428	5.00E-33	141.4	EF1A1_SCHPO	reviewed	Elongation factor 1-alpha-A (EF-1-alpha-A)	tef101 ef1a-a tef1a tef1e SPCC794.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	460	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0002182; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005829; GO:0005853; GO:0006412; GO:0006414	cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c10_g1_i1	P0CT53	EF1A1_SCHPO	75.9	87	21	0	262	2	351	437	1.40E-32	139.8	EF1A1_SCHPO	reviewed	Elongation factor 1-alpha-A (EF-1-alpha-A)	tef101 ef1a-a tef1a tef1e SPCC794.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	460	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0002182; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005829; GO:0005853; GO:0006412; GO:0006414	cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN15341_c2_g1_i1	P0CT53	EF1A1_SCHPO	75.9	83	20	0	252	4	342	424	1.10E-32	140.2	EF1A1_SCHPO	reviewed	Elongation factor 1-alpha-A (EF-1-alpha-A)	tef101 ef1a-a tef1a tef1e SPCC794.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	460	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0002182; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005829; GO:0005853; GO:0006412; GO:0006414	cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17245_c0_g2_i1	P0CT53	EF1A1_SCHPO	53.3	150	58	1	415	2	199	348	4.90E-43	175.3	EF1A1_SCHPO	reviewed	Elongation factor 1-alpha-A (EF-1-alpha-A)	tef101 ef1a-a tef1a tef1e SPCC794.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	460	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0002182; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005829; GO:0005853; GO:0006412; GO:0006414	cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN319_c2_g1_i1	P0CT53	EF1A1_SCHPO	81	79	15	0	238	2	6	84	5.00E-32	137.9	EF1A1_SCHPO	reviewed	Elongation factor 1-alpha-A (EF-1-alpha-A)	tef101 ef1a-a tef1a tef1e SPCC794.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	460	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0002182; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005829; GO:0005853; GO:0006412; GO:0006414	cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN38546_c0_g1_i1	P29522	EF1B2_BOMMO	71.6	109	31	0	65	391	114	222	5.20E-38	158.7	EF1B2_BOMMO	reviewed	Elongation factor 1-beta'		Bombyx mori (Silk moth)	222	eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]	eukaryotic translation elongation factor 1 complex [GO:0005853]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005853			blue	blue	NA	NA	NA	NA
TRINITY_DN22299_c0_g1_i1	P29522	EF1B2_BOMMO	62.9	89	33	0	267	1	115	203	2.70E-26	119	EF1B2_BOMMO	reviewed	Elongation factor 1-beta'		Bombyx mori (Silk moth)	222	eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]	eukaryotic translation elongation factor 1 complex [GO:0005853]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005853			NA	NA	NA	NA	NA	NA
TRINITY_DN19995_c0_g1_i1	P12262	EF1B_ARTSA	72.1	68	19	0	2	205	140	207	4.30E-22	104.8	EF1B_ARTSA	reviewed	Elongation factor 1-beta (EF-1-beta)		Artemia salina (Brine shrimp)	207	eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]	eukaryotic translation elongation factor 1 complex [GO:0005853]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005853			NA	NA	NA	NA	NA	NA
TRINITY_DN31059_c0_g1_i1	Q5E983	EF1B_BOVIN	100	63	0	0	41	229	117	179	2.70E-28	125.6	EF1B_BOVIN	reviewed	Elongation factor 1-beta (EF-1-beta)	EEF1B	Bos taurus (Bovine)	225	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN37498_c0_g1_i1	P32192	EF1D_ARTSA	72.5	40	11	0	199	80	149	188	9.10E-11	67	EF1D_ARTSA	reviewed	Elongation factor 1-delta (EF-1-delta)		Artemia salina (Brine shrimp)	237	eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]	eukaryotic translation elongation factor 1 complex [GO:0005853]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005853			NA	NA	NA	NA	NA	NA
TRINITY_DN2453_c0_g1_i3	Q4R3D4	EF1D_MACFA	48.1	291	118	6	110	931	6	280	1.20E-47	191.8	EF1D_MACFA	reviewed	Elongation factor 1-delta (EF-1-delta)	EEF1D QthA-21064 QtsA-17735	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	281	eukaryotic translation elongation factor 1 complex [GO:0005853]; nucleus [GO:0005634]; DNA binding [GO:0003677]; translation elongation factor activity [GO:0003746]	eukaryotic translation elongation factor 1 complex [GO:0005853]; nucleus [GO:0005634]	DNA binding [GO:0003677]; translation elongation factor activity [GO:0003746]	GO:0003677; GO:0003746; GO:0005634; GO:0005853			NA	NA	NA	NA	NA	NA
TRINITY_DN12234_c0_g1_i1	P29692	EF1D_HUMAN	100	75	0	0	226	2	171	245	4.20E-35	148.3	EF1D_HUMAN	reviewed	Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4)	EEF1D EF1D	Homo sapiens (Human)	281	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; heat shock protein binding [GO:0031072]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; cellular response to ionizing radiation [GO:0071479]; mRNA transcription [GO:0009299]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of cell death [GO:0010941]; translational elongation [GO:0006414]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; heat shock protein binding [GO:0031072]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]"	GO:0001650; GO:0003677; GO:0003746; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005853; GO:0006414; GO:0008135; GO:0009299; GO:0010941; GO:0031072; GO:0033613; GO:0043123; GO:0045296; GO:0071479	cellular response to ionizing radiation [GO:0071479]; mRNA transcription [GO:0009299]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of cell death [GO:0010941]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN19995_c1_g1_i1	P29693	EF1D_XENLA	61.6	86	33	0	259	2	153	238	1.50E-21	103.2	EF1D_XENLA	reviewed	Elongation factor 1-delta (EF-1-delta) (P36)	eef1d	Xenopus laevis (African clawed frog)	265	eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]	eukaryotic translation elongation factor 1 complex [GO:0005853]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005853			NA	NA	NA	NA	NA	NA
TRINITY_DN12469_c0_g1_i1	P26641	EF1G_HUMAN	100	122	0	0	404	39	112	233	5.20E-66	251.5	EF1G_HUMAN	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)	EEF1G EF1G PRO1608	Homo sapiens (Human)	437	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746]; response to virus [GO:0009615]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005634; GO:0005737; GO:0005829; GO:0006414; GO:0009615; GO:0016020; GO:0045296; GO:0070062	response to virus [GO:0009615]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN19789_c0_g1_i1	Q3SZV3	EF1G_BOVIN	100	86	0	0	260	3	1	86	5.80E-46	184.5	EF1G_BOVIN	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)	EEF1G	Bos taurus (Bovine)	440	translation elongation factor activity [GO:0003746]		translation elongation factor activity [GO:0003746]	GO:0003746			NA	NA	NA	NA	NA	NA
TRINITY_DN19789_c0_g1_i2	Q3SZV3	EF1G_BOVIN	100	85	0	0	257	3	1	85	2.80E-45	182.2	EF1G_BOVIN	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)	EEF1G	Bos taurus (Bovine)	440	translation elongation factor activity [GO:0003746]		translation elongation factor activity [GO:0003746]	GO:0003746			NA	NA	NA	NA	NA	NA
TRINITY_DN35109_c0_g1_i1	Q3SZV3	EF1G_BOVIN	97.6	125	3	0	1	375	112	236	1.10E-66	253.8	EF1G_BOVIN	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)	EEF1G	Bos taurus (Bovine)	440	translation elongation factor activity [GO:0003746]		translation elongation factor activity [GO:0003746]	GO:0003746			NA	NA	NA	NA	NA	NA
TRINITY_DN16508_c0_g1_i1	P12261	EF1G_ARTSA	70.7	82	24	0	300	55	4	85	1.90E-27	123.2	EF1G_ARTSA	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)		Artemia salina (Brine shrimp)	430	translation elongation factor activity [GO:0003746]		translation elongation factor activity [GO:0003746]	GO:0003746			NA	NA	NA	NA	NA	NA
TRINITY_DN20376_c0_g1_i1	P12261	EF1G_ARTSA	68.9	222	69	0	49	714	4	225	4.60E-89	328.9	EF1G_ARTSA	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)		Artemia salina (Brine shrimp)	430	translation elongation factor activity [GO:0003746]		translation elongation factor activity [GO:0003746]	GO:0003746			blue	blue	NA	NA	NA	NA
TRINITY_DN20376_c0_g1_i2	P12261	EF1G_ARTSA	69.4	222	68	0	49	714	4	225	8.10E-90	331.6	EF1G_ARTSA	reviewed	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)		Artemia salina (Brine shrimp)	430	translation elongation factor activity [GO:0003746]		translation elongation factor activity [GO:0003746]	GO:0003746			blue	blue	NA	NA	NA	NA
TRINITY_DN52_c0_g1_i1	Q23716	EF2_CRYPV	70.9	382	111	0	3	1148	335	716	1.40E-161	570.5	EF2_CRYPV	reviewed	Elongation factor 2 (EF-2)		Cryptosporidium parvum	832	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN52_c0_g1_i2	Q23716	EF2_CRYPV	70.8	384	112	0	3	1154	335	718	5.90E-163	575.1	EF2_CRYPV	reviewed	Elongation factor 2 (EF-2)		Cryptosporidium parvum	832	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN19008_c1_g1_i1	P29691	EF2_CAEEL	59.3	86	35	0	259	2	601	686	1.10E-21	103.6	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN26138_c0_g1_i1	Q23716	EF2_CRYPV	62	71	27	0	213	1	551	621	2.80E-18	92	EF2_CRYPV	reviewed	Elongation factor 2 (EF-2)		Cryptosporidium parvum	832	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN16394_c0_g1_i1	A0SXL6	EF2_CALJA	100	193	0	0	580	2	1	193	1.60E-101	370.2	EF2_CALJA	reviewed	Elongation factor 2 (EF-2)	EEF2	Callithrix jacchus (White-tufted-ear marmoset)	858	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN16394_c0_g1_i2	Q3SYU2	EF2_BOVIN	100	199	0	0	598	2	1	199	1.90E-105	383.3	EF2_BOVIN	reviewed	Elongation factor 2 (EF-2)	EEF2	Bos taurus (Bovine)	858	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN39727_c0_g1_i1	Q23716	EF2_CRYPV	57.3	75	32	0	5	229	267	341	4.30E-17	88.2	EF2_CRYPV	reviewed	Elongation factor 2 (EF-2)		Cryptosporidium parvum	832	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN25753_c0_g1_i1	Q3SYU2	EF2_BOVIN	100	71	0	0	2	214	10	80	4.00E-33	141.4	EF2_BOVIN	reviewed	Elongation factor 2 (EF-2)	EEF2	Bos taurus (Bovine)	858	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN2555_c0_g1_i1	Q23716	EF2_CRYPV	71.5	186	53	0	14	571	1	186	5.30E-72	271.9	EF2_CRYPV	reviewed	Elongation factor 2 (EF-2)		Cryptosporidium parvum	832	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN2555_c0_g1_i2	Q23716	EF2_CRYPV	71.5	186	53	0	11	568	1	186	2.40E-72	273.1	EF2_CRYPV	reviewed	Elongation factor 2 (EF-2)		Cryptosporidium parvum	832	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6590_c0_g1_i1	P58252	EF2_MOUSE	100	598	0	0	1835	42	261	858	0	1232.6	EF2_MOUSE	reviewed	Elongation factor 2 (EF-2)	Eef2	Mus musculus (Mouse)	858	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; 5S rRNA binding [GO:0008097]; actin filament binding [GO:0051015]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; aging [GO:0007568]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; glial cell proliferation [GO:0014009]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of translation [GO:0045727]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to hydrogen peroxide [GO:0042542]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle contraction [GO:0003009]; translational elongation [GO:0006414]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]	5S rRNA binding [GO:0008097]; actin filament binding [GO:0051015]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0002039; GO:0002244; GO:0002931; GO:0003009; GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006414; GO:0007568; GO:0008097; GO:0014009; GO:0016235; GO:0019901; GO:0032355; GO:0034976; GO:0035914; GO:0042493; GO:0042542; GO:0042788; GO:0043022; GO:0045121; GO:0045471; GO:0045727; GO:0051015; GO:0051593; GO:1990416; GO:1990904; GO:2000767	aging [GO:0007568]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; glial cell proliferation [GO:0014009]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of translation [GO:0045727]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to hydrogen peroxide [GO:0042542]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle contraction [GO:0003009]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN6590_c0_g2_i1	P13639	EF2_HUMAN	99.7	598	2	0	1848	55	261	858	0	1228	EF2_HUMAN	reviewed	Elongation factor 2 (EF-2)	EEF2 EF2	Homo sapiens (Human)	858	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; 5S rRNA binding [GO:0008097]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; aging [GO:0007568]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; glial cell proliferation [GO:0014009]; hematopoietic progenitor cell differentiation [GO:0002244]; neutrophil degranulation [GO:0043312]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of translation [GO:0045727]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to hydrogen peroxide [GO:0042542]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle contraction [GO:0003009]; translational elongation [GO:0006414]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]	5S rRNA binding [GO:0008097]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0002039; GO:0002244; GO:0002931; GO:0003009; GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006414; GO:0007568; GO:0008097; GO:0014009; GO:0016020; GO:0016235; GO:0019901; GO:0032355; GO:0034774; GO:0034976; GO:0035914; GO:0042493; GO:0042542; GO:0042788; GO:0043022; GO:0043312; GO:0045121; GO:0045296; GO:0045471; GO:0045727; GO:0051015; GO:0051593; GO:0070062; GO:1904813; GO:1990416; GO:1990904; GO:2000767	aging [GO:0007568]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; glial cell proliferation [GO:0014009]; hematopoietic progenitor cell differentiation [GO:0002244]; neutrophil degranulation [GO:0043312]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of translation [GO:0045727]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to hydrogen peroxide [GO:0042542]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle contraction [GO:0003009]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c0_g1_i3	P29691	EF2_CAEEL	77.6	156	35	0	2	469	620	775	1.20E-66	253.8	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c1_g1_i1	P29691	EF2_CAEEL	77.1	140	32	0	421	2	623	762	2.20E-59	229.6	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c1_g1_i2	Q90705	EF2_CHICK	80.2	86	17	0	259	2	683	768	2.50E-37	155.6	EF2_CHICK	reviewed	Elongation factor 2 (EF-2)	EEF2	Gallus gallus (Chicken)	858	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c1_g2_i2	P29691	EF2_CAEEL	80.8	104	20	0	315	4	509	612	3.10E-42	172.2	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c3_g1_i1	P29691	EF2_CAEEL	79.3	121	25	0	3	365	655	775	9.00E-49	194.1	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN20816_c2_g1_i1	Q90705	EF2_CHICK	79.8	89	18	0	271	5	652	740	1.20E-38	160.2	EF2_CHICK	reviewed	Elongation factor 2 (EF-2)	EEF2	Gallus gallus (Chicken)	858	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN22105_c1_g1_i1	Q3SYU2	EF2_BOVIN	83.8	80	13	0	2	241	528	607	4.50E-33	141.4	EF2_BOVIN	reviewed	Elongation factor 2 (EF-2)	EEF2	Bos taurus (Bovine)	858	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN22105_c0_g1_i1	P29691	EF2_CAEEL	84	81	13	0	3	245	681	761	1.00E-32	140.2	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17889_c0_g2_i1	P29691	EF2_CAEEL	71.1	114	33	0	346	5	609	722	2.70E-42	172.6	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN24309_c0_g1_i1	P29691	EF2_CAEEL	67.5	123	40	0	11	379	600	722	1.10E-41	170.6	EF2_CAEEL	reviewed	Elongation factor 2 (EF-2)	eef-2 F25H5.4	Caenorhabditis elegans	852	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904	defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN19116_c0_g1_i1	Q3SYU2	EF2_BOVIN	72	118	33	0	4	357	319	436	2.60E-45	182.6	EF2_BOVIN	reviewed	Elongation factor 2 (EF-2)	EEF2	Bos taurus (Bovine)	858	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN29897_c0_g1_i1	Q8SQT7	EF2_ENCCU	68.8	125	39	0	2	376	64	188	3.90E-42	172.2	EF2_ENCCU	reviewed	Elongation factor 2 (EF-2) (Eukaryotic elongation factor 2) (eEF2) (Ribosomal translocase) (Translation elongation factor 2)	EFT1 ECU11_1460	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	850	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; rRNA binding [GO:0019843]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; rRNA binding [GO:0019843]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0019843			NA	NA	NA	NA	NA	NA
TRINITY_DN14954_c0_g1_i1	Q8SQT7	EF2_ENCCU	52.5	120	57	0	33	392	627	746	4.90E-37	155.2	EF2_ENCCU	reviewed	Elongation factor 2 (EF-2) (Eukaryotic elongation factor 2) (eEF2) (Ribosomal translocase) (Translation elongation factor 2)	EFT1 ECU11_1460	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	850	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; rRNA binding [GO:0019843]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; rRNA binding [GO:0019843]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0019843			NA	NA	NA	NA	NA	NA
TRINITY_DN36163_c0_g1_i1	Q8SQT7	EF2_ENCCU	57.1	105	45	0	318	4	437	541	7.30E-31	134.4	EF2_ENCCU	reviewed	Elongation factor 2 (EF-2) (Eukaryotic elongation factor 2) (eEF2) (Ribosomal translocase) (Translation elongation factor 2)	EFT1 ECU11_1460	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	850	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; rRNA binding [GO:0019843]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; rRNA binding [GO:0019843]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0019843			NA	NA	1	NA	NA	NA
TRINITY_DN33506_c0_g1_i1	A1K601	LEPA_AZOSB	85.1	74	11	0	1	222	12	85	2.30E-31	135.6	LEPA_AZOSB	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA azo1639	Azoarcus sp. (strain BH72)	598	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN20928_c0_g2_i1	Q2G550	LEPA_NOVAD	90	70	7	0	212	3	521	590	2.10E-29	129	LEPA_NOVAD	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA Saro_2587	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	605	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN20928_c0_g1_i1	A5VB59	LEPA_SPHWW	91.2	80	7	0	243	4	522	601	3.20E-34	145.2	LEPA_SPHWW	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA Swit_3177	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	607	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN5328_c0_g3_i1	A5VB59	LEPA_SPHWW	87.2	148	14	1	429	1	1	148	6.20E-66	251.5	LEPA_SPHWW	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA Swit_3177	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	607	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN5328_c0_g2_i1	Q2G550	LEPA_NOVAD	94.6	149	8	0	449	3	1	149	1.80E-74	280	LEPA_NOVAD	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA Saro_2587	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	605	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN5328_c0_g1_i1	A5VB59	LEPA_SPHWW	90.3	113	11	0	341	3	1	113	7.80E-51	201.1	LEPA_SPHWW	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA Swit_3177	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	607	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN15842_c0_g1_i1	Q1GRH5	LEPA_SPHAL	92.9	141	10	0	2	424	457	597	1.60E-70	266.5	LEPA_SPHAL	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA Sala_2036	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	607	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN38630_c0_g1_i1	Q6A9B2	LEPA_CUTAK	100	71	0	0	2	214	309	379	3.60E-34	144.8	LEPA_CUTAK	reviewed	Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)	lepA PPA0901	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	611	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translation [GO:0045727]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005886; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c0_g1_i4	Q1GP96	EFG_SPHAL	90	170	17	0	56	565	1	170	4.70E-89	328.6	EFG_SPHAL	reviewed	Elongation factor G (EF-G)	fusA Sala_2821	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	697	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c0_g1_i6	Q2G8Y3	EFG_NOVAD	95.7	163	7	0	44	532	1	163	5.20E-90	331.6	EFG_NOVAD	reviewed	Elongation factor G (EF-G)	fusA Saro_1246	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c1_g1_i1	Q6A6L5	EFG_CUTAK	100	103	0	0	2	310	53	155	1.20E-54	213.4	EFG_CUTAK	reviewed	Elongation factor G (EF-G)	fusA PPA1875	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	697	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c0_g3_i1	A5ELN0	EFG_BRASB	98.9	88	1	0	2	265	77	164	5.70E-45	181	EFG_BRASB	reviewed	Elongation factor G (EF-G)	fusA BBta_5073	Bradyrhizobium sp. (strain BTAi1 / ATCC BAA-1182)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN25748_c0_g1_i1	Q2G8Y3	EFG_NOVAD	91.5	82	7	0	248	3	420	501	2.20E-38	159.1	EFG_NOVAD	reviewed	Elongation factor G (EF-G)	fusA Saro_1246	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12530_c0_g1_i1	Q2G8Y3	EFG_NOVAD	93.6	141	9	0	2	424	427	567	9.30E-74	277.3	EFG_NOVAD	reviewed	Elongation factor G (EF-G)	fusA Saro_1246	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12530_c0_g1_i2	Q2G8Y3	EFG_NOVAD	93.6	141	9	0	2	424	427	567	2.70E-73	275.8	EFG_NOVAD	reviewed	Elongation factor G (EF-G)	fusA Saro_1246	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12530_c0_g1_i3	Q2G8Y3	EFG_NOVAD	92.9	141	10	0	2	424	427	567	1.00E-72	273.9	EFG_NOVAD	reviewed	Elongation factor G (EF-G)	fusA Saro_1246	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12530_c0_g1_i4	Q2G8Y3	EFG_NOVAD	91.1	135	12	0	1	405	433	567	9.60E-68	257.3	EFG_NOVAD	reviewed	Elongation factor G (EF-G)	fusA Saro_1246	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17922_c0_g1_i1	Q5NQ66	EFG_ZYMMO	85.7	105	15	0	316	2	468	572	2.00E-49	196.1	EFG_ZYMMO	reviewed	Elongation factor G (EF-G)	fusA ZMO0515	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	690	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c0_g2_i1	Q46WE0	EFG1_CUPPJ	99.4	159	1	0	39	515	1	159	3.50E-91	335.5	EFG1_CUPPJ	reviewed	Elongation factor G 1 (EF-G 1)	fusA1 Reut_A3183	Cupriavidus pinatubonensis (strain JMP 134 / LMG 1197) (Cupriavidus necator (strain JMP 134))	702	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12530_c1_g1_i1	Q1LI29	EFG1_CUPMC	98.8	81	1	0	243	1	426	506	1.20E-38	159.8	EFG1_CUPMC	reviewed	Elongation factor G 1 (EF-G 1)	fusA1 Rmet_3325	Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) (Ralstonia metallidurans)	703	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c0_g1_i1	Q8XRM7	EFG2_RALSO	91.5	189	16	0	56	622	1	189	3.50E-101	369	EFG2_RALSO	reviewed	Elongation factor G 2 (EF-G 2)	fusB fusA2 RSp0804 RS06124	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	700	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN11877_c0_g1_i2	Q8XRM7	EFG2_RALSO	89.5	181	19	0	2	544	9	189	1.70E-91	336.7	EFG2_RALSO	reviewed	Elongation factor G 2 (EF-G 2)	fusB fusA2 RSp0804 RS06124	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	700	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	1
TRINITY_DN28363_c0_g1_i1	Q6MP77	EFG2_BDEBA	49.3	67	33	1	203	3	629	694	1.30E-09	63.2	EFG2_BDEBA	reviewed	Elongation factor G 2 (EF-G 2)	fusA2 fusA-2 Bd0987	Bdellovibrio bacteriovorus (strain ATCC 15356 / DSM 50701 / NCIB 9529 / HD100)	702	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12530_c0_g2_i1	Q8XRM7	EFG2_RALSO	92.9	99	7	0	2	298	427	525	1.10E-47	190.3	EFG2_RALSO	reviewed	Elongation factor G 2 (EF-G 2)	fusB fusA2 RSp0804 RS06124	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	700	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN28734_c0_g1_i1	A5DK38	EFGM_PICGU	75	160	39	1	3	482	64	222	5.20E-68	258.5	EFGM_PICGU	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	MEF1 PGUG_03639	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	760	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN38854_c0_g1_i1	Q16S14	EFGM_AEDAE	74	319	83	0	1008	1964	30	348	2.60E-134	480.7	EFGM_AEDAE	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	AAEL010742	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	748	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN3364_c0_g1_i1	B0WGM1	EFGM_CULQU	66.4	339	113	1	1103	87	406	743	4.80E-138	492.3	EFGM_CULQU	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	CPIJ005834	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	744	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrial translational elongation [GO:0070125]		blue	blue	NA	NA	NA	NA
TRINITY_DN34173_c0_g1_i1	Q9FE64	EFGM_ORYSJ	65.5	113	39	0	373	35	465	577	1.10E-38	160.6	EFGM_ORYSJ	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	Os03g0565500 LOC_Os03g36780 OSJNBa0026A15.1	Oryza sativa subsp. japonica (Rice)	757	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN31859_c0_g1_i1	Q8K0D5	EFGM_MOUSE	100	120	0	0	2	361	193	312	3.10E-62	238.8	EFGM_MOUSE	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	Gfm1 Efg Efg1 Gfm	Mus musculus (Mouse)	751	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN23027_c0_g1_i1	Q96RP9	EFGM_HUMAN	100	152	0	0	2	457	582	733	3.30E-85	315.5	EFGM_HUMAN	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (hEFG1)"	GFM1 EFG EFG1 GFM	Homo sapiens (Human)	751	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN36145_c0_g1_i1	Q96RP9	EFGM_HUMAN	100	106	0	0	319	2	457	562	6.40E-59	227.6	EFGM_HUMAN	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (hEFG1)"	GFM1 EFG EFG1 GFM	Homo sapiens (Human)	751	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN36375_c0_g1_i1	Q96RP9	EFGM_HUMAN	98.6	73	1	0	220	2	143	215	8.90E-36	150.2	EFGM_HUMAN	reviewed	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (hEFG1)"	GFM1 EFG EFG1 GFM	Homo sapiens (Human)	751	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125	mitochondrial translational elongation [GO:0070125]		NA	NA	NA	NA	NA	NA
TRINITY_DN25154_c0_g1_i1	B0WC25	EFTS_CULQU	41.1	214	114	4	122	733	59	270	9.30E-37	155.2	EFTS_CULQU	reviewed	"Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)"	CPIJ004698	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	317	mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746]	mitochondrion [GO:0005739]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN25154_c0_g1_i2	B0WC25	EFTS_CULQU	44.3	244	124	4	86	787	29	270	5.10E-49	196.1	EFTS_CULQU	reviewed	"Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)"	CPIJ004698	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	317	mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746]	mitochondrion [GO:0005739]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN5686_c0_g1_i1	Q5F5Q8	EFTU_NEIG1	100	72	0	0	218	3	50	121	8.10E-37	153.7	EFTU_NEIG1	reviewed	Elongation factor Tu (EF-Tu)	tuf1 NGO1842; tuf2 NGO1858	Neisseria gonorrhoeae (strain ATCC 700825 / FA 1090)	394	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN36739_c0_g1_i1	A1ALS6	EFTU_PELPD	78	186	41	0	560	3	6	191	3.40E-80	299.3	EFTU_PELPD	reviewed	Elongation factor Tu (EF-Tu)	tuf1 Ppro_0665; tuf2 Ppro_0678	Pelobacter propionicus (strain DSM 2379 / NBRC 103807 / OttBd1)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN18867_c1_g1_i1	Q0K5Z9	EFTU_CUPNH	86.8	68	3	2	206	3	197	258	3.30E-24	111.7	EFTU_CUPNH	reviewed	Elongation factor Tu (EF-Tu)	tuf1 tufA H16_A3491; tuf2 tufB H16_A3505	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN18867_c0_g1_i1	Q1GP97	EFTU_SPHAL	84	81	13	0	243	1	146	226	2.50E-31	135.6	EFTU_SPHAL	reviewed	Elongation factor Tu (EF-Tu)	tuf Sala_2820	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	397	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN2879_c0_g1_i1	Q8XGZ0	EFTU_RALSO	98.7	77	1	0	44	274	1	77	1.00E-36	153.7	EFTU_RALSO	reviewed	Elongation factor Tu (EF-Tu)	tufA tuf1 RSc3021 RS06071; tufB tuf2 RSc3041 RS04716	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN31923_c0_g1_i1	B1MY04	EFTU_LEUCK	61.9	63	24	0	190	2	254	316	2.00E-16	85.9	EFTU_LEUCK	reviewed	Elongation factor Tu (EF-Tu)	tuf LCK_00573	Leuconostoc citreum (strain KM20)	395	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN33140_c0_g1_i1	Q6A6L7	EFTU_CUTAK	98	101	2	0	3	305	202	302	1.50E-49	196.4	EFTU_CUTAK	reviewed	Elongation factor Tu (EF-Tu)	tuf PPA1873	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	397	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7579_c0_g4_i1	A1TJ05	EFTU_ACIAC	100	128	0	0	385	2	9	136	6.30E-69	261.2	EFTU_ACIAC	reviewed	Elongation factor Tu (EF-Tu)	tuf1 Aave_0336; tuf2 Aave_4538	Acidovorax citrulli (strain AAC00-1) (Acidovorax avenae subsp. citrulli)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7579_c0_g4_i2	Q2G8Y2	EFTU_NOVAD	91.9	136	11	0	409	2	1	136	4.10E-69	261.9	EFTU_NOVAD	reviewed	Elongation factor Tu (EF-Tu)	tuf Saro_1247	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7579_c0_g3_i1	A5V604	EFTU_SPHWW	90	341	33	1	1025	3	1	340	1.10E-173	610.5	EFTU_SPHWW	reviewed	Elongation factor Tu (EF-Tu)	tuf Swit_1355	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7579_c0_g1_i1	Q2G8Y2	EFTU_NOVAD	77.5	71	15	1	215	3	10	79	6.50E-23	107.8	EFTU_NOVAD	reviewed	Elongation factor Tu (EF-Tu)	tuf Saro_1247	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	1
TRINITY_DN7579_c0_g1_i2	Q2G8Y2	EFTU_NOVAD	87.3	79	10	0	239	3	1	79	3.70E-33	141.7	EFTU_NOVAD	reviewed	Elongation factor Tu (EF-Tu)	tuf Saro_1247	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN7579_c0_g2_i1	Q6A6L7	EFTU_CUTAK	99.3	145	1	0	435	1	1	145	9.30E-80	297.4	EFTU_CUTAK	reviewed	Elongation factor Tu (EF-Tu)	tuf PPA1873	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	397	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN10131_c0_g1_i1	Q8XGZ0	EFTU_RALSO	100	67	0	0	202	2	265	331	1.20E-34	146.4	EFTU_RALSO	reviewed	Elongation factor Tu (EF-Tu)	tufA tuf1 RSc3021 RS06071; tufB tuf2 RSc3041 RS04716	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN34062_c0_g1_i1	Q7U4D1	EFTU_SYNPX	62.9	70	26	0	5	214	189	258	1.40E-17	89.7	EFTU_SYNPX	reviewed	Elongation factor Tu (EF-Tu)	tuf SYNW2138	Synechococcus sp. (strain WH8102)	399	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN36779_c0_g1_i1	A4VHL6	EFTU1_PSEU5	97.1	69	2	0	2	208	2	70	2.50E-32	138.7	EFTU1_PSEU5	reviewed	Elongation factor Tu 1 (EF-Tu 1)	tuf1 PST_0769	Pseudomonas stutzeri (strain A1501)	397	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN18751_c0_g1_i1	B0SUQ7	EFTU1_CAUSK	81.8	66	12	0	203	6	130	195	3.60E-23	108.2	EFTU1_CAUSK	reviewed	Elongation factor Tu 1 (EF-Tu 1)	tuf1 Caul_0804	Caulobacter sp. (strain K31)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN10131_c0_g1_i2	Q21SF0	EFTU1_RHOFT	94	67	4	0	202	2	265	331	3.30E-32	138.3	EFTU1_RHOFT	reviewed	Elongation factor Tu 1 (EF-Tu 1)	tuf1 Rfer_3599	Rhodoferax ferrireducens (strain ATCC BAA-621 / DSM 15236 / T118) (Albidiferax ferrireducens)	396	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN4962_c0_g1_i1	P49410	EFTU_BOVIN	61.9	436	160	5	1297	2	1	434	4.60E-151	535.8	EFTU_BOVIN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu)"	TUFM	Bos taurus (Bovine)	452	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006414; GO:0042645; GO:0070125	mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i10	P49411	EFTU_HUMAN	53.3	289	134	1	1101	238	112	400	2.50E-84	314.3	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i10	P49411	EFTU_HUMAN	65.2	66	23	0	1313	1116	57	122	4.00E-18	94.4	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i2	P49411	EFTU_HUMAN	59.1	291	118	1	950	81	57	347	2.10E-96	354	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i3	P49411	EFTU_HUMAN	51.7	333	160	1	1071	76	112	444	2.60E-94	347.4	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i3	P49411	EFTU_HUMAN	65.2	66	23	0	1283	1086	57	122	3.90E-18	94.4	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i5	P49411	EFTU_HUMAN	46.2	325	150	2	1047	76	144	444	1.70E-76	287.7	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i6	P49411	EFTU_HUMAN	51.1	231	102	3	743	81	118	347	1.30E-58	228.4	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2854_c2_g1_i6	P49411	EFTU_HUMAN	67.2	64	21	0	880	689	57	120	2.90E-18	94.4	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN12121_c0_g1_i1	P49411	EFTU_HUMAN	100	380	0	0	1142	3	28	407	2.60E-219	762.3	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN12121_c0_g1_i2	P49411	EFTU_HUMAN	98.2	380	7	0	1142	3	28	407	2.00E-216	752.7	EFTU_HUMAN	reviewed	"Elongation factor Tu, mitochondrial (EF-Tu) (P43)"	TUFM	Homo sapiens (Human)	452	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0016032; GO:0042645; GO:0045471; GO:0070062; GO:0070125	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN5208_c0_g1_i1	Q7Z2Z2	EFL1_HUMAN	53.4	438	186	5	104	1411	5	426	2.20E-125	450.7	EFL1_HUMAN	reviewed	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	EFL1 EFTUD1 FAM42A	Homo sapiens (Human)	1120	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN5208_c0_g1_i2	Q8C0D5	EFL1_MOUSE	68.6	121	38	0	122	484	11	131	2.90E-43	176.4	EFL1_MOUSE	reviewed	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	Efl1 Eftud1	Mus musculus (Mouse)	1127	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN32752_c0_g1_i1	Q8C0D5	EFL1_MOUSE	41.7	657	288	8	1862	84	502	1127	1.50E-134	481.5	EFL1_MOUSE	reviewed	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	Efl1 Eftud1	Mus musculus (Mouse)	1127	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN29684_c0_g1_i1	Q7Z2Z2	EFL1_HUMAN	98.6	71	1	0	2	214	990	1060	1.40E-33	142.9	EFL1_HUMAN	reviewed	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	EFL1 EFTUD1 FAM42A	Homo sapiens (Human)	1120	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN4979_c0_g2_i1	Q8C0D5	EFL1_MOUSE	75	56	14	0	36	203	19	74	3.80E-17	88.2	EFL1_MOUSE	reviewed	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	Efl1 Eftud1	Mus musculus (Mouse)	1127	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN4979_c0_g1_i1	Q7Z2Z2	EFL1_HUMAN	57.1	105	43	1	316	2	68	170	7.60E-28	124.4	EFL1_HUMAN	reviewed	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	EFL1 EFTUD1 FAM42A	Homo sapiens (Human)	1120	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN15349_c0_g1_i2	Q9VHX7	ELOVL_DROME	53.4	116	54	0	349	2	9	124	2.70E-34	146.4	ELOVL_DROME	reviewed	Elongation of very long chain fatty acids protein (EC 2.3.1.199) (Elongation of very long chain fatty acids elongase) (Very-long-chain 3-oxoacyl-CoA synthase)	ELOVL CG2781	Drosophila melanogaster (Fruit fly)	329	"integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]"	integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0001676; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0030497; GO:0034625; GO:0034626; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid metabolic process [GO:0001676]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32183_c0_g1_i1	Q9BW60	ELOV1_HUMAN	100	93	0	0	1	279	140	232	6.60E-52	204.1	ELOV1_HUMAN	reviewed	Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1)	ELOVL1 SSC1 CGI-88	Homo sapiens (Human)	279	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; alpha-linolenic acid metabolic process [GO:0036109]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016020; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042761; GO:0043651; GO:0046513; GO:0061436; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"alpha-linolenic acid metabolic process [GO:0036109]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c1_g1_i1	Q9GZR5	ELOV4_HUMAN	43.3	277	156	1	60	890	6	281	5.20E-58	226.1	ELOV4_HUMAN	reviewed	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	ELOVL4	Homo sapiens (Human)	314	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c1_g1_i2	Q95K73	ELOV4_MACFA	44.7	219	121	0	60	716	6	224	5.50E-48	192.6	ELOV4_MACFA	reviewed	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	ELOVL4 QtrA-14469	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	314	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030176; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"		NA	NA	NA	NA	NA	NA
TRINITY_DN416_c0_g1_i1	Q6PC64	ELOV6_DANRE	50	242	117	2	864	145	27	266	4.30E-57	223	ELOV6_DANRE	reviewed	Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6)	elovl6	Danio rerio (Zebrafish) (Brachydanio rerio)	266	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"		NA	NA	NA	NA	NA	NA
TRINITY_DN416_c0_g1_i2	Q5ZJR8	ELOV6_CHICK	51.6	254	120	2	918	157	11	261	2.20E-66	254.2	ELOV6_CHICK	reviewed	Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6)	ELOVL6 RCJMB04_16d24	Gallus gallus (Chicken)	265	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"		blue	blue	NA	NA	NA	NA
TRINITY_DN416_c0_g1_i3	Q5ZJR8	ELOV6_CHICK	50.8	254	122	2	918	157	11	261	4.40E-65	250	ELOV6_CHICK	reviewed	Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6)	ELOVL6 RCJMB04_16d24	Gallus gallus (Chicken)	265	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15349_c0_g1_i1	Q1HRV8	ELVL1_AEDAE	49.4	87	44	0	286	26	3	89	2.60E-19	96.3	ELVL1_AEDAE	reviewed	Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004)	AAEL008004	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	358	integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]	integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN15349_c0_g1_i3	Q1HRV8	ELVL1_AEDAE	50.9	110	53	1	339	13	3	112	9.30E-29	127.9	ELVL1_AEDAE	reviewed	Elongation of very long chain fatty acids protein AAEL008004 (EC 2.3.1.199) (3-keto acyl-CoA synthase AAEL008004) (Very-long-chain 3-oxoacyl-CoA synthase AAEL008004)	AAEL008004	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	358	integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]	integral component of endoplasmic reticulum membrane [GO:0030176]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0006633; GO:0030176; GO:0102336; GO:0102337; GO:0102338; GO:0102756	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN6725_c0_g1_i1	O59704	ELP1_SCHPO	28.6	385	270	2	1430	291	825	1209	8.20E-21	103.2	ELP1_SCHPO	reviewed	Elongator complex protein 1 (Protein iki3)	iki3 SPBC36.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1253	cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; tRNA binding [GO:0000049]; protein transport [GO:0015031]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]	cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]	tRNA binding [GO:0000049]	GO:0000049; GO:0002926; GO:0005829; GO:0015031; GO:0033588; GO:0140018	protein transport [GO:0015031]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]		NA	NA	NA	NA	NA	NA
TRINITY_DN26214_c0_g1_i1	Q6IA86	ELP2_HUMAN	100	75	0	0	2	226	426	500	4.80E-40	164.5	ELP2_HUMAN	reviewed	Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)	ELP2 STATIP1	Homo sapiens (Human)	826	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	protein kinase binding [GO:0019901]	GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0008023; GO:0019901; GO:0033588; GO:0046425	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN34187_c0_g1_i1	Q6IA86	ELP2_HUMAN	100	70	0	0	3	212	645	714	2.40E-38	158.7	ELP2_HUMAN	reviewed	Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)	ELP2 STATIP1	Homo sapiens (Human)	826	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	protein kinase binding [GO:0019901]	GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0008023; GO:0019901; GO:0033588; GO:0046425	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1653_c0_g1_i1	Q6IA86	ELP2_HUMAN	37.4	840	456	23	2476	98	6	822	6.20E-150	533.1	ELP2_HUMAN	reviewed	Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)	ELP2 STATIP1	Homo sapiens (Human)	826	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	protein kinase binding [GO:0019901]	GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0008023; GO:0019901; GO:0033588; GO:0046425	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1653_c0_g1_i2	Q6IA86	ELP2_HUMAN	37.4	840	456	23	2476	98	6	822	5.80E-150	533.1	ELP2_HUMAN	reviewed	Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)	ELP2 STATIP1	Homo sapiens (Human)	826	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	protein kinase binding [GO:0019901]	GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0008023; GO:0019901; GO:0033588; GO:0046425	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN838_c1_g1_i1	Q5XG58	ELP4_XENLA	43.7	371	191	5	1171	113	16	386	1.10E-77	292	ELP4_XENLA	reviewed	Elongator complex protein 4	elp4	Xenopus laevis (African clawed frog)	408	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]	phosphorylase kinase regulator activity [GO:0008607]	GO:0002098; GO:0005737; GO:0006357; GO:0008023; GO:0008607; GO:0033588	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN27618_c0_g1_i1	Q96EB1	ELP4_HUMAN	100	72	0	0	3	218	320	391	5.20E-36	151	ELP4_HUMAN	reviewed	Elongator complex protein 4 (hELP4) (PAX6 neighbor gene protein)	ELP4 C11orf19 PAXNEB	Homo sapiens (Human)	424	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	phosphorylase kinase regulator activity [GO:0008607]	GO:0002098; GO:0005654; GO:0005737; GO:0006357; GO:0006368; GO:0008023; GO:0008607; GO:0033588	regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN245_c0_g1_i1	A1A5V9	ELP5_DANRE	27.5	305	189	8	1611	751	6	296	4.40E-16	87.8	ELP5_DANRE	reviewed	Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12)	elp5 derp6 Rai12 zgc:158278 zgc:158285	Danio rerio (Zebrafish) (Brachydanio rerio)	296	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]		GO:0002098; GO:0005634; GO:0005737; GO:0030335; GO:0033588	positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN245_c0_g1_i3	A1A5V9	ELP5_DANRE	27.5	305	189	8	1611	751	6	296	4.50E-16	87.8	ELP5_DANRE	reviewed	Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12)	elp5 derp6 Rai12 zgc:158278 zgc:158285	Danio rerio (Zebrafish) (Brachydanio rerio)	296	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]		GO:0002098; GO:0005634; GO:0005737; GO:0030335; GO:0033588	positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN245_c0_g1_i4	A1A5V9	ELP5_DANRE	27.3	242	149	6	1428	751	66	296	6.40E-12	73.9	ELP5_DANRE	reviewed	Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12)	elp5 derp6 Rai12 zgc:158278 zgc:158285	Danio rerio (Zebrafish) (Brachydanio rerio)	296	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]		GO:0002098; GO:0005634; GO:0005737; GO:0030335; GO:0033588	positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN245_c0_g1_i5	A1A5V9	ELP5_DANRE	27.3	242	149	6	1427	750	66	296	9.10E-12	73.2	ELP5_DANRE	reviewed	Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12)	elp5 derp6 Rai12 zgc:158278 zgc:158285	Danio rerio (Zebrafish) (Brachydanio rerio)	296	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]		GO:0002098; GO:0005634; GO:0005737; GO:0030335; GO:0033588	positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN13984_c0_g1_i1	P62869	ELOB_MOUSE	100	61	0	0	48	230	1	61	2.50E-28	125.6	ELOB_MOUSE	reviewed	Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)	Elob Tceb2	Mus musculus (Mouse)	118	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]	GO:0003713; GO:0005667; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0044877; GO:0045944; GO:0070449	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN13984_c0_g1_i2	Q15370	ELOB_HUMAN	100	118	0	0	48	401	1	118	4.70E-62	238.4	ELOB_HUMAN	reviewed	Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)	ELOB TCEB2	Homo sapiens (Human)	118	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891]; ubiquitin protein ligase binding [GO:0031625]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891]	ubiquitin protein ligase binding [GO:0031625]	GO:0005654; GO:0005829; GO:0006366; GO:0006368; GO:0016032; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0043687; GO:0061418; GO:0065003; GO:0070449	post-translational protein modification [GO:0043687]; protein-containing complex assembly [GO:0065003]; protein ubiquitination [GO:0016567]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN13984_c0_g1_i3	P62869	ELOB_MOUSE	99.1	117	1	0	48	398	1	117	6.50E-61	234.6	ELOB_MOUSE	reviewed	Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)	Elob Tceb2	Mus musculus (Mouse)	118	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]	GO:0003713; GO:0005667; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0044877; GO:0045944; GO:0070449	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN10730_c0_g1_i1	P62869	ELOB_MOUSE	57.7	111	44	2	447	115	1	108	3.00E-26	119.8	ELOB_MOUSE	reviewed	Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)	Elob Tceb2	Mus musculus (Mouse)	118	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891]	protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]	GO:0003713; GO:0005667; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0044877; GO:0045944; GO:0070449	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]		blue	blue	NA	NA	NA	NA
TRINITY_DN8066_c0_g1_i1	Q2KII4	ELOC_BOVIN	100	106	0	0	2	319	7	112	2.00E-57	223	ELOC_BOVIN	reviewed	Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1)	ELOC TCEB1	Bos taurus (Bovine)	112	nucleus [GO:0005634]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]		GO:0005634; GO:0006511	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8066_c0_g2_i1	Q2KII4	ELOC_BOVIN	100	112	0	0	35	370	1	112	4.70E-61	235	ELOC_BOVIN	reviewed	Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1)	ELOC TCEB1	Bos taurus (Bovine)	112	nucleus [GO:0005634]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]		GO:0005634; GO:0006511	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2460_c0_g1_i1	Q2KII4	ELOC_BOVIN	96.3	109	4	0	109	435	4	112	1.50E-57	223.8	ELOC_BOVIN	reviewed	Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1)	ELOC TCEB1	Bos taurus (Bovine)	112	nucleus [GO:0005634]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]		GO:0005634; GO:0006511	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2460_c0_g1_i2	Q2KII4	ELOC_BOVIN	96.3	109	4	0	87	413	4	112	1.50E-57	223.8	ELOC_BOVIN	reviewed	Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1)	ELOC TCEB1	Bos taurus (Bovine)	112	nucleus [GO:0005634]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]		GO:0005634; GO:0006511	ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN1470_c0_g1_i1	O01971	EMR1_CAEEL	46.2	52	28	0	129	284	1	52	3.90E-05	49.3	EMR1_CAEEL	reviewed	Emerin homolog 1 (Ce-emerin)	emr-1 M01D7.6	Caenorhabditis elegans	166	integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; lamin binding [GO:0005521]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; response to X-ray [GO:0010165]	integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]	lamin binding [GO:0005521]	GO:0000281; GO:0005521; GO:0005635; GO:0005639; GO:0007059; GO:0010165	chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; response to X-ray [GO:0010165]		blue	blue	NA	NA	NA	NA
TRINITY_DN19007_c0_g1_i1	Q9UI08	EVL_HUMAN	100	97	0	0	293	3	15	111	1.50E-51	203	EVL_HUMAN	reviewed	Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)	EVL RNB6	Homo sapiens (Human)	416	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]	actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]	GO:0003779; GO:0005522; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007015; GO:0007166; GO:0007399; GO:0007411; GO:0008154; GO:0009887; GO:0010633; GO:0016020; GO:0017124; GO:0030027; GO:0030838; GO:0045010; GO:0045335; GO:0051289; GO:0051496; GO:0071346; GO:1900028	actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN26549_c0_g1_i1	P36362	CHIT_MANSE	65	80	28	0	240	1	101	180	1.00E-24	113.6	CHIT_MANSE	reviewed	Endochitinase (EC 3.2.1.14)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	554	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]	extracellular region [GO:0005576]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]		NA	NA	NA	NA	NA	NA
TRINITY_DN31734_c0_g1_i1	O48766	GUN11_ARATH	62.2	90	34	0	10	279	121	210	1.10E-28	127.1	GUN11_ARATH	reviewed	"Endoglucanase 11 (EC 3.2.1.4) (Endo-1,4-beta glucanase 11)"	At2g32990 T21L14.7	Arabidopsis thaliana (Mouse-ear cress)	525	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g4_i1	Q6L4I2	GUN15_ORYSJ	49.1	57	29	0	240	70	238	294	1.00E-07	57.4	GUN15_ORYSJ	reviewed	"Endoglucanase 15 (EC 3.2.1.4) (Endo-1,4-beta glucanase 15) (OsCel9C)"	Os05g0212300 LOC_Os05g12150 OSJNBa0074P11.11	Oryza sativa subsp. japonica (Rice)	629	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0030246; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN35069_c0_g1_i1	Q652F9	GUN17_ORYSJ	53	66	27	1	36	233	14	75	3.30E-12	72	GUN17_ORYSJ	reviewed	"Endoglucanase 17 (EC 3.2.1.4) (Endo-1,4-beta glucanase 17) (OsGLU13)"	GLU13 Os06g0256900 LOC_Os06g14540 OsJ_020012 P0624H09.19	Oryza sativa subsp. japonica (Rice)	497	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN11468_c0_g1_i2	Q8L7I0	GUN19_ARATH	56.3	206	89	1	662	45	25	229	7.10E-60	232.6	GUN19_ARATH	reviewed	"Endoglucanase 19 (EC 3.2.1.4) (Endo-1,4-beta glucanase 19)"	At4g11050 F2P3.1 T22B4.30	Arabidopsis thaliana (Mouse-ear cress)	626	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0030246; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN11468_c0_g1_i5	Q8L7I0	GUN19_ARATH	56.3	206	89	1	662	45	25	229	6.60E-60	232.6	GUN19_ARATH	reviewed	"Endoglucanase 19 (EC 3.2.1.4) (Endo-1,4-beta glucanase 19)"	At4g11050 F2P3.1 T22B4.30	Arabidopsis thaliana (Mouse-ear cress)	626	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0030246; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN4619_c0_g1_i3	Q84Q51	GUN21_ORYSJ	54.2	59	26	1	234	61	238	296	3.60E-10	65.5	GUN21_ORYSJ	reviewed	"Endoglucanase 21 (EC 3.2.1.4) (Endo-1,4-beta glucanase 21) (OsGLU9)"	GLU9 Os08g0425300 LOC_Os08g32940 P0456B03.110	Oryza sativa subsp. japonica (Rice)	529	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN24253_c0_g2_i1	Q6H3Z9	GUN22_ORYSJ	59	78	32	0	237	4	98	175	2.50E-23	109	GUN22_ORYSJ	reviewed	"Endoglucanase 22 (EC 3.2.1.4) (Endo-1,4-beta glucanase 22) (OsGLU11)"	GLU11 Os09g0394300 LOC_Os09g23084 B1339H09.3 OSJNOa018M17.6	Oryza sativa subsp. japonica (Rice)	556	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cell wall organization [GO:0071555]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	cellulase activity [GO:0008810]	GO:0005576; GO:0008810; GO:0030245; GO:0071555	cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]		NA	NA	NA	NA	NA	NA
TRINITY_DN24253_c0_g3_i1	P28622	GUN4_BACS5	64.4	45	16	0	146	12	25	69	2.80E-10	65.5	GUN4_BACS5	reviewed	"Endoglucanase 4 (EC 3.2.1.4) (Cellulase 4) (EG-IV) (Endo-1,4-beta-glucanase 4)"		Bacillus sp. (strain KSM-522)	636	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]	extracellular region [GO:0005576]	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0005576; GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN17060_c0_g1_i3	P22534	GUNA_CALSA	49.5	109	43	3	407	87	361	459	4.50E-19	95.9	GUNA_CALSA	reviewed	"Endoglucanase A (EC 3.2.1.4) (Cellulase A) (Endo-1,4-beta-glucanase A)"	celA	Caldicellulosiruptor saccharolyticus (Caldocellum saccharolyticum)	1742	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN29887_c0_g1_i1	P22534	GUNA_CALSA	57.1	112	40	2	361	29	360	464	1.40E-28	127.1	GUNA_CALSA	reviewed	"Endoglucanase A (EC 3.2.1.4) (Cellulase A) (Endo-1,4-beta-glucanase A)"	celA	Caldicellulosiruptor saccharolyticus (Caldocellum saccharolyticum)	1742	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN11468_c0_g2_i1	P26225	GUNB_CELFI	55.6	54	23	1	189	28	443	495	6.70E-07	54.3	GUNB_CELFI	reviewed	"Endoglucanase B (EC 3.2.1.4) (Cellulase B) (Endo-1,4-beta-glucanase B)"	cenB	Cellulomonas fimi	1045	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN24253_c0_g2_i2	P26225	GUNB_CELFI	62.2	45	17	0	213	79	80	124	2.50E-11	68.9	GUNB_CELFI	reviewed	"Endoglucanase B (EC 3.2.1.4) (Cellulase B) (Endo-1,4-beta-glucanase B)"	cenB	Cellulomonas fimi	1045	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN11468_c0_g1_i1	P26221	GUN4_THEFU	65.5	87	29	1	345	85	50	135	1.50E-26	121.3	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN11468_c0_g1_i7	P26221	GUN4_THEFU	42.7	239	112	8	670	2	255	484	2.50E-40	167.2	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN33678_c0_g1_i1	P26221	GUN4_THEFU	43.6	179	85	6	498	4	248	424	1.90E-31	137.1	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN4619_c0_g1_i4	P26221	GUN4_THEFU	47.4	477	221	9	1419	49	22	488	6.30E-114	412.5	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN4619_c0_g1_i5	P26221	GUN4_THEFU	52.2	295	134	2	927	61	22	315	9.20E-82	305.1	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN4619_c0_g1_i7	P26221	GUN4_THEFU	57	114	49	0	423	82	22	135	5.00E-30	132.1	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN38780_c0_g1_i1	P26221	GUN4_THEFU	73.6	72	19	0	4	219	50	121	7.60E-27	120.6	GUN4_THEFU	reviewed	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	celD	Thermobifida fusca (Thermomonospora fusca)	880	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]		cellulase activity [GO:0008810]; cellulose binding [GO:0030248]	GO:0008810; GO:0030245; GO:0030248	cellulose catabolic process [GO:0030245]		NA	NA	NA	NA	NA	NA
TRINITY_DN1155_c1_g1_i5	Q96FI4	NEIL1_HUMAN	47.8	324	142	5	1068	100	1	298	4.50E-77	290	NEIL1_HUMAN	reviewed	Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (FPG1) (Nei homolog 1) (NEH1) (Nei-like protein 1)	NEIL1	Homo sapiens (Human)	390	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]"	GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0006284; GO:0006289; GO:0006979; GO:0008022; GO:0008270; GO:0016798; GO:0019104; GO:0032074; GO:0045008; GO:0140078	base-excision repair [GO:0006284]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN1155_c1_g1_i7	Q96FI4	NEIL1_HUMAN	55.4	186	81	2	614	60	1	185	3.90E-52	206.1	NEIL1_HUMAN	reviewed	Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (FPG1) (Nei homolog 1) (NEH1) (Nei-like protein 1)	NEIL1	Homo sapiens (Human)	390	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]"	GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0006284; GO:0006289; GO:0006979; GO:0008022; GO:0008270; GO:0016798; GO:0019104; GO:0032074; GO:0045008; GO:0140078	base-excision repair [GO:0006284]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN17900_c0_g1_i1	Q8K203	NEIL3_MOUSE	41.4	304	149	5	865	35	1	302	6.80E-61	235.7	NEIL3_MOUSE	reviewed	Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3)	Neil3	Mus musculus (Mouse)	606	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; MCM complex binding [GO:1904931]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; MCM complex binding [GO:1904931]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]	GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0036297; GO:0140078; GO:1904931	base-excision repair [GO:0006284]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]		NA	NA	NA	NA	NA	NA
TRINITY_DN17900_c0_g1_i3	Q8TAT5	NEIL3_HUMAN	41.1	107	57	1	337	35	195	301	2.60E-20	100.1	NEIL3_HUMAN	reviewed	Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3)	NEIL3	Homo sapiens (Human)	605	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; MCM complex binding [GO:1904931]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; MCM complex binding [GO:1904931]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]	GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0036297; GO:0140078; GO:1904931	base-excision repair [GO:0006284]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]		NA	NA	NA	NA	NA	NA
TRINITY_DN17458_c0_g1_i1	Q95NM6	NUCG_CAEEL	56.7	252	109	0	361	1116	53	304	3.50E-81	303.5	NUCG_CAEEL	reviewed	"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) (Ced-3 protease suppressor 6)"	cps-6 C41D11.8	Caenorhabditis elegans	308	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000737; GO:0004518; GO:0004519; GO:0004520; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0006401; GO:0042803; GO:0043565; GO:0046872	"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17458_c0_g1_i2	Q95NM6	NUCG_CAEEL	55.6	160	71	0	361	840	53	212	8.10E-49	196.1	NUCG_CAEEL	reviewed	"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) (Ced-3 protease suppressor 6)"	cps-6 C41D11.8	Caenorhabditis elegans	308	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000737; GO:0004518; GO:0004519; GO:0004520; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0006401; GO:0042803; GO:0043565; GO:0046872	"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17458_c0_g1_i2	Q95NM6	NUCG_CAEEL	58.5	94	39	0	873	1154	211	304	3.10E-24	114.4	NUCG_CAEEL	reviewed	"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) (Ced-3 protease suppressor 6)"	cps-6 C41D11.8	Caenorhabditis elegans	308	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000737; GO:0004518; GO:0004519; GO:0004520; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0006401; GO:0042803; GO:0043565; GO:0046872	"apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39374_c0_g1_i1	Q2KID2	NTH_BOVIN	64.6	223	79	0	242	910	81	303	4.00E-86	319.7	NTH_BOVIN	reviewed	Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase)	NTHL1	Bos taurus (Bovine)	305	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"	mitochondrion [GO:0005739]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]"	GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006296; GO:0046872; GO:0051539; GO:0140078	"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33485_c0_g1_i1	P78549	NTH_HUMAN	100	112	0	0	1	336	201	312	8.90E-62	237.3	NTH_HUMAN	reviewed	Endonuclease III-like protein 1 (hNTH1) (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase)	NTHL1 NTH1 OCTS3	Homo sapiens (Human)	312	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]"	GO:0000703; GO:0000790; GO:0003690; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006285; GO:0006296; GO:0008534; GO:0019104; GO:0045008; GO:0046872; GO:0051539; GO:0140078	"base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35044_c0_g1_i1	P78549	NTH_HUMAN	100	86	0	0	1	258	115	200	6.80E-43	174.1	NTH_HUMAN	reviewed	Endonuclease III-like protein 1 (hNTH1) (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase)	NTHL1 NTH1 OCTS3	Homo sapiens (Human)	312	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]"	GO:0000703; GO:0000790; GO:0003690; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006285; GO:0006296; GO:0008534; GO:0019104; GO:0045008; GO:0046872; GO:0051539; GO:0140078	"base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12551_c0_g1_i1	Q6IND4	EEPD1_XENLA	39.4	350	156	9	1063	20	21	316	1.30E-49	198.7	EEPD1_XENLA	reviewed	Endonuclease/exonuclease/phosphatase family domain-containing protein 1	eepd1	Xenopus laevis (African clawed frog)	556	DNA binding [GO:0003677]; DNA repair [GO:0006281]		DNA binding [GO:0003677]	GO:0003677; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN12551_c0_g1_i3	Q7L9B9	EEPD1_HUMAN	36.2	574	304	11	1824	124	21	539	3.40E-92	340.9	EEPD1_HUMAN	reviewed	Endonuclease/exonuclease/phosphatase family domain-containing protein 1	EEPD1 KIAA1706	Homo sapiens (Human)	569	anchored component of plasma membrane [GO:0046658]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of cholesterol efflux [GO:0010875]	anchored component of plasma membrane [GO:0046658]	DNA binding [GO:0003677]	GO:0003677; GO:0006281; GO:0010875; GO:0046658	DNA repair [GO:0006281]; positive regulation of cholesterol efflux [GO:0010875]		NA	NA	NA	NA	NA	NA
TRINITY_DN9142_c0_g1_i2	Q9JJ22	ERAP1_RAT	47	168	84	2	6	506	134	297	1.40E-38	161	ERAP1_RAT	reviewed	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP)	Erap1 Appils Arts1	Rattus norvegicus (Rat)	930	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]	GO:0002250; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008233; GO:0008235; GO:0008270; GO:0016021; GO:0019882; GO:0019885; GO:0042277; GO:0043171; GO:0043231; GO:0045766; GO:0070006	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN9142_c0_g1_i4	Q9JJ22	ERAP1_RAT	51.9	260	120	2	6	782	134	389	1.00E-76	288.1	ERAP1_RAT	reviewed	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP)	Erap1 Appils Arts1	Rattus norvegicus (Rat)	930	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]	GO:0002250; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008233; GO:0008235; GO:0008270; GO:0016021; GO:0019882; GO:0019885; GO:0042277; GO:0043171; GO:0043231; GO:0045766; GO:0070006	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN25743_c0_g1_i1	Q9NZ08	ERAP1_HUMAN	96.4	111	4	0	335	3	348	458	9.40E-61	233.8	ERAP1_HUMAN	reviewed	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)	ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154	Homo sapiens (Human)	941	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"	GO:0001525; GO:0002250; GO:0002474; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8194_c0_g1_i1	Q9NZ08	ERAP1_HUMAN	62.5	120	45	0	373	14	268	387	7.10E-44	177.9	ERAP1_HUMAN	reviewed	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)	ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154	Homo sapiens (Human)	941	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"	GO:0001525; GO:0002250; GO:0002474; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN34092_c0_g1_i1	Q9NZ08	ERAP1_HUMAN	99.3	139	1	0	2	418	144	282	1.30E-72	273.5	ERAP1_HUMAN	reviewed	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)	ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154	Homo sapiens (Human)	941	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"	GO:0001525; GO:0002250; GO:0002474; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37306_c0_g1_i1	Q9EQH2	ERAP1_MOUSE	60	45	18	0	79	213	166	210	2.20E-09	62.8	ERAP1_MOUSE	reviewed	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (VEGF-induced aminopeptidase)	Erap1 Appils Arts1	Mus musculus (Mouse)	930	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]	GO:0002250; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008233; GO:0008235; GO:0008270; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0043231; GO:0045766; GO:0070006	adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36705_c0_g1_i1	Q6P179	ERAP2_HUMAN	99.4	178	1	0	537	4	224	401	6.70E-101	367.9	ERAP2_HUMAN	reviewed	Endoplasmic reticulum aminopeptidase 2 (EC 3.4.11.-) (Leukocyte-derived arginine aminopeptidase) (L-RAP)	ERAP2 LRAP	Homo sapiens (Human)	960	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0002250; GO:0002474; GO:0004177; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0070006	adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN10970_c1_g1_i2	P29844	BIP_DROME	84.9	657	96	2	2107	143	1	656	0	1094.3	BIP_DROME	reviewed	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein homolog) (GRP-78 homolog) (Binding-immunoglobulin protein homolog) (BiP) (Heat shock 70 kDa protein cognate 3) (Heat shock protein cognate 72)	Hsc70-3 Hsc3 CG4147	Drosophila melanogaster (Fruit fly)	656	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006986; GO:0012505; GO:0016020; GO:0016246; GO:0016887; GO:0030431; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0034976; GO:0036335; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN10970_c1_g1_i4	P29844	BIP_DROME	84.9	657	96	2	1480	3444	1	656	0	1094.3	BIP_DROME	reviewed	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein homolog) (GRP-78 homolog) (Binding-immunoglobulin protein homolog) (BiP) (Heat shock 70 kDa protein cognate 3) (Heat shock protein cognate 72)	Hsc70-3 Hsc3 CG4147	Drosophila melanogaster (Fruit fly)	656	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006986; GO:0012505; GO:0016020; GO:0016246; GO:0016887; GO:0030431; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0034976; GO:0036335; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; intestinal stem cell homeostasis [GO:0036335]; protein refolding [GO:0042026]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; RNA interference [GO:0016246]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN4786_c0_g1_i1	P20029	BIP_MOUSE	99.5	655	3	0	2003	39	1	655	0	1263.1	BIP_MOUSE	reviewed	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	Hspa5 Grp78	Mus musculus (Mouse)	655	"cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of embryonic development [GO:0040019]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; response to methamphetamine hydrochloride [GO:1904313]; response to unfolded protein [GO:0006986]; stress response to metal ion [GO:0097501]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001554; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0006986; GO:0008180; GO:0009986; GO:0010976; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0021589; GO:0021680; GO:0030176; GO:0030182; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0032991; GO:0034620; GO:0034663; GO:0034976; GO:0035437; GO:0035690; GO:0040019; GO:0042026; GO:0042149; GO:0042220; GO:0043022; GO:0043066; GO:0043209; GO:0043231; GO:0044183; GO:0051082; GO:0051085; GO:0051402; GO:0051603; GO:0051787; GO:0071236; GO:0071277; GO:0071287; GO:0071320; GO:0071353; GO:0071480; GO:0097501; GO:1901998; GO:1903895; GO:1904313; GO:1990090	"cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of embryonic development [GO:0040019]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; response to methamphetamine hydrochloride [GO:1904313]; response to unfolded protein [GO:0006986]; stress response to metal ion [GO:0097501]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4786_c0_g1_i2	P20029	BIP_MOUSE	99.2	655	5	0	2003	39	1	655	0	1261.5	BIP_MOUSE	reviewed	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	Hspa5 Grp78	Mus musculus (Mouse)	655	"cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of embryonic development [GO:0040019]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; response to methamphetamine hydrochloride [GO:1904313]; response to unfolded protein [GO:0006986]; stress response to metal ion [GO:0097501]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001554; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0006986; GO:0008180; GO:0009986; GO:0010976; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0021589; GO:0021680; GO:0030176; GO:0030182; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0032991; GO:0034620; GO:0034663; GO:0034976; GO:0035437; GO:0035690; GO:0040019; GO:0042026; GO:0042149; GO:0042220; GO:0043022; GO:0043066; GO:0043209; GO:0043231; GO:0044183; GO:0051082; GO:0051085; GO:0051402; GO:0051603; GO:0051787; GO:0071236; GO:0071277; GO:0071287; GO:0071320; GO:0071353; GO:0071480; GO:0097501; GO:1901998; GO:1903895; GO:1904313; GO:1990090	"cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of embryonic development [GO:0040019]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; response to methamphetamine hydrochloride [GO:1904313]; response to unfolded protein [GO:0006986]; stress response to metal ion [GO:0097501]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40203_c0_g1_i1	Q9HG01	BIP_PICAN	52.6	76	36	0	229	2	180	255	3.10E-15	82	BIP_PICAN	reviewed	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (Immunoglobulin heavy chain-binding protein homolog) (BiP)	BiP	Pichia angusta (Yeast) (Hansenula polymorpha)	665	endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; response to unfolded protein [GO:0006986]	endoplasmic reticulum lumen [GO:0005788]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	GO:0005524; GO:0005788; GO:0006986; GO:0016787	response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN21794_c0_g1_i1	Q16956	BIP_APLCA	81	58	11	0	174	1	31	88	6.70E-20	97.8	BIP_APLCA	reviewed	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (Immunoglobulin heavy chain-binding protein homolog) (BiP) (Protein 1603)		Aplysia californica (California sea hare)	667	endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	endoplasmic reticulum lumen [GO:0005788]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	GO:0005524; GO:0005788; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN38666_c0_g1_i1	Q7TQ95	LNP_MOUSE	36.7	177	110	1	757	227	1	175	4.50E-24	113.2	LNP_MOUSE	reviewed	Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark) (Protein ulnaless)	Lnpk Kiaa1715 Lnp Uln	Mus musculus (Mouse)	425	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0005654; GO:0005783; GO:0005789; GO:0007029; GO:0007596; GO:0030176; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0046872; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373	blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330]		blue	blue	NA	NA	NA	NA
TRINITY_DN10829_c0_g1_i1	Q7ZU80	LNPA_DANRE	58	112	47	0	9	344	205	316	1.20E-31	137.5	LNPA_DANRE	reviewed	Endoplasmic reticulum junction formation protein lunapark-A (ER junction formation factor lunapark)	lnpka lnp lnpa zgc:56261	Danio rerio (Zebrafish) (Brachydanio rerio)	393	endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]	endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0030176; GO:0042802; GO:0046872; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373	endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]		NA	NA	NA	NA	NA	NA
TRINITY_DN12415_c1_g1_i1	Q5R8S4	ERLEC_PONAB	38.7	504	244	10	1731	289	17	478	1.40E-97	358.6	ERLEC_PONAB	reviewed	Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin)	ERLEC1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	483	endoplasmic reticulum lumen [GO:0005788]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum lumen [GO:0005788]		GO:0005788; GO:0030433	ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN12415_c1_g1_i2	Q8VEH8	ERLEC_MOUSE	50.4	131	59	1	663	289	348	478	7.20E-37	155.6	ERLEC_MOUSE	reviewed	Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin)	Erlec1	Mus musculus (Mouse)	483	"endoplasmic reticulum lumen [GO:0005788]; unfolded protein binding [GO:0051082]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum lumen [GO:0005788]	unfolded protein binding [GO:0051082]	GO:0005788; GO:0030433; GO:0051082; GO:1904153	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38550_c0_g1_i1	Q9UKM7	MA1B1_HUMAN	100	75	0	0	225	1	238	312	1.20E-40	166.4	MA1B1_HUMAN	reviewed	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	MAN1B1 UNQ747/PRO1477	Homo sapiens (Human)	699	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382	"endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35125_c0_g1_i1	Q9UKM7	MA1B1_HUMAN	50	74	36	1	1	222	290	362	3.10E-15	82	MA1B1_HUMAN	reviewed	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	MAN1B1 UNQ747/PRO1477	Homo sapiens (Human)	699	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382	"endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g2_i3	A2AJ15	MA1B1_MOUSE	53.4	459	207	5	1467	100	202	656	2.60E-140	500.4	MA1B1_MOUSE	reviewed	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	Man1b1	Mus musculus (Mouse)	658	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006486; GO:0006491; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0044322; GO:1904380; GO:1904382	"carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i15	A2AJ15	MA1B1_MOUSE	48.1	289	145	3	31	882	202	490	1.90E-72	274.6	MA1B1_MOUSE	reviewed	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	Man1b1	Mus musculus (Mouse)	658	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006486; GO:0006491; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0044322; GO:1904380; GO:1904382	"carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26301_c0_g1_i1	Q9UKM7	MA1B1_HUMAN	100	68	0	0	2	205	425	492	4.60E-34	144.4	MA1B1_HUMAN	reviewed	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	MAN1B1 UNQ747/PRO1477	Homo sapiens (Human)	699	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382	"endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13450_c0_g1_i1	Q64375	SC65_RAT	26.5	393	265	7	1198	80	8	396	8.40E-33	142.9	SC65_RAT	reviewed	Endoplasmic reticulum protein SC65 (Leprecan-like protein 4) (Prolyl 3-hydroxylase family member 4) (Synaptonemal complex protein SC65)	P3h4 Leprel4 Sc65	Rattus norvegicus (Rat)	443	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; synaptonemal complex [GO:0000795]; bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; synaptonemal complex [GO:0000795]		GO:0000795; GO:0005783; GO:0017185; GO:0030199; GO:0032964; GO:0046849; GO:1902494	bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]		NA	NA	NA	NA	NA	NA
TRINITY_DN13450_c0_g1_i2	Q64375	SC65_RAT	26.6	395	266	7	1195	71	8	398	4.40E-34	147.1	SC65_RAT	reviewed	Endoplasmic reticulum protein SC65 (Leprecan-like protein 4) (Prolyl 3-hydroxylase family member 4) (Synaptonemal complex protein SC65)	P3h4 Leprel4 Sc65	Rattus norvegicus (Rat)	443	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; synaptonemal complex [GO:0000795]; bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; synaptonemal complex [GO:0000795]		GO:0000795; GO:0005783; GO:0017185; GO:0030199; GO:0032964; GO:0046849; GO:1902494	bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]		NA	NA	NA	NA	NA	NA
TRINITY_DN36648_c0_g1_i1	P57759	ERP29_MOUSE	97.1	68	2	0	206	3	67	134	5.60E-32	137.5	ERP29_MOUSE	reviewed	Endoplasmic reticulum resident protein 29 (ERp29)	Erp29	Mus musculus (Mouse)	262	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; activation of MAPK activity [GO:0000187]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]	chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]	GO:0000187; GO:0001934; GO:0005783; GO:0005788; GO:0005790; GO:0006888; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0030133; GO:0042470; GO:0042803; GO:0050709; GO:0051087; GO:1902235	activation of MAPK activity [GO:0000187]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]		NA	NA	NA	NA	NA	NA
TRINITY_DN8600_c0_g1_i1	P81623	ERP29_BOVIN	39.8	221	129	4	3	659	30	248	8.20E-41	168.7	ERP29_BOVIN	reviewed	Endoplasmic reticulum resident protein 29 (ERp29)	ERP29	Bos taurus (Bovine)	258	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; activation of MAPK activity [GO:0000187]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]		GO:0000187; GO:0005783; GO:0005788; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0042470; GO:0050709; GO:1902235	activation of MAPK activity [GO:0000187]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]		NA	NA	NA	NA	NA	NA
TRINITY_DN38911_c0_g1_i1	Q9BS26	ERP44_HUMAN	100	74	0	0	1	222	213	286	3.30E-38	158.3	ERP44_HUMAN	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075	Homo sapiens (Human)	406	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0043312; GO:0045454; GO:0070062	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN19304_c0_g1_i1	Q9BS26	ERP44_HUMAN	100	109	0	0	330	4	45	153	1.20E-57	223.4	ERP44_HUMAN	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075	Homo sapiens (Human)	406	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0043312; GO:0045454; GO:0070062	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN19304_c0_g1_i2	Q9D1Q6	ERP44_MOUSE	97.4	152	4	0	459	4	45	196	4.50E-82	305.1	ERP44_MOUSE	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	Erp44 Kiaa0573 Txndc4	Mus musculus (Mouse)	406	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976	glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN16108_c0_g1_i1	Q9D1Q6	ERP44_MOUSE	98.9	94	1	0	2	283	287	380	5.20E-52	204.5	ERP44_MOUSE	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	Erp44 Kiaa0573 Txndc4	Mus musculus (Mouse)	406	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976	glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN16108_c0_g2_i1	Q9BS26	ERP44_HUMAN	100	116	0	0	2	349	286	401	5.00E-65	248.1	ERP44_HUMAN	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075	Homo sapiens (Human)	406	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0043312; GO:0045454; GO:0070062	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN27400_c0_g1_i1	Q9BS26	ERP44_HUMAN	49	404	191	3	14	1222	17	406	9.50E-109	395.2	ERP44_HUMAN	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075	Homo sapiens (Human)	406	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0043312; GO:0045454; GO:0070062	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		blue	blue	NA	NA	NA	NA
TRINITY_DN3797_c0_g1_i1	Q96RQ1	ERGI2_HUMAN	43.4	343	193	1	100	1128	5	346	2.20E-80	300.8	ERGI2_HUMAN	reviewed	Endoplasmic reticulum-Golgi intermediate compartment protein 2	ERGIC2 ERV41 PTX1 CDA14	Homo sapiens (Human)	377	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0006888; GO:0006890; GO:0016020; GO:0016021; GO:0030134; GO:0033116; GO:0043231	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25010_c0_g1_i1	Q9CR89	ERGI2_MOUSE	100	123	0	0	370	2	158	280	3.60E-69	261.9	ERGI2_MOUSE	reviewed	Endoplasmic reticulum-Golgi intermediate compartment protein 2	Ergic2	Mus musculus (Mouse)	377	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0006890; GO:0016021; GO:0030134; GO:0033116; GO:0043231	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN355_c2_g2_i1	Q803I2	ERGI3_DANRE	52	127	58	1	437	57	6	129	1.30E-32	141.4	ERGI3_DANRE	reviewed	Endoplasmic reticulum-Golgi intermediate compartment protein 3	ergic3 zgc:113959 zgc:55762	Danio rerio (Zebrafish) (Brachydanio rerio)	383	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]		GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27857_c0_g1_i1	Q9Y282	ERGI3_HUMAN	100	87	0	0	3	263	39	125	2.80E-44	178.7	ERGI3_HUMAN	reviewed	Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Serologically defined breast cancer antigen NY-BR-84)	ERGIC3 C20orf47 ERV46 SDBCAG84 CGI-54 PRO0989	Homo sapiens (Human)	383	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]		GO:0005783; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5277_c0_g1_i1	P08113	ENPL_MOUSE	99.7	393	1	0	3	1181	341	733	1.00E-223	776.9	ENPL_MOUSE	reviewed	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Endoplasmic reticulum resident protein 99) (ERp99) (Heat shock protein 90 kDa beta member 1) (Polymorphic tumor rejection antigen 1) (Tumor rejection antigen gp96)	Hsp90b1 Grp94 Tra-1 Tra1	Mus musculus (Mouse)	802	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]	ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0003723; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005829; GO:0005886; GO:0006457; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034663; GO:0042470; GO:0043066; GO:0043666; GO:0048471; GO:0050750; GO:0051082; GO:0071318	"actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5191_c0_g1_i1	Q66HD0	ENPL_RAT	99.7	293	1	0	938	60	4	296	1.90E-159	563.1	ENPL_RAT	reviewed	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1)	Hsp90b1 Grp94 Tra1	Rattus norvegicus (Rat)	804	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; cellular response to manganese ion [GO:0071287]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]	ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0003723; GO:0005524; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005829; GO:0005886; GO:0006457; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034663; GO:0042470; GO:0043066; GO:0043666; GO:0048471; GO:0050750; GO:0051082; GO:0071287; GO:0071318	"actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; cellular response to manganese ion [GO:0071287]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN291_c0_g1_i13	P41148	ENPL_CANLF	51.7	87	42	0	372	112	673	759	3.60E-19	95.9	ENPL_CANLF	reviewed	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1)	HSP90B1 GRP94 TRA1	Canis lupus familiaris (Dog) (Canis familiaris)	804	endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0006457; GO:0030433; GO:0033018; GO:0042470; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN1208_c0_g1_i1	Q66HD0	ENPL_RAT	71.2	288	82	1	115	975	9	296	1.20E-109	397.9	ENPL_RAT	reviewed	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1)	Hsp90b1 Grp94 Tra1	Rattus norvegicus (Rat)	804	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; cellular response to manganese ion [GO:0071287]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]	ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0003723; GO:0005524; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005829; GO:0005886; GO:0006457; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034663; GO:0042470; GO:0043066; GO:0043666; GO:0048471; GO:0050750; GO:0051082; GO:0071287; GO:0071318	"actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; cellular response to manganese ion [GO:0071287]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5191_c0_g2_i1	P14625	ENPL_HUMAN	100	289	0	0	932	66	6	294	1.50E-156	553.5	ENPL_HUMAN	reviewed	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog)	HSP90B1 GRP94 TRA1	Homo sapiens (Human)	803	"collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cellular response to ATP [GO:0071318]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; toll-like receptor signaling pathway [GO:0002224]; ubiquitin-dependent ERAD pathway [GO:0030433]"	collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0002224; GO:0003723; GO:0005509; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0006457; GO:0006898; GO:0015031; GO:0016020; GO:0019221; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034663; GO:0034975; GO:0034976; GO:0036500; GO:0042470; GO:0043066; GO:0043666; GO:0043687; GO:0044267; GO:0048471; GO:0050750; GO:0051082; GO:0051208; GO:0062023; GO:0070062; GO:0071318; GO:0071682	"actin rod assembly [GO:0031247]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cellular response to ATP [GO:0071318]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; toll-like receptor signaling pathway [GO:0002224]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5277_c0_g1_i4	P14625	ENPL_HUMAN	100	396	0	0	3	1190	341	736	1.00E-226	786.9	ENPL_HUMAN	reviewed	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog)	HSP90B1 GRP94 TRA1	Homo sapiens (Human)	803	"collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cellular response to ATP [GO:0071318]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; toll-like receptor signaling pathway [GO:0002224]; ubiquitin-dependent ERAD pathway [GO:0030433]"	collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0002224; GO:0003723; GO:0005509; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0006457; GO:0006898; GO:0015031; GO:0016020; GO:0019221; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034663; GO:0034975; GO:0034976; GO:0036500; GO:0042470; GO:0043066; GO:0043666; GO:0043687; GO:0044267; GO:0048471; GO:0050750; GO:0051082; GO:0051208; GO:0062023; GO:0070062; GO:0071318; GO:0071682	"actin rod assembly [GO:0031247]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cellular response to ATP [GO:0071318]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; toll-like receptor signaling pathway [GO:0002224]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN291_c0_g1_i10	Q22235	ENPL1_CAEEL	64	419	150	1	1368	115	317	735	1.00E-149	531.6	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN291_c0_g1_i2	Q22235	ENPL1_CAEEL	64	419	150	1	1	1254	317	735	2.00E-149	530.4	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN291_c0_g1_i7	Q22235	ENPL1_CAEEL	66.4	333	111	1	595	1590	317	649	5.70E-124	446	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN291_c0_g1_i7	Q22235	ENPL1_CAEEL	52.7	165	78	0	609	115	571	735	2.70E-41	171.4	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN5746_c0_g1_i1	Q22235	ENPL1_CAEEL	59.4	143	58	0	483	55	311	453	4.20E-47	189.1	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN5746_c0_g1_i2	Q22235	ENPL1_CAEEL	60.4	144	57	0	482	51	310	453	2.60E-48	193	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN777_c0_g1_i1	Q22235	ENPL1_CAEEL	57.3	143	61	0	431	3	311	453	6.50E-46	184.9	ENPL1_CAEEL	reviewed	Endoplasmin homolog	enpl-1 T05E11.3	Caenorhabditis elegans	760	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005783; GO:0005788; GO:0006457; GO:0030433; GO:0048471; GO:0051082	protein folding [GO:0006457]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN910_c0_g1_i1	P36183	ENPL_HORVU	58.6	220	89	1	658	5	71	290	1.70E-67	257.3	ENPL_HORVU	reviewed	Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog)		Hordeum vulgare (Barley)	809	chloroplast [GO:0009507]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	chloroplast [GO:0009507]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005739; GO:0005774; GO:0005788; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0051082	protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		NA	NA	NA	NA	NA	NA
TRINITY_DN910_c0_g1_i3	P36183	ENPL_HORVU	58.7	218	88	1	652	5	73	290	5.90E-67	255.4	ENPL_HORVU	reviewed	Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog)		Hordeum vulgare (Barley)	809	chloroplast [GO:0009507]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	chloroplast [GO:0009507]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005739; GO:0005774; GO:0005788; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0051082	protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		NA	NA	NA	NA	NA	NA
TRINITY_DN29615_c0_g1_i1	P36183	ENPL_HORVU	58	224	90	2	675	16	73	296	1.50E-66	254.2	ENPL_HORVU	reviewed	Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog)		Hordeum vulgare (Barley)	809	chloroplast [GO:0009507]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	chloroplast [GO:0009507]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005739; GO:0005774; GO:0005788; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0051082	protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		NA	NA	NA	NA	NA	NA
TRINITY_DN6840_c0_g1_i1	Q9STX5	ENPL_ARATH	46.8	94	49	1	282	4	662	755	5.70E-19	94.7	ENPL_ARATH	reviewed	Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog) (Heat shock protein 90-7) (AtHSP90.7) (AtHsp90-7) (Protein SHEPHERD)	HSP90-7 SHD At4g24190 T19F6.1 T22A6.20	Arabidopsis thaliana (Mouse-ear cress)	823	chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005739; GO:0005773; GO:0005774; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0048471; GO:0051082; GO:0099503	protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		NA	NA	NA	NA	NA	NA
TRINITY_DN6840_c0_g1_i2	Q9STX5	ENPL_ARATH	47.9	94	48	1	282	4	662	755	4.40E-19	95.1	ENPL_ARATH	reviewed	Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog) (Heat shock protein 90-7) (AtHSP90.7) (AtHsp90-7) (Protein SHEPHERD)	HSP90-7 SHD At4g24190 T19F6.1 T22A6.20	Arabidopsis thaliana (Mouse-ear cress)	823	chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005739; GO:0005773; GO:0005774; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0048471; GO:0051082; GO:0099503	protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		NA	NA	NA	NA	NA	NA
TRINITY_DN33686_c0_g1_i1	Q9STX5	ENPL_ARATH	49.4	85	41	1	6	254	668	752	3.20E-16	85.5	ENPL_ARATH	reviewed	Endoplasmin homolog (Glucose-regulated protein 94 homolog) (GRP-94 homolog) (Heat shock protein 90-7) (AtHSP90.7) (AtHsp90-7) (Protein SHEPHERD)	HSP90-7 SHD At4g24190 T19F6.1 T22A6.20	Arabidopsis thaliana (Mouse-ear cress)	823	chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	chloroplast [GO:0009507]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005739; GO:0005773; GO:0005774; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0006457; GO:0009306; GO:0009409; GO:0009414; GO:0009506; GO:0009507; GO:0009651; GO:0009934; GO:0010075; GO:0016887; GO:0034976; GO:0046686; GO:0048471; GO:0051082; GO:0099503	protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of meristem growth [GO:0010075]; regulation of meristem structural organization [GO:0009934]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to endoplasmic reticulum stress [GO:0034976]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		red	red	NA	NA	NA	NA
TRINITY_DN36757_c0_g1_i1	Q9VCU9	DCR1_DROME	62.7	75	28	0	240	16	540	614	8.30E-22	104	DCR1_DROME	reviewed	Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-)	Dcr-1 CG4792	Drosophila melanogaster (Fruit fly)	2249	"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; RNA phosphodiester bond hydrolysis [GO:0090501]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]"	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0003723; GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883; GO:0090501	"apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; RNA phosphodiester bond hydrolysis [GO:0090501]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17942_c0_g1_i1	Q9VCU9	DCR1_DROME	86.7	83	11	0	251	3	1993	2075	1.10E-34	146.7	DCR1_DROME	reviewed	Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-)	Dcr-1 CG4792	Drosophila melanogaster (Fruit fly)	2249	"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; RNA phosphodiester bond hydrolysis [GO:0090501]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]"	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0003723; GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883; GO:0090501	"apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; RNA phosphodiester bond hydrolysis [GO:0090501]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6101_c0_g1_i1	Q25BN1	DICER_CHICK	25.4	1682	801	44	3	3779	113	1764	8.00E-124	446.8	DICER_CHICK	reviewed	Endoribonuclease Dicer (EC 3.1.26.3)	DICER1 DICER	Gallus gallus (Chicken)	1921	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005737; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0046872; GO:0070578	pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]		NA	NA	NA	NA	NA	NA
TRINITY_DN9727_c0_g1_i1	Q9SP32	DCL1_ARATH	34.2	117	74	2	11	358	1684	1798	1.60E-07	57.4	DCL1_ARATH	reviewed	Endoribonuclease Dicer homolog 1 (EC 3.1.26.-) (Dicer-like protein 1) (AtDCL1) (Protein ABNORMAL SUSPENSOR 1) (Protein CARPEL FACTORY) (Protein SHORT INTEGUMENTS 1) (Protein SUSPENSOR 1)	DCL1 ASU1 CAF SIN1 SUS1 At1g01040 T25K16.4	Arabidopsis thaliana (Mouse-ear cress)	1909	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; production of siRNA involved in RNA interference [GO:0030422]; rRNA catabolic process [GO:0016075]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0016075; GO:0030422; GO:0046872	production of siRNA involved in RNA interference [GO:0030422]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN4653_c0_g1_i1	Q6NYF0	LACB2_DANRE	53.6	289	124	3	88	945	1	282	1.60E-79	297.7	LACB2_DANRE	reviewed	Endoribonuclease LACTB2 (Beta-lactamase-like protein 2) (EC 3.1.27.-)	lactb2 zgc:77065	Danio rerio (Zebrafish) (Brachydanio rerio)	289	"mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	mitochondrial matrix [GO:0005759]	endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003727; GO:0004521; GO:0005759; GO:0008270; GO:0090502	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4653_c0_g1_i2	Q5XGR8	LACB2_XENLA	49	198	100	1	87	680	80	276	9.90E-48	191.8	LACB2_XENLA	reviewed	Endoribonuclease LACTB2 (Beta-lactamase-like protein 2) (EC 3.1.27.-)	lactb2	Xenopus laevis (African clawed frog)	287	"mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	mitochondrial matrix [GO:0005759]	endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003727; GO:0004521; GO:0005759; GO:0008270; GO:0090502	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4653_c0_g1_i3	Q5XGR8	LACB2_XENLA	57.1	140	60	0	51	470	137	276	2.30E-41	170.2	LACB2_XENLA	reviewed	Endoribonuclease LACTB2 (Beta-lactamase-like protein 2) (EC 3.1.27.-)	lactb2	Xenopus laevis (African clawed frog)	287	"mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	mitochondrial matrix [GO:0005759]	endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003727; GO:0004521; GO:0005759; GO:0008270; GO:0090502	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11837_c0_g1_i1	O13794	YSH1_SCHPO	53.8	119	55	0	2	358	39	157	1.20E-37	157.1	YSH1_SCHPO	reviewed	Endoribonuclease ysh1 (EC 3.1.27.-) (mRNA 3'-end-processing protein ysh1)	ysh1 SPAC17G6.16c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	757	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005634; GO:0005829; GO:0005847; GO:0006378; GO:0006379; GO:0008409; GO:0046872	mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN321_c0_g1_i2	Q3UZV7	K132L_MOUSE	38.6	145	86	2	435	1	57	198	6.50E-25	115.5	ELAP2_MOUSE	reviewed	Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein)	Elapor2 Eig121l	Mus musculus (Mouse)	1028	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; BMP receptor binding [GO:0070700]; negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	BMP receptor binding [GO:0070700]	GO:0005886; GO:0016021; GO:0030513; GO:0045684; GO:0051961; GO:0070700	negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684]		NA	NA	NA	NA	NA	NA
TRINITY_DN321_c0_g1_i1	Q6DDW2	K132L_XENLA	37.9	145	87	2	435	1	25	166	3.60E-25	116.3	ELAP2_XENLA	reviewed	Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (xEIG121L)	elapor2 eig121l kiaa1324l	Xenopus laevis (African clawed frog)	995	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; BMP receptor binding [GO:0070700]; negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	BMP receptor binding [GO:0070700]	GO:0005886; GO:0016021; GO:0030513; GO:0045684; GO:0051961; GO:0070700	negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684]		NA	NA	NA	NA	NA	NA
TRINITY_DN13586_c0_g1_i3	Q3T0V7	EDF1_BOVIN	100	122	0	0	3	368	27	148	6.00E-62	238	EDF1_BOVIN	reviewed	Endothelial differentiation-related factor 1 (EDF-1)	EDF1	Bos taurus (Bovine)	148	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of DNA binding [GO:0043388]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0001094; GO:0003677; GO:0003713; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007275; GO:0030154; GO:0043388	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of DNA binding [GO:0043388]		NA	NA	NA	NA	NA	NA
TRINITY_DN13586_c0_g1_i2	Q9JMG1	EDF1_MOUSE	100	148	0	0	3	446	1	148	3.00E-76	285.8	EDF1_MOUSE	reviewed	Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1)	Edf1	Mus musculus (Mouse)	148	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of DNA binding [GO:0043388]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0001094; GO:0003677; GO:0003713; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007275; GO:0030154; GO:0043388	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of DNA binding [GO:0043388]		NA	NA	NA	NA	NA	NA
TRINITY_DN1992_c0_g1_i1	Q6GPQ6	EDF1_XENLA	64.9	148	51	1	89	532	1	147	1.40E-46	187.6	EDF1_XENLA	reviewed	Endothelial differentiation-related factor 1 homolog (EDF-1)	edf1	Xenopus laevis (African clawed frog)	147	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN3817_c0_g1_i1	Q9NQZ8	ZNF71_HUMAN	28.6	339	200	8	859	1842	181	488	2.50E-32	142.1	ZNF71_HUMAN	reviewed	Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71)	ZNF71 EZFIT	Homo sapiens (Human)	489	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30111_c0_g1_i1	P97739	ECE1_CAVPO	57.3	124	52	1	1	369	631	754	2.00E-37	156.8	ECE1_CAVPO	reviewed	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	ECE1	Cavia porcellus (Guinea pig)	754	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN29110_c0_g1_i1	P42892	ECE1_HUMAN	99.3	144	1	0	2	433	574	717	5.00E-83	308.1	ECE1_HUMAN	reviewed	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	ECE1	Homo sapiens (Human)	770	early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; substance P catabolic process [GO:0010814]	early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0070062	bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; substance P catabolic process [GO:0010814]		NA	NA	NA	NA	NA	NA
TRINITY_DN40812_c0_g1_i1	P42891	ECE1_BOVIN	100	71	0	0	216	4	549	619	9.40E-38	156.8	ECE1_BOVIN	reviewed	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	ECE1	Bos taurus (Bovine)	754	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]	GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0042803; GO:0046872	peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN3404_c0_g1_i2	F1N476	ECE2_BOVIN	49.6	117	59	0	351	1	518	634	2.40E-27	122.9	ECE2_BOVIN	reviewed	Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71)	ECE2	Bos taurus (Bovine)	765	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; peptide hormone processing [GO:0016486]	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0000139; GO:0004222; GO:0007420; GO:0007507; GO:0010002; GO:0016021; GO:0016486; GO:0030658; GO:0030659; GO:0046872	brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; peptide hormone processing [GO:0016486]		NA	NA	NA	NA	NA	NA
TRINITY_DN32667_c0_g1_i1	B2RQR8	ECE2_MOUSE	42.5	73	42	0	11	229	267	339	1.80E-11	69.7	ECE2_MOUSE	reviewed	Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71)	Ece2	Mus musculus (Mouse)	763	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide hormone processing [GO:0016486]	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0000139; GO:0004222; GO:0005802; GO:0016021; GO:0016486; GO:0030658; GO:0030659; GO:0046872	peptide hormone processing [GO:0016486]		NA	NA	NA	NA	NA	NA
TRINITY_DN32667_c0_g1_i2	Q8IS64	ECE_LOCMI	50.3	386	191	1	2	1156	221	606	1.20E-115	417.9	ECE_LOCMI	reviewed	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)		Locusta migratoria (Migratory locust)	727	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN27346_c0_g1_i1	Q8IS64	ECE_LOCMI	50.5	107	52	1	352	35	47	153	5.90E-28	125.2	ECE_LOCMI	reviewed	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)		Locusta migratoria (Migratory locust)	727	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5350_c0_g1_i1	P45127	ETTA_HAEIN	75	76	19	0	228	1	440	515	6.00E-27	120.9	ETTA_HAEIN	reviewed	Energy-dependent translational throttle protein EttA (EC 3.6.1.-) (Translational regulatory factor EttA)	ettA HI_1252	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	556	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; negative regulation of translational elongation [GO:0045900]; translation [GO:0006412]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]	GO:0000049; GO:0005524; GO:0005737; GO:0006412; GO:0016887; GO:0019843; GO:0043022; GO:0045900	negative regulation of translational elongation [GO:0045900]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2070_c0_g1_i1	Q92556	ELMO1_HUMAN	46.4	744	357	15	2246	81	1	724	1.90E-176	620.9	ELMO1_HUMAN	reviewed	Engulfment and cell motility protein 1 (Protein ced-12 homolog)	ELMO1 KIAA0281	Homo sapiens (Human)	727	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0038096; GO:0048010; GO:0048365; GO:0048870; GO:0050690	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2070_c0_g1_i2	Q92556	ELMO1_HUMAN	45.6	699	338	15	2101	71	1	679	9.50E-162	572	ELMO1_HUMAN	reviewed	Engulfment and cell motility protein 1 (Protein ced-12 homolog)	ELMO1 KIAA0281	Homo sapiens (Human)	727	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0038096; GO:0048010; GO:0048365; GO:0048870; GO:0050690	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2070_c0_g1_i3	Q92556	ELMO1_HUMAN	46.4	744	357	15	2246	81	1	724	1.10E-176	621.7	ELMO1_HUMAN	reviewed	Engulfment and cell motility protein 1 (Protein ced-12 homolog)	ELMO1 KIAA0281	Homo sapiens (Human)	727	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0038096; GO:0048010; GO:0048365; GO:0048870; GO:0050690	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40957_c0_g1_i1	Q92556	ELMO1_HUMAN	80.7	88	17	0	17	280	348	435	5.70E-35	147.9	ELMO1_HUMAN	reviewed	Engulfment and cell motility protein 1 (Protein ced-12 homolog)	ELMO1 KIAA0281	Homo sapiens (Human)	727	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0038096; GO:0048010; GO:0048365; GO:0048870; GO:0050690	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35379_c0_g1_i1	Q92556	ELMO1_HUMAN	100	178	0	0	535	2	336	513	1.50E-100	366.7	ELMO1_HUMAN	reviewed	Engulfment and cell motility protein 1 (Protein ced-12 homolog)	ELMO1 KIAA0281	Homo sapiens (Human)	727	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0038096; GO:0048010; GO:0048365; GO:0048870; GO:0050690	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of defense response to virus by virus [GO:0050690]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36667_c0_g1_i1	A4FUD6	ELMO2_BOVIN	100	66	0	0	199	2	334	399	1.90E-32	139	ELMO2_BOVIN	reviewed	Engulfment and cell motility protein 2	ELMO2	Bos taurus (Bovine)	720	cytosol [GO:0005829]; membrane [GO:0016020]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; membrane [GO:0016020]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0006909; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0048365; GO:0048870; GO:0060326; GO:0098609	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; phagocytosis [GO:0006909]		NA	NA	NA	NA	NA	NA
TRINITY_DN23087_c0_g1_i1	A4FUD6	ELMO2_BOVIN	100	70	0	0	211	2	416	485	6.60E-36	150.6	ELMO2_BOVIN	reviewed	Engulfment and cell motility protein 2	ELMO2	Bos taurus (Bovine)	720	cytosol [GO:0005829]; membrane [GO:0016020]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; membrane [GO:0016020]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0006909; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0048365; GO:0048870; GO:0060326; GO:0098609	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; phagocytosis [GO:0006909]		NA	NA	NA	NA	NA	NA
TRINITY_DN23087_c0_g1_i2	A4FUD6	ELMO2_BOVIN	100	100	0	0	301	2	386	485	3.40E-54	211.8	ELMO2_BOVIN	reviewed	Engulfment and cell motility protein 2	ELMO2	Bos taurus (Bovine)	720	cytosol [GO:0005829]; membrane [GO:0016020]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; membrane [GO:0016020]	Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0006909; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0048365; GO:0048870; GO:0060326; GO:0098609	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; phagocytosis [GO:0006909]		NA	NA	NA	NA	NA	NA
TRINITY_DN36426_c0_g1_i1	Q96JJ3	ELMO2_HUMAN	100	77	0	0	1	231	644	720	4.40E-39	161.4	ELMO2_HUMAN	reviewed	Engulfment and cell motility protein 2 (Protein ced-12 homolog A) (hCed-12A)	ELMO2 CED12A KIAA1834	Homo sapiens (Human)	720	cytosol [GO:0005829]; membrane [GO:0016020]; Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytosol [GO:0005829]; membrane [GO:0016020]	Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0030971; GO:0038096; GO:0048010; GO:0048365; GO:0048870; GO:0060326; GO:0098609	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN12016_c0_g1_i4	Q5XH48	EDC3_XENLA	43.7	119	55	4	174	494	164	282	8.30E-13	75.1	EDC3_XENLA	reviewed	Enhancer of mRNA-decapping protein 3 (YjeF domain-containing protein 1)	edc3 yjdc	Xenopus laevis (African clawed frog)	505	P-body [GO:0000932]; mRNA binding [GO:0003729]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]	P-body [GO:0000932]	mRNA binding [GO:0003729]	GO:0000932; GO:0003729; GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]		NA	NA	NA	NA	NA	NA
TRINITY_DN35042_c0_g1_i1	Q6P2E9	EDC4_HUMAN	99.2	133	1	0	401	3	301	433	2.30E-77	289.3	EDC4_HUMAN	reviewed	Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls)	EDC4 HEDLS	Homo sapiens (Human)	1401	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]		GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0031087; GO:0036464; GO:0043928	deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]		NA	NA	NA	NA	NA	NA
TRINITY_DN7317_c0_g1_i13	Q6P2E9	EDC4_HUMAN	36.4	360	210	5	588	1613	1039	1397	5.10E-55	217.2	EDC4_HUMAN	reviewed	Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls)	EDC4 HEDLS	Homo sapiens (Human)	1401	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]		GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0031087; GO:0036464; GO:0043928	deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]		NA	NA	NA	NA	NA	NA
TRINITY_DN13220_c0_g1_i1	Q6P2E9	EDC4_HUMAN	32.8	546	298	15	48	1622	57	554	2.30E-70	268.1	EDC4_HUMAN	reviewed	Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls)	EDC4 HEDLS	Homo sapiens (Human)	1401	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]		GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0031087; GO:0036464; GO:0043928	deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]		NA	NA	NA	NA	NA	NA
TRINITY_DN13220_c0_g1_i2	Q6P2E9	EDC4_HUMAN	37	392	233	8	48	1208	57	439	1.30E-69	265.4	EDC4_HUMAN	reviewed	Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls)	EDC4 HEDLS	Homo sapiens (Human)	1401	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]		GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0031087; GO:0036464; GO:0043928	deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]		NA	NA	NA	NA	NA	NA
TRINITY_DN9488_c0_g1_i1	Q01069	ESMB_DROME	56.4	156	55	3	94	525	1	155	7.80E-35	148.7	ESMB_DROME	reviewed	Enhancer of split mbeta protein (E(spl)mbeta) (HLH-mbeta) (Split locus enhancer protein mA)	E(spl)mbeta-HLH HLHmbeta CG14548	Drosophila melanogaster (Fruit fly)	195	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0009952; GO:0043565; GO:0046983; GO:0050767; GO:1902692; GO:1990837	anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28894_c0_g1_i1	Q01070	ESMC_DROME	48.8	127	64	1	55	435	1	126	1.40E-24	114.4	ESMC_DROME	reviewed	Enhancer of split mgamma protein (E(spl)mgamma) (Split locus enhancer protein mB)	E(spl)mgamma-HLH HLHmgamma CG8333	Drosophila melanogaster (Fruit fly)	205	"nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0008134; GO:0009952; GO:0043565; GO:0046983; GO:0048190; GO:0050767; GO:0097150; GO:1902692; GO:1990837	anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN9488_c0_g2_i1	Q01070	ESMC_DROME	82.8	58	10	0	3	176	17	74	1.20E-19	96.7	ESMC_DROME	reviewed	Enhancer of split mgamma protein (E(spl)mgamma) (Split locus enhancer protein mB)	E(spl)mgamma-HLH HLHmgamma CG8333	Drosophila melanogaster (Fruit fly)	205	"nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0008134; GO:0009952; GO:0043565; GO:0046983; GO:0048190; GO:0050767; GO:0097150; GO:1902692; GO:1990837	anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN6565_c0_g2_i1	Q3T078	ENKD1_BOVIN	38.3	128	74	2	1860	2228	220	347	2.80E-15	85.5	ENKD1_BOVIN	reviewed	Enkurin domain-containing protein 1	ENKD1	Bos taurus (Bovine)	348	ciliary base [GO:0097546]; cytoplasmic microtubule [GO:0005881]	ciliary base [GO:0097546]; cytoplasmic microtubule [GO:0005881]		GO:0005881; GO:0097546			pink	pink	NA	NA	NA	NA
TRINITY_DN14785_c0_g1_i1	Q2G662	ENO_NOVAD	94.3	70	4	0	211	2	280	349	2.20E-31	135.6	ENO_NOVAD	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	eno Saro_2223	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	428	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN20248_c0_g1_i1	P56252	ENO_HOMGA	94.6	56	3	0	96	263	1	56	5.50E-24	111.3	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN20248_c0_g1_i2	P56252	ENO_HOMGA	94.6	56	3	0	49	216	1	56	5.90E-24	110.9	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN20248_c0_g3_i1	P56252	ENO_HOMGA	79.2	77	16	0	41	271	71	147	1.00E-28	127.1	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN20248_c1_g1_i1	P56252	ENO_HOMGA	89.3	75	8	0	2	226	5	79	1.30E-31	136.7	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN22549_c0_g2_i1	Q2G662	ENO_NOVAD	89.9	89	9	0	274	8	3	91	1.40E-38	159.8	ENO_NOVAD	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	eno Saro_2223	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	428	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN22549_c0_g1_i1	A5V3E8	ENO_SPHWW	86.8	68	9	0	205	2	3	70	6.50E-28	124	ENO_SPHWW	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	eno Swit_0446	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	427	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN39323_c1_g1_i1	P56252	ENO_HOMGA	78.8	80	17	0	242	3	293	372	1.40E-29	129.8	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN13054_c0_g1_i1	P56252	ENO_HOMGA	94.9	78	4	0	2	235	334	411	1.70E-37	156	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN32765_c0_g1_i1	Q1GI52	ENO_RUEST	87.4	103	13	0	3	311	283	385	3.30E-44	178.7	ENO_RUEST	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	eno TM1040_0931	Ruegeria sp. (strain TM1040) (Silicibacter sp.)	425	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN27519_c0_g1_i1	P56252	ENO_HOMGA	79.2	72	15	0	14	229	307	378	5.30E-23	107.8	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN5708_c0_g1_i1	A5V3E8	ENO_SPHWW	90.9	66	6	0	5	202	359	424	5.30E-27	120.9	ENO_SPHWW	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	eno Swit_0446	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	427	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN5799_c0_g1_i1	B2U9C3	ENO_RALPJ	98.6	146	2	0	1	438	274	419	7.90E-76	284.3	ENO_RALPJ	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	eno Rpic_0972	Ralstonia pickettii (strain 12J)	427	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN6475_c0_g2_i1	Q9U615	ENO_MASBA	72.6	84	23	0	20	271	1	84	4.90E-28	124.8	ENO_MASBA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	ENOL	Mastigamoeba balamuthi (Phreatamoeba balamuthi)	439	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN6475_c0_g1_i1	Q8IJN7	ENO_PLAF7	73.3	363	94	2	1160	78	81	442	1.50E-145	517.3	ENO_PLAF7	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)	ENO PF10_0155	Plasmodium falciparum (isolate 3D7)	446	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; food vacuole [GO:0020020]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; activation of immune response [GO:0002253]; autophagosome assembly [GO:0000045]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; transcription, DNA-templated [GO:0006351]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; food vacuole [GO:0020020]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000045; GO:0000287; GO:0002253; GO:0004634; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0006096; GO:0006351; GO:0009986; GO:0020020; GO:0032889	"activation of immune response [GO:0002253]; autophagosome assembly [GO:0000045]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19082_c3_g1_i1	P56252	ENO_HOMGA	89.6	106	11	0	319	2	134	239	1.70E-48	193	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN29651_c0_g1_i1	P56252	ENO_HOMGA	94.4	432	24	0	1385	90	1	432	2.20E-239	829.3	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN29651_c0_g1_i2	P56252	ENO_HOMGA	94.4	432	24	0	1385	90	1	432	1.30E-239	830.1	ENO_HOMGA	reviewed	Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)		Homarus gammarus (European lobster) (Homarus vulgaris)	433	phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096	glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN29798_c0_g1_i1	Q1LPI5	ENO1_CUPMC	100	86	0	0	2	259	6	91	2.90E-41	168.7	ENO1_CUPMC	reviewed	Enolase 1 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase 1) (2-phosphoglycerate dehydratase 1)	eno1 Rmet_1055	Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) (Ralstonia metallidurans)	429	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]	cell surface [GO:0009986]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0006096; GO:0009986	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN3447_c0_g1_i1	Q5PPH0	ENOPH_RAT	42.6	223	100	3	624	40	3	225	1.40E-37	157.9	ENOPH_RAT	reviewed	"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)"	Enoph1 Masa	Rattus norvegicus (Rat)	261	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0005634; GO:0005737; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN3447_c0_g1_i3	Q0VD27	ENOPH_BOVIN	48.3	261	120	4	965	204	3	255	6.80E-57	222.6	ENOPH_BOVIN	reviewed	"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)"	ENOPH1 MASA	Bos taurus (Bovine)	261	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0005634; GO:0005737; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN6294_c0_g1_i1	Q9V6U9	MECR_DROME	51.8	338	160	2	156	1163	17	353	1.60E-89	331.3	MECR_DROME	reviewed	"Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase)"	CG16935	Drosophila melanogaster (Fruit fly)	357	mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]	mitochondrion [GO:0005739]	trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]	GO:0005739; GO:0006631; GO:0006633; GO:0019166	fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN6294_c0_g1_i2	Q7YS70	MECR_BOVIN	55.6	108	47	1	183	506	46	152	3.90E-25	116.3	MECR_BOVIN	reviewed	"Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase) (Nuclear receptor-binding factor 1) (BtNrbf-1) (NRBF-1)"	MECR NBRF1	Bos taurus (Bovine)	373	mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]	mitochondrion [GO:0005739]	trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]	GO:0005739; GO:0006631; GO:0006633; GO:0019166	fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN33194_c0_g1_i1	Q9WUR2	ECI2_MOUSE	100	76	0	0	3	230	228	303	4.20E-36	151.4	ECI2_MOUSE	reviewed	"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI)"	Eci2 Peci	Mus musculus (Mouse)	391	"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]"	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]"	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0009062; GO:0016863; GO:0043231	fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]		NA	NA	NA	NA	NA	NA
TRINITY_DN39902_c0_g1_i1	Q9WUR2	ECI2_MOUSE	51.8	110	47	2	314	3	194	303	9.70E-23	107.5	ECI2_MOUSE	reviewed	"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI)"	Eci2 Peci	Mus musculus (Mouse)	391	"intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]"	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]"	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0009062; GO:0016863; GO:0043231	fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]		blue	blue	NA	NA	NA	NA
TRINITY_DN6043_c0_g1_i1	O75521	ECI2_HUMAN	46.8	220	90	4	7	651	197	394	4.20E-45	183	ECI2_HUMAN	reviewed	"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)"	ECI2 DRS1 HCA88 PECI	Homo sapiens (Human)	394	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0009062; GO:0016020; GO:0033540; GO:0043231	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN6043_c0_g1_i2	O75521	ECI2_HUMAN	51.5	200	90	3	7	591	197	394	2.20E-48	193.7	ECI2_HUMAN	reviewed	"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)"	ECI2 DRS1 HCA88 PECI	Homo sapiens (Human)	394	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0009062; GO:0016020; GO:0033540; GO:0043231	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]		blue	blue	NA	NA	NA	NA
TRINITY_DN26531_c0_g1_i1	O75521	ECI2_HUMAN	66	159	54	0	5	481	183	341	1.30E-58	227.3	ECI2_HUMAN	reviewed	"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)"	ECI2 DRS1 HCA88 PECI	Homo sapiens (Human)	394	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0009062; GO:0016020; GO:0033540; GO:0043231	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]		blue	blue	NA	NA	NA	NA
TRINITY_DN4759_c0_g1_i2	A9JS71	ECHD3_XENLA	55.1	247	109	1	738	4	45	291	2.60E-69	263.8	ECHD3_XENLA	reviewed	"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial"	echdc3	Xenopus laevis (African clawed frog)	294	mitochondrion [GO:0005739]; catalytic activity [GO:0003824]; fatty acid metabolic process [GO:0006631]	mitochondrion [GO:0005739]	catalytic activity [GO:0003824]	GO:0003824; GO:0005739; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4759_c0_g1_i5	A9JS71	ECHD3_XENLA	55.2	248	109	1	738	1	45	292	8.50E-70	265.4	ECHD3_XENLA	reviewed	"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial"	echdc3	Xenopus laevis (African clawed frog)	294	mitochondrion [GO:0005739]; catalytic activity [GO:0003824]; fatty acid metabolic process [GO:0006631]	mitochondrion [GO:0005739]	catalytic activity [GO:0003824]	GO:0003824; GO:0005739; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4274_c0_g1_i1	Q8BH95	ECHM_MOUSE	66.4	265	89	0	827	33	25	289	1.20E-98	361.3	ECHM_MOUSE	reviewed	"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)"	Echs1	Mus musculus (Mouse)	290	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0005739; GO:0005759; GO:0006635	fatty acid beta-oxidation [GO:0006635]		blue	blue	NA	NA	NA	NA
TRINITY_DN2366_c0_g1_i1	P30084	ECHM_HUMAN	99.4	165	1	0	496	2	35	199	2.90E-90	332.4	ECHM_HUMAN	reviewed	"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)"	ECHS1	Homo sapiens (Human)	290	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0005739; GO:0005759; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN2366_c0_g1_i2	P30084	ECHM_HUMAN	95.6	90	4	0	271	2	110	199	1.50E-43	176.4	ECHM_HUMAN	reviewed	"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)"	ECHS1	Homo sapiens (Human)	290	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0005739; GO:0005759; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN28596_c0_g1_i1	Q8BH95	ECHM_MOUSE	91.2	91	8	0	280	8	76	166	1.50E-43	176.4	ECHM_MOUSE	reviewed	"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)"	Echs1	Mus musculus (Mouse)	290	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0005739; GO:0005759; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN4735_c0_g1_i1	P98073	ENTK_HUMAN	55.6	90	37	2	4	270	928	1015	3.00E-22	105.9	ENTK_HUMAN	reviewed	Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]	TMPRSS15 ENTK PRSS7	Homo sapiens (Human)	1019	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0005903; GO:0016020; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN35497_c0_g1_i1	P98073	ENTK_HUMAN	47.2	72	38	0	217	2	933	1004	1.40E-16	86.7	ENTK_HUMAN	reviewed	Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]	TMPRSS15 ENTK PRSS7	Homo sapiens (Human)	1019	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0005903; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN29529_c0_g1_i1	P98073	ENTK_HUMAN	42.3	52	27	1	93	248	346	394	3.20E-05	48.9	ENTK_HUMAN	reviewed	Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]	TMPRSS15 ENTK PRSS7	Homo sapiens (Human)	1019	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0005903; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35714_c0_g1_i2	P98073	ENTK_HUMAN	62.7	67	25	0	333	133	950	1016	1.60E-19	97.1	ENTK_HUMAN	reviewed	Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]	TMPRSS15 ENTK PRSS7	Homo sapiens (Human)	1019	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0005903; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35417_c0_g1_i1	O95936	EOMES_HUMAN	100	62	0	0	26	211	260	321	1.30E-31	136.3	EOMES_HUMAN	reviewed	Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2)	EOMES TBR2	Homo sapiens (Human)	686	"nuclear chromatin [GO:0000790]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; heart looping [GO:0001947]; interferon-gamma production [GO:0032609]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]"	nuclear chromatin [GO:0000790]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001102; GO:0001706; GO:0001707; GO:0001708; GO:0001714; GO:0001829; GO:0001947; GO:0002250; GO:0002302; GO:0003677; GO:0003682; GO:0007420; GO:0010002; GO:0019827; GO:0021772; GO:0021796; GO:0021895; GO:0032609; GO:0035914; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0060706; GO:0060809; GO:1990837	"adaptive immune response [GO:0002250]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; endodermal cell fate specification [GO:0001714]; endoderm formation [GO:0001706]; heart looping [GO:0001947]; interferon-gamma production [GO:0032609]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; mesoderm formation [GO:0001707]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19635_c0_g1_i2	A5LFW4	EID3_MACFA	29.4	303	185	7	220	1065	72	366	5.30E-26	120.2	EID3_MACFA	reviewed	EP300-interacting inhibitor of differentiation 3 (EID-3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B) (NS4EB) (Non-SMC element 4 homolog B)	EID3 QtsA-13676	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	371	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]"		GO:0000781; GO:0005634; GO:0005737; GO:0006281; GO:0006310; GO:0030915	DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN13943_c0_g1_i4	Q8N5V2	NGEF_HUMAN	50	40	20	0	253	134	648	687	3.20E-06	52.8	NGEF_HUMAN	reviewed	Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor)	NGEF	Homo sapiens (Human)	710	cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of apoptotic process [GO:0043065]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0016020; GO:0030426; GO:0043065; GO:0043087; GO:0048013; GO:0051056; GO:0061002; GO:0090630	activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of apoptotic process [GO:0043065]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN34784_c0_g1_i1	P00533	EGFR_HUMAN	98.4	64	1	0	9	200	760	823	9.40E-32	136.7	EGFR_HUMAN	reviewed	Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)	EGFR ERBB ERBB1 HER1	Homo sapiens (Human)	1210	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; Shc-EGFR complex [GO:0070435]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; astrocyte activation [GO:0048143]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ossification [GO:0001503]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of cell motility [GO:2000145]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]"	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; Shc-EGFR complex [GO:0070435]; synapse [GO:0045202]"	actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor binding [GO:0048408]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]	GO:0000139; GO:0000165; GO:0001503; GO:0001618; GO:0001892; GO:0001934; GO:0001942; GO:0003682; GO:0003690; GO:0004709; GO:0004713; GO:0004714; GO:0004888; GO:0005006; GO:0005178; GO:0005516; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006357; GO:0006412; GO:0006970; GO:0007165; GO:0007166; GO:0007169; GO:0007173; GO:0007202; GO:0007275; GO:0007435; GO:0007494; GO:0007611; GO:0007623; GO:0008284; GO:0009925; GO:0009986; GO:0010008; GO:0010750; GO:0010960; GO:0014066; GO:0016020; GO:0016101; GO:0016323; GO:0016324; GO:0018108; GO:0019899; GO:0019901; GO:0019903; GO:0021795; GO:0030054; GO:0030139; GO:0030154; GO:0030307; GO:0030324; GO:0030335; GO:0030665; GO:0031625; GO:0031901; GO:0031965; GO:0032930; GO:0032991; GO:0033138; GO:0033590; GO:0033594; GO:0033674; GO:0034614; GO:0035690; GO:0038083; GO:0038128; GO:0042059; GO:0042060; GO:0042177; GO:0042327; GO:0042698; GO:0042743; GO:0042802; GO:0043006; GO:0043066; GO:0043235; GO:0043406; GO:0043586; GO:0045121; GO:0045202; GO:0045296; GO:0045737; GO:0045739; GO:0045740; GO:0045746; GO:0045780; GO:0045893; GO:0045907; GO:0045930; GO:0045944; GO:0046328; GO:0046777; GO:0048143; GO:0048146; GO:0048408; GO:0048471; GO:0048546; GO:0048661; GO:0048812; GO:0050679; GO:0050729; GO:0050730; GO:0050999; GO:0051015; GO:0051117; GO:0051205; GO:0051592; GO:0051897; GO:0051968; GO:0060571; GO:0061024; GO:0061029; GO:0070141; GO:0070372; GO:0070374; GO:0070435; GO:0071230; GO:0071260; GO:0071276; GO:0071364; GO:0071392; GO:0071549; GO:0090263; GO:0097421; GO:0097489; GO:0097755; GO:0098609; GO:1900020; GO:1900087; GO:1901185; GO:1901224; GO:1902722; GO:1903078; GO:1903800; GO:1905208; GO:2000145	"activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; astrocyte activation [GO:0048143]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ossification [GO:0001503]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of cell motility [GO:2000145]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28849_c0_g1_i1	P0CY46	EGFR_APIME	48.9	88	35	5	46	291	1113	1196	7.60E-10	64.7	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN37824_c0_g1_i1	P0CY46	EGFR_APIME	59	178	58	4	2	529	908	1072	1.40E-50	200.7	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN34279_c0_g1_i1	P0CY46	EGFR_APIME	48.5	132	60	3	6	401	308	431	1.30E-32	140.6	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN35720_c0_g1_i1	P0CY46	EGFR_APIME	69.6	148	45	0	447	4	119	266	5.00E-49	195.3	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN22408_c0_g1_i1	P0CY46	EGFR_APIME	69.2	91	28	0	44	316	659	749	2.10E-31	136.3	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN22408_c0_g1_i2	P0CY46	EGFR_APIME	71.9	121	34	0	44	406	659	779	3.90E-45	182.2	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN14665_c0_g1_i4	P04412	EGFR_DROME	64.7	150	51	2	1	447	191	339	2.60E-58	226.1	EGFR_DROME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo)	Egfr c-erbB DER top CG10079	Drosophila melanogaster (Fruit fly)	1426	"basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"	basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0005887; GO:0007169; GO:0007173; GO:0007275; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030381; GO:0030718; GO:0033674; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043703; GO:0045198; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234	"behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye-antennal disc morphogenesis [GO:0007455]; eye development [GO:0001654]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36548_c0_g1_i1	P04412	EGFR_DROME	48.3	89	45	1	4	270	663	750	5.60E-21	102.1	EGFR_DROME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo)	Egfr c-erbB DER top CG10079	Drosophila melanogaster (Fruit fly)	1426	"basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"	basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0005887; GO:0007169; GO:0007173; GO:0007275; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030381; GO:0030718; GO:0033674; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043703; GO:0045198; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234	"behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye-antennal disc morphogenesis [GO:0007455]; eye development [GO:0001654]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36134_c0_g1_i1	P04412	EGFR_DROME	76.8	69	16	0	77	283	101	169	5.70E-27	121.3	EGFR_DROME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo)	Egfr c-erbB DER top CG10079	Drosophila melanogaster (Fruit fly)	1426	"basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"	basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0005887; GO:0007169; GO:0007173; GO:0007275; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030381; GO:0030718; GO:0033674; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043703; GO:0045198; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234	"behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye-antennal disc morphogenesis [GO:0007455]; eye development [GO:0001654]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20632_c0_g1_i1	Q12929	EPS8_HUMAN	35.3	85	55	0	351	97	516	600	7.00E-09	62.4	EPS8_HUMAN	reviewed	Epidermal growth factor receptor kinase substrate 8	EPS8	Homo sapiens (Human)	822	brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]	actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]	GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030426; GO:0030832; GO:0031532; GO:0031982; GO:0032420; GO:0032426; GO:0032587; GO:0035023; GO:0035591; GO:0036336; GO:0048149; GO:0048365; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070358; GO:0098978; GO:1900029; GO:1990830	actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN20632_c0_g1_i4	Q8TE68	ES8L1_HUMAN	50	126	59	1	380	3	255	376	4.30E-28	125.9	ES8L1_HUMAN	reviewed	Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1)	EPS8L1 DRC3 EPS8R1 PP10566	Homo sapiens (Human)	723	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608]; positive regulation of ruffle assembly [GO:1900029]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608]	GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0032587; GO:0032991; GO:0035023; GO:0042608; GO:0045296; GO:0070062; GO:1900029	positive regulation of ruffle assembly [GO:1900029]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN20632_c0_g1_i2	Q9H6S3	ES8L2_HUMAN	35.9	401	179	8	1314	124	226	552	9.70E-53	209.1	ES8L2_HUMAN	reviewed	Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2)	EPS8L2 EPS8R2 PP13181	Homo sapiens (Human)	715	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; positive regulation of ruffle assembly [GO:1900029]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0007605; GO:0031982; GO:0032421; GO:0032426; GO:0032587; GO:0032991; GO:0035023; GO:0045296; GO:0070062; GO:1900029	positive regulation of ruffle assembly [GO:1900029]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN35017_c0_g1_i1	Q60902	EP15R_MOUSE	55.9	68	30	0	207	4	129	196	5.10E-17	87.8	EP15R_MOUSE	reviewed	Epidermal growth factor receptor substrate 15-like 1 (Epidermal growth factor receptor pathway substrate 15-related sequence) (Eps15-rs) (Eps15-related protein) (Eps15R)	Eps15l1 Eps15-rs Eps15R	Mus musculus (Mouse)	907	clathrin coat of coated pit [GO:0030132]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]	clathrin coat of coated pit [GO:0030132]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005634; GO:0006897; GO:0016197; GO:0030132	endocytosis [GO:0006897]; endosomal transport [GO:0016197]		NA	NA	NA	NA	NA	NA
TRINITY_DN3565_c0_g1_i1	P36368	EGFB2_MOUSE	29.2	264	155	13	61	798	4	253	1.00E-13	79	EGFB2_MOUSE	reviewed	Epidermal growth factor-binding protein type B (EGF-BP B) (EC 3.4.21.119) (Glandular kallikrein K13) (mGK-13) (Prorenin-converting enzyme 1) (PRECE-1) (Tissue kallikrein 13)	Egfbp2 Egfbp-2 Klk-13 Klk13	Mus musculus (Mouse)	261	extracellular space [GO:0005615]; secretory granule [GO:0030141]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; regulation of systemic arterial blood pressure [GO:0003073]; zymogen activation [GO:0031638]	extracellular space [GO:0005615]; secretory granule [GO:0030141]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0003073; GO:0004252; GO:0005615; GO:0008233; GO:0030141; GO:0031638	regulation of systemic arterial blood pressure [GO:0003073]; zymogen activation [GO:0031638]		black	black	1	NA	1	1
TRINITY_DN7399_c1_g1_i4	O75715	GPX5_HUMAN	47.3	186	95	2	668	117	33	217	4.50E-45	183	GPX5_HUMAN	reviewed	Epididymal secretory glutathione peroxidase (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP) (Glutathione peroxidase 5) (GPx-5) (GSHPx-5)	GPX5	Homo sapiens (Human)	221	extracellular region [GO:0005576]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599]; lipid metabolic process [GO:0006629]	extracellular region [GO:0005576]	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]	GO:0004601; GO:0004602; GO:0005576; GO:0006629; GO:0034599	cellular response to oxidative stress [GO:0034599]; lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN25604_c0_g1_i1	Q9NRG7	D39U1_HUMAN	52.8	108	50	1	374	51	3	109	4.00E-25	115.9	D39U1_HUMAN	reviewed	Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1)	SDR39U1 C14orf124 HCDI	Homo sapiens (Human)	293	nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]	nucleus [GO:0005634]	oxidoreductase activity [GO:0016491]	GO:0005634; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN25604_c0_g1_i2	Q9NRG7	D39U1_HUMAN	51.7	290	138	2	987	118	3	290	6.70E-84	312.4	D39U1_HUMAN	reviewed	Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1)	SDR39U1 C14orf124 HCDI	Homo sapiens (Human)	293	nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]	nucleus [GO:0005634]	oxidoreductase activity [GO:0016491]	GO:0005634; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN25604_c0_g1_i3	Q9NRG7	D39U1_HUMAN	61.4	44	17	0	189	58	3	46	1.80E-07	56.6	D39U1_HUMAN	reviewed	Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1)	SDR39U1 C14orf124 HCDI	Homo sapiens (Human)	293	nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]	nucleus [GO:0005634]	oxidoreductase activity [GO:0016491]	GO:0005634; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN36684_c0_g1_i1	Q08345	DDR1_HUMAN	46.5	101	48	3	1	294	687	784	3.50E-19	95.5	DDR1_HUMAN	reviewed	Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)	DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE	Homo sapiens (Human)	913	"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001558; GO:0001952; GO:0004714; GO:0005518; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007275; GO:0007566; GO:0007595; GO:0008285; GO:0010715; GO:0014909; GO:0030198; GO:0033674; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:0070062; GO:1990138	"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell-matrix adhesion [GO:0061302]; smooth muscle cell migration [GO:0014909]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24535_c0_g1_i1	Q03146	DDR1_MOUSE	60	100	38	2	300	1	782	879	7.70E-30	131	DDR1_MOUSE	reviewed	Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)	Ddr1 Cak Eddr1 Mpk6	Mus musculus (Mouse)	911	"basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"	basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001558; GO:0001952; GO:0004714; GO:0005518; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0007169; GO:0007275; GO:0007566; GO:0007595; GO:0008285; GO:0010715; GO:0014909; GO:0016323; GO:0018108; GO:0033674; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138	"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell-matrix adhesion [GO:0061302]; smooth muscle cell migration [GO:0014909]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36101_c0_g1_i1	Q03146	DDR1_MOUSE	46.8	126	65	2	2	379	780	903	9.50E-32	137.9	DDR1_MOUSE	reviewed	Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)	Ddr1 Cak Eddr1 Mpk6	Mus musculus (Mouse)	911	"basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"	basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001558; GO:0001952; GO:0004714; GO:0005518; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0007169; GO:0007275; GO:0007566; GO:0007595; GO:0008285; GO:0010715; GO:0014909; GO:0016323; GO:0018108; GO:0033674; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138	"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell-matrix adhesion [GO:0061302]; smooth muscle cell migration [GO:0014909]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29818_c0_g1_i1	Q6NXG1	ESRP1_HUMAN	42.7	75	42	1	243	22	453	527	5.10E-08	58.2	ESRP1_HUMAN	reviewed	Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A)	ESRP1 RBM35A	Homo sapiens (Human)	681	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0008543; GO:0016604; GO:0042669; GO:0043484; GO:1990904	fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]		red	red	NA	NA	NA	NA
TRINITY_DN39245_c0_g1_i1	Q7ZY29	ESRP1_XENLA	79.5	44	9	0	1	132	269	312	1.20E-15	83.6	ESRP1_XENLA	reviewed	Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A)	esrp1 rbm35a	Xenopus laevis (African clawed frog)	688	nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0006397; GO:0008380; GO:0043484	mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN15706_c0_g2_i1	Q7L775	EPMIP_HUMAN	27.2	136	87	6	6	401	9	136	1.80E-05	50.4	EPMIP_HUMAN	reviewed	EPM2A-interacting protein 1 (Laforin-interacting protein)	EPM2AIP1 KIAA0766 My007	Homo sapiens (Human)	607	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]	identical protein binding [GO:0042802]	GO:0005634; GO:0032868; GO:0042802; GO:0045725; GO:0098554; GO:2000467	positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN15706_c0_g2_i2	Q7L775	EPMIP_HUMAN	27.2	136	87	6	6	401	9	136	3.10E-05	49.7	EPMIP_HUMAN	reviewed	EPM2A-interacting protein 1 (Laforin-interacting protein)	EPM2AIP1 KIAA0766 My007	Homo sapiens (Human)	607	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]	identical protein binding [GO:0042802]	GO:0005634; GO:0032868; GO:0042802; GO:0045725; GO:0098554; GO:2000467	positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN29273_c0_g1_i1	Q9D379	HYEP_MOUSE	100	92	0	0	3	278	170	261	5.20E-49	194.5	HYEP_MOUSE	reviewed	Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH)	Ephx1	Mus musculus (Mouse)	455	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; arachidonic acid metabolic process [GO:0019369]; aromatic compound catabolic process [GO:0019439]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; liver development [GO:0001889]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]	GO:0001889; GO:0004301; GO:0005789; GO:0005886; GO:0006725; GO:0009636; GO:0014070; GO:0016020; GO:0016021; GO:0019369; GO:0019439; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176	arachidonic acid metabolic process [GO:0019369]; aromatic compound catabolic process [GO:0019439]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; liver development [GO:0001889]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN15309_c0_g5_i1	D4A2Z2	EPPI_RAT	38.9	54	33	0	70	231	74	127	1.30E-07	58.5	EPPI_RAT	reviewed	Eppin (Epididymal protease inhibitor) (Serine protease inhibitor-like with Kunitz and WAP domains 1)	Eppin Spinlw1	Rattus norvegicus (Rat)	134	acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; serine-type endopeptidase inhibitor activity [GO:0004867]; defense response to bacterium [GO:0042742]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of peptidase activity [GO:0010466]	acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0001669; GO:0004867; GO:0005615; GO:0005737; GO:0009986; GO:0010466; GO:0032991; GO:0042742; GO:0090281; GO:1901318	defense response to bacterium [GO:0042742]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of peptidase activity [GO:0010466]		NA	NA	NA	NA	NA	NA
TRINITY_DN2558_c0_g1_i1	Q9Z1Z3	EPN2_RAT	43.6	491	232	10	95	1471	1	478	8.00E-70	266.2	EPN2_RAT	reviewed	Epsin-2 (EPS-15-interacting protein 2)	Epn2	Rattus norvegicus (Rat)	583	clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]	clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0007219; GO:0030100; GO:0030125; GO:0030128; GO:0030276; GO:0030948; GO:0043231; GO:0045747; GO:0048568; GO:1903671	embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2558_c0_g1_i2	Q9Z1Z3	EPN2_RAT	40.7	506	250	12	95	1546	1	478	4.40E-71	270.4	EPN2_RAT	reviewed	Epsin-2 (EPS-15-interacting protein 2)	Epn2	Rattus norvegicus (Rat)	583	clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]	clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0007219; GO:0030100; GO:0030125; GO:0030128; GO:0030276; GO:0030948; GO:0043231; GO:0045747; GO:0048568; GO:1903671	embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2558_c0_g1_i3	Q9Z1Z3	EPN2_RAT	38.1	527	252	11	95	1600	1	478	5.20E-67	256.9	EPN2_RAT	reviewed	Epsin-2 (EPS-15-interacting protein 2)	Epn2	Rattus norvegicus (Rat)	583	clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]	clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0007219; GO:0030100; GO:0030125; GO:0030128; GO:0030276; GO:0030948; GO:0043231; GO:0045747; GO:0048568; GO:1903671	embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN9105_c0_g1_i1	O54698	S29A1_RAT	39.9	298	159	3	55	888	154	451	8.90E-51	202.2	S29A1_RAT	reviewed	"Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)"	Slc29a1 Ent1	Rattus norvegicus (Rat)	457	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]; adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; uridine transport [GO:0015862]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]	GO:0001504; GO:0005326; GO:0005337; GO:0005886; GO:0005887; GO:0006836; GO:0007595; GO:0015211; GO:0015213; GO:0015858; GO:0015860; GO:0015862; GO:0016021; GO:0016323; GO:0016324; GO:0030431; GO:0032238; GO:0060079; GO:0071333; GO:0071456; GO:0072531; GO:0098793; GO:0098794; GO:0098810; GO:1901642	adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; uridine transport [GO:0015862]		NA	NA	NA	NA	NA	NA
TRINITY_DN9105_c0_g1_i2	O54698	S29A1_RAT	37.6	442	234	5	94	1299	12	451	4.90E-71	270	S29A1_RAT	reviewed	"Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)"	Slc29a1 Ent1	Rattus norvegicus (Rat)	457	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]; adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; uridine transport [GO:0015862]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]	GO:0001504; GO:0005326; GO:0005337; GO:0005886; GO:0005887; GO:0006836; GO:0007595; GO:0015211; GO:0015213; GO:0015858; GO:0015860; GO:0015862; GO:0016021; GO:0016323; GO:0016324; GO:0030431; GO:0032238; GO:0060079; GO:0071333; GO:0071456; GO:0072531; GO:0098793; GO:0098794; GO:0098810; GO:1901642	adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; uridine transport [GO:0015862]		NA	NA	NA	NA	NA	NA
TRINITY_DN9105_c0_g1_i3	O54698	S29A1_RAT	37.6	442	234	5	101	1306	12	451	4.90E-71	270	S29A1_RAT	reviewed	"Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)"	Slc29a1 Ent1	Rattus norvegicus (Rat)	457	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]; adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; uridine transport [GO:0015862]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]	GO:0001504; GO:0005326; GO:0005337; GO:0005886; GO:0005887; GO:0006836; GO:0007595; GO:0015211; GO:0015213; GO:0015858; GO:0015860; GO:0015862; GO:0016021; GO:0016323; GO:0016324; GO:0030431; GO:0032238; GO:0060079; GO:0071333; GO:0071456; GO:0072531; GO:0098793; GO:0098794; GO:0098810; GO:1901642	adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; uridine transport [GO:0015862]		NA	NA	NA	NA	NA	NA
TRINITY_DN6959_c0_g1_i2	Q7RTT9	S29A4_HUMAN	57.9	145	60	1	616	182	63	206	9.60E-39	161.8	S29A4_HUMAN	reviewed	Equilibrative nucleoside transporter 4 (hENT4) (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)	SLC29A4 ENT4 PMAT PSEC0113	Homo sapiens (Human)	530	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0001692; GO:0005326; GO:0005337; GO:0005342; GO:0005886; GO:0006836; GO:0008324; GO:0008504; GO:0015101; GO:0015562; GO:0015695; GO:0015844; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098655; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1903825	cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN6959_c0_g1_i3	Q7RTT9	S29A4_HUMAN	57.9	145	60	1	1084	650	63	206	1.60E-38	161.8	S29A4_HUMAN	reviewed	Equilibrative nucleoside transporter 4 (hENT4) (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)	SLC29A4 ENT4 PMAT PSEC0113	Homo sapiens (Human)	530	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0001692; GO:0005326; GO:0005337; GO:0005342; GO:0005886; GO:0006836; GO:0008324; GO:0008504; GO:0015101; GO:0015562; GO:0015695; GO:0015844; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098655; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1903825	cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN6959_c0_g1_i3	Q7RTT9	S29A4_HUMAN	40.7	118	70	0	357	4	334	451	2.70E-22	107.8	S29A4_HUMAN	reviewed	Equilibrative nucleoside transporter 4 (hENT4) (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)	SLC29A4 ENT4 PMAT PSEC0113	Homo sapiens (Human)	530	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0001692; GO:0005326; GO:0005337; GO:0005342; GO:0005886; GO:0006836; GO:0008324; GO:0008504; GO:0015101; GO:0015562; GO:0015695; GO:0015844; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098655; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1903825	cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN26254_c0_g1_i1	Q92611	EDEM1_HUMAN	100	84	0	0	253	2	307	390	1.10E-42	173.3	EDEM1_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	EDEM1 EDEM KIAA0212	Homo sapiens (Human)	657	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0016235; GO:0030176; GO:0030433; GO:0036498; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN459_c0_g1_i1	Q925U4	EDEM1_MOUSE	64.7	360	126	1	1078	2	110	469	5.10E-136	485.7	EDEM1_MOUSE	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	Edem1 Edem	Mus musculus (Mouse)	652	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006986; GO:0016235; GO:0030176; GO:0030433; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN459_c0_g1_i3	Q925U4	EDEM1_MOUSE	58.9	56	22	1	254	90	110	165	1.20E-12	74.3	EDEM1_MOUSE	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	Edem1 Edem	Mus musculus (Mouse)	652	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006986; GO:0016235; GO:0030176; GO:0030433; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN459_c0_g1_i5	Q925U4	EDEM1_MOUSE	61.7	240	91	1	762	46	110	349	1.40E-82	307.8	EDEM1_MOUSE	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	Edem1 Edem	Mus musculus (Mouse)	652	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006986; GO:0016235; GO:0030176; GO:0030433; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN459_c0_g1_i6	Q925U4	EDEM1_MOUSE	60.2	176	69	1	609	85	110	285	6.50E-57	222.2	EDEM1_MOUSE	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	Edem1 Edem	Mus musculus (Mouse)	652	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006986; GO:0016235; GO:0030176; GO:0030433; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39032_c0_g1_i1	Q92611	EDEM1_HUMAN	100	130	0	0	3	392	133	262	7.60E-70	264.2	EDEM1_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	EDEM1 EDEM KIAA0212	Homo sapiens (Human)	657	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0016235; GO:0030176; GO:0030433; GO:0036498; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39872_c0_g1_i1	Q92611	EDEM1_HUMAN	100	153	0	0	460	2	266	418	5.20E-86	318.2	EDEM1_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	EDEM1 EDEM KIAA0212	Homo sapiens (Human)	657	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0016235; GO:0030176; GO:0030433; GO:0036498; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30911_c0_g1_i1	Q92611	EDEM1_HUMAN	76.7	90	21	0	316	47	472	561	3.40E-36	152.1	EDEM1_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	EDEM1 EDEM KIAA0212	Homo sapiens (Human)	657	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0016235; GO:0030176; GO:0030433; GO:0036498; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30911_c0_g1_i2	Q92611	EDEM1_HUMAN	70.8	120	35	0	368	9	472	591	1.70E-47	189.9	EDEM1_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 1	EDEM1 EDEM KIAA0212	Homo sapiens (Human)	657	"aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]"	GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0016235; GO:0030176; GO:0030433; GO:0036498; GO:0036510; GO:0044322; GO:0051787; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; IRE1-mediated unfolded protein response [GO:0036498]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14266_c0_g1_i1	Q9BV94	EDEM2_HUMAN	98.9	183	2	0	3	551	280	462	1.20E-105	383.6	EDEM2_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 2	EDEM2 C20orf31 C20orf49 UNQ573/PRO1135	Homo sapiens (Human)	578	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14266_c0_g1_i2	Q8BJT9	EDEM2_MOUSE	100	162	0	0	3	488	280	441	4.60E-93	341.7	EDEM2_MOUSE	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 2	Edem2	Mus musculus (Mouse)	577	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0036509; GO:0044322; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21421_c0_g1_i1	Q8BJT9	EDEM2_MOUSE	99.7	291	1	0	1	873	34	324	7.10E-169	594.3	EDEM2_MOUSE	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 2	Edem2	Mus musculus (Mouse)	577	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0036509; GO:0044322; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c3_g1_i1	Q9BV94	EDEM2_HUMAN	62.6	463	172	1	2343	958	36	498	2.10E-181	637.5	EDEM2_HUMAN	reviewed	ER degradation-enhancing alpha-mannosidase-like protein 2	EDEM2 C20orf31 C20orf49 UNQ573/PRO1135	Homo sapiens (Human)	578	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:0097466; GO:1904154; GO:1904382	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13884_c0_g1_i1	Q9BZQ6	EDEM3_HUMAN	84.2	38	6	0	69	182	358	395	5.00E-12	71.6	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g2_i1	Q9BZQ6	EDEM3_HUMAN	56.2	737	305	5	3085	914	60	791	7.20E-240	832	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g2_i4	Q6GQB9	EDEM3_XENLA	56.2	523	212	5	2446	914	261	778	3.70E-162	573.5	EDEM3_XENLA	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	edem3	Xenopus laevis (African clawed frog)	913	"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i1	Q6GQB9	EDEM3_XENLA	73.3	60	16	0	1	180	287	346	2.30E-20	100.1	EDEM3_XENLA	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	edem3	Xenopus laevis (African clawed frog)	913	"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i20	Q6GQB9	EDEM3_XENLA	73.3	60	16	0	1	180	287	346	1.90E-20	100.1	EDEM3_XENLA	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	edem3	Xenopus laevis (African clawed frog)	913	"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i29	Q6GQB9	EDEM3_XENLA	73.3	60	16	0	1	180	287	346	2.50E-20	100.1	EDEM3_XENLA	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	edem3	Xenopus laevis (African clawed frog)	913	"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i30	Q9BZQ6	EDEM3_HUMAN	64.1	301	106	1	3	899	60	360	2.30E-112	407.1	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i32	Q9BZQ6	EDEM3_HUMAN	64.1	301	106	1	3	899	60	360	2.30E-112	407.1	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i8	Q9BZQ6	EDEM3_HUMAN	66.2	337	112	1	3	1007	60	396	3.00E-132	473	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c0_g1_i9	Q6GQB9	EDEM3_XENLA	54.5	497	209	5	1	1455	287	778	1.90E-147	524.6	EDEM3_XENLA	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	edem3	Xenopus laevis (African clawed frog)	913	"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c4_g1_i2	Q9BZQ6	EDEM3_HUMAN	90.9	22	2	0	66	1	279	300	2.10E-05	49.7	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN37596_c0_g1_i1	Q9BZQ6	EDEM3_HUMAN	99.5	203	1	0	2	610	224	426	3.70E-116	418.7	EDEM3_HUMAN	reviewed	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	EDEM3 C1orf22	Homo sapiens (Human)	932	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904382	carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN28559_c0_g1_i1	Q76NM1	ERD2_PLAF7	47.9	71	37	0	217	5	93	163	1.80E-12	72.8	ERD2_PLAF7	reviewed	ER lumen protein-retaining receptor	ERD2 PF13_0280	Plasmodium falciparum (isolate 3D7)	221	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; signaling receptor activity [GO:0038023]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; signaling receptor activity [GO:0038023]	GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0015031; GO:0016021; GO:0038023; GO:0046923	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN37346_c0_g1_i1	P33946	ERD21_BOVIN	100	70	0	0	210	1	8	77	2.00E-32	139	ERD21_BOVIN	reviewed	ER lumen protein-retaining receptor 1 (KDEL endoplasmic reticulum protein retention receptor 1) (KDEL receptor 1)	KDELR1 KDELR	Bos taurus (Bovine)	212	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; T cell apoptotic process [GO:0070231]; T cell cytokine production [GO:0002369]; T cell differentiation [GO:0030217]"	cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]	GO:0000139; GO:0002369; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030217; GO:0030663; GO:0033116; GO:0046923; GO:0070231	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; T cell apoptotic process [GO:0070231]; T cell cytokine production [GO:0002369]; T cell differentiation [GO:0030217]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18966_c0_g1_i1	P33947	ERD22_HUMAN	100	212	0	0	48	683	1	212	1.10E-114	414.1	ERD22_HUMAN	reviewed	ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2)	KDELR2 ERD2.2	Homo sapiens (Human)	212	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]	GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030663; GO:0046923	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18966_c0_g1_i2	P33947	ERD22_HUMAN	94.8	212	11	0	48	683	1	212	4.20E-111	402.1	ERD22_HUMAN	reviewed	ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2)	KDELR2 ERD2.2	Homo sapiens (Human)	212	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]	GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030663; GO:0046923	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18966_c0_g2_i1	Q2KJ37	ERD22_BOVIN	100	212	0	0	48	683	1	212	1.10E-114	414.1	ERD22_BOVIN	reviewed	ER lumen protein-retaining receptor 2 (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2)	KDELR2	Bos taurus (Bovine)	212	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]	GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663; GO:0046923	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27158_c0_g1_i1	Q5ZKX9	ERD22_CHICK	78.3	212	46	0	853	218	1	212	4.70E-94	345.9	ERD22_CHICK	reviewed	ER lumen protein-retaining receptor 2 (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2)	KDELR2 RCJMB04_8l23	Gallus gallus (Chicken)	212	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]	GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663; GO:0046923	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		blue	blue	NA	NA	NA	NA
TRINITY_DN38983_c0_g1_i1	Q8R1L4	ERD23_MOUSE	100	197	0	0	592	2	15	211	4.40E-106	385.2	ERD23_MOUSE	reviewed	ER lumen protein-retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3) (KDEL receptor 3)	Kdelr3	Mus musculus (Mouse)	214	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]	GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663; GO:0046923	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3699_c0_g1_i1	Q6NRB9	EMC1_XENLA	35.3	1002	529	29	22	2715	1	987	1.20E-140	502.3	EMC1_XENLA	reviewed	ER membrane protein complex subunit 1	emc1	Xenopus laevis (African clawed frog)	987	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN40655_c0_g1_i1	Q8N766	EMC1_HUMAN	99.2	127	1	0	2	382	695	821	4.00E-68	258.5	EMC1_HUMAN	reviewed	ER membrane protein complex subunit 1	EMC1 KIAA0090 PSEC0263	Homo sapiens (Human)	993	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]		GO:0016021; GO:0032991; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN32640_c0_g1_i1	Q8N766	EMC1_HUMAN	98.9	89	1	0	1	267	905	993	5.10E-44	177.9	EMC1_HUMAN	reviewed	ER membrane protein complex subunit 1	EMC1 KIAA0090 PSEC0263	Homo sapiens (Human)	993	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]		GO:0016021; GO:0032991; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN26476_c0_g1_i1	Q9CRD2	EMC2_MOUSE	100	104	0	0	313	2	18	121	3.60E-54	211.8	EMC2_MOUSE	reviewed	ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35)	Emc2 Kiaa0103 Ttc35	Mus musculus (Mouse)	297	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN2668_c0_g1_i1	Q6TGY8	EMC2_DANRE	51.4	148	72	0	445	2	9	156	1.80E-39	163.7	EMC2_DANRE	reviewed	ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35)	emc2 ttc35 zgc:86891	Danio rerio (Zebrafish) (Brachydanio rerio)	297	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005783; GO:0072546			blue	blue	NA	NA	NA	NA
TRINITY_DN17371_c0_g1_i8	Q7SXW4	EMC3_DANRE	71.2	240	68	1	268	984	5	244	4.20E-97	356.3	EMC3_DANRE	reviewed	ER membrane protein complex subunit 3 (Protein pob) (Transmembrane protein 111)	emc3 pob tmem111 zgc:63727	Danio rerio (Zebrafish) (Brachydanio rerio)	261	ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network transport vesicle [GO:0030140]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]	ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network transport vesicle [GO:0030140]		GO:0005794; GO:0016021; GO:0030140; GO:0045494; GO:0060041; GO:0072546	photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]		blue	blue	NA	NA	NA	NA
TRINITY_DN16409_c0_g1_i1	Q9P0I2	EMC3_HUMAN	99.6	244	1	0	36	767	1	244	6.50E-134	478	EMC3_HUMAN	reviewed	ER membrane protein complex subunit 3 (Transmembrane protein 111)	EMC3 TMEM111	Homo sapiens (Human)	261	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN16409_c0_g1_i2	Q9P0I2	EMC3_HUMAN	100	244	0	0	36	767	1	244	1.30E-134	480.3	EMC3_HUMAN	reviewed	ER membrane protein complex subunit 3 (Transmembrane protein 111)	EMC3 TMEM111	Homo sapiens (Human)	261	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN1128_c0_g1_i1	Q6PBF7	EMC4_XENTR	55	169	68	4	567	79	14	180	2.90E-40	166.8	EMC4_XENTR	reviewed	ER membrane protein complex subunit 4 (Transmembrane protein 85)	emc4 tmem85	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	180	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			blue	blue	NA	NA	NA	NA
TRINITY_DN1128_c0_g1_i2	Q6PBF7	EMC4_XENTR	55	169	68	4	567	79	14	180	2.20E-40	167.2	EMC4_XENTR	reviewed	ER membrane protein complex subunit 4 (Transmembrane protein 85)	emc4 tmem85	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	180	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN27081_c0_g1_i1	Q3T0K8	EMC4_BOVIN	100	130	0	0	421	32	54	183	3.10E-69	262.3	EMC4_BOVIN	reviewed	ER membrane protein complex subunit 4 (Transmembrane protein 85)	EMC4 TMEM85	Bos taurus (Bovine)	183	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0006915; GO:0016021; GO:0072546	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN19412_c0_g1_i1	Q9NPA0	EMC7_HUMAN	99.1	106	1	0	320	3	93	198	9.60E-55	213.8	EMC7_HUMAN	reviewed	ER membrane protein complex subunit 7	EMC7 C11orf3 C15orf24 HT022 UNQ905/PRO1926	Homo sapiens (Human)	242	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]	GO:0016021; GO:0030246; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN19412_c0_g1_i2	Q9EP72	EMC7_MOUSE	97.3	110	3	0	332	3	88	197	1.00E-54	213.8	EMC7_MOUSE	reviewed	ER membrane protein complex subunit 7	Emc7 Orf3	Mus musculus (Mouse)	241	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]	GO:0016021; GO:0030246; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN7006_c0_g2_i1	Q0IHY5	EMC7_XENTR	52.8	161	67	4	38	496	53	212	4.20E-38	159.5	EMC7_XENTR	reviewed	ER membrane protein complex subunit 7	emc7	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	237	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN7006_c0_g1_i2	Q0IHY5	EMC7_XENTR	52.8	161	67	4	594	136	53	212	4.20E-38	159.5	EMC7_XENTR	reviewed	ER membrane protein complex subunit 7	emc7	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	237	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]		GO:0016021; GO:0072546			blue	blue	NA	NA	NA	NA
TRINITY_DN7006_c0_g1_i1	Q8WQG1	YLC1_CAEEL	58.2	79	31	1	363	133	120	198	1.20E-15	84.3	YLC1_CAEEL	reviewed	ER membrane protein complex subunit 7 homolog	C35D10.1	Caenorhabditis elegans	222	ER membrane protein complex [GO:0072546]	ER membrane protein complex [GO:0072546]		GO:0072546			NA	NA	NA	NA	NA	NA
TRINITY_DN1400_c0_g1_i1	Q5FVL2	EMC8_RAT	41.1	209	108	4	94	693	4	206	2.40E-35	150.6	EMC8_RAT	reviewed	ER membrane protein complex subunit 8 (Neighbor of COX4)	Emc8 Cox4nb	Rattus norvegicus (Rat)	207	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]		GO:0005737; GO:0005829; GO:0072546			blue	blue	NA	NA	NA	NA
TRINITY_DN626_c0_g1_i10	A6QLH5	ERI3_BOVIN	52.9	172	77	3	228	734	140	310	2.10E-45	184.1	ERI3_BOVIN	reviewed	ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein)	ERI3 PINT1 PRNPIP PRNPIP1	Bos taurus (Bovine)	337	"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0000467; GO:0000738; GO:0003676; GO:0006259; GO:0046872	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		NA	NA	NA	NA	NA	NA
TRINITY_DN626_c0_g1_i13	A6QLH5	ERI3_BOVIN	53.5	185	82	3	184	729	140	323	1.40E-51	204.9	ERI3_BOVIN	reviewed	ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein)	ERI3 PINT1 PRNPIP PRNPIP1	Bos taurus (Bovine)	337	"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0000467; GO:0000738; GO:0003676; GO:0006259; GO:0046872	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		NA	NA	NA	NA	NA	NA
TRINITY_DN626_c0_g1_i4	A6QLH5	ERI3_BOVIN	53.5	185	82	3	228	773	140	323	1.50E-51	204.9	ERI3_BOVIN	reviewed	ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein)	ERI3 PINT1 PRNPIP PRNPIP1	Bos taurus (Bovine)	337	"3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0000467; GO:0000738; GO:0003676; GO:0006259; GO:0046872	"DNA catabolic process, exonucleolytic [GO:0000738]; DNA metabolic process [GO:0006259]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1027_c0_g1_i1	Q9V3A6	ERO1L_DROME	53.1	471	197	10	1511	147	17	479	8.90E-139	495.4	ERO1L_DROME	reviewed	Ero1-like protein (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductin-1-like protein)	Ero1L CG1333	Drosophila melanogaster (Fruit fly)	483	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding in endoplasmic reticulum [GO:0034975]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0003756; GO:0005783; GO:0005789; GO:0015035; GO:0016491; GO:0016671; GO:0034975; GO:0051085	chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding in endoplasmic reticulum [GO:0034975]		NA	NA	NA	NA	NA	NA
TRINITY_DN1027_c0_g1_i3	Q9V3A6	ERO1L_DROME	52.7	469	196	10	1493	147	17	479	1.20E-138	495	ERO1L_DROME	reviewed	Ero1-like protein (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductin-1-like protein)	Ero1L CG1333	Drosophila melanogaster (Fruit fly)	483	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding in endoplasmic reticulum [GO:0034975]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0003756; GO:0005783; GO:0005789; GO:0015035; GO:0016491; GO:0016671; GO:0034975; GO:0051085	chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding in endoplasmic reticulum [GO:0034975]		NA	NA	NA	NA	NA	NA
TRINITY_DN33867_c0_g1_i1	Q96HE7	ERO1A_HUMAN	100	93	0	0	281	3	27	119	2.70E-53	208.8	ERO1A_HUMAN	reviewed	ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)	ERO1A ERO1L UNQ434/PRO865	Homo sapiens (Human)	468	"dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]"	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006464; GO:0009266; GO:0010260; GO:0015035; GO:0016020; GO:0016491; GO:0016671; GO:0018401; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034599; GO:0034975; GO:0034976; GO:0043231; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456	animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]		NA	NA	NA	NA	NA	NA
TRINITY_DN14878_c0_g1_i1	Q96HE7	ERO1A_HUMAN	100	204	0	0	2	613	143	346	1.60E-119	429.9	ERO1A_HUMAN	reviewed	ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)	ERO1A ERO1L UNQ434/PRO865	Homo sapiens (Human)	468	"dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]"	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006464; GO:0009266; GO:0010260; GO:0015035; GO:0016020; GO:0016491; GO:0016671; GO:0018401; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034599; GO:0034975; GO:0034976; GO:0043231; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456	animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]		NA	NA	NA	NA	NA	NA
TRINITY_DN14878_c0_g1_i2	Q96HE7	ERO1A_HUMAN	98.2	166	3	0	2	499	143	308	9.20E-97	354	ERO1A_HUMAN	reviewed	ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)	ERO1A ERO1L UNQ434/PRO865	Homo sapiens (Human)	468	"dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]"	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006464; GO:0009266; GO:0010260; GO:0015035; GO:0016020; GO:0016491; GO:0016671; GO:0018401; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034599; GO:0034975; GO:0034976; GO:0043231; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456	animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c0_g1_i3	Q3B7T1	EDRF1_HUMAN	47.8	136	63	4	143	529	47	181	8.40E-27	122.1	EDRF1_HUMAN	reviewed	Erythroid differentiation-related factor 1	EDRF1 C10orf137	Homo sapiens (Human)	1238	"nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]		GO:0005634; GO:0045893	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c0_g1_i4	Q5R9R1	EDRF1_PONAB	42.4	554	272	14	143	1735	47	576	2.40E-107	391	EDRF1_PONAB	reviewed	Erythroid differentiation-related factor 1	EDRF1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	1204	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN39209_c0_g1_i1	Q3B7T1	EDRF1_HUMAN	100	84	0	0	1	252	86	169	2.40E-40	165.6	EDRF1_HUMAN	reviewed	Erythroid differentiation-related factor 1	EDRF1 C10orf137	Homo sapiens (Human)	1238	"nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]		GO:0005634; GO:0045893	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2983_c0_g1_i2	P56571	ES1_RAT	63.4	205	73	1	1	615	61	263	1.40E-66	254.2	ES1_RAT	reviewed	"ES1 protein homolog, mitochondrial"		Rattus norvegicus (Rat)	266	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			blue	blue	NA	NA	NA	NA
TRINITY_DN1346_c0_g1_i3	Q76MT4	ESF1_RAT	43.3	178	72	2	534	1	322	470	4.20E-32	139.8	ESF1_RAT	reviewed	ESF1 homolog (ABT1-associated protein)	Esf1 Abtap	Rattus norvegicus (Rat)	842	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1346_c0_g1_i5	Q76MT4	ESF1_RAT	43.6	179	71	3	582	46	322	470	3.40E-32	140.2	ESF1_RAT	reviewed	ESF1 homolog (ABT1-associated protein)	Esf1 Abtap	Rattus norvegicus (Rat)	842	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN37418_c0_g1_i1	Q9ET47	ESPN_MOUSE	52.6	57	27	0	39	209	226	282	5.50E-11	67.8	ESPN_MOUSE	reviewed	Espin (Ectoplasmic specialization protein)	Espn	Mus musculus (Mouse)	871	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; locomotory behavior [GO:0007626]; microvillar actin bundle assembly [GO:0030034]; negative regulation of cytoskeleton organization [GO:0051494]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of filopodium assembly [GO:0051491]; sensory perception of sound [GO:0007605]	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]	actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005902; GO:0005903; GO:0007605; GO:0007626; GO:0015629; GO:0017124; GO:0030034; GO:0030046; GO:0031941; GO:0032420; GO:0032421; GO:0032426; GO:0043197; GO:0051015; GO:0051017; GO:0051491; GO:0051494; GO:0051639	actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; locomotory behavior [GO:0007626]; microvillar actin bundle assembly [GO:0030034]; negative regulation of cytoskeleton organization [GO:0051494]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of filopodium assembly [GO:0051491]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN37979_c0_g1_i1	Q9H0W9	CK054_HUMAN	100	70	0	0	3	212	135	204	2.70E-37	155.2	CK054_HUMAN	reviewed	Ester hydrolase C11orf54 (EC 3.1.-.-)	C11orf54 LP4947 PTD012	Homo sapiens (Human)	315	"extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	GO:0005634; GO:0005654; GO:0008270; GO:0016604; GO:0016788; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN36626_c0_g1_i1	Q9H0W9	CK054_HUMAN	100	68	0	0	205	2	6	73	2.70E-34	145.2	CK054_HUMAN	reviewed	Ester hydrolase C11orf54 (EC 3.1.-.-)	C11orf54 LP4947 PTD012	Homo sapiens (Human)	315	"extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	GO:0005634; GO:0005654; GO:0008270; GO:0016604; GO:0016788; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN33044_c0_g1_i1	Q5U2Q3	CK054_RAT	53.7	309	136	4	996	91	7	315	4.30E-94	346.3	CK054_RAT	reviewed	Ester hydrolase C11orf54 homolog (EC 3.1.-.-)		Rattus norvegicus (Rat)	315	"nuclear body [GO:0016604]; nucleus [GO:0005634]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	nuclear body [GO:0016604]; nucleus [GO:0005634]	"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	GO:0005634; GO:0008270; GO:0016604; GO:0016788			blue	blue	NA	NA	NA	NA
TRINITY_DN28367_c0_g1_i1	P47982	EST6_DROMA	44.3	88	40	4	261	4	28	108	1.10E-11	70.5	EST6_DROMA	reviewed	Esterase 6 (Est-6) (EC 3.1.1.1) (Carboxylic-ester hydrolase 6) (Carboxylesterase-6)	Est-6 est6	Drosophila mauritiana (Fruit fly)	542	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i6	P35501	ESTE_MYZPE	37.9	95	51	1	1221	937	29	115	9.30E-11	69.7	ESTE_MYZPE	reviewed	Esterase E4 (EC 3.1.1.1) (Carboxylic-ester hydrolase)		Myzus persicae (Green peach aphid) (Aphis persicae)	552	methyl indole-3-acetate esterase activity [GO:0080030]		methyl indole-3-acetate esterase activity [GO:0080030]	GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN35028_c0_g1_i1	Q8NBQ5	DHB11_HUMAN	100	75	0	0	225	1	164	238	6.30E-37	154.1	DHB11_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03) (CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2) (retSDR2) (Short chain dehydrogenase/reductase family 16C member 2)	HSD17B11 DHRS8 PAN1B SDR16C2 PSEC0029 UNQ207/PRO233	Homo sapiens (Human)	300	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	"estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]"	GO:0004303; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006703; GO:0006710; GO:0016229; GO:0016616	androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]		NA	NA	NA	NA	NA	NA
TRINITY_DN1112_c0_g1_i1	Q9EQ06	DHB11_MOUSE	36.7	259	160	2	132	908	6	260	3.40E-42	173.7	DHB11_MOUSE	reviewed	Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Dehydrogenase/reductase SDR family member 8)	Hsd17b11 Dhrs8 Pan1b	Mus musculus (Mouse)	298	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	"estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]"	GO:0004303; GO:0005737; GO:0005783; GO:0005811; GO:0006694; GO:0006710; GO:0016229; GO:0016616	androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN1112_c0_g1_i2	Q9EQ06	DHB11_MOUSE	36.7	259	160	2	141	917	6	260	3.50E-42	173.7	DHB11_MOUSE	reviewed	Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Dehydrogenase/reductase SDR family member 8)	Hsd17b11 Dhrs8 Pan1b	Mus musculus (Mouse)	298	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	"estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]"	GO:0004303; GO:0005737; GO:0005783; GO:0005811; GO:0006694; GO:0006710; GO:0016229; GO:0016616	androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2705_c0_g1_i4	Q62730	DHB2_RAT	37	273	161	5	805	2	84	350	2.10E-42	174.5	DHB2_RAT	reviewed	Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239)	Hsd17b2 Edh17b2	Rattus norvegicus (Rat)	381	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]	GO:0001701; GO:0001890; GO:0004303; GO:0006702; GO:0006703; GO:0016021; GO:0032526; GO:0043231; GO:0047035; GO:0060348; GO:0071248	androgen biosynthetic process [GO:0006702]; bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c1_g1_i1	Q92506	DHB8_HUMAN	47.9	257	130	3	82	843	6	261	2.10E-54	214.2	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c1_g1_i2	Q92506	DHB8_HUMAN	47.9	257	130	3	82	843	6	261	1.60E-54	214.5	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c1_g1_i3	Q92506	DHB8_HUMAN	47.9	257	130	3	82	843	6	261	1.20E-54	214.9	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN1700_c0_g1_i1	Q92506	DHB8_HUMAN	43.2	264	137	2	49	816	3	261	2.50E-47	190.7	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	1	NA	NA	1
TRINITY_DN5187_c0_g1_i2	Q92506	DHB8_HUMAN	35.4	127	74	1	474	118	3	129	3.90E-13	76.3	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN5187_c0_g2_i2	Q92506	DHB8_HUMAN	40.4	265	145	2	815	45	2	261	9.10E-47	188.7	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN5187_c0_g2_i3	Q92506	DHB8_HUMAN	40.4	267	144	2	895	119	2	261	9.90E-47	188.7	DHB8_HUMAN	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8 FABGL HKE6 RING2 SDR30C1	Homo sapiens (Human)	261	"mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003857; GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0046949; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN1700_c0_g1_i2	Q5TJF5	DHB8_CANLF	42	188	96	2	67	606	7	189	5.30E-27	123.2	DHB8_CANLF	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8	Canis lupus familiaris (Dog) (Canis familiaris)	259	"mitochondrial matrix [GO:0005759]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial matrix [GO:0005759]	"3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0004303; GO:0005759; GO:0006633; GO:0006703; GO:0016616; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN1700_c0_g1_i3	Q5TJF5	DHB8_CANLF	41.3	121	63	1	67	405	7	127	4.10E-14	79.3	DHB8_CANLF	reviewed	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	HSD17B8	Canis lupus familiaris (Dog) (Canis familiaris)	259	"mitochondrial matrix [GO:0005759]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"	mitochondrial matrix [GO:0005759]	"3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0004303; GO:0005759; GO:0006633; GO:0006703; GO:0016616; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN12172_c0_g1_i1	Q9D4V0	EKI1_MOUSE	40.9	347	201	3	77	1105	17	363	1.80E-74	281.2	EKI1_MOUSE	reviewed	Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)	Etnk1 Eki1	Mus musculus (Mouse)	363	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]	GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN12172_c0_g1_i4	Q9HBU6	EKI1_HUMAN	32.7	153	90	3	53	472	86	238	3.70E-20	99.8	EKI1_HUMAN	reviewed	Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)	ETNK1 EKI1	Homo sapiens (Human)	452	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]	GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646; GO:0016020	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN30418_c0_g1_i1	Q9ZVI9	PECT1_ARATH	46.2	78	42	0	3	236	270	347	6.40E-16	84.3	PECT1_ARATH	reviewed	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine cytidylyltransferase 1)	PECT1 At2g38670 T6A23.13	Arabidopsis thaliana (Mouse-ear cress)	421	Golgi apparatus [GO:0005794]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]	Golgi apparatus [GO:0005794]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0005739; GO:0005794; GO:0006646; GO:0031307	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN37943_c0_g1_i1	Q55BZ4	PCY2_DICDI	44.9	89	49	0	27	293	195	283	1.00E-18	94	PCY2_DICDI	reviewed	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)	pctA DDB_G0270298	Dictyostelium discoideum (Slime mold)	360	phagocytic vesicle [GO:0045335]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]	phagocytic vesicle [GO:0045335]	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0006646; GO:0045335	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN39638_c0_g1_i1	Q99447	PCY2_HUMAN	100	111	0	0	334	2	262	372	9.60E-58	223.8	PCY2_HUMAN	reviewed	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)	PCYT2	Homo sapiens (Human)	389	endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum membrane [GO:0005789]	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0005789; GO:0006646; GO:0008654	phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]		NA	NA	NA	NA	NA	NA
TRINITY_DN160_c0_g1_i1	Q99447	PCY2_HUMAN	66.5	355	111	4	1268	219	9	360	2.30E-142	506.9	PCY2_HUMAN	reviewed	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)	PCYT2	Homo sapiens (Human)	389	endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum membrane [GO:0005789]	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0005789; GO:0006646; GO:0008654	phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]		blue	blue	NA	NA	NA	NA
TRINITY_DN37990_c0_g1_i1	Q5EA75	PCY2_BOVIN	99.4	160	1	0	483	4	74	233	1.30E-90	333.6	PCY2_BOVIN	reviewed	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)	PCYT2	Bos taurus (Bovine)	389	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]		ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0006646	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN28154_c0_g1_i1	Q55BZ4	PCY2_DICDI	59.5	74	30	0	234	13	10	83	6.10E-22	104.4	PCY2_DICDI	reviewed	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)	pctA DDB_G0270298	Dictyostelium discoideum (Slime mold)	360	phagocytic vesicle [GO:0045335]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]	phagocytic vesicle [GO:0045335]	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0006646; GO:0045335	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN20638_c0_g1_i1	Q6DEB1	AT2L1_XENLA	81.6	114	21	0	3	344	45	158	1.10E-48	193.7	AT2L1_XENLA	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1	Xenopus laevis (African clawed frog)	509	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0050459			NA	NA	NA	NA	NA	NA
TRINITY_DN20638_c0_g2_i1	Q6DEB1	AT2L1_XENLA	66.7	120	40	0	2	361	201	320	2.70E-45	182.6	AT2L1_XENLA	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1	Xenopus laevis (African clawed frog)	509	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0050459			NA	NA	NA	NA	NA	NA
TRINITY_DN27668_c0_g1_i1	Q8BWU8	AT2L1_MOUSE	70.8	72	21	0	1	216	7	78	2.60E-27	122.1	AT2L1_MOUSE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	Etnppl Agxt2l1	Mus musculus (Mouse)	499	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0050459			NA	NA	NA	NA	NA	NA
TRINITY_DN40219_c0_g1_i1	Q8TBG4	AT2L1_HUMAN	49.6	137	63	2	395	3	203	339	1.30E-32	140.6	AT2L1_HUMAN	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	ETNPPL AGXT2L1	Homo sapiens (Human)	499	mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; phosphatidylethanolamine biosynthetic process [GO:0006646]	mitochondrial matrix [GO:0005759]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005759; GO:0006646; GO:0008483; GO:0030170; GO:0050459	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i10	Q7SY54	AT2L1_DANRE	38.9	440	259	4	1514	213	17	452	3.70E-86	320.5	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i11	Q7SY54	AT2L1_DANRE	39.2	426	252	3	1515	256	28	452	7.60E-86	319.7	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i12	Q7SY54	AT2L1_DANRE	39.2	426	252	3	1515	256	28	452	7.00E-86	319.7	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i4	Q7SY54	AT2L1_DANRE	39.2	426	252	3	1472	213	28	452	7.50E-86	319.7	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i5	Q7SY54	AT2L1_DANRE	39.2	426	252	3	1515	256	28	452	7.70E-86	319.7	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i6	Q7SY54	AT2L1_DANRE	39.2	426	252	3	1515	256	28	452	8.30E-86	319.7	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i8	Q7SY54	AT2L1_DANRE	38.9	440	259	4	1557	256	17	452	3.80E-86	320.5	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9974_c0_g1_i9	Q7SY54	AT2L1_DANRE	39.2	426	252	3	1515	256	28	452	6.30E-86	319.7	AT2L1_DANRE	reviewed	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	etnppl agxt2l1 zgc:63486	Danio rerio (Zebrafish) (Brachydanio rerio)	492	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; embryonic hemopoiesis [GO:0035162]	mitochondrion [GO:0005739]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005739; GO:0008483; GO:0030170; GO:0035162; GO:0050459	embryonic hemopoiesis [GO:0035162]		NA	NA	NA	NA	NA	NA
TRINITY_DN9819_c0_g1_i1	Q17QM4	EPT1_BOVIN	49.9	387	185	4	93	1244	1	381	4.10E-107	389.8	EPT1_BOVIN	reviewed	Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI)	SELENOI	Bos taurus (Bovine)	397	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; phosphatidylethanolamine biosynthetic process [GO:0006646]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0016021; GO:0016780; GO:0046872	phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN40972_c0_g1_i1	Q3IZP4	EPI_RHOS4	60.3	73	27	1	36	248	51	123	3.00E-19	95.5	EPI_RHOS4	reviewed	Ethylmalonyl-CoA/methylmalonyl-CoA epimerase (EC 5.1.99.-) (EC 5.1.99.1)	epi RSP_0812	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	134	metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]		metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]	GO:0004493; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3520_c0_g1_i1	Q08DE5	EI24_BOVIN	43.9	246	138	0	886	149	64	309	8.00E-51	202.6	EI24_BOVIN	reviewed	Etoposide-induced protein 2.4 homolog	EI24	Bos taurus (Bovine)	340	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN3520_c0_g1_i2	Q08DE5	EI24_BOVIN	38.1	333	180	1	1147	149	3	309	3.00E-56	220.7	EI24_BOVIN	reviewed	Etoposide-induced protein 2.4 homolog	EI24	Bos taurus (Bovine)	340	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN25832_c0_g1_i1	O14681	EI24_HUMAN	100	102	0	0	2	307	210	311	1.30E-53	209.9	EI24_HUMAN	reviewed	Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein)	EI24 PIG8	Homo sapiens (Human)	340	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; importin-alpha family protein binding [GO:0061676]; apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	importin-alpha family protein binding [GO:0061676]	GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0016236; GO:0030308; GO:0031965; GO:0061676	apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]		NA	NA	NA	NA	NA	NA
TRINITY_DN29775_c0_g1_i1	Q01842	POK_DROME	84.7	111	17	0	585	253	387	497	2.10E-49	198.4	POK_DROME	reviewed	Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan)	aop pok Yan CG3166	Drosophila melanogaster (Fruit fly)	732	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0001751; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0048747; GO:0050767; GO:0060233; GO:0090090; GO:0090175; GO:1903688	"border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle fiber development [GO:0048747]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4497_c0_g1_i1	P41970	ELK3_HUMAN	81.1	90	17	0	281	12	5	94	5.70E-38	157.9	ELK3_HUMAN	reviewed	ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2)	ELK3 NET SAP2	Homo sapiens (Human)	407	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]"	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045892; GO:0045944; GO:1990837	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4497_c0_g1_i2	P41970	ELK3_HUMAN	81.6	76	14	0	239	12	19	94	8.70E-32	137.1	ELK3_HUMAN	reviewed	ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2)	ELK3 NET SAP2	Homo sapiens (Human)	407	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]"	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045892; GO:0045944; GO:1990837	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39220_c0_g1_i1	Q32LN0	EHF_BOVIN	55.1	107	46	1	323	3	185	289	3.20E-25	115.9	EHF_BOVIN	reviewed	ETS homologous factor (ETS domain-containing transcription factor)	EHF	Bos taurus (Bovine)	300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0006366; GO:0030154; GO:0030855; GO:0043565; GO:0050673	cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i1	P51023	PNT_DROME	80	135	21	1	866	462	590	718	2.60E-57	224.6	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i2	P51023	PNT_DROME	78.7	122	20	1	442	77	590	705	5.20E-50	200.3	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i5	P51023	PNT_DROME	78.7	122	20	1	442	77	590	705	3.60E-50	200.3	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i6	P51023	PNT_DROME	78.7	122	20	1	442	77	590	705	5.50E-50	200.3	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i7	P51023	PNT_DROME	78.7	122	20	1	442	77	590	705	5.40E-50	200.3	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i8	P51023	PNT_DROME	80	135	21	1	866	462	590	718	3.40E-57	224.6	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21256_c0_g1_i9	P51023	PNT_DROME	78.7	122	20	1	442	77	590	705	5.30E-50	200.3	PNT_DROME	reviewed	ETS-like protein pointed	pnt DMPOINT1A ETS2 Ets58AB pointed CG17077	Drosophila melanogaster (Fruit fly)	718	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001228; GO:0001742; GO:0001751; GO:0005634; GO:0006357; GO:0007173; GO:0007424; GO:0007427; GO:0007428; GO:0007429; GO:0007455; GO:0007464; GO:0007465; GO:0007476; GO:0007479; GO:0008284; GO:0008340; GO:0008543; GO:0009997; GO:0010628; GO:0016318; GO:0030154; GO:0035154; GO:0035169; GO:0035170; GO:0035225; GO:0042461; GO:0043433; GO:0043565; GO:0043697; GO:0045500; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0048190; GO:0048747; GO:0050767; GO:0060438; GO:0061320; GO:0061331; GO:0090175; GO:1902692; GO:2001234	"cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; muscle fiber development [GO:0048747]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oenocyte differentiation [GO:0001742]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; pericardial nephrocyte differentiation [GO:0061320]; photoreceptor cell development [GO:0042461]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary branching, open tracheal system [GO:0007428]; R3/R4 cell fate commitment [GO:0007464]; R7 cell fate commitment [GO:0007465]; regulation of establishment of planar polarity [GO:0090175]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary branching, open tracheal system [GO:0007429]; sevenless signaling pathway [GO:0045500]; terminal cell fate specification, open tracheal system [GO:0035154]; trachea development [GO:0060438]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21280_c0_g1_i1	Q60775	ELF1_MOUSE	94.8	115	6	0	1	345	192	306	1.80E-59	229.6	ELF1_MOUSE	reviewed	ETS-related transcription factor Elf-1 (E74-like factor 1)	Elf1	Mus musculus (Mouse)	612	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0001817; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0030154; GO:0045893; GO:0045944; GO:0050860; GO:1990837	"cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21280_c0_g1_i2	P32519	ELF1_HUMAN	100	120	0	0	1	360	192	311	1.90E-65	249.6	ELF1_HUMAN	reviewed	ETS-related transcription factor Elf-1 (E74-like factor 1)	ELF1	Homo sapiens (Human)	619	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cytokine production [GO:0001817]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001817; GO:0001959; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045893; GO:0045944; GO:0050855; GO:0050860; GO:1990837	"cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21280_c0_g1_i3	P32519	ELF1_HUMAN	100	91	0	0	2	274	221	311	2.40E-47	189.1	ELF1_HUMAN	reviewed	ETS-related transcription factor Elf-1 (E74-like factor 1)	ELF1	Homo sapiens (Human)	619	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cytokine production [GO:0001817]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001817; GO:0001959; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045893; GO:0045944; GO:0050855; GO:0050860; GO:1990837	"cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1538_c0_g1_i1	P70531	EF2K_RAT	46.1	697	319	10	2042	87	40	724	2.70E-159	563.9	EF2K_RAT	reviewed	Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)	Eef2k	Rattus norvegicus (Rat)	724	dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]	dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]	GO:0002931; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637	cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]		blue	blue	NA	NA	NA	NA
TRINITY_DN1538_c0_g1_i4	P70531	EF2K_RAT	46.1	697	319	10	2042	87	40	724	1.50E-159	564.7	EF2K_RAT	reviewed	Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)	Eef2k	Rattus norvegicus (Rat)	724	dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]	dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]	GO:0002931; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637	cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]		NA	NA	NA	NA	NA	NA
TRINITY_DN1863_c0_g1_i1	P27639	IF4A_CAEEL	46.8	111	53	2	1	333	281	385	2.00E-24	113.2	IF4A_CAEEL	reviewed	Eukaryotic initiation factor 4A (eIF-4A) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A) (Initiation factor 1)	inf-1 F57B9.6	Caenorhabditis elegans	402	cytoplasmic stress granule [GO:0010494]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytoplasmic stress granule [GO:0010494]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003724; GO:0003743; GO:0005524; GO:0010494	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN16886_c0_g3_i1	Q3SZ54	IF4A1_BOVIN	100	400	0	0	1	1200	7	406	3.70E-227	788.5	IF4A1_BOVIN	reviewed	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)	EIF4A1	Bos taurus (Bovine)	406	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003724; GO:0003725; GO:0003743; GO:0005524; GO:0005737	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN16886_c0_g2_i1	Q3SZ54	IF4A1_BOVIN	100	377	0	0	1	1131	30	406	1.10E-212	740.3	IF4A1_BOVIN	reviewed	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)	EIF4A1	Bos taurus (Bovine)	406	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003724; GO:0003725; GO:0003743; GO:0005524; GO:0005737	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN19852_c1_g1_i1	Q3SZ54	IF4A1_BOVIN	88.2	68	8	0	205	2	286	353	1.40E-27	122.9	IF4A1_BOVIN	reviewed	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)	EIF4A1	Bos taurus (Bovine)	406	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003724; GO:0003725; GO:0003743; GO:0005524; GO:0005737	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c1_g1_i1	Q3SZ65	IF4A2_BOVIN	80	405	80	1	1272	61	3	407	7.80E-188	657.9	IF4A2_BOVIN	reviewed	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)	EIF4A2	Bos taurus (Bovine)	407	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003729; GO:0003743; GO:0005524; GO:0005730; GO:0071013			blue	blue	NA	NA	NA	NA
TRINITY_DN16886_c0_g1_i1	Q3SZ65	IF4A2_BOVIN	99.7	292	1	0	944	69	116	407	1.80E-165	583.2	IF4A2_BOVIN	reviewed	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)	EIF4A2	Bos taurus (Bovine)	407	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003729; GO:0003743; GO:0005524; GO:0005730; GO:0071013			NA	NA	NA	NA	NA	NA
TRINITY_DN16886_c0_g1_i5	Q3SZ65	IF4A2_BOVIN	100	401	0	0	1248	46	7	407	4.60E-230	798.1	IF4A2_BOVIN	reviewed	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)	EIF4A2	Bos taurus (Bovine)	407	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003729; GO:0003743; GO:0005524; GO:0005730; GO:0071013			NA	NA	NA	NA	NA	NA
TRINITY_DN16886_c0_g1_i6	Q3SZ65	IF4A2_BOVIN	100	401	0	0	1248	46	7	407	4.60E-230	798.1	IF4A2_BOVIN	reviewed	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)	EIF4A2	Bos taurus (Bovine)	407	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003729; GO:0003743; GO:0005524; GO:0005730; GO:0071013			NA	NA	NA	NA	NA	NA
TRINITY_DN7491_c0_g1_i1	Q2NL22	IF4A3_BOVIN	100	394	0	0	1244	63	18	411	1.30E-224	780	IF4A3_BOVIN	reviewed	"Eukaryotic initiation factor 4A-III (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]"	EIF4A3 DDX48	Bos taurus (Bovine)	411	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; rRNA processing [GO:0006364]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0008143; GO:0016607; GO:0017148; GO:0035145; GO:0045727; GO:0048701; GO:0051028; GO:0071006; GO:0071013	"embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23113_c0_g1_i1	Q2NL22	IF4A3_BOVIN	100	203	0	0	610	2	96	298	1.10E-112	407.1	IF4A3_BOVIN	reviewed	"Eukaryotic initiation factor 4A-III (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]"	EIF4A3 DDX48	Bos taurus (Bovine)	411	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; rRNA processing [GO:0006364]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0008143; GO:0016607; GO:0017148; GO:0035145; GO:0045727; GO:0048701; GO:0051028; GO:0071006; GO:0071013	"embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23575_c0_g1_i1	Q9VHS8	IF4A3_DROME	92.6	391	29	0	1263	91	9	399	5.70E-210	731.5	IF4A3_DROME	reviewed	Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13)	CG7483	Drosophila melanogaster (Fruit fly)	399	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0006325; GO:0008380; GO:0010628; GO:0045451; GO:0045495; GO:0051028; GO:0071011; GO:0071013; GO:1903040	"chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4162_c0_g2_i1	Q9VHS8	IF4A3_DROME	78.3	295	64	0	971	87	105	399	2.00E-135	483.4	IF4A3_DROME	reviewed	Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13)	CG7483	Drosophila melanogaster (Fruit fly)	399	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0006325; GO:0008380; GO:0010628; GO:0045451; GO:0045495; GO:0051028; GO:0071011; GO:0071013; GO:1903040	"chromatin organization [GO:0006325]; exon-exon junction complex assembly [GO:1903040]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of gene expression [GO:0010628]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4162_c0_g1_i1	Q5U526	I4A3A_XENLA	64	75	27	0	12	236	31	105	1.10E-22	107.1	I4A3A_XENLA	reviewed	Eukaryotic initiation factor 4A-III-A (eIF-4A-III-A) (eIF4A-III-A) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48-A) (ATP-dependent RNA helicase eIF4A-3-A) (DEAD box protein 48-A) (Eukaryotic translation initiation factor 4A isoform 3 A)	eif4a3-a ddx48-a	Xenopus laevis (African clawed frog)	415	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000381; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0051028	"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14140_c0_g1_i1	O42226	I4A3B_XENLA	98.3	120	2	0	2	361	291	410	1.10E-62	240.4	I4A3B_XENLA	reviewed	Eukaryotic initiation factor 4A-III-B (XeIF-4AIII) (eIF-4A-III-B) (eIF4A-III-B) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48-B) (ATP-dependent RNA helicase eIF4A-3-B) (DEAD box protein 48-B) (Eukaryotic translation initiation factor 4A isoform 3-B)	eif4a3-b ddx48	Xenopus laevis (African clawed frog)	414	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000381; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0051028	"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26_c0_g1_i1	P15170	ERF3A_HUMAN	72.7	440	118	1	57	1376	58	495	9.10E-193	674.5	ERF3A_HUMAN	reviewed	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)	GSPT1 ERF3A	Homo sapiens (Human)	499	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]	GO:0000082; GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006449; GO:0006479; GO:0018444	"cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34391_c0_g1_i1	P15170	ERF3A_HUMAN	75.9	158	38	0	479	6	72	229	1.70E-66	253.4	ERF3A_HUMAN	reviewed	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)	GSPT1 ERF3A	Homo sapiens (Human)	499	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]	GO:0000082; GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006449; GO:0006479; GO:0018444	"cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33901_c0_g1_i1	P15170	ERF3A_HUMAN	100	160	0	0	2	481	340	499	9.20E-90	330.9	ERF3A_HUMAN	reviewed	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)	GSPT1 ERF3A	Homo sapiens (Human)	499	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]	GO:0000082; GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006449; GO:0006479; GO:0018444	"cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40022_c0_g1_i1	P15170	ERF3A_HUMAN	56.9	109	46	1	331	5	71	178	1.50E-30	133.7	ERF3A_HUMAN	reviewed	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)	GSPT1 ERF3A	Homo sapiens (Human)	499	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]	GO:0000082; GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006449; GO:0006479; GO:0018444	"cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36085_c0_g1_i1	P15170	ERF3A_HUMAN	99.3	283	2	0	20	868	57	339	5.60E-166	584.7	ERF3A_HUMAN	reviewed	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)	GSPT1 ERF3A	Homo sapiens (Human)	499	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]	GO:0000082; GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006449; GO:0006479; GO:0018444	"cytoplasmic translational termination [GO:0002184]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4582_c0_g1_i1	O59948	ERF1_PODAS	52.9	70	24	1	31	240	373	433	3.80E-14	78.6	ERF1_PODAS	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	SU2	Podospora anserina (Pleurage anserina)	435	cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]	cytoplasm [GO:0005737]	translation release factor activity [GO:0003747]	GO:0003747; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN26031_c0_g1_i1	O59948	ERF1_PODAS	52.7	74	32	1	231	10	362	432	1.80E-18	92.8	ERF1_PODAS	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	SU2	Podospora anserina (Pleurage anserina)	435	cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]	cytoplasm [GO:0005737]	translation release factor activity [GO:0003747]	GO:0003747; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN33960_c0_g1_i1	Q9VPH7	ERF1_DROME	73	311	82	2	933	4	1	310	1.20E-134	480.7	ERF1_DROME	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	eRF1 CG5605	Drosophila melanogaster (Fruit fly)	438	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]; cytoplasmic translational termination [GO:0002184]; translational termination [GO:0006415]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	"sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]"	GO:0002184; GO:0005829; GO:0006415; GO:0016149; GO:0018444; GO:1990825	cytoplasmic translational termination [GO:0002184]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN4854_c0_g1_i1	Q9VPH7	ERF1_DROME	88.3	437	50	1	101	1408	2	438	1.10E-222	773.9	ERF1_DROME	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	eRF1 CG5605	Drosophila melanogaster (Fruit fly)	438	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]; cytoplasmic translational termination [GO:0002184]; translational termination [GO:0006415]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	"sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]"	GO:0002184; GO:0005829; GO:0006415; GO:0016149; GO:0018444; GO:1990825	cytoplasmic translational termination [GO:0002184]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN6465_c0_g1_i1	Q9U8U5	ERF1_TETTH	66.3	83	28	0	6	254	114	196	2.10E-25	115.9	ERF1_TETTH	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	ERF1	Tetrahymena thermophila	435	cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]	cytoplasm [GO:0005737]	translation release factor activity [GO:0003747]	GO:0003747; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN16679_c0_g1_i1	Q0VCX5	ERF1_BOVIN	100	437	0	0	1340	30	1	437	1.80E-251	869.4	ERF1_BOVIN	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	ETF1	Bos taurus (Bovine)	437	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]	"sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]"	GO:0000184; GO:0002184; GO:0005737; GO:0005829; GO:0006449; GO:0006479; GO:0008079; GO:0016149; GO:0018444; GO:1990825	"cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16679_c0_g1_i2	Q0VCX5	ERF1_BOVIN	100	437	0	0	1340	30	1	437	1.80E-251	869.4	ERF1_BOVIN	reviewed	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	ETF1	Bos taurus (Bovine)	437	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]	"sequence-specific mRNA binding [GO:1990825]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]"	GO:0000184; GO:0002184; GO:0005737; GO:0005829; GO:0006449; GO:0006479; GO:0008079; GO:0016149; GO:0018444; GO:1990825	"cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3448_c0_g1_i1	D5LHJ0	ERF1X_BRAOB	53.1	113	53	0	19	357	2	114	6.50E-28	124.8	ERF1X_BRAOB	reviewed	Eukaryotic peptide chain release factor subunit 1-1 (BoeRF1-1) (Eukaryotic release factor 1-1)	ERF1-1	Brassica oleracea var. botrytis (Cauliflower)	434	cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]; regulation of growth [GO:0040008]	cytoplasm [GO:0005737]	translation release factor activity [GO:0003747]	GO:0003747; GO:0005737; GO:0040008	regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4781_c0_g1_i1	P13060	EF2_DROME	61.5	91	35	0	273	1	752	842	1.20E-26	120.2	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN4781_c0_g1_i2	P13060	EF2_DROME	59.2	98	40	0	294	1	745	842	3.20E-28	125.6	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN19008_c0_g2_i1	P13060	EF2_DROME	84.8	66	10	0	201	4	425	490	3.40E-26	118.2	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN19008_c3_g1_i1	P13060	EF2_DROME	75.3	85	21	0	258	4	417	501	2.70E-32	139	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16394_c1_g1_i1	P13060	EF2_DROME	82.3	79	14	0	3	239	5	83	6.10E-30	131	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c0_g1_i1	P13060	EF2_DROME	82	89	14	1	1	267	743	829	2.00E-37	156	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN22904_c0_g1_i1	P13060	EF2_DROME	75.7	70	17	0	1	210	741	810	4.70E-26	117.9	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c0_g1_i1	P13060	EF2_DROME	86.8	53	7	0	251	93	460	512	1.50E-18	93.2	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c2_g1_i1	P13060	EF2_DROME	83.1	71	12	0	8	220	482	552	1.50E-27	122.9	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c4_g1_i1	P13060	EF2_DROME	69.5	95	29	0	2	286	379	473	2.50E-30	132.5	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN21227_c2_g1_i1	P13060	EF2_DROME	82.9	82	14	0	254	9	3	84	3.50E-31	135.2	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN39440_c1_g1_i1	P13060	EF2_DROME	71.6	67	19	0	202	2	436	502	9.20E-19	93.6	EF2_DROME	reviewed	Eukaryotic translation elongation factor 2 (Elongation factor 2) (EF-2)	eEF2 EF2 Ef2b CG2238	Drosophila melanogaster (Fruit fly)	844	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0043022; GO:1990904	translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN2905_c0_g1_i1	Q5E938	EIF1_BOVIN	100	113	0	0	385	47	1	113	1.80E-61	236.5	EIF1_BOVIN	reviewed	Eukaryotic translation initiation factor 1 (eIF1) (Protein translation factor SUI1 homolog)	EIF1 SUI1	Bos taurus (Bovine)	113	eukaryotic 43S preinitiation complex [GO:0016282]; nucleus [GO:0005634]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; nucleus [GO:0005634]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0006446; GO:0009048; GO:0016282; GO:0043024	dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN2905_c0_g1_i2	Q5E938	EIF1_BOVIN	98	49	1	0	193	47	65	113	8.10E-23	107.5	EIF1_BOVIN	reviewed	Eukaryotic translation initiation factor 1 (eIF1) (Protein translation factor SUI1 homolog)	EIF1 SUI1	Bos taurus (Bovine)	113	eukaryotic 43S preinitiation complex [GO:0016282]; nucleus [GO:0005634]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; nucleus [GO:0005634]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0006446; GO:0009048; GO:0016282; GO:0043024	dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN36537_c0_g1_i1	O60739	EIF1B_HUMAN	100	98	0	0	3	296	16	113	3.70E-52	205.3	EIF1B_HUMAN	reviewed	Eukaryotic translation initiation factor 1b (eIF1b) (Protein translation factor SUI1 homolog GC20)	EIF1B	Homo sapiens (Human)	113	eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0006446; GO:0016282; GO:0043024	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN28782_c0_g1_i1	Q869N9	IF2A_DICDI	39.4	71	41	1	1	207	21	91	1.90E-06	52.8	IF2A_DICDI	reviewed	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha)	eif2s1 eif2a DDB_G0271862	Dictyostelium discoideum (Slime mold)	341	eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; multi-eIF complex [GO:0043614]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; multi-eIF complex [GO:0043614]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005850; GO:0005851; GO:0033290; GO:0043022; GO:0043614			NA	NA	NA	NA	NA	NA
TRINITY_DN147_c4_g1_i1	P41374	IF2A_DROME	69.4	294	90	0	970	89	1	294	2.80E-111	403.3	IF2A_DROME	reviewed	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha)	eIF2alpha eIF2-alpha eIF2a CG9946	Drosophila melanogaster (Fruit fly)	341	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; multi-eIF complex [GO:0043614]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; multi-eIF complex [GO:0043614]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005829; GO:0005850; GO:0005851; GO:0006413; GO:0033290; GO:0043022; GO:0043614	translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN14758_c0_g1_i1	P05198	IF2A_HUMAN	45.3	86	47	0	265	8	162	247	2.40E-14	79.3	IF2A_HUMAN	reviewed	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	EIF2S1 EIF2A	Homo sapiens (Human)	315	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; translation initiation ternary complex [GO:0044207]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043614; GO:0044207; GO:0046777; GO:0055085; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN17833_c0_g1_i1	P05198	IF2A_HUMAN	100	258	0	0	61	834	1	258	5.40E-142	505	IF2A_HUMAN	reviewed	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	EIF2S1 EIF2A	Homo sapiens (Human)	315	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; translation initiation ternary complex [GO:0044207]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043614; GO:0044207; GO:0046777; GO:0055085; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN17833_c0_g1_i2	P68102	IF2A_BOVIN	100	211	0	0	3	635	59	269	7.30E-115	414.5	IF2A_BOVIN	reviewed	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	EIF2S1 EIF2A	Bos taurus (Bovine)	315	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cellular response to amino acid starvation [GO:0034198]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; stress granule assembly [GO:0034063]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005850; GO:0005851; GO:0006412; GO:0010494; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034644; GO:0034976; GO:0043022; GO:0043558; GO:0043614; GO:0046777; GO:1901216	cellular response to amino acid starvation [GO:0034198]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; stress granule assembly [GO:0034063]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN17833_c0_g1_i3	P05198	IF2A_HUMAN	100	200	0	0	3	602	59	258	1.30E-108	393.7	IF2A_HUMAN	reviewed	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	EIF2S1 EIF2A	Homo sapiens (Human)	315	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; translation initiation ternary complex [GO:0044207]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043614; GO:0044207; GO:0046777; GO:0055085; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN34748_c0_g1_i1	Q5E9D0	IF2B_BOVIN	47.5	122	60	2	372	13	186	305	1.70E-29	130.2	IF2B_BOVIN	reviewed	Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)	EIF2S2	Bos taurus (Bovine)	333	eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]	eukaryotic translation initiation factor 2 complex [GO:0005850]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001731; GO:0001732; GO:0003729; GO:0003743; GO:0005850; GO:0031369; GO:0046872	formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]		NA	NA	NA	NA	NA	NA
TRINITY_DN27146_c0_g1_i1	Q99L45	IF2B_MOUSE	100	150	0	0	452	3	152	301	7.00E-83	307.8	IF2B_MOUSE	reviewed	Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)	Eif2s2	Mus musculus (Mouse)	331	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001701; GO:0001731; GO:0001732; GO:0002176; GO:0003729; GO:0003743; GO:0005737; GO:0005850; GO:0008584; GO:0031369; GO:0046872	formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]		NA	NA	NA	NA	NA	NA
TRINITY_DN35610_c0_g1_i1	P20042	IF2B_HUMAN	74	181	45	1	633	91	155	333	6.30E-75	282	IF2B_HUMAN	reviewed	Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)	EIF2S2 EIF2B	Homo sapiens (Human)	333	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"	GO:0001701; GO:0001731; GO:0001732; GO:0002176; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008584; GO:0031369; GO:0046872; GO:0055085	formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]		blue	blue	NA	NA	NA	NA
TRINITY_DN26924_c0_g1_i1	Q2KHU8	IF2G_BOVIN	100	87	0	0	261	1	118	204	4.00E-43	174.9	IF2G_BOVIN	reviewed	Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma) (eIF-2-gamma)	EIF2S3	Bos taurus (Bovine)	472	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0045903	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN33691_c0_g1_i1	Q2KHU8	IF2G_BOVIN	100	88	0	0	266	3	300	387	3.70E-44	178.3	IF2G_BOVIN	reviewed	Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma) (eIF-2-gamma)	EIF2S3	Bos taurus (Bovine)	472	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0045903	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN32951_c0_g1_i1	Q2KHU8	IF2G_BOVIN	98	203	4	0	615	7	211	413	2.60E-109	396	IF2G_BOVIN	reviewed	Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma) (eIF-2-gamma)	EIF2S3	Bos taurus (Bovine)	472	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0045903	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN32943_c0_g1_i1	Q2KHU8	IF2G_BOVIN	70.7	270	78	1	810	1	137	405	9.40E-107	387.9	IF2G_BOVIN	reviewed	Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma) (eIF-2-gamma)	EIF2S3	Bos taurus (Bovine)	472	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0045903	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN1649_c0_g1_i1	C9WPN6	IF2H_RAT	85.8	303	42	1	910	2	122	423	1.90E-148	526.6	IF2H_RAT	reviewed	"Eukaryotic translation initiation factor 2 subunit 3, Y-linked (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma, Y-linked) (eIF-2-gamma Y)"	Eif2s3y	Rattus norvegicus (Rat)	472	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005850; GO:0045903	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]		blue	blue	NA	NA	NA	NA
TRINITY_DN14758_c0_g2_i1	P56286	IF2A_SCHPO	64.1	117	42	0	12	362	4	120	2.40E-36	152.9	IF2A_SCHPO	reviewed	Eukaryotic translation initiation factor 2 subunit alpha (eIF-2-alpha)	tif211 SPAC3G9.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	306	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; multi-eIF complex [GO:0043614]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; mitotic G1 DNA damage checkpoint [GO:0031571]	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; multi-eIF complex [GO:0043614]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003723; GO:0003743; GO:0005829; GO:0005850; GO:0005851; GO:0031571; GO:0033290; GO:0043022; GO:0043614	cytoplasmic translational initiation [GO:0002183]; mitotic G1 DNA damage checkpoint [GO:0031571]		NA	NA	NA	NA	NA	NA
TRINITY_DN12194_c0_g1_i1	O96719	IF2G_ENCCU	53.6	112	50	1	3	338	193	302	1.80E-27	123.2	IF2G_ENCCU	reviewed	Eukaryotic translation initiation factor 2 subunit gamma (eIF-2-gamma) (EC 3.6.5.3)	ECU01_0700	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	439	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN417_c0_g1_i1	Q4QRJ7	EIF2A_DANRE	41.5	583	313	7	1806	85	15	578	1.10E-110	402.1	EIF2A_DANRE	reviewed	Eukaryotic translation initiation factor 2A (eIF-2A)	eif2a zgc:110460	Danio rerio (Zebrafish) (Brachydanio rerio)	580	cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]	cytosolic small ribosomal subunit [GO:0022627]	mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]	GO:0000049; GO:0003729; GO:0003743; GO:0022627; GO:0043022			blue	blue	NA	NA	NA	NA
TRINITY_DN11940_c0_g2_i3	Q9NIV1	E2AK3_DROME	35.6	494	184	11	1168	74	632	1120	7.10E-66	252.7	E2AK3_DROME	reviewed	Eukaryotic translation initiation factor 2-alpha kinase (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (DmPEK) (PEK) (PERK)	PEK EIF2AK3 CG2087	Drosophila melanogaster (Fruit fly)	1162	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004686; GO:0004694; GO:0005524; GO:0005789; GO:0010389; GO:0010508; GO:0016021; GO:0022626; GO:0036499; GO:0046330	PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN11940_c0_g2_i5	Q9NIV1	E2AK3_DROME	30.1	352	118	8	737	63	632	982	9.10E-30	132.1	E2AK3_DROME	reviewed	Eukaryotic translation initiation factor 2-alpha kinase (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (DmPEK) (PEK) (PERK)	PEK EIF2AK3 CG2087	Drosophila melanogaster (Fruit fly)	1162	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004686; GO:0004694; GO:0005524; GO:0005789; GO:0010389; GO:0010508; GO:0016021; GO:0022626; GO:0036499; GO:0046330	PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN23554_c0_g1_i1	Q9NIV1	E2AK3_DROME	37.8	164	91	5	3	479	238	395	2.20E-21	103.6	E2AK3_DROME	reviewed	Eukaryotic translation initiation factor 2-alpha kinase (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (DmPEK) (PEK) (PERK)	PEK EIF2AK3 CG2087	Drosophila melanogaster (Fruit fly)	1162	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004686; GO:0004694; GO:0005524; GO:0005789; GO:0010389; GO:0010508; GO:0016021; GO:0022626; GO:0036499; GO:0046330	PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN9830_c0_g1_i1	Q9NIV1	E2AK3_DROME	47.8	113	53	3	38	373	59	166	2.60E-22	106.7	E2AK3_DROME	reviewed	Eukaryotic translation initiation factor 2-alpha kinase (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (DmPEK) (PEK) (PERK)	PEK EIF2AK3 CG2087	Drosophila melanogaster (Fruit fly)	1162	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004686; GO:0004694; GO:0005524; GO:0005789; GO:0010389; GO:0010508; GO:0016021; GO:0022626; GO:0036499; GO:0046330	PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN9830_c0_g1_i3	Q9NIV1	E2AK3_DROME	44.9	138	70	3	409	819	59	191	1.20E-27	125.2	E2AK3_DROME	reviewed	Eukaryotic translation initiation factor 2-alpha kinase (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (DmPEK) (PEK) (PERK)	PEK EIF2AK3 CG2087	Drosophila melanogaster (Fruit fly)	1162	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	cytosolic ribosome [GO:0022626]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; elongation factor-2 kinase activity [GO:0004686]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004686; GO:0004694; GO:0005524; GO:0005789; GO:0010389; GO:0010508; GO:0016021; GO:0022626; GO:0036499; GO:0046330	PERK-mediated unfolded protein response [GO:0036499]; positive regulation of autophagy [GO:0010508]; positive regulation of JNK cascade [GO:0046330]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN10470_c0_g1_i1	Q63185	E2AK1_RAT	40.5	168	96	3	12	512	417	581	6.90E-26	119	E2AK1_RAT	reviewed	Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase)	Eif2ak1 Hri	Rattus norvegicus (Rat)	620	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; response to iron ion starvation [GO:1990641]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]	GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006417; GO:0006909; GO:0008285; GO:0010999; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0055072; GO:0140467; GO:0140468; GO:1990641	acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; response to iron ion starvation [GO:1990641]		NA	NA	NA	NA	NA	NA
TRINITY_DN36736_c0_g1_i1	Q9BQI3	E2AK1_HUMAN	100	84	0	0	255	4	475	558	3.90E-43	174.9	E2AK1_HUMAN	reviewed	Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (hHRI) (Hemin-sensitive initiation factor 2-alpha kinase)	EIF2AK1 HRI KIAA1369 PRO1362	Homo sapiens (Human)	630	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]	GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006909; GO:0008285; GO:0010999; GO:0020037; GO:0030225; GO:0042803; GO:0045993; GO:0046501; GO:0046777; GO:0046986; GO:0055072; GO:0140467; GO:0140468; GO:1990641	acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]		NA	NA	NA	NA	NA	NA
TRINITY_DN11940_c0_g2_i4	Q9Z2B5	E2AK3_MOUSE	33.2	533	213	11	1512	322	584	1109	8.30E-67	256.1	E2AK3_MOUSE	reviewed	Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase)	Eif2ak3 Pek Perk	Mus musculus (Mouse)	1114	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic initiation factor eIF2 binding [GO:0071074]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic initiation factor eIF2 binding [GO:0071074]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0010998; GO:0016021; GO:0017148; GO:0018105; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0022626; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032092; GO:0032933; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0043066; GO:0045444; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0071074; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990440	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN11940_c0_g2_i8	Q9Z1Z1	E2AK3_RAT	33.5	540	216	12	1524	301	576	1104	2.00E-68	261.5	E2AK3_RAT	reviewed	Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase)	Eif2ak3 Pek Perk	Rattus norvegicus (Rat)	1108	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0010998; GO:0016021; GO:0017148; GO:0018105; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0022626; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032092; GO:0032933; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0043066; GO:0045444; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990440; GO:1990737	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN33657_c0_g1_i1	Q9NZJ5	E2AK3_HUMAN	100	98	0	0	1	294	959	1056	1.20E-51	203.4	E2AK3_HUMAN	reviewed	Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK)	EIF2AK3 PEK PERK	Homo sapiens (Human)	1116	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0010998; GO:0016020; GO:0017148; GO:0018105; GO:0019722; GO:0019899; GO:0019903; GO:0022626; GO:0030176; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032057; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070417; GO:1900182; GO:1902235; GO:1990737	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN16649_c0_g1_i1	Q9NZJ5	E2AK3_HUMAN	47.4	78	34	2	9	227	869	944	2.60E-14	79	E2AK3_HUMAN	reviewed	Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK)	EIF2AK3 PEK PERK	Homo sapiens (Human)	1116	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0010998; GO:0016020; GO:0017148; GO:0018105; GO:0019722; GO:0019899; GO:0019903; GO:0022626; GO:0030176; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032057; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070417; GO:1900182; GO:1902235; GO:1990737	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN6088_c0_g1_i1	B4K250	EIF3A_DROGR	63	46	17	0	139	2	1	46	2.60E-08	59.3	EIF3A_DROGR	reviewed	Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10)	eIF3a eIF3-S10 GH11742	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	893	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN7500_c0_g1_i1	Q173M7	EIF3A_AEDAE	59.4	367	149	0	1279	179	199	565	2.40E-117	423.7	EIF3A_AEDAE	reviewed	Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10)	eIF3-S10 AAEL007078	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1133	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN32532_c0_g1_i1	Q14152	EIF3A_HUMAN	98.6	73	1	0	3	221	330	402	1.00E-34	146.7	EIF3A_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185)	EIF3A EIF3S10 KIAA0139	Homo sapiens (Human)	1382	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]"	mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002188; GO:0003723; GO:0003729; GO:0003743; GO:0005198; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005852; GO:0005874; GO:0006413; GO:0014069; GO:0016020; GO:0016282; GO:0030971; GO:0033290; GO:0043614; GO:0070373; GO:0071540; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translational initiation [GO:0006413]; translation reinitiation [GO:0002188]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN39973_c0_g1_i1	Q14152	EIF3A_HUMAN	100	80	0	0	240	1	236	315	1.70E-40	166	EIF3A_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185)	EIF3A EIF3S10 KIAA0139	Homo sapiens (Human)	1382	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]"	mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002188; GO:0003723; GO:0003729; GO:0003743; GO:0005198; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005852; GO:0005874; GO:0006413; GO:0014069; GO:0016020; GO:0016282; GO:0030971; GO:0033290; GO:0043614; GO:0070373; GO:0071540; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translational initiation [GO:0006413]; translation reinitiation [GO:0002188]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i11	B0W562	EIF3B_CULQU	81.2	32	6	0	98	3	374	405	4.00E-10	65.5	EIF3B_CULQU	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)	eIF3-S9 CPIJ002177	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	688	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i17	Q1HDZ5	EIF3B_BOMMO	58.9	158	60	1	476	3	259	411	5.40E-52	205.3	EIF3B_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)	eIF3-S9	Bombyx mori (Silk moth)	695	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i8	B0W562	EIF3B_CULQU	81.2	32	6	0	98	3	374	405	8.20E-10	65.5	EIF3B_CULQU	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)	eIF3-S9 CPIJ002177	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	688	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN2229_c0_g1_i1	Q1HDZ5	EIF3B_BOMMO	65.7	140	48	0	3	422	416	555	1.00E-52	207.6	EIF3B_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)	eIF3-S9	Bombyx mori (Silk moth)	695	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN36034_c0_g1_i1	A7MB16	EIF3B_BOVIN	100	94	0	0	282	1	275	368	5.10E-52	204.5	EIF3B_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta)	EIF3B EIF3S9	Bos taurus (Bovine)	786	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN36034_c0_g1_i2	A7MB16	EIF3B_BOVIN	100	80	0	0	240	1	289	368	7.50E-44	177.2	EIF3B_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta)	EIF3B EIF3S9	Bos taurus (Bovine)	786	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN2229_c0_g1_i2	A7MB16	EIF3B_BOVIN	66.7	33	11	0	95	193	617	649	2.10E-08	59.3	EIF3B_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta)	EIF3B EIF3S9	Bos taurus (Bovine)	786	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i16	Q8JZQ9	EIF3B_MOUSE	55.1	296	127	4	985	98	136	425	7.00E-96	352.1	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i16	Q8JZQ9	EIF3B_MOUSE	68.8	32	10	0	98	3	493	524	2.70E-07	57.8	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i18	Q8JZQ9	EIF3B_MOUSE	54.9	297	128	4	978	88	136	426	2.40E-96	353.6	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i3	Q8JZQ9	EIF3B_MOUSE	59.3	391	157	2	1175	3	136	524	1.60E-147	523.9	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN15534_c0_g1_i1	Q8JZQ9	EIF3B_MOUSE	99.2	237	2	0	1	711	567	803	4.00E-133	475.3	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN15534_c0_g1_i2	Q8JZQ9	EIF3B_MOUSE	99.6	237	1	0	1	711	567	803	1.10E-133	477.2	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN20504_c0_g2_i1	Q8JZQ9	EIF3B_MOUSE	100	76	0	0	228	1	150	225	2.90E-37	155.2	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN2229_c0_g1_i4	Q8JZQ9	EIF3B_MOUSE	56.6	166	72	0	95	592	634	799	4.30E-52	206.5	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN2229_c0_g1_i5	Q8JZQ9	EIF3B_MOUSE	57	272	117	0	24	839	528	799	7.80E-91	335.5	EIF3B_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)	Eif3b Eif3s9	Mus musculus (Mouse)	803	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN20023_c0_g1_i1	P55884	EIF3B_HUMAN	99.2	124	1	0	375	4	395	518	3.30E-70	265.4	EIF3B_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)	EIF3B EIF3S9	Homo sapiens (Human)	814	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]"	molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN20023_c0_g1_i2	P55884	EIF3B_HUMAN	99.2	127	1	0	381	1	393	519	5.40E-73	274.6	EIF3B_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)	EIF3B EIF3S9	Homo sapiens (Human)	814	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]"	molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN20504_c0_g1_i1	P55884	EIF3B_HUMAN	100	153	0	0	460	2	168	320	7.20E-88	324.3	EIF3B_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)	EIF3B EIF3S9	Homo sapiens (Human)	814	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]"	molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN30043_c0_g1_i2	Q4P0P0	EIF3C_USTMA	55.2	58	25	1	178	8	626	683	3.20E-11	68.6	EIF3C_USTMA	reviewed	"Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 93 kDa subunit homolog) (eIF3 p93) (Translation initiation factor eIF3, p93 subunit homolog)"	NIP1 UMAG_06323	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	895	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0071540; GO:0071541	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN9238_c0_g1_i1	Q17Q06	EIF3C_AEDAE	60.2	394	157	0	1270	89	281	674	1.20E-141	504.6	EIF3C_AEDAE	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8)	eIF3-S8 AAEL000175	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	910	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		NA	NA	NA	NA	NA	NA
TRINITY_DN9238_c0_g1_i2	Q17Q06	EIF3C_AEDAE	62.6	583	216	1	1911	169	281	863	2.60E-214	746.5	EIF3C_AEDAE	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8)	eIF3-S8 AAEL000175	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	910	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN103_c0_g1_i1	B3NML0	EIF3C_DROER	60.2	171	66	2	90	602	2	170	4.30E-46	186.4	EIF3C_DROER	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8)	eIF3c eIF3-S8 GG21805	Drosophila erecta (Fruit fly)	910	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN27900_c0_g1_i1	Q99613	EIF3C_HUMAN	100	94	0	0	285	4	309	402	3.80E-47	188.3	EIF3C_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	EIF3C EIF3S8	Homo sapiens (Human)	913	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0043022; GO:0045727; GO:1902416	formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN19953_c0_g1_i1	Q3SYW6	EIF3C_BOVIN	100	342	0	0	2	1027	522	863	3.20E-192	672.2	EIF3C_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	EIF3C EIF3S8	Bos taurus (Bovine)	912	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0071541	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN19953_c0_g1_i2	Q3SYW6	EIF3C_BOVIN	100	342	0	0	2	1027	522	863	3.20E-192	672.2	EIF3C_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	EIF3C EIF3S8	Bos taurus (Bovine)	912	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0071541	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN19953_c0_g1_i4	Q3SYW6	EIF3C_BOVIN	100	304	0	0	3	914	560	863	1.80E-170	599.7	EIF3C_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	EIF3C EIF3S8	Bos taurus (Bovine)	912	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0071541	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN30043_c0_g1_i1	Q9XHM1	EIF3C_MEDTR	50.7	136	64	2	415	8	535	667	7.10E-26	118.2	EIF3C_MEDTR	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	TIF3C1 AM3-1	Medicago truncatula (Barrel medic) (Medicago tribuloides)	935	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		NA	NA	NA	NA	NA	NA
TRINITY_DN30968_c0_g1_i1	Q99613	EIF3C_HUMAN	100	163	0	0	516	28	8	170	1.10E-84	313.9	EIF3C_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	EIF3C EIF3S8	Homo sapiens (Human)	913	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0043022; GO:0045727; GO:1902416	formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN27372_c0_g1_i1	Q99613	EIF3C_HUMAN	100	120	0	0	362	3	408	527	1.20E-64	246.9	EIF3C_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)	EIF3C EIF3S8	Homo sapiens (Human)	913	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0043022; GO:0045727; GO:1902416	formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN4121_c0_g1_i1	K7IM66	EIF3D_NASVI	66.1	542	169	5	1715	99	21	550	7.30E-208	724.9	EIF3D_NASVI	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7)		Nasonia vitripennis (Parasitic wasp)	558	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0098808	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN13985_c0_g2_i1	Q3T122	EIF3D_BOVIN	100	353	0	0	1068	10	179	531	1.00E-209	730.3	EIF3D_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta)	EIF3D EIF3S7	Bos taurus (Bovine)	548	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN13985_c0_g2_i2	Q3T122	EIF3D_BOVIN	100	307	0	0	923	3	179	485	8.60E-181	634	EIF3D_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta)	EIF3D EIF3S7	Bos taurus (Bovine)	548	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN23133_c0_g1_i2	Q3T122	EIF3D_BOVIN	100	66	0	0	72	269	1	66	2.40E-35	149.1	EIF3D_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta)	EIF3D EIF3S7	Bos taurus (Bovine)	548	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN13985_c0_g1_i1	O70194	EIF3D_MOUSE	100	140	0	0	422	3	209	348	1.00E-75	283.9	EIF3D_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)	Eif3d Eif3s7	Mus musculus (Mouse)	548	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN23133_c0_g1_i1	O15371	EIF3D_HUMAN	100	110	0	0	72	401	1	110	7.20E-60	231.1	EIF3D_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)	EIF3D EIF3S7	Homo sapiens (Human)	548	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]"	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN31151_c0_g1_i1	O94236	EIF3D_SCHPO	54.1	74	29	1	2	208	413	486	1.80E-17	89.4	EIF3D_SCHPO	reviewed	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Microtubule-destabilizing protein moe1)	moe1 eif3d SPAC637.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	567	"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0010494; GO:0016282; GO:0033290; GO:0071540; GO:0071541; GO:0098808	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN30381_c0_g1_i1	A7RWP6	EIF3E_NEMVE	54.9	122	55	0	381	16	298	419	1.40E-31	137.1	EIF3E_NEMVE	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6)	v1g163572	Nematostella vectensis (Starlet sea anemone)	448	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]"	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN14378_c0_g1_i1	Q3T102	EIF3E_BOVIN	100	162	0	0	1	486	91	252	1.30E-92	340.1	EIF3E_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (eIF-3 p48)	EIF3E EIF3S6 INT6	Bos taurus (Bovine)	445	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]"	translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0016605; GO:0033290; GO:0071540	"formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14378_c0_g2_i2	Q3T102	EIF3E_BOVIN	100	154	0	0	2	463	99	252	1.60E-87	323.2	EIF3E_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (eIF-3 p48)	EIF3E EIF3S6 INT6	Bos taurus (Bovine)	445	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]"	translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0016605; GO:0033290; GO:0071540	"formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20204_c0_g1_i1	Q3T102	EIF3E_BOVIN	96.1	102	4	0	2	307	284	385	1.60E-51	203	EIF3E_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (eIF-3 p48)	EIF3E EIF3S6 INT6	Bos taurus (Bovine)	445	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]"	translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0016605; GO:0033290; GO:0071540	"formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34971_c0_g1_i1	Q3T102	EIF3E_BOVIN	100	89	0	0	52	318	1	89	2.90E-43	175.6	EIF3E_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (eIF-3 p48)	EIF3E EIF3S6 INT6	Bos taurus (Bovine)	445	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]"	translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0016605; GO:0033290; GO:0071540	"formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24636_c0_g1_i1	P60228	EIF3E_HUMAN	100	91	0	0	286	14	355	445	1.60E-45	183	EIF3E_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)	EIF3E EIF3S6 INT6	Homo sapiens (Human)	445	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0016605; GO:0033290; GO:0045296; GO:0045727; GO:0045947; GO:0047485; GO:0070062; GO:0071540; GO:1902416	"formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29913_c0_g1_i1	P60228	EIF3E_HUMAN	100	194	0	0	3	584	252	445	1.50E-106	386.7	EIF3E_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)	EIF3E EIF3S6 INT6	Homo sapiens (Human)	445	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0016605; GO:0033290; GO:0045296; GO:0045727; GO:0045947; GO:0047485; GO:0070062; GO:0071540; GO:1902416	"formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14378_c0_g2_i1	Q6DRI1	EI3EA_DANRE	98.3	60	1	0	2	181	100	159	3.60E-28	125.2	EI3EA_DANRE	reviewed	Eukaryotic translation initiation factor 3 subunit E-A (eIF3e-A) (Eukaryotic translation initiation factor 3 subunit 6-A)	eif3ea eif3s6a int6	Danio rerio (Zebrafish) (Brachydanio rerio)	446	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]"	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN2940_c0_g1_i1	Q1LUA8	EI3EB_DANRE	70.4	439	127	2	1386	79	1	439	7.80E-181	634.8	EI3EB_DANRE	reviewed	Eukaryotic translation initiation factor 3 subunit E-B (eIF3e-B) (Eukaryotic translation initiation factor 3 subunit 6-B)	eif3eb eif3s6b si:ch211-129b17.1	Danio rerio (Zebrafish) (Brachydanio rerio)	446	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]"	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		blue	blue	NA	NA	NA	NA
TRINITY_DN18209_c1_g1_i1	Q1HQN4	EIF3G_AEDAE	48.1	81	37	1	244	2	61	136	1.60E-15	83.2	EIF3G_AEDAE	reviewed	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4)	eIF3-S4-1 AAEL006851; eIF3-S4-2 AAEL012661	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	272	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		NA	NA	NA	NA	NA	NA
TRINITY_DN2190_c0_g1_i1	A7SKE9	EIF3G_NEMVE	81.9	83	15	0	332	84	209	291	1.60E-33	143.7	EIF3G_NEMVE	reviewed	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4)	v1g171563	Nematostella vectensis (Starlet sea anemone)	294	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		NA	NA	NA	NA	NA	NA
TRINITY_DN2190_c0_g1_i2	Q6DRC4	EIF3G_DANRE	56.4	273	108	5	884	84	24	291	9.10E-79	295	EIF3G_DANRE	reviewed	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4)	eif3g eif3s4	Danio rerio (Zebrafish) (Brachydanio rerio)	293	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		blue	blue	NA	NA	NA	NA
TRINITY_DN36619_c0_g1_i1	Q3ZC12	EIF3G_BOVIN	51.9	77	28	2	3	215	213	286	4.70E-13	74.7	EIF3G_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)	EIF3G EIF3S4	Bos taurus (Bovine)	320	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0048471	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN17875_c0_g2_i1	Q3ZC12	EIF3G_BOVIN	100	113	0	0	2	340	208	320	1.60E-59	229.9	EIF3G_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)	EIF3G EIF3S4	Bos taurus (Bovine)	320	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0048471	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN31783_c0_g1_i1	Q3ZC12	EIF3G_BOVIN	100	75	0	0	2	226	127	201	5.20E-39	161	EIF3G_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)	EIF3G EIF3S4	Bos taurus (Bovine)	320	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0048471	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN18209_c0_g1_i1	Q6DJI8	EI3GA_XENLA	51	102	37	3	285	4	147	243	9.20E-17	87.4	EI3GA_XENLA	reviewed	Eukaryotic translation initiation factor 3 subunit G-A (eIF3g-A) (Eukaryotic translation initiation factor 3 RNA-binding subunit A) (eIF-3 RNA-binding subunit A) (Eukaryotic translation initiation factor 3 subunit 4-A)	eif3g-a eif3s4-a	Xenopus laevis (African clawed frog)	308	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN17875_c0_g1_i1	Q6DJI8	EI3GA_XENLA	100	81	0	0	2	244	228	308	7.10E-41	167.5	EI3GA_XENLA	reviewed	Eukaryotic translation initiation factor 3 subunit G-A (eIF3g-A) (Eukaryotic translation initiation factor 3 RNA-binding subunit A) (eIF-3 RNA-binding subunit A) (Eukaryotic translation initiation factor 3 subunit 4-A)	eif3g-a eif3s4-a	Xenopus laevis (African clawed frog)	308	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN5635_c0_g1_i1	Q9GV27	EIF3H_BOMMO	61.5	231	88	1	24	716	5	234	1.30E-80	300.8	EIF3H_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit H (eIF3h)		Bombyx mori (Silk moth)	337	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0008237; GO:0016282; GO:0033290; GO:0070122	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN1938_c0_g1_i1	Q9GV27	EIF3H_BOMMO	55.8	104	46	0	373	62	234	337	2.50E-22	106.3	EIF3H_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit H (eIF3h)		Bombyx mori (Silk moth)	337	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0008237; GO:0016282; GO:0033290; GO:0070122	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN13255_c0_g1_i2	O15372	EIF3H_HUMAN	99.5	188	1	0	565	2	42	229	7.50E-103	374.4	EIF3H_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)	EIF3H EIF3S3	Homo sapiens (Human)	352	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; ubiquitinyl hydrolase activity [GO:0101005]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]"	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0008237; GO:0016020; GO:0016282; GO:0032435; GO:0033290; GO:0042788; GO:0070062; GO:0070122; GO:0071541; GO:0101005	formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN13255_c0_g1_i3	Q91WK2	EIF3H_MOUSE	99.5	188	1	0	565	2	42	229	1.30E-102	373.6	EIF3H_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)	Eif3h Eif3s3	Mus musculus (Mouse)	352	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; polysomal ribosome [GO:0042788]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; polysomal ribosome [GO:0042788]"	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0008237; GO:0016282; GO:0033290; GO:0042788; GO:0070122; GO:0071541	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN3436_c0_g1_i1	Q1HPW4	EIF3I_BOMMO	67.5	169	51	2	68	574	162	326	1.30E-61	237.7	EIF3I_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i)		Bombyx mori (Silk moth)	329	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN3436_c0_g1_i2	Q1HPW4	EIF3I_BOMMO	62.6	230	79	3	49	732	102	326	5.40E-78	292.4	EIF3I_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i)		Bombyx mori (Silk moth)	329	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		NA	NA	NA	NA	NA	NA
TRINITY_DN3436_c0_g1_i3	Q1HPW4	EIF3I_BOMMO	59.4	286	109	3	2	853	46	326	7.80E-97	355.1	EIF3I_BOMMO	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i)		Bombyx mori (Silk moth)	329	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN228_c0_g1_i1	P79083	EIF3I_SCHPO	55.7	79	34	1	277	44	247	325	2.10E-21	102.8	EIF3I_SCHPO	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 39 kDa subunit homolog) (eIF-3 39 kDa subunit homolog) (eIF3 p39) (Suppressor of uncontrolled mitosis 1)	sum1 eif3i tif34 SPAC4D7.05	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	328	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; nuclear periphery [GO:0034399]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]"	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; nuclear periphery [GO:0034399]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002183; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005852; GO:0010494; GO:0016282; GO:0033290; GO:0034399; GO:0071540; GO:0071541	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]		red	red	NA	NA	NA	NA
TRINITY_DN17723_c0_g1_i1	Q5E966	EIF3I_BOVIN	100	137	0	0	429	19	189	325	5.00E-75	281.6	EIF3I_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (eIF-3-beta) (eIF3 p36)	EIF3I EIF3S2	Bos taurus (Bovine)	325	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002183; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071541	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN17723_c0_g1_i2	Q5E966	EIF3I_BOVIN	100	137	0	0	441	31	189	325	5.20E-75	281.6	EIF3I_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (eIF-3-beta) (eIF3 p36)	EIF3I EIF3S2	Bos taurus (Bovine)	325	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002183; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071541	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN22863_c0_g1_i1	Q28C65	EIF3K_XENTR	61.3	212	82	0	720	85	5	216	1.60E-74	280.8	EIF3K_XENTR	reviewed	Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25)	eif3k eif3s12 TTpA007f24.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	218	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0033290; GO:0043022	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		blue	blue	NA	NA	NA	NA
TRINITY_DN22863_c0_g1_i4	Q28C65	EIF3K_XENTR	61.3	212	82	0	720	85	5	216	1.60E-74	280.8	EIF3K_XENTR	reviewed	Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25)	eif3k eif3s12 TTpA007f24.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	218	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0033290; GO:0043022	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		blue	blue	NA	NA	NA	NA
TRINITY_DN7899_c0_g1_i1	Q9UBQ5	EIF3K_HUMAN	100	111	0	0	354	22	108	218	2.90E-60	232.3	EIF3K_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)	EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001	Homo sapiens (Human)	218	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN7899_c0_g1_i2	Q9UBQ5	EIF3K_HUMAN	100	218	0	0	675	22	1	218	9.80E-124	444.1	EIF3K_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)	EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001	Homo sapiens (Human)	218	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN7899_c0_g1_i3	Q9UBQ5	EIF3K_HUMAN	100	218	0	0	675	22	1	218	9.80E-124	444.1	EIF3K_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)	EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001	Homo sapiens (Human)	218	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN11006_c0_g1_i1	Q8QZY1	EIF3L_MOUSE	100	279	0	0	1	837	91	369	8.60E-164	577.4	EIF3L_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (66 kDa tyrosine-rich heat shock protein) (67 kDa polymerase-associated factor) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein) (HSP-66Y) (PAF67)	Eif3l Eif3eip Eif3s6ip Paf67	Mus musculus (Mouse)	564	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	translation initiation factor activity [GO:0003743]	GO:0001650; GO:0001732; GO:0003743; GO:0005654; GO:0005730; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN30561_c0_g1_i1	Q8QZY1	EIF3L_MOUSE	100	72	0	0	1	216	385	456	1.80E-36	153.3	EIF3L_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (66 kDa tyrosine-rich heat shock protein) (67 kDa polymerase-associated factor) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein) (HSP-66Y) (PAF67)	Eif3l Eif3eip Eif3s6ip Paf67	Mus musculus (Mouse)	564	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	translation initiation factor activity [GO:0003743]	GO:0001650; GO:0001732; GO:0003743; GO:0005654; GO:0005730; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN30561_c0_g1_i1	Q8QZY1	EIF3L_MOUSE	77	74	17	0	158	379	437	510	1.80E-23	110.2	EIF3L_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (66 kDa tyrosine-rich heat shock protein) (67 kDa polymerase-associated factor) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein) (HSP-66Y) (PAF67)	Eif3l Eif3eip Eif3s6ip Paf67	Mus musculus (Mouse)	564	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	translation initiation factor activity [GO:0003743]	GO:0001650; GO:0001732; GO:0003743; GO:0005654; GO:0005730; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN30561_c0_g1_i2	Q8QZY1	EIF3L_MOUSE	100	126	0	0	1	378	385	510	8.90E-68	257.3	EIF3L_MOUSE	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (66 kDa tyrosine-rich heat shock protein) (67 kDa polymerase-associated factor) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein) (HSP-66Y) (PAF67)	Eif3l Eif3eip Eif3s6ip Paf67	Mus musculus (Mouse)	564	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	translation initiation factor activity [GO:0003743]	GO:0001650; GO:0001732; GO:0003743; GO:0005654; GO:0005730; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN33943_c0_g1_i1	Q3ZCK1	EIF3L_BOVIN	51.1	45	22	0	176	42	304	348	2.00E-06	52.8	EIF3L_BOVIN	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein)	EIF3L EIF3EIP EIF3S6IP	Bos taurus (Bovine)	564	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	translation initiation factor activity [GO:0003743]	GO:0001650; GO:0001732; GO:0003743; GO:0005654; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN11006_c0_g2_i1	Q9Y262	EIF3L_HUMAN	100	287	0	0	3	863	102	388	3.90E-167	588.6	EIF3L_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein)	EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005	Homo sapiens (Human)	564	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001650; GO:0001732; GO:0003723; GO:0003743; GO:0005654; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0075525	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]		NA	NA	NA	NA	NA	NA
TRINITY_DN1691_c0_g1_i10	Q7T2A5	EIF3L_DANRE	63.6	546	161	8	92	1654	16	548	4.90E-195	682.2	EIF3L_DANRE	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein)	eif3l eif3eip eif3s6ip	Danio rerio (Zebrafish) (Brachydanio rerio)	576	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		blue	blue	NA	NA	NA	NA
TRINITY_DN1691_c0_g1_i14	Q7T2A5	EIF3L_DANRE	73	374	98	2	2	1123	178	548	3.10E-156	552.7	EIF3L_DANRE	reviewed	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein)	eif3l eif3eip eif3s6ip	Danio rerio (Zebrafish) (Brachydanio rerio)	576	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290	formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN1196_c8_g1_i1	Q7Q068	EIF3M_ANOGA	57.1	375	156	4	1227	106	7	377	2.60E-112	407.1	EIF3M_ANOGA	reviewed	Eukaryotic translation initiation factor 3 subunit M (eIF3m)	AGAP012281	Anopheles gambiae (African malaria mosquito)	385	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]"	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002183; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0071541	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]		blue	blue	NA	NA	NA	NA
TRINITY_DN10618_c0_g1_i1	Q7L2H7	EIF3M_HUMAN	100	172	0	0	3	518	165	336	7.80E-91	334.3	EIF3M_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit M (eIF3m) (Fetal lung protein B5) (hFL-B5) (PCI domain-containing protein 1)	EIF3M HFLB5 PCID1 GA17 PNAS-125	Homo sapiens (Human)	374	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral process [GO:0016032]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0002183; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016032; GO:0016282; GO:0031369; GO:0033290; GO:0071541	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN10618_c0_g1_i2	Q7L2H7	EIF3M_HUMAN	100	172	0	0	2	517	165	336	7.80E-91	334.3	EIF3M_HUMAN	reviewed	Eukaryotic translation initiation factor 3 subunit M (eIF3m) (Fetal lung protein B5) (hFL-B5) (PCI domain-containing protein 1)	EIF3M HFLB5 PCID1 GA17 PNAS-125	Homo sapiens (Human)	374	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral process [GO:0016032]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]"	translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0002183; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016032; GO:0016282; GO:0031369; GO:0033290; GO:0071541	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN35584_c0_g1_i1	Q6NZJ6	IF4G1_MOUSE	99.2	124	1	0	374	3	900	1023	1.20E-64	246.9	IF4G1_MOUSE	reviewed	Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1)	Eif4g1	Mus musculus (Mouse)	1600	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]	"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0001662; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0010801; GO:0010942; GO:0016281; GO:0030307; GO:0031669; GO:0032270; GO:0033138; GO:0034645; GO:0036493; GO:0042802; GO:0045666; GO:0097009; GO:0098794; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696	behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29912_c0_g1_i2	Q62448	IF4G2_MOUSE	77.2	57	13	0	265	95	838	894	2.40E-22	106.3	IF4G2_MOUSE	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Novel APOBEC-1 target 1) (Translation repressor NAT1) (p97)	Eif4g2 Nat1	Mus musculus (Mouse)	906	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	"mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0006446; GO:0008135; GO:0010507; GO:0016281; GO:0030307; GO:0030424; GO:0034645; GO:0045727; GO:0045773; GO:0060999	cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]		blue	blue	NA	NA	NA	NA
TRINITY_DN29912_c0_g1_i3	Q62448	IF4G2_MOUSE	55.2	239	106	1	808	95	656	894	8.80E-74	278.5	IF4G2_MOUSE	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Novel APOBEC-1 target 1) (Translation repressor NAT1) (p97)	Eif4g2 Nat1	Mus musculus (Mouse)	906	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	"mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0006446; GO:0008135; GO:0010507; GO:0016281; GO:0030307; GO:0030424; GO:0034645; GO:0045727; GO:0045773; GO:0060999	cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN19232_c0_g1_i2	Q62448	IF4G2_MOUSE	100	128	0	0	2	385	779	906	2.00E-66	253.1	IF4G2_MOUSE	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Novel APOBEC-1 target 1) (Translation repressor NAT1) (p97)	Eif4g2 Nat1	Mus musculus (Mouse)	906	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	"mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0006446; GO:0008135; GO:0010507; GO:0016281; GO:0030307; GO:0030424; GO:0034645; GO:0045727; GO:0045773; GO:0060999	cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN29912_c0_g1_i1	Q95L46	IF4G2_BOVIN	40.1	464	255	5	1483	95	454	895	3.00E-88	327.4	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		blue	blue	NA	NA	NA	NA
TRINITY_DN16164_c0_g1_i1	Q95L46	IF4G2_BOVIN	100	119	0	0	3	359	220	338	7.50E-64	244.2	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN19232_c0_g1_i1	Q95L46	IF4G2_BOVIN	100	127	0	0	2	382	781	907	2.50E-66	252.7	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN35871_c0_g1_i1	Q95L46	IF4G2_BOVIN	100	121	0	0	2	364	56	176	3.50E-61	235.3	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN35643_c0_g1_i1	Q95L46	IF4G2_BOVIN	51.5	268	121	2	879	100	79	345	2.70E-68	260.4	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		blue	blue	NA	NA	NA	NA
TRINITY_DN17607_c0_g1_i1	Q95L46	IF4G2_BOVIN	100	157	0	0	3	473	630	786	3.60E-82	305.4	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN17607_c0_g1_i2	Q95L46	IF4G2_BOVIN	100	154	0	0	2	463	633	786	2.50E-80	299.3	IF4G2_BOVIN	reviewed	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (p97)	EIF4G2	Bos taurus (Bovine)	907	"eukaryotic translation initiation factor 4F complex [GO:0016281]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"	eukaryotic translation initiation factor 4F complex [GO:0016281]	"translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0006446; GO:0008135; GO:0016281	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN8886_c0_g1_i1	Q80XI3	IF4G3_MOUSE	34.2	892	499	20	2622	100	721	1575	2.00E-121	438.3	IF4G3_MOUSE	reviewed	Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)	Eif4g3	Mus musculus (Mouse)	1579	eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]	eukaryotic translation initiation factor 4F complex [GO:0016281]	mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]	GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903	positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN2119_c0_g1_i1	P23588	IF4B_HUMAN	39.7	78	42	2	436	203	96	168	1.00E-05	51.6	IF4B_HUMAN	reviewed	Eukaryotic translation initiation factor 4B (eIF-4B)	EIF4B	Homo sapiens (Human)	611	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]	GO:0001731; GO:0002181; GO:0003723; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010	cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]		blue	blue	NA	NA	NA	NA
TRINITY_DN3688_c0_g1_i1	O77210	IF4E_APLCA	62.2	193	73	0	671	93	23	215	2.10E-71	270.4	IF4E_APLCA	reviewed	Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)		Aplysia californica (California sea hare)	215	cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN5241_c0_g1_i2	P06730	IF4E_HUMAN	100	168	0	0	3	506	31	198	2.40E-100	365.9	IF4E_HUMAN	reviewed	Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)	EIF4E EIF4EL1 EIF4F	Homo sapiens (Human)	217	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; RISC complex [GO:0016442]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; mRNA export from nucleus [GO:0006406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; RNA export from nucleus [GO:0006405]; stem cell population maintenance [GO:0019827]; translational initiation [GO:0006413]; viral process [GO:0016032]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; RISC complex [GO:0016442]	enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]	GO:0000082; GO:0000339; GO:0000340; GO:0000932; GO:0001662; GO:0003723; GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005845; GO:0006405; GO:0006406; GO:0006413; GO:0006417; GO:0010494; GO:0016032; GO:0016281; GO:0016442; GO:0017148; GO:0019827; GO:0019899; GO:0030324; GO:0031370; GO:0033391; GO:0036464; GO:0045665; GO:0045931; GO:0048471; GO:0070062; GO:0070491; GO:0071549; GO:0098978; GO:0099524	behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; mRNA export from nucleus [GO:0006406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; RNA export from nucleus [GO:0006405]; stem cell population maintenance [GO:0019827]; translational initiation [GO:0006413]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN33347_c0_g1_i1	Q9N0T5	IF4E_BOVIN	50.7	69	33	1	2	205	66	134	7.60E-13	73.9	IF4E_BOVIN	reviewed	Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (mRNA cap-binding protein)	EIF4E	Bos taurus (Bovine)	217	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]	enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]	GO:0000340; GO:0000932; GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005845; GO:0006417; GO:0010494; GO:0016281; GO:0019899; GO:0031370; GO:0048471; GO:0070491	regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN5241_c0_g1_i1	P63073	IF4E_MOUSE	100	168	0	0	3	506	31	198	1.40E-100	366.7	IF4E_MOUSE	reviewed	Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (mRNA cap-binding protein) (eIF-4F 25 kDa subunit)	Eif4e	Mus musculus (Mouse)	217	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; RISC complex [GO:0016442]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; stem cell population maintenance [GO:0019827]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; RISC complex [GO:0016442]	enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; repressing transcription factor binding [GO:0070491]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]	GO:0000082; GO:0000340; GO:0000932; GO:0001662; GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005845; GO:0006417; GO:0010494; GO:0016281; GO:0016442; GO:0017148; GO:0019827; GO:0019899; GO:0030324; GO:0031370; GO:0032991; GO:0033391; GO:0036464; GO:0045665; GO:0045931; GO:0048471; GO:0070491; GO:0071549; GO:0098794; GO:0098978; GO:0099524	behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN17370_c0_g1_i1	Q8BMB3	IF4E2_MOUSE	62.1	206	63	2	576	1	1	205	3.10E-71	269.6	IF4E2_MOUSE	reviewed	Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (eIF4E-2) (mRNA cap-binding protein type 2) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP)	Eif4e2 Eif4el3	Mus musculus (Mouse)	245	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; gene silencing by RNA [GO:0031047]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]	RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]	GO:0000340; GO:0000932; GO:0001701; GO:0003743; GO:0005737; GO:0005845; GO:0016281; GO:0017148; GO:0031047; GO:0031625; GO:1905618	gene silencing by RNA [GO:0031047]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]		blue	blue	NA	NA	NA	NA
TRINITY_DN39752_c0_g1_i1	O60573	IF4E2_HUMAN	100	134	0	0	1	402	57	190	1.50E-76	286.6	IF4E2_HUMAN	reviewed	Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3)	EIF4E2 EIF4EL3	Homo sapiens (Human)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; gene silencing by RNA [GO:0031047]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]	"RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000339; GO:0000340; GO:0000932; GO:0001701; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005845; GO:0008135; GO:0016281; GO:0017148; GO:0031047; GO:0031625; GO:1905618	gene silencing by RNA [GO:0031047]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]		NA	NA	NA	NA	NA	NA
TRINITY_DN35496_c0_g1_i1	Q8N5X7	IF4E3_HUMAN	100	114	0	0	3	344	71	184	2.50E-61	235.7	IF4E3_HUMAN	reviewed	Eukaryotic translation initiation factor 4E type 3 (eIF-4E type 3) (eIF-4E3) (eIF4E type 3) (eIF4E-3)	EIF4E3	Homo sapiens (Human)	224	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]	RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]	GO:0000340; GO:0003743; GO:0005829; GO:0005845; GO:0016281			NA	NA	NA	NA	NA	NA
TRINITY_DN30142_c0_g1_i1	Q6NU27	I4E3B_XENLA	57.1	184	79	0	613	62	30	213	1.50E-64	247.7	I4E3B_XENLA	reviewed	Eukaryotic translation initiation factor 4E type 3-B (eIF-4E type 3-B) (eIF-4E3-B) (eIF4E type 3-B) (eIF4E-3-B)	eif4e3-b	Xenopus laevis (African clawed frog)	218	mRNA cap binding complex [GO:0005845]; translation initiation factor activity [GO:0003743]	mRNA cap binding complex [GO:0005845]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005845			NA	NA	NA	NA	NA	NA
TRINITY_DN24208_c0_g1_i1	Q60876	4EBP1_MOUSE	50.7	69	31	2	234	434	50	117	2.00E-09	63.9	4EBP1_MOUSE	reviewed	Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I)	Eif4ebp1	Mus musculus (Mouse)	117	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; eukaryotic initiation factor 4E binding [GO:0008190]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; translation repressor activity [GO:0030371]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hypoxia [GO:0071456]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; lung development [GO:0030324]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to ethanol [GO:0045471]; response to ischemia [GO:0002931]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]	eukaryotic initiation factor 4E binding [GO:0008190]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; translation repressor activity [GO:0030371]	GO:0000082; GO:0002192; GO:0002931; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0008190; GO:0008286; GO:0030324; GO:0030371; GO:0031333; GO:0031369; GO:0031929; GO:0032991; GO:0045471; GO:0045931; GO:0045947; GO:0051721; GO:0071456; GO:0071549; GO:0098978; GO:0099524; GO:1990928	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hypoxia [GO:0071456]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; lung development [GO:0030324]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to ethanol [GO:0045471]; response to ischemia [GO:0002931]; TOR signaling [GO:0031929]		blue	blue	NA	NA	NA	NA
TRINITY_DN27133_c0_g1_i1	Q60876	4EBP1_MOUSE	95.8	72	3	0	217	2	31	102	1.40E-28	126.3	4EBP1_MOUSE	reviewed	Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I)	Eif4ebp1	Mus musculus (Mouse)	117	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; eukaryotic initiation factor 4E binding [GO:0008190]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; translation repressor activity [GO:0030371]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hypoxia [GO:0071456]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; lung development [GO:0030324]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to ethanol [GO:0045471]; response to ischemia [GO:0002931]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]	eukaryotic initiation factor 4E binding [GO:0008190]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; translation repressor activity [GO:0030371]	GO:0000082; GO:0002192; GO:0002931; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0008190; GO:0008286; GO:0030324; GO:0030371; GO:0031333; GO:0031369; GO:0031929; GO:0032991; GO:0045471; GO:0045931; GO:0045947; GO:0051721; GO:0071456; GO:0071549; GO:0098978; GO:0099524; GO:1990928	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hypoxia [GO:0071456]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; lung development [GO:0030324]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to ethanol [GO:0045471]; response to ischemia [GO:0002931]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN37975_c0_g1_i1	P62924	IF5A_SPOEX	72.1	68	19	0	3	206	48	115	1.10E-22	106.7	IF5A_SPOEX	reviewed	Eukaryotic translation initiation factor 5A (eIF-5A)	eIF-5A eIF5A	Spodoptera exigua (Beet armyworm) (Noctua fulgens)	160	cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]	cytoplasm [GO:0005737]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005737; GO:0043022; GO:0045901; GO:0045905	positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]		NA	NA	NA	NA	NA	NA
TRINITY_DN29952_c1_g1_i1	P62924	IF5A_SPOEX	67.7	155	50	0	74	538	1	155	2.80E-60	233	IF5A_SPOEX	reviewed	Eukaryotic translation initiation factor 5A (eIF-5A)	eIF-5A eIF5A	Spodoptera exigua (Beet armyworm) (Noctua fulgens)	160	cytoplasm [GO:0005737]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]	cytoplasm [GO:0005737]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005737; GO:0043022; GO:0045901; GO:0045905	positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]		blue	blue	NA	NA	NA	NA
TRINITY_DN3773_c0_g1_i1	Q6EWQ7	IF5A1_BOVIN	100	153	0	0	460	2	1	153	2.00E-83	309.7	IF5A1_BOVIN	reviewed	Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D)	EIF5A	Bos taurus (Bovine)	154	endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005643; GO:0005789; GO:0015031; GO:0043022; GO:0043065; GO:0045901; GO:0045905; GO:0051028	mRNA transport [GO:0051028]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i11	P19211	IF5A2_YEAST	66.4	119	38	1	364	8	1	117	3.80E-39	162.2	IF5A2_YEAST	reviewed	Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (Anaerobically induced protein 1) (Hypusine-containing protein HP1) (eIF-4D)	ANB1 HYP1 TIF51B YJR047C J1651	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	157	cytosolic ribosome [GO:0022626]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]	cytosolic ribosome [GO:0022626]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0006452; GO:0022626; GO:0043022; GO:0045901; GO:0045905	positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; translational frameshifting [GO:0006452]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i13	Q9GZV4	IF5A2_HUMAN	63	119	37	3	356	15	11	127	1.80E-36	153.3	IF5A2_HUMAN	reviewed	Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2)	EIF5A2	Homo sapiens (Human)	153	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; polyamine homeostasis [GO:0010509]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005643; GO:0005789; GO:0005829; GO:0007283; GO:0008284; GO:0010509; GO:0015031; GO:0043022; GO:0043231; GO:0045901; GO:0045905; GO:0051028	mRNA transport [GO:0051028]; polyamine homeostasis [GO:0010509]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i4	Q9GZV4	IF5A2_HUMAN	68.5	108	32	2	331	8	11	116	2.50E-37	156	IF5A2_HUMAN	reviewed	Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2)	EIF5A2	Homo sapiens (Human)	153	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; polyamine homeostasis [GO:0010509]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005643; GO:0005789; GO:0005829; GO:0007283; GO:0008284; GO:0010509; GO:0015031; GO:0043022; GO:0043231; GO:0045901; GO:0045905; GO:0051028	mRNA transport [GO:0051028]; polyamine homeostasis [GO:0010509]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i8	Q9GZV4	IF5A2_HUMAN	68.2	107	32	2	328	8	12	116	7.10E-37	154.5	IF5A2_HUMAN	reviewed	Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2)	EIF5A2	Homo sapiens (Human)	153	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; polyamine homeostasis [GO:0010509]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005643; GO:0005789; GO:0005829; GO:0007283; GO:0008284; GO:0010509; GO:0015031; GO:0043022; GO:0043231; GO:0045901; GO:0045905; GO:0051028	mRNA transport [GO:0051028]; polyamine homeostasis [GO:0010509]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i1	Q07460	IF5A2_CHICK	66	100	32	1	302	3	12	109	4.40E-33	141.7	IF5A2_CHICK	reviewed	Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2) (eIF-4D)	EIF5A2	Gallus gallus (Chicken)	153	endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005643; GO:0005789; GO:0008284; GO:0015031; GO:0043022; GO:0045901; GO:0045905; GO:0051028	mRNA transport [GO:0051028]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i12	Q9C505	IF5A3_ARATH	66	106	35	1	353	36	13	117	3.20E-35	149.1	IF5A3_ARATH	reviewed	Eukaryotic translation initiation factor 5A-3 (AtELF5A-3) (eIF-5A-3)	ELF5A-3 At1g69410 F10D13.8 F23O10.2	Arabidopsis thaliana (Mouse-ear cress)	158	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003746; GO:0005739; GO:0005829; GO:0043022; GO:0045901; GO:0045905	positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i2	Q9C505	IF5A3_ARATH	64.4	118	41	1	389	36	1	117	5.40E-39	161.8	IF5A3_ARATH	reviewed	Eukaryotic translation initiation factor 5A-3 (AtELF5A-3) (eIF-5A-3)	ELF5A-3 At1g69410 F10D13.8 F23O10.2	Arabidopsis thaliana (Mouse-ear cress)	158	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003746; GO:0005739; GO:0005829; GO:0043022; GO:0045901; GO:0045905	positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]		NA	NA	NA	NA	NA	NA
TRINITY_DN1634_c0_g1_i9	Q9C505	IF5A3_ARATH	65.3	118	40	1	389	36	1	117	3.20E-39	162.5	IF5A3_ARATH	reviewed	Eukaryotic translation initiation factor 5A-3 (AtELF5A-3) (eIF-5A-3)	ELF5A-3 At1g69410 F10D13.8 F23O10.2	Arabidopsis thaliana (Mouse-ear cress)	158	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003746; GO:0005739; GO:0005829; GO:0043022; GO:0045901; GO:0045905	positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]		NA	NA	NA	NA	NA	NA
TRINITY_DN28967_c0_g1_i1	B2GUV7	IF2P_RAT	99	100	1	0	26	325	604	703	6.60E-51	201.1	IF2P_RAT	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Annexin V-binding protein ABP-7) (Translation initiation factor IF-2)	Eif5b If2	Rattus norvegicus (Rat)	1216	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0006446; GO:0046872	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN1163_c0_g1_i1	Q05D44	IF2P_MOUSE	55.4	148	60	1	637	194	831	972	5.80E-35	149.1	IF2P_MOUSE	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	Eif5b If2	Mus musculus (Mouse)	1216	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0006446; GO:0046872	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN1163_c0_g1_i2	O60841	IF2P_HUMAN	65.2	609	212	0	1917	91	612	1220	2.60E-235	816.2	IF2P_HUMAN	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	EIF5B IF2 KIAA0741	Homo sapiens (Human)	1220	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN40686_c0_g1_i1	G0S8G9	IF2P_CHATD	77.4	137	29	1	432	28	521	657	1.20E-56	220.7	IF2P_CHATD	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	CTHT_0029840	Chaetomium thermophilum (strain DSM 1495 / CBS 144.50 / IMI 039719)	1116	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN30454_c0_g1_i1	Q10251	IF2P_SCHPO	62.7	75	28	0	232	8	729	803	1.80E-18	92.8	IF2P_SCHPO	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	SPAC56F8.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1079	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003743; GO:0003924; GO:0005525; GO:0005829; GO:0033290; GO:0046872	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN36499_c0_g1_i1	P39730	IF2P_YEAST	65.4	136	39	2	1	384	421	556	1.80E-47	189.9	IF2P_YEAST	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	FUN12 YAL035W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1002	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 48S preinitiation complex [GO:0033290]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; small ribosomal subunit rRNA binding [GO:0070181]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mature ribosome assembly [GO:0042256]; regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 48S preinitiation complex [GO:0033290]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; small ribosomal subunit rRNA binding [GO:0070181]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0000462; GO:0001732; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006446; GO:0010494; GO:0022627; GO:0031369; GO:0033290; GO:0042255; GO:0042256; GO:0043022; GO:0046872; GO:0070181	"formation of cytoplasmic translation initiation complex [GO:0001732]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mature ribosome assembly [GO:0042256]; regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13314_c0_g1_i1	O60841	IF2P_HUMAN	45.8	59	31	1	11	187	1127	1184	2.90E-07	55.8	IF2P_HUMAN	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	EIF5B IF2 KIAA0741	Homo sapiens (Human)	1220	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN40124_c0_g1_i1	Q10251	IF2P_SCHPO	60.8	153	60	0	460	2	636	788	3.10E-46	186	IF2P_SCHPO	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	SPAC56F8.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1079	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]	cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]	GO:0002183; GO:0003743; GO:0003924; GO:0005525; GO:0005829; GO:0033290; GO:0046872	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN31312_c0_g1_i1	O60841	IF2P_HUMAN	100	85	0	0	256	2	844	928	3.70E-41	168.3	IF2P_HUMAN	reviewed	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	EIF5B IF2 KIAA0741	Homo sapiens (Human)	1220	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN25700_c0_g1_i1	Q6GR45	IF6_XENLA	70.2	245	73	0	820	86	1	245	2.30E-98	360.1	IF6_XENLA	reviewed	Eukaryotic translation initiation factor 6 (eIF-6)	eif6	Xenopus laevis (African clawed frog)	245	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005730; GO:0005737; GO:0042256; GO:0042273; GO:0043022; GO:0043023	mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]		blue	blue	NA	NA	NA	NA
TRINITY_DN30295_c0_g1_i1	Q8SS47	IF6_ENCCU	56.2	80	33	1	1	234	50	129	3.60E-19	95.1	IF6_ENCCU	reviewed	Eukaryotic translation initiation factor 6 (eIF-6)	TIF6 ECU04_0780	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	241	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0000054; GO:0003743; GO:0005730; GO:0005737; GO:0042256; GO:0042273; GO:0043022; GO:0043023	mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054]		NA	NA	NA	NA	NA	NA
TRINITY_DN6205_c0_g1_i1	B9PVB9	IF6_TOXGV	68.3	249	72	1	6	731	16	264	4.20E-93	342.4	IF6_TOXGV	reviewed	Eukaryotic translation initiation factor 6 (eIF-6)	EIF6 TGVEG_318700	Toxoplasma gondii (strain ATCC 50861 / VEG)	264	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005730; GO:0005737; GO:0042256; GO:0042273; GO:0043022; GO:0043023	mature ribosome assembly [GO:0042256]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN6739_c0_g2_i1	P56537	IF6_HUMAN	100	237	0	0	3	713	9	245	9.10E-133	474.2	IF6_HUMAN	reviewed	Eukaryotic translation initiation factor 6 (eIF-6) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP))	EIF6 EIF3A ITGB4BP OK/SW-cl.27	Homo sapiens (Human)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0000054; GO:0000460; GO:0000470; GO:0003743; GO:0005634; GO:0005638; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006110; GO:0030687; GO:0032868; GO:0035195; GO:0035278; GO:0042256; GO:0042304; GO:0043022; GO:0043023; GO:0045652; GO:0045727; GO:0070062; GO:1902626; GO:2000377	assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]		NA	NA	NA	NA	NA	NA
TRINITY_DN6739_c0_g1_i1	O55135	IF6_MOUSE	100	245	0	0	6	740	1	245	1.40E-136	486.9	IF6_MOUSE	reviewed	Eukaryotic translation initiation factor 6 (eIF-6) (B4 integrin interactor) (CAB) (p27(BBP))	Eif6 Itgb4bp	Mus musculus (Mouse)	245	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0000054; GO:0000460; GO:0000470; GO:0003743; GO:0005634; GO:0005638; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005882; GO:0006110; GO:0030687; GO:0032868; GO:0035195; GO:0035278; GO:0042256; GO:0042304; GO:0043022; GO:0043023; GO:0045652; GO:0045727; GO:1902626; GO:2000377	assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]		NA	NA	NA	NA	NA	NA
TRINITY_DN2053_c0_g1_i1	P42678	ETIF1_ANOGA	89.1	110	12	0	94	423	1	110	3.50E-53	209.1	ETIF1_ANOGA	reviewed	Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog)	eIF1 AGAP006459	Anopheles gambiae (African malaria mosquito)	110	eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	eukaryotic 43S preinitiation complex [GO:0016282]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0016282; GO:0043024			blue	blue	NA	NA	NA	NA
TRINITY_DN26830_c0_g1_i1	Q6K641	IF4G2_ORYSJ	26.5	253	164	4	144	836	185	437	3.20E-16	87.4	IF4G2_ORYSJ	reviewed	Eukaryotic translation initiation factor isoform 4G-2 (eIF(iso)-4G-2) (eIF(iso)4G-2) (Eukaryotic initiation factor iso-4F subunit p82) (eIF-(iso)4F p82 subunit)	Os02g0611500 LOC_Os02g39840 OJ1004_A05.11 OsJ_07496	Oryza sativa subsp. japonica (Rice)	780	eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]	eukaryotic translation initiation factor 4F complex [GO:0016281]	mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]	GO:0003729; GO:0003743; GO:0016281			NA	NA	NA	NA	NA	NA
TRINITY_DN11913_c0_g1_i1	Q96CN4	EVI5L_HUMAN	34	153	96	1	910	467	551	703	1.30E-12	75.5	EVI5L_HUMAN	reviewed	EVI5-like protein (Ecotropic viral integration site 5-like protein)	EVI5L	Homo sapiens (Human)	794	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547]		GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0043547; GO:0090630; GO:1902018	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547]		NA	NA	NA	NA	NA	NA
TRINITY_DN20825_c0_g1_i1	Q9U6M0	ECSIT_DROME	53.3	319	144	3	1078	137	62	380	2.90E-92	340.5	ECSIT_DROME	reviewed	"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial"	ECSIT CG10610	Drosophila melanogaster (Fruit fly)	409	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005739; GO:0045087; GO:0051341; GO:0061635	innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]		NA	NA	NA	NA	NA	NA
TRINITY_DN20825_c0_g1_i2	Q9U6M0	ECSIT_DROME	57.6	224	95	0	788	117	62	285	2.10E-74	280.8	ECSIT_DROME	reviewed	"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial"	ECSIT CG10610	Drosophila melanogaster (Fruit fly)	409	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005739; GO:0045087; GO:0051341; GO:0061635	innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]		NA	NA	NA	NA	NA	NA
TRINITY_DN8592_c0_g1_i1	P43004	EAA2_HUMAN	42.9	340	177	3	1248	280	168	507	4.70E-73	276.6	EAA2_HUMAN	reviewed	Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)	SLC1A2 EAAT2 GLT1	Homo sapiens (Human)	574	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; synapse [GO:0045202]	glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007632; GO:0009611; GO:0009986; GO:0010259; GO:0014047; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0043200; GO:0044297; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070633; GO:0070778; GO:0070779; GO:0097449; GO:0098712; GO:0098796; GO:0150104	adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]		NA	NA	NA	NA	NA	NA
TRINITY_DN8592_c0_g1_i2	P43004	EAA2_HUMAN	42.9	340	177	3	1176	208	168	507	5.80E-73	276.2	EAA2_HUMAN	reviewed	Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)	SLC1A2 EAAT2 GLT1	Homo sapiens (Human)	574	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; synapse [GO:0045202]	glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007632; GO:0009611; GO:0009986; GO:0010259; GO:0014047; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0043200; GO:0044297; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070633; GO:0070778; GO:0070779; GO:0097449; GO:0098712; GO:0098796; GO:0150104	adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]		NA	NA	NA	NA	NA	NA
TRINITY_DN8592_c0_g2_i1	P43004	EAA2_HUMAN	46.5	101	49	2	3	290	51	151	1.70E-16	86.7	EAA2_HUMAN	reviewed	Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)	SLC1A2 EAAT2 GLT1	Homo sapiens (Human)	574	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; synapse [GO:0045202]	glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007632; GO:0009611; GO:0009986; GO:0010259; GO:0014047; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0043200; GO:0044297; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070633; GO:0070778; GO:0070779; GO:0097449; GO:0098712; GO:0098796; GO:0150104	adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]		NA	NA	NA	NA	NA	NA
TRINITY_DN5135_c0_g1_i2	P51906	EAA3_MOUSE	52.6	470	214	5	1531	131	20	483	9.60E-122	438.7	EAA3_MOUSE	reviewed	Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1)	Slc1a1 Eaac1 Eaat3	Mus musculus (Mouse)	523	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; distal dendrite [GO:0150002]; early endosome membrane [GO:0031901]; glial cell projection [GO:0097386]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; proximal dendrite [GO:1990635]; recycling endosome membrane [GO:0055038]; synaptic cleft [GO:0043083]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; D-aspartate transmembrane transporter activity [GO:0140010]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; blood vessel morphogenesis [GO:0048514]; chloride transmembrane transport [GO:1902476]; cysteine transmembrane transport [GO:1903712]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; D-aspartate transport [GO:0070777]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; maintenance of blood-brain barrier [GO:0035633]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of heart rate [GO:0010460]	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; distal dendrite [GO:0150002]; early endosome membrane [GO:0031901]; glial cell projection [GO:0097386]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; proximal dendrite [GO:1990635]; recycling endosome membrane [GO:0055038]; synaptic cleft [GO:0043083]	chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; D-aspartate transmembrane transporter activity [GO:0140010]; glutamate:sodium symporter activity [GO:0015501]; glutamate binding [GO:0016595]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0010460; GO:0015108; GO:0015183; GO:0015501; GO:0015813; GO:0016020; GO:0016324; GO:0016595; GO:0030424; GO:0030425; GO:0031901; GO:0031902; GO:0032279; GO:0033229; GO:0035633; GO:0036475; GO:0042802; GO:0042883; GO:0043025; GO:0043083; GO:0043197; GO:0043198; GO:0043204; GO:0043679; GO:0046872; GO:0048514; GO:0051938; GO:0055038; GO:0070777; GO:0070778; GO:0070779; GO:0071944; GO:0097386; GO:0097440; GO:0098712; GO:0098793; GO:0099544; GO:0140009; GO:0140010; GO:0150002; GO:1902476; GO:1903712; GO:1990635	blood vessel morphogenesis [GO:0048514]; chloride transmembrane transport [GO:1902476]; cysteine transmembrane transport [GO:1903712]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; D-aspartate transport [GO:0070777]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; maintenance of blood-brain barrier [GO:0035633]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of heart rate [GO:0010460]		NA	NA	NA	NA	NA	NA
TRINITY_DN5135_c0_g1_i1	Q9N1R2	EAA4_CANLF	43.8	137	74	1	491	81	53	186	4.20E-22	106.3	EAA4_CANLF	reviewed	Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)	SLC1A6 EAAT4	Canis lupus familiaris (Dog) (Canis familiaris)	564	integral component of plasma membrane [GO:0005887]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]; L-glutamate import across plasma membrane [GO:0098712]	integral component of plasma membrane [GO:0005887]	high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]	GO:0005314; GO:0005887; GO:0046872; GO:0098712	L-glutamate import across plasma membrane [GO:0098712]		NA	NA	NA	NA	NA	NA
TRINITY_DN38866_c0_g1_i1	Q9VVG4	EXOC1_DROME	47.5	760	368	8	2259	4	132	868	6.30E-193	675.6	EXOC1_DROME	reviewed	Exocyst complex component 1 (Exocyst complex component Sec3)	Sec3 CG3885	Drosophila melanogaster (Fruit fly)	889	"exocyst [GO:0000145]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]"	exocyst [GO:0000145]; plasma membrane [GO:0005886]	"GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000145; GO:0005546; GO:0005886; GO:0006887; GO:0006893; GO:0015031; GO:0017049; GO:0051601	exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN28104_c0_g1_i1	Q9NV70	EXOC1_HUMAN	100	93	0	0	2	280	767	859	2.90E-47	188.7	EXOC1_HUMAN	reviewed	Exocyst complex component 1 (Exocyst complex component Sec3)	EXOC1 SEC3 SEC3L1 BM-012	Homo sapiens (Human)	894	"cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000145; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0015031; GO:0016020; GO:0016032; GO:0016241; GO:0017049; GO:0048015; GO:0048471; GO:0050714; GO:0051601; GO:0051607; GO:0090543; GO:0098592	defense response to virus [GO:0051607]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1050_c0_g1_i2	Q9VQQ9	EXOC2_DROME	62	71	26	1	238	26	68	137	1.10E-18	93.6	EXOC2_DROME	reviewed	Exocyst complex component 2 (Exocyst complex component Sec5)	Sec5 CG8843	Drosophila melanogaster (Fruit fly)	894	"annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]; Rab GTPase binding [GO:0017137]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]"	annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]	Rab GTPase binding [GO:0017137]	GO:0000145; GO:0000281; GO:0005642; GO:0005737; GO:0005886; GO:0005938; GO:0006887; GO:0006893; GO:0007269; GO:0007298; GO:0007349; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0017137; GO:0030136; GO:0031594; GO:0032456; GO:0035003; GO:0035147; GO:0043001; GO:0045056; GO:0045087; GO:0048215; GO:0048599; GO:0055037; GO:0060074; GO:0071896; GO:0072657; GO:0072659; GO:0072697; GO:0098793	"border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1050_c0_g1_i3	Q9VQQ9	EXOC2_DROME	35.5	794	436	14	2364	94	140	894	4.80E-135	483.4	EXOC2_DROME	reviewed	Exocyst complex component 2 (Exocyst complex component Sec5)	Sec5 CG8843	Drosophila melanogaster (Fruit fly)	894	"annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]; Rab GTPase binding [GO:0017137]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]"	annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]	Rab GTPase binding [GO:0017137]	GO:0000145; GO:0000281; GO:0005642; GO:0005737; GO:0005886; GO:0005938; GO:0006887; GO:0006893; GO:0007269; GO:0007298; GO:0007349; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0017137; GO:0030136; GO:0031594; GO:0032456; GO:0035003; GO:0035147; GO:0043001; GO:0045056; GO:0045087; GO:0048215; GO:0048599; GO:0055037; GO:0060074; GO:0071896; GO:0072657; GO:0072659; GO:0072697; GO:0098793	"border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1050_c0_g1_i7	Q9VQQ9	EXOC2_DROME	39.1	931	489	16	3554	873	5	894	3.00E-184	647.5	EXOC2_DROME	reviewed	Exocyst complex component 2 (Exocyst complex component Sec5)	Sec5 CG8843	Drosophila melanogaster (Fruit fly)	894	"annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]; Rab GTPase binding [GO:0017137]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]"	annulate lamellae [GO:0005642]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003]	Rab GTPase binding [GO:0017137]	GO:0000145; GO:0000281; GO:0005642; GO:0005737; GO:0005886; GO:0005938; GO:0006887; GO:0006893; GO:0007269; GO:0007298; GO:0007349; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0017137; GO:0030136; GO:0031594; GO:0032456; GO:0035003; GO:0035147; GO:0043001; GO:0045056; GO:0045087; GO:0048215; GO:0048599; GO:0055037; GO:0060074; GO:0071896; GO:0072657; GO:0072659; GO:0072697; GO:0098793	"border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; synapse maturation [GO:0060074]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35652_c0_g1_i1	Q96KP1	EXOC2_HUMAN	100	109	0	0	3	329	252	360	7.50E-55	214.2	EXOC2_HUMAN	reviewed	Exocyst complex component 2 (Exocyst complex component Sec5)	EXOC2 SEC5 SEC5L1	Homo sapiens (Human)	924	cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]	GO:0000145; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0015031; GO:0016020; GO:0016192; GO:0017160; GO:0019901; GO:0047485; GO:0090543; GO:2000535	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN618_c0_g1_i2	Q9V8K2	EXOC3_DROME	43.5	747	412	5	2330	93	1	738	6.40E-175	615.9	EXOC3_DROME	reviewed	Exocyst complex component 3 (Exocyst complex component Sec6)	Sec6 CG5341	Drosophila melanogaster (Fruit fly)	738	cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; SNARE binding [GO:0000149]; border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]	SNARE binding [GO:0000149]	GO:0000145; GO:0000149; GO:0005737; GO:0005915; GO:0006887; GO:0007009; GO:0007269; GO:0007298; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030707; GO:0032456; GO:0043001; GO:0045313; GO:0051601; GO:0072659; GO:0072697; GO:0098793	border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN618_c0_g1_i3	Q9V8K2	EXOC3_DROME	53.7	283	131	0	933	85	1	283	2.40E-78	293.9	EXOC3_DROME	reviewed	Exocyst complex component 3 (Exocyst complex component Sec6)	Sec6 CG5341	Drosophila melanogaster (Fruit fly)	738	cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]; SNARE binding [GO:0000149]; border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; exocyst [GO:0000145]; membrane [GO:0016020]; presynapse [GO:0098793]; rhabdomere [GO:0016028]; zonula adherens [GO:0005915]	SNARE binding [GO:0000149]	GO:0000145; GO:0000149; GO:0005737; GO:0005915; GO:0006887; GO:0007009; GO:0007269; GO:0007298; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030707; GO:0032456; GO:0043001; GO:0045313; GO:0051601; GO:0072659; GO:0072697; GO:0098793	border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5783_c0_g1_i1	O35382	EXOC4_MOUSE	44.3	115	64	0	534	190	100	214	2.50E-23	110.2	EXOC4_MOUSE	reviewed	Exocyst complex component 4 (Exocyst complex component Sec8)	Exoc4 Sec8 Sec8l1	Mus musculus (Mouse)	975	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; Ral GTPase binding [GO:0017160]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]	GO:0000145; GO:0005737; GO:0005886; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0017160; GO:0030010; GO:0030165; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0043209; GO:0044091; GO:0044877; GO:0045202; GO:0047485; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0090522; GO:0090543	chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]		NA	NA	NA	NA	NA	NA
TRINITY_DN5544_c0_g1_i1	P97878	EXOC5_RAT	52.9	157	74	0	3	473	547	703	1.20E-47	191	EXOC5_RAT	reviewed	Exocyst complex component 5 (71 kDa component of rsec6/8 secretory complex) (Exocyst complex component Sec10) (p71)	Exoc5 Sec10l1	Rattus norvegicus (Rat)	708	cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]	cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]	protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]	GO:0000145; GO:0005829; GO:0006887; GO:0006893; GO:0015031; GO:0017160; GO:0030496; GO:0047485; GO:0072659	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5544_c0_g1_i2	P97878	EXOC5_RAT	52.9	157	74	0	3	473	547	703	1.60E-47	190.7	EXOC5_RAT	reviewed	Exocyst complex component 5 (71 kDa component of rsec6/8 secretory complex) (Exocyst complex component Sec10) (p71)	Exoc5 Sec10l1	Rattus norvegicus (Rat)	708	cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]	cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]	protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]	GO:0000145; GO:0005829; GO:0006887; GO:0006893; GO:0015031; GO:0017160; GO:0030496; GO:0047485; GO:0072659	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN33111_c0_g1_i1	Q9XTM1	EXOC5_DROME	48.9	190	92	2	569	3	1	186	4.20E-46	186	EXOC5_DROME	reviewed	Exocyst complex component 5 (Exocyst complex component Sec10)	Sec10 CG6159	Drosophila melanogaster (Fruit fly)	710	exocyst [GO:0000145]; presynapse [GO:0098793]; beta-catenin binding [GO:0008013]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle tethering involved in exocytosis [GO:0090522]; vesicle-mediated transport [GO:0016192]	exocyst [GO:0000145]; presynapse [GO:0098793]	beta-catenin binding [GO:0008013]	GO:0000145; GO:0006887; GO:0006893; GO:0007269; GO:0008013; GO:0015031; GO:0016080; GO:0016081; GO:0016192; GO:0090522; GO:0098793	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]; vesicle tethering involved in exocytosis [GO:0090522]		blue	blue	NA	NA	NA	NA
TRINITY_DN32892_c0_g1_i1	O00471	EXOC5_HUMAN	100	109	0	0	1	327	573	681	6.60E-59	227.6	EXOC5_HUMAN	reviewed	Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10)	EXOC5 SEC10 SEC10L1	Homo sapiens (Human)	708	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]	protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]	GO:0000145; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0015031; GO:0017160; GO:0030496; GO:0047485; GO:0072659	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN37508_c0_g1_i1	E2R766	EXOC6_CANLF	100	82	0	0	248	3	348	429	3.60E-41	168.3	EXOC6_CANLF	reviewed	Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1)	EXOC6 SEC15A SEC15L SEC15L1	Canis lupus familiaris (Dog) (Canis familiaris)	803	exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]	exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]		GO:0000145; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0030426; GO:0048471; GO:0090543	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN49_c0_g1_i1	A6H5Z3	EXC6B_MOUSE	53.2	793	351	5	2405	81	20	810	2.70E-234	813.1	EXC6B_MOUSE	reviewed	Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2)	Exoc6b Sec15b Sec15l2	Mus musculus (Mouse)	810	exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]	exocyst [GO:0000145]; membrane [GO:0016020]		GO:0000145; GO:0006887; GO:0006893; GO:0006904; GO:0016020	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN49_c0_g1_i2	A6H5Z3	EXC6B_MOUSE	53.8	775	338	5	2351	81	38	810	8.20E-231	801.6	EXC6B_MOUSE	reviewed	Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2)	Exoc6b Sec15b Sec15l2	Mus musculus (Mouse)	810	exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]	exocyst [GO:0000145]; membrane [GO:0016020]		GO:0000145; GO:0006887; GO:0006893; GO:0006904; GO:0016020	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN49_c0_g1_i3	A6H5Z3	EXC6B_MOUSE	53.9	799	347	6	2420	81	14	810	1.50E-237	823.9	EXC6B_MOUSE	reviewed	Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2)	Exoc6b Sec15b Sec15l2	Mus musculus (Mouse)	810	exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]	exocyst [GO:0000145]; membrane [GO:0016020]		GO:0000145; GO:0006887; GO:0006893; GO:0006904; GO:0016020	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN9084_c0_g1_i1	O54922	EXOC7_RAT	39.9	358	203	5	1	1065	305	653	2.60E-70	267.3	EXOC7_RAT	reviewed	Exocyst complex component 7 (Exocyst complex component Exo70) (rExo70)	Exoc7 Exo70	Rattus norvegicus (Rat)	653	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; microtubule organizing center [GO:0005815]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; microtubule organizing center [GO:0005815]		GO:0000145; GO:0005815; GO:0005829; GO:0006887; GO:0015031; GO:0032584; GO:0034451; GO:0090543; GO:2000535	exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]		NA	NA	NA	NA	NA	NA
TRINITY_DN9084_c0_g1_i2	O54922	EXOC7_RAT	40.1	279	155	5	1	828	305	574	2.80E-51	203.8	EXOC7_RAT	reviewed	Exocyst complex component 7 (Exocyst complex component Exo70) (rExo70)	Exoc7 Exo70	Rattus norvegicus (Rat)	653	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; microtubule organizing center [GO:0005815]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; microtubule organizing center [GO:0005815]		GO:0000145; GO:0005815; GO:0005829; GO:0006887; GO:0015031; GO:0032584; GO:0034451; GO:0090543; GO:2000535	exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]		NA	NA	NA	NA	NA	NA
TRINITY_DN29750_c0_g1_i1	Q5U247	EXOC8_XENLA	41.9	683	371	7	43	2091	11	667	4.00E-139	496.9	EXOC8_XENLA	reviewed	Exocyst complex component 8	exoc8	Xenopus laevis (African clawed frog)	685	exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; protein transport [GO:0015031]	exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]		GO:0000145; GO:0006887; GO:0015031; GO:0030426; GO:0048471	exocytosis [GO:0006887]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN35493_c0_g1_i1	Q9NVH0	EXD2_HUMAN	41.4	551	281	11	263	1831	82	618	4.40E-108	393.7	EXD2_HUMAN	reviewed	Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)	EXD2 C14orf114 EXDL2	Homo sapiens (Human)	621	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]	GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0090305; GO:0090734	DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]		blue	blue	NA	NA	NA	NA
TRINITY_DN2496_c0_g1_i1	Q8VEG4	EXD2_MOUSE	46.3	67	36	0	313	113	102	168	9.90E-12	71.6	EXD2_MOUSE	reviewed	Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)	Exd2 Exdl2	Mus musculus (Mouse)	650	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]	GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0090305; GO:0090734	DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN2496_c0_g1_i2	Q8VEG4	EXD2_MOUSE	41.2	563	267	10	1813	236	102	637	6.90E-114	412.9	EXD2_MOUSE	reviewed	Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)	Exd2 Exdl2	Mus musculus (Mouse)	650	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]	GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0090305; GO:0090734	DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN7625_c0_g1_i1	Q8N9H8	MUT7_HUMAN	25.7	755	484	19	2328	253	104	844	9.50E-55	216.9	MUT7_HUMAN	reviewed	Exonuclease mut-7 homolog (EC 3.1.-.-) (Exonuclease 3'-5' domain-containing protein 3)	EXD3 HBE269	Homo sapiens (Human)	876	3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]		3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0008408; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27770_c0_g1_i1	Q86TP1	PRUN1_HUMAN	40.7	366	208	6	1157	66	3	361	8.90E-64	245.7	PRUN1_HUMAN	reviewed	Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune)	PRUNE1 PRUNE	Homo sapiens (Human)	453	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]	GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006798; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767	polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]		brown	brown	1	NA	NA	NA
TRINITY_DN36984_c0_g1_i1	Q9Y3B2	EXOS1_HUMAN	100	82	0	0	247	2	89	170	1.80E-40	166	EXOS1_HUMAN	reviewed	Exosome complex component CSL4 (Exosome component 1)	EXOSC1 CSL4 CGI-108	Homo sapiens (Human)	195	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000176; GO:0000178; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0043488; GO:0043928; GO:0090503	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33829_c0_g1_i1	Q9Y3B2	EXOS1_HUMAN	45.1	184	96	4	636	97	8	190	3.00E-33	143.7	EXOS1_HUMAN	reviewed	Exosome complex component CSL4 (Exosome component 1)	EXOSC1 CSL4 CGI-108	Homo sapiens (Human)	195	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000176; GO:0000178; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0043488; GO:0043928; GO:0090503	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8771_c1_g1_i1	Q6P0I8	EXOS6_DANRE	32.3	269	167	5	57	860	4	258	7.00E-31	136	EXOS6_DANRE	reviewed	Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog)	exosc6 mtr3	Danio rerio (Zebrafish) (Brachydanio rerio)	271	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005730; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0071028; GO:0071051	"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8771_c1_g1_i6	Q6P0I8	EXOS6_DANRE	53.5	43	20	0	66	194	44	86	1.90E-07	56.2	EXOS6_DANRE	reviewed	Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog)	exosc6 mtr3	Danio rerio (Zebrafish) (Brachydanio rerio)	271	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005730; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0071028; GO:0071051	"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8771_c1_g1_i7	Q6P0I8	EXOS6_DANRE	41.2	85	48	1	57	311	4	86	1.60E-10	67	EXOS6_DANRE	reviewed	Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog)	exosc6 mtr3	Danio rerio (Zebrafish) (Brachydanio rerio)	271	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005730; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0071028; GO:0071051	"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1269_c0_g2_i3	Q8VBV3	EXOS2_MOUSE	48.3	290	144	3	82	945	3	288	3.10E-68	260.4	EXOS2_MOUSE	reviewed	Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4)	Exosc2 Rrp4	Mus musculus (Mouse)	293	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0030307; GO:0034427; GO:0034475; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1269_c0_g2_i4	Q8VBV3	EXOS2_MOUSE	48.3	290	144	3	82	945	3	288	3.10E-68	260.4	EXOS2_MOUSE	reviewed	Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4)	Exosc2 Rrp4	Mus musculus (Mouse)	293	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0030307; GO:0034427; GO:0034475; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25411_c0_g1_i1	Q3T0E1	EXOS3_BOVIN	37.8	241	125	3	768	121	27	267	4.10E-39	163.3	EXOS3_BOVIN	reviewed	Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40)	EXOSC3 RRP40	Bos taurus (Bovine)	275	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005654; GO:0005730; GO:0034427; GO:0034475; GO:0035327; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31884_c0_g1_i1	Q9NQT5	EXOS3_HUMAN	100	87	0	0	262	2	99	185	6.70E-46	184.1	EXOS3_HUMAN	reviewed	Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10)	EXOSC3 RRP40 CGI-102	Homo sapiens (Human)	275	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2112_c0_g1_i1	Q9NQT5	EXOS3_HUMAN	41.7	204	113	1	144	737	61	264	1.20E-40	168.3	EXOS3_HUMAN	reviewed	Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10)	EXOSC3 RRP40 CGI-102	Homo sapiens (Human)	275	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34889_c0_g1_i1	Q7YRA3	EXOS4_BOVIN	98.5	66	1	0	3	200	17	82	5.10E-30	131	EXOS4_BOVIN	reviewed	Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41)	EXOSC4 RRP41	Bos taurus (Bovine)	245	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; intermediate filament cytoskeleton [GO:0045111]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; transcriptionally active chromatin [GO:0035327]; exonuclease activity [GO:0004527]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; intermediate filament cytoskeleton [GO:0045111]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; transcriptionally active chromatin [GO:0035327]	exonuclease activity [GO:0004527]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000460; GO:0004527; GO:0005730; GO:0005829; GO:0016075; GO:0030307; GO:0034427; GO:0034475; GO:0035327; GO:0035925; GO:0045006; GO:0045111; GO:0051607; GO:0071028; GO:0071044; GO:0071051	"defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN147_c0_g4_i1	Q9SP08	RRP41_ARATH	41.6	245	137	3	842	114	1	241	8.50E-43	175.6	RRP41_ARATH	reviewed	Exosome complex component RRP41 homolog (Ribosomal RNA-processing protein 41) (AtRRP41) (AtRrp41p)	RRP41 At3g61620 F15G16.10	Arabidopsis thaliana (Mouse-ear cress)	241	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0003723; GO:0005730; GO:0005829; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0071028; GO:0071051	"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		blue	blue	NA	NA	NA	NA
TRINITY_DN35301_c0_g1_i1	Q15024	EXOS7_HUMAN	100	77	0	0	234	4	115	191	5.40E-39	161	EXOS7_HUMAN	reviewed	Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8)	EXOSC7 KIAA0116 RRP42	Homo sapiens (Human)	291	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006401; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40406_c0_g1_i1	Q15024	EXOS7_HUMAN	99	100	1	0	3	302	18	117	9.30E-52	203.8	EXOS7_HUMAN	reviewed	Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8)	EXOSC7 KIAA0116 RRP42	Homo sapiens (Human)	291	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006401; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22391_c0_g1_i2	Q96B26	EXOS8_HUMAN	100	75	0	0	226	2	108	182	1.80E-36	152.5	EXOS8_HUMAN	reviewed	Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9)	EXOSC8 OIP2 RRP43	Homo sapiens (Human)	276	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36858_c0_g1_i1	Q96B26	EXOS8_HUMAN	100	96	0	0	2	289	5	100	7.60E-51	200.7	EXOS8_HUMAN	reviewed	Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9)	EXOSC8 OIP2 RRP43	Homo sapiens (Human)	276	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4507_c0_g1_i2	Q9D753	EXOS8_MOUSE	46.9	254	135	0	905	144	5	258	2.40E-67	257.3	EXOS8_MOUSE	reviewed	Exosome complex component RRP43 (Exosome component 8) (Ribosomal RNA-processing protein 43)	Exosc8 Rrp43	Mus musculus (Mouse)	276	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4507_c0_g1_i5	Q9D753	EXOS8_MOUSE	46.6	249	133	0	890	144	10	258	1.50E-65	251.5	EXOS8_MOUSE	reviewed	Exosome complex component RRP43 (Exosome component 8) (Ribosomal RNA-processing protein 43)	Exosc8 Rrp43	Mus musculus (Mouse)	276	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22391_c0_g1_i1	Q9D753	EXOS8_MOUSE	100	66	0	0	199	2	117	182	1.20E-31	136.3	EXOS8_MOUSE	reviewed	Exosome complex component RRP43 (Exosome component 8) (Ribosomal RNA-processing protein 43)	Exosc8 Rrp43	Mus musculus (Mouse)	276	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4601_c0_g1_i1	Q3SWZ4	EXOS9_BOVIN	45.4	280	150	2	82	921	1	277	6.40E-69	262.7	EXOS9_BOVIN	reviewed	Exosome complex component RRP45 (Exosome component 9)	EXOSC9	Bos taurus (Bovine)	440	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000178; GO:0000228; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN4999_c0_g1_i1	Q9NQT4	EXOS5_HUMAN	34.3	143	91	2	3	425	91	232	2.10E-14	80.5	EXOS5_HUMAN	reviewed	Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B)	EXOSC5 CML28 RRP46	Homo sapiens (Human)	235	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051	"defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4999_c0_g1_i2	Q9CRA8	EXOS5_MOUSE	36.4	228	144	1	165	848	6	232	1.10E-37	158.7	EXOS5_MOUSE	reviewed	Exosome complex component RRP46 (Exosome component 5) (Ribosomal RNA-processing protein 46)	Exosc5 D7Wsu180e Rrp46	Mus musculus (Mouse)	235	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0035327; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051	"defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2776_c1_g1_i1	Q9D0M0	EXOS7_MOUSE	42.1	290	166	2	91	957	1	289	1.60E-62	241.5	EXOS7_MOUSE	reviewed	Exosome complex exonuclease RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42)	Exosc7 Rrp42	Mus musculus (Mouse)	291	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; AU-rich element binding [GO:0017091]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]	AU-rich element binding [GO:0017091]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0005730; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40541_c0_g1_i1	Q9D0M0	EXOS7_MOUSE	99	97	1	0	2	292	82	178	5.10E-51	201.4	EXOS7_MOUSE	reviewed	Exosome complex exonuclease RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42)	Exosc7 Rrp42	Mus musculus (Mouse)	291	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; AU-rich element binding [GO:0017091]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]	AU-rich element binding [GO:0017091]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0005730; GO:0016075; GO:0017091; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN92_c0_g1_i1	Q9Y2L1	RRP44_HUMAN	52	694	298	6	3	2078	293	953	1.30E-200	701	RRP44_HUMAN	reviewed	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	DIS3 KIAA1008 RRP44	Homo sapiens (Human)	958	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005654; GO:0005829; GO:0006364; GO:0016020; GO:0016075; GO:0043488; GO:0043928; GO:0071034	CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN92_c0_g1_i2	Q9Y2L1	RRP44_HUMAN	53.3	668	280	7	53	2038	312	953	5.20E-197	689.1	RRP44_HUMAN	reviewed	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	DIS3 KIAA1008 RRP44	Homo sapiens (Human)	958	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005654; GO:0005829; GO:0006364; GO:0016020; GO:0016075; GO:0043488; GO:0043928; GO:0071034	CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN26078_c0_g1_i1	Q9CSH3	RRP44_MOUSE	57.4	54	23	0	2	163	745	798	7.20E-12	70.9	RRP44_MOUSE	reviewed	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	Dis3 Kiaa1008 Rrp44	Mus musculus (Mouse)	958	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016075; GO:0071034	CUT catabolic process [GO:0071034]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN30296_c0_g1_i1	Q9Y2L1	RRP44_HUMAN	100	138	0	0	3	416	588	725	1.80E-69	263.1	RRP44_HUMAN	reviewed	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	DIS3 KIAA1008 RRP44	Homo sapiens (Human)	958	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005654; GO:0005829; GO:0006364; GO:0016020; GO:0016075; GO:0043488; GO:0043928; GO:0071034	CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN30512_c0_g1_i1	Q9Y2L1	RRP44_HUMAN	100	145	0	0	437	3	445	589	5.70E-82	304.7	RRP44_HUMAN	reviewed	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	DIS3 KIAA1008 RRP44	Homo sapiens (Human)	958	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005654; GO:0005829; GO:0006364; GO:0016020; GO:0016075; GO:0043488; GO:0043928; GO:0071034	CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN25928_c0_g1_i1	Q9SHL7	RP44A_ARATH	56.9	216	91	1	33	674	377	592	3.90E-66	252.7	RP44A_ARATH	reviewed	Exosome complex exonuclease RRP44 homolog A (RRP44 homolog A) (EC 3.1.13.-) (EC 3.1.26.-) (Protein EMBRYO DEFECTIVE 2763) (Ribosomal RNA-processing protein 44A) (AtRRP44A)	RRP44A EMB2763 At2g17510	Arabidopsis thaliana (Mouse-ear cress)	933	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0006364; GO:0016075; GO:0046872	rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN26583_c0_g1_i1	Q9SHL7	RP44A_ARATH	58.9	107	42	2	324	4	719	823	1.50E-27	123.6	RP44A_ARATH	reviewed	Exosome complex exonuclease RRP44 homolog A (RRP44 homolog A) (EC 3.1.13.-) (EC 3.1.26.-) (Protein EMBRYO DEFECTIVE 2763) (Ribosomal RNA-processing protein 44A) (AtRRP44A)	RRP44A EMB2763 At2g17510	Arabidopsis thaliana (Mouse-ear cress)	933	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0006364; GO:0016075; GO:0046872	rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN15092_c0_g1_i1	Q12149	RRP6_YEAST	60.4	96	38	0	306	19	229	324	3.50E-30	132.1	RRP6_YEAST	reviewed	Exosome complex exonuclease RRP6 (EC 3.1.13.-) (Ribosomal RNA-processing protein 6)	RRP6 UNC733 YOR001W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	733	"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleotide binding [GO:0000166]; rRNA primary transcript binding [GO:0042134]; single-stranded RNA binding [GO:0003727]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; nucleotide binding [GO:0000166]; rRNA primary transcript binding [GO:0042134]; single-stranded RNA binding [GO:0003727]	GO:0000166; GO:0000175; GO:0000176; GO:0000467; GO:0000973; GO:0003727; GO:0005634; GO:0005730; GO:0034473; GO:0034475; GO:0034476; GO:0042134; GO:0071028; GO:0071033; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071042; GO:0071044; GO:0071048; GO:0071049; GO:0071051	"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN595_c0_g2_i1	P56960	EXOSX_MOUSE	39.3	621	326	9	2219	492	4	618	3.30E-117	424.1	EXOSX_MOUSE	reviewed	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog)	Exosc10 Pmscl2	Mus musculus (Mouse)	887	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; single-stranded RNA binding [GO:0003727]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; single-stranded RNA binding [GO:0003727]	GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000956; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0009048; GO:0032211; GO:0035327; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071048; GO:0071051; GO:1904872	"CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39067_c0_g1_i1	Q01780	EXOSX_HUMAN	100	82	0	0	261	16	282	363	6.40E-41	167.5	EXOSX_HUMAN	reviewed	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2)	EXOSC10 PMSCL PMSCL2 RRP6	Homo sapiens (Human)	885	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]	GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0009048; GO:0016020; GO:0032211; GO:0035327; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071048; GO:0071051; GO:1904872	"CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36935_c0_g1_i1	Q01780	EXOSX_HUMAN	100	121	0	0	365	3	371	491	2.70E-69	262.3	EXOSX_HUMAN	reviewed	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2)	EXOSC10 PMSCL PMSCL2 RRP6	Homo sapiens (Human)	885	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]	GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0009048; GO:0016020; GO:0032211; GO:0035327; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071048; GO:0071051; GO:1904872	"CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31267_c0_g1_i1	Q01780	EXOSX_HUMAN	100	85	0	0	257	3	513	597	7.90E-44	177.2	EXOSX_HUMAN	reviewed	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2)	EXOSC10 PMSCL PMSCL2 RRP6	Homo sapiens (Human)	885	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]	GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0009048; GO:0016020; GO:0032211; GO:0035327; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071048; GO:0071051; GO:1904872	"CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21037_c0_g1_i1	Q9CZU3	MTREX_MOUSE	65.5	168	58	0	507	4	374	541	9.80E-62	237.7	MTREX_MOUSE	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	Mtrex Skiv2l2	Mus musculus (Mouse)	1040	catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0008380; GO:0016607; GO:0031499; GO:0071013	maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN26274_c0_g1_i1	Q9CZU3	MTREX_MOUSE	97.9	95	2	0	288	4	439	533	2.30E-47	189.1	MTREX_MOUSE	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	Mtrex Skiv2l2	Mus musculus (Mouse)	1040	catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0008380; GO:0016607; GO:0031499; GO:0071013	maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5637_c0_g1_i1	P42285	MTREX_HUMAN	76.7	193	45	0	579	1	362	554	9.30E-83	307.8	MTREX_HUMAN	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	MTREX DOB1 KIAA0052 MTR4 SKIV2L2	Homo sapiens (Human)	1042	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016076; GO:0016607; GO:0031499; GO:0071013	"maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28790_c0_g1_i1	P42285	MTREX_HUMAN	100	150	0	0	450	1	818	967	1.40E-75	283.5	MTREX_HUMAN	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	MTREX DOB1 KIAA0052 MTR4 SKIV2L2	Homo sapiens (Human)	1042	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016076; GO:0016607; GO:0031499; GO:0071013	"maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21037_c0_g2_i1	P42285	MTREX_HUMAN	74.7	186	47	0	563	6	141	326	2.50E-82	306.2	MTREX_HUMAN	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	MTREX DOB1 KIAA0052 MTR4 SKIV2L2	Homo sapiens (Human)	1042	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016076; GO:0016607; GO:0031499; GO:0071013	"maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8961_c0_g1_i1	P42285	MTREX_HUMAN	79.9	169	34	0	11	517	131	299	6.00E-75	281.6	MTREX_HUMAN	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	MTREX DOB1 KIAA0052 MTR4 SKIV2L2	Homo sapiens (Human)	1042	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016076; GO:0016607; GO:0031499; GO:0071013	"maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1335_c0_g1_i1	P42285	MTREX_HUMAN	60.3	224	89	0	2	673	756	979	9.40E-68	258.1	MTREX_HUMAN	reviewed	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	MTREX DOB1 KIAA0052 MTR4 SKIV2L2	Homo sapiens (Human)	1042	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016076; GO:0016607; GO:0031499; GO:0071013	"maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30348_c0_g1_i1	A5D7I4	EXT1_BOVIN	65.4	81	28	0	8	250	556	636	1.20E-28	126.7	EXT1_BOVIN	reviewed	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1 homolog)	EXT1	Bos taurus (Bovine)	746	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; synapse [GO:0045202]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endoderm development [GO:0007492]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell differentiation [GO:0072112]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organismal water homeostasis [GO:0050891]; olfactory bulb development [GO:0021772]; ossification [GO:0001503]; perichondral bone morphogenesis [GO:0061974]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; response to virus [GO:0009615]; smoothened signaling pathway [GO:0007224]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; synapse [GO:0045202]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0001503; GO:0002062; GO:0003416; GO:0005794; GO:0006486; GO:0007033; GO:0007155; GO:0007224; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008283; GO:0008375; GO:0008543; GO:0009615; GO:0009642; GO:0010467; GO:0015014; GO:0015020; GO:0016757; GO:0017145; GO:0021772; GO:0030176; GO:0030199; GO:0030210; GO:0032836; GO:0035176; GO:0035249; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0045165; GO:0045202; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0055078; GO:0060047; GO:0060070; GO:0060560; GO:0061744; GO:0061974; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0120193; GO:1990823	"axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; canonical Wnt signaling pathway [GO:0060070]; cell adhesion [GO:0007155]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endoderm development [GO:0007492]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell differentiation [GO:0072112]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organismal water homeostasis [GO:0050891]; olfactory bulb development [GO:0021772]; ossification [GO:0001503]; perichondral bone morphogenesis [GO:0061974]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; response to virus [GO:0009615]; smoothened signaling pathway [GO:0007224]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11479_c0_g1_i1	Q9V730	EXT1_DROME	54	235	106	2	5	706	305	538	5.40E-69	262.3	EXT1_DROME	reviewed	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Protein tout-velu)	ttv DEXT1 CG10117	Drosophila melanogaster (Fruit fly)	760	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007411; GO:0008354; GO:0008375; GO:0008589; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016055; GO:0016757; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0050508; GO:0050509; GO:0090263	"axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11479_c0_g1_i2	Q9V730	EXT1_DROME	43.3	157	87	2	28	495	383	538	2.10E-30	133.7	EXT1_DROME	reviewed	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Protein tout-velu)	ttv DEXT1 CG10117	Drosophila melanogaster (Fruit fly)	760	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007411; GO:0008354; GO:0008375; GO:0008589; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016055; GO:0016757; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0050508; GO:0050509; GO:0090263	"axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2276_c0_g1_i1	P70428	EXT2_MOUSE	55.9	665	284	6	2119	143	57	718	3.60E-223	776.2	EXT2_MOUSE	reviewed	Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2 homolog)	Ext2	Mus musculus (Mouse)	718	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]; cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0001503; GO:0001707; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0008217; GO:0008375; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016757; GO:0030154; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0042803; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0055078; GO:0060047; GO:0060350	"cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2276_c0_g1_i3	P70428	EXT2_MOUSE	55.9	665	284	6	2034	58	57	718	3.40E-223	776.2	EXT2_MOUSE	reviewed	Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2 homolog)	Ext2	Mus musculus (Mouse)	718	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]; cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0001503; GO:0001707; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0008217; GO:0008375; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016757; GO:0030154; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0042803; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0055078; GO:0060047; GO:0060350	"cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2276_c0_g1_i4	P70428	EXT2_MOUSE	55.9	665	284	6	2075	99	57	718	3.50E-223	776.2	EXT2_MOUSE	reviewed	Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2 homolog)	Ext2	Mus musculus (Mouse)	718	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]; cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0001503; GO:0001707; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0008217; GO:0008375; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016757; GO:0030154; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0042803; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0055078; GO:0060047; GO:0060350	"cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23001_c0_g1_i1	Q93063	EXT2_HUMAN	100	299	0	0	3	899	420	718	2.00E-180	632.9	EXT2_HUMAN	reviewed	Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2)	EXT2	Homo sapiens (Human)	718	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; transferase activity, transferring glycosyl groups [GO:0016757]; cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]	"glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0001503; GO:0001707; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007165; GO:0008217; GO:0015012; GO:0015014; GO:0015020; GO:0016020; GO:0016021; GO:0016757; GO:0030154; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0055078; GO:0060047; GO:0060350; GO:0070062	"cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein glycosylation [GO:0006486]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30665_c0_g1_i1	P14068	XPO1_SCHPO	62.3	114	43	0	4	345	651	764	2.20E-33	142.9	XPO1_SCHPO	reviewed	Exportin-1 (Caffeine resistance protein 2) (Chromosome region maintenance protein 1)	xpo1 caf2 crm1 SPAC1805.17 SPAC1B2.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1078	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0000055; GO:0000056; GO:0005049; GO:0005525; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005829; GO:0006611; GO:0008536; GO:0034399; GO:0046825	protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN39588_c0_g1_i1	Q9TVM2	XPO1_DROME	48.9	94	48	0	283	2	489	582	8.60E-23	107.5	XPO1_DROME	reviewed	Exportin-1 (Chromosome region maintenance 1 protein) (Protein embargoed)	emb Crm1 CG13387	Drosophila melanogaster (Fruit fly)	1063	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; centriole replication [GO:0007099]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; nuclear pore complex assembly [GO:0051292]; protein export from nucleus [GO:0006611]; protein transport [GO:0015031]; regulation of cellular response to hypoxia [GO:1900037]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0000055; GO:0000056; GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0007099; GO:0007275; GO:0008536; GO:0015031; GO:0031965; GO:0046825; GO:0051028; GO:0051168; GO:0051292; GO:1900037	centriole replication [GO:0007099]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; nuclear pore complex assembly [GO:0051292]; protein export from nucleus [GO:0006611]; protein transport [GO:0015031]; regulation of cellular response to hypoxia [GO:1900037]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN5557_c0_g1_i3	Q9TVM2	XPO1_DROME	73.3	90	24	0	351	82	9	98	5.40E-34	145.2	XPO1_DROME	reviewed	Exportin-1 (Chromosome region maintenance 1 protein) (Protein embargoed)	emb Crm1 CG13387	Drosophila melanogaster (Fruit fly)	1063	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; centriole replication [GO:0007099]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; nuclear pore complex assembly [GO:0051292]; protein export from nucleus [GO:0006611]; protein transport [GO:0015031]; regulation of cellular response to hypoxia [GO:1900037]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0000055; GO:0000056; GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0007099; GO:0007275; GO:0008536; GO:0015031; GO:0031965; GO:0046825; GO:0051028; GO:0051168; GO:0051292; GO:1900037	centriole replication [GO:0007099]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; nuclear pore complex assembly [GO:0051292]; protein export from nucleus [GO:0006611]; protein transport [GO:0015031]; regulation of cellular response to hypoxia [GO:1900037]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN38295_c0_g1_i1	O14980	XPO1_HUMAN	100	82	0	0	3	248	274	355	1.70E-38	159.5	XPO1_HUMAN	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	XPO1 CRM1	Homo sapiens (Human)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0016020; GO:0016032; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0042493; GO:0043231; GO:0043488; GO:0043657; GO:0046825; GO:0051028; GO:0075733; GO:1990904	intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN37533_c0_g1_i1	O14980	XPO1_HUMAN	72.3	94	26	0	288	7	498	591	2.40E-36	152.5	XPO1_HUMAN	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	XPO1 CRM1	Homo sapiens (Human)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0016020; GO:0016032; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0042493; GO:0043231; GO:0043488; GO:0043657; GO:0046825; GO:0051028; GO:0075733; GO:1990904	intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN40230_c0_g1_i1	O14980	XPO1_HUMAN	100	87	0	0	1	261	622	708	1.30E-44	179.9	XPO1_HUMAN	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	XPO1 CRM1	Homo sapiens (Human)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0016020; GO:0016032; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0042493; GO:0043231; GO:0043488; GO:0043657; GO:0046825; GO:0051028; GO:0075733; GO:1990904	intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN27520_c0_g1_i1	Q6P5F9	XPO1_MOUSE	97.4	117	3	0	353	3	101	217	4.10E-59	228.4	XPO1_MOUSE	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	Xpo1 Crm1	Mus musculus (Mouse)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0042493; GO:0043231; GO:0046825; GO:0051028; GO:1990904	mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN24080_c0_g1_i1	O14980	XPO1_HUMAN	100	329	0	0	988	2	682	1010	3.50E-188	658.7	XPO1_HUMAN	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	XPO1 CRM1	Homo sapiens (Human)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0016020; GO:0016032; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0042493; GO:0043231; GO:0043488; GO:0043657; GO:0046825; GO:0051028; GO:0075733; GO:1990904	intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN24080_c0_g1_i2	O14980	XPO1_HUMAN	100	134	0	0	404	3	682	815	5.40E-71	268.1	XPO1_HUMAN	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	XPO1 CRM1	Homo sapiens (Human)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0016020; GO:0016032; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0042493; GO:0043231; GO:0043488; GO:0043657; GO:0046825; GO:0051028; GO:0075733; GO:1990904	intracellular transport of virus [GO:0075733]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN20933_c0_g1_i1	Q6P5F9	XPO1_MOUSE	100	80	0	0	1	240	222	301	1.00E-37	156.8	XPO1_MOUSE	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	Xpo1 Crm1	Mus musculus (Mouse)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0042493; GO:0043231; GO:0046825; GO:0051028; GO:1990904	mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5557_c0_g1_i1	Q6P5F9	XPO1_MOUSE	77.1	663	145	3	1976	3	13	673	7.40E-302	1037.3	XPO1_MOUSE	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	Xpo1 Crm1	Mus musculus (Mouse)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0042493; GO:0043231; GO:0046825; GO:0051028; GO:1990904	mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5557_c0_g1_i2	Q6P5F9	XPO1_MOUSE	75.9	403	92	2	1282	74	674	1071	1.20E-172	607.4	XPO1_MOUSE	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	Xpo1 Crm1	Mus musculus (Mouse)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0042493; GO:0043231; GO:0046825; GO:0051028; GO:1990904	mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5557_c0_g1_i4	Q80U96	XPO1_RAT	76.5	1073	233	7	3277	74	13	1071	0	1633.6	XPO1_RAT	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	Xpo1 Crm1	Rattus norvegicus (Rat)	1071	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0008536; GO:0010824; GO:0015030; GO:0019904; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0042493; GO:0046825; GO:0051028; GO:1990904	mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN6253_c0_g1_i1	Q8AY73	XPO2_ORENI	45	302	165	1	3	905	381	682	6.70E-69	262.3	XPO2_ORENI	reviewed	Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)	cse1l cas xpo2	Oreochromis niloticus (Nile tilapia) (Tilapia nilotica)	971	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005737; GO:0006886; GO:0008536	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN210_c0_g1_i2	Q802D3	XPO4_DANRE	38.1	391	240	2	1261	89	3	391	1.10E-77	292	XPO4_DANRE	reviewed	Exportin-4	xpo4 zgc:55678	Danio rerio (Zebrafish) (Brachydanio rerio)	1150	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]	nuclear export signal receptor activity [GO:0005049]	GO:0005049; GO:0005643; GO:0005737; GO:0006611	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN210_c0_g1_i5	Q499Y0	XPO4_XENLA	40.5	410	235	3	1293	91	741	1150	2.80E-84	313.9	XPO4_XENLA	reviewed	Exportin-4	xpo4	Xenopus laevis (African clawed frog)	1150	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN210_c0_g1_i6	Q499Y0	XPO4_XENLA	36.9	203	121	1	652	65	283	485	1.30E-38	161.4	XPO4_XENLA	reviewed	Exportin-4	xpo4	Xenopus laevis (African clawed frog)	1150	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN210_c0_g1_i1	Q9C0E2	XPO4_HUMAN	39.1	486	287	3	1501	65	3	486	4.10E-103	376.7	XPO4_HUMAN	reviewed	Exportin-4 (Exp4)	XPO4 KIAA1721	Homo sapiens (Human)	1151	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	nuclear export signal receptor activity [GO:0005049]	GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827	positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN210_c0_g1_i3	Q9C0E2	XPO4_HUMAN	40.1	1152	663	9	3474	91	3	1151	1.30E-253	877.9	XPO4_HUMAN	reviewed	Exportin-4 (Exp4)	XPO4 KIAA1721	Homo sapiens (Human)	1151	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	nuclear export signal receptor activity [GO:0005049]	GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827	positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN29686_c0_g1_i1	Q9HAV4	XPO5_HUMAN	100	85	0	0	257	3	127	211	9.80E-42	170.2	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6172_c0_g1_i1	Q9HAV4	XPO5_HUMAN	33.3	147	88	2	413	3	427	573	3.90E-16	85.9	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6172_c0_g3_i1	Q9HAV4	XPO5_HUMAN	47.5	423	216	3	42	1301	2	421	3.00E-107	390.2	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6172_c0_g3_i4	Q9HAV4	XPO5_HUMAN	43.1	109	61	1	17	343	314	421	1.10E-19	97.4	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6172_c0_g2_i1	Q9HAV4	XPO5_HUMAN	37.1	542	326	6	1602	1	594	1128	7.60E-100	365.9	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6172_c0_g2_i3	Q9HAV4	XPO5_HUMAN	33.5	194	118	4	646	83	926	1114	4.30E-20	99.8	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6172_c0_g2_i4	Q9HAV4	XPO5_HUMAN	36.5	301	180	4	885	1	833	1128	1.40E-48	194.9	XPO5_HUMAN	reviewed	Exportin-5 (Exp5) (Ran-binding protein 21)	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; Ran GTPase binding [GO:0008536]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0008536; GO:0010586; GO:0016032; GO:0016442; GO:0035281; GO:0042565; GO:0046825; GO:0070883; GO:1900370; GO:1905172	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32415_c0_g1_i1	Q96QU8	XPO6_HUMAN	100	91	0	0	3	275	91	181	4.10E-46	184.9	XPO6_HUMAN	reviewed	Exportin-6 (Exp6) (Ran-binding protein 20)	XPO6 KIAA0370 RANBP20	Homo sapiens (Human)	1125	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN2158_c0_g1_i1	Q96QU8	XPO6_HUMAN	45.3	1166	577	15	107	3556	1	1121	2.50E-273	943.3	XPO6_HUMAN	reviewed	Exportin-6 (Exp6) (Ran-binding protein 20)	XPO6 KIAA0370 RANBP20	Homo sapiens (Human)	1125	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN2158_c0_g1_i5	Q96QU8	XPO6_HUMAN	48.9	307	139	2	107	1027	1	289	4.40E-72	273.1	XPO6_HUMAN	reviewed	Exportin-6 (Exp6) (Ran-binding protein 20)	XPO6 KIAA0370 RANBP20	Homo sapiens (Human)	1125	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN2158_c0_g1_i6	Q96QU8	XPO6_HUMAN	48.5	544	237	8	107	1711	1	510	9.90E-133	475.3	XPO6_HUMAN	reviewed	Exportin-6 (Exp6) (Ran-binding protein 20)	XPO6 KIAA0370 RANBP20	Homo sapiens (Human)	1125	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN39518_c0_g1_i1	Q96QU8	XPO6_HUMAN	100	101	0	0	303	1	951	1051	6.70E-50	197.6	XPO6_HUMAN	reviewed	Exportin-6 (Exp6) (Ran-binding protein 20)	XPO6 KIAA0370 RANBP20	Homo sapiens (Human)	1125	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN2158_c0_g1_i3	Q53I77	XPO6A_XENLA	43.6	610	327	7	292	2103	533	1131	1.30E-136	488.4	XPO6A_XENLA	reviewed	Exportin-6-A	xpo6-a	Xenopus laevis (African clawed frog)	1135	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005737; GO:0006611; GO:0008536	protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN32851_c0_g1_i1	Q9EPK7	XPO7_MOUSE	64.2	148	51	1	448	11	927	1074	2.90E-49	196.1	XPO7_MOUSE	reviewed	Exportin-7 (Exp7) (Ran-binding protein 16)	Xpo7 Kiaa0745 Ranbp16	Mus musculus (Mouse)	1087	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0006913; GO:0008536	nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN32851_c0_g1_i2	Q9EPK7	XPO7_MOUSE	65.8	111	38	0	343	11	964	1074	5.30E-37	155.2	XPO7_MOUSE	reviewed	Exportin-7 (Exp7) (Ran-binding protein 16)	Xpo7 Kiaa0745 Ranbp16	Mus musculus (Mouse)	1087	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]	GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0006913; GO:0008536	nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN9685_c0_g1_i1	O43592	XPOT_HUMAN	57	142	59	2	483	61	821	961	1.00E-43	177.9	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN9685_c0_g1_i2	O43592	XPOT_HUMAN	54.3	151	67	2	510	61	812	961	2.70E-43	176.4	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN33244_c0_g1_i1	O43592	XPOT_HUMAN	98.9	89	1	0	269	3	443	531	4.20E-43	174.9	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN10311_c1_g1_i1	Q5SPJ8	XPOT_DANRE	47	621	308	4	17	1873	96	697	2.10E-157	557.4	XPOT_DANRE	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	xpot si:ch211-286m4.4	Danio rerio (Zebrafish) (Brachydanio rerio)	961	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005643; GO:0005737; GO:0008536; GO:0016363; GO:0071528	tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN10311_c1_g1_i2	O43592	XPOT_HUMAN	42.1	114	66	0	97	438	586	699	2.30E-19	96.7	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN10311_c1_g1_i3	O43592	XPOT_HUMAN	53.1	96	45	0	17	304	96	191	9.70E-26	117.5	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN10311_c1_g1_i4	Q5SPJ8	XPOT_DANRE	47.1	240	113	1	32	751	357	582	1.20E-55	218	XPOT_DANRE	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	xpot si:ch211-286m4.4	Danio rerio (Zebrafish) (Brachydanio rerio)	961	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005643; GO:0005737; GO:0008536; GO:0016363; GO:0071528	tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN28537_c0_g1_i1	O43592	XPOT_HUMAN	100	85	0	0	2	256	355	439	2.60E-39	162.2	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN28184_c0_g1_i1	O43592	XPOT_HUMAN	100	99	0	0	299	3	816	914	2.40E-52	205.7	XPOT_HUMAN	reviewed	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]	GO:0000049; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]		NA	NA	NA	NA	NA	NA
TRINITY_DN39939_c0_g1_i1	Q9BSJ8	ESYT1_HUMAN	100	148	0	0	3	446	216	363	3.80E-78	292	ESYT1_HUMAN	reviewed	Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein)	ESYT1 FAM62A KIAA0747 MBC2	Homo sapiens (Human)	1104	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0005544; GO:0005783; GO:0005789; GO:0006687; GO:0006869; GO:0008429; GO:0016020; GO:0030176; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0061817	endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN35184_c0_g1_i1	A0FGR8	ESYT2_HUMAN	100	86	0	0	259	2	536	621	3.60E-44	178.3	ESYT2_HUMAN	reviewed	Extended synaptotagmin-2 (E-Syt2) (Chr2Syt)	ESYT2 FAM62B KIAA1228	Homo sapiens (Human)	921	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cadherin binding [GO:0045296]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0005544; GO:0005789; GO:0005887; GO:0006687; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN27712_c0_g1_i1	A0FGR8	ESYT2_HUMAN	100	115	0	0	345	1	341	455	1.60E-60	233	ESYT2_HUMAN	reviewed	Extended synaptotagmin-2 (E-Syt2) (Chr2Syt)	ESYT2 FAM62B KIAA1228	Homo sapiens (Human)	921	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cadherin binding [GO:0045296]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0005544; GO:0005789; GO:0005887; GO:0006687; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN39796_c0_g1_i1	A0FGR8	ESYT2_HUMAN	100	89	0	0	269	3	788	876	5.70E-45	181	ESYT2_HUMAN	reviewed	Extended synaptotagmin-2 (E-Syt2) (Chr2Syt)	ESYT2 FAM62B KIAA1228	Homo sapiens (Human)	921	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cadherin binding [GO:0045296]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0005544; GO:0005789; GO:0005887; GO:0006687; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN19_c0_g1_i10	Q7ZWU7	EST2B_XENLA	36.7	580	328	11	1787	141	48	619	7.80E-107	389.4	EST2B_XENLA	reviewed	Extended synaptotagmin-2-B (E-Syt2-B)	esyt2-b fam62b-b	Xenopus laevis (African clawed frog)	876	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]	calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0006869; GO:0006897; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN19_c0_g1_i2	Q7ZWU7	EST2B_XENLA	36.4	580	326	10	1722	88	48	619	1.30E-106	388.7	EST2B_XENLA	reviewed	Extended synaptotagmin-2-B (E-Syt2-B)	esyt2-b fam62b-b	Xenopus laevis (African clawed frog)	876	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]	calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0006869; GO:0006897; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN19_c0_g1_i4	Q7ZWU7	EST2B_XENLA	36.7	580	328	11	1734	88	48	619	7.60E-107	389.4	EST2B_XENLA	reviewed	Extended synaptotagmin-2-B (E-Syt2-B)	esyt2-b fam62b-b	Xenopus laevis (African clawed frog)	876	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]	calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0006869; GO:0006897; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN19_c0_g1_i5	Q7ZWU7	EST2B_XENLA	36.4	580	326	10	1775	141	48	619	1.30E-106	388.7	EST2B_XENLA	reviewed	Extended synaptotagmin-2-B (E-Syt2-B)	esyt2-b fam62b-b	Xenopus laevis (African clawed frog)	876	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]	calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0006869; GO:0006897; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN19_c0_g2_i1	Q7ZWU7	EST2B_XENLA	41.6	166	80	7	582	127	703	865	8.70E-22	105.5	EST2B_XENLA	reviewed	Extended synaptotagmin-2-B (E-Syt2-B)	esyt2-b fam62b-b	Xenopus laevis (African clawed frog)	876	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]	calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0006869; GO:0006897; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN4782_c0_g1_i1	Q80T14	FRAS1_MOUSE	28.4	257	158	8	263	1003	435	675	1.20E-06	55.8	FRAS1_MOUSE	reviewed	Extracellular matrix protein FRAS1	Fras1 Kiaa1500	Mus musculus (Mouse)	4010	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0002009; GO:0003338; GO:0005604; GO:0005886; GO:0007154; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021; GO:0062023	cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]		NA	NA	NA	NA	NA	NA
TRINITY_DN32986_c1_g1_i1	Q6PQG3	EPI10_PHYIN	41.8	55	31	1	72	233	154	208	2.70E-05	49.3	EPI10_PHYIN	reviewed	Extracellular protease inhibitor 10 (Secreted effector EPI10)	EPI10	Phytophthora infestans (Potato late blight fungus) (Botrytis infestans)	224	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0009405	pathogenesis [GO:0009405]		blue	blue	NA	NA	NA	NA
TRINITY_DN39161_c0_g1_i1	A4VCL2	FA20C_DROME	65.6	334	115	0	3	1004	632	965	2.50E-139	496.5	FA20C_DROME	reviewed	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	CG31145	Drosophila melanogaster (Fruit fly)	980	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN11441_c0_g1_i1	A4VCL2	FA20C_DROME	62.7	193	72	0	56	634	771	963	3.00E-72	273.1	FA20C_DROME	reviewed	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	CG31145	Drosophila melanogaster (Fruit fly)	980	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN11441_c0_g1_i2	A4VCL2	FA20C_DROME	47.8	513	237	5	27	1496	459	963	6.30E-131	469.2	FA20C_DROME	reviewed	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	CG31145	Drosophila melanogaster (Fruit fly)	980	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN11441_c0_g1_i3	A4VCL2	FA20C_DROME	74.1	58	15	0	76	249	666	723	3.60E-19	95.5	FA20C_DROME	reviewed	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	CG31145	Drosophila melanogaster (Fruit fly)	980	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN11441_c0_g1_i5	A4VCL2	FA20C_DROME	52.1	48	23	0	79	222	916	963	3.00E-08	59.3	FA20C_DROME	reviewed	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	CG31145	Drosophila melanogaster (Fruit fly)	980	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN11292_c0_g1_i1	Q54QB1	ERK2_DICDI	68.7	150	46	1	3	449	112	261	3.20E-56	219.2	ERK2_DICDI	reviewed	Extracellular signal-regulated kinase 2 (ERK2) (EC 2.7.11.24) (Defective in aggregation protein C) (MAP kinase 2)	erkB dagC erk2 DDB_G0283903	Dictyostelium discoideum (Slime mold)	369	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; activation of adenylate cyclase activity [GO:0007190]; aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; peptidyl-threonine autophosphorylation [GO:1990443]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of chemotaxis [GO:0050921]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of gene expression [GO:0010468]; regulation of macropinocytosis [GO:1905301]; response to cisplatin [GO:0072718]; response to differentiation-inducing factor 1 [GO:1903013]; response to lipopolysaccharide [GO:0032496]; sorocarp spore cell differentiation [GO:0044671]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007166; GO:0007186; GO:0007190; GO:0010468; GO:0010628; GO:0016301; GO:0019933; GO:0031152; GO:0032496; GO:0035556; GO:0038083; GO:0043326; GO:0043327; GO:0044671; GO:0046777; GO:0050921; GO:0051301; GO:0051344; GO:0072718; GO:1903013; GO:1905301; GO:1990443	activation of adenylate cyclase activity [GO:0007190]; aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; peptidyl-threonine autophosphorylation [GO:1990443]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of chemotaxis [GO:0050921]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of gene expression [GO:0010468]; regulation of macropinocytosis [GO:1905301]; response to cisplatin [GO:0072718]; response to differentiation-inducing factor 1 [GO:1903013]; response to lipopolysaccharide [GO:0032496]; sorocarp spore cell differentiation [GO:0044671]		NA	NA	NA	NA	NA	NA
TRINITY_DN28536_c0_g1_i1	Q54QB1	ERK2_DICDI	48	125	62	1	2	367	100	224	7.20E-30	131.3	ERK2_DICDI	reviewed	Extracellular signal-regulated kinase 2 (ERK2) (EC 2.7.11.24) (Defective in aggregation protein C) (MAP kinase 2)	erkB dagC erk2 DDB_G0283903	Dictyostelium discoideum (Slime mold)	369	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; activation of adenylate cyclase activity [GO:0007190]; aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; peptidyl-threonine autophosphorylation [GO:1990443]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of chemotaxis [GO:0050921]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of gene expression [GO:0010468]; regulation of macropinocytosis [GO:1905301]; response to cisplatin [GO:0072718]; response to differentiation-inducing factor 1 [GO:1903013]; response to lipopolysaccharide [GO:0032496]; sorocarp spore cell differentiation [GO:0044671]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007166; GO:0007186; GO:0007190; GO:0010468; GO:0010628; GO:0016301; GO:0019933; GO:0031152; GO:0032496; GO:0035556; GO:0038083; GO:0043326; GO:0043327; GO:0044671; GO:0046777; GO:0050921; GO:0051301; GO:0051344; GO:0072718; GO:1903013; GO:1905301; GO:1990443	activation of adenylate cyclase activity [GO:0007190]; aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; peptidyl-threonine autophosphorylation [GO:1990443]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of chemotaxis [GO:0050921]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of gene expression [GO:0010468]; regulation of macropinocytosis [GO:1905301]; response to cisplatin [GO:0072718]; response to differentiation-inducing factor 1 [GO:1903013]; response to lipopolysaccharide [GO:0032496]; sorocarp spore cell differentiation [GO:0044671]		NA	NA	NA	NA	NA	NA
TRINITY_DN14639_c0_g1_i1	Q9VEX0	SULF1_DROME	69.9	83	25	0	249	1	299	381	4.40E-31	134.8	SULF1_DROME	reviewed	Extracellular sulfatase SULF-1 homolog (DmSulf-1) (EC 3.1.6.-)	Sulf1 CG6725	Drosophila melanogaster (Fruit fly)	1114	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; heparin metabolic process [GO:0030202]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; synaptic target inhibition [GO:0016201]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]	glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]	GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0008045; GO:0008449; GO:0009986; GO:0016201; GO:0030202; GO:0042059; GO:0045879; GO:0045880; GO:0046872; GO:0048100; GO:0048190; GO:0090090	heparin metabolic process [GO:0030202]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; synaptic target inhibition [GO:0016201]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]		NA	NA	NA	NA	NA	NA
TRINITY_DN38420_c0_g1_i1	Q08420	SODE_RAT	87.2	78	10	0	235	2	153	230	1.10E-34	146.7	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]	GO:0001666; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006979; GO:0019430; GO:0046688; GO:0062023	removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN1641_c0_g1_i1	Q504Y2	PKDCC_HUMAN	33.9	366	189	8	1056	103	130	490	1.60E-40	168.3	PKDCC_HUMAN	reviewed	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	493	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN1641_c0_g1_i15	Q504Y2	PKDCC_HUMAN	36.4	371	219	8	1194	103	130	490	3.10E-52	207.6	PKDCC_HUMAN	reviewed	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	493	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN1641_c0_g1_i16	Q504Y2	PKDCC_HUMAN	35.4	226	100	4	548	3	130	353	2.60E-24	114	PKDCC_HUMAN	reviewed	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	493	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN1641_c0_g1_i18	Q504Y2	PKDCC_HUMAN	39.1	238	135	4	711	7	130	360	6.50E-38	159.1	PKDCC_HUMAN	reviewed	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	493	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN1641_c0_g1_i5	Q504Y2	PKDCC_HUMAN	36.4	371	219	8	1194	103	130	490	2.80E-52	207.6	PKDCC_HUMAN	reviewed	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	493	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN1641_c0_g1_i8	Q504Y2	PKDCC_HUMAN	36	242	146	5	816	103	254	490	1.90E-30	134.4	PKDCC_HUMAN	reviewed	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	493	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN35217_c0_g1_i1	Q58DB6	EYA2_BOVIN	63	54	19	1	177	19	250	303	1.10E-11	70.1	EYA2_BOVIN	reviewed	Eyes absent homolog 2 (EC 3.1.3.48)	EYA2	Bos taurus (Bovine)	537	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; DNA repair [GO:0006281]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; histone dephosphorylation [GO:0016576]; mitochondrial outer membrane permeabilization [GO:0097345]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; striated muscle tissue development [GO:0014706]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000287; GO:0004725; GO:0005634; GO:0005739; GO:0005829; GO:0006281; GO:0007275; GO:0014706; GO:0016576; GO:0030154; GO:0045739; GO:0048856; GO:0097192; GO:0097345; GO:2001240	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; DNA repair [GO:0006281]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; histone dephosphorylation [GO:0016576]; mitochondrial outer membrane permeabilization [GO:0097345]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; striated muscle tissue development [GO:0014706]		NA	NA	NA	NA	NA	NA
TRINITY_DN27729_c0_g1_i1	Q58DB6	EYA2_BOVIN	69.8	63	19	0	190	2	401	463	2.50E-17	89.4	EYA2_BOVIN	reviewed	Eyes absent homolog 2 (EC 3.1.3.48)	EYA2	Bos taurus (Bovine)	537	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; DNA repair [GO:0006281]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; histone dephosphorylation [GO:0016576]; mitochondrial outer membrane permeabilization [GO:0097345]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; striated muscle tissue development [GO:0014706]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000287; GO:0004725; GO:0005634; GO:0005739; GO:0005829; GO:0006281; GO:0007275; GO:0014706; GO:0016576; GO:0030154; GO:0045739; GO:0048856; GO:0097192; GO:0097345; GO:2001240	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; DNA repair [GO:0006281]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; histone dephosphorylation [GO:0016576]; mitochondrial outer membrane permeabilization [GO:0097345]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; striated muscle tissue development [GO:0014706]		NA	NA	NA	NA	NA	NA
TRINITY_DN30844_c0_g1_i1	Q99504	EYA3_HUMAN	68.4	57	18	0	6	176	514	570	8.60E-18	90.5	EYA3_HUMAN	reviewed	Eyes absent homolog 3 (EC 3.1.3.48)	EYA3	Homo sapiens (Human)	573	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; histone dephosphorylation [GO:0016576]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; visual perception [GO:0007601]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006302; GO:0007275; GO:0007601; GO:0009653; GO:0010212; GO:0016576; GO:0030154; GO:0045739; GO:0046872; GO:0048856; GO:2001240	anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; histone dephosphorylation [GO:0016576]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11436_c0_g1_i1	Q09103	DGK2_DROME	74.8	151	36	1	449	3	796	946	2.60E-61	236.1	DGK2_DROME	reviewed	Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein)	rdgA DGK2 CG34344	Drosophila melanogaster (Fruit fly)	1457	membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	membrane [GO:0016020]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872	deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN4492_c0_g1_i1	Q09103	DGK2_DROME	51.1	135	66	0	270	674	1315	1449	1.60E-31	137.9	DGK2_DROME	reviewed	Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein)	rdgA DGK2 CG34344	Drosophila melanogaster (Fruit fly)	1457	membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	membrane [GO:0016020]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872	deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN4492_c0_g1_i2	Q09103	DGK2_DROME	51.1	135	66	0	111	515	1315	1449	1.30E-31	137.9	DGK2_DROME	reviewed	Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein)	rdgA DGK2 CG34344	Drosophila melanogaster (Fruit fly)	1457	membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	membrane [GO:0016020]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872	deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN31401_c0_g1_i1	Q09103	DGK2_DROME	63.6	88	30	1	264	7	943	1030	3.10E-27	122.1	DGK2_DROME	reviewed	Eye-specific diacylglycerol kinase (DAG kinase 2) (DGK 2) (Diglyceride kinase 2) (EC 2.7.1.107) (Retinal degeneration A protein)	rdgA DGK2 CG34344	Drosophila melanogaster (Fruit fly)	1457	membrane [GO:0016020]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	membrane [GO:0016020]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0006654; GO:0006661; GO:0007205; GO:0007601; GO:0007602; GO:0007605; GO:0007608; GO:0016020; GO:0016056; GO:0016059; GO:0035556; GO:0043052; GO:0045494; GO:0046339; GO:0046486; GO:0046834; GO:0046872	deactivation of rhodopsin mediated signaling [GO:0016059]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; photoreceptor cell maintenance [GO:0045494]; phototransduction [GO:0007602]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; thermotaxis [GO:0043052]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN22748_c0_g1_i1	P15311	EZRI_HUMAN	100	316	0	0	989	42	1	316	6.60E-185	647.9	EZRI_HUMAN	reviewed	Ezrin (Cytovillin) (Villin-2) (p81)	EZR VIL2	Homo sapiens (Human)	586	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; invadopodium [GO:0071437]; membrane [GO:0016020]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; axon guidance [GO:0007411]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; invadopodium [GO:0071437]; membrane [GO:0016020]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]	GO:0000122; GO:0001650; GO:0001726; GO:0001772; GO:0001931; GO:0001951; GO:0003376; GO:0003723; GO:0003779; GO:0005615; GO:0005737; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0005925; GO:0007159; GO:0007411; GO:0008017; GO:0008022; GO:0008360; GO:0010628; GO:0010737; GO:0015629; GO:0016020; GO:0016323; GO:0016324; GO:0019898; GO:0019904; GO:0022614; GO:0030033; GO:0030175; GO:0030315; GO:0030863; GO:0030953; GO:0031528; GO:0031532; GO:0031623; GO:0031982; GO:0032532; GO:0032587; GO:0032703; GO:0032991; GO:0034236; GO:0034237; GO:0034629; GO:0035088; GO:0036064; GO:0040018; GO:0042802; GO:0042995; GO:0043622; GO:0044297; GO:0044393; GO:0044548; GO:0044853; GO:0045177; GO:0045296; GO:0046847; GO:0048015; GO:0048471; GO:0050714; GO:0050839; GO:0050860; GO:0051015; GO:0051017; GO:0051018; GO:0051117; GO:0051286; GO:0051660; GO:0061028; GO:0070062; GO:0070373; GO:0071320; GO:0071437; GO:0071944; GO:0072659; GO:0072697; GO:0097449; GO:0097454; GO:0097718; GO:0098592; GO:1902115; GO:1902896; GO:1902966; GO:1903078; GO:1903364; GO:1903753; GO:2000643	actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; axon guidance [GO:0007411]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]		NA	NA	NA	NA	NA	NA
TRINITY_DN22748_c0_g1_i2	P15311	EZRI_HUMAN	100	265	0	0	837	43	1	265	1.20E-155	550.4	EZRI_HUMAN	reviewed	Ezrin (Cytovillin) (Villin-2) (p81)	EZR VIL2	Homo sapiens (Human)	586	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; invadopodium [GO:0071437]; membrane [GO:0016020]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; axon guidance [GO:0007411]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; invadopodium [GO:0071437]; membrane [GO:0016020]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]	GO:0000122; GO:0001650; GO:0001726; GO:0001772; GO:0001931; GO:0001951; GO:0003376; GO:0003723; GO:0003779; GO:0005615; GO:0005737; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0005925; GO:0007159; GO:0007411; GO:0008017; GO:0008022; GO:0008360; GO:0010628; GO:0010737; GO:0015629; GO:0016020; GO:0016323; GO:0016324; GO:0019898; GO:0019904; GO:0022614; GO:0030033; GO:0030175; GO:0030315; GO:0030863; GO:0030953; GO:0031528; GO:0031532; GO:0031623; GO:0031982; GO:0032532; GO:0032587; GO:0032703; GO:0032991; GO:0034236; GO:0034237; GO:0034629; GO:0035088; GO:0036064; GO:0040018; GO:0042802; GO:0042995; GO:0043622; GO:0044297; GO:0044393; GO:0044548; GO:0044853; GO:0045177; GO:0045296; GO:0046847; GO:0048015; GO:0048471; GO:0050714; GO:0050839; GO:0050860; GO:0051015; GO:0051017; GO:0051018; GO:0051117; GO:0051286; GO:0051660; GO:0061028; GO:0070062; GO:0070373; GO:0071320; GO:0071437; GO:0071944; GO:0072659; GO:0072697; GO:0097449; GO:0097454; GO:0097718; GO:0098592; GO:1902115; GO:1902896; GO:1902966; GO:1903078; GO:1903364; GO:1903753; GO:2000643	actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; axon guidance [GO:0007411]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]		NA	NA	NA	NA	NA	NA
TRINITY_DN8998_c0_g2_i1	P15311	EZRI_HUMAN	100	65	0	0	1	195	522	586	7.20E-28	124	EZRI_HUMAN	reviewed	Ezrin (Cytovillin) (Villin-2) (p81)	EZR VIL2	Homo sapiens (Human)	586	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; invadopodium [GO:0071437]; membrane [GO:0016020]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; axon guidance [GO:0007411]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; invadopodium [GO:0071437]; membrane [GO:0016020]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]	GO:0000122; GO:0001650; GO:0001726; GO:0001772; GO:0001931; GO:0001951; GO:0003376; GO:0003723; GO:0003779; GO:0005615; GO:0005737; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0005925; GO:0007159; GO:0007411; GO:0008017; GO:0008022; GO:0008360; GO:0010628; GO:0010737; GO:0015629; GO:0016020; GO:0016323; GO:0016324; GO:0019898; GO:0019904; GO:0022614; GO:0030033; GO:0030175; GO:0030315; GO:0030863; GO:0030953; GO:0031528; GO:0031532; GO:0031623; GO:0031982; GO:0032532; GO:0032587; GO:0032703; GO:0032991; GO:0034236; GO:0034237; GO:0034629; GO:0035088; GO:0036064; GO:0040018; GO:0042802; GO:0042995; GO:0043622; GO:0044297; GO:0044393; GO:0044548; GO:0044853; GO:0045177; GO:0045296; GO:0046847; GO:0048015; GO:0048471; GO:0050714; GO:0050839; GO:0050860; GO:0051015; GO:0051017; GO:0051018; GO:0051117; GO:0051286; GO:0051660; GO:0061028; GO:0070062; GO:0070373; GO:0071320; GO:0071437; GO:0071944; GO:0072659; GO:0072697; GO:0097449; GO:0097454; GO:0097718; GO:0098592; GO:1902115; GO:1902896; GO:1902966; GO:1903078; GO:1903364; GO:1903753; GO:2000643	actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; axon guidance [GO:0007411]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]		NA	NA	NA	NA	NA	NA
TRINITY_DN24943_c0_g1_i2	B4GAP7	TRET1_DROPE	30.1	156	104	1	551	99	691	846	1.40E-13	77.8	TRET1_DROPE	reviewed	Facilitated trehalose transporter Tret1	Tret1 GL11419	Drosophila persimilis (Fruit fly)	869	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN33081_c0_g1_i1	B4LPX5	TRET1_DROVI	42.7	443	247	5	255	1577	450	887	1.40E-88	328.6	TRET1_DROVI	reviewed	Facilitated trehalose transporter Tret1	Tret1 GJ20366	Drosophila virilis (Fruit fly)	911	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i1	B0WC46	TRET1_CULQU	33.2	214	138	1	85	711	287	500	2.50E-29	130.6	TRET1_CULQU	reviewed	Facilitated trehalose transporter Tret1	Tret1 CPIJ004516	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	517	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i10	B4P624	TRET1_DROYA	32.4	182	118	1	4	534	652	833	1.50E-23	110.9	TRET1_DROYA	reviewed	Facilitated trehalose transporter Tret1	Tret1 GE12373	Drosophila yakuba (Fruit fly)	856	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i11	B0WC46	TRET1_CULQU	33.2	214	138	1	88	714	287	500	4.30E-29	129.8	TRET1_CULQU	reviewed	Facilitated trehalose transporter Tret1	Tret1 CPIJ004516	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	517	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i13	B0WC46	TRET1_CULQU	32.6	215	140	1	72	701	290	504	9.70E-29	128.6	TRET1_CULQU	reviewed	Facilitated trehalose transporter Tret1	Tret1 CPIJ004516	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	517	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i2	B0WC46	TRET1_CULQU	32.6	218	142	1	85	723	287	504	2.60E-29	130.6	TRET1_CULQU	reviewed	Facilitated trehalose transporter Tret1	Tret1 CPIJ004516	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	517	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i3	B0WC46	TRET1_CULQU	33.2	211	136	1	72	689	290	500	9.30E-29	128.6	TRET1_CULQU	reviewed	Facilitated trehalose transporter Tret1	Tret1 CPIJ004516	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	517	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN568_c5_g1_i4	B0WC46	TRET1_CULQU	32.6	218	142	1	88	726	287	504	4.50E-29	129.8	TRET1_CULQU	reviewed	Facilitated trehalose transporter Tret1	Tret1 CPIJ004516	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	517	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN8527_c0_g1_i1	Q7PIR5	TRET1_ANOGA	49.9	417	181	4	1311	67	401	791	8.60E-110	398.7	TRET1_ANOGA	reviewed	Facilitated trehalose transporter Tret1 (AgTRET1)	Tret1 AGAP005563	Anopheles gambiae (African malaria mosquito)	793	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN1402_c0_g1_i1	A9ZSY2	TRET1_APILI	29.9	324	223	2	320	1279	159	482	5.30E-41	170.2	TRET1_APILI	reviewed	Facilitated trehalose transporter Tret1 (AmTRET1)	Tret1	Apis mellifera ligustica (Common honeybee) (Italian honeybee)	502	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN1402_c0_g1_i3	A9ZSY2	TRET1_APILI	29.9	445	306	4	172	1488	38	482	5.40E-53	210.3	TRET1_APILI	reviewed	Facilitated trehalose transporter Tret1 (AmTRET1)	Tret1	Apis mellifera ligustica (Common honeybee) (Italian honeybee)	502	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN16463_c0_g1_i1	A9ZSY2	TRET1_APILI	42.1	57	33	0	56	226	304	360	4.80E-06	52	TRET1_APILI	reviewed	Facilitated trehalose transporter Tret1 (AmTRET1)	Tret1	Apis mellifera ligustica (Common honeybee) (Italian honeybee)	502	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		brown	brown	NA	NA	NA	NA
TRINITY_DN866_c0_g2_i3	A9ZSY3	TRET1_BOMMO	32.4	497	285	8	1584	118	51	504	5.90E-58	226.9	TRET1_BOMMO	reviewed	Facilitated trehalose transporter Tret1 (BmTRET1)	Tret1	Bombyx mori (Silk moth)	505	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN866_c0_g1_i1	A9ZSY3	TRET1_BOMMO	32.4	497	285	8	153	1619	51	504	5.90E-58	226.9	TRET1_BOMMO	reviewed	Facilitated trehalose transporter Tret1 (BmTRET1)	Tret1	Bombyx mori (Silk moth)	505	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN866_c0_g1_i6	A9ZSY3	TRET1_BOMMO	32.4	497	285	8	185	1651	51	504	1.30E-57	225.7	TRET1_BOMMO	reviewed	Facilitated trehalose transporter Tret1 (BmTRET1)	Tret1	Bombyx mori (Silk moth)	505	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN10646_c0_g1_i1	A9ZSY3	TRET1_BOMMO	35.8	400	244	5	37	1224	51	441	4.50E-63	243.4	TRET1_BOMMO	reviewed	Facilitated trehalose transporter Tret1 (BmTRET1)	Tret1	Bombyx mori (Silk moth)	505	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN10646_c0_g1_i8	A9ZSY3	TRET1_BOMMO	34.2	447	281	5	37	1365	51	488	1.60E-64	248.4	TRET1_BOMMO	reviewed	Facilitated trehalose transporter Tret1 (BmTRET1)	Tret1	Bombyx mori (Silk moth)	505	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN1517_c0_g1_i2	A5LGM7	TRET1_POLVA	29.1	450	312	6	1538	195	37	481	6.20E-46	186.8	TRET1_POLVA	reviewed	Facilitated trehalose transporter Tret1 (PvTret1)	Tret1	Polypedilum vanderplanki (Sleeping chironomid midge)	504	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN1517_c0_g1_i3	A5LGM7	TRET1_POLVA	31	397	267	6	1379	195	90	481	1.40E-43	179.1	TRET1_POLVA	reviewed	Facilitated trehalose transporter Tret1 (PvTret1)	Tret1	Polypedilum vanderplanki (Sleeping chironomid midge)	504	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN1517_c0_g1_i5	A5LGM7	TRET1_POLVA	31.7	303	201	5	1360	455	95	392	6.80E-33	143.3	TRET1_POLVA	reviewed	Facilitated trehalose transporter Tret1 (PvTret1)	Tret1	Polypedilum vanderplanki (Sleeping chironomid midge)	504	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN37275_c0_g1_i1	A5LGM7	TRET1_POLVA	39.8	83	50	0	2	250	127	209	7.10E-11	67.8	TRET1_POLVA	reviewed	Facilitated trehalose transporter Tret1 (PvTret1)	Tret1	Polypedilum vanderplanki (Sleeping chironomid midge)	504	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN10646_c0_g1_i2	B4HNS0	TRE11_DROSE	42.5	181	102	1	37	573	396	576	1.30E-28	127.9	TRE11_DROSE	reviewed	Facilitated trehalose transporter Tret1-1	Tret1-1 GM21298	Drosophila sechellia (Fruit fly)	857	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trehalose transmembrane transporter activity [GO:0015574]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	trehalose transmembrane transporter activity [GO:0015574]	GO:0005886; GO:0015574; GO:0015771; GO:0016021	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN866_c0_g2_i1	Q8MKK4	TRE12_DROME	31.7	249	164	2	903	175	218	466	2.00E-28	128.6	TRE12_DROME	reviewed	Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)	Tret1-2 CG8234	Drosophila melanogaster (Fruit fly)	488	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0015771; GO:0016020; GO:0016021; GO:0022857	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN866_c0_g1_i3	Q8MKK4	TRE12_DROME	31.7	249	164	2	715	1443	218	466	2.00E-28	128.6	TRE12_DROME	reviewed	Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)	Tret1-2 CG8234	Drosophila melanogaster (Fruit fly)	488	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0015771; GO:0016020; GO:0016021; GO:0022857	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN866_c0_g1_i4	Q8MKK4	TRE12_DROME	31.7	249	164	2	747	1475	218	466	2.10E-28	128.6	TRE12_DROME	reviewed	Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)	Tret1-2 CG8234	Drosophila melanogaster (Fruit fly)	488	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0015771; GO:0016020; GO:0016021; GO:0022857	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN22395_c0_g2_i1	Q8MKK4	TRE12_DROME	43.9	98	52	1	295	11	348	445	3.10E-23	109.4	TRE12_DROME	reviewed	Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)	Tret1-2 CG8234	Drosophila melanogaster (Fruit fly)	488	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; trehalose transport [GO:0015771]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0015771; GO:0016020; GO:0016021; GO:0022857	trehalose transport [GO:0015771]		NA	NA	NA	NA	NA	NA
TRINITY_DN27967_c0_g1_i1	Q9Y5B9	SP16H_HUMAN	100	210	0	0	630	1	492	701	1.50E-115	416.8	SP16H_HUMAN	reviewed	FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16)	SUPT16H FACT140 FACTP140	Homo sapiens (Human)	1047	"FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	FACT complex [GO:0035101]; nucleoplasm [GO:0005654]	nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:1901796	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37432_c0_g1_i1	Q9Y5B9	SP16H_HUMAN	100	234	0	0	2	703	704	937	2.60E-135	482.6	SP16H_HUMAN	reviewed	FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16)	SUPT16H FACT140 FACTP140	Homo sapiens (Human)	1047	"FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	FACT complex [GO:0035101]; nucleoplasm [GO:0005654]	nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:1901796	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30840_c0_g1_i1	Q9Y5B9	SP16H_HUMAN	100	104	0	0	29	340	1	104	1.90E-53	209.5	SP16H_HUMAN	reviewed	FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16)	SUPT16H FACT140 FACTP140	Homo sapiens (Human)	1047	"FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	FACT complex [GO:0035101]; nucleoplasm [GO:0005654]	nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:1901796	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28592_c0_g1_i1	Q9Y5B9	SP16H_HUMAN	100	110	0	0	1	330	176	285	3.60E-57	221.9	SP16H_HUMAN	reviewed	FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16)	SUPT16H FACT140 FACTP140	Homo sapiens (Human)	1047	"FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	FACT complex [GO:0035101]; nucleoplasm [GO:0005654]	nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:1901796	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28134_c0_g1_i1	Q9Y5B9	SP16H_HUMAN	96.7	90	3	0	270	1	320	409	9.30E-43	173.7	SP16H_HUMAN	reviewed	FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16)	SUPT16H FACT140 FACTP140	Homo sapiens (Human)	1047	"FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	FACT complex [GO:0035101]; nucleoplasm [GO:0005654]	nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:1901796	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1409_c0_g1_i1	Q8IRG6	SPT16_DROME	61	947	365	3	2915	81	3	947	0	1189.9	SPT16_DROME	reviewed	FACT complex subunit spt16 (Facilitates chromatin transcription complex subunit SPT16) (dSPT16)	dre4 spt16 CG1828	Drosophila melanogaster (Fruit fly)	1083	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]	chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]	GO:0001672; GO:0003682; GO:0005634; GO:0005703; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006368; GO:0031491; GO:0032968; GO:0034724; GO:0035101; GO:0046982; GO:0047485	DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN1409_c0_g1_i10	Q8IRG6	SPT16_DROME	61	947	365	3	2915	81	3	947	0	1189.9	SPT16_DROME	reviewed	FACT complex subunit spt16 (Facilitates chromatin transcription complex subunit SPT16) (dSPT16)	dre4 spt16 CG1828	Drosophila melanogaster (Fruit fly)	1083	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]	chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]	GO:0001672; GO:0003682; GO:0005634; GO:0005703; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006368; GO:0031491; GO:0032968; GO:0034724; GO:0035101; GO:0046982; GO:0047485	DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN1409_c0_g1_i2	Q8IRG6	SPT16_DROME	61	947	365	3	2915	81	3	947	0	1189.9	SPT16_DROME	reviewed	FACT complex subunit spt16 (Facilitates chromatin transcription complex subunit SPT16) (dSPT16)	dre4 spt16 CG1828	Drosophila melanogaster (Fruit fly)	1083	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]	chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]	GO:0001672; GO:0003682; GO:0005634; GO:0005703; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006368; GO:0031491; GO:0032968; GO:0034724; GO:0035101; GO:0046982; GO:0047485	DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN1409_c0_g1_i9	Q8IRG6	SPT16_DROME	61	947	365	3	2915	81	3	947	0	1189.9	SPT16_DROME	reviewed	FACT complex subunit spt16 (Facilitates chromatin transcription complex subunit SPT16) (dSPT16)	dre4 spt16 CG1828	Drosophila melanogaster (Fruit fly)	1083	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]	chromatin binding [GO:0003682]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]	GO:0001672; GO:0003682; GO:0005634; GO:0005703; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006368; GO:0031491; GO:0032968; GO:0034724; GO:0035101; GO:0046982; GO:0047485	DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN27777_c0_g1_i1	Q08945	SSRP1_HUMAN	100	86	0	0	2	259	93	178	1.30E-46	186.4	SSRP1_HUMAN	reviewed	FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160)	SSRP1 FACT80	Homo sapiens (Human)	709	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of chromatin organization [GO:1902275]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0000790; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0035101; GO:0042393; GO:1901796; GO:1902275	DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of chromatin organization [GO:1902275]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN36045_c0_g1_i1	Q08945	SSRP1_HUMAN	100	113	0	0	2	340	336	448	3.60E-60	231.9	SSRP1_HUMAN	reviewed	FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160)	SSRP1 FACT80	Homo sapiens (Human)	709	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of chromatin organization [GO:1902275]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0000790; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006366; GO:0006368; GO:0016032; GO:0031491; GO:0035101; GO:0042393; GO:1901796; GO:1902275	DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of chromatin organization [GO:1902275]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN20493_c0_g1_i1	Q04678	SSRP1_CHICK	99.3	147	1	0	442	2	165	311	3.70E-81	302	SSRP1_CHICK	reviewed	FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (T160)	SSRP1 CIIDBP RCJMB04_4n20	Gallus gallus (Chicken)	706	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]	GO:0000790; GO:0003677; GO:0005730; GO:0006260; GO:0006281; GO:0031491; GO:0035101; GO:0042393	DNA repair [GO:0006281]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN20493_c0_g1_i2	Q04678	SSRP1_CHICK	100	147	0	0	442	2	165	311	2.80E-81	302.4	SSRP1_CHICK	reviewed	FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (T160)	SSRP1 CIIDBP RCJMB04_4n20	Gallus gallus (Chicken)	706	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]	GO:0000790; GO:0003677; GO:0005730; GO:0006260; GO:0006281; GO:0031491; GO:0035101; GO:0042393	DNA repair [GO:0006281]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN977_c0_g1_i1	Q293F6	SSRP1_DROPS	61.1	458	176	2	99	1469	5	461	5.90E-166	585.5	SSRP1_DROPS	reviewed	FACT complex subunit Ssrp1 (Facilitates chromatin transcription complex subunit Ssrp1) (Recombination signal sequence recognition protein) (Single-strand recognition protein)	Ssrp GA18454	Drosophila pseudoobscura pseudoobscura (Fruit fly)	727	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; chromo shadow domain binding [GO:0070087]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of protein phosphorylation [GO:0001933]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; regulation of chromatin assembly or disassembly [GO:0001672]; regulation of DNA binding [GO:0051101]	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]	chromo shadow domain binding [GO:0070087]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; protein self-association [GO:0043621]; RNA binding [GO:0003723]	GO:0001672; GO:0001933; GO:0003723; GO:0005703; GO:0005705; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0030707; GO:0030838; GO:0031492; GO:0035101; GO:0043621; GO:0046982; GO:0051101; GO:0070087	DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of protein phosphorylation [GO:0001933]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; regulation of chromatin assembly or disassembly [GO:0001672]; regulation of DNA binding [GO:0051101]		NA	NA	NA	NA	NA	NA
TRINITY_DN977_c0_g1_i2	Q293F6	SSRP1_DROPS	60.9	460	176	2	99	1475	5	461	1.00E-165	584.7	SSRP1_DROPS	reviewed	FACT complex subunit Ssrp1 (Facilitates chromatin transcription complex subunit Ssrp1) (Recombination signal sequence recognition protein) (Single-strand recognition protein)	Ssrp GA18454	Drosophila pseudoobscura pseudoobscura (Fruit fly)	727	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; chromo shadow domain binding [GO:0070087]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of protein phosphorylation [GO:0001933]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; regulation of chromatin assembly or disassembly [GO:0001672]; regulation of DNA binding [GO:0051101]	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]	chromo shadow domain binding [GO:0070087]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; protein self-association [GO:0043621]; RNA binding [GO:0003723]	GO:0001672; GO:0001933; GO:0003723; GO:0005703; GO:0005705; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0030707; GO:0030838; GO:0031492; GO:0035101; GO:0043621; GO:0046982; GO:0051101; GO:0070087	DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of protein phosphorylation [GO:0001933]; ovarian follicle cell development [GO:0030707]; positive regulation of actin filament polymerization [GO:0030838]; regulation of chromatin assembly or disassembly [GO:0001672]; regulation of DNA binding [GO:0051101]		NA	NA	NA	NA	NA	NA
TRINITY_DN16313_c0_g1_i1	Q9W2N0	CAPZA_DROME	65.1	281	96	1	915	79	6	286	3.40E-113	409.5	CAPZA_DROME	reviewed	F-actin-capping protein subunit alpha	cpa CG10540	Drosophila melanogaster (Fruit fly)	286	apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]	apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]	GO:0000902; GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030036; GO:0030837; GO:0035220; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051489; GO:0051490; GO:0051491; GO:0071203	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]		blue	blue	NA	NA	NA	NA
TRINITY_DN20661_c0_g1_i1	P47753	CAZA1_MOUSE	98.1	103	2	0	2	310	184	286	1.30E-50	200.3	CAZA1_MOUSE	reviewed	F-actin-capping protein subunit alpha-1 (CapZ alpha-1)	Capza1 Cappa1	Mus musculus (Mouse)	286	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; WASH complex [GO:0071203]	actin binding [GO:0003779]	GO:0003779; GO:0005903; GO:0005911; GO:0008290; GO:0016020; GO:0030036; GO:0030863; GO:0034329; GO:0051016; GO:0071203	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]		NA	NA	NA	NA	NA	NA
TRINITY_DN20661_c0_g1_i2	P52907	CAZA1_HUMAN	100	157	0	0	1	471	130	286	2.90E-88	325.9	CAZA1_HUMAN	reviewed	F-actin-capping protein subunit alpha-1 (CapZ alpha-1)	CAPZA1	Homo sapiens (Human)	286	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; barbed-end actin filament capping [GO:0051016]; blood coagulation [GO:0007596]; cell junction assembly [GO:0034329]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; innate immune response [GO:0045087]; interleukin-12-mediated signaling pathway [GO:0035722]; protein-containing complex assembly [GO:0065003]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]	GO:0003779; GO:0005576; GO:0005829; GO:0005856; GO:0006888; GO:0007596; GO:0008290; GO:0015629; GO:0019886; GO:0030036; GO:0034329; GO:0035722; GO:0045087; GO:0045296; GO:0051015; GO:0051016; GO:0065003; GO:0070062; GO:0071203	actin cytoskeleton organization [GO:0030036]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; barbed-end actin filament capping [GO:0051016]; blood coagulation [GO:0007596]; cell junction assembly [GO:0034329]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; innate immune response [GO:0045087]; interleukin-12-mediated signaling pathway [GO:0035722]; protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN34451_c0_g1_i1	P47753	CAZA1_MOUSE	100	101	0	0	304	2	27	127	1.20E-54	213.4	CAZA1_MOUSE	reviewed	F-actin-capping protein subunit alpha-1 (CapZ alpha-1)	Capza1 Cappa1	Mus musculus (Mouse)	286	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; WASH complex [GO:0071203]	actin binding [GO:0003779]	GO:0003779; GO:0005903; GO:0005911; GO:0008290; GO:0016020; GO:0030036; GO:0030863; GO:0034329; GO:0051016; GO:0071203	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]		NA	NA	NA	NA	NA	NA
TRINITY_DN36980_c0_g1_i1	A4FUA8	CAZA1_BOVIN	100	114	0	0	343	2	20	133	6.00E-63	241.1	CAZA1_BOVIN	reviewed	F-actin-capping protein subunit alpha-1 (CapZ alpha-1)	CAPZA1	Bos taurus (Bovine)	286	F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]	F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin filament binding [GO:0051015]	GO:0008290; GO:0030036; GO:0034329; GO:0051015; GO:0051016; GO:0071203	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]		NA	NA	NA	NA	NA	NA
TRINITY_DN26752_c0_g1_i1	P47754	CAZA2_MOUSE	99.6	265	1	0	1	795	22	286	7.10E-155	547.7	CAZA2_MOUSE	reviewed	F-actin-capping protein subunit alpha-2 (CapZ alpha-2)	Capza2 Cappa2	Mus musculus (Mouse)	286	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]	actin filament binding [GO:0051015]	GO:0005903; GO:0008290; GO:0016020; GO:0030036; GO:0030863; GO:0051015; GO:0051016	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]		NA	NA	NA	NA	NA	NA
TRINITY_DN26752_c0_g1_i2	P47754	CAZA2_MOUSE	99.2	265	2	0	1	795	22	286	7.10E-155	547.7	CAZA2_MOUSE	reviewed	F-actin-capping protein subunit alpha-2 (CapZ alpha-2)	Capza2 Cappa2	Mus musculus (Mouse)	286	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]	actin filament binding [GO:0051015]	GO:0005903; GO:0008290; GO:0016020; GO:0030036; GO:0030863; GO:0051015; GO:0051016	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]		NA	NA	NA	NA	NA	NA
TRINITY_DN30937_c0_g1_i1	Q2IBA7	CAZA2_CHLAE	100	128	0	0	385	2	15	142	7.20E-73	274.2	CAZA2_CHLAE	reviewed	F-actin-capping protein subunit alpha-2 (CapZ alpha-2)	CAPZA2	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	286	F-actin capping protein complex [GO:0008290]; actin binding [GO:0003779]; barbed-end actin filament capping [GO:0051016]	F-actin capping protein complex [GO:0008290]	actin binding [GO:0003779]	GO:0003779; GO:0008290; GO:0051016	barbed-end actin filament capping [GO:0051016]		NA	NA	NA	NA	NA	NA
TRINITY_DN30069_c0_g1_i1	P48603	CAPZB_DROME	78.7	89	19	0	2	268	140	228	3.90E-33	141.7	CAPZB_DROME	reviewed	F-actin-capping protein subunit beta	cpb ANCP-BETA CG17158	Drosophila melanogaster (Fruit fly)	276	"cytosol [GO:0005829]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; microtubule-based movement [GO:0007018]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of actin filament length [GO:0030832]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]"	cytosol [GO:0005829]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]	GO:0000902; GO:0005829; GO:0005869; GO:0007015; GO:0007018; GO:0007298; GO:0007303; GO:0008290; GO:0010591; GO:0030036; GO:0030832; GO:0035220; GO:0045887; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051490; GO:0071203	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; microtubule-based movement [GO:0007018]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of actin filament length [GO:0030832]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18446_c0_g1_i1	P48603	CAPZB_DROME	84.9	86	13	0	2	259	153	238	3.40E-34	145.2	CAPZB_DROME	reviewed	F-actin-capping protein subunit beta	cpb ANCP-BETA CG17158	Drosophila melanogaster (Fruit fly)	276	"cytosol [GO:0005829]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; microtubule-based movement [GO:0007018]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of actin filament length [GO:0030832]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]"	cytosol [GO:0005829]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]	GO:0000902; GO:0005829; GO:0005869; GO:0007015; GO:0007018; GO:0007298; GO:0007303; GO:0008290; GO:0010591; GO:0030036; GO:0030832; GO:0035220; GO:0045887; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051490; GO:0071203	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; microtubule-based movement [GO:0007018]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of actin filament length [GO:0030832]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17101_c0_g1_i1	P79136	CAPZB_BOVIN	97.2	282	8	0	13	858	20	301	2.40E-156	552.7	CAPZB_BOVIN	reviewed	F-actin-capping protein subunit beta (CapZ beta)	CAPZB	Bos taurus (Bovine)	301	cytoskeletal calyx [GO:0033150]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]	cytoskeletal calyx [GO:0033150]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000902; GO:0003779; GO:0007010; GO:0008290; GO:0010591; GO:0022604; GO:0030036; GO:0033150; GO:0051015; GO:0051016; GO:0051490; GO:0071203	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]		NA	NA	NA	NA	NA	NA
TRINITY_DN17101_c0_g1_i2	P79136	CAPZB_BOVIN	97.2	282	8	0	25	870	20	301	5.40E-156	551.6	CAPZB_BOVIN	reviewed	F-actin-capping protein subunit beta (CapZ beta)	CAPZB	Bos taurus (Bovine)	301	cytoskeletal calyx [GO:0033150]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]	cytoskeletal calyx [GO:0033150]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000902; GO:0003779; GO:0007010; GO:0008290; GO:0010591; GO:0022604; GO:0030036; GO:0033150; GO:0051015; GO:0051016; GO:0051490; GO:0071203	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]		NA	NA	NA	NA	NA	NA
TRINITY_DN32707_c2_g1_i1	P14315	CAPZB_CHICK	84.8	270	41	0	928	119	1	270	2.80E-132	473	CAPZB_CHICK	reviewed	F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2)	CAPZB	Gallus gallus (Chicken)	277	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm connecting piece [GO:0097224]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm connecting piece [GO:0097224]; Z disc [GO:0030018]	actin filament binding [GO:0051015]	GO:0000902; GO:0005829; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0010591; GO:0014069; GO:0016020; GO:0022604; GO:0030018; GO:0030027; GO:0030032; GO:0030863; GO:0051015; GO:0051016; GO:0051490; GO:0097224; GO:0098685; GO:0098686	actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]		blue	blue	NA	NA	NA	NA
TRINITY_DN32707_c2_g1_i2	P14315	CAPZB_CHICK	84.8	270	41	0	945	136	1	270	3.70E-132	472.6	CAPZB_CHICK	reviewed	F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2)	CAPZB	Gallus gallus (Chicken)	277	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm connecting piece [GO:0097224]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]	brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm connecting piece [GO:0097224]; Z disc [GO:0030018]	actin filament binding [GO:0051015]	GO:0000902; GO:0005829; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0010591; GO:0014069; GO:0016020; GO:0022604; GO:0030018; GO:0030027; GO:0030032; GO:0030863; GO:0051015; GO:0051016; GO:0051490; GO:0097224; GO:0098685; GO:0098686	actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]		NA	NA	NA	NA	NA	NA
TRINITY_DN1862_c0_g1_i1	Q6EDY6	CARL1_MOUSE	42	193	104	3	576	1	51	236	1.30E-38	161	CARL1_MOUSE	reviewed	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Carmil1 Carmil Lrrc16 Lrrc16a	Mus musculus (Mouse)	1374	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]		NA	NA	NA	NA	NA	NA
TRINITY_DN1862_c0_g1_i3	Q6EDY6	CARL1_MOUSE	38.9	162	91	3	562	80	51	205	1.60E-28	127.5	CARL1_MOUSE	reviewed	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Carmil1 Carmil Lrrc16 Lrrc16a	Mus musculus (Mouse)	1374	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]		NA	NA	NA	NA	NA	NA
TRINITY_DN1862_c0_g1_i4	Q6EDY6	CARL1_MOUSE	41.2	199	103	4	594	1	51	236	5.80E-37	155.6	CARL1_MOUSE	reviewed	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Carmil1 Carmil Lrrc16 Lrrc16a	Mus musculus (Mouse)	1374	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]		NA	NA	NA	NA	NA	NA
TRINITY_DN1862_c0_g1_i5	Q6EDY6	CARL1_MOUSE	38.4	164	93	3	590	102	51	207	1.70E-28	127.5	CARL1_MOUSE	reviewed	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)"	Carmil1 Carmil Lrrc16 Lrrc16a	Mus musculus (Mouse)	1374	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813	actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]		NA	NA	NA	NA	NA	NA
TRINITY_DN37973_c0_g1_i1	Q5EA45	FXRD1_BOVIN	39.3	84	46	2	298	47	184	262	6.00E-11	68.2	FXRD1_BOVIN	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	FOXRED1	Bos taurus (Bovine)	486	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN39657_c0_g1_i1	Q96CU9	FXRD1_HUMAN	100	87	0	0	261	1	293	379	7.80E-47	187.2	FXRD1_HUMAN	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	FOXRED1 FP634	Homo sapiens (Human)	486	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005739; GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN20906_c0_g1_i1	Q6DCP1	FXRD1_XENLA	51.5	194	85	3	598	32	310	499	1.80E-54	213.8	FXRD1_XENLA	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	foxred1	Xenopus laevis (African clawed frog)	499	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	oxidoreductase activity [GO:0016491]	GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN20906_c0_g1_i2	Q6DCP1	FXRD1_XENLA	47.3	112	50	3	409	89	310	417	3.30E-23	109.4	FXRD1_XENLA	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	foxred1	Xenopus laevis (African clawed frog)	499	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	oxidoreductase activity [GO:0016491]	GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN2454_c0_g1_i1	Q6DCP1	FXRD1_XENLA	48.4	430	216	4	363	1637	71	499	5.20E-123	443	FXRD1_XENLA	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	foxred1	Xenopus laevis (African clawed frog)	499	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	oxidoreductase activity [GO:0016491]	GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN30907_c0_g1_i1	Q3TQB2	FXRD1_MOUSE	99.4	156	1	0	1	468	313	468	7.60E-93	340.9	FXRD1_MOUSE	reviewed	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	Foxred1	Mus musculus (Mouse)	487	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005739; GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN11250_c0_g2_i1	P56213	ALR_MOUSE	38.9	211	65	2	85	696	45	198	1.60E-39	164.5	ALR_MOUSE	reviewed	FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration)	Gfer Alr MNCb-0663	Mus musculus (Mouse)	198	cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein disulfide oxidoreductase activity [GO:0015035]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573]	cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0097421; GO:1903204; GO:2000573	liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573]		NA	NA	NA	NA	NA	NA
TRINITY_DN12_c0_g1_i1	Q95RI5	FAXC_DROME	61.5	286	104	2	945	106	83	368	2.80E-102	373.2	FAXC_DROME	reviewed	Failed axon connections	fax CG4609	Drosophila melanogaster (Fruit fly)	418	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0007409; GO:0036099	axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]		blue	blue	NA	NA	NA	NA
TRINITY_DN12_c0_g1_i2	Q95RI5	FAXC_DROME	61.5	286	104	2	945	106	83	368	9.00E-101	368.2	FAXC_DROME	reviewed	Failed axon connections	fax CG4609	Drosophila melanogaster (Fruit fly)	418	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0007409; GO:0036099	axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]		blue	blue	NA	NA	NA	NA
TRINITY_DN12_c0_g1_i3	Q95RI5	FAXC_DROME	62.2	286	102	2	945	106	83	368	2.70E-105	383.3	FAXC_DROME	reviewed	Failed axon connections	fax CG4609	Drosophila melanogaster (Fruit fly)	418	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0007409; GO:0036099	axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]		NA	NA	NA	NA	NA	NA
TRINITY_DN12_c0_g1_i4	Q95RI5	FAXC_DROME	51.5	163	75	1	582	106	206	368	2.80E-45	183.3	FAXC_DROME	reviewed	Failed axon connections	fax CG4609	Drosophila melanogaster (Fruit fly)	418	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0007409; GO:0036099	axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]		blue	blue	NA	NA	NA	1
TRINITY_DN25625_c0_g1_i1	F7E235	FAXC_XENTR	36.3	113	71	1	336	1	87	199	3.70E-18	92.4	FAXC_XENTR	reviewed	Failed axon connections homolog	faxc	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]		GO:0005737; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1043_c0_g1_i1	F7E235	FAXC_XENTR	31.6	297	181	5	79	951	52	332	1.50E-38	161.8	FAXC_XENTR	reviewed	Failed axon connections homolog	faxc	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]		GO:0005737; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN15938_c0_g1_i7	Q8BHL6	FAP24_MOUSE	32	200	130	4	751	155	19	213	3.30E-25	117.1	FAP24_MOUSE	reviewed	Fanconi anemia core complex-associated protein 24 (Fanconi anemia-associated protein of 24 kDa)	Faap24	Mus musculus (Mouse)	221	Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]	Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0003677; GO:0003682; GO:0005654; GO:0036297; GO:0043231; GO:0043240	interstrand cross-link repair [GO:0036297]		NA	NA	NA	NA	NA	NA
TRINITY_DN7633_c0_g1_i1	Q9BXW9	FACD2_HUMAN	29.7	1291	851	20	92	3856	4	1273	4.50E-152	540.8	FACD2_HUMAN	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	Homo sapiens (Human)	1451	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA polymerase binding [GO:0070182]	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990918; GO:2000348	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]		NA	NA	NA	NA	NA	NA
TRINITY_DN7633_c0_g1_i1	Q9BXW9	FACD2_HUMAN	49	98	50	0	3867	4160	1278	1375	6.50E-18	95.1	FACD2_HUMAN	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	Homo sapiens (Human)	1451	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA polymerase binding [GO:0070182]	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990918; GO:2000348	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]		NA	NA	NA	NA	NA	NA
TRINITY_DN7633_c0_g1_i2	Q9BXW9	FACD2_HUMAN	30.4	1156	751	17	92	3454	4	1141	4.30E-139	497.7	FACD2_HUMAN	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	Homo sapiens (Human)	1451	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA polymerase binding [GO:0070182]	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990918; GO:2000348	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]		NA	NA	NA	NA	NA	NA
TRINITY_DN7633_c0_g1_i2	Q9BXW9	FACD2_HUMAN	37.2	207	129	1	3556	4176	1170	1375	1.00E-31	141	FACD2_HUMAN	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	Homo sapiens (Human)	1451	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA polymerase binding [GO:0070182]	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990918; GO:2000348	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]		NA	NA	NA	NA	NA	NA
TRINITY_DN7633_c0_g1_i3	Q9BXW9	FACD2_HUMAN	32.7	382	250	5	38	1177	999	1375	2.40E-55	217.6	FACD2_HUMAN	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	Homo sapiens (Human)	1451	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA polymerase binding [GO:0070182]	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990918; GO:2000348	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]		NA	NA	NA	NA	NA	NA
TRINITY_DN7633_c0_g1_i6	Q9BXW9	FACD2_HUMAN	30.9	1393	905	20	92	4162	4	1375	3.60E-178	627.5	FACD2_HUMAN	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	Homo sapiens (Human)	1451	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA polymerase binding [GO:0070182]	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990918; GO:2000348	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; intra-S DNA damage checkpoint [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]		NA	NA	NA	NA	NA	NA
TRINITY_DN28440_c0_g1_i1	Q9BX63	FANCJ_HUMAN	50.8	120	53	2	35	376	755	874	4.90E-29	128.6	FANCJ_HUMAN	reviewed	Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	BRIP1 BACH1 FANCJ	Homo sapiens (Human)	1249	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1901796; GO:1904385; GO:1990918	cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN34234_c0_g1_i1	Q9BX63	FANCJ_HUMAN	59.2	71	29	0	214	2	335	405	6.00E-21	100.9	FANCJ_HUMAN	reviewed	Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	BRIP1 BACH1 FANCJ	Homo sapiens (Human)	1249	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1901796; GO:1904385; GO:1990918	cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN26131_c0_g1_i1	Q3YK19	FANCJ_CHICK	53.6	97	44	1	3	293	768	863	1.40E-23	110.2	FANCJ_CHICK	reviewed	Fanconi anemia group J protein homolog (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1)	BRIP1 FANCJ	Gallus gallus (Chicken)	1252	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006357; GO:0007284; GO:0007286; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0072520; GO:1990918	chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN6872_c0_g1_i1	Q5SXJ3	FANCJ_MOUSE	54.7	190	72	3	44	607	710	887	1.80E-50	200.7	FANCJ_MOUSE	reviewed	Fanconi anemia group J protein homolog (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	Brip1 Bach1 Fancj	Mus musculus (Mouse)	1174	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006357; GO:0007129; GO:0007283; GO:0007284; GO:0007286; GO:0008285; GO:0008584; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918	cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN6872_c0_g1_i3	Q5SXJ3	FANCJ_MOUSE	50.8	264	115	4	3	764	529	787	7.90E-64	245.4	FANCJ_MOUSE	reviewed	Fanconi anemia group J protein homolog (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	Brip1 Bach1 Fancj	Mus musculus (Mouse)	1174	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006357; GO:0007129; GO:0007283; GO:0007284; GO:0007286; GO:0008285; GO:0008584; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918	cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN6872_c0_g1_i5	Q5SXJ3	FANCJ_MOUSE	53.9	371	149	5	3	1085	529	887	3.60E-104	379.8	FANCJ_MOUSE	reviewed	Fanconi anemia group J protein homolog (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	Brip1 Bach1 Fancj	Mus musculus (Mouse)	1174	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006289; GO:0006357; GO:0007129; GO:0007283; GO:0007284; GO:0007286; GO:0008285; GO:0008584; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918	cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male gonad development [GO:0008584]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogonial cell division [GO:0007284]		NA	NA	NA	NA	NA	NA
TRINITY_DN5253_c0_g1_i1	Q8IYD8	FANCM_HUMAN	46.4	716	347	15	2154	58	112	807	6.70E-168	592.4	FANCM_HUMAN	reviewed	Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog)	FANCM KIAA1596	Homo sapiens (Human)	2048	FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712]	FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]	GO:0000400; GO:0000712; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0009378; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:0071932; GO:1902527	double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712]		NA	NA	NA	NA	NA	NA
TRINITY_DN353_c0_g1_i1	Q96AE4	FUBP1_HUMAN	46.8	79	22	1	348	112	200	258	3.20E-11	69.3	FUBP1_HUMAN	reviewed	Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V)	FUBP1	Homo sapiens (Human)	644	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0010628	positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN353_c0_g1_i2	Q96AE4	FUBP1_HUMAN	61	59	22	1	285	112	200	258	6.20E-13	74.7	FUBP1_HUMAN	reviewed	Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V)	FUBP1	Homo sapiens (Human)	644	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0010628	positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2727_c0_g1_i1	Q96I24	FUBP3_HUMAN	60.5	76	28	1	78	299	351	426	7.70E-19	94.7	FUBP3_HUMAN	reviewed	Far upstream element-binding protein 3 (FUSE-binding protein 3)	FUBP3 FBP3	Homo sapiens (Human)	572	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006351; GO:0010468; GO:0010628; GO:0016020; GO:0045893; GO:0045944	"positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2727_c0_g1_i2	Q96I24	FUBP3_HUMAN	60.5	76	28	1	78	299	351	426	6.70E-19	94.7	FUBP3_HUMAN	reviewed	Far upstream element-binding protein 3 (FUSE-binding protein 3)	FUBP3 FBP3	Homo sapiens (Human)	572	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006351; GO:0010468; GO:0010628; GO:0016020; GO:0045893; GO:0045944	"positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13415_c0_g1_i1	Q8WMY2	FPPS_BOVIN	51.5	136	66	0	20	427	216	351	1.40E-33	144.1	FPPS_BOVIN	reviewed	"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)"	FDPS	Bos taurus (Bovine)	353	cytoplasmic vesicle [GO:0031410]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; viral process [GO:0016032]	cytoplasmic vesicle [GO:0031410]	dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]	GO:0004161; GO:0004337; GO:0006695; GO:0016032; GO:0031410; GO:0033384; GO:0045337; GO:0046872	cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN33688_c0_g1_i1	P14324	FPPS_HUMAN	100	80	0	0	2	241	274	353	3.60E-41	168.3	FPPS_HUMAN	reviewed	"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)"	FDPS FPS KIAA1293	Homo sapiens (Human)	419	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; regulation of cholesterol biosynthetic process [GO:0045540]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004161; GO:0004337; GO:0005654; GO:0005737; GO:0005829; GO:0006695; GO:0016032; GO:0033384; GO:0045337; GO:0045540; GO:0046872	cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; regulation of cholesterol biosynthetic process [GO:0045540]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN876_c0_g1_i1	Q96CS3	FAF2_HUMAN	50	192	88	2	574	2	90	274	1.30E-44	181.4	FAF2_HUMAN	reviewed	FAS-associated factor 2 (Protein ETEA) (UBX domain-containing protein 3B) (UBX domain-containing protein 8)	FAF2 ETEA KIAA0887 UBXD8 UBXN3B	Homo sapiens (Human)	445	"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; lipid droplet organization [GO:0034389]; neutrophil degranulation [GO:0043312]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005576; GO:0005783; GO:0005811; GO:0006986; GO:0030433; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035578; GO:0043130; GO:0043312; GO:0055102	"lipid droplet organization [GO:0034389]; neutrophil degranulation [GO:0043312]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN876_c0_g1_i2	Q96CS3	FAF2_HUMAN	51.9	185	87	2	550	2	90	274	8.40E-46	185.3	FAF2_HUMAN	reviewed	FAS-associated factor 2 (Protein ETEA) (UBX domain-containing protein 3B) (UBX domain-containing protein 8)	FAF2 ETEA KIAA0887 UBXD8 UBXN3B	Homo sapiens (Human)	445	"azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; lipid droplet organization [GO:0034389]; neutrophil degranulation [GO:0043312]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005576; GO:0005783; GO:0005811; GO:0006986; GO:0030433; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035578; GO:0043130; GO:0043312; GO:0055102	"lipid droplet organization [GO:0034389]; neutrophil degranulation [GO:0043312]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27930_c0_g1_i1	Q3TDN2	FAF2_MOUSE	97.1	70	2	0	11	220	159	228	1.00E-34	146.7	FAF2_MOUSE	reviewed	FAS-associated factor 2 (UBX domain-containing protein 8)	Faf2 Kiaa0887 Ubxd8	Mus musculus (Mouse)	445	"endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005783; GO:0005811; GO:0006986; GO:0030433; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0043130; GO:0043161; GO:0055102	"lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40405_c0_g1_i1	Q2HJD0	FAF2_BOVIN	100	76	0	0	3	230	190	265	4.50E-38	157.9	FAF2_BOVIN	reviewed	FAS-associated factor 2 (UBX domain-containing protein 8)	FAF2 UBXD8	Bos taurus (Bovine)	445	"lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; lipid droplet organization [GO:0034389]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005811; GO:0006986; GO:0030433; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0043130; GO:0055102	"lipid droplet organization [GO:0034389]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39162_c0_g1_i1	Q6AZH6	FAF2A_XENLA	47.9	48	25	0	34	177	4	51	2.50E-06	52.8	FAF2A_XENLA	reviewed	FAS-associated factor 2-A (UBX domain-containing protein 8-A)	faf2-a ubxd8-a	Xenopus laevis (African clawed frog)	445	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]		GO:0005783; GO:0005811			NA	NA	NA	NA	NA	NA
TRINITY_DN41_c0_g1_i1	P22648	FAS2_SCHAM	35.8	723	427	12	2658	592	22	741	1.30E-131	472.2	FAS2_SCHAM	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	FAS2	Schistocerca americana (American grasshopper)	898	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007155; GO:0007399; GO:0016021; GO:0030154	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN41_c0_g1_i2	P22648	FAS2_SCHAM	35.8	723	427	12	2370	304	22	741	1.20E-131	472.2	FAS2_SCHAM	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	FAS2	Schistocerca americana (American grasshopper)	898	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007155; GO:0007399; GO:0016021; GO:0030154	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN41_c0_g1_i3	P22648	FAS2_SCHAM	35.8	732	433	12	2742	649	22	750	4.20E-133	477.2	FAS2_SCHAM	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	FAS2	Schistocerca americana (American grasshopper)	898	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007155; GO:0007399; GO:0016021; GO:0030154	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN41_c0_g1_i4	P22648	FAS2_SCHAM	35.8	732	433	12	2454	361	22	750	3.80E-133	477.2	FAS2_SCHAM	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	FAS2	Schistocerca americana (American grasshopper)	898	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007155; GO:0007399; GO:0016021; GO:0030154	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN41_c0_g1_i5	P22648	FAS2_SCHAM	35.8	732	433	12	2577	484	22	750	3.90E-133	477.2	FAS2_SCHAM	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	FAS2	Schistocerca americana (American grasshopper)	898	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007155; GO:0007399; GO:0016021; GO:0030154	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN41_c0_g1_i6	P22648	FAS2_SCHAM	35.8	723	427	12	2493	427	22	741	1.20E-131	472.2	FAS2_SCHAM	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	FAS2	Schistocerca americana (American grasshopper)	898	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007155; GO:0007399; GO:0016021; GO:0030154	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN25290_c0_g1_i1	P34082	FAS2_DROME	29.8	104	58	1	425	114	229	317	4.20E-07	56.6	FAS2_DROME	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	Fas2 CG3665	Drosophila melanogaster (Fruit fly)	873	"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; leading edge membrane [GO:0031256]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; presynaptic periactive zone [GO:0036062]; type I terminal bouton [GO:0061174]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; behavioral response to ethanol [GO:0048149]; Bolwig's organ morphogenesis [GO:0001746]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron remodeling [GO:1904800]; neuromuscular junction development [GO:0007528]; neuron recognition [GO:0008038]; olfactory learning [GO:0008355]; photoreceptor cell axon guidance [GO:0072499]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic plasticity [GO:0048167]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; short-term memory [GO:0007614]; synapse organization [GO:0050808]; terminal button organization [GO:0072553]"	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; leading edge membrane [GO:0031256]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; presynaptic periactive zone [GO:0036062]; type I terminal bouton [GO:0061174]	cell-cell adhesion mediator activity [GO:0098632]	GO:0001746; GO:0005737; GO:0005829; GO:0005886; GO:0007156; GO:0007411; GO:0007413; GO:0007528; GO:0007611; GO:0007614; GO:0008038; GO:0008045; GO:0008355; GO:0008582; GO:0016021; GO:0016319; GO:0016324; GO:0030424; GO:0030426; GO:0031225; GO:0031256; GO:0031594; GO:0035158; GO:0035159; GO:0036062; GO:0042059; GO:0042734; GO:0042995; GO:0043005; GO:0048149; GO:0048167; GO:0048667; GO:0048786; GO:0048803; GO:0050803; GO:0050808; GO:0061174; GO:0070593; GO:0072499; GO:0072553; GO:0097482; GO:0098632; GO:1904800	"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; Bolwig's organ morphogenesis [GO:0001746]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron remodeling [GO:1904800]; neuromuscular junction development [GO:0007528]; neuron recognition [GO:0008038]; olfactory learning [GO:0008355]; photoreceptor cell axon guidance [GO:0072499]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic plasticity [GO:0048167]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; short-term memory [GO:0007614]; synapse organization [GO:0050808]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25290_c0_g1_i2	P34082	FAS2_DROME	29.8	104	58	1	425	114	229	317	3.40E-07	56.6	FAS2_DROME	reviewed	Fasciclin-2 (Fasciclin II) (FAS II)	Fas2 CG3665	Drosophila melanogaster (Fruit fly)	873	"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; leading edge membrane [GO:0031256]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; presynaptic periactive zone [GO:0036062]; type I terminal bouton [GO:0061174]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; behavioral response to ethanol [GO:0048149]; Bolwig's organ morphogenesis [GO:0001746]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron remodeling [GO:1904800]; neuromuscular junction development [GO:0007528]; neuron recognition [GO:0008038]; olfactory learning [GO:0008355]; photoreceptor cell axon guidance [GO:0072499]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic plasticity [GO:0048167]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; short-term memory [GO:0007614]; synapse organization [GO:0050808]; terminal button organization [GO:0072553]"	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; leading edge membrane [GO:0031256]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; presynaptic periactive zone [GO:0036062]; type I terminal bouton [GO:0061174]	cell-cell adhesion mediator activity [GO:0098632]	GO:0001746; GO:0005737; GO:0005829; GO:0005886; GO:0007156; GO:0007411; GO:0007413; GO:0007528; GO:0007611; GO:0007614; GO:0008038; GO:0008045; GO:0008355; GO:0008582; GO:0016021; GO:0016319; GO:0016324; GO:0030424; GO:0030426; GO:0031225; GO:0031256; GO:0031594; GO:0035158; GO:0035159; GO:0036062; GO:0042059; GO:0042734; GO:0042995; GO:0043005; GO:0048149; GO:0048167; GO:0048667; GO:0048786; GO:0048803; GO:0050803; GO:0050808; GO:0061174; GO:0070593; GO:0072499; GO:0072553; GO:0097482; GO:0098632; GO:1904800	"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; Bolwig's organ morphogenesis [GO:0001746]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron remodeling [GO:1904800]; neuromuscular junction development [GO:0007528]; neuron recognition [GO:0008038]; olfactory learning [GO:0008355]; photoreceptor cell axon guidance [GO:0072499]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic plasticity [GO:0048167]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; short-term memory [GO:0007614]; synapse organization [GO:0050808]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7154_c0_g1_i1	Q6DI86	FAKD1_MOUSE	21.3	864	600	24	2631	100	21	824	4.90E-46	188	FAKD1_MOUSE	reviewed	"FAST kinase domain-containing protein 1, mitochondrial"	Fastkd1 Kiaa1800	Mus musculus (Mouse)	829	mitochondrion [GO:0005739]; mitochondrial RNA metabolic process [GO:0000959]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrion [GO:0005739]		GO:0000959; GO:0005739; GO:0044528	mitochondrial RNA metabolic process [GO:0000959]; regulation of mitochondrial mRNA stability [GO:0044528]		NA	NA	NA	NA	NA	NA
TRINITY_DN26694_c0_g2_i1	Q68FN9	FAKD3_RAT	24.3	440	307	7	786	2054	195	625	1.60E-31	139.4	FAKD3_RAT	reviewed	"FAST kinase domain-containing protein 3, mitochondrial"	Fastkd3	Rattus norvegicus (Rat)	656	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005739; GO:0033617; GO:0044528; GO:0070131	mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]		NA	NA	NA	NA	NA	NA
TRINITY_DN26694_c0_g1_i1	Q68FN9	FAKD3_RAT	24.3	440	307	7	1438	170	195	625	1.60E-31	139.4	FAKD3_RAT	reviewed	"FAST kinase domain-containing protein 3, mitochondrial"	Fastkd3	Rattus norvegicus (Rat)	656	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005739; GO:0033617; GO:0044528; GO:0070131	mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]		NA	NA	NA	NA	NA	NA
TRINITY_DN5235_c0_g1_i1	Q9VRJ2	FITM_DROME	35.8	400	213	9	85	1194	7	392	1.90E-65	251.5	FITM_DROME	reviewed	Fat storage-inducing transmembrane protein	Fitm CG10671	Drosophila melanogaster (Fruit fly)	423	integral component of endoplasmic reticulum membrane [GO:0030176]; adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730]	integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0007605; GO:0008344; GO:0008654; GO:0019915; GO:0030176; GO:0030730; GO:0034389; GO:0050773	adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN1585_c0_g1_i1	Q8N6M3	FITM2_HUMAN	27.8	248	136	7	263	979	29	242	2.50E-14	81.3	FITM2_HUMAN	reviewed	Fat storage-inducing transmembrane protein 2 (Fat-inducing protein 2)	FITM2 C20orf142 FIT2	Homo sapiens (Human)	262	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005789; GO:0007010; GO:0008654; GO:0010866; GO:0010890; GO:0019915; GO:0022604; GO:0030176; GO:0030730; GO:0034389; GO:0035356; GO:0140042	cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN1585_c0_g1_i2	Q8N6M3	FITM2_HUMAN	27.8	248	136	7	329	1045	29	242	2.70E-14	81.3	FITM2_HUMAN	reviewed	Fat storage-inducing transmembrane protein 2 (Fat-inducing protein 2)	FITM2 C20orf142 FIT2	Homo sapiens (Human)	262	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005789; GO:0007010; GO:0008654; GO:0010866; GO:0010890; GO:0019915; GO:0022604; GO:0030176; GO:0030730; GO:0034389; GO:0035356; GO:0140042	cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]		NA	NA	NA	NA	NA	NA
TRINITY_DN10706_c0_g1_i2	Q9VW71	FAT2_DROME	41.1	95	48	1	83	367	3492	3578	1.50E-17	90.5	FAT2_DROME	reviewed	Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)	kug fat2 CG7749	Drosophila melanogaster (Fruit fly)	4699	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]	GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN10706_c0_g1_i3	Q9VW71	FAT2_DROME	42.3	189	101	1	74	640	3398	3578	1.20E-41	171.4	FAT2_DROME	reviewed	Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)	kug fat2 CG7749	Drosophila melanogaster (Fruit fly)	4699	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]	GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN10706_c0_g1_i4	Q9VW71	FAT2_DROME	44.8	252	131	1	10	765	3335	3578	2.40E-62	240.4	FAT2_DROME	reviewed	Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)	kug fat2 CG7749	Drosophila melanogaster (Fruit fly)	4699	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]	GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN10706_c0_g1_i5	Q9VW71	FAT2_DROME	44.4	329	175	1	6	992	3258	3578	1.10E-80	301.6	FAT2_DROME	reviewed	Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)	kug fat2 CG7749	Drosophila melanogaster (Fruit fly)	4699	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]	GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN28115_c0_g1_i1	Q9VW71	FAT2_DROME	50.7	69	34	0	4	210	194	262	1.90E-13	76.3	FAT2_DROME	reviewed	Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)	kug fat2 CG7749	Drosophila melanogaster (Fruit fly)	4699	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]	GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN37121_c0_g1_i1	P63398	FATRP_MYCBO	68.6	102	32	0	317	12	530	631	3.00E-32	139	FATRP_MYCBO	reviewed	Fatty acid ABC transporter ATP-binding/permease protein (EC 7.6.2.-)	BQ2027_MB1303C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	631	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN4376_c0_g1_i1	P63398	FATRP_MYCBO	78.5	79	17	0	237	1	535	613	4.10E-26	118.2	FATRP_MYCBO	reviewed	Fatty acid ABC transporter ATP-binding/permease protein (EC 7.6.2.-)	BQ2027_MB1303C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	631	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN39036_c0_g1_i1	Q96IV6	FXDC2_HUMAN	44.9	49	27	0	42	188	282	330	1.30E-06	53.9	FXDC2_HUMAN	reviewed	Fatty acid hydroxylase domain-containing protein 2	FAXDC2 C5orf4	Homo sapiens (Human)	333	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0000254; GO:0001934; GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0045654	positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN39036_c0_g1_i2	Q96IV6	FXDC2_HUMAN	55.3	132	59	0	91	486	199	330	4.40E-40	166	FXDC2_HUMAN	reviewed	Fatty acid hydroxylase domain-containing protein 2	FAXDC2 C5orf4	Homo sapiens (Human)	333	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0000254; GO:0001934; GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0045654	positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1057_c0_g1_i1	Q96IV6	FXDC2_HUMAN	46.2	329	171	2	1510	2487	2	327	4.50E-89	330.9	FXDC2_HUMAN	reviewed	Fatty acid hydroxylase domain-containing protein 2	FAXDC2 C5orf4	Homo sapiens (Human)	333	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0000254; GO:0001934; GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0045654	positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126]		blue	blue	NA	NA	NA	NA
TRINITY_DN1057_c0_g1_i3	Q9GKT2	FXDC2_MACFA	46.3	326	175	0	95	1072	2	327	1.20E-89	331.6	FXDC2_MACFA	reviewed	Fatty acid hydroxylase domain-containing protein 2	FAXDC2 QccE-20373 QflA-14437	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	333	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]	GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654	lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]		NA	NA	NA	NA	NA	NA
TRINITY_DN37045_c0_g1_i1	A3QFP3	FADJ_SHELP	62.4	85	32	0	257	3	95	179	4.10E-24	111.7	FADJ_SHELP	reviewed	Fatty acid oxidation complex subunit alpha [Includes: Enoyl-CoA hydratase/3-hydroxybutyryl-CoA epimerase (EC 4.2.1.17) (EC 5.1.2.3); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]	fadJ Shew_2425	Shewanella loihica (strain ATCC BAA-1088 / PV-4)	706	cytoplasm [GO:0005737]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA epimerase activity [GO:0008692]; enoyl-CoA hydratase activity [GO:0004300]; NAD binding [GO:0051287]; fatty acid beta-oxidation [GO:0006635]	cytoplasm [GO:0005737]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA epimerase activity [GO:0008692]; enoyl-CoA hydratase activity [GO:0004300]; NAD binding [GO:0051287]	GO:0003857; GO:0004300; GO:0005737; GO:0006635; GO:0008692; GO:0051287	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN11086_c0_g1_i2	P12785	FAS_RAT	40.2	858	370	17	2225	69	982	1835	8.40E-151	535.8	FAS_RAT	reviewed	Fatty acid synthase (EC 2.3.1.85) (Type I FAS) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	Fasn	Rattus norvegicus (Rat)	2505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]"	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008610; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0047117; GO:0047451; GO:0071353; GO:0102131; GO:0102132	acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]		NA	NA	NA	NA	NA	NA
TRINITY_DN11086_c0_g1_i3	P12785	FAS_RAT	37.9	551	313	10	1731	103	1968	2497	2.70E-85	317.8	FAS_RAT	reviewed	Fatty acid synthase (EC 2.3.1.85) (Type I FAS) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	Fasn	Rattus norvegicus (Rat)	2505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]"	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008610; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0047117; GO:0047451; GO:0071353; GO:0102131; GO:0102132	acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]		NA	NA	NA	NA	NA	NA
TRINITY_DN11086_c0_g1_i6	P12785	FAS_RAT	40.4	1541	746	27	4284	103	982	2497	1.80E-284	980.7	FAS_RAT	reviewed	Fatty acid synthase (EC 2.3.1.85) (Type I FAS) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	Fasn	Rattus norvegicus (Rat)	2505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]"	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008610; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0047117; GO:0047451; GO:0071353; GO:0102131; GO:0102132	acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]		NA	NA	NA	NA	NA	NA
TRINITY_DN11086_c0_g1_i7	P19096	FAS_MOUSE	46.9	1138	537	12	3472	86	1	1080	1.30E-288	994.2	FAS_MOUSE	reviewed	Fatty acid synthase (EC 2.3.1.85) (Type I Fatty Acid Synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	Fasn	Mus musculus (Mouse)	2504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; mammary gland development [GO:0030879]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]"	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008144; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0047117; GO:0047451; GO:0070402; GO:0071353; GO:0102131; GO:0102132	acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; mammary gland development [GO:0030879]		NA	NA	NA	NA	NA	NA
TRINITY_DN26676_c0_g1_i1	P49327	FAS_HUMAN	97.3	75	2	0	2	226	1652	1726	5.10E-34	144.4	FAS_HUMAN	reviewed	Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	FASN FAS	Homo sapiens (Human)	2511	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]; acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949]; mammary gland development [GO:0030879]; osteoblast differentiation [GO:0001649]; positive regulation of cellular metabolic process [GO:0031325]; regulation of cholesterol biosynthetic process [GO:0045540]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]"	GO:0001649; GO:0003723; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006631; GO:0006633; GO:0008144; GO:0008659; GO:0008693; GO:0016020; GO:0016295; GO:0016296; GO:0030879; GO:0031177; GO:0031325; GO:0042470; GO:0042587; GO:0042802; GO:0045296; GO:0045540; GO:0046949; GO:0047117; GO:0047451; GO:0070062; GO:0070402; GO:0071353; GO:0102131; GO:0102132	acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949]; mammary gland development [GO:0030879]; osteoblast differentiation [GO:0001649]; positive regulation of cellular metabolic process [GO:0031325]; regulation of cholesterol biosynthetic process [GO:0045540]		NA	NA	NA	NA	NA	NA
TRINITY_DN11086_c0_g1_i1	Q71SP7	FAS_BOVIN	70.2	94	28	0	320	39	1	94	1.80E-33	143.7	FAS_BOVIN	reviewed	Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	FASN	Bos taurus (Bovine)	2513	"cytoplasm [GO:0005737]; melanosome [GO:0042470]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]"	cytoplasm [GO:0005737]; melanosome [GO:0042470]	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]"	GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0006633; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0031177; GO:0042470; GO:0047117; GO:0047451; GO:0102131; GO:0102132	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN29593_c0_g1_i1	Q01469	FABP5_HUMAN	100	61	0	0	24	206	1	61	3.40E-29	128.3	FABP5_HUMAN	reviewed	"Fatty acid-binding protein 5 (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein, epidermal) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP)"	FABP5	Homo sapiens (Human)	135	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; long-chain fatty acid transporter activity [GO:0005324]; retinoic acid binding [GO:0001972]; epidermis development [GO:0008544]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid transport [GO:0015909]; negative regulation of glucose transmembrane transport [GO:0010829]; neutrophil degranulation [GO:0043312]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; regulation of prostaglandin biosynthetic process [GO:0031392]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; regulation of sensory perception of pain [GO:0051930]; triglyceride catabolic process [GO:0019433]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]	fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; long-chain fatty acid transporter activity [GO:0005324]; retinoic acid binding [GO:0001972]	GO:0001972; GO:0005324; GO:0005504; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006656; GO:0008289; GO:0008544; GO:0010829; GO:0014069; GO:0015909; GO:0019433; GO:0030667; GO:0031392; GO:0035360; GO:0035578; GO:0042593; GO:0042802; GO:0043312; GO:0045202; GO:0051930; GO:0070062; GO:0099178; GO:0120162; GO:1990379	epidermis development [GO:0008544]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid transport [GO:0015909]; negative regulation of glucose transmembrane transport [GO:0010829]; neutrophil degranulation [GO:0043312]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; regulation of prostaglandin biosynthetic process [GO:0031392]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; regulation of sensory perception of pain [GO:0051930]; triglyceride catabolic process [GO:0019433]		NA	NA	NA	NA	NA	NA
TRINITY_DN37706_c0_g1_i1	Q04791	SASB_ANAPL	50.7	75	36	1	224	3	120	194	5.10E-14	78.2	SASB_ANAPL	reviewed	"Fatty acyl-CoA hydrolase precursor, medium chain (EC 3.1.2.-) (Thioesterase B)"		Anas platyrhynchos (Mallard) (Anas boschas)	557	hydrolase activity [GO:0016787]; fatty acid biosynthetic process [GO:0006633]		hydrolase activity [GO:0016787]	GO:0006633; GO:0016787	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN21664_c0_g1_i1	Q04791	SASB_ANAPL	39.2	176	99	3	21	524	25	200	7.10E-31	135.2	SASB_ANAPL	reviewed	"Fatty acyl-CoA hydrolase precursor, medium chain (EC 3.1.2.-) (Thioesterase B)"		Anas platyrhynchos (Mallard) (Anas boschas)	557	hydrolase activity [GO:0016787]; fatty acid biosynthetic process [GO:0006633]		hydrolase activity [GO:0016787]	GO:0006633; GO:0016787	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN39289_c0_g1_i3	Q6GMR7	FAAH2_HUMAN	41.9	74	32	3	383	574	459	531	8.30E-07	55.5	FAAH2_HUMAN	reviewed	Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)	FAAH2 AMDD	Homo sapiens (Human)	532	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN28730_c0_g1_i1	Q6GMR7	FAAH2_HUMAN	61.4	44	17	0	61	192	167	210	7.20E-09	60.8	FAAH2_HUMAN	reviewed	Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)	FAAH2 AMDD	Homo sapiens (Human)	532	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN1950_c0_g1_i1	Q6GMR7	FAAH2_HUMAN	49.9	491	240	2	188	1648	43	531	4.30E-133	476.5	FAAH2_HUMAN	reviewed	Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)	FAAH2 AMDD	Homo sapiens (Human)	532	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN1950_c0_g1_i10	Q6GMR7	FAAH2_HUMAN	49.9	491	240	2	258	1718	43	531	4.50E-133	476.5	FAAH2_HUMAN	reviewed	Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)	FAAH2 AMDD	Homo sapiens (Human)	532	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN1950_c0_g1_i12	Q6GMR7	FAAH2_HUMAN	49.9	491	240	2	258	1718	43	531	4.50E-133	476.5	FAAH2_HUMAN	reviewed	Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)	FAAH2 AMDD	Homo sapiens (Human)	532	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN16136_c0_g1_i1	Q6GMR7	FAAH2_HUMAN	42.7	89	50	1	53	319	224	311	8.40E-11	67.8	FAAH2_HUMAN	reviewed	Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)	FAAH2 AMDD	Homo sapiens (Human)	532	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i1	Q6DH69	FAH2A_DANRE	35.7	446	273	7	11	1327	54	492	8.00E-63	242.7	FAH2A_DANRE	reviewed	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	faah2a zgc:92625	Danio rerio (Zebrafish) (Brachydanio rerio)	532	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i12	Q6DH69	FAH2A_DANRE	50.9	159	77	1	11	487	54	211	2.30E-35	150.2	FAH2A_DANRE	reviewed	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	faah2a zgc:92625	Danio rerio (Zebrafish) (Brachydanio rerio)	532	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		pink	pink	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i2	Q6DH69	FAH2A_DANRE	36.7	479	289	7	11	1426	54	525	7.60E-73	276.2	FAH2A_DANRE	reviewed	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	faah2a zgc:92625	Danio rerio (Zebrafish) (Brachydanio rerio)	532	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i3	Q6DH69	FAH2A_DANRE	35.8	452	276	7	11	1345	54	498	2.30E-65	251.1	FAH2A_DANRE	reviewed	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	faah2a zgc:92625	Danio rerio (Zebrafish) (Brachydanio rerio)	532	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i7	Q6DH69	FAH2A_DANRE	35.3	405	248	7	11	1204	54	451	1.10E-55	218.8	FAH2A_DANRE	reviewed	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	faah2a zgc:92625	Danio rerio (Zebrafish) (Brachydanio rerio)	532	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i8	Q6DH69	FAH2A_DANRE	42.2	64	37	0	53	244	435	498	6.60E-07	54.7	FAH2A_DANRE	reviewed	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	faah2a zgc:92625	Danio rerio (Zebrafish) (Brachydanio rerio)	532	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2742_c0_g1_i14	Q05AM4	FAH2B_DANRE	27.5	251	170	6	79	813	205	449	2.60E-16	87.4	FAH2B_DANRE	reviewed	Fatty-acid amide hydrolase 2-B (EC 3.5.1.99)	faah2b zgc:153568	Danio rerio (Zebrafish) (Brachydanio rerio)	526	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN39289_c0_g1_i4	Q05AM4	FAH2B_DANRE	42.2	204	95	2	33	638	341	523	1.50E-36	154.5	FAH2B_DANRE	reviewed	Fatty-acid amide hydrolase 2-B (EC 3.5.1.99)	faah2b zgc:153568	Danio rerio (Zebrafish) (Brachydanio rerio)	526	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]	anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]	GO:0016021; GO:0016042; GO:0102077; GO:0103073	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN28483_c0_g1_i1	O14526	FCHO1_HUMAN	100	69	0	0	3	209	821	889	8.70E-32	137.1	FCHO1_HUMAN	reviewed	F-BAR domain only protein 1	FCHO1 KIAA0290	Homo sapiens (Human)	889	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; AP-2 adaptor complex binding [GO:0035612]; cytoskeletal protein binding [GO:0008092]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	AP-2 adaptor complex binding [GO:0035612]; cytoskeletal protein binding [GO:0008092]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0008092; GO:0035612; GO:0048268; GO:0061024; GO:0072583	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]		NA	NA	NA	NA	NA	NA
TRINITY_DN14912_c0_g1_i2	Q0JRZ9	FCHO2_HUMAN	55.4	121	54	0	453	91	689	809	7.00E-35	148.3	FCHO2_HUMAN	reviewed	F-BAR domain only protein 2	FCHO2	Homo sapiens (Human)	810	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]	"cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]"	GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0008092; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0061024; GO:0072583; GO:0072659; GO:0098835	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN26146_c0_g1_i1	F1ND48	FBH1_CHICK	43.8	73	40	1	6	221	631	703	6.40E-08	57.8	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN10486_c0_g1_i1	Q8K2I9	FBH1_MOUSE	41.2	131	66	2	8	400	402	521	2.10E-19	96.7	FBH1_MOUSE	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	Fbh1 Fbx18 Fbxo18	Mus musculus (Mouse)	1042	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i1	F1ND48	FBH1_CHICK	37.2	395	217	11	44	1189	612	988	1.80E-60	235	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i11	F1ND48	FBH1_CHICK	33.4	584	341	16	8	1702	434	988	2.80E-80	301.2	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i15	F1ND48	FBH1_CHICK	38	324	179	6	44	988	612	922	4.20E-56	219.9	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i17	F1ND48	FBH1_CHICK	34.6	358	204	10	2	1036	648	988	3.70E-46	187.2	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i3	F1ND48	FBH1_CHICK	33.1	773	454	15	94	2346	191	922	4.50E-109	397.1	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i9	F1ND48	FBH1_CHICK	31.7	851	505	18	94	2577	191	988	3.90E-107	391	FBH1_CHICK	reviewed	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Gallus gallus (Chicken)	1012	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN36321_c0_g1_i1	Q8NFZ0	FBH1_HUMAN	99.2	126	1	0	380	3	612	737	5.60E-70	264.6	FBH1_HUMAN	reviewed	F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Homo sapiens (Human)	1043	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c2_g1_i2	Q8NFZ0	FBH1_HUMAN	52	50	24	0	193	44	215	264	2.20E-07	56.2	FBH1_HUMAN	reviewed	F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Homo sapiens (Human)	1043	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c2_g1_i3	Q8NFZ0	FBH1_HUMAN	52	50	24	0	193	44	215	264	2.30E-07	56.2	FBH1_HUMAN	reviewed	F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Homo sapiens (Human)	1043	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i12	Q8NFZ0	FBH1_HUMAN	35.5	527	301	15	7	1530	499	1005	6.50E-73	276.6	FBH1_HUMAN	reviewed	F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Homo sapiens (Human)	1043	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i16	Q8NFZ0	FBH1_HUMAN	39	82	46	3	7	249	499	577	7.80E-07	55.1	FBH1_HUMAN	reviewed	F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Homo sapiens (Human)	1043	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1752_c0_g1_i5	Q8NFZ0	FBH1_HUMAN	38.3	167	94	5	8	493	449	611	9.00E-23	108.2	FBH1_HUMAN	reviewed	F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18)	FBH1 FBX18 FBXO18	Homo sapiens (Human)	1043	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9890_c0_g1_i1	Q7TPD1	FBX11_MOUSE	70.8	800	218	8	122	2497	136	927	0	1176.4	FBX11_MOUSE	reviewed	F-box only protein 11	Fbxo11	Mus musculus (Mouse)	930	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0042981	cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN25760_c0_g1_i1	Q86XK2	FBX11_HUMAN	100	81	0	0	3	245	843	923	9.60E-47	186.8	FBX11_HUMAN	reviewed	F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1)	FBXO11 FBX11 PRMT9 VIT1 UG063H01	Homo sapiens (Human)	927	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0042981; GO:0043687	cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2784_c1_g1_i1	Q5R5S1	FBX21_PONAB	35.5	411	246	5	20	1219	198	600	1.20E-66	255.4	FBX21_PONAB	reviewed	F-box only protein 21	FBXO21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	621	DNA binding [GO:0003677]		DNA binding [GO:0003677]	GO:0003677			NA	NA	NA	NA	NA	NA
TRINITY_DN2784_c1_g1_i2	Q5R5S1	FBX21_PONAB	35.5	411	246	6	20	1219	198	600	3.50E-66	253.8	FBX21_PONAB	reviewed	F-box only protein 21	FBXO21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	621	DNA binding [GO:0003677]		DNA binding [GO:0003677]	GO:0003677			NA	NA	NA	NA	NA	NA
TRINITY_DN2784_c1_g1_i4	O94952	FBX21_HUMAN	36.5	170	97	3	20	511	198	362	1.70E-25	117.5	FBX21_HUMAN	reviewed	F-box only protein 21	FBXO21 FBX21 KIAA0875	Homo sapiens (Human)	628	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]	DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0003677; GO:0004842; GO:0005829; GO:0006511; GO:0043687	post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN849_c0_g1_i1	Q2NL16	FBX28_BOVIN	62.2	156	57	1	36	503	67	220	1.00E-50	202.6	FBX28_BOVIN	reviewed	F-box only protein 28	FBXO28	Bos taurus (Bovine)	368	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]	identical protein binding [GO:0042802]	GO:0000209; GO:0000776; GO:0000777; GO:0042802	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN849_c0_g1_i2	Q2NL16	FBX28_BOVIN	67.4	135	42	1	247	651	88	220	3.20E-45	184.5	FBX28_BOVIN	reviewed	F-box only protein 28	FBXO28	Bos taurus (Bovine)	368	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]	identical protein binding [GO:0042802]	GO:0000209; GO:0000776; GO:0000777; GO:0042802	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN18588_c0_g1_i1	Q2NL16	FBX28_BOVIN	100	84	0	0	252	1	113	196	7.30E-42	170.6	FBX28_BOVIN	reviewed	F-box only protein 28	FBXO28	Bos taurus (Bovine)	368	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]	identical protein binding [GO:0042802]	GO:0000209; GO:0000776; GO:0000777; GO:0042802	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN8566_c0_g1_i1	Q8BIG4	FBX28_MOUSE	35.2	230	135	4	182	871	67	282	4.90E-29	131	FBX28_MOUSE	reviewed	F-box only protein 28	Fbxo28 D1Ertd578e Kiaa0483	Mus musculus (Mouse)	368	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]	identical protein binding [GO:0042802]	GO:0000209; GO:0000776; GO:0000777; GO:0042802	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN9683_c0_g1_i1	Q8BK06	FBX9_MOUSE	47	164	77	3	485	3	104	260	3.40E-35	149.4	FBX9_MOUSE	reviewed	F-box only protein 9	Fbxo9 MNCb-2471	Mus musculus (Mouse)	437	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006; GO:0045087; GO:0045444	fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN38958_c0_g1_i1	F6Y9J3	FBX9_XENTR	32	172	108	4	591	94	263	431	1.80E-19	97.4	FBX9_XENTR	reviewed	F-box only protein 9	fbxo9	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	431	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006	protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		blue	blue	NA	NA	NA	NA
TRINITY_DN26737_c0_g1_i1	Q17R01	FXL14_BOVIN	68.9	389	121	0	1252	86	3	391	6.90E-152	538.5	FXL14_BOVIN	reviewed	F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14)	FBXL14	Bos taurus (Bovine)	400	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0006511	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35984_c0_g1_i1	Q17R01	FXL14_BOVIN	100	104	0	0	2	313	244	347	2.10E-54	212.6	FXL14_BOVIN	reviewed	F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14)	FBXL14	Bos taurus (Bovine)	400	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0006511	ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN634_c0_g1_i3	Q8RWU5	FBL3_ARATH	24.7	385	239	10	1269	133	47	386	1.20E-15	86.7	FBL3_ARATH	reviewed	F-box/LRR-repeat protein 3	FBL3 At5g01720 F7A7.240	Arabidopsis thaliana (Mouse-ear cress)	665	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005634; GO:0006511; GO:0016567; GO:0019005; GO:0031146	protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN634_c0_g1_i4	Q8RWU5	FBL3_ARATH	28.1	146	85	4	629	198	47	174	5.90E-06	53.9	FBL3_ARATH	reviewed	F-box/LRR-repeat protein 3	FBL3 At5g01720 F7A7.240	Arabidopsis thaliana (Mouse-ear cress)	665	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005634; GO:0006511; GO:0016567; GO:0019005; GO:0031146	protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6083_c0_g1_i1	Q0VD31	FBXL4_BOVIN	35.5	634	342	11	1968	103	38	616	1.10E-95	352.4	FBXL4_BOVIN	reviewed	F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4)	FBXL4	Bos taurus (Bovine)	621	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]		GO:0005634; GO:0005758			NA	NA	NA	NA	NA	NA
TRINITY_DN6083_c0_g1_i4	Q0VD31	FBXL4_BOVIN	35.5	636	343	11	1974	103	36	616	4.90E-96	353.6	FBXL4_BOVIN	reviewed	F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4)	FBXL4	Bos taurus (Bovine)	621	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]		GO:0005634; GO:0005758			NA	NA	NA	NA	NA	NA
TRINITY_DN6083_c0_g1_i5	Q0VD31	FBXL4_BOVIN	37.7	191	109	2	673	128	38	227	1.00E-30	135.2	FBXL4_BOVIN	reviewed	F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4)	FBXL4	Bos taurus (Bovine)	621	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]		GO:0005634; GO:0005758			NA	NA	NA	NA	NA	NA
TRINITY_DN11485_c0_g1_i1	A2VE78	FBXL5_BOVIN	42.9	161	83	3	764	282	1	152	7.90E-29	129	FBXL5_BOVIN	reviewed	F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5)	FBXL5	Bos taurus (Bovine)	691	perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; iron ion binding [GO:0005506]; iron ion homeostasis [GO:0055072]; positive regulation of cellular protein catabolic process [GO:1903364]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]	iron ion binding [GO:0005506]	GO:0005506; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072; GO:1903364	iron ion homeostasis [GO:0055072]; positive regulation of cellular protein catabolic process [GO:1903364]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6853_c0_g1_i1	Q6INS1	FBXL5_XENLA	43.5	108	58	2	444	761	572	678	5.00E-17	89.7	FBXL5_XENLA	reviewed	F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5)	fbxl5	Xenopus laevis (African clawed frog)	678	perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; iron ion binding [GO:0005506]; iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]	iron ion binding [GO:0005506]	GO:0005506; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072	iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN6719_c0_g1_i2	Q8N531	FBXL6_HUMAN	34	212	120	8	633	1244	107	306	1.30E-17	92.4	FBXL6_HUMAN	reviewed	F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A)	FBXL6 FBL6	Homo sapiens (Human)	539	cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin-protein transferase activity [GO:0004842]	GO:0000086; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0019005; GO:0031146; GO:0043153; GO:0051726	entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN634_c0_g1_i1	A1A5X2	FBXL7_DANRE	25.7	152	103	2	546	121	232	383	3.80E-08	60.5	FBXL7_DANRE	reviewed	F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7)	fbxl7 zgc:158346	Danio rerio (Zebrafish) (Brachydanio rerio)	489	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005737; GO:0005815; GO:0006511; GO:0016567; GO:0019005; GO:0031146	protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN34952_c0_g1_i1	Q9UJT9	FBXL7_HUMAN	47.4	97	50	1	290	3	357	453	2.10E-24	112.8	FBXL7_HUMAN	reviewed	F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7)	FBXL7 FBL6 FBL7 KIAA0840	Homo sapiens (Human)	491	centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]		GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0005813; GO:0005829; GO:0006511; GO:0010265; GO:0010972; GO:0016567; GO:0019005; GO:0031146; GO:0043687; GO:0051301	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9721_c0_g1_i1	B4LMQ3	FBSP1_DROVI	87.8	188	23	0	656	93	65	252	1.40E-100	367.1	FBSP1_DROVI	reviewed	F-box/SPRY domain-containing protein 1	Fsn GJ21788	Drosophila virilis (Fruit fly)	252	cell cortex [GO:0005938]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]	cell cortex [GO:0005938]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005634; GO:0005938; GO:0007274; GO:0007399; GO:0010629; GO:0016567; GO:0019005; GO:0031594; GO:0045495; GO:0045732; GO:0045886	negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9721_c0_g1_i2	B4LMQ3	FBSP1_DROVI	82.8	244	42	0	824	93	9	252	1.40E-125	450.7	FBSP1_DROVI	reviewed	F-box/SPRY domain-containing protein 1	Fsn GJ21788	Drosophila virilis (Fruit fly)	252	cell cortex [GO:0005938]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]	cell cortex [GO:0005938]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005634; GO:0005938; GO:0007274; GO:0007399; GO:0010629; GO:0016567; GO:0019005; GO:0031594; GO:0045495; GO:0045732; GO:0045886	negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN31673_c0_g1_i1	P0C2W1	FBSP1_HUMAN	100	68	0	0	204	1	168	235	7.00E-35	147.1	FBSP1_HUMAN	reviewed	F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45)	FBXO45 FBX45	Homo sapiens (Human)	286	cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202]; anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511]	cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202]		GO:0001764; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0098978	anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN30831_c0_g1_i1	Q9UKB1	FBW1B_HUMAN	100	100	0	0	300	1	387	486	1.40E-55	216.5	FBW1B_HUMAN	reviewed	F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS)	FBXW11 BTRCP2 FBW1B FBXW1B KIAA0696	Homo sapiens (Human)	542	"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; interleukin-1-mediated signaling pathway [GO:0070498]; microtubule organizing center organization [GO:0031023]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; nuclear migration [GO:0007097]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; vesicle transport along microtubule [GO:0047496]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000086; GO:0000132; GO:0000151; GO:0000209; GO:0000776; GO:0002223; GO:0004842; GO:0005634; GO:0005635; GO:0005813; GO:0005829; GO:0005875; GO:0005881; GO:0006470; GO:0007097; GO:0007281; GO:0008090; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031023; GO:0031146; GO:0031648; GO:0038061; GO:0038095; GO:0042753; GO:0043005; GO:0043025; GO:0043161; GO:0043687; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0047496; GO:0048511; GO:0048854; GO:0050852; GO:0051010; GO:0051403; GO:0061630; GO:0070498; GO:0070840; GO:1901223; GO:1904115; GO:2000574	"brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; interleukin-1-mediated signaling pathway [GO:0070498]; microtubule organizing center organization [GO:0031023]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; nuclear migration [GO:0007097]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; vesicle transport along microtubule [GO:0047496]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27150_c0_g1_i1	Q9UKB1	FBW1B_HUMAN	96.9	128	4	0	386	3	358	485	4.40E-70	265	FBW1B_HUMAN	reviewed	F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS)	FBXW11 BTRCP2 FBW1B FBXW1B KIAA0696	Homo sapiens (Human)	542	"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; interleukin-1-mediated signaling pathway [GO:0070498]; microtubule organizing center organization [GO:0031023]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; nuclear migration [GO:0007097]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; vesicle transport along microtubule [GO:0047496]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000086; GO:0000132; GO:0000151; GO:0000209; GO:0000776; GO:0002223; GO:0004842; GO:0005634; GO:0005635; GO:0005813; GO:0005829; GO:0005875; GO:0005881; GO:0006470; GO:0007097; GO:0007281; GO:0008090; GO:0016032; GO:0016055; GO:0016567; GO:0019005; GO:0031023; GO:0031146; GO:0031648; GO:0038061; GO:0038095; GO:0042753; GO:0043005; GO:0043025; GO:0043161; GO:0043687; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0047496; GO:0048511; GO:0048854; GO:0050852; GO:0051010; GO:0051403; GO:0061630; GO:0070498; GO:0070840; GO:1901223; GO:1904115; GO:2000574	"brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; interleukin-1-mediated signaling pathway [GO:0070498]; microtubule organizing center organization [GO:0031023]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; nuclear migration [GO:0007097]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; vesicle transport along microtubule [GO:0047496]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29991_c0_g1_i1	B2RZ17	FBXW2_RAT	27.1	446	259	13	1567	248	44	429	3.50E-29	131.3	FBXW2_RAT	reviewed	F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6)	Fbxw2	Rattus norvegicus (Rat)	454	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN27480_c0_g1_i1	Q969U6	FBXW5_HUMAN	100	186	0	0	3	560	371	556	1.70E-107	389.8	FBXW5_HUMAN	reviewed	F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5)	FBXW5 FBW5 PP3971	Homo sapiens (Human)	566	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]	protein kinase binding [GO:0019901]	GO:0000209; GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN6386_c0_g1_i1	Q969U6	FBXW5_HUMAN	41.8	244	135	2	736	23	60	302	4.50E-47	189.5	FBXW5_HUMAN	reviewed	F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5)	FBXW5 FBW5 PP3971	Homo sapiens (Human)	566	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]	protein kinase binding [GO:0019901]	GO:0000209; GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN2150_c0_g1_i1	Q9QXW2	FBXW5_MOUSE	55.1	236	79	3	834	127	342	550	6.60E-67	255.8	FBXW5_MOUSE	reviewed	F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5)	Fbxw5 Fbw5	Mus musculus (Mouse)	573	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]	protein kinase binding [GO:0019901]	GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN34023_c0_g1_i1	Q969U6	FBXW5_HUMAN	100	75	0	0	2	226	113	187	4.90E-37	154.5	FBXW5_HUMAN	reviewed	F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5)	FBXW5 FBW5 PP3971	Homo sapiens (Human)	566	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]	protein kinase binding [GO:0019901]	GO:0000209; GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0043687; GO:0080008	post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN35141_c0_g1_i1	F1MNN4	FBXW7_BOVIN	79.2	72	15	0	2	217	365	436	4.70E-29	127.9	FBXW7_BOVIN	reviewed	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7)	FBXW7 FBW7	Bos taurus (Bovine)	627	"COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]; phosphothreonine residue binding [GO:0050816]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"	COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]	phosphothreonine residue binding [GO:0050816]	GO:0005634; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0031146; GO:0050816	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28158_c0_g1_i1	F1MNN4	FBXW7_BOVIN	100	132	0	0	396	1	299	430	1.40E-76	286.6	FBXW7_BOVIN	reviewed	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7)	FBXW7 FBW7	Bos taurus (Bovine)	627	"COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]; phosphothreonine residue binding [GO:0050816]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"	COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]	phosphothreonine residue binding [GO:0050816]	GO:0005634; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0031146; GO:0050816	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30068_c0_g1_i1	Q9VZF4	FBXW7_DROME	88.5	157	18	0	9	479	1162	1318	7.30E-81	301.2	FBXW7_DROME	reviewed	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago)	ago CG15010	Drosophila melanogaster (Fruit fly)	1326	"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]; branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]	GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381	"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3623_c0_g1_i2	Q9VZF4	FBXW7_DROME	32.8	393	210	7	1156	101	852	1231	3.20E-60	234.2	FBXW7_DROME	reviewed	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago)	ago CG15010	Drosophila melanogaster (Fruit fly)	1326	"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]; branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]	GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381	"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3623_c0_g1_i3	Q9VZF4	FBXW7_DROME	36.3	433	250	9	1334	54	852	1264	3.50E-71	270.8	FBXW7_DROME	reviewed	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago)	ago CG15010	Drosophila melanogaster (Fruit fly)	1326	"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]; branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]	GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381	"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5126_c0_g1_i1	P87053	POF1_SCHPO	29.5	132	83	2	423	58	256	387	6.10E-09	63.2	POF1_SCHPO	reviewed	F-box/WD repeat-containing protein pof1 (Skp1-binding protein 1)	pof1 sbp1 SPAC57A10.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	605	"COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein-macromolecule adaptor activity [GO:0030674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"	COPI vesicle coat [GO:0030126]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	protein-macromolecule adaptor activity [GO:0030674]	GO:0005634; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0019005; GO:0030126; GO:0030674; GO:0031146	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38355_c0_g1_i1	O60907	TBL1X_HUMAN	99	100	1	0	3	302	47	146	3.30E-49	195.3	TBL1X_HUMAN	reviewed	"F-box-like/WD repeat-containing protein TBL1X (SMAP55) (Transducin beta-like protein 1X) (Transducin-beta-like protein 1, X-linked)"	TBL1X TBL1	Homo sapiens (Human)	577	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019216; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0045893; GO:0045944; GO:0050821; GO:0072686; GO:0090263	"histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29109_c0_g1_i1	O60907	TBL1X_HUMAN	98.8	85	1	0	1	255	358	442	4.50E-47	188	TBL1X_HUMAN	reviewed	"F-box-like/WD repeat-containing protein TBL1X (SMAP55) (Transducin beta-like protein 1X) (Transducin-beta-like protein 1, X-linked)"	TBL1X TBL1	Homo sapiens (Human)	577	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019216; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0045893; GO:0045944; GO:0050821; GO:0072686; GO:0090263	"histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28236_c0_g1_i1	O60907	TBL1X_HUMAN	100	91	0	0	2	274	236	326	3.90E-49	194.9	TBL1X_HUMAN	reviewed	"F-box-like/WD repeat-containing protein TBL1X (SMAP55) (Transducin beta-like protein 1X) (Transducin-beta-like protein 1, X-linked)"	TBL1X TBL1	Homo sapiens (Human)	577	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019216; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0045893; GO:0045944; GO:0050821; GO:0072686; GO:0090263	"histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25438_c0_g1_i1	Q9QXE7	TBL1X_MOUSE	100	147	0	0	520	80	381	527	6.50E-85	314.7	TBL1X_MOUSE	reviewed	F-box-like/WD repeat-containing protein TBL1X (Transducin beta-like protein 1X)	Tbl1x Tbl1	Mus musculus (Mouse)	527	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; fat cell differentiation [GO:0045444]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to steroid hormone [GO:0048545]; sensory perception of sound [GO:0007605]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0043627; GO:0045444; GO:0045892; GO:0045893; GO:0045944; GO:0048545; GO:0050821; GO:0072686; GO:0090263	"fat cell differentiation [GO:0045444]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to steroid hormone [GO:0048545]; sensory perception of sound [GO:0007605]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3541_c0_g1_i1	Q8BHJ5	TBL1R_MOUSE	76.7	515	93	4	1550	84	1	514	1.30E-232	807	TBL1R_MOUSE	reviewed	F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1)	Tbl1xr1 Ira1 Tblr1	Mus musculus (Mouse)	514	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0016575; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263	"adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3541_c0_g1_i2	Q8BHJ5	TBL1R_MOUSE	76.7	514	91	4	1538	84	1	514	1.30E-232	807	TBL1R_MOUSE	reviewed	F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1)	Tbl1xr1 Ira1 Tblr1	Mus musculus (Mouse)	514	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0016575; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263	"adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37661_c0_g1_i1	Q9BZK7	TBL1R_HUMAN	100	73	0	0	221	3	329	401	5.50E-41	167.5	TBL1R_HUMAN	reviewed	F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1)	TBL1XR1 IRA1 TBLR1	Homo sapiens (Human)	514	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"	histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0016042; GO:0016575; GO:0017053; GO:0019216; GO:0035264; GO:0042393; GO:0043161; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060613; GO:0072686; GO:0090207; GO:0090263	"blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40278_c0_g1_i1	Q9Y5Y0	FLVC1_HUMAN	81.2	48	9	0	149	6	437	484	2.30E-15	82.4	FLVC1_HUMAN	reviewed	Feline leukemia virus subgroup C receptor-related protein 1 (Feline leukemia virus subgroup C receptor) (hFLVCR)	FLVCR1 FLVCR	Homo sapiens (Human)	555	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; blood vessel development [GO:0001568]; cellular iron ion homeostasis [GO:0006879]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; head morphogenesis [GO:0060323]; heme export [GO:0097037]; heme transport [GO:0015886]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; multicellular organism growth [GO:0035264]; regulation of organ growth [GO:0046620]; spleen development [GO:0048536]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]	GO:0001568; GO:0001701; GO:0005739; GO:0005886; GO:0006839; GO:0006879; GO:0015232; GO:0015886; GO:0016021; GO:0020037; GO:0030218; GO:0031966; GO:0035264; GO:0042733; GO:0043249; GO:0046620; GO:0048536; GO:0048704; GO:0060323; GO:0097037	blood vessel development [GO:0001568]; cellular iron ion homeostasis [GO:0006879]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; head morphogenesis [GO:0060323]; heme export [GO:0097037]; heme transport [GO:0015886]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; multicellular organism growth [GO:0035264]; regulation of organ growth [GO:0046620]; spleen development [GO:0048536]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i1	A2A2Y4	FRMD3_HUMAN	49.4	348	173	3	1565	525	24	369	2.00E-95	351.3	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i10	A2A2Y4	FRMD3_HUMAN	49.4	348	173	3	1390	350	24	369	1.80E-95	351.3	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i14	A2A2Y4	FRMD3_HUMAN	46	372	174	4	1462	350	24	369	7.30E-92	339.3	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i3	A2A2Y4	FRMD3_HUMAN	49.4	348	173	3	1163	123	24	369	1.50E-95	351.3	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i5	A2A2Y4	FRMD3_HUMAN	46	372	174	4	1235	123	24	369	6.30E-92	339.3	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i8	A2A2Y4	FRMD3_HUMAN	47.4	213	110	2	758	123	158	369	7.40E-50	199.5	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4289_c0_g1_i8	A2A2Y4	FRMD3_HUMAN	52.2	138	65	1	1182	769	24	160	2.50E-37	157.9	FRMD3_HUMAN	reviewed	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O)	FRMD3 EPB41L4O	Homo sapiens (Human)	597	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	actomyosin structure organization [GO:0031032]		NA	NA	NA	NA	NA	NA
TRINITY_DN33613_c0_g1_i1	Q86UX7	URP2_HUMAN	100	126	0	0	2	379	542	667	4.40E-70	265	URP2_HUMAN	reviewed	Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2)	FERMT3 KIND3 MIG2B URP2	Homo sapiens (Human)	667	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]	integrin binding [GO:0005178]	GO:0002102; GO:0002576; GO:0005178; GO:0005576; GO:0007159; GO:0007160; GO:0007229; GO:0016020; GO:0030055; GO:0030335; GO:0031093; GO:0033622; GO:0033632; GO:0034446; GO:0042995; GO:0070062; GO:0070527	cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN34503_c0_g1_i1	Q86UX7	URP2_HUMAN	100	94	0	0	284	3	409	502	2.40E-49	195.7	URP2_HUMAN	reviewed	Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2)	FERMT3 KIND3 MIG2B URP2	Homo sapiens (Human)	667	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]	integrin binding [GO:0005178]	GO:0002102; GO:0002576; GO:0005178; GO:0005576; GO:0007159; GO:0007160; GO:0007229; GO:0016020; GO:0030055; GO:0030335; GO:0031093; GO:0033622; GO:0033632; GO:0034446; GO:0042995; GO:0070062; GO:0070527	cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN7110_c0_g1_i1	Q86UX7	URP2_HUMAN	97.9	192	0	1	565	2	217	408	4.70E-105	381.7	URP2_HUMAN	reviewed	Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2)	FERMT3 KIND3 MIG2B URP2	Homo sapiens (Human)	667	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]	integrin binding [GO:0005178]	GO:0002102; GO:0002576; GO:0005178; GO:0005576; GO:0007159; GO:0007160; GO:0007229; GO:0016020; GO:0030055; GO:0030335; GO:0031093; GO:0033622; GO:0033632; GO:0034446; GO:0042995; GO:0070062; GO:0070527	cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN38860_c0_g1_i1	Q8K1B8	URP2_MOUSE	100	107	0	0	324	4	214	320	4.20E-58	224.9	URP2_MOUSE	reviewed	Fermitin family homolog 3 (Kindlin-3) (Unc-112-related protein 2)	Fermt3 Kind3 Urp2	Mus musculus (Mouse)	665	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; podosome [GO:0002102]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]	cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; podosome [GO:0002102]	integrin binding [GO:0005178]	GO:0002102; GO:0005178; GO:0007159; GO:0007160; GO:0007229; GO:0030055; GO:0030335; GO:0033622; GO:0033632; GO:0034446; GO:0042995; GO:0070527	cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN39524_c0_g1_i1	Q6P4F2	FDX2_HUMAN	55.1	98	44	0	338	45	89	186	2.90E-25	115.9	FDX2_HUMAN	reviewed	"Ferredoxin-2, mitochondrial (Adrenodoxin-like protein) (Ferredoxin-1-like protein)"	FDX2 FDX1L	Homo sapiens (Human)	186	"mitochondrial matrix [GO:0005759]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; C21-steroid hormone biosynthetic process [GO:0006700]; small molecule metabolic process [GO:0044281]; sterol metabolic process [GO:0016125]"	mitochondrial matrix [GO:0005759]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	GO:0005759; GO:0006700; GO:0009055; GO:0016125; GO:0044281; GO:0046872; GO:0051537	C21-steroid hormone biosynthetic process [GO:0006700]; small molecule metabolic process [GO:0044281]; sterol metabolic process [GO:0016125]		NA	NA	NA	NA	NA	NA
TRINITY_DN40402_c0_g1_i1	Q9CPW2	FDX2_MOUSE	100	61	0	0	3	185	114	174	1.10E-29	130.2	FDX2_MOUSE	reviewed	"Ferredoxin-2, mitochondrial (Adrenodoxin-like protein) (Ferredoxin-1-like protein)"	Fdx2 Fdx1l	Mus musculus (Mouse)	174	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	GO:0005739; GO:0005759; GO:0009055; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN9948_c0_g1_i1	P55037	GLTB_SYNY3	60	85	34	0	255	1	238	322	9.80E-26	117.1	GLTB_SYNY3	reviewed	Ferredoxin-dependent glutamate synthase 1 (EC 1.4.7.1) (Fd-GOGAT)	gltB sll1502	Synechocystis sp. (strain PCC 6803 / Kazusa)	1550	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (ferredoxin) activity [GO:0016041]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (ferredoxin) activity [GO:0016041]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0006537; GO:0015930; GO:0016041; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN32995_c0_g1_i1	P02794	FRIH_HUMAN	100	61	0	0	185	3	1	61	1.80E-27	122.5	FRIH_HUMAN	reviewed	"Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]"	FTH1 FTH FTHL6 OK/SW-cl.84 PIG15	Homo sapiens (Human)	183	autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506]; cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; neutrophil degranulation [GO:0043312]	autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506]	GO:0004322; GO:0005506; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006826; GO:0006879; GO:0006880; GO:0006955; GO:0008043; GO:0008198; GO:0008199; GO:0008285; GO:0043312; GO:0044754; GO:0048147; GO:0070062; GO:1904724; GO:1904813	cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; neutrophil degranulation [GO:0043312]		blue	blue	NA	NA	NA	NA
TRINITY_DN29760_c0_g1_i1	Q8MIP0	FRIH_HORSE	44.7	94	52	0	161	442	7	100	3.50E-15	82.8	FRIH_HORSE	reviewed	"Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) [Cleaved into: Ferritin heavy chain, N-terminally processed]"	FTH1 FTH	Equus caballus (Horse)	182	cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]	cytoplasm [GO:0005737]	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506]	GO:0004322; GO:0005506; GO:0005737; GO:0006826; GO:0006880; GO:0006955; GO:0008198; GO:0008199; GO:0008285	immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN40598_c0_g1_i1	P22830	HEMH_HUMAN	100	79	0	0	239	3	260	338	1.80E-42	172.6	HEMH_HUMAN	reviewed	"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)"	FECH	Homo sapiens (Human)	423	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; cellular response to dexamethasone stimulus [GO:0071549]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insecticide [GO:0017085]; response to lead ion [GO:0010288]; response to light stimulus [GO:0009416]; response to methylmercury [GO:0051597]; response to platinum ion [GO:0070541]"	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]"	GO:0004325; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006783; GO:0008198; GO:0009416; GO:0010288; GO:0017085; GO:0042493; GO:0045471; GO:0046501; GO:0046685; GO:0051537; GO:0051597; GO:0070541; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insecticide [GO:0017085]; response to lead ion [GO:0010288]; response to light stimulus [GO:0009416]; response to methylmercury [GO:0051597]; response to platinum ion [GO:0070541]		NA	NA	NA	NA	NA	NA
TRINITY_DN1728_c0_g1_i1	Q9V9S8	HEMH_DROME	58.9	287	103	2	944	84	108	379	3.80E-99	362.8	HEMH_DROME	reviewed	"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)"	FeCh CG2098	Drosophila melanogaster (Fruit fly)	384	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]"	GO:0004325; GO:0005739; GO:0005743; GO:0006782; GO:0006783; GO:0046872; GO:0051537	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN1728_c0_g1_i2	Q9V9S8	HEMH_DROME	61.8	272	104	0	899	84	108	379	1.30E-101	370.9	HEMH_DROME	reviewed	"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)"	FeCh CG2098	Drosophila melanogaster (Fruit fly)	384	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]"	GO:0004325; GO:0005739; GO:0005743; GO:0006782; GO:0006783; GO:0046872; GO:0051537	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		blue	blue	NA	NA	NA	NA
TRINITY_DN35336_c0_g1_i1	P22315	HEMH_MOUSE	100	221	0	0	2	664	154	374	1.20E-131	470.3	HEMH_MOUSE	reviewed	"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)"	Fech	Mus musculus (Mouse)	420	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; iron-responsive element binding [GO:0030350]; tetrapyrrole binding [GO:0046906]; cholesterol metabolic process [GO:0008203]; detection of UV [GO:0009589]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; iron ion homeostasis [GO:0055072]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of gene expression [GO:0010468]; regulation of hemoglobin biosynthetic process [GO:0046984]; response to light stimulus [GO:0009416]; very-low-density lipoprotein particle assembly [GO:0034379]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; iron-responsive element binding [GO:0030350]; tetrapyrrole binding [GO:0046906]"	GO:0004325; GO:0005506; GO:0005739; GO:0005743; GO:0006779; GO:0006783; GO:0008203; GO:0009416; GO:0009589; GO:0010468; GO:0010999; GO:0020037; GO:0030218; GO:0030350; GO:0034379; GO:0046501; GO:0046906; GO:0046984; GO:0051537; GO:0055072	cholesterol metabolic process [GO:0008203]; detection of UV [GO:0009589]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; iron ion homeostasis [GO:0055072]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; regulation of gene expression [GO:0010468]; regulation of hemoglobin biosynthetic process [GO:0046984]; response to light stimulus [GO:0009416]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN36765_c0_g1_i1	Q0JJS8	HF101_ORYSJ	60.5	76	30	0	3	230	263	338	5.80E-22	104.4	HF101_ORYSJ	reviewed	"Fe-S cluster assembly factor HCF101, chloroplastic (Protein HIGH CHLOROPHYLL FLUORESCENCE 101 homolog)"	HCF101 Os01g0719700 LOC_Os01g52170 OsJ_03276 P0480C01.27	Oryza sativa subsp. japonica (Rice)	531	"chloroplast stroma [GO:0009570]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	chloroplast stroma [GO:0009570]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0009570; GO:0016226; GO:0046872; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN101_c0_g1_i1	Q8AVR2	FGOP2_XENLA	45.4	183	93	2	94	624	5	186	8.20E-24	112.5	FGOP2_XENLA	reviewed	FGFR1 oncogene partner 2 homolog	fgfr1op2	Xenopus laevis (African clawed frog)	215	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN8635_c2_g1_i1	Q96C11	FGGY_HUMAN	43.9	123	69	0	417	49	427	549	1.30E-19	97.4	FGGY_HUMAN	reviewed	FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-)	FGGY	Homo sapiens (Human)	551	D-ribulokinase activity [GO:0019150]; carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321]		D-ribulokinase activity [GO:0019150]	GO:0019150; GO:0019321; GO:0046835; GO:0070050	carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321]		NA	NA	NA	NA	NA	NA
TRINITY_DN17203_c0_g1_i1	P98133	FBN1_BOVIN	41.2	80	43	2	238	2	1171	1247	1.00E-11	70.5	FBN1_BOVIN	reviewed	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	FBN1	Bos taurus (Bovine)	2871	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]		NA	NA	NA	NA	NA	NA
TRINITY_DN32250_c0_g1_i1	P35556	FBN2_HUMAN	60.3	121	47	1	375	16	2450	2570	6.40E-42	171.4	FBN2_HUMAN	reviewed	Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide]	FBN2	Homo sapiens (Human)	2912	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]	calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]	GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0030023; GO:0030198; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023	anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]		NA	NA	NA	NA	NA	NA
TRINITY_DN2054_c0_g1_i6	Q0P4P2	FBCD1_XENTR	48.1	104	52	2	2	313	351	452	2.90E-22	105.9	FBCD1_XENTR	reviewed	Fibrinogen C domain-containing protein 1	fibcd1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	457	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	chitin binding [GO:0008061]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0007155; GO:0008061; GO:0016021; GO:0046872; GO:0062023	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g1_i4	Q8N539	FBCD1_HUMAN	45.3	128	61	2	3	371	333	456	2.30E-25	116.7	FBCD1_HUMAN	reviewed	Fibrinogen C domain-containing protein 1	FIBCD1 UNQ701/PRO1346	Homo sapiens (Human)	461	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	chitin binding [GO:0008061]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0007155; GO:0008061; GO:0016020; GO:0016021; GO:0046872; GO:0062023	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g1_i3	Q3SZZ7	FGL1_BOVIN	47.4	76	40	0	15	242	229	304	4.10E-16	85.5	FGL1_BOVIN	reviewed	Fibrinogen-like protein 1	FGL1	Bos taurus (Bovine)	312	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	GO:0002250; GO:0005102; GO:0005576; GO:0005615; GO:0050776; GO:0050868; GO:0062023; GO:0072574	adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776]		NA	NA	NA	NA	NA	NA
TRINITY_DN632_c0_g1_i1	P19477	FIBA_APOPA	49.5	97	47	1	306	16	108	202	8.70E-21	100.9	FIBA_APOPA	reviewed	Fibrinogen-like protein A (FREP-A)		Apostichopus parvimensis (Warty sea cucumber) (Stichopus parvimensis)	282							NA	NA	NA	NA	NA	NA
TRINITY_DN632_c0_g1_i2	P19477	FIBA_APOPA	48.5	97	48	1	306	16	108	202	1.10E-20	100.5	FIBA_APOPA	reviewed	Fibrinogen-like protein A (FREP-A)		Apostichopus parvimensis (Warty sea cucumber) (Stichopus parvimensis)	282							NA	NA	NA	NA	NA	NA
TRINITY_DN21281_c0_g1_i2	Q26614	FGFR_STRPU	64.1	39	14	0	29	145	821	859	1.90E-09	62.8	FGFR_STRPU	reviewed	Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1)	FGFR	Strongylocentrotus purpuratus (Purple sea urchin)	972	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005007; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0017134; GO:0033674; GO:0043235	multicellular organism development [GO:0007275]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN27696_c0_g1_i1	P21802	FGFR2_HUMAN	99	102	1	0	306	1	583	684	1.20E-54	213.4	FGFR2_HUMAN	reviewed	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)	FGFR2 BEK KGFR KSAM	Homo sapiens (Human)	821	cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; MAPK cascade [GO:0000165]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; multicellular organism development [GO:0007275]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000122; GO:0000165; GO:0001525; GO:0001657; GO:0001701; GO:0001837; GO:0002053; GO:0003148; GO:0003149; GO:0003416; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005938; GO:0006915; GO:0007169; GO:0007267; GO:0007275; GO:0007409; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0009986; GO:0010518; GO:0010839; GO:0016020; GO:0016021; GO:0016331; GO:0017134; GO:0018108; GO:0021769; GO:0021847; GO:0021860; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031069; GO:0031410; GO:0032496; GO:0032808; GO:0033674; GO:0033688; GO:0035265; GO:0035602; GO:0035603; GO:0035604; GO:0035607; GO:0042060; GO:0042472; GO:0042476; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0045165; GO:0045471; GO:0045667; GO:0045787; GO:0045944; GO:0046777; GO:0048286; GO:0048333; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048661; GO:0048701; GO:0048705; GO:0048730; GO:0048755; GO:0048762; GO:0050679; GO:0051150; GO:0051781; GO:0051897; GO:0055010; GO:0060045; GO:0060076; GO:0060174; GO:0060348; GO:0060349; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060595; GO:0060601; GO:0060615; GO:0060664; GO:0060667; GO:0060670; GO:0060688; GO:0060915; GO:0060916; GO:0070372; GO:0070374; GO:0071300; GO:0071560; GO:0090263	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; mammary gland bud formation [GO:0060615]; MAPK cascade [GO:0000165]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; multicellular organism development [GO:0007275]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smooth muscle cell differentiation [GO:0051150]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN20985_c0_g1_i2	Q91286	FGFR2_PLEWA	53.6	84	39	0	254	3	635	718	4.60E-23	108.2	FGFR2_PLEWA	reviewed	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (PFR2)	FGFR2	Pleurodeles waltl (Iberian ribbed newt)	824	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; digestive tract development [GO:0048565]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; gland morphogenesis [GO:0022612]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]	GO:0000122; GO:0001525; GO:0001657; GO:0002053; GO:0003148; GO:0003149; GO:0005007; GO:0005524; GO:0005634; GO:0005794; GO:0005886; GO:0006915; GO:0007267; GO:0007409; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0016021; GO:0016331; GO:0017134; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031410; GO:0032808; GO:0035265; GO:0042472; GO:0042476; GO:0045165; GO:0045944; GO:0048286; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048730; GO:0048755; GO:0048762; GO:0050679; GO:0051150; GO:0051781; GO:0055010; GO:0060045; GO:0060174; GO:0060348; GO:0060349; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060601; GO:0060664; GO:0060667; GO:0060688; GO:0060915; GO:0060916; GO:0070372; GO:0070374; GO:0090263	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; digestive tract development [GO:0048565]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; gland morphogenesis [GO:0022612]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smooth muscle cell differentiation [GO:0051150]; reproductive structure development [GO:0048608]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]		NA	NA	NA	NA	NA	NA
TRINITY_DN20985_c0_g1_i1	P18461	FGFR2_CHICK	52.9	85	40	0	257	3	639	723	4.60E-23	108.2	FGFR2_CHICK	reviewed	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Tyrosine kinase receptor CEK3)	FGFR2 CEK3	Gallus gallus (Chicken)	823	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005007; GO:0005524; GO:0005794; GO:0005887; GO:0006915; GO:0007169; GO:0007275; GO:0008284; GO:0017134; GO:0031410; GO:0033674; GO:0043235	apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN9657_c1_g1_i1	Q90330	FGFR4_COTCO	51	49	24	0	226	80	582	630	4.60E-11	68.2	FGFR4_COTCO	reviewed	Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Fibroblast growth factor receptor-like embryonic kinase)	FGFR4 FREK	Coturnix coturnix (Common quail) (Tetrao coturnix)	713	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; positive regulation of cell population proliferation [GO:0008284]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]	GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005886; GO:0008284; GO:0016021	positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN32960_c0_g1_i1	Q07407	FGFR1_DROME	72.1	61	17	0	209	27	447	507	2.10E-21	102.4	FGFR1_DROME	reviewed	Fibroblast growth factor receptor homolog 1 (EC 2.7.10.1) (DmHD-38) (Protein heartless) (Tyrosine kinase 1) (dTk1)	htl FR1 Tk1 CG7223	Drosophila melanogaster (Fruit fly)	729	integral component of plasma membrane [GO:0005887]; postsynapse of neuromuscular junction [GO:0098975]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cardioblast differentiation [GO:0010002]; central nervous system development [GO:0007417]; defense response to Gram-negative bacterium [GO:0050829]; endodermal cell fate determination [GO:0007493]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell migration [GO:0008354]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell growth [GO:0042065]; glial cell migration [GO:0008347]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; larval visceral muscle development [GO:0007523]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell fate commitment [GO:0001710]; mesodermal cell fate determination [GO:0007500]; mesodermal cell migration [GO:0008078]; multicellular organism development [GO:0007275]; muscle fiber development [GO:0048747]; myoblast fate specification [GO:0048626]; myotube cell migration [GO:0110122]; pericardial nephrocyte differentiation [GO:0061320]; pole cell migration [GO:0007280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell migration [GO:1903977]; positive regulation of innate immune response [GO:0045089]; positive regulation of kinase activity [GO:0033674]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of cell shape [GO:0008360]; salivary gland development [GO:0007431]; somatic muscle development [GO:0007525]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventral cord development [GO:0007419]; visceral muscle development [GO:0007522]	integral component of plasma membrane [GO:0005887]; postsynapse of neuromuscular junction [GO:0098975]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001710; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0007280; GO:0007417; GO:0007419; GO:0007431; GO:0007493; GO:0007500; GO:0007506; GO:0007507; GO:0007509; GO:0007522; GO:0007523; GO:0007525; GO:0008078; GO:0008284; GO:0008347; GO:0008354; GO:0008360; GO:0008543; GO:0010001; GO:0010002; GO:0021782; GO:0033674; GO:0035169; GO:0035170; GO:0042065; GO:0043235; GO:0045089; GO:0045887; GO:0048542; GO:0048626; GO:0048747; GO:0050829; GO:0061320; GO:0098975; GO:0110122; GO:1903977	cardioblast differentiation [GO:0010002]; central nervous system development [GO:0007417]; defense response to Gram-negative bacterium [GO:0050829]; endodermal cell fate determination [GO:0007493]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell migration [GO:0008354]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell growth [GO:0042065]; glial cell migration [GO:0008347]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; larval visceral muscle development [GO:0007523]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; mesodermal cell fate commitment [GO:0001710]; mesodermal cell fate determination [GO:0007500]; mesodermal cell migration [GO:0008078]; mesoderm migration involved in gastrulation [GO:0007509]; multicellular organism development [GO:0007275]; muscle fiber development [GO:0048747]; myoblast fate specification [GO:0048626]; myotube cell migration [GO:0110122]; pericardial nephrocyte differentiation [GO:0061320]; pole cell migration [GO:0007280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell migration [GO:1903977]; positive regulation of innate immune response [GO:0045089]; positive regulation of kinase activity [GO:0033674]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of cell shape [GO:0008360]; salivary gland development [GO:0007431]; somatic muscle development [GO:0007525]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventral cord development [GO:0007419]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN30184_c0_g1_i1	Q8C180	FRS2_MOUSE	52.3	107	48	1	898	587	1	107	5.20E-27	123.6	FRS2_MOUSE	reviewed	Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (FRS2-alpha) (Suc1-associated neurotrophic factor target 1) (SNT-1)	Frs2 Frs2a	Mus musculus (Mouse)	508	"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; activation of MAPK activity [GO:0000187]; anterior/posterior axis specification, embryo [GO:0008595]; cellular response to fibroblast growth factor stimulus [GO:0044344]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; gastrulation with mouth forming second [GO:0001702]; lens development in camera-type eye [GO:0002088]; lens fiber cell development [GO:0070307]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; optic placode formation involved in camera-type eye formation [GO:0046619]; organ induction [GO:0001759]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular septum development [GO:0003281]"	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0000187; GO:0001702; GO:0001759; GO:0002088; GO:0003281; GO:0005068; GO:0005104; GO:0005168; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007169; GO:0007405; GO:0008543; GO:0008595; GO:0030900; GO:0042981; GO:0044344; GO:0046619; GO:0050678; GO:0060527; GO:0070307; GO:0070372; GO:1904707; GO:2000726	"activation of MAPK activity [GO:0000187]; anterior/posterior axis specification, embryo [GO:0008595]; cellular response to fibroblast growth factor stimulus [GO:0044344]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; gastrulation with mouth forming second [GO:0001702]; lens development in camera-type eye [GO:0002088]; lens fiber cell development [GO:0070307]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; optic placode formation involved in camera-type eye formation [GO:0046619]; organ induction [GO:0001759]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular septum development [GO:0003281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i6	Q86WI1	PKHL1_HUMAN	62.5	48	18	0	199	56	3791	3838	1.60E-13	76.3	PKHL1_HUMAN	reviewed	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)	PKHD1L1	Homo sapiens (Human)	4243	cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]	cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023	immune response [GO:0006955]		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i7	Q86WI1	PKHL1_HUMAN	37.7	762	455	11	2421	169	3226	3978	1.60E-149	531.6	PKHL1_HUMAN	reviewed	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)	PKHD1L1	Homo sapiens (Human)	4243	cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]	cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0005615; GO:0005829; GO:0005929; GO:0006955; GO:0016021; GO:0038023	immune response [GO:0006955]		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i3	Q80ZA4	PKHL1_MOUSE	41.1	414	237	4	1353	118	3469	3877	4.10E-89	330.1	PKHL1_MOUSE	reviewed	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	Pkhd1l1	Mus musculus (Mouse)	4249	integral component of membrane [GO:0016021]; stereocilium tip [GO:0032426]; sensory perception of sound [GO:0007605]	integral component of membrane [GO:0016021]; stereocilium tip [GO:0032426]		GO:0007605; GO:0016021; GO:0032426	sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i4	Q80ZA4	PKHL1_MOUSE	36.9	656	390	10	1956	19	3371	4012	2.40E-119	431	PKHL1_MOUSE	reviewed	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	Pkhd1l1	Mus musculus (Mouse)	4249	integral component of membrane [GO:0016021]; stereocilium tip [GO:0032426]; sensory perception of sound [GO:0007605]	integral component of membrane [GO:0016021]; stereocilium tip [GO:0032426]		GO:0007605; GO:0016021; GO:0032426	sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN9658_c0_g2_i8	Q80ZA4	PKHL1_MOUSE	36.4	802	484	12	2388	19	3225	4012	7.00E-150	532.7	PKHL1_MOUSE	reviewed	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	Pkhd1l1	Mus musculus (Mouse)	4249	integral component of membrane [GO:0016021]; stereocilium tip [GO:0032426]; sensory perception of sound [GO:0007605]	integral component of membrane [GO:0016021]; stereocilium tip [GO:0032426]		GO:0007605; GO:0016021; GO:0032426	sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN4393_c0_g1_i1	Q5ZJP5	FND3A_CHICK	37.5	969	539	20	286	3078	257	1196	1.40E-169	598.6	FND3A_CHICK	reviewed	Fibronectin type-III domain-containing protein 3a	FNDC3A FNDC3 RCJMB04_16k12	Gallus gallus (Chicken)	1198	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4393_c0_g1_i2	Q5ZJP5	FND3A_CHICK	37.6	951	526	20	43	2781	275	1196	2.60E-167	590.9	FND3A_CHICK	reviewed	Fibronectin type-III domain-containing protein 3a	FNDC3A FNDC3 RCJMB04_16k12	Gallus gallus (Chicken)	1198	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN13398_c0_g1_i1	P10079	FBP1_STRPU	54.1	109	50	0	1	327	749	857	1.40E-35	150.2	FBP1_STRPU	reviewed	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	EGF1	Strongylocentrotus purpuratus (Purple sea urchin)	1064	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]	biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579			NA	NA	NA	NA	NA	NA
TRINITY_DN13398_c0_g1_i2	P10079	FBP1_STRPU	53.7	82	38	0	1	246	749	830	4.20E-25	115.5	FBP1_STRPU	reviewed	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	EGF1	Strongylocentrotus purpuratus (Purple sea urchin)	1064	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]	biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579			NA	NA	NA	NA	NA	NA
TRINITY_DN38744_c0_g1_i1	P10079	FBP1_STRPU	51.2	129	62	1	4	387	730	858	9.10E-39	161	FBP1_STRPU	reviewed	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	EGF1	Strongylocentrotus purpuratus (Purple sea urchin)	1064	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]	biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579			NA	NA	NA	NA	NA	NA
TRINITY_DN11607_c0_g1_i5	O42182	FBLN1_DANRE	44.1	254	127	9	59	793	332	579	3.50E-53	210.3	FBLN1_DANRE	reviewed	Fibulin-1 (FIBL-1)	fbln1	Danio rerio (Zebrafish) (Brachydanio rerio)	681	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]; embryonic medial fin morphogenesis [GO:0035122]; extracellular matrix organization [GO:0030198]; mesenchymal cell migration [GO:0090497]; skin morphogenesis [GO:0043589]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]	GO:0005509; GO:0005576; GO:0016504; GO:0030198; GO:0035122; GO:0043589; GO:0090497	embryonic medial fin morphogenesis [GO:0035122]; extracellular matrix organization [GO:0030198]; mesenchymal cell migration [GO:0090497]; skin morphogenesis [GO:0043589]		NA	NA	NA	NA	NA	NA
TRINITY_DN11607_c0_g1_i6	O73775	FBLN1_CHICK	43.2	190	101	5	37	597	309	494	9.10E-41	168.3	FBLN1_CHICK	reviewed	Fibulin-1 (FIBL-1)	FBLN1	Gallus gallus (Chicken)	704	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]; extracellular matrix organization [GO:0030198]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]	GO:0005509; GO:0005576; GO:0016504; GO:0030198	extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN11607_c0_g1_i8	P23142	FBLN1_HUMAN	41.9	203	101	7	37	636	308	496	6.80E-39	162.2	FBLN1_HUMAN	reviewed	Fibulin-1 (FIBL-1)	FBLN1 PP213	Homo sapiens (Human)	703	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; viral process [GO:0016032]"	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016032; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070062; GO:0070373; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647; GO:2001202	"blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30481_c0_g1_i1	O73775	FBLN1_CHICK	44.7	76	41	1	12	239	400	474	3.80E-14	78.6	FBLN1_CHICK	reviewed	Fibulin-1 (FIBL-1)	FBLN1	Gallus gallus (Chicken)	704	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]; extracellular matrix organization [GO:0030198]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]	GO:0005509; GO:0005576; GO:0016504; GO:0030198	extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN11607_c0_g1_i4	P98095	FBLN2_HUMAN	36.9	382	211	12	37	1167	810	1166	3.90E-69	263.5	FBLN2_HUMAN	reviewed	Fibulin-2 (FIBL-2)	FBLN2	Homo sapiens (Human)	1184	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]	calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005576; GO:0010811; GO:0030023; GO:0030198; GO:0031012; GO:0050840; GO:0062023; GO:1903561	extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i10	O70165	FCN1_MOUSE	46.8	216	108	4	744	100	123	332	1.20E-48	195.3	FCN1_MOUSE	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Mus musculus (Mouse)	334	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"		blue	blue	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i21	Q9WTS8	FCN1_RAT	47.9	217	106	4	747	100	123	333	1.50E-51	204.9	FCN1_RAT	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Rattus norvegicus (Rat)	335	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; recognition of apoptotic cell [GO:0043654]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0006956; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0062023; GO:0097367; GO:1902679	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i24	O70165	FCN1_MOUSE	46.8	216	108	4	744	100	123	332	8.40E-49	195.7	FCN1_MOUSE	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Mus musculus (Mouse)	334	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i27	O70165	FCN1_MOUSE	46.8	216	108	4	744	100	123	332	9.60E-49	195.7	FCN1_MOUSE	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Mus musculus (Mouse)	334	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i32	O70165	FCN1_MOUSE	46.3	216	109	4	744	100	123	332	4.50E-48	193.4	FCN1_MOUSE	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Mus musculus (Mouse)	334	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i33	Q9WTS8	FCN1_RAT	49.3	217	103	4	747	100	123	333	9.00E-52	205.7	FCN1_RAT	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Rattus norvegicus (Rat)	335	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; recognition of apoptotic cell [GO:0043654]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0006956; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0062023; GO:0097367; GO:1902679	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; recognition of apoptotic cell [GO:0043654]"		blue	blue	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i52	O70165	FCN1_MOUSE	47.7	216	106	4	744	100	123	332	1.90E-49	198	FCN1_MOUSE	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Mus musculus (Mouse)	334	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19988_c0_g1_i1	O70165	FCN1_MOUSE	48	102	47	4	320	27	126	225	2.00E-20	100.1	FCN1_MOUSE	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	Fcn1 Fcna	Mus musculus (Mouse)	334	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31863_c0_g1_i1	O00602	FCN1_HUMAN	100	98	0	0	1	294	110	207	8.50E-58	223.8	FCN1_HUMAN	reviewed	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	FCN1 FCNM	Homo sapiens (Human)	326	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-8 production [GO:0032757]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006956; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043312; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1904813	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-8 production [GO:0032757]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g1_i5	Q29042	FCN1_PIG	53.3	90	41	1	3	269	206	295	2.60E-21	102.4	FCN1_PIG	reviewed	Ficolin-1 (Ficolin-A) (Ficolin-alpha)	FCN1	Sus scrofa (Pig)	326	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; complement activation, lectin pathway [GO:0001867]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0030246; GO:0046872; GO:0062023; GO:0097367	"complement activation, lectin pathway [GO:0001867]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2054_c0_g1_i2	Q15485	FCN2_HUMAN	59.3	59	23	1	58	234	229	286	1.60E-12	73.2	FCN2_HUMAN	reviewed	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	FCN2 FCNL	Homo sapiens (Human)	313	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:2001065	"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i15	Q15485	FCN2_HUMAN	45.2	219	112	5	747	94	102	313	2.00E-48	194.5	FCN2_HUMAN	reviewed	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	FCN2 FCNL	Homo sapiens (Human)	313	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:2001065	"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i34	Q15485	FCN2_HUMAN	47	219	108	5	747	94	102	313	1.50E-50	201.4	FCN2_HUMAN	reviewed	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	FCN2 FCNL	Homo sapiens (Human)	313	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:2001065	"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i55	Q15485	FCN2_HUMAN	46.1	219	110	5	747	94	102	313	5.00E-50	199.9	FCN2_HUMAN	reviewed	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	FCN2 FCNL	Homo sapiens (Human)	313	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:2001065	"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"		blue	blue	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i57	Q15485	FCN2_HUMAN	45.7	219	111	5	747	94	102	313	5.70E-49	196.4	FCN2_HUMAN	reviewed	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	FCN2 FCNL	Homo sapiens (Human)	313	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:2001065	"complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN632_c1_g1_i1	Q5I2E5	FCN2_BOVIN	40.7	81	46	1	7	249	145	223	2.30E-11	69.3	FCN2_BOVIN	reviewed	Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)	FCN2	Bos taurus (Bovine)	329	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; complement activation, lectin pathway [GO:0001867]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0046872; GO:0062023; GO:0097367	"complement activation, lectin pathway [GO:0001867]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16700_c0_g1_i1	Q5I2E5	FCN2_BOVIN	57.7	52	20	1	203	48	143	192	1.40E-10	67	FCN2_BOVIN	reviewed	Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)	FCN2	Bos taurus (Bovine)	329	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; complement activation, lectin pathway [GO:0001867]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0046872; GO:0062023; GO:0097367	"complement activation, lectin pathway [GO:0001867]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i7	P57756	FCN2_RAT	47.8	92	46	1	1	276	135	224	2.10E-18	92.8	FCN2_RAT	reviewed	Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)	Fcn2 Fcnb	Rattus norvegicus (Rat)	319	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654]"	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6339_c0_g1_i1	Q6PIW4	FIGL1_HUMAN	72.8	195	53	0	605	21	389	583	5.10E-76	285.4	FIGL1_HUMAN	reviewed	Fidgetin-like protein 1 (EC 3.6.4.-)	FIGNL1	Homo sapiens (Human)	674	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]	GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0031122; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243	ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]		NA	NA	NA	NA	NA	NA
TRINITY_DN6339_c0_g1_i2	Q6GX84	FIGL1_RAT	67.1	73	24	0	239	21	514	586	5.30E-21	101.3	FIGL1_RAT	reviewed	Fidgetin-like protein 1 (EC 3.6.4.-)	Fignl1 S30	Rattus norvegicus (Rat)	677	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]	GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0031122; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0071479; GO:2001243	ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]		NA	NA	NA	NA	NA	NA
TRINITY_DN37465_c0_g1_i1	P21333	FLNA_HUMAN	98.6	74	1	0	223	2	2036	2109	1.10E-36	153.3	FLNA_HUMAN	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001664; GO:0002576; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032233; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051607; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37688_c0_g1_i1	Q8BTM8	FLNA_MOUSE	99.2	118	1	0	356	3	1799	1916	4.30E-64	245	FLNA_MOUSE	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	Flna Fln Fln1	Mus musculus (Mouse)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0008134; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048365; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25903_c0_g1_i1	P21333	FLNA_HUMAN	100	97	0	0	345	55	2551	2647	1.80E-51	203	FLNA_HUMAN	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001664; GO:0002576; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032233; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051607; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35416_c0_g1_i1	P21333	FLNA_HUMAN	100	198	0	0	595	2	1963	2160	4.20E-112	405.2	FLNA_HUMAN	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001664; GO:0002576; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032233; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051607; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16035_c0_g1_i1	P21333	FLNA_HUMAN	92.1	164	13	0	492	1	2188	2351	4.40E-83	308.5	FLNA_HUMAN	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001664; GO:0002576; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032233; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051607; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33282_c0_g1_i1	P21333	FLNA_HUMAN	100	142	0	0	427	2	2371	2512	1.00E-80	300.4	FLNA_HUMAN	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001664; GO:0002576; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032233; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051607; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30913_c0_g1_i1	Q8BTM8	FLNA_MOUSE	100	88	0	0	332	69	2560	2647	3.40E-47	188.7	FLNA_MOUSE	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	Flna Fln Fln1	Mus musculus (Mouse)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0008134; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048365; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29648_c0_g1_i1	P21333	FLNA_HUMAN	100	151	0	0	453	1	1806	1956	7.90E-87	320.9	FLNA_HUMAN	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001664; GO:0002576; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0031532; GO:0031852; GO:0032233; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051607; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15479_c0_g1_i1	Q9VEN1	FLNA_DROME	72	82	23	0	247	2	1581	1662	9.10E-29	127.1	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1920_c0_g1_i1	Q9VEN1	FLNA_DROME	66.5	929	295	2	1	2742	1282	2209	0	1324.3	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1920_c0_g1_i2	Q9VEN1	FLNA_DROME	69	751	232	1	2	2254	1460	2209	0	1126.3	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1920_c0_g1_i9	Q9VEN1	FLNA_DROME	55.5	182	66	1	1	501	1282	1463	8.10E-52	204.9	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22388_c0_g1_i1	Q9VEN1	FLNA_DROME	79.7	64	12	1	202	11	68	130	2.60E-21	102.1	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		blue	blue	NA	NA	NA	NA
TRINITY_DN23918_c0_g1_i1	Q9VEN1	FLNA_DROME	35.6	87	50	1	275	535	1618	1698	8.00E-07	55.5	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17858_c0_g1_i1	Q9VEN1	FLNA_DROME	35.4	147	94	1	64	504	896	1041	5.80E-23	109	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16035_c0_g1_i2	O75369	FLNB_HUMAN	100	119	0	0	358	2	2143	2261	1.30E-65	250	FLNB_HUMAN	reviewed	Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP)	FLNB FLN1L FLN3 TABP TAP	Homo sapiens (Human)	2602	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0001725; GO:0003334; GO:0003382; GO:0003723; GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007165; GO:0007519; GO:0015629; GO:0016021; GO:0030018; GO:0030036; GO:0042802; GO:0043005; GO:0043025; GO:0045296; GO:0045335; GO:0070062; GO:0071346	actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN17858_c0_g1_i2	Q8VHX6	FLNC_MOUSE	44.1	68	34	2	39	233	2469	2535	1.50E-09	63.2	FLNC_MOUSE	reviewed	Filamin-C (FLN-C) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)	Flnc Abpl Fln2	Mus musculus (Mouse)	2726	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament-based process [GO:0030029]; muscle fiber development [GO:0048747]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0008092; GO:0015629; GO:0016528; GO:0030018; GO:0030029; GO:0030506; GO:0042383; GO:0042802; GO:0048747	actin filament-based process [GO:0030029]; muscle fiber development [GO:0048747]		NA	NA	NA	NA	NA	NA
TRINITY_DN35962_c0_g1_i1	Q9UM11	FZR1_HUMAN	100	177	0	0	1	531	160	336	6.20E-99	361.3	FZR1_HUMAN	reviewed	Fizzy-related protein homolog (Fzr) (CDC20-like protein 1) (Cdh1/Hct1 homolog) (hCDH1)	FZR1 CDH1 FYR FZR KIAA1242	Homo sapiens (Human)	496	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0007049; GO:0008284; GO:0010997; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0070306; GO:0070979; GO:0072425; GO:0090344; GO:1901990; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN29333_c0_g1_i1	Q9UM11	FZR1_HUMAN	70.9	86	24	1	255	1	153	238	2.70E-28	125.6	FZR1_HUMAN	reviewed	Fizzy-related protein homolog (Fzr) (CDC20-like protein 1) (Cdh1/Hct1 homolog) (hCDH1)	FZR1 CDH1 FYR FZR KIAA1242	Homo sapiens (Human)	496	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0007049; GO:0008284; GO:0010997; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0070306; GO:0070979; GO:0072425; GO:0090344; GO:1901990; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4798_c0_g1_i1	Q9R1K5	FZR1_MOUSE	72.3	495	125	5	1541	87	1	493	4.50E-201	702.2	FZR1_MOUSE	reviewed	Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog)	Fzr1 Fyr Fzr	Mus musculus (Mouse)	493	anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005654; GO:0005680; GO:0006281; GO:0007049; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0070306; GO:0072425; GO:0090344; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN4798_c0_g1_i2	Q9R1K5	FZR1_MOUSE	72.3	495	125	5	1541	87	1	493	3.50E-201	702.6	FZR1_MOUSE	reviewed	Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog)	Fzr1 Fyr Fzr	Mus musculus (Mouse)	493	anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005654; GO:0005680; GO:0006281; GO:0007049; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0070306; GO:0072425; GO:0090344; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN4798_c0_g1_i3	Q9R1K5	FZR1_MOUSE	72.3	495	125	5	1541	87	1	493	3.50E-201	702.6	FZR1_MOUSE	reviewed	Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog)	Fzr1 Fyr Fzr	Mus musculus (Mouse)	493	anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005654; GO:0005680; GO:0006281; GO:0007049; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0070306; GO:0072425; GO:0090344; GO:1904668; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of meiotic nuclear division [GO:0040020]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN26164_c0_g1_i1	P28725	FKBP_STRAQ	74	73	18	1	220	5	50	122	7.10E-25	114	FKBP_STRAQ	reviewed	FK506-binding protein (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	fkbP	Streptomyces anulatus (Streptomyces chrysomallus)	124	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]		peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755			NA	NA	NA	NA	NA	NA
TRINITY_DN780_c0_g1_i2	Q54SR7	FKBP2_DICDI	61.8	68	26	0	44	247	65	132	5.00E-20	98.2	FKBP2_DICDI	reviewed	FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	fkbp2 DDB_G0282267	Dictyostelium discoideum (Slime mold)	133	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]		peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755			NA	NA	NA	NA	NA	NA
TRINITY_DN780_c0_g1_i3	P0CP97	FKBP2_CRYNB	63.3	60	22	0	44	223	66	125	1.90E-15	82.8	FKBP2_CRYNB	reviewed	FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	FPR2 CNBE2370	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	141	endoplasmic reticulum [GO:0005783]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	endoplasmic reticulum [GO:0005783]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005783			blue	blue	NA	NA	NA	NA
TRINITY_DN38377_c0_g1_i1	P0C1J5	FKB2B_RHIO9	64.4	73	26	0	9	227	67	139	4.20E-21	101.7	FKB2B_RHIO9	reviewed	FK506-binding protein 2B (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	FKBP3 fpr3 RO3G_11675	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	209	integral component of membrane [GO:0016021]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	integral component of membrane [GO:0016021]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1767_c0_g1_i1	P0C1J5	FKB2B_RHIO9	53.1	81	34	3	241	2	49	126	6.30E-14	77.8	FKB2B_RHIO9	reviewed	FK506-binding protein 2B (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	FKBP3 fpr3 RO3G_11675	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	209	integral component of membrane [GO:0016021]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	integral component of membrane [GO:0016021]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0016021			red	red	NA	NA	NA	NA
TRINITY_DN780_c0_g1_i1	P0C1J5	FKB2B_RHIO9	67.8	90	29	0	1	270	46	135	1.80E-31	136.3	FKB2B_RHIO9	reviewed	FK506-binding protein 2B (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	FKBP3 fpr3 RO3G_11675	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	209	integral component of membrane [GO:0016021]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	integral component of membrane [GO:0016021]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN33605_c0_g1_i1	P0C1J6	FKBP4_RHIO9	61.4	83	27	3	283	47	300	381	1.50E-19	96.7	FKBP4_RHIO9	reviewed	FK506-binding protein 4 (EC 5.2.1.8) (Histone proline isomerase) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	FKBP4 fpr4 RO3G_04236	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	382	nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN29283_c0_g1_i1	O08437	FKBA_AERHY	64.8	71	25	0	214	2	164	234	3.30E-20	98.6	FKBA_AERHY	reviewed	FKBP-type peptidyl-prolyl cis-trans isomerase FkpA (PPIase) (EC 5.2.1.8) (Rotamase)	fkpA	Aeromonas hydrophila	268	periplasmic space [GO:0042597]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	periplasmic space [GO:0042597]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0006457; GO:0042597	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN36845_c0_g1_i1	P93107	PF20_CHLRE	53.6	112	52	0	1	336	413	524	4.80E-36	151.8	PF20_CHLRE	reviewed	Flagellar WD repeat-containing protein Pf20	PF20	Chlamydomonas reinhardtii (Chlamydomonas smithii)	606	motile cilium [GO:0031514]	motile cilium [GO:0031514]		GO:0031514			NA	NA	NA	NA	NA	NA
TRINITY_DN35892_c0_g1_i1	P52556	BLVRB_BOVIN	31.6	209	122	5	736	119	5	195	8.40E-15	82.4	BLVRB_BOVIN	reviewed	Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)	BLVRB	Bos taurus (Bovine)	206	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0106276; GO:0106277	heme catabolic process [GO:0042167]		NA	NA	NA	NA	NA	NA
TRINITY_DN35892_c0_g1_i2	P52556	BLVRB_BOVIN	31.6	209	122	5	734	117	5	195	8.40E-15	82.4	BLVRB_BOVIN	reviewed	Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)	BLVRB	Bos taurus (Bovine)	206	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0106276; GO:0106277	heme catabolic process [GO:0042167]		NA	NA	NA	NA	NA	NA
TRINITY_DN35892_c0_g1_i3	P52556	BLVRB_BOVIN	31.6	209	122	5	734	117	5	195	8.50E-15	82.4	BLVRB_BOVIN	reviewed	Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)	BLVRB	Bos taurus (Bovine)	206	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0106276; GO:0106277	heme catabolic process [GO:0042167]		NA	NA	NA	NA	NA	NA
TRINITY_DN35892_c0_g1_i4	P52556	BLVRB_BOVIN	31.6	209	122	5	736	119	5	195	8.50E-15	82.4	BLVRB_BOVIN	reviewed	Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)	BLVRB	Bos taurus (Bovine)	206	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0106276; GO:0106277	heme catabolic process [GO:0042167]		NA	NA	NA	NA	NA	NA
TRINITY_DN35892_c0_g1_i6	P52556	BLVRB_BOVIN	33.1	172	99	4	570	64	5	163	1.60E-13	77.8	BLVRB_BOVIN	reviewed	Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)	BLVRB	Bos taurus (Bovine)	206	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0106276; GO:0106277	heme catabolic process [GO:0042167]		NA	NA	NA	NA	NA	NA
TRINITY_DN27062_c0_g1_i1	P30043	BLVRB_HUMAN	44.8	67	36	1	270	73	127	193	4.80E-10	65.1	BLVRB_HUMAN	reviewed	Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)	BLVRB FLR	Homo sapiens (Human)	206	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]	biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0043195; GO:0043231; GO:0070062; GO:0106276; GO:0106277	heme catabolic process [GO:0042167]		blue	blue	NA	NA	NA	NA
TRINITY_DN28015_c0_g1_i1	Q9SXE1	GSOX3_ARATH	35.1	242	145	5	819	121	165	403	1.10E-38	161.8	GSOX3_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX3 (EC 1.14.13.237) (Flavin-monooxygenase glucosinolate S-oxygenase 3)	FMOGS-OX3 At1g62560 T3P18.12	Arabidopsis thaliana (Mouse-ear cress)	462	"integral component of membrane [GO:0016021]; 3-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080102]; 4-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080103]; 5-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080104]; 6-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080105]; 7-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080106]; 8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]"	integral component of membrane [GO:0016021]	"3-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080102]; 4-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080103]; 5-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080104]; 6-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080105]; 7-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080106]; 8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0016021; GO:0019761; GO:0050660; GO:0050661; GO:0080102; GO:0080103; GO:0080104; GO:0080105; GO:0080106; GO:0080107	glucosinolate biosynthetic process [GO:0019761]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i7	A8MRX0	GSOX5_ARATH	49.3	67	28	2	278	93	13	78	1.00E-07	57.4	GSOX5_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX5 (EC 1.14.13.237) (Flavin-monooxygenase glucosinolate S-oxygenase 5)	FMOGS-OX5 At1g12140 T28K15.12	Arabidopsis thaliana (Mouse-ear cress)	459	"8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; floral organ morphogenesis [GO:0048444]; glucosinolate biosynthetic process [GO:0019761]; regulation of hormone biosynthetic process [GO:0046885]; regulation of organ growth [GO:0046620]"		"8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004497; GO:0004499; GO:0019761; GO:0046620; GO:0046885; GO:0048444; GO:0050660; GO:0050661; GO:0080107	floral organ morphogenesis [GO:0048444]; glucosinolate biosynthetic process [GO:0019761]; regulation of hormone biosynthetic process [GO:0046885]; regulation of organ growth [GO:0046620]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i11	Q9FWW6	GSXL1_ARATH	48.1	79	39	2	233	3	247	325	8.90E-12	71.2	GSXL1_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 1 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 1)	At1g12160 T28K15.10	Arabidopsis thaliana (Mouse-ear cress)	468	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]; response to jasmonic acid [GO:0009753]; response to salicylic acid [GO:0009751]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0009751; GO:0009753; GO:0019761; GO:0050660; GO:0050661	glucosinolate biosynthetic process [GO:0019761]; response to jasmonic acid [GO:0009753]; response to salicylic acid [GO:0009751]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i12	Q9FWW9	GSXL2_ARATH	34.5	429	248	10	1485	271	14	433	9.30E-60	232.6	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i14	Q9FWW9	GSXL2_ARATH	34.7	429	247	10	1485	271	14	433	6.80E-61	236.5	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i16	Q9FWW9	GSXL2_ARATH	37.8	365	194	10	1056	34	14	369	5.50E-60	233	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i17	Q9FWW9	GSXL2_ARATH	34.7	429	247	10	1485	271	14	433	6.80E-61	236.5	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i18	Q9FWW9	GSXL2_ARATH	37.8	365	194	10	1056	34	14	369	4.20E-60	233.4	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i19	Q9FWW9	GSXL2_ARATH	34.7	429	247	10	1485	271	14	433	8.90E-61	236.1	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i3	Q9FWW9	GSXL2_ARATH	37.8	365	194	10	1056	34	14	369	7.10E-60	232.6	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i9	Q9FWW9	GSXL2_ARATH	37.5	365	195	10	1056	34	14	369	4.30E-59	229.9	GSXL2_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)	At1g12200 T28K15.7	Arabidopsis thaliana (Mouse-ear cress)	465	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661; GO:0050832	defense response to fungus [GO:0050832]		NA	NA	NA	NA	NA	NA
TRINITY_DN30293_c0_g1_i1	Q94BV5	GSXL4_ARATH	37.8	143	73	4	62	448	13	153	3.60E-15	82.8	GSXL4_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 4 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 4)	At1g62600 T3P18.16	Arabidopsis thaliana (Mouse-ear cress)	452	"vacuole [GO:0005773]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	vacuole [GO:0005773]	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0005773; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i13	Q9FLK4	GSXL8_ARATH	53.7	67	31	0	388	188	174	240	4.70E-13	75.9	GSXL8_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 8 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 8)	At5g61290 MFB13.9	Arabidopsis thaliana (Mouse-ear cress)	461	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i4	Q9FLK4	GSXL8_ARATH	40.5	341	177	11	1074	118	14	350	4.10E-55	216.9	GSXL8_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 8 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 8)	At5g61290 MFB13.9	Arabidopsis thaliana (Mouse-ear cress)	461	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i5	Q9FLK4	GSXL8_ARATH	40.8	341	176	11	1074	118	14	350	1.70E-55	218	GSXL8_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 8 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 8)	At5g61290 MFB13.9	Arabidopsis thaliana (Mouse-ear cress)	461	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i6	Q9FLK4	GSXL8_ARATH	40.5	341	177	11	1074	118	14	350	5.30E-55	216.5	GSXL8_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 8 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 8)	At5g61290 MFB13.9	Arabidopsis thaliana (Mouse-ear cress)	461	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN1353_c0_g1_i8	Q9FLK4	GSXL8_ARATH	40.5	341	177	11	1074	118	14	350	4.10E-55	216.9	GSXL8_ARATH	reviewed	Flavin-containing monooxygenase FMO GS-OX-like 8 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 8)	At5g61290 MFB13.9	Arabidopsis thaliana (Mouse-ear cress)	461	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"		"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004499; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c1_g1_i1	O61491	FLOT1_DROME	56.1	155	68	0	560	96	5	159	1.40E-44	181	FLOT1_DROME	reviewed	Flotillin-1	Flo1 Flo Flo-1 FLODM-1 CG8200	Drosophila melanogaster (Fruit fly)	426	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049	multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c1_g1_i2	O61491	FLOT1_DROME	54.4	206	94	0	623	6	5	210	2.00E-57	223.8	FLOT1_DROME	reviewed	Flotillin-1	Flo1 Flo Flo-1 FLODM-1 CG8200	Drosophila melanogaster (Fruit fly)	426	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049	multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]		NA	NA	NA	NA	NA	NA
TRINITY_DN3120_c0_g1_i1	O61491	FLOT1_DROME	76.3	211	50	0	634	2	1	211	3.30E-87	322.8	FLOT1_DROME	reviewed	Flotillin-1	Flo1 Flo Flo-1 FLODM-1 CG8200	Drosophila melanogaster (Fruit fly)	426	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049	multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]		blue	blue	NA	NA	NA	NA
TRINITY_DN5283_c0_g1_i1	O61491	FLOT1_DROME	48.7	76	39	0	100	327	350	425	3.20E-12	72.8	FLOT1_DROME	reviewed	Flotillin-1	Flo1 Flo Flo-1 FLODM-1 CG8200	Drosophila melanogaster (Fruit fly)	426	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049	multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]		NA	NA	NA	NA	NA	NA
TRINITY_DN534_c0_g1_i1	O61491	FLOT1_DROME	63.6	77	28	0	325	95	350	426	4.60E-19	95.5	FLOT1_DROME	reviewed	Flotillin-1	Flo1 Flo Flo-1 FLODM-1 CG8200	Drosophila melanogaster (Fruit fly)	426	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049	multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]		blue	blue	NA	NA	NA	NA
TRINITY_DN534_c0_g1_i2	O61491	FLOT1_DROME	64.5	76	27	0	288	61	350	425	1.10E-19	97.4	FLOT1_DROME	reviewed	Flotillin-1	Flo1 Flo Flo-1 FLODM-1 CG8200	Drosophila melanogaster (Fruit fly)	426	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]	structural molecule activity [GO:0005198]	GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049	multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090]		blue	blue	NA	NA	NA	NA
TRINITY_DN16705_c0_g1_i1	Q08DN8	FLOT1_BOVIN	100	155	0	0	467	3	25	179	5.10E-81	301.6	FLOT1_BOVIN	reviewed	Flotillin-1	FLOT1	Bos taurus (Bovine)	427	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell contact zone [GO:0044291]; centriolar satellite [GO:0034451]; COP9 signalosome [GO:0008180]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; flotillin complex [GO:0016600]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; uropod [GO:0001931]; protease binding [GO:0002020]; axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to membrane raft [GO:1903044]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell contact zone [GO:0044291]; centriolar satellite [GO:0034451]; COP9 signalosome [GO:0008180]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; flotillin complex [GO:0016600]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; uropod [GO:0001931]	protease binding [GO:0002020]	GO:0001931; GO:0001934; GO:0002020; GO:0002090; GO:0005768; GO:0005769; GO:0005886; GO:0005912; GO:0007409; GO:0008180; GO:0009897; GO:0016323; GO:0016600; GO:0022617; GO:0030027; GO:0030864; GO:0031410; GO:0032092; GO:0032226; GO:0032728; GO:0033227; GO:0034116; GO:0034141; GO:0034451; GO:0034976; GO:0035023; GO:0042383; GO:0042470; GO:0044291; GO:0044854; GO:0045121; GO:0045807; GO:0048643; GO:0050821; GO:0051092; GO:0051580; GO:0060355; GO:0070528; GO:0071360; GO:0072659; GO:0098691; GO:1901741; GO:1901890; GO:1903044; GO:2000049	"axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to membrane raft [GO:1903044]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27735_c0_g1_i1	A6QLR4	FLOT2_BOVIN	72.3	159	44	0	498	22	28	186	2.20E-61	236.5	FLOT2_BOVIN	reviewed	Flotillin-2	FLOT2	Bos taurus (Bovine)	428	cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; protein localization to plasma membrane [GO:0072659]; regulation of myoblast differentiation [GO:0045661]	cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]		GO:0005768; GO:0005886; GO:0007155; GO:0016600; GO:0030139; GO:0031410; GO:0045661; GO:0072659	cell adhesion [GO:0007155]; protein localization to plasma membrane [GO:0072659]; regulation of myoblast differentiation [GO:0045661]		blue	blue	NA	NA	NA	NA
TRINITY_DN35019_c0_g1_i1	Q14254	FLOT2_HUMAN	100	112	0	0	1	336	66	177	1.00E-54	213.8	FLOT2_HUMAN	reviewed	Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1)	FLOT2 ESA1 M17S1	Homo sapiens (Human)	428	acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982]; ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]; anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; membrane raft assembly [GO:0001765]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]	acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982]	ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]	GO:0001765; GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0035255; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0051092; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905	anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; membrane raft assembly [GO:0001765]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]		NA	NA	NA	NA	NA	NA
TRINITY_DN33239_c0_g1_i1	Q9VZW5	FMAR_DROME	54.4	103	46	1	24	329	313	415	3.20E-18	93.6	FMAR_DROME	reviewed	FMRFamide receptor (DFR) (DrmFMRFa-R)	FMRFaR FR CG2114	Drosophila melanogaster (Fruit fly)	549	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; flight behavior [GO:0007629]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0002209; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0007629; GO:0008188; GO:0008344; GO:0008345; GO:0016021; GO:0032226	"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; flight behavior [GO:0007629]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35275_c0_g1_i1	Q9VZW5	FMAR_DROME	52.3	88	42	0	267	4	145	232	1.70E-17	89.7	FMAR_DROME	reviewed	FMRFamide receptor (DFR) (DrmFMRFa-R)	FMRFaR FR CG2114	Drosophila melanogaster (Fruit fly)	549	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; flight behavior [GO:0007629]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0002209; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0007629; GO:0008188; GO:0008344; GO:0008345; GO:0016021; GO:0032226	"adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; flight behavior [GO:0007629]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34799_c0_g1_i1	Q00944	FAK1_CHICK	86.8	91	12	0	317	45	522	612	1.90E-40	166.4	FAK1_CHICK	reviewed	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	PTK2 FAK FAK1	Gallus gallus (Chicken)	1053	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protease binding [GO:0002020]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; innate immune response [GO:0045087]; negative regulation of anoikis [GO:2000811]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of protein autophosphorylation [GO:0031953]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; protein autophosphorylation [GO:0046777]; pyramidal neuron migration [GO:0021852]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; response to muscle stretch [GO:0035994]; response to pH [GO:0009268]; signal complex assembly [GO:0007172]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]	ATP binding [GO:0005524]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protease binding [GO:0002020]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0002020; GO:0004198; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005925; GO:0007015; GO:0007169; GO:0007172; GO:0007173; GO:0008284; GO:0009268; GO:0010812; GO:0021852; GO:0030154; GO:0030155; GO:0031234; GO:0031953; GO:0032092; GO:0035994; GO:0036064; GO:0038083; GO:0042127; GO:0042383; GO:0042802; GO:0043197; GO:0044319; GO:0045087; GO:0046777; GO:0048471; GO:0051894; GO:0060055; GO:0061098; GO:1904237; GO:2000811	"actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; innate immune response [GO:0045087]; negative regulation of anoikis [GO:2000811]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of protein autophosphorylation [GO:0031953]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; protein autophosphorylation [GO:0046777]; pyramidal neuron migration [GO:0021852]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; response to muscle stretch [GO:0035994]; response to pH [GO:0009268]; signal complex assembly [GO:0007172]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40041_c0_g1_i1	Q05397	FAK1_HUMAN	100	92	0	0	276	1	542	633	1.20E-50	199.9	FAK1_HUMAN	reviewed	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	PTK2 FAK FAK1	Homo sapiens (Human)	1052	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; central nervous system neuron axonogenesis [GO:0021955]; detection of muscle stretch [GO:0035995]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; extracellular matrix organization [GO:0030198]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]	GO:0000165; GO:0000226; GO:0001525; GO:0001570; GO:0001725; GO:0001764; GO:0001890; GO:0001932; GO:0001934; GO:0003007; GO:0003779; GO:0004672; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007097; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010594; GO:0010613; GO:0010632; GO:0010759; GO:0010763; GO:0014068; GO:0016324; GO:0018108; GO:0019901; GO:0019903; GO:0021955; GO:0022408; GO:0030010; GO:0030027; GO:0030154; GO:0030155; GO:0030198; GO:0030335; GO:0031234; GO:0033628; GO:0035995; GO:0036064; GO:0038007; GO:0038083; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0043087; GO:0043197; GO:0043231; GO:0043542; GO:0043552; GO:0045087; GO:0045667; GO:0045860; GO:0046621; GO:0046777; GO:0048010; GO:0048013; GO:0048870; GO:0050771; GO:0051493; GO:0051893; GO:0051897; GO:0051964; GO:0060396; GO:0090303; GO:0120041; GO:1900024; GO:2000060; GO:2000811	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; central nervous system neuron axonogenesis [GO:0021955]; detection of muscle stretch [GO:0035995]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; extracellular matrix organization [GO:0030198]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN34799_c0_g1_i2	Q91738	FAK1_XENLA	85.6	125	18	0	375	1	535	659	3.60E-59	228.8	FAK1_XENLA	reviewed	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Protein-tyrosine kinase 2) (pp125FAK)	ptk2 fak1	Xenopus laevis (African clawed frog)	1068	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; multicellular organism development [GO:0007275]; signal complex assembly [GO:0007172]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524; GO:0005737; GO:0005886; GO:0005925; GO:0007172; GO:0007275; GO:0036064	multicellular organism development [GO:0007275]; signal complex assembly [GO:0007172]		NA	NA	NA	NA	NA	NA
TRINITY_DN26165_c0_g1_i1	P35378	FSHR_MOUSE	32.6	92	59	1	1	267	589	680	1.20E-06	53.9	FSHR_MOUSE	reviewed	Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)	Fshr	Mus musculus (Mouse)	692	"cell surface [GO:0009986]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; basement membrane organization [GO:0071711]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular water homeostasis [GO:0009992]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; locomotory behavior [GO:0007626]; male gonad development [GO:0008584]; negative regulation of bone resorption [GO:0045779]; neuron projection development [GO:0031175]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; primary ovarian follicle growth [GO:0001545]; regulation of acetylcholine metabolic process [GO:0060408]; regulation of chromosome organization [GO:0033044]; regulation of hormone metabolic process [GO:0032350]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of MAPK cascade [GO:0043408]; regulation of osteoclast differentiation [GO:0045670]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein phosphorylation [GO:0001932]; regulation of systemic arterial blood pressure [GO:0003073]; Sertoli cell development [GO:0060009]; Sertoli cell proliferation [GO:0060011]; sperm chromatin condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; transcytosis [GO:0045056]; uterus development [GO:0060065]"	cell surface [GO:0009986]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]	GO:0001541; GO:0001545; GO:0001932; GO:0003073; GO:0004963; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007188; GO:0007189; GO:0007190; GO:0007193; GO:0007200; GO:0007283; GO:0007286; GO:0007626; GO:0008528; GO:0008584; GO:0009755; GO:0009986; GO:0009992; GO:0010640; GO:0010738; GO:0014068; GO:0016021; GO:0017046; GO:0022602; GO:0031175; GO:0032350; GO:0033044; GO:0033146; GO:0033148; GO:0035092; GO:0035093; GO:0042699; GO:0043235; GO:0043408; GO:0045056; GO:0045670; GO:0045779; GO:0060009; GO:0060011; GO:0060065; GO:0060408; GO:0070374; GO:0071372; GO:0071711	"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; basement membrane organization [GO:0071711]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular water homeostasis [GO:0009992]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; locomotory behavior [GO:0007626]; male gonad development [GO:0008584]; negative regulation of bone resorption [GO:0045779]; neuron projection development [GO:0031175]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; primary ovarian follicle growth [GO:0001545]; regulation of acetylcholine metabolic process [GO:0060408]; regulation of chromosome organization [GO:0033044]; regulation of hormone metabolic process [GO:0032350]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of MAPK cascade [GO:0043408]; regulation of osteoclast differentiation [GO:0045670]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein phosphorylation [GO:0001932]; regulation of systemic arterial blood pressure [GO:0003073]; Sertoli cell development [GO:0060009]; Sertoli cell proliferation [GO:0060011]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; sperm chromatin condensation [GO:0035092]; transcytosis [GO:0045056]; uterus development [GO:0060065]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21302_c0_g3_i1	Q7ZTV5	FSHR_CAIMO	44.9	89	47	2	263	3	485	573	1.40E-14	80.5	FSHR_CAIMO	reviewed	Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)	FSHR	Cairina moschata (Muscovy duck)	693	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled receptor activity [GO:0004930]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0004963; GO:0005886; GO:0007186; GO:0010738; GO:0014068; GO:0016021; GO:0042699; GO:0043235; GO:0070374; GO:0071372	cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]		NA	NA	NA	NA	NA	NA
TRINITY_DN21302_c0_g3_i2	Q7ZTV5	FSHR_CAIMO	44.9	89	47	2	99	359	485	573	1.40E-14	80.5	FSHR_CAIMO	reviewed	Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)	FSHR	Cairina moschata (Muscovy duck)	693	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled receptor activity [GO:0004930]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0004963; GO:0005886; GO:0007186; GO:0010738; GO:0014068; GO:0016021; GO:0042699; GO:0043235; GO:0070374; GO:0071372	cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]		NA	NA	NA	NA	NA	NA
TRINITY_DN1750_c0_g1_i2	Q5M7Q1	FLCN_XENTR	42.3	310	150	4	72	953	1	297	1.50E-66	256.1	FLCN_XENTR	reviewed	Folliculin	flcn	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	579	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0001932; GO:0001934; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044877; GO:0045785; GO:0045944; GO:0046578; GO:0051898; GO:0070373; GO:0072686; GO:0097009; GO:1900181; GO:1901723; GO:1903444; GO:1904263; GO:2000973; GO:2001170	cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN1750_c0_g1_i4	Q3B7L5	FLCN_BOVIN	32.9	559	266	10	72	1547	1	517	1.00E-78	296.6	FLCN_BOVIN	reviewed	Folliculin	FLCN	Bos taurus (Bovine)	579	cell-cell contact zone [GO:0044291]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]	cell-cell contact zone [GO:0044291]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030496; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044291; GO:0044877; GO:0045785; GO:0045944; GO:0046578; GO:0051898; GO:0070373; GO:0072686; GO:0097009; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1903444; GO:1904263; GO:2000973; GO:2001170; GO:2001244	cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN1750_c0_g1_i5	Q3B7L5	FLCN_BOVIN	33.9	463	216	9	26	1234	85	517	4.10E-66	253.8	FLCN_BOVIN	reviewed	Folliculin	FLCN	Bos taurus (Bovine)	579	cell-cell contact zone [GO:0044291]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]	cell-cell contact zone [GO:0044291]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030496; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044291; GO:0044877; GO:0045785; GO:0045944; GO:0046578; GO:0051898; GO:0070373; GO:0072686; GO:0097009; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1903444; GO:1904263; GO:2000973; GO:2001170; GO:2001244	cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN26073_c0_g1_i1	Q76JQ2	FLCN_RAT	98.8	85	1	0	255	1	118	202	5.50E-45	181	FLCN_RAT	reviewed	Folliculin (Birt-Hogg-Dube syndrome protein homolog)	Flcn Bhd	Rattus norvegicus (Rat)	579	"centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]"	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044877; GO:0045785; GO:0045892; GO:0045944; GO:0046578; GO:0051898; GO:0070373; GO:0072686; GO:0097009; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1903444; GO:1904263; GO:2000973; GO:2001170; GO:2001244	"cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]"		NA	NA	NA	NA	NA	NA
TRINITY_DN882_c2_g1_i5	Q9YHV4	FSTA_DANRE	43.1	51	26	2	314	162	122	169	4.10E-05	49.7	FSTA_DANRE	reviewed	Follistatin-A (FS) (Activin-binding protein) (Follistatin-1) (zFst1)	fsta fst fst1 si:dkey-111k10.2 si:dkeyp-88a5.1	Danio rerio (Zebrafish) (Brachydanio rerio)	322	extracellular region [GO:0005576]; extracellular space [GO:0005615]; activin binding [GO:0048185]; cell differentiation [GO:0030154]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; midbrain development [GO:0030901]; multicellular organism development [GO:0007275]; negative regulation of activin receptor signaling pathway [GO:0032926]; oocyte differentiation [GO:0009994]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	activin binding [GO:0048185]	GO:0005576; GO:0005615; GO:0007275; GO:0009953; GO:0009994; GO:0030154; GO:0030510; GO:0030901; GO:0032926; GO:0043049; GO:0048185; GO:0048263; GO:0048703	cell differentiation [GO:0030154]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; midbrain development [GO:0030901]; multicellular organism development [GO:0007275]; negative regulation of activin receptor signaling pathway [GO:0032926]; oocyte differentiation [GO:0009994]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]		blue	blue	NA	NA	NA	NA
TRINITY_DN2685_c0_g1_i1	O60129	FKH2_SCHPO	59.5	74	30	0	270	49	231	304	2.50E-19	95.9	FKH2_SCHPO	reviewed	Fork head protein homolog 2	fkh2 SPBC16G5.15c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	642	"M/G1 phase-specific MADS box-forkhead transcription factor complex [GO:0097221]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; chromatin remodeling [GO:0006338]; division septum assembly [GO:0000917]; negative regulation of cell cycle switching, mitotic to meiotic cell cycle [GO:0110045]; positive regulation of induction of conjugation with cellular fusion [GO:1900237]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	M/G1 phase-specific MADS box-forkhead transcription factor complex [GO:0097221]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000917; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006338; GO:0006357; GO:0045944; GO:0097221; GO:0110045; GO:1900237	"chromatin remodeling [GO:0006338]; division septum assembly [GO:0000917]; negative regulation of cell cycle switching, mitotic to meiotic cell cycle [GO:0110045]; positive regulation of induction of conjugation with cellular fusion [GO:1900237]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32145_c0_g1_i1	Q61572	FOXC1_MOUSE	100	81	0	0	244	2	58	138	1.30E-43	176.4	FOXC1_MOUSE	reviewed	Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3) (Mesoderm/mesenchyme forkhead 1) (MF-1) (Transcription factor FKH-1)	Foxc1 Fkh1 Fkhl7 Freac3 Mf1	Mus musculus (Mouse)	553	"cytosol [GO:0005829]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to chemokine [GO:1990869]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellum development [GO:0021549]; chemokine-mediated signaling pathway [GO:0070098]; collagen fibril organization [GO:0030199]; embryonic heart tube development [GO:0035050]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; germ cell migration [GO:0008354]; glomerular epithelium development [GO:0072010]; glycosaminoglycan metabolic process [GO:0030203]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lacrimal gland development [GO:0032808]; lymph vessel development [GO:0001945]; maintenance of lens transparency [GO:0036438]; mesenchymal cell development [GO:0014031]; mesenchymal cell differentiation [GO:0048762]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902257]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; paraxial mesoderm formation [GO:0048341]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood vessel diameter [GO:0097746]; regulation of organ growth [GO:0046620]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756]; ureteric bud development [GO:0001657]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"	cytosol [GO:0005829]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001503; GO:0001525; GO:0001541; GO:0001568; GO:0001654; GO:0001657; GO:0001701; GO:0001756; GO:0001822; GO:0001945; GO:0001958; GO:0001974; GO:0003007; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005720; GO:0005829; GO:0006355; GO:0006357; GO:0007219; GO:0007420; GO:0007507; GO:0008134; GO:0008283; GO:0008301; GO:0008354; GO:0009653; GO:0010628; GO:0010718; GO:0014031; GO:0014032; GO:0016477; GO:0016525; GO:0021549; GO:0030154; GO:0030199; GO:0030203; GO:0032808; GO:0035050; GO:0036438; GO:0038084; GO:0042475; GO:0043010; GO:0043388; GO:0043565; GO:0045618; GO:0045893; GO:0045930; GO:0045944; GO:0046620; GO:0048010; GO:0048341; GO:0048762; GO:0048844; GO:0055010; GO:0060038; GO:0070098; GO:0071364; GO:0072010; GO:0097746; GO:1901491; GO:1901534; GO:1902038; GO:1902257; GO:1904798; GO:1990841; GO:1990869	"anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to chemokine [GO:1990869]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellum development [GO:0021549]; chemokine-mediated signaling pathway [GO:0070098]; collagen fibril organization [GO:0030199]; embryonic heart tube development [GO:0035050]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; germ cell migration [GO:0008354]; glomerular epithelium development [GO:0072010]; glycosaminoglycan metabolic process [GO:0030203]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lacrimal gland development [GO:0032808]; lymph vessel development [GO:0001945]; maintenance of lens transparency [GO:0036438]; mesenchymal cell development [GO:0014031]; mesenchymal cell differentiation [GO:0048762]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902257]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; paraxial mesoderm formation [GO:0048341]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of blood vessel diameter [GO:0097746]; regulation of organ growth [GO:0046620]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756]; ureteric bud development [GO:0001657]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38140_c0_g1_i1	Q12946	FOXF1_HUMAN	80.7	83	15	1	1	246	78	160	1.30E-35	149.8	FOXF1_HUMAN	reviewed	Forkhead box protein F1 (Forkhead-related activator 1) (FREAC-1) (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1)	FOXF1 FKHL5 FREAC1	Homo sapiens (Human)	379	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001570; GO:0001701; GO:0001756; GO:0001763; GO:0002053; GO:0003197; GO:0003214; GO:0003677; GO:0005634; GO:0005667; GO:0007224; GO:0007368; GO:0007494; GO:0007507; GO:0010811; GO:0014822; GO:0030198; GO:0030323; GO:0030324; GO:0030335; GO:0031016; GO:0043305; GO:0043565; GO:0045198; GO:0045893; GO:0045944; GO:0048286; GO:0048371; GO:0048557; GO:0048565; GO:0048613; GO:0048617; GO:0050728; GO:0051145; GO:0060426; GO:0060438; GO:0060441; GO:0060461; GO:0060463; GO:0060841; GO:0061030; GO:0071345; GO:0071407; GO:0072189; GO:0090131; GO:0097070; GO:0098609	"blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smoothened signaling pathway [GO:0007224]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1304_c0_g1_i1	Q5NDM2	FXI2A_XENLA	48.6	72	37	0	6	221	132	203	6.60E-14	77.8	FXI2A_XENLA	reviewed	Forkhead box protein I2-A (XlFoxI2-A)	foxi2-a	Xenopus laevis (African clawed frog)	369	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN35729_c0_g1_i1	Q9UPW0	FOXJ3_HUMAN	100	79	0	0	237	1	78	156	1.30E-43	176.4	FOXJ3_HUMAN	reviewed	Forkhead box protein J3	FOXJ3 KIAA1041	Homo sapiens (Human)	622	"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0043565; GO:0045944; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN34863_c0_g2_i1	Q9UPW0	FOXJ3_HUMAN	57.4	68	29	0	12	215	75	142	1.80E-17	89.7	FOXJ3_HUMAN	reviewed	Forkhead box protein J3	FOXJ3 KIAA1041	Homo sapiens (Human)	622	"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0043565; GO:0045944; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN29229_c0_g1_i1	P85037	FOXK1_HUMAN	88.8	89	10	0	3	269	313	401	4.60E-42	171.4	FOXK1_HUMAN	reviewed	Forkhead box protein K1 (Myocyte nuclear factor) (MNF)	FOXK1 MNF	Homo sapiens (Human)	733	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007517; GO:0010507; GO:0010906; GO:0016032; GO:0016579; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837	"canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3024_c0_g1_i1	P85037	FOXK1_HUMAN	62.9	159	57	2	178	651	103	260	1.20E-49	198	FOXK1_HUMAN	reviewed	Forkhead box protein K1 (Myocyte nuclear factor) (MNF)	FOXK1 MNF	Homo sapiens (Human)	733	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007517; GO:0010507; GO:0010906; GO:0016032; GO:0016579; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837	"canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3024_c0_g1_i2	P85037	FOXK1_HUMAN	65.9	85	29	0	178	432	103	187	6.70E-29	128.6	FOXK1_HUMAN	reviewed	Forkhead box protein K1 (Myocyte nuclear factor) (MNF)	FOXK1 MNF	Homo sapiens (Human)	733	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007517; GO:0010507; GO:0010906; GO:0016032; GO:0016579; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837	"canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36600_c0_g1_i1	Q64731	FOXL1_MOUSE	84.3	102	16	0	37	342	45	146	1.10E-48	193.7	FOXL1_MOUSE	reviewed	Forkhead box protein L1 (Forkhead-related protein FKHL11) (Transcription factor FKH-6)	Foxl1 Fkh6 Fkhl11	Mus musculus (Mouse)	336	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007495; GO:0007507; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146	"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25588_c0_g1_i1	O15353	FOXN1_HUMAN	75	68	15	1	207	4	285	350	1.80E-25	115.9	FOXN1_HUMAN	reviewed	Forkhead box protein N1 (Winged-helix transcription factor nude)	FOXN1 RONU WHN	Homo sapiens (Human)	648	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; defense response [GO:0006952]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; keratinocyte differentiation [GO:0030216]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus epithelium morphogenesis [GO:0097536]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000981; GO:0001228; GO:0001942; GO:0002360; GO:0005634; GO:0006357; GO:0006952; GO:0008544; GO:0009887; GO:0030216; GO:0030858; GO:0035878; GO:0043029; GO:0043565; GO:0048514; GO:0051798; GO:0097535; GO:0097536; GO:1902232	animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; defense response [GO:0006952]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; keratinocyte differentiation [GO:0030216]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus epithelium morphogenesis [GO:0097536]		NA	NA	NA	NA	NA	NA
TRINITY_DN25588_c0_g1_i4	O15353	FOXN1_HUMAN	77.9	68	13	1	204	1	286	351	6.00E-26	117.5	FOXN1_HUMAN	reviewed	Forkhead box protein N1 (Winged-helix transcription factor nude)	FOXN1 RONU WHN	Homo sapiens (Human)	648	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; defense response [GO:0006952]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; keratinocyte differentiation [GO:0030216]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus epithelium morphogenesis [GO:0097536]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000981; GO:0001228; GO:0001942; GO:0002360; GO:0005634; GO:0006357; GO:0006952; GO:0008544; GO:0009887; GO:0030216; GO:0030858; GO:0035878; GO:0043029; GO:0043565; GO:0048514; GO:0051798; GO:0097535; GO:0097536; GO:1902232	animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; defense response [GO:0006952]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; keratinocyte differentiation [GO:0030216]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus epithelium morphogenesis [GO:0097536]		NA	NA	NA	NA	NA	NA
TRINITY_DN38561_c0_g1_i1	P32314	FOXN2_HUMAN	98.2	112	2	0	3	338	117	228	5.50E-61	234.6	FOXN2_HUMAN	reviewed	Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor)	FOXN2 HTLF	Homo sapiens (Human)	431	"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; skeletal muscle cell differentiation [GO:0035914]"	intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000981; GO:0003700; GO:0005654; GO:0035914; GO:0043231; GO:1990837	skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1660_c0_g1_i1	Q3BJS3	FOXN3_XENLA	68.8	32	10	0	3	98	182	213	8.20E-08	57.4	FOXN3_XENLA	reviewed	Forkhead box protein N3	foxn3	Xenopus laevis (African clawed frog)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0007049; GO:0043565; GO:0045892	"cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1660_c0_g1_i2	Q28G71	FOXN3_XENTR	52.7	188	52	5	3	554	59	213	4.60E-46	186	FOXN3_XENTR	reviewed	Forkhead box protein N3	foxn3 TGas136a14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	464	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0007049; GO:0043565; GO:0045892	"cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1660_c0_g1_i3	Q28G71	FOXN3_XENTR	52.6	190	53	5	3	566	59	213	4.70E-46	186	FOXN3_XENTR	reviewed	Forkhead box protein N3	foxn3 TGas136a14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	464	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0007049; GO:0043565; GO:0045892	"cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19212_c0_g1_i1	O00409	FOXN3_HUMAN	100	69	0	0	2	208	124	192	2.00E-37	155.6	FOXN3_HUMAN	reviewed	Forkhead box protein N3 (Checkpoint suppressor 1)	FOXN3 C14orf116 CHES1	Homo sapiens (Human)	490	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; sequence-specific DNA binding [GO:0043565]; craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000981; GO:0005634; GO:0007095; GO:0008022; GO:0043565; GO:0045892; GO:0097094	"craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19212_c0_g1_i2	O00409	FOXN3_HUMAN	100	67	0	0	1	201	126	192	3.70E-36	151.4	FOXN3_HUMAN	reviewed	Forkhead box protein N3 (Checkpoint suppressor 1)	FOXN3 C14orf116 CHES1	Homo sapiens (Human)	490	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; sequence-specific DNA binding [GO:0043565]; craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000981; GO:0005634; GO:0007095; GO:0008022; GO:0043565; GO:0045892; GO:0097094	"craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18993_c0_g1_i3	B4NFR1	FOXO_DROWI	71	183	42	5	1	534	103	279	3.20E-63	243.4	FOXO_DROWI	reviewed	Forkhead box protein O	foxo GK22687	Drosophila willistoni (Fruit fly)	628	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627	"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18993_c0_g1_i4	B4MB78	FOXO_DROVI	67.9	134	32	4	407	793	145	272	1.40E-39	165.2	FOXO_DROVI	reviewed	Forkhead box protein O	foxo GJ14344	Drosophila virilis (Fruit fly)	609	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627	"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4207_c0_g1_i1	Q8MJ99	FOXP2_GORGO	68.3	104	20	5	1	291	528	625	3.60E-28	125.6	FOXP2_GORGO	reviewed	Forkhead box protein P2	FOXP2	Gorilla gorilla gorilla (Western lowland gorilla)	713	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; caudate nucleus development [GO:0021757]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; putamen development [GO:0021758]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0021757; GO:0021758; GO:0042803; GO:0045944; GO:0046872	caudate nucleus development [GO:0021757]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; putamen development [GO:0021758]		NA	NA	NA	NA	NA	NA
TRINITY_DN4207_c0_g1_i2	Q8MJ99	FOXP2_GORGO	73.8	103	18	4	1	300	528	624	1.80E-32	140.2	FOXP2_GORGO	reviewed	Forkhead box protein P2	FOXP2	Gorilla gorilla gorilla (Western lowland gorilla)	713	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; caudate nucleus development [GO:0021757]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; putamen development [GO:0021758]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0021757; GO:0021758; GO:0042803; GO:0045944; GO:0046872	caudate nucleus development [GO:0021757]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; putamen development [GO:0021758]		NA	NA	NA	NA	NA	NA
TRINITY_DN32127_c0_g1_i1	P28723	FTHS_SPIOL	79.7	64	13	0	209	18	117	180	3.70E-23	108.2	FTHS_SPIOL	reviewed	Formate--tetrahydrofolate ligase (EC 6.3.4.3) (10-formyletrahydrofolate synthetase) (FHS) (FTHFS) (Formyltetrahydrofolate synthetase)		Spinacia oleracea (Spinach)	637	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; tetrahydrofolate interconversion [GO:0035999]		ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]	GO:0004329; GO:0005524; GO:0035999	tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN9744_c0_g1_i2	O88618	FTCD_RAT	69.7	198	60	0	597	4	78	275	4.90E-77	288.9	FTCD_RAT	reviewed	Formimidoyltransferase-cyclodeaminase (58 kDa microtubule-binding protein) (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]	Ftcd	Rattus norvegicus (Rat)	541	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]	folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]	GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0007010; GO:0008017; GO:0019215; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0030868; GO:0035999	cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN9744_c0_g1_i3	O88618	FTCD_RAT	67.5	126	41	0	381	4	150	275	2.60E-45	183	FTCD_RAT	reviewed	Formimidoyltransferase-cyclodeaminase (58 kDa microtubule-binding protein) (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]	Ftcd	Rattus norvegicus (Rat)	541	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]	folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]	GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0007010; GO:0008017; GO:0019215; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0030868; GO:0035999	cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN9744_c0_g1_i4	O88618	FTCD_RAT	67.5	126	41	0	381	4	150	275	2.00E-45	183.3	FTCD_RAT	reviewed	Formimidoyltransferase-cyclodeaminase (58 kDa microtubule-binding protein) (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]	Ftcd	Rattus norvegicus (Rat)	541	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]	folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]	GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0007010; GO:0008017; GO:0019215; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0030868; GO:0035999	cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN9744_c0_g1_i5	O88618	FTCD_RAT	67.6	275	89	0	828	4	1	275	7.10E-104	378.6	FTCD_RAT	reviewed	Formimidoyltransferase-cyclodeaminase (58 kDa microtubule-binding protein) (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]	Ftcd	Rattus norvegicus (Rat)	541	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]	folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]	GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0007010; GO:0008017; GO:0019215; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0030868; GO:0035999	cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN35397_c0_g1_i1	O88618	FTCD_RAT	49.3	138	70	0	3	416	304	441	1.40E-29	130.6	FTCD_RAT	reviewed	Formimidoyltransferase-cyclodeaminase (58 kDa microtubule-binding protein) (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]	Ftcd	Rattus norvegicus (Rat)	541	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]	folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]	GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0007010; GO:0008017; GO:0019215; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0030868; GO:0035999	cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN21528_c0_g1_i2	Q68DA7	FMN1_HUMAN	42	162	87	3	55	519	1003	1164	5.10E-25	115.9	FMN1_HUMAN	reviewed	Formin-1 (Limb deformity protein homolog)	FMN1 FMN LD	Homo sapiens (Human)	1419	actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124]; actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092]	actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124]	GO:0003779; GO:0005634; GO:0005737; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0010467; GO:0017124; GO:0035136; GO:0035137; GO:0045010; GO:0048705; GO:0051127; GO:0051894; GO:0072092	actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092]		NA	NA	NA	NA	NA	NA
TRINITY_DN28364_c0_g1_i1	Q9VUC6	FRL_DROME	71.9	160	36	1	480	28	72	231	1.00E-58	227.6	FRL_DROME	reviewed	Formin-like protein (Formin related in leukocytes)	Frl CG32138	Drosophila melanogaster (Fruit fly)	1183	cytosol [GO:0005829]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; Rho GTPase binding [GO:0017048]; axon extension [GO:0048675]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; regulation of cell shape [GO:0008360]	cytosol [GO:0005829]	actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; Rho GTPase binding [GO:0017048]	GO:0005829; GO:0008360; GO:0016318; GO:0016319; GO:0016477; GO:0017048; GO:0030866; GO:0048675; GO:0051015; GO:0051020	axon extension [GO:0048675]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN9838_c0_g1_i1	Q9VUC6	FRL_DROME	59.5	220	85	3	2	658	681	897	3.60E-64	246.1	FRL_DROME	reviewed	Formin-like protein (Formin related in leukocytes)	Frl CG32138	Drosophila melanogaster (Fruit fly)	1183	cytosol [GO:0005829]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; Rho GTPase binding [GO:0017048]; axon extension [GO:0048675]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; regulation of cell shape [GO:0008360]	cytosol [GO:0005829]	actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; Rho GTPase binding [GO:0017048]	GO:0005829; GO:0008360; GO:0016318; GO:0016319; GO:0016477; GO:0017048; GO:0030866; GO:0048675; GO:0051015; GO:0051020	axon extension [GO:0048675]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN38903_c0_g1_i1	Q8NBK3	SUMF1_HUMAN	97.4	77	2	0	234	4	210	286	7.30E-44	177.2	SUMF1_HUMAN	reviewed	Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)	SUMF1 PSEC0152 UNQ3037/PRO9852	Homo sapiens (Human)	374	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]	GO:0005783; GO:0005788; GO:0006687; GO:0016491; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135	glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]		NA	NA	NA	NA	NA	NA
TRINITY_DN5842_c0_g1_i1	Q0P5L5	SUMF1_BOVIN	58.7	368	132	3	115	1203	19	371	1.80E-123	444.1	SUMF1_BOVIN	reviewed	Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)	SUMF1	Bos taurus (Bovine)	374	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802]	GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135	post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]		NA	NA	NA	NA	NA	NA
TRINITY_DN14270_c0_g1_i1	Q2KI95	FHL2_BOVIN	58.5	53	22	0	85	243	225	277	4.90E-14	78.2	FHL2_BOVIN	reviewed	Four and a half LIM domains protein 2 (FHL-2)	FHL2	Bos taurus (Bovine)	279	nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]	nucleus [GO:0005634]; Z disc [GO:0030018]	bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885	atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]		NA	NA	NA	NA	NA	NA
TRINITY_DN21940_c0_g1_i1	Q2KI95	FHL2_BOVIN	45.7	94	51	0	3	284	21	114	3.70E-26	118.6	FHL2_BOVIN	reviewed	Four and a half LIM domains protein 2 (FHL-2)	FHL2	Bos taurus (Bovine)	279	nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]	nucleus [GO:0005634]; Z disc [GO:0030018]	bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885	atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]		NA	NA	NA	NA	NA	NA
TRINITY_DN21940_c1_g1_i1	Q2KI95	FHL2_BOVIN	54.5	66	30	0	9	206	118	183	3.20E-19	95.1	FHL2_BOVIN	reviewed	Four and a half LIM domains protein 2 (FHL-2)	FHL2	Bos taurus (Bovine)	279	nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]	nucleus [GO:0005634]; Z disc [GO:0030018]	bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885	atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]		blue	blue	NA	NA	NA	NA
TRINITY_DN568_c0_g2_i1	Q2KI95	FHL2_BOVIN	56	273	120	0	926	108	5	277	4.70E-108	392.5	FHL2_BOVIN	reviewed	Four and a half LIM domains protein 2 (FHL-2)	FHL2	Bos taurus (Bovine)	279	nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]	nucleus [GO:0005634]; Z disc [GO:0030018]	bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885	atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]		blue	blue	NA	NA	NA	NA
TRINITY_DN882_c0_g1_i1	P82968	MCPI_MELCP	43	100	48	3	372	79	1	93	4.20E-14	79.7	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN882_c0_g1_i6	P82968	MCPI_MELCP	43.9	155	71	4	556	98	1	141	5.40E-29	129.8	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			blue	blue	NA	NA	NA	NA
TRINITY_DN882_c0_g1_i9	P82968	MCPI_MELCP	42.6	155	73	4	556	98	1	141	5.00E-28	126.3	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN4545_c0_g1_i1	P82968	MCPI_MELCP	40	110	62	2	347	21	35	141	1.80E-17	90.1	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN8336_c0_g1_i2	P82968	MCPI_MELCP	38.5	148	82	5	72	509	1	141	1.30E-22	107.8	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN168_c0_g1_i3	P82968	MCPI_MELCP	44.1	152	74	5	499	44	1	141	1.50E-31	137.9	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN18730_c0_g1_i1	P82968	MCPI_MELCP	45.7	46	24	1	57	191	97	142	7.90E-06	50.8	MCPI_MELCP	reviewed	Four-domain proteases inhibitor (McaPI)		Melithaea caledonica	197	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			blue	blue	NA	NA	NA	NA
TRINITY_DN14106_c0_g1_i1	Q86VR8	FJX1_HUMAN	35.5	310	162	10	126	1031	118	397	2.00E-35	151.4	FJX1_HUMAN	reviewed	Four-jointed box protein 1 (Four-jointed protein homolog)	FJX1	Homo sapiens (Human)	437	extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]	extracellular space [GO:0005615]		GO:0005615; GO:0007267; GO:0010842	cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN14106_c0_g1_i4	Q86VR8	FJX1_HUMAN	35.5	310	162	10	75	980	118	397	1.90E-35	151.4	FJX1_HUMAN	reviewed	Four-jointed box protein 1 (Four-jointed protein homolog)	FJX1	Homo sapiens (Human)	437	extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]	extracellular space [GO:0005615]		GO:0005615; GO:0007267; GO:0010842	cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN14106_c0_g1_i5	Q86VR8	FJX1_HUMAN	38.2	233	111	7	163	837	190	397	3.60E-27	123.6	FJX1_HUMAN	reviewed	Four-jointed box protein 1 (Four-jointed protein homolog)	FJX1	Homo sapiens (Human)	437	extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]	extracellular space [GO:0005615]		GO:0005615; GO:0007267; GO:0010842	cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN30495_c0_g1_i1	Q16595	FRDA_HUMAN	48.1	133	68	1	478	83	78	210	1.60E-28	127.9	FRDA_HUMAN	reviewed	"Frataxin, mitochondrial (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Cleaved into: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)]"	FXN FRDA X25	Homo sapiens (Human)	210	"cytosol [GO:0005829]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]; small molecule metabolic process [GO:0044281]"	cytosol [GO:0005829]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]"	GO:0004322; GO:0005739; GO:0005759; GO:0005829; GO:0006119; GO:0006783; GO:0006811; GO:0006879; GO:0007005; GO:0007628; GO:0008198; GO:0008199; GO:0008284; GO:0009060; GO:0009792; GO:0010039; GO:0010722; GO:0016226; GO:0016540; GO:0018283; GO:0019230; GO:0030307; GO:0034986; GO:0040015; GO:0043066; GO:0043085; GO:0044281; GO:0046621; GO:0051349; GO:0051537; GO:0070301; GO:0090201; GO:1904231; GO:1904234; GO:1990221	adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]; small molecule metabolic process [GO:0044281]		NA	NA	NA	NA	NA	NA
TRINITY_DN20364_c0_g1_i1	Q29RS8	FLI1_BOVIN	80	50	10	0	230	81	282	331	2.80E-16	85.5	FLI1_BOVIN	reviewed	Friend leukemia integration 1 transcription factor (Proto-oncogene Fli-1)	FLI1	Bos taurus (Bovine)	452	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34814_c0_g1_i1	Q29RS8	FLI1_BOVIN	100	84	0	0	2	253	297	380	1.90E-45	182.6	FLI1_BOVIN	reviewed	Friend leukemia integration 1 transcription factor (Proto-oncogene Fli-1)	FLI1	Bos taurus (Bovine)	452	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN41018_c0_g1_i1	P26323	FLI1_MOUSE	85	80	11	1	4	243	300	378	4.20E-34	144.8	FLI1_MOUSE	reviewed	Friend leukemia integration 1 transcription factor (Retroviral integration site protein Fli-1)	Fli1 Fli-1	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; cellular process [GO:0009987]; megakaryocyte development [GO:0035855]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008015; GO:0009887; GO:0009987; GO:0016604; GO:0030154; GO:0035855; GO:0043565; GO:0045893; GO:0045944; GO:1990837	"animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; cellular process [GO:0009987]; megakaryocyte development [GO:0035855]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i17	Q24760	FRIZ_DROVI	52.9	85	40	0	3	257	17	101	5.10E-14	78.2	FRIZ_DROVI	reviewed	Frizzled (Frizzled-1) (dFz1)	fz GJ11377	Drosophila virilis (Fruit fly)	580	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; establishment or maintenance of cell polarity [GO:0007163]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007163; GO:0007275; GO:0016021; GO:0016055	establishment or maintenance of cell polarity [GO:0007163]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i1	Q9I9M5	FZD1_XENLA	68	125	37	2	105	476	49	171	3.00E-46	186.8	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i10	Q9I9M5	FZD1_XENLA	70.6	51	15	0	582	734	49	99	4.10E-16	86.7	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i14	Q9I9M5	FZD1_XENLA	66.7	129	40	2	77	460	45	171	2.10E-47	190.7	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i19	Q9I9M5	FZD1_XENLA	65.6	131	41	3	107	496	44	171	2.90E-46	186.4	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i20	Q9I9M5	FZD1_XENLA	67.5	126	39	2	107	481	44	168	8.30E-48	191.4	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i8	Q9I9M5	FZD1_XENLA	67.7	124	39	1	77	445	45	168	1.20E-48	194.1	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10272_c0_g1_i9	Q9I9M5	FZD1_XENLA	66.7	129	40	2	77	460	45	171	2.60E-47	189.9	FZD1_XENLA	reviewed	Frizzled-1 (Fz-1) (Xfz1)	fzd1 fz1	Xenopus laevis (African clawed frog)	559	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN26087_c0_g1_i1	Q8BKG4	FZD10_MOUSE	58.5	53	22	0	176	18	66	118	1.80E-12	72.8	FZD10_MOUSE	reviewed	Frizzled-10 (Fz-10) (CD antigen CD350)	Fzd10 Fz10	Mus musculus (Mouse)	582	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; negative regulation of GTPase activity [GO:0034260]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0007275; GO:0009986; GO:0016021; GO:0016055; GO:0017147; GO:0032956; GO:0034260; GO:0038031; GO:0042813; GO:0043507; GO:0043547; GO:0060070	canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; negative regulation of GTPase activity [GO:0034260]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN36040_c0_g1_i1	Q9H461	FZD8_HUMAN	76.3	97	23	0	5	295	51	147	1.00E-42	173.7	FZD8_HUMAN	reviewed	Frizzled-8 (Fz-8) (hFz8)	FZD8	Homo sapiens (Human)	694	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; neuron differentiation [GO:0030182]; positive regulation of JUN kinase activity [GO:0043507]; T cell differentiation in thymus [GO:0033077]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001525; GO:0004930; GO:0005102; GO:0005794; GO:0005886; GO:0016021; GO:0017147; GO:0030165; GO:0030182; GO:0031625; GO:0033077; GO:0042813; GO:0043507; GO:0060070; GO:1990851	angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; neuron differentiation [GO:0030182]; positive regulation of JUN kinase activity [GO:0043507]; T cell differentiation in thymus [GO:0033077]		NA	NA	NA	NA	NA	NA
TRINITY_DN39428_c0_g1_i1	Q9QXD6	F16P1_MOUSE	59.1	115	44	3	345	1	55	166	6.70E-30	131.3	F16P1_MOUSE	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Fructose-1,6-bisphosphatase isozyme 3) (FBPase 3) (Liver FBPase)"	Fbp1 Fbp Fbp3	Mus musculus (Mouse)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]; carbohydrate metabolic process [GO:0005975]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]"	GO:0000122; GO:0001085; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	"carbohydrate metabolic process [GO:0005975]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19004_c1_g1_i1	P00637	F16P1_RABIT	64.5	76	27	0	11	238	153	228	1.10E-20	100.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN19004_c0_g1_i1	P00637	F16P1_RABIT	65.1	83	29	0	3	251	253	335	2.10E-28	126.3	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN36676_c0_g1_i1	P09467	F16P1_HUMAN	100	112	0	0	3	338	70	181	1.50E-58	226.5	F16P1_HUMAN	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Homo sapiens (Human)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]"	GO:0000122; GO:0001085; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0070062; GO:0071286	"cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3155_c0_g1_i2	P09199	F16P1_SHEEP	53.4	58	26	1	489	316	2	58	3.40E-07	56.6	F16P1_SHEEP	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Ovis aries (Sheep)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN3155_c0_g1_i6	P09199	F16P1_SHEEP	54.4	57	25	1	225	55	2	57	1.70E-07	56.6	F16P1_SHEEP	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Ovis aries (Sheep)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN3155_c0_g1_i7	P09199	F16P1_SHEEP	53.4	58	26	1	489	316	2	58	4.50E-07	56.2	F16P1_SHEEP	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Ovis aries (Sheep)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN3155_c0_g1_i8	P09199	F16P1_SHEEP	53.4	58	26	1	446	273	2	58	4.20E-07	56.2	F16P1_SHEEP	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Ovis aries (Sheep)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN1698_c1_g1_i1	P00637	F16P1_RABIT	65.3	331	109	2	103	1080	8	337	1.60E-123	444.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		blue	blue	NA	NA	NA	NA
TRINITY_DN1698_c1_g1_i2	P00637	F16P1_RABIT	65.3	331	109	2	103	1080	8	337	1.60E-123	444.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		blue	blue	NA	NA	NA	NA
TRINITY_DN1698_c1_g1_i4	P00637	F16P1_RABIT	65.3	331	109	2	103	1080	8	337	1.60E-123	444.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN1698_c1_g1_i5	P00637	F16P1_RABIT	65.3	331	109	2	103	1080	8	337	1.60E-123	444.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		blue	blue	NA	NA	NA	NA
TRINITY_DN1698_c1_g1_i6	P00637	F16P1_RABIT	65.3	331	109	2	103	1080	8	337	1.60E-123	444.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		blue	blue	NA	NA	NA	NA
TRINITY_DN1698_c1_g1_i7	P00637	F16P1_RABIT	65.3	331	109	2	103	1080	8	337	1.60E-123	444.1	F16P1_RABIT	reviewed	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Oryctolagus cuniculus (Rabbit)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"	GO:0005737; GO:0005829; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0071286	cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 6-phosphate metabolic process [GO:0006002]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of gluconeogenesis [GO:0006111]		NA	NA	NA	NA	NA	NA
TRINITY_DN20912_c0_g2_i1	B2U8C4	F16PA_RALPJ	95.1	102	5	0	308	3	96	197	4.80E-51	201.4	F16PA_RALPJ	reviewed	"Fructose-1,6-bisphosphatase class 1 (FBPase class 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase class 1)"	fbp Rpic_2266	Ralstonia pickettii (strain 12J)	338	"cytoplasm [GO:0005737]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]; gluconeogenesis [GO:0006094]"	cytoplasm [GO:0005737]	"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0005737; GO:0006094; GO:0042132	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	NA
TRINITY_DN20912_c0_g1_i1	B2U8C4	F16PA_RALPJ	98.9	87	1	0	264	4	225	311	7.90E-47	187.2	F16PA_RALPJ	reviewed	"Fructose-1,6-bisphosphatase class 1 (FBPase class 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase class 1)"	fbp Rpic_2266	Ralstonia pickettii (strain 12J)	338	"cytoplasm [GO:0005737]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]; gluconeogenesis [GO:0006094]"	cytoplasm [GO:0005737]	"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0005737; GO:0006094; GO:0042132	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	NA
TRINITY_DN3155_c0_g1_i3	Q9Z1N1	F16P2_RAT	57.8	83	34	1	251	3	2	83	1.80E-18	93.2	F16P2_RAT	reviewed	"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)"	Fbp2	Rattus norvegicus (Rat)	339	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]"	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28636_c0_g1_i1	Q9XF47	F16P2_MUSAC	64.6	96	27	2	4	276	205	298	1.10E-27	123.6	F16P2_MUSAC	reviewed	"Fructose-1,6-bisphosphatase, cytosolic (FBPase) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase)"	FBPban1	Musa acuminata (Banana) (Musa cavendishii)	341	"cytoplasm [GO:0005737]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]"	cytoplasm [GO:0005737]	"fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]"	GO:0005737; GO:0005975; GO:0042132; GO:0046872	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN30192_c0_g1_i1	P32604	F26_YEAST	54.1	74	33	1	260	39	335	407	7.20E-16	84.3	F26_YEAST	reviewed	"Fructose-2,6-bisphosphatase (EC 3.1.3.46)"	FBP26 YJL155C J0575	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	452	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"	GO:0003873; GO:0004331; GO:0005524; GO:0005737; GO:0005829; GO:0006000; GO:0006003; GO:0006006	"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1026_c0_g1_i1	B1WAX6	TIGAR_XENTR	41.2	153	88	2	462	10	7	159	1.30E-24	114.8	TIGAR_XENTR	reviewed	"Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator)"	tigar	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	275	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; bisphosphoglycerate 2-phosphatase activity [GO:0004083]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA repair [GO:0045739]; regulation of pentose-phosphate shunt [GO:0043456]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"bisphosphoglycerate 2-phosphatase activity [GO:0004083]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"	GO:0004083; GO:0004331; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006003; GO:0006914; GO:0006915; GO:0030388; GO:0043069; GO:0043456; GO:0045739; GO:0045820	"apoptotic process [GO:0006915]; autophagy [GO:0006914]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA repair [GO:0045739]; regulation of pentose-phosphate shunt [GO:0043456]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21507_c0_g1_i1	P07764	ALF_DROME	73.6	87	23	0	262	2	84	170	3.80E-33	141.7	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18959_c0_g1_i2	P07764	ALF_DROME	70.1	67	20	0	105	305	1	67	1.40E-18	93.6	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18959_c0_g1_i3	P07764	ALF_DROME	70.1	67	20	0	94	294	1	67	1.80E-18	93.2	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1179_c0_g1_i5	Q7KQL9	ALF_PLAF7	64.7	102	36	0	2	307	17	118	3.50E-30	132.1	ALF_PLAF7	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	PF14_0425	Plasmodium falciparum (isolate 3D7)	369	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; actin binding [GO:0003779]; fructose-bisphosphate aldolase activity [GO:0004332]; actin polymerization or depolymerization [GO:0008154]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	actin binding [GO:0003779]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0003779; GO:0004332; GO:0005737; GO:0005829; GO:0006096; GO:0008154; GO:0030388	"actin polymerization or depolymerization [GO:0008154]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1179_c0_g1_i6	Q7KQL9	ALF_PLAF7	61.7	128	49	0	2	385	17	144	9.90E-38	157.5	ALF_PLAF7	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	PF14_0425	Plasmodium falciparum (isolate 3D7)	369	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; actin binding [GO:0003779]; fructose-bisphosphate aldolase activity [GO:0004332]; actin polymerization or depolymerization [GO:0008154]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	actin binding [GO:0003779]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0003779; GO:0004332; GO:0005737; GO:0005829; GO:0006096; GO:0008154; GO:0030388	"actin polymerization or depolymerization [GO:0008154]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27717_c0_g1_i1	Q9GP32	ALF_ECHMU	66.7	48	16	0	164	21	69	116	9.20E-12	70.5	ALF_ECHMU	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	FBPA	Echinococcus multilocularis (Fox tapeworm)	363	fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]		fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN12929_c0_g1_i1	P07764	ALF_DROME	79.8	84	17	0	1	252	83	166	1.50E-34	146.4	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13353_c2_g1_i1	P07764	ALF_DROME	73.1	167	44	1	503	3	93	258	8.90E-63	241.1	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13353_c0_g1_i1	P07764	ALF_DROME	81.2	101	19	0	305	3	110	210	1.50E-41	169.9	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19875_c0_g2_i1	P07764	ALF_DROME	62	79	27	2	242	12	275	352	1.80E-16	86.3	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19875_c0_g1_i1	P07764	ALF_DROME	67.9	159	47	3	535	65	191	347	6.50E-48	191.8	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19875_c0_g1_i2	P07764	ALF_DROME	64.6	127	41	3	439	65	223	347	1.70E-33	143.7	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19875_c0_g1_i3	P07764	ALF_DROME	63.7	124	41	3	430	65	226	347	3.80E-30	132.5	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35391_c1_g1_i1	P07764	ALF_DROME	73.1	167	41	3	1	501	199	361	1.00E-57	224.6	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i11	P07764	ALF_DROME	74	365	89	4	1228	140	1	361	9.80E-146	518.1	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i13	P07764	ALF_DROME	74	365	89	4	1228	140	1	361	1.70E-145	517.3	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i2	P07764	ALF_DROME	74.8	365	86	4	1228	140	1	361	6.00E-148	525.4	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	1
TRINITY_DN389_c0_g1_i3	P07764	ALF_DROME	74	365	89	4	1228	140	1	361	1.70E-145	517.3	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i4	P07764	ALF_DROME	80.2	253	49	1	761	3	1	252	1.50E-112	407.1	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i5	P07764	ALF_DROME	75.1	365	85	4	1228	140	1	361	1.20E-148	527.7	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i7	P07764	ALF_DROME	74	365	89	4	1228	140	1	361	1.60E-145	517.3	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i8	P07764	ALF_DROME	74.2	365	88	4	1228	140	1	361	2.60E-146	520	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN389_c0_g1_i9	P07764	ALF_DROME	79.8	253	50	1	761	3	1	252	7.50E-112	404.8	ALF_DROME	reviewed	Fructose-bisphosphate aldolase (EC 4.1.2.13)	Ald1 CG6058	Drosophila melanogaster (Fruit fly)	361	"cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"	cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006096; GO:0007498; GO:0030018; GO:0030388; GO:0031430; GO:0042593	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; mesoderm development [GO:0007498]"		blue	blue	NA	NA	NA	NA
TRINITY_DN12929_c2_g1_i1	P54216	ALF1_CAEEL	68.7	67	21	0	3	203	11	77	6.00E-18	90.9	ALF1_CAEEL	reviewed	Fructose-bisphosphate aldolase 1 (EC 4.1.2.13) (Aldolase CE-1) (CE1)	aldo-1 T05D4.1	Caenorhabditis elegans	366	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear heterochromatin [GO:0005720]; sarcomere [GO:0030017]; striated muscle dense body [GO:0055120]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear heterochromatin [GO:0005720]; sarcomere [GO:0030017]; striated muscle dense body [GO:0055120]	fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]	GO:0004332; GO:0005720; GO:0005737; GO:0005783; GO:0005829; GO:0006096; GO:0030017; GO:0030388; GO:0042802; GO:0055120	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1179_c0_g1_i2	P49577	ALF2_PLABA	64.7	139	49	0	3	419	5	143	2.60E-44	179.5	ALF2_PLABA	reviewed	Fructose-bisphosphate aldolase 2 (ALDO-2) (EC 4.1.2.13)	ALDO2	Plasmodium berghei (strain Anka)	358	fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]		fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN1179_c0_g1_i3	P49577	ALF2_PLABA	63.5	126	46	0	4	381	8	133	2.60E-38	159.5	ALF2_PLABA	reviewed	Fructose-bisphosphate aldolase 2 (ALDO-2) (EC 4.1.2.13)	ALDO2	Plasmodium berghei (strain Anka)	358	fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]		fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i5	Q5N725	ALFC3_ORYSJ	65.2	178	61	1	534	1	159	335	9.90E-60	231.1	ALFC3_ORYSJ	reviewed	"Fructose-bisphosphate aldolase 3, cytoplasmic (EC 4.1.2.13) (Aldolase C-1) (AldC-1)"	FBA3 Os01g0905800 LOC_Os01g67860 B1417F08.1-1	Oryza sativa subsp. japonica (Rice)	358	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i6	Q5N725	ALFC3_ORYSJ	65.7	178	60	1	535	2	159	335	6.90E-61	235	ALFC3_ORYSJ	reviewed	"Fructose-bisphosphate aldolase 3, cytoplasmic (EC 4.1.2.13) (Aldolase C-1) (AldC-1)"	FBA3 Os01g0905800 LOC_Os01g67860 B1417F08.1-1	Oryza sativa subsp. japonica (Rice)	358	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37958_c0_g1_i1	F4KGQ0	ALFC4_ARATH	75.5	53	12	1	83	241	285	336	1.90E-15	82.8	ALFC4_ARATH	reviewed	"Fructose-bisphosphate aldolase 4, cytosolic (AtFBA4) (EC 4.1.2.13) (Cytosolic aldolase 3) (cAld3)"	FBA4 At5g03690 F17C15_110	Arabidopsis thaliana (Mouse-ear cress)	393	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]	GO:0003729; GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i1	F4KGQ0	ALFC4_ARATH	62.8	180	67	0	542	3	189	368	9.80E-60	231.1	ALFC4_ARATH	reviewed	"Fructose-bisphosphate aldolase 4, cytosolic (AtFBA4) (EC 4.1.2.13) (Cytosolic aldolase 3) (cAld3)"	FBA4 At5g03690 F17C15_110	Arabidopsis thaliana (Mouse-ear cress)	393	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]	GO:0003729; GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i2	F4KGQ0	ALFC4_ARATH	62.5	192	72	0	578	3	177	368	1.70E-65	250.4	ALFC4_ARATH	reviewed	"Fructose-bisphosphate aldolase 4, cytosolic (AtFBA4) (EC 4.1.2.13) (Cytosolic aldolase 3) (cAld3)"	FBA4 At5g03690 F17C15_110	Arabidopsis thaliana (Mouse-ear cress)	393	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]	GO:0003729; GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i4	F4KGQ0	ALFC4_ARATH	62.4	194	73	0	583	2	177	370	3.40E-66	252.7	ALFC4_ARATH	reviewed	"Fructose-bisphosphate aldolase 4, cytosolic (AtFBA4) (EC 4.1.2.13) (Cytosolic aldolase 3) (cAld3)"	FBA4 At5g03690 F17C15_110	Arabidopsis thaliana (Mouse-ear cress)	393	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]	GO:0003729; GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i8	F4KGQ0	ALFC4_ARATH	63.6	195	71	0	585	1	176	370	3.40E-66	252.7	ALFC4_ARATH	reviewed	"Fructose-bisphosphate aldolase 4, cytosolic (AtFBA4) (EC 4.1.2.13) (Cytosolic aldolase 3) (cAld3)"	FBA4 At5g03690 F17C15_110	Arabidopsis thaliana (Mouse-ear cress)	393	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]	GO:0003729; GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN322_c0_g1_i9	F4KGQ0	ALFC4_ARATH	63.7	193	70	0	581	3	176	368	3.40E-66	252.7	ALFC4_ARATH	reviewed	"Fructose-bisphosphate aldolase 4, cytosolic (AtFBA4) (EC 4.1.2.13) (Cytosolic aldolase 3) (cAld3)"	FBA4 At5g03690 F17C15_110	Arabidopsis thaliana (Mouse-ear cress)	393	"cytosol [GO:0005829]; fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"	cytosol [GO:0005829]	fructose-bisphosphate aldolase activity [GO:0004332]; mRNA binding [GO:0003729]	GO:0003729; GO:0004332; GO:0005829; GO:0006094; GO:0006096; GO:0030388	"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c0_g3_i1	P05064	ALDOA_MOUSE	99.5	364	2	0	1097	6	1	364	1.80E-209	729.6	ALDOA_MOUSE	reviewed	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Aldolase 1) (Muscle-type aldolase)	Aldoa Aldo1	Mus musculus (Mouse)	364	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm fibrous sheath [GO:0035686]; sperm head [GO:0061827]; Z disc [GO:0030018]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; methylglyoxal biosynthetic process [GO:0019242]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of cell migration [GO:0030335]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm fibrous sheath [GO:0035686]; sperm head [GO:0061827]; Z disc [GO:0030018]	cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; protease binding [GO:0002020]	GO:0002020; GO:0004332; GO:0005615; GO:0005720; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006000; GO:0006096; GO:0006754; GO:0006941; GO:0007339; GO:0008092; GO:0008360; GO:0015629; GO:0016020; GO:0019242; GO:0030018; GO:0030335; GO:0030388; GO:0031430; GO:0032991; GO:0035686; GO:0042802; GO:0043209; GO:0046716; GO:0051289; GO:0061615; GO:0061827; GO:0070061; GO:0070062	"ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; methylglyoxal biosynthetic process [GO:0019242]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of cell migration [GO:0030335]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c0_g2_i1	P04075	ALDOA_HUMAN	100	364	0	0	1104	13	1	364	5.60E-211	734.6	ALDOA_HUMAN	reviewed	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)	ALDOA ALDA	Homo sapiens (Human)	364	"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]"	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]	GO:0002576; GO:0003723; GO:0003779; GO:0004332; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0006000; GO:0006094; GO:0006096; GO:0006754; GO:0006941; GO:0007015; GO:0007339; GO:0008092; GO:0008360; GO:0015629; GO:0015631; GO:0016020; GO:0030388; GO:0031093; GO:0031430; GO:0031674; GO:0034774; GO:0042802; GO:0043312; GO:0045296; GO:0046716; GO:0051289; GO:0061621; GO:0061827; GO:0070061; GO:0070062; GO:1904724; GO:1904813	"actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13353_c1_g1_i1	P53447	ALDOB_SPAAU	70.2	84	25	0	253	2	206	289	5.70E-26	117.9	ALDOB_SPAAU	reviewed	Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase)	aldob	Sparus aurata (Gilthead sea bream)	364	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005737; GO:0005815; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN13353_c1_g1_i2	P53447	ALDOB_SPAAU	64.6	96	34	0	289	2	194	289	3.10E-28	125.6	ALDOB_SPAAU	reviewed	Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase)	aldob	Sparus aurata (Gilthead sea bream)	364	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005737; GO:0005815; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN21669_c1_g1_i1	P52210	ALDOB_SHEEP	66.7	123	40	1	371	3	213	334	5.50E-38	158.3	ALDOB_SHEEP	reviewed	Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase)	ALDOB	Ovis aries (Sheep)	364	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005737; GO:0005815; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c1_g1_i1	P09972	ALDOC_HUMAN	100	151	0	0	453	1	1	151	2.70E-82	305.8	ALDOC_HUMAN	reviewed	Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)	ALDOC ALDC	Homo sapiens (Human)	364	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006094; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0043312; GO:0061621; GO:0070062; GO:1904724; GO:1904813	"canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c1_g2_i1	P09972	ALDOC_HUMAN	92.3	142	11	0	5	430	209	350	1.10E-69	263.8	ALDOC_HUMAN	reviewed	Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)	ALDOC ALDC	Homo sapiens (Human)	364	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006094; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0043312; GO:0061621; GO:0070062; GO:1904724; GO:1904813	"canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c1_g2_i2	P09972	ALDOC_HUMAN	97.7	176	4	0	2	529	175	350	9.90E-97	354	ALDOC_HUMAN	reviewed	Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)	ALDOC ALDC	Homo sapiens (Human)	364	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006094; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0043312; GO:0061621; GO:0070062; GO:1904724; GO:1904813	"canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"		NA	NA	NA	NA	NA	NA
TRINITY_DN389_c1_g2_i3	P09972	ALDOC_HUMAN	97.7	173	4	0	2	520	178	350	2.40E-95	349.4	ALDOC_HUMAN	reviewed	Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)	ALDOC ALDC	Homo sapiens (Human)	364	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006094; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0043312; GO:0061621; GO:0070062; GO:1904724; GO:1904813	"canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35593_c0_g1_i1	Q0P563	FUCM_BOVIN	52.7	148	60	4	18	449	4	145	3.60E-33	142.9	FUCM_BOVIN	reviewed	Fucose mutarotase (EC 5.1.3.29)	FUOM	Bos taurus (Bovine)	153	"fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]"		"fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]"	GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806	fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]		NA	NA	NA	NA	NA	NA
TRINITY_DN37479_c0_g1_i1	O14772	FPGT_HUMAN	43.7	87	42	2	262	2	138	217	7.80E-10	64.3	FPGT_HUMAN	reviewed	Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase)	FPGT GFPP	Homo sapiens (Human)	607	cytoplasm [GO:0005737]; cytosol [GO:0005829]; catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]; fucose metabolic process [GO:0006004]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]	GO:0003824; GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0047341	fucose metabolic process [GO:0006004]		NA	NA	NA	NA	NA	NA
TRINITY_DN27656_c0_g1_i1	O14772	FPGT_HUMAN	37.5	120	73	2	21	377	18	136	2.60E-14	79.7	FPGT_HUMAN	reviewed	Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase)	FPGT GFPP	Homo sapiens (Human)	607	cytoplasm [GO:0005737]; cytosol [GO:0005829]; catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]; fucose metabolic process [GO:0006004]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]	GO:0003824; GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0047341	fucose metabolic process [GO:0006004]		NA	NA	NA	NA	NA	NA
TRINITY_DN4828_c0_g1_i1	G5E8F4	FPGT_MOUSE	29.6	159	92	3	546	130	215	373	3.20E-13	76.6	FPGT_MOUSE	reviewed	Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase)	Fpgt	Mus musculus (Mouse)	590	cytoplasm [GO:0005737]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]	cytoplasm [GO:0005737]	fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0047341			NA	NA	NA	NA	NA	NA
TRINITY_DN29039_c0_g1_i1	Q8XQE8	FUMC_RALSO	95.5	66	3	0	200	3	371	436	8.80E-30	130.2	FUMC_RALSO	reviewed	Fumarate hydratase class II (Fumarase C) (EC 4.2.1.2) (Aerobic fumarase) (Iron-independent fumarase)	fumC RSp1279 RS05324	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	461	tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]	tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0004333; GO:0006099; GO:0006106; GO:0045239	fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN37268_c0_g1_i1	Q8XQE8	FUMC_RALSO	92.7	165	12	0	496	2	72	236	5.30E-84	311.6	FUMC_RALSO	reviewed	Fumarate hydratase class II (Fumarase C) (EC 4.2.1.2) (Aerobic fumarase) (Iron-independent fumarase)	fumC RSp1279 RS05324	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	461	tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]	tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0004333; GO:0006099; GO:0006106; GO:0045239	fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN12601_c0_g1_i1	P28894	FUMC2_BRADU	90.1	71	7	0	214	2	310	380	4.50E-32	137.9	FUMC2_BRADU	reviewed	Fumarate hydratase class II 2 (Fumarase C 2) (EC 4.2.1.2) (Aerobic fumarase 2) (Iron-independent fumarase 2)	fumC2 fumC blr6519	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	473	tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]	tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0004333; GO:0006099; GO:0006106; GO:0006108; GO:0045239	fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN5619_c0_g1_i1	P10173	FUMH_PIG	81.3	107	20	0	2	322	307	413	2.50E-42	172.6	FUMH_PIG	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	FH	Sus scrofa (Pig)	512	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0045239; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN17023_c0_g1_i1	P55250	FUMH_RHIOR	66	103	34	1	1	309	158	259	1.20E-30	133.7	FUMH_RHIOR	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	FUMR	Rhizopus oryzae (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	494	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0004333; GO:0005634; GO:0005739; GO:0005759; GO:0006099; GO:0006106; GO:0006302; GO:0006974; GO:0045239	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17023_c0_g2_i1	P10173	FUMH_PIG	80	115	23	0	349	5	290	404	2.20E-44	179.5	FUMH_PIG	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	FH	Sus scrofa (Pig)	512	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0045239; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN2640_c0_g1_i1	P10173	FUMH_PIG	79.3	468	96	1	1501	98	46	512	3.40E-220	765.8	FUMH_PIG	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	FH	Sus scrofa (Pig)	512	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0045239; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		blue	blue	NA	NA	NA	NA
TRINITY_DN15366_c0_g1_i1	P97807	FUMH_MOUSE	100	172	0	0	536	21	336	507	4.20E-95	348.6	FUMH_MOUSE	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) (EF-3)"	Fh Fh1	Mus musculus (Mouse)	507	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0120162; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN18329_c0_g2_i1	P97807	FUMH_MOUSE	99.4	346	2	0	2	1039	44	389	1.10E-192	673.7	FUMH_MOUSE	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) (EF-3)"	Fh Fh1	Mus musculus (Mouse)	507	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0120162; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN15366_c0_g1_i2	P07954	FUMH_HUMAN	100	80	0	0	260	21	431	510	3.20E-40	165.2	FUMH_HUMAN	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (HsFH) (EC 4.2.1.2)"	FH	Homo sapiens (Human)	510	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0070062; GO:0120162; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN18329_c0_g1_i1	P07954	FUMH_HUMAN	100	162	0	0	2	487	166	327	1.60E-85	316.6	FUMH_HUMAN	reviewed	"Fumarate hydratase, mitochondrial (Fumarase) (HsFH) (EC 4.2.1.2)"	FH	Homo sapiens (Human)	510	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0070062; GO:0120162; GO:2001034	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]		NA	NA	NA	NA	NA	NA
TRINITY_DN9466_c0_g3_i1	Q6H7M1	FAH_ORYSJ	56	75	33	0	229	5	316	390	1.80E-23	109.4	FAH_ORYSJ	reviewed	Fumarylacetoacetase (EC 3.7.1.2) (Fumarylacetoacetate hydrolase)	FAH Os02g0196800 LOC_Os02g10310 OJ1524_D08.17 OsJ_05754	Oryza sativa subsp. japonica (Rice)	429	cytosol [GO:0005829]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; cell death [GO:0008219]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	cytosol [GO:0005829]	fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]	GO:0004334; GO:0005829; GO:0006559; GO:0006572; GO:0008219; GO:0046872; GO:1902000	cell death [GO:0008219]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN30077_c1_g1_i1	P35505	FAAA_MOUSE	68.9	383	119	0	91	1239	2	384	3.10E-162	572.8	FAAA_MOUSE	reviewed	Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)	Fah	Mus musculus (Mouse)	419	fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]	GO:0004334; GO:0006527; GO:0006559; GO:0006572; GO:0046872; GO:1902000	arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN26838_c0_g1_i1	P35505	FAAA_MOUSE	61.8	246	93	1	4	738	115	360	6.60E-91	335.1	FAAA_MOUSE	reviewed	Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)	Fah	Mus musculus (Mouse)	419	fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]	GO:0004334; GO:0006527; GO:0006559; GO:0006572; GO:0046872; GO:1902000	arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN9466_c0_g2_i1	P16930	FAAA_HUMAN	64.1	78	27	1	233	3	108	185	2.10E-22	105.9	FAAA_HUMAN	reviewed	Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)	FAH	Homo sapiens (Human)	419	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]	GO:0004334; GO:0005829; GO:0006527; GO:0006559; GO:0006572; GO:0046872; GO:0070062; GO:1902000	arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN9466_c0_g1_i1	P25093	FAAA_RAT	63.2	106	39	0	322	5	182	287	1.00E-35	150.6	FAAA_RAT	reviewed	Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)	Fah	Rattus norvegicus (Rat)	419	fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]	GO:0004334; GO:0006527; GO:0006559; GO:0006572; GO:0046872; GO:1902000	arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN35979_c0_g1_i1	P16930	FAAA_HUMAN	100	171	0	0	515	3	96	266	4.90E-101	368.2	FAAA_HUMAN	reviewed	Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)	FAH	Homo sapiens (Human)	419	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]	GO:0004334; GO:0005829; GO:0006527; GO:0006559; GO:0006572; GO:0046872; GO:0070062; GO:1902000	arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN21638_c0_g1_i1	D2D3B6	FUMD_SPHMC	46.2	52	28	0	105	260	203	254	1.10E-09	63.9	FUMD_SPHMC	reviewed	Fumonisin B1 esterase (EC 3.1.1.87)	fumD	Sphingopyxis macrogoltabida (Sphingomonas macrogoltabidus)	540	cholinesterase activity [GO:0004104]		cholinesterase activity [GO:0004104]	GO:0004104			NA	NA	NA	NA	NA	NA
TRINITY_DN467_c1_g1_i1	F1N5S9	FUND1_BOVIN	40.1	137	76	2	506	114	19	155	3.00E-23	110.2	FUND1_BOVIN	reviewed	FUN14 domain-containing protein 1	FUNDC1	Bos taurus (Bovine)	155	integral component of mitochondrial outer membrane [GO:0031307]; autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]	integral component of mitochondrial outer membrane [GO:0031307]		GO:0000422; GO:0001666; GO:0031307	autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN467_c1_g1_i2	F1N5S9	FUND1_BOVIN	40.1	137	76	2	506	114	19	155	3.20E-23	110.2	FUND1_BOVIN	reviewed	FUN14 domain-containing protein 1	FUNDC1	Bos taurus (Bovine)	155	integral component of mitochondrial outer membrane [GO:0031307]; autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]	integral component of mitochondrial outer membrane [GO:0031307]		GO:0000422; GO:0001666; GO:0031307	autophagy of mitochondrion [GO:0000422]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN27785_c0_g1_i1	Q9BWH2	FUND2_HUMAN	100	67	0	0	203	3	81	147	3.30E-32	138.3	FUND2_HUMAN	reviewed	FUN14 domain-containing protein 2 (Cervical cancer proto-oncogene 3 protein) (HCC-3) (Hepatitis C virus core-binding protein 6)	FUNDC2 HCBP6 DC44 HCC3 PD03104	Homo sapiens (Human)	189	integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; autophagy of mitochondrion [GO:0000422]	integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0000422; GO:0005634; GO:0005739; GO:0031307	autophagy of mitochondrion [GO:0000422]		NA	NA	NA	NA	NA	NA
TRINITY_DN20581_c0_g1_i1	P09958	FURIN_HUMAN	100	363	0	0	1	1089	109	471	2.40E-214	745.7	FURIN_HUMAN	reviewed	Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	FURIN FUR PACE PCSK3	Homo sapiens (Human)	794	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; blastocyst formation [GO:0001825]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; cornification [GO:0070268]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of endopeptidase activity [GO:0052548]; regulation of lipoprotein lipase activity [GO:0051004]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0000139; GO:0001825; GO:0002020; GO:0004175; GO:0004252; GO:0004867; GO:0005576; GO:0005783; GO:0005796; GO:0005802; GO:0005886; GO:0006465; GO:0007179; GO:0008233; GO:0009966; GO:0009986; GO:0010008; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0019082; GO:0022617; GO:0030140; GO:0030173; GO:0030198; GO:0030574; GO:0031638; GO:0032455; GO:0032804; GO:0032902; GO:0032911; GO:0032940; GO:0042176; GO:0042277; GO:0043043; GO:0044267; GO:0045121; GO:0045714; GO:0046872; GO:0048406; GO:0051004; GO:0051044; GO:0052548; GO:0070062; GO:0070268; GO:0090472; GO:0097341; GO:1901394	blastocyst formation [GO:0001825]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; cornification [GO:0070268]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of endopeptidase activity [GO:0052548]; regulation of lipoprotein lipase activity [GO:0051004]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341]		NA	NA	NA	NA	NA	NA
TRINITY_DN20581_c0_g2_i1	P09958	FURIN_HUMAN	100	91	0	0	276	4	468	558	1.20E-48	193.4	FURIN_HUMAN	reviewed	Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	FURIN FUR PACE PCSK3	Homo sapiens (Human)	794	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; blastocyst formation [GO:0001825]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; cornification [GO:0070268]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of endopeptidase activity [GO:0052548]; regulation of lipoprotein lipase activity [GO:0051004]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0000139; GO:0001825; GO:0002020; GO:0004175; GO:0004252; GO:0004867; GO:0005576; GO:0005783; GO:0005796; GO:0005802; GO:0005886; GO:0006465; GO:0007179; GO:0008233; GO:0009966; GO:0009986; GO:0010008; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0019082; GO:0022617; GO:0030140; GO:0030173; GO:0030198; GO:0030574; GO:0031638; GO:0032455; GO:0032804; GO:0032902; GO:0032911; GO:0032940; GO:0042176; GO:0042277; GO:0043043; GO:0044267; GO:0045121; GO:0045714; GO:0046872; GO:0048406; GO:0051004; GO:0051044; GO:0052548; GO:0070062; GO:0070268; GO:0090472; GO:0097341; GO:1901394	blastocyst formation [GO:0001825]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; cornification [GO:0070268]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of endopeptidase activity [GO:0052548]; regulation of lipoprotein lipase activity [GO:0051004]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341]		NA	NA	NA	NA	NA	NA
TRINITY_DN3312_c0_g1_i1	P29119	FURI1_XENLA	45.9	407	199	7	34	1242	128	517	5.90E-92	339.3	FURI1_XENLA	reviewed	Furin-1 (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	furin	Xenopus laevis (African clawed frog)	783	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; positive regulation of transforming growth factor beta1 activation [GO:1901394]	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0046872; GO:1901394	positive regulation of transforming growth factor beta1 activation [GO:1901394]		NA	NA	NA	NA	NA	NA
TRINITY_DN8080_c1_g1_i1	P30430	FUR1C_DROME	63.8	561	181	5	2216	540	333	873	2.30E-211	736.9	FUR1C_DROME	reviewed	"Furin-like protease 1, isoform 1-CRR (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1)"	Fur1 CG10772	Drosophila melanogaster (Fruit fly)	1101	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	serine-type endopeptidase activity [GO:0004252]	GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688	glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN8080_c1_g1_i3	P30430	FUR1C_DROME	40.6	256	130	5	1301	540	638	873	3.60E-50	200.7	FUR1C_DROME	reviewed	"Furin-like protease 1, isoform 1-CRR (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1)"	Fur1 CG10772	Drosophila melanogaster (Fruit fly)	1101	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	serine-type endopeptidase activity [GO:0004252]	GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688	glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN8080_c1_g1_i2	P26016	FUR11_DROME	80.2	111	22	0	367	35	333	443	5.90E-48	191.4	FUR11_DROME	reviewed	"Furin-like protease 1, isoforms 1/1-X/2 (Furin-1) (EC 3.4.21.75) (Kex2-like endoprotease 1) (dKLIP-1)"	Fur1 CG10772	Drosophila melanogaster (Fruit fly)	1269	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	serine-type endopeptidase activity [GO:0004252]	GO:0001941; GO:0004252; GO:0005802; GO:0005886; GO:0008039; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0097090; GO:0097688	glutamate receptor clustering [GO:0097688]; peptide hormone processing [GO:0016486]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; protein processing [GO:0016485]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN8059_c0_g1_i1	P30432	FUR2_DROME	80.9	356	68	0	9	1076	374	729	3.70E-175	615.5	FUR2_DROME	reviewed	Furin-like protease 2 (Furin-2) (EC 3.4.21.75)	Fur2 CG18734	Drosophila melanogaster (Fruit fly)	1679	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0005886; GO:0016020; GO:0016485; GO:0030173; GO:0045464; GO:0051048	negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]		NA	NA	NA	NA	NA	NA
TRINITY_DN1161_c0_g1_i1	Q6ZV73	FGD6_HUMAN	40.5	242	111	5	389	1093	1215	1430	6.80E-42	172.9	FGD6_HUMAN	reviewed	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	FGD6 KIAA1362 ZFYVE24	Homo sapiens (Human)	1430	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN1161_c0_g1_i4	Q6ZV73	FGD6_HUMAN	43.3	217	85	5	15	641	1066	1252	1.10E-37	158.3	FGD6_HUMAN	reviewed	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	FGD6 KIAA1362 ZFYVE24	Homo sapiens (Human)	1430	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN1161_c0_g1_i5	Q6ZV73	FGD6_HUMAN	40.1	242	112	5	87	791	1215	1430	2.50E-41	170.6	FGD6_HUMAN	reviewed	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	FGD6 KIAA1362 ZFYVE24	Homo sapiens (Human)	1430	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN1161_c0_g1_i7	Q6ZV73	FGD6_HUMAN	39	420	186	9	15	1229	1066	1430	4.30E-69	263.5	FGD6_HUMAN	reviewed	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	FGD6 KIAA1362 ZFYVE24	Homo sapiens (Human)	1430	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN2012_c0_g1_i2	Q9BRR8	GPTC1_HUMAN	34.9	711	336	23	2804	927	7	675	3.80E-86	321.2	GPTC1_HUMAN	reviewed	G patch domain-containing protein 1 (Evolutionarily conserved G-patch domain-containing protein)	GPATCH1 ECGP GPATC1	Homo sapiens (Human)	931	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2012_c0_g1_i1	Q9VUA0	GPTC1_DROME	57	93	39	1	367	92	2	94	5.40E-23	108.6	GPTC1_DROME	reviewed	G patch domain-containing protein 1 homolog	CG8833	Drosophila melanogaster (Fruit fly)	952	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2012_c0_g1_i3	Q9VUA0	GPTC1_DROME	41.4	415	206	13	2805	1660	2	412	7.90E-68	260.4	GPTC1_DROME	reviewed	G patch domain-containing protein 1 homolog	CG8833	Drosophila melanogaster (Fruit fly)	952	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1183_c0_g2_i1	Q6DF57	GPT11_XENTR	42.6	272	136	6	111	902	2	261	1.70E-42	174.9	GPT11_XENTR	reviewed	G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75)	gpatch11 ccdc75	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	261	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]	nucleic acid binding [GO:0003676]	GO:0000776; GO:0000777; GO:0003676			NA	NA	NA	NA	NA	NA
TRINITY_DN4225_c0_g1_i2	Q6PE65	GPT2L_MOUSE	30.9	165	98	5	937	455	230	382	1.40E-06	55.8	GPT2L_MOUSE	reviewed	G patch domain-containing protein 2-like	Gpatch2l Kiaa1152	Mus musculus (Mouse)	482							NA	NA	NA	NA	NA	NA
TRINITY_DN651_c0_g1_i5	P16378	GNAO_DROME	87.4	135	17	0	406	2	197	331	2.60E-66	252.7	GNAO_DROME	reviewed	G protein alpha o subunit (Guanine nucleotide-binding protein G(o) subunit alpha 47A)	Galphao G-oa47A G-oalpha47A CG2204	Drosophila melanogaster (Fruit fly)	354	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; asymmetric cell division [GO:0008356]; axon ensheathment in central nervous system [GO:0032291]; behavioral response to starvation [GO:0042595]; calcium-mediated signaling [GO:0019722]; cell adhesion involved in heart morphogenesis [GO:0061343]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; non-canonical Wnt signaling pathway [GO:0035567]; sensory perception of sweet taste [GO:0050916]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0001737; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007419; GO:0007507; GO:0008356; GO:0019722; GO:0019991; GO:0030866; GO:0031683; GO:0032291; GO:0035567; GO:0042595; GO:0045886; GO:0046872; GO:0050916; GO:0060857; GO:0061343	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; asymmetric cell division [GO:0008356]; axon ensheathment in central nervous system [GO:0032291]; behavioral response to starvation [GO:0042595]; calcium-mediated signaling [GO:0019722]; cell adhesion involved in heart morphogenesis [GO:0061343]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; non-canonical Wnt signaling pathway [GO:0035567]; sensory perception of sweet taste [GO:0050916]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN7107_c0_g1_i4	P48051	KCNJ6_HUMAN	45.7	151	78	2	492	49	95	244	4.90E-36	152.5	KCNJ6_HUMAN	reviewed	"G protein-activated inward rectifier potassium channel 2 (GIRK-2) (BIR1) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6)"	KCNJ6 GIRK2 KATP2 KCNJ7	Homo sapiens (Human)	423	Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]	Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]	GO:0005242; GO:0005794; GO:0005886; GO:0006813; GO:0008076; GO:0015467; GO:0034765; GO:1990573	potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN7107_c0_g1_i2	F1MYR9	KCNJ5_BOVIN	43	158	86	2	564	91	237	390	2.90E-31	136.7	KCNJ5_BOVIN	reviewed	"G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)"	KCNJ5 GIRK4	Bos taurus (Bovine)	419	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]	GO:0005242; GO:0005886; GO:0008076; GO:0015467; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:1990573	membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN7107_c0_g1_i5	F1MYR9	KCNJ5_BOVIN	45.6	307	153	4	993	91	92	390	4.90E-74	279.6	KCNJ5_BOVIN	reviewed	"G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)"	KCNJ5 GIRK4	Bos taurus (Bovine)	419	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]	GO:0005242; GO:0005886; GO:0008076; GO:0015467; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:1990573	membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN7107_c0_g1_i9	F1MYR9	KCNJ5_BOVIN	45.2	321	162	4	1035	91	78	390	3.40E-75	283.5	KCNJ5_BOVIN	reviewed	"G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)"	KCNJ5 GIRK4	Bos taurus (Bovine)	419	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]	GO:0005242; GO:0005886; GO:0008076; GO:0015467; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:1990573	membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN906_c0_g1_i1	P32865	GPRK1_DROME	77.7	229	51	0	3	689	88	316	3.30E-103	375.9	GPRK1_DROME	reviewed	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129	Drosophila melanogaster (Fruit fly)	700	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007603; GO:0016060; GO:0035091; GO:0045880; GO:0050254	"metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN906_c0_g1_i2	P32865	GPRK1_DROME	65	100	35	0	3	302	88	187	5.60E-33	141.7	GPRK1_DROME	reviewed	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129	Drosophila melanogaster (Fruit fly)	700	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007603; GO:0016060; GO:0035091; GO:0045880; GO:0050254	"metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN906_c0_g1_i3	P32865	GPRK1_DROME	60	80	32	0	3	242	88	167	4.30E-21	102.1	GPRK1_DROME	reviewed	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129	Drosophila melanogaster (Fruit fly)	700	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007603; GO:0016060; GO:0035091; GO:0045880; GO:0050254	"metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"		blue	blue	NA	NA	NA	NA
TRINITY_DN906_c0_g1_i4	P32865	GPRK1_DROME	79.5	584	116	1	3	1742	88	671	8.10E-281	967.2	GPRK1_DROME	reviewed	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129	Drosophila melanogaster (Fruit fly)	700	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007603; GO:0016060; GO:0035091; GO:0045880; GO:0050254	"metarhodopsin inactivation [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]"		blue	blue	NA	NA	NA	NA
TRINITY_DN111_c0_g1_i1	P32866	GPRK2_DROME	59.9	666	144	3	1741	113	19	684	3.10E-224	779.2	GPRK2_DROME	reviewed	G protein-coupled receptor kinase 2 (EC 2.7.11.16)	Gprk2 Gprk-2 CG17998	Drosophila melanogaster (Fruit fly)	714	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein serine/threonine kinase activity [GO:0004674]; apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein serine/threonine kinase activity [GO:0004674]	GO:0003384; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0043950; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273	apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN111_c0_g1_i3	P32866	GPRK2_DROME	59.9	666	144	3	1853	225	19	684	4.30E-224	778.9	GPRK2_DROME	reviewed	G protein-coupled receptor kinase 2 (EC 2.7.11.16)	Gprk2 Gprk-2 CG17998	Drosophila melanogaster (Fruit fly)	714	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein serine/threonine kinase activity [GO:0004674]; apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein serine/threonine kinase activity [GO:0004674]	GO:0003384; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0043950; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273	apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31573_c0_g1_i1	Q8VEB1	GRK5_MOUSE	100	91	0	0	275	3	414	504	2.50E-48	192.2	GRK5_MOUSE	reviewed	G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5)	Grk5 Gprk5	Mus musculus (Mouse)	590	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; fat cell differentiation [GO:0045444]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]	GO:0002029; GO:0004674; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006915; GO:0007217; GO:0008277; GO:0008284; GO:0008289; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726; GO:0106072	apoptotic process [GO:0006915]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; fat cell differentiation [GO:0045444]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15159_c0_g1_i1	P43250	GRK6_HUMAN	99.6	280	1	0	3	842	151	430	1.30E-162	573.5	GRK6_HUMAN	reviewed	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	GRK6 GPRK6	Homo sapiens (Human)	576	membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; Wnt signaling pathway [GO:0016055]	membrane [GO:0016020]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0005886; GO:0007186; GO:0008277; GO:0016020; GO:0016055; GO:0047696	G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15159_c0_g1_i2	O70293	GRK6_MOUSE	96.6	89	3	0	3	269	151	239	4.40E-45	181.4	GRK6_MOUSE	reviewed	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	Grk6 Gprk6	Mus musculus (Mouse)	576	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; negative regulation of anion channel activity [GO:0010360]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0010360; GO:0016055; GO:0047696	desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; negative regulation of anion channel activity [GO:0010360]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN39048_c0_g1_i1	O70293	GRK6_MOUSE	100	107	0	0	323	3	307	413	2.10E-57	222.6	GRK6_MOUSE	reviewed	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	Grk6 Gprk6	Mus musculus (Mouse)	576	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; negative regulation of anion channel activity [GO:0010360]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0010360; GO:0016055; GO:0047696	desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; negative regulation of anion channel activity [GO:0010360]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN18141_c0_g1_i1	P43250	GRK6_HUMAN	98.9	95	1	0	1	285	459	553	1.40E-52	206.5	GRK6_HUMAN	reviewed	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	GRK6 GPRK6	Homo sapiens (Human)	576	membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; Wnt signaling pathway [GO:0016055]	membrane [GO:0016020]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0005886; GO:0007186; GO:0008277; GO:0016020; GO:0016055; GO:0047696	G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN28927_c0_g1_i1	Q13569	TDG_HUMAN	100	75	0	0	226	2	143	217	3.20E-41	168.3	TDG_HUMAN	reviewed	G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG)	TDG	Homo sapiens (Human)	410	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]	ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0000122; GO:0000287; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0008134; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0045995; GO:0080111; GO:1902544	"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]"		NA	NA	NA	NA	NA	NA
TRINITY_DN338_c0_g3_i1	Q13569	TDG_HUMAN	57.1	212	84	2	753	139	103	314	7.60E-61	236.9	TDG_HUMAN	reviewed	G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG)	TDG	Homo sapiens (Human)	410	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]	ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0000122; GO:0000287; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0008134; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0045995; GO:0080111; GO:1902544	"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21673_c0_g2_i1	P25322	CCND1_MOUSE	100	126	0	0	379	2	16	141	9.90E-67	253.8	CCND1_MOUSE	reviewed	G1/S-specific cyclin-D1	Ccnd1 Cyl-1	Mus musculus (Mouse)	295	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; proline-rich region binding [GO:0070064]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; endoplasmic reticulum unfolded protein response [GO:0030968]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; lactation [GO:0007595]; Leydig cell differentiation [GO:0033327]; liver regeneration [GO:0097421]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; mitotic cell cycle phase transition [GO:0044772]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to leptin [GO:0044321]; response to magnesium ion [GO:0032026]; response to organonitrogen compound [GO:0010243]; response to UV-A [GO:0070141]; response to vitamin E [GO:0033197]; response to X-ray [GO:0010165]; Wnt signaling pathway [GO:0016055]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; proline-rich region binding [GO:0070064]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000079; GO:0000082; GO:0000122; GO:0000307; GO:0000320; GO:0001934; GO:0003714; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0007595; GO:0008134; GO:0008284; GO:0010039; GO:0010165; GO:0010243; GO:0010971; GO:0016055; GO:0016301; GO:0016538; GO:0017053; GO:0019899; GO:0019901; GO:0030968; GO:0031571; GO:0031965; GO:0032026; GO:0032355; GO:0033197; GO:0033327; GO:0033598; GO:0033601; GO:0042493; GO:0042826; GO:0043627; GO:0044321; GO:0044772; GO:0044877; GO:0045444; GO:0045471; GO:0045737; GO:0051301; GO:0051412; GO:0051592; GO:0051726; GO:0060749; GO:0070064; GO:0070141; GO:0071157; GO:0071310; GO:0097421; GO:1900087; GO:2000045	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; endoplasmic reticulum unfolded protein response [GO:0030968]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; lactation [GO:0007595]; Leydig cell differentiation [GO:0033327]; liver regeneration [GO:0097421]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; mitotic cell cycle phase transition [GO:0044772]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to leptin [GO:0044321]; response to magnesium ion [GO:0032026]; response to organonitrogen compound [GO:0010243]; response to UV-A [GO:0070141]; response to vitamin E [GO:0033197]; response to X-ray [GO:0010165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN33788_c0_g1_i2	P39948	CCND1_RAT	31.4	140	58	3	465	94	176	293	3.60E-08	59.7	CCND1_RAT	reviewed	G1/S-specific cyclin-D1	Ccnd1	Rattus norvegicus (Rat)	295	bicellular tight junction [GO:0005923]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; proline-rich region binding [GO:0070064]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; endoplasmic reticulum unfolded protein response [GO:0030968]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; lactation [GO:0007595]; Leydig cell differentiation [GO:0033327]; liver development [GO:0001889]; liver regeneration [GO:0097421]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; mitotic cell cycle phase transition [GO:0044772]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to iron ion [GO:0010039]; response to leptin [GO:0044321]; response to magnesium ion [GO:0032026]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to steroid hormone [GO:0048545]; response to UV-A [GO:0070141]; response to vitamin E [GO:0033197]; response to X-ray [GO:0010165]; Wnt signaling pathway [GO:0016055]	bicellular tight junction [GO:0005923]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; proline-rich region binding [GO:0070064]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000079; GO:0000082; GO:0000122; GO:0000307; GO:0000320; GO:0001889; GO:0001934; GO:0003714; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005923; GO:0006468; GO:0006974; GO:0007595; GO:0008134; GO:0008284; GO:0010033; GO:0010039; GO:0010165; GO:0010243; GO:0010971; GO:0014070; GO:0016055; GO:0016301; GO:0016538; GO:0017053; GO:0019899; GO:0019901; GO:0030968; GO:0031100; GO:0031571; GO:0031965; GO:0032026; GO:0032355; GO:0033197; GO:0033327; GO:0033598; GO:0033601; GO:0042493; GO:0042826; GO:0043627; GO:0044321; GO:0044772; GO:0044877; GO:0045444; GO:0045471; GO:0045737; GO:0048545; GO:0051301; GO:0051384; GO:0051412; GO:0051592; GO:0051726; GO:0060749; GO:0070064; GO:0070141; GO:0071157; GO:0071310; GO:0097421; GO:1900087; GO:2000045	animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; endoplasmic reticulum unfolded protein response [GO:0030968]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; lactation [GO:0007595]; Leydig cell differentiation [GO:0033327]; liver development [GO:0001889]; liver regeneration [GO:0097421]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; mitotic cell cycle phase transition [GO:0044772]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to iron ion [GO:0010039]; response to leptin [GO:0044321]; response to magnesium ion [GO:0032026]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to steroid hormone [GO:0048545]; response to UV-A [GO:0070141]; response to vitamin E [GO:0033197]; response to X-ray [GO:0010165]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21673_c0_g1_i1	P30279	CCND2_HUMAN	100	133	0	0	400	2	8	140	7.50E-73	274.2	CCND2_HUMAN	reviewed	G1/S-specific cyclin-D2	CCND2	Homo sapiens (Human)	289	chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN12186_c0_g1_i1	Q0P5D3	CCND2_BOVIN	40.6	303	158	4	993	100	2	287	9.70E-51	202.2	CCND2_BOVIN	reviewed	G1/S-specific cyclin-D2	CCND2	Bos taurus (Bovine)	289	cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; adult locomotory behavior [GO:0008344]; cell division [GO:0051301]; cellular response to X-ray [GO:0071481]; long-term memory [GO:0007616]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0007616; GO:0008344; GO:0016020; GO:0016538; GO:0044772; GO:0051301; GO:0071481; GO:0097129; GO:1900087	adult locomotory behavior [GO:0008344]; cell division [GO:0051301]; cellular response to X-ray [GO:0071481]; long-term memory [GO:0007616]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN12186_c0_g1_i2	P30279	CCND2_HUMAN	49	192	95	1	660	85	2	190	7.70E-47	188.7	CCND2_HUMAN	reviewed	G1/S-specific cyclin-D2	CCND2	Homo sapiens (Human)	289	chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN13758_c0_g1_i1	P30282	CCND3_MOUSE	100	118	0	0	354	1	29	146	2.10E-63	242.7	CCND3_MOUSE	reviewed	G1/S-specific cyclin-D3	Ccnd3 Cyl-3	Mus musculus (Mouse)	292	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; hyaluronan biosynthetic process [GO:0030213]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000122; GO:0000307; GO:0001934; GO:0004693; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008284; GO:0016020; GO:0016538; GO:0016604; GO:0019901; GO:0030213; GO:0042098; GO:0042127; GO:0043434; GO:0044772; GO:0045737; GO:0046626; GO:0051301; GO:0051726; GO:1900087	cell division [GO:0051301]; hyaluronan biosynthetic process [GO:0030213]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN27381_c0_g1_i1	P30281	CCND3_HUMAN	100	120	0	0	3	362	27	146	3.30E-64	245.4	CCND3_HUMAN	reviewed	G1/S-specific cyclin-D3	CCND3	Homo sapiens (Human)	292	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000122; GO:0000307; GO:0001934; GO:0004693; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0016538; GO:0016604; GO:0019901; GO:0042098; GO:0042127; GO:0044772; GO:0045737; GO:0046626; GO:0051301; GO:1900087	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN7293_c0_g1_i1	O15995	CCNE_HEMPU	55.2	143	61	2	128	553	83	223	2.80E-38	159.8	CCNE_HEMPU	reviewed	G1/S-specific cyclin-E	CYCE	Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)	424	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]	nucleus [GO:0005634]		GO:0005634; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN33457_c0_g1_i1	O15995	CCNE_HEMPU	38.2	178	98	3	568	35	255	420	5.20E-27	122.5	CCNE_HEMPU	reviewed	G1/S-specific cyclin-E	CYCE	Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)	424	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]	nucleus [GO:0005634]		GO:0005634; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN9050_c0_g1_i2	P24861	CCNA_PATVU	39.1	468	224	7	99	1490	8	418	1.50E-79	298.5	CCNA_PATVU	reviewed	G2/mitotic-specific cyclin-A		Patella vulgata (Common limpet)	426	cell cycle [GO:0007049]; cell division [GO:0051301]			GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN9050_c0_g1_i4	P24861	CCNA_PATVU	38.8	376	169	7	99	1214	8	326	6.00E-55	216.5	CCNA_PATVU	reviewed	G2/mitotic-specific cyclin-A		Patella vulgata (Common limpet)	426	cell cycle [GO:0007049]; cell division [GO:0051301]			GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN9050_c0_g1_i5	P04962	CCNA_SPISO	49.1	226	110	2	295	966	96	318	5.50E-53	209.5	CCNA_SPISO	reviewed	G2/mitotic-specific cyclin-A		Spisula solidissima (Atlantic surf-clam)	422	cell cycle [GO:0007049]; cell division [GO:0051301]			GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN14896_c0_g2_i1	P13952	CCNB_SPISO	58.6	290	119	1	419	1288	139	427	5.00E-89	329.7	CCNB_SPISO	reviewed	G2/mitotic-specific cyclin-B		Spisula solidissima (Atlantic surf-clam)	428	cell cycle [GO:0007049]; cell division [GO:0051301]			GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN14896_c0_g2_i3	P13952	CCNB_SPISO	58.6	290	119	1	396	1265	139	427	4.90E-89	329.7	CCNB_SPISO	reviewed	G2/mitotic-specific cyclin-B		Spisula solidissima (Atlantic surf-clam)	428	cell cycle [GO:0007049]; cell division [GO:0051301]			GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN29961_c0_g1_i1	P14635	CCNB1_HUMAN	100	124	0	0	1	372	171	294	1.20E-64	246.9	CCNB1_HUMAN	reviewed	G2/mitotic-specific cyclin-B1	CCNB1 CCNB	Homo sapiens (Human)	433	"centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]"	centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000079; GO:0000086; GO:0000307; GO:0000922; GO:0000942; GO:0001556; GO:0001701; GO:0001933; GO:0005113; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0006367; GO:0006977; GO:0007052; GO:0007077; GO:0007080; GO:0007283; GO:0009612; GO:0010629; GO:0010971; GO:0016020; GO:0016538; GO:0019901; GO:0031145; GO:0031442; GO:0033129; GO:0042246; GO:0042493; GO:0044389; GO:0044772; GO:0045931; GO:0046680; GO:0048146; GO:0048565; GO:0051301; GO:0051726; GO:0051987; GO:0055015; GO:0060045; GO:0060623; GO:0061575; GO:0065003; GO:0071283; GO:0071398; GO:0071407; GO:0071456; GO:0090266; GO:0097125; GO:1901990; GO:1905448; GO:2000775	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to drug [GO:0042493]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39375_c0_g1_i1	P30276	CCNB2_MOUSE	100	113	0	0	1	339	128	240	5.20E-59	228	CCNB2_MOUSE	reviewed	G2/mitotic-specific cyclin-B2	Ccnb2 Cycb2	Mus musculus (Mouse)	398	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0001701; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0015630; GO:0016020; GO:0016538; GO:0040008; GO:0043029; GO:0044772; GO:0048538; GO:0051301	cell division [GO:0051301]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN14896_c0_g2_i2	Q9IBG0	CCNB2_ORYLA	59.6	57	23	0	60	230	134	190	3.80E-13	75.5	CCNB2_ORYLA	reviewed	G2/mitotic-specific cyclin-B2	ccnb2	Oryzias latipes (Japanese rice fish) (Japanese killifish)	387	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0016538; GO:0044772; GO:0051301	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN1789_c0_g1_i1	P39963	CCNB3_CHICK	52.8	282	132	1	667	1512	108	388	7.20E-82	306.2	CCNB3_CHICK	reviewed	G2/mitotic-specific cyclin-B3	CCNB3 CYCB3	Gallus gallus (Chicken)	403	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0019901; GO:0044772; GO:0051301	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN1789_c0_g1_i2	P39963	CCNB3_CHICK	52	275	131	1	667	1491	108	381	2.10E-78	294.7	CCNB3_CHICK	reviewed	G2/mitotic-specific cyclin-B3	CCNB3 CYCB3	Gallus gallus (Chicken)	403	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0019901; GO:0044772; GO:0051301	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN1789_c0_g1_i3	Q9I7I0	CCNB3_DROME	49.4	340	146	3	517	1500	231	556	3.20E-82	307.4	CCNB3_DROME	reviewed	G2/mitotic-specific cyclin-B3	CycB3 CG5814	Drosophila melanogaster (Fruit fly)	575	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic cytokinesis [GO:0000281]; regulation of chromatin binding [GO:0035561]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; syncytial blastoderm mitotic cell cycle [GO:0035186]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000278; GO:0000281; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0019901; GO:0035186; GO:0035561; GO:0044772	mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic cytokinesis [GO:0000281]; regulation of chromatin binding [GO:0035561]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; syncytial blastoderm mitotic cell cycle [GO:0035186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1789_c0_g1_i5	P39963	CCNB3_CHICK	56.9	181	77	1	646	1188	108	287	7.20E-53	209.5	CCNB3_CHICK	reviewed	G2/mitotic-specific cyclin-B3	CCNB3 CYCB3	Gallus gallus (Chicken)	403	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0019901; GO:0044772; GO:0051301	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN1789_c0_g1_i6	P39963	CCNB3_CHICK	52	275	131	1	646	1470	108	381	2.10E-78	294.7	CCNB3_CHICK	reviewed	G2/mitotic-specific cyclin-B3	CCNB3 CYCB3	Gallus gallus (Chicken)	403	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0019901; GO:0044772; GO:0051301	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN40505_c0_g1_i1	Q1RMI3	GABP1_BOVIN	100	72	0	0	1	216	58	129	9.70E-35	146.7	GABP1_BOVIN	reviewed	GA-binding protein subunit beta-1 (GABP subunit beta-1) (GABPB-1) (GABP subunit beta-2) (GABPB-2)	GABPB1 GABPB2	Bos taurus (Bovine)	383	nucleus [GO:0005634]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0007005; GO:0045944	mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN38095_c0_g1_i1	Q8TAK5	GABP2_HUMAN	62.9	70	26	0	2	211	47	116	3.90E-20	98.2	GABP2_HUMAN	reviewed	GA-binding protein subunit beta-2 (GABP subunit beta-2) (GABPB-2)	GABPB2	Homo sapiens (Human)	448	nucleus [GO:0005634]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN9252_c0_g1_i5	P31821	GAG_FIVT2	40.8	49	28	1	272	126	364	411	4.90E-05	48.9	GAG_FIVT2	reviewed	Gag polyprotein [Cleaved into: Matrix protein p15 (MA); Capsid protein p24 (CA); p1; Nucleocapsid protein p13 (NC)]	gag	Feline immunodeficiency virus (isolate TM2) (FIV)	449	viral nucleocapsid [GO:0019013]; nucleic acid binding [GO:0003676]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; viral budding via host ESCRT complex [GO:0039702]	viral nucleocapsid [GO:0019013]	nucleic acid binding [GO:0003676]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0019013; GO:0039660; GO:0039702	viral budding via host ESCRT complex [GO:0039702]		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c0_g1_i10	Q9TTC1	POL_KORV	27.6	366	237	10	1928	2974	656	1010	3.50E-23	112.8	POL_KORV	reviewed	Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]	pro-pol	Koala retrovirus (KoRV)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c0_g1_i3	Q9TTC1	POL_KORV	27.6	366	237	10	1928	2974	656	1010	2.70E-23	112.8	POL_KORV	reviewed	Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]	pro-pol	Koala retrovirus (KoRV)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN13522_c0_g2_i1	Q9TTC1	POL_KORV	33.1	121	81	0	6	368	890	1010	1.50E-10	67.4	POL_KORV	reviewed	Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]	pro-pol	Koala retrovirus (KoRV)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN13522_c0_g2_i2	Q9TTC1	POL_KORV	33.1	121	81	0	6	368	890	1010	2.50E-10	66.6	POL_KORV	reviewed	Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]	pro-pol	Koala retrovirus (KoRV)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN8011_c0_g2_i5	Q9TTC1	POL_KORV	45.2	62	34	0	3	188	949	1010	2.00E-06	53.9	POL_KORV	reviewed	Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]	pro-pol	Koala retrovirus (KoRV)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN10031_c0_g2_i1	P19560	POL_BIV29	24.6	130	87	4	364	2	613	740	8.10E-05	48.1	POL_BIV29	reviewed	Gag-Pol polyprotein (Pr170Gag-Pol) [Cleaved into: Matrix protein p16 (MA); p2L; Capsid protein p26 (CA); p3; Transframe peptide (p11); Protease (EC 3.4.23.-) (P119) (Retropepsin); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (P72); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Bovine immunodeficiency virus (strain R29) (BIV) (Bovine immunodeficiency-like virus)	1475	host cell [GO:0043657]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exoribonuclease H activity [GO:0004533]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; microtubule-dependent intracellular transport of viral material towards nucleus [GO:0075521]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]	host cell [GO:0043657]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exoribonuclease H activity [GO:0004533]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0006310; GO:0008270; GO:0015074; GO:0019013; GO:0039660; GO:0043657; GO:0044826; GO:0046718; GO:0075521; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; microtubule-dependent intracellular transport of viral material towards nucleus [GO:0075521]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		NA	NA	NA	NA	NA	NA
TRINITY_DN13983_c0_g1_i1	O92815	POL_WDSV	27.3	194	134	4	584	3	1412	1598	9.10E-14	78.6	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN13983_c0_g1_i11	O92815	POL_WDSV	26.2	237	166	6	969	262	1412	1640	2.70E-15	84.3	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN13983_c0_g1_i13	O92815	POL_WDSV	26.2	237	166	6	799	92	1412	1640	2.20E-15	84.3	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN13983_c0_g1_i15	O92815	POL_WDSV	34.8	69	45	0	234	28	1530	1598	4.40E-06	52	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		brown	brown	NA	NA	NA	NA
TRINITY_DN13983_c0_g1_i3	O92815	POL_WDSV	36.5	74	47	0	224	3	1525	1598	2.00E-07	56.2	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN9263_c0_g1_i12	O92815	POL_WDSV	25.5	196	135	4	383	964	1412	1598	2.00E-15	84.7	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN9263_c0_g1_i14	O92815	POL_WDSV	31.8	132	88	2	70	462	1510	1640	1.20E-14	82	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN9263_c0_g1_i15	O92815	POL_WDSV	25.1	239	166	6	383	1090	1412	1640	3.30E-17	91.3	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN9263_c0_g1_i2	O92815	POL_WDSV	27.2	180	126	3	670	1206	1465	1640	1.80E-16	89	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN29105_c0_g1_i1	O92815	POL_WDSV	34.8	92	60	0	307	32	1507	1598	1.50E-11	70.5	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN913_c0_g1_i10	O92815	POL_WDSV	26.4	276	175	8	42	866	1462	1710	3.20E-19	98.6	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN913_c0_g1_i2	O92815	POL_WDSV	26.4	276	175	8	42	866	1462	1710	1.90E-19	98.6	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN913_c0_g1_i3	O92815	POL_WDSV	26.4	276	175	8	42	866	1462	1710	3.20E-19	98.6	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c1_g2_i10	O92815	POL_WDSV	31.2	109	73	2	503	826	1533	1640	2.40E-08	61.2	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c1_g2_i12	O92815	POL_WDSV	29.3	184	124	4	353	901	1462	1640	7.60E-16	86.3	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c1_g2_i12	O92815	POL_WDSV	37.5	56	35	0	171	4	1507	1562	2.70E-05	51.2	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c1_g2_i4	O92815	POL_WDSV	28.8	184	125	4	218	766	1462	1640	1.50E-15	85.1	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c1_g2_i7	O92815	POL_WDSV	28.8	184	125	4	218	766	1462	1640	3.00E-16	87.4	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c1_g2_i9	O92815	POL_WDSV	31.9	138	92	2	519	929	1504	1640	6.60E-15	83.2	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN31042_c0_g1_i1	O92815	POL_WDSV	33	88	58	1	59	319	1506	1593	1.10E-08	60.8	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN35659_c0_g1_i1	O92815	POL_WDSV	30.6	111	74	2	377	54	1483	1593	2.20E-06	53.5	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN35659_c0_g1_i3	O92815	POL_WDSV	30.6	111	74	2	377	54	1483	1593	2.80E-06	53.1	POL_WDSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p10 (MA); p20; Capsid protein p25 (CA); Nucleocapsid protein p14 (NC-pol); Protease p15 (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H p90 (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase p46 (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	gag-pol	Walleye dermal sarcoma virus (WDSV)	1752	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039660	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i12	P03359	POL_WMSV	33.1	127	82	2	582	202	954	1077	1.40E-06	54.7	POL_WMSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p80); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p46)]	pol	Woolly monkey sarcoma virus (WMSV) (Smian sarcoma-associated virus)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i3	P03359	POL_WMSV	38.5	78	48	0	1858	2091	933	1010	6.20E-07	57.8	POL_WMSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p80); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p46)]	pol	Woolly monkey sarcoma virus (WMSV) (Smian sarcoma-associated virus)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i3	P03359	POL_WMSV	31.1	148	99	2	1892	1449	933	1077	8.10E-07	57.4	POL_WMSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p80); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p46)]	pol	Woolly monkey sarcoma virus (WMSV) (Smian sarcoma-associated virus)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN7639_c0_g1_i11	P03359	POL_WMSV	40.3	72	43	0	270	485	939	1010	5.40E-07	55.8	POL_WMSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p80); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p46)]	pol	Woolly monkey sarcoma virus (WMSV) (Smian sarcoma-associated virus)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN7639_c0_g1_i11	P03359	POL_WMSV	35.9	92	55	1	358	95	912	1003	1.60E-06	54.3	POL_WMSV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p80); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p46)]	pol	Woolly monkey sarcoma virus (WMSV) (Smian sarcoma-associated virus)	1687	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN7337_c0_g1_i17	P10273	POL_FLV	36.5	96	59	2	378	97	1446	1541	6.60E-10	65.1	POL_FLV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15; RNA-binding phosphoprotein p12 (pp12); Capsid protein p30; Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	pol	Feline leukemia virus	1712	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN7337_c0_g1_i7	P10273	POL_FLV	36.5	96	59	2	360	79	1446	1541	4.80E-10	65.5	POL_FLV	reviewed	Gag-Pol polyprotein [Cleaved into: Matrix protein p15; RNA-binding phosphoprotein p12 (pp12); Capsid protein p30; Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	pol	Feline leukemia virus	1712	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN25924_c0_g1_i1	P03360	POL_AVIRE	33.7	83	55	0	249	1	321	403	3.60E-08	58.9	POL_AVIRE	reviewed	Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)	pol	Avian reticuloendotheliosis virus	1152	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		NA	NA	NA	NA	NA	NA
TRINITY_DN12591_c0_g1_i8	P25059	POL_BLVAU	32.4	71	48	0	137	349	1224	1294	1.00E-05	51.2	POL_BLVAU	reviewed	Gag-Pro-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); Capsid protein p24 (CA); Nucleocapsid protein p12-pro; Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	pol	Bovine leukemia virus (isolate Australian) (BLV)	1416	viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral budding via host ESCRT complex [GO:0039702]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]	viral nucleocapsid [GO:0019013]	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0019013; GO:0039660; GO:0039702; GO:0044826; GO:0046718; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral budding via host ESCRT complex [GO:0039702]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		NA	NA	NA	NA	NA	NA
TRINITY_DN26760_c0_g1_i1	Q8K157	GALM_MOUSE	50	76	37	1	230	3	242	316	2.40E-15	82.4	GALM_MOUSE	reviewed	Galactose mutarotase (EC 5.1.3.3) (Aldose 1-epimerase)	Galm	Mus musculus (Mouse)	342	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]	GO:0004034; GO:0005737; GO:0005975; GO:0006006; GO:0006012; GO:0030246; GO:0033499	carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN12127_c3_g1_i1	Q9GKX6	GALM_PIG	45.8	354	178	8	158	1216	1	341	4.00E-83	310.1	GALM_PIG	reviewed	Galactose mutarotase (EC 5.1.3.3) (Aldose 1-epimerase)	GALM	Sus scrofa (Pig)	342	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]	GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]		blue	blue	NA	NA	NA	NA
TRINITY_DN34073_c0_g1_i1	Q96C23	GALM_HUMAN	100	119	0	0	359	3	92	210	2.10E-66	252.7	GALM_HUMAN	reviewed	Galactose mutarotase (EC 5.1.3.3) (Aldose 1-epimerase)	GALM BLOCK25	Homo sapiens (Human)	342	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]	GO:0004034; GO:0005737; GO:0005975; GO:0006006; GO:0006012; GO:0030246; GO:0033499; GO:0070062	carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN40740_c0_g1_i1	P07902	GALT_HUMAN	100	76	0	0	230	3	208	283	5.90E-38	157.5	GALT_HUMAN	reviewed	Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)	GALT	Homo sapiens (Human)	379	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0019388; GO:0033499	galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]		NA	NA	NA	NA	NA	NA
TRINITY_DN12531_c0_g1_i1	P07902	GALT_HUMAN	60.7	285	111	1	867	13	23	306	1.60E-104	380.6	GALT_HUMAN	reviewed	Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)	GALT	Homo sapiens (Human)	379	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0019388; GO:0033499	galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]		NA	NA	NA	NA	NA	NA
TRINITY_DN21881_c0_g2_i1	P07902	GALT_HUMAN	100	74	0	0	3	224	141	214	1.50E-38	159.5	GALT_HUMAN	reviewed	Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)	GALT	Homo sapiens (Human)	379	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0019388; GO:0033499	galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]		NA	NA	NA	NA	NA	NA
TRINITY_DN21881_c0_g1_i1	P07902	GALT_HUMAN	94.7	76	4	0	2	229	52	127	4.10E-39	161.4	GALT_HUMAN	reviewed	Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)	GALT	Homo sapiens (Human)	379	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0019388; GO:0033499	galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]		NA	NA	NA	NA	NA	NA
TRINITY_DN5905_c0_g1_i1	Q96A11	G3ST3_HUMAN	32.5	381	211	14	1100	51	37	402	9.40E-36	152.5	G3ST3_HUMAN	reviewed	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GAL3ST3	Homo sapiens (Human)	431	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]	GO:0001733; GO:0005996; GO:0006790; GO:0008146; GO:0009247; GO:0009311; GO:0016021; GO:0030166; GO:0030246; GO:0030309; GO:0032580; GO:0050656; GO:0050694; GO:0050698	glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN36656_c0_g1_i1	P0AEP2	GALP_ECOL6	24.9	177	130	2	571	50	169	345	7.00E-09	62.4	GALP_ECOL6	reviewed	Galactose-proton symporter (Galactose transporter)	galP c3529	Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	symporter activity [GO:0015293]	GO:0005886; GO:0008643; GO:0015293; GO:0016021	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN2074_c0_g1_i1	Q9JHE4	G3ST1_MOUSE	31.8	277	157	8	841	68	19	282	1.10E-26	122.1	G3ST1_MOUSE	reviewed	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	Gal3st1 Cst Gcst	Mus musculus (Mouse)	423	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0008146; GO:0009247; GO:0016021; GO:0042552; GO:0046486; GO:0050694	galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN2074_c0_g1_i2	Q9JHE4	G3ST1_MOUSE	31.8	277	157	8	841	68	19	282	1.10E-26	122.1	G3ST1_MOUSE	reviewed	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	Gal3st1 Cst Gcst	Mus musculus (Mouse)	423	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0008146; GO:0009247; GO:0016021; GO:0042552; GO:0046486; GO:0050694	galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN38325_c0_g1_i1	Q9JHE4	G3ST1_MOUSE	43.1	65	37	0	196	2	251	315	7.50E-07	54.3	G3ST1_MOUSE	reviewed	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	Gal3st1 Cst Gcst	Mus musculus (Mouse)	423	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0008146; GO:0009247; GO:0016021; GO:0042552; GO:0046486; GO:0050694	galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN5905_c0_g1_i9	A6QNK1	G3ST1_BOVIN	33.2	187	110	4	599	81	216	401	1.00E-14	82	G3ST1_BOVIN	reviewed	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	GAL3ST1	Bos taurus (Bovine)	423	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0008146; GO:0016021; GO:0042552; GO:0046486; GO:0050694	galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN36216_c0_g1_i1	Q9P2W7	B3GA1_HUMAN	53.5	258	111	3	850	86	83	334	2.10E-72	273.9	B3GA1_HUMAN	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P)"	B3GAT1 GLCATP	Homo sapiens (Human)	334	"endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; carbohydrate metabolic process [GO:0005975]; cellular response to hypoxia [GO:0071456]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; protein glycosylation [GO:0006486]"	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	"galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0005576; GO:0005789; GO:0005975; GO:0006486; GO:0008499; GO:0015018; GO:0016021; GO:0030203; GO:0043231; GO:0046872; GO:0050650; GO:0071456	carbohydrate metabolic process [GO:0005975]; cellular response to hypoxia [GO:0071456]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN32567_c0_g1_i1	O94766	B3GA3_HUMAN	100	57	0	0	206	36	279	335	9.30E-27	120.2	B3GA3_HUMAN	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)"	B3GAT3	Homo sapiens (Human)	335	cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486]	cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]	GO:0000139; GO:0005794; GO:0005801; GO:0005975; GO:0006024; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0030203; GO:0043085; GO:0046872; GO:0050650; GO:0050651; GO:0070062; GO:0072542; GO:0090316	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3824_c0_g1_i1	Q9VTG7	B3G2P_DROME	56.3	247	105	3	69	803	231	476	1.40E-69	264.6	B3G2P_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII)"	GlcAT-P GLCAT-BSII CG6207	Drosophila melanogaster (Fruit fly)	479	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695	carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27050_c0_g1_i1	Q9VTG7	B3G2P_DROME	53.4	253	112	5	831	79	231	479	1.40E-73	278.1	B3G2P_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII)"	GlcAT-P GLCAT-BSII CG6207	Drosophila melanogaster (Fruit fly)	479	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695	carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27050_c0_g1_i2	Q9VTG7	B3G2P_DROME	55.3	190	79	5	642	79	294	479	7.30E-57	222.6	B3G2P_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII)"	GlcAT-P GLCAT-BSII CG6207	Drosophila melanogaster (Fruit fly)	479	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695	carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27050_c0_g1_i2	Q9VTG7	B3G2P_DROME	45.1	71	39	0	860	648	231	301	1.90E-09	65.1	B3G2P_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII)"	GlcAT-P GLCAT-BSII CG6207	Drosophila melanogaster (Fruit fly)	479	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695	carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27050_c0_g1_i3	Q9VTG7	B3G2P_DROME	47.1	87	42	4	333	79	395	479	2.00E-13	76.6	B3G2P_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase P) (Glucuronosyltransferase P) (GlcAT-P) (UDP-glucuronosyltransferase P) (DmGlcAT-BSII)"	GlcAT-P GLCAT-BSII CG6207	Drosophila melanogaster (Fruit fly)	479	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0006688; GO:0007422; GO:0009101; GO:0015018; GO:0015020; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650; GO:0052695	carbohydrate metabolic process [GO:0005975]; cellular glucuronidation [GO:0052695]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; peripheral nervous system development [GO:0007422]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27454_c0_g1_i1	Q9VLA1	B3G2S_DROME	55.9	68	30	0	235	32	209	276	1.70E-16	86.3	B3G2S_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase S (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase S) (Glucuronosyltransferase S) (GlcAT-S) (UDP-glucuronosyltransferase S) (DmGlcAT-BSI)"	GlcAT-S GLCAT-BSI CG3881	Drosophila melanogaster (Fruit fly)	409	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005975; GO:0006486; GO:0006688; GO:0009101; GO:0015018; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN27454_c0_g1_i2	Q9VLA1	B3G2S_DROME	56.8	125	54	0	378	4	209	333	1.80E-36	153.3	B3G2S_DROME	reviewed	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase S (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase S) (Glucuronosyltransferase S) (GlcAT-S) (UDP-glucuronosyltransferase S) (DmGlcAT-BSI)"	GlcAT-S GLCAT-BSI CG3881	Drosophila melanogaster (Fruit fly)	409	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO:0046988]; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO:0046989]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO:0046987]"	GO:0000139; GO:0005975; GO:0006486; GO:0006688; GO:0009101; GO:0015018; GO:0016021; GO:0030166; GO:0046872; GO:0046987; GO:0046988; GO:0046989; GO:0050650	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN38657_c0_g1_i1	P16110	LEG3_MOUSE	30.1	133	79	5	134	520	134	256	7.50E-09	62.4	LEG3_MOUSE	reviewed	Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (IgE-binding protein) (L-34 galactoside-binding lectin) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)	Lgals3	Mus musculus (Mouse)	264	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glial cell projection [GO:0097386]; immunological synapse [GO:0001772]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; other organism cell [GO:0044216]; spliceosomal complex [GO:0005681]; advanced glycation end-product receptor activity [GO:0050785]; chemoattractant activity [GO:0042056]; disaccharide binding [GO:0048030]; Fc-gamma receptor I complex binding [GO:0034988]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; monosaccharide binding [GO:0048029]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell differentiation [GO:0030154]; eosinophil chemotaxis [GO:0048245]; extracellular matrix organization [GO:0030198]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation in bone marrow [GO:1903769]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of serotonin secretion [GO:0014064]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380]; skeletal system development [GO:0001501]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glial cell projection [GO:0097386]; immunological synapse [GO:0001772]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; other organism cell [GO:0044216]; spliceosomal complex [GO:0005681]	advanced glycation end-product receptor activity [GO:0050785]; chemoattractant activity [GO:0042056]; disaccharide binding [GO:0048030]; Fc-gamma receptor I complex binding [GO:0034988]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; monosaccharide binding [GO:0048029]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]	GO:0001501; GO:0001772; GO:0002548; GO:0005576; GO:0005615; GO:0005634; GO:0005681; GO:0005737; GO:0005743; GO:0006397; GO:0008284; GO:0008380; GO:0009897; GO:0009986; GO:0014064; GO:0019863; GO:0019903; GO:0030154; GO:0030198; GO:0030593; GO:0031012; GO:0031334; GO:0031640; GO:0034988; GO:0042056; GO:0042129; GO:0043066; GO:0043236; GO:0044216; GO:0045087; GO:0045766; GO:0045806; GO:0048029; GO:0048030; GO:0048245; GO:0048246; GO:0050785; GO:0050860; GO:0050918; GO:0061844; GO:0062023; GO:0070232; GO:0070492; GO:0071674; GO:0071677; GO:0090280; GO:0097386; GO:1902041; GO:1903078; GO:1903769; GO:2000521; GO:2001189; GO:2001237	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell differentiation [GO:0030154]; eosinophil chemotaxis [GO:0048245]; extracellular matrix organization [GO:0030198]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation in bone marrow [GO:1903769]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of serotonin secretion [GO:0014064]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380]; skeletal system development [GO:0001501]		blue	blue	NA	NA	NA	NA
TRINITY_DN4067_c0_g1_i1	Q9H3C7	GGNB2_HUMAN	43.7	261	134	3	78	857	1	249	4.50E-51	203	GGNB2_HUMAN	reviewed	Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403)	GGNBP2 LCRG1 LZK1 ZNF403	Homo sapiens (Human)	697	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0033140; GO:0042532; GO:0060716; GO:0061099	cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN26958_c0_g1_i1	Q9UEY8	ADDG_HUMAN	100	121	0	0	3	365	211	331	1.70E-63	243	ADDG_HUMAN	reviewed	Gamma-adducin (Adducin-like protein 70)	ADD3 ADDL	Homo sapiens (Human)	706	brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; transmembrane transport [GO:0055085]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0000794; GO:0005198; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0014069; GO:0016020; GO:0030507; GO:0044853; GO:0051015; GO:0051016; GO:0051017; GO:0055085	actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN33433_c0_g1_i1	Q9UEY8	ADDG_HUMAN	100	68	0	0	205	2	107	174	8.60E-33	140.2	ADDG_HUMAN	reviewed	Gamma-adducin (Adducin-like protein 70)	ADD3 ADDL	Homo sapiens (Human)	706	brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; transmembrane transport [GO:0055085]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0000794; GO:0005198; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0014069; GO:0016020; GO:0030507; GO:0044853; GO:0051015; GO:0051016; GO:0051017; GO:0055085	actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN30964_c0_g1_i1	Q9UEY8	ADDG_HUMAN	100	69	0	0	208	2	348	416	1.20E-34	146.4	ADDG_HUMAN	reviewed	Gamma-adducin (Adducin-like protein 70)	ADD3 ADDL	Homo sapiens (Human)	706	brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; transmembrane transport [GO:0055085]	brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0000794; GO:0005198; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0014069; GO:0016020; GO:0030507; GO:0044853; GO:0051015; GO:0051016; GO:0051017; GO:0055085	actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN35186_c0_g1_i1	Q24352	GBRAL_DROME	84.3	51	8	0	187	35	377	427	5.20E-20	97.8	GBRAL_DROME	reviewed	Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD)	Grd CG7446	Drosophila melanogaster (Fruit fly)	686	"chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]	GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1902476; GO:1904456	"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27234_c0_g1_i1	Q08832	GBRB3_DROME	57.1	84	30	2	273	34	414	495	4.20E-17	88.6	GBRB3_DROME	reviewed	Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor)	Lcch3 CG17336	Drosophila melanogaster (Fruit fly)	496	chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; neurotransmitter receptor activity [GO:0030594]	GO:0004890; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022851; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476; GO:1902711	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8716_c0_g1_i1	Q9GJW7	GBRAP_BOVIN	100	117	0	0	377	27	1	117	1.20E-62	240.4	GBRAP_BOVIN	reviewed	Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein)	GABARAP	Bos taurus (Bovine)	117	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]	beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008625; GO:0015031; GO:0015629; GO:0016236; GO:0031410; GO:0031625; GO:0048487; GO:0050811; GO:0097225	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN8716_c0_g1_i2	Q9GJW7	GBRAP_BOVIN	100	115	0	0	347	3	1	115	8.40E-61	234.2	GBRAP_BOVIN	reviewed	Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein)	GABARAP	Bos taurus (Bovine)	117	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]	beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008625; GO:0015031; GO:0015629; GO:0016236; GO:0031410; GO:0031625; GO:0048487; GO:0050811; GO:0097225	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN36373_c0_g1_i1	Q9GJW7	GBRAP_BOVIN	94.9	117	6	0	384	34	1	117	2.50E-59	229.6	GBRAP_BOVIN	reviewed	Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein)	GABARAP	Bos taurus (Bovine)	117	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]	beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008625; GO:0015031; GO:0015629; GO:0016236; GO:0031410; GO:0031625; GO:0048487; GO:0050811; GO:0097225	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN37388_c0_g1_i1	Q8HYB6	GBRL1_BOVIN	100	77	0	0	1	231	33	109	3.10E-39	161.8	GBRL1_BOVIN	reviewed	Gamma-aminobutyric acid receptor-associated protein-like 1 (GABA(A) receptor-associated protein-like 1)	GABARAPL1	Bos taurus (Bovine)	117	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; GABA receptor binding [GO:0050811]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]	GABA receptor binding [GO:0050811]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006995; GO:0016236; GO:0030659; GO:0031625; GO:0050811	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]		NA	NA	NA	NA	NA	NA
TRINITY_DN10652_c0_g1_i1	P60519	GBRL2_BOVIN	100	96	0	0	290	3	11	106	2.70E-48	192.2	GBRL2_BOVIN	reviewed	Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16) (MAP1 light chain 3-related protein)	GABARAPL2 GEF2	Bos taurus (Bovine)	117	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; ATPase binding [GO:0051117]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATPase activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	ATPase binding [GO:0051117]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000139; GO:0000149; GO:0000421; GO:0000422; GO:0005776; GO:0005789; GO:0005829; GO:0006891; GO:0006995; GO:0015031; GO:0016236; GO:0031410; GO:0031625; GO:0032781; GO:0051117; GO:0070972; GO:1901799	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATPase activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN10652_c0_g1_i2	P60519	GBRL2_BOVIN	100	96	0	0	290	3	11	106	2.70E-48	192.2	GBRL2_BOVIN	reviewed	Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16) (MAP1 light chain 3-related protein)	GABARAPL2 GEF2	Bos taurus (Bovine)	117	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; ATPase binding [GO:0051117]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATPase activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	ATPase binding [GO:0051117]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000139; GO:0000149; GO:0000421; GO:0000422; GO:0005776; GO:0005789; GO:0005829; GO:0006891; GO:0006995; GO:0015031; GO:0016236; GO:0031410; GO:0031625; GO:0032781; GO:0051117; GO:0070972; GO:1901799	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATPase activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN33470_c0_g1_i1	Q9UBS5	GABR1_HUMAN	52.8	72	30	1	273	58	802	869	2.00E-12	73.2	GABR1_HUMAN	reviewed	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GABBR1 GPRC3A	Homo sapiens (Human)	961	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]	G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]		NA	NA	NA	NA	NA	NA
TRINITY_DN38769_c0_g1_i1	Q9UBS5	GABR1_HUMAN	48.5	99	51	0	3	299	472	570	1.30E-23	110.5	GABR1_HUMAN	reviewed	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GABBR1 GPRC3A	Homo sapiens (Human)	961	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]	G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]		brown	brown	NA	NA	NA	NA
TRINITY_DN34009_c0_g1_i1	O75899	GABR2_HUMAN	65.8	79	27	0	257	21	666	744	1.20E-23	110.2	GABR2_HUMAN	reviewed	Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)	GABBR2 GPR51 GPRC3B	Homo sapiens (Human)	941	cytoplasm [GO:0005737]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]	cytoplasm [GO:0005737]; GABA receptor complex [GO:1902710]; G protein-coupled receptor heterodimeric complex [GO:0038039]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0150099; GO:1902710	chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2652_c0_g1_i1	Q9QZU7	BODG_RAT	33.1	372	238	6	194	1294	17	382	2.10E-57	224.9	BODG_RAT	reviewed	"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	Bbox1 Bbh	Rattus norvegicus (Rat)	387	mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	mitochondrion [GO:0005739]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0042802; GO:0045329	carnitine biosynthetic process [GO:0045329]		NA	NA	1	NA	NA	NA
TRINITY_DN19205_c0_g2_i2	Q9QZU7	BODG_RAT	34.2	222	126	5	280	918	5	215	4.90E-35	149.8	BODG_RAT	reviewed	"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	Bbox1 Bbh	Rattus norvegicus (Rat)	387	mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	mitochondrion [GO:0005739]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0042802; GO:0045329	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN19205_c0_g1_i2	O75936	BODG_HUMAN	44.7	170	91	3	741	235	214	381	1.10E-32	141.7	BODG_HUMAN	reviewed	"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	BBOX1 BBH BBOX	Homo sapiens (Human)	387	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN19205_c0_g1_i5	O75936	BODG_HUMAN	44.1	102	56	1	537	235	280	381	2.90E-17	90.1	BODG_HUMAN	reviewed	"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	BBOX1 BBH BBOX	Homo sapiens (Human)	387	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN2652_c0_g1_i2	Q9QZU7	BODG_RAT	31.3	326	215	5	194	1162	17	336	4.30E-45	184.1	BODG_RAT	reviewed	"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	Bbox1 Bbh	Rattus norvegicus (Rat)	387	mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	mitochondrion [GO:0005739]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0042802; GO:0045329	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN38457_c0_g1_i1	O75936	BODG_HUMAN	37.3	83	50	2	247	5	284	366	3.00E-11	68.9	BODG_HUMAN	reviewed	"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	BBOX1 BBH BBOX	Homo sapiens (Human)	387	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN19082_c2_g1_i1	P09104	ENOG_HUMAN	100	164	0	0	50	541	1	164	2.50E-87	322.8	ENOG_HUMAN	reviewed	Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE)	ENO2	Homo sapiens (Human)	434	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0001917; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0016020; GO:0032889; GO:0043204; GO:0061621; GO:0070062	"canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19082_c1_g1_i1	P09104	ENOG_HUMAN	99.6	275	1	0	1	825	160	434	6.30E-159	561.2	ENOG_HUMAN	reviewed	Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE)	ENO2	Homo sapiens (Human)	434	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0001917; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0016020; GO:0032889; GO:0043204; GO:0061621; GO:0070062	"canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19082_c1_g1_i2	P09104	ENOG_HUMAN	99.5	197	1	0	1	591	160	356	1.90E-110	399.8	ENOG_HUMAN	reviewed	Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE)	ENO2	Homo sapiens (Human)	434	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0001917; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0016020; GO:0032889; GO:0043204; GO:0061621; GO:0070062	"canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of vacuole fusion, non-autophagic [GO:0032889]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4905_c0_g1_i1	A7YWG4	GGH_BOVIN	38.9	293	167	6	232	1098	34	318	4.20E-47	190.3	GGH_BOVIN	reviewed	Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)	GGH	Bos taurus (Bovine)	318	extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]	extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]	gamma-glutamyl-peptidase activity [GO:0034722]	GO:0005615; GO:0005764; GO:0005773; GO:0034722; GO:0042470; GO:0046900	tetrahydrofolylpolyglutamate metabolic process [GO:0046900]		NA	NA	NA	NA	NA	NA
TRINITY_DN29823_c0_g1_i1	Q32LE4	GGCT_BOVIN	44.1	170	89	2	112	609	10	177	7.00E-34	145.6	GGCT_BOVIN	reviewed	Gamma-glutamylcyclotransferase (EC 4.3.2.9)	GGCT	Bos taurus (Bovine)	188	cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836]	cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]	GO:0001836; GO:0003839; GO:0005829; GO:0042803	release of cytochrome c from mitochondria [GO:0001836]		NA	NA	NA	NA	NA	NA
TRINITY_DN10649_c0_g1_i1	E7E2N8	GILT_CARAU	39.8	196	114	2	691	110	54	247	2.90E-36	153.7	GILT_CARAU	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-)	ifi30 GILT	Carassius auratus (Goldfish)	251	extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]	extracellular region [GO:0005576]; lysosome [GO:0005764]	protein-disulfide reductase activity [GO:0047134]	GO:0005576; GO:0005764; GO:0019882; GO:0047134	antigen processing and presentation [GO:0019882]		black	black	1	NA	1	NA
TRINITY_DN19146_c0_g1_i1	Q5XJN2	GILT_DANRE	36.5	126	76	3	30	401	61	184	1.50E-17	90.5	GILT_DANRE	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)	ifi30 GILT	Danio rerio (Zebrafish) (Brachydanio rerio)	255	"extracellular region [GO:0005576]; lysosome [GO:0005764]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376]"	extracellular region [GO:0005576]; lysosome [GO:0005764]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; protein-disulfide reductase activity [GO:0047134]"	GO:0002376; GO:0005576; GO:0005764; GO:0016491; GO:0016667; GO:0047134	immune system process [GO:0002376]		NA	NA	NA	NA	NA	NA
TRINITY_DN106_c0_g1_i1	Q5XJN2	GILT_DANRE	34.9	195	125	2	720	139	59	252	3.60E-29	130.2	GILT_DANRE	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)	ifi30 GILT	Danio rerio (Zebrafish) (Brachydanio rerio)	255	"extracellular region [GO:0005576]; lysosome [GO:0005764]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376]"	extracellular region [GO:0005576]; lysosome [GO:0005764]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; protein-disulfide reductase activity [GO:0047134]"	GO:0002376; GO:0005576; GO:0005764; GO:0016491; GO:0016667; GO:0047134	immune system process [GO:0002376]		NA	NA	NA	NA	NA	NA
TRINITY_DN106_c0_g1_i2	Q5XJN2	GILT_DANRE	34.9	195	125	2	720	139	59	252	3.70E-29	130.2	GILT_DANRE	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)	ifi30 GILT	Danio rerio (Zebrafish) (Brachydanio rerio)	255	"extracellular region [GO:0005576]; lysosome [GO:0005764]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376]"	extracellular region [GO:0005576]; lysosome [GO:0005764]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; protein-disulfide reductase activity [GO:0047134]"	GO:0002376; GO:0005576; GO:0005764; GO:0016491; GO:0016667; GO:0047134	immune system process [GO:0002376]		NA	NA	NA	NA	NA	NA
TRINITY_DN29703_c0_g1_i1	P13284	GILT_HUMAN	100	81	0	0	2	244	51	131	2.90E-43	175.3	GILT_HUMAN	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30) (Legumaturain)	IFI30 GILT IP30	Homo sapiens (Human)	250	"cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; interferon-gamma-mediated signaling pathway [GO:0060333]"	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]"	GO:0005576; GO:0005764; GO:0005829; GO:0016491; GO:0016667; GO:0019886; GO:0030054; GO:0042590; GO:0043202; GO:0043231; GO:0060333	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; interferon-gamma-mediated signaling pathway [GO:0060333]		NA	NA	NA	NA	NA	NA
TRINITY_DN3743_c0_g1_i1	Q9ESY9	GILT_MOUSE	33.5	182	112	5	63	599	57	232	5.60E-25	115.9	GILT_MOUSE	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30) (Lysosomal thiol reductase IP30)	Ifi30 Gilt Ip30	Mus musculus (Mouse)	248	"cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]"	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	"disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]"	GO:0005576; GO:0005764; GO:0005829; GO:0015036; GO:0016491; GO:0016667; GO:0019886; GO:0030054; GO:0042590; GO:0043231; GO:0048147; GO:0050821	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]		brown	brown	NA	NA	NA	NA
TRINITY_DN3743_c0_g1_i3	Q9ESY9	GILT_MOUSE	33.5	182	112	5	356	892	57	232	1.10E-24	115.5	GILT_MOUSE	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30) (Lysosomal thiol reductase IP30)	Ifi30 Gilt Ip30	Mus musculus (Mouse)	248	"cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]"	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	"disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]"	GO:0005576; GO:0005764; GO:0005829; GO:0015036; GO:0016491; GO:0016667; GO:0019886; GO:0030054; GO:0042590; GO:0043231; GO:0048147; GO:0050821	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN3743_c0_g1_i4	Q9ESY9	GILT_MOUSE	35.1	154	96	3	356	811	57	208	2.40E-23	110.9	GILT_MOUSE	reviewed	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30) (Lysosomal thiol reductase IP30)	Ifi30 Gilt Ip30	Mus musculus (Mouse)	248	"cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]"	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	"disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]"	GO:0005576; GO:0005764; GO:0005829; GO:0015036; GO:0016491; GO:0016667; GO:0019886; GO:0030054; GO:0042590; GO:0043231; GO:0048147; GO:0050821	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]		brown	brown	NA	NA	NA	NA
TRINITY_DN2981_c0_g1_i1	Q9VQG2	APH1_DROME	55.6	234	100	3	908	213	1	232	4.60E-63	243	APH1_DROME	reviewed	Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor)	aph-1 PSF CG2855	Drosophila melanogaster (Fruit fly)	238	"endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; protein stabilization [GO:0050821]"	endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005770; GO:0005783; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0034205; GO:0035333; GO:0043085; GO:0050821; GO:0055037; GO:0070765	"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; protein stabilization [GO:0050821]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2981_c0_g1_i2	Q9VQG2	APH1_DROME	55.6	234	100	3	872	177	1	232	4.50E-63	243	APH1_DROME	reviewed	Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor)	aph-1 PSF CG2855	Drosophila melanogaster (Fruit fly)	238	"endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; protein stabilization [GO:0050821]"	endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005770; GO:0005783; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0034205; GO:0035333; GO:0043085; GO:0050821; GO:0055037; GO:0070765	"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; protein stabilization [GO:0050821]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2981_c0_g1_i3	Q9VQG2	APH1_DROME	55.6	234	100	3	858	163	1	232	4.40E-63	243	APH1_DROME	reviewed	Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor)	aph-1 PSF CG2855	Drosophila melanogaster (Fruit fly)	238	"endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; protein stabilization [GO:0050821]"	endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005770; GO:0005783; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0034205; GO:0035333; GO:0043085; GO:0050821; GO:0055037; GO:0070765	"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; protein stabilization [GO:0050821]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28767_c0_g1_i1	Q96BI3	APH1A_HUMAN	100	97	0	0	292	2	94	190	7.10E-49	194.1	APH1A_HUMAN	reviewed	Gamma-secretase subunit APH-1A (APH-1a) (Aph-1alpha) (Presenilin-stabilization factor)	APH1A PSF CGI-78 UNQ579/PRO1141	Homo sapiens (Human)	265	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; endopeptidase activity [GO:0004175]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular protein metabolic process [GO:0044267]; ephrin receptor signaling pathway [GO:0048013]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; metanephros development [GO:0001656]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	endopeptidase activity [GO:0004175]	GO:0001656; GO:0004175; GO:0005739; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0008021; GO:0010008; GO:0016020; GO:0016021; GO:0016485; GO:0031293; GO:0032580; GO:0034205; GO:0035333; GO:0042982; GO:0042987; GO:0043065; GO:0043085; GO:0044267; GO:0048013; GO:0070765; GO:0099056	"amyloid-beta formation [GO:0034205]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; cellular protein metabolic process [GO:0044267]; ephrin receptor signaling pathway [GO:0048013]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; metanephros development [GO:0001656]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31869_c0_g1_i1	Q9CQR7	PEN2_MOUSE	100	59	0	0	177	1	1	59	2.20E-29	129	PEN2_MOUSE	reviewed	Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2)	Psenen Pen2	Mus musculus (Mouse)	101	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]		GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0010950; GO:0016021; GO:0016485; GO:0032580; GO:0034205; GO:0042982; GO:0043085; GO:0070765; GO:0099056	amyloid-beta formation [GO:0034205]; amyloid precursor protein metabolic process [GO:0042982]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN5304_c0_g1_i1	Q86BE9	PEN2_DROME	60.6	99	39	0	97	393	1	99	7.40E-33	141.7	PEN2_DROME	reviewed	Gamma-secretase subunit pen-2 (Presenilin enhancer protein 2)	pen-2 CG33198	Drosophila melanogaster (Fruit fly)	101	"gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]"	gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005770; GO:0006509; GO:0007219; GO:0007220; GO:0010950; GO:0016021; GO:0016485; GO:0034205; GO:0035333; GO:0055037; GO:0070765	"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5304_c0_g1_i6	Q86BE9	PEN2_DROME	60.6	99	39	0	97	393	1	99	7.40E-33	141.7	PEN2_DROME	reviewed	Gamma-secretase subunit pen-2 (Presenilin enhancer protein 2)	pen-2 CG33198	Drosophila melanogaster (Fruit fly)	101	"gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]"	gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005770; GO:0006509; GO:0007219; GO:0007220; GO:0010950; GO:0016021; GO:0016485; GO:0034205; GO:0035333; GO:0055037; GO:0070765	"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5304_c0_g1_i7	Q86BE9	PEN2_DROME	60.6	99	39	0	97	393	1	99	7.40E-33	141.7	PEN2_DROME	reviewed	Gamma-secretase subunit pen-2 (Presenilin enhancer protein 2)	pen-2 CG33198	Drosophila melanogaster (Fruit fly)	101	"gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]"	gamma-secretase complex [GO:0070765]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005770; GO:0006509; GO:0007219; GO:0007220; GO:0010950; GO:0016021; GO:0016485; GO:0034205; GO:0035333; GO:0055037; GO:0070765	"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26801_c0_g1_i1	Q921G8	GCP2_MOUSE	97.7	88	2	0	265	2	479	566	2.10E-39	162.5	GCP2_MOUSE	reviewed	Gamma-tubulin complex component 2 (GCP-2)	Tubgcp2 Gcp2	Mus musculus (Mouse)	905	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0007420; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN1552_c0_g1_i1	Q921G8	GCP2_MOUSE	43.2	891	453	10	86	2611	1	887	1.00E-192	675.2	GCP2_MOUSE	reviewed	Gamma-tubulin complex component 2 (GCP-2)	Tubgcp2 Gcp2	Mus musculus (Mouse)	905	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0007420; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN29457_c0_g1_i1	Q921G8	GCP2_MOUSE	100	80	0	0	242	3	268	347	1.20E-36	153.3	GCP2_MOUSE	reviewed	Gamma-tubulin complex component 2 (GCP-2)	Tubgcp2 Gcp2	Mus musculus (Mouse)	905	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0007420; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN22996_c0_g1_i1	Q9BSJ2	GCP2_HUMAN	100	149	0	0	3	449	633	781	6.20E-84	311.2	GCP2_HUMAN	reviewed	Gamma-tubulin complex component 2 (GCP-2) (hGCP2) (Gamma-ring complex protein 103 kDa) (h103p) (hGrip103) (Spindle pole body protein Spc97 homolog) (hSpc97)	TUBGCP2 GCP2	Homo sapiens (Human)	902	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0005881; GO:0007020; GO:0007420; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0065003	brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN32581_c0_g1_i1	Q9BSJ2	GCP2_HUMAN	100	68	0	0	206	3	483	550	7.40E-32	137.1	GCP2_HUMAN	reviewed	Gamma-tubulin complex component 2 (GCP-2) (hGCP2) (Gamma-ring complex protein 103 kDa) (h103p) (hGrip103) (Spindle pole body protein Spc97 homolog) (hSpc97)	TUBGCP2 GCP2	Homo sapiens (Human)	902	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0005881; GO:0007020; GO:0007420; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0065003	brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN7291_c0_g2_i1	Q9XYP8	GCP3_DROME	47.5	59	31	0	254	78	841	899	6.80E-07	54.7	GCP3_DROME	reviewed	Gamma-tubulin complex component 3 (Gamma-ring complex protein 91 kDa)	Grip91 l(1)dd4 CG10988	Drosophila melanogaster (Fruit fly)	917	cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000212; GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005737; GO:0005874; GO:0007020; GO:0007140; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	cytoplasmic microtubule organization [GO:0031122]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN7291_c0_g1_i1	O73787	GCP3_XENLA	47.3	203	107	0	620	12	633	835	7.80E-48	191.8	GCP3_XENLA	reviewed	Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p)	tubgcp3	Xenopus laevis (African clawed frog)	906	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule nucleation [GO:0007020]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000922; GO:0005737; GO:0005815; GO:0005874; GO:0007020; GO:0043015	microtubule nucleation [GO:0007020]		NA	NA	NA	NA	NA	NA
TRINITY_DN15515_c0_g2_i1	Q9D4F8	GCP4_MOUSE	37.2	430	238	9	1	1233	245	661	2.00E-66	254.6	GCP4_MOUSE	reviewed	Gamma-tubulin complex component 4 (GCP-4)	Tubgcp4 D2Ertd435e Gcp4	Mus musculus (Mouse)	667	centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0055037	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN13806_c0_g1_i1	Q9D4F8	GCP4_MOUSE	34.1	214	133	3	628	8	1	213	2.50E-28	127.1	GCP4_MOUSE	reviewed	Gamma-tubulin complex component 4 (GCP-4)	Tubgcp4 D2Ertd435e Gcp4	Mus musculus (Mouse)	667	centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0055037	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN13806_c0_g1_i2	Q9D4F8	GCP4_MOUSE	32.8	189	120	2	556	8	26	213	3.20E-22	106.7	GCP4_MOUSE	reviewed	Gamma-tubulin complex component 4 (GCP-4)	Tubgcp4 D2Ertd435e Gcp4	Mus musculus (Mouse)	667	centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005874; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0055037	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN7219_c0_g2_i1	Q96RT7	GCP6_HUMAN	30.1	123	79	2	369	22	564	686	3.90E-10	65.9	GCP6_HUMAN	reviewed	Gamma-tubulin complex component 6 (GCP-6)	TUBGCP6 GCP6 KIAA1669	Homo sapiens (Human)	1819	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN7219_c0_g1_i2	G5E8P0	GCP6_MOUSE	29	435	298	6	1346	57	270	698	3.40E-45	184.1	GCP6_MOUSE	reviewed	Gamma-tubulin complex component 6 (GCP-6)	Tubgcp6 Kiaa1669	Mus musculus (Mouse)	1769	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; spindle pole [GO:0000922]	gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005737; GO:0005813; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN7008_c0_g1_i2	Q60648	SAP3_MOUSE	39.6	159	92	2	572	102	34	190	9.50E-34	145.6	SAP3_MOUSE	reviewed	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3)	Gm2a	Mus musculus (Mouse)	193	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]	beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]	GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0006869; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345	ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i12	P80035	LIPG_CANLF	41	271	152	5	874	71	128	393	5.20E-54	213.4	LIPG_CANLF	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)	LIPF	Canis lupus familiaris (Dog) (Canis familiaris)	398	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0043231	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i12	P80035	LIPG_CANLF	43.3	120	61	2	1224	865	28	140	1.50E-24	115.5	LIPG_CANLF	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)	LIPF	Canis lupus familiaris (Dog) (Canis familiaris)	398	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0043231	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i3	P80035	LIPG_CANLF	41	271	152	5	874	71	128	393	4.90E-54	213.4	LIPG_CANLF	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)	LIPF	Canis lupus familiaris (Dog) (Canis familiaris)	398	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0043231	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i3	P80035	LIPG_CANLF	45.5	110	53	2	1194	865	38	140	2.20E-22	108.2	LIPG_CANLF	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)	LIPF	Canis lupus familiaris (Dog) (Canis familiaris)	398	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0043231	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN17808_c0_g1_i2	Q9CPP7	LIPG_MOUSE	38.5	96	56	2	331	47	299	392	6.90E-13	75.1	LIPG_MOUSE	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)	Lipf	Mus musculus (Mouse)	395	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0016042; GO:0016615; GO:0043231	lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]		NA	NA	NA	NA	NA	NA
TRINITY_DN12143_c0_g1_i1	Q9CPP7	LIPG_MOUSE	52.1	94	45	0	287	6	76	169	6.60E-26	117.9	LIPG_MOUSE	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)	Lipf	Mus musculus (Mouse)	395	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0016042; GO:0016615; GO:0043231	lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i11	P04634	LIPG_RAT	40.6	382	212	7	1210	71	24	392	3.10E-83	310.5	LIPG_RAT	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase)	Lipf	Rattus norvegicus (Rat)	395	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0007586; GO:0016042; GO:0016298; GO:0016615; GO:0043231	digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i4	P04634	LIPG_RAT	41.2	369	202	7	1171	71	37	392	1.60E-81	304.7	LIPG_RAT	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase)	Lipf	Rattus norvegicus (Rat)	395	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0007586; GO:0016042; GO:0016298; GO:0016615; GO:0043231	digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i8	P04634	LIPG_RAT	41.2	369	202	7	1171	71	37	392	1.20E-81	305.1	LIPG_RAT	reviewed	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase)	Lipf	Rattus norvegicus (Rat)	395	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0007586; GO:0016042; GO:0016298; GO:0016615; GO:0043231	digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]		NA	NA	NA	NA	NA	NA
TRINITY_DN6545_c0_g1_i1	P30550	GRPR_HUMAN	35.4	113	71	1	367	35	86	198	5.20E-12	72	GRPR_HUMAN	reviewed	Gastrin-releasing peptide receptor (GRP-R) (GRP-preferring bombesin receptor)	GRPR	Homo sapiens (Human)	384	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007611; GO:0008188; GO:0008528; GO:0035176; GO:0036343; GO:0042127; GO:0042923; GO:0043207; GO:0061744	G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g3_i1	P18714	ZG20_XENLA	46.2	80	43	0	240	1	519	598	9.10E-16	84	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c2_g2_i1	P18714	ZG20_XENLA	40.3	72	43	0	217	2	412	483	2.10E-13	75.9	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11995_c0_g1_i1	P18714	ZG20_XENLA	44.8	67	37	0	201	1	519	585	1.50E-09	63.2	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c0_g1_i1	P18714	ZG20_XENLA	44.6	101	56	0	392	90	490	590	2.40E-21	104	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c0_g1_i4	P18714	ZG20_XENLA	44.6	101	56	0	392	90	490	590	1.90E-21	104	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13346_c0_g1_i2	P18714	ZG20_XENLA	42.9	77	44	0	232	2	115	191	6.60E-13	74.3	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2136_c0_g1_i1	P18714	ZG20_XENLA	49.2	61	30	1	283	104	502	562	9.70E-11	68.6	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c6_g1_i1	P18714	ZG20_XENLA	46.8	79	42	0	245	9	118	196	9.20E-21	100.5	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN31703_c0_g1_i1	P18714	ZG20_XENLA	51.6	93	45	0	18	296	507	599	3.00E-26	119	ZG20_XENLA	reviewed	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)		Xenopus laevis (African clawed frog)	675	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c42_g1_i1	P18712	ZG16_XENLA	53.6	56	26	0	38	205	57	112	2.80E-13	75.5	ZG16_XENLA	reviewed	Gastrula zinc finger protein XlCGF16.1 (Fragment)		Xenopus laevis (African clawed frog)	112	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6614_c0_g1_i1	P18713	ZG17_XENLA	49.5	101	50	1	306	4	24	123	1.30E-21	103.6	ZG17_XENLA	reviewed	Gastrula zinc finger protein XlCGF17.1 (Fragment)		Xenopus laevis (African clawed frog)	197	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6614_c0_g1_i2	P18713	ZG17_XENLA	47.2	108	56	1	327	4	17	123	6.40E-22	104.8	ZG17_XENLA	reviewed	Gastrula zinc finger protein XlCGF17.1 (Fragment)		Xenopus laevis (African clawed frog)	197	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c1_g1_i1	P18715	ZG26_XENLA	38.7	106	65	0	363	46	200	305	9.70E-20	97.8	ZG26_XENLA	reviewed	Gastrula zinc finger protein XlCGF26.1 (Fragment)		Xenopus laevis (African clawed frog)	337	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g1_i5	P18716	ZG28_XENLA	49.4	83	42	0	250	2	169	251	1.00E-19	97.4	ZG28_XENLA	reviewed	Gastrula zinc finger protein XlCGF28.1 (Fragment)		Xenopus laevis (African clawed frog)	252	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i2	P18720	ZG42_XENLA	36.4	55	35	0	94	258	87	141	9.00E-06	50.8	ZG42_XENLA	reviewed	Gastrula zinc finger protein XlCGF42.1 (Fragment)		Xenopus laevis (African clawed frog)	168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g3_i1	P18720	ZG42_XENLA	52.8	53	25	0	207	49	84	136	5.60E-11	67.8	ZG42_XENLA	reviewed	Gastrula zinc finger protein XlCGF42.1 (Fragment)		Xenopus laevis (African clawed frog)	168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19613_c0_g1_i1	P18720	ZG42_XENLA	36.9	65	41	0	18	212	86	150	6.40E-09	61.2	ZG42_XENLA	reviewed	Gastrula zinc finger protein XlCGF42.1 (Fragment)		Xenopus laevis (African clawed frog)	168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19613_c0_g1_i2	P18720	ZG42_XENLA	41.7	48	28	0	18	161	86	133	2.60E-06	52.4	ZG42_XENLA	reviewed	Gastrula zinc finger protein XlCGF42.1 (Fragment)		Xenopus laevis (African clawed frog)	168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i10	P18722	ZG46_XENLA	56.6	53	23	0	160	2	202	254	5.80E-12	71.6	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i50	P18722	ZG46_XENLA	41.9	105	61	0	315	1	128	232	2.30E-19	97.4	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c0_g1_i1	P18722	ZG46_XENLA	49.3	75	38	0	3	227	168	242	5.70E-17	87.8	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i5	P18722	ZG46_XENLA	54.5	66	30	0	199	2	187	252	3.30E-16	85.1	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i17	P18722	ZG46_XENLA	44.9	89	33	2	227	3	189	275	7.40E-14	77.8	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i1	P18722	ZG46_XENLA	52.8	89	42	0	3	269	164	252	1.40E-23	110.5	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i5	P18722	ZG46_XENLA	54.1	85	39	0	3	257	164	248	8.50E-23	107.8	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i11	P18722	ZG46_XENLA	51.5	97	47	0	364	74	164	260	4.40E-27	122.1	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i9	P18722	ZG46_XENLA	51	104	51	0	315	4	164	267	6.30E-30	131.3	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN16301_c0_g1_i3	P18722	ZG46_XENLA	48.4	62	32	0	255	70	107	168	9.40E-13	73.9	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g1_i4	P18722	ZG46_XENLA	44	84	47	0	2	253	169	252	5.50E-17	88.6	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i4	P18722	ZG46_XENLA	49.5	101	51	0	8	310	167	267	2.10E-27	122.9	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g1_i2	P18722	ZG46_XENLA	42.7	82	47	0	254	9	171	252	4.70E-15	81.6	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8372_c0_g2_i1	P18722	ZG46_XENLA	58	69	29	0	27	233	192	260	1.90E-20	99.4	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g2_i1	P18722	ZG46_XENLA	52.1	48	23	0	2	145	205	252	1.60E-09	63.2	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19613_c1_g1_i1	P18722	ZG46_XENLA	52.7	74	35	0	9	230	164	237	3.60E-19	95.1	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i13	P18722	ZG46_XENLA	45.1	51	25	1	53	205	120	167	8.70E-05	47.8	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i6	P18722	ZG46_XENLA	55.3	85	36	1	32	280	168	252	3.90E-23	109	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i1	P18722	ZG46_XENLA	53.2	47	22	0	236	96	206	252	9.10E-10	63.9	ZG46_XENLA	reviewed	Gastrula zinc finger protein XlCGF46.1 (Fragment)		Xenopus laevis (African clawed frog)	280	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13056_c0_g1_i1	P18723	ZG48_XENLA	36.5	63	40	0	157	345	453	515	1.50E-05	50.4	ZG48_XENLA	reviewed	Gastrula zinc finger protein XlCGF48.2 (Fragment)		Xenopus laevis (African clawed frog)	647	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13056_c0_g1_i11	P18723	ZG48_XENLA	36.5	63	40	0	120	308	453	515	1.40E-05	50.4	ZG48_XENLA	reviewed	Gastrula zinc finger protein XlCGF48.2 (Fragment)		Xenopus laevis (African clawed frog)	647	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i1	P18727	ZG52_XENLA	41.8	189	110	0	4	570	35	223	5.10E-42	172.6	ZG52_XENLA	reviewed	Gastrula zinc finger protein XlCGF52.1 (Fragment)		Xenopus laevis (African clawed frog)	223	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g3_i1	P18728	ZG53_XENLA	53.3	45	21	0	4	138	356	400	2.80E-08	58.9	ZG53_XENLA	reviewed	Gastrula zinc finger protein XlCGF53.1 (Fragment)		Xenopus laevis (African clawed frog)	516	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i6	P18729	ZG57_XENLA	46.1	89	48	0	273	7	30	118	1.60E-17	90.5	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i4	P18729	ZG57_XENLA	48.8	293	125	4	3	881	45	312	2.50E-71	270.8	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN14732_c0_g1_i1	P18729	ZG57_XENLA	50	130	65	0	392	3	103	232	1.50E-38	160.2	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i6	P18729	ZG57_XENLA	44.9	78	43	0	103	336	34	111	2.50E-13	76.3	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i21	P18729	ZG57_XENLA	63.2	76	28	0	50	277	80	155	1.20E-22	107.1	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i7	P18729	ZG57_XENLA	36.3	146	86	3	1005	1442	56	194	8.30E-16	86.7	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i1	P18729	ZG57_XENLA	65.3	72	25	0	11	226	80	151	3.10E-23	108.6	ZG57_XENLA	reviewed	Gastrula zinc finger protein XlCGF57.1 (Fragment)		Xenopus laevis (African clawed frog)	336	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i1	P18730	ZG58_XENLA	45.2	73	40	0	405	187	152	224	2.20E-13	77	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i13	P18730	ZG58_XENLA	55.6	36	16	0	109	2	195	230	4.70E-06	51.6	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c8_g2_i1	P18730	ZG58_XENLA	44.6	56	31	0	170	337	46	101	1.50E-06	53.9	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c5_g1_i12	P18730	ZG58_XENLA	44.1	59	33	0	5	181	166	224	1.00E-08	61.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c5_g1_i14	P18730	ZG58_XENLA	44.1	59	33	0	5	181	166	224	1.10E-08	61.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c5_g1_i22	P18730	ZG58_XENLA	44.1	59	33	0	5	181	166	224	1.10E-08	61.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c5_g1_i8	P18730	ZG58_XENLA	44.1	59	33	0	5	181	166	224	1.10E-08	61.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g2_i1	P18730	ZG58_XENLA	45.4	97	53	0	3	293	12	108	3.00E-18	92.4	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g1_i4	P18730	ZG58_XENLA	51.1	137	67	0	416	6	10	146	5.40E-34	145.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i1	P18730	ZG58_XENLA	47.4	133	70	0	4	402	36	168	3.40E-33	142.9	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2762_c0_g1_i1	P18730	ZG58_XENLA	45.3	106	58	0	319	2	36	141	1.60E-21	103.6	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2762_c0_g1_i2	P18730	ZG58_XENLA	43	149	85	0	448	2	105	253	6.60E-33	141.7	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2762_c0_g1_i3	P18730	ZG58_XENLA	47.1	121	63	1	361	2	21	141	7.70E-24	111.3	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i16	P18730	ZG58_XENLA	41.9	222	108	2	155	757	24	245	3.70E-44	179.9	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i4	P18730	ZG58_XENLA	44.3	176	98	0	441	968	32	207	7.70E-39	162.5	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i4	P18730	ZG58_XENLA	39.6	154	82	1	5	433	92	245	2.80E-25	117.5	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i6	P18730	ZG58_XENLA	44.6	177	86	2	5	529	4	170	5.70E-36	152.1	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i6	P18730	ZG58_XENLA	39.1	179	67	5	3	425	66	240	1.80E-24	113.6	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g2_i1	P18730	ZG58_XENLA	53.1	49	23	0	149	3	8	56	3.00E-10	65.5	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c1_g1_i2	P18730	ZG58_XENLA	42.9	42	24	0	340	215	183	224	7.50E-05	48.1	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c4_g1_i1	P18730	ZG58_XENLA	46	100	52	1	18	311	3	102	1.80E-18	93.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c0_g2_i4	P18730	ZG58_XENLA	45.5	145	77	2	508	74	90	232	3.10E-31	136.3	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17691_c0_g1_i1	P18730	ZG58_XENLA	42.9	42	24	0	210	85	183	224	3.50E-05	48.5	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22387_c0_g1_i1	P18730	ZG58_XENLA	46.9	64	34	0	4	195	161	224	2.80E-11	68.9	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22387_c0_g1_i13	P18730	ZG58_XENLA	43.8	64	36	0	7	198	161	224	8.20E-11	67.4	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c4_g1_i1	P18730	ZG58_XENLA	47.8	69	36	0	6	212	286	354	3.20E-14	78.6	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5058_c0_g1_i2	P18730	ZG58_XENLA	42.2	64	37	0	12	203	161	224	4.30E-11	68.2	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15910_c0_g1_i2	P18730	ZG58_XENLA	48.5	68	24	2	351	551	191	248	3.30E-10	66.6	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15910_c0_g1_i2	P18730	ZG58_XENLA	43.5	62	25	1	178	363	197	248	8.90E-08	58.5	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15910_c0_g1_i3	P18730	ZG58_XENLA	48.5	68	24	2	318	518	191	248	3.10E-10	66.6	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15910_c0_g1_i3	P18730	ZG58_XENLA	45.6	68	26	2	130	330	191	248	2.00E-09	63.9	ZG58_XENLA	reviewed	Gastrula zinc finger protein XlCGF58.1 (Fragment)		Xenopus laevis (African clawed frog)	420	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i9	P18734	ZG67_XENLA	53.6	56	26	0	3	170	37	92	1.60E-10	67.8	ZG67_XENLA	reviewed	Gastrula zinc finger protein XlCGF67.1 (Fragment)		Xenopus laevis (African clawed frog)	139	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13767_c1_g1_i4	P18735	ZG7_XENLA	44.9	69	38	0	11	217	16	84	1.40E-12	73.2	ZG7_XENLA	reviewed	Gastrula zinc finger protein XlCGF7.1 (Fragment)		Xenopus laevis (African clawed frog)	168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g2_i9	P18735	ZG7_XENLA	40	55	33	0	66	230	4	58	3.20E-07	55.5	ZG7_XENLA	reviewed	Gastrula zinc finger protein XlCGF7.1 (Fragment)		Xenopus laevis (African clawed frog)	168	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24310_c0_g1_i2	P23825	GATA3_CHICK	98.8	160	2	0	480	1	233	392	2.10E-90	332.8	GATA3_CHICK	reviewed	GATA-binding factor 3 (GATA-3) (Transcription factor NF-E1c)	GATA3	Gallus gallus (Chicken)	444	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; anatomical structure formation involved in morphogenesis [GO:0048646]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to estrogen [GO:0043627]; response to virus [GO:0009615]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud formation [GO:0060676]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001709; GO:0001764; GO:0001822; GO:0001823; GO:0002088; GO:0002520; GO:0002572; GO:0003180; GO:0003215; GO:0003281; GO:0003713; GO:0005134; GO:0005634; GO:0005654; GO:0006338; GO:0006959; GO:0007165; GO:0007411; GO:0008134; GO:0008270; GO:0008285; GO:0008584; GO:0009615; GO:0009791; GO:0009967; GO:0010595; GO:0010719; GO:0010975; GO:0014065; GO:0030218; GO:0030856; GO:0031929; GO:0032609; GO:0032633; GO:0032689; GO:0032703; GO:0032736; GO:0032753; GO:0032754; GO:0033600; GO:0035162; GO:0035457; GO:0035799; GO:0035898; GO:0042035; GO:0042421; GO:0042472; GO:0042491; GO:0042802; GO:0043370; GO:0043523; GO:0043583; GO:0043627; GO:0045061; GO:0045064; GO:0045165; GO:0045582; GO:0045599; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0048485; GO:0048538; GO:0048568; GO:0048589; GO:0048646; GO:0050728; GO:0050852; GO:0051569; GO:0051897; GO:0060017; GO:0060037; GO:0060065; GO:0060231; GO:0060374; GO:0060676; GO:0061085; GO:0061290; GO:0070888; GO:0071353; GO:0071356; GO:0071442; GO:0071599; GO:0071773; GO:0071837; GO:0072107; GO:0072178; GO:0072179; GO:0072182; GO:0072197; GO:0072676; GO:1901536; GO:1902895; GO:2000114; GO:2000146; GO:2000352; GO:2000553; GO:2000607; GO:2000611; GO:2000617; GO:2000679; GO:2000683; GO:2000703; GO:2000734	"anatomical structure formation involved in morphogenesis [GO:0048646]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to estrogen [GO:0043627]; response to virus [GO:0009615]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; ureteric bud formation [GO:0060676]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN128_c0_g1_i3	P43695	GAT5A_XENLA	54.1	170	74	3	764	1267	131	298	1.40E-43	178.7	GAT5A_XENLA	reviewed	GATA-binding factor 5-A (Transcription factor xGATA-5A)	gata5-a gata-4a gata5a	Xenopus laevis (African clawed frog)	390	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000976; GO:0000981; GO:0005634; GO:0008270; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN128_c0_g1_i4	P43695	GAT5A_XENLA	52.6	175	74	4	764	1282	131	298	3.60E-42	174.1	GAT5A_XENLA	reviewed	GATA-binding factor 5-A (Transcription factor xGATA-5A)	gata5-a gata-4a gata5a	Xenopus laevis (African clawed frog)	390	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000976; GO:0000981; GO:0005634; GO:0008270; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN27916_c0_g1_i1	P52168	PNR_DROME	64.9	37	13	0	72	182	243	279	3.20E-07	55.5	PNR_DROME	reviewed	GATA-binding factor A (Protein pannier) (Transcription factor GATA-A) (dGATA-A)	pnr GATA-A CG3978	Drosophila melanogaster (Fruit fly)	540	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0001085; GO:0001103; GO:0005634; GO:0006963; GO:0007350; GO:0007510; GO:0008270; GO:0010002; GO:0022416; GO:0035050; GO:0035051; GO:0042440; GO:0045165; GO:0045892; GO:0045944; GO:0046982; GO:0048542; GO:0060047; GO:0061320	"blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; lymph gland development [GO:0048542]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27916_c0_g1_i2	P52168	PNR_DROME	64.8	54	19	0	70	231	226	279	3.00E-15	82.4	PNR_DROME	reviewed	GATA-binding factor A (Protein pannier) (Transcription factor GATA-A) (dGATA-A)	pnr GATA-A CG3978	Drosophila melanogaster (Fruit fly)	540	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0001085; GO:0001103; GO:0005634; GO:0006963; GO:0007350; GO:0007510; GO:0008270; GO:0010002; GO:0022416; GO:0035050; GO:0035051; GO:0042440; GO:0045165; GO:0045892; GO:0045944; GO:0046982; GO:0048542; GO:0060047; GO:0061320	"blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; lymph gland development [GO:0048542]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26306_c0_g1_i1	P52168	PNR_DROME	89.2	37	4	0	218	108	242	278	3.70E-13	75.1	PNR_DROME	reviewed	GATA-binding factor A (Protein pannier) (Transcription factor GATA-A) (dGATA-A)	pnr GATA-A CG3978	Drosophila melanogaster (Fruit fly)	540	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0001085; GO:0001103; GO:0005634; GO:0006963; GO:0007350; GO:0007510; GO:0008270; GO:0010002; GO:0022416; GO:0035050; GO:0035051; GO:0042440; GO:0045165; GO:0045892; GO:0045944; GO:0046982; GO:0048542; GO:0060047; GO:0061320	"blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; embryonic heart tube development [GO:0035050]; heart contraction [GO:0060047]; lymph gland development [GO:0048542]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38676_c0_g1_i1	O75140	DEPD5_HUMAN	49.6	123	57	3	409	47	3	122	1.60E-24	114	DEPD5_HUMAN	reviewed	GATOR complex protein DEPDC5 (DEP domain-containing protein 5)	DEPDC5 KIAA0645	Homo sapiens (Human)	1603	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; regulation of autophagy [GO:0010506]	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010506; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130	cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN38676_c0_g1_i2	O75140	DEPD5_HUMAN	47.8	180	87	4	537	4	3	177	9.00E-41	168.3	DEPD5_HUMAN	reviewed	GATOR complex protein DEPDC5 (DEP domain-containing protein 5)	DEPDC5 KIAA0645	Homo sapiens (Human)	1603	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; regulation of autophagy [GO:0010506]	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010506; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130	cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN35571_c0_g1_i1	Q9W0E3	IML1_DROME	60	255	72	6	722	3	256	495	3.80E-75	282.7	IML1_DROME	reviewed	GATOR complex protein Iml1 (Increased minichromosome loss 1)	Iml1 DEPDC5 SEA1 CG12090	Drosophila melanogaster (Fruit fly)	1544	"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]; GTPase activator activity [GO:0005096]; cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; regulation of autophagy [GO:0010506]"	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005764; GO:0005765; GO:0010506; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130	"cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagy [GO:0010506]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28719_c0_g1_i1	Q9W0E3	IML1_DROME	41.4	152	38	3	92	403	695	843	2.10E-22	106.7	IML1_DROME	reviewed	GATOR complex protein Iml1 (Increased minichromosome loss 1)	Iml1 DEPDC5 SEA1 CG12090	Drosophila melanogaster (Fruit fly)	1544	"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]; GTPase activator activity [GO:0005096]; cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; regulation of autophagy [GO:0010506]"	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005764; GO:0005765; GO:0010506; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130	"cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagy [GO:0010506]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3532_c0_g1_i1	Q9W0E3	IML1_DROME	37.6	303	143	10	959	99	1246	1518	4.50E-47	189.9	IML1_DROME	reviewed	GATOR complex protein Iml1 (Increased minichromosome loss 1)	Iml1 DEPDC5 SEA1 CG12090	Drosophila melanogaster (Fruit fly)	1544	"GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]; GTPase activator activity [GO:0005096]; cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; regulation of autophagy [GO:0010506]"	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005764; GO:0005765; GO:0010506; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130	"cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagy [GO:0010506]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36617_c0_g1_i1	Q8VE19	MIO_MOUSE	98.6	72	1	0	3	218	800	871	6.00E-40	164.1	MIO_MOUSE	reviewed	GATOR complex protein MIOS	Mios	Mus musculus (Mouse)	875	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0030054; GO:0032008; GO:0034198; GO:0034629; GO:0061700	cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3110_c0_g1_i1	Q5U5D4	MIOA_XENLA	40.7	902	489	20	2690	57	1	880	3.00E-189	663.7	MIOA_XENLA	reviewed	GATOR complex protein MIOS-A	mios-a	Xenopus laevis (African clawed frog)	880	lysosomal membrane [GO:0005765]	lysosomal membrane [GO:0005765]		GO:0005765			NA	NA	NA	NA	NA	NA
TRINITY_DN2556_c0_g1_i1	Q9WUE4	NPRL2_MOUSE	40	450	199	4	115	1464	2	380	2.00E-86	321.2	NPRL2_MOUSE	reviewed	GATOR complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein)	Nprl2	Mus musculus (Mouse)	380	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]	GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005096; GO:0005765; GO:0006995; GO:0010508; GO:0032007; GO:0033673; GO:0034198; GO:1990130; GO:2000785	cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]		NA	NA	NA	NA	NA	NA
TRINITY_DN2556_c0_g1_i3	Q9WUE4	NPRL2_MOUSE	40	450	199	4	115	1464	2	380	2.00E-86	321.2	NPRL2_MOUSE	reviewed	GATOR complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein)	Nprl2	Mus musculus (Mouse)	380	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]	GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005096; GO:0005765; GO:0006995; GO:0010508; GO:0032007; GO:0033673; GO:0034198; GO:1990130; GO:2000785	cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]		NA	NA	NA	NA	NA	NA
TRINITY_DN2556_c0_g1_i5	Q9WUE4	NPRL2_MOUSE	40.2	435	189	4	2	1306	17	380	1.10E-83	312	NPRL2_MOUSE	reviewed	GATOR complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein)	Nprl2	Mus musculus (Mouse)	380	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]	GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005096; GO:0005765; GO:0006995; GO:0010508; GO:0032007; GO:0033673; GO:0034198; GO:1990130; GO:2000785	cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]		NA	NA	NA	NA	NA	NA
TRINITY_DN2556_c0_g1_i2	Q8WTW4	NPRL2_HUMAN	47.2	229	114	2	37	723	159	380	6.90E-54	212.2	NPRL2_HUMAN	reviewed	GATOR complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein) (Tumor suppressor candidate 4)	NPRL2 TUSC4	Homo sapiens (Human)	380	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]	GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005096; GO:0005765; GO:0006995; GO:0010508; GO:0032007; GO:0033673; GO:0034198; GO:1990130; GO:2000785	cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]		NA	NA	NA	NA	NA	NA
TRINITY_DN31374_c0_g1_i1	Q8WTW4	NPRL2_HUMAN	100	86	0	0	260	3	152	237	4.00E-43	174.9	NPRL2_HUMAN	reviewed	GATOR complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein) (Tumor suppressor candidate 4)	NPRL2 TUSC4	Homo sapiens (Human)	380	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]	GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005096; GO:0005765; GO:0006995; GO:0010508; GO:0032007; GO:0033673; GO:0034198; GO:1990130; GO:2000785	cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]		NA	NA	NA	NA	NA	NA
TRINITY_DN8624_c0_g1_i2	Q12980	NPRL3_HUMAN	50.6	77	38	0	277	47	488	564	2.30E-14	80.5	NPRL3_HUMAN	reviewed	GATOR complex protein NPRL3 (-14 gene protein) (Alpha-globin regulatory element-containing gene protein) (Nitrogen permease regulator 3-like protein) (Protein CGTHBA)	NPRL3 C16orf35 CGTHBA MARE	Homo sapiens (Human)	569	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagosome assembly [GO:2000785]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]	GTPase activator activity [GO:0005096]	GO:0003281; GO:0005096; GO:0005765; GO:0032007; GO:0034198; GO:0035909; GO:0038202; GO:0048738; GO:0060021; GO:1990130; GO:2000785	aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagosome assembly [GO:2000785]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN9808_c0_g1_i1	Q9VUB4	NPRL3_DROME	42.4	198	96	4	73	654	4	187	4.40E-33	142.9	NPRL3_DROME	reviewed	GATOR complex protein NPRL3 (Nitrogen permease regulator 3-like protein)	Nprl3 CG8783	Drosophila melanogaster (Fruit fly)	610	autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; oogenesis [GO:0048477]; positive regulation of macroautophagy [GO:0016239]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of autophagosome assembly [GO:2000785]; TORC1 signaling [GO:0038202]	autolysosome [GO:0044754]; cytoplasm [GO:0005737]; GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; lysosome [GO:0005764]; nucleus [GO:0005634]; Seh1-associated complex [GO:0035859]		GO:0005634; GO:0005737; GO:0005764; GO:0007293; GO:0010898; GO:0016239; GO:0032007; GO:0034198; GO:0035859; GO:0038202; GO:0044754; GO:0045792; GO:0048477; GO:0051301; GO:0051321; GO:0061700; GO:1904262; GO:1904766; GO:1990130; GO:2000785	cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; germarium-derived egg chamber formation [GO:0007293]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; oogenesis [GO:0048477]; positive regulation of macroautophagy [GO:0016239]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of autophagosome assembly [GO:2000785]; TORC1 signaling [GO:0038202]		NA	NA	NA	NA	NA	NA
TRINITY_DN11369_c0_g1_i13	Q5ZMV9	WDR24_CHICK	65.5	55	19	0	608	444	651	705	8.00E-18	92	WDR24_CHICK	reviewed	GATOR complex protein WDR24	WDR24 RCJMB04_1a19	Gallus gallus (Chicken)	705	lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]	lysosomal membrane [GO:0005765]		GO:0005765; GO:0006914; GO:0032008	autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN29441_c0_g1_i1	Q96S15	WDR24_HUMAN	100	91	0	0	274	2	55	145	8.90E-49	193.7	WDR24_HUMAN	reviewed	GATOR complex protein WDR24 (WD repeat-containing protein 24)	WDR24 C16orf21 JFP7	Homo sapiens (Human)	790	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005829; GO:0006914; GO:0010506; GO:0032008; GO:0034198; GO:0043231; GO:0061700	autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN11369_c0_g1_i6	Q8CFJ9	WDR24_MOUSE	42.1	787	421	12	2738	438	19	790	3.90E-176	620.2	WDR24_MOUSE	reviewed	GATOR complex protein WDR24 (WD repeat-containing protein 24)	Wdr24	Mus musculus (Mouse)	790	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005829; GO:0006914; GO:0010506; GO:0032008; GO:0034198; GO:0043231; GO:0061700	autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN11369_c0_g1_i8	Q8CFJ9	WDR24_MOUSE	42.1	787	421	12	2591	291	19	790	3.70E-176	620.2	WDR24_MOUSE	reviewed	GATOR complex protein WDR24 (WD repeat-containing protein 24)	Wdr24	Mus musculus (Mouse)	790	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005829; GO:0006914; GO:0010506; GO:0032008; GO:0034198; GO:0043231; GO:0061700	autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN11369_c0_g1_i9	Q8CFJ9	WDR24_MOUSE	40.7	730	398	12	2222	93	19	733	3.60E-151	537	WDR24_MOUSE	reviewed	GATOR complex protein WDR24 (WD repeat-containing protein 24)	Wdr24	Mus musculus (Mouse)	790	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005829; GO:0006914; GO:0010506; GO:0032008; GO:0034198; GO:0043231; GO:0061700	autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN498_c0_g1_i1	Q5ZLG9	WDR59_CHICK	48.8	123	63	0	481	113	848	970	1.90E-36	154.1	WDR59_CHICK	reviewed	GATOR complex protein WDR59	WDR59 RCJMB04_6d21	Gallus gallus (Chicken)	973	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN498_c0_g1_i2	Q5ZLG9	WDR59_CHICK	52.6	329	152	3	1720	740	1	327	2.60E-101	370.9	WDR59_CHICK	reviewed	GATOR complex protein WDR59	WDR59 RCJMB04_6d21	Gallus gallus (Chicken)	973	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN498_c0_g1_i3	Q5ZLG9	WDR59_CHICK	39.6	1061	516	22	3193	113	1	970	1.30E-204	714.9	WDR59_CHICK	reviewed	GATOR complex protein WDR59	WDR59 RCJMB04_6d21	Gallus gallus (Chicken)	973	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN498_c0_g1_i4	Q5ZLG9	WDR59_CHICK	49.6	244	122	1	823	92	1	243	1.80E-68	260.8	WDR59_CHICK	reviewed	GATOR complex protein WDR59	WDR59 RCJMB04_6d21	Gallus gallus (Chicken)	973	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN498_c0_g1_i6	Q5ZLG9	WDR59_CHICK	48.8	123	63	0	481	113	848	970	2.00E-36	154.1	WDR59_CHICK	reviewed	GATOR complex protein WDR59	WDR59 RCJMB04_6d21	Gallus gallus (Chicken)	973	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN498_c0_g1_i7	Q6PJI9	WDR59_HUMAN	39.5	1060	529	18	3223	113	1	971	2.70E-205	717.2	WDR59_HUMAN	reviewed	GATOR complex protein WDR59 (WD repeat-containing protein 59)	WDR59 KIAA1923 FP977	Homo sapiens (Human)	974	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN41067_c0_g1_i1	Q6PJI9	WDR59_HUMAN	100	79	0	0	239	3	252	330	1.20E-41	169.9	WDR59_HUMAN	reviewed	GATOR complex protein WDR59 (WD repeat-containing protein 59)	WDR59 KIAA1923 FP977	Homo sapiens (Human)	974	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0032008; GO:0034198; GO:0061700	cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i11	Q08CA1	GDPP1_DANRE	36	333	194	4	1161	169	7	322	4.60E-55	216.9	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i12	Q08CA1	GDPP1_DANRE	37.1	175	92	3	777	256	7	164	6.00E-25	116.3	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i14	Q08CA1	GDPP1_DANRE	36.9	314	179	4	990	55	7	303	6.40E-53	209.5	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i16	Q08CA1	GDPP1_DANRE	36.9	314	179	4	990	55	7	303	4.80E-53	209.9	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i17	Q08CA1	GDPP1_DANRE	37.1	175	92	3	777	256	7	164	4.50E-25	116.7	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i18	Q08CA1	GDPP1_DANRE	36	333	194	4	1161	169	7	322	4.60E-55	216.9	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i19	Q08CA1	GDPP1_DANRE	37.1	175	92	3	741	220	7	164	4.30E-25	116.7	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i20	Q08CA1	GDPP1_DANRE	37.1	175	92	3	741	220	7	164	5.80E-25	116.3	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i22	Q08CA1	GDPP1_DANRE	36.9	314	179	4	990	55	7	303	4.80E-53	209.9	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i5	Q08CA1	GDPP1_DANRE	36	333	194	4	1161	169	7	322	4.60E-55	216.9	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3286_c0_g1_i9	Q08CA1	GDPP1_DANRE	37.1	175	92	3	777	256	7	164	4.50E-25	116.7	GDPP1_DANRE	reviewed	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	gdpgp1 zgc:153343	Danio rerio (Zebrafish) (Brachydanio rerio)	343	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN7320_c3_g1_i1	Q6EV56	OFUT2_PANTR	48.6	331	163	6	19	1002	103	429	5.10E-84	312.8	OFUT2_PANTR	reviewed	GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2)	POFUT2 FUT13	Pan troglodytes (Chimpanzee)	429	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]	peptide-O-fucosyltransferase activity [GO:0046922]	GO:0005783; GO:0005794; GO:0006004; GO:0036066; GO:0046922	fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN17386_c0_g1_i2	Q8BLX4	FUCT1_MOUSE	55.1	334	134	5	1056	55	38	355	1.10E-92	341.7	FUCT1_MOUSE	reviewed	GDP-fucose transporter 1 (Solute carrier family 35 member C1)	Slc35c1 Fuct1	Mus musculus (Mouse)	363	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]	GO:0000139; GO:0005338; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0022857; GO:0030259; GO:0036066; GO:0036085; GO:0045746	carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN17386_c0_g1_i6	Q8BLX4	FUCT1_MOUSE	57.5	214	77	3	696	55	156	355	6.50E-59	228.8	FUCT1_MOUSE	reviewed	GDP-fucose transporter 1 (Solute carrier family 35 member C1)	Slc35c1 Fuct1	Mus musculus (Mouse)	363	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]	GO:0000139; GO:0005338; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0022857; GO:0030259; GO:0036066; GO:0036085; GO:0045746	carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN31043_c0_g1_i1	Q8BLX4	FUCT1_MOUSE	100	91	0	0	1	273	121	211	1.70E-44	179.5	FUCT1_MOUSE	reviewed	GDP-fucose transporter 1 (Solute carrier family 35 member C1)	Slc35c1 Fuct1	Mus musculus (Mouse)	363	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]	GO:0000139; GO:0005338; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0022857; GO:0030259; GO:0036066; GO:0036085; GO:0045746	carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]		NA	NA	NA	NA	NA	NA
TRINITY_DN4697_c0_g1_i1	Q8K3X2	FCL_CRIGR	76	204	49	0	614	3	103	306	3.60E-90	332.4	FCL_CRIGR	reviewed	"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein)"	GFUS TSTA3	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	321	"GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; T cell mediated cytotoxicity [GO:0001913]"		"GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]"	GO:0001913; GO:0010595; GO:0019673; GO:0042351; GO:0042802; GO:0047918; GO:0050577; GO:1904906	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN36409_c0_g1_i1	Q8K3X2	FCL_CRIGR	58.2	110	46	0	335	6	142	251	8.00E-36	151	FCL_CRIGR	reviewed	"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein)"	GFUS TSTA3	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	321	"GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; T cell mediated cytotoxicity [GO:0001913]"		"GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]"	GO:0001913; GO:0010595; GO:0019673; GO:0042351; GO:0042802; GO:0047918; GO:0050577; GO:1904906	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN23696_c0_g1_i1	Q13630	FCL_HUMAN	100	123	0	0	3	371	119	241	1.40E-70	266.5	FCL_HUMAN	reviewed	"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)"	GFUS SDR4E1 TSTA3	Homo sapiens (Human)	321	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; T cell mediated cytotoxicity [GO:0001913]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]"	GO:0001913; GO:0005829; GO:0007159; GO:0009055; GO:0010595; GO:0019673; GO:0042351; GO:0042356; GO:0042802; GO:0047918; GO:0050577; GO:0070062; GO:1904906	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN37199_c0_g1_i1	P23591	FCL_MOUSE	97.8	134	3	0	402	1	149	282	7.00E-71	267.7	FCL_MOUSE	reviewed	"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Transplantation antigen P35B) (Tum-P35B antigen)"	Gfus P35b Tsta3 Tstap35b	Mus musculus (Mouse)	321	"GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; T cell mediated cytotoxicity [GO:0001913]"		"GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]"	GO:0001913; GO:0010595; GO:0019673; GO:0042351; GO:0042802; GO:0047918; GO:0050577; GO:1904906	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN4023_c0_g1_i1	Q7ZW24	ALG11_DANRE	54.4	443	194	3	271	1575	55	497	5.40E-133	476.1	ALG11_DANRE	reviewed	"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)"	alg11	Danio rerio (Zebrafish) (Brachydanio rerio)	500	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]"	GO:0004377; GO:0005789; GO:0006487; GO:0006490; GO:0016021	oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN4023_c0_g1_i2	Q2TAA5	ALG11_HUMAN	83.9	31	5	0	286	378	62	92	2.10E-10	67	ALG11_HUMAN	reviewed	"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)"	ALG11 GT8	Homo sapiens (Human)	492	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]"	GO:0004377; GO:0005789; GO:0006487; GO:0006490; GO:0016020; GO:0016021	oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	1
TRINITY_DN3487_c0_g1_i1	Q8K0C9	GMDS_MOUSE	73.4	349	93	0	74	1120	24	372	2.70E-155	549.7	GMDS_MOUSE	reviewed	"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)"	Gmds	Mus musculus (Mouse)	372	"cytoplasm [GO:0005737]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]"	cytoplasm [GO:0005737]	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"	GO:0005737; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]		NA	NA	NA	NA	NA	NA
TRINITY_DN3487_c0_g1_i2	Q8K3X3	GMDS_CRIGR	72.9	351	95	0	55	1107	22	372	4.20E-156	552.4	GMDS_CRIGR	reviewed	"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)"	GMDS GMD	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	372	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]"		"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"	GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]		NA	NA	NA	NA	NA	NA
TRINITY_DN36927_c0_g1_i1	O60547	GMDS_HUMAN	100	159	0	0	1	477	81	239	2.00E-88	326.2	GMDS_HUMAN	reviewed	"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)"	GMDS	Homo sapiens (Human)	372	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"	GO:0005737; GO:0005829; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070062; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]		NA	NA	NA	NA	NA	NA
TRINITY_DN37928_c0_g1_i1	Q9JRN5	GM4D_AGGAC	85.7	84	12	0	2	253	181	264	1.80E-35	149.4	GM4D_AGGAC	reviewed	"GDP-mannose 4,6-dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase)"	gmd	Aggregatibacter actinomycetemcomitans (Actinobacillus actinomycetemcomitans) (Haemophilus actinomycetemcomitans)	344	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; O antigen biosynthetic process [GO:0009243]"		"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]"	GO:0008446; GO:0009243; GO:0019673; GO:0042351; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; O antigen biosynthetic process [GO:0009243]		NA	NA	NA	NA	NA	NA
TRINITY_DN33249_c0_g1_i1	O85713	GM4D_RHIFH	78.5	321	69	0	964	2	1	321	1.10E-149	530.8	GM4D_RHIFH	reviewed	"GDP-mannose 4,6-dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase)"	gmd noeL SFHH103_04266	Rhizobium fredii (strain HH103) (Sinorhizobium fredii)	351	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; nodulation [GO:0009877]"		"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]"	GO:0008446; GO:0009877; GO:0019673; GO:0042351; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; nodulation [GO:0009877]		NA	NA	NA	NA	NA	NA
TRINITY_DN39326_c0_g1_i1	Q56872	GM4D_YERE8	67.8	276	82	1	62	868	2	277	6.30E-109	395.2	GM4D_YERE8	reviewed	"GDP-mannose 4,6-dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase)"	gmd YE3075	Yersinia enterocolitica serotype O:8 / biotype 1B (strain NCTC 13174 / 8081)	372	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; O antigen biosynthetic process [GO:0009243]"		"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]"	GO:0008446; GO:0009243; GO:0019673; GO:0042351; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; O antigen biosynthetic process [GO:0009243]		NA	NA	NA	NA	NA	NA
TRINITY_DN25543_c0_g1_i1	P0AC90	GM4D_ECO57	87.8	278	34	0	74	907	3	280	4.80E-144	511.9	GM4D_ECO57	reviewed	"GDP-mannose 4,6-dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase)"	gmd Z3217 ECs2858	Escherichia coli O157:H7	373	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]"		"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]"	GO:0008446; GO:0019673; GO:0042351; GO:0070401	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]		NA	NA	NA	NA	NA	NA
TRINITY_DN40088_c0_g1_i1	A2YXC7	GDT14_ORYSI	50.8	65	32	0	207	13	57	121	3.00E-09	62	GDT14_ORYSI	reviewed	GDT1-like protein 4	OsI_29993	Oryza sativa subsp. indica (Rice)	281	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8045_c0_g1_i1	Q07171	GELS_DROME	54.1	109	39	1	397	71	74	171	1.90E-26	120.6	GELS_DROME	reviewed	Gelsolin	Gel CG1106	Drosophila melanogaster (Fruit fly)	798	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]	"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005546; GO:0005576; GO:0005737; GO:0005829; GO:0005884; GO:0008154; GO:0015629; GO:0030041; GO:0046872; GO:0051014; GO:0051015; GO:0051016	actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]		NA	NA	NA	NA	NA	NA
TRINITY_DN8045_c0_g1_i3	Q07171	GELS_DROME	41.3	281	146	6	839	9	74	339	3.40E-50	200.3	GELS_DROME	reviewed	Gelsolin	Gel CG1106	Drosophila melanogaster (Fruit fly)	798	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]"	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]	"actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005546; GO:0005576; GO:0005737; GO:0005829; GO:0005884; GO:0008154; GO:0015629; GO:0030041; GO:0046872; GO:0051014; GO:0051015; GO:0051016	actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]		NA	NA	NA	NA	NA	NA
TRINITY_DN37891_c0_g1_i1	P13020	GELS_MOUSE	100	67	0	0	2	202	662	728	3.90E-33	141.4	GELS_MOUSE	reviewed	Gelsolin (Actin-depolymerizing factor) (ADF) (Brevin)	Gsn Gsb	Mus musculus (Mouse)	780	"actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellipodium [GO:0030027]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; aging [GO:0007568]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to cadmium ion [GO:0071276]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; oligodendrocyte development [GO:0014003]; phagocytosis, engulfment [GO:0006911]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of cell adhesion [GO:0030155]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]; tissue regeneration [GO:0042246]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060]"	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellipodium [GO:0030027]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; sarcoplasm [GO:0016528]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0001726; GO:0002102; GO:0003779; GO:0005509; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007417; GO:0007568; GO:0008154; GO:0010628; GO:0014003; GO:0014891; GO:0015629; GO:0016192; GO:0016528; GO:0030027; GO:0030031; GO:0030036; GO:0030041; GO:0030042; GO:0030155; GO:0030478; GO:0030864; GO:0031648; GO:0032991; GO:0035994; GO:0036313; GO:0042060; GO:0042246; GO:0042989; GO:0043209; GO:0045010; GO:0045159; GO:0045335; GO:0045471; GO:0046597; GO:0048015; GO:0048471; GO:0051014; GO:0051015; GO:0051016; GO:0051127; GO:0051593; GO:0051693; GO:0055119; GO:0060271; GO:0071276; GO:0071346; GO:0071801; GO:0086003; GO:0090527; GO:0097017; GO:0097284; GO:1902174; GO:1903903; GO:1903906; GO:1903909; GO:1903923; GO:1990000; GO:2001269	"actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; aging [GO:0007568]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to cadmium ion [GO:0071276]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; oligodendrocyte development [GO:0014003]; phagocytosis, engulfment [GO:0006911]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of cell adhesion [GO:0030155]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]; tissue regeneration [GO:0042246]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36557_c0_g1_i1	P13020	GELS_MOUSE	100	75	0	0	228	4	96	170	2.60E-38	158.7	GELS_MOUSE	reviewed	Gelsolin (Actin-depolymerizing factor) (ADF) (Brevin)	Gsn Gsb	Mus musculus (Mouse)	780	"actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellipodium [GO:0030027]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; aging [GO:0007568]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to cadmium ion [GO:0071276]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; oligodendrocyte development [GO:0014003]; phagocytosis, engulfment [GO:0006911]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of cell adhesion [GO:0030155]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]; tissue regeneration [GO:0042246]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060]"	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellipodium [GO:0030027]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; sarcoplasm [GO:0016528]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0001726; GO:0002102; GO:0003779; GO:0005509; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007417; GO:0007568; GO:0008154; GO:0010628; GO:0014003; GO:0014891; GO:0015629; GO:0016192; GO:0016528; GO:0030027; GO:0030031; GO:0030036; GO:0030041; GO:0030042; GO:0030155; GO:0030478; GO:0030864; GO:0031648; GO:0032991; GO:0035994; GO:0036313; GO:0042060; GO:0042246; GO:0042989; GO:0043209; GO:0045010; GO:0045159; GO:0045335; GO:0045471; GO:0046597; GO:0048015; GO:0048471; GO:0051014; GO:0051015; GO:0051016; GO:0051127; GO:0051593; GO:0051693; GO:0055119; GO:0060271; GO:0071276; GO:0071346; GO:0071801; GO:0086003; GO:0090527; GO:0097017; GO:0097284; GO:1902174; GO:1903903; GO:1903906; GO:1903909; GO:1903923; GO:1990000; GO:2001269	"actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; aging [GO:0007568]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to cadmium ion [GO:0071276]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; oligodendrocyte development [GO:0014003]; phagocytosis, engulfment [GO:0006911]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of cell adhesion [GO:0030155]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]; tissue regeneration [GO:0042246]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9470_c0_g1_i1	Q27319	GELS_HOMAM	91.5	94	8	0	6	287	441	534	1.60E-45	183	GELS_HOMAM	reviewed	"Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF)"		Homarus americanus (American lobster)	754	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693	actin filament capping [GO:0051693]		blue	blue	NA	NA	NA	NA
TRINITY_DN8045_c0_g1_i2	Q27319	GELS_HOMAM	50.7	146	57	2	511	80	16	148	2.00E-35	150.6	GELS_HOMAM	reviewed	"Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF)"		Homarus americanus (American lobster)	754	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693	actin filament capping [GO:0051693]		blue	blue	NA	NA	NA	NA
TRINITY_DN31472_c0_g1_i1	Q27319	GELS_HOMAM	85.6	125	18	0	25	399	1	125	1.60E-59	229.9	GELS_HOMAM	reviewed	"Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF)"		Homarus americanus (American lobster)	754	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693	actin filament capping [GO:0051693]		blue	blue	NA	NA	NA	NA
TRINITY_DN8947_c0_g1_i1	Q27319	GELS_HOMAM	83.3	90	15	0	1	270	616	705	1.90E-40	166	GELS_HOMAM	reviewed	"Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF)"		Homarus americanus (American lobster)	754	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament capping [GO:0051693]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693	actin filament capping [GO:0051693]		blue	blue	NA	NA	NA	NA
TRINITY_DN38855_c0_g1_i1	Q9CQQ4	GEMI2_MOUSE	33.5	254	162	5	837	97	13	266	1.10E-32	142.1	GEMI2_MOUSE	reviewed	Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1)	Gemin2 Sip1	Mus musculus (Mouse)	269	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]		GO:0000245; GO:0000387; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504	spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN4865_c0_g1_i1	Q8TEQ6	GEMI5_HUMAN	25.8	717	452	16	2665	623	598	1270	1.40E-40	169.9	GEMI5_HUMAN	reviewed	Gem-associated protein 5 (Gemin5)	GEMIN5	Homo sapiens (Human)	1508	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]	mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0051170; GO:0065003; GO:0097504	"import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1756_c0_g1_i1	Q8BHE1	GEMI8_MOUSE	23.1	242	150	5	105	755	6	236	1.80E-07	58.2	GEMI8_MOUSE	reviewed	Gem-associated protein 8 (Gemin-8) (Protein FAM51A1)	Gemin8 Fam51a1	Mus musculus (Mouse)	238	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal snRNP assembly [GO:0000387]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]		GO:0000387; GO:0005634; GO:0005737; GO:0005829; GO:0032797; GO:0034719; GO:0097504	spliceosomal snRNP assembly [GO:0000387]		blue	blue	NA	NA	NA	NA
TRINITY_DN32833_c0_g1_i1	Q02870	ERCC3_DROME	66.2	797	232	12	104	2434	18	797	4.60E-293	1008.4	ERCC3_DROME	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (ATP-dependent DNA helicase hay) (DNA excision repair protein haywire) (ERCC-3 homolog protein) (ERCC3Dm)	hay ERCC3 CG8019	Drosophila melanogaster (Fruit fly)	798	"nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; transcription factor binding [GO:0008134]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]"	nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; transcription factor binding [GO:0008134]	GO:0000112; GO:0001111; GO:0001113; GO:0003677; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005675; GO:0006289; GO:0006366; GO:0006367; GO:0008134; GO:0009411; GO:0033683; GO:0043138; GO:0097550	"nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37577_c0_g1_i1	P19447	ERCC3_HUMAN	100	155	0	0	467	3	267	421	6.90E-86	317.8	ERCC3_HUMAN	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)	ERCC3 XPB XPBC	Homo sapiens (Human)	782	"nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; 7-methylguanosine mRNA capping [GO:0006370]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]; viral process [GO:0016032]"	nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0003678; GO:0003684; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0009411; GO:0009650; GO:0016032; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0070911; GO:0097550; GO:1901990; GO:1990841	"7-methylguanosine mRNA capping [GO:0006370]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; UV protection [GO:0009650]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33792_c0_g1_i1	P19447	ERCC3_HUMAN	95.4	109	5	0	1	327	426	534	3.00E-56	218.8	ERCC3_HUMAN	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)	ERCC3 XPB XPBC	Homo sapiens (Human)	782	"nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; 7-methylguanosine mRNA capping [GO:0006370]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]; viral process [GO:0016032]"	nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0003678; GO:0003684; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0009411; GO:0009650; GO:0016032; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0070911; GO:0097550; GO:1901990; GO:1990841	"7-methylguanosine mRNA capping [GO:0006370]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; UV protection [GO:0009650]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33462_c0_g1_i1	P19447	ERCC3_HUMAN	100	109	0	0	3	329	100	208	4.30E-58	224.9	ERCC3_HUMAN	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)	ERCC3 XPB XPBC	Homo sapiens (Human)	782	"nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; 7-methylguanosine mRNA capping [GO:0006370]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]; viral process [GO:0016032]"	nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0003678; GO:0003684; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0009411; GO:0009650; GO:0016032; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0070911; GO:0097550; GO:1901990; GO:1990841	"7-methylguanosine mRNA capping [GO:0006370]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; UV protection [GO:0009650]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8361_c0_g2_i1	O00835	ERCC3_DICDI	57	172	71	1	520	5	429	597	1.90E-52	206.8	ERCC3_DICDI	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA excision repair cross-complementing protein-3 homolog) (DNA repair helicase repB) (DNA repair protein B)	repB ercc3 DDB_G0278729	Dictyostelium discoideum (Slime mold)	800	"nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; transcription factor binding [GO:0008134]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]"	nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; transcription factor binding [GO:0008134]	GO:0000112; GO:0003677; GO:0003678; GO:0005524; GO:0005675; GO:0006289; GO:0006366; GO:0006367; GO:0006974; GO:0008134; GO:0009411; GO:0009650; GO:0033683; GO:0043138; GO:0097550	"cellular response to DNA damage stimulus [GO:0006974]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39744_c0_g1_i1	Q1RMT1	ERCC3_BOVIN	100	72	0	0	3	218	513	584	1.80E-36	152.5	ERCC3_BOVIN	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA excision repair protein ERCC-3)	ERCC3	Bos taurus (Bovine)	782	"nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	GO:0000112; GO:0000439; GO:0000717; GO:0003677; GO:0003678; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	"apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39273_c0_g1_i1	Q1RMT1	ERCC3_BOVIN	100	108	0	0	2	325	578	685	6.80E-56	217.6	ERCC3_BOVIN	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA excision repair protein ERCC-3)	ERCC3	Bos taurus (Bovine)	782	"nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	GO:0000112; GO:0000439; GO:0000717; GO:0003677; GO:0003678; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	"apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8361_c0_g1_i1	O13768	ERCC3_SCHPO	61	82	32	0	5	250	316	397	1.70E-22	106.3	ERCC3_SCHPO	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA repair helicase ptr8) (Poly(A)+ RNA transport protein 8) (RNA polymerase II transcription factor B subunit ercc3) (TFB subunit ercc3)	ptr8 ercc3 SPAC17A5.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	804	"nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription factor binding [GO:0008134]; nucleotide-excision repair, DNA incision [GO:0033683]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription factor binding [GO:0008134]	GO:0000112; GO:0000439; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005675; GO:0006283; GO:0006366; GO:0006367; GO:0008134; GO:0009411; GO:0016251; GO:0033683; GO:0043138; GO:0097550	"nucleotide-excision repair, DNA incision [GO:0033683]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32799_c0_g1_i1	A9CRJ7	RAD25_ENTBH	77	126	29	0	378	1	286	411	5.80E-51	201.4	RAD25_ENTBH	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA repair helicase RAD25) (RNA polymerase II transcription factor B subunit SSL2) (TFB subunit SSL2) (Suppressor of stem-loop mutation 2)	SSL2 RAD25 EBI_23223	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	609	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006289; GO:0006367	nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN15779_c0_g1_i1	Q8SSK1	RAD25_ENCCU	87.8	123	15	0	372	4	456	578	1.10E-57	223.8	RAD25_ENCCU	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA repair helicase RAD25) (RNA polymerase II transcription factor B subunit SSL2) (TFB subunit SSL2) (Suppressor of stem-loop mutation 2)	SSL2 RAD25 ECU01_1060	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	672	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006289; GO:0006367	nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN31875_c0_g1_i1	A9CRJ7	RAD25_ENTBH	87.1	70	9	0	14	223	183	252	5.40E-28	124.4	RAD25_ENTBH	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA repair helicase RAD25) (RNA polymerase II transcription factor B subunit SSL2) (TFB subunit SSL2) (Suppressor of stem-loop mutation 2)	SSL2 RAD25 EBI_23223	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	609	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006289; GO:0006367	nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN34082_c0_g1_i1	A9CRJ7	RAD25_ENTBH	67.5	83	27	0	2	250	12	94	5.00E-27	121.3	RAD25_ENTBH	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA repair helicase RAD25) (RNA polymerase II transcription factor B subunit SSL2) (TFB subunit SSL2) (Suppressor of stem-loop mutation 2)	SSL2 RAD25 EBI_23223	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	609	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006289; GO:0006367	nucleotide-excision repair [GO:0006289]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN2562_c0_g2_i1	Q60452	ERCC2_CRIGR	63.6	758	273	1	2339	75	1	758	1.20E-298	1026.9	ERCC2_CRIGR	reviewed	General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein)	ERCC2 XPD	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	760	"CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]"	CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]	"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]"	GO:0003677; GO:0005524; GO:0005634; GO:0005675; GO:0005737; GO:0005819; GO:0006283; GO:0006366; GO:0006915; GO:0006979; GO:0007059; GO:0008022; GO:0033683; GO:0035315; GO:0043139; GO:0046872; GO:0047485; GO:0051539; GO:0070516; GO:0071817; GO:1901990	"apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29136_c0_g1_i1	A6QLJ0	ERCC2_BOVIN	61.5	65	25	0	205	11	32	96	2.00E-16	85.9	ERCC2_BOVIN	reviewed	General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein)	ERCC2	Bos taurus (Bovine)	760	"CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic recombination [GO:0000019]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]"	CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]	"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]"	GO:0000019; GO:0000717; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005675; GO:0005737; GO:0005819; GO:0006366; GO:0006979; GO:0007059; GO:0008022; GO:0009411; GO:0033683; GO:0035315; GO:0043139; GO:0045951; GO:0046872; GO:0051539; GO:0070516; GO:0071817; GO:1901990	"chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic recombination [GO:0000019]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4308_c0_g1_i1	P26659	RAD15_SCHPO	62.8	129	48	0	389	3	583	711	1.70E-43	176.8	RAD15_SCHPO	reviewed	General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (DNA repair helicase RAD3 homolog) (Protein rhp3) (DNA repair helicase rad15) (RNA polymerase II transcription factor B subunit rad15) (TFB subunit rad15)	rad15 rad5 rhp3 SPAC1D4.12	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	772	"cytosol [GO:0005829]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic recombination [GO:0000019]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytosol [GO:0005829]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]"	GO:0000019; GO:0000112; GO:0000439; GO:0000717; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005675; GO:0005829; GO:0006366; GO:0006367; GO:0006979; GO:0009411; GO:0016251; GO:0033683; GO:0043139; GO:0045951; GO:0046872; GO:0051539	"nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic recombination [GO:0000019]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28054_c0_g1_i1	Q8W4M7	ERCC2_ARATH	48.5	103	52	1	311	6	400	502	2.90E-24	112.5	ERCC2_ARATH	reviewed	General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (ERCC2 homolog) (RAD3 homolog) (UV hypersensitive protein 6) (AtUVH6) (XPD homolog) (AtXPD)	XPD UVH6 At1g03190 F15K9.20	Arabidopsis thaliana (Mouse-ear cress)	758	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic recombination [GO:0000019]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000019; GO:0000717; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0006281; GO:0006366; GO:0006979; GO:0009408; GO:0009411; GO:0033683; GO:0045951; GO:0046872; GO:0051539	"DNA repair [GO:0006281]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic recombination [GO:0000019]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33415_c0_g1_i1	Q8W4M7	ERCC2_ARATH	68.5	124	39	0	6	377	580	703	1.50E-46	186.8	ERCC2_ARATH	reviewed	General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (ERCC2 homolog) (RAD3 homolog) (UV hypersensitive protein 6) (AtUVH6) (XPD homolog) (AtXPD)	XPD UVH6 At1g03190 F15K9.20	Arabidopsis thaliana (Mouse-ear cress)	758	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic recombination [GO:0000019]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000019; GO:0000717; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0006281; GO:0006366; GO:0006979; GO:0009408; GO:0009411; GO:0033683; GO:0045951; GO:0046872; GO:0051539	"DNA repair [GO:0006281]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic recombination [GO:0000019]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3334_c0_g1_i1	Q12789	TF3C1_HUMAN	29.1	764	435	19	219	2342	576	1288	4.00E-73	277.7	TF3C1_HUMAN	reviewed	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)	GTF3C1	Homo sapiens (Human)	2109	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904	5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN3334_c0_g1_i2	Q8K284	TF3C1_MOUSE	33.1	444	212	9	70	1281	884	1282	2.80E-52	207.6	TF3C1_MOUSE	reviewed	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)	Gtf3c1	Mus musculus (Mouse)	2101	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0005730; GO:0006384; GO:0042791; GO:1990904	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN3334_c0_g1_i3	Q8K284	TF3C1_MOUSE	50.6	89	44	0	70	336	884	972	4.20E-20	99	TF3C1_MOUSE	reviewed	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)	Gtf3c1	Mus musculus (Mouse)	2101	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0005730; GO:0006384; GO:0042791; GO:1990904	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN3334_c0_g1_i4	Q8K284	TF3C1_MOUSE	31.8	556	264	14	104	1561	772	1282	1.10E-60	235.7	TF3C1_MOUSE	reviewed	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)	Gtf3c1	Mus musculus (Mouse)	2101	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0005730; GO:0006384; GO:0042791; GO:1990904	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN3334_c0_g1_i5	Q12789	TF3C1_HUMAN	29.1	764	435	19	256	2379	576	1288	4.00E-73	277.7	TF3C1_HUMAN	reviewed	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)	GTF3C1	Homo sapiens (Human)	2109	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904	5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN3334_c0_g1_i6	Q12789	TF3C1_HUMAN	29.2	742	420	18	55	2112	596	1288	6.10E-73	276.9	TF3C1_HUMAN	reviewed	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)	GTF3C1	Homo sapiens (Human)	2109	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904	5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN1053_c0_g1_i2	Q9UKN8	TF3C4_HUMAN	21.9	429	282	12	2133	940	58	464	5.80E-13	77.8	TF3C4_HUMAN	reviewed	General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta)	GTF3C4	Homo sapiens (Human)	822	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]	GO:0000127; GO:0003677; GO:0004402; GO:0005654; GO:0005739; GO:0006383; GO:0006384; GO:0008047; GO:0042791; GO:0042797	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN23217_c0_g1_i1	Q9Y5Q8	TF3C5_HUMAN	100	69	0	0	2	208	275	343	3.50E-37	154.8	TF3C5_HUMAN	reviewed	General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)	GTF3C5 CDABP0017	Homo sapiens (Human)	519	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0006383; GO:0006384; GO:0035914; GO:0042791; GO:0042797	5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN395_c0_g1_i2	Q8R2T8	TF3C5_MOUSE	36.6	415	223	9	5	1201	75	465	1.00E-65	252.3	TF3C5_MOUSE	reviewed	General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)	Gtf3c5	Mus musculus (Mouse)	520	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0006384; GO:0035914	skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN395_c0_g1_i4	Q8R2T8	TF3C5_MOUSE	37.7	358	185	8	5	1030	75	410	2.90E-58	227.3	TF3C5_MOUSE	reviewed	General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)	Gtf3c5	Mus musculus (Mouse)	520	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0006384; GO:0035914	skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN395_c0_g1_i6	Q8R2T8	TF3C5_MOUSE	39.3	267	138	4	5	784	75	324	2.10E-48	194.1	TF3C5_MOUSE	reviewed	General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)	Gtf3c5	Mus musculus (Mouse)	520	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0006384; GO:0035914	skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]		NA	NA	NA	NA	NA	NA
TRINITY_DN7647_c0_g1_i1	Q9D8P7	TF3C6_MOUSE	45.3	106	53	3	9	326	26	126	6.90E-18	91.7	TF3C6_MOUSE	reviewed	General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit) (TFIIIC 35 kDa subunit) (TFIIIC35) (Transcription factor IIIC subunit 6)	Gtf3c6	Mus musculus (Mouse)	227	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; transcription by RNA polymerase III [GO:0006383]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0006383; GO:0016604	transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN38416_c0_g1_i1	Q969F1	TF3C6_HUMAN	93.5	77	5	0	1	231	14	90	3.00E-34	145.2	TF3C6_HUMAN	reviewed	General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit) (TFIIIC 35 kDa subunit) (TFIIIC35) (Transcription factor IIIC subunit 6)	GTF3C6 C6orf51 CDA020 NPD020	Homo sapiens (Human)	213	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	GO:0000127; GO:0003677; GO:0005654; GO:0006383; GO:0016604; GO:0042791; GO:0042797	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]		NA	NA	NA	NA	NA	NA
TRINITY_DN32942_c0_g1_i1	P29083	T2EA_HUMAN	42.6	251	127	3	838	128	38	285	1.00E-50	201.8	T2EA_HUMAN	reviewed	General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha)	GTF2E1 TF2E1	Homo sapiens (Human)	439	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550]	metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000993; GO:0001113; GO:0005634; GO:0005654; GO:0005669; GO:0005673; GO:0005829; GO:0006366; GO:0006367; GO:0016032; GO:0016251; GO:0042795; GO:0046872; GO:0097550	snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32942_c0_g1_i2	P29083	T2EA_HUMAN	45.1	286	140	3	943	128	3	285	1.00E-62	241.9	T2EA_HUMAN	reviewed	General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha)	GTF2E1 TF2E1	Homo sapiens (Human)	439	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550]	metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000993; GO:0001113; GO:0005634; GO:0005654; GO:0005669; GO:0005673; GO:0005829; GO:0006366; GO:0006367; GO:0016032; GO:0016251; GO:0042795; GO:0046872; GO:0097550	snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN23409_c0_g1_i1	P35269	T2FA_HUMAN	99	102	1	0	323	18	83	184	5.10E-56	218	T2FA_HUMAN	reviewed	General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74)	GTF2F1 RAP74	Homo sapiens (Human)	517	"cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transcription factor binding [GO:0008134]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of viral transcription [GO:0050434]; response to virus [GO:0009615]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transcription factor binding [GO:0008134]	GO:0000398; GO:0001096; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005669; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008134; GO:0008543; GO:0009615; GO:0016070; GO:0016251; GO:0019211; GO:0019903; GO:0019904; GO:0030054; GO:0032091; GO:0032968; GO:0032991; GO:0042795; GO:0043231; GO:0045944; GO:0050434; GO:1990841	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of viral transcription [GO:0050434]; response to virus [GO:0009615]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6142_c0_g1_i1	Q05913	T2FA_DROME	57.9	209	86	2	659	36	37	244	1.70E-64	247.3	T2FA_DROME	reviewed	General transcription factor IIF subunit 1 (Transcription factor 5 large chain) (TF5A) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)	TfIIFalpha CG10281	Drosophila melanogaster (Fruit fly)	577	nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]	GO:0001096; GO:0003677; GO:0005634; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0016251; GO:0016740; GO:0032968; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		blue	blue	NA	NA	NA	NA
TRINITY_DN6142_c0_g1_i2	Q05913	T2FA_DROME	57.8	154	64	1	494	36	91	244	6.70E-44	179.1	T2FA_DROME	reviewed	General transcription factor IIF subunit 1 (Transcription factor 5 large chain) (TF5A) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)	TfIIFalpha CG10281	Drosophila melanogaster (Fruit fly)	577	nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]	GO:0001096; GO:0003677; GO:0005634; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0016251; GO:0016740; GO:0032968; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN6142_c0_g1_i2	Q05913	T2FA_DROME	58.2	55	22	1	780	616	37	90	5.20E-12	73.2	T2FA_DROME	reviewed	General transcription factor IIF subunit 1 (Transcription factor 5 large chain) (TF5A) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)	TfIIFalpha CG10281	Drosophila melanogaster (Fruit fly)	577	nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transferase activity [GO:0016740]	GO:0001096; GO:0003677; GO:0005634; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0016251; GO:0016740; GO:0032968; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN8082_c0_g1_i1	Q3THK3	T2FA_MOUSE	47.4	97	51	0	80	370	412	508	5.50E-16	85.5	T2FA_MOUSE	reviewed	General transcription factor IIF subunit 1 (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)	Gtf2f1	Mus musculus (Mouse)	508	cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transcription factor binding [GO:0008134]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to virus [GO:0009615]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transcription factor binding [GO:0008134]	GO:0001096; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005674; GO:0006367; GO:0006368; GO:0008134; GO:0009615; GO:0016251; GO:0019211; GO:0019903; GO:0019904; GO:0030054; GO:0032091; GO:0032968; GO:0032991; GO:0043231; GO:0045944; GO:1990841	negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to virus [GO:0009615]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN33240_c0_g1_i1	P32780	TF2H1_HUMAN	100	76	0	0	3	230	22	97	2.00E-38	159.1	TF2H1_HUMAN	reviewed	General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit)	GTF2H1 BTF2	Homo sapiens (Human)	548	"nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; chromatin binding [GO:0003682]; thyroid hormone receptor binding [GO:0046966]; 7-methylguanosine mRNA capping [GO:0006370]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"	nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	chromatin binding [GO:0003682]; thyroid hormone receptor binding [GO:0046966]	GO:0000079; GO:0000439; GO:0000717; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006360; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0009755; GO:0033683; GO:0045893; GO:0046966; GO:0070816; GO:0070911	"7-methylguanosine mRNA capping [GO:0006370]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12484_c0_g1_i1	Q960E8	TF2H1_DROME	50.7	223	107	3	699	37	50	271	1.00E-54	214.9	TF2H1_DROME	reviewed	General transcription factor IIH subunit 1 (TFIIH basal transcription factor complex subunit 1)	Tfb1 CG8151	Drosophila melanogaster (Fruit fly)	585	nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]	nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]		GO:0000439; GO:0001111; GO:0001113; GO:0005634; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009411; GO:0070816	DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]		NA	NA	NA	NA	NA	NA
TRINITY_DN12484_c0_g1_i2	Q960E8	TF2H1_DROME	51.1	272	130	3	846	37	1	271	7.90E-70	265.4	TF2H1_DROME	reviewed	General transcription factor IIH subunit 1 (TFIIH basal transcription factor complex subunit 1)	Tfb1 CG8151	Drosophila melanogaster (Fruit fly)	585	nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]	nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]		GO:0000439; GO:0001111; GO:0001113; GO:0005634; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009411; GO:0070816	DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; promoter clearance from RNA polymerase II promoter [GO:0001111]; response to UV [GO:0009411]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]		NA	NA	NA	NA	NA	NA
TRINITY_DN3456_c0_g1_i1	Q13888	TF2H2_HUMAN	50.3	388	181	5	1263	124	2	385	2.40E-118	427.2	TF2H2_HUMAN	reviewed	General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit) (BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)	GTF2H2 BTF2P44	Homo sapiens (Human)	395	"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]; 7-methylguanosine mRNA capping [GO:0006370]; G protein-coupled receptor internalization [GO:0002031]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]	GO:0000438; GO:0000439; GO:0000717; GO:0002031; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006357; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008270; GO:0009411; GO:0016032; GO:0016251; GO:0016607; GO:0033683; GO:0047485; GO:0070911; GO:1905776	"7-methylguanosine mRNA capping [GO:0006370]; global genome nucleotide-excision repair [GO:0070911]; G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3456_c0_g1_i2	Q13888	TF2H2_HUMAN	50.3	388	181	5	1218	79	2	385	2.30E-118	427.2	TF2H2_HUMAN	reviewed	General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit) (BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)	GTF2H2 BTF2P44	Homo sapiens (Human)	395	"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]; 7-methylguanosine mRNA capping [GO:0006370]; G protein-coupled receptor internalization [GO:0002031]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]	GO:0000438; GO:0000439; GO:0000717; GO:0002031; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006357; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008270; GO:0009411; GO:0016032; GO:0016251; GO:0016607; GO:0033683; GO:0047485; GO:0070911; GO:1905776	"7-methylguanosine mRNA capping [GO:0006370]; global genome nucleotide-excision repair [GO:0070911]; G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36026_c0_g1_i1	Q6P1K8	T2H2L_HUMAN	98.9	88	1	0	2	265	150	237	1.20E-42	173.3	T2H2L_HUMAN	reviewed	General transcription factor IIH subunit 2-like protein (General transcription factor IIH polypeptide 2-like protein)	GTF2H2C; GTF2H2C_2 GTF2H2D	Homo sapiens (Human)	395	"nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	zinc ion binding [GO:0008270]	GO:0000439; GO:0005675; GO:0006289; GO:0006351; GO:0006357; GO:0008270; GO:0016607	"nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31854_c0_g1_i1	Q6P1K8	T2H2L_HUMAN	100	83	0	0	2	250	30	112	7.30E-42	170.6	T2H2L_HUMAN	reviewed	General transcription factor IIH subunit 2-like protein (General transcription factor IIH polypeptide 2-like protein)	GTF2H2C; GTF2H2C_2 GTF2H2D	Homo sapiens (Human)	395	"nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	zinc ion binding [GO:0008270]	GO:0000439; GO:0005675; GO:0006289; GO:0006351; GO:0006357; GO:0008270; GO:0016607	"nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38681_c0_g1_i1	Q6P1K8	T2H2L_HUMAN	100	81	0	0	3	245	259	339	5.80E-44	177.6	T2H2L_HUMAN	reviewed	General transcription factor IIH subunit 2-like protein (General transcription factor IIH polypeptide 2-like protein)	GTF2H2C; GTF2H2C_2 GTF2H2D	Homo sapiens (Human)	395	"nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	zinc ion binding [GO:0008270]	GO:0000439; GO:0005675; GO:0006289; GO:0006351; GO:0006357; GO:0008270; GO:0016607	"nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10776_c0_g1_i1	Q13889	TF2H3_HUMAN	37.7	297	160	4	913	89	10	303	5.20E-46	186.4	TF2H3_HUMAN	reviewed	General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit) (BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit)	GTF2H3	Homo sapiens (Human)	308	"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; 7-methylguanosine mRNA capping [GO:0006370]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000438; GO:0000439; GO:0000717; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0016251; GO:0033683; GO:0046872; GO:0047485; GO:0070816; GO:0070911; GO:0097550	"7-methylguanosine mRNA capping [GO:0006370]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34552_c0_g1_i1	O70422	TF2H4_MOUSE	33	106	60	2	1	315	61	156	1.60E-09	63.5	TF2H4_MOUSE	reviewed	General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit)	Gtf2h4	Mus musculus (Mouse)	463	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; double-stranded DNA binding [GO:0003690]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	ATPase activator activity [GO:0001671]; double-stranded DNA binding [GO:0003690]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005669; GO:0005675; GO:0006289; GO:0006366; GO:0016251; GO:0016607; GO:0070816	nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]		blue	blue	NA	NA	NA	NA
TRINITY_DN2769_c0_g1_i1	A4IFA3	GT2D2_BOVIN	37.6	186	112	2	624	73	734	917	8.80E-28	125.2	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN2769_c0_g1_i10	A4IFA3	GT2D2_BOVIN	36.8	576	315	6	1817	102	419	949	6.90E-100	366.3	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN2769_c0_g1_i14	A4IFA3	GT2D2_BOVIN	40.3	283	165	2	944	102	669	949	1.30E-53	212.2	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN2769_c0_g1_i16	A4IFA3	GT2D2_BOVIN	36.3	576	318	5	1817	102	419	949	6.90E-100	366.3	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN39709_c0_g1_i1	A4IFA3	GT2D2_BOVIN	40.6	106	63	0	2	319	527	632	3.60E-17	89	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN1975_c0_g1_i1	A4IFA3	GT2D2_BOVIN	37.6	109	68	0	330	4	524	632	5.20E-14	78.6	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN6896_c0_g2_i1	A4IFA3	GT2D2_BOVIN	35.4	82	53	0	251	6	506	587	4.80E-08	58.5	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN6896_c0_g1_i1	Q99NI3	GT2D2_MOUSE	43.5	69	39	0	47	253	522	590	1.30E-07	57	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN6896_c0_g1_i5	Q99NI3	GT2D2_MOUSE	44.3	70	39	0	21	230	521	590	1.80E-08	59.7	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN15392_c1_g1_i1	Q99NI3	GT2D2_MOUSE	45.5	55	30	0	184	20	412	466	8.00E-07	53.9	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN15392_c0_g1_i1	Q99NI3	GT2D2_MOUSE	40.9	88	50	2	248	508	405	491	3.40E-10	66.6	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN15392_c0_g1_i2	Q99NI3	GT2D2_MOUSE	43.2	81	44	2	269	508	412	491	7.60E-10	65.5	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i1	A4IFA3	GT2D2_BOVIN	31.7	281	153	4	109	948	417	659	3.60E-33	143.7	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i10	A4IFA3	GT2D2_BOVIN	30.5	285	155	4	109	960	417	659	1.00E-30	135.6	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i11	A4IFA3	GT2D2_BOVIN	33.9	342	182	5	109	1128	417	716	2.60E-46	187.6	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i12	A4IFA3	GT2D2_BOVIN	28.7	254	139	3	198	959	448	659	6.90E-24	112.8	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i3	A4IFA3	GT2D2_BOVIN	30.9	282	152	4	86	928	420	659	8.70E-32	139	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i5	A4IFA3	GT2D2_BOVIN	31.3	278	152	4	86	916	420	659	2.30E-32	141	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i7	A4IFA3	GT2D2_BOVIN	31	281	155	4	109	948	417	659	2.00E-31	137.9	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i8	A4IFA3	GT2D2_BOVIN	35.3	580	328	6	109	1845	417	950	1.20E-97	359	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN19247_c0_g1_i1	A4IFA3	GT2D2_BOVIN	32.8	134	82	3	574	173	730	855	1.10E-11	71.6	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN11117_c0_g1_i1	A4IFA3	GT2D2_BOVIN	41.3	104	60	1	3	314	848	950	3.70E-16	85.9	GT2D2_BOVIN	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	GTF2IRD2	Bos taurus (Bovine)	950	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		brown	brown	1	NA	1	1
TRINITY_DN15706_c0_g1_i5	Q99NI3	GT2D2_MOUSE	46.8	62	32	1	44	226	405	466	9.70E-09	60.5	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN14101_c0_g1_i1	Q99NI3	GT2D2_MOUSE	46.7	60	32	0	30	209	521	580	3.10E-06	52	GT2D2_MOUSE	reviewed	General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)	Gtf2ird2	Mus musculus (Mouse)	936	nucleus [GO:0005634]; DNA binding [GO:0003677]; transition between fast and slow fiber [GO:0014883]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0014883	transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c6_g1_i6	Q86UP8	GTD2A_HUMAN	41.6	149	81	2	2	433	671	818	1.80E-23	110.5	GTD2A_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha)	GTF2IRD2 GTF2IRD2A	Homo sapiens (Human)	949	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN3509_c0_g1_i1	Q86UP8	GTD2A_HUMAN	46	174	92	1	522	7	622	795	4.40E-37	156.4	GTD2A_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha)	GTF2IRD2 GTF2IRD2A	Homo sapiens (Human)	949	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN3509_c0_g1_i2	Q86UP8	GTD2A_HUMAN	46	174	92	1	522	7	622	795	4.40E-37	156.4	GTD2A_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha)	GTF2IRD2 GTF2IRD2A	Homo sapiens (Human)	949	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634			brown	brown	NA	NA	NA	1
TRINITY_DN6410_c0_g2_i5	Q86UP8	GTD2A_HUMAN	43.3	67	38	0	202	2	674	740	7.20E-09	61.2	GTD2A_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha)	GTF2IRD2 GTF2IRD2A	Homo sapiens (Human)	949	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN6410_c0_g2_i6	Q86UP8	GTD2A_HUMAN	43.7	71	40	0	214	2	670	740	4.20E-09	62.8	GTD2A_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha)	GTF2IRD2 GTF2IRD2A	Homo sapiens (Human)	949	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2769_c0_g1_i12	Q6EKJ0	GTD2B_HUMAN	37.3	118	58	4	838	491	418	521	4.30E-10	67	GTD2B_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2B (GTF2I repeat domain-containing protein 2B) (Transcription factor GTF2IRD2-beta)	GTF2IRD2B	Homo sapiens (Human)	949	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634; GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2769_c0_g1_i6	Q6EKJ0	GTD2B_HUMAN	36.8	220	135	2	764	111	728	945	4.10E-32	140.6	GTD2B_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2B (GTF2I repeat domain-containing protein 2B) (Transcription factor GTF2IRD2-beta)	GTF2IRD2B	Homo sapiens (Human)	949	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634; GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6896_c0_g1_i4	Q6EKJ0	GTD2B_HUMAN	37.3	110	69	0	18	347	526	635	2.90E-13	76.3	GTD2B_HUMAN	reviewed	General transcription factor II-I repeat domain-containing protein 2B (GTF2I repeat domain-containing protein 2B) (Transcription factor GTF2IRD2-beta)	GTF2IRD2B	Homo sapiens (Human)	949	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0005634; GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN8595_c0_g2_i1	Q9W3N6	USO1_DROME	41	178	99	2	1	516	499	676	2.60E-31	137.1	USO1_DROME	reviewed	General vesicular transport factor p115	p115 CG1422	Drosophila melanogaster (Fruit fly)	836	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]; Golgi stack [GO:0005795]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of imaginal disc-derived wing size [GO:0044719]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]; Golgi stack [GO:0005795]		GO:0005783; GO:0005789; GO:0005795; GO:0006886; GO:0006888; GO:0007030; GO:0010389; GO:0012507; GO:0032580; GO:0044719; GO:0045056; GO:0048211; GO:0048280; GO:0061025	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of imaginal disc-derived wing size [GO:0044719]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]		NA	NA	NA	NA	NA	NA
TRINITY_DN25367_c0_g1_i1	P41541	USO1_BOVIN	100	103	0	0	310	2	94	196	6.40E-48	191	USO1_BOVIN	reviewed	General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein)	USO1 VDP	Bos taurus (Bovine)	961	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of Golgi membrane [GO:0090498]; fibrillar center [GO:0001650]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; protein homooligomerization [GO:0051260]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of Golgi membrane [GO:0090498]; fibrillar center [GO:0001650]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]	identical protein binding [GO:0042802]	GO:0001650; GO:0005783; GO:0005795; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0007264; GO:0012507; GO:0032252; GO:0042802; GO:0045056; GO:0048211; GO:0048219; GO:0048280; GO:0048471; GO:0051260; GO:0061025; GO:0090498; GO:1900076	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; protein homooligomerization [GO:0051260]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]		NA	NA	NA	NA	NA	NA
TRINITY_DN36844_c0_g1_i1	O60763	USO1_HUMAN	100	245	0	0	736	2	222	466	5.50E-138	491.5	USO1_HUMAN	reviewed	General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein)	USO1 VDP	Homo sapiens (Human)	962	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0000139; GO:0001650; GO:0003723; GO:0005783; GO:0005794; GO:0005795; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0007264; GO:0012507; GO:0016020; GO:0030133; GO:0032252; GO:0045056; GO:0045296; GO:0048208; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]		NA	NA	NA	NA	NA	NA
TRINITY_DN5532_c0_g1_i2	O60763	USO1_HUMAN	61.9	485	177	4	1449	1	5	483	1.60E-163	577.4	USO1_HUMAN	reviewed	General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein)	USO1 VDP	Homo sapiens (Human)	962	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0000139; GO:0001650; GO:0003723; GO:0005783; GO:0005794; GO:0005795; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0007264; GO:0012507; GO:0016020; GO:0030133; GO:0032252; GO:0045056; GO:0045296; GO:0048208; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280]		NA	NA	NA	NA	NA	NA
TRINITY_DN2709_c0_g1_i1	Q9PW38	GEPH_CHICK	40.9	450	179	4	1099	2	10	456	7.40E-81	302.4	GEPH_CHICK	reviewed	Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]	GPHN	Gallus gallus (Chicken)	736	anchored component of synaptic membrane [GO:0099144]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]	anchored component of synaptic membrane [GO:0099144]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]	GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0014069; GO:0018315; GO:0030425; GO:0032324; GO:0042802; GO:0045211; GO:0046872; GO:0061598; GO:0061599; GO:0072579; GO:0097112; GO:0098970; GO:0099144; GO:0099572; GO:0099634	establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]		NA	NA	NA	NA	NA	NA
TRINITY_DN2709_c0_g1_i2	Q9PW38	GEPH_CHICK	57.4	94	39	1	363	85	10	103	7.40E-23	108.2	GEPH_CHICK	reviewed	Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]	GPHN	Gallus gallus (Chicken)	736	anchored component of synaptic membrane [GO:0099144]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]	anchored component of synaptic membrane [GO:0099144]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]	GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0014069; GO:0018315; GO:0030425; GO:0032324; GO:0042802; GO:0045211; GO:0046872; GO:0061598; GO:0061599; GO:0072579; GO:0097112; GO:0098970; GO:0099144; GO:0099572; GO:0099634	establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]		NA	NA	NA	NA	NA	NA
TRINITY_DN7856_c0_g1_i1	Q9WTN0	GGPPS_MOUSE	66.1	192	65	0	658	83	6	197	5.30E-74	278.9	GGPPS_MOUSE	reviewed	"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)"	Ggps1	Mus musculus (Mouse)	300	cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]	cytoplasm [GO:0005737]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]	GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005737; GO:0006720; GO:0008299; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872	farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]		NA	NA	NA	NA	NA	NA
TRINITY_DN7856_c0_g1_i2	Q9WTN0	GGPPS_MOUSE	62.6	286	107	0	863	6	6	291	4.00E-106	386	GGPPS_MOUSE	reviewed	"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)"	Ggps1	Mus musculus (Mouse)	300	cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]	cytoplasm [GO:0005737]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]	GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005737; GO:0006720; GO:0008299; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872	farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]		NA	NA	NA	NA	NA	NA
TRINITY_DN7856_c0_g1_i4	Q54BK1	GGPPS_DICDI	54.5	44	20	0	171	40	198	241	5.70E-09	61.2	GGPPS_DICDI	reviewed	"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)"	ggps1 DDB_G0293588	Dictyostelium discoideum (Slime mold)	303	cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]	cytoplasm [GO:0005737]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]	GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005737; GO:0008299; GO:0033384; GO:0033386; GO:0045337; GO:0046872	farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]		NA	NA	NA	NA	NA	NA
TRINITY_DN33223_c0_g1_i1	Q9WTN0	GGPPS_MOUSE	100	78	0	0	235	2	82	159	1.70E-40	166	GGPPS_MOUSE	reviewed	"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)"	Ggps1	Mus musculus (Mouse)	300	cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]	cytoplasm [GO:0005737]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]	GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005737; GO:0006720; GO:0008299; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872	farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]		NA	NA	NA	NA	NA	NA
TRINITY_DN39068_c0_g1_i1	O95749	GGPPS_HUMAN	100	89	0	0	1	267	78	166	1.80E-46	186	GGPPS_HUMAN	reviewed	"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)"	GGPS1	Homo sapiens (Human)	300	cytosol [GO:0005829]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540]	cytosol [GO:0005829]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]	GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005829; GO:0006695; GO:0006720; GO:0008299; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0045540; GO:0046872	cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540]		NA	NA	NA	NA	NA	NA
TRINITY_DN3544_c0_g1_i1	Q5EAD5	PGTB1_BOVIN	47.1	87	45	1	1	261	236	321	1.20E-18	93.6	PGTB1_BOVIN	reviewed	Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta)	PGGT1B	Bos taurus (Bovine)	377	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]	CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]	GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018342; GO:0018344	protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]		blue	blue	NA	NA	NA	NA
TRINITY_DN29921_c0_g1_i1	P53612	PGTB2_MOUSE	100	193	0	0	3	581	60	252	5.20E-115	414.8	PGTB2_MOUSE	reviewed	Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)	Rabggtb	Mus musculus (Mouse)	339	Rab-protein geranylgeranyltransferase complex [GO:0005968]; isoprenoid binding [GO:0019840]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]	Rab-protein geranylgeranyltransferase complex [GO:0005968]	isoprenoid binding [GO:0019840]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]	GO:0004663; GO:0005968; GO:0008270; GO:0017137; GO:0018342; GO:0018344; GO:0019840	protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]		NA	NA	NA	NA	NA	NA
TRINITY_DN29790_c0_g1_i1	P53612	PGTB2_MOUSE	98.8	83	1	0	274	26	257	339	1.60E-42	172.9	PGTB2_MOUSE	reviewed	Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)	Rabggtb	Mus musculus (Mouse)	339	Rab-protein geranylgeranyltransferase complex [GO:0005968]; isoprenoid binding [GO:0019840]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]	Rab-protein geranylgeranyltransferase complex [GO:0005968]	isoprenoid binding [GO:0019840]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]	GO:0004663; GO:0005968; GO:0008270; GO:0017137; GO:0018342; GO:0018344; GO:0019840	protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]		NA	NA	NA	NA	NA	NA
TRINITY_DN12535_c0_g1_i1	P53611	PGTB2_HUMAN	67.5	332	107	1	69	1064	1	331	2.00E-139	496.9	PGTB2_HUMAN	reviewed	Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)	RABGGTB GGTB	Homo sapiens (Human)	331	cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; regulation of apoptotic process [GO:0042981]; visual perception [GO:0007601]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]	Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]	GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006464; GO:0007601; GO:0008270; GO:0017137; GO:0018342; GO:0018344; GO:0042981; GO:0043687	cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; regulation of apoptotic process [GO:0042981]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN13607_c0_g1_i1	G5EEN4	GCK3_CAEEL	86	129	17	1	9	392	210	338	2.90E-61	235.7	GCK3_CAEEL	reviewed	Germinal center kinase 3 (EC 2.7.11.1) (STE20-like serine/threonine kinase)	gck-3 Y59A8B.23	Caenorhabditis elegans	596	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; epithelial tube morphogenesis [GO:0060562]; hyperosmotic response [GO:0006972]; meiotic cell cycle [GO:0051321]; multicellular organismal water homeostasis [GO:0050891]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006972; GO:0007283; GO:0010628; GO:0018105; GO:0018107; GO:0019901; GO:0030154; GO:0050891; GO:0051321; GO:0060562	cell differentiation [GO:0030154]; epithelial tube morphogenesis [GO:0060562]; hyperosmotic response [GO:0006972]; meiotic cell cycle [GO:0051321]; multicellular organismal water homeostasis [GO:0050891]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7149_c0_g1_i1	O60318	GANP_HUMAN	28.1	171	117	2	116	625	628	793	2.20E-15	84.3	GANP_HUMAN	reviewed	Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (80 kDa MCM3-associated protein) (MCM3 acetylating protein) (MCM3AP) (EC 2.3.1.-) (MCM3 acetyltransferase)	MCM3AP GANP KIAA0572 MAP80	Homo sapiens (Human)	1980	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390	mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN40971_c0_g1_i1	Q94B08	RDL1_ARATH	58.1	74	30	1	8	229	270	342	2.90E-19	95.5	RDL1_ARATH	reviewed	Germination-specific cysteine protease 1 (EC 3.4.22.-) (RD21A-like protease 1)	GCP1 RDL1 At4g36880 C7A10.480	Arabidopsis thaliana (Mouse-ear cress)	376	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN1155_c0_g1_i1	Q8CA72	GAN_MOUSE	27.9	456	289	12	146	1471	12	441	6.30E-43	176.8	GAN_MOUSE	reviewed	Gigaxonin	Gan	Mus musculus (Mouse)	597	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0007010; GO:0016567; GO:0031463	cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1155_c0_g1_i3	Q8CA72	GAN_MOUSE	28	560	359	14	133	1764	12	543	2.30E-53	211.8	GAN_MOUSE	reviewed	Gigaxonin	Gan	Mus musculus (Mouse)	597	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0007010; GO:0016567; GO:0031463	cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1155_c0_g1_i4	Q8CA72	GAN_MOUSE	28	560	359	14	146	1777	12	543	2.30E-53	211.8	GAN_MOUSE	reviewed	Gigaxonin	Gan	Mus musculus (Mouse)	597	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0007010; GO:0016567; GO:0031463	cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1155_c0_g1_i5	Q8CA72	GAN_MOUSE	28	560	359	14	124	1755	12	543	2.30E-53	211.8	GAN_MOUSE	reviewed	Gigaxonin	Gan	Mus musculus (Mouse)	597	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0007010; GO:0016567; GO:0031463	cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN0_c3_g1_i1	Q9ERL7	GMFG_MOUSE	52.9	136	63	1	642	235	4	138	2.70E-36	153.7	GMFG_MOUSE	reviewed	Glia maturation factor gamma (GMF-gamma)	Gmfg	Mus musculus (Mouse)	142	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]		actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]	GO:0003779; GO:0008083; GO:0034316; GO:0071846; GO:0071933; GO:2000249	actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]		blue	blue	NA	NA	NA	NA
TRINITY_DN28051_c0_g1_i1	O60234	GMFG_HUMAN	100	86	0	0	1	258	43	128	8.00E-44	177.2	GMFG_HUMAN	reviewed	Glia maturation factor gamma (GMF-gamma)	GMFG	Homo sapiens (Human)	142	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; protein kinase inhibitor activity [GO:0004860]; actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neutrophil degranulation [GO:0043312]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; protein kinase inhibitor activity [GO:0004860]	GO:0003779; GO:0004860; GO:0005576; GO:0006468; GO:0008047; GO:0008083; GO:0034316; GO:0034774; GO:0043312; GO:0071846; GO:0071933; GO:1904813; GO:2000249	actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neutrophil degranulation [GO:0043312]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]		NA	NA	NA	NA	NA	NA
TRINITY_DN31658_c0_g1_i1	Q9ERL7	GMFG_MOUSE	100	70	0	0	210	1	54	123	4.50E-35	148.7	GMFG_MOUSE	reviewed	Glia maturation factor gamma (GMF-gamma)	Gmfg	Mus musculus (Mouse)	142	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]		actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]	GO:0003779; GO:0008083; GO:0034316; GO:0071846; GO:0071933; GO:2000249	actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]		NA	NA	NA	NA	NA	NA
TRINITY_DN31658_c0_g1_i1	Q9ERL7	GMFG_MOUSE	83.1	65	11	0	365	171	2	66	5.70E-22	105.1	GMFG_MOUSE	reviewed	Glia maturation factor gamma (GMF-gamma)	Gmfg	Mus musculus (Mouse)	142	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]		actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]	GO:0003779; GO:0008083; GO:0034316; GO:0071846; GO:0071933; GO:2000249	actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; regulation of actin cytoskeleton reorganization [GO:2000249]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c0_g1_i1	Q54796	DEXB_STRPN	36.4	107	67	1	1070	750	2	107	3.90E-16	87.4	DEXB_STRPN	reviewed	"Glucan 1,6-alpha-glucosidase (EC 3.2.1.70) (Dextran glucosidase) (Exo-1,6-alpha-glucosidase) (Glucodextranase)"	dexB SP_0342	Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)	535	"cytoplasm [GO:0005737]; glucan 1,6-alpha-glucosidase activity [GO:0043896]; carbohydrate metabolic process [GO:0005975]"	cytoplasm [GO:0005737]	"glucan 1,6-alpha-glucosidase activity [GO:0043896]"	GO:0005737; GO:0005975; GO:0043896	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN16612_c0_g1_i2	Q54796	DEXB_STRPN	36.4	107	67	1	1345	1025	2	107	5.60E-16	87.4	DEXB_STRPN	reviewed	"Glucan 1,6-alpha-glucosidase (EC 3.2.1.70) (Dextran glucosidase) (Exo-1,6-alpha-glucosidase) (Glucodextranase)"	dexB SP_0342	Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)	535	"cytoplasm [GO:0005737]; glucan 1,6-alpha-glucosidase activity [GO:0043896]; carbohydrate metabolic process [GO:0005975]"	cytoplasm [GO:0005737]	"glucan 1,6-alpha-glucosidase activity [GO:0043896]"	GO:0005737; GO:0005975; GO:0043896	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN4197_c0_g1_i3	Q16HW7	GNPI_AEDAE	75.7	272	66	0	923	108	1	272	1.10E-123	444.5	GNPI_AEDAE	reviewed	Glucosamine-6-phosphate isomerase (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase) (GNPDA) (GlcN6P deaminase)	Gnpda1 AAEL013877	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	278	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006044; GO:0006091	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]		NA	NA	NA	NA	NA	NA
TRINITY_DN4197_c0_g1_i5	Q16HW7	GNPI_AEDAE	73.9	276	68	1	972	145	1	272	2.70E-122	439.9	GNPI_AEDAE	reviewed	Glucosamine-6-phosphate isomerase (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase) (GNPDA) (GlcN6P deaminase)	Gnpda1 AAEL013877	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	278	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006044; GO:0006091	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]		NA	NA	NA	NA	NA	NA
TRINITY_DN4197_c0_g1_i6	Q16HW7	GNPI_AEDAE	73.9	276	68	1	972	145	1	272	6.10E-122	438.7	GNPI_AEDAE	reviewed	Glucosamine-6-phosphate isomerase (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase) (GNPDA) (GlcN6P deaminase)	Gnpda1 AAEL013877	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	278	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006044; GO:0006091	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]		blue	blue	NA	NA	NA	NA
TRINITY_DN4197_c0_g1_i7	Q16HW7	GNPI_AEDAE	73.2	276	70	1	972	145	1	272	1.50E-120	434.1	GNPI_AEDAE	reviewed	Glucosamine-6-phosphate isomerase (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase) (GNPDA) (GlcN6P deaminase)	Gnpda1 AAEL013877	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	278	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006044; GO:0006091	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]		NA	NA	NA	NA	NA	NA
TRINITY_DN19466_c0_g1_i1	P46926	GNPI1_HUMAN	99.5	187	1	0	563	3	85	271	3.00E-104	379	GNPI1_HUMAN	reviewed	Glucosamine-6-phosphate isomerase 1 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin)	GNPDA1 GNPI HLN KIAA0060	Homo sapiens (Human)	289	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; single fertilization [GO:0007338]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]	GO:0004342; GO:0005737; GO:0005829; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0006091; GO:0007338; GO:0019262; GO:0042802; GO:0070062	carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; single fertilization [GO:0007338]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN39167_c0_g1_i1	Q17QL1	GNPI2_BOVIN	100	84	0	0	253	2	140	223	4.80E-41	167.9	GNPI2_BOVIN	reviewed	Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2)	GNPDA2	Bos taurus (Bovine)	276	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0019262; GO:0042802	carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN32886_c0_g1_i1	Q9CRC9	GNPI2_MOUSE	100	109	0	0	8	334	1	109	5.80E-63	241.1	GNPI2_MOUSE	reviewed	Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2)	Gnpda2 Kiaa4008	Mus musculus (Mouse)	276	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0019262; GO:0042802	carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN30985_c0_g1_i1	Q9CRC9	GNPI2_MOUSE	100	84	0	0	254	3	188	271	3.90E-43	174.9	GNPI2_MOUSE	reviewed	Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2)	Gnpda2 Kiaa4008	Mus musculus (Mouse)	276	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytoplasm [GO:0005737]	glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0019262; GO:0042802	carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN34109_c0_g1_i1	Q6PCE3	PGM2L_HUMAN	42.5	80	37	1	5	217	543	622	2.70E-11	68.9	PGM2L_HUMAN	reviewed	"Glucose 1,6-bisphosphate synthase (EC 2.7.1.106) (PMMLP) (Phosphoglucomutase-2-like 1)"	PGM2L1 BM32A	Homo sapiens (Human)	622	"cytosol [GO:0005829]; glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]; canonical glycolysis [GO:0061621]; galactose catabolic process [GO:0019388]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]"	cytosol [GO:0005829]	"glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]"	GO:0005829; GO:0005978; GO:0005980; GO:0016868; GO:0019388; GO:0046872; GO:0047933; GO:0061621	canonical glycolysis [GO:0061621]; galactose catabolic process [GO:0019388]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i13	P18173	DHGL_DROME	42.9	198	106	3	60	644	202	395	1.90E-32	141	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i15	P18172	DHGL_DROPS	39.3	572	284	11	11	1615	64	609	2.00E-98	361.3	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i22	P18173	DHGL_DROME	52.7	55	26	0	63	227	137	191	3.50E-12	72.4	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i27	P18172	DHGL_DROPS	41.1	577	291	11	11	1687	64	609	3.70E-108	393.7	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i33	P18173	DHGL_DROME	38.4	401	193	8	1	1149	245	609	1.20E-60	235.3	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i36	P18173	DHGL_DROME	38.4	385	214	7	79	1215	242	609	2.50E-61	237.7	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i38	P18173	DHGL_DROME	33.9	112	55	1	290	568	452	563	1.20E-10	68.2	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i42	P18172	DHGL_DROPS	46.6	163	82	1	636	1124	452	609	3.20E-34	147.5	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i42	P18172	DHGL_DROPS	41.3	155	84	3	1	456	245	395	2.60E-20	101.3	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i9	P18172	DHGL_DROPS	43.6	78	42	2	11	244	64	139	9.70E-11	67.4	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN38252_c0_g1_i1	P18172	DHGL_DROPS	47.9	48	25	0	30	173	519	566	6.50E-07	54.3	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN9135_c0_g1_i1	P18172	DHGL_DROPS	64.4	73	26	0	4	222	528	600	3.10E-22	105.9	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN9135_c0_g1_i1	P18172	DHGL_DROPS	52.6	38	18	0	349	236	577	614	3.40E-05	49.3	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN9135_c0_g1_i2	P18172	DHGL_DROPS	58.6	87	36	0	4	264	528	614	1.50E-24	113.6	DHGL_DROPS	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld GA11047	Drosophila pseudoobscura pseudoobscura (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN35866_c0_g1_i1	P18173	DHGL_DROME	53	66	31	0	38	235	68	133	1.70E-13	76.3	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		NA	NA	NA	NA	NA	NA
TRINITY_DN37977_c0_g1_i1	P18173	DHGL_DROME	58.6	58	24	0	226	53	143	200	5.80E-14	78.6	DHGL_DROME	reviewed	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	Gld CG1152	Drosophila melanogaster (Fruit fly)	625	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660	glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]		brown	brown	1	NA	NA	NA
TRINITY_DN14233_c0_g1_i1	Q8IRI6	GTR1_DROME	74.8	131	33	0	394	2	93	223	6.20E-52	204.9	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN14233_c0_g1_i2	Q8IRI6	GTR1_DROME	78	100	22	0	339	40	93	192	5.30E-39	161.8	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN14233_c0_g1_i3	Q8IRI6	GTR1_DROME	89.7	58	6	0	213	40	135	192	2.00E-22	106.3	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN14233_c0_g1_i4	Q8IRI6	GTR1_DROME	80.9	89	17	0	268	2	135	223	3.20E-35	149.1	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN32691_c0_g1_i1	Q8IRI6	GTR1_DROME	60	85	34	0	3	257	88	172	4.10E-23	108.6	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN32691_c0_g1_i2	Q8IRI6	GTR1_DROME	51.9	241	116	0	3	725	88	328	2.20E-62	240.4	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN34473_c0_g1_i1	Q8IRI6	GTR1_DROME	69.1	110	34	0	332	3	228	337	1.20E-34	147.1	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN27280_c0_g1_i1	Q8IRI6	GTR1_DROME	75	68	17	0	249	46	362	429	4.70E-25	114.8	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]		NA	NA	NA	NA	NA	NA
TRINITY_DN38079_c0_g1_i1	O42153	G6PC_HAPNU	55.1	49	22	0	196	50	229	277	2.10E-10	65.9	G6PC_HAPNU	reviewed	Glucose-6-phosphatase (G-6-Pase) (G6Pase) (EC 3.1.3.9)	g6pc g6pt	Haplochromis nubilus (Blue Victoria mouthbrooder) (Tilapia nubila)	352	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucose-6-phosphatase activity [GO:0004346]	GO:0004346; GO:0005789; GO:0006094; GO:0016021	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	NA
TRINITY_DN8420_c3_g1_i1	P43428	G6PC_RAT	33.7	329	210	3	1096	119	19	342	7.90E-45	183	G6PC_RAT	reviewed	Glucose-6-phosphatase (G-6-Pase) (G6Pase) (EC 3.1.3.9)	G6pc G6pt	Rattus norvegicus (Rat)	357	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucose-6-phosphatase activity [GO:0004346]; phosphate ion binding [GO:0042301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose-6-phosphate transport [GO:0015760]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; phosphate-containing compound metabolic process [GO:0006796]; phosphorylated carbohydrate dephosphorylation [GO:0046838]; regulation of gene expression [GO:0010468]; response to carbohydrate [GO:0009743]; response to food [GO:0032094]; response to insulin [GO:0032868]; response to resveratrol [GO:1904638]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; urate metabolic process [GO:0046415]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	"glucose-6-phosphatase activity [GO:0004346]; phosphate ion binding [GO:0042301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004346; GO:0005783; GO:0005789; GO:0005977; GO:0005980; GO:0006094; GO:0006641; GO:0006796; GO:0008202; GO:0009743; GO:0010468; GO:0015760; GO:0016021; GO:0016773; GO:0032094; GO:0032868; GO:0032869; GO:0035264; GO:0042301; GO:0042593; GO:0042632; GO:0043231; GO:0046415; GO:0046838; GO:0051156; GO:0055088; GO:1904638	cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; phosphate-containing compound metabolic process [GO:0006796]; phosphorylated carbohydrate dephosphorylation [GO:0046838]; regulation of gene expression [GO:0010468]; response to carbohydrate [GO:0009743]; response to food [GO:0032094]; response to insulin [GO:0032868]; response to resveratrol [GO:1904638]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; urate metabolic process [GO:0046415]		blue	blue	NA	NA	NA	NA
TRINITY_DN27402_c0_g1_i1	Q148G2	G6PC3_BOVIN	45.7	81	43	1	246	4	33	112	4.20E-18	91.7	G6PC3_BOVIN	reviewed	Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 3.1.3.9)	G6PC3	Bos taurus (Bovine)	346	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucose-6-phosphatase activity [GO:0004346]	GO:0004346; GO:0005789; GO:0006094; GO:0015760; GO:0016021; GO:0051156	gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]		NA	NA	NA	NA	NA	NA
TRINITY_DN5715_c0_g1_i1	O68282	G6PD_PSEAE	58.1	74	31	0	226	5	207	280	8.30E-21	100.5	G6PD_PSEAE	reviewed	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.363) (Glucose-6-phosphate dehydrogenase (NAD(P)(+)))	zwf PA3183	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	489	glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]		glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]	GO:0004345; GO:0006006; GO:0006098; GO:0050661	glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5715_c0_g1_i2	O68282	G6PD_PSEAE	59.5	74	30	0	226	5	207	280	3.70E-21	101.7	G6PD_PSEAE	reviewed	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.363) (Glucose-6-phosphate dehydrogenase (NAD(P)(+)))	zwf PA3183	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	489	glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]		glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]	GO:0004345; GO:0006006; GO:0006098; GO:0050661	glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN18180_c0_g1_i1	P54996	G6PD_TAKRU	74.2	337	87	0	1116	106	191	527	7.70E-152	538.1	G6PD_TAKRU	reviewed	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	g6pd	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	530	cytosol [GO:0005829]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]	glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]	GO:0004345; GO:0005829; GO:0006006; GO:0006098; GO:0006739; GO:0050661; GO:0051156	glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]		blue	blue	NA	NA	NA	NA
TRINITY_DN37850_c0_g1_i1	P21907	G6PD_ZYMMO	67.1	73	24	0	224	6	197	269	2.30E-23	109	G6PD_ZYMMO	reviewed	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	zwf ZMO0367	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	485	glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]		glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]	GO:0004345; GO:0006006; GO:0006098; GO:0050661	glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN40320_c0_g1_i1	Q00612	G6PD1_MOUSE	100	141	0	0	3	425	190	330	6.70E-80	297.7	G6PD1_MOUSE	reviewed	Glucose-6-phosphate 1-dehydrogenase X (G6PD) (EC 1.1.1.49)	G6pdx G6pd G6pd-1	Mus musculus (Mouse)	515	"centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; cytokine production [GO:0001816]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390]"	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	carbohydrate binding [GO:0030246]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0001816; GO:0001998; GO:0002033; GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006741; GO:0006749; GO:0006979; GO:0009051; GO:0009898; GO:0010734; GO:0019322; GO:0030246; GO:0032613; GO:0032615; GO:0034451; GO:0034599; GO:0040014; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0048821; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:1904879; GO:2000378	"angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; cytokine production [GO:0001816]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; NADP biosynthetic process [GO:0006741]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35395_c0_g1_i1	Q00612	G6PD1_MOUSE	100	159	0	0	3	479	327	485	1.90E-91	336.3	G6PD1_MOUSE	reviewed	Glucose-6-phosphate 1-dehydrogenase X (G6PD) (EC 1.1.1.49)	G6pdx G6pd G6pd-1	Mus musculus (Mouse)	515	"centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; cytokine production [GO:0001816]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390]"	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	carbohydrate binding [GO:0030246]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0001816; GO:0001998; GO:0002033; GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006741; GO:0006749; GO:0006979; GO:0009051; GO:0009898; GO:0010734; GO:0019322; GO:0030246; GO:0032613; GO:0032615; GO:0034451; GO:0034599; GO:0040014; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0048821; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:1904879; GO:2000378	"angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; cytokine production [GO:0001816]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; NADP biosynthetic process [GO:0006741]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4333_c0_g1_i1	Q03161	YMY9_YEAST	36.6	279	163	8	897	97	10	286	1.60E-41	171.4	YMY9_YEAST	reviewed	Glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (D-hexose-6-phosphate mutarotase)	YMR099C YM6543.06C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	297	cytoplasm [GO:0005737]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; cellular carbohydrate metabolic process [GO:0044262]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]	GO:0005634; GO:0005737; GO:0030246; GO:0044262; GO:0047938	cellular carbohydrate metabolic process [GO:0044262]		blue	blue	NA	NA	NA	NA
TRINITY_DN6041_c0_g1_i1	Q8AVC3	G6PT3_XENLA	53.4	487	202	3	1580	132	21	486	2.00E-138	494.2	G6PT3_XENLA	reviewed	Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2)	slc37a2	Xenopus laevis (African clawed frog)	499	integral component of endoplasmic reticulum membrane [GO:0030176]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]	integral component of endoplasmic reticulum membrane [GO:0030176]	glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]	GO:0008643; GO:0015760; GO:0030176; GO:0035435; GO:0061513	carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]		blue	blue	NA	NA	NA	NA
TRINITY_DN27470_c0_g1_i1	Q9WU81	G6PT3_MOUSE	100	75	0	0	3	227	160	234	3.10E-39	161.8	G6PT3_MOUSE	reviewed	Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2) (cAMP-inducible protein 2)	Slc37a2 Ci2	Mus musculus (Mouse)	501	integral component of endoplasmic reticulum membrane [GO:0030176]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]	integral component of endoplasmic reticulum membrane [GO:0030176]	glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]	GO:0006072; GO:0006127; GO:0008643; GO:0015169; GO:0015760; GO:0015794; GO:0030176; GO:0035435; GO:0061513	carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN37156_c0_g1_i1	O43826	G6PT1_HUMAN	45.5	156	85	0	476	9	13	168	3.00E-36	152.9	G6PT1_HUMAN	reviewed	Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19)	SLC37A4 G6PT G6PT1 PRO0685 TRG19	Homo sapiens (Human)	429	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152]; carbohydrate transport [GO:0008643]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152]	GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0008643; GO:0015152; GO:0015760; GO:0016020; GO:0016021; GO:0030176; GO:0035435; GO:0042593; GO:0061513	carbohydrate transport [GO:0008643]; gluconeogenesis [GO:0006094]; glucose-6-phosphate transport [GO:0015760]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN20893_c4_g1_i1	P06745	G6PI_MOUSE	100	102	0	0	309	4	251	352	2.10E-59	229.2	G6PI_MOUSE	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	Gpi Gpi1	Mus musculus (Mouse)	558	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; glycolytic process through glucose-6-phosphate [GO:0061620]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	GO:0001701; GO:0001707; GO:0004347; GO:0005125; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0007611; GO:0008083; GO:0010595; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043209; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051024; GO:0051156; GO:0060170; GO:0061620	carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; glycolytic process through glucose-6-phosphate [GO:0061620]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN19115_c0_g1_i1	P06745	G6PI_MOUSE	97.7	342	8	0	1	1026	51	392	2.30E-198	692.6	G6PI_MOUSE	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	Gpi Gpi1	Mus musculus (Mouse)	558	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; glycolytic process through glucose-6-phosphate [GO:0061620]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	GO:0001701; GO:0001707; GO:0004347; GO:0005125; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0007611; GO:0008083; GO:0010595; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043209; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051024; GO:0051156; GO:0060170; GO:0061620	carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; glycolytic process through glucose-6-phosphate [GO:0061620]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN34790_c0_g1_i1	P06745	G6PI_MOUSE	100	76	0	0	229	2	439	514	2.60E-38	158.7	G6PI_MOUSE	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	Gpi Gpi1	Mus musculus (Mouse)	558	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; glycolytic process through glucose-6-phosphate [GO:0061620]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	GO:0001701; GO:0001707; GO:0004347; GO:0005125; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0007611; GO:0008083; GO:0010595; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043209; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051024; GO:0051156; GO:0060170; GO:0061620	carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; glycolytic process through glucose-6-phosphate [GO:0061620]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN31565_c0_g1_i1	P06744	G6PI_HUMAN	100	144	0	0	3	434	415	558	2.60E-77	289.3	G6PI_HUMAN	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)	GPI	Homo sapiens (Human)	558	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; neutrophil degranulation [GO:0043312]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	GO:0004347; GO:0005125; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0006959; GO:0007599; GO:0008083; GO:0010595; GO:0016020; GO:0031625; GO:0034774; GO:0043312; GO:0048029; GO:0051024; GO:0051156; GO:0061621; GO:0070062; GO:1904813	canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; neutrophil degranulation [GO:0043312]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]		NA	NA	NA	NA	NA	NA
TRINITY_DN19115_c0_g1_i2	P06744	G6PI_HUMAN	100	361	0	0	3	1085	32	392	7.40E-216	750.7	G6PI_HUMAN	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)	GPI	Homo sapiens (Human)	558	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; neutrophil degranulation [GO:0043312]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	GO:0004347; GO:0005125; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0006959; GO:0007599; GO:0008083; GO:0010595; GO:0016020; GO:0031625; GO:0034774; GO:0043312; GO:0048029; GO:0051024; GO:0051156; GO:0061621; GO:0070062; GO:1904813	canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; neutrophil degranulation [GO:0043312]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024]		NA	NA	NA	NA	NA	NA
TRINITY_DN6003_c0_g1_i1	P52031	G6PI_DROYA	73	159	43	0	597	121	396	554	6.10E-63	241.9	G6PI_DROYA	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	Pgi GE22729	Drosophila yakuba (Fruit fly)	558	cytosol [GO:0005829]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]	cytosol [GO:0005829]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005829; GO:0006094; GO:0006096; GO:0042593	gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN31631_c0_g1_i1	Q3IKH4	G6PI_PSEHT	58.2	79	32	1	1	237	245	322	2.90E-24	112.1	G6PI_PSET1	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	pgi PSHAa1139	Pseudoalteromonas translucida (strain TAC 125)	548	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN36951_c0_g1_i1	A8FSH2	G6PI_SHESH	56.2	73	31	1	218	3	234	306	2.00E-14	79.3	G6PI_SHESH	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	pgi Ssed_1184	Shewanella sediminis (strain HAW-EB3)	545	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN40888_c0_g1_i1	A2SKF8	G6PI_METPP	67.2	67	22	0	1	201	123	189	4.50E-18	91.3	G6PI_METPP	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	pgi Mpe_A3094	Methylibium petroleiphilum (strain ATCC BAA-1232 / LMG 22953 / PM1)	545	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN40553_c0_g1_i1	B2UF65	G6PI_RALPJ	99.2	125	1	0	389	15	415	539	4.70E-64	245	G6PI_RALPJ	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	pgi Rpic_1861	Ralstonia pickettii (strain 12J)	539	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN31493_c0_g1_i1	B4RX41	G6PI_ALTMD	64.9	57	20	0	231	61	462	518	2.80E-16	85.5	G6PI_ALTMD	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	pgi MADE_1015455	Alteromonas mediterranea (strain DSM 17117 / CIP 110805 / LMG 28347 / Deep ecotype)	549	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN20893_c0_g1_i1	P52030	G6PI_DROSI	72.8	389	106	0	1168	2	8	396	3.20E-169	596.3	G6PI_DROSI	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	Pgi	Drosophila simulans (Fruit fly)	558	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN40881_c0_g1_i1	B2UF65	G6PI_RALPJ	90.4	114	11	0	343	2	60	173	6.70E-54	211.1	G6PI_RALPJ	reviewed	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	pgi Rpic_1861	Ralstonia pickettii (strain 12J)	539	cytoplasm [GO:0005737]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	glucose-6-phosphate isomerase activity [GO:0004347]	GO:0004347; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN12136_c0_g1_i1	Q8IVV7	GID4_HUMAN	84.1	69	11	0	263	57	120	188	1.90E-27	122.9	GID4_HUMAN	reviewed	Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog)	GID4 C17orf39 VID24	Homo sapiens (Human)	300	ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0043161; GO:0061630	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN12136_c0_g1_i2	Q8IVV7	GID4_HUMAN	85.1	67	10	0	231	31	120	186	2.80E-27	122.1	GID4_HUMAN	reviewed	Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog)	GID4 C17orf39 VID24	Homo sapiens (Human)	300	ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0043161; GO:0061630	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN12136_c0_g1_i4	Q8IVV7	GID4_HUMAN	83	88	15	0	377	114	120	207	2.30E-39	162.9	GID4_HUMAN	reviewed	Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog)	GID4 C17orf39 VID24	Homo sapiens (Human)	300	ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0043161; GO:0061630	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN12136_c0_g1_i5	Q8IVV7	GID4_HUMAN	83.4	181	30	0	632	90	120	300	9.70E-91	334.3	GID4_HUMAN	reviewed	Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog)	GID4 C17orf39 VID24	Homo sapiens (Human)	300	ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	ubiquitin ligase complex [GO:0000151]	ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0043161; GO:0061630	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN24219_c0_g1_i1	Q32L52	GID8_BOVIN	100	62	0	0	219	34	167	228	3.10E-28	125.2	GID8_BOVIN	reviewed	Glucose-induced degradation protein 8 homolog	GID8	Bos taurus (Bovine)	228	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	protein homodimerization activity [GO:0042803]	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0043161; GO:0090263	positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3481_c0_g1_i1	Q9NWU2	GID8_HUMAN	63	216	79	1	689	42	14	228	3.10E-71	270	GID8_HUMAN	reviewed	Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM) (Twa1)	GID8 C20orf11 TWA1	Homo sapiens (Human)	228	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	protein homodimerization activity [GO:0042803]	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0043161; GO:0090263	positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3481_c0_g1_i2	Q9NWU2	GID8_HUMAN	61.8	220	79	2	701	42	14	228	1.00E-69	265	GID8_HUMAN	reviewed	Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM) (Twa1)	GID8 C20orf11 TWA1	Homo sapiens (Human)	228	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	protein homodimerization activity [GO:0042803]	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0043161; GO:0090263	positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN29224_c0_g1_i1	O08795	GLU2B_MOUSE	100	77	0	0	233	3	7	83	2.80E-43	175.3	GLU2B_MOUSE	reviewed	Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)	Prkcsh	Mus musculus (Mouse)	521	endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; negative regulation of neuron projection development [GO:0010977]; nitrogen compound metabolic process [GO:0006807]	endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]	calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein-containing complex binding [GO:0044877]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]	GO:0001701; GO:0001889; GO:0003723; GO:0005080; GO:0005509; GO:0005783; GO:0006491; GO:0006807; GO:0010977; GO:0017177; GO:0043231; GO:0044325; GO:0044877; GO:0051219	in utero embryonic development [GO:0001701]; liver development [GO:0001889]; negative regulation of neuron projection development [GO:0010977]; N-glycan processing [GO:0006491]; nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN1740_c0_g1_i1	P14314	GLU2B_HUMAN	56.7	157	68	0	484	14	14	170	2.10E-45	183.7	GLU2B_HUMAN	reviewed	Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)	PRKCSH G19P1	Homo sapiens (Human)	528	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]	calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]	GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006457; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0043687; GO:0044267; GO:0044325; GO:0051219	cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN1740_c0_g1_i3	P14314	GLU2B_HUMAN	51.1	174	68	1	535	14	14	170	8.70E-42	171.8	GLU2B_HUMAN	reviewed	Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)	PRKCSH G19P1	Homo sapiens (Human)	528	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]	calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]	GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006457; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0043687; GO:0044267; GO:0044325; GO:0051219	cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN36463_c0_g1_i1	P14314	GLU2B_HUMAN	100	93	0	0	279	1	28	120	4.90E-55	214.5	GLU2B_HUMAN	reviewed	Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)	PRKCSH G19P1	Homo sapiens (Human)	528	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]	calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]	GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006457; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0043687; GO:0044267; GO:0044325; GO:0051219	cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN38742_c0_g1_i1	P14314	GLU2B_HUMAN	48.4	91	41	3	401	129	37	121	1.90E-15	84.7	GLU2B_HUMAN	reviewed	Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)	PRKCSH G19P1	Homo sapiens (Human)	528	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]	calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]	GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006457; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0043687; GO:0044267; GO:0044325; GO:0051219	cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN33929_c0_g1_i1	Q4G148	GXLT1_HUMAN	100	81	0	0	243	1	176	256	1.90E-42	172.6	GXLT1_HUMAN	reviewed	Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3)	GXYLT1 GLT8D3	Homo sapiens (Human)	440	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1503_c0_g1_i5	Q5ZKI6	GXLT1_CHICK	33.2	205	117	6	77	646	119	318	5.00E-27	122.9	GXLT1_CHICK	reviewed	Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3)	GXYLT1 GLT8D3 RCJMB04_10i5	Gallus gallus (Chicken)	433	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1503_c0_g1_i6	Q5ZKI6	GXLT1_CHICK	33	300	178	7	77	931	119	410	3.30E-43	177.2	GXLT1_CHICK	reviewed	Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3)	GXYLT1 GLT8D3 RCJMB04_10i5	Gallus gallus (Chicken)	433	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN7125_c0_g1_i1	Q3UHH8	GXLT1_MOUSE	62.6	91	33	1	10	282	144	233	3.80E-30	132.1	GXLT1_MOUSE	reviewed	Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3)	Gxylt1 Glt8d3 Gm87	Mus musculus (Mouse)	404	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		blue	blue	NA	NA	NA	NA
TRINITY_DN15812_c0_g1_i2	A0PJZ3	GXLT2_HUMAN	40.9	137	69	3	31	414	257	390	5.30E-21	102.4	GXLT2_HUMAN	reviewed	Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)	GXYLT2 GLT8D4	Homo sapiens (Human)	443	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN31531_c0_g1_i1	Q6DE37	GXLT2_XENLA	46.4	69	37	0	14	220	94	162	4.60E-11	68.2	GXLT2_XENLA	reviewed	Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)	gxylt2 glt8d4	Xenopus laevis (African clawed frog)	423	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN21903_c0_g1_i2	Q810K9	GXLT2_MOUSE	31.5	124	84	1	187	558	121	243	5.30E-14	79.3	GXLT2_MOUSE	reviewed	Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)	Gxylt2 Glt8d4	Mus musculus (Mouse)	444	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN7125_c0_g1_i2	Q6DE37	GXLT2_XENLA	54.4	239	97	2	10	693	158	395	2.30E-77	290	GXLT2_XENLA	reviewed	Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)	gxylt2 glt8d4	Xenopus laevis (African clawed frog)	423	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of membrane [GO:0016021]	UDP-xylosyltransferase activity [GO:0035252]	GO:0016021; GO:0016266; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN9475_c1_g3_i1	B3P2E5	NMDA1_DROER	55.1	363	149	5	19	1074	438	797	2.80E-112	406.8	NMDA1_DROER	reviewed	Glutamate [NMDA] receptor subunit 1	Nmdar1 GG10981	Drosophila erecta (Fruit fly)	997	NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]	NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]	GO:0004970; GO:0004972; GO:0007268; GO:0007616; GO:0008355; GO:0014069; GO:0017146; GO:0035235; GO:0042331; GO:0042391; GO:0045211; GO:0048149; GO:0050975; GO:0055074; GO:0072375	behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN9475_c1_g3_i2	B3P2E5	NMDA1_DROER	53.6	431	181	8	19	1266	438	864	1.50E-127	457.6	NMDA1_DROER	reviewed	Glutamate [NMDA] receptor subunit 1	Nmdar1 GG10981	Drosophila erecta (Fruit fly)	997	NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]	NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]	GO:0004970; GO:0004972; GO:0007268; GO:0007616; GO:0008355; GO:0014069; GO:0017146; GO:0035235; GO:0042331; GO:0042391; GO:0045211; GO:0048149; GO:0050975; GO:0055074; GO:0072375	behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN40216_c0_g1_i1	B3LZ39	NMDA1_DROAN	88.9	54	6	0	182	21	634	687	4.10E-20	98.2	NMDA1_DROAN	reviewed	Glutamate [NMDA] receptor subunit 1	Nmdar1 GF17704	Drosophila ananassae (Fruit fly)	994	NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; olfactory learning [GO:0008355]; regulation of membrane potential [GO:0042391]	NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]	GO:0004970; GO:0007268; GO:0007616; GO:0008355; GO:0014069; GO:0017146; GO:0035235; GO:0042391; GO:0045211; GO:0055074	calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; olfactory learning [GO:0008355]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN30006_c0_g1_i1	Q04609	FOLH1_HUMAN	58.4	77	27	2	259	32	161	233	9.30E-16	84	FOLH1_HUMAN	reviewed	Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)	FOLH1 FOLH NAALAD1 PSM PSMA GIG27	Homo sapiens (Human)	750	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]; C-terminal protein deglutamylation [GO:0035609]; cellular amino acid biosynthetic process [GO:0008652]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]	GO:0004180; GO:0004181; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0006760; GO:0008233; GO:0008652; GO:0009986; GO:0016020; GO:0016805; GO:0035609; GO:0046872; GO:0070062; GO:1904492; GO:1904493	cellular amino acid biosynthetic process [GO:0008652]; C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN791_c50_g1_i2	P20228	DCE_DROME	63.6	55	19	1	187	26	290	344	8.50E-16	84	DCE_DROME	reviewed	Glutamate decarboxylase (GAD) (EC 4.1.1.15)	Gad1 Gad Glb CG14994	Drosophila melanogaster (Fruit fly)	510	cytosol [GO:0005829]; glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate catabolic process [GO:0006538]; larval locomotory behavior [GO:0008345]; neuromuscular junction development [GO:0007528]; neurotransmitter biosynthetic process [GO:0042136]; neurotransmitter receptor metabolic process [GO:0045213]; olfactory learning [GO:0008355]; response to mechanical stimulus [GO:0009612]; synapse assembly [GO:0007416]	cytosol [GO:0005829]	glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]	GO:0004351; GO:0005829; GO:0006538; GO:0007416; GO:0007528; GO:0008345; GO:0008355; GO:0009449; GO:0009612; GO:0030170; GO:0042136; GO:0045213	gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate catabolic process [GO:0006538]; larval locomotory behavior [GO:0008345]; neuromuscular junction development [GO:0007528]; neurotransmitter biosynthetic process [GO:0042136]; neurotransmitter receptor metabolic process [GO:0045213]; olfactory learning [GO:0008355]; response to mechanical stimulus [GO:0009612]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN40585_c0_g1_i1	P48319	DCE1_PIG	61.3	93	36	0	3	281	345	437	1.20E-29	130.2	DCE1_PIG	reviewed	Glutamate decarboxylase 1 (EC 4.1.1.15) (67 kDa glutamic acid decarboxylase) (GAD-67) (Glutamate decarboxylase 67 kDa isoform)	GAD1 GAD67	Sus scrofa (Pig)	594	axon terminus [GO:0043679]; cell cortex [GO:0005938]; inhibitory synapse [GO:0060077]; presynaptic active zone [GO:0048786]; glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; carboxylic acid metabolic process [GO:0019752]; locomotory exploration behavior [GO:0035641]; neurotransmitter biosynthetic process [GO:0042136]; social behavior [GO:0035176]	axon terminus [GO:0043679]; cell cortex [GO:0005938]; inhibitory synapse [GO:0060077]; presynaptic active zone [GO:0048786]	glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]	GO:0004351; GO:0005938; GO:0019752; GO:0030170; GO:0035176; GO:0035641; GO:0042136; GO:0043679; GO:0048786; GO:0060077	carboxylic acid metabolic process [GO:0019752]; locomotory exploration behavior [GO:0035641]; neurotransmitter biosynthetic process [GO:0042136]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN22950_c0_g1_i1	P00367	DHE3_HUMAN	99.1	110	1	0	2	331	83	192	2.10E-57	222.6	DHE3_HUMAN	reviewed	"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)"	GLUD1 GLUD	Homo sapiens (Human)	558	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0008652; GO:0021762; GO:0032024; GO:0042802; GO:0043531; GO:0070403; GO:0070728; GO:0072350	cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350]		NA	NA	NA	NA	NA	NA
TRINITY_DN22950_c0_g1_i2	P00367	DHE3_HUMAN	100	212	0	0	2	637	83	294	6.20E-122	438	DHE3_HUMAN	reviewed	"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)"	GLUD1 GLUD	Homo sapiens (Human)	558	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0008652; GO:0021762; GO:0032024; GO:0042802; GO:0043531; GO:0070403; GO:0070728; GO:0072350	cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350]		NA	NA	NA	NA	NA	NA
TRINITY_DN8285_c0_g1_i10	P54385	DHE3_DROME	69.2	221	66	1	80	742	22	240	1.30E-89	330.9	DHE3_DROME	reviewed	"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)"	Gdh Glud CG5320	Drosophila melanogaster (Fruit fly)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0019551; GO:0042802	glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]		NA	NA	NA	NA	NA	NA
TRINITY_DN8285_c0_g1_i12	P54385	DHE3_DROME	75.2	282	68	1	151	996	22	301	1.00E-126	454.5	DHE3_DROME	reviewed	"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)"	Gdh Glud CG5320	Drosophila melanogaster (Fruit fly)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0019551; GO:0042802	glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]		blue	blue	NA	NA	NA	NA
TRINITY_DN8285_c0_g1_i2	P54385	DHE3_DROME	74.8	282	69	1	80	925	22	301	7.10E-127	454.9	DHE3_DROME	reviewed	"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)"	Gdh Glud CG5320	Drosophila melanogaster (Fruit fly)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0019551; GO:0042802	glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]		NA	NA	NA	NA	NA	NA
TRINITY_DN8285_c0_g1_i8	P54385	DHE3_DROME	74.8	282	69	1	156	1001	22	301	1.70E-126	453.8	DHE3_DROME	reviewed	"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)"	Gdh Glud CG5320	Drosophila melanogaster (Fruit fly)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0019551; GO:0042802	glutamate catabolic process [GO:0006538]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]		blue	blue	NA	NA	NA	NA
TRINITY_DN6335_c0_g2_i1	Q03445	GLR1_DROME	59.7	62	25	0	82	267	225	286	2.10E-15	82.8	GLR1_DROME	reviewed	Glutamate receptor 1 (Glutamate receptor I) (dGLUR-I) (Kainate-selective glutamate receptor)	GluRIA Glu-RI CG8442	Drosophila melanogaster (Fruit fly)	991	ionotropic glutamate receptor complex [GO:0008328]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; cation transport [GO:0006812]	ionotropic glutamate receptor complex [GO:0008328]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0006812; GO:0008328; GO:0015276; GO:0015277; GO:0038023; GO:0045211	cation transport [GO:0006812]		NA	NA	NA	NA	NA	NA
TRINITY_DN6335_c0_g2_i2	Q03445	GLR1_DROME	60.3	63	25	0	40	228	224	286	4.80E-16	84.7	GLR1_DROME	reviewed	Glutamate receptor 1 (Glutamate receptor I) (dGLUR-I) (Kainate-selective glutamate receptor)	GluRIA Glu-RI CG8442	Drosophila melanogaster (Fruit fly)	991	ionotropic glutamate receptor complex [GO:0008328]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; cation transport [GO:0006812]	ionotropic glutamate receptor complex [GO:0008328]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0006812; GO:0008328; GO:0015276; GO:0015277; GO:0038023; GO:0045211	cation transport [GO:0006812]		NA	NA	NA	NA	NA	NA
TRINITY_DN25353_c0_g1_i1	P39086	GRIK1_HUMAN	64.6	96	34	0	5	292	621	716	1.40E-31	136.7	GRIK1_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)"	GRIK1 GLUR5	Homo sapiens (Human)	918	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007399; GO:0007417; GO:0008066; GO:0015276; GO:0015277; GO:0035249; GO:0038023; GO:0045211; GO:0050804; GO:0051966; GO:1904315	"central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16743_c0_g1_i1	Q13002	GRIK2_HUMAN	52.1	71	28	1	217	5	525	589	3.50E-11	68.6	GRIK2_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"	GRIK2 GLUR6	Homo sapiens (Human)	908	"dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"	dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]	GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:0120169; GO:1904315	"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16743_c0_g1_i2	Q13002	GRIK2_HUMAN	54.7	64	23	1	192	1	525	582	2.00E-10	65.9	GRIK2_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"	GRIK2 GLUR6	Homo sapiens (Human)	908	"dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"	dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]	GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:0120169; GO:1904315	"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23146_c0_g1_i1	Q13002	GRIK2_HUMAN	46.1	76	34	2	410	183	787	855	1.20E-09	64.3	GRIK2_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"	GRIK2 GLUR6	Homo sapiens (Human)	908	"dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"	dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]	GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:0120169; GO:1904315	"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23146_c1_g1_i1	Q13002	GRIK2_HUMAN	51.5	66	30	1	199	2	708	771	2.00E-13	75.9	GRIK2_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)"	GRIK2 GLUR6	Homo sapiens (Human)	908	"dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"	dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]	GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0098686; GO:0098978; GO:0099507; GO:0120169; GO:1904315	"behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuronal action potential [GO:0019228]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32063_c0_g1_i1	Q13003	GRIK3_HUMAN	55.3	47	21	0	62	202	539	585	1.30E-09	63.5	GRIK3_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)"	GRIK3 GLUR7	Homo sapiens (Human)	919	"axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"	axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015276; GO:0015277; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:1904315	"glutamate receptor signaling pathway [GO:0007215]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37277_c0_g1_i1	Q13003	GRIK3_HUMAN	53.7	67	30	1	3	203	445	510	3.10E-17	88.6	GRIK3_HUMAN	reviewed	"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)"	GRIK3 GLUR7	Homo sapiens (Human)	919	"axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"	axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015276; GO:0015277; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:1904315	"glutamate receptor signaling pathway [GO:0007215]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i11	Q12680	GLT1_YEAST	53.2	79	36	1	90	326	209	286	4.10E-18	92.4	GLT1_YEAST	reviewed	Glutamate synthase [NADH] (EC 1.4.1.14) (NADH-GOGAT)	GLT1 YDL171C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	2145	"mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0005739; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g2_i1	Q03460	GLSN_MEDSA	57.9	318	130	3	18	959	1847	2164	5.60E-107	389	GLSN_MEDSA	reviewed	"Glutamate synthase [NADH], amyloplastic (EC 1.4.1.14) (NADH-GOGAT)"		Medicago sativa (Alfalfa)	2194	"amyloplast [GO:0009501]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"	amyloplast [GO:0009501]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]"	GO:0005506; GO:0006541; GO:0009501; GO:0010181; GO:0016040; GO:0050660; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g2_i2	Q03460	GLSN_MEDSA	57.5	259	109	1	69	842	1906	2164	5.80E-87	322.4	GLSN_MEDSA	reviewed	"Glutamate synthase [NADH], amyloplastic (EC 1.4.1.14) (NADH-GOGAT)"		Medicago sativa (Alfalfa)	2194	"amyloplast [GO:0009501]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"	amyloplast [GO:0009501]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]"	GO:0005506; GO:0006541; GO:0009501; GO:0010181; GO:0016040; GO:0050660; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN26561_c0_g1_i1	Q03460	GLSN_MEDSA	70.8	72	18	1	11	217	1489	1560	1.60E-21	102.8	GLSN_MEDSA	reviewed	"Glutamate synthase [NADH], amyloplastic (EC 1.4.1.14) (NADH-GOGAT)"		Medicago sativa (Alfalfa)	2194	"amyloplast [GO:0009501]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"	amyloplast [GO:0009501]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]"	GO:0005506; GO:0006541; GO:0009501; GO:0010181; GO:0016040; GO:0050660; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN29241_c0_g1_i1	P96218	GLTB_MYCTU	68.8	80	25	0	245	6	364	443	1.20E-25	116.7	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN10005_c0_g1_i1	P96218	GLTB_MYCTU	76.6	141	33	0	1	423	953	1093	6.10E-57	221.5	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN10005_c0_g2_i1	P96218	GLTB_MYCTU	85.5	124	18	0	1	372	955	1078	7.00E-57	221.1	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN11491_c1_g1_i1	P96218	GLTB_MYCTU	71.9	167	47	0	504	4	1050	1216	2.90E-66	252.7	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN11491_c0_g2_i1	P96218	GLTB_MYCTU	81.2	154	29	0	464	3	981	1134	1.00E-65	250.8	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN35051_c0_g1_i1	P96218	GLTB_MYCTU	57.7	71	30	0	11	223	718	788	3.80E-18	91.7	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN33341_c0_g1_i1	P96218	GLTB_MYCTU	68.8	77	24	0	9	239	282	358	2.20E-27	122.5	GLTB_MYCTU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain)	gltB Rv3859c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	1527	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN2404_c0_g1_i1	Q05755	GLTB_AZOBR	80.2	192	38	0	577	2	874	1065	1.60E-84	313.5	GLTB_AZOBR	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain) (NADPH-GOGAT)	gltB	Azospirillum brasilense	1515	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0006541; GO:0046872; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN2404_c0_g1_i2	Q05755	GLTB_AZOBR	82.1	179	32	0	538	2	887	1065	3.80E-80	298.9	GLTB_AZOBR	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain) (NADPH-GOGAT)	gltB	Azospirillum brasilense	1515	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0006541; GO:0046872; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN30319_c0_g1_i1	Q05755	GLTB_AZOBR	76.1	67	16	0	2	202	720	786	5.70E-21	100.9	GLTB_AZOBR	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain) (NADPH-GOGAT)	gltB	Azospirillum brasilense	1515	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0006541; GO:0046872; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN39867_c0_g1_i1	Q05755	GLTB_AZOBR	72.5	91	25	0	288	16	497	587	1.50E-30	133.3	GLTB_AZOBR	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain) (NADPH-GOGAT)	gltB	Azospirillum brasilense	1515	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0006541; GO:0046872; GO:0051538; GO:0097054	glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN23790_c0_g1_i1	P39812	GLTA_BACSU	59.8	97	39	0	294	4	663	759	7.30E-25	114.4	GLTA_BACSU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (NADPH-GOGAT)	gltA BSU18450	Bacillus subtilis (strain 168)	1520	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN12682_c0_g1_i1	P39812	GLTA_BACSU	73	122	33	0	1	366	1053	1174	9.00E-49	194.1	GLTA_BACSU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (NADPH-GOGAT)	gltA BSU18450	Bacillus subtilis (strain 168)	1520	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i3	P39812	GLTA_BACSU	50	120	59	1	5	361	126	245	9.00E-27	121.3	GLTA_BACSU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (NADPH-GOGAT)	gltA BSU18450	Bacillus subtilis (strain 168)	1520	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN26303_c0_g1_i1	P39812	GLTA_BACSU	67.6	74	24	0	3	224	851	924	1.90E-20	99.4	GLTA_BACSU	reviewed	Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (NADPH-GOGAT)	gltA BSU18450	Bacillus subtilis (strain 168)	1520	"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"		"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0006537; GO:0015930; GO:0016491; GO:0019676; GO:0046872; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN38349_c0_g1_i1	P9WN18	GLTD_MYCTO	86.5	74	10	0	223	2	48	121	1.80E-36	152.5	GLTD_MYCTO	reviewed	Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (Glutamate synthase subunit beta) (GLTS beta chain)	gltD MT3973	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	488	"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; L-glutamate biosynthetic process [GO:0097054]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0046872; GO:0051539; GO:0097054	L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN32410_c0_g1_i1	P9WN18	GLTD_MYCTO	74.4	82	21	0	247	2	134	215	1.70E-27	122.9	GLTD_MYCTO	reviewed	Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (Glutamate synthase subunit beta) (GLTS beta chain)	gltD MT3973	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	488	"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; L-glutamate biosynthetic process [GO:0097054]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0046872; GO:0051539; GO:0097054	L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN7369_c0_g2_i1	P9WN18	GLTD_MYCTO	66.7	81	26	1	11	250	31	111	3.20E-29	128.6	GLTD_MYCTO	reviewed	Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (Glutamate synthase subunit beta) (GLTS beta chain)	gltD MT3973	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	488	"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; L-glutamate biosynthetic process [GO:0097054]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0046872; GO:0051539; GO:0097054	L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN40509_c0_g1_i1	Q05756	GLTD_AZOBR	64.6	96	34	0	299	12	127	222	9.10E-31	134	GLTD_AZOBR	reviewed	Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (Glutamate synthase subunit beta) (GLTS beta chain) (NADPH-GOGAT)	gltD	Azospirillum brasilense	482	"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; L-glutamate biosynthetic process [GO:0097054]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]"	GO:0004355; GO:0046872; GO:0051539; GO:0097054	L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN28961_c0_g1_i1	O34399	GLTB_BACSU	60.6	66	22	2	3	200	432	493	8.20E-13	73.9	GLTB_BACSU	reviewed	Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (NADPH-GOGAT)	gltB BSU18440	Bacillus subtilis (strain 168)	493	glutamate synthase (NADPH) activity [GO:0004355]; iron-sulfur cluster binding [GO:0051536]; L-glutamate biosynthetic process [GO:0097054]		glutamate synthase (NADPH) activity [GO:0004355]; iron-sulfur cluster binding [GO:0051536]	GO:0004355; GO:0051536; GO:0097054	L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN40877_c0_g1_i1	O34399	GLTB_BACSU	64.4	73	26	0	220	2	127	199	4.30E-22	104.8	GLTB_BACSU	reviewed	Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (NADPH-GOGAT)	gltB BSU18440	Bacillus subtilis (strain 168)	493	glutamate synthase (NADPH) activity [GO:0004355]; iron-sulfur cluster binding [GO:0051536]; L-glutamate biosynthetic process [GO:0097054]		glutamate synthase (NADPH) activity [GO:0004355]; iron-sulfur cluster binding [GO:0051536]	GO:0004355; GO:0051536; GO:0097054	L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN20233_c0_g1_i1	Q0JKD0	GLT1_ORYSJ	71.3	265	76	0	795	1	1047	1311	6.50E-108	391.7	GLT1_ORYSJ	reviewed	"Glutamate synthase 1 [NADH], chloroplastic (EC 1.4.1.14) (NADH-dependent glutamate synthase 1) (NADH-GOGAT 1)"	Os01g0681900 LOC_Os01g48960	Oryza sativa subsp. japonica (Rice)	2167	"chloroplast [GO:0009507]; plastid [GO:0009536]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to ammonium ion [GO:0060359]"	chloroplast [GO:0009507]; plastid [GO:0009536]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0006537; GO:0009507; GO:0009536; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0048589; GO:0050660; GO:0051538; GO:0060359; GO:0097054	ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to ammonium ion [GO:0060359]		NA	NA	NA	NA	NA	NA
TRINITY_DN40295_c0_g1_i1	Q0JKD0	GLT1_ORYSJ	63.9	72	26	0	1	216	1454	1525	2.30E-20	99	GLT1_ORYSJ	reviewed	"Glutamate synthase 1 [NADH], chloroplastic (EC 1.4.1.14) (NADH-dependent glutamate synthase 1) (NADH-GOGAT 1)"	Os01g0681900 LOC_Os01g48960	Oryza sativa subsp. japonica (Rice)	2167	"chloroplast [GO:0009507]; plastid [GO:0009536]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to ammonium ion [GO:0060359]"	chloroplast [GO:0009507]; plastid [GO:0009536]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0006537; GO:0009507; GO:0009536; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0048589; GO:0050660; GO:0051538; GO:0060359; GO:0097054	ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to ammonium ion [GO:0060359]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i8	Q9LV03	GLUT1_ARATH	53.7	328	139	6	5	955	223	548	3.50E-95	349.7	GLUT1_ARATH	reviewed	"Glutamate synthase 1 [NADH], chloroplastic (EC 1.4.1.14) (NADH-dependent glutamate synthase 1) (NADH-GOGAT 1)"	GLT1 At5g53460 MYN8.7	Arabidopsis thaliana (Mouse-ear cress)	2208	"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; plastid [GO:0009536]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to cadmium ion [GO:0046686]"	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; plastid [GO:0009536]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0006537; GO:0009507; GO:0009536; GO:0009570; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0046686; GO:0048589; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN7369_c0_g1_i1	Q0JKD0	GLT1_ORYSJ	65.1	86	25	1	4	246	1710	1795	7.40E-31	134	GLT1_ORYSJ	reviewed	"Glutamate synthase 1 [NADH], chloroplastic (EC 1.4.1.14) (NADH-dependent glutamate synthase 1) (NADH-GOGAT 1)"	Os01g0681900 LOC_Os01g48960	Oryza sativa subsp. japonica (Rice)	2167	"chloroplast [GO:0009507]; plastid [GO:0009536]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to ammonium ion [GO:0060359]"	chloroplast [GO:0009507]; plastid [GO:0009536]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0006537; GO:0009507; GO:0009536; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0048589; GO:0050660; GO:0051538; GO:0060359; GO:0097054	ammonia assimilation cycle [GO:0019676]; developmental growth [GO:0048589]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]; response to ammonium ion [GO:0060359]		NA	NA	NA	NA	NA	NA
TRINITY_DN37355_c0_g1_i1	Q0DG35	GLT2_ORYSJ	64.4	73	26	0	4	222	1399	1471	2.20E-21	102.4	GLT2_ORYSJ	reviewed	"Glutamate synthase 2 [NADH], chloroplastic (EC 1.4.1.14) (NADH-dependent glutamate synthase 2) (NADH-GOGAT 2)"	Os05g0555600 LOC_Os05g48200 OJ1214_E03.1 OJ1263_E10.17	Oryza sativa subsp. japonica (Rice)	2188	"chloroplast [GO:0009507]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	chloroplast [GO:0009507]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0006537; GO:0009507; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN27014_c0_g1_i1	Q0DG35	GLT2_ORYSJ	67.2	67	22	0	203	3	1383	1449	1.60E-18	92.8	GLT2_ORYSJ	reviewed	"Glutamate synthase 2 [NADH], chloroplastic (EC 1.4.1.14) (NADH-dependent glutamate synthase 2) (NADH-GOGAT 2)"	Os05g0555600 LOC_Os05g48200 OJ1214_E03.1 OJ1263_E10.17	Oryza sativa subsp. japonica (Rice)	2188	"chloroplast [GO:0009507]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]"	chloroplast [GO:0009507]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0005506; GO:0006537; GO:0009507; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN2832_c0_g1_i1	Q9W3K5	GSH1_DROME	55.8	181	78	1	708	172	27	207	1.90E-55	217.2	GSH1_DROME	reviewed	Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase)	Gclc GCSh CG2259	Drosophila melanogaster (Fruit fly)	717	glutamate-cysteine ligase complex [GO:0017109]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357]; axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688]	glutamate-cysteine ligase complex [GO:0017109]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357]	GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471	axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688]		NA	NA	NA	NA	NA	NA
TRINITY_DN2832_c0_g1_i10	P48506	GSH1_HUMAN	56.1	599	242	7	1919	171	27	620	1.20E-197	691	GSH1_HUMAN	reviewed	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	GCLC GLCL GLCLC	Homo sapiens (Human)	637	"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2832_c0_g1_i2	P48506	GSH1_HUMAN	56.1	599	242	7	1919	171	27	620	1.20E-197	691	GSH1_HUMAN	reviewed	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	GCLC GLCL GLCLC	Homo sapiens (Human)	637	"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2832_c0_g1_i6	P97494	GSH1_MOUSE	57.5	351	134	3	1160	153	277	627	1.20E-113	411.4	GSH1_MOUSE	reviewed	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	Mus musculus (Mouse)	637	"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26744_c0_g1_i1	P48506	GSH1_HUMAN	55.7	131	49	1	401	9	369	490	3.00E-37	156	GSH1_HUMAN	reviewed	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	GCLC GLCL GLCLC	Homo sapiens (Human)	637	"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29967_c0_g1_i1	P97494	GSH1_MOUSE	100	82	0	0	248	3	286	367	5.50E-42	171	GSH1_MOUSE	reviewed	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	Gclc Glclc	Mus musculus (Mouse)	637	"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25783_c0_g1_i1	P48506	GSH1_HUMAN	100	106	0	0	3	320	343	448	7.80E-57	220.7	GSH1_HUMAN	reviewed	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	GCLC GLCL GLCLC	Homo sapiens (Human)	637	"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"	cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29708_c0_g1_i1	P48508	GSH0_RAT	33.1	248	156	5	120	833	20	267	7.50E-31	136	GSH0_RAT	reviewed	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	Gclm Glclr	Rattus norvegicus (Rat)	274	glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]	glutamate-cysteine ligase complex [GO:0017109]	enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877]	GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237	aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN38312_c0_g1_i1	Q94900	GLUCL_DROME	70	60	18	0	1	180	97	156	3.00E-20	98.6	GLUCL_DROME	reviewed	Glutamate-gated chloride channel (DrosGluCl)	GluClalpha GluCl CG7535	Drosophila melanogaster (Fruit fly)	456	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN40681_c0_g1_i1	Q94900	GLUCL_DROME	86.3	51	7	0	287	135	288	338	6.50E-18	91.3	GLUCL_DROME	reviewed	Glutamate-gated chloride channel (DrosGluCl)	GluClalpha GluCl CG7535	Drosophila melanogaster (Fruit fly)	456	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN18148_c0_g2_i1	Q94900	GLUCL_DROME	76.3	59	14	0	207	31	98	156	1.40E-22	106.3	GLUCL_DROME	reviewed	Glutamate-gated chloride channel (DrosGluCl)	GluClalpha GluCl CG7535	Drosophila melanogaster (Fruit fly)	456	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN18148_c0_g1_i1	Q94900	GLUCL_DROME	48	50	25	1	76	222	24	73	4.70E-08	58.2	GLUCL_DROME	reviewed	Glutamate-gated chloride channel (DrosGluCl)	GluClalpha GluCl CG7535	Drosophila melanogaster (Fruit fly)	456	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN22366_c0_g1_i1	Q94900	GLUCL_DROME	60.5	81	27	2	92	319	376	456	3.40E-22	105.9	GLUCL_DROME	reviewed	Glutamate-gated chloride channel (DrosGluCl)	GluClalpha GluCl CG7535	Drosophila melanogaster (Fruit fly)	456	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN18731_c0_g1_i1	Q94900	GLUCL_DROME	91	67	6	0	202	2	228	294	2.30E-28	125.9	GLUCL_DROME	reviewed	Glutamate-gated chloride channel (DrosGluCl)	GluClalpha GluCl CG7535	Drosophila melanogaster (Fruit fly)	456	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel activity [GO:0005254]; extracellularly glutamate-gated chloride channel activity [GO:0008068]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005254; GO:0005887; GO:0006821; GO:0007165; GO:0007268; GO:0008068; GO:0016021; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37814_c0_g1_i1	B2U9R2	SYE_RALPJ	100	47	0	0	143	3	1	47	1.50E-21	102.8	SYE_RALPJ	reviewed	Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)	gltX Rpic_1022	Ralstonia pickettii (strain 12J)	465	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004818; GO:0005524; GO:0005737; GO:0006424; GO:0008270	glutamyl-tRNA aminoacylation [GO:0006424]		NA	NA	NA	NA	NA	NA
TRINITY_DN34299_c0_g1_i1	O94925	GLSK_HUMAN	100	172	0	0	517	2	282	453	1.10E-97	357.1	GLSK_HUMAN	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GLS GLS1 KIAA0838	Homo sapiens (Human)	669	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN32693_c0_g1_i1	O94925	GLSK_HUMAN	56.8	44	19	0	199	68	573	616	7.50E-09	60.8	GLSK_HUMAN	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GLS GLS1 KIAA0838	Homo sapiens (Human)	669	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN36834_c0_g1_i1	O94925	GLSK_HUMAN	100	100	0	0	313	14	451	550	8.50E-56	217.2	GLSK_HUMAN	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GLS GLS1 KIAA0838	Homo sapiens (Human)	669	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN5085_c0_g1_i1	O94925	GLSK_HUMAN	61.5	309	115	1	930	4	326	630	8.30E-115	414.8	GLSK_HUMAN	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GLS GLS1 KIAA0838	Homo sapiens (Human)	669	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN854_c0_g1_i2	D3Z7P3	GLSK_MOUSE	51.1	186	81	3	557	3	143	319	1.80E-47	190.7	GLSK_MOUSE	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	Gls Gls1 Kiaa0838	Mus musculus (Mouse)	674	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0042802; GO:0045202; GO:0051289; GO:0090461	chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN854_c0_g1_i5	D3Z7P3	GLSK_MOUSE	43.3	224	79	3	671	3	143	319	3.10E-43	176.8	GLSK_MOUSE	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	Gls Gls1 Kiaa0838	Mus musculus (Mouse)	674	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0042802; GO:0045202; GO:0051289; GO:0090461	chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN854_c0_g1_i7	D3Z7P3	GLSK_MOUSE	43.3	224	79	3	671	3	143	319	7.00E-43	175.6	GLSK_MOUSE	reviewed	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	Gls Gls1 Kiaa0838	Mus musculus (Mouse)	674	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0042802; GO:0045202; GO:0051289; GO:0090461	chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN19289_c0_g1_i1	Q9UI32	GLSL_HUMAN	67.1	76	25	0	3	230	343	418	2.90E-25	115.5	GLSL_HUMAN	reviewed	"Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase)"	GLS2 GA	Homo sapiens (Human)	602	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	glutaminase activity [GO:0004359]	GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0008652; GO:0014047; GO:0042981; GO:0072593	cellular amino acid biosynthetic process [GO:0008652]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN24054_c0_g1_i1	Q32NG4	GALD1_XENLA	43.7	215	120	1	712	68	16	229	5.20E-43	176	GALD1_XENLA	reviewed	Glutamine amidotransferase-like class 1 domain-containing protein 1 (Parkinson disease 7 domain-containing protein 1)	gatd1 pddc1	Xenopus laevis (African clawed frog)	229	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN24054_c0_g1_i2	Q32NG4	GALD1_XENLA	41.9	186	103	2	613	68	45	229	1.20E-32	141.4	GALD1_XENLA	reviewed	Glutamine amidotransferase-like class 1 domain-containing protein 1 (Parkinson disease 7 domain-containing protein 1)	gatd1 pddc1	Xenopus laevis (African clawed frog)	229	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN24054_c0_g1_i3	Q32NG4	GALD1_XENLA	44.7	103	56	1	376	68	128	229	3.80E-17	89.4	GALD1_XENLA	reviewed	Glutamine amidotransferase-like class 1 domain-containing protein 1 (Parkinson disease 7 domain-containing protein 1)	gatd1 pddc1	Xenopus laevis (African clawed frog)	229	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i1	Q04831	GLNA_PANAR	84.9	239	36	0	717	1	1	239	7.60E-128	458	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i10	Q04831	GLNA_PANAR	85.3	360	53	0	1175	96	1	360	2.00E-191	669.8	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i12	Q04831	GLNA_PANAR	84.2	360	57	0	1173	94	1	360	2.40E-189	662.9	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i3	Q04831	GLNA_PANAR	85.8	360	51	0	1175	96	1	360	3.60E-193	675.6	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i5	Q04831	GLNA_PANAR	86	121	17	0	458	96	240	360	3.60E-55	215.7	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i8	Q04831	GLNA_PANAR	87.6	121	15	0	458	96	240	360	6.60E-57	221.5	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN110_c0_g1_i9	Q04831	GLNA_PANAR	88.7	53	6	0	252	94	308	360	2.70E-20	99	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN25075_c0_g1_i1	Q04831	GLNA_PANAR	74.5	55	14	0	115	279	4	58	6.70E-20	97.8	GLNA_PANAR	reviewed	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)		Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	361	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	glutamine biosynthetic process [GO:0006542]		NA	NA	NA	NA	NA	NA
TRINITY_DN6344_c0_g1_i1	P15105	GLNA_MOUSE	97.7	173	4	0	11	529	1	173	2.70E-102	372.5	GLNA_MOUSE	reviewed	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	Glul Glns	Mus musculus (Mouse)	373	"axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate metabolic process [GO:0006536]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"	axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate-ammonia ligase activity [GO:0004356]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000287; GO:0001525; GO:0004356; GO:0005524; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006536; GO:0006542; GO:0008283; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0042995; GO:0043005; GO:0043204; GO:0043209; GO:0043231; GO:0043679; GO:0044297; GO:0045503; GO:0050679; GO:0051968; GO:0097386; GO:1903670; GO:1904749	"ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate metabolic process [GO:0006536]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6344_c0_g1_i3	P15104	GLNA_HUMAN	100	203	0	0	379	987	159	361	3.70E-121	436	GLNA_HUMAN	reviewed	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GLUL GLNS	Homo sapiens (Human)	373	"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate-ammonia ligase activity [GO:0004356]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000287; GO:0001504; GO:0001525; GO:0004356; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006538; GO:0006542; GO:0008283; GO:0008652; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0043204; GO:0043209; GO:0043679; GO:0045503; GO:0050679; GO:0051968; GO:0070062; GO:0097386; GO:1903670; GO:1904749	"ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6344_c0_g1_i3	P15104	GLNA_HUMAN	86.8	151	17	1	11	454	1	151	7.70E-71	268.9	GLNA_HUMAN	reviewed	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GLUL GLNS	Homo sapiens (Human)	373	"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate-ammonia ligase activity [GO:0004356]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000287; GO:0001504; GO:0001525; GO:0004356; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006538; GO:0006542; GO:0008283; GO:0008652; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0043204; GO:0043209; GO:0043679; GO:0045503; GO:0050679; GO:0051968; GO:0070062; GO:0097386; GO:1903670; GO:1904749	"ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6344_c0_g1_i4	P15104	GLNA_HUMAN	100	361	0	0	11	1093	1	361	1.10E-222	773.5	GLNA_HUMAN	reviewed	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GLUL GLNS	Homo sapiens (Human)	373	"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate-ammonia ligase activity [GO:0004356]; glutamate binding [GO:0016595]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000287; GO:0001504; GO:0001525; GO:0004356; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006538; GO:0006542; GO:0008283; GO:0008652; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0043204; GO:0043209; GO:0043679; GO:0045503; GO:0050679; GO:0051968; GO:0070062; GO:0097386; GO:1903670; GO:1904749	"ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8271_c0_g3_i1	Q9VYA0	NADE_DROME	65	223	78	0	670	2	1	223	1.20E-87	324.3	NADE_DROME	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing])	Nadsyn CG9940	Drosophila melanogaster (Fruit fly)	787	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]; negative regulation of neuromuscular synaptic transmission [GO:1900074]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435; GO:1900074	NAD biosynthetic process [GO:0009435]; negative regulation of neuromuscular synaptic transmission [GO:1900074]		NA	NA	NA	NA	NA	NA
TRINITY_DN8271_c0_g2_i1	Q9VYA0	NADE_DROME	62	495	187	1	2001	520	202	696	1.70E-181	637.5	NADE_DROME	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing])	Nadsyn CG9940	Drosophila melanogaster (Fruit fly)	787	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]; negative regulation of neuromuscular synaptic transmission [GO:1900074]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435; GO:1900074	NAD biosynthetic process [GO:0009435]; negative regulation of neuromuscular synaptic transmission [GO:1900074]		NA	NA	NA	NA	NA	NA
TRINITY_DN36198_c0_g1_i1	Q54ML1	NADE_DICDI	63.8	127	46	0	383	3	4	130	2.40E-45	183	NADE_DICDI	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing])	nadsyn1 DDB_G0285877	Dictyostelium discoideum (Slime mold)	713	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]"	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435; GO:0016811	NAD biosynthetic process [GO:0009435]		NA	NA	NA	NA	NA	NA
TRINITY_DN40035_c0_g1_i1	P38795	NADE_YEAST	64.3	112	37	1	348	13	474	582	4.60E-34	145.2	NADE_YEAST	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing])	QNS1 YHR074W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	714	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005634; GO:0005737; GO:0009435	NAD biosynthetic process [GO:0009435]		NA	NA	NA	NA	NA	NA
TRINITY_DN39378_c0_g1_i1	Q5ZMA6	NADE_CHICK	64.5	62	20	1	184	5	631	692	2.80E-16	85.5	NADE_CHICK	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)	NADSYN1 RCJMB04_2l1	Gallus gallus (Chicken)	707	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435	NAD biosynthetic process [GO:0009435]		NA	NA	NA	NA	NA	NA
TRINITY_DN30440_c0_g1_i1	Q6IA69	NADE_HUMAN	100	147	0	0	443	3	463	609	3.20E-77	288.9	NADE_HUMAN	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)	NADSYN1	Homo sapiens (Human)	706	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0019674	NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]		NA	NA	NA	NA	NA	NA
TRINITY_DN25896_c0_g1_i1	Q6IA69	NADE_HUMAN	99	99	1	0	2	298	299	397	1.40E-52	206.5	NADE_HUMAN	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)	NADSYN1	Homo sapiens (Human)	706	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0019674	NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]		NA	NA	NA	NA	NA	NA
TRINITY_DN39821_c0_g1_i1	Q6IA69	NADE_HUMAN	99.1	106	1	0	318	1	106	211	2.00E-58	226.1	NADE_HUMAN	reviewed	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)	NADSYN1	Homo sapiens (Human)	706	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0019674	NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]		NA	NA	NA	NA	NA	NA
TRINITY_DN15101_c0_g1_i1	Q5NRH4	GLMS_ZYMMO	74.6	71	18	0	214	2	70	140	5.80E-24	110.9	GLMS_ZYMMO	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase)	glmS ZMO0056	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	607	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005737; GO:0005975; GO:0006541; GO:0097367; GO:1901137	carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN36305_c0_g1_i1	Q9KG45	GLMS_BACHD	55.6	99	44	0	298	2	4	102	2.10E-27	122.9	GLMS_BACHD	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase)	glmS BH0268	Bacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125)	600	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005737; GO:0005975; GO:0006541; GO:0097367; GO:1901137	carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN2842_c0_g1_i1	Q8Y303	GLMS_RALSO	97.7	87	2	0	2	262	468	554	1.50E-42	172.9	GLMS_RALSO	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase)	glmS RSc0178 RS00609	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	612	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005737; GO:0005975; GO:0006541; GO:0097367; GO:1901137	carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN39603_c0_g1_i1	Q5NRH4	GLMS_ZYMMO	74.4	78	20	0	2	235	52	129	1.50E-28	126.3	GLMS_ZYMMO	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase)	glmS ZMO0056	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	607	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005737; GO:0005975; GO:0006541; GO:0097367; GO:1901137	carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate metabolic process [GO:0005975]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN4134_c0_g1_i1	Q56206	GLMS_SPHYA	88.9	99	11	0	1	297	1	99	2.70E-43	175.6	GLMS_SPHYA	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase) (Fragment)	glmS	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	156	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; carbohydrate derivative biosynthetic process [GO:1901137]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005737; GO:0006541; GO:0097367; GO:1901137	carbohydrate derivative biosynthetic process [GO:1901137]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN4134_c0_g1_i2	Q56206	GLMS_SPHYA	88.9	99	11	0	1	297	1	99	3.50E-43	175.3	GLMS_SPHYA	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase) (Fragment)	glmS	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	156	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; carbohydrate derivative biosynthetic process [GO:1901137]; glutamine metabolic process [GO:0006541]	cytoplasm [GO:0005737]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005737; GO:0006541; GO:0097367; GO:1901137	carbohydrate derivative biosynthetic process [GO:1901137]; glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN27407_c0_g1_i1	P53704	GFA1_CANAL	64.9	74	25	1	9	227	640	713	2.60E-20	99	GFA1_CANAL	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (GFAT) (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (Hexosephosphate aminotransferase)	GFA1 CAALFM_C302280CA CaO19.1618	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	713	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cell wall chitin biosynthetic process [GO:0006038]; cellular response to drug [GO:0035690]; chitin biosynthetic process [GO:0006031]; fructose 6-phosphate metabolic process [GO:0006002]; fungal-type cell wall chitin biosynthetic process [GO:0034221]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; hyphal growth [GO:0030448]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0006002; GO:0006031; GO:0006038; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0030448; GO:0034221; GO:0035690; GO:0097367	cellular response to drug [GO:0035690]; cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; fructose 6-phosphate metabolic process [GO:0006002]; fungal-type cell wall chitin biosynthetic process [GO:0034221]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; hyphal growth [GO:0030448]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN26123_c0_g1_i1	Q06210	GFPT1_HUMAN	100	109	0	0	2	328	250	358	1.20E-55	216.9	GFPT1_HUMAN	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	GFPT1 GFAT GFPT	Homo sapiens (Human)	699	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367	circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c1_g1_i3	P82808	GFPT1_RAT	59.7	231	82	3	76	738	1	230	7.30E-75	282	GFPT1_RAT	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	Gfpt1	Rattus norvegicus (Rat)	681	amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; identical protein binding [GO:0042802]; cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; identical protein binding [GO:0042802]	GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0009744; GO:0016597; GO:0030246; GO:0032868; GO:0032869; GO:0032922; GO:0042802; GO:0045719; GO:0097367	cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN40293_c0_g1_i1	Q06210	GFPT1_HUMAN	100	129	0	0	403	17	571	699	5.60E-68	258.1	GFPT1_HUMAN	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	GFPT1 GFAT GFPT	Homo sapiens (Human)	699	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367	circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN40075_c0_g1_i1	Q06210	GFPT1_HUMAN	100	69	0	0	208	2	1	69	1.40E-34	146.4	GFPT1_HUMAN	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	GFPT1 GFAT GFPT	Homo sapiens (Human)	699	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367	circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN39673_c0_g1_i1	Q06210	GFPT1_HUMAN	99.2	119	1	0	2	358	89	207	6.30E-63	241.1	GFPT1_HUMAN	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	GFPT1 GFAT GFPT	Homo sapiens (Human)	699	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367	circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN29664_c0_g1_i1	Q06210	GFPT1_HUMAN	100	240	0	0	720	1	301	540	5.20E-133	474.9	GFPT1_HUMAN	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	GFPT1 GFAT GFPT	Homo sapiens (Human)	699	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367	circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c1_g1_i1	Q4KMC4	GFPT2_RAT	67.7	703	199	7	76	2163	1	682	2.00E-268	926.4	GFPT2_RAT	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2)	Gfpt2	Rattus norvegicus (Rat)	682	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0006002; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0097367; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c1_g1_i2	Q4KMC4	GFPT2_RAT	66.9	711	199	7	76	2187	1	682	2.20E-267	922.9	GFPT2_RAT	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2)	Gfpt2	Rattus norvegicus (Rat)	682	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0006002; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0097367; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c1_g1_i4	Q4KMC4	GFPT2_RAT	67.7	703	199	7	76	2163	1	682	2.00E-268	926.4	GFPT2_RAT	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2)	Gfpt2	Rattus norvegicus (Rat)	682	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0006002; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0097367; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c1_g1_i5	Q4KMC4	GFPT2_RAT	66.9	711	199	7	76	2187	1	682	2.30E-267	922.9	GFPT2_RAT	reviewed	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2)	Gfpt2	Rattus norvegicus (Rat)	682	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0006002; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0097367; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN29794_c0_g1_i1	P47897	SYQ_HUMAN	99.7	395	1	0	1186	2	247	641	2.70E-243	842	SYQ_HUMAN	reviewed	Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)	QARS1 QARS	Homo sapiens (Human)	775	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0006469; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234	"brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31381_c0_g1_i1	P47897	SYQ_HUMAN	100	123	0	0	371	3	642	764	2.10E-69	262.7	SYQ_HUMAN	reviewed	Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)	QARS1 QARS	Homo sapiens (Human)	775	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0006469; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234	"brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9142_c0_g1_i1	Q95334	AMPE_PIG	66.7	102	34	0	21	326	332	433	1.00E-35	150.6	AMPE_PIG	reviewed	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	ENPEP	Sus scrofa (Pig)	942	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3422_c0_g1_i1	Q95334	AMPE_PIG	37.6	237	146	2	48	758	705	939	1.00E-45	185.3	AMPE_PIG	reviewed	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	ENPEP	Sus scrofa (Pig)	942	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3422_c0_g1_i2	Q95334	AMPE_PIG	40.2	813	460	12	63	2477	145	939	1.70E-181	637.9	AMPE_PIG	reviewed	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	ENPEP	Sus scrofa (Pig)	942	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3422_c0_g1_i3	Q95334	AMPE_PIG	43.2	498	262	8	63	1541	145	626	2.00E-119	431	AMPE_PIG	reviewed	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	ENPEP	Sus scrofa (Pig)	942	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN35283_c0_g1_i1	Q6A8P5	GATA_CUTAK	100	91	0	0	2	274	112	202	5.30E-46	184.5	GATA_CUTAK	reviewed	Glutamyl-tRNA(Gln) amidotransferase subunit A (Glu-ADT subunit A) (EC 6.3.5.7)	gatA PPA1123	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	501	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]; translation [GO:0006412]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]	GO:0005524; GO:0006412; GO:0016787; GO:0030956; GO:0050567	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN6140_c0_g2_i2	B7PDC5	GATA_IXOSC	54.2	485	206	2	20	1468	21	491	4.10E-143	509.6	GATA_IXOSC	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7)"	gatA ISCW003184	Ixodes scapularis (Black-legged tick) (Deer tick)	505	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]	GO:0005524; GO:0005739; GO:0016787; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN6140_c0_g2_i4	B7PDC5	GATA_IXOSC	54.2	485	206	2	20	1468	21	491	5.70E-143	509.2	GATA_IXOSC	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7)"	gatA ISCW003184	Ixodes scapularis (Black-legged tick) (Deer tick)	505	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]	GO:0005524; GO:0005739; GO:0016787; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN6140_c0_g2_i5	Q17H91	GATA_AEDAE	51.4	74	36	0	53	274	416	489	5.20E-14	79	GATA_AEDAE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7)"	gatA AAEL002766	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	494	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]	GO:0005524; GO:0005739; GO:0016787; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN6140_c0_g2_i1	Q0VFI5	GATA_XENTR	48.2	85	44	0	5	259	235	319	5.90E-18	91.3	GATA_XENTR	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7) (Glutaminyl-tRNA synthase-like protein 1)"	qrsl1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	524	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; hydrolase activity [GO:0016787]	GO:0005524; GO:0005739; GO:0016787; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i11	D0N761	GATB_PHYIT	29.8	225	143	4	58	723	357	569	2.40E-19	97.8	GATB_PHYIT	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)"	PITG_07062	Phytophthora infestans (strain T30-4) (Potato late blight fungus)	574	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i14	Q16UG2	GATB_AEDAE	59.1	44	18	0	5	136	263	306	3.60E-08	59.3	GATB_AEDAE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)"	AAEL009908	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	528	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i2	Q16UG2	GATB_AEDAE	59.7	278	111	1	139	969	29	306	5.00E-92	340.1	GATB_AEDAE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)"	AAEL009908	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	528	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i4	Q16UG2	GATB_AEDAE	47.3	448	228	6	65	1396	78	521	2.10E-108	394.4	GATB_AEDAE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)"	AAEL009908	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	528	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i6	Q16UG2	GATB_AEDAE	57.2	145	61	1	139	570	29	173	1.80E-41	170.6	GATB_AEDAE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)"	AAEL009908	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	528	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i8	Q16UG2	GATB_AEDAE	47.9	497	250	7	139	1614	29	521	6.90E-124	446	GATB_AEDAE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)"	AAEL009908	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	528	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN35328_c0_g1_i1	Q99JT1	GATB_MOUSE	100	69	0	0	210	4	224	292	4.40E-32	137.9	GATB_MOUSE	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog)"	Gatb Pet112 Pet112l	Mus musculus (Mouse)	557	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN4628_c1_g1_i9	O75879	GATB_HUMAN	39.4	269	159	3	32	832	290	556	2.70E-43	177.6	GATB_HUMAN	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog)"	GATB PET112 PET112L HSPC199	Homo sapiens (Human)	557	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN10718_c0_g1_i1	E2RK33	GATC_CANLF	47.7	109	57	0	445	119	37	145	2.80E-22	107.1	GATC_CANLF	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-)"	GATC	Canis lupus familiaris (Dog) (Canis familiaris)	155	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN10718_c0_g1_i10	C3XVM1	GATC_BRAFL	36.4	121	51	2	394	110	27	147	5.80E-11	69.3	GATC_BRAFL	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-)"	BRAFLDRAFT_270748	Branchiostoma floridae (Florida lancelet) (Amphioxus)	149	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN10718_c0_g1_i11	E2RK33	GATC_CANLF	47.7	109	57	0	461	135	37	145	2.80E-22	107.1	GATC_CANLF	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-)"	GATC	Canis lupus familiaris (Dog) (Canis familiaris)	155	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN10718_c0_g1_i12	E2RK33	GATC_CANLF	47.7	109	57	0	419	93	37	145	2.70E-22	107.1	GATC_CANLF	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-)"	GATC	Canis lupus familiaris (Dog) (Canis familiaris)	155	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN10718_c0_g1_i9	C3XVM1	GATC_BRAFL	36.4	121	51	2	410	126	27	147	5.90E-11	69.3	GATC_BRAFL	reviewed	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-)"	BRAFLDRAFT_270748	Branchiostoma floridae (Florida lancelet) (Amphioxus)	149	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]		NA	NA	NA	NA	NA	NA
TRINITY_DN7611_c0_g1_i1	Q88RC0	DAVD_PSEPK	73.2	112	30	0	336	1	93	204	1.40E-43	176.8	DAVD_PSEPK	reviewed	Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-)	davD PP_0213	Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)	480	glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0009013; GO:0009450; GO:0019477; GO:0047949	gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		NA	NA	NA	NA	NA	NA
TRINITY_DN7611_c0_g1_i2	Q88RC0	DAVD_PSEPK	73.6	129	34	0	387	1	76	204	4.60E-51	201.8	DAVD_PSEPK	reviewed	Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-)	davD PP_0213	Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)	480	glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0009013; GO:0009450; GO:0019477; GO:0047949	gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		NA	NA	NA	NA	NA	NA
TRINITY_DN24759_c0_g1_i1	Q9I6M5	DAVD_PSEAE	77.7	242	54	0	2	727	73	314	2.50E-106	386.3	DAVD_PSEAE	reviewed	Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-)	davD PA0265	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	483	glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0009013; GO:0009450; GO:0019477; GO:0047949	gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		NA	NA	NA	NA	NA	NA
TRINITY_DN24759_c0_g1_i2	Q9I6M5	DAVD_PSEAE	75.6	234	57	0	6	707	81	314	1.20E-97	357.5	DAVD_PSEAE	reviewed	Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-)	davD PA0265	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	483	glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0009013; GO:0009450; GO:0019477; GO:0047949	gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		NA	NA	NA	NA	NA	NA
TRINITY_DN36120_c0_g1_i1	Q9I6M5	DAVD_PSEAE	78.8	66	14	0	3	200	412	477	1.40E-24	112.8	DAVD_PSEAE	reviewed	Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-)	davD PA0265	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	483	glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0009013; GO:0009450; GO:0019477; GO:0047949	gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		NA	NA	NA	NA	NA	NA
TRINITY_DN33313_c0_g1_i1	Q9I6M5	DAVD_PSEAE	80.7	83	16	0	1	249	401	483	1.20E-35	150.2	DAVD_PSEAE	reviewed	Glutarate-semialdehyde dehydrogenase (EC 1.2.1.-)	davD PA0265	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	483	glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		glutarate-semialdehyde dehydrogenase (NAD+) activity [GO:0047949]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0009013; GO:0009450; GO:0019477; GO:0047949	gamma-aminobutyric acid catabolic process [GO:0009450]; L-lysine catabolic process [GO:0019477]		NA	NA	NA	NA	NA	NA
TRINITY_DN4844_c0_g1_i1	Q923X4	GLRX2_MOUSE	57.1	91	39	0	275	3	53	143	1.00E-24	114.4	GLRX2_MOUSE	reviewed	"Glutaredoxin-2, mitochondrial"	Glrx2 Grx2	Mus musculus (Mouse)	156	"dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]"	dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0009055; GO:0010033; GO:0015035; GO:0030425; GO:0042542; GO:0043025; GO:0043231; GO:0046872; GO:0051537	response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]		NA	NA	NA	NA	NA	NA
TRINITY_DN4844_c0_g1_i2	Q923X4	GLRX2_MOUSE	57.1	91	39	0	275	3	53	143	1.10E-24	114.4	GLRX2_MOUSE	reviewed	"Glutaredoxin-2, mitochondrial"	Glrx2 Grx2	Mus musculus (Mouse)	156	"dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]"	dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0009055; GO:0010033; GO:0015035; GO:0030425; GO:0042542; GO:0043025; GO:0043231; GO:0046872; GO:0051537	response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]		blue	blue	NA	NA	NA	NA
TRINITY_DN745_c1_g1_i1	Q32L67	GLRX2_BOVIN	37.3	83	46	2	273	25	29	105	1.00E-07	57.4	GLRX2_BOVIN	reviewed	"Glutaredoxin-2, mitochondrial"	GLRX2	Bos taurus (Bovine)	157	"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005739; GO:0009055; GO:0015035; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN745_c1_g1_i2	Q32L67	GLRX2_BOVIN	39.3	122	68	2	469	104	31	146	1.90E-19	97.4	GLRX2_BOVIN	reviewed	"Glutaredoxin-2, mitochondrial"	GLRX2	Bos taurus (Bovine)	157	"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005739; GO:0009055; GO:0015035; GO:0046872; GO:0051537			blue	blue	NA	NA	NA	NA
TRINITY_DN745_c1_g1_i4	Q32L67	GLRX2_BOVIN	39.3	122	68	2	474	109	31	146	1.90E-19	97.4	GLRX2_BOVIN	reviewed	"Glutaredoxin-2, mitochondrial"	GLRX2	Bos taurus (Bovine)	157	"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005739; GO:0009055; GO:0015035; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN27847_c0_g1_i1	Q28ID3	GLRX3_XENTR	64.9	74	26	0	223	2	114	187	3.80E-21	101.7	GLRX3_XENTR	reviewed	Glutaredoxin-3 (Thioredoxin-like protein 2)	glrx3 txnl2 TNeu109g06.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	326	cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	cytosol [GO:0005829]; nucleus [GO:0005634]	electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0005634; GO:0005829; GO:0006879; GO:0009055; GO:0015035; GO:0044571; GO:0046872; GO:0051536; GO:0097428	[2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		blue	blue	NA	NA	NA	NA
TRINITY_DN5263_c0_g1_i1	Q86SX6	GLRX5_HUMAN	70.9	117	33	1	446	99	41	157	1.90E-43	177.2	GLRX5_HUMAN	reviewed	"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)"	GLRX5 C14orf87	Homo sapiens (Human)	157	"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]; small molecule metabolic process [GO:0044281]"	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0009249; GO:0015035; GO:0030097; GO:0030425; GO:0043025; GO:0044281; GO:0046872; GO:0051537	hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]; small molecule metabolic process [GO:0044281]		blue	blue	NA	NA	NA	NA
TRINITY_DN24496_c0_g1_i1	Q80Y14	GLRX5_MOUSE	100	100	0	0	2	301	18	117	5.50E-52	204.5	GLRX5_MOUSE	reviewed	"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)"	Glrx5	Mus musculus (Mouse)	152	"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]"	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0009249; GO:0015035; GO:0030097; GO:0030425; GO:0043025; GO:0046872; GO:0051537	hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN24496_c0_g1_i2	Q80Y14	GLRX5_MOUSE	99.2	125	1	0	2	376	18	142	2.20E-66	252.7	GLRX5_MOUSE	reviewed	"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)"	Glrx5	Mus musculus (Mouse)	152	"dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]"	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0009249; GO:0015035; GO:0030097; GO:0030425; GO:0043025; GO:0046872; GO:0051537	hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN5631_c0_g1_i1	Q2KHZ9	GCDH_BOVIN	56.8	132	54	2	1	390	101	231	9.10E-39	161	GCDH_BOVIN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Bos taurus (Bovine)	438	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN8700_c0_g1_i1	Q2KHZ9	GCDH_BOVIN	64.4	191	63	3	3	569	74	261	2.60E-63	243	GCDH_BOVIN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Bos taurus (Bovine)	438	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN8700_c0_g1_i2	Q60759	GCDH_MOUSE	68.4	158	45	3	2	469	107	261	1.30E-55	217.2	GCDH_MOUSE	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	Gcdh	Mus musculus (Mouse)	438	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid oxidation [GO:0019395]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005743; GO:0005759; GO:0006568; GO:0006637; GO:0019395; GO:0033539; GO:0046949; GO:0050660	acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid oxidation [GO:0019395]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN38372_c0_g1_i1	Q54R47	GCDH_DICDI	80	85	17	0	255	1	222	306	2.80E-33	142.1	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN30180_c0_g1_i1	Q2KHZ9	GCDH_BOVIN	73	189	51	0	617	51	246	434	1.10E-75	284.3	GCDH_BOVIN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Bos taurus (Bovine)	438	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN32461_c0_g1_i1	Q60759	GCDH_MOUSE	60.9	69	27	0	7	213	352	420	6.20E-18	90.9	GCDH_MOUSE	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	Gcdh	Mus musculus (Mouse)	438	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid oxidation [GO:0019395]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005743; GO:0005759; GO:0006568; GO:0006637; GO:0019395; GO:0033539; GO:0046949; GO:0050660	acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid oxidation [GO:0019395]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN31172_c0_g1_i1	Q54R47	GCDH_DICDI	67.9	84	27	0	252	1	251	334	1.80E-27	122.9	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN196_c4_g1_i1	Q92947	GCDH_HUMAN	97.8	89	2	0	4	270	96	184	2.90E-44	178.7	GCDH_HUMAN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Homo sapiens (Human)	438	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006554; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN196_c0_g1_i1	Q92947	GCDH_HUMAN	60.7	56	18	2	194	36	96	150	9.40E-11	67.8	GCDH_HUMAN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Homo sapiens (Human)	438	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006554; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN196_c0_g1_i2	Q2KHZ9	GCDH_BOVIN	74.5	392	97	1	1256	90	45	436	6.30E-178	625.2	GCDH_BOVIN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Bos taurus (Bovine)	438	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN196_c0_g1_i3	Q92947	GCDH_HUMAN	60.7	56	18	2	197	39	96	150	1.50E-10	67	GCDH_HUMAN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Homo sapiens (Human)	438	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006554; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN196_c0_g1_i4	Q2KHZ9	GCDH_BOVIN	75.7	341	80	1	1103	90	96	436	1.40E-157	557.4	GCDH_BOVIN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Bos taurus (Bovine)	438	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7039_c0_g1_i1	Q92947	GCDH_HUMAN	76.6	77	18	0	265	35	358	434	4.50E-29	128.3	GCDH_HUMAN	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GCDH	Homo sapiens (Human)	438	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006554; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7039_c0_g3_i1	Q54R47	GCDH_DICDI	71.3	136	39	0	411	4	253	388	1.70E-51	203.4	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7039_c0_g2_i1	Q54R47	GCDH_DICDI	71.4	77	22	0	1	231	302	378	1.70E-24	112.8	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7039_c0_g2_i2	Q54R47	GCDH_DICDI	70.6	68	20	0	1	204	302	369	1.70E-20	100.1	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7039_c0_g2_i2	Q54R47	GCDH_DICDI	75.5	53	13	0	350	192	363	415	2.50E-16	86.3	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN40169_c0_g1_i1	Q60759	GCDH_MOUSE	64.8	159	50	2	3	473	123	277	7.00E-54	211.5	GCDH_MOUSE	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	Gcdh	Mus musculus (Mouse)	438	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid oxidation [GO:0019395]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005743; GO:0005759; GO:0006568; GO:0006637; GO:0019395; GO:0033539; GO:0046949; GO:0050660	acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid oxidation [GO:0019395]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN25070_c0_g1_i1	Q54R47	GCDH_DICDI	72.7	172	44	2	518	6	173	342	3.50E-62	239.2	GCDH_DICDI	reviewed	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	gcdh DDB_G0283411	Dictyostelium discoideum (Slime mold)	420	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN31751_c0_g1_i1	P19440	GGT1_HUMAN	100	124	0	0	373	2	380	503	1.20E-64	246.9	GGT1_HUMAN	reviewed	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GGT1 GGT	Homo sapiens (Human)	569	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; cellular amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; xenobiotic metabolic process [GO:0006805]; zymogen activation [GO:0031638]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene-C(4) hydrolase [GO:0002951]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; peptidyltransferase activity [GO:0000048]	GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0006805; GO:0007283; GO:0016021; GO:0019344; GO:0031179; GO:0031638; GO:0032355; GO:0032496; GO:0034612; GO:0036374; GO:0050727; GO:0070062; GO:0102953; GO:0103068; GO:1901750	cellular amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; xenobiotic metabolic process [GO:0006805]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN25538_c0_g1_i1	G9JJU2	GPX_PROCL	74.4	164	41	1	575	84	10	172	1.90E-69	263.5	GPX_PROCL	reviewed	Glutathione peroxidase (PcGPx) (Se-PcGPx) (EC 1.11.1.9)	GPx	Procambarus clarkii (Red swamp crayfish)	172	glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]		glutathione peroxidase activity [GO:0004602]	GO:0004602; GO:0006979	response to oxidative stress [GO:0006979]	x	NA	NA	1	NA	NA	NA
TRINITY_DN13912_c0_g2_i1	P07203	GPX1_HUMAN	100	71	0	0	1	213	53	123	7.10E-38	157.1	GPX1_HUMAN	reviewed	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	Homo sapiens (Human)	203	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; purine nucleotide catabolic process [GO:0006195]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]	GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006195; GO:0006641; GO:0006749; GO:0007605; GO:0009410; GO:0009609; GO:0009650; GO:0010269; GO:0010332; GO:0017124; GO:0018158; GO:0019369; GO:0019372; GO:0033194; GO:0033599; GO:0034599; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045454; GO:0047066; GO:0048741; GO:0051450; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0090201; GO:1902042; GO:1902176; GO:1902905	"angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; purine nucleotide catabolic process [GO:0006195]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8265_c0_g1_i1	Q865R2	GPX1_MACFU	57.1	161	68	1	516	37	34	194	4.00E-50	199.1	GPX1_MACFU	reviewed	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	Macaca fuscata fuscata (Japanese macaque)	201	cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; arachidonic acid metabolic process [GO:0019369]; lipoxygenase pathway [GO:0019372]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]	glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]	GO:0004602; GO:0005737; GO:0006979; GO:0019369; GO:0019372; GO:0047066	arachidonic acid metabolic process [GO:0019369]; lipoxygenase pathway [GO:0019372]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN13912_c0_g1_i1	P11352	GPX1_MOUSE	100	151	0	0	1	453	51	201	2.30E-89	329.3	GPX1_MOUSE	reviewed	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) (Selenium-dependent glutathione peroxidase 1)	Gpx1	Mus musculus (Mouse)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; blood vessel endothelial cell migration [GO:0043534]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]	GO:0000302; GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006641; GO:0006749; GO:0006979; GO:0007605; GO:0008283; GO:0009410; GO:0009609; GO:0009611; GO:0009636; GO:0009650; GO:0010269; GO:0010332; GO:0014902; GO:0017124; GO:0018158; GO:0019369; GO:0019372; GO:0033194; GO:0033599; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045454; GO:0047066; GO:0048741; GO:0051450; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:0097413; GO:1902042; GO:1902176	"angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; blood vessel endothelial cell migration [GO:0043534]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13912_c0_g1_i2	P11352	GPX1_MOUSE	97.9	146	3	0	1	438	51	196	7.40E-85	314.3	GPX1_MOUSE	reviewed	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) (Selenium-dependent glutathione peroxidase 1)	Gpx1	Mus musculus (Mouse)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; blood vessel endothelial cell migration [GO:0043534]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]	GO:0000302; GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006641; GO:0006749; GO:0006979; GO:0007605; GO:0008283; GO:0009410; GO:0009609; GO:0009611; GO:0009636; GO:0009650; GO:0010269; GO:0010332; GO:0014902; GO:0017124; GO:0018158; GO:0019369; GO:0019372; GO:0033194; GO:0033599; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045454; GO:0047066; GO:0048741; GO:0051450; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:0097413; GO:1902042; GO:1902176	"angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; blood vessel endothelial cell migration [GO:0043534]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; interaction with symbiont [GO:0051702]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of protein kinase B signaling [GO:0051897]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7399_c0_g1_i1	P22352	GPX3_HUMAN	43.4	219	118	5	896	255	3	220	6.50E-43	176	GPX3_HUMAN	reviewed	Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P)	GPX3 GPXP	Homo sapiens (Human)	226	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; transcription factor binding [GO:0008134]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; transcription factor binding [GO:0008134]	GO:0004601; GO:0004602; GO:0005576; GO:0005615; GO:0006982; GO:0008134; GO:0008430; GO:0034599; GO:0042744; GO:0042802; GO:0070062	cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982]		NA	NA	NA	NA	NA	NA
TRINITY_DN7399_c0_g1_i2	P22352	GPX3_HUMAN	43.4	219	118	5	930	289	3	220	6.80E-43	176	GPX3_HUMAN	reviewed	Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P)	GPX3 GPXP	Homo sapiens (Human)	226	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; transcription factor binding [GO:0008134]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; transcription factor binding [GO:0008134]	GO:0004601; GO:0004602; GO:0005576; GO:0005615; GO:0006982; GO:0008134; GO:0008430; GO:0034599; GO:0042744; GO:0042802; GO:0070062	cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982]		NA	NA	NA	NA	NA	NA
TRINITY_DN7399_c1_g1_i2	Q91WR8	GPX6_MOUSE	45.2	115	62	1	455	111	106	219	1.50E-23	110.9	GPX6_MOUSE	reviewed	Glutathione peroxidase 6 (GPx-6) (GSHPx-6) (EC 1.11.1.9)	Gpx6	Mus musculus (Mouse)	221	extracellular region [GO:0005576]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]	extracellular region [GO:0005576]	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]	GO:0004601; GO:0004602; GO:0005576; GO:0006979	response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN38831_c0_g1_i4	Q93112	GST1C_ANOGA	68.5	111	35	0	102	434	1	111	2.80E-40	166.4	GST1C_ANOGA	reviewed	"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)"	GstD1 GST1a AGAP004164	Anopheles gambiae (African malaria mosquito)	209	DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]		DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0018833			NA	NA	NA	NA	NA	NA
TRINITY_DN4632_c0_g1_i1	Q93112	GST1C_ANOGA	55.3	208	92	1	736	116	1	208	2.40E-65	250.4	GST1C_ANOGA	reviewed	"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)"	GstD1 GST1a AGAP004164	Anopheles gambiae (African malaria mosquito)	209	DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]		DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0018833			blue	blue	NA	NA	NA	NA
TRINITY_DN11451_c0_g1_i1	Q93113	GST1D_ANOGA	48.6	140	70	1	2	421	5	142	1.20E-33	144.1	GST1D_ANOGA	reviewed	"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)"	GstD1 GST1a AGAP004164	Anopheles gambiae (African malaria mosquito)	209	cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]	DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006749; GO:0018833	glutathione metabolic process [GO:0006749]		blue	blue	NA	NA	NA	NA
TRINITY_DN38831_c0_g1_i1	Q93113	GST1D_ANOGA	54.1	209	93	3	102	722	1	208	3.80E-58	226.5	GST1D_ANOGA	reviewed	"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)"	GstD1 GST1a AGAP004164	Anopheles gambiae (African malaria mosquito)	209	cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]	DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006749; GO:0018833	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN6438_c0_g1_i1	Q93113	GST1D_ANOGA	52.9	210	98	1	724	95	1	209	1.60E-61	237.7	GST1D_ANOGA	reviewed	"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)"	GstD1 GST1a AGAP004164	Anopheles gambiae (African malaria mosquito)	209	cytoplasm [GO:0005737]; DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]	DDT-dehydrochlorinase activity [GO:0018833]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006749; GO:0018833	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN11053_c0_g1_i1	P20136	GSTM2_CHICK	58.6	128	52	1	10	390	5	132	7.40E-41	167.9	GSTM2_CHICK	reviewed	Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1)	GSTM2	Gallus gallus (Chicken)	220	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; intercellular bridge [GO:0045171]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0004464; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171	glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN11053_c0_g1_i4	P20136	GSTM2_CHICK	54.5	132	58	2	32	421	1	132	6.00E-36	151.8	GSTM2_CHICK	reviewed	Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1)	GSTM2	Gallus gallus (Chicken)	220	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; intercellular bridge [GO:0045171]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0004464; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171	glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN11053_c0_g1_i5	P20136	GSTM2_CHICK	58.6	128	52	1	69	449	5	132	3.20E-40	166	GSTM2_CHICK	reviewed	Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1)	GSTM2	Gallus gallus (Chicken)	220	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; intercellular bridge [GO:0045171]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0004464; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171	glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN38831_c0_g1_i3	P46433	GSTT4_MUSDO	39.8	83	49	1	33	278	114	196	2.60E-10	66.6	GSTT4_MUSDO	reviewed	Glutathione S-transferase 4 (EC 2.5.1.18) (GST class-theta)	Gst4 Gst-4	Musca domestica (House fly)	210	glutathione transferase activity [GO:0004364]		glutathione transferase activity [GO:0004364]	GO:0004364			NA	NA	NA	NA	NA	NA
TRINITY_DN277_c0_g1_i1	P08515	GST26_SCHJA	47.2	212	110	2	732	100	1	211	4.80E-53	209.5	GST26_SCHJA	reviewed	Glutathione S-transferase class-mu 26 kDa isozyme (GST 26) (EC 2.5.1.18) (Sj26 antigen) (SjGST)		Schistosoma japonicum (Blood fluke)	218	glutathione transferase activity [GO:0004364]		glutathione transferase activity [GO:0004364]	GO:0004364			NA	NA	NA	NA	NA	NA
TRINITY_DN277_c0_g1_i4	P08515	GST26_SCHJA	47.2	212	110	2	732	100	1	211	6.20E-53	209.1	GST26_SCHJA	reviewed	Glutathione S-transferase class-mu 26 kDa isozyme (GST 26) (EC 2.5.1.18) (Sj26 antigen) (SjGST)		Schistosoma japonicum (Blood fluke)	218	glutathione transferase activity [GO:0004364]		glutathione transferase activity [GO:0004364]	GO:0004364			blue	blue	NA	NA	NA	NA
TRINITY_DN9315_c0_g1_i3	Q9VG93	GSTD7_DROME	53.4	103	47	1	362	57	6	108	2.00E-23	110.2	GSTD7_DROME	reviewed	Glutathione S-transferase D7 (EC 2.5.1.18)	GstD7 gstD26 GSTD7-7 CG4371	Drosophila melanogaster (Fruit fly)	224	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006749; GO:0009636	glutathione metabolic process [GO:0006749]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN9315_c0_g1_i1	O76483	GSTT7_ANOGA	40.3	221	126	3	754	98	1	217	1.40E-38	161.4	GSTT7_ANOGA	reviewed	Glutathione S-transferase D7 (EC 2.5.1.18) (Aggst1-7) (GST class-theta) (Gst1-beta)	GstD7 GST1-7 AGAP004163	Anopheles gambiae (African malaria mosquito)	218	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005576; GO:0005737; GO:0006749	glutathione metabolic process [GO:0006749]		NA	NA	NA	NA	NA	NA
TRINITY_DN9315_c0_g1_i2	O76483	GSTT7_ANOGA	40.3	221	126	3	754	98	1	217	1.90E-38	161	GSTT7_ANOGA	reviewed	Glutathione S-transferase D7 (EC 2.5.1.18) (Aggst1-7) (GST class-theta) (Gst1-beta)	GstD7 GST1-7 AGAP004163	Anopheles gambiae (African malaria mosquito)	218	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005576; GO:0005737; GO:0006749	glutathione metabolic process [GO:0006749]		blue	blue	NA	NA	NA	NA
TRINITY_DN2502_c0_g1_i1	P46422	GSTF2_ARATH	35.9	78	50	0	304	71	4	81	4.70E-06	52.4	GSTF2_ARATH	reviewed	Glutathione S-transferase F2 (AtGSTF2) (EC 2.5.1.18) (24 kDa auxin-binding protein) (AtPM24) (GST class-phi member 2)	GSTF2 PM24.1 At4g02520 T10P11.18	Arabidopsis thaliana (Mouse-ear cress)	212	apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; camalexin binding [GO:2001147]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; protein domain specific binding [GO:0019904]; quercitrin binding [GO:2001227]; auxin-activated signaling pathway [GO:0009734]; defense response to bacterium [GO:0042742]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to oomycetes [GO:0002239]; response to zinc ion [GO:0010043]; toxin catabolic process [GO:0009407]	apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]	camalexin binding [GO:2001147]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; protein domain specific binding [GO:0019904]; quercitrin binding [GO:2001227]	GO:0002239; GO:0004364; GO:0004601; GO:0005737; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0009407; GO:0009409; GO:0009506; GO:0009507; GO:0009570; GO:0009734; GO:0010043; GO:0019904; GO:0042742; GO:0043231; GO:0043295; GO:0046686; GO:0048046; GO:2001147; GO:2001227	auxin-activated signaling pathway [GO:0009734]; defense response to bacterium [GO:0042742]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to oomycetes [GO:0002239]; response to zinc ion [GO:0010043]; toxin catabolic process [GO:0009407]		NA	NA	NA	NA	NA	NA
TRINITY_DN2502_c0_g1_i2	Q9SLM6	GSTF3_ARATH	30.6	124	80	2	1028	657	4	121	9.00E-07	56.2	GSTF3_ARATH	reviewed	Glutathione S-transferase F3 (AtGSTF3) (EC 2.5.1.18) (GST class-phi member 3) (Glutathione S-transferase 16)	GSTF3 GST16 At2g02930 T17M13.10	Arabidopsis thaliana (Mouse-ear cress)	212	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; response to oomycetes [GO:0002239]; toxin catabolic process [GO:0009407]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]	GO:0002239; GO:0004364; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0009407; GO:0043295	response to oomycetes [GO:0002239]; toxin catabolic process [GO:0009407]		NA	NA	NA	NA	NA	NA
TRINITY_DN3952_c0_g1_i1	Q9Y2Q3	GSTK1_HUMAN	37.3	158	99	0	12	485	69	226	2.90E-27	123.2	GSTK1_HUMAN	reviewed	Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13)	GSTK1 HDCMD47P	Homo sapiens (Human)	226	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006749; GO:0015035; GO:0016020; GO:0030855; GO:0070062; GO:1901687	epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625]		blue	blue	NA	NA	NA	NA
TRINITY_DN13691_c0_g1_i1	Q9Y2Q3	GSTK1_HUMAN	43.8	64	36	0	91	282	8	71	6.40E-10	64.7	GSTK1_HUMAN	reviewed	Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13)	GSTK1 HDCMD47P	Homo sapiens (Human)	226	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006749; GO:0015035; GO:0016020; GO:0030855; GO:0070062; GO:1901687	epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625]		blue	blue	NA	NA	NA	NA
TRINITY_DN2519_c0_g1_i1	Q9DCM2	GSTK1_MOUSE	42.9	219	125	0	753	97	8	226	2.70E-48	193.7	GSTK1_MOUSE	reviewed	Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (mGSTK1) (Glutathione S-transferase subunit 13)	Gstk1	Mus musculus (Mouse)	226	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0004364; GO:0004602; GO:0005739; GO:0005743; GO:0005759; GO:0005777; GO:0006749; GO:0015035; GO:0030855	epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]		blue	blue	NA	NA	NA	NA
TRINITY_DN36220_c0_g1_i1	O43813	LANC1_HUMAN	100	71	0	0	3	215	215	285	1.10E-38	159.8	LANC1_HUMAN	reviewed	Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)	LANCL1 GPR69A	Homo sapiens (Human)	399	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; G protein-coupled receptor activity [GO:0004930]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]	GO:0004364; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0005975; GO:0007186; GO:0008270; GO:0017124; GO:0043295; GO:0043523; GO:0050750; GO:1903203	carbohydrate metabolic process [GO:0005975]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]		NA	NA	NA	NA	NA	NA
TRINITY_DN36981_c0_g1_i1	O89112	LANC1_MOUSE	100	73	0	0	2	220	75	147	3.60E-37	154.8	LANC1_MOUSE	reviewed	Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)	Lancl1 Gpr69a	Mus musculus (Mouse)	399	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]	GO:0004364; GO:0005737; GO:0005886; GO:0005975; GO:0008270; GO:0017124; GO:0043295; GO:0043523; GO:0050750; GO:1903203	carbohydrate metabolic process [GO:0005975]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]		NA	NA	NA	NA	NA	NA
TRINITY_DN37314_c0_g1_i1	O43813	LANC1_HUMAN	100	69	0	0	1	207	292	360	6.90E-38	157.1	LANC1_HUMAN	reviewed	Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)	LANCL1 GPR69A	Homo sapiens (Human)	399	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; G protein-coupled receptor activity [GO:0004930]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]	GO:0004364; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0005975; GO:0007186; GO:0008270; GO:0017124; GO:0043295; GO:0043523; GO:0050750; GO:1903203	carbohydrate metabolic process [GO:0005975]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]		NA	NA	NA	NA	NA	NA
TRINITY_DN29327_c0_g1_i1	O89112	LANC1_MOUSE	100	78	0	0	2	235	260	337	3.30E-44	178.3	LANC1_MOUSE	reviewed	Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)	Lancl1 Gpr69a	Mus musculus (Mouse)	399	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]	GO:0004364; GO:0005737; GO:0005886; GO:0005975; GO:0008270; GO:0017124; GO:0043295; GO:0043523; GO:0050750; GO:1903203	carbohydrate metabolic process [GO:0005975]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]		NA	NA	NA	NA	NA	NA
TRINITY_DN18377_c0_g1_i2	P10649	GSTM1_MOUSE	94	117	7	0	352	2	1	117	2.50E-60	232.6	GSTM1_MOUSE	reviewed	Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST 1-1) (GST class-mu 1) (Glutathione S-transferase GT8.7) (pmGT10)	Gstm1	Mus musculus (Mouse)	218	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercellular bridge [GO:0045171]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; nickel cation binding [GO:0016151]; protein kinase binding [GO:0019901]; steroid binding [GO:0005496]; cellular response to drug [GO:0035690]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercellular bridge [GO:0045171]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]	glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; nickel cation binding [GO:0016151]; protein kinase binding [GO:0019901]; steroid binding [GO:0005496]	GO:0004364; GO:0005496; GO:0005576; GO:0005829; GO:0006693; GO:0006749; GO:0016151; GO:0019901; GO:0032991; GO:0035690; GO:0042178; GO:0042802; GO:0043209; GO:0043295; GO:0045171; GO:0051122; GO:1901687	cellular response to drug [GO:0035690]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN18377_c0_g1_i1	Q9TSM5	GSTM1_MACFA	95.7	94	4	0	284	3	1	94	2.10E-49	196.1	GSTM1_MACFA	reviewed	Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST class-mu 1) (GSTM1-1)	GSTM1	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	218	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione derivative biosynthetic process [GO:1901687]; hepoxilin biosynthetic process [GO:0051122]; prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006693; GO:0051122; GO:1901687	glutathione derivative biosynthetic process [GO:1901687]; hepoxilin biosynthetic process [GO:0051122]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1965_c0_g1_i1	P08010	GSTM2_RAT	55.9	211	91	2	784	158	1	211	7.30E-64	245.4	GSTM2_RAT	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 4-4) (GSTM2-2) (Glutathione S-transferase Yb-2) (GST Yb2)	Gstm2	Rattus norvegicus (Rat)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006805; GO:0007568; GO:0007608; GO:0010038; GO:0010880; GO:0014070; GO:0016529; GO:0018916; GO:0019899; GO:0032991; GO:0033595; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043651; GO:0051122; GO:0060315; GO:0060316; GO:0070458; GO:0071313; GO:1902168	aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN1965_c0_g1_i2	P08010	GSTM2_RAT	51.3	119	56	2	457	107	93	211	1.50E-29	130.6	GSTM2_RAT	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 4-4) (GSTM2-2) (Glutathione S-transferase Yb-2) (GST Yb2)	Gstm2	Rattus norvegicus (Rat)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006805; GO:0007568; GO:0007608; GO:0010038; GO:0010880; GO:0014070; GO:0016529; GO:0018916; GO:0019899; GO:0032991; GO:0033595; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043651; GO:0051122; GO:0060315; GO:0060316; GO:0070458; GO:0071313; GO:1902168	aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN1965_c0_g1_i3	P08010	GSTM2_RAT	55.5	211	92	2	733	107	1	211	1.40E-62	241.1	GSTM2_RAT	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 4-4) (GSTM2-2) (Glutathione S-transferase Yb-2) (GST Yb2)	Gstm2	Rattus norvegicus (Rat)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006805; GO:0007568; GO:0007608; GO:0010038; GO:0010880; GO:0014070; GO:0016529; GO:0018916; GO:0019899; GO:0032991; GO:0033595; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043651; GO:0051122; GO:0060315; GO:0060316; GO:0070458; GO:0071313; GO:1902168	aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN1965_c0_g1_i7	P08010	GSTM2_RAT	56.4	211	90	2	784	158	1	211	2.80E-64	246.9	GSTM2_RAT	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 4-4) (GSTM2-2) (Glutathione S-transferase Yb-2) (GST Yb2)	Gstm2	Rattus norvegicus (Rat)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006805; GO:0007568; GO:0007608; GO:0010038; GO:0010880; GO:0014070; GO:0016529; GO:0018916; GO:0019899; GO:0032991; GO:0033595; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043651; GO:0051122; GO:0060315; GO:0060316; GO:0070458; GO:0071313; GO:1902168	aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]		blue	blue	NA	NA	NA	NA
TRINITY_DN1965_c0_g1_i8	P08010	GSTM2_RAT	56.1	157	67	2	622	158	55	211	2.10E-45	183.7	GSTM2_RAT	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 4-4) (GSTM2-2) (Glutathione S-transferase Yb-2) (GST Yb2)	Gstm2	Rattus norvegicus (Rat)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006805; GO:0007568; GO:0007608; GO:0010038; GO:0010880; GO:0014070; GO:0016529; GO:0018916; GO:0019899; GO:0032991; GO:0033595; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043651; GO:0051122; GO:0060315; GO:0060316; GO:0070458; GO:0071313; GO:1902168	aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN1965_c0_g1_i9	P08010	GSTM2_RAT	55.9	211	91	2	784	158	1	211	3.10E-63	243.4	GSTM2_RAT	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 4-4) (GSTM2-2) (Glutathione S-transferase Yb-2) (GST Yb2)	Gstm2	Rattus norvegicus (Rat)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006805; GO:0007568; GO:0007608; GO:0010038; GO:0010880; GO:0014070; GO:0016529; GO:0018916; GO:0019899; GO:0032991; GO:0033595; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043651; GO:0051122; GO:0060315; GO:0060316; GO:0070458; GO:0071313; GO:1902168	aging [GO:0007568]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to catechin [GO:1902168]; response to genistein [GO:0033595]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; sensory perception of smell [GO:0007608]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN277_c0_g1_i3	P15626	GSTM2_MOUSE	52.1	219	98	3	724	86	1	218	1.60E-56	221.1	GSTM2_MOUSE	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 5-5) (GST class-mu 2) (Glutathione S-transferase pmGT2)	Gstm2	Mus musculus (Mouse)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005737; GO:0005829; GO:0005886; GO:0006693; GO:0006749; GO:0018916; GO:0019899; GO:0032991; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0045171; GO:0051122; GO:0070458; GO:1901687	cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]		blue	blue	NA	NA	NA	NA
TRINITY_DN18377_c0_g1_i4	P15626	GSTM2_MOUSE	99.2	129	1	0	389	3	1	129	2.60E-71	269.2	GSTM2_MOUSE	reviewed	Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST 5-5) (GST class-mu 2) (Glutathione S-transferase pmGT2)	Gstm2	Mus musculus (Mouse)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005737; GO:0005829; GO:0005886; GO:0006693; GO:0006749; GO:0018916; GO:0019899; GO:0032991; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0045171; GO:0051122; GO:0070458; GO:1901687	cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c4_g1_i1	P21266	GSTM3_HUMAN	55.3	215	95	1	100	741	8	222	2.10E-69	263.8	GSTM3_HUMAN	reviewed	Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3)	GSTM3 GST5	Homo sapiens (Human)	225	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458; GO:1901687	cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]		blue	blue	NA	NA	NA	NA
TRINITY_DN16095_c0_g1_i1	P21266	GSTM3_HUMAN	100	168	0	0	49	552	1	168	1.50E-95	350.1	GSTM3_HUMAN	reviewed	Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3)	GSTM3 GST5	Homo sapiens (Human)	225	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458; GO:1901687	cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN36730_c0_g1_i1	P48774	GSTM5_MOUSE	100	145	0	0	1	435	39	183	1.90E-82	306.2	GSTM5_MOUSE	reviewed	Glutathione S-transferase Mu 5 (EC 2.5.1.18) (Fibrous sheath component 2) (Fsc2) (GST class-mu 5)	Gstm5 Fsc2 Gstm3	Mus musculus (Mouse)	224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070458	cellular detoxification of nitrogen compound [GO:0070458]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN19846_c0_g1_i1	P48774	GSTM5_MOUSE	47.7	88	45	1	264	4	98	185	1.30E-17	90.1	GSTM5_MOUSE	reviewed	Glutathione S-transferase Mu 5 (EC 2.5.1.18) (Fibrous sheath component 2) (Fsc2) (GST class-mu 5)	Gstm5 Fsc2 Gstm3	Mus musculus (Mouse)	224	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070458	cellular detoxification of nitrogen compound [GO:0070458]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN27925_c0_g1_i1	P78417	GSTO1_HUMAN	100	91	0	0	1	273	19	109	2.30E-49	195.7	GSTO1_HUMAN	reviewed	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)	GSTO1 GSTTLP28	Homo sapiens (Human)	241	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]	GO:0004364; GO:0005654; GO:0005737; GO:0005829; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0035722; GO:0042178; GO:0045174; GO:0050610; GO:0055114; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687	cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN39945_c0_g1_i1	O09131	GSTO1_MOUSE	100	94	0	0	284	3	41	134	6.90E-49	194.1	GSTO1_MOUSE	reviewed	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R) (p28)	Gsto1 Gstx Gtsttl	Mus musculus (Mouse)	240	axon [GO:0030424]; basement membrane [GO:0005604]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; L-ascorbic acid biosynthetic process [GO:0019853]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]	axon [GO:0030424]; basement membrane [GO:0005604]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]	GO:0004364; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0010880; GO:0016491; GO:0019852; GO:0019853; GO:0030424; GO:0031965; GO:0042178; GO:0043209; GO:0044297; GO:0045174; GO:0050610; GO:0055114; GO:0060315; GO:0060316; GO:0071243	cellular response to arsenic-containing substance [GO:0071243]; L-ascorbic acid biosynthetic process [GO:0019853]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN7703_c0_g1_i1	Q2NL00	GSTT1_BOVIN	44.8	221	121	1	78	737	3	223	8.40E-50	198.7	GSTT1_BOVIN	reviewed	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1)	GSTT1	Bos taurus (Bovine)	240	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006749	glutathione metabolic process [GO:0006749]		blue	blue	NA	NA	NA	NA
TRINITY_DN13077_c0_g1_i2	P30711	GSTT1_HUMAN	37.9	211	124	2	106	723	3	211	9.50E-33	142.1	GSTT1_HUMAN	reviewed	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) (Glutathione transferase T1-1)	GSTT1	Homo sapiens (Human)	240	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0004602; GO:0005737; GO:0005829; GO:0006749; GO:0070062; GO:1901687	glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]		blue	blue	NA	NA	NA	NA
TRINITY_DN38199_c0_g1_i1	P48637	GSHB_HUMAN	100	76	0	0	230	3	325	400	2.10E-35	149.1	GSHB_HUMAN	reviewed	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	GSS	Homo sapiens (Human)	474	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006520; GO:0006750; GO:0006979; GO:0007399; GO:0007568; GO:0009410; GO:0016594; GO:0031667; GO:0034612; GO:0042802; GO:0042803; GO:0043200; GO:0043295; GO:0046686; GO:0070062	aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]		NA	NA	NA	NA	NA	NA
TRINITY_DN206_c0_g1_i1	P35668	GSHB_XENLA	45.3	464	245	5	242	1615	13	473	6.20E-108	392.9	GSHB_XENLA	reviewed	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	gss	Xenopus laevis (African clawed frog)	474	ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]		ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295			NA	NA	NA	NA	NA	NA
TRINITY_DN206_c0_g1_i2	P35668	GSHB_XENLA	43.8	473	251	5	242	1651	13	473	7.70E-106	386	GSHB_XENLA	reviewed	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	gss	Xenopus laevis (African clawed frog)	474	ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]		ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295			blue	blue	NA	NA	NA	NA
TRINITY_DN3349_c0_g1_i2	O59346	G3PP_PYRHO	26.1	234	160	5	112	801	2	226	3.80E-16	87	G3PP_PYRHO	reviewed	Glyceraldehyde 3-phosphate phosphatase (EC 3.1.3.-)	PH1655	Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3)	241	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3349_c0_g1_i4	O59346	G3PP_PYRHO	29	162	110	3	234	707	66	226	3.60E-13	77	G3PP_PYRHO	reviewed	Glyceraldehyde 3-phosphate phosphatase (EC 3.1.3.-)	PH1655	Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3)	241	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3653_c5_g1_i1	Q4U3L0	G3P_GLOMM	96.2	26	1	0	16	93	1	26	1.00E-05	50.4	G3P_GLOMM	reviewed	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)	Gapdh	Glossina morsitans morsitans (Savannah tsetse fly)	333	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0015630; GO:0050661; GO:0051287	glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN32425_c0_g1_i1	Q5FP70	GLPK_GLUOX	74.8	131	33	0	1	393	248	378	5.90E-54	211.5	GLPK_GLUOX	reviewed	Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK)	glpK GOX2090	Gluconobacter oxydans (strain 621H) (Gluconobacter suboxydans)	512	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	1
TRINITY_DN40754_c0_g1_i1	B2UF87	GLPK_RALPJ	88.6	79	9	0	240	4	232	310	4.20E-34	144.8	GLPK_RALPJ	reviewed	Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK)	glpK Rpic_3334	Ralstonia pickettii (strain 12J)	498	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	NA
TRINITY_DN32280_c0_g1_i1	B2UF87	GLPK_RALPJ	98.5	68	1	0	3	206	116	183	2.70E-34	145.2	GLPK_RALPJ	reviewed	Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK)	glpK Rpic_3334	Ralstonia pickettii (strain 12J)	498	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	NA
TRINITY_DN28185_c0_g1_i1	Q5FP70	GLPK_GLUOX	76.3	118	28	0	355	2	243	360	3.30E-48	192.2	GLPK_GLUOX	reviewed	Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK)	glpK GOX2090	Gluconobacter oxydans (strain 621H) (Gluconobacter suboxydans)	512	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	NA
TRINITY_DN7190_c0_g1_i1	C5C1C4	GLPK_BEUC1	73.9	211	55	0	635	3	79	289	1.70E-90	333.6	GLPK_BEUC1	reviewed	Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK)	glpK Bcav_3291	Beutenbergia cavernae (strain ATCC BAA-8 / DSM 12333 / NBRC 16432)	505	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	NA
TRINITY_DN26596_c0_g1_i1	A9MB89	GLPK_BRUC2	55.7	79	33	1	1	231	139	217	1.30E-21	103.2	GLPK_BRUC2	reviewed	Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK)	glpK BCAN_B0445	Brucella canis (strain ATCC 23365 / NCTC 10854)	498	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	NA
TRINITY_DN5879_c0_g1_i1	Q0IID9	GLPK_BOVIN	64.2	67	24	0	265	65	9	75	3.00E-18	92.8	GLPK_BOVIN	reviewed	Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase)	GK	Bos taurus (Bovine)	559	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN5879_c0_g1_i4	Q0IID9	GLPK_BOVIN	64.2	67	24	0	319	119	9	75	3.40E-18	92.8	GLPK_BOVIN	reviewed	Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase)	GK	Bos taurus (Bovine)	559	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN5879_c0_g1_i3	Q63060	GLPK_RAT	67.5	424	137	1	1280	9	9	431	1.10E-166	587.8	GLPK_RAT	reviewed	Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP-stimulated glucocorticoid-receptor translocation promoter) (ASTP) (ATP:glycerol 3-phosphotransferase)	Gk Gyk	Rattus norvegicus (Rat)	524	"cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]"	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006071; GO:0006641; GO:0009409; GO:0010033; GO:0016310; GO:0016773; GO:0019217; GO:0019563; GO:0042393; GO:0042493; GO:0042593; GO:0045471; GO:0046167	glucose homeostasis [GO:0042593]; glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN5879_c0_g1_i5	Q63060	GLPK_RAT	64.5	423	147	2	1277	9	12	431	8.00E-157	555.1	GLPK_RAT	reviewed	Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP-stimulated glucocorticoid-receptor translocation promoter) (ASTP) (ATP:glycerol 3-phosphotransferase)	Gk Gyk	Rattus norvegicus (Rat)	524	"cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]"	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006071; GO:0006641; GO:0009409; GO:0010033; GO:0016310; GO:0016773; GO:0019217; GO:0019563; GO:0042393; GO:0042493; GO:0042593; GO:0045471; GO:0046167	glucose homeostasis [GO:0042593]; glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN5879_c0_g1_i6	Q63060	GLPK_RAT	68.5	355	111	1	1073	9	78	431	8.10E-141	501.5	GLPK_RAT	reviewed	Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP-stimulated glucocorticoid-receptor translocation promoter) (ASTP) (ATP:glycerol 3-phosphotransferase)	Gk Gyk	Rattus norvegicus (Rat)	524	"cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]"	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006071; GO:0006641; GO:0009409; GO:0010033; GO:0016310; GO:0016773; GO:0019217; GO:0019563; GO:0042393; GO:0042493; GO:0042593; GO:0045471; GO:0046167	glucose homeostasis [GO:0042593]; glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic substance [GO:0010033]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN10915_c0_g1_i1	Q9WU65	GLPK2_MOUSE	51.3	78	33	1	221	3	51	128	2.70E-16	85.5	GLPK2_MOUSE	reviewed	"Glycerol kinase 2 (GK 2) (Glycerokinase 2) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)"	Gk2 Gk-rs2 Gkrs2	Mus musculus (Mouse)	554	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN39750_c0_g1_i1	Q826J2	GLPK3_STRAW	69.4	85	23	1	247	2	215	299	2.70E-25	115.5	GLPK3_STRAW	reviewed	Glycerol kinase 3 (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 3) (Glycerokinase 3) (GK 3)	glpK3 SAV_7201	Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)	505	ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072]		ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]	GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563	glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]		NA	NA	NA	NA	NA	NA
TRINITY_DN33501_c0_g1_i1	Q14409	GLPK3_HUMAN	98.9	188	2	0	565	2	141	328	6.60E-107	387.9	GLPK3_HUMAN	reviewed	"Glycerol kinase 3 (GK 3) (Glycerokinase 3) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 3) (Glycerol kinase 3 pseudogene) (Glycerol kinase, testis specific 1)"	GK3P GKP3 GKTB	Homo sapiens (Human)	553	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN1277_c0_g1_i1	Q9HCL2	GPAT1_HUMAN	33.9	576	303	10	625	2337	72	574	9.10E-86	319.7	GPAT1_HUMAN	reviewed	"Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15)"	GPAM GPAT1 KIAA1560	Homo sapiens (Human)	828	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; interleukin-2 production [GO:0032623]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of cytokine secretion [GO:0050707]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0004366; GO:0005741; GO:0005886; GO:0006072; GO:0006631; GO:0006637; GO:0006651; GO:0006654; GO:0006655; GO:0008654; GO:0009749; GO:0016021; GO:0016024; GO:0019432; GO:0031966; GO:0032623; GO:0033146; GO:0040018; GO:0042104; GO:0045540; GO:0050707; GO:0051607; GO:0055089; GO:0055091; GO:0070236; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; interleukin-2 production [GO:0032623]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of cytokine secretion [GO:0050707]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN17199_c0_g1_i1	Q6DG38	GPAT3_DANRE	46.3	108	48	2	357	40	334	433	8.10E-20	98.2	GPAT3_DANRE	reviewed	Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta)	gpat3 agpat9 si:ch211-85e10.5 zgc:91857	Danio rerio (Zebrafish) (Brachydanio rerio)	449	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0016021; GO:0016024; GO:0019432; GO:0102420	CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN619_c0_g1_i4	Q68F37	GPAT3_XENLA	42.5	447	162	3	64	1161	6	438	3.20E-93	343.6	GPAT3_XENLA	reviewed	Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta)	gpat3 agpat9	Xenopus laevis (African clawed frog)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0016021; GO:0016024; GO:0019432; GO:0102420	CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN619_c0_g1_i6	Q68F37	GPAT3_XENLA	42	457	159	4	64	1188	6	438	1.00E-91	338.6	GPAT3_XENLA	reviewed	Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta)	gpat3 agpat9	Xenopus laevis (African clawed frog)	446	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0016021; GO:0016024; GO:0019432; GO:0102420	CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN25955_c0_g1_i1	Q6DG38	GPAT3_DANRE	49.7	163	81	1	2	487	165	327	1.10E-37	157.9	GPAT3_DANRE	reviewed	Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta)	gpat3 agpat9 si:ch211-85e10.5 zgc:91857	Danio rerio (Zebrafish) (Brachydanio rerio)	449	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0016021; GO:0016024; GO:0019432; GO:0102420	CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN9555_c0_g1_i1	A3KGT9	GPT3L_DANRE	50.2	319	155	3	1041	94	116	433	4.60E-90	332.8	GPT3L_DANRE	reviewed	Glycerol-3-phosphate acyltransferase 3-like (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9-like) (1-AGP acyltransferase 9-like) (1-AGPAT 9-like) (EC 2.3.1.51) (Lysophosphatidic acid acyltransferase theta-like) (LPAAT-theta-like)	agpat9l si:ch211-155m12.4	Danio rerio (Zebrafish) (Brachydanio rerio)	443	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005789; GO:0016021; GO:0016024; GO:0019432; GO:0102420	CDP-diacylglycerol biosynthetic process [GO:0016024]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN26843_c0_g1_i1	Q86UL3	GPAT4_HUMAN	100	85	0	0	3	257	100	184	5.70E-42	171	GPAT4_HUMAN	reviewed	Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7)	GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108	Homo sapiens (Human)	456	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006654; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN30786_c0_g1_i1	Q86UL3	GPAT4_HUMAN	97.5	122	3	0	2	367	273	394	2.10E-65	250	GPAT4_HUMAN	reviewed	Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7)	GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108	Homo sapiens (Human)	456	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006654; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN30786_c0_g1_i1	Q86UL3	GPAT4_HUMAN	100	61	0	0	367	549	396	456	1.00E-27	124.8	GPAT4_HUMAN	reviewed	Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7)	GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108	Homo sapiens (Human)	456	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006654; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN619_c0_g1_i1	Q8K2C8	GPAT4_MOUSE	50	456	201	4	58	1413	14	446	1.40E-122	441.4	GPAT4_MOUSE	reviewed	Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7)	Gpat4 Agpat6 Tsarg7	Mus musculus (Mouse)	456	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN619_c0_g1_i2	Q8K2C8	GPAT4_MOUSE	50.7	456	197	5	58	1410	14	446	5.10E-122	439.5	GPAT4_MOUSE	reviewed	Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7)	Gpat4 Agpat6 Tsarg7	Mus musculus (Mouse)	456	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN619_c0_g1_i3	Q8K2C8	GPAT4_MOUSE	51.5	447	198	4	58	1383	14	446	4.60E-123	443	GPAT4_MOUSE	reviewed	Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7)	Gpat4 Agpat6 Tsarg7	Mus musculus (Mouse)	456	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN619_c0_g1_i5	Q8K2C8	GPAT4_MOUSE	50.8	447	202	3	58	1386	14	446	1.20E-123	444.9	GPAT4_MOUSE	reviewed	Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7)	Gpat4 Agpat6 Tsarg7	Mus musculus (Mouse)	456	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN27097_c0_g1_i1	Q8GWG0	GPAT9_ARATH	49.4	77	39	0	21	251	209	285	1.80E-16	86.3	GPAT9_ARATH	reviewed	Glycerol-3-phosphate acyltransferase 9 (AtGPAT9) (EC 2.3.1.15)	GPAT9 At5g60620 MUP24.4	Arabidopsis thaliana (Mouse-ear cress)	376	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; protein self-association [GO:0043621]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid biosynthetic process [GO:0006633]; gametophyte development [GO:0048229]; glycerol-3-phosphate metabolic process [GO:0006072]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; pollen maturation [GO:0010152]; seed oilbody biogenesis [GO:0010344]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; protein self-association [GO:0043621]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0004366; GO:0005783; GO:0005789; GO:0005886; GO:0006072; GO:0006633; GO:0006651; GO:0008654; GO:0010152; GO:0010344; GO:0016021; GO:0019432; GO:0019915; GO:0043621; GO:0048229; GO:0102420	diacylglycerol biosynthetic process [GO:0006651]; fatty acid biosynthetic process [GO:0006633]; gametophyte development [GO:0048229]; glycerol-3-phosphate metabolic process [GO:0006072]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; pollen maturation [GO:0010152]; seed oilbody biogenesis [GO:0010344]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN4033_c0_g1_i1	A6QLU1	GPDM_BOVIN	64.1	702	240	7	2160	82	29	727	5.60E-258	891.7	GPDM_BOVIN	reviewed	"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3)"	GPD2	Bos taurus (Bovine)	727	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; multicellular organism growth [GO:0035264]	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]	calcium ion binding [GO:0005509]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]	GO:0005509; GO:0005739; GO:0006072; GO:0006094; GO:0009331; GO:0019563; GO:0035264; GO:0043010; GO:0052591	camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN34658_c0_g1_i1	Q64521	GPDM_MOUSE	100	170	0	0	510	1	431	600	2.20E-93	342.8	GPDM_MOUSE	reviewed	"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (Protein TISP38)"	Gpd2 Gdm1	Mus musculus (Mouse)	727	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; multicellular organism growth [GO:0035264]; NADH metabolic process [GO:0006734]	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]	GO:0004367; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006734; GO:0009331; GO:0019563; GO:0035264; GO:0043010; GO:0052591	camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; multicellular organism growth [GO:0035264]; NADH metabolic process [GO:0006734]		NA	NA	NA	NA	NA	NA
TRINITY_DN24711_c0_g1_i1	Q64521	GPDM_MOUSE	98.1	216	4	0	650	3	56	271	3.30E-118	425.6	GPDM_MOUSE	reviewed	"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (Protein TISP38)"	Gpd2 Gdm1	Mus musculus (Mouse)	727	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; multicellular organism growth [GO:0035264]; NADH metabolic process [GO:0006734]	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]	GO:0004367; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006734; GO:0009331; GO:0019563; GO:0035264; GO:0043010; GO:0052591	camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; multicellular organism growth [GO:0035264]; NADH metabolic process [GO:0006734]		NA	NA	NA	NA	NA	NA
TRINITY_DN26036_c0_g1_i1	Q8BGN3	ENPP6_MOUSE	40	100	59	1	15	311	25	124	4.50E-17	88.6	ENPP6_MOUSE	reviewed	Glycerophosphocholine cholinephosphodiesterase ENPP6 (GPC-Cpde) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) (E-NPP 6) (NPP-6)	Enpp6	Mus musculus (Mouse)	440	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0005576; GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0016042; GO:0019695; GO:0031225; GO:0046872; GO:0047390	choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN4193_c2_g1_i2	Q80VJ4	GPCP1_RAT	49.7	175	84	2	801	283	456	628	1.70E-44	181	GPCP1_RAT	reviewed	Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5)	Gpcpd1 Gde5	Rattus norvegicus (Rat)	672	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]	GO:0005737; GO:0005829; GO:0007519; GO:0046475; GO:0047389; GO:2001070	glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519]		blue	blue	NA	NA	NA	NA
TRINITY_DN37905_c0_g1_i1	Q2W9A4	GCSH_MAGSA	69.3	75	23	0	230	6	47	121	4.60E-22	104.8	GCSH_MAGSA	reviewed	Glycine cleavage system H protein	gcvH amb0767	Magnetospirillum magneticum (strain AMB-1 / ATCC 700264)	125	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN31244_c0_g1_i1	B5Y8S2	GCSH_COPPD	50	64	32	0	198	7	9	72	7.40E-15	80.9	GCSH_COPPD	reviewed	Glycine cleavage system H protein	gcvH COPRO5265_0831	Coprothermobacter proteolyticus (strain ATCC 35245 / DSM 5265 / BT)	127	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN38129_c0_g1_i1	Q2W9A4	GCSH_MAGSA	67.5	77	25	0	233	3	1	77	8.20E-24	110.9	GCSH_MAGSA	reviewed	Glycine cleavage system H protein	gcvH amb0767	Magnetospirillum magneticum (strain AMB-1 / ATCC 700264)	125	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN32297_c0_g1_i1	Q89I87	GCSH_BRADU	91	67	6	0	203	3	1	67	4.60E-27	121.3	GCSH_BRADU	reviewed	Glycine cleavage system H protein	gcvH blr5752	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	122	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN7035_c0_g1_i1	Q6FYZ6	GCSH_BARQU	65.3	75	26	0	3	227	27	101	1.70E-21	102.8	GCSH_BARQU	reviewed	Glycine cleavage system H protein	gcvH BQ10120	Bartonella quintana (strain Toulouse) (Rochalimaea quintana)	122	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN37592_c0_g1_i1	A1UTQ4	GCSH_BARBK	70.7	92	27	0	278	3	5	96	3.00E-31	135.6	GCSH_BARBK	reviewed	Glycine cleavage system H protein	gcvH BARBAKC583_1095	Bartonella bacilliformis (strain ATCC 35685 / NCTC 12138 / KC583)	122	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN27443_c0_g1_i1	Q2W9A4	GCSH_MAGSA	67.9	112	36	0	340	5	6	117	8.00E-39	161	GCSH_MAGSA	reviewed	Glycine cleavage system H protein	gcvH amb0767	Magnetospirillum magneticum (strain AMB-1 / ATCC 700264)	125	glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464]	glycine cleavage complex [GO:0005960]		GO:0005960; GO:0019464	glycine decarboxylation via glycine cleavage system [GO:0019464]		NA	NA	NA	NA	NA	NA
TRINITY_DN7865_c0_g2_i1	P23434	GCSH_HUMAN	63.4	123	45	0	97	465	51	173	1.10E-42	174.5	GCSH_HUMAN	reviewed	"Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)"	GCSH	Homo sapiens (Human)	173	glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249]	glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]	GO:0004047; GO:0005739; GO:0005759; GO:0005960; GO:0006546; GO:0009249; GO:0019464	glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN7865_c0_g2_i2	P23434	GCSH_HUMAN	63.5	126	46	0	173	550	48	173	4.40E-43	176	GCSH_HUMAN	reviewed	"Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)"	GCSH	Homo sapiens (Human)	173	glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249]	glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminomethyltransferase activity [GO:0004047]	GO:0004047; GO:0005739; GO:0005759; GO:0005960; GO:0006546; GO:0009249; GO:0019464	glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN6749_c0_g1_i1	P13255	GNMT_RAT	60	300	104	3	991	101	5	291	4.00E-100	366.3	GNMT_RAT	reviewed	Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein)	Gnmt	Rattus norvegicus (Rat)	293	cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleus [GO:0005634]; folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; folic acid metabolic process [GO:0046655]; glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052]	cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleus [GO:0005634]	folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005542; GO:0005634; GO:0005829; GO:0005977; GO:0006111; GO:0006544; GO:0006555; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0046655; GO:0051289; GO:1901052; GO:1904047	folic acid metabolic process [GO:0046655]; glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052]		NA	NA	NA	NA	NA	NA
TRINITY_DN16989_c0_g1_i1	P23416	GLRA2_HUMAN	52.5	59	28	0	5	181	241	299	1.70E-13	76.3	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		brown	brown	NA	NA	NA	NA
TRINITY_DN16989_c0_g1_i2	P23416	GLRA2_HUMAN	54.5	88	40	0	5	268	241	328	2.50E-24	112.5	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11533_c0_g1_i1	P23416	GLRA2_HUMAN	25.5	188	126	4	61	582	152	339	3.90E-12	73.6	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13800_c0_g1_i1	P23416	GLRA2_HUMAN	23.6	301	197	7	1091	216	65	341	1.80E-15	85.9	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13800_c0_g1_i3	P23416	GLRA2_HUMAN	23.6	301	197	7	1244	369	65	341	2.00E-15	85.9	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28328_c0_g1_i1	P23416	GLRA2_HUMAN	45.3	64	35	0	270	79	281	344	1.60E-10	66.6	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31164_c0_g1_i1	P23416	GLRA2_HUMAN	54.9	71	32	0	223	11	238	308	3.60E-17	88.6	GLRA2_HUMAN	reviewed	Glycine receptor subunit alpha-2	GLRA2	Homo sapiens (Human)	452	"chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	"cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8362_c0_g1_i11	Q9GJS9	GLRB_BOVIN	31.1	119	72	3	97	423	138	256	1.80E-09	63.9	GLRB_BOVIN	reviewed	Glycine receptor subunit beta (Glycine receptor 58 kDa subunit)	GLRB	Bos taurus (Bovine)	497	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0001964; GO:0004888; GO:0005737; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:0060013; GO:0097112; GO:0098982; GO:1902476	"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"		brown	brown	1	NA	NA	NA
TRINITY_DN8362_c0_g1_i4	Q9GJS9	GLRB_BOVIN	35.8	81	42	3	73	285	176	256	2.80E-06	52.8	GLRB_BOVIN	reviewed	Glycine receptor subunit beta (Glycine receptor 58 kDa subunit)	GLRB	Bos taurus (Bovine)	497	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0001964; GO:0004888; GO:0005737; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:0060013; GO:0097112; GO:0098982; GO:1902476	"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5855_c0_g1_i2	Q9GJS9	GLRB_BOVIN	25	340	219	8	381	1352	60	379	1.50E-15	85.9	GLRB_BOVIN	reviewed	Glycine receptor subunit beta (Glycine receptor 58 kDa subunit)	GLRB	Bos taurus (Bovine)	497	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0001964; GO:0004888; GO:0005737; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:0060013; GO:0097112; GO:0098982; GO:1902476	"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5855_c0_g1_i3	Q9GJS9	GLRB_BOVIN	24.9	342	225	7	1409	2404	60	379	3.30E-15	85.5	GLRB_BOVIN	reviewed	Glycine receptor subunit beta (Glycine receptor 58 kDa subunit)	GLRB	Bos taurus (Bovine)	497	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]	GO:0001964; GO:0004888; GO:0005737; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:0060013; GO:0097112; GO:0098982; GO:1902476	"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5855_c0_g1_i5	P48167	GLRB_HUMAN	25.9	313	198	7	223	1119	60	352	6.80E-15	83.6	GLRB_HUMAN	reviewed	Glycine receptor subunit beta (Glycine receptor 58 kDa subunit)	GLRB	Homo sapiens (Human)	497	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]	GO:0001964; GO:0004888; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:0060013; GO:0097112; GO:0098690; GO:0098982; GO:1902476	"acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37924_c0_g1_i1	Q03878	GRP1_DAUCA	47.1	70	35	1	213	10	16	85	2.90E-10	65.5	GRP1_DAUCA	reviewed	Glycine-rich RNA-binding protein		Daucus carota (Wild carrot)	157	"cell wall [GO:0005618]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; mRNA binding [GO:0003729]; alternative mRNA splicing, via spliceosome [GO:0000380]; innate immune response [GO:0045087]; response to abscisic acid [GO:0009737]; response to cold [GO:0009409]; response to zinc ion [GO:0010043]"	cell wall [GO:0005618]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	mRNA binding [GO:0003729]	GO:0000380; GO:0003729; GO:0005618; GO:0005730; GO:0005777; GO:0005794; GO:0005886; GO:0009409; GO:0009506; GO:0009737; GO:0010043; GO:0045087	"alternative mRNA splicing, via spliceosome [GO:0000380]; innate immune response [GO:0045087]; response to abscisic acid [GO:0009737]; response to cold [GO:0009409]; response to zinc ion [GO:0010043]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6954_c0_g1_i1	Q9CZD3	GARS_MOUSE	52.5	257	117	2	849	91	468	723	4.80E-70	266.2	GARS_MOUSE	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 1) (GlyRS)	Gars1 Gars	Mus musculus (Mouse)	729	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN40236_c0_g1_i1	Q9CZD3	GARS_MOUSE	100	76	0	0	230	3	530	605	1.70E-37	156	GARS_MOUSE	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 1) (GlyRS)	Gars1 Gars	Mus musculus (Mouse)	729	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16052_c0_g1_i2	Q9CZD3	GARS_MOUSE	100	110	0	0	1	330	381	490	1.90E-61	236.1	GARS_MOUSE	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 1) (GlyRS)	Gars1 Gars	Mus musculus (Mouse)	729	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN17487_c0_g1_i1	Q9CZD3	GARS_MOUSE	100	124	0	0	375	4	48	171	1.20E-64	246.9	GARS_MOUSE	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 1) (GlyRS)	Gars1 Gars	Mus musculus (Mouse)	729	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN6954_c0_g1_i2	Q04451	SYG_BOMMO	54.6	767	250	8	2376	91	3	676	2.10E-232	807	SYG_BOMMO	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS)		Bombyx mori (Silk moth)	680	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004820; GO:0005524; GO:0005737; GO:0006426; GO:0015966; GO:0016740; GO:0046983	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]		NA	NA	NA	NA	NA	NA
TRINITY_DN6954_c0_g1_i4	Q04451	SYG_BOMMO	61.5	678	252	6	2109	91	3	676	5.40E-243	842	SYG_BOMMO	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS)		Bombyx mori (Silk moth)	680	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004820; GO:0005524; GO:0005737; GO:0006426; GO:0015966; GO:0016740; GO:0046983	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]		NA	NA	NA	NA	NA	NA
TRINITY_DN36915_c0_g1_i1	P41250	GARS_HUMAN	100	153	0	0	461	3	61	213	9.10E-83	307.4	GARS_HUMAN	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)	GARS1 GARS	Homo sapiens (Human)	739	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN18814_c0_g1_i1	P41250	GARS_HUMAN	100	114	0	0	344	3	609	722	5.30E-59	228	GARS_HUMAN	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)	GARS1 GARS	Homo sapiens (Human)	739	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN18814_c0_g1_i2	Q5RBL1	GARS_PONAB	99.1	107	1	0	322	2	609	715	2.10E-54	212.6	GARS_PONAB	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)	GARS1 GARS	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	739	axon [GO:0030424]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005739; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070062	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16052_c0_g1_i1	Q5RBL1	GARS_PONAB	100	106	0	0	1	318	395	500	6.40E-59	227.6	GARS_PONAB	reviewed	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)	GARS1 GARS	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	739	axon [GO:0030424]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005739; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070062	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN7574_c0_g1_i1	P38088	SYG_YEAST	59.2	76	31	0	3	230	370	445	1.30E-22	106.7	SYG_YEAST	reviewed	"Glycine--tRNA ligase 1, mitochondrial (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 1) (GlyRS 1) (GlyRS1)"	GRS1 YBR121C YBR0917	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	690	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; DNA-templated transcription, termination [GO:0006353]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006353; GO:0006426; GO:0015966; GO:0016740; GO:0046983; GO:0070150	"diadenosine tetraphosphate biosynthetic process [GO:0015966]; DNA-templated transcription, termination [GO:0006353]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29250_c0_g1_i1	Q06817	SYG2_YEAST	40.5	74	44	0	227	6	517	590	5.00E-13	74.7	SYG2_YEAST	reviewed	Glycine--tRNA ligase 2 (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase 2) (GlyRS 2) (GlyRS2)	GRS2 YPR081C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	618	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0006426; GO:0015966; GO:0016740; GO:0046983; GO:0070150	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]		NA	NA	NA	NA	NA	NA
TRINITY_DN6_c0_g1_i1	Q2PQH8	GDE_CANLF	48.4	570	274	8	1702	5	6	559	1.40E-156	554.7	GDE_CANLF	reviewed	"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]"	AGL	Canis lupus familiaris (Dog) (Canis familiaris)	1533	"cytoplasm [GO:0005737]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]"	cytoplasm [GO:0005737]	"4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]"	GO:0004134; GO:0004135; GO:0005737; GO:0005978; GO:0005980; GO:0102500	glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN6_c0_g1_i2	A8BQB4	GDE_HORSE	52.9	998	443	13	3034	80	550	1533	2.80E-289	996.1	GDE_HORSE	reviewed	"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]"	AGL	Equus caballus (Horse)	1533	"cytoplasm [GO:0005737]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]"	cytoplasm [GO:0005737]	"4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]"	GO:0004134; GO:0004135; GO:0005737; GO:0005978; GO:0005980; GO:0102500	glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN6_c0_g1_i3	A8BQB4	GDE_HORSE	51.1	1558	715	21	4702	80	6	1533	0	1528.5	GDE_HORSE	reviewed	"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]"	AGL	Equus caballus (Horse)	1533	"cytoplasm [GO:0005737]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]"	cytoplasm [GO:0005737]	"4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]"	GO:0004134; GO:0004135; GO:0005737; GO:0005978; GO:0005980; GO:0102500	glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN26833_c0_g1_i1	P73511	PHSG_SYNY3	75.4	65	16	0	203	9	134	198	5.00E-25	114.4	PHSG_SYNY3	reviewed	Glycogen phosphorylase (EC 2.4.1.1)	glgP sll1356	Synechocystis sp. (strain PCC 6803 / Kazusa)	849	cytoplasm [GO:0005737]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]	cytoplasm [GO:0005737]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005737; GO:0005980; GO:0008184; GO:0030170; GO:0102250; GO:0102499	glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN964_c0_g1_i2	Q9XTL9	PYG_DROME	78.6	790	169	0	2486	117	51	840	0	1306.6	PYG_DROME	reviewed	Glycogen phosphorylase (EC 2.4.1.1)	GlyP Glp1 CG7254	Drosophila melanogaster (Fruit fly)	844	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499	defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]		blue	blue	NA	NA	NA	NA
TRINITY_DN964_c0_g1_i5	Q9XTL9	PYG_DROME	80.6	677	131	0	2054	24	51	727	0	1142.1	PYG_DROME	reviewed	Glycogen phosphorylase (EC 2.4.1.1)	GlyP Glp1 CG7254	Drosophila melanogaster (Fruit fly)	844	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499	defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]		NA	NA	NA	NA	NA	NA
TRINITY_DN17445_c0_g1_i1	Q9CN90	PHSG_PASMU	54.5	77	35	0	233	3	524	600	2.30E-21	102.4	PHSG_PASMU	reviewed	Glycogen phosphorylase (EC 2.4.1.1)	glgP PM0545	Pasteurella multocida (strain Pm70)	818	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen metabolic process [GO:0005977]		glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005977; GO:0008184; GO:0030170; GO:0102250; GO:0102499	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN17445_c0_g1_i2	Q9CN90	PHSG_PASMU	56.5	85	37	0	257	3	516	600	3.00E-22	105.5	PHSG_PASMU	reviewed	Glycogen phosphorylase (EC 2.4.1.1)	glgP PM0545	Pasteurella multocida (strain Pm70)	818	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen metabolic process [GO:0005977]		glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005977; GO:0008184; GO:0030170; GO:0102250; GO:0102499	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN28904_c0_g1_i1	Q5MIB6	PYGB_SHEEP	67.5	80	26	0	243	4	329	408	7.50E-29	127.5	PYGB_SHEEP	reviewed	"Glycogen phosphorylase, brain form (EC 2.4.1.1)"	PYGB	Ovis aries (Sheep)	843	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen metabolic process [GO:0005977]		glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005977; GO:0008184; GO:0030170; GO:0102250; GO:0102499	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN37571_c0_g1_i1	P11216	PYGB_HUMAN	100	141	0	0	425	3	346	486	7.40E-79	294.3	PYGB_HUMAN	reviewed	"Glycogen phosphorylase, brain form (EC 2.4.1.1)"	PYGB	Homo sapiens (Human)	843	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005576; GO:0005737; GO:0005980; GO:0008184; GO:0016020; GO:0030170; GO:0035578; GO:0043312; GO:0070062; GO:0102250; GO:0102499	glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN18167_c0_g1_i1	Q5MIB6	PYGB_SHEEP	81.7	93	17	0	1	279	337	429	4.50E-40	164.9	PYGB_SHEEP	reviewed	"Glycogen phosphorylase, brain form (EC 2.4.1.1)"	PYGB	Ovis aries (Sheep)	843	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen metabolic process [GO:0005977]		glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005977; GO:0008184; GO:0030170; GO:0102250; GO:0102499	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN40982_c0_g1_i1	Q3B7M9	PYGB_BOVIN	89.6	96	10	0	1	288	103	198	1.10E-44	180.3	PYGB_BOVIN	reviewed	"Glycogen phosphorylase, brain form (EC 2.4.1.1)"	PYGB	Bos taurus (Bovine)	843	cytoplasm [GO:0005737]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]	cytoplasm [GO:0005737]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005737; GO:0005980; GO:0008184; GO:0030170; GO:0102250; GO:0102499	glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN37986_c0_g1_i1	Q8CI94	PYGB_MOUSE	100	68	0	0	1	204	182	249	6.80E-38	157.1	PYGB_MOUSE	reviewed	"Glycogen phosphorylase, brain form (EC 2.4.1.1)"	Pygb	Mus musculus (Mouse)	843	axon [GO:0030424]; cytoplasm [GO:0005737]; carbohydrate binding [GO:0030246]; drug binding [GO:0008144]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]	axon [GO:0030424]; cytoplasm [GO:0005737]	carbohydrate binding [GO:0030246]; drug binding [GO:0008144]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005737; GO:0005977; GO:0005980; GO:0008144; GO:0008184; GO:0030170; GO:0030246; GO:0030424; GO:0042802; GO:0102250; GO:0102499	glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN38691_c0_g1_i1	P11216	PYGB_HUMAN	100	259	0	0	1	777	522	780	1.90E-144	513.1	PYGB_HUMAN	reviewed	"Glycogen phosphorylase, brain form (EC 2.4.1.1)"	PYGB	Homo sapiens (Human)	843	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005576; GO:0005737; GO:0005980; GO:0008184; GO:0016020; GO:0030170; GO:0035578; GO:0043312; GO:0070062; GO:0102250; GO:0102499	glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN15060_c0_g1_i1	P06737	PYGL_HUMAN	61	77	30	0	5	235	102	178	6.60E-21	100.9	PYGL_HUMAN	reviewed	"Glycogen phosphorylase, liver form (EC 2.4.1.1)"	PYGL	Homo sapiens (Human)	847	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; drug binding [GO:0008144]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; neutrophil degranulation [GO:0043312]; response to bacterium [GO:0009617]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; drug binding [GO:0008144]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]	GO:0002060; GO:0005524; GO:0005536; GO:0005576; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0006015; GO:0008144; GO:0008184; GO:0009617; GO:0016208; GO:0019842; GO:0030170; GO:0032052; GO:0034774; GO:0042593; GO:0042802; GO:0043312; GO:0070062; GO:0070266; GO:0102250; GO:0102499; GO:1904813	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; neutrophil degranulation [GO:0043312]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN36073_c0_g1_i1	P06737	PYGL_HUMAN	54.8	93	42	0	1	279	436	528	9.10E-25	114	PYGL_HUMAN	reviewed	"Glycogen phosphorylase, liver form (EC 2.4.1.1)"	PYGL	Homo sapiens (Human)	847	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; drug binding [GO:0008144]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; neutrophil degranulation [GO:0043312]; response to bacterium [GO:0009617]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; drug binding [GO:0008144]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]	GO:0002060; GO:0005524; GO:0005536; GO:0005576; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0006015; GO:0008144; GO:0008184; GO:0009617; GO:0016208; GO:0019842; GO:0030170; GO:0032052; GO:0034774; GO:0042593; GO:0042802; GO:0043312; GO:0070062; GO:0070266; GO:0102250; GO:0102499; GO:1904813	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; neutrophil degranulation [GO:0043312]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN36190_c0_g1_i1	P49840	GSK3A_HUMAN	100	118	0	0	2	355	336	453	5.10E-65	248.1	GSK3A_HUMAN	reviewed	Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)	GSK3A	Homo sapiens (Human)	483	"apical dendrite [GO:0097440]; axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]; ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dendrite development [GO:2000171]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of neuron projection development [GO:0010975]; regulation of systemic arterial blood pressure [GO:0003073]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"	apical dendrite [GO:0097440]; axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]	ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0003073; GO:0003214; GO:0004674; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0005977; GO:0006349; GO:0006468; GO:0007165; GO:0007212; GO:0007568; GO:0008286; GO:0010508; GO:0010628; GO:0010800; GO:0010905; GO:0010975; GO:0016055; GO:0016477; GO:0018105; GO:0018107; GO:0030424; GO:0030877; GO:0031398; GO:0032007; GO:0032436; GO:0032869; GO:0033138; GO:0034236; GO:0036016; GO:0036498; GO:0043025; GO:0043161; GO:0043525; GO:0044027; GO:0045719; GO:0045732; GO:0045823; GO:0045944; GO:0046325; GO:0046627; GO:0048156; GO:0050321; GO:0060079; GO:0061052; GO:0071285; GO:0071879; GO:0090090; GO:0097191; GO:0097192; GO:0097440; GO:0098794; GO:0106071; GO:1901030; GO:1902004; GO:1903146; GO:1903955; GO:1904227; GO:1990635; GO:2000077; GO:2000171; GO:2000466; GO:2000467	"aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dendrite development [GO:2000171]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of neuron projection development [GO:0010975]; regulation of systemic arterial blood pressure [GO:0003073]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21205_c0_g1_i1	P49840	GSK3A_HUMAN	100	186	0	0	3	560	96	281	3.70E-102	372.1	GSK3A_HUMAN	reviewed	Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)	GSK3A	Homo sapiens (Human)	483	"apical dendrite [GO:0097440]; axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]; ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dendrite development [GO:2000171]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of neuron projection development [GO:0010975]; regulation of systemic arterial blood pressure [GO:0003073]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"	apical dendrite [GO:0097440]; axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]	ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0003073; GO:0003214; GO:0004674; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0005977; GO:0006349; GO:0006468; GO:0007165; GO:0007212; GO:0007568; GO:0008286; GO:0010508; GO:0010628; GO:0010800; GO:0010905; GO:0010975; GO:0016055; GO:0016477; GO:0018105; GO:0018107; GO:0030424; GO:0030877; GO:0031398; GO:0032007; GO:0032436; GO:0032869; GO:0033138; GO:0034236; GO:0036016; GO:0036498; GO:0043025; GO:0043161; GO:0043525; GO:0044027; GO:0045719; GO:0045732; GO:0045823; GO:0045944; GO:0046325; GO:0046627; GO:0048156; GO:0050321; GO:0060079; GO:0061052; GO:0071285; GO:0071879; GO:0090090; GO:0097191; GO:0097192; GO:0097440; GO:0098794; GO:0106071; GO:1901030; GO:1902004; GO:1903146; GO:1903955; GO:1904227; GO:1990635; GO:2000077; GO:2000171; GO:2000466; GO:2000467	"aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dendrite development [GO:2000171]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of neuron projection development [GO:0010975]; regulation of systemic arterial blood pressure [GO:0003073]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12094_c0_g1_i1	P49841	GSK3B_HUMAN	81	368	69	1	21	1121	22	389	1.60E-179	630.2	GSK3B_HUMAN	reviewed	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	Homo sapiens (Human)	420	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein-containing complex assembly [GO:0031334]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]	GO:0001085; GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010822; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043547; GO:0045719; GO:0045732; GO:0046777; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0070507; GO:0070885; GO:0071109; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1902042; GO:1904339; GO:1904646; GO:1904781; GO:1904885; GO:1904886; GO:1990909; GO:2000077; GO:2000466	beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN35721_c0_g1_i1	P49841	GSK3B_HUMAN	100	99	0	0	299	3	42	140	1.60E-51	203	GSK3B_HUMAN	reviewed	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	Homo sapiens (Human)	420	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein-containing complex assembly [GO:0031334]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]	GO:0001085; GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010822; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043547; GO:0045719; GO:0045732; GO:0046777; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0070507; GO:0070885; GO:0071109; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1902042; GO:1904339; GO:1904646; GO:1904781; GO:1904885; GO:1904886; GO:1990909; GO:2000077; GO:2000466	beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN35721_c0_g1_i2	P49841	GSK3B_HUMAN	100	53	0	0	203	45	42	94	5.60E-24	110.9	GSK3B_HUMAN	reviewed	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	Homo sapiens (Human)	420	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein-containing complex assembly [GO:0031334]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]	GO:0001085; GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010822; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043547; GO:0045719; GO:0045732; GO:0046777; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0070507; GO:0070885; GO:0071109; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1902042; GO:1904339; GO:1904646; GO:1904781; GO:1904885; GO:1904886; GO:1990909; GO:2000077; GO:2000466	beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN40858_c0_g1_i1	P49841	GSK3B_HUMAN	100	82	0	0	3	248	252	333	8.60E-43	173.7	GSK3B_HUMAN	reviewed	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	Homo sapiens (Human)	420	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein-containing complex assembly [GO:0031334]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]	GO:0001085; GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010822; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043547; GO:0045719; GO:0045732; GO:0046777; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0070507; GO:0070885; GO:0071109; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1902042; GO:1904339; GO:1904646; GO:1904781; GO:1904885; GO:1904886; GO:1990909; GO:2000077; GO:2000466	beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN25780_c0_g1_i1	P49841	GSK3B_HUMAN	100	111	0	0	335	3	131	241	1.60E-60	233	GSK3B_HUMAN	reviewed	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	Homo sapiens (Human)	420	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein-containing complex assembly [GO:0031334]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]	GO:0001085; GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010822; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043547; GO:0045719; GO:0045732; GO:0046777; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0070507; GO:0070885; GO:0071109; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1902042; GO:1904339; GO:1904646; GO:1904781; GO:1904885; GO:1904886; GO:1990909; GO:2000077; GO:2000466	beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN20315_c0_g1_i1	P46976	GLYG_HUMAN	98.4	127	2	0	1	381	114	240	2.30E-71	269.2	GLYG_HUMAN	reviewed	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GYG1 GYG	Homo sapiens (Human)	350	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]	GO:0005576; GO:0005829; GO:0005978; GO:0008466; GO:0016020; GO:0030145; GO:0034774; GO:0042803; GO:0043202; GO:0043312; GO:0102751; GO:1904813	glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN3772_c0_g1_i1	P13280	GLYG_RABIT	53.2	331	141	6	1046	93	4	333	1.30E-90	334.7	GLYG_RABIT	reviewed	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GYG1 GYG	Oryctolagus cuniculus (Rabbit)	333	glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]		glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]	GO:0005978; GO:0008466; GO:0030145; GO:0042803; GO:0102751	glycogen biosynthetic process [GO:0005978]		NA	NA	NA	NA	NA	NA
TRINITY_DN3772_c0_g1_i2	P13280	GLYG_RABIT	53.2	331	141	6	1046	93	4	333	2.20E-90	334	GLYG_RABIT	reviewed	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GYG1 GYG	Oryctolagus cuniculus (Rabbit)	333	glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]		glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]	GO:0005978; GO:0008466; GO:0030145; GO:0042803; GO:0102751	glycogen biosynthetic process [GO:0005978]		blue	blue	NA	NA	NA	NA
TRINITY_DN3772_c0_g1_i3	P13280	GLYG_RABIT	53.2	331	141	6	1046	93	4	333	2.20E-90	334	GLYG_RABIT	reviewed	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GYG1 GYG	Oryctolagus cuniculus (Rabbit)	333	glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]		glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]	GO:0005978; GO:0008466; GO:0030145; GO:0042803; GO:0102751	glycogen biosynthetic process [GO:0005978]		blue	blue	NA	NA	NA	NA
TRINITY_DN3772_c0_g1_i4	P13280	GLYG_RABIT	53.2	331	141	6	1046	93	4	333	2.20E-90	334	GLYG_RABIT	reviewed	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GYG1 GYG	Oryctolagus cuniculus (Rabbit)	333	glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]		glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]	GO:0005978; GO:0008466; GO:0030145; GO:0042803; GO:0102751	glycogen biosynthetic process [GO:0005978]		blue	blue	NA	NA	NA	NA
TRINITY_DN3772_c0_g1_i5	P46976	GLYG_HUMAN	60.3	78	31	0	235	2	1	78	5.50E-18	91.7	GLYG_HUMAN	reviewed	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GYG1 GYG	Homo sapiens (Human)	350	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]	GO:0005576; GO:0005829; GO:0005978; GO:0008466; GO:0016020; GO:0030145; GO:0034774; GO:0042803; GO:0043202; GO:0043312; GO:0102751; GO:1904813	glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN1873_c0_g1_i3	Q9VUL9	FUCTA_DROME	36.1	277	163	6	183	998	191	458	8.60E-44	179.1	FUCTA_DROME	reviewed	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	FucTA CG6869	Drosophila melanogaster (Fruit fly)	503	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920	fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1873_c0_g1_i7	Q9VUL9	FUCTA_DROME	36.1	277	163	6	231	1046	191	458	9.00E-44	179.1	FUCTA_DROME	reviewed	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	FucTA CG6869	Drosophila melanogaster (Fruit fly)	503	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920	fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN16720_c0_g1_i1	Q9VUL9	FUCTA_DROME	60.8	288	102	3	52	906	175	454	3.10E-106	386.3	FUCTA_DROME	reviewed	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	FucTA CG6869	Drosophila melanogaster (Fruit fly)	503	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920	fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN30378_c0_g1_i1	Q9NS00	C1GLT_HUMAN	100	215	0	0	645	1	141	355	3.70E-130	465.3	C1GLT_HUMAN	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GALT1	Homo sapiens (Human)	363	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing [GO:0016266]; O-glycan processing, core 1 [GO:0016267]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]	GO:0000139; GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016266; GO:0016267; GO:0046872; GO:0060576	"angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing [GO:0016266]; O-glycan processing, core 1 [GO:0016267]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6802_c0_g1_i2	Q18515	C1GLT_CAEEL	35.6	174	106	5	521	3	176	344	4.20E-23	109.4	C1GLT_CAEEL	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C38H2.2	Caenorhabditis elegans	389	"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; O-glycan processing, core 1 [GO:0016267]"	integral component of membrane [GO:0016021]	glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]	GO:0016021; GO:0016263; GO:0016267; GO:0046872	"O-glycan processing, core 1 [GO:0016267]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6802_c0_g1_i4	Q18515	C1GLT_CAEEL	34.3	143	88	5	504	79	176	313	1.70E-16	87.4	C1GLT_CAEEL	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C38H2.2	Caenorhabditis elegans	389	"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; O-glycan processing, core 1 [GO:0016267]"	integral component of membrane [GO:0016021]	glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]	GO:0016021; GO:0016263; GO:0016267; GO:0046872	"O-glycan processing, core 1 [GO:0016267]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10028_c0_g1_i1	Q7K237	C1GLT_DROME	58.1	332	134	3	96	1091	20	346	2.30E-116	420.6	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10028_c0_g1_i2	Q7K237	C1GLT_DROME	68.6	255	80	0	106	870	92	346	4.60E-113	409.5	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10028_c0_g1_i3	Q7K237	C1GLT_DROME	64.8	287	96	3	104	964	65	346	3.60E-116	419.9	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2531_c0_g1_i2	Q7K237	C1GLT_DROME	53.7	324	138	5	153	1091	24	346	8.80E-99	362.1	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2531_c0_g1_i3	Q7K237	C1GLT_DROME	53.7	324	138	5	87	1025	24	346	6.40E-99	362.5	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2531_c0_g1_i4	Q7K237	C1GLT_DROME	53.7	324	138	5	93	1031	24	346	6.40E-99	362.5	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31033_c0_g1_i1	Q7K237	C1GLT_DROME	39.3	112	61	2	377	51	100	207	4.60E-17	89	C1GLT_DROME	reviewed	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	C1GalTA CG9520	Drosophila melanogaster (Fruit fly)	388	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"	integral component of membrane [GO:0016021]	"beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6450_c0_g1_i1	O75063	XYLK_HUMAN	52.2	253	117	3	842	87	63	312	5.20E-73	276.6	XYLK_HUMAN	reviewed	Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase)	FAM20B KIAA0475	Homo sapiens (Human)	409	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016773; GO:0030166; GO:0046872	proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN6450_c0_g1_i2	O75063	XYLK_HUMAN	52.4	273	126	3	843	28	63	332	2.00E-80	301.2	XYLK_HUMAN	reviewed	Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase)	FAM20B KIAA0475	Homo sapiens (Human)	409	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016773; GO:0030166; GO:0046872	proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN6450_c0_g1_i3	O75063	XYLK_HUMAN	55.6	126	56	0	671	294	63	188	2.40E-34	147.9	XYLK_HUMAN	reviewed	Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase)	FAM20B KIAA0475	Homo sapiens (Human)	409	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016773; GO:0030166; GO:0046872	proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN6450_c0_g1_i3	O75063	XYLK_HUMAN	51.2	86	39	2	282	28	249	332	3.80E-19	97.4	XYLK_HUMAN	reviewed	Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase)	FAM20B KIAA0475	Homo sapiens (Human)	409	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; proteoglycan biosynthetic process [GO:0030166]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016773; GO:0030166; GO:0046872	proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN6450_c0_g1_i4	Q95T10	XYLK_DROME	51.2	84	32	2	279	28	278	352	1.10E-19	98.2	XYLK_DROME	reviewed	Glycosaminoglycan xylosylkinase homolog (EC 2.7.1.-) (Xylose kinase homolog)	CG3631	Drosophila melanogaster (Fruit fly)	421	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein phosphorylation [GO:0006468]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]"	GO:0004672; GO:0005524; GO:0005783; GO:0005794; GO:0006468; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN6450_c0_g1_i5	Q95T10	XYLK_DROME	51.2	84	32	2	279	28	278	352	8.70E-20	98.2	XYLK_DROME	reviewed	Glycosaminoglycan xylosylkinase homolog (EC 2.7.1.-) (Xylose kinase homolog)	CG3631	Drosophila melanogaster (Fruit fly)	421	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein phosphorylation [GO:0006468]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]"	GO:0004672; GO:0005524; GO:0005783; GO:0005794; GO:0006468; GO:0016773; GO:0046872	protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2813_c0_g2_i1	C0HBB2	GLMP_SALSA	26.7	393	250	11	1229	87	30	396	3.00E-25	117.9	GLMP_SALSA	reviewed	Glycosylated lysosomal membrane protein (Lysosomal protein NCU-G1)	glmp	Salmo salar (Atlantic salmon)	406	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]		GO:0005764; GO:0005765; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33199_c0_g1_i1	A4FUP9	GL1D1_MOUSE	50	84	42	0	2	253	248	331	4.00E-15	82	GL1D1_MOUSE	reviewed	Glycosyltransferase 1 domain-containing protein 1 (EC 2.4.-.-)	Glt1d1	Mus musculus (Mouse)	346	"cytosol [GO:0005829]; extracellular region [GO:0005576]; transferase activity, transferring glycosyl groups [GO:0016757]"	cytosol [GO:0005829]; extracellular region [GO:0005576]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005576; GO:0005829; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN14079_c0_g1_i1	Q6DIQ1	GL1D1_XENTR	30.6	121	80	2	21	383	8	124	2.10E-08	60.5	GL1D1_XENTR	reviewed	Glycosyltransferase 1 domain-containing protein 1 (EC 2.4.-.-)	glt1d1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	345	"extracellular region [GO:0005576]; transferase activity, transferring glycosyl groups [GO:0016757]"	extracellular region [GO:0005576]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005576; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN3692_c0_g1_i1	Q5U3H3	GL8D1_DANRE	58.2	55	21	1	377	213	307	359	7.50E-15	81.6	GL8D1_DANRE	reviewed	Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-)	glt8d1 zgc:103525	Danio rerio (Zebrafish) (Brachydanio rerio)	365	"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]"	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005794; GO:0016021; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN3692_c0_g1_i2	Q6NSU3	GL8D1_MOUSE	31	332	207	7	1160	225	29	358	1.20E-40	169.1	GL8D1_MOUSE	reviewed	Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-)	Glt8d1	Mus musculus (Mouse)	371	"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]"	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005794; GO:0016021; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN3692_c0_g1_i4	Q6DJM3	GL8D1_XENLA	32.3	313	186	6	1109	225	52	356	1.80E-39	165.2	GL8D1_XENLA	reviewed	Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-)	glt8d1	Xenopus laevis (African clawed frog)	364	"integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]"	integral component of membrane [GO:0016021]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016021; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN3692_c0_g1_i5	Q6DJM3	GL8D1_XENLA	29.4	252	159	5	761	60	60	310	1.90E-22	107.8	GL8D1_XENLA	reviewed	Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-)	glt8d1	Xenopus laevis (African clawed frog)	364	"integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]"	integral component of membrane [GO:0016021]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016021; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN3692_c0_g1_i7	Q6DJM3	GL8D1_XENLA	32.2	298	183	5	1064	225	60	356	4.70E-40	167.2	GL8D1_XENLA	reviewed	Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-)	glt8d1	Xenopus laevis (African clawed frog)	364	"integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]"	integral component of membrane [GO:0016021]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016021; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN3692_c0_g1_i9	Q6NSU3	GL8D1_MOUSE	31	332	207	7	1160	225	29	358	8.00E-41	169.5	GL8D1_MOUSE	reviewed	Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-)	Glt8d1	Mus musculus (Mouse)	371	"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]"	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0005794; GO:0016021; GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN29850_c0_g1_i1	Q568B7	GTDC1_DANRE	46.4	375	129	4	944	30	47	419	3.80E-91	336.3	GTDC1_DANRE	reviewed	Glycosyltransferase-like domain-containing protein 1	gtdc1 si:dkey-52o2.3 zgc:110568	Danio rerio (Zebrafish) (Brachydanio rerio)	433	central nervous system development [GO:0007417]			GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN26313_c0_g1_i1	Q9LTR9	NMT1_ARATH	65.9	91	31	0	279	7	195	285	3.50E-29	128.6	NMT1_ARATH	reviewed	Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase 1) (Peptide N-myristoyltransferase 1)	NMT1 At5g57020 MHM17.15	Arabidopsis thaliana (Mouse-ear cress)	434	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plastid [GO:0009536]; ribosome [GO:0005840]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; embryonic shoot morphogenesis [GO:0010064]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plastid [GO:0009536]; ribosome [GO:0005840]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]	GO:0004379; GO:0005737; GO:0005829; GO:0005840; GO:0006499; GO:0009536; GO:0010064; GO:0018008; GO:0019107	embryonic shoot morphogenesis [GO:0010064]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]		NA	NA	NA	NA	NA	NA
TRINITY_DN33507_c0_g1_i1	P31717	NMT1_BOVIN	100	100	0	0	1	300	262	361	3.20E-52	205.3	NMT1_BOVIN	reviewed	Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1)	NMT1 NMT	Bos taurus (Bovine)	497	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]	GO:0004379; GO:0005737; GO:0005829; GO:0016020; GO:0018008	N-terminal peptidyl-glycine N-myristoylation [GO:0018008]		NA	NA	NA	NA	NA	NA
TRINITY_DN28565_c0_g1_i1	P30419	NMT1_HUMAN	100	74	0	0	3	224	401	474	1.80E-36	152.5	NMT1_HUMAN	reviewed	Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1)	NMT1 NMT	Homo sapiens (Human)	496	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]	GO:0001701; GO:0004379; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006499; GO:0018008; GO:0019107; GO:0019898; GO:0022400; GO:0042180; GO:1900740	cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of rhodopsin mediated signaling pathway [GO:0022400]		NA	NA	NA	NA	NA	NA
TRINITY_DN23784_c0_g1_i1	O60551	NMT2_HUMAN	100	90	0	0	3	272	409	498	6.30E-48	191	NMT2_HUMAN	reviewed	Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase)	NMT2	Homo sapiens (Human)	498	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]	GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0018008; GO:0019898; GO:0022400; GO:0043657; GO:0075733	intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400]		NA	NA	NA	NA	NA	NA
TRINITY_DN11444_c0_g1_i1	O60551	NMT2_HUMAN	71.1	249	71	1	3	746	250	498	3.20E-102	372.9	NMT2_HUMAN	reviewed	Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase)	NMT2	Homo sapiens (Human)	498	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]	GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0018008; GO:0019898; GO:0022400; GO:0043657; GO:0075733	intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400]		NA	NA	NA	NA	NA	NA
TRINITY_DN29799_c0_g1_i1	O70311	NMT2_MOUSE	58.2	91	34	2	338	610	140	226	7.70E-21	102.1	NMT2_MOUSE	reviewed	Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase)	Nmt2	Mus musculus (Mouse)	529	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]	GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006499; GO:0018008; GO:0019898	N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]		NA	NA	NA	NA	NA	NA
TRINITY_DN539_c0_g1_i1	A7YT82	NMT2_DANRE	68.3	63	20	0	7	195	429	491	3.40E-19	95.1	NMT2_DANRE	reviewed	Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase)	nmt2	Danio rerio (Zebrafish) (Brachydanio rerio)	492	cytoplasm [GO:0005737]; membrane [GO:0016020]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]	cytoplasm [GO:0005737]; membrane [GO:0016020]	glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]	GO:0004379; GO:0005737; GO:0016020; GO:0018008	N-terminal peptidyl-glycine N-myristoylation [GO:0018008]		NA	NA	NA	NA	NA	NA
TRINITY_DN38228_c0_g1_i1	Q9CPV4	GLOD4_MOUSE	57.5	40	17	0	76	195	258	297	2.60E-05	48.9	GLOD4_MOUSE	reviewed	Glyoxalase domain-containing protein 4	Glod4	Mus musculus (Mouse)	298	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN29221_c0_g1_i1	Q9CPV4	GLOD4_MOUSE	100	71	0	0	214	2	225	295	1.30E-34	146.4	GLOD4_MOUSE	reviewed	Glyoxalase domain-containing protein 4	Glod4	Mus musculus (Mouse)	298	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN36353_c0_g1_i1	Q9HC38	GLOD4_HUMAN	100	77	0	0	231	1	176	252	1.50E-38	159.5	GLOD4_HUMAN	reviewed	Glyoxalase domain-containing protein 4	GLOD4 C17orf25 CGI-150 My027	Homo sapiens (Human)	313	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; cadherin binding [GO:0045296]	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	cadherin binding [GO:0045296]	GO:0005739; GO:0045296; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN33714_c0_g1_i1	Q9CPV4	GLOD4_MOUSE	93.3	104	7	0	314	3	1	104	3.70E-53	208.8	GLOD4_MOUSE	reviewed	Glyoxalase domain-containing protein 4	Glod4	Mus musculus (Mouse)	298	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN1383_c0_g1_i10	Q9CPV4	GLOD4_MOUSE	66.1	109	37	0	419	93	189	297	1.60E-35	150.6	GLOD4_MOUSE	reviewed	Glyoxalase domain-containing protein 4	Glod4	Mus musculus (Mouse)	298	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN1383_c0_g1_i2	Q9CPV4	GLOD4_MOUSE	60.1	298	115	3	977	93	1	297	2.10E-101	370.5	GLOD4_MOUSE	reviewed	Glyoxalase domain-containing protein 4	Glod4	Mus musculus (Mouse)	298	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			blue	blue	NA	NA	NA	NA
TRINITY_DN3140_c0_g1_i1	Q91Z53	GRHPR_MOUSE	55	322	139	4	1050	94	8	326	3.80E-93	343.2	GRHPR_MOUSE	reviewed	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	Grhpr Glxr	Mus musculus (Mouse)	328	"catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]"	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"	GO:0005737; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0055114; GO:0070402; GO:1902494	dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN3140_c0_g1_i2	Q91Z53	GRHPR_MOUSE	55	322	139	4	1050	94	8	326	3.20E-93	343.6	GRHPR_MOUSE	reviewed	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	Grhpr Glxr	Mus musculus (Mouse)	328	"catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]"	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"	GO:0005737; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0055114; GO:0070402; GO:1902494	dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN3140_c0_g1_i3	Q91Z53	GRHPR_MOUSE	55	322	139	4	1050	94	8	326	4.30E-93	343.2	GRHPR_MOUSE	reviewed	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	Grhpr Glxr	Mus musculus (Mouse)	328	"catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]"	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"	GO:0005737; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0055114; GO:0070402; GO:1902494	dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN3140_c0_g1_i4	Q91Z53	GRHPR_MOUSE	55	322	139	4	1050	94	8	326	2.80E-93	343.6	GRHPR_MOUSE	reviewed	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	Grhpr Glxr	Mus musculus (Mouse)	328	"catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]"	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"	GO:0005737; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0055114; GO:0070402; GO:1902494	dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN29749_c0_g1_i1	Q9UBQ7	GRHPR_HUMAN	100	159	0	0	3	479	30	188	2.60E-88	325.9	GRHPR_HUMAN	reviewed	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GRHPR GLXR MSTP035	Homo sapiens (Human)	328	"catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]"	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]	"carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]"	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0055114; GO:0070062; GO:0070402; GO:1902494	cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN21800_c0_g1_i1	Q8FIT1	GHRA_ECOL6	45	100	55	0	305	6	176	275	1.90E-19	96.7	GHRA_ECOL6	reviewed	Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase)	ghrA c1295	Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC)	312	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN1443_c0_g1_i10	A8GD46	GHRA_SERP5	36	214	123	5	724	101	66	271	1.00E-28	129	GHRA_SERP5	reviewed	Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase)	ghrA Spro_1933	Serratia proteamaculans (strain 568)	313	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN1443_c0_g1_i20	Q32HN5	GHRA_SHIDS	34.9	238	147	3	973	260	83	312	5.80E-36	153.3	GHRA_SHIDS	reviewed	Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase)	ghrA SDY_1004	Shigella dysenteriae serotype 1 (strain Sd197)	312	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN1443_c0_g1_i4	Q32HN5	GHRA_SHIDS	34.9	238	147	3	973	260	83	312	6.50E-36	153.3	GHRA_SHIDS	reviewed	Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase)	ghrA SDY_1004	Shigella dysenteriae serotype 1 (strain Sd197)	312	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN1443_c0_g1_i7	A8GD46	GHRA_SERP5	35.5	256	151	5	1009	260	66	313	5.60E-36	153.3	GHRA_SERP5	reviewed	Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase)	ghrA Spro_1933	Serratia proteamaculans (strain 568)	313	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN6556_c0_g1_i1	P51655	GPC4_MOUSE	43.3	342	190	2	1078	65	33	374	6.30E-82	305.8	GPC4_MOUSE	reviewed	Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]	Gpc4	Mus musculus (Mouse)	557	anchored component of presynaptic membrane [GO:0099026]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055]	anchored component of presynaptic membrane [GO:0099026]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; synapse [GO:0045202]		GO:0005576; GO:0005615; GO:0005796; GO:0009897; GO:0009966; GO:0009986; GO:0016055; GO:0016477; GO:0045202; GO:0062023; GO:0098696; GO:0098978; GO:0099026; GO:0099560; GO:1905475; GO:1905606	cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN36901_c0_g1_i1	A7ZHJ5	GUAC_ECO24	100	59	0	0	59	235	1	59	8.10E-27	120.6	GUAC_ECO24	reviewed	GMP reductase (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase) (Guanosine monophosphate reductase)	guaC EcE24377A_0106	Escherichia coli O139:H28 (strain E24377A / ETEC)	347	GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; purine nucleotide metabolic process [GO:0006163]	GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0006163; GO:0046872; GO:1902560	purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN9476_c0_g1_i1	Q9DCZ1	GMPR1_MOUSE	68	344	110	0	30	1061	1	344	1.70E-135	483.8	GMPR1_MOUSE	reviewed	GMP reductase 1 (GMPR 1) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 1) (Guanosine monophosphate reductase 1)	Gmpr Gmpr1	Mus musculus (Mouse)	345	GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]	GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0006144; GO:0006163; GO:0046872; GO:1902560	purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN2366_c0_g3_i1	P36959	GMPR1_HUMAN	100	51	0	0	2	154	170	220	8.20E-23	107.1	GMPR1_HUMAN	reviewed	GMP reductase 1 (GMPR 1) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 1) (Guanosine monophosphate reductase 1)	GMPR GMPR1	Homo sapiens (Human)	345	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; purine-containing compound salvage [GO:0043101]; response to cold [GO:0009409]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0005829; GO:0006144; GO:0006163; GO:0009409; GO:0043101; GO:0046872; GO:1902560	purine-containing compound salvage [GO:0043101]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN35075_c0_g1_i1	Q9P2T1	GMPR2_HUMAN	100	81	0	0	37	279	1	81	1.30E-39	163.3	GMPR2_HUMAN	reviewed	GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2)	GMPR2	Homo sapiens (Human)	348	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0005829; GO:0006144; GO:0043101; GO:0046037; GO:0046872; GO:1902560	GMP metabolic process [GO:0046037]; purine-containing compound salvage [GO:0043101]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN5755_c0_g1_i1	Q32L93	GMPR2_BOVIN	68.5	124	39	0	92	463	1	124	1.00E-43	177.9	GMPR2_BOVIN	reviewed	GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2)	GMPR2	Bos taurus (Bovine)	348	GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]	GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0006144; GO:0046037; GO:0046872; GO:1902560	GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN5755_c0_g1_i2	Q32L93	GMPR2_BOVIN	75.9	344	83	0	92	1123	1	344	6.80E-154	545	GMPR2_BOVIN	reviewed	GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2)	GMPR2	Bos taurus (Bovine)	348	GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]	GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0006144; GO:0046037; GO:0046872; GO:1902560	GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN28970_c0_g1_i1	Q9P2T1	GMPR2_HUMAN	100	84	0	0	1	252	265	348	8.70E-42	170.6	GMPR2_HUMAN	reviewed	GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2)	GMPR2	Homo sapiens (Human)	348	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0005829; GO:0006144; GO:0043101; GO:0046037; GO:0046872; GO:1902560	GMP metabolic process [GO:0046037]; purine-containing compound salvage [GO:0043101]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN29289_c0_g1_i1	Q99L27	GMPR2_MOUSE	96.2	106	4	0	319	2	214	319	8.90E-53	207.2	GMPR2_MOUSE	reviewed	GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2)	Gmpr2	Mus musculus (Mouse)	348	GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP catabolic process [GO:0046038]; GMP metabolic process [GO:0046037]; monocyte differentiation [GO:0030224]; purine nucleobase metabolic process [GO:0006144]	GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0006144; GO:0030224; GO:0046037; GO:0046038; GO:0046872; GO:1902560	GMP catabolic process [GO:0046038]; GMP metabolic process [GO:0046037]; monocyte differentiation [GO:0030224]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN36821_c0_g1_i1	Q9P2T1	GMPR2_HUMAN	100	145	0	0	437	3	123	267	3.10E-80	298.9	GMPR2_HUMAN	reviewed	GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2)	GMPR2	Homo sapiens (Human)	348	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine-containing compound salvage [GO:0043101]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0005829; GO:0006144; GO:0043101; GO:0046037; GO:0046872; GO:1902560	GMP metabolic process [GO:0046037]; purine-containing compound salvage [GO:0043101]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN24618_c0_g1_i1	Q3THK7	GUAA_MOUSE	98.9	189	2	0	575	9	505	693	5.50E-109	394.8	GUAA_MOUSE	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	Gmps	Mus musculus (Mouse)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]		NA	NA	NA	NA	NA	NA
TRINITY_DN38976_c0_g1_i1	P49915	GUAA_HUMAN	100	157	0	0	3	473	29	185	1.80E-86	319.7	GUAA_HUMAN	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	GMPS	Homo sapiens (Human)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN29937_c0_g1_i1	A2SG95	GUAA_METPP	86.3	51	7	0	228	76	484	534	5.50E-20	97.8	GUAA_METPP	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	guaA Mpe_A1622	Methylibium petroleiphilum (strain ATCC BAA-1232 / LMG 22953 / PM1)	534	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]	GO:0003922; GO:0005524; GO:0006541; GO:0016462	glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN36228_c0_g1_i1	Q3THK7	GUAA_MOUSE	100	108	0	0	3	326	72	179	4.20E-58	224.9	GUAA_MOUSE	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	Gmps	Mus musculus (Mouse)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]		NA	NA	NA	NA	NA	NA
TRINITY_DN29728_c0_g1_i1	Q3THK7	GUAA_MOUSE	100	149	0	0	450	4	421	569	1.30E-84	313.5	GUAA_MOUSE	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	Gmps	Mus musculus (Mouse)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]		NA	NA	NA	NA	NA	NA
TRINITY_DN112_c0_g1_i2	P49915	GUAA_HUMAN	64.9	666	234	0	2080	83	28	693	8.60E-264	911	GUAA_HUMAN	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	GMPS	Homo sapiens (Human)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN112_c0_g1_i5	P49915	GUAA_HUMAN	64.4	615	219	0	1918	74	28	642	1.00E-239	830.9	GUAA_HUMAN	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	GMPS	Homo sapiens (Human)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		blue	blue	NA	NA	NA	NA
TRINITY_DN36072_c0_g1_i1	B9J7L1	GUAA_AGRRK	68.1	69	22	0	1	207	55	123	2.60E-21	102.1	GUAA_AGRRK	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	guaA Arad_0510	Agrobacterium radiobacter (strain K84 / ATCC BAA-868)	520	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]		ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]	GO:0003922; GO:0005524; GO:0006541; GO:0016462	glutamine metabolic process [GO:0006541]		NA	NA	NA	NA	NA	NA
TRINITY_DN35648_c0_g1_i1	P49915	GUAA_HUMAN	100	169	0	0	509	3	231	399	8.00E-88	324.3	GUAA_HUMAN	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	GMPS	Homo sapiens (Human)	693	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cytosol [GO:0005829]	ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462	glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN33624_c0_g1_i1	Q5R9I4	TV23B_PONAB	100	88	0	0	264	1	53	140	2.60E-45	182.2	TV23B_PONAB	reviewed	Golgi apparatus membrane protein TVP23 homolog B	TVP23B FAM18B FAM18B1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	205	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN37666_c0_g1_i1	Q8BS95	GPHR_MOUSE	100	99	0	0	16	312	1	99	1.60E-46	186.4	GPHR_MOUSE	reviewed	Golgi pH regulator (Protein GPR89)	Gpr89 Gphr Gpr89a	Mus musculus (Mouse)	455	Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; voltage-gated anion channel activity [GO:0008308]; intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; skin development [GO:0043588]; T cell differentiation [GO:0030217]	Golgi-associated vesicle membrane [GO:0030660]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	voltage-gated anion channel activity [GO:0008308]	GO:0008308; GO:0015031; GO:0016021; GO:0030217; GO:0030660; GO:0032580; GO:0034765; GO:0043588; GO:0051452	intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; skin development [GO:0043588]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN33270_c0_g1_i1	B5X1G3	GPHR_SALSA	63	451	163	3	1493	141	1	447	2.10E-155	550.4	GPHR_SALSA	reviewed	Golgi pH regulator (Protein gpr89)	gpr89 gphr	Salmo salar (Atlantic salmon)	455	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; voltage-gated ion channel activity [GO:0005244]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	voltage-gated ion channel activity [GO:0005244]	GO:0000139; GO:0005244; GO:0015031; GO:0016021; GO:0034765	protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN27070_c0_g1_i1	B7ZAQ6	GPHRA_HUMAN	98.9	92	1	0	2	277	364	455	6.90E-42	171	GPHRA_HUMAN	reviewed	Golgi pH regulator A (Protein GPR89A) (Putative MAPK-activating protein PM01) (Putative NF-kappa-B-activating protein 90)	GPR89A GPHRA GPR89 SH120 CGI-13 UNQ192/PRO218	Homo sapiens (Human)	455	Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; voltage-gated anion channel activity [GO:0008308]; intracellular pH reduction [GO:0051452]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; T cell differentiation [GO:0030217]	Golgi-associated vesicle membrane [GO:0030660]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	voltage-gated anion channel activity [GO:0008308]	GO:0008308; GO:0015031; GO:0016021; GO:0030217; GO:0030660; GO:0032580; GO:0034765; GO:0043123; GO:0051452	intracellular pH reduction [GO:0051452]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN21165_c0_g1_i1	B7ZAQ6	GPHRA_HUMAN	98.7	75	1	0	227	3	19	93	1.10E-33	143.3	GPHRA_HUMAN	reviewed	Golgi pH regulator A (Protein GPR89A) (Putative MAPK-activating protein PM01) (Putative NF-kappa-B-activating protein 90)	GPR89A GPHRA GPR89 SH120 CGI-13 UNQ192/PRO218	Homo sapiens (Human)	455	Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; voltage-gated anion channel activity [GO:0008308]; intracellular pH reduction [GO:0051452]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; T cell differentiation [GO:0030217]	Golgi-associated vesicle membrane [GO:0030660]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	voltage-gated anion channel activity [GO:0008308]	GO:0008308; GO:0015031; GO:0016021; GO:0030217; GO:0030660; GO:0032580; GO:0034765; GO:0043123; GO:0051452	intracellular pH reduction [GO:0051452]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN9784_c0_g1_i1	Q9H4A6	GOLP3_HUMAN	74.7	154	32	2	513	73	7	160	1.40E-46	187.6	GOLP3_HUMAN	reviewed	Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS)	GOLPH3 GPP34	Homo sapiens (Human)	298	"cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273]; asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0043231; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0072752; GO:0090161; GO:0090164	"asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16041_c0_g1_i1	Q9H4A6	GOLP3_HUMAN	99.6	247	1	0	762	22	52	298	5.20E-139	495	GOLP3_HUMAN	reviewed	Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS)	GOLPH3 GPP34	Homo sapiens (Human)	298	"cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273]; asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0043231; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0072752; GO:0090161; GO:0090164	"asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9784_c0_g1_i2	Q9VQ93	GOLP3_DROME	68.5	302	72	2	952	92	1	294	1.70E-113	410.6	GOLP3_DROME	reviewed	Golgi phosphoprotein 3 homolog sauron (Protein rotini)	sau GOLPH3 l(2)s5379 rti CG7085	Drosophila melanogaster (Fruit fly)	294	"cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]"	cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0017137; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307	"actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8927_c0_g1_i1	Q9H8Y8	GORS2_HUMAN	100	235	0	0	708	4	1	235	3.60E-137	488.8	GORS2_HUMAN	reviewed	Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59)	GORASP2 GOLPH6	Homo sapiens (Human)	452	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]		GO:0000139; GO:0005789; GO:0005794; GO:0006996; GO:0007030; GO:0007283; GO:0016020; GO:0030154; GO:0034976; GO:0061951; GO:0070925	cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6884_c0_g5_i1	Q99JX3	GORS2_MOUSE	60.4	280	91	3	97	885	1	277	4.50E-92	339.3	GORS2_MOUSE	reviewed	Golgi reassembly-stacking protein 2 (GRS2) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55)	Gorasp2	Mus musculus (Mouse)	451	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005789; GO:0005794; GO:0005797; GO:0006996; GO:0007030; GO:0007283; GO:0030154; GO:0034976; GO:0061951; GO:0070925	cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8927_c0_g2_i1	Q99JX3	GORS2_MOUSE	100	227	0	0	684	4	1	227	2.60E-132	472.6	GORS2_MOUSE	reviewed	Golgi reassembly-stacking protein 2 (GRS2) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55)	Gorasp2	Mus musculus (Mouse)	451	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005789; GO:0005794; GO:0005797; GO:0006996; GO:0007030; GO:0007283; GO:0030154; GO:0034976; GO:0061951; GO:0070925	cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8124_c0_g1_i1	Q8BMP6	GCP60_MOUSE	42.7	117	67	0	430	80	69	185	6.10E-23	109	GCP60_MOUSE	reviewed	Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7)	Acbd3 Gcp60 Pap7	Mus musculus (Mouse)	525	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0034237	steroid biosynthetic process [GO:0006694]		blue	blue	NA	NA	NA	NA
TRINITY_DN5077_c0_g1_i1	Q9H3P7	GCP60_HUMAN	56.9	204	73	4	710	99	340	528	9.00E-53	208.4	GCP60_HUMAN	reviewed	"Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed]"	ACBD3 GCP60 GOCAP1 GOLPH1	Homo sapiens (Human)	528	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694]; viral process [GO:0016032]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0016020; GO:0016032; GO:0034237	steroid biosynthetic process [GO:0006694]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN11998_c2_g1_i1	Q5RBL6	GOSR1_PONAB	49	239	107	5	773	102	9	247	3.40E-51	203.4	GOSR1_PONAB	reviewed	Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28)	GOSR1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	248	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	SNAP receptor activity [GO:0005484]	GO:0000139; GO:0005484; GO:0005801; GO:0005829; GO:0006888; GO:0015031; GO:0016021; GO:0042147	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"		pink	pink	NA	NA	NA	NA
TRINITY_DN29017_c0_g1_i1	O08522	GOSR1_CRIGR	100	96	0	0	290	3	62	157	6.00E-48	191	GOSR1_CRIGR	reviewed	Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28)	GOSR1 GS28	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	250	cis-Golgi network [GO:0005801]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]	cis-Golgi network [GO:0005801]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]	SNAP receptor activity [GO:0005484]	GO:0000138; GO:0000139; GO:0005484; GO:0005801; GO:0006888; GO:0006891; GO:0015031; GO:0016021	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5696_c0_g1_i1	O14653	GOSR2_HUMAN	49.2	65	33	0	7	201	147	211	3.10E-11	68.9	GOSR2_HUMAN	reviewed	Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin)	GOSR2 GS27	Homo sapiens (Human)	212	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]"	cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0012507; GO:0016020; GO:0016021; GO:0031201; GO:0031902; GO:0033116; GO:0036498; GO:0042147; GO:0048208; GO:0048280	"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5696_c0_g1_i2	O14653	GOSR2_HUMAN	49.2	65	33	0	7	201	147	211	4.00E-11	68.6	GOSR2_HUMAN	reviewed	Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin)	GOSR2 GS27	Homo sapiens (Human)	212	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]"	cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0012507; GO:0016020; GO:0016021; GO:0031201; GO:0031902; GO:0033116; GO:0036498; GO:0042147; GO:0048208; GO:0048280	"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]"		blue	blue	NA	NA	NA	NA
TRINITY_DN147_c2_g1_i1	O35166	GOSR2_MOUSE	44.4	214	116	3	90	731	1	211	8.50E-43	175.6	GOSR2_MOUSE	reviewed	Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin)	Gosr2 Gs27	Mus musculus (Mouse)	212	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0012507; GO:0016021; GO:0016192; GO:0031201; GO:0031902; GO:0042147; GO:0048280	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]"		blue	blue	NA	NA	NA	NA
TRINITY_DN23291_c0_g1_i1	Q9D1H7	GET4_MOUSE	100	167	0	0	2	502	106	272	1.30E-95	350.1	GET4_MOUSE	reviewed	Golgi to ER traffic protein 4 homolog	Get4	Mus musculus (Mouse)	327	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]	GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0045048; GO:0051087; GO:0051220; GO:0071816; GO:0071818; GO:1904378	cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		NA	NA	NA	NA	NA	NA
TRINITY_DN8634_c0_g1_i1	A1Z3X3	GET4_ORYLA	59.5	289	114	2	984	118	17	302	1.60E-98	360.9	GET4_ORYLA	reviewed	Golgi to ER traffic protein 4 homolog (Conserved edge expressed protein)	get4 cee	Oryzias latipes (Japanese rice fish) (Japanese killifish)	323	BAT3 complex [GO:0071818]; cytosol [GO:0005829]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	BAT3 complex [GO:0071818]; cytosol [GO:0005829]		GO:0005829; GO:0045048; GO:0071816; GO:0071818	protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		blue	blue	NA	NA	NA	NA
TRINITY_DN12044_c0_g1_i1	Q7L5D6	GET4_HUMAN	100	191	0	0	576	4	109	299	7.60E-111	401	GET4_HUMAN	reviewed	Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35)	GET4 C7orf20 CEE TRC35 CGI-20	Homo sapiens (Human)	327	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chaperone binding [GO:0051087]	GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0045048; GO:0051087; GO:0051220; GO:0071816; GO:0071818; GO:1904378	cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		NA	NA	NA	NA	NA	NA
TRINITY_DN397_c0_g1_i1	Q9H4G4	GAPR1_HUMAN	40.9	137	73	2	518	117	9	140	6.10E-23	109.8	GAPR1_HUMAN	reviewed	Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)	GLIPR2 C9orf19 GAPR1	Homo sapiens (Human)	154	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]	protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374	positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]		blue	blue	NA	NA	NA	NA
TRINITY_DN34223_c0_g1_i1	Q9CW79	GOGA1_MOUSE	56.3	71	29	2	90	299	684	753	8.70E-14	77.8	GOGA1_MOUSE	reviewed	Golgin subfamily A member 1 (Golgin-97)	Golga1	Mus musculus (Mouse)	758	acrosomal vesicle [GO:0001669]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]	acrosomal vesicle [GO:0001669]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]		GO:0001669; GO:0005794; GO:0005802; GO:0016020; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN3163_c0_g1_i1	Q62839	GOGA2_RAT	36.9	160	100	1	496	20	212	371	6.40E-13	75.9	GOGA2_RAT	reviewed	Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130)	Golga2	Rattus norvegicus (Rat)	998	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]	GO:0000137; GO:0000139; GO:0000922; GO:0005737; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0032991; GO:0033116; GO:0042802; GO:0043025; GO:0044877; GO:0048471; GO:0050772; GO:0051225; GO:0051289; GO:0051645; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307	asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN814_c0_g1_i3	Q5U4E6	GOGA4_RAT	48.6	70	32	2	274	68	2188	2254	1.10E-08	62	GOGA4_RAT	reviewed	Golgin subfamily A member 4	Golga4	Rattus norvegicus (Rat)	2259	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	GTPase binding [GO:0051020]	GO:0000139; GO:0005737; GO:0005794; GO:0043001; GO:0045773; GO:0051020	Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]		NA	NA	NA	NA	NA	NA
TRINITY_DN814_c0_g1_i5	Q5U4E6	GOGA4_RAT	48.6	70	32	2	274	68	2188	2254	1.30E-08	62	GOGA4_RAT	reviewed	Golgin subfamily A member 4	Golga4	Rattus norvegicus (Rat)	2259	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	GTPase binding [GO:0051020]	GO:0000139; GO:0005737; GO:0005794; GO:0043001; GO:0045773; GO:0051020	Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i10	Q8TBA6	GOGA5_HUMAN	46.7	210	104	3	750	142	516	724	4.50E-39	163.3	GOGA5_HUMAN	reviewed	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	GOLGA5 RETII RFG5 PIG31	Homo sapiens (Human)	731	"cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0017137; GO:0030133; GO:0031985; GO:0042803; GO:0048193	"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i5	Q8TBA6	GOGA5_HUMAN	62.7	51	19	0	231	79	573	623	1.80E-08	60.8	GOGA5_HUMAN	reviewed	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	GOLGA5 RETII RFG5 PIG31	Homo sapiens (Human)	731	"cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0017137; GO:0030133; GO:0031985; GO:0042803; GO:0048193	"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i6	Q8TBA6	GOGA5_HUMAN	52.9	153	64	3	579	142	573	724	5.40E-31	136.3	GOGA5_HUMAN	reviewed	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	GOLGA5 RETII RFG5 PIG31	Homo sapiens (Human)	731	"cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0017137; GO:0030133; GO:0031985; GO:0042803; GO:0048193	"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i8	Q8TBA6	GOGA5_HUMAN	50.7	152	67	2	573	142	573	724	3.90E-30	132.9	GOGA5_HUMAN	reviewed	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	GOLGA5 RETII RFG5 PIG31	Homo sapiens (Human)	731	"cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0017137; GO:0030133; GO:0031985; GO:0042803; GO:0048193	"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i2	Q6GNT7	GOGA5_XENLA	31.8	745	445	10	2277	142	1	715	4.70E-69	264.2	GOGA5_XENLA	reviewed	Golgin subfamily A member 5 (Golgin-84)	golga5	Xenopus laevis (African clawed frog)	722	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005794; GO:0007030; GO:0016021; GO:0042803; GO:0048193	Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i4	Q6GNT7	GOGA5_XENLA	31.8	745	445	10	2277	142	1	715	6.00E-69	263.8	GOGA5_XENLA	reviewed	Golgin subfamily A member 5 (Golgin-84)	golga5	Xenopus laevis (African clawed frog)	722	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005794; GO:0007030; GO:0016021; GO:0042803; GO:0048193	Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]		NA	NA	NA	NA	NA	NA
TRINITY_DN2178_c0_g1_i7	Q6GNT7	GOGA5_XENLA	31.8	745	445	10	2277	142	1	715	7.60E-69	263.5	GOGA5_XENLA	reviewed	Golgin subfamily A member 5 (Golgin-84)	golga5	Xenopus laevis (African clawed frog)	722	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005794; GO:0007030; GO:0016021; GO:0042803; GO:0048193	Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]		NA	NA	NA	NA	NA	NA
TRINITY_DN38063_c0_g1_i1	Q5EA55	GOGA7_BOVIN	100	77	0	0	231	1	1	77	1.20E-38	159.8	GOGA7_BOVIN	reviewed	Golgin subfamily A member 7	GOLGA7	Bos taurus (Bovine)	137	Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; Golgi to plasma membrane protein transport [GO:0043001]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612]	Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]		GO:0002178; GO:0005795; GO:0006612; GO:0018230; GO:0031228; GO:0043001; GO:0050821	Golgi to plasma membrane protein transport [GO:0043001]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN36286_c0_g1_i1	Q2TAP0	GOG7B_HUMAN	56.6	106	46	0	321	4	20	125	1.10E-34	147.5	GOG7B_HUMAN	reviewed	Golgin subfamily A member 7B	GOLGA7B C10orf132 C10orf133	Homo sapiens (Human)	167	Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]; enzyme binding [GO:0019899]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]	Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]	enzyme binding [GO:0019899]	GO:0000139; GO:0002178; GO:0006612; GO:0018230; GO:0019899	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN11_c1_g1_i1	Q6AYB8	GO45_RAT	35.9	217	131	3	715	80	130	343	3.70E-22	106.7	GO45_RAT	reviewed	Golgin-45 (Basic leucine zipper nuclear factor 1)	Blzf1	Rattus norvegicus (Rat)	400	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001	Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN11_c1_g1_i3	Q6AYB8	GO45_RAT	35.1	279	165	5	1019	198	130	397	2.40E-30	134.4	GO45_RAT	reviewed	Golgin-45 (Basic leucine zipper nuclear factor 1)	Blzf1	Rattus norvegicus (Rat)	400	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001	Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN11_c1_g1_i4	Q8R2X8	GO45_MOUSE	41.4	133	75	1	485	96	130	262	8.30E-18	91.7	GO45_MOUSE	reviewed	Golgin-45 (Basic leucine zipper nuclear factor 1)	Blzf1	Mus musculus (Mouse)	403	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005634; GO:0005654; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001	Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN11_c1_g1_i5	Q6AYB8	GO45_RAT	35.9	217	131	3	1036	401	130	343	5.40E-22	106.7	GO45_RAT	reviewed	Golgin-45 (Basic leucine zipper nuclear factor 1)	Blzf1	Rattus norvegicus (Rat)	400	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001	Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN11_c1_g1_i5	Q6AYB8	GO45_RAT	69.6	23	7	0	266	198	375	397	5.00E-04	47	GO45_RAT	reviewed	Golgin-45 (Basic leucine zipper nuclear factor 1)	Blzf1	Rattus norvegicus (Rat)	400	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001	Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN36439_c0_g1_i1	Q535K8	GON4L_RAT	30.8	107	66	3	122	439	237	336	6.60E-05	49.3	GON4L_RAT	reviewed	GON-4-like protein (GON-4 homolog) (Protein GON4)	Gon4l Gon4	Rattus norvegicus (Rat)	2256	"nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892	"B cell differentiation [GO:0030183]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30020_c0_g1_i1	P22468	GDL_DROME	34.3	178	100	2	577	44	30	190	1.80E-21	104.4	GDL_DROME	reviewed	Gonadal protein gdl	gdl CG7268	Drosophila melanogaster (Fruit fly)	194							blue	blue	NA	NA	NA	NA
TRINITY_DN15731_c0_g1_i1	P55320	GIH_HOMAM	29.7	64	44	1	283	95	36	99	4.20E-05	49.3	GIH_HOMAM	reviewed	Gonad-inhibiting hormone (GIH) (Vitellogenesis-inhibiting hormone) (VIH)		Homarus americanus (American lobster)	112	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN12043_c0_g1_i2	Q90X38	GPKOW_DANRE	42.6	115	66	0	438	94	387	501	4.50E-21	102.8	GPKOW_DANRE	reviewed	G-patch domain and KOW motifs-containing protein (Protein T54-like)	gpkow t54l si:dz150f13.5 zgc:152714	Danio rerio (Zebrafish) (Brachydanio rerio)	506	"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005681	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4209_c0_g1_i1	Q5H8A4	PIGG_HUMAN	33	524	318	10	133	1620	47	565	5.20E-72	273.5	PIGG_HUMAN	reviewed	GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G)	PIGG GPI7 UNQ1930/PRO4405	Homo sapiens (Human)	983	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	"CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267	GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN28425_c0_g1_i1	Q5H8A4	PIGG_HUMAN	34.2	187	112	5	653	105	798	977	7.10E-18	92.4	PIGG_HUMAN	reviewed	GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G)	PIGG GPI7 UNQ1930/PRO4405	Homo sapiens (Human)	983	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	"CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267	GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN8358_c0_g1_i1	Q8TEQ8	PIGO_HUMAN	55.2	250	110	1	22	765	98	347	3.70E-76	286.2	PIGO_HUMAN	reviewed	GPI ethanolamine phosphate transferase 3 (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class O protein) (PIG-O)	PIGO UNQ632/PRO1249	Homo sapiens (Human)	1089	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	mannose-ethanolamine phosphotransferase activity [GO:0051377]	GO:0005789; GO:0006506; GO:0016020; GO:0016021; GO:0051377	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN3719_c0_g1_i1	Q75T13	PGAP1_HUMAN	47.8	157	78	2	20	478	49	205	1.80E-32	140.6	PGAP1_HUMAN	reviewed	GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1)	PGAP1 UNQ3024/PRO9822	Homo sapiens (Human)	922	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; nuclease activity [GO:0004518]; phosphatidylinositol deacylase activity [GO:0050185]; phosphoric ester hydrolase activity [GO:0042578]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"hydrolase activity, acting on ester bonds [GO:0016788]; nuclease activity [GO:0004518]; phosphatidylinositol deacylase activity [GO:0050185]; phosphoric ester hydrolase activity [GO:0042578]"	GO:0004518; GO:0005783; GO:0005789; GO:0006505; GO:0006888; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0015798; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0042578; GO:0050185	anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN3719_c0_g1_i2	Q75T13	PGAP1_HUMAN	31	746	458	21	20	2182	49	762	2.50E-85	318.2	PGAP1_HUMAN	reviewed	GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1)	PGAP1 UNQ3024/PRO9822	Homo sapiens (Human)	922	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; nuclease activity [GO:0004518]; phosphatidylinositol deacylase activity [GO:0050185]; phosphoric ester hydrolase activity [GO:0042578]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"hydrolase activity, acting on ester bonds [GO:0016788]; nuclease activity [GO:0004518]; phosphatidylinositol deacylase activity [GO:0050185]; phosphoric ester hydrolase activity [GO:0042578]"	GO:0004518; GO:0005783; GO:0005789; GO:0006505; GO:0006888; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0015798; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0042578; GO:0050185	anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN6728_c0_g1_i1	Q5EA10	PIGM_BOVIN	43.7	394	205	6	1238	102	24	415	2.30E-81	304.3	PIGM_BOVIN	reviewed	GPI mannosyltransferase 1 (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M)	PIGM	Bos taurus (Bovine)	423	"endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-mannosyltransferase I complex [GO:1990529]; integral component of membrane [GO:0016021]; alpha-1,4-mannosyltransferase activity [GO:0051751]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-mannosyltransferase I complex [GO:1990529]; integral component of membrane [GO:0016021]	"alpha-1,4-mannosyltransferase activity [GO:0051751]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0051751; GO:1990529	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1331_c0_g1_i1	Q7TPN3	PIGV_MOUSE	38.3	475	246	12	755	2137	52	493	4.80E-68	260.8	PIGV_MOUSE	reviewed	GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V)	Pigv	Mus musculus (Mouse)	493	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0031501	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1331_c0_g1_i10	Q7TPN3	PIGV_MOUSE	38.3	475	246	12	126	1508	52	493	3.40E-68	260.8	PIGV_MOUSE	reviewed	GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V)	Pigv	Mus musculus (Mouse)	493	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0031501	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1331_c0_g1_i2	Q7TPN3	PIGV_MOUSE	38.3	475	246	12	755	2137	52	493	4.80E-68	260.8	PIGV_MOUSE	reviewed	GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V)	Pigv	Mus musculus (Mouse)	493	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0031501	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1331_c0_g1_i6	Q7TPN3	PIGV_MOUSE	36.2	276	143	9	295	1071	234	493	1.10E-36	155.6	PIGV_MOUSE	reviewed	GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V)	Pigv	Mus musculus (Mouse)	493	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0031501	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1331_c0_g1_i7	Q7TPN3	PIGV_MOUSE	36.2	276	143	9	295	1071	234	493	1.10E-36	155.6	PIGV_MOUSE	reviewed	GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V)	Pigv	Mus musculus (Mouse)	493	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0031501	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i10	Q9VZM5	PIGB_DROME	52.5	101	43	1	476	189	335	435	2.10E-23	110.5	PIGB_DROME	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein)	PIG-B CG12006	Drosophila melanogaster (Fruit fly)	561	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006506; GO:0016021	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i11	Q9VZM5	PIGB_DROME	58.1	43	18	0	317	189	393	435	3.20E-08	59.7	PIGB_DROME	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein)	PIG-B CG12006	Drosophila melanogaster (Fruit fly)	561	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006506; GO:0016021	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i3	Q9VZM5	PIGB_DROME	64.9	37	13	0	193	83	8	44	2.00E-06	53.1	PIGB_DROME	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein)	PIG-B CG12006	Drosophila melanogaster (Fruit fly)	561	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006506; GO:0016021	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i2	Q9JJQ0	PIGB_MOUSE	35.8	352	173	4	1082	183	129	479	8.00E-53	209.1	PIGB_MOUSE	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B)	Pigb	Mus musculus (Mouse)	542	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006505; GO:0006506; GO:0016021; GO:0097502	GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i5	Q9JJQ0	PIGB_MOUSE	43.3	439	233	4	1487	183	53	479	7.70E-97	355.9	PIGB_MOUSE	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B)	Pigb	Mus musculus (Mouse)	542	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006505; GO:0006506; GO:0016021; GO:0097502	GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i8	Q9JJQ0	PIGB_MOUSE	41.1	365	199	4	1265	183	127	479	2.30E-72	274.6	PIGB_MOUSE	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B)	Pigb	Mus musculus (Mouse)	542	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006505; GO:0006506; GO:0016021; GO:0097502	GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]		NA	NA	NA	NA	NA	NA
TRINITY_DN6070_c0_g1_i8	Q9JJQ0	PIGB_MOUSE	52.6	78	37	0	1503	1270	53	130	8.00E-17	90.1	PIGB_MOUSE	reviewed	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B)	Pigb	Mus musculus (Mouse)	542	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0004376; GO:0005783; GO:0005789; GO:0006505; GO:0006506; GO:0016021; GO:0097502	GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; mannosylation [GO:0097502]		NA	NA	NA	NA	NA	NA
TRINITY_DN6174_c0_g1_i1	Q8MT80	PIGZ_DROME	33.1	602	364	9	2039	339	24	621	3.50E-79	297.7	PIGZ_DROME	reviewed	GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol glycan anchor biosynthesis protein class Z)	PIG-Z CG45068	Drosophila melanogaster (Fruit fly)	696	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN13590_c0_g1_i1	Q6PD26	PIGS_MOUSE	45.3	95	52	0	319	35	459	553	9.70E-15	80.9	PIGS_MOUSE	reviewed	GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein)	Pigs	Mus musculus (Mouse)	555	GPI-anchor transamidase complex [GO:0042765]; attachment of GPI anchor to protein [GO:0016255]	GPI-anchor transamidase complex [GO:0042765]		GO:0016255; GO:0042765	attachment of GPI anchor to protein [GO:0016255]		NA	NA	NA	NA	NA	NA
TRINITY_DN1809_c0_g1_i1	Q6PD26	PIGS_MOUSE	30.7	460	286	9	1304	9	7	461	1.60E-45	185.3	PIGS_MOUSE	reviewed	GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein)	Pigs	Mus musculus (Mouse)	555	GPI-anchor transamidase complex [GO:0042765]; attachment of GPI anchor to protein [GO:0016255]	GPI-anchor transamidase complex [GO:0042765]		GO:0016255; GO:0042765	attachment of GPI anchor to protein [GO:0016255]		NA	NA	NA	NA	NA	NA
TRINITY_DN28602_c0_g1_i1	Q8BXQ2	PIGT_MOUSE	100	146	0	0	2	439	83	228	2.70E-84	312.4	PIGT_MOUSE	reviewed	GPI transamidase component PIG-T (Neuronal development-associated protein 7) (Phosphatidylinositol-glycan biosynthesis class T protein)	Pigt Ndap7	Mus musculus (Mouse)	582	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GPI-anchor transamidase complex [GO:0042765]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; GPI-anchor transamidase complex [GO:0042765]		GO:0005737; GO:0016255; GO:0030182; GO:0031410; GO:0042765; GO:0051402	attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]		NA	NA	NA	NA	NA	NA
TRINITY_DN2972_c0_g1_i1	Q969N2	PIGT_HUMAN	48.6	276	127	3	169	984	28	292	2.70E-74	280.4	PIGT_HUMAN	reviewed	GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)	PIGT CGI-06 PSEC0163 UNQ716/PRO1379	Homo sapiens (Human)	578	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]		GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402	attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]		NA	NA	NA	NA	NA	NA
TRINITY_DN2972_c0_g1_i2	Q969N2	PIGT_HUMAN	45.5	303	153	3	169	1074	28	319	5.10E-76	286.2	PIGT_HUMAN	reviewed	GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)	PIGT CGI-06 PSEC0163 UNQ716/PRO1379	Homo sapiens (Human)	578	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]		GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402	attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]		blue	blue	NA	NA	NA	NA
TRINITY_DN35581_c0_g1_i1	Q969N2	PIGT_HUMAN	100	162	0	0	487	2	42	203	4.20E-94	345.1	PIGT_HUMAN	reviewed	GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)	PIGT CGI-06 PSEC0163 UNQ716/PRO1379	Homo sapiens (Human)	578	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]		GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402	attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]		NA	NA	NA	NA	NA	NA
TRINITY_DN4769_c0_g2_i1	P49018	GPI8_YEAST	52.9	170	77	1	2	502	94	263	7.20E-49	194.9	GPI8_YEAST	reviewed	GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-)	GPI8 YDR331W D9798.2	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	411	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]	GPI-anchor transamidase activity [GO:0003923]	GO:0003923; GO:0005783; GO:0005789; GO:0016255; GO:0030176; GO:0034394; GO:0042765	attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]		NA	NA	NA	NA	NA	NA
TRINITY_DN36378_c0_g1_i1	P49018	GPI8_YEAST	78.2	78	17	0	2	235	60	137	5.40E-31	134.4	GPI8_YEAST	reviewed	GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-)	GPI8 YDR331W D9798.2	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	411	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]	GPI-anchor transamidase activity [GO:0003923]	GO:0003923; GO:0005783; GO:0005789; GO:0016255; GO:0030176; GO:0034394; GO:0042765	attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]		NA	NA	NA	NA	NA	NA
TRINITY_DN35517_c0_g1_i1	Q92643	GPI8_HUMAN	98.1	159	3	0	487	11	35	193	2.00E-88	326.2	GPI8_HUMAN	reviewed	GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (GPI8 homolog) (hGPI8) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K)	PIGK GPI8	Homo sapiens (Human)	395	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; GPI-anchor transamidase activity [GO:0003923]; protein disulfide isomerase activity [GO:0003756]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]	GPI-anchor transamidase activity [GO:0003923]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0003923; GO:0005789; GO:0016020; GO:0016255; GO:0034394; GO:0042765	attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]		NA	NA	NA	NA	NA	NA
TRINITY_DN4769_c0_g1_i1	Q3MHZ7	GPI8_BOVIN	50	82	33	1	227	6	22	103	3.40E-18	92	GPI8_BOVIN	reviewed	GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K)	PIGK	Bos taurus (Bovine)	395	GPI-anchor transamidase complex [GO:0042765]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]	GPI-anchor transamidase complex [GO:0042765]	GPI-anchor transamidase activity [GO:0003923]	GO:0003923; GO:0016255; GO:0034394; GO:0042765	attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]		NA	NA	NA	NA	NA	NA
TRINITY_DN26629_c0_g1_i1	Q9CXY9	GPI8_MOUSE	100	171	0	0	516	4	103	273	1.60E-96	353.2	GPI8_MOUSE	reviewed	GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K)	Pigk	Mus musculus (Mouse)	395	GPI-anchor transamidase complex [GO:0042765]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]	GPI-anchor transamidase complex [GO:0042765]	GPI-anchor transamidase activity [GO:0003923]	GO:0003923; GO:0016255; GO:0034394; GO:0042765	attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]		NA	NA	NA	NA	NA	NA
TRINITY_DN8536_c0_g1_i1	Q6CK18	GWT1_KLULA	32	169	108	3	591	91	15	178	4.60E-11	69.7	GWT1_KLULA	reviewed	GPI-anchored wall transfer protein 1 (EC 2.3.-.-)	GWT1 KLLA0F14278g	Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica)	446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]	GO:0005789; GO:0006506; GO:0016021; GO:0032216	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN8536_c0_g1_i4	Q6CK18	GWT1_KLULA	32.2	202	121	4	573	1	15	211	1.10E-12	75.1	GWT1_KLULA	reviewed	GPI-anchored wall transfer protein 1 (EC 2.3.-.-)	GWT1 KLLA0F14278g	Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica)	446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]	GO:0005789; GO:0006506; GO:0016021; GO:0032216	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN9647_c0_g1_i4	Q9UTL4	GWT1_SCHPO	33.5	245	136	6	104	787	191	425	3.60E-22	107.5	GWT1_SCHPO	reviewed	GPI-anchored wall transfer protein 1 (EC 2.3.-.-) (Meiotically up-regulated gene 59 protein)	gwt1 mug59 SPAC144.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	459	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]; GPI anchor biosynthetic process [GO:0006506]; meiotic cell cycle [GO:0051321]; protein localization to plasma membrane [GO:0072659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]	GO:0005789; GO:0006506; GO:0016021; GO:0032216; GO:0051321; GO:0072659	GPI anchor biosynthetic process [GO:0006506]; meiotic cell cycle [GO:0051321]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN11742_c0_g1_i1	Q9HCN4	GPN1_HUMAN	97.3	222	6	0	667	2	1	222	6.20E-120	431.4	GPN1_HUMAN	reviewed	GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1)	GPN1 MBDIN RPAP4 XAB1 HUSSY-23	Homo sapiens (Human)	374	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN11742_c0_g1_i3	Q9HCN4	GPN1_HUMAN	100	86	0	0	259	2	1	86	1.40E-43	176.4	GPN1_HUMAN	reviewed	GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1)	GPN1 MBDIN RPAP4 XAB1 HUSSY-23	Homo sapiens (Human)	374	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN3287_c0_g1_i1	Q8VCE2	GPN1_MOUSE	61.6	255	86	2	762	1	2	245	2.20E-84	313.9	GPN1_MOUSE	reviewed	GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (XPA-binding protein 1)	Gpn1 Mbdin Xab1	Mus musculus (Mouse)	372	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN11742_c0_g1_i2	Q8VCE2	GPN1_MOUSE	100	141	0	0	424	2	82	222	3.80E-75	282	GPN1_MOUSE	reviewed	GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (XPA-binding protein 1)	Gpn1 Mbdin Xab1	Mus musculus (Mouse)	372	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN29886_c0_g1_i1	Q9H9Y4	GPN2_HUMAN	100	118	0	0	355	2	1	118	2.30E-66	252.7	GPN2_HUMAN	reviewed	GPN-loop GTPase 2 (ATP-binding domain 1 family member B)	GPN2 ATPBD1B UNQ5828/PRO19647	Homo sapiens (Human)	310	GTP binding [GO:0005525]; GTPase activity [GO:0003924]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN40198_c0_g1_i1	Q58DD9	GPN2_PIG	61.2	67	26	0	203	3	22	88	7.10E-19	94	GPN2_PIG	reviewed	GPN-loop GTPase 2 (ATP-binding domain 1 family member B)	GPN2 ATPBD1B	Sus scrofa (Pig)	310	GTP binding [GO:0005525]; GTPase activity [GO:0003924]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN17555_c1_g1_i1	Q6PUR6	GPN2_DANRE	49.5	305	147	2	517	1428	10	308	1.40E-82	308.5	GPN2_DANRE	reviewed	GPN-loop GTPase 2 (ATP-binding domain 1 family member B)	gpn2 atpbd1b zgc:92877	Danio rerio (Zebrafish) (Brachydanio rerio)	311	GTP binding [GO:0005525]; GTPase activity [GO:0003924]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525			blue	blue	NA	NA	NA	NA
TRINITY_DN31356_c0_g1_i1	Q9H9Y4	GPN2_HUMAN	99.2	130	1	0	1	390	102	231	1.40E-71	270	GPN2_HUMAN	reviewed	GPN-loop GTPase 2 (ATP-binding domain 1 family member B)	GPN2 ATPBD1B UNQ5828/PRO19647	Homo sapiens (Human)	310	GTP binding [GO:0005525]; GTPase activity [GO:0003924]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN27453_c0_g1_i1	Q54NK8	GPN3_DICDI	54.2	192	84	2	567	1	1	191	2.70E-56	219.9	GPN3_DICDI	reviewed	GPN-loop GTPase 3 (ATP-binding domain 1 family member C homolog)	gpn3 atpbd1c DDB_G0285197	Dictyostelium discoideum (Slime mold)	285	GTP binding [GO:0005525]; GTPase activity [GO:0003924]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN40062_c0_g1_i1	Q9UHW5	GPN3_HUMAN	100	134	0	0	402	1	1	134	3.50E-76	285.4	GPN3_HUMAN	reviewed	GPN-loop GTPase 3 (ATP-binding domain 1 family member C)	GPN3 ATPBD1C AD-009 UNQ1876/PRO4319	Homo sapiens (Human)	284	protein-containing complex [GO:0032991]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	protein-containing complex [GO:0032991]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN6605_c0_g1_i1	Q9UHW5	GPN3_HUMAN	53.5	275	118	3	906	82	3	267	1.10E-83	311.6	GPN3_HUMAN	reviewed	GPN-loop GTPase 3 (ATP-binding domain 1 family member C)	GPN3 ATPBD1C AD-009 UNQ1876/PRO4319	Homo sapiens (Human)	284	protein-containing complex [GO:0032991]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	protein-containing complex [GO:0032991]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN6605_c0_g1_i2	Q9UHW5	GPN3_HUMAN	53.5	275	118	3	906	82	3	267	1.20E-83	311.6	GPN3_HUMAN	reviewed	GPN-loop GTPase 3 (ATP-binding domain 1 family member C)	GPN3 ATPBD1C AD-009 UNQ1876/PRO4319	Homo sapiens (Human)	284	protein-containing complex [GO:0032991]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	protein-containing complex [GO:0032991]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN6605_c0_g1_i4	Q9UHW5	GPN3_HUMAN	53.5	275	118	3	906	82	3	267	1.20E-83	311.6	GPN3_HUMAN	reviewed	GPN-loop GTPase 3 (ATP-binding domain 1 family member C)	GPN3 ATPBD1C AD-009 UNQ1876/PRO4319	Homo sapiens (Human)	284	protein-containing complex [GO:0032991]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	protein-containing complex [GO:0032991]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN28971_c0_g1_i1	Q9D3W4	GPN3_MOUSE	100	68	0	0	204	1	39	106	3.70E-36	151.4	GPN3_MOUSE	reviewed	GPN-loop GTPase 3 (ATP-binding domain 1 family member C)	Gpn3 Atpbd1c D5Ertd708e	Mus musculus (Mouse)	284	protein-containing complex [GO:0032991]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	protein-containing complex [GO:0032991]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN25921_c0_g1_i1	Q8W586	QQT2_ARATH	62.3	159	60	0	478	2	80	238	1.10E-54	214.2	QQT2_ARATH	reviewed	GPN-loop GTPase QQT2 (EC 3.6.5.-) (Protein QUATRE QUART 2)	QQT2 quatre-quart2 At4g21800 F17L22.260 T8O5.10	Arabidopsis thaliana (Mouse-ear cress)	379	microtubule [GO:0005874]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell division [GO:0051301]; embryo development ending in seed dormancy [GO:0009793]	microtubule [GO:0005874]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005874; GO:0009524; GO:0009793; GO:0051301	cell division [GO:0051301]; embryo development ending in seed dormancy [GO:0009793]		NA	NA	NA	NA	NA	NA
TRINITY_DN6059_c0_g1_i1	P51810	GP143_HUMAN	29	124	79	2	415	71	192	315	2.00E-11	70.5	GP143_HUMAN	reviewed	G-protein coupled receptor 143 (Ocular albinism type 1 protein)	GPR143 OA1	Homo sapiens (Human)	404	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]	dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]	GO:0004930; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006726; GO:0007165; GO:0007186; GO:0007601; GO:0016020; GO:0016021; GO:0016324; GO:0032400; GO:0032402; GO:0032438; GO:0033162; GO:0035240; GO:0035584; GO:0035643; GO:0042470; GO:0048015; GO:0050848; GO:0072544; GO:0072545; GO:1902908; GO:1903056	calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN6059_c0_g1_i2	P51810	GP143_HUMAN	29.2	329	201	9	1003	71	1	315	5.40E-30	133.3	GP143_HUMAN	reviewed	G-protein coupled receptor 143 (Ocular albinism type 1 protein)	GPR143 OA1	Homo sapiens (Human)	404	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]	dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]	GO:0004930; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006726; GO:0007165; GO:0007186; GO:0007601; GO:0016020; GO:0016021; GO:0016324; GO:0032400; GO:0032402; GO:0032438; GO:0033162; GO:0035240; GO:0035584; GO:0035643; GO:0042470; GO:0048015; GO:0050848; GO:0072544; GO:0072545; GO:1902908; GO:1903056	calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN31818_c0_g1_i1	P46023	GR101_LYMST	64.6	65	23	0	39	233	800	864	8.10E-17	87.4	GR101_LYMST	reviewed	G-protein coupled receptor GRL101		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	1115	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN31818_c0_g2_i1	P46023	GR101_LYMST	53.3	135	54	3	6	404	835	962	4.60E-30	132.1	GR101_LYMST	reviewed	G-protein coupled receptor GRL101		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	1115	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35647_c0_g1_i1	P46023	GR101_LYMST	61.1	54	21	0	168	7	734	787	1.50E-11	69.7	GR101_LYMST	reviewed	G-protein coupled receptor GRL101		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	1115	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN22191_c0_g1_i3	Q9W534	MOODY_DROME	49.1	348	137	4	927	1	32	378	2.20E-89	330.5	MOODY_DROME	reviewed	G-protein coupled receptor moody	moody CG4322	Drosophila melanogaster (Fruit fly)	670	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857	axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]		brown	brown	1	NA	NA	NA
TRINITY_DN22191_c0_g1_i1	Q9W534	MOODY_DROME	49.1	348	137	4	927	1	32	378	2.40E-89	330.5	MOODY_DROME	reviewed	G-protein coupled receptor moody	moody CG4322	Drosophila melanogaster (Fruit fly)	670	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857	axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN22191_c0_g1_i2	Q9W534	MOODY_DROME	49.3	347	136	4	927	4	32	377	3.30E-89	330.1	MOODY_DROME	reviewed	G-protein coupled receptor moody	moody CG4322	Drosophila melanogaster (Fruit fly)	670	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857	axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN3706_c0_g1_i1	Q9W534	MOODY_DROME	36.2	69	44	0	562	356	306	374	1.40E-06	55.1	MOODY_DROME	reviewed	G-protein coupled receptor moody	moody CG4322	Drosophila melanogaster (Fruit fly)	670	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857	axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]		blue	blue	NA	NA	NA	NA
TRINITY_DN33825_c0_g1_i1	Q95NT6	MTH2_DROYA	29	107	65	2	7	294	367	473	4.10E-07	55.5	MTH2_DROYA	reviewed	G-protein coupled receptor Mth2 (Protein methuselah-2)	mth2	Drosophila yakuba (Fruit fly)	536	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0016021	cell surface receptor signaling pathway [GO:0007166]		NA	NA	NA	NA	NA	NA
TRINITY_DN4691_c0_g1_i1	Q95NT6	MTH2_DROYA	23.9	452	289	16	1523	282	73	507	7.20E-25	117.5	MTH2_DROYA	reviewed	G-protein coupled receptor Mth2 (Protein methuselah-2)	mth2	Drosophila yakuba (Fruit fly)	536	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0016021	cell surface receptor signaling pathway [GO:0007166]		NA	NA	NA	NA	NA	NA
TRINITY_DN4691_c0_g1_i2	Q95NT6	MTH2_DROYA	23.7	414	265	15	1233	106	73	473	3.20E-24	115.2	MTH2_DROYA	reviewed	G-protein coupled receptor Mth2 (Protein methuselah-2)	mth2	Drosophila yakuba (Fruit fly)	536	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0016021	cell surface receptor signaling pathway [GO:0007166]		NA	NA	NA	NA	NA	NA
TRINITY_DN11561_c0_g1_i1	Q7ZYA0	LMBD2_XENLA	36.8	136	75	2	9	386	557	691	3.10E-15	82.8	LMBD2_XENLA	reviewed	G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2)	lmbrd2	Xenopus laevis (African clawed frog)	713	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenergic receptor signaling pathway [GO:0071875]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0071875	adrenergic receptor signaling pathway [GO:0071875]		NA	NA	NA	NA	NA	NA
TRINITY_DN31069_c0_g1_i1	Q6IR34	GPSM1_MOUSE	98.5	67	1	0	203	3	293	359	7.30E-32	137.1	GPSM1_MOUSE	reviewed	G-protein-signaling modulator 1 (Activator of G-protein signaling 3)	Gpsm1 Ags3 C10a	Mus musculus (Mouse)	673	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]	GO:0000139; GO:0001965; GO:0005092; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0007399; GO:0008277; GO:0016239; GO:0030154; GO:0032991; GO:0034260; GO:1905098	cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN23835_c0_g1_i1	P81274	GPSM2_HUMAN	99.2	125	1	0	378	4	35	159	8.90E-68	257.3	GPSM2_HUMAN	reviewed	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	684	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN34694_c0_g1_i1	P81274	GPSM2_HUMAN	100	68	0	0	1	204	222	289	2.10E-31	135.6	GPSM2_HUMAN	reviewed	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	684	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i1	P81274	GPSM2_HUMAN	67.5	381	124	0	1203	61	22	402	3.40E-151	536.2	GPSM2_HUMAN	reviewed	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	684	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i11	P81274	GPSM2_HUMAN	66.9	393	120	1	1152	4	22	414	3.00E-152	539.7	GPSM2_HUMAN	reviewed	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	684	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i14	P81274	GPSM2_HUMAN	66.7	399	123	1	1248	82	22	420	6.90E-155	548.5	GPSM2_HUMAN	reviewed	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	684	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i8	P81274	GPSM2_HUMAN	66.7	399	123	1	1248	82	22	420	6.90E-155	548.5	GPSM2_HUMAN	reviewed	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	684	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN30147_c0_g1_i1	Q8VDU0	GPSM2_MOUSE	99.4	169	1	0	507	1	168	336	4.10E-92	338.6	GPSM2_MOUSE	reviewed	G-protein-signaling modulator 2 (Pins homolog)	Gpsm2 Lgn Pins	Mus musculus (Mouse)	679	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i10	Q8VDU0	GPSM2_MOUSE	72	332	93	0	997	2	22	353	1.60E-141	503.8	GPSM2_MOUSE	reviewed	G-protein-signaling modulator 2 (Pins homolog)	Gpsm2 Lgn Pins	Mus musculus (Mouse)	679	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i2	Q8VDU0	GPSM2_MOUSE	71.9	334	94	0	1092	91	22	355	3.50E-142	506.1	GPSM2_MOUSE	reviewed	G-protein-signaling modulator 2 (Pins homolog)	Gpsm2 Lgn Pins	Mus musculus (Mouse)	679	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN1906_c0_g1_i6	Q8VDU0	GPSM2_MOUSE	71.9	334	94	0	1092	91	22	355	3.50E-142	506.1	GPSM2_MOUSE	reviewed	G-protein-signaling modulator 2 (Pins homolog)	Gpsm2 Lgn Pins	Mus musculus (Mouse)	679	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN3156_c0_g1_i1	Q8CB44	GRAM4_MOUSE	36.8	182	89	3	1	468	365	546	5.00E-22	107.1	GRAM4_MOUSE	reviewed	GRAM domain-containing protein 4 (Death-inducing protein)	Gramd4 Dip Kiaa0767	Mus musculus (Mouse)	633	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]		GO:0005739; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0034164; GO:0043280	apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]		NA	NA	NA	NA	NA	NA
TRINITY_DN3156_c0_g1_i2	Q8CB44	GRAM4_MOUSE	38.6	197	95	3	1	513	365	561	1.00E-27	124.8	GRAM4_MOUSE	reviewed	GRAM domain-containing protein 4 (Death-inducing protein)	Gramd4 Dip Kiaa0767	Mus musculus (Mouse)	633	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]		GO:0005739; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0034164; GO:0043280	apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]		NA	NA	NA	NA	NA	NA
TRINITY_DN41049_c0_g1_i1	P12544	GRAA_HUMAN	100	76	0	0	1	228	173	248	1.90E-41	169.1	GRAA_HUMAN	reviewed	Granzyme A (EC 3.4.21.78) (CTL tryptase) (Cytotoxic T-lymphocyte proteinase 1) (Fragmentin-1) (Granzyme-1) (Hanukkah factor) (H factor) (HF)	GZMA CTLA3 HFSP	Homo sapiens (Human)	262	extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to bacterium [GO:0009617]	extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]	protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]	GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0006915; GO:0006955; GO:0009617; GO:0019835; GO:0032078; GO:0042803; GO:0043065; GO:0043392; GO:0051354; GO:0051603	apoptotic process [GO:0006915]; cytolysis [GO:0019835]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN15262_c0_g1_i1	P10144	GRAB_HUMAN	98.8	81	1	0	3	245	16	96	1.30E-43	176.4	GRAB_HUMAN	reviewed	Granzyme B (EC 3.4.21.79) (C11) (CTLA-1) (Cathepsin G-like 1) (CTSGL1) (Cytotoxic T-lymphocyte proteinase 2) (Lymphocyte protease) (Fragmentin-2) (Granzyme-2) (Human lymphocyte protein) (HLP) (SECT) (T-cell serine protease 1-3E)	GZMB CGL1 CSPB CTLA1 GRB	Homo sapiens (Human)	247	cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001772; GO:0004252; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008236; GO:0008626; GO:0016020; GO:0017148; GO:0019835; GO:0042267; GO:1900740	apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]		NA	NA	NA	NA	NA	NA
TRINITY_DN33512_c0_g1_i1	P16260	GDC_HUMAN	100	67	0	0	202	2	216	282	5.00E-33	141	GDC_HUMAN	reviewed	Graves disease carrier protein (GDC) (Graves disease autoantigen) (GDA) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16)	SLC25A16 GDA	Homo sapiens (Human)	332	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; secondary active transmembrane transporter activity [GO:0015291]; mitochondrial transport [GO:0006839]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; secondary active transmembrane transporter activity [GO:0015291]	GO:0005347; GO:0005739; GO:0005743; GO:0006839; GO:0015291; GO:0015297; GO:0016021	mitochondrial transport [GO:0006839]		NA	NA	NA	NA	NA	NA
TRINITY_DN1497_c0_g1_i2	P16260	GDC_HUMAN	58	50	21	0	91	240	283	332	1.50E-10	67	GDC_HUMAN	reviewed	Graves disease carrier protein (GDC) (Graves disease autoantigen) (GDA) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16)	SLC25A16 GDA	Homo sapiens (Human)	332	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; secondary active transmembrane transporter activity [GO:0015291]; mitochondrial transport [GO:0006839]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; secondary active transmembrane transporter activity [GO:0015291]	GO:0005347; GO:0005739; GO:0005743; GO:0006839; GO:0015291; GO:0015297; GO:0016021	mitochondrial transport [GO:0006839]		NA	NA	NA	NA	NA	NA
TRINITY_DN1497_c0_g1_i1	Q8C0K5	GDC_MOUSE	53.6	302	136	2	44	949	35	332	1.10E-86	321.6	GDC_MOUSE	reviewed	Graves disease carrier protein homolog (GDC) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16)	Slc25a16 Gda	Mus musculus (Mouse)	332	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005739; GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1497_c0_g1_i3	Q8C0K5	GDC_MOUSE	67.4	43	14	0	44	172	35	77	1.30E-11	70.1	GDC_MOUSE	reviewed	Graves disease carrier protein homolog (GDC) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16)	Slc25a16 Gda	Mus musculus (Mouse)	332	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005739; GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1497_c0_g1_i4	Q8C0K5	GDC_MOUSE	54.4	248	110	1	44	787	35	279	1.20E-70	268.1	GDC_MOUSE	reviewed	Graves disease carrier protein homolog (GDC) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16)	Slc25a16 Gda	Mus musculus (Mouse)	332	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005739; GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35591_c0_g1_i1	O75420	GGYF1_HUMAN	50.4	119	53	3	343	2	1	118	5.70E-23	108.6	GGYF1_HUMAN	reviewed	GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1)	GIGYF1 CDS2 PERQ1 PP3360	Homo sapiens (Human)	1035	protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009]	protein-containing complex [GO:0032991]		GO:0032991; GO:0048009	insulin-like growth factor receptor signaling pathway [GO:0048009]		NA	NA	NA	NA	NA	NA
TRINITY_DN15423_c0_g1_i2	Q6Y7W6	GGYF2_HUMAN	50.6	77	36	1	228	4	1107	1183	1.30E-14	80.5	GGYF2_HUMAN	reviewed	GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein)	GIGYF2 KIAA0642 PERQ2 TNRC15	Homo sapiens (Human)	1299	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]	GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016021; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0032991; GO:0035264; GO:0043204; GO:0044267; GO:0045296; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0061157; GO:0070064; GO:1990635	adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN7803_c0_g2_i3	Q96CN9	GCC1_HUMAN	28.8	617	392	12	1858	128	161	770	5.90E-43	177.2	GCC1_HUMAN	reviewed	GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1)	GCC1	Homo sapiens (Human)	775	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005794; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN7803_c0_g1_i2	Q96CN9	GCC1_HUMAN	57.1	56	24	0	241	74	13	68	6.20E-09	61.6	GCC1_HUMAN	reviewed	GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1)	GCC1	Homo sapiens (Human)	775	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005794; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN10581_c0_g1_i4	Q8CHG3	GCC2_MOUSE	45.9	135	71	1	441	43	1542	1676	1.70E-23	110.5	GCC2_MOUSE	reviewed	GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185)	Gcc2 Kiaa0336	Mus musculus (Mouse)	1679	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	identical protein binding [GO:0042802]	GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161	"Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10581_c0_g1_i1	Q8IWJ2	GCC2_HUMAN	50.8	59	29	0	219	43	1623	1681	4.40E-11	68.6	GCC2_HUMAN	reviewed	GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4) (RanBP2L4) (Renal carcinoma antigen NY-REN-53)	GCC2 KIAA0336 RANBP2L4	Homo sapiens (Human)	1684	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	identical protein binding [GO:0042802]	GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161	"Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10581_c0_g1_i2	Q8IWJ2	GCC2_HUMAN	45.7	129	70	0	429	43	1553	1681	2.70E-23	109.8	GCC2_HUMAN	reviewed	GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4) (RanBP2L4) (Renal carcinoma antigen NY-REN-53)	GCC2 KIAA0336 RANBP2L4	Homo sapiens (Human)	1684	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	identical protein binding [GO:0042802]	GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161	"Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5577_c0_g1_i4	Q8VD04	GRAP1_MOUSE	40.7	270	134	8	155	922	543	800	2.50E-35	151	GRAP1_MOUSE	reviewed	GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)]	Gripap1 DXImx47e Kiaa1167	Mus musculus (Mouse)	806	"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	identical protein binding [GO:0042802]	GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5577_c0_g1_i5	Q8VD04	GRAP1_MOUSE	34.4	122	70	2	745	407	543	663	6.20E-06	53.1	GRAP1_MOUSE	reviewed	GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)]	Gripap1 DXImx47e Kiaa1167	Mus musculus (Mouse)	806	"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	identical protein binding [GO:0042802]	GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5577_c0_g1_i5	Q8VD04	GRAP1_MOUSE	31.8	148	89	3	155	565	543	689	1.80E-05	51.6	GRAP1_MOUSE	reviewed	GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)]	Gripap1 DXImx47e Kiaa1167	Mus musculus (Mouse)	806	"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	identical protein binding [GO:0042802]	GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5516_c0_g1_i2	Q8VD04	GRAP1_MOUSE	37.5	136	78	1	5	412	25	153	7.10E-12	73.2	GRAP1_MOUSE	reviewed	GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)]	Gripap1 DXImx47e Kiaa1167	Mus musculus (Mouse)	806	"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	identical protein binding [GO:0042802]	GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5516_c0_g1_i1	Q4V328	GRAP1_HUMAN	43	93	50	1	5	283	25	114	8.40E-10	64.3	GRAP1_HUMAN	reviewed	GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)]	GRIPAP1 KIAA1167	Homo sapiens (Human)	841	"axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	identical protein binding [GO:0042802]	GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0072562; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36016_c0_g1_i1	P62993	GRB2_HUMAN	100	215	0	0	647	3	1	215	1.00E-128	460.7	GRB2_HUMAN	reviewed	Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2)	GRB2 ASH	Homo sapiens (Human)	217	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; interleukin-15-mediated signaling pathway [GO:0035723]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770]; T cell costimulation [GO:0031295]; viral process [GO:0016032]	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]	GO:0000165; GO:0001784; GO:0003723; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005911; GO:0007173; GO:0007265; GO:0007411; GO:0007568; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0016032; GO:0017124; GO:0019221; GO:0019901; GO:0019903; GO:0030674; GO:0030838; GO:0031295; GO:0031532; GO:0031623; GO:0035635; GO:0035723; GO:0038095; GO:0038096; GO:0038128; GO:0042059; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0046579; GO:0046875; GO:0048011; GO:0048646; GO:0050900; GO:0051897; GO:0060670; GO:0061024; GO:0070062; GO:0070436; GO:0071479; GO:2000379	actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; interleukin-15-mediated signaling pathway [GO:0035723]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770]; T cell costimulation [GO:0031295]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31881_c0_g1_i1	Q60631	GRB2_MOUSE	100	104	0	0	3	314	92	195	3.10E-58	225.3	GRB2_MOUSE	reviewed	Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2)	Grb2	Mus musculus (Mouse)	217	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770]	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]	GO:0001784; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005911; GO:0007173; GO:0007265; GO:0007568; GO:0008180; GO:0008286; GO:0012506; GO:0016020; GO:0017124; GO:0019899; GO:0019901; GO:0019903; GO:0019904; GO:0030154; GO:0030674; GO:0030838; GO:0031532; GO:0031623; GO:0032991; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0046875; GO:0048646; GO:0051219; GO:0060670; GO:0070436; GO:0071479; GO:2000379	actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770]		NA	NA	NA	NA	NA	NA
TRINITY_DN30648_c0_g1_i1	Q91VC9	GHITM_MOUSE	61.2	67	26	0	286	486	80	146	5.40E-17	89	GHITM_MOUSE	reviewed	Growth hormone-inducible transmembrane protein (Mitochondrial morphology and cristae structure 1) (MICS1)	Ghitm Mics1	Mus musculus (Mouse)	346	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006915; GO:0016021	apoptotic process [GO:0006915]		blue	blue	NA	NA	NA	NA
TRINITY_DN30648_c0_g1_i2	Q91VC9	GHITM_MOUSE	61.2	67	26	0	276	476	80	146	5.30E-17	89	GHITM_MOUSE	reviewed	Growth hormone-inducible transmembrane protein (Mitochondrial morphology and cristae structure 1) (MICS1)	Ghitm Mics1	Mus musculus (Mouse)	346	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006915; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN32815_c0_g1_i1	Q6PBU5	GRT1A_DANRE	49.2	179	89	2	535	2	11	188	2.50E-42	173.3	GRT1A_DANRE	reviewed	Growth hormone-regulated TBC protein 1-A	grtp1a grtp1	Danio rerio (Zebrafish) (Brachydanio rerio)	356	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN37322_c0_g1_i1	B3PQ08	MOAA_RHIE6	57.4	68	29	0	204	1	13	80	8.30E-18	90.5	MOAA_RHIE6	reviewed	"GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A)"	moaA RHECIAT_CH0002485	Rhizobium etli (strain CIAT 652)	348	"molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]"	molybdopterin synthase complex [GO:0019008]	"4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]"	GO:0005525; GO:0006777; GO:0019008; GO:0046872; GO:0051539; GO:0061798; GO:1904047	Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN25472_c0_g1_i1	Q2NCE3	MOAA_ERYLH	64.8	105	37	0	318	4	2	106	5.80E-34	144.8	MOAA_ERYLH	reviewed	"GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A)"	moaA ELI_02780	Erythrobacter litoralis (strain HTCC2594)	332	"molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]"	molybdopterin synthase complex [GO:0019008]	"4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]"	GO:0005525; GO:0006777; GO:0019008; GO:0046872; GO:0051539; GO:0061798; GO:1904047	Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN31090_c0_g1_i1	Q8Y0K4	MOAA_RALSO	92.6	81	6	0	246	4	5	85	2.20E-38	159.1	MOAA_RALSO	reviewed	"GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A)"	moaA RSc1039 RS04211	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	345	"molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]"	molybdopterin synthase complex [GO:0019008]	"4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]"	GO:0005525; GO:0006777; GO:0019008; GO:0046872; GO:0051539; GO:0061798; GO:1904047	Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN26471_c0_g1_i1	Q39055	CNX2_ARATH	50	72	35	1	214	2	203	274	3.00E-16	85.5	CNX2_ARATH	reviewed	"GTP 3',8-cyclase, mitochondrial (EC 4.1.99.22) (Molybdenum cofactor biosynthesis enzyme CNX2) (Molybdopterin biosynthesis protein CNX2) (Molybdopterin precursor Z synthase)"	CNX2 At2g31955 F20M17.1 F22D22.30	Arabidopsis thaliana (Mouse-ear cress)	390	"chloroplast [GO:0009507]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]"	chloroplast [GO:0009507]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; molybdopterin synthase complex [GO:0019008]	"4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"	GO:0005525; GO:0005739; GO:0005759; GO:0006777; GO:0009507; GO:0019008; GO:0046872; GO:0051539; GO:0061798	Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN26088_c0_g1_i1	P30793	GCH1_HUMAN	100	122	0	0	2	367	88	209	3.50E-62	238.8	GCH1_HUMAN	reviewed	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	GCH1 DYT5 GCH	Homo sapiens (Human)	250	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]	GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0006809; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042802; GO:0042803; GO:0044306; GO:0044877; GO:0045776; GO:0046654; GO:0048265; GO:0050884; GO:0051000; GO:0051019; GO:0065003; GO:2000121	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27205_c0_g1_i1	Q55759	GCH1_SYNY3	68	153	49	0	5	463	57	209	4.30E-56	218.8	GCH1_SYNY3	reviewed	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	folE slr0426	Synechocystis sp. (strain PCC 6803 / Kazusa)	234	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]	GO:0003934; GO:0005525; GO:0005737; GO:0006729; GO:0006730; GO:0008270; GO:0035998; GO:0046654	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31486_c0_g1_i1	Q8P3B0	GCH1_XANCP	64.7	85	30	0	256	2	84	168	5.20E-27	121.3	GCH1_XANCP	reviewed	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	folE XCC4166	Xanthomonas campestris pv. campestris (strain ATCC 33913 / DSM 3586 / NCPPB 528 / LMG 568 / P 25)	200	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]	GO:0003934; GO:0005525; GO:0005737; GO:0006729; GO:0006730; GO:0008270; GO:0035998; GO:0046654	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25804_c0_g1_i1	Q8P3B0	GCH1_XANCP	65.7	70	24	0	212	3	90	159	2.10E-21	102.4	GCH1_XANCP	reviewed	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	folE XCC4166	Xanthomonas campestris pv. campestris (strain ATCC 33913 / DSM 3586 / NCPPB 528 / LMG 568 / P 25)	200	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]	GO:0003934; GO:0005525; GO:0005737; GO:0006729; GO:0006730; GO:0008270; GO:0035998; GO:0046654	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5961_c0_g1_i1	P48596	GCH1_DROME	78.6	210	45	0	709	80	112	321	1.40E-94	347.4	GCH1_DROME	reviewed	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I) (Protein punch)	Pu CG9441	Drosophila melanogaster (Fruit fly)	324	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP cyclohydrolase I regulator activity [GO:0060308]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; compound eye pigmentation [GO:0048072]; cuticle pigmentation [GO:0048067]; embryonic pattern specification [GO:0009880]; larval chitin-based cuticle development [GO:0008363]; preblastoderm mitotic cell cycle [GO:0035185]; pteridine biosynthetic process [GO:0006728]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of GTP cyclohydrolase I activity [GO:0043095]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP cyclohydrolase I regulator activity [GO:0060308]; zinc ion binding [GO:0008270]	GO:0003934; GO:0005525; GO:0005737; GO:0006728; GO:0006729; GO:0008270; GO:0008363; GO:0009880; GO:0035185; GO:0035998; GO:0043095; GO:0046654; GO:0048067; GO:0048072; GO:0060308; GO:2000274	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; compound eye pigmentation [GO:0048072]; cuticle pigmentation [GO:0048067]; embryonic pattern specification [GO:0009880]; larval chitin-based cuticle development [GO:0008363]; preblastoderm mitotic cell cycle [GO:0035185]; pteridine biosynthetic process [GO:0006728]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of GTP cyclohydrolase I activity [GO:0043095]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5961_c0_g1_i2	P48596	GCH1_DROME	79.8	193	39	0	658	80	129	321	1.00E-86	321.2	GCH1_DROME	reviewed	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I) (Protein punch)	Pu CG9441	Drosophila melanogaster (Fruit fly)	324	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP cyclohydrolase I regulator activity [GO:0060308]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; compound eye pigmentation [GO:0048072]; cuticle pigmentation [GO:0048067]; embryonic pattern specification [GO:0009880]; larval chitin-based cuticle development [GO:0008363]; preblastoderm mitotic cell cycle [GO:0035185]; pteridine biosynthetic process [GO:0006728]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of GTP cyclohydrolase I activity [GO:0043095]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP cyclohydrolase I regulator activity [GO:0060308]; zinc ion binding [GO:0008270]	GO:0003934; GO:0005525; GO:0005737; GO:0006728; GO:0006729; GO:0008270; GO:0008363; GO:0009880; GO:0035185; GO:0035998; GO:0043095; GO:0046654; GO:0048067; GO:0048072; GO:0060308; GO:2000274	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; compound eye pigmentation [GO:0048072]; cuticle pigmentation [GO:0048067]; embryonic pattern specification [GO:0009880]; larval chitin-based cuticle development [GO:0008363]; preblastoderm mitotic cell cycle [GO:0035185]; pteridine biosynthetic process [GO:0006728]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of GTP cyclohydrolase I activity [GO:0043095]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27616_c0_g1_i1	Q9UIJ7	KAD3_HUMAN	100	100	0	0	303	4	85	184	7.70E-54	210.7	KAD3_HUMAN	reviewed	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	AK3 AK3L1 AK6 AKL3L	Homo sapiens (Human)	227	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside monophosphate phosphorylation [GO:0046940]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006163; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899; GO:0046940	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside monophosphate phosphorylation [GO:0046940]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]		NA	NA	NA	NA	NA	NA
TRINITY_DN5429_c0_g1_i1	P08760	KAD3_BOVIN	52.8	72	34	0	220	5	31	102	1.40E-15	83.2	KAD3_BOVIN	reviewed	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	AK3 AK3L1	Bos taurus (Bovine)	227	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0004017; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006163; GO:0006172; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046899	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN5429_c0_g1_i2	P08760	KAD3_BOVIN	52.8	72	34	0	220	5	31	102	1.40E-15	83.2	KAD3_BOVIN	reviewed	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	AK3 AK3L1	Bos taurus (Bovine)	227	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0004017; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006163; GO:0006172; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046899	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN658_c2_g1_i10	Q9WTP7	KAD3_MOUSE	54.7	212	96	0	96	731	6	217	1.50E-64	248.1	KAD3_MOUSE	reviewed	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	Ak3 Ak3l Ak3l1 Akl3l	Mus musculus (Mouse)	227	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0004017; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0006163; GO:0006172; GO:0006756; GO:0009142; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046041; GO:0046051; GO:0046060; GO:0046899	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]		NA	NA	NA	NA	NA	NA
TRINITY_DN658_c2_g1_i3	Q9WTP7	KAD3_MOUSE	54.7	212	96	0	96	731	6	217	1.40E-64	248.1	KAD3_MOUSE	reviewed	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	Ak3 Ak3l Ak3l1 Akl3l	Mus musculus (Mouse)	227	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0004017; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0006163; GO:0006172; GO:0006756; GO:0009142; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046041; GO:0046051; GO:0046060; GO:0046899	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]		NA	NA	NA	NA	NA	NA
TRINITY_DN35166_c0_g1_i1	Q9WTP7	KAD3_MOUSE	100	69	0	0	208	2	15	83	4.30E-32	137.9	KAD3_MOUSE	reviewed	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	Ak3 Ak3l Ak3l1 Akl3l	Mus musculus (Mouse)	227	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0004017; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0006163; GO:0006172; GO:0006756; GO:0009142; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046041; GO:0046051; GO:0046060; GO:0046899	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; UTP metabolic process [GO:0046051]		NA	NA	NA	NA	NA	NA
TRINITY_DN1074_c0_g1_i2	B5X2B8	ERAL1_SALSA	36.3	325	166	5	979	5	105	388	3.40E-50	200.3	ERAL1_SALSA	reviewed	"GTPase Era, mitochondrial (ERA-like protein 1)"	eral1	Salmo salar (Atlantic salmon)	457	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; ribosomal small subunit assembly [GO:0000028]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]	GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024	ribosomal small subunit assembly [GO:0000028]		NA	NA	NA	NA	NA	NA
TRINITY_DN1074_c0_g1_i1	Q8JIF5	ERAL1_CHICK	36.7	294	167	5	981	100	88	362	6.80E-43	176	ERAL1_CHICK	reviewed	"GTPase Era, mitochondrial (GdERA) (ERA-like protein 1)"	ERAL1	Gallus gallus (Chicken)	461	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; ribosomal small subunit assembly [GO:0000028]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]	GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024	ribosomal small subunit assembly [GO:0000028]		NA	NA	NA	NA	NA	NA
TRINITY_DN31815_c0_g1_i1	Q3AFV0	HFLX_CARHZ	54.9	71	32	0	1	213	168	238	1.50E-14	79.7	HFLX_CARHZ	reviewed	GTPase HflX (GTP-binding protein HflX)	hflX CHY_0112	Carboxydothermus hydrogenoformans (strain ATCC BAA-161 / DSM 6008 / Z-2901)	414	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN32102_c0_g1_i1	A0L4B2	HFLX_MAGMM	64.8	71	25	0	3	215	224	294	1.30E-18	93.2	HFLX_MAGMM	reviewed	GTPase HflX (GTP-binding protein HflX)	hflX Mmc1_0278	Magnetococcus marinus (strain ATCC BAA-1437 / JCM 17883 / MC-1)	432	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN21462_c0_g1_i2	P01112	RASH_HUMAN	100	163	0	0	57	545	1	163	7.00E-90	331.3	RASH_HUMAN	reviewed	"GTPase HRas (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]"	HRAS HRAS1	Homo sapiens (Human)	189	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; intrinsic apoptotic signaling pathway [GO:0097193]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to isolation stress [GO:0035900]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0000139; GO:0000165; GO:0001889; GO:0001934; GO:0002223; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0006935; GO:0007050; GO:0007093; GO:0007165; GO:0007166; GO:0007265; GO:0008022; GO:0008284; GO:0008285; GO:0009887; GO:0010629; GO:0010863; GO:0019003; GO:0030335; GO:0032729; GO:0034260; GO:0035900; GO:0042088; GO:0042832; GO:0043406; GO:0043410; GO:0043524; GO:0043547; GO:0044877; GO:0045740; GO:0045944; GO:0046330; GO:0046579; GO:0048013; GO:0048169; GO:0048471; GO:0050679; GO:0050852; GO:0070374; GO:0071480; GO:0090303; GO:0090314; GO:0090398; GO:0097193; GO:1900029; GO:2000251; GO:2000630	animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; intrinsic apoptotic signaling pathway [GO:0097193]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to isolation stress [GO:0035900]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]		NA	NA	NA	NA	NA	NA
TRINITY_DN37622_c0_g1_i1	P01112	RASH_HUMAN	100	141	0	0	423	1	36	176	6.90E-77	287.7	RASH_HUMAN	reviewed	"GTPase HRas (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]"	HRAS HRAS1	Homo sapiens (Human)	189	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; intrinsic apoptotic signaling pathway [GO:0097193]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to isolation stress [GO:0035900]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0000139; GO:0000165; GO:0001889; GO:0001934; GO:0002223; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0006935; GO:0007050; GO:0007093; GO:0007165; GO:0007166; GO:0007265; GO:0008022; GO:0008284; GO:0008285; GO:0009887; GO:0010629; GO:0010863; GO:0019003; GO:0030335; GO:0032729; GO:0034260; GO:0035900; GO:0042088; GO:0042832; GO:0043406; GO:0043410; GO:0043524; GO:0043547; GO:0044877; GO:0045740; GO:0045944; GO:0046330; GO:0046579; GO:0048013; GO:0048169; GO:0048471; GO:0050679; GO:0050852; GO:0070374; GO:0071480; GO:0090303; GO:0090314; GO:0090398; GO:0097193; GO:1900029; GO:2000251; GO:2000630	animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; intrinsic apoptotic signaling pathway [GO:0097193]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; response to isolation stress [GO:0035900]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]		NA	NA	NA	NA	NA	NA
TRINITY_DN20884_c0_g1_i1	P79800	RASK_MELGA	99	100	1	0	303	4	53	152	1.40E-52	206.5	RASK_MELGA	reviewed	GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (K-ras)	KRAS	Meleagris gallopavo (Wild turkey)	188	cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0007165; GO:0008284; GO:0031234	positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN20884_c0_g1_i2	P79800	RASK_MELGA	100	100	0	0	303	4	53	152	3.80E-53	208.4	RASK_MELGA	reviewed	GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (K-ras)	KRAS	Meleagris gallopavo (Wild turkey)	188	cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0007165; GO:0008284; GO:0031234	positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN21462_c0_g1_i1	P12825	RASN_CAVPO	100	136	0	0	57	464	1	136	4.60E-74	278.5	RASN_CAVPO	reviewed	GTPase NRas (EC 3.6.5.2) (Transforming protein N-Ras)	NRAS	Cavia porcellus (Guinea pig)	189	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; positive regulation of endothelial cell proliferation [GO:0001938]; Ras protein signal transduction [GO:0007265]	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]	GO:0000139; GO:0001938; GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0044877	positive regulation of endothelial cell proliferation [GO:0001938]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN38622_c0_g1_i1	Q1DC95	OBG_MYXXD	51.4	148	62	2	415	2	119	266	7.90E-36	151.4	OBG_MYXXD	reviewed	GTPase Obg (EC 3.6.5.-) (GTP-binding protein Obg)	obg MXAN_1471	Myxococcus xanthus (strain DK 1622)	485	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0003924; GO:0005525; GO:0005737; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN16975_c0_g1_i2	A2RV61	GAPD1_XENLA	39.7	494	292	5	1482	13	2	493	3.50E-94	347.1	GAPD1_XENLA	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1	gapvd1	Xenopus laevis (African clawed frog)	1452	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0006897; GO:0007165; GO:0016020; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1844_c0_g1_i1	A5D794	GAPD1_BOVIN	49.3	67	34	0	69	269	1240	1306	1.20E-13	77	GAPD1_BOVIN	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1	GAPVD1	Bos taurus (Bovine)	1413	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0006897; GO:0007165; GO:0016020; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36452_c0_g1_i1	A5D794	GAPD1_BOVIN	98.8	80	1	0	241	2	63	142	5.60E-39	161	GAPD1_BOVIN	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1	GAPVD1	Bos taurus (Bovine)	1413	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0006897; GO:0007165; GO:0016020; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN16975_c0_g1_i3	Q6PAR5	GAPD1_MOUSE	45.4	368	199	2	1155	58	5	372	9.10E-90	332	GAPD1_MOUSE	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)	Gapvd1 Gapex5 Kiaa1521	Mus musculus (Mouse)	1458	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN29428_c0_g1_i1	Q14C86	GAPD1_HUMAN	100	82	0	0	246	1	162	243	3.90E-40	164.9	GAPD1_HUMAN	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)	GAPVD1 GAPEX5 KIAA1521 RAP6	Homo sapiens (Human)	1478	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0032794; GO:0045296; GO:0051223; GO:0061024	endocytosis [GO:0006897]; membrane organization [GO:0061024]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1844_c0_g1_i2	Q6PAR5	GAPD1_MOUSE	47.3	201	106	0	6	608	1151	1351	2.60E-48	193.4	GAPD1_MOUSE	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)	Gapvd1 Gapex5 Kiaa1521	Mus musculus (Mouse)	1458	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1844_c0_g1_i4	Q6PAR5	GAPD1_MOUSE	44.6	213	106	1	6	644	1151	1351	2.50E-46	186.8	GAPD1_MOUSE	reviewed	GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)	Gapvd1 Gapex5 Kiaa1521	Mus musculus (Mouse)	1458	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1754_c0_g1_i1	Q9VIH7	SKY_DROME	43.6	578	284	5	1700	36	29	587	3.20E-144	513.8	SKY_DROME	reviewed	GTPase-activating protein skywalker	sky CG9339	Drosophila melanogaster (Fruit fly)	587	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]	GO:0003924; GO:0005096; GO:0005737; GO:0007268; GO:0007274; GO:0008289; GO:0010008; GO:0030672; GO:0031175; GO:0031594; GO:0036466; GO:0043087; GO:0043195; GO:0046929; GO:0098794; GO:1903422	chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN1754_c0_g1_i2	Q9VIH7	SKY_DROME	43.6	578	284	5	1700	36	29	587	3.20E-144	513.8	SKY_DROME	reviewed	GTPase-activating protein skywalker	sky CG9339	Drosophila melanogaster (Fruit fly)	587	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]	GO:0003924; GO:0005096; GO:0005737; GO:0007268; GO:0007274; GO:0008289; GO:0010008; GO:0030672; GO:0031175; GO:0031594; GO:0036466; GO:0043087; GO:0043195; GO:0046929; GO:0098794; GO:1903422	chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN1754_c0_g2_i1	Q9VIH7	SKY_DROME	43.6	578	284	5	593	2257	29	587	3.20E-144	513.8	SKY_DROME	reviewed	GTPase-activating protein skywalker	sky CG9339	Drosophila melanogaster (Fruit fly)	587	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]	GO:0003924; GO:0005096; GO:0005737; GO:0007268; GO:0007274; GO:0008289; GO:0010008; GO:0030672; GO:0031175; GO:0031594; GO:0036466; GO:0043087; GO:0043195; GO:0046929; GO:0098794; GO:1903422	chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]		NA	NA	NA	NA	NA	NA
TRINITY_DN34397_c0_g1_i1	Q9VZ23	RAN_DROME	91	67	6	0	202	2	65	131	9.40E-32	136.7	RAN_DROME	reviewed	GTP-binding nuclear protein Ran (Ras-related nuclear protein)	Ran Ran10A CG1404	Drosophila melanogaster (Fruit fly)	216	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; meiotic spindle organization [GO:0000212]; nuclear pore complex assembly [GO:0051292]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; ribosomal subunit export from nucleus [GO:0000054]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0000054; GO:0000132; GO:0000212; GO:0003924; GO:0005525; GO:0005634; GO:0005635; GO:0005737; GO:0005938; GO:0006606; GO:0006611; GO:0006886; GO:0007346; GO:0032880; GO:0046872; GO:0051292; GO:0051301; GO:1990498	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; meiotic spindle organization [GO:0000212]; nuclear pore complex assembly [GO:0051292]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; ribosomal subunit export from nucleus [GO:0000054]		NA	NA	NA	NA	NA	NA
TRINITY_DN1411_c0_g1_i1	D2XV59	GTPB1_RAT	69.9	511	152	1	235	1761	64	574	1.10E-211	737.6	GTPB1_RAT	reviewed	GTP-binding protein 1	Gtpbp1	Rattus norvegicus (Rat)	669	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014	GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN40490_c0_g1_i1	P32235	GTP1_SCHPO	50	54	27	0	213	52	205	258	2.20E-10	65.9	GTP1_SCHPO	reviewed	GTP-binding protein 1	gtp1 SPBC354.01 SPBC649.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	364	cell tip [GO:0051286]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]	cell tip [GO:0051286]; cytoplasm [GO:0005737]	GTP binding [GO:0005525]	GO:0002181; GO:0005525; GO:0005737; GO:0051286	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN27114_c0_g1_i1	Q58DC5	GTPB1_BOVIN	100	74	0	0	21	242	506	579	6.80E-37	154.1	GTPB1_BOVIN	reviewed	GTP-binding protein 1	GTPBP1	Bos taurus (Bovine)	669	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014	GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN30269_c0_g1_i1	Q58DC5	GTPB1_BOVIN	100	143	0	0	2	430	428	570	8.30E-78	290.8	GTPB1_BOVIN	reviewed	GTP-binding protein 1	GTPBP1	Bos taurus (Bovine)	669	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014	GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN21866_c0_g1_i1	Q58DC5	GTPB1_BOVIN	100	191	0	0	2	574	208	398	2.80E-105	382.5	GTPB1_BOVIN	reviewed	GTP-binding protein 1	GTPBP1	Bos taurus (Bovine)	669	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014	GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN36392_c0_g1_i1	Q58DC5	GTPB1_BOVIN	100	110	0	0	3	332	89	198	2.00E-55	216.1	GTPB1_BOVIN	reviewed	GTP-binding protein 1	GTPBP1	Bos taurus (Bovine)	669	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014	GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN33097_c0_g1_i1	A4D1E9	GTPBA_HUMAN	100	104	0	0	2	313	145	248	3.60E-54	211.8	GTPBA_HUMAN	reviewed	GTP-binding protein 10 (Protein obg homolog 2) (ObgH2)	GTPBP10 OBGH2 UG0751c10	Homo sapiens (Human)	387	chromosome [GO:0005694]; nucleolus [GO:0005730]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	chromosome [GO:0005694]; nucleolus [GO:0005730]	GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0003723; GO:0005525; GO:0005694; GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN9654_c0_g1_i1	Q9I7M2	GTPBA_DROME	65.3	98	34	0	13	306	142	239	6.20E-35	147.9	GTPBA_DROME	reviewed	GTP-binding protein 10 homolog	CG10628	Drosophila melanogaster (Fruit fly)	383	nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]	GTP binding [GO:0005525]	GO:0005525; GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3543_c0_g1_i1	P32234	128UP_DROME	82.8	366	62	1	90	1184	3	368	1.90E-178	626.7	128UP_DROME	reviewed	GTP-binding protein 128up	128up GTP-bp CG8340	Drosophila melanogaster (Fruit fly)	368	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]	GO:0002181; GO:0005525; GO:0005737	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN4154_c0_g1_i1	Q9BX10	GTPB2_HUMAN	44.2	181	98	3	72	605	344	524	2.50E-35	150.2	GTPB2_HUMAN	reviewed	GTP-binding protein 2	GTPBP2	Homo sapiens (Human)	602	"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; platelet degranulation [GO:0002576]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]	GO:0002576; GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0043231; GO:0070966; GO:0072344	"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; platelet degranulation [GO:0002576]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4154_c0_g1_i3	Q9BX10	GTPB2_HUMAN	65.5	87	30	0	2	262	160	246	1.10E-25	117.1	GTPB2_HUMAN	reviewed	GTP-binding protein 2	GTPBP2	Homo sapiens (Human)	602	"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; platelet degranulation [GO:0002576]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]	GO:0002576; GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0043231; GO:0070966; GO:0072344	"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; platelet degranulation [GO:0002576]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4154_c0_g1_i6	Q9BX10	GTPB2_HUMAN	40.4	109	63	2	9	329	410	518	1.60E-15	83.6	GTPB2_HUMAN	reviewed	GTP-binding protein 2	GTPBP2	Homo sapiens (Human)	602	"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; platelet degranulation [GO:0002576]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]	GO:0002576; GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0043231; GO:0070966; GO:0072344	"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; platelet degranulation [GO:0002576]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4154_c0_g1_i4	Q3UJK4	GTPB2_MOUSE	51.5	433	203	4	2	1291	160	588	3.30E-115	416.8	GTPB2_MOUSE	reviewed	GTP-binding protein 2 (GTP-binding-like protein 2)	Gtpbp2	Mus musculus (Mouse)	602	"intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"	intracellular membrane-bounded organelle [GO:0043231]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0042802; GO:0043231; GO:0070966; GO:0072344	"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4154_c0_g1_i7	Q3UJK4	GTPB2_MOUSE	50.7	408	193	5	2	1216	160	562	1.30E-104	381.3	GTPB2_MOUSE	reviewed	GTP-binding protein 2 (GTP-binding-like protein 2)	Gtpbp2	Mus musculus (Mouse)	602	"intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"	intracellular membrane-bounded organelle [GO:0043231]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0042802; GO:0043231; GO:0070966; GO:0072344	"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14151_c0_g1_i1	Q17045	AGP1_ASCSU	55.1	98	44	0	298	5	211	308	1.90E-28	126.3	AGP1_ASCSU	reviewed	GTP-binding protein AGP-1	AGP-1	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	591	GTP binding [GO:0005525]; GTPase activity [GO:0003924]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN441_c15_g1_i1	Q96HU8	DIRA2_HUMAN	80.4	199	39	0	211	807	1	199	1.90E-86	321.2	DIRA2_HUMAN	reviewed	GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2)	DIRAS2	Homo sapiens (Human)	199	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]	plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN18083_c0_g1_i1	Q15382	RHEB_HUMAN	100	177	0	0	1	531	8	184	1.70E-93	343.2	RHEB_HUMAN	reviewed	GTP-binding protein Rheb (Ras homolog enriched in brain)	RHEB RHEB2	Homo sapiens (Human)	184	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]	GO:0000139; GO:0000287; GO:0003924; GO:0005525; GO:0005681; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0007050; GO:0007165; GO:0007264; GO:0016020; GO:0016241; GO:0019003; GO:0019901; GO:0032008; GO:0048714; GO:0070062; GO:0120163; GO:2000074	cell cycle arrest [GO:0007050]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN18083_c0_g1_i2	Q921J2	RHEB_MOUSE	100	157	0	0	1	471	8	164	3.60E-82	305.4	RHEB_MOUSE	reviewed	GTP-binding protein Rheb (Ras homolog enriched in brain)	Rheb	Mus musculus (Mouse)	184	cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]	GO:0000139; GO:0000287; GO:0003924; GO:0005525; GO:0005681; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0014069; GO:0019003; GO:0019901; GO:0030425; GO:0032006; GO:0032008; GO:0043025; GO:0048714; GO:0098978; GO:0099175; GO:0120163; GO:2000074	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN18083_c1_g1_i1	Q15382	RHEB_HUMAN	100	77	0	0	253	23	1	77	1.30E-37	156.8	RHEB_HUMAN	reviewed	GTP-binding protein Rheb (Ras homolog enriched in brain)	RHEB RHEB2	Homo sapiens (Human)	184	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]	GO:0000139; GO:0000287; GO:0003924; GO:0005525; GO:0005681; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0007050; GO:0007165; GO:0007264; GO:0016020; GO:0016241; GO:0019003; GO:0019901; GO:0032008; GO:0048714; GO:0070062; GO:0120163; GO:2000074	cell cycle arrest [GO:0007050]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN15514_c0_g1_i1	Q9VND8	RHEB_DROME	66.2	80	27	0	12	251	47	126	7.00E-24	110.9	RHEB_DROME	reviewed	GTP-binding protein Rheb homolog	Rheb CG1081	Drosophila melanogaster (Fruit fly)	182	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0000082; GO:0000139; GO:0002052; GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0007430; GO:0008286; GO:0010506; GO:0010507; GO:0010942; GO:0019003; GO:0030307; GO:0033500; GO:0035264; GO:0042594; GO:0042632; GO:0045176; GO:0045727; GO:0045793; GO:0045887; GO:0046872; GO:0055088; GO:0090070; GO:1902669; GO:1903940; GO:1904263; GO:1904503; GO:2000377	"apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34939_c0_g1_i1	Q9VND8	RHEB_DROME	48.3	60	29	1	79	258	107	164	3.20E-07	55.8	RHEB_DROME	reviewed	GTP-binding protein Rheb homolog	Rheb CG1081	Drosophila melanogaster (Fruit fly)	182	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0000082; GO:0000139; GO:0002052; GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0007430; GO:0008286; GO:0010506; GO:0010507; GO:0010942; GO:0019003; GO:0030307; GO:0033500; GO:0035264; GO:0042594; GO:0042632; GO:0045176; GO:0045727; GO:0045793; GO:0045887; GO:0046872; GO:0055088; GO:0090070; GO:1902669; GO:1903940; GO:1904263; GO:1904503; GO:2000377	"apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"		brown	brown	1	NA	NA	NA
TRINITY_DN32705_c1_g1_i1	Q9VND8	RHEB_DROME	67	182	60	0	86	631	1	182	2.60E-68	260	RHEB_DROME	reviewed	GTP-binding protein Rheb homolog	Rheb CG1081	Drosophila melanogaster (Fruit fly)	182	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0000082; GO:0000139; GO:0002052; GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0007430; GO:0008286; GO:0010506; GO:0010507; GO:0010942; GO:0019003; GO:0030307; GO:0033500; GO:0035264; GO:0042594; GO:0042632; GO:0045176; GO:0045727; GO:0045793; GO:0045887; GO:0046872; GO:0055088; GO:0090070; GO:1902669; GO:1903940; GO:1904263; GO:1904503; GO:2000377	"apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"		blue	blue	NA	NA	NA	NA
TRINITY_DN20062_c0_g1_i1	Q9VND8	RHEB_DROME	81	42	8	0	193	68	9	50	7.60E-13	73.9	RHEB_DROME	reviewed	GTP-binding protein Rheb homolog	Rheb CG1081	Drosophila melanogaster (Fruit fly)	182	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0000082; GO:0000139; GO:0002052; GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0007430; GO:0008286; GO:0010506; GO:0010507; GO:0010942; GO:0019003; GO:0030307; GO:0033500; GO:0035264; GO:0042594; GO:0042632; GO:0045176; GO:0045727; GO:0045793; GO:0045887; GO:0046872; GO:0055088; GO:0090070; GO:1902669; GO:1903940; GO:1904263; GO:1904503; GO:2000377	"apical protein localization [GO:0045176]; carbohydrate homeostasis [GO:0033500]; cholesterol homeostasis [GO:0042632]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of lipophagy [GO:1904503]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; regulation of autophagy [GO:0010506]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to starvation [GO:0042594]; small GTPase mediated signal transduction [GO:0007264]; terminal branching, open tracheal system [GO:0007430]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29755_c1_g1_i1	Q92963	RIT1_HUMAN	61.1	190	73	1	686	120	22	211	4.60E-61	236.1	RIT1_HUMAN	reviewed	GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1)	RIT1 RIBB RIT ROC1	Homo sapiens (Human)	219	plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]	plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003	Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN34159_c0_g1_i1	Q92963	RIT1_HUMAN	100	81	0	0	3	245	13	93	2.30E-40	165.6	RIT1_HUMAN	reviewed	GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1)	RIT1 RIBB RIT ROC1	Homo sapiens (Human)	219	plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]	plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003	Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37841_c0_g1_i1	Q99578	RIT2_HUMAN	57	121	52	0	28	390	9	129	1.10E-31	137.5	RIT2_HUMAN	reviewed	GTP-binding protein Rit2 (EC 3.6.5.2) (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2)	RIT2 RIN ROC2	Homo sapiens (Human)	217	cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]	cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]	GO:0003682; GO:0003924; GO:0005516; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045202; GO:0045944; GO:0050848; GO:0097447	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN38427_c0_g1_i1	Q99578	RIT2_HUMAN	65.9	41	14	0	119	241	17	57	2.20E-11	69.3	RIT2_HUMAN	reviewed	GTP-binding protein Rit2 (EC 3.6.5.2) (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2)	RIT2 RIN ROC2	Homo sapiens (Human)	217	cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]	cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]	GO:0003682; GO:0003924; GO:0005516; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045202; GO:0045944; GO:0050848; GO:0097447	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN16919_c0_g1_i1	Q9NR31	SAR1A_HUMAN	99.4	158	1	0	476	3	1	158	6.40E-87	321.2	SAR1A_HUMAN	reviewed	GTP-binding protein SAR1a (COPII-associated small GTPase)	SAR1A SAR1 SARA SARA1	Homo sapiens (Human)	198	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0061024; GO:0070863; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN16919_c0_g1_i2	Q9NR31	SAR1A_HUMAN	100	198	0	0	638	45	1	198	9.10E-113	407.5	SAR1A_HUMAN	reviewed	GTP-binding protein SAR1a (COPII-associated small GTPase)	SAR1A SAR1 SARA SARA1	Homo sapiens (Human)	198	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0061024; GO:0070863; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1101_c0_g1_i1	Q9CQC9	SAR1B_MOUSE	73.3	180	48	0	595	56	19	198	3.10E-76	286.2	SAR1B_MOUSE	reviewed	GTP-binding protein SAR1b	Sar1b Sara1b Sara2	Mus musculus (Mouse)	198	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032580; GO:0046872; GO:0061024; GO:0070863; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1101_c0_g1_i2	Q9CQC9	SAR1B_MOUSE	69.9	196	55	1	631	56	3	198	1.60E-78	293.9	SAR1B_MOUSE	reviewed	GTP-binding protein SAR1b	Sar1b Sara1b Sara2	Mus musculus (Mouse)	198	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032580; GO:0046872; GO:0061024; GO:0070863; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN13031_c0_g1_i2	Q9CQC9	SAR1B_MOUSE	99.4	176	1	0	530	3	22	197	1.20E-99	363.6	SAR1B_MOUSE	reviewed	GTP-binding protein SAR1b	Sar1b Sara1b Sara2	Mus musculus (Mouse)	198	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032580; GO:0046872; GO:0061024; GO:0070863; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN13031_c0_g1_i1	Q9Y6B6	SAR1B_HUMAN	100	166	0	0	500	3	32	197	5.60E-94	344.7	SAR1B_HUMAN	reviewed	GTP-binding protein SAR1b (GTP-binding protein B) (GTBPB)	SAR1B SARA2 SARB	Homo sapiens (Human)	198	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0002474; GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0012507; GO:0016050; GO:0019886; GO:0030127; GO:0032580; GO:0046872; GO:0048208; GO:0061024; GO:0070863; GO:0070971	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN34753_c0_g1_i1	Q99260	YPT6_YEAST	53.3	107	50	0	321	1	6	112	2.60E-31	136	YPT6_YEAST	reviewed	GTP-binding protein YPT6	YPT6 YLR262C L8479.11	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	215	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular protein-containing complex localization [GO:0034629]; cytoplasm to vacuole transport by the Cvt pathway [GO:0032258]; Golgi to endosome transport [GO:0006895]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; protein localization to phagophore assembly site [GO:0034497]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000301; GO:0003924; GO:0005525; GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0006895; GO:0012505; GO:0016236; GO:0032258; GO:0034497; GO:0034629; GO:0042147	"cellular protein-containing complex localization [GO:0034629]; cytoplasm to vacuole transport by the Cvt pathway [GO:0032258]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; protein localization to phagophore assembly site [GO:0034497]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c0_g1_i2	Q39571	YPTC1_CHLRE	83.5	115	19	0	347	3	1	115	4.40E-52	205.3	YPTC1_CHLRE	reviewed	GTP-binding protein YPTC1	YPTC1	Chlamydomonas reinhardtii (Chlamydomonas smithii)	203	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN35541_c0_g1_i1	Q9I3S3	GBUA_PSEAE	72.2	306	82	1	962	54	14	319	6.10E-129	461.8	GBUA_PSEAE	reviewed	Guanidinobutyrase (EC 3.5.3.7)	gbuA PA1421	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	319	"agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]"		agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]	GO:0006527; GO:0008783; GO:0033389; GO:0046872; GO:0047971	"arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3028_c0_g2_i3	Q9I3S3	GBUA_PSEAE	65.6	151	52	0	519	67	139	289	8.90E-55	214.9	GBUA_PSEAE	reviewed	Guanidinobutyrase (EC 3.5.3.7)	gbuA PA1421	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	319	"agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]"		agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]	GO:0006527; GO:0008783; GO:0033389; GO:0046872; GO:0047971	"arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5818_c0_g1_i2	Q9R111	GUAD_MOUSE	48.2	440	218	5	1363	65	12	448	2.50E-113	411.4	GUAD_MOUSE	reviewed	Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH)	Gda	Mus musculus (Mouse)	454	deaminase activity [GO:0019239]; guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147]; guanine metabolic process [GO:0046098]; positive regulation of microtubule polymerization [GO:0031116]		deaminase activity [GO:0019239]; guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]	GO:0006147; GO:0008270; GO:0008892; GO:0019239; GO:0031116; GO:0046098	guanine catabolic process [GO:0006147]; guanine metabolic process [GO:0046098]; positive regulation of microtubule polymerization [GO:0031116]		NA	NA	NA	NA	NA	NA
TRINITY_DN2311_c0_g1_i1	Q9Y2T3	GUAD_HUMAN	48.9	407	200	4	1	1203	43	447	3.60E-103	376.7	GUAD_HUMAN	reviewed	Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH) (p51-nedasin)	GDA KIAA1258	Homo sapiens (Human)	454	cytosol [GO:0005829]; intracellular [GO:0005622]; deaminase activity [GO:0019239]; guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147]; guanine metabolic process [GO:0046098]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide catabolic process [GO:0006195]	cytosol [GO:0005829]; intracellular [GO:0005622]	deaminase activity [GO:0019239]; guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]	GO:0005622; GO:0005829; GO:0006139; GO:0006147; GO:0006195; GO:0007399; GO:0008270; GO:0008892; GO:0019239; GO:0046098	guanine catabolic process [GO:0006147]; guanine metabolic process [GO:0046098]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide catabolic process [GO:0006195]		NA	NA	NA	NA	NA	NA
TRINITY_DN5011_c0_g1_i1	Q96LT7	CI072_HUMAN	26.2	381	239	7	1114	89	86	463	8.00E-29	130.6	CI072_HUMAN	reviewed	Guanine nucleotide exchange C9orf72	C9orf72	Homo sapiens (Human)	481	autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of GTP binding [GO:1904425]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063]	autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]	GO:0000932; GO:0001933; GO:0005085; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0017137; GO:0030425; GO:0031965; GO:0032045; GO:0034063; GO:0043204; GO:0044295; GO:0044304; GO:0048675; GO:0110053; GO:1902774; GO:1903432; GO:1904425; GO:2000785	autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of GTP binding [GO:1904425]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN12838_c1_g3_i6	O15068	MCF2L_HUMAN	45.8	83	43	1	9	251	149	231	5.90E-15	81.6	MCF2L_HUMAN	reviewed	Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein)	MCF2L KIAA0362 OST	Homo sapiens (Human)	1137	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0012505; GO:0031234; GO:0035025; GO:0035091; GO:0035556; GO:0043065; GO:0051056	G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]		brown	brown	1	NA	NA	NA
TRINITY_DN19375_c1_g1_i1	Q63406	MCF2L_RAT	61.2	80	29	2	4	243	696	773	1.60E-22	106.3	MCF2L_RAT	reviewed	Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene)	Mcf2l Ost	Rattus norvegicus (Rat)	1149	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; lamellipodium [GO:0030027]; membrane [GO:0016020]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; lamellipodium [GO:0030027]; membrane [GO:0016020]	1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005545; GO:0005737; GO:0007266; GO:0012505; GO:0016020; GO:0019898; GO:0030027; GO:0031234; GO:0035025; GO:0035091; GO:0045944	positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN28662_c0_g1_i1	Q8VDV3	R3GEF_MOUSE	100	69	0	0	209	3	302	370	4.20E-35	147.9	R3GEF_MOUSE	reviewed	Guanine nucleotide exchange factor for Rab-3A (Rab-3A-interacting-like protein 1) (Rab3A-interacting-like protein 1) (Rabin3-like 1)	Rab3il1	Mus musculus (Mouse)	383	Golgi to plasma membrane transport vesicle [GO:0070319]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; exocytosis [GO:0006887]; protein transport [GO:0015031]	Golgi to plasma membrane transport vesicle [GO:0070319]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0006887; GO:0015031; GO:0017112; GO:0019900; GO:0042802; GO:0070319	exocytosis [GO:0006887]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5086_c0_g1_i1	Q8VDV3	R3GEF_MOUSE	40.1	299	149	7	949	83	100	378	8.90E-48	192.2	R3GEF_MOUSE	reviewed	Guanine nucleotide exchange factor for Rab-3A (Rab-3A-interacting-like protein 1) (Rab3A-interacting-like protein 1) (Rabin3-like 1)	Rab3il1	Mus musculus (Mouse)	383	Golgi to plasma membrane transport vesicle [GO:0070319]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; exocytosis [GO:0006887]; protein transport [GO:0015031]	Golgi to plasma membrane transport vesicle [GO:0070319]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0006887; GO:0015031; GO:0017112; GO:0019900; GO:0042802; GO:0070319	exocytosis [GO:0006887]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4539_c0_g1_i1	Q9VLP3	MSS4_DROME	43	114	63	1	48	383	6	119	2.10E-21	103.6	MSS4_DROME	reviewed	Guanine nucleotide exchange factor MSS4 homolog (Guanine nucleotide exchange factor stratum)	strat CG7787	Drosophila melanogaster (Fruit fly)	122	basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; zinc ion binding [GO:0008270]; polarized secretion of basement membrane proteins in epithelium [GO:0061865]; positive regulation of GTPase activity [GO:0043547]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]	basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0009925; GO:0015031; GO:0016020; GO:0017112; GO:0043547; GO:0045180; GO:0061865	polarized secretion of basement membrane proteins in epithelium [GO:0061865]; positive regulation of GTPase activity [GO:0043547]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN7387_c0_g1_i2	E7FA21	SMR8A_DANRE	36.8	190	105	4	114	641	17	205	5.40E-26	121.3	SMR8A_DANRE	reviewed	Guanine nucleotide exchange protein smcr8a (Smith-Magenis syndrome chromosomal region candidate gene 8 protein homolog A)	smcr8a	Danio rerio (Zebrafish) (Brachydanio rerio)	853	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; autophagy [GO:0006914]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005634; GO:0005737; GO:0006914; GO:0032045	autophagy [GO:0006914]		NA	NA	NA	NA	NA	NA
TRINITY_DN3973_c0_g1_i1	P41776	GNAI_HOMAM	94.4	198	11	0	87	680	1	198	8.60E-102	371.3	GNAI_HOMAM	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha (Adenylate cyclase-inhibiting G alpha protein)		Homarus americanus (American lobster)	355	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		NA	NA	NA	NA	NA	NA
TRINITY_DN3973_c0_g1_i2	P41776	GNAI_HOMAM	95.5	355	16	0	87	1151	1	355	2.80E-195	682.6	GNAI_HOMAM	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha (Adenylate cyclase-inhibiting G alpha protein)		Homarus americanus (American lobster)	355	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		NA	NA	NA	NA	NA	NA
TRINITY_DN10582_c0_g1_i1	P08753	GNAI3_RAT	99.3	302	2	0	994	89	53	354	4.90E-174	611.7	GNAI3_RAT	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha (G(i) alpha-3)	Gnai3 Gnai-3	Rattus norvegicus (Rat)	354	centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; GTP metabolic process [GO:0046039]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of secretion [GO:0051048]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; vesicle fusion [GO:0006906]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]	GDP binding [GO:0019003]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0001664; GO:0003924; GO:0005525; GO:0005737; GO:0005789; GO:0005794; GO:0005813; GO:0005834; GO:0005886; GO:0006906; GO:0007049; GO:0007188; GO:0007193; GO:0007212; GO:0007420; GO:0016020; GO:0016239; GO:0019003; GO:0019904; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0032930; GO:0033864; GO:0042588; GO:0045121; GO:0046039; GO:0046872; GO:0051048; GO:0051301; GO:1904707; GO:2001234	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; GTP metabolic process [GO:0046039]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of secretion [GO:0051048]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN10582_c0_g1_i2	P08754	GNAI3_HUMAN	100	302	0	0	994	89	53	354	5.80E-175	614.8	GNAI3_HUMAN	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha (G(i) alpha-3)	GNAI3	Homo sapiens (Human)	354	centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; vesicle fusion [GO:0006906]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]	GDP binding [GO:0019003]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0001664; GO:0003924; GO:0005525; GO:0005737; GO:0005765; GO:0005794; GO:0005813; GO:0005834; GO:0005886; GO:0006457; GO:0006906; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0007194; GO:0007212; GO:0007420; GO:0016020; GO:0016239; GO:0019003; GO:0019904; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0032930; GO:0033864; GO:0042588; GO:0045121; GO:0046039; GO:0046872; GO:0051301; GO:0070062; GO:1904707; GO:2001234	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN4600_c0_g1_i1	P04899	GNAI2_HUMAN	100	355	0	0	24	1088	1	355	6.30E-205	714.5	GNAI2_HUMAN	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein)	GNAI2 GNAI2B	Homo sapiens (Human)	355	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0001973; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005834; GO:0005886; GO:0006457; GO:0007049; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007194; GO:0007213; GO:0007214; GO:0007584; GO:0008283; GO:0008284; GO:0016020; GO:0030335; GO:0030425; GO:0030496; GO:0031683; GO:0032930; GO:0033864; GO:0035810; GO:0035815; GO:0044297; GO:0045121; GO:0045202; GO:0045955; GO:0046628; GO:0046872; GO:0050805; GO:0051301; GO:0051924; GO:0070062; GO:0070374; GO:0140199; GO:1903561; GO:1903614; GO:1904707; GO:2000179; GO:2001234	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4600_c0_g1_i2	P04899	GNAI2_HUMAN	99.2	259	2	0	2	778	97	355	6.20E-149	528.1	GNAI2_HUMAN	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein)	GNAI2 GNAI2B	Homo sapiens (Human)	355	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0001973; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005834; GO:0005886; GO:0006457; GO:0007049; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007194; GO:0007213; GO:0007214; GO:0007584; GO:0008283; GO:0008284; GO:0016020; GO:0030335; GO:0030425; GO:0030496; GO:0031683; GO:0032930; GO:0033864; GO:0035810; GO:0035815; GO:0044297; GO:0045121; GO:0045202; GO:0045955; GO:0046628; GO:0046872; GO:0050805; GO:0051301; GO:0051924; GO:0070062; GO:0070374; GO:0140199; GO:1903561; GO:1903614; GO:1904707; GO:2000179; GO:2001234	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4600_c0_g1_i3	P08752	GNAI2_MOUSE	100	355	0	0	24	1088	1	355	9.10E-204	710.7	GNAI2_MOUSE	reviewed	Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein)	Gnai2 Gnai-2	Mus musculus (Mouse)	355	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924]	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0001973; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005834; GO:0005886; GO:0007049; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007213; GO:0007214; GO:0008283; GO:0008284; GO:0016020; GO:0030335; GO:0030425; GO:0030496; GO:0031683; GO:0032930; GO:0033864; GO:0035810; GO:0035815; GO:0044297; GO:0045121; GO:0045202; GO:0045955; GO:0046628; GO:0046872; GO:0050805; GO:0051301; GO:0051924; GO:0070374; GO:0140199; GO:1903614; GO:1904707; GO:2000179; GO:2001234	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924]		NA	NA	NA	NA	NA	NA
TRINITY_DN13962_c0_g2_i2	P62871	GBB1_BOVIN	99.7	306	1	0	995	78	35	340	2.30E-184	646	GBB1_BOVIN	reviewed	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)	GNB1	Bos taurus (Bovine)	340	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; G-protein gamma-subunit binding [GO:0031682]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]	G-protein gamma-subunit binding [GO:0031682]	GO:0005737; GO:0005834; GO:0007186; GO:0007191; GO:0016020; GO:0031682; GO:0071380; GO:0071870; GO:0097381	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN13962_c0_g2_i3	P62871	GBB1_BOVIN	100	265	0	0	894	100	76	340	3.70E-160	565.5	GBB1_BOVIN	reviewed	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)	GNB1	Bos taurus (Bovine)	340	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; G-protein gamma-subunit binding [GO:0031682]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]	G-protein gamma-subunit binding [GO:0031682]	GO:0005737; GO:0005834; GO:0007186; GO:0007191; GO:0016020; GO:0031682; GO:0071380; GO:0071870; GO:0097381	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN40842_c0_g1_i1	P62871	GBB1_BOVIN	100	80	0	0	241	2	9	88	1.50E-39	162.9	GBB1_BOVIN	reviewed	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)	GNB1	Bos taurus (Bovine)	340	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; G-protein gamma-subunit binding [GO:0031682]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]	G-protein gamma-subunit binding [GO:0031682]	GO:0005737; GO:0005834; GO:0007186; GO:0007191; GO:0016020; GO:0031682; GO:0071380; GO:0071870; GO:0097381	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN38655_c0_g1_i1	O45040	GBB1_HOMAM	98.5	338	5	0	1103	90	3	340	2.00E-200	699.5	GBB1_HOMAM	reviewed	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)	GBETA1	Homarus americanus (American lobster)	340	signal transduction [GO:0007165]			GO:0007165	signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN13962_c0_g1_i1	P11017	GBB2_BOVIN	100	290	0	0	964	95	51	340	3.00E-176	619	GBB2_BOVIN	reviewed	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2)	GNB2	Bos taurus (Bovine)	340	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; perinuclear region of cytoplasm [GO:0048471]; G-protein gamma-subunit binding [GO:0031682]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; perinuclear region of cytoplasm [GO:0048471]	G-protein gamma-subunit binding [GO:0031682]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]	GO:0003924; GO:0005737; GO:0005834; GO:0007186; GO:0031682; GO:0044877; GO:0048471; GO:0051020	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN13962_c0_g1_i2	P11017	GBB2_BOVIN	100	128	0	0	478	95	213	340	1.10E-73	277.3	GBB2_BOVIN	reviewed	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2)	GNB2	Bos taurus (Bovine)	340	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; perinuclear region of cytoplasm [GO:0048471]; G-protein gamma-subunit binding [GO:0031682]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; perinuclear region of cytoplasm [GO:0048471]	G-protein gamma-subunit binding [GO:0031682]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]	GO:0003924; GO:0005737; GO:0005834; GO:0007186; GO:0031682; GO:0044877; GO:0048471; GO:0051020	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN651_c0_g1_i1	P38404	GNAO_LOCMI	92.1	354	28	0	1144	83	1	354	3.70E-189	662.1	GNAO_LOCMI	reviewed	Guanine nucleotide-binding protein G(o) subunit alpha		Locusta migratoria (Migratory locust)	354	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		NA	NA	NA	NA	NA	NA
TRINITY_DN651_c0_g1_i10	P38404	GNAO_LOCMI	94.6	354	19	0	1144	83	1	354	1.90E-193	676.4	GNAO_LOCMI	reviewed	Guanine nucleotide-binding protein G(o) subunit alpha		Locusta migratoria (Migratory locust)	354	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		blue	blue	NA	NA	NA	NA
TRINITY_DN651_c0_g1_i4	P38404	GNAO_LOCMI	94.3	158	9	0	535	62	197	354	2.50E-85	316.2	GNAO_LOCMI	reviewed	Guanine nucleotide-binding protein G(o) subunit alpha		Locusta migratoria (Migratory locust)	354	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		NA	NA	NA	NA	NA	NA
TRINITY_DN651_c0_g1_i6	P38404	GNAO_LOCMI	91.5	331	28	0	994	2	1	331	8.60E-174	610.9	GNAO_LOCMI	reviewed	Guanine nucleotide-binding protein G(o) subunit alpha		Locusta migratoria (Migratory locust)	354	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		NA	NA	NA	NA	NA	NA
TRINITY_DN651_c0_g1_i9	P38404	GNAO_LOCMI	89	354	37	1	1138	83	1	354	1.80E-183	643.3	GNAO_LOCMI	reviewed	Guanine nucleotide-binding protein G(o) subunit alpha		Locusta migratoria (Migratory locust)	354	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]		NA	NA	NA	NA	NA	NA
TRINITY_DN32463_c0_g1_i1	P38405	GNAL_HUMAN	45.7	70	36	2	205	2	259	328	1.00E-10	67	GNAL_HUMAN	reviewed	"Guanine nucleotide-binding protein G(olf) subunit alpha (Adenylate cyclase-stimulating G alpha protein, olfactory type)"	GNAL	Homo sapiens (Human)	381	extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165]	extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0007189; GO:0007191; GO:0007193; GO:0007606; GO:0031683; GO:0046872; GO:0070062	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN25631_c0_g1_i1	P91950	GNAQ_HOMAM	100	82	0	0	246	1	16	97	2.80E-38	158.7	GNAQ_HOMAM	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Homarus americanus (American lobster)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN14939_c0_g1_i1	P38411	GNAQ_LYMST	33.8	151	91	3	160	606	33	176	4.10E-20	100.1	GNAQ_LYMST	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN14939_c0_g1_i14	P38411	GNAQ_LYMST	34.6	185	112	3	253	801	33	210	3.30E-27	123.6	GNAQ_LYMST	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		blue	blue	NA	NA	NA	NA
TRINITY_DN14939_c0_g1_i2	P38411	GNAQ_LYMST	33.8	151	91	3	253	699	33	176	4.20E-20	100.1	GNAQ_LYMST	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		blue	blue	NA	NA	NA	NA
TRINITY_DN14939_c0_g1_i5	P38411	GNAQ_LYMST	35	157	92	4	160	621	33	182	1.80E-21	104.4	GNAQ_LYMST	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		blue	blue	NA	NA	NA	NA
TRINITY_DN14939_c0_g1_i6	P38411	GNAQ_LYMST	33.8	151	91	3	232	678	33	176	4.10E-20	100.1	GNAQ_LYMST	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN2863_c0_g1_i1	P91950	GNAQ_HOMAM	85.7	56	8	0	235	68	101	156	5.40E-23	107.8	GNAQ_HOMAM	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Homarus americanus (American lobster)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN2863_c0_g1_i2	P91950	GNAQ_HOMAM	95.7	253	11	0	812	54	101	353	6.50E-140	498	GNAQ_HOMAM	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Homarus americanus (American lobster)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN2863_c0_g1_i3	P91950	GNAQ_HOMAM	91.3	253	22	0	812	54	101	353	5.30E-134	478.4	GNAQ_HOMAM	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)		Homarus americanus (American lobster)	353	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN12915_c0_g2_i1	P29797	GNAS_PIG	99	102	0	1	307	2	2	102	2.00E-46	186	GNAS_PIG	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein)	GNAS	Sus scrofa (Pig)	397	heterotrimeric G-protein complex [GO:0005834]; adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of GTPase activity [GO:0043547]; sensory perception of chemical stimulus [GO:0007606]	heterotrimeric G-protein complex [GO:0005834]	adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]	GO:0001664; GO:0003924; GO:0005159; GO:0005525; GO:0005834; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0010856; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0035255; GO:0043547; GO:0043950; GO:0046872; GO:0051430; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of GTPase activity [GO:0043547]; sensory perception of chemical stimulus [GO:0007606]		NA	NA	NA	NA	NA	NA
TRINITY_DN29635_c0_g1_i1	O16118	GNAS_HOMAM	93.9	379	23	0	94	1230	1	379	6.90E-208	724.5	GNAS_HOMAM	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein)		Homarus americanus (American lobster)	379	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]		G-protein beta/gamma-subunit complex binding [GO:0031683]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor signaling pathway [GO:0007186]		blue	blue	NA	NA	NA	NA
TRINITY_DN12915_c0_g2_i2	P04896	GNAS2_BOVIN	100	116	0	0	349	2	2	117	4.20E-56	218.4	GNAS2_BOVIN	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein)	GNAS GNAS1	Bos taurus (Bovine)	394	heterotrimeric G-protein complex [GO:0005834]; adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of GTPase activity [GO:0043547]; sensory perception of chemical stimulus [GO:0007606]	heterotrimeric G-protein complex [GO:0005834]	adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]	GO:0001664; GO:0003924; GO:0005159; GO:0005525; GO:0005834; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0010856; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0035255; GO:0043547; GO:0043950; GO:0046872; GO:0051430; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of GTPase activity [GO:0043547]; sensory perception of chemical stimulus [GO:0007606]		NA	NA	NA	NA	NA	NA
TRINITY_DN12915_c0_g1_i1	Q5JWF2	GNAS1_HUMAN	100	271	0	0	1	813	767	1037	9.60E-161	567.4	GNAS1_HUMAN	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)	GNAS GNAS1	Homo sapiens (Human)	1037	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; regulation of parathyroid hormone secretion [GO:2000828]; response to drug [GO:0042493]; sensory perception of chemical stimulus [GO:0007606]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]	adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]	GO:0001664; GO:0001894; GO:0001958; GO:0003924; GO:0005159; GO:0005525; GO:0005829; GO:0005834; GO:0006112; GO:0006306; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0010856; GO:0016020; GO:0016324; GO:0030425; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0035116; GO:0035255; GO:0035264; GO:0040032; GO:0042493; GO:0043588; GO:0045669; GO:0045672; GO:0046872; GO:0048589; GO:0048701; GO:0051216; GO:0051430; GO:0060348; GO:0070062; GO:0070527; GO:0071514; GO:0120162; GO:2000828	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; regulation of parathyroid hormone secretion [GO:2000828]; response to drug [GO:0042493]; sensory perception of chemical stimulus [GO:0007606]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]		NA	NA	NA	NA	NA	NA
TRINITY_DN12915_c0_g1_i2	Q6R0H7	GNAS1_MOUSE	100	269	0	0	2	808	865	1133	1.80E-159	563.1	GNAS1_MOUSE	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)	Gnas Gnas1	Mus musculus (Mouse)	1133	apical plasma membrane [GO:0016324]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; heterotrimeric G-protein complex [GO:0005834]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]; adenylate cyclase activator activity [GO:0010856]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; alpha-tubulin binding [GO:0043014]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; protein domain specific binding [GO:0019904]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; cognition [GO:0050890]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway [GO:0007186]; genetic imprinting [GO:0071514]; hair follicle placode formation [GO:0060789]; multicellular organism growth [GO:0035264]; negative regulation of blood pressure [GO:0045776]; negative regulation of renal sodium excretion [GO:0035814]; platelet aggregation [GO:0070527]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sodium ion transport [GO:0010765]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to parathyroid hormone [GO:0071107]; sensory perception of chemical stimulus [GO:0007606]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]	apical plasma membrane [GO:0016324]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; heterotrimeric G-protein complex [GO:0005834]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]	adenylate cyclase activator activity [GO:0010856]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; alpha-tubulin binding [GO:0043014]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; protein domain specific binding [GO:0019904]	GO:0001501; GO:0001664; GO:0001726; GO:0001894; GO:0001934; GO:0001958; GO:0001965; GO:0003924; GO:0005159; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005834; GO:0005886; GO:0006112; GO:0006306; GO:0006357; GO:0007186; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0008284; GO:0009791; GO:0009966; GO:0010765; GO:0010856; GO:0016020; GO:0016324; GO:0019904; GO:0030142; GO:0030425; GO:0031224; GO:0031681; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0032588; GO:0035116; GO:0035255; GO:0035264; GO:0035814; GO:0040032; GO:0042493; GO:0043014; GO:0043025; GO:0043547; GO:0043588; GO:0043950; GO:0045121; GO:0045669; GO:0045672; GO:0045776; GO:0046872; GO:0047391; GO:0048471; GO:0048589; GO:0048701; GO:0050890; GO:0051216; GO:0051430; GO:0055037; GO:0055074; GO:0060348; GO:0060789; GO:0070527; GO:0071107; GO:0071380; GO:0071514; GO:0071870; GO:0071880; GO:0120162; GO:2000828	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; cognition [GO:0050890]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle placode formation [GO:0060789]; multicellular organism growth [GO:0035264]; negative regulation of blood pressure [GO:0045776]; negative regulation of renal sodium excretion [GO:0035814]; platelet aggregation [GO:0070527]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sodium ion transport [GO:0010765]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to parathyroid hormone [GO:0071107]; sensory perception of chemical stimulus [GO:0007606]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]		NA	NA	NA	NA	NA	NA
TRINITY_DN12915_c0_g1_i3	Q5JWF2	GNAS1_HUMAN	100	271	0	0	1	813	767	1037	7.40E-161	567.8	GNAS1_HUMAN	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)	GNAS GNAS1	Homo sapiens (Human)	1037	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; regulation of parathyroid hormone secretion [GO:2000828]; response to drug [GO:0042493]; sensory perception of chemical stimulus [GO:0007606]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]	adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]	GO:0001664; GO:0001894; GO:0001958; GO:0003924; GO:0005159; GO:0005525; GO:0005829; GO:0005834; GO:0006112; GO:0006306; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0010856; GO:0016020; GO:0016324; GO:0030425; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0035116; GO:0035255; GO:0035264; GO:0040032; GO:0042493; GO:0043588; GO:0045669; GO:0045672; GO:0046872; GO:0048589; GO:0048701; GO:0051216; GO:0051430; GO:0060348; GO:0070062; GO:0070527; GO:0071514; GO:0120162; GO:2000828	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cartilage development [GO:0051216]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; multicellular organism growth [GO:0035264]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; post-embryonic body morphogenesis [GO:0040032]; regulation of parathyroid hormone secretion [GO:2000828]; response to drug [GO:0042493]; sensory perception of chemical stimulus [GO:0007606]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]		NA	NA	NA	NA	NA	NA
TRINITY_DN12915_c0_g1_i4	Q6R0H7	GNAS1_MOUSE	100	269	0	0	2	808	865	1133	1.40E-159	563.5	GNAS1_MOUSE	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)	Gnas Gnas1	Mus musculus (Mouse)	1133	apical plasma membrane [GO:0016324]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; heterotrimeric G-protein complex [GO:0005834]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]; adenylate cyclase activator activity [GO:0010856]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; alpha-tubulin binding [GO:0043014]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; protein domain specific binding [GO:0019904]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; cognition [GO:0050890]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway [GO:0007186]; genetic imprinting [GO:0071514]; hair follicle placode formation [GO:0060789]; multicellular organism growth [GO:0035264]; negative regulation of blood pressure [GO:0045776]; negative regulation of renal sodium excretion [GO:0035814]; platelet aggregation [GO:0070527]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sodium ion transport [GO:0010765]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to parathyroid hormone [GO:0071107]; sensory perception of chemical stimulus [GO:0007606]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]	apical plasma membrane [GO:0016324]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; heterotrimeric G-protein complex [GO:0005834]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]	adenylate cyclase activator activity [GO:0010856]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; alpha-tubulin binding [GO:0043014]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; protein domain specific binding [GO:0019904]	GO:0001501; GO:0001664; GO:0001726; GO:0001894; GO:0001934; GO:0001958; GO:0001965; GO:0003924; GO:0005159; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005834; GO:0005886; GO:0006112; GO:0006306; GO:0006357; GO:0007186; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0008284; GO:0009791; GO:0009966; GO:0010765; GO:0010856; GO:0016020; GO:0016324; GO:0019904; GO:0030142; GO:0030425; GO:0031224; GO:0031681; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0032588; GO:0035116; GO:0035255; GO:0035264; GO:0035814; GO:0040032; GO:0042493; GO:0043014; GO:0043025; GO:0043547; GO:0043588; GO:0043950; GO:0045121; GO:0045669; GO:0045672; GO:0045776; GO:0046872; GO:0047391; GO:0048471; GO:0048589; GO:0048701; GO:0050890; GO:0051216; GO:0051430; GO:0055037; GO:0055074; GO:0060348; GO:0060789; GO:0070527; GO:0071107; GO:0071380; GO:0071514; GO:0071870; GO:0071880; GO:0120162; GO:2000828	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; cognition [GO:0050890]; developmental growth [GO:0048589]; DNA methylation [GO:0006306]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hindlimb morphogenesis [GO:0035116]; endochondral ossification [GO:0001958]; energy reserve metabolic process [GO:0006112]; genetic imprinting [GO:0071514]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle placode formation [GO:0060789]; multicellular organism growth [GO:0035264]; negative regulation of blood pressure [GO:0045776]; negative regulation of renal sodium excretion [GO:0035814]; platelet aggregation [GO:0070527]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sodium ion transport [GO:0010765]; post-embryonic body morphogenesis [GO:0040032]; post-embryonic development [GO:0009791]; regulation of parathyroid hormone secretion [GO:2000828]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to parathyroid hormone [GO:0071107]; sensory perception of chemical stimulus [GO:0007606]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tissue homeostasis [GO:0001894]		NA	NA	NA	NA	NA	NA
TRINITY_DN9384_c0_g1_i1	P25157	GNAL_DROME	65.3	150	51	1	449	3	265	414	3.60E-50	199.1	GNAL_DROME	reviewed	Guanine nucleotide-binding protein subunit alpha homolog (Protein concertina)	cta CTR CG17678	Drosophila melanogaster (Fruit fly)	457	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; actin-mediated cell contraction [GO:0070252]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apical constriction involved in gastrulation [GO:0003384]; convergent extension involved in gastrulation [GO:0060027]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; gastrulation involving germ band extension [GO:0010004]; mesectoderm development [GO:0048383]; regulation of embryonic cell shape [GO:0016476]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]; Rho protein signal transduction [GO:0007266]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]	D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003380; GO:0003384; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0005886; GO:0007188; GO:0007266; GO:0010004; GO:0010470; GO:0016476; GO:0031526; GO:0031683; GO:0031752; GO:0043519; GO:0046872; GO:0048383; GO:0060027; GO:0070252	actin-mediated cell contraction [GO:0070252]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apical constriction involved in gastrulation [GO:0003384]; convergent extension involved in gastrulation [GO:0060027]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; gastrulation involving germ band extension [GO:0010004]; mesectoderm development [GO:0048383]; regulation of embryonic cell shape [GO:0016476]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN9384_c0_g1_i3	P25157	GNAL_DROME	60.5	311	121	2	932	3	105	414	1.30E-102	374.4	GNAL_DROME	reviewed	Guanine nucleotide-binding protein subunit alpha homolog (Protein concertina)	cta CTR CG17678	Drosophila melanogaster (Fruit fly)	457	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; actin-mediated cell contraction [GO:0070252]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apical constriction involved in gastrulation [GO:0003384]; convergent extension involved in gastrulation [GO:0060027]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; gastrulation involving germ band extension [GO:0010004]; mesectoderm development [GO:0048383]; regulation of embryonic cell shape [GO:0016476]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]; Rho protein signal transduction [GO:0007266]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]	D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001664; GO:0003380; GO:0003384; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0005886; GO:0007188; GO:0007266; GO:0010004; GO:0010470; GO:0016476; GO:0031526; GO:0031683; GO:0031752; GO:0043519; GO:0046872; GO:0048383; GO:0060027; GO:0070252	actin-mediated cell contraction [GO:0070252]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apical constriction involved in gastrulation [GO:0003384]; convergent extension involved in gastrulation [GO:0060027]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; gastrulation involving germ band extension [GO:0010004]; mesectoderm development [GO:0048383]; regulation of embryonic cell shape [GO:0016476]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN32449_c0_g1_i1	Q14344	GNA13_HUMAN	100	116	0	0	2	349	12	127	4.00E-62	238.4	GNA13_HUMAN	reviewed	Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)	GNA13	Homo sapiens (Human)	377	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0016020; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0042470; GO:0043065; GO:0046872; GO:0051056; GO:0070062	activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN9384_c0_g1_i2	Q14344	GNA13_HUMAN	52.2	157	69	1	540	88	14	170	3.50E-39	162.9	GNA13_HUMAN	reviewed	Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)	GNA13	Homo sapiens (Human)	377	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0016020; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0042470; GO:0043065; GO:0046872; GO:0051056; GO:0070062	activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32211_c0_g1_i1	Q14344	GNA13_HUMAN	100	90	0	0	8	277	148	237	1.20E-48	193.4	GNA13_HUMAN	reviewed	Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)	GNA13	Homo sapiens (Human)	377	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0016020; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0042470; GO:0043065; GO:0046872; GO:0051056; GO:0070062	activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN28919_c0_g1_i1	P30678	GNA15_MOUSE	98.8	84	1	0	1	252	223	306	4.80E-41	167.9	GNA15_MOUSE	reviewed	Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15)	Gna15 Gna-15	Mus musculus (Mouse)	374	heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]	heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]	GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0007186; GO:0007188; GO:0007200; GO:0016020; GO:0031683; GO:0031826; GO:0046872; GO:0051482; GO:0060158	action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]		NA	NA	NA	NA	NA	NA
TRINITY_DN37732_c0_g1_i1	P30679	GNA15_HUMAN	100	69	0	0	1	207	25	93	3.30E-32	138.3	GNA15_HUMAN	reviewed	Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15) (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16) (G alpha-16) (G-protein subunit alpha-16)	GNA15 GNA16	Homo sapiens (Human)	374	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]	GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007202; GO:0007207; GO:0030168; GO:0031683; GO:0031826; GO:0045202; GO:0046872; GO:0051482; GO:0060158	action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]		NA	NA	NA	NA	NA	NA
TRINITY_DN31104_c0_g1_i1	P30679	GNA15_HUMAN	99.4	158	1	0	476	3	160	317	2.20E-87	322.8	GNA15_HUMAN	reviewed	Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15) (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16) (G alpha-16) (G-protein subunit alpha-16)	GNA15 GNA16	Homo sapiens (Human)	374	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]	GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007202; GO:0007207; GO:0030168; GO:0031683; GO:0031826; GO:0045202; GO:0046872; GO:0051482; GO:0060158	action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]		NA	NA	NA	NA	NA	NA
TRINITY_DN2410_c0_g1_i3	Q20636	GBB2_CAEEL	67.6	346	112	0	112	1149	11	356	1.30E-148	527.7	GBB2_CAEEL	reviewed	Guanine nucleotide-binding protein subunit beta-2	gpb-2 eat-11 gbp-2 F52A8.2	Caenorhabditis elegans	369	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; G-protein gamma-subunit binding [GO:0031682]; dopamine receptor signaling pathway [GO:0007212]; feeding behavior [GO:0007631]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of locomotion [GO:0040012]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; response to food [GO:0032094]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	G-protein gamma-subunit binding [GO:0031682]	GO:0005737; GO:0005834; GO:0007186; GO:0007212; GO:0007213; GO:0007631; GO:0008277; GO:0010629; GO:0031682; GO:0032094; GO:0040012; GO:0043025; GO:0043051; GO:0043547; GO:0045202; GO:0046662	dopamine receptor signaling pathway [GO:0007212]; feeding behavior [GO:0007631]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of locomotion [GO:0040012]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; response to food [GO:0032094]		blue	blue	NA	NA	NA	NA
TRINITY_DN2410_c0_g1_i7	Q20636	GBB2_CAEEL	67.6	346	112	0	112	1149	11	356	1.20E-148	527.7	GBB2_CAEEL	reviewed	Guanine nucleotide-binding protein subunit beta-2	gpb-2 eat-11 gbp-2 F52A8.2	Caenorhabditis elegans	369	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; G-protein gamma-subunit binding [GO:0031682]; dopamine receptor signaling pathway [GO:0007212]; feeding behavior [GO:0007631]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of locomotion [GO:0040012]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; response to food [GO:0032094]	cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	G-protein gamma-subunit binding [GO:0031682]	GO:0005737; GO:0005834; GO:0007186; GO:0007212; GO:0007213; GO:0007631; GO:0008277; GO:0010629; GO:0031682; GO:0032094; GO:0040012; GO:0043025; GO:0043051; GO:0043547; GO:0045202; GO:0046662	dopamine receptor signaling pathway [GO:0007212]; feeding behavior [GO:0007631]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of gene expression [GO:0010629]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of locomotion [GO:0040012]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; response to food [GO:0032094]		blue	blue	NA	NA	NA	NA
TRINITY_DN39178_c0_g1_i1	O42248	GBLP_DANRE	64.8	267	91	1	803	3	1	264	1.90E-102	373.6	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN234_c0_g1_i2	O42248	GBLP_DANRE	79.5	317	65	0	1041	91	1	317	6.70E-158	558.1	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		blue	blue	NA	NA	NA	NA
TRINITY_DN234_c0_g1_i3	O42248	GBLP_DANRE	65.2	310	105	1	979	59	3	312	5.30E-120	432.2	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		red	red	NA	NA	NA	NA
TRINITY_DN234_c0_g1_i4	O42248	GBLP_DANRE	79.5	317	65	0	1041	91	1	317	5.50E-158	558.5	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN234_c0_g1_i6	O42248	GBLP_DANRE	85.9	71	10	0	214	2	182	252	2.90E-31	135.2	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		blue	blue	NA	NA	NA	NA
TRINITY_DN234_c0_g1_i7	O42248	GBLP_DANRE	79.5	317	65	0	1041	91	1	317	5.60E-158	558.5	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		blue	blue	NA	NA	NA	NA
TRINITY_DN10926_c0_g1_i1	O42248	GBLP_DANRE	81.6	49	9	0	1	147	201	249	6.10E-18	91.3	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN10926_c0_g1_i1	O42248	GBLP_DANRE	76.2	42	10	0	143	268	249	290	1.30E-12	73.6	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN10926_c0_g1_i2	O42248	GBLP_DANRE	82.4	91	16	0	2	274	159	249	1.10E-41	171	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN10926_c0_g1_i2	O42248	GBLP_DANRE	78.3	69	15	0	270	476	249	317	7.70E-27	121.7	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN17825_c1_g1_i1	O42248	GBLP_DANRE	73.1	104	28	0	3	314	210	313	5.30E-42	171.4	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		blue	blue	NA	NA	NA	NA
TRINITY_DN33295_c0_g1_i1	O42248	GBLP_DANRE	69.9	83	25	0	253	5	235	317	6.40E-30	131	GBLP_DANRE	reviewed	Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)	gnb2l1 rack1	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]; angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; ribosome binding [GO:0043022]	GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0019899; GO:0022627; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543	angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]		NA	NA	NA	NA	NA	NA
TRINITY_DN234_c0_g2_i1	Q4R7Y4	GBLP_MACFA	100	317	0	0	976	26	1	317	9.30E-192	670.6	GBLP_MACFA	reviewed	"Guanine nucleotide-binding protein subunit beta-2-like 1 [Cleaved into: Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed]"	GNB2L1 QtsA-14081	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	317	cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribosome [GO:0005840]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of translation [GO:0006417]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribosome [GO:0005840]	protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]	GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006417; GO:0006915; GO:0007049; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:2000114; GO:2000543	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of translation [GO:0006417]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN234_c0_g2_i2	Q4R7Y4	GBLP_MACFA	100	317	0	0	976	26	1	317	9.30E-192	670.6	GBLP_MACFA	reviewed	"Guanine nucleotide-binding protein subunit beta-2-like 1 [Cleaved into: Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed]"	GNB2L1 QtsA-14081	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	317	cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribosome [GO:0005840]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of translation [GO:0006417]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribosome [GO:0005840]	protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]	GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006417; GO:0006915; GO:0007049; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:2000114; GO:2000543	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of translation [GO:0006417]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN30999_c0_g1_i1	Q4R7Y4	GBLP_MACFA	100	106	0	0	60	377	1	106	1.40E-57	223.4	GBLP_MACFA	reviewed	"Guanine nucleotide-binding protein subunit beta-2-like 1 [Cleaved into: Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed]"	GNB2L1 QtsA-14081	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	317	cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribosome [GO:0005840]; protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of translation [GO:0006417]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribosome [GO:0005840]	protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]	GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006417; GO:0006915; GO:0007049; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:2000114; GO:2000543	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of translation [GO:0006417]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40346_c0_g1_i1	Q9HAV0	GBB4_HUMAN	100	97	0	0	292	2	27	123	9.10E-52	203.8	GBB4_HUMAN	reviewed	Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4)	GNB4	Homo sapiens (Human)	340	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; G-protein gamma-subunit binding [GO:0031682]; protein-containing complex binding [GO:0044877]; G protein-coupled receptor signaling pathway [GO:0007186]; protein folding [GO:0006457]; substantia nigra development [GO:0021762]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]	G-protein gamma-subunit binding [GO:0031682]; protein-containing complex binding [GO:0044877]	GO:0005737; GO:0005765; GO:0005829; GO:0005834; GO:0006457; GO:0007186; GO:0021762; GO:0031682; GO:0044877; GO:0070062	G protein-coupled receptor signaling pathway [GO:0007186]; protein folding [GO:0006457]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN37888_c0_g1_i1	O14775	GNB5_HUMAN	100	103	0	0	311	3	259	361	7.20E-55	214.2	GNB5_HUMAN	reviewed	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0006457; GO:0007165; GO:0007186; GO:0007212; GO:0031682; GO:0043547; GO:0051087; GO:1901386; GO:1902773	dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN35543_c0_g1_i1	O14775	GNB5_HUMAN	100	72	0	0	2	217	118	189	1.60E-37	156	GNB5_HUMAN	reviewed	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0006457; GO:0007165; GO:0007186; GO:0007212; GO:0031682; GO:0043547; GO:0051087; GO:1901386; GO:1902773	dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2410_c0_g1_i1	O14775	GNB5_HUMAN	72.8	313	83	1	90	1022	83	395	2.20E-140	500	GNB5_HUMAN	reviewed	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0006457; GO:0007165; GO:0007186; GO:0007212; GO:0031682; GO:0043547; GO:0051087; GO:1901386; GO:1902773	dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2410_c0_g1_i6	O14775	GNB5_HUMAN	72.8	313	83	1	9	941	83	395	4.00E-140	499.2	GNB5_HUMAN	reviewed	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	Homo sapiens (Human)	395	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0006457; GO:0007165; GO:0007186; GO:0007212; GO:0031682; GO:0043547; GO:0051087; GO:1901386; GO:1902773	dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN36418_c0_g1_i1	P62881	GNB5_MOUSE	100	179	0	0	1	537	173	351	3.90E-101	368.6	GNB5_MOUSE	reviewed	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	Gnb5	Mus musculus (Mouse)	395	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]	GO:0001750; GO:0001917; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0007212; GO:0031682; GO:0032794; GO:0032991; GO:0043209; GO:0043547; GO:0044297; GO:0051087; GO:1901386	dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]		NA	NA	NA	NA	NA	NA
TRINITY_DN17825_c0_g1_i1	O18640	GBLP_DROME	67.1	155	19	1	2	466	81	203	1.30E-55	217.2	GBLP_DROME	reviewed	Guanine nucleotide-binding protein subunit beta-like protein (Receptor of activated protein kinase C homolog)	Rack1 CG7111	Drosophila melanogaster (Fruit fly)	318	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; ribosome binding [GO:0043022]; cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; wing disc development [GO:0035220]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; ribosome binding [GO:0043022]	GO:0001933; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0007626; GO:0009267; GO:0016243; GO:0018991; GO:0019899; GO:0022627; GO:0030674; GO:0030838; GO:0031398; GO:0035220; GO:0042335; GO:0043022; GO:0044829; GO:0045725; GO:0045879; GO:0046716; GO:0048477; GO:0072344; GO:0075522; GO:1903003	cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN17825_c0_g1_i2	O18640	GBLP_DROME	63.7	113	9	1	2	340	81	161	1.10E-32	140.6	GBLP_DROME	reviewed	Guanine nucleotide-binding protein subunit beta-like protein (Receptor of activated protein kinase C homolog)	Rack1 CG7111	Drosophila melanogaster (Fruit fly)	318	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; ribosome binding [GO:0043022]; cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; wing disc development [GO:0035220]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; ribosome binding [GO:0043022]	GO:0001933; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0007626; GO:0009267; GO:0016243; GO:0018991; GO:0019899; GO:0022627; GO:0030674; GO:0030838; GO:0031398; GO:0035220; GO:0042335; GO:0043022; GO:0044829; GO:0045725; GO:0045879; GO:0046716; GO:0048477; GO:0072344; GO:0075522; GO:1903003	cellular response to starvation [GO:0009267]; cuticle development [GO:0042335]; IRES-dependent viral translational initiation [GO:0075522]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of smoothened signaling pathway [GO:0045879]; oogenesis [GO:0048477]; oviposition [GO:0018991]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; regulation of autophagosome size [GO:0016243]; rescue of stalled ribosome [GO:0072344]; wing disc development [GO:0035220]		blue	blue	NA	NA	NA	NA
TRINITY_DN5801_c0_g1_i1	Q6MG06	GNL1_RAT	41.4	471	243	8	1370	42	79	544	8.40E-97	355.9	GNL1_RAT	reviewed	Guanine nucleotide-binding protein-like 1	Gnl1	Rattus norvegicus (Rat)	607	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to DNA damage stimulus [GO:0006974]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0006974	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN26309_c0_g1_i1	P36915	GNL1_HUMAN	100	92	0	0	3	278	344	435	1.50E-48	193	GNL1_HUMAN	reviewed	Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1)	GNL1 HSR1	Homo sapiens (Human)	607	extracellular space [GO:0005615]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198]; cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]	extracellular space [GO:0005615]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural molecule activity [GO:0005198]	GO:0002456; GO:0003924; GO:0005198; GO:0005525; GO:0005615; GO:0005634; GO:0006974; GO:0007165	cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]		NA	NA	NA	NA	NA	NA
TRINITY_DN39845_c0_g1_i1	P36916	GNL1_MOUSE	98.2	112	2	0	339	4	154	265	7.30E-61	234.2	GNL1_MOUSE	reviewed	Guanine nucleotide-binding protein-like 1 (GTP-binding protein MMR1)	Gnl1 Gna-rs1 Mmr1	Mus musculus (Mouse)	607	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to DNA damage stimulus [GO:0006974]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0006974	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN5801_c0_g1_i2	P36916	GNL1_MOUSE	42.6	455	228	8	1339	59	79	528	1.40E-96	355.1	GNL1_MOUSE	reviewed	Guanine nucleotide-binding protein-like 1 (GTP-binding protein MMR1)	Gnl1 Gna-rs1 Mmr1	Mus musculus (Mouse)	607	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to DNA damage stimulus [GO:0006974]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0006974	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN38901_c0_g1_i1	Q9BVP2	GNL3_HUMAN	100	67	0	0	201	1	134	200	4.60E-31	134.4	GNL3_HUMAN	reviewed	Guanine nucleotide-binding protein-like 3 (E2-induced gene 3 protein) (Novel nucleolar protein 47) (NNP47) (Nucleolar GTP-binding protein 3) (Nucleostemin)	GNL3 E2IG3 NS	Homo sapiens (Human)	549	"extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell population proliferation [GO:0042127]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]"	extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]	GO:0003723; GO:0005525; GO:0005615; GO:0005634; GO:0005730; GO:0008283; GO:0016020; GO:0016604; GO:0017145; GO:0019827; GO:0032206; GO:0033235; GO:0042127; GO:0048027; GO:1902895; GO:1904816	"cell population proliferation [GO:0008283]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell population proliferation [GO:0042127]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12411_c0_g1_i1	Q8MT06	GNL3_DROME	54.1	111	50	1	40	372	246	355	1.40E-25	117.1	GNL3_DROME	reviewed	Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin 1) (Nucleostemin homolog)	Ns1 CG3983	Drosophila melanogaster (Fruit fly)	581	granular component [GO:0001652]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; ribosomal large subunit biogenesis [GO:0042273]	granular component [GO:0001652]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001652; GO:0003924; GO:0005525; GO:0005730; GO:0016887; GO:0040014; GO:0042127; GO:0042273	regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2483_c0_g1_i1	Q21086	GNL3_CAEEL	41.6	358	197	7	92	1153	7	356	1.60E-70	268.5	GNL3_CAEEL	reviewed	Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1)	nst-1 K01C8.9	Caenorhabditis elegans	556	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127	germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]		NA	NA	NA	NA	NA	NA
TRINITY_DN2483_c0_g1_i2	Q21086	GNL3_CAEEL	42	457	249	9	92	1438	7	455	2.10E-96	354.8	GNL3_CAEEL	reviewed	Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1)	nst-1 K01C8.9	Caenorhabditis elegans	556	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127	germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]		NA	NA	NA	NA	NA	NA
TRINITY_DN2483_c0_g1_i3	Q21086	GNL3_CAEEL	42	457	249	9	92	1438	7	455	2.10E-96	354.8	GNL3_CAEEL	reviewed	Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1)	nst-1 K01C8.9	Caenorhabditis elegans	556	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127	germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]		blue	blue	NA	NA	NA	NA
TRINITY_DN12411_c0_g2_i1	Q9NVN8	GNL3L_HUMAN	55.3	85	36	1	280	32	118	202	1.20E-18	94	GNL3L_HUMAN	reviewed	Guanine nucleotide-binding protein-like 3-like protein	GNL3L	Homo sapiens (Human)	582	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]	GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0003723; GO:0005525; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0016020; GO:0031334; GO:0031397; GO:0031647; GO:0032091; GO:0032211; GO:0033234; GO:0042254; GO:1904816	"negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30_c0_g1_i1	O77086	C3G_DROME	57.7	326	120	2	930	4	1234	1558	8.30E-99	361.7	C3G_DROME	reviewed	Guanine nucleotide-releasing factor 2 (CRK SH3-binding GNRP) (DC3G)	C3G CG42328	Drosophila melanogaster (Fruit fly)	1571	Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; SH3 domain binding [GO:0017124]; muscle attachment [GO:0016203]; positive regulation of GTPase activity [GO:0043547]; positive regulation of smoothened signaling pathway [GO:0045880]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]		Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; SH3 domain binding [GO:0017124]	GO:0005088; GO:0007265; GO:0007525; GO:0016203; GO:0017034; GO:0017124; GO:0043087; GO:0043547; GO:0045214; GO:0045880	muscle attachment [GO:0016203]; positive regulation of GTPase activity [GO:0043547]; positive regulation of smoothened signaling pathway [GO:0045880]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]		NA	NA	NA	NA	NA	NA
TRINITY_DN10488_c0_g2_i1	Q96254	GDI1_ARATH	56.3	167	64	1	506	6	1	158	6.40E-51	201.8	GDI1_ARATH	reviewed	Guanosine nucleotide diphosphate dissociation inhibitor 1 (AtGDI1)	GDI1 At2g44100 F6E13.23	Arabidopsis thaliana (Mouse-ear cress)	445	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005093; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0015031; GO:0016192; GO:0017137	protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3554_c0_g1_i1	Q28C98	MESH1_XENTR	67.6	37	12	0	120	230	3	39	5.00E-08	58.9	MESH1_XENTR	reviewed	"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)"	hddc3 Mesh1 TGas061b07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	179	"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"		"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"	GO:0008893; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN3554_c0_g1_i2	Q568P1	MESH1_DANRE	60.5	177	69	1	120	647	4	180	7.90E-55	215.3	MESH1_DANRE	reviewed	"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)"	hddc3 Mesh1 zgc:110184	Danio rerio (Zebrafish) (Brachydanio rerio)	180	"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"		"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"	GO:0008893; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN3554_c0_g1_i3	Q568P1	MESH1_DANRE	60.5	177	69	1	120	647	4	180	8.60E-55	215.3	MESH1_DANRE	reviewed	"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)"	hddc3 Mesh1 zgc:110184	Danio rerio (Zebrafish) (Brachydanio rerio)	180	"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"		"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"	GO:0008893; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN26286_c0_g1_i1	Q8N4P3	MESH1_HUMAN	99.3	153	1	0	11	469	1	153	4.60E-82	305.1	MESH1_HUMAN	reviewed	"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)"	HDDC3 MESH1	Homo sapiens (Human)	179	"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"		"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"	GO:0008893; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN31011_c0_g1_i1	P22717	GCYB2_RAT	64.3	56	20	0	25	192	492	547	2.00E-14	79.3	GCYB2_RAT	reviewed	Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2)	Gucy1b2	Rattus norvegicus (Rat)	682	cytosol [GO:0005829]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; ion binding [GO:0043167]; metal ion binding [GO:0046872]; cGMP-mediated signaling [GO:0019934]	cytosol [GO:0005829]	GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; ion binding [GO:0043167]; metal ion binding [GO:0046872]	GO:0004383; GO:0005525; GO:0005829; GO:0019934; GO:0020037; GO:0043167; GO:0046872	cGMP-mediated signaling [GO:0019934]		NA	NA	NA	NA	NA	NA
TRINITY_DN30987_c0_g1_i1	P31006	KGUA_PIG	56.1	98	40	1	294	1	7	101	2.50E-23	109.4	KGUA_PIG	reviewed	Guanylate kinase (EC 2.7.4.8) (GMP kinase)	GUK1 GUK	Sus scrofa (Pig)	198	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; nucleoside monophosphate kinase activity [GO:0050145]; purine nucleotide metabolic process [GO:0006163]	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]	ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; nucleoside monophosphate kinase activity [GO:0050145]	GO:0001917; GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0050145	purine nucleotide metabolic process [GO:0006163]		NA	NA	NA	NA	NA	NA
TRINITY_DN28148_c0_g1_i1	Q8XXF9	KGUA_RALSO	95.7	70	3	0	210	1	37	106	1.40E-33	142.9	KGUA_RALSO	reviewed	Guanylate kinase (EC 2.7.4.8) (GMP kinase)	gmk RSc2155 RS01447	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	221	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]	GO:0004385; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN33902_c0_g1_i1	Q64520	KGUA_MOUSE	56.8	190	82	0	669	100	4	193	1.20E-55	218	KGUA_MOUSE	reviewed	Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1)	Guk1 Gmk	Mus musculus (Mouse)	198	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]	ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]	GO:0001917; GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0019673; GO:0034436; GO:0046034; GO:0046037; GO:0046054; GO:0046060; GO:0046711; GO:0046939	ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN28073_c0_g1_i1	Q16774	KGUA_HUMAN	100	131	0	0	28	420	1	131	8.10E-70	264.2	KGUA_HUMAN	reviewed	Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1)	GUK1 GMK GMPK	Homo sapiens (Human)	197	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]	ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]	GO:0001917; GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0015949; GO:0019673; GO:0034436; GO:0046034; GO:0046054; GO:0046060; GO:0046711; GO:0046939	ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN18240_c0_g1_i3	Q8L870	GCC1_ARATH	47.7	86	40	2	263	9	59	140	2.80E-14	79.7	GCC1_ARATH	reviewed	Guanylyl cyclase 1 (AtGC1) (EC 4.6.1.2)	GC1 At5g05930 K18J17.8	Arabidopsis thaliana (Mouse-ear cress)	274	guanylate cyclase activity [GO:0004383]; cGMP biosynthetic process [GO:0006182]		guanylate cyclase activity [GO:0004383]	GO:0004383; GO:0006182	cGMP biosynthetic process [GO:0006182]		NA	NA	NA	NA	NA	NA
TRINITY_DN18240_c0_g1_i4	Q8L870	GCC1_ARATH	51.3	39	19	0	125	9	102	140	2.00E-05	50.4	GCC1_ARATH	reviewed	Guanylyl cyclase 1 (AtGC1) (EC 4.6.1.2)	GC1 At5g05930 K18J17.8	Arabidopsis thaliana (Mouse-ear cress)	274	guanylate cyclase activity [GO:0004383]; cGMP biosynthetic process [GO:0006182]		guanylate cyclase activity [GO:0004383]	GO:0004383; GO:0006182	cGMP biosynthetic process [GO:0006182]		NA	NA	NA	NA	NA	NA
TRINITY_DN31162_c0_g1_i1	P25807	CPR1_CAEEL	59.6	52	21	0	24	179	275	326	5.20E-14	77.8	CPR1_CAEEL	reviewed	Gut-specific cysteine proteinase (EC 3.4.22.-)	cpr-1 gcp-1 C52E4.1	Caenorhabditis elegans	329	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN10890_c0_g1_i1	A4FUB7	GIN1_BOVIN	48.2	56	28	1	38	205	1	55	5.90E-07	54.7	GIN1_BOVIN	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1)	GIN1	Bos taurus (Bovine)	499	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10890_c0_g1_i2	Q5RBK0	GIN1_PONAB	33.4	323	207	4	38	985	1	322	3.00E-55	217.2	GIN1_PONAB	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1)	GIN1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	522	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN32883_c0_g1_i2	Q9NXP7	GIN1_HUMAN	36.8	185	106	3	4	552	59	234	1.50E-31	137.5	GIN1_HUMAN	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1) (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)	GIN1 TGIN1 ZH2C2	Homo sapiens (Human)	522	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN32883_c0_g1_i6	Q9NXP7	GIN1_HUMAN	36.8	163	96	2	4	486	59	216	2.40E-29	130.2	GIN1_HUMAN	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1) (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)	GIN1 TGIN1 ZH2C2	Homo sapiens (Human)	522	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN7355_c0_g1_i4	Q9NXP7	GIN1_HUMAN	39.5	205	117	2	666	58	17	216	6.70E-42	172.2	GIN1_HUMAN	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1) (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)	GIN1 TGIN1 ZH2C2	Homo sapiens (Human)	522	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN7355_c0_g1_i5	Q9NXP7	GIN1_HUMAN	39.7	252	144	3	786	37	17	262	1.00E-49	198.4	GIN1_HUMAN	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1) (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)	GIN1 TGIN1 ZH2C2	Homo sapiens (Human)	522	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN29909_c0_g1_i1	Q9R279	CLCN3_CAVPO	68.3	309	97	1	61	984	18	326	3.30E-122	439.5	CLCN3_CAVPO	reviewed	H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3)	CLCN3	Cavia porcellus (Guinea pig)	818	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0010008; GO:0012506; GO:0015297; GO:0016021; GO:0030165; GO:0031901; GO:0031902; GO:0055037			NA	NA	NA	NA	NA	NA
TRINITY_DN40270_c0_g1_i1	Q9R279	CLCN3_CAVPO	55.1	69	30	1	28	231	511	579	1.10E-12	73.6	CLCN3_CAVPO	reviewed	H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3)	CLCN3	Cavia porcellus (Guinea pig)	818	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0010008; GO:0012506; GO:0015297; GO:0016021; GO:0030165; GO:0031901; GO:0031902; GO:0055037			NA	NA	NA	NA	NA	NA
TRINITY_DN37855_c0_g1_i1	Q9R279	CLCN3_CAVPO	100	81	0	0	244	2	245	325	1.10E-37	156.8	CLCN3_CAVPO	reviewed	H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3)	CLCN3	Cavia porcellus (Guinea pig)	818	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0010008; GO:0012506; GO:0015297; GO:0016021; GO:0030165; GO:0031901; GO:0031902; GO:0055037			NA	NA	NA	NA	NA	NA
TRINITY_DN16096_c0_g1_i1	Q9R279	CLCN3_CAVPO	68.2	66	20	1	196	2	511	576	1.90E-16	86.3	CLCN3_CAVPO	reviewed	H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3)	CLCN3	Cavia porcellus (Guinea pig)	818	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle membrane [GO:0012506]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0010008; GO:0012506; GO:0015297; GO:0016021; GO:0030165; GO:0031901; GO:0031902; GO:0055037			NA	NA	NA	NA	NA	NA
TRINITY_DN37519_c0_g1_i1	Q61418	CLCN4_MOUSE	100	137	0	0	411	1	498	634	2.20E-72	272.7	CLCN4_MOUSE	reviewed	H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4)	Clcn4 Clc4 Clcn4-2	Mus musculus (Mouse)	747	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031404; GO:0031901; GO:0031902; GO:0055037; GO:0055038	chloride transport [GO:0006821]		NA	NA	NA	NA	NA	NA
TRINITY_DN34771_c0_g1_i1	P51793	CLCN4_HUMAN	71.1	128	37	0	10	393	178	305	5.10E-42	171.8	CLCN4_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4)	CLCN4	Homo sapiens (Human)	760	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031404; GO:0031901; GO:0031902; GO:0034220; GO:0055037; GO:0055038	chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN16520_c0_g1_i1	P51793	CLCN4_HUMAN	65.5	342	115	2	1063	47	317	658	9.40E-123	441.4	CLCN4_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4)	CLCN4	Homo sapiens (Human)	760	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031404; GO:0031901; GO:0031902; GO:0034220; GO:0055037; GO:0055038	chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN16520_c0_g1_i4	P51793	CLCN4_HUMAN	64	444	156	3	1395	76	317	760	6.30E-159	562	CLCN4_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4)	CLCN4	Homo sapiens (Human)	760	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031404; GO:0031901; GO:0031902; GO:0034220; GO:0055037; GO:0055038	chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN27116_c0_g1_i1	P51793	CLCN4_HUMAN	98.8	80	1	0	3	242	33	112	5.10E-40	164.5	CLCN4_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4)	CLCN4	Homo sapiens (Human)	760	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031404; GO:0031901; GO:0031902; GO:0034220; GO:0055037; GO:0055038	chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN13205_c0_g1_i1	P51793	CLCN4_HUMAN	50	114	41	2	295	2	442	555	1.20E-19	97.1	CLCN4_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4)	CLCN4	Homo sapiens (Human)	760	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031404; GO:0031901; GO:0031902; GO:0034220; GO:0055037; GO:0055038	chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN16520_c0_g1_i3	P51796	CLCN5_RAT	62.9	105	38	1	387	76	642	746	2.00E-30	133.3	CLCN5_RAT	reviewed	H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5)	Clcn5	Rattus norvegicus (Rat)	816	apical part of cell [GO:0045177]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; endocytosis [GO:0006897]	apical part of cell [GO:0045177]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]	GO:0000139; GO:0005247; GO:0005524; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006821; GO:0006897; GO:0008021; GO:0010008; GO:0015299; GO:0016020; GO:0031404; GO:0042802; GO:0045177	chloride transport [GO:0006821]; endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN35802_c0_g1_i1	Q99P66	CLCN5_CAVPO	63.7	146	53	0	1	438	148	293	1.10E-45	184.1	CLCN5_CAVPO	reviewed	H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5)	CLCN5	Cavia porcellus (Guinea pig)	746	endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]	endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]	GO:0000139; GO:0005247; GO:0005524; GO:0005886; GO:0010008; GO:0015297; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN28915_c0_g1_i1	P51798	CLCN7_HUMAN	100	79	0	0	238	2	493	571	2.50E-36	152.1	CLCN7_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	CLCN7	Homo sapiens (Human)	805	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN30805_c0_g1_i1	Q4PKH3	CLCN7_BOVIN	99	99	1	0	297	1	251	349	1.80E-47	189.5	CLCN7_BOVIN	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	CLCN7	Bos taurus (Bovine)	809	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005654; GO:0005765; GO:0015108; GO:0015297; GO:0016021; GO:0022857; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN16526_c0_g2_i2	P51799	CLCN7_RAT	55.4	728	304	6	244	2412	87	798	2.30E-220	766.9	CLCN7_RAT	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	Clcn7	Rattus norvegicus (Rat)	803	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016021; GO:0022857; GO:0031410; GO:0043231	response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN16526_c0_g2_i6	P51798	CLCN7_HUMAN	69.9	173	52	0	56	574	164	336	1.30E-62	240.7	CLCN7_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	CLCN7	Homo sapiens (Human)	805	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN16526_c0_g2_i7	P51798	CLCN7_HUMAN	56.4	369	154	2	404	1504	89	452	9.50E-108	392.1	CLCN7_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	CLCN7	Homo sapiens (Human)	805	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN16526_c0_g2_i9	P51799	CLCN7_RAT	55.4	728	304	6	404	2572	87	798	2.40E-220	766.9	CLCN7_RAT	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	Clcn7	Rattus norvegicus (Rat)	803	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016021; GO:0022857; GO:0031410; GO:0043231	response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN31520_c0_g1_i1	P51798	CLCN7_HUMAN	100	84	0	0	2	253	569	652	1.80E-40	166	CLCN7_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	CLCN7	Homo sapiens (Human)	805	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN39192_c0_g1_i1	P51798	CLCN7_HUMAN	100	82	0	0	248	3	173	254	7.00E-37	154.1	CLCN7_HUMAN	reviewed	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	CLCN7	Homo sapiens (Human)	805	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]		NA	NA	NA	NA	NA	NA
TRINITY_DN34278_c0_g1_i1	Q3UMQ8	NAF1_MOUSE	42.1	121	68	2	397	35	194	312	2.10E-22	106.7	NAF1_MOUSE	reviewed	H/ACA ribonucleoprotein complex non-core subunit NAF1	Naf1	Mus musculus (Mouse)	489	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000454; GO:0000493; GO:0003723; GO:0005634; GO:0005654; GO:0005732; GO:0005737; GO:0042254; GO:0042802; GO:0043489; GO:0051973; GO:0070034; GO:0090669; GO:1904358; GO:1905323	box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]		NA	NA	NA	NA	NA	NA
TRINITY_DN36127_c0_g1_i1	Q6XIP0	NHP2_DROYA	67.1	85	28	0	257	3	64	148	9.30E-32	137.1	NHP2_DROYA	reviewed	H/ACA ribonucleoprotein complex subunit 2-like protein (H/ACA snoRNP protein NHP2)	NHP2 GE20000	Drosophila yakuba (Fruit fly)	160	nucleolus [GO:0005730]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; rRNA pseudouridine synthesis [GO:0031118]	nucleolus [GO:0005730]; small nucleolar ribonucleoprotein complex [GO:0005732]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005732; GO:0031118	rRNA pseudouridine synthesis [GO:0031118]		blue	blue	NA	NA	NA	NA
TRINITY_DN13915_c0_g1_i1	Q6DRH5	NOP10_DANRE	64.4	59	21	0	4	180	1	59	2.00E-16	86.3	NOP10_DANRE	reviewed	H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10)	nop10 nola3	Danio rerio (Zebrafish) (Brachydanio rerio)	64	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034]; primitive hemopoiesis [GO:0060215]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034]	GO:0005697; GO:0006364; GO:0007004; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0060215; GO:0070034; GO:0090661	primitive hemopoiesis [GO:0060215]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]		blue	blue	NA	NA	NA	NA
TRINITY_DN13915_c0_g1_i2	Q6DRH5	NOP10_DANRE	64.4	59	21	0	4	180	1	59	2.00E-16	86.3	NOP10_DANRE	reviewed	H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10)	nop10 nola3	Danio rerio (Zebrafish) (Brachydanio rerio)	64	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034]; primitive hemopoiesis [GO:0060215]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034]	GO:0005697; GO:0006364; GO:0007004; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0060215; GO:0070034; GO:0090661	primitive hemopoiesis [GO:0060215]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]		blue	blue	NA	NA	NA	NA
TRINITY_DN14043_c0_g1_i1	Q9LD90	CBF5_ARATH	80.6	31	6	0	3	95	130	160	6.40E-07	54.3	CBF5_ARATH	reviewed	H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp-140-associated protein of 57 kDa homolog) (AtNAP57) (Nucleolar protein NAP57 homolog)	CBF5 NAP57 At3g57150 F24I3.230	Arabidopsis thaliana (Mouse-ear cress)	565	box H/ACA snoRNP complex [GO:0031429]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; box H/ACA snoRNA 3'-end processing [GO:0000495]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]	box H/ACA snoRNP complex [GO:0031429]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasmodesma [GO:0009506]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000495; GO:0003723; GO:0005730; GO:0005829; GO:0009506; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:1990481	box H/ACA snoRNA 3'-end processing [GO:0000495]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]		NA	NA	NA	NA	NA	NA
TRINITY_DN13167_c0_g1_i1	O44081	DKC1_DROME	69.8	172	51	1	520	5	25	195	3.90E-68	259.2	DKC1_DROME	reviewed	H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Nucleolar protein AT band 60B) (Protein minifly)	Nop60B mfl CG3333	Drosophila melanogaster (Fruit fly)	508	box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; box H/ACA snoRNA 3'-end processing [GO:0000495]; germ cell development [GO:0007281]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; wing disc development [GO:0035220]	box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000495; GO:0001522; GO:0003723; GO:0005730; GO:0006364; GO:0007281; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0035220; GO:0042254; GO:1990481	box H/ACA snoRNA 3'-end processing [GO:0000495]; germ cell development [GO:0007281]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; wing disc development [GO:0035220]		blue	blue	NA	NA	NA	NA
TRINITY_DN37226_c0_g1_i1	P33322	CBF5_YEAST	68.3	145	43	2	434	3	10	152	4.00E-52	205.7	CBF5_YEAST	reviewed	H/ACA ribonucleoprotein complex subunit CBF5 (EC 5.4.99.-) (Centromere-binding factor 5) (Centromere/microtubule-binding protein CBF5) (H/ACA snoRNP protein CBF5) (Small nucleolar RNP protein CBF5) (p64')	CBF5 YLR175W L9470.11	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	483	"90S preribosome [GO:0030686]; box H/ACA snoRNP complex [GO:0031429]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; pseudouridine synthase activity [GO:0009982]; box H/ACA snoRNA 3'-end processing [GO:0000495]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA pseudouridine synthesis [GO:1990481]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]"	"90S preribosome [GO:0030686]; box H/ACA snoRNP complex [GO:0031429]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]"	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; pseudouridine synthase activity [GO:0009982]	GO:0000154; GO:0000495; GO:0000775; GO:0003677; GO:0003729; GO:0005730; GO:0005737; GO:0005874; GO:0006364; GO:0007049; GO:0009982; GO:0030686; GO:0031118; GO:0031120; GO:0031429; GO:0051301; GO:1990481	box H/ACA snoRNA 3'-end processing [GO:0000495]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA pseudouridine synthesis [GO:1990481]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]		NA	NA	NA	NA	NA	NA
TRINITY_DN1377_c0_g1_i1	P33322	CBF5_YEAST	56.2	121	52	1	8	367	30	150	1.60E-34	146.7	CBF5_YEAST	reviewed	H/ACA ribonucleoprotein complex subunit CBF5 (EC 5.4.99.-) (Centromere-binding factor 5) (Centromere/microtubule-binding protein CBF5) (H/ACA snoRNP protein CBF5) (Small nucleolar RNP protein CBF5) (p64')	CBF5 YLR175W L9470.11	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	483	"90S preribosome [GO:0030686]; box H/ACA snoRNP complex [GO:0031429]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; pseudouridine synthase activity [GO:0009982]; box H/ACA snoRNA 3'-end processing [GO:0000495]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA pseudouridine synthesis [GO:1990481]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]"	"90S preribosome [GO:0030686]; box H/ACA snoRNP complex [GO:0031429]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]"	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; pseudouridine synthase activity [GO:0009982]	GO:0000154; GO:0000495; GO:0000775; GO:0003677; GO:0003729; GO:0005730; GO:0005737; GO:0005874; GO:0006364; GO:0007049; GO:0009982; GO:0030686; GO:0031118; GO:0031120; GO:0031429; GO:0051301; GO:1990481	box H/ACA snoRNA 3'-end processing [GO:0000495]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA pseudouridine synthesis [GO:1990481]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]		NA	NA	NA	NA	NA	NA
TRINITY_DN27042_c0_g1_i1	Q9ESX5	DKC1_MOUSE	100	145	0	0	1	435	23	167	8.10E-81	300.8	DKC1_MOUSE	reviewed	H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)	Dkc1	Mus musculus (Mouse)	509	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; box H/ACA snoRNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]	GO:0000454; GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0007004; GO:0008284; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0033979; GO:0034513; GO:0051973; GO:0070034; GO:0090661; GO:0090666; GO:0090669; GO:1904851; GO:1904872; GO:1904874; GO:1990481	box H/ACA snoRNA 3'-end processing [GO:0000495]; box H/ACA snoRNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN39180_c0_g1_i1	Q9P7H0	NHP2_SCHPO	48.5	68	35	0	4	207	56	123	5.90E-14	77.8	NHP2_SCHPO	reviewed	H/ACA ribonucleoprotein complex subunit nhp2 (H/ACA snoRNP protein NHP2) (High mobility group-like nuclear protein 2) (P17-nhp2)	nhp2 SPAC1782.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	154	box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]	box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]	box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000469; GO:0000470; GO:0003723; GO:0005634; GO:0005730; GO:0005732; GO:0019843; GO:0031118; GO:0031120; GO:0031429; GO:0034513	cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]		red	red	NA	NA	NA	NA
TRINITY_DN30552_c0_g1_i1	Q9P7H0	NHP2_SCHPO	37	54	31	1	211	50	59	109	4.10E-06	51.6	NHP2_SCHPO	reviewed	H/ACA ribonucleoprotein complex subunit nhp2 (H/ACA snoRNP protein NHP2) (High mobility group-like nuclear protein 2) (P17-nhp2)	nhp2 SPAC1782.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	154	box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]	box H/ACA snoRNP complex [GO:0031429]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]	box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000469; GO:0000470; GO:0003723; GO:0005634; GO:0005730; GO:0005732; GO:0019843; GO:0031118; GO:0031120; GO:0031429; GO:0034513	cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]		NA	NA	NA	NA	NA	NA
TRINITY_DN443_c0_g1_i3	Q91WM2	HDHD5_MOUSE	45.8	426	208	7	1320	82	1	416	2.10E-98	360.9	HDHD5_MOUSE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5 homolog)	Hdhd5 Cecr5	Mus musculus (Mouse)	419	mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]	mitochondrion [GO:0005739]		GO:0005739; GO:0046474	glycerophospholipid biosynthetic process [GO:0046474]		NA	NA	NA	NA	NA	NA
TRINITY_DN443_c0_g1_i4	Q91WM2	HDHD5_MOUSE	50.9	338	160	4	1321	320	1	336	3.40E-93	343.6	HDHD5_MOUSE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5 homolog)	Hdhd5 Cecr5	Mus musculus (Mouse)	419	mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]	mitochondrion [GO:0005739]		GO:0005739; GO:0046474	glycerophospholipid biosynthetic process [GO:0046474]		NA	NA	NA	NA	NA	NA
TRINITY_DN443_c0_g1_i1	Q9BXW7	HDHD5_HUMAN	57.9	145	60	1	464	33	187	331	2.90E-46	186.4	HDHD5_HUMAN	reviewed	Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5)	HDHD5 CECR5	Homo sapiens (Human)	423	mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]	mitochondrion [GO:0005739]		GO:0005739; GO:0046474	glycerophospholipid biosynthetic process [GO:0046474]		blue	blue	NA	NA	NA	NA
TRINITY_DN29267_c0_g1_i1	Q9BXW7	HDHD5_HUMAN	100	107	0	0	3	323	203	309	7.20E-58	224.2	HDHD5_HUMAN	reviewed	Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5)	HDHD5 CECR5	Homo sapiens (Human)	423	mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]	mitochondrion [GO:0005739]		GO:0005739; GO:0046474	glycerophospholipid biosynthetic process [GO:0046474]		NA	NA	NA	NA	NA	NA
TRINITY_DN35242_c0_g1_i1	Q3UGR5	HDHD2_MOUSE	100	117	0	0	352	2	88	204	6.20E-63	241.1	HDHD2_MOUSE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	Hdhd2	Mus musculus (Mouse)	259	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0019899; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3477_c0_g1_i10	Q3ZCH9	HDHD2_BOVIN	70	30	9	0	11	100	5	34	8.20E-05	47.4	HDHD2_BOVIN	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	HDHD2	Bos taurus (Bovine)	259	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0019899; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3477_c0_g1_i18	Q3ZCH9	HDHD2_BOVIN	70	30	9	0	11	100	5	34	9.60E-05	47.4	HDHD2_BOVIN	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	HDHD2	Bos taurus (Bovine)	259	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0019899; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3477_c0_g1_i4	Q3ZCH9	HDHD2_BOVIN	70	30	9	0	11	100	5	34	8.50E-05	47.4	HDHD2_BOVIN	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	HDHD2	Bos taurus (Bovine)	259	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0019899; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN7356_c0_g2_i1	Q5BJJ5	HDHD2_DANRE	56.7	90	39	0	328	59	173	262	1.70E-23	110.5	HDHD2_DANRE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	hdhd2 zgc:110332	Danio rerio (Zebrafish) (Brachydanio rerio)	262	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN7356_c0_g2_i2	Q5BJJ5	HDHD2_DANRE	46.1	254	83	1	820	59	63	262	3.30E-59	229.9	HDHD2_DANRE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	hdhd2 zgc:110332	Danio rerio (Zebrafish) (Brachydanio rerio)	262	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN7356_c0_g2_i3	Q5BJJ5	HDHD2_DANRE	56.7	90	39	0	328	59	173	262	1.70E-23	110.5	HDHD2_DANRE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	hdhd2 zgc:110332	Danio rerio (Zebrafish) (Brachydanio rerio)	262	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN7356_c0_g2_i4	Q5BJJ5	HDHD2_DANRE	56.7	90	39	0	328	59	173	262	1.30E-23	110.9	HDHD2_DANRE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	hdhd2 zgc:110332	Danio rerio (Zebrafish) (Brachydanio rerio)	262	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN7356_c0_g2_i5	Q5BJJ5	HDHD2_DANRE	58.5	200	83	0	658	59	63	262	2.30E-66	253.4	HDHD2_DANRE	reviewed	Haloacid dehalogenase-like hydrolase domain-containing protein 2	hdhd2 zgc:110332	Danio rerio (Zebrafish) (Brachydanio rerio)	262	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]		metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]	GO:0016311; GO:0016791; GO:0046872	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN7632_c0_g1_i1	Q92574	TSC1_HUMAN	22.4	1118	686	24	3593	330	6	971	6.70E-43	177.9	TSC1_HUMAN	reviewed	Hamartin (Tuberous sclerosis 1 protein)	TSC1 KIAA0243 TSC	Homo sapiens (Human)	1164	cell cortex [GO:0005938]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; regulation of stress fiber assembly [GO:0051492]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808]	cell cortex [GO:0005938]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]	ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]	GO:0001822; GO:0001843; GO:0001952; GO:0002250; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006407; GO:0006417; GO:0006813; GO:0007160; GO:0008285; GO:0008344; GO:0010977; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0017148; GO:0021766; GO:0021987; GO:0030027; GO:0030030; GO:0030426; GO:0030544; GO:0032007; GO:0032780; GO:0032794; GO:0032868; GO:0032991; GO:0033596; GO:0034260; GO:0042030; GO:0042552; GO:0043379; GO:0043666; GO:0044877; GO:0045792; GO:0045859; GO:0046323; GO:0046627; GO:0047485; GO:0048471; GO:0050808; GO:0050821; GO:0051087; GO:0051492; GO:0051496; GO:0051726; GO:0051879; GO:0051894; GO:0055007; GO:0090630; GO:0090650; GO:0101031; GO:1901214; GO:1903204	activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell-matrix adhesion [GO:0007160]; cell projection organization [GO:0030030]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; regulation of stress fiber assembly [GO:0051492]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN2504_c0_g1_i1	Q6AXM7	HBS1L_RAT	69.8	106	32	0	3	320	311	416	3.50E-36	152.1	HBS1L_RAT	reviewed	HBS1-like protein	Hbs1l	Rattus norvegicus (Rat)	679	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]		GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40453_c0_g1_i1	Q9Y450	HBS1L_HUMAN	98.8	81	1	0	3	245	295	375	5.70E-39	161	HBS1L_HUMAN	reviewed	HBS1-like protein (ERFS)	HBS1L HBS1 KIAA1038	Homo sapiens (Human)	684	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; signal transduction [GO:0007165]; translation [GO:0006412]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007165; GO:0016020; GO:0043928; GO:0070062	exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; signal transduction [GO:0007165]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29157_c0_g1_i1	P57102	HAND2_DANRE	89.8	49	5	0	149	3	87	135	6.70E-17	87.4	HAND2_DANRE	reviewed	"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)"	hand2 dhand	Danio rerio (Zebrafish) (Brachydanio rerio)	208	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; developmental process [GO:0032502]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0032502; GO:0035051; GO:0035118; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908	cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; developmental process [GO:0032502]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]		NA	NA	NA	NA	NA	NA
TRINITY_DN32464_c0_g1_i1	Q9P2D3	HTR5B_HUMAN	98.9	95	1	0	286	2	915	1009	2.00E-48	192.6	HTR5B_HUMAN	reviewed	HEAT repeat-containing protein 5B	HEATR5B KIAA1414	Homo sapiens (Human)	2071	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]		GO:0005829; GO:0006897; GO:0008104; GO:0016020; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35569_c0_g1_i1	Q9P2D3	HTR5B_HUMAN	100	67	0	0	3	203	787	853	1.40E-30	132.9	HTR5B_HUMAN	reviewed	HEAT repeat-containing protein 5B	HEATR5B KIAA1414	Homo sapiens (Human)	2071	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]		GO:0005829; GO:0006897; GO:0008104; GO:0016020; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6292_c0_g1_i4	Q9P2D3	HTR5B_HUMAN	56.7	746	312	3	2315	99	1	742	3.10E-246	852.8	HTR5B_HUMAN	reviewed	HEAT repeat-containing protein 5B	HEATR5B KIAA1414	Homo sapiens (Human)	2071	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]		GO:0005829; GO:0006897; GO:0008104; GO:0016020; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6292_c0_g1_i5	A1A5F2	HTR5B_XENTR	32.9	456	284	7	1453	98	1614	2051	5.10E-58	226.9	HTR5B_XENTR	reviewed	HEAT repeat-containing protein 5B	heatr5b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2052	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]		GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6292_c0_g1_i6	A1A5F2	HTR5B_XENTR	65.2	434	148	2	1334	42	742	1175	8.10E-156	551.6	HTR5B_XENTR	reviewed	HEAT repeat-containing protein 5B	heatr5b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2052	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]		GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6292_c0_g1_i7	Q9P2D3	HTR5B_HUMAN	59.8	204	82	0	672	61	1	204	1.80E-67	257.3	HTR5B_HUMAN	reviewed	HEAT repeat-containing protein 5B	HEATR5B KIAA1414	Homo sapiens (Human)	2071	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]		GO:0005829; GO:0006897; GO:0008104; GO:0016020; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6292_c0_g1_i8	A1A5F2	HTR5B_XENTR	65.3	435	148	2	1345	50	742	1176	2.10E-156	553.5	HTR5B_XENTR	reviewed	HEAT repeat-containing protein 5B	heatr5b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2052	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]		GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6292_c0_g1_i9	A1A5F2	HTR5B_XENTR	51.4	2081	941	19	6217	98	1	2051	0	1990.7	HTR5B_XENTR	reviewed	HEAT repeat-containing protein 5B	heatr5b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	2052	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]		GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5740_c1_g1_i1	A1EC95	HEAT6_RAT	33.3	243	140	5	680	15	468	709	2.40E-23	112.1	HEAT6_RAT	reviewed	HEAT repeat-containing protein 6	Heatr6	Rattus norvegicus (Rat)	1252							NA	NA	NA	NA	NA	NA
TRINITY_DN26079_c0_g1_i1	P41753	HSP70_ACHKL	63.5	219	78	1	658	8	263	481	2.70E-72	273.1	HSP70_ACHKL	reviewed	Heat shock 70 kDa protein	HSP70	Achlya klebsiana	652	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN14701_c0_g5_i1	P25840	HSP70_CHLRE	65.7	70	24	0	20	229	337	406	1.00E-18	93.6	HSP70_CHLRE	reviewed	Heat shock 70 kDa protein	HSP70	Chlamydomonas reinhardtii (Chlamydomonas smithii)	650	axonemal central pair projection [GO:1990718]; ATP binding [GO:0005524]	axonemal central pair projection [GO:1990718]	ATP binding [GO:0005524]	GO:0005524; GO:1990718			NA	NA	NA	NA	NA	NA
TRINITY_DN14701_c0_g2_i1	P41753	HSP70_ACHKL	63.6	99	36	0	3	299	401	499	1.10E-31	137.1	HSP70_ACHKL	reviewed	Heat shock 70 kDa protein	HSP70	Achlya klebsiana	652	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN12688_c0_g2_i1	P05456	HSP70_TRYCR	67.9	156	50	0	5	472	100	255	2.80E-55	216.1	HSP70_TRYCR	reviewed	Heat shock 70 kDa protein	HSP70	Trypanosoma cruzi	680	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN12688_c0_g1_i1	P27541	HSP70_BRUMA	67.7	99	32	0	297	1	3	101	3.00E-34	145.6	HSP70_BRUMA	reviewed	Heat shock 70 kDa protein	HSP70	Brugia malayi (Filarial nematode worm)	644	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN21623_c0_g1_i1	Q05944	HSP70_HYDVU	47.8	69	36	0	2	208	532	600	6.50E-12	70.9	HSP70_HYDVU	reviewed	Heat shock 70 kDa protein	HSP70.1	Hydra vulgaris (Hydra) (Hydra attenuata)	654	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN22733_c2_g1_i1	P27541	HSP70_BRUMA	81.9	83	15	0	2	250	467	549	9.10E-32	137.1	HSP70_BRUMA	reviewed	Heat shock 70 kDa protein	HSP70	Brugia malayi (Filarial nematode worm)	644	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN22733_c0_g1_i4	P41753	HSP70_ACHKL	71.6	278	78	1	849	19	342	619	1.90E-110	400.2	HSP70_ACHKL	reviewed	Heat shock 70 kDa protein	HSP70	Achlya klebsiana	652	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN668_c1_g1_i1	P16019	HSP70_THEAN	70.9	258	75	0	47	820	6	263	4.40E-104	379	HSP70_THEAN	reviewed	Heat shock 70 kDa protein (70 kDa heat shock protein) (HSP 70.1)	TA11610	Theileria annulata	646	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN3562_c1_g1_i1	P16019	HSP70_THEAN	67	91	30	0	275	3	2	92	3.50E-29	128.6	HSP70_THEAN	reviewed	Heat shock 70 kDa protein (70 kDa heat shock protein) (HSP 70.1)	TA11610	Theileria annulata	646	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN14506_c0_g1_i1	Q92260	HSP70_PENCI	63.7	256	89	1	769	2	165	416	2.40E-88	326.6	HSP70_PENCI	reviewed	Heat shock 70 kDa protein (allergen Pen c 19) (Fragment)	HSP70	Penicillium citrinum	503	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN31714_c0_g1_i1	Q91233	HSP70_ONCTS	89.7	68	7	0	1	204	23	90	2.90E-28	125.2	HSP70_ONCTS	reviewed	Heat shock 70 kDa protein (HSP70)	hsp70	Oncorhynchus tshawytscha (Chinook salmon) (Salmo tshawytscha)	644	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN14701_c0_g4_i1	P11144	HSP70_PLAFA	65.6	154	53	0	462	1	110	263	1.10E-54	214.2	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c1_g1_i1	P11144	HSP70_PLAFA	75.2	612	151	1	1863	31	21	632	1.70E-265	916.4	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i3	P11144	HSP70_PLAFA	77.1	559	128	0	28	1704	16	574	1.70E-251	869.8	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i7	P11144	HSP70_PLAFA	76.4	559	132	0	28	1704	16	574	1.60E-249	863.2	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN3559_c0_g1_i1	P11144	HSP70_PLAFA	65.5	368	123	1	2	1093	103	470	5.20E-132	472.2	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN10200_c1_g1_i1	P11144	HSP70_PLAFA	76.7	617	144	0	32	1882	16	632	5.00E-276	951.4	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN9372_c1_g2_i1	P11144	HSP70_PLAFA	68.8	160	50	0	482	3	108	267	5.10E-60	231.9	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN9372_c0_g3_i1	P11144	HSP70_PLAFA	65.1	502	170	2	13	1506	9	509	1.40E-185	650.6	HSP70_PLAFA	reviewed	Heat shock 70 kDa protein (HSP70) (74.3 kDa protein) (Cytoplasmic antigen)		Plasmodium falciparum	681	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN14701_c0_g1_i1	Q05746	HSP70_PLACB	73.3	101	27	0	303	1	13	113	6.70E-37	154.5	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN14701_c0_g3_i1	Q05746	HSP70_PLACB	63.9	83	30	0	3	251	258	340	5.10E-22	104.8	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i10	Q05746	HSP70_PLACB	77.8	445	99	0	28	1362	16	460	1.10E-200	700.7	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i11	Q05746	HSP70_PLACB	79.7	261	53	0	2	784	22	282	4.70E-119	428.7	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i15	Q05746	HSP70_PLACB	78.1	439	96	0	2	1318	22	460	3.80E-198	692.2	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i17	Q05746	HSP70_PLACB	77.8	465	103	0	28	1422	16	480	4.20E-211	735.3	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i4	Q05746	HSP70_PLACB	78	445	98	0	28	1362	16	460	1.90E-200	699.9	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i6	Q05746	HSP70_PLACB	80.4	255	50	0	6	770	206	460	2.20E-113	409.8	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN256_c0_g1_i9	Q05746	HSP70_PLACB	77.8	445	99	0	28	1362	16	460	9.30E-200	697.6	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN668_c1_g3_i1	Q05746	HSP70_PLACB	67	91	27	1	2	274	179	266	7.80E-29	127.5	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN12546_c0_g1_i1	Q05746	HSP70_PLACB	68.6	528	163	3	1595	12	18	542	1.60E-204	713.8	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN9732_c0_g1_i1	Q05746	HSP70_PLACB	79.9	194	39	0	582	1	138	331	7.10E-88	324.7	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN14506_c0_g2_i1	Q05746	HSP70_PLACB	64.9	265	88	3	789	7	13	276	7.70E-93	341.7	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN9372_c0_g4_i1	Q05746	HSP70_PLACB	69.1	288	89	0	2	865	107	394	4.30E-113	409.1	HSP70_PLACB	reviewed	Heat shock 70 kDa protein (HSP70) (74.6 kDa protein) (Cytoplasmic antigen)		Plasmodium cynomolgi (strain Berok)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN9372_c0_g2_i1	P11503	HSP70_ONCVO	63.9	133	47	1	25	420	144	276	2.00E-39	163.3	HSP70_ONCVO	reviewed	Heat shock 70 kDa protein (HSP70) (Fragment)		Onchocerca volvulus	322	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN15609_c0_g1_i1	P22953	MD37E_ARATH	77.6	76	17	0	3	230	29	104	5.50E-28	124.4	HS701_ARATH	reviewed	Heat shock 70 kDa protein 1 (Heat shock cognate 70 kDa protein 1) (Heat shock cognate protein 70-1) (AtHsc70-1) (Heat shock protein 70-1) (AtHsp70-1) (Protein EARLY-RESPONSIVE TO DEHYDRATION 2)	HSP70-1 ERD2 HSC70-1 MED37_4 MED37E At5g02500 T22P11.90	Arabidopsis thaliana (Mouse-ear cress)	651	apoplast [GO:0048046]; cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; mRNA binding [GO:0003729]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to other organism [GO:0098542]; heat acclimation [GO:0010286]; negative regulation of seed germination [GO:0010187]; protein refolding [GO:0042026]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; stomatal closure [GO:0090332]	apoplast [GO:0048046]; cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; mRNA binding [GO:0003729]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0002020; GO:0003729; GO:0005524; GO:0005618; GO:0005634; GO:0005730; GO:0005737; GO:0005774; GO:0005794; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0009506; GO:0009507; GO:0009615; GO:0010187; GO:0010286; GO:0016887; GO:0022626; GO:0031072; GO:0034620; GO:0042026; GO:0042742; GO:0044183; GO:0046686; GO:0048046; GO:0050832; GO:0051082; GO:0051085; GO:0051787; GO:0090332; GO:0098542	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to other organism [GO:0098542]; heat acclimation [GO:0010286]; negative regulation of seed germination [GO:0010187]; protein refolding [GO:0042026]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; stomatal closure [GO:0090332]		NA	NA	NA	NA	NA	NA
TRINITY_DN14217_c0_g2_i1	P22953	MD37E_ARATH	57	228	98	0	16	699	304	531	1.50E-68	260.8	HS701_ARATH	reviewed	Heat shock 70 kDa protein 1 (Heat shock cognate 70 kDa protein 1) (Heat shock cognate protein 70-1) (AtHsc70-1) (Heat shock protein 70-1) (AtHsp70-1) (Protein EARLY-RESPONSIVE TO DEHYDRATION 2)	HSP70-1 ERD2 HSC70-1 MED37_4 MED37E At5g02500 T22P11.90	Arabidopsis thaliana (Mouse-ear cress)	651	apoplast [GO:0048046]; cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; mRNA binding [GO:0003729]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to other organism [GO:0098542]; heat acclimation [GO:0010286]; negative regulation of seed germination [GO:0010187]; protein refolding [GO:0042026]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; stomatal closure [GO:0090332]	apoplast [GO:0048046]; cell wall [GO:0005618]; chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; mRNA binding [GO:0003729]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0002020; GO:0003729; GO:0005524; GO:0005618; GO:0005634; GO:0005730; GO:0005737; GO:0005774; GO:0005794; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0009409; GO:0009506; GO:0009507; GO:0009615; GO:0010187; GO:0010286; GO:0016887; GO:0022626; GO:0031072; GO:0034620; GO:0042026; GO:0042742; GO:0044183; GO:0046686; GO:0048046; GO:0050832; GO:0051082; GO:0051085; GO:0051787; GO:0090332; GO:0098542	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to other organism [GO:0098542]; heat acclimation [GO:0010286]; negative regulation of seed germination [GO:0010187]; protein refolding [GO:0042026]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; stomatal closure [GO:0090332]		NA	NA	NA	NA	NA	NA
TRINITY_DN19244_c0_g2_i1	Q9I8F9	HSP71_ORYLA	78.2	642	134	3	160	2082	3	639	2.10E-286	986.1	HSP71_ORYLA	reviewed	Heat shock 70 kDa protein 1 (HSP70-1)		Oryzias latipes (Japanese rice fish) (Japanese killifish)	639	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19244_c0_g1_i1	Q9I8F9	HSP71_ORYLA	78.2	642	134	3	2016	94	3	639	2.10E-286	986.1	HSP71_ORYLA	reviewed	Heat shock 70 kDa protein 1 (HSP70-1)		Oryzias latipes (Japanese rice fish) (Japanese killifish)	639	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN12695_c0_g2_i3	Q8K0U4	HS12A_MOUSE	52.5	375	172	2	25	1149	305	673	6.20E-110	399.1	HS12A_MOUSE	reviewed	Heat shock 70 kDa protein 12A	Hspa12a Kiaa0417	Mus musculus (Mouse)	675	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12695_c0_g2_i4	Q96MM6	HS12B_HUMAN	51.4	220	106	1	76	732	466	685	1.30E-55	218	HS12B_HUMAN	reviewed	Heat shock 70 kDa protein 12B	HSPA12B C20orf60	Homo sapiens (Human)	686	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN30658_c0_g1_i1	P48723	HSP13_HUMAN	100	76	0	0	229	2	157	232	1.60E-35	149.4	HSP13_HUMAN	reviewed	Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein)	HSPA13 STCH	Homo sapiens (Human)	471	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005739; GO:0005783; GO:0006986; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0043231; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070062	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN12498_c0_g1_i1	Q2YDD0	HSP7E_BOVIN	36.5	498	296	9	1559	99	18	506	3.50E-68	260.8	HSP7E_BOVIN	reviewed	Heat shock 70 kDa protein 14	HSPA14	Bos taurus (Bovine)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12498_c0_g1_i2	Q2YDD0	HSP7E_BOVIN	36.8	513	304	9	1604	99	3	506	2.20E-73	278.1	HSP7E_BOVIN	reviewed	Heat shock 70 kDa protein 14	HSPA14	Bos taurus (Bovine)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN41023_c0_g1_i1	Q0VDF9	HSP7E_HUMAN	100	73	0	0	30	248	1	73	6.10E-33	141	HSP7E_HUMAN	reviewed	Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60)	HSPA14 HSP60 HSP70L1	Homo sapiens (Human)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016020; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051083; GO:0051085; GO:0051787	'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38149_c0_g1_i1	Q99M31	HSP7E_MOUSE	100	74	0	0	223	2	305	378	9.20E-36	150.2	HSP7E_MOUSE	reviewed	Heat shock 70 kDa protein 14 (NST-1) (hsr.1)	Hspa14 Hsp70-4	Mus musculus (Mouse)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribosome [GO:0005840]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN16189_c0_g1_i1	Q27975	HS71A_BOVIN	100	235	0	0	2	706	186	420	1.20E-126	453.8	HS71A_BOVIN	reviewed	Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70.1)	HSPA1A HSP70-1	Bos taurus (Bovine)	641	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; lysosomal transport [GO:0007041]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0003714; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006986; GO:0007041; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0032436; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090063; GO:0097201; GO:0097718; GO:1901673	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; lysosomal transport [GO:0007041]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN16189_c1_g1_i1	P0DMV8	HS71A_HUMAN	99.6	239	1	0	717	1	390	628	2.20E-128	459.5	HS71A_HUMAN	reviewed	Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1)	HSPA1A HSP72 HSPA1 HSX70	Homo sapiens (Human)	641	aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]; ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil degranulation [GO:0043312]; positive regulation of endoribonuclease activity [GO:1902380]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of RNA splicing [GO:0033120]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mRNA stability [GO:0043488]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001664; GO:0003714; GO:0003723; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005925; GO:0006402; GO:0006986; GO:0007041; GO:0008285; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0030512; GO:0031072; GO:0031249; GO:0031396; GO:0031397; GO:0031625; GO:0031982; GO:0032436; GO:0032757; GO:0032991; GO:0033120; GO:0034599; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0043312; GO:0043488; GO:0044183; GO:0045296; GO:0045648; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051131; GO:0051787; GO:0055131; GO:0060548; GO:0070062; GO:0070370; GO:0070434; GO:0072562; GO:0090063; GO:0090084; GO:0097201; GO:0097718; GO:1900034; GO:1901029; GO:1901673; GO:1902236; GO:1902380; GO:1903265; GO:1904813; GO:1990904; GO:2001240	ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil degranulation [GO:0043312]; positive regulation of endoribonuclease activity [GO:1902380]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of RNA splicing [GO:0033120]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mRNA stability [GO:0043488]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10200_c0_g1_i2	P0DMV8	HS71A_HUMAN	99.5	210	1	0	633	4	1	210	8.00E-117	421	HS71A_HUMAN	reviewed	Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1)	HSPA1A HSP72 HSPA1 HSX70	Homo sapiens (Human)	641	aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]; ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil degranulation [GO:0043312]; positive regulation of endoribonuclease activity [GO:1902380]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of RNA splicing [GO:0033120]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mRNA stability [GO:0043488]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001664; GO:0003714; GO:0003723; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005925; GO:0006402; GO:0006986; GO:0007041; GO:0008285; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0030512; GO:0031072; GO:0031249; GO:0031396; GO:0031397; GO:0031625; GO:0031982; GO:0032436; GO:0032757; GO:0032991; GO:0033120; GO:0034599; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0043312; GO:0043488; GO:0044183; GO:0045296; GO:0045648; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051131; GO:0051787; GO:0055131; GO:0060548; GO:0070062; GO:0070370; GO:0070434; GO:0072562; GO:0090063; GO:0090084; GO:0097201; GO:0097718; GO:1900034; GO:1901029; GO:1901673; GO:1902236; GO:1902380; GO:1903265; GO:1904813; GO:1990904; GO:2001240	ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil degranulation [GO:0043312]; positive regulation of endoribonuclease activity [GO:1902380]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of RNA splicing [GO:0033120]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mRNA stability [GO:0043488]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g2_i1	Q61696	HS71A_MOUSE	98.8	84	1	0	2	253	267	350	1.20E-39	163.3	HS71A_MOUSE	reviewed	Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 3) (HSP70.3) (Hsp68)	Hspa1a Hsp70-3 Hsp70A1	Mus musculus (Mouse)	641	aggresome [GO:0016235]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein folding [GO:0006457]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]	aggresome [GO:0016235]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000723; GO:0001664; GO:0002020; GO:0003714; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006402; GO:0006457; GO:0006986; GO:0007041; GO:0008285; GO:0009408; GO:0016192; GO:0016234; GO:0016235; GO:0016323; GO:0016324; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031249; GO:0031625; GO:0032436; GO:0032991; GO:0034620; GO:0042026; GO:0042826; GO:0044183; GO:0045121; GO:0047485; GO:0048471; GO:0051059; GO:0051082; GO:0051085; GO:0051787; GO:0055131; GO:0090063; GO:0097201; GO:0097718; GO:1901673; GO:1990904	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein folding [GO:0006457]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10200_c0_g1_i1	Q61696	HS71A_MOUSE	98.1	210	4	0	633	4	1	210	7.50E-115	414.5	HS71A_MOUSE	reviewed	Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 3) (HSP70.3) (Hsp68)	Hspa1a Hsp70-3 Hsp70A1	Mus musculus (Mouse)	641	aggresome [GO:0016235]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein folding [GO:0006457]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]	aggresome [GO:0016235]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; denatured protein binding [GO:0031249]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000723; GO:0001664; GO:0002020; GO:0003714; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006402; GO:0006457; GO:0006986; GO:0007041; GO:0008285; GO:0009408; GO:0016192; GO:0016234; GO:0016235; GO:0016323; GO:0016324; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031249; GO:0031625; GO:0032436; GO:0032991; GO:0034620; GO:0042026; GO:0042826; GO:0044183; GO:0045121; GO:0047485; GO:0048471; GO:0051059; GO:0051082; GO:0051085; GO:0051787; GO:0055131; GO:0090063; GO:0097201; GO:0097718; GO:1901673; GO:1990904	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein folding [GO:0006457]; protein refolding [GO:0042026]; regulation of mitotic spindle assembly [GO:1901673]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38553_c0_g1_i1	Q61316	HSP74_MOUSE	42.7	234	127	1	793	92	561	787	2.40E-44	180.6	HSP74_MOUSE	reviewed	Heat shock 70 kDa protein 4 (Heat shock 70-related protein APG-2)	Hspa4 Apg2 Hsp110	Mus musculus (Mouse)	841	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]; chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]	GO:0001085; GO:0001933; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0009408; GO:0010628; GO:0010629; GO:0032092; GO:0033613; GO:0043066; GO:0043392; GO:0044877; GO:0045040; GO:0051131; GO:0060548; GO:0070062	chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN23895_c0_g1_i1	Q61316	HSP74_MOUSE	100	104	0	0	314	3	150	253	9.30E-55	213.8	HSP74_MOUSE	reviewed	Heat shock 70 kDa protein 4 (Heat shock 70-related protein APG-2)	Hspa4 Apg2 Hsp110	Mus musculus (Mouse)	841	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]; chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]	GO:0001085; GO:0001933; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0009408; GO:0010628; GO:0010629; GO:0032092; GO:0033613; GO:0043066; GO:0043392; GO:0044877; GO:0045040; GO:0051131; GO:0060548; GO:0070062	chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN14217_c0_g1_i1	Q9LHA8	MD37C_ARATH	65.4	179	54	3	520	2	94	270	8.30E-56	218	HS704_ARATH	reviewed	Heat shock 70 kDa protein 4 (Heat shock cognate 70 kDa protein 4) (Heat shock cognate protein 70-4) (AtHsc70-4) (Heat shock protein 70-4) (AtHsp70-4)	HSP70-4 HSC70-4 HSP70 MED37_2 MED37C At3g12580 T16H11.7 T2E22.11	Arabidopsis thaliana (Mouse-ear cress)	650	cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; protein ubiquitination [GO:0016567]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to temperature stimulus [GO:0009266]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]	cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005618; GO:0005634; GO:0005737; GO:0005739; GO:0005774; GO:0005794; GO:0005829; GO:0005886; GO:0006986; GO:0009266; GO:0009408; GO:0009615; GO:0009617; GO:0016567; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0046686; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; protein ubiquitination [GO:0016567]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to temperature stimulus [GO:0009266]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN39317_c0_g1_i1	P34932	HSP74_HUMAN	100	321	0	0	965	3	1	321	1.10E-181	637.1	HSP74_HUMAN	reviewed	Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2)	HSPA4 APG2	Homo sapiens (Human)	840	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006986; GO:0045040; GO:0051131; GO:0070062	chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN40149_c0_g1_i1	P34932	HSP74_HUMAN	98.6	70	1	0	212	3	602	671	9.00E-33	140.2	HSP74_HUMAN	reviewed	Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2)	HSPA4 APG2	Homo sapiens (Human)	840	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006986; GO:0045040; GO:0051131; GO:0070062	chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN40652_c0_g1_i1	P48722	HS74L_MOUSE	100	87	0	0	3	263	240	326	2.40E-43	175.6	HS74L_MOUSE	reviewed	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	Hspa4l Apg1 Hsp4l Osp94	Mus musculus (Mouse)	838	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN14217_c0_g3_i1	Q53RJ5	BIP2_ORYSJ	62.4	85	31	1	277	531	38	121	2.90E-24	113.2	BIP2_ORYSJ	reviewed	Heat shock 70 kDa protein BIP2 (Luminal-binding protein 2) (OsBiP2)	BIP2 Os03g0710500 LOC_Os03g50250	Oryza sativa subsp. japonica (Rice)	669	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN19664_c0_g1_i1	Q9U639	HSP7D_MANSE	55.6	99	44	0	299	3	497	595	9.70E-25	114	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2332_c0_g1_i1	Q9U639	HSP7D_MANSE	66.9	520	164	5	1548	4	3	519	1.50E-193	677.2	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i1	Q9U639	HSP7D_MANSE	78	651	123	2	100	1998	4	652	2.30E-290	999.2	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i2	Q9U639	HSP7D_MANSE	87.9	618	75	0	77	1930	1	618	0	1091.3	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i5	Q9U639	HSP7D_MANSE	78.7	654	119	2	77	1984	1	652	7.60E-294	1010.7	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i6	Q9U639	HSP7D_MANSE	87.2	615	79	0	100	1944	4	618	0	1079.7	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i7	Q9U639	HSP7D_MANSE	86.4	560	76	0	56	1735	59	618	5.80E-282	971.1	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9372_c1_g1_i1	Q9U639	HSP7D_MANSE	73.3	60	16	0	182	3	389	448	1.80E-17	89.4	HSP7D_MANSE	reviewed	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	652	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN174_c0_g1_i13	P29845	HSP7E_DROME	79.6	633	129	0	1983	85	27	659	2.90E-285	982.2	HSP7E_DROME	reviewed	Heat shock 70 kDa protein cognate 5	Hsc70-5 Hsc5 CG8542	Drosophila melanogaster (Fruit fly)	686	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; autophagy of mitochondrion [GO:0000422]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mitochondrion morphogenesis [GO:0070584]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000422; GO:0005524; GO:0005737; GO:0005739; GO:0006457; GO:0006986; GO:0010918; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070584	autophagy of mitochondrion [GO:0000422]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mitochondrion morphogenesis [GO:0070584]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein folding [GO:0006457]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]		blue	blue	NA	NA	NA	NA
TRINITY_DN14806_c0_g1_i1	P20147	HSP90_PLAFP	76.3	76	18	0	2	229	31	106	2.30E-26	119	HSP90_PLAFP	reviewed	Heat shock 90 kDa protein homolog (Fragment)		Plasmodium falciparum (isolate Palo Alto / Uganda)	193	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN22733_c0_g1_i1	Q24789	HSP70_ECHGR	70.9	282	82	0	849	4	342	623	2.30E-111	403.3	HSP70_ECHGR	reviewed	Heat shock cognate 70 kDa protein (HSP70)	HSP70	Echinococcus granulosus (Hydatid tapeworm)	665	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN26571_c6_g1_i1	P08108	HSP70_ONCMY	87.8	616	75	0	122	1969	1	616	0	1079.3	HSP70_ONCMY	reviewed	Heat shock cognate 70 kDa protein (HSP70)	hsc71	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	651	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; response to arsenite ion [GO:1903842]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0009408; GO:0016020; GO:0046686; GO:0046688; GO:1903842	response to arsenite ion [GO:1903842]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN5106_c0_g1_i1	P36415	HS7C1_DICDI	63.6	195	69	1	2	580	308	502	2.80E-60	233	HS7C1_DICDI	reviewed	Heat shock cognate 70 kDa protein 1 (HSC70-1)	hspB hsc70 DDB_G0269144	Dictyostelium discoideum (Slime mold)	640	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]	actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005829; GO:0006986; GO:0016887; GO:0031012; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051015; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN4799_c0_g1_i1	P19378	HSP7C_CRIGR	100	92	0	0	340	65	527	618	4.30E-45	181.8	HSP7C_CRIGR	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	646	"melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]"	melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005886; GO:0006397; GO:0008380; GO:0042470; GO:0045892; GO:1990904	"mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33216_c0_g1_i1	P19120	HSP7C_BOVIN	70.7	75	22	0	225	1	498	572	7.50E-22	104	HSP7C_BOVIN	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Bos taurus (Bovine)	650	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016191; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g1_i1	P19120	HSP7C_BOVIN	100	454	0	0	1362	1	1	454	6.80E-257	887.5	HSP7C_BOVIN	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Bos taurus (Bovine)	650	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016191; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g1_i2	A2Q0Z1	HSP7C_HORSE	100	644	0	0	1935	4	1	644	0	1210.7	HSP7C_HORSE	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Equus caballus (Horse)	646	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g1_i3	P19120	HSP7C_BOVIN	100	360	0	0	1082	3	214	573	7.70E-197	687.6	HSP7C_BOVIN	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Bos taurus (Bovine)	650	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016191; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g1_i4	A2Q0Z1	HSP7C_HORSE	99.8	645	1	0	1935	1	1	645	0	1212.6	HSP7C_HORSE	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Equus caballus (Horse)	646	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g1_i5	P19120	HSP7C_BOVIN	100	453	0	0	1362	4	1	453	3.30E-256	885.2	HSP7C_BOVIN	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Bos taurus (Bovine)	650	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016191; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g1_i6	A2Q0Z1	HSP7C_HORSE	100	147	0	0	444	4	498	644	2.70E-63	242.7	HSP7C_HORSE	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Equus caballus (Horse)	646	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c1_g2_i1	P19120	HSP7C_BOVIN	97.1	69	2	0	210	4	443	511	1.20E-32	139.8	HSP7C_BOVIN	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Bos taurus (Bovine)	650	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016191; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22733_c1_g1_i1	P19120	HSP7C_BOVIN	92	175	14	0	527	3	342	516	3.90E-85	315.5	HSP7C_BOVIN	reviewed	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)	HSPA8 HSC70	Bos taurus (Bovine)	650	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; clathrin-uncoating ATPase activity [GO:1990833]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0006397; GO:0006986; GO:0008088; GO:0008380; GO:0016191; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0031072; GO:0034620; GO:0042026; GO:0042470; GO:0043195; GO:0044183; GO:0045892; GO:0051082; GO:0051085; GO:0051787; GO:0061738; GO:0061740; GO:0061741; GO:0099523; GO:0099524; GO:1904764; GO:1990832; GO:1990833; GO:1990904	"axo-dendritic transport [GO:0008088]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; late endosomal microautophagy [GO:0061738]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; response to unfolded protein [GO:0006986]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; synaptic vesicle uncoating [GO:0016191]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25147_c0_g1_i1	Q9W6Y1	HSP7C_ORYLA	86.9	84	11	0	252	1	1	84	1.80E-35	149.8	HSP7C_ORYLA	reviewed	Heat shock cognate 71 kDa protein (Hsc70.1)	hsc70	Oryzias latipes (Japanese rice fish) (Japanese killifish)	686	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17777_c0_g1_i1	Q04619	HS90B_CHICK	78.4	74	16	0	3	224	447	520	5.00E-26	117.9	HS90B_CHICK	reviewed	Heat shock cognate protein HSP 90-beta	HSP90AB1 HSPCB	Gallus gallus (Chicken)	725	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0006457; GO:0030511; GO:0032435; GO:0034751; GO:0042470; GO:0046983; GO:0051082; GO:0071157; GO:1901389	negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN17414_c0_g1_i1	Q04619	HS90B_CHICK	82.2	73	13	0	221	3	149	221	9.80E-28	123.6	HS90B_CHICK	reviewed	Heat shock cognate protein HSP 90-beta	HSP90AB1 HSPCB	Gallus gallus (Chicken)	725	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0006457; GO:0030511; GO:0032435; GO:0034751; GO:0042470; GO:0046983; GO:0051082; GO:0071157; GO:1901389	negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN35705_c0_g1_i1	P22813	HSF_DROME	71.4	63	18	0	265	77	44	106	1.10E-20	100.9	HSF_DROME	reviewed	Heat shock factor protein (HSF) (Heat shock transcription factor) (HSTF)	Hsf CG5748	Drosophila melanogaster (Fruit fly)	691	"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]"	chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000785; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0009408; GO:0042742; GO:0042802; GO:0043388; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0050832	"defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35705_c0_g1_i2	P22813	HSF_DROME	68.5	92	29	0	278	3	44	135	5.10E-34	145.2	HSF_DROME	reviewed	Heat shock factor protein (HSF) (Heat shock transcription factor) (HSTF)	Hsf CG5748	Drosophila melanogaster (Fruit fly)	691	"chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]"	chromatin [GO:0000785]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000785; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0009408; GO:0042742; GO:0042802; GO:0043388; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0050832	"defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]"		NA	NA	NA	NA	NA	NA
TRINITY_DN78_c0_g1_i1	Q9CQZ1	HSBP1_MOUSE	61.5	39	15	0	131	15	1	39	8.10E-05	47.4	HSBP1_MOUSE	reviewed	Heat shock factor-binding protein 1	Hsbp1	Mus musculus (Mouse)	76	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; muscle contraction [GO:0006936]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006936; GO:0035987; GO:0042802; GO:0070370	cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; muscle contraction [GO:0006936]		blue	blue	NA	NA	NA	NA
TRINITY_DN40684_c0_g1_i1	Q61699	HS105_MOUSE	99.1	114	1	0	342	1	604	717	6.20E-60	231.1	HS105_MOUSE	reviewed	Heat shock protein 105 kDa (42 degrees C-HSP) (Heat shock 110 kDa protein) (Heat shock-related 100 kDa protein E7I) (HSP-E7I)	Hsph1 Hsp105 Hsp110 Kiaa0201	Mus musculus (Mouse)	858	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule cytoskeleton organization [GO:0070507]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]	GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006986; GO:0032991; GO:0043014; GO:0043524; GO:0045345; GO:0045944; GO:0051085; GO:0051135; GO:0061098; GO:0070507; GO:1903748; GO:1903751; GO:1903753; GO:2001234	chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule cytoskeleton organization [GO:0070507]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN39106_c0_g1_i1	Q92598	HS105_HUMAN	100	63	0	0	41	229	1	63	1.40E-28	126.3	HS105_HUMAN	reviewed	Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein)	HSPH1 HSP105 HSP110 KIAA0201	Homo sapiens (Human)	858	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]	GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006898; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN4111_c0_g1_i1	Q92598	HS105_HUMAN	59.8	331	133	0	93	1085	1	331	6.20E-106	385.6	HS105_HUMAN	reviewed	Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein)	HSPH1 HSP105 HSP110 KIAA0201	Homo sapiens (Human)	858	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]	GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006898; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]		blue	blue	NA	NA	NA	NA
TRINITY_DN39479_c0_g1_i1	Q92598	HS105_HUMAN	100	144	0	0	434	3	110	253	6.40E-78	291.2	HS105_HUMAN	reviewed	Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein)	HSPH1 HSP105 HSP110 KIAA0201	Homo sapiens (Human)	858	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]	GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006898; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:1900034	chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN3754_c0_g1_i1	P02517	HSP26_DROME	42.9	84	46	2	270	521	86	167	1.20E-09	64.7	HSP26_DROME	reviewed	Heat shock protein 26	Hsp26 CG4183	Drosophila melanogaster (Fruit fly)	208	cytoplasm [GO:0005737]; myosin binding [GO:0017022]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; cold acclimation [GO:0009631]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]	myosin binding [GO:0017022]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0008340; GO:0009408; GO:0009631; GO:0017022; GO:0042026; GO:0051082; GO:0061077	chaperone-mediated protein folding [GO:0061077]; cold acclimation [GO:0009631]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN37144_c0_g1_i1	P02518	HSP27_DROME	47.4	76	39	1	242	18	88	163	1.30E-11	70.1	HSP27_DROME	reviewed	Heat shock protein 27	Hsp27 CG4466	Drosophila melanogaster (Fruit fly)	213	cytoplasm [GO:0005737]; nucleus [GO:0005634]; unfolded protein binding [GO:0051082]; behavioral response to starvation [GO:0042595]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0008340; GO:0009408; GO:0042026; GO:0042595; GO:0042742; GO:0050832; GO:0051082; GO:0061077	behavioral response to starvation [GO:0042595]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN30548_c0_g1_i1	O60008	HSP60_PARBA	91.7	72	6	0	218	3	206	277	4.20E-30	131.3	HSP60_PARBA	reviewed	"Heat shock protein 60, mitochondrial (60 kDa chaperonin) (Protein Cpn60)"	HSP60 PAAG_08059	Paracoccidioides lutzii (strain ATCC MYA-826 / Pb01) (Paracoccidioides brasiliensis)	592	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein refolding [GO:0042026]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0042026	protein refolding [GO:0042026]		NA	NA	NA	NA	NA	NA
TRINITY_DN22237_c0_g1_i1	O02649	CH60A_DROME	63.5	52	19	0	4	159	283	334	6.10E-12	71.2	CH60A_DROME	reviewed	Heat shock protein 60A	Hsp60A hsp60 CG12101	Drosophila melanogaster (Fruit fly)	573	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrial unfolded protein response [GO:0034514]; mitochondrion organization [GO:0007005]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006457; GO:0006458; GO:0006626; GO:0007005; GO:0008637; GO:0016887; GO:0034514; GO:0034605; GO:0042026; GO:0045041; GO:0051082; GO:0051087	'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrial unfolded protein response [GO:0034514]; mitochondrion organization [GO:0007005]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]		blue	blue	NA	NA	NA	NA
TRINITY_DN3251_c0_g1_i2	O02649	CH60A_DROME	81.5	335	59	2	1074	79	1	335	1.60E-147	523.9	CH60A_DROME	reviewed	Heat shock protein 60A	Hsp60A hsp60 CG12101	Drosophila melanogaster (Fruit fly)	573	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrial unfolded protein response [GO:0034514]; mitochondrion organization [GO:0007005]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006457; GO:0006458; GO:0006626; GO:0007005; GO:0008637; GO:0016887; GO:0034514; GO:0034605; GO:0042026; GO:0045041; GO:0051082; GO:0051087	'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrial unfolded protein response [GO:0034514]; mitochondrion organization [GO:0007005]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]		NA	NA	NA	NA	NA	NA
TRINITY_DN30157_c0_g1_i1	Q12931	TRAP1_HUMAN	100	168	0	0	505	2	70	237	2.00E-86	319.7	TRAP1_HUMAN	reviewed	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	TRAP1 HSP75	Homo sapiens (Human)	704	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]	GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0019901; GO:0051082; GO:0061077; GO:1901856; GO:1903427; GO:1903751	chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]		NA	NA	NA	NA	NA	NA
TRINITY_DN9241_c0_g1_i1	Q9CQN1	TRAP1_MOUSE	55.9	622	264	4	1944	94	90	706	6.90E-200	698.7	TRAP1_MOUSE	reviewed	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	Mus musculus (Mouse)	706	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0019901; GO:0051082; GO:1901856; GO:1903751	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]		NA	NA	NA	NA	NA	NA
TRINITY_DN19712_c0_g1_i1	Q9CQN1	TRAP1_MOUSE	96.1	181	7	0	2	544	241	421	1.10E-95	350.5	TRAP1_MOUSE	reviewed	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	Mus musculus (Mouse)	706	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0019901; GO:0051082; GO:1901856; GO:1903751	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]		NA	NA	NA	NA	NA	NA
TRINITY_DN33564_c0_g1_i1	Q9CQN1	TRAP1_MOUSE	100	171	0	0	515	3	402	572	2.70E-91	335.9	TRAP1_MOUSE	reviewed	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	Trap1 Hsp75	Mus musculus (Mouse)	706	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0019901; GO:0051082; GO:1901856; GO:1903751	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]		NA	NA	NA	NA	NA	NA
TRINITY_DN26754_c0_g1_i1	Q12931	TRAP1_HUMAN	100	235	0	0	2	706	326	560	5.80E-129	461.5	TRAP1_HUMAN	reviewed	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	TRAP1 HSP75	Homo sapiens (Human)	704	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]	GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0019901; GO:0051082; GO:0061077; GO:1901856; GO:1903427; GO:1903751	chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]		NA	NA	NA	NA	NA	NA
TRINITY_DN13107_c0_g1_i1	Q9BLC5	HSP83_BOMMO	81.2	101	19	0	45	347	3	103	8.90E-38	157.5	HSP83_BOMMO	reviewed	Heat shock protein 83 (BmHSP90)	Hsp83 Hsp90	Bombyx mori (Silk moth)	716	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN26000_c0_g1_i1	P04809	HSP83_DROPS	76.9	39	9	0	145	261	264	302	6.90E-11	67.8	HSP83_DROPS	reviewed	Heat shock protein 83 (HSP 82)	Hsp83 Hsp82 GA11622	Drosophila pseudoobscura pseudoobscura (Fruit fly)	717	"centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471]; polytene chromosome interband [GO:0005705]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; centrosome cycle [GO:0007098]; cold acclimation [GO:0009631]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transposition [GO:0010529]; pole plasm mRNA localization [GO:0019094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of small RNA loading onto RISC [GO:0106161]; proteasome assembly [GO:0043248]; protein folding [GO:0006457]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to heat [GO:0009408]"	centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471]; polytene chromosome interband [GO:0005705]	ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]	GO:0002052; GO:0005158; GO:0005524; GO:0005705; GO:0005813; GO:0006457; GO:0007098; GO:0008285; GO:0009408; GO:0009631; GO:0010529; GO:0019094; GO:0030911; GO:0043248; GO:0045187; GO:0046628; GO:0048471; GO:0051082; GO:0106161	"centrosome cycle [GO:0007098]; cold acclimation [GO:0009631]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transposition [GO:0010529]; pole plasm mRNA localization [GO:0019094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of small RNA loading onto RISC [GO:0106161]; proteasome assembly [GO:0043248]; protein folding [GO:0006457]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to heat [GO:0009408]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27987_c0_g1_i1	Q8SSE8	HSP82_ENCCU	48.9	178	88	3	531	1	19	194	8.40E-41	168.3	HSP82_ENCCU	reviewed	Heat shock protein 90	HSP90 ECU02_1100	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	690	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2718_c0_g1_i12	O44001	HSP90_EIMTE	74.8	131	31	1	446	54	94	222	1.30E-49	197.2	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		red	red	NA	NA	NA	NA
TRINITY_DN2718_c0_g1_i13	O44001	HSP90_EIMTE	77.8	216	46	1	705	58	9	222	9.10E-90	331.3	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		red	red	NA	NA	NA	NA
TRINITY_DN2718_c0_g1_i15	O44001	HSP90_EIMTE	77.7	224	48	1	725	54	1	222	2.50E-93	343.2	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		red	red	NA	NA	NA	NA
TRINITY_DN2718_c0_g1_i6	O44001	HSP90_EIMTE	77.7	224	48	1	729	58	1	222	2.90E-94	346.3	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		red	red	NA	NA	NA	NA
TRINITY_DN2718_c0_g1_i8	O44001	HSP90_EIMTE	77.2	224	49	1	725	54	1	222	4.30E-93	342.4	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2718_c0_g1_i9	O44001	HSP90_EIMTE	78.6	224	46	1	725	54	1	222	9.00E-96	351.3	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN10069_c0_g1_i1	O44001	HSP90_EIMTE	83.3	72	12	0	216	1	266	337	3.70E-30	131.7	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN36638_c0_g1_i1	O61998	HSP90_BRUPA	46.4	112	58	2	330	1	433	544	7.20E-21	101.3	HSP90_BRUPA	reviewed	Heat shock protein 90	HSP90	Brugia pahangi (Filarial nematode worm)	717	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN149_c0_g1_i1	O44001	HSP90_EIMTE	77.8	451	96	2	1357	8	266	713	2.10E-199	696.4	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN149_c0_g1_i10	O44001	HSP90_EIMTE	75.1	402	96	2	1210	8	315	713	1.30E-168	594	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN149_c0_g1_i5	O44001	HSP90_EIMTE	75.7	371	87	2	1117	8	345	713	4.00E-156	552.4	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN149_c0_g1_i6	O44001	HSP90_EIMTE	76.3	451	103	2	1357	8	266	713	9.30E-195	681	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN149_c0_g1_i7	O44001	HSP90_EIMTE	77.3	450	99	2	1354	8	266	713	2.60E-197	689.5	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN149_c0_g1_i9	O44001	HSP90_EIMTE	75.4	402	95	2	1210	8	315	713	2.60E-169	596.3	HSP90_EIMTE	reviewed	Heat shock protein 90	HSP90	Eimeria tenella (Coccidian parasite)	713	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN25558_c0_g1_i1	P24724	HSP90_THEPA	85.3	68	10	0	206	3	294	361	4.90E-28	124.4	HSP90_THEPA	reviewed	Heat shock protein 90 (HSP90)	TP02_0244	Theileria parva (East coast fever infection agent)	721	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN40914_c0_g1_i1	P24724	HSP90_THEPA	40.3	62	37	0	210	25	464	525	2.90E-07	55.5	HSP90_THEPA	reviewed	Heat shock protein 90 (HSP90)	TP02_0244	Theileria parva (East coast fever infection agent)	721	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN26048_c0_g1_i1	P41887	HSP90_SCHPO	47.1	70	37	0	211	2	461	530	4.60E-13	74.7	HSP90_SCHPO	reviewed	Heat shock protein 90 homolog	swo1 hsp90 SPAC926.04c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	704	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein aggregate center [GO:0140453]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway [GO:0010619]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; heterochromatin assembly by small RNA [GO:0031048]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type cell wall [GO:0009277]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein aggregate center [GO:0140453]; protein-containing complex [GO:0032991]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006458; GO:0009277; GO:0009986; GO:0010619; GO:0016887; GO:0031048; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0061077; GO:0140453	'de novo' protein folding [GO:0006458]; adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway [GO:0010619]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; heterochromatin assembly by small RNA [GO:0031048]; protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN910_c0_g1_i2	P55737	HS902_ARATH	60.3	121	48	0	369	7	86	206	1.70E-39	163.3	HS902_ARATH	reviewed	Heat shock protein 90-2 (AtHSP90.2) (AtHsp90-2) (Heat shock protein 81-2) (Hsp81-2) (Protein EARLY-RESPONSIVE TO DEHYDRATION 8) (Protein LOSS OF RECOGNITION OF AVRRPM1 2) (Protein MUTANT SNC1-ENHANCING 12)	HSP90-2 ERD8 HSP81-2 LRA2 MUSE12 At5g56030 MDA7.7	Arabidopsis thaliana (Mouse-ear cress)	699	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]; protein folding [GO:0006457]; protein stabilization [GO:0050821]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009816; GO:0009986; GO:0016887; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0061077	"cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; defense response to bacterium, incompatible interaction [GO:0009816]; protein folding [GO:0006457]; protein stabilization [GO:0050821]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33524_c0_g1_i1	Q8SSB1	HSP7B_ENCCU	50	78	37	2	235	5	200	276	4.00E-13	75.1	HSP7B_ENCCU	reviewed	Heat shock protein homolog ECU03_0520	ECU03_0520	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	683	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN30233_c0_g1_i1	P11501	HS90A_CHICK	70.2	84	24	1	1	252	646	728	7.80E-25	114.4	HS90A_CHICK	reviewed	Heat shock protein HSP 90-alpha	HSP90AA1 HSPCA	Gallus gallus (Chicken)	728	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; phosphoprotein binding [GO:0051219]; progesterone receptor binding [GO:0033142]; protein C-terminus binding [GO:0008022]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; cellular response to heat [GO:0034605]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; phosphoprotein binding [GO:0051219]; progesterone receptor binding [GO:0033142]; protein C-terminus binding [GO:0008022]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0008022; GO:0008284; GO:0009408; GO:0009409; GO:0009986; GO:0010243; GO:0014070; GO:0016887; GO:0030235; GO:0030331; GO:0030424; GO:0030911; GO:0031072; GO:0032570; GO:0032991; GO:0033142; GO:0034605; GO:0042470; GO:0042802; GO:0043025; GO:0043204; GO:0043209; GO:0043235; GO:0045429; GO:0046677; GO:0046790; GO:0048471; GO:0050821; GO:0051082; GO:0051087; GO:0051219; GO:0051879; GO:0097718; GO:1902751	cellular response to heat [GO:0034605]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]		NA	NA	NA	NA	NA	NA
TRINITY_DN13107_c0_g1_i2	P11501	HS90A_CHICK	89.3	103	11	0	66	374	14	116	4.00E-44	178.7	HS90A_CHICK	reviewed	Heat shock protein HSP 90-alpha	HSP90AA1 HSPCA	Gallus gallus (Chicken)	728	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; phosphoprotein binding [GO:0051219]; progesterone receptor binding [GO:0033142]; protein C-terminus binding [GO:0008022]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; cellular response to heat [GO:0034605]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; phosphoprotein binding [GO:0051219]; progesterone receptor binding [GO:0033142]; protein C-terminus binding [GO:0008022]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0008022; GO:0008284; GO:0009408; GO:0009409; GO:0009986; GO:0010243; GO:0014070; GO:0016887; GO:0030235; GO:0030331; GO:0030424; GO:0030911; GO:0031072; GO:0032570; GO:0032991; GO:0033142; GO:0034605; GO:0042470; GO:0042802; GO:0043025; GO:0043204; GO:0043209; GO:0043235; GO:0045429; GO:0046677; GO:0046790; GO:0048471; GO:0050821; GO:0051082; GO:0051087; GO:0051219; GO:0051879; GO:0097718; GO:1902751	cellular response to heat [GO:0034605]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to progesterone [GO:0032570]		NA	NA	NA	NA	NA	NA
TRINITY_DN18764_c0_g1_i2	Q76LV2	HS90A_BOVIN	100	119	0	0	17	373	281	399	1.20E-64	246.9	HS90A_BOVIN	reviewed	Heat shock protein HSP 90-alpha	HSP90AA1 HSP90A HSPCA	Bos taurus (Bovine)	733	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009408; GO:0009409; GO:0009986; GO:0016887; GO:0030235; GO:0030911; GO:0032991; GO:0034605; GO:0042470; GO:0042803; GO:0043025; GO:0043209; GO:0045429; GO:0046677; GO:0048471; GO:0050821; GO:0051082; GO:0097718	cellular response to heat [GO:0034605]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN13653_c0_g4_i1	Q76LV2	HS90A_BOVIN	79.1	239	42	1	810	94	1	231	3.10E-101	369.8	HS90A_BOVIN	reviewed	Heat shock protein HSP 90-alpha	HSP90AA1 HSP90A HSPCA	Bos taurus (Bovine)	733	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009408; GO:0009409; GO:0009986; GO:0016887; GO:0030235; GO:0030911; GO:0032991; GO:0034605; GO:0042470; GO:0042803; GO:0043025; GO:0043209; GO:0045429; GO:0046677; GO:0048471; GO:0050821; GO:0051082; GO:0097718	cellular response to heat [GO:0034605]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN16751_c0_g1_i1	P46633	HS90A_CRIGR	99.1	106	1	0	319	2	427	532	3.30E-55	215.3	HS90A_CRIGR	reviewed	Heat shock protein HSP 90-alpha	HSP90AA1 HSP90A HSPCA	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	733	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nitric-oxide synthase regulator activity [GO:0030235]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; nitric-oxide synthase regulator activity [GO:0030235]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0009408; GO:0009409; GO:0016887; GO:0030235; GO:0030911; GO:0042470; GO:0045429; GO:0046677; GO:0051082	positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN25002_c0_g1_i1	P30946	HS90A_RABIT	79.6	108	21	1	326	6	587	694	4.00E-40	165.2	HS90A_RABIT	reviewed	Heat shock protein HSP 90-alpha	HSP90AA1 HSPCA	Oryctolagus cuniculus (Rabbit)	694	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; phosphoprotein binding [GO:0051219]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; phosphoprotein binding [GO:0051219]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0009408; GO:0009409; GO:0016887; GO:0042470; GO:0046677; GO:0051082; GO:0051219	protein folding [GO:0006457]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN18764_c0_g1_i1	P07900	HS90A_HUMAN	99.8	453	1	0	17	1375	280	732	4.90E-252	871.3	HS90A_HUMAN	reviewed	Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)	HSP90AA1 HSP90A HSPC1 HSPCA	Homo sapiens (Human)	732	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; ERBB2 signaling pathway [GO:0038128]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrial transport [GO:0006839]; neutrophil degranulation [GO:0043312]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000086; GO:0001934; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006839; GO:0006898; GO:0006986; GO:0007004; GO:0009408; GO:0009409; GO:0009986; GO:0010389; GO:0016020; GO:0016032; GO:0016887; GO:0019221; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030911; GO:0031396; GO:0031625; GO:0032273; GO:0032991; GO:0033138; GO:0034605; GO:0034774; GO:0038096; GO:0038128; GO:0042026; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0043025; GO:0043202; GO:0043209; GO:0043254; GO:0043312; GO:0043335; GO:0044183; GO:0044294; GO:0044295; GO:0045040; GO:0045429; GO:0046677; GO:0048010; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0050999; GO:0051020; GO:0051082; GO:0051131; GO:0051897; GO:0051973; GO:0061684; GO:0070062; GO:0070182; GO:0071682; GO:0097110; GO:0097711; GO:0097718; GO:1900034; GO:1902949; GO:1903364; GO:1903827; GO:1904813; GO:1905323; GO:1990782	axon extension [GO:0048675]; cellular response to heat [GO:0034605]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; ERBB2 signaling pathway [GO:0038128]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrial transport [GO:0006839]; neutrophil degranulation [GO:0043312]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of protein-containing complex assembly [GO:0043254]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN13653_c0_g2_i1	P07900	HS90A_HUMAN	99.6	234	1	0	703	2	1	234	8.20E-126	451.1	HS90A_HUMAN	reviewed	Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)	HSP90AA1 HSP90A HSPC1 HSPCA	Homo sapiens (Human)	732	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; ERBB2 signaling pathway [GO:0038128]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrial transport [GO:0006839]; neutrophil degranulation [GO:0043312]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000086; GO:0001934; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006839; GO:0006898; GO:0006986; GO:0007004; GO:0009408; GO:0009409; GO:0009986; GO:0010389; GO:0016020; GO:0016032; GO:0016887; GO:0019221; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030911; GO:0031396; GO:0031625; GO:0032273; GO:0032991; GO:0033138; GO:0034605; GO:0034774; GO:0038096; GO:0038128; GO:0042026; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0043025; GO:0043202; GO:0043209; GO:0043254; GO:0043312; GO:0043335; GO:0044183; GO:0044294; GO:0044295; GO:0045040; GO:0045429; GO:0046677; GO:0048010; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0050999; GO:0051020; GO:0051082; GO:0051131; GO:0051897; GO:0051973; GO:0061684; GO:0070062; GO:0070182; GO:0071682; GO:0097110; GO:0097711; GO:0097718; GO:1900034; GO:1902949; GO:1903364; GO:1903827; GO:1904813; GO:1905323; GO:1990782	axon extension [GO:0048675]; cellular response to heat [GO:0034605]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; ERBB2 signaling pathway [GO:0038128]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrial transport [GO:0006839]; neutrophil degranulation [GO:0043312]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of protein-containing complex assembly [GO:0043254]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN13653_c0_g1_i2	P07901	HS90A_MOUSE	100	235	0	0	734	30	1	235	3.80E-126	452.2	HS90A_MOUSE	reviewed	Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Tumor-specific transplantation 86 kDa antigen) (TSTA)	Hsp90aa1 Hsp86 Hsp86-1 Hspca	Mus musculus (Mouse)	733	apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTP binding [GO:0005525]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; axon extension [GO:0048675]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; neuron migration [GO:0001764]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; skeletal muscle contraction [GO:0003009]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]	apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]	GO:0001764; GO:0001934; GO:0002134; GO:0002135; GO:0003009; GO:0003729; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006809; GO:0006986; GO:0007004; GO:0009408; GO:0009409; GO:0009651; GO:0009986; GO:0010592; GO:0010659; GO:0016323; GO:0016324; GO:0016887; GO:0017098; GO:0019903; GO:0021955; GO:0030010; GO:0030235; GO:0030911; GO:0031396; GO:0031526; GO:0031625; GO:0032273; GO:0032564; GO:0032991; GO:0033138; GO:0034605; GO:0036126; GO:0042026; GO:0042220; GO:0042307; GO:0042470; GO:0042493; GO:0042802; GO:0042803; GO:0042826; GO:0043005; GO:0043025; GO:0043209; GO:0043627; GO:0044183; GO:0044294; GO:0044295; GO:0044325; GO:0045040; GO:0045429; GO:0045585; GO:0045793; GO:0046677; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051020; GO:0051022; GO:0051082; GO:0051131; GO:0051897; GO:0051973; GO:0060452; GO:0062023; GO:0070182; GO:0097110; GO:0097226; GO:0097524; GO:0097718; GO:1902949; GO:1903364; GO:1903827; GO:1905323; GO:1990782	axon extension [GO:0048675]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; neuron migration [GO:0001764]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; skeletal muscle contraction [GO:0003009]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN18773_c0_g1_i1	Q76LV1	HS90B_BOVIN	100	453	0	0	1398	40	272	724	1.70E-255	882.9	HS90B_BOVIN	reviewed	Heat shock protein HSP 90-beta	HSP90AB1 HSPCB	Bos taurus (Bovine)	724	aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; extracellular region [GO:0005576]; HSP90-CDC37 chaperone complex [GO:1990565]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]	aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; extracellular region [GO:0005576]; HSP90-CDC37 chaperone complex [GO:1990565]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001890; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0007004; GO:0008180; GO:0009986; GO:0019062; GO:0019887; GO:0019901; GO:0021955; GO:0030010; GO:0030511; GO:0031072; GO:0031396; GO:0031625; GO:0032435; GO:0032516; GO:0032991; GO:0033138; GO:0034605; GO:0034751; GO:0042277; GO:0042470; GO:0042803; GO:0042826; GO:0043008; GO:0043025; GO:0043066; GO:0044183; GO:0044294; GO:0044295; GO:0045597; GO:0046983; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051082; GO:0051131; GO:0051897; GO:0051973; GO:0060334; GO:0060338; GO:0070182; GO:0071157; GO:0071353; GO:0097435; GO:0097718; GO:1901389; GO:1904031; GO:1905323; GO:1990226; GO:1990565; GO:2000010	axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]		NA	NA	NA	NA	NA	NA
TRINITY_DN18773_c1_g1_i1	P30947	HS90B_RABIT	82.8	453	77	1	1446	91	274	726	9.50E-217	754.2	HS90B_RABIT	reviewed	Heat shock protein HSP 90-beta	HSP90AB1 HSPCB	Oryctolagus cuniculus (Rabbit)	726	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0030511; GO:0032435; GO:0034751; GO:0042470; GO:0046983; GO:0051082; GO:0071157; GO:1901389	negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN13653_c0_g5_i1	Q9GKX8	HS90B_HORSE	100	227	0	0	743	63	1	227	1.80E-123	443.4	HS90B_HORSE	reviewed	Heat shock protein HSP 90-beta	HSP90AB1 HSPCB	Equus caballus (Horse)	724	aryl hydrocarbon receptor complex [GO:0034751]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein dimerization activity [GO:0046983]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	aryl hydrocarbon receptor complex [GO:0034751]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein dimerization activity [GO:0046983]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009986; GO:0030235; GO:0030511; GO:0030911; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0042470; GO:0045429; GO:0046983; GO:0048471; GO:0050821; GO:0051082; GO:0071157; GO:0097718; GO:1901389	cellular response to heat [GO:0034605]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN13653_c0_g3_i1	Q9GKX8	HS90B_HORSE	100	227	0	0	743	63	1	227	1.80E-123	443.4	HS90B_HORSE	reviewed	Heat shock protein HSP 90-beta	HSP90AB1 HSPCB	Equus caballus (Horse)	724	aryl hydrocarbon receptor complex [GO:0034751]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein dimerization activity [GO:0046983]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	aryl hydrocarbon receptor complex [GO:0034751]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein dimerization activity [GO:0046983]; TPR domain binding [GO:0030911]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0009986; GO:0030235; GO:0030511; GO:0030911; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0042470; GO:0045429; GO:0046983; GO:0048471; GO:0050821; GO:0051082; GO:0071157; GO:0097718; GO:1901389	cellular response to heat [GO:0034605]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN18773_c0_g2_i1	P08238	HS90B_HUMAN	100	453	0	0	1400	42	272	724	2.80E-255	882.1	HS90B_HUMAN	reviewed	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1 HSP90B HSPC2 HSPCB	Homo sapiens (Human)	724	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; axon extension [GO:0048675]; cellular response to drug [GO:0035690]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; neutrophil degranulation [GO:0043312]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]; xenobiotic metabolic process [GO:0006805]	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]	ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]	GO:0001890; GO:0002134; GO:0002135; GO:0003723; GO:0003725; GO:0005524; GO:0005525; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005886; GO:0006457; GO:0006805; GO:0006986; GO:0007004; GO:0008144; GO:0009651; GO:0009986; GO:0016020; GO:0016234; GO:0016323; GO:0016324; GO:0017098; GO:0019062; GO:0019887; GO:0019900; GO:0019901; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030511; GO:0030911; GO:0031072; GO:0031396; GO:0031526; GO:0031625; GO:0032092; GO:0032435; GO:0032516; GO:0032564; GO:0032991; GO:0033138; GO:0034605; GO:0034751; GO:0034774; GO:0035690; GO:0038096; GO:0042220; GO:0042277; GO:0042307; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0043008; GO:0043025; GO:0043312; GO:0043524; GO:0044183; GO:0044294; GO:0044295; GO:0044325; GO:0045296; GO:0045429; GO:0045597; GO:0045793; GO:0046983; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051082; GO:0051131; GO:0051248; GO:0051897; GO:0051973; GO:0060334; GO:0060338; GO:0070062; GO:0070182; GO:0071157; GO:0071353; GO:0071407; GO:0071902; GO:0097435; GO:0097718; GO:1900034; GO:1901389; GO:1901799; GO:1902949; GO:1903660; GO:1903827; GO:1904031; GO:1904813; GO:1905323; GO:1990226; GO:1990565; GO:1990913; GO:1990917; GO:2000010	axon extension [GO:0048675]; cellular response to drug [GO:0035690]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; neutrophil degranulation [GO:0043312]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN668_c1_g2_i1	P09446	HSP7A_CAEEL	75.7	185	45	0	33	587	5	189	1.30E-76	287.3	HSP1_CAEEL	reviewed	Heat shock protein hsp-1 (Heat shock 70 kDa protein A)	hsp-1 hsp70a F26D10.3	Caenorhabditis elegans	640	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0008340; GO:0009408; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0042147; GO:0044183; GO:0051082; GO:0051085; GO:0051787	"cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i3	P09446	HSP7A_CAEEL	64.4	202	67	1	1	591	439	640	4.70E-67	255.8	HSP1_CAEEL	reviewed	Heat shock protein hsp-1 (Heat shock 70 kDa protein A)	hsp-1 hsp70a F26D10.3	Caenorhabditis elegans	640	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0008340; GO:0009408; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0042147; GO:0044183; GO:0051082; GO:0051085; GO:0051787	"cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1250_c0_g1_i4	P09446	HSP7A_CAEEL	78.3	584	119	3	56	1789	59	640	2.70E-258	892.5	HSP1_CAEEL	reviewed	Heat shock protein hsp-1 (Heat shock 70 kDa protein A)	hsp-1 hsp70a F26D10.3	Caenorhabditis elegans	640	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0008340; GO:0009408; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0042147; GO:0044183; GO:0051082; GO:0051085; GO:0051787	"cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9372_c0_g1_i1	P09446	HSP7A_CAEEL	73.2	97	26	0	292	2	3	99	1.50E-36	153.3	HSP1_CAEEL	reviewed	Heat shock protein hsp-1 (Heat shock 70 kDa protein A)	hsp-1 hsp70a F26D10.3	Caenorhabditis elegans	640	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0008340; GO:0009408; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0042147; GO:0044183; GO:0051082; GO:0051085; GO:0051787	"cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32368_c0_g1_i1	P10591	HSP71_YEAST	51.7	60	28	1	212	33	313	371	5.80E-11	67.8	HSP71_YEAST	reviewed	Heat shock protein SSA1 (Heat shock protein YG100)	SSA1 YAL005C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	642	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole membrane [GO:0000329]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tRNA binding [GO:0000049]; unfolded protein binding [GO:0051082]; cellular response to osmotic stress [GO:0071470]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; cytoplasmic translation [GO:0002181]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; negative regulation of cell aging [GO:0090344]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein folding [GO:0006457]; protein import into nucleus [GO:0006606]; protein polyubiquitination [GO:0000209]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; stress granule disassembly [GO:0035617]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; fungal-type vacuole membrane [GO:0000329]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tRNA binding [GO:0000049]; unfolded protein binding [GO:0051082]	GO:0000049; GO:0000209; GO:0000329; GO:0002181; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006457; GO:0006606; GO:0006616; GO:0006626; GO:0006986; GO:0009277; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0035617; GO:0042026; GO:0043161; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0071470; GO:0072318; GO:0072671; GO:0090344	"cellular response to osmotic stress [GO:0071470]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; cytoplasmic translation [GO:0002181]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; negative regulation of cell aging [GO:0090344]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein folding [GO:0006457]; protein import into nucleus [GO:0006606]; protein polyubiquitination [GO:0000209]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; stress granule disassembly [GO:0035617]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12688_c0_g3_i1	P34933	HSP72_BOVIN	59.6	228	88	1	5	676	261	488	7.60E-70	265	HSP72_BOVIN	reviewed	Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 3) (HSP70.3)	HSPA2 HSP70-3 HSPA3	Bos taurus (Bovine)	636	CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; ATP binding [GO:0005524]; cell differentiation [GO:0030154]; response to cold [GO:0009409]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]	CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0007283; GO:0009408; GO:0009409; GO:0030154; GO:0036128; GO:0072687	cell differentiation [GO:0030154]; response to cold [GO:0009409]; response to heat [GO:0009408]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11969_c0_g1_i1	A4IHD2	ARIP4_XENTR	84.9	93	14	0	280	2	443	535	2.80E-42	172.2	ARIP4_XENTR	reviewed	Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2)	rad54l2 arip4	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1396	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN8012_c0_g1_i1	Q9Y4B4	ARIP4_HUMAN	53.5	86	39	1	56	313	309	393	4.50E-20	98.6	ARIP4_HUMAN	reviewed	Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2)	RAD54L2 ARIP4 KIAA0809	Homo sapiens (Human)	1467	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN39158_c0_g1_i1	Q9NDJ2	DOM_DROME	83.5	127	21	0	381	1	1031	1157	7.60E-59	227.6	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24458_c0_g1_i1	Q9NDJ2	DOM_DROME	66.1	62	21	0	2	187	1050	1111	3.80E-18	91.7	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN334_c0_g1_i1	Q9NDJ2	DOM_DROME	48.1	528	246	13	1	1542	1810	2323	1.20E-118	428.3	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN334_c0_g1_i3	Q9NDJ2	DOM_DROME	48.1	208	96	5	1	588	1810	2017	6.10E-34	147.1	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN334_c0_g2_i1	Q9NDJ2	DOM_DROME	84.2	177	28	0	4	534	1636	1812	2.70E-86	319.3	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4948_c0_g1_i2	Q9NDJ2	DOM_DROME	73	63	17	0	285	97	873	935	1.50E-18	94	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN773_c0_g2_i1	Q9NDJ2	DOM_DROME	61.8	204	67	2	688	110	433	636	1.10E-60	235.7	DOM_DROME	reviewed	Helicase domino (EC 3.6.4.-)	dom CG9696	Drosophila melanogaster (Fruit fly)	3198	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]	GO:0000123; GO:0000381; GO:0000812; GO:0002165; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016458; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043044; GO:0043486; GO:0048477; GO:0048813; GO:0070983	"ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; gene silencing [GO:0016458]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; instar larval or pupal development [GO:0002165]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3878_c0_g1_i1	Q8TDG4	HELQ_HUMAN	44.7	349	172	6	1080	55	269	603	1.30E-72	275.4	HELQ_HUMAN	reviewed	Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase)	HELQ HEL308	Homo sapiens (Human)	1101	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]	GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006364; GO:1990518	double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1313_c0_g1_i1	Q2VPA6	HELQ_MOUSE	45.5	77	36	1	57	269	979	1055	9.50E-09	60.8	HELQ_MOUSE	reviewed	Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase)	Helq Hel308	Mus musculus (Mouse)	1069	nucleus [GO:0005634]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]; DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]	GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006259; GO:0006364; GO:0017116; GO:0017117	DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1313_c0_g1_i2	Q8TDG4	HELQ_HUMAN	38.9	488	267	4	34	1494	627	1084	9.80E-89	328.9	HELQ_HUMAN	reviewed	Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase)	HELQ HEL308	Homo sapiens (Human)	1101	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]	GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006364; GO:1990518	double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1313_c0_g1_i3	Q2VPA6	HELQ_MOUSE	36.1	485	268	6	129	1556	604	1055	3.50E-73	277.3	HELQ_MOUSE	reviewed	Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase)	Helq Hel308	Mus musculus (Mouse)	1069	nucleus [GO:0005634]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]; DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]	GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006259; GO:0006364; GO:0017116; GO:0017117	DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN278_c0_g1_i4	Q00416	SEN1_YEAST	27.7	792	419	27	2325	157	1147	1853	3.20E-56	222.2	SEN1_YEAST	reviewed	Helicase SEN1 (EC 3.6.4.-) (tRNA-splicing endonuclease positive effector)	SEN1 YLR430W L9576.1	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	2231	"cytoplasm [GO:0005737]; Nrd1 complex [GO:0035649]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell redox homeostasis [GO:0045454]; DNA-dependent DNA replication maintenance of fidelity [GO:0045005]; DNA-templated transcription, termination [GO:0006353]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; negative regulation of flocculation [GO:0060257]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; rRNA processing [GO:0006364]; snoRNA 3'-end processing [GO:0031126]; snRNA processing [GO:0016180]; termination of RNA polymerase II transcription [GO:0006369]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA processing [GO:0008033]"	cytoplasm [GO:0005737]; Nrd1 complex [GO:0035649]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]	5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0001147; GO:0003723; GO:0003729; GO:0005524; GO:0005634; GO:0005657; GO:0005737; GO:0006283; GO:0006353; GO:0006364; GO:0006369; GO:0006378; GO:0008033; GO:0016180; GO:0016604; GO:0019904; GO:0031124; GO:0031126; GO:0032574; GO:0033678; GO:0035649; GO:0043139; GO:0045005; GO:0045454; GO:0060257; GO:1990248	"cell redox homeostasis [GO:0045454]; DNA-dependent DNA replication maintenance of fidelity [GO:0045005]; DNA-templated transcription, termination [GO:0006353]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; negative regulation of flocculation [GO:0060257]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; rRNA processing [GO:0006364]; snoRNA 3'-end processing [GO:0031126]; snRNA processing [GO:0016180]; termination of RNA polymerase II transcription [GO:0006369]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA processing [GO:0008033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN278_c0_g1_i5	Q00416	SEN1_YEAST	29	756	418	27	2214	157	1147	1853	1.80E-59	233	SEN1_YEAST	reviewed	Helicase SEN1 (EC 3.6.4.-) (tRNA-splicing endonuclease positive effector)	SEN1 YLR430W L9576.1	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	2231	"cytoplasm [GO:0005737]; Nrd1 complex [GO:0035649]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell redox homeostasis [GO:0045454]; DNA-dependent DNA replication maintenance of fidelity [GO:0045005]; DNA-templated transcription, termination [GO:0006353]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; negative regulation of flocculation [GO:0060257]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; rRNA processing [GO:0006364]; snoRNA 3'-end processing [GO:0031126]; snRNA processing [GO:0016180]; termination of RNA polymerase II transcription [GO:0006369]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA processing [GO:0008033]"	cytoplasm [GO:0005737]; Nrd1 complex [GO:0035649]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]	5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0001147; GO:0003723; GO:0003729; GO:0005524; GO:0005634; GO:0005657; GO:0005737; GO:0006283; GO:0006353; GO:0006364; GO:0006369; GO:0006378; GO:0008033; GO:0016180; GO:0016604; GO:0019904; GO:0031124; GO:0031126; GO:0032574; GO:0033678; GO:0035649; GO:0043139; GO:0045005; GO:0045454; GO:0060257; GO:1990248	"cell redox homeostasis [GO:0045454]; DNA-dependent DNA replication maintenance of fidelity [GO:0045005]; DNA-templated transcription, termination [GO:0006353]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; negative regulation of flocculation [GO:0060257]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; rRNA processing [GO:0006364]; snoRNA 3'-end processing [GO:0031126]; snRNA processing [GO:0016180]; termination of RNA polymerase II transcription [GO:0006369]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA processing [GO:0008033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25775_c0_g1_i1	Q00416	SEN1_YEAST	51.3	76	37	0	243	16	1775	1850	1.50E-18	93.2	SEN1_YEAST	reviewed	Helicase SEN1 (EC 3.6.4.-) (tRNA-splicing endonuclease positive effector)	SEN1 YLR430W L9576.1	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	2231	"cytoplasm [GO:0005737]; Nrd1 complex [GO:0035649]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell redox homeostasis [GO:0045454]; DNA-dependent DNA replication maintenance of fidelity [GO:0045005]; DNA-templated transcription, termination [GO:0006353]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; negative regulation of flocculation [GO:0060257]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; rRNA processing [GO:0006364]; snoRNA 3'-end processing [GO:0031126]; snRNA processing [GO:0016180]; termination of RNA polymerase II transcription [GO:0006369]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA processing [GO:0008033]"	cytoplasm [GO:0005737]; Nrd1 complex [GO:0035649]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]	5'-3' DNA/RNA helicase activity [GO:0033678]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0001147; GO:0003723; GO:0003729; GO:0005524; GO:0005634; GO:0005657; GO:0005737; GO:0006283; GO:0006353; GO:0006364; GO:0006369; GO:0006378; GO:0008033; GO:0016180; GO:0016604; GO:0019904; GO:0031124; GO:0031126; GO:0032574; GO:0033678; GO:0035649; GO:0043139; GO:0045005; GO:0045454; GO:0060257; GO:1990248	"cell redox homeostasis [GO:0045454]; DNA-dependent DNA replication maintenance of fidelity [GO:0045005]; DNA-templated transcription, termination [GO:0006353]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; negative regulation of flocculation [GO:0060257]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; rRNA processing [GO:0006364]; snoRNA 3'-end processing [GO:0031126]; snRNA processing [GO:0016180]; termination of RNA polymerase II transcription [GO:0006369]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA processing [GO:0008033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33101_c0_g1_i1	Q15477	SKIV2_HUMAN	60.6	132	52	0	402	7	598	729	4.70E-43	175.3	SKIV2_HUMAN	reviewed	Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP)	SKIV2L DDX13 SKI2W SKIV2 W	Homo sapiens (Human)	1246	"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0043928; GO:0055087; GO:0070478	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32997_c0_g1_i1	Q15477	SKIV2_HUMAN	66.5	185	62	0	39	593	309	493	8.00E-69	261.5	SKIV2_HUMAN	reviewed	Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP)	SKIV2L DDX13 SKI2W SKIV2 W	Homo sapiens (Human)	1246	"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0043928; GO:0055087; GO:0070478	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1667_c0_g2_i1	Q15477	SKIV2_HUMAN	46	1240	629	13	56	3718	29	1246	2.10E-297	1023.5	SKIV2_HUMAN	reviewed	Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP)	SKIV2L DDX13 SKI2W SKIV2 W	Homo sapiens (Human)	1246	"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0043928; GO:0055087; GO:0070478	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"		brown	brown	NA	NA	NA	NA
TRINITY_DN33562_c0_g1_i1	Q6ZRS2	SRCAP_HUMAN	68.4	114	36	0	348	7	2061	2174	1.00E-41	170.6	SRCAP_HUMAN	reviewed	Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator)	SRCAP KIAA0309	Homo sapiens (Human)	3230	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006338; GO:0006357; GO:0016032; GO:0016458; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043044; GO:0043486; GO:0048471	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN28609_c0_g1_i1	Q6ZRS2	SRCAP_HUMAN	100	52	0	0	2	157	113	164	1.30E-26	119.8	SRCAP_HUMAN	reviewed	Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator)	SRCAP KIAA0309	Homo sapiens (Human)	3230	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006338; GO:0006357; GO:0016032; GO:0016458; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043044; GO:0043486; GO:0048471	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4948_c0_g1_i1	Q6ZRS2	SRCAP_HUMAN	83.3	150	25	0	450	1	582	731	1.30E-73	277.3	SRCAP_HUMAN	reviewed	Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator)	SRCAP KIAA0309	Homo sapiens (Human)	3230	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006338; GO:0006357; GO:0016032; GO:0016458; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043044; GO:0043486; GO:0048471	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]		blue	blue	NA	NA	NA	NA
TRINITY_DN24458_c0_g2_i1	Q4WAS9	SWR1_ASPFU	68.1	91	28	1	3	275	821	910	6.40E-31	134.4	SWR1_ASPFU	reviewed	Helicase swr1 (EC 3.6.4.12)	swr1 AFUA_7G02370	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	1695	Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]	Swr1 complex [GO:0000812]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]	GO:0000812; GO:0003677; GO:0003678; GO:0005524; GO:0006338; GO:0016458; GO:0016887; GO:0042393; GO:0043044; GO:0043486	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]		NA	NA	NA	NA	NA	NA
TRINITY_DN39606_c0_g1_i1	Q94BR5	CHR28_ARATH	51.6	95	46	0	2	286	857	951	9.00E-23	107.5	CHR28_ARATH	reviewed	Helicase-like transcription factor CHR28 (EC 3.6.4.-) (Protein CHROMATIN REMODELING 28) (Protein SNF2-RING-HELICASE-LIKE 2)	CHR28 FRG2 At1g50410 F11F12.23 F14I3.1	Arabidopsis thaliana (Mouse-ear cress)	981	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; gene silencing by RNA-directed DNA methylation [GO:0080188]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0046872; GO:0080188	chromatin organization [GO:0006325]; gene silencing by RNA-directed DNA methylation [GO:0080188]		NA	NA	NA	NA	NA	NA
TRINITY_DN7475_c2_g1_i1	P41894	DEI_DROME	56.2	73	29	1	611	402	83	155	3.00E-12	73.6	DEI_DROME	reviewed	Helix-loop-helix protein delilah (Protein taxi)	tx dei CG5441	Drosophila melanogaster (Fruit fly)	384	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]"	nucleus [GO:0005634]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983	"cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7475_c0_g1_i1	P41894	DEI_DROME	38.6	145	64	4	123	488	13	155	1.10E-09	65.5	DEI_DROME	reviewed	Helix-loop-helix protein delilah (Protein taxi)	tx dei CG5441	Drosophila melanogaster (Fruit fly)	384	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]"	nucleus [GO:0005634]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983	"cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7475_c0_g1_i3	P41894	DEI_DROME	54.8	73	30	1	34	243	83	155	5.70E-11	69.3	DEI_DROME	reviewed	Helix-loop-helix protein delilah (Protein taxi)	tx dei CG5441	Drosophila melanogaster (Fruit fly)	384	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]"	nucleus [GO:0005634]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983	"cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7475_c0_g1_i7	P41894	DEI_DROME	37.1	143	69	3	123	488	13	155	2.00E-09	64.3	DEI_DROME	reviewed	Helix-loop-helix protein delilah (Protein taxi)	tx dei CG5441	Drosophila melanogaster (Fruit fly)	384	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]"	nucleus [GO:0005634]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983	"cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30474_c0_g1_i1	P14317	HCLS1_HUMAN	99.5	192	1	0	577	2	46	237	6.30E-105	381.3	HCLS1_HUMAN	reviewed	Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75)	HCLS1 HS1	Homo sapiens (Human)	486	"cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II transcription factor binding [GO:0001085]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]"	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667]	actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II transcription factor binding [GO:0001085]; SH3 domain binding [GO:0017124]	GO:0000122; GO:0001085; GO:0005634; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0008284; GO:0009725; GO:0014068; GO:0017124; GO:0019901; GO:0030041; GO:0030218; GO:0030427; GO:0030833; GO:0030854; GO:0030864; GO:0033138; GO:0035556; GO:0042307; GO:0042531; GO:0045651; GO:0045944; GO:0050731; GO:0051015; GO:0051091; GO:0051897; GO:0071345; GO:2000107; GO:2000251	"actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13462_c0_g1_i1	Q9JHF7	HPGDS_MOUSE	51	49	23	1	150	4	1	48	9.30E-07	53.9	HPGDS_MOUSE	reviewed	Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)	Hpgds Gsts Pgds Ptgds2	Mus musculus (Mouse)	199	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005654; GO:0005829; GO:0006693; GO:0006749; GO:0042803; GO:0043231; GO:2000255	glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1275_c1_g1_i1	O60760	HPGDS_HUMAN	32	203	131	4	708	103	1	197	2.70E-26	120.6	HPGDS_HUMAN	reviewed	Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)	HPGDS GSTS PGDS PTGDS2	Homo sapiens (Human)	199	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; cyclooxygenase pathway [GO:0019371]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; locomotory behavior [GO:0007626]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin metabolic process [GO:0006693]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004364; GO:0004667; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0006749; GO:0007165; GO:0007626; GO:0019371; GO:0042803; GO:0043231; GO:1901687; GO:2000255	cyclooxygenase pathway [GO:0019371]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; locomotory behavior [GO:0007626]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin metabolic process [GO:0006693]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1099_c0_g1_i1	Q9JHF7	HPGDS_MOUSE	36.8	201	123	1	700	98	1	197	5.30E-30	132.9	HPGDS_MOUSE	reviewed	Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)	Hpgds Gsts Pgds Ptgds2	Mus musculus (Mouse)	199	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005654; GO:0005829; GO:0006693; GO:0006749; GO:0042803; GO:0043231; GO:2000255	glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]		blue	blue	NA	NA	NA	NA
TRINITY_DN33403_c0_g1_i1	Q9JHF7	HPGDS_MOUSE	64.4	45	16	0	82	216	1	45	1.70E-11	69.7	HPGDS_MOUSE	reviewed	Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)	Hpgds Gsts Pgds Ptgds2	Mus musculus (Mouse)	199	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005654; GO:0005829; GO:0006693; GO:0006749; GO:0042803; GO:0043231; GO:2000255	glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN8769_c0_g1_i4	Q96RW7	HMCN1_HUMAN	36	89	57	0	589	323	4086	4174	9.50E-10	66.2	HMCN1_HUMAN	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	HMCN1 FIBL6	Homo sapiens (Human)	5635	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN13576_c0_g1_i2	D3YXG0	HMCN1_MOUSE	28	307	181	6	1	918	2210	2477	2.60E-28	127.5	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN17338_c0_g1_i1	D3YXG0	HMCN1_MOUSE	31.7	227	153	2	710	30	1728	1952	7.50E-26	119	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN17338_c0_g1_i2	D3YXG0	HMCN1_MOUSE	37.4	91	52	2	369	103	2109	2196	1.40E-11	70.9	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN17338_c0_g1_i6	D3YXG0	HMCN1_MOUSE	32	228	153	2	712	29	1728	1953	3.10E-27	123.6	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN11157_c0_g1_i1	D3YXG0	HMCN1_MOUSE	37.3	322	185	6	105	1022	2101	2421	4.40E-51	203.4	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN11157_c0_g1_i2	D3YXG0	HMCN1_MOUSE	33.1	157	99	3	6	467	1348	1501	4.20E-18	92.8	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN11157_c0_g1_i5	Q96RW7	HMCN1_HUMAN	36.4	426	244	11	12	1229	2004	2422	2.10E-68	261.2	HMCN1_HUMAN	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	HMCN1 FIBL6	Homo sapiens (Human)	5635	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN3523_c0_g1_i1	Q96RW7	HMCN1_HUMAN	24.3	210	133	8	2039	1461	2963	3163	4.50E-05	51.6	HMCN1_HUMAN	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	HMCN1 FIBL6	Homo sapiens (Human)	5635	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN3523_c0_g1_i5	Q96RW7	HMCN1_HUMAN	24.3	210	133	8	2039	1461	2963	3163	4.80E-05	51.6	HMCN1_HUMAN	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	HMCN1 FIBL6	Homo sapiens (Human)	5635	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN35451_c0_g1_i1	Q96RW7	HMCN1_HUMAN	37.7	114	71	0	10	351	4785	4898	2.00E-17	90.1	HMCN1_HUMAN	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	HMCN1 FIBL6	Homo sapiens (Human)	5635	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN9892_c0_g1_i14	D3YXG0	HMCN1_MOUSE	37.7	557	279	8	2	1612	5126	5634	1.50E-111	404.8	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN9892_c0_g1_i2	D3YXG0	HMCN1_MOUSE	44.1	170	91	2	74	583	5469	5634	2.90E-37	156.8	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN9892_c0_g1_i5	D3YXG0	HMCN1_MOUSE	37.8	368	206	4	59	1105	5271	5634	7.10E-71	269.2	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005604; GO:0005912; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN40359_c0_g1_i1	Q8NDA2	HMCN2_HUMAN	70.5	44	13	0	50	181	161	204	6.50E-13	74.3	HMCN2_HUMAN	reviewed	Hemicentin-2	HMCN2	Homo sapiens (Human)	5059	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN12901_c1_g4_i1	Q8NDA2	HMCN2_HUMAN	38.7	75	44	1	179	397	2228	2302	1.20E-06	54.7	HMCN2_HUMAN	reviewed	Hemicentin-2	HMCN2	Homo sapiens (Human)	5059	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	response to stimulus [GO:0050896]		brown	brown	1	NA	NA	NA
TRINITY_DN28564_c0_g1_i1	Q8NDA2	HMCN2_HUMAN	36.1	108	57	3	341	27	1796	1894	1.10E-09	64.7	HMCN2_HUMAN	reviewed	Hemicentin-2	HMCN2	Homo sapiens (Human)	5059	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN9892_c0_g1_i11	Q8NDA2	HMCN2_HUMAN	55.6	45	17	1	62	196	4860	4901	1.20E-08	60.5	HMCN2_HUMAN	reviewed	Hemicentin-2	HMCN2	Homo sapiens (Human)	5059	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN9892_c0_g1_i4	Q8NDA2	HMCN2_HUMAN	48.1	187	94	2	17	574	4615	4799	4.30E-50	199.5	HMCN2_HUMAN	reviewed	Hemicentin-2	HMCN2	Homo sapiens (Human)	5059	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN9892_c0_g1_i7	Q8NDA2	HMCN2_HUMAN	41.2	405	214	7	272	1441	4613	5008	8.60E-90	332.4	HMCN2_HUMAN	reviewed	Hemicentin-2	HMCN2	Homo sapiens (Human)	5059	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN4344_c0_g1_i5	P80888	HCY_PALVU	76.2	80	19	0	1	240	241	320	6.50E-32	137.5	HCY_PALVU	reviewed	Hemocyanin		Palinurus vulgaris (European spiny lobster)	657	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1685_c0_g1_i2	P04254	HCYA_PANIN	54.4	237	108	0	10	720	198	434	1.50E-76	287.3	HCYA_PANIN	reviewed	Hemocyanin A chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	657	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	NA	NA	NA	NA
TRINITY_DN1685_c0_g1_i3	P04254	HCYA_PANIN	54.4	237	108	0	10	720	198	434	4.50E-76	285.8	HCYA_PANIN	reviewed	Hemocyanin A chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	657	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			blue	blue	NA	NA	NA	1
TRINITY_DN1685_c0_g1_i6	P04254	HCYA_PANIN	54.4	237	108	0	10	720	198	434	4.50E-76	285.8	HCYA_PANIN	reviewed	Hemocyanin A chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	657	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1685_c0_g1_i8	P04254	HCYA_PANIN	52.9	272	127	1	10	825	198	468	3.90E-84	312.8	HCYA_PANIN	reviewed	Hemocyanin A chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	657	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1685_c0_g1_i7	P04254	HCYA_PANIN	53.3	152	71	0	6	461	283	434	8.40E-44	177.9	HCYA_PANIN	reviewed	Hemocyanin A chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	657	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	1	NA	NA	1
TRINITY_DN4426_c0_g1_i1	P83180	HCYB_ASTLP	50	52	24	1	189	34	512	561	6.80E-08	57.8	HCYB_ASTLP	reviewed	Hemocyanin B chain		Astacus leptodactylus (Turkish narrow-clawed crayfish) (Pontastacus leptodactylus)	566	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	NA	NA	1	1
TRINITY_DN4426_c0_g1_i2	P83180	HCYB_ASTLP	49	49	23	1	187	41	512	558	2.80E-06	52.4	HCYB_ASTLP	reviewed	Hemocyanin B chain		Astacus leptodactylus (Turkish narrow-clawed crayfish) (Pontastacus leptodactylus)	566	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12360_c0_g1_i1	P80096	HCYC_PANIN	63.2	193	71	0	3	581	397	589	6.60E-70	265	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i10	P80096	HCYC_PANIN	69.8	420	126	1	1686	427	238	656	8.00E-177	621.7	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i10	P80096	HCYC_PANIN	68.8	32	10	0	413	318	625	656	8.70E-06	53.5	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i10	P80096	HCYC_PANIN	62.5	32	12	0	304	209	625	656	6.30E-04	47.4	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i18	P80096	HCYC_PANIN	70.3	585	172	2	2168	414	74	656	1.60E-254	880.2	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i18	P80096	HCYC_PANIN	68.8	32	10	0	400	305	625	656	1.10E-05	53.5	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i20	P80096	HCYC_PANIN	67.7	623	199	2	2282	414	36	656	1.80E-259	896.7	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	1	1
TRINITY_DN172_c0_g1_i20	P80096	HCYC_PANIN	68.8	32	10	0	400	305	625	656	1.20E-05	53.5	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	1	1
TRINITY_DN172_c0_g1_i24	P80096	HCYC_PANIN	75.1	269	67	0	810	4	238	506	3.30E-120	432.6	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i25	P80096	HCYC_PANIN	74.3	269	69	0	810	4	238	506	8.20E-119	427.9	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i26	P80096	HCYC_PANIN	61.1	131	50	1	710	318	527	656	7.90E-41	168.7	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	NA	NA	1	1
TRINITY_DN172_c0_g1_i26	P80096	HCYC_PANIN	65.6	32	11	0	195	100	625	656	1.20E-04	48.5	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	NA	NA	1	1
TRINITY_DN172_c0_g1_i26	P80096	HCYC_PANIN	62.5	32	12	0	304	209	625	656	2.60E-04	47.4	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	NA	NA	1	1
TRINITY_DN172_c0_g1_i3	P80096	HCYC_PANIN	67.4	657	210	3	2347	383	2	656	6.20E-271	934.9	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i3	P80096	HCYC_PANIN	68.8	32	10	0	369	274	625	656	1.30E-05	53.5	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i5	P80096	HCYC_PANIN	64.7	371	127	2	1101	1	74	444	4.30E-147	522.3	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	1
TRINITY_DN172_c0_g1_i9	P80096	HCYC_PANIN	74.3	148	38	0	447	4	359	506	1.10E-61	237.3	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12184_c0_g1_i2	P80096	HCYC_PANIN	76.2	101	24	0	14	316	319	419	3.70E-43	175.3	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN172_c0_g1_i11	P80096	HCYC_PANIN	67.4	657	210	3	2391	427	2	656	6.30E-271	934.9	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	1	NA	1	1
TRINITY_DN172_c0_g1_i11	P80096	HCYC_PANIN	68.8	32	10	0	413	318	625	656	1.30E-05	53.5	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			black	black	1	NA	1	1
TRINITY_DN6281_c0_g1_i1	P80096	HCYC_PANIN	70.4	142	42	0	453	28	379	520	3.60E-55	215.7	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6281_c0_g1_i3	P80096	HCYC_PANIN	66.3	279	93	1	936	100	379	656	1.60E-105	384	HCYC_PANIN	reviewed	Hemocyanin C chain		Panulirus interruptus (California spiny lobster) (Palinurus interruptus)	661	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	1
TRINITY_DN4344_c0_g1_i1	P84293	HCY2_CARAE	74.6	279	69	2	4	837	77	354	1.10E-121	437.6	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4344_c0_g1_i10	P84293	HCY2_CARAE	74.4	203	50	2	1	606	153	354	9.50E-88	324.3	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4344_c0_g1_i14	P84293	HCY2_CARAE	78	177	38	1	2	529	84	260	3.20E-79	295.8	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4344_c0_g1_i8	P84293	HCY2_CARAE	77.3	238	52	2	2	712	84	320	1.40E-106	387.1	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12184_c0_g1_i1	P84293	HCY2_CARAE	73.6	72	19	0	2	217	309	380	9.70E-27	120.2	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8413_c0_g1_i1	P84293	HCY2_CARAE	65.3	98	34	0	97	390	8	105	2.00E-30	133.3	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8413_c0_g1_i2	P84293	HCY2_CARAE	66.7	105	35	0	20	334	1	105	1.70E-33	143.3	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8413_c0_g1_i3	P84293	HCY2_CARAE	69.4	98	30	0	97	390	8	105	2.50E-33	142.9	HCY2_CARAE	reviewed	Hemocyanin subunit 2 (CaeSS2)		Carcinus aestuarii (Green crab) (Carcinus mediterraneus)	650	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005615; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5128_c2_g1_i1	Q05187	TGMH_TACTR	56.3	245	102	2	735	1	353	592	2.50E-75	283.5	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN5128_c2_g1_i2	Q05187	TGMH_TACTR	67	88	25	1	348	85	353	436	1.50E-28	127.1	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		blue	blue	NA	NA	NA	NA
TRINITY_DN12062_c4_g1_i1	Q05187	TGMH_TACTR	50.7	67	24	1	202	2	349	406	6.00E-10	64.3	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN12062_c1_g1_i1	Q05187	TGMH_TACTR	51.6	93	43	1	17	295	448	538	1.00E-18	94	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN36756_c0_g1_i1	Q05187	TGMH_TACTR	49.2	59	30	0	265	89	426	484	2.00E-10	66.2	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN193_c1_g1_i1	Q05187	TGMH_TACTR	49.6	569	272	6	10	1710	209	764	1.30E-153	544.7	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		blue	blue	NA	NA	NA	NA
TRINITY_DN19984_c0_g1_i1	Q05187	TGMH_TACTR	63.4	131	38	2	3	392	330	451	8.00E-43	174.5	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		blue	blue	NA	NA	NA	NA
TRINITY_DN19984_c1_g1_i1	Q05187	TGMH_TACTR	53.6	110	49	2	17	343	254	362	1.70E-25	116.7	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN19984_c0_g2_i1	Q05187	TGMH_TACTR	53	83	38	1	1	249	254	335	1.10E-18	93.6	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN6141_c0_g1_i1	Q05187	TGMH_TACTR	39.3	145	85	2	521	87	622	763	2.20E-23	110.5	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN6141_c0_g1_i4	Q05187	TGMH_TACTR	39	195	116	2	671	87	572	763	4.40E-34	146.4	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN21928_c1_g1_i1	Q05187	TGMH_TACTR	59.2	76	22	1	230	3	338	404	5.40E-18	91.3	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN18419_c0_g1_i1	Q05187	TGMH_TACTR	56.6	159	69	0	13	489	209	367	1.20E-48	194.1	TGMH_TACTR	reviewed	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)		Tachypleus tridentatus (Japanese horseshoe crab)	764	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0016020; GO:0018149; GO:0046872	peptide cross-linking [GO:0018149]		NA	NA	NA	NA	NA	NA
TRINITY_DN22_c4_g1_i1	P98092	HMCT_BOMMO	33.5	424	252	9	1188	1	1793	2214	3.60E-70	266.9	HMCT_BOMMO	reviewed	Hemocytin (Humoral lectin)		Bombyx mori (Silk moth)	3133	carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]		carbohydrate binding [GO:0030246]	GO:0007155; GO:0030246	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN31876_c0_g1_i1	Q54316	HLYB_BRAHO	63	73	27	0	222	4	617	689	9.10E-20	97.1	HLYB_BRAHO	reviewed	Hemolysin B	tlyB	Brachyspira hyodysenteriae (Treponema hyodysenteriae)	828	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; pathogenesis [GO:0009405]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; toxin activity [GO:0090729]	GO:0005524; GO:0009405; GO:0016887; GO:0044179; GO:0090729	hemolysis in other organism [GO:0044179]; pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN3746_c0_g1_i2	Q5R621	HS2ST_PONAB	58.8	284	116	1	64	915	72	354	2.10E-103	377.1	HS2ST_PONAB	reviewed	Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-)	HS2ST1 HS2ST	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	356	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3746_c0_g1_i3	Q76KB1	HS2ST_CHICK	44	50	27	1	66	215	308	356	9.60E-07	53.9	HS2ST_CHICK	reviewed	Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-)	HS2ST1 HS2ST	Gallus gallus (Chicken)	356	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0004394; GO:0008146; GO:0015014; GO:0015015; GO:0016021; GO:0030202; GO:0042802; GO:0060676	"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13257_c0_g1_i3	Q76KB1	HS2ST_CHICK	55.3	322	129	2	1057	92	48	354	1.40E-106	387.9	HS2ST_CHICK	reviewed	Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-)	HS2ST1 HS2ST	Gallus gallus (Chicken)	356	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0004394; GO:0008146; GO:0015014; GO:0015015; GO:0016021; GO:0030202; GO:0042802; GO:0060676	"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13257_c0_g1_i2	O93336	HS2ST_XENLA	63	162	60	0	691	206	70	231	1.10E-63	245	HS2ST_XENLA	reviewed	Heparan sulfate 2-O-sulfotransferase 1 (EC 2.8.2.-)	hs2st1 hs2st	Xenopus laevis (African clawed frog)	356	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0000139; GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14561_c0_g1_i1	Q86BJ3	PIPE_DROME	60	45	18	0	263	129	445	489	1.60E-07	56.6	PIPE_DROME	reviewed	Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-)	pip CG9614	Drosophila melanogaster (Fruit fly)	514	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]	sulfotransferase activity [GO:0008146]	GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005	dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]		NA	NA	NA	NA	NA	NA
TRINITY_DN14561_c0_g2_i2	Q86BJ3	PIPE_DROME	43.8	128	66	3	410	45	311	438	3.00E-24	112.8	PIPE_DROME	reviewed	Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-)	pip CG9614	Drosophila melanogaster (Fruit fly)	514	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]	sulfotransferase activity [GO:0008146]	GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005	dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]		NA	NA	NA	NA	NA	NA
TRINITY_DN8958_c0_g1_i1	Q86BJ3	PIPE_DROME	43.9	107	60	0	167	487	206	312	6.80E-20	98.6	PIPE_DROME	reviewed	Heparan sulfate 2-O-sulfotransferase pipe (EC 2.8.2.-)	pip CG9614	Drosophila melanogaster (Fruit fly)	514	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; sulfotransferase activity [GO:0008146]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]	sulfotransferase activity [GO:0008146]	GO:0005634; GO:0005694; GO:0005794; GO:0008146; GO:0009880; GO:0009950; GO:0030173; GO:0040014; GO:0045752; GO:1900005	dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; positive regulation of serine-type endopeptidase activity [GO:1900005]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of multicellular organism growth [GO:0040014]		NA	NA	NA	NA	NA	NA
TRINITY_DN28832_c0_g1_i1	Q8BKN6	HS3SA_MOUSE	64.6	79	28	0	15	251	313	391	4.90E-28	124.8	HS3SA_MOUSE	reviewed	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (Heparan sulfate 3-O-sulfotransferase 3A1)	Hs3st3a1 3ost3a1 Hs3st3a	Mus musculus (Mouse)	393	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]	GO:0000139; GO:0008467; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5509_c0_g1_i1	Q68CP4	HGNAT_HUMAN	37.3	624	335	12	1843	29	77	663	1.80E-100	368.2	HGNAT_HUMAN	reviewed	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	HGSNAT TMEM76	Homo sapiens (Human)	663	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]"	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005765; GO:0005886; GO:0006027; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0043312; GO:0051259; GO:0070821	glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]		NA	NA	NA	NA	NA	NA
TRINITY_DN18694_c0_g1_i2	Q3UDW8	HGNAT_MOUSE	43.6	401	217	5	135	1319	251	648	4.10E-89	330.5	HGNAT_MOUSE	reviewed	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	Hgsnat D8Ertd354e Tmem76	Mus musculus (Mouse)	656	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]"	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259	lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]		NA	NA	NA	NA	NA	NA
TRINITY_DN18694_c0_g1_i2	Q3UDW8	HGNAT_MOUSE	42.9	161	91	1	1810	1331	496	656	1.20E-29	132.9	HGNAT_MOUSE	reviewed	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	Hgsnat D8Ertd354e Tmem76	Mus musculus (Mouse)	656	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]"	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259	lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]		NA	NA	NA	NA	NA	NA
TRINITY_DN18694_c0_g1_i3	Q68CP4	HGNAT_HUMAN	60.6	66	26	0	159	356	266	331	6.20E-20	98.6	HGNAT_HUMAN	reviewed	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	HGSNAT TMEM76	Homo sapiens (Human)	663	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]"	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005765; GO:0005886; GO:0006027; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0043312; GO:0051259; GO:0070821	glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]		NA	NA	NA	NA	NA	NA
TRINITY_DN18694_c0_g1_i4	Q3UDW8	HGNAT_MOUSE	40.4	354	202	5	30	1073	306	656	2.70E-67	257.3	HGNAT_MOUSE	reviewed	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	Hgsnat D8Ertd354e Tmem76	Mus musculus (Mouse)	656	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]"	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	"heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259	lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]		NA	NA	NA	NA	NA	NA
TRINITY_DN33193_c0_g1_i1	Q76LW2	H6ST2_CHICK	55.9	295	123	4	178	1056	72	361	1.40E-89	331.3	H6ST2_CHICK	reviewed	Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (cHS6ST-2) (EC 2.8.2.-)	HS6ST2 RCJMB04_19a20	Gallus gallus (Chicken)	403	"integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; limb development [GO:0060173]"	integral component of membrane [GO:0016021]	heparan sulfate 6-O-sulfotransferase activity [GO:0017095]	GO:0015015; GO:0016021; GO:0017095; GO:0060173	"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; limb development [GO:0060173]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26256_c0_g1_i1	Q16534	HLF_HUMAN	75.7	37	8	1	19	126	62	98	1.60E-09	63.2	HLF_HUMAN	reviewed	Hepatic leukemia factor	HLF	Homo sapiens (Human)	295	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:1990837	multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1309_c0_g1_i1	Q16534	HLF_HUMAN	57.4	129	41	2	74	457	174	289	4.10E-28	125.9	HLF_HUMAN	reviewed	Hepatic leukemia factor	HLF	Homo sapiens (Human)	295	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:1990837	multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1309_c0_g1_i2	Q16534	HLF_HUMAN	65	120	41	1	197	553	170	289	2.70E-34	146.7	HLF_HUMAN	reviewed	Hepatic leukemia factor	HLF	Homo sapiens (Human)	295	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:1990837	multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1309_c0_g1_i3	Q16534	HLF_HUMAN	63.8	116	41	1	74	418	174	289	1.80E-30	133.7	HLF_HUMAN	reviewed	Hepatic leukemia factor	HLF	Homo sapiens (Human)	295	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:1990837	multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN4105_c0_g1_i4	Q04756	HGFA_HUMAN	47.9	73	33	2	281	69	580	649	5.00E-10	65.9	HGFA_HUMAN	reviewed	Hepatocyte growth factor activator (HGF activator) (HGFA) (EC 3.4.21.-) [Cleaved into: Hepatocyte growth factor activator short chain; Hepatocyte growth factor activator long chain]	HGFAC	Homo sapiens (Human)	655	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0005615; GO:0005791; GO:0005829; GO:0006508; GO:0007596; GO:0008236; GO:0031638	blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN40077_c0_g1_i1	Q99LI8	HGS_MOUSE	100	120	0	0	3	362	65	184	5.20E-65	248.1	HGS_MOUSE	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate	Hgs Hrs	Mus musculus (Mouse)	775	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016020; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0042802; GO:0043231; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0072657; GO:0140036; GO:1903543	endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]		NA	NA	NA	NA	NA	NA
TRINITY_DN2259_c0_g1_i1	Q99LI8	HGS_MOUSE	44	175	89	3	761	264	320	494	6.90E-32	139.4	HGS_MOUSE	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate	Hgs Hrs	Mus musculus (Mouse)	775	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016020; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0042802; GO:0043231; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0072657; GO:0140036; GO:1903543	endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]		NA	NA	NA	NA	NA	NA
TRINITY_DN2259_c0_g1_i2	Q99LI8	HGS_MOUSE	44	175	89	3	761	264	320	494	8.70E-32	139	HGS_MOUSE	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate	Hgs Hrs	Mus musculus (Mouse)	775	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016020; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0042802; GO:0043231; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0072657; GO:0140036; GO:1903543	endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]		NA	NA	NA	NA	NA	NA
TRINITY_DN30834_c0_g1_i1	O14964	HGS_HUMAN	100	76	0	0	2	229	169	244	1.60E-40	166	HGS_HUMAN	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)	HGS HRS	Homo sapiens (Human)	777	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein deubiquitination [GO:0016579]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]	metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0008285; GO:0010324; GO:0010628; GO:0010642; GO:0016197; GO:0016236; GO:0016525; GO:0016579; GO:0019904; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0036258; GO:0042059; GO:0042176; GO:0043231; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0061024; GO:0070062; GO:0072657; GO:1903543	endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein deubiquitination [GO:0016579]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33318_c0_g1_i1	O14964	HGS_HUMAN	100	91	0	0	1	273	29	119	2.60E-45	182.2	HGS_HUMAN	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)	HGS HRS	Homo sapiens (Human)	777	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein deubiquitination [GO:0016579]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]	metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0008285; GO:0010324; GO:0010628; GO:0010642; GO:0016197; GO:0016236; GO:0016525; GO:0016579; GO:0019904; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0036258; GO:0042059; GO:0042176; GO:0043231; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0061024; GO:0070062; GO:0072657; GO:1903543	endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein deubiquitination [GO:0016579]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3269_c0_g2_i1	Q9JJ50	HGS_RAT	54.4	215	94	2	639	7	40	254	3.00E-61	236.5	HGS_RAT	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate (SNAP-25-interacting protein Hrs-2)	Hgs Hrs Hrs2	Rattus norvegicus (Rat)	776	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005737; GO:0005769; GO:0005829; GO:0006622; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016020; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0042802; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0072657; GO:0140036; GO:1903543	endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]		NA	NA	NA	NA	NA	NA
TRINITY_DN3269_c0_g2_i2	Q9JJ50	HGS_RAT	54.8	250	109	2	744	7	5	254	3.40E-72	273.1	HGS_RAT	reviewed	Hepatocyte growth factor-regulated tyrosine kinase substrate (SNAP-25-interacting protein Hrs-2)	Hgs Hrs Hrs2	Rattus norvegicus (Rat)	776	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; membrane [GO:0016020]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-dependent protein binding [GO:0140036]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005737; GO:0005769; GO:0005829; GO:0006622; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016020; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0042802; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0072657; GO:0140036; GO:1903543	endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]		NA	NA	NA	NA	NA	NA
TRINITY_DN3811_c0_g1_i1	Q6P4K1	HDGR2_XENTR	50.6	87	41	1	765	505	20	104	8.20E-20	99	HDGR2_XENTR	reviewed	Hepatoma-derived growth factor-related protein 2 (HRP-2)	hdgfl2 hdgfrp2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	643	nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712]	GO:0003690; GO:0003712; GO:0005634; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9862_c0_g1_i2	Q9ZUH8	HHP3_ARATH	29.2	168	81	3	497	102	66	231	1.20E-09	64.7	HHP3_ARATH	reviewed	Heptahelical transmembrane protein 3 (PAQR family protein HHP3)	HHP3 At2g24150 F27D4.6	Arabidopsis thaliana (Mouse-ear cress)	344	integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]	integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0006979; GO:0009725; GO:0009744; GO:0016021; GO:0038023	response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]		NA	NA	NA	NA	NA	NA
TRINITY_DN9862_c0_g1_i3	Q9ZUH8	HHP3_ARATH	30.2	205	105	3	608	102	29	231	4.00E-16	86.7	HHP3_ARATH	reviewed	Heptahelical transmembrane protein 3 (PAQR family protein HHP3)	HHP3 At2g24150 F27D4.6	Arabidopsis thaliana (Mouse-ear cress)	344	integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]	integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0006979; GO:0009725; GO:0009744; GO:0016021; GO:0038023	response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]		NA	NA	NA	NA	NA	NA
TRINITY_DN4258_c0_g1_i1	Q60HF3	HPS1_MACFA	24.1	357	241	7	1183	128	331	662	1.10E-23	112.5	HPS1_MACFA	reviewed	Hermansky-Pudlak syndrome 1 protein homolog	HPS1 QflA-21346	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	667	BLOC-3 complex [GO:0031085]; guanyl-nucleotide exchange factor activity [GO:0005085]; melanosome assembly [GO:1903232]; vesicle-mediated transport [GO:0016192]	BLOC-3 complex [GO:0031085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0016192; GO:0031085; GO:1903232	melanosome assembly [GO:1903232]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN8188_c1_g1_i2	P29227	HP1_DROVI	68.4	38	12	0	115	228	24	61	2.50E-10	66.2	HP1_DROVI	reviewed	Heterochromatin protein 1 (HP1)	HP1A HP1 Su(var)205 GJ17281	Drosophila virilis (Fruit fly)	213	"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; pericentric heterochromatin [GO:0005721]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]"	"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; pericentric heterochromatin [GO:0005721]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]"	chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]	GO:0000182; GO:0000278; GO:0000723; GO:0000780; GO:0000781; GO:0000791; GO:0003682; GO:0003696; GO:0003723; GO:0005701; GO:0005703; GO:0005704; GO:0005705; GO:0005720; GO:0005721; GO:0030544; GO:0030674; GO:0031507; GO:0033697; GO:0034773; GO:0042981; GO:0044877; GO:0061408; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646	heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]		blue	blue	NA	NA	NA	NA
TRINITY_DN8188_c1_g1_i3	P29227	HP1_DROVI	70.6	34	10	0	115	216	24	57	1.90E-09	63.2	HP1_DROVI	reviewed	Heterochromatin protein 1 (HP1)	HP1A HP1 Su(var)205 GJ17281	Drosophila virilis (Fruit fly)	213	"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; pericentric heterochromatin [GO:0005721]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]"	"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; pericentric heterochromatin [GO:0005721]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]"	chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]	GO:0000182; GO:0000278; GO:0000723; GO:0000780; GO:0000781; GO:0000791; GO:0003682; GO:0003696; GO:0003723; GO:0005701; GO:0005703; GO:0005704; GO:0005705; GO:0005720; GO:0005721; GO:0030544; GO:0030674; GO:0031507; GO:0033697; GO:0034773; GO:0042981; GO:0044877; GO:0061408; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646	heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]		blue	blue	NA	NA	NA	NA
TRINITY_DN171_c0_g1_i2	P05205	HP1_DROME	42.2	64	35	1	327	518	17	78	4.80E-08	60.5	HP1_DROME	reviewed	Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen)	Su(var)205 HP1 CG8409	Drosophila melanogaster (Fruit fly)	206	"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]"	"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]	GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000780; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005704; GO:0005720; GO:0005721; GO:0006342; GO:0006355; GO:0010369; GO:0010629; GO:0016458; GO:0030544; GO:0030674; GO:0031060; GO:0031507; GO:0031508; GO:0033697; GO:0034773; GO:0035064; GO:0042393; GO:0042981; GO:0044877; GO:0045892; GO:0045893; GO:0051276; GO:0061408; GO:0070063; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646	"chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN171_c0_g1_i4	P05205	HP1_DROME	42.2	64	35	1	504	695	17	78	5.50E-08	60.5	HP1_DROME	reviewed	Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen)	Su(var)205 HP1 CG8409	Drosophila melanogaster (Fruit fly)	206	"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]; chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]"	"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696]	GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000780; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005704; GO:0005720; GO:0005721; GO:0006342; GO:0006355; GO:0010369; GO:0010629; GO:0016458; GO:0030544; GO:0030674; GO:0031060; GO:0031507; GO:0031508; GO:0033697; GO:0034773; GO:0035064; GO:0042393; GO:0042981; GO:0044877; GO:0045892; GO:0045893; GO:0051276; GO:0061408; GO:0070063; GO:0070868; GO:0090309; GO:0099122; GO:1900111; GO:1905632; GO:1905634; GO:1905646	"chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; gene silencing [GO:0016458]; heterochromatin assembly [GO:0031507]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H4-K20 trimethylation [GO:0034773]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of extent of heterochromatin assembly [GO:0033697]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein localization to euchromatin [GO:1905632]; regulation of apoptotic process [GO:0042981]; regulation of histone methylation [GO:0031060]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7228_c0_g1_i1	P48809	RB27C_DROME	73.5	136	35	1	487	80	4	138	2.10E-56	220.3	RB27C_DROME	reviewed	Heterogeneous nuclear ribonucleoprotein 27C (Hrb27-C) (HRP48.1) (hnRNP 48)	Hrb27C hrp48 Rbp7 CG10377	Drosophila melanogaster (Fruit fly)	421	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]	GO:0003697; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0007319; GO:0008266; GO:0030371; GO:0032991; GO:0034046; GO:0043186; GO:0045451; GO:0045727; GO:0048024; GO:0048026; GO:0048027; GO:1903688; GO:1990904	"negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"		blue	blue	NA	NA	NA	1
TRINITY_DN7228_c0_g1_i2	P48809	RB27C_DROME	66.5	200	59	3	729	151	4	202	5.80E-73	275.8	RB27C_DROME	reviewed	Heterogeneous nuclear ribonucleoprotein 27C (Hrb27-C) (HRP48.1) (hnRNP 48)	Hrb27C hrp48 Rbp7 CG10377	Drosophila melanogaster (Fruit fly)	421	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]	GO:0003697; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0007319; GO:0008266; GO:0030371; GO:0032991; GO:0034046; GO:0043186; GO:0045451; GO:0045727; GO:0048024; GO:0048026; GO:0048027; GO:1903688; GO:1990904	"negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7228_c0_g1_i6	P48809	RB27C_DROME	61.6	216	59	4	777	151	4	202	8.30E-70	265.4	RB27C_DROME	reviewed	Heterogeneous nuclear ribonucleoprotein 27C (Hrb27-C) (HRP48.1) (hnRNP 48)	Hrb27C hrp48 Rbp7 CG10377	Drosophila melanogaster (Fruit fly)	421	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; single-stranded DNA binding [GO:0003697]; translation repressor activity [GO:0030371]	GO:0003697; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0007283; GO:0007319; GO:0008266; GO:0030371; GO:0032991; GO:0034046; GO:0043186; GO:0045451; GO:0045727; GO:0048024; GO:0048026; GO:0048027; GO:1903688; GO:1990904	"negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1629_c0_g2_i1	P48810	RB87F_DROME	51.9	185	83	1	986	432	20	198	1.20E-53	211.8	RB87F_DROME	reviewed	Heterogeneous nuclear ribonucleoprotein 87F (HRP36.1 protein) (Protein P11)	Hrb87F hrp36 CG12749	Drosophila melanogaster (Fruit fly)	385	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; sequence-specific DNA binding [GO:0043565]	GO:0000278; GO:0000381; GO:0000785; GO:0000792; GO:0001745; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0008266; GO:0008585; GO:0009408; GO:0034046; GO:0035062; GO:0042594; GO:0043565; GO:0048026; GO:1990904	"compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18380_c0_g1_i1	Q99729	ROAA_HUMAN	100	96	0	0	3	290	53	148	5.00E-50	198	ROAA_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1)	HNRNPAB ABBP1 HNRPAB	Homo sapiens (Human)	332	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0043565; GO:0045893; GO:0090575; GO:1990837; GO:1990904	"epithelial to mesenchymal transition [GO:0001837]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18380_c0_g1_i2	Q99020	ROAA_MOUSE	99.4	157	1	0	3	473	59	215	3.10E-86	318.9	ROAA_MOUSE	reviewed	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A)	Hnrnpab Cbf-a Cgbfa Hnrpab	Mus musculus (Mouse)	285	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]	RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000122; GO:0001837; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0045893; GO:0090575; GO:0099523; GO:1990837; GO:1990904	"epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17680_c0_g1_i1	P09867	ROA1_BOVIN	100	185	0	0	28	582	1	185	2.40E-104	379.4	ROA1_BOVIN	reviewed	"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (Unwinding protein 1) (UP1) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]"	HNRNPA1 HNRPA1	Bos taurus (Bovine)	320	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; cellular response to sodium arsenite [GO:1903936]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	miRNA binding [GO:0035198]	GO:0005634; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0035198; GO:0051028; GO:1903936; GO:1990904	cellular response to sodium arsenite [GO:1903936]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN17680_c0_g1_i3	P09867	ROA1_BOVIN	100	185	0	0	28	582	1	185	2.40E-104	379.4	ROA1_BOVIN	reviewed	"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (Unwinding protein 1) (UP1) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]"	HNRNPA1 HNRPA1	Bos taurus (Bovine)	320	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; cellular response to sodium arsenite [GO:1903936]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	miRNA binding [GO:0035198]	GO:0005634; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0035198; GO:0051028; GO:1903936; GO:1990904	cellular response to sodium arsenite [GO:1903936]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN6049_c0_g1_i1	P21522	ROA1_SCHAM	68.7	182	56	1	659	114	8	188	9.40E-70	265	ROA1_SCHAM	reviewed	"Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog"	HNRNP	Schistocerca americana (American grasshopper)	342	nucleus [GO:0005634]; mRNA binding [GO:0003729]	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN6049_c0_g1_i2	P21522	ROA1_SCHAM	68.7	182	56	1	659	114	8	188	9.20E-70	265	ROA1_SCHAM	reviewed	"Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog"	HNRNP	Schistocerca americana (American grasshopper)	342	nucleus [GO:0005634]; mRNA binding [GO:0003729]	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN21591_c0_g1_i1	P21522	ROA1_SCHAM	73.8	80	21	0	242	3	40	119	4.00E-29	128.3	ROA1_SCHAM	reviewed	"Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog"	HNRNP	Schistocerca americana (American grasshopper)	342	nucleus [GO:0005634]; mRNA binding [GO:0003729]	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN22102_c0_g1_i1	P21522	ROA1_SCHAM	67	91	30	0	274	2	49	139	2.40E-30	132.5	ROA1_SCHAM	reviewed	"Heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog"	HNRNP	Schistocerca americana (American grasshopper)	342	nucleus [GO:0005634]; mRNA binding [GO:0003729]	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN27765_c0_g1_i1	P51991	ROA3_HUMAN	100	160	0	0	482	3	54	213	4.70E-90	331.6	ROA3_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3)	HNRNPA3 HNRPA3	Homo sapiens (Human)	378	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA transmembrane transporter activity [GO:0051033]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; RNA metabolic process [GO:0016070]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA transmembrane transporter activity [GO:0051033]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0016070; GO:0035770; GO:0043005; GO:0051028; GO:0051033; GO:0071013; GO:1990124; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27487_c0_g1_i1	Q14103	HNRPD_HUMAN	100	171	0	0	1	513	76	246	2.80E-96	352.4	HNRPD_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1)	HNRNPD AUF1 HNRPD	Homo sapiens (Human)	355	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; telomeric DNA binding [GO:0042162]; transcription factor binding [GO:0008134]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of mRNA stability [GO:0043488]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; telomeric DNA binding [GO:0042162]; transcription factor binding [GO:0008134]	GO:0000398; GO:0000790; GO:0001889; GO:0003680; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006396; GO:0006401; GO:0008134; GO:0016070; GO:0021549; GO:0032204; GO:0035925; GO:0042162; GO:0042752; GO:0042789; GO:0042826; GO:0043488; GO:0043565; GO:0045727; GO:0045893; GO:0045944; GO:0048255; GO:0051592; GO:0051602; GO:0061158; GO:0071230; GO:0071392; GO:0071732; GO:0097167; GO:1901355; GO:1904355; GO:1904383; GO:1904586; GO:1905663; GO:1990828; GO:1990837; GO:1990904	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of mRNA stability [GO:0043488]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27936_c0_g1_i1	O14979	HNRDL_HUMAN	100	167	0	0	3	503	129	295	1.80E-92	339.7	HNRDL_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)	HNRNPDL HNRPDL JKTBP	Homo sapiens (Human)	420	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; interleukin-12-mediated signaling pathway [GO:0035722]; regulation of gene expression [GO:0010468]; RNA processing [GO:0006396]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]	GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008143; GO:0010468; GO:0034046; GO:0035722; GO:0043565; GO:1990837	interleukin-12-mediated signaling pathway [GO:0035722]; regulation of gene expression [GO:0010468]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN13548_c0_g1_i1	P52597	HNRPF_HUMAN	100	189	0	0	16	582	1	189	1.60E-108	393.3	HNRPF_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]"	HNRNPF HNRPF	Homo sapiens (Human)	415	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]	GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13548_c0_g1_i2	P52597	HNRPF_HUMAN	89.6	154	16	0	16	477	1	154	3.10E-78	292.7	HNRPF_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]"	HNRNPF HNRPF	Homo sapiens (Human)	415	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]	GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13548_c0_g1_i2	P52597	HNRPF_HUMAN	98.4	62	1	0	420	605	136	197	8.50E-28	125.2	HNRPF_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]"	HNRNPF HNRPF	Homo sapiens (Human)	415	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]	GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13281_c0_g2_i1	P52597	HNRPF_HUMAN	100	117	0	0	352	2	276	392	4.00E-62	238.4	HNRPF_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]"	HNRNPF HNRPF	Homo sapiens (Human)	415	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]	GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13281_c0_g1_i1	P52597	HNRPF_HUMAN	100	109	0	0	330	4	284	392	4.70E-57	221.5	HNRPF_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]"	HNRNPF HNRPF	Homo sapiens (Human)	415	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]	GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13548_c0_g2_i2	P31943	HNRH1_HUMAN	96.6	88	3	0	2	265	89	176	3.70E-44	178.3	HNRH1_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]"	HNRNPH1 HNRPH HNRPH1	Homo sapiens (Human)	449	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0008543; GO:0016020; GO:0016070; GO:0042802; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13548_c0_g3_i1	P31943	HNRH1_HUMAN	99.2	118	1	0	2	355	89	206	1.20E-63	243.4	HNRH1_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]"	HNRNPH1 HNRPH HNRPH1	Homo sapiens (Human)	449	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0008543; GO:0016020; GO:0016070; GO:0042802; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25811_c0_g1_i1	P31943	HNRH1_HUMAN	65.3	95	33	0	380	96	276	370	3.40E-30	132.5	HNRH1_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]"	HNRNPH1 HNRPH HNRPH1	Homo sapiens (Human)	449	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0008543; GO:0016020; GO:0016070; GO:0042802; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13281_c1_g1_i1	P31943	HNRH1_HUMAN	100	98	0	0	295	2	278	375	1.10E-52	206.8	HNRH1_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]"	HNRNPH1 HNRPH HNRPH1	Homo sapiens (Human)	449	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0008543; GO:0016020; GO:0016070; GO:0042802; GO:0043484; GO:0071013; GO:1990904	"fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1237_c0_g1_i2	P55795	HNRH2_HUMAN	58.7	189	78	0	600	34	9	197	1.20E-61	238	HNRH2_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]"	HNRNPH2 FTP3 HNRPH2	Homo sapiens (Human)	449	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016020; GO:0016070; GO:0043484; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1237_c0_g1_i3	P55795	HNRH2_HUMAN	58.1	172	72	0	640	125	9	180	9.60E-56	218.4	HNRH2_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]"	HNRNPH2 FTP3 HNRPH2	Homo sapiens (Human)	449	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016020; GO:0016070; GO:0043484; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39953_c0_g1_i1	P55795	HNRH2_HUMAN	100	87	0	0	263	3	1	87	1.70E-44	179.5	HNRH2_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]"	HNRNPH2 FTP3 HNRPH2	Homo sapiens (Human)	449	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016020; GO:0016070; GO:0043484; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13281_c1_g2_i1	Q3SZF3	HNRH2_BOVIN	100	96	0	0	291	4	277	372	2.60E-51	202.2	HNRH2_BOVIN	reviewed	"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]"	HNRNPH2 HNRPH2	Bos taurus (Bovine)	449	nucleoplasm [GO:0005654]; RNA binding [GO:0003723]	nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN13548_c0_g2_i1	P31942	HNRH3_HUMAN	96.2	78	3	0	3	236	4	81	3.00E-37	155.2	HNRH3_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9)	HNRNPH3 HNRPH3	Homo sapiens (Human)	346	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0030855; GO:0043484; GO:1990904	"epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27375_c0_g1_i1	P31942	HNRH3_HUMAN	100	92	0	0	15	290	186	277	1.40E-48	193.4	HNRH3_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9)	HNRNPH3 HNRPH3	Homo sapiens (Human)	346	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0030855; GO:0043484; GO:1990904	"epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1157_c0_g1_i1	Q3T0D0	HNRPK_BOVIN	39.5	253	103	6	89	760	8	239	1.10E-36	155.2	HNRPK_BOVIN	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK	Bos taurus (Bovine)	464	"catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0002102; GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010988; GO:0019904; GO:0030054; GO:0042802; GO:0042995; GO:0043066; GO:0045716; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0071013; GO:1902165	"mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1157_c0_g1_i2	Q5ZIQ3	HNRPK_CHICK	42.4	217	100	5	86	724	17	212	4.90E-37	156.4	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1157_c0_g1_i3	Q5ZIQ3	HNRPK_CHICK	43.1	211	95	5	101	721	23	212	1.10E-36	155.2	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1157_c0_g1_i4	Q5ZIQ3	HNRPK_CHICK	46.5	198	100	4	86	667	17	212	3.10E-41	170.2	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6716_c0_g1_i3	Q3T0D0	HNRPK_BOVIN	100	100	0	0	331	32	365	464	2.50E-50	199.1	HNRPK_BOVIN	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK	Bos taurus (Bovine)	464	"catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0002102; GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010988; GO:0019904; GO:0030054; GO:0042802; GO:0042995; GO:0043066; GO:0045716; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0071013; GO:1902165	"mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6716_c0_g1_i4	Q3T0D0	HNRPK_BOVIN	100	103	0	0	340	32	362	464	1.30E-52	206.8	HNRPK_BOVIN	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK	Bos taurus (Bovine)	464	"catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0002102; GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010988; GO:0019904; GO:0030054; GO:0042802; GO:0042995; GO:0043066; GO:0045716; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0071013; GO:1902165	"mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18501_c0_g1_i1	Q3T0D0	HNRPK_BOVIN	100	68	0	0	206	3	24	91	2.00E-29	129	HNRPK_BOVIN	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK	Bos taurus (Bovine)	464	"catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0002102; GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010988; GO:0019904; GO:0030054; GO:0042802; GO:0042995; GO:0043066; GO:0045716; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0071013; GO:1902165	"mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18501_c0_g1_i2	Q3T0D0	HNRPK_BOVIN	100	68	0	0	206	3	24	91	2.00E-29	129	HNRPK_BOVIN	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK	Bos taurus (Bovine)	464	"catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]	GO:0000790; GO:0002102; GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010988; GO:0019904; GO:0030054; GO:0042802; GO:0042995; GO:0043066; GO:0045716; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0071013; GO:1902165	"mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1244_c0_g1_i1	Q5ZIQ3	HNRPK_CHICK	54.2	96	41	2	464	183	327	421	1.20E-17	91.3	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1244_c0_g1_i2	Q5ZIQ3	HNRPK_CHICK	54.2	96	41	2	459	178	327	421	1.20E-17	91.3	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1244_c0_g1_i3	Q5ZIQ3	HNRPK_CHICK	52.9	102	45	2	423	124	327	427	1.60E-19	97.4	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1244_c0_g1_i4	Q5ZIQ3	HNRPK_CHICK	52.9	102	45	2	428	129	327	427	1.20E-19	97.8	HNRPK_CHICK	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	HNRNPK HNRPK RCJMB04_24e23	Gallus gallus (Chicken)	427	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0010468; GO:0048024	"mRNA processing [GO:0006397]; regulation of gene expression [GO:0010468]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6716_c0_g1_i1	P61978	HNRPK_HUMAN	100	102	0	0	331	26	362	463	2.10E-52	206.1	HNRPK_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP)	HNRNPK HNRPK	Homo sapiens (Human)	463	"catalytic step 2 spliceosome [GO:0071013]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; signal transduction [GO:0007165]; viral process [GO:0016032]"	catalytic step 2 spliceosome [GO:0071013]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000398; GO:0000790; GO:0002102; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006357; GO:0006396; GO:0007165; GO:0010468; GO:0010494; GO:0010988; GO:0016020; GO:0016032; GO:0016070; GO:0019904; GO:0042802; GO:0042995; GO:0043066; GO:0045296; GO:0045716; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0070062; GO:0071013; GO:1902165	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; signal transduction [GO:0007165]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1403_c0_g2_i1	P14866	HNRPL_HUMAN	42.9	56	32	0	278	111	264	319	2.90E-07	55.8	HNRPL_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)	HNRNPL HNRPL P/OKcl.14	Homo sapiens (Human)	589	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000381; GO:0000398; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006417; GO:0016020; GO:0016070; GO:0035770; GO:0043484; GO:0045120; GO:0070062; GO:0097157; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1403_c0_g1_i1	Q8R081	HNRPL_MOUSE	51	208	99	2	736	113	380	584	5.70E-54	212.6	HNRPL_MOUSE	reviewed	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)	Hnrnpl Hnrpl	Mus musculus (Mouse)	586	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; response to peptide [GO:1901652]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000381; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0007623; GO:0034198; GO:0035770; GO:0043484; GO:0045120; GO:0045727; GO:0048025; GO:0048471; GO:0097157; GO:1901652; GO:1902416; GO:1990715; GO:1990904	"cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; response to peptide [GO:1901652]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1403_c0_g1_i2	Q8R081	HNRPL_MOUSE	50	212	99	3	748	113	380	584	4.10E-52	206.5	HNRPL_MOUSE	reviewed	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)	Hnrnpl Hnrpl	Mus musculus (Mouse)	586	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; response to peptide [GO:1901652]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000381; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0007623; GO:0034198; GO:0035770; GO:0043484; GO:0045120; GO:0045727; GO:0048025; GO:0048471; GO:0097157; GO:1901652; GO:1902416; GO:1990715; GO:1990904	"cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; response to peptide [GO:1901652]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40175_c0_g1_i1	P14866	HNRPL_HUMAN	100	73	0	0	9	227	217	289	1.30E-37	156.4	HNRPL_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)	HNRNPL HNRPL P/OKcl.14	Homo sapiens (Human)	589	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000381; GO:0000398; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006417; GO:0016020; GO:0016070; GO:0035770; GO:0043484; GO:0045120; GO:0070062; GO:0097157; GO:1990904	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22752_c0_g1_i1	O60506	HNRPQ_HUMAN	98.8	86	1	0	260	3	139	224	1.90E-45	182.6	HNRPQ_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)"	SYNCRIP HNRPQ NSAP1	Homo sapiens (Human)	623	"catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; viral process [GO:0016032]"	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005783; GO:0006396; GO:0008143; GO:0008380; GO:0016020; GO:0016032; GO:0017148; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:1990904	"cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39608_c0_g1_i1	O60506	HNRPQ_HUMAN	100	66	0	0	200	3	131	196	1.30E-33	142.9	HNRPQ_HUMAN	reviewed	"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)"	SYNCRIP HNRPQ NSAP1	Homo sapiens (Human)	623	"catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; viral process [GO:0016032]"	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005783; GO:0006396; GO:0008143; GO:0008380; GO:0016020; GO:0016032; GO:0017148; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:1990904	"cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17948_c0_g1_i1	Q7TMK9	HNRPQ_MOUSE	60.2	166	66	0	498	1	246	411	3.00E-55	216.1	HNRPQ_MOUSE	reviewed	"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)"	Syncrip Hnrpq Nsap1 Nsap1l	Mus musculus (Mouse)	623	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0008143; GO:0008380; GO:0017148; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:1990904	cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN26202_c0_g1_i1	O43390	HNRPR_HUMAN	100	82	0	0	1	246	144	225	6.10E-44	177.6	HNRPR_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein R (hnRNP R)	HNRNPR HNRPR	Homo sapiens (Human)	633	"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"	axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904	"circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33553_c0_g1_i1	O43390	HNRPR_HUMAN	100	90	0	0	1	270	135	224	6.60E-49	194.1	HNRPR_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein R (hnRNP R)	HNRNPR HNRPR	Homo sapiens (Human)	633	"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"	axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904	"circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17948_c0_g2_i1	O43390	HNRPR_HUMAN	71.4	119	32	1	351	1	120	238	3.80E-44	178.7	HNRPR_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein R (hnRNP R)	HNRNPR HNRPR	Homo sapiens (Human)	633	"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"	axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904	"circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2699_c0_g1_i2	Q8VDM6	HNRL1_MOUSE	67.3	98	32	0	398	105	506	603	2.50E-30	133.3	HNRL1_MOUSE	reviewed	Heterogeneous nuclear ribonucleoprotein U-like protein 1	Hnrnpul1 Hnrpul1	Mus musculus (Mouse)	859	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899	response to virus [GO:0009615]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN2699_c0_g1_i3	Q8VDM6	HNRL1_MOUSE	62.4	125	47	0	479	105	479	603	1.30E-39	164.1	HNRL1_MOUSE	reviewed	Heterogeneous nuclear ribonucleoprotein U-like protein 1	Hnrnpul1 Hnrpul1	Mus musculus (Mouse)	859	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899	response to virus [GO:0009615]; RNA processing [GO:0006396]		blue	blue	NA	NA	NA	NA
TRINITY_DN38782_c0_g1_i1	Q8VDM6	HNRL1_MOUSE	38.6	88	53	1	266	3	511	597	7.10E-11	67.8	HNRL1_MOUSE	reviewed	Heterogeneous nuclear ribonucleoprotein U-like protein 1	Hnrnpul1 Hnrpul1	Mus musculus (Mouse)	859	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899	response to virus [GO:0009615]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN142_c0_g2_i1	Q9BUJ2	HNRL1_HUMAN	49.8	247	121	3	362	1096	206	451	3.10E-68	260.4	HNRL1_HUMAN	reviewed	Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5)	HNRNPUL1 E1BAP5 HNRPUL1	Homo sapiens (Human)	856	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899	"mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9667_c0_g1_i1	Q2HJ60	ROA2_BOVIN	100	188	0	0	52	615	1	188	7.40E-104	377.9	ROA2_BOVIN	reviewed	Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)	HNRNPA2B1 HNRPA2B1	Bos taurus (Bovine)	341	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000398; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006406; GO:0031053; GO:0035198; GO:0043047; GO:0070062; GO:1990247; GO:1990428; GO:1990904	"miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9667_c0_g1_i2	Q2HJ60	ROA2_BOVIN	100	188	0	0	52	615	1	188	7.40E-104	377.9	ROA2_BOVIN	reviewed	Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)	HNRNPA2B1 HNRPA2B1	Bos taurus (Bovine)	341	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000398; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006406; GO:0031053; GO:0035198; GO:0043047; GO:0070062; GO:1990247; GO:1990428; GO:1990904	"miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8826_c0_g1_i1	Q2TB90	HKDC1_HUMAN	32	147	87	3	478	56	774	913	1.60E-11	70.9	HKDC1_HUMAN	reviewed	Hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1)	HKDC1	Homo sapiens (Human)	917	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006096; GO:0008865; GO:0019158; GO:0019318; GO:0031966; GO:0051156	cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]		NA	NA	NA	NA	NA	NA
TRINITY_DN8826_c0_g1_i2	Q2TB90	HKDC1_HUMAN	32	147	87	3	478	56	774	913	9.10E-12	71.6	HKDC1_HUMAN	reviewed	Hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1)	HKDC1	Homo sapiens (Human)	917	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006096; GO:0008865; GO:0019158; GO:0019318; GO:0031966; GO:0051156	cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]		NA	NA	NA	NA	NA	NA
TRINITY_DN561_c0_g1_i1	Q9NFT7	HXK2_DROME	51	443	212	3	39	1355	38	479	2.20E-130	468	HXK2_DROME	reviewed	Hexokinase type 2 (EC 2.7.1.1)	Hex-t2 Hex CG32849	Drosophila melanogaster (Fruit fly)	486	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158; GO:0051156	cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN561_c0_g1_i5	Q9NFT7	HXK2_DROME	50.6	449	217	3	39	1373	38	485	2.00E-131	470.7	HXK2_DROME	reviewed	Hexokinase type 2 (EC 2.7.1.1)	Hex-t2 Hex CG32849	Drosophila melanogaster (Fruit fly)	486	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158; GO:0051156	cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN561_c0_g1_i8	Q9NFT7	HXK2_DROME	50.6	449	217	3	39	1373	38	485	4.40E-131	469.5	HXK2_DROME	reviewed	Hexokinase type 2 (EC 2.7.1.1)	Hex-t2 Hex CG32849	Drosophila melanogaster (Fruit fly)	486	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158; GO:0051156	cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN561_c0_g1_i9	Q9NFT7	HXK2_DROME	50.6	449	217	3	39	1373	38	485	3.40E-131	469.9	HXK2_DROME	reviewed	Hexokinase type 2 (EC 2.7.1.1)	Hex-t2 Hex CG32849	Drosophila melanogaster (Fruit fly)	486	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158; GO:0051156	cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]		blue	blue	NA	NA	NA	NA
TRINITY_DN12340_c0_g2_i1	P19367	HXK1_HUMAN	100	135	0	0	3	407	198	332	2.40E-74	279.3	HXK1_HUMAN	reviewed	Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)	HK1	Homo sapiens (Human)	917	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]	GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042802; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]		NA	NA	NA	NA	NA	NA
TRINITY_DN12340_c0_g1_i1	P19367	HXK1_HUMAN	100	286	0	0	3	860	506	791	7.80E-168	590.9	HXK1_HUMAN	reviewed	Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)	HK1	Homo sapiens (Human)	917	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]	GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042802; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]		NA	NA	NA	NA	NA	NA
TRINITY_DN12340_c0_g1_i2	P19367	HXK1_HUMAN	93.5	169	11	0	3	509	623	791	5.60E-89	328.2	HXK1_HUMAN	reviewed	Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)	HK1	Homo sapiens (Human)	917	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]	GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042802; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]		NA	NA	NA	NA	NA	NA
TRINITY_DN561_c0_g1_i4	P19367	HXK1_HUMAN	44.6	83	39	2	124	354	801	882	1.90E-10	67	HXK1_HUMAN	reviewed	Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)	HK1	Homo sapiens (Human)	917	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]	GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042802; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i16	P19367	HXK1_HUMAN	42.3	291	164	2	872	6	479	767	6.80E-66	252.3	HXK1_HUMAN	reviewed	Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)	HK1	Homo sapiens (Human)	917	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]	GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042802; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]		NA	NA	NA	NA	NA	NA
TRINITY_DN19497_c0_g1_i1	P17710	HXK1_MOUSE	100	80	0	0	2	241	308	387	1.90E-39	162.5	HXK1_MOUSE	reviewed	"Hexokinase-1 (EC 2.7.1.1) (Hexokinase type I) (HK I) (Hexokinase, tumor isozyme)"	Hk1	Mus musculus (Mouse)	974	caveola [GO:0005901]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of anion channel activity [GO:0010359]; response to ischemia [GO:0002931]	caveola [GO:0005901]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; sperm principal piece [GO:0097228]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; identical protein binding [GO:0042802]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]	GO:0001678; GO:0002720; GO:0002931; GO:0004340; GO:0004396; GO:0004672; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0005901; GO:0005929; GO:0006002; GO:0006013; GO:0006096; GO:0006468; GO:0006954; GO:0008865; GO:0010359; GO:0018105; GO:0018107; GO:0018108; GO:0019158; GO:0032731; GO:0032991; GO:0042802; GO:0042834; GO:0043066; GO:0044877; GO:0045087; GO:0045121; GO:0046777; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:0097228	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of anion channel activity [GO:0010359]; response to ischemia [GO:0002931]		NA	NA	NA	NA	NA	NA
TRINITY_DN28944_c0_g1_i1	P52789	HXK2_HUMAN	100	74	0	0	2	223	257	330	9.20E-36	150.2	HXK2_HUMAN	reviewed	Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase)	HK2	Homo sapiens (Human)	917	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0006002; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0019158; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1904925; GO:1990830; GO:2000378	apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]		NA	NA	NA	NA	NA	NA
TRINITY_DN30857_c0_g1_i1	A6QNR0	HEXD_BOVIN	46.3	82	41	2	271	26	252	330	1.90E-14	79.7	HEXD_BOVIN	reviewed	Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)	HEXD HEXDC	Bos taurus (Bovine)	346	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]	beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561	carbohydrate metabolic process [GO:0005975]		blue	blue	NA	NA	NA	NA
TRINITY_DN8046_c0_g1_i1	A6QNR0	HEXD_BOVIN	49.7	189	88	2	43	588	2	190	6.10E-47	188.7	HEXD_BOVIN	reviewed	Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)	HEXD HEXDC	Bos taurus (Bovine)	346	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]	beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN14545_c0_g1_i1	Q3U4H6	HEXD_MOUSE	40.9	462	261	7	68	1438	10	464	1.20E-94	348.6	HEXD_MOUSE	reviewed	Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)	Hexd Hexdc	Mus musculus (Mouse)	486	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]	beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN14545_c0_g1_i2	A6QNR0	HEXD_BOVIN	44.8	299	162	3	68	958	2	299	3.60E-71	270	HEXD_BOVIN	reviewed	Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)	HEXD HEXDC	Bos taurus (Bovine)	346	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]	beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN7231_c0_g1_i1	Q3U4H6	HEXD_MOUSE	39.2	479	271	10	1529	123	10	478	1.20E-89	332.4	HEXD_MOUSE	reviewed	Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)	Hexd Hexdc	Mus musculus (Mouse)	486	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]	beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN21878_c0_g1_i1	Q8WVB3	HEXD_HUMAN	100	68	0	0	3	206	59	126	5.00E-33	141	HEXD_HUMAN	reviewed	Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)	HEXD HEXDC	Homo sapiens (Human)	486	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]	cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]	beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN17366_c0_g1_i2	Q9Y241	HIG1A_HUMAN	50	78	38	1	367	137	7	84	8.00E-15	81.6	HIG1A_HUMAN	reviewed	"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)"	HIGD1A HIG1 HSPC010	Homo sapiens (Human)	93	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; respirasome [GO:0070469]; cellular response to glucose starvation [GO:0042149]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidation-reduction process [GO:0055114]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; respirasome [GO:0070469]		GO:0005654; GO:0005739; GO:0005743; GO:0016021; GO:0032991; GO:0042149; GO:0043066; GO:0055114; GO:0061418; GO:0070469; GO:0071902; GO:0090201; GO:0097250	cellular response to glucose starvation [GO:0042149]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidation-reduction process [GO:0055114]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]		blue	blue	NA	NA	NA	NA
TRINITY_DN17366_c0_g1_i3	Q9Y241	HIG1A_HUMAN	50	78	38	1	367	137	7	84	8.10E-15	81.6	HIG1A_HUMAN	reviewed	"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)"	HIGD1A HIG1 HSPC010	Homo sapiens (Human)	93	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; respirasome [GO:0070469]; cellular response to glucose starvation [GO:0042149]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidation-reduction process [GO:0055114]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; respirasome [GO:0070469]		GO:0005654; GO:0005739; GO:0005743; GO:0016021; GO:0032991; GO:0042149; GO:0043066; GO:0055114; GO:0061418; GO:0070469; GO:0071902; GO:0090201; GO:0097250	cellular response to glucose starvation [GO:0042149]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidation-reduction process [GO:0055114]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]		blue	blue	NA	NA	NA	NA
TRINITY_DN2275_c0_g1_i6	Q9BW72	HIG2A_HUMAN	61.5	65	25	0	331	137	38	102	4.20E-15	82.8	HIG2A_HUMAN	reviewed	"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b)"	HIGD2A	Homo sapiens (Human)	106	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]		GO:0005739; GO:0005743; GO:0016021; GO:0043066; GO:0055114; GO:0070469; GO:0097250	mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN2275_c0_g1_i7	Q9BW72	HIG2A_HUMAN	61.5	65	25	0	529	335	38	102	5.80E-15	82.8	HIG2A_HUMAN	reviewed	"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b)"	HIGD2A	Homo sapiens (Human)	106	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]		GO:0005739; GO:0005743; GO:0016021; GO:0043066; GO:0055114; GO:0070469; GO:0097250	mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]		blue	blue	NA	NA	NA	NA
TRINITY_DN2275_c0_g1_i8	Q9BW72	HIG2A_HUMAN	61.5	65	25	0	529	335	38	102	5.80E-15	82.8	HIG2A_HUMAN	reviewed	"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b)"	HIGD2A	Homo sapiens (Human)	106	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]		GO:0005739; GO:0005743; GO:0016021; GO:0043066; GO:0055114; GO:0070469; GO:0097250	mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN2275_c0_g1_i9	Q9BW72	HIG2A_HUMAN	61.5	65	25	0	331	137	38	102	4.20E-15	82.8	HIG2A_HUMAN	reviewed	"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b)"	HIGD2A	Homo sapiens (Human)	106	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]		GO:0005739; GO:0005743; GO:0016021; GO:0043066; GO:0055114; GO:0070469; GO:0097250	mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN34454_c0_g1_i1	Q13946	PDE7A_HUMAN	100	109	0	0	3	329	210	318	2.30E-59	229.2	PDE7A_HUMAN	reviewed	"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (EC 3.1.4.53) (HCP1) (TM22)"	PDE7A	Homo sapiens (Human)	482	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0019933; GO:0046872	cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN413_c0_g1_i2	O95263	PDE8B_HUMAN	37.7	629	322	9	42	1877	112	687	5.90E-104	379.8	PDE8B_HUMAN	reviewed	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	PDE8B PIG22	Homo sapiens (Human)	885	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0046872	cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN413_c0_g1_i3	O95263	PDE8B_HUMAN	34.3	210	138	0	42	671	112	321	3.20E-29	130.2	PDE8B_HUMAN	reviewed	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	PDE8B PIG22	Homo sapiens (Human)	885	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0046872	cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN413_c0_g1_i4	O95263	PDE8B_HUMAN	40.1	769	389	11	42	2312	112	820	5.00E-145	516.5	PDE8B_HUMAN	reviewed	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	PDE8B PIG22	Homo sapiens (Human)	885	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0046872	cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN413_c0_g1_i5	O95263	PDE8B_HUMAN	29.3	352	212	4	42	1067	112	436	4.10E-33	143.7	PDE8B_HUMAN	reviewed	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	PDE8B PIG22	Homo sapiens (Human)	885	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0046872	cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN413_c0_g1_i6	O95263	PDE8B_HUMAN	37.8	640	334	9	42	1925	112	699	5.90E-107	389.8	PDE8B_HUMAN	reviewed	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	PDE8B PIG22	Homo sapiens (Human)	885	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]"	cytosol [GO:0005829]	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0046872	cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN40342_c0_g1_i1	H2QL32	PDE9A_PANTR	53.3	60	28	0	35	214	338	397	1.60E-11	69.7	PDE9A_PANTR	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)"	PDE9A	Pan troglodytes (Chimpanzee)	593	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0005783; GO:0005794; GO:0007165; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i10	Q9I7S6	PDE9A_DROME	40.7	189	97	1	146	712	620	793	6.60E-41	169.1	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i12	Q9I7S6	PDE9A_DROME	56	359	142	2	146	1219	620	963	7.90E-116	418.7	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i13	Q9I7S6	PDE9A_DROME	46.9	544	213	6	146	1594	620	1148	3.20E-124	447.6	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i3	Q9I7S6	PDE9A_DROME	51.5	400	133	5	442	1458	749	1148	3.20E-94	347.8	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i6	Q9I7S6	PDE9A_DROME	55.8	362	144	2	146	1228	620	966	5.90E-116	419.1	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i7	Q9I7S6	PDE9A_DROME	47.5	238	110	1	146	859	620	842	4.60E-62	239.6	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5585_c0_g1_i9	Q9I7S6	PDE9A_DROME	56	359	142	2	146	1219	620	963	4.80E-116	419.5	PDE9A_DROME	reviewed	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) (Phosphodiesterase 9)"	Pde9 CG42276	Drosophila melanogaster (Fruit fly)	1526	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0007165; GO:0009187; GO:0019934; GO:0046069; GO:0046872; GO:0047555	cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cyclic nucleotide metabolic process [GO:0009187]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g2_i1	Q8WNR0	COPT1_PIG	49.4	154	71	2	724	266	42	189	2.00E-31	137.9	COPT1_PIG	reviewed	High affinity copper uptake protein 1 (Copper transporter 1) (CTR1) (Solute carrier family 31 member 1)	SLC31A1 CTR1	Sus scrofa (Pig)	189	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; copper ion import [GO:0015677]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]	GO:0005375; GO:0005770; GO:0005886; GO:0006878; GO:0015677; GO:0016021; GO:0042802; GO:0055037	cellular copper ion homeostasis [GO:0006878]; copper ion import [GO:0015677]		NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g1_i3	O15431	COPT1_HUMAN	71.9	64	18	0	414	223	127	190	1.30E-20	101.7	COPT1_HUMAN	reviewed	High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1)	SLC31A1 COPT1 CTR1	Homo sapiens (Human)	190	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]	GO:0005375; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0042802; GO:0043025; GO:0055037; GO:0072719; GO:0098705	cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g1_i4	O15431	COPT1_HUMAN	71.9	64	18	0	414	223	127	190	1.10E-20	101.7	COPT1_HUMAN	reviewed	High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1)	SLC31A1 COPT1 CTR1	Homo sapiens (Human)	190	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]	GO:0005375; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0042802; GO:0043025; GO:0055037; GO:0072719; GO:0098705	cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g2_i2	O15431	COPT1_HUMAN	49.3	152	70	2	718	266	45	190	5.90E-31	136.3	COPT1_HUMAN	reviewed	High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1)	SLC31A1 COPT1 CTR1	Homo sapiens (Human)	190	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]	GO:0005375; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0042802; GO:0043025; GO:0055037; GO:0072719; GO:0098705	cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]		blue	blue	NA	NA	NA	NA
TRINITY_DN13543_c0_g1_i1	Q6DIJ5	HM20A_XENTR	45.1	102	56	0	409	714	79	180	5.90E-18	92.8	HM20A_XENTR	reviewed	High mobility group protein 20A (HMG box-containing protein 20A)	hmg20a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	345	nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0010468	regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN7765_c0_g1_i1	P10103	HMGB1_BOVIN	100	82	0	0	247	2	1	82	1.20E-41	170.2	HMGB1_BOVIN	reviewed	High mobility group protein B1 (High mobility group protein 1) (HMG-1)	HMGB1 HMG1	Bos taurus (Bovine)	215	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; bubble DNA binding [GO:0000405]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; activation of innate immune response [GO:0002218]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; cell chemotaxis [GO:0060326]; chromatin remodeling [GO:0006338]; dendritic cell chemotaxis [GO:0002407]; developmental process [GO:0032502]; DNA geometric change [GO:0032392]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; neutrophil clearance [GO:0097350]; nucleosome assembly [GO:0006334]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of signaling receptor activity [GO:0010469]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; toll-like receptor 9 signaling pathway [GO:0034162]; tumor necrosis factor secretion [GO:1990774]; V(D)J recombination [GO:0033151]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]	"bubble DNA binding [GO:0000405]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"	GO:0000400; GO:0000405; GO:0000790; GO:0000793; GO:0001773; GO:0002218; GO:0002250; GO:0002270; GO:0002322; GO:0002407; GO:0002840; GO:0003682; GO:0003684; GO:0003690; GO:0003697; GO:0005576; GO:0005737; GO:0005768; GO:0005793; GO:0005886; GO:0006265; GO:0006310; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0006914; GO:0006954; GO:0008134; GO:0008301; GO:0010469; GO:0010508; GO:0017055; GO:0032392; GO:0032502; GO:0032727; GO:0032732; GO:0032755; GO:0032760; GO:0033151; GO:0034162; GO:0034165; GO:0042056; GO:0042393; GO:0043277; GO:0044378; GO:0045087; GO:0045089; GO:0045322; GO:0045944; GO:0050786; GO:0051103; GO:0051106; GO:0060326; GO:0070374; GO:0097100; GO:0097350; GO:1901224; GO:1990774	"activation of innate immune response [GO:0002218]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; cell chemotaxis [GO:0060326]; chromatin remodeling [GO:0006338]; dendritic cell chemotaxis [GO:0002407]; developmental process [GO:0032502]; DNA geometric change [GO:0032392]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; neutrophil clearance [GO:0097350]; nucleosome assembly [GO:0006334]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of signaling receptor activity [GO:0010469]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 9 signaling pathway [GO:0034162]; tumor necrosis factor secretion [GO:1990774]; V(D)J recombination [GO:0033151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7765_c0_g1_i2	P10103	HMGB1_BOVIN	100	82	0	0	247	2	1	82	1.20E-41	170.2	HMGB1_BOVIN	reviewed	High mobility group protein B1 (High mobility group protein 1) (HMG-1)	HMGB1 HMG1	Bos taurus (Bovine)	215	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; bubble DNA binding [GO:0000405]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; activation of innate immune response [GO:0002218]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; cell chemotaxis [GO:0060326]; chromatin remodeling [GO:0006338]; dendritic cell chemotaxis [GO:0002407]; developmental process [GO:0032502]; DNA geometric change [GO:0032392]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; neutrophil clearance [GO:0097350]; nucleosome assembly [GO:0006334]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of signaling receptor activity [GO:0010469]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; toll-like receptor 9 signaling pathway [GO:0034162]; tumor necrosis factor secretion [GO:1990774]; V(D)J recombination [GO:0033151]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]	"bubble DNA binding [GO:0000405]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]"	GO:0000400; GO:0000405; GO:0000790; GO:0000793; GO:0001773; GO:0002218; GO:0002250; GO:0002270; GO:0002322; GO:0002407; GO:0002840; GO:0003682; GO:0003684; GO:0003690; GO:0003697; GO:0005576; GO:0005737; GO:0005768; GO:0005793; GO:0005886; GO:0006265; GO:0006310; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0006914; GO:0006954; GO:0008134; GO:0008301; GO:0010469; GO:0010508; GO:0017055; GO:0032392; GO:0032502; GO:0032727; GO:0032732; GO:0032755; GO:0032760; GO:0033151; GO:0034162; GO:0034165; GO:0042056; GO:0042393; GO:0043277; GO:0044378; GO:0045087; GO:0045089; GO:0045322; GO:0045944; GO:0050786; GO:0051103; GO:0051106; GO:0060326; GO:0070374; GO:0097100; GO:0097350; GO:1901224; GO:1990774	"activation of innate immune response [GO:0002218]; adaptive immune response [GO:0002250]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; cell chemotaxis [GO:0060326]; chromatin remodeling [GO:0006338]; dendritic cell chemotaxis [GO:0002407]; developmental process [GO:0032502]; DNA geometric change [GO:0032392]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; neutrophil clearance [GO:0097350]; nucleosome assembly [GO:0006334]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of signaling receptor activity [GO:0010469]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 9 signaling pathway [GO:0034162]; tumor necrosis factor secretion [GO:1990774]; V(D)J recombination [GO:0033151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3738_c0_g1_i1	P40673	HMGB2_BOVIN	100	82	0	0	248	3	1	82	4.30E-41	168.3	HMGB2_BOVIN	reviewed	High mobility group protein B2 (High mobility group protein 2) (HMG-2)	HMGB2 HMG2	Bos taurus (Bovine)	209	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin remodeling [GO:0006338]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; V(D)J recombination [GO:0033151]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	"chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"	GO:0000400; GO:0000790; GO:0000793; GO:0000987; GO:0001938; GO:0002437; GO:0003682; GO:0003684; GO:0003690; GO:0003697; GO:0003713; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0008134; GO:0008301; GO:0010628; GO:0010629; GO:0032075; GO:0032392; GO:0032496; GO:0032991; GO:0033151; GO:0042056; GO:0042393; GO:0043388; GO:0044378; GO:0045087; GO:0045089; GO:0045648; GO:0045654; GO:0045892; GO:0045944; GO:0048471; GO:0050767; GO:0050786; GO:0050829; GO:0050830; GO:0060326; GO:0071222; GO:0072091; GO:0097100	"cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin remodeling [GO:0006338]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; V(D)J recombination [GO:0033151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3738_c0_g1_i2	P40673	HMGB2_BOVIN	100	82	0	0	248	3	1	82	4.30E-41	168.3	HMGB2_BOVIN	reviewed	High mobility group protein B2 (High mobility group protein 2) (HMG-2)	HMGB2 HMG2	Bos taurus (Bovine)	209	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin remodeling [GO:0006338]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; V(D)J recombination [GO:0033151]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	"chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; RAGE receptor binding [GO:0050786]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]"	GO:0000400; GO:0000790; GO:0000793; GO:0000987; GO:0001938; GO:0002437; GO:0003682; GO:0003684; GO:0003690; GO:0003697; GO:0003713; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0008134; GO:0008301; GO:0010628; GO:0010629; GO:0032075; GO:0032392; GO:0032496; GO:0032991; GO:0033151; GO:0042056; GO:0042393; GO:0043388; GO:0044378; GO:0045087; GO:0045089; GO:0045648; GO:0045654; GO:0045892; GO:0045944; GO:0048471; GO:0050767; GO:0050786; GO:0050829; GO:0050830; GO:0060326; GO:0071222; GO:0072091; GO:0097100	"cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin remodeling [GO:0006338]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; V(D)J recombination [GO:0033151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7814_c0_g1_i1	Q24537	HMG2_DROME	49.4	180	82	2	715	176	169	339	5.90E-45	182.6	HMG2_DROME	reviewed	High mobility group protein DSP1 (Protein dorsal switch 1)	Dsp1 ssrp2 CG12223	Drosophila melanogaster (Fruit fly)	393	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0003677; GO:0003682; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944	"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2563_c2_g2_i1	Q24537	HMG2_DROME	60.7	178	65	3	229	753	170	345	1.10E-56	221.5	HMG2_DROME	reviewed	High mobility group protein DSP1 (Protein dorsal switch 1)	Dsp1 ssrp2 CG12223	Drosophila melanogaster (Fruit fly)	393	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0003677; GO:0003682; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944	"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2563_c2_g2_i3	Q24537	HMG2_DROME	60.7	178	65	3	72	596	170	345	1.10E-56	221.1	HMG2_DROME	reviewed	High mobility group protein DSP1 (Protein dorsal switch 1)	Dsp1 ssrp2 CG12223	Drosophila melanogaster (Fruit fly)	393	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0003677; GO:0003682; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944	"chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3679_c0_g1_i1	Q06943	HMGZ_DROME	61.2	67	26	0	122	322	7	73	3.00E-16	86.3	HMGZ_DROME	reviewed	High mobility group protein Z (HMG-Z)	HmgZ CG17921	Drosophila melanogaster (Fruit fly)	111	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]	"chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0003682; GO:0005737; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0008134; GO:0008301; GO:0045089; GO:0045944	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31195_c0_g1_i1	P21629	BRAF_PSEAE	47	66	35	0	3	200	6	71	2.90E-12	72	BRAF_PSEAE	reviewed	High-affinity branched-chain amino acid transport ATP-binding protein BraF	braF PA1071	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	255	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-valine transmembrane transporter activity [GO:0005304]; D-alanine transport [GO:0042941]; L-alanine transport [GO:0015808]; L-isoleucine import across plasma membrane [GO:1903806]; L-valine import across plasma membrane [GO:1903805]; leucine import across plasma membrane [GO:0098713]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-valine transmembrane transporter activity [GO:0005304]	GO:0005304; GO:0005524; GO:0005886; GO:0015188; GO:0015190; GO:0015192; GO:0015808; GO:0016887; GO:0042941; GO:0098713; GO:1903805; GO:1903806	D-alanine transport [GO:0042941]; L-alanine transport [GO:0015808]; leucine import across plasma membrane [GO:0098713]; L-isoleucine import across plasma membrane [GO:1903806]; L-valine import across plasma membrane [GO:1903805]		NA	NA	NA	NA	NA	NA
TRINITY_DN23205_c0_g1_i1	Q9VE46	SC5A7_DROME	52.7	110	52	0	43	372	385	494	3.00E-23	109.4	SC5A7_DROME	reviewed	High-affinity choline transporter 1	ChT CG7708	Drosophila melanogaster (Fruit fly)	614	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; choline:sodium symporter activity [GO:0005307]; choline transmembrane transporter activity [GO:0015220]	GO:0003333; GO:0005307; GO:0005886; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021	acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]		NA	NA	NA	NA	NA	NA
TRINITY_DN29572_c0_g1_i1	Q9VE46	SC5A7_DROME	80	55	11	0	1	165	307	361	3.20E-16	85.1	SC5A7_DROME	reviewed	High-affinity choline transporter 1	ChT CG7708	Drosophila melanogaster (Fruit fly)	614	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; choline:sodium symporter activity [GO:0005307]; choline transmembrane transporter activity [GO:0015220]	GO:0003333; GO:0005307; GO:0005886; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021	acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]		NA	NA	NA	NA	NA	NA
TRINITY_DN29928_c0_g1_i1	Q0E908	HIL_DROME	50.5	91	38	3	256	2	85	174	6.60E-14	77.8	HIL_DROME	reviewed	Hillarin (D-Hillarin) (D-hil)	Hil CG30147	Drosophila melanogaster (Fruit fly)	818	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]	metal ion binding [GO:0046872]	GO:0005938; GO:0032154; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27138_c0_g1_i1	Q0E908	HIL_DROME	72.5	102	15	1	306	1	635	723	1.80E-37	156.4	HIL_DROME	reviewed	Hillarin (D-Hillarin) (D-hil)	Hil CG30147	Drosophila melanogaster (Fruit fly)	818	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]	metal ion binding [GO:0046872]	GO:0005938; GO:0032154; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27138_c0_g1_i1	Q0E908	HIL_DROME	85.7	21	3	0	311	249	620	640	0.0028	42.7	HIL_DROME	reviewed	Hillarin (D-Hillarin) (D-hil)	Hil CG30147	Drosophila melanogaster (Fruit fly)	818	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]	metal ion binding [GO:0046872]	GO:0005938; GO:0032154; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN33786_c0_g1_i1	Q0E908	HIL_DROME	75	76	19	0	7	234	504	579	1.50E-28	126.7	HIL_DROME	reviewed	Hillarin (D-Hillarin) (D-hil)	Hil CG30147	Drosophila melanogaster (Fruit fly)	818	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]	metal ion binding [GO:0046872]	GO:0005938; GO:0032154; GO:0046872			yellow	yellow	NA	NA	NA	NA
TRINITY_DN29445_c0_g1_i1	Q0E908	HIL_DROME	87.7	106	12	1	4	321	405	509	6.80E-52	204.5	HIL_DROME	reviewed	Hillarin (D-Hillarin) (D-hil)	Hil CG30147	Drosophila melanogaster (Fruit fly)	818	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]	metal ion binding [GO:0046872]	GO:0005938; GO:0032154; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN35471_c0_g1_i1	P62748	HPCL1_MOUSE	99.2	128	1	0	386	3	13	140	3.30E-70	265.4	HPCL1_MOUSE	reviewed	Hippocalcin-like protein 1 (Neural visinin-like protein 3) (NVL-3) (NVP-3) (Visinin-like protein 3) (VILIP-3)	Hpcal1	Mus musculus (Mouse)	193	membrane [GO:0016020]; calcium ion binding [GO:0005509]	membrane [GO:0016020]	calcium ion binding [GO:0005509]	GO:0005509; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN535_c0_g1_i1	Q96MC6	MF14A_HUMAN	65.3	464	150	4	27	1409	5	460	1.70E-162	573.9	MF14A_HUMAN	reviewed	Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein)	MFSD14A HIAT1	Homo sapiens (Human)	490	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid nucleus differentiation [GO:0007289]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0001675; GO:0007289; GO:0016021; GO:0022857; GO:0030382	acrosome assembly [GO:0001675]; spermatid nucleus differentiation [GO:0007289]; sperm mitochondrion organization [GO:0030382]		blue	blue	NA	NA	NA	NA
TRINITY_DN535_c0_g1_i2	Q96MC6	MF14A_HUMAN	64.3	471	150	5	27	1430	5	460	1.60E-160	567.4	MF14A_HUMAN	reviewed	Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein)	MFSD14A HIAT1	Homo sapiens (Human)	490	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid nucleus differentiation [GO:0007289]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0001675; GO:0007289; GO:0016021; GO:0022857; GO:0030382	acrosome assembly [GO:0001675]; spermatid nucleus differentiation [GO:0007289]; sperm mitochondrion organization [GO:0030382]		blue	blue	NA	NA	NA	NA
TRINITY_DN21160_c0_g1_i1	Q96MC6	MF14A_HUMAN	100	362	0	0	1086	1	71	432	1.70E-199	696.4	MF14A_HUMAN	reviewed	Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein)	MFSD14A HIAT1	Homo sapiens (Human)	490	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid nucleus differentiation [GO:0007289]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0001675; GO:0007289; GO:0016021; GO:0022857; GO:0030382	acrosome assembly [GO:0001675]; spermatid nucleus differentiation [GO:0007289]; sperm mitochondrion organization [GO:0030382]		NA	NA	NA	NA	NA	NA
TRINITY_DN22489_c0_g1_i1	Q5SR56	MF14B_HUMAN	98.9	94	1	0	3	284	37	130	2.00E-48	192.6	MF14B_HUMAN	reviewed	Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B)	MFSD14B HIATL1	Homo sapiens (Human)	506	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN22489_c0_g1_i2	Q5SR56	MF14B_HUMAN	100	141	0	0	3	425	37	177	4.50E-76	285	MF14B_HUMAN	reviewed	Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B)	MFSD14B HIATL1	Homo sapiens (Human)	506	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN35982_c0_g1_i1	Q5SR56	MF14B_HUMAN	100	156	0	0	468	1	284	439	1.30E-81	303.5	MF14B_HUMAN	reviewed	Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B)	MFSD14B HIATL1	Homo sapiens (Human)	506	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN37254_c0_g1_i1	Q5SR56	MF14B_HUMAN	100	77	0	0	232	2	204	280	5.00E-37	154.5	MF14B_HUMAN	reviewed	Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B)	MFSD14B HIATL1	Homo sapiens (Human)	506	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN36540_c0_g1_i1	P31389	HRH1_CAVPO	54.8	84	38	0	287	36	404	487	1.80E-23	109.8	HRH1_CAVPO	reviewed	Histamine H1 receptor (H1R) (HH1R)	HRH1	Cavia porcellus (Guinea pig)	488	integral component of plasma membrane [GO:0005887]; calcium ion transmembrane transporter activity [GO:0015085]; histamine receptor activity [GO:0004969]; calcium ion import [GO:0070509]; cellular response to histamine [GO:0071420]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; manganese ion transmembrane transport [GO:0071421]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of vascular permeability [GO:0043114]	integral component of plasma membrane [GO:0005887]	calcium ion transmembrane transporter activity [GO:0015085]; histamine receptor activity [GO:0004969]	GO:0004969; GO:0005887; GO:0007186; GO:0007200; GO:0015085; GO:0032962; GO:0043114; GO:0045907; GO:0048016; GO:0048245; GO:0070509; GO:0071420; GO:0071421	calcium ion import [GO:0070509]; cellular response to histamine [GO:0071420]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; manganese ion transmembrane transport [GO:0071421]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of vascular permeability [GO:0043114]		NA	NA	NA	NA	NA	NA
TRINITY_DN2599_c0_g1_i2	P47747	HRH2_CAVPO	24.9	293	204	5	174	1028	20	304	4.50E-22	107.8	HRH2_CAVPO	reviewed	Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)	HRH2	Cavia porcellus (Guinea pig)	359	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; histamine receptor activity [GO:0004969]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	histamine receptor activity [GO:0004969]	GO:0001696; GO:0004969; GO:0005886; GO:0016021; GO:0045907	gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]		NA	NA	NA	NA	NA	NA
TRINITY_DN30961_c0_g1_i1	Q8XW29	HUTH_RALSO	95.6	68	3	0	2	205	105	172	2.00E-29	129	HUTH_RALSO	reviewed	Histidine ammonia-lyase (Histidase) (EC 4.3.1.3)	hutH RSc2646 RS04570	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	515	cytoplasm [GO:0005737]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytoplasm [GO:0005737]	histidine ammonia-lyase activity [GO:0004397]	GO:0004397; GO:0005737; GO:0019556; GO:0019557	histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN7287_c0_g1_i3	Q2KIJ2	MET18_BOVIN	39.7	237	121	6	320	1003	147	370	9.00E-38	159.1	MET18_BOVIN	reviewed	Histidine protein methyltransferase 1 homolog (Methyltransferase-like protein 18) (EC 2.1.1.-)	METTL18	Bos taurus (Bovine)	373	"protein-histidine N-methyltransferase activity [GO:0018064]; peptidyl-histidine methylation, to form tele-methylhistidine [GO:0042038]"		protein-histidine N-methyltransferase activity [GO:0018064]	GO:0018064; GO:0042038	"peptidyl-histidine methylation, to form tele-methylhistidine [GO:0042038]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7287_c0_g1_i10	Q55DL2	MET18_DICDI	39	213	95	4	399	1031	128	307	1.10E-35	152.1	MET18_DICDI	reviewed	Histidine protein methyltransferase 1 homolog (Protein METTL18 homolog) (EC 2.1.1.-)	DDB_G0270580	Dictyostelium discoideum (Slime mold)	309	"protein-histidine N-methyltransferase activity [GO:0018064]; peptidyl-histidine methylation, to form tele-methylhistidine [GO:0042038]"		protein-histidine N-methyltransferase activity [GO:0018064]	GO:0018064; GO:0042038	"peptidyl-histidine methylation, to form tele-methylhistidine [GO:0042038]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4848_c0_g2_i1	P49773	HINT1_HUMAN	100	126	0	0	32	409	1	126	2.50E-70	266.2	HINT1_HUMAN	reviewed	Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)	HINT1 HINT PKCI1 PRKCNH1	Homo sapiens (Human)	126	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine 5'-monophosphoramidase activity [GO:0043530]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; protein kinase C binding [GO:0005080]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of calcium-mediated signaling [GO:0050850]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenosine 5'-monophosphoramidase activity [GO:0043530]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; protein kinase C binding [GO:0005080]	GO:0000118; GO:0000166; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007165; GO:0009154; GO:0016787; GO:0043530; GO:0050850; GO:0070062; GO:0072332	"intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of calcium-mediated signaling [GO:0050850]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4848_c0_g1_i1	P70349	HINT1_MOUSE	100	116	0	0	1	348	11	126	4.70E-65	248.4	HINT1_MOUSE	reviewed	Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)	Hint1 Hint Pkci Pkci1 Prkcnh1	Mus musculus (Mouse)	126	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of calcium-mediated signaling [GO:0050850]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000118; GO:0000166; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006355; GO:0009154; GO:0016787; GO:0050850; GO:0072332	"intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of calcium-mediated signaling [GO:0050850]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29960_c0_g1_i1	Q9D0S9	HINT2_MOUSE	100	77	0	0	231	1	83	159	1.30E-37	156.4	HINT2_MOUSE	reviewed	"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3)"	Hint2	Mus musculus (Mouse)	163	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005737; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757	apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN25490_c0_g1_i1	Q9D0S9	HINT2_MOUSE	57.2	138	57	1	80	493	28	163	4.10E-40	166	HINT2_MOUSE	reviewed	"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3)"	Hint2	Mus musculus (Mouse)	163	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005737; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757	apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]		blue	blue	NA	NA	NA	NA
TRINITY_DN25490_c0_g1_i2	Q9D0S9	HINT2_MOUSE	49.4	83	40	1	80	328	28	108	6.00E-14	78.6	HINT2_MOUSE	reviewed	"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3)"	Hint2	Mus musculus (Mouse)	163	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005737; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757	apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2451_c0_g1_i1	Q9D0S9	HINT2_MOUSE	62.7	126	45	1	471	100	38	163	7.80E-43	174.9	HINT2_MOUSE	reviewed	"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3)"	Hint2	Mus musculus (Mouse)	163	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005737; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757	apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]		blue	blue	NA	NA	NA	NA
TRINITY_DN29270_c0_g1_i1	Q9BX68	HINT2_HUMAN	100	112	0	0	1	336	52	163	4.10E-60	231.9	HINT2_HUMAN	reviewed	"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3) (HIT-17kDa) (PKCI-1-related HIT protein)"	HINT2	Homo sapiens (Human)	163	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005737; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757	apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN9610_c0_g1_i1	Q28BZ2	HINT3_XENTR	42.3	142	80	2	169	588	10	151	9.90E-33	141.7	HINT3_XENTR	reviewed	Histidine triad nucleotide-binding protein 3 (HINT-3) (EC 3.-.-.-)	hint3 TEgg107p05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	153	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005634; GO:0005737; GO:0016787			blue	blue	NA	NA	NA	NA
TRINITY_DN27934_c0_g1_i1	Q61035	SYHC_MOUSE	100	101	0	0	2	304	336	436	2.60E-49	195.7	HARS1_MOUSE	reviewed	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	Hars1 Hars	Mus musculus (Mouse)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802; GO:0042803	histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN36629_c0_g1_i1	P12081	SYHC_HUMAN	100	238	0	0	1	714	41	278	1.30E-136	486.9	HARS1_HUMAN	reviewed	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	HARS1 HARS HRS	Homo sapiens (Human)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0006418; GO:0006427; GO:0032543; GO:0042802; GO:0042803	histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN38816_c0_g1_i1	P12081	SYHC_HUMAN	100	156	0	0	1	468	311	466	2.30E-81	302.8	HARS1_HUMAN	reviewed	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	HARS1 HARS HRS	Homo sapiens (Human)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0006418; GO:0006427; GO:0032543; GO:0042802; GO:0042803	histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN2402_c0_g1_i1	Q2KI84	SYHC_BOVIN	61.7	459	173	2	1453	83	46	503	1.70E-160	567.4	HARS1_BOVIN	reviewed	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	HARS1 HARS	Bos taurus (Bovine)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802; GO:0042803	histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN2402_c0_g1_i2	Q2KI84	SYHC_BOVIN	61.7	459	173	2	1453	83	46	503	1.70E-160	567.4	HARS1_BOVIN	reviewed	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	HARS1 HARS	Bos taurus (Bovine)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802; GO:0042803	histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN2402_c0_g1_i3	Q2KI84	SYHC_BOVIN	61.7	459	173	2	1453	83	46	503	1.90E-160	567.4	HARS1_BOVIN	reviewed	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	HARS1 HARS	Bos taurus (Bovine)	509	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802; GO:0042803	histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN35385_c0_g1_i1	Q6C710	ESA1_YARLI	56.5	170	70	2	513	10	245	412	2.30E-50	199.9	ESA1_YARLI	reviewed	Histone acetyltransferase ESA1 (EC 2.3.1.48)	ESA1 YALI0E04675g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	469	"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]	histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0004402; GO:0035267; GO:0042393; GO:0045892; GO:0045944	"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28020_c0_g1_i1	Q92830	KAT2A_HUMAN	68	50	16	0	87	236	81	130	3.60E-14	79	KAT2A_HUMAN	reviewed	Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)	KAT2A GCN5 GCN5L2	Homo sapiens (Human)	837	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000123; GO:0000790; GO:0001701; GO:0001756; GO:0001816; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005671; GO:0005737; GO:0005813; GO:0006338; GO:0006357; GO:0007507; GO:0007616; GO:0008134; GO:0008283; GO:0010484; GO:0014070; GO:0016032; GO:0016573; GO:0016578; GO:0016579; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0030914; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0042826; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045722; GO:0045815; GO:0045893; GO:0045944; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:1903010; GO:1990090; GO:2000036; GO:2000727	"alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26357_c0_g1_i1	Q92830	KAT2A_HUMAN	100	74	0	0	3	224	504	577	4.30E-38	157.9	KAT2A_HUMAN	reviewed	Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)	KAT2A GCN5 GCN5L2	Homo sapiens (Human)	837	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000123; GO:0000790; GO:0001701; GO:0001756; GO:0001816; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005671; GO:0005737; GO:0005813; GO:0006338; GO:0006357; GO:0007507; GO:0007616; GO:0008134; GO:0008283; GO:0010484; GO:0014070; GO:0016032; GO:0016573; GO:0016578; GO:0016579; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0030914; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0042826; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045722; GO:0045815; GO:0045893; GO:0045944; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:1903010; GO:1990090; GO:2000036; GO:2000727	"alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5555_c0_g1_i1	Q92830	KAT2A_HUMAN	57.9	732	272	7	2232	46	138	836	6.60E-243	841.6	KAT2A_HUMAN	reviewed	Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)	KAT2A GCN5 GCN5L2	Homo sapiens (Human)	837	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000123; GO:0000790; GO:0001701; GO:0001756; GO:0001816; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005671; GO:0005737; GO:0005813; GO:0006338; GO:0006357; GO:0007507; GO:0007616; GO:0008134; GO:0008283; GO:0010484; GO:0014070; GO:0016032; GO:0016573; GO:0016578; GO:0016579; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0030914; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0042826; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045722; GO:0045815; GO:0045893; GO:0045944; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:1903010; GO:1990090; GO:2000036; GO:2000727	"alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38222_c0_g1_i1	Q9JHD2	KAT2A_MOUSE	100	118	0	0	356	3	580	697	1.30E-63	243.4	KAT2A_MOUSE	reviewed	Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (MmGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A)	Kat2a Gcn5l2	Mus musculus (Mouse)	830	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000123; GO:0000790; GO:0001701; GO:0001756; GO:0001816; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005671; GO:0005813; GO:0007399; GO:0007507; GO:0007616; GO:0008080; GO:0008134; GO:0008283; GO:0010484; GO:0014070; GO:0016407; GO:0016573; GO:0016578; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0030914; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0042826; GO:0043966; GO:0043983; GO:0043997; GO:0044154; GO:0045252; GO:0045589; GO:0045722; GO:0045893; GO:0045944; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:1903010; GO:1990090; GO:2000036; GO:2000727	"alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24302_c0_g1_i1	Q92831	KAT2B_HUMAN	93.9	98	6	0	296	3	728	825	1.10E-49	196.8	KAT2B_HUMAN	reviewed	Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF) (Spermidine acetyltransferase KAT2B) (EC 2.3.1.57)	KAT2B PCAF	Homo sapiens (Human)	832	"A band [GO:0031672]; actomyosin [GO:0042641]; Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; I band [GO:0031674]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; protein-containing complex [GO:0032991]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; Notch signaling pathway [GO:0007219]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein acetylation [GO:0006473]; protein deubiquitination [GO:0016579]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of protein ADP-ribosylation [GO:0010835]; rhythmic process [GO:0048511]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"	A band [GO:0031672]; actomyosin [GO:0042641]; Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; I band [GO:0031674]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; protein-containing complex [GO:0032991]	"acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]"	GO:0000125; GO:0000776; GO:0000977; GO:0003682; GO:0003712; GO:0003713; GO:0004145; GO:0004402; GO:0004468; GO:0004861; GO:0005634; GO:0005654; GO:0005671; GO:0005813; GO:0006338; GO:0006367; GO:0006473; GO:0007050; GO:0007219; GO:0007221; GO:0007507; GO:0008134; GO:0008285; GO:0010835; GO:0016032; GO:0016407; GO:0016579; GO:0018076; GO:0018393; GO:0018394; GO:0019901; GO:0031672; GO:0031674; GO:0032869; GO:0032991; GO:0042641; GO:0042826; GO:0043966; GO:0043970; GO:0045652; GO:0045722; GO:0045747; GO:0045815; GO:0045944; GO:0046600; GO:0048511; GO:0060173; GO:0061733; GO:2000233	"cell cycle arrest [GO:0007050]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein acetylation [GO:0006473]; protein deubiquitination [GO:0016579]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of protein ADP-ribosylation [GO:0010835]; rhythmic process [GO:0048511]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28471_c0_g1_i1	Q92993	KAT5_HUMAN	100	159	0	0	518	42	283	441	1.90E-92	339.7	KAT5_HUMAN	reviewed	Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (cPLA(2)-interacting protein)	KAT5 HTATIP TIP60	Homo sapiens (Human)	513	"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to estradiol stimulus [GO:0071392]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone acetylation [GO:0016573]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of autophagy [GO:0010508]; positive regulation of protein acetylation [GO:1901985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of growth [GO:0040008]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]; viral process [GO:0016032]"	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; transcription regulator complex [GO:0005667]	acetyltransferase activity [GO:0016407]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0000729; GO:0000790; GO:0000812; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006302; GO:0006303; GO:0006978; GO:0010212; GO:0010508; GO:0016032; GO:0016407; GO:0016573; GO:0018394; GO:0032703; GO:0032777; GO:0035267; GO:0040008; GO:0042393; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048471; GO:0061733; GO:0070491; GO:0071392; GO:1901796; GO:1901985; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; cellular response to estradiol stimulus [GO:0071392]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone acetylation [GO:0016573]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of autophagy [GO:0010508]; positive regulation of protein acetylation [GO:1901985]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of growth [GO:0040008]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35922_c0_g1_i1	Q92794	KAT6A_HUMAN	100	82	0	0	3	248	242	323	4.80E-46	184.5	KAT6A_HUMAN	reviewed	"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)"	KAT6A MOZ MYST3 RUNXBP2 ZNF220	Homo sapiens (Human)	2004	"cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"	cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000786; GO:0000790; GO:0003677; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006323; GO:0006334; GO:0006473; GO:0008134; GO:0008270; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0070776; GO:0090398; GO:1901796	"cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30573_c0_g1_i1	Q92794	KAT6A_HUMAN	100	65	0	0	29	223	494	558	8.60E-34	143.7	KAT6A_HUMAN	reviewed	"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)"	KAT6A MOZ MYST3 RUNXBP2 ZNF220	Homo sapiens (Human)	2004	"cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"	cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000786; GO:0000790; GO:0003677; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006323; GO:0006334; GO:0006473; GO:0008134; GO:0008270; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0070776; GO:0090398; GO:1901796	"cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3288_c0_g1_i1	Q8WYB5	KAT6B_HUMAN	69.4	258	72	2	775	2	688	938	1.30E-101	370.9	KAT6B_HUMAN	reviewed	"Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)"	KAT6B KIAA0383 MORF MOZ2 MYST4	Homo sapiens (Human)	2073	"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	GO:0000786; GO:0000790; GO:0003677; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0008134; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0070776; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	1	NA	NA	NA
TRINITY_DN3288_c0_g1_i3	Q8WYB5	KAT6B_HUMAN	69.4	258	72	2	775	2	688	938	1.70E-101	370.9	KAT6B_HUMAN	reviewed	"Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)"	KAT6B KIAA0383 MORF MOZ2 MYST4	Homo sapiens (Human)	2073	"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	GO:0000786; GO:0000790; GO:0003677; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0008134; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0070776; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3288_c0_g1_i2	Q8WML3	KAT6B_MACFA	69.4	258	72	2	775	2	396	646	1.40E-101	370.9	KAT6B_MACFA	reviewed	"Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4)"	KAT6B MYST4 QflA-12408	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	1784	"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]"	MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]	GO:0000786; GO:0003677; GO:0004402; GO:0006334; GO:0008134; GO:0016407; GO:0016573; GO:0043966; GO:0045892; GO:0045893; GO:0046872; GO:0070776	"histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5655_c0_g1_i1	O95251	KAT7_HUMAN	56.4	424	171	5	414	1643	184	607	1.30E-137	491.5	KAT7_HUMAN	reviewed	"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)"	KAT7 HBO1 HBOa MYST2	Homo sapiens (Human)	611	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"	DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000123; GO:0000775; GO:0000790; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006281; GO:0006355; GO:0008270; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000819	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5655_c0_g1_i2	O95251	KAT7_HUMAN	54.2	441	171	6	414	1694	184	607	8.00E-135	482.3	KAT7_HUMAN	reviewed	"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)"	KAT7 HBO1 HBOa MYST2	Homo sapiens (Human)	611	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"	DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000123; GO:0000775; GO:0000790; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006281; GO:0006355; GO:0008270; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000819	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29149_c0_g1_i1	O95251	KAT7_HUMAN	100	71	0	0	3	215	438	508	3.00E-36	151.8	KAT7_HUMAN	reviewed	"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)"	KAT7 HBO1 HBOa MYST2	Homo sapiens (Human)	611	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"	DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000123; GO:0000775; GO:0000790; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006281; GO:0006355; GO:0008270; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000819	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32620_c0_g1_i1	O95251	KAT7_HUMAN	100	94	0	0	283	2	346	439	2.70E-53	208.8	KAT7_HUMAN	reviewed	"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)"	KAT7 HBO1 HBOa MYST2	Homo sapiens (Human)	611	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"	DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000123; GO:0000775; GO:0000790; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006281; GO:0006355; GO:0008270; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000819	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2963_c0_g1_i4	Q9D1P2	KAT8_MOUSE	81	284	54	0	853	2	154	437	4.60E-145	515.4	KAT8_MOUSE	reviewed	"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1)"	Kat8 Mof Myst1	Mus musculus (Mouse)	458	"histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]"	histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	GO:0000123; GO:0000776; GO:0000790; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0008134; GO:0010506; GO:0016363; GO:0016407; GO:0016573; GO:0019899; GO:0030099; GO:0035064; GO:0042393; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046972; GO:0071339; GO:0072487	"histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1207_c1_g2_i1	Q09472	EP300_HUMAN	75.9	58	14	0	261	88	569	626	2.10E-20	100.5	EP300_HUMAN	reviewed	Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)	EP300 P300	Homo sapiens (Human)	2414	"chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; peptide butyryltransferase activity [GO:0140065]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]	"acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; peptide butyryltransferase activity [GO:0140065]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000123; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005829; GO:0006110; GO:0006283; GO:0006355; GO:0006473; GO:0006475; GO:0006915; GO:0006977; GO:0006990; GO:0007219; GO:0007221; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008022; GO:0008134; GO:0008270; GO:0009887; GO:0010506; GO:0010742; GO:0010821; GO:0010976; GO:0016032; GO:0016407; GO:0016573; GO:0016579; GO:0016746; GO:0018076; GO:0018393; GO:0018394; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0032092; GO:0032481; GO:0032993; GO:0033613; GO:0034644; GO:0035257; GO:0035264; GO:0035855; GO:0036268; GO:0042771; GO:0043627; GO:0043923; GO:0043967; GO:0043969; GO:0045444; GO:0045652; GO:0045721; GO:0045747; GO:0045815; GO:0045893; GO:0045944; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0051726; GO:0060325; GO:0060765; GO:0061418; GO:0061733; GO:0061920; GO:0061921; GO:0090043; GO:0097157; GO:0097677; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:1900034; GO:1901224; GO:1901796; GO:1904837; GO:1905636	"animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1207_c1_g2_i3	Q09472	EP300_HUMAN	57.1	140	51	3	589	197	514	653	9.70E-31	135.6	EP300_HUMAN	reviewed	Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)	EP300 P300	Homo sapiens (Human)	2414	"chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; peptide butyryltransferase activity [GO:0140065]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]	"acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; peptide butyryltransferase activity [GO:0140065]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000123; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005829; GO:0006110; GO:0006283; GO:0006355; GO:0006473; GO:0006475; GO:0006915; GO:0006977; GO:0006990; GO:0007219; GO:0007221; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008022; GO:0008134; GO:0008270; GO:0009887; GO:0010506; GO:0010742; GO:0010821; GO:0010976; GO:0016032; GO:0016407; GO:0016573; GO:0016579; GO:0016746; GO:0018076; GO:0018393; GO:0018394; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0032092; GO:0032481; GO:0032993; GO:0033613; GO:0034644; GO:0035257; GO:0035264; GO:0035855; GO:0036268; GO:0042771; GO:0043627; GO:0043923; GO:0043967; GO:0043969; GO:0045444; GO:0045652; GO:0045721; GO:0045747; GO:0045815; GO:0045893; GO:0045944; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0051726; GO:0060325; GO:0060765; GO:0061418; GO:0061733; GO:0061920; GO:0061921; GO:0090043; GO:0097157; GO:0097677; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:1900034; GO:1901224; GO:1901796; GO:1904837; GO:1905636	"animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; N-terminal peptidyl-lysine acetylation [GO:0018076]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription-coupled nucleotide-excision repair [GO:0006283]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2963_c0_g1_i2	Q960X4	TIP60_DROME	81.3	273	51	0	836	18	269	541	1.40E-134	480.3	TIP60_DROME	reviewed	Histone acetyltransferase Tip60 (EC 2.3.1.48)	Tip60 CG6121	Drosophila melanogaster (Fruit fly)	541	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; euchromatin binding [GO:1990188]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H4 acetylation [GO:0043967]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of synaptic plasticity [GO:0048167]; regulation of terminal button organization [GO:2000331]; regulation of transcription, DNA-templated [GO:0006355]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]	euchromatin binding [GO:1990188]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000123; GO:0000790; GO:0003712; GO:0004402; GO:0005634; GO:0005705; GO:0006355; GO:0007399; GO:0010468; GO:0016573; GO:0035267; GO:0042393; GO:0043486; GO:0043524; GO:0043967; GO:0045892; GO:0045944; GO:0046872; GO:0048167; GO:1990188; GO:2000331	"histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H4 acetylation [GO:0043967]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of synaptic plasticity [GO:0048167]; regulation of terminal button organization [GO:2000331]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22676_c0_g1_i1	O14929	HAT1_HUMAN	97.1	171	5	0	514	2	145	315	1.10E-95	350.5	HAT1_HUMAN	reviewed	Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)	HAT1 KAT1	Homo sapiens (Human)	419	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]"	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]	GO:0000784; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006323; GO:0006335; GO:0006336; GO:0006348; GO:0006475; GO:0007584; GO:0010485; GO:0016363; GO:0032991; GO:0042393; GO:0043967	chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN22676_c0_g1_i2	Q8BY71	HAT1_MOUSE	98.8	171	2	0	514	2	142	312	2.50E-97	355.9	HAT1_MOUSE	reviewed	Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)	Hat1	Mus musculus (Mouse)	416	"chromosome, telomeric region [GO:0000781]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; response to nutrient [GO:0007584]"	"chromosome, telomeric region [GO:0000781]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]"	H4 histone acetyltransferase activity [GO:0010485]; histone binding [GO:0042393]	GO:0000781; GO:0000790; GO:0005654; GO:0006335; GO:0006336; GO:0006348; GO:0007584; GO:0010485; GO:0016363; GO:0032991; GO:0042393; GO:0043967	chromatin silencing at telomere [GO:0006348]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN26626_c0_g1_i1	O14929	HAT1_HUMAN	47.6	319	165	2	957	4	39	356	2.40E-81	303.9	HAT1_HUMAN	reviewed	Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)	HAT1 KAT1	Homo sapiens (Human)	419	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]"	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]	GO:0000784; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006323; GO:0006335; GO:0006336; GO:0006348; GO:0006475; GO:0007584; GO:0010485; GO:0016363; GO:0032991; GO:0042393; GO:0043967	chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN8778_c0_g1_i1	Q9V464	ASF1_DROME	65.2	198	69	0	86	679	1	198	6.50E-71	268.9	ASF1_DROME	reviewed	Histone chaperone asf1 (Anti-silencing function protein 1) (Replication-coupling assembly factor subunit ASF1) (RCAF subunit ASF1) (dASF1)	asf1 CG9383	Drosophila melanogaster (Fruit fly)	218	"nuclear chromatin [GO:0000790]; polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; transcription repressor complex [GO:0017053]; histone binding [GO:0042393]; RNA polymerase II repressing transcription factor binding [GO:0001103]; chromatin organization [GO:0006325]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	nuclear chromatin [GO:0000790]; polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; transcription repressor complex [GO:0017053]	histone binding [GO:0042393]; RNA polymerase II repressing transcription factor binding [GO:0001103]	GO:0000122; GO:0000790; GO:0001103; GO:0005700; GO:0006325; GO:0006334; GO:0006335; GO:0006336; GO:0017053; GO:0035059; GO:0042393; GO:0048024	"chromatin organization [GO:0006325]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of mRNA splicing, via spliceosome [GO:0048024]"		blue	blue	NA	NA	NA	NA
TRINITY_DN39894_c0_g1_i1	Q2KIG1	ASF1A_BOVIN	100	74	0	0	223	2	91	164	1.60E-37	156	ASF1A_BOVIN	reviewed	Histone chaperone ASF1A (Anti-silencing function protein 1 homolog A)	ASF1A	Bos taurus (Bovine)	204	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; DNA repair [GO:0006281]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; muscle cell differentiation [GO:0042692]; osteoblast differentiation [GO:0001649]	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000790; GO:0001649; GO:0003682; GO:0005654; GO:0006281; GO:0006335; GO:0006336; GO:0032991; GO:0042393; GO:0042692	DNA repair [GO:0006281]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; muscle cell differentiation [GO:0042692]; osteoblast differentiation [GO:0001649]		NA	NA	NA	NA	NA	NA
TRINITY_DN32256_c0_g1_i1	Q69DB9	AS1AA_XENLA	100	119	0	0	359	3	1	119	1.30E-64	246.9	AS1AA_XENLA	reviewed	Histone chaperone asf1a-A (Anti-silencing function protein 1 homolog) (XAsf1) (Anti-silencing function protein 1 homolog A-A)	asf1aa asf1 asf1a	Xenopus laevis (African clawed frog)	201	nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333]	nucleus [GO:0005634]		GO:0005634; GO:0006333	chromatin assembly or disassembly [GO:0006333]		NA	NA	NA	NA	NA	NA
TRINITY_DN29453_c0_g1_i1	Q9NVP2	ASF1B_HUMAN	100	51	0	0	154	2	1	51	2.50E-22	105.5	ASF1B_HUMAN	reviewed	Histone chaperone ASF1B (Anti-silencing function protein 1 homolog B) (hAsf1) (hAsf1b) (CCG1-interacting factor A-II) (CIA-II) (hCIA-II)	ASF1B	Homo sapiens (Human)	202	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; spermatogenesis [GO:0007283]	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	histone binding [GO:0042393]	GO:0000790; GO:0001835; GO:0005654; GO:0006335; GO:0006336; GO:0007283; GO:0030154; GO:0032991; GO:0042393	blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN31372_c0_g1_i1	Q9NVP2	ASF1B_HUMAN	100	116	0	0	1	348	56	171	5.50E-64	244.6	ASF1B_HUMAN	reviewed	Histone chaperone ASF1B (Anti-silencing function protein 1 homolog B) (hAsf1) (hAsf1b) (CCG1-interacting factor A-II) (CIA-II) (hCIA-II)	ASF1B	Homo sapiens (Human)	202	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; spermatogenesis [GO:0007283]	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	histone binding [GO:0042393]	GO:0000790; GO:0001835; GO:0005654; GO:0006335; GO:0006336; GO:0007283; GO:0030154; GO:0032991; GO:0042393	blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN20259_c0_g1_i1	Q32PJ8	HDAC1_BOVIN	100	100	0	0	3	302	114	213	1.30E-53	209.9	HDAC1_BOVIN	reviewed	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	Bos taurus (Bovine)	482	"histone deacetylase complex [GO:0000118]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	histone deacetylase complex [GO:0000118]	deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0000118; GO:0004407; GO:0019213; GO:0032041; GO:0032922; GO:0045892; GO:0045944; GO:0070932; GO:0070933	"circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18692_c1_g1_i1	Q32PJ8	HDAC1_BOVIN	98.6	69	1	0	209	3	144	212	2.00E-34	146	HDAC1_BOVIN	reviewed	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	Bos taurus (Bovine)	482	"histone deacetylase complex [GO:0000118]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	histone deacetylase complex [GO:0000118]	deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0000118; GO:0004407; GO:0019213; GO:0032041; GO:0032922; GO:0045892; GO:0045944; GO:0070932; GO:0070933	"circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		pink	pink	NA	NA	NA	NA
TRINITY_DN18692_c1_g1_i2	P56518	HDAC1_STRPU	95.9	98	4	0	296	3	114	211	5.90E-51	201.1	HDAC1_STRPU	reviewed	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	Strongylocentrotus purpuratus (Purple sea urchin)	576	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]	histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]	GO:0000118; GO:0004407; GO:0005634; GO:0005737; GO:0006325; GO:0008134; GO:0032041; GO:0045944; GO:0070932; GO:0070933	chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c0_g1_i12	Q9GKU5	HDA11_MACFA	56.6	325	141	0	123	1097	1	325	1.40E-103	377.9	HDA11_MACFA	reviewed	Histone deacetylase 11 (HD11) (EC 3.5.1.98)	HDAC11 QccE-18183	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	347	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]	histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]	GO:0000118; GO:0004407; GO:0005634; GO:0005737; GO:0006325; GO:0008134; GO:0032041	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c0_g1_i4	Q9GKU5	HDA11_MACFA	57	321	138	0	93	1055	5	325	1.30E-103	377.9	HDA11_MACFA	reviewed	Histone deacetylase 11 (HD11) (EC 3.5.1.98)	HDAC11 QccE-18183	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	347	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]	histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]	GO:0000118; GO:0004407; GO:0005634; GO:0005737; GO:0006325; GO:0008134; GO:0032041	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c0_g1_i9	Q96DB2	HDA11_HUMAN	45.3	128	69	1	123	506	1	127	3.80E-24	112.8	HDA11_HUMAN	reviewed	Histone deacetylase 11 (HD11) (EC 3.5.1.98)	HDAC11	Homo sapiens (Human)	347	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; oligodendrocyte development [GO:0014003]	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]	GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0008134; GO:0014003; GO:0016575; GO:0032041	chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; oligodendrocyte development [GO:0014003]		NA	NA	NA	NA	NA	NA
TRINITY_DN34704_c0_g1_i1	Q92769	HDAC2_HUMAN	100	88	0	0	265	2	131	218	1.60E-47	189.5	HDAC2_HUMAN	reviewed	Histone deacetylase 2 (HD2) (EC 3.5.1.98)	HDAC2	Homo sapiens (Human)	488	"cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; behavioral response to ethanol [GO:0048149]; blood coagulation [GO:0007596]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]"	cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]	chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]	GO:0000118; GO:0000122; GO:0000790; GO:0001103; GO:0001975; GO:0003300; GO:0003682; GO:0003723; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0007596; GO:0008134; GO:0008284; GO:0009913; GO:0010718; GO:0010870; GO:0010977; GO:0016358; GO:0016575; GO:0016580; GO:0016581; GO:0019213; GO:0019899; GO:0031000; GO:0031072; GO:0032041; GO:0032496; GO:0032732; GO:0032760; GO:0032922; GO:0032967; GO:0032991; GO:0033558; GO:0034605; GO:0035094; GO:0035098; GO:0042220; GO:0042475; GO:0042493; GO:0042531; GO:0042733; GO:0042826; GO:0043044; GO:0043066; GO:0043392; GO:0043433; GO:0043565; GO:0045347; GO:0045862; GO:0045892; GO:0045893; GO:0045944; GO:0048149; GO:0048714; GO:0051059; GO:0055093; GO:0060789; GO:0061000; GO:0061029; GO:0061198; GO:0070301; GO:0070829; GO:0070932; GO:0070933; GO:0071300; GO:0071560; GO:1901796; GO:1902437; GO:1903351; GO:1990841; GO:2000757	"ATP-dependent chromatin remodeling [GO:0043044]; behavioral response to ethanol [GO:0048149]; blood coagulation [GO:0007596]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12220_c0_g1_i1	Q803C3	HDAC3_DANRE	88.2	110	13	0	2	331	105	214	1.20E-55	216.9	HDAC3_DANRE	reviewed	Histone deacetylase 3 (HD3) (EC 3.5.1.98)	hdac3 zgc:55927	Danio rerio (Zebrafish) (Brachydanio rerio)	428	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; circadian regulation of gene expression [GO:0032922]; dorsal/ventral pattern formation [GO:0009953]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line development [GO:0048916]; regulation of circadian rhythm [GO:0042752]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0001525; GO:0001889; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0009953; GO:0017053; GO:0032041; GO:0032922; GO:0042752; GO:0045944; GO:0048916; GO:0070932; GO:0070933	angiogenesis [GO:0001525]; circadian regulation of gene expression [GO:0032922]; dorsal/ventral pattern formation [GO:0009953]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line development [GO:0048916]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN1431_c0_g1_i1	P83038	HDAC4_CHICK	43.5	851	409	16	264	2681	237	1060	3.40E-164	580.5	HDAC4_CHICK	reviewed	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	HDAC4	Gallus gallus (Chicken)	1080	"actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; transcription repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"	actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; transcription repressor complex [GO:0017053]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003682; GO:0003714; GO:0004407; GO:0005829; GO:0006325; GO:0006338; GO:0006954; GO:0007399; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010832; GO:0010882; GO:0014894; GO:0016607; GO:0017053; GO:0019901; GO:0030183; GO:0030955; GO:0031594; GO:0032041; GO:0033235; GO:0033613; GO:0034983; GO:0040029; GO:0042113; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045668; GO:0045820; GO:0045843; GO:0045892; GO:0045944; GO:0048742; GO:0051091; GO:0070491; GO:0070555; GO:0070933; GO:1902894	"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1431_c0_g1_i2	Q6NZM9	HDAC4_MOUSE	42.5	890	403	22	264	2765	237	1073	5.90E-164	579.7	HDAC4_MOUSE	reviewed	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	Hdac4	Mus musculus (Mouse)	1076	"A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; transcription repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of male mating behavior [GO:1902437]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"	A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; transcription repressor complex [GO:0017053]; Z disc [GO:0030018]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003677; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006476; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010592; GO:0010832; GO:0010882; GO:0014894; GO:0014911; GO:0016575; GO:0016607; GO:0017053; GO:0019789; GO:0019901; GO:0030017; GO:0030018; GO:0030955; GO:0031594; GO:0031672; GO:0032041; GO:0032991; GO:0033235; GO:0033558; GO:0033613; GO:0034983; GO:0040029; GO:0042493; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0043525; GO:0045668; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0048661; GO:0048742; GO:0051091; GO:0051153; GO:0070491; GO:0070555; GO:0070932; GO:0070933; GO:0071260; GO:0071356; GO:0071374; GO:1902437; GO:1902894; GO:1903428; GO:1990841	"cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of male mating behavior [GO:1902437]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1431_c0_g1_i3	Q6NZM9	HDAC4_MOUSE	42.5	894	401	23	264	2777	237	1073	6.00E-164	579.7	HDAC4_MOUSE	reviewed	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	Hdac4	Mus musculus (Mouse)	1076	"A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; transcription repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of male mating behavior [GO:1902437]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"	A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; transcription repressor complex [GO:0017053]; Z disc [GO:0030018]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003677; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006476; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010592; GO:0010832; GO:0010882; GO:0014894; GO:0014911; GO:0016575; GO:0016607; GO:0017053; GO:0019789; GO:0019901; GO:0030017; GO:0030018; GO:0030955; GO:0031594; GO:0031672; GO:0032041; GO:0032991; GO:0033235; GO:0033558; GO:0033613; GO:0034983; GO:0040029; GO:0042493; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0043525; GO:0045668; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0048661; GO:0048742; GO:0051091; GO:0051153; GO:0070491; GO:0070555; GO:0070932; GO:0070933; GO:0071260; GO:0071356; GO:0071374; GO:1902437; GO:1902894; GO:1903428; GO:1990841	"cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of male mating behavior [GO:1902437]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1431_c0_g1_i4	P83038	HDAC4_CHICK	43.6	851	404	17	264	2669	237	1060	5.80E-164	579.7	HDAC4_CHICK	reviewed	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	HDAC4	Gallus gallus (Chicken)	1080	"actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; transcription repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"	actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; transcription repressor complex [GO:0017053]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003682; GO:0003714; GO:0004407; GO:0005829; GO:0006325; GO:0006338; GO:0006954; GO:0007399; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010832; GO:0010882; GO:0014894; GO:0016607; GO:0017053; GO:0019901; GO:0030183; GO:0030955; GO:0031594; GO:0032041; GO:0033235; GO:0033613; GO:0034983; GO:0040029; GO:0042113; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045668; GO:0045820; GO:0045843; GO:0045892; GO:0045944; GO:0048742; GO:0051091; GO:0070491; GO:0070555; GO:0070933; GO:1902894	"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25905_c0_g1_i1	Q9FML2	HDA6_ARATH	72.1	111	31	0	339	7	122	232	1.40E-43	176.8	HDA6_ARATH	reviewed	Histone deacetylase 6 (AtHDA6) (EC 3.5.1.98)	HDA6 RPD3B At5g63110 MDC12.7	Arabidopsis thaliana (Mouse-ear cress)	471	chloroplast envelope [GO:0009941]; nucleolus [GO:0005730]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; embryo development ending in seed dormancy [GO:0009793]; gene silencing [GO:0016458]; histone deacetylation [GO:0016575]; posttranscriptional gene silencing [GO:0016441]; response to abscisic acid [GO:0009737]; response to salt stress [GO:0009651]; seed maturation [GO:0010431]; vegetative to reproductive phase transition of meristem [GO:0010228]	chloroplast envelope [GO:0009941]; nucleolus [GO:0005730]; nucleus [GO:0005634]	histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0004407; GO:0005634; GO:0005730; GO:0009651; GO:0009737; GO:0009793; GO:0009941; GO:0010228; GO:0010431; GO:0016441; GO:0016458; GO:0016575; GO:0032041	embryo development ending in seed dormancy [GO:0009793]; gene silencing [GO:0016458]; histone deacetylation [GO:0016575]; posttranscriptional gene silencing [GO:0016441]; response to abscisic acid [GO:0009737]; response to salt stress [GO:0009651]; seed maturation [GO:0010431]; vegetative to reproductive phase transition of meristem [GO:0010228]		NA	NA	NA	NA	NA	NA
TRINITY_DN10670_c2_g1_i1	Q9UBN7	HDAC6_HUMAN	100	87	0	0	3	263	260	346	7.90E-47	187.2	HDAC6_HUMAN	reviewed	Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)	HDAC6 KIAA0901 JM21	Homo sapiens (Human)	1215	"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"	aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000209; GO:0000978; GO:0001226; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005881; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032041; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090042; GO:1901300; GO:1903146	"aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein-containing complex disassembly [GO:0032984]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36569_c0_g1_i1	Q9UBN7	HDAC6_HUMAN	100	125	0	0	378	4	590	714	2.50E-70	265.8	HDAC6_HUMAN	reviewed	Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)	HDAC6 KIAA0901 JM21	Homo sapiens (Human)	1215	"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"	aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000209; GO:0000978; GO:0001226; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005881; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032041; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090042; GO:1901300; GO:1903146	"aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein-containing complex disassembly [GO:0032984]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34993_c0_g1_i1	Q9UBN7	HDAC6_HUMAN	60.5	114	42	2	337	2	590	702	1.10E-35	150.6	HDAC6_HUMAN	reviewed	Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)	HDAC6 KIAA0901 JM21	Homo sapiens (Human)	1215	"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"	aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000209; GO:0000978; GO:0001226; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005881; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032041; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090042; GO:1901300; GO:1903146	"aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; protein-containing complex disassembly [GO:0032984]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29169_c0_g1_i1	Q8C2B3	HDAC7_MOUSE	61.7	94	36	0	286	5	643	736	5.40E-31	134.8	HDAC7_MOUSE	reviewed	Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a)	Hdac7 Hdac7a	Mus musculus (Mouse)	938	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cell-cell junction assembly [GO:0007043]; chromatin organization [GO:0006325]; inflammatory response [GO:0006954]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of neuron death [GO:1901215]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; protein deacetylation [GO:0006476]; vasculogenesis [GO:0001570]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000118; GO:0000122; GO:0001570; GO:0003682; GO:0003714; GO:0004407; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0006325; GO:0006476; GO:0006954; GO:0007043; GO:0007399; GO:0008134; GO:0019901; GO:0030183; GO:0032041; GO:0032703; GO:0033558; GO:0033613; GO:0042113; GO:0045668; GO:0045843; GO:0045892; GO:0046872; GO:0070491; GO:0071889; GO:0090050; GO:1901215; GO:1901223	"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cell-cell junction assembly [GO:0007043]; chromatin organization [GO:0006325]; inflammatory response [GO:0006954]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of neuron death [GO:1901215]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; protein deacetylation [GO:0006476]; vasculogenesis [GO:0001570]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25712_c0_g1_i1	Q8WUI4	HDAC7_HUMAN	100	117	0	0	3	353	724	840	3.60E-63	241.9	HDAC7_HUMAN	reviewed	Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a)	HDAC7 HDAC7A	Homo sapiens (Human)	952	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cell-cell junction assembly [GO:0007043]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; protein deacetylation [GO:0006476]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0001570; GO:0003682; GO:0003714; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006476; GO:0007043; GO:0019901; GO:0032041; GO:0032703; GO:0033558; GO:0033613; GO:0045668; GO:0046872; GO:0070491; GO:0071889; GO:0090050; GO:1901223	cell-cell junction assembly [GO:0007043]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; protein deacetylation [GO:0006476]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN33397_c0_g1_i1	B1H369	HDAC8_XENTR	46	341	183	1	1074	55	28	368	7.70E-94	345.5	HDAC8_XENTR	reviewed	Histone deacetylase 8 (HD8) (EC 3.5.1.98)	hdac8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	369	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]	histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0000118; GO:0004407; GO:0005737; GO:0032041; GO:0045944; GO:0046872; GO:0070932; GO:0070933	histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN33397_c0_g1_i2	Q7SXM0	HDAC8_DANRE	45.1	195	107	0	639	55	183	377	2.90E-50	200.7	HDAC8_DANRE	reviewed	Histone deacetylase 8 (HD8) (EC 3.5.1.98)	hdac8	Danio rerio (Zebrafish) (Brachydanio rerio)	378	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]	histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0000118; GO:0004407; GO:0005737; GO:0032041; GO:0045944; GO:0046872; GO:0070932; GO:0070933	histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN33397_c0_g1_i2	Q7SXM0	HDAC8_DANRE	38.9	131	79	1	1027	638	17	147	8.10E-24	112.8	HDAC8_DANRE	reviewed	Histone deacetylase 8 (HD8) (EC 3.5.1.98)	hdac8	Danio rerio (Zebrafish) (Brachydanio rerio)	378	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]	histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0000118; GO:0004407; GO:0005737; GO:0032041; GO:0045944; GO:0046872; GO:0070932; GO:0070933	histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN33397_c0_g1_i4	Q7SXM0	HDAC8_DANRE	44.3	361	200	1	1134	55	17	377	2.10E-97	357.5	HDAC8_DANRE	reviewed	Histone deacetylase 8 (HD8) (EC 3.5.1.98)	hdac8	Danio rerio (Zebrafish) (Brachydanio rerio)	378	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]	histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0000118; GO:0004407; GO:0005737; GO:0032041; GO:0045944; GO:0046872; GO:0070932; GO:0070933	histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN1797_c0_g1_i2	Q9H0E3	SP130_HUMAN	36.7	60	38	0	94	273	985	1044	4.50E-06	52	SP130_HUMAN	reviewed	Histone deacetylase complex subunit SAP130 (130 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p130)	SAP130	Homo sapiens (Human)	1048	nuclear speck [GO:0016607]; Sin3-type complex [GO:0070822]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nuclear speck [GO:0016607]; Sin3-type complex [GO:0070822]		GO:0000122; GO:0016607; GO:0070822	negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1797_c0_g1_i1	Q5M7C3	SP13B_XENLA	38.6	153	89	2	70	528	887	1034	1.80E-24	114	SP13B_XENLA	reviewed	Histone deacetylase complex subunit SAP130-B (130 kDa Sin3-associated polypeptide B) (Sin3-associated polypeptide p130 B)	sap130-b	Xenopus laevis (African clawed frog)	1041	"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]		GO:0005634; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27814_c0_g1_i1	Q9HXM1	HDAH_PSEAE	51.9	108	50	1	2	319	108	215	7.90E-25	114.4	HDAH_PSEAE	reviewed	Histone deacetylase-like amidohydrolase (HDAH) (EC 3.5.1.-) (Acetylated lysine deacetylase) (Histone deacetylase homolog PA3774)	PA3774	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	380	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN26769_c0_g1_i1	P79457	UTY_MOUSE	82.6	69	12	0	2	208	864	932	2.50E-24	112.1	UTY_MOUSE	reviewed	Histone demethylase UTY (EC 1.14.11.68) (Male-specific histocompatibility antigen H-YDB) (Ubiquitously transcribed TPR protein on the Y chromosome) (Ubiquitously transcribed Y chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase UTY)	Uty Kdm6c	Mus musculus (Mouse)	1212	MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell contraction [GO:0086003]; embryonic organ development [GO:0048568]; establishment of protein localization [GO:0045184]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; regulation of chromatin silencing [GO:0031935]; regulation of gene expression [GO:0010468]	MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0003007; GO:0003682; GO:0005634; GO:0007507; GO:0010468; GO:0031490; GO:0031935; GO:0032991; GO:0043565; GO:0044666; GO:0045184; GO:0046872; GO:0048568; GO:0051864; GO:0060070; GO:0071558; GO:0086003	canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell contraction [GO:0086003]; embryonic organ development [GO:0048568]; establishment of protein localization [GO:0045184]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; regulation of chromatin silencing [GO:0031935]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN31049_c0_g1_i1	O14607	UTY_HUMAN	100	89	0	0	2	268	233	321	1.00E-46	186.8	UTY_HUMAN	reviewed	Histone demethylase UTY (EC 1.14.11.68) (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase UTY)	UTY KDM6C	Homo sapiens (Human)	1347	MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; regulation of gene expression [GO:0010468]	MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0003682; GO:0005634; GO:0005654; GO:0010468; GO:0031490; GO:0043565; GO:0044666; GO:0046872; GO:0051213; GO:0071558	regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN8218_c1_g2_i1	P35061	H2A_ACRFO	100	22	0	0	3	68	102	123	7.30E-05	47.8	H2A_ACRFO	reviewed	Histone H2A		Acropora formosa (Staghorn coral)	125	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN25965_c0_g1_i1	P0CN99	H2A_CRYNB	51.9	81	38	1	6	245	21	101	1.30E-14	80.1	H2A_CRYNB	reviewed	Histone H2A	HTA1 CNBB5150	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	131	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA repair [GO:0006281]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006281; GO:0046982	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g2_i1	Q6PV61	H2A_PENVA	99.2	123	1	0	122	490	1	123	1.90E-61	236.9	H2A_PENVA	reviewed	Histone H2A		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0042742; GO:0046982	defense response to bacterium [GO:0042742]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g2_i3	Q6PV61	H2A_PENVA	99.2	123	1	0	122	490	1	123	2.50E-61	236.5	H2A_PENVA	reviewed	Histone H2A		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0042742; GO:0046982	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN608_c0_g2_i6	Q6PV61	H2A_PENVA	99.2	123	1	0	85	453	1	123	1.80E-61	236.9	H2A_PENVA	reviewed	Histone H2A		Penaeus vannamei (Whiteleg shrimp) (Litopenaeus vannamei)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0042742; GO:0046982	defense response to bacterium [GO:0042742]		blue	blue	NA	NA	NA	NA
TRINITY_DN812_c0_g1_i1	B6MUN4	MYSM1_BRAFL	43.4	346	175	4	1253	2278	408	736	1.30E-75	286.2	MYSM1_BRAFL	reviewed	"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)"	MYSM1 BRAFLDRAFT_86936	Branchiostoma floridae (Florida lancelet) (Amphioxus)	809	nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0004843; GO:0005634; GO:0006338; GO:0008237; GO:0035522; GO:0042393; GO:0045944; GO:0046872; GO:0070122	chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN812_c0_g1_i2	B6MUN4	MYSM1_BRAFL	42.8	353	181	4	1233	2279	401	736	1.90E-76	288.9	MYSM1_BRAFL	reviewed	"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)"	MYSM1 BRAFLDRAFT_86936	Branchiostoma floridae (Florida lancelet) (Amphioxus)	809	nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0004843; GO:0005634; GO:0006338; GO:0008237; GO:0035522; GO:0042393; GO:0045944; GO:0046872; GO:0070122	chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN812_c0_g1_i3	B6MUN4	MYSM1_BRAFL	42.8	353	181	4	1233	2279	401	736	1.90E-76	288.9	MYSM1_BRAFL	reviewed	"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)"	MYSM1 BRAFLDRAFT_86936	Branchiostoma floridae (Florida lancelet) (Amphioxus)	809	nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0004843; GO:0005634; GO:0006338; GO:0008237; GO:0035522; GO:0042393; GO:0045944; GO:0046872; GO:0070122	chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN812_c0_g1_i4	Q5RGA4	MYSM1_DANRE	38	453	259	9	1283	2614	321	760	9.60E-76	286.6	MYSM1_DANRE	reviewed	"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)"	mysm1 si:ch211-59d15.8	Danio rerio (Zebrafish) (Brachydanio rerio)	822	nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; cranial skeletal system development [GO:1904888]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0004843; GO:0005634; GO:0006338; GO:0008237; GO:0035522; GO:0042393; GO:0045944; GO:0046872; GO:0070122; GO:1904888	chromatin remodeling [GO:0006338]; cranial skeletal system development [GO:1904888]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g1_i3	P04908	H2A1B_HUMAN	100	93	0	0	56	334	1	93	1.60E-44	179.9	H2A1B_HUMAN	reviewed	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	H2AC4 H2AFM HIST1H2AB; H2AC8 H2AFA HIST1H2AE	Homo sapiens (Human)	130	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0006342; GO:0008285; GO:0046982; GO:0070062	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g1_i5	P0C170	H2A1E_RAT	100	93	0	0	56	334	1	93	2.70E-44	179.1	H2A1E_RAT	reviewed	Histone H2A type 1-E		Rattus norvegicus (Rat)	130	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0006342; GO:0019899; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g1_i1	Q6FI13	H2A2A_HUMAN	100	93	0	0	43	321	1	93	2.60E-44	179.1	H2A2A_HUMAN	reviewed	Histone H2A type 2-A (H2A-clustered histone 18) (H2A-clustered histone 19) (Histone H2A.2) (Histone H2A/o)	H2AC18 H2AFO HIST2H2AA HIST2H2AA3; H2AC19 HIST2H2AA4	Homo sapiens (Human)	130	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0006342; GO:0046982; GO:0070062	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g1_i2	Q6FI13	H2A2A_HUMAN	100	93	0	0	62	340	1	93	2.10E-44	179.5	H2A2A_HUMAN	reviewed	Histone H2A type 2-A (H2A-clustered histone 18) (H2A-clustered histone 19) (Histone H2A.2) (Histone H2A/o)	H2AC18 H2AFO HIST2H2AA HIST2H2AA3; H2AC19 HIST2H2AA4	Homo sapiens (Human)	130	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0006342; GO:0046982; GO:0070062	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g1_i4	Q6FI13	H2A2A_HUMAN	100	93	0	0	23	301	1	93	2.50E-44	179.1	H2A2A_HUMAN	reviewed	Histone H2A type 2-A (H2A-clustered histone 18) (H2A-clustered histone 19) (Histone H2A.2) (Histone H2A/o)	H2AC18 H2AFO HIST2H2AA HIST2H2AA3; H2AC19 HIST2H2AA4	Homo sapiens (Human)	130	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0006342; GO:0046982; GO:0070062	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN40119_c0_g1_i1	Q7L7L0	H2A3_HUMAN	99.1	106	1	0	320	3	1	106	5.10E-51	201.4	H2A3_HUMAN	reviewed	Histone H2A type 3	H2AW HIST3H2A	Homo sapiens (Human)	130	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nuclear nucleosome [GO:0000788]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; nucleosome disassembly [GO:0006337]; UV-damage excision repair [GO:0070914]	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nuclear nucleosome [GO:0000788]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000788; GO:0000790; GO:0003677; GO:0006325; GO:0006337; GO:0006342; GO:0046982; GO:0070062; GO:0070914	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; nucleosome disassembly [GO:0006337]; UV-damage excision repair [GO:0070914]		NA	NA	NA	NA	NA	NA
TRINITY_DN38409_c0_g1_i1	O23628	H2AV1_ARATH	65.9	85	29	0	255	1	30	114	1.20E-24	113.6	H2AV1_ARATH	reviewed	Histone H2A variant 1 (H2A.F/Z 1) (H2AvAt) (HTA11)	H2AV At3g54560 T14E10.130	Arabidopsis thaliana (Mouse-ear cress)	136	"nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; defense response to bacterium [GO:0042742]; detection of temperature stimulus [GO:0016048]; flower development [GO:0009908]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; response to osmotic stress [GO:0006970]"	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0006970; GO:0009908; GO:0010468; GO:0016048; GO:0042742; GO:0044030; GO:0045892; GO:0046982	"chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; defense response to bacterium [GO:0042742]; detection of temperature stimulus [GO:0016048]; flower development [GO:0009908]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; response to osmotic stress [GO:0006970]"		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g2_i2	Q8R1M2	H2AJ_MOUSE	93.8	129	7	1	85	468	1	129	9.50E-60	231.1	H2AJ_MOUSE	reviewed	Histone H2A.J (H2a/j)	H2aj	Mus musculus (Mouse)	129	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN608_c0_g2_i4	Q8R1M2	H2AJ_MOUSE	99.2	129	1	0	7	393	1	129	1.60E-63	243.4	H2AJ_MOUSE	reviewed	Histone H2A.J (H2a/j)	H2aj	Mus musculus (Mouse)	129	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN12389_c0_g1_i1	Q32LA7	H2AV_BOVIN	100	121	0	0	369	7	8	128	1.30E-60	233.4	H2AV_BOVIN	reviewed	Histone H2A.V (H2A.F/Z)	H2AZ2 H2AV	Bos taurus (Bovine)	128	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN26899_c0_g1_i1	P08991	H2AV_STRPU	100	123	0	0	393	25	1	123	3.30E-61	235.7	H2AV_STRPU	reviewed	Histone H2A.V (H2A.F/Z) (Fragment)	H2A.F/Z	Strongylocentrotus purpuratus (Purple sea urchin)	125	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		blue	blue	NA	NA	NA	NA
TRINITY_DN19540_c0_g1_i1	P08991	H2AV_STRPU	93.8	81	5	0	245	3	23	103	2.50E-34	145.6	H2AV_STRPU	reviewed	Histone H2A.V (H2A.F/Z) (Fragment)	H2A.F/Z	Strongylocentrotus purpuratus (Purple sea urchin)	125	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN5326_c0_g1_i1	P0C0S4	H2AZ_BOVIN	100	128	0	0	390	7	1	128	4.90E-64	245	H2AZ_BOVIN	reviewed	Histone H2A.Z (H2A/z)	H2AZ1 H2AZ	Bos taurus (Bovine)	128	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN5326_c0_g1_i2	P0C0S4	H2AZ_BOVIN	100	128	0	0	390	7	1	128	4.90E-64	245	H2AZ_BOVIN	reviewed	Histone H2A.Z (H2A/z)	H2AZ1 H2AZ	Bos taurus (Bovine)	128	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0006342; GO:0046982	chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]		NA	NA	NA	NA	NA	NA
TRINITY_DN7175_c0_g1_i1	P16865	H2A3_VOLCA	71	107	31	0	3	323	16	122	1.50E-34	146.7	H2A3_VOLCA	reviewed	Histone H2A-III		Volvox carteri (Green alga)	129	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4354_c0_g1_i1	Q7ZUY3	H2AX_DANRE	76.1	142	26	1	54	455	1	142	4.40E-51	202.2	H2AX_DANRE	reviewed	Histone H2AX (H2a/x) (Histone H2A.X)	h2ax zgc:56329	Danio rerio (Zebrafish) (Brachydanio rerio)	142	centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]	centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0000790; GO:0003677; GO:0005813; GO:0006281; GO:0006310; GO:0006325; GO:0006342; GO:0006974; GO:0046982; GO:0051321	cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]		blue	blue	NA	NA	NA	NA
TRINITY_DN686_c0_g2_i1	P59781	H2B_DROER	96.7	123	4	0	447	79	1	123	8.10E-47	188	H2B_DROER	reviewed	Histone H2B	His2B; GG10953; GG11014; GG11016; GG11018; GG11020; GG11022; GG12581; GG12583; GG12585; GG12957; GG13028; GG13030; GG13032; GG13035; GG13036; GG13057; GG13061; GG16373; GG18684; GG19831; GG19845; GG19848; GG21488; GG21492; GG21494	Drosophila erecta (Fruit fly)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0044877; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN686_c0_g2_i2	P59781	H2B_DROER	96.7	123	4	0	451	83	1	123	8.20E-47	188	H2B_DROER	reviewed	Histone H2B	His2B; GG10953; GG11014; GG11016; GG11018; GG11020; GG11022; GG12581; GG12583; GG12585; GG12957; GG13028; GG13030; GG13032; GG13035; GG13036; GG13057; GG13061; GG16373; GG18684; GG19831; GG19845; GG19848; GG21488; GG21492; GG21494	Drosophila erecta (Fruit fly)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0044877; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN686_c0_g2_i3	P59781	H2B_DROER	96.7	123	4	0	447	79	1	123	8.20E-47	188	H2B_DROER	reviewed	Histone H2B	His2B; GG10953; GG11014; GG11016; GG11018; GG11020; GG11022; GG12581; GG12583; GG12585; GG12957; GG13028; GG13030; GG13032; GG13035; GG13036; GG13057; GG13061; GG16373; GG18684; GG19831; GG19845; GG19848; GG21488; GG21492; GG21494	Drosophila erecta (Fruit fly)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0044877; GO:0046982			brown	brown	NA	NA	NA	NA
TRINITY_DN686_c0_g1_i2	P33778	H2B1B_HUMAN	98.8	84	1	0	325	74	43	126	8.80E-40	164.1	H2B1B_HUMAN	reviewed	Histone H2B type 1-B (H2B-clustered histone 3) (Histone H2B.1) (Histone H2B.f) (H2B/f)	H2BC3 H2BFF HIST1H2BB	Homo sapiens (Human)	126	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]; protein ubiquitination [GO:0016567]"	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]"	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000784; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0016567; GO:0046982	nucleosome assembly [GO:0006334]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN686_c0_g1_i3	P33778	H2B1B_HUMAN	98.8	85	1	0	328	74	42	126	2.30E-40	166	H2B1B_HUMAN	reviewed	Histone H2B type 1-B (H2B-clustered histone 3) (Histone H2B.1) (Histone H2B.f) (H2B/f)	H2BC3 H2BFF HIST1H2BB	Homo sapiens (Human)	126	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]; protein ubiquitination [GO:0016567]"	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]"	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000784; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0016567; GO:0046982	nucleosome assembly [GO:0006334]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN686_c0_g1_i1	Q64525	H2B2B_MOUSE	99.1	107	1	0	394	74	20	126	3.50E-51	202.2	H2B2B_MOUSE	reviewed	Histone H2B type 2-B (H2b 616)	Hist2h2bb	Mus musculus (Mouse)	126	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005654; GO:0005829; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN28798_c0_g1_i1	P06145	H2BS1_STRPU	48.4	64	33	0	2	193	73	136	3.00E-11	68.9	H2BS1_STRPU	reviewed	"Histone H2B.1, sperm"		Strongylocentrotus purpuratus (Purple sea urchin)	140	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN29173_c0_g1_i1	P35068	H2B1_TIGCA	81.3	75	14	0	228	4	30	104	1.80E-26	119.4	H2B1_TIGCA	reviewed	Histone H2B.1/H2B.2		Tigriopus californicus (Marine copepod)	123	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0044877; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN40055_c0_g1_i1	O65819	H2B3_SOLLC	57.8	64	27	0	2	193	71	134	6.50E-14	77.8	H2B3_SOLLC	reviewed	Histone H2B.3 (LeH2B-3) (Fragment)	H2B-3	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	137	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i16	Q6C0C4	H3_YARLI	68.3	41	13	0	124	2	24	64	5.00E-08	58.2	H3_YARLI	reviewed	Histone H3	HHT1 YALI0F25905g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	139	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; rRNA transcription [GO:0009303]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0009303; GO:0046982	rRNA transcription [GO:0009303]		yellow	yellow	1	NA	NA	NA
TRINITY_DN4986_c0_g1_i16	Q6C0C4	H3_YARLI	88	25	3	0	118	192	44	68	2.30E-05	49.3	H3_YARLI	reviewed	Histone H3	HHT1 YALI0F25905g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	139	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; rRNA transcription [GO:0009303]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0009303; GO:0046982	rRNA transcription [GO:0009303]		yellow	yellow	1	NA	NA	NA
TRINITY_DN27323_c0_g1_i1	Q9U7D1	H3_MASBA	57.1	91	39	0	8	280	45	135	1.40E-22	107.1	H3_MASBA	reviewed	Histone H3		Mastigamoeba balamuthi (Phreatamoeba balamuthi)	135	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i15	P68432	H31_BOVIN	100	73	0	0	82	300	1	73	8.20E-32	137.5	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i28	P68432	H31_BOVIN	94	50	3	0	171	320	24	73	6.50E-19	94.7	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i28	P68432	H31_BOVIN	92	25	2	0	163	89	39	63	1.40E-05	50.4	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i29	P68432	H31_BOVIN	100	58	0	0	117	290	39	96	1.20E-24	113.6	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i29	P68432	H31_BOVIN	88.9	36	4	0	109	2	24	59	4.50E-11	68.6	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i4	P68432	H31_BOVIN	87.5	40	5	0	208	89	24	63	2.60E-12	72.8	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			yellow	yellow	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i7	P68432	H31_BOVIN	83.7	43	7	0	171	299	24	66	8.10E-13	74.7	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i12	P68432	H31_BOVIN	86	43	6	0	171	299	24	66	2.20E-13	76.6	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			yellow	yellow	1	NA	NA	NA
TRINITY_DN4986_c0_g1_i26	P68432	H31_BOVIN	87.5	40	5	0	208	89	24	63	2.60E-12	72.8	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			yellow	yellow	1	NA	NA	NA
TRINITY_DN4986_c0_g1_i27	P68432	H31_BOVIN	91.7	96	8	0	87	374	1	96	4.60E-40	165.2	H31_BOVIN	reviewed	Histone H3.1		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	1	NA	NA	NA
TRINITY_DN4986_c0_g1_i6	Q16695	H31T_HUMAN	54	63	29	0	82	270	1	63	8.70E-08	57.8	H31T_HUMAN	reviewed	Histone H3.1t (H3/t) (H3t) (H3/g) (Histone H3.4)	H3-4 H3FT HIST3H3	Homo sapiens (Human)	136	"extracellular exosome [GO:0070062]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleosome assembly [GO:0006334]; telomere capping [GO:0016233]"	"extracellular exosome [GO:0070062]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]"	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000784; GO:0000786; GO:0000788; GO:0003677; GO:0005634; GO:0005654; GO:0006303; GO:0006334; GO:0016233; GO:0046982; GO:0070062	double-strand break repair via nonhomologous end joining [GO:0006303]; nucleosome assembly [GO:0006334]; telomere capping [GO:0016233]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i9	P84227	H32_BOVIN	97.4	39	1	0	146	262	81	119	3.90E-14	78.6	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			blue	blue	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i11	P84227	H32_BOVIN	98.5	68	1	0	286	83	69	136	1.50E-29	130.6	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i11	P84227	H32_BOVIN	96.6	59	2	0	271	447	42	100	3.60E-23	109.4	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i13	P84227	H32_BOVIN	100	98	0	0	376	83	39	136	7.50E-48	191.8	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i13	P84227	H32_BOVIN	94.8	77	4	0	384	614	24	100	6.80E-33	142.1	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i14	P84227	H32_BOVIN	97.3	113	3	0	421	83	24	136	1.10E-54	214.5	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i14	P84227	H32_BOVIN	100	62	0	0	429	614	39	100	1.60E-26	120.9	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i23	P84227	H32_BOVIN	100	98	0	0	382	89	39	136	7.40E-48	191.8	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i23	P84227	H32_BOVIN	94.5	73	4	0	390	608	24	96	8.20E-31	135.2	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i25	P84227	H32_BOVIN	98.5	68	1	0	292	89	69	136	1.20E-29	130.6	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i9	P84227	H32_BOVIN	100	98	0	0	382	89	39	136	7.40E-48	191.8	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			yellow	yellow	NA	NA	NA	NA
TRINITY_DN4986_c0_g1_i9	P84227	H32_BOVIN	86	43	6	0	390	518	24	66	3.50E-13	76.6	H32_BOVIN	reviewed	Histone H3.2		Bos taurus (Bovine)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			yellow	yellow	NA	NA	NA	NA
TRINITY_DN33085_c0_g1_i1	Q6BMU4	H33_DEBHA	57.6	85	36	0	256	2	51	135	1.00E-19	97.1	H33_DEBHA	reviewed	Histone H3.3	HHT3 DEHA2F02574g	Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN2961_c0_g1_i1	Q10453	H331_CAEEL	96.4	56	2	0	79	246	39	94	2.40E-21	103.6	H331_CAEEL	reviewed	Histone H3.3 type 1	his-71 F45E1.6	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN2961_c0_g1_i1	Q10453	H331_CAEEL	100	43	0	0	330	458	94	136	2.70E-17	90.1	H331_CAEEL	reviewed	Histone H3.3 type 1	his-71 F45E1.6	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN2961_c0_g1_i3	Q10453	H331_CAEEL	92.6	136	10	0	88	495	1	136	1.00E-62	241.1	H331_CAEEL	reviewed	Histone H3.3 type 1	his-71 F45E1.6	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN2961_c0_g1_i4	Q10453	H331_CAEEL	98	98	2	0	79	372	39	136	6.80E-46	184.9	H331_CAEEL	reviewed	Histone H3.3 type 1	his-71 F45E1.6	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN21347_c1_g1_i1	Q10453	H331_CAEEL	87.1	93	12	0	5	283	43	135	9.10E-37	154.1	H331_CAEEL	reviewed	Histone H3.3 type 1	his-71 F45E1.6	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN21218_c0_g1_i1	Q10453	H331_CAEEL	94.9	98	5	0	3	296	39	136	4.00E-46	185.3	H331_CAEEL	reviewed	Histone H3.3 type 1	his-71 F45E1.6	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN2961_c0_g2_i1	C0HL66	H33A_DROME	94.9	136	7	0	85	492	1	136	1.40E-64	247.3	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i1	C0HL66	H33A_DROME	81.3	134	25	0	47	448	1	134	7.60E-50	198	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i10	C0HL66	H33A_DROME	78.8	113	24	0	47	385	1	113	2.30E-39	162.9	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i11	C0HL66	H33A_DROME	78.5	93	20	0	47	325	1	93	1.10E-29	130.6	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i2	C0HL66	H33A_DROME	78.8	113	24	0	47	385	1	113	1.50E-38	160.2	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i3	C0HL66	H33A_DROME	76.2	105	25	0	3	317	32	136	4.40E-35	148.7	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i6	C0HL66	H33A_DROME	77.5	102	23	0	47	352	1	102	6.60E-33	141.4	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i7	C0HL66	H33A_DROME	79.6	113	23	0	47	385	1	113	8.00E-40	164.5	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i8	C0HL66	H33A_DROME	80.8	130	25	0	47	436	1	130	1.20E-47	190.7	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i9	C0HL66	H33A_DROME	82.1	134	24	0	47	448	1	134	5.30E-51	201.8	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN4280_c0_g1_i1	C0HL66	H33A_DROME	100	136	0	0	85	492	1	136	1.00E-67	257.7	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN4280_c0_g1_i2	C0HL66	H33A_DROME	100	94	0	0	85	366	1	94	1.30E-43	177.2	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN4280_c0_g1_i3	C0HL66	H33A_DROME	100	136	0	0	85	492	1	136	1.00E-67	257.7	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN19349_c0_g1_i1	C0HL66	H33A_DROME	97.1	136	4	0	457	50	1	136	7.20E-65	248.1	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN40222_c0_g1_i1	C0HL66	H33A_DROME	95.3	64	3	0	29	220	1	64	1.90E-25	115.9	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN21347_c0_g1_i1	C0HL66	H33A_DROME	91.5	82	7	0	247	2	8	89	5.20E-32	137.9	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN32756_c5_g1_i1	C0HL66	H33A_DROME	100	136	0	0	483	76	1	136	4.60E-68	258.8	H33A_DROME	reviewed	Histone H3.3A (H3.A)	His3.3A CG5825	Drosophila melanogaster (Fruit fly)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0005700; GO:0006334; GO:0006336; GO:0007140; GO:0030527; GO:0046982	DNA replication-independent nucleosome assembly [GO:0006336]; male meiotic nuclear division [GO:0007140]; nucleosome assembly [GO:0006334]		blue	blue	NA	NA	NA	NA
TRINITY_DN17391_c0_g1_i1	Q402E2	H33A_LILLO	62.9	132	43	3	25	417	1	127	1.90E-34	146.7	H33A_LILLO	reviewed	Histone H3.3a (Histone soH3-2) (Somatic-like histone H3-2)	MPH3 soH3-2	Lilium longiflorum (Trumpet lily)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN16760_c0_g1_i1	Q402E2	H33A_LILLO	77.9	104	20	1	15	326	34	134	2.00E-37	156.4	H33A_LILLO	reviewed	Histone H3.3a (Histone soH3-2) (Somatic-like histone H3-2)	MPH3 soH3-2	Lilium longiflorum (Trumpet lily)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i5	P02301	H3C_MOUSE	75	124	31	0	8	379	11	134	5.50E-41	168.3	H3C_MOUSE	reviewed	Histone H3.3C (Embryonic)	H3-5 Gm14384 H3f3c	Mus musculus (Mouse)	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN27704_c0_g1_i1	Q6NXT2	H3C_HUMAN	59.4	106	43	0	383	66	28	133	1.90E-27	124	H3C_HUMAN	reviewed	Histone H3.3C (Histone H3.5)	H3-5 H3F3C	Homo sapiens (Human)	135	nuclear euchromatin [GO:0005719]; nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; positive regulation of cell growth [GO:0030307]	nuclear euchromatin [GO:0005719]; nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0005634; GO:0005719; GO:0030307; GO:0031492; GO:0046982	positive regulation of cell growth [GO:0030307]		NA	NA	NA	NA	NA	NA
TRINITY_DN27704_c0_g1_i2	Q6NXT2	H3C_HUMAN	59.4	106	43	0	383	66	28	133	1.70E-27	124	H3C_HUMAN	reviewed	Histone H3.3C (Histone H3.5)	H3-5 H3F3C	Homo sapiens (Human)	135	nuclear euchromatin [GO:0005719]; nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; positive regulation of cell growth [GO:0030307]	nuclear euchromatin [GO:0005719]; nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0005634; GO:0005719; GO:0030307; GO:0031492; GO:0046982	positive regulation of cell growth [GO:0030307]		NA	NA	NA	NA	NA	NA
TRINITY_DN27285_c0_g1_i1	Q6NXT2	H3C_HUMAN	93.2	44	3	0	207	76	92	135	6.30E-15	80.9	H3C_HUMAN	reviewed	Histone H3.3C (Histone H3.5)	H3-5 H3F3C	Homo sapiens (Human)	135	nuclear euchromatin [GO:0005719]; nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; positive regulation of cell growth [GO:0030307]	nuclear euchromatin [GO:0005719]; nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0005634; GO:0005719; GO:0030307; GO:0031492; GO:0046982	positive regulation of cell growth [GO:0030307]		NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i12	Q27532	H33L2_CAEEL	77.5	102	23	0	6	311	33	134	3.70E-35	148.7	H33L2_CAEEL	reviewed	Histone H3.3-like type 2	his-74 W05B10.1	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN18962_c0_g1_i4	Q27532	H33L2_CAEEL	74.5	98	25	0	6	299	33	130	2.10E-32	139.4	H33L2_CAEEL	reviewed	Histone H3.3-like type 2	his-74 W05B10.1	Caenorhabditis elegans	136	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN25453_c0_g1_i1	Q9LR02	H3L3_ARATH	86.7	98	13	0	332	39	37	134	8.20E-42	171	H3L3_ARATH	reviewed	Histone H3-like 3	At1g75600 F10A5.19 F10A5.32 F10A5_23	Arabidopsis thaliana (Mouse-ear cress)	136	mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0005739; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN25952_c0_g1_i1	P62784	H4_CAEEL	79.8	94	19	0	70	351	9	102	7.80E-38	157.9	H4_CAEEL	reviewed	Histone H4	his-1 T10C6.14; his-5 F45F2.3; his-10 ZK131.4; his-14 ZK131.8; his-18 K06C4.10; his-26 ZK131.1; his-28 K06C4.2; his-31 F17E9.12; his-37 C50F4.7; his-38 K03A1.6; his-46 B0035.9; his-50 F07B7.9; his-56 F54E12.3; his-60 F55G1.11; his-64 F22B3.1; his-67 T23D8.5	Caenorhabditis elegans	103	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN31553_c0_g1_i1	P62784	H4_CAEEL	80.9	94	18	0	351	70	9	102	2.90E-38	159.5	H4_CAEEL	reviewed	Histone H4	his-1 T10C6.14; his-5 F45F2.3; his-10 ZK131.4; his-14 ZK131.8; his-18 K06C4.10; his-26 ZK131.1; his-28 K06C4.2; his-31 F17E9.12; his-37 C50F4.7; his-38 K03A1.6; his-46 B0035.9; his-50 F07B7.9; his-56 F54E12.3; his-60 F55G1.11; his-64 F22B3.1; his-67 T23D8.5	Caenorhabditis elegans	103	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c0_g1_i1	P84048	H4_ACRAS	100	103	0	0	390	82	1	103	7.80E-51	201.4	H4_ACRAS	reviewed	Histone H4	His4 H4	Acrolepiopsis assectella (Leek moth)	103	"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3092_c0_g1_i4	P84048	H4_ACRAS	100	103	0	0	390	82	1	103	6.00E-51	201.8	H4_ACRAS	reviewed	Histone H4	His4 H4	Acrolepiopsis assectella (Leek moth)	103	"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c0_g2_i1	P84048	H4_ACRAS	100	43	0	0	219	91	1	43	2.40E-16	86.3	H4_ACRAS	reviewed	Histone H4	His4 H4	Acrolepiopsis assectella (Leek moth)	103	"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c0_g2_i2	P84048	H4_ACRAS	100	103	0	0	398	90	1	103	4.60E-51	202.2	H4_ACRAS	reviewed	Histone H4	His4 H4	Acrolepiopsis assectella (Leek moth)	103	"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c0_g3_i1	P62784	H4_CAEEL	81.9	94	17	0	354	73	9	102	1.50E-38	160.2	H4_CAEEL	reviewed	Histone H4	his-1 T10C6.14; his-5 F45F2.3; his-10 ZK131.4; his-14 ZK131.8; his-18 K06C4.10; his-26 ZK131.1; his-28 K06C4.2; his-31 F17E9.12; his-37 C50F4.7; his-38 K03A1.6; his-46 B0035.9; his-50 F07B7.9; his-56 F54E12.3; his-60 F55G1.11; his-64 F22B3.1; his-67 T23D8.5	Caenorhabditis elegans	103	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c1_g1_i1	P62784	H4_CAEEL	79.5	83	17	0	2	250	20	102	5.00E-33	141.4	H4_CAEEL	reviewed	Histone H4	his-1 T10C6.14; his-5 F45F2.3; his-10 ZK131.4; his-14 ZK131.8; his-18 K06C4.10; his-26 ZK131.1; his-28 K06C4.2; his-31 F17E9.12; his-37 C50F4.7; his-38 K03A1.6; his-46 B0035.9; his-50 F07B7.9; his-56 F54E12.3; his-60 F55G1.11; his-64 F22B3.1; his-67 T23D8.5	Caenorhabditis elegans	103	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN36027_c0_g1_i1	P84048	H4_ACRAS	100	88	0	0	3	266	16	103	1.40E-42	173.3	H4_ACRAS	reviewed	Histone H4	His4 H4	Acrolepiopsis assectella (Leek moth)	103	"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8306_c0_g1_i1	P62803	H4_BOVIN	100	103	0	0	347	39	1	103	3.40E-51	202.2	H4_BOVIN	reviewed	Histone H4 (H4.1)		Bos taurus (Bovine)	103	"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005654; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c0_g1_i5	P62803	H4_BOVIN	100	103	0	0	390	82	1	103	2.50E-51	203	H4_BOVIN	reviewed	Histone H4 (H4.1)		Bos taurus (Bovine)	103	"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005654; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3092_c0_g1_i6	P62803	H4_BOVIN	100	103	0	0	390	82	1	103	2.50E-51	203	H4_BOVIN	reviewed	Histone H4 (H4.1)		Bos taurus (Bovine)	103	"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005654; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36027_c0_g1_i2	P62803	H4_BOVIN	100	103	0	0	61	369	1	103	2.20E-51	203	H4_BOVIN	reviewed	Histone H4 (H4.1)		Bos taurus (Bovine)	103	"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005654; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3449_c0_g1_i1	Q8K1K9	HINFP_MOUSE	39	228	122	6	402	1040	9	234	8.10E-45	182.6	HINFP_MOUSE	reviewed	Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)	Hinfp Mizf	Mus musculus (Mouse)	503	"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"	Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3449_c0_g1_i2	Q8K1K9	HINFP_MOUSE	45.5	279	135	6	402	1193	9	285	3.20E-72	273.9	HINFP_MOUSE	reviewed	Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)	Hinfp Mizf	Mus musculus (Mouse)	503	"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"	Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3449_c0_g1_i3	Q8K1K9	HINFP_MOUSE	34.5	165	91	6	402	851	9	171	4.10E-23	110.2	HINFP_MOUSE	reviewed	Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)	Hinfp Mizf	Mus musculus (Mouse)	503	"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"	Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3449_c0_g1_i4	Q9BQA5	HINFP_HUMAN	46.2	398	195	6	402	1541	9	405	2.70E-108	394	HINFP_HUMAN	reviewed	Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)	HINFP MIZF ZNF743	Homo sapiens (Human)	517	"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"	Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000077; GO:0000082; GO:0000083; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19338_c0_g1_i1	P70081	H48_CHICK	96.7	61	2	0	184	2	3	63	3.90E-25	114.8	H48_CHICK	reviewed	Histone H4 type VIII	H4-VIII	Gallus gallus (Chicken)	103	"nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0006352; GO:0046982	"DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1207_c1_g2_i4	P45481	CBP_MOUSE	54.3	140	49	4	601	203	540	671	5.60E-30	132.9	CBP_MOUSE	reviewed	Histone lysine acetyltransferase CREBBP (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-)	Crebbp Cbp	Mus musculus (Mouse)	2441	"condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"	condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]	acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000123; GO:0000790; GO:0000940; GO:0000977; GO:0001085; GO:0001093; GO:0002039; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006473; GO:0008134; GO:0008140; GO:0008270; GO:0008283; GO:0010628; GO:0016407; GO:0016573; GO:0016604; GO:0016605; GO:0018076; GO:0019904; GO:0030511; GO:0030718; GO:0031490; GO:0031648; GO:0032688; GO:0032793; GO:0032991; GO:0033613; GO:0034644; GO:0035729; GO:0042975; GO:0043426; GO:0045893; GO:0045944; GO:0046332; GO:0048511; GO:0048525; GO:0051091; GO:0060325; GO:0060355; GO:0061733; GO:0090575; GO:0097718; GO:0098586; GO:1900087; GO:1901224; GO:1990258	"cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; N-terminal peptidyl-lysine acetylation [GO:0018076]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33031_c0_g1_i1	Q9UPP1	PHF8_HUMAN	100	123	0	0	2	370	250	372	4.80E-74	278.1	PHF8_HUMAN	reviewed	Histone lysine demethylase PHF8 (EC 1.14.11.27) (EC 1.14.11.65) (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8)	PHF8 KIAA1111 ZNF422	Homo sapiens (Human)	1060	"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]"	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558	"brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26634_c0_g1_i1	P0CH95	PHF8_DANRE	33.2	714	365	16	2269	320	191	856	1.20E-82	309.3	PHF8_DANRE	reviewed	Histone lysine demethylase PHF8 (EC 1.14.11.27) (EC 1.14.11.65) (PHD finger protein 8) (zPHF8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8)	phf8	Danio rerio (Zebrafish) (Brachydanio rerio)	1032	"nucleolus [GO:0005730]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; brain development [GO:0007420]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]"	nucleolus [GO:0005730]	chromatin binding [GO:0003682]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000082; GO:0003682; GO:0005730; GO:0007420; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0043523; GO:0045893; GO:0045943; GO:0046872; GO:0048703; GO:0051864; GO:0060319; GO:0061188; GO:0070544; GO:0071557; GO:0071558	"brain development [GO:0007420]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]"		NA	NA	NA	NA	NA	NA
TRINITY_DN76_c0_g1_i1	Q9NWY4	HPF1_HUMAN	43.8	331	176	5	416	1378	6	336	2.80E-72	274.2	HPF1_HUMAN	reviewed	Histone PARylation factor 1	HPF1 C4orf27	Homo sapiens (Human)	346	nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]	nucleus [GO:0005634]	histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006974; GO:0008270; GO:0010835; GO:0018312; GO:0042393; GO:0072572	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]		NA	NA	NA	NA	NA	NA
TRINITY_DN76_c0_g1_i2	Q9NWY4	HPF1_HUMAN	43.8	331	176	5	376	1338	6	336	2.70E-72	274.2	HPF1_HUMAN	reviewed	Histone PARylation factor 1	HPF1 C4orf27	Homo sapiens (Human)	346	nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]	nucleus [GO:0005634]	histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006974; GO:0008270; GO:0010835; GO:0018312; GO:0042393; GO:0072572	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]		NA	NA	NA	NA	NA	NA
TRINITY_DN76_c0_g1_i3	Q9NWY4	HPF1_HUMAN	43.8	331	176	5	380	1342	6	336	2.80E-72	274.2	HPF1_HUMAN	reviewed	Histone PARylation factor 1	HPF1 C4orf27	Homo sapiens (Human)	346	nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]	nucleus [GO:0005634]	histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]	GO:0005634; GO:0006974; GO:0008270; GO:0010835; GO:0018312; GO:0042393; GO:0072572	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]		NA	NA	NA	NA	NA	NA
TRINITY_DN25705_c0_g1_i1	Q86X55	CARM1_HUMAN	100	76	0	0	3	230	221	296	3.80E-37	154.8	CARM1_HUMAN	reviewed	Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4)	CARM1 PRMT4	Homo sapiens (Human)	608	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; aging [GO:0007568]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endochondral bone morphogenesis [GO:0060350]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein binding [GO:0032091]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromatin [GO:0071168]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of lipid metabolic process [GO:0019216]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	beta-catenin binding [GO:0008013]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein homodimerization activity [GO:0042803]; protein methyltransferase activity [GO:0008276]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003420; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006977; GO:0007568; GO:0008013; GO:0008276; GO:0008284; GO:0008469; GO:0016032; GO:0016274; GO:0016571; GO:0019216; GO:0030374; GO:0030520; GO:0032091; GO:0033146; GO:0034970; GO:0034971; GO:0035242; GO:0035642; GO:0042054; GO:0042803; GO:0045600; GO:0045944; GO:0051092; GO:0051591; GO:0060350; GO:0070577; GO:0071168; GO:0090575; GO:1902415; GO:2000171	"aging [GO:0007568]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endochondral bone morphogenesis [GO:0060350]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein binding [GO:0032091]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromatin [GO:0071168]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of lipid metabolic process [GO:0019216]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15015_c0_g1_i1	B4GZ20	CARM1_DROPE	77.1	140	32	0	1	420	154	293	5.50E-58	224.9	CARM1_DROPE	reviewed	Histone-arginine methyltransferase CARMER (EC 2.1.1.319)	Art4 GL27288	Drosophila persimilis (Fruit fly)	531	"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; chromatin remodeling [GO:0006338]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	histone methyltransferase activity [GO:0042054]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]	GO:0005634; GO:0005737; GO:0006338; GO:0006355; GO:0019919; GO:0034969; GO:0035097; GO:0035241; GO:0035242; GO:0042054	"chromatin remodeling [GO:0006338]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN37374_c0_g1_i1	Q7Q2B7	CARM1_ANOGA	65.4	81	28	0	254	12	124	204	1.90E-21	102.8	CARM1_ANOGA	reviewed	Histone-arginine methyltransferase CARMER (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (AgCARM1)	CARM1 AGAP003923	Anopheles gambiae (African malaria mosquito)	622	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; chromatin remodeling [GO:0006338]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	histone methyltransferase activity [GO:0042054]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]	GO:0005634; GO:0005737; GO:0006338; GO:0006355; GO:0019919; GO:0034969; GO:0035241; GO:0035242; GO:0042054	"chromatin remodeling [GO:0006338]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14970_c0_g1_i1	Q3MHL3	RBBP4_BOVIN	100	425	0	0	1325	51	1	425	2.30E-259	895.6	RBBP4_BOVIN	reviewed	Histone-binding protein RBBP4 (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4)	RBBP4	Bos taurus (Bovine)	425	CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]	CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]	DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005829; GO:0006260; GO:0006335; GO:0006336; GO:0006338; GO:0007049; GO:0008094; GO:0016581; GO:0016589; GO:0031497; GO:0033186; GO:0035098; GO:0042826	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]		NA	NA	NA	NA	NA	NA
TRINITY_DN14970_c0_g1_i3	Q3MHL3	RBBP4_BOVIN	100	425	0	0	1307	33	1	425	1.80E-259	896	RBBP4_BOVIN	reviewed	Histone-binding protein RBBP4 (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4)	RBBP4	Bos taurus (Bovine)	425	CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]	CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]	DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005829; GO:0006260; GO:0006335; GO:0006336; GO:0006338; GO:0007049; GO:0008094; GO:0016581; GO:0016589; GO:0031497; GO:0033186; GO:0035098; GO:0042826	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]		NA	NA	NA	NA	NA	NA
TRINITY_DN36209_c0_g1_i1	O93377	RBP4A_XENLA	48.6	70	33	1	38	238	126	195	5.20E-13	74.7	RBP4A_XENLA	reviewed	Histone-binding protein RBBP4-A (Retinoblastoma-binding protein 4-A) (RBBP-4-A) (Retinoblastoma-binding protein p48-A)	rbbp4-a rbap48-a	Xenopus laevis (African clawed frog)	425	CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA replication [GO:0006260]	CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]		GO:0006260; GO:0007049; GO:0031497; GO:0033186; GO:0035098	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN14970_c0_g2_i1	Q16576	RBBP7_HUMAN	100	425	0	0	1326	52	1	425	3.10E-259	895.2	RBBP7_HUMAN	reviewed	Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46)	RBBP7 RBAP46	Homo sapiens (Human)	425	"cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; RNA binding [GO:0003723]; cellular heat acclimation [GO:0070370]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to steroid hormone [GO:0048545]"	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0016581; GO:0030308; GO:0034080; GO:0035098; GO:0043687; GO:0045814; GO:0048545; GO:0070317; GO:0070370; GO:1901796	"cellular heat acclimation [GO:0070370]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to steroid hormone [GO:0048545]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14970_c0_g2_i2	Q16576	RBBP7_HUMAN	100	425	0	0	1326	52	1	425	3.10E-259	895.2	RBBP7_HUMAN	reviewed	Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46)	RBBP7 RBAP46	Homo sapiens (Human)	425	"cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; RNA binding [GO:0003723]; cellular heat acclimation [GO:0070370]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to steroid hormone [GO:0048545]"	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0016581; GO:0030308; GO:0034080; GO:0035098; GO:0043687; GO:0045814; GO:0048545; GO:0070317; GO:0070370; GO:1901796	"cellular heat acclimation [GO:0070370]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to steroid hormone [GO:0048545]"		NA	NA	NA	NA	NA	NA
TRINITY_DN800_c0_g1_i1	Q7ZTY4	RBBP7_DANRE	95.4	131	6	0	86	478	296	426	1.50E-71	270.4	RBBP7_DANRE	reviewed	Histone-binding protein RBBP7 (Retinoblastoma-binding protein 7) (RBBP-7)	rbbp7 rbb4l	Danio rerio (Zebrafish) (Brachydanio rerio)	426	ESC/E(Z) complex [GO:0035098]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; fin regeneration [GO:0031101]; hematopoietic progenitor cell differentiation [GO:0002244]	ESC/E(Z) complex [GO:0035098]		GO:0002244; GO:0006260; GO:0006325; GO:0031101; GO:0035098	chromatin organization [GO:0006325]; DNA replication [GO:0006260]; fin regeneration [GO:0031101]; hematopoietic progenitor cell differentiation [GO:0002244]		NA	NA	NA	NA	NA	NA
TRINITY_DN800_c0_g1_i2	Q7ZTY4	RBBP7_DANRE	95.4	131	6	0	86	478	296	426	2.00E-71	270	RBBP7_DANRE	reviewed	Histone-binding protein RBBP7 (Retinoblastoma-binding protein 7) (RBBP-7)	rbbp7 rbb4l	Danio rerio (Zebrafish) (Brachydanio rerio)	426	ESC/E(Z) complex [GO:0035098]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; fin regeneration [GO:0031101]; hematopoietic progenitor cell differentiation [GO:0002244]	ESC/E(Z) complex [GO:0035098]		GO:0002244; GO:0006260; GO:0006325; GO:0031101; GO:0035098	chromatin organization [GO:0006325]; DNA replication [GO:0006260]; fin regeneration [GO:0031101]; hematopoietic progenitor cell differentiation [GO:0002244]		NA	NA	NA	NA	NA	NA
TRINITY_DN2938_c0_g1_i1	Q8NEZ4	KMT2C_HUMAN	28.2	966	372	18	1980	7	130	1081	8.50E-111	402.9	KMT2C_HUMAN	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	KMT2C HALR KIAA1506 MLL3	Homo sapiens (Human)	4911	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]"	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0097692	histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]		NA	NA	NA	NA	NA	NA
TRINITY_DN2938_c0_g1_i3	Q8NEZ4	KMT2C_HUMAN	27.3	938	356	18	1913	36	130	1053	1.00E-97	359.4	KMT2C_HUMAN	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	KMT2C HALR KIAA1506 MLL3	Homo sapiens (Human)	4911	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]"	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0097692	histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]		NA	NA	NA	NA	NA	NA
TRINITY_DN2938_c0_g1_i4	Q8NEZ4	KMT2C_HUMAN	28.1	966	369	18	1968	7	130	1081	1.60E-109	398.7	KMT2C_HUMAN	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	KMT2C HALR KIAA1506 MLL3	Homo sapiens (Human)	4911	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]"	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0097692	histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]		NA	NA	NA	NA	NA	NA
TRINITY_DN2938_c0_g1_i5	Q8NEZ4	KMT2C_HUMAN	27.4	938	359	18	1925	36	130	1053	5.60E-99	363.6	KMT2C_HUMAN	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	KMT2C HALR KIAA1506 MLL3	Homo sapiens (Human)	4911	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]"	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0097692	histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]		NA	NA	NA	NA	NA	NA
TRINITY_DN25782_c0_g1_i1	Q8NEZ4	KMT2C_HUMAN	100	142	0	0	427	2	935	1076	5.10E-88	324.7	KMT2C_HUMAN	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	KMT2C HALR KIAA1506 MLL3	Homo sapiens (Human)	4911	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]"	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0097692	histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]		NA	NA	NA	NA	NA	NA
TRINITY_DN34494_c0_g1_i1	Q9NR48	ASH1L_HUMAN	62.1	66	25	0	200	3	2577	2642	1.60E-22	106.3	ASH1L_HUMAN	reviewed	Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.-) (EC 2.1.1.359) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H)	ASH1L KIAA1420 KMT2H	Homo sapiens (Human)	2969	bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; interleukin-6 production [GO:0032635]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]	bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]	GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0007338; GO:0009791; GO:0030317; GO:0032635; GO:0042800; GO:0043124; GO:0043409; GO:0045944; GO:0046697; GO:0046872; GO:0046974; GO:0046975; GO:0061038; GO:0097676; GO:1903699; GO:1903709	decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; interleukin-6 production [GO:0032635]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]		NA	NA	NA	NA	NA	NA
TRINITY_DN5455_c0_g1_i2	P42124	EZ_DROME	55.6	824	275	15	2432	30	5	760	1.50E-214	747.7	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	1	NA	NA	NA
TRINITY_DN5455_c0_g1_i3	P42124	EZ_DROME	60.7	468	133	7	1430	30	343	760	8.80E-130	466.1	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	1	NA	NA	NA
TRINITY_DN5455_c0_g1_i3	P42124	EZ_DROME	50.4	345	141	7	2520	1552	5	341	7.80E-78	293.5	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	1	NA	NA	NA
TRINITY_DN5455_c0_g1_i1	P42124	EZ_DROME	60.7	468	133	7	1430	30	343	760	6.70E-130	466.5	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5455_c0_g1_i1	P42124	EZ_DROME	50.4	345	141	7	2493	1525	5	341	7.70E-78	293.5	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5455_c0_g1_i12	P42124	EZ_DROME	56.3	815	274	15	2405	30	5	760	2.60E-216	753.4	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5455_c0_g1_i5	P42124	EZ_DROME	52.1	745	270	16	2261	96	5	685	1.70E-169	597.8	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5455_c0_g1_i9	P42124	EZ_DROME	93.3	135	9	0	434	30	626	760	6.20E-72	271.6	EZ_DROME	reviewed	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.356) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	E(z) KMT6 CG6502	Drosophila melanogaster (Fruit fly)	760	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c3_g1_i2	Q28Z18	SETB1_DROPS	30.4	411	238	10	479	1675	366	740	2.50E-45	184.9	SETB1_DROPS	reviewed	Histone-lysine N-methyltransferase eggless (EC 2.1.1.355) (SETDB1 homolog)	egg GA30484	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1254	chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]	chromosome [GO:0005694]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038	multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c3_g1_i5	Q28Z18	SETB1_DROPS	30.4	411	238	10	280	1476	366	740	2.20E-45	184.9	SETB1_DROPS	reviewed	Histone-lysine N-methyltransferase eggless (EC 2.1.1.355) (SETDB1 homolog)	egg GA30484	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1254	chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]	chromosome [GO:0005694]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005694; GO:0007275; GO:0008270; GO:0018024; GO:0048477; GO:0051038	multicellular organism development [GO:0007275]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN28512_c0_g1_i1	Q32KD2	SETB1_DROME	74.3	74	19	0	224	3	1168	1241	8.90E-31	133.7	SETB1_DROME	reviewed	Histone-lysine N-methyltransferase eggless (EC 2.1.1.355) (SETDB1 homolog)	egg CG12196	Drosophila melanogaster (Fruit fly)	1262	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; female germ-line stem cell asymmetric division [GO:0048132]; heterochromatin organization [GO:0070828]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H3-K9 methylation [GO:0051567]; multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene silencing [GO:0060968]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005700; GO:0005737; GO:0007275; GO:0008270; GO:0010629; GO:0018024; GO:0040029; GO:0046974; GO:0048132; GO:0048477; GO:0051038; GO:0051567; GO:0060968; GO:0070828; GO:0070868; GO:0090309	"female germ-line stem cell asymmetric division [GO:0048132]; heterochromatin organization [GO:0070828]; heterochromatin organization involved in chromatin silencing [GO:0070868]; histone H3-K9 methylation [GO:0051567]; multicellular organism development [GO:0007275]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription involved in meiotic cell cycle [GO:0051038]; oogenesis [GO:0048477]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene silencing [GO:0060968]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18703_c0_g1_i1	Q9Z148	EHMT2_MOUSE	58.2	342	142	1	10	1035	895	1235	5.40E-121	435.6	EHMT2_MOUSE	reviewed	Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)	Ehmt2 Bat8 G9a Ng36	Mus musculus (Mouse)	1263	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000977; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0006357; GO:0007130; GO:0007281; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010424; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0035265; GO:0035690; GO:0036166; GO:0044030; GO:0045471; GO:0046974; GO:0046976; GO:0048148; GO:0048665; GO:0051567; GO:0051569; GO:0051570; GO:0060992; GO:0070734; GO:0070742; GO:0071314; GO:1902902; GO:1990841	behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]		NA	NA	NA	NA	NA	NA
TRINITY_DN18703_c0_g1_i2	Q9Z148	EHMT2_MOUSE	62.9	259	95	1	53	829	978	1235	1.70E-101	370.5	EHMT2_MOUSE	reviewed	Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)	Ehmt2 Bat8 G9a Ng36	Mus musculus (Mouse)	1263	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000977; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0006357; GO:0007130; GO:0007281; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010424; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0035265; GO:0035690; GO:0036166; GO:0044030; GO:0045471; GO:0046974; GO:0046976; GO:0048148; GO:0048665; GO:0051567; GO:0051569; GO:0051570; GO:0060992; GO:0070734; GO:0070742; GO:0071314; GO:1902902; GO:1990841	behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]		NA	NA	NA	NA	NA	NA
TRINITY_DN18703_c0_g1_i3	Q9Z148	EHMT2_MOUSE	60.9	289	112	1	122	988	948	1235	1.90E-107	390.6	EHMT2_MOUSE	reviewed	Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)	Ehmt2 Bat8 G9a Ng36	Mus musculus (Mouse)	1263	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000977; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0006357; GO:0007130; GO:0007281; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010424; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0035265; GO:0035690; GO:0036166; GO:0044030; GO:0045471; GO:0046974; GO:0046976; GO:0048148; GO:0048665; GO:0051567; GO:0051569; GO:0051570; GO:0060992; GO:0070734; GO:0070742; GO:0071314; GO:1902902; GO:1990841	behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]		NA	NA	NA	NA	NA	NA
TRINITY_DN30451_c0_g1_i1	Q92800	EZH1_HUMAN	100	70	0	0	213	4	217	286	7.30E-35	147.1	EZH1_HUMAN	reviewed	Histone-lysine N-methyltransferase EZH1 (EC 2.1.1.356) (ENX-2) (Enhancer of zeste homolog 1)	EZH1 KIAA0388	Homo sapiens (Human)	747	"chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription corepressor activity [GO:0003714]; anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; chromatin silencing at telomere [GO:0006348]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	"chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]"	chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000781; GO:0003682; GO:0003714; GO:0005654; GO:0006338; GO:0006348; GO:0009653; GO:0018024; GO:0021766; GO:0031507; GO:0035098; GO:0045944; GO:0070734	anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; chromatin silencing at telomere [GO:0006348]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN34802_c0_g1_i1	Q61188	EZH2_MOUSE	99.1	106	1	0	320	3	206	311	3.80E-59	228.4	EZH2_MOUSE	reviewed	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2)	Ezh2 Enx1h	Mus musculus (Mouse)	746	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of cell population proliferation [GO:0042127]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of gliogenesis [GO:0014013]; regulation of neurogenesis [GO:0050767]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]"	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000781; GO:0000790; GO:0000976; GO:0000978; GO:0000979; GO:0001226; GO:0001932; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006306; GO:0006348; GO:0006357; GO:0008284; GO:0010468; GO:0010629; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0031490; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042127; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0043565; GO:0045120; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0050767; GO:0051154; GO:0070301; GO:0070314; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1902808; GO:1904772; GO:1990841; GO:2000134	"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of cell population proliferation [GO:0042127]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of gliogenesis [GO:0014013]; regulation of neurogenesis [GO:0050767]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28914_c0_g1_i1	Q15910	EZH2_HUMAN	100	143	0	0	2	430	604	746	9.80E-82	303.9	EZH2_HUMAN	reviewed	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)	EZH2 KMT6	Homo sapiens (Human)	746	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]"	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000781; GO:0000790; GO:0000978; GO:0000979; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006306; GO:0006325; GO:0006348; GO:0006355; GO:0008284; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0031490; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0045120; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0051154; GO:0070301; GO:0070314; GO:0070317; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1902808; GO:1904772; GO:1990841; GO:2000134	"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39057_c0_g1_i1	Q15910	EZH2_HUMAN	100	109	0	0	1	327	209	317	2.00E-60	232.6	EZH2_HUMAN	reviewed	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)	EZH2 KMT6	Homo sapiens (Human)	746	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]"	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000781; GO:0000790; GO:0000978; GO:0000979; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006306; GO:0006325; GO:0006348; GO:0006355; GO:0008284; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0031490; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0045120; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0051154; GO:0070301; GO:0070314; GO:0070317; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1902808; GO:1904772; GO:1990841; GO:2000134	"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40032_c0_g1_i1	Q15910	EZH2_HUMAN	100	96	0	0	1	288	426	521	5.20E-52	204.5	EZH2_HUMAN	reviewed	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)	EZH2 KMT6	Homo sapiens (Human)	746	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]"	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000781; GO:0000790; GO:0000978; GO:0000979; GO:0001226; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006306; GO:0006325; GO:0006348; GO:0006355; GO:0008284; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0031490; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0045120; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0051154; GO:0070301; GO:0070314; GO:0070317; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1902808; GO:1904772; GO:1990841; GO:2000134	"cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35443_c0_g1_i1	Q03112	MECOM_HUMAN	78.6	112	24	0	7	342	317	428	4.20E-50	198.7	MECOM_HUMAN	reviewed	Histone-lysine N-methyltransferase MECOM (EC 2.1.1.-) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1)	MECOM EVI1 MDS1 PRDM3	Homo sapiens (Human)	1230	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0016607; GO:0030154; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0070828; GO:0071425	"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3798_c0_g1_i1	O96028	NSD2_HUMAN	62.7	249	89	3	1314	574	1061	1307	7.60E-82	305.8	NSD2_HUMAN	reviewed	Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)	NSD2 KIAA1090 MMSET TRX5 WHSC1	Homo sapiens (Human)	1365	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair via nonhomologous end joining [GO:0006303]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006303; GO:0006355; GO:0042799; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:2001032	"atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair via nonhomologous end joining [GO:0006303]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c7_g1_i2	Q96EQ9	PRDM9_MOUSE	62.3	77	29	0	236	6	541	617	8.00E-22	104	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i1	Q96EQ9	PRDM9_MOUSE	58.4	209	75	1	723	133	534	742	9.60E-77	288.1	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i1	Q96EQ9	PRDM9_MOUSE	37	119	50	6	350	18	531	632	2.70E-10	67.4	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i2	Q96EQ9	PRDM9_MOUSE	58	200	77	1	580	2	534	733	3.40E-72	272.7	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i3	Q96EQ9	PRDM9_MOUSE	57.1	156	52	2	515	84	534	686	1.70E-51	203.8	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i4	Q96EQ9	PRDM9_MOUSE	57.1	268	100	2	851	84	534	798	2.00E-97	357.1	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i5	Q96EQ9	PRDM9_MOUSE	60.8	209	82	0	650	24	534	742	1.40E-82	307.4	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i6	Q96EQ9	PRDM9_MOUSE	58.3	156	50	2	564	133	534	686	2.20E-52	206.8	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i6	Q96EQ9	PRDM9_MOUSE	37.2	121	50	6	359	18	531	632	1.60E-10	67.8	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i7	Q96EQ9	PRDM9_MOUSE	58.4	209	75	1	876	286	534	742	1.20E-76	288.1	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN295_c0_g1_i7	Q96EQ9	PRDM9_MOUSE	40.5	148	60	7	503	84	531	658	2.60E-20	100.9	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i6	Q96EQ9	PRDM9_MOUSE	51.1	90	44	0	272	3	639	728	7.70E-21	100.9	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c1_g1_i1	Q96EQ9	PRDM9_MOUSE	54.6	108	49	0	6	329	539	646	3.20E-29	129	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g1_i5	Q96EQ9	PRDM9_MOUSE	51.4	70	30	1	212	3	537	602	2.40E-14	79	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i8	P0C6Y7	PRDM9_RAT	48.3	87	45	0	312	52	678	764	1.20E-16	88.6	PRDM9_RAT	reviewed	Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9	Rattus norvegicus (Rat)	796	chromatin [GO:0000785]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g2_i1	Q9NQV7	PRDM9_HUMAN	48.6	111	57	0	338	6	750	860	7.60E-26	117.9	PRDM9_HUMAN	reviewed	Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	PRDM9 PFM6	Homo sapiens (Human)	894	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0006355; GO:0007129; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	"double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29155_c0_g1_i1	Q6P2A1	PRDM9_DANRE	41	78	44	2	19	246	733	810	1.30E-12	73.6	PRDM9_DANRE	reviewed	Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	prdm9 zgc:63970	Danio rerio (Zebrafish) (Brachydanio rerio)	853	chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	chromosome [GO:0005694]; nucleus [GO:0005634]	histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]	GO:0005634; GO:0005694; GO:0007129; GO:0007292; GO:0010468; GO:0010844; GO:0034968; GO:0042800; GO:0042803; GO:0043066; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN3557_c0_g1_i1	P0C6Y7	PRDM9_RAT	49	257	131	0	817	47	540	796	5.10E-66	252.7	PRDM9_RAT	reviewed	Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)	Prdm9	Rattus norvegicus (Rat)	796	chromatin [GO:0000785]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0034968; GO:0042054; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN35807_c0_g1_i1	Q297V5	KMT5A_DROPS	50	172	76	2	509	3	492	656	5.20E-39	163.7	KMT5A_DROPS	reviewed	Histone-lysine N-methyltransferase PR-Set7 (EC 2.1.1.361) (PR/SET domain-containing protein 07)	PR-Set7 GA17259	Drosophila pseudoobscura pseudoobscura (Fruit fly)	691	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone methylation [GO:0016571]	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	histone methyltransferase activity (H4-K20 specific) [GO:0042799]	GO:0005634; GO:0005700; GO:0007049; GO:0016571; GO:0042799; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; histone methylation [GO:0016571]		blue	blue	NA	NA	NA	NA
TRINITY_DN25910_c0_g1_i1	Q5LJZ2	SET1_DROME	79.4	136	28	0	462	55	1506	1641	3.10E-62	239.2	SET1_DROME	reviewed	Histone-lysine N-methyltransferase SETD1 (EC 2.1.1.354)	Set1 CG40351	Drosophila melanogaster (Fruit fly)	1641	euchromatin [GO:0000791]; polytene chromosome [GO:0005700]; Set1C/COMPASS complex [GO:0048188]; transcriptionally active chromatin [GO:0035327]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]	euchromatin [GO:0000791]; polytene chromosome [GO:0005700]; Set1C/COMPASS complex [GO:0048188]; transcriptionally active chromatin [GO:0035327]	histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]	GO:0000791; GO:0003723; GO:0005700; GO:0035327; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0080182	histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]		NA	NA	NA	NA	NA	NA
TRINITY_DN16697_c0_g1_i1	Q9BYW2	SETD2_HUMAN	51.9	108	51	1	425	105	2449	2556	1.00E-25	117.9	SETD2_HUMAN	reviewed	Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)	SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069	Homo sapiens (Human)	2564	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	alpha-tubulin binding [GO:0043014]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010569; GO:0010793; GO:0016032; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634	"angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c3_g1_i1	Q6INA9	SETB1_XENLA	47.9	163	80	4	65	541	286	447	1.10E-32	141.4	SETB1_XENLA	reviewed	Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.-) (SET domain bifurcated 1)	setdb1	Xenopus laevis (African clawed frog)	1269	chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]	chromosome [GO:0005694]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005694; GO:0007265; GO:0008270; GO:0018024; GO:0090309; GO:1990841	positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN5082_c0_g1_i1	Q9CWR2	SMYD3_MOUSE	35.3	258	151	5	1697	939	20	266	1.10E-38	162.9	SMYD3_MOUSE	reviewed	Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)	Smyd3 Zmynd1	Mus musculus (Mouse)	428	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]	GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0034968; GO:0045184; GO:0045944; GO:0046872; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i8	Q6NRE8	SUV91_XENLA	44.1	145	58	4	452	18	300	421	2.90E-26	119.8	SUV91_XENLA	reviewed	Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1)	suv39h1	Xenopus laevis (African clawed frog)	421	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0018024; GO:0030154	cell cycle [GO:0007049]; cell differentiation [GO:0030154]		NA	NA	NA	NA	NA	NA
TRINITY_DN39858_c0_g1_i1	Q9H5I1	SUV92_HUMAN	100	81	0	0	3	245	268	348	4.60E-41	167.9	SUV92_HUMAN	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	SUV39H2 KMT1B	Homo sapiens (Human)	410	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; S-adenosyl-L-methionine binding [GO:1904047]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; S-adenosyl-L-methionine binding [GO:1904047]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000775; GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006333; GO:0006338; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0036123; GO:0036124; GO:0042754; GO:0045892; GO:0046974; GO:0048511; GO:0071456; GO:1904047	"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36520_c0_g1_i1	Q9EQQ0	SUV92_MOUSE	97.3	73	2	0	220	2	316	388	4.00E-36	151.4	SUV92_MOUSE	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	Suv39h2	Mus musculus (Mouse)	477	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; protein methyltransferase activity [GO:0008276]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; S-adenosyl-L-methionine binding [GO:1904047]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 methylation [GO:0051567]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; male meiotic nuclear division [GO:0007140]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]"	chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; methyltransferase activity [GO:0008168]; protein methyltransferase activity [GO:0008276]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; S-adenosyl-L-methionine binding [GO:1904047]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000775; GO:0000785; GO:0000976; GO:0000977; GO:0003682; GO:0005634; GO:0005720; GO:0006333; GO:0006338; GO:0007140; GO:0008168; GO:0008270; GO:0008276; GO:0018024; GO:0030154; GO:0034968; GO:0036123; GO:0036124; GO:0042754; GO:0045892; GO:0046974; GO:0048511; GO:0051567; GO:0071456; GO:1904047	"cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 methylation [GO:0051567]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; male meiotic nuclear division [GO:0007140]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i1	Q28CQ7	SUV92_XENTR	45.5	55	30	0	455	291	116	170	5.60E-06	53.1	SUV92_XENTR	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	suv39h2 TEgg055l20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i2	Q28CQ7	SUV92_XENTR	47.2	290	116	5	881	24	148	404	7.30E-70	266.2	SUV92_XENTR	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	suv39h2 TEgg055l20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i2	Q28CQ7	SUV92_XENTR	45.5	55	30	0	1068	904	116	170	9.70E-06	53.1	SUV92_XENTR	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	suv39h2 TEgg055l20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i4	Q28CQ7	SUV92_XENTR	45.5	55	30	0	455	291	116	170	3.90E-06	53.1	SUV92_XENTR	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	suv39h2 TEgg055l20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i5	Q28CQ7	SUV92_XENTR	52.9	223	73	3	692	24	214	404	2.50E-61	236.9	SUV92_XENTR	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	suv39h2 TEgg055l20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]		NA	NA	NA	NA	NA	NA
TRINITY_DN315_c0_g1_i6	Q28CQ7	SUV92_XENTR	49.1	322	131	4	989	24	116	404	1.60E-83	311.6	SUV92_XENTR	reviewed	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	suv39h2 TEgg055l20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]		NA	NA	NA	NA	NA	NA
TRINITY_DN3468_c1_g1_i1	Q9W5E0	SUV42_DROME	66.1	224	75	1	147	818	147	369	2.10E-85	317	SUV42_DROME	reviewed	Histone-lysine N-methyltransferase Suv4-20 (EC 2.1.1.361) (EC 2.1.1.362) (Suppressor of variegation 4-20) (Su(var)4-20)	Hmt4-20 Suv4-20 CG13363	Drosophila melanogaster (Fruit fly)	1300	"nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; chromatin silencing [GO:0006342]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 methylation [GO:0034770]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; regulation of gene expression, epigenetic [GO:0040029]"	nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]	histone methyltransferase activity (H4-K20 specific) [GO:0042799]	GO:0005634; GO:0005720; GO:0006342; GO:0016571; GO:0034770; GO:0034772; GO:0034773; GO:0040029; GO:0042799	"chromatin silencing [GO:0006342]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 methylation [GO:0034770]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; regulation of gene expression, epigenetic [GO:0040029]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3468_c1_g1_i2	Q9W5E0	SUV42_DROME	62.7	193	71	1	147	725	147	338	9.60E-69	261.5	SUV42_DROME	reviewed	Histone-lysine N-methyltransferase Suv4-20 (EC 2.1.1.361) (EC 2.1.1.362) (Suppressor of variegation 4-20) (Su(var)4-20)	Hmt4-20 Suv4-20 CG13363	Drosophila melanogaster (Fruit fly)	1300	"nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; chromatin silencing [GO:0006342]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 methylation [GO:0034770]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; regulation of gene expression, epigenetic [GO:0040029]"	nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]	histone methyltransferase activity (H4-K20 specific) [GO:0042799]	GO:0005634; GO:0005720; GO:0006342; GO:0016571; GO:0034770; GO:0034772; GO:0034773; GO:0040029; GO:0042799	"chromatin silencing [GO:0006342]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 methylation [GO:0034770]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; regulation of gene expression, epigenetic [GO:0040029]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4132_c0_g1_i1	Q24742	TRX_DROVI	54.2	319	107	3	899	42	3516	3828	1.80E-96	354	TRX_DROVI	reviewed	Histone-lysine N-methyltransferase trithorax (EC 2.1.1.355)	trx	Drosophila virilis (Fruit fly)	3828	histone methyltransferase complex [GO:0035097]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	histone methyltransferase complex [GO:0035097]	DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0007275; GO:0008270; GO:0035097; GO:0042800; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN4132_c0_g1_i2	Q24742	TRX_DROVI	53.4	341	120	3	965	42	3494	3828	1.20E-102	375.6	TRX_DROVI	reviewed	Histone-lysine N-methyltransferase trithorax (EC 2.1.1.355)	trx	Drosophila virilis (Fruit fly)	3828	histone methyltransferase complex [GO:0035097]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	histone methyltransferase complex [GO:0035097]	DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0007275; GO:0008270; GO:0035097; GO:0042800; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN6476_c0_g1_i1	Q24742	TRX_DROVI	45.5	88	43	2	1	252	3719	3805	6.10E-12	71.2	TRX_DROVI	reviewed	Histone-lysine N-methyltransferase trithorax (EC 2.1.1.355)	trx	Drosophila virilis (Fruit fly)	3828	histone methyltransferase complex [GO:0035097]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	histone methyltransferase complex [GO:0035097]	DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0007275; GO:0008270; GO:0035097; GO:0042800; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8616_c0_g1_i2	Q24742	TRX_DROVI	22.6	1148	440	22	3337	119	1220	1993	4.70E-78	294.7	TRX_DROVI	reviewed	Histone-lysine N-methyltransferase trithorax (EC 2.1.1.355)	trx	Drosophila virilis (Fruit fly)	3828	histone methyltransferase complex [GO:0035097]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	histone methyltransferase complex [GO:0035097]	DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0007275; GO:0008270; GO:0035097; GO:0042800; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN4132_c0_g1_i4	P20659	TRX_DROME	34.6	188	79	3	499	50	3385	3566	7.80E-25	116.7	TRX_DROME	reviewed	Histone-lysine N-methyltransferase trithorax (EC 2.1.1.355) (Lysine N-methyltransferase 2A)	trx KMT2A CG8651	Drosophila melanogaster (Fruit fly)	3726	"histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; eye development [GO:0001654]; germ cell migration [GO:0008354]; haltere development [GO:0007482]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]"	histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; transcription elongation factor complex [GO:0008023]	chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000123; GO:0001654; GO:0003682; GO:0003700; GO:0005634; GO:0005700; GO:0005704; GO:0007482; GO:0007507; GO:0008023; GO:0008157; GO:0008270; GO:0008354; GO:0016571; GO:0016573; GO:0032968; GO:0035097; GO:0042800; GO:0042802; GO:0042803; GO:0043565; GO:0043966; GO:0044665; GO:0045893; GO:0045944; GO:0051568	"eye development [GO:0001654]; germ cell migration [GO:0008354]; haltere development [GO:0007482]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2845_c0_g1_i1	Q8IRW8	TRR_DROME	34.3	1023	462	28	337	3015	1355	2297	5.90E-133	476.9	TRR_DROME	reviewed	Histone-lysine N-methyltransferase trr (EC 2.1.1.354) (Lysine N-methyltransferase 2C) (Trithorax-related protein)	trr KMT2C CG3848	Drosophila melanogaster (Fruit fly)	2431	"MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; core promoter sequence-specific DNA binding [GO:0001046]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]"	MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]	core promoter sequence-specific DNA binding [GO:0001046]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]	GO:0001046; GO:0003713; GO:0005102; GO:0005634; GO:0005700; GO:0005703; GO:0007458; GO:0016571; GO:0035075; GO:0042393; GO:0042800; GO:0044666; GO:0045893; GO:0045944; GO:0046872; GO:0048749; GO:0051568; GO:1900114	"compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2845_c0_g1_i2	Q8IRW8	TRR_DROME	39.2	1157	492	29	337	3414	1355	2431	8.20E-200	699.1	TRR_DROME	reviewed	Histone-lysine N-methyltransferase trr (EC 2.1.1.354) (Lysine N-methyltransferase 2C) (Trithorax-related protein)	trr KMT2C CG3848	Drosophila melanogaster (Fruit fly)	2431	"MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; core promoter sequence-specific DNA binding [GO:0001046]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]"	MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]	core promoter sequence-specific DNA binding [GO:0001046]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]	GO:0001046; GO:0003713; GO:0005102; GO:0005634; GO:0005700; GO:0005703; GO:0007458; GO:0016571; GO:0035075; GO:0042393; GO:0042800; GO:0044666; GO:0045893; GO:0045944; GO:0046872; GO:0048749; GO:0051568; GO:1900114	"compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32797_c0_g1_i2	Q8INR6	DOT1L_DROME	44.6	271	130	6	824	39	593	852	3.30E-46	186.8	DOT1L_DROME	reviewed	"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (dDOT1L) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Protein grappa)"	gpp CG10272	Drosophila melanogaster (Fruit fly)	1848	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]"	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K79 specific) [GO:0031151]	GO:0000077; GO:0000781; GO:0005634; GO:0006281; GO:0006342; GO:0006348; GO:0016571; GO:0031151; GO:0034729; GO:0035097; GO:0048096; GO:2000677	chromatin-mediated maintenance of transcription [GO:0048096]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]		NA	NA	NA	NA	NA	NA
TRINITY_DN11125_c0_g1_i1	Q8INR6	DOT1L_DROME	75	188	47	0	1	564	124	311	9.50E-82	304.3	DOT1L_DROME	reviewed	"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (dDOT1L) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Protein grappa)"	gpp CG10272	Drosophila melanogaster (Fruit fly)	1848	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]"	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K79 specific) [GO:0031151]	GO:0000077; GO:0000781; GO:0005634; GO:0006281; GO:0006342; GO:0006348; GO:0016571; GO:0031151; GO:0034729; GO:0035097; GO:0048096; GO:2000677	chromatin-mediated maintenance of transcription [GO:0048096]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]		NA	NA	NA	NA	NA	NA
TRINITY_DN11125_c0_g1_i2	Q8INR6	DOT1L_DROME	66.7	84	28	0	1	252	124	207	1.20E-27	123.6	DOT1L_DROME	reviewed	"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (dDOT1L) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Protein grappa)"	gpp CG10272	Drosophila melanogaster (Fruit fly)	1848	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]"	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K79 specific) [GO:0031151]	GO:0000077; GO:0000781; GO:0005634; GO:0006281; GO:0006342; GO:0006348; GO:0016571; GO:0031151; GO:0034729; GO:0035097; GO:0048096; GO:2000677	chromatin-mediated maintenance of transcription [GO:0048096]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]		NA	NA	NA	NA	NA	NA
TRINITY_DN2196_c5_g1_i1	Q8INR6	DOT1L_DROME	80.6	36	7	0	182	75	291	326	3.50E-11	68.6	DOT1L_DROME	reviewed	"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (dDOT1L) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Protein grappa)"	gpp CG10272	Drosophila melanogaster (Fruit fly)	1848	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]"	"chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]"	histone methyltransferase activity (H3-K79 specific) [GO:0031151]	GO:0000077; GO:0000781; GO:0005634; GO:0006281; GO:0006342; GO:0006348; GO:0016571; GO:0031151; GO:0034729; GO:0035097; GO:0048096; GO:2000677	chromatin-mediated maintenance of transcription [GO:0048096]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone H3-K79 methylation [GO:0034729]; histone methylation [GO:0016571]; regulation of transcription regulatory region DNA binding [GO:2000677]		NA	NA	NA	NA	NA	NA
TRINITY_DN40299_c0_g1_i1	Q90655	AKR_CHICK	94.7	95	5	0	287	3	13	107	2.30E-47	189.1	AKR_CHICK	reviewed	Homeobox protein AKR (Avian knotted-related protein)		Gallus gallus (Chicken)	269	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39076_c0_g1_i1	P10180	CUT_DROME	48.3	58	17	1	256	122	1974	2031	2.20E-05	49.7	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39076_c0_g1_i2	P10180	CUT_DROME	48.3	58	17	1	257	123	1974	2031	2.20E-05	49.7	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2577_c0_g1_i1	P10180	CUT_DROME	68.6	86	27	0	177	434	1281	1366	4.40E-26	119	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2577_c0_g1_i2	P10180	CUT_DROME	61.8	102	35	1	210	515	1269	1366	1.20E-25	117.9	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6343_c0_g2_i1	P10180	CUT_DROME	50.9	214	83	3	1	594	1651	1858	7.60E-46	185.3	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6343_c0_g1_i1	P10180	CUT_DROME	85.7	49	7	0	146	292	1603	1651	1.40E-15	83.6	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6343_c0_g1_i2	P10180	CUT_DROME	85.7	49	7	0	86	232	1603	1651	8.30E-16	84	CUT_DROME	reviewed	Homeobox protein cut	ct CG11387	Drosophila melanogaster (Fruit fly)	2175	"Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"	Golgi membrane [GO:0000139]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007417; GO:0007422; GO:0007424; GO:0007443; GO:0007469; GO:0007605; GO:0008585; GO:0008587; GO:0035277; GO:0048098; GO:0048193; GO:0048477; GO:0048813; GO:0060288; GO:0061332; GO:0070983	"antennal development [GO:0007469]; antennal joint development [GO:0048098]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; female gonad development [GO:0008585]; formation of a compartment boundary [GO:0060288]; Golgi vesicle transport [GO:0048193]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Malpighian tubule bud morphogenesis [GO:0061332]; Malpighian tubule morphogenesis [GO:0007443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; spiracle morphogenesis, open tracheal system [GO:0035277]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26688_c0_g1_i1	P21711	MIX1_XENLA	36.2	80	44	1	255	37	75	154	5.10E-05	48.9	MIX1_XENLA	reviewed	Homeobox protein Mix.1	mix-a mix1	Xenopus laevis (African clawed frog)	377	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0001103; GO:0005634; GO:0007275; GO:0043565; GO:0045893	"multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35716_c0_g1_i1	O95343	SIX3_HUMAN	52.4	105	45	2	1	306	74	176	1.10E-20	100.5	SIX3_HUMAN	reviewed	Homeobox protein SIX3 (Sine oculis homeobox homolog 3)	SIX3	Homo sapiens (Human)	332	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription corepressor binding [GO:0001222]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; circadian behavior [GO:0048512]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; lens induction in camera-type eye [GO:0060235]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; protein import into nucleus [GO:0006606]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; visual perception [GO:0007601]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription corepressor binding [GO:0001222]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001228; GO:0001654; GO:0002070; GO:0002088; GO:0003404; GO:0005102; GO:0005634; GO:0005667; GO:0006606; GO:0007420; GO:0007601; GO:0009946; GO:0014016; GO:0021537; GO:0021797; GO:0021798; GO:0021846; GO:0021978; GO:0021983; GO:0030178; GO:0042127; GO:0042826; GO:0045665; GO:0045892; GO:0048512; GO:0048856; GO:0060235; GO:0061074; GO:0070306; GO:0097402; GO:1901987; GO:1902692; GO:1902742; GO:1990086; GO:1990837; GO:2000177	"anatomical structure development [GO:0048856]; apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; circadian behavior [GO:0048512]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; lens induction in camera-type eye [GO:0060235]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; protein import into nucleus [GO:0006606]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27008_c0_g1_i1	P70284	TGIF1_MOUSE	100	93	0	0	279	1	39	131	6.20E-48	191	TGIF1_MOUSE	reviewed	Homeobox protein TGIF1 (5'-TG-3'-interacting factor 1)	Tgif1 Tgif	Mus musculus (Mouse)	272	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; JUN kinase binding [GO:0008432]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; nodal signaling pathway [GO:0038092]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; JUN kinase binding [GO:0008432]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001843; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0007368; GO:0008285; GO:0008432; GO:0009953; GO:0010470; GO:0010629; GO:0038092; GO:0045666; GO:0048146; GO:0048387; GO:0060041; GO:0070410; GO:1990837	determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; nodal signaling pathway [GO:0038092]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN33860_c0_g1_i1	Q9GZN2	TGIF2_HUMAN	98.9	89	1	0	268	2	1	89	1.60E-45	183	TGIF2_HUMAN	reviewed	Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2) (TGFB-induced factor 2)	TGIF2	Homo sapiens (Human)	237	"centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0010470; GO:0038092; GO:0045666; GO:0060041; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37239_c0_g1_i1	Q9GZN2	TGIF2_HUMAN	60.5	43	17	0	287	159	62	104	4.90E-10	65.1	TGIF2_HUMAN	reviewed	Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2) (TGFB-induced factor 2)	TGIF2	Homo sapiens (Human)	237	"centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0010470; GO:0038092; GO:0045666; GO:0060041; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34665_c0_g1_i1	Q28ZA9	UNPG_DROPS	70.1	67	17	2	274	77	365	429	2.60E-16	85.9	UNPG_DROPS	reviewed	Homeobox protein unplugged	unpg GA14073	Drosophila pseudoobscura pseudoobscura (Fruit fly)	491	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; regulation of nervous system development [GO:0051960]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007420; GO:0051960	"brain development [GO:0007420]; regulation of nervous system development [GO:0051960]; regulation of transcription, DNA-templated [GO:0006355]"		brown	brown	1	NA	NA	NA
TRINITY_DN14005_c0_g2_i1	Q9WUM7	HIPK2_MESAU	53.4	760	256	16	95	2275	118	812	1.50E-195	684.5	HIPK2_MESAU	reviewed	Homeodomain-interacting protein kinase 2 (EC 2.7.11.1) (Mx-interacting protein kinase) (PKM)	Hipk2	Mesocricetus auratus (Golden hamster)	1168	cytoplasm [GO:0005737]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]	cytoplasm [GO:0005737]; PML body [GO:0016605]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0006974; GO:0016605	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN30956_c0_g1_i1	Q9H422	HIPK3_HUMAN	100	81	0	0	247	5	182	262	9.30E-42	170.2	HIPK3_HUMAN	reviewed	Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1)	HIPK3 DYRK6 FIST3 PKY	Homo sapiens (Human)	1215	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0009299; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0043066; GO:0043508	apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN40379_c0_g1_i1	P02833	ANTP_DROME	94.2	69	4	0	37	243	296	364	2.40E-30	132.5	ANTP_DROME	reviewed	Homeotic protein antennapedia	Antp CG1028	Drosophila melanogaster (Fruit fly)	378	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; heart development [GO:0007507]; lymph gland development [GO:0048542]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, thorax [GO:0007384]; ventral cord development [GO:0007419]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0007383; GO:0007384; GO:0007419; GO:0007494; GO:0007507; GO:0009948; GO:0009952; GO:0014019; GO:0042694; GO:0043565; GO:0045944; GO:0048542; GO:0050767	"anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; heart development [GO:0007507]; lymph gland development [GO:0048542]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, thorax [GO:0007384]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24845_c0_g1_i2	P18488	EMS_DROME	87	54	5	2	73	228	379	432	8.20E-16	84	EMS_DROME	reviewed	Homeotic protein empty spiracles	ems E4 CG2988	Drosophila melanogaster (Fruit fly)	497	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000978; GO:0000981; GO:0001700; GO:0005634; GO:0006357; GO:0007389; GO:0007409; GO:0007419; GO:0007420; GO:0007424; GO:0010468; GO:0014019; GO:0030154; GO:0035277; GO:0035284; GO:0035288; GO:0048813	"anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24845_c0_g1_i3	P18488	EMS_DROME	73.5	83	18	1	197	445	354	432	7.70E-26	118.2	EMS_DROME	reviewed	Homeotic protein empty spiracles	ems E4 CG2988	Drosophila melanogaster (Fruit fly)	497	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000978; GO:0000981; GO:0001700; GO:0005634; GO:0006357; GO:0007389; GO:0007409; GO:0007419; GO:0007420; GO:0007424; GO:0010468; GO:0014019; GO:0030154; GO:0035277; GO:0035284; GO:0035288; GO:0048813	"anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN919_c0_g1_i1	P13709	FSH_DROME	73.7	152	40	0	195	650	5	156	5.60E-66	252.3	FSH_DROME	reviewed	Homeotic protein female sterile (Fragile-chorion membrane protein)	fs(1)h fsh CG2252	Drosophila melanogaster (Fruit fly)	2038	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0007362; GO:0016021; GO:0032968; GO:0045892; GO:0048813	"dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"		blue	blue	NA	NA	NA	NA
TRINITY_DN919_c0_g1_i2	P13709	FSH_DROME	73.7	152	40	0	157	612	5	156	5.30E-66	252.3	FSH_DROME	reviewed	Homeotic protein female sterile (Fragile-chorion membrane protein)	fs(1)h fsh CG2252	Drosophila melanogaster (Fruit fly)	2038	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0007362; GO:0016021; GO:0032968; GO:0045892; GO:0048813	"dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"		blue	blue	NA	NA	NA	NA
TRINITY_DN919_c0_g1_i3	P13709	FSH_DROME	73.7	152	40	0	153	608	5	156	5.30E-66	252.3	FSH_DROME	reviewed	Homeotic protein female sterile (Fragile-chorion membrane protein)	fs(1)h fsh CG2252	Drosophila melanogaster (Fruit fly)	2038	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0007362; GO:0016021; GO:0032968; GO:0045892; GO:0048813	"dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28619_c0_g1_i1	P13709	FSH_DROME	85.6	90	13	0	272	3	482	571	1.60E-42	172.9	FSH_DROME	reviewed	Homeotic protein female sterile (Fragile-chorion membrane protein)	fs(1)h fsh CG2252	Drosophila melanogaster (Fruit fly)	2038	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0007362; GO:0016021; GO:0032968; GO:0045892; GO:0048813	"dendrite morphogenesis [GO:0048813]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; terminal region determination [GO:0007362]"		blue	blue	NA	NA	NA	NA
TRINITY_DN40770_c0_g1_i1	P39770	SALM_DROME	44	50	28	0	200	51	452	501	2.00E-06	52.8	SALM_DROME	reviewed	Homeotic protein spalt-major	salm sal CG6464	Drosophila melanogaster (Fruit fly)	1365	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; antennal joint development [GO:0048098]; compound eye photoreceptor cell differentiation [GO:0001751]; glial cell development [GO:0021782]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; muscle organ morphogenesis [GO:0048644]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; notum cell fate specification [GO:0035310]; oenocyte development [GO:0007438]; open tracheal system development [GO:0007424]; R7 cell differentiation [GO:0045466]; R8 cell differentiation [GO:0045465]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; somatic muscle development [GO:0007525]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000381; GO:0000976; GO:0000981; GO:0001751; GO:0005634; GO:0006355; GO:0006357; GO:0007423; GO:0007424; GO:0007438; GO:0007525; GO:0007605; GO:0008584; GO:0008586; GO:0021782; GO:0030539; GO:0035155; GO:0035202; GO:0035277; GO:0035310; GO:0042659; GO:0045465; GO:0045466; GO:0046872; GO:0048098; GO:0048644	"antennal joint development [GO:0048098]; compound eye photoreceptor cell differentiation [GO:0001751]; glial cell development [GO:0021782]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; muscle organ morphogenesis [GO:0048644]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; notum cell fate specification [GO:0035310]; oenocyte development [GO:0007438]; open tracheal system development [GO:0007424]; R7 cell differentiation [GO:0045466]; R8 cell differentiation [GO:0045465]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell fate specification [GO:0042659]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; somatic muscle development [GO:0007525]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31213_c0_g1_i1	P83949	UBX_DROME	92.3	52	2	1	152	3	283	334	8.20E-20	97.1	UBX_DROME	reviewed	Homeotic protein ultrabithorax	Ubx CG10388	Drosophila melanogaster (Fruit fly)	389	"nucleus [GO:0005634]; polytene chromosome band [GO:0005704]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; anterior Malpighian tubule development [GO:0061327]; anterior/posterior pattern specification [GO:0009952]; cell fate determination [GO:0001709]; dorsal vessel aortic cell fate commitment [GO:0035052]; endoderm formation [GO:0001706]; haltere development [GO:0007482]; heart development [GO:0007507]; imaginal disc-derived leg morphogenesis [GO:0007480]; mesodermal cell fate specification [GO:0007501]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of gene silencing [GO:0060969]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; open tracheal system development [GO:0007424]; positive regulation of muscle organ development [GO:0048636]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of imaginal disc growth [GO:0045570]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]; specification of animal organ identity [GO:0010092]; specification of segmental identity, thorax [GO:0007384]"	nucleus [GO:0005634]; polytene chromosome band [GO:0005704]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]"	GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001221; GO:0001706; GO:0001709; GO:0003677; GO:0005634; GO:0005667; GO:0005704; GO:0006355; GO:0007384; GO:0007424; GO:0007480; GO:0007482; GO:0007494; GO:0007501; GO:0007507; GO:0007525; GO:0009952; GO:0010092; GO:0017053; GO:0019904; GO:0032993; GO:0035052; GO:0042659; GO:0042694; GO:0043565; GO:0045570; GO:0045892; GO:0045893; GO:0048636; GO:0060969; GO:0061327	"anterior/posterior pattern specification [GO:0009952]; anterior Malpighian tubule development [GO:0061327]; cell fate determination [GO:0001709]; dorsal vessel aortic cell fate commitment [GO:0035052]; endoderm formation [GO:0001706]; haltere development [GO:0007482]; heart development [GO:0007507]; imaginal disc-derived leg morphogenesis [GO:0007480]; mesodermal cell fate specification [GO:0007501]; midgut development [GO:0007494]; muscle cell fate specification [GO:0042694]; negative regulation of gene silencing [GO:0060969]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of muscle organ development [GO:0048636]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of imaginal disc growth [GO:0045570]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]; specification of animal organ identity [GO:0010092]; specification of segmental identity, thorax [GO:0007384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38604_c0_g1_i1	O88801	HOME2_RAT	49	102	48	1	659	354	162	259	4.30E-18	93.2	HOME2_RAT	reviewed	Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2)	Homer2 Vesl2	Rattus norvegicus (Rat)	354	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]	actin binding [GO:0003779]; glutamate receptor binding [GO:0035254]; G protein-coupled glutamate receptor binding [GO:0035256]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; synaptic receptor adaptor activity [GO:0030160]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0035584; GO:0042802; GO:0043005; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0048875; GO:0070885; GO:0098978; GO:2001256	behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN38604_c0_g1_i2	O88801	HOME2_RAT	45.5	88	44	1	617	354	176	259	1.40E-12	74.7	HOME2_RAT	reviewed	Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2)	Homer2 Vesl2	Rattus norvegicus (Rat)	354	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]	actin binding [GO:0003779]; glutamate receptor binding [GO:0035254]; G protein-coupled glutamate receptor binding [GO:0035256]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; synaptic receptor adaptor activity [GO:0030160]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0035584; GO:0042802; GO:0043005; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0048875; GO:0070885; GO:0098978; GO:2001256	behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN4638_c0_g1_i3	O31463	HMT_BACSU	39.7	247	126	7	2	730	85	312	9.50E-35	148.7	HMT_BACSU	reviewed	Homocysteine S-methyltransferase YbgG (EC 2.1.1.10) (S-methylmethionine:homocysteine methyltransferase)	ybgG BSU02410	Bacillus subtilis (strain 168)	315	betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; S-methylmethionine cycle [GO:0033528]		betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]	GO:0008270; GO:0008898; GO:0009086; GO:0032259; GO:0033528; GO:0047150	methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; S-methylmethionine cycle [GO:0033528]		NA	NA	NA	NA	NA	NA
TRINITY_DN36581_c0_g1_i1	Q9VKJ0	HGD_DROME	75.2	141	35	0	515	93	294	434	4.50E-63	242.3	HGD_DROME	reviewed	"Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	hgo CG4779	Drosophila melanogaster (Fruit fly)	439	"cytoplasm [GO:0005737]; homogentisate 1,2-dioxygenase activity [GO:0004411]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"	cytoplasm [GO:0005737]	"homogentisate 1,2-dioxygenase activity [GO:0004411]; metal ion binding [GO:0046872]"	GO:0004411; GO:0005737; GO:0006520; GO:0006559; GO:0006572; GO:0046872	cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN34416_c0_g1_i1	B2UJ73	HGD_RALPJ	97.2	72	2	0	220	5	244	315	6.20E-37	154.1	HGD_RALPJ	reviewed	"Homogentisate 1,2-dioxygenase (HGDO) (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	hmgA Rpic_4534	Ralstonia pickettii (strain 12J)	448	"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"		"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]"	GO:0004411; GO:0005506; GO:0006559; GO:0006572	L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN2517_c0_g1_i1	B7VA96	HGD_PSEA8	73.9	69	17	1	1	204	291	359	1.50E-24	112.8	HGD_PSEA8	reviewed	"Homogentisate 1,2-dioxygenase (HGDO) (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	hmgA PLES_33141	Pseudomonas aeruginosa (strain LESB58)	432	"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"		"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]"	GO:0004411; GO:0005506; GO:0006559; GO:0006572	L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN23701_c0_g1_i1	Q9A5B8	HGD_CAUVC	79.7	69	14	0	5	211	235	303	1.80E-28	125.9	HGD_CAUVC	reviewed	"Homogentisate 1,2-dioxygenase (HGDO) (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	hmgA CC_2532	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	425	"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"		"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]"	GO:0004411; GO:0005506; GO:0006559; GO:0006572	L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN8158_c0_g1_i1	B0T816	HGD_CAUSK	79.7	79	16	0	244	8	292	370	8.50E-35	147.1	HGD_CAUSK	reviewed	"Homogentisate 1,2-dioxygenase (HGDO) (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	hmgA Caul_3652	Caulobacter sp. (strain K31)	427	"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"		"homogentisate 1,2-dioxygenase activity [GO:0004411]; iron ion binding [GO:0005506]"	GO:0004411; GO:0005506; GO:0006559; GO:0006572	L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN32777_c0_g1_i1	Q63ZL2	HOP2_XENLA	37.7	154	79	3	445	35	1	154	1.10E-18	94.7	HOP2_XENLA	reviewed	Homologous-pairing protein 2 homolog (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein)	psmc3ip	Xenopus laevis (African clawed frog)	214	nucleus [GO:0005634]; reciprocal meiotic recombination [GO:0007131]	nucleus [GO:0005634]		GO:0005634; GO:0007131	reciprocal meiotic recombination [GO:0007131]		NA	NA	NA	NA	NA	NA
TRINITY_DN32777_c0_g1_i2	Q63ZL2	HOP2_XENLA	42	212	120	2	689	63	1	212	2.10E-39	164.1	HOP2_XENLA	reviewed	Homologous-pairing protein 2 homolog (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein)	psmc3ip	Xenopus laevis (African clawed frog)	214	nucleus [GO:0005634]; reciprocal meiotic recombination [GO:0007131]	nucleus [GO:0005634]		GO:0005634; GO:0007131	reciprocal meiotic recombination [GO:0007131]		NA	NA	NA	NA	NA	NA
TRINITY_DN28794_c0_g1_i1	O35047	HOP2_MOUSE	100	49	0	0	68	214	46	94	1.00E-20	100.1	HOP2_MOUSE	reviewed	Homologous-pairing protein 2 homolog (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein) (Tat-binding protein 1-interacting protein) (TBP-1-interacting protein)	Psmc3ip Hop2 Tbpip	Mus musculus (Mouse)	217	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reciprocal meiotic recombination [GO:0007131]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]	GO:0003677; GO:0005634; GO:0005654; GO:0007131; GO:0030331; GO:0030374; GO:0035259; GO:0044877; GO:0045944; GO:0046966; GO:0050681; GO:0050692	positive regulation of transcription by RNA polymerase II [GO:0045944]; reciprocal meiotic recombination [GO:0007131]		NA	NA	NA	NA	NA	NA
TRINITY_DN25502_c0_g1_i1	Q9W539	HR4_DROME	66.1	174	34	6	470	3	844	1010	1.20E-57	224.2	HR4_DROME	reviewed	Hormone receptor 4 (dHR4) (Nuclear receptor subfamily 6 group A member 2)	Hr4 NR6A2 CG43934	Drosophila melanogaster (Fruit fly)	1518	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; negative regulation of ecdysone receptor-mediated signaling pathway [GO:0120143]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of multicellular organism growth [GO:0040018]; regulation of developmental growth [GO:0048638]; regulation of pupariation [GO:0106023]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]	GO:0000790; GO:0000978; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0040018; GO:0045892; GO:0048638; GO:0071456; GO:0106023; GO:0120143	"cellular response to hypoxia [GO:0071456]; negative regulation of ecdysone receptor-mediated signaling pathway [GO:0120143]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of multicellular organism growth [GO:0040018]; regulation of developmental growth [GO:0048638]; regulation of pupariation [GO:0106023]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4236_c0_g1_i1	Q9V4C8	HCF_DROME	85.1	47	7	0	73	213	59	105	3.20E-18	92	HCF_DROME	reviewed	Host cell factor (dHcf) [Cleaved into: HCF N-terminal chain; HCF C-terminal chain]	Hcf CG1710	Drosophila melanogaster (Fruit fly)	1500	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone H4 acetylation [GO:0043967]; positive regulation of growth [GO:0045927]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0005634; GO:0005671; GO:0006338; GO:0006355; GO:0007049; GO:0016573; GO:0035097; GO:0043966; GO:0043967; GO:0044665; GO:0044666; GO:0045893; GO:0045927; GO:0048188; GO:0051568	"cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone H4 acetylation [GO:0043967]; positive regulation of growth [GO:0045927]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4236_c0_g1_i2	P51610	HCFC1_HUMAN	72.3	303	81	2	66	968	107	408	5.10E-139	495.4	HCFC1_HUMAN	reviewed	Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	HCFC1 HCF1 HFC1	Homo sapiens (Human)	2035	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0071407	"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4236_c0_g1_i3	P51610	HCFC1_HUMAN	73.9	345	87	2	100	1128	65	408	5.30E-164	578.6	HCFC1_HUMAN	reviewed	Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	HCFC1 HCF1 HFC1	Homo sapiens (Human)	2035	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0071407	"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4236_c0_g1_i4	P51610	HCFC1_HUMAN	73.6	402	101	3	49	1242	8	408	4.00E-189	662.1	HCFC1_HUMAN	reviewed	Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	HCFC1 HCF1 HFC1	Homo sapiens (Human)	2035	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0071407	"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33082_c0_g1_i1	P51610	HCFC1_HUMAN	100	90	0	0	271	2	70	159	2.50E-51	202.2	HCFC1_HUMAN	reviewed	Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	HCFC1 HCF1 HFC1	Homo sapiens (Human)	2035	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0071407	"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"		NA	NA	NA	NA	NA	NA
TRINITY_DN929_c0_g1_i1	Q61191	HCFC1_MOUSE	56.4	236	96	4	150	857	1817	2045	1.60E-67	257.7	HCFC1_MOUSE	reviewed	Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	Hcfc1	Mus musculus (Mouse)	2045	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA-type complex [GO:0070461]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA-type complex [GO:0070461]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005671; GO:0005737; GO:0006338; GO:0006355; GO:0007049; GO:0010628; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0062023; GO:0070461; GO:0071339; GO:0071407	"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"		NA	NA	NA	NA	NA	NA
TRINITY_DN929_c0_g1_i2	Q61191	HCFC1_MOUSE	56.2	240	94	4	150	869	1817	2045	9.70E-68	258.5	HCFC1_MOUSE	reviewed	Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	Hcfc1	Mus musculus (Mouse)	2045	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA-type complex [GO:0070461]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA-type complex [GO:0070461]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005671; GO:0005737; GO:0006338; GO:0006355; GO:0007049; GO:0010628; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0062023; GO:0070461; GO:0071339; GO:0071407	"blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39733_c0_g1_i1	Q9Y5Z7	HCFC2_HUMAN	100	83	0	0	1	249	218	300	2.20E-46	185.7	HCFC2_HUMAN	reviewed	Host cell factor 2 (HCF-2) (C2 factor)	HCFC2	Homo sapiens (Human)	792	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	transcription coactivator activity [GO:0003713]	GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0016032; GO:0016604; GO:0035097; GO:0071339	"chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5041_c0_g1_i1	Q9U1N0	HRP65_CHITE	53.4	178	79	2	184	708	85	261	1.80E-46	187.6	HRP65_CHITE	reviewed	Hrp65 protein (Ct-Hrp65)	HRP65	Chironomus tentans (Midge) (Camptochironomus tentans)	535	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005856; GO:0006406	mRNA export from nucleus [GO:0006406]		NA	NA	NA	NA	NA	NA
TRINITY_DN5041_c0_g1_i2	Q9U1N0	HRP65_CHITE	53.2	237	107	2	184	882	85	321	1.10E-65	251.9	HRP65_CHITE	reviewed	Hrp65 protein (Ct-Hrp65)	HRP65	Chironomus tentans (Midge) (Camptochironomus tentans)	535	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005856; GO:0006406	mRNA export from nucleus [GO:0006406]		NA	NA	NA	NA	NA	NA
TRINITY_DN5041_c0_g1_i3	Q9U1N0	HRP65_CHITE	53.2	237	107	2	184	882	85	321	1.10E-65	251.9	HRP65_CHITE	reviewed	Hrp65 protein (Ct-Hrp65)	HRP65	Chironomus tentans (Midge) (Camptochironomus tentans)	535	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005856; GO:0006406	mRNA export from nucleus [GO:0006406]		NA	NA	NA	NA	NA	NA
TRINITY_DN28318_c0_g1_i1	Q99L47	F10A1_MOUSE	50.2	215	103	1	634	2	9	223	4.20E-41	169.5	F10A1_MOUSE	reviewed	Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog)	St13 Fam10a1 Hip	Mus musculus (Mouse)	371	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; dATP binding [GO:0032564]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; negative regulation of protein refolding [GO:0061084]; protein-containing complex assembly [GO:0065003]; response to bacterium [GO:0009617]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; dATP binding [GO:0032564]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; unfolded protein binding [GO:0051082]	GO:0005829; GO:0009617; GO:0019904; GO:0030544; GO:0031072; GO:0032564; GO:0032991; GO:0042802; GO:0044877; GO:0046983; GO:0051082; GO:0051085; GO:0051087; GO:0061077; GO:0061084; GO:0065003	chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; negative regulation of protein refolding [GO:0061084]; protein-containing complex assembly [GO:0065003]; response to bacterium [GO:0009617]		blue	blue	NA	NA	NA	NA
TRINITY_DN465_c1_g1_i1	Q99P31	HPBP1_MOUSE	36.1	313	186	5	1045	134	37	344	4.70E-43	176.8	HPBP1_MOUSE	reviewed	Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-interacting protein 1)	Hspbp1 Hspbp	Mus musculus (Mouse)	357	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]	adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]	GO:0000774; GO:0005737; GO:0005783; GO:0031398; GO:0031625; GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]		blue	blue	NA	NA	NA	NA
TRINITY_DN465_c1_g1_i2	Q99P31	HPBP1_MOUSE	36.1	313	186	5	1007	96	37	344	4.60E-43	176.8	HPBP1_MOUSE	reviewed	Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-interacting protein 1)	Hspbp1 Hspbp	Mus musculus (Mouse)	357	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]	adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]	GO:0000774; GO:0005737; GO:0005783; GO:0031398; GO:0031625; GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]		NA	NA	NA	NA	NA	NA
TRINITY_DN4337_c0_g1_i1	Q43468	HSOP1_SOYBN	37.5	128	74	3	809	438	380	505	1.40E-15	85.1	HSOP1_SOYBN	reviewed	Hsp70-Hsp90 organizing protein 1 (GmHop-1) (Heat shock protein STI) (GmSTI) (Stress-inducible protein)	HOP1 STI Glyma17g137700	Glycine max (Soybean) (Glycine hispida)	572	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; preprotein binding [GO:0070678]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; chaperone-mediated protein complex assembly [GO:0051131]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to wounding [GO:0009611]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	Hsp90 protein binding [GO:0051879]; preprotein binding [GO:0070678]	GO:0005634; GO:0005737; GO:0006986; GO:0009408; GO:0009611; GO:0034605; GO:0051131; GO:0051879; GO:0070417; GO:0070678	cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; chaperone-mediated protein complex assembly [GO:0051131]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to wounding [GO:0009611]		NA	NA	NA	NA	NA	NA
TRINITY_DN25463_c0_g1_i1	Q24740	CDC37_DROVI	54.1	338	149	2	72	1082	12	344	1.20E-92	341.7	CDC37_DROVI	reviewed	Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit)	Cdc37 GJ12421	Drosophila virilis (Fruit fly)	399	cytoplasm [GO:0005737]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]	cytoplasm [GO:0005737]	insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]	GO:0002052; GO:0005158; GO:0005737; GO:0019901; GO:0046628	positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]		NA	NA	NA	NA	NA	NA
TRINITY_DN25463_c0_g1_i2	Q24740	CDC37_DROVI	55.3	349	150	2	91	1134	1	344	3.00E-99	363.6	CDC37_DROVI	reviewed	Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit)	Cdc37 GJ12421	Drosophila virilis (Fruit fly)	399	cytoplasm [GO:0005737]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]	cytoplasm [GO:0005737]	insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]	GO:0002052; GO:0005158; GO:0005737; GO:0019901; GO:0046628	positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]		blue	blue	NA	NA	NA	NA
TRINITY_DN25463_c0_g1_i3	Q24740	CDC37_DROVI	59.8	244	97	1	285	1013	101	344	1.10E-81	305.1	CDC37_DROVI	reviewed	Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit)	Cdc37 GJ12421	Drosophila virilis (Fruit fly)	399	cytoplasm [GO:0005737]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]	cytoplasm [GO:0005737]	insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]	GO:0002052; GO:0005158; GO:0005737; GO:0019901; GO:0046628	positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]		NA	NA	NA	NA	NA	NA
TRINITY_DN25463_c0_g1_i3	Q24740	CDC37_DROVI	88.2	34	4	0	2	103	12	45	5.20E-10	67	CDC37_DROVI	reviewed	Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit)	Cdc37 GJ12421	Drosophila virilis (Fruit fly)	399	cytoplasm [GO:0005737]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]	cytoplasm [GO:0005737]	insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]	GO:0002052; GO:0005158; GO:0005737; GO:0019901; GO:0046628	positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]		NA	NA	NA	NA	NA	NA
TRINITY_DN37614_c0_g1_i1	O57476	CDC37_CHICK	98.2	56	1	0	83	250	1	56	2.30E-26	119.4	CDC37_CHICK	reviewed	Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37)	CDC37	Gallus gallus (Chicken)	393	cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0006457; GO:0019901; GO:0031072; GO:0050821; GO:0051082; GO:0051087	protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN33257_c0_g1_i1	Q61081	CDC37_MOUSE	100	93	0	0	280	2	278	370	2.00E-48	192.6	CDC37_MOUSE	reviewed	"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]"	Cdc37	Mus musculus (Mouse)	379	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HSP90-CDC37 chaperone complex [GO:1990565]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein kinase activity [GO:0045859]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HSP90-CDC37 chaperone complex [GO:1990565]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0005829; GO:0006457; GO:0008022; GO:0010608; GO:0019900; GO:0019901; GO:0031072; GO:0031435; GO:0032587; GO:0032991; GO:0043422; GO:0045859; GO:0050821; GO:0051082; GO:0051087; GO:0051879; GO:0060334; GO:0060338; GO:0097110; GO:0098779; GO:0101031; GO:1990565	positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein kinase activity [GO:0045859]; regulation of type I interferon-mediated signaling pathway [GO:0060338]		NA	NA	NA	NA	NA	NA
TRINITY_DN23396_c0_g1_i1	Q5EAC6	CDC37_BOVIN	100	92	0	0	50	325	165	256	1.80E-48	193	CDC37_BOVIN	reviewed	"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]"	CDC37	Bos taurus (Bovine)	380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; HSP90-CDC37 chaperone complex [GO:1990565]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; HSP90-CDC37 chaperone complex [GO:1990565]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005829; GO:0006457; GO:0010608; GO:0019887; GO:0019901; GO:0031072; GO:0050821; GO:0051082; GO:0051087; GO:0051879; GO:0060334; GO:0060338; GO:0097110; GO:0098779; GO:1990565	positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of type I interferon-mediated signaling pathway [GO:0060338]		NA	NA	NA	NA	NA	NA
TRINITY_DN23396_c0_g2_i1	Q16543	CDC37_HUMAN	100	113	0	0	341	3	250	362	1.20E-58	226.9	CDC37_HUMAN	reviewed	"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]"	CDC37 CDC37A	Homo sapiens (Human)	378	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; HSP90-CDC37 chaperone complex [GO:1990565]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]; ERBB2 signaling pathway [GO:0038128]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; HSP90-CDC37 chaperone complex [GO:1990565]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]	GO:0000079; GO:0005737; GO:0005829; GO:0006457; GO:0006605; GO:0010608; GO:0019887; GO:0019900; GO:0019901; GO:0031072; GO:0038128; GO:0050821; GO:0051082; GO:0051087; GO:0051879; GO:0060334; GO:0060338; GO:0070062; GO:0097110; GO:0098779; GO:0101031; GO:1990565	ERBB2 signaling pathway [GO:0038128]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of type I interferon-mediated signaling pathway [GO:0060338]		NA	NA	NA	NA	NA	NA
TRINITY_DN36093_c0_g1_i1	Q61081	CDC37_MOUSE	100	95	0	0	1	285	149	243	4.80E-50	198	CDC37_MOUSE	reviewed	"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]"	Cdc37	Mus musculus (Mouse)	379	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HSP90-CDC37 chaperone complex [GO:1990565]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein kinase activity [GO:0045859]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HSP90-CDC37 chaperone complex [GO:1990565]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0005829; GO:0006457; GO:0008022; GO:0010608; GO:0019900; GO:0019901; GO:0031072; GO:0031435; GO:0032587; GO:0032991; GO:0043422; GO:0045859; GO:0050821; GO:0051082; GO:0051087; GO:0051879; GO:0060334; GO:0060338; GO:0097110; GO:0098779; GO:0101031; GO:1990565	positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; posttranscriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein kinase activity [GO:0045859]; regulation of type I interferon-mediated signaling pathway [GO:0060338]		NA	NA	NA	NA	NA	NA
TRINITY_DN1501_c0_g1_i1	Q58CU3	HBAP1_BOVIN	40	290	157	6	178	1035	19	295	1.30E-54	215.7	HBAP1_BOVIN	reviewed	HSPB1-associated protein 1 (27 kDa heat shock protein-associated protein 1)	HSPBAP1	Bos taurus (Bovine)	484	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]	cytoplasm [GO:0005737]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]	GO:0005737; GO:0016706			blue	blue	NA	NA	NA	NA
TRINITY_DN1501_c0_g1_i2	Q58CU3	HBAP1_BOVIN	40	290	157	6	181	1038	19	295	1.30E-54	215.7	HBAP1_BOVIN	reviewed	HSPB1-associated protein 1 (27 kDa heat shock protein-associated protein 1)	HSPBAP1	Bos taurus (Bovine)	484	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]	cytoplasm [GO:0005737]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]	GO:0005737; GO:0016706			NA	NA	NA	NA	NA	NA
TRINITY_DN6794_c0_g1_i1	P51112	HD_TAKRU	48.9	94	48	0	3	284	1562	1655	1.10E-18	94	HD_TAKRU	reviewed	Huntingtin (Huntington disease protein homolog) (HD protein homolog)	htt hd	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	3148	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6794_c0_g1_i2	P51112	HD_TAKRU	44.9	136	75	0	3	410	1562	1697	1.00E-28	127.9	HD_TAKRU	reviewed	Huntingtin (Huntington disease protein homolog) (HD protein homolog)	htt hd	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	3148	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN33324_c0_g1_i1	P42858	HD_HUMAN	40.4	156	89	2	520	56	1223	1375	2.30E-24	113.6	HD_HUMAN	reviewed	"Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]"	HTT HD IT15	Homo sapiens (Human)	3142	"autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"	autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]	beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]	GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237	"apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2245_c0_g1_i1	P42858	HD_HUMAN	36.5	480	283	9	1472	75	2664	3135	6.20E-78	293.1	HD_HUMAN	reviewed	"Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]"	HTT HD IT15	Homo sapiens (Human)	3142	"autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"	autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]	beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]	GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237	"apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2245_c0_g1_i2	P42858	HD_HUMAN	36.5	480	283	9	1472	75	2664	3135	6.10E-78	293.1	HD_HUMAN	reviewed	"Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]"	HTT HD IT15	Homo sapiens (Human)	3142	"autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"	autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]	beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]	GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237	"apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6568_c0_g1_i1	Q8VD75	HIP1_MOUSE	50.7	221	109	0	746	84	797	1017	9.40E-53	208.4	HIP1_MOUSE	reviewed	Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I)	Hip1 Kiaa4113	Mus musculus (Mouse)	1029	"clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]"	clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]	"actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"	GO:0005634; GO:0005737; GO:0005794; GO:0006897; GO:0006915; GO:0006919; GO:0007015; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045211; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:2000588	actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN9416_c0_g1_i1	Q9NX55	HYPK_HUMAN	99.2	125	1	0	1	375	5	129	8.20E-59	227.6	HYPK_HUMAN	reviewed	Huntingtin-interacting protein K (Huntingtin yeast partner K)	HYPK C15orf63 HSPC136	Homo sapiens (Human)	129	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	protein N-terminus binding [GO:0047485]	GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0047485; GO:0050821	negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN35546_c0_g1_i1	Q9NX55	HYPK_HUMAN	100	112	0	0	366	31	18	129	5.10E-52	204.9	HYPK_HUMAN	reviewed	Huntingtin-interacting protein K (Huntingtin yeast partner K)	HYPK C15orf63 HSPC136	Homo sapiens (Human)	129	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	protein N-terminus binding [GO:0047485]	GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0047485; GO:0050821	negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN1632_c0_g1_i1	Q9NX55	HYPK_HUMAN	55.1	127	52	2	454	89	3	129	5.70E-25	115.5	HYPK_HUMAN	reviewed	Huntingtin-interacting protein K (Huntingtin yeast partner K)	HYPK C15orf63 HSPC136	Homo sapiens (Human)	129	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	protein N-terminus binding [GO:0047485]	GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0047485; GO:0050821	negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821]		blue	blue	NA	NA	NA	NA
TRINITY_DN2447_c0_g1_i11	J3S820	HYAL_CROAD	32.3	331	203	9	403	1347	33	358	1.60E-44	182.2	HYAL_CROAD	reviewed	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)		Crotalus adamanteus (Eastern diamondback rattlesnake)	449	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005576; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2447_c0_g1_i13	J3S820	HYAL_CROAD	32.3	331	203	9	370	1314	33	358	1.50E-44	182.2	HYAL_CROAD	reviewed	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)		Crotalus adamanteus (Eastern diamondback rattlesnake)	449	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005576; GO:0005975	carbohydrate metabolic process [GO:0005975]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN2447_c0_g1_i15	J3S820	HYAL_CROAD	32.3	331	203	9	403	1347	33	358	1.50E-44	182.2	HYAL_CROAD	reviewed	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)		Crotalus adamanteus (Eastern diamondback rattlesnake)	449	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005576; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2447_c0_g1_i17	J3S820	HYAL_CROAD	32.3	331	203	9	1301	2245	33	358	2.40E-44	182.2	HYAL_CROAD	reviewed	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)		Crotalus adamanteus (Eastern diamondback rattlesnake)	449	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005576; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2447_c0_g1_i2	J3S820	HYAL_CROAD	35.2	182	111	4	344	868	33	214	7.30E-29	129.8	HYAL_CROAD	reviewed	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)		Crotalus adamanteus (Eastern diamondback rattlesnake)	449	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005576; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2447_c0_g1_i22	J3S820	HYAL_CROAD	32.3	331	203	9	370	1314	33	358	1.50E-44	182.2	HYAL_CROAD	reviewed	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)		Crotalus adamanteus (Eastern diamondback rattlesnake)	449	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005576; GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN5499_c0_g1_i1	Q6P121	HYCCI_DANRE	28.4	388	230	7	112	1266	7	349	2.90E-31	137.9	HYCCI_DANRE	reviewed	Hyccin (Protein FAM126A)	fam126a zgc:77228	Danio rerio (Zebrafish) (Brachydanio rerio)	518	cytosol [GO:0005829]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005829; GO:0005886; GO:0042552; GO:0046854; GO:0072659	myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN5499_c0_g1_i3	Q6P121	HYCCI_DANRE	32.4	210	137	3	112	738	7	212	2.60E-21	104	HYCCI_DANRE	reviewed	Hyccin (Protein FAM126A)	fam126a zgc:77228	Danio rerio (Zebrafish) (Brachydanio rerio)	518	cytosol [GO:0005829]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005829; GO:0005886; GO:0042552; GO:0046854; GO:0072659	myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN33057_c0_g1_i1	P9WQI8	BACA_MYCTO	53.3	75	35	0	11	235	534	608	4.30E-15	81.6	BACA_MYCTO	reviewed	Hydrophilic compounds import ATP-binding/permease protein BacA (EC 7.6.2.-) (Hydrophilic compounds ABC transporter BacA)	bacA MT1867	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	639	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN469_c0_g1_i1	A6QP15	HOT_BOVIN	68.7	447	139	1	3	1340	20	466	6.50E-180	631.7	HOT_BOVIN	reviewed	"Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1)"	ADHFE1	Bos taurus (Bovine)	466	mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]	mitochondrion [GO:0005739]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]	GO:0004022; GO:0005739; GO:0006539; GO:0046872; GO:0047988	glutamate catabolic process via 2-oxoglutarate [GO:0006539]		NA	NA	NA	NA	NA	NA
TRINITY_DN26316_c0_g1_i1	Q8IWW8	HOT_HUMAN	96.4	83	3	0	3	251	220	302	2.10E-42	172.6	HOT_HUMAN	reviewed	"Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) (Fe-containing alcohol dehydrogenase)"	ADHFE1 HMFT2263	Homo sapiens (Human)	467	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]	GO:0004022; GO:0005739; GO:0005759; GO:0006103; GO:0006539; GO:0046872; GO:0047988	2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]		NA	NA	NA	NA	NA	NA
TRINITY_DN27201_c0_g1_i1	Q16836	HCDH_HUMAN	100	89	0	0	3	269	223	311	3.30E-48	191.8	HCDH_HUMAN	reviewed	"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)"	HADH HAD HAD1 HADHSC SCHAD	Homo sapiens (Human)	314	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]	GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0014823; GO:0016740; GO:0032868; GO:0042493; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162	fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN188_c0_g1_i2	Q16836	HCDH_HUMAN	56.7	314	130	2	1010	87	1	314	2.40E-89	330.5	HCDH_HUMAN	reviewed	"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)"	HADH HAD HAD1 HADHSC SCHAD	Homo sapiens (Human)	314	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]	GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0014823; GO:0016740; GO:0032868; GO:0042493; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162	fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN188_c0_g1_i4	Q16836	HCDH_HUMAN	59.9	314	120	2	1010	87	1	314	5.70E-99	362.5	HCDH_HUMAN	reviewed	"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)"	HADH HAD HAD1 HADHSC SCHAD	Homo sapiens (Human)	314	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]	GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0014823; GO:0016740; GO:0032868; GO:0042493; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162	fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]		blue	blue	NA	NA	NA	NA
TRINITY_DN23417_c0_g1_i1	Q16775	GLO2_HUMAN	97.2	72	2	0	2	217	68	139	1.10E-35	149.8	GLO2_HUMAN	reviewed	"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)"	HAGH GLO2 HAGH1	Homo sapiens (Human)	308	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; glutathione biosynthetic process [GO:0006750]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; pyruvate metabolic process [GO:0006090]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]	hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]	GO:0004416; GO:0005737; GO:0005759; GO:0005829; GO:0006090; GO:0006750; GO:0019243; GO:0046872	glutathione biosynthetic process [GO:0006750]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; pyruvate metabolic process [GO:0006090]		NA	NA	NA	NA	NA	NA
TRINITY_DN2888_c0_g1_i1	Q6P963	GLO2_DANRE	62.4	213	76	2	7	636	29	240	2.80E-74	279.6	GLO2_DANRE	reviewed	"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)"	hagh zgc:73161	Danio rerio (Zebrafish) (Brachydanio rerio)	303	mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]	mitochondrial matrix [GO:0005759]	hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]	GO:0004416; GO:0005759; GO:0019243; GO:0046872	methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]		NA	NA	NA	NA	NA	NA
TRINITY_DN29352_c0_g1_i1	Q99KB8	GLO2_MOUSE	100	67	0	0	1	201	164	230	5.30E-35	147.5	GLO2_MOUSE	reviewed	"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)"	Hagh Glo2	Mus musculus (Mouse)	309	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]	GO:0004416; GO:0005737; GO:0005739; GO:0005759; GO:0005975; GO:0006749; GO:0006750; GO:0019243; GO:0046872	carbohydrate metabolic process [GO:0005975]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]		NA	NA	NA	NA	NA	NA
TRINITY_DN30671_c0_g1_i1	Q29448	HMGCL_BOVIN	67.6	312	99	1	87	1016	11	322	1.40E-118	427.6	HMGCL_BOVIN	reviewed	"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)"	HMGCL	Bos taurus (Bovine)	325	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]	GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005759; GO:0005777; GO:0006552; GO:0006629; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951	ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN30671_c0_g1_i2	Q29448	HMGCL_BOVIN	70.4	247	73	0	109	849	76	322	2.50E-100	366.7	HMGCL_BOVIN	reviewed	"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)"	HMGCL	Bos taurus (Bovine)	325	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]	GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005759; GO:0005777; GO:0006552; GO:0006629; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951	ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN30671_c0_g1_i3	Q29448	HMGCL_BOVIN	70.3	293	87	0	87	965	30	322	3.00E-118	426.4	HMGCL_BOVIN	reviewed	"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)"	HMGCL	Bos taurus (Bovine)	325	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]	GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005759; GO:0005777; GO:0006552; GO:0006629; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951	ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN30760_c0_g1_i1	P35914	HMGCL_HUMAN	100	100	0	0	2	301	18	117	3.90E-51	201.8	HMGCL_HUMAN	reviewed	"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)"	HMGCL	Homo sapiens (Human)	325	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; carboxylic acid binding [GO:0031406]; fatty-acyl-CoA binding [GO:0000062]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; acyl-CoA metabolic process [GO:0006637]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; protein targeting to peroxisome [GO:0006625]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	carboxylic acid binding [GO:0031406]; fatty-acyl-CoA binding [GO:0000062]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]	GO:0000062; GO:0000287; GO:0001889; GO:0004419; GO:0005198; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006552; GO:0006625; GO:0006629; GO:0006637; GO:0007005; GO:0007584; GO:0030145; GO:0031406; GO:0032991; GO:0042594; GO:0046872; GO:0046951; GO:0070542	acyl-CoA metabolic process [GO:0006637]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; protein targeting to peroxisome [GO:0006625]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN38464_c0_g1_i1	Q8HXZ6	HMGCL_MACFA	63.5	74	27	0	3	224	30	103	5.40E-20	97.8	HMGCL_MACFA	reviewed	"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)"	HMGCL QccE-12283	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	325	mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]	mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]	GO:0004419; GO:0005759; GO:0005777; GO:0046872; GO:0046951	ketone body biosynthetic process [GO:0046951]		NA	NA	NA	NA	NA	NA
TRINITY_DN28248_c0_g1_i1	O81027	HMGCL_ARATH	58.5	217	90	0	651	1	240	456	1.60E-69	263.8	HMGCL_ARATH	reviewed	"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)"	HMGCL At2g26800 F12C20.16	Arabidopsis thaliana (Mouse-ear cress)	468	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]	GO:0004419; GO:0005739; GO:0005759; GO:0006552; GO:0006629; GO:0046872; GO:0046951	ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN36523_c0_g1_i1	Q01581	HMCS1_HUMAN	100	105	0	0	317	3	288	392	2.90E-51	202.2	HMCS1_HUMAN	reviewed	"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)"	HMGCS1 HMGCS	Homo sapiens (Human)	520	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]	GO:0001889; GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0007420; GO:0008144; GO:0008584; GO:0009645; GO:0010142; GO:0014074; GO:0016853; GO:0019216; GO:0033197; GO:0042493; GO:0042803; GO:0043177; GO:0045540; GO:0046690; GO:0071372; GO:0071397; GO:0071404	"acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2661_c0_g1_i1	Q5R7Z9	HMCS1_PONAB	66.2	470	156	1	1584	184	1	470	1.40E-181	637.5	HMCS1_PONAB	reviewed	"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)"	HMGCS1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	520	cytoplasm [GO:0005737]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isoprenoid biosynthetic process [GO:0008299]	cytoplasm [GO:0005737]	hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]	GO:0004421; GO:0005737; GO:0006695; GO:0008299; GO:0042803	cholesterol biosynthetic process [GO:0006695]; isoprenoid biosynthetic process [GO:0008299]		NA	NA	NA	NA	NA	NA
TRINITY_DN2661_c0_g1_i2	Q5R7Z9	HMCS1_PONAB	66.2	470	156	1	1584	184	1	470	1.10E-181	637.9	HMCS1_PONAB	reviewed	"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)"	HMGCS1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	520	cytoplasm [GO:0005737]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isoprenoid biosynthetic process [GO:0008299]	cytoplasm [GO:0005737]	hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]	GO:0004421; GO:0005737; GO:0006695; GO:0008299; GO:0042803	cholesterol biosynthetic process [GO:0006695]; isoprenoid biosynthetic process [GO:0008299]		NA	NA	NA	NA	NA	NA
TRINITY_DN32945_c0_g1_i1	Q01581	HMCS1_HUMAN	99.4	158	1	0	475	2	1	158	1.20E-88	327	HMCS1_HUMAN	reviewed	"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)"	HMGCS1 HMGCS	Homo sapiens (Human)	520	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]	GO:0001889; GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0007420; GO:0008144; GO:0008584; GO:0009645; GO:0010142; GO:0014074; GO:0016853; GO:0019216; GO:0033197; GO:0042493; GO:0042803; GO:0043177; GO:0045540; GO:0046690; GO:0071372; GO:0071397; GO:0071404	"acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36874_c0_g1_i1	Q01581	HMCS1_HUMAN	100	78	0	0	236	3	212	289	3.10E-42	171.8	HMCS1_HUMAN	reviewed	"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)"	HMGCS1 HMGCS	Homo sapiens (Human)	520	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]	GO:0001889; GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0007420; GO:0008144; GO:0008584; GO:0009645; GO:0010142; GO:0014074; GO:0016853; GO:0019216; GO:0033197; GO:0042493; GO:0042803; GO:0043177; GO:0045540; GO:0046690; GO:0071372; GO:0071397; GO:0071404	"acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14979_c0_g1_i1	A6QQ74	HYPDH_BOVIN	45.1	235	110	5	2	706	242	457	1.00E-41	171.8	HYPDH_BOVIN	reviewed	Hydroxyproline dehydrogenase (HYPDH) (EC 1.5.5.3) (Probable proline dehydrogenase 2) (EC 1.5.5.2) (Probable proline oxidase 2)	PRODH2 HYPDH	Bos taurus (Bovine)	461	"mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133]"	mitochondrion [GO:0005739]	"FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]"	GO:0004657; GO:0005739; GO:0010133; GO:0016645; GO:0071949	proline catabolic process to glutamate [GO:0010133]		NA	NA	NA	NA	NA	NA
TRINITY_DN30225_c0_g1_i1	Q9LV16	B3GTJ_ARATH	28.5	158	105	4	268	726	481	635	7.30E-11	69.3	B3GTJ_ARATH	reviewed	"Hydroxyproline O-galactosyltransferase GALT6 (EC 2.4.1.-) (Beta-1,3-galactosyltransferase 19)"	GALT6 B3GALT19 At5g62620 MRG21.3	Arabidopsis thaliana (Mouse-ear cress)	681	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; hydroxyproline O-galactosyltransferase activity [GO:1990714]; arabinogalactan protein metabolic process [GO:0010405]; mucilage biosynthetic process involved in seed coat development [GO:0048354]; negative regulation of leaf senescence [GO:1900056]; protein O-linked glycosylation via hydroxyproline [GO:0018258]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; hydroxyproline O-galactosyltransferase activity [GO:1990714]	GO:0000139; GO:0005794; GO:0010405; GO:0016021; GO:0018258; GO:0030246; GO:0048354; GO:1900056; GO:1990714	arabinogalactan protein metabolic process [GO:0010405]; mucilage biosynthetic process involved in seed coat development [GO:0048354]; negative regulation of leaf senescence [GO:1900056]; protein O-linked glycosylation via hydroxyproline [GO:0018258]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i10	Q5ZJG8	HSDL1_CHICK	39.6	283	168	3	1009	167	17	298	4.10E-51	204.5	HSDL1_CHICK	reviewed	Hydroxysteroid dehydrogenase-like protein 1 (EC 1.1.1.-)	HSDL1 RCJMB04_18f7	Gallus gallus (Chicken)	331	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005783; GO:0006694; GO:0016491; GO:0030497	fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN6126_c0_g1_i1	Q5ZJG8	HSDL1_CHICK	50.7	221	109	0	665	3	68	288	6.60E-56	218.8	HSDL1_CHICK	reviewed	Hydroxysteroid dehydrogenase-like protein 1 (EC 1.1.1.-)	HSDL1 RCJMB04_18f7	Gallus gallus (Chicken)	331	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005783; GO:0006694; GO:0016491; GO:0030497	fatty acid elongation [GO:0030497]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2177_c0_g1_i1	Q6P5L8	HSDL2_DANRE	64.1	418	143	4	1334	84	4	415	1.80E-150	533.9	HSDL2_DANRE	reviewed	Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)	hsdl2	Danio rerio (Zebrafish) (Brachydanio rerio)	415	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]	mitochondrion [GO:0005739]; peroxisome [GO:0005777]	oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005777; GO:0016491			blue	blue	NA	NA	NA	NA
TRINITY_DN32185_c0_g1_i1	Q66KC4	HSDL2_XENTR	65.4	78	27	0	1	234	54	131	1.20E-22	106.7	HSDL2_XENTR	reviewed	Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)	hsdl2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	417	peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]	peroxisome [GO:0005777]	oxidoreductase activity [GO:0016491]	GO:0005777; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i8	Q90W33	HIC2_DANRE	46.6	73	39	0	4	222	480	552	4.80E-13	74.7	HIC2_DANRE	reviewed	Hypermethylated in cancer 2 protein	hic2 hrg22	Danio rerio (Zebrafish) (Brachydanio rerio)	560	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN20992_c0_g1_i1	Q6WIT9	HPRT_CANLF	60.2	83	33	0	1	249	103	185	8.30E-22	104	HPRT_CANLF	reviewed	Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)	HPRT1 HPRT	Canis lupus familiaris (Dog) (Canis familiaris)	218	cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]	guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657	adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN9829_c0_g1_i1	Q45FY6	HPRT_PIG	65.3	216	74	1	79	726	3	217	9.00E-80	298.5	HPRT_PIG	reviewed	Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)	HPRT1 HPRT	Sus scrofa (Pig)	218	cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]	guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657	adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN9829_c0_g1_i2	Q45FY6	HPRT_PIG	65.3	216	74	1	79	726	3	217	9.20E-80	298.5	HPRT_PIG	reviewed	Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)	HPRT1 HPRT	Sus scrofa (Pig)	218	cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]	guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657	adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]		blue	blue	NA	NA	NA	NA
TRINITY_DN25756_c0_g1_i1	P00493	HPRT_MOUSE	100	183	0	0	628	80	36	218	9.20E-102	370.9	HPRT_MOUSE	reviewed	Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8) (HPRT B)	Hprt1 Hprt	Mus musculus (Mouse)	218	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenine metabolic process [GO:0046083]; adenine salvage [GO:0006168]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000287; GO:0001913; GO:0001975; GO:0004422; GO:0005737; GO:0005829; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0007625; GO:0007626; GO:0021756; GO:0021895; GO:0021954; GO:0032263; GO:0032264; GO:0042417; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046083; GO:0046100; GO:0046651; GO:0048813; GO:0051289; GO:0052657	adenine metabolic process [GO:0046083]; adenine salvage [GO:0006168]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913]		NA	NA	NA	NA	NA	NA
TRINITY_DN37427_c0_g1_i1	P20035	HGXR_PLAFG	64.6	127	42	2	457	80	103	227	2.10E-39	163.3	HGXR_PLAFG	reviewed	Hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGPRT) (HGXPRT) (HGXPRTase) (EC 2.4.2.22) (EC 2.4.2.8)	LACZ	Plasmodium falciparum (isolate FCR-3 / Gambia)	231	cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; xanthine phosphoribosyltransferase activity [GO:0000310]; GMP salvage [GO:0032263]; IMP salvage [GO:0032264]; XMP salvage [GO:0032265]	cytoplasm [GO:0005737]	guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; xanthine phosphoribosyltransferase activity [GO:0000310]	GO:0000166; GO:0000310; GO:0004422; GO:0005737; GO:0032263; GO:0032264; GO:0032265; GO:0046872; GO:0052657	GMP salvage [GO:0032263]; IMP salvage [GO:0032264]; XMP salvage [GO:0032265]		NA	NA	NA	NA	NA	NA
TRINITY_DN4322_c0_g1_i1	Q5ZLK7	HYOU1_CHICK	61.4	88	33	1	266	6	335	422	1.40E-22	106.7	HYOU1_CHICK	reviewed	Hypoxia up-regulated protein 1	HYOU1 RCJMB04_5l9	Gallus gallus (Chicken)	1002	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]	ATP binding [GO:0005524]	GO:0005524; GO:0005783; GO:0005788; GO:0034663; GO:0071456; GO:1903298	cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]		blue	blue	NA	NA	NA	NA
TRINITY_DN2546_c0_g1_i1	Q7ZUW2	HYOU1_DANRE	58.4	267	107	2	145	945	23	285	1.40E-80	301.2	HYOU1_DANRE	reviewed	Hypoxia up-regulated protein 1	hyou1	Danio rerio (Zebrafish) (Brachydanio rerio)	980	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]	ATP binding [GO:0005524]	GO:0005524; GO:0005783; GO:0005788; GO:0034663; GO:0071456; GO:1903298	cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]		NA	NA	NA	NA	NA	NA
TRINITY_DN34489_c0_g1_i1	Q9JKR6	HYOU1_MOUSE	100	99	0	0	298	2	153	251	3.60E-48	191.8	HYOU1_MOUSE	reviewed	Hypoxia up-regulated protein 1 (GRP-170) (140 kDa Ca(2+)-binding protein) (CBP-140)	Hyou1 Grp170	Mus musculus (Mouse)	999	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; smooth endoplasmic reticulum [GO:0005790]	ATP binding [GO:0005524]	GO:0001666; GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0006888; GO:0034663; GO:0034976; GO:0043066; GO:0071456; GO:1903298; GO:1903382	cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]		NA	NA	NA	NA	NA	NA
TRINITY_DN32565_c0_g1_i1	Q9JKR6	HYOU1_MOUSE	100	71	0	0	216	4	351	421	5.90E-32	137.5	HYOU1_MOUSE	reviewed	Hypoxia up-regulated protein 1 (GRP-170) (140 kDa Ca(2+)-binding protein) (CBP-140)	Hyou1 Grp170	Mus musculus (Mouse)	999	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; smooth endoplasmic reticulum [GO:0005790]	ATP binding [GO:0005524]	GO:0001666; GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0006888; GO:0034663; GO:0034976; GO:0043066; GO:0071456; GO:1903298; GO:1903382	cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]		NA	NA	NA	NA	NA	NA
TRINITY_DN6637_c0_g1_i2	Q0PGG7	HIF1A_BOSMU	40.1	162	80	2	35	502	2	152	8.20E-24	111.7	HIF1A_BOSMU	reviewed	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha)	HIF1A	Bos mutus grunniens (Wild yak) (Bos grunniens)	823	"axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]"	axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0001666; GO:0003700; GO:0005634; GO:0005829; GO:0010575; GO:0016607; GO:0019896; GO:0035035; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0061419; GO:0071456; GO:1904115; GO:2000434	"axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6637_c0_g1_i3	Q0PGG7	HIF1A_BOSMU	39.8	161	80	2	44	508	3	152	5.40E-23	109	HIF1A_BOSMU	reviewed	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha)	HIF1A	Bos mutus grunniens (Wild yak) (Bos grunniens)	823	"axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]"	axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0001666; GO:0003700; GO:0005634; GO:0005829; GO:0010575; GO:0016607; GO:0019896; GO:0035035; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0061419; GO:0071456; GO:1904115; GO:2000434	"axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37185_c0_g1_i1	Q0PGG7	HIF1A_BOSMU	100	67	0	0	3	203	228	294	2.60E-34	145.2	HIF1A_BOSMU	reviewed	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha)	HIF1A	Bos mutus grunniens (Wild yak) (Bos grunniens)	823	"axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]"	axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0001666; GO:0003700; GO:0005634; GO:0005829; GO:0010575; GO:0016607; GO:0019896; GO:0035035; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0061419; GO:0071456; GO:1904115; GO:2000434	"axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c1_g1_i1	Q9NWT6	HIF1N_HUMAN	71.8	209	58	1	765	142	140	348	7.20E-88	325.1	HIF1N_HUMAN	reviewed	Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)	HIF1AN FIH1	Homo sapiens (Human)	349	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0055114; GO:0061418; GO:0061428; GO:0071532; GO:0102113; GO:2001214	negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c1_g1_i2	Q9NWT6	HIF1N_HUMAN	71.8	209	58	1	737	114	140	348	7.00E-88	325.1	HIF1N_HUMAN	reviewed	Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)	HIF1AN FIH1	Homo sapiens (Human)	349	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0055114; GO:0061418; GO:0061428; GO:0071532; GO:0102113; GO:2001214	negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]		NA	NA	NA	NA	NA	NA
TRINITY_DN28467_c0_g1_i1	Q9NWT6	HIF1N_HUMAN	100	53	0	0	203	45	297	349	1.50E-24	112.8	HIF1N_HUMAN	reviewed	Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)	HIF1AN FIH1	Homo sapiens (Human)	349	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0055114; GO:0061418; GO:0061428; GO:0071532; GO:0102113; GO:2001214	negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]		NA	NA	NA	NA	NA	NA
TRINITY_DN28239_c0_g1_i1	Q9NWT6	HIF1N_HUMAN	100	145	0	0	436	2	142	286	3.10E-88	325.5	HIF1N_HUMAN	reviewed	Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)	HIF1AN FIH1	Homo sapiens (Human)	349	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0055114; GO:0061418; GO:0061428; GO:0071532; GO:0102113; GO:2001214	negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c1_g1_i3	P59723	HIF1N_DANRE	67.2	58	19	0	253	80	127	184	4.90E-17	88.2	HIF1N_DANRE	reviewed	Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Hypoxia-inducible factor asparagine hydroxylase)	hif1an si:rp71-68n3.1	Danio rerio (Zebrafish) (Brachydanio rerio)	344	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of vasculature development [GO:1901343]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0008198; GO:0008270; GO:0016706; GO:0030947; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045746; GO:0048471; GO:0055114; GO:0061428; GO:0071532; GO:0102113; GO:1901343	negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of vasculature development [GO:1901343]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]		NA	NA	NA	NA	NA	NA
TRINITY_DN30779_c0_g1_i1	E2AX35	PROH4_CAMFO	84.8	92	14	0	296	21	46	137	2.40E-42	172.6	PROH4_CAMFO	reviewed	IDLSRF-like peptide	EAG_01737	Camponotus floridanus (Florida carpenter ant)	201	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]		GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN30779_c0_g1_i2	E2AX35	PROH4_CAMFO	88.2	51	6	0	173	21	87	137	5.30E-19	94.4	PROH4_CAMFO	reviewed	IDLSRF-like peptide	EAG_01737	Camponotus floridanus (Florida carpenter ant)	201	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]		GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN230_c0_g1_i1	Q08890	IDS_MOUSE	45.6	502	182	8	3492	2005	24	440	4.30E-119	431	IDS_MOUSE	reviewed	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	Ids	Mus musculus (Mouse)	552	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]	lysosome [GO:0005764]	calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	glycosaminoglycan catabolic process [GO:0006027]		brown	brown	NA	NA	NA	NA
TRINITY_DN230_c0_g1_i3	Q08890	IDS_MOUSE	45.6	502	182	8	3478	1991	24	440	4.30E-119	431	IDS_MOUSE	reviewed	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	Ids	Mus musculus (Mouse)	552	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]	lysosome [GO:0005764]	calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	glycosaminoglycan catabolic process [GO:0006027]		NA	NA	NA	NA	NA	NA
TRINITY_DN29804_c0_g1_i1	P22304	IDS_HUMAN	99.3	149	1	0	450	4	30	178	2.10E-84	312.8	IDS_HUMAN	reviewed	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]	IDS SIDS	Homo sapiens (Human)	550	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030207; GO:0043202	chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]		NA	NA	NA	NA	NA	NA
TRINITY_DN28570_c0_g1_i1	P22304	IDS_HUMAN	100	123	0	0	1	369	205	327	5.70E-67	254.6	IDS_HUMAN	reviewed	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]	IDS SIDS	Homo sapiens (Human)	550	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030207; GO:0043202	chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]		NA	NA	NA	NA	NA	NA
TRINITY_DN29770_c0_g1_i1	Q5RKR3	ISLR2_MOUSE	24.5	319	198	7	1862	933	2	286	3.50E-19	98.2	ISLR2_MOUSE	reviewed	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein)	Islr2 Kiaa1465 Linx	Mus musculus (Mouse)	745	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; positive regulation of axon extension [GO:0045773]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0009986; GO:0016021; GO:0045773	positive regulation of axon extension [GO:0045773]		NA	NA	NA	NA	NA	NA
TRINITY_DN1098_c0_g1_i21	Q86VF2	IGFN1_HUMAN	30.5	82	53	1	117	362	1167	1244	5.00E-05	48.9	IGFN1_HUMAN	reviewed	Immunoglobulin-like and fibronectin type III domain-containing protein 1 (EEF1A2-binding protein 1) (KY-interacting protein 1)	IGFN1 EEF1A2BP1 KYIP1	Homo sapiens (Human)	1251	nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]		GO:0005634; GO:0007156; GO:0007416; GO:0010842; GO:0030018; GO:0045202	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1098_c0_g1_i3	Q86VF2	IGFN1_HUMAN	32.1	81	52	1	114	356	1167	1244	1.70E-05	50.4	IGFN1_HUMAN	reviewed	Immunoglobulin-like and fibronectin type III domain-containing protein 1 (EEF1A2-binding protein 1) (KY-interacting protein 1)	IGFN1 EEF1A2BP1 KYIP1	Homo sapiens (Human)	1251	nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]		GO:0005634; GO:0007156; GO:0007416; GO:0010842; GO:0030018; GO:0045202	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1098_c0_g1_i33	Q86VF2	IGFN1_HUMAN	32.1	81	52	1	155	397	1167	1244	1.90E-05	50.4	IGFN1_HUMAN	reviewed	Immunoglobulin-like and fibronectin type III domain-containing protein 1 (EEF1A2-binding protein 1) (KY-interacting protein 1)	IGFN1 EEF1A2BP1 KYIP1	Homo sapiens (Human)	1251	nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]		GO:0005634; GO:0007156; GO:0007416; GO:0010842; GO:0030018; GO:0045202	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN29301_c0_g1_i1	B6HJ92	KAPA_PENRW	95.2	62	3	0	189	4	250	311	2.80E-26	118.6	KAPA_PENRW	reviewed	Importin subunit alpha (Karyopherin alpha)	kapA Pc21g01970	Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255) (Penicillium chrysogenum)	552	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]	GO:0005634; GO:0005737; GO:0006606; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN30062_c0_g1_i1	G5EB89	KAPA_EMENI	57.9	133	56	0	404	6	252	384	2.70E-38	159.5	KAPA_EMENI	reviewed	Importin subunit alpha (Karyopherin alpha)	kapA srp1 AN2142	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	553	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005737; GO:0006606; GO:0006607; GO:0008139; GO:0061608	NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN34871_c0_g1_i1	Q02821	IMA1_YEAST	60	45	18	0	85	219	333	377	6.10E-08	57.8	IMA1_YEAST	reviewed	Importin subunit alpha (Karyopherin subunit alpha) (Karyopherin-60) (Serine-rich RNA polymerase I suppressor protein)	SRP1 KAP60 YNL189W N1606	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	542	cytoplasm [GO:0005737]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; NLS-bearing protein import into nucleus [GO:0006607]; proteasome localization [GO:0031144]; protein targeting to membrane [GO:0006612]	cytoplasm [GO:0005737]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005654; GO:0005737; GO:0006607; GO:0006612; GO:0008139; GO:0031144; GO:0032991; GO:0042564; GO:0044877; GO:0048471; GO:0061608; GO:0097718	NLS-bearing protein import into nucleus [GO:0006607]; proteasome localization [GO:0031144]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN38368_c0_g1_i1	P52293	IMA1_MOUSE	100	78	0	0	1	234	437	514	1.20E-35	149.8	IMA1_MOUSE	reviewed	Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha)	Kpna2 Rch1	Mus musculus (Mouse)	529	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; repressing transcription factor binding [GO:0070491]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; repressing transcription factor binding [GO:0070491]	GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0010494; GO:0042826; GO:0043657; GO:0061608; GO:0070491; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902	entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN26575_c0_g1_i1	P52293	IMA1_MOUSE	100	154	0	0	3	464	73	226	7.80E-82	304.3	IMA1_MOUSE	reviewed	Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha)	Kpna2 Rch1	Mus musculus (Mouse)	529	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; repressing transcription factor binding [GO:0070491]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; repressing transcription factor binding [GO:0070491]	GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0010494; GO:0042826; GO:0043657; GO:0061608; GO:0070491; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902	entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN16389_c0_g1_i1	P52292	IMA1_HUMAN	100	516	0	0	1549	2	9	524	1.80E-292	1005.7	IMA1_HUMAN	reviewed	Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)	KPNA2 RCH1 SRP1	Homo sapiens (Human)	529	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; regulation of DNA recombination [GO:0000018]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]	GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:1903902	DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; regulation of DNA recombination [GO:0000018]		NA	NA	NA	NA	NA	NA
TRINITY_DN16389_c0_g1_i2	P52292	IMA1_HUMAN	98.4	254	4	0	763	2	271	524	3.10E-136	485.7	IMA1_HUMAN	reviewed	Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)	KPNA2 RCH1 SRP1	Homo sapiens (Human)	529	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; regulation of DNA recombination [GO:0000018]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]	GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:1903902	DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; regulation of DNA recombination [GO:0000018]		NA	NA	NA	NA	NA	NA
TRINITY_DN3970_c0_g1_i1	P52292	IMA1_HUMAN	59.3	518	201	6	1620	94	13	529	5.80E-165	582.4	IMA1_HUMAN	reviewed	Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)	KPNA2 RCH1 SRP1	Homo sapiens (Human)	529	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; regulation of DNA recombination [GO:0000018]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]	GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:1903902	DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; regulation of DNA recombination [GO:0000018]		blue	blue	NA	NA	NA	NA
TRINITY_DN39619_c0_g1_i1	F4JL11	IMPA2_ARATH	70.6	85	25	0	20	274	132	216	2.90E-28	125.6	IMPA2_ARATH	reviewed	Importin subunit alpha-2 (IMPa-2)	IMPA2 At4g16143	Arabidopsis thaliana (Mouse-ear cress)	535	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005635; GO:0005730; GO:0005829; GO:0006607; GO:0008139; GO:0009506; GO:0061608	NLS-bearing protein import into nucleus [GO:0006607]		NA	NA	NA	NA	NA	NA
TRINITY_DN36135_c0_g1_i1	O94374	IMA2_SCHPO	58.7	104	43	0	312	1	286	389	5.70E-28	124.8	IMA2_SCHPO	reviewed	Importin subunit alpha-2 (Importin-1) (Karyopherin subunit alpha-2)	imp1 SPBC1604.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	539	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; cell cycle [GO:0007049]; cell division [GO:0051301]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTP binding [GO:0005525]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005525; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006606; GO:0006607; GO:0007049; GO:0008139; GO:0034399; GO:0051301; GO:0061608; GO:1990023	cell cycle [GO:0007049]; cell division [GO:0051301]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN27187_c0_g1_i1	O35343	IMA3_MOUSE	78.9	431	90	1	1319	30	72	502	4.40E-194	678.7	IMA3_MOUSE	reviewed	Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4)	Kpna4 Qip1	Mus musculus (Mouse)	521	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005737; GO:0006606; GO:0006607; GO:0008139; GO:0031965; GO:0042542; GO:0061608	NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; response to hydrogen peroxide [GO:0042542]		blue	blue	NA	NA	NA	NA
TRINITY_DN30392_c0_g1_i1	O00629	IMA3_HUMAN	100	98	0	0	294	1	118	215	2.00E-51	202.6	IMA3_HUMAN	reviewed	Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4)	KPNA4 QIP1	Homo sapiens (Human)	521	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; response to hydrogen peroxide [GO:0042542]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0019054; GO:0031965; GO:0042542; GO:0061608	modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN37319_c0_g1_i1	O00629	IMA3_HUMAN	100	74	0	0	1	222	280	353	5.30E-36	151	IMA3_HUMAN	reviewed	Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4)	KPNA4 QIP1	Homo sapiens (Human)	521	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; response to hydrogen peroxide [GO:0042542]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0019054; GO:0031965; GO:0042542; GO:0061608	modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN31214_c0_g1_i1	O80480	IMPA4_ARATH	67.5	77	24	1	240	10	139	214	9.30E-24	110.5	IMPA4_ARATH	reviewed	Importin subunit alpha-4 (IMPa-4)	IMPA4 At1g09270 T12M4.2	Arabidopsis thaliana (Mouse-ear cress)	538	"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; host response to induction by symbiont of tumor, nodule or growth in host [GO:0080034]; NLS-bearing protein import into nucleus [GO:0006607]; symbiont intracellular protein transport in host [GO:0030581]"	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005635; GO:0005829; GO:0006607; GO:0008139; GO:0030581; GO:0061608; GO:0080034	"host response to induction by symbiont of tumor, nodule or growth in host [GO:0080034]; NLS-bearing protein import into nucleus [GO:0006607]; symbiont intracellular protein transport in host [GO:0030581]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19038_c0_g1_i1	O35344	IMA4_MOUSE	98.1	105	2	0	1	315	153	257	2.20E-56	219.2	IMA4_MOUSE	reviewed	Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3)	Kpna3 Qip2	Mus musculus (Mouse)	521	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]; NLS-bearing protein import into nucleus [GO:0006607]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]	GO:0005634; GO:0005654; GO:0005737; GO:0006607; GO:0008022; GO:0008139; GO:0061608	NLS-bearing protein import into nucleus [GO:0006607]		NA	NA	NA	NA	NA	NA
TRINITY_DN32021_c0_g1_i1	O00505	IMA4_HUMAN	100	67	0	0	2	202	267	333	1.60E-31	136	IMA4_HUMAN	reviewed	Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma)	KPNA3 QIP2	Homo sapiens (Human)	521	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex assembly [GO:0065003]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]	GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008022; GO:0008139; GO:0019054; GO:0043657; GO:0046718; GO:0061608; GO:0065003; GO:0075732	modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex assembly [GO:0065003]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN15484_c1_g1_i1	P52170	IMA5_XENLA	57.5	80	32	1	6	245	358	435	1.60E-20	99.8	IMA5_XENLA	reviewed	Importin subunit alpha-5 (Karyopherin subunit alpha-1)	kpna1	Xenopus laevis (African clawed frog)	522	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]	GO:0005634; GO:0005737; GO:0006606; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN23119_c0_g1_i2	P52294	IMA5_HUMAN	100	230	0	0	2	691	239	468	1.30E-128	460.3	IMA5_HUMAN	reviewed	"Importin subunit alpha-5 (Karyopherin subunit alpha-1) (Nucleoprotein interactor 1) (NPI-1) (RAG cohort protein 2) (SRP1-beta) [Cleaved into: Importin subunit alpha-5, N-terminally processed]"	KPNA1 RCH2	Homo sapiens (Human)	538	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; apoptotic DNA fragmentation [GO:0006309]; intracellular transport of virus [GO:0075733]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0000018; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006607; GO:0008139; GO:0019054; GO:0030425; GO:0043657; GO:0061608; GO:0075733; GO:0098978; GO:0099527	apoptotic DNA fragmentation [GO:0006309]; intracellular transport of virus [GO:0075733]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]		NA	NA	NA	NA	NA	NA
TRINITY_DN23119_c0_g1_i1	A2VE08	IMA5_BOVIN	99	96	1	0	2	289	373	468	3.90E-47	188.3	IMA5_BOVIN	reviewed	"Importin subunit alpha-5 (Karyopherin subunit alpha-1) [Cleaved into: Importin subunit alpha-5, N-terminally processed]"	KPNA1	Bos taurus (Bovine)	538	cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]	cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0030425; GO:0061608; GO:0098978; GO:0099527	NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]		NA	NA	NA	NA	NA	NA
TRINITY_DN40108_c0_g1_i1	O15131	IMA6_HUMAN	100	82	0	0	1	246	365	446	1.50E-39	162.9	IMA6_HUMAN	reviewed	Importin subunit alpha-6 (Karyopherin subunit alpha-5)	KPNA5	Homo sapiens (Human)	536	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0019054; GO:0061608	modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]		NA	NA	NA	NA	NA	NA
TRINITY_DN21773_c0_g1_i1	O60684	IMA7_HUMAN	99	204	2	0	3	614	211	414	2.80E-111	402.5	IMA7_HUMAN	reviewed	Importin subunit alpha-7 (Karyopherin subunit alpha-6)	KPNA6 IPOA7	Homo sapiens (Human)	536	cytoplasm [GO:0005737]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; mitigation of host defenses by symbiont [GO:0030682]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079]	cytoplasm [GO:0005737]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005737; GO:0006607; GO:0008139; GO:0016020; GO:0019079; GO:0030682; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902	entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; mitigation of host defenses by symbiont [GO:0030682]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079]		NA	NA	NA	NA	NA	NA
TRINITY_DN32666_c0_g1_i1	O60684	IMA7_HUMAN	75	539	121	7	1693	95	4	534	2.80E-220	766.1	IMA7_HUMAN	reviewed	Importin subunit alpha-7 (Karyopherin subunit alpha-6)	KPNA6 IPOA7	Homo sapiens (Human)	536	cytoplasm [GO:0005737]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; mitigation of host defenses by symbiont [GO:0030682]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079]	cytoplasm [GO:0005737]; host cell [GO:0043657]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005737; GO:0006607; GO:0008139; GO:0016020; GO:0019079; GO:0030682; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902	entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; mitigation of host defenses by symbiont [GO:0030682]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079]		NA	NA	NA	NA	NA	NA
TRINITY_DN35270_c0_g1_i1	Q14974	IMB1_HUMAN	100	77	0	0	232	2	739	815	1.60E-38	159.5	IMB1_HUMAN	reviewed	Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)	KPNB1 NTF97	Homo sapiens (Human)	876	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0008536; GO:0010494; GO:0016020; GO:0019054; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0043312; GO:0043657; GO:0045184; GO:0045540; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0075733; GO:0090307; GO:1904813	apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN37047_c0_g1_i1	Q14974	IMB1_HUMAN	100	146	0	0	439	2	306	451	2.40E-80	299.3	IMB1_HUMAN	reviewed	Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)	KPNB1 NTF97	Homo sapiens (Human)	876	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0008536; GO:0010494; GO:0016020; GO:0019054; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0043312; GO:0043657; GO:0045184; GO:0045540; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0075733; GO:0090307; GO:1904813	apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN29073_c0_g1_i1	Q14974	IMB1_HUMAN	100	65	0	0	216	22	812	876	1.60E-29	129.4	IMB1_HUMAN	reviewed	Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)	KPNB1 NTF97	Homo sapiens (Human)	876	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0008536; GO:0010494; GO:0016020; GO:0019054; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0043312; GO:0043657; GO:0045184; GO:0045540; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0075733; GO:0090307; GO:1904813	apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN37220_c0_g1_i1	Q14974	IMB1_HUMAN	100	72	0	0	2	217	512	583	7.00E-33	140.6	IMB1_HUMAN	reviewed	Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)	KPNB1 NTF97	Homo sapiens (Human)	876	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006309; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0008536; GO:0010494; GO:0016020; GO:0019054; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0043312; GO:0043657; GO:0045184; GO:0045540; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0075733; GO:0090307; GO:1904813	apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host cellular process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN26070_c0_g1_i1	O13864	IMB1_SCHPO	40.3	77	46	0	1	231	351	427	1.00E-10	67	IMB1_SCHPO	reviewed	Importin subunit beta-1 (Importin-95) (Karyopherin subunit beta-1) (Karyopherin-95)	kap95 SPAC1B1.03c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	863	cytoplasm [GO:0005737]; mitotic spindle midzone [GO:1990023]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; GTP binding [GO:0005525]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; mitotic spindle midzone [GO:1990023]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	GTP binding [GO:0005525]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]	GO:0005525; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0034399; GO:0051028; GO:0061608; GO:1990023	mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN1711_c0_g1_i1	P70168	IMB1_MOUSE	69	809	249	2	5	2428	67	874	0	1129.4	IMB1_MOUSE	reviewed	Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG)	Kpnb1 Impnb	Mus musculus (Mouse)	876	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008536; GO:0010494; GO:0019894; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0032991; GO:0040001; GO:0044877; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307	astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN1711_c0_g1_i2	P70168	IMB1_MOUSE	69	809	249	2	5	2428	67	874	0	1129	IMB1_MOUSE	reviewed	Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG)	Kpnb1 Impnb	Mus musculus (Mouse)	876	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008536; GO:0010494; GO:0019894; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0032991; GO:0040001; GO:0044877; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307	astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN72_c0_g1_i1	Q9UI26	IPO11_HUMAN	34.8	336	210	3	36	1022	637	970	5.40E-49	196.4	IPO11_HUMAN	reviewed	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	IPO11 RANBP11	Homo sapiens (Human)	975	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]	nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN72_c0_g1_i2	Q9UI26	IPO11_HUMAN	47.2	930	479	6	79	2844	45	970	4.50E-244	845.9	IPO11_HUMAN	reviewed	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	IPO11 RANBP11	Homo sapiens (Human)	975	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]	nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN72_c0_g1_i3	Q9UI26	IPO11_HUMAN	47.3	972	500	6	379	3270	3	970	8.30E-258	891.7	IPO11_HUMAN	reviewed	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	IPO11 RANBP11	Homo sapiens (Human)	975	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]	nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN34198_c0_g1_i1	Q9UI26	IPO11_HUMAN	100	223	0	0	2	670	351	573	5.70E-126	451.4	IPO11_HUMAN	reviewed	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	IPO11 RANBP11	Homo sapiens (Human)	975	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]	nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN10707_c0_g1_i1	O94829	IPO13_HUMAN	30.9	848	548	15	90	2594	19	841	1.60E-110	402.1	IPO13_HUMAN	reviewed	Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13)	IPO13 KIAA0724 RANBP13	Homo sapiens (Human)	963	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005737; GO:0006606; GO:0008536	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN10707_c0_g1_i2	O94829	IPO13_HUMAN	30.9	848	548	15	82	2586	19	841	1.60E-110	402.1	IPO13_HUMAN	reviewed	Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13)	IPO13 KIAA0724 RANBP13	Homo sapiens (Human)	963	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005737; GO:0006606; GO:0008536	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN1854_c0_g1_i3	Q8VI75	IPO4_MOUSE	35	414	242	5	1205	6	69	469	2.60E-68	260.8	IPO4_MOUSE	reviewed	Importin-4 (Imp4) (Importin-4a) (Imp4a) (Ran-binding protein 4) (RanBP4)	Ipo4 Imp4a Ranbp4	Mus musculus (Mouse)	1082	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; protein import into nucleus [GO:0006606]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]	GO:0000790; GO:0005634; GO:0005737; GO:0006335; GO:0006336; GO:0006606; GO:0008139; GO:0008536; GO:0032991; GO:0042254; GO:0061608	DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; protein import into nucleus [GO:0006606]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN7411_c0_g1_i1	Q8BKC5	IPO5_MOUSE	47.8	272	140	2	816	1	75	344	9.00E-65	248.4	IPO5_MOUSE	reviewed	Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5)	Ipo5 Kpnb3 Ranbp5	Mus musculus (Mouse)	1097	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0008536; GO:0042307; GO:0061608; GO:0071230	cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]		NA	NA	NA	NA	NA	NA
TRINITY_DN5657_c0_g1_i1	O95373	IPO7_HUMAN	53.2	94	44	0	359	78	939	1032	3.30E-20	99.8	IPO7_HUMAN	reviewed	Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7)	IPO7 RANBP7	Homo sapiens (Human)	1038	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]	GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0008536; GO:0016020; GO:0016032; GO:0030695; GO:0042393; GO:0045087; GO:0045736; GO:0046332	innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6434_c0_g1_i1	O95373	IPO7_HUMAN	56.6	431	187	0	1377	85	161	591	7.10E-147	521.9	IPO7_HUMAN	reviewed	Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7)	IPO7 RANBP7	Homo sapiens (Human)	1038	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]	GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0008536; GO:0016020; GO:0016032; GO:0030695; GO:0042393; GO:0045087; GO:0045736; GO:0046332	innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6434_c0_g1_i2	O95373	IPO7_HUMAN	54.9	721	320	3	2220	70	161	880	1.70E-238	827	IPO7_HUMAN	reviewed	Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7)	IPO7 RANBP7	Homo sapiens (Human)	1038	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]	GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0008536; GO:0016020; GO:0016032; GO:0030695; GO:0042393; GO:0045087; GO:0045736; GO:0046332	innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN9284_c0_g1_i1	Q91YE6	IPO9_MOUSE	50.8	835	403	3	11	2494	208	1041	5.30E-236	818.9	IPO9_MOUSE	reviewed	Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9)	Ipo9 Imp9 Ranbp9	Mus musculus (Mouse)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0042254; GO:0042393; GO:0050821; GO:0061608	protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN9284_c0_g1_i3	Q91YE6	IPO9_MOUSE	52.9	552	259	1	1	1656	374	924	1.10E-167	591.3	IPO9_MOUSE	reviewed	Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9)	Ipo9 Imp9 Ranbp9	Mus musculus (Mouse)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0042254; GO:0042393; GO:0050821; GO:0061608	protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN9284_c0_g1_i5	Q91YE6	IPO9_MOUSE	49.5	669	330	3	64	2049	374	1041	8.90E-181	635.2	IPO9_MOUSE	reviewed	Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9)	Ipo9 Imp9 Ranbp9	Mus musculus (Mouse)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0042254; GO:0042393; GO:0050821; GO:0061608	protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN9284_c0_g1_i7	Q91YE6	IPO9_MOUSE	50.8	835	403	3	11	2494	208	1041	5.30E-236	818.9	IPO9_MOUSE	reviewed	Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9)	Ipo9 Imp9 Ranbp9	Mus musculus (Mouse)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0042254; GO:0042393; GO:0050821; GO:0061608	protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN40995_c0_g1_i1	Q96P70	IPO9_HUMAN	100	70	0	0	211	2	296	365	2.00E-32	139	IPO9_HUMAN	reviewed	Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9)	IPO9 IMP9 KIAA1192 RANBP9 HSPC273	Homo sapiens (Human)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0016020; GO:0042393; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN35944_c0_g1_i1	Q96P70	IPO9_HUMAN	100	75	0	0	3	227	681	755	1.40E-39	162.9	IPO9_HUMAN	reviewed	Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9)	IPO9 IMP9 KIAA1192 RANBP9 HSPC273	Homo sapiens (Human)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0016020; GO:0042393; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN24008_c0_g1_i1	Q96P70	IPO9_HUMAN	99.4	162	1	0	487	2	749	910	1.80E-84	313.2	IPO9_HUMAN	reviewed	Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9)	IPO9 IMP9 KIAA1192 RANBP9 HSPC273	Homo sapiens (Human)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0016020; GO:0042393; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN9284_c0_g1_i4	Q96P70	IPO9_HUMAN	49.3	339	164	3	1	996	704	1041	2.20E-82	307.4	IPO9_HUMAN	reviewed	Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9)	IPO9 IMP9 KIAA1192 RANBP9 HSPC273	Homo sapiens (Human)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0016020; GO:0042393; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN38764_c0_g1_i1	Q96P70	IPO9_HUMAN	100	91	0	0	275	3	494	584	1.00E-44	180.3	IPO9_HUMAN	reviewed	Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9)	IPO9 IMP9 KIAA1192 RANBP9 HSPC273	Homo sapiens (Human)	1041	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	histone binding [GO:0042393]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0016020; GO:0042393; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN39526_c0_g1_i1	Q24008	INAD_DROME	56.4	55	24	0	284	120	388	442	6.30E-10	64.7	INAD_DROME	reviewed	Inactivation-no-after-potential D protein	inaD CG3504	Drosophila melanogaster (Fruit fly)	674	inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; myosin III binding [GO:0031473]; photoreceptor activity [GO:0009881]; signaling receptor complex adaptor activity [GO:0030159]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of light stimulus involved in sensory perception [GO:0050962]; phototransduction [GO:0007602]; protein localization [GO:0008104]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]	calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; myosin III binding [GO:0031473]; photoreceptor activity [GO:0009881]; signaling receptor complex adaptor activity [GO:0030159]	GO:0005516; GO:0007601; GO:0007602; GO:0007605; GO:0008104; GO:0009881; GO:0016027; GO:0016028; GO:0016059; GO:0017022; GO:0030159; GO:0031473; GO:0050962; GO:0071482	cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; detection of light stimulus involved in sensory perception [GO:0050962]; phototransduction [GO:0007602]; protein localization [GO:0008104]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN36959_c0_g1_i1	Q3UG20	KMT2E_MOUSE	54.1	85	37	1	340	86	118	200	1.40E-22	107.1	KMT2E_MOUSE	reviewed	Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog)	Kmt2e Mll5	Mus musculus (Mouse)	1868	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]; enzyme binding [GO:0019899]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; cell cycle arrest [GO:0007050]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; retinoic acid receptor signaling pathway [GO:0048384]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]	enzyme binding [GO:0019899]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006306; GO:0007050; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0035327; GO:0042119; GO:0042800; GO:0043231; GO:0045893; GO:0046872; GO:0048384; GO:1900087; GO:1905437	"cell cycle arrest [GO:0007050]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; retinoic acid receptor signaling pathway [GO:0048384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30329_c0_g1_i1	Q3UG20	KMT2E_MOUSE	51.3	76	34	2	566	348	393	468	3.40E-15	83.2	KMT2E_MOUSE	reviewed	Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog)	Kmt2e Mll5	Mus musculus (Mouse)	1868	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]; enzyme binding [GO:0019899]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; cell cycle arrest [GO:0007050]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; retinoic acid receptor signaling pathway [GO:0048384]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]	enzyme binding [GO:0019899]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006306; GO:0007050; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0035327; GO:0042119; GO:0042800; GO:0043231; GO:0045893; GO:0046872; GO:0048384; GO:1900087; GO:1905437	"cell cycle arrest [GO:0007050]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; retinoic acid receptor signaling pathway [GO:0048384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21691_c0_g2_i2	A5PJF6	HSDL1_BOVIN	32.4	253	158	4	866	123	65	309	3.70E-32	140.2	HSDL1_BOVIN	reviewed	Inactive hydroxysteroid dehydrogenase-like protein 1	HSDL1	Bos taurus (Bovine)	330	intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]	intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]		GO:0005739; GO:0045111; GO:0055114	oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN6126_c0_g1_i2	Q3SXM5	HSDL1_HUMAN	48.5	241	123	1	722	3	48	288	2.00E-60	233.8	HSDL1_HUMAN	reviewed	Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3)	HSDL1 SDR12C3	Homo sapiens (Human)	330	intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]	intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]		GO:0005739; GO:0043231; GO:0045111; GO:0055114	oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN8631_c0_g1_i2	P06857	LIPR1_CANLF	40.6	202	114	4	638	36	61	257	2.30E-34	147.1	LIPR1_CANLF	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	PNLIPRP1 PLRP1	Canis lupus familiaris (Dog) (Canis familiaris)	467	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carboxylic ester hydrolase activity [GO:0052689]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; carboxylic ester hydrolase activity [GO:0052689]	GO:0005509; GO:0005576; GO:0016042; GO:0052689	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN10670_c0_g1_i1	Q9UPR0	PLCL2_HUMAN	43.7	970	509	15	28	2865	118	1074	5.60E-238	825.9	PLCL2_HUMAN	reviewed	Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2)	PLCL2 KIAA1092 PLCE2	Homo sapiens (Human)	1127	"cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]	"GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]"	GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0048015; GO:0050811; GO:0050859; GO:0070679; GO:0120163; GO:1900122	"B-1a B cell differentiation [GO:0002337]; B cell proliferation involved in immune response [GO:0002322]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10670_c0_g1_i2	Q9UPR0	PLCL2_HUMAN	43.7	970	509	15	28	2865	118	1074	5.40E-238	825.9	PLCL2_HUMAN	reviewed	Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2)	PLCL2 KIAA1092 PLCE2	Homo sapiens (Human)	1127	"cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]	"GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]"	GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0048015; GO:0050811; GO:0050859; GO:0070679; GO:0120163; GO:1900122	"B-1a B cell differentiation [GO:0002337]; B cell proliferation involved in immune response [GO:0002322]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10670_c0_g1_i4	Q9UPR0	PLCL2_HUMAN	43.4	970	517	14	28	2880	118	1074	1.10E-236	821.6	PLCL2_HUMAN	reviewed	Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2)	PLCL2 KIAA1092 PLCE2	Homo sapiens (Human)	1127	"cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]	"GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]"	GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0048015; GO:0050811; GO:0050859; GO:0070679; GO:0120163; GO:1900122	"B-1a B cell differentiation [GO:0002337]; B cell proliferation involved in immune response [GO:0002322]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34597_c0_g1_i1	Q9UPR0	PLCL2_HUMAN	99.4	166	1	0	500	3	704	869	4.60E-96	351.7	PLCL2_HUMAN	reviewed	Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2)	PLCL2 KIAA1092 PLCE2	Homo sapiens (Human)	1127	"cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]	"GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]"	GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0048015; GO:0050811; GO:0050859; GO:0070679; GO:0120163; GO:1900122	"B-1a B cell differentiation [GO:0002337]; B cell proliferation involved in immune response [GO:0002322]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36461_c0_g1_i1	Q9UPR0	PLCL2_HUMAN	100	120	0	0	360	1	370	489	3.10E-70	265.4	PLCL2_HUMAN	reviewed	Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2)	PLCL2 KIAA1092 PLCE2	Homo sapiens (Human)	1127	"cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]	"GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]"	GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0048015; GO:0050811; GO:0050859; GO:0070679; GO:0120163; GO:1900122	"B-1a B cell differentiation [GO:0002337]; B cell proliferation involved in immune response [GO:0002322]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38230_c0_g1_i1	Q6PIX5	RHDF1_MOUSE	96.4	138	5	0	3	416	624	761	1.10E-71	270.4	RHDF1_MOUSE	reviewed	Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid family member 1)	Rhbdf1 Dist1 Irhom1 Kiaa4242	Mus musculus (Mouse)	856	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005789; GO:0006508; GO:0008283; GO:0016021; GO:0016477; GO:0042058; GO:0050708; GO:0050709; GO:0061136	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]		NA	NA	NA	NA	NA	NA
TRINITY_DN14909_c0_g1_i1	Q6GMF8	RHDF1_DANRE	55.3	300	131	2	94	993	557	853	5.10E-100	365.9	RHDF1_DANRE	reviewed	Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1)	rhbdf1 zgc:91984	Danio rerio (Zebrafish) (Brachydanio rerio)	857	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	growth factor binding [GO:0019838]	GO:0000139; GO:0005789; GO:0006508; GO:0008283; GO:0015031; GO:0016021; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]		NA	NA	NA	NA	NA	NA
TRINITY_DN14909_c0_g1_i2	Q6GMF8	RHDF1_DANRE	49.6	490	238	5	312	1769	369	853	4.70E-146	519.6	RHDF1_DANRE	reviewed	Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1)	rhbdf1 zgc:91984	Danio rerio (Zebrafish) (Brachydanio rerio)	857	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	growth factor binding [GO:0019838]	GO:0000139; GO:0005789; GO:0006508; GO:0008283; GO:0015031; GO:0016021; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]		NA	NA	NA	NA	NA	NA
TRINITY_DN32541_c0_g1_i1	Q6PJF5	RHDF2_HUMAN	100	113	0	0	341	3	667	779	2.40E-59	229.2	RHDF2_HUMAN	reviewed	Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6)	RHBDF2 IRHOM2 RHBDL5 RHBDL6	Homo sapiens (Human)	856	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	growth factor binding [GO:0019838]	GO:0005789; GO:0005886; GO:0006508; GO:0015031; GO:0016021; GO:0019838; GO:0042058; GO:0050708; GO:0050709	negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708]		NA	NA	NA	NA	NA	NA
TRINITY_DN1714_c0_g1_i1	O18373	SPS1_DROME	80.6	392	73	2	1286	111	10	398	5.80E-182	638.6	SPS1_DROME	reviewed	"Inactive selenide, water dikinase-like protein (Protein patufet) (dSelD)"	SelD PTF1 ptuf CG8553	Drosophila melanogaster (Fruit fly)	398	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenocysteine biosynthetic process [GO:0016260]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]	GO:0005524; GO:0005737; GO:0007049; GO:0007275; GO:0010637; GO:0016260; GO:0016301; GO:2000378	cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenocysteine biosynthetic process [GO:0016260]		blue	blue	NA	NA	NA	NA
TRINITY_DN39676_c0_g1_i1	Q96N87	S6A18_HUMAN	54.5	55	17	1	73	237	54	100	1.40E-10	66.6	S6A18_HUMAN	reviewed	Inactive sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3)	SLC6A18 XTRP2	Homo sapiens (Human)	628	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015293; GO:0016324; GO:0031526; GO:0035725	amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN1779_c0_g1_i1	Q01973	ROR1_HUMAN	49.9	603	280	8	151	1899	154	754	2.90E-173	610.1	ROR1_HUMAN	reviewed	"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)"	ROR1 NTRKR1	Homo sapiens (Human)	937	"axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0007399; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043408; GO:0043410; GO:0043679; GO:0048839; GO:0051092; GO:1904929	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1779_c0_g1_i2	Q01973	ROR1_HUMAN	49.9	603	280	8	169	1917	154	754	2.90E-173	610.1	ROR1_HUMAN	reviewed	"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)"	ROR1 NTRKR1	Homo sapiens (Human)	937	"axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0007399; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043408; GO:0043410; GO:0043679; GO:0048839; GO:0051092; GO:1904929	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1779_c0_g1_i3	Q01973	ROR1_HUMAN	50	604	288	7	151	1929	154	754	2.60E-174	613.6	ROR1_HUMAN	reviewed	"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)"	ROR1 NTRKR1	Homo sapiens (Human)	937	"axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0007399; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043408; GO:0043410; GO:0043679; GO:0048839; GO:0051092; GO:1904929	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1779_c0_g1_i4	Q01973	ROR1_HUMAN	50	604	288	7	169	1947	154	754	2.70E-174	613.6	ROR1_HUMAN	reviewed	"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)"	ROR1 NTRKR1	Homo sapiens (Human)	937	"axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0007399; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043408; GO:0043410; GO:0043679; GO:0048839; GO:0051092; GO:1904929	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1779_c0_g1_i5	Q01973	ROR1_HUMAN	52.9	448	197	7	32	1342	310	754	8.00E-133	475.3	ROR1_HUMAN	reviewed	"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)"	ROR1 NTRKR1	Homo sapiens (Human)	937	"axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0007399; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043408; GO:0043410; GO:0043679; GO:0048839; GO:0051092; GO:1904929	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN5610_c0_g1_i2	Q7G193	ALDO1_ARATH	32.2	1045	630	28	3058	83	273	1292	8.20E-119	429.9	ALDO1_ARATH	reviewed	Indole-3-acetaldehyde oxidase (IAA oxidase) (EC 1.2.3.7) (Aldehyde oxidase 1) (AO-1) (AtAO-1) (AtAO1)	AAO1 AO1 At5g20960 F22D1.130	Arabidopsis thaliana (Mouse-ear cress)	1368	"plastid [GO:0009536]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; indole-3-acetaldehyde oxidase activity [GO:0050302]; iron ion binding [GO:0005506]; abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]"	plastid [GO:0009536]	"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; indole-3-acetaldehyde oxidase activity [GO:0050302]; iron ion binding [GO:0005506]"	GO:0004031; GO:0005506; GO:0009055; GO:0009536; GO:0009688; GO:0009851; GO:0050302; GO:0051537; GO:0071949	abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]		NA	NA	NA	NA	NA	NA
TRINITY_DN41074_c0_g1_i1	Q9Y6Y0	NS1BP_HUMAN	100	83	0	0	1	249	349	431	1.60E-44	179.5	NS1BP_HUMAN	reviewed	Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39)	IVNS1ABP ARA3 FLARA3 KIAA0850 KLHL39 NS1 NS1BP HSPC068	Homo sapiens (Human)	642	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]		GO:0005654; GO:0005667; GO:0005681; GO:0005829; GO:0005856; GO:0006383; GO:0008380; GO:0009615; GO:0016032; GO:0031397; GO:2001243	negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN16723_c0_g1_i1	Q9Y6Y0	NS1BP_HUMAN	100	152	0	0	461	6	491	642	1.00E-89	330.5	NS1BP_HUMAN	reviewed	Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39)	IVNS1ABP ARA3 FLARA3 KIAA0850 KLHL39 NS1 NS1BP HSPC068	Homo sapiens (Human)	642	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]		GO:0005654; GO:0005667; GO:0005681; GO:0005829; GO:0005856; GO:0006383; GO:0008380; GO:0009615; GO:0016032; GO:0031397; GO:2001243	negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN16723_c0_g1_i2	Q9Y6Y0	NS1BP_HUMAN	98.7	152	2	0	461	6	491	642	1.20E-87	323.6	NS1BP_HUMAN	reviewed	Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39)	IVNS1ABP ARA3 FLARA3 KIAA0850 KLHL39 NS1 NS1BP HSPC068	Homo sapiens (Human)	642	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]		GO:0005654; GO:0005667; GO:0005681; GO:0005829; GO:0005856; GO:0006383; GO:0008380; GO:0009615; GO:0016032; GO:0031397; GO:2001243	negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN565_c2_g1_i1	Q6DFU2	NS1BP_XENLA	31.8	132	78	4	572	183	461	582	6.80E-11	68.9	NS1BP_XENLA	reviewed	Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog)	ivns1abp	Xenopus laevis (African clawed frog)	638	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN7009_c0_g1_i1	Q920Q8	NS1BP_MOUSE	33.3	481	289	11	110	1522	4	462	3.00E-56	221.1	NS1BP_MOUSE	reviewed	Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S)	Ivns1abp Kiaa0850 Nd1 Nd1L Nd1S Ns1 Ns1bp	Mus musculus (Mouse)	642	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0005856; GO:0008380; GO:0009615; GO:0031397; GO:2001243	negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN7009_c0_g1_i2	Q920Q8	NS1BP_MOUSE	36.7	656	381	12	110	2041	4	637	1.60E-111	405.2	NS1BP_MOUSE	reviewed	Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S)	Ivns1abp Kiaa0850 Nd1 Nd1L Nd1S Ns1 Ns1bp	Mus musculus (Mouse)	642	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0005856; GO:0008380; GO:0009615; GO:0031397; GO:2001243	negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN1155_c0_g1_i2	Q7ZVQ8	NS1BB_DANRE	32.7	107	67	2	14	334	509	610	5.50E-10	65.5	NS1BB_DANRE	reviewed	Influenza virus NS1A-binding protein homolog B (NS1-BP homolog B) (NS1-binding protein homolog B)	ivns1abpb	Danio rerio (Zebrafish) (Brachydanio rerio)	640	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN30292_c0_g1_i1	O61643	INHB_DROME	52.9	70	32	1	220	14	832	901	1.90E-17	89.4	INHB_DROME	reviewed	Inhibin beta chain (Activin beta chain) (dAct) (dActivin)	Actbeta activin-beta CG11062	Drosophila melanogaster (Fruit fly)	946	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; activin receptor signaling pathway [GO:0032924]; glucose homeostasis [GO:0042593]; mushroom body development [GO:0016319]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; R8 cell fate specification [GO:0045464]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of synapse structure or activity [GO:0050803]; response to glucose [GO:0009749]; SMAD protein signal transduction [GO:0060395]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	GO:0002052; GO:0005125; GO:0005615; GO:0008083; GO:0009749; GO:0010862; GO:0016319; GO:0032924; GO:0042593; GO:0044719; GO:0045464; GO:0045572; GO:0050803; GO:0060395	activin receptor signaling pathway [GO:0032924]; glucose homeostasis [GO:0042593]; mushroom body development [GO:0016319]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; R8 cell fate specification [GO:0045464]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of synapse structure or activity [GO:0050803]; response to glucose [GO:0009749]; SMAD protein signal transduction [GO:0060395]		NA	NA	NA	NA	NA	NA
TRINITY_DN3935_c0_g1_i1	Q9P2D0	IBTK_HUMAN	36.3	987	605	14	103	3030	7	980	1.10E-169	599	IBTK_HUMAN	reviewed	Inhibitor of Bruton tyrosine kinase (IBtk)	IBTK BTKI KIAA1417	Homo sapiens (Human)	1353	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]	GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209	negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]		NA	NA	NA	NA	NA	NA
TRINITY_DN3935_c0_g1_i2	Q9P2D0	IBTK_HUMAN	35.6	733	456	10	103	2274	7	732	4.10E-124	447.2	IBTK_HUMAN	reviewed	Inhibitor of Bruton tyrosine kinase (IBtk)	IBTK BTKI KIAA1417	Homo sapiens (Human)	1353	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]	GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209	negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]		NA	NA	NA	NA	NA	NA
TRINITY_DN34898_c0_g1_i1	Q9P2D0	IBTK_HUMAN	100	88	0	0	266	3	239	326	8.60E-49	193.7	IBTK_HUMAN	reviewed	Inhibitor of Bruton tyrosine kinase (IBtk)	IBTK BTKI KIAA1417	Homo sapiens (Human)	1353	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]	GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209	negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]		NA	NA	NA	NA	NA	NA
TRINITY_DN30437_c0_g1_i1	Q9QXV3	ING1_MOUSE	52.8	288	109	4	103	924	1	275	1.20E-47	191.8	ING1_MOUSE	reviewed	Inhibitor of growth protein 1	Ing1	Mus musculus (Mouse)	279	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0005634; GO:0006606; GO:0007049; GO:0008285; GO:0010941; GO:0035064; GO:0045893; GO:0046872	"cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26043_c0_g1_i1	Q9H160	ING2_HUMAN	80.3	76	15	0	2	229	173	248	2.90E-29	128.6	ING2_HUMAN	reviewed	Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein) (ING1Lp) (p32) (p33ING2)	ING2 ING1L	Homo sapiens (Human)	280	"CCAAT-binding factor complex [GO:0016602]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]"	CCAAT-binding factor complex [GO:0016602]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0007141; GO:0007165; GO:0007283; GO:0007286; GO:0008285; GO:0016580; GO:0016602; GO:0030317; GO:0030511; GO:0031065; GO:0035064; GO:0035091; GO:0040008; GO:0044877; GO:0045893; GO:0046872; GO:0048133; GO:0072520; GO:1902166; GO:2000772; GO:2001020	"chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29065_c0_g1_i1	Q5ZK36	ING3_CHICK	52.5	59	24	2	197	24	355	410	6.20E-14	77.8	ING3_CHICK	reviewed	Inhibitor of growth protein 3	ING3 RCJMB04_13g20	Gallus gallus (Chicken)	417	NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]	NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000812; GO:0035064; GO:0035267; GO:0040008; GO:0043065; GO:0043967; GO:0043968; GO:0046872	histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN6641_c0_g1_i1	Q5ZK36	ING3_CHICK	67.1	82	26	1	26	271	335	415	1.00E-29	130.6	ING3_CHICK	reviewed	Inhibitor of growth protein 3	ING3 RCJMB04_13g20	Gallus gallus (Chicken)	417	NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]	NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000812; GO:0035064; GO:0035267; GO:0040008; GO:0043065; GO:0043967; GO:0043968; GO:0046872	histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]		blue	blue	NA	NA	NA	NA
TRINITY_DN2964_c0_g1_i3	Q5ZKY4	ING4_CHICK	70.4	159	43	3	560	90	93	249	1.40E-42	174.5	ING4_CHICK	reviewed	Inhibitor of growth protein 4 (p29ING4)	ING4 RCJMB04_8l5	Gallus gallus (Chicken)	249	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0003713; GO:0005634; GO:0005829; GO:0006260; GO:0006915; GO:0006978; GO:0007050; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2964_c0_g1_i4	Q5ZKY4	ING4_CHICK	61.4	241	89	3	806	90	11	249	1.20E-62	241.5	ING4_CHICK	reviewed	Inhibitor of growth protein 4 (p29ING4)	ING4 RCJMB04_8l5	Gallus gallus (Chicken)	249	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0003713; GO:0005634; GO:0005829; GO:0006260; GO:0006915; GO:0006978; GO:0007050; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2964_c0_g1_i5	Q5ZKY4	ING4_CHICK	61	251	94	3	836	90	1	249	9.70E-65	248.4	ING4_CHICK	reviewed	Inhibitor of growth protein 4 (p29ING4)	ING4 RCJMB04_8l5	Gallus gallus (Chicken)	249	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0003713; GO:0005634; GO:0005829; GO:0006260; GO:0006915; GO:0006978; GO:0007050; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2964_c0_g1_i8	Q5ZKY4	ING4_CHICK	70.4	159	43	3	560	90	93	249	9.90E-43	174.9	ING4_CHICK	reviewed	Inhibitor of growth protein 4 (p29ING4)	ING4 RCJMB04_8l5	Gallus gallus (Chicken)	249	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0003713; GO:0005634; GO:0005829; GO:0006260; GO:0006915; GO:0006978; GO:0007050; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30441_c0_g1_i1	Q9UNL4	ING4_HUMAN	100	75	0	0	3	227	175	249	1.20E-43	176.8	ING4_HUMAN	reviewed	Inhibitor of growth protein 4 (p29ING4)	ING4 My036	Homo sapiens (Human)	249	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; protein acetylation [GO:0006473]"	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006473; GO:0006915; GO:0006978; GO:0007050; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; protein acetylation [GO:0006473]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2964_c0_g1_i1	Q8WYH8	ING5_HUMAN	50.5	97	48	0	362	72	1	97	9.80E-20	97.8	ING5_HUMAN	reviewed	Inhibitor of growth protein 5 (p28ING5)	ING5	Homo sapiens (Human)	240	"chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000123; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006473; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0043967; GO:0044154; GO:0045893; GO:0045926; GO:0046872; GO:0070776; GO:1901796; GO:2001235	"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"		blue	blue	NA	NA	NA	NA
TRINITY_DN27304_c0_g1_i1	Q5ZJB4	IKKA_CHICK	55	231	95	1	133	825	28	249	6.90E-73	275.4	IKKA_CHICK	reviewed	Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA)	CHUK IKKA RCJMB04_19h23	Gallus gallus (Chicken)	759	cytoplasm [GO:0005737]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634]; ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; cellular response to tumor necrosis factor [GO:0071356]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634]	ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0002224; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008384; GO:0008385; GO:0018105; GO:0033209; GO:0042803; GO:0045944; GO:0046982; GO:0051092; GO:0071356	cellular response to tumor necrosis factor [GO:0071356]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]		NA	NA	NA	NA	NA	NA
TRINITY_DN27213_c0_g1_i1	Q95KV0	IKKB_BOVIN	100	71	0	0	1	213	107	177	1.30E-34	146.4	IKKB_BOVIN	reviewed	Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1)	IKBKB	Bos taurus (Bovine)	756	cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to tumor necrosis factor [GO:0071356]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; membrane raft [GO:0045121]; nucleus [GO:0005634]	ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008384; GO:0008385; GO:0018105; GO:0033209; GO:0042803; GO:0045121; GO:0045944; GO:0046982; GO:0051092; GO:0071356	cellular response to tumor necrosis factor [GO:0071356]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; tumor necrosis factor-mediated signaling pathway [GO:0033209]		NA	NA	NA	NA	NA	NA
TRINITY_DN26297_c0_g1_i1	Q14164	IKKE_HUMAN	100	82	0	0	247	2	115	196	9.50E-42	170.2	IKKE_HUMAN	reviewed	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i)	IKBKE IKKE IKKI KIAA0151	Homo sapiens (Human)	716	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; response to interferon-beta [GO:0035456]; response to type I interferon [GO:0034340]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0004672; GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008384; GO:0008630; GO:0010008; GO:0010884; GO:0016032; GO:0016605; GO:0018105; GO:0019903; GO:0031625; GO:0031966; GO:0032480; GO:0034340; GO:0035456; GO:0035666; GO:0036435; GO:0042802; GO:0043123; GO:0060340; GO:0098586	cellular response to virus [GO:0098586]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; response to interferon-beta [GO:0035456]; response to type I interferon [GO:0034340]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31075_c0_g1_i1	Q14164	IKKE_HUMAN	100	93	0	0	3	281	12	104	7.80E-45	180.6	IKKE_HUMAN	reviewed	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i)	IKBKE IKKE IKKI KIAA0151	Homo sapiens (Human)	716	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; response to interferon-beta [GO:0035456]; response to type I interferon [GO:0034340]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0004672; GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008384; GO:0008630; GO:0010008; GO:0010884; GO:0016032; GO:0016605; GO:0018105; GO:0019903; GO:0031625; GO:0031966; GO:0032480; GO:0034340; GO:0035456; GO:0035666; GO:0036435; GO:0042802; GO:0043123; GO:0060340; GO:0098586	cellular response to virus [GO:0098586]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; response to interferon-beta [GO:0035456]; response to type I interferon [GO:0034340]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN961_c1_g1_i2	Q9WU40	MAN1_MOUSE	52.2	180	75	4	23	559	736	905	3.90E-39	162.9	MAN1_MOUSE	reviewed	Inner nuclear membrane protein Man1 (LEM domain-containing protein 3)	Lemd3 Man1	Mus musculus (Mouse)	921	integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; chromatin DNA binding [GO:0031490]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration involved in intussusceptive angiogenesis [GO:0002044]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; regulation of cell cycle [GO:0051726]; regulation of extracellular matrix organization [GO:1903053]; regulation of intracellular signal transduction [GO:1902531]; skeletal muscle cell differentiation [GO:0035914]	integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]	chromatin DNA binding [GO:0031490]	GO:0001525; GO:0002044; GO:0005635; GO:0005637; GO:0005639; GO:0006997; GO:0006998; GO:0016021; GO:0030512; GO:0030514; GO:0031490; GO:0031965; GO:0032926; GO:0035914; GO:0051726; GO:1902531; GO:1903053	angiogenesis [GO:0001525]; blood vessel endothelial cell migration involved in intussusceptive angiogenesis [GO:0002044]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; regulation of cell cycle [GO:0051726]; regulation of extracellular matrix organization [GO:1903053]; regulation of intracellular signal transduction [GO:1902531]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1979_c0_g1_i2	Q9XYN0	INX1_SCHAM	52.1	328	152	2	3	986	39	361	3.30E-107	389.8	INX1_SCHAM	reviewed	Innexin inx1 (Innexin-1) (G-Inx1)	inx1	Schistocerca americana (American grasshopper)	361	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN1979_c0_g1_i3	Q9XYN0	INX1_SCHAM	53.6	233	103	2	3	701	39	266	1.20E-76	287.7	INX1_SCHAM	reviewed	Innexin inx1 (Innexin-1) (G-Inx1)	inx1	Schistocerca americana (American grasshopper)	361	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN1979_c0_g1_i4	Q9XYN0	INX1_SCHAM	53.1	192	90	0	61	636	170	361	5.20E-64	245.7	INX1_SCHAM	reviewed	Innexin inx1 (Innexin-1) (G-Inx1)	inx1	Schistocerca americana (American grasshopper)	361	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g2_i1	Q9V427	INX2_DROME	39.1	289	169	4	9	872	84	366	1.30E-57	224.9	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	1	NA	NA	NA
TRINITY_DN1345_c0_g2_i2	Q9V427	INX2_DROME	38.4	289	171	2	9	872	84	366	3.10E-56	220.3	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	1	NA	NA	NA
TRINITY_DN11586_c0_g1_i1	Q9V427	INX2_DROME	35.7	364	217	7	1215	142	1	353	4.50E-58	226.9	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1793_c0_g1_i3	Q9V427	INX2_DROME	47.6	143	68	6	68	487	1	139	3.20E-25	116.3	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1793_c1_g1_i1	Q9V427	INX2_DROME	51.2	164	80	0	2	493	106	269	2.70E-48	193.4	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN34659_c0_g1_i1	Q9V427	INX2_DROME	46.3	67	36	0	81	281	11	77	4.40E-11	68.6	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN23883_c1_g1_i1	Q9V427	INX2_DROME	56.1	66	27	1	28	219	106	171	5.60E-14	77.8	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN40401_c0_g1_i1	Q9V427	INX2_DROME	47.7	111	58	0	3	335	148	258	2.90E-25	115.9	INX2_DROME	reviewed	Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)	Inx2 prp33 CG4590	Drosophila melanogaster (Fruit fly)	367	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098	cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN21515_c0_g2_i1	Q9XYN1	INX2_SCHAM	54.9	51	23	0	53	205	1	51	1.30E-09	63.2	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN21515_c0_g1_i1	Q9XYN1	INX2_SCHAM	50.3	151	71	2	2	448	45	193	6.50E-41	168.3	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN5490_c0_g1_i1	Q9XYN1	INX2_SCHAM	46.6	365	186	5	1221	133	1	358	3.80E-94	346.7	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN26858_c0_g1_i1	Q9XYN1	INX2_SCHAM	52.2	67	31	1	201	1	227	292	4.40E-13	74.7	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN36246_c0_g1_i1	Q9XYN1	INX2_SCHAM	48.8	80	40	1	251	12	214	292	6.50E-14	77.8	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN12977_c0_g1_i1	Q9XYN1	INX2_SCHAM	49.4	89	44	1	347	84	267	355	1.10E-19	97.4	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		blue	blue	NA	NA	NA	NA
TRINITY_DN12977_c1_g1_i1	Q9XYN1	INX2_SCHAM	48.1	210	107	2	627	1	138	346	7.90E-53	208.4	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN38904_c0_g1_i1	Q9XYN1	INX2_SCHAM	64.4	360	123	3	1174	98	1	356	3.10E-141	503.1	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	1	NA	NA	NA
TRINITY_DN1793_c0_g1_i1	Q9XYN1	INX2_SCHAM	45.3	276	144	3	7	822	31	303	2.20E-66	253.8	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		blue	blue	NA	NA	NA	NA
TRINITY_DN1793_c0_g1_i4	Q9XYN1	INX2_SCHAM	44	302	162	6	102	998	6	303	8.30E-68	258.8	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN38844_c0_g1_i1	Q9XYN1	INX2_SCHAM	50.8	63	23	2	3	191	65	119	1.10E-08	60.5	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN23883_c0_g1_i1	Q9XYN1	INX2_SCHAM	54.2	144	64	1	430	5	85	228	4.60E-39	162.2	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN7320_c0_g1_i1	Q9XYN1	INX2_SCHAM	52.2	358	165	4	95	1159	1	355	9.20E-110	398.7	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		blue	blue	NA	NA	NA	NA
TRINITY_DN27355_c0_g1_i1	Q9XYN1	INX2_SCHAM	56.2	64	27	1	2	193	230	292	4.90E-15	81.3	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN30572_c0_g1_i1	Q9XYN1	INX2_SCHAM	52.3	107	50	1	2	319	253	359	9.70E-29	127.5	INX2_SCHAM	reviewed	Innexin inx2 (Innexin-2) (G-Inx2)	inx2	Schistocerca americana (American grasshopper)	359	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; ion transport [GO:0006811]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN37010_c0_g1_i1	Q9VAS7	INX3_DROME	38	92	57	0	5	280	203	294	8.80E-12	70.9	INX3_DROME	reviewed	Innexin inx3 (Innexin-3)	Inx3 CG1448	Drosophila melanogaster (Fruit fly)	395	"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"	apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328	"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22028_c0_g1_i1	Q9VAS7	INX3_DROME	35.4	353	212	6	1238	210	6	352	3.10E-59	230.7	INX3_DROME	reviewed	Innexin inx3 (Innexin-3)	Inx3 CG1448	Drosophila melanogaster (Fruit fly)	395	"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"	apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328	"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"		blue	blue	NA	NA	NA	NA
TRINITY_DN22028_c0_g1_i3	Q9VAS7	INX3_DROME	35.4	353	212	6	1238	210	6	352	3.30E-59	230.7	INX3_DROME	reviewed	Innexin inx3 (Innexin-3)	Inx3 CG1448	Drosophila melanogaster (Fruit fly)	395	"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"	apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328	"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30750_c0_g1_i1	Q9VAS7	INX3_DROME	40.9	66	39	0	200	3	168	233	1.30E-07	56.6	INX3_DROME	reviewed	Innexin inx3 (Innexin-3)	Inx3 CG1448	Drosophila melanogaster (Fruit fly)	395	"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"	apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328	"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11353_c4_g1_i1	Q9VAS7	INX3_DROME	42.3	52	30	0	161	6	199	250	1.10E-05	50.8	INX3_DROME	reviewed	Innexin inx3 (Innexin-3)	Inx3 CG1448	Drosophila melanogaster (Fruit fly)	395	"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"	apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328	"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4646_c0_g1_i1	Q9VAS7	INX3_DROME	33.2	367	235	3	80	1150	3	369	1.00E-57	225.7	INX3_DROME	reviewed	Innexin inx3 (Innexin-3)	Inx3 CG1448	Drosophila melanogaster (Fruit fly)	395	"apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"	apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328	"dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1793_c0_g1_i2	Q9V3W6	INX7_DROME	44	134	69	4	114	506	12	142	2.80E-24	113.2	INX7_DROME	reviewed	Innexin inx7 (Innexin-7) (Gap junction protein prp7) (Pas-related protein 7)	Inx7 prp7 CG2977	Drosophila melanogaster (Fruit fly)	438	cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; medium-term memory [GO:0072375]; phototransduction [GO:0007602]	cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005634; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0010496; GO:0016021; GO:0072375	intercellular transport [GO:0010496]; ion transport [GO:0006811]; medium-term memory [GO:0072375]; phototransduction [GO:0007602]		NA	NA	NA	NA	NA	NA
TRINITY_DN371_c1_g1_i3	Q9V3W6	INX7_DROME	22	359	228	9	1175	228	22	371	4.40E-05	50.8	INX7_DROME	reviewed	Innexin inx7 (Innexin-7) (Gap junction protein prp7) (Pas-related protein 7)	Inx7 prp7 CG2977	Drosophila melanogaster (Fruit fly)	438	cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; medium-term memory [GO:0072375]; phototransduction [GO:0007602]	cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005634; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0010496; GO:0016021; GO:0072375	intercellular transport [GO:0010496]; ion transport [GO:0006811]; medium-term memory [GO:0072375]; phototransduction [GO:0007602]		NA	NA	NA	NA	NA	NA
TRINITY_DN34701_c0_g1_i1	P33085	SHAKB_DROME	69.7	66	20	0	2	199	208	273	3.30E-24	111.7	SHAKB_DROME	reviewed	Innexin shaking-B (Protein passover)	shakB Pas shak-B CG34358	Drosophila melanogaster (Fruit fly)	372	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]; cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gap junction channel activity [GO:0005243]; photoreceptor activity [GO:0009881]	GO:0003254; GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007602; GO:0007630; GO:0009416; GO:0009881; GO:0010496; GO:0010644; GO:0016021; GO:0016264; GO:0055085	cell communication by electrical coupling [GO:0010644]; gap junction assembly [GO:0016264]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; jump response [GO:0007630]; phototransduction [GO:0007602]; regulation of membrane depolarization [GO:0003254]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN4795_c0_g1_i1	Q9C086	IN80B_HUMAN	33.3	195	123	4	691	113	150	339	8.70E-09	62.4	IN80B_HUMAN	reviewed	INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4)	INO80B HMGA1L4 PAPA1 ZNHIT4	Homo sapiens (Human)	356	Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ATP-dependent chromatin remodeling [GO:0043044]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; protein deubiquitination [GO:0016579]	Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016579; GO:0031011; GO:0043044; GO:0046872	ATP-dependent chromatin remodeling [GO:0043044]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN31_c0_g2_i1	Q29RS4	IN80E_BOVIN	73.5	68	18	0	112	315	6	73	2.10E-19	97.1	IN80E_BOVIN	reviewed	INO80 complex subunit E (Coiled-coil domain-containing protein 95)	INO80E CCDC95	Bos taurus (Bovine)	244	Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006338; GO:0031011	chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN35249_c0_g1_i1	O77460	IPYR_DROME	55.7	97	43	0	292	2	137	233	7.50E-30	131	IPYR_DROME	reviewed	Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase)	Nurf-38 CG4634	Drosophila melanogaster (Fruit fly)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; NURF complex [GO:0016589]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; NURF complex [GO:0016589]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766; GO:0045893	"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4416_c0_g1_i1	O77460	IPYR_DROME	61.7	287	109	1	58	915	52	338	3.20E-104	379.8	IPYR_DROME	reviewed	Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase)	Nurf-38 CG4634	Drosophila melanogaster (Fruit fly)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; NURF complex [GO:0016589]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; NURF complex [GO:0016589]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766; GO:0045893	"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4416_c0_g1_i2	O77460	IPYR_DROME	64.1	262	94	0	110	895	77	338	5.50E-101	369	IPYR_DROME	reviewed	Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase)	Nurf-38 CG4634	Drosophila melanogaster (Fruit fly)	338	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; NURF complex [GO:0016589]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; NURF complex [GO:0016589]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766; GO:0045893	"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26554_c0_g1_i1	Q15181	IPYR_HUMAN	100	225	0	0	3	677	15	239	6.20E-136	484.6	IPYR_HUMAN	reviewed	Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase)	PPA1 IOPPP PP	Homo sapiens (Human)	289	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004427; GO:0005737; GO:0005829; GO:0006418; GO:0006796; GO:0070062; GO:0071344	diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN4128_c0_g1_i1	Q8SR69	IPYR_ENCCU	62.4	170	61	2	501	1	26	195	1.70E-53	210.3	IPYR_ENCCU	reviewed	Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase)	IPP1 ECU10_0340	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	277	cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796]	cytoplasm [GO:0005737]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004427; GO:0005737; GO:0006796	phosphate-containing compound metabolic process [GO:0006796]		NA	NA	NA	NA	NA	NA
TRINITY_DN36079_c0_g1_i1	Q9D819	IPYR_MOUSE	100	132	0	0	396	1	40	171	1.90E-76	286.2	IPYR_MOUSE	reviewed	Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase)	Ppa1 Pp Pyp	Mus musculus (Mouse)	289	cytosol [GO:0005829]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; pyrophosphatase activity [GO:0016462]; phosphate-containing compound metabolic process [GO:0006796]	cytosol [GO:0005829]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; pyrophosphatase activity [GO:0016462]	GO:0000287; GO:0004427; GO:0005829; GO:0006796; GO:0016462	phosphate-containing compound metabolic process [GO:0006796]		NA	NA	NA	NA	NA	NA
TRINITY_DN11188_c0_g1_i1	Q9H2U2	IPYR2_HUMAN	99.3	147	1	0	441	1	143	289	2.50E-85	315.8	IPYR2_HUMAN	reviewed	"Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2)"	PPA2 HSPC124	Homo sapiens (Human)	334	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004427; GO:0004722; GO:0005759; GO:0005829; GO:0006418; GO:0006796; GO:0051881; GO:0071344	diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN11188_c0_g1_i2	Q9H2U2	IPYR2_HUMAN	94.2	138	8	0	416	3	143	280	2.20E-75	282.7	IPYR2_HUMAN	reviewed	"Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2)"	PPA2 HSPC124	Homo sapiens (Human)	334	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004427; GO:0004722; GO:0005759; GO:0005829; GO:0006418; GO:0006796; GO:0051881; GO:0071344	diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN36718_c0_g1_i1	F6Y089	ITPA_CIOIN	62	71	27	0	214	2	34	104	1.40E-21	103.2	ITPA_CIOIN	reviewed	Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase)		Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis)	192	cytoplasm [GO:0005737]; dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0009117; GO:0009143; GO:0009204; GO:0035529; GO:0036218; GO:0046872; GO:0047429	deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN18888_c0_g1_i1	Q9D892	ITPA_MOUSE	99.2	122	1	0	3	368	11	132	7.30E-67	254.2	ITPA_MOUSE	reviewed	Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase)	Itpa	Mus musculus (Mouse)	198	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005654; GO:0005737; GO:0005829; GO:0006193; GO:0009143; GO:0009204; GO:0016604; GO:0035529; GO:0035870; GO:0036218; GO:0042802; GO:0046872; GO:0047429; GO:0051276	chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]		NA	NA	NA	NA	NA	NA
TRINITY_DN25935_c0_g1_i1	Q9BY32	ITPA_HUMAN	99	105	1	0	3	317	20	124	2.20E-56	219.2	ITPA_HUMAN	reviewed	Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (Putative oncogene protein hlc14-06-p)	ITPA C20orf37 My049 OK/SW-cl.9	Homo sapiens (Human)	194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]; purine nucleotide catabolic process [GO:0006195]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005654; GO:0005737; GO:0005829; GO:0006193; GO:0006195; GO:0009143; GO:0009204; GO:0016604; GO:0035529; GO:0035870; GO:0036218; GO:0042802; GO:0046872; GO:0047429; GO:0051276	chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]; purine nucleotide catabolic process [GO:0006195]		NA	NA	NA	NA	NA	NA
TRINITY_DN39595_c0_g1_i1	E0VVF6	ITPA_PEDHC	58.5	53	22	0	39	197	63	115	3.90E-15	81.6	ITPA_PEDHC	reviewed	Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase)	Phum_PHUM462900	Pediculus humanus subsp. corporis (Body louse)	190	cytoplasm [GO:0005737]; dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0009117; GO:0009204; GO:0035529; GO:0036218; GO:0046872	deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN25473_c0_g1_i1	Q2NLA8	ITPA_XENLA	72.6	135	37	0	406	2	5	139	2.80E-53	209.5	ITPA_XENLA	reviewed	Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase)	itpa	Xenopus laevis (African clawed frog)	195	cytoplasm [GO:0005737]; dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleotide metabolic process [GO:0009117]	cytoplasm [GO:0005737]	dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005737; GO:0009117; GO:0009204; GO:0035529; GO:0036218; GO:0046872	deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleotide metabolic process [GO:0009117]		blue	blue	NA	NA	NA	NA
TRINITY_DN36760_c0_g1_i1	P31002	IMDH_ACICA	76.4	72	17	0	216	1	257	328	1.40E-25	116.3	IMDH_ACICA	reviewed	Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205)	guaB	Acinetobacter calcoaceticus	488	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]		IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0006177; GO:0046872	GMP biosynthetic process [GO:0006177]		NA	NA	NA	NA	NA	NA
TRINITY_DN26823_c0_g1_i1	Q54QQ0	IMDH_DICDI	62.9	70	26	0	211	2	36	105	3.30E-19	95.1	IMDH_DICDI	reviewed	Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205)	impdh guaB DDB_G0283701	Dictyostelium discoideum (Slime mold)	515	cytoplasm [GO:0005737]; phagocytic vesicle [GO:0045335]; chromatin binding [GO:0003682]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; phagocytic vesicle [GO:0045335]	chromatin binding [GO:0003682]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003682; GO:0003938; GO:0005737; GO:0006177; GO:0006183; GO:0045335; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN34357_c0_g1_i1	Q9KH33	IMDH_RHITR	80	90	18	0	3	272	316	405	1.30E-33	143.3	IMDH_RHITR	reviewed	Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205)	guaB	Rhizobium tropici	498	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]		IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0006177; GO:0046872	GMP biosynthetic process [GO:0006177]		NA	NA	NA	NA	NA	NA
TRINITY_DN30386_c0_g1_i1	A0JNA3	IMDH1_BOVIN	72.7	333	90	1	997	2	1	333	7.60E-136	485	IMDH1_BOVIN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	IMPDH1	Bos taurus (Bovine)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN4133_c0_g1_i1	F6S675	IMDH1_XENTR	74.6	59	15	0	2	178	454	512	5.60E-20	98.6	IMDH1_XENTR	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	impdh1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	512	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN4133_c0_g1_i2	A0JNA3	IMDH1_BOVIN	78	59	13	0	2	178	456	514	2.60E-22	105.5	IMDH1_BOVIN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	IMPDH1	Bos taurus (Bovine)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN27764_c0_g1_i1	A0JNA3	IMDH1_BOVIN	86.8	68	9	0	205	2	59	126	2.70E-28	125.9	IMDH1_BOVIN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	IMPDH1	Bos taurus (Bovine)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN27764_c0_g1_i1	A0JNA3	IMDH1_BOVIN	84.6	39	6	0	324	208	19	57	1.00E-11	70.9	IMDH1_BOVIN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	IMPDH1	Bos taurus (Bovine)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN27764_c0_g1_i2	A0JNA3	IMDH1_BOVIN	98.6	70	1	0	212	3	59	128	3.40E-34	145.6	IMDH1_BOVIN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	IMPDH1	Bos taurus (Bovine)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN27764_c0_g1_i2	A0JNA3	IMDH1_BOVIN	84.6	39	6	0	331	215	19	57	1.10E-11	70.9	IMDH1_BOVIN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205)	IMPDH1	Bos taurus (Bovine)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]		NA	NA	NA	NA	NA	NA
TRINITY_DN26076_c0_g1_i1	P20839	IMDH1_HUMAN	99.4	175	1	0	527	3	124	298	3.90E-93	342	IMDH1_HUMAN	reviewed	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I)	IMPDH1 IMPD1	Homo sapiens (Human)	514	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	GO:0000166; GO:0003676; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006177; GO:0006183; GO:0009168; GO:0034774; GO:0035578; GO:0042802; GO:0043312; GO:0046651; GO:0046872; GO:1904813	GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN26525_c0_g1_i1	P12268	IMDH2_HUMAN	99.4	171	1	0	514	2	134	304	1.40E-92	340.1	IMDH2_HUMAN	reviewed	Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II)	IMPDH2 IMPD2	Homo sapiens (Human)	514	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; retina development in camera-type eye [GO:0060041]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	GO:0000166; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005778; GO:0005829; GO:0006177; GO:0006183; GO:0007623; GO:0009168; GO:0016020; GO:0034774; GO:0042802; GO:0043312; GO:0046651; GO:0046872; GO:0060041; GO:0070062; GO:0071353; GO:1904813	cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN37359_c0_g1_i1	P12269	IMDH2_CRIGR	100	127	0	0	383	3	1	127	1.60E-68	260	IMDH2_CRIGR	reviewed	Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II)	IMPDH2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	514	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; lymphocyte proliferation [GO:0046651]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0005829; GO:0006177; GO:0007623; GO:0046651; GO:0046872; GO:0071353	cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; lymphocyte proliferation [GO:0046651]		NA	NA	NA	NA	NA	NA
TRINITY_DN3073_c0_g1_i1	Q5RHB5	LRMP_DANRE	42.2	135	77	1	152	553	1131	1265	2.00E-20	100.9	IRAG2_DANRE	reviewed	"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein)"	irag2 lrmp si:dkey-172o10.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1447	centrosome [GO:0005813]; chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear membrane [GO:0031965]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; positive regulation of chromosome segregation [GO:0051984]; pronuclear fusion [GO:0007344]; pronuclear migration [GO:0035046]	centrosome [GO:0005813]; chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear membrane [GO:0031965]		GO:0000785; GO:0005789; GO:0005813; GO:0007052; GO:0007344; GO:0016021; GO:0031965; GO:0035046; GO:0051028; GO:0051984; GO:0072686; GO:0097431	mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; positive regulation of chromosome segregation [GO:0051984]; pronuclear fusion [GO:0007344]; pronuclear migration [GO:0035046]		NA	NA	NA	NA	NA	NA
TRINITY_DN14784_c0_g1_i2	P29993	ITPR_DROME	59.1	132	54	0	399	4	2276	2407	1.10E-39	164.1	ITPR_DROME	reviewed	"Inositol 1,4,5-trisphosphate receptor (InsP3 receptor) (IP3R) (InsP3R)"	Itpr dip InsP3R Itp-r83A CG1063	Drosophila melanogaster (Fruit fly)	2838	"axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]"	axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]	"calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"	GO:0000280; GO:0005220; GO:0005509; GO:0005783; GO:0005789; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0006979; GO:0007591; GO:0007601; GO:0007608; GO:0007629; GO:0009267; GO:0010888; GO:0016021; GO:0016319; GO:0016529; GO:0030322; GO:0030536; GO:0030659; GO:0030667; GO:0035071; GO:0035091; GO:0042594; GO:0044295; GO:0046000; GO:0050909; GO:0051209; GO:0051482; GO:0055088; GO:0055089; GO:0060259; GO:0070588; GO:0070679; GO:0071361	"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7423_c0_g1_i1	P29993	ITPR_DROME	57.8	427	164	7	1243	5	1786	2210	2.40E-117	423.7	ITPR_DROME	reviewed	"Inositol 1,4,5-trisphosphate receptor (InsP3 receptor) (IP3R) (InsP3R)"	Itpr dip InsP3R Itp-r83A CG1063	Drosophila melanogaster (Fruit fly)	2838	"axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]"	axonal growth cone [GO:0044295]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum [GO:0005790]	"calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"	GO:0000280; GO:0005220; GO:0005509; GO:0005783; GO:0005789; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0006979; GO:0007591; GO:0007601; GO:0007608; GO:0007629; GO:0009267; GO:0010888; GO:0016021; GO:0016319; GO:0016529; GO:0030322; GO:0030536; GO:0030659; GO:0030667; GO:0035071; GO:0035091; GO:0042594; GO:0044295; GO:0046000; GO:0050909; GO:0051209; GO:0051482; GO:0055088; GO:0055089; GO:0060259; GO:0070588; GO:0070679; GO:0071361	"calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to starvation [GO:0009267]; fatty acid homeostasis [GO:0055089]; flight behavior [GO:0007629]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; molting cycle, chitin-based cuticle [GO:0007591]; mushroom body development [GO:0016319]; negative regulation of lipid storage [GO:0010888]; nuclear division [GO:0000280]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ecdysteroid secretion [GO:0046000]; regulation of feeding behavior [GO:0060259]; release of sequestered calcium ion into cytosol [GO:0051209]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; salivary gland cell autophagic cell death [GO:0035071]; sensory perception of smell [GO:0007608]; sensory perception of taste [GO:0050909]; stabilization of membrane potential [GO:0030322]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20282_c0_g1_i1	Q14643	ITPR1_HUMAN	50.8	177	60	5	659	135	2413	2564	3.90E-34	146.4	ITPR1_HUMAN	reviewed	"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)"	ITPR1 INSP3R1	Homo sapiens (Human)	2758	"calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]"	calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]	"calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"	GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0030168; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050796; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:1903779	calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]		NA	NA	NA	NA	NA	NA
TRINITY_DN20282_c0_g1_i2	Q14643	ITPR1_HUMAN	53.1	194	64	5	596	21	2413	2581	1.00E-41	171.4	ITPR1_HUMAN	reviewed	"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)"	ITPR1 INSP3R1	Homo sapiens (Human)	2758	"calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]"	calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]	"calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"	GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0030168; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050796; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:1903779	calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]		NA	NA	NA	NA	NA	NA
TRINITY_DN40741_c0_g1_i1	Q14643	ITPR1_HUMAN	100	75	0	0	247	23	2507	2581	1.20E-36	153.3	ITPR1_HUMAN	reviewed	"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)"	ITPR1 INSP3R1	Homo sapiens (Human)	2758	"calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]"	calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]	"calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]"	GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0030168; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050796; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:1903779	calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]		NA	NA	NA	NA	NA	NA
TRINITY_DN14784_c0_g1_i1	Q8WN96	ITPR2_BOVIN	69.1	68	21	0	293	90	2138	2205	5.90E-22	104.8	ITPR2_BOVIN	reviewed	"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)"	ITPR2	Bos taurus (Bovine)	2701	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]	"inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]"	GO:0005220; GO:0005789; GO:0005791; GO:0016021; GO:0030658; GO:0030667; GO:0070679			NA	NA	NA	NA	NA	NA
TRINITY_DN6828_c0_g1_i1	Q9VR59	VIP1_DROME	82.9	428	72	1	96	1379	65	491	7.10E-211	734.6	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN5306_c0_g1_i2	Q9VR59	VIP1_DROME	74.2	387	95	1	44	1204	569	950	3.90E-168	592.4	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN5306_c0_g1_i4	Q9VR59	VIP1_DROME	71.8	273	72	1	44	862	569	836	3.90E-109	396	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN5306_c0_g1_i7	Q9VR59	VIP1_DROME	66.7	51	12	1	60	212	791	836	1.10E-11	70.5	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN5306_c0_g1_i8	Q9VR59	VIP1_DROME	75.5	237	53	1	102	812	719	950	5.50E-105	382.1	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN5306_c0_g2_i1	Q9VR59	VIP1_DROME	84.8	33	5	0	91	189	918	950	1.90E-11	69.7	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN8479_c0_g1_i1	Q9VR59	VIP1_DROME	65.6	125	42	1	386	12	191	314	4.20E-44	178.7	VIP1_DROME	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)	l(1)G0196 CG14616	Drosophila melanogaster (Fruit fly)	1696	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]		NA	NA	NA	NA	NA	NA
TRINITY_DN32284_c0_g1_i1	O43314	VIP2_HUMAN	54.5	44	20	0	175	44	168	211	2.60E-08	58.9	VIP2_HUMAN	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2)	PPIP5K2 HISPPD1 KIAA0433 VIP2	Homo sapiens (Human)	1243	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN29676_c0_g1_i1	O43314	VIP2_HUMAN	100	97	0	0	3	293	139	235	7.70E-51	200.7	VIP2_HUMAN	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2)	PPIP5K2 HISPPD1 KIAA0433 VIP2	Homo sapiens (Human)	1243	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN18323_c0_g1_i1	O43314	VIP2_HUMAN	100	100	0	0	300	1	708	807	6.40E-53	207.6	VIP2_HUMAN	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2)	PPIP5K2 HISPPD1 KIAA0433 VIP2	Homo sapiens (Human)	1243	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]"	cytosol [GO:0005829]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN30172_c0_g1_i1	F4J8C6	VIP1L_ARATH	61.6	73	26	1	236	24	516	588	4.50E-17	88.2	VIP1L_ARATH	reviewed	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase VIP1 (EC 2.7.4.21) (EC 2.7.4.24) (Probable protein QUANTITATIVE VITAMIN E-7) (Protein VIP HOMOLOG 2) (VIP1 homolog protein 1) (Arabidopsis homolog protein of yeast VIP1 1) (AtVIP1)	VIP1 QVE7 VIH2 At3g01310 T22N4.6 T4P13.1	Arabidopsis thaliana (Mouse-ear cress)	1050	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; defense response to fungus, incompatible interaction [GO:0009817]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; jasmonic acid and ethylene-dependent systemic resistance [GO:0009861]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of defense response to insect [GO:1900367]; positive regulation of vitamin E biosynthetic process [GO:1904966]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0005886; GO:0006020; GO:0009817; GO:0009861; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092; GO:1900367; GO:1904966; GO:1905036	"defense response to fungus, incompatible interaction [GO:0009817]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; jasmonic acid and ethylene-dependent systemic resistance [GO:0009861]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of defense response to insect [GO:1900367]; positive regulation of vitamin E biosynthetic process [GO:1904966]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4515_c0_g1_i1	Q2YDR3	IMPA3_DANRE	48.7	337	152	7	106	1080	6	333	2.00E-73	277.7	IMPA3_DANRE	reviewed	"Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3)"	bpnt2 impa3 impad1 zgc:123256	Danio rerio (Zebrafish) (Brachydanio rerio)	341	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; 3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]	3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]	GO:0006021; GO:0008254; GO:0008934; GO:0012505; GO:0016021; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833	inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]		blue	blue	NA	NA	NA	NA
TRINITY_DN33211_c0_g1_i1	Q4V8T0	MIOX_DANRE	68.1	138	44	0	481	68	141	278	1.10E-59	230.7	MIOX_DANRE	reviewed	Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase)	miox zgc:114168	Danio rerio (Zebrafish) (Brachydanio rerio)	278	cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; inositol catabolic process [GO:0019310]	cytoplasm [GO:0005737]	ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]	GO:0005737; GO:0008199; GO:0019310; GO:0050113	inositol catabolic process [GO:0019310]		NA	NA	NA	NA	NA	NA
TRINITY_DN896_c0_g1_i1	P21327	INPP_BOVIN	44.2	385	188	8	1226	129	1	377	5.80E-80	299.7	INPP_BOVIN	reviewed	Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57)	INPP1	Bos taurus (Bovine)	400	"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]"		"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]"	GO:0004441; GO:0046854; GO:0046855; GO:0046872	inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN896_c0_g1_i2	P21327	INPP_BOVIN	44.2	385	188	8	1226	129	1	377	4.10E-80	300.1	INPP_BOVIN	reviewed	Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57)	INPP1	Bos taurus (Bovine)	400	"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]"		"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]"	GO:0004441; GO:0046854; GO:0046855; GO:0046872	inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN17417_c0_g2_i3	Q01968	OCRL_HUMAN	41.9	899	458	18	208	2805	29	896	4.20E-189	663.3	OCRL_HUMAN	reviewed	"Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Lowe oculocerebrorenal syndrome protein) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86)"	OCRL OCRL1	Homo sapiens (Human)	901	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; Golgi-associated vesicle [GO:0005798]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; Rac GTPase binding [GO:0048365]; cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; lipid metabolic process [GO:0006629]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi-associated vesicle [GO:0005798]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	"GTPase activator activity [GO:0005096]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol phosphate phosphatase activity [GO:0052745]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; Rac GTPase binding [GO:0048365]"	GO:0001701; GO:0001750; GO:0004439; GO:0004445; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005769; GO:0005795; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005905; GO:0006629; GO:0006661; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031901; GO:0043087; GO:0043647; GO:0046855; GO:0046856; GO:0048365; GO:0051056; GO:0052658; GO:0052659; GO:0052745; GO:0060271; GO:0061024	cilium assembly [GO:0060271]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; in utero embryonic development [GO:0001701]; lipid metabolic process [GO:0006629]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN9183_c0_g1_i1	Q96PE3	INP4A_HUMAN	36	89	55	1	383	123	89	177	1.80E-06	53.9	INP4A_HUMAN	reviewed	"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)"	INPP4A	Homo sapiens (Human)	977	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]	"phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0031901; GO:0034597; GO:0043647; GO:0055038	inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1881_c0_g1_i1	Q29467	I5P1_CANLF	48.8	414	196	6	2743	1544	1	412	4.60E-108	394	I5P1_CANLF	reviewed	"Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)"	INPP5A	Canis lupus familiaris (Dog) (Canis familiaris)	412	"dendrite [GO:0030425]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]"	dendrite [GO:0030425]; plasma membrane [GO:0005886]	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]"	GO:0004445; GO:0005886; GO:0030425; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN1881_c0_g1_i10	Q29467	I5P1_CANLF	49.7	388	184	5	1393	257	1	386	4.20E-105	383.3	I5P1_CANLF	reviewed	"Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)"	INPP5A	Canis lupus familiaris (Dog) (Canis familiaris)	412	"dendrite [GO:0030425]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]"	dendrite [GO:0030425]; plasma membrane [GO:0005886]	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]"	GO:0004445; GO:0005886; GO:0030425; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN1881_c0_g1_i3	Q29467	I5P1_CANLF	49.2	392	188	5	1221	73	1	390	1.30E-105	384.8	I5P1_CANLF	reviewed	"Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)"	INPP5A	Canis lupus familiaris (Dog) (Canis familiaris)	412	"dendrite [GO:0030425]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]"	dendrite [GO:0030425]; plasma membrane [GO:0005886]	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]"	GO:0004445; GO:0005886; GO:0030425; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN1881_c0_g1_i5	Q29467	I5P1_CANLF	41.9	136	69	4	390	7	228	361	1.50E-20	100.5	I5P1_CANLF	reviewed	"Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)"	INPP5A	Canis lupus familiaris (Dog) (Canis familiaris)	412	"dendrite [GO:0030425]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]"	dendrite [GO:0030425]; plasma membrane [GO:0005886]	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]"	GO:0004445; GO:0005886; GO:0030425; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i1	Q5F480	ITPK1_CHICK	39.5	337	190	4	1182	178	2	326	5.10E-67	256.5	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i2	Q5F480	ITPK1_CHICK	41.4	222	127	2	689	30	2	222	2.50E-48	193.7	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i4	Q5F480	ITPK1_CHICK	40.5	328	188	4	1149	178	2	326	2.70E-67	257.3	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i5	Q5F480	ITPK1_CHICK	40.5	328	188	4	1149	178	2	326	4.60E-67	256.9	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i7	Q5F480	ITPK1_CHICK	39.5	337	190	4	1182	178	2	326	8.00E-67	256.1	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i8	Q5F480	ITPK1_CHICK	40.5	328	188	4	1149	178	2	326	2.90E-67	257.3	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1252_c0_g1_i9	Q5F480	ITPK1_CHICK	41.4	222	127	2	689	30	2	222	2.30E-48	193.7	ITPK1_CHICK	reviewed	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	ITPK1 RCJMB04_2g4	Gallus gallus (Chicken)	407	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]		NA	NA	NA	NA	NA	NA
TRINITY_DN38593_c0_g1_i1	P23677	IP3KA_HUMAN	60.4	235	91	2	6	707	225	458	2.30E-76	287	IP3KA_HUMAN	reviewed	"Inositol-trisphosphate 3-kinase A (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase A) (IP3 3-kinase A) (IP3K A) (InsP 3-kinase A)"	ITPKA	Homo sapiens (Human)	461	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol hexakisphosphate kinase activity [GO:0000828]; kinase activity [GO:0016301]; Rac GTPase binding [GO:0048365]"	GO:0000828; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006020; GO:0007165; GO:0008440; GO:0016301; GO:0030036; GO:0032958; GO:0043197; GO:0043647; GO:0046854; GO:0048167; GO:0048365; GO:0061003; GO:0097062	actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1025_c0_g1_i1	Q95Q62	IP3KH_CAEEL	47.7	298	151	3	609	1487	172	469	1.80E-72	275	IP3KH_CAEEL	reviewed	"Inositol-trisphosphate 3-kinase homolog (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase homolog) (IP3 3-kinase) (IP3K) (InsP 3-kinase) (let-23 fertility effector 2)"	lfe-2 C46H11.4	Caenorhabditis elegans	494	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; hermaphrodite genitalia morphogenesis [GO:0048815]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphorylation [GO:0046854]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol hexakisphosphate kinase activity [GO:0000828]; kinase activity [GO:0016301]"	GO:0000828; GO:0005524; GO:0005634; GO:0005737; GO:0008440; GO:0016301; GO:0032958; GO:0046854; GO:0048815	hermaphrodite genitalia morphogenesis [GO:0048815]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3680_c0_g1_i2	P35569	IRS1_MOUSE	35.9	251	128	5	71	739	22	267	9.30E-41	169.9	IRS1_MOUSE	reviewed	Insulin receptor substrate 1 (IRS-1)	Irs1 Irs-1	Mus musculus (Mouse)	1233	caveola [GO:0005901]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lipid catabolic process [GO:0016042]; mammary gland development [GO:0030879]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell migration [GO:0030335]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein kinase B signaling [GO:0043491]; protein localization to nucleus [GO:0034504]; regulation of gene expression [GO:0010468]; response to caffeine [GO:0031000]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]	caveola [GO:0005901]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001784; GO:0002053; GO:0005068; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0005901; GO:0008286; GO:0010468; GO:0010907; GO:0014065; GO:0016042; GO:0019901; GO:0019904; GO:0030159; GO:0030335; GO:0030879; GO:0031000; GO:0032000; GO:0032868; GO:0032869; GO:0034504; GO:0036064; GO:0042169; GO:0042327; GO:0043231; GO:0043434; GO:0043491; GO:0043548; GO:0043552; GO:0044877; GO:0045725; GO:0046326; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0070094; GO:0071398; GO:0090275; GO:1904385	cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; lipid catabolic process [GO:0016042]; mammary gland development [GO:0030879]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell migration [GO:0030335]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein kinase B signaling [GO:0043491]; protein localization to nucleus [GO:0034504]; regulation of gene expression [GO:0010468]; response to caffeine [GO:0031000]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3680_c0_g1_i3	P35569	IRS1_MOUSE	36.9	260	131	5	1	696	13	267	7.40E-43	176.8	IRS1_MOUSE	reviewed	Insulin receptor substrate 1 (IRS-1)	Irs1 Irs-1	Mus musculus (Mouse)	1233	caveola [GO:0005901]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; lipid catabolic process [GO:0016042]; mammary gland development [GO:0030879]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell migration [GO:0030335]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein kinase B signaling [GO:0043491]; protein localization to nucleus [GO:0034504]; regulation of gene expression [GO:0010468]; response to caffeine [GO:0031000]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]	caveola [GO:0005901]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001784; GO:0002053; GO:0005068; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0005901; GO:0008286; GO:0010468; GO:0010907; GO:0014065; GO:0016042; GO:0019901; GO:0019904; GO:0030159; GO:0030335; GO:0030879; GO:0031000; GO:0032000; GO:0032868; GO:0032869; GO:0034504; GO:0036064; GO:0042169; GO:0042327; GO:0043231; GO:0043434; GO:0043491; GO:0043548; GO:0043552; GO:0044877; GO:0045725; GO:0046326; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0070094; GO:0071398; GO:0090275; GO:1904385	cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; lipid catabolic process [GO:0016042]; mammary gland development [GO:0030879]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell migration [GO:0030335]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein kinase B signaling [GO:0043491]; protein localization to nucleus [GO:0034504]; regulation of gene expression [GO:0010468]; response to caffeine [GO:0031000]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3680_c0_g1_i4	Q28224	IRS1_CHLAE	28.6	654	335	23	71	1744	22	639	1.10E-39	166.4	IRS1_CHLAE	reviewed	Insulin receptor substrate 1 (IRS-1)	IRS1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	1251	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]	GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0008286; GO:0042169; GO:0043231; GO:0043548; GO:0048009	insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]		NA	NA	NA	NA	NA	NA
TRINITY_DN3680_c0_g1_i6	Q6P4Y6	IRS1_XENTR	35.9	251	132	5	1	705	4	241	3.80E-42	174.5	IRS1_XENTR	reviewed	Insulin receptor substrate 1 (IRS-1)	irs1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	654	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]	GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0042169; GO:0043231; GO:0043548; GO:0048009	insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]		NA	NA	NA	NA	NA	NA
TRINITY_DN3680_c0_g1_i1	P84770	IRS1B_XENLA	34.3	175	89	4	1	450	16	189	8.00E-21	101.7	IRS1B_XENLA	reviewed	Insulin receptor substrate 1-B (IRS1-B) (xIRS-1-B) (XIRS-L')	irs1-b	Xenopus laevis (African clawed frog)	1088	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; SH2 domain binding [GO:0042169]	GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0008286; GO:0042169; GO:0043231; GO:0043548; GO:0048009	insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]		NA	NA	NA	NA	NA	NA
TRINITY_DN14355_c0_g1_i1	Q9JHR7	IDE_MOUSE	71.3	101	29	0	3	305	73	173	5.40E-39	161.4	IDE_MOUSE	reviewed	Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)	Ide	Mus musculus (Mouse)	1019	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]	GO:0001324; GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0044877; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715	age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]		blue	blue	NA	NA	NA	NA
TRINITY_DN6804_c0_g1_i1	Q24K02	IDE_BOVIN	62.4	85	32	0	255	1	304	388	2.90E-25	115.5	IDE_BOVIN	reviewed	Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)	IDE	Bos taurus (Bovine)	1019	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0008270; GO:0008340; GO:0009897; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0032092; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0050435; GO:0051603; GO:0140036; GO:0150094; GO:1901143; GO:1903715	amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]		blue	blue	NA	NA	NA	NA
TRINITY_DN2653_c0_g1_i1	P35559	IDE_RAT	50.6	627	307	2	3	1883	389	1012	1.70E-186	654.1	IDE_RAT	reviewed	Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)	Ide	Rattus norvegicus (Rat)	1019	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]	GO:0001324; GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008233; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0044877; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715	age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]		blue	blue	NA	NA	NA	NA
TRINITY_DN12848_c0_g1_i1	Q9JHR7	IDE_MOUSE	100	76	0	0	229	2	70	145	1.30E-37	156.4	IDE_MOUSE	reviewed	Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)	Ide	Mus musculus (Mouse)	1019	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	amyloid-beta binding [GO:0001540]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]	GO:0001324; GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0044877; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715	age-dependent response to oxidative stress involved in chronological cell aging [GO:0001324]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]		NA	NA	NA	NA	NA	NA
TRINITY_DN2871_c0_g1_i10	O73798	IGF1R_XENLA	37.4	377	213	6	1163	87	934	1305	2.70E-67	258.5	IGF1R_XENLA	reviewed	Insulin-like growth factor 1 receptor (xIGF-1R) (xIGFR) (EC 2.7.10.1) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain]	igf1r	Xenopus laevis (African clawed frog)	1358	integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor-activated receptor activity [GO:0005010]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; insulin-like growth factor receptor signaling pathway [GO:0048009]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; protein autophosphorylation [GO:0046777]	integral component of plasma membrane [GO:0005887]	ATP binding [GO:0005524]; insulin-like growth factor-activated receptor activity [GO:0005010]; insulin-like growth factor binding [GO:0005520]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]	GO:0001556; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005887; GO:0007275; GO:0043548; GO:0043560; GO:0046777; GO:0046872; GO:0048009	insulin-like growth factor receptor signaling pathway [GO:0048009]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN2871_c0_g1_i19	O73798	IGF1R_XENLA	37.4	377	213	6	1163	87	934	1305	4.10E-67	258.5	IGF1R_XENLA	reviewed	Insulin-like growth factor 1 receptor (xIGF-1R) (xIGFR) (EC 2.7.10.1) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain]	igf1r	Xenopus laevis (African clawed frog)	1358	integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor-activated receptor activity [GO:0005010]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; insulin-like growth factor receptor signaling pathway [GO:0048009]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; protein autophosphorylation [GO:0046777]	integral component of plasma membrane [GO:0005887]	ATP binding [GO:0005524]; insulin-like growth factor-activated receptor activity [GO:0005010]; insulin-like growth factor binding [GO:0005520]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]	GO:0001556; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005887; GO:0007275; GO:0043548; GO:0043560; GO:0046777; GO:0046872; GO:0048009	insulin-like growth factor receptor signaling pathway [GO:0048009]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN12283_c0_g1_i12	O42254	IF2B1_CHICK	42.6	352	168	6	1925	876	237	556	2.50E-65	251.5	IF2B1_CHICK	reviewed	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	IGF2BP1 VICKZ1 ZBP1	Gallus gallus (Chicken)	576	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]	GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007399; GO:0010468; GO:0010976; GO:0017148; GO:0030027; GO:0030175; GO:0030426; GO:0048471; GO:0051028; GO:0051252; GO:0070937	mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		NA	NA	NA	NA	NA	NA
TRINITY_DN12283_c0_g1_i23	Q5SF07	IF2B2_MOUSE	45.9	407	204	7	40	1248	173	567	1.50E-80	301.6	IF2B2_MOUSE	reviewed	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)	Igf2bp2 Imp2 Vickz2	Mus musculus (Mouse)	592	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006417; GO:0007399; GO:0010468; GO:0048027; GO:0051028; GO:0051252	mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN12283_c0_g1_i4	Q5SF07	IF2B2_MOUSE	47	413	203	7	40	1266	173	573	1.30E-83	312.8	IF2B2_MOUSE	reviewed	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)	Igf2bp2 Imp2 Vickz2	Mus musculus (Mouse)	592	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006417; GO:0007399; GO:0010468; GO:0048027; GO:0051028; GO:0051252	mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN12283_c0_g1_i8	Q5SF07	IF2B2_MOUSE	45.9	407	204	7	40	1248	173	567	1.60E-80	301.6	IF2B2_MOUSE	reviewed	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)	Igf2bp2 Imp2 Vickz2	Mus musculus (Mouse)	592	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006417; GO:0007399; GO:0010468; GO:0048027; GO:0051028; GO:0051252	mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN12283_c0_g1_i10	Q9PW80	IF2B3_DANRE	43.4	396	196	5	10	1194	168	536	4.90E-78	293.1	IF2B3_DANRE	reviewed	Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP)	igf2bp3 dvr1rbp vickz3	Danio rerio (Zebrafish) (Brachydanio rerio)	582	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]	GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007399; GO:0010468; GO:0051028; GO:0051252	mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN24410_c0_g1_i1	P35859	ALS_RAT	33.7	89	58	1	289	23	412	499	8.70E-06	51.6	ALS_RAT	reviewed	Insulin-like growth factor-binding protein complex acid labile subunit (ALS)	Igfals Als	Rattus norvegicus (Rat)	603	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567]; insulin-like growth factor binding [GO:0005520]; aging [GO:0007568]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to interleukin-1 [GO:0071347]; response to nutrient levels [GO:0031667]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567]	insulin-like growth factor binding [GO:0005520]	GO:0005520; GO:0005615; GO:0007155; GO:0007568; GO:0031012; GO:0031667; GO:0042567; GO:0071347; GO:0071364; GO:0071378; GO:0071549	aging [GO:0007568]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to interleukin-1 [GO:0071347]; response to nutrient levels [GO:0031667]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i1	Q5R9A7	GP155_PONAB	37.7	764	434	11	2	2272	107	835	8.10E-119	429.5	GP155_PONAB	reviewed	Integral membrane protein GPR155	GPR155	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	872	integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0055085	intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i10	Q5R9A7	GP155_PONAB	32.5	572	324	8	3	1613	291	835	4.70E-68	260.4	GP155_PONAB	reviewed	Integral membrane protein GPR155	GPR155	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	872	integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0055085	intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i3	Q5R9A7	GP155_PONAB	38.9	211	119	3	264	884	631	835	4.70E-33	143.3	GP155_PONAB	reviewed	Integral membrane protein GPR155	GPR155	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	872	integral component of membrane [GO:0016021]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0055085	intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i6	Q7Z3F1	GP155_HUMAN	43.4	449	240	6	2	1345	105	540	8.50E-85	315.8	GP155_HUMAN	reviewed	Integral membrane protein GPR155 (G-protein coupled receptor PGR22)	GPR155 PGR22	Homo sapiens (Human)	870	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062	cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i7	Q7Z3F1	GP155_HUMAN	40.2	301	175	2	64	966	245	540	2.00E-51	204.5	GP155_HUMAN	reviewed	Integral membrane protein GPR155 (G-protein coupled receptor PGR22)	GPR155 PGR22	Homo sapiens (Human)	870	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062	cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i8	Q7Z3F1	GP155_HUMAN	62.9	89	32	1	2	265	105	193	3.30E-23	109	GP155_HUMAN	reviewed	Integral membrane protein GPR155 (G-protein coupled receptor PGR22)	GPR155 PGR22	Homo sapiens (Human)	870	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062	cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15037_c0_g1_i9	Q7Z3F1	GP155_HUMAN	50.5	190	85	4	2	568	105	286	6.50E-36	152.1	GP155_HUMAN	reviewed	Integral membrane protein GPR155 (G-protein coupled receptor PGR22)	GPR155 PGR22	Homo sapiens (Human)	870	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062	cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN9022_c0_g1_i1	Q5ZLS8	INT10_CHICK	38.2	144	82	3	3	419	91	232	1.90E-18	93.6	INT10_CHICK	reviewed	Integrator complex subunit 10 (Int10)	INTS10 RCJMB04_4p16	Gallus gallus (Chicken)	710	integrator complex [GO:0032039]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]		GO:0016180; GO:0032039	snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN10058_c0_g1_i1	Q9VAH9	INT11_DROME	35	123	78	2	49	414	473	594	1.40E-17	90.9	INT11_DROME	reviewed	Integrator complex subunit 11 (EC 3.1.27.-)	IntS11 CG1972	Drosophila melanogaster (Fruit fly)	597	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005737; GO:0016180; GO:0016787; GO:0032039; GO:0034472	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN7766_c0_g1_i1	Q9VAH9	INT11_DROME	81.5	92	17	0	2	277	297	388	4.00E-40	165.2	INT11_DROME	reviewed	Integrator complex subunit 11 (EC 3.1.27.-)	IntS11 CG1972	Drosophila melanogaster (Fruit fly)	597	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005737; GO:0016180; GO:0016787; GO:0032039; GO:0034472	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN7766_c0_g1_i2	Q9VAH9	INT11_DROME	79.6	147	30	0	2	442	297	443	2.30E-67	256.1	INT11_DROME	reviewed	Integrator complex subunit 11 (EC 3.1.27.-)	IntS11 CG1972	Drosophila melanogaster (Fruit fly)	597	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005737; GO:0016180; GO:0016787; GO:0032039; GO:0034472	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN30265_c0_g1_i1	Q9CWS4	INT11_MOUSE	100	58	0	0	2	175	305	362	6.90E-30	130.6	INT11_MOUSE	reviewed	Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein)	Ints11 Cpsf3l	Mus musculus (Mouse)	600	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0016787; GO:0032039	snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN29871_c0_g1_i1	Q503E1	INT11_DANRE	80.9	89	17	0	1	267	193	281	2.30E-38	159.1	INT11_DANRE	reviewed	Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein)	cpsf3l ints11 zgc:110671	Danio rerio (Zebrafish) (Brachydanio rerio)	598	nucleus [GO:0005634]; hydrolase activity [GO:0016787]; regulation of RNA splicing [GO:0043484]; snRNA processing [GO:0016180]	nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0016180; GO:0016787; GO:0043484	regulation of RNA splicing [GO:0043484]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN39445_c0_g1_i1	Q5TA45	INT11_HUMAN	99.1	107	1	0	323	3	284	390	3.20E-58	225.3	INT11_HUMAN	reviewed	Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein) (Protein related to CPSF subunits of 68 kDa) (RC-68)	INTS11 CPSF3L RC68	Homo sapiens (Human)	600	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0016787; GO:0032039; GO:0042795; GO:0072562	snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN1380_c0_g1_i1	Q9D168	INT12_MOUSE	34.2	225	125	3	676	50	2	219	1.40E-30	134.8	INT12_MOUSE	reviewed	Integrator complex subunit 12 (Int12) (PHD finger protein 22)	Ints12 Phf22	Mus musculus (Mouse)	461	integrator complex [GO:0032039]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0016180; GO:0032039; GO:0034472; GO:0046872	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN1380_c0_g1_i2	Q9D168	INT12_MOUSE	34.1	226	129	4	691	50	2	219	5.40E-30	132.9	INT12_MOUSE	reviewed	Integrator complex subunit 12 (Int12) (PHD finger protein 22)	Ints12 Phf22	Mus musculus (Mouse)	461	integrator complex [GO:0032039]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0016180; GO:0032039; GO:0034472; GO:0046872	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN36024_c0_g1_i1	Q9H0H0	INT2_HUMAN	100	83	0	0	250	2	36	118	3.40E-39	161.8	INT2_HUMAN	reviewed	Integrator complex subunit 2 (Int2)	INTS2 KIAA1287	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN1042_c0_g1_i1	Q9H0H0	INT2_HUMAN	41.4	331	150	6	1196	303	815	1134	1.60E-60	235	INT2_HUMAN	reviewed	Integrator complex subunit 2 (Int2)	INTS2 KIAA1287	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN1042_c0_g1_i2	Q9H0H0	INT2_HUMAN	44.6	56	30	1	252	85	815	869	5.80E-08	58.5	INT2_HUMAN	reviewed	Integrator complex subunit 2 (Int2)	INTS2 KIAA1287	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		blue	blue	NA	NA	NA	NA
TRINITY_DN1042_c0_g1_i3	Q9H0H0	INT2_HUMAN	43	1075	483	15	3114	58	18	1018	3.30E-227	790	INT2_HUMAN	reviewed	Integrator complex subunit 2 (Int2)	INTS2 KIAA1287	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN1042_c0_g1_i4	Q9H0H0	INT2_HUMAN	43.7	1193	540	16	3713	303	18	1134	1.20E-260	901.4	INT2_HUMAN	reviewed	Integrator complex subunit 2 (Int2)	INTS2 KIAA1287	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN1042_c0_g1_i5	Q5ZKU4	INT2_CHICK	45.2	918	414	11	2769	85	10	861	1.80E-208	727.6	INT2_CHICK	reviewed	Integrator complex subunit 2 (Int2)	INTS2 RCJMB04_9c3	Gallus gallus (Chicken)	1192	integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; snRNA 3'-end processing [GO:0034472]	integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]		GO:0016021; GO:0031965; GO:0032039; GO:0034472	snRNA 3'-end processing [GO:0034472]		NA	NA	NA	NA	NA	NA
TRINITY_DN1042_c0_g1_i7	Q9H0H0	INT2_HUMAN	41.2	277	120	5	1034	303	868	1134	2.00E-46	188	INT2_HUMAN	reviewed	Integrator complex subunit 2 (Int2)	INTS2 KIAA1287	Homo sapiens (Human)	1204	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN35453_c0_g1_i1	Q1LXC9	INT3_DANRE	34.4	340	204	4	1104	94	629	952	1.20E-51	205.3	INT3_DANRE	reviewed	Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A)	ints3 si:dkey-27c15.2	Danio rerio (Zebrafish) (Brachydanio rerio)	1017	nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]	nucleus [GO:0005634]; SOSS complex [GO:0070876]		GO:0005634; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0070876	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN35453_c0_g1_i2	Q1LXC9	INT3_DANRE	35.3	153	91	1	512	54	629	773	1.50E-20	100.9	INT3_DANRE	reviewed	Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A)	ints3 si:dkey-27c15.2	Danio rerio (Zebrafish) (Brachydanio rerio)	1017	nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]	nucleus [GO:0005634]; SOSS complex [GO:0070876]		GO:0005634; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0070876	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN36738_c0_g1_i1	Q96HW7	INT4_HUMAN	93.1	101	7	0	306	4	326	426	5.40E-47	188	INT4_HUMAN	reviewed	Integrator complex subunit 4 (Int4)	INTS4 MSTP093	Homo sapiens (Human)	963	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0016180; GO:0032039; GO:0042795	snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN4509_c0_g1_i1	Q8CIM8	INT4_MOUSE	36	339	199	7	59	1045	1	331	6.30E-42	172.9	INT4_MOUSE	reviewed	Integrator complex subunit 4 (Int4)	Ints4	Mus musculus (Mouse)	964	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0016180; GO:0032039	snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN4509_c0_g1_i2	Q96HW7	INT4_HUMAN	56.2	73	32	0	62	280	258	330	1.20E-14	80.5	INT4_HUMAN	reviewed	Integrator complex subunit 4 (Int4)	INTS4 MSTP093	Homo sapiens (Human)	963	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0016180; GO:0032039; GO:0042795	snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN4509_c0_g1_i4	Q8CIM8	INT4_MOUSE	41.9	515	281	7	59	1573	1	507	1.00E-96	355.5	INT4_MOUSE	reviewed	Integrator complex subunit 4 (Int4)	Ints4	Mus musculus (Mouse)	964	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0016180; GO:0032039	snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN5298_c0_g1_i1	Q8CHT3	INT5_MOUSE	29.7	929	545	25	2770	233	56	959	4.60E-74	281.2	INT5_MOUSE	reviewed	Integrator complex subunit 5 (Int5)	Ints5	Mus musculus (Mouse)	1018	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN20565_c0_g1_i1	Q9UL03	INT6_HUMAN	42.4	66	38	0	334	137	809	874	4.20E-08	59.3	INT6_HUMAN	reviewed	Integrator complex subunit 6 (Int6) (DBI-1) (Protein DDX26) (Protein deleted in cancer 1) (DICE1)	INTS6 DBI1 DDX26 DDX26A	Homo sapiens (Human)	887	actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transmembrane signaling receptor activity [GO:0004888]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005634; GO:0005654; GO:0015629; GO:0016180; GO:0032039; GO:0034472; GO:0042795	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN4116_c0_g2_i1	Q7TQK1	INT7_MOUSE	39.3	969	517	20	128	2950	12	937	3.20E-174	614	INT7_MOUSE	reviewed	Integrator complex subunit 7 (Int7)	Ints7	Mus musculus (Mouse)	966	chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleus [GO:0005634]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleus [GO:0005634]		GO:0000077; GO:0005634; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034472; GO:0071479	cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN27675_c0_g1_i1	Q2KJA6	INT9_BOVIN	100	68	0	0	206	3	104	171	1.80E-33	142.5	INT9_BOVIN	reviewed	Integrator complex subunit 9 (Int9)	INTS9	Bos taurus (Bovine)	658	integrator complex [GO:0032039]; nucleus [GO:0005634]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleus [GO:0005634]		GO:0005634; GO:0016180; GO:0032039	snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN1316_c0_g1_i1	Q8K114	INT9_MOUSE	51.1	666	295	6	97	2025	1	658	7.00E-199	695.3	INT9_MOUSE	reviewed	Integrator complex subunit 9 (Int9)	Ints9 D14Ertd231e	Mus musculus (Mouse)	658	cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]	cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005829; GO:0016180; GO:0032039	snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN41077_c0_g1_i1	Q9NV88	INT9_HUMAN	100	87	0	0	263	3	398	484	1.00E-46	186.8	INT9_HUMAN	reviewed	Integrator complex subunit 9 (Int9) (Protein related to CPSF subunits of 74 kDa) (RC-74)	INTS9 RC74	Homo sapiens (Human)	658	cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005829; GO:0016180; GO:0032039; GO:0042795	snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN33681_c0_g1_i1	Q9NV88	INT9_HUMAN	100	100	0	0	2	301	269	368	1.20E-54	213.4	INT9_HUMAN	reviewed	Integrator complex subunit 9 (Int9) (Protein related to CPSF subunits of 74 kDa) (RC-74)	INTS9 RC74	Homo sapiens (Human)	658	cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]	cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005829; GO:0016180; GO:0032039; GO:0042795	snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN26668_c0_g1_i2	P34446	PAT2_CAEEL	56.6	53	22	1	115	270	1148	1200	6.20E-10	65.1	PAT2_CAEEL	reviewed	Integrin alpha pat-2 (Paralyzed arrest at two-fold protein 2)	pat-2 F54F2.1	Caenorhabditis elegans	1226	cell surface [GO:0009986]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; regulation of vulval development [GO:0040028]; vulval cell fate specification [GO:0072327]	cell surface [GO:0009986]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]	transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0007005; GO:0007155; GO:0007229; GO:0008305; GO:0009986; GO:0031430; GO:0040017; GO:0040028; GO:0042059; GO:0046716; GO:0055120; GO:0060298; GO:0072327; GO:1901076	cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; regulation of vulval development [GO:0040028]; vulval cell fate specification [GO:0072327]		NA	NA	NA	NA	NA	NA
TRINITY_DN40323_c0_g1_i1	F1MMS9	ITA3_BOVIN	52.8	127	58	2	416	36	343	467	6.90E-29	128.3	ITA3_BOVIN	reviewed	Integrin alpha-3 (CD49 antigen-like family member C) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain]	ITGA3	Bos taurus (Bovine)	1050	cell junction [GO:0030054]; filopodium membrane [GO:0031527]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]	cell junction [GO:0030054]; filopodium membrane [GO:0031527]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]	GO:0007155; GO:0007229; GO:0008305; GO:0030054; GO:0031527; GO:0046872; GO:0046982; GO:0071438; GO:1903078	cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]		NA	NA	NA	NA	NA	NA
TRINITY_DN29815_c0_g1_i1	Q62470	ITA3_MOUSE	100	80	0	0	1	240	373	452	5.90E-41	167.5	ITA3_MOUSE	reviewed	Integrin alpha-3 (CD49 antigen-like family member C) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain]	Itga3	Mus musculus (Mouse)	1053	basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; invadopodium membrane [GO:0071438]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cell adhesion [GO:0007155]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to drug [GO:0042493]; response to gonadotropin [GO:0034698]; skin development [GO:0043588]	basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; invadopodium membrane [GO:0071438]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; synaptic membrane [GO:0097060]	collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	GO:0001764; GO:0001968; GO:0002020; GO:0005178; GO:0005518; GO:0005886; GO:0007155; GO:0007229; GO:0007507; GO:0007613; GO:0009897; GO:0009986; GO:0010628; GO:0010634; GO:0010811; GO:0010976; GO:0016323; GO:0017015; GO:0019904; GO:0030111; GO:0030324; GO:0030426; GO:0030510; GO:0031345; GO:0031527; GO:0034667; GO:0034698; GO:0035024; GO:0035640; GO:0042493; GO:0043235; GO:0043236; GO:0043588; GO:0044877; GO:0045202; GO:0046982; GO:0048333; GO:0048471; GO:0060076; GO:0060135; GO:0071438; GO:0071944; GO:0072006; GO:0097060; GO:0097062; GO:0097205; GO:1903078; GO:1990812	cell adhesion [GO:0007155]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to drug [GO:0042493]; response to gonadotropin [GO:0034698]; skin development [GO:0043588]		NA	NA	NA	NA	NA	NA
TRINITY_DN4626_c0_g1_i1	Q91687	ITA4_XENLA	40.4	265	140	9	765	4	252	509	6.20E-42	172.6	ITA4_XENLA	reviewed	Integrin alpha-4 (Integrin alpha-IV) (VLA-4 subunit alpha)	itga4	Xenopus laevis (African clawed frog)	1032	integrin complex [GO:0008305]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]	integrin complex [GO:0008305]	metal ion binding [GO:0046872]	GO:0007155; GO:0007229; GO:0008305; GO:0046872	cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]		blue	blue	NA	NA	NA	NA
TRINITY_DN36864_c0_g1_i1	P08648	ITA5_HUMAN	44.3	70	38	1	246	40	980	1049	1.10E-07	57.4	ITA5_HUMAN	reviewed	Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]	ITGA5 FNRA	Homo sapiens (Human)	1049	"alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]"	alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]	GO:0001525; GO:0001618; GO:0001726; GO:0005154; GO:0005161; GO:0005178; GO:0005783; GO:0005794; GO:0005886; GO:0005925; GO:0007044; GO:0007155; GO:0007157; GO:0007159; GO:0007229; GO:0007565; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0010811; GO:0023035; GO:0030198; GO:0030335; GO:0030949; GO:0031410; GO:0031589; GO:0033627; GO:0033631; GO:0034113; GO:0034674; GO:0035313; GO:0035987; GO:0043184; GO:0045202; GO:0046872; GO:0050731; GO:0050900; GO:0071062; GO:1903672; GO:2000811	"angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3052_c0_g2_i1	Q06274	ITA5_XENLA	47	100	47	3	21	311	336	432	2.50E-14	79.7	ITA5_XENLA	reviewed	Integrin alpha-5 (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]	itga5	Xenopus laevis (African clawed frog)	1050	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; integrin-mediated signaling pathway [GO:0007229]	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005886; GO:0005925; GO:0007229; GO:0008305; GO:0009986; GO:0033627; GO:0046872	cell adhesion mediated by integrin [GO:0033627]; integrin-mediated signaling pathway [GO:0007229]		blue	blue	NA	NA	NA	NA
TRINITY_DN32038_c0_g1_i1	P53708	ITA8_HUMAN	47.7	65	30	1	20	202	372	436	1.60E-10	66.2	ITA8_HUMAN	reviewed	Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]	ITGA8	Homo sapiens (Human)	1063	apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]	apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	metal ion binding [GO:0046872]	GO:0001656; GO:0001822; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009986; GO:0014069; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0046872; GO:0048333; GO:0048745; GO:0098609; GO:2000721	brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell projection organization [GO:0030030]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN38741_c0_g1_i1	Q13797	ITA9_HUMAN	27.4	219	132	11	749	93	30	221	1.80E-12	74.7	ITA9_HUMAN	reviewed	Integrin alpha-9 (Integrin alpha-RLC)	ITGA9	Homo sapiens (Human)	1035	basal plasma membrane [GO:0009925]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; wound healing [GO:0042060]	basal plasma membrane [GO:0009925]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]	GO:0005518; GO:0005886; GO:0007155; GO:0007229; GO:0008305; GO:0009925; GO:0030198; GO:0030593; GO:0034679; GO:0042060; GO:0043236; GO:0046872	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN17988_c0_g1_i2	P12080	ITA2_DROME	35.9	195	113	6	595	23	446	632	2.30E-25	117.1	ITA2_DROME	reviewed	Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]	if CG9623	Drosophila melanogaster (Fruit fly)	1396	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]	GO:0005886; GO:0005887; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609	"apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31270_c0_g1_i1	P12080	ITA2_DROME	50.7	134	56	2	3	395	324	450	1.50E-29	130.6	ITA2_DROME	reviewed	Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]	if CG9623	Drosophila melanogaster (Fruit fly)	1396	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]	GO:0005886; GO:0005887; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609	"apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN404_c0_g1_i11	O44386	ITA3_DROME	25.7	1139	685	39	301	3408	13	1093	5.00E-80	301.2	ITA3_DROME	reviewed	Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]	scb alphaPS3 Vol CG8095	Drosophila melanogaster (Fruit fly)	1115	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; protein heterodimerization activity [GO:0046982]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]	protein heterodimerization activity [GO:0046982]	GO:0001555; GO:0003344; GO:0005737; GO:0005925; GO:0006909; GO:0007157; GO:0007160; GO:0007229; GO:0007391; GO:0007411; GO:0007431; GO:0007494; GO:0007508; GO:0007613; GO:0007614; GO:0008305; GO:0009925; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0030336; GO:0033627; GO:0035001; GO:0042060; GO:0043277; GO:0045886; GO:0046982; GO:0048149	"apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN404_c0_g1_i12	O44386	ITA3_DROME	25.6	990	599	35	92	2764	143	1093	1.50E-66	256.1	ITA3_DROME	reviewed	Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]	scb alphaPS3 Vol CG8095	Drosophila melanogaster (Fruit fly)	1115	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; protein heterodimerization activity [GO:0046982]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]	protein heterodimerization activity [GO:0046982]	GO:0001555; GO:0003344; GO:0005737; GO:0005925; GO:0006909; GO:0007157; GO:0007160; GO:0007229; GO:0007391; GO:0007411; GO:0007431; GO:0007494; GO:0007508; GO:0007613; GO:0007614; GO:0008305; GO:0009925; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0030336; GO:0033627; GO:0035001; GO:0042060; GO:0043277; GO:0045886; GO:0046982; GO:0048149	"apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN404_c0_g1_i14	O44386	ITA3_DROME	25.7	1139	685	39	115	3222	13	1093	3.60E-80	301.6	ITA3_DROME	reviewed	Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]	scb alphaPS3 Vol CG8095	Drosophila melanogaster (Fruit fly)	1115	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; protein heterodimerization activity [GO:0046982]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]	protein heterodimerization activity [GO:0046982]	GO:0001555; GO:0003344; GO:0005737; GO:0005925; GO:0006909; GO:0007157; GO:0007160; GO:0007229; GO:0007391; GO:0007411; GO:0007431; GO:0007494; GO:0007508; GO:0007613; GO:0007614; GO:0008305; GO:0009925; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0030336; GO:0033627; GO:0035001; GO:0042060; GO:0043277; GO:0045886; GO:0046982; GO:0048149	"apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"		blue	blue	NA	NA	NA	NA
TRINITY_DN404_c0_g1_i2	O44386	ITA3_DROME	25.5	999	607	35	92	2821	143	1093	5.60E-66	254.2	ITA3_DROME	reviewed	Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]	scb alphaPS3 Vol CG8095	Drosophila melanogaster (Fruit fly)	1115	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; protein heterodimerization activity [GO:0046982]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]	protein heterodimerization activity [GO:0046982]	GO:0001555; GO:0003344; GO:0005737; GO:0005925; GO:0006909; GO:0007157; GO:0007160; GO:0007229; GO:0007391; GO:0007411; GO:0007431; GO:0007494; GO:0007508; GO:0007613; GO:0007614; GO:0008305; GO:0009925; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0030336; GO:0033627; GO:0035001; GO:0042060; GO:0043277; GO:0045886; GO:0046982; GO:0048149	"apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN404_c0_g1_i9	O44386	ITA3_DROME	25.7	1139	685	39	115	3222	13	1093	3.70E-80	301.6	ITA3_DROME	reviewed	Integrin alpha-PS3 (Position-specific antigen subunit alpha-3) (Protein scab) (Protein volado) [Cleaved into: Integrin alpha-PS3 heavy chain; Integrin alpha-PS3 light chain]	scb alphaPS3 Vol CG8095	Drosophila melanogaster (Fruit fly)	1115	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; protein heterodimerization activity [GO:0046982]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]	protein heterodimerization activity [GO:0046982]	GO:0001555; GO:0003344; GO:0005737; GO:0005925; GO:0006909; GO:0007157; GO:0007160; GO:0007229; GO:0007391; GO:0007411; GO:0007431; GO:0007494; GO:0007508; GO:0007613; GO:0007614; GO:0008305; GO:0009925; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0030336; GO:0033627; GO:0035001; GO:0042060; GO:0043277; GO:0045886; GO:0046982; GO:0048149	"apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; behavioral response to ethanol [GO:0048149]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; memory [GO:0007613]; midgut development [GO:0007494]; negative regulation of cell migration [GO:0030336]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte growth [GO:0001555]; pericardium morphogenesis [GO:0003344]; phagocytosis [GO:0006909]; salivary gland development [GO:0007431]; short-term memory [GO:0007614]; wound healing [GO:0042060]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3052_c0_g1_i1	P80746	ITAV_BOVIN	42.6	176	89	6	530	12	361	527	9.40E-26	118.2	ITAV_BOVIN	reviewed	Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]	ITGAV	Bos taurus (Bovine)	1048	focal adhesion [GO:0005925]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; metal ion binding [GO:0046872]; virus receptor activity [GO:0001618]; blood vessel development [GO:0001568]; cell adhesion mediated by integrin [GO:0033627]; integrin-mediated signaling pathway [GO:0007229]; regulation of transforming growth factor beta activation [GO:1901388]	focal adhesion [GO:0005925]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]	metal ion binding [GO:0046872]; virus receptor activity [GO:0001618]	GO:0001568; GO:0001618; GO:0005925; GO:0007229; GO:0033627; GO:0034685; GO:0034686; GO:0046872; GO:1901388	blood vessel development [GO:0001568]; cell adhesion mediated by integrin [GO:0033627]; integrin-mediated signaling pathway [GO:0007229]; regulation of transforming growth factor beta activation [GO:1901388]		blue	blue	NA	NA	NA	NA
TRINITY_DN4588_c5_g2_i1	Q27874	PAT3_CAEEL	37.9	219	122	9	607	1242	524	735	1.00E-33	146	PAT3_CAEEL	reviewed	Integrin beta pat-3 (Paralyzed arrest at two-fold protein 3)	pat-3 ZK1058.2	Caenorhabditis elegans	809	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of axon regeneration [GO:0048680]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]	integrin binding [GO:0005178]	GO:0005178; GO:0005604; GO:0005925; GO:0007005; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0016323; GO:0016328; GO:0016477; GO:0030018; GO:0031430; GO:0032956; GO:0033627; GO:0040017; GO:0040028; GO:0042059; GO:0043005; GO:0043025; GO:0045987; GO:0046716; GO:0048680; GO:0055001; GO:0055002; GO:0055120; GO:0060279; GO:0060298; GO:0072327; GO:1903354; GO:1903356; GO:1904901	cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of axon regeneration [GO:0048680]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]		NA	NA	NA	NA	NA	NA
TRINITY_DN4588_c5_g2_i2	Q27874	PAT3_CAEEL	37.9	219	122	9	470	1105	524	735	9.30E-34	146	PAT3_CAEEL	reviewed	Integrin beta pat-3 (Paralyzed arrest at two-fold protein 3)	pat-3 ZK1058.2	Caenorhabditis elegans	809	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of axon regeneration [GO:0048680]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]	integrin binding [GO:0005178]	GO:0005178; GO:0005604; GO:0005925; GO:0007005; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0016323; GO:0016328; GO:0016477; GO:0030018; GO:0031430; GO:0032956; GO:0033627; GO:0040017; GO:0040028; GO:0042059; GO:0043005; GO:0043025; GO:0045987; GO:0046716; GO:0048680; GO:0055001; GO:0055002; GO:0055120; GO:0060279; GO:0060298; GO:0072327; GO:1903354; GO:1903356; GO:1904901	cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of axon regeneration [GO:0048680]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]		blue	blue	NA	NA	NA	NA
TRINITY_DN9741_c0_g1_i3	Q27874	PAT3_CAEEL	34	523	324	11	1538	9	88	602	7.90E-84	312.8	PAT3_CAEEL	reviewed	Integrin beta pat-3 (Paralyzed arrest at two-fold protein 3)	pat-3 ZK1058.2	Caenorhabditis elegans	809	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of axon regeneration [GO:0048680]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]	integrin binding [GO:0005178]	GO:0005178; GO:0005604; GO:0005925; GO:0007005; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0016323; GO:0016328; GO:0016477; GO:0030018; GO:0031430; GO:0032956; GO:0033627; GO:0040017; GO:0040028; GO:0042059; GO:0043005; GO:0043025; GO:0045987; GO:0046716; GO:0048680; GO:0055001; GO:0055002; GO:0055120; GO:0060279; GO:0060298; GO:0072327; GO:1903354; GO:1903356; GO:1904901	cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of axon regeneration [GO:0048680]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327]		NA	NA	NA	NA	NA	NA
TRINITY_DN9741_c0_g1_i4	P05107	ITB2_HUMAN	35.1	171	99	5	527	24	409	570	4.80E-23	109.4	ITB2_HUMAN	reviewed	"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"	ITGB2 CD18 MFI7	Homo sapiens (Human)	769	"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; endothelial cell migration [GO:0043542]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte migration involved in inflammatory response [GO:0002523]; microglial cell activation [GO:0001774]; natural killer cell activation [GO:0030101]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of angiogenesis [GO:0045766]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of immune response [GO:0050776]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; toll-like receptor 4 signaling pathway [GO:0034142]"	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0001540; GO:0001774; GO:0001851; GO:0002523; GO:0005178; GO:0005886; GO:0005925; GO:0006898; GO:0006911; GO:0006915; GO:0006954; GO:0007155; GO:0007159; GO:0007160; GO:0007229; GO:0007267; GO:0007568; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016020; GO:0016477; GO:0019221; GO:0019901; GO:0030101; GO:0030198; GO:0030369; GO:0030593; GO:0031072; GO:0031623; GO:0032930; GO:0033627; GO:0034113; GO:0034142; GO:0034687; GO:0034688; GO:0034689; GO:0035579; GO:0035987; GO:0043113; GO:0043235; GO:0043312; GO:0043315; GO:0043542; GO:0044853; GO:0045123; GO:0045429; GO:0045766; GO:0045963; GO:0046872; GO:0050730; GO:0050776; GO:0050839; GO:0050900; GO:0051092; GO:0070062; GO:0070821; GO:0071404; GO:0090314; GO:0097242; GO:0098609; GO:0098742; GO:0101003; GO:1901216; GO:1903561; GO:1904996; GO:1990266; GO:2000363	"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular extravasation [GO:0045123]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; endothelial cell migration [GO:0043542]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte migration involved in inflammatory response [GO:0002523]; microglial cell activation [GO:0001774]; natural killer cell activation [GO:0030101]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of angiogenesis [GO:0045766]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of immune response [GO:0050776]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; toll-like receptor 4 signaling pathway [GO:0034142]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28472_c0_g1_i1	P05107	ITB2_HUMAN	100	69	0	0	1	207	469	537	1.80E-38	159.1	ITB2_HUMAN	reviewed	"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"	ITGB2 CD18 MFI7	Homo sapiens (Human)	769	"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; endothelial cell migration [GO:0043542]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte migration involved in inflammatory response [GO:0002523]; microglial cell activation [GO:0001774]; natural killer cell activation [GO:0030101]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of angiogenesis [GO:0045766]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of immune response [GO:0050776]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; toll-like receptor 4 signaling pathway [GO:0034142]"	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0001540; GO:0001774; GO:0001851; GO:0002523; GO:0005178; GO:0005886; GO:0005925; GO:0006898; GO:0006911; GO:0006915; GO:0006954; GO:0007155; GO:0007159; GO:0007160; GO:0007229; GO:0007267; GO:0007568; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016020; GO:0016477; GO:0019221; GO:0019901; GO:0030101; GO:0030198; GO:0030369; GO:0030593; GO:0031072; GO:0031623; GO:0032930; GO:0033627; GO:0034113; GO:0034142; GO:0034687; GO:0034688; GO:0034689; GO:0035579; GO:0035987; GO:0043113; GO:0043235; GO:0043312; GO:0043315; GO:0043542; GO:0044853; GO:0045123; GO:0045429; GO:0045766; GO:0045963; GO:0046872; GO:0050730; GO:0050776; GO:0050839; GO:0050900; GO:0051092; GO:0070062; GO:0070821; GO:0071404; GO:0090314; GO:0097242; GO:0098609; GO:0098742; GO:0101003; GO:1901216; GO:1903561; GO:1904996; GO:1990266; GO:2000363	"aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular extravasation [GO:0045123]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; endothelial cell migration [GO:0043542]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte migration involved in inflammatory response [GO:0002523]; microglial cell activation [GO:0001774]; natural killer cell activation [GO:0030101]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of angiogenesis [GO:0045766]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of immune response [GO:0050776]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; toll-like receptor 4 signaling pathway [GO:0034142]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18678_c0_g1_i1	P53714	ITB2_PIG	39.3	140	77	3	421	2	431	562	2.80E-25	116.3	ITB2_PIG	reviewed	"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"	ITGB2 CD18	Sus scrofa (Pig)	769	focal adhesion [GO:0005925]; integrin complex [GO:0008305]; membrane [GO:0016020]; amyloid-beta binding [GO:0001540]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis [GO:0006909]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of phagocytosis [GO:0050766]; receptor internalization [GO:0031623]	focal adhesion [GO:0005925]; integrin complex [GO:0008305]; membrane [GO:0016020]	amyloid-beta binding [GO:0001540]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]	GO:0001540; GO:0005178; GO:0005925; GO:0006909; GO:0007160; GO:0007229; GO:0008305; GO:0016020; GO:0016477; GO:0031623; GO:0033627; GO:0038023; GO:0046872; GO:0050766; GO:0071404; GO:1904996	cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis [GO:0006909]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of phagocytosis [GO:0050766]; receptor internalization [GO:0031623]		NA	NA	NA	NA	NA	NA
TRINITY_DN1164_c0_g1_i2	O54890	ITB3_MOUSE	30.2	212	143	3	771	139	574	781	1.30E-20	101.7	ITB3_MOUSE	reviewed	Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)	Itgb3	Mus musculus (Mouse)	787	alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of serotonin uptake [GO:0051611]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718]	alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202]	cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0001938; GO:0001954; GO:0001968; GO:0002020; GO:0002687; GO:0003756; GO:0005080; GO:0005178; GO:0005634; GO:0005654; GO:0005886; GO:0005911; GO:0005925; GO:0007044; GO:0007160; GO:0007229; GO:0008277; GO:0008305; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0010745; GO:0010763; GO:0010888; GO:0014909; GO:0014911; GO:0016020; GO:0016324; GO:0016477; GO:0019899; GO:0030168; GO:0030334; GO:0030335; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032147; GO:0032369; GO:0032587; GO:0032880; GO:0032956; GO:0032991; GO:0033627; GO:0033630; GO:0033690; GO:0034113; GO:0034446; GO:0034679; GO:0034683; GO:0035866; GO:0035867; GO:0035868; GO:0036120; GO:0038027; GO:0042470; GO:0042802; GO:0043184; GO:0043235; GO:0043277; GO:0045202; GO:0045211; GO:0045672; GO:0045715; GO:0045766; GO:0045780; GO:0046718; GO:0048008; GO:0048146; GO:0048661; GO:0048858; GO:0050731; GO:0050748; GO:0050839; GO:0050840; GO:0050919; GO:0051279; GO:0051611; GO:0060548; GO:0061097; GO:0070374; GO:0070527; GO:0071133; GO:0072126; GO:0098978; GO:0099149; GO:1900026; GO:1900731; GO:1903053; GO:2000406	activation of protein kinase activity [GO:0032147]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of serotonin uptake [GO:0051611]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718]		blue	blue	NA	NA	NA	NA
TRINITY_DN1164_c0_g1_i3	P11584	ITBX_DROME	41.1	112	63	2	465	130	735	843	5.10E-19	95.9	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13862_c0_g1_i1	P11584	ITBX_DROME	55.6	81	36	0	3	245	180	260	8.40E-19	94	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3460_c0_g1_i1	P11584	ITBX_DROME	47.2	322	156	5	933	1	264	582	2.10E-70	267.3	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3460_c0_g1_i2	P11584	ITBX_DROME	61.4	101	39	0	339	37	264	364	4.50E-34	145.2	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9741_c0_g2_i1	P11584	ITBX_DROME	35.1	148	83	5	17	430	679	823	1.20E-17	91.3	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9741_c0_g2_i2	P11584	ITBX_DROME	34.5	168	97	5	17	490	679	843	3.40E-22	106.3	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27418_c0_g1_i1	P11584	ITBX_DROME	77.9	68	15	0	206	3	290	357	1.10E-27	123.2	ITBX_DROME	reviewed	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	mys l(1)mys olfC CG1560	Drosophila melanogaster (Fruit fly)	846	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"actin filament organization [GO:0007015]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18362_c0_g1_i1	Q3SWY2	ILK_BOVIN	100	105	0	0	315	1	1	105	9.40E-59	227.3	ILK_BOVIN	reviewed	Integrin-linked protein kinase (EC 2.7.11.1)	ILK	Bos taurus (Bovine)	452	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0001658; GO:0001934; GO:0003151; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008284; GO:0010761; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0090263; GO:1901224; GO:2000178	"branching involved in ureteric bud morphogenesis [GO:0001658]; cell-matrix adhesion [GO:0007160]; cell projection organization [GO:0030030]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16374_c0_g1_i1	Q13418	ILK_HUMAN	100	267	0	0	835	35	186	452	2.90E-159	562.4	ILK_HUMAN	reviewed	Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK)	ILK ILK1 ILK2	Homo sapiens (Human)	452	"cell junction [GO:0030054]; cell-cell junction [GO:0005911]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cell junction [GO:0030054]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]	GO:0001658; GO:0001725; GO:0001934; GO:0001954; GO:0003151; GO:0004672; GO:0004674; GO:0005178; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006469; GO:0007050; GO:0007160; GO:0007229; GO:0007569; GO:0008284; GO:0009967; GO:0010667; GO:0010761; GO:0014912; GO:0016020; GO:0017124; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030054; GO:0030335; GO:0030513; GO:0032288; GO:0032956; GO:0032991; GO:0033209; GO:0034329; GO:0034446; GO:0042327; GO:0043025; GO:0043034; GO:0043195; GO:0043198; GO:0043406; GO:0043491; GO:0043524; GO:0045197; GO:0045663; GO:0045669; GO:0045773; GO:0045893; GO:0048662; GO:0048812; GO:0050775; GO:0051897; GO:0070527; GO:0090263; GO:0097435; GO:1901224; GO:2000178	"branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16374_c0_g1_i2	Q13418	ILK_HUMAN	100	267	0	0	857	57	186	452	1.70E-159	563.1	ILK_HUMAN	reviewed	Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK)	ILK ILK1 ILK2	Homo sapiens (Human)	452	"cell junction [GO:0030054]; cell-cell junction [GO:0005911]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cell junction [GO:0030054]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]	GO:0001658; GO:0001725; GO:0001934; GO:0001954; GO:0003151; GO:0004672; GO:0004674; GO:0005178; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006469; GO:0007050; GO:0007160; GO:0007229; GO:0007569; GO:0008284; GO:0009967; GO:0010667; GO:0010761; GO:0014912; GO:0016020; GO:0017124; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030054; GO:0030335; GO:0030513; GO:0032288; GO:0032956; GO:0032991; GO:0033209; GO:0034329; GO:0034446; GO:0042327; GO:0043025; GO:0043034; GO:0043195; GO:0043198; GO:0043406; GO:0043491; GO:0043524; GO:0045197; GO:0045663; GO:0045669; GO:0045773; GO:0045893; GO:0048662; GO:0048812; GO:0050775; GO:0051897; GO:0070527; GO:0090263; GO:0097435; GO:1901224; GO:2000178	"branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27883_c0_g1_i1	Q13418	ILK_HUMAN	100	142	0	0	427	2	4	145	1.10E-82	307	ILK_HUMAN	reviewed	Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK)	ILK ILK1 ILK2	Homo sapiens (Human)	452	"cell junction [GO:0030054]; cell-cell junction [GO:0005911]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cell junction [GO:0030054]; costamere [GO:0043034]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; terminal bouton [GO:0043195]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]	GO:0001658; GO:0001725; GO:0001934; GO:0001954; GO:0003151; GO:0004672; GO:0004674; GO:0005178; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006469; GO:0007050; GO:0007160; GO:0007229; GO:0007569; GO:0008284; GO:0009967; GO:0010667; GO:0010761; GO:0014912; GO:0016020; GO:0017124; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030054; GO:0030335; GO:0030513; GO:0032288; GO:0032956; GO:0032991; GO:0033209; GO:0034329; GO:0034446; GO:0042327; GO:0043025; GO:0043034; GO:0043195; GO:0043198; GO:0043406; GO:0043491; GO:0043524; GO:0045197; GO:0045663; GO:0045669; GO:0045773; GO:0045893; GO:0048662; GO:0048812; GO:0050775; GO:0051897; GO:0070527; GO:0090263; GO:0097435; GO:1901224; GO:2000178	"branching involved in ureteric bud morphogenesis [GO:0001658]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelin assembly [GO:0032288]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; substrate adhesion-dependent cell spreading [GO:0034446]; supramolecular fiber organization [GO:0097435]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32795_c0_g1_i1	Q9TZC4	ILKH_CAEEL	61.1	447	173	1	1440	103	18	464	4.00E-175	615.9	ILKH_CAEEL	reviewed	Integrin-linked protein kinase homolog pat-4 (ILK homolog) (Paralyzed and arrested elongation at two-fold protein 4)	pat-4 C29F9.7	Caenorhabditis elegans	466	adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-macromolecule adaptor activity [GO:0030674]; cell-matrix adhesion [GO:0007160]; embryo development ending in birth or egg hatching [GO:0009792]; hermaphrodite genitalia morphogenesis [GO:0048815]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; myofibril assembly [GO:0030239]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; striated muscle cell development [GO:0055002]; substrate adhesion-dependent cell spreading [GO:0034446]	adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein-macromolecule adaptor activity [GO:0030674]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005178; GO:0005524; GO:0005912; GO:0005925; GO:0006468; GO:0007005; GO:0007160; GO:0007229; GO:0008305; GO:0009792; GO:0009925; GO:0030239; GO:0030674; GO:0031430; GO:0032956; GO:0034446; GO:0040017; GO:0045987; GO:0046716; GO:0048815; GO:0055002; GO:0055120; GO:0060279; GO:0060298; GO:1903356; GO:1903829; GO:1904901; GO:1904951	cell-matrix adhesion [GO:0007160]; embryo development ending in birth or egg hatching [GO:0009792]; hermaphrodite genitalia morphogenesis [GO:0048815]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; myofibril assembly [GO:0030239]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; striated muscle cell development [GO:0055002]; substrate adhesion-dependent cell spreading [GO:0034446]		blue	blue	NA	NA	NA	NA
TRINITY_DN7081_c0_g2_i8	P19827	ITIH1_HUMAN	29.3	341	209	10	70	1047	437	760	6.90E-29	129.8	ITIH1_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1 IGHEP1	Homo sapiens (Human)	911	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005509; GO:0005576; GO:0030212; GO:0062023; GO:0070062; GO:0072562	hyaluronan metabolic process [GO:0030212]		NA	NA	NA	NA	NA	NA
TRINITY_DN16447_c0_g2_i1	P19827	ITIH1_HUMAN	31.5	143	77	6	391	5	572	707	1.50E-08	60.8	ITIH1_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1 IGHEP1	Homo sapiens (Human)	911	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005509; GO:0005576; GO:0030212; GO:0062023; GO:0070062; GO:0072562	hyaluronan metabolic process [GO:0030212]		NA	NA	NA	NA	NA	NA
TRINITY_DN16447_c0_g3_i1	P19827	ITIH1_HUMAN	24.7	178	125	3	13	525	398	573	1.80E-10	67.4	ITIH1_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1 IGHEP1	Homo sapiens (Human)	911	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005509; GO:0005576; GO:0030212; GO:0062023; GO:0070062; GO:0072562	hyaluronan metabolic process [GO:0030212]		NA	NA	NA	NA	NA	NA
TRINITY_DN7833_c1_g1_i1	Q14624	ITIH4_HUMAN	46.4	84	36	2	296	66	211	292	9.30E-15	80.9	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]	endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]		NA	NA	NA	NA	NA	NA
TRINITY_DN7081_c0_g2_i5	Q14624	ITIH4_HUMAN	27.8	436	280	6	45	1334	14	420	9.60E-38	159.5	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]	endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]		NA	NA	NA	NA	NA	NA
TRINITY_DN7081_c0_g2_i4	Q86UX2	ITIH5_HUMAN	28.4	777	470	20	123	2333	56	786	3.30E-70	268.1	ITIH5_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H5 (ITI heavy chain H5) (ITI-HC5) (Inter-alpha-inhibitor heavy chain 5)	ITIH5 KIAA1953 PP14776 UNQ311/PRO354	Homo sapiens (Human)	942	collagen-containing extracellular matrix [GO:0062023]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	collagen-containing extracellular matrix [GO:0062023]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0030212; GO:0062023	hyaluronan metabolic process [GO:0030212]		NA	NA	NA	NA	NA	NA
TRINITY_DN7081_c0_g2_i7	Q86UX2	ITIH5_HUMAN	28.5	488	315	9	123	1565	56	516	3.80E-49	197.6	ITIH5_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H5 (ITI heavy chain H5) (ITI-HC5) (Inter-alpha-inhibitor heavy chain 5)	ITIH5 KIAA1953 PP14776 UNQ311/PRO354	Homo sapiens (Human)	942	collagen-containing extracellular matrix [GO:0062023]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	collagen-containing extracellular matrix [GO:0062023]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0030212; GO:0062023	hyaluronan metabolic process [GO:0030212]		NA	NA	NA	NA	NA	NA
TRINITY_DN37385_c0_g1_i1	Q7Z5L9	I2BP2_HUMAN	100	78	0	0	2	235	489	566	2.80E-43	175.3	I2BP2_HUMAN	reviewed	Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2)	IRF2BP2	Homo sapiens (Human)	587	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; immature B cell differentiation [GO:0002327]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002327; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0046872	immature B cell differentiation [GO:0002327]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1227_c0_g1_i1	Q7T2G1	I2B2B_DANRE	64.9	77	27	0	132	362	9	85	4.60E-23	110.2	I2B2B_DANRE	reviewed	Interferon regulatory factor 2-binding protein 2-B (IRF-2-binding protein 2-B) (IRF-2BP2-B)	irf2bp2b irf2bp2 zgc:63864	Danio rerio (Zebrafish) (Brachydanio rerio)	501	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1227_c0_g1_i2	Q7T2G1	I2B2B_DANRE	64.9	77	27	0	132	362	9	85	5.80E-23	110.2	I2B2B_DANRE	reviewed	Interferon regulatory factor 2-binding protein 2-B (IRF-2-binding protein 2-B) (IRF-2BP2-B)	irf2bp2b irf2bp2 zgc:63864	Danio rerio (Zebrafish) (Brachydanio rerio)	501	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1227_c0_g1_i3	Q7T2G1	I2B2B_DANRE	64.9	77	27	0	132	362	9	85	5.60E-23	110.2	I2B2B_DANRE	reviewed	Interferon regulatory factor 2-binding protein 2-B (IRF-2-binding protein 2-B) (IRF-2BP2-B)	irf2bp2b irf2bp2 zgc:63864	Danio rerio (Zebrafish) (Brachydanio rerio)	501	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34524_c0_g1_i1	P20591	MX1_HUMAN	100	114	0	0	344	3	160	273	5.40E-56	218	MX1_HUMAN	reviewed	"Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed]"	MX1	Homo sapiens (Human)	662	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; innate immune response [GO:0045087]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of viral genome replication [GO:0045071]; organelle fission [GO:0048285]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; type I interferon signaling pathway [GO:0060337]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]	GO:0000266; GO:0003374; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006915; GO:0006952; GO:0007165; GO:0008017; GO:0009615; GO:0014069; GO:0015630; GO:0016020; GO:0016185; GO:0030424; GO:0031410; GO:0031623; GO:0031965; GO:0031966; GO:0034340; GO:0042802; GO:0043197; GO:0044327; GO:0045071; GO:0045087; GO:0045202; GO:0045211; GO:0048285; GO:0048471; GO:0050803; GO:0051607; GO:0060337; GO:0061025; GO:0098793; GO:0098844; GO:0098884	apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; innate immune response [GO:0045087]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of viral genome replication [GO:0045071]; organelle fission [GO:0048285]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; type I interferon signaling pathway [GO:0060337]		NA	NA	NA	NA	NA	NA
TRINITY_DN4503_c0_g1_i1	Q7ZYA5	PRKAA_XENLA	40.6	69	41	0	223	429	28	96	6.60E-09	62	PRKAA_XENLA	reviewed	Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog A	prkra-a prkra	Xenopus laevis (African clawed frog)	309	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]	GO:0003725; GO:0005634; GO:0005737; GO:0008047; GO:0030422; GO:0048471	production of siRNA involved in RNA interference [GO:0030422]		NA	NA	NA	NA	NA	NA
TRINITY_DN4503_c0_g1_i2	Q7ZYA5	PRKAA_XENLA	40.6	69	41	0	205	411	28	96	6.30E-09	62	PRKAA_XENLA	reviewed	Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog A	prkra-a prkra	Xenopus laevis (African clawed frog)	309	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]	GO:0003725; GO:0005634; GO:0005737; GO:0008047; GO:0030422; GO:0048471	production of siRNA involved in RNA interference [GO:0030422]		NA	NA	NA	NA	NA	NA
TRINITY_DN15358_c1_g1_i3	Q5S1U6	IFRD1_PIG	37	395	236	6	1287	112	60	444	3.40E-51	204.1	IFRD1_PIG	reviewed	Interferon-related developmental regulator 1	IFRD1	Sus scrofa (Pig)	450	cytoplasm [GO:0005737]; nucleus [GO:0005634]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006357; GO:0014706; GO:0030517; GO:0042692; GO:0043403; GO:0048671	muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]		NA	NA	NA	NA	NA	NA
TRINITY_DN32278_c0_g1_i1	Q96AZ6	ISG20_HUMAN	100	77	0	0	231	1	1	77	2.10E-39	162.5	ISG20_HUMAN	reviewed	Interferon-stimulated gene 20 kDa protein (EC 3.1.13.1) (Estrogen-regulated transcript 45 protein) (Promyelocytic leukemia nuclear body-associated protein ISG20)	ISG20 HEM45	Homo sapiens (Human)	181	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U3 snoRNA binding [GO:0034511]; defense response to virus [GO:0051607]; DNA catabolic process, exonucleolytic [GO:0000738]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; type I interferon signaling pathway [GO:0060337]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U3 snoRNA binding [GO:0034511]	GO:0000175; GO:0000738; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0006401; GO:0008310; GO:0008859; GO:0009615; GO:0015030; GO:0016605; GO:0030619; GO:0030620; GO:0034511; GO:0045071; GO:0046872; GO:0051607; GO:0060337	"defense response to virus [GO:0051607]; DNA catabolic process, exonucleolytic [GO:0000738]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; type I interferon signaling pathway [GO:0060337]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10795_c0_g1_i1	Q12905	ILF2_HUMAN	100	341	0	0	1044	22	22	362	3.90E-193	675.2	ILF2_HUMAN	reviewed	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)	ILF2 NF45 PRO3063	Homo sapiens (Human)	390	"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0043312; GO:0045893; GO:1904724; GO:1904813; GO:1990904	"neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1023_c0_g1_i1	Q12905	ILF2_HUMAN	70.3	343	93	4	163	1188	24	358	4.50E-135	482.6	ILF2_HUMAN	reviewed	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)	ILF2 NF45 PRO3063	Homo sapiens (Human)	390	"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0043312; GO:0045893; GO:1904724; GO:1904813; GO:1990904	"neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1023_c0_g1_i2	Q12905	ILF2_HUMAN	71.3	338	93	3	163	1173	24	358	3.60E-137	489.6	ILF2_HUMAN	reviewed	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)	ILF2 NF45 PRO3063	Homo sapiens (Human)	390	"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0043312; GO:0045893; GO:1904724; GO:1904813; GO:1990904	"neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13626_c0_g1_i1	Q12905	ILF2_HUMAN	100	122	0	0	367	2	132	253	3.20E-62	238.8	ILF2_HUMAN	reviewed	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)	ILF2 NF45 PRO3063	Homo sapiens (Human)	390	"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0043312; GO:0045893; GO:1904724; GO:1904813; GO:1990904	"neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22309_c0_g1_i1	Q9Z1X4	ILF3_MOUSE	97.6	82	2	0	246	1	68	149	1.20E-36	153.3	ILF3_MOUSE	reviewed	Interleukin enhancer-binding factor 3	Ilf3	Mus musculus (Mouse)	898	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; single-stranded RNA binding [GO:0003727]	GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0006468; GO:0006479; GO:0017148; GO:0019899; GO:0035925; GO:0045071; GO:0045892; GO:0045893; GO:0051607; GO:1990904	"defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28014_c0_g1_i1	Q12906	ILF3_HUMAN	100	140	0	0	422	3	216	355	1.20E-78	293.5	ILF3_HUMAN	reviewed	Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80)	ILF3 DRBF MPHOSPH4 NF90	Homo sapiens (Human)	894	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0006468; GO:0016020; GO:0017148; GO:0035925; GO:0045071; GO:0045892; GO:0045893; GO:0051607; GO:1990904	"defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17379_c0_g1_i1	Q1RMT8	IRAK4_BOVIN	54.6	108	43	2	1	324	292	393	5.90E-26	118.2	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN17379_c0_g1_i2	Q1RMT8	IRAK4_BOVIN	51.4	70	31	1	92	301	327	393	2.40E-13	76.3	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN6317_c1_g1_i10	Q1RMT8	IRAK4_BOVIN	35.2	105	58	3	829	1125	140	240	1.30E-08	62.4	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN6317_c1_g1_i3	Q1RMT8	IRAK4_BOVIN	35.2	105	58	3	430	726	140	240	8.10E-09	62.4	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN6317_c1_g1_i5	Q1RMT8	IRAK4_BOVIN	35.2	105	58	3	821	1117	140	240	6.00E-09	63.5	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN6317_c1_g1_i6	Q1RMT8	IRAK4_BOVIN	35.2	105	58	3	231	527	140	240	5.90E-09	62.4	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN6317_c1_g1_i8	Q1RMT8	IRAK4_BOVIN	40.6	128	66	3	821	1186	140	263	1.10E-18	95.9	IRAK4_BOVIN	reviewed	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	IRAK4	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN5403_c0_g1_i2	Q10439	ICP55_SCHPO	56.6	76	33	0	452	225	288	363	1.90E-19	97.1	ICP55_SCHPO	reviewed	Intermediate cleaving peptidase 55 (EC 3.4.11.26)	icp55 SPAC12B10.05	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	486	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]	GO:0004177; GO:0005739; GO:0005743; GO:0007005; GO:0008233; GO:0030145; GO:0034982; GO:0070006	mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN6449_c0_g1_i1	O42287	ITSN1_XENLA	41.1	129	72	2	417	34	1579	1704	5.70E-23	108.6	ITSN1_XENLA	reviewed	Intersectin-1	itsn1	Xenopus laevis (African clawed frog)	1705	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; recycling endosome [GO:0055037]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0035556; GO:0043005; GO:0045202; GO:0055037	endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN26936_c0_g1_i1	Q9Z0R4	ITSN1_MOUSE	52.1	169	81	0	507	1	1310	1478	3.60E-48	192.6	ITSN1_MOUSE	reviewed	Intersectin-1 (EH and SH3 domains protein 1)	Itsn1 Ese1 Itsn	Mus musculus (Mouse)	1714	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007420; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0034613; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0150007; GO:1905274; GO:2001288	brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c2_g1_i2	Q9Z0R4	ITSN1_MOUSE	34.6	353	122	10	60	827	736	1076	2.00E-48	194.1	ITSN1_MOUSE	reviewed	Intersectin-1 (EH and SH3 domains protein 1)	Itsn1 Ese1 Itsn	Mus musculus (Mouse)	1714	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007420; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0034613; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0150007; GO:1905274; GO:2001288	brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c2_g1_i3	Q9Z0R4	ITSN1_MOUSE	31.3	380	157	10	60	923	736	1103	2.60E-44	180.6	ITSN1_MOUSE	reviewed	Intersectin-1 (EH and SH3 domains protein 1)	Itsn1 Ese1 Itsn	Mus musculus (Mouse)	1714	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007420; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0034613; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0150007; GO:1905274; GO:2001288	brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c2_g1_i6	Q9Z0R4	ITSN1_MOUSE	32.8	323	110	9	48	725	764	1076	8.90E-40	165.2	ITSN1_MOUSE	reviewed	Intersectin-1 (EH and SH3 domains protein 1)	Itsn1 Ese1 Itsn	Mus musculus (Mouse)	1714	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007420; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0034613; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0150007; GO:1905274; GO:2001288	brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN6859_c2_g1_i5	Q9WVE9	ITSN1_RAT	42.3	123	52	3	41	376	935	1049	4.80E-24	112.1	ITSN1_RAT	reviewed	Intersectin-1 (EH domain and SH3 domain regulator of endocytosis 1)	Itsn1 Ehsh1 Itsn	Rattus norvegicus (Rat)	1713	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; terminal bouton [GO:0043195]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007420; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0034613; GO:0043025; GO:0043195; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098978; GO:0150007; GO:1905274; GO:2001288	brain development [GO:0007420]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN25750_c0_g1_i1	A8WGF4	IF122_XENTR	42.6	190	92	3	666	100	1015	1188	1.40E-36	154.5	IF122_XENTR	reviewed	Intraflagellar transport protein 122 homolog	ift122	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1189	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]		GO:0005737; GO:0005929; GO:0007275; GO:0030991; GO:0035721; GO:0036064; GO:0042073; GO:0045879; GO:0060271; GO:0061512; GO:0097730; GO:1905515	cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]		NA	NA	NA	NA	NA	NA
TRINITY_DN26089_c0_g1_i1	E9PY46	IF140_MOUSE	64.2	120	42	1	2	361	1200	1318	3.40E-38	159.1	IF140_MOUSE	reviewed	Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2)	Ift140 WDTC2	Mus musculus (Mouse)	1464	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]		GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]		NA	NA	NA	NA	NA	NA
TRINITY_DN35486_c0_g1_i1	E9PY46	IF140_MOUSE	35.8	288	172	5	70	927	1	277	1.70E-46	188	IF140_MOUSE	reviewed	Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2)	Ift140 WDTC2	Mus musculus (Mouse)	1464	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]		GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]		NA	NA	NA	NA	NA	NA
TRINITY_DN30333_c0_g1_i1	E9PY46	IF140_MOUSE	66.3	104	35	0	363	52	907	1010	4.30E-35	148.7	IF140_MOUSE	reviewed	Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2)	Ift140 WDTC2	Mus musculus (Mouse)	1464	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]		GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]		NA	NA	NA	NA	NA	NA
TRINITY_DN30333_c0_g1_i2	E9PY46	IF140_MOUSE	53.7	525	234	4	1671	121	907	1430	1.20E-164	581.3	IF140_MOUSE	reviewed	Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2)	Ift140 WDTC2	Mus musculus (Mouse)	1464	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]		GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]		NA	NA	NA	NA	NA	NA
TRINITY_DN38059_c0_g1_i1	Q5DM57	IF172_CHLRE	48.6	74	38	0	226	5	1132	1205	1.80E-15	82.8	IF172_CHLRE	reviewed	Intraflagellar transport protein 172	IFT172 FLA11 CHLREDRAFT_183240	Chlamydomonas reinhardtii (Chlamydomonas smithii)	1755	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; multicellular organism development [GO:0007275]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]		GO:0005737; GO:0007275; GO:0030992; GO:0031514; GO:0036064	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN5150_c5_g1_i1	Q5RHH4	IF172_DANRE	59.8	497	193	3	1	1491	829	1318	1.10E-172	607.8	IF172_DANRE	reviewed	Intraflagellar transport protein 172 homolog	ift172 si:dkey-221h15.5	Danio rerio (Zebrafish) (Brachydanio rerio)	1745	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]		GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN11103_c0_g2_i1	Q5RHH4	IF172_DANRE	64.3	389	139	0	26	1192	347	735	2.20E-149	530	IF172_DANRE	reviewed	Intraflagellar transport protein 172 homolog	ift172 si:dkey-221h15.5	Danio rerio (Zebrafish) (Brachydanio rerio)	1745	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]		GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN11103_c0_g2_i2	Q5RHH4	IF172_DANRE	64.5	372	132	0	51	1166	364	735	4.40E-142	505.8	IF172_DANRE	reviewed	Intraflagellar transport protein 172 homolog	ift172 si:dkey-221h15.5	Danio rerio (Zebrafish) (Brachydanio rerio)	1745	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]		GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN11103_c0_g1_i1	Q9UG01	IF172_HUMAN	57.8	102	43	0	1	306	731	832	6.60E-29	127.9	IF172_HUMAN	reviewed	Intraflagellar transport protein 172 homolog	IFT172 KIAA1179	Homo sapiens (Human)	1749	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]		GO:0001843; GO:0001947; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007420; GO:0008544; GO:0009953; GO:0016485; GO:0021522; GO:0030992; GO:0031122; GO:0035735; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097542; GO:0097598; GO:1903561; GO:1905515	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN11103_c0_g3_i2	Q9UG01	IF172_HUMAN	65.1	344	115	2	37	1068	13	351	4.10E-134	479.2	IF172_HUMAN	reviewed	Intraflagellar transport protein 172 homolog	IFT172 KIAA1179	Homo sapiens (Human)	1749	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]		GO:0001843; GO:0001947; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007420; GO:0008544; GO:0009953; GO:0016485; GO:0021522; GO:0030992; GO:0031122; GO:0035735; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097542; GO:0097598; GO:1903561; GO:1905515	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN12082_c0_g1_i1	Q6VH22	IF172_MOUSE	53.5	71	33	0	234	22	1387	1457	3.70E-16	85.5	IF172_MOUSE	reviewed	Intraflagellar transport protein 172 homolog (Protein wimple)	Ift172 Kiaa1179 Wim	Mus musculus (Mouse)	1749	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; transcription factor binding [GO:0008134]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	transcription factor binding [GO:0008134]	GO:0000122; GO:0001841; GO:0001843; GO:0001947; GO:0005634; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007368; GO:0007420; GO:0007507; GO:0008134; GO:0008544; GO:0008589; GO:0009953; GO:0016485; GO:0021522; GO:0021915; GO:0030992; GO:0031122; GO:0031514; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097598; GO:1905515	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN12082_c0_g1_i3	Q6VH22	IF172_MOUSE	56.7	363	154	3	1092	13	1387	1749	1.80E-119	430.6	IF172_MOUSE	reviewed	Intraflagellar transport protein 172 homolog (Protein wimple)	Ift172 Kiaa1179 Wim	Mus musculus (Mouse)	1749	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; transcription factor binding [GO:0008134]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	transcription factor binding [GO:0008134]	GO:0000122; GO:0001841; GO:0001843; GO:0001947; GO:0005634; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007368; GO:0007420; GO:0007507; GO:0008134; GO:0008544; GO:0008589; GO:0009953; GO:0016485; GO:0021522; GO:0021915; GO:0030992; GO:0031122; GO:0031514; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097598; GO:1905515	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN12082_c0_g1_i4	Q6VH22	IF172_MOUSE	57.3	433	182	3	1302	13	1317	1749	1.80E-144	513.8	IF172_MOUSE	reviewed	Intraflagellar transport protein 172 homolog (Protein wimple)	Ift172 Kiaa1179 Wim	Mus musculus (Mouse)	1749	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; transcription factor binding [GO:0008134]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	transcription factor binding [GO:0008134]	GO:0000122; GO:0001841; GO:0001843; GO:0001947; GO:0005634; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007368; GO:0007420; GO:0007507; GO:0008134; GO:0008544; GO:0008589; GO:0009953; GO:0016485; GO:0021522; GO:0021915; GO:0030992; GO:0031122; GO:0031514; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097598; GO:1905515	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN11103_c0_g3_i1	Q9JKU3	IF172_RAT	77.6	147	33	0	37	477	13	159	6.70E-64	245	IF172_RAT	reviewed	Intraflagellar transport protein 172 homolog (Selective LIM-binding factor)	Ift172 Slb	Rattus norvegicus (Rat)	1749	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; transcription factor binding [GO:0008134]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	transcription factor binding [GO:0008134]	GO:0000122; GO:0001841; GO:0001843; GO:0001947; GO:0005634; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007368; GO:0007420; GO:0007507; GO:0008134; GO:0008544; GO:0008589; GO:0009953; GO:0016485; GO:0021522; GO:0021915; GO:0030992; GO:0031122; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097598; GO:1905515	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN6457_c1_g2_i1	Q66I67	IFT20_DANRE	59.8	132	53	0	592	197	1	132	6.40E-37	155.6	IFT20_DANRE	reviewed	Intraflagellar transport protein 20 homolog	ift20 zgc:103674	Danio rerio (Zebrafish) (Brachydanio rerio)	132	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]		GO:0005794; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0030154; GO:0030992; GO:0036064; GO:0042073; GO:0051642; GO:0061512; GO:2000583	cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN26763_c0_g1_i1	Q61025	IFT20_MOUSE	99.1	112	1	0	1	336	5	116	1.90E-53	209.5	IFT20_MOUSE	reviewed	Intraflagellar transport protein 20 homolog (mIFT20)	Ift20	Mus musculus (Mouse)	132	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; kinociliary basal body [GO:1902636]; microvillus [GO:0005902]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; opsin binding [GO:0002046]; Rab GTPase binding [GO:0017137]; cardiac muscle cell differentiation [GO:0055007]; centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; opsin transport [GO:0036372]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; regulation of autophagosome assembly [GO:2000785]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cilium assembly [GO:1902017]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; kinociliary basal body [GO:1902636]; microvillus [GO:0005902]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]	opsin binding [GO:0002046]; Rab GTPase binding [GO:0017137]	GO:0001736; GO:0001750; GO:0001822; GO:0002046; GO:0005794; GO:0005801; GO:0005813; GO:0005814; GO:0005902; GO:0005929; GO:0007224; GO:0007283; GO:0008542; GO:0017137; GO:0022008; GO:0030992; GO:0031514; GO:0032391; GO:0032420; GO:0034067; GO:0035845; GO:0036064; GO:0036372; GO:0042073; GO:0044292; GO:0045198; GO:0051642; GO:0055007; GO:0060122; GO:0060271; GO:0060828; GO:0061351; GO:0061512; GO:0072659; GO:0090102; GO:0097546; GO:1902017; GO:1902636; GO:2000583; GO:2000785	cardiac muscle cell differentiation [GO:0055007]; centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; opsin transport [GO:0036372]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; regulation of autophagosome assembly [GO:2000785]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cilium assembly [GO:1902017]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN1807_c0_g1_i2	Q567Y6	IFT22_DANRE	50	126	63	0	195	572	3	128	7.30E-34	146	IFT22_DANRE	reviewed	Intraflagellar transport protein 22 homolog (Rab-like protein 5)	ift22 rabl5 zgc:110645	Danio rerio (Zebrafish) (Brachydanio rerio)	187	endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030992	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN1807_c0_g1_i3	Q567Y6	IFT22_DANRE	44	184	101	1	195	740	3	186	1.70E-42	174.5	IFT22_DANRE	reviewed	Intraflagellar transport protein 22 homolog (Rab-like protein 5)	ift22 rabl5 zgc:110645	Danio rerio (Zebrafish) (Brachydanio rerio)	187	endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030992	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN1807_c0_g1_i5	Q567Y6	IFT22_DANRE	50	126	63	0	195	572	3	128	7.60E-34	146	IFT22_DANRE	reviewed	Intraflagellar transport protein 22 homolog (Rab-like protein 5)	ift22 rabl5 zgc:110645	Danio rerio (Zebrafish) (Brachydanio rerio)	187	endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030992	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN8387_c1_g1_i1	A7MBP4	IFT46_DANRE	65.9	44	15	0	71	202	283	326	4.50E-12	71.6	IFT46_DANRE	reviewed	Intraflagellar transport protein 46 homolog	ift46	Danio rerio (Zebrafish) (Brachydanio rerio)	384	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]		GO:0005737; GO:0005813; GO:0030992; GO:0031514; GO:0036064; GO:0042073; GO:0048264; GO:0048793; GO:0060041; GO:0060271	cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN8387_c1_g1_i2	Q1LZB4	IFT46_BOVIN	62.8	180	66	1	1	537	98	277	3.90E-61	236.1	IFT46_BOVIN	reviewed	Intraflagellar transport protein 46 homolog	IFT46	Bos taurus (Bovine)	301	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; smoothened signaling pathway [GO:0007224]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]		GO:0005737; GO:0005813; GO:0007224; GO:0030992; GO:0031514; GO:0042073; GO:0060271	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN8387_c1_g1_i4	Q5DHJ5	IFT46_SCHJA	67.3	101	33	0	1	303	149	249	3.60E-34	145.6	IFT46_SCHJA	reviewed	Intraflagellar transport protein 46 homolog	SJCHGC08984	Schistosoma japonicum (Blood fluke)	330	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport [GO:0042073]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0005929; GO:0042073	intraciliary transport [GO:0042073]		NA	NA	NA	NA	NA	NA
TRINITY_DN15601_c0_g2_i1	Q9Y366	IFT52_HUMAN	54.5	66	29	1	48	242	164	229	7.70E-15	80.9	IFT52_HUMAN	reviewed	Intraflagellar transport protein 52 homolog (Protein NGD5 homolog)	IFT52 C20orf9 NGD5 CGI-53	Homo sapiens (Human)	437	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]	protein C-terminus binding [GO:0008022]	GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0008022; GO:0009953; GO:0030992; GO:0031514; GO:0032391; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:1905515	cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN33023_c0_g1_i1	Q9Y366	IFT52_HUMAN	58.7	426	174	1	34	1305	3	428	2.40E-147	523.5	IFT52_HUMAN	reviewed	Intraflagellar transport protein 52 homolog (Protein NGD5 homolog)	IFT52 C20orf9 NGD5 CGI-53	Homo sapiens (Human)	437	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]	protein C-terminus binding [GO:0008022]	GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0008022; GO:0009953; GO:0030992; GO:0031514; GO:0032391; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:1905515	cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN15601_c0_g1_i1	Q62559	IFT52_MOUSE	58.1	86	36	0	3	260	59	144	7.80E-27	120.9	IFT52_MOUSE	reviewed	Intraflagellar transport protein 52 homolog (Protein NGD5)	Ift52 Ngd5	Mus musculus (Mouse)	426	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]		GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0007368; GO:0009953; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:0097733; GO:1905515	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN27609_c0_g1_i1	Q62559	IFT52_MOUSE	99.6	227	1	0	682	2	76	302	1.60E-128	459.9	IFT52_MOUSE	reviewed	Intraflagellar transport protein 52 homolog (Protein NGD5)	Ift52 Ngd5	Mus musculus (Mouse)	426	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]		GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0007368; GO:0009953; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:0097733; GO:1905515	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN30849_c0_g1_i1	Q62559	IFT52_MOUSE	56.1	173	74	1	13	525	252	424	3.60E-52	206.1	IFT52_MOUSE	reviewed	Intraflagellar transport protein 52 homolog (Protein NGD5)	Ift52 Ngd5	Mus musculus (Mouse)	426	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]		GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0007368; GO:0009953; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:0097733; GO:1905515	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN31154_c0_g1_i1	Q62559	IFT52_MOUSE	100	91	0	0	1	273	321	411	1.40E-46	186.4	IFT52_MOUSE	reviewed	Intraflagellar transport protein 52 homolog (Protein NGD5)	Ift52 Ngd5	Mus musculus (Mouse)	426	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]		GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0007368; GO:0009953; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0044292; GO:0050680; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:0097733; GO:1905515	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN16024_c0_g3_i1	Q8BS45	IFT56_MOUSE	79.9	249	50	0	776	30	87	335	2.50E-112	406.4	IFT56_MOUSE	reviewed	Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)	Ttc26 Hop Ift56	Mus musculus (Mouse)	554	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	intraciliary transport particle B binding [GO:0120170]	GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0046530; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]		NA	NA	NA	NA	NA	NA
TRINITY_DN16024_c0_g1_i1	A4III8	IFT56_XENTR	94.8	58	3	0	204	31	344	401	2.40E-27	122.1	IFT56_XENTR	reviewed	Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)	ttc26 ift56	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	554	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	intraciliary transport particle B binding [GO:0120170]	GO:0005929; GO:0007224; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0061512; GO:0097546; GO:0120170	axoneme assembly [GO:0035082]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN16024_c0_g2_i1	A4III8	IFT56_XENTR	85.4	123	18	0	63	431	396	518	9.60E-61	234.2	IFT56_XENTR	reviewed	Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)	ttc26 ift56	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	554	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	intraciliary transport particle B binding [GO:0120170]	GO:0005929; GO:0007224; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0061512; GO:0097546; GO:0120170	axoneme assembly [GO:0035082]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN39928_c0_g1_i1	A0AVF1	IFT56_HUMAN	66.7	438	141	3	1348	35	122	554	1.00E-169	597.8	IFT56_HUMAN	reviewed	Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)	TTC26 IFT56	Homo sapiens (Human)	554	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	intraciliary transport particle B binding [GO:0120170]	GO:0005813; GO:0005929; GO:0007224; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:0097546; GO:0120170; GO:1905198	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN5508_c0_g2_i1	Q5EA95	IFT57_BOVIN	48.6	296	145	3	963	82	139	429	7.70E-71	268.9	IFT57_BOVIN	reviewed	Intraflagellar transport protein 57 homolog	IFT57	Bos taurus (Bovine)	429	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]	DNA binding [GO:0003677]	GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0006915; GO:0006919; GO:0030992; GO:0036064; GO:0042073; GO:0042981; GO:1905515	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN5508_c0_g1_i1	Q5EA95	IFT57_BOVIN	48.6	296	145	3	17	898	139	429	7.70E-71	268.9	IFT57_BOVIN	reviewed	Intraflagellar transport protein 57 homolog	IFT57	Bos taurus (Bovine)	429	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]	DNA binding [GO:0003677]	GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0006915; GO:0006919; GO:0030992; GO:0036064; GO:0042073; GO:0042981; GO:1905515	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN37815_c0_g1_i1	Q9NWB7	IFT57_HUMAN	100	105	0	0	318	4	232	336	8.90E-53	207.2	IFT57_HUMAN	reviewed	Intraflagellar transport protein 57 homolog (Dermal papilla-derived protein 8) (Estrogen-related receptor beta-like protein 1) (HIP1-interacting protein) (MHS4R2)	IFT57 DERP8 ESRRBL1 HIPPI	Homo sapiens (Human)	429	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]	DNA binding [GO:0003677]	GO:0001843; GO:0001947; GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0006919; GO:0007224; GO:0030992; GO:0032391; GO:0035735; GO:0036064; GO:0042073; GO:0042981; GO:0044292; GO:0044458; GO:0050680; GO:0060972; GO:0097542; GO:1905515	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN3916_c0_g1_i10	Q8WYA0	IFT81_HUMAN	50	142	71	0	5	430	388	529	5.30E-32	138.7	IFT81_HUMAN	reviewed	Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1)	IFT81 CDV1	Homo sapiens (Human)	676	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	tubulin binding [GO:0015631]	GO:0005813; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3916_c0_g1_i2	Q8WYA0	IFT81_HUMAN	50	122	61	0	5	370	388	509	1.40E-27	124.4	IFT81_HUMAN	reviewed	Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1)	IFT81 CDV1	Homo sapiens (Human)	676	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	tubulin binding [GO:0015631]	GO:0005813; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3916_c0_g1_i4	Q8WYA0	IFT81_HUMAN	47.9	142	74	0	5	430	388	529	1.10E-29	131	IFT81_HUMAN	reviewed	Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1)	IFT81 CDV1	Homo sapiens (Human)	676	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	tubulin binding [GO:0015631]	GO:0005813; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542	cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3916_c0_g1_i5	O35594	IFT81_MOUSE	46.7	122	65	0	5	370	388	509	2.90E-25	116.7	IFT81_MOUSE	reviewed	Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1)	Ift81 Cdv-1 Cdv1	Mus musculus (Mouse)	676	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	tubulin binding [GO:0015631]	GO:0005813; GO:0005929; GO:0007275; GO:0007283; GO:0008589; GO:0015631; GO:0030154; GO:0030992; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228	cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15173_c0_g2_i1	Q61371	IFT88_MOUSE	65.4	107	37	0	53	373	576	682	4.30E-38	158.7	IFT88_MOUSE	reviewed	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	Mus musculus (Mouse)	824	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain development [GO:0030900]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]	kinesin binding [GO:0019894]	GO:0001654; GO:0001822; GO:0001886; GO:0001889; GO:0002080; GO:0002081; GO:0003341; GO:0005737; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030900; GO:0030992; GO:0031016; GO:0031122; GO:0031514; GO:0032391; GO:0034405; GO:0036064; GO:0036126; GO:0036334; GO:0042073; GO:0042487; GO:0042733; GO:0043568; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:0097730; GO:1902017; GO:1903929; GO:1905515; GO:2000785	animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain development [GO:0030900]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN15173_c0_g1_i1	Q61371	IFT88_MOUSE	58.9	231	95	0	6	698	347	577	2.90E-72	273.1	IFT88_MOUSE	reviewed	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	Mus musculus (Mouse)	824	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain development [GO:0030900]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]	kinesin binding [GO:0019894]	GO:0001654; GO:0001822; GO:0001886; GO:0001889; GO:0002080; GO:0002081; GO:0003341; GO:0005737; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030900; GO:0030992; GO:0031016; GO:0031122; GO:0031514; GO:0032391; GO:0034405; GO:0036064; GO:0036126; GO:0036334; GO:0042073; GO:0042487; GO:0042733; GO:0043568; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:0097730; GO:1902017; GO:1903929; GO:1905515; GO:2000785	animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain development [GO:0030900]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN24321_c0_g1_i1	Q61371	IFT88_MOUSE	60.1	183	73	0	6	554	158	340	1.00E-59	231.1	IFT88_MOUSE	reviewed	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	Ift88 Tg737 Tg737Rpw TgN737Rpw Ttc10	Mus musculus (Mouse)	824	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain development [GO:0030900]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]	kinesin binding [GO:0019894]	GO:0001654; GO:0001822; GO:0001886; GO:0001889; GO:0002080; GO:0002081; GO:0003341; GO:0005737; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030900; GO:0030992; GO:0031016; GO:0031122; GO:0031514; GO:0032391; GO:0034405; GO:0036064; GO:0036126; GO:0036334; GO:0042073; GO:0042487; GO:0042733; GO:0043568; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:0097730; GO:1902017; GO:1903929; GO:1905515; GO:2000785	animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain development [GO:0030900]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; spermatid nucleus elongation [GO:0007290]; sperm axoneme assembly [GO:0007288]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN3363_c0_g1_i1	Q71S21	INVSB_XENLA	32.7	220	133	6	1191	550	112	322	5.20E-16	87	INVSB_XENLA	reviewed	Inversin-B	invs-b inv2 invs-2	Xenopus laevis (African clawed frog)	1002	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN35480_c0_g1_i1	Q6NTV6	INF2_XENLA	40.4	208	124	0	624	1	692	899	1.40E-38	161	INF2_XENLA	reviewed	Inverted formin-2	inf2	Xenopus laevis (African clawed frog)	1099	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]		actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]	GO:0003779; GO:0017048; GO:0030036	actin cytoskeleton organization [GO:0030036]		NA	NA	NA	NA	NA	NA
TRINITY_DN7107_c0_g1_i7	P52186	KCNJ2_CHICK	47.5	139	73	0	422	6	85	223	1.10E-34	147.5	KCNJ2_CHICK	reviewed	"Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2)"	KCNJ2 IRK1	Gallus gallus (Chicken)	427	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]	inward rectifier potassium channel activity [GO:0005242]	GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573	potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN26630_c0_g1_i1	Q05B45	T120A_BOVIN	100	86	0	0	258	1	204	289	8.60E-46	183.7	TACAN_BOVIN	reviewed	Ion channel TACAN (Transmembrane protein 120A)	TMEM120A	Bos taurus (Bovine)	343	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]	ion channel activity [GO:0005216]	GO:0005216; GO:0005637; GO:0005886; GO:0016020; GO:0016021; GO:0034220; GO:0045444; GO:0050966; GO:0051260; GO:0051291	detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN35243_c0_g1_i1	Q9BXJ8	T120A_HUMAN	100	74	0	0	3	224	226	299	1.60E-37	156	TACAN_HUMAN	reviewed	Ion channel TACAN (Transmembrane protein 120A) (Transmembrane protein induced by tumor necrosis factor alpha)	TMEM120A TACAN TMPIT	Homo sapiens (Human)	343	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]	ion channel activity [GO:0005216]	GO:0005216; GO:0005637; GO:0005886; GO:0016020; GO:0016021; GO:0034220; GO:0045444; GO:0050966; GO:0051260; GO:0051291	detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN15142_c0_g1_i1	Q80U22	RUSC2_MOUSE	42	100	57	1	556	852	984	1083	1.10E-12	75.5	RUSC2_MOUSE	reviewed	Iporin (Interacting protein of Rab1) (RUN and SH3 domain-containing protein 2)	Rusc2 Kiaa0375	Mus musculus (Mouse)	1514	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Rab GTPase binding [GO:0017137]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	Rab GTPase binding [GO:0017137]	GO:0005829; GO:0017137; GO:0031410			NA	NA	NA	NA	NA	NA
TRINITY_DN5614_c0_g1_i1	Q6DN90	IQEC1_HUMAN	64.5	76	27	0	1	228	652	727	1.70E-21	102.8	IQEC1_HUMAN	reviewed	IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2)	IQSEC1 ARFGEP100 BRAG2 KIAA0763	Homo sapiens (Human)	963	intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]	intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]	GO:0005086; GO:0005730; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0043547; GO:0051549; GO:0060996; GO:0120183	actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012]		blue	blue	NA	NA	NA	NA
TRINITY_DN29650_c0_g1_i1	Q8SSM2	ISU1_ENCCU	77.1	118	26	1	354	4	18	135	6.90E-46	184.5	ISU1_ENCCU	reviewed	Iron sulfur cluster assembly protein 1 (Iron sulfur cluster scaffold protein 1)	ISU1 ECU01_0510	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	140	"mitosome [GO:0032047]; 2 iron, 2 sulfur cluster binding [GO:0051537]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]"	mitosome [GO:0032047]	"2 iron, 2 sulfur cluster binding [GO:0051537]; iron ion binding [GO:0005506]"	GO:0005506; GO:0016226; GO:0032047; GO:0051537	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN32088_c0_g1_i1	Q12056	ISU2_YEAST	71.4	77	20	1	227	3	60	136	2.00E-25	115.9	ISU2_YEAST	reviewed	"Iron sulfur cluster assembly protein 2, mitochondrial (Iron sulfur cluster scaffold protein 2)"	ISU2 NUA2 YOR226C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	156	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; tRNA wobble uridine modification [GO:0002098]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]"	GO:0002098; GO:0005737; GO:0005759; GO:0006879; GO:0008198; GO:0016226; GO:0051537; GO:0051539	cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN4319_c0_g2_i1	Q09920	FIO1_SCHPO	36.2	105	59	1	99	413	394	490	2.70E-17	89.7	FIO1_SCHPO	reviewed	Iron transport multicopper oxidase fio1 (EC 1.-.-.-)	fio1 SPAC1F7.08	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	622	endoplasmic reticulum [GO:0005783]; high-affinity iron permease complex [GO:0033573]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular response to iron ion starvation [GO:0010106]; iron ion transmembrane transport [GO:0034755]; reductive iron assimilation [GO:0033215]	endoplasmic reticulum [GO:0005783]; high-affinity iron permease complex [GO:0033573]	copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]	GO:0004322; GO:0005507; GO:0005783; GO:0010106; GO:0016491; GO:0033215; GO:0033573; GO:0034755	cellular response to iron ion starvation [GO:0010106]; iron ion transmembrane transport [GO:0034755]; reductive iron assimilation [GO:0033215]		blue	blue	NA	NA	NA	NA
TRINITY_DN40724_c0_g1_i1	P78859	ISA1_SCHPO	44.2	52	29	0	2	157	136	187	1.50E-08	59.7	ISA1_SCHPO	reviewed	Iron-sulfur assembly protein 1	isa1 SPCC645.03c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	190	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur transferase activity [GO:0036455]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; [4Fe-4S] cluster assembly [GO:0044572]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur transferase activity [GO:0036455]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0036455; GO:0044572; GO:0046872; GO:0051536; GO:0051537; GO:0097428	[4Fe-4S] cluster assembly [GO:0044572]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN2987_c0_g1_i4	Q4QRC6	ISCA1_DANRE	73.4	109	29	0	63	389	21	129	2.00E-40	166.8	ISCA1_DANRE	reviewed	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA)"	isca1 hbld2 zgc:114185	Danio rerio (Zebrafish) (Brachydanio rerio)	129	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005737; GO:0005739; GO:0006783; GO:0016226; GO:0046872; GO:0051537; GO:0097428	heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN14797_c0_g1_i1	Q3SZG8	ISCA1_BOVIN	100	101	0	0	3	305	29	129	1.90E-53	209.5	ISCA1_BOVIN	reviewed	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA)"	ISCA1 HBLD2	Bos taurus (Bovine)	129	mitochondrion [GO:0005739]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	mitochondrion [GO:0005739]	iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005739; GO:0046872; GO:0051536; GO:0097428	protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN14797_c0_g2_i1	Q9D924	ISCA1_MOUSE	100	101	0	0	3	305	29	129	1.30E-53	210.3	ISCA1_MOUSE	reviewed	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA)"	Isca1 Hbld2	Mus musculus (Mouse)	129	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005737; GO:0005739; GO:0016226; GO:0046872; GO:0051537; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN2987_c0_g1_i1	Q8T3X9	ISCA1_DROME	83.3	84	14	0	84	335	47	130	3.40E-36	152.5	ISCA1_DROME	reviewed	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (Lethal (1) G0136) (Putative magnetoreceptor subunit MagR)"	MagR Isca1 l(1)G0136 CG8198	Drosophila melanogaster (Fruit fly)	130	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005737; GO:0005739; GO:0016226; GO:0046872; GO:0051537; GO:0071000; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]		NA	NA	NA	NA	NA	NA
TRINITY_DN2987_c0_g1_i2	Q8T3X9	ISCA1_DROME	76.8	125	29	0	13	387	6	130	1.80E-49	196.8	ISCA1_DROME	reviewed	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (Lethal (1) G0136) (Putative magnetoreceptor subunit MagR)"	MagR Isca1 l(1)G0136 CG8198	Drosophila melanogaster (Fruit fly)	130	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005737; GO:0005739; GO:0016226; GO:0046872; GO:0051537; GO:0071000; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]		blue	blue	NA	NA	NA	NA
TRINITY_DN27657_c0_g1_i1	Q8T3X9	ISCA1_DROME	50.5	105	50	2	3	317	28	130	2.90E-24	112.8	ISCA1_DROME	reviewed	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (Lethal (1) G0136) (Putative magnetoreceptor subunit MagR)"	MagR Isca1 l(1)G0136 CG8198	Drosophila melanogaster (Fruit fly)	130	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005737; GO:0005739; GO:0016226; GO:0046872; GO:0051537; GO:0071000; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to magnetism [GO:0071000]		NA	NA	NA	NA	NA	NA
TRINITY_DN8388_c0_g1_i1	Q86U28	ISCA2_HUMAN	48.7	76	37	1	310	89	79	154	1.50E-14	80.5	ISCA2_HUMAN	reviewed	"Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1)"	ISCA2 HBLD1	Homo sapiens (Human)	154	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; small molecule metabolic process [GO:0044281]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]"	GO:0005198; GO:0005506; GO:0005739; GO:0005759; GO:0016226; GO:0044281; GO:0051537; GO:0051539; GO:0051604; GO:0106035	iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; small molecule metabolic process [GO:0044281]		NA	NA	NA	NA	NA	NA
TRINITY_DN8388_c0_g1_i2	Q5R788	ISCA2_PONAB	51.4	140	66	1	508	89	17	154	1.60E-32	141	ISCA2_PONAB	reviewed	"Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1)"	ISCA2 HBLD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	154	mitochondrion [GO:0005739]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	mitochondrion [GO:0005739]	iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005739; GO:0046872; GO:0051536; GO:0097428	protein maturation by iron-sulfur cluster transfer [GO:0097428]		blue	blue	NA	NA	NA	NA
TRINITY_DN34678_c0_g1_i1	Q9H1K1	ISCU_HUMAN	100	90	0	0	9	278	39	128	2.00E-45	182.6	ISCU_HUMAN	reviewed	"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)"	ISCU NIFUN	Homo sapiens (Human)	167	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; small molecule metabolic process [GO:0044281]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]"	GO:0005506; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006879; GO:0008198; GO:0016226; GO:0044281; GO:0051537; GO:0051539; GO:0060090; GO:1902958; GO:1904234; GO:1904439	"cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; small molecule metabolic process [GO:0044281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3407_c0_g1_i1	Q9H1K1	ISCU_HUMAN	82.9	105	18	0	368	54	35	139	9.50E-46	184.1	ISCU_HUMAN	reviewed	"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)"	ISCU NIFUN	Homo sapiens (Human)	167	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; small molecule metabolic process [GO:0044281]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]"	GO:0005506; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006879; GO:0008198; GO:0016226; GO:0044281; GO:0051537; GO:0051539; GO:0060090; GO:1902958; GO:1904234; GO:1904439	"cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; small molecule metabolic process [GO:0044281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3407_c0_g1_i2	Q9D7P6	ISCU_MOUSE	78.9	133	28	0	408	10	36	168	4.30E-55	215.3	ISCU_MOUSE	reviewed	"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)"	Iscu Nifun	Mus musculus (Mouse)	168	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; molecular adaptor activity [GO:0060090]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; molecular adaptor activity [GO:0060090]"	GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006879; GO:0008198; GO:0016226; GO:0051537; GO:0051539; GO:0060090; GO:1902958; GO:1904234; GO:1904439	"cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3928_c0_g1_i1	O31270	ISCU_AZOVI	85.7	84	12	0	253	2	32	115	3.50E-36	151.8	ISCU_AZOVI	reviewed	Iron-sulfur cluster assembly scaffold protein IscU	iscU	Azotobacter vinelandii	128	iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]		iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]	GO:0005506; GO:0016226; GO:0051536	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN12414_c0_g3_i1	Q9RVM9	APBC_DEIRA	58.6	87	35	1	2	259	175	261	3.50E-23	108.6	APBC_DEIRA	reviewed	Iron-sulfur cluster carrier protein	mrp DR_0998	Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)	350	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0016226; GO:0016887; GO:0046872; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN12414_c0_g2_i1	Q9RVM9	APBC_DEIRA	62.2	82	30	1	1	243	182	263	1.10E-21	103.6	APBC_DEIRA	reviewed	Iron-sulfur cluster carrier protein	mrp DR_0998	Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)	350	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0016226; GO:0016887; GO:0046872; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN12414_c1_g1_i1	P45135	APBC_HAEIN	52.2	92	38	3	1	270	146	233	2.20E-20	99.4	APBC_HAEIN	reviewed	Iron-sulfur cluster carrier protein	mrp HI_1277	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	370	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	cytosol [GO:0005829]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005829; GO:0016226; GO:0016887; GO:0046872; GO:0051539	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN15367_c0_g1_i1	P72190	APBC_PSEFR	56.2	89	36	2	9	266	23	111	2.30E-17	89.4	APBC_PSEFR	reviewed	Iron-sulfur cluster carrier protein		Pseudomonas fragi	287	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]	GO:0005524; GO:0016887; GO:0046872; GO:0051536			NA	NA	NA	NA	NA	NA
TRINITY_DN30511_c0_g1_i1	P72190	APBC_PSEFR	68.8	144	45	0	435	4	105	248	1.30E-57	223.8	APBC_PSEFR	reviewed	Iron-sulfur cluster carrier protein		Pseudomonas fragi	287	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]	GO:0005524; GO:0016887; GO:0046872; GO:0051536			NA	NA	NA	NA	NA	NA
TRINITY_DN33078_c0_g1_i1	Q2ULH4	ATM1_ASPOR	54	150	69	0	2	451	472	621	2.90E-41	169.5	ATM1_ASPOR	reviewed	"Iron-sulfur clusters transporter atm1, mitochondrial"	atm1 AO090003000411	Aspergillus oryzae (strain ATCC 42149 / RIB 40) (Yellow koji mold)	720	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0006811; GO:0016021; GO:0016226; GO:0016887; GO:0042626; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN31248_c0_g1_i1	Q8TB37	NUBPL_HUMAN	100	113	0	0	2	340	82	194	4.40E-58	224.9	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i2	Q8TB37	NUBPL_HUMAN	61.1	270	104	1	868	62	45	314	2.70E-92	340.1	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i4	Q8TB37	NUBPL_HUMAN	59.9	192	77	0	637	62	123	314	2.00E-64	247.7	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i4	Q8TB37	NUBPL_HUMAN	61.9	84	31	1	902	654	45	128	6.60E-20	99.8	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i5	Q8TB37	NUBPL_HUMAN	61.1	270	104	1	868	62	45	314	2.80E-92	340.1	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i6	Q8TB37	NUBPL_HUMAN	62.7	255	94	1	812	51	45	299	1.20E-89	331.3	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i8	Q8TB37	NUBPL_HUMAN	59.9	192	77	0	637	62	123	314	1.90E-64	247.7	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN9720_c0_g1_i8	Q8TB37	NUBPL_HUMAN	61.9	84	31	1	902	654	45	128	4.90E-20	100.1	NUBPL_HUMAN	reviewed	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	319	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]		NA	NA	NA	NA	NA	NA
TRINITY_DN12414_c0_g1_i1	Q54F15	NUBPL_DICDI	53.9	128	58	1	6	386	137	264	3.90E-34	145.6	NUBPL_DICDI	reviewed	Iron-sulfur protein NUBPL (Nucleotide-binding protein-like)	nubpl DDB_G0291193	Dictyostelium discoideum (Slime mold)	323	"mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0016226; GO:0032981; GO:0046872; GO:0051539	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN9945_c0_g1_i1	Q5BKW9	ASGL1_DANRE	47.3	311	156	2	987	55	2	304	1.20E-69	265	ASGL1_DANRE	reviewed	Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain]	asrgl1 zgc:103568	Danio rerio (Zebrafish) (Brachydanio rerio)	310	cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345]	cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]	asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]	GO:0001917; GO:0004067; GO:0005737; GO:0008798; GO:0033345	asparagine catabolic process via L-aspartate [GO:0033345]		NA	NA	NA	NA	NA	NA
TRINITY_DN33735_c0_g1_i1	Q54IM8	ACAD8_DICDI	58.7	208	85	1	626	6	125	332	1.00E-68	261.2	ACAD8_DICDI	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8 homolog)"	acad8 DDB_G0288647	Dictyostelium discoideum (Slime mold)	416	mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660	lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN3342_c0_g1_i1	Q54IM8	ACAD8_DICDI	54.5	77	35	0	11	241	335	411	9.30E-16	84	ACAD8_DICDI	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8 homolog)"	acad8 DDB_G0288647	Dictyostelium discoideum (Slime mold)	416	mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660	lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	1
TRINITY_DN29965_c0_g1_i1	Q0NXR6	ACAD8_BOVIN	53	83	39	0	251	3	286	368	7.50E-15	80.9	ACAD8_BOVIN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8	Bos taurus (Bovine)	416	mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660	lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4998_c0_g1_i1	Q0NXR6	ACAD8_BOVIN	43.8	73	41	0	224	6	37	109	1.40E-12	73.2	ACAD8_BOVIN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8	Bos taurus (Bovine)	416	mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660	lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4401_c1_g1_i6	Q0NXR6	ACAD8_BOVIN	72.5	51	14	0	226	74	77	127	5.80E-14	77.8	ACAD8_BOVIN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8	Bos taurus (Bovine)	416	mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660	lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN32190_c0_g1_i1	Q0NXR6	ACAD8_BOVIN	57.1	56	24	0	3	170	360	415	1.40E-14	79.7	ACAD8_BOVIN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8	Bos taurus (Bovine)	416	mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660	lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN35875_c0_g1_i1	Q9UKU7	ACAD8_HUMAN	100	96	0	0	2	289	320	415	3.50E-46	185.3	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN30815_c0_g1_i1	Q9UKU7	ACAD8_HUMAN	100	161	0	0	2	484	126	286	1.80E-92	339.7	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4401_c1_g1_i1	Q9UKU7	ACAD8_HUMAN	68.6	207	64	1	660	40	24	229	8.60E-79	295	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4401_c1_g1_i3	Q9UKU7	ACAD8_HUMAN	71.5	340	97	0	1115	96	76	415	1.20E-141	504.6	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4401_c1_g1_i3	Q9UKU7	ACAD8_HUMAN	51.1	47	23	0	1255	1115	24	70	7.40E-06	53.5	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4401_c1_g1_i4	Q9UKU7	ACAD8_HUMAN	69.4	392	120	0	1271	96	24	415	1.70E-159	563.9	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN4401_c1_g1_i7	Q9UKU7	ACAD8_HUMAN	71	279	81	0	932	96	137	415	1.40E-113	411	ACAD8_HUMAN	reviewed	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	ACAD8 ARC42 IBD	Homo sapiens (Human)	415	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN40457_c0_g1_i1	Q96AB3	ISOC2_HUMAN	100	100	0	0	302	3	99	198	3.50E-49	195.3	ISOC2_HUMAN	reviewed	Isochorismatase domain-containing protein 2	ISOC2	Homo sapiens (Human)	205	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein destabilization [GO:0031648]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0031648	protein destabilization [GO:0031648]		NA	NA	NA	NA	NA	NA
TRINITY_DN38689_c0_g1_i1	Q5PQ71	ISOC2_XENLA	55.3	199	86	2	707	114	6	202	3.30E-56	219.9	ISOC2_XENLA	reviewed	Isochorismatase domain-containing protein 2	isoc2	Xenopus laevis (African clawed frog)	205							blue	blue	NA	NA	NA	NA
TRINITY_DN29924_c0_g1_i1	P41563	IDH3A_BOVIN	100	96	0	0	290	3	230	325	1.20E-48	193.4	IDH3A_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitrate dehydrogenase subunits 3/4) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)"	IDH3A	Bos taurus (Bovine)	366	mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN29046_c0_g1_i1	P50213	IDH3A_HUMAN	100	68	0	0	205	2	168	235	2.50E-32	138.7	IDH3A_HUMAN	reviewed	"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)"	IDH3A	Homo sapiens (Human)	366	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0006102; GO:0051287	carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN29888_c0_g1_i1	O77784	IDH3B_BOVIN	98.3	120	2	0	1	360	120	239	4.10E-62	238.4	IDH3B_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-isocitrate dehydrogenase subunit 1) (IDH1) (NAD(+)-specific ICDH subunit beta)"	IDH3B	Bos taurus (Bovine)	385	mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN36346_c0_g1_i1	Q68FX0	IDH3B_RAT	74	192	50	0	9	584	123	314	4.60E-79	295.4	IDH3B_RAT	reviewed	"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)"	Idh3B	Rattus norvegicus (Rat)	385	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0051287	2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN28485_c0_g1_i1	Q68FX0	IDH3B_RAT	48.2	83	39	2	257	12	34	113	1.70E-12	73.2	IDH3B_RAT	reviewed	"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)"	Idh3B	Rattus norvegicus (Rat)	385	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0051287	2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN39421_c0_g1_i1	O43837	IDH3B_HUMAN	100	146	0	0	438	1	233	378	2.90E-78	292.4	IDH3B_HUMAN	reviewed	"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)"	IDH3B	Homo sapiens (Human)	385	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0006099; GO:0006102; GO:0009055; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN14195_c0_g1_i2	P70404	IDHG1_MOUSE	100	184	0	0	3	554	124	307	1.20E-100	367.1	IDHG1_MOUSE	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	Idh3g	Mus musculus (Mouse)	393	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; negative regulation of growth [GO:0045926]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0045926; GO:0051287	2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; negative regulation of growth [GO:0045926]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i4	P70404	IDHG1_MOUSE	47.2	377	154	7	139	1212	34	384	9.40E-82	305.4	IDHG1_MOUSE	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	Idh3g	Mus musculus (Mouse)	393	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; negative regulation of growth [GO:0045926]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0045926; GO:0051287	2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; negative regulation of growth [GO:0045926]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN14195_c0_g1_i1	P51553	IDH3G_HUMAN	100	184	0	0	3	554	124	307	2.00E-100	366.3	IDH3G_HUMAN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Homo sapiens (Human)	393	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0006102; GO:0051287	carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i10	Q58CP0	IDH3G_BOVIN	60	245	98	0	525	1259	139	383	4.80E-81	303.1	IDH3G_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Bos taurus (Bovine)	392	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i10	Q58CP0	IDH3G_BOVIN	44.1	136	72	3	115	519	4	136	1.50E-21	105.5	IDH3G_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Bos taurus (Bovine)	392	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i8	Q58CP0	IDH3G_BOVIN	60	245	98	0	69	803	139	383	2.00E-81	303.9	IDH3G_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Bos taurus (Bovine)	392	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i9	Q58CP0	IDH3G_BOVIN	60	245	98	0	525	1259	139	383	4.80E-81	303.1	IDH3G_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Bos taurus (Bovine)	392	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i9	Q58CP0	IDH3G_BOVIN	44.1	136	72	3	115	519	4	136	4.30E-21	104	IDH3G_BOVIN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Bos taurus (Bovine)	392	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN30315_c0_g1_i1	P51553	IDH3G_HUMAN	100	67	0	0	202	2	21	87	8.20E-36	150.2	IDH3G_HUMAN	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Homo sapiens (Human)	393	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0006102; GO:0051287	carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN16512_c1_g1_i1	P41564	IDH3G_MACFA	48.7	359	150	7	136	1155	3	346	5.40E-82	306.2	IDH3G_MACFA	reviewed	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma) (Fragment)"	IDH3G	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	355	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3888_c0_g1_i1	P50215	IDH_SPHYA	85.3	197	29	0	592	2	65	261	1.20E-98	360.5	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3888_c0_g1_i2	P50215	IDH_SPHYA	88	391	47	0	1175	3	1	391	2.40E-210	732.6	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3888_c0_g1_i3	P50215	IDH_SPHYA	84.2	222	35	0	666	1	65	286	2.10E-112	406.4	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3888_c0_g1_i4	P50215	IDH_SPHYA	82.4	261	46	0	784	2	1	261	2.60E-128	459.5	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3888_c0_g1_i5	P50215	IDH_SPHYA	81.6	391	72	0	1175	3	1	391	3.30E-196	685.6	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3888_c0_g1_i7	P50215	IDH_SPHYA	90.2	388	38	0	1165	2	1	388	6.60E-213	741.1	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN29765_c0_g1_i1	P50215	IDH_SPHYA	91.4	70	6	0	3	212	250	319	1.50E-32	139.4	IDH_SPHYA	reviewed	Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	icd idhA	Sphingobium yanoikuyae (Sphingomonas yanoikuyae)	406	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0006097; GO:0006099; GO:0006102; GO:0051287	glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN23628_c0_g1_i1	O88844	IDHC_MOUSE	99.8	414	1	0	53	1294	1	414	3.20E-245	848.6	IDHC_MOUSE	reviewed	Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	Idh1	Mus musculus (Mouse)	414	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004448; GO:0004450; GO:0005737; GO:0005739; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0014070; GO:0042802; GO:0042803; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0071071	2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN139_c0_g1_i1	P41562	IDHC_RAT	74.2	403	103	1	185	1390	10	412	2.40E-180	633.3	IDHC_RAT	reviewed	Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	Idh1	Rattus norvegicus (Rat)	414	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004448; GO:0004450; GO:0005739; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0014070; GO:0042802; GO:0042803; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0071071	2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN139_c0_g1_i4	P41562	IDHC_RAT	74.9	410	101	2	81	1307	4	412	6.90E-185	648.3	IDHC_RAT	reviewed	Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	Idh1	Rattus norvegicus (Rat)	414	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004448; GO:0004450; GO:0005739; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0014070; GO:0042802; GO:0042803; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0071071	2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN139_c0_g1_i2	Q4R502	IDHP_MACFA	72.1	427	116	3	107	1381	24	449	3.90E-183	642.5	IDHP_MACFA	reviewed	"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	IDH2 QnpA-13564	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	452	mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0005739; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287	2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN8980_c0_g2_i1	P54071	IDHP_MOUSE	100	230	0	0	2	691	223	452	1.10E-135	483.8	IDHP_MOUSE	reviewed	"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	Idh2	Mus musculus (Mouse)	452	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004448; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006741; GO:0051287; GO:0060253; GO:1903976; GO:1904465	2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN8980_c0_g1_i2	P48735	IDHP_HUMAN	100	437	0	0	1	1311	14	450	2.00E-263	909.1	IDHP_HUMAN	reviewed	"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	IDH2	Homo sapiens (Human)	452	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0005975; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006741; GO:0051287; GO:0060253; GO:0070062; GO:1903976; GO:1904465	2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN8980_c0_g1_i4	P54071	IDHP_MOUSE	100	198	0	0	1	594	14	211	1.20E-114	413.7	IDHP_MOUSE	reviewed	"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	Idh2	Mus musculus (Mouse)	452	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004448; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006741; GO:0051287; GO:0060253; GO:1903976; GO:1904465	2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN25466_c0_g1_i1	Q5YYW9	SYI_NOCFA	83.3	60	10	0	25	204	47	106	6.40E-28	124	SYI_NOCFA	reviewed	Isoleucine--tRNA ligase (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)	ileS NFA_17760	Nocardia farcinica (strain IFM 10152)	1042	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0006428; GO:0008270	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN6135_c0_g1_i3	Q7NF75	SYI_GLOVI	70.9	79	23	0	301	65	604	682	2.30E-26	119.4	SYI_GLOVI	reviewed	Isoleucine--tRNA ligase (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)	ileS gll3651	Gloeobacter violaceus (strain ATCC 29082 / PCC 7421)	983	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0006428; GO:0008270	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN37183_c0_g1_i1	P36422	SYI_TETTH	74	131	34	0	2	394	16	146	1.70E-56	219.9	SYI_TETTH	reviewed	Isoleucine--tRNA ligase (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)	ILSA CUPC	Tetrahymena thermophila	1081	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]		aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0006428	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN6378_c0_g2_i1	Q21926	SYIC_CAEEL	53.8	65	29	1	196	2	313	376	3.40E-11	68.6	SYIC_CAEEL	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	iars-1 irs-1 R11A8.6	Caenorhabditis elegans	1141	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0006428	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN15977_c0_g1_i1	O13651	SYIC_SCHPO	61.9	97	36	1	295	8	148	244	5.70E-30	131.3	SYIC_SCHPO	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	irs1 pi058 SPBC8D2.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1064	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0002181; GO:0004822; GO:0005524; GO:0005829; GO:0006428	cytoplasmic translation [GO:0002181]; isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN25401_c0_g1_i1	P41252	SYIC_HUMAN	100	148	0	0	1	444	284	431	8.50E-86	317.4	SYIC_HUMAN	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	IARS1 IARS	Homo sapiens (Human)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN32009_c0_g1_i1	P41252	SYIC_HUMAN	100	73	0	0	3	221	795	867	3.20E-33	141.7	SYIC_HUMAN	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	IARS1 IARS	Homo sapiens (Human)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN29180_c0_g1_i1	Q8BU30	SYIC_MOUSE	100	105	0	0	1	315	64	168	5.20E-61	234.6	SYIC_MOUSE	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	Iars1 Iars	Mus musculus (Mouse)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006428; GO:0017101; GO:0051020	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN7430_c0_g1_i1	Q8BU30	SYIC_MOUSE	55.7	1301	514	20	106	3969	2	1253	0	1416.4	SYIC_MOUSE	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	Iars1 Iars	Mus musculus (Mouse)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006428; GO:0017101; GO:0051020	isoleucyl-tRNA aminoacylation [GO:0006428]		blue	blue	NA	NA	NA	NA
TRINITY_DN36558_c0_g1_i1	P41252	SYIC_HUMAN	100	264	0	0	793	2	10	273	8.50E-161	567.4	SYIC_HUMAN	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	IARS1 IARS	Homo sapiens (Human)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16865_c0_g1_i1	P41252	SYIC_HUMAN	98.4	373	6	0	3	1121	435	807	2.10E-218	759.2	SYIC_HUMAN	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	IARS1 IARS	Homo sapiens (Human)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16865_c0_g1_i2	P41252	SYIC_HUMAN	100	364	0	0	3	1094	435	798	1.30E-215	750	SYIC_HUMAN	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	IARS1 IARS	Homo sapiens (Human)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16865_c0_g2_i1	Q8BU30	SYIC_MOUSE	100	184	0	0	3	554	406	589	3.10E-109	395.6	SYIC_MOUSE	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	Iars1 Iars	Mus musculus (Mouse)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006428; GO:0017101; GO:0051020	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN26308_c0_g1_i1	P41252	SYIC_HUMAN	100	76	0	0	2	229	949	1024	8.50E-37	153.7	SYIC_HUMAN	reviewed	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	IARS1 IARS	Homo sapiens (Human)	1262	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN37502_c0_g1_i1	Q9NSE4	SYIM_HUMAN	100	78	0	0	1	234	647	724	2.20E-40	165.6	SYIM_HUMAN	reviewed	"Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	IARS2	Homo sapiens (Human)	1012	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006428; GO:0032543	isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN6135_c0_g1_i1	Q9NSE4	SYIM_HUMAN	56.4	156	61	2	620	162	619	770	3.10E-41	169.9	SYIM_HUMAN	reviewed	"Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	IARS2	Homo sapiens (Human)	1012	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006428; GO:0032543	isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN6135_c0_g1_i2	Q9NSE4	SYIM_HUMAN	51.1	184	83	2	548	6	619	798	2.20E-43	176.8	SYIM_HUMAN	reviewed	"Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	IARS2	Homo sapiens (Human)	1012	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006428; GO:0032543	isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN40715_c0_g1_i1	Q8J0E9	CEFD1_ACRCH	64.2	67	24	0	6	206	425	491	2.60E-19	95.5	CEFD1_ACRCH	reviewed	Isopenicillin N epimerase component 1 (IPN epimerase component 1) (EC 5.1.1.17) (Isopenicillin N epimerase acyl-CoA synthase component) (EC 6.2.1.-)	cefD1	Acremonium chrysogenum (Cephalosporium acremonium)	609	isopenicillin-N epimerase activity [GO:0045439]; ligase activity [GO:0016874]; penicillin biosynthetic process [GO:0042318]		isopenicillin-N epimerase activity [GO:0045439]; ligase activity [GO:0016874]	GO:0016874; GO:0042318; GO:0045439	penicillin biosynthetic process [GO:0042318]		NA	NA	NA	NA	NA	NA
TRINITY_DN27260_c0_g1_i1	Q75IM9	IVD_ORYSJ	74.6	67	17	0	3	203	111	177	8.10E-23	107.1	IVD_ORYSJ	reviewed	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4)"	Os05g0125500 OsJ_16966 OSJNBb0079L11.8 P0683F12.2	Oryza sativa subsp. japonica (Rice)	409	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0005524; GO:0005759; GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN25771_c0_g1_i1	Q75IM9	IVD_ORYSJ	75.4	61	15	0	212	30	348	408	2.30E-20	99	IVD_ORYSJ	reviewed	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4)"	Os05g0125500 OsJ_16966 OSJNBb0079L11.8 P0683F12.2	Oryza sativa subsp. japonica (Rice)	409	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0005524; GO:0005759; GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN6045_c0_g1_i1	Q3SZI8	IVD_BOVIN	67.1	79	26	0	10	246	222	300	7.40E-23	107.5	IVD_BOVIN	reviewed	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)"	IVD	Bos taurus (Bovine)	426	mitochondrial matrix [GO:0005759]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]	butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0004085; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0042802; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN12575_c0_g1_i1	Q9JHI5	IVD_MOUSE	69.1	123	38	0	411	43	150	272	8.80E-45	181	IVD_MOUSE	reviewed	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)"	Ivd	Mus musculus (Mouse)	424	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0004085; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0031966; GO:0033539; GO:0042802; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN12575_c0_g1_i2	Q5RBD5	IVD_PONAB	71.2	177	51	0	533	3	149	325	8.70E-69	261.2	IVD_PONAB	reviewed	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)"	IVD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	423	mitochondrial matrix [GO:0005759]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]	butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0004085; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0042802; GO:0050660	branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN8667_c1_g1_i1	Q9FS87	IVD_SOLTU	77.1	70	16	0	210	1	204	273	2.20E-23	109	IVD_SOLTU	reviewed	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Isovaleryl-CoA dehydrogenase 2) (St-IVD2)"	IVD IVD2 PGSC0003DMG400008113	Solanum tuberosum (Potato)	412	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; 3-methylbut-2-enoyl-CoA(4-) metabolic process [GO:1902198]; isovaleryl-CoA(4-) catabolic process [GO:1902196]; leucine catabolic process [GO:0006552]	mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0005739; GO:0006552; GO:0008470; GO:0050660; GO:1902196; GO:1902198	3-methylbut-2-enoyl-CoA(4-) metabolic process [GO:1902198]; isovaleryl-CoA(4-) catabolic process [GO:1902196]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN2424_c0_g1_i2	Q9U6V7	JDP_BOMMO	47.7	176	76	3	596	90	4	170	9.00E-38	158.3	JDP_BOMMO	reviewed	J domain-containing protein	jdp	Bombyx mori (Silk moth)	170							NA	NA	NA	NA	NA	NA
TRINITY_DN2424_c0_g1_i1	Q9TVP3	JDP_DROME	59.5	42	17	0	182	57	62	103	1.30E-08	60.1	JDP_DROME	reviewed	J domain-containing protein (dJDP)	jdp CG2239	Drosophila melanogaster (Fruit fly)	195	cytosol [GO:0005829]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]	cytosol [GO:0005829]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005829; GO:0051082; GO:0051085; GO:0051087	chaperone cofactor-dependent protein refolding [GO:0051085]		NA	NA	NA	NA	NA	NA
TRINITY_DN17182_c0_g1_i1	Q60976	JERKY_MOUSE	48.6	111	54	1	333	1	143	250	4.80E-25	115.2	JERKY_MOUSE	reviewed	Jerky protein	Jrk	Mus musculus (Mouse)	557	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN27254_c0_g1_i1	Q60976	JERKY_MOUSE	28.4	134	86	4	390	10	15	145	5.70E-06	52.4	JERKY_MOUSE	reviewed	Jerky protein	Jrk	Mus musculus (Mouse)	557	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN4773_c0_g1_i1	O75564	JERKY_HUMAN	53.5	245	109	2	735	4	15	255	2.00E-69	263.8	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN4773_c0_g1_i2	O75564	JERKY_HUMAN	51.4	37	18	0	3	113	298	334	2.60E-05	48.9	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN4773_c0_g1_i4	O75564	JERKY_HUMAN	52.3	149	71	0	455	9	15	163	5.70E-41	168.7	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN4773_c0_g1_i7	O75564	JERKY_HUMAN	50	48	24	0	256	113	287	334	3.30E-08	58.9	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN4773_c0_g1_i8	O75564	JERKY_HUMAN	54.1	185	80	2	555	4	75	255	1.30E-49	197.6	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN39373_c0_g1_i1	O75564	JERKY_HUMAN	42	81	38	2	13	252	287	359	2.70E-12	72.4	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c1_g1_i1	O75564	JERKY_HUMAN	52.7	150	71	0	90	539	13	162	4.20E-39	162.9	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c1_g1_i2	O75564	JERKY_HUMAN	49.4	174	81	1	90	611	13	179	5.80E-40	165.6	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c1_g1_i3	O75564	JERKY_HUMAN	54.1	135	62	0	90	494	13	147	1.10E-36	154.8	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN10539_c0_g1_i1	O75564	JERKY_HUMAN	58.3	84	35	0	274	23	111	194	1.30E-23	110.2	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN10539_c0_g1_i2	O75564	JERKY_HUMAN	58.3	84	35	0	274	23	111	194	2.90E-23	109	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN30877_c0_g1_i1	O75564	JERKY_HUMAN	52.5	59	28	0	181	5	213	271	2.00E-11	69.3	JERKY_HUMAN	reviewed	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	positive regulation of canonical Wnt signaling pathway [GO:0090263]		NA	NA	NA	NA	NA	NA
TRINITY_DN11418_c0_g1_i2	B2RRL2	JERKL_MOUSE	34.6	133	86	1	324	719	4	136	7.80E-15	83.2	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i16	B2RRL2	JERKL_MOUSE	41.8	55	32	0	106	270	157	211	2.30E-06	53.1	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i17	B2RRL2	JERKL_MOUSE	43.6	55	31	0	70	234	173	227	4.20E-08	58.5	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i20	B2RRL2	JERKL_MOUSE	44.6	65	36	0	143	337	163	227	1.60E-10	67	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i22	B2RRL2	JERKL_MOUSE	42.3	71	41	0	106	318	157	227	4.10E-11	68.9	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i23	B2RRL2	JERKL_MOUSE	44.6	65	36	0	187	381	163	227	1.80E-10	67	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i26	B2RRL2	JERKL_MOUSE	44.6	65	36	0	124	318	163	227	1.20E-10	67.4	JERKL_MOUSE	reviewed	Jerky protein homolog-like	Jrkl	Mus musculus (Mouse)	523	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN7882_c0_g1_i5	Q9Y4A0	JERKL_HUMAN	25.7	179	116	4	161	685	45	210	1.00E-12	75.5	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN7882_c0_g1_i9	Q9Y4A0	JERKL_HUMAN	35.3	68	44	0	256	459	143	210	5.00E-06	52.8	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN16188_c0_g1_i1	Q9Y4A0	JERKL_HUMAN	48.8	41	21	0	48	170	198	238	8.30E-05	47.8	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN16188_c0_g2_i1	Q9Y4A0	JERKL_HUMAN	48.8	41	21	0	246	124	198	238	8.30E-05	47.8	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i10	Q9Y4A0	JERKL_HUMAN	43.7	71	40	0	169	381	157	227	2.30E-10	66.6	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i2	Q9Y4A0	JERKL_HUMAN	43.7	71	40	0	189	401	157	227	2.40E-10	66.6	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN927_c0_g1_i7	Q9Y4A0	JERKL_HUMAN	54.5	55	25	0	97	261	2	56	5.30E-07	55.1	JERKL_HUMAN	reviewed	Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)	JRKL	Homo sapiens (Human)	524	nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007417	central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN8079_c0_g1_i1	Q9VHH9	JHD1_DROME	81.3	166	31	0	501	4	204	369	2.20E-82	306.2	JHD1_DROME	reviewed	JmjC domain-containing histone demethylation protein 1 (EC 1.14.11.27) (Lysine (K)-specific demethylase 2) ([Histone-H3]-lysine-36 demethylase 1)	Kdm2 Jhd1 CG11033	Drosophila melanogaster (Fruit fly)	1345	"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]"	nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]	DNA binding [GO:0003677]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007379; GO:0007526; GO:0008270; GO:0019005; GO:0031061; GO:0031146; GO:0031519; GO:0033183; GO:0033522; GO:0034647; GO:0034721; GO:0051864; GO:0070544	"histone H2A ubiquitination [GO:0033522]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; larval somatic muscle development [GO:0007526]; negative regulation of histone methylation [GO:0031061]; negative regulation of histone ubiquitination [GO:0033183]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; segment specification [GO:0007379]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2166_c0_g1_i1	Q6AY40	JMJD8_RAT	52.8	142	67	0	83	508	67	208	1.40E-39	164.1	JMJD8_RAT	reviewed	JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)	Jmjd8	Rattus norvegicus (Rat)	271	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]		NA	NA	NA	NA	NA	NA
TRINITY_DN2166_c0_g1_i3	Q3TA59	JMJD8_MOUSE	60.6	71	28	0	69	281	138	208	1.20E-21	103.6	JMJD8_MOUSE	reviewed	JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)	Jmjd8	Mus musculus (Mouse)	271	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]		NA	NA	NA	NA	NA	NA
TRINITY_DN24477_c0_g1_i1	Q8BI36	JKAMP_MOUSE	100	110	0	0	332	3	122	231	2.20E-54	212.6	JKAMP_MOUSE	reviewed	JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4 homolog)	Jkamp Jamp	Mus musculus (Mouse)	311	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase binding [GO:0031625]	GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625	response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN3610_c0_g1_i1	Q9P055	JKAMP_HUMAN	43.8	304	157	6	974	87	17	314	6.90E-66	252.7	JKAMP_HUMAN	reviewed	JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4)	JKAMP C14orf100 JAMP CDA06 HSPC213 HSPC327	Homo sapiens (Human)	311	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase binding [GO:0031625]	GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625	response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN33438_c0_g1_i1	Q9P055	JKAMP_HUMAN	100	98	0	0	2	295	104	201	6.60E-50	197.6	JKAMP_HUMAN	reviewed	JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4)	JKAMP C14orf100 JAMP CDA06 HSPC213 HSPC327	Homo sapiens (Human)	311	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase binding [GO:0031625]	GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625	response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN27626_c0_g1_i1	P34609	JIP_CAEEL	57.8	64	27	0	3	194	141	204	3.00E-14	79.7	JIP_CAEEL	reviewed	JNK-interacting protein (JIP) (JNK MAP kinase scaffold protein) (Uncoordinated protein 16)	unc-16 egl-39 ZK1098.10	Caenorhabditis elegans	1190	axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell body [GO:0044297]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; defecation [GO:0030421]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of JNK cascade [GO:0046328]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell body [GO:0044297]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	JUN kinase binding [GO:0008432]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0005078; GO:0005737; GO:0007257; GO:0008432; GO:0016192; GO:0018991; GO:0019894; GO:0019900; GO:0030159; GO:0030421; GO:0030424; GO:0040011; GO:0043194; GO:0043679; GO:0044297; GO:0046328; GO:0048471; GO:0048489	activation of JUN kinase activity [GO:0007257]; defecation [GO:0030421]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of JNK cascade [GO:0046328]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN21029_c0_g1_i1	Q9W0K0	JIP1_DROME	53.9	284	110	4	1	843	153	418	4.00E-76	286.2	JIP1_DROME	reviewed	JNK-interacting protein 1 (JIP-1) (APP-like-interacting protein 1) (APLIP1) (Protein eye developmental SP512)	Aplip1 SP512 CG1200	Drosophila melanogaster (Fruit fly)	490	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; anterograde synaptic vesicle transport [GO:0048490]; axonal transport of mitochondrion [GO:0019896]; JNK cascade [GO:0007254]; multicellular organism development [GO:0007275]; regulation of JNK cascade [GO:0046328]; regulation of terminal button organization [GO:2000331]; retrograde synaptic vesicle transport [GO:0048491]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]	GO:0005078; GO:0005737; GO:0007254; GO:0007275; GO:0019894; GO:0019896; GO:0019901; GO:0030424; GO:0042802; GO:0046328; GO:0048490; GO:0048491; GO:1904115; GO:2000331	anterograde synaptic vesicle transport [GO:0048490]; axonal transport of mitochondrion [GO:0019896]; JNK cascade [GO:0007254]; multicellular organism development [GO:0007275]; regulation of JNK cascade [GO:0046328]; regulation of terminal button organization [GO:2000331]; retrograde synaptic vesicle transport [GO:0048491]		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c2_g1_i1	Q29EP6	JIP3_DROPS	73.5	68	18	0	6	209	59	126	2.50E-18	92.4	JIP3_DROPS	reviewed	JNK-interacting protein 3 (Protein sunday driver)	syd GA20831	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1235	Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]	kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]	GO:0000139; GO:0005078; GO:0008088; GO:0016192; GO:0019894; GO:0030140; GO:0043005; GO:0046328	axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c2_g1_i2	Q29EP6	JIP3_DROPS	81.2	32	6	0	76	171	95	126	1.60E-05	49.7	JIP3_DROPS	reviewed	JNK-interacting protein 3 (Protein sunday driver)	syd GA20831	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1235	Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]	kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]	GO:0000139; GO:0005078; GO:0008088; GO:0016192; GO:0019894; GO:0030140; GO:0043005; GO:0046328	axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c2_g1_i3	Q29EP6	JIP3_DROPS	81.2	32	6	0	81	176	95	126	1.20E-05	50.1	JIP3_DROPS	reviewed	JNK-interacting protein 3 (Protein sunday driver)	syd GA20831	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1235	Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]	kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]	GO:0000139; GO:0005078; GO:0008088; GO:0016192; GO:0019894; GO:0030140; GO:0043005; GO:0046328	axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c2_g1_i4	Q9GQF1	JIP3_DROME	73.8	61	16	0	6	188	59	119	4.30E-16	84.7	JIP3_DROME	reviewed	JNK-interacting protein 3 (Protein sunday driver)	syd CG8110	Drosophila melanogaster (Fruit fly)	1227	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008088; GO:0008432; GO:0016020; GO:0016192; GO:0019894; GO:0030140; GO:0030159; GO:0043005; GO:0046328	activation of JUN kinase activity [GO:0007257]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c2_g2_i1	Q9GQF1	JIP3_DROME	86.2	29	4	0	90	176	91	119	6.10E-05	48.5	JIP3_DROME	reviewed	JNK-interacting protein 3 (Protein sunday driver)	syd CG8110	Drosophila melanogaster (Fruit fly)	1227	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008088; GO:0008432; GO:0016020; GO:0016192; GO:0019894; GO:0030140; GO:0030159; GO:0043005; GO:0046328	activation of JUN kinase activity [GO:0007257]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN8549_c0_g2_i2	Q15040	JOS1_HUMAN	55	151	67	1	514	65	14	164	3.40E-44	179.9	JOS1_HUMAN	reviewed	Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1)	JOSD1 JSPH1 KIAA0063	Homo sapiens (Human)	202	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0005886; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN8549_c0_g2_i4	Q15040	JOS1_HUMAN	53	185	86	1	857	306	14	198	1.90E-51	204.5	JOS1_HUMAN	reviewed	Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1)	JOSD1 JSPH1 KIAA0063	Homo sapiens (Human)	202	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0005886; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN29247_c0_g1_i1	Q8TAC2	JOS2_HUMAN	100	74	0	0	222	1	99	172	7.60E-35	147.1	JOS2_HUMAN	reviewed	Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2)	JOSD2 SBBI54	Homo sapiens (Human)	188	cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN8549_c0_g2_i1	Q9CR30	JOS2_MOUSE	46.8	94	49	1	578	297	95	187	1.00E-16	88.6	JOS2_MOUSE	reviewed	Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2)	Josd2	Mus musculus (Mouse)	188	cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN8549_c0_g2_i3	Q9CR30	JOS2_MOUSE	59.6	57	22	1	235	65	95	150	3.40E-13	75.9	JOS2_MOUSE	reviewed	Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2)	Josd2	Mus musculus (Mouse)	188	cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN16209_c0_g1_i1	Q8TAC2	JOS2_HUMAN	100	71	0	0	213	1	26	96	3.30E-35	148.3	JOS2_HUMAN	reviewed	Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2)	JOSD2 SBBI54	Homo sapiens (Human)	188	cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN16209_c0_g1_i2	Q8TAC2	JOS2_HUMAN	100	75	0	0	227	3	26	100	1.70E-37	156	JOS2_HUMAN	reviewed	Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2)	JOSD2 SBBI54	Homo sapiens (Human)	188	cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN4415_c0_g1_i2	Q8N157	AHI1_HUMAN	38.3	564	325	14	9	1655	360	915	1.50E-109	398.7	AHI1_HUMAN	reviewed	Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1)	AHI1	Homo sapiens (Human)	1196	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]	identical protein binding [GO:0042802]	GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097711; GO:0097730	cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4415_c0_g1_i6	Q8K3E5	AHI1_MOUSE	32.8	778	462	23	9	2249	210	957	5.90E-112	406.8	AHI1_MOUSE	reviewed	Jouberin (Abelson helper integration site 1 protein) (AHI-1)	Ahi1	Mus musculus (Mouse)	1047	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; eye photoreceptor cell development [GO:0042462]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucose import [GO:0046325]; non-motile cilium assembly [GO:1905515]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of neuron projection development [GO:0010976]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization to organelle [GO:0033365]; regulation of behavior [GO:0050795]; regulation of protein secretion [GO:0050708]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle targeting [GO:0006903]; vesicle-mediated transport [GO:0016192]	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]	identical protein binding [GO:0042802]	GO:0001738; GO:0001750; GO:0001947; GO:0002092; GO:0005737; GO:0005813; GO:0005814; GO:0005911; GO:0005912; GO:0005929; GO:0006903; GO:0007169; GO:0007417; GO:0010628; GO:0010842; GO:0010976; GO:0016192; GO:0030862; GO:0030902; GO:0033365; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042462; GO:0042802; GO:0043066; GO:0045927; GO:0045944; GO:0046325; GO:0046548; GO:0046549; GO:0050708; GO:0050795; GO:0060041; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097730; GO:0120206; GO:1905515	cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; eye photoreceptor cell development [GO:0042462]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucose import [GO:0046325]; non-motile cilium assembly [GO:1905515]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of neuron projection development [GO:0010976]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization to organelle [GO:0033365]; regulation of behavior [GO:0050795]; regulation of protein secretion [GO:0050708]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]; vesicle targeting [GO:0006903]		NA	NA	NA	NA	NA	NA
TRINITY_DN36898_c0_g1_i1	Q8SPJ1	PLAK_BOVIN	100	72	0	0	217	2	388	459	1.20E-32	139.8	PLAK_BOVIN	reviewed	Junction plakoglobin (Desmoplakin III) (Desmoplakin-3)	JUP	Bos taurus (Bovine)	745	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; gamma-catenin-TCF7L2 complex [GO:0071665]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; protein-DNA complex [GO:0032993]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cytoskeletal protein-membrane anchor activity [GO:0106006]; nuclear hormone receptor binding [GO:0035257]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; structural molecule activity [GO:0005198]; transcription coactivator activity [GO:0003713]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cellular response to indole-3-methanol [GO:0071681]; desmosome assembly [GO:0002159]; detection of mechanical stimulus [GO:0050982]; endothelial cell-cell adhesion [GO:0071603]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell population proliferation [GO:0042127]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; gamma-catenin-TCF7L2 complex [GO:0071665]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; protein-DNA complex [GO:0032993]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cytoskeletal protein-membrane anchor activity [GO:0106006]; nuclear hormone receptor binding [GO:0035257]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; structural molecule activity [GO:0005198]; transcription coactivator activity [GO:0003713]	GO:0001954; GO:0002159; GO:0003713; GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0005912; GO:0005915; GO:0009898; GO:0014704; GO:0016342; GO:0016477; GO:0019903; GO:0030018; GO:0030057; GO:0032993; GO:0035257; GO:0042127; GO:0042307; GO:0042803; GO:0043537; GO:0043588; GO:0045294; GO:0045296; GO:0045766; GO:0045944; GO:0050982; GO:0051091; GO:0071603; GO:0071665; GO:0071681; GO:0072659; GO:0086073; GO:0086091; GO:0098911; GO:0106006	bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cellular response to indole-3-methanol [GO:0071681]; desmosome assembly [GO:0002159]; detection of mechanical stimulus [GO:0050982]; endothelial cell-cell adhesion [GO:0071603]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell population proliferation [GO:0042127]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]		NA	NA	NA	NA	NA	NA
TRINITY_DN26022_c0_g1_i1	Q8WXH2	JPH3_HUMAN	50	48	24	0	54	197	284	331	5.00E-07	54.7	JPH3_HUMAN	reviewed	Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein)	JPH3 JP3 TNRC22	Homo sapiens (Human)	748	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0014701; GO:0016021; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060314; GO:0060402	calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167]		NA	NA	NA	NA	NA	NA
TRINITY_DN35520_c0_g1_i1	Q9VJK8	JHAMT_DROME	36.8	231	139	4	745	71	46	275	2.10E-36	154.1	JHAMT_DROME	reviewed	Juvenile hormone acid O-methyltransferase (EC 2.1.1.325) (Juvenile hormone acid methyltransferase) (DmJHAMT)	jhamt CG17330	Drosophila melanogaster (Fruit fly)	297	farnesoic acid O-methyltransferase activity [GO:0019010]; juvenile hormone acid methyltransferase activity [GO:0035049]; juvenile hormone biosynthetic process [GO:0006718]; male courtship behavior [GO:0008049]; methylation [GO:0032259]		farnesoic acid O-methyltransferase activity [GO:0019010]; juvenile hormone acid methyltransferase activity [GO:0035049]	GO:0006718; GO:0008049; GO:0019010; GO:0032259; GO:0035049	juvenile hormone biosynthetic process [GO:0006718]; male courtship behavior [GO:0008049]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4713_c0_g1_i1	Q8MZR6	HYEP1_CTEFE	48.2	419	211	5	12	1265	37	450	2.90E-116	420.2	HYEP1_CTEFE	reviewed	Juvenile hormone epoxide hydrolase 1 (EC 3.3.2.9) (CfEH1) (Juvenile hormone epoxide hydrolase I) (JHEH I) (Juvenile hormone-specific epoxide hydrolase I)	EH1	Ctenocephalides felis (Cat flea)	464	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cis-stilbene-oxide hydrolase activity [GO:0033961]; aromatic compound catabolic process [GO:0019439]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cis-stilbene-oxide hydrolase activity [GO:0033961]	GO:0005789; GO:0016021; GO:0019439; GO:0033961	aromatic compound catabolic process [GO:0019439]		NA	NA	NA	NA	NA	NA
TRINITY_DN1524_c0_g1_i1	Q86VZ6	JAZF1_HUMAN	42.3	97	44	3	686	396	7	91	2.80E-09	63.9	JAZF1_HUMAN	reviewed	Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802)	JAZF1 TIP27 ZNF802	Homo sapiens (Human)	243	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1524_c0_g1_i1	Q86VZ6	JAZF1_HUMAN	74.2	31	8	0	192	100	169	199	2.40E-08	60.8	JAZF1_HUMAN	reviewed	Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802)	JAZF1 TIP27 ZNF802	Homo sapiens (Human)	243	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1524_c0_g1_i2	Q86VZ6	JAZF1_HUMAN	42.3	97	44	3	638	348	7	91	2.60E-09	63.9	JAZF1_HUMAN	reviewed	Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802)	JAZF1 TIP27 ZNF802	Homo sapiens (Human)	243	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1524_c0_g1_i3	Q86VZ6	JAZF1_HUMAN	59.7	62	25	0	1027	842	169	230	5.40E-16	87	JAZF1_HUMAN	reviewed	Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802)	JAZF1 TIP27 ZNF802	Homo sapiens (Human)	243	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1524_c0_g1_i4	Q86VZ6	JAZF1_HUMAN	40.5	269	115	6	1648	842	7	230	3.30E-21	104.8	JAZF1_HUMAN	reviewed	Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802)	JAZF1 TIP27 ZNF802	Homo sapiens (Human)	243	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN19375_c0_g1_i5	P97924	KALRN_RAT	47.6	1446	623	21	4248	1	243	1583	0	1267.7	KALRN_RAT	reviewed	Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (PAM COOH-terminal interactor protein 10) (P-CIP10) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	Kalrn Duo Hapip	Rattus norvegicus (Rat)	2959	"cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to formalin induced pain [GO:0061368]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; social behavior [GO:0035176]"	cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]	GO:0001662; GO:0004674; GO:0005085; GO:0005524; GO:0005856; GO:0007266; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0009612; GO:0014069; GO:0014909; GO:0019899; GO:0030676; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048148; GO:0048168; GO:0048471; GO:0048659; GO:0050773; GO:0051966; GO:0060125; GO:0060137; GO:0060999; GO:0061003; GO:0061368; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1900273; GO:1903076	"adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to formalin induced pain [GO:0061368]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; social behavior [GO:0035176]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19375_c0_g1_i3	A2CG49	KALRN_MOUSE	48.1	1681	737	21	4953	1	8	1583	0	1518.1	KALRN_MOUSE	reviewed	Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	Kalrn	Mus musculus (Mouse)	2964	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019899; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274	adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN19375_c0_g1_i4	A2CG49	KALRN_MOUSE	48	440	182	3	1363	44	243	635	3.50E-112	406.8	KALRN_MOUSE	reviewed	Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	Kalrn	Mus musculus (Mouse)	2964	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019899; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274	adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN19375_c0_g1_i9	A2CG49	KALRN_MOUSE	49.2	920	400	15	2718	1	717	1583	1.80E-242	840.5	KALRN_MOUSE	reviewed	Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	Kalrn	Mus musculus (Mouse)	2964	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019899; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043005; GO:0043025; GO:0043547; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:1905274	adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rho protein signal transduction [GO:0035023]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN33909_c0_g1_i1	Q9BWU0	NADAP_HUMAN	100	83	0	0	249	1	169	251	8.30E-46	183.7	NADAP_HUMAN	reviewed	Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)	SLC4A1AP HLC3	Homo sapiens (Human)	796	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	mRNA binding [GO:0003729]	GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN39259_c0_g1_i1	Q9BWU0	NADAP_HUMAN	36.1	280	148	7	7	834	335	587	4.70E-37	156.4	NADAP_HUMAN	reviewed	Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)	SLC4A1AP HLC3	Homo sapiens (Human)	796	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	mRNA binding [GO:0003729]	GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN440_c0_g1_i1	Q80TG1	KANL1_MOUSE	26.7	544	291	15	2	1474	400	888	2.30E-21	105.1	KANL1_MOUSE	reviewed	KAT8 regulatory NSL complex subunit 1 (NSL complex protein NSL1) (Non-specific lethal 1 homolog)	Kansl1 Kiaa1267 Nsl1	Mus musculus (Mouse)	1036	condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone acetyltransferase binding [GO:0035035]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone acetyltransferase binding [GO:0035035]	GO:0000123; GO:0000777; GO:0005634; GO:0005654; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0046972; GO:0071339	histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		NA	NA	NA	NA	NA	NA
TRINITY_DN440_c0_g1_i2	Q80TG1	KANL1_MOUSE	27.1	532	291	15	2	1435	400	888	5.00E-21	104	KANL1_MOUSE	reviewed	KAT8 regulatory NSL complex subunit 1 (NSL complex protein NSL1) (Non-specific lethal 1 homolog)	Kansl1 Kiaa1267 Nsl1	Mus musculus (Mouse)	1036	condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone acetyltransferase binding [GO:0035035]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone acetyltransferase binding [GO:0035035]	GO:0000123; GO:0000777; GO:0005634; GO:0005654; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0046972; GO:0071339	histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		NA	NA	NA	NA	NA	NA
TRINITY_DN1180_c0_g1_i1	Q9H9L4	KANL2_HUMAN	38.5	369	208	10	86	1162	8	367	2.00E-54	214.9	KANL2_HUMAN	reviewed	KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog)	KANSL2 C12orf41 NSL2	Homo sapiens (Human)	492	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0000123; GO:0005654; GO:0005829; GO:0005886; GO:0015629; GO:0043981; GO:0043982; GO:0043984; GO:0044545	histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		NA	NA	NA	NA	NA	NA
TRINITY_DN35780_c0_g1_i1	Q9SEX2	KTNA1_ARATH	63.2	106	36	1	6	323	239	341	2.00E-31	136.3	KTNA1_ARATH	reviewed	Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 5.6.1.1) (CAD ATPase) (Katanin-1) (AtKTN1) (Katanin-like microtubule-severing protein) (AtKSS) (Protein BOTERO 1) (Protein ECTOPIC ROOT HAIR 3) (Protein FAT ROOT) (Protein FRAGILE FIBER 2) (AtAAA1) (p60 katanin) (Atp60)	AAA1 BOT1 ERH3 FRA2 FTR KSS KTN1 LUE1 At1g80350 F5I6.10	Arabidopsis thaliana (Mouse-ear cress)	523	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cortical microtubule organization [GO:0043622]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; multidimensional cell growth [GO:0009825]; plant-type cell wall biogenesis [GO:0009832]; trichome branching [GO:0010091]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0008017; GO:0008568; GO:0009825; GO:0009832; GO:0010091; GO:0015630; GO:0016853; GO:0016887; GO:0031122; GO:0043622; GO:0051013	cortical microtubule organization [GO:0043622]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; multidimensional cell growth [GO:0009825]; plant-type cell wall biogenesis [GO:0009832]; trichome branching [GO:0010091]		NA	NA	NA	NA	NA	NA
TRINITY_DN18983_c0_g1_i1	O75449	KTNA1_HUMAN	98.6	70	1	0	210	1	343	412	1.30E-31	136.3	KTNA1_HUMAN	reviewed	Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 5.6.1.1) (p60 katanin)	KATNA1	Homo sapiens (Human)	491	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0030496; GO:0031122; GO:0046982; GO:0051301; GO:0097431	cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]		NA	NA	NA	NA	NA	NA
TRINITY_DN27248_c0_g1_i1	Q1HGK7	KTNA1_CHICK	81	205	36	3	2	610	208	411	4.30E-88	325.5	KTNA1_CHICK	reviewed	Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 5.6.1.1) (p60 katanin)	KATNA1	Gallus gallus (Chicken)	492	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0030496; GO:0031122; GO:0051301; GO:0097431	cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]		blue	blue	NA	NA	NA	NA
TRINITY_DN36708_c0_g1_i1	Q9BW62	KATL1_HUMAN	64	211	73	1	633	1	203	410	8.20E-74	278.1	KATL1_HUMAN	reviewed	Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1)	KATNAL1	Homo sapiens (Human)	490	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0031122; GO:0042802; GO:0051013	cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN32162_c0_g1_i1	Q8IYT4	KATL2_HUMAN	83.9	87	14	0	266	6	259	345	9.80E-37	153.7	KATL2_HUMAN	reviewed	Katanin p60 ATPase-containing subunit A-like 2 (Katanin p60 subunit A-like 2) (EC 5.6.1.1) (p60 katanin-like 2)	KATNAL2	Homo sapiens (Human)	538	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0031122	cytoplasmic microtubule organization [GO:0031122]		NA	NA	NA	NA	NA	NA
TRINITY_DN3814_c0_g1_i6	Q5ZIU8	KTNB1_CHICK	31.9	113	56	3	291	1	61	168	5.20E-07	55.1	KTNB1_CHICK	reviewed	Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin)	KATNB1 RCJMB04_23h13	Gallus gallus (Chicken)	657	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; katanin complex [GO:0008352]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of microtubule depolymerization [GO:0031117]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; katanin complex [GO:0008352]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]	GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0007019; GO:0007026; GO:0007049; GO:0008017; GO:0008352; GO:0030424; GO:0031117; GO:0046982; GO:0051013; GO:0051301; GO:0060590; GO:0070840	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of microtubule depolymerization [GO:0031117]		NA	NA	NA	NA	NA	NA
TRINITY_DN11361_c0_g1_i1	Q6NVM2	KTNB1_XENTR	68.3	104	33	0	314	3	87	190	2.80E-43	175.6	KTNB1_XENTR	reviewed	Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin)	katnb1 TEgg076g13.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	655	centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]	GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007019; GO:0007049; GO:0008017; GO:0008352; GO:0051013; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]		blue	blue	NA	NA	NA	NA
TRINITY_DN35365_c0_g1_i1	A9C3W3	KAZRA_DANRE	54.4	57	26	0	1	171	644	700	7.50E-11	68.2	KAZRA_DANRE	reviewed	Kazrin-A	kazna kaza si:dkey-159f12.3	Danio rerio (Zebrafish) (Brachydanio rerio)	786							NA	NA	NA	NA	NA	NA
TRINITY_DN4399_c0_g1_i1	Q5U580	KLD10_XENLA	42.6	366	205	3	169	1266	51	411	4.90E-87	323.2	KLD10_XENLA	reviewed	Kelch domain-containing protein 10	klhdc10	Xenopus laevis (African clawed frog)	411	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN3805_c0_g1_i2	Q58CV6	KLDC3_BOVIN	42.9	133	63	3	2	400	258	377	1.50E-21	104	KLDC3_BOVIN	reviewed	Kelch domain-containing protein 3	KLHDC3	Bos taurus (Bovine)	382	cytoplasm [GO:0005737]; meiotic cell cycle [GO:0051321]	cytoplasm [GO:0005737]		GO:0005737; GO:0051321	meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN36065_c0_g1_i1	Q58CV6	KLDC3_BOVIN	95.8	71	3	0	214	2	252	322	7.30E-35	147.1	KLDC3_BOVIN	reviewed	Kelch domain-containing protein 3	KLHDC3	Bos taurus (Bovine)	382	cytoplasm [GO:0005737]; meiotic cell cycle [GO:0051321]	cytoplasm [GO:0005737]		GO:0005737; GO:0051321	meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN6009_c0_g1_i1	Q921I2	KLDC4_MOUSE	50.2	207	96	2	617	3	1	202	1.40E-50	201.1	KLDC4_MOUSE	reviewed	Kelch domain-containing protein 4	Klhdc4	Mus musculus (Mouse)	584							blue	blue	NA	NA	NA	NA
TRINITY_DN2145_c0_g1_i1	B1H285	KBTB8_RAT	46.6	103	54	1	354	49	5	107	2.90E-17	90.1	KBTB8_RAT	reviewed	Kelch repeat and BTB domain-containing protein 8	Kbtbd8	Rattus norvegicus (Rat)	575	Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]	Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]		GO:0005794; GO:0005819; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463	neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN3067_c0_g1_i1	Q684M4	KEAP1_PIG	42	219	122	1	715	74	54	272	4.00E-44	179.9	KEAP1_PIG	reviewed	Kelch-like ECH-associated protein 1	KEAP1	Sus scrofa (Pig)	624	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0008134; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0045604; GO:0071353; GO:0097718	cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3067_c0_g1_i3	Q684M4	KEAP1_PIG	51.5	392	187	3	1184	12	214	603	2.90E-115	416.8	KEAP1_PIG	reviewed	Kelch-like ECH-associated protein 1	KEAP1	Sus scrofa (Pig)	624	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0008134; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0045604; GO:0071353; GO:0097718	cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3067_c0_g1_i4	Q684M4	KEAP1_PIG	48.6	552	276	4	1649	12	54	603	4.20E-152	539.7	KEAP1_PIG	reviewed	Kelch-like ECH-associated protein 1	KEAP1	Sus scrofa (Pig)	624	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0008134; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0045604; GO:0071353; GO:0097718	cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN34960_c0_g1_i1	Q9Z2X8	KEAP1_MOUSE	100	132	0	0	397	2	370	501	4.20E-76	285	KEAP1_MOUSE	reviewed	Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2)	Keap1 Inrf2 Kiaa0132	Mus musculus (Mouse)	624	"actin filament [GO:0005884]; adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to carbohydrate stimulus [GO:0071322]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of gene expression [GO:0010629]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	actin filament [GO:0005884]; adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0005912; GO:0005925; GO:0006355; GO:0006511; GO:0008134; GO:0010506; GO:0010629; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032991; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0045604; GO:0071322; GO:0071353; GO:0097718	"cellular response to carbohydrate stimulus [GO:0071322]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of gene expression [GO:0010629]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37208_c0_g1_i1	Q9Z2X8	KEAP1_MOUSE	100	75	0	0	1	225	539	613	6.10E-40	164.1	KEAP1_MOUSE	reviewed	Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2)	Keap1 Inrf2 Kiaa0132	Mus musculus (Mouse)	624	"actin filament [GO:0005884]; adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to carbohydrate stimulus [GO:0071322]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of gene expression [GO:0010629]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	actin filament [GO:0005884]; adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0005912; GO:0005925; GO:0006355; GO:0006511; GO:0008134; GO:0010506; GO:0010629; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032991; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0045604; GO:0071322; GO:0071353; GO:0097718	"cellular response to carbohydrate stimulus [GO:0071322]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of gene expression [GO:0010629]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36917_c0_g1_i1	Q14145	KEAP1_HUMAN	100	122	0	0	368	3	396	517	2.20E-71	269.2	KEAP1_HUMAN	reviewed	Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)	KEAP1 INRF2 KIAA0132 KLHL19	Homo sapiens (Human)	624	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0008134; GO:0010506; GO:0016032; GO:0016234; GO:0016567; GO:0016579; GO:0030496; GO:0031463; GO:0032436; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0043433; GO:0043687; GO:0045604; GO:0071353; GO:0097718	cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31742_c0_g1_i1	Q14145	KEAP1_HUMAN	100	86	0	0	3	260	518	603	3.50E-47	188.3	KEAP1_HUMAN	reviewed	Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)	KEAP1 INRF2 KIAA0132 KLHL19	Homo sapiens (Human)	624	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]	GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0008134; GO:0010506; GO:0016032; GO:0016234; GO:0016567; GO:0016579; GO:0030496; GO:0031463; GO:0032436; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0043433; GO:0043687; GO:0045604; GO:0071353; GO:0097718	cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN26590_c0_g1_i1	Q9NR64	KLHL1_HUMAN	22.2	239	166	5	146	823	152	383	7.50E-12	73.6	KLHL1_HUMAN	reviewed	Kelch-like protein 1	KLHL1 KIAA1490	Homo sapiens (Human)	748	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0007628; GO:0016358; GO:0021680; GO:0030036; GO:0030425; GO:0043025	actin cytoskeleton organization [GO:0030036]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358]		NA	NA	NA	NA	NA	NA
TRINITY_DN38024_c0_g1_i1	E1B932	KLH12_BOVIN	100	68	0	0	2	205	25	92	3.90E-33	141.4	KLH12_BOVIN	reviewed	Kelch-like protein 12	KLHL12	Bos taurus (Bovine)	568	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]		GO:0000139; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN18309_c0_g1_i1	Q5U374	KLH12_DANRE	34	247	151	4	2504	1782	1	241	1.30E-29	133.3	KLH12_DANRE	reviewed	Kelch-like protein 12	klhl12 si:dkeyp-53e12.5 zgc:92570	Danio rerio (Zebrafish) (Brachydanio rerio)	564	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]		GO:0000139; GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208; GO:0060028	anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN29420_c0_g1_i1	Q6TDP3	KLH17_MOUSE	54.2	59	27	0	69	245	476	534	6.50E-11	67.8	KLH17_MOUSE	reviewed	Kelch-like protein 17 (Actinfilin)	Klhl17	Mus musculus (Mouse)	640	actin cytoskeleton [GO:0015629]; dendrite cytoplasm [GO:0032839]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]	actin cytoskeleton [GO:0015629]; dendrite cytoplasm [GO:0032839]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]	GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0032839; GO:0043025; GO:0051015; GO:0060090	actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9243_c0_g3_i1	O94889	KLH18_HUMAN	50.8	132	65	0	484	89	123	254	3.60E-37	156	KLH18_HUMAN	reviewed	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	574	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]			GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9243_c0_g3_i2	O94889	KLH18_HUMAN	59.7	318	128	0	986	33	254	571	3.40E-112	406.4	KLH18_HUMAN	reviewed	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	574	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]			GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9243_c0_g3_i3	O94889	KLH18_HUMAN	57	449	193	0	1379	33	123	571	2.90E-156	553.1	KLH18_HUMAN	reviewed	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	574	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]			GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9243_c0_g3_i4	O94889	KLH18_HUMAN	53.2	79	37	0	263	27	123	201	1.10E-19	97.1	KLH18_HUMAN	reviewed	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	574	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]			GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN37026_c0_g1_i1	O94889	KLH18_HUMAN	100	137	0	0	2	412	162	298	5.70E-76	284.6	KLH18_HUMAN	reviewed	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	574	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]			GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN34656_c0_g1_i1	O94889	KLH18_HUMAN	68.5	89	28	0	103	369	8	96	5.20E-28	125.2	KLH18_HUMAN	reviewed	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	574	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]			GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN29378_c0_g1_i1	Q8JZP3	KLHL2_MOUSE	100	90	0	0	3	272	417	506	2.80E-47	188.7	KLHL2_MOUSE	reviewed	Kelch-like protein 2	Klhl2	Mus musculus (Mouse)	593	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567]	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0001725; GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0042803	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN34715_c0_g1_i1	O95198	KLHL2_HUMAN	100	82	0	0	2	247	48	129	1.10E-39	163.3	KLHL2_HUMAN	reviewed	Kelch-like protein 2 (Actin-binding protein Mayven)	KLHL2	Homo sapiens (Human)	593	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	actin binding [GO:0003779]; identical protein binding [GO:0042802]	GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0043687	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN31157_c0_g1_i1	O95198	KLHL2_HUMAN	100	111	0	0	3	335	473	583	6.50E-62	237.7	KLHL2_HUMAN	reviewed	Kelch-like protein 2 (Actin-binding protein Mayven)	KLHL2	Homo sapiens (Human)	593	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	actin binding [GO:0003779]; identical protein binding [GO:0042802]	GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0043687	post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3076_c1_g1_i2	F1LZF0	KLHL2_RAT	29.5	562	367	8	222	1889	37	575	8.00E-65	250	KLHL2_RAT	reviewed	Kelch-like protein 2 (Mayven)	Klhl2	Rattus norvegicus (Rat)	593	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein ubiquitination [GO:0016567]	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	actin binding [GO:0003779]; identical protein binding [GO:0042802]	GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3076_c1_g1_i5	F1LZF0	KLHL2_RAT	29.5	562	367	8	222	1889	37	575	8.20E-65	250	KLHL2_RAT	reviewed	Kelch-like protein 2 (Mayven)	Klhl2	Rattus norvegicus (Rat)	593	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein ubiquitination [GO:0016567]	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	actin binding [GO:0003779]; identical protein binding [GO:0042802]	GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN2145_c0_g1_i2	Q08DK3	KLH20_BOVIN	44.3	149	83	0	523	77	45	193	4.80E-33	142.9	KLH20_BOVIN	reviewed	Kelch-like protein 20	KLHL20	Bos taurus (Bovine)	609	axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]	axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]	actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390	Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN565_c2_g2_i1	Q8BGY4	KLH26_MOUSE	35.1	410	232	12	1215	46	36	431	2.40E-49	198	KLH26_MOUSE	reviewed	Kelch-like protein 26	Klhl26	Mus musculus (Mouse)	606							NA	NA	NA	NA	NA	NA
TRINITY_DN26767_c0_g1_i1	Q9CR40	KLH28_MOUSE	100	76	0	0	3	230	372	447	2.60E-38	158.7	KLH28_MOUSE	reviewed	Kelch-like protein 28 (BTB/POZ domain-containing protein 5)	Klhl28 Btbd5	Mus musculus (Mouse)	571							NA	NA	NA	NA	NA	NA
TRINITY_DN1482_c0_g1_i3	Q9C0H6	KLHL4_HUMAN	62.5	80	30	0	9	248	164	243	6.60E-21	101.3	KLHL4_HUMAN	reviewed	Kelch-like protein 4	KLHL4 KIAA1687	Homo sapiens (Human)	718	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0015630; GO:0034451			NA	NA	NA	NA	NA	NA
TRINITY_DN2307_c0_g1_i1	O60662	KLH41_HUMAN	27.6	87	61	1	374	120	29	115	7.90E-06	52	KLH41_HUMAN	reviewed	Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin)	KLHL41 KBTBD10 KRP1	Homo sapiens (Human)	606	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]; striated muscle contraction [GO:0006941]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]		GO:0001726; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0006941; GO:0016567; GO:0030239; GO:0031143; GO:0031275; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0043687; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014	myofibril assembly [GO:0030239]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN28398_c0_g1_i1	Q96PQ7	KLHL5_HUMAN	100	105	0	0	316	2	220	324	4.20E-55	214.9	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN1482_c0_g1_i1	Q96PQ7	KLHL5_HUMAN	61.1	144	56	0	9	440	202	345	1.60E-44	180.6	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN1482_c0_g1_i2	Q96PQ7	KLHL5_HUMAN	59.8	256	102	1	9	776	202	456	2.40E-83	310.1	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN37641_c0_g1_i1	Q96PQ7	KLHL5_HUMAN	100	72	0	0	3	218	420	491	1.30E-34	146.4	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN4655_c0_g1_i1	Q96PQ7	KLHL5_HUMAN	73.5	306	76	1	1019	102	454	754	1.90E-133	476.9	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN4655_c0_g1_i3	Q96PQ7	KLHL5_HUMAN	70.1	301	86	1	992	102	454	754	2.80E-124	446.4	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN4655_c0_g1_i4	Q96PQ7	KLHL5_HUMAN	74.6	232	54	1	773	78	454	680	3.70E-100	365.9	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN35985_c0_g1_i1	Q96PQ7	KLHL5_HUMAN	99.1	112	1	0	337	2	614	725	1.70E-62	239.6	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN14099_c0_g1_i1	Q96PQ7	KLHL5_HUMAN	99.4	179	1	0	1	537	498	676	4.50E-105	381.7	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN14099_c0_g1_i2	Q96PQ7	KLHL5_HUMAN	100	95	0	0	1	285	498	592	7.20E-54	210.7	KLHL5_HUMAN	reviewed	Kelch-like protein 5	KLHL5	Homo sapiens (Human)	755	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN25515_c0_g1_i1	B4GRJ2	KLHDB_DROPE	83.4	187	31	0	2	562	333	519	1.60E-92	340.1	KLHDB_DROPE	reviewed	Kelch-like protein diablo	dbo GL25213	Drosophila persimilis (Fruit fly)	628	actin binding [GO:0003779]; protein homodimerization activity [GO:0042803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein autoubiquitination [GO:0051865]		actin binding [GO:0003779]; protein homodimerization activity [GO:0042803]	GO:0003779; GO:0042803; GO:0045886; GO:0051865	negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN4915_c0_g1_i1	B4J045	KLHDB_DROGR	82.7	277	48	0	2	832	56	332	3.00E-132	472.6	KLHDB_DROGR	reviewed	Kelch-like protein diablo	dbo GH17090	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	624	actin binding [GO:0003779]; protein homodimerization activity [GO:0042803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein autoubiquitination [GO:0051865]		actin binding [GO:0003779]; protein homodimerization activity [GO:0042803]	GO:0003779; GO:0042803; GO:0045886; GO:0051865	negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN4915_c0_g1_i2	Q16RL8	KLHDB_AEDAE	74.8	131	33	0	2	394	24	154	1.50E-53	210.3	KLHDB_AEDAE	reviewed	Kelch-like protein diablo	dbo AAEL010911	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	589	actin binding [GO:0003779]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]		actin binding [GO:0003779]	GO:0003779; GO:0016567; GO:0045886	negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]		blue	blue	NA	NA	NA	NA
TRINITY_DN30905_c0_g1_i1	Q16RL8	KLHDB_AEDAE	90.1	91	9	0	275	3	480	570	1.70E-44	179.5	KLHDB_AEDAE	reviewed	Kelch-like protein diablo	dbo AAEL010911	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	589	actin binding [GO:0003779]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]		actin binding [GO:0003779]	GO:0003779; GO:0016567; GO:0045886	negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN8312_c0_g1_i1	A6QQ59	KTAP2_BOVIN	100	88	0	0	265	2	27	114	3.50E-42	171.8	KTAP2_BOVIN	reviewed	Keratinocyte-associated protein 2 (KCP-2) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2) (Oligosaccharyl transferase subunit KCP2)	KRTCAP2	Bos taurus (Bovine)	136	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein N-linked glycosylation via arginine [GO:0042543]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021; GO:0042543	protein N-linked glycosylation via arginine [GO:0042543]		NA	NA	NA	NA	NA	NA
TRINITY_DN8312_c0_g1_i2	A6QQ59	KTAP2_BOVIN	100	88	0	0	265	2	27	114	3.50E-42	171.8	KTAP2_BOVIN	reviewed	Keratinocyte-associated protein 2 (KCP-2) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2) (Oligosaccharyl transferase subunit KCP2)	KRTCAP2	Bos taurus (Bovine)	136	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein N-linked glycosylation via arginine [GO:0042543]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021; GO:0042543	protein N-linked glycosylation via arginine [GO:0042543]		NA	NA	NA	NA	NA	NA
TRINITY_DN21969_c0_g1_i1	P86229	KTAP2_CANLF	50.4	125	62	0	112	486	3	127	1.80E-27	124	KTAP2_CANLF	reviewed	Keratinocyte-associated protein 2 (KCP-2) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2) (Oligosaccharyl transferase subunit KCP2)	KRTCAP2 KCP2	Canis lupus familiaris (Dog) (Canis familiaris)	136	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation via arginine [GO:0042543]	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0008250; GO:0016021; GO:0042543	protein N-linked glycosylation via arginine [GO:0042543]		blue	blue	NA	NA	NA	NA
TRINITY_DN5712_c0_g1_i1	P97328	KHK_MOUSE	46.5	297	152	1	109	999	6	295	4.60E-72	273.1	KHK_MOUSE	reviewed	Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase)	Khk	Mus musculus (Mouse)	298	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process through fructose-1-phosphate [GO:0061625]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]	GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0032868; GO:0061624; GO:0061625; GO:0070873	fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process through fructose-1-phosphate [GO:0061625]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN5712_c0_g1_i2	P97328	KHK_MOUSE	48.3	286	148	0	1	858	10	295	2.80E-73	276.9	KHK_MOUSE	reviewed	Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase)	Khk	Mus musculus (Mouse)	298	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process through fructose-1-phosphate [GO:0061625]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]	GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0032868; GO:0061624; GO:0061625; GO:0070873	fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process through fructose-1-phosphate [GO:0061625]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN5712_c0_g1_i4	Q02974	KHK_RAT	47.2	144	69	1	109	540	6	142	6.50E-33	142.1	KHK_RAT	reviewed	Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase)	Khk	Rattus norvegicus (Rat)	298	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]; carbohydrate catabolic process [GO:0016052]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]	GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0016052; GO:0032868; GO:0070873	carbohydrate catabolic process [GO:0016052]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN27334_c0_g1_i1	Q5ZL54	KHDC4_CHICK	48.5	130	57	2	97	462	65	192	3.80E-21	102.8	KHDC4_CHICK	reviewed	KH homology domain-containing protein 4 (Brings lots of money 7) (Pre-mRNA splicing factor protein KHDC4)	KHDC4 BLOM7 RCJMB04_7l9	Gallus gallus (Chicken)	619	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006376	mRNA splice site selection [GO:0006376]		NA	NA	NA	NA	NA	NA
TRINITY_DN6035_c0_g1_i2	Q96MD2	CL066_HUMAN	38.6	446	249	6	1545	229	14	441	1.40E-88	328.6	CL066_HUMAN	reviewed	KICSTOR complex protein C12orf66	C12orf66	Homo sapiens (Human)	445	intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]	intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]		GO:0005764; GO:0005765; GO:0034198; GO:0042149; GO:0045171; GO:0061462; GO:0140007; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]		NA	NA	NA	NA	NA	NA
TRINITY_DN6035_c0_g1_i1	Q6P1I3	CL066_MOUSE	42	307	175	2	1146	229	137	441	1.20E-67	258.5	CL066_MOUSE	reviewed	KICSTOR complex protein C12orf66 homolog		Mus musculus (Mouse)	445	intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]	intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]		GO:0005764; GO:0005765; GO:0034198; GO:0042149; GO:0045171; GO:0061462; GO:0140007; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c0_g1_i10	Q5RBH8	ITFG2_PONAB	35.2	506	232	11	1507	50	1	430	2.40E-73	278.5	ITFG2_PONAB	reviewed	KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2)	ITFG2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	433	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0034198; GO:0042149; GO:0140007; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c0_g1_i4	Q969R8	ITFG2_HUMAN	34.3	70	46	0	259	50	361	430	2.20E-06	53.5	ITFG2_HUMAN	reviewed	KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2)	ITFG2	Homo sapiens (Human)	447	cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006]	cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]		GO:0002314; GO:0005654; GO:0005765; GO:0005829; GO:0032006; GO:0034198; GO:0042149; GO:0140007; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN6993_c0_g1_i2	Q5T011	SZT2_HUMAN	35.6	735	387	22	3322	1241	460	1149	4.90E-109	397.5	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN6993_c0_g1_i3	Q5T011	SZT2_HUMAN	35.6	735	387	22	3375	1294	460	1149	5.00E-109	397.5	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN3488_c0_g1_i10	Q5T011	SZT2_HUMAN	29.9	471	257	10	203	1570	3020	3432	1.10E-42	176	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN3488_c0_g1_i2	Q5T011	SZT2_HUMAN	28.3	930	484	29	1287	3953	2645	3432	9.50E-67	257.3	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN3488_c0_g1_i3	Q5T011	SZT2_HUMAN	28.8	709	366	25	1580	3598	2645	3250	5.20E-47	191.8	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN3488_c0_g1_i5	Q5T011	SZT2_HUMAN	28.3	930	484	29	1580	4246	2645	3432	1.00E-66	257.3	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN3488_c0_g1_i6	Q5T011	SZT2_HUMAN	28.3	930	484	29	1430	4096	2645	3432	9.80E-67	257.3	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN21211_c0_g1_i1	Q5T011	SZT2_HUMAN	29.8	181	108	3	805	278	1607	1773	2.20E-08	61.2	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN21211_c0_g1_i3	Q5T011	SZT2_HUMAN	29.9	304	174	9	1135	278	1491	1773	3.00E-18	94.4	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN21211_c0_g1_i4	Q5T011	SZT2_HUMAN	30.8	263	152	6	1039	278	1532	1773	4.70E-19	97.1	SZT2_HUMAN	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	3432	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		NA	NA	NA	NA	NA	NA
TRINITY_DN6993_c0_g1_i8	A2A9C3	SZT2_MOUSE	44.2	224	118	3	705	46	460	680	4.60E-52	206.1	SZT2_MOUSE	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)	Szt2	Mus musculus (Mouse)	3431	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]		NA	NA	NA	NA	NA	NA
TRINITY_DN22562_c0_g1_i2	A2A9C3	SZT2_MOUSE	41.5	265	145	3	79	870	3	258	1.00E-45	185.3	SZT2_MOUSE	reviewed	KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)	Szt2	Mus musculus (Mouse)	3431	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]		NA	NA	NA	NA	NA	NA
TRINITY_DN30128_c0_g1_i1	Q3U492	KCP_MOUSE	50	64	23	1	50	241	136	190	6.10E-12	71.2	KCP_MOUSE	reviewed	Kielin/chordin-like protein (Cysteine-rich BMP regulator 2) (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin/chordin-like protein 1) (KCP-1)	Kcp Crim2 Kcp1	Mus musculus (Mouse)	1550	extracellular space [GO:0005615]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of BMP signaling pathway [GO:0030513]	extracellular space [GO:0005615]		GO:0002244; GO:0005615; GO:0030513	hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of BMP signaling pathway [GO:0030513]		NA	NA	NA	NA	NA	NA
TRINITY_DN3079_c0_g1_i1	A8WE67	KBP_DANRE	39.8	488	272	6	1484	75	142	625	9.50E-92	339	KBP_DANRE	reviewed	KIF-binding protein (KIF1-binding protein)	kifbp kbp kif1bp	Danio rerio (Zebrafish) (Brachydanio rerio)	631	cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; central nervous system projection neuron axonogenesis [GO:0021952]; efferent axon development in posterior lateral line nerve [GO:0048929]; enteric nervous system development [GO:0048484]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]; neuron projection maintenance [GO:1990535]	cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]		GO:0000226; GO:0005739; GO:0005856; GO:0006839; GO:0007399; GO:0021952; GO:0048484; GO:0048929; GO:1990535	central nervous system projection neuron axonogenesis [GO:0021952]; efferent axon development in posterior lateral line nerve [GO:0048929]; enteric nervous system development [GO:0048484]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]; neuron projection maintenance [GO:1990535]		NA	NA	NA	NA	NA	NA
TRINITY_DN3079_c0_g1_i3	A8WE67	KBP_DANRE	39.3	321	175	4	986	75	308	625	1.10E-59	231.9	KBP_DANRE	reviewed	KIF-binding protein (KIF1-binding protein)	kifbp kbp kif1bp	Danio rerio (Zebrafish) (Brachydanio rerio)	631	cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; central nervous system projection neuron axonogenesis [GO:0021952]; efferent axon development in posterior lateral line nerve [GO:0048929]; enteric nervous system development [GO:0048484]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]; neuron projection maintenance [GO:1990535]	cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]		GO:0000226; GO:0005739; GO:0005856; GO:0006839; GO:0007399; GO:0021952; GO:0048484; GO:0048929; GO:1990535	central nervous system projection neuron axonogenesis [GO:0021952]; efferent axon development in posterior lateral line nerve [GO:0048929]; enteric nervous system development [GO:0048484]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]; neuron projection maintenance [GO:1990535]		NA	NA	NA	NA	NA	NA
TRINITY_DN25446_c0_g1_i1	Q9ULH0	KDIS_HUMAN	100	116	0	0	348	1	102	217	6.50E-65	247.7	KDIS_HUMAN	reviewed	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	1771	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g2_i1	Q9ULH0	KDIS_HUMAN	34.6	338	173	9	90	980	951	1281	1.10E-37	159.1	KDIS_HUMAN	reviewed	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	1771	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g2_i2	Q9ULH0	KDIS_HUMAN	36.4	338	167	9	2	892	951	1281	1.10E-43	178.7	KDIS_HUMAN	reviewed	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	1771	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g2_i5	Q9ULH0	KDIS_HUMAN	36	642	321	13	35	1837	689	1281	8.00E-94	346.3	KDIS_HUMAN	reviewed	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	1771	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g2_i8	Q9ULH0	KDIS_HUMAN	36.9	626	321	13	35	1789	689	1281	1.90E-95	351.7	KDIS_HUMAN	reviewed	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	1771	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]		NA	NA	NA	NA	NA	NA
TRINITY_DN31306_c0_g1_i1	Q9ULH0	KDIS_HUMAN	99	105	1	0	316	2	397	501	4.50E-57	221.5	KDIS_HUMAN	reviewed	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	1771	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g1_i1	Q7T163	KDISB_DANRE	38.9	72	43	1	38	253	6	76	7.70E-07	54.7	KDISB_DANRE	reviewed	Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B)	kidins220b arms kidins220 si:dkeyp-7f8.3 si:dz119j18.2 zgc:63531	Danio rerio (Zebrafish) (Brachydanio rerio)	1680	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902	nervous system development [GO:0007399]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN933_c0_g1_i2	Q7T163	KDISB_DANRE	50.9	591	281	4	38	1795	6	592	4.40E-163	576.2	KDISB_DANRE	reviewed	Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B)	kidins220b arms kidins220 si:dkeyp-7f8.3 si:dz119j18.2 zgc:63531	Danio rerio (Zebrafish) (Brachydanio rerio)	1680	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g1_i4	Q7T163	KDISB_DANRE	48.5	687	338	7	38	2083	6	681	9.60E-178	625.2	KDISB_DANRE	reviewed	Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B)	kidins220b arms kidins220 si:dkeyp-7f8.3 si:dz119j18.2 zgc:63531	Danio rerio (Zebrafish) (Brachydanio rerio)	1680	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN933_c0_g1_i5	Q7T163	KDISB_DANRE	47.7	417	204	5	41	1279	275	681	2.40E-97	357.5	KDISB_DANRE	reviewed	Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B)	kidins220b arms kidins220 si:dkeyp-7f8.3 si:dz119j18.2 zgc:63531	Danio rerio (Zebrafish) (Brachydanio rerio)	1680	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN32076_c0_g1_i1	Q7T163	KDISB_DANRE	42.4	99	56	1	316	23	118	216	2.80E-14	79.3	KDISB_DANRE	reviewed	Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B)	kidins220b arms kidins220 si:dkeyp-7f8.3 si:dz119j18.2 zgc:63531	Danio rerio (Zebrafish) (Brachydanio rerio)	1680	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN279_c0_g1_i1	P17210	KINH_DROME	68	103	31	1	2	310	13	113	2.00E-33	143.3	KINH_DROME	reviewed	Kinesin heavy chain	Khc kin CG7765	Drosophila melanogaster (Fruit fly)	975	"actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; tropomyosin binding [GO:0005523]; actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; larval somatic muscle development [GO:0007526]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; microtubule-based movement [GO:0007018]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]"	actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; tropomyosin binding [GO:0005523]"	GO:0001754; GO:0003774; GO:0003777; GO:0005523; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007097; GO:0007303; GO:0007310; GO:0007315; GO:0007317; GO:0007409; GO:0007411; GO:0007526; GO:0008017; GO:0008088; GO:0008103; GO:0008345; GO:0008574; GO:0010970; GO:0016887; GO:0030478; GO:0030705; GO:0032839; GO:0035371; GO:0035617; GO:0045451; GO:0046785; GO:0046843; GO:0048311; GO:0048312; GO:0048489; GO:0048813; GO:0051012; GO:0051299; GO:0061572; GO:0070868; GO:0098937; GO:0098957; GO:0098971; GO:1904115	"actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; larval somatic muscle development [GO:0007526]; microtubule-based movement [GO:0007018]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1929_c0_g1_i1	P17210	KINH_DROME	75.8	194	47	0	600	19	765	958	3.30E-72	272.7	KINH_DROME	reviewed	Kinesin heavy chain	Khc kin CG7765	Drosophila melanogaster (Fruit fly)	975	"actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; tropomyosin binding [GO:0005523]; actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; larval somatic muscle development [GO:0007526]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; microtubule-based movement [GO:0007018]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]"	actin cap [GO:0030478]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; tropomyosin binding [GO:0005523]"	GO:0001754; GO:0003774; GO:0003777; GO:0005523; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007097; GO:0007303; GO:0007310; GO:0007315; GO:0007317; GO:0007409; GO:0007411; GO:0007526; GO:0008017; GO:0008088; GO:0008103; GO:0008345; GO:0008574; GO:0010970; GO:0016887; GO:0030478; GO:0030705; GO:0032839; GO:0035371; GO:0035617; GO:0045451; GO:0046785; GO:0046843; GO:0048311; GO:0048312; GO:0048489; GO:0048813; GO:0051012; GO:0051299; GO:0061572; GO:0070868; GO:0098937; GO:0098957; GO:0098971; GO:1904115	"actin filament bundle organization [GO:0061572]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axo-dendritic transport [GO:0008088]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; centrosome separation [GO:0051299]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; eye photoreceptor cell differentiation [GO:0001754]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intracellular distribution of mitochondria [GO:0048312]; larval locomotory behavior [GO:0008345]; larval somatic muscle development [GO:0007526]; microtubule-based movement [GO:0007018]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; mitochondrion distribution [GO:0048311]; nuclear migration [GO:0007097]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; regulation of pole plasm oskar mRNA localization [GO:0007317]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; transport along microtubule [GO:0010970]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26933_c0_g1_i1	O43093	KINH_SYNRA	61.2	273	105	1	818	3	60	332	1.30E-90	334.3	KINH_SYNRA	reviewed	Kinesin heavy chain (Synkin)		Syncephalastrum racemosum (Filamentous fungus)	935	cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN279_c0_g1_i2	P33175	KIF5A_MOUSE	57.5	725	284	6	2	2131	10	725	1.00E-216	754.6	KIF5A_MOUSE	reviewed	Kinesin heavy chain isoform 5A (Kinesin heavy chain neuron-specific 1) (Neuronal kinesin heavy chain) (NKHC)	Kif5a Kiaa4086 Kif5 Nkhc1	Mus musculus (Mouse)	1027	"apical dendrite [GO:0097440]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; central region of growth cone [GO:0090724]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; P-body [GO:0000932]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]"	apical dendrite [GO:0097440]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; central region of growth cone [GO:0090724]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; P-body [GO:0000932]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]"	GO:0000932; GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007411; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030705; GO:0032839; GO:0035253; GO:0043005; GO:0043025; GO:0043204; GO:0044877; GO:0048471; GO:0048489; GO:0090724; GO:0097110; GO:0097440; GO:0098971; GO:0099641; GO:1904115; GO:1990049	anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN279_c0_g2_i1	P33175	KIF5A_MOUSE	60.1	932	355	5	109	2871	3	928	2.20E-281	969.9	KIF5A_MOUSE	reviewed	Kinesin heavy chain isoform 5A (Kinesin heavy chain neuron-specific 1) (Neuronal kinesin heavy chain) (NKHC)	Kif5a Kiaa4086 Kif5 Nkhc1	Mus musculus (Mouse)	1027	"apical dendrite [GO:0097440]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; central region of growth cone [GO:0090724]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; P-body [GO:0000932]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]"	apical dendrite [GO:0097440]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; central region of growth cone [GO:0090724]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; P-body [GO:0000932]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]"	GO:0000932; GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007411; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030705; GO:0032839; GO:0035253; GO:0043005; GO:0043025; GO:0043204; GO:0044877; GO:0048471; GO:0048489; GO:0090724; GO:0097110; GO:0097440; GO:0098971; GO:0099641; GO:1904115; GO:1990049	anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN387_c0_g1_i2	P46824	KLC_DROME	90.4	292	28	0	18	893	178	469	3.60E-153	542.3	KLC_DROME	reviewed	Kinesin light chain (KLC)	Klc CG5433	Drosophila melanogaster (Fruit fly)	508	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]		GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0046843	dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN387_c0_g1_i3	P46824	KLC_DROME	86	307	28	1	18	938	178	469	3.90E-150	532.3	KLC_DROME	reviewed	Kinesin light chain (KLC)	Klc CG5433	Drosophila melanogaster (Fruit fly)	508	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]		GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0046843	dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN387_c0_g1_i4	P46824	KLC_DROME	79	343	54	2	18	1046	178	502	5.20E-151	535.4	KLC_DROME	reviewed	Kinesin light chain (KLC)	Klc CG5433	Drosophila melanogaster (Fruit fly)	508	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]		GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0046843	dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN387_c0_g1_i6	P46824	KLC_DROME	82.6	328	54	1	18	1001	178	502	2.80E-154	546.2	KLC_DROME	reviewed	Kinesin light chain (KLC)	Klc CG5433	Drosophila melanogaster (Fruit fly)	508	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]		GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0046843	dorsal appendage formation [GO:0046843]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN32776_c0_g1_i1	Q07866	KLC1_HUMAN	100	248	0	0	1	744	221	468	2.00E-143	509.6	KLC1_HUMAN	reviewed	Kinesin light chain 1 (KLC 1)	KLC1 KLC KNS2	Homo sapiens (Human)	573	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; stress granule disassembly [GO:0035617]; viral process [GO:0016032]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]	motor activity [GO:0003774]	GO:0003774; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0016020; GO:0016032; GO:0019886; GO:0030426; GO:0031410; GO:0035617	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; stress granule disassembly [GO:0035617]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31901_c0_g1_i1	P37285	KLC1_RAT	100	81	0	0	243	1	224	304	3.90E-40	164.9	KLC1_RAT	reviewed	Kinesin light chain 1 (KLC 1)	Klc1 Klc Kns2	Rattus norvegicus (Rat)	560	axon [GO:0030424]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; intracellular protein transport [GO:0006886]; protein localization to synapse [GO:0035418]; stress granule disassembly [GO:0035617]	axon [GO:0030424]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; vesicle [GO:0031982]	tubulin binding [GO:0015631]	GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0006886; GO:0008088; GO:0015631; GO:0016020; GO:0030424; GO:0030426; GO:0031410; GO:0031982; GO:0035253; GO:0035418; GO:0035617; GO:0043005; GO:0043025; GO:0043227	axo-dendritic transport [GO:0008088]; intracellular protein transport [GO:0006886]; protein localization to synapse [GO:0035418]; stress granule disassembly [GO:0035617]		NA	NA	NA	NA	NA	NA
TRINITY_DN21045_c0_g1_i1	Q9H0B6	KLC2_HUMAN	96.6	87	3	0	3	263	288	374	1.30E-41	169.9	KLC2_HUMAN	reviewed	Kinesin light chain 2 (KLC 2)	KLC2	Homo sapiens (Human)	622	"cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cadherin binding [GO:0045296]; kinesin binding [GO:0019894]	GO:0005654; GO:0005739; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0006890; GO:0007018; GO:0016020; GO:0016938; GO:0019886; GO:0019894; GO:0032991; GO:0045296	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21045_c0_g1_i2	Q9H0B6	KLC2_HUMAN	97.2	108	3	0	3	326	267	374	1.70E-54	213	KLC2_HUMAN	reviewed	Kinesin light chain 2 (KLC 2)	KLC2	Homo sapiens (Human)	622	"cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cadherin binding [GO:0045296]; kinesin binding [GO:0019894]	GO:0005654; GO:0005739; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0006890; GO:0007018; GO:0016020; GO:0016938; GO:0019886; GO:0019894; GO:0032991; GO:0045296	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21069_c0_g1_i1	P33176	KINH_HUMAN	100	294	0	0	884	3	52	345	7.40E-166	584.3	KINH_HUMAN	reviewed	Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC)	KIF5B KNS KNS1	Homo sapiens (Human)	963	"axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; microtubule motor activity [GO:0003777]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]"	axonal growth cone [GO:0044295]; axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007028; GO:0007411; GO:0008017; GO:0008432; GO:0008574; GO:0016020; GO:0016887; GO:0021766; GO:0030705; GO:0031340; GO:0031982; GO:0032230; GO:0032839; GO:0034451; GO:0035253; GO:0035617; GO:0035774; GO:0042391; GO:0042802; GO:0043268; GO:0044295; GO:0045296; GO:0045335; GO:0047496; GO:0048471; GO:0048489; GO:0051642; GO:0071346; GO:0072383; GO:0090316; GO:0098971; GO:0099609; GO:0099641; GO:1903078; GO:1904115; GO:1905152; GO:1990048; GO:1990049	"anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40891_c0_g1_i1	Q61768	KINH_MOUSE	100	73	0	0	30	248	768	840	1.20E-31	136.7	KINH_MOUSE	reviewed	Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC)	Kif5b Khcs Kns1	Mus musculus (Mouse)	963	"axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; kinesin complex [GO:0005871]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; microtubule motor activity [GO:0003777]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; mitochondrial transport [GO:0006839]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]"	axonal growth cone [GO:0044295]; axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; kinesin complex [GO:0005871]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0006839; GO:0007017; GO:0007018; GO:0007028; GO:0007411; GO:0008017; GO:0008432; GO:0008574; GO:0015630; GO:0016887; GO:0021766; GO:0030139; GO:0030705; GO:0031340; GO:0031982; GO:0032230; GO:0032839; GO:0034451; GO:0035253; GO:0035617; GO:0035774; GO:0042391; GO:0042802; GO:0043005; GO:0043227; GO:0043268; GO:0044295; GO:0045335; GO:0047496; GO:0048471; GO:0048489; GO:0051642; GO:0071346; GO:0072383; GO:0090316; GO:0098971; GO:0099609; GO:0099641; GO:1903078; GO:1904115; GO:1905152; GO:1990049	"anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; mitochondrial transport [GO:0006839]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37892_c0_g1_i1	P70188	KIFA3_MOUSE	98.7	79	1	0	238	2	1	79	7.90E-38	157.1	KIFA3_MOUSE	reviewed	Kinesin-associated protein 3 (KAP-3) (KAP3)	Kifap3	Mus musculus (Mouse)	793	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]	GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005876; GO:0005930; GO:0007017; GO:0007018; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019894; GO:0019903; GO:0032391; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0120170; GO:1990075	cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]		NA	NA	NA	NA	NA	NA
TRINITY_DN36256_c0_g1_i1	P70188	KIFA3_MOUSE	100	109	0	0	327	1	121	229	2.30E-56	219.2	KIFA3_MOUSE	reviewed	Kinesin-associated protein 3 (KAP-3) (KAP3)	Kifap3	Mus musculus (Mouse)	793	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]	intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]	GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005876; GO:0005930; GO:0007017; GO:0007018; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019894; GO:0019903; GO:0032391; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0120170; GO:1990075	cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]		NA	NA	NA	NA	NA	NA
TRINITY_DN40604_c0_g1_i1	Q92845	KIFA3_HUMAN	66.7	36	12	0	44	151	614	649	4.90E-07	54.7	KIFA3_HUMAN	reviewed	Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein)	KIFAP3 KIF3AP SMAP	Homo sapiens (Human)	792	"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cilium organization [GO:0044782]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]"	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]	GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0019903; GO:0032391; GO:0035735; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:0120170; GO:1990075	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cilium organization [GO:0044782]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36171_c0_g1_i1	Q92845	KIFA3_HUMAN	100	81	0	0	246	4	17	97	1.10E-39	163.3	KIFA3_HUMAN	reviewed	Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein)	KIFAP3 KIF3AP SMAP	Homo sapiens (Human)	792	"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cilium organization [GO:0044782]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]"	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]	GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0019903; GO:0032391; GO:0035735; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:0120170; GO:1990075	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cilium organization [GO:0044782]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31024_c0_g1_i1	Q92845	KIFA3_HUMAN	98.4	125	2	0	376	2	429	553	7.80E-64	244.2	KIFA3_HUMAN	reviewed	Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein)	KIFAP3 KIF3AP SMAP	Homo sapiens (Human)	792	"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cilium organization [GO:0044782]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]"	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]	GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0019903; GO:0032391; GO:0035735; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:0120170; GO:1990075	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cilium organization [GO:0044782]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN850_c0_g1_i1	Q26626	KIFA3_STRPU	56.1	776	320	9	2405	126	1	771	6.10E-242	838.6	KIFA3_STRPU	reviewed	Kinesin-associated protein 3 (SpKAP115)	KAP115	Strongylocentrotus purpuratus (Purple sea urchin)	828	axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]	axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; kinesin II complex [GO:0016939]	kinesin binding [GO:0019894]	GO:0005930; GO:0007017; GO:0007018; GO:0016939; GO:0019894; GO:0035869; GO:0044782	cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN20324_c0_g2_i1	P46872	KRP85_STRPU	46.4	110	49	2	380	78	58	166	4.10E-20	99	KRP85_STRPU	reviewed	Kinesin-II 85 kDa subunit (KRP-85/95 85 kDa subunit)	KRP85	Strongylocentrotus purpuratus (Purple sea urchin)	699	axon cytoplasm [GO:1904115]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]	axon cytoplasm [GO:1904115]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0007411; GO:0008017; GO:0008089; GO:0016887; GO:0060271; GO:1904115	anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN1907_c0_g1_i1	P46871	KRP95_STRPU	80.3	71	14	0	223	11	302	372	2.50E-27	122.5	KRP95_STRPU	reviewed	Kinesin-II 95 kDa subunit (KRP-85/95 95 kDa subunit)	KRP95	Strongylocentrotus purpuratus (Purple sea urchin)	742	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN1907_c0_g1_i2	P46871	KRP95_STRPU	78.2	367	80	0	1111	11	6	372	1.40E-165	583.9	KRP95_STRPU	reviewed	Kinesin-II 95 kDa subunit (KRP-85/95 95 kDa subunit)	KRP95	Strongylocentrotus purpuratus (Purple sea urchin)	742	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN1907_c0_g1_i3	P46871	KRP95_STRPU	67.5	126	40	1	385	11	247	372	3.10E-41	169.5	KRP95_STRPU	reviewed	Kinesin-II 95 kDa subunit (KRP-85/95 95 kDa subunit)	KRP95	Strongylocentrotus purpuratus (Purple sea urchin)	742	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN37882_c0_g1_i1	Q9US03	KLP2_SCHPO	53.8	78	36	0	236	3	728	805	1.60E-14	79.7	KLP2_SCHPO	reviewed	Kinesin-like protein 2	klp2 SPAC664.10	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	817	"astral microtubule [GO:0000235]; condensed nuclear chromosome kinetochore [GO:0000778]; cortical microtubule [GO:0055028]; cytoplasmic microtubule [GO:0005881]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule minus-end [GO:0036449]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; minus-end kinesin complex [GO:0005872]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoplasmic microtubule organization [GO:0031122]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; karyogamy involved in conjugation with cellular fusion [GO:0000742]; meiotic centromere clustering [GO:1990571]; microtubule anchoring at mitotic spindle pole body [GO:1990810]; microtubule bundle formation [GO:0001578]; microtubule sliding [GO:0051012]; microtubule sliding involved in mitotic metaphase chromosome recapture [GO:1905185]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; nuclear migration during mitotic telophase [GO:0090561]; plus-end directed microtubule sliding [GO:0031535]"	astral microtubule [GO:0000235]; condensed nuclear chromosome kinetochore [GO:0000778]; cortical microtubule [GO:0055028]; cytoplasmic microtubule [GO:0005881]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule minus-end [GO:0036449]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; minus-end kinesin complex [GO:0005872]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0000022; GO:0000235; GO:0000742; GO:0000778; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005815; GO:0005871; GO:0005872; GO:0005874; GO:0005881; GO:0007018; GO:0008017; GO:0008569; GO:0008574; GO:0015630; GO:0016887; GO:0030951; GO:0031122; GO:0031534; GO:0031535; GO:0035371; GO:0036449; GO:0051012; GO:0051256; GO:0055028; GO:0072686; GO:0090307; GO:0090561; GO:1905185; GO:1990571; GO:1990810	cytoplasmic microtubule organization [GO:0031122]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; karyogamy involved in conjugation with cellular fusion [GO:0000742]; meiotic centromere clustering [GO:1990571]; microtubule anchoring at mitotic spindle pole body [GO:1990810]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; microtubule sliding [GO:0051012]; microtubule sliding involved in mitotic metaphase chromosome recapture [GO:1905185]; minus-end directed microtubule sliding [GO:0031534]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; nuclear migration during mitotic telophase [GO:0090561]; plus-end directed microtubule sliding [GO:0031535]		NA	NA	NA	NA	NA	NA
TRINITY_DN26283_c0_g1_i1	Q9US03	KLP2_SCHPO	47.1	70	36	1	227	18	528	596	4.20E-12	71.6	KLP2_SCHPO	reviewed	Kinesin-like protein 2	klp2 SPAC664.10	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	817	"astral microtubule [GO:0000235]; condensed nuclear chromosome kinetochore [GO:0000778]; cortical microtubule [GO:0055028]; cytoplasmic microtubule [GO:0005881]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule minus-end [GO:0036449]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; minus-end kinesin complex [GO:0005872]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoplasmic microtubule organization [GO:0031122]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; karyogamy involved in conjugation with cellular fusion [GO:0000742]; meiotic centromere clustering [GO:1990571]; microtubule anchoring at mitotic spindle pole body [GO:1990810]; microtubule bundle formation [GO:0001578]; microtubule sliding [GO:0051012]; microtubule sliding involved in mitotic metaphase chromosome recapture [GO:1905185]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; nuclear migration during mitotic telophase [GO:0090561]; plus-end directed microtubule sliding [GO:0031535]"	astral microtubule [GO:0000235]; condensed nuclear chromosome kinetochore [GO:0000778]; cortical microtubule [GO:0055028]; cytoplasmic microtubule [GO:0005881]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule minus-end [GO:0036449]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; minus-end kinesin complex [GO:0005872]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0000022; GO:0000235; GO:0000742; GO:0000778; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005815; GO:0005871; GO:0005872; GO:0005874; GO:0005881; GO:0007018; GO:0008017; GO:0008569; GO:0008574; GO:0015630; GO:0016887; GO:0030951; GO:0031122; GO:0031534; GO:0031535; GO:0035371; GO:0036449; GO:0051012; GO:0051256; GO:0055028; GO:0072686; GO:0090307; GO:0090561; GO:1905185; GO:1990571; GO:1990810	cytoplasmic microtubule organization [GO:0031122]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; karyogamy involved in conjugation with cellular fusion [GO:0000742]; meiotic centromere clustering [GO:1990571]; microtubule anchoring at mitotic spindle pole body [GO:1990810]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; microtubule sliding [GO:0051012]; microtubule sliding involved in mitotic metaphase chromosome recapture [GO:1905185]; minus-end directed microtubule sliding [GO:0031534]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; nuclear migration during mitotic telophase [GO:0090561]; plus-end directed microtubule sliding [GO:0031535]		NA	NA	NA	NA	NA	NA
TRINITY_DN39256_c0_g1_i1	Q9US60	KLP3_SCHPO	58.7	75	30	1	228	7	251	325	3.20E-18	92	KLP3_SCHPO	reviewed	Kinesin-like protein 3 (Kinesin-related protein 1)	klp3 krp1 SPAC1834.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	554	"cell cortex [GO:0005938]; cytoplasmic microtubule [GO:0005881]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; microtubule-based movement [GO:0007018]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; transport along microtubule [GO:0010970]"	cell cortex [GO:0005938]; cytoplasmic microtubule [GO:0005881]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0000301; GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0006887; GO:0007018; GO:0008017; GO:0008574; GO:0010970; GO:0016887; GO:0030705; GO:0071963	"cytoskeleton-dependent intracellular transport [GO:0030705]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; microtubule-based movement [GO:0007018]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; transport along microtubule [GO:0010970]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22188_c0_g1_i1	O14343	KLP5_SCHPO	65.2	69	24	0	5	211	333	401	5.00E-20	97.8	KLP5_SCHPO	reviewed	Kinesin-like protein 5	klp5 SPBC2F12.13	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	883	"condensed nuclear chromosome kinetochore [GO:0000778]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; plus-end kinesin complex [GO:0005873]; post-anaphase microtubule array [GO:1990295]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; cytoplasmic microtubule depolymerization [GO:0010938]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome recapture [GO:1990942]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; plus-end specific microtubule depolymerization [GO:0070462]; protein transport along microtubule to kinetochore [GO:0140210]; regulation of mitotic spindle elongation [GO:0032888]"	condensed nuclear chromosome kinetochore [GO:0000778]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; plus-end kinesin complex [GO:0005873]; post-anaphase microtubule array [GO:1990295]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0000070; GO:0000778; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007079; GO:0008017; GO:0008574; GO:0010938; GO:0015630; GO:0016887; GO:0016938; GO:0032888; GO:0044732; GO:0051301; GO:0055028; GO:0061673; GO:0070462; GO:0072686; GO:0099607; GO:0140210; GO:1902426; GO:1990023; GO:1990295; GO:1990758; GO:1990942	cell division [GO:0051301]; cytoplasmic microtubule depolymerization [GO:0010938]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome recapture [GO:1990942]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; plus-end specific microtubule depolymerization [GO:0070462]; protein transport along microtubule to kinetochore [GO:0140210]; regulation of mitotic spindle elongation [GO:0032888]		NA	NA	NA	NA	NA	NA
TRINITY_DN23105_c0_g1_i1	P46869	FLA10_CHLRE	49.3	152	60	3	8	415	203	353	6.90E-29	128.3	FLA10_CHLRE	reviewed	Kinesin-like protein FLA10 (Protein KHP1)	FLA10	Chlamydomonas reinhardtii (Chlamydomonas smithii)	786	ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cilium [GO:0005929]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; intraciliary anterograde transport [GO:0035720]; motile cilium assembly [GO:0044458]	ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cilium [GO:0005929]; microtubule [GO:0005874]; motile cilium [GO:0031514]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005874; GO:0005929; GO:0008017; GO:0031514; GO:0035720; GO:0036064; GO:0044458; GO:0097014	intraciliary anterograde transport [GO:0035720]; motile cilium assembly [GO:0044458]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g1_i3	B2GU58	KIF11_XENTR	61.7	287	105	5	930	85	26	312	3.10E-93	343.2	KIF11_XENTR	reviewed	Kinesin-like protein KIF11 (Costal2)	kif11 cos2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1067	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]"	GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0007018; GO:0008017; GO:0008574; GO:0019901; GO:0051301; GO:0090307	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g1_i4	Q6P9P6	KIF11_MOUSE	63.1	293	103	5	948	85	19	311	3.90E-96	352.8	KIF11_MOUSE	reviewed	Kinesin-like protein KIF11 (Kinesin-related motor protein Eg5)	Kif11	Mus musculus (Mouse)	1052	"cytosol [GO:0005829]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]"	cytosol [GO:0005829]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]"	GO:0000922; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005874; GO:0005876; GO:0007018; GO:0007051; GO:0007100; GO:0008017; GO:0008574; GO:0019901; GO:0032991; GO:0046602; GO:0051225; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g2_i1	Q6P9P6	KIF11_MOUSE	52.3	218	98	3	636	1	107	324	1.40E-50	201.4	KIF11_MOUSE	reviewed	Kinesin-like protein KIF11 (Kinesin-related motor protein Eg5)	Kif11	Mus musculus (Mouse)	1052	"cytosol [GO:0005829]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]"	cytosol [GO:0005829]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]"	GO:0000922; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005874; GO:0005876; GO:0007018; GO:0007051; GO:0007100; GO:0008017; GO:0008574; GO:0019901; GO:0032991; GO:0046602; GO:0051225; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g2_i1	Q6P9P6	KIF11_MOUSE	54.6	97	40	4	887	609	19	115	3.40E-17	90.5	KIF11_MOUSE	reviewed	Kinesin-like protein KIF11 (Kinesin-related motor protein Eg5)	Kif11	Mus musculus (Mouse)	1052	"cytosol [GO:0005829]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]"	cytosol [GO:0005829]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]"	GO:0000922; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005874; GO:0005876; GO:0007018; GO:0007051; GO:0007100; GO:0008017; GO:0008574; GO:0019901; GO:0032991; GO:0046602; GO:0051225; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g1_i1	Q91783	KI11A_XENLA	90.7	54	5	0	246	85	259	312	1.80E-20	99.8	KI11A_XENLA	reviewed	Kinesin-like protein KIF11-A (Kinesin-5) (Kinesin-related motor protein Eg5-2) (XLEg5K2)	kif11-a eg5	Xenopus laevis (African clawed frog)	1067	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005876; GO:0007018; GO:0007049; GO:0008017; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g1_i2	Q91783	KI11A_XENLA	82.9	82	14	0	170	415	294	375	2.00E-31	136.7	KI11A_XENLA	reviewed	Kinesin-like protein KIF11-A (Kinesin-5) (Kinesin-related motor protein Eg5-2) (XLEg5K2)	kif11-a eg5	Xenopus laevis (African clawed frog)	1067	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005876; GO:0007018; GO:0007049; GO:0008017; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN17788_c0_g1_i2	Q91783	KI11A_XENLA	77.8	36	8	0	192	85	277	312	7.00E-08	58.5	KI11A_XENLA	reviewed	Kinesin-like protein KIF11-A (Kinesin-5) (Kinesin-related motor protein Eg5-2) (XLEg5K2)	kif11-a eg5	Xenopus laevis (African clawed frog)	1067	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005876; GO:0007018; GO:0007049; GO:0008017; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN32935_c0_g1_i1	Q91783	KI11A_XENLA	49.2	63	32	0	190	2	208	270	8.50E-09	60.5	KI11A_XENLA	reviewed	Kinesin-like protein KIF11-A (Kinesin-5) (Kinesin-related motor protein Eg5-2) (XLEg5K2)	kif11-a eg5	Xenopus laevis (African clawed frog)	1067	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005876; GO:0007018; GO:0007049; GO:0008017; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN32673_c0_g1_i1	Q9H1H9	KI13A_HUMAN	70.9	103	30	0	44	352	1084	1186	1.60E-35	150.2	KI13A_HUMAN	reviewed	Kinesin-like protein KIF13A (Kinesin-like protein RBKIN)	KIF13A RBKIN	Homo sapiens (Human)	1805	centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]	centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383	cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]		NA	NA	NA	NA	NA	NA
TRINITY_DN12049_c0_g1_i1	Q9NQT8	KI13B_HUMAN	70.6	401	105	3	10	1212	68	455	2.80E-147	523.1	KI13B_HUMAN	reviewed	Kinesin-like protein KIF13B (Kinesin-like protein GAKIN)	KIF13B GAKIN KIAA0639	Homo sapiens (Human)	1826	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]	14-3-3 protein binding [GO:0071889]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005902; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0033270; GO:0042110; GO:0050770; GO:0071889	microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN12049_c0_g1_i2	Q9NQT8	KI13B_HUMAN	66.3	190	52	2	114	683	278	455	1.60E-59	230.7	KI13B_HUMAN	reviewed	Kinesin-like protein KIF13B (Kinesin-like protein GAKIN)	KIF13B GAKIN KIAA0639	Homo sapiens (Human)	1826	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]	14-3-3 protein binding [GO:0071889]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005902; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0033270; GO:0042110; GO:0050770; GO:0071889	microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN23105_c0_g2_i1	Q9NQT8	KI13B_HUMAN	53.6	84	37	1	1	246	79	162	3.10E-20	99	KI13B_HUMAN	reviewed	Kinesin-like protein KIF13B (Kinesin-like protein GAKIN)	KIF13B GAKIN KIAA0639	Homo sapiens (Human)	1826	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]	14-3-3 protein binding [GO:0071889]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005902; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0033270; GO:0042110; GO:0050770; GO:0071889	microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN31932_c0_g1_i1	Q15058	KIF14_HUMAN	74.4	82	21	0	254	9	622	703	7.50E-26	117.5	KIF14_HUMAN	reviewed	Kinesin-like protein KIF14	KIF14 KIAA0042	Homo sapiens (Human)	1648	"cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446]"	cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]"	GO:0001558; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0008284; GO:0008574; GO:0010389; GO:0015631; GO:0016020; GO:0016887; GO:0019901; GO:0021685; GO:0021693; GO:0021695; GO:0021766; GO:0021772; GO:0021846; GO:0021987; GO:0030155; GO:0030165; GO:0030334; GO:0030496; GO:0031146; GO:0031641; GO:0032147; GO:0032467; GO:0032487; GO:0033624; GO:0034446; GO:0043066; GO:0043161; GO:0043523; GO:0043524; GO:0045184; GO:0051233; GO:0051301; GO:0090543; GO:1903429; GO:2000045	activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN1907_c1_g1_i1	Q9P2E2	KIF17_HUMAN	77.8	261	55	2	930	154	108	367	1.50E-111	404.1	KIF17_HUMAN	reviewed	Kinesin-like protein KIF17 (KIF3-related motor protein)	KIF17 KIAA1405 KIF3X	Homo sapiens (Human)	1029	"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]"	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030030; GO:0032391; GO:0032839; GO:0035735; GO:0036064; GO:0043005; GO:0098971; GO:1990075	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1907_c1_g1_i2	Q9P2E2	KIF17_HUMAN	77.8	261	55	2	894	118	108	367	1.80E-111	403.7	KIF17_HUMAN	reviewed	Kinesin-like protein KIF17 (KIF3-related motor protein)	KIF17 KIAA1405 KIF3X	Homo sapiens (Human)	1029	"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]"	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030030; GO:0032391; GO:0032839; GO:0035735; GO:0036064; GO:0043005; GO:0098971; GO:1990075	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17217_c1_g1_i7	Q99PW8	KIF17_MOUSE	46.2	169	89	1	63	563	747	915	1.90E-35	150.6	KIF17_MOUSE	reviewed	Kinesin-like protein KIF17 (MmKIF17)	Kif17	Mus musculus (Mouse)	1038	"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]"	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0008017; GO:0008574; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098971; GO:1990075	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17217_c1_g1_i8	Q99PW8	KIF17_MOUSE	54.5	44	20	0	53	184	872	915	2.90E-10	65.5	KIF17_MOUSE	reviewed	Kinesin-like protein KIF17 (MmKIF17)	Kif17	Mus musculus (Mouse)	1038	"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]"	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0008017; GO:0008574; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098971; GO:1990075	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]		brown	brown	NA	NA	NA	NA
TRINITY_DN17217_c1_g1_i4	Q99PW8	KIF17_MOUSE	54.5	44	20	0	53	184	872	915	2.50E-10	65.9	KIF17_MOUSE	reviewed	Kinesin-like protein KIF17 (MmKIF17)	Kif17	Mus musculus (Mouse)	1038	"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]"	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0008017; GO:0008574; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098971; GO:1990075	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]		brown	brown	1	NA	NA	1
TRINITY_DN11145_c0_g1_i1	Q91WD7	KI18A_MOUSE	41.3	92	45	2	251	3	73	164	1.70E-11	69.7	KI18A_MOUSE	reviewed	Kinesin-like protein KIF18A	Kif18a	Mus musculus (Mouse)	886	"caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0072520; GO:1990023	male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i1	Q91WD7	KI18A_MOUSE	59.8	112	39	3	296	613	153	264	1.30E-24	114.8	KI18A_MOUSE	reviewed	Kinesin-like protein KIF18A	Kif18a	Mus musculus (Mouse)	886	"caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0072520; GO:1990023	male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i13	Q91WD7	KI18A_MOUSE	59.8	112	39	3	296	613	153	264	1.30E-24	114.8	KI18A_MOUSE	reviewed	Kinesin-like protein KIF18A	Kif18a	Mus musculus (Mouse)	886	"caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0072520; GO:1990023	male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i16	Q91WD7	KI18A_MOUSE	41.6	243	124	7	142	834	153	389	5.80E-35	149.4	KI18A_MOUSE	reviewed	Kinesin-like protein KIF18A	Kif18a	Mus musculus (Mouse)	886	"caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0072520; GO:1990023	male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i6	Q91WD7	KI18A_MOUSE	40.4	277	143	7	94	876	119	389	2.30E-42	174.1	KI18A_MOUSE	reviewed	Kinesin-like protein KIF18A	Kif18a	Mus musculus (Mouse)	886	"caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0072520; GO:1990023	male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i10	Q8NI77	KI18A_HUMAN	47.3	186	93	3	226	774	11	194	1.50E-41	171.8	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i10	Q8NI77	KI18A_HUMAN	59.8	112	39	3	758	1075	153	264	4.90E-24	113.6	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i11	Q8NI77	KI18A_HUMAN	56.6	122	50	1	278	634	268	389	2.20E-34	147.1	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i11	Q8NI77	KI18A_HUMAN	61.2	85	33	0	13	267	180	264	6.80E-20	99	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i2	Q8NI77	KI18A_HUMAN	52.3	256	118	3	226	987	11	264	1.90E-67	257.7	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i3	Q8NI77	KI18A_HUMAN	42.6	385	201	6	226	1338	11	389	1.70E-73	278.1	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i7	Q8NI77	KI18A_HUMAN	69.1	55	17	0	7	171	210	264	2.70E-12	73.2	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i7	Q8NI77	KI18A_HUMAN	38.1	63	38	1	240	428	328	389	8.40E-06	51.6	KI18A_HUMAN	reviewed	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	KIF18A OK/SW-cl.108	Homo sapiens (Human)	898	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	"actin binding [GO:0003779]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]"	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i12	Q6PFD6	KI18B_MOUSE	61	82	32	0	41	286	306	387	8.10E-21	100.9	KI18B_MOUSE	reviewed	Kinesin-like protein KIF18B	Kif18b	Mus musculus (Mouse)	834	"astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]"	astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]"	GO:0000070; GO:0000235; GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0008574; GO:0016604; GO:0016887; GO:0019894; GO:0035371; GO:0051301; GO:0051302; GO:0061673; GO:1990023; GO:1990752	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]		NA	NA	NA	NA	NA	NA
TRINITY_DN360_c0_g1_i4	Q5ZLK6	KI18B_CHICK	53.1	160	73	2	94	567	116	275	5.90E-37	155.6	KI18B_CHICK	reviewed	Kinesin-like protein KIF18B	KIF18B RCJMB04_5l15	Gallus gallus (Chicken)	797	"cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]"	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0000070; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0008574; GO:0016604; GO:0016887; GO:0019894; GO:0035371; GO:0051301; GO:0051302; GO:0061673; GO:1990023	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]		NA	NA	NA	NA	NA	NA
TRINITY_DN35089_c0_g1_i1	Q2TAC6	KIF19_HUMAN	40	75	45	0	231	7	507	581	1.90E-07	56.6	KIF19_HUMAN	reviewed	Kinesin-like protein KIF19	KIF19	Homo sapiens (Human)	998	"axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]"	axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0060404; GO:0070462	axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]		NA	NA	NA	NA	NA	NA
TRINITY_DN39419_c0_g1_i1	Q7ZXX2	KIF19_XENLA	68.3	120	36	1	1	354	241	360	1.20E-37	157.1	KIF19_XENLA	reviewed	Kinesin-like protein KIF19	kif19	Xenopus laevis (African clawed frog)	997	"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]"	axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]"	GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0060404; GO:0070462	axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]		NA	NA	NA	NA	NA	NA
TRINITY_DN26207_c0_g1_i1	O60333	KIF1B_HUMAN	100	84	0	0	284	33	310	393	2.00E-40	166	KIF1B_HUMAN	reviewed	Kinesin-like protein KIF1B (Klp)	KIF1B KIAA0591 KIAA1448	Homo sapiens (Human)	1816	"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; scaffold protein binding [GO:0097110]; anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; apoptotic process [GO:0006915]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; mitochondrion transport along microtubule [GO:0047497]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of gene expression [GO:0010628]; protein localization to cell periphery [GO:1990778]; response to rotenone [GO:1904647]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192]"	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; scaffold protein binding [GO:0097110]"	GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0005875; GO:0006915; GO:0007018; GO:0007270; GO:0007274; GO:0008017; GO:0008021; GO:0008089; GO:0008574; GO:0010628; GO:0016192; GO:0016887; GO:0019894; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0030705; GO:0031410; GO:0032418; GO:0043005; GO:0047497; GO:0097110; GO:1904115; GO:1904647; GO:1990048; GO:1990049; GO:1990090; GO:1990778	anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; apoptotic process [GO:0006915]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; mitochondrion transport along microtubule [GO:0047497]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of gene expression [GO:0010628]; protein localization to cell periphery [GO:1990778]; response to rotenone [GO:1904647]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN35484_c0_g1_i1	O43896	KIF1C_HUMAN	100	119	0	0	1	357	91	209	4.80E-63	241.5	KIF1C_HUMAN	reviewed	Kinesin-like protein KIF1C	KIF1C KIAA0706	Homo sapiens (Human)	1103	"axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; RNA binding [GO:0003723]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuron projection [GO:0043005]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; RNA binding [GO:0003723]"	GO:0003723; GO:0003774; GO:0003777; GO:0005524; GO:0005783; GO:0005794; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:0043005; GO:1904115; GO:1990048; GO:1990049	"anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3501_c0_g1_i1	O95235	KI20A_HUMAN	41.5	465	255	10	1386	1	49	499	7.10E-82	306.2	KI20A_HUMAN	reviewed	Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6)	KIF20A MKLP2 RAB6KIFL	Homo sapiens (Human)	890	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032154; GO:0032465; GO:0045171; GO:0061952	microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN35824_c0_g1_i1	P97329	KI20A_MOUSE	100	72	0	0	217	2	388	459	3.40E-35	148.3	KI20A_MOUSE	reviewed	Kinesin-like protein KIF20A (Kinesin-like protein 174) (Rab6-interacting kinesin-like protein) (Rabkinesin-6)	Kif20a Rab6kifl	Mus musculus (Mouse)	887	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032154; GO:0032465; GO:0045171; GO:0061952	microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN23305_c0_g1_i1	P97329	KI20A_MOUSE	83.1	59	10	0	1	177	129	187	2.90E-20	98.6	KI20A_MOUSE	reviewed	Kinesin-like protein KIF20A (Kinesin-like protein 174) (Rab6-interacting kinesin-like protein) (Rabkinesin-6)	Kif20a Rab6kifl	Mus musculus (Mouse)	887	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032154; GO:0032465; GO:0045171; GO:0061952	microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN1967_c0_g1_i1	Q9QXL2	KI21A_MOUSE	53.8	186	83	2	641	84	1479	1661	8.90E-55	214.9	KI21A_MOUSE	reviewed	Kinesin-like protein KIF21A	Kif21a Kiaa1708	Mus musculus (Mouse)	1672	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887; GO:0030424; GO:0030425	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN36551_c0_g1_i1	Q7Z4S6	KI21A_HUMAN	88.7	97	11	0	2	292	296	392	2.50E-41	169.1	KI21A_HUMAN	reviewed	Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62)	KIF21A KIAA1708 KIF2	Homo sapiens (Human)	1674	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN39847_c0_g1_i1	Q7Z4S6	KI21A_HUMAN	82.1	84	15	0	5	256	292	375	3.10E-32	138.7	KI21A_HUMAN	reviewed	Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62)	KIF21A KIAA1708 KIF2	Homo sapiens (Human)	1674	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN7417_c0_g1_i2	Q02241	KIF23_HUMAN	36	178	92	8	534	34	793	959	9.80E-16	85.1	KIF23_HUMAN	reviewed	Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1)	KIF23 KNSL5 MKLP1	Homo sapiens (Human)	960	"centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000022; GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	"actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25392_c0_g1_i1	Q7M6Z4	KIF27_MOUSE	48.6	109	53	2	337	11	42	147	6.60E-22	104.8	KIF27_MOUSE	reviewed	Kinesin-like protein KIF27	Kif27	Mus musculus (Mouse)	1394	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271	cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN6266_c0_g1_i1	Q7M6Z4	KIF27_MOUSE	26.8	537	331	9	1511	75	711	1243	2.40E-26	121.7	KIF27_MOUSE	reviewed	Kinesin-like protein KIF27	Kif27	Mus musculus (Mouse)	1394	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271	cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN1922_c0_g1_i1	Q5ZKV8	KIF2A_CHICK	53	670	286	8	2	1981	49	699	1.30E-168	594.7	KIF2A_CHICK	reviewed	Kinesin-like protein KIF2A	KIF2A RCJMB04_9a7	Gallus gallus (Chicken)	706	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301	cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN1922_c0_g1_i2	P28740	KIF2A_MOUSE	62.1	419	142	4	65	1300	290	698	5.20E-129	462.6	KIF2A_MOUSE	reviewed	Kinesin-like protein KIF2A (Kinesin-2)	Kif2a Kif2 Kns2	Mus musculus (Mouse)	705	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; lysosome [GO:0005764]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; lysosome [GO:0005764]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000226; GO:0000922; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005764; GO:0005813; GO:0005814; GO:0005819; GO:0005871; GO:0005874; GO:0005876; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016604; GO:0016887; GO:0019901; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0097228; GO:0120103	cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]		NA	NA	NA	NA	NA	NA
TRINITY_DN1922_c0_g1_i3	P28740	KIF2A_MOUSE	60.8	523	188	4	674	2221	186	698	3.00E-166	587	KIF2A_MOUSE	reviewed	Kinesin-like protein KIF2A (Kinesin-2)	Kif2a Kif2 Kns2	Mus musculus (Mouse)	705	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; lysosome [GO:0005764]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; lysosome [GO:0005764]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0000226; GO:0000922; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005764; GO:0005813; GO:0005814; GO:0005819; GO:0005871; GO:0005874; GO:0005876; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016604; GO:0016887; GO:0019901; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0097228; GO:0120103	cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]		NA	NA	NA	NA	NA	NA
TRINITY_DN32375_c0_g1_i1	O00139	KIF2A_HUMAN	100	130	0	0	392	3	276	405	1.70E-69	263.1	KIF2A_HUMAN	reviewed	Kinesin-like protein KIF2A (Kinesin-2) (hK2)	KIF2A KIF2 KNS2	Homo sapiens (Human)	706	"centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]	GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0019886; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0097228; GO:0120103	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40717_c0_g1_i1	O00139	KIF2A_HUMAN	100	142	0	0	426	1	407	548	1.10E-74	280.4	KIF2A_HUMAN	reviewed	Kinesin-like protein KIF2A (Kinesin-2) (hK2)	KIF2A KIF2 KNS2	Homo sapiens (Human)	706	"centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]	GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0019886; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0097228; GO:0120103	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28865_c0_g1_i1	Q99661	KIF2C_HUMAN	54.7	86	39	0	1	258	477	562	1.50E-18	93.2	KIF2C_HUMAN	reviewed	Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin) (MCAK)	KIF2C KNSL6	Homo sapiens (Human)	725	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]	GO:0000775; GO:0000776; GO:0000777; GO:0003777; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019237; GO:0019886; GO:0030951; GO:0035371; GO:0051010; GO:0051301; GO:0051310; GO:0051315; GO:0051983	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29761_c0_g1_i1	Q99661	KIF2C_HUMAN	100	119	0	0	360	4	249	367	5.70E-64	244.6	KIF2C_HUMAN	reviewed	Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin) (MCAK)	KIF2C KNSL6	Homo sapiens (Human)	725	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]	GO:0000775; GO:0000776; GO:0000777; GO:0003777; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019237; GO:0019886; GO:0030951; GO:0035371; GO:0051010; GO:0051301; GO:0051310; GO:0051315; GO:0051983	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34774_c0_g1_i1	Q99661	KIF2C_HUMAN	100	74	0	0	1	222	448	521	1.30E-34	146.4	KIF2C_HUMAN	reviewed	Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin) (MCAK)	KIF2C KNSL6	Homo sapiens (Human)	725	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]	GO:0000775; GO:0000776; GO:0000777; GO:0003777; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019237; GO:0019886; GO:0030951; GO:0035371; GO:0051010; GO:0051301; GO:0051310; GO:0051315; GO:0051983	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33892_c0_g1_i1	P28741	KIF3A_MOUSE	100	114	0	0	343	2	65	178	1.20E-60	233.4	KIF3A_MOUSE	reviewed	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	Kif3a Kif3	Mus musculus (Mouse)	701	axon cytoplasm [GO:1904115]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; ribbon synapse [GO:0097470]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]; anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]	axon cytoplasm [GO:1904115]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; photoreceptor connecting cilium [GO:0032391]; ribbon synapse [GO:0097470]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; protein phosphatase binding [GO:0019903]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]	GO:0001701; GO:0001822; GO:0001947; GO:0003341; GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0007224; GO:0007368; GO:0007411; GO:0007507; GO:0008017; GO:0008089; GO:0008544; GO:0009952; GO:0009953; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0017137; GO:0019894; GO:0019903; GO:0021542; GO:0021904; GO:0021915; GO:0030507; GO:0030900; GO:0031514; GO:0032391; GO:0034454; GO:0036334; GO:0043005; GO:0043025; GO:0044458; GO:0044877; GO:0048260; GO:0050679; GO:0060122; GO:0060271; GO:0061351; GO:0090316; GO:0097470; GO:0120170; GO:1902414; GO:1904115; GO:1905128; GO:1905515; GO:2000771	anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; inner ear receptor cell stereocilium organization [GO:0060122]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN2865_c0_g1_i1	Q4R628	KIF3A_MACFA	83.5	316	52	0	46	993	56	371	6.10E-151	535	KIF3A_MACFA	reviewed	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	KIF3A QtsA-19288	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	702	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0010457; GO:0034454; GO:0060271	centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN2865_c0_g1_i2	Q4R628	KIF3A_MACFA	84.4	263	41	0	46	834	56	318	3.30E-126	452.6	KIF3A_MACFA	reviewed	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	KIF3A QtsA-19288	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	702	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0010457; GO:0034454; GO:0060271	centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]		brown	brown	NA	NA	NA	NA
TRINITY_DN40573_c0_g1_i1	P28741	KIF3A_MOUSE	99.2	129	1	0	387	1	184	312	2.90E-66	252.3	KIF3A_MOUSE	reviewed	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	Kif3a Kif3	Mus musculus (Mouse)	701	axon cytoplasm [GO:1904115]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; ribbon synapse [GO:0097470]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]; anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]	axon cytoplasm [GO:1904115]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; photoreceptor connecting cilium [GO:0032391]; ribbon synapse [GO:0097470]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; protein phosphatase binding [GO:0019903]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]	GO:0001701; GO:0001822; GO:0001947; GO:0003341; GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0007224; GO:0007368; GO:0007411; GO:0007507; GO:0008017; GO:0008089; GO:0008544; GO:0009952; GO:0009953; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0017137; GO:0019894; GO:0019903; GO:0021542; GO:0021904; GO:0021915; GO:0030507; GO:0030900; GO:0031514; GO:0032391; GO:0034454; GO:0036334; GO:0043005; GO:0043025; GO:0044458; GO:0044877; GO:0048260; GO:0050679; GO:0060122; GO:0060271; GO:0061351; GO:0090316; GO:0097470; GO:0120170; GO:1902414; GO:1904115; GO:1905128; GO:1905515; GO:2000771	anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; inner ear receptor cell stereocilium organization [GO:0060122]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN34612_c0_g1_i1	Q9Y496	KIF3A_HUMAN	100	78	0	0	3	236	298	375	1.30E-36	153.3	KIF3A_HUMAN	reviewed	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	KIF3A KIF3	Homo sapiens (Human)	699	"axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein phosphatase binding [GO:0019903]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein phosphatase binding [GO:0019903]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]"	GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006890; GO:0006996; GO:0007018; GO:0007411; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0017137; GO:0019886; GO:0019903; GO:0030507; GO:0034454; GO:0035735; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115	"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39816_c0_g1_i1	Q9Y496	KIF3A_HUMAN	100	191	0	0	2	574	49	239	6.60E-107	387.9	KIF3A_HUMAN	reviewed	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	KIF3A KIF3	Homo sapiens (Human)	699	"axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein phosphatase binding [GO:0019903]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein phosphatase binding [GO:0019903]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]"	GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006890; GO:0006996; GO:0007018; GO:0007411; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0017137; GO:0019886; GO:0019903; GO:0030507; GO:0034454; GO:0035735; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115	"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33252_c0_g1_i3	O15066	KIF3B_HUMAN	65.2	89	31	0	88	354	526	614	2.70E-24	112.8	KIF3B_HUMAN	reviewed	"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]"	KIF3B KIAA0359	Homo sapiens (Human)	747	"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]"	GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016887; GO:0016939; GO:0017048; GO:0019886; GO:0030496; GO:0032467; GO:0035735; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0120170; GO:1904115	"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18506_c0_g1_i1	O15066	KIF3B_HUMAN	72.9	255	66	3	799	38	117	369	1.30E-97	357.5	KIF3B_HUMAN	reviewed	"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]"	KIF3B KIAA0359	Homo sapiens (Human)	747	"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]"	GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016887; GO:0016939; GO:0017048; GO:0019886; GO:0030496; GO:0032467; GO:0035735; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0120170; GO:1904115	"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32346_c0_g1_i1	O15066	KIF3B_HUMAN	100	76	0	0	229	2	281	356	1.40E-36	152.9	KIF3B_HUMAN	reviewed	"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]"	KIF3B KIAA0359	Homo sapiens (Human)	747	"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]"	GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016887; GO:0016939; GO:0017048; GO:0019886; GO:0030496; GO:0032467; GO:0035735; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0120170; GO:1904115	"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38719_c0_g1_i1	O15066	KIF3B_HUMAN	78.5	149	30	1	3	449	223	369	1.20E-58	227.3	KIF3B_HUMAN	reviewed	"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]"	KIF3B KIAA0359	Homo sapiens (Human)	747	"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]"	GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016887; GO:0016939; GO:0017048; GO:0019886; GO:0030496; GO:0032467; GO:0035735; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0120170; GO:1904115	"anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33252_c0_g1_i2	Q61771	KIF3B_MOUSE	55.9	179	76	3	88	618	526	703	1.40E-46	188	KIF3B_MOUSE	reviewed	"Kinesin-like protein KIF3B (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]"	Kif3b	Mus musculus (Mouse)	747	axon [GO:0030424]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; positive regulation of cytokinesis [GO:0032467]	axon [GO:0030424]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]	GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0015630; GO:0016887; GO:0016939; GO:0017048; GO:0030424; GO:0030496; GO:0032467; GO:0090307; GO:0120170	microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; positive regulation of cytokinesis [GO:0032467]		NA	NA	NA	NA	NA	NA
TRINITY_DN33252_c0_g1_i4	Q61771	KIF3B_MOUSE	55.9	179	76	3	88	618	526	703	1.50E-46	188	KIF3B_MOUSE	reviewed	"Kinesin-like protein KIF3B (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]"	Kif3b	Mus musculus (Mouse)	747	axon [GO:0030424]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; positive regulation of cytokinesis [GO:0032467]	axon [GO:0030424]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]	GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0015630; GO:0016887; GO:0016939; GO:0017048; GO:0030424; GO:0030496; GO:0032467; GO:0090307; GO:0120170	microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; positive regulation of cytokinesis [GO:0032467]		NA	NA	NA	NA	NA	NA
TRINITY_DN16390_c0_g1_i2	Q2M1P5	KIF7_HUMAN	39.4	348	197	7	47	1060	13	356	1.40E-61	238.4	KIF7_HUMAN	reviewed	Kinesin-like protein KIF7	KIF7 UNQ340/PRO539	Homo sapiens (Human)	1343	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0036064; GO:0045879; GO:0045880; GO:0097542	microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]		NA	NA	NA	NA	NA	NA
TRINITY_DN34501_c0_g1_i1	Q2M1P5	KIF7_HUMAN	58.2	67	27	1	198	1	60	126	8.60E-12	70.5	KIF7_HUMAN	reviewed	Kinesin-like protein KIF7	KIF7 UNQ340/PRO539	Homo sapiens (Human)	1343	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0036064; GO:0045879; GO:0045880; GO:0097542	microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]		NA	NA	NA	NA	NA	NA
TRINITY_DN4297_c0_g1_i1	Q60443	KIFC1_CRIGR	63.1	84	30	1	253	5	323	406	3.10E-24	112.1	KIFC1_CRIGR	reviewed	Kinesin-like protein KIFC1 (CHO2 antigen)		Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	622	early endosome [GO:0005769]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]	early endosome [GO:0005769]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005634; GO:0005769; GO:0005815; GO:0005819; GO:0005874; GO:0007018; GO:0007049; GO:0008017; GO:0030496; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN6387_c0_g1_i1	Q9BW19	KIFC1_HUMAN	51.9	77	32	2	241	14	370	442	6.30E-14	77.8	KIFC1_HUMAN	reviewed	Kinesin-like protein KIFC1 (Kinesin-like protein 2) (Kinesin-related protein HSET)	KIFC1 HSET KNSL2	Homo sapiens (Human)	673	early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; spermatogenesis [GO:0007283]	early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000070; GO:0003777; GO:0005524; GO:0005634; GO:0005769; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0007283; GO:0008017; GO:0016020; GO:0016887; GO:0051301; GO:0072686; GO:0090307	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN26221_c0_g1_i1	Q9BVG8	KIFC3_HUMAN	61.7	120	45	1	362	3	646	764	5.80E-32	138.3	KIFC3_HUMAN	reviewed	Kinesin-like protein KIFC3	KIFC3	Homo sapiens (Human)	833	"centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218]"	centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007018; GO:0007030; GO:0007601; GO:0008017; GO:0008569; GO:0030659; GO:0042802; GO:0045218; GO:0070062; GO:0090136	epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218]		NA	NA	NA	NA	NA	NA
TRINITY_DN26154_c0_g1_i1	Q75LL2	KN12G_ORYSJ	68.1	69	22	0	10	216	315	383	4.80E-18	91.3	KN12G_ORYSJ	reviewed	Kinesin-like protein KIN-12G	KIN12G Os03g0750200/Os03g0750300 LOC_Os03g53920 OsJ_12582 OSJNBa0047E24.25	Oryza sativa subsp. japonica (Rice)	1266	kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN13656_c0_g1_i1	Q940Y8	KN13B_ARATH	62.6	155	57	1	3	467	331	484	1.80E-46	186.8	KN13B_ARATH	reviewed	Kinesin-like protein KIN-13B (AtKINESIN-13B) (AtKIN13B)	KIN13B KINESIN-13B At3g16060 MSL1.9	Arabidopsis thaliana (Mouse-ear cress)	684	microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; regulation of cell wall organization or biogenesis [GO:1903338]	microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005634; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:1903338	microtubule-based movement [GO:0007018]; regulation of cell wall organization or biogenesis [GO:1903338]		NA	NA	NA	NA	NA	NA
TRINITY_DN4019_c0_g1_i1	Q07970	KN14C_ARATH	55.8	113	47	2	330	1	662	774	3.70E-25	115.5	KN14C_ARATH	reviewed	Kinesin-like protein KIN-14C (AtKIN14a) (Kinesin-like protein KatA)	KIN14C ATK1 KATA At4g21270 F7J7.210 T6K22.10	Arabidopsis thaliana (Mouse-ear cress)	793	"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; minus-end kinesin complex [GO:0005872]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anastral spindle assembly involved in male meiosis [GO:0009971]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]"	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; minus-end kinesin complex [GO:0005872]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; spindle [GO:0005819]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0000777; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005871; GO:0005872; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0009971; GO:0016887; GO:0051225; GO:0051301	anastral spindle assembly involved in male meiosis [GO:0009971]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN32748_c0_g1_i1	Q0E2L3	KN14D_ORYSJ	55.3	76	34	0	1	228	658	733	3.80E-13	75.1	KN14D_ORYSJ	reviewed	Kinesin-like protein KIN-14D	KIN14D Os02g0229500/Os02g0229600 LOC_Os02g13570/LOC_Os02g13580 OsJ_05972 OSJNBb0035N08.18	Oryza sativa subsp. japonica (Rice)	977	microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0008017	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN34393_c0_g1_i1	F4JGP4	KN14D_ARATH	52.8	72	28	2	211	14	491	562	2.50E-11	68.9	KN14D_ARATH	reviewed	Kinesin-like protein KIN-14D (AtKIN14b)	KIN14D ATK5 At4g05190 C17L7.110 C6L9.1	Arabidopsis thaliana (Mouse-ear cress)	790	kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]	kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000226; GO:0003777; GO:0005524; GO:0005634; GO:0005871; GO:0005874; GO:0005876; GO:0007018; GO:0008017; GO:0009524; GO:0016887; GO:0051225; GO:0051301	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN2760_c0_g2_i1	Q9FHN8	KN14E_ARATH	53	134	61	1	4	405	1081	1212	4.70E-31	135.6	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN2760_c0_g1_i1	Q9FHN8	KN14E_ARATH	53.7	134	60	1	4	405	1081	1212	6.10E-31	135.2	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN34717_c0_g1_i1	Q9FHN8	KN14E_ARATH	60	70	28	0	210	1	1114	1183	2.70E-16	85.5	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN35032_c0_g1_i1	Q9FHN8	KN14E_ARATH	55.2	67	30	0	216	16	1145	1211	8.60E-15	80.5	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN37645_c0_g1_i1	Q9FHN8	KN14E_ARATH	59.3	118	48	0	379	26	1094	1211	2.30E-29	129.8	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN34259_c0_g1_i1	Q9FHN8	KN14E_ARATH	52.7	148	68	1	444	1	1070	1215	7.00E-35	148.3	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN32490_c0_g1_i1	Q9FHN8	KN14E_ARATH	54.6	108	49	0	330	7	1104	1211	5.30E-24	111.7	KN14E_ARATH	reviewed	Kinesin-like protein KIN-14E (Kinesin-like calmodulin-binding protein) (Protein ZWICHEL)	KIN14E KCBP ZWI At5g65930 K14B20.10	Arabidopsis thaliana (Mouse-ear cress)	1260	"cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; cortical microtubule organization [GO:0043622]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]"	cortical microtubule [GO:0055028]; cytoskeleton [GO:0005856]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; phragmoplast [GO:0009524]	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0001578; GO:0003777; GO:0005509; GO:0005516; GO:0005524; GO:0005856; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0009524; GO:0010091; GO:0016491; GO:0016887; GO:0019901; GO:0042803; GO:0043531; GO:0043622; GO:0048629; GO:0051015; GO:0055028; GO:0072686	cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; trichome branching [GO:0010091]; trichome patterning [GO:0048629]		NA	NA	NA	NA	NA	NA
TRINITY_DN29402_c0_g1_i1	Q10MN5	KN14F_ORYSJ	66	106	36	0	37	354	611	716	1.30E-31	137.1	KN14F_ORYSJ	reviewed	Kinesin-like protein KIN-14F	KIN14F Os03g0301800 LOC_Os03g18980 OsJ_10528	Oryza sativa subsp. japonica (Rice)	1007	microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0008017	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN36486_c0_g1_i1	F4HZF0	KN14H_ARATH	58.1	93	39	0	288	10	658	750	6.20E-24	111.3	KN14H_ARATH	reviewed	Kinesin-like protein KIN-14H	KIN14H At1g09170 T12M4.14	Arabidopsis thaliana (Mouse-ear cress)	1040	microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0008017	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN12548_c0_g1_i1	Q7XPJ0	KN14I_ORYSJ	54.7	223	99	2	3	668	937	1158	9.60E-58	224.9	KN14I_ORYSJ	reviewed	Kinesin-like protein KIN-14I (Kinesin-like calmodulin-binding protein) (OsKCBP)	KIN14I KCBP Os04g0666900 LOC_Os04g57140 OsJ_16543 OSJNBa0087O24.20	Oryza sativa subsp. japonica (Rice)	1248	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]	GO:0003777; GO:0005516; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016491; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN12548_c0_g1_i2	Q7XPJ0	KN14I_ORYSJ	57.1	273	116	1	3	821	937	1208	7.10E-78	292	KN14I_ORYSJ	reviewed	Kinesin-like protein KIN-14I (Kinesin-like calmodulin-binding protein) (OsKCBP)	KIN14I KCBP Os04g0666900 LOC_Os04g57140 OsJ_16543 OSJNBa0087O24.20	Oryza sativa subsp. japonica (Rice)	1248	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; oxidoreductase activity [GO:0016491]	GO:0003777; GO:0005516; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016491; GO:0016887	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN37273_c0_g1_i1	F4J2M6	KN14L_ARATH	68	50	16	0	240	91	404	453	9.50E-15	80.5	KN14L_ARATH	reviewed	Kinesin-like protein KIN-14L	KIN14L At3g10310 F14P13.9	Arabidopsis thaliana (Mouse-ear cress)	955	microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	microtubule [GO:0005874]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005874; GO:0007018; GO:0008017	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN34749_c0_g1_i1	F4I1T9	KN14T_ARATH	47.5	80	42	0	260	21	126	205	2.50E-16	85.9	KN14T_ARATH	reviewed	Kinesin-like protein KIN-14T	KIN14T At1g55550 T5A14.3	Arabidopsis thaliana (Mouse-ear cress)	859	"kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]"	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030705	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN32762_c0_g1_i1	F4I1T9	KN14T_ARATH	55.7	70	30	1	208	2	128	197	2.50E-16	85.5	KN14T_ARATH	reviewed	Kinesin-like protein KIN-14T	KIN14T At1g55550 T5A14.3	Arabidopsis thaliana (Mouse-ear cress)	859	"kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]"	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030705	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN36721_c0_g1_i1	Q8W0Y9	KN14U_ARATH	48.4	62	31	1	212	27	124	184	1.80E-09	62.8	KN14U_ARATH	reviewed	Kinesin-like protein KIN-14U	KIN14U At5g27950 F15F15_20	Arabidopsis thaliana (Mouse-ear cress)	625	"kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]"	kinesin complex [GO:0005871]; microtubule [GO:0005874]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030705	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN27974_c0_g1_i1	A0A068FIK2	KN4A_GOSHI	57	79	29	1	224	3	286	364	4.30E-17	88.2	KN4A_GOSHI	reviewed	Kinesin-like protein KIN-4A (GhKINESIN-4A)	KIN4A	Gossypium hirsutum (Upland cotton) (Gossypium mexicanum)	1033	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell wall organization [GO:0071555]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]	cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0007018; GO:0007052; GO:0008017; GO:0055028; GO:0071555	cell wall organization [GO:0071555]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN32270_c0_g1_i1	Q9LZU5	KN5D_ARATH	64	86	28	1	266	9	290	372	1.90E-19	96.3	KN5D_ARATH	reviewed	Kinesin-like protein KIN-5D	KIN5D At3g45850 F16L2_60	Arabidopsis thaliana (Mouse-ear cress)	1058	"cytoplasm [GO:0005737]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule-based movement [GO:0007018]"	cytoplasm [GO:0005737]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; spindle [GO:0005819]	"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]"	GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0008574	microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN39743_c0_g1_i1	Q965T6	KLP20_CAEEL	56.5	62	27	0	38	223	277	338	4.30E-12	71.6	KLP20_CAEEL	reviewed	Kinesin-like protein klp-20	klp-20 Y50D7A.6	Caenorhabditis elegans	646	axon cytoplasm [GO:1904115]; axonemal heterotrimeric kinesin-II complex [GO:0030993]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]	axon cytoplasm [GO:1904115]; axonemal heterotrimeric kinesin-II complex [GO:0030993]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0007411; GO:0008017; GO:0008089; GO:0016887; GO:0030993; GO:0060271; GO:1904115	anterograde axonal transport [GO:0008089]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]		NA	NA	NA	NA	NA	NA
TRINITY_DN25813_c0_g1_i1	Q9VB25	KL98A_DROME	55.9	59	26	0	3	179	80	138	3.40E-13	75.1	KL98A_DROME	reviewed	Kinesin-like protein Klp98A	Klp98A CG5658	Drosophila melanogaster (Fruit fly)	1265	"cytosol [GO:0005829]; early endosome [GO:0005769]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; asymmetric protein localization involved in cell fate determination [GO:0045167]; autophagy [GO:0006914]; early endosome to late endosome transport [GO:0045022]; microtubule-based movement [GO:0007018]; plus-end-directed endosome transport along mitotic spindle midzone microtubule [GO:0140024]"	cytosol [GO:0005829]; early endosome [GO:0005769]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]"	GO:0003777; GO:0005524; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006914; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0032266; GO:0045022; GO:0045167; GO:0140024; GO:1901981	asymmetric protein localization involved in cell fate determination [GO:0045167]; autophagy [GO:0006914]; early endosome to late endosome transport [GO:0045022]; microtubule-based movement [GO:0007018]; plus-end-directed endosome transport along mitotic spindle midzone microtubule [GO:0140024]		NA	NA	NA	NA	NA	NA
TRINITY_DN2792_c0_g1_i2	P28739	KLPA_EMENI	74.2	93	22	1	1	273	671	763	1.70E-28	126.3	KLPA_EMENI	reviewed	Kinesin-like protein klpA	klpA AN6340	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	770	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0016887; GO:0072686; GO:0090307	microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i10	Q7PHR1	KIF1A_ANOGA	59.4	1243	375	21	3801	142	509	1644	0	1363.2	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i11	Q7PHR1	KIF1A_ANOGA	64.5	978	295	17	3607	749	509	1459	0	1206.8	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i11	Q7PHR1	KIF1A_ANOGA	73.8	126	33	0	519	142	1519	1644	1.00E-48	197.2	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i14	Q7PHR1	KIF1A_ANOGA	71	279	72	4	857	42	580	856	6.40E-106	385.2	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i18	Q7PHR1	KIF1A_ANOGA	65.8	638	181	13	1907	39	573	1188	1.50E-230	800.4	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i19	Q7PHR1	KIF1A_ANOGA	43.2	1621	328	16	3354	142	67	1644	0	1130.5	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i20	Q7PHR1	KIF1A_ANOGA	62.5	1181	375	20	3615	142	509	1644	0	1390.9	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i21	Q7PHR1	KIF1A_ANOGA	78.4	402	78	2	1203	4	67	461	2.80E-171	602.8	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i25	Q7PHR1	KIF1A_ANOGA	71	131	29	2	390	4	338	461	1.70E-38	160.2	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i26	Q28WQ1	KIF1A_DROPS	88.2	136	16	0	410	3	143	278	2.50E-59	229.6	KIF1A_DROPS	reviewed	Kinesin-like protein unc-104	unc-104 GA21168	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1671	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489	synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i5	Q7PHR1	KIF1A_ANOGA	79.1	383	71	2	1146	4	86	461	1.30E-163	577.4	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i7	Q7PHR1	KIF1A_ANOGA	67.1	304	88	5	985	104	509	810	1.90E-106	387.1	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i8	Q7PHR1	KIF1A_ANOGA	42.8	1602	321	17	3288	142	86	1644	0	1092.4	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN7226_c0_g1_i9	Q7PHR1	KIF1A_ANOGA	73.8	126	33	0	519	142	1519	1644	2.00E-49	197.2	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN39439_c0_g1_i1	Q7PHR1	KIF1A_ANOGA	71.7	113	31	1	2	340	120	231	1.60E-39	163.3	KIF1A_ANOGA	reviewed	Kinesin-like protein unc-104	unc-104 AGAP010519	Anopheles gambiae (African malaria mosquito)	1644	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005875; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030705; GO:0047496; GO:0048489	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN16151_c0_g1_i1	Q9NGQ2	KIF1_DICDI	54.7	86	39	0	270	13	280	365	1.30E-15	83.6	KIF1_DICDI	reviewed	Kinesin-related protein 1 (Kinesin family member 1) (Kinesin-3)	kif1 kif1A unc104 DDB_G0290963	Dictyostelium discoideum (Slime mold)	2205	"cytoplasmic vesicle membrane [GO:0030659]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; plus-end-directed organelle transport along microtubule [GO:0072386]; plus-end-directed vesicle transport along microtubule [GO:0072383]; vesicle transport along microtubule [GO:0047496]"	cytoplasmic vesicle membrane [GO:0030659]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003777; GO:0005524; GO:0005546; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030659; GO:0030705; GO:0042802; GO:0047496; GO:0072383; GO:0072386	cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; plus-end-directed organelle transport along microtubule [GO:0072386]; plus-end-directed vesicle transport along microtubule [GO:0072383]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN27104_c0_g1_i1	Q9BPU3	KIF2_DICDI	45.1	71	38	1	223	11	500	569	9.00E-15	80.5	KIF2_DICDI	reviewed	Kinesin-related protein 2 (Kinesin family member 2) (Kinesin-14)	kif2 GPK2 K2 ksnB DDB_G0267396	Dictyostelium discoideum (Slime mold)	792	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0072686; GO:0090307	microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN40864_c0_g1_i1	Q9BPU3	KIF2_DICDI	56.6	76	33	0	229	2	625	700	1.20E-14	80.1	KIF2_DICDI	reviewed	Kinesin-related protein 2 (Kinesin family member 2) (Kinesin-14)	kif2 GPK2 K2 ksnB DDB_G0267396	Dictyostelium discoideum (Slime mold)	792	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]"	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0072686; GO:0090307	microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN34414_c0_g1_i1	Q14678	KANK1_HUMAN	38.2	89	55	0	277	11	1228	1316	3.00E-08	59.3	KANK1_HUMAN	reviewed	KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein)	KANK1 ANKRD15 KANK KIAA0172	Homo sapiens (Human)	1352	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	beta-catenin binding [GO:0008013]	GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393	actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]		NA	NA	NA	NA	NA	NA
TRINITY_DN24086_c0_g1_i1	Q14678	KANK1_HUMAN	55	209	93	1	4	627	1091	1299	1.30E-58	227.6	KANK1_HUMAN	reviewed	KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein)	KANK1 ANKRD15 KANK KIAA0172	Homo sapiens (Human)	1352	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	beta-catenin binding [GO:0008013]	GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393	actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]		NA	NA	NA	NA	NA	NA
TRINITY_DN25829_c0_g1_i1	Q8BX02	KANK2_MOUSE	100	85	0	0	2	256	711	795	2.80E-41	168.7	KANK2_MOUSE	reviewed	KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25)	Kank2 Ankrd25	Mus musculus (Mouse)	843	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]		GO:0000122; GO:0005737; GO:0005739; GO:0006915; GO:0008285; GO:0033147; GO:0035023; GO:0043069; GO:0051497; GO:0070563; GO:0072073; GO:0090521; GO:2000134	apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023]		NA	NA	NA	NA	NA	NA
TRINITY_DN22714_c0_g1_i1	Q9Z1P7	KANK3_MOUSE	96.1	128	5	0	386	3	652	779	1.70E-61	236.5	KANK3_MOUSE	reviewed	KN motif and ankyrin repeat domain-containing protein 3 (Ankyrin repeat domain-containing protein 47)	Kank3 Ankrd47 D17Ertd288e Ng28	Mus musculus (Mouse)	791	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0030837; GO:0051497	negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]		NA	NA	NA	NA	NA	NA
TRINITY_DN22714_c0_g1_i2	Q9Z1P7	KANK3_MOUSE	97.9	142	3	0	428	3	638	779	1.10E-69	263.8	KANK3_MOUSE	reviewed	KN motif and ankyrin repeat domain-containing protein 3 (Ankyrin repeat domain-containing protein 47)	Kank3 Ankrd47 D17Ertd288e Ng28	Mus musculus (Mouse)	791	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0030837; GO:0051497	negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]		NA	NA	NA	NA	NA	NA
TRINITY_DN27302_c0_g1_i1	B3LU25	KRR1_YEAS1	70.9	179	52	0	21	557	54	232	2.00E-68	260	KRR1_YEAS1	reviewed	KRR1 small subunit processome component (KRR-R motif-containing protein 1) (Ribosomal RNA assembly protein KRR1)	KRR1 SCRG_05350	Saccharomyces cerevisiae (strain RM11-1a) (Baker's yeast)	316	nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN36455_c0_g1_i1	Q13601	KRR1_HUMAN	100	150	0	0	2	451	65	214	1.10E-80	300.4	KRR1_HUMAN	reviewed	KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1)	KRR1 HRB2	Homo sapiens (Human)	381	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0016020; GO:0032040; GO:0045171	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2620_c0_g1_i1	B4N0P7	KRR1_DROWI	59.5	274	111	0	1077	256	4	277	4.50E-94	346.3	KRR1_DROWI	reviewed	KRR1 small subunit processome component homolog (KRR-R motif-containing protein 1) (Protein dribble)	dbe dribble GK24616	Drosophila willistoni (Fruit fly)	347	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007275; GO:1990904	multicellular organism development [GO:0007275]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN14139_c1_g1_i1	P08155	KRH1_DROME	71.6	67	19	0	4	204	293	359	2.50E-25	115.9	KRH1_DROME	reviewed	Krueppel homolog 1 (Krueppel homologous protein 1)	Kr-h1 Kr-h CG9167	Drosophila melanogaster (Fruit fly)	845	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]; response to starvation [GO:0042594]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0006357; GO:0007552; GO:0010977; GO:0035075; GO:0042594; GO:0045316; GO:0046872	"metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to starvation [GO:0042594]"		NA	NA	NA	NA	NA	NA
TRINITY_DN507_c0_g3_i2	P08155	KRH1_DROME	70.4	203	58	1	1698	1096	265	467	3.00E-91	338.2	KRH1_DROME	reviewed	Krueppel homolog 1 (Krueppel homologous protein 1)	Kr-h1 Kr-h CG9167	Drosophila melanogaster (Fruit fly)	845	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]; response to starvation [GO:0042594]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0006357; GO:0007552; GO:0010977; GO:0035075; GO:0042594; GO:0045316; GO:0046872	"metamorphosis [GO:0007552]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of neuron projection development [GO:0010977]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to starvation [GO:0042594]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9913_c0_g1_i1	Q9V447	KRH2_DROME	48	229	117	2	789	103	41	267	1.70E-54	214.5	KRH2_DROME	reviewed	Krueppel homolog 2 (Protein Kr-h2)	Kr-h2 CG9159	Drosophila melanogaster (Fruit fly)	276	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]		GO:0005783; GO:0012505; GO:0016021; GO:0061024; GO:0071786	endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]		blue	blue	NA	NA	NA	NA
TRINITY_DN28813_c0_g1_i1	Q13118	KLF10_HUMAN	100	75	0	0	227	3	359	433	1.30E-40	166.4	KLF10_HUMAN	reviewed	Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1)	KLF10 TIEG TIEG1	Homo sapiens (Human)	480	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to peptide [GO:1901653]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:0046872; GO:1901653; GO:1990837	"bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to peptide [GO:1901653]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33342_c0_g1_i1	Q8K1S5	KLF11_MOUSE	58.1	105	42	1	5	313	362	466	2.60E-30	132.9	KLF11_MOUSE	reviewed	Krueppel-like factor 11 (TGFB-inducible early growth response protein 2b) (Transforming growth factor-beta-inducible early growth response protein 3) (TGFB-inducible early growth response protein 3) (TIEG-3)	Klf11 Tieg2b Tieg3	Mus musculus (Mouse)	502	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; apoptotic process [GO:0006915]; cellular response to peptide [GO:1901653]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000083; GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006357; GO:0006915; GO:0008285; GO:0016604; GO:0043065; GO:0045892; GO:0046872; GO:1901653; GO:1990837	"apoptotic process [GO:0006915]; cellular response to peptide [GO:1901653]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26990_c0_g1_i1	Q9Y4X4	KLF12_HUMAN	80.7	88	17	0	67	330	312	399	3.00E-42	172.6	KLF12_HUMAN	reviewed	Krueppel-like factor 12 (Transcriptional repressor AP-2rep)	KLF12 AP2REP HSPC122	Homo sapiens (Human)	402	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0045944; GO:0046872; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26876_c0_g1_i1	Q9JJZ6	KLF13_MOUSE	69.6	112	32	1	270	605	152	261	3.30E-42	173.3	KLF13_MOUSE	reviewed	Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Erythroid transcription factor FKLF-2) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3)	Klf13 Bteb3 Fklf2	Mus musculus (Mouse)	289	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	nuclear chromatin [GO:0000790]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0045944; GO:0046872; GO:1990837	negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN36349_c0_g1_i1	Q9Y2Y9	KLF13_HUMAN	100	130	0	0	392	3	149	278	7.30E-73	274.2	KLF13_HUMAN	reviewed	Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1)	KLF13 BTEB3 NSLP1	Homo sapiens (Human)	288	"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837	negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1555_c0_g1_i1	Q9UIH9	KLF15_HUMAN	75.3	89	22	0	58	324	319	407	3.80E-38	158.7	KLF15_HUMAN	reviewed	Krueppel-like factor 15 (Kidney-enriched krueppel-like factor)	KLF15 KKLF	Homo sapiens (Human)	416	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0005634; GO:0006357; GO:0010001; GO:0014898; GO:0032868; GO:0045944; GO:0046326; GO:0046872; GO:0072112; GO:1901653; GO:1990837; GO:2000757	cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN31557_c0_g1_i1	Q60843	KLF2_MOUSE	100	93	0	0	2	280	262	354	1.30E-54	213.4	KLF2_MOUSE	reviewed	Krueppel-like factor 2 (Lung krueppel-like factor)	Klf2 Lklf	Mus musculus (Mouse)	354	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte homeostasis [GO:0034101]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000902; GO:0000978; GO:0000981; GO:0001701; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0032715; GO:0034101; GO:0035264; GO:0036003; GO:0040029; GO:0043249; GO:0045429; GO:0045893; GO:0045944; GO:0046872; GO:0048386; GO:0051247; GO:0060509; GO:0070301; GO:0071347; GO:0071356; GO:0071409; GO:0071498; GO:0071499; GO:0097533; GO:1901653; GO:1903671; GO:1990837	"cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte homeostasis [GO:0034101]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27060_c0_g1_i1	Q9Y5W3	KLF2_HUMAN	100	99	0	0	355	59	257	355	1.60E-58	226.5	KLF2_HUMAN	reviewed	Krueppel-like factor 2 (Lung krueppel-like factor)	KLF2 LKLF	Homo sapiens (Human)	355	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000902; GO:0000978; GO:0000981; GO:0001701; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0032715; GO:0035264; GO:0036003; GO:0040029; GO:0043249; GO:0045429; GO:0045893; GO:0045944; GO:0046872; GO:0048386; GO:0051247; GO:0060509; GO:0070301; GO:0071347; GO:0071356; GO:0071409; GO:0071498; GO:0071499; GO:0097533; GO:1901653; GO:1903671; GO:1990837	"cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28882_c0_g1_i1	O43474	KLF4_HUMAN	100	99	0	0	2	298	415	513	5.00E-59	228	KLF4_HUMAN	reviewed	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	KLF4 EZF GKLF	Homo sapiens (Human)	513	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cycloheximide [GO:0071409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; cellular response to retinoic acid [GO:0071300]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001010; GO:0001085; GO:0001221; GO:0001228; GO:0003700; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0006351; GO:0006357; GO:0007500; GO:0008013; GO:0008270; GO:0008285; GO:0009913; GO:0010628; GO:0010629; GO:0014067; GO:0014740; GO:0016525; GO:0019827; GO:0031077; GO:0032088; GO:0032270; GO:0032717; GO:0034115; GO:0035014; GO:0035019; GO:0035166; GO:0042826; GO:0043154; GO:0045429; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046985; GO:0048662; GO:0048679; GO:0048730; GO:0050728; GO:0051247; GO:0051898; GO:0051973; GO:0060070; GO:0060761; GO:0070301; GO:0070373; GO:0071300; GO:0071363; GO:0071409; GO:0071499; GO:0090051; GO:0120222; GO:1901653; GO:1902895; GO:1903672; GO:1904798; GO:1904998; GO:1990830; GO:1990837; GO:1990841; GO:2000134; GO:2000342	"canonical Wnt signaling pathway [GO:0060070]; cellular response to cycloheximide [GO:0071409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; cellular response to retinoic acid [GO:0071300]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27469_c0_g1_i1	O43474	KLF4_HUMAN	75.3	77	18	1	17	247	417	492	2.80E-30	132.1	KLF4_HUMAN	reviewed	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	KLF4 EZF GKLF	Homo sapiens (Human)	513	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cycloheximide [GO:0071409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; cellular response to retinoic acid [GO:0071300]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cofactor binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001010; GO:0001085; GO:0001221; GO:0001228; GO:0003700; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0006351; GO:0006357; GO:0007500; GO:0008013; GO:0008270; GO:0008285; GO:0009913; GO:0010628; GO:0010629; GO:0014067; GO:0014740; GO:0016525; GO:0019827; GO:0031077; GO:0032088; GO:0032270; GO:0032717; GO:0034115; GO:0035014; GO:0035019; GO:0035166; GO:0042826; GO:0043154; GO:0045429; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046985; GO:0048662; GO:0048679; GO:0048730; GO:0050728; GO:0051247; GO:0051898; GO:0051973; GO:0060070; GO:0060761; GO:0070301; GO:0070373; GO:0071300; GO:0071363; GO:0071409; GO:0071499; GO:0090051; GO:0120222; GO:1901653; GO:1902895; GO:1903672; GO:1904798; GO:1904998; GO:1990830; GO:1990837; GO:1990841; GO:2000134; GO:2000342	"canonical Wnt signaling pathway [GO:0060070]; cellular response to cycloheximide [GO:0071409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; cellular response to retinoic acid [GO:0071300]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i1	Q99612	KLF6_HUMAN	96.8	62	2	0	1	186	168	229	3.10E-29	128.6	KLF6_HUMAN	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	Homo sapiens (Human)	283	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837	"B cell differentiation [GO:0030183]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i2	Q99612	KLF6_HUMAN	100	42	0	0	88	213	226	267	1.60E-21	103.2	KLF6_HUMAN	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	Homo sapiens (Human)	283	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837	"B cell differentiation [GO:0030183]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i4	Q99612	KLF6_HUMAN	100	42	0	0	82	207	226	267	9.20E-22	104	KLF6_HUMAN	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	Homo sapiens (Human)	283	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837	"B cell differentiation [GO:0030183]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i6	Q99612	KLF6_HUMAN	100	58	0	0	88	261	226	283	1.10E-31	137.1	KLF6_HUMAN	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	Homo sapiens (Human)	283	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837	"B cell differentiation [GO:0030183]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i7	Q99612	KLF6_HUMAN	100	116	0	0	1	348	168	283	1.60E-67	256.5	KLF6_HUMAN	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	Homo sapiens (Human)	283	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837	"B cell differentiation [GO:0030183]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i9	Q99612	KLF6_HUMAN	100	58	0	0	82	255	226	283	6.50E-32	137.9	KLF6_HUMAN	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	KLF6 BCD1 COPEB CPBP ST12	Homo sapiens (Human)	283	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837	"B cell differentiation [GO:0030183]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8407_c0_g1_i5	O08584	KLF6_MOUSE	100	104	0	0	2	313	180	283	3.90E-60	231.9	KLF6_MOUSE	reviewed	Krueppel-like factor 6 (Core promoter element-binding protein)	Klf6 Copeb Cpbp	Mus musculus (Mouse)	283	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0019221; GO:0043231; GO:0045944; GO:0046872; GO:1905205; GO:1990837	cytokine-mediated signaling pathway [GO:0019221]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28816_c0_g1_i1	O35819	KLF6_RAT	88.4	95	11	0	56	340	188	282	7.20E-49	194.5	KLF6_RAT	reviewed	Krueppel-like factor 6 (Core promoter element-binding protein) (Transcription factor Zf9)	Klf6 Copeb	Rattus norvegicus (Rat)	283	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to cycloheximide [GO:0071409]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003690; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0019221; GO:0042060; GO:0045944; GO:0046872; GO:0070301; GO:0071407; GO:0071409; GO:1901653; GO:1905205; GO:1990837	cellular response to cycloheximide [GO:0071409]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN40796_c0_g1_i1	Q99JB0	KLF7_MOUSE	100	85	0	0	3	257	195	279	5.90E-47	187.6	KLF7_MOUSE	reviewed	Krueppel-like factor 7	Klf7	Mus musculus (Mouse)	301	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007409; GO:0007411; GO:0042593; GO:0045604; GO:0045893; GO:0045944; GO:0046872; GO:0048813; GO:0061179; GO:1904178	"axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6881_c0_g1_i2	D2Y490	VKT1C_CONCL	66.7	51	17	0	223	71	7	57	6.20E-14	77.8	VKT1C_CONCL	reviewed	Kunitz-type serine protease inhibitor conotoxin Cal9.1c (Fragment)		Californiconus californicus (California cone) (Conus californicus)	60	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0090729			blue	blue	NA	NA	NA	NA
TRINITY_DN10519_c0_g1_i1	C0HLB2	VKT_PSEPC	48.3	58	30	0	17	190	7	64	4.10E-14	78.2	VKT_PSEPC	reviewed	Kunitz-type serine protease inhibitor PPTI (Pseudocerastes persicus trypsin inhibitor) (PPTI)		Pseudocerastes persicus (Persian horned viper) (False horned viper)	68	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN29488_c0_g1_i1	Q80XH1	KXDL1_MOUSE	90	90	9	0	1	270	15	104	3.80E-36	151.8	KXDL1_MOUSE	reviewed	KxDL motif-containing protein 1	Kxd1	Mus musculus (Mouse)	177	BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]; lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]	BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0016192; GO:0032418; GO:0099078	lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN34346_c0_g1_i1	Q9BQD3	KXDL1_HUMAN	100	110	0	0	3	332	1	110	8.30E-55	214.2	KXDL1_HUMAN	reviewed	KxDL motif-containing protein 1	KXD1 C19orf50	Homo sapiens (Human)	176	BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]; lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]	BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0016192; GO:0031083; GO:0032418; GO:0099078	lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2547_c0_g1_i1	Q9VTY4	KXDL1_DROME	60.4	106	41	1	406	89	18	122	3.20E-27	122.9	KXDL1_DROME	reviewed	KxDL motif-containing protein CG10681	CG10681	Drosophila melanogaster (Fruit fly)	212	BORC complex [GO:0099078]; lysosome localization [GO:0032418]	BORC complex [GO:0099078]		GO:0032418; GO:0099078	lysosome localization [GO:0032418]		NA	NA	NA	NA	NA	NA
TRINITY_DN2547_c0_g1_i2	Q9VTY4	KXDL1_DROME	58.6	111	45	1	408	76	18	127	1.90E-27	123.6	KXDL1_DROME	reviewed	KxDL motif-containing protein CG10681	CG10681	Drosophila melanogaster (Fruit fly)	212	BORC complex [GO:0099078]; lysosome localization [GO:0032418]	BORC complex [GO:0099078]		GO:0032418; GO:0099078	lysosome localization [GO:0032418]		NA	NA	NA	NA	NA	NA
TRINITY_DN2547_c0_g1_i3	Q9VTY4	KXDL1_DROME	60.4	106	41	1	395	78	18	122	3.10E-27	122.9	KXDL1_DROME	reviewed	KxDL motif-containing protein CG10681	CG10681	Drosophila melanogaster (Fruit fly)	212	BORC complex [GO:0099078]; lysosome localization [GO:0032418]	BORC complex [GO:0099078]		GO:0032418; GO:0099078	lysosome localization [GO:0032418]		NA	NA	NA	NA	NA	NA
TRINITY_DN4011_c2_g1_i3	Q9MZS9	KMO_PIG	54.1	74	33	1	267	46	27	99	6.90E-14	77.8	KMO_PIG	reviewed	Kynurenine 3-monooxygenase (EC 1.14.13.9) (Fpk) (Kynurenine 3-hydroxylase)	KMO	Sus scrofa (Pig)	471	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]	GO:0004502; GO:0005739; GO:0005741; GO:0006569; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071949	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]		NA	NA	NA	NA	NA	NA
TRINITY_DN4011_c2_g1_i2	Q7Q6A7	KMO_ANOGA	52.5	183	85	2	814	269	40	221	1.50E-51	204.5	KMO_ANOGA	reviewed	Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)	kh AGAP005948	Anopheles gambiae (African malaria mosquito)	486	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]	GO:0004502; GO:0005739; GO:0005741; GO:0006569; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071949	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN4011_c2_g1_i4	Q7Q6A7	KMO_ANOGA	58.2	400	165	2	1292	96	40	438	4.20E-141	502.7	KMO_ANOGA	reviewed	Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)	kh AGAP005948	Anopheles gambiae (African malaria mosquito)	486	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]	GO:0004502; GO:0005739; GO:0005741; GO:0006569; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071949	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]		NA	NA	NA	NA	NA	NA
TRINITY_DN34584_c0_g1_i1	Q86PM2	KMO_AEDAE	89.6	67	7	0	26	226	297	363	8.90E-31	133.7	KMO_AEDAE	reviewed	Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)	kh AAEL008879	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	476	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; FAD binding [GO:0071949]; kynurenine 3-monooxygenase activity [GO:0004502]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	FAD binding [GO:0071949]; kynurenine 3-monooxygenase activity [GO:0004502]	GO:0004502; GO:0005741; GO:0006569; GO:0016021; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0071949	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process [GO:0006569]		NA	NA	NA	NA	NA	NA
TRINITY_DN9780_c0_g1_i1	B5XB27	KFA_SALSA	44.2	156	82	4	479	15	11	162	2.30E-20	100.1	KFA_SALSA	reviewed	Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF)	afmid	Salmo salar (Atlantic salmon)	294	cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]	cytosol [GO:0005829]; nucleus [GO:0005634]	arylformamidase activity [GO:0004061]	GO:0004061; GO:0005634; GO:0005829; GO:0019441; GO:0034354	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]		NA	NA	NA	NA	NA	NA
TRINITY_DN9780_c0_g1_i2	B5XB27	KFA_SALSA	43.6	156	83	4	479	15	11	162	1.60E-19	97.4	KFA_SALSA	reviewed	Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF)	afmid	Salmo salar (Atlantic salmon)	294	cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]	cytosol [GO:0005829]; nucleus [GO:0005634]	arylformamidase activity [GO:0004061]	GO:0004061; GO:0005634; GO:0005829; GO:0019441; GO:0034354	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]		NA	NA	NA	NA	NA	NA
TRINITY_DN9780_c0_g1_i3	B5XB27	KFA_SALSA	43	165	89	4	506	15	2	162	3.00E-21	103.2	KFA_SALSA	reviewed	Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF)	afmid	Salmo salar (Atlantic salmon)	294	cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]	cytosol [GO:0005829]; nucleus [GO:0005634]	arylformamidase activity [GO:0004061]	GO:0004061; GO:0005634; GO:0005829; GO:0019441; GO:0034354	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]		NA	NA	NA	NA	NA	NA
TRINITY_DN768_c0_g1_i1	Q8N5Z0	AADAT_HUMAN	41.8	177	97	1	15	527	1	177	3.00E-37	156.4	AADAT_HUMAN	reviewed	"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Kynurenine aminotransferase II) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II)"	AADAT KAT2	Homo sapiens (Human)	425	mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569]	mitochondrial matrix [GO:0005759]	2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005759; GO:0006103; GO:0006536; GO:0006554; GO:0006569; GO:0008483; GO:0009058; GO:0016212; GO:0030170; GO:0033512; GO:0042803; GO:0047536; GO:0070189; GO:1901605	2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569]		blue	blue	NA	NA	NA	NA
TRINITY_DN508_c0_g1_i1	Q71RI9	KAT3_MOUSE	54.3	409	180	4	219	1439	43	446	4.60E-131	469.5	KAT3_MOUSE	reviewed	Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)	Kyat3 Ccbl2 Kat3	Mus musculus (Mouse)	455	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]		blue	blue	NA	NA	NA	NA
TRINITY_DN508_c0_g1_i2	Q71RI9	KAT3_MOUSE	54.3	409	180	4	233	1453	43	446	4.60E-131	469.5	KAT3_MOUSE	reviewed	Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)	Kyat3 Ccbl2 Kat3	Mus musculus (Mouse)	455	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]		blue	blue	NA	NA	NA	NA
TRINITY_DN5475_c0_g1_i1	A7SMW7	L2HDH_NEMVE	61.7	287	107	2	858	7	39	325	1.40E-106	387.5	L2HDH_NEMVE	reviewed	"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)"	v1g172254	Nematostella vectensis (Starlet sea anemone)	456	mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	mitochondrion [GO:0005739]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0047545			NA	NA	NA	NA	NA	NA
TRINITY_DN5475_c0_g1_i2	A8X2R1	L2HDH_CAEBR	70.4	81	24	0	327	85	24	104	1.50E-27	123.6	L2HDH_CAEBR	reviewed	"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)"	CBG06643	Caenorhabditis briggsae	434	mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	mitochondrion [GO:0005739]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0047545			NA	NA	NA	NA	NA	NA
TRINITY_DN5475_c0_g1_i3	A7SMW7	L2HDH_NEMVE	59.4	155	60	2	462	7	171	325	3.20E-53	210.3	L2HDH_NEMVE	reviewed	"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)"	v1g172254	Nematostella vectensis (Starlet sea anemone)	456	mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	mitochondrion [GO:0005739]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0047545			NA	NA	NA	NA	NA	NA
TRINITY_DN5475_c0_g1_i3	A7SMW7	L2HDH_NEMVE	64.4	132	47	0	926	531	39	170	3.20E-45	183.7	L2HDH_NEMVE	reviewed	"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)"	v1g172254	Nematostella vectensis (Starlet sea anemone)	456	mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	mitochondrion [GO:0005739]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0047545			NA	NA	NA	NA	NA	NA
TRINITY_DN5475_c0_g1_i4	A8X2R1	L2HDH_CAEBR	60.9	156	52	3	462	1	157	305	2.50E-53	210.3	L2HDH_CAEBR	reviewed	"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)"	CBG06643	Caenorhabditis briggsae	434	mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	mitochondrion [GO:0005739]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0047545			NA	NA	NA	NA	NA	NA
TRINITY_DN5475_c0_g1_i4	A8X2R1	L2HDH_CAEBR	70.4	81	24	0	703	461	24	104	3.00E-27	123.6	L2HDH_CAEBR	reviewed	"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2)"	CBG06643	Caenorhabditis briggsae	434	mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	mitochondrion [GO:0005739]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0047545			NA	NA	NA	NA	NA	NA
TRINITY_DN946_c0_g1_i1	Q26457	LA_AEDAL	40.5	316	168	5	328	1263	42	341	1.40E-51	205.3	LA_AEDAL	reviewed	La protein homolog (La autoantigen homolog) (La ribonucleoprotein)		Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	383	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006396; GO:1990904	RNA processing [GO:0006396]		blue	blue	NA	NA	NA	NA
TRINITY_DN5337_c0_g1_i9	J9VY90	LAC1_CRYNH	46.7	105	39	3	397	86	76	164	8.70E-19	95.5	LAC1_CRYNH	reviewed	Laccase-1 (EC 1.10.3.2) (Diphenol oxidase 1)	LAC1 CNAG_03465	Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)	624	cell wall [GO:0005618]; extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]	cell wall [GO:0005618]; extracellular region [GO:0005576]	copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]	GO:0005507; GO:0005576; GO:0005618; GO:0052716			NA	NA	NA	NA	NA	NA
TRINITY_DN5337_c0_g1_i10	Q339K6	LAC15_ORYSJ	29.4	598	296	24	1661	6	63	580	5.30E-42	174.1	LAC15_ORYSJ	reviewed	Laccase-15 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 15) (Diphenol oxidase 15) (Urishiol oxidase 15)	LAC15 Os10g0346300 LOC_Os10g20610 OSJNBa0045C13.15	Oryza sativa subsp. japonica (Rice)	599	apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; oxidoreductase activity [GO:0016491]; lignin catabolic process [GO:0046274]	apoplast [GO:0048046]	copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; oxidoreductase activity [GO:0016491]	GO:0005507; GO:0016491; GO:0046274; GO:0048046; GO:0052716	lignin catabolic process [GO:0046274]		NA	NA	NA	NA	NA	NA
TRINITY_DN5337_c0_g1_i12	Q941X2	LAC3_ORYSJ	26.3	415	211	14	1148	6	192	545	3.90E-25	117.5	LAC3_ORYSJ	reviewed	Laccase-3 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 3) (Diphenol oxidase 3) (Urishiol oxidase 3)	LAC3 Os01g0827300 LOC_Os01g61160 B1088C09.5 OsJ_03932	Oryza sativa subsp. japonica (Rice)	567	apoplast [GO:0048046]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; oxidoreductase activity [GO:0016491]; lignin catabolic process [GO:0046274]	apoplast [GO:0048046]	copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; oxidoreductase activity [GO:0016491]	GO:0005507; GO:0016491; GO:0046274; GO:0048046; GO:0052716	lignin catabolic process [GO:0046274]		NA	NA	NA	NA	NA	NA
TRINITY_DN4099_c0_g1_i12	Q24372	LACH_DROME	27.8	291	186	6	105	926	35	318	3.80E-26	120.9	LACH_DROME	reviewed	Lachesin	Lac CG12369	Drosophila melanogaster (Fruit fly)	359	"anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"	anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	protein homodimerization activity [GO:0042803]	GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343	"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4099_c0_g1_i5	Q24372	LACH_DROME	27.8	291	186	6	105	926	35	318	3.40E-26	120.9	LACH_DROME	reviewed	Lachesin	Lac CG12369	Drosophila melanogaster (Fruit fly)	359	"anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"	anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	protein homodimerization activity [GO:0042803]	GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343	"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4099_c0_g1_i7	Q24372	LACH_DROME	33	100	66	1	63	359	129	228	1.70E-08	60.5	LACH_DROME	reviewed	Lachesin	Lac CG12369	Drosophila melanogaster (Fruit fly)	359	"anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"	anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	protein homodimerization activity [GO:0042803]	GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343	"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25589_c0_g1_i1	Q24372	LACH_DROME	29.9	261	173	5	35	805	70	324	3.30E-28	127.1	LACH_DROME	reviewed	Lachesin	Lac CG12369	Drosophila melanogaster (Fruit fly)	359	"anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"	anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	protein homodimerization activity [GO:0042803]	GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343	"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40798_c0_g1_i1	Q24372	LACH_DROME	42.6	68	35	2	249	58	64	131	1.50E-05	50.1	LACH_DROME	reviewed	Lachesin	Lac CG12369	Drosophila melanogaster (Fruit fly)	359	"anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"	anchored component of membrane [GO:0031225]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]	protein homodimerization activity [GO:0042803]	GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0031225; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343	"cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]"		NA	NA	NA	NA	NA	NA
TRINITY_DN660_c0_g1_i2	Q99NB2	B3GN5_RAT	24.3	222	154	5	297	926	72	291	8.50E-14	79.7	B3GN5_RAT	reviewed	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)"	B3gnt5	Rattus norvegicus (Rat)	377	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]; brain development [GO:0007420]; central nervous system development [GO:0007417]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0007417; GO:0007420; GO:0008375; GO:0008376; GO:0008457; GO:0016021; GO:0016758; GO:0047256	brain development [GO:0007420]; central nervous system development [GO:0007417]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN660_c0_g1_i3	Q99NB2	B3GN5_RAT	24.3	222	154	5	339	968	72	291	6.80E-14	80.1	B3GN5_RAT	reviewed	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)"	B3gnt5	Rattus norvegicus (Rat)	377	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]; brain development [GO:0007420]; central nervous system development [GO:0007417]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0007417; GO:0007420; GO:0008375; GO:0008376; GO:0008457; GO:0016021; GO:0016758; GO:0047256	brain development [GO:0007420]; central nervous system development [GO:0007417]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN18366_c0_g1_i1	Q864U8	B3GN5_PIG	28.8	257	157	5	376	1140	64	296	1.20E-21	105.9	B3GN5_PIG	reviewed	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)"	B3GNT5	Sus scrofa (Pig)	377	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]; brain development [GO:0007420]; central nervous system development [GO:0007417]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0007417; GO:0007420; GO:0008375; GO:0008376; GO:0008457; GO:0016021; GO:0016758; GO:0047256	brain development [GO:0007420]; central nervous system development [GO:0007417]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11209_c0_g1_i1	Q5XJP0	B3G5B_DANRE	26.9	219	147	6	904	284	69	286	3.60E-15	84.3	B3G5B_DANRE	reviewed	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B (EC 2.4.1.206) (Lactotriaosylceramide synthase B) (Lc(3)Cer synthase B) (Lc3 synthase B) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5B) (BGnT-5B) (Beta-1,3-Gn-T5B) (Beta-1,3-N-acetylglucosaminyltransferase 5B) (Beta3Gn-T5B)"	b3gnt5b zgc:101733	Danio rerio (Zebrafish) (Brachydanio rerio)	382	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]; brain development [GO:0007420]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0007420; GO:0008375; GO:0008376; GO:0008457; GO:0016021; GO:0016758; GO:0047256	brain development [GO:0007420]; protein glycosylation [GO:0006486]		blue	blue	NA	NA	NA	NA
TRINITY_DN11209_c0_g1_i2	Q5XJP0	B3G5B_DANRE	26.9	219	147	6	904	284	69	286	2.70E-15	84.3	B3G5B_DANRE	reviewed	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B (EC 2.4.1.206) (Lactotriaosylceramide synthase B) (Lc(3)Cer synthase B) (Lc3 synthase B) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5B) (BGnT-5B) (Beta-1,3-Gn-T5B) (Beta-1,3-N-acetylglucosaminyltransferase 5B) (Beta3Gn-T5B)"	b3gnt5b zgc:101733	Danio rerio (Zebrafish) (Brachydanio rerio)	382	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]; brain development [GO:0007420]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0007420; GO:0008375; GO:0008376; GO:0008457; GO:0016021; GO:0016758; GO:0047256	brain development [GO:0007420]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11209_c0_g1_i3	Q5XJP0	B3G5B_DANRE	26.9	219	147	6	904	284	69	286	2.80E-15	84.3	B3G5B_DANRE	reviewed	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B (EC 2.4.1.206) (Lactotriaosylceramide synthase B) (Lc(3)Cer synthase B) (Lc3 synthase B) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5B) (BGnT-5B) (Beta-1,3-Gn-T5B) (Beta-1,3-N-acetylglucosaminyltransferase 5B) (Beta3Gn-T5B)"	b3gnt5b zgc:101733	Danio rerio (Zebrafish) (Brachydanio rerio)	382	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]; brain development [GO:0007420]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0007420; GO:0008375; GO:0008376; GO:0008457; GO:0016021; GO:0016758; GO:0047256	brain development [GO:0007420]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN20583_c0_g2_i1	Q9NPC4	A4GAT_HUMAN	35.6	202	122	3	6	593	58	257	1.00E-28	128.3	A4GAT_HUMAN	reviewed	"Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (CD77 synthase) (Globotriaosylceramide synthase) (Gb3 synthase) (P1/Pk synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase)"	A4GALT A14GALT A4GALT1	Homo sapiens (Human)	353	"integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; transferase activity, transferring hexosyl groups [GO:0016758]; globoside biosynthetic process [GO:0001576]; glycosphingolipid biosynthetic process [GO:0006688]; plasma membrane organization [GO:0007009]"	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0001576; GO:0006688; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016758; GO:0030173; GO:0050512	globoside biosynthetic process [GO:0001576]; glycosphingolipid biosynthetic process [GO:0006688]; plasma membrane organization [GO:0007009]		NA	NA	NA	NA	NA	NA
TRINITY_DN15109_c0_g1_i1	Q9JI93	A4GAT_RAT	37.8	74	43	2	79	297	280	351	8.20E-08	57.8	A4GAT_RAT	reviewed	"Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (Globotriaosylceramide synthase) (Gb3 synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase)"	A4galt	Rattus norvegicus (Rat)	360	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; transferase activity, transferring hexosyl groups [GO:0016758]; globoside biosynthetic process [GO:0001576]; glycosphingolipid biosynthetic process [GO:0006688]; plasma membrane organization [GO:0007009]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"galactosyltransferase activity [GO:0008378]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0001576; GO:0006688; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016021; GO:0016758; GO:0050512	globoside biosynthetic process [GO:0001576]; glycosphingolipid biosynthetic process [GO:0006688]; plasma membrane organization [GO:0007009]		NA	NA	NA	NA	NA	NA
TRINITY_DN3238_c0_g1_i1	Q6P7Q4	LGUL_RAT	68	181	53	2	632	102	1	180	6.80E-69	261.9	LGUL_RAT	reviewed	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	Glo1	Rattus norvegicus (Rat)	184	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066	carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3238_c0_g1_i2	Q6P7Q4	LGUL_RAT	68	181	53	2	632	102	1	180	5.20E-69	262.3	LGUL_RAT	reviewed	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	Glo1	Rattus norvegicus (Rat)	184	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066	carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3238_c0_g1_i3	Q6P7Q4	LGUL_RAT	68.5	181	52	2	632	102	1	180	1.40E-69	264.2	LGUL_RAT	reviewed	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	Glo1	Rattus norvegicus (Rat)	184	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066	carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34622_c0_g1_i1	Q9CPU0	LGUL_MOUSE	100	178	0	0	599	66	7	184	6.70E-102	371.3	LGUL_MOUSE	reviewed	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	Glo1	Mus musculus (Mouse)	184	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0019243; GO:0030316; GO:0043066	carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27813_c0_g1_i1	Q04760	LGUL_HUMAN	100	166	0	0	3	500	19	184	1.80E-96	353.2	LGUL_HUMAN	reviewed	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	GLO1	Homo sapiens (Human)	184	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; pyruvate metabolic process [GO:0006090]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006090; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066; GO:0070062	carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; pyruvate metabolic process [GO:0006090]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1470_c0_g1_i2	Q61029	LAP2B_MOUSE	32.7	199	97	6	89	574	9	207	4.20E-11	69.7	LAP2B_MOUSE	reviewed	"Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma (Thymopoietin isoforms beta/delta/epsilon/gamma) (TP beta/delta/epsilon/gamma)"	Tmpo Lap2	Mus musculus (Mouse)	452	"chromatin [GO:0000785]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005634; GO:0005635; GO:0005637; GO:0006355; GO:0016021; GO:0031965	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25685_c0_g1_i1	Q00174	LAMA_DROME	51.5	134	65	0	403	2	1291	1424	2.90E-43	176	LAMA_DROME	reviewed	Laminin subunit alpha (Laminin A chain)	LanA lamA CG10236	Drosophila melanogaster (Fruit fly)	3712	"axon [GO:0030424]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]"	axon [GO:0030424]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0062023; GO:0071711	"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14883_c0_g2_i2	P25391	LAMA1_HUMAN	25.1	1023	680	33	2972	3	1563	2532	1.00E-57	226.9	LAMA1_HUMAN	reviewed	Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)	LAMA1 LAMA	Homo sapiens (Human)	3075	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]	extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030155; GO:0030198; GO:0030334; GO:0031012; GO:0043010; GO:0043208; GO:0045198; GO:0045995; GO:0048514; GO:0060441; GO:0060445; GO:0061304; GO:0062023	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN14883_c0_g2_i4	P25391	LAMA1_HUMAN	25.5	884	584	28	2618	54	1563	2400	1.90E-47	192.6	LAMA1_HUMAN	reviewed	Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)	LAMA1 LAMA	Homo sapiens (Human)	3075	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]	extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030155; GO:0030198; GO:0030334; GO:0031012; GO:0043010; GO:0043208; GO:0045198; GO:0045995; GO:0048514; GO:0060441; GO:0060445; GO:0061304; GO:0062023	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN34759_c0_g1_i1	P24043	LAMA2_HUMAN	52.5	40	19	0	201	320	918	957	5.90E-07	55.1	LAMA2_HUMAN	reviewed	Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain)	LAMA2 LAMM	Homo sapiens (Human)	3122	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888]"	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]	extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0014037; GO:0030155; GO:0030198; GO:0030334; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0043197; GO:0045995; GO:0062023	"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4403_c1_g1_i2	Q61001	LAMA5_MOUSE	42.7	239	120	6	15	728	1495	1717	4.00E-52	206.5	LAMA5_MOUSE	reviewed	Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha)	Lama5	Mus musculus (Mouse)	3718	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]	GO:0001658; GO:0001738; GO:0001755; GO:0001822; GO:0001942; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0007229; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0016331; GO:0016477; GO:0030155; GO:0030324; GO:0030334; GO:0031012; GO:0031594; GO:0034446; GO:0042127; GO:0042475; GO:0043083; GO:0043259; GO:0045995; GO:0048754; GO:0060271; GO:0060445; GO:0062023; GO:0072659; GO:0098609	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN24196_c0_g1_i3	P11046	LAMB1_DROME	54.2	48	21	1	63	203	679	726	1.20E-05	50.1	LAMB1_DROME	reviewed	Laminin subunit beta-1 (Laminin B1 chain)	LanB1 lamB1 CG7123	Drosophila melanogaster (Fruit fly)	1788	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]; animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]		GO:0003143; GO:0005604; GO:0008406; GO:0009887; GO:0009888; GO:0016477; GO:0030198; GO:0033627; GO:0034446; GO:0043256; GO:0045089; GO:0048513; GO:0050829; GO:0055013; GO:0062023; GO:0070831; GO:0071711	animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN11787_c4_g1_i1	P11046	LAMB1_DROME	62.1	227	82	1	675	7	272	498	1.50E-93	344	LAMB1_DROME	reviewed	Laminin subunit beta-1 (Laminin B1 chain)	LanB1 lamB1 CG7123	Drosophila melanogaster (Fruit fly)	1788	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]; animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]		GO:0003143; GO:0005604; GO:0008406; GO:0009887; GO:0009888; GO:0016477; GO:0030198; GO:0033627; GO:0034446; GO:0043256; GO:0045089; GO:0048513; GO:0050829; GO:0055013; GO:0062023; GO:0070831; GO:0071711	animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN11787_c4_g1_i2	P11046	LAMB1_DROME	70.6	85	20	2	290	48	272	355	7.80E-33	141.4	LAMB1_DROME	reviewed	Laminin subunit beta-1 (Laminin B1 chain)	LanB1 lamB1 CG7123	Drosophila melanogaster (Fruit fly)	1788	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]; animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]		GO:0003143; GO:0005604; GO:0008406; GO:0009887; GO:0009888; GO:0016477; GO:0030198; GO:0033627; GO:0034446; GO:0043256; GO:0045089; GO:0048513; GO:0050829; GO:0055013; GO:0062023; GO:0070831; GO:0071711	animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN39535_c0_g1_i1	P11046	LAMB1_DROME	49	51	25	1	232	80	73	122	2.00E-09	62.8	LAMB1_DROME	reviewed	Laminin subunit beta-1 (Laminin B1 chain)	LanB1 lamB1 CG7123	Drosophila melanogaster (Fruit fly)	1788	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]; animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; laminin complex [GO:0043256]		GO:0003143; GO:0005604; GO:0008406; GO:0009887; GO:0009888; GO:0016477; GO:0030198; GO:0033627; GO:0034446; GO:0043256; GO:0045089; GO:0048513; GO:0050829; GO:0055013; GO:0062023; GO:0070831; GO:0071711	animal organ development [GO:0048513]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; defense response to Gram-negative bacterium [GO:0050829]; embryonic heart tube morphogenesis [GO:0003143]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; positive regulation of innate immune response [GO:0045089]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN33261_c0_g1_i1	P02469	LAMB1_MOUSE	100	164	0	0	492	1	204	367	1.20E-99	363.6	LAMB1_MOUSE	reviewed	Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)	Lamb1 Lamb-1 Lamb1-1	Mus musculus (Mouse)	1786	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-1 complex [GO:0005606]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; laminin complex [GO:0043256]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]	GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0048471; GO:0062023; GO:0070831	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; neuron projection development [GO:0031175]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN24196_c0_g1_i2	P07942	LAMB1_HUMAN	46.1	180	95	2	2	535	526	705	1.30E-40	167.5	LAMB1_HUMAN	reviewed	Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)	LAMB1	Homo sapiens (Human)	1786	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-1 complex [GO:0005606]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; laminin complex [GO:0043256]; perinuclear region of cytoplasm [GO:0048471]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0009887; GO:0009888; GO:0016477; GO:0021812; GO:0030198; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043256; GO:0043257; GO:0043259; GO:0043687; GO:0044267; GO:0048471; GO:0050679; GO:0062023; GO:0070062; GO:0070831	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; neuron projection development [GO:0031175]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN11999_c0_g1_i1	Q01635	LAMB1_CHICK	71.5	144	41	0	20	451	39	182	2.90E-57	222.6	LAMB1_CHICK	reviewed	Laminin subunit beta-1 (Laminin beta-1-1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) (Fragment)	LAMB1	Gallus gallus (Chicken)	303	basement membrane [GO:0005604]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; positive regulation of cell migration [GO:0030335]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-1 complex [GO:0005606]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; laminin complex [GO:0043256]; perinuclear region of cytoplasm [GO:0048471]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]	GO:0005178; GO:0005201; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0007162; GO:0009887; GO:0009888; GO:0016477; GO:0030335; GO:0031175; GO:0034446; GO:0043256; GO:0043257; GO:0043259; GO:0048471; GO:0070831	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; positive regulation of cell migration [GO:0030335]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN29194_c0_g1_i1	Q61292	LAMB2_MOUSE	56.5	62	26	1	3	185	502	563	1.10E-14	80.1	LAMB2_MOUSE	reviewed	Laminin subunit beta-2 (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta)	Lamb2 Lams	Mus musculus (Mouse)	1799	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; synapse organization [GO:0050808]; tissue development [GO:0009888]; visual perception [GO:0007601]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-3 complex [GO:0005608]; laminin complex [GO:0043256]; neuromuscular junction [GO:0031594]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]	GO:0000904; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0031175; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0045202; GO:0048677; GO:0050808; GO:0060041; GO:0062023; GO:0070831; GO:0072249; GO:0072274	animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; synapse organization [GO:0050808]; tissue development [GO:0009888]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN22368_c0_g1_i1	A0JP86	LAMC1_XENTR	29.3	92	65	0	14	289	1499	1590	3.20E-06	52.8	LAMC1_XENTR	reviewed	Laminin subunit gamma-1	lamc1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1592	basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005604; GO:0009887; GO:0009888; GO:0016477; GO:0034446	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN38379_c0_g1_i1	Q21313	EPI1_CAEEL	39.3	84	49	2	47	298	1415	1496	5.00E-13	75.1	EPI1_CAEEL	reviewed	Laminin-like protein epi-1	epi-1 K08C7.3	Caenorhabditis elegans	3672	basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproduction [GO:0000003]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888]	basement membrane [GO:0005604]	extracellular matrix structural constituent [GO:0005201]	GO:0000003; GO:0001764; GO:0005201; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0010950; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711	animal organ morphogenesis [GO:0009887]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproduction [GO:0000003]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN32808_c0_g1_i1	Q18823	LAM2_CAEEL	40.8	130	76	1	2	388	916	1045	3.70E-24	112.5	LAM2_CAEEL	reviewed	Laminin-like protein lam-2	lam-2 C54D1.5	Caenorhabditis elegans	1633	basement membrane [GO:0005604]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; positive regulation of locomotion [GO:0040017]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]		GO:0005604; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0040017	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; positive regulation of locomotion [GO:0040017]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN4461_c0_g1_i4	Q9CQF6	ADPPT_MOUSE	50	86	42	1	201	458	10	94	1.70E-17	90.9	ADPPT_MOUSE	reviewed	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.7) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT)	Aasdhppt	Mus musculus (Mouse)	309	cytoplasm [GO:0005737]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; lysine biosynthetic process via aminoadipic acid [GO:0019878]	cytoplasm [GO:0005737]	holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005737; GO:0008897; GO:0019878	lysine biosynthetic process via aminoadipic acid [GO:0019878]		NA	NA	NA	NA	NA	NA
TRINITY_DN5395_c0_g1_i1	Q9JJK2	LANC2_MOUSE	48.4	378	192	2	202	1329	68	444	7.30E-110	399.1	LANC2_MOUSE	reviewed	LanC-like protein 2 (Testis-specific adriamycin sensitivity protein)	Lancl2 Tasp	Mus musculus (Mouse)	450	"cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; carbohydrate metabolic process [GO:0005975]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]"	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]	GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273	"carbohydrate metabolic process [GO:0005975]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8570_c0_g1_i1	Q9VAW5	LARP_DROME	53.3	90	42	0	7	276	725	814	6.90E-20	98.2	LARP_DROME	reviewed	La-related protein 1 (dLarp)	larp CG42551	Drosophila melanogaster (Fruit fly)	1673	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; male meiotic nuclear division [GO:0007140]; mitochondrion inheritance [GO:0000001]; spindle assembly involved in male meiosis [GO:0007053]; syncytial blastoderm mitotic cell cycle [GO:0035186]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]	GO:0000001; GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0007053; GO:0007140; GO:0035186	male meiotic nuclear division [GO:0007140]; mitochondrion inheritance [GO:0000001]; spindle assembly involved in male meiosis [GO:0007053]; syncytial blastoderm mitotic cell cycle [GO:0035186]		NA	NA	NA	NA	NA	NA
TRINITY_DN27207_c0_g1_i1	Q9BRS8	LARP6_HUMAN	35.4	302	159	9	194	1018	10	302	3.50E-32	140.6	LARP6_HUMAN	reviewed	La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6)	LARP6	Homo sapiens (Human)	491	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]	mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]	GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904	positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN6022_c0_g1_i10	Q01650	LAT1_HUMAN	50	64	28	2	54	239	104	165	1.60E-07	56.6	LAT1_HUMAN	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	SLC7A5 CD98LC LAT1 MPE16	Homo sapiens (Human)	507	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015804; GO:0015823; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042605; GO:0042908; GO:0043231; GO:0050900; GO:0070062; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:0150104; GO:1902475; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN6022_c0_g1_i11	Q01650	LAT1_HUMAN	51.4	72	34	1	56	271	104	174	1.10E-13	77.4	LAT1_HUMAN	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	SLC7A5 CD98LC LAT1 MPE16	Homo sapiens (Human)	507	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015804; GO:0015823; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042605; GO:0042908; GO:0043231; GO:0050900; GO:0070062; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:0150104; GO:1902475; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN6022_c0_g1_i6	Q01650	LAT1_HUMAN	43.5	92	48	2	56	331	104	191	7.60E-13	74.7	LAT1_HUMAN	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	SLC7A5 CD98LC LAT1 MPE16	Homo sapiens (Human)	507	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015804; GO:0015823; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042605; GO:0042908; GO:0043231; GO:0050900; GO:0070062; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:0150104; GO:1902475; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN32052_c0_g1_i1	Q01650	LAT1_HUMAN	100	69	0	0	1	207	312	380	1.80E-33	142.5	LAT1_HUMAN	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	SLC7A5 CD98LC LAT1 MPE16	Homo sapiens (Human)	507	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015804; GO:0015823; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042605; GO:0042908; GO:0043231; GO:0050900; GO:0070062; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:0150104; GO:1902475; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN34526_c0_g1_i1	Q01650	LAT1_HUMAN	100	91	0	0	274	2	219	309	2.20E-44	179.1	LAT1_HUMAN	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	SLC7A5 CD98LC LAT1 MPE16	Homo sapiens (Human)	507	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015804; GO:0015823; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042605; GO:0042908; GO:0043231; GO:0050900; GO:0070062; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:0150104; GO:1902475; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN24977_c0_g1_i1	Q01650	LAT1_HUMAN	97.5	161	4	0	485	3	55	215	5.50E-78	291.6	LAT1_HUMAN	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	SLC7A5 CD98LC LAT1 MPE16	Homo sapiens (Human)	507	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015804; GO:0015823; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042605; GO:0042908; GO:0043231; GO:0050900; GO:0070062; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:0150104; GO:1902475; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; leucine import across plasma membrane [GO:0098713]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN36884_c0_g1_i1	Q9Z127	LAT1_MOUSE	58.7	109	45	0	47	373	43	151	4.30E-30	132.1	LAT1_MOUSE	reviewed	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (L-type amino acid transporter 1) (LAT1) (Solute carrier family 7 member 5)	Slc7a5 Lat1	Mus musculus (Mouse)	512	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; thyroid hormone transmembrane transporter activity [GO:0015349]; xenobiotic transmembrane transporter activity [GO:0042910]; amino acid import across plasma membrane [GO:0089718]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; negative regulation of gene expression [GO:0010629]; phenylalanine transport [GO:0015823]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; xenobiotic transport [GO:0042908]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; thyroid hormone transmembrane transporter activity [GO:0015349]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010629; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015349; GO:0015807; GO:0015823; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042908; GO:0042910; GO:0043231; GO:0070327; GO:0089718; GO:0098591; GO:0098713; GO:1903801; GO:1904556; GO:1990184	amino acid import across plasma membrane [GO:0089718]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; negative regulation of gene expression [GO:0010629]; phenylalanine transport [GO:0015823]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; thyroid hormone transport [GO:0070327]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN261_c0_g1_i1	Q9N1Q4	LAT2_RABIT	54.6	432	191	2	44	1324	34	465	5.60E-125	449.1	LAT2_RABIT	reviewed	Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Oryctolagus cuniculus (Rabbit)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0009925; GO:0015101; GO:0015171; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015827; GO:0015829; GO:0016021; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:1903801; GO:1904273	L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		blue	blue	NA	NA	NA	NA
TRINITY_DN26979_c0_g1_i1	Q9N1Q4	LAT2_RABIT	46.7	441	228	2	50	1357	56	494	1.50E-112	407.9	LAT2_RABIT	reviewed	Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Oryctolagus cuniculus (Rabbit)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0009925; GO:0015101; GO:0015171; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015827; GO:0015829; GO:0016021; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:1903801; GO:1904273	L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN26979_c0_g1_i2	Q9N1Q4	LAT2_RABIT	47.5	461	235	2	147	1514	36	494	5.40E-119	429.5	LAT2_RABIT	reviewed	Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Oryctolagus cuniculus (Rabbit)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0009925; GO:0015101; GO:0015171; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015827; GO:0015829; GO:0016021; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:1903801; GO:1904273	L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN27028_c0_g1_i1	Q9N1Q4	LAT2_RABIT	55.8	181	73	2	3	530	201	379	6.90E-45	181.8	LAT2_RABIT	reviewed	Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Oryctolagus cuniculus (Rabbit)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0009925; GO:0015101; GO:0015171; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015827; GO:0015829; GO:0016021; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:1903801; GO:1904273	L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN1489_c0_g2_i2	Q9UHI5	LAT2_HUMAN	50.2	508	230	5	1494	19	14	514	9.00E-135	481.9	LAT2_HUMAN	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Homo sapiens (Human)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0009636; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0050900; GO:0055065; GO:0070327; GO:0089718; GO:0098713; GO:0150104; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN1489_c0_g1_i1	Q9UHI5	LAT2_HUMAN	50.2	508	230	5	31	1506	14	514	9.00E-135	481.9	LAT2_HUMAN	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Homo sapiens (Human)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0009636; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0050900; GO:0055065; GO:0070327; GO:0089718; GO:0098713; GO:0150104; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN1489_c0_g1_i2	Q9UHI5	LAT2_HUMAN	60.2	83	27	1	31	261	14	96	1.00E-17	90.9	LAT2_HUMAN	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8)	SLC7A8 LAT2	Homo sapiens (Human)	535	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0009636; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0050900; GO:0055065; GO:0070327; GO:0089718; GO:0098713; GO:0150104; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		blue	blue	NA	NA	NA	NA
TRINITY_DN30752_c0_g1_i1	Q9QXW9	LAT2_MOUSE	100	157	0	0	3	473	49	205	1.00E-81	303.9	LAT2_MOUSE	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8)	Slc7a8 Lat2	Mus musculus (Mouse)	531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005275; GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN36314_c0_g1_i1	Q9WVR6	LAT2_RAT	48.6	70	35	1	216	7	139	207	6.80E-13	74.7	LAT2_RAT	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	Slc7a8 Lat2 Lat4	Rattus norvegicus (Rat)	533	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN36314_c0_g1_i1	Q9WVR6	LAT2_RAT	53.8	39	18	0	199	315	105	143	5.80E-04	45.1	LAT2_RAT	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	Slc7a8 Lat2 Lat4	Rattus norvegicus (Rat)	533	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2437_c0_g1_i1	Q9WVR6	LAT2_RAT	65.7	67	23	0	271	471	35	101	7.20E-18	92	LAT2_RAT	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	Slc7a8 Lat2 Lat4	Rattus norvegicus (Rat)	533	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2437_c0_g1_i10	Q9WVR6	LAT2_RAT	64.7	51	18	0	254	406	51	101	2.30E-12	73.6	LAT2_RAT	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	Slc7a8 Lat2 Lat4	Rattus norvegicus (Rat)	533	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2437_c0_g1_i2	Q9WVR6	LAT2_RAT	68.8	64	20	0	24	215	35	98	5.00E-18	91.7	LAT2_RAT	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	Slc7a8 Lat2 Lat4	Rattus norvegicus (Rat)	533	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2437_c0_g1_i4	Q9WVR6	LAT2_RAT	65.7	67	23	0	489	689	35	101	1.00E-17	92	LAT2_RAT	reviewed	Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	Slc7a8 Lat2 Lat4	Rattus norvegicus (Rat)	533	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0070327; GO:0089718; GO:0098713; GO:1903801; GO:1904273	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829]		NA	NA	NA	NA	NA	NA
TRINITY_DN37063_c0_g1_i1	Q10190	LSG1_SCHPO	51.4	74	36	0	222	1	284	357	2.50E-17	89	LSG1_SCHPO	reviewed	Large subunit GTPase 1 (EC 3.6.1.-)	lsg1 SPAC3F10.16c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	616	cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal large subunit assembly [GO:0000027]; ribosomal subunit export from nucleus [GO:0000054]	cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000027; GO:0000054; GO:0003924; GO:0005525; GO:0005829	ribosomal large subunit assembly [GO:0000027]; ribosomal subunit export from nucleus [GO:0000054]		NA	NA	NA	NA	NA	NA
TRINITY_DN35026_c0_g1_i1	Q9W590	LSG1_DROME	70	90	27	0	272	3	322	411	2.00E-29	129.4	LSG1_DROME	reviewed	Large subunit GTPase 1 homolog (EC 3.6.1.-) (Nucleostemin-3)	Ns3 l(1)G0431 CG14788	Drosophila melanogaster (Fruit fly)	606	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; regulation of growth [GO:0040008]; regulation of insulin receptor signaling pathway [GO:0046626]; ribosomal subunit export from nucleus [GO:0000054]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000054; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005829; GO:0007275; GO:0015030; GO:0040008; GO:0046626; GO:0051168	multicellular organism development [GO:0007275]; nuclear export [GO:0051168]; regulation of growth [GO:0040008]; regulation of insulin receptor signaling pathway [GO:0046626]; ribosomal subunit export from nucleus [GO:0000054]		blue	blue	NA	NA	NA	NA
TRINITY_DN3552_c2_g1_i2	O95461	LARG1_HUMAN	70.7	164	48	0	42	533	579	742	1.30E-68	260.8	LARG1_HUMAN	reviewed	"LARGE xylosyl- and glucuronyltransferase 1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) [Includes: Xylosyltransferase LARGE (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE (EC 2.4.1.-)]"	LARGE1 KIAA0609 LARGE	Homo sapiens (Human)	756	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]"	GO:0000139; GO:0005794; GO:0006044; GO:0006486; GO:0006493; GO:0006688; GO:0008375; GO:0009101; GO:0015020; GO:0016757; GO:0030145; GO:0030173; GO:0035252; GO:0035269; GO:0042285; GO:0043403; GO:0046716; GO:0060538	glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN3552_c2_g1_i3	O95461	LARG1_HUMAN	72.1	147	41	0	42	482	579	725	2.00E-62	240	LARG1_HUMAN	reviewed	"LARGE xylosyl- and glucuronyltransferase 1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) [Includes: Xylosyltransferase LARGE (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE (EC 2.4.1.-)]"	LARGE1 KIAA0609 LARGE	Homo sapiens (Human)	756	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	"acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]"	GO:0000139; GO:0005794; GO:0006044; GO:0006486; GO:0006493; GO:0006688; GO:0008375; GO:0009101; GO:0015020; GO:0016757; GO:0030145; GO:0030173; GO:0035252; GO:0035269; GO:0042285; GO:0043403; GO:0046716; GO:0060538	glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN3552_c2_g2_i2	Q66PG4	LARG2_CHICK	59.6	223	83	2	285	944	57	275	2.50E-71	270.4	LARG2_CHICK	reviewed	"LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]"	LARGE2 GYLTL1B	Gallus gallus (Chicken)	739	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]; protein O-linked mannosylation [GO:0035269]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]"	GO:0000139; GO:0005794; GO:0015020; GO:0016021; GO:0016757; GO:0035269; GO:0042285; GO:0046872	protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN3552_c2_g1_i4	Q66PG1	LARG2_DANRE	68	425	133	1	1	1266	314	738	4.00E-179	629	LARG2_DANRE	reviewed	"LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]"	large2 gyltl1b si:ch211-206g24.1 si:ch211-282n12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	750	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]"	GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0016757; GO:0035269; GO:0042285; GO:0046872	protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN3552_c2_g1_i5	Q66PG1	LARG2_DANRE	69.8	367	108	1	1	1092	314	680	2.80E-157	556.2	LARG2_DANRE	reviewed	"LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]"	large2 gyltl1b si:ch211-206g24.1 si:ch211-282n12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	750	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]"	GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0016757; GO:0035269; GO:0042285; GO:0046872	protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN920_c1_g1_i1	Q9UK59	DBR1_HUMAN	39.5	304	156	8	1151	261	169	451	1.90E-52	208.4	DBR1_HUMAN	reviewed	Lariat debranching enzyme (EC 3.1.-.-)	DBR1	Homo sapiens (Human)	544	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN920_c1_g1_i1	Q9UK59	DBR1_HUMAN	69.8	96	29	0	1455	1168	1	96	9.10E-34	146.4	DBR1_HUMAN	reviewed	Lariat debranching enzyme (EC 3.1.-.-)	DBR1	Homo sapiens (Human)	544	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN920_c1_g1_i3	Q9UK59	DBR1_HUMAN	50.2	472	207	8	1655	261	1	451	4.60E-127	456.4	DBR1_HUMAN	reviewed	Lariat debranching enzyme (EC 3.1.-.-)	DBR1	Homo sapiens (Human)	544	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33034_c0_g1_i1	Q6P886	DBR1_XENTR	58.7	92	37	1	275	3	16	107	7.30E-27	120.9	DBR1_XENTR	reviewed	Lariat debranching enzyme (EC 3.1.-.-)	dbr1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	534	"nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleus [GO:0005634]	RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0000398; GO:0005634; GO:0008419	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37264_c0_g1_i1	Q9UK59	DBR1_HUMAN	100	75	0	0	2	226	36	110	2.50E-41	168.7	DBR1_HUMAN	reviewed	Lariat debranching enzyme (EC 3.1.-.-)	DBR1	Homo sapiens (Human)	544	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN920_c1_g1_i2	Q6GPB8	DBR1A_XENLA	65.1	249	87	0	1440	694	1	249	2.10E-99	364.4	DBR1A_XENLA	reviewed	Lariat debranching enzyme A (EC 3.1.-.-)	dbr1-a	Xenopus laevis (African clawed frog)	534	"nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleus [GO:0005634]	RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0005634; GO:0006397; GO:0008419	"mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27685_c0_g1_i1	O02387	CU17_BOMMO	47.9	48	21	1	68	211	78	121	4.20E-06	52	CU17_BOMMO	reviewed	Larval cuticle protein LCP-17	LCP17	Bombyx mori (Silk moth)	143	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN8411_c0_g2_i1	O02387	CU17_BOMMO	50	48	20	1	220	77	78	121	3.90E-07	55.1	CU17_BOMMO	reviewed	Larval cuticle protein LCP-17	LCP17	Bombyx mori (Silk moth)	143	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN8411_c0_g1_i1	O02387	CU17_BOMMO	47.9	48	21	1	236	93	78	121	2.80E-07	55.8	CU17_BOMMO	reviewed	Larval cuticle protein LCP-17	LCP17	Bombyx mori (Silk moth)	143	structural constituent of cuticle [GO:0042302]		structural constituent of cuticle [GO:0042302]	GO:0042302			NA	NA	NA	NA	NA	NA
TRINITY_DN332_c0_g1_i4	P53281	LSB1_YEAST	42.6	47	27	0	324	184	62	108	4.60E-05	50.8	LSB1_YEAST	reviewed	LAS seventeen-binding protein 1 (LAS17-binding protein 1)	LSB1 YGR136W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	241	actin cortical patch [GO:0030479]; cytoplasm [GO:0005737]; ESCRT-0 complex [GO:0033565]; nucleus [GO:0005634]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]	actin cortical patch [GO:0030479]; cytoplasm [GO:0005737]; ESCRT-0 complex [GO:0033565]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0030479; GO:0033565; GO:0034316; GO:0043328	negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]		NA	NA	NA	NA	NA	NA
TRINITY_DN151_c0_g1_i1	Q8NBF6	AVL9_HUMAN	49	243	110	3	832	146	17	259	5.50E-58	226.1	AVL9_HUMAN	reviewed	Late secretory pathway protein AVL9 homolog	AVL9 KIAA0241	Homo sapiens (Human)	648	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; cell migration [GO:0016477]	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]		GO:0016021; GO:0016477; GO:0055037	cell migration [GO:0016477]		NA	NA	NA	NA	NA	NA
TRINITY_DN151_c0_g1_i2	Q80U56	AVL9_MOUSE	47.5	255	124	3	967	233	7	261	1.50E-59	231.5	AVL9_MOUSE	reviewed	Late secretory pathway protein AVL9 homolog	Avl9 Kiaa0241	Mus musculus (Mouse)	649	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; cell migration [GO:0016477]	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]		GO:0016021; GO:0016477; GO:0055037	cell migration [GO:0016477]		NA	NA	NA	NA	NA	NA
TRINITY_DN151_c0_g1_i3	Q8NBF6	AVL9_HUMAN	58.5	147	58	1	567	136	17	163	1.00E-45	184.9	AVL9_HUMAN	reviewed	Late secretory pathway protein AVL9 homolog	AVL9 KIAA0241	Homo sapiens (Human)	648	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; cell migration [GO:0016477]	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]		GO:0016021; GO:0016477; GO:0055037	cell migration [GO:0016477]		NA	NA	NA	NA	NA	NA
TRINITY_DN28339_c0_g1_i1	Q8CG19	LTBP1_MOUSE	100	90	0	0	271	2	900	989	1.40E-51	203	LTBP1_MOUSE	reviewed	Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1)	Ltbp1	Mus musculus (Mouse)	1712	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; large latent transforming growth factor-beta complex [GO:0038045]; microfibril [GO:0001527]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; positive regulation of collagen biosynthetic process [GO:0032967]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum development [GO:0003281]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; large latent transforming growth factor-beta complex [GO:0038045]; microfibril [GO:0001527]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]	GO:0001527; GO:0003281; GO:0005509; GO:0005737; GO:0005739; GO:0007179; GO:0030425; GO:0031012; GO:0032967; GO:0032991; GO:0035583; GO:0035904; GO:0038045; GO:0043025; GO:0048471; GO:0050431; GO:0050436; GO:0060976; GO:0062023; GO:1901388	aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; positive regulation of collagen biosynthetic process [GO:0032967]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN32844_c0_g1_i1	O08999	LTBP2_MOUSE	98.1	104	1	1	1	309	1154	1257	6.20E-59	227.6	LTBP2_MOUSE	reviewed	Latent-transforming growth factor beta-binding protein 2 (LTBP-2)	Ltbp2	Mus musculus (Mouse)	1813	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]; supramolecular fiber organization [GO:0097435]	collagen-containing extracellular matrix [GO:0062023]	calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]	GO:0005509; GO:0008201; GO:0019838; GO:0050436; GO:0062023; GO:0097435	supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN37678_c0_g1_i1	O08999	LTBP2_MOUSE	96.2	79	3	0	240	4	1484	1562	1.50E-44	179.5	LTBP2_MOUSE	reviewed	Latent-transforming growth factor beta-binding protein 2 (LTBP-2)	Ltbp2	Mus musculus (Mouse)	1813	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]; supramolecular fiber organization [GO:0097435]	collagen-containing extracellular matrix [GO:0062023]	calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]	GO:0005509; GO:0008201; GO:0019838; GO:0050436; GO:0062023; GO:0097435	supramolecular fiber organization [GO:0097435]		NA	NA	NA	NA	NA	NA
TRINITY_DN26932_c0_g1_i1	Q9NS15	LTBP3_HUMAN	100	74	0	0	1	222	808	881	2.60E-43	175.3	LTBP3_HUMAN	reviewed	Latent-transforming growth factor beta-binding protein 3 (LTBP-3)	LTBP3	Homo sapiens (Human)	1303	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]	GO:0005509; GO:0005576; GO:0007179; GO:0030502; GO:0032331; GO:0036363; GO:0045780; GO:0046849; GO:0048251; GO:0050431; GO:0060349; GO:0060430; GO:0062023; GO:0070062; GO:1902462; GO:2000741	bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN39437_c0_g1_i1	A8XJZ8	LST2_CAEBR	48.4	62	30	1	8	187	551	612	2.60E-11	68.9	LST2_CAEBR	reviewed	Lateral signaling target protein 2	lst-2 CBG14460	Caenorhabditis briggsae	651	early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]	early endosome membrane [GO:0031901]	metal ion binding [GO:0046872]	GO:0031901; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4224_c0_g1_i1	A0JMD2	LST2_DANRE	51.9	79	38	0	528	764	882	960	4.50E-22	106.7	LST2_DANRE	reviewed	Lateral signaling target protein 2 homolog (Zinc finger FYVE domain-containing protein 28)	zfyve28 lst2 zgc:152894	Danio rerio (Zebrafish) (Brachydanio rerio)	969	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0005829; GO:0007175; GO:0031901; GO:0032266; GO:0042059; GO:0046872	negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]		NA	NA	NA	NA	NA	NA
TRINITY_DN8181_c0_g1_i2	B4GD14	LPHN_DROPE	33.8	450	170	8	1144	26	324	722	3.80E-60	233.8	LPHN_DROPE	reviewed	Latrophilin Cirl	Cirl GL10904	Drosophila persimilis (Fruit fly)	1684	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246	cell surface receptor signaling pathway [GO:0007166]		NA	NA	NA	NA	NA	NA
TRINITY_DN8181_c0_g2_i1	B4J780	LPHN_DROGR	55.6	63	26	2	2	184	92	154	4.10E-12	72.8	LPHN_DROGR	reviewed	Latrophilin Cirl	Cirl GH20083	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	1777	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0016021; GO:0030246	cell surface receptor signaling pathway [GO:0007166]		NA	NA	NA	NA	NA	NA
TRINITY_DN19724_c0_g1_i1	Q8T9B6	MESD_DROME	60	50	20	0	152	3	4	53	2.00E-08	59.3	MESD_DROME	reviewed	LDLR chaperone boca	boca CG30498	Drosophila melanogaster (Fruit fly)	180	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN19724_c1_g1_i1	Q8T9B6	MESD_DROME	64.7	51	18	0	40	192	50	100	9.20E-11	67	MESD_DROME	reviewed	LDLR chaperone boca	boca CG30498	Drosophila melanogaster (Fruit fly)	180	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN17701_c0_g1_i1	Q8T9B6	MESD_DROME	62.7	169	63	0	683	177	4	172	7.00E-54	212.2	MESD_DROME	reviewed	LDLR chaperone boca	boca CG30498	Drosophila melanogaster (Fruit fly)	180	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN29463_c0_g1_i1	Q8T9B6	MESD_DROME	63.1	65	24	0	197	3	84	148	2.50E-16	85.5	MESD_DROME	reviewed	LDLR chaperone boca	boca CG30498	Drosophila melanogaster (Fruit fly)	180	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0006612; GO:0006888; GO:0012505; GO:0016055; GO:0042802; GO:0045177	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein targeting to membrane [GO:0006612]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1196_c0_g1_i14	Q9R0J8	LGMN_RAT	38.2	296	172	5	1116	241	143	431	1.10E-49	198.7	LGMN_RAT	reviewed	"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)"	Lgmn Prsc1	Rattus norvegicus (Rat)	435	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]	GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0032801; GO:0035729; GO:0040015; GO:0043524; GO:0045177; GO:0045931; GO:0048471; GO:0051603; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028	activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]		NA	NA	NA	NA	NA	1
TRINITY_DN26907_c0_g1_i1	O89017	LGMN_MOUSE	99	105	1	0	315	1	172	276	4.50E-57	221.5	LGMN_MOUSE	reviewed	"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)"	Lgmn Prsc1	Mus musculus (Mouse)	435	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]	GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0032801; GO:0035729; GO:0040015; GO:0043524; GO:0045177; GO:0045931; GO:0048471; GO:0051603; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028	activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]		NA	NA	NA	NA	NA	NA
TRINITY_DN4219_c0_g1_i1	Q561T9	OBRG_DANRE	58.2	134	51	2	46	444	1	130	1.30E-37	157.5	OBRG_DANRE	reviewed	Leptin receptor gene-related protein (Endospanin-1) (OB-R gene-related protein) (OB-RGRP)	leprot lepr-grp zgc:112430	Danio rerio (Zebrafish) (Brachydanio rerio)	130	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	signaling receptor binding [GO:0005102]	GO:0000139; GO:0005102; GO:0005768; GO:0010008; GO:0016021; GO:0032511; GO:0046426; GO:0060400; GO:2000009	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]		NA	NA	NA	NA	NA	NA
TRINITY_DN32488_c0_g1_i1	O89013	OBRG_MOUSE	100	74	0	0	1	222	22	95	3.40E-35	148.3	OBRG_MOUSE	reviewed	Leptin receptor gene-related protein (Endospanin-1) (OB-R gene-related protein) (OB-RGRP)	Leprot Lepr Obr	Mus musculus (Mouse)	131	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	signaling receptor binding [GO:0005102]	GO:0000139; GO:0005102; GO:0005768; GO:0005794; GO:0010008; GO:0016021; GO:0032511; GO:0046426; GO:0060400; GO:2000009	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]		NA	NA	NA	NA	NA	NA
TRINITY_DN89_c0_g1_i2	Q24332	NT56_DROVI	50.2	464	156	4	1315	149	26	489	1.50E-115	417.9	NT56_DROVI	reviewed	Lethal(2)neighbour of Tid protein (NOT58)	l(2)not not	Drosophila virilis (Fruit fly)	526	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; multicellular organism development [GO:0007275]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005789; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]		brown	brown	NA	NA	NA	NA
TRINITY_DN89_c0_g1_i3	Q24332	NT56_DROVI	58.9	282	116	0	1439	594	26	307	1.60E-86	321.6	NT56_DROVI	reviewed	Lethal(2)neighbour of Tid protein (NOT58)	l(2)not not	Drosophila virilis (Fruit fly)	526	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; multicellular organism development [GO:0007275]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005789; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN89_c0_g1_i3	Q24332	NT56_DROVI	71.1	83	24	0	397	149	407	489	2.70E-30	134.8	NT56_DROVI	reviewed	Lethal(2)neighbour of Tid protein (NOT58)	l(2)not not	Drosophila virilis (Fruit fly)	526	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; multicellular organism development [GO:0007275]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005789; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN14523_c0_g1_i1	Q96JM7	LMBL3_HUMAN	53.2	109	47	2	322	2	266	372	3.70E-30	132.1	LMBL3_HUMAN	reviewed	Lethal(3)malignant brain tumor-like protein 3 (H-l(3)mbt-like protein 3) (L(3)mbt-like protein 3) (L3mbt-like 3) (MBT-1)	L3MBTL3 KIAA1798 MBT1	Homo sapiens (Human)	780	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008270; GO:0030225; GO:0030851; GO:0042393; GO:0042802; GO:0043249; GO:0045892	"chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2541_c0_g1_i1	Q3T0H0	LCMT1_BOVIN	46	309	163	2	92	1012	21	327	1.90E-78	294.3	LCMT1_BOVIN	reviewed	Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)	LCMT1	Bos taurus (Bovine)	332	cytosol [GO:0005829]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; C-terminal protein methylation [GO:0006481]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	cytosol [GO:0005829]	protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]	GO:0005829; GO:0006481; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266	C-terminal protein methylation [GO:0006481]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]		NA	NA	NA	NA	NA	NA
TRINITY_DN2541_c0_g1_i2	Q9UIC8	LCMT1_HUMAN	55.6	63	28	0	92	280	23	85	1.00E-13	78.2	LCMT1_HUMAN	reviewed	Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)	LCMT1 LCMT CGI-68	Homo sapiens (Human)	334	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266	cellular protein modification process [GO:0006464]; C-terminal protein methylation [GO:0006481]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]		NA	NA	NA	NA	NA	NA
TRINITY_DN40350_c0_g1_i1	Q9UIC8	LCMT1_HUMAN	100	71	0	0	1	213	156	226	4.80E-34	144.4	LCMT1_HUMAN	reviewed	Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)	LCMT1 LCMT CGI-68	Homo sapiens (Human)	334	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266	cellular protein modification process [GO:0006464]; C-terminal protein methylation [GO:0006481]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]		NA	NA	NA	NA	NA	NA
TRINITY_DN25778_c0_g1_i1	Q9UIC8	LCMT1_HUMAN	100	85	0	0	1	255	51	135	4.20E-45	181.4	LCMT1_HUMAN	reviewed	Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)	LCMT1 LCMT CGI-68	Homo sapiens (Human)	334	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266	cellular protein modification process [GO:0006464]; C-terminal protein methylation [GO:0006481]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]		NA	NA	NA	NA	NA	NA
TRINITY_DN11054_c0_g1_i1	Q8N5H3	LRA25_HUMAN	75.5	49	12	0	525	671	81	129	1.50E-12	75.1	LRA25_HUMAN	reviewed	Leucine repeat adapter protein 25	FAM89B Lrap25	Homo sapiens (Human)	189	cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; transcription corepressor binding [GO:0001222]; establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]	cytoplasm [GO:0005737]; lamellipodium [GO:0030027]	transcription corepressor binding [GO:0001222]	GO:0001222; GO:0005737; GO:0030010; GO:0030027; GO:0030335; GO:0030512; GO:0060392	establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]		NA	NA	NA	NA	NA	NA
TRINITY_DN32544_c0_g1_i1	Q9QUI1	LRA25_MOUSE	100	56	0	0	224	57	74	129	7.30E-25	114	LRA25_MOUSE	reviewed	Leucine repeat adapter protein 25 (C184L ORF2 protein) (C184M protein) (MMTV receptor)	Fam89b C184m Lrap25 Mtvr2	Mus musculus (Mouse)	189	cell surface [GO:0009986]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; transcription corepressor binding [GO:0001222]; establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]	transcription corepressor binding [GO:0001222]	GO:0001222; GO:0005737; GO:0009986; GO:0030010; GO:0030027; GO:0030335; GO:0030512; GO:0060392	establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]		NA	NA	NA	NA	NA	NA
TRINITY_DN4137_c0_g1_i1	Q28C74	LPPRC_XENTR	25.7	510	315	11	1453	65	744	1236	1.60E-35	152.1	LPPRC_XENTR	reviewed	"Leucine-rich PPR motif-containing protein, mitochondrial"	lrpprc TTpA007l07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1391	mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005634; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN13053_c0_g1_i1	Q960C5	LRCH_DROME	43.5	138	73	2	3	407	218	353	4.40E-20	99	LRCH_DROME	reviewed	Leucine-rich repeat and calponin homology domain-containing protein (dLRCH)	Lrch CG6860	Drosophila melanogaster (Fruit fly)	809	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]		GO:0005856; GO:0005938; GO:0032154			NA	NA	NA	NA	NA	NA
TRINITY_DN5257_c0_g1_i2	P62046	LRCH1_MOUSE	61.4	127	49	0	98	478	574	700	2.00E-36	154.1	LRCH1_MOUSE	reviewed	Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1)	Lrch1 Chdc1 Kiaa1016	Mus musculus (Mouse)	709	cytoplasm [GO:0005737]; cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405]	cytoplasm [GO:0005737]		GO:0005737; GO:0034260; GO:1990869; GO:2000405	cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405]		NA	NA	NA	NA	NA	NA
TRINITY_DN31983_c0_g1_i1	Q9Y2L9	LRCH1_HUMAN	98.8	81	1	0	244	2	565	645	1.40E-37	156.4	LRCH1_HUMAN	reviewed	Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81)	LRCH1 CHDC1 KIAA1016	Homo sapiens (Human)	728	cytoplasm [GO:0005737]; cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405]	cytoplasm [GO:0005737]		GO:0005737; GO:0034260; GO:1990869; GO:2000405	cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405]		NA	NA	NA	NA	NA	NA
TRINITY_DN5257_c0_g1_i3	P41737	LRCH1_FELCA	66.7	126	42	0	98	475	116	241	1.10E-41	171	LRCH1_FELCA	reviewed	Leucine-rich repeat and calponin homology domain-containing protein 1 (Neuronal protein) (Fragment)		Felis catus (Cat) (Felis silvestris catus)	251	cytoplasm [GO:0005737]; cellular response to chemokine [GO:1990869]; negative regulation of T cell migration [GO:2000405]	cytoplasm [GO:0005737]		GO:0005737; GO:1990869; GO:2000405	cellular response to chemokine [GO:1990869]; negative regulation of T cell migration [GO:2000405]		NA	NA	NA	NA	NA	NA
TRINITY_DN5257_c0_g1_i1	Q5VUJ6	LRCH2_HUMAN	70.4	98	29	0	53	346	656	753	4.40E-35	148.7	LRCH2_HUMAN	reviewed	Leucine-rich repeat and calponin homology domain-containing protein 2	LRCH2 KIAA1495	Homo sapiens (Human)	765							NA	NA	NA	NA	NA	NA
TRINITY_DN35008_c0_g1_i1	Q6PJG9	LRFN4_HUMAN	40.8	71	42	0	49	261	143	213	3.40E-05	48.9	LRFN4_HUMAN	reviewed	Leucine-rich repeat and fibronectin type-III domain-containing protein 4	LRFN4 SALM3	Homo sapiens (Human)	635	cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]	cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]		GO:0005886; GO:0009986; GO:0098978; GO:0098982; GO:0099061; GO:0099151; GO:0099560; GO:1905606	regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]		NA	NA	NA	NA	NA	NA
TRINITY_DN1108_c0_g1_i15	Q66HV9	LIG1B_DANRE	24.2	422	262	14	1476	253	28	405	7.90E-12	73.6	LIG1B_DANRE	reviewed	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1-B	lingo1b lingo1 si:ch211-116a8.1 zgc:92338	Danio rerio (Zebrafish) (Brachydanio rerio)	622	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; myelination [GO:0042552]; neuron development [GO:0048666]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]	GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012; GO:0042552; GO:0048666	myelination [GO:0042552]; neuron development [GO:0048666]		blue	blue	NA	NA	NA	NA
TRINITY_DN1108_c0_g1_i3	Q66HV9	LIG1B_DANRE	32.6	193	100	6	1086	523	28	195	3.40E-07	57.8	LIG1B_DANRE	reviewed	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1-B	lingo1b lingo1 si:ch211-116a8.1 zgc:92338	Danio rerio (Zebrafish) (Brachydanio rerio)	622	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; myelination [GO:0042552]; neuron development [GO:0048666]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]	GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012; GO:0042552; GO:0048666	myelination [GO:0042552]; neuron development [GO:0048666]		NA	NA	NA	NA	NA	NA
TRINITY_DN25695_c0_g1_i2	Q3URE9	LIGO2_MOUSE	28.6	332	230	7	221	1207	62	389	5.20E-21	104	LIGO2_MOUSE	reviewed	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C)	Lingo2 Lrrn6c	Mus musculus (Mouse)	606	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN25695_c0_g1_i3	Q3URE9	LIGO2_MOUSE	28.6	332	230	7	217	1203	62	389	5.20E-21	104	LIGO2_MOUSE	reviewed	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C)	Lingo2 Lrrn6c	Mus musculus (Mouse)	606	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN25695_c0_g1_i4	Q3URE9	LIGO2_MOUSE	28.6	332	230	7	206	1192	62	389	5.20E-21	104	LIGO2_MOUSE	reviewed	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C)	Lingo2 Lrrn6c	Mus musculus (Mouse)	606	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN24884_c0_g1_i1	Q8BGX3	LRTM2_MOUSE	43.8	89	46	1	581	847	58	142	6.10E-08	59.7	LRTM2_MOUSE	reviewed	Leucine-rich repeat and transmembrane domain-containing protein 2	Lrtm2	Mus musculus (Mouse)	370	integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965]	integral component of membrane [GO:0016021]	heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919; GO:0051965	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN12485_c0_g1_i1	Q9UFC0	LRWD1_HUMAN	32.1	399	227	16	2	1177	283	644	1.70E-43	178.3	LRWD1_HUMAN	reviewed	Leucine-rich repeat and WD repeat-containing protein 1 (Centromere protein 33) (CENP-33) (Origin recognition complex-associated protein) (ORC-associated protein) (ORCA)	LRWD1 CENP-33 ORCA	Homo sapiens (Human)	647	"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169]"	"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]	GO:0000776; GO:0000777; GO:0000781; GO:0003682; GO:0005634; GO:0005654; GO:0005664; GO:0005721; GO:0005730; GO:0005737; GO:0005815; GO:0006270; GO:0006325; GO:0008327; GO:0035064; GO:0043231; GO:0071169	chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169]		NA	NA	NA	NA	NA	NA
TRINITY_DN35660_c0_g1_i1	B2GUE2	LRRF2_XENTR	29.6	199	126	3	88	684	92	276	6.10E-14	79.3	LRRF2_XENTR	reviewed	Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2)	lrrfip2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	404	"LRR domain binding [GO:0030275]; dorsal/ventral axis specification [GO:0009950]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"		LRR domain binding [GO:0030275]	GO:0006355; GO:0009950; GO:0016055; GO:0030275	"dorsal/ventral axis specification [GO:0009950]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"		blue	blue	NA	NA	NA	NA
TRINITY_DN11011_c0_g1_i2	Q32Q07	LRRN1_RAT	30.7	371	222	11	1343	246	89	429	1.10E-31	139.4	LRRN1_RAT	reviewed	Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1) (NLRR-1)	Lrrn1	Rattus norvegicus (Rat)	716	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN25410_c0_g1_i1	Q5F4C4	SHOC2_CHICK	32	228	142	9	402	1076	122	339	1.60E-11	72.8	SHOC2_CHICK	reviewed	Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog)	SHOC2 RCJMB04_1b13	Gallus gallus (Chicken)	529	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]	protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]	GO:0000164; GO:0005634; GO:0005737; GO:0007165; GO:0008157; GO:0019903; GO:0046579	positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN35534_c0_g1_i1	A6QLV3	SHOC2_BOVIN	100	91	0	0	2	274	195	285	7.80E-45	180.6	SHOC2_BOVIN	reviewed	Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog)	SHOC2	Bos taurus (Bovine)	582	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]	protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]	GO:0000164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008157; GO:0019903; GO:0046579	positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33098_c0_g1_i1	O88520	SHOC2_MOUSE	100	97	0	0	374	84	486	582	2.60E-51	202.6	SHOC2_MOUSE	reviewed	Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog)	Shoc2	Mus musculus (Mouse)	582	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]	protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]	GO:0000164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008157; GO:0019903; GO:0046579	positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN20238_c0_g1_i1	B0W6M9	SUR8_CULQU	67.1	70	23	0	288	79	324	393	6.90E-20	97.8	SUR8_CULQU	reviewed	Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)	Sur-8 CPIJ002780	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	628							blue	blue	NA	NA	NA	NA
TRINITY_DN3799_c0_g1_i1	B0W6M9	SUR8_CULQU	68.4	512	161	1	185	1717	117	628	1.10E-200	701	SUR8_CULQU	reviewed	Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)	Sur-8 CPIJ002780	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	628							blue	blue	NA	NA	NA	NA
TRINITY_DN1361_c0_g1_i13	B0W6M9	SUR8_CULQU	32.3	220	114	6	59	634	182	394	6.80E-16	85.9	SUR8_CULQU	reviewed	Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)	Sur-8 CPIJ002780	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	628							NA	NA	NA	NA	NA	NA
TRINITY_DN1361_c0_g1_i6	B0W6M9	SUR8_CULQU	31	232	128	5	37	648	167	394	3.70E-17	90.1	SUR8_CULQU	reviewed	Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)	Sur-8 CPIJ002780	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	628							NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i1	Q9TZM3	LRK1_CAEEL	30.4	1721	918	43	5271	310	84	1591	2.40E-190	668.3	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i10	Q9TZM3	LRK1_CAEEL	30.3	175	84	3	834	310	1455	1591	2.20E-14	81.3	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i11	Q9TZM3	LRK1_CAEEL	28.3	480	258	14	1510	119	463	872	6.60E-37	156.8	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i2	Q9TZM3	LRK1_CAEEL	57.1	105	41	2	353	48	1040	1143	3.20E-28	125.9	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i3	Q9TZM3	LRK1_CAEEL	31.2	1418	768	36	4239	187	84	1360	1.60E-163	578.9	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i5	Q9TZM3	LRK1_CAEEL	30.4	1721	918	43	5187	226	84	1591	2.40E-190	668.3	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN10283_c0_g1_i3	Q9TZM3	LRK1_CAEEL	36.3	782	382	21	2278	74	1679	2391	2.70E-122	441	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN10283_c0_g1_i4	Q9TZM3	LRK1_CAEEL	41.5	236	134	2	768	70	1605	1839	1.60E-48	194.5	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN10283_c0_g1_i6	Q9TZM3	LRK1_CAEEL	55.8	330	142	3	1151	165	1679	2005	6.60E-104	379	LRK1_CAEEL	reviewed	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	lrk-1 T27C10.6	Caenorhabditis elegans	2393	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN11011_c0_g1_i1	Q86VH5	LRRT3_HUMAN	31	184	103	6	653	111	34	196	2.90E-07	57.4	LRRT3_HUMAN	reviewed	Leucine-rich repeat transmembrane neuronal protein 3	LRRTM3 UNQ803/PRO1693	Homo sapiens (Human)	581	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]		GO:0005615; GO:0016021; GO:0031012; GO:0045211; GO:0051965; GO:0098978; GO:0099054; GO:1902004	positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]		NA	NA	NA	NA	NA	NA
TRINITY_DN11011_c0_g1_i3	Q86VH5	LRRT3_HUMAN	31	184	103	6	570	28	34	196	3.10E-07	57	LRRT3_HUMAN	reviewed	Leucine-rich repeat transmembrane neuronal protein 3	LRRTM3 UNQ803/PRO1693	Homo sapiens (Human)	581	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]		GO:0005615; GO:0016021; GO:0031012; GO:0045211; GO:0051965; GO:0098978; GO:0099054; GO:1902004	positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]		NA	NA	NA	NA	NA	NA
TRINITY_DN6821_c0_g1_i1	Q86VH4	LRRT4_HUMAN	26.2	237	142	4	837	205	90	319	7.00E-12	73.2	LRRT4_HUMAN	reviewed	Leucine-rich repeat transmembrane neuronal protein 4	LRRTM4 UNQ3075/PRO9907	Homo sapiens (Human)	590	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]		GO:0005615; GO:0016021; GO:0031012; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN6821_c0_g1_i2	Q80XG9	LRRT4_MOUSE	31	158	102	4	714	253	90	244	2.40E-08	61.2	LRRT4_MOUSE	reviewed	Leucine-rich repeat transmembrane neuronal protein 4	Lrrtm4	Mus musculus (Mouse)	590	AMPA glutamate receptor complex [GO:0032281]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; heparan sulfate proteoglycan binding [GO:0043395]; AMPA glutamate receptor clustering [GO:0097113]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynaptic membrane organization [GO:1901629]; synapse organization [GO:0050808]	AMPA glutamate receptor complex [GO:0032281]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]	heparan sulfate proteoglycan binding [GO:0043395]	GO:0005615; GO:0016021; GO:0031012; GO:0032281; GO:0043395; GO:0045211; GO:0050808; GO:0051965; GO:0072578; GO:0097113; GO:0098978; GO:0099061; GO:1901629	AMPA glutamate receptor clustering [GO:0097113]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynaptic membrane organization [GO:1901629]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN39763_c0_g1_i1	Q8TF66	LRC15_HUMAN	36.8	117	73	1	354	7	269	385	1.30E-09	64.7	LRC15_HUMAN	reviewed	Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib)	LRRC15 LIB	Homo sapiens (Human)	581	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]	GO:0001968; GO:0005518; GO:0005615; GO:0016021; GO:0030335; GO:0031012; GO:0043236; GO:0046813; GO:0070062; GO:1903077	negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]		NA	NA	NA	NA	NA	NA
TRINITY_DN21639_c0_g1_i2	Q50LG9	LRC24_HUMAN	28	168	112	4	473	967	54	215	3.10E-07	57.8	LRC24_HUMAN	reviewed	Leucine-rich repeat-containing protein 24	LRRC24	Homo sapiens (Human)	513	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN9603_c2_g1_i2	Q9HBW1	LRRC4_HUMAN	29.3	259	157	3	999	1772	75	308	5.20E-21	104.8	LRRC4_HUMAN	reviewed	Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2)	LRRC4 BAG NAG14 UNQ554/PRO1111	Homo sapiens (Human)	653	dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]	dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]		GO:0043197; GO:0050804; GO:0060076; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861	excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]		NA	NA	NA	NA	NA	NA
TRINITY_DN9603_c2_g1_i3	Q9HBW1	LRRC4_HUMAN	29.3	259	157	3	999	1772	75	308	5.80E-21	104.8	LRRC4_HUMAN	reviewed	Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2)	LRRC4 BAG NAG14 UNQ554/PRO1111	Homo sapiens (Human)	653	dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]	dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]		GO:0043197; GO:0050804; GO:0060076; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861	excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]		NA	NA	NA	NA	NA	NA
TRINITY_DN24045_c0_g1_i1	Q8CIM1	LRC45_MOUSE	43.6	179	95	2	600	76	1	177	7.90E-32	138.7	LRC45_MOUSE	reviewed	Leucine-rich repeat-containing protein 45	Lrrc45	Mus musculus (Mouse)	670	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005813; GO:0005829; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN24045_c0_g1_i2	Q5ZI11	LRC45_CHICK	32.7	428	278	2	1357	92	1	424	6.70E-52	206.5	LRC45_CHICK	reviewed	Leucine-rich repeat-containing protein 45	LRRC45 RCJMB04_31i7	Gallus gallus (Chicken)	670	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]		GO:0005737; GO:0005815			NA	NA	NA	NA	NA	NA
TRINITY_DN24045_c0_g1_i3	Q8CIM1	LRC45_MOUSE	36.5	337	208	2	1180	182	1	335	6.50E-51	203	LRC45_MOUSE	reviewed	Leucine-rich repeat-containing protein 45	Lrrc45	Mus musculus (Mouse)	670	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005813; GO:0005829; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN25380_c0_g1_i1	Q505F5	LRC47_MOUSE	31	113	47	2	351	100	470	580	2.40E-05	50.1	LRC47_MOUSE	reviewed	Leucine-rich repeat-containing protein 47	Lrrc47 Kiaa1185	Mus musculus (Mouse)	581	phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]		phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0003723; GO:0004826			blue	blue	NA	NA	NA	NA
TRINITY_DN25380_c0_g1_i2	Q505F5	LRC47_MOUSE	38.3	582	288	15	1662	100	9	580	3.50E-82	307.4	LRC47_MOUSE	reviewed	Leucine-rich repeat-containing protein 47	Lrrc47 Kiaa1185	Mus musculus (Mouse)	581	phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]		phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0003723; GO:0004826			blue	blue	NA	NA	NA	NA
TRINITY_DN6067_c0_g1_i1	Q5FVI3	LRC57_RAT	52.8	235	109	2	78	776	3	237	7.80E-59	228.8	LRC57_RAT	reviewed	Leucine-rich repeat-containing protein 57	Lrrc57	Rattus norvegicus (Rat)	239	membrane [GO:0016020]	membrane [GO:0016020]		GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN1361_c0_g1_i7	Q9D1G5	LRC57_MOUSE	27.5	167	119	2	550	1044	39	205	7.90E-08	59.7	LRC57_MOUSE	reviewed	Leucine-rich repeat-containing protein 57	Lrrc57	Mus musculus (Mouse)	239	membrane [GO:0016020]	membrane [GO:0016020]		GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN6815_c0_g1_i1	Q32NT4	LRC58_XENLA	46.2	320	166	3	360	1319	37	350	2.50E-70	267.7	LRC58_XENLA	reviewed	Leucine-rich repeat-containing protein 58	lrrc58	Xenopus laevis (African clawed frog)	350							blue	blue	NA	NA	NA	NA
TRINITY_DN6815_c0_g1_i2	Q32NT4	LRC58_XENLA	52.2	205	93	2	94	708	151	350	2.80E-50	200.3	LRC58_XENLA	reviewed	Leucine-rich repeat-containing protein 58	lrrc58	Xenopus laevis (African clawed frog)	350							NA	NA	NA	NA	NA	NA
TRINITY_DN34087_c0_g1_i1	Q3UGP9	LRC58_MOUSE	100	91	0	0	2	274	241	331	9.60E-51	200.3	LRC58_MOUSE	reviewed	Leucine-rich repeat-containing protein 58	Lrrc58	Mus musculus (Mouse)	366							NA	NA	NA	NA	NA	NA
TRINITY_DN5634_c0_g1_i1	Q5E9X4	LRC59_BOVIN	53.8	143	65	1	1440	1012	11	152	5.50E-39	163.7	LRC59_BOVIN	reviewed	"Leucine-rich repeat-containing protein 59 [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]"	LRRC59	Bos taurus (Bovine)	306	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005789; GO:0016021; GO:0042645			blue	blue	NA	NA	NA	NA
TRINITY_DN27957_c0_g1_i1	Q922Q8	LRC59_MOUSE	100	117	0	0	354	4	39	155	1.80E-62	239.6	LRC59_MOUSE	reviewed	"Leucine-rich repeat-containing protein 59 [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]"	Lrrc59	Mus musculus (Mouse)	307	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005783; GO:0005789; GO:0016021; GO:0042645			NA	NA	NA	NA	NA	NA
TRINITY_DN39008_c0_g1_i1	Q80TE7	LRRC7_MOUSE	54.9	175	79	0	531	7	104	278	2.10E-53	210.3	LRRC7_MOUSE	reviewed	Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1)	Lrrc7 Kiaa1365 Lap1	Mus musculus (Mouse)	1490	axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]	axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	protein C-terminus binding [GO:0008022]	GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0008022; GO:0010976; GO:0014069; GO:0016323; GO:0030054; GO:0030175; GO:0043005; GO:0043113; GO:0043194; GO:0043197; GO:0045197; GO:0045202; GO:0097120; GO:0098609; GO:0098978; GO:0099061	cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]		NA	NA	NA	NA	NA	NA
TRINITY_DN4228_c0_g1_i3	P70193	LRIG1_MOUSE	36.4	121	68	5	779	426	670	784	1.50E-09	65.1	LRIG1_MOUSE	reviewed	Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1)	Lrig1	Mus musculus (Mouse)	1091	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005615; GO:0005886; GO:0007605; GO:0016021; GO:0022405; GO:0031012; GO:0032474; GO:0060384	hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN9976_c0_g1_i1	O94898	LRIG2_HUMAN	32.4	244	147	6	706	2	47	281	3.30E-23	110.2	LRIG2_HUMAN	reviewed	Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2)	LRIG2 KIAA0806 LIG2	Homo sapiens (Human)	1065	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0031012; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222	innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN10713_c0_g1_i2	Q6P1C6	LRIG3_MOUSE	41.2	469	269	5	1431	28	270	732	1.60E-93	344.7	LRIG3_MOUSE	reviewed	Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)	Lrig3 Kiaa3016	Mus musculus (Mouse)	1117	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0030659; GO:0032474	otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN10713_c0_g1_i3	Q6P1C6	LRIG3_MOUSE	42.2	374	210	4	1149	28	365	732	1.00E-77	292	LRIG3_MOUSE	reviewed	Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)	Lrig3 Kiaa3016	Mus musculus (Mouse)	1117	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0030659; GO:0032474	otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN32662_c0_g1_i1	Q6UXM1	LRIG3_HUMAN	36	89	53	1	29	283	330	418	8.10E-06	51.2	LRIG3_HUMAN	reviewed	Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)	LRIG3 LIG3 UNQ287/PRO326/PRO335	Homo sapiens (Human)	1119	cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]	cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005615; GO:0005886; GO:0016021; GO:0030659; GO:0031012; GO:0032474	otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN37964_c0_g1_i1	Q47MY0	SYL_THEFY	67.1	70	23	0	214	5	404	473	6.90E-25	114	SYL_THEFY	reviewed	Leucine--tRNA ligase (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)	leuS Tfu_2156	Thermobifida fusca (strain YX)	830	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN38941_c0_g1_i1	A1SHV9	SYL_NOCSJ	71	69	18	1	3	209	496	562	4.50E-24	111.3	SYL_NOCSJ	reviewed	Leucine--tRNA ligase (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)	leuS Noca_1884	Nocardioides sp. (strain ATCC BAA-499 / JS614)	848	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN2280_c0_g2_i1	B2UCA1	SYL_RALPJ	100	103	0	0	2	310	420	522	1.10E-60	233.4	SYL_RALPJ	reviewed	Leucine--tRNA ligase (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)	leuS Rpic_2983	Ralstonia pickettii (strain 12J)	877	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN2280_c0_g3_i1	Q2G3C3	SYL_NOVAD	88.2	76	9	0	5	232	401	476	3.80E-37	154.8	SYL_NOVAD	reviewed	Leucine--tRNA ligase (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)	leuS Saro_3215	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	848	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN2280_c0_g1_i1	A5VA89	SYL_SPHWW	83.6	73	12	0	1	219	404	476	3.20E-33	141.7	SYL_SPHWW	reviewed	Leucine--tRNA ligase (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)	leuS Swit_2852	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	835	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN17111_c0_g1_i1	Q9P2J5	SYLC_HUMAN	98.6	74	1	0	224	3	25	98	5.20E-39	161	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN17111_c0_g1_i2	Q9P2J5	SYLC_HUMAN	100	96	0	0	353	66	25	120	1.10E-54	213.8	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN27633_c0_g1_i1	Q9P2J5	SYLC_HUMAN	98	150	3	0	20	469	146	295	1.40E-83	310.1	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN32389_c0_g1_i1	Q9P2J5	SYLC_HUMAN	54.9	91	41	0	293	21	686	776	6.90E-23	107.8	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN3486_c0_g1_i1	Q8BMJ2	SYLC_MOUSE	55.6	1173	503	10	95	3574	9	1176	0	1340.5	SYLC_MOUSE	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	Lars1 Lars	Mus musculus (Mouse)	1178	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN31183_c0_g1_i1	Q8BMJ2	SYLC_MOUSE	100	95	0	0	287	3	95	189	9.00E-44	177.2	SYLC_MOUSE	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	Lars1 Lars	Mus musculus (Mouse)	1178	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN27483_c0_g1_i1	Q8BMJ2	SYLC_MOUSE	40.7	54	31	1	34	195	836	888	9.40E-07	53.9	SYLC_MOUSE	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	Lars1 Lars	Mus musculus (Mouse)	1178	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN39811_c0_g1_i1	Q9P2J5	SYLC_HUMAN	99.2	127	1	0	383	3	716	842	2.90E-66	252.3	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN37235_c0_g1_i1	Q9P2J5	SYLC_HUMAN	100	124	0	0	1	372	368	491	9.10E-65	247.3	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN18382_c0_g1_i1	F4I116	SYLC_ARATH	56.6	122	53	0	3	368	221	342	1.60E-35	150.2	SYLC_ARATH	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	At1g09620	Arabidopsis thaliana (Mouse-ear cress)	1091	chloroplast [GO:0009507]; cytosol [GO:0005829]; plasmodesma [GO:0009506]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	chloroplast [GO:0009507]; cytosol [GO:0005829]; plasmodesma [GO:0009506]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005829; GO:0006429; GO:0009506; GO:0009507	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN25834_c0_g1_i1	Q9P2J5	SYLC_HUMAN	89.7	107	7	1	323	3	539	641	1.90E-53	209.5	SYLC_HUMAN	reviewed	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	1176	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN36952_c0_g1_i1	Q8N653	LZTR1_HUMAN	100	90	0	0	1	270	238	327	5.40E-51	201.1	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3003_c0_g1_i11	Q8N653	LZTR1_HUMAN	80.2	182	36	0	832	287	26	207	5.10E-88	325.9	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3003_c0_g1_i13	Q8N653	LZTR1_HUMAN	59	839	257	9	2437	104	26	838	2.80E-290	999.2	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3003_c0_g1_i14	Q8N653	LZTR1_HUMAN	57.6	721	238	7	2083	104	125	838	7.80E-241	834.7	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3003_c0_g1_i5	Q8N653	LZTR1_HUMAN	57.6	721	245	6	2104	104	125	838	2.00E-241	836.6	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3003_c0_g1_i9	Q8N653	LZTR1_HUMAN	60.4	820	257	7	2380	104	26	838	9.10E-294	1010.7	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN28538_c0_g1_i1	Q9CQ33	LZTR1_MOUSE	100	76	0	0	2	229	394	469	1.10E-41	169.9	LZTR1_MOUSE	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	Lztr1 Tcfl2	Mus musculus (Mouse)	837	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN27822_c0_g1_i1	Q8N653	LZTR1_HUMAN	100	116	0	0	351	4	11	126	1.60E-66	253.1	LZTR1_HUMAN	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	LZTR1 TCFL2	Homo sapiens (Human)	840	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]	Ras GTPase binding [GO:0017016]	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN32333_c0_g1_i1	Q9UIQ6	LCAP_HUMAN	99.1	112	1	0	3	338	382	493	2.10E-60	232.6	LCAP_HUMAN	reviewed	"Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form]"	LNPEP OTASE	Homo sapiens (Human)	1025	"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]"	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002480; GO:0004177; GO:0005576; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0007565; GO:0008217; GO:0008237; GO:0008270; GO:0016020; GO:0030163; GO:0030659; GO:0031905; GO:0042277; GO:0043171; GO:0048471; GO:0060395; GO:0070006; GO:0120163	"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29731_c0_g1_i1	Q1JPB0	ILEU_BOVIN	33.6	372	231	9	1184	102	11	377	2.10E-45	184.9	ILEU_BOVIN	reviewed	Leukocyte elastase inhibitor (LEI) (Serpin B1)	SERPINB1	Bos taurus (Bovine)	377	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0005737; GO:0010951	negative regulation of endopeptidase activity [GO:0010951]		blue	blue	NA	NA	NA	NA
TRINITY_DN6756_c0_g1_i2	Q4G075	ILEUA_RAT	58.4	77	31	1	21	251	288	363	3.40E-18	92	ILEUA_RAT	reviewed	Leukocyte elastase inhibitor A (Serine protease inhibitor EIA) (Serpin B1a)	Serpinb1a	Rattus norvegicus (Rat)	379	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867]; cellular homeostasis [GO:0019725]; inflammatory response [GO:0006954]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; regulation of innate immune response [GO:0045088]; regulation of protein catabolic process [GO:0042176]; type B pancreatic cell proliferation [GO:0044342]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0010951; GO:0019725; GO:0030414; GO:0032691; GO:0042176; GO:0044342; GO:0045088	cellular homeostasis [GO:0019725]; inflammatory response [GO:0006954]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; regulation of innate immune response [GO:0045088]; regulation of protein catabolic process [GO:0042176]; type B pancreatic cell proliferation [GO:0044342]		NA	NA	NA	NA	NA	NA
TRINITY_DN18061_c0_g1_i1	Q96BZ8	LENG1_HUMAN	37.9	206	86	5	798	190	1	167	3.00E-21	104	LENG1_HUMAN	reviewed	Leukocyte receptor cluster member 1	LENG1	Homo sapiens (Human)	264							NA	NA	NA	NA	NA	NA
TRINITY_DN18061_c0_g1_i2	Q96BZ8	LENG1_HUMAN	37.9	206	86	5	798	190	1	167	3.00E-21	104	LENG1_HUMAN	reviewed	Leukocyte receptor cluster member 1	LENG1	Homo sapiens (Human)	264							NA	NA	NA	NA	NA	NA
TRINITY_DN7823_c0_g1_i1	Q32NW2	LENG8_XENLA	51.2	336	145	4	173	1162	476	798	9.90E-84	312	LENG8_XENLA	reviewed	Leukocyte receptor cluster member 8 homolog	leng8	Xenopus laevis (African clawed frog)	800							NA	NA	NA	NA	NA	NA
TRINITY_DN7823_c0_g1_i3	Q32NW2	LENG8_XENLA	52.3	285	118	3	173	1009	476	748	3.40E-72	273.5	LENG8_XENLA	reviewed	Leukocyte receptor cluster member 8 homolog	leng8	Xenopus laevis (African clawed frog)	800							NA	NA	NA	NA	NA	NA
TRINITY_DN6839_c0_g1_i1	Q8BTN6	LENG9_MOUSE	44.4	162	73	4	1301	828	9	157	3.00E-31	137.9	LENG9_MOUSE	reviewed	Leukocyte receptor cluster member 9	Leng9	Mus musculus (Mouse)	485	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN35693_c0_g1_i1	Q3T181	LT4R1_BOVIN	27.7	141	94	2	2	424	20	152	5.00E-05	49.3	LT4R1_BOVIN	reviewed	Leukotriene B4 receptor 1 (LTB4-R 1) (LTB4-R1)	LTB4R	Bos taurus (Bovine)	349	integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; inflammatory response [GO:0006954]; neuropeptide signaling pathway [GO:0007218]	integral component of plasma membrane [GO:0005887]	G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]	GO:0001632; GO:0005887; GO:0006954; GO:0007218; GO:0008528	inflammatory response [GO:0006954]; neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN35644_c0_g1_i1	O60711	LPXN_HUMAN	100	256	0	0	769	2	131	386	3.40E-167	588.6	LPXN_HUMAN	reviewed	Leupaxin	LPXN LDLP	Homo sapiens (Human)	386	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]	metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0002102; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007162; GO:0007165; GO:0007179; GO:0016020; GO:0016607; GO:0033628; GO:0034446; GO:0042995; GO:0043542; GO:0046872; GO:0048471; GO:0050859; GO:0065003	cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN7957_c0_g1_i2	Q8N0W3	FCSK_HUMAN	33.6	107	60	1	17	337	2	97	9.30E-10	65.1	FCSK_HUMAN	reviewed	L-fucose kinase (Fucokinase) (EC 2.7.1.52)	FCSK FUK	Homo sapiens (Human)	1084	cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	cytosol [GO:0005829]	ATP binding [GO:0005524]; fucokinase activity [GO:0050201]	GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350	carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]		NA	NA	NA	NA	NA	NA
TRINITY_DN7957_c0_g1_i3	Q8N0W3	FCSK_HUMAN	27.5	527	323	15	17	1540	2	488	2.20E-35	151.8	FCSK_HUMAN	reviewed	L-fucose kinase (Fucokinase) (EC 2.7.1.52)	FCSK FUK	Homo sapiens (Human)	1084	cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	cytosol [GO:0005829]	ATP binding [GO:0005524]; fucokinase activity [GO:0050201]	GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350	carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]		NA	NA	NA	NA	NA	NA
TRINITY_DN8849_c0_g1_i2	Q8N0W3	FCSK_HUMAN	49.5	200	100	1	54	653	822	1020	3.90E-47	189.5	FCSK_HUMAN	reviewed	L-fucose kinase (Fucokinase) (EC 2.7.1.52)	FCSK FUK	Homo sapiens (Human)	1084	cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	cytosol [GO:0005829]	ATP binding [GO:0005524]; fucokinase activity [GO:0050201]	GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350	carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]		NA	NA	NA	NA	NA	NA
TRINITY_DN8849_c0_g1_i4	Q8N0W3	FCSK_HUMAN	47.1	87	46	0	43	303	934	1020	2.20E-16	86.3	FCSK_HUMAN	reviewed	L-fucose kinase (Fucokinase) (EC 2.7.1.52)	FCSK FUK	Homo sapiens (Human)	1084	cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	cytosol [GO:0005829]	ATP binding [GO:0005524]; fucokinase activity [GO:0050201]	GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350	carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]		NA	NA	NA	NA	NA	NA
TRINITY_DN8849_c0_g1_i5	Q8N0W3	FCSK_HUMAN	41.4	519	287	8	1	1542	514	1020	1.50E-97	358.2	FCSK_HUMAN	reviewed	L-fucose kinase (Fucokinase) (EC 2.7.1.52)	FCSK FUK	Homo sapiens (Human)	1084	cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	cytosol [GO:0005829]	ATP binding [GO:0005524]; fucokinase activity [GO:0050201]	GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350	carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]		NA	NA	NA	NA	NA	NA
TRINITY_DN38053_c0_g1_i1	Q9HDV4	LID2_SCHPO	59.6	47	19	0	203	63	270	316	1.50E-12	73.2	LID2_SCHPO	reviewed	Lid2 complex component lid2 (Lid2C component lid2)	lid2 SPBP19A11.06 SPBP4H10.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1513	histone methyltransferase complex [GO:0035097]; Lid2 complex [GO:0048189]; mating-type region heterochromatin [GO:0031934]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of extent of heterochromatin assembly [GO:0033696]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]	histone methyltransferase complex [GO:0035097]; Lid2 complex [GO:0048189]; mating-type region heterochromatin [GO:0031934]; nuclear pericentric heterochromatin [GO:0031618]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0005634; GO:0006338; GO:0031048; GO:0031618; GO:0031934; GO:0032452; GO:0033696; GO:0034647; GO:0035097; GO:0046872; GO:0048189; GO:0070647; GO:1904499	chromatin remodeling [GO:0006338]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of extent of heterochromatin assembly [GO:0033696]; protein modification by small protein conjugation or removal [GO:0070647]; regulation of chromatin-mediated maintenance of transcription [GO:1904499]		NA	NA	NA	NA	NA	NA
TRINITY_DN11568_c0_g1_i1	Q91XL2	LNX2_MOUSE	39.5	385	173	9	183	1193	47	419	1.00E-63	245.7	LNX2_MOUSE	reviewed	Ligand of Numb protein X 2 (Numb-binding protein 2)	Lnx2	Mus musculus (Mouse)	687	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]		identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]	GO:0030165; GO:0042802; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13359_c0_g2_i1	Q99JW4	LIMS1_MOUSE	100	185	0	0	2	556	130	314	2.00E-116	419.5	LIMS1_MOUSE	reviewed	LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1)	Lims1 Pinch1	Mus musculus (Mouse)	325	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; chordate embryonic development [GO:0043009]; establishment of protein localization [GO:0045184]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005886; GO:0005911; GO:0005925; GO:0007160; GO:0007163; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0032991; GO:0033209; GO:0043009; GO:0043066; GO:0043547; GO:0044877; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0050680; GO:0051894; GO:0098609; GO:1900026; GO:1901224; GO:2000178; GO:2000346; GO:2001046	"cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; chordate embryonic development [GO:0043009]; establishment of protein localization [GO:0045184]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20551_c0_g1_i1	P48059	LIMS1_HUMAN	100	131	0	0	393	1	8	138	8.70E-82	303.9	LIMS1_HUMAN	reviewed	LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48)	LIMS1 PINCH PINCH1	Homo sapiens (Human)	325	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046	"cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell junction assembly [GO:0034329]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20551_c0_g2_i1	P48059	LIMS1_HUMAN	100	111	0	0	333	1	8	118	4.60E-68	258.1	LIMS1_HUMAN	reviewed	LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48)	LIMS1 PINCH PINCH1	Homo sapiens (Human)	325	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046	"cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell junction assembly [GO:0034329]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2365_c0_g1_i1	P48059	LIMS1_HUMAN	70.4	324	86	1	1011	40	4	317	1.00E-148	527.7	LIMS1_HUMAN	reviewed	LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48)	LIMS1 PINCH PINCH1	Homo sapiens (Human)	325	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046	"cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell junction assembly [GO:0034329]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13359_c0_g1_i1	P48059	LIMS1_HUMAN	100	155	0	0	1	465	135	289	1.00E-97	357.1	LIMS1_HUMAN	reviewed	LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48)	LIMS1 PINCH PINCH1	Homo sapiens (Human)	325	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046	"cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell junction assembly [GO:0034329]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2880_c0_g1_i1	Q8IR79	LIMK1_DROME	52.2	500	186	10	1667	312	229	723	2.60E-133	477.2	LIMK1_DROME	reviewed	LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (dLIMK)	LIMK1 LIMK CG1848	Drosophila melanogaster (Fruit fly)	1257	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007560; GO:0030036; GO:0030496; GO:0032154; GO:0046872	actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN2880_c0_g1_i3	Q8IR79	LIMK1_DROME	45.7	223	90	7	623	36	229	447	6.90E-37	155.6	LIMK1_DROME	reviewed	LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (dLIMK)	LIMK1 LIMK CG1848	Drosophila melanogaster (Fruit fly)	1257	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007560; GO:0030036; GO:0030496; GO:0032154; GO:0046872	actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN2213_c0_g1_i1	Q8IR79	LIMK1_DROME	63.4	82	24	3	271	44	97	178	6.10E-23	108.2	LIMK1_DROME	reviewed	LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (dLIMK)	LIMK1 LIMK CG1848	Drosophila melanogaster (Fruit fly)	1257	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007560; GO:0030036; GO:0030496; GO:0032154; GO:0046872	actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN2213_c0_g1_i2	Q8IR79	LIMK1_DROME	58.6	111	43	1	414	91	33	143	1.20E-38	161	LIMK1_DROME	reviewed	LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (dLIMK)	LIMK1 LIMK CG1848	Drosophila melanogaster (Fruit fly)	1257	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007560; GO:0030036; GO:0030496; GO:0032154; GO:0046872	actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN2213_c0_g1_i3	Q8IR79	LIMK1_DROME	74.5	47	10	1	225	91	97	143	2.30E-15	82.8	LIMK1_DROME	reviewed	LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (dLIMK)	LIMK1 LIMK CG1848	Drosophila melanogaster (Fruit fly)	1257	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007560; GO:0030036; GO:0030496; GO:0032154; GO:0046872	actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN2213_c0_g1_i4	Q8IR79	LIMK1_DROME	56.2	146	57	3	460	44	33	178	2.90E-46	186.4	LIMK1_DROME	reviewed	LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (dLIMK)	LIMK1 LIMK CG1848	Drosophila melanogaster (Fruit fly)	1257	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007560; GO:0030036; GO:0030496; GO:0032154; GO:0046872	actin cytoskeleton organization [GO:0030036]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN4705_c0_g1_i2	Q8WWI1	LMO7_HUMAN	62.7	51	19	0	50	202	1622	1672	1.20E-14	80.5	LMO7_HUMAN	reviewed	LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP)	LMO7 FBX20 FBXO20 KIAA0858	Homo sapiens (Human)	1683	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0043687; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]		NA	NA	NA	NA	NA	NA
TRINITY_DN4705_c0_g1_i3	Q8WWI1	LMO7_HUMAN	62.1	66	25	0	413	610	1607	1672	1.70E-19	97.8	LMO7_HUMAN	reviewed	LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP)	LMO7 FBX20 FBXO20 KIAA0858	Homo sapiens (Human)	1683	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0043687; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]		NA	NA	NA	NA	NA	NA
TRINITY_DN35455_c0_g1_i1	Q6NVL6	LDB1_XENTR	100	62	0	0	187	2	296	357	2.60E-29	129	LDB1_XENTR	reviewed	LIM domain-binding protein 1 (LDB-1)	ldb1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	373	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0001102; GO:0003712; GO:0005634; GO:0005667; GO:0007399; GO:0030274; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38898_c0_g1_i1	O42252	LDB1_CHICK	100	97	0	0	293	3	45	141	6.00E-56	217.6	LDB1_CHICK	reviewed	LIM domain-binding protein 1 (LDB-1) (Carboxyl-terminal LIM domain-binding protein 2) (CLIM-2) (LIM domain-binding factor CLIM2) (cLdb1) (Neural Src-interacting protein) (Nuclear LIM interactor)	LDB1 CLIM2 NSIP	Gallus gallus (Chicken)	411	"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; anterior/posterior axis specification [GO:0009948]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Wnt signaling pathway [GO:0016055]"	nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0001102; GO:0003712; GO:0005634; GO:0005667; GO:0007399; GO:0009948; GO:0016055; GO:0030182; GO:0030274; GO:0032991; GO:0042803; GO:0045647; GO:0045892; GO:0045944	"anterior/posterior axis specification [GO:0009948]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17931_c0_g1_i1	Q86U70	LDB1_HUMAN	100	136	0	0	410	3	102	237	3.00E-77	288.9	LDB1_HUMAN	reviewed	LIM domain-binding protein 1 (LDB-1) (Carboxyl-terminal LIM domain-binding protein 2) (CLIM-2) (LIM domain-binding factor CLIM2) (hLdb1) (Nuclear LIM interactor)	LDB1 CLIM2	Homo sapiens (Human)	411	"beta-catenin-TCF complex [GO:1990907]; cell leading edge [GO:0031252]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; histone H3-K4 acetylation [GO:0043973]; multicellular organism development [GO:0007275]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of kinase activity [GO:0043549]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; regulation of transcription, DNA-templated [GO:0006355]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]"	beta-catenin-TCF complex [GO:1990907]; cell leading edge [GO:0031252]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0000790; GO:0000972; GO:0001102; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0007275; GO:0007399; GO:0019899; GO:0030182; GO:0030274; GO:0030334; GO:0031252; GO:0032991; GO:0034243; GO:0042803; GO:0043549; GO:0043973; GO:0045647; GO:0045892; GO:0045944; GO:0046985; GO:0051893; GO:0140297; GO:1902036; GO:1990907	"histone H3-K4 acetylation [GO:0043973]; multicellular organism development [GO:0007275]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of kinase activity [GO:0043549]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2823_c0_g1_i1	Q9W676	LDB2_CHICK	82.2	230	40	1	950	264	17	246	1.50E-114	414.1	LDB2_CHICK	reviewed	LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1) (cLdb2)	LDB2 CLIM1	Gallus gallus (Chicken)	371	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0001102; GO:0003712; GO:0005634; GO:0005667; GO:0007399; GO:0030274; GO:0045892; GO:0045944	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2823_c0_g1_i3	Q9W676	LDB2_CHICK	82.2	230	40	1	950	264	17	246	3.50E-114	412.9	LDB2_CHICK	reviewed	LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1) (cLdb2)	LDB2 CLIM1	Gallus gallus (Chicken)	371	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0001102; GO:0003712; GO:0005634; GO:0005667; GO:0007399; GO:0030274; GO:0045892; GO:0045944	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2823_c0_g1_i2	Q1EQW7	LDB2_XENLA	65.4	353	87	4	1071	91	17	360	2.00E-126	453.8	LDB2_XENLA	reviewed	LIM domain-binding protein 2 (LDB-2) (xLdb2)	ldb2	Xenopus laevis (African clawed frog)	398	nucleus [GO:0005634]; LIM domain binding [GO:0030274]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	LIM domain binding [GO:0030274]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0030274	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2823_c0_g1_i4	Q1EQW7	LDB2_XENLA	65.4	353	87	4	1071	91	17	360	8.80E-127	454.9	LDB2_XENLA	reviewed	LIM domain-binding protein 2 (LDB-2) (xLdb2)	ldb2	Xenopus laevis (African clawed frog)	398	nucleus [GO:0005634]; LIM domain binding [GO:0030274]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	LIM domain binding [GO:0030274]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0030274	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37415_c0_g1_i1	G5E5X0	LIMD1_BOVIN	100	85	0	0	3	257	550	634	2.60E-50	198.7	LIMD1_BOVIN	reviewed	LIM domain-containing protein 1	LIMD1	Bos taurus (Bovine)	674	"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RISC complex [GO:0016442]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; gene silencing by miRNA [GO:0035195]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; P-body assembly [GO:0033962]; phosphorylation [GO:0016310]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of cell shape [GO:0008360]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RISC complex [GO:0016442]; transcription regulator complex [GO:0005667]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000932; GO:0001666; GO:0002076; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005925; GO:0006355; GO:0007010; GO:0008360; GO:0016310; GO:0016442; GO:0016477; GO:0033962; GO:0035195; GO:0035331; GO:0045668; GO:0045892; GO:0046872; GO:0090090; GO:2000637	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; gene silencing by miRNA [GO:0035195]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; P-body assembly [GO:0033962]; phosphorylation [GO:0016310]; positive regulation of gene silencing by miRNA [GO:2000637]; regulation of cell shape [GO:0008360]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5315_c0_g1_i1	Q9VY77	AJUBA_DROME	85.8	120	17	0	491	132	587	706	1.50E-63	243.8	AJUBA_DROME	reviewed	LIM domain-containing protein jub	jub CG11063	Drosophila melanogaster (Fruit fly)	728	"adherens junction [GO:0005912]; apical cortex [GO:0045179]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"	adherens junction [GO:0005912]; apical cortex [GO:0045179]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]	metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714]	GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311; GO:2000637	"cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5315_c0_g1_i2	Q9VY77	AJUBA_DROME	86.1	223	31	0	800	132	484	706	3.20E-123	442.6	AJUBA_DROME	reviewed	LIM domain-containing protein jub	jub CG11063	Drosophila melanogaster (Fruit fly)	728	"adherens junction [GO:0005912]; apical cortex [GO:0045179]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"	adherens junction [GO:0005912]; apical cortex [GO:0045179]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]	metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714]	GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311; GO:2000637	"cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23316_c0_g1_i1	Q9M047	WLI2B_ARATH	43.3	67	38	0	36	236	1	67	3.50E-12	72.8	WLI2B_ARATH	reviewed	LIM domain-containing protein WLIM2b (Widely-expressed LIM protein 2B)	WLIM2B At3g55770 F1I16.180	Arabidopsis thaliana (Mouse-ear cress)	199	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; actin filament bundle assembly [GO:0051017]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0003729; GO:0005737; GO:0005886; GO:0015629; GO:0046872; GO:0051015; GO:0051017	actin filament bundle assembly [GO:0051017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23316_c0_g1_i2	Q9M047	WLI2B_ARATH	43.3	67	38	0	36	236	1	67	4.10E-12	72.8	WLI2B_ARATH	reviewed	LIM domain-containing protein WLIM2b (Widely-expressed LIM protein 2B)	WLIM2B At3g55770 F1I16.180	Arabidopsis thaliana (Mouse-ear cress)	199	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; actin filament bundle assembly [GO:0051017]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0003729; GO:0005737; GO:0005886; GO:0015629; GO:0046872; GO:0051015; GO:0051017	actin filament bundle assembly [GO:0051017]		NA	NA	NA	NA	NA	NA
TRINITY_DN15429_c0_g1_i1	Q26422	LFC_CARRO	35.9	92	58	1	351	76	166	256	1.30E-15	84	LFC_CARRO	reviewed	Limulus clotting factor C (FC) (EC 3.4.21.84) [Cleaved into: Limulus clotting factor C heavy chain; Limulus clotting factor C light chain; Limulus clotting factor C chain A; Limulus clotting factor C chain B]		Carcinoscorpius rotundicauda (Mangrove horseshoe crab) (Limulus rotundicauda)	1019	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; serine-type endopeptidase activity [GO:0004252]; cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0007155; GO:0030246; GO:0042381	cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]		NA	NA	NA	NA	NA	NA
TRINITY_DN11512_c1_g2_i1	P11369	LORF2_MOUSE	35.3	85	54	1	68	319	479	563	5.50E-08	58.5	LORF2_MOUSE	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]	Pol Gm17492	Mus musculus (Mouse)	1281	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; DNA recombination [GO:0006310]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0006310; GO:0046872	DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN14870_c0_g1_i1	P11369	LORF2_MOUSE	31.2	109	72	2	23	346	469	575	1.60E-05	50.4	LORF2_MOUSE	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]	Pol Gm17492	Mus musculus (Mouse)	1281	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; DNA recombination [GO:0006310]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0006310; GO:0046872	DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN1110_c0_g1_i1	O00370	LORF2_HUMAN	24.4	614	377	21	412	2100	199	776	6.10E-25	118.2	LORF2_HUMAN	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]		Homo sapiens (Human)	1275	"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]	GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305	"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1110_c0_g1_i2	O00370	LORF2_HUMAN	24.4	614	377	21	412	2100	199	776	6.00E-25	118.2	LORF2_HUMAN	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]		Homo sapiens (Human)	1275	"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]	GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305	"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1110_c0_g1_i3	O00370	LORF2_HUMAN	24.4	614	377	21	412	2100	199	776	6.10E-25	118.2	LORF2_HUMAN	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]		Homo sapiens (Human)	1275	"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]	GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305	"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1110_c0_g1_i4	O00370	LORF2_HUMAN	24.4	614	377	21	412	2100	199	776	6.10E-25	118.2	LORF2_HUMAN	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]		Homo sapiens (Human)	1275	"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]	GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305	"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1110_c0_g1_i7	O00370	LORF2_HUMAN	24.4	614	377	21	412	2100	199	776	5.50E-25	118.2	LORF2_HUMAN	reviewed	LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]		Homo sapiens (Human)	1275	"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]	GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305	"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6097_c0_g1_i1	P08548	LIN1_NYCCO	36.8	76	45	2	235	17	485	560	1.20E-05	50.4	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17010_c3_g1_i1	P08548	LIN1_NYCCO	36.4	66	41	1	353	159	485	550	4.60E-05	48.9	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN258_c1_g1_i11	P08548	LIN1_NYCCO	34.5	55	36	0	1287	1451	502	556	1.70E-05	52.4	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN258_c1_g1_i12	P08548	LIN1_NYCCO	29.6	115	77	3	891	559	423	537	5.40E-05	50.4	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i14	P08548	LIN1_NYCCO	24.8	157	113	3	521	66	619	775	6.90E-10	65.5	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i15	P08548	LIN1_NYCCO	29.1	86	59	1	276	25	619	704	7.90E-05	47.8	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i19	P08548	LIN1_NYCCO	24.2	157	114	3	521	66	619	775	5.30E-10	65.9	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i5	P08548	LIN1_NYCCO	24.2	157	114	3	521	66	619	775	7.60E-09	62	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i8	P08548	LIN1_NYCCO	25	152	109	3	448	8	619	770	5.10E-09	62.4	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i9	P08548	LIN1_NYCCO	24.6	138	101	2	525	121	619	756	1.20E-09	64.7	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN612_c2_g1_i27	P08548	LIN1_NYCCO	28.9	121	81	3	592	245	655	775	1.10E-09	65.1	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19944_c0_g1_i1	P08548	LIN1_NYCCO	42.9	70	37	2	13	213	655	724	1.60E-08	59.7	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8820_c2_g1_i3	P08548	LIN1_NYCCO	32.5	123	73	4	849	499	657	775	2.10E-09	64.7	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			brown	brown	NA	NA	NA	NA
TRINITY_DN8820_c2_g1_i4	P08548	LIN1_NYCCO	31.7	123	74	4	849	499	657	775	2.10E-09	64.7	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8820_c2_g1_i6	P08548	LIN1_NYCCO	31.1	119	79	2	355	8	657	775	3.50E-10	66.2	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8820_c2_g1_i8	P08548	LIN1_NYCCO	32.5	123	73	4	849	499	657	775	2.80E-09	64.3	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN10930_c0_g1_i6	P08548	LIN1_NYCCO	38.2	89	52	2	1237	980	653	741	1.70E-09	65.5	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			brown	brown	NA	NA	NA	NA
TRINITY_DN10930_c0_g1_i7	P08548	LIN1_NYCCO	38.2	89	52	2	1161	904	653	741	1.60E-09	65.5	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i1	P08548	LIN1_NYCCO	28	150	91	6	648	238	653	798	1.20E-08	62	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i10	P08548	LIN1_NYCCO	28.6	98	67	2	858	574	653	750	8.20E-07	56.2	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i14	P08548	LIN1_NYCCO	28	150	91	6	962	552	653	798	5.60E-09	63.5	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			brown	brown	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i15	P08548	LIN1_NYCCO	28.6	98	67	2	641	357	653	750	6.40E-07	56.2	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i8	P08548	LIN1_NYCCO	28	150	91	6	1412	1002	653	798	7.90E-09	63.5	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN9894_c0_g1_i4	P08548	LIN1_NYCCO	29.8	84	58	1	258	10	626	709	4.50E-05	48.5	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g1_i1	P08548	LIN1_NYCCO	25.8	260	183	5	1299	2063	429	683	2.70E-18	95.9	LIN1_NYCCO	reviewed	LINE-1 reverse transcriptase homolog (EC 2.7.7.49)		Nycticebus coucang (Slow loris)	1260	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0046872			brown	brown	1	NA	NA	NA
TRINITY_DN17808_c0_g1_i3	O46107	LIP1_DROME	40.2	336	191	3	1006	2	103	429	1.20E-66	255	LIP1_DROME	reviewed	Lipase 1 (DmLip1) (EC 3.1.1.-)	Lip1 CG7279	Drosophila melanogaster (Fruit fly)	439	extracellular region [GO:0005576]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005576; GO:0007586; GO:0016042	digestion [GO:0007586]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN17808_c0_g1_i4	O46107	LIP1_DROME	41	305	170	3	941	30	103	398	4.40E-63	243	LIP1_DROME	reviewed	Lipase 1 (DmLip1) (EC 3.1.1.-)	Lip1 CG7279	Drosophila melanogaster (Fruit fly)	439	extracellular region [GO:0005576]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005576; GO:0007586; GO:0016042	digestion [GO:0007586]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN337_c0_g1_i1	O46108	LIP3_DROME	43.3	358	201	2	1129	62	30	387	6.30E-79	296.2	LIP3_DROME	reviewed	Lipase 3 (DmLip3) (EC 3.1.1.-)	Lip3 CG8823	Drosophila melanogaster (Fruit fly)	394	sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]		sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0016042	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g1_i10	Q5VXJ0	LIPK_HUMAN	41.3	356	198	6	1079	15	28	373	6.00E-78	292.7	LIPK_HUMAN	reviewed	Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)	LIPK LIPL2	Homo sapiens (Human)	399	"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; hydrolase activity, acting on ester bonds [GO:0016788]; cornification [GO:0070268]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	"hydrolase activity, acting on ester bonds [GO:0016788]"	GO:0005576; GO:0016042; GO:0016788; GO:0043231; GO:0070268	cornification [GO:0070268]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN17808_c0_g1_i1	Q5VXJ0	LIPK_HUMAN	50.8	63	31	0	230	42	78	140	1.30E-14	80.1	LIPK_HUMAN	reviewed	Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)	LIPK LIPL2	Homo sapiens (Human)	399	"extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; hydrolase activity, acting on ester bonds [GO:0016788]; cornification [GO:0070268]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	"hydrolase activity, acting on ester bonds [GO:0016788]"	GO:0005576; GO:0016042; GO:0016788; GO:0043231; GO:0070268	cornification [GO:0070268]; lipid catabolic process [GO:0016042]		brown	brown	1	NA	NA	NA
TRINITY_DN337_c0_g1_i4	Q8K2A6	LIPM_MOUSE	29	145	100	2	478	47	267	409	4.90E-15	82.8	LIPM_MOUSE	reviewed	Lipase member M (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 3)	Lipm Lipl3	Mus musculus (Mouse)	422	"extracellular region [GO:0005576]; hydrolase activity, acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]	"hydrolase activity, acting on ester bonds [GO:0016788]"	GO:0005576; GO:0016042; GO:0016788	lipid catabolic process [GO:0016042]		black	black	1	NA	1	1
TRINITY_DN337_c0_g1_i5	Q8K2A6	LIPM_MOUSE	27.7	177	124	3	574	47	236	409	1.70E-15	84.3	LIPM_MOUSE	reviewed	Lipase member M (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 3)	Lipm Lipl3	Mus musculus (Mouse)	422	"extracellular region [GO:0005576]; hydrolase activity, acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]	"hydrolase activity, acting on ester bonds [GO:0016788]"	GO:0005576; GO:0016042; GO:0016788	lipid catabolic process [GO:0016042]		NA	NA	1	NA	NA	1
TRINITY_DN15732_c0_g1_i1	Q9GZE9	LDP1_CAEEL	53.2	77	36	0	238	8	48	124	5.80E-15	81.3	LDP1_CAEEL	reviewed	Lipid droplet localized protein	ldp-1 F22F7.1	Caenorhabditis elegans	426	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005811; GO:0005886; GO:0009247; GO:0016021; GO:0016491	glycolipid biosynthetic process [GO:0009247]		NA	NA	NA	NA	NA	NA
TRINITY_DN4684_c0_g1_i1	Q5F477	LDAH_CHICK	31.8	321	198	6	1008	97	2	318	3.70E-45	183.7	LDAH_CHICK	reviewed	Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase)	LDAH RCJMB04_2g19	Gallus gallus (Chicken)	324	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipase activity [GO:0016298]; lipid storage [GO:0019915]	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	lipase activity [GO:0016298]	GO:0005783; GO:0005811; GO:0016298; GO:0019915	lipid storage [GO:0019915]		blue	blue	NA	NA	NA	NA
TRINITY_DN4684_c0_g1_i2	Q5F477	LDAH_CHICK	32.8	274	170	4	888	97	49	318	8.80E-43	175.6	LDAH_CHICK	reviewed	Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase)	LDAH RCJMB04_2g19	Gallus gallus (Chicken)	324	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipase activity [GO:0016298]; lipid storage [GO:0019915]	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	lipase activity [GO:0016298]	GO:0005783; GO:0005811; GO:0016298; GO:0019915	lipid storage [GO:0019915]		NA	NA	NA	NA	NA	NA
TRINITY_DN2862_c0_g1_i1	Q6PBN5	AUP1_DANRE	31.9	455	249	8	109	1410	3	417	3.40E-49	197.6	AUP1_DANRE	reviewed	Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1)	aup1	Danio rerio (Zebrafish) (Brachydanio rerio)	423	Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; membrane [GO:0016020]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activator activity [GO:0097027]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; protein localization to lipid droplet [GO:1990044]; ubiquitin-dependent ERAD pathway [GO:0030433]	Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; membrane [GO:0016020]	ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activator activity [GO:0097027]	GO:0000839; GO:0005811; GO:0016020; GO:0030176; GO:0030433; GO:0034389; GO:0043130; GO:0071712; GO:0097027; GO:0140042; GO:1990044	ER-associated misfolded protein catabolic process [GO:0071712]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; protein localization to lipid droplet [GO:1990044]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN7720_c0_g1_i1	P11182	ODB2_HUMAN	62.9	167	62	0	548	48	238	404	4.20E-56	219.2	ODB2_HUMAN	reviewed	"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2) (BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)"	DBT BCATE2	Homo sapiens (Human)	482	cytoplasm [GO:0005737]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]; branched-chain amino acid catabolic process [GO:0009083]	cytoplasm [GO:0005737]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005739; GO:0005759; GO:0005947; GO:0009083; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754	branched-chain amino acid catabolic process [GO:0009083]		NA	NA	NA	NA	NA	NA
TRINITY_DN7720_c0_g1_i2	P11182	ODB2_HUMAN	65.7	245	84	0	772	38	238	482	2.10E-90	333.6	ODB2_HUMAN	reviewed	"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2) (BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)"	DBT BCATE2	Homo sapiens (Human)	482	cytoplasm [GO:0005737]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]; branched-chain amino acid catabolic process [GO:0009083]	cytoplasm [GO:0005737]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005739; GO:0005759; GO:0005947; GO:0009083; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754	branched-chain amino acid catabolic process [GO:0009083]		NA	NA	NA	NA	NA	NA
TRINITY_DN33202_c0_g1_i1	P11181	ODB2_BOVIN	73.3	90	24	0	216	485	57	146	6.90E-31	135.2	ODB2_BOVIN	reviewed	"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)"	DBT	Bos taurus (Bovine)	482	cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]	cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005739; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754			NA	NA	NA	NA	NA	NA
TRINITY_DN35198_c0_g1_i1	Q8BFW7	LPP_MOUSE	100	81	0	0	246	4	398	478	1.60E-46	186	LPP_MOUSE	reviewed	Lipoma-preferred partner homolog	Lpp	Mus musculus (Mouse)	613	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]	metal ion binding [GO:0046872]	GO:0001725; GO:0005634; GO:0005829; GO:0005925; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN12354_c0_g1_i1	Q5F464	LPP_CHICK	57.5	275	91	5	906	82	356	604	4.00E-96	352.8	LPP_CHICK	reviewed	Lipoma-preferred partner homolog	LPP RCJMB04_2l20	Gallus gallus (Chicken)	604	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]	metal ion binding [GO:0046872]	GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN37027_c0_g1_i1	Q2G712	LIPA_NOVAD	64.9	74	26	0	2	223	65	138	1.70E-21	102.8	LIPA_NOVAD	reviewed	Lipoyl synthase (EC 2.8.1.8) (Lip-syn) (LS) (Lipoate synthase) (Lipoic acid synthase) (Sulfur insertion protein LipA)	lipA Saro_1921	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	310	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN31532_c0_g1_i1	A0KNA3	LIPA_AERHH	96.6	89	3	0	269	3	210	298	4.00E-46	184.9	LIPA_AERHH	reviewed	Lipoyl synthase (EC 2.8.1.8) (Lip-syn) (LS) (Lipoate synthase) (Lipoic acid synthase) (Sulfur insertion protein LipA)	lipA AHA_3263	Aeromonas hydrophila subsp. hydrophila (strain ATCC 7966 / DSM 30187 / JCM 1027 / KCTC 2358 / NCIMB 9240)	321	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN27809_c0_g1_i1	B2UE01	LIPA_RALPJ	98.5	68	1	0	204	1	114	181	1.50E-32	139.4	LIPA_RALPJ	reviewed	Lipoyl synthase (EC 2.8.1.8) (Lip-syn) (LS) (Lipoate synthase) (Lipoic acid synthase) (Sulfur insertion protein LipA)	lipA Rpic_0178	Ralstonia pickettii (strain 12J)	333	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN25830_c0_g1_i1	A5V2U6	LIPA_SPHWW	85.7	70	10	0	1	210	76	145	1.30E-28	126.3	LIPA_SPHWW	reviewed	Lipoyl synthase (EC 2.8.1.8) (Lip-syn) (LS) (Lipoate synthase) (Lipoic acid synthase) (Sulfur insertion protein LipA)	lipA Swit_0241	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	312	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN2738_c0_g1_i1	Q6GQ48	LIAS_XENLA	71.9	114	32	0	452	111	257	370	4.40E-42	172.6	LIAS_XENLA	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)"	lias	Xenopus laevis (African clawed frog)	372	"mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]"	mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005739; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	protein lipoylation [GO:0009249]		blue	blue	NA	NA	NA	NA
TRINITY_DN2738_c0_g1_i2	C3Y3G4	LIAS_BRAFL	69.8	348	104	1	1148	105	22	368	3.70E-145	516.2	LIAS_BRAFL	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)"	BRAFLDRAFT_125969	Branchiostoma floridae (Florida lancelet) (Amphioxus)	376	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0005739; GO:0009107; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]		blue	blue	NA	NA	NA	NA
TRINITY_DN28634_c0_g1_i1	O43766	LIAS_HUMAN	100	96	0	0	1	288	150	245	4.40E-51	201.4	LIAS_HUMAN	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)"	LIAS LAS HUSSY-01	Homo sapiens (Human)	372	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; cellular nitrogen compound metabolic process [GO:0034641]; inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0001843; GO:0005737; GO:0005739; GO:0005759; GO:0006954; GO:0006979; GO:0009107; GO:0009249; GO:0016992; GO:0032496; GO:0034641; GO:0046872; GO:0051539; GO:0102552; GO:0102553	cellular nitrogen compound metabolic process [GO:0034641]; inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN9888_c0_g2_i1	O13642	LIPA_SCHPO	64.9	74	26	0	225	4	133	206	7.30E-23	107.5	LIPA_SCHPO	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)"	lip5 pi050 SPBC8D2.15	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	370	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0005739; GO:0009107; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN9888_c0_g2_i2	O13642	LIPA_SCHPO	69.8	86	26	0	261	4	121	206	3.10E-30	132.1	LIPA_SCHPO	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)"	lip5 pi050 SPBC8D2.15	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	370	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005737; GO:0005739; GO:0009107; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN9888_c0_g1_i1	Q16W22	LIAS_AEDAE	57.7	168	71	0	514	11	220	387	1.40E-50	200.7	LIAS_AEDAE	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)"	AAEL009368	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	393	"mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249]"	mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0005739; GO:0009249; GO:0016992; GO:0046872; GO:0051539; GO:0102552; GO:0102553	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN22638_c0_g1_i1	Q99M04	LIAS_MOUSE	100	120	0	0	2	361	101	220	4.50E-69	261.5	LIAS_MOUSE	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (mLIP1) (Lipoic acid synthase)"	Lias Lip1	Mus musculus (Mouse)	373	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0001843; GO:0005737; GO:0005739; GO:0006954; GO:0006979; GO:0009107; GO:0009249; GO:0016992; GO:0032496; GO:0046872; GO:0051539; GO:0102552; GO:0102553	inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN27055_c0_g1_i1	Q99M04	LIAS_MOUSE	98.6	74	1	0	2	223	233	306	2.20E-34	145.6	LIAS_MOUSE	reviewed	"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (mLIP1) (Lipoic acid synthase)"	Lias Lip1	Mus musculus (Mouse)	373	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]"	GO:0001843; GO:0005737; GO:0005739; GO:0006954; GO:0006979; GO:0009107; GO:0009249; GO:0016992; GO:0032496; GO:0046872; GO:0051539; GO:0102552; GO:0102553	inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN1717_c0_g1_i1	Q8VCM4	LIPT_MOUSE	39	344	198	8	1101	88	21	358	3.80E-57	223.8	LIPT_MOUSE	reviewed	"Lipoyltransferase 1, mitochondrial (EC 2.3.1.-) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase)"	Lipt1	Mus musculus (Mouse)	373	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; lipoate-protein ligase activity [GO:0016979]; lipoyltransferase activity [GO:0017118]; protein lipoylation [GO:0009249]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	lipoate-protein ligase activity [GO:0016979]; lipoyltransferase activity [GO:0017118]	GO:0005737; GO:0005739; GO:0009249; GO:0016979; GO:0017118	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN1717_c0_g1_i2	Q9Y234	LIPT_HUMAN	40.5	309	175	6	1062	145	36	338	4.90E-57	223.4	LIPT_HUMAN	reviewed	"Lipoyltransferase 1, mitochondrial (EC 2.3.1.-) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase)"	LIPT1	Homo sapiens (Human)	373	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; lipoate-protein ligase activity [GO:0016979]; lipoyltransferase activity [GO:0017118]; transferase activity, transferring acyl groups [GO:0016746]; cellular nitrogen compound metabolic process [GO:0034641]; cellular protein modification process [GO:0006464]; lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"lipoate-protein ligase activity [GO:0016979]; lipoyltransferase activity [GO:0017118]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005737; GO:0005739; GO:0005759; GO:0006464; GO:0006629; GO:0009249; GO:0016746; GO:0016979; GO:0017118; GO:0034641	cellular nitrogen compound metabolic process [GO:0034641]; cellular protein modification process [GO:0006464]; lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN33293_c0_g1_i1	Q13136	LIPA1_HUMAN	70	70	21	0	4	213	1034	1103	7.10E-22	104	LIPA1_HUMAN	reviewed	Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)	PPFIA1 LIP1	Homo sapiens (Human)	1202	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cell-matrix adhesion [GO:0007160]; glutamate secretion [GO:0014047]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; neurotransmitter secretion [GO:0007269]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]		GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0007269; GO:0014047; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077	cell-matrix adhesion [GO:0007160]; glutamate secretion [GO:0014047]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; neurotransmitter secretion [GO:0007269]; signal transduction [GO:0007165]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN3083_c0_g1_i1	Q8C8U0	LIPB1_MOUSE	46.1	410	195	10	1262	60	505	897	2.10E-87	324.3	LIPB1_MOUSE	reviewed	Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1)	Ppfibp1 Kiaa1230	Mus musculus (Mouse)	969	presynaptic active zone [GO:0048786]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]	presynaptic active zone [GO:0048786]		GO:0007528; GO:0048786; GO:0050808	neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN3083_c0_g1_i2	Q8C8U0	LIPB1_MOUSE	45	467	218	15	1421	60	457	897	5.50E-94	346.3	LIPB1_MOUSE	reviewed	Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1)	Ppfibp1 Kiaa1230	Mus musculus (Mouse)	969	presynaptic active zone [GO:0048786]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]	presynaptic active zone [GO:0048786]		GO:0007528; GO:0048786; GO:0050808	neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN39667_c0_g1_i1	Q9PTR5	LIS1_CHICK	100	128	0	0	384	1	1	128	3.20E-66	252.3	LIS1_CHICK	reviewed	Lissencephaly-1 homolog	PAFAH1B1 LIS1	Gallus gallus (Chicken)	410	astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; synapse [GO:0045202]; dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]; acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]	astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; synapse [GO:0045202]	dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]	GO:0000132; GO:0000235; GO:0000776; GO:0001667; GO:0001675; GO:0001764; GO:0001961; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0005938; GO:0007097; GO:0007268; GO:0007281; GO:0007405; GO:0007611; GO:0008090; GO:0008344; GO:0009306; GO:0019226; GO:0021540; GO:0021766; GO:0021819; GO:0030036; GO:0031023; GO:0031252; GO:0031514; GO:0032420; GO:0036035; GO:0040019; GO:0042249; GO:0042802; GO:0043005; GO:0043025; GO:0043087; GO:0043622; GO:0045202; GO:0046329; GO:0047496; GO:0048471; GO:0048854; GO:0050885; GO:0051010; GO:0051012; GO:0051081; GO:0051219; GO:0051301; GO:0051661; GO:0060117; GO:0061003; GO:0070507; GO:0070840; GO:0090102; GO:0090176; GO:1904115; GO:2000574	acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN2110_c0_g1_i1	B7PS00	LIS1_IXOSC	74.9	415	93	3	1318	95	1	411	6.50E-196	684.9	LIS1_IXOSC	reviewed	Lissencephaly-1 homolog	IscW_ISCW007420	Ixodes scapularis (Black-legged tick) (Deer tick)	411	axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]	dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]	GO:0000132; GO:0000776; GO:0005635; GO:0005815; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115; GO:2000574	brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]		blue	blue	NA	NA	NA	NA
TRINITY_DN2110_c0_g1_i3	Q17N69	LIS1_AEDAE	75.3	369	90	1	1198	95	41	409	1.00E-173	610.9	LIS1_AEDAE	reviewed	Lissencephaly-1 homolog	AAEL000770	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	409	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; dynein complex binding [GO:0070840]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule sliding [GO:0051012]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]	dynein complex binding [GO:0070840]	GO:0000132; GO:0005737; GO:0005815; GO:0005874; GO:0005875; GO:0051012; GO:0051301; GO:0070840	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule sliding [GO:0051012]		NA	NA	NA	NA	NA	NA
TRINITY_DN10758_c0_g1_i1	Q64148	CP3AA_MESAU	40.5	220	126	3	44	703	282	496	1.10E-45	184.9	CP3AA_MESAU	reviewed	Lithocholate 6-beta-hydroxylase (6 beta-hydroxylase) (EC 1.14.14.138) (CYPIIIA10) (Cytochrome P450 3A10)	CYP3A10	Mesocricetus auratus (Golden hamster)	503	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lithocholate 6beta-hydroxylase activity [GO:0033777]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; lithocholate 6beta-hydroxylase activity [GO:0033777]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"	GO:0005506; GO:0005789; GO:0016712; GO:0020037; GO:0033777			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i1	O46421	EST1_MACFA	25	252	155	12	900	172	323	549	1.30E-07	58.9	EST1_MACFA	reviewed	Liver carboxylesterase 1 (EC 3.1.1.1) (Cholesteryl ester hydrolase) (CEH) (EC 3.1.1.13)	CES1	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	566	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; reverse cholesterol transport [GO:0043691]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]	methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]	GO:0004771; GO:0005737; GO:0005788; GO:0005811; GO:0008203; GO:0010875; GO:0010887; GO:0043691; GO:0070857; GO:0080030; GO:0090205; GO:0120188	cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; reverse cholesterol transport [GO:0043691]		NA	NA	NA	NA	NA	NA
TRINITY_DN22284_c3_g1_i1	Q95028	LDH_DROME	65	360	96	1	1173	94	3	332	2.30E-128	460.3	LDH_DROME	reviewed	L-lactate dehydrogenase (EC 1.1.1.27)	Ldh Imp-L3 ImpL3 CG10160	Drosophila melanogaster (Fruit fly)	332	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN22284_c3_g1_i2	Q95028	LDH_DROME	70	330	99	0	1083	94	3	332	7.90E-131	468.4	LDH_DROME	reviewed	L-lactate dehydrogenase (EC 1.1.1.27)	Ldh Imp-L3 ImpL3 CG10160	Drosophila melanogaster (Fruit fly)	332	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		blue	blue	NA	NA	NA	NA
TRINITY_DN22284_c3_g1_i3	Q95028	LDH_DROME	65	360	96	1	1173	94	3	332	2.30E-128	460.3	LDH_DROME	reviewed	L-lactate dehydrogenase (EC 1.1.1.27)	Ldh Imp-L3 ImpL3 CG10160	Drosophila melanogaster (Fruit fly)	332	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN22284_c3_g1_i4	Q95028	LDH_DROME	70	330	99	0	1083	94	3	332	7.90E-131	468.4	LDH_DROME	reviewed	L-lactate dehydrogenase (EC 1.1.1.27)	Ldh Imp-L3 ImpL3 CG10160	Drosophila melanogaster (Fruit fly)	332	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		blue	blue	NA	NA	NA	NA
TRINITY_DN22284_c3_g1_i5	Q95028	LDH_DROME	70.9	330	96	0	1083	94	3	332	1.90E-132	473.8	LDH_DROME	reviewed	L-lactate dehydrogenase (EC 1.1.1.27)	Ldh Imp-L3 ImpL3 CG10160	Drosophila melanogaster (Fruit fly)	332	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		blue	blue	NA	NA	NA	NA
TRINITY_DN22284_c3_g1_i6	Q95028	LDH_DROME	70.9	330	96	0	1083	94	3	332	1.90E-132	473.8	LDH_DROME	reviewed	L-lactate dehydrogenase (EC 1.1.1.27)	Ldh Imp-L3 ImpL3 CG10160	Drosophila melanogaster (Fruit fly)	332	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		blue	blue	NA	NA	NA	NA
TRINITY_DN17381_c0_g1_i1	P33571	LDH_PETMA	67.7	99	32	0	298	2	73	171	2.20E-29	129.4	LDH_PETMA	reviewed	L-lactate dehydrogenase (LDH) (EC 1.1.1.27)		Petromyzon marinus (Sea lamprey)	334	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN22304_c0_g1_i1	Q9W7K5	LDHA_CYPCA	75	68	16	1	34	234	94	161	7.10E-23	107.5	LDHA_CYPCA	reviewed	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27)	ldha	Cyprinus carpio (Common carp)	333	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN3624_c0_g2_i1	P00338	LDHA_HUMAN	100	332	0	0	1027	32	1	332	8.60E-190	664.1	LDHA_HUMAN	reviewed	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA PIG19	Homo sapiens (Human)	332	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase activity [GO:0004459]; NAD binding [GO:0051287]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]; positive regulation of apoptotic process [GO:0043065]; post-embryonic animal organ development [GO:0048569]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase activity [GO:0004459]; NAD binding [GO:0051287]	GO:0001666; GO:0004459; GO:0005634; GO:0005829; GO:0006089; GO:0006090; GO:0006096; GO:0007584; GO:0009749; GO:0016020; GO:0019674; GO:0019900; GO:0021762; GO:0042493; GO:0042542; GO:0042802; GO:0043065; GO:0043627; GO:0045296; GO:0048569; GO:0051287; GO:0051591; GO:0070062	glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]; positive regulation of apoptotic process [GO:0043065]; post-embryonic animal organ development [GO:0048569]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN3624_c0_g1_i1	P06151	LDHA_MOUSE	99.4	332	2	0	1031	36	1	332	6.20E-188	657.9	LDHA_MOUSE	reviewed	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (LDH muscle subunit) (LDH-M)	Ldha Ldh-1 Ldh1	Mus musculus (Mouse)	332	cytosol [GO:0005829]; mitochondrion [GO:0005739]; sperm fibrous sheath [GO:0035686]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]; lactate dehydrogenase activity [GO:0004457]; cellular response to extracellular stimulus [GO:0031668]; glucose catabolic process to lactate via pyruvate [GO:0019661]; lactate biosynthetic process from pyruvate [GO:0019244]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; sperm fibrous sheath [GO:0035686]	identical protein binding [GO:0042802]; lactate dehydrogenase activity [GO:0004457]; L-lactate dehydrogenase activity [GO:0004459]	GO:0004457; GO:0004459; GO:0005739; GO:0005829; GO:0019244; GO:0019661; GO:0031668; GO:0035686; GO:0042802	cellular response to extracellular stimulus [GO:0031668]; glucose catabolic process to lactate via pyruvate [GO:0019661]; lactate biosynthetic process from pyruvate [GO:0019244]		NA	NA	NA	NA	NA	NA
TRINITY_DN37471_c0_g1_i1	Q9W7L4	LDHB_SCEUN	54.9	71	32	0	216	4	3	73	1.60E-13	76.3	LDHB_SCEUN	reviewed	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27)	LDHB	Sceloporus undulatus (Eastern fence lizard) (Stellio undulatus)	335	cytoplasm [GO:0005737]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]	cytoplasm [GO:0005737]	L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005975; GO:0019752	carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]		NA	NA	NA	NA	NA	NA
TRINITY_DN14190_c0_g1_i1	P16125	LDHB_MOUSE	99.4	180	1	0	3	542	121	300	1.00E-101	370.5	LDHB_MOUSE	reviewed	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H)	Ldhb Ldh-2 Ldh2	Mus musculus (Mouse)	334	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase activity [GO:0004459]; lactate dehydrogenase activity [GO:0004457]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; lactate biosynthetic process from pyruvate [GO:0019244]; lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; lactate dehydrogenase activity [GO:0004457]; L-lactate dehydrogenase activity [GO:0004459]; NAD binding [GO:0051287]	GO:0004457; GO:0004459; GO:0005739; GO:0005829; GO:0005975; GO:0006089; GO:0019244; GO:0019674; GO:0019900; GO:0042802; GO:0043209; GO:0045121; GO:0051287	carbohydrate metabolic process [GO:0005975]; lactate biosynthetic process from pyruvate [GO:0019244]; lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]		NA	NA	NA	NA	NA	NA
TRINITY_DN25988_c0_g1_i1	P07195	LDHB_HUMAN	100	295	0	0	3	887	4	298	7.50E-166	584.3	LDHB_HUMAN	reviewed	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	Homo sapiens (Human)	334	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]; carbohydrate metabolic process [GO:0005975]; pyruvate metabolic process [GO:0006090]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]	identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005829; GO:0005975; GO:0006090; GO:0016020; GO:0042802; GO:0045121; GO:0070062	carbohydrate metabolic process [GO:0005975]; pyruvate metabolic process [GO:0006090]		NA	NA	NA	NA	NA	NA
TRINITY_DN16940_c0_g1_i1	Q7SZE3	L2GL2_DANRE	49.2	189	86	2	10	570	273	453	1.70E-46	187.2	L2GL2_DANRE	reviewed	LLGL scribble cell polarity complex component 2 (Lethal(2) giant larvae protein homolog 2) (Protein penner)	llgl2 pen	Danio rerio (Zebrafish) (Brachydanio rerio)	1020	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; epidermis development [GO:0008544]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; hemidesmosome assembly [GO:0031581]; Kupffer's vesicle development [GO:0070121]; motile cilium assembly [GO:0044458]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; photoreceptor cell morphogenesis [GO:0008594]; posterior lateral line neuromast development [GO:0048919]; regulation of epidermis development [GO:0045682]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]; skin development [GO:0043588]; skin epidermis development [GO:0098773]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005737; GO:0005886; GO:0006887; GO:0007010; GO:0008285; GO:0008544; GO:0008593; GO:0008594; GO:0010719; GO:0017137; GO:0030031; GO:0030336; GO:0030864; GO:0030866; GO:0031581; GO:0032878; GO:0043588; GO:0044458; GO:0045159; GO:0045682; GO:0048919; GO:0050680; GO:0050708; GO:0051294; GO:0070121; GO:0098773	cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; epidermis development [GO:0008544]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; hemidesmosome assembly [GO:0031581]; Kupffer's vesicle development [GO:0070121]; motile cilium assembly [GO:0044458]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; photoreceptor cell morphogenesis [GO:0008594]; posterior lateral line neuromast development [GO:0048919]; regulation of epidermis development [GO:0045682]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]; skin development [GO:0043588]; skin epidermis development [GO:0098773]		NA	NA	NA	NA	NA	NA
TRINITY_DN15506_c0_g1_i1	Q29BL9	LMBD2_DROPS	55.8	197	80	1	3	572	113	309	5.70E-52	205.7	LMBD2_DROPS	reviewed	LMBR1 domain-containing protein 2 homolog	GA20843	Drosophila pseudoobscura pseudoobscura (Fruit fly)	699	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3257_c0_g1_i1	Q496Y0	LONF3_HUMAN	34.3	715	388	12	2042	81	65	758	2.90E-113	411	LONF3_HUMAN	reviewed	LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127)	LONRF3 RNF127	Homo sapiens (Human)	759	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6098_c0_g2_i1	P77810	LON_AZOBR	81.5	173	32	0	2	520	333	505	5.30E-79	295	LON_AZOBR	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon	Azospirillum brasilense	810	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN6098_c0_g1_i1	P0CAW0	LON_CAUVC	91.7	72	6	0	2	217	324	395	1.30E-31	136.3	LON_CAUVC	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon CC_1960	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	799	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN6098_c0_g4_i1	A8HYF7	LON_AZOC5	82	89	16	0	3	269	417	505	4.40E-37	154.8	LON_AZOC5	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon AZC_1610	Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / NBRC 14845 / NCIMB 13405 / ORS 571)	856	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN6098_c0_g3_i1	P77810	LON_AZOBR	75.9	87	21	0	3	263	448	534	4.90E-33	141.4	LON_AZOBR	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon	Azospirillum brasilense	810	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN26856_c0_g1_i1	A8M1E8	LON_SALAI	73.9	69	18	0	207	1	676	744	6.90E-22	104	LON_SALAI	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon Sare_2249	Salinispora arenicola (strain CNS-205)	778	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN40738_c0_g1_i1	A8HYF7	LON_AZOC5	80.8	120	23	0	361	2	688	807	1.30E-47	190.3	LON_AZOC5	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon AZC_1610	Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / NBRC 14845 / NCIMB 13405 / ORS 571)	856	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN38181_c0_g1_i1	P77810	LON_AZOBR	79.5	78	16	0	3	236	477	554	1.30E-29	129.8	LON_AZOBR	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon	Azospirillum brasilense	810	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN7222_c0_g1_i1	Q8RHK0	LON_FUSNN	61	41	16	0	200	78	650	690	1.60E-08	60.1	LON_FUSNN	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon FN2014	Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355)	768	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		blue	blue	NA	NA	NA	NA
TRINITY_DN27125_c0_g1_i1	B2V6N0	LON_SULSY	59.3	123	42	1	353	9	636	758	2.10E-34	146.4	LON_SULSY	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon SYO3AOP1_0116	Sulfurihydrogenibium sp. (strain YO3AOP1)	800	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN16487_c0_g2_i1	O84348	LON_CHLTR	58.7	109	41	1	321	7	692	800	1.40E-28	127.1	LON_CHLTR	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon CT_344	Chlamydia trachomatis (strain D/UW-3/Cx)	819	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN4982_c0_g1_i1	P0A9M1	LON_ECOL6	80.8	229	44	0	688	2	330	558	7.50E-105	381.3	LON_ECOL6	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon c0555	Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC)	784	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN37188_c0_g1_i1	P77810	LON_AZOBR	80	95	19	0	2	286	427	521	2.30E-39	162.5	LON_AZOBR	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon	Azospirillum brasilense	810	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN7155_c0_g1_i1	P77810	LON_AZOBR	72.6	124	34	0	1	372	644	767	2.10E-48	193	LON_AZOBR	reviewed	Lon protease (EC 3.4.21.53) (ATP-dependent protease La)	lon	Azospirillum brasilense	810	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN31334_c0_g1_i1	P36774	LON2_MYXXA	64.3	185	66	0	568	14	356	540	1.60E-65	250.4	LON2_MYXXA	reviewed	Lon protease 2 (EC 3.4.21.53) (ATP-dependent protease La 2)	lon2 bsgA lonD	Myxococcus xanthus	827	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005737; GO:0006515; GO:0034605; GO:0043565	cellular response to heat [GO:0034605]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN7222_c0_g1_i2	Q5PQY6	LONP2_DANRE	60.5	129	48	1	489	103	709	834	1.90E-37	157.1	LONP2_DANRE	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53)"	lonp2 zgc:92557	Danio rerio (Zebrafish) (Brachydanio rerio)	840	peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]	peroxisomal matrix [GO:0005782]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558	protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN7222_c0_g1_i3	Q5PQY6	LONP2_DANRE	59.8	530	183	7	1683	103	332	834	7.90E-172	605.1	LONP2_DANRE	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53)"	lonp2 zgc:92557	Danio rerio (Zebrafish) (Brachydanio rerio)	840	peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]	peroxisomal matrix [GO:0005782]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558	protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN33124_c0_g1_i1	Q2TAF8	LONP2_XENLA	41.5	207	116	3	7	612	37	243	7.40E-38	158.7	LONP2_XENLA	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53)"	lonp2	Xenopus laevis (African clawed frog)	856	peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	peroxisomal matrix [GO:0005782]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005782; GO:0006515; GO:0016485; GO:0016558	protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN30178_c0_g1_i1	Q3SX23	LONP2_BOVIN	100	114	0	0	3	344	364	477	1.30E-62	240	LONP2_BOVIN	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease)"	LONP2	Bos taurus (Bovine)	852	nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]	nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]	GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558; GO:0031998	protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]		NA	NA	NA	NA	NA	NA
TRINITY_DN21761_c0_g1_i1	Q9DBN5	LONP2_MOUSE	98.4	122	2	0	367	2	679	800	5.40E-62	238	LONP2_MOUSE	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease)"	Lonp2	Mus musculus (Mouse)	852	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]	GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005737; GO:0005777; GO:0005782; GO:0006515; GO:0006625; GO:0008233; GO:0014070; GO:0016485; GO:0016558; GO:0019899; GO:0031998	protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN21761_c0_g1_i2	Q86WA8	LONP2_HUMAN	97.5	118	3	0	355	2	683	800	4.20E-59	228.4	LONP2_HUMAN	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) (pLon)"	LONP2 LONP	Homo sapiens (Human)	852	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]	GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0016558; GO:0019899; GO:0031998	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN31496_c0_g1_i1	Q86WA8	LONP2_HUMAN	100	129	0	0	389	3	476	604	2.50E-65	249.2	LONP2_HUMAN	reviewed	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) (pLon)"	LONP2 LONP	Homo sapiens (Human)	852	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]	GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0016558; GO:0019899; GO:0031998	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN15605_c0_g1_i1	B7FSL4	LONM_PHATC	59.6	208	68	5	579	4	670	877	8.90E-59	228	LONM_PHATC	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53)"	PHATRDRAFT_18202	Phaeodactylum tricornutum (strain CCAP 1055/1)	882	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]	GO:0004176; GO:0004252; GO:0005524; GO:0005759; GO:0006515; GO:0034599; GO:0043565; GO:0051131; GO:0070407	cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN20909_c0_g1_i1	Q4X0Z7	LONM_ASPFU	75.3	174	43	0	524	3	563	736	8.60E-77	287.7	LONM_ASPFU	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53)"	pim1 AFUA_2G11740	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	1108	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004176; GO:0004252; GO:0005524; GO:0005759; GO:0006515; GO:0007005; GO:0034599; GO:0043565; GO:0051131; GO:0070407	cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN28525_c0_g1_i1	Q7S8C4	LONM_NEUCR	72.9	192	51	1	578	3	558	748	3.50E-79	295.8	LONM_NEUCR	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53)"	pim1 NCU05261	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	1107	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004176; GO:0004252; GO:0005524; GO:0005759; GO:0006515; GO:0007005; GO:0034599; GO:0043565; GO:0051131; GO:0070407	cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN16487_c0_g1_i1	Q59HJ6	LONM_BOVIN	54	87	36	1	251	3	723	809	5.70E-18	91.3	LONM_BOVIN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Bos taurus (Bovine)	961	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; modification-dependent protein catabolic process [GO:0019941]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004176; GO:0004252; GO:0005524; GO:0005759; GO:0006515; GO:0007005; GO:0019941; GO:0034599; GO:0043565; GO:0051131; GO:0070407	cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; modification-dependent protein catabolic process [GO:0019941]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN36863_c0_g1_i1	Q8CGK3	LONM_MOUSE	100	78	0	0	1	234	647	724	4.70E-35	147.9	LONM_MOUSE	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	Lonp1 Prss15	Mus musculus (Mouse)	949	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006508; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016887; GO:0034599; GO:0034622; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN5829_c0_g1_i1	Q8CGK3	LONM_MOUSE	53.7	134	54	2	1	378	108	241	6.90E-33	141.7	LONM_MOUSE	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	Lonp1 Prss15	Mus musculus (Mouse)	949	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006508; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016887; GO:0034599; GO:0034622; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN4318_c0_g1_i1	P36776	LONM_HUMAN	74.7	482	116	2	3	1430	468	949	1.70E-210	733.4	LONM_HUMAN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Homo sapiens (Human)	959	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN16466_c0_g1_i1	P36776	LONM_HUMAN	100	111	0	0	336	4	477	587	1.50E-58	226.5	LONM_HUMAN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Homo sapiens (Human)	959	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN6144_c0_g1_i1	P36776	LONM_HUMAN	72	93	26	0	280	2	289	381	3.40E-29	129	LONM_HUMAN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Homo sapiens (Human)	959	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN6144_c0_g1_i2	P36776	LONM_HUMAN	68	100	32	0	355	56	259	358	8.90E-31	134.4	LONM_HUMAN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Homo sapiens (Human)	959	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN6144_c0_g1_i3	P36776	LONM_HUMAN	69.1	123	38	0	370	2	259	381	2.00E-38	159.8	LONM_HUMAN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Homo sapiens (Human)	959	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN36425_c0_g1_i1	P36776	LONM_HUMAN	99.6	263	1	0	791	3	653	915	7.20E-144	511.1	LONM_HUMAN	reviewed	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	LONP1 PRSS15	Homo sapiens (Human)	959	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407	aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN38257_c0_g1_i1	Q8LKS5	LACS7_ARATH	50.8	65	29	2	16	207	240	302	3.40E-09	62	LACS7_ARATH	reviewed	"Long chain acyl-CoA synthetase 7, peroxisomal (AtLACS7) (EC 6.2.1.3)"	LACS7 At5g27600 F15A18.60	Arabidopsis thaliana (Mouse-ear cress)	700	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; peroxisome [GO:0005777]; plastid [GO:0009536]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]; response to ozone [GO:0010193]; response to salt stress [GO:0009651]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; peroxisome [GO:0005777]; plastid [GO:0009536]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005783; GO:0006631; GO:0009536; GO:0009651; GO:0010193; GO:0016020; GO:0102391	fatty acid metabolic process [GO:0006631]; response to ozone [GO:0010193]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN19328_c0_g1_i1	Q8LKS5	LACS7_ARATH	52.7	74	33	1	20	241	243	314	2.00E-12	72.8	LACS7_ARATH	reviewed	"Long chain acyl-CoA synthetase 7, peroxisomal (AtLACS7) (EC 6.2.1.3)"	LACS7 At5g27600 F15A18.60	Arabidopsis thaliana (Mouse-ear cress)	700	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; peroxisome [GO:0005777]; plastid [GO:0009536]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]; response to ozone [GO:0010193]; response to salt stress [GO:0009651]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; peroxisome [GO:0005777]; plastid [GO:0009536]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005777; GO:0005783; GO:0006631; GO:0009536; GO:0009651; GO:0010193; GO:0016020; GO:0102391	fatty acid metabolic process [GO:0006631]; response to ozone [GO:0010193]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN2001_c0_g1_i4	Q9SJD4	LACS8_ARATH	54.3	35	16	0	199	95	686	720	2.80E-05	49.3	LACS8_ARATH	reviewed	Long chain acyl-CoA synthetase 8 (EC 6.2.1.3)	LACS8 At2g04350 T1O3 T23O15.3	Arabidopsis thaliana (Mouse-ear cress)	720	chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]	chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005783; GO:0005794; GO:0006631; GO:0009941; GO:0016020; GO:0102391	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN13447_c0_g1_i1	Q9SJD4	LACS8_ARATH	55.2	58	26	0	212	39	662	719	4.00E-10	65.1	LACS8_ARATH	reviewed	Long chain acyl-CoA synthetase 8 (EC 6.2.1.3)	LACS8 At2g04350 T1O3 T23O15.3	Arabidopsis thaliana (Mouse-ear cress)	720	chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]	chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005783; GO:0005794; GO:0006631; GO:0009941; GO:0016020; GO:0102391	fatty acid metabolic process [GO:0006631]		blue	blue	NA	NA	NA	NA
TRINITY_DN35825_c0_g1_i1	Q9SJD4	LACS8_ARATH	43.9	82	46	0	249	4	125	206	1.10E-13	77	LACS8_ARATH	reviewed	Long chain acyl-CoA synthetase 8 (EC 6.2.1.3)	LACS8 At2g04350 T1O3 T23O15.3	Arabidopsis thaliana (Mouse-ear cress)	720	chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid metabolic process [GO:0006631]	chloroplast envelope [GO:0009941]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005783; GO:0005794; GO:0006631; GO:0009941; GO:0016020; GO:0102391	fatty acid metabolic process [GO:0006631]		blue	blue	NA	NA	NA	NA
TRINITY_DN6977_c0_g1_i1	Q60714	S27A1_MOUSE	53.5	303	141	0	969	61	344	646	3.60E-97	356.3	S27A1_MOUSE	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Fatty acid transport protein) (Solute carrier family 27 member 1)	Slc27a1 Fatp Fatp1	Mus musculus (Mouse)	646	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015908; GO:0015909; GO:0015911; GO:0031410; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0043231; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN3640_c0_g1_i1	Q60714	S27A1_MOUSE	51.3	534	258	1	1766	171	106	639	4.70E-162	572.8	S27A1_MOUSE	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Fatty acid transport protein) (Solute carrier family 27 member 1)	Slc27a1 Fatp Fatp1	Mus musculus (Mouse)	646	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015908; GO:0015909; GO:0015911; GO:0031410; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0043231; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN3640_c0_g1_i2	Q60714	S27A1_MOUSE	47	644	324	4	2090	171	9	639	7.30E-170	599	S27A1_MOUSE	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Fatty acid transport protein) (Solute carrier family 27 member 1)	Slc27a1 Fatp Fatp1	Mus musculus (Mouse)	646	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015908; GO:0015909; GO:0015911; GO:0031410; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0043231; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN29469_c0_g1_i1	Q60714	S27A1_MOUSE	98.5	68	1	0	207	4	569	636	1.90E-32	139	S27A1_MOUSE	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Fatty acid transport protein) (Solute carrier family 27 member 1)	Slc27a1 Fatp Fatp1	Mus musculus (Mouse)	646	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015908; GO:0015909; GO:0015911; GO:0031410; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0043231; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN19226_c0_g2_i1	P97849	S27A1_RAT	51.8	114	55	0	573	232	220	333	9.90E-29	128.3	S27A1_RAT	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Fatty acid transport protein) (Solute carrier family 27 member 1)	Slc27a1 Fatp Fatp1	Rattus norvegicus (Rat)	646	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015908; GO:0015909; GO:0015911; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0042802; GO:0043231; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN27398_c0_g1_i1	P97849	S27A1_RAT	84.6	65	10	0	201	7	496	560	3.80E-25	114.8	S27A1_RAT	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Fatty acid transport protein) (Solute carrier family 27 member 1)	Slc27a1 Fatp Fatp1	Rattus norvegicus (Rat)	646	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]	basal plasma membrane [GO:0009925]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015908; GO:0015909; GO:0015911; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0042802; GO:0043231; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN31108_c0_g1_i1	Q6PCB7	S27A1_HUMAN	100	77	0	0	233	3	276	352	4.40E-41	167.9	S27A1_HUMAN	reviewed	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.15) (Solute carrier family 27 member 1)	SLC27A1 ACSVL5 FATP1	Homo sapiens (Human)	646	basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of lipid metabolic process [GO:0019216]; response to cold [GO:0009409]; response to insulin [GO:0032868]; transport across blood-brain barrier [GO:0150104]	basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015909; GO:0015911; GO:0016020; GO:0019216; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0140115; GO:0150104; GO:1905135; GO:1990379	adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of lipid metabolic process [GO:0019216]; response to cold [GO:0009409]; response to insulin [GO:0032868]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN26850_c0_g1_i1	Q4R3Y4	S27A4_MACFA	43	121	67	1	12	368	71	191	1.70E-24	113.6	S27A4_MACFA	reviewed	Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-)	SLC27A4 FATP4 QtsA-13277	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	643	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid transport [GO:0015908]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0004467; GO:0005789; GO:0015908; GO:0016021; GO:0031957; GO:0047676	fatty acid transport [GO:0015908]		NA	NA	NA	NA	NA	NA
TRINITY_DN10746_c0_g1_i1	P51174	ACADL_MOUSE	71.6	67	19	0	220	20	360	426	6.30E-21	100.9	ACADL_MOUSE	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	Acadl	Mus musculus (Mouse)	430	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0055114; GO:0090181; GO:0120162	"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5705_c0_g1_i1	P79274	ACADL_PIG	61.5	182	68	1	1	546	113	292	7.00E-57	221.9	ACADL_PIG	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	ACADL	Sus scrofa (Pig)	430	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0033539; GO:0042758; GO:0050660	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5705_c0_g1_i2	P79274	ACADL_PIG	74.4	78	20	0	77	310	179	256	3.10E-26	119	ACADL_PIG	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	ACADL	Sus scrofa (Pig)	430	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0033539; GO:0042758; GO:0050660	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5705_c0_g1_i3	P51174	ACADL_MOUSE	71.5	193	55	0	1	579	113	305	1.60E-76	287	ACADL_MOUSE	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	Acadl	Mus musculus (Mouse)	430	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0055114; GO:0090181; GO:0120162	"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34641_c0_g1_i1	P51174	ACADL_MOUSE	100	71	0	0	1	213	359	429	3.00E-36	151.8	ACADL_MOUSE	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	Acadl	Mus musculus (Mouse)	430	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0055114; GO:0090181; GO:0120162	"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36843_c0_g1_i1	P51174	ACADL_MOUSE	100	159	0	0	479	3	125	283	8.90E-89	327.4	ACADL_MOUSE	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	Acadl	Mus musculus (Mouse)	430	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0055114; GO:0090181; GO:0120162	"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33308_c0_g1_i1	P28330	ACADL_HUMAN	42.9	63	36	0	191	3	253	315	3.10E-09	62	ACADL_HUMAN	reviewed	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	ACADL	Homo sapiens (Human)	430	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0006635; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0055114; GO:0090181; GO:0120162	"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7843_c0_g1_i1	Q9FDS1	ALD1_ACISP	79.2	72	15	0	217	2	136	207	6.70E-28	124	ALD1_ACISP	reviewed	Long-chain-aldehyde dehydrogenase (EC 1.2.1.48) (Aldehyde dehydrogenase 1)	ald1	Acinetobacter sp.	503	long-chain-aldehyde dehydrogenase activity [GO:0050061]; protein homotetramerization [GO:0051289]		long-chain-aldehyde dehydrogenase activity [GO:0050061]	GO:0050061; GO:0051289	protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN36399_c0_g1_i1	P94547	LCFA_BACSU	62	71	27	0	1	213	404	474	7.90E-21	100.5	LCFA_BACSU	reviewed	Long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) (Long-chain acyl-CoA synthetase)	lcfA BSU28560	Bacillus subtilis (strain 168)	560	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]		acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN34583_c0_g1_i1	P33121	ACSL1_HUMAN	68.6	86	27	0	260	3	500	585	2.10E-29	129.4	ACSL1_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24)	ACSL1 FACL1 FACL2 LACS LACS1 LACS2	Homo sapiens (Human)	698	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]	GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0007584; GO:0008610; GO:0014070; GO:0016020; GO:0016021; GO:0019216; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0036109; GO:0042178; GO:0042493; GO:0043651; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162	adiponectin-activated signaling pathway [GO:0033211]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN40110_c0_g1_i1	P33121	ACSL1_HUMAN	100	89	0	0	268	2	483	571	1.30E-49	196.4	ACSL1_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24)	ACSL1 FACL1 FACL2 LACS LACS1 LACS2	Homo sapiens (Human)	698	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]	GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0007584; GO:0008610; GO:0014070; GO:0016020; GO:0016021; GO:0019216; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0036109; GO:0042178; GO:0042493; GO:0043651; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162	adiponectin-activated signaling pathway [GO:0033211]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN32121_c0_g1_i1	P33121	ACSL1_HUMAN	49.3	71	35	1	220	8	417	486	1.70E-10	66.2	ACSL1_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24)	ACSL1 FACL1 FACL2 LACS LACS1 LACS2	Homo sapiens (Human)	698	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]	GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0007584; GO:0008610; GO:0014070; GO:0016020; GO:0016021; GO:0019216; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0036109; GO:0042178; GO:0042493; GO:0043651; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162	adiponectin-activated signaling pathway [GO:0033211]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN813_c0_g1_i1	P41216	ACSL1_MOUSE	49.7	660	322	5	4	1968	43	697	2.10E-198	693.7	ACSL1_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24)	Acsl1 Acsl2 Facl2	Mus musculus (Mouse)	699	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]	GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0014070; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0042493; GO:0044539; GO:0047676; GO:0050197; GO:0071902; GO:0102391; GO:0120162	adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN2001_c0_g1_i2	O95573	ACSL3_HUMAN	40.1	314	178	6	991	65	30	338	1.70E-58	228	ACSL3_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	ACSL3 ACS3 FACL3 LACS3	Homo sapiens (Human)	720	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0030182; GO:0034379; GO:0035336; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247	brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]		brown	brown	NA	NA	NA	NA
TRINITY_DN2001_c0_g1_i5	Q5R668	ACSL3_PONAB	46.7	694	358	8	2161	98	30	717	2.40E-176	620.5	ACSL3_PONAB	reviewed	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	ACSL3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	720	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391	long-chain fatty acid metabolic process [GO:0001676]		NA	NA	NA	NA	NA	NA
TRINITY_DN2001_c0_g1_i8	Q5R668	ACSL3_PONAB	46.7	694	358	8	2161	98	30	717	2.40E-176	620.5	ACSL3_PONAB	reviewed	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	ACSL3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	720	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391	long-chain fatty acid metabolic process [GO:0001676]		NA	NA	NA	NA	NA	NA
TRINITY_DN19637_c0_g1_i1	O95573	ACSL3_HUMAN	95.3	169	8	0	1	507	259	427	8.80E-87	320.9	ACSL3_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	ACSL3 ACS3 FACL3 LACS3	Homo sapiens (Human)	720	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0030182; GO:0034379; GO:0035336; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247	brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN19637_c0_g1_i2	Q9CZW4	ACSL3_MOUSE	98.8	80	1	0	1	240	259	338	1.00E-37	156.8	ACSL3_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	Acsl3 Acs3 Facl3	Mus musculus (Mouse)	720	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0030182; GO:0034379; GO:0035336; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247	brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN23580_c0_g1_i1	Q5R668	ACSL3_PONAB	55.3	114	50	1	350	12	491	604	7.80E-29	127.9	ACSL3_PONAB	reviewed	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	ACSL3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	720	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005789; GO:0016021; GO:0047676; GO:0102391	long-chain fatty acid metabolic process [GO:0001676]		NA	NA	NA	NA	NA	NA
TRINITY_DN2001_c0_g1_i6	O60488	ACSL4_HUMAN	52.7	374	175	2	1216	98	336	708	7.10E-114	412.1	ACSL4_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)	ACSL4 ACS4 FACL4 LACS4	Homo sapiens (Human)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN4347_c0_g1_i1	O60488	ACSL4_HUMAN	41.7	216	125	1	1	645	276	491	3.80E-42	172.9	ACSL4_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)	ACSL4 ACS4 FACL4 LACS4	Homo sapiens (Human)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		blue	blue	NA	NA	NA	NA
TRINITY_DN14956_c0_g1_i1	O60488	ACSL4_HUMAN	49.6	117	58	1	2	349	507	623	5.40E-27	121.7	ACSL4_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)	ACSL4 ACS4 FACL4 LACS4	Homo sapiens (Human)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		blue	blue	NA	NA	NA	NA
TRINITY_DN27277_c0_g1_i1	O60488	ACSL4_HUMAN	100	141	0	0	425	3	335	475	1.60E-78	293.1	ACSL4_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)	ACSL4 ACS4 FACL4 LACS4	Homo sapiens (Human)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN28046_c0_g1_i1	Q9QUJ7	ACSL4_MOUSE	100	66	0	0	3	200	250	315	5.00E-33	141	ACSL4_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) (mACS4)	Acsl4 Acs4 Facl4	Mus musculus (Mouse)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019217; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0031966; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN38233_c0_g1_i1	Q9QUJ7	ACSL4_MOUSE	98.7	75	1	0	226	2	554	628	8.30E-37	153.7	ACSL4_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) (mACS4)	Acsl4 Acs4 Facl4	Mus musculus (Mouse)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019217; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0031966; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN27672_c0_g1_i1	Q9QUJ7	ACSL4_MOUSE	100	97	0	0	292	2	313	409	3.80E-50	198.4	ACSL4_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) (mACS4)	Acsl4 Acs4 Facl4	Mus musculus (Mouse)	711	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019217; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0031966; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391	dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN26466_c0_g1_i1	Q9ULC5	ACSL5_HUMAN	100	123	0	0	1	369	314	436	2.20E-63	242.7	ACSL5_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)	ACSL5 ACS5 FACL5 UNQ633/PRO1250	Homo sapiens (Human)	683	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0010747; GO:0016020; GO:0016021; GO:0035338; GO:0047676; GO:0102391; GO:2001236	lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]		NA	NA	NA	NA	NA	NA
TRINITY_DN33534_c0_g1_i1	Q8JZR0	ACSL5_MOUSE	99	105	1	0	1	315	464	568	5.30E-58	224.6	ACSL5_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)	Acsl5 Facl5	Mus musculus (Mouse)	683	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0008654; GO:0010747; GO:0010867; GO:0015908; GO:0016020; GO:0016021; GO:0032000; GO:0035338; GO:0047676; GO:0102391; GO:2001236	fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]		NA	NA	NA	NA	NA	NA
TRINITY_DN32325_c0_g1_i1	Q8JZR0	ACSL5_MOUSE	100	97	0	0	291	1	308	404	1.30E-50	199.9	ACSL5_MOUSE	reviewed	Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)	Acsl5 Facl5	Mus musculus (Mouse)	683	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0008654; GO:0010747; GO:0010867; GO:0015908; GO:0016020; GO:0016021; GO:0032000; GO:0035338; GO:0047676; GO:0102391; GO:2001236	fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]		NA	NA	NA	NA	NA	NA
TRINITY_DN36122_c0_g1_i1	Q9ULC5	ACSL5_HUMAN	100	147	0	0	442	2	453	599	2.70E-84	312.4	ACSL5_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)	ACSL5 ACS5 FACL5 UNQ633/PRO1250	Homo sapiens (Human)	683	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0010747; GO:0016020; GO:0016021; GO:0035338; GO:0047676; GO:0102391; GO:2001236	lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]		NA	NA	NA	NA	NA	NA
TRINITY_DN29571_c0_g1_i1	Q9ULC5	ACSL5_HUMAN	100	76	0	0	228	1	604	679	2.90E-37	155.2	ACSL5_HUMAN	reviewed	Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)	ACSL5 ACS5 FACL5 UNQ633/PRO1250	Homo sapiens (Human)	683	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0010747; GO:0016020; GO:0016021; GO:0035338; GO:0047676; GO:0102391; GO:2001236	lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]		NA	NA	NA	NA	NA	NA
TRINITY_DN36710_c0_g1_i1	Q7ZYC4	ACBG2_XENLA	48.6	179	89	1	21	548	249	427	1.30E-39	164.5	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN31624_c0_g1_i1	Q7ZYC4	ACBG2_XENLA	41.4	70	39	1	234	25	438	505	3.80E-08	58.5	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN3478_c0_g1_i1	Q7ZYC4	ACBG2_XENLA	54.7	673	294	4	2048	63	67	739	1.10E-218	761.5	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			blue	blue	NA	NA	NA	NA
TRINITY_DN38785_c0_g1_i1	Q7ZYC4	ACBG2_XENLA	46.6	73	34	2	213	4	267	337	4.00E-11	68.6	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN21542_c0_g1_i1	Q7ZYC4	ACBG2_XENLA	50.6	233	108	3	8	703	507	733	3.40E-58	226.5	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN34603_c0_g1_i1	Q5ZKR7	ACBG2_CHICK	64	75	27	0	2	226	540	614	1.20E-22	106.7	ACBG2_CHICK	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	ACSBG2 RCJMB04_9i11	Gallus gallus (Chicken)	763	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005783; GO:0016020; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN36710_c0_g1_i2	Q7ZYC4	ACBG2_XENLA	47.7	65	34	0	21	215	249	313	2.10E-10	66.2	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			NA	NA	1	NA	NA	NA
TRINITY_DN24311_c0_g1_i1	Q5ZKR7	ACBG2_CHICK	51.9	108	41	1	5	328	520	616	1.30E-25	117.1	ACBG2_CHICK	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	ACSBG2 RCJMB04_9i11	Gallus gallus (Chicken)	763	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005783; GO:0016020; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN39424_c0_g1_i1	Q7ZYC4	ACBG2_XENLA	50.9	57	28	0	8	178	359	415	6.40E-10	64.3	ACBG2_XENLA	reviewed	Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2) (EC 6.2.1.15)	acsbg2	Xenopus laevis (African clawed frog)	739	cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0047676; GO:0102391			NA	NA	NA	NA	NA	NA
TRINITY_DN44_c2_g1_i4	P42283	LOLA1_DROME	48.6	72	37	0	100	315	3	74	2.50E-12	73.2	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c2_g1_i2	P42283	LOLA1_DROME	46.5	114	61	0	1104	763	3	116	4.10E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c2_g1_i4	P42283	LOLA1_DROME	46.5	114	61	0	1418	1077	3	116	5.20E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c2_g1_i5	P42283	LOLA1_DROME	47.4	114	60	0	963	622	3	116	2.10E-26	121.3	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN402_c0_g1_i2	P42283	LOLA1_DROME	46.9	113	60	0	95	433	4	116	9.10E-27	121.7	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN402_c0_g1_i3	P42283	LOLA1_DROME	46.9	113	60	0	63	401	4	116	1.10E-26	121.3	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN402_c0_g1_i4	P42283	LOLA1_DROME	44.4	126	64	1	95	472	4	123	8.40E-27	121.7	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN402_c0_g1_i5	P42283	LOLA1_DROME	46.9	113	60	0	86	424	4	116	9.00E-27	121.7	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN402_c0_g1_i6	P42283	LOLA1_DROME	44.4	126	64	1	86	463	4	123	8.20E-27	121.7	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12069_c0_g1_i1	P42283	LOLA1_DROME	57.1	84	36	0	314	63	33	116	4.40E-20	99	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12069_c0_g1_i2	P42283	LOLA1_DROME	46	113	61	0	401	63	4	116	3.70E-22	105.9	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c2_g1_i1	P42283	LOLA1_DROME	46.5	114	61	0	968	627	3	116	3.60E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	1	NA	NA	NA
TRINITY_DN35539_c0_g1_i1	P42283	LOLA1_DROME	48.7	113	58	0	132	470	4	116	1.60E-26	120.9	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25610_c0_g1_i1	P42283	LOLA1_DROME	51.9	108	52	0	413	90	9	116	2.20E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5269_c0_g1_i3	P42283	LOLA1_DROME	55.5	155	65	2	1880	1428	1	155	1.10E-39	166.4	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37348_c0_g1_i1	P42283	LOLA1_DROME	39.1	110	65	1	408	79	9	116	3.90E-18	92.8	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2608_c0_g2_i1	P42283	LOLA1_DROME	48.1	108	56	0	660	337	9	116	1.60E-26	121.3	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1763_c0_g1_i1	P42283	LOLA1_DROME	46.8	109	57	1	412	86	9	116	2.30E-21	103.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN105_c0_g1_i1	P42283	LOLA1_DROME	47.4	114	60	0	430	89	3	116	1.30E-26	120.9	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2497_c0_g1_i3	P42283	LOLA1_DROME	44.3	122	67	1	91	453	9	130	1.80E-24	115.5	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2497_c0_g1_i5	P42283	LOLA1_DROME	44.3	122	67	1	100	462	9	130	3.00E-24	114.8	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c0_g1_i1	P42283	LOLA1_DROME	47.4	116	61	0	87	434	1	116	5.20E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c0_g1_i2	P42283	LOLA1_DROME	47.4	116	61	0	87	434	1	116	5.10E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c0_g1_i3	P42283	LOLA1_DROME	47.4	116	61	0	87	434	1	116	5.70E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c0_g1_i4	P42283	LOLA1_DROME	47.4	116	61	0	87	434	1	116	4.40E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c0_g1_i6	P42283	LOLA1_DROME	47.4	116	61	0	87	434	1	116	5.40E-26	120.6	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1677_c0_g1_i2	P42283	LOLA1_DROME	50.9	108	53	0	470	147	9	116	6.90E-27	122.1	LOLA1_DROME	reviewed	"Longitudinals lacking protein, isoform G"	lola CG12052	Drosophila melanogaster (Fruit fly)	891	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c2_g2_i1	Q7KRI2	LOLAL_DROME	40.5	121	69	1	432	70	10	127	6.80E-21	102.1	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9633_c0_g1_i1	Q7KRI2	LOLAL_DROME	38.9	108	66	0	1206	883	10	117	4.60E-18	94	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39016_c0_g1_i1	Q7KRI2	LOLAL_DROME	41.5	94	54	1	332	51	25	117	3.40E-16	85.9	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29874_c0_g1_i1	Q7KRI2	LOLAL_DROME	50	114	57	0	443	102	4	117	7.20E-28	125.2	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38818_c0_g1_i1	Q7KRI2	LOLAL_DROME	33.9	127	83	1	402	22	1	126	7.70E-17	88.2	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN27074_c0_g1_i1	Q7KRI2	LOLAL_DROME	40.2	112	67	0	44	379	5	116	5.50E-22	105.5	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN599_c0_g2_i1	Q7KRI2	LOLAL_DROME	59.3	123	50	0	383	15	5	127	1.40E-38	160.6	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1260_c0_g1_i1	Q7KRI2	LOLAL_DROME	41.5	118	69	0	10	363	10	127	9.20E-21	102.1	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1260_c0_g1_i2	Q7KRI2	LOLAL_DROME	41.5	118	69	0	10	363	10	127	9.50E-21	102.1	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4973_c0_g1_i1	Q7KRI2	LOLAL_DROME	75.4	130	27	1	487	98	2	126	1.10E-50	201.4	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4973_c0_g1_i2	Q7KRI2	LOLAL_DROME	69.7	66	20	0	295	98	61	126	2.60E-19	96.3	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4973_c0_g1_i3	Q7KRI2	LOLAL_DROME	70	50	15	0	220	71	2	51	1.50E-15	84	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4973_c0_g1_i4	Q7KRI2	LOLAL_DROME	78.4	125	27	0	472	98	2	126	1.10E-52	208	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9376_c0_g1_i5	Q7KRI2	LOLAL_DROME	52.1	96	44	1	24	305	22	117	1.40E-21	105.5	LOLAL_DROME	reviewed	Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)	lolal ban CG5738	Drosophila melanogaster (Fruit fly)	127	"condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"	condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; polytene chromosome [GO:0005700]	DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]	GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006342; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0016458; GO:0031208; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944	"chromatin silencing [GO:0006342]; dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing [GO:0016458]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3609_c0_g1_i2	P20693	FCER2_MOUSE	28.6	119	71	5	203	559	204	308	4.30E-06	53.1	FCER2_MOUSE	reviewed	Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23)	Fcer2 Fcer2a	Mus musculus (Mouse)	331	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]	GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770	positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]		NA	NA	NA	NA	NA	NA
TRINITY_DN21553_c0_g1_i2	P20693	FCER2_MOUSE	34.8	89	55	2	276	13	186	272	4.50E-09	62	FCER2_MOUSE	reviewed	Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23)	Fcer2 Fcer2a	Mus musculus (Mouse)	331	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]	GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770	positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]		NA	NA	NA	NA	NA	NA
TRINITY_DN11564_c0_g1_i2	Q67FQ3	ARHB_XENLA	52.5	158	74	1	574	104	23	180	3.00E-42	173.3	ARHB_XENLA	reviewed	Low density lipoprotein receptor adapter protein 1-B (Autosomal recessive hypercholesterolemia protein homolog beta) (ARH beta) (xARH beta)	ldlrap1-b	Xenopus laevis (African clawed frog)	309	cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]	cytoplasm [GO:0005737]		GO:0005737; GO:0006897; GO:0008203	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN11564_c0_g1_i3	Q67FQ3	ARHB_XENLA	52.5	158	74	1	804	334	23	180	4.10E-42	173.3	ARHB_XENLA	reviewed	Low density lipoprotein receptor adapter protein 1-B (Autosomal recessive hypercholesterolemia protein homolog beta) (ARH beta) (xARH beta)	ldlrap1-b	Xenopus laevis (African clawed frog)	309	cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]	cytoplasm [GO:0005737]		GO:0005737; GO:0006897; GO:0008203	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN11564_c0_g1_i5	Q67FQ3	ARHB_XENLA	59.1	66	26	1	289	95	115	180	3.80E-16	85.5	ARHB_XENLA	reviewed	Low density lipoprotein receptor adapter protein 1-B (Autosomal recessive hypercholesterolemia protein homolog beta) (ARH beta) (xARH beta)	ldlrap1-b	Xenopus laevis (African clawed frog)	309	cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]	cytoplasm [GO:0005737]		GO:0005737; GO:0006897; GO:0008203	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN38962_c0_g1_i1	P11064	PPAC_BOVIN	52	150	68	3	551	111	7	155	3.60E-40	166.4	PPAC_BOVIN	reviewed	Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2)	ACP1	Bos taurus (Bovine)	158	cytoplasm [GO:0005737]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	cytoplasm [GO:0005737]	acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0003993; GO:0004725; GO:0004726; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN25565_c0_g1_i1	P01130	LDLR_HUMAN	100	121	0	0	2	364	489	609	7.80E-69	260.8	LDLR_HUMAN	reviewed	Low-density lipoprotein receptor (LDL receptor)	LDLR	Homo sapiens (Human)	860	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]	GO:0001540; GO:0001618; GO:0002020; GO:0005041; GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010008; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016020; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0030669; GO:0032050; GO:0034362; GO:0034381; GO:0034382; GO:0034383; GO:0034384; GO:0036020; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0061024; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]		NA	NA	NA	NA	NA	NA
TRINITY_DN34633_c0_g1_i1	P01130	LDLR_HUMAN	86.6	67	9	0	3	203	65	131	4.70E-31	134.4	LDLR_HUMAN	reviewed	Low-density lipoprotein receptor (LDL receptor)	LDLR	Homo sapiens (Human)	860	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]	GO:0001540; GO:0001618; GO:0002020; GO:0005041; GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010008; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016020; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0030669; GO:0032050; GO:0034362; GO:0034381; GO:0034382; GO:0034383; GO:0034384; GO:0036020; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0061024; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]		NA	NA	NA	NA	NA	NA
TRINITY_DN28646_c0_g1_i1	P01130	LDLR_HUMAN	100	90	0	0	272	3	309	398	3.40E-53	208.4	LDLR_HUMAN	reviewed	Low-density lipoprotein receptor (LDL receptor)	LDLR	Homo sapiens (Human)	860	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]	GO:0001540; GO:0001618; GO:0002020; GO:0005041; GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010008; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016020; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0030669; GO:0032050; GO:0034362; GO:0034381; GO:0034382; GO:0034383; GO:0034384; GO:0036020; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0061024; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]		NA	NA	NA	NA	NA	NA
TRINITY_DN9944_c0_g1_i1	P20063	LDLR_RABIT	41.7	559	277	12	47	1594	263	815	3.30E-120	433.7	LDLR_RABIT	reviewed	Low-density lipoprotein receptor (LDL receptor) (Fragment)	LDLR	Oryctolagus cuniculus (Rabbit)	837	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN9944_c0_g1_i3	P20063	LDLR_RABIT	39.5	86	40	4	57	296	736	815	1.60E-05	50.8	LDLR_RABIT	reviewed	Low-density lipoprotein receptor (LDL receptor) (Fragment)	LDLR	Oryctolagus cuniculus (Rabbit)	837	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN9944_c0_g1_i6	P20063	LDLR_RABIT	39.5	86	40	4	57	296	736	815	1.60E-05	50.8	LDLR_RABIT	reviewed	Low-density lipoprotein receptor (LDL receptor) (Fragment)	LDLR	Oryctolagus cuniculus (Rabbit)	837	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN9944_c0_g1_i7	P20063	LDLR_RABIT	41.7	559	277	12	47	1594	263	815	3.30E-120	433.7	LDLR_RABIT	reviewed	Low-density lipoprotein receptor (LDL receptor) (Fragment)	LDLR	Oryctolagus cuniculus (Rabbit)	837	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN3637_c0_g1_i1	Q99087	LDLR1_XENLA	36.5	721	412	19	2601	496	27	720	6.10E-134	479.9	LDLR1_XENLA	reviewed	Low-density lipoprotein receptor 1 (LDL receptor 1)	ldlr-a ldlr1	Xenopus laevis (African clawed frog)	909	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005905; GO:0006869; GO:0006897; GO:0008203; GO:0009986; GO:0016021; GO:0034362	cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN9072_c0_g1_i1	Q04833	LRP_CAEEL	44.1	188	99	4	5	562	1468	1651	6.20E-44	178.7	LRP_CAEEL	reviewed	Low-density lipoprotein receptor-related protein (LRP)	lrp-1 F29D11.1	Caenorhabditis elegans	4753	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"	apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16870_c0_g1_i1	Q04833	LRP_CAEEL	32.1	781	436	18	2240	3	709	1430	3.60E-100	367.5	LRP_CAEEL	reviewed	Low-density lipoprotein receptor-related protein (LRP)	lrp-1 F29D11.1	Caenorhabditis elegans	4753	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"	apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16870_c0_g1_i2	Q04833	LRP_CAEEL	34.3	727	438	16	2078	3	709	1430	2.20E-107	391.3	LRP_CAEEL	reviewed	Low-density lipoprotein receptor-related protein (LRP)	lrp-1 F29D11.1	Caenorhabditis elegans	4753	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"	apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27143_c0_g1_i1	Q04833	LRP_CAEEL	36.1	133	81	2	65	460	1624	1753	2.70E-16	86.7	LRP_CAEEL	reviewed	Low-density lipoprotein receptor-related protein (LRP)	lrp-1 F29D11.1	Caenorhabditis elegans	4753	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"	apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34144_c0_g1_i1	Q04833	LRP_CAEEL	42.1	95	51	2	14	286	1164	1258	2.30E-14	79.7	LRP_CAEEL	reviewed	Low-density lipoprotein receptor-related protein (LRP)	lrp-1 F29D11.1	Caenorhabditis elegans	4753	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"	apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29977_c0_g1_i1	Q04833	LRP_CAEEL	57.4	47	17	2	266	135	1193	1239	1.30E-09	63.9	LRP_CAEEL	reviewed	Low-density lipoprotein receptor-related protein (LRP)	lrp-1 F29D11.1	Caenorhabditis elegans	4753	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"	apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19665_c0_g1_i1	P98157	LRP1_CHICK	43.4	143	79	2	426	4	527	669	8.60E-33	141.4	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN19665_c0_g1_i3	P98157	LRP1_CHICK	44.3	97	54	0	342	52	527	623	1.50E-22	107.1	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN36945_c0_g1_i1	P98157	LRP1_CHICK	40.3	72	42	1	88	300	1190	1261	3.80E-10	65.9	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN24498_c0_g2_i1	P98157	LRP1_CHICK	43.4	198	95	7	602	27	2726	2912	6.30E-39	162.2	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN28980_c0_g1_i1	P98157	LRP1_CHICK	40.7	59	34	1	265	92	2029	2087	3.90E-09	62	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN25529_c0_g1_i1	P98157	LRP1_CHICK	59.5	84	34	0	38	289	1325	1408	9.60E-26	117.5	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN12808_c0_g1_i2	P98157	LRP1_CHICK	51.9	133	59	1	400	2	3155	3282	2.20E-41	169.9	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN19101_c0_g1_i1	P98157	LRP1_CHICK	53.2	79	36	1	2	235	3249	3327	2.00E-20	99.4	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964			NA	NA	NA	NA	NA	NA
TRINITY_DN23033_c0_g1_i1	Q7Z4F1	LRP10_HUMAN	100	75	0	0	1	225	401	475	2.10E-40	165.6	LRP10_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 10 (LRP-10)	LRP10 MSTP087 SP220 UNQ389/PRO724	Homo sapiens (Human)	713	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; low-density lipoprotein particle receptor activity [GO:0005041]; inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	low-density lipoprotein particle receptor activity [GO:0005041]	GO:0005041; GO:0005905; GO:0006629; GO:0006869; GO:0016020; GO:0016021; GO:0048839	inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN23033_c0_g1_i2	Q7Z4F1	LRP10_HUMAN	98.5	68	1	0	1	204	401	468	2.40E-35	148.7	LRP10_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 10 (LRP-10)	LRP10 MSTP087 SP220 UNQ389/PRO724	Homo sapiens (Human)	713	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; low-density lipoprotein particle receptor activity [GO:0005041]; inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	low-density lipoprotein particle receptor activity [GO:0005041]	GO:0005041; GO:0005905; GO:0006629; GO:0006869; GO:0016020; GO:0016021; GO:0048839	inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN2011_c0_g1_i1	Q9BE74	LRP12_MACFA	46.6	146	70	4	455	30	224	365	1.70E-28	127.1	LRP12_MACFA	reviewed	Low-density lipoprotein receptor-related protein 12 (LRP-12) (Fragment)	LRP12 QnpA-21564	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	701	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]		GO:0005905; GO:0006897; GO:0016021	endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN2011_c0_g1_i2	Q9BE74	LRP12_MACFA	46.6	146	70	4	455	30	224	365	1.70E-28	127.1	LRP12_MACFA	reviewed	Low-density lipoprotein receptor-related protein 12 (LRP-12) (Fragment)	LRP12 QnpA-21564	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	701	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]		GO:0005905; GO:0006897; GO:0016021	endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN2011_c0_g1_i3	Q9BE74	LRP12_MACFA	46.6	146	70	4	455	30	224	365	1.70E-28	127.1	LRP12_MACFA	reviewed	Low-density lipoprotein receptor-related protein 12 (LRP-12) (Fragment)	LRP12 QnpA-21564	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	701	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]		GO:0005905; GO:0006897; GO:0016021	endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN2011_c0_g1_i4	Q9BE74	LRP12_MACFA	46.6	146	70	4	455	30	224	365	1.70E-28	127.1	LRP12_MACFA	reviewed	Low-density lipoprotein receptor-related protein 12 (LRP-12) (Fragment)	LRP12 QnpA-21564	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	701	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]		GO:0005905; GO:0006897; GO:0016021	endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN27970_c0_g1_i1	Q9JI18	LRP1B_MOUSE	43.4	83	45	1	319	71	2718	2798	3.50E-16	85.9	LRP1B_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	Lrp1b Lrpdit	Mus musculus (Mouse)	4599	integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001701; GO:0005041; GO:0005509; GO:0016020; GO:0016021; GO:0043235; GO:0050750	in utero embryonic development [GO:0001701]		NA	NA	NA	NA	NA	NA
TRINITY_DN19665_c0_g1_i2	Q9NZR2	LRP1B_HUMAN	41.5	53	31	0	204	46	522	574	1.10E-07	57	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN9072_c0_g1_i3	Q9NZR2	LRP1B_HUMAN	34.4	151	97	1	5	451	1245	1395	1.90E-20	100.5	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN155_c0_g2_i1	Q9NZR2	LRP1B_HUMAN	28.7	188	114	8	799	254	904	1077	1.40E-13	79	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN155_c0_g2_i3	Q9NZR2	LRP1B_HUMAN	28.7	188	114	8	925	380	904	1077	1.60E-13	79	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		blue	blue	NA	NA	NA	NA
TRINITY_DN8828_c0_g1_i1	Q9NZR2	LRP1B_HUMAN	39.6	96	52	2	290	9	1023	1114	6.30E-13	74.7	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		blue	blue	NA	NA	NA	NA
TRINITY_DN28129_c0_g1_i1	Q9NZR2	LRP1B_HUMAN	38.2	89	52	2	279	16	3581	3667	6.80E-12	71.2	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN39498_c0_g1_i1	Q9NZR2	LRP1B_HUMAN	36.9	65	39	2	3	194	573	636	4.50E-05	48.1	LRP1B_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	LRP1B LRPDIT	Homo sapiens (Human)	4599	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN18_c0_g1_i1	P98158	LRP2_RAT	40.5	74	32	3	1018	818	3022	3090	5.30E-07	57	LRP2_RAT	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Rattus norvegicus (Rat)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		black	black	1	NA	NA	1
TRINITY_DN5101_c0_g1_i2	A2ARV4	LRP2_MOUSE	51.9	52	20	2	759	911	3788	3835	5.00E-06	53.5	LRP2_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Mus musculus (Mouse)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035258; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN5101_c0_g1_i5	P98158	LRP2_RAT	32.8	131	43	5	932	1315	3788	3876	6.70E-07	57	LRP2_RAT	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Rattus norvegicus (Rat)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN39380_c0_g1_i1	C0HL13	LRP2_PIG	28.5	291	178	12	6	851	3173	3442	8.80E-23	109	LRP2_PIG	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Sus scrofa (Pig)	4652	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124]	GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167	coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]		NA	NA	NA	NA	NA	NA
TRINITY_DN40225_c0_g1_i2	P98164	LRP2_HUMAN	33.6	110	69	4	367	47	1960	2068	4.10E-09	62.8	LRP2_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Homo sapiens (Human)	4655	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]	GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0015031; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1905167	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]		NA	NA	NA	NA	NA	NA
TRINITY_DN6811_c0_g1_i3	P98158	LRP2_RAT	34.2	395	217	12	1595	438	2706	3066	2.00E-52	208.4	LRP2_RAT	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Rattus norvegicus (Rat)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN24498_c0_g1_i1	P98158	LRP2_RAT	54	87	38	2	256	2	2810	2896	2.30E-22	105.9	LRP2_RAT	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Rattus norvegicus (Rat)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN40921_c0_g1_i1	P98164	LRP2_HUMAN	47.1	51	18	2	69	203	3923	3970	1.20E-05	50.1	LRP2_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Homo sapiens (Human)	4655	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]	GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0015031; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1905167	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]		NA	NA	NA	NA	NA	NA
TRINITY_DN35679_c0_g1_i1	C0HL13	LRP2_PIG	44.2	251	130	2	6	734	3212	3460	4.80E-65	249.2	LRP2_PIG	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Sus scrofa (Pig)	4652	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124]	GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167	coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]		NA	NA	NA	NA	NA	NA
TRINITY_DN39674_c0_g1_i1	P98164	LRP2_HUMAN	48.6	70	36	0	228	19	3109	3178	4.60E-17	88.2	LRP2_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Homo sapiens (Human)	4655	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]	GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0015031; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1905167	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]		NA	NA	NA	NA	NA	NA
TRINITY_DN27143_c0_g1_i2	P98158	LRP2_RAT	37.4	353	199	8	10	1035	326	667	3.30E-64	246.9	LRP2_RAT	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Rattus norvegicus (Rat)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to leptin [GO:0044321]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN39218_c0_g1_i1	A2ARV4	LRP2_MOUSE	51.2	41	20	0	172	50	3685	3725	7.90E-05	47.4	LRP2_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Mus musculus (Mouse)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035258; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN2405_c0_g1_i1	P98164	LRP2_HUMAN	40.9	843	456	20	18	2483	3522	4343	1.00E-159	565.5	LRP2_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Homo sapiens (Human)	4655	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]	GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0015031; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1905167	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]		NA	NA	NA	NA	NA	NA
TRINITY_DN2405_c0_g1_i3	P98164	LRP2_HUMAN	45.2	341	176	6	18	1028	3522	3855	4.00E-58	227.3	LRP2_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Homo sapiens (Human)	4655	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]	GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0015031; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1905167	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]		NA	NA	NA	NA	NA	NA
TRINITY_DN33453_c0_g1_i1	A2ARV4	LRP2_MOUSE	44.8	96	48	3	30	302	3672	3767	1.00E-14	80.9	LRP2_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	Lrp2	Mus musculus (Mouse)	4660	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]	GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035258; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]		NA	NA	NA	NA	NA	NA
TRINITY_DN32391_c0_g1_i1	Q8VI56	LRP4_MOUSE	57.8	64	24	2	249	58	45	105	1.10E-13	77	LRP4_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)	Lrp4 Kiaa0816	Mus musculus (Mouse)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21813_c0_g1_i1	Q8VI56	LRP4_MOUSE	67.1	82	27	0	71	316	816	897	4.30E-31	135.2	LRP4_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)	Lrp4 Kiaa0816	Mus musculus (Mouse)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15399_c1_g1_i3	Q8VI56	LRP4_MOUSE	42.4	262	147	4	782	3	1093	1352	8.30E-63	241.9	LRP4_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)	Lrp4 Kiaa0816	Mus musculus (Mouse)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15399_c1_g1_i4	Q8VI56	LRP4_MOUSE	42.3	111	62	2	393	64	1093	1202	8.50E-19	94.7	LRP4_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)	Lrp4 Kiaa0816	Mus musculus (Mouse)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN10464_c0_g1_i2	O75096	LRP4_HUMAN	29.7	118	75	2	73	411	78	192	4.60E-09	62.4	LRP4_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21813_c0_g1_i2	O75096	LRP4_HUMAN	69.1	55	17	0	71	235	816	870	7.40E-19	94.4	LRP4_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		pink	pink	NA	NA	NA	NA
TRINITY_DN24507_c0_g1_i1	O75096	LRP4_HUMAN	50.7	71	35	0	218	6	925	995	8.10E-16	84	LRP4_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN15399_c1_g1_i2	O75096	LRP4_HUMAN	40.6	138	81	1	464	54	1503	1640	2.00E-31	137.1	LRP4_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN33782_c0_g1_i1	O75096	LRP4_HUMAN	55.7	79	35	0	2	238	1485	1563	4.60E-22	104.8	LRP4_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	1905	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3743_c1_g1_i1	O75197	LRP5_HUMAN	61.2	129	50	0	392	6	397	525	3.10E-45	182.6	LRP5_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	LRP5 LR3 LRP7	Homo sapiens (Human)	1615	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]	coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1901998; GO:1902262; GO:1904928; GO:1990851; GO:1990909	"adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling involved in mammary gland development [GO:0060764]; cell migration involved in gastrulation [GO:0042074]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retinal blood vessel morphogenesis [GO:0061304]; retina morphogenesis in camera-type eye [GO:0060042]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3743_c1_g1_i2	O75197	LRP5_HUMAN	69.6	56	17	0	252	85	397	452	1.80E-17	89.7	LRP5_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	LRP5 LR3 LRP7	Homo sapiens (Human)	1615	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]	coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1901998; GO:1902262; GO:1904928; GO:1990851; GO:1990909	"adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling involved in mammary gland development [GO:0060764]; cell migration involved in gastrulation [GO:0042074]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retinal blood vessel morphogenesis [GO:0061304]; retina morphogenesis in camera-type eye [GO:0060042]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39631_c0_g1_i1	O75197	LRP5_HUMAN	69.7	89	27	0	2	268	689	777	1.40E-35	149.8	LRP5_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	LRP5 LR3 LRP7	Homo sapiens (Human)	1615	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]	coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1901998; GO:1902262; GO:1904928; GO:1990851; GO:1990909	"adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling involved in mammary gland development [GO:0060764]; cell migration involved in gastrulation [GO:0042074]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retinal blood vessel morphogenesis [GO:0061304]; retina morphogenesis in camera-type eye [GO:0060042]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4682_c0_g1_i1	O75197	LRP5_HUMAN	49.6	137	64	2	494	87	33	165	1.10E-33	144.8	LRP5_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	LRP5 LR3 LRP7	Homo sapiens (Human)	1615	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]	coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1901998; GO:1902262; GO:1904928; GO:1990851; GO:1990909	"adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling involved in mammary gland development [GO:0060764]; cell migration involved in gastrulation [GO:0042074]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retinal blood vessel morphogenesis [GO:0061304]; retina morphogenesis in camera-type eye [GO:0060042]; somatic stem cell population maintenance [GO:0035019]; toxin transport [GO:1901998]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12808_c0_g1_i1	Q91VN0	LRP5_MOUSE	42.6	68	39	0	286	83	472	539	9.40E-13	74.3	LRP5_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	Lrp5 Lr3 Lrp7	Mus musculus (Mouse)	1614	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity [GO:0015026]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	coreceptor activity [GO:0015026]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0061178; GO:0061299; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262	"adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling involved in mammary gland development [GO:0060764]; cell migration involved in gastrulation [GO:0042074]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retinal blood vessel morphogenesis [GO:0061304]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4682_c0_g1_i2	O88572	LRP6_MOUSE	50	264	122	4	791	6	7	262	5.20E-74	279.3	LRP6_MOUSE	reviewed	Low-density lipoprotein receptor-related protein 6 (LRP-6)	Lrp6	Mus musculus (Mouse)	1613	"cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; Wnt signalosome [GO:1990909]	apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030278; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168	"anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell-cell adhesion [GO:0098609]; cell migration involved in gastrulation [GO:0042074]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10464_c0_g1_i1	Q98931	LRP8_CHICK	34.1	287	176	5	3	848	29	307	9.20E-44	178.7	LRP8_CHICK	reviewed	Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) (Protein LR8B)	LRP8 LR8B	Gallus gallus (Chicken)	917	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; ventral spinal cord development [GO:0021517]	integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006897; GO:0016021; GO:0021517	endocytosis [GO:0006897]; ventral spinal cord development [GO:0021517]		NA	NA	NA	NA	NA	NA
TRINITY_DN31064_c0_g1_i1	Q98931	LRP8_CHICK	40	55	33	0	224	60	509	563	2.20E-05	49.7	LRP8_CHICK	reviewed	Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) (Protein LR8B)	LRP8 LR8B	Gallus gallus (Chicken)	917	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; ventral spinal cord development [GO:0021517]	integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]	GO:0005509; GO:0006897; GO:0016021; GO:0021517	endocytosis [GO:0006897]; ventral spinal cord development [GO:0021517]		NA	NA	NA	NA	NA	NA
TRINITY_DN25560_c0_g1_i1	Q5U2R7	MESD_RAT	94.7	133	7	0	3	401	25	157	5.60E-68	258.1	MESD_RAT	reviewed	LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein)	Mesd Mesdc2	Rattus norvegicus (Rat)	224	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395	ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN39756_c0_g1_i1	Q14696	MESD_HUMAN	100	115	0	0	54	398	55	169	6.50E-61	234.6	MESD_HUMAN	reviewed	LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61)	MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369	Homo sapiens (Human)	234	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395	mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN7486_c0_g1_i1	Q47944	SDH_GLUOY	54.3	105	47	1	407	93	193	296	9.00E-24	111.3	SDH_GLUOY	reviewed	L-sorbose 1-dehydrogenase (SDH) (EC 1.1.99.32)		Gluconobacter oxydans (Gluconobacter suboxydans)	531	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"		"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN41096_c0_g1_i1	P36007	LTHAD_YEAST	81.6	76	14	0	2	229	153	228	1.30E-29	129.8	LTHAD_YEAST	reviewed	L-threo-3-hydroxyaspartate ammonia-lyase (EC 4.3.1.16) (L-threo-3-hydroxyaspartate dehydratase)	SRY1 YKL218C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	326	ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threo-3-hydroxyaspartate ammonia-lyase activity [GO:0030848]; threonine racemase activity [GO:0018114]; cellular modified amino acid catabolic process [GO:0042219]; D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]		ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threo-3-hydroxyaspartate ammonia-lyase activity [GO:0030848]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005524; GO:0006563; GO:0008721; GO:0018114; GO:0030170; GO:0030378; GO:0030848; GO:0042219; GO:0042866; GO:0070179	cellular modified amino acid catabolic process [GO:0042219]; D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]		NA	NA	NA	NA	NA	NA
TRINITY_DN554_c0_g1_i1	A4F2N8	LTHAD_PSESP	41	78	43	3	351	118	238	312	5.90E-07	55.5	LTHAD_PSESP	reviewed	L-threo-3-hydroxyaspartate ammonia-lyase (EC 4.3.1.16) (L-threo-3-hydroxyaspartate dehydratase) (L-THA DH)	thadh	Pseudomonas sp.	319	pyridoxal phosphate binding [GO:0030170]; threo-3-hydroxyaspartate ammonia-lyase activity [GO:0030848]; cellular amino acid metabolic process [GO:0006520]; cellular modified amino acid catabolic process [GO:0042219]		pyridoxal phosphate binding [GO:0030170]; threo-3-hydroxyaspartate ammonia-lyase activity [GO:0030848]	GO:0006520; GO:0030170; GO:0030848; GO:0042219	cellular amino acid metabolic process [GO:0006520]; cellular modified amino acid catabolic process [GO:0042219]		NA	NA	NA	NA	NA	NA
TRINITY_DN26787_c0_g1_i1	Q72L62	TDH_THET2	45.3	53	29	0	252	94	290	342	3.40E-09	62.4	TDH_THET2	reviewed	L-threonine 3-dehydrogenase (TDH) (EC 1.1.1.103)	tdh TT_C0201	Thermus thermophilus (strain HB27 / ATCC BAA-163 / DSM 7039)	343	cytoplasm [GO:0005737]; L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]	cytoplasm [GO:0005737]	L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008743; GO:0019518	L-threonine catabolic process to glycine [GO:0019518]		NA	NA	NA	NA	NA	NA
TRINITY_DN26787_c0_g1_i2	A7Z4X0	TDH_BACVZ	39.5	195	117	1	681	97	154	347	8.20E-38	158.7	TDH_BACVZ	reviewed	L-threonine 3-dehydrogenase (TDH) (EC 1.1.1.103)	tdh RBAM_016830	Bacillus velezensis (strain DSM 23117 / BGSC 10A6 / FZB42) (Bacillus amyloliquefaciens subsp. plantarum)	347	cytoplasm [GO:0005737]; L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]	cytoplasm [GO:0005737]	L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008743; GO:0019518	L-threonine catabolic process to glycine [GO:0019518]		NA	NA	NA	NA	NA	NA
TRINITY_DN4446_c0_g1_i2	A7Z4X0	TDH_BACVZ	24.9	334	219	10	1053	97	31	347	1.10E-16	89.4	TDH_BACVZ	reviewed	L-threonine 3-dehydrogenase (TDH) (EC 1.1.1.103)	tdh RBAM_016830	Bacillus velezensis (strain DSM 23117 / BGSC 10A6 / FZB42) (Bacillus amyloliquefaciens subsp. plantarum)	347	cytoplasm [GO:0005737]; L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]	cytoplasm [GO:0005737]	L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008743; GO:0019518	L-threonine catabolic process to glycine [GO:0019518]		blue	blue	NA	NA	NA	NA
TRINITY_DN38363_c0_g1_i1	Q2KIR8	TDH_BOVIN	68.8	48	14	1	78	221	199	245	1.10E-14	80.5	TDH_BOVIN	reviewed	"L-threonine 3-dehydrogenase, mitochondrial (EC 1.1.1.103)"	TDH	Bos taurus (Bovine)	373	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]	GO:0005739; GO:0006567; GO:0008743; GO:0019518; GO:0042802	L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]		NA	NA	NA	NA	NA	NA
TRINITY_DN32783_c0_g1_i1	Q3SX41	LC7L3_BOVIN	100	122	0	0	3	368	116	237	8.70E-60	230.7	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i10	Q3SX41	LC7L3_BOVIN	48.6	253	114	3	837	79	3	239	2.70E-65	251.1	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i11	Q3SX41	LC7L3_BOVIN	45.8	155	69	2	552	91	100	240	2.30E-30	133.7	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i14	Q3SX41	LC7L3_BOVIN	50.2	237	111	2	47	757	3	232	7.50E-66	251.9	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i2	Q3SX41	LC7L3_BOVIN	48.3	147	69	2	528	91	100	240	4.50E-31	136	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i5	Q3SX41	LC7L3_BOVIN	47.8	253	117	2	849	91	3	240	7.90E-65	249.6	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i6	Q3SX41	LC7L3_BOVIN	47.1	155	66	3	540	79	100	239	6.00E-31	135.6	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c0_g1_i8	Q3SX41	LC7L3_BOVIN	49.7	147	66	3	516	79	100	239	1.20E-31	137.9	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN21242_c0_g1_i2	Q3SX41	LC7L3_BOVIN	100	101	0	0	305	3	1	101	2.30E-54	212.6	LC7L3_BOVIN	reviewed	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)	LUC7L3 CROP	Bos taurus (Bovine)	432	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN7955_c0_g1_i2	Q26304	LUCI_LUCMI	60.3	58	23	0	21	194	394	451	5.70E-13	74.3	LUCI_LUCMI	reviewed	Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7)		Luciola mingrelica (Southern Russian firefly)	548	peroxisome [GO:0005777]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity [GO:0047077]; bioluminescence [GO:0008218]	peroxisome [GO:0005777]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity [GO:0047077]	GO:0000287; GO:0005524; GO:0005777; GO:0008218; GO:0047077	bioluminescence [GO:0008218]		NA	NA	NA	NA	NA	NA
TRINITY_DN7955_c0_g1_i7	P08659	LUCI_PHOPY	55.1	107	46	1	21	335	392	498	5.30E-26	118.6	LUCI_PHOPY	reviewed	Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7)		Photinus pyralis (Common eastern firefly) (Lampyris pyralis)	550	peroxisome [GO:0005777]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity [GO:0047077]; bioluminescence [GO:0008218]	peroxisome [GO:0005777]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing) activity [GO:0047077]	GO:0005524; GO:0005777; GO:0008218; GO:0046872; GO:0047077; GO:0051087	bioluminescence [GO:0008218]		NA	NA	NA	NA	NA	NA
TRINITY_DN35878_c0_g1_i1	A0A173GP47	LST_PHOPY	38.8	80	47	1	161	394	147	226	3.60E-11	69.3	LST_PHOPY	reviewed	Luciferin sulfotransferase (EC 2.8.2.-)	LST	Photinus pyralis (Common eastern firefly) (Lampyris pyralis)	370	sulfotransferase activity [GO:0008146]		sulfotransferase activity [GO:0008146]	GO:0008146			NA	NA	NA	NA	NA	NA
TRINITY_DN13451_c0_g1_i1	A0A173GP47	LST_PHOPY	38.4	73	44	1	255	37	53	124	1.00E-09	63.9	LST_PHOPY	reviewed	Luciferin sulfotransferase (EC 2.8.2.-)	LST	Photinus pyralis (Common eastern firefly) (Lampyris pyralis)	370	sulfotransferase activity [GO:0008146]		sulfotransferase activity [GO:0008146]	GO:0008146			blue	blue	NA	NA	NA	NA
TRINITY_DN25663_c0_g1_i1	A0A173GP47	LST_PHOPY	47.8	46	24	0	215	78	67	112	1.90E-08	59.7	LST_PHOPY	reviewed	Luciferin sulfotransferase (EC 2.8.2.-)	LST	Photinus pyralis (Common eastern firefly) (Lampyris pyralis)	370	sulfotransferase activity [GO:0008146]		sulfotransferase activity [GO:0008146]	GO:0008146			NA	NA	NA	NA	NA	NA
TRINITY_DN3562_c0_g2_i1	Q03684	BIP4_TOBAC	75.2	444	106	2	1345	26	143	586	3.50E-191	669.1	BIP4_TOBAC	reviewed	Luminal-binding protein 4 (BiP 4) (78 kDa glucose-regulated protein homolog 4) (GRP-78-4)	BIP4	Nicotiana tabacum (Common tobacco)	667	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN668_c0_g1_i1	Q03685	BIP5_TOBAC	71.6	577	155	5	1718	3	22	594	1.90E-234	813.1	BIP5_TOBAC	reviewed	Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5)	BIP5	Nicotiana tabacum (Common tobacco)	668	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN668_c0_g1_i2	Q03685	BIP5_TOBAC	73.5	563	141	5	1671	4	21	582	1.10E-234	813.9	BIP5_TOBAC	reviewed	Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5)	BIP5	Nicotiana tabacum (Common tobacco)	668	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN668_c0_g1_i3	Q03685	BIP5_TOBAC	72.7	565	148	4	1710	31	22	585	6.60E-235	814.7	BIP5_TOBAC	reviewed	Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5)	BIP5	Nicotiana tabacum (Common tobacco)	668	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN668_c0_g1_i4	Q03685	BIP5_TOBAC	72.6	336	89	3	1003	2	22	356	1.50E-133	477.2	BIP5_TOBAC	reviewed	Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5)	BIP5	Nicotiana tabacum (Common tobacco)	668	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN668_c0_g1_i6	Q03685	BIP5_TOBAC	72.4	573	149	5	1706	3	26	594	6.00E-236	818.1	BIP5_TOBAC	reviewed	Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5)	BIP5	Nicotiana tabacum (Common tobacco)	668	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN3562_c0_g1_i1	Q03685	BIP5_TOBAC	72	107	28	2	1	321	28	132	8.90E-40	164.1	BIP5_TOBAC	reviewed	Luminal-binding protein 5 (BiP 5) (78 kDa glucose-regulated protein homolog 5) (GRP-78-5)	BIP5	Nicotiana tabacum (Common tobacco)	668	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034620; GO:0034663; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN27161_c0_g1_i1	P32067	LA_MOUSE	98.8	85	1	0	256	2	1	85	2.70E-42	172.2	LA_MOUSE	reviewed	Lupus La protein homolog (La autoantigen homolog) (La ribonucleoprotein)	Ssb Ss-b	Mus musculus (Mouse)	415	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]	GO:0000049; GO:0001682; GO:0003723; GO:0005634; GO:0005737; GO:0006409; GO:0008033; GO:0008266; GO:0042780; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904	IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN27161_c0_g1_i2	P32067	LA_MOUSE	98.8	85	1	0	256	2	1	85	2.70E-42	172.2	LA_MOUSE	reviewed	Lupus La protein homolog (La autoantigen homolog) (La ribonucleoprotein)	Ssb Ss-b	Mus musculus (Mouse)	415	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]	GO:0000049; GO:0001682; GO:0003723; GO:0005634; GO:0005737; GO:0006409; GO:0008033; GO:0008266; GO:0042780; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904	IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN21302_c0_g2_i1	Q90674	LSHR_CHICK	47.4	152	78	2	452	3	444	595	4.90E-34	145.6	LSHR_CHICK	reviewed	Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R) (cLH-R)	LHCGR	Gallus gallus (Chicken)	728	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]	GO:0001541; GO:0004964; GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]		NA	NA	NA	NA	NA	NA
TRINITY_DN29419_c0_g1_i1	Q7Z4W1	DCXR_HUMAN	100	75	0	0	2	226	74	148	3.30E-33	141.7	DCXR_HUMAN	reviewed	L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)	DCXR SDR20C1	Homo sapiens (Human)	244	"brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; xylulose metabolic process [GO:0005997]"	brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"	GO:0004090; GO:0005634; GO:0005881; GO:0005886; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016655; GO:0019640; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0055114; GO:0070062	D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN27335_c0_g1_i1	Q7Z4W1	DCXR_HUMAN	100	93	0	0	286	8	152	244	2.10E-48	192.6	DCXR_HUMAN	reviewed	L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)	DCXR SDR20C1	Homo sapiens (Human)	244	"brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; xylulose metabolic process [GO:0005997]"	brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"	GO:0004090; GO:0005634; GO:0005881; GO:0005886; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016655; GO:0019640; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0055114; GO:0070062	D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i1	Q91XV4	DCXR_MESAU	54	200	92	0	920	321	6	205	1.50E-56	221.5	DCXR_MESAU	reviewed	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	DCXR	Mesocricetus auratus (Golden hamster)	244	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; xylulose metabolic process [GO:0005997]"	acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]	"identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038	D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i8	Q91XV4	DCXR_MESAU	56.1	237	104	0	786	76	6	242	2.40E-71	270.4	DCXR_MESAU	reviewed	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	DCXR	Mesocricetus auratus (Golden hamster)	244	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; xylulose metabolic process [GO:0005997]"	acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]	"identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038	D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN21553_c0_g1_i1	Q60767	LY75_MOUSE	26.1	134	86	3	387	13	322	451	1.20E-09	64.3	LY75_MOUSE	reviewed	Lymphocyte antigen 75 (Ly-75) (DEC-205) (CD antigen CD205)	Ly75 Cd205	Mus musculus (Mouse)	1723	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; endocytosis [GO:0006897]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]	GO:0006897; GO:0009897; GO:0016021; GO:0030246; GO:0038023	endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i17	Q60848	HELLS_MOUSE	50.3	195	91	3	40	624	280	468	1.10E-48	195.3	HELLS_MOUSE	reviewed	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)	Hells Lsh Pasg	Mus musculus (Mouse)	821	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0001655; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006342; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0030098; GO:0031508; GO:0043066; GO:0046651; GO:0051301; GO:1990830; GO:2001243	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i3	Q60848	HELLS_MOUSE	50.3	195	91	3	47	631	280	468	8.30E-49	195.7	HELLS_MOUSE	reviewed	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)	Hells Lsh Pasg	Mus musculus (Mouse)	821	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0001655; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006342; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0030098; GO:0031508; GO:0043066; GO:0046651; GO:0051301; GO:1990830; GO:2001243	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i4	Q60848	HELLS_MOUSE	51.6	182	82	3	1	546	280	455	5.30E-47	189.5	HELLS_MOUSE	reviewed	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)	Hells Lsh Pasg	Mus musculus (Mouse)	821	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0001655; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006342; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0030098; GO:0031508; GO:0043066; GO:0046651; GO:0051301; GO:1990830; GO:2001243	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN33677_c0_g1_i1	Q60848	HELLS_MOUSE	66	97	30	1	296	6	204	297	7.30E-33	141	HELLS_MOUSE	reviewed	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)	Hells Lsh Pasg	Mus musculus (Mouse)	821	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0001655; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006342; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0030098; GO:0031508; GO:0043066; GO:0046651; GO:0051301; GO:1990830; GO:2001243	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN17928_c0_g1_i1	Q60848	HELLS_MOUSE	62.1	153	56	2	1	459	603	753	8.40E-44	177.9	HELLS_MOUSE	reviewed	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)	Hells Lsh Pasg	Mus musculus (Mouse)	821	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0001655; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006342; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0030098; GO:0031508; GO:0043066; GO:0046651; GO:0051301; GO:1990830; GO:2001243	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i13	Q9NRZ9	HELLS_HUMAN	45.3	232	118	3	47	742	297	519	1.80E-53	211.1	HELLS_HUMAN	reviewed	Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6)	HELLS PASG SMARCA6 Nbla10143	Homo sapiens (Human)	838	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; pericentric heterochromatin assembly [GO:0031508]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0031508; GO:0046651; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; pericentric heterochromatin assembly [GO:0031508]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i18	Q9NRZ9	HELLS_HUMAN	45.3	232	118	3	40	735	297	519	2.30E-53	210.7	HELLS_HUMAN	reviewed	Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6)	HELLS PASG SMARCA6 Nbla10143	Homo sapiens (Human)	838	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; pericentric heterochromatin assembly [GO:0031508]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]	GO:0000775; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0031508; GO:0046651; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; pericentric heterochromatin assembly [GO:0031508]		NA	NA	NA	NA	NA	NA
TRINITY_DN1421_c0_g1_i2	Q96KB5	TOPK_HUMAN	48.8	322	155	8	78	1028	4	320	7.80E-78	292.4	TOPK_HUMAN	reviewed	Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase)	PBK TOPK	Homo sapiens (Human)	322	nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]	nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004674; GO:0004708; GO:0005524; GO:0005634; GO:0032435; GO:0032873; GO:0034644; GO:0050728	cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]		NA	NA	NA	NA	NA	NA
TRINITY_DN1421_c0_g1_i8	Q96KB5	TOPK_HUMAN	48.8	322	155	8	78	1028	4	320	8.00E-78	292.4	TOPK_HUMAN	reviewed	Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase)	PBK TOPK	Homo sapiens (Human)	322	nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]	nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004674; GO:0004708; GO:0005524; GO:0005634; GO:0032435; GO:0032873; GO:0034644; GO:0050728	cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of stress-activated MAPK cascade [GO:0032873]		NA	NA	NA	NA	NA	NA
TRINITY_DN34734_c0_g1_i1	Q9JJ78	TOPK_MOUSE	100	92	0	0	276	1	148	239	3.00E-49	195.3	TOPK_MOUSE	reviewed	Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (PDZ-binding kinase) (T-LAK cell-originated protein kinase)	Pbk Topk	Mus musculus (Mouse)	330	nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]	nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0001933; GO:0004674; GO:0004708; GO:0005524; GO:0005634; GO:0018105; GO:0018107; GO:0032435; GO:0032873; GO:0034644; GO:0050728	cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]		NA	NA	NA	NA	NA	NA
TRINITY_DN5192_c0_g1_i1	B5X5L2	LYRM1_SALSA	43.3	120	63	2	555	208	1	119	1.30E-18	94.7	LYRM1_SALSA	reviewed	LYR motif-containing protein 1	lyrm1	Salmo salar (Atlantic salmon)	120							NA	NA	NA	NA	NA	NA
TRINITY_DN14644_c0_g2_i1	B5X8M4	BRCC3_SALSA	42.6	263	146	3	322	1110	1	258	1.30E-51	205.3	BRCC3_SALSA	reviewed	Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)	brcc3 brcc36	Salmo salar (Atlantic salmon)	260	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]	isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0007049; GO:0008237; GO:0010212; GO:0031593; GO:0045739; GO:0046872; GO:0051301; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0072425	cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN14644_c0_g2_i3	B5X8M4	BRCC3_SALSA	42.6	263	146	3	334	1122	1	258	1.30E-51	205.3	BRCC3_SALSA	reviewed	Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)	brcc3 brcc36	Salmo salar (Atlantic salmon)	260	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]	isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0007049; GO:0008237; GO:0010212; GO:0031593; GO:0045739; GO:0046872; GO:0051301; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0072425	cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN14644_c0_g2_i4	B5X8M4	BRCC3_SALSA	42.6	263	146	3	289	1077	1	258	1.30E-51	205.3	BRCC3_SALSA	reviewed	Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)	brcc3 brcc36	Salmo salar (Atlantic salmon)	260	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]	isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0007049; GO:0008237; GO:0010212; GO:0031593; GO:0045739; GO:0046872; GO:0051301; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0072425	cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN14644_c0_g2_i6	B5X8M4	BRCC3_SALSA	42.6	263	146	3	301	1089	1	258	1.30E-51	205.3	BRCC3_SALSA	reviewed	Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)	brcc3 brcc36	Salmo salar (Atlantic salmon)	260	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]	isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0007049; GO:0008237; GO:0010212; GO:0031593; GO:0045739; GO:0046872; GO:0051301; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0072425	cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN30871_c0_g1_i1	Q9Y4C1	KDM3A_HUMAN	100	221	0	0	663	1	965	1185	1.10E-132	473.8	KDM3A_HUMAN	reviewed	Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)	KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA	Homo sapiens (Human)	1321	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA-binding transcription factor activity [GO:0003700]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA-binding transcription factor activity [GO:0003700]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0000979; GO:0003700; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007290; GO:0009755; GO:0016020; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051213; GO:0051573; GO:0120162; GO:1990830; GO:2000036; GO:2000736	"androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18227_c0_g1_i1	Q6PCM1	KDM3A_MOUSE	99.4	168	1	0	541	38	1156	1323	2.90E-96	352.4	KDM3A_MOUSE	reviewed	Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)	Kdm3a Jhdm2a Jmjd1a Kiaa0742	Mus musculus (Mouse)	1323	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003682; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007283; GO:0007290; GO:0009755; GO:0010468; GO:0010628; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051213; GO:0051573; GO:0120162; GO:1990830; GO:2000036; GO:2000736	"androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18227_c0_g1_i2	Q9Y4C1	KDM3A_HUMAN	100	156	0	0	505	38	1166	1321	6.50E-90	331.3	KDM3A_HUMAN	reviewed	Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)	KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA	Homo sapiens (Human)	1321	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA-binding transcription factor activity [GO:0003700]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA-binding transcription factor activity [GO:0003700]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0000979; GO:0003700; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007290; GO:0009755; GO:0016020; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051213; GO:0051573; GO:0120162; GO:1990830; GO:2000036; GO:2000736	"androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4579_c0_g1_i1	Q7LBC6	KDM3B_HUMAN	50.2	243	113	5	1300	584	888	1126	3.10E-62	240.7	KDM3B_HUMAN	reviewed	Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B)	KDM3B C5orf7 JHDM2B JMJD1B KIAA1082	Homo sapiens (Human)	1761	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cisplatin [GO:0072718]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0016209; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718	histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cisplatin [GO:0072718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4579_c0_g1_i2	Q7LBC6	KDM3B_HUMAN	44.6	890	381	16	2577	166	888	1751	7.90E-203	708.8	KDM3B_HUMAN	reviewed	Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B)	KDM3B C5orf7 JHDM2B JMJD1B KIAA1082	Homo sapiens (Human)	1761	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cisplatin [GO:0072718]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0016209; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718	histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cisplatin [GO:0072718]		NA	NA	NA	NA	NA	NA
TRINITY_DN40428_c0_g1_i1	Q9H3R0	KDM4C_HUMAN	82.6	86	15	0	258	1	162	247	5.40E-40	164.5	KDM4C_HUMAN	reviewed	Lysine-specific demethylase 4C (EC 1.14.11.66) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C)	KDM4C GASC1 JHDM3C JMJD2C KIAA0780	Homo sapiens (Human)	1056	histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; zinc ion binding [GO:0008270]	GO:0000790; GO:0001825; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0006357; GO:0008270; GO:0008284; GO:0010628; GO:0019827; GO:0019899; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045666; GO:0050681; GO:0051864; GO:0070544; GO:1900113; GO:2000736	blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]		blue	blue	NA	NA	NA	NA
TRINITY_DN40_c0_g1_i1	P29375	KDM5A_HUMAN	49.1	1682	721	25	4848	115	12	1662	0	1437.2	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40_c0_g1_i2	P29375	KDM5A_HUMAN	49.1	1688	725	25	4917	166	12	1668	0	1439.5	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40_c0_g1_i3	P29375	KDM5A_HUMAN	48.7	1666	705	24	4707	115	12	1662	0	1414.8	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40_c0_g1_i4	P29375	KDM5A_HUMAN	48.6	1672	709	24	4776	166	12	1668	0	1416.7	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		blue	blue	NA	NA	NA	NA
TRINITY_DN39083_c0_g1_i1	P29375	KDM5A_HUMAN	100	69	0	0	2	208	345	413	3.50E-34	144.8	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16525_c0_g1_i1	P29375	KDM5A_HUMAN	100	76	0	0	3	230	649	724	4.80E-40	164.5	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33932_c0_g1_i1	P29375	KDM5A_HUMAN	100	156	0	0	2	469	416	571	2.20E-92	339.3	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40277_c0_g1_i1	P29375	KDM5A_HUMAN	99.2	120	1	0	363	4	29	148	2.60E-64	245.7	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30439_c0_g1_i1	Q3UXZ9	KDM5A_MOUSE	97.8	90	2	0	3	272	994	1083	1.60E-42	172.9	KDM5A_MOUSE	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	Kdm5a Jarid1a Rbp2	Mus musculus (Mouse)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32907_c0_g1_i1	P29375	KDM5A_HUMAN	100	125	0	0	376	2	887	1011	8.60E-63	240.7	KDM5A_HUMAN	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	1690	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"	histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33263_c0_g1_i1	Q9UGL1	KDM5B_HUMAN	100	130	0	0	1	390	529	658	8.10E-72	270.8	KDM5B_HUMAN	reviewed	Lysine-specific demethylase 5B (EC 1.14.11.67) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)	KDM5B JARID1B PLU1 RBBP2H1	Homo sapiens (Human)	1544	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0035097; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864	"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30456_c0_g1_i1	Q9UGL1	KDM5B_HUMAN	100	83	0	0	9	257	6	88	2.00E-47	189.1	KDM5B_HUMAN	reviewed	Lysine-specific demethylase 5B (EC 1.14.11.67) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)	KDM5B JARID1B PLU1 RBBP2H1	Homo sapiens (Human)	1544	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0035097; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864	"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31721_c0_g1_i1	Q9UGL1	KDM5B_HUMAN	100	138	0	0	417	4	82	219	5.20E-77	288.1	KDM5B_HUMAN	reviewed	Lysine-specific demethylase 5B (EC 1.14.11.67) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)	KDM5B JARID1B PLU1 RBBP2H1	Homo sapiens (Human)	1544	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0035097; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864	"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38809_c0_g1_i1	Q38JA7	KDM5C_CANLF	100	112	0	0	100	435	499	610	4.80E-65	248.4	KDM5C_CANLF	reviewed	Lysine-specific demethylase 5C (EC 1.14.11.67) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)	KDM5C JARID1C SMCX	Canis lupus familiaris (Dog) (Canis familiaris)	1556	"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006338; GO:0032452; GO:0034647; GO:0035097; GO:0045892; GO:0046872; GO:0048511; GO:0051213	"chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38809_c0_g1_i1	Q38JA7	KDM5C_CANLF	97.1	34	1	0	102	1	461	494	2.70E-12	73.2	KDM5C_CANLF	reviewed	Lysine-specific demethylase 5C (EC 1.14.11.67) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)	KDM5C JARID1C SMCX	Canis lupus familiaris (Dog) (Canis familiaris)	1556	"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006338; GO:0032452; GO:0034647; GO:0035097; GO:0045892; GO:0046872; GO:0048511; GO:0051213	"chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31976_c0_g1_i1	P41229	KDM5C_HUMAN	100	72	0	0	218	3	1056	1127	3.00E-36	151.8	KDM5C_HUMAN	reviewed	Lysine-specific demethylase 5C (EC 1.14.11.67) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)	KDM5C DXS1272E JARID1C SMCX XE169	Homo sapiens (Human)	1560	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0008270; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0035097; GO:0045892; GO:0048511; GO:0051213	"chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31619_c0_g1_i1	Q9BY66	KDM5D_HUMAN	100	75	0	0	227	3	580	654	1.60E-40	166	KDM5D_HUMAN	reviewed	Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)	KDM5D HY HYA JARID1D KIAA0234 SMCY	Homo sapiens (Human)	1539	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0035097; GO:0046872; GO:0050681; GO:0051213; GO:0060765	chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]		NA	NA	NA	NA	NA	NA
TRINITY_DN29530_c0_g1_i1	Q9BY66	KDM5D_HUMAN	100	106	0	0	3	320	1210	1315	6.20E-54	211.1	KDM5D_HUMAN	reviewed	Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)	KDM5D HY HYA JARID1D KIAA0234 SMCY	Homo sapiens (Human)	1539	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0035097; GO:0046872; GO:0050681; GO:0051213; GO:0060765	chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]		NA	NA	NA	NA	NA	NA
TRINITY_DN38072_c0_g1_i1	Q9BY66	KDM5D_HUMAN	100	84	0	0	254	3	718	801	3.70E-41	168.3	KDM5D_HUMAN	reviewed	Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)	KDM5D HY HYA JARID1D KIAA0234 SMCY	Homo sapiens (Human)	1539	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0035097; GO:0046872; GO:0050681; GO:0051213; GO:0060765	chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]		NA	NA	NA	NA	NA	NA
TRINITY_DN34492_c0_g1_i1	Q9BY66	KDM5D_HUMAN	100	103	0	0	311	3	1	103	7.90E-58	224.2	KDM5D_HUMAN	reviewed	Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)	KDM5D HY HYA JARID1D KIAA0234 SMCY	Homo sapiens (Human)	1539	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0035097; GO:0046872; GO:0050681; GO:0051213; GO:0060765	chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]		NA	NA	NA	NA	NA	NA
TRINITY_DN35578_c0_g1_i1	Q9BY66	KDM5D_HUMAN	100	78	0	0	1	234	379	456	9.20E-39	160.2	KDM5D_HUMAN	reviewed	Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)	KDM5D HY HYA JARID1D KIAA0234 SMCY	Homo sapiens (Human)	1539	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]	fibrillar center [GO:0001650]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0035097; GO:0046872; GO:0050681; GO:0051213; GO:0060765	chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]		NA	NA	NA	NA	NA	NA
TRINITY_DN6818_c0_g1_i1	O70546	KDM6A_MOUSE	63.6	291	101	1	83	955	151	436	1.80E-106	387.5	KDM6A_MOUSE	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	Kdm6a Utx	Mus musculus (Mouse)	1401	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0010628; GO:0021915; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048568; GO:0048570; GO:0051213; GO:0060070; GO:0071557; GO:0071558; GO:0072359	canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]		NA	NA	NA	NA	NA	NA
TRINITY_DN6818_c0_g1_i2	O70546	KDM6A_MOUSE	64.7	286	101	0	83	940	151	436	2.50E-108	393.7	KDM6A_MOUSE	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	Kdm6a Utx	Mus musculus (Mouse)	1401	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0010628; GO:0021915; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048568; GO:0048570; GO:0051213; GO:0060070; GO:0071557; GO:0071558; GO:0072359	canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]		NA	NA	NA	NA	NA	NA
TRINITY_DN35783_c0_g1_i1	O70546	KDM6A_MOUSE	97.9	95	2	0	286	2	1068	1162	6.80E-50	197.6	KDM6A_MOUSE	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	Kdm6a Utx	Mus musculus (Mouse)	1401	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0010628; GO:0021915; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048568; GO:0048570; GO:0051213; GO:0060070; GO:0071557; GO:0071558; GO:0072359	canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]		NA	NA	NA	NA	NA	NA
TRINITY_DN32789_c0_g1_i1	O15550	KDM6A_HUMAN	59.4	542	204	5	385	1962	851	1392	9.30E-188	658.3	KDM6A_HUMAN	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	KDM6A UTX	Homo sapiens (Human)	1401	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558	canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]		NA	NA	NA	NA	NA	NA
TRINITY_DN32789_c0_g1_i3	O15550	KDM6A_HUMAN	59.4	542	204	5	3608	2031	851	1392	1.10E-187	659.1	KDM6A_HUMAN	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	KDM6A UTX	Homo sapiens (Human)	1401	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558	canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]		NA	NA	NA	NA	NA	NA
TRINITY_DN31858_c0_g1_i1	O15550	KDM6A_HUMAN	98.7	75	1	0	1	225	1302	1376	1.20E-38	159.8	KDM6A_HUMAN	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	KDM6A UTX	Homo sapiens (Human)	1401	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558	canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]		NA	NA	NA	NA	NA	NA
TRINITY_DN36923_c0_g1_i1	Q3UWM4	KDM7A_MOUSE	64.2	53	19	0	49	207	38	90	3.60E-18	91.7	KDM7A_MOUSE	reviewed	Lysine-specific demethylase 7A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7)	Kdm7a Jhdm1d Kdm7 Kiaa1718	Mus musculus (Mouse)	940	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005654; GO:0005730; GO:0008270; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558	"histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29757_c0_g1_i1	Q6ZMT4	KDM7A_HUMAN	100	67	0	0	201	1	271	337	1.10E-35	149.8	KDM7A_HUMAN	reviewed	Lysine-specific demethylase 7A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7)	KDM7A JHDM1D KDM7 KIAA1718	Homo sapiens (Human)	941	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0008270; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558	"histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27272_c0_g1_i1	Q5VWQ0	RSBN1_HUMAN	100	101	0	0	303	1	604	704	1.70E-56	219.5	RSBN1_HUMAN	reviewed	Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1)	RSBN1	Homo sapiens (Human)	802	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]	nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0006325; GO:0046872; GO:0051213	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN3254_c0_g1_i2	Q23541	KDM5_CAEEL	41.4	87	51	0	56	316	9	95	1.40E-09	63.9	KDM5_CAEEL	reviewed	Lysine-specific demethylase rbr-2 (Histone demethylase rbr-2) (EC 1.14.11.67) (Jumonji/ARID domain-containing protein rbr-2) ([histone H3]-trimethyl-L-lysine(4) demethylase rbr-2)	rbr-2 ZK593.4	Caenorhabditis elegans	1477	"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; determination of adult lifespan [GO:0008340]; histone H3-K4 demethylation [GO:0034720]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vulval development [GO:0040028]"	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006338; GO:0006355; GO:0008340; GO:0032452; GO:0034647; GO:0034648; GO:0034720; GO:0035097; GO:0040028; GO:0046872; GO:0051213	"chromatin remodeling [GO:0006338]; determination of adult lifespan [GO:0008340]; histone H3-K4 demethylation [GO:0034720]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vulval development [GO:0040028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4554_c1_g1_i1	Q6PCB5	RSBNL_HUMAN	66.4	119	40	0	15	371	583	701	4.80E-46	185.3	RSBNL_HUMAN	reviewed	Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein)	RSBN1L	Homo sapiens (Human)	846	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN4554_c1_g1_i2	Q6PCB5	RSBNL_HUMAN	59.6	312	121	2	7	942	378	684	1.80E-112	407.1	RSBNL_HUMAN	reviewed	Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein)	RSBN1L	Homo sapiens (Human)	846	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN4554_c1_g1_i4	Q6PCB5	RSBNL_HUMAN	59.6	329	128	2	7	993	378	701	7.30E-120	431.8	RSBNL_HUMAN	reviewed	Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein)	RSBN1L	Homo sapiens (Human)	846	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN28504_c0_g1_i1	Q6PCB5	RSBNL_HUMAN	100	82	0	0	1	246	603	684	1.10E-42	173.3	RSBNL_HUMAN	reviewed	Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein)	RSBN1L	Homo sapiens (Human)	846	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN26066_c0_g1_i1	O60341	KDM1A_HUMAN	100	105	0	0	2	316	333	437	2.00E-52	206.1	KDM1A_HUMAN	reviewed	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	Homo sapiens (Human)	852	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:1990841; GO:2000179; GO:2000648	"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21831_c0_g1_i1	O60341	KDM1A_HUMAN	98.3	118	2	0	355	2	170	287	5.30E-62	238	KDM1A_HUMAN	reviewed	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	Homo sapiens (Human)	852	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:1990841; GO:2000179; GO:2000648	"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21831_c0_g1_i2	O60341	KDM1A_HUMAN	99.1	115	1	0	346	2	173	287	1.90E-61	236.1	KDM1A_HUMAN	reviewed	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	Homo sapiens (Human)	852	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:1990841; GO:2000179; GO:2000648	"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2649_c0_g1_i1	O60341	KDM1A_HUMAN	66.9	688	198	3	324	2366	173	837	6.10E-274	944.9	KDM1A_HUMAN	reviewed	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	Homo sapiens (Human)	852	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:1990841; GO:2000179; GO:2000648	"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2649_c0_g1_i2	O60341	KDM1A_HUMAN	66.9	688	198	3	312	2354	173	837	6.10E-274	944.9	KDM1A_HUMAN	reviewed	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	Homo sapiens (Human)	852	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:1990841; GO:2000179; GO:2000648	"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23931_c0_g1_i1	O60341	KDM1A_HUMAN	100	214	0	0	2	643	491	704	2.30E-124	446	KDM1A_HUMAN	reviewed	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	Homo sapiens (Human)	852	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:1990841; GO:2000179; GO:2000648	"alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2050_c0_g1_i1	Q99MN1	SYK_MOUSE	66.7	528	175	1	1661	81	65	592	9.40E-209	728	SYK_MOUSE	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	Kars1 Kars	Mus musculus (Mouse)	595	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2050_c0_g1_i3	Q99MN1	SYK_MOUSE	66.7	528	175	1	1639	59	65	592	7.10E-209	728.4	SYK_MOUSE	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	Kars1 Kars	Mus musculus (Mouse)	595	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2050_c0_g1_i4	Q99MN1	SYK_MOUSE	66.7	528	175	1	1668	88	65	592	9.50E-209	728	SYK_MOUSE	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	Kars1 Kars	Mus musculus (Mouse)	595	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		blue	blue	NA	NA	NA	NA
TRINITY_DN17148_c0_g1_i1	Q15046	SYK_HUMAN	98.9	360	4	0	4	1083	174	533	2.50E-211	735.7	SYK_HUMAN	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	KARS1 KARS KIAA0070	Homo sapiens (Human)	597	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006418; GO:0006430; GO:0008033; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016032; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17148_c0_g1_i2	Q15046	SYK_HUMAN	99.5	416	2	0	4	1251	174	589	3.20E-247	855.1	SYK_HUMAN	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	KARS1 KARS KIAA0070	Homo sapiens (Human)	597	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006418; GO:0006430; GO:0008033; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016032; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37166_c0_g1_i1	Q99MN1	SYK_MOUSE	67.8	211	67	1	632	3	184	394	2.90E-82	306.2	SYK_MOUSE	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	Kars1 Kars	Mus musculus (Mouse)	595	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36357_c0_g1_i1	Q99MN1	SYK_MOUSE	73.8	145	38	0	23	457	430	574	5.00E-61	235.3	SYK_MOUSE	reviewed	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	Kars1 Kars	Mus musculus (Mouse)	595	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002720; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050	"activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13871_c0_g1_i1	Q48F26	SYK_PSE14	77.1	70	16	0	2	211	222	291	1.40E-25	116.3	SYK_PSE14	reviewed	Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	lysS PSPPH_3873	Pseudomonas savastanoi pv. phaseolicola (strain 1448A / Race 6) (Pseudomonas syringae pv. phaseolicola (strain 1448A / Race 6))	500	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]	GO:0000287; GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN13871_c0_g2_i1	B2U8U9	SYK_RALPJ	100	159	0	0	3	479	139	297	2.00E-88	326.2	SYK_RALPJ	reviewed	Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	lysS Rpic_0893	Ralstonia pickettii (strain 12J)	514	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]	GO:0000287; GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN22371_c0_g1_i1	A5UPG6	SYK_ROSS1	61.9	126	48	0	3	380	176	301	1.20E-40	167.2	SYK_ROSS1	reviewed	Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	lysS RoseRS_0078	Roseiflexus sp. (strain RS-1)	489	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]	GO:0000287; GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN22371_c0_g2_i1	Q6F2U9	SYK_ORYSJ	54.7	128	46	3	415	65	470	596	1.60E-33	143.7	SYK_ORYSJ	reviewed	Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	Os03g0586800 LOC_Os03g38980 OSJNBa0010D22.26	Oryza sativa subsp. japonica (Rice)	602	cytosol [GO:0005829]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; tRNA binding [GO:0000049]; lysyl-tRNA aminoacylation [GO:0006430]	cytosol [GO:0005829]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; tRNA binding [GO:0000049]	GO:0000049; GO:0004824; GO:0005524; GO:0005829; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN2638_c0_g1_i4	Q5PQ30	LYSM1_XENLA	32.5	117	71	1	671	321	37	145	2.30E-08	60.8	LYSM1_XENLA	reviewed	LysM and putative peptidoglycan-binding domain-containing protein 1	lysmd1	Xenopus laevis (African clawed frog)	215							NA	NA	NA	NA	NA	NA
TRINITY_DN2638_c0_g1_i5	Q5PQ30	LYSM1_XENLA	32.5	117	71	1	469	119	37	145	1.20E-08	61.2	LYSM1_XENLA	reviewed	LysM and putative peptidoglycan-binding domain-containing protein 1	lysmd1	Xenopus laevis (African clawed frog)	215							NA	NA	NA	NA	NA	NA
TRINITY_DN665_c0_g1_i2	Q99LE3	LYSM3_MOUSE	27.6	254	136	8	735	4	19	234	1.20E-14	82	LYSM3_MOUSE	reviewed	LysM and putative peptidoglycan-binding domain-containing protein 3	Lysmd3	Mus musculus (Mouse)	305	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Golgi organization [GO:0007030]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005794; GO:0005886; GO:0007030; GO:0016021	Golgi organization [GO:0007030]		NA	NA	NA	NA	NA	NA
TRINITY_DN17417_c0_g3_i1	Q6NYV8	LCLT1_DANRE	53.8	104	48	0	315	4	122	225	2.00E-27	123.2	LCLT1_DANRE	reviewed	Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1)	lclat1 agpat8 lycat zgc:77380	Danio rerio (Zebrafish) (Brachydanio rerio)	388	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; hemangioblast cell differentiation [GO:0060217]; phosphatidylinositol acyl-chain remodeling [GO:0036149]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0001885; GO:0003841; GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0016024; GO:0016746; GO:0035162; GO:0036149; GO:0060217	CDP-diacylglycerol biosynthetic process [GO:0016024]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; hemangioblast cell differentiation [GO:0060217]; phosphatidylinositol acyl-chain remodeling [GO:0036149]		NA	NA	NA	NA	NA	NA
TRINITY_DN17417_c0_g3_i4	Q6NYV8	LCLT1_DANRE	47	219	113	2	657	1	11	226	1.10E-51	205.3	LCLT1_DANRE	reviewed	Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1)	lclat1 agpat8 lycat zgc:77380	Danio rerio (Zebrafish) (Brachydanio rerio)	388	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; hemangioblast cell differentiation [GO:0060217]; phosphatidylinositol acyl-chain remodeling [GO:0036149]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0001885; GO:0003841; GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0016024; GO:0016746; GO:0035162; GO:0036149; GO:0060217	CDP-diacylglycerol biosynthetic process [GO:0016024]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; hemangioblast cell differentiation [GO:0060217]; phosphatidylinositol acyl-chain remodeling [GO:0036149]		NA	NA	NA	NA	NA	NA
TRINITY_DN8618_c0_g1_i1	Q8N2K0	ABD12_HUMAN	46.9	243	126	2	9	737	157	396	8.00E-63	241.9	ABD12_HUMAN	reviewed	Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (hABHD12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-)	ABHD12 C20orf22	Homo sapiens (Human)	398	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016020; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0050727; GO:0052651	acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]		NA	NA	NA	NA	NA	NA
TRINITY_DN40838_c0_g1_i1	Q8N2K0	ABD12_HUMAN	100	109	0	0	3	329	207	315	9.80E-63	240.4	ABD12_HUMAN	reviewed	Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (hABHD12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-)	ABHD12 C20orf22	Homo sapiens (Human)	398	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016020; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0050727; GO:0052651	acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]		NA	NA	NA	NA	NA	NA
TRINITY_DN10306_c0_g1_i2	Q08C93	ABD12_DANRE	47.5	318	161	3	1037	87	62	374	4.60E-90	333.2	ABD12_DANRE	reviewed	Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-)	abhd12 si:ch211-79l10.2 zgc:153367	Danio rerio (Zebrafish) (Brachydanio rerio)	382	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0008474; GO:0009395; GO:0010842; GO:0016020; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651	acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]		NA	NA	NA	NA	NA	NA
TRINITY_DN10306_c0_g1_i3	Q08C93	ABD12_DANRE	47.5	318	161	3	1037	87	62	374	4.50E-90	333.2	ABD12_DANRE	reviewed	Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-)	abhd12 si:ch211-79l10.2 zgc:153367	Danio rerio (Zebrafish) (Brachydanio rerio)	382	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0008474; GO:0009395; GO:0010842; GO:0016020; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651	acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i1	Q8N9F7	GDPD1_HUMAN	61.1	36	14	0	2	109	127	162	1.10E-05	50.8	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i10	Q8N9F7	GDPD1_HUMAN	60.7	135	51	1	121	525	48	180	1.20E-39	164.5	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i11	Q8N9F7	GDPD1_HUMAN	57.6	118	48	1	121	474	48	163	4.60E-30	132.5	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i15	Q8N9F7	GDPD1_HUMAN	57.2	145	60	1	1	435	20	162	1.20E-40	167.9	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i18	Q8N9F7	GDPD1_HUMAN	58.4	101	42	0	1	303	20	120	7.10E-28	125.2	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i2	Q8N9F7	GDPD1_HUMAN	57.3	117	48	1	121	471	48	162	1.70E-29	131	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i3	Q8N9F7	GDPD1_HUMAN	60.1	163	63	1	1	489	20	180	8.00E-51	201.4	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i4	Q8N9F7	GDPD1_HUMAN	55.2	58	26	0	90	263	63	120	2.40E-09	63.2	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i5	Q8N9F7	GDPD1_HUMAN	57.5	146	60	1	1	438	20	163	4.10E-41	169.1	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i6	Q8N9F7	GDPD1_HUMAN	58.4	101	42	0	1	303	20	120	7.40E-28	125.2	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i7	Q8N9F7	GDPD1_HUMAN	58.9	73	30	0	121	339	48	120	6.50E-17	88.6	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN1550_c0_g1_i8	Q8N9F7	GDPD1_HUMAN	58.4	101	42	0	1	303	20	120	5.80E-28	125.2	GDPD1_HUMAN	reviewed	Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GDPD1 GDE4	Homo sapiens (Human)	314	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN14871_c0_g1_i1	Q91V01	MBOA5_MOUSE	46	450	240	2	1467	127	28	477	4.40E-113	409.8	MBOA5_MOUSE	reviewed	Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (mLPCAT3) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5)	Lpcat3 Grcc3f Mboat5 Oact5	Mus musculus (Mouse)	487	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617]; transferase activity, transferring acyl groups [GO:0016746]; chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005789; GO:0006656; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1901310; GO:1903573; GO:1905885	chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN28191_c0_g1_i1	Q6P1A2	MBOA5_HUMAN	100	67	0	0	2	202	140	206	1.00E-33	143.3	MBOA5_HUMAN	reviewed	Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5)	LPCAT3 MBOAT5 OACT5	Homo sapiens (Human)	487	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617]; transferase activity, transferring acyl groups [GO:0016746]; chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005789; GO:0006656; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1901310; GO:1903573; GO:1905885	chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN11439_c0_g1_i1	Q7SZQ0	MBOA7_DANRE	36.4	121	75	2	378	16	1	119	1.80E-12	73.9	MBOA7_DANRE	reviewed	Lysophospholipid acyltransferase 7 (LPLAT 7) (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7)	mboat7 leng4 oact7	Danio rerio (Zebrafish) (Brachydanio rerio)	467	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374]; transferase activity, transferring acyl groups [GO:0016746]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]	"lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0006661; GO:0008374; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617	lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN17210_c0_g1_i1	Q2KHZ8	GLCM_BOVIN	58.2	67	28	0	77	277	143	209	6.50E-15	81.3	GLCM_BOVIN	reviewed	Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase)	GBA	Bos taurus (Bovine)	536	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; steryl-beta-glucosidase activity [GO:0050295]; autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0016787; GO:0030259; GO:0032006; GO:0046527; GO:0050295	autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN17210_c0_g1_i2	Q2KHZ8	GLCM_BOVIN	58.2	55	23	0	77	241	143	197	1.00E-11	70.9	GLCM_BOVIN	reviewed	Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase)	GBA	Bos taurus (Bovine)	536	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; steryl-beta-glucosidase activity [GO:0050295]; autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0016787; GO:0030259; GO:0032006; GO:0046527; GO:0050295	autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN13879_c2_g1_i1	Q5R8E3	GLCM_PONAB	39.9	386	214	6	56	1192	158	532	7.20E-81	302.8	GLCM_PONAB	reviewed	Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase)	GBA	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	536	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0030259; GO:0032006; GO:0046527; GO:0050295	autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN7989_c0_g1_i1	P04062	GLCM_HUMAN	52.2	134	63	1	404	3	369	501	8.70E-37	154.5	GLCM_HUMAN	reviewed	Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase)	GBA GC GLUC	Homo sapiens (Human)	536	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005102; GO:0005124; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006687; GO:0006914; GO:0007040; GO:0008203; GO:0009267; GO:0009268; GO:0016241; GO:0016787; GO:0019898; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032436; GO:0032715; GO:0033561; GO:0033574; GO:0035307; GO:0043202; GO:0043243; GO:0043407; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0050295; GO:0050728; GO:0051247; GO:0070062; GO:0071356; GO:0071548; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037; GO:1905165	autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN31488_c0_g1_i1	P04062	GLCM_HUMAN	48.3	89	42	1	11	265	196	284	4.90E-20	98.2	GLCM_HUMAN	reviewed	Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase)	GBA GC GLUC	Homo sapiens (Human)	536	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005102; GO:0005124; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006687; GO:0006914; GO:0007040; GO:0008203; GO:0009267; GO:0009268; GO:0016241; GO:0016787; GO:0019898; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032436; GO:0032715; GO:0033561; GO:0033574; GO:0035307; GO:0043202; GO:0043243; GO:0043407; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0050295; GO:0050728; GO:0051247; GO:0070062; GO:0071356; GO:0071548; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037; GO:1905165	autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN28553_c0_g1_i1	P17439	GLCM_MOUSE	48.9	88	43	1	11	274	365	450	1.80E-22	106.3	GLCM_MOUSE	reviewed	Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase)	Gba	Mus musculus (Mouse)	515	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0009267; GO:0009268; GO:0016787; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032269; GO:0032436; GO:0032715; GO:0033561; GO:0033574; GO:0035307; GO:0043202; GO:0043243; GO:0043407; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0050295; GO:0051246; GO:0051247; GO:0071356; GO:0071548; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037	autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN31282_c0_g1_i1	P17439	GLCM_MOUSE	52.6	97	43	1	77	367	94	187	1.60E-21	103.6	GLCM_MOUSE	reviewed	Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase)	Gba	Mus musculus (Mouse)	515	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0009267; GO:0009268; GO:0016787; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032269; GO:0032436; GO:0032715; GO:0033561; GO:0033574; GO:0035307; GO:0043202; GO:0043243; GO:0043407; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0050295; GO:0051246; GO:0051247; GO:0071356; GO:0071548; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037	autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN19502_c0_g1_i1	P38571	LICH_HUMAN	100	80	0	0	241	2	43	122	5.80E-44	177.6	LICH_HUMAN	reviewed	Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)	LIPA	Homo sapiens (Human)	399	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]	GO:0000902; GO:0001650; GO:0001816; GO:0004771; GO:0005764; GO:0006954; GO:0008283; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0048771; GO:0048873	cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]		NA	NA	NA	NA	NA	NA
TRINITY_DN19502_c0_g1_i2	P38571	LICH_HUMAN	95.6	114	5	0	342	1	43	156	3.50E-63	241.9	LICH_HUMAN	reviewed	Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)	LIPA	Homo sapiens (Human)	399	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]	GO:0000902; GO:0001650; GO:0001816; GO:0004771; GO:0005764; GO:0006954; GO:0008283; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0048771; GO:0048873	cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]		NA	NA	NA	NA	NA	NA
TRINITY_DN337_c0_g1_i2	Q9Z0M5	LICH_MOUSE	46.7	184	96	1	574	29	31	214	1.70E-44	181	LICH_MOUSE	reviewed	Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)	Lipa Lip1	Mus musculus (Mouse)	397	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; fatty acid metabolic process [GO:0006631]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]	GO:0000902; GO:0001650; GO:0001816; GO:0004771; GO:0005764; GO:0006631; GO:0006954; GO:0008283; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0043231; GO:0048771; GO:0048873	cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; fatty acid metabolic process [GO:0006631]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]		NA	NA	NA	NA	NA	NA
TRINITY_DN30092_c0_g1_i1	P70699	LYAG_MOUSE	100	94	0	0	6	287	611	704	2.30E-52	205.7	LYAG_MOUSE	reviewed	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase)	Gaa	Mus musculus (Mouse)	953	"lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"	lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0043181; GO:0046716; GO:0050884; GO:0050885; GO:0060048	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15515_c0_g1_i1	P10253	LYAG_HUMAN	46.2	898	436	11	3266	627	83	951	8.70E-240	832	LYAG_HUMAN	reviewed	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]	GAA	Homo sapiens (Human)	952	"azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043312; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0070062; GO:0070821; GO:0101003	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15515_c0_g1_i3	P10253	LYAG_HUMAN	50.8	675	305	7	2063	42	83	731	1.50E-203	711.1	LYAG_HUMAN	reviewed	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]	GAA	Homo sapiens (Human)	952	"azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043312; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0070062; GO:0070821; GO:0101003	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15515_c0_g1_i4	P10253	LYAG_HUMAN	46.2	898	436	11	2852	213	83	951	7.80E-240	832	LYAG_HUMAN	reviewed	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]	GAA	Homo sapiens (Human)	952	"azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043312; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0070062; GO:0070821; GO:0101003	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]		NA	NA	NA	NA	NA	NA
TRINITY_DN15515_c0_g1_i6	P10253	LYAG_HUMAN	46.2	898	436	11	3223	584	83	951	1.10E-239	831.6	LYAG_HUMAN	reviewed	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]	GAA	Homo sapiens (Human)	952	"azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043312; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0070062; GO:0070821; GO:0101003	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neutrophil degranulation [GO:0043312]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]		blue	blue	NA	NA	NA	NA
TRINITY_DN5700_c0_g1_i1	Q8VHC8	MA2B1_CAVPO	48.2	1023	464	21	144	3176	34	1002	7.80E-253	875.2	MA2B1_CAVPO	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)	MAN2B1 MANB	Cavia porcellus (Guinea pig)	1007	lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]	lysosome [GO:0005764]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN5700_c0_g1_i2	Q8VHC8	MA2B1_CAVPO	48.1	1023	465	21	144	3176	34	1002	1.30E-252	874.4	MA2B1_CAVPO	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)	MAN2B1 MANB	Cavia porcellus (Guinea pig)	1007	lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]	lysosome [GO:0005764]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0046872	mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN32614_c0_g1_i1	O09159	MA2B1_MOUSE	100	99	0	0	298	2	745	843	2.40E-52	205.7	MA2B1_MOUSE	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)	Man2b1 Laman Man2b Manb	Mus musculus (Mouse)	1013	extracellular space [GO:0005615]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; cellular protein modification process [GO:0006464]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]	extracellular space [GO:0005615]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]	alpha-mannosidase activity [GO:0004559]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0004559; GO:0005537; GO:0005615; GO:0005764; GO:0005774; GO:0006013; GO:0006464; GO:0007611; GO:0046872	cellular protein modification process [GO:0006464]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN32642_c0_g1_i1	O09159	MA2B1_MOUSE	98.5	67	1	0	202	2	152	218	9.00E-35	146.7	MA2B1_MOUSE	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)	Man2b1 Laman Man2b Manb	Mus musculus (Mouse)	1013	extracellular space [GO:0005615]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; cellular protein modification process [GO:0006464]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]	extracellular space [GO:0005615]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]	alpha-mannosidase activity [GO:0004559]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0004559; GO:0005537; GO:0005615; GO:0005764; GO:0005774; GO:0006013; GO:0006464; GO:0007611; GO:0046872	cellular protein modification process [GO:0006464]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]		NA	NA	NA	NA	NA	NA
TRINITY_DN32671_c0_g1_i1	O00754	MA2B1_HUMAN	99	100	1	0	303	4	253	352	1.80E-55	216.1	MA2B1_HUMAN	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]	MAN2B1 LAMAN MANB	Homo sapiens (Human)	1011	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cellular protein modification process [GO:0006464]; mannose metabolic process [GO:0006013]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005576; GO:0005615; GO:0005764; GO:0005774; GO:0006013; GO:0006464; GO:0006517; GO:0009313; GO:0030246; GO:0035578; GO:0043202; GO:0043312; GO:0046872; GO:0070062	cellular protein modification process [GO:0006464]; mannose metabolic process [GO:0006013]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN23868_c0_g1_i1	O00754	MA2B1_HUMAN	100	178	0	0	537	4	60	237	4.50E-105	381.7	MA2B1_HUMAN	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]	MAN2B1 LAMAN MANB	Homo sapiens (Human)	1011	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cellular protein modification process [GO:0006464]; mannose metabolic process [GO:0006013]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005576; GO:0005615; GO:0005764; GO:0005774; GO:0006013; GO:0006464; GO:0006517; GO:0009313; GO:0030246; GO:0035578; GO:0043202; GO:0043312; GO:0046872; GO:0070062	cellular protein modification process [GO:0006464]; mannose metabolic process [GO:0006013]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN37618_c0_g1_i1	O00754	MA2B1_HUMAN	100	135	0	0	3	407	705	839	1.10E-76	287	MA2B1_HUMAN	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]	MAN2B1 LAMAN MANB	Homo sapiens (Human)	1011	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cellular protein modification process [GO:0006464]; mannose metabolic process [GO:0006013]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005576; GO:0005615; GO:0005764; GO:0005774; GO:0006013; GO:0006464; GO:0006517; GO:0009313; GO:0030246; GO:0035578; GO:0043202; GO:0043312; GO:0046872; GO:0070062	cellular protein modification process [GO:0006464]; mannose metabolic process [GO:0006013]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN1419_c0_g1_i1	Q03168	ASPP_AEDAE	66.6	386	126	2	71	1225	3	386	3.40E-154	546.2	ASPP_AEDAE	reviewed	Lysosomal aspartic protease (EC 3.4.23.-)	AAEL006169	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	387	lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]	lysosome [GO:0005764]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0005764			blue	blue	NA	NA	NA	NA
TRINITY_DN1419_c0_g1_i4	Q03168	ASPP_AEDAE	58.7	104	42	1	27	335	3	106	1.30E-30	134	ASPP_AEDAE	reviewed	Lysosomal aspartic protease (EC 3.4.23.-)	AAEL006169	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	387	lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]	lysosome [GO:0005764]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN1419_c0_g1_i5	Q03168	ASPP_AEDAE	66.6	386	126	2	53	1207	3	386	2.50E-154	546.6	ASPP_AEDAE	reviewed	Lysosomal aspartic protease (EC 3.4.23.-)	AAEL006169	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	387	lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]	lysosome [GO:0005764]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN1149_c0_g1_i1	Q03168	ASPP_AEDAE	52.1	328	151	4	1014	40	60	384	9.80E-99	361.7	ASPP_AEDAE	reviewed	Lysosomal aspartic protease (EC 3.4.23.-)	AAEL006169	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	387	lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]	lysosome [GO:0005764]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0005764			black	black	1	NA	1	1
TRINITY_DN640_c0_g1_i1	O14678	ABCD4_HUMAN	41.5	615	325	7	125	1960	17	599	5.20E-125	449.9	ABCD4_HUMAN	reviewed	Lysosomal cobalamin transporter ABCD4 (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69)	ABCD4 PXMP1L	Homo sapiens (Human)	606	ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]	GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015910; GO:0016021; GO:0016887; GO:0042626; GO:0042760; GO:0043190; GO:0055085; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN640_c0_g1_i5	O89016	ABCD4_MOUSE	40.9	489	254	6	567	2024	143	599	1.30E-99	365.5	ABCD4_MOUSE	reviewed	Lysosomal cobalamin transporter ABCD4 (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69)	Abcd4 Pxmp1l	Mus musculus (Mouse)	606	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]	GO:0005324; GO:0005524; GO:0005765; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015910; GO:0016021; GO:0016887; GO:0042626; GO:0042760; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN12088_c0_g2_i1	P10619	PPGB_HUMAN	100	110	0	0	345	16	371	480	6.30E-60	231.1	PPGB_HUMAN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Homo sapiens (Human)	480	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]; glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]	carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]	GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006687; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0043312; GO:0070062; GO:1904714; GO:1904715	glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN12088_c0_g1_i1	P16675	PPGB_MOUSE	100	119	0	0	357	1	352	470	2.70E-66	252.3	PPGB_MOUSE	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	Ctsa Ppgb	Mus musculus (Mouse)	474	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005739; GO:0005765; GO:0006508; GO:0031647; GO:0043231; GO:1904715	negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN7565_c0_g1_i1	P16675	PPGB_MOUSE	99.5	214	1	0	3	644	47	260	7.70E-128	457.6	PPGB_MOUSE	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	Ctsa Ppgb	Mus musculus (Mouse)	474	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005739; GO:0005765; GO:0006508; GO:0031647; GO:0043231; GO:1904715	negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN7565_c0_g1_i2	P10619	PPGB_HUMAN	97.4	231	6	0	1	693	35	265	4.50E-134	478.4	PPGB_HUMAN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Homo sapiens (Human)	480	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]; glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]	carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]	GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006687; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0043312; GO:0070062; GO:1904714; GO:1904715	glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN18278_c0_g2_i1	P10619	PPGB_HUMAN	66.7	51	16	1	15	167	143	192	1.30E-11	70.1	PPGB_HUMAN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Homo sapiens (Human)	480	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]; glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]	carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]	GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006687; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0043312; GO:0070062; GO:1904714; GO:1904715	glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN18278_c0_g2_i2	P10619	PPGB_HUMAN	63	92	30	2	15	290	143	230	2.00E-25	116.3	PPGB_HUMAN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Homo sapiens (Human)	480	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]; glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]	carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]	GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006687; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0043312; GO:0070062; GO:1904714; GO:1904715	glycosphingolipid metabolic process [GO:0006687]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN16732_c0_g1_i1	P16675	PPGB_MOUSE	71.7	53	15	0	60	218	61	113	1.40E-17	89.7	PPGB_MOUSE	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	Ctsa Ppgb	Mus musculus (Mouse)	474	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005739; GO:0005765; GO:0006508; GO:0031647; GO:0043231; GO:1904715	negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN16732_c1_g1_i1	P16675	PPGB_MOUSE	70.3	37	11	0	2	112	80	116	4.70E-10	64.7	PPGB_MOUSE	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	Ctsa Ppgb	Mus musculus (Mouse)	474	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005739; GO:0005765; GO:0006508; GO:0031647; GO:0043231; GO:1904715	negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN22350_c0_g1_i1	Q3MI05	PPGB_BOVIN	54.5	44	20	0	209	78	436	479	7.30E-08	57.8	PPGB_BOVIN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Cathepsin A) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Bos taurus (Bovine)	479	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN20069_c0_g1_i1	Q3MI05	PPGB_BOVIN	52.6	38	18	0	35	148	324	361	8.80E-06	50.4	PPGB_BOVIN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Cathepsin A) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Bos taurus (Bovine)	479	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN18278_c0_g1_i1	Q3MI05	PPGB_BOVIN	54	126	50	2	4	381	160	277	2.50E-33	142.9	PPGB_BOVIN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Cathepsin A) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Bos taurus (Bovine)	479	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN17525_c0_g1_i1	Q3MI05	PPGB_BOVIN	50.1	483	210	10	1440	43	11	479	5.80E-134	479.2	PPGB_BOVIN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Cathepsin A) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Bos taurus (Bovine)	479	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			red	red	NA	NA	NA	NA
TRINITY_DN17525_c0_g1_i3	Q3MI05	PPGB_BOVIN	50.1	483	210	10	1486	89	11	479	3.50E-134	479.9	PPGB_BOVIN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Cathepsin A) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Bos taurus (Bovine)	479	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			blue	blue	NA	NA	NA	NA
TRINITY_DN15829_c0_g1_i1	Q3MI05	PPGB_BOVIN	41.9	105	47	4	285	1	270	370	1.00E-13	77.4	PPGB_BOVIN	reviewed	Lysosomal protective protein (EC 3.4.16.5) (Cathepsin A) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]	CTSA PPGB	Bos taurus (Bovine)	479	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN30096_c0_g1_i1	P42785	PCP_HUMAN	100	96	0	0	288	1	395	490	1.40E-52	206.5	PCP_HUMAN	reviewed	Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP)	PRCP PCP	Homo sapiens (Human)	496	"azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]; angiogenesis involved in wound healing [GO:0060055]; blood coagulation, intrinsic pathway [GO:0007597]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; neutrophil degranulation [GO:0043312]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]"	azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]	GO:0002155; GO:0002353; GO:0003085; GO:0004185; GO:0005886; GO:0006508; GO:0007597; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043312; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377	"angiogenesis involved in wound healing [GO:0060055]; blood coagulation, intrinsic pathway [GO:0007597]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; neutrophil degranulation [GO:0043312]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28674_c0_g1_i1	P42785	PCP_HUMAN	100	123	0	0	1	369	70	192	7.10E-70	264.2	PCP_HUMAN	reviewed	Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP)	PRCP PCP	Homo sapiens (Human)	496	"azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]; angiogenesis involved in wound healing [GO:0060055]; blood coagulation, intrinsic pathway [GO:0007597]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; neutrophil degranulation [GO:0043312]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]"	azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]	GO:0002155; GO:0002353; GO:0003085; GO:0004185; GO:0005886; GO:0006508; GO:0007597; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043312; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377	"angiogenesis involved in wound healing [GO:0060055]; blood coagulation, intrinsic pathway [GO:0007597]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; neutrophil degranulation [GO:0043312]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1643_c0_g1_i1	Q5RBU7	PCP_PONAB	51.3	450	218	1	108	1457	45	493	8.60E-141	501.9	PCP_PONAB	reviewed	Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP)	PRCP	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	496	lysosome [GO:0005764]; serine-type carboxypeptidase activity [GO:0004185]	lysosome [GO:0005764]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005764			NA	NA	NA	NA	NA	NA
TRINITY_DN6805_c0_g1_i3	Q1JQA0	PPT2_BOVIN	53.2	62	28	1	225	43	86	147	1.20E-11	70.1	PPT2_BOVIN	reviewed	Lysosomal thioesterase PPT2 (PPT-2) (EC 3.1.2.-)	PPT2	Bos taurus (Bovine)	305	cytoplasm [GO:0005737]; lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]	cytoplasm [GO:0005737]; lysosome [GO:0005764]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0005737; GO:0005764; GO:0008474			NA	NA	NA	NA	NA	NA
TRINITY_DN40511_c0_g1_i1	O35448	PPT2_MOUSE	100	82	0	0	1	246	182	263	5.30E-45	181	PPT2_MOUSE	reviewed	Lysosomal thioesterase PPT2 (PPT-2) (EC 3.1.2.-)	Ppt2	Mus musculus (Mouse)	302	intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; palmitoyl hydrolase activity [GO:0098599]; palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790]	intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl hydrolase activity [GO:0098599]; thiolester hydrolase activity [GO:0016790]	GO:0005764; GO:0008474; GO:0016790; GO:0043231; GO:0098599			NA	NA	NA	NA	NA	NA
TRINITY_DN6805_c0_g1_i2	Q9VKH6	PPT2_DROME	66.7	36	11	1	147	43	96	131	5.70E-07	54.7	PPT2_DROME	reviewed	Lysosomal thioesterase PPT2 homolog (PPT-2) (EC 3.1.2.-)	Ppt2 CG4851	Drosophila melanogaster (Fruit fly)	288	intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; palmitoyl hydrolase activity [GO:0098599]; palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790]; macromolecule depalmitoylation [GO:0098734]	intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl hydrolase activity [GO:0098599]; thiolester hydrolase activity [GO:0016790]	GO:0005764; GO:0008474; GO:0016790; GO:0043231; GO:0098599; GO:0098734	macromolecule depalmitoylation [GO:0098734]		NA	NA	NA	NA	NA	NA
TRINITY_DN6805_c0_g2_i1	Q6PCJ9	PPT2A_XENLA	52.3	128	61	0	2	385	168	295	2.50E-38	159.8	PPT2A_XENLA	reviewed	Lysosomal thioesterase PPT2-A (PPT-2-A) (EC 3.1.2.-)	ppt2-a	Xenopus laevis (African clawed frog)	296	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]	lysosome [GO:0005764]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0005764; GO:0008474			NA	NA	NA	NA	NA	NA
TRINITY_DN6805_c0_g1_i4	Q6PCJ9	PPT2A_XENLA	55.3	85	35	3	246	1	76	160	1.90E-18	92.8	PPT2A_XENLA	reviewed	Lysosomal thioesterase PPT2-A (PPT-2-A) (EC 3.1.2.-)	ppt2-a	Xenopus laevis (African clawed frog)	296	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]	lysosome [GO:0005764]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0005764; GO:0008474			NA	NA	NA	NA	NA	NA
TRINITY_DN27164_c0_g1_i1	Q6QRN8	LAP4A_BOVIN	100	73	0	0	220	2	88	160	9.90E-35	146.7	LAP4A_BOVIN	reviewed	Lysosomal-associated transmembrane protein 4A	LAPTM4A	Bos taurus (Bovine)	233	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005794; GO:0016021; GO:0031902			NA	NA	NA	NA	NA	NA
TRINITY_DN27164_c0_g1_i2	Q6QRN8	LAP4A_BOVIN	100	81	0	0	243	1	88	168	2.80E-38	158.7	LAP4A_BOVIN	reviewed	Lysosomal-associated transmembrane protein 4A	LAPTM4A	Bos taurus (Bovine)	233	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005794; GO:0016021; GO:0031902			NA	NA	NA	NA	NA	NA
TRINITY_DN367_c0_g1_i2	Q6P501	LAP4A_RAT	28.2	280	133	6	375	1214	19	230	1.70E-24	115.5	LAP4A_RAT	reviewed	Lysosomal-associated transmembrane protein 4A	Laptm4a	Rattus norvegicus (Rat)	233	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]		GO:0005765; GO:0005794; GO:0016020; GO:0016021; GO:0031902			NA	NA	NA	NA	NA	NA
TRINITY_DN17305_c0_g1_i2	Q9TTK4	LYST_BOVIN	31.9	141	93	2	502	86	2966	3105	2.80E-11	70.1	LYST_BOVIN	reviewed	Lysosomal-trafficking regulator	LYST	Bos taurus (Bovine)	3796	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; lysosome organization [GO:0007040]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]		GO:0005737; GO:0007040; GO:0015031; GO:0015630; GO:0032510; GO:0042267; GO:0043473	endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; lysosome organization [GO:0007040]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN17305_c0_g1_i3	Q9TTK4	LYST_BOVIN	29.4	398	271	7	1273	86	2716	3105	7.10E-40	166.8	LYST_BOVIN	reviewed	Lysosomal-trafficking regulator	LYST	Bos taurus (Bovine)	3796	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; lysosome organization [GO:0007040]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]		GO:0005737; GO:0007040; GO:0015031; GO:0015630; GO:0032510; GO:0042267; GO:0043473	endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; lysosome organization [GO:0007040]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN8883_c0_g1_i3	Q99698	LYST_HUMAN	37.6	181	112	1	7	546	3615	3795	1.40E-30	134.4	LYST_HUMAN	reviewed	Lysosomal-trafficking regulator (Beige homolog)	LYST CHS CHS1	Homo sapiens (Human)	3801	cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; protein kinase binding [GO:0019901]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031]	cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	protein kinase binding [GO:0019901]	GO:0005829; GO:0006909; GO:0007040; GO:0008104; GO:0015031; GO:0015630; GO:0016020; GO:0019901; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607	defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN8883_c0_g2_i2	P97412	LYST_MOUSE	46.7	420	180	8	1	1128	3160	3579	1.20E-97	358.2	LYST_MOUSE	reviewed	Lysosomal-trafficking regulator (Beige protein) (CHS1 homolog)	Lyst Bg Chs1	Mus musculus (Mouse)	3788	cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; protein kinase binding [GO:0019901]; blood coagulation [GO:0007596]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; microtubule-based process [GO:0007017]; natural killer cell mediated cytotoxicity [GO:0042267]; neutrophil mediated immunity [GO:0002446]; phagocytosis [GO:0006909]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; pigment granule organization [GO:0048753]; pigmentation [GO:0043473]; positive regulation of natural killer cell activation [GO:0032816]; protein localization [GO:0008104]; response to drug [GO:0042493]; secretion of lysosomal enzymes [GO:0033299]; T cell mediated immunity [GO:0002456]	cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	protein kinase binding [GO:0019901]	GO:0002446; GO:0002456; GO:0005829; GO:0006644; GO:0006909; GO:0007017; GO:0007040; GO:0007596; GO:0008104; GO:0015630; GO:0016020; GO:0019901; GO:0030595; GO:0032438; GO:0032510; GO:0032816; GO:0033299; GO:0033364; GO:0042267; GO:0042493; GO:0042742; GO:0042832; GO:0043473; GO:0048753; GO:0051607; GO:0055091	blood coagulation [GO:0007596]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; microtubule-based process [GO:0007017]; natural killer cell mediated cytotoxicity [GO:0042267]; neutrophil mediated immunity [GO:0002446]; phagocytosis [GO:0006909]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; pigmentation [GO:0043473]; pigment granule organization [GO:0048753]; positive regulation of natural killer cell activation [GO:0032816]; protein localization [GO:0008104]; response to drug [GO:0042493]; secretion of lysosomal enzymes [GO:0033299]; T cell mediated immunity [GO:0002456]		NA	NA	NA	NA	NA	NA
TRINITY_DN6327_c0_g1_i1	Q14108	SCRB2_HUMAN	37	108	67	1	388	65	37	143	4.50E-18	92.4	SCRB2_HUMAN	reviewed	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)	SCARB2 CD36L2 LIMP2 LIMPII	Homo sapiens (Human)	478	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0010008; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0030666; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671	aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]		NA	NA	NA	NA	NA	NA
TRINITY_DN6327_c0_g1_i2	Q14108	SCRB2_HUMAN	37.7	106	65	1	382	65	39	143	7.60E-18	91.7	SCRB2_HUMAN	reviewed	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)	SCARB2 CD36L2 LIMP2 LIMPII	Homo sapiens (Human)	478	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0010008; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0030666; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671	aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]		NA	NA	NA	NA	NA	NA
TRINITY_DN6327_c0_g1_i3	Q14108	SCRB2_HUMAN	37.7	106	65	1	382	65	39	143	1.50E-17	90.5	SCRB2_HUMAN	reviewed	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)	SCARB2 CD36L2 LIMP2 LIMPII	Homo sapiens (Human)	478	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0010008; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0030666; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671	aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]		NA	NA	NA	NA	NA	NA
TRINITY_DN1034_c0_g1_i1	P27615	SCRB2_RAT	31.6	430	274	8	1457	195	29	447	6.80E-69	263.1	SCRB2_RAT	reviewed	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)	Scarb2 Cd36l2 Limpii	Rattus norvegicus (Rat)	478	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]	GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123	aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]		NA	NA	NA	NA	NA	NA
TRINITY_DN8364_c0_g1_i1	O35114	SCRB2_MOUSE	40.7	167	91	4	363	860	206	365	8.60E-34	145.6	SCRB2_MOUSE	reviewed	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2)	Scarb2	Mus musculus (Mouse)	478	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]	GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123	aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]		NA	NA	NA	NA	NA	NA
TRINITY_DN8364_c0_g1_i2	O35114	SCRB2_MOUSE	41.4	174	94	4	33	551	199	365	7.00E-37	155.2	SCRB2_MOUSE	reviewed	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2)	Scarb2	Mus musculus (Mouse)	478	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]	GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0010976; GO:0015485; GO:0015917; GO:0016021; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:1905123	aminophospholipid transport [GO:0015917]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of glucosylceramidase activity [GO:1905123]		NA	NA	NA	NA	NA	NA
TRINITY_DN10321_c0_g1_i3	P58215	LOXL3_HUMAN	43.5	393	185	7	44	1210	371	730	5.50E-90	332.8	LOXL3_HUMAN	reviewed	Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3)	LOXL3 LOXL	Homo sapiens (Human)	753	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10321_c0_g1_i4	P58215	LOXL3_HUMAN	37.4	123	49	2	44	406	371	467	5.30E-15	82.4	LOXL3_HUMAN	reviewed	Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3)	LOXL3 LOXL	Homo sapiens (Human)	753	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29307_c0_g1_i1	P58215	LOXL3_HUMAN	100	104	0	0	313	2	618	721	3.00E-61	235.3	LOXL3_HUMAN	reviewed	Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3)	LOXL3 LOXL	Homo sapiens (Human)	753	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10321_c0_g1_i1	B8A4W9	LOX3B_DANRE	55	140	63	0	44	463	624	763	7.60E-43	174.9	LOX3B_DANRE	reviewed	Lysyl oxidase homolog 3B (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3B)	loxl3b	Danio rerio (Zebrafish) (Brachydanio rerio)	807	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; embryonic viscerocranium morphogenesis [GO:0048703]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0048703; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	collagen fibril organization [GO:0030199]; embryonic viscerocranium morphogenesis [GO:0048703]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN19297_c0_g2_i1	Q5REQ8	DCP2_PONAB	41.2	245	142	2	120	848	8	252	4.20E-58	226.5	DCP2_PONAB	reviewed	m7GpppN-mRNA hydrolase (EC 3.6.1.62) (mRNA-decapping enzyme 2)	DCP2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	385	"nucleus [GO:0005634]; P-body [GO:0000932]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]"	nucleus [GO:0005634]; P-body [GO:0000932]	m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]	GO:0000184; GO:0000932; GO:0003723; GO:0005634; GO:0006402; GO:0030145; GO:0043488; GO:0050072; GO:0071044	"histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19297_c0_g2_i2	Q9CYC6	DCP2_MOUSE	44	166	92	1	21	515	87	252	1.30E-41	171	DCP2_MOUSE	reviewed	m7GpppN-mRNA hydrolase (EC 3.6.1.62) (mRNA-decapping enzyme 2)	Dcp2	Mus musculus (Mouse)	422	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; 5'-3' exoribonuclease activity [GO:0004534]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]"	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]	5'-3' exoribonuclease activity [GO:0004534]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]	GO:0000184; GO:0000290; GO:0000932; GO:0003723; GO:0004534; GO:0005654; GO:0005737; GO:0006402; GO:0016442; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0050072; GO:0071044; GO:1904872	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39723_c0_g1_i1	Q96C86	DCPS_HUMAN	100	76	0	0	230	3	235	310	2.40E-39	162.2	DCPS_HUMAN	reviewed	m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS)	DCPS DCS1 HINT5 HSPC015	Homo sapiens (Human)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; identical protein binding [GO:0042802]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]	exoribonuclease activity [GO:0004532]; identical protein binding [GO:0042802]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000288; GO:0000290; GO:0000340; GO:0000932; GO:0004532; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0036245; GO:0042802; GO:0043069; GO:0043928; GO:0045292; GO:0050072	"cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2569_c0_g1_i1	D3K0N9	DCPS_ASCSU	46.4	295	153	3	1000	119	6	296	8.30E-72	272.3	DCPS_ASCSU	reviewed	m7GpppX diphosphatase (EC 3.6.1.59) (Decapping scavenger enzyme) (Scavenger mRNA-decapping enzyme DcpS)		Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	301	"nucleus [GO:0005634]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; response to heat [GO:0009408]"	nucleus [GO:0005634]	m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000288; GO:0000290; GO:0000340; GO:0005634; GO:0009408; GO:0050072	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; response to heat [GO:0009408]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2569_c0_g1_i2	D3K0N9	DCPS_ASCSU	46.4	295	153	3	1000	119	6	296	8.20E-72	272.3	DCPS_ASCSU	reviewed	m7GpppX diphosphatase (EC 3.6.1.59) (Decapping scavenger enzyme) (Scavenger mRNA-decapping enzyme DcpS)		Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	301	"nucleus [GO:0005634]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; response to heat [GO:0009408]"	nucleus [GO:0005634]	m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000288; GO:0000290; GO:0000340; GO:0005634; GO:0009408; GO:0050072	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; response to heat [GO:0009408]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32924_c0_g1_i1	Q4V7D3	MACOI_RAT	50	90	45	0	18	287	382	471	2.90E-13	75.9	MACOI_RAT	reviewed	Macoilin (Macoilin-1) (Transmembrane protein 57)	Maco1 Tmem57	Rattus norvegicus (Rat)	664	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]	actin filament binding [GO:0051015]; microtubule binding [GO:0008017]	GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0016021; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0043005; GO:0044306; GO:0045202; GO:0051015	brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]		NA	NA	NA	NA	NA	NA
TRINITY_DN3951_c0_g1_i1	Q2TLY2	MACO1_DANRE	54.2	144	64	1	601	176	502	645	3.90E-33	142.9	MACO1_DANRE	reviewed	Macoilin-1 (Transmembrane protein 57a)	Maco1a tmem57a si:dkey-264p5.3	Danio rerio (Zebrafish) (Brachydanio rerio)	664	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]	actin filament binding [GO:0051015]; microtubule binding [GO:0008017]	GO:0006935; GO:0008017; GO:0016021; GO:0023041; GO:0030867; GO:0031965; GO:0051015	chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]		NA	NA	NA	NA	NA	NA
TRINITY_DN3951_c0_g1_i3	Q2TLY2	MACO1_DANRE	54.2	144	64	1	680	255	502	645	4.40E-33	142.9	MACO1_DANRE	reviewed	Macoilin-1 (Transmembrane protein 57a)	Maco1a tmem57a si:dkey-264p5.3	Danio rerio (Zebrafish) (Brachydanio rerio)	664	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]	actin filament binding [GO:0051015]; microtubule binding [GO:0008017]	GO:0006935; GO:0008017; GO:0016021; GO:0023041; GO:0030867; GO:0031965; GO:0051015	chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]		NA	NA	NA	NA	NA	NA
TRINITY_DN4577_c0_g1_i1	Q2TLY1	MACO2_DANRE	78.6	70	15	0	248	39	9	78	3.30E-26	118.6	MACO2_DANRE	reviewed	Macoilin-2 (Transmembrane protein 57b)	maco1b tmem57b si:dkey-9g4.5 zgc:63610	Danio rerio (Zebrafish) (Brachydanio rerio)	699	axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]	axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]	actin filament binding [GO:0051015]; microtubule binding [GO:0008017]	GO:0006935; GO:0008017; GO:0016021; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0051015	chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]		NA	NA	NA	NA	NA	NA
TRINITY_DN4577_c0_g1_i2	Q2TLY1	MACO2_DANRE	79.2	178	35	1	536	3	9	184	1.00E-80	300.8	MACO2_DANRE	reviewed	Macoilin-2 (Transmembrane protein 57b)	maco1b tmem57b si:dkey-9g4.5 zgc:63610	Danio rerio (Zebrafish) (Brachydanio rerio)	699	axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]	axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; rough endoplasmic reticulum membrane [GO:0030867]	actin filament binding [GO:0051015]; microtubule binding [GO:0008017]	GO:0006935; GO:0008017; GO:0016021; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0051015	chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]		NA	NA	NA	NA	NA	NA
TRINITY_DN37579_c0_g1_i1	P09581	CSF1R_MOUSE	100	150	0	0	450	1	739	888	1.30E-84	313.5	CSF1R_MOUSE	reviewed	Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)	Csf1r Csfmr Fms	Mus musculus (Mouse)	977	cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon guidance [GO:0007411]; cell population proliferation [GO:0008283]; cell-cell junction maintenance [GO:0045217]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cytokine-mediated signaling pathway [GO:0019221]; forebrain neuron differentiation [GO:0021879]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; microglial cell proliferation [GO:0061518]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation by host of viral process [GO:0044794]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; response to ischemia [GO:0002931]; ruffle organization [GO:0031529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; cytokine binding [GO:0019955]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001934; GO:0002244; GO:0002931; GO:0004714; GO:0005011; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006954; GO:0007169; GO:0007275; GO:0007411; GO:0008283; GO:0008284; GO:0008285; GO:0008360; GO:0009986; GO:0010759; GO:0016020; GO:0018108; GO:0019221; GO:0019903; GO:0019955; GO:0021772; GO:0021879; GO:0030097; GO:0030316; GO:0030335; GO:0031529; GO:0033674; GO:0036006; GO:0038145; GO:0042531; GO:0042803; GO:0043066; GO:0043231; GO:0043235; GO:0044794; GO:0045087; GO:0045124; GO:0045217; GO:0045672; GO:0046488; GO:0046777; GO:0048015; GO:0061098; GO:0061518; GO:0070374; GO:0071345; GO:0071902; GO:0090197; GO:0120041; GO:1990682; GO:2000147; GO:2000249	axon guidance [GO:0007411]; cell-cell junction maintenance [GO:0045217]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cytokine-mediated signaling pathway [GO:0019221]; forebrain neuron differentiation [GO:0021879]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; microglial cell proliferation [GO:0061518]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation by host of viral process [GO:0044794]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; response to ischemia [GO:0002931]; ruffle organization [GO:0031529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN23886_c0_g1_i1	Q61830	MRC1_MOUSE	30.8	91	43	4	22	234	917	1007	7.10E-06	51.2	MRC1_MOUSE	reviewed	Macrophage mannose receptor 1 (MMR) (CD antigen CD206)	Mrc1	Mus musculus (Mouse)	1456	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]		brown	brown	NA	NA	NA	NA
TRINITY_DN29844_c0_g1_i1	Q8N8Q9	NIPA2_HUMAN	100	70	0	0	211	2	241	310	2.60E-32	138.7	NIPA2_HUMAN	reviewed	Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2)	NIPA2	Homo sapiens (Human)	360	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021	magnesium ion transport [GO:0015693]		NA	NA	NA	NA	NA	NA
TRINITY_DN21267_c0_g1_i1	Q8N8Q9	NIPA2_HUMAN	100	152	0	0	457	2	4	155	1.90E-80	299.7	NIPA2_HUMAN	reviewed	Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2)	NIPA2	Homo sapiens (Human)	360	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021	magnesium ion transport [GO:0015693]		NA	NA	NA	NA	NA	NA
TRINITY_DN33306_c0_g1_i1	Q8N8Q9	NIPA2_HUMAN	55.4	341	151	1	142	1161	7	347	4.10E-104	379.8	NIPA2_HUMAN	reviewed	Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2)	NIPA2	Homo sapiens (Human)	360	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021	magnesium ion transport [GO:0015693]		NA	NA	NA	NA	NA	NA
TRINITY_DN15245_c0_g1_i1	Q9H0U3	MAGT1_HUMAN	100	127	0	0	2	382	146	272	6.70E-71	267.7	MAGT1_HUMAN	reviewed	Magnesium transporter protein 1 (MagT1) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1) (Oligosaccharyl transferase subunit MAGT1) (Implantation-associated protein) (IAP)	MAGT1 IAG2 PSEC0084 UNQ628/PRO1244	Homo sapiens (Human)	335	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; neutrophil degranulation [GO:0043312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005783; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0016020; GO:0018279; GO:0035577; GO:0043312; GO:0050890; GO:0055085	cognition [GO:0050890]; magnesium ion transport [GO:0015693]; neutrophil degranulation [GO:0043312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15245_c0_g1_i2	Q9CQY5	MAGT1_MOUSE	99.5	189	1	0	2	568	84	272	4.10E-109	395.2	MAGT1_MOUSE	reviewed	Magnesium transporter protein 1 (MagT1) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1) (Oligosaccharyl transferase subunit MAGT1) (Implantation-associated protein) (IAP)	Magt1 Iag2	Mus musculus (Mouse)	335	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005783; GO:0005886; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890	cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN2948_c0_g1_i1	Q86V88	MGDP1_HUMAN	48.8	82	42	0	334	89	78	159	3.40E-18	92.4	MGDP1_HUMAN	reviewed	Magnesium-dependent phosphatase 1 (MDP-1) (EC 3.1.3.-) (EC 3.1.3.48)	MDP1	Homo sapiens (Human)	176	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; fructosamine metabolic process [GO:0030389]		acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]	GO:0003993; GO:0004725; GO:0030389; GO:0046872	fructosamine metabolic process [GO:0030389]		NA	NA	NA	NA	NA	NA
TRINITY_DN4469_c0_g2_i2	E2QY99	MPP5_CANLF	56.7	238	102	1	781	71	437	674	1.10E-74	281.6	MPP5_CANLF	reviewed	MAGUK p55 subfamily member 5	MPP5 PALS1	Canis lupus familiaris (Dog) (Canis familiaris)	675	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]	ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]	GO:0002011; GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0019904; GO:0030424; GO:0032287; GO:0032991; GO:0035749; GO:0035750; GO:0043204; GO:0043219; GO:0043220; GO:0070830; GO:0090162	bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]		NA	NA	NA	NA	NA	NA
TRINITY_DN4469_c0_g2_i4	E2QY99	MPP5_CANLF	56.7	238	102	1	781	71	437	674	1.10E-74	281.6	MPP5_CANLF	reviewed	MAGUK p55 subfamily member 5	MPP5 PALS1	Canis lupus familiaris (Dog) (Canis familiaris)	675	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]	ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]	GO:0002011; GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0019904; GO:0030424; GO:0032287; GO:0032991; GO:0035749; GO:0035750; GO:0043204; GO:0043219; GO:0043220; GO:0070830; GO:0090162	bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]		NA	NA	NA	NA	NA	NA
TRINITY_DN4469_c0_g1_i1	Q8N3R9	MPP5_HUMAN	73	100	18	3	298	2	348	439	1.40E-34	146.7	MPP5_HUMAN	reviewed	MAGUK p55 subfamily member 5	MPP5 PALS1	Homo sapiens (Human)	675	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]	ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]	GO:0002011; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005886; GO:0005912; GO:0005923; GO:0016324; GO:0019904; GO:0030424; GO:0032287; GO:0032288; GO:0032991; GO:0035749; GO:0035750; GO:0043204; GO:0043219; GO:0043220; GO:0070062; GO:0070830; GO:0072659; GO:0090162	bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4469_c0_g1_i2	Q8N3R9	MPP5_HUMAN	75.8	95	19	2	283	2	348	439	9.10E-36	150.6	MPP5_HUMAN	reviewed	MAGUK p55 subfamily member 5	MPP5 PALS1	Homo sapiens (Human)	675	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]	ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]	GO:0002011; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005886; GO:0005912; GO:0005923; GO:0016324; GO:0019904; GO:0030424; GO:0032287; GO:0032288; GO:0032991; GO:0035749; GO:0035750; GO:0043204; GO:0043219; GO:0043220; GO:0070062; GO:0070830; GO:0072659; GO:0090162	bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN39395_c0_g1_i1	Q8JHF4	MPP5A_DANRE	46.8	231	119	3	264	953	119	346	1.20E-49	198.4	MPP5A_DANRE	reviewed	MAGUK p55 subfamily member 5-A (MAGUK family factor) (Nagie oko protein)	mpp5a mpp5 nok	Danio rerio (Zebrafish) (Brachydanio rerio)	677	apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; intrinsic component of plasma membrane [GO:0031226]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; ATP binding [GO:0005524]; apical protein localization [GO:0045176]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell adhesion [GO:0098609]; dorsal motor nucleus of vagus nerve development [GO:0021744]; embryonic heart tube development [GO:0035050]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; generation of neurons [GO:0048699]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesodermal cell migration [GO:0008078]; morphogenesis of an epithelial sheet [GO:0002011]; neural tube formation [GO:0001841]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; ventricular system development [GO:0021591]	apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; intrinsic component of plasma membrane [GO:0031226]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	ATP binding [GO:0005524]	GO:0001841; GO:0001917; GO:0002011; GO:0005524; GO:0005634; GO:0005923; GO:0007420; GO:0008078; GO:0016324; GO:0016332; GO:0021591; GO:0021744; GO:0031226; GO:0035050; GO:0035088; GO:0043296; GO:0045176; GO:0045197; GO:0045199; GO:0048699; GO:0055008; GO:0060041; GO:0060042; GO:0060059; GO:0070830; GO:0090162; GO:0098609	apical protein localization [GO:0045176]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell adhesion [GO:0098609]; dorsal motor nucleus of vagus nerve development [GO:0021744]; embryonic heart tube development [GO:0035050]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; generation of neurons [GO:0048699]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesodermal cell migration [GO:0008078]; morphogenesis of an epithelial sheet [GO:0002011]; neural tube formation [GO:0001841]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c0_g1_i1	Q9JLB0	MPP6_MOUSE	40.7	162	83	5	32	505	79	231	9.50E-23	108.2	MPP6_MOUSE	reviewed	MAGUK p55 subfamily member 6 (Dlgh4 protein) (P55T protein) (Protein associated with Lin-7 2)	Mpp6 Dlgh4 Pals2	Mus musculus (Mouse)	553	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; guanylate kinase activity [GO:0004385]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	guanylate kinase activity [GO:0004385]	GO:0004385; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN41006_c0_g1_i1	Q9NZW5	MPP6_HUMAN	97.5	80	2	0	3	242	213	292	4.40E-44	177.9	MPP6_HUMAN	reviewed	MAGUK p55 subfamily member 6 (Veli-associated MAGUK 1) (VAM-1)	MPP6 VAM1	Homo sapiens (Human)	540	extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex assembly [GO:0065003]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0065003; GO:0070062	protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c0_g3_i1	Q9NZW5	MPP6_HUMAN	46.2	359	158	5	39	1115	217	540	7.00E-92	339	MPP6_HUMAN	reviewed	MAGUK p55 subfamily member 6 (Veli-associated MAGUK 1) (VAM-1)	MPP6 VAM1	Homo sapiens (Human)	540	extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex assembly [GO:0065003]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0065003; GO:0070062	protein-containing complex assembly [GO:0065003]		NA	NA	NA	NA	NA	NA
TRINITY_DN3894_c0_g1_i1	Q8BVD5	MPP7_MOUSE	42.4	573	316	9	92	1777	5	574	1.00E-124	448.7	MPP7_MOUSE	reviewed	MAGUK p55 subfamily member 7	Mpp7	Mus musculus (Mouse)	576	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]	molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]	GO:0005654; GO:0005912; GO:0005923; GO:0019904; GO:0030054; GO:0031334; GO:0060090; GO:0070830; GO:0071896; GO:0097025	bicellular tight junction assembly [GO:0070830]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]		NA	NA	NA	NA	NA	NA
TRINITY_DN9164_c0_g1_i1	Q1JQC1	MFSD1_BOVIN	60.4	298	115	2	174	1058	17	314	2.00E-96	354	MFSD1_BOVIN	reviewed	Major facilitator superfamily domain-containing protein 1	MFSD1	Bos taurus (Bovine)	468	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN29103_c0_g1_i1	Q9DC37	MFSD1_MOUSE	100	76	0	0	2	229	83	158	5.30E-39	161	MFSD1_MOUSE	reviewed	Major facilitator superfamily domain-containing protein 1	Mfsd1	Mus musculus (Mouse)	464	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN33305_c0_g1_i1	Q9H3U5	MFSD1_HUMAN	100	127	0	0	1	381	66	192	4.00E-68	258.5	MFSD1_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 1 (Smooth muscle cell-associated protein 4) (SMAP-4)	MFSD1 SMAP4 UG0581B09	Homo sapiens (Human)	465	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN13060_c0_g1_i2	Q0P5M9	MFS10_BOVIN	43.4	440	233	7	1383	85	18	448	2.80E-88	327.4	MFS10_BOVIN	reviewed	Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)	MFSD10 TETRAN	Bos taurus (Bovine)	456	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	transmembrane transporter activity [GO:0022857]	GO:0005637; GO:0006915; GO:0016021; GO:0022857; GO:0031526	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN13060_c0_g1_i3	Q0P5M9	MFS10_BOVIN	43.4	440	233	7	1383	85	18	448	2.90E-88	327.4	MFS10_BOVIN	reviewed	Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)	MFSD10 TETRAN	Bos taurus (Bovine)	456	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	transmembrane transporter activity [GO:0022857]	GO:0005637; GO:0006915; GO:0016021; GO:0022857; GO:0031526	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN37640_c0_g1_i1	Q14728	MFS10_HUMAN	98.5	66	1	0	2	199	60	125	2.00E-32	139	MFS10_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)	MFSD10 TETRAN	Homo sapiens (Human)	455	brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]	brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]	GO:0005637; GO:0006915; GO:0008493; GO:0008514; GO:0016021; GO:0030659; GO:0031526; GO:0043252	apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN12678_c0_g1_i1	Q6NUT3	MFS12_HUMAN	56.1	57	25	0	40	210	17	73	1.90E-11	69.3	MFS12_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 12	MFSD12 C19orf28	Homo sapiens (Human)	480	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]	symporter activity [GO:0015293]	GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN20184_c0_g1_i1	Q6NUT3	MFS12_HUMAN	45.5	101	45	1	26	298	244	344	4.80E-16	85.1	MFS12_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 12	MFSD12 C19orf28	Homo sapiens (Human)	480	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]	symporter activity [GO:0015293]	GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN38076_c0_g1_i1	Q3U481	MFS12_MOUSE	56.1	98	42	1	1	291	99	196	1.80E-26	119.8	MFS12_MOUSE	reviewed	Major facilitator superfamily domain-containing protein 12	Mfsd12	Mus musculus (Mouse)	476	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]	symporter activity [GO:0015293]	GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN37670_c0_g1_i1	Q3U481	MFS12_MOUSE	57	79	32	1	233	3	360	438	1.90E-17	89.7	MFS12_MOUSE	reviewed	Major facilitator superfamily domain-containing protein 12	Mfsd12	Mus musculus (Mouse)	476	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]	symporter activity [GO:0015293]	GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN9357_c0_g1_i1	Q6NUT3	MFS12_HUMAN	40.6	330	159	7	8	991	134	428	4.20E-56	220.3	MFS12_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 12	MFSD12 C19orf28	Homo sapiens (Human)	480	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]	symporter activity [GO:0015293]	GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN9357_c0_g1_i3	Q6NUT3	MFS12_HUMAN	40.2	346	168	8	8	1039	134	442	8.80E-57	222.2	MFS12_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 12	MFSD12 C19orf28	Homo sapiens (Human)	480	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]	symporter activity [GO:0015293]	GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN22320_c0_g1_i1	Q6NUT3	MFS12_HUMAN	52.5	61	29	0	184	2	15	75	1.10E-11	70.1	MFS12_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 12	MFSD12 C19orf28	Homo sapiens (Human)	480	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]	symporter activity [GO:0015293]	GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0048022; GO:0071702	carbohydrate transport [GO:0008643]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]		NA	NA	NA	NA	NA	NA
TRINITY_DN20495_c0_g2_i1	Q6ZSS7	MFSD6_HUMAN	47.1	138	62	1	5	418	61	187	4.90E-30	132.1	MFSD6_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)	MFSD6 MMR2	Homo sapiens (Human)	791	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]		NA	NA	NA	NA	NA	NA
TRINITY_DN24927_c0_g1_i1	Q1LUQ4	MFD6A_DANRE	52.5	99	43	2	1	288	304	401	3.00E-20	99.4	MFD6A_DANRE	reviewed	Major facilitator superfamily domain-containing protein 6-A (Macrophage MHC class I receptor 2 homolog A)	mfsd6a mfsd6 mmr2 si:dkey-188p4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	793	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]		NA	NA	NA	NA	NA	NA
TRINITY_DN24927_c0_g1_i2	Q1LUQ4	MFD6A_DANRE	48.7	119	57	2	1	348	304	421	4.30E-22	105.9	MFD6A_DANRE	reviewed	Major facilitator superfamily domain-containing protein 6-A (Macrophage MHC class I receptor 2 homolog A)	mfsd6a mfsd6 mmr2 si:dkey-188p4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	793	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]		NA	NA	NA	NA	NA	NA
TRINITY_DN3477_c0_g1_i11	B0UYT5	MFD6B_DANRE	21.5	354	205	10	873	1766	224	560	8.30E-06	53.9	MFD6B_DANRE	reviewed	Major facilitator superfamily domain-containing protein 6-B (Macrophage MHC class I receptor 2 homolog B)	mfsd6b si:dkey-42h23.5 zgc:92925	Danio rerio (Zebrafish) (Brachydanio rerio)	747	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]		NA	NA	NA	NA	NA	NA
TRINITY_DN6124_c0_g2_i1	B0UYT5	MFD6B_DANRE	29.4	102	55	3	399	662	224	322	5.60E-05	49.7	MFD6B_DANRE	reviewed	Major facilitator superfamily domain-containing protein 6-B (Macrophage MHC class I receptor 2 homolog B)	mfsd6b si:dkey-42h23.5 zgc:92925	Danio rerio (Zebrafish) (Brachydanio rerio)	747	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]		NA	NA	NA	NA	NA	NA
TRINITY_DN24120_c0_g1_i1	Q6GPQ3	MFSD8_XENLA	29.9	344	191	8	93	1106	203	502	1.30E-33	145.6	MFSD8_XENLA	reviewed	Major facilitator superfamily domain-containing protein 8	mfsd8	Xenopus laevis (African clawed frog)	510	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN39277_c0_g1_i1	Q8BH31	MFSD8_MOUSE	43.8	73	39	1	184	402	13	83	7.80E-09	61.6	MFSD8_MOUSE	reviewed	Major facilitator superfamily domain-containing protein 8	Mfsd8	Mus musculus (Mouse)	519	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005764; GO:0005765; GO:0007040; GO:0010506; GO:0016020; GO:0016021; GO:0022857; GO:0038202; GO:0043231; GO:0048666; GO:0097352; GO:1905165	autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202]		NA	NA	NA	NA	NA	NA
TRINITY_DN36146_c0_g1_i1	Q8NHS3	MFSD8_HUMAN	27.8	490	264	7	1542	88	107	511	1.00E-48	196.1	MFSD8_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 8 (Ceroid-lipofuscinosis neuronal protein 7)	MFSD8 CLN7	Homo sapiens (Human)	518	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005765; GO:0007040; GO:0010506; GO:0016021; GO:0022857; GO:0038202; GO:0043231; GO:0048666; GO:0097352; GO:1905165	autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202]		NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c0_g1_i1	Q8NBP5	MFSD9_HUMAN	37.3	338	177	6	119	1030	99	435	5.10E-49	196.4	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c0_g1_i2	Q8NBP5	MFSD9_HUMAN	36.1	191	71	3	117	539	49	238	2.50E-19	97.8	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c0_g1_i3	Q8NBP5	MFSD9_HUMAN	34.5	296	159	6	263	1048	141	435	4.60E-37	156.8	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c0_g1_i3	Q8NBP5	MFSD9_HUMAN	54.5	55	25	0	117	281	49	103	2.40E-06	54.7	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c0_g1_i4	Q8NBP5	MFSD9_HUMAN	39.7	388	199	6	117	1178	49	435	5.40E-63	243	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN4903_c0_g1_i1	Q8NBP5	MFSD9_HUMAN	34.7	404	240	5	1301	159	49	451	5.20E-55	216.9	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN4903_c0_g1_i2	Q8NBP5	MFSD9_HUMAN	35.9	351	201	5	1398	415	49	398	7.10E-50	199.9	MFSD9_HUMAN	reviewed	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)	474	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	1	NA	NA	NA
TRINITY_DN6787_c0_g1_i3	Q9V0D5	MDH_PYRAB	42.8	299	165	4	1048	161	13	308	7.40E-57	222.6	MDH_PYRAB	reviewed	Malate dehydrogenase (EC 1.1.1.37)	mdh PYRAB08550 PAB1791	Pyrococcus abyssi (strain GE5 / Orsay)	362	cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]	L-malate dehydrogenase activity [GO:0030060]	GO:0005737; GO:0006099; GO:0030060	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6787_c0_g1_i4	Q9V0D5	MDH_PYRAB	42.8	299	165	4	1048	161	13	308	7.30E-57	222.6	MDH_PYRAB	reviewed	Malate dehydrogenase (EC 1.1.1.37)	mdh PYRAB08550 PAB1791	Pyrococcus abyssi (strain GE5 / Orsay)	362	cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]	L-malate dehydrogenase activity [GO:0030060]	GO:0005737; GO:0006099; GO:0030060	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6357_c0_g1_i1	Q9V0D5	MDH_PYRAB	41.9	310	173	5	1124	207	18	324	3.60E-62	240.7	MDH_PYRAB	reviewed	Malate dehydrogenase (EC 1.1.1.37)	mdh PYRAB08550 PAB1791	Pyrococcus abyssi (strain GE5 / Orsay)	362	cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]	L-malate dehydrogenase activity [GO:0030060]	GO:0005737; GO:0006099; GO:0030060	tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN6357_c0_g1_i2	Q9V0D5	MDH_PYRAB	41.9	310	173	5	1124	207	18	324	3.50E-62	240.7	MDH_PYRAB	reviewed	Malate dehydrogenase (EC 1.1.1.37)	mdh PYRAB08550 PAB1791	Pyrococcus abyssi (strain GE5 / Orsay)	362	cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]	L-malate dehydrogenase activity [GO:0030060]	GO:0005737; GO:0006099; GO:0030060	tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN6834_c0_g1_i1	Q42972	MDHG_ORYSJ	65.5	267	91	1	73	870	46	312	1.90E-89	330.5	MDHG_ORYSJ	reviewed	"Malate dehydrogenase, glyoxysomal (EC 1.1.1.37)"	Os12g0632700 LOC_Os12g43630 OsJ_36976	Oryza sativa subsp. japonica (Rice)	356	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; glyoxysome [GO:0009514]; L-malate dehydrogenase activity [GO:0030060]; glyoxylate cycle [GO:0006097]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; glyoxysome [GO:0009514]	L-malate dehydrogenase activity [GO:0030060]	GO:0005737; GO:0006097; GO:0006099; GO:0006108; GO:0009507; GO:0009514; GO:0030060	glyoxylate cycle [GO:0006097]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN7668_c0_g2_i1	P40926	MDHM_HUMAN	99.7	337	1	0	2	1012	2	338	1.10E-187	657.1	MDHM_HUMAN	reviewed	"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)"	MDH2	Homo sapiens (Human)	338	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; protein self-association [GO:0043621]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0006094; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0009060; GO:0016020; GO:0030060; GO:0043621; GO:0046554; GO:0070062	aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN7668_c0_g1_i1	P08249	MDHM_MOUSE	100	338	0	0	10	1023	1	338	6.90E-190	664.5	MDHM_MOUSE	reviewed	"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)"	Mdh2 Mor1	Mus musculus (Mouse)	338	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; malate dehydrogenase activity [GO:0016615]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; malate dehydrogenase activity [GO:0016615]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005975; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0009060; GO:0016020; GO:0016615; GO:0030060; GO:0042803; GO:0043209; GO:0043621; GO:0046554	aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN11714_c0_g1_i1	Q5NVR2	MDHM_PONAB	70.3	340	97	2	1097	81	1	337	5.90E-134	478.8	MDHM_PONAB	reviewed	"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)"	MDH2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	338	mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]	L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]	GO:0005759; GO:0005975; GO:0006099; GO:0006108; GO:0009060; GO:0030060; GO:0042803	aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN8206_c0_g1_i7	Q9ZH77	MASY_STRC2	44.2	471	238	10	1489	140	23	489	1.30E-94	348.6	MASY_STRCL	reviewed	Malate synthase (EC 2.3.3.9)	aceB	Streptomyces clavuligerus	541	cytoplasm [GO:0005737]; malate synthase activity [GO:0004474]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]	malate synthase activity [GO:0004474]	GO:0004474; GO:0005737; GO:0006097; GO:0006099	glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN8206_c0_g1_i10	P17815	MASY_RICCO	31.2	128	81	4	574	200	36	159	5.80E-10	66.2	MASY_RICCO	reviewed	"Malate synthase, glyoxysomal (EC 2.3.3.9)"		Ricinus communis (Castor bean)	567	glyoxysome [GO:0009514]; malate synthase activity [GO:0004474]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]	glyoxysome [GO:0009514]	malate synthase activity [GO:0004474]	GO:0004474; GO:0006097; GO:0006099; GO:0009514	glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN8206_c0_g1_i4	P28345	MASY_NEUCR	40.4	527	286	11	1595	63	17	531	4.50E-98	360.1	MASY_NEUCR	reviewed	"Malate synthase, glyoxysomal (EC 2.3.3.9) (Acetate utilization protein 9)"	acu-9 NCU10007	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	542	cytoplasm [GO:0005737]; glyoxysome [GO:0009514]; peroxisomal matrix [GO:0005782]; malate synthase activity [GO:0004474]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; glyoxysome [GO:0009514]; peroxisomal matrix [GO:0005782]	malate synthase activity [GO:0004474]	GO:0004474; GO:0005737; GO:0005782; GO:0006097; GO:0006099; GO:0009514	glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN25994_c0_g1_i1	Q14165	MLEC_HUMAN	100	119	0	0	359	3	45	163	2.30E-65	249.2	MLEC_HUMAN	reviewed	Malectin	MLEC KIAA0152	Homo sapiens (Human)	292	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; carbohydrate metabolic process [GO:0005975]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]	GO:0005783; GO:0005789; GO:0005886; GO:0005975; GO:0006457; GO:0016020; GO:0016021; GO:0019899; GO:0030246; GO:0035579; GO:0043312	carbohydrate metabolic process [GO:0005975]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN40432_c0_g1_i1	Q6ZQI3	MLEC_MOUSE	100	70	0	0	212	3	75	144	6.20E-34	144.1	MLEC_MOUSE	reviewed	Malectin	Mlec Kiaa0152	Mus musculus (Mouse)	291	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; carbohydrate metabolic process [GO:0005975]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]	GO:0005783; GO:0005789; GO:0005975; GO:0016021; GO:0019899; GO:0030246	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN9577_c0_g1_i1	Q6INX3	MLECA_XENLA	53.7	287	111	5	100	942	6	276	6.00E-66	252.7	MLECA_XENLA	reviewed	Malectin-A	mlec-a	Xenopus laevis (African clawed frog)	276	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	carbohydrate binding [GO:0030246]	GO:0005783; GO:0005789; GO:0005975; GO:0006487; GO:0016020; GO:0016021; GO:0030246	carbohydrate metabolic process [GO:0005975]; protein N-linked glycosylation [GO:0006487]		blue	blue	NA	NA	NA	NA
TRINITY_DN8597_c0_g1_i1	A9JRX0	MSL1_DANRE	39.9	168	89	5	533	54	321	484	1.90E-22	108.2	MSL1_DANRE	reviewed	Male-specific lethal 1-like 1 (MSL1-like 1) (Male-specific lethal-1 homolog 1) (MSL-1)	msl1l1 zgc:175094	Danio rerio (Zebrafish) (Brachydanio rerio)	489	MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone H4-K16 acetylation [GO:0043984]	MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0016607; GO:0043984; GO:0072487	histone H4-K16 acetylation [GO:0043984]		NA	NA	NA	NA	NA	NA
TRINITY_DN40024_c0_g1_i2	Q8N5Y2	MS3L1_HUMAN	61.7	94	36	0	347	66	1	94	5.30E-29	128.6	MS3L1_HUMAN	reviewed	Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1)	MSL3 MSL3L1	Homo sapiens (Human)	521	"histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]"	histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0006342; GO:0006355; GO:0016573; GO:0016575; GO:0035064; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0046972; GO:0072487	"chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40024_c0_g1_i3	Q8N5Y2	MS3L1_HUMAN	61.7	94	36	0	347	66	1	94	2.80E-29	129.4	MS3L1_HUMAN	reviewed	Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1)	MSL3 MSL3L1	Homo sapiens (Human)	521	"histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]"	histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0006342; GO:0006355; GO:0016573; GO:0016575; GO:0035064; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0046972; GO:0072487	"chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40024_c0_g1_i4	Q8N5Y2	MS3L1_HUMAN	61.7	94	36	0	347	66	1	94	2.90E-29	129.4	MS3L1_HUMAN	reviewed	Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1)	MSL3 MSL3L1	Homo sapiens (Human)	521	"histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]"	histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0006342; GO:0006355; GO:0016573; GO:0016575; GO:0035064; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0046972; GO:0072487	"chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38479_c0_g1_i1	Q9Y4C4	MFHA1_HUMAN	36.8	76	48	0	229	2	157	232	1.10E-07	57	MFHA1_HUMAN	reviewed	Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1)	MFHAS1 MASL1	Homo sapiens (Human)	1052	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]	GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034136; GO:0034137; GO:0034144; GO:0035308; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745	erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN18172_c0_g1_i1	Q7ZV34	MCTS1_DANRE	67.2	183	58	2	581	33	1	181	9.30E-68	258.1	MCTS1_DANRE	reviewed	Malignant T-cell-amplified sequence 1 (MCT-1)	mcts1 zgc:56242	Danio rerio (Zebrafish) (Brachydanio rerio)	181	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; formation of translation preinitiation complex [GO:0001731]; regulation of growth [GO:0040008]; translation reinitiation [GO:0002188]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]	GO:0001731; GO:0002188; GO:0003723; GO:0005737; GO:0007049; GO:0040008	cell cycle [GO:0007049]; formation of translation preinitiation complex [GO:0001731]; regulation of growth [GO:0040008]; translation reinitiation [GO:0002188]		blue	blue	NA	NA	NA	NA
TRINITY_DN28121_c0_g1_i1	Q2KIE4	MCTS1_BOVIN	100	128	0	0	385	2	50	177	1.10E-70	266.9	MCTS1_BOVIN	reviewed	Malignant T-cell-amplified sequence 1 (MCT-1)	MCTS1	Bos taurus (Bovine)	181	cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; formation of translation preinitiation complex [GO:0001731]; regulation of growth [GO:0040008]; translation reinitiation [GO:0002188]	cytoplasm [GO:0005737]	translation initiation factor activity [GO:0003743]	GO:0001731; GO:0002188; GO:0003743; GO:0005737; GO:0006974; GO:0007049; GO:0040008	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; formation of translation preinitiation complex [GO:0001731]; regulation of growth [GO:0040008]; translation reinitiation [GO:0002188]		NA	NA	NA	NA	NA	NA
TRINITY_DN37280_c0_g1_i1	Q4G176	ACSF3_HUMAN	100	62	0	0	29	214	470	531	9.30E-30	130.2	ACSF3_HUMAN	reviewed	"Malonate--CoA ligase ACSF3, mitochondrial (EC 6.2.1.n3) (Acyl-CoA synthetase family member 3)"	ACSF3 PSEC0197	Homo sapiens (Human)	576	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0005524; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0016405; GO:0016878; GO:0031957; GO:0035338; GO:0090409; GO:0090410	fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410]		NA	NA	NA	NA	NA	NA
TRINITY_DN1695_c0_g1_i1	Q4G176	ACSF3_HUMAN	41.8	268	145	5	133	918	10	272	1.40E-53	211.5	ACSF3_HUMAN	reviewed	"Malonate--CoA ligase ACSF3, mitochondrial (EC 6.2.1.n3) (Acyl-CoA synthetase family member 3)"	ACSF3 PSEC0197	Homo sapiens (Human)	576	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0005524; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0016405; GO:0016878; GO:0031957; GO:0035338; GO:0090409; GO:0090410	fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410]		NA	NA	NA	NA	NA	NA
TRINITY_DN1695_c0_g1_i2	Q4G176	ACSF3_HUMAN	48.7	573	276	9	133	1824	10	573	1.60E-152	541.2	ACSF3_HUMAN	reviewed	"Malonate--CoA ligase ACSF3, mitochondrial (EC 6.2.1.n3) (Acyl-CoA synthetase family member 3)"	ACSF3 PSEC0197	Homo sapiens (Human)	576	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0005524; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0016405; GO:0016878; GO:0031957; GO:0035338; GO:0090409; GO:0090410	fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410]		NA	NA	NA	NA	NA	NA
TRINITY_DN36381_c0_g1_i1	A5YBJ3	IOLA_LACCA	57.5	80	34	0	1	240	162	241	2.40E-18	92.4	IOLA_LACCA	reviewed	Malonate-semialdehyde dehydrogenase (MSA dehydrogenase) (EC 1.2.1.-) (Methylmalonate-semialdehyde dehydrogenase) (MMSA dehydrogenase) (MSDH) (EC 1.2.1.27)	iolA	Lactobacillus casei	492	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; inositol catabolic process [GO:0019310]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0018478; GO:0019310	inositol catabolic process [GO:0019310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4424_c0_g1_i2	P12617	DCMC_ANSAN	47.4	430	207	6	1455	172	85	497	7.70E-107	389.4	DCMC_ANSAN	reviewed	"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)"	MLYCD	Anser anser anser (Western greylag goose)	504	mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]; malonyl-CoA decarboxylase activity [GO:0050080]; acetyl-CoA biosynthetic process [GO:0006085]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]	mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]	malonyl-CoA decarboxylase activity [GO:0050080]	GO:0005759; GO:0005777; GO:0006085; GO:0006633; GO:0046321; GO:0050080; GO:2001294	acetyl-CoA biosynthetic process [GO:0006085]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]		NA	NA	NA	NA	NA	NA
TRINITY_DN16183_c0_g1_i1	O16098	MAL1_DROVI	49.2	193	94	3	598	26	356	546	6.90E-46	185.3	MAL1_DROVI	reviewed	Maltase 1 (EC 3.2.1.20)	Mal-B1 Mav1 GJ22501	Drosophila virilis (Fruit fly)	632	maltose alpha-glucosidase activity [GO:0032450]		maltose alpha-glucosidase activity [GO:0032450]	GO:0032450			NA	NA	NA	NA	NA	NA
TRINITY_DN6202_c0_g1_i2	Q5VYJ5	MALR1_HUMAN	33.6	143	89	2	30	458	1757	1893	5.00E-15	82.4	MALR1_HUMAN	reviewed	MAM and LDL-receptor class A domain-containing protein 1	MALRD1 C10orf112 DIET1	Homo sapiens (Human)	2156	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858	cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]		NA	NA	NA	NA	NA	NA
TRINITY_DN6202_c0_g1_i4	A2AJX4	MALR1_MOUSE	38.9	113	64	2	27	350	1675	1787	3.10E-16	86.3	MALR1_MOUSE	reviewed	MAM and LDL-receptor class A domain-containing protein 1	Malrd1 Diet1 Gm13318	Mus musculus (Mouse)	2123	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005737; GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858	cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]		NA	NA	NA	NA	NA	NA
TRINITY_DN18771_c0_g1_i1	B3EWZ6	MLRP2_ACRMI	30.9	194	128	4	28	609	4868	5055	4.10E-22	106.3	MLRP2_ACRMI	reviewed	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	7311	extracellular region [GO:0005576]; membrane [GO:0016020]	extracellular region [GO:0005576]; membrane [GO:0016020]		GO:0005576; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN30599_c0_g1_i1	B3EWZ6	MLRP2_ACRMI	42	81	43	1	83	313	4875	4955	1.90E-13	77	MLRP2_ACRMI	reviewed	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	7311	extracellular region [GO:0005576]; membrane [GO:0016020]	extracellular region [GO:0005576]; membrane [GO:0016020]		GO:0005576; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c0_g1_i1	P56688	MOIH_LIBEM	55.8	104	46	0	365	54	2	105	6.60E-26	118.2	MOIH_LIBEM	reviewed	Mandibular organ-inhibiting hormone (MOIH) [Cleaved into: MOIH precursor-related peptide; Mandibular organ-inhibiting hormone]		Libinia emarginata (Portly spider crab)	137	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c0_g1_i2	P56688	MOIH_LIBEM	57.7	104	44	0	365	54	2	105	9.20E-28	124.4	MOIH_LIBEM	reviewed	Mandibular organ-inhibiting hormone (MOIH) [Cleaved into: MOIH precursor-related peptide; Mandibular organ-inhibiting hormone]		Libinia emarginata (Portly spider crab)	137	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c0_g1_i3	P56688	MOIH_LIBEM	77.6	49	11	0	180	34	57	105	1.20E-16	87.4	MOIH_LIBEM	reviewed	Mandibular organ-inhibiting hormone (MOIH) [Cleaved into: MOIH precursor-related peptide; Mandibular organ-inhibiting hormone]		Libinia emarginata (Portly spider crab)	137	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c0_g1_i4	P56688	MOIH_LIBEM	59.6	94	38	0	315	34	12	105	7.00E-26	117.9	MOIH_LIBEM	reviewed	Mandibular organ-inhibiting hormone (MOIH) [Cleaved into: MOIH precursor-related peptide; Mandibular organ-inhibiting hormone]		Libinia emarginata (Portly spider crab)	137	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN6071_c0_g1_i5	P56688	MOIH_LIBEM	55.8	104	46	0	359	48	2	105	6.50E-26	118.2	MOIH_LIBEM	reviewed	Mandibular organ-inhibiting hormone (MOIH) [Cleaved into: MOIH precursor-related peptide; Mandibular organ-inhibiting hormone]		Libinia emarginata (Portly spider crab)	137	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN15971_c0_g1_i1	P56688	MOIH_LIBEM	91.7	36	3	0	96	203	102	137	1.30E-12	73.6	MOIH_LIBEM	reviewed	Mandibular organ-inhibiting hormone (MOIH) [Cleaved into: MOIH precursor-related peptide; Mandibular organ-inhibiting hormone]		Libinia emarginata (Portly spider crab)	137	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]	GO:0005184; GO:0005576; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN40760_c0_g1_i1	P0A503	CTPC_MYCBO	60	85	33	1	3	254	560	644	1.20E-20	100.1	CTPC_MYCBO	reviewed	Manganese-exporting P-type ATPase (EC 7.2.2.-)	ctpC mtaA BQ2027_MB3298	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	718	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0016021; GO:0019829; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4222_c0_g1_i1	Q9EPE9	AT131_MOUSE	56.9	288	123	1	904	44	909	1196	1.70E-83	310.8	AT131_MOUSE	reviewed	Manganese-transporting ATPase 13A1 (CATP) (EC 7.2.2.-)	Atp13a1 Atp13a	Mus musculus (Mouse)	1200	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005789; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN4222_c0_g1_i2	Q9EPE9	AT131_MOUSE	56.6	288	124	1	904	44	909	1196	3.70E-83	309.7	AT131_MOUSE	reviewed	Manganese-transporting ATPase 13A1 (CATP) (EC 7.2.2.-)	Atp13a1 Atp13a	Mus musculus (Mouse)	1200	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005789; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN4222_c0_g1_i6	Q9EPE9	AT131_MOUSE	56.9	288	123	1	904	44	909	1196	1.70E-83	310.8	AT131_MOUSE	reviewed	Manganese-transporting ATPase 13A1 (CATP) (EC 7.2.2.-)	Atp13a1 Atp13a	Mus musculus (Mouse)	1200	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005789; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN5398_c0_g1_i2	Q9HD20	AT131_HUMAN	63	73	27	0	36	254	806	878	1.00E-18	94	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		brown	brown	1	NA	NA	NA
TRINITY_DN38467_c0_g1_i1	Q9HD20	AT131_HUMAN	100	64	0	0	13	204	326	389	4.70E-31	134.4	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN36061_c0_g1_i1	Q9HD20	AT131_HUMAN	100	86	0	0	258	1	1083	1168	2.60E-42	172.2	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN36061_c0_g1_i2	Q9HD20	AT131_HUMAN	100	85	0	0	256	2	1083	1167	9.70E-42	170.2	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN5398_c0_g1_i1	Q9HD20	AT131_HUMAN	61.2	80	31	0	73	312	815	894	6.70E-19	95.1	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN5398_c0_g1_i3	Q9HD20	AT131_HUMAN	60.7	89	35	0	36	302	806	894	9.70E-23	107.8	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN16658_c0_g1_i1	Q9HD20	AT131_HUMAN	98	99	2	0	238	534	936	1034	5.60E-47	188.7	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN16658_c0_g1_i2	Q9HD20	AT131_HUMAN	98	99	2	0	310	14	936	1034	5.60E-47	188.7	AT131_HUMAN	reviewed	Manganese-transporting ATPase 13A1 (EC 7.2.2.-)	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	1204	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005789; GO:0006874; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c1_g4_i1	O14072	ATC4_SCHPO	57.8	45	18	1	193	62	801	845	3.20E-06	52	ATC4_SCHPO	reviewed	Manganese-transporting ATPase 4 (EC 7.2.2.-)	cta4 SPAC2E11.07c SPACUNK4.07c SPAPYUK71.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1211	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]"	GO:0005388; GO:0005524; GO:0005783; GO:0006874; GO:0016887; GO:0030176; GO:0046872; GO:1903515	calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN8801_c0_g1_i1	Q8WPJ2	MANA_MYTED	37.2	199	122	3	38	631	141	337	5.30E-37	156	MANA_MYTED	reviewed	"Mannan endo-1,4-beta-mannosidase (EC 3.2.1.78) (Beta-mannanase) (Endo-beta-1,4-mannanase) (Man5A) (ManA)"		Mytilus edulis (Blue mussel)	367	"mannan endo-1,4-beta-mannosidase activity [GO:0016985]; mannan catabolic process [GO:0046355]"		"mannan endo-1,4-beta-mannosidase activity [GO:0016985]"	GO:0016985; GO:0046355	mannan catabolic process [GO:0046355]		NA	NA	NA	NA	NA	NA
TRINITY_DN11705_c0_g1_i1	I3LUP1	GMPPA_PIG	58.5	53	22	0	205	47	140	192	9.90E-13	73.6	GMPPA_PIG	reviewed	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase 43-kDa subunit) (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)	GMPPA	Sus scrofa (Pig)	420	cytoplasm [GO:0005737]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779	biosynthetic process [GO:0009058]		blue	blue	NA	NA	NA	NA
TRINITY_DN35160_c0_g1_i1	Q96IJ6	GMPPA_HUMAN	100	79	0	0	327	91	218	296	4.70E-41	168.3	GMPPA_HUMAN	reviewed	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)	GMPPA	Homo sapiens (Human)	420	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779; GO:0070062	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN29764_c0_g1_i1	Q96IJ6	GMPPA_HUMAN	98.6	69	1	0	1	207	352	420	8.70E-32	137.1	GMPPA_HUMAN	reviewed	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)	GMPPA	Homo sapiens (Human)	420	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779; GO:0070062	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN24300_c0_g1_i1	Q96IJ6	GMPPA_HUMAN	100	162	0	0	2	487	40	201	4.60E-93	341.7	GMPPA_HUMAN	reviewed	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)	GMPPA	Homo sapiens (Human)	420	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779; GO:0070062	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN24300_c0_g1_i2	Q96IJ6	GMPPA_HUMAN	99.4	162	1	0	2	487	40	201	1.30E-92	340.1	GMPPA_HUMAN	reviewed	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)	GMPPA	Homo sapiens (Human)	420	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779; GO:0070062	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN1941_c0_g1_i1	Q0VFM6	GMPPA_XENTR	67.1	85	27	1	78	332	338	421	2.70E-28	126.3	GMPPA_XENTR	reviewed	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GTP-mannose-1-phosphate guanylyltransferase alpha)	gmppa	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	421	cytoplasm [GO:0005737]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN1941_c0_g1_i2	Q6GMK8	GMPAA_DANRE	58.4	423	171	3	92	1348	1	422	1.40E-137	491.1	GMPAA_DANRE	reviewed	Mannose-1-phosphate guanyltransferase alpha-A (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A-A) (GTP-mannose-1-phosphate guanylyltransferase subunit alpha-A)	gmppaa zgc:91853	Danio rerio (Zebrafish) (Brachydanio rerio)	422	GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]		GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]	GO:0004475; GO:0005525; GO:0009298	GDP-mannose biosynthetic process [GO:0009298]		blue	blue	NA	NA	NA	NA
TRINITY_DN14644_c0_g1_i1	Q7JZB4	GMPPB_DROME	74.6	351	89	0	291	1343	12	362	2.10E-149	530.4	GMPPB_DROME	reviewed	Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)	CG1129	Drosophila melanogaster (Fruit fly)	369	GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167]		GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]	GO:0004475; GO:0005525; GO:0009298; GO:0035167	GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN14644_c0_g1_i3	Q295Y7	GMPPB_DROPS	72.1	362	100	1	57	1139	3	364	7.90E-150	531.6	GMPPB_DROPS	reviewed	Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)	GA10892	Drosophila pseudoobscura pseudoobscura (Fruit fly)	371	GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]		GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]	GO:0004475; GO:0005525; GO:0009298	GDP-mannose biosynthetic process [GO:0009298]		NA	NA	NA	NA	NA	NA
TRINITY_DN14897_c0_g1_i1	Q9Y5P6	GMPPB_HUMAN	99.4	317	2	0	951	1	5	321	1.20E-174	613.6	GMPPB_HUMAN	reviewed	Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)	GMPPB	Homo sapiens (Human)	360	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]	GO:0004475; GO:0005525; GO:0005737; GO:0009298	GDP-mannose biosynthetic process [GO:0009298]		NA	NA	NA	NA	NA	NA
TRINITY_DN32680_c0_g1_i1	Q68FX1	MPI_RAT	48.2	421	199	6	98	1321	9	423	5.80E-104	379.4	MPI_RAT	reviewed	Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI)	Mpi	Rattus norvegicus (Rat)	423	cytosol [GO:0005829]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]	cytosol [GO:0005829]	mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]	GO:0004476; GO:0005829; GO:0006486; GO:0008270; GO:0009298; GO:0061611	GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]		blue	blue	NA	NA	NA	NA
TRINITY_DN30629_c0_g1_i1	P34949	MPI_HUMAN	100	95	0	0	287	3	90	184	3.80E-50	198.4	MPI_HUMAN	reviewed	Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI)	MPI PMI1	Homo sapiens (Human)	423	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]	GO:0004476; GO:0005829; GO:0006486; GO:0008270; GO:0009298; GO:0061611; GO:0070062	GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN4519_c0_g1_i1	Q66S58	MBL2_NOMCO	35.6	101	57	4	437	736	155	248	3.80E-10	67	MBL2_NOMCO	reviewed	Mannose-binding protein C (MBP-C) (MBP1) (Mannan-binding protein) (Mannose-binding lectin)	MBL2	Nomascus concolor (Black crested gibbon) (Hylobates concolor)	248	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; mannose binding [GO:0005537]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]"	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	mannose binding [GO:0005537]	GO:0001867; GO:0005537; GO:0005576; GO:0005581; GO:0006958	"complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4519_c0_g1_i2	Q66S58	MBL2_NOMCO	35.6	101	57	4	156	455	155	248	2.60E-10	67	MBL2_NOMCO	reviewed	Mannose-binding protein C (MBP-C) (MBP1) (Mannan-binding protein) (Mannose-binding lectin)	MBL2	Nomascus concolor (Black crested gibbon) (Hylobates concolor)	248	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; mannose binding [GO:0005537]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]"	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	mannose binding [GO:0005537]	GO:0001867; GO:0005537; GO:0005576; GO:0005581; GO:0006958	"complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27582_c0_g1_i1	O75352	MPU1_HUMAN	100	101	0	0	305	3	1	101	2.00E-49	196.1	MPU1_HUMAN	reviewed	Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15)	MPDU1	Homo sapiens (Human)	247	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005789; GO:0006457; GO:0006488; GO:0009312; GO:0016020; GO:0016021	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN33435_c0_g1_i1	Q60441	MPU1_CRIGR	90.1	101	10	0	3	305	147	247	1.30E-46	186.8	MPU1_CRIGR	reviewed	Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation) (SL15)	MPDU1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	247	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN10744_c0_g1_i1	Q9VMW8	MPU1_DROME	49.4	237	120	0	942	1652	1	237	1.40E-62	242.3	MPU1_DROME	reviewed	Mannose-P-dolichol utilization defect 1 protein homolog	CG3792	Drosophila melanogaster (Fruit fly)	252	integral component of membrane [GO:0016021]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	integral component of membrane [GO:0016021]		GO:0006486; GO:0009312; GO:0016021	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN26190_c0_g1_i1	O60476	MA1A2_HUMAN	100	72	0	0	2	217	560	631	9.50E-38	156.8	MA1A2_HUMAN	reviewed	"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)"	MAN1A2 MAN1B	Homo sapiens (Human)	641	"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]"	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381	carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]		NA	NA	NA	NA	NA	NA
TRINITY_DN25774_c0_g1_i1	O60476	MA1A2_HUMAN	98.7	75	1	0	2	226	164	238	5.20E-39	161	MA1A2_HUMAN	reviewed	"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)"	MAN1A2 MAN1B	Homo sapiens (Human)	641	"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]"	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381	carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]		NA	NA	NA	NA	NA	NA
TRINITY_DN26121_c0_g1_i1	P53624	MA1A1_DROME	61	59	21	1	228	52	590	646	8.70E-13	73.9	MA1A1_DROME	reviewed	"Mannosyl-oligosaccharide alpha-1,2-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Mannosidase-1)"	alpha-Man-Ia alpha-man-1 mas-1 CG32684	Drosophila melanogaster (Fruit fly)	667	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006486; GO:0006491; GO:0008340; GO:0012505; GO:0016021; GO:0035010; GO:0072347	carbohydrate metabolic process [GO:0005975]; determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]		NA	NA	NA	NA	NA	NA
TRINITY_DN36191_c0_g1_i1	P53624	MA1A1_DROME	40	350	161	5	965	3	13	342	1.60E-58	228	MA1A1_DROME	reviewed	"Mannosyl-oligosaccharide alpha-1,2-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Mannosidase-1)"	alpha-Man-Ia alpha-man-1 mas-1 CG32684	Drosophila melanogaster (Fruit fly)	667	"endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]"	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006486; GO:0006491; GO:0008340; GO:0012505; GO:0016021; GO:0035010; GO:0072347	carbohydrate metabolic process [GO:0005975]; determination of adult lifespan [GO:0008340]; encapsulation of foreign target [GO:0035010]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; response to anesthetic [GO:0072347]		NA	NA	NA	NA	NA	NA
TRINITY_DN134_c0_g1_i1	Q80UM7	MOGS_MOUSE	45.4	755	375	12	2266	83	90	834	4.90E-186	652.9	MOGS_MOUSE	reviewed	Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Glucosidase 1) (Glycoprotein-processing glucosidase I)	Mogs Gcs1	Mus musculus (Mouse)	834	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	mannosyl-oligosaccharide glucosidase activity [GO:0004573]	GO:0004573; GO:0005783; GO:0005789; GO:0006487; GO:0009311; GO:0016021	oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN25501_c0_g1_i1	Q13724	MOGS_HUMAN	100	110	0	0	2	331	405	514	2.90E-62	238.8	MOGS_HUMAN	reviewed	Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Processing A-glucosidase I)	MOGS GCS1	Homo sapiens (Human)	837	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucosidase activity [GO:0015926]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glucosidase activity [GO:0015926]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]	GO:0004573; GO:0005783; GO:0005789; GO:0006457; GO:0006487; GO:0009311; GO:0015926; GO:0016020; GO:0016021; GO:0070062	oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN37229_c0_g1_i1	Q13724	MOGS_HUMAN	100	86	0	0	1	258	548	633	1.60E-44	179.5	MOGS_HUMAN	reviewed	Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Processing A-glucosidase I)	MOGS GCS1	Homo sapiens (Human)	837	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucosidase activity [GO:0015926]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	glucosidase activity [GO:0015926]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]	GO:0004573; GO:0005783; GO:0005789; GO:0006457; GO:0006487; GO:0009311; GO:0015926; GO:0016020; GO:0016021; GO:0070062	oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN38715_c0_g1_i1	P49071	MAPK2_DROME	70.7	335	98	0	1111	107	9	343	1.20E-140	501.1	MAPK2_DROME	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAPK-2) (EC 2.7.11.1)	MAPk-Ak2 CG3086	Drosophila melanogaster (Fruit fly)	359	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009651; GO:0009931; GO:0018105; GO:0035556; GO:0045793; GO:0046328; GO:0046777; GO:0051019	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN38715_c0_g1_i2	P49071	MAPK2_DROME	71.8	273	77	0	896	78	9	281	1.00E-116	421.4	MAPK2_DROME	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAPK-2) (EC 2.7.11.1)	MAPk-Ak2 CG3086	Drosophila melanogaster (Fruit fly)	359	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009651; GO:0009931; GO:0018105; GO:0035556; GO:0045793; GO:0046328; GO:0046777; GO:0051019	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN38715_c0_g1_i4	P49071	MAPK2_DROME	70.7	335	98	0	1111	107	9	343	1.20E-140	501.1	MAPK2_DROME	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAPK-2) (EC 2.7.11.1)	MAPk-Ak2 CG3086	Drosophila melanogaster (Fruit fly)	359	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0009651; GO:0009931; GO:0018105; GO:0035556; GO:0045793; GO:0046328; GO:0046777; GO:0051019	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell size [GO:0045793]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN38793_c0_g1_i1	P49138	MAPK2_MOUSE	100	67	0	0	1	201	97	163	2.50E-32	138.7	MAPK2_MOUSE	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1)	Mapkapk2 Rps6kc1	Mus musculus (Mouse)	386	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; mRNA stabilization [GO:0048255]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]	GO:0002224; GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0042535; GO:0044351; GO:0046777; GO:0048010; GO:0048255; GO:0048839; GO:0051019; GO:0070935	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; mRNA stabilization [GO:0048255]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN14185_c0_g1_i1	P49136	MAPK2_CRILO	100	75	0	0	226	2	157	231	3.20E-41	168.3	MAPK2_CRILO	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) (P45-54 HSP27 kinase) (Fragment)	MAPKAPK2	Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)	329	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002224; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0006974; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0044351; GO:0070935	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN14185_c0_g1_i2	P49136	MAPK2_CRILO	99.1	110	1	0	331	2	122	231	3.70E-62	238.4	MAPK2_CRILO	reviewed	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) (P45-54 HSP27 kinase) (Fragment)	MAPKAPK2	Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)	329	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002224; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0006974; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0044351; GO:0070935	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN21173_c0_g1_i2	Q3SYZ2	MAPK3_BOVIN	97.8	92	2	0	278	3	33	124	8.10E-50	197.2	MAPK3_BOVIN	reviewed	MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1)	MAPKAPK3	Bos taurus (Bovine)	384	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]	GO:0002224; GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009931; GO:0018105; GO:0032496; GO:0034097; GO:0035556; GO:0044351; GO:0046777; GO:0051019	intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN21173_c0_g1_i1	Q16644	MAPK3_HUMAN	100	293	0	0	879	1	31	323	2.70E-176	619	MAPK3_HUMAN	reviewed	MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK)	MAPKAPK3	Homo sapiens (Human)	382	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]	GO:0000187; GO:0002224; GO:0004674; GO:0004708; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0009931; GO:0018105; GO:0032496; GO:0034097; GO:0035556; GO:0044351; GO:0046777; GO:0048010; GO:0051019	activation of MAPK activity [GO:0000187]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN28854_c0_g1_i1	Q8IW41	MAPK5_HUMAN	100	79	0	0	239	3	110	188	5.90E-41	167.5	MAPK5_HUMAN	reviewed	MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK)	MAPKAPK5 PRAK	Homo sapiens (Human)	473	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0002039; GO:0004674; GO:0004708; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0007165; GO:0007265; GO:0009931; GO:0018105; GO:0032007; GO:0032212; GO:0035556; GO:0046777; GO:0051019; GO:0051973; GO:0090400; GO:1901796; GO:1904355	intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400]		NA	NA	NA	NA	NA	NA
TRINITY_DN26826_c0_g1_i1	Q8IW41	MAPK5_HUMAN	100	74	0	0	3	224	227	300	6.30E-37	154.1	MAPK5_HUMAN	reviewed	MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK)	MAPKAPK5 PRAK	Homo sapiens (Human)	473	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0002039; GO:0004674; GO:0004708; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0007165; GO:0007265; GO:0009931; GO:0018105; GO:0032007; GO:0032212; GO:0035556; GO:0046777; GO:0051019; GO:0051973; GO:0090400; GO:1901796; GO:1904355	intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400]		NA	NA	NA	NA	NA	NA
TRINITY_DN26913_c0_g1_i1	Q8WXG6	MADD_HUMAN	100	79	0	0	238	2	315	393	6.10E-38	157.5	MADD_HUMAN	reviewed	MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor)	MADD DENN IG20 KIAA0358	Homo sapiens (Human)	1647	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0010803; GO:0016021; GO:0017112; GO:0030295; GO:0032483; GO:0042981; GO:0045202; GO:0051726; GO:0097194; GO:1902041; GO:2001236	activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]		NA	NA	NA	NA	NA	NA
TRINITY_DN31222_c0_g1_i1	Q8WXG6	MADD_HUMAN	88.1	176	0	1	3	467	1275	1450	8.70E-81	300.8	MADD_HUMAN	reviewed	MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor)	MADD DENN IG20 KIAA0358	Homo sapiens (Human)	1647	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0010803; GO:0016021; GO:0017112; GO:0030295; GO:0032483; GO:0042981; GO:0045202; GO:0051726; GO:0097194; GO:1902041; GO:2001236	activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]		NA	NA	NA	NA	NA	NA
TRINITY_DN27325_c0_g1_i1	Q8WXG6	MADD_HUMAN	100	94	0	0	3	284	1540	1633	5.30E-49	194.5	MADD_HUMAN	reviewed	MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor)	MADD DENN IG20 KIAA0358	Homo sapiens (Human)	1647	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0010803; GO:0016021; GO:0017112; GO:0030295; GO:0032483; GO:0042981; GO:0045202; GO:0051726; GO:0097194; GO:1902041; GO:2001236	activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]		NA	NA	NA	NA	NA	NA
TRINITY_DN1106_c0_g1_i1	Q9VXY2	MADD_DROME	66.2	80	27	0	290	51	226	305	5.40E-27	122.1	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1106_c0_g1_i2	Q9VXY2	MADD_DROME	70.7	297	84	2	912	28	226	521	1.50E-123	444.1	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1106_c0_g1_i4	Q9VXY2	MADD_DROME	66.2	80	27	0	290	51	226	305	5.60E-27	122.1	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1106_c0_g1_i6	Q9VXY2	MADD_DROME	73.5	49	13	0	179	33	305	353	6.90E-15	80.9	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1106_c0_g2_i2	Q9VXY2	MADD_DROME	74.1	170	44	0	29	538	590	759	4.50E-65	248.8	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1106_c0_g2_i3	Q9VXY2	MADD_DROME	65.3	98	34	0	92	385	662	759	3.20E-28	125.9	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3714_c0_g1_i1	Q9VXY2	MADD_DROME	73.8	160	42	0	10	489	1414	1573	3.70E-64	245.7	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3714_c0_g1_i2	Q9VXY2	MADD_DROME	73.7	376	77	3	369	1448	1414	1783	4.50E-161	569.3	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3714_c0_g1_i3	Q9VXY2	MADD_DROME	76.6	376	80	2	76	1197	1414	1783	1.80E-171	603.6	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3714_c0_g1_i4	Q9VXY2	MADD_DROME	76.6	376	80	2	369	1490	1414	1783	4.90E-171	602.4	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3714_c0_g1_i5	Q9VXY2	MADD_DROME	73.8	320	76	2	369	1322	1414	1727	2.90E-137	490	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3714_c0_g1_i8	Q9VXY2	MADD_DROME	79.4	68	14	0	60	263	1716	1783	1.40E-26	120.6	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14130_c0_g1_i1	Q9VXY2	MADD_DROME	56.4	195	78	3	322	903	1144	1332	3.00E-53	210.3	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14130_c0_g1_i3	Q9VXY2	MADD_DROME	61	105	39	2	496	810	1144	1246	1.30E-27	125.2	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14130_c0_g1_i6	Q9VXY2	MADD_DROME	57.7	196	75	4	496	1080	1144	1332	1.50E-54	214.9	MADD_DROME	reviewed	MAP kinase-activating death domain protein (Rab3 guanyl-nucleotide exchange factor)	Rab3-GEF CG5627	Drosophila melanogaster (Fruit fly)	2084	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; neuromuscular junction of somatic muscle [GO:0098527]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0000187; GO:0006915; GO:0007269; GO:0008021; GO:0016021; GO:0016192; GO:0017112; GO:0032483; GO:0042981; GO:0043025; GO:0043195; GO:0045202; GO:0048789; GO:0051726; GO:0098527; GO:1902041	activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cytoskeletal matrix organization at active zone [GO:0048789]; neurotransmitter secretion [GO:0007269]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i10	Q66JF3	MKNK1_XENTR	52	50	24	0	136	285	273	322	3.80E-07	56.6	MKNK1_XENTR	reviewed	MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1)	mknk1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	417	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i5	Q66JF3	MKNK1_XENTR	52	50	24	0	136	285	273	322	3.70E-07	56.6	MKNK1_XENTR	reviewed	MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1)	mknk1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	417	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN35344_c0_g1_i1	O08605	MKNK1_MOUSE	97.8	139	3	0	3	419	133	271	3.30E-79	295.4	MKNK1_MOUSE	reviewed	MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1)	Mknk1 Mnk1	Mus musculus (Mouse)	427	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translational initiation [GO:0006446]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006446; GO:0006468; GO:0009651; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872; GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translational initiation [GO:0006446]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN22992_c0_g1_i1	Q9HBH9	MKNK2_HUMAN	100	308	0	0	1	924	75	382	1.30E-184	646.7	MKNK2_HUMAN	reviewed	MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2)	MKNK2 GPRK7 MNK2	Homo sapiens (Human)	465	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell surface receptor signaling pathway [GO:0007166]; cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006417; GO:0006468; GO:0007166; GO:0009931; GO:0016604; GO:0016605; GO:0018105; GO:0030097; GO:0035556; GO:0046777; GO:0046872; GO:0071243; GO:0097192	cell surface receptor signaling pathway [GO:0007166]; cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1919_c0_g1_i1	Q6P431	MKNK2_XENLA	59.6	371	143	3	219	1316	78	446	1.20E-131	471.5	MKNK2_XENLA	reviewed	MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2)	mknk2	Xenopus laevis (African clawed frog)	467	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; regulation of translation [GO:0006417]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0006417; GO:0046872	regulation of translation [GO:0006417]		blue	blue	NA	NA	NA	NA
TRINITY_DN1919_c0_g1_i3	Q8CDB0	MKNK2_MOUSE	37.5	80	50	0	422	183	366	445	4.40E-07	55.8	MKNK2_MOUSE	reviewed	MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2)	Mknk2 Mnk2	Mus musculus (Mouse)	459	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006417; GO:0006468; GO:0009931; GO:0016604; GO:0016605; GO:0018105; GO:0030097; GO:0035556; GO:0046777; GO:0046872; GO:0071243; GO:0097192	cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]		blue	blue	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i29	Q8VHF0	MARK3_RAT	54	803	282	14	2406	85	53	797	2.20E-204	714.5	MARK3_RAT	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1)	Mark3	Rattus norvegicus (Rat)	797	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i44	Q8VHF0	MARK3_RAT	48	692	268	14	2027	39	98	726	2.10E-142	507.7	MARK3_RAT	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1)	Mark3	Rattus norvegicus (Rat)	797	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i61	Q8VHF0	MARK3_RAT	77.6	308	67	1	64	987	98	403	1.80E-136	487.6	MARK3_RAT	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1)	Mark3	Rattus norvegicus (Rat)	797	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN40633_c0_g1_i1	P27448	MARK3_HUMAN	100	110	0	0	3	332	644	753	1.50E-58	226.5	MARK3_HUMAN	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78)	MARK3 CTAK1 EMK2	Homo sapiens (Human)	753	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000165; GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0048156; GO:0050321; GO:0070062	intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN15679_c0_g1_i1	P27448	MARK3_HUMAN	99.5	205	1	0	617	3	133	337	3.40E-117	422.2	MARK3_HUMAN	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78)	MARK3 CTAK1 EMK2	Homo sapiens (Human)	753	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000165; GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0048156; GO:0050321; GO:0070062	intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN15679_c0_g1_i2	P27448	MARK3_HUMAN	100	205	0	0	617	3	133	337	1.50E-117	423.3	MARK3_HUMAN	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78)	MARK3 CTAK1 EMK2	Homo sapiens (Human)	753	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000165; GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0048156; GO:0050321; GO:0070062	intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i30	Q03141	MARK3_MOUSE	50.5	620	237	12	1793	39	98	682	6.00E-141	502.7	MARK3_MOUSE	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (ELKL motif kinase 2) (EMK-2) (MPK-10)	Mark3 Emk2 Mpk10	Mus musculus (Mouse)	753	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i35	Q03141	MARK3_MOUSE	54.3	647	251	11	1895	39	53	682	6.70E-165	583.2	MARK3_MOUSE	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (ELKL motif kinase 2) (EMK-2) (MPK-10)	Mark3 Emk2 Mpk10	Mus musculus (Mouse)	753	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i37	Q03141	MARK3_MOUSE	50.1	625	237	12	1808	39	98	682	2.30E-140	500.7	MARK3_MOUSE	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (ELKL motif kinase 2) (EMK-2) (MPK-10)	Mark3 Emk2 Mpk10	Mus musculus (Mouse)	753	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i38	Q03141	MARK3_MOUSE	54.4	642	253	10	1880	39	53	682	2.30E-165	584.7	MARK3_MOUSE	reviewed	MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (ELKL motif kinase 2) (EMK-2) (MPK-10)	Mark3 Emk2 Mpk10	Mus musculus (Mouse)	753	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN28071_c0_g1_i1	Q9LJD8	M3KE1_ARATH	77	74	15	1	1	216	98	171	9.90E-25	113.6	M3KE1_ARATH	reviewed	MAP3K epsilon protein kinase 1 (AtM3KE1) (EC 2.7.11.1) (Mitogen-activated protein kinase kinase kinase 7)	M3KE1 MAPKKK7 At3g13530 MRP15.19	Arabidopsis thaliana (Mouse-ear cress)	1368	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein autophosphorylation [GO:0046777]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of extent of cell growth [GO:0061387]; regulation of unidimensional cell growth [GO:0051510]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0007049; GO:0045995; GO:0046777; GO:0051301; GO:0051302; GO:0051510; GO:0061387	cell cycle [GO:0007049]; cell division [GO:0051301]; protein autophosphorylation [GO:0046777]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of extent of cell growth [GO:0061387]; regulation of unidimensional cell growth [GO:0051510]		NA	NA	NA	NA	NA	NA
TRINITY_DN2996_c0_g1_i1	Q9NS73	MBIP1_HUMAN	38	142	43	5	1	420	195	293	6.80E-14	78.6	MBIP1_HUMAN	reviewed	MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein)	MBIP BM-015	Homo sapiens (Human)	344	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860]; histone H3 acetylation [GO:0043966]; inactivation of MAPK activity involved in osmosensory signaling pathway [GO:0000173]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860]	GO:0000173; GO:0004860; GO:0005654; GO:0005671; GO:0005730; GO:0005829; GO:0042802; GO:0043966	histone H3 acetylation [GO:0043966]; inactivation of MAPK activity involved in osmosensory signaling pathway [GO:0000173]		NA	NA	NA	NA	NA	NA
TRINITY_DN33586_c0_g1_i1	Q9UQ07	MOK_HUMAN	74.4	90	23	0	3	272	100	189	6.90E-38	157.5	MOK_HUMAN	reviewed	MAPK/MAK/MRK overlapping kinase (EC 2.7.11.22) (MOK protein kinase) (Renal tumor antigen 1) (RAGE-1)	MOK RAGE RAGE1	Homo sapiens (Human)	419	ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]	ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0004693; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007165; GO:0010468; GO:0035556; GO:0046872; GO:0097546	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15561_c0_g1_i1	Q9CQC8	SPG21_MOUSE	99.4	166	1	0	500	3	14	179	1.60E-96	353.2	SPG21_MOUSE	reviewed	Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)	Spg21	Mus musculus (Mouse)	308	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]	CD4 receptor binding [GO:0042609]	GO:0005829; GO:0030140; GO:0042609; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN15561_c0_g1_i2	Q9CQC8	SPG21_MOUSE	100	200	0	0	603	4	14	213	5.70E-117	421.4	SPG21_MOUSE	reviewed	Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)	Spg21	Mus musculus (Mouse)	308	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]	CD4 receptor binding [GO:0042609]	GO:0005829; GO:0030140; GO:0042609; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN39422_c0_g1_i1	Q9CQC8	SPG21_MOUSE	100	72	0	0	217	2	224	295	2.60E-35	148.7	SPG21_MOUSE	reviewed	Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)	Spg21	Mus musculus (Mouse)	308	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]	CD4 receptor binding [GO:0042609]	GO:0005829; GO:0030140; GO:0042609; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN34825_c0_g1_i1	Q9NZD8	SPG21_HUMAN	99	99	1	0	298	2	1	99	4.80E-56	218	SPG21_HUMAN	reviewed	Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein) (Spastic paraplegia 21 protein)	SPG21 ACP33 BM-019 GL010	Homo sapiens (Human)	308	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]; antigen receptor-mediated signaling pathway [GO:0050851]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]	CD4 receptor binding [GO:0042609]	GO:0005794; GO:0005829; GO:0010008; GO:0030140; GO:0042609; GO:0043231; GO:0050851	antigen receptor-mediated signaling pathway [GO:0050851]		NA	NA	NA	NA	NA	NA
TRINITY_DN30941_c0_g1_i1	Q5FVD6	SPG21_XENLA	41.8	55	32	0	3	167	220	274	3.30E-08	58.5	SPG21_XENLA	reviewed	Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)	spg21	Xenopus laevis (African clawed frog)	310	cytosol [GO:0005829]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]	cytosol [GO:0005829]; trans-Golgi network transport vesicle [GO:0030140]	CD4 receptor binding [GO:0042609]	GO:0005829; GO:0030140; GO:0042609			NA	NA	NA	NA	NA	NA
TRINITY_DN1375_c0_g1_i1	Q8MJJ1	SPG21_BOVIN	59.4	283	114	1	960	115	3	285	1.00E-100	368.2	SPG21_BOVIN	reviewed	Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)	SPG21	Bos taurus (Bovine)	308	cytosol [GO:0005829]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]	cytosol [GO:0005829]; trans-Golgi network transport vesicle [GO:0030140]	CD4 receptor binding [GO:0042609]	GO:0005829; GO:0030140; GO:0042609			blue	blue	NA	NA	NA	NA
TRINITY_DN16469_c0_g1_i2	Q5FWY4	MCM6M_XENLA	53.6	110	44	4	333	7	540	643	3.40E-22	105.9	MCM6M_XENLA	reviewed	Maternal DNA replication licensing factor mcm6 (EC 3.6.4.12) (Maternal minichromosome maintenance protein 6) (mMCM6) (xMCM6)	mmcm6	Xenopus laevis (African clawed frog)	821	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]	GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN33413_c0_g1_i1	Q61846	MELK_MOUSE	46.2	65	34	1	7	201	91	154	4.10E-11	68.2	MELK_MOUSE	reviewed	Maternal embryonic leucine zipper kinase (EC 2.7.11.1) (Protein kinase PK38) (mPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2)	Melk Kiaa0175 Pk38	Mus musculus (Mouse)	643	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0008631; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0061351	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN39000_c0_g1_i2	Q91821	MELK_XENLA	72.3	253	70	0	760	2	3	255	8.30E-109	394.8	MELK_XENLA	reviewed	Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase)	melk	Xenopus laevis (African clawed frog)	651	cell cortex [GO:0005938]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]	cell cortex [GO:0005938]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN39000_c0_g1_i1	F1QGZ6	MELK_DANRE	81.6	38	7	0	178	65	186	223	2.20E-12	72.4	MELK_DANRE	reviewed	Maternal embryonic leucine zipper kinase (zMelk) (EC 2.7.11.1) (Protein kinase PK38)	melk	Danio rerio (Zebrafish) (Brachydanio rerio)	676	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; erythrocyte development [GO:0048821]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0007049; GO:0008016; GO:0008283; GO:0008289; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0048821; GO:0061351	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; erythrocyte development [GO:0048821]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of heart contraction [GO:0008016]		NA	NA	NA	NA	NA	NA
TRINITY_DN6620_c0_g1_i1	P25822	PUM_DROME	43.2	95	25	3	186	470	783	848	2.50E-09	64.3	PUM_DROME	reviewed	Maternal protein pumilio	pum CG9755	Drosophila melanogaster (Fruit fly)	1533	"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; CCR4-NOT complex binding [GO:1905762]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; pole cell migration [GO:0007280]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]	"CCR4-NOT complex binding [GO:1905762]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000278; GO:0000288; GO:0000900; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005635; GO:0005737; GO:0007268; GO:0007280; GO:0007281; GO:0007616; GO:0008258; GO:0008582; GO:0008595; GO:0010608; GO:0016441; GO:0016477; GO:0017148; GO:0031594; GO:0042059; GO:0042078; GO:0045727; GO:0045786; GO:0045892; GO:0048149; GO:0048477; GO:0048813; GO:0050804; GO:0060213; GO:0061176; GO:0061177; GO:0071598; GO:0097482; GO:1900153; GO:1901835; GO:1905762; GO:1990124; GO:1990825	"anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; pole cell migration [GO:0007280]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6620_c0_g1_i2	P25822	PUM_DROME	43.2	95	25	3	186	470	783	848	2.00E-09	64.3	PUM_DROME	reviewed	Maternal protein pumilio	pum CG9755	Drosophila melanogaster (Fruit fly)	1533	"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; CCR4-NOT complex binding [GO:1905762]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; pole cell migration [GO:0007280]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; muscle cell postsynaptic specialization [GO:0097482]; neuromuscular junction [GO:0031594]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]	"CCR4-NOT complex binding [GO:1905762]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000278; GO:0000288; GO:0000900; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005635; GO:0005737; GO:0007268; GO:0007280; GO:0007281; GO:0007616; GO:0008258; GO:0008582; GO:0008595; GO:0010608; GO:0016441; GO:0016477; GO:0017148; GO:0031594; GO:0042059; GO:0042078; GO:0045727; GO:0045786; GO:0045892; GO:0048149; GO:0048477; GO:0048813; GO:0050804; GO:0060213; GO:0061176; GO:0061177; GO:0071598; GO:0097482; GO:1900153; GO:1901835; GO:1905762; GO:1990124; GO:1990825	"anterior/posterior axis specification, embryo [GO:0008595]; behavioral response to ethanol [GO:0048149]; cell migration [GO:0016477]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; germ cell development [GO:0007281]; germ-line stem cell division [GO:0042078]; head involution [GO:0008258]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell cycle [GO:0045786]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; oogenesis [GO:0048477]; pole cell migration [GO:0007280]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26942_c0_g1_i1	P51512	MMP16_HUMAN	45.1	142	69	3	1	423	169	302	3.40E-26	119.8	MMP16_HUMAN	reviewed	Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)	MMP16 C8orf57 MMPX2	Homo sapiens (Human)	607	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0001501; GO:0001958; GO:0004222; GO:0005796; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094	chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN14731_c0_g1_i1	Q9R0S2	MMP24_MOUSE	54.7	86	36	1	261	4	190	272	1.70E-20	99.8	MMP24_MOUSE	reviewed	Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]	Mmp24 Mmp21 Mt5mmp	Mus musculus (Mouse)	618	extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]	extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]	cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005887; GO:0006508; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742	cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN15309_c0_g4_i1	Q9NR99	MXRA5_HUMAN	26.9	364	216	11	960	4	2058	2416	1.00E-19	99	MXRA5_HUMAN	reviewed	Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican)	MXRA5	Homo sapiens (Human)	2828	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; response to transforming growth factor beta [GO:0071559]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559	response to transforming growth factor beta [GO:0071559]		NA	NA	NA	NA	NA	NA
TRINITY_DN11420_c0_g3_i1	B0WYS3	SCC4_CULQU	51.5	99	48	0	300	4	53	151	8.80E-21	100.9	SCC4_CULQU	reviewed	MAU2 chromatid cohesion factor homolog (Cohesin loading complex subunit SCC4 homolog)	CPIJ012302	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	616	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]; cell division [GO:0051301]; maintenance of mitotic sister chromatid cohesion [GO:0034088]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]		GO:0000785; GO:0005634; GO:0005654; GO:0032116; GO:0034088; GO:0051301	cell division [GO:0051301]; maintenance of mitotic sister chromatid cohesion [GO:0034088]		NA	NA	NA	NA	NA	NA
TRINITY_DN34336_c0_g1_i1	B0WYS3	SCC4_CULQU	64	75	27	0	254	30	1	75	1.40E-22	106.7	SCC4_CULQU	reviewed	MAU2 chromatid cohesion factor homolog (Cohesin loading complex subunit SCC4 homolog)	CPIJ012302	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	616	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]; cell division [GO:0051301]; maintenance of mitotic sister chromatid cohesion [GO:0034088]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]		GO:0000785; GO:0005634; GO:0005654; GO:0032116; GO:0034088; GO:0051301	cell division [GO:0051301]; maintenance of mitotic sister chromatid cohesion [GO:0034088]		NA	NA	NA	NA	NA	NA
TRINITY_DN18689_c0_g1_i4	B0WYS3	SCC4_CULQU	57.1	196	81	2	40	618	395	590	1.70E-56	220.7	SCC4_CULQU	reviewed	MAU2 chromatid cohesion factor homolog (Cohesin loading complex subunit SCC4 homolog)	CPIJ012302	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	616	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]; cell division [GO:0051301]; maintenance of mitotic sister chromatid cohesion [GO:0034088]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116]		GO:0000785; GO:0005634; GO:0005654; GO:0032116; GO:0034088; GO:0051301	cell division [GO:0051301]; maintenance of mitotic sister chromatid cohesion [GO:0034088]		NA	NA	NA	NA	NA	NA
TRINITY_DN28263_c0_g1_i1	Q9Y6X3	SCC4_HUMAN	100	97	0	0	291	1	457	553	5.50E-49	194.5	SCC4_HUMAN	reviewed	MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog)	MAU2 KIAA0892 SCC4	Homo sapiens (Human)	613	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; double-stranded DNA binding [GO:0003690]; protein N-terminus binding [GO:0047485]; cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]	double-stranded DNA binding [GO:0003690]; protein N-terminus binding [GO:0047485]	GO:0000785; GO:0003690; GO:0005634; GO:0005654; GO:0016604; GO:0032116; GO:0034088; GO:0047485; GO:0051301; GO:0071921; GO:0090694	cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]		NA	NA	NA	NA	NA	NA
TRINITY_DN18689_c0_g1_i2	B4ZIX8	SCC4_XENLA	57.8	367	153	2	51	1145	224	590	1.30E-115	417.9	SCC4_XENLA	reviewed	MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog)	mau2	Xenopus laevis (African clawed frog)	607	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]		GO:0000785; GO:0005634; GO:0005654; GO:0032116; GO:0034088; GO:0051301; GO:0071921; GO:0090694	cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]		NA	NA	NA	NA	NA	NA
TRINITY_DN18689_c0_g1_i6	B4ZIX8	SCC4_XENLA	56.9	411	174	3	8	1234	181	590	3.70E-124	446.4	SCC4_XENLA	reviewed	MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog)	mau2	Xenopus laevis (African clawed frog)	607	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]		GO:0000785; GO:0005634; GO:0005654; GO:0032116; GO:0034088; GO:0051301; GO:0071921; GO:0090694	cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]		NA	NA	NA	NA	NA	NA
TRINITY_DN5300_c0_g2_i1	O08789	MNT_MOUSE	57.4	68	29	0	96	299	204	271	1.50E-14	80.5	MNT_MOUSE	reviewed	Max-binding protein MNT (Myc antagonist MNT) (Protein ROX)	Mnt Rox	Mus musculus (Mouse)	591	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell aging [GO:0007569]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007569; GO:0046983; GO:0051726; GO:2001234	"cell aging [GO:0007569]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5300_c0_g2_i2	O08789	MNT_MOUSE	65.6	96	33	0	96	383	204	299	1.00E-26	120.9	MNT_MOUSE	reviewed	Max-binding protein MNT (Myc antagonist MNT) (Protein ROX)	Mnt Rox	Mus musculus (Mouse)	591	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell aging [GO:0007569]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007569; GO:0046983; GO:0051726; GO:2001234	"cell aging [GO:0007569]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5300_c0_g2_i3	O08789	MNT_MOUSE	57.4	68	29	0	96	299	204	271	1.20E-14	80.9	MNT_MOUSE	reviewed	Max-binding protein MNT (Myc antagonist MNT) (Protein ROX)	Mnt Rox	Mus musculus (Mouse)	591	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell aging [GO:0007569]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007569; GO:0046983; GO:0051726; GO:2001234	"cell aging [GO:0007569]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3369_c0_g1_i2	Q9UH92	MLX_HUMAN	54.5	189	83	2	641	78	94	280	6.10E-45	182.6	MLX_HUMAN	reviewed	Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)	MLX BHLHD13 TCFL4	Homo sapiens (Human)	298	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3369_c0_g1_i3	Q9UH92	MLX_HUMAN	55.4	202	87	2	718	116	94	293	1.50E-49	198	MLX_HUMAN	reviewed	Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)	MLX BHLHD13 TCFL4	Homo sapiens (Human)	298	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3369_c0_g1_i4	Q9UH92	MLX_HUMAN	62.7	161	59	1	595	116	133	293	1.60E-50	201.1	MLX_HUMAN	reviewed	Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)	MLX BHLHD13 TCFL4	Homo sapiens (Human)	298	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25029_c0_g1_i1	Q9UH92	MLX_HUMAN	98.1	103	2	0	310	2	152	254	6.90E-50	197.6	MLX_HUMAN	reviewed	Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)	MLX BHLHD13 TCFL4	Homo sapiens (Human)	298	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5138_c0_g1_i1	Q6DIN3	MBTD1_XENTR	30.6	186	90	6	98	643	75	225	2.40E-16	87.4	MBTD1_XENTR	reviewed	MBT domain-containing protein 1	mbtd1 TTpA012c17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	651	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0035064; GO:0042393; GO:0045892	"chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN5138_c0_g1_i4	Q6DIN3	MBTD1_XENTR	31.1	193	94	6	482	1048	68	225	8.80E-18	92.8	MBTD1_XENTR	reviewed	MBT domain-containing protein 1	mbtd1 TTpA012c17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	651	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0035064; GO:0042393; GO:0045892	"chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5138_c0_g1_i5	Q6DIN3	MBTD1_XENTR	31.1	193	94	6	492	1058	68	225	8.90E-18	92.8	MBTD1_XENTR	reviewed	MBT domain-containing protein 1	mbtd1 TTpA012c17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	651	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0035064; GO:0042393; GO:0045892	"chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38573_c0_g1_i1	Q27433	MEC2_CAEEL	85.4	82	12	0	251	6	256	337	2.40E-29	129	MEC2_CAEEL	reviewed	Mechanosensory protein 2	mec-2 F14D12.4	Caenorhabditis elegans	481	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]	GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792	detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]		NA	NA	NA	NA	NA	NA
TRINITY_DN14692_c0_g1_i1	Q8BR76	MKS3_MOUSE	33.9	363	216	10	1046	3	237	590	4.90E-47	189.9	MKS3_MOUSE	reviewed	Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67)	Tmem67 Mks3	Mus musculus (Mouse)	992	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; plasma membrane [GO:0005886]; filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]; branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857]; ubiquitin-dependent ERAD pathway [GO:0030433]	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; plasma membrane [GO:0005886]	filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]	GO:0001822; GO:0005789; GO:0005813; GO:0005886; GO:0007368; GO:0007507; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035845; GO:0035869; GO:0036038; GO:0048754; GO:0051082; GO:0051787; GO:0060170; GO:0060271; GO:0060322; GO:1902857; GO:1904294	branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN14692_c0_g2_i1	P0C152	MKS3_RAT	42.6	404	221	3	1210	2	593	986	2.00E-89	330.9	MKS3_RAT	reviewed	Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67)	Tmem67 Mks3 Wpk	Rattus norvegicus (Rat)	992	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; plasma membrane [GO:0005886]; filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]; branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857]; ubiquitin-dependent ERAD pathway [GO:0030433]	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; plasma membrane [GO:0005886]	filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]	GO:0001822; GO:0005789; GO:0005813; GO:0005886; GO:0007368; GO:0007507; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035845; GO:0035869; GO:0036038; GO:0048754; GO:0051082; GO:0051787; GO:0060170; GO:0060271; GO:0060322; GO:1902857; GO:1904294	branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN8569_c0_g1_i1	Q15648	MED1_HUMAN	44.4	117	64	1	51	401	15	130	6.10E-18	92	MED1_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)	MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2	Homo sapiens (Human)	1581	"chromatin [GO:0000785]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; mediator complex binding [GO:0036033]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERK1 and ERK2 cascade [GO:0070371]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of lipid metabolic process [GO:0019216]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	chromatin [GO:0000785]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; mediator complex binding [GO:0036033]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]	GO:0000122; GO:0000151; GO:0000785; GO:0000902; GO:0000978; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006367; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0008134; GO:0010628; GO:0010839; GO:0016020; GO:0016592; GO:0016922; GO:0019216; GO:0030216; GO:0030224; GO:0030331; GO:0030374; GO:0030375; GO:0030518; GO:0031100; GO:0031490; GO:0032993; GO:0033148; GO:0035050; GO:0035116; GO:0035162; GO:0035257; GO:0035357; GO:0035729; GO:0035855; GO:0036033; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0060261; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0061630; GO:0070318; GO:0070371; GO:0070562; GO:0071364; GO:0071383; GO:0097067; GO:1990841; GO:2000273; GO:2000347; GO:2001141	"androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERK1 and ERK2 cascade [GO:0070371]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of lipid metabolic process [GO:0019216]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4780_c0_g2_i1	Q6INP8	MED1_XENLA	42.1	107	61	1	1	318	394	500	1.90E-15	85.5	MED1_XENLA	reviewed	Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)	med1	Xenopus laevis (African clawed frog)	1570	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4780_c0_g1_i1	Q172G3	MED1_AEDAE	44.1	238	125	3	5	709	216	448	7.10E-50	198.7	MED1_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)	AAEL007402	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1760	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4780_c0_g1_i2	Q172G3	MED1_AEDAE	59.3	59	24	0	5	181	216	274	1.40E-11	70.1	MED1_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)	AAEL007402	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1760	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN8569_c0_g1_i3	Q172G3	MED1_AEDAE	46.5	155	76	3	45	503	69	218	2.30E-31	136.7	MED1_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)	AAEL007402	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1760	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8569_c0_g1_i4	Q172G3	MED1_AEDAE	48.3	120	57	2	39	398	104	218	9.20E-23	107.8	MED1_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)	AAEL007402	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1760	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5242_c0_g1_i1	Q7Q5R5	MED10_ANOGA	66.4	128	42	1	65	448	1	127	9.10E-45	181.4	MED10_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10)	MED10 AGAP006248	Anopheles gambiae (African malaria mosquito)	130	mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0016592; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN15858_c0_g1_i1	Q3ZCF2	MED10_BOVIN	100	83	0	0	280	32	53	135	3.60E-42	171.8	MED10_BOVIN	reviewed	Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10)	MED10	Bos taurus (Bovine)	135	mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0016592; GO:0019827; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN15858_c0_g2_i1	Q3ZCF2	MED10_BOVIN	100	129	0	0	388	2	1	129	1.50E-68	260	MED10_BOVIN	reviewed	Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10)	MED10	Bos taurus (Bovine)	135	mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0016592; GO:0019827; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN1134_c0_g4_i1	Q9VVS4	MED11_DROME	57.8	109	46	0	482	156	2	110	4.50E-28	126.3	MED11_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) (dMED21)	MED11 Med21 CG6884	Drosophila melanogaster (Fruit fly)	176	mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN7914_c0_g1_i1	Q9VW47	MED12_DROME	52.6	253	104	5	50	808	1673	1909	5.60E-69	263.1	MED12_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (Mediator complex subunit Kohtalo) (dTRAP230)	kto Med12 Trap230 CG8491	Drosophila melanogaster (Fruit fly)	2531	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003713; GO:0005634; GO:0005700; GO:0006357; GO:0016592; GO:0022416; GO:0035072; GO:0036011; GO:0045498; GO:0048749; GO:0070847; GO:0090263	chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]		NA	NA	NA	NA	NA	NA
TRINITY_DN36785_c0_g1_i1	Q9VW47	MED12_DROME	51.7	180	79	4	2	532	1153	1327	1.50E-39	164.1	MED12_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (Mediator complex subunit Kohtalo) (dTRAP230)	kto Med12 Trap230 CG8491	Drosophila melanogaster (Fruit fly)	2531	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003713; GO:0005634; GO:0005700; GO:0006357; GO:0016592; GO:0022416; GO:0035072; GO:0036011; GO:0045498; GO:0048749; GO:0070847; GO:0090263	chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]		NA	NA	NA	NA	NA	NA
TRINITY_DN7914_c0_g1_i3	A2AGH6	MED12_MOUSE	53.1	162	70	3	50	523	1522	1681	1.30E-36	154.5	MED12_MOUSE	reviewed	Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) (Trinucleotide repeat-containing gene 11 protein)	Med12 Kiaa0192 Mopa Tnrc11 Trap230	Mus musculus (Mouse)	2190	"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000978; GO:0001756; GO:0001843; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0007492; GO:0007507; GO:0008013; GO:0008022; GO:0008134; GO:0014003; GO:0014044; GO:0016567; GO:0016592; GO:0019827; GO:0019904; GO:0021510; GO:0021915; GO:0036342; GO:0045893; GO:0045944; GO:0046966; GO:0048568; GO:0048702; GO:0060070; GO:0060071; GO:0060261; GO:0061630; GO:0090245; GO:1990403	"axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic organ development [GO:0048568]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; oligodendrocyte development [GO:0014003]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-anal tail morphogenesis [GO:0036342]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14699_c0_g1_i1	Q9UHV7	MED13_HUMAN	44.8	248	115	6	4	747	1945	2170	1.30E-47	191.4	MED13_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250)	MED13 ARC250 KIAA0593 THRAP1 TRAP240	Homo sapiens (Human)	2174	"mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328]"	mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0016020; GO:0016592; GO:0030374; GO:0042632; GO:0042809; GO:0043433; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328	"cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4928_c0_g1_i1	O60244	MED14_HUMAN	35.5	301	179	8	98	979	1160	1452	1.30E-42	175.3	MED14_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150)	MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170	Homo sapiens (Human)	1454	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0016020; GO:0016592; GO:0019827; GO:0030374; GO:0042809; GO:0045893; GO:0045944; GO:0060261; GO:0070847	"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN928_c0_g1_i1	Q16U49	MED14_AEDAE	46.9	1089	475	13	109	3174	29	1081	7.40E-264	911.8	MED14_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)	MED14 AAEL010020	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1578	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN928_c0_g1_i2	Q16U49	MED14_AEDAE	62.3	332	125	0	109	1104	29	360	2.50E-116	420.2	MED14_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)	MED14 AAEL010020	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1578	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN928_c0_g1_i3	Q16U49	MED14_AEDAE	46.8	1096	472	14	109	3192	29	1081	2.80E-263	909.8	MED14_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)	MED14 AAEL010020	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1578	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26543_c0_g1_i1	Q7PVZ2	MED17_ANOGA	57.1	254	107	1	846	91	390	643	5.20E-80	299.3	MED17_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 17 (Mediator complex subunit 17)	MED17 AGAP009141	Anopheles gambiae (African malaria mosquito)	645	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2551_c0_g1_i1	Q9VVL6	MED19_DROME	60	50	15	2	211	65	11	56	1.70E-07	57	MED19_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19)	MED19 CG5546	Drosophila melanogaster (Fruit fly)	337	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	GO:0003712; GO:0006357; GO:0008134; GO:0016592; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2551_c0_g1_i2	Q174D3	MED19_AEDAE	60.5	162	62	2	484	2	10	170	5.10E-49	195.7	MED19_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19)	MED19 AAEL006934	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	253	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2551_c0_g1_i3	Q174D3	MED19_AEDAE	60.5	167	63	3	809	312	10	174	7.10E-50	199.1	MED19_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19)	MED19 AAEL006934	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	253	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN17236_c1_g1_i2	Q7ZTI5	MED21_DANRE	56.4	78	34	0	43	276	53	130	2.50E-15	83.6	MED21_DANRE	reviewed	Mediator of RNA polymerase II transcription subunit 21 (Mediator complex subunit 21) (RNA polymerase II holoenzyme component SRB7) (RNAPII complex component SRB7)	med21 surb7 si:ch211-203h15.4	Danio rerio (Zebrafish) (Brachydanio rerio)	145	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17236_c1_g1_i3	Q7ZTI5	MED21_DANRE	50.8	130	64	0	36	425	1	130	1.60E-25	117.9	MED21_DANRE	reviewed	Mediator of RNA polymerase II transcription subunit 21 (Mediator complex subunit 21) (RNA polymerase II holoenzyme component SRB7) (RNAPII complex component SRB7)	med21 surb7 si:ch211-203h15.4	Danio rerio (Zebrafish) (Brachydanio rerio)	145	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2326_c0_g1_i1	Q9V439	MED22_DROME	64.9	111	39	0	1	333	33	143	3.10E-32	139.4	MED22_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (dMED24)	MED22 Med24 CG3034	Drosophila melanogaster (Fruit fly)	143	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0000278; GO:0000785; GO:0003712; GO:0005634; GO:0005730; GO:0006357; GO:0016592; GO:1902064	mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]		blue	blue	NA	NA	NA	NA
TRINITY_DN2326_c0_g1_i2	Q9V439	MED22_DROME	64.9	111	39	0	1	333	33	143	3.00E-32	139.4	MED22_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (dMED24)	MED22 Med24 CG3034	Drosophila melanogaster (Fruit fly)	143	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0000278; GO:0000785; GO:0003712; GO:0005634; GO:0005730; GO:0006357; GO:0016592; GO:1902064	mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]		NA	NA	NA	NA	NA	NA
TRINITY_DN27257_c0_g1_i1	Q9ULK4	MED23_HUMAN	100	71	0	0	3	215	781	851	2.60E-35	148.7	MED23_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130)	MED23 ARC130 CRSP3 DRIP130 KIAA1216 SUR2	Homo sapiens (Human)	1368	"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592	"positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36650_c0_g1_i1	Q9ULK4	MED23_HUMAN	100	166	0	0	52	549	870	1035	6.60E-96	351.3	MED23_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130)	MED23 ARC130 CRSP3 DRIP130 KIAA1216 SUR2	Homo sapiens (Human)	1368	"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592	"positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8893_c0_g1_i2	Q9ULK4	MED23_HUMAN	60.6	327	123	4	1059	91	674	998	9.80E-112	404.8	MED23_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130)	MED23 ARC130 CRSP3 DRIP130 KIAA1216 SUR2	Homo sapiens (Human)	1368	"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592	"positive regulation of gene expression [GO:0010628]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13932_c0_g1_i1	Q16HH9	MED23_AEDAE	52	125	58	1	459	91	1226	1350	1.30E-33	144.1	MED23_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)	MED23 AAEL014021	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1409	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN8893_c0_g1_i3	Q16HH9	MED23_AEDAE	56.7	420	171	3	1253	3	693	1104	1.80E-144	513.8	MED23_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)	MED23 AAEL014021	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1409	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN8893_c0_g1_i5	Q16HH9	MED23_AEDAE	56.8	292	116	2	940	71	693	976	5.00E-99	362.5	MED23_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)	MED23 AAEL014021	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1409	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4201_c0_g1_i1	Q2PW47	MED24_DANRE	30.7	952	588	22	3207	421	2	904	1.10E-116	422.9	MED24_DANRE	reviewed	Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24) (Protein lessen) (Thyroid hormone receptor-associated protein 4 homolog) (Trap100 homolog)	med24 lsn thrap4 trap100	Danio rerio (Zebrafish) (Brachydanio rerio)	989	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0016592; GO:0046549; GO:0048484; GO:0048538; GO:0061453	enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN13617_c0_g1_i1	Q9VDR1	MED25_DROME	40	70	42	0	216	7	522	591	1.20E-13	77	MED25_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) (dmPTOV2)	MED25 Arc92 CG12254	Drosophila melanogaster (Fruit fly)	863	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; transcription coregulator activity [GO:0003712]; nervous system development [GO:0007399]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005654; GO:0005667; GO:0006357; GO:0006963; GO:0007399; GO:0016592; GO:0045944	nervous system development [GO:0007399]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1750_c0_g1_i3	Q7QCJ9	MED27_ANOGA	69.8	43	13	0	222	94	252	294	3.20E-14	79	MED27_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 27 (Mediator complex subunit 27)	MED27 AGAP002664	Anopheles gambiae (African malaria mosquito)	295	mediator complex [GO:0016592]	mediator complex [GO:0016592]		GO:0016592			blue	blue	NA	NA	NA	NA
TRINITY_DN3591_c0_g1_i1	Q172Y1	MED30_AEDAE	42.9	175	93	3	522	1	135	303	1.70E-29	131	MED30_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30)	MED30 AAEL007230	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	306	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN1777_c0_g1_i4	Q17DI7	MED31_AEDAE	74.3	113	29	0	111	449	12	124	2.30E-34	147.1	MED31_AEDAE	reviewed	Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31)	MED31 AAEL004132	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	218	"mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription, DNA-templated [GO:0006355]"	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006355; GO:0016592	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1777_c0_g1_i1	Q8IH24	MED31_DROME	76.1	109	26	0	93	419	13	121	2.90E-34	146.7	MED31_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Protein SOH1) (dSOH1)	MED31 Trap18 CG1057	Drosophila melanogaster (Fruit fly)	204	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of nucleic acid-templated transcription [GO:1903508]; regulation of transcription by RNA polymerase II [GO:0006357]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0008595; GO:0016592; GO:0070847; GO:1903508	"anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of nucleic acid-templated transcription [GO:1903508]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1777_c0_g1_i2	Q8IH24	MED31_DROME	74.3	109	28	0	133	459	13	121	5.20E-34	146	MED31_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Protein SOH1) (dSOH1)	MED31 Trap18 CG1057	Drosophila melanogaster (Fruit fly)	204	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of nucleic acid-templated transcription [GO:1903508]; regulation of transcription by RNA polymerase II [GO:0006357]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0008595; GO:0016592; GO:0070847; GO:1903508	"anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of nucleic acid-templated transcription [GO:1903508]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1777_c0_g1_i3	Q8IH24	MED31_DROME	74.3	109	28	0	186	512	13	121	2.50E-34	147.1	MED31_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Protein SOH1) (dSOH1)	MED31 Trap18 CG1057	Drosophila melanogaster (Fruit fly)	204	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of nucleic acid-templated transcription [GO:1903508]; regulation of transcription by RNA polymerase II [GO:0006357]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0008595; GO:0016592; GO:0070847; GO:1903508	"anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of nucleic acid-templated transcription [GO:1903508]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2392_c0_g1_i2	Q7QH62	MED4_ANOGA	46.4	209	96	4	740	153	21	226	4.00E-41	169.9	MED4_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4)	MED4 AGAP004063	Anopheles gambiae (African malaria mosquito)	263	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2392_c0_g1_i3	Q7QH62	MED4_ANOGA	46.9	224	103	4	785	153	6	226	2.10E-45	184.1	MED4_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4)	MED4 AGAP004063	Anopheles gambiae (African malaria mosquito)	263	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2392_c0_g1_i4	Q7QH62	MED4_ANOGA	46.4	209	96	4	740	153	21	226	5.30E-41	169.5	MED4_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4)	MED4 AGAP004063	Anopheles gambiae (African malaria mosquito)	263	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN2392_c0_g1_i5	Q7QH62	MED4_ANOGA	52.1	146	70	0	532	95	12	157	2.60E-33	143.3	MED4_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4)	MED4 AGAP004063	Anopheles gambiae (African malaria mosquito)	263	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2392_c0_g1_i6	Q7QH62	MED4_ANOGA	47.2	218	99	4	767	153	12	226	1.90E-44	181	MED4_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4)	MED4 AGAP004063	Anopheles gambiae (African malaria mosquito)	263	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN35608_c0_g1_i1	O75586	MED6_HUMAN	97.6	82	2	0	1	246	40	121	5.10E-39	161.4	MED6_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 6 (Activator-recruited cofactor 33 kDa component) (ARC33) (Mediator complex subunit 6) (hMed6) (Renal carcinoma antigen NY-REN-28)	MED6 ARC33	Homo sapiens (Human)	246	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0008134; GO:0016020; GO:0016592; GO:0045944; GO:0070847	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN16767_c0_g1_i1	O75586	MED6_HUMAN	99.1	116	1	0	351	4	42	157	1.50E-61	236.5	MED6_HUMAN	reviewed	Mediator of RNA polymerase II transcription subunit 6 (Activator-recruited cofactor 33 kDa component) (ARC33) (Mediator complex subunit 6) (hMed6) (Renal carcinoma antigen NY-REN-28)	MED6 ARC33	Homo sapiens (Human)	246	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0008134; GO:0016020; GO:0016592; GO:0045944; GO:0070847	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN35592_c0_g1_i1	Q3SZY9	MED6_BOVIN	51.2	209	79	2	81	707	7	192	6.30E-55	215.7	MED6_BOVIN	reviewed	Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6)	MED6	Bos taurus (Bovine)	246	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35516_c0_g1_i1	Q3T123	MED7_BOVIN	100	89	0	0	269	3	54	142	1.40E-43	176.4	MED7_BOVIN	reviewed	Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7)	MED7 CRSP9	Bos taurus (Bovine)	233	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35420_c0_g1_i1	Q7PR68	MED7_ANOGA	55.8	217	94	1	734	84	5	219	3.20E-65	250	MED7_ANOGA	reviewed	Mediator of RNA polymerase II transcription subunit 7 (Mediator complex subunit 7)	MED7 AGAP002823	Anopheles gambiae (African malaria mosquito)	219	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN27351_c0_g1_i1	A1ZBT5	MED8_DROME	45.2	252	123	2	107	817	1	252	3.00E-53	210.3	MED8_DROME	reviewed	Mediator of RNA polymerase II transcription subunit 8 (Mediator complex subunit 8)	MED8 Arc32 CG13867	Drosophila melanogaster (Fruit fly)	252	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	core mediator complex [GO:0070847]; mediator complex [GO:0016592]	RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]	GO:0000978; GO:0003712; GO:0006357; GO:0016592; GO:0070847	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN944_c0_g1_i1	Q3SZB4	ACADM_BOVIN	79.2	318	66	0	3	956	103	420	4.60E-146	518.8	ACADM_BOVIN	reviewed	"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)"	ACADM	Bos taurus (Bovine)	421	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; cardiac muscle cell differentiation [GO:0055007]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; glycogen biosynthetic process [GO:0005978]; liver development [GO:0001889]; medium-chain fatty acid catabolic process [GO:0051793]; post-embryonic development [GO:0009791]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to starvation [GO:0042594]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]	GO:0001889; GO:0003995; GO:0005739; GO:0005759; GO:0005978; GO:0006111; GO:0006635; GO:0009409; GO:0009791; GO:0019254; GO:0033539; GO:0042594; GO:0050660; GO:0051793; GO:0055007; GO:0070991	"cardiac muscle cell differentiation [GO:0055007]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; glycogen biosynthetic process [GO:0005978]; liver development [GO:0001889]; medium-chain fatty acid catabolic process [GO:0051793]; post-embryonic development [GO:0009791]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to starvation [GO:0042594]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27476_c0_g1_i1	P11310	ACADM_HUMAN	100	135	0	0	3	407	248	382	2.50E-68	259.2	ACADM_HUMAN	reviewed	"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7) (Medium chain acyl-CoA dehydrogenase) (MCADH)"	ACADM	Homo sapiens (Human)	421	"axon [GO:0030424]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; oxidation-reduction process [GO:0055114]; regulation of lipid metabolic process [GO:0019216]"	axon [GO:0030424]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]	GO:0003995; GO:0005634; GO:0005739; GO:0005759; GO:0006635; GO:0019216; GO:0019254; GO:0030424; GO:0031966; GO:0033539; GO:0042802; GO:0045329; GO:0050660; GO:0051791; GO:0051793; GO:0055114; GO:0070991	"carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; oxidation-reduction process [GO:0055114]; regulation of lipid metabolic process [GO:0019216]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38030_c0_g1_i1	P11310	ACADM_HUMAN	100	137	0	0	412	2	103	239	1.80E-77	289.7	ACADM_HUMAN	reviewed	"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7) (Medium chain acyl-CoA dehydrogenase) (MCADH)"	ACADM	Homo sapiens (Human)	421	"axon [GO:0030424]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; oxidation-reduction process [GO:0055114]; regulation of lipid metabolic process [GO:0019216]"	axon [GO:0030424]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]	GO:0003995; GO:0005634; GO:0005739; GO:0005759; GO:0006635; GO:0019216; GO:0019254; GO:0030424; GO:0031966; GO:0033539; GO:0042802; GO:0045329; GO:0050660; GO:0051791; GO:0051793; GO:0055114; GO:0070991	"carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; oxidation-reduction process [GO:0055114]; regulation of lipid metabolic process [GO:0019216]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3889_c0_g1_i1	E1BZ85	MARF1_CHICK	51.8	245	116	2	937	1668	342	585	7.50E-61	236.5	MARF1_CHICK	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)	MARF1 LKAP	Gallus gallus (Chicken)	1741	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]	GO:0005737; GO:0005777; GO:0016441; GO:0048477; GO:0051321; GO:1903231; GO:1905762	meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]		NA	NA	NA	NA	NA	NA
TRINITY_DN3889_c0_g1_i2	B2GUN4	MARF1_XENTR	40.4	648	345	9	2445	4301	780	1415	1.80E-138	495.7	MARF1_XENTR	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)	marf1 lkap	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1681	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]	GO:0005737; GO:0005777; GO:0016441; GO:0048477; GO:0051321; GO:1903231; GO:1905762	meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]		NA	NA	NA	NA	NA	NA
TRINITY_DN3889_c0_g1_i2	B2GUN4	MARF1_XENTR	51.7	234	112	1	937	1638	337	569	1.60E-59	233.4	MARF1_XENTR	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)	marf1 lkap	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1681	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]	GO:0005737; GO:0005777; GO:0016441; GO:0048477; GO:0051321; GO:1903231; GO:1905762	meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]		NA	NA	NA	NA	NA	NA
TRINITY_DN3889_c0_g1_i4	B2GUN4	MARF1_XENTR	38	1121	620	21	937	4200	337	1415	8.40E-202	706.1	MARF1_XENTR	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)	marf1 lkap	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1681	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]	GO:0005737; GO:0005777; GO:0016441; GO:0048477; GO:0051321; GO:1903231; GO:1905762	meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]		NA	NA	NA	NA	NA	NA
TRINITY_DN3889_c0_g1_i5	E1BZ85	MARF1_CHICK	51.6	223	106	2	937	1605	342	562	5.00E-54	213.8	MARF1_CHICK	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)	MARF1 LKAP	Gallus gallus (Chicken)	1741	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]	GO:0005737; GO:0005777; GO:0016441; GO:0048477; GO:0051321; GO:1903231; GO:1905762	meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]		NA	NA	NA	NA	NA	NA
TRINITY_DN3889_c0_g1_i7	B2GUN4	MARF1_XENTR	40.4	648	345	9	36	1892	780	1415	8.20E-139	495.7	MARF1_XENTR	reviewed	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1 homolog)	marf1 lkap	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1681	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]	GO:0005737; GO:0005777; GO:0016441; GO:0048477; GO:0051321; GO:1903231; GO:1905762	meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]		NA	NA	NA	NA	NA	NA
TRINITY_DN14602_c0_g1_i1	A2AG06	MEIOC_MOUSE	52.4	170	77	3	53	556	746	913	2.20E-38	160.2	MEIOC_MOUSE	reviewed	Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein)	Meioc Gm1564	Mus musculus (Mouse)	965	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192	"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14602_c0_g1_i2	A2AG06	MEIOC_MOUSE	66.2	80	27	0	58	297	753	832	5.60E-23	108.2	MEIOC_MOUSE	reviewed	Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein)	Meioc Gm1564	Mus musculus (Mouse)	965	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192	"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31245_c0_g1_i1	P50265	DLH1_CANAX	65	80	28	0	5	244	81	160	1.20E-25	116.7	DLH1_CANAX	reviewed	Meiotic recombination protein DLH1 (DMC1 homolog)	DLH1	Candida albicans (Yeast)	324	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; reciprocal meiotic recombination [GO:0007131]	nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]	GO:0000150; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0007131; GO:0008094; GO:0016887	DNA repair [GO:0006281]; reciprocal meiotic recombination [GO:0007131]		NA	NA	NA	NA	NA	NA
TRINITY_DN32082_c0_g1_i1	P50265	DLH1_CANAX	63.7	91	33	0	273	1	88	178	2.60E-29	129	DLH1_CANAX	reviewed	Meiotic recombination protein DLH1 (DMC1 homolog)	DLH1	Candida albicans (Yeast)	324	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; reciprocal meiotic recombination [GO:0007131]	nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]	GO:0000150; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0007131; GO:0008094; GO:0016887	DNA repair [GO:0006281]; reciprocal meiotic recombination [GO:0007131]		NA	NA	NA	NA	NA	NA
TRINITY_DN7_c0_g1_i1	Q14565	DMC1_HUMAN	64.1	256	88	1	3	758	85	340	2.30E-89	330.1	DMC1_HUMAN	reviewed	Meiotic recombination protein DMC1/LIM15 homolog	DMC1 DMC1H LIM15	Homo sapiens (Human)	340	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]"	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]	GO:0000150; GO:0000730; GO:0000781; GO:0000794; GO:0001541; GO:0001556; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006312; GO:0007129; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0007292; GO:0008094; GO:0010212; GO:0042148; GO:0042802; GO:0051321; GO:0070192	chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]		NA	NA	NA	NA	NA	NA
TRINITY_DN30363_c0_g1_i1	Q14565	DMC1_HUMAN	55.8	77	30	2	228	1	252	325	2.80E-16	85.5	DMC1_HUMAN	reviewed	Meiotic recombination protein DMC1/LIM15 homolog	DMC1 DMC1H LIM15	Homo sapiens (Human)	340	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]"	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]	GO:0000150; GO:0000730; GO:0000781; GO:0000794; GO:0001541; GO:0001556; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006312; GO:0007129; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0007292; GO:0008094; GO:0010212; GO:0042148; GO:0042802; GO:0051321; GO:0070192	chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]		NA	NA	NA	NA	NA	NA
TRINITY_DN5822_c0_g1_i2	Q9TTY4	MAGBA_CANLF	26.5	253	165	5	904	188	71	316	1.10E-13	79	MAGBA_CANLF	reviewed	Melanoma-associated antigen B10 (MAGE-B10 antigen)	MAGEB10	Canis lupus familiaris (Dog) (Canis familiaris)	378							NA	NA	NA	NA	NA	NA
TRINITY_DN2714_c0_g1_i2	P08582	TRFM_HUMAN	34.1	634	340	24	1143	2942	23	612	1.40E-81	306.6	TRFM_HUMAN	reviewed	Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228)	MELTF MAP97 MFI2	Homo sapiens (Human)	738	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; iron ion binding [GO:0005506]; cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	iron ion binding [GO:0005506]	GO:0005506; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0043687; GO:0044267; GO:0046658; GO:0055037; GO:0055072; GO:0070062; GO:0090091; GO:1900025	cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN2714_c0_g1_i5	P08582	TRFM_HUMAN	34.1	634	340	24	966	2765	23	612	9.90E-82	306.6	TRFM_HUMAN	reviewed	Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228)	MELTF MAP97 MFI2	Homo sapiens (Human)	738	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; iron ion binding [GO:0005506]; cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	iron ion binding [GO:0005506]	GO:0005506; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0043687; GO:0044267; GO:0046658; GO:0055037; GO:0055072; GO:0070062; GO:0090091; GO:1900025	cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN2714_c0_g1_i6	P08582	TRFM_HUMAN	34.1	634	340	24	1101	2900	23	612	1.40E-81	306.6	TRFM_HUMAN	reviewed	Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228)	MELTF MAP97 MFI2	Homo sapiens (Human)	738	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; iron ion binding [GO:0005506]; cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	iron ion binding [GO:0005506]	GO:0005506; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0043687; GO:0044267; GO:0046658; GO:0055037; GO:0055072; GO:0070062; GO:0090091; GO:1900025	cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i3	O97490	TRFM_RABIT	36.1	191	113	4	184	747	26	210	3.00E-27	123.6	TRFM_RABIT	reviewed	Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228)	MELTF MFI2	Oryctolagus cuniculus (Rabbit)	736	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005615; GO:0005886; GO:0006811; GO:0031225; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i5	O97490	TRFM_RABIT	38.7	349	192	9	1187	2218	26	357	3.00E-60	235	TRFM_RABIT	reviewed	Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228)	MELTF MFI2	Oryctolagus cuniculus (Rabbit)	736	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005615; GO:0005886; GO:0006811; GO:0031225; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i9	O97490	TRFM_RABIT	36.3	193	114	4	716	1285	26	212	8.20E-28	126.3	TRFM_RABIT	reviewed	Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228)	MELTF MFI2	Oryctolagus cuniculus (Rabbit)	736	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005615; GO:0005886; GO:0006811; GO:0031225; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN2599_c0_g1_i1	Q8CIQ6	MTR1B_MOUSE	28	236	159	5	165	863	39	266	3.50E-15	84	MTR1B_MOUSE	reviewed	Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor)	Mtnr1b	Mus musculus (Mouse)	364	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007623; GO:0008502; GO:0010754; GO:0042593; GO:0042753; GO:0043524; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0097755; GO:0098908; GO:1902260	"circadian rhythm [GO:0007623]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6648_c0_g1_i1	Q4ZIN3	MBRL_HUMAN	72.2	212	55	1	636	1	183	390	7.40E-81	302	MBRL_HUMAN	reviewed	Membralin (Transmembrane protein 259)	TMEM259 C19orf6	Homo sapiens (Human)	620	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294	negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN28576_c0_g1_i1	Q4ZIN3	MBRL_HUMAN	100	199	0	0	2	598	183	381	1.00E-105	384	MBRL_HUMAN	reviewed	Membralin (Transmembrane protein 259)	TMEM259 C19orf6	Homo sapiens (Human)	620	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294	negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN22991_c0_g1_i1	Q495T6	MMEL1_HUMAN	50	58	29	0	243	70	668	725	1.50E-09	63.5	MMEL1_HUMAN	reviewed	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	MMEL1 MELL1 MMEL2 NEP2	Homo sapiens (Human)	779	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0016020; GO:0016021; GO:0046872	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c1_g2_i1	P0C1T0	MMEL1_RAT	36.2	105	54	4	433	149	49	150	7.00E-13	75.9	MMEL1_RAT	reviewed	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	Mmel1 Mell1 Nep2	Rattus norvegicus (Rat)	774	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c1_g2_i5	P0C1T0	MMEL1_RAT	29.7	222	123	12	900	295	49	257	8.50E-16	86.3	MMEL1_RAT	reviewed	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	Mmel1 Mell1 Nep2	Rattus norvegicus (Rat)	774	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c1_g2_i6	P0C1T0	MMEL1_RAT	28.8	222	121	12	888	295	49	257	4.20E-15	84	MMEL1_RAT	reviewed	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	Mmel1 Mell1 Nep2	Rattus norvegicus (Rat)	774	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN37006_c0_g1_i1	Q4L1J4	MAGI1_RAT	53.3	120	43	2	466	143	279	397	8.50E-31	134.8	MAGI1_RAT	reviewed	"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1)"	Magi1 Baiap1 Bap1	Rattus norvegicus (Rat)	1255	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0042995; GO:0051393; GO:0060090; GO:0071944	positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN27082_c0_g1_i1	O35954	PITM1_MOUSE	100	80	0	0	1	240	959	1038	2.20E-40	165.6	PITM1_MOUSE	reviewed	"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog 1) (RdgB1) (Mpt-1) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)"	Pitpnm1 Dres9 Mpt1 Nir2 Pitpnm	Mus musculus (Mouse)	1243	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; receptor tyrosine kinase binding [GO:0030971]; phospholipid transport [GO:0015914]; protein transport [GO:0015031]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; midbody [GO:0030496]	calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005543; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0036464; GO:0044297; GO:0070300	phospholipid transport [GO:0015914]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN40940_c0_g1_i1	O00562	PITM1_HUMAN	100	68	0	0	3	206	170	237	2.00E-37	155.6	PITM1_HUMAN	reviewed	"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)"	PITPNM1 DRES9 NIR2 PITPNM	Homo sapiens (Human)	1244	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]	calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0036464; GO:0044297; GO:0070300	brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN36498_c0_g1_i1	O00562	PITM1_HUMAN	100	122	0	0	369	4	952	1073	4.30E-67	255	PITM1_HUMAN	reviewed	"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)"	PITPNM1 DRES9 NIR2 PITPNM	Homo sapiens (Human)	1244	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]	calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0036464; GO:0044297; GO:0070300	brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN31752_c0_g1_i1	O00562	PITM1_HUMAN	100	89	0	0	1	267	854	942	1.40E-46	186.4	PITM1_HUMAN	reviewed	"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)"	PITPNM1 DRES9 NIR2 PITPNM	Homo sapiens (Human)	1244	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]	calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0036464; GO:0044297; GO:0070300	brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN30025_c0_g1_i1	O00562	PITM1_HUMAN	100	69	0	0	1	207	720	788	1.80E-33	142.5	PITM1_HUMAN	reviewed	"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)"	PITPNM1 DRES9 NIR2 PITPNM	Homo sapiens (Human)	1244	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]	calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0036464; GO:0044297; GO:0070300	brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5816_c0_g1_i1	Q5ZKN2	PGRC1_CHICK	52.4	187	77	5	38	574	1	183	4.60E-43	176	PGRC1_CHICK	reviewed	Membrane-associated progesterone receptor component 1 (mPR)	PGRMC1 RCJMB04_7g20 RCJMB04_9p4	Gallus gallus (Chicken)	192	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; smooth endoplasmic reticulum membrane [GO:0030868]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; heme biosynthetic process [GO:0006783]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; smooth endoplasmic reticulum membrane [GO:0030868]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]	GO:0005496; GO:0005741; GO:0006783; GO:0012505; GO:0016020; GO:0016021; GO:0020037; GO:0030868; GO:0042803; GO:0046872	heme biosynthetic process [GO:0006783]		blue	blue	NA	NA	NA	NA
TRINITY_DN29611_c0_g1_i1	O00264	PGRC1_HUMAN	100	89	0	0	268	2	93	181	3.60E-47	188.3	PGRC1_HUMAN	reviewed	Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA)	PGRMC1 HPR6.6 PGRMC	Homo sapiens (Human)	195	cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; heme biosynthetic process [GO:0006783]; neutrophil degranulation [GO:0043312]	cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]	amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]	GO:0001540; GO:0005496; GO:0005741; GO:0005783; GO:0005886; GO:0005887; GO:0006783; GO:0012505; GO:0016020; GO:0020037; GO:0030868; GO:0035579; GO:0042803; GO:0043005; GO:0043025; GO:0043312; GO:0044297; GO:0045202; GO:0046872	heme biosynthetic process [GO:0006783]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN32388_c0_g1_i1	O15173	PGRC2_HUMAN	100	73	0	0	222	4	96	168	1.10E-36	153.3	PGRC2_HUMAN	reviewed	Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6)	PGRMC2 DG6 PMBP	Homo sapiens (Human)	223	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; adipose tissue development [GO:0060612]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]	GO:0003707; GO:0005496; GO:0005635; GO:0005783; GO:0012505; GO:0015232; GO:0016020; GO:0016021; GO:0020037; GO:0060612	adipose tissue development [GO:0060612]		NA	NA	NA	NA	NA	NA
TRINITY_DN819_c0_g1_i1	P55162	HEM_DROME	77.1	35	8	0	192	88	1	35	1.10E-06	53.9	HEM_DROME	reviewed	Membrane-associated protein Hem (dHem-2)	Hem HEM2 CG5837	Drosophila melanogaster (Fruit fly)	1126	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]		GO:0000902; GO:0001764; GO:0005886; GO:0007010; GO:0007409; GO:0007417; GO:0007520; GO:0007528; GO:0008360; GO:0008407; GO:0016021; GO:0016477; GO:0030031; GO:0030036; GO:0030866; GO:0031209; GO:0031594; GO:0033627; GO:0048812; GO:0050807	actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		blue	blue	NA	NA	NA	NA
TRINITY_DN819_c0_g1_i2	P55162	HEM_DROME	65.2	1122	380	6	3441	97	1	1119	0	1436.4	HEM_DROME	reviewed	Membrane-associated protein Hem (dHem-2)	Hem HEM2 CG5837	Drosophila melanogaster (Fruit fly)	1126	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]		GO:0000902; GO:0001764; GO:0005886; GO:0007010; GO:0007409; GO:0007417; GO:0007520; GO:0007528; GO:0008360; GO:0008407; GO:0016021; GO:0016477; GO:0030031; GO:0030036; GO:0030866; GO:0031209; GO:0031594; GO:0033627; GO:0048812; GO:0050807	actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; chaeta morphogenesis [GO:0008407]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		blue	blue	NA	NA	NA	NA
TRINITY_DN27210_c0_g1_i1	Q91618	PMYT1_XENLA	35.4	514	285	10	3	1472	55	545	1.80E-74	281.6	PMYT1_XENLA	reviewed	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase)	pkmyt1 myt1	Xenopus laevis (African clawed frog)	548	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; negative regulation of phosphatase activity [GO:0010923]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0005789; GO:0007049; GO:0010923; GO:0046872	cell cycle [GO:0007049]; negative regulation of phosphatase activity [GO:0010923]		NA	NA	NA	NA	NA	NA
TRINITY_DN31018_c0_g1_i1	Q99640	PMYT1_HUMAN	100	85	0	0	2	256	195	279	8.50E-46	183.7	PMYT1_HUMAN	reviewed	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase)	PKMYT1 MYT1	Homo sapiens (Human)	499	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; negative regulation of phosphatase activity [GO:0010923]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000079; GO:0000086; GO:0000139; GO:0000278; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0007088; GO:0010923; GO:0016020; GO:0016301; GO:0046872; GO:0051321	G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; negative regulation of phosphatase activity [GO:0010923]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN28548_c0_g1_i1	Q9Z2A8	MBTP1_CRIGR	99	96	1	0	10	297	281	376	7.80E-51	200.7	MBTP1_CRIGR	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Sterol-regulated luminal protease)	MBTPS1 S1P	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1052	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; cholesterol metabolic process [GO:0008203]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005789; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0031293; GO:0034976; GO:0060627	cholesterol metabolic process [GO:0008203]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN29622_c0_g1_i1	Q9Z2A8	MBTP1_CRIGR	100	142	0	0	1	426	145	286	1.00E-80	300.4	MBTP1_CRIGR	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Sterol-regulated luminal protease)	MBTPS1 S1P	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1052	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; cholesterol metabolic process [GO:0008203]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005789; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0031293; GO:0034976; GO:0060627	cholesterol metabolic process [GO:0008203]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN5356_c0_g1_i1	Q9WTZ2	MBTP1_MOUSE	58.9	1115	352	15	480	3794	34	1052	0	1275	MBTP1_MOUSE	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Sterol-regulated luminal protease) (Subtilisin/kexin isozyme 1) (SKI-1)	Mbtps1 S1p Ski1	Mus musculus (Mouse)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004175; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0006629; GO:0007040; GO:0008203; GO:0016021; GO:0060627	cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]		NA	NA	NA	NA	NA	NA
TRINITY_DN5356_c0_g1_i4	Q9WTZ2	MBTP1_MOUSE	58.9	1115	352	15	633	3947	34	1052	0	1275	MBTP1_MOUSE	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Sterol-regulated luminal protease) (Subtilisin/kexin isozyme 1) (SKI-1)	Mbtps1 S1p Ski1	Mus musculus (Mouse)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004175; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0006629; GO:0007040; GO:0008203; GO:0016021; GO:0060627	cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]		NA	NA	NA	NA	NA	NA
TRINITY_DN24971_c0_g1_i3	Q9WTZ2	MBTP1_MOUSE	100	97	0	0	2	292	595	691	8.00E-56	217.2	MBTP1_MOUSE	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Sterol-regulated luminal protease) (Subtilisin/kexin isozyme 1) (SKI-1)	Mbtps1 S1p Ski1	Mus musculus (Mouse)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004175; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0006629; GO:0007040; GO:0008203; GO:0016021; GO:0060627	cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of vesicle-mediated transport [GO:0060627]		NA	NA	NA	NA	NA	NA
TRINITY_DN20655_c0_g1_i1	Q14703	MBTP1_HUMAN	99.4	160	1	0	2	481	628	787	9.90E-96	350.5	MBTP1_HUMAN	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)	MBTPS1 KIAA0091 S1P SKI1	Homo sapiens (Human)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0043687; GO:0044267; GO:0045540; GO:0060627	ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN5356_c0_g1_i3	Q14703	MBTP1_HUMAN	58.6	674	254	9	69	2066	381	1037	2.50E-226	786.6	MBTP1_HUMAN	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)	MBTPS1 KIAA0091 S1P SKI1	Homo sapiens (Human)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0043687; GO:0044267; GO:0045540; GO:0060627	ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN24971_c0_g1_i1	Q14703	MBTP1_HUMAN	98.2	165	3	0	2	496	394	558	3.40E-91	335.5	MBTP1_HUMAN	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)	MBTPS1 KIAA0091 S1P SKI1	Homo sapiens (Human)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0043687; GO:0044267; GO:0045540; GO:0060627	ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN24971_c0_g1_i2	Q14703	MBTP1_HUMAN	99	298	3	0	2	895	394	691	4.40E-174	611.7	MBTP1_HUMAN	reviewed	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)	MBTPS1 KIAA0091 S1P SKI1	Homo sapiens (Human)	1052	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0043687; GO:0044267; GO:0045540; GO:0060627	ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN4237_c0_g1_i4	Q0III2	MBTP2_BOVIN	32.4	527	306	9	1547	66	4	513	7.60E-76	286.2	MBTP2_BOVIN	reviewed	Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P)	MBTPS2	Bos taurus (Bovine)	516	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005737; GO:0008203; GO:0016021; GO:0031293; GO:0046872; GO:0051091; GO:0070977; GO:1990440	bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]		NA	NA	NA	NA	NA	NA
TRINITY_DN15434_c0_g1_i1	Q9WVR8	MEN1_RAT	42.4	597	283	9	95	1720	3	593	1.00E-126	455.3	MEN1_RAT	reviewed	Menin	Men1	Rattus norvegicus (Rat)	610	"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]; brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin remodeling [GO:0006338]; decidualization [GO:0046697]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; histone methylation [GO:0016571]; leukocyte homeostasis [GO:0001776]; MAPK cascade [GO:0000165]; maternal process involved in female pregnancy [GO:0060135]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of histone methylation [GO:0031062]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; roof of mouth development [GO:0060021]; type B pancreatic cell differentiation [GO:0003309]"	"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-macromolecule adaptor activity [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]	GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000784; GO:0000785; GO:0000790; GO:0000976; GO:0001503; GO:0001776; GO:0001933; GO:0002051; GO:0002076; GO:0003309; GO:0003677; GO:0003682; GO:0003690; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007050; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010468; GO:0010628; GO:0010812; GO:0016363; GO:0016571; GO:0018024; GO:0030097; GO:0030511; GO:0030674; GO:0031062; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043065; GO:0043280; GO:0043433; GO:0043565; GO:0045597; GO:0045668; GO:0045669; GO:0045736; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046621; GO:0046697; GO:0047485; GO:0048704; GO:0050680; GO:0051781; GO:0051974; GO:0060021; GO:0060135; GO:0061469; GO:0070412; GO:0071333; GO:0071375; GO:0071559; GO:1902807	"brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin remodeling [GO:0006338]; decidualization [GO:0046697]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; histone methylation [GO:0016571]; leukocyte homeostasis [GO:0001776]; MAPK cascade [GO:0000165]; maternal process involved in female pregnancy [GO:0060135]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of histone methylation [GO:0031062]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; roof of mouth development [GO:0060021]; type B pancreatic cell differentiation [GO:0003309]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15434_c0_g1_i2	Q9WVR8	MEN1_RAT	46.3	203	100	5	95	688	3	201	1.80E-43	177.6	MEN1_RAT	reviewed	Menin	Men1	Rattus norvegicus (Rat)	610	"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]; brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin remodeling [GO:0006338]; decidualization [GO:0046697]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; histone methylation [GO:0016571]; leukocyte homeostasis [GO:0001776]; MAPK cascade [GO:0000165]; maternal process involved in female pregnancy [GO:0060135]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of histone methylation [GO:0031062]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; roof of mouth development [GO:0060021]; type B pancreatic cell differentiation [GO:0003309]"	"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-macromolecule adaptor activity [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]	GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000784; GO:0000785; GO:0000790; GO:0000976; GO:0001503; GO:0001776; GO:0001933; GO:0002051; GO:0002076; GO:0003309; GO:0003677; GO:0003682; GO:0003690; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007050; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010468; GO:0010628; GO:0010812; GO:0016363; GO:0016571; GO:0018024; GO:0030097; GO:0030511; GO:0030674; GO:0031062; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043065; GO:0043280; GO:0043433; GO:0043565; GO:0045597; GO:0045668; GO:0045669; GO:0045736; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0046329; GO:0046621; GO:0046697; GO:0047485; GO:0048704; GO:0050680; GO:0051781; GO:0051974; GO:0060021; GO:0060135; GO:0061469; GO:0070412; GO:0071333; GO:0071375; GO:0071559; GO:1902807	"brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin remodeling [GO:0006338]; decidualization [GO:0046697]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; histone methylation [GO:0016571]; leukocyte homeostasis [GO:0001776]; MAPK cascade [GO:0000165]; maternal process involved in female pregnancy [GO:0060135]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of histone methylation [GO:0031062]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; roof of mouth development [GO:0060021]; type B pancreatic cell differentiation [GO:0003309]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15434_c0_g1_i3	Q0P5I0	MEN1_BOVIN	48.1	474	220	8	95	1456	3	470	1.50E-124	448	MEN1_BOVIN	reviewed	Menin	MEN1	Bos taurus (Bovine)	610	chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]	chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]	chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-macromolecule adaptor activity [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]	GO:0000122; GO:0000165; GO:0000400; GO:0000403; GO:0000785; GO:0000790; GO:0000976; GO:0002076; GO:0003682; GO:0003690; GO:0005829; GO:0006357; GO:0006974; GO:0008285; GO:0009411; GO:0010332; GO:0016363; GO:0018024; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0035097; GO:0043433; GO:0045668; GO:0045736; GO:0045786; GO:0046329; GO:0047485; GO:0051974; GO:0070412	cellular response to DNA damage stimulus [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN28272_c0_g1_i1	Q0P5I0	MEN1_BOVIN	100	108	0	0	325	2	97	204	3.60E-57	221.9	MEN1_BOVIN	reviewed	Menin	MEN1	Bos taurus (Bovine)	610	chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]	chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]	chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein-macromolecule adaptor activity [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Y-form DNA binding [GO:0000403]	GO:0000122; GO:0000165; GO:0000400; GO:0000403; GO:0000785; GO:0000790; GO:0000976; GO:0002076; GO:0003682; GO:0003690; GO:0005829; GO:0006357; GO:0006974; GO:0008285; GO:0009411; GO:0010332; GO:0016363; GO:0018024; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0035097; GO:0043433; GO:0045668; GO:0045736; GO:0045786; GO:0046329; GO:0047485; GO:0051974; GO:0070412	cellular response to DNA damage stimulus [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN32857_c0_g1_i1	P46662	MERL_MOUSE	68.2	314	99	1	1005	64	17	329	7.10E-121	435.3	MERL_MOUSE	reviewed	Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)	Nf2 Nf-2	Mus musculus (Mouse)	596	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; synapse [GO:0045202]	actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; protein domain specific binding [GO:0019904]	GO:0001707; GO:0001726; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006469; GO:0007398; GO:0007420; GO:0008013; GO:0008285; GO:0014010; GO:0014013; GO:0019904; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030308; GO:0030864; GO:0031647; GO:0032154; GO:0032991; GO:0035330; GO:0042127; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045121; GO:0045177; GO:0045202; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0050767; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177	actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]		NA	NA	NA	NA	NA	NA
TRINITY_DN27089_c0_g1_i1	P0C5H9	MANF_RAT	100	70	0	0	212	3	102	171	2.10E-34	145.6	MANF_RAT	reviewed	Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET)	Manf Armet	Rattus norvegicus (Rat)	179	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]; growth factor activity [GO:0008083]; sulfatide binding [GO:0120146]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to unfolded protein [GO:0006986]; vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure [GO:0002014]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]	growth factor activity [GO:0008083]; sulfatide binding [GO:0120146]	GO:0002014; GO:0005615; GO:0005788; GO:0006986; GO:0008083; GO:0031175; GO:0033018; GO:0048471; GO:0071542; GO:0120146; GO:1905897	dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to unfolded protein [GO:0006986]; vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure [GO:0002014]		NA	NA	NA	NA	NA	NA
TRINITY_DN4275_c0_g1_i1	B3P113	ARMET_DROER	86.9	84	11	0	347	96	90	173	5.20E-38	158.3	ARMET_DROER	reviewed	Mesencephalic astrocyte-derived neurotrophic factor homolog (MANF/CDNF-like protein)	Manf GG16999	Drosophila erecta (Fruit fly)	173	"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; synapse [GO:0045202]; dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]"	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; synapse [GO:0045202]		GO:0001963; GO:0005576; GO:0005783; GO:0031175; GO:0042417; GO:0045202; GO:0070050	"dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8294_c0_g1_i1	B3M2I7	ARMET_DROAN	45	80	44	0	240	1	5	84	8.30E-14	77.8	ARMET_DROAN	reviewed	Mesencephalic astrocyte-derived neurotrophic factor homolog (MANF/CDNF-like protein)	Manf GF18493	Drosophila ananassae (Fruit fly)	173	"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]"	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; synapse [GO:0045202]	calcium ion binding [GO:0005509]	GO:0001963; GO:0005509; GO:0005576; GO:0005783; GO:0031175; GO:0042417; GO:0045202; GO:0070050	"dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4640_c0_g2_i1	P91685	GRM_DROME	87	100	13	0	5	304	784	883	7.80E-46	184.1	GRM_DROME	reviewed	Metabotropic glutamate receptor (DmGluRA)	mGluR Glu-RA GluRA mGluRA CG11144	Drosophila melanogaster (Fruit fly)	976	"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]"	G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]	GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553	"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5876_c0_g1_i1	P91685	GRM_DROME	62.9	132	49	0	1	396	625	756	1.10E-39	164.1	GRM_DROME	reviewed	Metabotropic glutamate receptor (DmGluRA)	mGluR Glu-RA GluRA mGluRA CG11144	Drosophila melanogaster (Fruit fly)	976	"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]"	G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]	GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553	"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33393_c0_g1_i1	Q14416	GRM2_HUMAN	53.5	71	29	1	4	204	613	683	3.00E-12	72	GRM2_HUMAN	reviewed	Metabotropic glutamate receptor 2 (mGluR2)	GRM2 GPRC1B MGLUR2	Homo sapiens (Human)	872	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of protein kinase B signaling [GO:0051896]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]	GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030424; GO:0030425; GO:0042734; GO:0051896; GO:0051966; GO:0090461; GO:0097110; GO:0097449	"chemical synaptic transmission [GO:0007268]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of protein kinase B signaling [GO:0051896]; regulation of synaptic transmission, glutamatergic [GO:0051966]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4868_c0_g1_i1	Q9QYS2	GRM3_MOUSE	36.3	830	487	17	2625	166	36	833	3.10E-138	494.2	GRM3_MOUSE	reviewed	Metabotropic glutamate receptor 3 (mGluR3)	Grm3 Gprc1c Mglur3	Mus musculus (Mouse)	879	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]	calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097110; GO:0097449	"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4868_c0_g1_i2	Q9QYS2	GRM3_MOUSE	37	538	310	11	1917	328	317	833	1.40E-87	325.5	GRM3_MOUSE	reviewed	Metabotropic glutamate receptor 3 (mGluR3)	Grm3 Gprc1c Mglur3	Mus musculus (Mouse)	879	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]	calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097110; GO:0097449	"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4640_c0_g1_i1	P41594	GRM5_HUMAN	58.6	116	48	0	26	373	746	861	2.00E-31	137.9	GRM5_HUMAN	reviewed	Metabotropic glutamate receptor 5 (mGluR5)	GRM5 GPRC1E MGLUR5	Homo sapiens (Human)	1212	"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]"	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]	glutamate receptor activity [GO:0008066]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]	GO:0001932; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006417; GO:0006448; GO:0007186; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0030296; GO:0035584; GO:0042802; GO:0043005; GO:0048169; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0090647; GO:0098839; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782	"calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32376_c0_g1_i1	Q14872	MTF1_HUMAN	98.9	94	1	0	284	3	123	216	1.40E-52	206.5	MTF1_HUMAN	reviewed	Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1)	MTF1	Homo sapiens (Human)	753	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006357; GO:0006979; GO:0007417; GO:0010038; GO:0035035; GO:0045944; GO:0046686; GO:0046872; GO:0071294; GO:1990079; GO:1990837	"cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3508_c0_g1_i1	Q14872	MTF1_HUMAN	52.5	160	74	1	481	2	73	230	3.40E-43	176	MTF1_HUMAN	reviewed	Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1)	MTF1	Homo sapiens (Human)	753	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006357; GO:0006979; GO:0007417; GO:0010038; GO:0035035; GO:0045944; GO:0046686; GO:0046872; GO:0071294; GO:1990079; GO:1990837	"cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30952_c0_g1_i1	Q14872	MTF1_HUMAN	63	73	27	0	221	3	229	301	2.20E-26	119	MTF1_HUMAN	reviewed	Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1)	MTF1	Homo sapiens (Human)	753	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006357; GO:0006979; GO:0007417; GO:0010038; GO:0035035; GO:0045944; GO:0046686; GO:0046872; GO:0071294; GO:1990079; GO:1990837	"cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7654_c0_g1_i1	Q498J9	MBLC1_XENLA	44	200	104	4	88	678	25	219	3.70E-40	166.8	MBLC1_XENLA	reviewed	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	mblac1	Xenopus laevis (African clawed frog)	233	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7654_c0_g1_i3	Q498J9	MBLC1_XENLA	44	200	104	4	88	678	25	219	2.30E-40	167.2	MBLC1_XENLA	reviewed	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	mblac1	Xenopus laevis (African clawed frog)	233	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7654_c0_g1_i4	Q498J9	MBLC1_XENLA	44	200	104	4	88	678	25	219	3.70E-40	166.8	MBLC1_XENLA	reviewed	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	mblac1	Xenopus laevis (African clawed frog)	233	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7654_c0_g1_i7	Q498J9	MBLC1_XENLA	42.3	149	83	2	88	525	25	173	2.50E-27	123.6	MBLC1_XENLA	reviewed	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	mblac1	Xenopus laevis (African clawed frog)	233	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN7654_c0_g1_i8	Q498J9	MBLC1_XENLA	38.5	226	105	5	88	756	25	219	1.50E-34	148.3	MBLC1_XENLA	reviewed	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	mblac1	Xenopus laevis (African clawed frog)	233	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7644_c0_g1_i1	D3ZS74	OMA1_RAT	37.8	381	222	5	63	1172	112	488	1.50E-69	265	OMA1_RAT	reviewed	"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)"	Oma1	Rattus norvegicus (Rat)	504	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0002024; GO:0004222; GO:0005739; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0007005; GO:0008289; GO:0010637; GO:0016021; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0042407; GO:0043065; GO:0046872; GO:0097009; GO:0120162; GO:0140467; GO:0140468; GO:1903850	cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN7644_c0_g1_i2	D3ZS74	OMA1_RAT	36.2	210	132	1	63	686	112	321	7.70E-37	156.4	OMA1_RAT	reviewed	"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)"	Oma1	Rattus norvegicus (Rat)	504	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0002024; GO:0004222; GO:0005739; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0007005; GO:0008289; GO:0010637; GO:0016021; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0042407; GO:0043065; GO:0046872; GO:0097009; GO:0120162; GO:0140467; GO:0140468; GO:1903850	cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN7644_c0_g1_i3	E9QBI7	OMA1_DANRE	37.2	298	178	4	38	919	168	460	1.90E-51	204.5	OMA1_DANRE	reviewed	"Metalloendopeptidase OMA1, mitochondrial (zfoma1) (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)"	oma1 si:ch73-215a11.1	Danio rerio (Zebrafish) (Brachydanio rerio)	478	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0010637; GO:0016021; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0043065; GO:0046872; GO:0097009; GO:0140467; GO:0140468; GO:1903850	diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN34437_c0_g1_i1	Q80XL7	MPPE1_MOUSE	90.4	73	7	0	219	1	289	361	1.70E-34	146	MPPE1_MOUSE	reviewed	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	Mppe1 Pgap5	Mus musculus (Mouse)	396	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]	GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1418_c0_g1_i1	Q5ZK82	MPPE1_CHICK	44.8	377	196	3	267	1394	14	379	7.90E-91	335.9	MPPE1_CHICK	reviewed	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	MPPE1 PGAP5 RCJMB04_12i13	Gallus gallus (Chicken)	398	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]	GO:0005654; GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1418_c0_g1_i2	Q0IHA5	MPPE1_XENLA	47.5	240	108	3	2	697	119	348	7.70E-58	225.3	MPPE1_XENLA	reviewed	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	mppe1 pgap5	Xenopus laevis (African clawed frog)	405	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]	GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]	GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1418_c0_g1_i3	Q5ZK82	MPPE1_CHICK	44.8	377	196	3	122	1249	14	379	7.20E-91	335.9	MPPE1_CHICK	reviewed	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	MPPE1 PGAP5 RCJMB04_12i13	Gallus gallus (Chicken)	398	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]	GO:0005654; GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1418_c0_g1_i4	Q0IHA5	MPPE1_XENLA	45.1	277	134	3	56	862	119	385	2.70E-63	243.8	MPPE1_XENLA	reviewed	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	mppe1 pgap5	Xenopus laevis (African clawed frog)	405	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]	GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]	GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN6883_c0_g1_i3	O15442	MPPD1_HUMAN	50	204	85	4	665	57	136	323	6.40E-54	212.2	MPPD1_HUMAN	reviewed	Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB)	MPPED1 C22orf1 FAM1A	Homo sapiens (Human)	326	hydrolase activity [GO:0016787]		hydrolase activity [GO:0016787]	GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN6883_c0_g1_i4	O15442	MPPD1_HUMAN	50.4	260	110	5	833	57	82	323	9.30E-72	271.9	MPPD1_HUMAN	reviewed	Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB)	MPPED1 C22orf1 FAM1A	Homo sapiens (Human)	326	hydrolase activity [GO:0016787]		hydrolase activity [GO:0016787]	GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN36424_c0_g1_i2	Q9UHE8	STEA1_HUMAN	46.8	62	33	0	294	109	214	275	1.80E-10	66.6	STEA1_HUMAN	reviewed	Metalloreductase STEAP1 (EC 1.16.1.-) (Six-transmembrane epithelial antigen of prostate 1)	STEAP1 PRSS24 STEAP	Homo sapiens (Human)	339	cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; channel activity [GO:0015267]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transporter activity [GO:0005215]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	channel activity [GO:0015267]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transporter activity [GO:0005215]	GO:0005215; GO:0005768; GO:0005886; GO:0005887; GO:0005911; GO:0006811; GO:0010008; GO:0015267; GO:0016020; GO:0016491; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN27238_c0_g1_i1	Q8CI59	STEA3_MOUSE	57.5	73	29	1	118	336	252	322	8.10E-15	81.3	STEA3_MOUSE	reviewed	Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Protein nm1054) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6)	Steap3 Tsap6	Mus musculus (Mouse)	488	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; ferric-chelate reductase activity [GO:0000293]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; exosomal secretion [GO:1990182]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; iron ion transport [GO:0006826]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein secretion [GO:0009306]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]	cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; ferric-chelate reductase activity [GO:0000293]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0000293; GO:0005737; GO:0005768; GO:0005771; GO:0005886; GO:0006826; GO:0006915; GO:0007049; GO:0008823; GO:0009306; GO:0010008; GO:0015677; GO:0016021; GO:0042802; GO:0043065; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0098706; GO:1902167; GO:1990182	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; exosomal secretion [GO:1990182]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; iron ion transport [GO:0006826]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN36424_c0_g1_i1	Q658P3	STEA3_HUMAN	40.9	115	68	0	402	58	355	469	2.50E-15	83.2	STEA3_HUMAN	reviewed	Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde)	STEAP3 TSAP6	Homo sapiens (Human)	488	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; oxidation-reduction process [GO:0055114]; protein secretion [GO:0009306]; regulation of apoptotic process [GO:0042981]; transferrin transport [GO:0033572]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]	cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0005737; GO:0005768; GO:0005771; GO:0005886; GO:0006915; GO:0007049; GO:0008823; GO:0009306; GO:0010008; GO:0015677; GO:0016021; GO:0033572; GO:0042802; GO:0042981; GO:0046872; GO:0052851; GO:0055072; GO:0055114	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; oxidation-reduction process [GO:0055114]; protein secretion [GO:0009306]; regulation of apoptotic process [GO:0042981]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN4281_c0_g1_i1	Q5RKL5	STEA3_RAT	45.1	237	120	3	707	12	89	320	1.40E-50	201.1	STEA3_RAT	reviewed	Metalloreductase STEAP3 (EC 1.16.1.-) (Six-transmembrane epithelial antigen of prostate 3) (pHyde)	Steap3	Rattus norvegicus (Rat)	488	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; ferric-chelate reductase activity [GO:0000293]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; exosomal secretion [GO:1990182]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein secretion [GO:0009306]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]	cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; ferric-chelate reductase activity [GO:0000293]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0000293; GO:0005737; GO:0005768; GO:0005771; GO:0005886; GO:0006826; GO:0006915; GO:0007049; GO:0008823; GO:0009306; GO:0010008; GO:0015677; GO:0016021; GO:0042802; GO:0043065; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:1902167; GO:1990182	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; exosomal secretion [GO:1990182]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN38833_c0_g1_i1	Q13330	MTA1_HUMAN	99.2	121	1	0	2	364	260	380	5.20E-65	248.1	MTA1_HUMAN	reviewed	Metastasis-associated protein MTA1	MTA1	Homo sapiens (Human)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006302; GO:0007165; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0032922; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i1	Q8K4B0	MTA1_MOUSE	62.3	512	126	7	2	1525	2	450	1.30E-173	611.3	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i1	Q8K4B0	MTA1_MOUSE	44.1	68	30	2	1800	2003	646	705	4.90E-06	54.7	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i2	Q62599	MTA1_RAT	49.2	831	277	14	2	2476	2	693	3.80E-202	706.4	MTA1_RAT	reviewed	Metastasis-associated protein MTA1	Mta1 Zg29	Rattus norvegicus (Rat)	703	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005794; GO:0005874; GO:0006302; GO:0007565; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0031410; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i3	Q62599	MTA1_RAT	47.2	779	205	10	2	1981	2	693	3.30E-180	633.3	MTA1_RAT	reviewed	Metastasis-associated protein MTA1	Mta1 Zg29	Rattus norvegicus (Rat)	703	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005794; GO:0005874; GO:0006302; GO:0007565; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0031410; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i4	Q8K4B0	MTA1_MOUSE	55.8	659	213	10	2	1948	2	592	4.40E-192	672.9	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i4	Q8K4B0	MTA1_MOUSE	44.1	68	30	2	2178	2381	646	705	5.70E-06	54.7	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i5	Q8K4B0	MTA1_MOUSE	66.7	477	123	7	2	1408	2	450	1.10E-174	614.8	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i5	Q8K4B0	MTA1_MOUSE	44.1	68	30	2	1683	1886	646	705	4.60E-06	54.7	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i6	Q62599	MTA1_RAT	49.3	744	202	10	2	1864	2	693	2.80E-181	636.7	MTA1_RAT	reviewed	Metastasis-associated protein MTA1	Mta1 Zg29	Rattus norvegicus (Rat)	703	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005794; GO:0005874; GO:0006302; GO:0007565; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0031410; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i8	Q62599	MTA1_RAT	51.3	796	274	14	2	2359	2	693	3.20E-203	709.9	MTA1_RAT	reviewed	Metastasis-associated protein MTA1	Mta1 Zg29	Rattus norvegicus (Rat)	703	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005794; GO:0005874; GO:0006302; GO:0007565; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0031410; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i9	Q8K4B0	MTA1_MOUSE	53.2	694	216	10	2	2065	2	592	5.10E-191	669.5	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN156_c0_g1_i9	Q8K4B0	MTA1_MOUSE	44.1	68	30	2	2295	2498	646	705	6.00E-06	54.7	MTA1_MOUSE	reviewed	Metastasis-associated protein MTA1	Mta1	Mus musculus (Mouse)	715	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15495_c0_g1_i1	O94776	MTA2_HUMAN	99.3	148	1	0	444	1	8	155	1.00E-78	293.9	MTA2_HUMAN	reviewed	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)	MTA2 MTA1L1 PID	Homo sapiens (Human)	668	histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]	histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0000790; GO:0001085; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005667; GO:0006306; GO:0006333; GO:0008270; GO:0010762; GO:0016020; GO:0016575; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:0043565; GO:0045944; GO:1901796	ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN15495_c0_g1_i2	O94776	MTA2_HUMAN	100	93	0	0	279	1	63	155	3.80E-47	188.3	MTA2_HUMAN	reviewed	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)	MTA2 MTA1L1 PID	Homo sapiens (Human)	668	histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]	histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0000790; GO:0001085; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005667; GO:0006306; GO:0006333; GO:0008270; GO:0010762; GO:0016020; GO:0016575; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:0043565; GO:0045944; GO:1901796	ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN36465_c0_g1_i1	O94776	MTA2_HUMAN	100	162	0	0	487	2	180	341	5.30E-89	328.2	MTA2_HUMAN	reviewed	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)	MTA2 MTA1L1 PID	Homo sapiens (Human)	668	histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]	histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0000790; GO:0001085; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005667; GO:0006306; GO:0006333; GO:0008270; GO:0010762; GO:0016020; GO:0016575; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:0043565; GO:0045944; GO:1901796	ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN39046_c0_g1_i1	Q9BTC8	MTA3_HUMAN	100	67	0	0	203	3	384	450	3.70E-36	151.4	MTA3_HUMAN	reviewed	Metastasis-associated protein MTA3	MTA3 KIAA1266	Homo sapiens (Human)	594	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010971; GO:0016575; GO:0016581; GO:0042826; GO:0043231; GO:0043565; GO:0044877; GO:0045892	"histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3747_c0_g1_i1	Q13505	MTX1_HUMAN	38	213	127	2	707	84	231	443	3.60E-38	159.8	MTX1_HUMAN	reviewed	Metaxin-1 (Mitochondrial outer membrane import complex protein 1)	MTX1 MTX MTXN	Homo sapiens (Human)	466	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; SAM complex [GO:0001401]; inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; SAM complex [GO:0001401]		GO:0001401; GO:0005737; GO:0007005; GO:0007007; GO:0007595; GO:0015031; GO:0016021; GO:0140275	inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN3747_c0_g1_i2	Q4R3I0	MTX1_MACFA	40.7	162	94	1	570	91	82	243	8.20E-33	141.7	MTX1_MACFA	reviewed	Metaxin-1 (Mitochondrial outer membrane import complex protein 1)	MTX1 QtsA-16827	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	317	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]; protein transport [GO:0015031]	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]		GO:0001401; GO:0015031; GO:0016021	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15660_c0_g1_i1	P17563	SBP1_MOUSE	100	118	0	0	3	356	355	472	2.10E-66	252.7	SBP1_MOUSE	reviewed	Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1)	Selenbp1 Lpsb	Mus musculus (Mouse)	472	cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; brown fat cell differentiation [GO:0050873]; protein transport [GO:0015031]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]	methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]	GO:0001650; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0050873	brown fat cell differentiation [GO:0050873]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN39189_c0_g1_i1	Q13228	SBP1_HUMAN	74.2	190	49	0	711	142	283	472	3.60E-86	319.3	SBP1_HUMAN	reviewed	Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1)	SELENBP1 SBP	Homo sapiens (Human)	472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]	methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]	GO:0001650; GO:0005615; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0070062	protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN12677_c1_g3_i1	Q52KZ7	SBP1A_XENLA	57.8	244	96	5	98	811	8	250	4.00E-81	302.8	SBP1A_XENLA	reviewed	Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1-A)	selenbp1-a	Xenopus laevis (African clawed frog)	472	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]	GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549	protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN29816_c0_g1_i1	Q52L34	MTHSD_XENLA	62.9	132	45	2	407	12	69	196	1.40E-37	157.1	MTHSD_XENLA	reviewed	Methenyltetrahydrofolate synthase domain-containing protein	mthfsd	Xenopus laevis (African clawed frog)	415	RNA binding [GO:0003723]		RNA binding [GO:0003723]	GO:0003723			NA	NA	NA	NA	NA	NA
TRINITY_DN1158_c0_g2_i2	Q566L8	MAT2B_XENTR	43	298	164	3	233	1111	27	323	8.80E-61	235.7	MAT2B_XENTR	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	mat2b TEgg038m14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	334	methionine adenosyltransferase complex [GO:0048269]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	methionine adenosyltransferase complex [GO:0048269]	methionine adenosyltransferase regulator activity [GO:0048270]	GO:0006556; GO:0006730; GO:0048269; GO:0048270	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN1158_c0_g2_i8	Q566L8	MAT2B_XENTR	43	298	164	3	246	1124	27	323	8.90E-61	235.7	MAT2B_XENTR	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	mat2b TEgg038m14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	334	methionine adenosyltransferase complex [GO:0048269]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	methionine adenosyltransferase complex [GO:0048269]	methionine adenosyltransferase regulator activity [GO:0048270]	GO:0006556; GO:0006730; GO:0048269; GO:0048270	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN28103_c0_g1_i1	Q9NZL9	MAT2B_HUMAN	100	115	0	0	346	2	112	226	9.70E-61	233.8	MAT2B_HUMAN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase)	MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995	Homo sapiens (Human)	334	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]	GO:0005634; GO:0005829; GO:0006556; GO:0006730; GO:0019899; GO:0032259; GO:0048269; GO:0048270; GO:0070062	methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN27653_c0_g1_i1	Q7ZWV9	MAP1_XENLA	74.2	66	17	0	9	206	175	240	6.00E-26	117.5	MAP1_XENLA	reviewed	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	metap1	Xenopus laevis (African clawed frog)	385	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN2741_c0_g1_i1	Q7ZWV9	MAP1_XENLA	68.5	267	84	0	7	807	118	384	2.90E-113	409.8	MAP1_XENLA	reviewed	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	metap1	Xenopus laevis (African clawed frog)	385	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN2741_c0_g1_i2	Q7ZWV9	MAP1_XENLA	68.5	267	84	0	7	807	118	384	3.40E-113	409.5	MAP1_XENLA	reviewed	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	metap1	Xenopus laevis (African clawed frog)	385	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		blue	blue	NA	NA	NA	NA
TRINITY_DN2741_c0_g1_i6	Q7ZWV9	MAP1_XENLA	68.5	267	84	0	7	807	118	384	3.90E-113	409.8	MAP1_XENLA	reviewed	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	metap1	Xenopus laevis (African clawed frog)	385	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN40267_c0_g1_i1	Q4QRK0	MAP11_DANRE	63.2	68	25	0	204	1	173	240	4.50E-24	111.3	MAP11_DANRE	reviewed	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	metap1	Danio rerio (Zebrafish) (Brachydanio rerio)	386	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN39944_c0_g1_i1	Q54WU3	MAP11_DICDI	67.7	65	20	1	2	196	297	360	2.00E-20	99.4	MAP11_DICDI	reviewed	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	metap1 DDB_G0279433	Dictyostelium discoideum (Slime mold)	367	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN13426_c0_g1_i1	Q9SLN5	MAP1A_ARATH	73.9	69	18	0	8	214	322	390	1.50E-24	113.2	MAP1A_ARATH	reviewed	Methionine aminopeptidase 1A (MAP 1A) (MetAP 1A) (EC 3.4.11.18) (Peptidase M 1A)	MAP1A At2g45240 F4L23.25	Arabidopsis thaliana (Mouse-ear cress)	398	cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; N-terminal protein amino acid modification [GO:0031365]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0005829; GO:0016485; GO:0031365; GO:0046872; GO:0070006; GO:0070084	N-terminal protein amino acid modification [GO:0031365]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN40007_c0_g1_i1	Q6UB28	MAP12_HUMAN	60	60	24	0	13	192	132	191	1.00E-17	90.1	MAP12_HUMAN	reviewed	"Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D)"	METAP1D MAP1D	Homo sapiens (Human)	335	mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]	mitochondrion [GO:0005739]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]	GO:0004177; GO:0005739; GO:0008235; GO:0018206; GO:0031365; GO:0046872; GO:0070006; GO:0070084	N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN34509_c0_g1_i1	Q4VBS4	MAP12_DANRE	67.5	77	25	0	232	2	119	195	9.40E-28	123.6	MAP12_DANRE	reviewed	"Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D)"	metap1d map1d zgc:110461	Danio rerio (Zebrafish) (Brachydanio rerio)	338	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005739; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN21352_c0_g1_i1	O08663	MAP2_MOUSE	100	161	0	0	483	1	189	349	1.70E-92	339.7	MAP2_MOUSE	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	Metap2 Mnpep P67eif2	Mus musculus (Mouse)	478	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]	GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0046872; GO:0070006; GO:0070084	N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN11553_c0_g1_i1	Q3ZC89	MAP2_BOVIN	100	123	0	0	2	370	355	477	2.00E-71	269.6	MAP2_BOVIN	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	METAP2	Bos taurus (Bovine)	477	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN11553_c0_g1_i3	Q3ZC89	MAP2_BOVIN	100	143	0	0	2	430	335	477	1.20E-83	310.5	MAP2_BOVIN	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	METAP2	Bos taurus (Bovine)	477	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN9923_c1_g1_i1	Q3ZC89	MAP2_BOVIN	84.4	90	14	0	3	272	388	477	5.60E-44	177.9	MAP2_BOVIN	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	METAP2	Bos taurus (Bovine)	477	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN9923_c0_g1_i1	Q3ZC89	MAP2_BOVIN	71.7	283	80	0	851	3	112	394	1.00E-119	431	MAP2_BOVIN	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	METAP2	Bos taurus (Bovine)	477	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN27544_c0_g1_i1	P50579	MAP2_HUMAN	100	67	0	0	1	201	271	337	1.10E-32	139.8	MAP2_HUMAN	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	METAP2 MNPEP P67EIF2	Homo sapiens (Human)	478	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723]	GO:0003723; GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0022400; GO:0031365; GO:0046872; GO:0070006; GO:0070084	N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]; regulation of rhodopsin mediated signaling pathway [GO:0022400]		NA	NA	NA	NA	NA	NA
TRINITY_DN34283_c0_g1_i1	Q8SR45	MAP2_ENCCU	56.4	78	34	0	1	234	107	184	2.40E-18	92.4	MAP2_ENCCU	reviewed	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M)	MAP2 ECU10_0750	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	358	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN33618_c0_g1_i1	B8NA06	MAP21_ASPFN	53.9	76	33	1	293	66	372	445	4.10E-20	98.6	MAP21_ASPFN	reviewed	Methionine aminopeptidase 2-1 (MAP 2-1) (MetAP 2-1) (EC 3.4.11.18) (Peptidase M)	AFLA_113020	Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / NRRL 3357 / JCM 12722 / SRRC 167)	445	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]		NA	NA	NA	NA	NA	NA
TRINITY_DN25739_c0_g1_i1	Q56Y85	MAP22_ARATH	68.2	296	94	0	978	91	144	439	4.40E-119	429.1	MAP22_ARATH	reviewed	Methionine aminopeptidase 2B (MAP 2B) (MetAP 2B) (EC 3.4.11.18) (Peptidase M)	MAP2B At3g59990 F24G16.26	Arabidopsis thaliana (Mouse-ear cress)	439	cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0005829; GO:0016485; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN16790_c0_g1_i1	Q56Y85	MAP22_ARATH	58.2	153	61	3	3	461	186	335	3.50E-42	172.6	MAP22_ARATH	reviewed	Methionine aminopeptidase 2B (MAP 2B) (MetAP 2B) (EC 3.4.11.18) (Peptidase M)	MAP2B At3g59990 F24G16.26	Arabidopsis thaliana (Mouse-ear cress)	439	cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0005829; GO:0016485; GO:0046872; GO:0070006; GO:0070084	protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN18943_c0_g1_i1	Q9I2Q2	METH_PSEAE	54.8	126	57	0	3	380	216	341	5.30E-36	151.8	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN39087_c0_g1_i1	Q9I2Q2	METH_PSEAE	68.1	91	29	0	3	275	33	123	4.60E-29	128.3	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN27563_c0_g1_i1	Q9I2Q2	METH_PSEAE	79.4	126	26	0	56	433	348	473	5.70E-50	198.4	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN3689_c0_g1_i1	P37586	METH_SALTY	69.4	268	81	1	18	818	356	623	2.80E-106	386.3	METH_SALTY	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH STM4188	Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)	1227	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	1
TRINITY_DN3689_c0_g1_i2	P37586	METH_SALTY	69.4	268	81	1	18	818	356	623	4.70E-106	385.6	METH_SALTY	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH STM4188	Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)	1227	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN31628_c0_g1_i1	Q9KUW9	METH_VIBCH	67.5	123	36	1	5	373	746	864	2.10E-40	166.4	METH_VIBCH	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH VC_0390	Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)	1226	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0042558	methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN3914_c0_g1_i1	Q9I2Q2	METH_PSEAE	59.7	67	27	0	2	202	291	357	9.50E-16	83.6	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN3914_c0_g2_i1	Q9I2Q2	METH_PSEAE	59.7	196	79	0	118	705	132	327	1.60E-65	250.8	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN3914_c0_g2_i2	Q9I2Q2	METH_PSEAE	58.3	235	97	1	2	703	93	327	4.80E-75	282.3	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN39992_c0_g1_i1	Q9I2Q2	METH_PSEAE	68.6	105	29	1	316	2	641	741	7.80E-33	141	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN34928_c0_g1_i1	Q5E814	METH_ALIF1	61.9	84	31	1	6	254	1051	1134	2.00E-23	109.4	METH_ALIF1	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH VF_0337	Aliivibrio fischeri (strain ATCC 700601 / ES114) (Vibrio fischeri)	1226	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN39634_c0_g1_i1	Q9I2Q2	METH_PSEAE	92.5	53	4	0	172	14	693	745	4.40E-21	101.3	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN37659_c0_g1_i1	Q9I2Q2	METH_PSEAE	55.7	79	35	0	239	3	918	996	6.80E-21	100.9	METH_PSEAE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH PA1843	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	1234	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN25055_c0_g1_i1	Q87L95	METH_VIBPA	67.1	76	25	0	4	231	139	214	2.40E-23	109	METH_VIBPA	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH VP2717	Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633)	1226	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN32091_c0_g1_i1	Q5E814	METH_ALIF1	64.9	114	38	1	338	3	1069	1182	2.10E-39	162.9	METH_ALIF1	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH VF_0337	Aliivibrio fischeri (strain ATCC 700601 / ES114) (Vibrio fischeri)	1226	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN32069_c0_g1_i1	Q87L95	METH_VIBPA	58.8	165	62	2	3	494	1032	1191	5.80E-51	201.8	METH_VIBPA	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH VP2717	Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633)	1226	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN18943_c0_g4_i1	O33465	METH_PSEPU	58.1	93	39	0	4	282	113	205	3.20E-25	115.5	METH_PSEPU	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS) (Fragment)"	metH	Pseudomonas putida (Arthrobacter siderocapsulatus)	607	cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methionine synthase activity [GO:0008705]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methionine synthase activity [GO:0008705]	GO:0008705; GO:0031419; GO:0032259; GO:0042558; GO:0046872	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN3879_c0_g1_i1	P13009	METH_ECOLI	68.7	150	46	1	451	2	726	874	1.00E-49	197.6	METH_ECOLI	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12-dependent) (MS)"	metH b4019 JW3979	Escherichia coli (strain K12)	1227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0035999; GO:0050667	homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	1
TRINITY_DN3879_c0_g1_i2	P13009	METH_ECOLI	74.2	178	45	1	535	2	698	874	2.40E-66	253.1	METH_ECOLI	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12-dependent) (MS)"	metH b4019 JW3979	Escherichia coli (strain K12)	1227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0035999; GO:0050667	homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3879_c0_g1_i3	P13009	METH_ECOLI	73.6	178	46	1	535	2	698	874	1.20E-65	250.8	METH_ECOLI	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12-dependent) (MS)"	metH b4019 JW3979	Escherichia coli (strain K12)	1227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0035999; GO:0050667	homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3879_c0_g1_i4	P13009	METH_ECOLI	69.3	150	45	1	451	2	726	874	2.60E-50	199.5	METH_ECOLI	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12-dependent) (MS)"	metH b4019 JW3979	Escherichia coli (strain K12)	1227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0035999; GO:0050667	homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN3689_c0_g2_i1	P13009	METH_ECOLI	78.1	247	54	0	5	745	349	595	7.30E-106	384.8	METH_ECOLI	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12-dependent) (MS)"	metH b4019 JW3979	Escherichia coli (strain K12)	1227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0035999; GO:0050667	homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN37337_c0_g1_i1	P13009	METH_ECOLI	76.7	86	19	1	259	2	772	856	1.50E-29	129.8	METH_ECOLI	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12-dependent) (MS)"	metH b4019 JW3979	Escherichia coli (strain K12)	1227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0035999; GO:0050667	homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN18943_c0_g3_i1	Q54P92	METH_DICDI	55.2	67	30	0	231	31	276	342	7.60E-17	87.4	METH_DICDI	reviewed	Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)	mtr DDB_G0284699	Dictyostelium discoideum (Slime mold)	1260	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0042558	methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN24012_c0_g2_i1	Q54P92	METH_DICDI	65.4	243	79	3	725	9	649	890	2.10E-81	303.5	METH_DICDI	reviewed	Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)	mtr DDB_G0284699	Dictyostelium discoideum (Slime mold)	1260	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0042558	methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN25055_c0_g2_i1	Q54P92	METH_DICDI	56.6	83	34	1	249	1	251	331	3.40E-23	108.6	METH_DICDI	reviewed	Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)	mtr DDB_G0284699	Dictyostelium discoideum (Slime mold)	1260	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0042558	methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN18943_c0_g2_i1	Q4JIJ3	METH_BOVIN	67.2	137	43	1	55	465	140	274	4.20E-46	185.7	METH_BOVIN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Bos taurus (Bovine)	1265	cytoplasm [GO:0005737]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytoplasm [GO:0005737]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN24012_c0_g1_i1	A6H5Y3	METH_MOUSE	50.4	115	54	1	6	341	948	1062	2.20E-28	126.3	METH_MOUSE	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	Mtr	Mus musculus (Mouse)	1253	cytosol [GO:0005829]; amino acid binding [GO:0016597]; cobalamin binding [GO:0031419]; folic acid binding [GO:0005542]; methionine synthase activity [GO:0008705]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; protein methylation [GO:0006479]; response to axon injury [GO:0048678]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]	amino acid binding [GO:0016597]; cobalamin binding [GO:0031419]; folic acid binding [GO:0005542]; methionine synthase activity [GO:0008705]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270]	GO:0005542; GO:0005829; GO:0006479; GO:0006555; GO:0008168; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0016597; GO:0031103; GO:0031419; GO:0046653; GO:0048678; GO:0050667; GO:0071732	axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; protein methylation [GO:0006479]; response to axon injury [GO:0048678]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN37342_c0_g1_i1	Q99707	METH_HUMAN	100	88	0	0	3	266	691	778	4.80E-44	177.9	METH_HUMAN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Homo sapiens (Human)	1265	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0000096; GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732	axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN35464_c0_g1_i1	Q99707	METH_HUMAN	99	104	1	0	313	2	319	422	6.50E-56	217.6	METH_HUMAN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Homo sapiens (Human)	1265	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0000096; GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732	axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN7095_c0_g1_i1	Q4JIJ3	METH_BOVIN	78.6	42	9	0	2	127	213	254	2.50E-11	69.7	METH_BOVIN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Bos taurus (Bovine)	1265	cytoplasm [GO:0005737]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytoplasm [GO:0005737]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN7095_c0_g1_i2	Q4JIJ3	METH_BOVIN	68.7	83	17	1	2	250	213	286	2.80E-25	115.5	METH_BOVIN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Bos taurus (Bovine)	1265	cytoplasm [GO:0005737]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytoplasm [GO:0005737]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN21145_c0_g1_i1	Q99707	METH_HUMAN	100	147	0	0	2	442	71	217	4.20E-77	288.5	METH_HUMAN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Homo sapiens (Human)	1265	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0000096; GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732	axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN11327_c0_g1_i1	Q99707	METH_HUMAN	67.6	182	59	0	550	5	442	623	3.60E-65	249.2	METH_HUMAN	reviewed	Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)	MTR	Homo sapiens (Human)	1265	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0000096; GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732	axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN29773_c0_g1_i1	Q9UBK8	MTRR_HUMAN	52.6	114	43	3	63	371	520	633	5.80E-27	121.7	MTRR_HUMAN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Homo sapiens (Human)	698	"cytosol [GO:0005829]; [methionine synthase] reductase activity [GO:0030586]; aquacobalamin reductase (NADPH) activity [GO:0050444]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; cobalamin metabolic process [GO:0009235]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; oxidation-reduction process [GO:0055114]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]"	cytosol [GO:0005829]	"[methionine synthase] reductase activity [GO:0030586]; aquacobalamin reductase (NADPH) activity [GO:0050444]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0000096; GO:0003958; GO:0005829; GO:0006306; GO:0006555; GO:0009086; GO:0009235; GO:0010181; GO:0016491; GO:0016709; GO:0016723; GO:0030586; GO:0032259; GO:0033353; GO:0043418; GO:0046655; GO:0050444; GO:0050660; GO:0050661; GO:0050667; GO:0055114; GO:0070402; GO:0071949; GO:1904042	cobalamin metabolic process [GO:0009235]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; oxidation-reduction process [GO:0055114]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i1	Q4JIJ2	MTRR_BOVIN	49.5	93	45	1	366	94	30	122	3.10E-17	89.4	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i2	Q4JIJ2	MTRR_BOVIN	47.6	143	73	1	593	171	30	172	1.40E-27	124.4	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i3	Q4JIJ2	MTRR_BOVIN	36.2	426	226	7	1260	10	30	418	5.30E-56	219.9	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i4	Q4JIJ2	MTRR_BOVIN	49.5	93	45	1	412	140	30	122	6.00E-17	88.6	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i5	Q4JIJ2	MTRR_BOVIN	33	339	181	7	990	1	122	423	9.70E-32	139.4	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i5	Q4JIJ2	MTRR_BOVIN	49.5	93	45	1	1349	1077	30	122	2.00E-16	88.6	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN3323_c0_g1_i6	Q4JIJ2	MTRR_BOVIN	49.5	93	45	1	371	99	30	122	2.40E-17	89.7	MTRR_BOVIN	reviewed	Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) (EC 1.16.1.-)	MTRR	Bos taurus (Bovine)	695	"cytoplasm [GO:0005737]; [methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]"	cytoplasm [GO:0005737]	"[methionine synthase] reductase activity [GO:0030586]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0005737; GO:0006306; GO:0009086; GO:0010181; GO:0016723; GO:0030586; GO:0046655; GO:0050660	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; methionine biosynthetic process [GO:0009086]		NA	NA	NA	NA	NA	NA
TRINITY_DN34143_c0_g1_i1	Q8INK9	MSRB_DROME	55.6	126	51	1	512	150	75	200	9.20E-40	164.9	MSRB_DROME	reviewed	Methionine-R-sulfoxide reductase B1 (EC 1.8.4.12) (Selenoprotein R)	SelR MsrB MsrB1 CG6584	Drosophila melanogaster (Fruit fly)	208	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]; skeletal muscle thin filament assembly [GO:0030240]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006979; GO:0007015; GO:0007411; GO:0008270; GO:0008407; GO:0030041; GO:0030091; GO:0030240; GO:0033743	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]; skeletal muscle thin filament assembly [GO:0030240]		NA	NA	NA	NA	NA	NA
TRINITY_DN34143_c0_g1_i2	Q8INK9	MSRB_DROME	57.1	147	58	1	575	150	54	200	1.10E-46	188.3	MSRB_DROME	reviewed	Methionine-R-sulfoxide reductase B1 (EC 1.8.4.12) (Selenoprotein R)	SelR MsrB MsrB1 CG6584	Drosophila melanogaster (Fruit fly)	208	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]; skeletal muscle thin filament assembly [GO:0030240]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006979; GO:0007015; GO:0007411; GO:0008270; GO:0008407; GO:0030041; GO:0030091; GO:0030240; GO:0033743	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]; skeletal muscle thin filament assembly [GO:0030240]		NA	NA	NA	NA	NA	NA
TRINITY_DN27997_c0_g1_i1	P59952	SYM_MYCBO	77.3	75	16	1	1	222	197	271	1.50E-30	132.9	SYM_MYCBO	reviewed	Methionine--tRNA ligase (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)	metG metS BQ2027_MB1034C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	519	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]	GO:0004825; GO:0005524; GO:0005737; GO:0006431	methionyl-tRNA aminoacylation [GO:0006431]		NA	NA	NA	NA	NA	NA
TRINITY_DN31293_c0_g1_i1	A6UUN1	SYM_META3	42.4	85	45	3	246	1	94	177	4.50E-12	71.6	SYM_META3	reviewed	Methionine--tRNA ligase (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)	metG Maeo_0619	Methanococcus aeolicus (strain ATCC BAA-1280 / DSM 17508 / OCM 812 / Nankai-3)	672	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; methionyl-tRNA aminoacylation [GO:0006431]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005737; GO:0006431; GO:0046872	methionyl-tRNA aminoacylation [GO:0006431]		NA	NA	1	NA	NA	NA
TRINITY_DN20701_c0_g1_i1	Q68FL6	SYMC_MOUSE	98.4	129	2	0	1	387	379	507	4.50E-75	281.6	SYMC_MOUSE	reviewed	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	Mars1 Mars	Mus musculus (Mouse)	902	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0017101; GO:0032869; GO:0036120; GO:0071364; GO:1901838	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN20701_c0_g1_i2	P56192	SYMC_HUMAN	97.2	141	4	0	1	423	551	691	3.70E-78	292	SYMC_HUMAN	reviewed	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	MARS1 MARS	Homo sapiens (Human)	900	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0016020; GO:0017101; GO:0032869; GO:0036120; GO:0070062; GO:0071364; GO:1901838	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN20701_c0_g1_i3	P56192	SYMC_HUMAN	96.5	315	11	0	1	945	377	691	3.60E-190	665.2	SYMC_HUMAN	reviewed	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	MARS1 MARS	Homo sapiens (Human)	900	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0016020; GO:0017101; GO:0032869; GO:0036120; GO:0070062; GO:0071364; GO:1901838	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN2582_c0_g1_i1	P56192	SYMC_HUMAN	51.8	842	356	19	2805	349	84	898	2.10E-226	787.3	SYMC_HUMAN	reviewed	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	MARS1 MARS	Homo sapiens (Human)	900	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0016020; GO:0017101; GO:0032869; GO:0036120; GO:0070062; GO:0071364; GO:1901838	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN2582_c0_g1_i4	P56192	SYMC_HUMAN	52.8	798	332	16	2688	349	128	898	1.20E-222	774.6	SYMC_HUMAN	reviewed	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	MARS1 MARS	Homo sapiens (Human)	900	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0016020; GO:0017101; GO:0032869; GO:0036120; GO:0070062; GO:0071364; GO:1901838	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN30415_c0_g1_i1	P56192	SYMC_HUMAN	100	238	0	0	1	714	227	464	5.10E-141	501.5	SYMC_HUMAN	reviewed	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	MARS1 MARS	Homo sapiens (Human)	900	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009267; GO:0009303; GO:0016020; GO:0017101; GO:0032869; GO:0036120; GO:0070062; GO:0071364; GO:1901838	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN5000_c0_g1_i1	Q9VFL5	SYMM_DROME	46.9	524	250	8	1652	111	24	529	4.20E-130	466.5	SYMM_DROME	reviewed	"Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS)"	MetRS-m Aats-met Aats-met-m CG31322 CG8684	Drosophila melanogaster (Fruit fly)	582	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]	GO:0004825; GO:0005524; GO:0005739; GO:0005759; GO:0006431	methionyl-tRNA aminoacylation [GO:0006431]		NA	NA	NA	NA	NA	NA
TRINITY_DN8089_c0_g1_i1	Q6A8H1	FMT_CUTAK	100	71	0	0	215	3	87	157	1.40E-36	152.9	FMT_CUTAK	reviewed	Methionyl-tRNA formyltransferase (EC 2.1.2.9)	fmt PPA1195	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	315	methionyl-tRNA formyltransferase activity [GO:0004479]		methionyl-tRNA formyltransferase activity [GO:0004479]	GO:0004479			NA	NA	NA	NA	NA	NA
TRINITY_DN38367_c0_g1_i1	Q96DP5	FMT_HUMAN	100	71	0	0	1	213	107	177	2.70E-37	155.2	FMT_HUMAN	reviewed	"Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)"	MTFMT FMT FMT1	Homo sapiens (Human)	389	mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	mitochondrion [GO:0005739]	methionyl-tRNA formyltransferase activity [GO:0004479]	GO:0004479; GO:0005739; GO:0071951	conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]		NA	NA	NA	NA	NA	NA
TRINITY_DN1457_c0_g1_i1	Q9D799	FMT_MOUSE	37.4	372	167	7	217	1323	37	345	1.10E-62	242.3	FMT_MOUSE	reviewed	"Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)"	Mtfmt Fmt	Mus musculus (Mouse)	386	mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	mitochondrion [GO:0005739]	methionyl-tRNA formyltransferase activity [GO:0004479]	GO:0004479; GO:0005739; GO:0071951	conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]		NA	NA	NA	NA	NA	NA
TRINITY_DN1457_c0_g1_i2	Q9D799	FMT_MOUSE	47.7	199	100	3	217	804	37	234	4.60E-48	193	FMT_MOUSE	reviewed	"Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)"	Mtfmt Fmt	Mus musculus (Mouse)	386	mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	mitochondrion [GO:0005739]	methionyl-tRNA formyltransferase activity [GO:0004479]	GO:0004479; GO:0005739; GO:0071951	conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c1_g1_i2	Q6R7M4	C15A1_DIPPU	39.2	492	289	4	67	1512	1	492	2.10E-102	374.4	C15A1_DIPPU	reviewed	Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1)	CYP15A1	Diploptera punctata (Pacific beetle cockroach)	493	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0005506; GO:0006718; GO:0016709; GO:0020037	juvenile hormone biosynthetic process [GO:0006718]		NA	NA	NA	NA	NA	NA
TRINITY_DN21659_c1_g1_i5	Q6R7M4	C15A1_DIPPU	38.1	155	90	3	67	513	1	155	2.90E-23	110.2	C15A1_DIPPU	reviewed	Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1)	CYP15A1	Diploptera punctata (Pacific beetle cockroach)	493	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0005506; GO:0006718; GO:0016709; GO:0020037	juvenile hormone biosynthetic process [GO:0006718]		NA	NA	NA	NA	NA	NA
TRINITY_DN1201_c0_g1_i1	Q9UBB5	MBD2_HUMAN	56.1	244	102	4	775	47	148	387	2.50E-68	260.4	MBD2_HUMAN	reviewed	Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2)	MBD2	Homo sapiens (Human)	411	"cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]"	cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]	GO:0000118; GO:0000122; GO:0000183; GO:0000790; GO:0000792; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006346; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0032991; GO:0034622; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0043044; GO:0044030; GO:0045892; GO:0048568; GO:0070742; GO:0071407	"aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35182_c0_g1_i1	Q3ULD5	MCCB_MOUSE	53.3	92	39	1	8	283	50	137	1.50E-19	96.7	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN39691_c0_g1_i1	Q9HCC0	MCCB_HUMAN	100	87	0	0	262	2	386	472	3.90E-46	184.9	MCCB_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCC2 MCCB	Homo sapiens (Human)	563	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0015936; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN36358_c0_g1_i1	Q9HCC0	MCCB_HUMAN	98.8	162	2	0	1	486	90	251	6.90E-89	327.8	MCCB_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCC2 MCCB	Homo sapiens (Human)	563	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0015936; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN7978_c0_g2_i1	Q3ULD5	MCCB_MOUSE	75.6	443	106	1	1330	2	38	478	3.70E-201	702.2	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN7978_c0_g2_i3	Q3ULD5	MCCB_MOUSE	75.6	443	106	1	1330	2	38	478	3.70E-201	702.2	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN41098_c0_g1_i1	Q8T2J9	MCCB_DICDI	67.1	79	26	0	239	3	333	411	1.80E-25	116.3	MCCB_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	mccb mccc2 DDB_G0271960	Dictyostelium discoideum (Slime mold)	588	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN37834_c0_g1_i1	Q8T2J9	MCCB_DICDI	73.9	111	29	0	2	334	370	480	5.20E-43	174.9	MCCB_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	mccb mccc2 DDB_G0271960	Dictyostelium discoideum (Slime mold)	588	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN19302_c0_g2_i1	Q8T2J9	MCCB_DICDI	81.2	138	26	0	415	2	163	300	3.00E-61	235.7	MCCB_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	mccb mccc2 DDB_G0271960	Dictyostelium discoideum (Slime mold)	588	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN19302_c0_g1_i1	Q9HCC0	MCCB_HUMAN	71.4	91	26	0	277	5	212	302	5.50E-30	131.3	MCCB_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCC2 MCCB	Homo sapiens (Human)	563	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0015936; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN19302_c0_g1_i2	Q3ULD5	MCCB_MOUSE	72.8	195	52	1	586	5	108	302	9.60E-77	287.7	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN34480_c0_g1_i1	Q8T2J9	MCCB_DICDI	61.1	90	34	1	2	271	389	477	5.10E-25	114.8	MCCB_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	mccb mccc2 DDB_G0271960	Dictyostelium discoideum (Slime mold)	588	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN15635_c0_g1_i1	Q3ULD5	MCCB_MOUSE	75.6	164	40	0	494	3	316	479	4.70E-69	261.9	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN15635_c0_g2_i1	Q3ULD5	MCCB_MOUSE	72.1	104	29	0	313	2	316	419	9.40E-39	160.6	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN39208_c0_g1_i1	Q3ULD5	MCCB_MOUSE	74.7	87	22	0	262	2	111	197	4.90E-36	151.4	MCCB_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2	Mus musculus (Mouse)	563	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202	coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN36014_c0_g1_i1	Q9HCC0	MCCB_HUMAN	59.6	89	35	1	265	2	49	137	6.80E-25	114.4	MCCB_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCC2 MCCB	Homo sapiens (Human)	563	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0015936; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN26612_c0_g1_i1	Q8T2J9	MCCB_DICDI	62.8	129	48	0	390	4	339	467	5.00E-45	181.8	MCCB_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	mccb mccc2 DDB_G0271960	Dictyostelium discoideum (Slime mold)	588	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN12017_c0_g1_i1	Q9LDD8	MCCB_ARATH	39.3	575	310	7	1695	61	4	569	3.40E-106	387.1	MCCB_ARATH	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCB At4g34030 F17I5.220 F28A23.210	Arabidopsis thaliana (Mouse-ear cress)	587	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006552; GO:0008270; GO:0050897; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN12017_c0_g1_i5	Q9LDD8	MCCB_ARATH	42.6	486	251	6	1404	4	86	562	2.10E-101	370.9	MCCB_ARATH	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCB At4g34030 F17I5.220 F28A23.210	Arabidopsis thaliana (Mouse-ear cress)	587	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006552; GO:0008270; GO:0050897; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN12017_c0_g1_i6	Q9LDD8	MCCB_ARATH	42.5	496	258	6	1494	61	83	569	3.40E-105	383.6	MCCB_ARATH	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCB At4g34030 F17I5.220 F28A23.210	Arabidopsis thaliana (Mouse-ear cress)	587	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006552; GO:0008270; GO:0050897; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN12017_c0_g1_i8	Q9LDD8	MCCB_ARATH	39.5	570	306	7	1684	65	4	564	2.90E-105	384	MCCB_ARATH	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCB At4g34030 F17I5.220 F28A23.210	Arabidopsis thaliana (Mouse-ear cress)	587	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006552; GO:0008270; GO:0050897; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN40642_c0_g1_i1	Q9LDD8	MCCB_ARATH	60	70	28	0	231	22	229	298	3.30E-18	92	MCCB_ARATH	reviewed	"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	MCCB At4g34030 F17I5.220 F28A23.210	Arabidopsis thaliana (Mouse-ear cress)	587	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; zinc ion binding [GO:0008270]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006552; GO:0008270; GO:0050897; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN5663_c0_g6_i1	Q5I0C3	MCCA_RAT	61.9	210	75	1	650	21	198	402	1.30E-69	264.2	MCCA_RAT	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	Mccc1 Mcca	Rattus norvegicus (Rat)	715	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN3647_c0_g2_i1	Q5I0C3	MCCA_RAT	75.7	115	28	0	2	346	251	365	1.20E-45	183.7	MCCA_RAT	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	Mccc1 Mcca	Rattus norvegicus (Rat)	715	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN3647_c0_g1_i1	Q54KE6	MCCA_DICDI	61.5	148	57	0	14	457	209	356	2.60E-48	193	MCCA_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	mccA mccc1 DDB_G0287377	Dictyostelium discoideum (Slime mold)	699	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN8582_c0_g1_i1	Q96RQ3	MCCA_HUMAN	74.7	229	58	0	745	59	66	294	2.90E-94	346.3	MCCA_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	725	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0016421; GO:0046872; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN8582_c0_g1_i5	Q96RQ3	MCCA_HUMAN	75.7	247	60	0	744	4	66	312	1.10E-101	370.9	MCCA_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	725	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0016421; GO:0046872; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN2543_c1_g2_i1	Q96RQ3	MCCA_HUMAN	69.4	49	15	0	233	87	39	87	6.20E-12	71.6	MCCA_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	725	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0016421; GO:0046872; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN2543_c1_g2_i2	Q96RQ3	MCCA_HUMAN	69.8	53	16	0	219	61	39	91	1.10E-13	77.4	MCCA_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	725	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0016421; GO:0046872; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		blue	blue	NA	NA	NA	NA
TRINITY_DN9228_c0_g1_i1	Q54KE6	MCCA_DICDI	71.6	81	23	0	248	6	225	305	1.00E-27	123.6	MCCA_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	mccA mccc1 DDB_G0287377	Dictyostelium discoideum (Slime mold)	699	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN31871_c0_g1_i1	Q54KE6	MCCA_DICDI	61.1	113	44	0	339	1	123	235	4.40E-34	145.2	MCCA_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	mccA mccc1 DDB_G0287377	Dictyostelium discoideum (Slime mold)	699	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN6612_c0_g1_i1	Q54KE6	MCCA_DICDI	60.6	71	28	0	214	2	235	305	1.00E-19	97.1	MCCA_DICDI	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	mccA mccc1 DDB_G0287377	Dictyostelium discoideum (Slime mold)	699	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN35404_c0_g1_i1	Q96RQ3	MCCA_HUMAN	61.5	78	30	0	3	236	298	375	4.60E-22	104.8	MCCA_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	725	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0016421; GO:0046872; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN6162_c0_g1_i1	Q99MR8	MCCA_MOUSE	53.7	395	181	2	4	1185	311	704	1.00E-112	408.3	MCCA_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	Mccc1 Mcca	Mus musculus (Mouse)	717	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006552; GO:0016421; GO:0046872; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN6162_c0_g1_i3	Q99MR8	MCCA_MOUSE	50.7	69	33	1	8	214	621	688	4.00E-10	65.5	MCCA_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	Mccc1 Mcca	Mus musculus (Mouse)	717	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006552; GO:0016421; GO:0046872; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN6162_c0_g1_i7	Q99MR8	MCCA_MOUSE	53.3	405	187	2	4	1215	311	714	4.00E-115	416.4	MCCA_MOUSE	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	Mccc1 Mcca	Mus musculus (Mouse)	717	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006552; GO:0016421; GO:0046872; GO:1905202	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN39527_c0_g1_i1	Q96RQ3	MCCA_HUMAN	100	94	0	0	283	2	272	365	1.00E-47	190.3	MCCA_HUMAN	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	725	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0016421; GO:0046872; GO:1905202	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN5663_c0_g3_i1	Q42523	MCCA_ARATH	62.1	66	21	1	203	6	310	371	3.20E-16	85.1	MCCA_ARATH	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCA At1g03090 F10O3.9 F10O3_8	Arabidopsis thaliana (Mouse-ear cress)	734	cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	cytosolic ribosome [GO:0022626]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; cobalt ion binding [GO:0050897]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005576; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0022626; GO:0050897	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN5663_c0_g2_i1	Q2QMG2	MCCA_ORYSJ	64.6	226	76	1	680	3	160	381	1.70E-77	290.4	MCCA_ORYSJ	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCA Os12g0605800 LOC_Os12g41250 OsJ_36794	Oryza sativa subsp. japonica (Rice)	737	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN30259_c0_g1_i1	Q2QMG2	MCCA_ORYSJ	65.3	101	35	0	305	3	39	139	2.30E-29	129.4	MCCA_ORYSJ	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCA Os12g0605800 LOC_Os12g41250 OsJ_36794	Oryza sativa subsp. japonica (Rice)	737	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN16478_c1_g1_i1	Q2QMG2	MCCA_ORYSJ	67.8	118	38	0	22	375	40	157	1.60E-37	156.8	MCCA_ORYSJ	reviewed	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCA Os12g0605800 LOC_Os12g41250 OsJ_36794	Oryza sativa subsp. japonica (Rice)	737	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0016421; GO:0046872	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN14547_c0_g1_i1	Q9WU20	MTHR_MOUSE	64.9	57	20	0	286	116	583	639	3.00E-17	89.4	MTHR_MOUSE	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	Mthfr	Mus musculus (Mouse)	654	cytosol [GO:0005829]; synapse [GO:0045202]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]; heterochromatin maintenance [GO:0070829]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; regulation of histone methylation [GO:0031060]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]; synapse [GO:0045202]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]	GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0006730; GO:0009086; GO:0031060; GO:0035999; GO:0044877; GO:0045202; GO:0046653; GO:0050660; GO:0050661; GO:0050667; GO:0070829; GO:0071949; GO:0072341	heterochromatin maintenance [GO:0070829]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; regulation of histone methylation [GO:0031060]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN14547_c0_g1_i3	Q5I598	MTHR_BOVIN	63.8	600	212	4	1912	116	44	639	2.10E-238	826.6	MTHR_BOVIN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Bos taurus (Bovine)	655	cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]	FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]	GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949	methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN27776_c0_g1_i1	P42898	MTHR_HUMAN	100	87	0	0	3	263	484	570	8.70E-46	183.7	MTHR_HUMAN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Homo sapiens (Human)	656	cytosol [GO:0005829]; synapse [GO:0045202]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]; folic acid metabolic process [GO:0046655]; heterochromatin maintenance [GO:0070829]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; synapse [GO:0045202]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]	GO:0001666; GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0006730; GO:0009086; GO:0031060; GO:0033274; GO:0035999; GO:0042493; GO:0043200; GO:0044877; GO:0045202; GO:0046500; GO:0046655; GO:0050660; GO:0050661; GO:0050667; GO:0051593; GO:0070555; GO:0070829; GO:0071949; GO:0072341	folic acid metabolic process [GO:0046655]; heterochromatin maintenance [GO:0070829]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN21933_c0_g1_i1	Q9SE60	MTHR1_ARATH	55.3	76	32	2	226	2	491	565	1.60E-16	86.3	MTHR1_ARATH	reviewed	Methylenetetrahydrofolate reductase 1 (AtMTHFR1) (EC 1.5.1.20)	MTHFR1 At3g59970 F24G16.240	Arabidopsis thaliana (Mouse-ear cress)	592	cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]	FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]	GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949	methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN18039_c0_g1_i1	Q13825	AUHM_HUMAN	100	103	0	0	324	16	237	339	1.70E-51	203	AUHM_HUMAN	reviewed	"Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)"	AUH	Homo sapiens (Human)	339	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0009083; GO:0050011	branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN25492_c0_g1_i1	Q13825	AUHM_HUMAN	98.5	133	2	0	402	4	121	253	2.60E-65	249.2	AUHM_HUMAN	reviewed	"Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)"	AUH	Homo sapiens (Human)	339	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0009083; GO:0050011	branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN32938_c0_g1_i1	Q13825	AUHM_HUMAN	60.6	264	104	0	208	999	76	339	3.20E-94	346.7	AUHM_HUMAN	reviewed	"Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)"	AUH	Homo sapiens (Human)	339	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0009083; GO:0050011	branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]		blue	blue	NA	NA	NA	NA
TRINITY_DN6037_c0_g3_i1	P28810	MMSA_PSEAE	69.5	95	29	0	2	286	110	204	1.70E-34	146.4	MMSA_PSEAE	reviewed	Methylmalonate-semialdehyde dehydrogenase [acylating] (MMSDH) (EC 1.2.1.27)	mmsA PA3570	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN26893_c0_g1_i1	Q0WM29	MMSA_ARATH	53.9	76	35	0	4	231	107	182	9.80E-17	87	MMSA_ARATH	reviewed	"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MM-ALDH) (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member B2)"	ALDH6B2 At2g14170 F15N24.6 T22C12.10	Arabidopsis thaliana (Mouse-ear cress)	607	cytosol [GO:0005829]; mitochondrion [GO:0005739]; copper ion binding [GO:0005507]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; response to oxidative stress [GO:0006979]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	copper ion binding [GO:0005507]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005507; GO:0005739; GO:0005829; GO:0006210; GO:0006573; GO:0006574; GO:0006979; GO:0018478	response to oxidative stress [GO:0006979]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN1945_c0_g1_i1	Q0WM29	MMSA_ARATH	69.8	116	35	0	352	5	202	317	4.00E-46	185.3	MMSA_ARATH	reviewed	"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MM-ALDH) (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member B2)"	ALDH6B2 At2g14170 F15N24.6 T22C12.10	Arabidopsis thaliana (Mouse-ear cress)	607	cytosol [GO:0005829]; mitochondrion [GO:0005739]; copper ion binding [GO:0005507]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; response to oxidative stress [GO:0006979]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	copper ion binding [GO:0005507]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005507; GO:0005739; GO:0005829; GO:0006210; GO:0006573; GO:0006574; GO:0006979; GO:0018478	response to oxidative stress [GO:0006979]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN19383_c0_g1_i1	Q07536	MMSA_BOVIN	62.9	89	33	0	267	1	270	358	1.10E-27	123.6	MMSA_BOVIN	reviewed	"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)"	ALDH6A1 MMSDH	Bos taurus (Bovine)	537	mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019859	thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN27477_c0_g1_i1	Q02252	MMSA_HUMAN	100	71	0	0	213	1	399	469	9.60E-35	146.7	MMSA_HUMAN	reviewed	"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)"	ALDH6A1 MMSDH	Homo sapiens (Human)	535	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]; branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]	GO:0000062; GO:0003723; GO:0004491; GO:0005654; GO:0005739; GO:0005759; GO:0006210; GO:0006573; GO:0006574; GO:0009083; GO:0018478; GO:0019859; GO:0050873	branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN33469_c0_g1_i1	Q02252	MMSA_HUMAN	100	112	0	0	1	336	241	352	3.60E-60	231.9	MMSA_HUMAN	reviewed	"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)"	ALDH6A1 MMSDH	Homo sapiens (Human)	535	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]; branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]	GO:0000062; GO:0003723; GO:0004491; GO:0005654; GO:0005739; GO:0005759; GO:0006210; GO:0006573; GO:0006574; GO:0009083; GO:0018478; GO:0019859; GO:0050873	branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN1580_c0_g1_i1	Q8C7H1	MMAA_MOUSE	59.7	330	133	0	150	1139	79	408	2.40E-109	397.1	MMAA_MOUSE	reviewed	"Methylmalonic aciduria type A homolog, mitochondrial (EC 3.6.-.-)"	Mmaa	Mus musculus (Mouse)	415	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0005525; GO:0005739; GO:0042802; GO:0042803			NA	NA	NA	NA	NA	NA
TRINITY_DN31770_c0_g1_i1	Q8IVH4	MMAA_HUMAN	100	68	0	0	205	2	154	221	8.60E-33	140.2	MMAA_HUMAN	reviewed	"Methylmalonic aciduria type A protein, mitochondrial (EC 3.6.-.-)"	MMAA	Homo sapiens (Human)	418	mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0005525; GO:0005759; GO:0009235; GO:0019626; GO:0042802; GO:0042803	cobalamin metabolic process [GO:0009235]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN25853_c0_g1_i1	Q8IVH4	MMAA_HUMAN	100	68	0	0	204	1	271	338	6.80E-30	130.6	MMAA_HUMAN	reviewed	"Methylmalonic aciduria type A protein, mitochondrial (EC 3.6.-.-)"	MMAA	Homo sapiens (Human)	418	mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0005525; GO:0005759; GO:0009235; GO:0019626; GO:0042802; GO:0042803	cobalamin metabolic process [GO:0009235]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN31295_c0_g1_i1	Q8GBW6	12S_PROFR	60.8	74	29	0	3	224	313	386	5.80E-22	104.4	12S_PROFR	reviewed	Methylmalonyl-CoA carboxyltransferase 12S subunit (EC 2.1.3.1) (Transcarboxylase 12S subunit)		Propionibacterium freudenreichii subsp. shermanii	611	acetyl-CoA carboxylase complex [GO:0009317]; acetyl-CoA carboxylase activity [GO:0003989]; methylmalonyl-CoA carboxytransferase activity [GO:0047154]; fatty acid biosynthetic process [GO:0006633]	acetyl-CoA carboxylase complex [GO:0009317]	acetyl-CoA carboxylase activity [GO:0003989]; methylmalonyl-CoA carboxytransferase activity [GO:0047154]	GO:0003989; GO:0006633; GO:0009317; GO:0047154	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN1855_c0_g1_i1	Q96PE7	MCEE_HUMAN	75.4	65	16	0	286	92	111	175	2.20E-23	109.8	MCEE_HUMAN	reviewed	"Methylmalonyl-CoA epimerase, mitochondrial (EC 5.1.99.1) (DL-methylmalonyl-CoA racemase)"	MCEE	Homo sapiens (Human)	176	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]	GO:0004493; GO:0005759; GO:0019626; GO:0046491; GO:0046872	L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626]		blue	blue	NA	NA	NA	NA
TRINITY_DN1855_c0_g1_i2	Q9D1I5	MCEE_MOUSE	64.9	151	53	0	544	92	27	177	1.80E-53	210.7	MCEE_MOUSE	reviewed	"Methylmalonyl-CoA epimerase, mitochondrial (EC 5.1.99.1) (DL-methylmalonyl-CoA racemase)"	Mcee	Mus musculus (Mouse)	178	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]	GO:0004493; GO:0005739; GO:0046491; GO:0046872	L-methylmalonyl-CoA metabolic process [GO:0046491]		blue	blue	NA	NA	NA	NA
TRINITY_DN1855_c0_g1_i4	Q96PE7	MCEE_HUMAN	75.4	65	16	0	287	93	111	175	2.20E-23	109.8	MCEE_HUMAN	reviewed	"Methylmalonyl-CoA epimerase, mitochondrial (EC 5.1.99.1) (DL-methylmalonyl-CoA racemase)"	MCEE	Homo sapiens (Human)	176	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]	GO:0004493; GO:0005759; GO:0019626; GO:0046491; GO:0046872	L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626]		blue	blue	NA	NA	NA	NA
TRINITY_DN1855_c0_g1_i5	Q9D1I5	MCEE_MOUSE	64.9	151	53	0	545	93	27	177	1.40E-53	211.1	MCEE_MOUSE	reviewed	"Methylmalonyl-CoA epimerase, mitochondrial (EC 5.1.99.1) (DL-methylmalonyl-CoA racemase)"	Mcee	Mus musculus (Mouse)	178	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]	GO:0004493; GO:0005739; GO:0046491; GO:0046872	L-methylmalonyl-CoA metabolic process [GO:0046491]		blue	blue	NA	NA	NA	NA
TRINITY_DN36610_c0_g1_i1	Q3J4D7	MCM_RHOS4	56.4	78	34	0	236	3	479	556	6.00E-14	77.8	MCM_RHOS4	reviewed	Methylmalonyl-CoA mutase (MCM) (EC 5.4.99.2)	mcm mcmA RSP_2192	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	709	cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]		cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]	GO:0004494; GO:0031419; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22509_c0_g1_i1	P27253	SCPA_ECOLI	84.1	69	11	0	2	208	309	377	7.60E-29	127.1	SCPA_ECOLI	reviewed	Methylmalonyl-CoA mutase (MCM) (EC 5.4.99.2)	scpA sbm yliK b2917 JW2884	Escherichia coli (strain K12)	714	cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]		cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]	GO:0004494; GO:0031419; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5348_c0_g1_i1	Q3J4D7	MCM_RHOS4	75.3	93	23	0	2	280	329	421	4.40E-35	148.3	MCM_RHOS4	reviewed	Methylmalonyl-CoA mutase (MCM) (EC 5.4.99.2)	mcm mcmA RSP_2192	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	709	cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]		cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]	GO:0004494; GO:0031419; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34339_c0_g1_i1	Q59677	MUTB_PORGI	97.3	74	2	0	224	3	315	388	2.00E-35	149.1	MUTB_PORGI	reviewed	Methylmalonyl-CoA mutase large subunit (EC 5.4.99.2) (MCM-alpha)	mutB mcmB PG_1657	Porphyromonas gingivalis (strain ATCC BAA-308 / W83)	715	cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]		cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]	GO:0004494; GO:0031419; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17851_c0_g1_i1	P11653	MUTB_PROFR	72.5	80	22	0	3	242	535	614	4.90E-27	121.3	MUTB_PROFR	reviewed	Methylmalonyl-CoA mutase large subunit (EC 5.4.99.2) (MCM-alpha)	mutB	Propionibacterium freudenreichii subsp. shermanii	728	cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]		cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]	GO:0004494; GO:0031419; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3998_c0_g1_i1	P22033	MUTA_HUMAN	72.2	418	115	1	3	1253	289	706	6.00E-169	595.1	MUTA_HUMAN	reviewed	"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)"	MMUT MUT	Homo sapiens (Human)	750	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0009235; GO:0009791; GO:0019626; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341	cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN3998_c0_g1_i4	P22033	MUTA_HUMAN	69.1	418	111	2	3	1202	289	706	1.70E-157	557	MUTA_HUMAN	reviewed	"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)"	MMUT MUT	Homo sapiens (Human)	750	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0009235; GO:0009791; GO:0019626; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341	cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN39298_c0_g1_i1	P22033	MUTA_HUMAN	99	104	1	0	1	312	398	501	7.40E-52	204.1	MUTA_HUMAN	reviewed	"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)"	MMUT MUT	Homo sapiens (Human)	750	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0009235; GO:0009791; GO:0019626; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341	cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN28128_c0_g1_i1	P16332	MUTA_MOUSE	100	79	0	0	240	4	366	444	4.70E-38	157.9	MUTA_MOUSE	reviewed	"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)"	Mmut Mut	Mus musculus (Mouse)	748	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0009791; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341	homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]		NA	NA	NA	NA	NA	NA
TRINITY_DN2123_c0_g1_i1	Q99J09	MEP50_MOUSE	35.1	319	193	10	1038	94	19	327	4.20E-45	183.7	MEP50_MOUSE	reviewed	Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77)	Wdr77 Mep50	Mus musculus (Mouse)	342	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pole plasm [GO:0045495]; methyl-CpG binding [GO:0008327]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; pole plasm assembly [GO:0007315]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pole plasm [GO:0045495]	methyl-CpG binding [GO:0008327]; nuclear receptor transcription coactivator activity [GO:0030374]	GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0007315; GO:0008284; GO:0008285; GO:0008327; GO:0030374; GO:0034709; GO:0045495; GO:0060528; GO:0060770	negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; pole plasm assembly [GO:0007315]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]		blue	blue	NA	NA	NA	NA
TRINITY_DN2123_c0_g1_i3	Q4QR85	MEP50_RAT	38.3	206	122	5	1037	423	19	220	5.60E-34	146.7	MEP50_RAT	reviewed	Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77)	Wdr77 Mep50	Rattus norvegicus (Rat)	342	cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pole plasm [GO:0045495]; methyl-CpG binding [GO:0008327]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; pole plasm assembly [GO:0007315]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pole plasm [GO:0045495]	methyl-CpG binding [GO:0008327]; nuclear receptor transcription coactivator activity [GO:0030374]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007315; GO:0008284; GO:0008285; GO:0008327; GO:0030374; GO:0034709; GO:0045495; GO:0060528; GO:0060770	negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; pole plasm assembly [GO:0007315]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]		NA	NA	NA	NA	NA	NA
TRINITY_DN38545_c0_g1_i1	Q9BV20	MTNA_HUMAN	100	102	0	0	306	1	137	238	7.30E-52	204.1	MTNA_HUMAN	reviewed	Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)	MRI1 MRDI UNQ6390/PRO21135	Homo sapiens (Human)	369	cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]	GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0042995; GO:0046523	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN30822_c0_g1_i1	Q9CQT1	MTNA_MOUSE	100	93	0	0	2	280	198	290	1.90E-46	186	MTNA_MOUSE	reviewed	Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)	Mri1	Mus musculus (Mouse)	369	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]	GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0046523	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN1001_c0_g1_i1	Q5HZE4	MTNA_RAT	52.9	87	41	0	306	46	278	364	7.70E-17	87.8	MTNA_RAT	reviewed	Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)	Mri1	Rattus norvegicus (Rat)	369	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]	GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0046523	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN1001_c0_g1_i2	Q2NL31	MTNA_BOVIN	59.1	357	139	4	1128	73	1	355	2.20E-107	390.6	MTNA_BOVIN	reviewed	Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)	MRI1	Bos taurus (Bovine)	358	cytoplasm [GO:0005737]; nucleus [GO:0005634]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]	GO:0005634; GO:0005737; GO:0019284; GO:0019509; GO:0046523	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN22670_c0_g1_i1	Q9CQT1	MTNA_MOUSE	100	43	0	0	2	130	141	183	4.90E-18	91.3	MTNA_MOUSE	reviewed	Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)	Mri1	Mus musculus (Mouse)	369	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]	GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0046523	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN181_c0_g1_i3	C1C4M8	MTNB_LITCT	64.1	209	75	0	746	120	24	232	8.20E-74	278.9	MTNB_LITCT	reviewed	Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog)	apip	Lithobates catesbeianus (American bullfrog) (Rana catesbeiana)	239	cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytoplasm [GO:0005737]	methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0046570	apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		blue	blue	NA	NA	NA	NA
TRINITY_DN181_c0_g1_i6	C1C4M8	MTNB_LITCT	62	216	79	2	758	120	17	232	6.10E-72	272.3	MTNB_LITCT	reviewed	Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog)	apip	Lithobates catesbeianus (American bullfrog) (Rana catesbeiana)	239	cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytoplasm [GO:0005737]	methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0046570	apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN27999_c0_g1_i1	Q96GX9	MTNB_HUMAN	100	83	0	0	251	3	60	142	1.90E-42	172.6	MTNB_HUMAN	reviewed	Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (hAPIP)	APIP CGI-29	Homo sapiens (Human)	242	cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372	apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372]		NA	NA	NA	NA	NA	NA
TRINITY_DN3019_c0_g1_i1	Q6SKR2	N6MT1_MOUSE	53.6	211	93	3	746	123	5	213	9.20E-54	211.8	N6MT1_MOUSE	reviewed	Methyltransferase N6AMT1 (HemK methyltransferase family member 2) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-)	N6amt1 Hemk2 Kmt9 Pred28	Mus musculus (Mouse)	214	eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone-lysine N-methyltransferase activity [GO:0018024]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; arsonoacetate metabolic process [GO:0018872]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]	eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	histone-lysine N-methyltransferase activity [GO:0018024]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein-glutamine N-methyltransferase activity [GO:0036009]; protein methyltransferase activity [GO:0008276]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]	GO:0003676; GO:0005634; GO:0008276; GO:0008757; GO:0009007; GO:0009404; GO:0018024; GO:0018364; GO:0018872; GO:0030307; GO:0030792; GO:0032259; GO:0032775; GO:0032991; GO:0034968; GO:0035657; GO:0036009; GO:1904047	arsonoacetate metabolic process [GO:0018872]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]		NA	NA	NA	NA	NA	NA
TRINITY_DN3019_c0_g1_i5	Q6SKR2	N6MT1_MOUSE	53.6	211	93	3	743	120	5	213	5.40E-54	212.6	N6MT1_MOUSE	reviewed	Methyltransferase N6AMT1 (HemK methyltransferase family member 2) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-)	N6amt1 Hemk2 Kmt9 Pred28	Mus musculus (Mouse)	214	eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone-lysine N-methyltransferase activity [GO:0018024]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; arsonoacetate metabolic process [GO:0018872]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]	eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	histone-lysine N-methyltransferase activity [GO:0018024]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein-glutamine N-methyltransferase activity [GO:0036009]; protein methyltransferase activity [GO:0008276]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]	GO:0003676; GO:0005634; GO:0008276; GO:0008757; GO:0009007; GO:0009404; GO:0018024; GO:0018364; GO:0018872; GO:0030307; GO:0030792; GO:0032259; GO:0032775; GO:0032991; GO:0034968; GO:0035657; GO:0036009; GO:1904047	arsonoacetate metabolic process [GO:0018872]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]		NA	NA	NA	NA	NA	NA
TRINITY_DN4326_c0_g1_i1	Q3U2U7	MET17_MOUSE	36.5	458	264	9	66	1421	7	443	1.20E-78	295.4	MET17_MOUSE	reviewed	"Methyltransferase-like protein 17, mitochondrial (EC 2.1.1.-)"	Mettl17 D14Ertd209e	Mus musculus (Mouse)	461	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]; methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0032259; GO:0042274; GO:0097177; GO:1904047	methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4326_c0_g1_i2	Q3U2U7	MET17_MOUSE	37.5	384	219	7	101	1249	80	443	1.50E-72	275	MET17_MOUSE	reviewed	"Methyltransferase-like protein 17, mitochondrial (EC 2.1.1.-)"	Mettl17 D14Ertd209e	Mus musculus (Mouse)	461	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]; methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0032259; GO:0042274; GO:0097177; GO:1904047	methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN31538_c0_g1_i1	Q9H7H0	MET17_HUMAN	100	99	0	0	3	299	189	287	4.60E-51	201.4	MET17_HUMAN	reviewed	"Methyltransferase-like protein 17, mitochondrial (EC 2.1.1.-) (False p73 target gene protein) (Methyltransferase 11 domain-containing protein 1) (Protein RSM22 homolog, mitochondrial)"	METTL17 METT11D1	Homo sapiens (Human)	456	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]; methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0032259; GO:0042274; GO:0097177; GO:1904047	methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2237_c0_g1_i1	Q8N6Q8	MET25_HUMAN	28.6	308	191	8	1860	952	151	434	1.50E-25	119.4	MET25_HUMAN	reviewed	Methyltransferase-like protein 25 (EC 2.1.1.-)	METTL25 C12orf26	Homo sapiens (Human)	603	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN2237_c0_g1_i2	Q6NXH8	MET25_MOUSE	37.5	96	58	2	1231	947	331	425	1.30E-09	66.2	MET25_MOUSE	reviewed	Methyltransferase-like protein 25 (EC 2.1.1.-)	Mettl25	Mus musculus (Mouse)	597	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	1
TRINITY_DN2237_c0_g1_i3	Q8N6Q8	MET25_HUMAN	27.7	285	177	8	1786	947	174	434	1.40E-20	102.8	MET25_HUMAN	reviewed	Methyltransferase-like protein 25 (EC 2.1.1.-)	METTL25 C12orf26	Homo sapiens (Human)	603	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN2237_c0_g1_i4	Q6NXH8	MET25_MOUSE	37.5	96	58	2	1236	952	331	425	1.40E-09	66.2	MET25_MOUSE	reviewed	Methyltransferase-like protein 25 (EC 2.1.1.-)	Mettl25	Mus musculus (Mouse)	597	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	1
TRINITY_DN2237_c0_g1_i5	Q8N6Q8	MET25_HUMAN	28.6	308	191	8	1855	947	151	434	1.50E-25	119.4	MET25_HUMAN	reviewed	Methyltransferase-like protein 25 (EC 2.1.1.-)	METTL25 C12orf26	Homo sapiens (Human)	603	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN2237_c0_g1_i6	Q8N6Q8	MET25_HUMAN	27.7	285	177	8	1791	952	174	434	1.40E-20	102.8	MET25_HUMAN	reviewed	Methyltransferase-like protein 25 (EC 2.1.1.-)	METTL25 C12orf26	Homo sapiens (Human)	603	methyltransferase activity [GO:0008168]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4541_c26_g1_i1	Q9H8H3	MET7A_HUMAN	38.4	229	119	6	210	884	34	244	2.80E-33	144.1	MET7A_HUMAN	reviewed	Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B)	METTL7A PRO0066 UNQ1902/PRO4348	Homo sapiens (Human)	244	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; neutrophil degranulation [GO:0043312]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]	methyltransferase activity [GO:0008168]	GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0032259; GO:0043312; GO:1904724	methylation [GO:0032259]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN5271_c0_g1_i1	Q9H8H3	MET7A_HUMAN	36.4	225	129	5	261	935	34	244	1.60E-31	138.3	MET7A_HUMAN	reviewed	Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B)	METTL7A PRO0066 UNQ1902/PRO4348	Homo sapiens (Human)	244	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; neutrophil degranulation [GO:0043312]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]	methyltransferase activity [GO:0008168]	GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0032259; GO:0043312; GO:1904724	methylation [GO:0032259]; neutrophil degranulation [GO:0043312]		blue	blue	NA	NA	NA	NA
TRINITY_DN12365_c0_g1_i1	Q9H8H3	MET7A_HUMAN	34.8	233	135	5	783	91	27	244	1.60E-33	144.8	MET7A_HUMAN	reviewed	Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B)	METTL7A PRO0066 UNQ1902/PRO4348	Homo sapiens (Human)	244	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; neutrophil degranulation [GO:0043312]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]	methyltransferase activity [GO:0008168]	GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0032259; GO:0043312; GO:1904724	methylation [GO:0032259]; neutrophil degranulation [GO:0043312]		blue	blue	NA	NA	NA	NA
TRINITY_DN12365_c0_g1_i2	Q9H8H3	MET7A_HUMAN	41.5	135	68	4	489	91	119	244	7.00E-20	99	MET7A_HUMAN	reviewed	Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B)	METTL7A PRO0066 UNQ1902/PRO4348	Homo sapiens (Human)	244	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; neutrophil degranulation [GO:0043312]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]	methyltransferase activity [GO:0008168]	GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0032259; GO:0043312; GO:1904724	methylation [GO:0032259]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN12365_c0_g1_i3	Q9H8H3	MET7A_HUMAN	35.2	227	130	5	765	91	33	244	1.90E-33	144.4	MET7A_HUMAN	reviewed	Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B)	METTL7A PRO0066 UNQ1902/PRO4348	Homo sapiens (Human)	244	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; neutrophil degranulation [GO:0043312]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]	methyltransferase activity [GO:0008168]	GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0032259; GO:0043312; GO:1904724	methylation [GO:0032259]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN34926_c0_g1_i1	Q6NT16	S18B1_HUMAN	37	73	46	0	3	221	336	408	6.00E-09	61.2	S18B1_HUMAN	reviewed	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	SLC18B1 C6orf192	Homo sapiens (Human)	456	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN33812_c0_g2_i1	Q6NT16	S18B1_HUMAN	40.4	136	75	1	9	416	129	258	1.90E-16	87	S18B1_HUMAN	reviewed	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	SLC18B1 C6orf192	Homo sapiens (Human)	456	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN27802_c0_g1_i1	Q6NT16	S18B1_HUMAN	45.2	177	97	0	552	22	30	206	9.20E-37	154.8	S18B1_HUMAN	reviewed	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	SLC18B1 C6orf192	Homo sapiens (Human)	456	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN4535_c0_g1_i1	Q3TN34	MILK2_MOUSE	60.3	73	29	0	220	2	5	77	1.50E-20	99.8	MILK2_MOUSE	reviewed	MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2)	Micall2 Jrab	Mus musculus (Mouse)	1009	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]	GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN1586_c0_g1_i2	Q3TN34	MILK2_MOUSE	41.8	91	53	0	386	114	888	978	1.80E-10	67	MILK2_MOUSE	reviewed	MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2)	Micall2 Jrab	Mus musculus (Mouse)	1009	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]	GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN1586_c0_g1_i3	Q3TN34	MILK2_MOUSE	41.8	91	53	0	525	253	888	978	2.40E-10	67	MILK2_MOUSE	reviewed	MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2)	Micall2 Jrab	Mus musculus (Mouse)	1009	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]	GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]		NA	NA	NA	NA	NA	NA
TRINITY_DN1420_c0_g1_i2	P91928	MIC60_DROME	35.4	522	316	9	1606	86	221	736	4.00E-67	257.3	MIC60_DROME	reviewed	MICOS complex subunit Mic60	Mitofilin CG6455	Drosophila melanogaster (Fruit fly)	739	cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; protein kinase binding [GO:0019901]; cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]	cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP-dependent protein binding [GO:0043008]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005739; GO:0005743; GO:0007005; GO:0019901; GO:0042407; GO:0043008; GO:0061617; GO:0070584	cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN1420_c0_g1_i3	P91928	MIC60_DROME	35.4	522	316	9	1606	86	221	736	4.00E-67	257.3	MIC60_DROME	reviewed	MICOS complex subunit Mic60	Mitofilin CG6455	Drosophila melanogaster (Fruit fly)	739	cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; protein kinase binding [GO:0019901]; cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]	cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP-dependent protein binding [GO:0043008]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005739; GO:0005743; GO:0007005; GO:0019901; GO:0042407; GO:0043008; GO:0061617; GO:0070584	cristae formation [GO:0042407]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN1420_c0_g1_i1	Q3KR86	MIC60_RAT	25.9	212	145	2	637	38	162	373	4.50E-11	69.7	MIC60_RAT	reviewed	MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin) (Fragment)	Immt Mic60	Rattus norvegicus (Rat)	609	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion morphogenesis [GO:0070584]; response to cold [GO:0009409]	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0005758; GO:0009409; GO:0042407; GO:0051560; GO:0061617; GO:0070584	cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion morphogenesis [GO:0070584]; response to cold [GO:0009409]		NA	NA	NA	NA	NA	NA
TRINITY_DN4764_c0_g1_i1	Q9W062	MFAP1_DROME	78.9	128	27	0	71	454	348	475	1.50E-53	210.7	MFAP1_DROME	reviewed	Microfibrillar-associated protein 1 (Spliceosome B complex protein MFAP1)	Mfap1 CG1017	Drosophila melanogaster (Fruit fly)	478	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; U2-type spliceosomal complex [GO:0005684]		GO:0000398; GO:0005684; GO:0010389; GO:0032991; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"		NA	NA	NA	NA	NA	NA
TRINITY_DN949_c0_g3_i1	Q9W062	MFAP1_DROME	68.6	51	16	0	460	308	2	52	1.50E-11	70.9	MFAP1_DROME	reviewed	Microfibrillar-associated protein 1 (Spliceosome B complex protein MFAP1)	Mfap1 CG1017	Drosophila melanogaster (Fruit fly)	478	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; U2-type spliceosomal complex [GO:0005684]		GO:0000398; GO:0005684; GO:0010389; GO:0032991; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39333_c0_g1_i1	C0HKD8	MFA1A_MOUSE	100	74	0	0	224	3	352	425	6.30E-37	154.1	MFA1A_MOUSE	reviewed	Microfibrillar-associated protein 1A (Spliceosome B complex protein MFAP1A)	Mfap1a	Mus musculus (Mouse)	439	"centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; microfibril [GO:0001527]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]"	centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; microfibril [GO:0001527]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]		GO:0000398; GO:0001527; GO:0005634; GO:0005654; GO:0005684; GO:0005813; GO:0062023; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34126_c0_g1_i1	O75030	MITF_HUMAN	70.1	67	14	1	217	17	305	365	1.40E-18	93.2	MITF_HUMAN	reviewed	Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32)	MITF BHLHE32	Homo sapiens (Human)	526	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006355; GO:0010628; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0044336; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141	"bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5512_c0_g1_i1	A6QR44	DGCR8_BOVIN	51.5	97	41	1	383	93	475	565	6.10E-19	95.1	DGCR8_BOVIN	reviewed	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog)	DGCR8	Bos taurus (Bovine)	760	"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]	double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]	GO:0003725; GO:0005730; GO:0020037; GO:0031053; GO:0042802; GO:0046872; GO:0070877; GO:0070878; GO:0090502	"primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5512_c0_g1_i3	A6QR44	DGCR8_BOVIN	46.2	78	36	1	251	18	475	546	1.80E-11	69.7	DGCR8_BOVIN	reviewed	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog)	DGCR8	Bos taurus (Bovine)	760	"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]	double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]	GO:0003725; GO:0005730; GO:0020037; GO:0031053; GO:0042802; GO:0046872; GO:0070877; GO:0070878; GO:0090502	"primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5512_c0_g1_i2	Q8WYQ5	DGCR8_HUMAN	49.4	265	126	3	919	125	488	744	2.30E-61	237.3	DGCR8_HUMAN	reviewed	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8)	DGCR8 C22orf12 DGCRK6 LP4941	Homo sapiens (Human)	773	"cytoplasm [GO:0005737]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; miRNA metabolic process [GO:0010586]; primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	cytoplasm [GO:0005737]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]	GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010586; GO:0020037; GO:0031053; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0090502	"miRNA metabolic process [GO:0010586]; primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN947_c0_g1_i1	P79382	MGST1_PIG	46.1	115	57	1	118	447	8	122	9.60E-19	95.1	MGST1_PIG	reviewed	Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I)	MGST1 GST12	Sus scrofa (Pig)	155	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular response to lipid hydroperoxide [GO:0071449]; oxidation-reduction process [GO:0055114]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0016021; GO:0055114; GO:0071449	cellular response to lipid hydroperoxide [GO:0071449]; oxidation-reduction process [GO:0055114]		blue	blue	NA	NA	NA	NA
TRINITY_DN947_c0_g1_i2	P79382	MGST1_PIG	46.1	115	57	1	149	478	8	122	1.00E-18	95.1	MGST1_PIG	reviewed	Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I)	MGST1 GST12	Sus scrofa (Pig)	155	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular response to lipid hydroperoxide [GO:0071449]; oxidation-reduction process [GO:0055114]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0016021; GO:0055114; GO:0071449	cellular response to lipid hydroperoxide [GO:0071449]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	1
TRINITY_DN38775_c0_g1_i1	O14880	MGST3_HUMAN	100	122	0	0	3	368	20	141	2.50E-67	255.8	MGST3_HUMAN	reviewed	Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20) (Microsomal glutathione S-transferase III) (Microsomal GST-III)	MGST3	Homo sapiens (Human)	152	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; transferase activity [GO:0016740]; glutathione derivative biosynthetic process [GO:1901687]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; transferase activity [GO:0016740]	GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0006805; GO:0010243; GO:0016020; GO:0016021; GO:0016740; GO:0019370; GO:0042802; GO:0043231; GO:1901687	glutathione derivative biosynthetic process [GO:1901687]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN35450_c0_g1_i1	Q9CPU4	MGST3_MOUSE	47.1	138	70	1	100	504	1	138	6.10E-29	129	MGST3_MOUSE	reviewed	Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III)	Mgst3	Mus musculus (Mouse)	153	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]	GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0010243; GO:0016020; GO:0016021; GO:0019370; GO:0042802; GO:0043231	leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]		blue	blue	NA	NA	NA	NA
TRINITY_DN21946_c0_g1_i1	Q99L90	MCRS1_MOUSE	59.4	424	157	4	225	1472	44	460	1.20E-131	471.5	MCRS1_MOUSE	reviewed	Microspherule protein 1 (58 kDa microspherule protein)	Mcrs1 Msp58	Mus musculus (Mouse)	462	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]	G-quadruplex RNA binding [GO:0002151]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]	GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0045944; GO:0046972; GO:0051974; GO:0071339; GO:1904357; GO:1904751	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN14868_c0_g1_i1	Q99L90	MCRS1_MOUSE	99.4	173	1	0	18	536	114	286	2.30E-93	342.8	MCRS1_MOUSE	reviewed	Microspherule protein 1 (58 kDa microspherule protein)	Mcrs1 Msp58	Mus musculus (Mouse)	462	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]	G-quadruplex RNA binding [GO:0002151]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]	GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0045944; GO:0046972; GO:0051974; GO:0071339; GO:1904357; GO:1904751	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN14868_c0_g1_i2	Q96EZ8	MCRS1_HUMAN	99.7	327	1	0	18	998	114	440	5.30E-184	644.8	MCRS1_HUMAN	reviewed	Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)	MCRS1 INO80Q MSP58	Homo sapiens (Human)	462	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; cellular protein modification process [GO:0006464]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; viral process [GO:0016032]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]	G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]	GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0006464; GO:0008266; GO:0010521; GO:0016032; GO:0016579; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045944; GO:0051974; GO:0071339; GO:1904357; GO:1904751	cellular protein modification process [GO:0006464]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3386_c0_g1_i1	Q9H492	MLP3A_HUMAN	73.3	116	31	0	437	90	5	120	1.20E-43	177.6	MLP3A_HUMAN	reviewed	Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha)	MAP1LC3A	Homo sapiens (Human)	121	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202]	microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005770; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0009267; GO:0010040; GO:0010288; GO:0016236; GO:0031090; GO:0031625; GO:0034198; GO:0043231; GO:0043278; GO:0044754; GO:0045202; GO:0070301; GO:0071280; GO:0097352	autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]		NA	NA	NA	NA	NA	NA
TRINITY_DN31117_c0_g1_i1	Q9H492	MLP3A_HUMAN	100	116	0	0	372	25	6	121	1.00E-60	233.8	MLP3A_HUMAN	reviewed	Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha)	MAP1LC3A	Homo sapiens (Human)	121	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202]	microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005770; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0009267; GO:0010040; GO:0010288; GO:0016236; GO:0031090; GO:0031625; GO:0034198; GO:0043231; GO:0043278; GO:0044754; GO:0045202; GO:0070301; GO:0071280; GO:0097352	autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]		NA	NA	NA	NA	NA	NA
TRINITY_DN30443_c0_g1_i1	Q9GZQ8	MLP3B_HUMAN	100	125	0	0	424	50	1	125	5.40E-64	245	MLP3B_HUMAN	reviewed	Microtubule-associated proteins 1A/1B light chain 3B (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta)	MAP1LC3B MAP1ALC3	Homo sapiens (Human)	125	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]	microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0000423; GO:0005739; GO:0005776; GO:0005829; GO:0005874; GO:0005930; GO:0006914; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0043231; GO:0097352	autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]		NA	NA	NA	NA	NA	NA
TRINITY_DN39993_c0_g1_i1	Q9CQV6	MLP3B_MOUSE	100	98	0	0	2	295	28	125	6.20E-49	194.5	MLP3B_MOUSE	reviewed	Microtubule-associated proteins 1A/1B light chain 3B (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta)	Map1lc3b Map1alc3 Map1lc3	Mus musculus (Mouse)	125	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein binding [GO:0032092]	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]	microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0000423; GO:0005737; GO:0005739; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0005930; GO:0006914; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0015631; GO:0016020; GO:0016236; GO:0019904; GO:0030424; GO:0030425; GO:0031410; GO:0031625; GO:0032092; GO:0043025; GO:0043231; GO:0044754; GO:0070257; GO:0097352	autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein binding [GO:0032092]		NA	NA	NA	NA	NA	NA
TRINITY_DN3386_c0_g1_i2	Q9CQV6	MLP3B_MOUSE	80.2	111	22	0	422	90	10	120	3.40E-44	179.1	MLP3B_MOUSE	reviewed	Microtubule-associated proteins 1A/1B light chain 3B (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta)	Map1lc3b Map1alc3 Map1lc3	Mus musculus (Mouse)	125	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein binding [GO:0032092]	autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]	microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0000423; GO:0005737; GO:0005739; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0005930; GO:0006914; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0015631; GO:0016020; GO:0016236; GO:0019904; GO:0030424; GO:0030425; GO:0031410; GO:0031625; GO:0032092; GO:0043025; GO:0043231; GO:0044754; GO:0070257; GO:0097352	autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein binding [GO:0032092]		NA	NA	NA	NA	NA	NA
TRINITY_DN13171_c1_g1_i1	Q9BXW4	MLP3C_HUMAN	68.2	110	35	0	100	429	17	126	1.10E-36	154.5	MLP3C_HUMAN	reviewed	Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma)	MAP1LC3C	Homo sapiens (Human)	147	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]	microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527]		blue	blue	NA	NA	NA	NA
TRINITY_DN2764_c0_g1_i1	Q6P0Q8	MAST2_HUMAN	57.1	212	78	5	85	699	301	506	1.40E-53	211.1	MAST2_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	1798	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2764_c0_g1_i2	Q6P0Q8	MAST2_HUMAN	55.4	392	130	14	1	1131	145	506	2.70E-91	337	MAST2_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	1798	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2764_c0_g2_i1	Q6P0Q8	MAST2_HUMAN	49.1	751	335	13	13	2157	497	1236	3.20E-181	636.7	MAST2_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	1798	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2764_c0_g2_i2	Q6P0Q8	MAST2_HUMAN	48.8	756	335	14	13	2172	497	1236	8.10E-180	632.1	MAST2_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	1798	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2764_c0_g2_i3	Q6P0Q8	MAST2_HUMAN	48.8	756	335	14	13	2172	497	1236	8.10E-180	632.1	MAST2_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	1798	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2764_c0_g2_i4	Q6P0Q8	MAST2_HUMAN	49.1	751	335	13	13	2157	497	1236	3.20E-181	636.7	MAST2_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	1798	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]		NA	NA	NA	NA	NA	NA
TRINITY_DN31993_c0_g1_i1	O60307	MAST3_HUMAN	95.6	160	7	0	482	3	358	517	7.90E-85	314.3	MAST3_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 3 (EC 2.7.11.1)	MAST3 KIAA0561	Homo sapiens (Human)	1309	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0007010; GO:0018105; GO:0035556	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN40016_c0_g1_i1	O60307	MAST3_HUMAN	100	83	0	0	3	251	516	598	2.40E-45	182.2	MAST3_HUMAN	reviewed	Microtubule-associated serine/threonine-protein kinase 3 (EC 2.7.11.1)	MAST3 KIAA0561	Homo sapiens (Human)	1309	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0007010; GO:0018105; GO:0035556	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN2229_c0_g1_i3	A0JMQ7	MTS1A_DANRE	35.4	161	100	1	192	662	280	440	3.50E-14	80.1	MTS1A_DANRE	reviewed	Microtubule-associated tumor suppressor 1 homolog A (Mitochondrial tumor suppressor 1 homolog A)	mtus1a mtus1 zgc:154168	Danio rerio (Zebrafish) (Brachydanio rerio)	440	Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]	Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	microtubule binding [GO:0008017]	GO:0005634; GO:0005739; GO:0005794; GO:0005886; GO:0007049; GO:0008017	cell cycle [GO:0007049]		NA	NA	NA	NA	NA	NA
TRINITY_DN1529_c0_g1_i1	A9UHW6	MI4GD_HUMAN	24.6	179	128	3	434	955	34	210	1.80E-06	55.5	MI4GD_HUMAN	reviewed	MIF4G domain-containing protein (SLBP-interacting protein 1) (hSLIP1)	MIF4GD SLIP1	Homo sapiens (Human)	222	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; regulation of translational initiation [GO:0006446]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]	identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]	GO:0003723; GO:0005730; GO:0005794; GO:0005829; GO:0006446; GO:0008022; GO:0008494; GO:0042802	regulation of translational initiation [GO:0006446]		blue	blue	NA	NA	NA	NA
TRINITY_DN8853_c0_g2_i1	P29496	MCM5_YEAST	75.8	165	39	1	492	1	370	534	2.20E-66	253.1	MCM5_YEAST	reviewed	Minichromosome maintenance protein 5 (EC 3.6.4.12) (Cell division control protein 46)	MCM5 CDC46 YLR274W L9328.1	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	775	"CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; chromatin silencing at telomere [GO:0006348]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; heterochromatin assembly [GO:0031507]; negative regulation of chromatin silencing at telomere [GO:0031939]; nuclear DNA replication [GO:0033260]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"	"CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; MCM complex [GO:0042555]; nuclear chromosome, telomeric region [GO:0000784]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]	GO:0000727; GO:0000784; GO:0003678; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0006267; GO:0006270; GO:0006348; GO:0030174; GO:0031261; GO:0031298; GO:0031507; GO:0031939; GO:0033260; GO:0042555; GO:0071162	chromatin silencing at telomere [GO:0006348]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; heterochromatin assembly [GO:0031507]; negative regulation of chromatin silencing at telomere [GO:0031939]; nuclear DNA replication [GO:0033260]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN12967_c1_g1_i1	Q8TCT9	HM13_HUMAN	100	350	0	0	1050	1	8	357	3.30E-197	688.7	HM13_HUMAN	reviewed	Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase)	HM13 H13 IMP1 PSL3 SPP MSTP086	Homo sapiens (Human)	377	"cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]"	cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0016020; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0071458; GO:0071556; GO:1904211	"membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17758_c0_g1_i1	Q9D8V0	HM13_MOUSE	65.8	336	114	1	1131	124	14	348	2.70E-121	436.8	HM13_MOUSE	reviewed	Minor histocompatibility antigen H13 (EC 3.4.23.-) (Presenilin-like protein 3) (Signal peptide peptidase)	Hm13 H13 Psl3	Mus musculus (Mouse)	378	"cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]"	cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0071458; GO:0071556; GO:1904211	"membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]"		blue	blue	NA	NA	NA	NA
TRINITY_DN14133_c0_g1_i1	Q9D8V0	HM13_MOUSE	98.9	95	1	0	287	3	245	339	5.10E-47	188	HM13_MOUSE	reviewed	Minor histocompatibility antigen H13 (EC 3.4.23.-) (Presenilin-like protein 3) (Signal peptide peptidase)	Hm13 H13 Psl3	Mus musculus (Mouse)	378	"cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]"	cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0071458; GO:0071556; GO:1904211	"membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30395_c0_g1_i1	Q9VTC4	GALL2_DROME	57.6	99	40	1	3	293	55	153	7.10E-23	107.8	GALL2_DROME	reviewed	MIP18 family protein galla-2	galla-2 CG7949	Drosophila melanogaster (Fruit fly)	156	CIA complex [GO:0097361]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]	CIA complex [GO:0097361]		GO:0007049; GO:0007059; GO:0016226; GO:0051301; GO:0097361; GO:0106035	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]		NA	NA	NA	NA	NA	NA
TRINITY_DN11215_c3_g1_i1	P54278	PMS2_HUMAN	64.9	74	26	0	2	223	291	364	2.80E-22	105.9	PMS2_HUMAN	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	PMS2 PMSL2	Homo sapiens (Human)	862	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]	GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0016446; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]		blue	blue	NA	NA	NA	NA
TRINITY_DN11215_c3_g1_i2	P54278	PMS2_HUMAN	64.9	74	26	0	2	223	291	364	3.40E-22	105.5	PMS2_HUMAN	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	PMS2 PMSL2	Homo sapiens (Human)	862	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]	GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0016446; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN3242_c0_g1_i1	P54278	PMS2_HUMAN	63	246	88	2	818	90	614	859	6.60E-89	329.7	PMS2_HUMAN	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	PMS2 PMSL2	Homo sapiens (Human)	862	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]	GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0016446; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN3242_c0_g1_i4	P54278	PMS2_HUMAN	65.6	192	66	0	665	90	668	859	3.50E-76	286.2	PMS2_HUMAN	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	PMS2 PMSL2	Homo sapiens (Human)	862	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]	GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0016446; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN38615_c0_g1_i1	F1NQJ3	PMS2_CHICK	73.1	67	18	0	236	36	17	83	2.10E-22	105.9	PMS2_CHICK	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	PMS2	Gallus gallus (Chicken)	869	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004519; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0007095; GO:0016446; GO:0016887; GO:0030890; GO:0032138; GO:0032300; GO:0032389; GO:0032407; GO:0036464	mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN38615_c0_g1_i2	F1NQJ3	PMS2_CHICK	71.7	120	34	0	362	3	17	136	1.00E-44	180.6	PMS2_CHICK	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	PMS2	Gallus gallus (Chicken)	869	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697]; mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004519; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0007095; GO:0016446; GO:0016887; GO:0030890; GO:0032138; GO:0032300; GO:0032389; GO:0032407; GO:0036464	mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; somatic hypermutation of immunoglobulin genes [GO:0016446]		NA	NA	NA	NA	NA	NA
TRINITY_DN39760_c0_g1_i1	Q8N4C8	MINK1_HUMAN	100	108	0	0	324	1	1188	1295	1.00E-59	230.3	MINK1_HUMAN	reviewed	Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6)	MINK1 B55 MAP4K6 MINK YSK2 ZC3	Homo sapiens (Human)	1332	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0001952; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007254; GO:0007268; GO:0007275; GO:0014069; GO:0022407; GO:0023014; GO:0030334; GO:0030424; GO:0030425; GO:0031098; GO:0031532; GO:0032147; GO:0046330; GO:0046777; GO:0048812; GO:0048813; GO:0070062; GO:1900745; GO:2000311	actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cell migration [GO:0030334]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1346_c1_g1_i1	Q00855	ALL2_DERFA	37.6	85	45	3	30	272	58	138	2.60E-08	59.7	ALL2_DERFA	reviewed	Mite group 2 allergen Der f 2 (Allergen Der f II) (allergen Der f 2)	DERF2	Dermatophagoides farinae (American house dust mite)	146	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN32769_c0_g1_i1	Q8BZ09	ODC_MOUSE	59.3	285	111	3	949	104	16	298	4.90E-95	349.4	ODC_MOUSE	reviewed	Mitochondrial 2-oxodicarboxylate carrier (Solute carrier family 25 member 21)	Slc25a21 Odc	Mus musculus (Mouse)	298	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN32737_c0_g1_i1	Q02978	M2OM_HUMAN	79.1	129	27	0	454	68	181	309	6.10E-55	214.9	M2OM_HUMAN	reviewed	Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11)	SLC25A11 SLC20A4	Homo sapiens (Human)	314	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; gluconeogenesis [GO:0006094]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]	GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005887; GO:0006094; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015367; GO:0015709; GO:0015729; GO:0035435; GO:0071422; GO:0071423	gluconeogenesis [GO:0006094]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]		blue	blue	NA	NA	NA	NA
TRINITY_DN17633_c0_g2_i1	P22292	M2OM_BOVIN	77.8	27	6	0	82	2	213	239	3.10E-05	48.9	M2OM_BOVIN	reviewed	Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11)	SLC25A11 SLC20A4	Bos taurus (Bovine)	314	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]	GO:0005739; GO:0005743; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0071422; GO:0071423	malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]		NA	NA	NA	NA	NA	NA
TRINITY_DN29440_c0_g1_i1	P22292	M2OM_BOVIN	100	75	0	0	3	227	191	265	1.20E-35	149.8	M2OM_BOVIN	reviewed	Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11)	SLC25A11 SLC20A4	Bos taurus (Bovine)	314	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]	GO:0005739; GO:0005743; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0071422; GO:0071423	malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]		NA	NA	NA	NA	NA	NA
TRINITY_DN5767_c0_g1_i5	Q922Q1	MARC2_MOUSE	41.9	93	54	0	663	385	52	144	7.60E-14	79.3	MARC2_MOUSE	reviewed	Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2)	Mtarc2 Marc2 Mg87 Mosc2	Mus musculus (Mouse)	338	mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005741; GO:0005743; GO:0005777; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0055114	nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN2291_c0_g2_i1	Q5U534	MARC1_XENLA	39.8	103	60	1	311	3	32	132	3.00E-13	75.9	MARC1_XENLA	reviewed	Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.7.-.-)	mtarc1 marc1	Xenopus laevis (African clawed frog)	343	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; molybdenum ion binding [GO:0030151]; oxidoreductase activity [GO:0016491]; pyridoxal phosphate binding [GO:0030170]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	molybdenum ion binding [GO:0030151]; oxidoreductase activity [GO:0016491]; pyridoxal phosphate binding [GO:0030170]	GO:0005741; GO:0016021; GO:0016491; GO:0030151; GO:0030170			NA	NA	NA	NA	NA	NA
TRINITY_DN2291_c0_g1_i1	Q5VT66	MARC1_HUMAN	31.8	349	197	12	1237	203	21	332	7.60E-34	146.4	MARC1_HUMAN	reviewed	Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1)	MTARC1 MARC1 MOSC1	Homo sapiens (Human)	337	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005741; GO:0006805; GO:0008940; GO:0016021; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0055114	detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]		blue	blue	NA	NA	NA	NA
TRINITY_DN736_c7_g1_i1	Q96EH3	MASU1_HUMAN	49.2	118	59	1	625	975	92	209	5.30E-26	120.2	MASU1_HUMAN	reviewed	Mitochondrial assembly of ribosomal large subunit protein 1	MALSU1 C7orf30	Homo sapiens (Human)	234	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ribosomal large subunit binding [GO:0043023]	GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071	negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN26952_c0_g1_i1	Q9Z2Z6	MCAT_MOUSE	100	74	0	0	223	2	118	191	3.70E-37	154.8	MCAT_MOUSE	reviewed	Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (mCAC) (Solute carrier family 25 member 20)	Slc25a20 Cac Cact	Mus musculus (Mouse)	301	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine transmembrane transport [GO:1902603]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	acyl carnitine transmembrane transporter activity [GO:0015227]	GO:0005739; GO:0005743; GO:0005829; GO:0015227; GO:0016021; GO:1902603	carnitine transmembrane transport [GO:1902603]		NA	NA	NA	NA	NA	NA
TRINITY_DN38554_c0_g1_i1	Q9Z2Z6	MCAT_MOUSE	66.4	295	97	2	3	884	8	301	4.20E-114	412.5	MCAT_MOUSE	reviewed	Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (mCAC) (Solute carrier family 25 member 20)	Slc25a20 Cac Cact	Mus musculus (Mouse)	301	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine transmembrane transport [GO:1902603]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	acyl carnitine transmembrane transporter activity [GO:0015227]	GO:0005739; GO:0005743; GO:0005829; GO:0015227; GO:0016021; GO:1902603	carnitine transmembrane transport [GO:1902603]		NA	NA	NA	NA	NA	NA
TRINITY_DN34376_c0_g1_i1	O43772	MCAT_HUMAN	97.3	75	2	0	227	3	50	124	3.40E-38	158.3	MCAT_HUMAN	reviewed	Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20)	SLC25A20 CAC CACT	Homo sapiens (Human)	301	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine shuttle [GO:0006853]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	acyl carnitine transmembrane transporter activity [GO:0015227]	GO:0005739; GO:0005743; GO:0005829; GO:0006853; GO:0015227; GO:0016021	carnitine shuttle [GO:0006853]		NA	NA	NA	NA	NA	NA
TRINITY_DN35564_c0_g1_i1	O43772	MCAT_HUMAN	100	184	0	0	620	69	118	301	3.90E-105	382.1	MCAT_HUMAN	reviewed	Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20)	SLC25A20 CAC CACT	Homo sapiens (Human)	301	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine shuttle [GO:0006853]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	acyl carnitine transmembrane transporter activity [GO:0015227]	GO:0005739; GO:0005743; GO:0005829; GO:0006853; GO:0015227; GO:0016021	carnitine shuttle [GO:0006853]		NA	NA	NA	NA	NA	NA
TRINITY_DN27545_c0_g1_i1	Q9NZJ7	MTCH1_HUMAN	100	83	0	0	2	250	209	291	1.90E-42	172.6	MTCH1_HUMAN	reviewed	Mitochondrial carrier homolog 1 (Presenilin-associated protein)	MTCH1 PSAP CGI-64 UNQ1871/PRO4314	Homo sapiens (Human)	389	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; neuronal ion channel clustering [GO:0045161]; positive regulation of apoptotic process [GO:0043065]; regulation of signal transduction [GO:0009966]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006915; GO:0006919; GO:0009966; GO:0016021; GO:0043065; GO:0045161	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; neuronal ion channel clustering [GO:0045161]; positive regulation of apoptotic process [GO:0043065]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN9836_c0_g1_i1	Q791V5	MTCH2_MOUSE	42.4	283	151	3	996	175	8	287	7.00E-57	222.6	MTCH2_MOUSE	reviewed	Mitochondrial carrier homolog 2	Mtch2	Mus musculus (Mouse)	303	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0005739; GO:0005741; GO:0005743; GO:0006089; GO:0010917; GO:0016021; GO:0035701; GO:0042775; GO:0043065; GO:0043280; GO:0045820; GO:0061484; GO:0070585; GO:0071478; GO:0090152; GO:0097284; GO:1902108; GO:1902231	cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]		blue	blue	NA	NA	NA	NA
TRINITY_DN16616_c0_g1_i1	Q9Y6C9	MTCH2_HUMAN	100	78	0	0	2	235	140	217	3.20E-39	161.8	MTCH2_HUMAN	reviewed	Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein)	MTCH2 MIMP HSPC032	Homo sapiens (Human)	303	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; positive regulation of apoptotic process [GO:0043065]; protein localization to mitochondrion [GO:0070585]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005739; GO:0005743; GO:0016020; GO:0016021; GO:0043065; GO:0070585	positive regulation of apoptotic process [GO:0043065]; protein localization to mitochondrion [GO:0070585]		NA	NA	NA	NA	NA	NA
TRINITY_DN10274_c0_g1_i2	Q9VQ37	RIM2_DROME	61.7	222	82	3	789	130	144	364	1.30E-73	277.7	RIM2_DROME	reviewed	Mitochondrial carrier protein Rim2	Rim2 CG18317	Drosophila melanogaster (Fruit fly)	365	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	pyrimidine nucleotide transmembrane transporter activity [GO:0015218]	GO:0005739; GO:0005743; GO:0006390; GO:0007005; GO:0015218; GO:0016021; GO:0030302; GO:0040011; GO:0045333; GO:0048311; GO:1990519	cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]		NA	NA	NA	NA	NA	NA
TRINITY_DN59_c0_g1_i1	Q5E9H5	BCS1_BOVIN	64.7	249	87	1	755	9	1	248	3.10E-99	363.2	BCS1_BOVIN	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	BCS1L	Bos taurus (Bovine)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		NA	NA	NA	NA	NA	NA
TRINITY_DN59_c0_g1_i2	Q5E9H5	BCS1_BOVIN	69.4	98	30	0	302	9	151	248	5.20E-39	162.9	BCS1_BOVIN	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	BCS1L	Bos taurus (Bovine)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		NA	NA	NA	NA	NA	NA
TRINITY_DN59_c0_g1_i2	Q5E9H5	BCS1_BOVIN	64.2	106	37	1	615	298	1	105	5.00E-34	146.4	BCS1_BOVIN	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	BCS1L	Bos taurus (Bovine)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		NA	NA	NA	NA	NA	NA
TRINITY_DN59_c0_g1_i3	Q7ZTL7	BCS1_XENLA	62.8	148	55	0	452	9	101	248	3.40E-54	213.8	BCS1_XENLA	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	bcs1l	Xenopus laevis (African clawed frog)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN59_c0_g1_i3	Q7ZTL7	BCS1_XENLA	59.1	154	62	1	895	434	1	153	1.70E-50	201.4	BCS1_XENLA	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	bcs1l	Xenopus laevis (African clawed frog)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN59_c0_g1_i4	Q7ZTL7	BCS1_XENLA	65.1	249	86	1	755	9	1	248	1.30E-97	357.8	BCS1_XENLA	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	bcs1l	Xenopus laevis (African clawed frog)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN37560_c0_g1_i1	Q5E9H5	BCS1_BOVIN	52.7	110	50	1	335	12	273	382	1.50E-26	120.2	BCS1_BOVIN	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	BCS1L	Bos taurus (Bovine)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		NA	NA	NA	NA	NA	NA
TRINITY_DN5728_c0_g1_i1	Q7ZV60	BCS1_DANRE	61	172	66	1	571	59	247	418	3.20E-53	209.5	BCS1_DANRE	reviewed	Mitochondrial chaperone BCS1 (BCS1-like protein)	bcs1l zgc:56205	Danio rerio (Zebrafish) (Brachydanio rerio)	420	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0032979; GO:0034551	mitochondrial respiratory chain complex III assembly [GO:0034551]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		blue	blue	NA	NA	NA	NA
TRINITY_DN30410_c0_g1_i1	Q9Y276	BCS1_HUMAN	100	107	0	0	324	4	278	384	4.70E-57	221.5	BCS1_HUMAN	reviewed	Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein)	BCS1L BCS1	Homo sapiens (Human)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0005743; GO:0005750; GO:0007005; GO:0016021; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		NA	NA	NA	NA	NA	NA
TRINITY_DN32989_c0_g1_i1	Q9Y276	BCS1_HUMAN	98.5	67	1	0	3	203	75	141	7.70E-34	143.7	BCS1_HUMAN	reviewed	Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein)	BCS1L BCS1	Homo sapiens (Human)	419	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0005743; GO:0005750; GO:0007005; GO:0016021; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]		NA	NA	NA	NA	NA	NA
TRINITY_DN14720_c0_g1_i1	Q0P483	S2542_DANRE	53.7	67	27	2	260	72	246	312	4.00E-11	68.6	S2542_DANRE	reviewed	Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42)	slc25a42 zgc:153304	Danio rerio (Zebrafish) (Brachydanio rerio)	321	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]	GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122	ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006]		NA	NA	NA	NA	NA	NA
TRINITY_DN11299_c0_g1_i1	P0C546	S2542_RAT	59.7	288	112	2	936	79	31	316	4.20E-93	343.2	S2542_RAT	reviewed	Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42)	Slc25a42	Rattus norvegicus (Rat)	318	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]	GO:0005347; GO:0005739; GO:0005743; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122	ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]		NA	NA	NA	NA	NA	NA
TRINITY_DN8653_c0_g1_i1	Q9VZJ9	MUL1_DROME	32.4	281	174	6	880	56	61	331	1.30E-30	135.2	MUL1_DROME	reviewed	Mitochondrial E3 ubiquitin protein ligase 1 (EC 2.3.2.27) (Mitochondrial E3 ubiquitin protein transferase 1)	Mul1 CG1134	Drosophila melanogaster (Fruit fly)	338	integral component of mitochondrial outer membrane [GO:0031307]; peroxisome [GO:0005777]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; organelle organization [GO:0006996]; positive regulation of mitochondrial fission [GO:0090141]; protein ubiquitination [GO:0016567]	integral component of mitochondrial outer membrane [GO:0031307]; peroxisome [GO:0005777]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005777; GO:0006996; GO:0008270; GO:0016567; GO:0031307; GO:0061630; GO:0090141	organelle organization [GO:0006996]; positive regulation of mitochondrial fission [GO:0090141]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1391_c0_g1_i1	Q6PCS6	MTFP1_DANRE	58.2	153	58	3	107	553	6	156	3.80E-37	156.4	MTFP1_DANRE	reviewed	Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein) (MTP18)	mtfp1 mtp18 zgc:63910	Danio rerio (Zebrafish) (Brachydanio rerio)	165	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0000266; GO:0005739; GO:0005743; GO:0006915; GO:0016021	apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1391_c0_g1_i2	Q6PCS6	MTFP1_DANRE	60	100	35	2	107	394	6	104	3.20E-22	106.3	MTFP1_DANRE	reviewed	Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein) (MTP18)	mtfp1 mtp18 zgc:63910	Danio rerio (Zebrafish) (Brachydanio rerio)	165	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0000266; GO:0005739; GO:0005743; GO:0006915; GO:0016021	apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]		blue	blue	NA	NA	NA	NA
TRINITY_DN616_c0_g1_i1	Q8BMG8	MFTC_MOUSE	58.2	294	116	3	988	107	18	304	3.90E-95	349.7	MFTC_MOUSE	reviewed	Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32)	Slc25a32 Mftc	Mus musculus (Mouse)	316	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; folate import into mitochondrion [GO:1904947]; mitochondrial FAD transmembrane transport [GO:1990548]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]	GO:0005739; GO:0005743; GO:0008517; GO:0015230; GO:0016021; GO:1904947; GO:1990548	folate import into mitochondrion [GO:1904947]; mitochondrial FAD transmembrane transport [GO:1990548]		blue	blue	NA	NA	NA	NA
TRINITY_DN616_c0_g1_i2	Q8BMG8	MFTC_MOUSE	59.6	302	115	3	1016	111	18	312	3.50E-99	363.2	MFTC_MOUSE	reviewed	Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32)	Slc25a32 Mftc	Mus musculus (Mouse)	316	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; folate import into mitochondrion [GO:1904947]; mitochondrial FAD transmembrane transport [GO:1990548]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]	GO:0005739; GO:0005743; GO:0008517; GO:0015230; GO:0016021; GO:1904947; GO:1990548	folate import into mitochondrion [GO:1904947]; mitochondrial FAD transmembrane transport [GO:1990548]		blue	blue	NA	NA	NA	NA
TRINITY_DN40079_c0_g1_i1	Q9H2D1	MFTC_HUMAN	100	142	0	0	1	426	132	273	7.00E-77	287.7	MFTC_HUMAN	reviewed	Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32)	SLC25A32 MFT MFTC	Homo sapiens (Human)	315	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; folate import into mitochondrion [GO:1904947]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; mitochondrial FAD transmembrane transport [GO:1990548]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]	GO:0005739; GO:0005743; GO:0008517; GO:0015230; GO:0015884; GO:0016021; GO:0046655; GO:1904947; GO:1990548	folate import into mitochondrion [GO:1904947]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; mitochondrial FAD transmembrane transport [GO:1990548]		NA	NA	NA	NA	NA	NA
TRINITY_DN33279_c0_g1_i1	Q9H2D1	MFTC_HUMAN	100	84	0	0	257	6	69	152	8.00E-44	177.2	MFTC_HUMAN	reviewed	Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32)	SLC25A32 MFT MFTC	Homo sapiens (Human)	315	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; folate import into mitochondrion [GO:1904947]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; mitochondrial FAD transmembrane transport [GO:1990548]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]	GO:0005739; GO:0005743; GO:0008517; GO:0015230; GO:0015884; GO:0016021; GO:0046655; GO:1904947; GO:1990548	folate import into mitochondrion [GO:1904947]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; mitochondrial FAD transmembrane transport [GO:1990548]		NA	NA	NA	NA	NA	NA
TRINITY_DN39675_c0_g1_i1	Q9H936	GHC1_HUMAN	100	108	0	0	325	2	54	161	8.20E-54	210.7	GHC1_HUMAN	reviewed	Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)	SLC25A22 GC1	Homo sapiens (Human)	323	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]	GO:0005313; GO:0005347; GO:0005743; GO:0006811; GO:0015183; GO:0015293; GO:0015810; GO:0015813; GO:0016021; GO:0043490	aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]		NA	NA	NA	NA	NA	NA
TRINITY_DN5552_c0_g1_i1	Q9H936	GHC1_HUMAN	57.7	317	114	3	1007	102	5	316	1.20E-96	354.8	GHC1_HUMAN	reviewed	Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)	SLC25A22 GC1	Homo sapiens (Human)	323	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]	GO:0005313; GO:0005347; GO:0005743; GO:0006811; GO:0015183; GO:0015293; GO:0015810; GO:0015813; GO:0016021; GO:0043490	aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]		NA	NA	NA	NA	NA	NA
TRINITY_DN5552_c0_g1_i2	Q5RD81	GHC1_PONAB	69.1	94	26	1	379	98	5	95	3.20E-33	142.9	GHC1_PONAB	reviewed	Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)	SLC25A22	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	323	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; symporter activity [GO:0015293]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]; symporter activity [GO:0015293]	GO:0005347; GO:0005743; GO:0015293; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4708_c0_g1_i1	Q568N4	T10B_DANRE	47.2	53	28	0	168	10	1	53	1.50E-08	59.7	T10B_DANRE	reviewed	Mitochondrial import inner membrane translocase subunit Tim10 B (Mitochondrial import inner membrane translocase subunit Tim9 B) (TIMM10B) (Tim10b)	timm10b fxc1 tim9b timm9b zgc:110193	Danio rerio (Zebrafish) (Brachydanio rerio)	202	mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; metal ion binding [GO:0046872]; protein transport [GO:0015031]	mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]	metal ion binding [GO:0046872]	GO:0015031; GO:0042719; GO:0042721; GO:0046872	protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN27048_c0_g1_i1	Q9VTJ8	TIM14_DROME	56	116	51	0	374	27	1	116	2.50E-32	139.8	TIM14_DROME	reviewed	Mitochondrial import inner membrane translocase subunit TIM14	Tim14 CG7394	Drosophila melanogaster (Fruit fly)	118	"integral component of membrane [GO:0016021]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATPase activator activity [GO:0001671]; protein import into mitochondrial matrix [GO:0030150]"	"integral component of membrane [GO:0016021]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]"	ATPase activator activity [GO:0001671]	GO:0001405; GO:0001671; GO:0005744; GO:0016021; GO:0030150	protein import into mitochondrial matrix [GO:0030150]		blue	blue	NA	NA	NA	NA
TRINITY_DN31181_c0_g1_i1	P59670	TIM17_NEUCR	78.3	69	15	0	2	208	9	77	2.30E-28	125.6	TIM17_NEUCR	reviewed	Mitochondrial import inner membrane translocase subunit tim17	tim17 NCU05623	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	155	integral component of mitochondrial inner membrane [GO:0031305]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; protein import into mitochondrial matrix [GO:0030150]	integral component of mitochondrial inner membrane [GO:0031305]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0005744; GO:0030150; GO:0031305	protein import into mitochondrial matrix [GO:0030150]		NA	NA	NA	NA	NA	NA
TRINITY_DN36364_c0_g1_i1	P39515	TIM17_YEAST	53.9	102	47	0	2	307	31	132	3.80E-27	122.1	TIM17_YEAST	reviewed	Mitochondrial import inner membrane translocase subunit TIM17 (Mitochondrial inner membrane protein MIM17) (Mitochondrial protein import protein 2)	TIM17 MIM17 MPI2 SMS1 YJL143W J0648	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	158	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial genome maintenance [GO:0000002]; protein import into mitochondrial matrix [GO:0030150]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0000002; GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0015450; GO:0030150; GO:0031305	mitochondrial genome maintenance [GO:0000002]; protein import into mitochondrial matrix [GO:0030150]		NA	NA	NA	NA	NA	NA
TRINITY_DN9931_c0_g1_i2	Q99595	TI17A_HUMAN	100	147	0	0	8	448	1	147	3.80E-81	302	TI17A_HUMAN	reviewed	Mitochondrial import inner membrane translocase subunit Tim17-A (Inner membrane preprotein translocase Tim17a)	TIMM17A MIMT17 TIM17 TIM17A TIMM17	Homo sapiens (Human)	171	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; positive regulation of protein processing [GO:0010954]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0010954; GO:0015450; GO:0030150; GO:0031305	positive regulation of protein processing [GO:0010954]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]		NA	NA	NA	NA	NA	NA
TRINITY_DN9931_c0_g1_i3	Q9Z0V8	TI17A_MOUSE	100	148	0	0	39	482	1	148	8.10E-82	304.3	TI17A_MOUSE	reviewed	Mitochondrial import inner membrane translocase subunit Tim17-A (Inner membrane preprotein translocase Tim17a)	Timm17a Tim17a	Mus musculus (Mouse)	171	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; enzyme binding [GO:0019899]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; positive regulation of protein processing [GO:0010954]; protein import into mitochondrial matrix [GO:0030150]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	enzyme binding [GO:0019899]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0010954; GO:0015450; GO:0019899; GO:0030150; GO:0031305	positive regulation of protein processing [GO:0010954]; protein import into mitochondrial matrix [GO:0030150]		NA	NA	NA	NA	NA	NA
TRINITY_DN8706_c0_g1_i1	Q9Z0V7	TI17B_MOUSE	100	101	0	0	303	1	71	171	2.70E-51	202.2	TI17B_MOUSE	reviewed	Mitochondrial import inner membrane translocase subunit Tim17-B	Timm17b Tim17b	Mus musculus (Mouse)	172	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein import into mitochondrial matrix [GO:0030150]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0005739; GO:0005743; GO:0005744; GO:0015450; GO:0030150; GO:0031305	protein import into mitochondrial matrix [GO:0030150]		NA	NA	NA	NA	NA	NA
TRINITY_DN8706_c0_g2_i1	O60830	TI17B_HUMAN	100	142	0	0	426	1	6	147	8.20E-78	290.8	TI17B_HUMAN	reviewed	Mitochondrial import inner membrane translocase subunit Tim17-B	TIMM17B TIM17B JM3	Homo sapiens (Human)	172	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0005743; GO:0005744; GO:0006626; GO:0015450; GO:0030150; GO:0031305	protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]		NA	NA	NA	NA	NA	NA
TRINITY_DN6486_c0_g1_i1	Q9Z0V7	TI17B_MOUSE	73.6	159	41	1	608	132	1	158	2.80E-61	236.5	TI17B_MOUSE	reviewed	Mitochondrial import inner membrane translocase subunit Tim17-B	Timm17b Tim17b	Mus musculus (Mouse)	172	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein import into mitochondrial matrix [GO:0030150]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0005739; GO:0005743; GO:0005744; GO:0015450; GO:0030150; GO:0031305	protein import into mitochondrial matrix [GO:0030150]		blue	blue	NA	NA	NA	NA
TRINITY_DN6662_c0_g1_i1	Q5XKA2	TIM21_XENLA	48.9	137	66	2	76	474	86	222	5.90E-33	142.1	TIM21_XENLA	reviewed	"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)"	timm21 tim21	Xenopus laevis (African clawed frog)	232	integral component of membrane [GO:0016021]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; protein import into mitochondrial matrix [GO:0030150]	integral component of membrane [GO:0016021]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0005744; GO:0016021; GO:0030150	protein import into mitochondrial matrix [GO:0030150]		blue	blue	NA	NA	NA	NA
TRINITY_DN6662_c0_g1_i2	Q5XKA2	TIM21_XENLA	49.7	147	70	2	76	504	86	232	1.40E-36	154.5	TIM21_XENLA	reviewed	"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)"	timm21 tim21	Xenopus laevis (African clawed frog)	232	integral component of membrane [GO:0016021]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; protein import into mitochondrial matrix [GO:0030150]	integral component of membrane [GO:0016021]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0005744; GO:0016021; GO:0030150	protein import into mitochondrial matrix [GO:0030150]		blue	blue	NA	NA	NA	NA
TRINITY_DN31958_c0_g1_i1	O14925	TIM23_HUMAN	100	67	0	0	1	201	130	196	1.40E-30	132.9	TIM23_HUMAN	reviewed	Mitochondrial import inner membrane translocase subunit Tim23	TIMM23 TIM23	Homo sapiens (Human)	209	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]	GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0008320; GO:0015450; GO:0030150; GO:0031305	protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]		NA	NA	NA	NA	NA	NA
TRINITY_DN323_c2_g2_i1	Q9WTQ8	TIM23_MOUSE	44.7	103	55	2	6	314	91	191	1.80E-12	73.6	TIM23_MOUSE	reviewed	Mitochondrial import inner membrane translocase subunit Tim23	Timm23 Tim23	Mus musculus (Mouse)	209	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; enzyme binding [GO:0019899]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; protein import into mitochondrial matrix [GO:0030150]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	enzyme binding [GO:0019899]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]	GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0008320; GO:0015450; GO:0019899; GO:0030150; GO:0031305	protein import into mitochondrial matrix [GO:0030150]		blue	blue	NA	NA	NA	NA
TRINITY_DN26721_c0_g1_i1	Q3ZBS8	TIM8A_BOVIN	100	65	0	0	1	195	33	97	1.90E-32	139	TIM8A_BOVIN	reviewed	Mitochondrial import inner membrane translocase subunit Tim8 A	TIMM8A TIM8A	Bos taurus (Bovine)	97	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]	metal ion binding [GO:0046872]	GO:0005743; GO:0005758; GO:0046872; GO:0072321	chaperone-mediated protein transport [GO:0072321]		NA	NA	NA	NA	NA	NA
TRINITY_DN15940_c0_g1_i1	Q9WVA1	TIM8A_RAT	63.9	72	26	0	305	90	12	83	4.60E-23	108.6	TIM8A_RAT	reviewed	Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1 homolog)	Timm8a Ddp1 Tim8a	Rattus norvegicus (Rat)	97	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; zinc ion binding [GO:0008270]; chaperone-mediated protein transport [GO:0072321]; protein targeting to mitochondrion [GO:0006626]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	zinc ion binding [GO:0008270]	GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0008270; GO:0072321	chaperone-mediated protein transport [GO:0072321]; protein targeting to mitochondrion [GO:0006626]		blue	blue	NA	NA	NA	NA
TRINITY_DN5945_c0_g1_i1	Q9VYD7	TIM9_DROME	58.2	79	33	0	137	373	17	95	5.20E-22	105.5	TIM9_DROME	reviewed	Mitochondrial import inner membrane translocase subunit Tim9	Tim9a Tim9 CG1660	Drosophila melanogaster (Fruit fly)	95	TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein targeting to mitochondrion [GO:0006626]	TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]	GO:0005744; GO:0006626; GO:0015450; GO:0046872	protein targeting to mitochondrion [GO:0006626]		blue	blue	NA	NA	NA	NA
TRINITY_DN1514_c1_g1_i1	Q9CPQ3	TOM22_MOUSE	40	95	57	0	347	63	41	135	2.70E-15	83.6	TOM22_MOUSE	reviewed	Mitochondrial import receptor subunit TOM22 homolog (Translocase of outer membrane 22 kDa subunit homolog)	Tomm22 Tom22	Mus musculus (Mouse)	142	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; positive regulation of apoptotic process [GO:0043065]; protein insertion into mitochondrial membrane [GO:0051204]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]	protein transmembrane transporter activity [GO:0008320]	GO:0005739; GO:0005741; GO:0005742; GO:0005743; GO:0006626; GO:0008320; GO:0016021; GO:0043065; GO:0045040; GO:0051204	positive regulation of apoptotic process [GO:0043065]; protein insertion into mitochondrial membrane [GO:0051204]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]		brown	brown	NA	NA	NA	NA
TRINITY_DN21828_c0_g1_i1	Q9QYA2	TOM40_MOUSE	100	109	0	0	2	328	141	249	1.60E-57	223	TOM40_MOUSE	reviewed	Mitochondrial import receptor subunit TOM40 homolog (Mitochondrial outer membrane protein of 35 kDa) (MOM35) (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog)	Tomm40 Mom35 Tom40	Mus musculus (Mouse)	361	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of mitochondrial membrane [GO:0032592]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; cation channel activity [GO:0005261]; porin activity [GO:0015288]; preprotein binding [GO:0070678]; protein transmembrane transporter activity [GO:0008320]; positive regulation of apoptotic process [GO:0043065]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial membrane [GO:0051204]; protein targeting to mitochondrion [GO:0006626]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of mitochondrial membrane [GO:0032592]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]	cation channel activity [GO:0005261]; porin activity [GO:0015288]; preprotein binding [GO:0070678]; protein transmembrane transporter activity [GO:0008320]	GO:0005261; GO:0005739; GO:0005741; GO:0005742; GO:0005743; GO:0005829; GO:0006626; GO:0008320; GO:0015288; GO:0016021; GO:0030150; GO:0031307; GO:0032592; GO:0043065; GO:0046930; GO:0051204; GO:0070678	positive regulation of apoptotic process [GO:0043065]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial membrane [GO:0051204]; protein targeting to mitochondrion [GO:0006626]		NA	NA	NA	NA	NA	NA
TRINITY_DN21828_c1_g1_i1	Q1LZB5	TOM40_BOVIN	99	102	1	0	306	1	83	184	3.90E-53	208.4	TOM40_BOVIN	reviewed	Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog)	TOMM40	Bos taurus (Bovine)	361	cytosol [GO:0005829]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane translocase complex [GO:0005742]; protein transmembrane transporter activity [GO:0008320]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	cytosol [GO:0005829]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane translocase complex [GO:0005742]	protein transmembrane transporter activity [GO:0008320]	GO:0005742; GO:0005743; GO:0005829; GO:0006626; GO:0008320; GO:0030150; GO:0032592	protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]		NA	NA	NA	NA	NA	NA
TRINITY_DN11915_c0_g1_i1	Q9U4L6	TO401_DROME	61.5	299	115	0	18	914	46	344	5.80E-106	385.6	TO401_DROME	reviewed	Mitochondrial import receptor subunit TOM40 homolog 1 (dtom40) (Male sterile protein 15) (Translocase of outer membrane 40 kDa subunit homolog 1)	Tom40 mit ms(1)15 CG12157	Drosophila melanogaster (Fruit fly)	344	mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; porin activity [GO:0015288]; protein transmembrane transporter activity [GO:0008320]; cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]	porin activity [GO:0015288]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]	GO:0005739; GO:0005742; GO:0006626; GO:0006811; GO:0008320; GO:0015288; GO:0015450; GO:0030150; GO:0046930; GO:0071456	cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]		blue	blue	NA	NA	NA	NA
TRINITY_DN132_c0_g1_i1	A4IGF3	ATP23_DANRE	44.1	238	118	7	99	800	24	250	2.70E-46	187.2	ATP23_DANRE	reviewed	Mitochondrial inner membrane protease ATP23 homolog (EC 3.4.24.-)	atp23 xrcc6bp1 zgc:162885	Danio rerio (Zebrafish) (Brachydanio rerio)	254	extrinsic component of mitochondrial inner membrane [GO:0031314]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	extrinsic component of mitochondrial inner membrane [GO:0031314]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0031314; GO:0033615; GO:0034982; GO:0046872	mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]		NA	NA	NA	NA	NA	NA
TRINITY_DN31095_c0_g1_i1	O74800	IMP1_SCHPO	52.9	51	22	1	86	232	103	153	1.90E-10	66.2	IMP1_SCHPO	reviewed	Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-)	imp1 SPBC2D10.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	157	integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; metalloendopeptidase activity [GO:0004222]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]	metalloendopeptidase activity [GO:0004222]; serine-type peptidase activity [GO:0008236]	GO:0004222; GO:0005739; GO:0006627; GO:0008236; GO:0016021; GO:0042720	protein processing involved in protein targeting to mitochondrion [GO:0006627]		red	red	NA	NA	NA	NA
TRINITY_DN30229_c0_g1_i1	Q9CQU8	IMP1L_MOUSE	99.3	144	1	0	434	3	1	144	1.00E-81	303.9	IMP1L_MOUSE	reviewed	Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein)	Immp1l	Mus musculus (Mouse)	166	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]	serine-type peptidase activity [GO:0008236]	GO:0005739; GO:0006627; GO:0008236; GO:0042720	protein processing involved in protein targeting to mitochondrion [GO:0006627]		NA	NA	NA	NA	NA	NA
TRINITY_DN19443_c0_g1_i1	Q96LU5	IMP1L_HUMAN	50.6	77	33	1	316	101	29	105	5.40E-18	91.7	IMP1L_HUMAN	reviewed	Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein)	IMMP1L	Homo sapiens (Human)	166	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]	serine-type peptidase activity [GO:0008236]	GO:0005739; GO:0006627; GO:0008236; GO:0042720	protein processing involved in protein targeting to mitochondrion [GO:0006627]		NA	NA	NA	NA	NA	NA
TRINITY_DN19443_c0_g1_i2	Q96LU5	IMP1L_HUMAN	56.6	129	50	2	521	153	29	157	9.20E-39	161.4	IMP1L_HUMAN	reviewed	Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein)	IMMP1L	Homo sapiens (Human)	166	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]	serine-type peptidase activity [GO:0008236]	GO:0005739; GO:0006627; GO:0008236; GO:0042720	protein processing involved in protein targeting to mitochondrion [GO:0006627]		blue	blue	NA	NA	NA	NA
TRINITY_DN19443_c0_g1_i3	Q96LU5	IMP1L_HUMAN	49.4	81	36	1	448	221	29	109	2.60E-18	93.2	IMP1L_HUMAN	reviewed	Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein)	IMMP1L	Homo sapiens (Human)	166	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]	serine-type peptidase activity [GO:0008236]	GO:0005739; GO:0006627; GO:0008236; GO:0042720	protein processing involved in protein targeting to mitochondrion [GO:0006627]		NA	NA	NA	NA	NA	NA
TRINITY_DN27087_c0_g1_i1	Q96T52	IMP2L_HUMAN	100	116	0	0	2	349	16	131	3.60E-63	241.9	IMP2L_HUMAN	reviewed	Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein)	IMMP2L	Homo sapiens (Human)	175	integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]	integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0001541; GO:0004252; GO:0006465; GO:0006627; GO:0006801; GO:0006974; GO:0007283; GO:0007420; GO:0008015; GO:0008233; GO:0016021; GO:0022904; GO:0030728; GO:0033108; GO:0042720; GO:0061300	blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN2804_c0_g1_i1	Q8BGA9	OXA1L_MOUSE	44.5	317	172	3	3	950	87	400	6.40E-76	285.8	OXA1L_MOUSE	reviewed	Mitochondrial inner membrane protein OXA1L (Oxidase assembly 1-like protein) (OXA1-like protein)	Oxa1l	Mus musculus (Mouse)	433	integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]	integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]	GO:0005739; GO:0005743; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0033617; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177	aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]		NA	NA	NA	NA	NA	NA
TRINITY_DN22925_c0_g1_i2	Q99797	MIPEP_HUMAN	51.7	172	83	0	3	518	321	492	9.10E-47	188	MIPEP_HUMAN	reviewed	Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59)	MIPEP MIP	Homo sapiens (Human)	713	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872	peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN32507_c0_g1_i1	Q99797	MIPEP_HUMAN	50.5	103	51	0	44	352	64	166	6.90E-23	108.2	MIPEP_HUMAN	reviewed	Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59)	MIPEP MIP	Homo sapiens (Human)	713	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872	peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN22925_c0_g1_i1	Q7SDD5	PMIP_NEUCR	41.6	101	58	1	3	302	363	463	6.90E-15	81.6	PMIP_NEUCR	reviewed	Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59) (Octapeptidyl aminopeptidase)	oct-1 NCU02063	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	805	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872	peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN4245_c0_g1_i1	Q6DEI8	MIA40_DANRE	67.7	65	21	0	370	176	41	105	2.10E-23	110.2	MIA40_DANRE	reviewed	Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)	chchd4 mia40 zgc:100849	Danio rerio (Zebrafish) (Brachydanio rerio)	146	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]	mitochondrial intermembrane space [GO:0005758]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005758; GO:0015035; GO:0022417; GO:0033108; GO:0045041; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]		NA	NA	NA	NA	NA	NA
TRINITY_DN4245_c0_g1_i2	Q6DEI8	MIA40_DANRE	67.7	65	21	0	370	176	41	105	4.00E-23	109.8	MIA40_DANRE	reviewed	Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)	chchd4 mia40 zgc:100849	Danio rerio (Zebrafish) (Brachydanio rerio)	146	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]	mitochondrial intermembrane space [GO:0005758]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005758; GO:0015035; GO:0022417; GO:0033108; GO:0045041; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]		NA	NA	NA	NA	NA	NA
TRINITY_DN4245_c0_g1_i2	Q6DEI8	MIA40_DANRE	75	32	8	0	560	465	1	32	1.50E-06	54.7	MIA40_DANRE	reviewed	Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)	chchd4 mia40 zgc:100849	Danio rerio (Zebrafish) (Brachydanio rerio)	146	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]	mitochondrial intermembrane space [GO:0005758]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005758; GO:0015035; GO:0022417; GO:0033108; GO:0045041; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]		NA	NA	NA	NA	NA	NA
TRINITY_DN4245_c0_g1_i3	Q6DEI8	MIA40_DANRE	67.7	65	21	0	370	176	41	105	3.90E-23	109.8	MIA40_DANRE	reviewed	Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)	chchd4 mia40 zgc:100849	Danio rerio (Zebrafish) (Brachydanio rerio)	146	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]	mitochondrial intermembrane space [GO:0005758]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005758; GO:0015035; GO:0022417; GO:0033108; GO:0045041; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]		NA	NA	NA	NA	NA	NA
TRINITY_DN4245_c0_g1_i4	Q6DEI8	MIA40_DANRE	61.9	97	33	1	454	176	9	105	4.50E-31	136	MIA40_DANRE	reviewed	Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)	chchd4 mia40 zgc:100849	Danio rerio (Zebrafish) (Brachydanio rerio)	146	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]	mitochondrial intermembrane space [GO:0005758]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005758; GO:0015035; GO:0022417; GO:0033108; GO:0045041; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]		NA	NA	NA	NA	NA	NA
TRINITY_DN4245_c0_g1_i5	Q6DEI8	MIA40_DANRE	64.8	105	33	1	478	176	1	105	3.60E-36	152.9	MIA40_DANRE	reviewed	Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)	chchd4 mia40 zgc:100849	Danio rerio (Zebrafish) (Brachydanio rerio)	146	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]	mitochondrial intermembrane space [GO:0005758]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005758; GO:0015035; GO:0022417; GO:0033108; GO:0045041; GO:0051084	'de novo' posttranslational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]		blue	blue	NA	NA	NA	NA
TRINITY_DN6152_c0_g1_i1	Q5HZI9	S2551_MOUSE	47.4	270	141	1	256	1065	30	298	2.90E-72	273.9	S2551_MOUSE	reviewed	Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51)	Slc25a51 Mcart1	Mus musculus (Mouse)	298	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN1508_c0_g1_i1	Q56A55	MITOS_DANRE	57.4	636	262	3	2041	134	83	709	2.50E-205	716.8	MITOS_DANRE	reviewed	"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)"	abcb8 mitosur zgc:113037	Danio rerio (Zebrafish) (Brachydanio rerio)	714	mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium ion transmembrane transport [GO:0071805]	mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005743; GO:0016887; GO:0042626; GO:0062157; GO:0071805	potassium ion transmembrane transport [GO:0071805]		NA	NA	NA	NA	NA	NA
TRINITY_DN26311_c0_g1_i1	O95202	LETM1_HUMAN	98.5	68	1	0	204	1	372	439	1.80E-30	132.5	LETM1_HUMAN	reviewed	Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1)	LETM1	Homo sapiens (Human)	739	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; cellular metal ion homeostasis [GO:0006875]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	calcium:proton antiporter activity [GO:0015369]; calcium ion binding [GO:0005509]; ribosome binding [GO:0043022]	GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0006875; GO:0015369; GO:0016021; GO:0034214; GO:0042407; GO:0043022; GO:0051260; GO:0051560; GO:0051562; GO:0099093; GO:1900069	calcium export from the mitochondrion [GO:0099093]; cellular metal ion homeostasis [GO:0006875]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]		NA	NA	NA	NA	NA	NA
TRINITY_DN2752_c0_g1_i1	P91927	LETM1_DROME	57.6	118	50	0	927	574	386	503	7.40E-31	136	LETM1_DROME	reviewed	Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1) (dLetm1)	Letm1 anon-60Da CG4589	Drosophila melanogaster (Fruit fly)	1013	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; potassium:proton antiporter activity [GO:0015386]; ribosome binding [GO:0043022]; cellular metal ion homeostasis [GO:0006875]; cellular response to hypoxia [GO:0071456]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion morphogenesis [GO:0070584]; neurotransmitter secretion [GO:0007269]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; presynapse [GO:0098793]	calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; potassium:proton antiporter activity [GO:0015386]; ribosome binding [GO:0043022]	GO:0005432; GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0006875; GO:0007269; GO:0015386; GO:0016021; GO:0031966; GO:0043022; GO:0070584; GO:0071456; GO:0071805; GO:0098793; GO:1902600	cellular metal ion homeostasis [GO:0006875]; cellular response to hypoxia [GO:0071456]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion morphogenesis [GO:0070584]; neurotransmitter secretion [GO:0007269]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN2752_c0_g1_i2	P91927	LETM1_DROME	57.6	118	50	0	928	575	386	503	7.40E-31	136	LETM1_DROME	reviewed	Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1) (dLetm1)	Letm1 anon-60Da CG4589	Drosophila melanogaster (Fruit fly)	1013	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; potassium:proton antiporter activity [GO:0015386]; ribosome binding [GO:0043022]; cellular metal ion homeostasis [GO:0006875]; cellular response to hypoxia [GO:0071456]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion morphogenesis [GO:0070584]; neurotransmitter secretion [GO:0007269]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; presynapse [GO:0098793]	calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; potassium:proton antiporter activity [GO:0015386]; ribosome binding [GO:0043022]	GO:0005432; GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0006875; GO:0007269; GO:0015386; GO:0016021; GO:0031966; GO:0043022; GO:0070584; GO:0071456; GO:0071805; GO:0098793; GO:1902600	cellular metal ion homeostasis [GO:0006875]; cellular response to hypoxia [GO:0071456]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion morphogenesis [GO:0070584]; neurotransmitter secretion [GO:0007269]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN5404_c0_g1_i1	P63030	MPC1_MOUSE	74.1	85	22	0	393	139	18	102	1.60E-31	137.1	MPC1_MOUSE	reviewed	Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein)	Mpc1 Brp44l	Mus musculus (Mouse)	109	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006850; GO:0031305; GO:0061732; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]		NA	NA	NA	NA	NA	NA
TRINITY_DN5404_c0_g1_i2	P63030	MPC1_MOUSE	71.7	99	28	0	435	139	4	102	5.20E-37	155.6	MPC1_MOUSE	reviewed	Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein)	Mpc1 Brp44l	Mus musculus (Mouse)	109	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006850; GO:0031305; GO:0061732; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]		blue	blue	NA	NA	NA	NA
TRINITY_DN5404_c0_g1_i4	P63030	MPC1_MOUSE	77.2	79	18	0	375	139	24	102	5.00E-31	135.6	MPC1_MOUSE	reviewed	Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein)	Mpc1 Brp44l	Mus musculus (Mouse)	109	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006850; GO:0031305; GO:0061732; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]		NA	NA	NA	NA	NA	NA
TRINITY_DN5404_c0_g1_i5	P63030	MPC1_MOUSE	71.7	99	28	0	435	139	4	102	3.90E-37	156	MPC1_MOUSE	reviewed	Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein)	Mpc1 Brp44l	Mus musculus (Mouse)	109	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006850; GO:0031305; GO:0061732; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]		NA	NA	NA	NA	NA	NA
TRINITY_DN5404_c0_g1_i6	P63030	MPC1_MOUSE	71.7	99	28	0	435	139	4	102	3.90E-37	156	MPC1_MOUSE	reviewed	Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein)	Mpc1 Brp44l	Mus musculus (Mouse)	109	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006850; GO:0031305; GO:0061732; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]		NA	NA	NA	NA	NA	NA
TRINITY_DN30452_c0_g1_i1	P63030	MPC1_MOUSE	100	105	0	0	317	3	1	105	4.30E-58	224.9	MPC1_MOUSE	reviewed	Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein)	Mpc1 Brp44l	Mus musculus (Mouse)	109	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006850; GO:0031305; GO:0061732; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]		NA	NA	NA	NA	NA	NA
TRINITY_DN33083_c1_g1_i1	O95563	MPC2_HUMAN	63.7	102	37	0	307	2	9	110	3.30E-33	142.5	MPC2_HUMAN	reviewed	Mitochondrial pyruvate carrier 2 (Brain protein 44)	MPC2 BRP44	Homo sapiens (Human)	127	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; pyruvate transmembrane transporter activity [GO:0050833]	GO:0005634; GO:0005739; GO:0006850; GO:0031305; GO:0035774; GO:0042802; GO:0050833; GO:0061732	mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		blue	blue	NA	NA	NA	NA
TRINITY_DN32745_c0_g1_i1	O49636	MPC4_ARATH	65.3	49	17	0	86	232	12	60	4.60E-14	78.2	MPC4_ARATH	reviewed	Mitochondrial pyruvate carrier 4	MPC4 At4g22310 T10I14_140	Arabidopsis thaliana (Mouse-ear cress)	108	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial pyruvate transmembrane transport [GO:0006850]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0005829; GO:0006850; GO:0016021	mitochondrial pyruvate transmembrane transport [GO:0006850]		NA	NA	NA	NA	NA	NA
TRINITY_DN1122_c0_g1_i1	Q8IMX7	MIRO_DROME	58.4	640	236	7	1942	101	7	642	5.80E-222	771.9	MIRO_DROME	reviewed	Mitochondrial Rho GTPase (Miro) (dMiro) (EC 3.6.5.-)	Miro CG5410	Drosophila melanogaster (Fruit fly)	652	"axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"	axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000226; GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0007005; GO:0010821; GO:0019725; GO:0019896; GO:0031307; GO:0034643; GO:0047497; GO:0048489; GO:0051646; GO:0097345; GO:1904115	"axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1122_c0_g1_i2	Q8IMX7	MIRO_DROME	58.4	640	236	7	1942	101	7	642	3.50E-222	772.7	MIRO_DROME	reviewed	Mitochondrial Rho GTPase (Miro) (dMiro) (EC 3.6.5.-)	Miro CG5410	Drosophila melanogaster (Fruit fly)	652	"axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"	axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000226; GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0007005; GO:0010821; GO:0019725; GO:0019896; GO:0031307; GO:0034643; GO:0047497; GO:0048489; GO:0051646; GO:0097345; GO:1904115	"axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1122_c0_g1_i3	Q8IMX7	MIRO_DROME	57.3	653	236	8	1981	101	7	642	1.70E-219	763.8	MIRO_DROME	reviewed	Mitochondrial Rho GTPase (Miro) (dMiro) (EC 3.6.5.-)	Miro CG5410	Drosophila melanogaster (Fruit fly)	652	"axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"	axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000226; GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0007005; GO:0010821; GO:0019725; GO:0019896; GO:0031307; GO:0034643; GO:0047497; GO:0048489; GO:0051646; GO:0097345; GO:1904115	"axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1122_c0_g1_i4	Q8IMX7	MIRO_DROME	57.3	653	236	8	1981	101	7	642	2.80E-219	763.1	MIRO_DROME	reviewed	Mitochondrial Rho GTPase (Miro) (dMiro) (EC 3.6.5.-)	Miro CG5410	Drosophila melanogaster (Fruit fly)	652	"axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"	axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000226; GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0007005; GO:0010821; GO:0019725; GO:0019896; GO:0031307; GO:0034643; GO:0047497; GO:0048489; GO:0051646; GO:0097345; GO:1904115	"axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; synaptic vesicle transport [GO:0048489]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27833_c0_g1_i1	Q2HJF8	MIRO1_BOVIN	97.8	89	2	0	267	1	3	91	2.60E-40	165.6	MIRO1_BOVIN	reviewed	Mitochondrial Rho GTPase 1 (MIRO-1) (EC 3.6.5.-) (Ras homolog gene family member T1)	RHOT1 ARHT1	Bos taurus (Bovine)	631	integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]	integral component of mitochondrial outer membrane [GO:0031307]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005509; GO:0005525; GO:0007005; GO:0010821; GO:0019725; GO:0031307; GO:0047497; GO:0097345	cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]		NA	NA	NA	NA	NA	NA
TRINITY_DN28892_c0_g1_i1	Q8IXI2	MIRO1_HUMAN	100	86	0	0	3	260	300	385	3.80E-49	194.9	MIRO1_HUMAN	reviewed	Mitochondrial Rho GTPase 1 (MIRO-1) (hMiro-1) (EC 3.6.5.-) (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1)	RHOT1 ARHT1	Homo sapiens (Human)	618	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization by microtubule attachment [GO:0034640]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; protein deubiquitination [GO:0016579]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of organelle transport along microtubule [GO:1902513]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0007005; GO:0010821; GO:0016020; GO:0016579; GO:0019725; GO:0031307; GO:0034640; GO:0046928; GO:0047497; GO:0051056; GO:0097345; GO:1902513	cellular homeostasis [GO:0019725]; establishment of mitochondrion localization by microtubule attachment [GO:0034640]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; protein deubiquitination [GO:0016579]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of organelle transport along microtubule [GO:1902513]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN28897_c0_g1_i1	Q8IXI2	MIRO1_HUMAN	100	67	0	0	202	2	458	524	3.00E-33	141.7	MIRO1_HUMAN	reviewed	Mitochondrial Rho GTPase 1 (MIRO-1) (hMiro-1) (EC 3.6.5.-) (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1)	RHOT1 ARHT1	Homo sapiens (Human)	618	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization by microtubule attachment [GO:0034640]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; protein deubiquitination [GO:0016579]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of organelle transport along microtubule [GO:1902513]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0007005; GO:0010821; GO:0016020; GO:0016579; GO:0019725; GO:0031307; GO:0034640; GO:0046928; GO:0047497; GO:0051056; GO:0097345; GO:1902513	cellular homeostasis [GO:0019725]; establishment of mitochondrion localization by microtubule attachment [GO:0034640]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; protein deubiquitination [GO:0016579]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of organelle transport along microtubule [GO:1902513]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN28297_c0_g1_i1	Q8IXI2	MIRO1_HUMAN	100	122	0	0	367	2	203	324	2.70E-69	262.3	MIRO1_HUMAN	reviewed	Mitochondrial Rho GTPase 1 (MIRO-1) (hMiro-1) (EC 3.6.5.-) (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1)	RHOT1 ARHT1	Homo sapiens (Human)	618	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization by microtubule attachment [GO:0034640]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; protein deubiquitination [GO:0016579]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of organelle transport along microtubule [GO:1902513]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0007005; GO:0010821; GO:0016020; GO:0016579; GO:0019725; GO:0031307; GO:0034640; GO:0046928; GO:0047497; GO:0051056; GO:0097345; GO:1902513	cellular homeostasis [GO:0019725]; establishment of mitochondrion localization by microtubule attachment [GO:0034640]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; protein deubiquitination [GO:0016579]; regulation of mitochondrion organization [GO:0010821]; regulation of neurotransmitter secretion [GO:0046928]; regulation of organelle transport along microtubule [GO:1902513]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN37898_c0_g1_i1	Q8IXI1	MIRO2_HUMAN	100	62	0	0	187	2	250	311	1.40E-31	136.3	MIRO2_HUMAN	reviewed	Mitochondrial Rho GTPase 2 (MIRO-2) (hMiro-2) (EC 3.6.5.-) (Ras homolog gene family member T2)	RHOT2 ARHT2 C16orf39	Homo sapiens (Human)	618	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005509; GO:0005525; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0007005; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0051056; GO:0097345	cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN21295_c0_g1_i1	Q8IXI1	MIRO2_HUMAN	100	201	0	0	35	637	1	201	4.60E-109	395.2	MIRO2_HUMAN	reviewed	Mitochondrial Rho GTPase 2 (MIRO-2) (hMiro-2) (EC 3.6.5.-) (Ras homolog gene family member T2)	RHOT2 ARHT2 C16orf39	Homo sapiens (Human)	618	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005509; GO:0005525; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0007005; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0051056; GO:0097345	cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN6576_c4_g3_i1	Q7JUX9	MRRP1_DROME	41	61	36	0	1	183	157	217	3.20E-08	58.9	MRRP1_DROME	reviewed	Mitochondrial ribonuclease P protein 1 homolog (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C)	trmt10c CG5190	Drosophila melanogaster (Fruit fly)	446	"mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0009019; GO:0030678; GO:0090502; GO:0090646	"mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6576_c4_g3_i2	Q7JUX9	MRRP1_DROME	50.2	215	106	1	1	642	157	371	2.50E-60	233.8	MRRP1_DROME	reviewed	Mitochondrial ribonuclease P protein 1 homolog (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C)	trmt10c CG5190	Drosophila melanogaster (Fruit fly)	446	"mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0009019; GO:0030678; GO:0090502; GO:0090646	"mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9160_c0_g1_i3	Q8R2R6	MTG1_MOUSE	53.8	264	117	2	872	81	16	274	9.10E-80	298.5	MTG1_MOUSE	reviewed	Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1)	Mtg1 Gm169 Gtpbp7	Mus musculus (Mouse)	326	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129	regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]		NA	NA	NA	NA	NA	NA
TRINITY_DN9160_c0_g1_i4	Q8R2R6	MTG1_MOUSE	50.5	309	144	3	992	78	16	319	1.20E-85	318.2	MTG1_MOUSE	reviewed	Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1)	Mtg1 Gm169 Gtpbp7	Mus musculus (Mouse)	326	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129	regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]		NA	NA	NA	NA	NA	NA
TRINITY_DN28707_c0_g1_i1	Q9BT17	MTG1_HUMAN	100	69	0	0	207	1	38	106	5.80E-33	141	MTG1_HUMAN	reviewed	Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1)	MTG1 GTPBP7	Homo sapiens (Human)	334	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129	regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]		NA	NA	NA	NA	NA	NA
TRINITY_DN3659_c0_g1_i1	Q5RDW1	MTG2_PONAB	50.6	330	163	0	1090	101	61	390	8.30E-90	332.4	MTG2_PONAB	reviewed	Mitochondrial ribosome-associated GTPase 2 (GTP-binding protein 5)	MTG2 GTPBP5	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	406	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0003924; GO:0005525; GO:0005743; GO:0005759; GO:0005761; GO:0042254; GO:0044065; GO:0070129	regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN32698_c0_g1_i1	Q4QQT0	RUSD4_RAT	42	269	140	6	881	117	93	359	3.30E-50	201.4	RUSD4_RAT	reviewed	Mitochondrial RNA pseudouridine synthase Rpusd4 (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 4)	Rpusd4	Rattus norvegicus (Rat)	377	mitochondrial matrix [GO:0005759]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; positive regulation of mitochondrial translation [GO:0070131]; tRNA processing [GO:0008033]	mitochondrial matrix [GO:0005759]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000455; GO:0003723; GO:0005759; GO:0008033; GO:0009982; GO:0070131	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; positive regulation of mitochondrial translation [GO:0070131]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g1_i11	P54815	MSP1_CAEEL	40.9	93	54	1	166	444	95	186	7.80E-11	68.6	MSP1_CAEEL	reviewed	Mitochondrial sorting homolog	mspn-1 K04D7.2	Caenorhabditis elegans	342	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005741; GO:0016021; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g1_i18	P54815	MSP1_CAEEL	31.5	124	52	2	166	537	95	185	9.00E-06	52	MSP1_CAEEL	reviewed	Mitochondrial sorting homolog	mspn-1 K04D7.2	Caenorhabditis elegans	342	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005741; GO:0016021; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN38340_c0_g1_i1	Q54BM3	MCFG_DICDI	43.1	65	33	1	193	11	14	78	1.90E-08	59.3	MCFG_DICDI	reviewed	Mitochondrial substrate carrier family protein G (Solute carrier family 25 member 20 homolog A)	mcfG slc25a20A DDB_G0293556	Dictyostelium discoideum (Slime mold)	300	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN37109_c0_g1_i1	Q54DU1	MCFP_DICDI	46.3	67	30	2	239	45	127	189	6.50E-08	57.8	MCFP_DICDI	reviewed	Mitochondrial substrate carrier family protein P (Solute carrier family 25 member 16 homolog A)	mcfP slc25a16A DDB_G0292034	Dictyostelium discoideum (Slime mold)	297	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; coenzyme A transport [GO:0015880]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]	GO:0005347; GO:0005743; GO:0015228; GO:0015880; GO:0016021	coenzyme A transport [GO:0015880]		NA	NA	NA	NA	NA	NA
TRINITY_DN1616_c0_g1_i1	Q9CQF4	MRES1_MOUSE	38.4	112	64	2	612	289	121	231	2.00E-12	74.3	MRES1_MOUSE	reviewed	Mitochondrial transcription rescue factor 1	Mtres1	Mus musculus (Mouse)	240	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; regulation of mitochondrial transcription [GO:1903108]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005759; GO:1903108	regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN1616_c0_g1_i2	Q9CQF4	MRES1_MOUSE	38.4	112	64	2	845	522	121	231	2.60E-12	74.3	MRES1_MOUSE	reviewed	Mitochondrial transcription rescue factor 1	Mtres1	Mus musculus (Mouse)	240	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; regulation of mitochondrial transcription [GO:1903108]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005759; GO:1903108	regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN1616_c0_g1_i6	Q9CQF4	MRES1_MOUSE	38.4	112	64	2	451	128	121	231	1.50E-12	74.3	MRES1_MOUSE	reviewed	Mitochondrial transcription rescue factor 1	Mtres1	Mus musculus (Mouse)	240	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; regulation of mitochondrial transcription [GO:1903108]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005759; GO:1903108	regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN3280_c0_g1_i1	Q8BTW8	CK5P1_MOUSE	57.9	316	125	3	351	1298	54	361	2.40E-104	380.6	CK5P1_MOUSE	reviewed	Mitochondrial tRNA methylthiotransferase CDK5RAP1 (EC 2.8.4.3) (CDK5 activator-binding protein C42) (CDK5 regulatory subunit-associated protein 1) (mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase) (mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase)	Cdk5rap1	Mus musculus (Mouse)	588	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein-containing complex binding [GO:0044877]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein-containing complex binding [GO:0044877]"	GO:0000079; GO:0005739; GO:0005829; GO:0035597; GO:0044877; GO:0045736; GO:0045903; GO:0046872; GO:0051539; GO:0070131; GO:0070900	mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		NA	NA	NA	NA	NA	NA
TRINITY_DN35638_c0_g1_i1	Q96SZ6	CK5P1_HUMAN	100	75	0	0	1	225	196	270	2.00E-35	149.1	CK5P1_HUMAN	reviewed	Mitochondrial tRNA methylthiotransferase CDK5RAP1 (EC 2.8.4.3) (CDK5 activator-binding protein C42) (CDK5 regulatory subunit-associated protein 1) (mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase) (mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase)	CDK5RAP1 C20orf34 CGI-05 HSPC167	Homo sapiens (Human)	601	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]"	GO:0005739; GO:0005829; GO:0007420; GO:0019901; GO:0035597; GO:0044877; GO:0045664; GO:0045736; GO:0045903; GO:0046872; GO:0051539; GO:0070131; GO:0070900	brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664]		NA	NA	NA	NA	NA	NA
TRINITY_DN3009_c0_g1_i4	Q5ZKW0	MTU1_CHICK	51.4	109	41	3	325	5	304	402	1.10E-22	107.8	MTU1_CHICK	reviewed	Mitochondrial tRNA-specific 2-thiouridylase 1 (EC 2.8.1.14)	TRMU MTU1 RCJMB04_8p20	Gallus gallus (Chicken)	424	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA wobble position uridine thiolation [GO:0002143]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]	GO:0000049; GO:0002143; GO:0005524; GO:0005654; GO:0005739; GO:0016783	tRNA wobble position uridine thiolation [GO:0002143]		NA	NA	NA	NA	NA	NA
TRINITY_DN3009_c0_g1_i5	Q5ZKW0	MTU1_CHICK	48.6	142	61	3	424	5	271	402	5.70E-31	135.2	MTU1_CHICK	reviewed	Mitochondrial tRNA-specific 2-thiouridylase 1 (EC 2.8.1.14)	TRMU MTU1 RCJMB04_8p20	Gallus gallus (Chicken)	424	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA wobble position uridine thiolation [GO:0002143]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]	GO:0000049; GO:0002143; GO:0005524; GO:0005654; GO:0005739; GO:0016783	tRNA wobble position uridine thiolation [GO:0002143]		NA	NA	NA	NA	NA	NA
TRINITY_DN29447_c0_g1_i1	Q9N2J1	UCP2_CANLF	100	75	0	0	3	227	235	309	1.10E-37	156.8	UCP2_CANLF	reviewed	Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8)	UCP2 SLC25A8	Canis lupus familiaris (Dog) (Canis familiaris)	309	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial transport [GO:0006839]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0006839; GO:0016021	mitochondrial transport [GO:0006839]		NA	NA	NA	NA	NA	NA
TRINITY_DN37833_c0_g1_i1	P70406	UCP2_MOUSE	100	76	0	0	3	230	234	309	4.40E-39	161.4	UCP2_MOUSE	reviewed	Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8) (UCPH)	Ucp2 Slc25a8	Mus musculus (Mouse)	309	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	oxidative phosphorylation uncoupler activity [GO:0017077]	GO:0000303; GO:0001666; GO:0005737; GO:0005739; GO:0005743; GO:0006839; GO:0007565; GO:0007568; GO:0009409; GO:0010942; GO:0016021; GO:0017077; GO:0032869; GO:0034198; GO:0043066; GO:0051881; GO:0061179; GO:0070542; GO:0071333; GO:0097421; GO:0120162; GO:1990542; GO:1990845	adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303]		NA	NA	NA	NA	NA	NA
TRINITY_DN8148_c0_g1_i1	O95847	UCP4_HUMAN	58.3	288	115	2	872	24	36	323	7.60E-100	365.2	UCP4_HUMAN	reviewed	Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27)	SLC25A27 UCP4 UNQ772/PRO1566	Homo sapiens (Human)	323	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]		GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0016021; GO:0031966; GO:0035356; GO:0043025; GO:0043066; GO:0045177; GO:0046324; GO:0048839; GO:0051562; GO:0070997; GO:1902600	cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]		NA	NA	NA	NA	NA	NA
TRINITY_DN8148_c0_g1_i2	O95847	UCP4_HUMAN	58.9	302	119	2	914	24	22	323	3.90E-105	382.9	UCP4_HUMAN	reviewed	Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27)	SLC25A27 UCP4 UNQ772/PRO1566	Homo sapiens (Human)	323	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]		GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0016021; GO:0031966; GO:0035356; GO:0043025; GO:0043066; GO:0045177; GO:0046324; GO:0048839; GO:0051562; GO:0070997; GO:1902600	cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]		NA	NA	NA	NA	NA	NA
TRINITY_DN9525_c0_g1_i1	Q7K566	BMCP_DROME	60.3	302	109	5	989	102	6	302	1.20E-96	354.8	BMCP_DROME	reviewed	Mitochondrial uncoupling protein Bmcp (Brain mitochondrial carrier protein 1) (Bmcp-1) (Mitochondrial uncoupling protein 5)	Bmcp Ucp5 CG7314	Drosophila melanogaster (Fruit fly)	303	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; regulation of metabolic process [GO:0019222]; sensory perception of sound [GO:0007605]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]	GO:0005347; GO:0005743; GO:0007605; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0019222; GO:0022857; GO:0035435; GO:0071422; GO:0071423	malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; regulation of metabolic process [GO:0019222]; sensory perception of sound [GO:0007605]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]		NA	NA	NA	NA	NA	NA
TRINITY_DN9525_c0_g1_i2	Q7K566	BMCP_DROME	63.8	94	33	1	383	102	210	302	2.20E-28	126.7	BMCP_DROME	reviewed	Mitochondrial uncoupling protein Bmcp (Brain mitochondrial carrier protein 1) (Bmcp-1) (Mitochondrial uncoupling protein 5)	Bmcp Ucp5 CG7314	Drosophila melanogaster (Fruit fly)	303	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; regulation of metabolic process [GO:0019222]; sensory perception of sound [GO:0007605]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]	GO:0005347; GO:0005743; GO:0007605; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0019222; GO:0022857; GO:0035435; GO:0071422; GO:0071423	malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; regulation of metabolic process [GO:0019222]; sensory perception of sound [GO:0007605]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]		NA	NA	NA	NA	NA	NA
TRINITY_DN4079_c0_g1_i1	Q9DC61	MPPA_MOUSE	54.2	522	223	4	1682	123	7	514	1.70E-153	544.3	MPPA_MOUSE	reviewed	Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55)	Pmpca Inpp5e	Mus musculus (Mouse)	524	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]	GO:0004175; GO:0005739; GO:0005743; GO:0005759; GO:0006508; GO:0006627; GO:0046872	protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN40261_c0_g1_i1	Q9DC61	MPPA_MOUSE	100	127	0	0	381	1	138	264	1.40E-68	260	MPPA_MOUSE	reviewed	Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55)	Pmpca Inpp5e	Mus musculus (Mouse)	524	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]	GO:0004175; GO:0005739; GO:0005743; GO:0005759; GO:0006508; GO:0006627; GO:0046872	protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN19963_c0_g1_i1	Q9DC61	MPPA_MOUSE	100	94	0	0	2	283	292	385	1.30E-50	199.9	MPPA_MOUSE	reviewed	Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55)	Pmpca Inpp5e	Mus musculus (Mouse)	524	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]	GO:0004175; GO:0005739; GO:0005743; GO:0005759; GO:0006508; GO:0006627; GO:0046872	protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN19963_c0_g2_i1	Q10713	MPPA_HUMAN	100	167	0	0	1	501	238	404	3.50E-96	352.1	MPPA_HUMAN	reviewed	Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55)	PMPCA INPP5E KIAA0123 MPPA	Homo sapiens (Human)	525	extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]	GO:0005615; GO:0005739; GO:0005743; GO:0005759; GO:0006627; GO:0006851; GO:0046872	mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]		NA	NA	NA	NA	NA	NA
TRINITY_DN4113_c0_g1_i1	Q3SZ71	MPPB_BOVIN	75.6	78	19	0	236	3	51	128	2.60E-28	125.6	MPPB_BOVIN	reviewed	Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP)	PMPCB	Bos taurus (Bovine)	490	mitochondrial processing peptidase complex [GO:0017087]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	mitochondrial processing peptidase complex [GO:0017087]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0006627; GO:0017087; GO:0046872	protein processing involved in protein targeting to mitochondrion [GO:0006627]		blue	blue	NA	NA	NA	NA
TRINITY_DN31561_c0_g1_i1	Q95YL7	HSP70_ENCHE	71.8	124	35	0	1	372	339	462	2.80E-45	182.6	HSP70_ENCHE	reviewed	Mitochondrial-type heat shock protein 70 (mit-hsp70)	HSP70	Encephalitozoon hellem (Microsporidian parasite)	593	nucleus [GO:0005634]; ATP binding [GO:0005524]	nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN22809_c0_g1_i1	Q920G8	MFRN1_MOUSE	99.1	110	1	0	1	330	229	338	1.60E-55	216.5	MFRN1_MOUSE	reviewed	Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37)	Slc25a37 Mfrn Mscp	Mus musculus (Mouse)	338	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	iron ion transmembrane transporter activity [GO:0005381]	GO:0005381; GO:0005739; GO:0005743; GO:0016021; GO:0048250; GO:0055072	iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN22809_c0_g1_i2	Q920G8	MFRN1_MOUSE	96.1	77	3	0	2	232	262	338	1.80E-35	149.4	MFRN1_MOUSE	reviewed	Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37)	Slc25a37 Mfrn Mscp	Mus musculus (Mouse)	338	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	iron ion transmembrane transporter activity [GO:0005381]	GO:0005381; GO:0005739; GO:0005743; GO:0016021; GO:0048250; GO:0055072	iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN697_c0_g1_i1	Q287T7	MFRN1_DANRE	56.1	296	126	3	103	978	22	317	4.90E-94	346.3	MFRN1_DANRE	reviewed	Mitoferrin-1 (Mitochondrial iron transporter 1) (Protein frascati) (Solute carrier family 25 member 37)	slc25a37 frs mfrn	Danio rerio (Zebrafish) (Brachydanio rerio)	332	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; iron ion transmembrane transporter activity [GO:0005381]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; iron ion transmembrane transporter activity [GO:0005381]	GO:0005347; GO:0005381; GO:0005739; GO:0005743; GO:0016021; GO:0035162; GO:0043249; GO:0048250; GO:0048821; GO:0055072	embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN25570_c0_g1_i1	Q96A46	MFRN2_HUMAN	100	149	0	0	450	4	151	299	6.90E-83	307.8	MFRN2_HUMAN	reviewed	Mitoferrin-2 (Mitochondrial RNA-splicing protein 3/4 homolog) (MRS3/4) (hMRS3/4) (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28)	SLC25A28 MFRN2 NPD016	Homo sapiens (Human)	364	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	iron ion transmembrane transporter activity [GO:0005381]	GO:0005381; GO:0005743; GO:0016021; GO:0048250; GO:0055072	iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN36931_c0_g1_i1	O95140	MFN2_HUMAN	100	79	0	0	2	238	182	260	2.70E-41	168.7	MFN2_HUMAN	reviewed	Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2)	MFN2 CPRP1 KIAA0214	Homo sapiens (Human)	757	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0007596; GO:0008053; GO:0016021; GO:0016236; GO:0031306; GO:0031625; GO:0034497; GO:0046580; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461	apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN6257_c0_g1_i1	O95140	MFN2_HUMAN	70.8	144	41	1	429	1	162	305	7.10E-53	208	MFN2_HUMAN	reviewed	Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2)	MFN2 CPRP1 KIAA0214	Homo sapiens (Human)	757	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0007596; GO:0008053; GO:0016021; GO:0016236; GO:0031306; GO:0031625; GO:0034497; GO:0046580; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461	apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN34689_c0_g1_i1	Q84UI5	MPK1_ORYSJ	65.4	133	43	1	3	401	153	282	6.40E-48	191.4	MPK1_ORYSJ	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (EC 2.7.11.24) (MAP kinase 6) (OsMAPK6) (OsSIPK)	MPK1 MAPK6 SIPK Os06g0154500 LOC_Os06g06090 OSJNBa0085L11.14	Oryza sativa subsp. japonica (Rice)	398	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; abscisic acid-activated signaling pathway [GO:0009738]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006952; GO:0009738; GO:0010468; GO:0035556	abscisic acid-activated signaling pathway [GO:0009738]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN13873_c0_g2_i1	P63085	MK01_MOUSE	100	230	0	0	692	3	23	252	4.10E-135	481.9	MK01_MOUSE	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	Mapk1 Erk2 Mapk Prkm1	Mus musculus (Mouse)	358	"axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription, DNA-templated [GO:0006351]"	axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]	GO:0000165; GO:0001784; GO:0003690; GO:0004672; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006351; GO:0006468; GO:0006915; GO:0006974; GO:0007049; GO:0007165; GO:0007166; GO:0007507; GO:0007568; GO:0008134; GO:0008353; GO:0009636; GO:0009887; GO:0010468; GO:0010628; GO:0010759; GO:0010800; GO:0014032; GO:0014069; GO:0015966; GO:0016301; GO:0018105; GO:0018107; GO:0019233; GO:0019858; GO:0019901; GO:0019902; GO:0030278; GO:0030424; GO:0030641; GO:0030878; GO:0031143; GO:0031435; GO:0031647; GO:0031663; GO:0032212; GO:0032496; GO:0032839; GO:0032872; GO:0032991; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0038127; GO:0042307; GO:0042473; GO:0042802; GO:0043204; GO:0043330; GO:0043627; GO:0045596; GO:0045727; GO:0045893; GO:0046697; GO:0048538; GO:0050852; GO:0050853; GO:0051090; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060045; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071310; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0097011; GO:0120041; GO:1903351; GO:1904355; GO:2000641	"aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22937_c0_g1_i1	P28482	MK01_HUMAN	96.8	124	4	0	2	373	237	360	6.00E-65	248.1	MK01_HUMAN	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	MAPK1 ERK2 PRKM1 PRKM2	Homo sapiens (Human)	360	"axon [GO:0030424]; azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; synapse [GO:0045202]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neutrophil degranulation [GO:0043312]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; viral process [GO:0016032]"	axon [GO:0030424]; azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; synapse [GO:0045202]	ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]	GO:0000165; GO:0000186; GO:0000187; GO:0001784; GO:0003690; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006915; GO:0006935; GO:0006974; GO:0007049; GO:0007165; GO:0007166; GO:0007268; GO:0007411; GO:0007568; GO:0007611; GO:0008134; GO:0008353; GO:0008543; GO:0009636; GO:0010468; GO:0010628; GO:0010759; GO:0010800; GO:0014066; GO:0015966; GO:0016032; GO:0016301; GO:0018105; GO:0018107; GO:0019233; GO:0019858; GO:0019902; GO:0030168; GO:0030278; GO:0030424; GO:0030641; GO:0030878; GO:0031143; GO:0031435; GO:0031647; GO:0031663; GO:0032212; GO:0032839; GO:0032872; GO:0032991; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0035578; GO:0038095; GO:0038096; GO:0038127; GO:0042307; GO:0042473; GO:0042802; GO:0043204; GO:0043312; GO:0043330; GO:0043627; GO:0045202; GO:0045596; GO:0045727; GO:0045893; GO:0046697; GO:0048538; GO:0050852; GO:0050853; GO:0051090; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060045; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0097011; GO:0120041; GO:1900034; GO:1903351; GO:1904355; GO:1904813; GO:2000641	"activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neutrophil degranulation [GO:0043312]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13873_c0_g1_i1	P46196	MK01_BOVIN	100	296	0	0	891	4	18	313	2.80E-176	619	MK01_BOVIN	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	MAPK1 ERK2 PRKM1	Bos taurus (Bovine)	360	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0001784; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005901; GO:0006468; GO:0006915; GO:0006974; GO:0007049; GO:0007166; GO:0008353; GO:0010468; GO:0010628; GO:0010759; GO:0010800; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032212; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0038127; GO:0042473; GO:0042802; GO:0043330; GO:0045596; GO:0048538; GO:0050852; GO:0050853; GO:0051403; GO:0051973; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071356; GO:0072686; GO:0097011; GO:0120041; GO:1903351; GO:1904355	apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]		NA	NA	NA	NA	NA	NA
TRINITY_DN25485_c0_g1_i1	P46196	MK01_BOVIN	86.9	344	45	0	116	1147	12	355	1.90E-175	616.7	MK01_BOVIN	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	MAPK1 ERK2 PRKM1	Bos taurus (Bovine)	360	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0001784; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005901; GO:0006468; GO:0006915; GO:0006974; GO:0007049; GO:0007166; GO:0008353; GO:0010468; GO:0010628; GO:0010759; GO:0010800; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032212; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0038127; GO:0042473; GO:0042802; GO:0043330; GO:0045596; GO:0048538; GO:0050852; GO:0050853; GO:0051403; GO:0051973; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071356; GO:0072686; GO:0097011; GO:0120041; GO:1903351; GO:1904355	apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]		blue	blue	NA	NA	NA	NA
TRINITY_DN17574_c0_g1_i1	P46196	MK01_BOVIN	82.1	28	5	0	178	95	12	39	8.90E-06	50.8	MK01_BOVIN	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	MAPK1 ERK2 PRKM1	Bos taurus (Bovine)	360	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0001784; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005901; GO:0006468; GO:0006915; GO:0006974; GO:0007049; GO:0007166; GO:0008353; GO:0010468; GO:0010628; GO:0010759; GO:0010800; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032212; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0038127; GO:0042473; GO:0042802; GO:0043330; GO:0045596; GO:0048538; GO:0050852; GO:0050853; GO:0051403; GO:0051973; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071356; GO:0072686; GO:0097011; GO:0120041; GO:1903351; GO:1904355	apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]		NA	NA	NA	NA	NA	NA
TRINITY_DN39592_c0_g1_i1	Q16539	MK14_HUMAN	100	104	0	0	3	314	204	307	2.60E-52	205.7	MK14_HUMAN	reviewed	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)	MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A	Homo sapiens (Human)	360	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; neutrophil degranulation [GO:0043312]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000187; GO:0000902; GO:0000922; GO:0001502; GO:0001525; GO:0001890; GO:0002062; GO:0002720; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006357; GO:0006915; GO:0006935; GO:0007165; GO:0007166; GO:0007178; GO:0007265; GO:0007519; GO:0010468; GO:0010628; GO:0010759; GO:0010831; GO:0016607; GO:0018105; GO:0019395; GO:0019899; GO:0019903; GO:0030278; GO:0030316; GO:0031281; GO:0031663; GO:0032495; GO:0032735; GO:0034774; GO:0035331; GO:0035556; GO:0035924; GO:0035994; GO:0038066; GO:0042307; GO:0042770; GO:0043312; GO:0045648; GO:0045663; GO:0045944; GO:0046326; GO:0048010; GO:0048273; GO:0051090; GO:0051146; GO:0051149; GO:0051525; GO:0060045; GO:0070935; GO:0071222; GO:0071223; GO:0071356; GO:0071479; GO:0090090; GO:0090336; GO:0090400; GO:0098586; GO:1900015; GO:1901741; GO:1901796; GO:1904813; GO:1905050; GO:2000379	3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; neutrophil degranulation [GO:0043312]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN859_c0_g1_i1	P47812	MK14_XENLA	75.6	353	85	1	1170	112	9	360	1.10E-154	547.7	MK14_XENLA	reviewed	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MPK2)	mapk14 mpk2	Xenopus laevis (African clawed frog)	361	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357]		ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0006357; GO:0010831; GO:0035556; GO:0038066; GO:0045663; GO:1901741	intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN859_c0_g1_i3	P47812	MK14_XENLA	75.1	353	87	1	1170	112	9	360	3.00E-155	549.7	MK14_XENLA	reviewed	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MPK2)	mapk14 mpk2	Xenopus laevis (African clawed frog)	361	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357]		ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0006357; GO:0010831; GO:0035556; GO:0038066; GO:0045663; GO:1901741	intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN39319_c0_g1_i1	Q95NE7	MK14_PANTR	100	91	0	0	274	2	140	230	4.20E-51	201.4	MK14_PANTR	reviewed	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a)	MAPK14 CSBP1	Pan troglodytes (Chimpanzee)	360	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006915; GO:0010468; GO:0010831; GO:0035556; GO:0038066; GO:0045663; GO:1901741	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN859_c0_g1_i2	Q90336	MK14A_CYPCA	77.2	259	59	0	821	45	6	264	1.90E-116	420.2	MK14A_CYPCA	reviewed	Mitogen-activated protein kinase 14A (MAP kinase 14A) (MAPK 14A) (EC 2.7.11.24) (Mitogen-activated protein kinase p38a) (MAP kinase p38a) (cp38a)	mapk14a	Cyprinus carpio (Common carp)	361	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0010831; GO:0035556; GO:0038066; GO:0045663; GO:1901741	intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32969_c0_g1_i1	Q501Q9	MK15_XENLA	59.6	250	95	3	798	49	109	352	1.60E-79	297.4	MK15_XENLA	reviewed	Mitogen-activated protein kinase 15 (EC 2.7.11.24)	mapk15	Xenopus laevis (African clawed frog)	586	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; regulation of cilium assembly [GO:1902017]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005737; GO:0005911; GO:0005929; GO:0035253; GO:0036064; GO:1902017	regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN28251_c0_g1_i1	Q63844	MK03_MOUSE	100	71	0	0	1	213	310	380	1.00E-35	150.2	MK03_MOUSE	reviewed	Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1)	Mapk3 Erk1 Prkm3	Mus musculus (Mouse)	380	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription, DNA-templated [GO:0006351]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0001784; GO:0001934; GO:0002720; GO:0004672; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006351; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0007049; GO:0007165; GO:0007166; GO:0007568; GO:0009636; GO:0009887; GO:0010468; GO:0010628; GO:0010759; GO:0014032; GO:0016310; GO:0018105; GO:0019233; GO:0019369; GO:0019902; GO:0030278; GO:0030509; GO:0030641; GO:0030878; GO:0031143; GO:0031281; GO:0031663; GO:0032212; GO:0032496; GO:0032872; GO:0032991; GO:0033129; GO:0034198; GO:0034614; GO:0035066; GO:0035556; GO:0038083; GO:0042473; GO:0042802; GO:0043330; GO:0045727; GO:0045944; GO:0046697; GO:0048538; GO:0051090; GO:0051216; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060324; GO:0060425; GO:0060440; GO:0061308; GO:0065003; GO:0070371; GO:0070374; GO:0070498; GO:0070849; GO:0071260; GO:0071276; GO:0071356; GO:0072584; GO:0090170; GO:0097110; GO:0120041; GO:1903351; GO:1904355; GO:1904417; GO:1905050; GO:2000641; GO:2000657	"aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein-containing complex assembly [GO:0065003]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39349_c0_g1_i1	A9S9Q8	MPK4B_PHYPA	62.3	146	52	1	442	5	121	263	9.90E-50	197.6	MPK4B_PHYPA	reviewed	Mitogen-activated protein kinase 4b (EC 2.7.11.24) (MAP kinase 4b) (PpMPK4b)	MPK4b PHYPADRAFT_126277	Physcomitrium patens (Spreading-leaved earth moss) (Physcomitrella patens)	380	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]		ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0002221; GO:0004707; GO:0005524; GO:0045087	innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]		NA	NA	NA	NA	NA	NA
TRINITY_DN34400_c0_g1_i1	A2XFC8	MPK5_ORYSI	59.6	136	50	2	411	4	120	250	3.40E-44	179.1	MPK5_ORYSI	reviewed	Mitogen-activated protein kinase 5 (MAP kinase 5) (EC 2.7.11.24) (Benzothiadiazole-induced MAP kinase 1) (MAP kinase 2) (Multiple stress-responsive MAP kinase 2) (OsBIMK1) (OsMAP1) (OsMAPK2) (OsMAPK5) (OsMPK3) (OsMSRMK2)	MPK5 BIMK1 MAPK2 MAPK5 MPK3 MSRMK2 OsI_010771	Oryza sativa subsp. indica (Rice)	369	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; defense response [GO:0006952]		ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0006952	defense response [GO:0006952]		NA	NA	NA	NA	NA	NA
TRINITY_DN27309_c0_g1_i1	Q61532	MK06_MOUSE	100	133	0	0	400	2	118	250	2.00E-73	276.2	MK06_MOUSE	reviewed	Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3)	Mapk6 Erk3 Prkm4 Prkm6	Mus musculus (Mouse)	720	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]	GO:0004672; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0010468; GO:0019901; GO:0032156; GO:0032991; GO:0035556; GO:0046982; GO:0060999	cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN40479_c0_g1_i1	Q39027	MPK7_ARATH	60	150	56	1	453	4	102	247	8.20E-52	204.5	MPK7_ARATH	reviewed	Mitogen-activated protein kinase 7 (AtMPK7) (MAP kinase 7) (EC 2.7.11.24)	MPK7 At2g18170 F8D23	Arabidopsis thaliana (Mouse-ear cress)	368	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; regulation of gene expression [GO:0010468]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006952; GO:0010468; GO:0035556; GO:0042542	defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; regulation of gene expression [GO:0010468]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN26449_c0_g1_i1	Q9WVS8	MK07_MOUSE	100	100	0	0	302	3	123	222	1.30E-53	209.9	MK07_MOUSE	reviewed	Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5)	Mapk7 Bmk1 Erk5	Mus musculus (Mouse)	806	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK5 cascade [GO:0070377]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0010468; GO:0016605; GO:0018105; GO:0030154; GO:0034115; GO:0035556; GO:0036003; GO:0043066; GO:0043407; GO:0045765; GO:0045944; GO:0051019; GO:0051247; GO:0060761; GO:0070301; GO:0070377; GO:0070885; GO:0071363; GO:0071499; GO:0071560; GO:1902176; GO:2000352; GO:2001240	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK5 cascade [GO:0070377]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN30366_c1_g1_i1	P45983	MK08_HUMAN	100	117	0	0	351	1	15	131	2.60E-61	235.7	MK08_HUMAN	reviewed	Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1)	MAPK8 JNK1 PRKM8 SAPK1 SAPK1C	Homo sapiens (Human)	427	axon [GO:0030424]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; JUN kinase activity [GO:0004705]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cyclase activity [GO:0031281]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein metabolic process [GO:0051247]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; stress-activated MAPK cascade [GO:0051403]	axon [GO:0030424]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; JUN kinase activity [GO:0004705]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004705; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0009411; GO:0009612; GO:0010468; GO:0010628; GO:0016241; GO:0016301; GO:0018105; GO:0018107; GO:0019899; GO:0030424; GO:0031281; GO:0032091; GO:0032880; GO:0034198; GO:0034614; GO:0035033; GO:0035556; GO:0038095; GO:0042752; GO:0042826; GO:0043065; GO:0043066; GO:0045202; GO:0048511; GO:0051090; GO:0051247; GO:0051403; GO:0071222; GO:0071260; GO:0071276; GO:0071345; GO:0090045; GO:0097441; GO:1900740; GO:1902595	cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cyclase activity [GO:0031281]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein metabolic process [GO:0051247]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of DNA replication origin binding [GO:1902595]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; stress-activated MAPK cascade [GO:0051403]		NA	NA	NA	NA	NA	NA
TRINITY_DN25394_c0_g1_i1	P45984	MK09_HUMAN	100	167	0	0	2	502	77	243	3.00E-95	349	MK09_HUMAN	reviewed	Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)	MAPK9 JNK2 PRKM9 SAPK1A	Homo sapiens (Human)	424	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription factor binding [GO:0008134]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription factor binding [GO:0008134]	GO:0004705; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0007254; GO:0008134; GO:0010468; GO:0010628; GO:0010744; GO:0018105; GO:0031398; GO:0034614; GO:0035556; GO:0038095; GO:0042752; GO:0048511; GO:0051090; GO:0061833; GO:0071276; GO:0071803; GO:1901485; GO:2001235	cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN30366_c0_g1_i1	P45984	MK09_HUMAN	98.8	84	1	0	1	252	88	171	7.30E-42	170.6	MK09_HUMAN	reviewed	Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)	MAPK9 JNK2 PRKM9 SAPK1A	Homo sapiens (Human)	424	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription factor binding [GO:0008134]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription factor binding [GO:0008134]	GO:0004705; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0007254; GO:0008134; GO:0010468; GO:0010628; GO:0010744; GO:0018105; GO:0031398; GO:0034614; GO:0035556; GO:0038095; GO:0042752; GO:0048511; GO:0051090; GO:0061833; GO:0071276; GO:0071803; GO:1901485; GO:2001235	cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN15232_c0_g1_i1	P40417	ERKA_DROME	58.1	43	18	0	185	57	143	185	9.30E-09	60.5	ERKA_DROME	reviewed	Mitogen-activated protein kinase ERK-A (EC 2.7.11.24) (Extracellular-regulated kinase A) (Protein rolled)	rl ERKa MAPK CG12559	Drosophila melanogaster (Fruit fly)	376	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; behavioral response to ethanol [GO:0048149]; branching involved in open tracheal system development [GO:0060446]; cell surface receptor signaling pathway [GO:0007166]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; MAPK cascade [GO:0000165]; metamorphosis [GO:0007552]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of macroautophagy [GO:0016242]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of wound healing [GO:0090303]; R7 cell fate commitment [GO:0007465]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of response to drug [GO:2001023]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; tracheal pit formation in open tracheal system [GO:0035202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]	GO:0000165; GO:0000278; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007173; GO:0007362; GO:0007430; GO:0007465; GO:0007474; GO:0007476; GO:0007479; GO:0007552; GO:0008134; GO:0008284; GO:0008286; GO:0008293; GO:0008340; GO:0008543; GO:0009267; GO:0010468; GO:0016242; GO:0019901; GO:0031594; GO:0034614; GO:0035169; GO:0035170; GO:0035202; GO:0035556; GO:0045500; GO:0045793; GO:0046534; GO:0046843; GO:0048010; GO:0048149; GO:0050804; GO:0051091; GO:0051607; GO:0060446; GO:0070371; GO:0071243; GO:0071276; GO:0090303; GO:2000826; GO:2001023	"behavioral response to ethanol [GO:0048149]; branching involved in open tracheal system development [GO:0060446]; cell surface receptor signaling pathway [GO:0007166]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; MAPK cascade [GO:0000165]; metamorphosis [GO:0007552]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of macroautophagy [GO:0016242]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of wound healing [GO:0090303]; R7 cell fate commitment [GO:0007465]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of response to drug [GO:2001023]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; tracheal pit formation in open tracheal system [GO:0035202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36800_c0_g1_i1	Q07176	MMK1_MEDSA	56.9	116	50	0	354	7	164	279	2.00E-38	159.8	MMK1_MEDSA	reviewed	Mitogen-activated protein kinase homolog MMK1 (EC 2.7.11.24) (MAP kinase ERK1) (MAP kinase MSK7)	MMK1 ERK1 MSK7	Medicago sativa (Alfalfa)	387	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; cell cycle [GO:0007049]; cell division [GO:0051301]; conjugation [GO:0000746]		ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0000746; GO:0004707; GO:0005524; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; conjugation [GO:0000746]		NA	NA	NA	NA	NA	NA
TRINITY_DN37719_c0_g1_i1	P53349	M3K1_MOUSE	41.5	212	120	4	634	2	643	851	5.50E-38	159.1	M3K1_MOUSE	reviewed	Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)	Map3k1 Mekk Mekk1	Mus musculus (Mouse)	1493	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JUN kinase activity [GO:0007257]; apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of actin filament polymerization [GO:0030838]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]	ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0007179; GO:0007254; GO:0007257; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0016020; GO:0019901; GO:0030054; GO:0030334; GO:0030838; GO:0031434; GO:0031941; GO:0042060; GO:0043010; GO:0044877; GO:0046625; GO:0051019; GO:0061029	activation of JUN kinase activity [GO:0007257]; apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of actin filament polymerization [GO:0030838]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN2749_c0_g1_i1	Q6ZN16	M3K15_HUMAN	51.1	270	128	3	1	810	266	531	1.00E-74	281.6	M3K15_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15)	MAP3K15 ASK3	Homo sapiens (Human)	1313	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]		ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]	GO:0000186; GO:0004672; GO:0004709; GO:0005524; GO:0046872	activation of MAPKK activity [GO:0000186]		NA	NA	NA	NA	NA	NA
TRINITY_DN2749_c0_g1_i2	Q6ZN16	M3K15_HUMAN	50.4	359	165	5	1	1077	266	611	2.30E-100	367.1	M3K15_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15)	MAP3K15 ASK3	Homo sapiens (Human)	1313	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]		ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]	GO:0000186; GO:0004672; GO:0004709; GO:0005524; GO:0046872	activation of MAPKK activity [GO:0000186]		NA	NA	NA	NA	NA	NA
TRINITY_DN4484_c0_g1_i3	Q9Y6R4	M3K4_HUMAN	58.2	263	103	4	879	100	1350	1608	4.30E-87	322.8	M3K4_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)	MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1	Homo sapiens (Human)	1608	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]	GO:0000186; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355	activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]		NA	NA	NA	NA	NA	NA
TRINITY_DN4484_c0_g1_i12	O08648	M3K4_MOUSE	34.1	1117	611	21	3147	76	510	1594	1.70E-162	575.1	M3K4_MOUSE	reviewed	Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)	Map3k4 Mekk4	Mus musculus (Mouse)	1597	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]	GO:0000186; GO:0001890; GO:0004672; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355	activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]		blue	blue	NA	NA	NA	NA
TRINITY_DN4484_c0_g1_i2	O08648	M3K4_MOUSE	34.1	1120	613	21	3180	100	510	1597	1.50E-163	578.6	M3K4_MOUSE	reviewed	Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)	Map3k4 Mekk4	Mus musculus (Mouse)	1597	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]	GO:0000186; GO:0001890; GO:0004672; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355	activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]		NA	NA	NA	NA	NA	NA
TRINITY_DN4484_c0_g1_i8	O08648	M3K4_MOUSE	38.3	622	300	12	1731	100	982	1597	7.40E-112	406	M3K4_MOUSE	reviewed	Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)	Map3k4 Mekk4	Mus musculus (Mouse)	1597	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]	GO:0000186; GO:0001890; GO:0004672; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355	activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]		NA	NA	NA	NA	NA	NA
TRINITY_DN4484_c0_g1_i9	O08648	M3K4_MOUSE	28.7	919	537	17	2536	50	510	1400	1.10E-92	342.8	M3K4_MOUSE	reviewed	Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)	Map3k4 Mekk4	Mus musculus (Mouse)	1597	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]	GO:0000186; GO:0001890; GO:0004672; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048263; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355	activation of MAPKK activity [GO:0000186]; chorionic trophoblast cell differentiation [GO:0060718]; determination of dorsal identity [GO:0048263]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]		NA	NA	NA	NA	NA	NA
TRINITY_DN10949_c0_g1_i1	Q99683	M3K5_HUMAN	73.3	247	63	1	746	6	665	908	2.70E-108	392.9	M3K5_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5)	MAP3K5 ASK1 MAPKKK5 MEKK5	Homo sapiens (Human)	1374	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein-containing complex [GO:0032991]; protein kinase complex [GO:1902911]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0000186; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007254; GO:0007257; GO:0008631; GO:0009897; GO:0010666; GO:0016032; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042802; GO:0042803; GO:0043065; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0097190; GO:0097300; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604	"activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34666_c0_g1_i1	Q99683	M3K5_HUMAN	100	68	0	0	3	206	836	903	8.30E-36	150.2	M3K5_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5)	MAP3K5 ASK1 MAPKKK5 MEKK5	Homo sapiens (Human)	1374	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein-containing complex [GO:0032991]; protein kinase complex [GO:1902911]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0000186; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007254; GO:0007257; GO:0008631; GO:0009897; GO:0010666; GO:0016032; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042802; GO:0042803; GO:0043065; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0097190; GO:0097300; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604	"activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32459_c0_g1_i1	A2VDU3	M3K7_BOVIN	100	71	0	0	215	3	121	191	9.30E-38	156.8	M3K7_BOVIN	reviewed	Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25)	MAP3K7	Bos taurus (Bovine)	579	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]	GO:0000287; GO:0004709; GO:0005524; GO:0005737; GO:0005886; GO:0006915; GO:0007252; GO:0007254; GO:0043123; GO:0043507	apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]		NA	NA	NA	NA	NA	NA
TRINITY_DN26699_c0_g1_i2	A2VDU3	M3K7_BOVIN	56.3	286	121	3	1037	186	18	301	1.60E-93	344.4	M3K7_BOVIN	reviewed	Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25)	MAP3K7	Bos taurus (Bovine)	579	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]	GO:0000287; GO:0004709; GO:0005524; GO:0005737; GO:0005886; GO:0006915; GO:0007252; GO:0007254; GO:0043123; GO:0043507	apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]		NA	NA	NA	NA	NA	NA
TRINITY_DN26699_c0_g1_i3	A2VDU3	M3K7_BOVIN	50	140	67	2	493	77	18	155	7.40E-34	145.2	M3K7_BOVIN	reviewed	Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25)	MAP3K7	Bos taurus (Bovine)	579	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]	GO:0000287; GO:0004709; GO:0005524; GO:0005737; GO:0005886; GO:0006915; GO:0007252; GO:0007254; GO:0043123; GO:0043507	apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]		NA	NA	NA	NA	NA	NA
TRINITY_DN28789_c0_g1_i1	Q54R82	MKKA_DICDI	47.1	121	60	2	2	358	281	399	3.30E-27	122.5	MKKA_DICDI	reviewed	Mitogen-activated protein kinase kinase kinase A (EC 2.7.11.25) (MAPK/ERK kinase 1) (MEK kinase 1) (MEKK 1) (MAPK/ERK kinase A) (MEK kinase A) (MEKK A) (MEKKalpha)	mkkA DDB_G0283265	Dictyostelium discoideum (Slime mold)	942	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; sorocarp development [GO:0030587]; sporulation resulting in formation of a cellular spore [GO:0030435]	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]	GO:0004709; GO:0005524; GO:0005938; GO:0009653; GO:0016021; GO:0030435; GO:0030587; GO:0046872	anatomical structure morphogenesis [GO:0009653]; sorocarp development [GO:0030587]; sporulation resulting in formation of a cellular spore [GO:0030435]		NA	NA	NA	NA	NA	NA
TRINITY_DN30468_c0_g1_i1	Q54R82	MKKA_DICDI	46.4	151	71	4	450	1	253	394	1.00E-33	144.4	MKKA_DICDI	reviewed	Mitogen-activated protein kinase kinase kinase A (EC 2.7.11.25) (MAPK/ERK kinase 1) (MEK kinase 1) (MEKK 1) (MAPK/ERK kinase A) (MEK kinase A) (MEKK A) (MEKKalpha)	mkkA DDB_G0283265	Dictyostelium discoideum (Slime mold)	942	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; sorocarp development [GO:0030587]; sporulation resulting in formation of a cellular spore [GO:0030435]	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]	GO:0004709; GO:0005524; GO:0005938; GO:0009653; GO:0016021; GO:0030435; GO:0030587; GO:0046872	anatomical structure morphogenesis [GO:0009653]; sorocarp development [GO:0030587]; sporulation resulting in formation of a cellular spore [GO:0030435]		NA	NA	NA	NA	NA	NA
TRINITY_DN34142_c0_g1_i1	Q92918	M4K1_HUMAN	100	77	0	0	1	231	487	563	2.20E-40	165.6	M4K1_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1)	MAP4K1 HPK1	Homo sapiens (Human)	833	membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	membrane [GO:0016020]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000185; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007257; GO:0008283; GO:0008349; GO:0016020; GO:0018105; GO:0046777; GO:1904628	activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN30608_c0_g1_i1	Q92918	M4K1_HUMAN	100	250	0	0	3	752	48	297	3.40E-143	508.8	M4K1_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1)	MAP4K1 HPK1	Homo sapiens (Human)	833	membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	membrane [GO:0016020]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000185; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007257; GO:0008283; GO:0008349; GO:0016020; GO:0018105; GO:0046777; GO:1904628	activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN12080_c0_g1_i1	Q12851	M4K2_HUMAN	100	215	0	0	647	3	6	220	4.70E-125	448.4	M4K2_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein)	MAP4K2 GCK RAB8IP	Homo sapiens (Human)	820	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0006468; GO:0006903; GO:0006955; GO:0007254; GO:0007257; GO:0008349; GO:0016323; GO:0031435; GO:0035556; GO:0045087; GO:0046330	activation of JUN kinase activity [GO:0007257]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]		NA	NA	NA	NA	NA	NA
TRINITY_DN12080_c0_g1_i2	Q12851	M4K2_HUMAN	83.1	260	0	1	649	2	6	265	3.30E-118	425.6	M4K2_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein)	MAP4K2 GCK RAB8IP	Homo sapiens (Human)	820	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0006468; GO:0006903; GO:0006955; GO:0007254; GO:0007257; GO:0008349; GO:0016323; GO:0031435; GO:0035556; GO:0045087; GO:0046330	activation of JUN kinase activity [GO:0007257]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]		NA	NA	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i1	Q12851	M4K2_HUMAN	58.1	43	18	0	68	196	99	141	2.70E-08	59.3	M4K2_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein)	MAP4K2 GCK RAB8IP	Homo sapiens (Human)	820	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0006468; GO:0006903; GO:0006955; GO:0007254; GO:0007257; GO:0008349; GO:0016323; GO:0031435; GO:0035556; GO:0045087; GO:0046330	activation of JUN kinase activity [GO:0007257]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]		NA	NA	NA	NA	NA	NA
TRINITY_DN33538_c0_g1_i1	Q8IVH8	M4K3_HUMAN	62.7	126	44	1	383	6	522	644	1.50E-41	170.2	M4K3_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	MAP4K3 RAB8IPL1	Homo sapiens (Human)	894	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		blue	blue	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i2	Q924I2	M4K3_RAT	69.2	247	76	0	68	808	99	345	3.70E-95	349.7	M4K3_RAT	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	Map4k3	Rattus norvegicus (Rat)	873	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]	GO:0004674; GO:0005524; GO:0006468; GO:0008349; GO:0009411; GO:0017124; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i3	Q8IVH8	M4K3_HUMAN	75.1	313	78	0	1	939	19	331	8.00E-140	498	M4K3_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	MAP4K3 RAB8IPL1	Homo sapiens (Human)	894	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i4	Q8IVH8	M4K3_HUMAN	73.7	327	86	0	1	981	19	345	1.60E-142	507.3	M4K3_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	MAP4K3 RAB8IPL1	Homo sapiens (Human)	894	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i5	Q8IVH8	M4K3_HUMAN	78.9	123	26	0	1	369	19	141	2.80E-55	216.1	M4K3_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	MAP4K3 RAB8IPL1	Homo sapiens (Human)	894	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i7	Q8IVH8	M4K3_HUMAN	73.7	327	86	0	1	981	19	345	2.60E-142	507.3	M4K3_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	MAP4K3 RAB8IPL1	Homo sapiens (Human)	894	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN393_c0_g1_i9	Q924I2	M4K3_RAT	69.2	247	76	0	68	808	99	345	6.30E-95	349.7	M4K3_RAT	reviewed	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	Map4k3	Rattus norvegicus (Rat)	873	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]	GO:0004674; GO:0005524; GO:0006468; GO:0008349; GO:0009411; GO:0017124; GO:0034612; GO:0035556	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN3025_c0_g1_i4	O95819	M4K4_HUMAN	60	45	17	1	225	91	893	936	1.20E-08	60.5	M4K4_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)	MAP4K4 HGK KIAA0687 NIK	Homo sapiens (Human)	1239	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0023014; GO:0030335; GO:0031098; GO:0032014; GO:0032147; GO:0035556; GO:0043066; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0120183	activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	x	brown	brown	NA	NA	NA	NA
TRINITY_DN3025_c0_g1_i5	P97820	M4K4_MOUSE	70.9	172	48	2	545	30	887	1056	4.90E-68	258.8	M4K4_MOUSE	reviewed	Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)	Map4k4 Nik	Mus musculus (Mouse)	1233	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron projection regeneration [GO:0070571]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0010977; GO:0023014; GO:0030335; GO:0031098; GO:0032014; GO:0032147; GO:0035556; GO:0043066; GO:0043547; GO:0046328; GO:0046330; GO:0048812; GO:0051549; GO:0051894; GO:0061179; GO:0070571; GO:0120183	activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron projection regeneration [GO:0070571]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN17914_c0_g1_i1	O95819	M4K4_HUMAN	100	103	0	0	1	309	1117	1219	8.40E-56	217.2	M4K4_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)	MAP4K4 HGK KIAA0687 NIK	Homo sapiens (Human)	1239	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0023014; GO:0030335; GO:0031098; GO:0032014; GO:0032147; GO:0035556; GO:0043066; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0120183	activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN17914_c0_g1_i2	O95819	M4K4_HUMAN	100	142	0	0	3	428	1078	1219	3.00E-80	298.9	M4K4_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)	MAP4K4 HGK KIAA0687 NIK	Homo sapiens (Human)	1239	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0023014; GO:0030335; GO:0031098; GO:0032014; GO:0032147; GO:0035556; GO:0043066; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0120183	activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN39443_c0_g1_i1	O95819	M4K4_HUMAN	100	163	0	0	2	490	119	281	1.70E-95	349.7	M4K4_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)	MAP4K4 HGK KIAA0687 NIK	Homo sapiens (Human)	1239	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0023014; GO:0030335; GO:0031098; GO:0032014; GO:0032147; GO:0035556; GO:0043066; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0120183	activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN37480_c0_g1_i1	Q9Y4K4	M4K5_HUMAN	100	139	0	0	418	2	69	207	3.00E-80	298.9	M4K5_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5)	MAP4K5	Homo sapiens (Human)	846	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007257; GO:0008349; GO:0035556	activation of JUN kinase activity [GO:0007257]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN9541_c0_g1_i1	A0A0K3AV08	MLK1_CAEEL	26.4	110	62	1	373	101	281	390	1.20E-05	51.6	MLK1_CAEEL	reviewed	Mitogen-activated protein kinase kinase kinase mlk-1 (EC 2.7.11.25) (Mixed lineage kinase homolog 1)	mlk-1 K11D12.10	Caenorhabditis elegans	1059	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; axon regeneration [GO:0031103]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; p38MAPK cascade [GO:0038066]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to copper ion [GO:0046688]; response to starvation [GO:0042594]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0000187; GO:0001934; GO:0004672; GO:0004709; GO:0005080; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0008340; GO:0019901; GO:0030971; GO:0031103; GO:0038066; GO:0042594; GO:0046688; GO:0046872; GO:0048680; GO:0048691; GO:0050829; GO:0097110	activation of MAPK activity [GO:0000187]; axon regeneration [GO:0031103]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; p38MAPK cascade [GO:0038066]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; response to copper ion [GO:0046688]; response to starvation [GO:0042594]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN859_c0_g1_i4	O62618	MK38A_DROME	63.9	36	13	0	149	42	233	268	3.20E-05	48.9	MK38A_DROME	reviewed	Mitogen-activated protein kinase p38a (MAP kinase p38a) (MAPK p38a) (EC 2.7.11.24) (MAP kinase 14A) (p38 MAPK)	p38a Mpk2 CG5475	Drosophila melanogaster (Fruit fly)	366	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; heart morphogenesis [GO:0003007]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mucosal immune response [GO:0002385]; negative regulation of antimicrobial humoral response [GO:0008348]; paracrine signaling [GO:0038001]; positive regulation of cell size [GO:0045793]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to osmotic stress [GO:0006970]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]	GO:0000165; GO:0002385; GO:0003007; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006955; GO:0006970; GO:0006979; GO:0008340; GO:0008348; GO:0009408; GO:0010468; GO:0034614; GO:0035556; GO:0038001; GO:0042542; GO:0042594; GO:0042742; GO:0045793; GO:0048082; GO:0050832; GO:0071243; GO:0071276; GO:1900407	cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; heart morphogenesis [GO:0003007]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mucosal immune response [GO:0002385]; negative regulation of antimicrobial humoral response [GO:0008348]; paracrine signaling [GO:0038001]; positive regulation of cell size [GO:0045793]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to osmotic stress [GO:0006970]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN1436_c0_g1_i1	Q6DFF9	MABP1_XENLA	57.5	725	302	3	2975	807	33	753	1.30E-257	891	MABP1_XENLA	reviewed	Mitogen-activated protein kinase-binding protein 1	mapkbp1	Xenopus laevis (African clawed frog)	1580							NA	NA	NA	NA	NA	NA
TRINITY_DN27730_c0_g1_i1	Q1JQB2	BUB3_BOVIN	100	138	0	0	2	415	168	305	3.00E-77	288.9	BUB3_BOVIN	reviewed	Mitotic checkpoint protein BUB3	BUB3	Bos taurus (Bovine)	326	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; ubiquitin binding [GO:0043130]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]	ubiquitin binding [GO:0043130]	GO:0000070; GO:0000776; GO:0000777; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]		NA	NA	NA	NA	NA	NA
TRINITY_DN19222_c0_g1_i1	Q1JQB2	BUB3_BOVIN	100	326	0	0	1012	35	1	326	3.30E-197	688.7	BUB3_BOVIN	reviewed	Mitotic checkpoint protein BUB3	BUB3	Bos taurus (Bovine)	326	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; ubiquitin binding [GO:0043130]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]	ubiquitin binding [GO:0043130]	GO:0000070; GO:0000776; GO:0000777; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]		NA	NA	NA	NA	NA	NA
TRINITY_DN9910_c0_g1_i1	Q9YGY3	BUB3_XENLA	73.1	320	85	1	1046	87	12	330	1.60E-144	513.8	BUB3_XENLA	reviewed	Mitotic checkpoint protein BUB3 (xbub3) (WD repeat protein Bub3)	bub3	Xenopus laevis (African clawed frog)	330	condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]	condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]		GO:0000777; GO:0005634; GO:0007059; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN9910_c0_g1_i2	Q9YGY3	BUB3_XENLA	73.1	320	85	1	1046	87	12	330	1.70E-144	513.8	BUB3_XENLA	reviewed	Mitotic checkpoint protein BUB3 (xbub3) (WD repeat protein Bub3)	bub3	Xenopus laevis (African clawed frog)	330	condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]	condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]		GO:0000777; GO:0005634; GO:0007059; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN439_c0_g1_i2	Q9Z1S0	BUB1B_MOUSE	33.6	423	247	15	4266	3073	11	424	2.70E-51	206.1	BUB1B_MOUSE	reviewed	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (BubR1) (Mitotic checkpoint kinase MAD3L)	Bub1b Mad3l	Mus musculus (Mouse)	1052	"condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]"	condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000776; GO:0000777; GO:0000778; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0005829; GO:0006915; GO:0007091; GO:0007094; GO:0048471; GO:0051301; GO:0051754; GO:0071459	"apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN439_c0_g1_i6	Q9Z1S0	BUB1B_MOUSE	33.6	423	247	15	4125	2932	11	424	2.60E-51	206.1	BUB1B_MOUSE	reviewed	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (BubR1) (Mitotic checkpoint kinase MAD3L)	Bub1b Mad3l	Mus musculus (Mouse)	1052	"condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]"	condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000776; GO:0000777; GO:0000778; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0005829; GO:0006915; GO:0007091; GO:0007094; GO:0048471; GO:0051301; GO:0051754; GO:0071459	"apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN439_c0_g1_i7	Q9Z1S0	BUB1B_MOUSE	33.6	423	247	15	4224	3031	11	424	2.70E-51	206.1	BUB1B_MOUSE	reviewed	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (BubR1) (Mitotic checkpoint kinase MAD3L)	Bub1b Mad3l	Mus musculus (Mouse)	1052	"condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]"	condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000776; GO:0000777; GO:0000778; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0005829; GO:0006915; GO:0007091; GO:0007094; GO:0048471; GO:0051301; GO:0051754; GO:0071459	"apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3838_c0_g1_i1	Q9Y6D9	MD1L1_HUMAN	33.3	399	247	5	1256	111	320	716	7.60E-47	189.9	MD1L1_HUMAN	reviewed	Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)	MAD1L1 MAD1 TXBP181	Homo sapiens (Human)	718	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]	identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]	GO:0000776; GO:0000777; GO:0000922; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN40779_c0_g1_i1	Q9Y6D9	MD1L1_HUMAN	100	54	0	0	1	162	665	718	1.10E-22	106.7	MD1L1_HUMAN	reviewed	Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)	MAD1L1 MAD1 TXBP181	Homo sapiens (Human)	718	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]	identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]	GO:0000776; GO:0000777; GO:0000922; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN38783_c0_g1_i1	Q13257	MD2L1_HUMAN	100	104	0	0	10	321	1	104	4.50E-52	204.9	MD2L1_HUMAN	reviewed	Mitotic spindle assembly checkpoint protein MAD2A (HsMAD2) (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1)	MAD2L1 MAD2	Homo sapiens (Human)	205	chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000070; GO:0000132; GO:0000776; GO:0000777; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006511; GO:0007093; GO:0007094; GO:0008022; GO:0031145; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1901990; GO:1904667	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35510_c0_g1_i1	Q9Z1B5	MD2L1_MOUSE	100	84	0	0	2	253	30	113	5.70E-42	171	MD2L1_MOUSE	reviewed	Mitotic spindle assembly checkpoint protein MAD2A (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1)	Mad2l1 Mad2a	Mus musculus (Mouse)	205	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]"	identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000070; GO:0000132; GO:0000775; GO:0000776; GO:0000777; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0007093; GO:0007094; GO:0008022; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045841; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1904667	cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]		NA	NA	NA	NA	NA	NA
TRINITY_DN23453_c0_g1_i1	Q9Z1B5	MD2L1_MOUSE	56.2	194	81	1	621	40	11	200	1.80E-55	217.2	MD2L1_MOUSE	reviewed	Mitotic spindle assembly checkpoint protein MAD2A (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1)	Mad2l1 Mad2a	Mus musculus (Mouse)	205	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]"	identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000070; GO:0000132; GO:0000775; GO:0000776; GO:0000777; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0007093; GO:0007094; GO:0008022; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045841; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1904667	cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]		NA	NA	NA	NA	NA	NA
TRINITY_DN23453_c0_g1_i2	Q9Z1B5	MD2L1_MOUSE	55.3	179	76	1	576	40	26	200	2.30E-49	196.8	MD2L1_MOUSE	reviewed	Mitotic spindle assembly checkpoint protein MAD2A (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1)	Mad2l1 Mad2a	Mus musculus (Mouse)	205	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]"	identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000070; GO:0000132; GO:0000775; GO:0000776; GO:0000777; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0007093; GO:0007094; GO:0008022; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045841; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1904667	cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]		NA	NA	NA	NA	NA	NA
TRINITY_DN3545_c0_g1_i1	Q2KIP7	MD2L2_BOVIN	46	198	105	1	703	110	16	211	8.00E-47	188.7	MD2L2_BOVIN	reviewed	Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2)	MAD2L2	Bos taurus (Bovine)	211	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035]; JUN kinase binding [GO:0008432]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035]	JUN kinase binding [GO:0008432]	GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006302; GO:0007049; GO:0008432; GO:0016035; GO:0033138; GO:0042177; GO:0042772; GO:0045893; GO:0051301; GO:1904667	"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33709_c0_g1_i1	Q8JIY8	MK67I_DANRE	41.2	102	57	2	214	516	11	110	7.80E-14	78.6	MK67I_DANRE	reviewed	MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein NOPP34-like protein)	nifk mki67ip mki67ipl	Danio rerio (Zebrafish) (Brachydanio rerio)	269	"nucleolus [GO:0005730]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; multicellular organism development [GO:0007275]"	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0000463; GO:0003723; GO:0005730; GO:0007275	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; multicellular organism development [GO:0007275]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4501_c0_g1_i1	Q2VPU4	MLXIP_MOUSE	44	109	43	4	329	3	74	164	4.60E-13	75.9	MLXIP_MOUSE	reviewed	MLX-interacting protein (Transcriptional activator MondoA)	Mlxip Mir	Mus musculus (Mouse)	917	"cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0005741; GO:0006357; GO:0006913; GO:0045944; GO:0046983	nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11317_c0_g1_i1	Q0V9L1	MMS19_XENTR	40.1	147	88	0	7	447	247	393	3.70E-23	109.8	MMS19_XENTR	reviewed	MMS19 nucleotide excision repair protein homolog (MMS19-like protein)	mms19	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1022	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006259; GO:0006281; GO:0006974; GO:0016226; GO:0071817; GO:0097361; GO:0097428; GO:1905168	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN11317_c0_g1_i2	Q0V9L1	MMS19_XENTR	40.1	147	88	0	7	447	247	393	3.90E-23	109.8	MMS19_XENTR	reviewed	MMS19 nucleotide excision repair protein homolog (MMS19-like protein)	mms19	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1022	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006259; GO:0006281; GO:0006974; GO:0016226; GO:0071817; GO:0097361; GO:0097428; GO:1905168	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN8119_c0_g1_i1	Q9H8S9	MOB1A_HUMAN	100	216	0	0	85	732	1	216	1.40E-125	450.3	MOB1A_HUMAN	reviewed	MOB kinase activator 1A (Mob1 alpha) (Mob1A) (Mob1 homolog 1B) (Mps one binder kinase activator-like 1B)	MOB1A C2orf6 MOB4B MOBK1B MOBKL1B	Homo sapiens (Human)	216	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; hippo signaling [GO:0035329]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]	GO:0005654; GO:0005730; GO:0005829; GO:0035329; GO:0046872; GO:0070062	hippo signaling [GO:0035329]		NA	NA	NA	NA	NA	NA
TRINITY_DN17523_c0_g1_i1	Q8BSU7	MOB3A_MOUSE	100	89	0	0	268	2	126	214	8.00E-47	187.2	MOB3A_MOUSE	reviewed	MOB kinase activator 3A (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A)	Mob3a Mobkl2a	Mus musculus (Mouse)	217	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN14610_c0_g1_i1	Q96BX8	MOB3A_HUMAN	100	217	0	0	32	682	1	217	1.90E-129	463	MOB3A_HUMAN	reviewed	MOB kinase activator 3A (MOB-LAK) (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A)	MOB3A MOBKL2A	Homo sapiens (Human)	217	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1061_c0_g1_i1	Q86TA1	MOB3B_HUMAN	69.3	212	65	0	947	312	5	216	4.30E-93	342.8	MOB3B_HUMAN	reviewed	MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B) (MOB kinase activator-like 2B)	MOB3B C9orf35 MOBKL2B	Homo sapiens (Human)	216	metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330]		metal ion binding [GO:0046872]	GO:0035330; GO:0046872	regulation of hippo signaling [GO:0035330]		NA	NA	1	NA	NA	NA
TRINITY_DN1061_c0_g1_i3	Q86TA1	MOB3B_HUMAN	71	207	60	0	932	312	10	216	5.50E-93	342.4	MOB3B_HUMAN	reviewed	MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B) (MOB kinase activator-like 2B)	MOB3B C9orf35 MOBKL2B	Homo sapiens (Human)	216	metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330]		metal ion binding [GO:0046872]	GO:0035330; GO:0046872	regulation of hippo signaling [GO:0035330]		NA	NA	NA	NA	NA	NA
TRINITY_DN17523_c0_g1_i2	Q5EAA4	MOB3C_BOVIN	89.3	75	8	0	226	2	139	213	2.10E-35	149.1	MOB3C_BOVIN	reviewed	MOB kinase activator 3C (Mob1 homolog 2C) (Mps one binder kinase activator-like 2C)	MOB3C MOBKL2C	Bos taurus (Bovine)	216	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6519_c0_g1_i1	Q95RA8	MOB1_DROME	91.2	215	19	0	93	737	1	215	8.60E-116	417.9	MOB1_DROME	reviewed	MOB kinase activator-like 1 (Mob as tumor suppressor protein 1) (Dmob1) (Mps one binder kinase activator-like 1)	mats CG13852	Drosophila melanogaster (Fruit fly)	219	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165]	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]	GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0006915; GO:0007059; GO:0007165; GO:0007275; GO:0008285; GO:0019901; GO:0030295; GO:0030707; GO:0035329; GO:0046872	apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN1129_c0_g1_i2	Q8IQG1	MOB2_DROME	65.1	212	73	1	761	1396	137	347	4.20E-77	290.4	MOB2_DROME	reviewed	MOB kinase activator-like 2 (Mob as tumor suppressor protein 2) (Dmob2) (Mps one binder kinase activator-like 2)	Mob2 CG11711	Drosophila melanogaster (Fruit fly)	566	cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; cell morphogenesis [GO:0000902]; long-term memory [GO:0007616]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; rhabdomere development [GO:0042052]	cell hair [GO:0070451]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]	metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0000902; GO:0005634; GO:0005737; GO:0005886; GO:0007616; GO:0016028; GO:0019901; GO:0042052; GO:0045886; GO:0046872; GO:0070451; GO:0071944	cell morphogenesis [GO:0000902]; long-term memory [GO:0007616]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN1129_c0_g1_i1	Q2LZ59	MOB2_DROPS	61.3	230	88	1	38	727	84	312	1.10E-77	291.6	MOB2_DROPS	reviewed	MOB kinase activator-like 2 (Mob as tumor suppressor protein 2) (Mps one binder kinase activator-like 2)	Mob1 GA11155	Drosophila pseudoobscura pseudoobscura (Fruit fly)	562	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell morphogenesis [GO:0000902]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0000902; GO:0005634; GO:0005737; GO:0046872	cell morphogenesis [GO:0000902]		NA	NA	NA	NA	NA	NA
TRINITY_DN1061_c0_g1_i2	Q9VL13	MOB3_DROME	74.2	217	56	0	959	309	2	218	1.90E-96	354	MOB3_DROME	reviewed	MOB kinase activator-like 3 (Mob as tumor suppressor protein 3) (Dmob3) (Mps one binder kinase activator-like 3)	Mob3 CG4946	Drosophila melanogaster (Fruit fly)	220	metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]		metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0019901; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN1061_c0_g1_i4	Q9VL13	MOB3_DROME	72.5	222	56	1	974	309	2	218	1.80E-94	347.4	MOB3_DROME	reviewed	MOB kinase activator-like 3 (Mob as tumor suppressor protein 3) (Dmob3) (Mps one binder kinase activator-like 3)	Mob3 CG4946	Drosophila melanogaster (Fruit fly)	220	metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]		metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0019901; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN24343_c0_g1_i1	Q9Y3A3	PHOCN_HUMAN	100	147	0	0	443	3	23	169	1.10E-85	317	PHOCN_HUMAN	reviewed	MOB-like protein phocein (2C4D) (Class II mMOB1) (Mob1 homolog 3) (Mob3) (Mps one binder kinase activator-like 3) (Preimplantation protein 3)	MOB4 MOB3 MOBKL3 PHOCN PREI3 CGI-95	Homo sapiens (Human)	225	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471]	metal ion binding [GO:0046872]	GO:0005737; GO:0005794; GO:0032580; GO:0046872; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN3237_c0_g1_i1	Q5F495	PHOCN_CHICK	85.4	137	20	0	504	94	9	145	1.60E-67	256.9	PHOCN_CHICK	reviewed	MOB-like protein phocein (Mob1 homolog 3) (Mob3) (Mps one binder kinase activator-like 3) (Preimplantation protein 3)	MOB4 MOB3 MOBKL3 PHOCN PREI3 RCJMB04_1o21	Gallus gallus (Chicken)	223	Golgi cisterna membrane [GO:0032580]; metal ion binding [GO:0046872]	Golgi cisterna membrane [GO:0032580]	metal ion binding [GO:0046872]	GO:0032580; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3237_c0_g1_i2	Q5F495	PHOCN_CHICK	85.9	206	29	0	620	3	9	214	9.90E-104	377.5	PHOCN_CHICK	reviewed	MOB-like protein phocein (Mob1 homolog 3) (Mob3) (Mps one binder kinase activator-like 3) (Preimplantation protein 3)	MOB4 MOB3 MOBKL3 PHOCN PREI3 RCJMB04_1o21	Gallus gallus (Chicken)	223	Golgi cisterna membrane [GO:0032580]; metal ion binding [GO:0046872]	Golgi cisterna membrane [GO:0032580]	metal ion binding [GO:0046872]	GO:0032580; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN33967_c0_g1_i1	P52962	MOES_LYTVA	68.3	60	19	0	183	4	246	305	4.60E-19	94.7	MOES_LYTVA	reviewed	Moesin		Lytechinus variegatus (Green sea urchin) (Variegated urchin)	572	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actin binding [GO:0003779]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0042995			NA	NA	NA	NA	NA	NA
TRINITY_DN15028_c1_g1_i2	Q2HJ49	MOES_BOVIN	63.8	47	17	0	31	171	99	145	3.90E-11	68.9	MOES_BOVIN	reviewed	Moesin (Membrane-organizing extension spike protein)	MSN	Bos taurus (Bovine)	577	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; uropod [GO:0001931]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; uropod [GO:0001931]	actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]	GO:0001771; GO:0001931; GO:0003725; GO:0003779; GO:0005102; GO:0005829; GO:0005856; GO:0005902; GO:0005925; GO:0008360; GO:0008361; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0019901; GO:0022612; GO:0022614; GO:0030175; GO:0031143; GO:0031528; GO:0042098; GO:0045198; GO:0048471; GO:0050839; GO:0061028; GO:0070489; GO:0071394; GO:0071437; GO:0071803; GO:0072678; GO:1902966; GO:1903364; GO:2000401; GO:2000643	cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN22748_c0_g2_i1	P26038	MOES_HUMAN	100	316	0	0	1005	58	4	319	6.50E-182	637.9	MOES_HUMAN	reviewed	Moesin (Membrane-organizing extension spike protein)	MSN	Homo sapiens (Human)	577	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]	actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]	GO:0001771; GO:0001931; GO:0003725; GO:0003779; GO:0005102; GO:0005200; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005925; GO:0007159; GO:0008360; GO:0008361; GO:0009986; GO:0010628; GO:0016032; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0022612; GO:0022614; GO:0030175; GO:0031143; GO:0031528; GO:0031982; GO:0035722; GO:0042098; GO:0045177; GO:0045198; GO:0048471; GO:0050839; GO:0050900; GO:0061028; GO:0070062; GO:0070489; GO:0071394; GO:0071437; GO:0071803; GO:0071944; GO:0072562; GO:0072678; GO:1902115; GO:1902966; GO:1903364; GO:2000401; GO:2000643	cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN22748_c0_g2_i2	P26038	MOES_HUMAN	100	316	0	0	1005	58	4	319	6.50E-182	637.9	MOES_HUMAN	reviewed	Moesin (Membrane-organizing extension spike protein)	MSN	Homo sapiens (Human)	577	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]	actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]	GO:0001771; GO:0001931; GO:0003725; GO:0003779; GO:0005102; GO:0005200; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005925; GO:0007159; GO:0008360; GO:0008361; GO:0009986; GO:0010628; GO:0016032; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0022612; GO:0022614; GO:0030175; GO:0031143; GO:0031528; GO:0031982; GO:0035722; GO:0042098; GO:0045177; GO:0045198; GO:0048471; GO:0050839; GO:0050900; GO:0061028; GO:0070062; GO:0070489; GO:0071394; GO:0071437; GO:0071803; GO:0071944; GO:0072562; GO:0072678; GO:1902115; GO:1902966; GO:1903364; GO:2000401; GO:2000643	cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN22748_c0_g2_i3	P26038	MOES_HUMAN	96.6	297	10	0	948	58	23	319	1.60E-166	586.6	MOES_HUMAN	reviewed	Moesin (Membrane-organizing extension spike protein)	MSN	Homo sapiens (Human)	577	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]	actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]	GO:0001771; GO:0001931; GO:0003725; GO:0003779; GO:0005102; GO:0005200; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005925; GO:0007159; GO:0008360; GO:0008361; GO:0009986; GO:0010628; GO:0016032; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0022612; GO:0022614; GO:0030175; GO:0031143; GO:0031528; GO:0031982; GO:0035722; GO:0042098; GO:0045177; GO:0045198; GO:0048471; GO:0050839; GO:0050900; GO:0061028; GO:0070062; GO:0070489; GO:0071394; GO:0071437; GO:0071803; GO:0071944; GO:0072562; GO:0072678; GO:1902115; GO:1902966; GO:1903364; GO:2000401; GO:2000643	cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN8998_c0_g1_i1	Q2HJ49	MOES_BOVIN	100	67	0	0	3	203	511	577	2.00E-29	129.4	MOES_BOVIN	reviewed	Moesin (Membrane-organizing extension spike protein)	MSN	Bos taurus (Bovine)	577	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; uropod [GO:0001931]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; uropod [GO:0001931]	actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]	GO:0001771; GO:0001931; GO:0003725; GO:0003779; GO:0005102; GO:0005829; GO:0005856; GO:0005902; GO:0005925; GO:0008360; GO:0008361; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0019901; GO:0022612; GO:0022614; GO:0030175; GO:0031143; GO:0031528; GO:0042098; GO:0045198; GO:0048471; GO:0050839; GO:0061028; GO:0070489; GO:0071394; GO:0071437; GO:0071803; GO:0072678; GO:1902966; GO:1903364; GO:2000401; GO:2000643	cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; membrane to membrane docking [GO:0022614]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN15028_c1_g1_i1	Q170J7	MOEH_AEDAE	70.4	71	20	1	93	302	73	143	4.20E-22	105.9	MOEH_AEDAE	reviewed	Moesin/ezrin/radixin homolog 1	Moe AAEL007915	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	583	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]		NA	NA	NA	NA	NA	NA
TRINITY_DN5748_c1_g1_i1	P46150	MOEH_DROME	80	80	16	0	304	65	499	578	1.90E-27	123.2	MOEH_DROME	reviewed	Moesin/ezrin/radixin homolog 1 (Ezrin-moesin-radixin 1) (Moesin) (dMoesin) (Protein D17)	Moe EMR1 CG10701	Drosophila melanogaster (Fruit fly)	578	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; subapical complex [GO:0035003]; transcriptionally active chromatin [GO:0035327]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; subapical complex [GO:0035003]; transcriptionally active chromatin [GO:0035327]	"actin binding [GO:0003779]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002009; GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005938; GO:0006405; GO:0007010; GO:0007314; GO:0007315; GO:0007318; GO:0007368; GO:0008017; GO:0008104; GO:0008284; GO:0008360; GO:0009952; GO:0016057; GO:0016324; GO:0016336; GO:0030029; GO:0030036; GO:0030866; GO:0032154; GO:0032956; GO:0034453; GO:0035003; GO:0035088; GO:0035149; GO:0035327; GO:0042052; GO:0042462; GO:0043622; GO:0045197; GO:0045313; GO:0045807; GO:0060446; GO:0072499; GO:1902846; GO:1990023	"actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]"		blue	blue	NA	NA	NA	NA
TRINITY_DN29390_c0_g1_i1	P46150	MOEH_DROME	75.3	73	18	0	1	219	506	578	6.80E-21	100.9	MOEH_DROME	reviewed	Moesin/ezrin/radixin homolog 1 (Ezrin-moesin-radixin 1) (Moesin) (dMoesin) (Protein D17)	Moe EMR1 CG10701	Drosophila melanogaster (Fruit fly)	578	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; subapical complex [GO:0035003]; transcriptionally active chromatin [GO:0035327]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polytene chromosome puff [GO:0005703]; subapical complex [GO:0035003]; transcriptionally active chromatin [GO:0035327]	"actin binding [GO:0003779]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002009; GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005938; GO:0006405; GO:0007010; GO:0007314; GO:0007315; GO:0007318; GO:0007368; GO:0008017; GO:0008104; GO:0008284; GO:0008360; GO:0009952; GO:0016057; GO:0016324; GO:0016336; GO:0030029; GO:0030036; GO:0030866; GO:0032154; GO:0032956; GO:0034453; GO:0035003; GO:0035088; GO:0035149; GO:0035327; GO:0042052; GO:0042462; GO:0043622; GO:0045197; GO:0045313; GO:0045807; GO:0060446; GO:0072499; GO:1902846; GO:1990023	"actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; anterior/posterior pattern specification [GO:0009952]; branching involved in open tracheal system development [GO:0060446]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; cytoskeleton organization [GO:0007010]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; eye photoreceptor cell development [GO:0042462]; lumen formation, open tracheal system [GO:0035149]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelium [GO:0002009]; oocyte anterior/posterior axis specification [GO:0007314]; photoreceptor cell axon guidance [GO:0072499]; pole plasm assembly [GO:0007315]; pole plasm protein localization [GO:0007318]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of mitotic spindle elongation [GO:1902846]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of membrane potential in photoreceptor cell [GO:0016057]; rhabdomere development [GO:0042052]; rhabdomere membrane biogenesis [GO:0045313]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39312_c0_g1_i1	Q921Y4	MFSD5_MOUSE	98.9	88	1	0	265	2	18	105	1.70E-44	179.5	MFSD5_MOUSE	reviewed	Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog)	Mfsd5	Mus musculus (Mouse)	450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	molybdate ion transmembrane transporter activity [GO:0015098]	GO:0005886; GO:0015098; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3573_c0_g1_i1	Q0VC03	MFSD5_BOVIN	45	444	236	4	1415	105	6	448	5.40E-103	376.3	MFSD5_BOVIN	reviewed	Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog)	MFSD5	Bos taurus (Bovine)	450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	molybdate ion transmembrane transporter activity [GO:0015098]	GO:0005886; GO:0015098; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN25590_c0_g1_i1	Q6N075	MFSD5_HUMAN	100	113	0	0	339	1	46	158	2.00E-58	226.1	MFSD5_HUMAN	reviewed	Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2)	MFSD5 UNQ832/PRO1759	Homo sapiens (Human)	450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	molybdate ion transmembrane transporter activity [GO:0015098]	GO:0005886; GO:0015098; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3261_c0_g1_i1	Q9NZB8	MOCS1_HUMAN	62.2	283	106	1	101	946	36	318	7.40E-103	375.2	MOCS1_HUMAN	reviewed	"Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]"	MOCS1 MIG11	Homo sapiens (Human)	636	"cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]"	cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"	GO:0005525; GO:0005634; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799	molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN4794_c0_g1_i1	Q14CH1	MOCOS_MOUSE	45	211	115	1	2	634	284	493	1.20E-54	214.9	MOCOS_MOUSE	reviewed	Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase)	Mocos	Mus musculus (Mouse)	862	lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545]		lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; pyridoxal phosphate binding [GO:0030170]	GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0043545; GO:0102867	molybdopterin cofactor metabolic process [GO:0043545]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN1248_c0_g1_i1	A2VD33	MOCOS_DANRE	31.8	396	137	6	1217	30	30	292	6.50E-44	179.9	MOCOS_DANRE	reviewed	Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase)	mocos zgc:110784	Danio rerio (Zebrafish) (Brachydanio rerio)	831	lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545]		lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; pyridoxal phosphate binding [GO:0030170]	GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0043545; GO:0102867	molybdopterin cofactor metabolic process [GO:0043545]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN7867_c0_g1_i1	Q8IU29	MOCOS_BOMMO	33.9	248	160	3	857	114	560	803	8.30E-37	155.6	MOCOS_BOMMO	reviewed	Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase) (Protein maroon-like) (Ma-l) (Protein organdy)	mal og	Bombyx mori (Silk moth)	822	lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545]		lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; pyridoxal phosphate binding [GO:0030170]	GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0043545; GO:0102867	molybdopterin cofactor metabolic process [GO:0043545]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]		NA	NA	NA	NA	NA	NA
TRINITY_DN7946_c0_g1_i1	A0QNZ7	MGLL_MYCS2	32.8	134	88	2	514	113	149	280	9.50E-12	71.6	MGLL_MYCS2	reviewed	Monoacylglycerol lipase (MGL) (EC 3.1.1.23)	MSMEG_0220 MSMEI_0213	Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium smegmatis)	280	cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]	cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	acylglycerol lipase activity [GO:0047372]	GO:0005576; GO:0005618; GO:0005886; GO:0006633; GO:0016042; GO:0047372	fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5751_c0_g1_i1	Q3MHW6	MOT1_BOVIN	22.4	495	302	10	1615	176	14	441	4.30E-16	87.8	MOT1_BOVIN	reviewed	Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1)	SLC16A1	Bos taurus (Bovine)	501	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0016021; GO:0035879	monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]		blue	blue	NA	NA	NA	NA
TRINITY_DN5299_c0_g1_i1	A1L1W9	MOT10_DANRE	46.3	244	124	3	12	740	228	465	7.20E-52	205.7	MOT10_DANRE	reviewed	Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)	slc16a10 si:ch211-241j12.1 zgc:158478	Danio rerio (Zebrafish) (Brachydanio rerio)	505	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005887; GO:0015173; GO:0015349; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8299_c0_g1_i2	Q6GM59	MOT12_XENLA	44.8	125	69	0	224	598	73	197	7.10E-21	104	MOT12_XENLA	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12	Xenopus laevis (African clawed frog)	460	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]	integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0015293; GO:0015881	creatine transmembrane transport [GO:0015881]		NA	NA	NA	NA	NA	NA
TRINITY_DN8299_c0_g1_i4	Q6GM59	MOT12_XENLA	38.1	189	117	0	228	794	9	197	2.20E-31	139	MOT12_XENLA	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12	Xenopus laevis (African clawed frog)	460	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]	integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0015293; GO:0015881	creatine transmembrane transport [GO:0015881]		NA	NA	NA	NA	NA	NA
TRINITY_DN11072_c0_g1_i1	D4A734	MOT12_RAT	53.7	67	31	0	201	1	120	186	8.60E-15	80.5	MOT12_RAT	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	Slc16a12 Mct12	Rattus norvegicus (Rat)	486	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021; GO:0016323	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN11072_c0_g1_i2	Q6GM59	MOT12_XENLA	52.5	80	38	0	240	1	107	186	2.00E-17	89.4	MOT12_XENLA	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12	Xenopus laevis (African clawed frog)	460	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]	integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0015293; GO:0015881	creatine transmembrane transport [GO:0015881]		NA	NA	NA	NA	NA	NA
TRINITY_DN4951_c0_g1_i3	Q6P2X9	MOT12_XENTR	42	200	114	1	1796	2395	8	205	3.50E-40	169.1	MOT12_XENTR	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12 TGas051g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	473	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4951_c0_g1_i3	Q6P2X9	MOT12_XENTR	30.9	194	132	1	3353	3928	246	439	9.80E-19	97.8	MOT12_XENTR	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12 TGas051g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	473	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4951_c0_g1_i5	Q6P2X9	MOT12_XENTR	42	200	114	1	1796	2395	8	205	3.40E-40	169.1	MOT12_XENTR	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12 TGas051g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	473	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4951_c0_g1_i5	Q6P2X9	MOT12_XENTR	29	162	111	2	3353	3832	246	405	1.50E-08	63.9	MOT12_XENTR	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12 TGas051g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	473	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4951_c0_g1_i7	Q6P2X9	MOT12_XENTR	42	200	114	1	1796	2395	8	205	3.30E-40	169.1	MOT12_XENTR	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12 TGas051g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	473	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4951_c0_g1_i7	Q6P2X9	MOT12_XENTR	29.3	157	109	1	3353	3817	246	402	1.00E-09	67.8	MOT12_XENTR	reviewed	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	slc16a12 TGas051g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	473	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN1412_c0_g1_i1	Q7RTY0	MOT13_HUMAN	26.3	133	98	0	474	76	229	361	2.70E-08	60.1	MOT13_HUMAN	reviewed	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	SLC16A13 MCT13	Homo sapiens (Human)	426	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0000139; GO:0005794; GO:0005829; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021	monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN1412_c0_g1_i3	Q7RTY0	MOT13_HUMAN	25.9	197	145	1	822	235	229	425	1.00E-10	68.9	MOT13_HUMAN	reviewed	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	SLC16A13 MCT13	Homo sapiens (Human)	426	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0000139; GO:0005794; GO:0005829; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021	monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN1412_c0_g1_i5	Q7RTY0	MOT13_HUMAN	26.4	197	144	1	822	235	229	425	3.70E-13	77	MOT13_HUMAN	reviewed	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	SLC16A13 MCT13	Homo sapiens (Human)	426	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0000139; GO:0005794; GO:0005829; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021	monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN28738_c0_g1_i1	Q7RTX9	MOT14_HUMAN	38.6	88	53	1	269	6	402	488	6.20E-10	64.7	MOT14_HUMAN	reviewed	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	SLC16A14 MCT14	Homo sapiens (Human)	510	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021	monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN34670_c0_g1_i1	P57788	MOT4_CHICK	44.1	59	33	0	6	182	143	201	5.40E-07	54.7	MOT4_CHICK	reviewed	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	SLC16A3 MCT4	Gallus gallus (Chicken)	473	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	integral component of plasma membrane [GO:0005887]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0005887; GO:0015129; GO:0015293			NA	NA	NA	NA	NA	NA
TRINITY_DN11348_c1_g1_i4	Q8R0M8	MOT5_MOUSE	23.8	214	157	3	1609	971	22	230	1.20E-07	59.7	MOT5_MOUSE	reviewed	Monocarboxylate transporter 5 (MCT 5)	Slc16a4 Mct5	Mus musculus (Mouse)	500	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021	monocarboxylic acid transport [GO:0015718]		NA	NA	NA	NA	NA	NA
TRINITY_DN4875_c0_g1_i3	Q8R189	PAQRA_MOUSE	43.6	110	59	2	198	524	29	136	5.80E-17	89	PAQRA_MOUSE	reviewed	Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X)	Mmd2 Paqr10	Mus musculus (Mouse)	247	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	protein kinase activity [GO:0004672]	GO:0000139; GO:0004672; GO:0016021; GO:0019835; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471	cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN4875_c0_g1_i4	Q8R189	PAQRA_MOUSE	44	200	109	2	763	167	41	238	8.70E-44	179.5	PAQRA_MOUSE	reviewed	Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X)	Mmd2 Paqr10	Mus musculus (Mouse)	247	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	protein kinase activity [GO:0004672]	GO:0000139; GO:0004672; GO:0016021; GO:0019835; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471	cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN4875_c0_g1_i4	Q8R189	PAQRA_MOUSE	43.4	113	61	2	1080	745	29	139	1.20E-16	89.4	PAQRA_MOUSE	reviewed	Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X)	Mmd2 Paqr10	Mus musculus (Mouse)	247	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	protein kinase activity [GO:0004672]	GO:0000139; GO:0004672; GO:0016021; GO:0019835; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471	cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN4875_c0_g1_i7	Q8R189	PAQRA_MOUSE	28	343	113	3	1192	167	29	238	2.60E-33	144.8	PAQRA_MOUSE	reviewed	Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X)	Mmd2 Paqr10	Mus musculus (Mouse)	247	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	protein kinase activity [GO:0004672]	GO:0000139; GO:0004672; GO:0016021; GO:0019835; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471	cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN33575_c0_g1_i1	Q3V3R1	C1TM_MOUSE	78.4	236	51	0	708	1	473	708	3.90E-101	369	C1TM_MOUSE	reviewed	"Monofunctional C1-tetrahydrofolate synthase, mitochondrial (EC 6.3.4.3) (Formyltetrahydrofolate synthetase)"	Mthfd1l Fthfsdc1	Mus musculus (Mouse)	977	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]	GO:0001843; GO:0004329; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006730; GO:0006760; GO:0009257; GO:0015942; GO:0035999; GO:0042803; GO:0048702; GO:0048703	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN27356_c0_g1_i1	Q3V3R1	C1TM_MOUSE	98.9	90	1	0	294	25	488	577	2.70E-43	175.6	C1TM_MOUSE	reviewed	"Monofunctional C1-tetrahydrofolate synthase, mitochondrial (EC 6.3.4.3) (Formyltetrahydrofolate synthetase)"	Mthfd1l Fthfsdc1	Mus musculus (Mouse)	977	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]	GO:0001843; GO:0004329; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006730; GO:0006760; GO:0009257; GO:0015942; GO:0035999; GO:0042803; GO:0048702; GO:0048703	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN34978_c0_g1_i1	Q9SD00	MSSP3_ARATH	50	46	22	1	275	138	179	223	1.30E-05	50.4	MSSP3_ARATH	reviewed	Monosaccharide-sensing protein 3 (Sugar transporter MSSP3)	MSSP3 At3g51490 F26O13.130	Arabidopsis thaliana (Mouse-ear cress)	729	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN5037_c1_g1_i7	Q9SD00	MSSP3_ARATH	29.6	162	107	2	81	545	49	210	2.40E-08	60.8	MSSP3_ARATH	reviewed	Monosaccharide-sensing protein 3 (Sugar transporter MSSP3)	MSSP3 At3g51490 F26O13.130	Arabidopsis thaliana (Mouse-ear cress)	729	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN30700_c0_g1_i1	Q9HDW8	GLRX5_SCHPO	61.5	65	25	0	262	68	60	124	1.70E-18	93.2	GLRX5_SCHPO	reviewed	Monothiol glutaredoxin-5	grx5 SPAPB2B4.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	146	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur transferase activity [GO:0036455]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur transferase activity [GO:0036455]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005739; GO:0005759; GO:0009055; GO:0015035; GO:0015038; GO:0036455; GO:0044571; GO:0044572; GO:0046872; GO:0051537; GO:0106034	[2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]		NA	NA	NA	NA	NA	NA
TRINITY_DN30700_c0_g1_i2	Q9HDW8	GLRX5_SCHPO	57.4	101	43	0	370	68	24	124	7.90E-30	131.3	GLRX5_SCHPO	reviewed	Monothiol glutaredoxin-5	grx5 SPAPB2B4.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	146	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur transferase activity [GO:0036455]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur transferase activity [GO:0036455]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005739; GO:0005759; GO:0009055; GO:0015035; GO:0015038; GO:0036455; GO:0044571; GO:0044572; GO:0046872; GO:0051537; GO:0106034	[2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]		NA	NA	NA	NA	NA	NA
TRINITY_DN36213_c0_g1_i1	Q0IWL9	GRS11_ORYSJ	66.3	98	33	0	46	339	392	489	3.80E-33	142.1	GRS11_ORYSJ	reviewed	Monothiol glutaredoxin-S11	GRXS11 Os10g0500700 LOC_Os10g35720 OsJ_32056 OSJNBa0078O01.9	Oryza sativa subsp. japonica (Rice)	491	"cytosol [GO:0005829]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cellular iron ion homeostasis [GO:0006879]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005634; GO:0005829; GO:0006879; GO:0009055; GO:0015035; GO:0046872; GO:0051537	cellular iron ion homeostasis [GO:0006879]		red	red	NA	NA	NA	NA
TRINITY_DN37100_c0_g1_i1	Q851Y7	GRXS7_ORYSJ	52	102	48	1	33	338	64	164	6.60E-26	118.2	GRXS7_ORYSJ	reviewed	"Monothiol glutaredoxin-S7, chloroplastic"	GRXS7 Os03g0851200 LOC_Os03g63420 OsJ_13389 OSJNBa0015N08.14	Oryza sativa subsp. japonica (Rice)	168	"chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; antiporter activity [GO:0015297]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cation transport [GO:0006812]"	chloroplast envelope [GO:0009941]; chloroplast stroma [GO:0009570]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; antiporter activity [GO:0015297]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0005739; GO:0005759; GO:0006812; GO:0009055; GO:0009570; GO:0009941; GO:0015035; GO:0015297; GO:0046872; GO:0051537	cation transport [GO:0006812]		NA	NA	NA	NA	NA	NA
TRINITY_DN30463_c0_g1_i1	Q1JQA2	SMAD1_BOVIN	100	66	0	0	198	1	1	66	5.30E-31	134.4	SMAD1_BOVIN	reviewed	Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (SMAD family member 1) (SMAD 1) (Smad1)	SMAD1	Bos taurus (Bovine)	465	"cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear inner membrane [GO:0005637]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear inner membrane [GO:0005637]	"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000165; GO:0000978; GO:0001228; GO:0001657; GO:0001710; GO:0002051; GO:0005637; GO:0005737; GO:0006954; GO:0007179; GO:0007183; GO:0007276; GO:0008134; GO:0008285; GO:0009653; GO:0017151; GO:0019901; GO:0030154; GO:0030509; GO:0030901; GO:0030902; GO:0031625; GO:0042592; GO:0042802; GO:0045669; GO:0045944; GO:0046872; GO:0051216; GO:0060038; GO:0060348; GO:0060395; GO:0061036; GO:0070410; GO:0070411; GO:0070878; GO:0071144; GO:0071407; GO:1901522; GO:1902895; GO:1903672	anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN38717_c0_g1_i1	Q1JQA2	SMAD1_BOVIN	100	108	0	0	381	58	358	465	1.00E-63	243.8	SMAD1_BOVIN	reviewed	Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (SMAD family member 1) (SMAD 1) (Smad1)	SMAD1	Bos taurus (Bovine)	465	"cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear inner membrane [GO:0005637]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear inner membrane [GO:0005637]	"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000165; GO:0000978; GO:0001228; GO:0001657; GO:0001710; GO:0002051; GO:0005637; GO:0005737; GO:0006954; GO:0007179; GO:0007183; GO:0007276; GO:0008134; GO:0008285; GO:0009653; GO:0017151; GO:0019901; GO:0030154; GO:0030509; GO:0030901; GO:0030902; GO:0031625; GO:0042592; GO:0042802; GO:0045669; GO:0045944; GO:0046872; GO:0051216; GO:0060038; GO:0060348; GO:0060395; GO:0061036; GO:0070410; GO:0070411; GO:0070878; GO:0071144; GO:0071407; GO:1901522; GO:1902895; GO:1903672	anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN38914_c0_g1_i1	Q9I9P9	SMAD2_DANRE	100	101	0	0	308	6	368	468	1.50E-57	223	SMAD2_DANRE	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (SMAD family member 2) (SMAD 2) (Smad2)	smad2 madh2	Danio rerio (Zebrafish) (Brachydanio rerio)	468	"cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; intracellular signal transduction [GO:0035556]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of oocyte development [GO:0060282]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007179; GO:0008134; GO:0009653; GO:0009880; GO:0021999; GO:0030154; GO:0030509; GO:0031625; GO:0035556; GO:0043565; GO:0045944; GO:0046872; GO:0060282; GO:0060395; GO:0070411; GO:0071144	"anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; intracellular signal transduction [GO:0035556]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of oocyte development [GO:0060282]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35842_c0_g1_i1	Q1W668	SMAD2_BOVIN	100	71	0	0	215	3	126	196	8.40E-39	160.2	SMAD2_BOVIN	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (SMAD family member 2) (SMAD 2) (Smad2)	SMAD2	Bos taurus (Bovine)	467	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0046872	transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN29796_c0_g1_i1	Q1W668	SMAD2_BOVIN	100	132	0	0	397	2	241	372	3.60E-75	282	SMAD2_BOVIN	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (SMAD family member 2) (SMAD 2) (Smad2)	SMAD2	Bos taurus (Bovine)	467	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0046872	transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN39447_c0_g1_i1	Q1W668	SMAD2_BOVIN	98.8	84	1	0	2	253	280	363	7.80E-44	177.2	SMAD2_BOVIN	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (SMAD family member 2) (SMAD 2) (Smad2)	SMAD2	Bos taurus (Bovine)	467	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0046872	transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN18717_c0_g1_i2	P84022	SMAD3_HUMAN	76	100	21	1	369	79	3	102	2.40E-39	162.9	SMAD3_HUMAN	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3)	SMAD3 MADH3	Homo sapiens (Human)	425	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell-cell junction organization [GO:0045216]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; viral process [GO:0016032]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001102; GO:0001223; GO:0001228; GO:0001657; GO:0001666; GO:0001701; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008013; GO:0008134; GO:0008270; GO:0009653; GO:0009880; GO:0010628; GO:0010694; GO:0010718; GO:0016032; GO:0016202; GO:0016579; GO:0017015; GO:0017151; GO:0019901; GO:0019902; GO:0023019; GO:0030154; GO:0030308; GO:0030325; GO:0030335; GO:0030501; GO:0030509; GO:0030512; GO:0030878; GO:0031053; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032731; GO:0032909; GO:0032916; GO:0032924; GO:0033689; GO:0035259; GO:0038092; GO:0042060; GO:0042110; GO:0042177; GO:0042307; GO:0042802; GO:0042803; GO:0043066; GO:0043130; GO:0043235; GO:0043425; GO:0043565; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045893; GO:0045930; GO:0045944; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0050821; GO:0050927; GO:0051091; GO:0051098; GO:0051481; GO:0051496; GO:0051894; GO:0060039; GO:0060290; GO:0060395; GO:0061045; GO:0061767; GO:0070306; GO:0070410; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071345; GO:0071560; GO:0090263; GO:0097191; GO:0097296; GO:1901203; GO:1902895; GO:1903243	"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; viral process [GO:0016032]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27045_c0_g1_i1	P84022	SMAD3_HUMAN	98.4	63	1	0	19	207	69	131	4.60E-34	144.4	SMAD3_HUMAN	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3)	SMAD3 MADH3	Homo sapiens (Human)	425	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell-cell junction organization [GO:0045216]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; viral process [GO:0016032]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001102; GO:0001223; GO:0001228; GO:0001657; GO:0001666; GO:0001701; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008013; GO:0008134; GO:0008270; GO:0009653; GO:0009880; GO:0010628; GO:0010694; GO:0010718; GO:0016032; GO:0016202; GO:0016579; GO:0017015; GO:0017151; GO:0019901; GO:0019902; GO:0023019; GO:0030154; GO:0030308; GO:0030325; GO:0030335; GO:0030501; GO:0030509; GO:0030512; GO:0030878; GO:0031053; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032731; GO:0032909; GO:0032916; GO:0032924; GO:0033689; GO:0035259; GO:0038092; GO:0042060; GO:0042110; GO:0042177; GO:0042307; GO:0042802; GO:0042803; GO:0043066; GO:0043130; GO:0043235; GO:0043425; GO:0043565; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045893; GO:0045930; GO:0045944; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0050821; GO:0050927; GO:0051091; GO:0051098; GO:0051481; GO:0051496; GO:0051894; GO:0060039; GO:0060290; GO:0060395; GO:0061045; GO:0061767; GO:0070306; GO:0070410; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071345; GO:0071560; GO:0090263; GO:0097191; GO:0097296; GO:1901203; GO:1902895; GO:1903243	"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; viral process [GO:0016032]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37802_c0_g1_i1	P84023	SMAD3_CHICK	98.8	83	1	0	264	16	344	426	1.40E-43	176.4	SMAD3_CHICK	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3)	SMAD3 MADH3	Gallus gallus (Chicken)	426	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000987; GO:0001102; GO:0001223; GO:0001228; GO:0001657; GO:0001666; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008134; GO:0008270; GO:0009653; GO:0009880; GO:0010718; GO:0016202; GO:0017015; GO:0017151; GO:0019901; GO:0019902; GO:0030154; GO:0030308; GO:0030509; GO:0030878; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032909; GO:0033689; GO:0035259; GO:0038092; GO:0042110; GO:0042803; GO:0043130; GO:0043235; GO:0043425; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045930; GO:0045944; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0051098; GO:0051481; GO:0060039; GO:0060395; GO:0061045; GO:0070306; GO:0070410; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0097191; GO:1901203; GO:1902895	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN30720_c0_g1_i1	P84023	SMAD3_CHICK	91.6	202	17	0	1	606	225	426	8.00E-112	404.4	SMAD3_CHICK	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3)	SMAD3 MADH3	Gallus gallus (Chicken)	426	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000987; GO:0001102; GO:0001223; GO:0001228; GO:0001657; GO:0001666; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008134; GO:0008270; GO:0009653; GO:0009880; GO:0010718; GO:0016202; GO:0017015; GO:0017151; GO:0019901; GO:0019902; GO:0030154; GO:0030308; GO:0030509; GO:0030878; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032909; GO:0033689; GO:0035259; GO:0038092; GO:0042110; GO:0042803; GO:0043130; GO:0043235; GO:0043425; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045930; GO:0045944; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0051098; GO:0051481; GO:0060039; GO:0060395; GO:0061045; GO:0070306; GO:0070410; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0097191; GO:1901203; GO:1902895	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN18717_c0_g1_i1	P84023	SMAD3_CHICK	74.3	140	33	1	454	44	3	142	7.30E-59	228	SMAD3_CHICK	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3)	SMAD3 MADH3	Gallus gallus (Chicken)	426	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000987; GO:0001102; GO:0001223; GO:0001228; GO:0001657; GO:0001666; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008134; GO:0008270; GO:0009653; GO:0009880; GO:0010718; GO:0016202; GO:0017015; GO:0017151; GO:0019901; GO:0019902; GO:0030154; GO:0030308; GO:0030509; GO:0030878; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032909; GO:0033689; GO:0035259; GO:0038092; GO:0042110; GO:0042803; GO:0043130; GO:0043235; GO:0043425; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045930; GO:0045944; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0051098; GO:0051481; GO:0060039; GO:0060395; GO:0061045; GO:0070306; GO:0070410; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0097191; GO:1901203; GO:1902895	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN34239_c0_g1_i1	P84023	SMAD3_CHICK	100	69	0	0	1	207	252	320	6.00E-34	144.1	SMAD3_CHICK	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3)	SMAD3 MADH3	Gallus gallus (Chicken)	426	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; collagen binding [GO:0005518]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; glucocorticoid receptor binding [GO:0035259]; I-SMAD binding [GO:0070411]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; R-SMAD binding [GO:0070412]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000987; GO:0001102; GO:0001223; GO:0001228; GO:0001657; GO:0001666; GO:0001707; GO:0001756; GO:0001889; GO:0001947; GO:0002076; GO:0002520; GO:0003700; GO:0005160; GO:0005518; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006919; GO:0006955; GO:0007050; GO:0007179; GO:0007183; GO:0007492; GO:0008134; GO:0008270; GO:0009653; GO:0009880; GO:0010718; GO:0016202; GO:0017015; GO:0017151; GO:0019901; GO:0019902; GO:0030154; GO:0030308; GO:0030509; GO:0030878; GO:0031490; GO:0031625; GO:0031962; GO:0032332; GO:0032909; GO:0033689; GO:0035259; GO:0038092; GO:0042110; GO:0042803; GO:0043130; GO:0043235; GO:0043425; GO:0045216; GO:0045429; GO:0045599; GO:0045668; GO:0045930; GO:0045944; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0050678; GO:0050728; GO:0050776; GO:0051098; GO:0051481; GO:0060039; GO:0060395; GO:0061045; GO:0070306; GO:0070410; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0097191; GO:1901203; GO:1902895	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]		NA	NA	NA	NA	NA	NA
TRINITY_DN30177_c0_g1_i1	Q1HE26	SMAD4_BOVIN	76.2	84	19	1	289	41	470	553	3.60E-32	138.7	SMAD4_BOVIN	reviewed	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)	SMAD4	Bos taurus (Bovine)	553	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0046872	transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN13439_c0_g1_i1	Q9GKQ9	SMAD4_PIG	64.7	218	63	2	622	5	257	472	1.40E-71	270.8	SMAD4_PIG	reviewed	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)	SMAD4 MADH4	Sus scrofa (Pig)	552	"activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]"	activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; R-SMAD binding [GO:0070412]; sulfate binding [GO:0043199]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000790; GO:0000978; GO:0001085; GO:0001223; GO:0001228; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005654; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007492; GO:0007498; GO:0008134; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0030154; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0031625; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042803; GO:0043199; GO:0045944; GO:0046872; GO:0046881; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0062009; GO:0070102; GO:0070373; GO:0070411; GO:0070412; GO:0071144; GO:0072133; GO:0072134; GO:0072520; GO:1902895; GO:1905305; GO:2000617	anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN13733_c0_g1_i1	Q9GKQ9	SMAD4_PIG	83.3	162	23	1	41	526	6	163	5.30E-75	282	SMAD4_PIG	reviewed	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)	SMAD4 MADH4	Sus scrofa (Pig)	552	"activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]"	activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; R-SMAD binding [GO:0070412]; sulfate binding [GO:0043199]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000790; GO:0000978; GO:0001085; GO:0001223; GO:0001228; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005654; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007492; GO:0007498; GO:0008134; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0030154; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0031625; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042803; GO:0043199; GO:0045944; GO:0046872; GO:0046881; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0062009; GO:0070102; GO:0070373; GO:0070411; GO:0070412; GO:0071144; GO:0072133; GO:0072134; GO:0072520; GO:1902895; GO:1905305; GO:2000617	anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN30538_c0_g1_i1	Q1HE26	SMAD4_BOVIN	98	153	3	0	462	4	323	475	3.60E-79	295.4	SMAD4_BOVIN	reviewed	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)	SMAD4	Bos taurus (Bovine)	553	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0046872	transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN8439_c0_g1_i2	Q9W734	SMAD6_CHICK	47.2	246	107	7	735	34	193	427	3.90E-54	213	SMAD6_CHICK	reviewed	Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6)	SMAD6 MADH6	Gallus gallus (Chicken)	431	"endosome [GO:0005768]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	endosome [GO:0005768]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000976; GO:0000978; GO:0001228; GO:0003682; GO:0005634; GO:0005768; GO:0007179; GO:0008134; GO:0009653; GO:0010693; GO:0030154; GO:0030509; GO:0031589; GO:0031625; GO:0032331; GO:0045944; GO:0046872; GO:0050767; GO:0060395; GO:0070411; GO:0071144; GO:1902832; GO:1902844	anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN1824_c0_g1_i1	Q8VEL0	MSPD1_MOUSE	39.9	218	119	4	745	92	7	212	2.90E-34	147.1	MSPD1_MOUSE	reviewed	Motile sperm domain-containing protein 1	Mospd1	Mus musculus (Mouse)	213	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0016021; GO:0030154; GO:0045944; GO:0048471	cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN2240_c0_g1_i1	Q9CWP6	MSPD2_MOUSE	47.4	57	30	0	288	118	136	192	1.30E-11	70.9	MSPD2_MOUSE	reviewed	Motile sperm domain-containing protein 2	Mospd2	Mus musculus (Mouse)	518	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; organelle membrane contact site [GO:0044232]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; organelle membrane contact site [GO:0044232]		GO:0005783; GO:0005789; GO:0005887; GO:0006935; GO:0044232; GO:0090023; GO:0090026; GO:0140284	chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]		NA	NA	NA	NA	NA	NA
TRINITY_DN2240_c0_g1_i2	Q9CWP6	MSPD2_MOUSE	34.2	161	106	0	600	118	32	192	2.60E-29	130.6	MSPD2_MOUSE	reviewed	Motile sperm domain-containing protein 2	Mospd2	Mus musculus (Mouse)	518	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; organelle membrane contact site [GO:0044232]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; organelle membrane contact site [GO:0044232]		GO:0005783; GO:0005789; GO:0005887; GO:0006935; GO:0044232; GO:0090023; GO:0090026; GO:0140284	chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]		NA	NA	NA	NA	NA	NA
TRINITY_DN2240_c0_g1_i3	Q9CWP6	MSPD2_MOUSE	34.6	191	125	0	575	3	32	222	1.50E-34	147.9	MSPD2_MOUSE	reviewed	Motile sperm domain-containing protein 2	Mospd2	Mus musculus (Mouse)	518	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; organelle membrane contact site [GO:0044232]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; organelle membrane contact site [GO:0044232]		GO:0005783; GO:0005789; GO:0005887; GO:0006935; GO:0044232; GO:0090023; GO:0090026; GO:0140284	chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]		NA	NA	NA	NA	NA	NA
TRINITY_DN22590_c0_g1_i1	Q9VUY0	MOX11_DROME	47.9	48	25	0	63	206	492	539	1.20E-08	60.1	MOX11_DROME	reviewed	MOXD1 homolog 1 (EC 1.14.17.-)	CG5235	Drosophila melanogaster (Fruit fly)	698	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN22590_c0_g1_i2	Q9VUY0	MOX11_DROME	47.8	69	36	0	3	209	471	539	2.80E-16	85.5	MOX11_DROME	reviewed	MOXD1 homolog 1 (EC 1.14.17.-)	CG5235	Drosophila melanogaster (Fruit fly)	698	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN4047_c0_g1_i1	Q9VUY0	MOX11_DROME	42.8	173	96	3	522	7	303	473	7.20E-39	161.8	MOX11_DROME	reviewed	MOXD1 homolog 1 (EC 1.14.17.-)	CG5235	Drosophila melanogaster (Fruit fly)	698	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN13096_c1_g1_i1	Q6NP60	MOX12_DROME	46.6	88	45	1	86	343	128	215	3.00E-16	86.3	MOX12_DROME	reviewed	MOXD1 homolog 2	olf413 CG12673	Drosophila melanogaster (Fruit fly)	760	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005829; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN16150_c0_g1_i1	Q6NP60	MOX12_DROME	47.2	53	26	1	56	208	170	222	7.80E-07	54.3	MOX12_DROME	reviewed	MOXD1 homolog 2	olf413 CG12673	Drosophila melanogaster (Fruit fly)	760	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005829; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN16427_c0_g2_i1	Q6NP60	MOX12_DROME	49.2	59	30	0	33	209	601	659	3.50E-12	72	MOX12_DROME	reviewed	MOXD1 homolog 2	olf413 CG12673	Drosophila melanogaster (Fruit fly)	760	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005829; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN2615_c0_g1_i1	P20483	MPIP_DROME	34.7	453	228	14	683	1963	66	476	1.30E-56	222.6	MPIP_DROME	reviewed	M-phase inducer phosphatase (EC 3.1.3.48) (Cdc25-like protein) (Protein string)	stg cdc25 CG1395	Drosophila melanogaster (Fruit fly)	479	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; centriole replication [GO:0007099]; G2/M transition of mitotic cell cycle [GO:0000086]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; histoblast morphogenesis [GO:0007488]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; protein dephosphorylation [GO:0006470]; regulation of mitotic cell cycle [GO:0007346]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	protein tyrosine phosphatase activity [GO:0004725]	GO:0000086; GO:0004725; GO:0005634; GO:0005694; GO:0005737; GO:0006470; GO:0007030; GO:0007099; GO:0007346; GO:0007369; GO:0007488; GO:0008284; GO:0010971; GO:0045792; GO:0045931; GO:0045977; GO:0051301; GO:0110032	"cell division [GO:0051301]; centriole replication [GO:0007099]; G2/M transition of mitotic cell cycle [GO:0000086]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; histoblast morphogenesis [GO:0007488]; negative regulation of cell size [GO:0045792]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; protein dephosphorylation [GO:0006470]; regulation of mitotic cell cycle [GO:0007346]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16427_c0_g1_i1	Q08CH3	MPND_DANRE	40.6	360	183	6	2	991	92	450	2.40E-75	284.3	MPND_DANRE	reviewed	MPN domain-containing protein (EC 3.4.-.-)	mpnd zgc:153076	Danio rerio (Zebrafish) (Brachydanio rerio)	458	histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]		histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0004843; GO:0006338; GO:0008237; GO:0042393; GO:0045944; GO:0046872; GO:0070122	chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c2_g1_i1	Q68F62	MP17L_XENLA	29.7	172	116	1	623	108	1	167	2.10E-22	107.5	MP17L_XENLA	reviewed	Mpv17-like protein	mpv17l	Xenopus laevis (African clawed frog)	203	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]		GO:0005778; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c2_g1_i5	Q68F62	MP17L_XENLA	29.3	174	118	1	783	262	1	169	4.00E-23	110.2	MP17L_XENLA	reviewed	Mpv17-like protein	mpv17l	Xenopus laevis (African clawed frog)	203	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]		GO:0005778; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2264_c0_g1_i1	Q60SZ2	MPV17_CAEBR	22.9	170	129	1	103	612	10	177	1.30E-10	68.2	MPV17_CAEBR	reviewed	Mpv17-like protein (Fragment)	CBG20693	Caenorhabditis briggsae	181	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005737; GO:0005743; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN38616_c0_g1_i1	Q6DIY8	M17L2_XENTR	47	183	94	2	610	65	7	187	1.80E-42	174.1	M17L2_XENTR	reviewed	Mpv17-like protein 2	mpv17l2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	222	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome assembly [GO:0061668]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005737; GO:0005743; GO:0016021; GO:0061668	mitochondrial ribosome assembly [GO:0061668]		NA	NA	NA	NA	NA	NA
TRINITY_DN496_c0_g1_i1	Q9DAT2	MRGBP_MOUSE	51.2	80	39	0	377	138	31	110	2.30E-18	93.6	MRGBP_MOUSE	reviewed	MRG/MORF4L-binding protein (MRG-binding protein)	Mrgbp	Mus musculus (Mouse)	204	NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; histone acetylation [GO:0016573]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]	NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]		GO:0005654; GO:0006357; GO:0016573; GO:0035267; GO:0040008	histone acetylation [GO:0016573]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN2296_c0_g4_i1	Q32PP1	MRNIP_DANRE	44.6	121	52	1	508	146	1	106	8.70E-17	88.6	MRNIP_DANRE	reviewed	MRN complex-interacting protein (MRN-interacting protein)	mrnip zgc:123335	Danio rerio (Zebrafish) (Brachydanio rerio)	395	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN2296_c0_g4_i2	Q32PP1	MRNIP_DANRE	44.6	121	52	1	508	146	1	106	6.10E-17	89	MRNIP_DANRE	reviewed	MRN complex-interacting protein (MRN-interacting protein)	mrnip zgc:123335	Danio rerio (Zebrafish) (Brachydanio rerio)	395	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]		NA	NA	NA	NA	NA	NA
TRINITY_DN26017_c0_g1_i1	Q9H4Z3	CAPAM_HUMAN	60.9	69	25	1	208	2	501	567	1.40E-14	79.7	CAPAM_HUMAN	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (hCAPAM) (Phosphorylated CTD-interacting factor 1) (hPCIF1) (Protein phosphatase 1 regulatory subunit 121)	PCIF1 C20orf67 CAPAM PPP1R121	Homo sapiens (Human)	704	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN21810_c0_g1_i1	Q9H4Z3	CAPAM_HUMAN	100	89	0	0	1	267	521	609	2.50E-48	192.2	CAPAM_HUMAN	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (hCAPAM) (Phosphorylated CTD-interacting factor 1) (hPCIF1) (Protein phosphatase 1 regulatory subunit 121)	PCIF1 C20orf67 CAPAM PPP1R121	Homo sapiens (Human)	704	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN24818_c0_g1_i1	Q9H4Z3	CAPAM_HUMAN	58.8	221	90	1	664	2	391	610	1.70E-74	280.4	CAPAM_HUMAN	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (hCAPAM) (Phosphorylated CTD-interacting factor 1) (hPCIF1) (Protein phosphatase 1 regulatory subunit 121)	PCIF1 C20orf67 CAPAM PPP1R121	Homo sapiens (Human)	704	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN13055_c0_g1_i1	Q9H4Z3	CAPAM_HUMAN	54.2	59	26	1	1	174	610	668	8.50E-12	70.9	CAPAM_HUMAN	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (hCAPAM) (Phosphorylated CTD-interacting factor 1) (hPCIF1) (Protein phosphatase 1 regulatory subunit 121)	PCIF1 C20orf67 CAPAM PPP1R121	Homo sapiens (Human)	704	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN34300_c0_g1_i1	Q9H4Z3	CAPAM_HUMAN	100	80	0	0	241	2	220	299	8.50E-40	163.7	CAPAM_HUMAN	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (hCAPAM) (Phosphorylated CTD-interacting factor 1) (hPCIF1) (Protein phosphatase 1 regulatory subunit 121)	PCIF1 C20orf67 CAPAM PPP1R121	Homo sapiens (Human)	704	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN21810_c0_g1_i2	P59114	CAPAM_MOUSE	100	153	0	0	2	460	456	608	1.70E-89	329.7	CAPAM_MOUSE	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (Phosphorylated CTD-interacting factor 1)	Pcif1	Mus musculus (Mouse)	706	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN4517_c2_g2_i1	A0A0R4IKJ1	CAPAM_DANRE	67.5	40	13	0	34	153	307	346	1.80E-09	62.8	CAPAM_DANRE	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (zCAPAM) (Phosphorylated CTD-interacting factor 1)	pcif1	Danio rerio (Zebrafish) (Brachydanio rerio)	721	nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; positive regulation of translation [GO:0045727]	nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0016422; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; positive regulation of translation [GO:0045727]		brown	brown	NA	NA	NA	NA
TRINITY_DN4517_c2_g2_i2	A0A0R4IKJ1	CAPAM_DANRE	66.4	143	47	1	18	446	234	375	4.40E-50	198.7	CAPAM_DANRE	reviewed	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (zCAPAM) (Phosphorylated CTD-interacting factor 1)	pcif1	Danio rerio (Zebrafish) (Brachydanio rerio)	721	nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; positive regulation of translation [GO:0045727]	nucleus [GO:0005634]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0016422; GO:0045727; GO:0080009; GO:0099122; GO:1904047	mRNA methylation [GO:0080009]; positive regulation of translation [GO:0045727]		NA	NA	NA	NA	NA	NA
TRINITY_DN2253_c0_g1_i2	Q9VJQ4	MCES_DROME	40.5	153	82	5	561	106	266	410	1.00E-20	101.7	MCES_DROME	reviewed	mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (mRNA (guanine-N(7)-)-methyltransferase)	Rnmt br9 l(2)br9 CG3688	Drosophila melanogaster (Fruit fly)	427	mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]	mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]	mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]	GO:0003723; GO:0004482; GO:0005634; GO:0005845; GO:0006370	7-methylguanosine mRNA capping [GO:0006370]		NA	NA	NA	NA	NA	NA
TRINITY_DN2253_c0_g1_i1	Q1MTD3	MCES_DANRE	46.7	353	170	7	1134	100	58	400	1.10E-85	318.5	MCES_DANRE	reviewed	mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7)-)-methyltransferase) (mRNA cap methyltransferase)	rnmt si:ch211-105d11.3	Danio rerio (Zebrafish) (Brachydanio rerio)	400	mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]	mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]	mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]	GO:0003723; GO:0004482; GO:0005634; GO:0005845; GO:0006370	7-methylguanosine mRNA capping [GO:0006370]		blue	blue	NA	NA	NA	NA
TRINITY_DN18954_c0_g1_i1	Q8C570	RAE1L_MOUSE	100	343	0	0	1057	29	26	368	4.80E-212	738	RAE1L_MOUSE	reviewed	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	Rae1 Mrnp41	Mus musculus (Mouse)	368	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0003723; GO:0005635; GO:0005643; GO:0005737; GO:0006405; GO:0006406; GO:0007049; GO:0043130; GO:0051301; GO:0060236; GO:0071407; GO:0097431	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]		NA	NA	NA	NA	NA	NA
TRINITY_DN18954_c0_g1_i2	Q8C570	RAE1L_MOUSE	99.7	343	1	0	1057	29	26	368	3.10E-211	735.3	RAE1L_MOUSE	reviewed	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	Rae1 Mrnp41	Mus musculus (Mouse)	368	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0003723; GO:0005635; GO:0005643; GO:0005737; GO:0006405; GO:0006406; GO:0007049; GO:0043130; GO:0051301; GO:0060236; GO:0071407; GO:0097431	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]		NA	NA	NA	NA	NA	NA
TRINITY_DN26291_c0_g1_i1	Q5FVA9	RAE1L_XENTR	50.6	81	38	1	4	240	115	195	1.60E-17	89.7	RAE1L_XENTR	reviewed	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	rae1 mrnp41 TEgg053e05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	368	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0003723; GO:0005643; GO:0005737; GO:0006405; GO:0006406; GO:0007049; GO:0043130; GO:0051301; GO:0060236; GO:0097431	cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]		NA	NA	NA	NA	NA	NA
TRINITY_DN1831_c0_g1_i1	P78406	RAE1L_HUMAN	71.1	350	97	3	1142	99	20	367	1.20E-152	540.8	RAE1L_HUMAN	reviewed	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	RAE1 MRNP41	Homo sapiens (Human)	368	cytoplasm [GO:0005737]; host cell [GO:0043657]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasm [GO:0005737]; host cell [GO:0043657]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0007049; GO:0008017; GO:0016032; GO:0016925; GO:0019083; GO:0043130; GO:0043657; GO:0051301; GO:0060236; GO:0060964; GO:0071407; GO:0075733; GO:0097431; GO:1900034	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN1831_c0_g1_i2	P78406	RAE1L_HUMAN	72.6	354	91	4	1154	99	18	367	1.80E-156	553.5	RAE1L_HUMAN	reviewed	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	RAE1 MRNP41	Homo sapiens (Human)	368	cytoplasm [GO:0005737]; host cell [GO:0043657]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasm [GO:0005737]; host cell [GO:0043657]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0007049; GO:0008017; GO:0016032; GO:0016925; GO:0019083; GO:0043130; GO:0043657; GO:0051301; GO:0060236; GO:0060964; GO:0071407; GO:0075733; GO:0097431; GO:1900034	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		blue	blue	NA	NA	NA	NA
TRINITY_DN33431_c0_g1_i1	P78406	RAE1L_HUMAN	100	185	0	0	3	557	21	205	4.80E-110	398.3	RAE1L_HUMAN	reviewed	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	RAE1 MRNP41	Homo sapiens (Human)	368	cytoplasm [GO:0005737]; host cell [GO:0043657]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasm [GO:0005737]; host cell [GO:0043657]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0007049; GO:0008017; GO:0016032; GO:0016925; GO:0019083; GO:0043130; GO:0043657; GO:0051301; GO:0060236; GO:0060964; GO:0071407; GO:0075733; GO:0097431; GO:1900034	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN40685_c0_g1_i1	O14134	ELF1_SCHPO	57.7	71	30	0	6	218	557	627	8.40E-18	90.5	ELF1_SCHPO	reviewed	mRNA export factor elf1	elf1 SPAC3C7.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1057	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0016887; GO:0016973; GO:0032991	poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN898_c0_g1_i1	Q9UKD2	MRT4_HUMAN	50.2	237	111	1	800	111	1	237	8.70E-62	238.8	MRT4_HUMAN	reviewed	mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4)	MRTO4 C1orf33 MRT4	Homo sapiens (Human)	239	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273	nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN898_c0_g1_i2	Q9UKD2	MRT4_HUMAN	50.2	237	111	1	800	111	1	237	8.90E-62	238.8	MRT4_HUMAN	reviewed	mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4)	MRTO4 C1orf33 MRT4	Homo sapiens (Human)	239	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273	nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN898_c0_g1_i3	Q9UKD2	MRT4_HUMAN	50.2	237	111	1	800	111	1	237	8.80E-62	238.8	MRT4_HUMAN	reviewed	mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4)	MRTO4 C1orf33 MRT4	Homo sapiens (Human)	239	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273	nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN31163_c0_g1_i1	Q9UKD2	MRT4_HUMAN	100	82	0	0	1	246	33	114	1.20E-41	169.9	MRT4_HUMAN	reviewed	mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4)	MRTO4 C1orf33 MRT4	Homo sapiens (Human)	239	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273	nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN18333_c0_g1_i1	O60942	MCE1_HUMAN	100	74	0	0	3	224	123	196	5.70E-41	167.5	MCE1_HUMAN	reviewed	mRNA-capping enzyme (HCAP1) (HCE) [Includes: Polynucleotide 5'-triphosphatase (EC 3.1.3.33) (mRNA 5'-triphosphatase) (TPase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]	RNGTT CAP1A	Homo sapiens (Human)	597	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355]	GO:0004484; GO:0004651; GO:0004725; GO:0005525; GO:0005634; GO:0005654; GO:0006366; GO:0006370; GO:0006396; GO:0008138; GO:0008192; GO:0016032; GO:0050355	7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2594_c0_g1_i1	Q6NY98	MCE1_DANRE	51.4	220	74	3	133	792	7	193	6.30E-63	242.3	MCE1_DANRE	reviewed	mRNA-capping enzyme [Includes: Polynucleotide 5'-triphosphatase (TPase) (mRNA 5'-triphosphatase) (EC 3.1.3.33); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]	rngtt si:ch211-241P10.5 zgc:76886	Danio rerio (Zebrafish) (Brachydanio rerio)	598	nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]	nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; triphosphatase activity [GO:0050355]	GO:0004484; GO:0004651; GO:0004725; GO:0005525; GO:0005634; GO:0006370; GO:0008138; GO:0050355	7-methylguanosine mRNA capping [GO:0006370]		NA	NA	NA	NA	NA	NA
TRINITY_DN2594_c0_g1_i2	Q6NY98	MCE1_DANRE	59.8	189	74	2	133	699	7	193	6.40E-68	258.8	MCE1_DANRE	reviewed	mRNA-capping enzyme [Includes: Polynucleotide 5'-triphosphatase (TPase) (mRNA 5'-triphosphatase) (EC 3.1.3.33); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]	rngtt si:ch211-241P10.5 zgc:76886	Danio rerio (Zebrafish) (Brachydanio rerio)	598	nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]	nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; triphosphatase activity [GO:0050355]	GO:0004484; GO:0004651; GO:0004725; GO:0005525; GO:0005634; GO:0006370; GO:0008138; GO:0050355	7-methylguanosine mRNA capping [GO:0006370]		NA	NA	NA	NA	NA	NA
TRINITY_DN2594_c0_g1_i3	Q6NY98	MCE1_DANRE	55.4	590	243	9	133	1863	7	589	7.30E-179	628.6	MCE1_DANRE	reviewed	mRNA-capping enzyme [Includes: Polynucleotide 5'-triphosphatase (TPase) (mRNA 5'-triphosphatase) (EC 3.1.3.33); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]	rngtt si:ch211-241P10.5 zgc:76886	Danio rerio (Zebrafish) (Brachydanio rerio)	598	nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]	nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; triphosphatase activity [GO:0050355]	GO:0004484; GO:0004651; GO:0004725; GO:0005525; GO:0005634; GO:0006370; GO:0008138; GO:0050355	7-methylguanosine mRNA capping [GO:0006370]		NA	NA	NA	NA	NA	NA
TRINITY_DN4824_c0_g1_i1	Q8IZD4	DCP1B_HUMAN	36.5	211	129	4	1506	883	4	212	5.20E-29	130.6	DCP1B_HUMAN	reviewed	mRNA-decapping enzyme 1B (EC 3.-.-.-)	DCP1B	Homo sapiens (Human)	617	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]	enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]	GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0030234; GO:0031087; GO:0043231; GO:0043928	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4824_c0_g1_i2	Q8IZD4	DCP1B_HUMAN	36.5	197	122	2	1464	883	16	212	3.40E-28	127.9	DCP1B_HUMAN	reviewed	mRNA-decapping enzyme 1B (EC 3.-.-.-)	DCP1B	Homo sapiens (Human)	617	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]	enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]	GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0030234; GO:0031087; GO:0043231; GO:0043928	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4824_c0_g1_i3	Q8IZD4	DCP1B_HUMAN	36.5	197	122	2	1464	883	16	212	2.00E-28	128.6	DCP1B_HUMAN	reviewed	mRNA-decapping enzyme 1B (EC 3.-.-.-)	DCP1B	Homo sapiens (Human)	617	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]	enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]	GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0030234; GO:0031087; GO:0043231; GO:0043928	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11462_c0_g1_i2	Q5ZJX5	MEAK7_CHICK	50.5	214	102	3	702	67	252	463	8.90E-56	218.8	MEAK7_CHICK	reviewed	MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1)	MEAK7 KIAA1609 TLDC1 RCJMB04_14k7	Gallus gallus (Chicken)	468	cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]		GO:0005737; GO:0005765; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032	positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN2670_c0_g1_i1	Q921L7	HEMK1_MOUSE	42.9	294	160	3	951	94	45	338	1.60E-58	228.4	HEMK1_MOUSE	reviewed	MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1)	Hemk1	Mus musculus (Mouse)	340	mitochondrion [GO:0005739]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]	mitochondrion [GO:0005739]	nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein methyltransferase activity [GO:0008276]	GO:0003676; GO:0005739; GO:0008276; GO:0102559			blue	blue	NA	NA	NA	NA
TRINITY_DN2670_c0_g1_i2	Q921L7	HEMK1_MOUSE	42.9	294	160	3	951	94	45	338	1.60E-58	228.4	HEMK1_MOUSE	reviewed	MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1)	Hemk1	Mus musculus (Mouse)	340	mitochondrion [GO:0005739]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]	mitochondrion [GO:0005739]	nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein methyltransferase activity [GO:0008276]	GO:0003676; GO:0005739; GO:0008276; GO:0102559			NA	NA	NA	NA	NA	NA
TRINITY_DN2670_c0_g1_i3	Q921L7	HEMK1_MOUSE	46.8	231	115	3	762	94	108	338	8.30E-50	198.7	HEMK1_MOUSE	reviewed	MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1)	Hemk1	Mus musculus (Mouse)	340	mitochondrion [GO:0005739]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]	mitochondrion [GO:0005739]	nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein methyltransferase activity [GO:0008276]	GO:0003676; GO:0005739; GO:0008276; GO:0102559			NA	NA	NA	NA	NA	NA
TRINITY_DN2670_c0_g1_i4	Q921L7	HEMK1_MOUSE	40.4	319	156	5	1023	94	45	338	1.00E-55	219.2	HEMK1_MOUSE	reviewed	MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1)	Hemk1	Mus musculus (Mouse)	340	mitochondrion [GO:0005739]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]	mitochondrion [GO:0005739]	nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein methyltransferase activity [GO:0008276]	GO:0003676; GO:0005739; GO:0008276; GO:0102559			NA	NA	1	NA	NA	NA
TRINITY_DN37672_c0_g1_i1	Q98UI9	MUC5B_CHICK	51.4	72	32	1	16	222	844	915	3.30E-17	88.6	MUC5B_CHICK	reviewed	"Mucin-5B (Ovomucin, alpha-subunit)"	MUC5B	Gallus gallus (Chicken)	2108	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; virion binding [GO:0046790]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; macrophage activation involved in immune response [GO:0002281]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	virion binding [GO:0046790]	GO:0002281; GO:0005615; GO:0030299; GO:0031012; GO:0042632; GO:0043231; GO:0046790	cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; macrophage activation involved in immune response [GO:0002281]		NA	NA	NA	NA	NA	NA
TRINITY_DN36269_c0_g1_i1	Q8K595	MCLN2_MOUSE	43.2	139	75	1	420	4	300	434	1.20E-25	117.5	MCLN2_MOUSE	reviewed	Mucolipin-2 (Transient receptor potential channel mucolipin 2) (TRPML2)	Mcoln2	Mus musculus (Mouse)	566	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane [GO:0016020]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane [GO:0016020]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]	GO:0002250; GO:0005764; GO:0015031; GO:0016020; GO:0016021; GO:0032722; GO:0042802; GO:0045087; GO:0055037; GO:0055038; GO:0071639; GO:0071642; GO:0071651; GO:0072345; GO:1905517; GO:1990266; GO:2000341; GO:2000343	adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]		NA	NA	NA	NA	NA	NA
TRINITY_DN28187_c0_g1_i1	Q00449	MDR49_DROME	52.9	70	29	2	204	4	1184	1252	1.70E-10	66.2	MDR49_DROME	reviewed	Multidrug resistance protein homolog 49 (EC 7.6.2.2) (P-glycoprotein 49)	Mdr49 CG3879	Drosophila melanogaster (Fruit fly)	1302	ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; xenobiotic transmembrane transporter activity [GO:0042910]; drug transmembrane transport [GO:0006855]; germ cell migration [GO:0008354]; renal tubular secretion [GO:0097254]; response to hypoxia [GO:0001666]; response to insecticide [GO:0017085]; response to toxic substance [GO:0009636]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0001666; GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008354; GO:0008559; GO:0009636; GO:0015562; GO:0016887; GO:0017085; GO:0042626; GO:0042908; GO:0042910; GO:0043190; GO:0055085; GO:0097254	drug transmembrane transport [GO:0006855]; germ cell migration [GO:0008354]; renal tubular secretion [GO:0097254]; response to hypoxia [GO:0001666]; response to insecticide [GO:0017085]; response to toxic substance [GO:0009636]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN13181_c0_g1_i1	P33527	MRP1_HUMAN	69.2	78	24	0	236	3	1415	1492	1.70E-19	96.3	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN2837_c0_g1_i2	Q6UR05	MRP1_CANLF	66.3	205	69	0	679	65	675	879	9.70E-73	274.6	MRP1_CANLF	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP1	Canis lupus familiaris (Dog) (Canis familiaris)	1531	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; xenobiotic transmembrane transporter activity [GO:0042910]; leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0008559; GO:0015431; GO:0016021; GO:0016887; GO:0042493; GO:0042910; GO:0050729; GO:0071716; GO:0140359	leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN2837_c0_g1_i4	O35379	MRP1_MOUSE	64.5	200	71	0	602	3	675	874	1.10E-70	267.7	MRP1_MOUSE	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	Abcc1 Abcc1a Abcc1b Mdrap Mrp	Mus musculus (Mouse)	1528	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008559; GO:0009925; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215; GO:1904646; GO:1990961	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4856_c0_g1_i1	P33527	MRP1_HUMAN	71.6	102	28	1	393	88	1431	1531	5.10E-32	138.7	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN21140_c0_g1_i1	P33527	MRP1_HUMAN	65.6	125	43	0	377	3	433	557	3.10E-44	179.1	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4635_c0_g1_i2	P33527	MRP1_HUMAN	66.6	299	100	0	988	92	1132	1430	1.20E-111	404.4	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4635_c0_g1_i3	P33527	MRP1_HUMAN	68.8	401	124	1	1270	68	1132	1531	5.90E-156	552	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4635_c0_g1_i4	P33527	MRP1_HUMAN	64.5	420	148	1	1327	68	1113	1531	4.60E-151	535.8	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4635_c0_g1_i5	Q8HXQ5	MRP1_BOVIN	65.2	420	145	1	1318	59	1112	1530	1.20E-151	537.7	MRP1_BOVIN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP1	Bos taurus (Bovine)	1530	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular response to amyloid-beta [GO:1904646]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005887; GO:0008559; GO:0009925; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1904646	cellular response to amyloid-beta [GO:1904646]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN4635_c0_g1_i6	P33527	MRP1_HUMAN	69.3	401	122	1	1261	59	1132	1531	2.00E-156	553.5	MRP1_HUMAN	reviewed	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	Homo sapiens (Human)	1531	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ABC-type transmembrane transporter activity [GO:0140359]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646	cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN12736_c0_g1_i1	O15439	MRP4_HUMAN	67.9	84	27	0	292	41	523	606	1.50E-27	123.6	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN34726_c0_g1_i1	O15439	MRP4_HUMAN	37.6	125	77	1	404	30	6	129	9.60E-21	101.3	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i1	O15439	MRP4_HUMAN	50	104	37	1	132	398	1150	1253	3.60E-19	96.3	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i11	O15439	MRP4_HUMAN	68	50	16	0	3	152	1204	1253	5.50E-12	71.2	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i6	O15439	MRP4_HUMAN	70.5	44	13	0	56	187	1210	1253	6.70E-10	64.7	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i7	O15439	MRP4_HUMAN	57.6	151	62	1	6	452	1060	1210	1.30E-44	180.6	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN36550_c0_g1_i1	O15439	MRP4_HUMAN	100	73	0	0	2	220	1048	1120	9.90E-35	146.7	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i1	O15439	MRP4_HUMAN	58.5	123	51	0	1534	1166	1028	1150	3.20E-37	157.9	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i10	O15439	MRP4_HUMAN	57.9	475	196	3	1496	78	819	1291	6.30E-152	538.9	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i3	O15439	MRP4_HUMAN	59.5	363	143	3	1160	78	931	1291	1.80E-117	424.1	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i5	O15439	MRP4_HUMAN	57	86	37	0	336	79	1210	1295	2.40E-21	103.2	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i6	O15439	MRP4_HUMAN	56.3	334	143	2	2164	1166	819	1150	1.20E-100	369	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i8	O15439	MRP4_HUMAN	57.6	479	199	3	1509	79	819	1295	1.30E-152	541.2	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN32589_c0_g1_i1	O15439	MRP4_HUMAN	41.9	74	43	0	222	1	246	319	9.60E-07	54.3	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN37240_c0_g1_i1	O15439	MRP4_HUMAN	50.8	65	31	1	206	15	961	1025	2.30E-09	62.4	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN37240_c0_g1_i2	O15439	MRP4_HUMAN	47.7	65	33	1	206	15	961	1025	3.70E-07	55.1	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN28182_c0_g1_i1	O15439	MRP4_HUMAN	63.6	66	24	0	199	2	554	619	4.20E-17	88.2	MRP4_HUMAN	reviewed	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	ABCC4 MRP4	Homo sapiens (Human)	1325	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]"	GO:0002576; GO:0005524; GO:0005886; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0038183; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115; GO:0150104	bile acid signaling pathway [GO:0038183]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN31446_c0_g1_i1	Q9QYM0	MRP5_RAT	47.8	207	102	2	611	3	1195	1399	5.80E-48	192.2	MRP5_RAT	reviewed	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5)	Abcc5 Abcc5a Mrp5	Rattus norvegicus (Rat)	1436	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005796; GO:0005886; GO:0008514; GO:0010008; GO:0015562; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016887; GO:0032496; GO:0032868; GO:0042626; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0140115	export across plasma membrane [GO:0140115]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN25945_c0_g1_i1	O15440	MRP5_HUMAN	66.4	214	72	0	2	643	1207	1420	8.90E-76	284.6	MRP5_HUMAN	reviewed	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11)	ABCC5 MRP5	Homo sapiens (Human)	1437	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; hyaluronan biosynthetic process [GO:0030213]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005796; GO:0005886; GO:0005887; GO:0008514; GO:0010008; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0030213; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0140115; GO:0150104	export across plasma membrane [GO:0140115]; hyaluronan biosynthetic process [GO:0030213]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN18496_c0_g1_i2	O95255	MRP6_HUMAN	51.2	84	41	0	259	8	1257	1340	9.80E-19	94	MRP6_HUMAN	reviewed	Multidrug resistance-associated protein 6 (ATP-binding cassette sub-family C member 6) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E)	ABCC6 ARA MRP6	Homo sapiens (Human)	1503	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transporter activity [GO:0005215]; response to drug [GO:0042493]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; transporter activity [GO:0005215]	GO:0005215; GO:0005524; GO:0005654; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016887; GO:0042493; GO:0042626; GO:0055085	response to drug [GO:0042493]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN37920_c0_g1_i1	Q5T3U5	MRP7_HUMAN	98	100	2	0	303	4	650	749	8.00E-51	200.7	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15098_c0_g1_i1	Q8R4P9	MRP7_MOUSE	51.3	269	127	1	3	797	1138	1406	1.10E-68	261.5	MRP7_MOUSE	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	Abcc10 Mrp7	Mus musculus (Mouse)	1501	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15098_c0_g1_i10	Q8R4P9	MRP7_MOUSE	51.7	331	156	1	3	983	1138	1468	2.00E-87	323.9	MRP7_MOUSE	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	Abcc10 Mrp7	Mus musculus (Mouse)	1501	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15098_c0_g1_i12	Q5T3U5	MRP7_HUMAN	56.8	176	76	0	1	528	1284	1459	2.20E-51	203.4	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15098_c0_g1_i13	Q5T3U5	MRP7_HUMAN	60.3	78	31	0	35	268	1320	1397	3.10E-22	105.9	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15098_c0_g1_i14	Q5T3U5	MRP7_HUMAN	57.1	140	60	0	35	454	1320	1459	8.70E-41	167.9	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN15098_c0_g1_i9	Q8R4P9	MRP7_MOUSE	43.8	128	68	1	3	374	1138	1265	6.70E-21	101.7	MRP7_MOUSE	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	Abcc10 Mrp7	Mus musculus (Mouse)	1501	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN14240_c0_g1_i1	Q8R4P9	MRP7_MOUSE	53.9	76	35	0	2	229	1005	1080	5.30E-15	81.3	MRP7_MOUSE	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	Abcc10 Mrp7	Mus musculus (Mouse)	1501	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8122_c0_g1_i1	Q5T3U5	MRP7_HUMAN	48.4	124	64	0	393	22	689	812	7.20E-28	124.8	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8122_c0_g1_i3	Q5T3U5	MRP7_HUMAN	51.6	192	93	0	597	22	621	812	2.70E-50	199.9	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8122_c0_g1_i4	Q5T3U5	MRP7_HUMAN	57.4	122	52	0	459	94	621	742	4.30E-32	139	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		brown	brown	NA	NA	NA	NA
TRINITY_DN8122_c0_g1_i5	Q5T3U5	MRP7_HUMAN	51.1	186	91	0	612	55	621	806	2.80E-47	189.9	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8122_c0_g1_i6	Q5T3U5	MRP7_HUMAN	50	84	42	0	306	55	723	806	2.20E-16	86.3	MRP7_HUMAN	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	1492	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		blue	blue	NA	NA	NA	NA
TRINITY_DN14040_c0_g1_i1	Q8R4P9	MRP7_MOUSE	46.9	226	117	1	6	683	387	609	2.60E-49	196.8	MRP7_MOUSE	reviewed	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	Abcc10 Mrp7	Mus musculus (Mouse)	1501	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g1_i2	Q96J65	MRP9_HUMAN	55.4	195	87	0	593	9	505	699	1.50E-61	237.3	MRP9_HUMAN	reviewed	Multidrug resistance-associated protein 9 (ATP-binding cassette sub-family C member 12)	ABCC12 MRP9	Homo sapiens (Human)	1359	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g1_i3	Q96J65	MRP9_HUMAN	58.3	156	65	0	589	122	505	660	5.90E-50	198.7	MRP9_HUMAN	reviewed	Multidrug resistance-associated protein 9 (ATP-binding cassette sub-family C member 12)	ABCC12 MRP9	Homo sapiens (Human)	1359	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN28144_c0_g1_i3	Q80WJ6	MRP9_MOUSE	61.4	158	61	0	3	476	516	673	1.10E-54	214.2	MRP9_MOUSE	reviewed	Multidrug resistance-associated protein 9 (ATP-binding cassette sub-family C member 12)	Abcc12 Mrp9	Mus musculus (Mouse)	1366	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN40433_c0_g1_i1	Q80WJ6	MRP9_MOUSE	49.4	83	42	0	250	2	863	945	8.30E-17	87.4	MRP9_MOUSE	reviewed	Multidrug resistance-associated protein 9 (ATP-binding cassette sub-family C member 12)	Abcc12 Mrp9	Mus musculus (Mouse)	1366	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN6685_c1_g1_i1	A1TDK2	KGD_MYCVP	90.1	81	8	0	245	3	646	726	3.10E-37	155.2	KGD_MYCVP	reviewed	Multifunctional 2-oxoglutarate metabolism enzyme (2-hydroxy-3-oxoadipate synthase) (HOA synthase) (HOAS) (EC 2.2.1.5) (2-oxoglutarate carboxy-lyase) (2-oxoglutarate decarboxylase) (Alpha-ketoglutarate decarboxylase) (KG decarboxylase) (KGD) (EC 4.1.1.71) (Alpha-ketoglutarate-glyoxylate carboligase) [Includes: 2-oxoglutarate dehydrogenase E1 component (ODH E1 component) (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase E1 component) (KDH E1 component); Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex E2 component) (ODH E2 component) (OGDC-E2) (Dihydrolipoamide succinyltransferase)]	kgd Mvan_4477	Mycolicibacterium vanbaalenii (strain DSM 7251 / JCM 13017 / NRRL B-24157 / PYR-1) (Mycobacterium vanbaalenii)	1243	2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; tricarboxylic acid cycle [GO:0006099]		2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004149; GO:0004591; GO:0006099; GO:0008683; GO:0030976; GO:0046872; GO:0050439	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN29010_c0_g1_i1	A1TDK2	KGD_MYCVP	69.2	78	21	2	1	225	613	690	8.90E-23	107.1	KGD_MYCVP	reviewed	Multifunctional 2-oxoglutarate metabolism enzyme (2-hydroxy-3-oxoadipate synthase) (HOA synthase) (HOAS) (EC 2.2.1.5) (2-oxoglutarate carboxy-lyase) (2-oxoglutarate decarboxylase) (Alpha-ketoglutarate decarboxylase) (KG decarboxylase) (KGD) (EC 4.1.1.71) (Alpha-ketoglutarate-glyoxylate carboligase) [Includes: 2-oxoglutarate dehydrogenase E1 component (ODH E1 component) (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase E1 component) (KDH E1 component); Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex E2 component) (ODH E2 component) (OGDC-E2) (Dihydrolipoamide succinyltransferase)]	kgd Mvan_4477	Mycolicibacterium vanbaalenii (strain DSM 7251 / JCM 13017 / NRRL B-24157 / PYR-1) (Mycobacterium vanbaalenii)	1243	2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; tricarboxylic acid cycle [GO:0006099]		2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004149; GO:0004591; GO:0006099; GO:0008683; GO:0030976; GO:0046872; GO:0050439	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN40472_c0_g1_i1	A1TDK2	KGD_MYCVP	67.5	77	25	0	232	2	688	764	2.10E-27	122.5	KGD_MYCVP	reviewed	Multifunctional 2-oxoglutarate metabolism enzyme (2-hydroxy-3-oxoadipate synthase) (HOA synthase) (HOAS) (EC 2.2.1.5) (2-oxoglutarate carboxy-lyase) (2-oxoglutarate decarboxylase) (Alpha-ketoglutarate decarboxylase) (KG decarboxylase) (KGD) (EC 4.1.1.71) (Alpha-ketoglutarate-glyoxylate carboligase) [Includes: 2-oxoglutarate dehydrogenase E1 component (ODH E1 component) (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase E1 component) (KDH E1 component); Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex E2 component) (ODH E2 component) (OGDC-E2) (Dihydrolipoamide succinyltransferase)]	kgd Mvan_4477	Mycolicibacterium vanbaalenii (strain DSM 7251 / JCM 13017 / NRRL B-24157 / PYR-1) (Mycobacterium vanbaalenii)	1243	2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; tricarboxylic acid cycle [GO:0006099]		2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004149; GO:0004591; GO:0006099; GO:0008683; GO:0030976; GO:0046872; GO:0050439	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN7969_c0_g1_i1	Q9VP65	TR112_DROME	51.6	124	60	0	542	171	1	124	1.30E-31	137.9	TR112_DROME	reviewed	Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog)	CG12975	Drosophila melanogaster (Fruit fly)	124	protein heterodimerization activity [GO:0046982]; peptidyl-glutamine methylation [GO:0018364]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]		protein heterodimerization activity [GO:0046982]	GO:0018364; GO:0030488; GO:0031167; GO:0046982; GO:0070476	peptidyl-glutamine methylation [GO:0018364]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]		blue	blue	NA	NA	NA	NA
TRINITY_DN7969_c0_g1_i2	Q9VP65	TR112_DROME	51.6	124	60	0	544	173	1	124	1.30E-31	137.9	TR112_DROME	reviewed	Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog)	CG12975	Drosophila melanogaster (Fruit fly)	124	protein heterodimerization activity [GO:0046982]; peptidyl-glutamine methylation [GO:0018364]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]		protein heterodimerization activity [GO:0046982]	GO:0018364; GO:0030488; GO:0031167; GO:0046982; GO:0070476	peptidyl-glutamine methylation [GO:0018364]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]		blue	blue	NA	NA	NA	NA
TRINITY_DN30154_c0_g1_i2	Q5U367	PLOD3_RAT	59.6	188	76	0	565	2	545	732	7.10E-69	261.5	PLOD3_RAT	reviewed	"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]"	Plod3	Rattus norvegicus (Rat)	741	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]		NA	NA	NA	NA	NA	NA
TRINITY_DN28461_c0_g1_i1	O60568	PLOD3_HUMAN	58.3	48	20	0	46	189	596	643	8.80E-12	70.9	PLOD3_HUMAN	reviewed	"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]"	PLOD3	Homo sapiens (Human)	738	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070062; GO:0070831	basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]		NA	NA	NA	NA	NA	NA
TRINITY_DN29493_c0_g1_i1	O60568	PLOD3_HUMAN	100	74	0	0	224	3	646	719	3.20E-41	168.3	PLOD3_HUMAN	reviewed	"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]"	PLOD3	Homo sapiens (Human)	738	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070062; GO:0070831	basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]		NA	NA	NA	NA	NA	NA
TRINITY_DN31505_c0_g1_i1	Q9R0E1	PLOD3_MOUSE	100	109	0	0	3	329	633	741	5.50E-64	244.6	PLOD3_MOUSE	reviewed	"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]"	Plod3	Mus musculus (Mouse)	741	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]		NA	NA	NA	NA	NA	NA
TRINITY_DN35477_c0_g1_i1	Q9I7S8	PUR6_DROME	60.7	410	160	1	209	1438	15	423	2.50E-145	516.9	PUR6_DROME	reviewed	Multifunctional protein ADE2 (Protein adenosine-5) [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	Paics ade5 CG3989	Drosophila melanogaster (Fruit fly)	429	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]	GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0043727	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN35477_c0_g1_i2	Q9I7S8	PUR6_DROME	61.5	361	138	1	209	1291	15	374	3.00E-129	463.4	PUR6_DROME	reviewed	Multifunctional protein ADE2 (Protein adenosine-5) [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	Paics ade5 CG3989	Drosophila melanogaster (Fruit fly)	429	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]	GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0043727	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN40632_c0_g1_i1	Q9DCL9	PUR6_MOUSE	100	101	0	0	306	4	59	159	1.30E-56	219.9	PUR6_MOUSE	reviewed	Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	Paics	Mus musculus (Mouse)	425	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]	GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0042802; GO:0043727	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN14173_c0_g1_i1	Q9DCL9	PUR6_MOUSE	98.5	332	5	0	2	997	69	400	2.40E-197	689.1	PUR6_MOUSE	reviewed	Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	Paics	Mus musculus (Mouse)	425	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]	GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0042802; GO:0043727	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN14173_c0_g1_i2	Q9DCL9	PUR6_MOUSE	100	245	0	0	1	735	156	400	9.60E-143	507.3	PUR6_MOUSE	reviewed	Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	Paics	Mus musculus (Mouse)	425	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]	GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0042802; GO:0043727	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN39812_c0_g1_i1	P22234	PUR6_HUMAN	100	100	0	0	2	301	274	373	6.20E-56	217.6	PUR6_HUMAN	reviewed	Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	PAICS ADE2 AIRC PAIS	Homo sapiens (Human)	425	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]	GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0009113; GO:0009168; GO:0016020; GO:0042802; GO:0043727; GO:0045296; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]		NA	NA	NA	NA	NA	NA
TRINITY_DN19983_c0_g2_i1	A1ZBD6	MCTP_DROME	65.1	43	15	0	407	535	226	268	1.70E-08	60.8	MCTP_DROME	reviewed	Multiple C2 and transmembrane domain-containing protein	Mctp CG15078	Drosophila melanogaster (Fruit fly)	912	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0030672; GO:0046928; GO:0048168	regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]		NA	NA	NA	NA	NA	NA
TRINITY_DN19983_c0_g2_i2	A1ZBD6	MCTP_DROME	65.1	43	15	0	392	520	226	268	1.70E-08	60.8	MCTP_DROME	reviewed	Multiple C2 and transmembrane domain-containing protein	Mctp CG15078	Drosophila melanogaster (Fruit fly)	912	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0030672; GO:0046928; GO:0048168	regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]		NA	NA	NA	NA	NA	NA
TRINITY_DN19983_c0_g1_i1	A1ZBD6	MCTP_DROME	53.8	582	246	9	1800	61	348	908	2.60E-157	557	MCTP_DROME	reviewed	Multiple C2 and transmembrane domain-containing protein	Mctp CG15078	Drosophila melanogaster (Fruit fly)	912	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0030672; GO:0046928; GO:0048168	regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]		NA	NA	NA	NA	NA	NA
TRINITY_DN19983_c0_g1_i2	A1ZBD6	MCTP_DROME	55	553	233	7	1690	38	348	886	2.70E-156	553.5	MCTP_DROME	reviewed	Multiple C2 and transmembrane domain-containing protein	Mctp CG15078	Drosophila melanogaster (Fruit fly)	912	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0030672; GO:0046928; GO:0048168	regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]		NA	NA	NA	NA	NA	NA
TRINITY_DN19983_c0_g1_i3	A1ZBD6	MCTP_DROME	54.2	577	246	8	1785	61	348	908	4.00E-158	559.7	MCTP_DROME	reviewed	Multiple C2 and transmembrane domain-containing protein	Mctp CG15078	Drosophila melanogaster (Fruit fly)	912	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0030672; GO:0046928; GO:0048168	regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]		NA	NA	NA	NA	NA	NA
TRINITY_DN19983_c0_g1_i4	A1ZBD6	MCTP_DROME	54.5	558	233	8	1705	38	348	886	1.80E-155	550.8	MCTP_DROME	reviewed	Multiple C2 and transmembrane domain-containing protein	Mctp CG15078	Drosophila melanogaster (Fruit fly)	912	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0030672; GO:0046928; GO:0048168	regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]		NA	NA	NA	NA	NA	NA
TRINITY_DN34362_c0_g1_i1	Q8NI22	MCFD2_HUMAN	51.7	60	27	1	207	34	48	107	2.10E-08	59.3	MCFD2_HUMAN	reviewed	Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein)	MCFD2 SDNSF	Homo sapiens (Human)	146	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]	calcium ion binding [GO:0005509]	GO:0000139; GO:0005509; GO:0005789; GO:0006888; GO:0012507; GO:0015031; GO:0018279; GO:0033116; GO:0048208	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN36824_c0_g1_i1	Q8K5B2	MCFD2_MOUSE	100	70	0	0	211	2	41	110	1.60E-34	146	MCFD2_MOUSE	reviewed	Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein)	Mcfd2 Sdnsf	Mus musculus (Mouse)	145	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192; GO:0019752; GO:0060548	carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN514_c0_g1_i2	A6BM72	MEG11_HUMAN	38.2	102	59	2	826	527	25	124	3.20E-16	87.4	MEG11_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	MEGF11 KIAA1781 UNQ1949/PRO4432	Homo sapiens (Human)	1044	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]		GO:0010842; GO:0016021; GO:0016323; GO:0034109	homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN514_c0_g1_i3	A6BM72	MEG11_HUMAN	38.2	102	59	2	729	430	25	124	2.80E-16	87.4	MEG11_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	MEGF11 KIAA1781 UNQ1949/PRO4432	Homo sapiens (Human)	1044	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]		GO:0010842; GO:0016021; GO:0016323; GO:0034109	homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN514_c0_g1_i3	A6BM72	MEG11_HUMAN	50	28	14	0	265	182	97	124	2.50E-04	47.8	MEG11_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	MEGF11 KIAA1781 UNQ1949/PRO4432	Homo sapiens (Human)	1044	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]		GO:0010842; GO:0016021; GO:0016323; GO:0034109	homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN514_c0_g1_i4	A6BM72	MEG11_HUMAN	35.9	64	39	1	194	3	63	124	1.80E-07	56.2	MEG11_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	MEGF11 KIAA1781 UNQ1949/PRO4432	Homo sapiens (Human)	1044	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]		GO:0010842; GO:0016021; GO:0016323; GO:0034109	homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN514_c0_g1_i5	A6BM72	MEG11_HUMAN	39.2	102	58	2	758	459	25	124	1.30E-16	88.6	MEG11_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	MEGF11 KIAA1781 UNQ1949/PRO4432	Homo sapiens (Human)	1044	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]		GO:0010842; GO:0016021; GO:0016323; GO:0034109	homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN7854_c0_g1_i1	Q7Z7M0	MEGF8_HUMAN	37.2	549	291	12	1681	65	1810	2314	8.80E-99	362.5	MEGF8_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)	MEGF8 C19orf49 EGFL4 KIAA0817	Homo sapiens (Human)	2845	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]	GO:0003143; GO:0005509; GO:0005634; GO:0009887; GO:0009888; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0070062; GO:0071907; GO:0097094; GO:0097155	animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN7531_c0_g1_i1	Q7Z7M0	MEGF8_HUMAN	36.3	168	63	4	547	137	2649	2803	2.90E-11	70.1	MEGF8_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)	MEGF8 C19orf49 EGFL4 KIAA0817	Homo sapiens (Human)	2845	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]	GO:0003143; GO:0005509; GO:0005634; GO:0009887; GO:0009888; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0070062; GO:0071907; GO:0097094; GO:0097155	animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]		brown	brown	NA	NA	NA	NA
TRINITY_DN31131_c0_g1_i1	Q9QYP0	MEGF8_RAT	49.6	113	44	1	302	3	1065	1177	1.10E-28	127.5	MEGF8_RAT	reviewed	Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)	Megf8 Egfl4	Rattus norvegicus (Rat)	2788	extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]	extracellular region [GO:0005576]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]	GO:0003143; GO:0005509; GO:0005576; GO:0005634; GO:0007368; GO:0009887; GO:0009888; GO:0010468; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0071907; GO:0097094; GO:0097155	animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]		NA	NA	NA	NA	NA	NA
TRINITY_DN27538_c0_g1_i1	Q8VBX6	MPDZ_MOUSE	62.5	88	33	0	39	302	1967	2054	1.10E-24	114	MPDZ_MOUSE	reviewed	Multiple PDZ domain protein (Multi-PDZ domain protein 1)	Mpdz Mupp1	Mus musculus (Mouse)	2055	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; myelination [GO:0042552]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]	protein C-terminus binding [GO:0008022]	GO:0005737; GO:0005923; GO:0007155; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0031410; GO:0042552; GO:0043220	cell adhesion [GO:0007155]; myelination [GO:0042552]		NA	NA	NA	NA	NA	NA
TRINITY_DN33121_c0_g1_i1	Q8VBX6	MPDZ_MOUSE	55.3	103	43	2	46	348	1140	1241	3.30E-21	102.8	MPDZ_MOUSE	reviewed	Multiple PDZ domain protein (Multi-PDZ domain protein 1)	Mpdz Mupp1	Mus musculus (Mouse)	2055	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; myelination [GO:0042552]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]	protein C-terminus binding [GO:0008022]	GO:0005737; GO:0005923; GO:0007155; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0031410; GO:0042552; GO:0043220	cell adhesion [GO:0007155]; myelination [GO:0042552]		NA	NA	NA	NA	NA	NA
TRINITY_DN26619_c0_g1_i1	O75970	MPDZ_HUMAN	64.4	194	69	0	671	90	1616	1809	6.90E-66	251.9	MPDZ_HUMAN	reviewed	Multiple PDZ domain protein (Multi-PDZ domain protein 1)	MPDZ MUPP1	Homo sapiens (Human)	2070	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]	protein C-terminus binding [GO:0008022]	GO:0005737; GO:0005923; GO:0007155; GO:0008022; GO:0014069; GO:0016032; GO:0016324; GO:0016327; GO:0030425; GO:0031410; GO:0043220	cell adhesion [GO:0007155]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN35348_c0_g1_i1	P38205	NCL1_YEAST	55.7	97	37	1	277	5	229	325	1.90E-27	122.9	NCL1_YEAST	reviewed	Multisite-specific tRNA:(cytosine-C(5))-methyltransferase (EC 2.1.1.202) (Multisite-specific tRNA:m5C-methyltransferase) (tRNA (cytosine-5-)-methyltransferase NCL1) (tRNA methyltransferase 4)	NCL1 TRM4 YBL024W YBL0437	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	684	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-cysteine [GO:0036346]; regulation of metabolic process [GO:0019222]; regulation of translation [GO:0006417]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA wobble base cytosine methylation [GO:0002127]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0002127; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006400; GO:0006417; GO:0008168; GO:0016428; GO:0019222; GO:0030488; GO:0036346; GO:0070301	cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-cysteine [GO:0036346]; regulation of metabolic process [GO:0019222]; regulation of translation [GO:0006417]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA wobble base cytosine methylation [GO:0002127]		NA	NA	NA	NA	NA	NA
TRINITY_DN3606_c0_g1_i2	Q08647	PUS7_YEAST	46.3	54	26	2	212	60	40	93	6.00E-05	48.1	PUS7_YEAST	reviewed	Multisubstrate pseudouridine synthase 7 (EC 5.4.99.-) (EC 5.4.99.27) (RNA pseudouridylate synthase 7) (RNA-uridine isomerase 7) (tRNA pseudouridine(13) synthase)	PUS7 YOR243C O5254	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	676	box H/ACA snoRNP complex [GO:0031429]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; RNA splicing [GO:0008380]; snRNA pseudouridine synthesis [GO:0031120]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119]	box H/ACA snoRNP complex [GO:0031429]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]	GO:0000455; GO:0001522; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006400; GO:0008380; GO:0009982; GO:0031119; GO:0031120; GO:0031429; GO:0106029; GO:1990481	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; RNA splicing [GO:0008380]; snRNA pseudouridine synthesis [GO:0031120]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119]		blue	blue	NA	NA	NA	NA
TRINITY_DN1008_c0_g1_i19	Q03626	MUG1_RAT	37.4	757	418	15	2339	177	743	1479	1.90E-134	481.5	MUG1_RAT	reviewed	Murinoglobulin-1 (Alpha-1 inhibitor 3 variant I) (Alpha-X protein)	Mug1 A1i3	Rattus norvegicus (Rat)	1487	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]	extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0006953; GO:0006954; GO:0007566; GO:0030414	acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]		NA	NA	1	NA	NA	NA
TRINITY_DN1008_c0_g1_i23	Q03626	MUG1_RAT	37.4	757	418	15	2339	177	743	1479	1.90E-134	481.5	MUG1_RAT	reviewed	Murinoglobulin-1 (Alpha-1 inhibitor 3 variant I) (Alpha-X protein)	Mug1 A1i3	Rattus norvegicus (Rat)	1487	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]	extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0006953; GO:0006954; GO:0007566; GO:0030414	acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]		NA	NA	NA	NA	NA	NA
TRINITY_DN1008_c0_g1_i24	Q03626	MUG1_RAT	37.4	757	418	15	2339	177	743	1479	1.90E-134	481.5	MUG1_RAT	reviewed	Murinoglobulin-1 (Alpha-1 inhibitor 3 variant I) (Alpha-X protein)	Mug1 A1i3	Rattus norvegicus (Rat)	1487	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]	extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0006953; GO:0006954; GO:0007566; GO:0030414	acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]		NA	NA	NA	NA	NA	NA
TRINITY_DN1008_c0_g1_i26	Q03626	MUG1_RAT	37.4	757	418	15	2339	177	743	1479	1.90E-134	481.5	MUG1_RAT	reviewed	Murinoglobulin-1 (Alpha-1 inhibitor 3 variant I) (Alpha-X protein)	Mug1 A1i3	Rattus norvegicus (Rat)	1487	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]	extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0006953; GO:0006954; GO:0007566; GO:0030414	acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]		blue	blue	NA	NA	NA	NA
TRINITY_DN1944_c0_g1_i1	P28666	MUG2_MOUSE	27	556	364	11	313	1938	86	613	1.00E-40	169.9	MUG2_MOUSE	reviewed	Murinoglobulin-2 (MuG2)	Mug2 Mug-2	Mus musculus (Mouse)	1451	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615			NA	NA	NA	NA	NA	NA
TRINITY_DN28772_c0_g1_i1	Q09388	ACM2_CAEEL	44.9	69	37	1	2	205	112	180	5.00E-12	71.2	ACM2_CAEEL	reviewed	Muscarinic acetylcholine receptor gar-2 (G-protein-linked acetylcholine receptor 2)	gar-2 F47D12.1	Caenorhabditis elegans	627	"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]"	axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]	GO:0004930; GO:0004993; GO:0005887; GO:0007186; GO:0007187; GO:0007213; GO:0007268; GO:0007271; GO:0016907; GO:0030424; GO:0030425; GO:0030594; GO:0032223; GO:0042493; GO:0045202	"chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37811_c0_g1_i1	Q09388	ACM2_CAEEL	50	62	26	1	241	71	563	624	1.20E-12	73.6	ACM2_CAEEL	reviewed	Muscarinic acetylcholine receptor gar-2 (G-protein-linked acetylcholine receptor 2)	gar-2 F47D12.1	Caenorhabditis elegans	627	"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]"	axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]	GO:0004930; GO:0004993; GO:0005887; GO:0007186; GO:0007187; GO:0007213; GO:0007268; GO:0007271; GO:0016907; GO:0030424; GO:0030425; GO:0030594; GO:0032223; GO:0042493; GO:0045202	"chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5104_c0_g1_i1	Q24400	MLP2_DROME	71.2	66	19	0	249	52	25	90	1.00E-22	107.1	MLP2_DROME	reviewed	Muscle LIM protein Mlp84B	Mlp84B LIM3 CG1019	Drosophila melanogaster (Fruit fly)	495	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]	metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]	GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0045214; GO:0046872; GO:0060537	actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]		blue	blue	1	NA	NA	NA
TRINITY_DN24065_c0_g1_i2	O01761	UNC89_CAEEL	31.1	135	92	1	124	525	3442	3576	8.60E-11	68.6	UNC89_CAEEL	reviewed	Muscle M-line assembly protein unc-89 (Inactive serine/threonine-protein kinase unc-89) (Obscurin) (Uncoordinated protein 89)	unc-89 C09D1.1	Caenorhabditis elegans	8081	A band [GO:0031672]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]	A band [GO:0031672]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]	ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004672; GO:0005089; GO:0005524; GO:0005887; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905	cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]		NA	NA	NA	NA	NA	NA
TRINITY_DN24000_c1_g1_i1	P14318	MP20_DROME	52.5	99	46	1	294	1	26	124	5.60E-26	118.6	MP20_DROME	reviewed	Muscle-specific protein 20	Mp20 Tpn CG4696	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]		GO:0005737; GO:0007520; GO:1901739	myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]		NA	NA	NA	NA	NA	NA
TRINITY_DN24000_c1_g1_i2	P14318	MP20_DROME	50.9	110	53	1	327	1	15	124	5.00E-29	128.6	MP20_DROME	reviewed	Muscle-specific protein 20	Mp20 Tpn CG4696	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]		GO:0005737; GO:0007520; GO:1901739	myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]		NA	NA	NA	NA	NA	NA
TRINITY_DN11106_c0_g1_i1	P14318	MP20_DROME	58.2	184	76	1	44	592	1	184	7.40E-59	228.4	MP20_DROME	reviewed	Muscle-specific protein 20	Mp20 Tpn CG4696	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]		GO:0005737; GO:0007520; GO:1901739	myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]		NA	NA	NA	NA	NA	NA
TRINITY_DN11106_c0_g1_i2	P14318	MP20_DROME	55.6	63	28	0	62	250	122	184	5.20E-15	81.6	MP20_DROME	reviewed	Muscle-specific protein 20	Mp20 Tpn CG4696	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]		GO:0005737; GO:0007520; GO:1901739	myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]		brown	brown	1	NA	NA	NA
TRINITY_DN18696_c0_g1_i1	P14318	MP20_DROME	41.1	73	40	1	1	210	103	175	9.80E-08	57	MP20_DROME	reviewed	Muscle-specific protein 20	Mp20 Tpn CG4696	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]		GO:0005737; GO:0007520; GO:1901739	myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]		NA	NA	NA	NA	NA	NA
TRINITY_DN33394_c0_g1_i1	P14318	MP20_DROME	48.4	91	46	1	290	18	45	134	1.00E-15	84	MP20_DROME	reviewed	Muscle-specific protein 20	Mp20 Tpn CG4696	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]		GO:0005737; GO:0007520; GO:1901739	myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]		NA	NA	NA	NA	NA	NA
TRINITY_DN38994_c0_g1_i1	Q7ZYM8	MSD3_XENLA	35.9	78	50	0	346	113	13	90	9.70E-08	58.2	MSD3_XENLA	reviewed	Myb/SANT-like DNA-binding domain-containing protein 3	msantd3	Xenopus laevis (African clawed frog)	365							NA	NA	NA	NA	NA	NA
TRINITY_DN6338_c0_g1_i2	O35821	MBB1A_RAT	28.9	128	77	1	1117	734	582	695	1.70E-05	52	MBB1A_RAT	reviewed	Myb-binding protein 1A (PAR-interacting protein) (PIP)	Mybbp1a	Rattus norvegicus (Rat)	1344	"cytoplasm [GO:0005737]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleus [GO:0005634]; E-box binding [GO:0070888]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]"	cytoplasm [GO:0005737]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleus [GO:0005634]	E-box binding [GO:0070888]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0008134; GO:0022904; GO:0032922; GO:0042149; GO:0042254; GO:0042564; GO:0043565; GO:0045892; GO:0070888; GO:0071158; GO:0072332; GO:2000210	"cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i16	Q9R9J1	MYCA_BACIU	32.4	275	163	12	826	17	3253	3509	2.90E-23	110.5	MYCA_BACIU	reviewed	Mycosubtilin synthase subunit A (EC 2.3.1.-) [Includes: Glutamate-1-semialdehyde aminotransferase (GSA-AT); ATP-dependent asparagine adenylase 1 (AsnA 1) (Asparagine activase 1)]	mycA	Bacillus subtilis	3971	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; antibiotic biosynthetic process [GO:0017000]; fatty acid biosynthetic process [GO:0006633]		3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0004315; GO:0006633; GO:0008483; GO:0016874; GO:0017000; GO:0030170; GO:0031177	antibiotic biosynthetic process [GO:0017000]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i18	Q9R9J1	MYCA_BACIU	33.7	261	150	12	822	55	3253	3495	8.50E-23	109	MYCA_BACIU	reviewed	Mycosubtilin synthase subunit A (EC 2.3.1.-) [Includes: Glutamate-1-semialdehyde aminotransferase (GSA-AT); ATP-dependent asparagine adenylase 1 (AsnA 1) (Asparagine activase 1)]	mycA	Bacillus subtilis	3971	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; antibiotic biosynthetic process [GO:0017000]; fatty acid biosynthetic process [GO:0006633]		3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0004315; GO:0006633; GO:0008483; GO:0016874; GO:0017000; GO:0030170; GO:0031177	antibiotic biosynthetic process [GO:0017000]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i1	Q9R9I9	MYCC_BACIU	34.1	123	80	1	427	62	396	518	2.40E-13	77	MYCC_BACIU	reviewed	Mycosubtilin synthase subunit C (EC 2.3.1.-) [Includes: ATP-dependent serine adenylase (SerA) (Serine activase); ATP-dependent asparagine adenylase 3 (AsnA 3) (Asparagine activase 3)]	mycC	Bacillus subtilis	2609	"hydrolase activity, acting on ester bonds [GO:0016788]; transferase activity [GO:0016740]; antibiotic biosynthetic process [GO:0017000]"		"hydrolase activity, acting on ester bonds [GO:0016788]; transferase activity [GO:0016740]"	GO:0016740; GO:0016788; GO:0017000	antibiotic biosynthetic process [GO:0017000]		NA	NA	NA	NA	NA	NA
TRINITY_DN2710_c0_g1_i1	Q8C854	MYEF2_MOUSE	40.5	74	39	1	134	340	514	587	7.00E-08	58.5	MYEF2_MOUSE	reviewed	Myelin expression factor 2 (MEF-2) (MyEF-2)	Myef2 Kiaa1341 Mef2	Mus musculus (Mouse)	591	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]"	GO:0000122; GO:0000978; GO:0001227; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0071014; GO:1990904; GO:2000815	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]		NA	NA	NA	NA	NA	NA
TRINITY_DN2288_c0_g1_i1	Q8C854	MYEF2_MOUSE	38	279	128	5	5	808	92	336	2.30E-43	177.6	MYEF2_MOUSE	reviewed	Myelin expression factor 2 (MEF-2) (MyEF-2)	Myef2 Kiaa1341 Mef2	Mus musculus (Mouse)	591	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]"	GO:0000122; GO:0000978; GO:0001227; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0071014; GO:1990904; GO:2000815	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c11_g1_i1	P24158	PRTN3_HUMAN	33.6	107	68	3	211	531	54	157	3.40E-07	56.6	PRTN3_HUMAN	reviewed	Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)	PRTN3 MBN	Homo sapiens (Human)	256	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; enzyme binding [GO:0019899]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; antimicrobial humoral response [GO:0019730]; blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; mature conventional dendritic cell differentiation [GO:0097029]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of phagocytosis [GO:0050765]; neutrophil degranulation [GO:0043312]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; proteolysis [GO:0006508]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]	enzyme binding [GO:0019899]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]	GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0006909; GO:0007596; GO:0008236; GO:0008284; GO:0019221; GO:0019730; GO:0019899; GO:0030574; GO:0035578; GO:0043312; GO:0043547; GO:0044853; GO:0045217; GO:0050765; GO:0070062; GO:0072672; GO:0097029	antimicrobial humoral response [GO:0019730]; blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; collagen catabolic process [GO:0030574]; cytokine-mediated signaling pathway [GO:0019221]; mature conventional dendritic cell differentiation [GO:0097029]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of phagocytosis [GO:0050765]; neutrophil degranulation [GO:0043312]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN37544_c0_g1_i1	P28698	MZF1_HUMAN	61.1	90	35	0	3	272	538	627	1.00E-31	137.1	MZF1_HUMAN	reviewed	Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42)	MZF1 MZF ZNF42 ZSCAN6	Homo sapiens (Human)	734	"nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0006355; GO:0042803; GO:0045944; GO:0046872	"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i2	P28698	MZF1_HUMAN	48.1	79	39	2	2	238	545	621	3.30E-15	82	MZF1_HUMAN	reviewed	Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42)	MZF1 MZF ZNF42 ZSCAN6	Homo sapiens (Human)	734	"nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0006355; GO:0042803; GO:0045944; GO:0046872	"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i14	P28698	MZF1_HUMAN	44.6	74	37	2	475	696	631	700	1.30E-08	61.6	MZF1_HUMAN	reviewed	Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42)	MZF1 MZF ZNF42 ZSCAN6	Homo sapiens (Human)	734	"nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0006355; GO:0042803; GO:0045944; GO:0046872	"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34399_c0_g1_i1	Q69ZN7	MYOF_MOUSE	42.5	73	42	0	33	251	373	445	5.60E-12	71.6	MYOF_MOUSE	reviewed	Myoferlin (Fer-1-like protein 3)	Myof Fer1l3 Kiaa1207	Mus musculus (Mouse)	2048	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; membrane fusion [GO:0061025]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0001778; GO:0005543; GO:0005886; GO:0005901; GO:0006071; GO:0007009; GO:0007520; GO:0016021; GO:0030659; GO:0030947; GO:0031410; GO:0031965; GO:0033292; GO:0034605; GO:0043231; GO:0046872; GO:0048747; GO:0061025	cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; membrane fusion [GO:0061025]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN27889_c0_g1_i1	Q9NZM1	MYOF_HUMAN	55.6	36	16	0	133	26	1049	1084	3.60E-05	48.5	MYOF_HUMAN	reviewed	Myoferlin (Fer-1-like protein 3)	MYOF FER1L3 KIAA1207	Homo sapiens (Human)	2061	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; blood circulation [GO:0008015]; cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0001778; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006071; GO:0006936; GO:0007009; GO:0007520; GO:0008015; GO:0016021; GO:0030659; GO:0030947; GO:0031410; GO:0031965; GO:0033292; GO:0034605; GO:0043231; GO:0046872; GO:0048747; GO:0061025; GO:0070062	blood circulation [GO:0008015]; cellular response to heat [GO:0034605]; glycerol metabolic process [GO:0006071]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN33388_c0_g1_i1	B3DLH6	MYOF_XENTR	52.7	55	25	1	169	5	79	132	1.50E-10	66.6	MYOF_XENTR	reviewed	Myoferlin (Fer-1-like protein 3)	myof fer1l3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1929	caveola [GO:0005901]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; membrane fusion [GO:0061025]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]	caveola [GO:0005901]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0001778; GO:0005543; GO:0005901; GO:0007009; GO:0007520; GO:0016021; GO:0030659; GO:0031965; GO:0046872; GO:0061025	membrane fusion [GO:0061025]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]		blue	blue	NA	NA	NA	NA
TRINITY_DN13717_c0_g1_i2	Q69ZQ1	MYORG_MOUSE	39	485	276	8	1506	91	236	713	2.10E-99	364.4	MYORG_MOUSE	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Nuclear envelope transmembrane protein 37) (Uncharacterized family 31 glucosidase KIAA1161)	Myorg Kiaa1161 Net37	Mus musculus (Mouse)	716	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN13717_c0_g1_i3	Q69ZQ1	MYORG_MOUSE	35.3	309	191	5	1519	602	236	538	1.70E-56	221.9	MYORG_MOUSE	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Nuclear envelope transmembrane protein 37) (Uncharacterized family 31 glucosidase KIAA1161)	Myorg Kiaa1161 Net37	Mus musculus (Mouse)	716	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN13717_c0_g1_i3	Q69ZQ1	MYORG_MOUSE	46.2	173	82	3	579	91	542	713	2.40E-34	148.3	MYORG_MOUSE	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Nuclear envelope transmembrane protein 37) (Uncharacterized family 31 glucosidase KIAA1161)	Myorg Kiaa1161 Net37	Mus musculus (Mouse)	716	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN13717_c0_g1_i5	Q69ZQ1	MYORG_MOUSE	38.8	565	322	11	1737	91	157	713	3.00E-114	414.1	MYORG_MOUSE	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Nuclear envelope transmembrane protein 37) (Uncharacterized family 31 glucosidase KIAA1161)	Myorg Kiaa1161 Net37	Mus musculus (Mouse)	716	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN2089_c0_g1_i1	Q6NSJ0	MYORG_HUMAN	28.6	569	346	11	1738	83	185	710	8.50E-60	233.4	MYORG_HUMAN	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	MYORG KIAA1161	Homo sapiens (Human)	714	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN2089_c0_g1_i2	Q6NSJ0	MYORG_HUMAN	28.6	569	346	11	1738	83	185	710	8.10E-60	233.4	MYORG_HUMAN	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	MYORG KIAA1161	Homo sapiens (Human)	714	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		pink	pink	NA	NA	NA	NA
TRINITY_DN13717_c0_g1_i1	Q6NSJ0	MYORG_HUMAN	40.5	121	70	2	450	91	592	711	1.30E-15	84.3	MYORG_HUMAN	reviewed	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	MYORG KIAA1161	Homo sapiens (Human)	714	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]		NA	NA	NA	NA	NA	NA
TRINITY_DN24946_c0_g1_i1	P22816	MYOD_DROME	37.3	110	55	2	328	2	77	173	2.30E-09	63.5	MYOD_DROME	reviewed	Myogenic-determination protein (Protein nautilus) (dMyd)	nau MYD CG10250	Drosophila melanogaster (Fruit fly)	332	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; determination of muscle attachment site [GO:0016204]; larval somatic muscle development [GO:0007526]; muscle organ development [GO:0007517]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005737; GO:0007517; GO:0007526; GO:0016204; GO:0030154; GO:0045663; GO:0045944; GO:0046983; GO:1901741	cell differentiation [GO:0030154]; determination of muscle attachment site [GO:0016204]; larval somatic muscle development [GO:0007526]; muscle organ development [GO:0007517]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN26247_c0_g1_i1	Q3B7N9	MYNN_BOVIN	37.3	102	63	1	1	303	333	434	1.30E-16	87	MYNN_BOVIN	reviewed	Myoneurin	MYNN	Bos taurus (Bovine)	581	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN637_c0_g1_i11	Q99MD8	MYNN_MOUSE	40	90	43	1	302	33	304	382	2.80E-14	79.3	MYNN_MOUSE	reviewed	Myoneurin	Mynn	Mus musculus (Mouse)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18900_c0_g1_i1	Q3B7N9	MYNN_BOVIN	50.9	53	26	0	1	159	329	381	8.20E-10	63.9	MYNN_BOVIN	reviewed	Myoneurin	MYNN	Bos taurus (Bovine)	581	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34367_c0_g1_i1	Q99MD8	MYNN_MOUSE	47.1	87	43	2	286	26	310	393	3.50E-16	85.5	MYNN_MOUSE	reviewed	Myoneurin	Mynn	Mus musculus (Mouse)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN1269_c3_g1_i3	Q99MD8	MYNN_MOUSE	33.8	228	142	3	68	745	275	495	4.00E-35	149.8	MYNN_MOUSE	reviewed	Myoneurin	Mynn	Mus musculus (Mouse)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2518_c0_g1_i1	Q9NPC7	MYNN_HUMAN	46.4	69	37	0	226	20	469	537	2.10E-12	72.8	MYNN_HUMAN	reviewed	Myoneurin (Zinc finger and BTB domain-containing protein 31)	MYNN OSZF ZBTB31 SBBIZ1	Homo sapiens (Human)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10728_c0_g1_i1	Q9NPC7	MYNN_HUMAN	27.3	165	107	3	611	156	358	522	2.10E-11	71.2	MYNN_HUMAN	reviewed	Myoneurin (Zinc finger and BTB domain-containing protein 31)	MYNN OSZF ZBTB31 SBBIZ1	Homo sapiens (Human)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24142_c0_g1_i1	Q9NPC7	MYNN_HUMAN	98.8	86	1	0	2	259	418	503	1.60E-47	189.5	MYNN_HUMAN	reviewed	Myoneurin (Zinc finger and BTB domain-containing protein 31)	MYNN OSZF ZBTB31 SBBIZ1	Homo sapiens (Human)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24142_c0_g1_i2	Q9NPC7	MYNN_HUMAN	98.7	77	1	0	1	231	427	503	1.20E-41	169.9	MYNN_HUMAN	reviewed	Myoneurin (Zinc finger and BTB domain-containing protein 31)	MYNN OSZF ZBTB31 SBBIZ1	Homo sapiens (Human)	610	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0046872; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29873_c0_g1_i1	Q86TC9	MYPN_HUMAN	34.2	79	44	1	233	21	431	509	3.80E-06	52.4	MYPN_HUMAN	reviewed	Myopalladin (145 kDa sarcomeric protein)	MYPN MYOP	Homo sapiens (Human)	1320	axon [GO:0030424]; I band [GO:0031674]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; cytoskeletal protein binding [GO:0008092]; muscle alpha-actinin binding [GO:0051371]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; sarcomere organization [GO:0045214]	axon [GO:0030424]; I band [GO:0031674]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; cytoskeletal protein binding [GO:0008092]; muscle alpha-actinin binding [GO:0051371]; SH3 domain binding [GO:0017124]	GO:0003779; GO:0005634; GO:0005886; GO:0007156; GO:0007411; GO:0008092; GO:0017124; GO:0030018; GO:0030424; GO:0031674; GO:0045214; GO:0051371; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN21602_c0_g1_i1	Q24799	MYPH_ECHGR	41.5	183	98	4	630	97	8	186	3.60E-33	143.3	MYPH_ECHGR	reviewed	Myophilin		Echinococcus granulosus (Hydatid tapeworm)	190							blue	blue	NA	NA	NA	NA
TRINITY_DN40202_c0_g1_i1	P19706	MYSB_ACACA	50	74	32	1	208	2	342	415	1.40E-14	79.7	MYSB_ACACA	reviewed	Myosin heavy chain IB (Myosin heavy chain IL)	MIB MIL	Acanthamoeba castellanii (Amoeba)	1147	myosin complex [GO:0016459]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]	myosin complex [GO:0016459]	actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0003774; GO:0003779; GO:0005524; GO:0016459			NA	NA	NA	NA	NA	NA
TRINITY_DN8202_c0_g1_i4	P05661	MYSA_DROME	63.3	349	127	1	1816	773	503	851	2.20E-132	474.2	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	1	NA	NA	NA
TRINITY_DN4803_c0_g1_i12	P05661	MYSA_DROME	59.5	158	63	1	121	591	10	167	1.10E-54	214.5	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	1	NA	NA	NA
TRINITY_DN2055_c0_g1_i1	P05661	MYSA_DROME	49.7	745	375	0	2337	103	1160	1904	8.40E-135	482.6	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i14	P05661	MYSA_DROME	65.8	193	65	1	127	702	10	202	6.60E-72	271.9	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	1	NA	NA	NA
TRINITY_DN4803_c0_g1_i17	P05661	MYSA_DROME	66.1	437	147	1	116	1423	10	446	1.60E-168	594	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	1	NA	NA	NA
TRINITY_DN4803_c0_g1_i17	P05661	MYSA_DROME	87.2	47	6	0	1530	1390	470	516	9.00E-18	93.2	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	1	NA	NA	NA
TRINITY_DN8202_c0_g1_i1	P05661	MYSA_DROME	67.9	184	58	1	619	71	503	686	4.10E-70	265.8	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8202_c0_g1_i10	P05661	MYSA_DROME	67.1	474	156	0	2157	736	378	851	7.60E-191	668.7	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8202_c0_g1_i11	P05661	MYSA_DROME	64.8	474	167	0	2194	773	378	851	9.80E-186	651.7	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8202_c0_g1_i2	P05661	MYSA_DROME	67.4	546	178	0	2373	736	306	851	9.80E-221	768.1	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8202_c0_g1_i3	P05661	MYSA_DROME	68.5	73	23	0	278	60	306	378	1.90E-22	106.3	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		brown	brown	NA	NA	NA	NA
TRINITY_DN8202_c0_g1_i6	P05661	MYSA_DROME	65.4	546	189	0	2410	773	306	851	1.30E-215	751.1	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12038_c0_g1_i1	P05661	MYSA_DROME	59.4	298	121	0	9	902	682	979	3.60E-62	240.4	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26363_c0_g1_i1	P05661	MYSA_DROME	52.8	72	34	0	4	219	1635	1706	6.40E-10	64.3	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34677_c0_g1_i1	P05661	MYSA_DROME	71.9	57	16	0	3	173	1428	1484	8.50E-17	87	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34677_c0_g1_i2	P05661	MYSA_DROME	73.2	56	15	0	3	170	1428	1483	2.70E-16	85.5	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34719_c0_g1_i1	P05661	MYSA_DROME	63.5	74	27	0	226	5	1255	1328	1.40E-18	93.6	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25633_c0_g1_i1	P05661	MYSA_DROME	74.5	102	26	0	1	306	1323	1424	5.80E-33	141.4	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30417_c0_g1_i1	P05661	MYSA_DROME	72.4	58	16	0	61	234	1323	1380	7.60E-17	87.4	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37301_c0_g1_i1	P05661	MYSA_DROME	79.4	63	13	0	252	64	1471	1533	3.80E-22	105.1	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35708_c0_g1_i1	P05661	MYSA_DROME	47.9	73	37	1	250	32	1252	1323	5.90E-13	74.7	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c1_g1_i1	P05661	MYSA_DROME	82.1	95	17	0	286	2	214	308	8.30E-41	167.5	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i10	P05661	MYSA_DROME	63.4	437	158	2	121	1425	10	446	1.10E-159	564.7	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i10	P05661	MYSA_DROME	87.2	47	6	0	1532	1392	470	516	9.00E-18	93.2	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i16	P05661	MYSA_DROME	64	203	73	0	81	689	244	446	9.00E-70	265	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i16	P05661	MYSA_DROME	87.2	47	6	0	796	656	470	516	4.70E-18	93.2	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i2	P05661	MYSA_DROME	58.2	158	65	1	121	591	10	167	6.10E-53	208.8	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i4	P05661	MYSA_DROME	65	437	152	1	127	1434	10	446	2.20E-165	583.6	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i4	P05661	MYSA_DROME	87.2	47	6	0	1541	1401	470	516	9.10E-18	93.2	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g1_i9	P05661	MYSA_DROME	58.2	158	65	1	121	591	10	167	2.80E-53	209.9	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g2_i1	P05661	MYSA_DROME	59.8	107	41	1	2	316	281	387	4.20E-30	132.1	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c0_g2_i2	P05661	MYSA_DROME	58.3	120	50	0	2	361	281	400	2.60E-35	149.4	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11794_c0_g1_i2	P05661	MYSA_DROME	53.6	755	350	0	2286	22	1160	1914	7.30E-165	582.4	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34214_c0_g1_i1	P05661	MYSA_DROME	69.9	73	22	0	39	257	1251	1323	5.60E-20	98.2	MYSA_DROME	reviewed	"Myosin heavy chain, muscle"	Mhc CG17927	Drosophila melanogaster (Fruit fly)	1962	"A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"	A band [GO:0031672]; myosin complex [GO:0016459]; polytene chromosome puff [GO:0005703]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0030898; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689	"adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i6	Q99323	MYSN_DROME	83.7	473	77	0	1562	144	511	983	1.70E-231	803.5	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	1	NA	NA	NA
TRINITY_DN317_c0_g1_i11	Q99323	MYSN_DROME	82.8	547	94	0	1784	144	437	983	3.50E-267	922.2	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i12	Q99323	MYSN_DROME	84.6	104	16	0	398	87	513	616	5.60E-45	182.6	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i13	Q99323	MYSN_DROME	84.6	104	16	0	398	87	513	616	5.30E-45	182.6	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i14	Q99323	MYSN_DROME	82.8	547	94	0	1784	144	437	983	3.50E-267	922.2	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i17	Q99323	MYSN_DROME	77.4	882	178	2	2726	144	102	983	0	1366.3	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		blue	blue	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i18	Q99323	MYSN_DROME	83.7	473	77	0	1562	144	511	983	1.70E-231	803.5	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i19	Q99323	MYSN_DROME	81.1	180	34	0	626	87	437	616	3.80E-81	302.8	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i20	Q99323	MYSN_DROME	84	106	17	0	404	87	511	616	2.40E-45	183.7	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i21	Q99323	MYSN_DROME	92.9	56	4	0	254	87	561	616	5.00E-24	112.5	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i8	Q99323	MYSN_DROME	70.3	37	11	0	188	78	437	473	1.80E-08	59.7	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i9	Q99323	MYSN_DROME	83.9	471	76	0	1556	144	513	983	3.00E-231	802.7	MYSN_DROME	reviewed	"Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)"	zip CG15792	Drosophila melanogaster (Fruit fly)	2057	"actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"	actomyosin contractile ring [GO:0005826]; apicomedial cortex [GO:0106037]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0000281; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005929; GO:0005938; GO:0006936; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007455; GO:0007496; GO:0008258; GO:0016460; GO:0030018; GO:0030239; GO:0030898; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042802; GO:0044291; GO:0045214; GO:0046663; GO:0046664; GO:0060289; GO:0060571; GO:0070986; GO:0071260; GO:0090175; GO:0106037; GO:1901739; GO:1903688	"anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; positive regulation of border follicle cell migration [GO:1903688]; regulation of establishment of planar polarity [GO:0090175]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11794_c0_g2_i1	P24733	MYS_ARGIR	65.7	178	61	0	544	11	1746	1923	3.10E-53	209.5	MYS_ARGIR	reviewed	"Myosin heavy chain, striated muscle"		Argopecten irradians (Bay scallop) (Aequipecten irradians)	1938	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN36856_c0_g1_i1	P24733	MYS_ARGIR	77.5	71	16	0	40	252	1561	1631	5.00E-22	104.8	MYS_ARGIR	reviewed	"Myosin heavy chain, striated muscle"		Argopecten irradians (Bay scallop) (Aequipecten irradians)	1938	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN11794_c0_g1_i6	P24733	MYS_ARGIR	47.1	750	397	0	2314	65	1153	1902	7.60E-160	565.8	MYS_ARGIR	reviewed	"Myosin heavy chain, striated muscle"		Argopecten irradians (Bay scallop) (Aequipecten irradians)	1938	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015			NA	NA	1	NA	NA	NA
TRINITY_DN1231_c0_g1_i1	Q24756	MLC1_DROVI	53.7	149	68	1	587	141	2	149	1.10E-41	171.4	MLC1_DROVI	reviewed	Myosin light chain alkali	Mlc1	Drosophila virilis (Fruit fly)	155	muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]	muscle myosin complex [GO:0005859]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005859; GO:0007498	mesoderm development [GO:0007498]		blue	blue	1	NA	NA	1
TRINITY_DN1231_c0_g1_i2	Q24756	MLC1_DROVI	54.7	150	67	1	641	192	2	150	5.50E-42	172.6	MLC1_DROVI	reviewed	Myosin light chain alkali	Mlc1	Drosophila virilis (Fruit fly)	155	muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]	muscle myosin complex [GO:0005859]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005859; GO:0007498	mesoderm development [GO:0007498]		NA	NA	NA	NA	NA	NA
TRINITY_DN1231_c0_g1_i3	Q24756	MLC1_DROVI	54.4	147	66	1	539	99	2	147	1.80E-41	170.6	MLC1_DROVI	reviewed	Myosin light chain alkali	Mlc1	Drosophila virilis (Fruit fly)	155	muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]	muscle myosin complex [GO:0005859]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005859; GO:0007498	mesoderm development [GO:0007498]		NA	NA	NA	NA	NA	NA
TRINITY_DN1231_c0_g1_i4	Q24756	MLC1_DROVI	54.7	150	67	1	593	144	2	150	5.10E-42	172.6	MLC1_DROVI	reviewed	Myosin light chain alkali	Mlc1	Drosophila virilis (Fruit fly)	155	muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; mesoderm development [GO:0007498]	muscle myosin complex [GO:0005859]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005859; GO:0007498	mesoderm development [GO:0007498]		NA	NA	NA	NA	NA	NA
TRINITY_DN1522_c0_g1_i1	P11799	MYLK_CHICK	61.1	216	84	0	650	3	1464	1679	1.10E-73	277.7	MYLK_CHICK	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Gallus gallus (Chicken)	1906	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]	GO:0001725; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006939; GO:0014820; GO:0030027; GO:0032154; GO:0046872	smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]		NA	NA	NA	NA	NA	NA
TRINITY_DN1522_c0_g1_i2	P11799	MYLK_CHICK	60	180	72	0	615	76	1464	1643	3.20E-59	229.6	MYLK_CHICK	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Gallus gallus (Chicken)	1906	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]	GO:0001725; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006939; GO:0014820; GO:0030027; GO:0032154; GO:0046872	smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]		NA	NA	NA	NA	NA	NA
TRINITY_DN31519_c0_g1_i1	Q15746	MYLK_HUMAN	35	140	83	3	8	403	564	703	1.40E-13	77.4	MYLK_HUMAN	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	MYLK MLCK MLCK1 MYLK1	Homo sapiens (Human)	1914	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]	GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006936; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]		NA	NA	NA	NA	NA	NA
TRINITY_DN3825_c0_g1_i2	P60661	MYL6_BOVIN	100	151	0	0	17	469	1	151	6.10E-84	311.6	MYL6_BOVIN	reviewed	Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3)	MYL6	Bos taurus (Bovine)	151	brush border [GO:0005903]; cytosol [GO:0005829]; unconventional myosin complex [GO:0016461]; actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307]	brush border [GO:0005903]; cytosol [GO:0005829]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307]	GO:0005509; GO:0005829; GO:0005903; GO:0008307; GO:0016461; GO:0030898			NA	NA	NA	NA	NA	NA
TRINITY_DN3825_c0_g1_i3	P60661	MYL6_BOVIN	100	151	0	0	17	469	1	151	6.10E-84	311.6	MYL6_BOVIN	reviewed	Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3)	MYL6	Bos taurus (Bovine)	151	brush border [GO:0005903]; cytosol [GO:0005829]; unconventional myosin complex [GO:0016461]; actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307]	brush border [GO:0005903]; cytosol [GO:0005829]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307]	GO:0005509; GO:0005829; GO:0005903; GO:0008307; GO:0016461; GO:0030898			NA	NA	NA	NA	NA	NA
TRINITY_DN3825_c0_g1_i1	Q64119	MYL6_RAT	99.3	151	1	0	17	469	1	151	2.80E-83	309.3	MYL6_RAT	reviewed	Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6)	Myl6	Rattus norvegicus (Rat)	151	myosin complex [GO:0016459]; unconventional myosin complex [GO:0016461]; actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519]	myosin complex [GO:0016459]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005509; GO:0006936; GO:0007519; GO:0008307; GO:0016459; GO:0016461; GO:0030049; GO:0030898	muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN3825_c0_g1_i4	Q64119	MYL6_RAT	99.3	151	1	0	17	469	1	151	1.60E-83	310.1	MYL6_RAT	reviewed	Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6)	Myl6	Rattus norvegicus (Rat)	151	myosin complex [GO:0016459]; unconventional myosin complex [GO:0016461]; actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519]	myosin complex [GO:0016459]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005509; GO:0006936; GO:0007519; GO:0008307; GO:0016459; GO:0016461; GO:0030049; GO:0030898	muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g2_i1	P19105	ML12A_HUMAN	100	171	0	0	53	565	1	171	1.40E-94	347.1	ML12A_HUMAN	reviewed	"Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)"	MYL12A MLCB MRLC3 RLC	Homo sapiens (Human)	171	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005829; GO:0006936; GO:0016459; GO:0070062; GO:0070527	muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g2_i2	P19105	ML12A_HUMAN	99.4	171	1	0	53	565	1	171	4.10E-94	345.5	ML12A_HUMAN	reviewed	"Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)"	MYL12A MLCB MRLC3 RLC	Homo sapiens (Human)	171	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005829; GO:0006936; GO:0016459; GO:0070062; GO:0070527	muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g1_i2	O14950	ML12B_HUMAN	100	172	0	0	41	556	1	172	8.20E-95	347.8	ML12B_HUMAN	reviewed	"Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)"	MYL12B MRLC2 MYLC2B	Homo sapiens (Human)	172	apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex region [GO:0099738]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; muscle contraction [GO:0006936]; regulation of cell shape [GO:0008360]	apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex region [GO:0099738]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0005829; GO:0005903; GO:0006936; GO:0008360; GO:0016460; GO:0030018; GO:0032036; GO:0045177; GO:0070062; GO:0099738	muscle contraction [GO:0006936]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g1_i4	O14950	ML12B_HUMAN	100	172	0	0	57	572	1	172	1.10E-94	347.4	ML12B_HUMAN	reviewed	"Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)"	MYL12B MRLC2 MYLC2B	Homo sapiens (Human)	172	apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex region [GO:0099738]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; muscle contraction [GO:0006936]; regulation of cell shape [GO:0008360]	apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex region [GO:0099738]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0005829; GO:0005903; GO:0006936; GO:0008360; GO:0016460; GO:0030018; GO:0032036; GO:0045177; GO:0070062; GO:0099738	muscle contraction [GO:0006936]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g1_i7	O14950	ML12B_HUMAN	99.4	172	1	0	33	548	1	172	4.00E-94	345.5	ML12B_HUMAN	reviewed	"Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)"	MYL12B MRLC2 MYLC2B	Homo sapiens (Human)	172	apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex region [GO:0099738]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; muscle contraction [GO:0006936]; regulation of cell shape [GO:0008360]	apical part of cell [GO:0045177]; brush border [GO:0005903]; cell cortex region [GO:0099738]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0005829; GO:0005903; GO:0006936; GO:0008360; GO:0016460; GO:0030018; GO:0032036; GO:0045177; GO:0070062; GO:0099738	muscle contraction [GO:0006936]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN38130_c0_g1_i1	Q1HPS0	MLR_BOMMO	65.5	87	30	0	261	1	38	124	3.70E-26	118.6	MLR_BOMMO	reviewed	Myosin regulatory light chain 2 (MLC-2)		Bombyx mori (Silk moth)	201	myosin complex [GO:0016459]; calcium ion binding [GO:0005509]	myosin complex [GO:0016459]	calcium ion binding [GO:0005509]	GO:0005509; GO:0016459			NA	NA	NA	NA	NA	NA
TRINITY_DN23025_c0_g1_i1	P40423	SQH_DROME	77.4	115	26	0	7	351	31	145	3.10E-46	185.7	SQH_DROME	reviewed	"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)"	sqh CG3595	Drosophila melanogaster (Fruit fly)	174	"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"	actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688	"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35457_c0_g1_i1	P40423	SQH_DROME	85.2	81	12	0	3	245	38	118	5.90E-36	151.4	SQH_DROME	reviewed	"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)"	sqh CG3595	Drosophila melanogaster (Fruit fly)	174	"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"	actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688	"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21270_c1_g1_i1	P40423	SQH_DROME	66.2	80	27	0	2	241	95	174	4.70E-23	108.2	SQH_DROME	reviewed	"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)"	sqh CG3595	Drosophila melanogaster (Fruit fly)	174	"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"	actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688	"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c1_g1_i1	P40423	SQH_DROME	83.9	174	26	2	637	122	1	174	1.50E-79	297.4	SQH_DROME	reviewed	"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)"	sqh CG3595	Drosophila melanogaster (Fruit fly)	174	"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"	actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688	"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10168_c0_g2_i1	P40423	SQH_DROME	79	105	22	0	1	315	70	174	2.30E-46	186	SQH_DROME	reviewed	"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)"	sqh CG3595	Drosophila melanogaster (Fruit fly)	174	"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"	actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688	"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26587_c0_g1_i1	P40423	SQH_DROME	75	48	12	0	3	146	76	123	1.80E-15	82.8	SQH_DROME	reviewed	"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)"	sqh CG3595	Drosophila melanogaster (Fruit fly)	174	"actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"	actomyosin contractile ring actin filament [GO:1903144]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cellularization cleavage furrow invagination front [GO:0110071]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688	"actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g1_i1	Q9CQ19	MYL9_MOUSE	86.6	119	16	0	57	413	1	119	3.60E-54	212.2	MYL9_MOUSE	reviewed	"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)"	Myl9 Myrl2	Mus musculus (Mouse)	172	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0016460; GO:0030018; GO:0032036			NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g1_i5	Q9CQ19	MYL9_MOUSE	97.1	172	5	0	57	572	1	172	3.40E-93	342.4	MYL9_MOUSE	reviewed	"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)"	Myl9 Myrl2	Mus musculus (Mouse)	172	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0016460; GO:0030018; GO:0032036			NA	NA	NA	NA	NA	NA
TRINITY_DN5080_c0_g1_i6	Q9CQ19	MYL9_MOUSE	87.2	109	14	0	1	327	11	119	1.90E-50	199.5	MYL9_MOUSE	reviewed	"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)"	Myl9 Myrl2	Mus musculus (Mouse)	172	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0016460; GO:0030018; GO:0032036			NA	NA	NA	NA	NA	NA
TRINITY_DN10168_c0_g1_i3	Q9CQ19	MYL9_MOUSE	91.7	36	3	0	1	108	45	80	1.50E-12	73.6	MYL9_MOUSE	reviewed	"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)"	Myl9 Myrl2	Mus musculus (Mouse)	172	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]	GO:0001725; GO:0005509; GO:0016460; GO:0030018; GO:0032036			blue	blue	NA	NA	NA	NA
TRINITY_DN33734_c0_g1_i1	P08964	MYO1_YEAST	56.1	57	25	0	182	12	62	118	5.70E-11	67.8	MYO1_YEAST	reviewed	Myosin-1 (Type II myosin)	MYO1 YHR023W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1928	cellular bud neck [GO:0005935]; cellular bud neck contractile ring [GO:0000142]; incipient cellular bud site [GO:0000131]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin II light chain binding [GO:0032033]; myosin light chain binding [GO:0032027]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic actomyosin contractile ring contraction [GO:1902404]; primary cell septum biogenesis [GO:0031671]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; septum digestion after cytokinesis [GO:0000920]	cellular bud neck [GO:0005935]; cellular bud neck contractile ring [GO:0000142]; incipient cellular bud site [GO:0000131]; myosin II complex [GO:0016460]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin II light chain binding [GO:0032033]; myosin light chain binding [GO:0032027]	GO:0000131; GO:0000142; GO:0000146; GO:0000920; GO:0005524; GO:0005935; GO:0016460; GO:0031671; GO:0032027; GO:0032033; GO:0051015; GO:1902404; GO:1903475; GO:1904498	mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic actomyosin contractile ring contraction [GO:1902404]; primary cell septum biogenesis [GO:0031671]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; septum digestion after cytokinesis [GO:0000920]		NA	NA	NA	NA	NA	NA
TRINITY_DN32926_c0_g1_i1	P10587	MYH11_CHICK	55.1	136	61	0	417	10	1644	1779	2.90E-27	122.9	MYH11_CHICK	reviewed	"Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle)"	MYH11	Gallus gallus (Chicken)	1979	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; magnesium ion binding [GO:0000287]; microfilament motor activity [GO:0000146]; myosin II binding [GO:0045159]; myosin light chain binding [GO:0032027]; structural constituent of muscle [GO:0008307]; cardiac muscle fiber development [GO:0048739]; elastic fiber assembly [GO:0048251]; myofibril assembly [GO:0030239]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939]	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; magnesium ion binding [GO:0000287]; microfilament motor activity [GO:0000146]; myosin II binding [GO:0045159]; myosin light chain binding [GO:0032027]; structural constituent of muscle [GO:0008307]	GO:0000146; GO:0000287; GO:0003779; GO:0005516; GO:0005524; GO:0005859; GO:0006939; GO:0008307; GO:0030016; GO:0030239; GO:0030241; GO:0030898; GO:0032027; GO:0032982; GO:0043531; GO:0045159; GO:0048251; GO:0048739; GO:0051015	cardiac muscle fiber development [GO:0048739]; elastic fiber assembly [GO:0048251]; myofibril assembly [GO:0030239]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939]		NA	NA	NA	NA	NA	NA
TRINITY_DN32774_c0_g1_i1	P35748	MYH11_RABIT	43.8	249	140	0	1	747	1154	1402	6.80E-43	175.6	MYH11_RABIT	reviewed	"Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)"	MYH11	Oryctolagus cuniculus (Rabbit)	1972	melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin II binding [GO:0045159]; structural constituent of muscle [GO:0008307]; cardiac muscle fiber development [GO:0048739]; elastic fiber assembly [GO:0048251]; myofibril assembly [GO:0030239]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939]	melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin II binding [GO:0045159]; structural constituent of muscle [GO:0008307]	GO:0000146; GO:0005516; GO:0005524; GO:0005859; GO:0006939; GO:0008307; GO:0030016; GO:0030239; GO:0030241; GO:0030898; GO:0032982; GO:0042470; GO:0045159; GO:0048251; GO:0048739; GO:0051015	cardiac muscle fiber development [GO:0048739]; elastic fiber assembly [GO:0048251]; myofibril assembly [GO:0030239]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939]		blue	blue	NA	NA	NA	NA
TRINITY_DN40811_c0_g1_i1	F4IUG9	MYO13_ARATH	57.8	64	27	0	25	216	434	497	3.90E-15	81.6	MYO13_ARATH	reviewed	Myosin-13 (Myosin XI G) (AtXIG)	XI-G XIG At2g20290 F11A3.16	Arabidopsis thaliana (Mouse-ear cress)	1493	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; root hair elongation [GO:0048767]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]	GO:0000146; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0015629; GO:0016459; GO:0030048; GO:0030050; GO:0030898; GO:0031982; GO:0048767; GO:0051015	actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; root hair elongation [GO:0048767]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN3628_c0_g1_i1	Q6URW6	MYH14_MOUSE	46	372	201	0	1190	75	1528	1899	3.60E-47	190.7	MYH14_MOUSE	reviewed	"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)"	Myh14	Mus musculus (Mouse)	2000	actomyosin [GO:0042641]; axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625]	actomyosin [GO:0042641]; axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0001725; GO:0003009; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007519; GO:0007605; GO:0008360; GO:0016459; GO:0016460; GO:0016887; GO:0019228; GO:0030048; GO:0030424; GO:0030426; GO:0030898; GO:0031032; GO:0042641; GO:0043209; GO:0051015; GO:0070584; GO:0071625; GO:0097513	actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625]		blue	blue	NA	NA	NA	NA
TRINITY_DN25378_c0_g1_i1	F1PT61	MYH16_CANLF	59.6	141	54	2	29	445	151	290	1.50E-40	167.2	MYH16_CANLF	reviewed	Myosin-16 (Myosin heavy chain 16)	MYH16	Canis lupus familiaris (Dog) (Canis familiaris)	1930	myofibril [GO:0030016]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0016459; GO:0030016; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN40581_c0_g1_i1	F1PT61	MYH16_CANLF	96	50	2	0	2	151	478	527	1.20E-22	107.1	MYH16_CANLF	reviewed	Myosin-16 (Myosin heavy chain 16)	MYH16	Canis lupus familiaris (Dog) (Canis familiaris)	1930	myofibril [GO:0030016]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0016459; GO:0030016; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN18210_c0_g1_i1	F4K5J1	MYO17_ARATH	53.8	143	54	2	412	20	82	224	3.10E-37	156	MYO17_ARATH	reviewed	Myosin-17 (Myosin XI K) (AtXIK)	XI-K XIK At5g20490 F7C8.80	Arabidopsis thaliana (Mouse-ear cress)	1531	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; plasmodesma [GO:0009506]; root hair tip [GO:0035619]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cell division [GO:0051301]; fruit development [GO:0010154]; Golgi localization [GO:0051645]; gynoecium development [GO:0048467]; leaf pavement cell development [GO:0090436]; mitochondrion localization [GO:0051646]; peroxisome localization [GO:0060151]; post-embryonic development [GO:0009791]; root hair cell tip growth [GO:0048768]; root hair elongation [GO:0048767]; trichome branching [GO:0010091]; trichome morphogenesis [GO:0010090]; unidimensional cell growth [GO:0009826]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; plasmodesma [GO:0009506]; root hair tip [GO:0035619]; transport vesicle [GO:0030133]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]	GO:0000146; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0009506; GO:0009791; GO:0009826; GO:0010090; GO:0010091; GO:0010154; GO:0015629; GO:0016459; GO:0030048; GO:0030050; GO:0030133; GO:0030898; GO:0031982; GO:0035619; GO:0048467; GO:0048767; GO:0048768; GO:0051015; GO:0051301; GO:0051645; GO:0051646; GO:0060151; GO:0090436	actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; cell division [GO:0051301]; fruit development [GO:0010154]; Golgi localization [GO:0051645]; gynoecium development [GO:0048467]; leaf pavement cell development [GO:0090436]; mitochondrion localization [GO:0051646]; peroxisome localization [GO:0060151]; post-embryonic development [GO:0009791]; root hair cell tip growth [GO:0048768]; root hair elongation [GO:0048767]; trichome branching [GO:0010091]; trichome morphogenesis [GO:0010090]; unidimensional cell growth [GO:0009826]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN33910_c0_g1_i1	P54357	MLC2_DROME	71.4	63	18	0	76	264	2	64	4.10E-19	95.1	MLC2_DROME	reviewed	Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)	Mlc-c CG3201	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]	calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]	GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036	actin filament-based movement [GO:0030048]		NA	NA	NA	NA	NA	NA
TRINITY_DN17839_c0_g1_i1	P54357	MLC2_DROME	63.1	176	34	1	568	41	2	146	2.50E-54	213.4	MLC2_DROME	reviewed	Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)	Mlc-c CG3201	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]	calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]	GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036	actin filament-based movement [GO:0030048]		NA	NA	NA	NA	NA	NA
TRINITY_DN17839_c0_g1_i2	P54357	MLC2_DROME	77.2	145	33	0	475	41	2	146	5.90E-60	231.9	MLC2_DROME	reviewed	Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)	Mlc-c CG3201	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]	calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]	GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036	actin filament-based movement [GO:0030048]		blue	blue	NA	NA	NA	NA
TRINITY_DN17839_c0_g1_i3	P54357	MLC2_DROME	69.6	56	17	0	316	149	2	57	1.30E-16	87.4	MLC2_DROME	reviewed	Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)	Mlc-c CG3201	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]	calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]	GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036	actin filament-based movement [GO:0030048]		NA	NA	NA	NA	NA	NA
TRINITY_DN30009_c0_g1_i1	P54357	MLC2_DROME	69.4	72	22	0	216	1	24	95	3.60E-21	101.7	MLC2_DROME	reviewed	Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)	Mlc-c CG3201	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]	cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]	calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]	GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036	actin filament-based movement [GO:0030048]		NA	NA	NA	NA	NA	NA
TRINITY_DN25287_c0_g1_i1	Q9Y623	MYH4_HUMAN	44.9	69	38	0	3	209	1182	1250	1.70E-07	56.2	MYH4_HUMAN	reviewed	"Myosin-4 (Myosin heavy chain 2b) (MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb) (MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal)"	MYH4	Homo sapiens (Human)	1939	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]	actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003725; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0016887; GO:0030016; GO:0030017; GO:0030048; GO:0030049; GO:0032982; GO:0046034; GO:0051015	actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]		NA	NA	NA	NA	NA	NA
TRINITY_DN36472_c0_g1_i1	P79293	MYH7_PIG	70.8	96	28	0	288	1	493	588	8.10E-35	147.5	MYH7_PIG	reviewed	"Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta)"	MYH7	Sus scrofa (Pig)	1935	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0030017; GO:0032982; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN34786_c0_g1_i1	P02564	MYH7_RAT	46.8	62	33	0	3	188	1037	1098	3.90E-09	61.6	MYH7_RAT	reviewed	"Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta)"	Myh7	Rattus norvegicus (Rat)	1935	"cytoplasm [GO:0005737]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein-containing complex binding [GO:0044877]; adult heart development [GO:0007512]; aging [GO:0007568]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to angiotensin [GO:1904385]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"	cytoplasm [GO:0005737]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein-containing complex binding [GO:0044877]	GO:0000146; GO:0001725; GO:0002026; GO:0002027; GO:0003009; GO:0005516; GO:0005524; GO:0005737; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0007568; GO:0014728; GO:0014883; GO:0014898; GO:0016459; GO:0016887; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0030898; GO:0031449; GO:0032982; GO:0042802; GO:0044877; GO:0046034; GO:0051015; GO:0055010; GO:0060048; GO:1904385; GO:1905243	"adult heart development [GO:0007512]; aging [GO:0007568]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to angiotensin [GO:1904385]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29925_c0_g1_i1	Q8VDD5	MYH9_MOUSE	97.7	523	12	0	1571	3	350	872	7.50E-302	1036.9	MYH9_MOUSE	reviewed	"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)"	Myh9	Mus musculus (Mouse)	1960	"actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]; uropod [GO:0001931]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]"	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]; uropod [GO:0001931]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]	GO:0000146; GO:0000212; GO:0000904; GO:0001525; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007520; GO:0008180; GO:0008360; GO:0015031; GO:0015629; GO:0016459; GO:0016460; GO:0016887; GO:0019904; GO:0030048; GO:0030220; GO:0030224; GO:0030863; GO:0030898; GO:0031032; GO:0031252; GO:0031532; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032991; GO:0042641; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0051015; GO:0051295; GO:0097513; GO:0098609; GO:1903919; GO:1903923; GO:1905684	"actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell morphogenesis involved in differentiation [GO:0000904]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18023_c0_g1_i1	P14105	MYH9_CHICK	94.7	94	5	0	284	3	67	160	8.60E-47	187.2	MYH9_CHICK	reviewed	"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)"	MYH9	Gallus gallus (Chicken)	1959	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myosin complex [GO:0016459]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; protein-membrane adaptor activity [GO:0043495]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myosin complex [GO:0016459]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; protein self-association [GO:0043621]	GO:0000146; GO:0001525; GO:0001725; GO:0001726; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0006509; GO:0008360; GO:0015031; GO:0015629; GO:0016459; GO:0016887; GO:0030048; GO:0030220; GO:0030224; GO:0031034; GO:0031252; GO:0031532; GO:0032154; GO:0032506; GO:0032991; GO:0042803; GO:0043495; GO:0043534; GO:0043621; GO:0051015	actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN18023_c0_g1_i2	P35579	MYH9_HUMAN	100	232	0	0	698	3	67	298	3.60E-131	468.8	MYH9_HUMAN	reviewed	"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)"	MYH9	Homo sapiens (Human)	1960	"actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]"	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723]	GO:0000146; GO:0000212; GO:0001525; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0003723; GO:0003774; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005826; GO:0005829; GO:0005886; GO:0005903; GO:0005912; GO:0005925; GO:0006509; GO:0006911; GO:0007229; GO:0007520; GO:0008360; GO:0015031; GO:0015629; GO:0016020; GO:0016460; GO:0016887; GO:0019904; GO:0030048; GO:0030220; GO:0030224; GO:0030898; GO:0031032; GO:0031252; GO:0031532; GO:0031594; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032991; GO:0042641; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045296; GO:0050900; GO:0051015; GO:0051295; GO:0070062; GO:0070527; GO:0097513; GO:1903919; GO:1903923; GO:1905684	"actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25549_c0_g1_i1	P14105	MYH9_CHICK	96.3	27	1	0	308	228	1497	1523	9.50E-07	54.3	MYH9_CHICK	reviewed	"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)"	MYH9	Gallus gallus (Chicken)	1959	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myosin complex [GO:0016459]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; protein-membrane adaptor activity [GO:0043495]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myosin complex [GO:0016459]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; protein self-association [GO:0043621]	GO:0000146; GO:0001525; GO:0001725; GO:0001726; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0006509; GO:0008360; GO:0015031; GO:0015629; GO:0016459; GO:0016887; GO:0030048; GO:0030220; GO:0030224; GO:0031034; GO:0031252; GO:0031532; GO:0032154; GO:0032506; GO:0032991; GO:0042803; GO:0043495; GO:0043534; GO:0043621; GO:0051015	actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN26206_c0_g1_i1	Q258K2	MYH9_CANLF	100	87	0	0	3	263	721	807	9.60E-45	180.3	MYH9_CANLF	reviewed	"Myosin-9 (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)"	MYH9	Canis lupus familiaris (Dog) (Canis familiaris)	1960	"actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; myosin complex [GO:0016459]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]; vesicle targeting [GO:0006903]"	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; myosin complex [GO:0016459]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]	GO:0000146; GO:0001525; GO:0001725; GO:0001726; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0006509; GO:0006903; GO:0006911; GO:0007155; GO:0008360; GO:0015031; GO:0015629; GO:0016459; GO:0016887; GO:0030048; GO:0030220; GO:0030224; GO:0031252; GO:0031532; GO:0032154; GO:0032506; GO:0032991; GO:0042803; GO:0043495; GO:0043534; GO:0051015; GO:0070382; GO:1903919; GO:1903923	"actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]; vesicle targeting [GO:0006903]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1224_c0_g1_i1	Q9U1M8	MYOI_DICDI	44	754	396	9	2378	135	15	748	1.10E-166	588.6	MYOI_DICDI	reviewed	Myosin-I heavy chain (Class VII unconventional myosin) (DdMVII) (DdM7)	myoI DDB_G0274455	Dictyostelium discoideum (Slime mold)	2357	actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]	GO:0000146; GO:0000902; GO:0001891; GO:0003774; GO:0003779; GO:0005524; GO:0005737; GO:0005829; GO:0006909; GO:0007015; GO:0008017; GO:0009847; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0030050; GO:0030175; GO:0030898; GO:0031252; GO:0031589; GO:0031982; GO:0032433; GO:0043621; GO:0046847; GO:0051015	actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847]; vesicle transport along actin filament [GO:0030050]		blue	blue	NA	NA	NA	NA
TRINITY_DN4862_c0_g1_i6	Q9TW28	MYOM_DICDI	31.9	191	118	4	893	327	1390	1570	5.80E-16	86.7	MYOM_DICDI	reviewed	Myosin-M heavy chain (RhoGEF domain-containing protein myoM)	myoM racGEF DDB_G0292262	Dictyostelium discoideum (Slime mold)	1737	actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; pseudopodium organization [GO:0031268]; regulation of Rac protein signal transduction [GO:0035020]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005085; GO:0005524; GO:0005737; GO:0006971; GO:0006972; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031268; GO:0031982; GO:0035020; GO:0042995; GO:0051015	actin filament organization [GO:0007015]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; pseudopodium organization [GO:0031268]; regulation of Rac protein signal transduction [GO:0035020]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN15175_c1_g1_i1	Q17LW0	MYO7A_AEDAE	91.3	69	6	0	246	40	2095	2163	1.60E-30	133.3	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN15175_c1_g1_i2	Q17LW0	MYO7A_AEDAE	81.8	165	30	0	534	40	1999	2163	1.50E-76	287	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN38577_c0_g1_i1	Q17LW0	MYO7A_AEDAE	88.5	78	9	0	236	3	584	661	6.90E-34	144.1	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN2894_c0_g1_i1	Q17LW0	MYO7A_AEDAE	26.1	448	282	15	337	1626	1130	1546	1.60E-26	122.9	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN2894_c0_g1_i2	Q17LW0	MYO7A_AEDAE	22.6	1073	686	33	337	3276	1130	2150	2.40E-50	202.6	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN31056_c0_g1_i1	Q17LW0	MYO7A_AEDAE	86.7	60	8	0	49	228	191	250	5.60E-25	114.4	MYO7A_AEDAE	reviewed	Myosin-VIIa (Protein crinkled)	ck AAEL001220	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	2163	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN37389_c0_g1_i1	Q3T0F7	MTPN_BOVIN	100	101	0	0	9	311	1	101	1.90E-55	216.1	MTPN_BOVIN	reviewed	Myotrophin	MTPN	Bos taurus (Bovine)	118	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0005634; GO:0005737; GO:0005829; GO:0008290; GO:0008361; GO:0010557; GO:0010613; GO:0030307; GO:0030424; GO:0048471; GO:0051092; GO:0051247; GO:2000812	positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN374_c1_g1_i1	Q7T2B9	MTPN_DANRE	55.6	117	50	2	97	444	2	117	3.40E-28	126.3	MTPN_DANRE	reviewed	Myotrophin	mtpn	Danio rerio (Zebrafish) (Brachydanio rerio)	118	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; regulation of barbed-end actin filament capping [GO:2000812]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0005634; GO:0005737; GO:0048471; GO:2000812	regulation of barbed-end actin filament capping [GO:2000812]		blue	blue	NA	NA	NA	NA
TRINITY_DN30195_c0_g1_i1	Q13496	MTM1_HUMAN	100	90	0	0	2	271	339	428	4.00E-46	184.9	MTM1_HUMAN	reviewed	"Myotubularin (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTM1 CG2	Homo sapiens (Human)	603	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"intermediate filament binding [GO:0019215]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol binding [GO:0035091]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0001726; GO:0004438; GO:0004721; GO:0004725; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008333; GO:0015031; GO:0019215; GO:0030175; GO:0031674; GO:0032007; GO:0032435; GO:0035091; GO:0044088; GO:0045109; GO:0046716; GO:0046856; GO:0048311; GO:0048633; GO:0051898; GO:0052629; GO:0070584; GO:1902902	endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]		NA	NA	NA	NA	NA	NA
TRINITY_DN28501_c0_g1_i1	Q13496	MTM1_HUMAN	100	76	0	0	230	3	238	313	7.60E-38	157.1	MTM1_HUMAN	reviewed	"Myotubularin (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTM1 CG2	Homo sapiens (Human)	603	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"intermediate filament binding [GO:0019215]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol binding [GO:0035091]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0001726; GO:0004438; GO:0004721; GO:0004725; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008333; GO:0015031; GO:0019215; GO:0030175; GO:0031674; GO:0032007; GO:0032435; GO:0035091; GO:0044088; GO:0045109; GO:0046716; GO:0046856; GO:0048311; GO:0048633; GO:0051898; GO:0052629; GO:0070584; GO:1902902	endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]		NA	NA	NA	NA	NA	NA
TRINITY_DN28648_c0_g1_i1	Q13613	MTMR1_HUMAN	100	83	0	0	3	251	335	417	8.60E-43	173.7	MTMR1_HUMAN	reviewed	"Myotubularin-related protein 1 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR1	Homo sapiens (Human)	665	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004725; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0042803; GO:0046856; GO:0052629; GO:0060304	phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN2587_c0_g2_i3	Q9NXD2	MTMRA_HUMAN	30.3	274	156	4	849	118	32	300	7.20E-28	126.3	MTMRA_HUMAN	reviewed	Myotubularin-related protein 10 (Inactive phosphatidylinositol 3-phosphatase 10)	MTMR10	Homo sapiens (Human)	777	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol dephosphorylation [GO:0046856]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	phosphatidylinositol-3-phosphatase activity [GO:0004438]	GO:0004438; GO:0005737; GO:0005829; GO:0046856	phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN2587_c0_g1_i5	Q6NU08	MTRAB_XENLA	33.5	504	295	9	55	1485	37	527	3.70E-69	264.6	MTRAB_XENLA	reviewed	Myotubularin-related protein 10-B (Inactive phosphatidylinositol 3-phosphatase 10-B)	mtmr10-b	Xenopus laevis (African clawed frog)	764							NA	NA	NA	NA	NA	NA
TRINITY_DN2587_c0_g1_i7	Q9C0I1	MTMRC_HUMAN	35.5	327	201	4	1444	482	231	553	9.30E-49	196.1	MTMRC_HUMAN	reviewed	Myotubularin-related protein 12 (Inactive phosphatidylinositol 3-phosphatase 12) (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit) (3-PAP) (3-phosphatase adapter protein)	MTMR12 KIAA1682 PIP3AP	Homo sapiens (Human)	747	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]	phosphatase regulator activity [GO:0019208]; phosphatidylinositol-3-phosphatase activity [GO:0004438]	GO:0004438; GO:0005737; GO:0005829; GO:0006661; GO:0016529; GO:0019208; GO:0030017; GO:0046856; GO:1901998	phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN2587_c0_g1_i8	Q9C0I1	MTMRC_HUMAN	35.5	327	201	4	1124	162	231	553	1.20E-48	195.3	MTMRC_HUMAN	reviewed	Myotubularin-related protein 12 (Inactive phosphatidylinositol 3-phosphatase 12) (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit) (3-PAP) (3-phosphatase adapter protein)	MTMR12 KIAA1682 PIP3AP	Homo sapiens (Human)	747	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]	phosphatase regulator activity [GO:0019208]; phosphatidylinositol-3-phosphatase activity [GO:0004438]	GO:0004438; GO:0005737; GO:0005829; GO:0006661; GO:0016529; GO:0019208; GO:0030017; GO:0046856; GO:1901998	phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN29223_c0_g1_i1	Q6NTN5	MTMRD_XENLA	62.4	125	46	1	375	1	1425	1548	3.70E-42	172.2	MTMRD_XENLA	reviewed	Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2)	sbf2 mtmr13	Xenopus laevis (African clawed frog)	1873	cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]	GO:0005085; GO:0005737; GO:0006914; GO:0016020; GO:0019208; GO:0043087	autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN8341_c0_g1_i1	Q6NTN5	MTMRD_XENLA	49.3	201	79	4	588	1	45	227	1.80E-46	187.2	MTMRD_XENLA	reviewed	Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2)	sbf2 mtmr13	Xenopus laevis (African clawed frog)	1873	cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]	GO:0005085; GO:0005737; GO:0006914; GO:0016020; GO:0019208; GO:0043087	autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN8341_c0_g1_i3	Q6NTN5	MTMRD_XENLA	45.8	144	55	4	469	53	45	170	3.30E-27	122.9	MTMRD_XENLA	reviewed	Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2)	sbf2 mtmr13	Xenopus laevis (African clawed frog)	1873	cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; membrane [GO:0016020]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]	GO:0005085; GO:0005737; GO:0006914; GO:0016020; GO:0019208; GO:0043087	autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN25427_c0_g1_i1	Q13614	MTMR2_HUMAN	100	130	0	0	391	2	390	519	9.50E-73	273.9	MTMR2_HUMAN	reviewed	"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR2 KIAA1073	Homo sapiens (Human)	643	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]	"identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0002091; GO:0004438; GO:0004725; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645	dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN26396_c0_g1_i1	Q13614	MTMR2_HUMAN	100	73	0	0	274	56	197	269	3.10E-38	158.7	MTMR2_HUMAN	reviewed	"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR2 KIAA1073	Homo sapiens (Human)	643	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]	"identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0002091; GO:0004438; GO:0004725; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645	dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN4324_c0_g1_i1	Q5ZIV1	MTMR2_CHICK	68.6	465	145	1	1491	97	96	559	1.30E-192	674.1	MTMR2_CHICK	reviewed	"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR2 RCJMB04_23g22	Gallus gallus (Chicken)	571	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; vacuolar membrane [GO:0005774]	"identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004725; GO:0005634; GO:0005774; GO:0005829; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0046855; GO:0046856; GO:0048666; GO:0052629; GO:0060304	inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN40793_c0_g1_i1	A6QLT2	MTMR2_BOVIN	100	73	0	0	1	219	299	371	5.80E-35	147.5	MTMR2_BOVIN	reviewed	"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR2	Bos taurus (Bovine)	643	"axon [GO:0030424]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	axon [GO:0030424]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]	"identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004725; GO:0005634; GO:0005774; GO:0005829; GO:0030424; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304	inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN11612_c0_g1_i2	Q13615	MTMR3_HUMAN	33.3	198	120	3	822	1409	988	1175	3.00E-26	121.3	MTMR3_HUMAN	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)"	MTMR3 KIAA0371 ZFYVE10	Homo sapiens (Human)	1198	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i11	Q13615	MTMR3_HUMAN	55	291	124	3	887	21	332	617	8.30E-95	349	MTMR3_HUMAN	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)"	MTMR3 KIAA0371 ZFYVE10	Homo sapiens (Human)	1198	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i11	Q13615	MTMR3_HUMAN	48.6	183	82	4	1395	862	165	340	4.60E-37	157.1	MTMR3_HUMAN	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)"	MTMR3 KIAA0371 ZFYVE10	Homo sapiens (Human)	1198	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i5	Q13615	MTMR3_HUMAN	53	466	200	7	1397	21	164	617	1.40E-140	501.1	MTMR3_HUMAN	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)"	MTMR3 KIAA0371 ZFYVE10	Homo sapiens (Human)	1198	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN36055_c0_g1_i1	Q13615	MTMR3_HUMAN	89.9	258	25	1	771	1	295	552	5.20E-139	495	MTMR3_HUMAN	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)"	MTMR3 KIAA0371 ZFYVE10	Homo sapiens (Human)	1198	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i1	Q8K296	MTMR3_MOUSE	56.2	418	178	4	1368	121	164	578	3.40E-139	496.5	MTMR3_MOUSE	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	Mtmr3	Mus musculus (Mouse)	1196	"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0006470; GO:0010506; GO:0016020; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i3	Q8K296	MTMR3_MOUSE	49.5	549	255	8	1649	21	85	617	1.60E-153	544.3	MTMR3_MOUSE	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	Mtmr3	Mus musculus (Mouse)	1196	"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0006470; GO:0010506; GO:0016020; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i7	Q8K296	MTMR3_MOUSE	48.2	624	301	8	1874	21	10	617	5.70E-174	612.5	MTMR3_MOUSE	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	Mtmr3	Mus musculus (Mouse)	1196	"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0006470; GO:0010506; GO:0016020; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN3377_c0_g1_i9	Q8K296	MTMR3_MOUSE	50.2	580	273	6	1845	121	10	578	6.20E-173	609	MTMR3_MOUSE	reviewed	"Myotubularin-related protein 3 (EC 3.1.3.48) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	Mtmr3	Mus musculus (Mouse)	1196	"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0006470; GO:0010506; GO:0016020; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN11612_c0_g1_i1	Q91XS1	MTMR4_MOUSE	31.8	236	143	6	729	1421	943	1165	1.10E-20	102.8	MTMR4_MOUSE	reviewed	Myotubularin-related protein 4 (EC 3.1.3.48)	Mtmr4	Mus musculus (Mouse)	1190	"endosome [GO:0005768]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	endosome [GO:0005768]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005768; GO:0007179; GO:0010506; GO:0014894; GO:0016020; GO:0019903; GO:0046856; GO:0046872; GO:0052629; GO:0060304	phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN34628_c0_g1_i1	Q9NYA4	MTMR4_HUMAN	100	94	0	0	1	282	415	508	5.10E-52	204.5	MTMR4_HUMAN	reviewed	Myotubularin-related protein 4 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 2) (FYVE-DSP2) (Zinc finger FYVE domain-containing protein 11)	MTMR4 KIAA0647 ZFYVE11	Homo sapiens (Human)	1195	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615]	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005615; GO:0005768; GO:0005829; GO:0006470; GO:0006661; GO:0007179; GO:0010506; GO:0014894; GO:0019903; GO:0030512; GO:0031901; GO:0046856; GO:0046872; GO:0052629; GO:0060304	negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN28377_c0_g1_i1	Q8VE11	MTMR6_MOUSE	96.2	185	7	0	557	3	174	358	5.80E-100	364.8	MTMR6_MOUSE	reviewed	"Myotubularin-related protein 6 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	Mtmr6	Mus musculus (Mouse)	617	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; ruffle membrane [GO:0032587]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; endocytosis [GO:0006897]; phosphatidylinositol dephosphorylation [GO:0046856]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; ruffle membrane [GO:0032587]	"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004725; GO:0005635; GO:0005737; GO:0005783; GO:0005793; GO:0006897; GO:0032587; GO:0046856; GO:0052629; GO:0106018	endocytosis [GO:0006897]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN4324_c0_g2_i2	Q5F452	MTMR8_CHICK	50.6	498	235	4	1944	457	107	595	8.20E-149	528.9	MTMR8_CHICK	reviewed	"Myotubularin-related protein 8 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR8 RCJMB04_3d12	Gallus gallus (Chicken)	629	"nuclear envelope [GO:0005635]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]"	nuclear envelope [GO:0005635]	"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004725; GO:0005635; GO:0010507; GO:0046856; GO:0052629; GO:0106018	negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN40470_c0_g1_i1	Q96EF0	MTMR8_HUMAN	62.1	66	22	1	195	7	334	399	3.00E-18	92	MTMR8_HUMAN	reviewed	"Myotubularin-related protein 8 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	MTMR8	Homo sapiens (Human)	704	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; protein-containing complex [GO:0032991]	"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004725; GO:0005635; GO:0005737; GO:0005829; GO:0006661; GO:0010507; GO:0032991; GO:0046856; GO:0052629; GO:0106018	negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN28459_c0_g1_i1	Q96QG7	MTMR9_HUMAN	100	79	0	0	239	3	16	94	3.40E-41	168.3	MTMR9_HUMAN	reviewed	Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9)	MTMR9 C8orf9 MTMR8	Homo sapiens (Human)	549	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]	GO:0004438; GO:0005737; GO:0005783; GO:0005829; GO:0006661; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304	endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN5259_c0_g1_i1	A7MB43	MTMR9_BOVIN	56.9	545	231	3	85	1716	1	542	4.00E-185	649.4	MTMR9_BOVIN	reviewed	Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9)	MTMR9	Bos taurus (Bovine)	549	endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]	GO:0004438; GO:0005783; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304	negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN5259_c0_g1_i2	A7MB43	MTMR9_BOVIN	56	554	231	4	85	1743	1	542	1.90E-182	640.6	MTMR9_BOVIN	reviewed	Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9)	MTMR9	Bos taurus (Bovine)	549	endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]	GO:0004438; GO:0005783; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304	negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]		NA	NA	NA	NA	NA	NA
TRINITY_DN20355_c0_g1_i1	Q64191	ASPG_MOUSE	94.1	119	7	0	2	358	35	153	1.80E-57	223	ASPG_MOUSE	reviewed	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain]	Aga	Mus musculus (Mouse)	346	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; protein deglycosylation [GO:0006517]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]	GO:0003948; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0006517; GO:0008233; GO:0043621	protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN20355_c0_g1_i2	Q64191	ASPG_MOUSE	100	118	0	0	2	355	36	153	6.90E-62	237.7	ASPG_MOUSE	reviewed	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain]	Aga	Mus musculus (Mouse)	346	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; protein deglycosylation [GO:0006517]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]	GO:0003948; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0006517; GO:0008233; GO:0043621	protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN24975_c0_g2_i1	Q64191	ASPG_MOUSE	98.5	67	1	0	201	1	210	276	6.10E-31	134	ASPG_MOUSE	reviewed	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain]	Aga	Mus musculus (Mouse)	346	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; protein deglycosylation [GO:0006517]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]	GO:0003948; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0006517; GO:0008233; GO:0043621	protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN24975_c0_g1_i1	P20933	ASPG_HUMAN	100	79	0	0	238	2	210	288	1.10E-39	163.3	ASPG_HUMAN	reviewed	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain]	AGA	Homo sapiens (Human)	346	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; neutrophil degranulation [GO:0043312]; protein deglycosylation [GO:0006517]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]	GO:0003948; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0006517; GO:0008233; GO:0035578; GO:0043312; GO:0043621	neutrophil degranulation [GO:0043312]; protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN630_c3_g1_i10	Q8N3J2	METL4_HUMAN	37.8	225	117	7	744	106	252	465	1.90E-36	154.8	METL4_HUMAN	reviewed	N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4) (EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4) (EC 2.1.1.-)	METTL4	Homo sapiens (Human)	472	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]	GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0006325; GO:0008168; GO:0008173; GO:0009007; GO:0032775; GO:0043484; GO:0090296; GO:0120049; GO:1902275; GO:1903108	chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]		NA	NA	NA	NA	NA	NA
TRINITY_DN630_c3_g1_i5	Q3U034	METL4_MOUSE	34.7	259	145	8	837	106	215	464	3.30E-37	157.5	METL4_MOUSE	reviewed	N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4) (EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4) (EC 2.1.1.-)	Mettl4	Mus musculus (Mouse)	471	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]	GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0006325; GO:0008168; GO:0008173; GO:0009007; GO:0032775; GO:0043484; GO:0090296; GO:0120049; GO:1902275; GO:1903108	chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]		NA	NA	NA	NA	NA	NA
TRINITY_DN16124_c0_g1_i1	Q3U034	METL4_MOUSE	50.8	63	31	0	193	5	402	464	2.80E-13	75.5	METL4_MOUSE	reviewed	N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4) (EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4) (EC 2.1.1.-)	Mettl4	Mus musculus (Mouse)	471	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]	GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0006325; GO:0008168; GO:0008173; GO:0009007; GO:0032775; GO:0043484; GO:0090296; GO:0120049; GO:1902275; GO:1903108	chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]		NA	NA	NA	NA	NA	NA
TRINITY_DN17334_c0_g1_i1	O94760	DDAH1_HUMAN	56.3	151	62	3	581	138	12	161	5.00E-40	166.4	DDAH1_HUMAN	reviewed	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	DDAH1 DDAH	Homo sapiens (Human)	285	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]"	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0016813; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]		blue	blue	NA	NA	NA	NA
TRINITY_DN17334_c0_g1_i2	O94760	DDAH1_HUMAN	50.4	272	125	5	911	120	12	281	5.90E-68	259.6	DDAH1_HUMAN	reviewed	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	DDAH1 DDAH	Homo sapiens (Human)	285	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]"	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0016813; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]		blue	blue	NA	NA	NA	NA
TRINITY_DN24011_c0_g1_i1	O94760	DDAH1_HUMAN	53.1	49	22	1	213	67	78	125	7.60E-08	57.4	DDAH1_HUMAN	reviewed	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	DDAH1 DDAH	Homo sapiens (Human)	285	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]"	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0016813; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]		blue	blue	NA	NA	NA	NA
TRINITY_DN15328_c0_g1_i1	O94760	DDAH1_HUMAN	43.1	144	76	2	3	419	139	281	3.50E-24	112.8	DDAH1_HUMAN	reviewed	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	DDAH1 DDAH	Homo sapiens (Human)	285	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]"	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0016813; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]		NA	NA	NA	NA	NA	NA
TRINITY_DN20931_c0_g1_i1	Q9CWS0	DDAH1_MOUSE	52.3	107	49	2	323	6	32	137	1.40E-24	113.6	DDAH1_MOUSE	reviewed	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	Ddah1	Mus musculus (Mouse)	285	"mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; zinc ion binding [GO:0008270]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014]; regulation of systemic arterial blood pressure [GO:0003073]"	mitochondrion [GO:0005739]	"amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; zinc ion binding [GO:0008270]"	GO:0000052; GO:0003073; GO:0005739; GO:0006525; GO:0006527; GO:0006809; GO:0008270; GO:0008285; GO:0016403; GO:0016597; GO:0016813; GO:0017014; GO:0043116; GO:0045429; GO:0045766; GO:1900038	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014]; regulation of systemic arterial blood pressure [GO:0003073]		NA	NA	NA	NA	NA	NA
TRINITY_DN23544_c1_g1_i1	O94760	DDAH1_HUMAN	53.4	73	31	3	210	1	12	84	4.60E-13	74.7	DDAH1_HUMAN	reviewed	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	DDAH1 DDAH	Homo sapiens (Human)	285	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines [GO:0016813]; metal ion binding [GO:0046872]"	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0016813; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]		NA	NA	NA	NA	NA	NA
TRINITY_DN26747_c0_g1_i1	Q86U44	MTA70_HUMAN	100	67	0	0	1	201	275	341	7.40E-37	153.7	MTA70_HUMAN	reviewed	N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)	METTL3 MTA70	Homo sapiens (Human)	580	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA metabolic process [GO:0016070]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006382; GO:0006397; GO:0006402; GO:0006974; GO:0007283; GO:0007623; GO:0008168; GO:0008173; GO:0009048; GO:0016070; GO:0016422; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0051445; GO:0060339; GO:0061157; GO:0080009; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990744	"adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA metabolic process [GO:0016070]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34208_c0_g1_i1	Q86U44	MTA70_HUMAN	100	225	0	0	3	677	355	579	4.00E-138	491.9	MTA70_HUMAN	reviewed	N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)	METTL3 MTA70	Homo sapiens (Human)	580	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA metabolic process [GO:0016070]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006382; GO:0006397; GO:0006402; GO:0006974; GO:0007283; GO:0007623; GO:0008168; GO:0008173; GO:0009048; GO:0016070; GO:0016422; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0051445; GO:0060339; GO:0061157; GO:0080009; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990744	"adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA metabolic process [GO:0016070]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17810_c0_g1_i2	Q9VCE6	MTA70_DROME	75.5	94	22	1	820	1098	503	596	2.10E-38	161.4	MTA70_DROME	reviewed	N6-adenosine-methyltransferase MT-A70-like protein (EC 2.1.1.348) (Inducer of meiosis 4) (Methyltransferase-like 3)	Mettl3 Ime4 CG5933	Drosophila melanogaster (Fruit fly)	608	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; dosage compensation [GO:0007549]; female sex determination [GO:0030237]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; ovarian follicle cell development [GO:0030707]; primary miRNA methylation [GO:1990744]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene silencing [GO:0060968]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0001510; GO:0001734; GO:0003723; GO:0005634; GO:0007530; GO:0007548; GO:0007549; GO:0008168; GO:0016422; GO:0016607; GO:0030237; GO:0030707; GO:0030708; GO:0036396; GO:0060968; GO:0080009; GO:1990744	"dosage compensation [GO:0007549]; female sex determination [GO:0030237]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; ovarian follicle cell development [GO:0030707]; primary miRNA methylation [GO:1990744]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene silencing [GO:0060968]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17810_c0_g1_i4	Q9VCE6	MTA70_DROME	83.3	192	31	1	88	660	405	596	1.80E-99	363.6	MTA70_DROME	reviewed	N6-adenosine-methyltransferase MT-A70-like protein (EC 2.1.1.348) (Inducer of meiosis 4) (Methyltransferase-like 3)	Mettl3 Ime4 CG5933	Drosophila melanogaster (Fruit fly)	608	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; dosage compensation [GO:0007549]; female sex determination [GO:0030237]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; ovarian follicle cell development [GO:0030707]; primary miRNA methylation [GO:1990744]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene silencing [GO:0060968]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0001510; GO:0001734; GO:0003723; GO:0005634; GO:0007530; GO:0007548; GO:0007549; GO:0008168; GO:0016422; GO:0016607; GO:0030237; GO:0030707; GO:0030708; GO:0036396; GO:0060968; GO:0080009; GO:1990744	"dosage compensation [GO:0007549]; female sex determination [GO:0030237]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; ovarian follicle cell development [GO:0030707]; primary miRNA methylation [GO:1990744]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene silencing [GO:0060968]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19306_c0_g1_i1	Q9VCE6	MTA70_DROME	70.5	207	59	2	8	625	387	592	5.60E-91	335.1	MTA70_DROME	reviewed	N6-adenosine-methyltransferase MT-A70-like protein (EC 2.1.1.348) (Inducer of meiosis 4) (Methyltransferase-like 3)	Mettl3 Ime4 CG5933	Drosophila melanogaster (Fruit fly)	608	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; dosage compensation [GO:0007549]; female sex determination [GO:0030237]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; ovarian follicle cell development [GO:0030707]; primary miRNA methylation [GO:1990744]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene silencing [GO:0060968]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0001510; GO:0001734; GO:0003723; GO:0005634; GO:0007530; GO:0007548; GO:0007549; GO:0008168; GO:0016422; GO:0016607; GO:0030237; GO:0030707; GO:0030708; GO:0036396; GO:0060968; GO:0080009; GO:1990744	"dosage compensation [GO:0007549]; female sex determination [GO:0030237]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; ovarian follicle cell development [GO:0030707]; primary miRNA methylation [GO:1990744]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene silencing [GO:0060968]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30455_c0_g1_i1	Q9VLP7	MET14_DROME	54.7	161	63	2	7	486	204	355	9.70E-46	184.5	MET14_DROME	reviewed	N6-adenosine-methyltransferase non-catalytic subunit (Karyogamy protein 4) (Methyltransferase-like protein 14) (dMettl14)	Mettl14 KAR4 CG7818	Drosophila melanogaster (Fruit fly)	397	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; female sex determination [GO:0030237]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]; sex differentiation [GO:0007548]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]	GO:0000381; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007548; GO:0008380; GO:0030154; GO:0030237; GO:0036396; GO:0080009	"cell differentiation [GO:0030154]; female sex determination [GO:0030237]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35461_c0_g1_i1	A4IFD8	MET14_BOVIN	45	111	60	1	23	355	94	203	7.20E-22	104.8	MET14_BOVIN	reviewed	N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14)	METTL14	Bos taurus (Bovine)	456	"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]	GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0061157; GO:0080009	"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26631_c0_g1_i1	Q3UIK4	MET14_MOUSE	64.8	403	109	5	1256	147	2	404	5.70E-149	528.9	MET14_MOUSE	reviewed	N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14)	Mettl14 Kiaa1627	Mus musculus (Mouse)	456	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]	GO:0000398; GO:0001510; GO:0003729; GO:0005634; GO:0005654; GO:0006402; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0061157; GO:0080009	"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"		brown	brown	NA	NA	NA	NA
TRINITY_DN17810_c0_g1_i7	F1R777	MTA70_DANRE	58.6	502	173	9	361	1785	88	581	5.60E-150	532.7	MTA70_DANRE	reviewed	N6-adenosine-methyltransferase subunit METTL3 (EC 2.1.1.348) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)	mettl3	Danio rerio (Zebrafish) (Brachydanio rerio)	584	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; endothelial to hematopoietic transition [GO:0098508]; flagellated sperm motility [GO:0030317]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; hematopoietic stem cell proliferation [GO:0071425]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of apoptotic process [GO:0042981]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of mRNA modification [GO:0090365]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0000398; GO:0001510; GO:0001556; GO:0001734; GO:0003729; GO:0005634; GO:0005737; GO:0006382; GO:0006402; GO:0006974; GO:0007283; GO:0007530; GO:0008168; GO:0008173; GO:0016422; GO:0016607; GO:0019827; GO:0021861; GO:0030317; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0042981; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0051445; GO:0060339; GO:0060853; GO:0061157; GO:0071425; GO:0080009; GO:0090365; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990744	"adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; endothelial to hematopoietic transition [GO:0098508]; flagellated sperm motility [GO:0030317]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; hematopoietic stem cell proliferation [GO:0071425]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of apoptotic process [GO:0042981]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of mRNA modification [GO:0090365]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37611_c0_g1_i1	Q9Y4X1	UD2A1_HUMAN	33.3	81	22	1	132	374	267	315	4.30E-05	49.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA
TRINITY_DN32787_c0_g1_i1	O14745	NHRF1_HUMAN	100	122	0	0	366	1	128	249	8.10E-66	250.8	NHRF1_HUMAN	reviewed	Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)	SLC9A3R1 NHERF NHERF1	Homo sapiens (Human)	358	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]	beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0001726; GO:0002009; GO:0003096; GO:0005102; GO:0005737; GO:0005902; GO:0007009; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0015185; GO:0015629; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0031799; GO:0031800; GO:0031982; GO:0032415; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0034767; GO:0043495; GO:0043621; GO:0044062; GO:0044782; GO:0044877; GO:0045121; GO:0045159; GO:0045198; GO:0045199; GO:0045859; GO:0045930; GO:0047485; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0051939; GO:0060088; GO:0060158; GO:0065003; GO:0070062; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0090660; GO:0097225; GO:0097291; GO:0098739; GO:0098797; GO:0150104; GO:2001244	actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein-containing complex assembly [GO:0065003]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of excretion [GO:0044062]; regulation of protein kinase activity [GO:0045859]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN25454_c0_g1_i1	Q9JHL1	NHRF2_MOUSE	52.9	104	45	2	118	429	149	248	9.30E-23	108.2	NHRF2_MOUSE	reviewed	Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (Octs2) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1) (TKA-1)	Slc9a3r2 Nherf2	Mus musculus (Mouse)	337	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; beta-catenin binding [GO:0008013]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; sensory perception of sound [GO:0007605]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]	beta-catenin binding [GO:0008013]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005634; GO:0005737; GO:0005886; GO:0007605; GO:0008013; GO:0008022; GO:0012505; GO:0014067; GO:0016324; GO:0019902; GO:0032420; GO:0032421; GO:0032991; GO:0034767; GO:0043495; GO:0047485; GO:0050750; GO:0060090; GO:0072659	negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; sensory perception of sound [GO:0007605]		blue	blue	NA	NA	NA	NA
TRINITY_DN40228_c0_g1_i1	Q9CZR2	NALD2_MOUSE	52.1	71	32	1	4	210	313	383	8.10E-18	90.5	NALD2_MOUSE	reviewed	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	Naalad2	Mus musculus (Mouse)	740	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]	GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN36249_c0_g1_i1	Q9Y3Q0	NALD2_HUMAN	55.8	120	53	0	362	3	331	450	1.80E-36	153.3	NALD2_HUMAN	reviewed	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	NAALAD2	Homo sapiens (Human)	740	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]	GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0008652; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN26501_c0_g1_i1	Q01415	GALK2_HUMAN	100	204	0	0	612	1	7	210	2.10E-114	412.9	GALK2_HUMAN	reviewed	N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)	GALK2 GK2	Homo sapiens (Human)	458	cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]	cytosol [GO:0005829]	ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]	GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858	carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]		NA	NA	NA	NA	NA	NA
TRINITY_DN6173_c0_g1_i2	Q5XIG6	GALK2_RAT	49.5	442	220	3	56	1378	18	457	1.40E-116	421.4	GALK2_RAT	reviewed	N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)	Galk2	Rattus norvegicus (Rat)	458	cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose metabolic process [GO:0006012]	cytosol [GO:0005829]	ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]	GO:0004335; GO:0005524; GO:0005829; GO:0006012; GO:0033858	galactose metabolic process [GO:0006012]		NA	NA	NA	NA	NA	NA
TRINITY_DN6173_c0_g1_i3	Q5XIG6	GALK2_RAT	49.5	442	220	3	180	1502	18	457	1.50E-116	421.4	GALK2_RAT	reviewed	N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)	Galk2	Rattus norvegicus (Rat)	458	cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose metabolic process [GO:0006012]	cytosol [GO:0005829]	ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]	GO:0004335; GO:0005524; GO:0005829; GO:0006012; GO:0033858	galactose metabolic process [GO:0006012]		NA	NA	NA	NA	NA	NA
TRINITY_DN6173_c0_g1_i4	Q01415	GALK2_HUMAN	47.1	461	238	5	123	1499	1	457	9.10E-114	412.1	GALK2_HUMAN	reviewed	N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)	GALK2 GK2	Homo sapiens (Human)	458	cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]	cytosol [GO:0005829]	ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]	GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858	carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]		NA	NA	NA	NA	NA	NA
TRINITY_DN225_c0_g1_i1	Q32KH5	GALNS_CANLF	56.7	383	163	3	1242	100	141	522	3.80E-129	463	GALNS_CANLF	reviewed	N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)	GALNS	Canis lupus familiaris (Dog) (Canis familiaris)	522	lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]	lysosome [GO:0005764]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]	GO:0004065; GO:0005764; GO:0043890; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN225_c0_g1_i2	Q32KH5	GALNS_CANLF	58.6	515	210	3	1638	100	9	522	2.20E-182	640.2	GALNS_CANLF	reviewed	N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)	GALNS	Canis lupus familiaris (Dog) (Canis familiaris)	522	lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]	lysosome [GO:0005764]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]	GO:0004065; GO:0005764; GO:0043890; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN225_c0_g1_i3	Q571E4	GALNS_MOUSE	66.9	127	42	0	427	47	12	138	1.00E-45	184.5	GALNS_MOUSE	reviewed	N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)	Galns	Mus musculus (Mouse)	520	lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]	lysosome [GO:0005764]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004065; GO:0005764; GO:0008484; GO:0043890; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN40415_c0_g1_i1	Q571E4	GALNS_MOUSE	94.6	112	6	0	3	338	105	216	3.50E-63	241.9	GALNS_MOUSE	reviewed	N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)	Galns	Mus musculus (Mouse)	520	lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]	lysosome [GO:0005764]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004065; GO:0005764; GO:0008484; GO:0043890; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34165_c0_g1_i1	Q8IA42	GALT4_DROME	63.9	61	22	0	218	36	349	409	3.20E-17	88.6	GALT4_DROME	reviewed	N-acetylgalactosaminyltransferase 4 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4) (pp-GaNTase 4)	Pgant4 CG31956	Drosophila melanogaster (Fruit fly)	644	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of secretion [GO:0051047]; protein O-linked glycosylation [GO:0006493]; secretory granule organization [GO:0033363]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0009312; GO:0016021; GO:0030246; GO:0033363; GO:0046872; GO:0051047	oligosaccharide biosynthetic process [GO:0009312]; positive regulation of secretion [GO:0051047]; protein O-linked glycosylation [GO:0006493]; secretory granule organization [GO:0033363]		NA	NA	NA	NA	NA	NA
TRINITY_DN16810_c0_g1_i1	Q8IA42	GALT4_DROME	52.8	72	33	1	29	241	422	493	6.00E-17	87.8	GALT4_DROME	reviewed	N-acetylgalactosaminyltransferase 4 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4) (pp-GaNTase 4)	Pgant4 CG31956	Drosophila melanogaster (Fruit fly)	644	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of secretion [GO:0051047]; protein O-linked glycosylation [GO:0006493]; secretory granule organization [GO:0033363]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0009312; GO:0016021; GO:0030246; GO:0033363; GO:0046872; GO:0051047	oligosaccharide biosynthetic process [GO:0009312]; positive regulation of secretion [GO:0051047]; protein O-linked glycosylation [GO:0006493]; secretory granule organization [GO:0033363]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c0_g1_i4	Q6WV16	GALT6_DROME	53.4	536	241	5	1688	108	126	661	1.30E-168	594.7	GALT6_DROME	reviewed	N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) (pp-GaNTase 6)	Pgant6 CG2103	Drosophila melanogaster (Fruit fly)	666	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005783; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1583_c0_g1_i2	Q6WV16	GALT6_DROME	66.7	279	91	2	838	8	256	534	5.00E-111	402.1	GALT6_DROME	reviewed	N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) (pp-GaNTase 6)	Pgant6 CG2103	Drosophila melanogaster (Fruit fly)	666	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005783; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1583_c0_g1_i3	Q6WV16	GALT6_DROME	54.9	91	40	1	277	8	444	534	1.30E-25	117.1	GALT6_DROME	reviewed	N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) (pp-GaNTase 6)	Pgant6 CG2103	Drosophila melanogaster (Fruit fly)	666	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005783; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1583_c0_g1_i4	Q6WV16	GALT6_DROME	67.2	274	88	2	934	119	256	529	8.80E-109	394.8	GALT6_DROME	reviewed	N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) (pp-GaNTase 6)	Pgant6 CG2103	Drosophila melanogaster (Fruit fly)	666	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005783; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN16810_c0_g1_i2	Q6WV16	GALT6_DROME	63.4	172	61	2	1	510	344	515	1.10E-60	234.2	GALT6_DROME	reviewed	N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) (pp-GaNTase 6)	Pgant6 CG2103	Drosophila melanogaster (Fruit fly)	666	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005783; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3346_c0_g1_i1	Q8MV48	GALT7_DROME	64.2	592	202	3	25	1773	1	591	9.20E-235	814.3	GALT7_DROME	reviewed	N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2)	Pgant7 GalNAc-T2 CG6394	Drosophila melanogaster (Fruit fly)	591	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN25989_c0_g1_i1	Q3T906	GNPTA_HUMAN	100	169	0	0	1	507	302	470	2.40E-100	365.9	GNPTA_HUMAN	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GNPTAB GNPTA KIAA1208	Homo sapiens (Human)	1256	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN38492_c0_g1_i1	Q3T906	GNPTA_HUMAN	100	94	0	0	283	2	1104	1197	4.80E-50	198	GNPTA_HUMAN	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GNPTAB GNPTA KIAA1208	Homo sapiens (Human)	1256	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN7505_c0_g1_i2	Q3T906	GNPTA_HUMAN	33.2	385	198	10	1104	82	25	394	6.10E-41	169.9	GNPTA_HUMAN	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GNPTAB GNPTA KIAA1208	Homo sapiens (Human)	1256	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN7505_c0_g1_i3	Q69ZN6	GNPTA_MOUSE	34	1248	671	28	3450	19	25	1223	8.20E-179	629.4	GNPTA_MOUSE	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	Gnptab Gnpta Kiaa1208	Mus musculus (Mouse)	1235	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0009306; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN7505_c0_g1_i5	Q69ZN6	GNPTA_MOUSE	31.9	736	419	17	2082	19	522	1223	6.80E-90	334	GNPTA_MOUSE	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	Gnptab Gnpta Kiaa1208	Mus musculus (Mouse)	1235	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0009306; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN7505_c0_g1_i5	Q69ZN6	GNPTA_MOUSE	37.9	451	221	10	3304	2084	25	460	1.60E-70	269.6	GNPTA_MOUSE	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	Gnptab Gnpta Kiaa1208	Mus musculus (Mouse)	1235	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0009306; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN28252_c0_g1_i1	Q3T906	GNPTA_HUMAN	100	106	0	0	321	4	921	1026	2.50E-55	215.7	GNPTA_HUMAN	reviewed	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GNPTAB GNPTA KIAA1208	Homo sapiens (Human)	1256	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]		NA	NA	NA	NA	NA	NA
TRINITY_DN1033_c0_g1_i1	Q9VR81	NAGA_DROME	58.9	392	154	4	1311	145	25	412	2.30E-132	473.8	NAGA_DROME	reviewed	N-acetylglucosamine-6-phosphate deacetylase (GlcNAc 6-P deacetylase) (EC 3.5.1.25)	CG17065	Drosophila melanogaster (Fruit fly)	417	metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]		metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]	GO:0005975; GO:0006046; GO:0008448; GO:0046872; GO:0047419	carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]		blue	blue	NA	NA	NA	NA
TRINITY_DN29880_c0_g1_i1	Q9Y303	NAGA_HUMAN	100	159	0	0	3	479	251	409	2.90E-87	322.4	NAGA_HUMAN	reviewed	N-acetylglucosamine-6-phosphate deacetylase (GlcNAc 6-P deacetylase) (EC 3.5.1.25) (Amidohydrolase domain-containing protein 2)	AMDHD2 CGI-14	Homo sapiens (Human)	409	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]	GO:0005634; GO:0005829; GO:0005975; GO:0006046; GO:0006048; GO:0008448; GO:0019262; GO:0046872; GO:0047419	carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN24932_c0_g1_i1	P15586	GNS_HUMAN	100	90	0	0	1	270	299	388	4.80E-47	188	GNS_HUMAN	reviewed	N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)	GNS	Homo sapiens (Human)	552	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]	glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005539; GO:0005576; GO:0006027; GO:0008449; GO:0008484; GO:0035578; GO:0042340; GO:0043202; GO:0043312; GO:0046872; GO:0070062; GO:1904813	glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN10343_c2_g1_i1	P50426	GNS_CAPHI	46.2	444	215	7	107	1426	102	525	4.90E-109	396.4	GNS_CAPHI	reviewed	N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)	GNS	Capra hircus (Goat)	559	lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; glycosaminoglycan metabolic process [GO:0030203]	lysosome [GO:0005764]	metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]	GO:0005764; GO:0008449; GO:0030203; GO:0046872	glycosaminoglycan metabolic process [GO:0030203]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c0_g1_i3	Q64323	PIGA_MOUSE	58.3	132	49	2	470	75	23	148	2.30E-39	163.3	PIGA_MOUSE	reviewed	N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	Piga	Mus musculus (Mouse)	485	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0005789; GO:0006506; GO:0016021; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c0_g1_i4	Q64323	PIGA_MOUSE	66.4	116	39	0	422	75	33	148	1.80E-42	173.7	PIGA_MOUSE	reviewed	N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	Piga	Mus musculus (Mouse)	485	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0005789; GO:0006506; GO:0016021; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c0_g1_i5	Q64323	PIGA_MOUSE	64.8	71	21	1	261	49	23	89	1.20E-21	103.6	PIGA_MOUSE	reviewed	N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	Piga	Mus musculus (Mouse)	485	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0005789; GO:0006506; GO:0016021; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c0_g1_i6	Q64323	PIGA_MOUSE	64.4	118	40	1	428	75	33	148	3.00E-40	166.4	PIGA_MOUSE	reviewed	N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	Piga	Mus musculus (Mouse)	485	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0005789; GO:0006506; GO:0016021; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN32682_c0_g1_i1	Q9Y2B2	PIGL_HUMAN	46.6	204	107	2	609	1	44	246	1.70E-45	184.1	PIGL_HUMAN	reviewed	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L)	PIGL	Homo sapiens (Human)	252	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]"	GO:0000225; GO:0005783; GO:0005789; GO:0006506; GO:0016021; GO:0016254; GO:0016811	GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN25877_c0_g1_i1	Q1LW89	CASD1_DANRE	41.9	236	131	3	781	83	549	781	3.90E-49	196.4	CASD1_DANRE	reviewed	N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT)	casd1 si:dkey-104m9.2 zgc:136291	Danio rerio (Zebrafish) (Brachydanio rerio)	781	integral component of Golgi membrane [GO:0030173]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975]	integral component of Golgi membrane [GO:0030173]	N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]	GO:0005975; GO:0030173; GO:0047186	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN7137_c0_g1_i1	Q1LW89	CASD1_DANRE	42.7	96	48	1	111	398	12	100	2.60E-17	89.7	CASD1_DANRE	reviewed	N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT)	casd1 si:dkey-104m9.2 zgc:136291	Danio rerio (Zebrafish) (Brachydanio rerio)	781	integral component of Golgi membrane [GO:0030173]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975]	integral component of Golgi membrane [GO:0030173]	N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]	GO:0005975; GO:0030173; GO:0047186	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN7137_c0_g1_i2	Q96PB1	CASD1_HUMAN	49.2	65	26	1	68	262	43	100	3.40E-13	75.5	CASD1_HUMAN	reviewed	N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT)	CASD1 C7orf12 Nbla04196	Homo sapiens (Human)	797	integral component of Golgi membrane [GO:0030173]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975]	integral component of Golgi membrane [GO:0030173]	N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]	GO:0005975; GO:0030173; GO:0047186	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN33371_c0_g1_i1	Q9DCJ9	NPL_MOUSE	30.6	183	125	1	623	75	125	305	2.70E-21	103.6	NPL_MOUSE	reviewed	N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)	Npl	Mus musculus (Mouse)	320	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]	cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]	GO:0005737; GO:0005975; GO:0008747; GO:0019262; GO:0042802	carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]		NA	NA	NA	NA	NA	NA
TRINITY_DN9905_c0_g1_i1	Q5SPR8	ESCO2_DANRE	36.1	205	119	4	586	2	336	538	2.60E-32	140.6	ESCO2_DANRE	reviewed	N-acetyltransferase ESCO2 (EC 2.3.1.-) (Establishment of cohesion 1 homolog 2) (ECO1 homolog 2)	esco2 si:dkey-217m5.6 zgc:111795	Danio rerio (Zebrafish) (Brachydanio rerio)	609	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; fin regeneration [GO:0031101]; heart development [GO:0007507]; mitotic cell cycle [GO:0000278]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]	GO:0000278; GO:0000785; GO:0005634; GO:0005694; GO:0006275; GO:0007062; GO:0007507; GO:0016407; GO:0031101; GO:0034421; GO:0043280; GO:0046872; GO:1990523	bone regeneration [GO:1990523]; fin regeneration [GO:0031101]; heart development [GO:0007507]; mitotic cell cycle [GO:0000278]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN9905_c0_g1_i2	Q5SPR8	ESCO2_DANRE	36.1	205	119	4	586	2	336	538	3.90E-32	140.6	ESCO2_DANRE	reviewed	N-acetyltransferase ESCO2 (EC 2.3.1.-) (Establishment of cohesion 1 homolog 2) (ECO1 homolog 2)	esco2 si:dkey-217m5.6 zgc:111795	Danio rerio (Zebrafish) (Brachydanio rerio)	609	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; fin regeneration [GO:0031101]; heart development [GO:0007507]; mitotic cell cycle [GO:0000278]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]	GO:0000278; GO:0000785; GO:0005634; GO:0005694; GO:0006275; GO:0007062; GO:0007507; GO:0016407; GO:0031101; GO:0034421; GO:0043280; GO:0046872; GO:1990523	bone regeneration [GO:1990523]; fin regeneration [GO:0031101]; heart development [GO:0007507]; mitotic cell cycle [GO:0000278]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN9905_c0_g1_i3	Q5SPR8	ESCO2_DANRE	36.1	205	119	4	586	2	336	538	4.00E-32	140.6	ESCO2_DANRE	reviewed	N-acetyltransferase ESCO2 (EC 2.3.1.-) (Establishment of cohesion 1 homolog 2) (ECO1 homolog 2)	esco2 si:dkey-217m5.6 zgc:111795	Danio rerio (Zebrafish) (Brachydanio rerio)	609	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; fin regeneration [GO:0031101]; heart development [GO:0007507]; mitotic cell cycle [GO:0000278]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]	GO:0000278; GO:0000785; GO:0005634; GO:0005694; GO:0006275; GO:0007062; GO:0007507; GO:0016407; GO:0031101; GO:0034421; GO:0043280; GO:0046872; GO:1990523	bone regeneration [GO:1990523]; fin regeneration [GO:0031101]; heart development [GO:0007507]; mitotic cell cycle [GO:0000278]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN4699_c0_g1_i1	Q86W26	NAL10_HUMAN	25.2	242	151	8	1147	479	242	472	3.10E-08	61.2	NAL10_HUMAN	reviewed	"NACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)"	NLRP10 NALP10 NOD8 PYNOD	Homo sapiens (Human)	655	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 type immune response [GO:2000318]	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]	GO:0002250; GO:0002827; GO:0003924; GO:0005524; GO:0005737; GO:0006954; GO:0016887; GO:0019897; GO:0032730; GO:0032755; GO:0032757; GO:0045087; GO:0050729; GO:0050829; GO:0050832; GO:1900426; GO:2000318	adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]		NA	NA	NA	NA	NA	NA
TRINITY_DN4699_c0_g1_i2	Q86W26	NAL10_HUMAN	25.9	316	201	11	1366	479	170	472	3.70E-13	77.8	NAL10_HUMAN	reviewed	"NACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)"	NLRP10 NALP10 NOD8 PYNOD	Homo sapiens (Human)	655	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 type immune response [GO:2000318]	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]	GO:0002250; GO:0002827; GO:0003924; GO:0005524; GO:0005737; GO:0006954; GO:0016887; GO:0019897; GO:0032730; GO:0032755; GO:0032757; GO:0045087; GO:0050729; GO:0050829; GO:0050832; GO:1900426; GO:2000318	adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]		NA	NA	NA	NA	NA	NA
TRINITY_DN12064_c0_g1_i1	Q0E671	NEUAA_DANRE	54.4	68	31	0	74	277	177	244	7.10E-15	81.6	NEUAA_DANRE	reviewed	N-acylneuraminate cytidylyltransferase A (EC 2.7.7.43) (CMP-sialic acid synthetase 1)	cmasa cmas cmas1	Danio rerio (Zebrafish) (Brachydanio rerio)	430	nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054]	nucleus [GO:0005634]	N-acylneuraminate cytidylyltransferase activity [GO:0008781]	GO:0005634; GO:0006054; GO:0008781	N-acetylneuraminate metabolic process [GO:0006054]		NA	NA	NA	NA	NA	NA
TRINITY_DN12064_c0_g1_i2	Q0E671	NEUAA_DANRE	45.8	214	110	2	86	709	31	244	2.80E-45	183.7	NEUAA_DANRE	reviewed	N-acylneuraminate cytidylyltransferase A (EC 2.7.7.43) (CMP-sialic acid synthetase 1)	cmasa cmas cmas1	Danio rerio (Zebrafish) (Brachydanio rerio)	430	nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054]	nucleus [GO:0005634]	N-acylneuraminate cytidylyltransferase activity [GO:0008781]	GO:0005634; GO:0006054; GO:0008781	N-acetylneuraminate metabolic process [GO:0006054]		NA	NA	NA	NA	NA	NA
TRINITY_DN12064_c0_g1_i3	Q0E671	NEUAA_DANRE	35.5	214	85	2	86	568	31	244	4.10E-26	119.8	NEUAA_DANRE	reviewed	N-acylneuraminate cytidylyltransferase A (EC 2.7.7.43) (CMP-sialic acid synthetase 1)	cmasa cmas cmas1	Danio rerio (Zebrafish) (Brachydanio rerio)	430	nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054]	nucleus [GO:0005634]	N-acylneuraminate cytidylyltransferase activity [GO:0008781]	GO:0005634; GO:0006054; GO:0008781	N-acetylneuraminate metabolic process [GO:0006054]		NA	NA	NA	NA	NA	NA
TRINITY_DN15527_c0_g1_i1	P58058	NADK_MOUSE	61.1	383	131	3	1283	177	59	437	9.60E-130	464.9	NADK_MOUSE	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	Nadk	Mus musculus (Mouse)	439	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0019674; GO:0035774; GO:0046872	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN15527_c0_g1_i2	P58058	NADK_MOUSE	67.5	265	72	2	929	177	173	437	4.40E-100	365.9	NADK_MOUSE	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	Nadk	Mus musculus (Mouse)	439	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0019674; GO:0035774; GO:0046872	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN15527_c0_g1_i3	P58058	NADK_MOUSE	56.5	138	60	0	441	28	59	196	1.10E-37	157.5	NADK_MOUSE	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	Nadk	Mus musculus (Mouse)	439	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0019674; GO:0035774; GO:0046872	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN15527_c0_g1_i4	P58058	NADK_MOUSE	62.2	331	111	2	951	1	59	389	6.10E-113	408.7	NADK_MOUSE	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	Nadk	Mus musculus (Mouse)	439	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0019674; GO:0035774; GO:0046872	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN15527_c0_g1_i5	P58058	NADK_MOUSE	61.5	379	132	2	1271	177	59	437	1.30E-131	471.1	NADK_MOUSE	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	Nadk	Mus musculus (Mouse)	439	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0019674; GO:0035774; GO:0046872	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN6181_c3_g1_i1	O95544	NADK_HUMAN	80.8	26	5	0	103	26	171	196	2.40E-05	49.3	NADK_HUMAN	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	NADK	Homo sapiens (Human)	446	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0016310; GO:0019674; GO:0035774; GO:0046034; GO:0046872	ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		brown	brown	1	NA	NA	NA
TRINITY_DN16070_c0_g1_i1	O95544	NADK_HUMAN	98.9	88	1	0	266	3	338	425	1.80E-46	186	NADK_HUMAN	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	NADK	Homo sapiens (Human)	446	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0016310; GO:0019674; GO:0035774; GO:0046034; GO:0046872	ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN16070_c0_g1_i2	O95544	NADK_HUMAN	100	149	0	0	449	3	277	425	2.20E-81	302.8	NADK_HUMAN	reviewed	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	NADK	Homo sapiens (Human)	446	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0016310; GO:0019674; GO:0035774; GO:0046034; GO:0046872	ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]		NA	NA	NA	NA	NA	NA
TRINITY_DN4070_c0_g1_i1	Q4G0N4	NAKD2_HUMAN	43.6	55	29	1	255	97	64	118	3.10E-06	53.1	NAKD2_HUMAN	reviewed	"NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)"	NADK2 C5orf33 MNADK NADKD1	Homo sapiens (Human)	442	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]		NA	NA	NA	NA	NA	NA
TRINITY_DN4070_c0_g1_i2	Q4G0N4	NAKD2_HUMAN	42.6	390	208	7	1234	77	64	441	1.80E-84	314.7	NAKD2_HUMAN	reviewed	"NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)"	NADK2 C5orf33 MNADK NADKD1	Homo sapiens (Human)	442	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]		NA	NA	NA	NA	NA	NA
TRINITY_DN8516_c0_g1_i3	Q6PDS3	SARM1_MOUSE	46.7	60	28	1	89	268	641	696	1.00E-10	67.4	SARM1_MOUSE	reviewed	NAD(+) hydrolase SARM1 (NADase SARM1) (EC 3.2.2.6) (NADP(+) hydrolase SARM1) (EC 3.2.2.-) (Sterile alpha and TIR motif-containing protein 1)	Sarm1 Kiaa0524	Mus musculus (Mouse)	724	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; synapse [GO:0045202]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; positive regulation of neuron death [GO:1901216]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; synapse [GO:0045202]	"identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]"	GO:0003953; GO:0005737; GO:0005739; GO:0005874; GO:0007165; GO:0009749; GO:0015630; GO:0019677; GO:0030424; GO:0030425; GO:0031315; GO:0034128; GO:0035591; GO:0042802; GO:0042981; GO:0045087; GO:0045202; GO:0048678; GO:0048814; GO:0050135; GO:0061809; GO:1901214; GO:1901216	innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; positive regulation of neuron death [GO:1901216]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8516_c0_g1_i1	Q6IDD9	SARM1_DROME	52.5	118	43	3	1	351	902	1007	6.40E-31	135.2	SARM1_DROME	reviewed	NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (Tir-1 homolog)	Sarm Ect4 CG43119	Drosophila melanogaster (Fruit fly)	1360	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]"	GO:0003953; GO:0005737; GO:0007165; GO:0019677; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:0050135; GO:0061809; GO:1901214	innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8516_c0_g1_i2	Q6IDD9	SARM1_DROME	49	102	39	3	89	391	918	1007	3.80E-21	102.8	SARM1_DROME	reviewed	NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (Tir-1 homolog)	Sarm Ect4 CG43119	Drosophila melanogaster (Fruit fly)	1360	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]"	GO:0003953; GO:0005737; GO:0007165; GO:0019677; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:0050135; GO:0061809; GO:1901214	innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN14942_c0_g1_i1	Q6IDD9	SARM1_DROME	61.2	539	197	4	57	1646	319	854	6.10E-188	658.7	SARM1_DROME	reviewed	NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (Tir-1 homolog)	Sarm Ect4 CG43119	Drosophila melanogaster (Fruit fly)	1360	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]"	GO:0003953; GO:0005737; GO:0007165; GO:0019677; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:0050135; GO:0061809; GO:1901214	innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN14942_c0_g2_i1	Q6IDD9	SARM1_DROME	78.8	66	14	0	290	93	853	918	2.80E-23	109.4	SARM1_DROME	reviewed	NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (Tir-1 homolog)	Sarm Ect4 CG43119	Drosophila melanogaster (Fruit fly)	1360	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]"	GO:0003953; GO:0005737; GO:0007165; GO:0019677; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:0050135; GO:0061809; GO:1901214	innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN30250_c0_g1_i1	P43842	PNTA_HAEIN	62.9	70	26	0	4	213	75	144	9.00E-17	87	PNTA_HAEIN	reviewed	NAD(P) transhydrogenase subunit alpha (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha) (Pyridine nucleotide transhydrogenase subunit alpha)	pntA HI_1362	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	512	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]	GO:0005886; GO:0005887; GO:0006740; GO:0008746; GO:0046983; GO:0050661; GO:0051287; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN31579_c0_g1_i1	P07001	PNTA_ECOLI	60	105	41	1	6	317	124	228	1.00E-24	114	PNTA_ECOLI	reviewed	NAD(P) transhydrogenase subunit alpha (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha) (Pyridine nucleotide transhydrogenase subunit alpha)	pntA b1603 JW1595	Escherichia coli (strain K12)	510	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]	GO:0005886; GO:0005887; GO:0006740; GO:0008746; GO:0008750; GO:0046983; GO:0050661; GO:0051287; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN34131_c0_g1_i1	Q9ALA2	PNTA_RHOSH	57	121	50	1	1	357	122	242	6.00E-27	121.7	PNTA_RHOSH	reviewed	NAD(P) transhydrogenase subunit alpha (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha) (Pyridine nucleotide transhydrogenase subunit alpha)	pntA	Rhodobacter sphaeroides (Rhodopseudomonas sphaeroides)	523	integral component of plasma membrane [GO:0005887]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; protein dimerization activity [GO:0046983]; cellular response to oxidative stress [GO:0034599]; NADH oxidation [GO:0006116]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]	integral component of plasma membrane [GO:0005887]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD binding [GO:0051287]; protein dimerization activity [GO:0046983]	GO:0005887; GO:0006116; GO:0006740; GO:0008750; GO:0034599; GO:0046983; GO:0051287; GO:1902600	cellular response to oxidative stress [GO:0034599]; NADH oxidation [GO:0006116]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN34255_c0_g1_i1	P07001	PNTA_ECOLI	63.6	66	24	0	3	200	92	157	3.60E-15	81.6	PNTA_ECOLI	reviewed	NAD(P) transhydrogenase subunit alpha (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha) (Pyridine nucleotide transhydrogenase subunit alpha)	pntA b1603 JW1595	Escherichia coli (strain K12)	510	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]	GO:0005886; GO:0005887; GO:0006740; GO:0008746; GO:0008750; GO:0046983; GO:0050661; GO:0051287; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	1
TRINITY_DN29567_c0_g1_i1	Q2RSB2	PNTAA_RHORT	59.8	87	35	0	1	261	249	335	2.50E-21	102.4	PNTAA_RHORT	reviewed	NAD(P) transhydrogenase subunit alpha part 1 (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha 1) (Proton-translocating transhydrogenase component 1) (Pyridine nucleotide transhydrogenase subunit alpha 1) (dI)	pntAA nntA1 Rru_A2183	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	384	NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD+ binding [GO:0070403]; NADH binding [GO:0070404]; protein dimerization activity [GO:0046983]; NADPH regeneration [GO:0006740]		NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; NADH binding [GO:0070404]; protein dimerization activity [GO:0046983]	GO:0003957; GO:0006740; GO:0008750; GO:0046983; GO:0051287; GO:0070403; GO:0070404	NADPH regeneration [GO:0006740]		NA	NA	NA	NA	NA	NA
TRINITY_DN3867_c0_g1_i1	Q2RSB3	PNTAB_RHORT	61.8	68	26	0	207	4	48	115	6.60E-15	80.9	PNTAB_RHORT	reviewed	NAD(P) transhydrogenase subunit alpha part 2 (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit alpha 2) (Proton-translocating transhydrogenase component 2) (Pyridine nucleotide transhydrogenase subunit alpha 2) (dII)	pntAB nntA2 Rru_A2182	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	139	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8282_c0_g1_i1	Q2RSB4	PNTB_RHORT	72.9	96	26	0	2	289	310	405	5.90E-35	147.9	PNTB_RHORT	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Proton-translocating transhydrogenase NADP(H)-binding component) (Pyridine nucleotide transhydrogenase subunit beta) (dIII)	pntB nntB Rru_A2181	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN4361_c0_g1_i2	Q2RSB4	PNTB_RHORT	72.8	81	22	0	250	8	185	265	5.70E-26	117.9	PNTB_RHORT	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Proton-translocating transhydrogenase NADP(H)-binding component) (Pyridine nucleotide transhydrogenase subunit beta) (dIII)	pntB nntB Rru_A2181	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN31257_c0_g1_i1	Q2RSB4	PNTB_RHORT	89.7	68	7	0	205	2	210	277	2.90E-28	125.2	PNTB_RHORT	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Proton-translocating transhydrogenase NADP(H)-binding component) (Pyridine nucleotide transhydrogenase subunit beta) (dIII)	pntB nntB Rru_A2181	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN31749_c0_g1_i1	Q2RSB4	PNTB_RHORT	89.2	93	10	0	2	280	310	402	5.80E-40	164.5	PNTB_RHORT	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Proton-translocating transhydrogenase NADP(H)-binding component) (Pyridine nucleotide transhydrogenase subunit beta) (dIII)	pntB nntB Rru_A2181	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN37887_c0_g1_i1	P0AB69	PNTB_ECO57	82.9	70	12	0	215	6	333	402	6.00E-27	120.9	PNTB_ECO57	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Pyridine nucleotide transhydrogenase subunit beta)	pntB Z2597 ECs2308	Escherichia coli O157:H7	462	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN13926_c0_g1_i1	P43010	PNTB_HAEIN	60.6	99	39	0	299	3	301	399	7.00E-26	117.9	PNTB_HAEIN	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Pyridine nucleotide transhydrogenase subunit beta)	pntB HI_1363	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	474	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN13926_c0_g2_i1	P0AB69	PNTB_ECO57	74.4	86	22	0	1	258	193	278	1.60E-29	129.8	PNTB_ECO57	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Pyridine nucleotide transhydrogenase subunit beta)	pntB Z2597 ECs2308	Escherichia coli O157:H7	462	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN4361_c0_g1_i3	P0AB69	PNTB_ECO57	78.2	87	18	1	275	15	194	279	8.60E-29	127.5	PNTB_ECO57	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Pyridine nucleotide transhydrogenase subunit beta)	pntB Z2597 ECs2308	Escherichia coli O157:H7	462	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN29422_c0_g1_i1	P43010	PNTB_HAEIN	67.1	73	24	0	227	9	269	341	3.90E-18	91.7	PNTB_HAEIN	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Pyridine nucleotide transhydrogenase subunit beta)	pntB HI_1363	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	474	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN17516_c0_g2_i1	P43010	PNTB_HAEIN	59.2	169	69	0	570	64	302	470	3.20E-48	193	PNTB_HAEIN	reviewed	NAD(P) transhydrogenase subunit beta (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase subunit beta) (Pyridine nucleotide transhydrogenase subunit beta)	pntB HI_1363	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	474	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]	GO:0005886; GO:0008750; GO:0016021; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN3923_c0_g1_i2	W5PFI3	NNTM_SHEEP	72.7	498	135	1	368	1861	588	1084	4.80E-205	715.7	NNTM_SHEEP	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase)"	NNT	Ovis aries (Sheep)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]	GO:0005743; GO:0008746; GO:0016021; GO:0042802; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN3923_c0_g1_i2	W5PFI3	NNTM_SHEEP	70.2	124	37	0	10	381	469	592	8.80E-42	173.3	NNTM_SHEEP	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase)"	NNT	Ovis aries (Sheep)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]	GO:0005743; GO:0008746; GO:0016021; GO:0042802; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN3923_c0_g1_i4	W5PFI3	NNTM_SHEEP	68.3	347	109	1	1	1041	593	938	3.30E-128	459.5	NNTM_SHEEP	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase)"	NNT	Ovis aries (Sheep)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]	GO:0005743; GO:0008746; GO:0016021; GO:0042802; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN3923_c0_g1_i7	W5PFI3	NNTM_SHEEP	72.3	617	170	1	10	1860	469	1084	7.20E-254	877.9	NNTM_SHEEP	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase)"	NNT	Ovis aries (Sheep)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]	GO:0005743; GO:0008746; GO:0016021; GO:0042802; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN1702_c0_g1_i1	W5PFI3	NNTM_SHEEP	59.1	391	142	3	58	1203	1	382	6.20E-115	415.6	NNTM_SHEEP	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase)"	NNT	Ovis aries (Sheep)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	identical protein binding [GO:0042802]; NAD(P)+ transhydrogenase activity [GO:0008746]	GO:0005743; GO:0008746; GO:0016021; GO:0042802; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN39147_c0_g1_i1	P11024	NNTM_BOVIN	48.6	72	37	0	245	30	292	363	2.30E-11	69.3	NNTM_BOVIN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Bos taurus (Bovine)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN38253_c0_g1_i1	Q13423	NNTM_HUMAN	100	84	0	0	254	3	24	107	1.00E-43	176.8	NNTM_HUMAN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	1086	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3923_c0_g1_i5	Q13423	NNTM_HUMAN	71	124	36	0	10	381	469	592	9.60E-43	175.3	NNTM_HUMAN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	1086	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3923_c0_g1_i5	Q13423	NNTM_HUMAN	61.2	121	46	1	368	730	588	707	1.10E-33	145.2	NNTM_HUMAN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	1086	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN24029_c0_g1_i1	Q61941	NNTM_MOUSE	96	99	4	0	3	299	471	569	3.80E-45	181.8	NNTM_MOUSE	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	Nnt	Mus musculus (Mouse)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN24029_c0_g1_i2	Q13423	NNTM_HUMAN	100	92	0	0	1	276	478	569	1.90E-43	176	NNTM_HUMAN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	1086	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN31899_c0_g1_i1	Q61941	NNTM_MOUSE	56.6	106	42	2	2	307	501	606	6.80E-22	104.8	NNTM_MOUSE	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	Nnt	Mus musculus (Mouse)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN38148_c0_g1_i1	Q13423	NNTM_HUMAN	99.1	109	1	0	328	2	144	252	1.70E-51	203	NNTM_HUMAN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	1086	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN26300_c0_g1_i1	P11024	NNTM_BOVIN	100	100	0	0	303	4	978	1077	1.20E-51	203.4	NNTM_BOVIN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Bos taurus (Bovine)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN36870_c0_g1_i1	Q61941	NNTM_MOUSE	96.1	103	4	0	3	311	148	250	6.00E-48	191.4	NNTM_MOUSE	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	Nnt	Mus musculus (Mouse)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN36870_c0_g1_i1	Q61941	NNTM_MOUSE	57.4	61	26	0	196	378	212	272	4.70E-08	58.9	NNTM_MOUSE	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	Nnt	Mus musculus (Mouse)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN15268_c0_g1_i1	Q13423	NNTM_HUMAN	100	167	0	0	502	2	817	983	4.60E-88	325.1	NNTM_HUMAN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	1086	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0001933; GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0010918; GO:0016020; GO:0016021; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0055114; GO:0072593; GO:0098869; GO:1902600; GO:1903285	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN15268_c0_g1_i2	Q61941	NNTM_MOUSE	99.4	167	1	0	502	2	817	983	1.30E-87	323.6	NNTM_MOUSE	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	Nnt	Mus musculus (Mouse)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN17516_c0_g1_i1	P11024	NNTM_BOVIN	67.5	80	26	0	271	32	812	891	3.80E-23	108.6	NNTM_BOVIN	reviewed	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Bos taurus (Bovine)	1086	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NAD(P)+ transhydrogenase activity [GO:0008746]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i21	Q86X67	NUD13_HUMAN	43.2	229	122	5	809	132	121	344	2.10E-46	187.6	NUD13_HUMAN	reviewed	"NAD(P)H pyrophosphatase NUDT13, mitochondrial (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 13) (Nudix motif 13) (Protein KiSS-16)"	NUDT13	Homo sapiens (Human)	352	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]	GO:0005739; GO:0005759; GO:0006734; GO:0006742; GO:0015949; GO:0016462; GO:0035529; GO:0046872	NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i22	Q86X67	NUD13_HUMAN	45.8	168	83	5	626	132	182	344	1.60E-33	144.4	NUD13_HUMAN	reviewed	"NAD(P)H pyrophosphatase NUDT13, mitochondrial (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 13) (Nudix motif 13) (Protein KiSS-16)"	NUDT13	Homo sapiens (Human)	352	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]	GO:0005739; GO:0005759; GO:0006734; GO:0006742; GO:0015949; GO:0016462; GO:0035529; GO:0046872	NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949]		NA	NA	NA	NA	NA	NA
TRINITY_DN721_c0_g1_i25	Q86X67	NUD13_HUMAN	37.8	328	186	8	1076	132	22	344	4.50E-52	206.8	NUD13_HUMAN	reviewed	"NAD(P)H pyrophosphatase NUDT13, mitochondrial (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 13) (Nudix motif 13) (Protein KiSS-16)"	NUDT13	Homo sapiens (Human)	352	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]	GO:0005739; GO:0005759; GO:0006734; GO:0006742; GO:0015949; GO:0016462; GO:0035529; GO:0046872	NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949]		NA	NA	NA	NA	NA	NA
TRINITY_DN35508_c0_g1_i1	A9AN00	BETB_BURM1	58.8	68	27	1	220	17	170	236	3.60E-13	75.1	BETB_BURM1	reviewed	NAD/NADP-dependent betaine aldehyde dehydrogenase (BADH) (EC 1.2.1.8)	betB Bmul_3537 BMULJ_04980	Burkholderia multivorans (strain ATCC 17616 / 249)	489	betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]	GO:0008802; GO:0019285; GO:0046872	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN25246_c0_g1_i1	A4WUY6	BETB_RHOS5	70.8	120	35	0	3	362	364	483	3.40E-48	192.2	BETB_RHOS5	reviewed	NAD/NADP-dependent betaine aldehyde dehydrogenase (BADH) (EC 1.2.1.8)	betB Rsph17025_2311	Rhodobacter sphaeroides (strain ATCC 17025 / ATH 2.4.3)	483	betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]	GO:0008802; GO:0019285; GO:0046872	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN27363_c0_g1_i1	Q8D3K3	BETB_VIBVU	58.1	117	49	0	2	352	199	315	2.40E-35	149.4	BETB_VIBVU	reviewed	NAD/NADP-dependent betaine aldehyde dehydrogenase (BADH) (EC 1.2.1.8)	betB VV2_1687	Vibrio vulnificus (strain CMCP6)	486	betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]	GO:0008802; GO:0019285; GO:0046872	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN32253_c0_g1_i1	B9JBA3	BETB_AGRRK	61.6	86	33	0	261	4	268	353	2.50E-24	112.5	BETB_AGRRK	reviewed	NAD/NADP-dependent betaine aldehyde dehydrogenase (BADH) (EC 1.2.1.8)	betB Arad_1352	Agrobacterium radiobacter (strain K84 / ATCC BAA-868)	487	betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; metal ion binding [GO:0046872]	GO:0008802; GO:0019285; GO:0046872	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN16092_c0_g1_i1	Q54QE6	SIR2A_DICDI	67.6	68	21	1	209	6	402	468	2.40E-19	95.9	SIR2A_DICDI	reviewed	NAD-dependent deacetylase sir2A (EC 2.3.1.286) (Silent information regulator sir2A)	sir2A DDB_G0283917	Dictyostelium discoideum (Slime mold)	512	cytoplasm [GO:0005737]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; autophagosome-lysosome fusion [GO:0061909]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0008270; GO:0010628; GO:0010629; GO:0016740; GO:0017136; GO:0031149; GO:0044671; GO:0061909; GO:0070403	autophagosome-lysosome fusion [GO:0061909]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149]		NA	NA	NA	NA	NA	NA
TRINITY_DN35120_c0_g1_i1	Q6LQM6	MAO11_PHOPR	75.8	66	16	0	201	4	112	177	3.00E-22	105.1	MAO11_PHOPR	reviewed	NAD-dependent malic enzyme 1 (NAD-ME 1) (EC 1.1.1.38)	maeA1 PBPRA1997	Photobacterium profundum (strain SS9)	562	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]		malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004471; GO:0008948; GO:0046872; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN32854_c0_g1_i1	P23368	MAOM_HUMAN	100	114	0	0	343	2	212	325	8.10E-60	230.7	MAOM_HUMAN	reviewed	"NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)"	ME2	Homo sapiens (Human)	584	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; tricarboxylic acid cycle [GO:0006099]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006108; GO:0008948; GO:0009055; GO:0043231; GO:0046872; GO:0051287; GO:1902031	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN29058_c0_g1_i1	P23368	MAOM_HUMAN	100	123	0	0	371	3	369	491	1.80E-65	249.6	MAOM_HUMAN	reviewed	"NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)"	ME2	Homo sapiens (Human)	584	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; tricarboxylic acid cycle [GO:0006099]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006108; GO:0008948; GO:0009055; GO:0043231; GO:0046872; GO:0051287; GO:1902031	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN22305_c0_g1_i1	P23368	MAOM_HUMAN	100	122	0	0	366	1	85	206	1.00E-68	260.4	MAOM_HUMAN	reviewed	"NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)"	ME2	Homo sapiens (Human)	584	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; tricarboxylic acid cycle [GO:0006099]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006099; GO:0006108; GO:0008948; GO:0009055; GO:0043231; GO:0046872; GO:0051287; GO:1902031	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN22305_c0_g1_i2	Q99KE1	MAOM_MOUSE	99.3	138	1	0	414	1	85	222	2.70E-78	292.4	MAOM_MOUSE	reviewed	"NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)"	Me2	Mus musculus (Mouse)	589	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0043231; GO:0046872; GO:0051287; GO:1902031	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]		NA	NA	NA	NA	NA	NA
TRINITY_DN20521_c0_g1_i1	Q9I7I7	SIRT2_DROME	49.6	129	64	1	3	389	99	226	8.90E-31	134.4	SIRT2_DROME	reviewed	NAD-dependent protein deacetylase Sirt2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog) (SIR2-related protein)	Sirt2 CG5085	Drosophila melanogaster (Fruit fly)	355	cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; protein deacetylation [GO:0006476]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0004407; GO:0005634; GO:0005737; GO:0006476; GO:0008270; GO:0008340; GO:0016575; GO:0016740; GO:0017136; GO:0070403	determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; protein deacetylation [GO:0006476]		NA	NA	NA	NA	NA	NA
TRINITY_DN6956_c0_g1_i1	Q9VH08	SIR6_DROME	51.9	320	127	3	1109	156	1	295	5.70E-92	339.3	SIR6_DROME	reviewed	NAD-dependent protein deacetylase Sirt6 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6)	Sirt6 CG6284	Drosophila melanogaster (Fruit fly)	317	nucleus [GO:0005634]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD(P)+-protein-arginine ADP-ribosyltransferase activity [GO:0003956]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; transcription corepressor activity [GO:0003714]; determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]	nucleus [GO:0005634]	deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD(P)+-protein-arginine ADP-ribosyltransferase activity [GO:0003956]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0003956; GO:0004407; GO:0005634; GO:0008340; GO:0016575; GO:0019213; GO:0031937; GO:0046872; GO:0046969; GO:0070403; GO:0070932	determination of adult lifespan [GO:0008340]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]		NA	NA	NA	NA	NA	NA
TRINITY_DN8503_c1_g1_i1	Q96EB6	SIR1_HUMAN	58.6	360	96	4	1077	4	172	480	6.80E-114	412.5	SIR1_HUMAN	reviewed	NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]	SIRT1 SIR2L1	Homo sapiens (Human)	747	"chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"	chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]	bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000790; GO:0000978; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005719; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006346; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007569; GO:0008022; GO:0008134; GO:0008284; GO:0009267; GO:0010629; GO:0010824; GO:0010875; GO:0010883; GO:0010906; GO:0010934; GO:0014068; GO:0016032; GO:0016239; GO:0016567; GO:0016575; GO:0016605; GO:0017136; GO:0018394; GO:0019213; GO:0019899; GO:0030225; GO:0030308; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032071; GO:0032088; GO:0032868; GO:0032922; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0034983; GO:0035257; GO:0035356; GO:0035358; GO:0042127; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043280; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045892; GO:0045944; GO:0046628; GO:0046872; GO:0046969; GO:0050872; GO:0051019; GO:0051097; GO:0051152; GO:0051574; GO:0051898; GO:0055089; GO:0060766; GO:0070301; GO:0070403; GO:0070829; GO:0070857; GO:0070914; GO:0070932; GO:0071356; GO:0071441; GO:0071456; GO:0071479; GO:0071900; GO:0090335; GO:0090400; GO:0106230; GO:0106231; GO:1900034; GO:1900113; GO:1901215; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000480; GO:2000481; GO:2000619; GO:2000655; GO:2000757; GO:2000773; GO:2000774	"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8503_c1_g1_i2	Q96EB6	SIR1_HUMAN	56.8	333	91	4	1078	86	172	453	3.00E-101	370.5	SIR1_HUMAN	reviewed	NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]	SIRT1 SIR2L1	Homo sapiens (Human)	747	"chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"	chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]	bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000790; GO:0000978; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005719; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006346; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007569; GO:0008022; GO:0008134; GO:0008284; GO:0009267; GO:0010629; GO:0010824; GO:0010875; GO:0010883; GO:0010906; GO:0010934; GO:0014068; GO:0016032; GO:0016239; GO:0016567; GO:0016575; GO:0016605; GO:0017136; GO:0018394; GO:0019213; GO:0019899; GO:0030225; GO:0030308; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032071; GO:0032088; GO:0032868; GO:0032922; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0034983; GO:0035257; GO:0035356; GO:0035358; GO:0042127; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043280; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045892; GO:0045944; GO:0046628; GO:0046872; GO:0046969; GO:0050872; GO:0051019; GO:0051097; GO:0051152; GO:0051574; GO:0051898; GO:0055089; GO:0060766; GO:0070301; GO:0070403; GO:0070829; GO:0070857; GO:0070914; GO:0070932; GO:0071356; GO:0071441; GO:0071456; GO:0071479; GO:0071900; GO:0090335; GO:0090400; GO:0106230; GO:0106231; GO:1900034; GO:1900113; GO:1901215; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000480; GO:2000481; GO:2000619; GO:2000655; GO:2000757; GO:2000773; GO:2000774	"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN57_c0_g1_i1	Q7ZVK3	SIR2_DANRE	67.6	105	34	0	399	85	49	153	3.90E-38	159.8	SIR2_DANRE	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	Danio rerio (Zebrafish) (Brachydanio rerio)	379	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]	histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0016525; GO:0016740; GO:0017136; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]		NA	NA	NA	NA	NA	NA
TRINITY_DN57_c0_g1_i2	Q7ZVK3	SIR2_DANRE	67.6	105	34	0	399	85	49	153	3.30E-38	159.8	SIR2_DANRE	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	Danio rerio (Zebrafish) (Brachydanio rerio)	379	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]	histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0016525; GO:0016740; GO:0017136; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]		NA	NA	NA	NA	NA	NA
TRINITY_DN40917_c0_g1_i1	Q8IXJ6	SIR2_HUMAN	100	87	0	0	263	3	278	364	1.10E-45	183.3	SIR2_HUMAN	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	SIRT2 SIR2L SIR2L2	Homo sapiens (Human)	389	"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]"	"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]"	chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000183; GO:0000781; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005677; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006342; GO:0006348; GO:0006471; GO:0006476; GO:0006914; GO:0007096; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0021762; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0042177; GO:0042325; GO:0042826; GO:0042903; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045087; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0051301; GO:0051321; GO:0051726; GO:0051775; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34878_c0_g1_i1	Q8IXJ6	SIR2_HUMAN	50.7	67	32	1	35	235	77	142	8.80E-13	73.9	SIR2_HUMAN	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	SIRT2 SIR2L SIR2L2	Homo sapiens (Human)	389	"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]"	"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]"	chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000183; GO:0000781; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005677; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006342; GO:0006348; GO:0006471; GO:0006476; GO:0006914; GO:0007096; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0021762; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0042177; GO:0042325; GO:0042826; GO:0042903; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045087; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0051301; GO:0051321; GO:0051726; GO:0051775; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at telomere [GO:0006348]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16092_c0_g2_i1	Q7ZVK3	SIR2_DANRE	56.6	129	52	2	5	385	62	188	1.00E-37	157.5	SIR2_DANRE	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	sirt2 zgc:77003	Danio rerio (Zebrafish) (Brachydanio rerio)	379	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]	histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]	GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0016525; GO:0016740; GO:0017136; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777	cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042]		NA	NA	NA	NA	NA	NA
TRINITY_DN57_c0_g1_i3	Q8VDQ8	SIR2_MOUSE	62.5	299	108	2	1029	139	49	345	3.50E-109	396.7	SIR2_MOUSE	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2)	Sirt2 Sir2l2	Mus musculus (Mouse)	389	"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]	chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006471; GO:0006476; GO:0006914; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0035748; GO:0042177; GO:0042826; GO:0042903; GO:0043066; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045598; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0048715; GO:0051301; GO:0051321; GO:0051726; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0097456; GO:0098978; GO:0099149; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"		NA	NA	NA	NA	NA	NA
TRINITY_DN57_c0_g1_i4	Q8VDQ8	SIR2_MOUSE	62.5	299	108	2	1029	139	49	345	3.20E-109	396.7	SIR2_MOUSE	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2)	Sirt2 Sir2l2	Mus musculus (Mouse)	389	"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]	chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006471; GO:0006476; GO:0006914; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0035748; GO:0042177; GO:0042826; GO:0042903; GO:0043066; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045598; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0048715; GO:0051301; GO:0051321; GO:0051726; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0097456; GO:0098978; GO:0099149; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25216_c0_g1_i1	Q8VDQ8	SIR2_MOUSE	96.4	250	9	0	3	752	47	296	1.60E-140	500	SIR2_MOUSE	reviewed	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2)	Sirt2 Sir2l2	Mus musculus (Mouse)	389	"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"	centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]	chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006471; GO:0006476; GO:0006914; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0035748; GO:0042177; GO:0042826; GO:0042903; GO:0043066; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045598; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0048715; GO:0051301; GO:0051321; GO:0051726; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0097456; GO:0098978; GO:0099149; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33068_c0_g1_i1	Q8R104	SIR3_MOUSE	100	71	0	0	1	213	193	263	6.60E-36	150.6	SIR3_MOUSE	reviewed	NAD-dependent protein deacetylase sirtuin-3 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3) (mSIR2L3)	Sirt3 Sir2l3	Mus musculus (Mouse)	334	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; histone H3 deacetylation [GO:0070932]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of superoxide dismutase activity [GO:1901671]; protein deacetylation [GO:0006476]	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006476; GO:0008270; GO:0009060; GO:0016020; GO:0016740; GO:0017136; GO:0019899; GO:0032024; GO:0032041; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070373; GO:0070403; GO:0070932; GO:1901671; GO:1902553; GO:1903109; GO:2000304; GO:2000378; GO:2000757	aerobic respiration [GO:0009060]; histone H3 deacetylation [GO:0070932]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of superoxide dismutase activity [GO:1901671]; protein deacetylation [GO:0006476]		NA	NA	NA	NA	NA	NA
TRINITY_DN36031_c0_g1_i1	Q9NTG7	SIR3_HUMAN	54.1	279	120	5	954	127	113	386	7.70E-77	288.9	SIR3_HUMAN	reviewed	"NAD-dependent protein deacetylase sirtuin-3, mitochondrial (hSIRT3) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)"	SIRT3 SIR2L3	Homo sapiens (Human)	399	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0007005; GO:0007568; GO:0008270; GO:0009060; GO:0017136; GO:0019899; GO:0032024; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070373; GO:0070403; GO:1901671; GO:1902553; GO:2000304; GO:2000378	aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]		NA	NA	NA	NA	NA	NA
TRINITY_DN36031_c0_g1_i2	Q9NTG7	SIR3_HUMAN	50	102	49	1	426	127	285	386	2.50E-19	96.7	SIR3_HUMAN	reviewed	"NAD-dependent protein deacetylase sirtuin-3, mitochondrial (hSIRT3) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)"	SIRT3 SIR2L3	Homo sapiens (Human)	399	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0007005; GO:0007568; GO:0008270; GO:0009060; GO:0017136; GO:0019899; GO:0032024; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070373; GO:0070403; GO:1901671; GO:1902553; GO:2000304; GO:2000378	aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion [GO:0032024]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]		NA	NA	NA	NA	NA	NA
TRINITY_DN39543_c0_g1_i1	Q0P595	SIR7_BOVIN	75.5	110	27	0	3	332	106	215	1.90E-45	183	SIR7_BOVIN	reviewed	NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7)	SIRT7	Bos taurus (Bovine)	400	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-propionyllysine depropionylase activity [GO:0106231]; protein-succinyllysine desuccinylase activity [GO:0036055]; transcription corepressor activity [GO:0003714]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone glutamine methylation [GO:1990258]; histone H3 deacetylation [GO:0070932]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transposition [GO:0010529]; osteoblast differentiation [GO:0001649]; peptidyl-lysine desuccinylation [GO:0036049]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop disassembly [GO:0062176]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of gluconeogenesis [GO:0006111]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-propionyllysine depropionylase activity [GO:0106231]; protein-succinyllysine desuccinylase activity [GO:0036055]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006111; GO:0006281; GO:0006282; GO:0006476; GO:0006974; GO:0007072; GO:0007129; GO:0009303; GO:0010529; GO:0010821; GO:0016570; GO:0019213; GO:0031397; GO:0034979; GO:0035861; GO:0036049; GO:0036055; GO:0045944; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0070932; GO:0097372; GO:0106230; GO:0106231; GO:1901836; GO:1990258; GO:2000234; GO:2001032	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone glutamine methylation [GO:1990258]; histone H3 deacetylation [GO:0070932]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transposition [GO:0010529]; osteoblast differentiation [GO:0001649]; peptidyl-lysine desuccinylation [GO:0036049]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of gluconeogenesis [GO:0006111]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; R-loop disassembly [GO:0062176]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN39543_c0_g1_i2	Q0P595	SIR7_BOVIN	75.8	95	23	0	3	287	106	200	1.00E-37	157.1	SIR7_BOVIN	reviewed	NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7)	SIRT7	Bos taurus (Bovine)	400	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-propionyllysine depropionylase activity [GO:0106231]; protein-succinyllysine desuccinylase activity [GO:0036055]; transcription corepressor activity [GO:0003714]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone glutamine methylation [GO:1990258]; histone H3 deacetylation [GO:0070932]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transposition [GO:0010529]; osteoblast differentiation [GO:0001649]; peptidyl-lysine desuccinylation [GO:0036049]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop disassembly [GO:0062176]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of gluconeogenesis [GO:0006111]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-propionyllysine depropionylase activity [GO:0106231]; protein-succinyllysine desuccinylase activity [GO:0036055]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006111; GO:0006281; GO:0006282; GO:0006476; GO:0006974; GO:0007072; GO:0007129; GO:0009303; GO:0010529; GO:0010821; GO:0016570; GO:0019213; GO:0031397; GO:0034979; GO:0035861; GO:0036049; GO:0036055; GO:0045944; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0070932; GO:0097372; GO:0106230; GO:0106231; GO:1901836; GO:1990258; GO:2000234; GO:2001032	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone glutamine methylation [GO:1990258]; histone H3 deacetylation [GO:0070932]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transposition [GO:0010529]; osteoblast differentiation [GO:0001649]; peptidyl-lysine desuccinylation [GO:0036049]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of gluconeogenesis [GO:0006111]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; R-loop disassembly [GO:0062176]; rRNA transcription [GO:0009303]		NA	NA	NA	NA	NA	NA
TRINITY_DN5349_c0_g1_i1	Q8R216	SIR4_MOUSE	52.1	286	137	0	947	90	21	306	2.10E-82	307.4	SIR4_MOUSE	reviewed	"NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)"	Sirt4 Sir2l4	Mus musculus (Mouse)	333	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; biotinidase activity [GO:0047708]; lipoamidase activity [GO:0061690]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; glutamine metabolic process [GO:0006541]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein ADP-ribosylation [GO:0006471]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	biotinidase activity [GO:0047708]; lipoamidase activity [GO:0061690]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; zinc ion binding [GO:0008270]	GO:0000820; GO:0003950; GO:0005739; GO:0005743; GO:0005759; GO:0006471; GO:0006541; GO:0006974; GO:0008270; GO:0010667; GO:0034979; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0047708; GO:0061690; GO:0070403; GO:0071456; GO:0072350; GO:1903217; GO:1904182	cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; glutamine metabolic process [GO:0006541]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein ADP-ribosylation [GO:0006471]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350]		NA	NA	NA	NA	NA	NA
TRINITY_DN5109_c0_g1_i1	A7YVD7	NDUF6_BOVIN	53.8	240	111	0	12	731	85	324	2.00E-71	270.4	NDUF6_BOVIN	reviewed	"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6"	NDUFAF6	Bos taurus (Bovine)	333	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN5281_c0_g1_i2	Q95KV7	NDUAD_BOVIN	42.6	108	56	3	515	201	3	107	2.20E-14	80.5	NDUAD_BOVIN	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit)	NDUFA13 GRIM19	Bos taurus (Bovine)	144	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005654; GO:0005737; GO:0005739; GO:0005746; GO:0005747; GO:0008137; GO:0016021; GO:0030308; GO:0032981; GO:0035458; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243	"apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5281_c0_g1_i3	Q95KV7	NDUAD_BOVIN	40.5	79	41	3	440	213	32	107	7.20E-07	55.5	NDUAD_BOVIN	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit)	NDUFA13 GRIM19	Bos taurus (Bovine)	144	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005654; GO:0005737; GO:0005739; GO:0005746; GO:0005747; GO:0008137; GO:0016021; GO:0030308; GO:0032981; GO:0035458; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243	"apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"		brown	brown	NA	NA	NA	NA
TRINITY_DN5281_c0_g1_i4	Q95KV7	NDUAD_BOVIN	42.6	108	56	3	527	213	3	107	2.30E-14	80.5	NDUAD_BOVIN	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit)	NDUFA13 GRIM19	Bos taurus (Bovine)	144	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005654; GO:0005737; GO:0005739; GO:0005746; GO:0005747; GO:0008137; GO:0016021; GO:0030308; GO:0032981; GO:0035458; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243	"apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7871_c0_g1_i1	Q0MQA1	NDUA5_GORGO	100	73	0	0	3	221	44	116	9.90E-37	153.7	NDUA5_GORGO	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit)	NDUFA5	Gorilla gorilla gorilla (Western lowland gorilla)	116	mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; respiratory electron transport chain [GO:0022904]	mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005747; GO:0008137; GO:0022904; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]; respiratory electron transport chain [GO:0022904]		NA	NA	NA	NA	NA	NA
TRINITY_DN9704_c0_g1_i1	P23935	NDUA5_BOVIN	64.9	111	39	0	67	399	6	116	6.80E-36	151.8	NDUA5_BOVIN	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit)	NDUFA5	Bos taurus (Bovine)	116	mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; respiratory electron transport chain [GO:0022904]	mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005747; GO:0008137; GO:0022904; GO:0032981	mitochondrial respiratory chain complex I assembly [GO:0032981]; respiratory electron transport chain [GO:0022904]		blue	blue	NA	NA	NA	NA
TRINITY_DN3296_c1_g2_i1	Q0MQA4	NDUA6_GORGO	48.4	124	56	1	489	142	4	127	7.70E-27	122.1	NDUA6_GORGO	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	NDUFA6	Gorilla gorilla gorilla (Western lowland gorilla)	128	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0006979; GO:0032981; GO:0055114	mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN25483_c0_g1_i1	Q0MQA4	NDUA6_GORGO	99.2	127	1	0	386	6	2	128	2.40E-68	259.2	NDUA6_GORGO	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	NDUFA6	Gorilla gorilla gorilla (Western lowland gorilla)	128	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0006979; GO:0032981; GO:0055114	mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN21162_c0_g1_i1	Q9CQZ5	NDUA6_MOUSE	52.4	63	30	0	205	17	63	125	2.40E-12	72.4	NDUA6_MOUSE	reviewed	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	Ndufa6	Mus musculus (Mouse)	131	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]		GO:0005739; GO:0005747; GO:0006979; GO:0031966; GO:0032981; GO:0055114	mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN4269_c0_g1_i1	Q0MQB3	NDUA9_GORGO	45.8	349	168	7	188	1225	41	371	1.90E-80	301.2	NDUA9_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)"	NDUFA9	Gorilla gorilla gorilla (Western lowland gorilla)	377	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase activity [GO:0003954]; mitochondrial respiratory chain complex I assembly [GO:0032981]; ubiquinone-6 biosynthetic process [GO:1901006]	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005747; GO:0005759; GO:0032981; GO:1901006	mitochondrial respiratory chain complex I assembly [GO:0032981]; ubiquinone-6 biosynthetic process [GO:1901006]		blue	blue	NA	NA	NA	NA
TRINITY_DN4269_c0_g1_i2	Q0MQB3	NDUA9_GORGO	45.8	349	168	7	185	1222	41	371	1.90E-80	301.2	NDUA9_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)"	NDUFA9	Gorilla gorilla gorilla (Western lowland gorilla)	377	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase activity [GO:0003954]; mitochondrial respiratory chain complex I assembly [GO:0032981]; ubiquinone-6 biosynthetic process [GO:1901006]	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005747; GO:0005759; GO:0032981; GO:1901006	mitochondrial respiratory chain complex I assembly [GO:0032981]; ubiquinone-6 biosynthetic process [GO:1901006]		NA	NA	NA	NA	NA	NA
TRINITY_DN16883_c0_g1_i1	Q16795	NDUA9_HUMAN	100	184	0	0	3	554	26	209	2.10E-105	382.9	NDUA9_HUMAN	reviewed	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)"	NDUFA9 NDUFS2L	Homo sapiens (Human)	377	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; circadian rhythm [GO:0007623]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]	GO:0003954; GO:0005634; GO:0005654; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0006814; GO:0007623; GO:0008137; GO:0009749; GO:0031966; GO:0032981; GO:0044877; GO:1901006	"circadian rhythm [GO:0007623]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16883_c1_g1_i1	Q9DC69	NDUA9_MOUSE	100	119	0	0	3	359	26	144	8.00E-66	250.8	NDUA9_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)"	Ndufa9	Mus musculus (Mouse)	377	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]	GO:0003954; GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0007623; GO:0009749; GO:0031966; GO:0032981; GO:0044877; GO:1901006	circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006]		NA	NA	NA	NA	NA	NA
TRINITY_DN11219_c0_g1_i2	Q1HPL8	NDUBA_BOMMO	58.1	148	62	0	69	512	5	152	2.20E-50	200.3	NDUBA_BOMMO	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10		Bombyx mori (Silk moth)	159	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; oxidation-reduction process [GO:0055114]	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]		GO:0005743; GO:0055114; GO:0070469	oxidation-reduction process [GO:0055114]		blue	blue	NA	NA	NA	NA
TRINITY_DN6234_c0_g1_i10	Q0MQD1	NDUB3_GORGO	47	66	28	3	345	536	14	74	3.50E-09	63.2	NDUB3_GORGO	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)	NDUFB3	Gorilla gorilla gorilla (Western lowland gorilla)	98	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0016021; GO:0022900; GO:0032981	electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN6234_c0_g1_i2	Q0MQD1	NDUB3_GORGO	47	66	28	3	225	416	14	74	2.10E-09	63.5	NDUB3_GORGO	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)	NDUFB3	Gorilla gorilla gorilla (Western lowland gorilla)	98	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0016021; GO:0022900; GO:0032981	electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]		blue	blue	NA	NA	NA	NA
TRINITY_DN6234_c0_g1_i8	Q0MQD1	NDUB3_GORGO	47	66	28	3	274	465	14	74	3.10E-09	63.2	NDUB3_GORGO	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)	NDUFB3	Gorilla gorilla gorilla (Western lowland gorilla)	98	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0016021; GO:0022900; GO:0032981	electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN20454_c0_g1_i1	Q0MQD6	NDUB5_PONPY	41.4	152	89	0	602	147	23	174	1.10E-20	101.7	NDUB5_PONPY	reviewed	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)"	NDUFB5	Pongo pygmaeus (Bornean orangutan)	189	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0016021; GO:0032981; GO:0055114	mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]		blue	blue	NA	NA	NA	NA
TRINITY_DN33093_c0_g1_i1	Q0MQE6	NDUB8_GORGO	100	74	0	0	2	223	9	82	6.70E-39	160.6	NDUB8_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)"	NDUFB8	Gorilla gorilla gorilla (Western lowland gorilla)	186	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005747; GO:0005783; GO:0006120; GO:0008137; GO:0016021; GO:0032981	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2117_c0_g1_i1	Q02372	NDUB8_BOVIN	42.1	140	76	2	521	108	26	162	4.10E-26	119.8	NDUB8_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)"	NDUFB8	Bos taurus (Bovine)	186	"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005747; GO:0006120; GO:0008137; GO:0016021; GO:0032981	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2117_c0_g1_i3	Q02372	NDUB8_BOVIN	41	134	74	2	483	88	26	156	3.10E-23	110.2	NDUB8_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)"	NDUFB8	Bos taurus (Bovine)	186	"integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005747; GO:0006120; GO:0008137; GO:0016021; GO:0032981	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4235_c0_g1_i1	Q9CQJ8	NDUB9_MOUSE	52	125	58	1	115	483	11	135	8.50E-28	125.2	NDUB9_MOUSE	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)	Ndufb9	Mus musculus (Mouse)	179	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0032981	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4235_c0_g1_i2	Q9CQJ8	NDUB9_MOUSE	51	102	48	1	92	391	34	135	1.10E-20	101.3	NDUB9_MOUSE	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)	Ndufb9	Mus musculus (Mouse)	179	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0032981	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28519_c0_g1_i1	Q9CQJ8	NDUB9_MOUSE	100	73	0	0	2	220	79	151	1.60E-40	166	NDUB9_MOUSE	reviewed	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)	Ndufb9	Mus musculus (Mouse)	179	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0032981	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2962_c0_g1_i1	Q9FNN5	NDUV1_ARATH	75.9	137	33	0	2	412	341	477	3.60E-60	232.3	NDUV1_ARATH	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2)"	At5g08530 MAH20.9	Arabidopsis thaliana (Mouse-ear cress)	486	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0005886; GO:0006120; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25617_c0_g1_i1	Q9FNN5	NDUV1_ARATH	56.1	82	36	0	3	248	387	468	1.10E-24	113.6	NDUV1_ARATH	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2)"	At5g08530 MAH20.9	Arabidopsis thaliana (Mouse-ear cress)	486	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0005886; GO:0006120; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3877_c0_g1_i1	P49821	NDUV1_HUMAN	100	275	0	0	826	2	16	290	3.50E-165	582	NDUV1_HUMAN	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	NDUFV1 UQOR1	Homo sapiens (Human)	464	"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005743; GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0010181; GO:0032981; GO:0042775; GO:0046872; GO:0051287; GO:0051539	"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3877_c0_g2_i1	Q91YT0	NDUV1_MOUSE	100	254	0	0	763	2	37	290	2.10E-153	542.7	NDUV1_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	Ndufv1	Mus musculus (Mouse)	464	"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005743; GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0010181; GO:0042775; GO:0046872; GO:0051287; GO:0051539	"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3950_c0_g1_i1	Q0MQI4	NDUV1_PONPY	86.8	423	56	0	1377	109	32	454	1.70E-229	796.6	NDUV1_PONPY	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	NDUFV1	Pongo pygmaeus (Bornean orangutan)	464	"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005743; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539; GO:0070469			blue	blue	NA	NA	NA	NA
TRINITY_DN3950_c0_g1_i3	Q0MQI4	NDUV1_PONPY	86.8	423	56	0	1377	109	32	454	1.70E-229	796.6	NDUV1_PONPY	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	NDUFV1	Pongo pygmaeus (Bornean orangutan)	464	"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005743; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539; GO:0070469			blue	blue	NA	NA	NA	NA
TRINITY_DN3950_c0_g1_i4	Q0MQI4	NDUV1_PONPY	86.8	423	56	0	1377	109	32	454	1.70E-229	796.6	NDUV1_PONPY	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	NDUFV1	Pongo pygmaeus (Bornean orangutan)	464	"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005743; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539; GO:0070469			blue	blue	NA	NA	NA	NA
TRINITY_DN20570_c0_g1_i1	Q0MQI5	NDUV1_GORGO	99.2	133	1	0	435	37	332	464	4.80E-73	275	NDUV1_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	NDUFV1	Gorilla gorilla gorilla (Western lowland gorilla)	464	"cytosol [GO:0005829]; mitochondrial respiratory chain complex I [GO:0005747]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	cytosol [GO:0005829]; mitochondrial respiratory chain complex I [GO:0005747]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20570_c0_g1_i2	Q0MQI5	NDUV1_GORGO	100	147	0	0	477	37	318	464	8.00E-82	304.3	NDUV1_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	NDUFV1	Gorilla gorilla gorilla (Western lowland gorilla)	464	"cytosol [GO:0005829]; mitochondrial respiratory chain complex I [GO:0005747]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	cytosol [GO:0005829]; mitochondrial respiratory chain complex I [GO:0005747]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1915_c0_g1_i1	P04394	NDUV2_BOVIN	69	229	68	2	739	59	22	249	4.40E-86	319.3	NDUV2_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase subunit II) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	NDUFV2	Bos taurus (Bovine)	249	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0022904; GO:0046872; GO:0048738; GO:0051537	"cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1915_c0_g1_i3	P04394	NDUV2_BOVIN	69	229	68	2	739	59	22	249	4.40E-86	319.3	NDUV2_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase subunit II) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	NDUFV2	Bos taurus (Bovine)	249	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0022904; GO:0046872; GO:0048738; GO:0051537	"cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1915_c0_g1_i6	P04394	NDUV2_BOVIN	69	229	68	2	739	59	22	249	4.40E-86	319.3	NDUV2_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase subunit II) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	NDUFV2	Bos taurus (Bovine)	249	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0022904; GO:0046872; GO:0048738; GO:0051537	"cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10477_c0_g1_i1	Q9D6J6	NDUV2_MOUSE	100	168	0	0	3	506	8	175	6.70E-95	347.8	NDUV2_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	Ndufv2	Mus musculus (Mouse)	248	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0022904; GO:0043209; GO:0046872; GO:0048738; GO:0051537	"cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10477_c0_g2_i1	P19404	NDUV2_HUMAN	99.4	160	1	0	1	480	17	176	9.50E-91	334	NDUV2_HUMAN	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	NDUFV2	Homo sapiens (Human)	249	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009055; GO:0022904; GO:0032981; GO:0046872; GO:0048738; GO:0051537	"cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1915_c0_g1_i2	P19234	NDUV2_RAT	65.5	113	39	0	397	59	136	248	1.10E-37	157.9	NDUV2_RAT	reviewed	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	Ndufv2	Rattus norvegicus (Rat)	248	"mitochondrial respiratory chain complex I [GO:0005747]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"	mitochondrial respiratory chain complex I [GO:0005747]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0022904; GO:0046872; GO:0048738; GO:0051537	"cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19384_c0_g1_i1	Q641Y2	NDUS2_RAT	74.1	433	112	0	155	1453	31	463	1.20E-198	694.1	NDUS2_RAT	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	Rattus norvegicus (Rat)	463	"mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; response to oxidative stress [GO:0006979]"	mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005654; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0031625; GO:0042775; GO:0046872; GO:0048038; GO:0051287; GO:0051539	"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; response to oxidative stress [GO:0006979]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10084_c0_g2_i1	O75306	NDUS2_HUMAN	100	423	0	0	3	1271	41	463	2.30E-256	885.6	NDUS2_HUMAN	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	NDUFS2	Homo sapiens (Human)	463	"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]"	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005654; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0006979; GO:0008137; GO:0009055; GO:0031625; GO:0032981; GO:0042775; GO:0046872; GO:0048038; GO:0051287; GO:0051539	"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10084_c0_g1_i1	Q91WD5	NDUS2_MOUSE	99.5	383	2	0	1	1149	81	463	4.20E-228	791.6	NDUS2_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	Ndufs2	Mus musculus (Mouse)	463	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; response to oxidative stress [GO:0006979]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005654; GO:0005739; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0031625; GO:0042775; GO:0046872; GO:0048038; GO:0051287; GO:0051539	"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; response to oxidative stress [GO:0006979]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15763_c0_g1_i1	O75306	NDUS2_HUMAN	63.3	90	33	0	6	275	51	140	2.10E-26	119.4	NDUS2_HUMAN	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	NDUFS2	Homo sapiens (Human)	463	"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]"	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005654; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0006979; GO:0008137; GO:0009055; GO:0031625; GO:0032981; GO:0042775; GO:0046872; GO:0048038; GO:0051287; GO:0051539	"mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1439_c0_g2_i1	Q0MQG6	NDUS3_PONPY	66.9	251	77	3	946	206	10	258	3.10E-91	336.7	NDUS3_PONPY	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)"	NDUFS3	Pongo pygmaeus (Bornean orangutan)	263	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005747; GO:0008137; GO:0030308; GO:0031966; GO:0072593; GO:2001243	negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]		blue	blue	NA	NA	NA	NA
TRINITY_DN31560_c0_g1_i1	Q9DCT2	NDUS3_MOUSE	100	28	0	0	2	85	181	208	1.90E-10	66.6	NDUS3_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)"	Ndufs3	Mus musculus (Mouse)	263	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0008137; GO:0016604; GO:0030308; GO:0031966; GO:0043209; GO:0072593; GO:2001243	negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN11319_c0_g1_i1	Q9DCT2	NDUS3_MOUSE	99.4	176	1	0	1	528	75	250	2.50E-100	365.9	NDUS3_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)"	Ndufs3	Mus musculus (Mouse)	263	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0008137; GO:0016604; GO:0030308; GO:0031966; GO:0043209; GO:0072593; GO:2001243	negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN11319_c0_g2_i1	Q0MQG7	NDUS3_GORGO	100	204	0	0	3	614	60	263	2.00E-117	422.9	NDUS3_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)"	NDUFS3	Gorilla gorilla gorilla (Western lowland gorilla)	263	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005747; GO:0008137; GO:0030308; GO:0031966; GO:0072593; GO:2001243	negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN32652_c0_g1_i1	P23709	NDUS3_BOVIN	67.5	40	13	0	122	3	210	249	2.10E-10	65.9	NDUS3_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)"	NDUFS3	Bos taurus (Bovine)	266	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]	mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]	GO:0003954; GO:0005747; GO:0008137; GO:0030308; GO:0031966; GO:0072593; GO:2001243	negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN15899_c0_g1_i1	Q02375	NDUS4_BOVIN	78.6	28	6	0	5	88	96	123	1.10E-07	57	NDUS4_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)"	NDUFS4	Bos taurus (Bovine)	175	mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]	mitochondrial respiratory chain complex I [GO:0005747]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0001932; GO:0005747; GO:0007420; GO:0008137; GO:0019933; GO:0022900; GO:0032981; GO:0045333; GO:0048146; GO:0051591; GO:0072593	brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]		NA	NA	NA	NA	NA	NA
TRINITY_DN15899_c0_g2_i1	Q9CXZ1	NDUS4_MOUSE	67.5	80	26	0	5	244	96	175	1.00E-27	124	NDUS4_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)"	Ndufs4	Mus musculus (Mouse)	175	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; cognition [GO:0050890]; dopamine metabolic process [GO:0042417]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron death [GO:0070997]; positive regulation of fibroblast proliferation [GO:0048146]; psychomotor behavior [GO:0036343]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of protein phosphorylation [GO:0001932]; respiratory electron transport chain [GO:0022904]; respiratory system process [GO:0003016]; response to cAMP [GO:0051591]; response to injury involved in regulation of muscle adaptation [GO:0014876]; sensory perception of sound [GO:0007605]; tricarboxylic acid cycle [GO:0006099]; visual perception [GO:0007601]	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0001932; GO:0003016; GO:0005739; GO:0005747; GO:0006099; GO:0006954; GO:0007420; GO:0007601; GO:0007605; GO:0007628; GO:0008137; GO:0014876; GO:0019933; GO:0022904; GO:0030534; GO:0032981; GO:0036343; GO:0042417; GO:0045087; GO:0045333; GO:0048146; GO:0050890; GO:0051591; GO:0051881; GO:0070997; GO:0072593	adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; cognition [GO:0050890]; dopamine metabolic process [GO:0042417]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron death [GO:0070997]; positive regulation of fibroblast proliferation [GO:0048146]; psychomotor behavior [GO:0036343]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of protein phosphorylation [GO:0001932]; respiratory electron transport chain [GO:0022904]; respiratory system process [GO:0003016]; response to cAMP [GO:0051591]; response to injury involved in regulation of muscle adaptation [GO:0014876]; sensory perception of sound [GO:0007605]; tricarboxylic acid cycle [GO:0006099]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN25533_c0_g1_i1	O75380	NDUS6_HUMAN	100	74	0	0	253	32	51	124	3.40E-39	161.8	NDUS6_HUMAN	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)"	NDUFS6	Homo sapiens (Human)	124	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; fatty acid metabolic process [GO:0006631]; kidney development [GO:0001822]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0001822; GO:0005743; GO:0005747; GO:0006120; GO:0006631; GO:0006936; GO:0008137; GO:0009055; GO:0010259; GO:0032981; GO:0035264; GO:0061458; GO:0070584	"fatty acid metabolic process [GO:0006631]; kidney development [GO:0001822]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15241_c0_g1_i1	P52503	NDUS6_MOUSE	100	64	0	0	229	38	53	116	3.90E-34	144.8	NDUS6_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)"	Ndufs6 Ip13	Mus musculus (Mouse)	116	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; circulatory system development [GO:0072359]; fatty acid metabolic process [GO:0006631]; kidney development [GO:0001822]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]; respiratory electron transport chain [GO:0022904]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]		GO:0001822; GO:0005739; GO:0005747; GO:0006120; GO:0006631; GO:0006936; GO:0010259; GO:0022904; GO:0032981; GO:0035264; GO:0061458; GO:0070584; GO:0072359	"circulatory system development [GO:0072359]; fatty acid metabolic process [GO:0006631]; kidney development [GO:0001822]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]; respiratory electron transport chain [GO:0022904]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17478_c0_g1_i1	P23934	NDUS6_BOVIN	50.5	95	44	2	392	111	30	122	3.50E-19	96.3	NDUS6_BOVIN	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)"	NDUFS6	Bos taurus (Bovine)	124	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	mitochondrial respiratory chain complex I [GO:0005747]		GO:0005747; GO:0006120	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28922_c0_g1_i1	Q0MQH9	NDUS7_GORGO	100	147	0	0	1	441	67	213	5.30E-84	311.6	NDUS7_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit)"	NDUFS7	Gorilla gorilla gorilla (Western lowland gorilla)	213	"mitochondrial respiratory chain complex I [GO:0005747]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial respiratory chain complex I [GO:0005747]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005747; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0046872; GO:0048038; GO:0051539	aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN91_c2_g1_i1	P0CB83	NDUS7_PONAB	82	150	27	0	533	84	64	213	9.00E-74	277.7	NDUS7_PONAB	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit)"	NDUFS7	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	213	"mitochondrial respiratory chain complex I [GO:0005747]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial respiratory chain complex I [GO:0005747]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005747; GO:0008137; GO:0032981; GO:0046872; GO:0048038; GO:0051539	mitochondrial respiratory chain complex I assembly [GO:0032981]		blue	blue	NA	NA	NA	NA
TRINITY_DN91_c2_g1_i2	Q0MQH9	NDUS7_GORGO	70.5	88	26	0	347	84	126	213	3.50E-34	146	NDUS7_GORGO	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit)"	NDUFS7	Gorilla gorilla gorilla (Western lowland gorilla)	213	"mitochondrial respiratory chain complex I [GO:0005747]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial respiratory chain complex I [GO:0005747]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005747; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0046872; GO:0048038; GO:0051539	aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN31580_c0_g1_i1	Q9DC70	NDUS7_MOUSE	100	135	0	0	440	36	90	224	3.60E-76	285.4	NDUS7_MOUSE	reviewed	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit)"	Ndufs7	Mus musculus (Mouse)	224	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protease binding [GO:0002020]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; synaptic membrane [GO:0097060]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protease binding [GO:0002020]; quinone binding [GO:0048038]"	GO:0002020; GO:0005739; GO:0005743; GO:0005747; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0043005; GO:0043025; GO:0046872; GO:0048038; GO:0051539; GO:0097060	aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981]		NA	NA	NA	NA	NA	NA
TRINITY_DN36271_c0_g1_i1	Q9UHQ9	NB5R1_HUMAN	100	137	0	0	2	412	169	305	3.90E-78	292	NB5R1_HUMAN	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	CYB5R1 NQO3A2 UNQ3049/PRO9865	Homo sapiens (Human)	305	"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; platelet degranulation [GO:0002576]; sterol biosynthetic process [GO:0016126]"	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0002576; GO:0004128; GO:0005739; GO:0005789; GO:0005886; GO:0015701; GO:0016020; GO:0016021; GO:0016126; GO:0031092; GO:0070062; GO:0071949	bicarbonate transport [GO:0015701]; platelet degranulation [GO:0002576]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN34420_c0_g1_i1	Q9DB73	NB5R1_MOUSE	100	97	0	0	293	3	94	190	9.10E-52	203.8	NB5R1_MOUSE	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	Cyb5r1 Nqo3a2	Mus musculus (Mouse)	305	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN832_c0_g1_i1	Q9DB73	NB5R1_MOUSE	61.1	234	90	1	824	123	16	248	2.00E-83	310.8	NB5R1_MOUSE	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	Cyb5r1 Nqo3a2	Mus musculus (Mouse)	305	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN832_c0_g1_i2	Q9DB73	NB5R1_MOUSE	61.5	291	111	1	962	90	16	305	9.00E-109	395.2	NB5R1_MOUSE	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	Cyb5r1 Nqo3a2	Mus musculus (Mouse)	305	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		blue	blue	NA	NA	NA	NA
TRINITY_DN832_c0_g1_i4	Q9DB73	NB5R1_MOUSE	58.6	249	97	2	854	123	1	248	1.40E-83	311.2	NB5R1_MOUSE	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	Cyb5r1 Nqo3a2	Mus musculus (Mouse)	305	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN832_c0_g1_i6	Q9DB73	NB5R1_MOUSE	59.5	306	118	2	992	90	1	305	6.50E-109	395.6	NB5R1_MOUSE	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	Cyb5r1 Nqo3a2	Mus musculus (Mouse)	305	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		blue	blue	NA	NA	NA	NA
TRINITY_DN832_c0_g1_i7	Q9DB73	NB5R1_MOUSE	61.6	159	61	0	566	90	147	305	3.80E-56	219.9	NB5R1_MOUSE	reviewed	NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)	Cyb5r1 Nqo3a2	Mus musculus (Mouse)	305	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1471_c0_g1_i10	A5DQ25	NCB5R_PICGU	33.9	239	156	2	859	146	32	269	6.30E-39	164.1	NCB5R_PICGU	reviewed	NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)	CBR1 PGUG_05376	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	284	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0004128; GO:0005741; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1471_c0_g1_i6	A5DQ25	NCB5R_PICGU	33.9	239	156	2	859	146	32	269	3.50E-39	164.1	NCB5R_PICGU	reviewed	NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)	CBR1 PGUG_05376	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	284	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0004128; GO:0005741; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1471_c0_g1_i9	A5DQ25	NCB5R_PICGU	33.9	239	156	2	859	146	32	269	4.50E-39	164.1	NCB5R_PICGU	reviewed	NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)	CBR1 PGUG_05376	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	284	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0004128; GO:0005741; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14882_c0_g1_i1	A5DQ25	NCB5R_PICGU	31.1	106	73	0	265	582	38	143	6.30E-12	72.4	NCB5R_PICGU	reviewed	NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)	CBR1 PGUG_05376	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	284	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0004128; GO:0005741; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14882_c0_g1_i2	A5DQ25	NCB5R_PICGU	35.6	59	38	0	89	265	85	143	1.20E-05	50.4	NCB5R_PICGU	reviewed	NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)	CBR1 PGUG_05376	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	284	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0004128; GO:0005741; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN832_c0_g1_i3	Q5BJ68	NB5R2_XENTR	57.1	91	39	0	361	89	147	237	2.40E-22	106.3	NB5R2_XENTR	reviewed	NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2)	cyb5r2 TNeu132f07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	304	"integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN31874_c0_g1_i1	Q5ZHX7	NB5R2_CHICK	62.7	67	23	1	5	205	240	304	1.00E-19	97.1	NB5R2_CHICK	reviewed	NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2)	CYB5R2 RCJMB04_32e2	Gallus gallus (Chicken)	304	"integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0016021; GO:0016126; GO:0071949	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN32664_c0_g1_i1	Q5PQA4	NB5R2_XENLA	51.2	121	45	4	353	9	102	214	1.50E-24	113.6	NB5R2_XENLA	reviewed	NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2)	cyb5r2	Xenopus laevis (African clawed frog)	296	"integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; sterol biosynthetic process [GO:0016126]"	integral component of membrane [GO:0016021]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]"	GO:0004128; GO:0016021; GO:0016126	sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN28372_c0_g1_i1	Q9DCN2	NB5R3_MOUSE	100	69	0	0	209	3	172	240	1.30E-33	142.9	NB5R3_MOUSE	reviewed	NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]	Cyb5r3 Dia1	Mus musculus (Mouse)	301	"endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; cholesterol biosynthetic process [GO:0006695]"	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]	"ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]"	GO:0004128; GO:0005741; GO:0005743; GO:0005789; GO:0005811; GO:0006695; GO:0016208; GO:0043531; GO:0050660; GO:0051287; GO:0071949	cholesterol biosynthetic process [GO:0006695]		NA	NA	NA	NA	NA	NA
TRINITY_DN12821_c0_g1_i1	P00387	NB5R3_HUMAN	95.2	271	13	0	3	815	30	300	7.60E-157	554.3	NB5R3_HUMAN	reviewed	NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]	CYB5R3 DIA1	Homo sapiens (Human)	301	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]; blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; xenobiotic metabolic process [GO:0006805]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]"	GO:0004128; GO:0005576; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005811; GO:0005833; GO:0006695; GO:0006805; GO:0008015; GO:0016020; GO:0016208; GO:0019852; GO:0035578; GO:0043312; GO:0043531; GO:0051287; GO:0071949	blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12821_c0_g1_i2	P00387	NB5R3_HUMAN	97.5	283	7	0	1	849	16	298	6.10E-165	581.3	NB5R3_HUMAN	reviewed	NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]	CYB5R3 DIA1	Homo sapiens (Human)	301	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]; blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; xenobiotic metabolic process [GO:0006805]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]"	GO:0004128; GO:0005576; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005811; GO:0005833; GO:0006695; GO:0006805; GO:0008015; GO:0016020; GO:0016208; GO:0019852; GO:0035578; GO:0043312; GO:0043531; GO:0051287; GO:0071949	blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12821_c0_g1_i3	P00387	NB5R3_HUMAN	99.6	285	1	0	1	855	16	300	3.10E-169	595.5	NB5R3_HUMAN	reviewed	NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]	CYB5R3 DIA1	Homo sapiens (Human)	301	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]; blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; xenobiotic metabolic process [GO:0006805]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]"	GO:0004128; GO:0005576; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005811; GO:0005833; GO:0006695; GO:0006805; GO:0008015; GO:0016020; GO:0016208; GO:0019852; GO:0035578; GO:0043312; GO:0043531; GO:0051287; GO:0071949	blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN12821_c0_g1_i4	Q9DCN2	NB5R3_MOUSE	95.2	269	13	0	3	809	30	298	2.40E-155	549.3	NB5R3_MOUSE	reviewed	NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]	Cyb5r3 Dia1	Mus musculus (Mouse)	301	"endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; cholesterol biosynthetic process [GO:0006695]"	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]	"ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]"	GO:0004128; GO:0005741; GO:0005743; GO:0005789; GO:0005811; GO:0006695; GO:0016208; GO:0043531; GO:0050660; GO:0051287; GO:0071949	cholesterol biosynthetic process [GO:0006695]		NA	NA	NA	NA	NA	NA
TRINITY_DN27853_c0_g1_i1	B1AS42	NB5R5_MOUSE	37.5	301	180	4	49	930	17	316	2.90E-54	213.8	NB5R5_MOUSE	reviewed	NADH-cytochrome b5 reductase-like (EC 1.6.2.2)	Cyb5rl	Mus musculus (Mouse)	316	"nucleoplasm [GO:0005654]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; oxidoreductase activity [GO:0016491]"	nucleoplasm [GO:0005654]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; oxidoreductase activity [GO:0016491]"	GO:0004128; GO:0005654; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN874_c0_g2_i1	P29913	NQO1_PARDE	74.9	231	57	1	697	5	32	261	5.10E-101	368.6	NQO1_PARDE	reviewed	"NADH-quinone oxidoreductase chain 1 (EC 7.1.1.-) (NADH dehydrogenase I, chain 1) (NDH-1, chain 1)"	nqo1	Paracoccus denitrificans	431	"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005886; GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN874_c0_g2_i2	P29913	NQO1_PARDE	79.3	241	49	1	724	2	26	265	8.70E-112	404.4	NQO1_PARDE	reviewed	"NADH-quinone oxidoreductase chain 1 (EC 7.1.1.-) (NADH dehydrogenase I, chain 1) (NDH-1, chain 1)"	nqo1	Paracoccus denitrificans	431	"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005886; GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN874_c0_g2_i3	P29913	NQO1_PARDE	78.1	237	51	1	715	5	26	261	2.30E-109	396.4	NQO1_PARDE	reviewed	"NADH-quinone oxidoreductase chain 1 (EC 7.1.1.-) (NADH dehydrogenase I, chain 1) (NDH-1, chain 1)"	nqo1	Paracoccus denitrificans	431	"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005886; GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN3865_c0_g2_i1	P29915	NQO3_PARDE	71	100	21	1	278	3	14	113	9.50E-35	147.1	NQO3_PARDE	reviewed	"NADH-quinone oxidoreductase chain 3 (EC 7.1.1.-) (NADH dehydrogenase I, chain 3) (NDH-1, chain 3)"	nqo3	Paracoccus denitrificans	673	"plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]"	plasma membrane [GO:0005886]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005886; GO:0008137; GO:0009055; GO:0042773; GO:0046872; GO:0048038; GO:0051537; GO:0051539	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN35939_c0_g1_i1	Q56222	NQO1_THET8	60.2	123	48	1	371	3	32	153	7.30E-38	157.9	NQO1_THET8	reviewed	NADH-quinone oxidoreductase subunit 1 (EC 7.1.1.-) (NADH dehydrogenase I chain 1) (NDH-1 subunit 1)	nqo1 TTHA0089	Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)	438	"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005886; GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN31145_c0_g1_i1	B2U7R0	NUOB_RALPJ	100	135	0	0	3	407	26	160	7.20E-77	287.7	NUOB_RALPJ	reviewed	NADH-quinone oxidoreductase subunit B (EC 7.1.1.-) (NADH dehydrogenase I subunit B) (NDH-1 subunit B)	nuoB Rpic_2213	Ralstonia pickettii (strain 12J)	160	"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005506; GO:0005886; GO:0008137; GO:0048038; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN36394_c0_g1_i1	Q2NA61	NUOB_ERYLH	94.6	130	7	0	392	3	58	187	4.80E-72	271.6	NUOB_ERYLH	reviewed	NADH-quinone oxidoreductase subunit B (EC 7.1.1.-) (NADH dehydrogenase I subunit B) (NDH-1 subunit B)	nuoB ELI_06690	Erythrobacter litoralis (strain HTCC2594)	187	"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	plasma membrane [GO:0005886]	"4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005506; GO:0005886; GO:0008137; GO:0048038; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN30403_c0_g1_i1	Q2G5Y5	NUOC_NOVAD	95.1	82	4	0	248	3	110	191	5.00E-43	174.5	NUOC_NOVAD	reviewed	NADH-quinone oxidoreductase subunit C (EC 7.1.1.-) (NADH dehydrogenase I subunit C) (NDH-1 subunit C)	nuoC Saro_2301	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	309	plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]	GO:0005886; GO:0008137; GO:0048038			NA	NA	NA	NA	NA	NA
TRINITY_DN34206_c0_g1_i1	Q2G5Y5	NUOC_NOVAD	87.1	70	9	0	3	212	131	200	8.40E-31	133.7	NUOC_NOVAD	reviewed	NADH-quinone oxidoreductase subunit C (EC 7.1.1.-) (NADH dehydrogenase I subunit C) (NDH-1 subunit C)	nuoC Saro_2301	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	309	plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]	GO:0005886; GO:0008137; GO:0048038			NA	NA	NA	NA	NA	NA
TRINITY_DN6947_c0_g4_i1	B2U7Q8	NUOD_RALPJ	100	185	0	0	555	1	1	185	1.40E-103	377.5	NUOD_RALPJ	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Rpic_2211	Ralstonia pickettii (strain 12J)	417	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN6947_c0_g3_i1	Q2G5Y6	NUOD_NOVAD	94.4	90	5	0	272	3	1	90	7.80E-46	184.1	NUOD_NOVAD	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Saro_2300	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	403	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN6947_c0_g2_i1	Q2G5Y6	NUOD_NOVAD	97.1	69	2	0	210	4	93	161	6.80E-33	140.6	NUOD_NOVAD	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Saro_2300	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	403	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN6947_c0_g1_i1	Q2G5Y6	NUOD_NOVAD	87	154	20	0	475	14	9	162	4.70E-77	288.5	NUOD_NOVAD	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Saro_2300	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	403	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN3600_c0_g2_i1	Q2G5Y6	NUOD_NOVAD	91.3	196	17	0	626	39	208	403	1.00E-105	384	NUOD_NOVAD	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Saro_2300	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	403	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN3600_c0_g1_i1	Q2G5Y6	NUOD_NOVAD	91.4	163	14	0	492	4	239	401	2.30E-87	322.8	NUOD_NOVAD	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Saro_2300	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	403	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN7027_c0_g1_i1	Q2G5Y6	NUOD_NOVAD	91.5	59	5	0	250	74	345	403	5.00E-27	121.3	NUOD_NOVAD	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Saro_2300	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	403	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN36474_c0_g1_i1	B2U7Q8	NUOD_RALPJ	99.6	227	1	0	734	54	191	417	5.30E-133	474.9	NUOD_RALPJ	reviewed	NADH-quinone oxidoreductase subunit D (EC 7.1.1.-) (NADH dehydrogenase I subunit D) (NDH-1 subunit D)	nuoD Rpic_2211	Ralstonia pickettii (strain 12J)	417	plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	plasma membrane [GO:0005886]	NAD binding [GO:0051287]; NADH dehydrogenase (quinone) activity [GO:0050136]; quinone binding [GO:0048038]	GO:0005886; GO:0048038; GO:0050136; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN14586_c0_g1_i1	Q92ID9	NUOE_RICCN	59.3	86	34	1	12	266	41	126	2.80E-23	109	NUOE_RICCN	reviewed	NADH-quinone oxidoreductase subunit E (EC 7.1.1.-) (NADH dehydrogenase I subunit E) (NDH-1 subunit E)	nuoE RC0481	Rickettsia conorii (strain ATCC VR-613 / Malish 7)	167	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]"	GO:0016491; GO:0046872; GO:0048038; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN14586_c0_g1_i2	Q1RJJ1	NUOE_RICBR	57.3	103	37	2	8	313	30	126	8.20E-27	120.9	NUOE_RICBR	reviewed	NADH-quinone oxidoreductase subunit E (EC 7.1.1.-) (NADH dehydrogenase I subunit E) (NDH-1 subunit E)	nuoE RBE_0392	Rickettsia bellii (strain RML369-C)	167	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]"	GO:0016491; GO:0046872; GO:0048038; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN874_c0_g1_i1	A8GYE0	NUOF_RICB8	70.4	81	24	0	251	9	138	218	3.00E-27	122.1	NUOF_RICB8	reviewed	NADH-quinone oxidoreductase subunit F (EC 7.1.1.-) (NADH dehydrogenase I subunit F) (NDH-1 subunit F)	nuoF A1I_01365	Rickettsia bellii (strain OSU 85-389)	417	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN28416_c0_g1_i1	O07948	NUOF_RHOCA	76.1	67	16	0	215	15	106	172	1.30E-23	109.8	NUOF_RHOCA	reviewed	NADH-quinone oxidoreductase subunit F (EC 7.1.1.-) (NADH dehydrogenase I subunit F) (NDH-1 subunit F)	nuoF	Rhodobacter capsulatus (Rhodopseudomonas capsulata)	431	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN31321_c0_g1_i1	Q8K9Y3	NUOF_BUCAP	64.6	48	17	0	145	2	167	214	3.80E-12	71.6	NUOF_BUCAP	reviewed	NADH-quinone oxidoreductase subunit F (EC 7.1.1.-) (NADH dehydrogenase I subunit F) (NDH-1 subunit F)	nuoF BUsg_151	Buchnera aphidicola subsp. Schizaphis graminum (strain Sg)	447	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN34846_c0_g1_i1	P56913	NUOF2_RHIME	53.8	78	36	0	3	236	46	123	4.70E-19	94.7	NUOF2_RHIME	reviewed	NADH-quinone oxidoreductase subunit F 2 (EC 7.1.1.-) (NADH dehydrogenase I subunit F 2) (NDH-1 subunit F 2)	nuoF2 RA0829 SMa1525	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	421	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN30657_c0_g1_i1	P56913	NUOF2_RHIME	54.4	79	35	1	235	2	18	96	1.40E-15	83.2	NUOF2_RHIME	reviewed	NADH-quinone oxidoreductase subunit F 2 (EC 7.1.1.-) (NADH dehydrogenase I subunit F 2) (NDH-1 subunit F 2)	nuoF2 RA0829 SMa1525	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	421	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN3865_c0_g1_i2	Q4UK22	NUOG_RICFE	72.3	166	46	0	498	1	72	237	8.00E-72	271.2	NUOG_RICFE	reviewed	NADH-quinone oxidoreductase subunit G (EC 7.1.1.-) (NADH dehydrogenase I subunit G) (NDH-1 subunit G)	nuoG RF_1262	Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)	671	"membrane [GO:0016020]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]"	membrane [GO:0016020]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0009055; GO:0016020; GO:0042773; GO:0046872; GO:0048038; GO:0051537; GO:0051539	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN3865_c0_g1_i5	Q4UK22	NUOG_RICFE	67.6	253	81	1	760	2	1	252	9.80E-106	384.4	NUOG_RICFE	reviewed	NADH-quinone oxidoreductase subunit G (EC 7.1.1.-) (NADH dehydrogenase I subunit G) (NDH-1 subunit G)	nuoG RF_1262	Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)	671	"membrane [GO:0016020]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]"	membrane [GO:0016020]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0009055; GO:0016020; GO:0042773; GO:0046872; GO:0048038; GO:0051537; GO:0051539	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN2962_c0_g1_i2	Q4UK22	NUOG_RICFE	72.4	152	41	1	436	891	1	151	2.70E-62	240.4	NUOG_RICFE	reviewed	NADH-quinone oxidoreductase subunit G (EC 7.1.1.-) (NADH dehydrogenase I subunit G) (NDH-1 subunit G)	nuoG RF_1262	Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)	671	"membrane [GO:0016020]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]"	membrane [GO:0016020]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0009055; GO:0016020; GO:0042773; GO:0046872; GO:0048038; GO:0051537; GO:0051539	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN32953_c0_g1_i1	Q92G92	NUOG_RICCN	58.3	211	87	1	6	638	19	228	9.10E-73	274.6	NUOG_RICCN	reviewed	NADH-quinone oxidoreductase subunit G (EC 7.1.1.-) (NADH dehydrogenase I subunit G) (NDH-1 subunit G)	nuoG RC1231	Rickettsia conorii (strain ATCC VR-613 / Malish 7)	671	"membrane [GO:0016020]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]"	membrane [GO:0016020]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0009055; GO:0016020; GO:0042773; GO:0046872; GO:0048038; GO:0051537; GO:0051539	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN31829_c0_g1_i1	Q68VV2	NUOG_RICTY	42.3	71	40	1	216	4	224	293	4.10E-12	71.6	NUOG_RICTY	reviewed	NADH-quinone oxidoreductase subunit G (EC 7.1.1.-) (NADH dehydrogenase I subunit G) (NDH-1 subunit G)	nuoG RT0784	Rickettsia typhi (strain ATCC VR-144 / Wilmington)	675	"membrane [GO:0016020]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]"	membrane [GO:0016020]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0008137; GO:0009055; GO:0016020; GO:0042773; GO:0046872; GO:0048038; GO:0051537; GO:0051539	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN34465_c0_g1_i1	P22142	NDUS2_NEUCR	76.1	71	17	0	2	214	154	224	1.90E-27	122.5	NDUS2_NEUCR	reviewed	"NADH-ubiquinone oxidoreductase 49 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD)"	nuo-49 NCU02534	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	478	"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]"	GO:0005743; GO:0006120; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0070469	"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g2_i1	Q66HF1	NDUS1_RAT	68.7	707	212	4	81	2192	1	701	1.60E-289	996.5	NDUS1_RAT	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2)"	Ndufs1	Rattus norvegicus (Rat)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i1	Q94511	NDUS1_DROME	82.7	127	20	1	138	512	24	150	6.80E-55	216.9	NDUS1_DROME	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	ND-75 ND75 CG2286	Drosophila melanogaster (Fruit fly)	731	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0005739; GO:0005747; GO:0008137; GO:0009055; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593	ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i10	Q94511	NDUS1_DROME	82.7	127	20	1	138	512	24	150	5.00E-55	216.9	NDUS1_DROME	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	ND-75 ND75 CG2286	Drosophila melanogaster (Fruit fly)	731	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]"	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]"	GO:0003954; GO:0005739; GO:0005747; GO:0008137; GO:0009055; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593	ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]		NA	NA	NA	NA	NA	NA
TRINITY_DN17051_c0_g1_i1	Q0MQG1	NDUS1_GORGO	95	179	9	0	539	3	400	578	3.80E-96	352.1	NDUS1_GORGO	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	NDUFS1	Gorilla gorilla gorilla (Western lowland gorilla)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN17051_c0_g1_i2	Q0MQG1	NDUS1_GORGO	100	130	0	0	393	4	400	529	7.10E-68	257.7	NDUS1_GORGO	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	NDUFS1	Gorilla gorilla gorilla (Western lowland gorilla)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN30066_c0_g1_i1	Q91VD9	NDUS1_MOUSE	99.2	126	1	0	2	379	327	452	1.40E-65	250	NDUS1_MOUSE	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	Ndufs1	Mus musculus (Mouse)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN11720_c0_g1_i1	P28331	NDUS1_HUMAN	99.6	262	1	0	3	788	101	362	2.50E-149	529.3	NDUS1_HUMAN	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	NDUFS1	Homo sapiens (Human)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0005758; GO:0005759; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0032981; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	"apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11720_c0_g1_i2	Q91VD9	NDUS1_MOUSE	100	83	0	0	3	251	101	183	1.30E-43	176.4	NDUS1_MOUSE	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	Ndufs1	Mus musculus (Mouse)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN11720_c1_g1_i1	Q91VD9	NDUS1_MOUSE	97.2	71	2	0	232	20	262	332	8.00E-35	147.1	NDUS1_MOUSE	reviewed	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	Ndufs1	Mus musculus (Mouse)	727	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN3865_c0_g1_i1	P24918	NDUS1_NEUCR	68.1	91	29	0	273	1	183	273	3.70E-31	135.2	NDUS1_NEUCR	reviewed	"NADH-ubiquinone oxidoreductase 78 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-78kD) (CI-78kD)"	nuo78 B17C10.90 NCU01765	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	744	"mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ATP synthesis coupled electron transport [GO:0042773]"	mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005743; GO:0008137; GO:0009055; GO:0042773; GO:0046872; GO:0051537; GO:0051539; GO:0070469	ATP synthesis coupled electron transport [GO:0042773]		NA	NA	NA	NA	NA	NA
TRINITY_DN244_c0_g1_i1	P28227	MAOX_ANAPL	58.9	129	53	0	473	87	1	129	7.60E-43	175.3	MAOX_ANAPL	reviewed	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40)	ME1	Anas platyrhynchos (Mallard) (Anas boschas)	557	cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	cytoplasm [GO:0005737]	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287			blue	blue	NA	NA	NA	NA
TRINITY_DN244_c0_g1_i2	P28227	MAOX_ANAPL	63.2	554	199	3	1774	116	1	550	1.80E-212	740.3	MAOX_ANAPL	reviewed	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40)	ME1	Anas platyrhynchos (Mallard) (Anas boschas)	557	cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	cytoplasm [GO:0005737]	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287			blue	blue	NA	NA	NA	NA
TRINITY_DN244_c0_g1_i3	P28227	MAOX_ANAPL	62.7	552	203	2	1902	250	1	550	1.50E-212	740.7	MAOX_ANAPL	reviewed	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40)	ME1	Anas platyrhynchos (Mallard) (Anas boschas)	557	cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	cytoplasm [GO:0005737]	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287			NA	NA	NA	NA	NA	NA
TRINITY_DN33040_c0_g1_i1	P06801	MAOX_MOUSE	100	96	0	0	290	3	253	348	5.10E-47	188	MAOX_MOUSE	reviewed	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1)	Me1 Mod-1 Mod1	Mus musculus (Mouse)	572	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to hormone [GO:0009725]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005829; GO:0006090; GO:0006108; GO:0008948; GO:0009725; GO:0030145; GO:0042802; GO:0050661; GO:0051287; GO:1902031	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to hormone [GO:0009725]		NA	NA	NA	NA	NA	NA
TRINITY_DN32975_c0_g1_i1	Q6TU48	MAOX_DICDI	62.2	74	28	0	227	6	111	184	1.40E-21	103.2	MAOX_DICDI	reviewed	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (SrfA-induced gene A protein)	malA sigA DDB_G0272524	Dictyostelium discoideum (Slime mold)	544	cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]	cytoplasm [GO:0005737]	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005737; GO:0006090; GO:0006108; GO:0008948; GO:0046872; GO:0051287	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]		NA	NA	NA	NA	NA	NA
TRINITY_DN33322_c0_g1_i1	Q9WV87	NOX1_RAT	38.9	95	55	1	292	8	287	378	2.10E-16	86.3	NOX1_RAT	reviewed	NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1)	Nox1 Mox1 Noh1	Rattus norvegicus (Rat)	563	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; invadopodium membrane [GO:0071438]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; Rac GTPase binding [GO:0048365]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to hyperoxia [GO:0071455]; cellular stress response to acidic pH [GO:1990451]; defense response [GO:0006952]; extracellular matrix organization [GO:0030198]; hydrogen peroxide metabolic process [GO:0042743]; intracellular pH elevation [GO:0051454]; oxidation-reduction process [GO:0055114]; oxygen metabolic process [GO:0072592]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; superoxide anion generation [GO:0042554]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; invadopodium membrane [GO:0071438]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; Rac GTPase binding [GO:0048365]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0000302; GO:0001525; GO:0003081; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0006952; GO:0007165; GO:0008284; GO:0010575; GO:0016174; GO:0016175; GO:0016477; GO:0030054; GO:0030198; GO:0042554; GO:0042743; GO:0043020; GO:0043410; GO:0045726; GO:0046330; GO:0046872; GO:0048365; GO:0048661; GO:0051454; GO:0055114; GO:0071438; GO:0071455; GO:0072592; GO:1902177; GO:1990451; GO:2000379	angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to hyperoxia [GO:0071455]; cellular stress response to acidic pH [GO:1990451]; defense response [GO:0006952]; extracellular matrix organization [GO:0030198]; hydrogen peroxide metabolic process [GO:0042743]; intracellular pH elevation [GO:0051454]; oxidation-reduction process [GO:0055114]; oxygen metabolic process [GO:0072592]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; superoxide anion generation [GO:0042554]		NA	NA	NA	NA	NA	NA
TRINITY_DN32500_c0_g1_i1	Q9NPH5	NOX4_HUMAN	47.9	71	37	0	13	225	101	171	2.80E-11	68.9	NOX4_HUMAN	reviewed	NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase)	NOX4 RENOX	Homo sapiens (Human)	578	apical plasma membrane [GO:0016324]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NADPH oxidase activity [GO:0016175]; bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell aging [GO:0007569]; cell morphogenesis [GO:0000902]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species biosynthetic process [GO:1903409]; reactive oxygen species metabolic process [GO:0072593]; response to hypoxia [GO:0001666]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	apical plasma membrane [GO:0016324]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase (H(2)O(2)-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0000166; GO:0000902; GO:0001666; GO:0001725; GO:0003015; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0006954; GO:0007569; GO:0008285; GO:0009055; GO:0010467; GO:0014911; GO:0016021; GO:0016174; GO:0016175; GO:0016324; GO:0019826; GO:0020037; GO:0034599; GO:0042554; GO:0043020; GO:0043065; GO:0043406; GO:0045453; GO:0048471; GO:0050660; GO:0050667; GO:0051496; GO:0051897; GO:0055007; GO:0055114; GO:0061098; GO:0070374; GO:0071320; GO:0071333; GO:0071480; GO:0071560; GO:0072341; GO:0072593; GO:0097038; GO:1903409; GO:1990782; GO:2000379; GO:2000573	bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell aging [GO:0007569]; cell morphogenesis [GO:0000902]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; oxidation-reduction process [GO:0055114]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species biosynthetic process [GO:1903409]; reactive oxygen species metabolic process [GO:0072593]; response to hypoxia [GO:0001666]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c14_g1_i1	Q96PH1	NOX5_HUMAN	36.1	986	349	12	2871	13	28	765	4.40E-165	583.6	NOX5_HUMAN	reviewed	NADPH oxidase 5 (EC 1.6.3.-)	NOX5	Homo sapiens (Human)	765	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; ferric-chelate reductase activity [GO:0000293]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proton transmembrane transport [GO:1902600]; reductive iron assimilation [GO:0033215]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; superoxide anion generation [GO:0042554]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; ferric-chelate reductase activity [GO:0000293]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0000293; GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0015252; GO:0016021; GO:0016175; GO:0020037; GO:0033215; GO:0034599; GO:0042554; GO:0043012; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:1902600; GO:2000379	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proton transmembrane transport [GO:1902600]; reductive iron assimilation [GO:0033215]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; superoxide anion generation [GO:0042554]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c14_g1_i2	Q96PH1	NOX5_HUMAN	41.6	495	240	6	1478	78	28	501	1.60E-100	368.2	NOX5_HUMAN	reviewed	NADPH oxidase 5 (EC 1.6.3.-)	NOX5	Homo sapiens (Human)	765	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; ferric-chelate reductase activity [GO:0000293]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proton transmembrane transport [GO:1902600]; reductive iron assimilation [GO:0033215]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; superoxide anion generation [GO:0042554]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; ferric-chelate reductase activity [GO:0000293]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0000293; GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0015252; GO:0016021; GO:0016175; GO:0020037; GO:0033215; GO:0034599; GO:0042554; GO:0043012; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:1902600; GO:2000379	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proton transmembrane transport [GO:1902600]; reductive iron assimilation [GO:0033215]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; superoxide anion generation [GO:0042554]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i1	P08165	ADRO_BOVIN	61.8	259	94	2	1484	708	14	267	8.70E-85	315.8	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i1	P08165	ADRO_BOVIN	44.7	217	118	2	654	7	265	480	3.70E-43	177.6	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i10	P08165	ADRO_BOVIN	61.7	196	70	2	672	85	14	204	2.00E-63	243.8	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i11	P08165	ADRO_BOVIN	61.8	259	94	2	1677	901	14	267	4.40E-85	317	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i11	P08165	ADRO_BOVIN	43.8	226	125	2	887	213	265	489	4.90E-44	180.6	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i12	P08165	ADRO_BOVIN	65.5	174	60	0	606	85	31	204	2.70E-63	243.4	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i13	P22570	ADRO_HUMAN	55.3	468	206	3	1611	211	23	488	8.80E-139	495.4	ADRO_HUMAN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Homo sapiens (Human)	491	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006700; GO:0006744; GO:0008203; GO:0015039; GO:0016125; GO:0016491; GO:0055114	C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i3	P22570	ADRO_HUMAN	55.3	468	206	3	1613	213	23	488	8.90E-139	495.4	ADRO_HUMAN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Homo sapiens (Human)	491	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006700; GO:0006744; GO:0008203; GO:0015039; GO:0016125; GO:0016491; GO:0055114	C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i4	P08165	ADRO_BOVIN	64.6	237	84	0	1418	708	31	267	1.10E-84	315.5	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i4	P08165	ADRO_BOVIN	44.7	217	118	2	654	7	265	480	3.70E-43	177.6	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i5	P22570	ADRO_HUMAN	55.3	468	206	3	1611	211	23	488	9.00E-139	495.4	ADRO_HUMAN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Homo sapiens (Human)	491	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006700; GO:0006744; GO:0008203; GO:0015039; GO:0016125; GO:0016491; GO:0055114	C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i6	P08165	ADRO_BOVIN	64.6	237	84	0	1611	901	31	267	7.60E-85	316.2	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i6	P08165	ADRO_BOVIN	43.8	226	125	2	887	213	265	489	5.00E-44	180.6	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i7	P08165	ADRO_BOVIN	61.8	259	94	2	1675	899	14	267	4.40E-85	317	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i7	P08165	ADRO_BOVIN	43.8	226	125	2	885	211	265	489	4.90E-44	180.6	ADRO_BOVIN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Bos taurus (Bovine)	492	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP binding [GO:0050661]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491; GO:0050660; GO:0050661; GO:0055114	cholesterol metabolic process [GO:0008203]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN7472_c0_g1_i9	P22570	ADRO_HUMAN	55.3	468	206	3	1613	213	23	488	9.00E-139	495.4	ADRO_HUMAN	reviewed	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	FDXR ADXR	Homo sapiens (Human)	491	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006700; GO:0006744; GO:0008203; GO:0015039; GO:0016125; GO:0016491; GO:0055114	C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN41053_c0_g1_i1	P16435	NCPR_HUMAN	100	77	0	0	2	232	403	479	1.60E-38	159.5	NCPR_HUMAN	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)	POR CYPOR	Homo sapiens (Human)	677	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016709; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0032332; GO:0032770; GO:0042493; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0055114; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0090031; GO:0090346	carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN25594_c0_g1_i1	P16435	NCPR_HUMAN	100	111	0	0	2	334	79	189	4.20E-61	235	NCPR_HUMAN	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)	POR CYPOR	Homo sapiens (Human)	677	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016709; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0032332; GO:0032770; GO:0042493; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0055114; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0090031; GO:0090346	carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN37863_c0_g1_i1	P16435	NCPR_HUMAN	100	98	0	0	2	295	486	583	1.10E-52	206.8	NCPR_HUMAN	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)	POR CYPOR	Homo sapiens (Human)	677	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016709; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0032332; GO:0032770; GO:0042493; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0055114; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0090031; GO:0090346	carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN33826_c0_g1_i1	P37040	NCPR_MOUSE	100	86	0	0	2	259	79	164	5.60E-45	181	NCPR_MOUSE	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)	Por	Mus musculus (Mouse)	678	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of cholesterol metabolic process [GO:0090181]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016709; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0032332; GO:0032770; GO:0042493; GO:0043066; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0055114; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0090031; GO:0090181; GO:0090346	carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of cholesterol metabolic process [GO:0090181]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN40823_c0_g1_i1	P37040	NCPR_MOUSE	100	153	0	0	2	460	455	607	9.80E-85	313.9	NCPR_MOUSE	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)	Por	Mus musculus (Mouse)	678	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of cholesterol metabolic process [GO:0090181]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016709; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0032332; GO:0032770; GO:0042493; GO:0043066; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0055114; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0090031; GO:0090181; GO:0090346	carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of cholesterol metabolic process [GO:0090181]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]		NA	NA	NA	NA	NA	NA
TRINITY_DN775_c0_g1_i1	Q07994	NCPR_MUSDO	58.8	674	271	4	89	2107	4	671	1.90E-247	856.7	NCPR_MUSDO	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)		Musca domestica (House fly)	671	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	GO:0003958; GO:0005789; GO:0010181; GO:0016021; GO:0050660; GO:0050661			blue	blue	NA	NA	NA	NA
TRINITY_DN775_c0_g1_i2	Q07994	NCPR_MUSDO	59.5	516	202	4	107	1651	4	513	3.40E-186	652.9	NCPR_MUSDO	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)		Musca domestica (House fly)	671	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	GO:0003958; GO:0005789; GO:0010181; GO:0016021; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN775_c0_g1_i3	Q07994	NCPR_MUSDO	58.8	674	271	4	107	2125	4	671	1.90E-247	856.7	NCPR_MUSDO	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)		Musca domestica (House fly)	671	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	GO:0003958; GO:0005789; GO:0010181; GO:0016021; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN775_c0_g1_i4	Q07994	NCPR_MUSDO	59.5	516	202	4	89	1633	4	513	2.60E-186	653.3	NCPR_MUSDO	reviewed	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)		Musca domestica (House fly)	671	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	GO:0003958; GO:0005789; GO:0010181; GO:0016021; GO:0050660; GO:0050661			NA	NA	NA	NA	NA	NA
TRINITY_DN627_c0_g1_i1	Q6NRG5	NDOR1_XENLA	48.4	566	279	6	1683	4	4	562	8.00E-149	528.9	NDOR1_XENLA	reviewed	NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase)	ndor1	Xenopus laevis (African clawed frog)	600	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]	GO:0003958; GO:0005829; GO:0008219; GO:0010181; GO:0016226; GO:0036245; GO:0048471; GO:0050660; GO:0050661	cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN31716_c0_g1_i1	Q9UHB4	NDOR1_HUMAN	100	90	0	0	1	270	39	128	2.50E-48	192.2	NDOR1_HUMAN	reviewed	NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1)	NDOR1 NR1	Homo sapiens (Human)	597	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	"flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0003958; GO:0005654; GO:0005737; GO:0005829; GO:0008219; GO:0010181; GO:0016226; GO:0016491; GO:0016709; GO:0036245; GO:0045111; GO:0048471; GO:0050660; GO:0050661; GO:0055114	cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i8	Q39172	AER_ARATH	38.5	78	48	0	832	1065	267	344	4.50E-11	70.5	AER_ARATH	reviewed	"NADPH-dependent oxidoreductase 2-alkenal reductase (AtAER) (EC 1.3.1.-) (EC 1.3.1.74) (NADP-dependent alkenal double bond reductase P1) (DBR1) (NADPH-azodicarbonyl/quinone reductase) (NADPH:2-alkenal/one alpha,beta-hydrogenase) (ALH) (P1-zeta-crystallin protein) (P1-ZCr)"	AER P1 At5g16970 F2K13_120	Arabidopsis thaliana (Mouse-ear cress)	345	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plastid [GO:0009536]; 2-alkenal reductase [NAD(P)+] activity [GO:0032440]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plastid [GO:0009536]	2-alkenal reductase [NAD(P)+] activity [GO:0032440]	GO:0005634; GO:0005654; GO:0005829; GO:0006979; GO:0009536; GO:0032440; GO:0046686	response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN10243_c0_g1_i1	Q39172	AER_ARATH	43.1	51	29	0	194	42	291	341	1.20E-05	50.1	AER_ARATH	reviewed	"NADPH-dependent oxidoreductase 2-alkenal reductase (AtAER) (EC 1.3.1.-) (EC 1.3.1.74) (NADP-dependent alkenal double bond reductase P1) (DBR1) (NADPH-azodicarbonyl/quinone reductase) (NADPH:2-alkenal/one alpha,beta-hydrogenase) (ALH) (P1-zeta-crystallin protein) (P1-ZCr)"	AER P1 At5g16970 F2K13_120	Arabidopsis thaliana (Mouse-ear cress)	345	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plastid [GO:0009536]; 2-alkenal reductase [NAD(P)+] activity [GO:0032440]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plastid [GO:0009536]	2-alkenal reductase [NAD(P)+] activity [GO:0032440]	GO:0005634; GO:0005654; GO:0005829; GO:0006979; GO:0009536; GO:0032440; GO:0046686	response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN11490_c0_g1_i1	Q8SSN5	NAA20_DICDI	60.7	122	48	0	4	369	38	159	6.10E-37	154.8	NAA20_DICDI	reviewed	N-alpha-acetyltransferase 20 (EC 2.3.1.-) (N-acetyltransferase 5 homolog) (N-terminal acetyltransferase B complex catalytic subunit NAA20 homolog) (NatB catalytic subunit)	nat5 DDB_G0276345	Dictyostelium discoideum (Slime mold)	173	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; NatB complex [GO:0031416]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005737; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN891_c0_g1_i1	Q6P632	NAA20_XENTR	74.4	176	40	2	118	630	3	178	2.00E-72	273.5	NAA20_XENTR	reviewed	N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit)	naa20 nat5	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	178	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		blue	blue	NA	NA	NA	NA
TRINITY_DN16090_c0_g2_i1	P61599	NAA20_HUMAN	100	91	0	0	3	275	61	151	2.00E-45	182.6	NAA20_HUMAN	reviewed	N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit)	NAA20 NAT5	Homo sapiens (Human)	178	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN16090_c0_g1_i1	P61599	NAA20_HUMAN	100	138	0	0	39	452	1	138	1.10E-75	283.9	NAA20_HUMAN	reviewed	N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit)	NAA20 NAT5	Homo sapiens (Human)	178	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN16090_c0_g1_i2	P61599	NAA20_HUMAN	100	138	0	0	39	452	1	138	1.10E-75	283.9	NAA20_HUMAN	reviewed	N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit)	NAA20 NAT5	Homo sapiens (Human)	178	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN8002_c0_g2_i2	Q6QI44	NAA25_RAT	42.2	339	176	6	60	1025	57	392	2.20E-60	234.2	NAA25_RAT	reviewed	"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Liver regeneration-related protein LRRGT00164) (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25)"	Naa25 Mdm20	Rattus norvegicus (Rat)	970	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; NatB complex [GO:0031416]		GO:0005737; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN15641_c0_g1_i1	Q6QI44	NAA25_RAT	44	141	79	0	1	423	578	718	1.20E-27	124.4	NAA25_RAT	reviewed	"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Liver regeneration-related protein LRRGT00164) (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25)"	Naa25 Mdm20	Rattus norvegicus (Rat)	970	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; NatB complex [GO:0031416]		GO:0005737; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN15641_c0_g1_i2	Q6QI44	NAA25_RAT	45.1	144	76	1	1	432	578	718	4.20E-27	122.5	NAA25_RAT	reviewed	"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Liver regeneration-related protein LRRGT00164) (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25)"	Naa25 Mdm20	Rattus norvegicus (Rat)	970	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; NatB complex [GO:0031416]		GO:0005737; GO:0017196; GO:0031416	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN33184_c0_g1_i1	Q147X3	NAA30_HUMAN	64.7	68	24	0	214	11	209	276	6.00E-20	97.8	NAA30_HUMAN	reviewed	N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)	NAA30 C14orf35 MAK3 NAT12	Homo sapiens (Human)	362	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN2602_c0_g1_i1	Q147X3	NAA30_HUMAN	73.2	138	37	0	450	37	209	346	3.30E-52	207.2	NAA30_HUMAN	reviewed	N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)	NAA30 C14orf35 MAK3 NAT12	Homo sapiens (Human)	362	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN2602_c0_g1_i3	Q147X3	NAA30_HUMAN	76	154	37	0	509	48	209	362	2.20E-62	241.1	NAA30_HUMAN	reviewed	N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)	NAA30 C14orf35 MAK3 NAT12	Homo sapiens (Human)	362	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN2602_c0_g1_i4	Q147X3	NAA30_HUMAN	76.2	105	25	0	362	48	258	362	7.90E-39	161.4	NAA30_HUMAN	reviewed	N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)	NAA30 C14orf35 MAK3 NAT12	Homo sapiens (Human)	362	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN31792_c0_g1_i1	Q147X3	NAA30_HUMAN	100	107	0	0	2	322	236	342	3.20E-58	225.3	NAA30_HUMAN	reviewed	N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)	NAA30 C14orf35 MAK3 NAT12	Homo sapiens (Human)	362	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]	peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417	N-terminal peptidyl-methionine acetylation [GO:0017196]		NA	NA	NA	NA	NA	NA
TRINITY_DN11005_c0_g1_i4	Q6DKG0	NAA35_RAT	47.6	208	107	1	722	99	519	724	5.10E-46	186	NAA35_RAT	reviewed	"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Corneal wound-healing-related protein) (Embryonic growth-associated protein) (Protein MAK10 homolog)"	Naa35 Egap Emb8 Mak10	Rattus norvegicus (Rat)	725	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; polysome [GO:0005844]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; polysome [GO:0005844]		GO:0005737; GO:0005844; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659	negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; smooth muscle cell proliferation [GO:0048659]		NA	NA	NA	NA	NA	NA
TRINITY_DN37942_c0_g1_i1	Q5VZE5	NAA35_HUMAN	100	73	0	0	222	4	465	537	2.00E-35	149.1	NAA35_HUMAN	reviewed	"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)"	NAA35 EGAP MAK10	Homo sapiens (Human)	725	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]		GO:0005737; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659	negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; smooth muscle cell proliferation [GO:0048659]		NA	NA	NA	NA	NA	NA
TRINITY_DN25987_c0_g1_i1	Q5VZE5	NAA35_HUMAN	100	123	0	0	384	16	429	551	2.50E-65	249.2	NAA35_HUMAN	reviewed	"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)"	NAA35 EGAP MAK10	Homo sapiens (Human)	725	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]		GO:0005737; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659	negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; smooth muscle cell proliferation [GO:0048659]		NA	NA	NA	NA	NA	NA
TRINITY_DN11005_c0_g1_i3	Q5VZE5	NAA35_HUMAN	50.1	714	347	5	2231	99	17	724	6.40E-204	712.2	NAA35_HUMAN	reviewed	"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)"	NAA35 EGAP MAK10	Homo sapiens (Human)	725	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]		GO:0005737; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659	negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; smooth muscle cell proliferation [GO:0048659]		NA	NA	NA	NA	NA	NA
TRINITY_DN11005_c0_g1_i2	Q7T322	NAA35_DANRE	55.7	88	38	1	306	46	18	105	1.80E-19	97.1	NAA35_DANRE	reviewed	"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein) (zEGAP) (Protein MAK10 homolog)"	naa35 egap mak10	Danio rerio (Zebrafish) (Brachydanio rerio)	724	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; blood vessel morphogenesis [GO:0048514]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; regulation of TOR signaling [GO:0032006]; smooth muscle cell proliferation [GO:0048659]; somitogenesis [GO:0001756]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]		GO:0001756; GO:0005737; GO:0006474; GO:0008284; GO:0017196; GO:0031417; GO:0032006; GO:0043066; GO:0048514; GO:0048659	blood vessel morphogenesis [GO:0048514]; negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; positive regulation of cell population proliferation [GO:0008284]; regulation of TOR signaling [GO:0032006]; smooth muscle cell proliferation [GO:0048659]; somitogenesis [GO:0001756]		NA	NA	NA	NA	NA	NA
TRINITY_DN33474_c0_g1_i1	Q9D2U5	LSMD1_MOUSE	96.4	83	3	0	251	3	28	110	2.70E-39	162.2	LSMD1_MOUSE	reviewed	"N-alpha-acetyltransferase 38, NatC auxiliary subunit (LSM domain-containing protein 1)"	Naa38 Lsmd1	Mus musculus (Mouse)	125	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; negative regulation of apoptotic process [GO:0043066]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]		GO:0005634; GO:0005654; GO:0005737; GO:0005844; GO:0031417; GO:0043066	negative regulation of apoptotic process [GO:0043066]		NA	NA	NA	NA	NA	NA
TRINITY_DN34470_c0_g1_i1	Q9BRA0	LSMD1_HUMAN	100	67	0	0	2	202	44	110	5.00E-33	141	LSMD1_HUMAN	reviewed	"N-alpha-acetyltransferase 38, NatC auxiliary subunit (LSM domain-containing protein 1) (Phosphonoformate immuno-associated protein 2)"	NAA38 LSMD1 MAK31 PFAAP2	Homo sapiens (Human)	125	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005737; GO:0031417; GO:0043066	negative regulation of apoptotic process [GO:0043066]		NA	NA	NA	NA	NA	NA
TRINITY_DN2130_c0_g2_i1	Q6NU60	LMD1B_XENLA	59.5	79	32	0	212	448	30	108	9.80E-21	101.3	LMD1B_XENLA	reviewed	"N-alpha-acetyltransferase 38-B, NatC auxiliary subunit (LSM domain-containing protein 1-B)"	naa38-b lsmd1-b	Xenopus laevis (African clawed frog)	111	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0031417; GO:0043066	negative regulation of apoptotic process [GO:0043066]		blue	blue	NA	NA	NA	NA
TRINITY_DN2130_c0_g1_i1	Q6NU60	LMD1B_XENLA	59.5	79	32	0	239	3	30	108	9.80E-21	101.3	LMD1B_XENLA	reviewed	"N-alpha-acetyltransferase 38-B, NatC auxiliary subunit (LSM domain-containing protein 1-B)"	naa38-b lsmd1-b	Xenopus laevis (African clawed frog)	111	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0031417; GO:0043066	negative regulation of apoptotic process [GO:0043066]		blue	blue	NA	NA	NA	NA
TRINITY_DN35688_c0_g1_i1	Q568K5	NAA40_DANRE	52.6	192	87	3	683	117	29	219	5.00E-50	199.5	NAA40_DANRE	reviewed	N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD)	naa40 nat11 zgc:110241	Danio rerio (Zebrafish) (Brachydanio rerio)	237	cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of ribosomal DNA heterochromatin assembly [GO:0061187]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]	GO:0005634; GO:0005737; GO:0006474; GO:0010485; GO:0043967; GO:0043968; GO:0043998; GO:0061187; GO:1990189	histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of ribosomal DNA heterochromatin assembly [GO:0061187]		NA	NA	NA	NA	NA	NA
TRINITY_DN33445_c0_g1_i1	Q0IIJ0	NAA50_BOVIN	100	112	0	0	364	29	58	169	2.00E-61	236.1	NAA50_BOVIN	reviewed	N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase 13) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit)	NAA50 NAT13	Bos taurus (Bovine)	169	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]	H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0010485; GO:0016573; GO:0031415; GO:0034087; GO:0052858; GO:0071962	"establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13133_c0_g2_i2	A3KPA3	NAA60_DANRE	51.2	164	80	0	495	4	5	168	8.00E-44	178.7	NAA60_DANRE	reviewed	N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF)	naa60 nat15 zgc:163109	Danio rerio (Zebrafish) (Brachydanio rerio)	242	Golgi membrane [GO:0000139]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]	Golgi membrane [GO:0000139]	H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0004402; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0043966; GO:0043967	cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN13133_c0_g1_i1	Q9H7X0	NAA60_HUMAN	50.8	59	29	0	1	177	163	221	1.70E-11	69.7	NAA60_HUMAN	reviewed	N-alpha-acetyltransferase 60 (hNaa60) (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF)	NAA60 HAT4 NAT15 UNQ2771/PRO7155	Homo sapiens (Human)	242	Golgi membrane [GO:0000139]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]	Golgi membrane [GO:0000139]	H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0004402; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0043966; GO:0043967	cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN5214_c3_g1_i5	Q59DX8	NAA80_DROME	40.5	153	79	3	452	907	25	166	1.60E-26	121.7	NAA80_DROME	reviewed	N-alpha-acetyltransferase 80 (DmNAA80) (EC 2.3.1.-)	Naa80 CG8481	Drosophila melanogaster (Fruit fly)	178	cytoplasm [GO:0005737]; acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]	cytoplasm [GO:0005737]	acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005737; GO:0006473; GO:0008080; GO:0017190; GO:0018002; GO:1905502	N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]		blue	blue	NA	NA	NA	NA
TRINITY_DN33569_c0_g1_i1	O09043	NAPSA_MOUSE	100	107	0	0	2	322	66	172	2.00E-60	232.6	NAPSA_MOUSE	reviewed	Napsin-A (EC 3.4.23.-) (KDAP-1) (Kidney-derived aspartic protease-like protein) (KAP)	Napsa Kdap Nap	Mus musculus (Mouse)	419	alveolar lamellar body [GO:0097208]; extracellular space [GO:0005615]; lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; membrane protein proteolysis [GO:0033619]; surfactant homeostasis [GO:0043129]	alveolar lamellar body [GO:0097208]; extracellular space [GO:0005615]; lysosome [GO:0005764]	aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]	GO:0004175; GO:0004190; GO:0005615; GO:0005764; GO:0008233; GO:0033619; GO:0043129; GO:0097208	membrane protein proteolysis [GO:0033619]; surfactant homeostasis [GO:0043129]		NA	NA	NA	NA	NA	NA
TRINITY_DN29519_c0_g1_i1	Q9ZGI5	PIKA1_STRVZ	60.9	69	25	1	3	203	397	465	2.30E-14	79	PIKA1_STRVZ	reviewed	"Narbonolide/10-deoxymethynolide synthase PikA1, modules 1 and 2 (EC 2.3.1.239) (EC 2.3.1.240) (Narbonolide/10-deoxymethynolide synthase PikAI) (Pikromycin polyketide synthase component PikAI) (Pikromycin PKS component PikAI) (Type I modular polyketide synthase PikAI) (PKS)"	pikAI	Streptomyces venezuelae	4613	"3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; fatty acid biosynthetic process [GO:0006633]; macrolide biosynthetic process [GO:0033068]"		"3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0004315; GO:0006633; GO:0016747; GO:0031177; GO:0033068	fatty acid biosynthetic process [GO:0006633]; macrolide biosynthetic process [GO:0033068]		NA	NA	NA	NA	NA	NA
TRINITY_DN37871_c0_g1_i1	O43847	NRDC_HUMAN	100	82	0	0	3	248	235	316	3.80E-43	174.9	NRDC_HUMAN	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	NRDC NRD1	Homo sapiens (Human)	1151	cell surface [GO:0009986]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; epidermal growth factor binding [GO:0048408]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	cell surface [GO:0009986]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	epidermal growth factor binding [GO:0048408]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005829; GO:0009986; GO:0046872; GO:0048408; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i10	Q8BHG1	NRDC_MOUSE	41.9	949	531	8	444	3260	222	1160	3.80E-205	716.8	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i10	Q8BHG1	NRDC_MOUSE	56.7	97	42	0	13	303	436	532	8.40E-27	124.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i2	Q8BHG1	NRDC_MOUSE	45	664	360	3	578	2560	222	883	8.00E-168	592.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i3	Q8BHG1	NRDC_MOUSE	41.9	949	531	8	444	3260	222	1160	3.00E-205	717.2	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i3	Q8BHG1	NRDC_MOUSE	56.7	97	42	0	13	303	436	532	8.60E-27	124.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i4	Q8BHG1	NRDC_MOUSE	43.9	845	467	4	1511	4030	222	1064	3.10E-199	697.6	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i4	Q8BHG1	NRDC_MOUSE	55	311	138	1	444	1370	222	532	1.00E-96	357.1	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i4	Q8BHG1	NRDC_MOUSE	56.7	97	42	0	13	303	436	532	1.10E-26	124.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i6	Q8BHG1	NRDC_MOUSE	45	664	360	3	320	2302	222	883	7.20E-168	592.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i7	Q8BHG1	NRDC_MOUSE	45	664	360	3	308	2290	222	883	7.20E-168	592.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i9	Q8BHG1	NRDC_MOUSE	41.9	949	531	8	1511	4327	222	1160	3.90E-205	717.2	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i9	Q8BHG1	NRDC_MOUSE	55	311	138	1	444	1370	222	532	1.00E-96	357.1	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN5354_c0_g1_i9	Q8BHG1	NRDC_MOUSE	56.7	97	42	0	13	303	436	532	1.10E-26	124.4	NRDC_MOUSE	reviewed	Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)	Nrdc Nrd1	Mus musculus (Mouse)	1161	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]	GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163	negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN3752_c0_g2_i2	Q1DI23	NACB_COCIM	61.5	78	30	0	237	4	37	114	2.30E-21	102.4	NACB_COCIM	reviewed	Nascent polypeptide-associated complex subunit beta (NAC-beta) (Beta-NAC)	EGD1 CIMG_10040	Coccidioides immitis (strain RS) (Valley fever fungus)	155	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN29255_c0_g1_i1	P41251	NRAM1_MOUSE	97.4	77	2	0	234	4	141	217	7.30E-36	150.6	NRAM1_MOUSE	reviewed	Natural resistance-associated macrophage protein 1 (NRAMP 1) (Solute carrier family 11 member 1)	Slc11a1 Bcg Ity Lsh Nramp1	Mus musculus (Mouse)	548	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion:proton antiporter activity [GO:0051139]; protein homodimerization activity [GO:0042803]; transition metal ion transmembrane transporter activity [GO:0046915]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of peptide antigen [GO:0048002]; cadmium ion transmembrane transport [GO:0070574]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; divalent metal ion export [GO:0070839]; inflammatory response [GO:0006954]; interleukin-2 production [GO:0032623]; interleukin-3 production [GO:0032632]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; L-arginine transport [GO:1902023]; macrophage activation [GO:0042116]; manganese ion transport [GO:0006828]; MAPK cascade [GO:0000165]; MHC class II biosynthetic process [GO:0045342]; mRNA stabilization [GO:0048255]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cytokine production [GO:0001818]; nitrite transport [GO:0015707]; phagocytosis [GO:0006909]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory burst [GO:0045730]; response to bacterium [GO:0009617]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; T cell cytokine production [GO:0002369]; T cell proliferation involved in immune response [GO:0002309]; vacuolar acidification [GO:0007035]; wound healing [GO:0042060]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion:proton antiporter activity [GO:0051139]; protein homodimerization activity [GO:0042803]; transition metal ion transmembrane transporter activity [GO:0046915]	GO:0000165; GO:0001818; GO:0001819; GO:0002309; GO:0002369; GO:0002606; GO:0002827; GO:0005381; GO:0005384; GO:0005764; GO:0005770; GO:0005886; GO:0006826; GO:0006828; GO:0006876; GO:0006879; GO:0006909; GO:0006954; GO:0007035; GO:0009617; GO:0010008; GO:0010628; GO:0015086; GO:0015707; GO:0016021; GO:0030670; GO:0032147; GO:0032496; GO:0032623; GO:0032632; GO:0032729; GO:0034341; GO:0042060; GO:0042116; GO:0042742; GO:0042803; GO:0042832; GO:0045342; GO:0045730; GO:0045944; GO:0046915; GO:0048002; GO:0048255; GO:0050766; GO:0050829; GO:0051139; GO:0055072; GO:0060586; GO:0070574; GO:0070821; GO:0070839; GO:1902023	activation of protein kinase activity [GO:0032147]; antigen processing and presentation of peptide antigen [GO:0048002]; cadmium ion transmembrane transport [GO:0070574]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; divalent metal ion export [GO:0070839]; inflammatory response [GO:0006954]; interleukin-2 production [GO:0032623]; interleukin-3 production [GO:0032632]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; L-arginine transport [GO:1902023]; macrophage activation [GO:0042116]; manganese ion transport [GO:0006828]; MAPK cascade [GO:0000165]; MHC class II biosynthetic process [GO:0045342]; mRNA stabilization [GO:0048255]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cytokine production [GO:0001818]; nitrite transport [GO:0015707]; phagocytosis [GO:0006909]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory burst [GO:0045730]; response to bacterium [GO:0009617]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; T cell cytokine production [GO:0002369]; T cell proliferation involved in immune response [GO:0002309]; vacuolar acidification [GO:0007035]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN39198_c0_g1_i1	P49279	NRAM1_HUMAN	100	255	0	0	3	767	66	320	5.50E-141	501.5	NRAM1_HUMAN	reviewed	Natural resistance-associated macrophage protein 1 (NRAMP 1) (Solute carrier family 11 member 1)	SLC11A1 LSH NRAMP NRAMP1	Homo sapiens (Human)	550	ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion:proton antiporter activity [GO:0051139]; protein homodimerization activity [GO:0042803]; transition metal ion transmembrane transporter activity [GO:0046915]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of peptide antigen [GO:0048002]; antimicrobial humoral response [GO:0019730]; cadmium ion transmembrane transport [GO:0070574]; cell redox homeostasis [GO:0045454]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; divalent metal ion export [GO:0070839]; inflammatory response [GO:0006954]; interleukin-2 production [GO:0032623]; interleukin-3 production [GO:0032632]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; L-arginine transport [GO:1902023]; macrophage activation [GO:0042116]; manganese ion transport [GO:0006828]; MHC class II biosynthetic process [GO:0045342]; mRNA stabilization [GO:0048255]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cytokine production [GO:0001818]; neutrophil degranulation [GO:0043312]; nitrite transport [GO:0015707]; phagocytosis [GO:0006909]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory burst [GO:0045730]; response to bacterium [GO:0009617]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; T cell cytokine production [GO:0002369]; T cell proliferation involved in immune response [GO:0002309]; vacuolar acidification [GO:0007035]; wound healing [GO:0042060]	ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion:proton antiporter activity [GO:0051139]; protein homodimerization activity [GO:0042803]; transition metal ion transmembrane transporter activity [GO:0046915]	GO:0001818; GO:0001819; GO:0002309; GO:0002369; GO:0002606; GO:0002827; GO:0005381; GO:0005384; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0006826; GO:0006828; GO:0006876; GO:0006879; GO:0006909; GO:0006954; GO:0007035; GO:0009617; GO:0010628; GO:0015086; GO:0015707; GO:0019730; GO:0030670; GO:0031902; GO:0032147; GO:0032496; GO:0032623; GO:0032632; GO:0032729; GO:0034341; GO:0042060; GO:0042116; GO:0042742; GO:0042803; GO:0042832; GO:0043312; GO:0045342; GO:0045454; GO:0045730; GO:0045944; GO:0046915; GO:0048002; GO:0048255; GO:0050766; GO:0050829; GO:0051139; GO:0055072; GO:0060586; GO:0070574; GO:0070821; GO:0070839; GO:0101003; GO:1902023	activation of protein kinase activity [GO:0032147]; antigen processing and presentation of peptide antigen [GO:0048002]; antimicrobial humoral response [GO:0019730]; cadmium ion transmembrane transport [GO:0070574]; cell redox homeostasis [GO:0045454]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; divalent metal ion export [GO:0070839]; inflammatory response [GO:0006954]; interleukin-2 production [GO:0032623]; interleukin-3 production [GO:0032632]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; L-arginine transport [GO:1902023]; macrophage activation [GO:0042116]; manganese ion transport [GO:0006828]; MHC class II biosynthetic process [GO:0045342]; mRNA stabilization [GO:0048255]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cytokine production [GO:0001818]; neutrophil degranulation [GO:0043312]; nitrite transport [GO:0015707]; phagocytosis [GO:0006909]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory burst [GO:0045730]; response to bacterium [GO:0009617]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; T cell cytokine production [GO:0002369]; T cell proliferation involved in immune response [GO:0002309]; vacuolar acidification [GO:0007035]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN35482_c0_g1_i1	P49281	NRAM2_HUMAN	100	68	0	0	2	205	175	242	2.10E-31	135.6	NRAM2_HUMAN	reviewed	Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2)	SLC11A2 DCT1 DMT1 NRAMP2 OK/SW-cl.20	Homo sapiens (Human)	568	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; calcium ion transmembrane transport [GO:0070588]; cellular iron ion homeostasis [GO:0006879]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676]; zinc ion transmembrane transport [GO:0071577]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]	cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001666; GO:0003032; GO:0005375; GO:0005381; GO:0005384; GO:0005385; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005887; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006879; GO:0006919; GO:0007611; GO:0009986; GO:0010039; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016020; GO:0016324; GO:0022890; GO:0031410; GO:0031526; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0055037; GO:0060586; GO:0070574; GO:0070588; GO:0070826; GO:0071577; GO:1903561; GO:1905394	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; calcium ion transmembrane transport [GO:0070588]; cellular iron ion homeostasis [GO:0006879]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676]; zinc ion transmembrane transport [GO:0071577]		NA	NA	NA	NA	NA	NA
TRINITY_DN31459_c0_g1_i1	P49281	NRAM2_HUMAN	100	68	0	0	2	205	63	130	8.00E-31	133.7	NRAM2_HUMAN	reviewed	Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2)	SLC11A2 DCT1 DMT1 NRAMP2 OK/SW-cl.20	Homo sapiens (Human)	568	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; calcium ion transmembrane transport [GO:0070588]; cellular iron ion homeostasis [GO:0006879]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676]; zinc ion transmembrane transport [GO:0071577]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]	cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001666; GO:0003032; GO:0005375; GO:0005381; GO:0005384; GO:0005385; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005887; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006879; GO:0006919; GO:0007611; GO:0009986; GO:0010039; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016020; GO:0016324; GO:0022890; GO:0031410; GO:0031526; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0055037; GO:0060586; GO:0070574; GO:0070588; GO:0070826; GO:0071577; GO:1903561; GO:1905394	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; calcium ion transmembrane transport [GO:0070588]; cellular iron ion homeostasis [GO:0006879]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676]; zinc ion transmembrane transport [GO:0071577]		NA	NA	NA	NA	NA	NA
TRINITY_DN27531_c0_g1_i1	P28660	NCKP1_MOUSE	100	131	0	0	3	395	470	600	8.20E-72	270.8	NCKP1_MOUSE	reviewed	Nck-associated protein 1 (NAP 1) (Brain protein H19) (MH19) (Membrane-associated protein HEM-2) (p125Nap1)	Nckap1 Hem2 Kiaa0587 Nap1	Mus musculus (Mouse)	1128	"filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]"	filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]		GO:0000902; GO:0001701; GO:0001726; GO:0001756; GO:0001843; GO:0007354; GO:0007492; GO:0008078; GO:0010172; GO:0010592; GO:0016021; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030838; GO:0030866; GO:0030903; GO:0030950; GO:0031209; GO:0031258; GO:0031941; GO:0032880; GO:0035050; GO:0042074; GO:0045175; GO:0045176; GO:0048339; GO:0048340; GO:0048570; GO:0048617; GO:0048812; GO:0050821; GO:0098794; GO:2000601	"apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32467_c0_g1_i1	Q9Y2A7	NCKP1_HUMAN	100	96	0	0	3	290	903	998	2.50E-46	185.7	NCKP1_HUMAN	reviewed	Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1)	NCKAP1 HEM2 KIAA0587 NAP1	Homo sapiens (Human)	1128	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]		GO:0000902; GO:0001726; GO:0005829; GO:0005925; GO:0006915; GO:0007417; GO:0010592; GO:0016021; GO:0016032; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030838; GO:0030866; GO:0031209; GO:0031258; GO:0031941; GO:0038096; GO:0048010; GO:0048812; GO:0070062; GO:2000601	apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN34135_c0_g1_i1	Q9Y2A7	NCKP1_HUMAN	100	76	0	0	230	3	726	801	7.20E-36	150.6	NCKP1_HUMAN	reviewed	Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1)	NCKAP1 HEM2 KIAA0587 NAP1	Homo sapiens (Human)	1128	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]		GO:0000902; GO:0001726; GO:0005829; GO:0005925; GO:0006915; GO:0007417; GO:0010592; GO:0016021; GO:0016032; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030838; GO:0030866; GO:0031209; GO:0031258; GO:0031941; GO:0038096; GO:0048010; GO:0048812; GO:0070062; GO:2000601	apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN38690_c0_g1_i1	Q9Y2A7	NCKP1_HUMAN	98.1	107	2	0	6	326	135	241	1.40E-53	209.9	NCKP1_HUMAN	reviewed	Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1)	NCKAP1 HEM2 KIAA0587 NAP1	Homo sapiens (Human)	1128	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]		GO:0000902; GO:0001726; GO:0005829; GO:0005925; GO:0006915; GO:0007417; GO:0010592; GO:0016021; GO:0016032; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030838; GO:0030866; GO:0031209; GO:0031258; GO:0031941; GO:0038096; GO:0048010; GO:0048812; GO:0070062; GO:2000601	apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN24175_c0_g2_i1	Q8K1X4	NCKPL_MOUSE	97.4	78	2	0	2	235	702	779	4.70E-35	147.9	NCKPL_MOUSE	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1)	Nckap1l Hem1	Mus musculus (Mouse)	1134	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; SCAR complex [GO:0031209]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]"	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; SCAR complex [GO:0031209]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0006935; GO:0016021; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070358; GO:0090023	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21283_c0_g1_i1	Q8K1X4	NCKPL_MOUSE	98.8	84	1	0	2	253	801	884	3.40E-39	161.8	NCKPL_MOUSE	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1)	Nckap1l Hem1	Mus musculus (Mouse)	1134	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; SCAR complex [GO:0031209]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]"	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; SCAR complex [GO:0031209]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0006935; GO:0016021; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070358; GO:0090023	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24175_c0_g1_i1	P55160	NCKPL_HUMAN	100	76	0	0	2	229	704	779	1.60E-35	149.4	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40987_c0_g1_i1	P55160	NCKPL_HUMAN	100	81	0	0	244	2	321	401	7.80E-41	167.2	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35864_c0_g1_i1	P55160	NCKPL_HUMAN	100	120	0	0	362	3	84	203	6.10E-66	251.1	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29011_c0_g1_i1	P55160	NCKPL_HUMAN	100	107	0	0	3	323	457	563	2.40E-53	209.1	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32946_c0_g1_i1	P55160	NCKPL_HUMAN	100	163	0	0	3	491	965	1127	8.80E-85	314.3	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21283_c0_g1_i2	P55160	NCKPL_HUMAN	100	73	0	0	1	219	812	884	1.10E-33	143.3	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39799_c0_g1_i1	P55160	NCKPL_HUMAN	98.9	89	1	0	1	267	197	285	1.00E-46	186.8	NCKPL_HUMAN	reviewed	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	Homo sapiens (Human)	1127	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]	GO:0000902; GO:0001782; GO:0002262; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0038096; GO:0042102; GO:0042327; GO:0042493; GO:0043029; GO:0043066; GO:0043312; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048010; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003	"actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; neutrophil degranulation [GO:0043312]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; protein-containing complex assembly [GO:0065003]; response to drug [GO:0042493]; T cell homeostasis [GO:0043029]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4342_c0_g1_i2	O14513	NCKP5_HUMAN	52.1	73	35	0	129	347	183	255	1.90E-09	65.5	NCKP5_HUMAN	reviewed	Nck-associated protein 5 (NAP-5) (Peripheral clock protein)	NCKAP5 ERIH NAP5	Homo sapiens (Human)	1909	microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]	microtubule plus-end [GO:0035371]		GO:0001578; GO:0007019; GO:0035371	microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]		NA	NA	NA	NA	NA	NA
TRINITY_DN4342_c0_g1_i3	O14513	NCKP5_HUMAN	37.4	123	74	1	253	621	136	255	2.60E-10	68.6	NCKP5_HUMAN	reviewed	Nck-associated protein 5 (NAP-5) (Peripheral clock protein)	NCKAP5 ERIH NAP5	Homo sapiens (Human)	1909	microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]	microtubule plus-end [GO:0035371]		GO:0001578; GO:0007019; GO:0035371	microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]		NA	NA	NA	NA	NA	NA
TRINITY_DN460_c0_g1_i1	Q9VXB0	NECAP_DROME	68.2	173	51	1	25	543	2	170	1.00E-65	251.1	NECAP_DROME	reviewed	NECAP-like protein CG9132	CG9132	Drosophila melanogaster (Fruit fly)	246	clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	clathrin-coated pit [GO:0005905]; clathrin vesicle coat [GO:0030125]		GO:0005905; GO:0006897; GO:0015031; GO:0016192; GO:0030125	endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN39929_c0_g1_i1	Q9NV92	NFIP2_HUMAN	40	115	65	2	388	56	222	336	1.60E-16	87.4	NFIP2_HUMAN	reviewed	NEDD4 family-interacting protein 2 (NEDD4 WW domain-binding protein 5A) (Putative MAPK-activating protein PM04/PM05/PM06/PM07) (Putative NF-kappa-B-activating protein 413)	NDFIP2 KIAA1165 N4WBP5A	Homo sapiens (Human)	336	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; perinuclear region of cytoplasm [GO:0048471]; WW domain binding [GO:0050699]; metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; perinuclear region of cytoplasm [GO:0048471]	WW domain binding [GO:0050699]	GO:0000139; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006511; GO:0007034; GO:0010629; GO:0016021; GO:0030001; GO:0031398; GO:0032410; GO:0032585; GO:0043123; GO:0043231; GO:0048471; GO:0050699; GO:0051224	metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]		NA	NA	NA	NA	NA	NA
TRINITY_DN56_c0_g1_i1	Q86UW6	N4BP2_HUMAN	23.1	1448	910	47	4168	83	441	1770	4.60E-28	129	N4BP2_HUMAN	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	N4BP2 B3BP KIAA1413	Homo sapiens (Human)	1770	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	GO:0004519; GO:0005524; GO:0005829; GO:0046404			NA	NA	NA	NA	NA	NA
TRINITY_DN56_c0_g1_i5	Q86UW6	N4BP2_HUMAN	22.8	1440	907	46	4144	83	449	1770	3.20E-25	119.4	N4BP2_HUMAN	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	N4BP2 B3BP KIAA1413	Homo sapiens (Human)	1770	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	GO:0004519; GO:0005524; GO:0005829; GO:0046404			NA	NA	NA	NA	NA	NA
TRINITY_DN1995_c0_g1_i1	Q86UW6	N4BP2_HUMAN	43	135	77	0	1344	940	441	575	2.80E-23	111.7	N4BP2_HUMAN	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	N4BP2 B3BP KIAA1413	Homo sapiens (Human)	1770	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	GO:0004519; GO:0005524; GO:0005829; GO:0046404			NA	NA	NA	NA	NA	NA
TRINITY_DN1995_c0_g1_i2	Q86UW6	N4BP2_HUMAN	44	134	75	0	1323	922	441	574	1.90E-24	115.5	N4BP2_HUMAN	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	N4BP2 B3BP KIAA1413	Homo sapiens (Human)	1770	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	GO:0004519; GO:0005524; GO:0005829; GO:0046404			NA	NA	NA	NA	NA	NA
TRINITY_DN25495_c0_g1_i1	Q86UW6	N4BP2_HUMAN	43.3	134	76	0	1300	899	441	574	4.50E-23	110.9	N4BP2_HUMAN	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	N4BP2 B3BP KIAA1413	Homo sapiens (Human)	1770	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	GO:0004519; GO:0005524; GO:0005829; GO:0046404			NA	NA	NA	NA	NA	NA
TRINITY_DN56_c0_g1_i2	Q5TBK1	N42L1_HUMAN	45	169	91	1	4173	3673	41	209	1.20E-35	154.1	N42L1_HUMAN	reviewed	NEDD4-binding protein 2-like 1	N4BP2L1 CG081	Homo sapiens (Human)	243							NA	NA	NA	NA	NA	NA
TRINITY_DN56_c0_g1_i3	Q5TBK1	N42L1_HUMAN	45	169	91	1	564	64	41	209	2.70E-36	154.1	N42L1_HUMAN	reviewed	NEDD4-binding protein 2-like 1	N4BP2L1 CG081	Homo sapiens (Human)	243							NA	NA	NA	NA	NA	NA
TRINITY_DN29985_c0_g1_i1	Q92802	N42L2_HUMAN	100	70	0	0	2	211	451	520	2.70E-37	155.2	N42L2_HUMAN	reviewed	NEDD4-binding protein 2-like 2 (Phosphonoformate immuno-associated protein 5)	N4BP2L2 CG005 PFAAP5	Homo sapiens (Human)	583	extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]	extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0017053; GO:0019899; GO:0070062; GO:1902035; GO:1902037	negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]		NA	NA	NA	NA	NA	NA
TRINITY_DN17120_c0_g1_i1	O00308	WWP2_HUMAN	98.6	69	1	0	209	3	537	605	2.20E-36	152.1	WWP2_HUMAN	reviewed	NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)	WWP2	Homo sapiens (Human)	870	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0001085; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0006858; GO:0008134; GO:0010629; GO:0016020; GO:0016567; GO:0032410; GO:0034765; GO:0042391; GO:0043161; GO:0043433; GO:0045732; GO:0045746; GO:0045892; GO:0045944; GO:0046718; GO:0051224; GO:0051865; GO:0061630; GO:0070062; GO:0070534; GO:1901016	"cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26898_c0_g1_i1	O00308	WWP2_HUMAN	100	101	0	0	1	303	635	735	1.30E-53	209.9	WWP2_HUMAN	reviewed	NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)	WWP2	Homo sapiens (Human)	870	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0001085; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0006858; GO:0008134; GO:0010629; GO:0016020; GO:0016567; GO:0032410; GO:0034765; GO:0042391; GO:0043161; GO:0043433; GO:0045732; GO:0045746; GO:0045892; GO:0045944; GO:0046718; GO:0051224; GO:0051865; GO:0061630; GO:0070062; GO:0070534; GO:1901016	"cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31583_c0_g1_i1	O00308	WWP2_HUMAN	100	68	0	0	2	205	803	870	4.50E-36	151.4	WWP2_HUMAN	reviewed	NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)	WWP2	Homo sapiens (Human)	870	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0001085; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0006858; GO:0008134; GO:0010629; GO:0016020; GO:0016567; GO:0032410; GO:0034765; GO:0042391; GO:0043161; GO:0043433; GO:0045732; GO:0045746; GO:0045892; GO:0045944; GO:0046718; GO:0051224; GO:0051865; GO:0061630; GO:0070062; GO:0070534; GO:1901016	"cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35110_c0_g1_i1	O00308	WWP2_HUMAN	100	75	0	0	228	4	291	365	1.50E-41	169.5	WWP2_HUMAN	reviewed	NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)	WWP2	Homo sapiens (Human)	870	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000151; GO:0000209; GO:0001085; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0006858; GO:0008134; GO:0010629; GO:0016020; GO:0016567; GO:0032410; GO:0034765; GO:0042391; GO:0043161; GO:0043433; GO:0045732; GO:0045746; GO:0045892; GO:0045944; GO:0046718; GO:0051224; GO:0051865; GO:0061630; GO:0070062; GO:0070534; GO:1901016	"cellular protein modification process [GO:0006464]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25869_c0_g1_i1	Q19360	UBA3_CAEEL	50.7	71	34	1	242	30	40	109	6.90E-11	67.8	UBA3_CAEEL	reviewed	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (Ectopic membrane ruffles in embryo protein 1) (Ubiquitin-activating enzyme 3 homolog)	rfl-1 uba-3 F11H8.1	Caenorhabditis elegans	430	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; multicellular organism development [GO:0007275]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]	GO:0005524; GO:0005634; GO:0005737; GO:0007275; GO:0019781; GO:0032446; GO:0043518; GO:0045116	"multicellular organism development [GO:0007275]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26167_c0_g1_i1	Q8C878	UBA3_MOUSE	100	115	0	0	345	1	173	287	1.50E-66	253.1	UBA3_MOUSE	reviewed	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3)	Uba3 Ube1c	Mus musculus (Mouse)	462	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; nuclear receptor binding [GO:0016922]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0000278; GO:0005524; GO:0005634; GO:0005737; GO:0007113; GO:0016922; GO:0019781; GO:0032446; GO:0032991; GO:0042802; GO:0044877; GO:0045116; GO:0045892; GO:0046982; GO:0051726	"endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2730_c0_g1_i1	Q7ZVX6	UBA3_DANRE	69.5	429	131	0	1382	96	31	459	1.60E-184	647.1	UBA3_DANRE	reviewed	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3)	uba3 ube1c zgc:55528	Danio rerio (Zebrafish) (Brachydanio rerio)	462	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]	GO:0005524; GO:0005634; GO:0005737; GO:0019781; GO:0032446; GO:0045116	protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]		blue	blue	NA	NA	NA	NA
TRINITY_DN15383_c0_g1_i1	Q8TBC4	UBA3_HUMAN	100	373	0	0	3	1121	28	400	1.30E-223	776.5	UBA3_HUMAN	reviewed	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3)	UBA3 UBE1C	Homo sapiens (Human)	463	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cellular protein modification process [GO:0006464]; endomitotic cell cycle [GO:0007113]; negative regulation of transcription, DNA-templated [GO:0045892]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; nuclear receptor binding [GO:0016922]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006508; GO:0007113; GO:0016922; GO:0019781; GO:0019788; GO:0032446; GO:0032991; GO:0042802; GO:0043687; GO:0044877; GO:0045116; GO:0045892; GO:0046982; GO:0051726	"cellular protein modification process [GO:0006464]; endomitotic cell cycle [GO:0007113]; negative regulation of transcription, DNA-templated [GO:0045892]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15383_c0_g1_i2	Q8TBC4	UBA3_HUMAN	100	377	0	0	3	1133	28	404	2.40E-225	782.3	UBA3_HUMAN	reviewed	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3)	UBA3 UBE1C	Homo sapiens (Human)	463	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cellular protein modification process [GO:0006464]; endomitotic cell cycle [GO:0007113]; negative regulation of transcription, DNA-templated [GO:0045892]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; nuclear receptor binding [GO:0016922]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006508; GO:0007113; GO:0016922; GO:0019781; GO:0019788; GO:0032446; GO:0032991; GO:0042802; GO:0043687; GO:0044877; GO:0045116; GO:0045892; GO:0046982; GO:0051726	"cellular protein modification process [GO:0006464]; endomitotic cell cycle [GO:0007113]; negative regulation of transcription, DNA-templated [GO:0045892]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11538_c0_g2_i1	O65041	UBA3_ARATH	54.3	70	32	0	4	213	253	322	4.90E-15	81.3	UBA3_ARATH	reviewed	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (RUB-activating enzyme) (Ubiquitin-activating enzyme E1-like protein)	ECR1 At5g19180 T24G5_80	Arabidopsis thaliana (Mouse-ear cress)	454	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0019781; GO:0032446; GO:0045116; GO:0046982	protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN11538_c0_g3_i1	Q9V6U8	UBA3_DROME	58.9	90	36	1	7	276	27	115	1.20E-24	113.6	UBA3_DROME	reviewed	Nedd8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (Ubiquitin-activating enzyme 3 homolog)	Uba3 CG13343	Drosophila melanogaster (Fruit fly)	450	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]	GO:0005524; GO:0005634; GO:0005737; GO:0019781; GO:0032446; GO:0032991; GO:0045116; GO:0045879; GO:0045880	negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN11538_c0_g1_i1	Q9V6U8	UBA3_DROME	63	81	30	0	259	17	163	243	8.10E-28	124	UBA3_DROME	reviewed	Nedd8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (Ubiquitin-activating enzyme 3 homolog)	Uba3 CG13343	Drosophila melanogaster (Fruit fly)	450	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]	GO:0005524; GO:0005634; GO:0005737; GO:0019781; GO:0032446; GO:0032991; GO:0045116; GO:0045879; GO:0045880	negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN9885_c0_g1_i2	Q4R3L6	ULA1_MACFA	51	286	136	3	927	79	226	510	8.50E-73	275.4	ULA1_MACFA	reviewed	"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1)"	NAE1 APPBP1 QtsA-16060	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	510	plasma membrane [GO:0005886]; NEDD8 activating enzyme activity [GO:0019781]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; protein neddylation [GO:0045116]	plasma membrane [GO:0005886]	NEDD8 activating enzyme activity [GO:0019781]	GO:0005886; GO:0006915; GO:0007049; GO:0019781; GO:0045116	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN37789_c0_g1_i1	Q13564	ULA1_HUMAN	100	76	0	0	260	33	459	534	5.10E-38	157.9	ULA1_HUMAN	reviewed	"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)"	NAE1 APPBP1 HPP1	Homo sapiens (Human)	534	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; mitotic DNA replication checkpoint [GO:0033314]; neuron apoptotic process [GO:0051402]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0019781; GO:0031625; GO:0032446; GO:0032991; GO:0033314; GO:0042981; GO:0043523; GO:0043687; GO:0045116; GO:0046982; GO:0051402	mitotic DNA replication checkpoint [GO:0033314]; neuron apoptotic process [GO:0051402]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31895_c0_g1_i1	Q13564	ULA1_HUMAN	100	81	0	0	3	245	454	534	7.20E-41	167.5	ULA1_HUMAN	reviewed	"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)"	NAE1 APPBP1 HPP1	Homo sapiens (Human)	534	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; mitotic DNA replication checkpoint [GO:0033314]; neuron apoptotic process [GO:0051402]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0019781; GO:0031625; GO:0032446; GO:0032991; GO:0033314; GO:0042981; GO:0043523; GO:0043687; GO:0045116; GO:0046982; GO:0051402	mitotic DNA replication checkpoint [GO:0033314]; neuron apoptotic process [GO:0051402]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN9885_c0_g1_i1	Q7SXP2	ULA1_DANRE	49.7	302	148	3	975	79	233	533	1.90E-77	290.8	ULA1_DANRE	reviewed	NEDD8-activating enzyme E1 regulatory subunit (APP-BP1) (Amyloid protein-binding protein 1)	nae1 appbp1	Danio rerio (Zebrafish) (Brachydanio rerio)	533	cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]	cytoplasm [GO:0005737]	NEDD8 activating enzyme activity [GO:0019781]	GO:0005737; GO:0019781; GO:0032446; GO:0045116	protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN9885_c0_g1_i3	Q7SXP2	ULA1_DANRE	48.4	190	96	2	645	79	345	533	1.40E-45	184.5	ULA1_DANRE	reviewed	NEDD8-activating enzyme E1 regulatory subunit (APP-BP1) (Amyloid protein-binding protein 1)	nae1 appbp1	Danio rerio (Zebrafish) (Brachydanio rerio)	533	cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]	cytoplasm [GO:0005737]	NEDD8 activating enzyme activity [GO:0019781]	GO:0005737; GO:0019781; GO:0032446; GO:0045116	protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]		NA	NA	NA	NA	NA	NA
TRINITY_DN35762_c0_g1_i1	Q9SDY5	RCE1_ARATH	72.5	80	22	0	245	6	79	158	1.10E-31	136.7	RCE1_ARATH	reviewed	NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.-) (RUB1 carrier protein 1) (RUB1-conjugating enzyme 1)	RCE1 At4g36800 C7A10.560	Arabidopsis thaliana (Mouse-ear cress)	184	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; response to auxin [GO:0009733]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0009733; GO:0019788; GO:0045116; GO:0061631	protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; response to auxin [GO:0009733]		NA	NA	NA	NA	NA	NA
TRINITY_DN24176_c1_g1_i1	A3KN22	UBC12_BOVIN	100	73	0	0	222	4	36	108	1.30E-39	162.9	UBC12_BOVIN	reviewed	NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M)	UBE2M UBC12	Bos taurus (Bovine)	183	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006464; GO:0019788; GO:0045116; GO:0061631	cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN24176_c0_g1_i1	A3KN22	UBC12_BOVIN	100	72	0	0	218	3	76	147	1.70E-39	162.5	UBC12_BOVIN	reviewed	NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M)	UBE2M UBC12	Bos taurus (Bovine)	183	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006464; GO:0019788; GO:0045116; GO:0061631	cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN33895_c0_g1_i1	Q6P8D9	UBC12_XENTR	88.9	135	15	0	407	3	25	159	7.20E-69	261.2	UBC12_XENTR	reviewed	NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M)	ube2m ubc12	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	183	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006464; GO:0019788; GO:0045116; GO:0061631	cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		blue	blue	NA	NA	NA	NA
TRINITY_DN6398_c0_g1_i1	P52491	UBC12_YEAST	44.4	81	43	2	10	249	78	157	5.60E-13	74.7	UBC12_YEAST	reviewed	NEDD8-conjugating enzyme UBC12 (EC 2.3.2.34) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12)	UBC12 YLR306W L2142.3	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	188	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0019788; GO:0045116; GO:0061631	protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN16575_c0_g1_i2	Q969M7	UBE2F_HUMAN	100	123	0	0	401	33	63	185	4.90E-72	271.6	UBE2F_HUMAN	reviewed	NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)	UBE2F NCE2	Homo sapiens (Human)	185	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0043687; GO:0045116; GO:0061631; GO:0061654	post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN5754_c0_g1_i1	Q1RMW1	UBE2F_BOVIN	62.3	183	63	1	74	604	1	183	1.00E-64	248.1	UBE2F_BOVIN	reviewed	NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)	UBE2F	Bos taurus (Bovine)	185	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0019788; GO:0045116; GO:0061631; GO:0061654	protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN5754_c0_g1_i2	Q1RMW1	UBE2F_BOVIN	62.3	183	63	1	60	590	1	183	1.70E-64	247.3	UBE2F_BOVIN	reviewed	NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)	UBE2F	Bos taurus (Bovine)	185	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0019788; GO:0045116; GO:0061631; GO:0061654	protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN16575_c0_g1_i1	Q9CY34	UB2FA_MOUSE	99.2	122	1	0	368	3	63	184	2.50E-70	265.8	UB2FA_MOUSE	reviewed	NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)	Ube2f Ube2fa	Mus musculus (Mouse)	185	nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0019788; GO:0045116; GO:0061631; GO:0061654	protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN33063_c0_g1_i1	Q86NP2	NELFA_DROME	63.6	209	76	0	30	656	1	209	1.30E-72	274.2	NELFA_DROME	reviewed	Negative elongation factor A	Nelf-A CG5874	Drosophila melanogaster (Fruit fly)	1251	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0007275; GO:0017053; GO:0032021; GO:0034244	multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]		NA	NA	NA	NA	NA	NA
TRINITY_DN33063_c0_g1_i2	Q86NP2	NELFA_DROME	61.4	88	34	0	115	378	122	209	1.20E-25	117.5	NELFA_DROME	reviewed	Negative elongation factor A	Nelf-A CG5874	Drosophila melanogaster (Fruit fly)	1251	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0007275; GO:0017053; GO:0032021; GO:0034244	multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]		NA	NA	NA	NA	NA	NA
TRINITY_DN2419_c0_g1_i1	Q9Y113	NELFB_DROME	69.2	584	172	3	1786	50	9	589	3.90E-233	808.9	NELFB_DROME	reviewed	Negative elongation factor B	NELF-B CG32721	Drosophila melanogaster (Fruit fly)	594	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0017053; GO:0032021; GO:0034244; GO:0045944	negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN40708_c0_g1_i1	Q8WX92	NELFB_HUMAN	100	55	0	0	165	1	1	55	8.70E-25	113.6	NELFB_HUMAN	reviewed	Negative elongation factor B (NELF-B) (Cofactor of BRCA1)	NELFB COBRA1 KIAA1182	Homo sapiens (Human)	580	cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005737; GO:0006366; GO:0006368; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:0050434; GO:2000737	cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN34679_c0_g1_i1	Q8C4Y3	NELFB_MOUSE	98.8	85	1	0	260	6	251	335	3.10E-43	175.3	NELFB_MOUSE	reviewed	Negative elongation factor B (NELF-B) (Cofactor of BRCA1)	Nelfb Cobra1 MNCb-5210	Mus musculus (Mouse)	580	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737	cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN38049_c0_g1_i1	Q8WX92	NELFB_HUMAN	100	106	0	0	320	3	198	303	2.30E-56	219.2	NELFB_HUMAN	reviewed	Negative elongation factor B (NELF-B) (Cofactor of BRCA1)	NELFB COBRA1 KIAA1182	Homo sapiens (Human)	580	cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005737; GO:0006366; GO:0006368; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:0050434; GO:2000737	cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN34196_c0_g1_i1	Q8C4Y3	NELFB_MOUSE	98.9	93	1	0	282	4	123	215	2.80E-45	182.2	NELFB_MOUSE	reviewed	Negative elongation factor B (NELF-B) (Cofactor of BRCA1)	Nelfb Cobra1 MNCb-5210	Mus musculus (Mouse)	580	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737	cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN29984_c0_g1_i1	Q8IXH7	NELFD_HUMAN	100	156	0	0	468	1	55	210	1.20E-85	317	NELFD_HUMAN	reviewed	Negative elongation factor C/D (NELF-C/D) (TH1-like protein)	NELFCD NELFD TH1 TH1L HSPC130	Homo sapiens (Human)	590	membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006366; GO:0006368; GO:0016020; GO:0032021; GO:0034244; GO:0050434	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN26735_c0_g1_i1	Q24134	NELFD_DROME	67.6	241	73	2	97	819	10	245	9.50E-91	334.7	NELFD_DROME	reviewed	Negative elongation factor D	TH1 NELF-D CG9984	Drosophila melanogaster (Fruit fly)	578	NELF complex [GO:0032021]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; transcription repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]	NELF complex [GO:0032021]; nucleus [GO:0005634]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; transcription repressor complex [GO:0017053]	RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0005634; GO:0005703; GO:0005705; GO:0008023; GO:0017053; GO:0032021; GO:0034244	negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]		NA	NA	NA	NA	NA	NA
TRINITY_DN16069_c0_g1_i1	P92204	NELFE_DROME	69	87	27	0	284	24	191	277	1.30E-26	120.2	NELFE_DROME	reviewed	Negative elongation factor E	Nelf-E anon-66Da CG5994	Drosophila melanogaster (Fruit fly)	280	"chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcription repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcription repressor complex [GO:0017053]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000122; GO:0003723; GO:0003729; GO:0005634; GO:0005694; GO:0008023; GO:0017053; GO:0032021; GO:0032785; GO:0034244; GO:0045944	"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6163_c2_g1_i1	P37571	CLPC_BACSU	76.3	93	22	0	281	3	553	645	1.60E-37	156.4	CLPC_BACSU	reviewed	Negative regulator of genetic competence ClpC/MecB	clpC mecB BSU00860	Bacillus subtilis (strain 168)	810	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; establishment of competence for transformation [GO:0030420]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887; GO:0030420	establishment of competence for transformation [GO:0030420]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i37	Q9VGP2	NINAG_DROME	39.3	56	32	1	248	415	396	449	5.10E-05	49.3	NINAG_DROME	reviewed	Neither inactivation nor afterpotential protein G (EC 1.-.-.-)	ninaG CG6728	Drosophila melanogaster (Fruit fly)	581	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidation-reduction process [GO:0055114]; protein localization to rhabdomere [GO:1990146]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; rhabdomere morphogenesis [GO:0061541]; rhodopsin metabolic process [GO:0046154]; visual perception [GO:0007601]"	extracellular region [GO:0005576]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0001523; GO:0005576; GO:0007601; GO:0016491; GO:0016614; GO:0046154; GO:0050660; GO:0050896; GO:0055114; GO:0061541; GO:1990146	oxidation-reduction process [GO:0055114]; protein localization to rhabdomere [GO:1990146]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; rhabdomere morphogenesis [GO:0061541]; rhodopsin metabolic process [GO:0046154]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN40078_c0_g1_i1	Q90610	NEO1_CHICK	30.3	145	93	4	429	4	233	372	6.00E-12	72	NEO1_CHICK	reviewed	Neogenin (Fragment)		Gallus gallus (Chicken)	1443	integral component of plasma membrane [GO:0005887]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; positive regulation of BMP signaling pathway [GO:0030513]	integral component of plasma membrane [GO:0005887]	signaling receptor activity [GO:0038023]	GO:0005887; GO:0007155; GO:0007411; GO:0030513; GO:0038023; GO:0055072	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; positive regulation of BMP signaling pathway [GO:0030513]		NA	NA	NA	NA	NA	NA
TRINITY_DN6987_c0_g1_i14	W4VS99	NEP_TRILK	32.4	475	310	4	1424	18	28	497	3.50E-73	277.3	NEP_TRILK	reviewed	Neprilysin-1 (EC 3.4.24.-)		Trittame loki (Brush-footed trapdoor spider)	722	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005576; GO:0046872			brown	brown	NA	NA	NA	NA
TRINITY_DN6987_c0_g1_i10	O16796	NPL11_CAEEL	51.7	180	82	1	540	1	615	789	8.30E-49	194.9	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6987_c0_g1_i4	O16796	NPL11_CAEEL	38.2	699	419	6	2164	86	157	848	4.10E-147	523.5	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6987_c0_g1_i9	O16796	NPL11_CAEEL	37.7	640	386	6	2163	262	157	789	1.40E-126	455.3	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6987_c0_g1_i9	O16796	NPL11_CAEEL	45.8	59	32	0	262	86	790	848	1.80E-12	76.3	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3969_c0_g4_i1	O16796	NPL11_CAEEL	45.2	104	52	1	373	62	692	790	3.10E-22	106.3	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3969_c0_g4_i2	O16796	NPL11_CAEEL	49.3	140	66	1	481	62	656	790	1.30E-35	151	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3404_c0_g1_i1	O16796	NPL11_CAEEL	56	84	37	0	255	4	620	703	1.40E-21	103.6	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6987_c0_g1_i8	O16796	NPL11_CAEEL	50.9	175	81	1	610	86	679	848	2.90E-50	199.9	NPL11_CAEEL	reviewed	Neprilysin-11 (EC 3.4.24.-)	nep-11 F18A12.8	Caenorhabditis elegans	848	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	1	NA	NA	NA
TRINITY_DN21659_c1_g2_i9	A0A0B4K692	NEP2_DROME	53.7	41	17	1	159	43	71	111	4.70E-05	48.1	NEP2_DROME	reviewed	"Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form]"	Nep2 CG9761	Drosophila melanogaster (Fruit fly)	774	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872	proteolysis [GO:0006508]; sperm competition [GO:0046692]		brown	brown	NA	NA	NA	NA
TRINITY_DN39454_c0_g1_i1	A0A0B4K692	NEP2_DROME	46.4	69	37	0	5	211	105	173	4.50E-13	75.1	NEP2_DROME	reviewed	"Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form]"	Nep2 CG9761	Drosophila melanogaster (Fruit fly)	774	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872	proteolysis [GO:0006508]; sperm competition [GO:0046692]		NA	NA	NA	NA	NA	NA
TRINITY_DN31384_c0_g1_i1	A0A0B4K692	NEP2_DROME	81.4	43	8	0	51	179	579	621	6.80E-15	80.9	NEP2_DROME	reviewed	"Neprilysin-2 (EC 3.4.24.11) [Cleaved into: Neprilysin-2, soluble form]"	Nep2 CG9761	Drosophila melanogaster (Fruit fly)	774	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; sperm competition [GO:0046692]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046692; GO:0046872	proteolysis [GO:0006508]; sperm competition [GO:0046692]		NA	NA	NA	NA	NA	NA
TRINITY_DN14282_c0_g1_i2	Q22523	NPL21_CAEEL	32.3	133	86	3	9	398	380	511	1.50E-11	70.9	NPL21_CAEEL	reviewed	Neprilysin-21 (EC 3.4.24.-)	nep-21 T16A9.4	Caenorhabditis elegans	769	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005886; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2978_c0_g1_i1	Q9W5Y0	NEP3_DROME	30.5	275	174	5	16	837	527	785	1.00E-29	132.1	NEP3_DROME	reviewed	Neprilysin-3 (EC 3.4.24.11)	Nep3 CG9565	Drosophila melanogaster (Fruit fly)	786	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptide hormone processing [GO:0016486]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016486; GO:0046872	peptide hormone processing [GO:0016486]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN27178_c0_g1_i1	Q9W5Y0	NEP3_DROME	46.1	76	41	0	228	1	589	664	5.10E-18	91.3	NEP3_DROME	reviewed	Neprilysin-3 (EC 3.4.24.11)	Nep3 CG9565	Drosophila melanogaster (Fruit fly)	786	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptide hormone processing [GO:0016486]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016486; GO:0046872	peptide hormone processing [GO:0016486]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN32654_c0_g1_i1	Q9W5Y0	NEP3_DROME	54.3	92	42	0	1	276	573	664	1.20E-26	120.2	NEP3_DROME	reviewed	Neprilysin-3 (EC 3.4.24.11)	Nep3 CG9565	Drosophila melanogaster (Fruit fly)	786	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptide hormone processing [GO:0016486]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016486; GO:0046872	peptide hormone processing [GO:0016486]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN38200_c0_g1_i1	Q8T062	NEP4_DROME	60	35	14	0	176	72	1005	1039	4.20E-06	51.6	NEP4_DROME	reviewed	Neprilysin-4 (EC 3.4.24.11)	Nep4 CG4058	Drosophila melanogaster (Fruit fly)	1040	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016529; GO:0046872	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN57_c1_g1_i3	Q8NF91	SYNE1_HUMAN	31	1079	688	10	85	3288	12	1045	2.00E-155	551.6	SYNE1_HUMAN	reviewed	Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)	SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1	Homo sapiens (Human)	8797	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007010; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090292; GO:0140444	cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN57_c1_g1_i4	Q8NF91	SYNE1_HUMAN	59.7	124	50	0	85	456	12	135	4.40E-38	159.1	SYNE1_HUMAN	reviewed	Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)	SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1	Homo sapiens (Human)	8797	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007010; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090292; GO:0140444	cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5812_c0_g1_i1	Q8NF91	SYNE1_HUMAN	23.9	410	271	12	70	1251	8413	8797	2.10E-07	58.5	SYNE1_HUMAN	reviewed	Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)	SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1	Homo sapiens (Human)	8797	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007010; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090292; GO:0140444	cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN40661_c0_g1_i1	Q8WXH0	SYNE2_HUMAN	100	81	0	0	245	3	82	162	2.30E-40	165.6	SYNE2_HUMAN	reviewed	Nesprin-2 (KASH domain-containing protein 2) (KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2)	SYNE2 KIAA1011 NUA	Homo sapiens (Human)	6885	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]	GO:0003779; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005925; GO:0007097; GO:0016021; GO:0016529; GO:0021817; GO:0030018; GO:0030335; GO:0031022; GO:0031258; GO:0031527; GO:0031965; GO:0031981; GO:0033017; GO:0034993; GO:0045111; GO:0051015; GO:0051642; GO:0070062; GO:0140444; GO:1902017	centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN39720_c0_g1_i1	Q8IZJ1	UNC5B_HUMAN	52.1	73	23	1	4	222	245	305	9.10E-12	70.5	UNC5B_HUMAN	reviewed	Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1)	UNC5B P53RDL1 UNC5H2 UNQ1883/PRO4326	Homo sapiens (Human)	945	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	netrin receptor activity [GO:0005042]	GO:0001525; GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0014068; GO:0016021; GO:0033564; GO:0043524; GO:0045121; GO:2001240	angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]		NA	NA	NA	NA	NA	NA
TRINITY_DN11020_c0_g2_i1	Q8IZJ1	UNC5B_HUMAN	49	51	26	0	183	335	853	903	3.40E-08	59.3	UNC5B_HUMAN	reviewed	Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1)	UNC5B P53RDL1 UNC5H2 UNQ1883/PRO4326	Homo sapiens (Human)	945	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	netrin receptor activity [GO:0005042]	GO:0001525; GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0014068; GO:0016021; GO:0033564; GO:0043524; GO:0045121; GO:2001240	angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]		NA	NA	NA	NA	NA	NA
TRINITY_DN5149_c0_g1_i1	Q9ULJ8	NEB1_HUMAN	59.6	193	69	1	30	608	432	615	8.20E-55	214.9	NEB1_HUMAN	reviewed	Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A)	PPP1R9A KIAA1222	Homo sapiens (Human)	1098	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]	GO:0005737; GO:0005829; GO:0007015; GO:0007568; GO:0008022; GO:0008157; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030175; GO:0030425; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042802; GO:0043025; GO:0044325; GO:0044326; GO:0045860; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761	actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]		NA	NA	NA	NA	NA	NA
TRINITY_DN32202_c0_g1_i1	Q9ULJ8	NEB1_HUMAN	81.9	72	13	0	2	217	520	591	1.40E-25	116.3	NEB1_HUMAN	reviewed	Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A)	PPP1R9A KIAA1222	Homo sapiens (Human)	1098	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]	GO:0005737; GO:0005829; GO:0007015; GO:0007568; GO:0008022; GO:0008157; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030175; GO:0030425; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042802; GO:0043025; GO:0044325; GO:0044326; GO:0045860; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761	actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]		NA	NA	NA	NA	NA	NA
TRINITY_DN5149_c0_g1_i3	Q96SB3	NEB2_HUMAN	65.4	52	18	0	68	223	549	600	3.40E-11	68.9	NEB2_HUMAN	reviewed	Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin)	PPP1R9B PPP1R6	Homo sapiens (Human)	817	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of dendritic spine plasma membrane [GO:1990780]; dendrite [GO:0030425]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; D2 dopamine receptor binding [GO:0031749]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to morphine [GO:0071315]; cellular response to peptide [GO:1901653]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; developmental process involved in reproduction [GO:0003006]; filopodium assembly [GO:0046847]; hippocampus development [GO:0021766]; learning [GO:0007612]; male mating behavior [GO:0060179]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; neuron projection development [GO:0031175]; positive regulation of protein localization to actin cortical patch [GO:1904372]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to actin cytoskeleton [GO:1903119]; protein localization to cell periphery [GO:1990778]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of protein phosphorylation [GO:0001932]; reproductive system development [GO:0061458]; response to amphetamine [GO:0001975]; response to clozapine [GO:0097338]; response to immobilization stress [GO:0035902]; response to kainic acid [GO:1904373]; response to L-phenylalanine derivative [GO:1904386]; response to nicotine [GO:0035094]; response to prostaglandin E [GO:0034695]; response to steroid hormone [GO:0048545]; RNA splicing [GO:0008380]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of dendritic spine plasma membrane [GO:1990780]; dendrite [GO:0030425]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; D2 dopamine receptor binding [GO:0031749]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]	GO:0000164; GO:0001560; GO:0001932; GO:0001975; GO:0003006; GO:0004672; GO:0004864; GO:0005654; GO:0005737; GO:0005886; GO:0005912; GO:0007015; GO:0007050; GO:0007096; GO:0007568; GO:0007612; GO:0008022; GO:0008157; GO:0008380; GO:0014069; GO:0015629; GO:0016358; GO:0016477; GO:0019722; GO:0019900; GO:0021766; GO:0021987; GO:0030027; GO:0030042; GO:0030175; GO:0030308; GO:0030425; GO:0030426; GO:0030864; GO:0031175; GO:0031749; GO:0032587; GO:0034695; GO:0035094; GO:0035690; GO:0035902; GO:0042127; GO:0043025; GO:0044325; GO:0044326; GO:0044327; GO:0046847; GO:0048545; GO:0050804; GO:0051015; GO:0060179; GO:0061458; GO:0071315; GO:0071364; GO:0071392; GO:0097338; GO:1901653; GO:1903078; GO:1903119; GO:1904372; GO:1904373; GO:1904386; GO:1990778; GO:1990780; GO:2000474	actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to morphine [GO:0071315]; cellular response to peptide [GO:1901653]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; developmental process involved in reproduction [GO:0003006]; filopodium assembly [GO:0046847]; hippocampus development [GO:0021766]; learning [GO:0007612]; male mating behavior [GO:0060179]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; neuron projection development [GO:0031175]; positive regulation of protein localization to actin cortical patch [GO:1904372]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to actin cytoskeleton [GO:1903119]; protein localization to cell periphery [GO:1990778]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of protein phosphorylation [GO:0001932]; reproductive system development [GO:0061458]; response to amphetamine [GO:0001975]; response to clozapine [GO:0097338]; response to immobilization stress [GO:0035902]; response to kainic acid [GO:1904373]; response to L-phenylalanine derivative [GO:1904386]; response to nicotine [GO:0035094]; response to prostaglandin E [GO:0034695]; response to steroid hormone [GO:0048545]; RNA splicing [GO:0008380]	x	brown	brown	NA	NA	NA	NA
TRINITY_DN30644_c0_g1_i1	P31836	NCAM1_BOVIN	38.6	101	44	3	735	433	228	310	3.50E-10	67	NCAM1_BOVIN	reviewed	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)	NCAM1 NCAM	Bos taurus (Bovine)	853	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0030424; GO:0070593; GO:0098632	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]		NA	NA	NA	NA	NA	NA
TRINITY_DN4099_c0_g1_i3	O35136	NCAM2_MOUSE	28.7	94	64	2	94	366	407	500	1.40E-05	51.6	NCAM2_MOUSE	reviewed	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)	Ncam2 Ocam Rncam	Mus musculus (Mouse)	837	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]	GO:0005886; GO:0007155; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0031225; GO:0042802; GO:0043005	axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN4099_c0_g1_i9	O35136	NCAM2_MOUSE	28.7	94	64	2	94	366	407	500	1.70E-05	51.6	NCAM2_MOUSE	reviewed	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)	Ncam2 Ocam Rncam	Mus musculus (Mouse)	837	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]	GO:0005886; GO:0007155; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0031225; GO:0042802; GO:0043005	axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN5608_c0_g1_i1	Q64322	NPDC1_MOUSE	47	132	64	4	26	415	194	321	1.90E-21	104	NPDC1_MOUSE	reviewed	Neural proliferation differentiation and control protein 1 (NPDC-1)	Npdc1 Npdc-1	Mus musculus (Mouse)	332	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN35148_c0_g1_i1	Q9NQX5	NPDC1_HUMAN	98.6	71	1	0	215	3	248	318	4.40E-35	147.9	NPDC1_HUMAN	reviewed	Neural proliferation differentiation and control protein 1 (NPDC-1)	NPDC1	Homo sapiens (Human)	325	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of immune response [GO:0050776]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0050776	regulation of immune response [GO:0050776]		NA	NA	NA	NA	NA	NA
TRINITY_DN28947_c0_g1_i1	O15943	CADN_DROME	46.6	58	31	0	177	4	2786	2843	2.20E-11	69.3	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i1	O15943	CADN_DROME	45.1	91	50	0	12	284	2758	2848	2.00E-22	106.7	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i12	O15943	CADN_DROME	41	78	46	0	23	256	2771	2848	1.40E-14	80.5	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i3	O15943	CADN_DROME	41	78	46	0	23	256	2771	2848	1.50E-14	80.1	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i6	O15943	CADN_DROME	48.4	64	33	0	68	259	2785	2848	1.10E-14	80.5	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN29210_c0_g1_i1	O15943	CADN_DROME	45.6	79	43	0	244	8	2787	2865	5.70E-16	84.7	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN30213_c0_g1_i1	O15943	CADN_DROME	61.9	97	37	0	1	291	2493	2589	4.40E-28	125.9	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN39713_c0_g1_i1	O15943	CADN_DROME	83.5	103	17	0	318	10	1625	1727	8.90E-45	180.6	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN39062_c0_g1_i1	O15943	CADN_DROME	82.7	81	14	0	246	4	1916	1996	2.60E-31	135.6	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8097_c0_g1_i2	O15943	CADN_DROME	44.8	67	36	1	254	57	1890	1956	6.80E-07	56.2	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN40250_c0_g1_i1	O15943	CADN_DROME	45.2	93	50	1	94	369	2362	2454	3.50E-16	85.9	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN20593_c0_g1_i1	O15943	CADN_DROME	76.8	95	22	0	1	285	2684	2778	2.10E-37	156	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN34274_c0_g1_i1	O15943	CADN_DROME	59.6	94	38	0	2	283	2189	2282	3.80E-31	135.2	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN1443_c1_g1_i3	O15943	CADN_DROME	52	50	23	1	219	70	2040	2088	1.30E-05	50.1	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN35695_c0_g1_i1	O15943	CADN_DROME	70.1	77	23	0	234	4	2111	2187	8.10E-27	120.6	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN35676_c0_g1_i1	O15943	CADN_DROME	47.5	80	39	2	262	32	1567	1646	1.20E-10	67	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN10263_c0_g5_i1	O15943	CADN_DROME	66.7	51	17	0	140	292	1645	1695	7.00E-12	71.2	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN10263_c0_g4_i1	O15943	CADN_DROME	68.8	80	25	0	40	279	1645	1724	3.90E-24	112.1	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN37983_c0_g1_i1	O15943	CADN_DROME	76.1	92	22	0	277	2	1798	1889	3.90E-36	151.8	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN6167_c0_g1_i1	O15943	CADN_DROME	38.3	180	106	2	33	566	2607	2783	1.40E-29	131	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN28466_c0_g1_i1	O15943	CADN_DROME	50	66	31	1	22	219	2786	2849	5.20E-13	74.7	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN18687_c0_g1_i1	O15943	CADN_DROME	44.4	54	30	0	166	5	2787	2840	8.00E-11	67.4	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN18687_c0_g1_i2	O15943	CADN_DROME	44.4	54	30	0	166	5	2787	2840	7.90E-11	67.4	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN18687_c0_g1_i3	O15943	CADN_DROME	44.4	54	30	0	166	5	2787	2840	6.60E-11	67.8	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN15296_c0_g1_i2	O15943	CADN_DROME	50	68	34	0	47	250	1890	1957	6.20E-12	71.2	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN15296_c0_g1_i3	O15943	CADN_DROME	50	68	34	0	47	250	1890	1957	4.90E-12	71.6	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8480_c0_g1_i1	O15943	CADN_DROME	45.6	68	36	1	302	99	2719	2785	5.10E-09	62.4	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8480_c0_g1_i2	O15943	CADN_DROME	44.1	68	37	1	213	10	2719	2785	9.10E-09	61.2	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8480_c0_g1_i4	O15943	CADN_DROME	45.6	68	36	1	302	99	2719	2785	5.10E-09	62.4	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8480_c0_g1_i5	O15943	CADN_DROME	45.6	68	36	1	302	99	2719	2785	3.90E-09	62.8	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8459_c0_g1_i1	O15943	CADN_DROME	39.3	150	87	2	32	469	1778	1927	1.90E-25	117.1	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN8459_c0_g1_i2	O15943	CADN_DROME	43.6	259	141	3	5	769	1670	1927	3.90E-57	223	CADN_DROME	reviewed	Neural-cadherin (Cadherin-N) (dN-cadherin)	CadN CG7100	Drosophila melanogaster (Fruit fly)	3097	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]		NA	NA	NA	NA	NA	NA
TRINITY_DN3086_c0_g1_i1	Q9D0S4	NEUL2_MOUSE	36.3	325	135	11	1039	89	25	285	4.30E-44	180.3	NEUL2_MOUSE	reviewed	Neuralized-like protein 2	Neurl2 Ozz	Mus musculus (Mouse)	285	muscle tendon junction [GO:0005927]; VCB complex [GO:0030891]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; myofibril assembly [GO:0030239]; sarcomere organization [GO:0045214]	muscle tendon junction [GO:0005927]; VCB complex [GO:0030891]	ubiquitin protein ligase activity [GO:0061630]	GO:0005927; GO:0030239; GO:0030891; GO:0035556; GO:0045214; GO:0061630	intracellular signal transduction [GO:0035556]; myofibril assembly [GO:0030239]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN26770_c0_g1_i1	Q5NCX5	NEUL4_MOUSE	28.8	313	178	8	933	49	88	373	6.50E-19	96.3	NEUL4_MOUSE	reviewed	Neuralized-like protein 4	Neurl4 Kiaa1787	Mus musculus (Mouse)	1563	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN33908_c0_g1_i1	Q5NCX5	NEUL4_MOUSE	57.8	166	69	1	646	149	47	211	2.40E-50	200.3	NEUL4_MOUSE	reviewed	Neuralized-like protein 4	Neurl4 Kiaa1787	Mus musculus (Mouse)	1563	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN39335_c0_g1_i1	Q5NCX5	NEUL4_MOUSE	50	68	34	0	219	16	1496	1563	3.10E-11	68.9	NEUL4_MOUSE	reviewed	Neuralized-like protein 4	Neurl4 Kiaa1787	Mus musculus (Mouse)	1563	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN39335_c0_g1_i2	Q96JN8	NEUL4_HUMAN	41.8	196	90	3	543	16	1371	1562	2.40E-34	146.7	NEUL4_HUMAN	reviewed	Neuralized-like protein 4	NEURL4 KIAA1787	Homo sapiens (Human)	1562	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN6863_c0_g2_i1	Q96JN8	NEUL4_HUMAN	50.6	81	40	0	758	1000	285	365	2.20E-15	84.7	NEUL4_HUMAN	reviewed	Neuralized-like protein 4	NEURL4 KIAA1787	Homo sapiens (Human)	1562	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN6863_c0_g2_i2	Q96JN8	NEUL4_HUMAN	61.8	131	50	0	883	1275	285	415	2.40E-40	167.9	NEUL4_HUMAN	reviewed	Neuralized-like protein 4	NEURL4 KIAA1787	Homo sapiens (Human)	1562	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN6863_c0_g1_i1	A1L0Y2	NEUL4_XENTR	69.6	168	51	0	78	581	451	618	2.00E-66	253.4	NEUL4_XENTR	reviewed	Neuralized-like protein 4	neurl4	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1477	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN6863_c0_g1_i3	A1L0Y2	NEUL4_XENTR	69.6	168	51	0	72	575	451	618	1.50E-66	253.8	NEUL4_XENTR	reviewed	Neuralized-like protein 4	neurl4	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1477	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN6863_c0_g1_i4	Q96JN8	NEUL4_HUMAN	59.8	87	35	0	60	320	314	400	1.20E-27	124	NEUL4_HUMAN	reviewed	Neuralized-like protein 4	NEURL4 KIAA1787	Homo sapiens (Human)	1562	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN33908_c0_g1_i2	Q5NCX5	NEUL4_MOUSE	59.5	116	46	1	496	149	97	211	4.00E-34	146	NEUL4_MOUSE	reviewed	Neuralized-like protein 4	Neurl4 Kiaa1787	Mus musculus (Mouse)	1563	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630			NA	NA	1	NA	NA	NA
TRINITY_DN12471_c0_g1_i2	Q94887	NRX4_DROME	62.2	423	159	1	1271	3	773	1194	2.20E-166	586.6	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]		GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016021; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12471_c0_g1_i3	Q94887	NRX4_DROME	64.8	162	57	0	538	53	1010	1171	1.30E-59	230.7	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]		GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016021; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14442_c0_g1_i1	Q94887	NRX4_DROME	48.4	395	192	5	1188	16	203	589	1.50E-105	384.4	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]		GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016021; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18968_c0_g1_i1	Q9W4E2	NBEA_DROME	87.1	70	9	0	1	210	2984	3053	3.40E-32	138.3	NBEA_DROME	reviewed	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	rg Akap550 CG44835	Drosophila melanogaster (Fruit fly)	3466	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016021; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN8352_c0_g1_i2	Q9W4E2	NBEA_DROME	71.8	163	41	1	86	559	2474	2636	1.40E-61	237.3	NBEA_DROME	reviewed	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	rg Akap550 CG44835	Drosophila melanogaster (Fruit fly)	3466	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016021; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN8352_c0_g1_i3	Q9W4E2	NBEA_DROME	63.8	127	41	1	69	434	2510	2636	2.90E-41	169.5	NBEA_DROME	reviewed	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	rg Akap550 CG44835	Drosophila melanogaster (Fruit fly)	3466	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016021; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN8352_c0_g1_i4	Q9W4E2	NBEA_DROME	93	43	3	0	33	161	2432	2474	9.40E-16	83.6	NBEA_DROME	reviewed	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	rg Akap550 CG44835	Drosophila melanogaster (Fruit fly)	3466	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016021; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]		brown	brown	NA	NA	NA	NA
TRINITY_DN8352_c0_g1_i5	Q9W4E2	NBEA_DROME	76.6	273	56	3	123	917	2364	2636	7.20E-111	401.7	NBEA_DROME	reviewed	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	rg Akap550 CG44835	Drosophila melanogaster (Fruit fly)	3466	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016021; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN8352_c0_g1_i7	Q9W4E2	NBEA_DROME	83.8	111	15	2	123	446	2364	2474	4.90E-42	172.2	NBEA_DROME	reviewed	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	rg Akap550 CG44835	Drosophila melanogaster (Fruit fly)	3466	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005829; GO:0007528; GO:0007614; GO:0008104; GO:0008355; GO:0016020; GO:0016021; GO:0016319; GO:0019901; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; protein localization [GO:0008104]; short-term memory [GO:0007614]		NA	NA	NA	NA	NA	NA
TRINITY_DN18657_c0_g1_i1	Q6ZNJ1	NBEL2_HUMAN	100	66	0	0	200	3	2256	2321	7.70E-34	143.7	NBEL2_HUMAN	reviewed	Neurobeachin-like protein 2	NBEAL2 KIAA0540 UNQ253/PRO290	Homo sapiens (Human)	2754	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; protein kinase binding [GO:0019901]; neutrophil degranulation [GO:0043312]; platelet formation [GO:0030220]; protein localization [GO:0008104]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	protein kinase binding [GO:0019901]	GO:0005783; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019901; GO:0030220; GO:0043312; GO:0070821; GO:0101003	neutrophil degranulation [GO:0043312]; platelet formation [GO:0030220]; protein localization [GO:0008104]		NA	NA	NA	NA	NA	NA
TRINITY_DN2222_c1_g2_i1	P42325	NCAH_DROME	88.9	72	8	0	97	312	63	134	5.90E-31	135.2	NCAH_DROME	reviewed	Neurocalcin homolog (DrosNCa)	Nca CG7641	Drosophila melanogaster (Fruit fly)	190	"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]"		calcium ion binding [GO:0005509]	GO:0005509; GO:0045938; GO:1902848	"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2222_c1_g2_i3	P42325	NCAH_DROME	96.8	189	6	0	87	653	1	189	1.30E-104	380.6	NCAH_DROME	reviewed	Neurocalcin homolog (DrosNCa)	Nca CG7641	Drosophila melanogaster (Fruit fly)	190	"calcium ion binding [GO:0005509]; negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]"		calcium ion binding [GO:0005509]	GO:0005509; GO:0045938; GO:1902848	"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32587_c0_g1_i1	P61602	NCALD_BOVIN	97.2	109	3	0	328	2	31	139	6.10E-57	221.1	NCALD_BOVIN	reviewed	Neurocalcin-delta	NCALD	Bos taurus (Bovine)	193	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; tubulin binding [GO:0015631]; calcium-mediated signaling [GO:0019722]; regulation of systemic arterial blood pressure [GO:0003073]		actin binding [GO:0003779]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; tubulin binding [GO:0015631]	GO:0003073; GO:0003779; GO:0005509; GO:0015631; GO:0019722; GO:0030276	calcium-mediated signaling [GO:0019722]; regulation of systemic arterial blood pressure [GO:0003073]		NA	NA	NA	NA	NA	NA
TRINITY_DN26625_c0_g1_i1	P29120	NEC1_HUMAN	66.2	74	25	0	8	229	294	367	4.50E-23	108.2	NEC1_HUMAN	reviewed	Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1)	PCSK1 NEC1	Homo sapiens (Human)	753	extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; cell-cell signaling [GO:0007267]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508]	extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]	identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508; GO:0007267; GO:0016020; GO:0016485; GO:0016486; GO:0030133; GO:0034774; GO:0042802; GO:0043005; GO:0043043	cell-cell signaling [GO:0007267]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN15291_c0_g1_i1	G5ECN9	NEC2_CAEEL	72.6	361	78	2	1061	42	214	574	1.30E-151	537.3	NEC2_CAEEL	reviewed	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Egg-laying defective protein 3) (Kex2-like prohormone convertase 2) (CELPC2) (Prohormone convertase 2) (PC2) (Proprotein convertase 2)	egl-3 kpc-2 C51E3.7	Caenorhabditis elegans	652	"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]; arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]"	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]	FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006937; GO:0007274; GO:0008340; GO:0008582; GO:0009612; GO:0014057; GO:0016020; GO:0016485; GO:0016486; GO:0030070; GO:0030424; GO:0030536; GO:0031410; GO:0043005; GO:0043058; GO:0045202; GO:0045887; GO:0060456; GO:0061096; GO:0061837; GO:0090325; GO:0090326; GO:0090472; GO:0090474; GO:0098770; GO:1900073; GO:1901046; GO:1903998; GO:1904014; GO:1904810; GO:1905850; GO:1905852; GO:1905910; GO:1905954	"arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15291_c0_g1_i3	G5ECN9	NEC2_CAEEL	74.3	374	76	1	1063	2	214	587	7.60E-165	581.3	NEC2_CAEEL	reviewed	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Egg-laying defective protein 3) (Kex2-like prohormone convertase 2) (CELPC2) (Prohormone convertase 2) (PC2) (Proprotein convertase 2)	egl-3 kpc-2 C51E3.7	Caenorhabditis elegans	652	"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]; arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]"	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]	FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006937; GO:0007274; GO:0008340; GO:0008582; GO:0009612; GO:0014057; GO:0016020; GO:0016485; GO:0016486; GO:0030070; GO:0030424; GO:0030536; GO:0031410; GO:0043005; GO:0043058; GO:0045202; GO:0045887; GO:0060456; GO:0061096; GO:0061837; GO:0090325; GO:0090326; GO:0090472; GO:0090474; GO:0098770; GO:1900073; GO:1901046; GO:1903998; GO:1904014; GO:1904810; GO:1905850; GO:1905852; GO:1905910; GO:1905954	"arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15291_c0_g1_i4	G5ECN9	NEC2_CAEEL	58.2	184	57	1	493	2	404	587	7.20E-60	231.5	NEC2_CAEEL	reviewed	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Egg-laying defective protein 3) (Kex2-like prohormone convertase 2) (CELPC2) (Prohormone convertase 2) (PC2) (Proprotein convertase 2)	egl-3 kpc-2 C51E3.7	Caenorhabditis elegans	652	"axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]; arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]"	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]	FBXO family protein binding [GO:0098770]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006937; GO:0007274; GO:0008340; GO:0008582; GO:0009612; GO:0014057; GO:0016020; GO:0016485; GO:0016486; GO:0030070; GO:0030424; GO:0030536; GO:0031410; GO:0043005; GO:0043058; GO:0045202; GO:0045887; GO:0060456; GO:0061096; GO:0061837; GO:0090325; GO:0090326; GO:0090472; GO:0090474; GO:0098770; GO:1900073; GO:1901046; GO:1903998; GO:1904014; GO:1904810; GO:1905850; GO:1905852; GO:1905910; GO:1905954	"arg-arg specific dibasic protein processing [GO:0090474]; determination of adult lifespan [GO:0008340]; dibasic protein processing [GO:0090472]; insulin processing [GO:0030070]; larval feeding behavior [GO:0030536]; negative regulation of dauer entry [GO:1905910]; negative regulation of dense core granule transport [GO:1904810]; negative regulation of turning behavior involved in mating [GO:0061096]; neuromuscular synaptic transmission [GO:0007274]; neuropeptide processing [GO:0061837]; peptide hormone processing [GO:0016486]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of backward locomotion [GO:1905852]; positive regulation of digestive system process [GO:0060456]; positive regulation of forward locomotion [GO:1905850]; positive regulation of lipid localization [GO:1905954]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of oviposition [GO:1901046]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein processing [GO:0016485]; regulation of backward locomotion [GO:0043058]; regulation of eating behavior [GO:1903998]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of muscle contraction [GO:0006937]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to mechanical stimulus [GO:0009612]; response to serotonin [GO:1904014]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25930_c0_g1_i1	Q04690	NF1_MOUSE	59.8	127	44	1	363	4	2186	2312	6.10E-35	148.3	NF1_MOUSE	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1)	Nf1	Mus musculus (Mouse)	2841	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010976; GO:0014044; GO:0014065; GO:0014069; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043005; GO:0043065; GO:0043087; GO:0043407; GO:0043408; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN902_c1_g2_i1	Q04690	NF1_MOUSE	56.3	263	94	4	784	5	834	1078	1.70E-68	260.8	NF1_MOUSE	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1)	Nf1	Mus musculus (Mouse)	2841	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010976; GO:0014044; GO:0014065; GO:0014069; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043005; GO:0043065; GO:0043087; GO:0043407; GO:0043408; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22138_c0_g1_i1	Q04690	NF1_MOUSE	49.5	289	89	5	3	704	492	778	5.50E-63	242.3	NF1_MOUSE	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1)	Nf1	Mus musculus (Mouse)	2841	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010976; GO:0014044; GO:0014065; GO:0014069; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043005; GO:0043065; GO:0043087; GO:0043407; GO:0043408; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12090_c0_g1_i2	P21359	NF1_HUMAN	53.9	462	203	6	91	1470	1	454	1.10E-134	481.5	NF1_HUMAN	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	Homo sapiens (Human)	2839	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36690_c0_g1_i1	P21359	NF1_HUMAN	75	196	49	0	589	2	1958	2153	3.00E-81	302.8	NF1_HUMAN	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	Homo sapiens (Human)	2839	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7514_c0_g1_i1	P21359	NF1_HUMAN	57.7	78	33	0	11	244	2357	2434	5.90E-19	94.7	NF1_HUMAN	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	Homo sapiens (Human)	2839	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7514_c0_g1_i2	P21359	NF1_HUMAN	63.4	101	37	0	11	313	2357	2457	4.10E-29	129	NF1_HUMAN	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	Homo sapiens (Human)	2839	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22138_c0_g1_i2	P21359	NF1_HUMAN	48.1	262	81	5	3	629	492	751	3.40E-54	213	NF1_HUMAN	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	Homo sapiens (Human)	2839	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22138_c0_g1_i4	P21359	NF1_HUMAN	42.8	180	50	4	67	453	574	751	6.40E-26	118.6	NF1_HUMAN	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	NF1	Homo sapiens (Human)	2839	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29376_c0_g1_i1	P46531	NOTC1_HUMAN	45.6	57	30	1	42	212	444	499	2.10E-09	62.8	NOTC1_HUMAN	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	NOTCH1 TAN1	Homo sapiens (Human)	2555	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	GO:0000122; GO:0000139; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006367; GO:0006955; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010614; GO:0010628; GO:0010629; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0032633; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i1	Q07008	NOTC1_RAT	51.8	85	32	2	96	350	937	1012	1.10E-19	97.8	NOTC1_RAT	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	Notch1	Rattus norvegicus (Rat)	2531	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	GO:0000122; GO:0001501; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007417; GO:0007420; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031012; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0032633; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	x	NA	NA	NA	NA	NA	1
TRINITY_DN30769_c0_g1_i1	G3I6Z6	NOTC1_CRIGR	35.9	145	90	2	446	21	931	1075	4.00E-22	105.9	NOTC1_CRIGR	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	NOTCH1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	2527	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]	GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0016021; GO:0016324; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29451_c0_g1_i1	G3I6Z6	NOTC1_CRIGR	42.1	76	43	1	5	232	512	586	6.60E-13	74.3	NOTC1_CRIGR	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	NOTCH1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	2527	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]	GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0016021; GO:0016324; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i13	Q07008	NOTC1_RAT	46.7	152	69	3	163	618	873	1012	1.60E-36	154.5	NOTC1_RAT	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	Notch1	Rattus norvegicus (Rat)	2531	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	GO:0000122; GO:0001501; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007417; GO:0007420; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031012; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0032633; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i5	Q07008	NOTC1_RAT	51.9	81	30	2	67	309	941	1012	1.10E-18	94.4	NOTC1_RAT	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	Notch1	Rattus norvegicus (Rat)	2531	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	GO:0000122; GO:0001501; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007417; GO:0007420; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031012; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0032633; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i6	Q07008	NOTC1_RAT	51.9	81	30	2	119	361	941	1012	2.10E-18	93.6	NOTC1_RAT	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	Notch1	Rattus norvegicus (Rat)	2531	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	GO:0000122; GO:0001501; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007417; GO:0007420; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031012; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0032633; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042802; GO:0043065; GO:0043086; GO:0043235; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26071_c0_g1_i1	Q04721	NOTC2_HUMAN	99.5	193	1	0	707	129	128	320	8.70E-125	447.6	NOTC2_HUMAN	reviewed	Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]	NOTCH2	Homo sapiens (Human)	2471	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006367; GO:0006915; GO:0006959; GO:0007050; GO:0007219; GO:0007275; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019827; GO:0019899; GO:0030097; GO:0030326; GO:0030513; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN27928_c0_g1_i1	Q04721	NOTC2_HUMAN	100	88	0	0	3	266	909	996	7.00E-51	200.7	NOTC2_HUMAN	reviewed	Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]	NOTCH2	Homo sapiens (Human)	2471	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006367; GO:0006915; GO:0006959; GO:0007050; GO:0007219; GO:0007275; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019827; GO:0019899; GO:0030097; GO:0030326; GO:0030513; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN38071_c0_g1_i1	Q04721	NOTC2_HUMAN	100	96	0	0	3	290	449	544	2.90E-58	225.3	NOTC2_HUMAN	reviewed	Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]	NOTCH2	Homo sapiens (Human)	2471	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006367; GO:0006915; GO:0006959; GO:0007050; GO:0007219; GO:0007275; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019827; GO:0019899; GO:0030097; GO:0030326; GO:0030513; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN15452_c0_g3_i1	O35516	NOTC2_MOUSE	34.7	101	62	2	66	368	908	1004	7.00E-14	79	NOTC2_MOUSE	reviewed	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	Notch2	Mus musculus (Mouse)	2473	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0001501; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0007417; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0031012; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:1990705; GO:2000249; GO:2001204	animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN15452_c0_g3_i2	O35516	NOTC2_MOUSE	38.1	63	38	1	227	415	943	1004	2.00E-06	54.3	NOTC2_MOUSE	reviewed	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	Notch2	Mus musculus (Mouse)	2473	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0001501; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0007417; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0031012; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:1990705; GO:2000249; GO:2001204	animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN35083_c0_g1_i1	Q9QW30	NOTC2_RAT	56.9	51	22	0	208	56	1134	1184	1.00E-12	73.6	NOTC2_RAT	reviewed	Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	Notch2	Rattus norvegicus (Rat)	2471	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0001501; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0007417; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0031012; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:1990705; GO:2000249; GO:2001204	animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN11260_c0_g1_i4	Q9UM47	NOTC3_HUMAN	32.8	259	135	12	70	762	717	964	5.90E-27	122.9	NOTC3_HUMAN	reviewed	Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain]	NOTCH3	Homo sapiens (Human)	2321	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription of Notch receptor target [GO:0007221]; transcription initiation from RNA polymerase II promoter [GO:0006367]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0000139; GO:0005509; GO:0005576; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006367; GO:0007219; GO:0007221; GO:0007411; GO:0009986; GO:0015629; GO:0016021; GO:0019899; GO:0030900; GO:0038023; GO:0042802; GO:0043235; GO:0045296; GO:0045665; GO:0045746; GO:0048661; GO:0048663; GO:0048844; GO:0072104	artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription of Notch receptor target [GO:0007221]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN39282_c0_g1_i1	Q61982	NOTC3_MOUSE	44.2	52	25	2	161	6	194	241	4.10E-05	48.5	NOTC3_MOUSE	reviewed	Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain]	Notch3	Mus musculus (Mouse)	2318	"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0005509; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0015629; GO:0019899; GO:0030900; GO:0038023; GO:0042802; GO:0043235; GO:0045596; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104	"artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1058_c0_g1_i1	P07207	NOTCH_DROME	52.3	2128	911	30	6805	611	61	2146	0	2287.3	NOTCH_DROME	reviewed	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	N CG3936	Drosophila melanogaster (Fruit fly)	2703	"cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699]; actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]"	cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699]	GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral axis specification [GO:0009950]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11525_c0_g1_i1	P20241	NRG_DROME	51.3	631	296	6	17	1900	613	1235	7.40E-191	668.7	NRG_DROME	reviewed	Neuroglian	Nrg CG1634	Drosophila melanogaster (Fruit fly)	1302	"axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"	axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0030424; GO:0030425; GO:0035011; GO:0035151; GO:0043025; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11525_c0_g1_i2	P20241	NRG_DROME	49.7	179	84	3	68	598	1061	1235	3.70E-40	166.8	NRG_DROME	reviewed	Neuroglian	Nrg CG1634	Drosophila melanogaster (Fruit fly)	1302	"axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"	axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0030424; GO:0030425; GO:0035011; GO:0035151; GO:0043025; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11525_c0_g1_i3	P20241	NRG_DROME	51.1	624	294	6	1	1863	620	1235	9.90E-188	658.3	NRG_DROME	reviewed	Neuroglian	Nrg CG1634	Drosophila melanogaster (Fruit fly)	1302	"axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"	axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0030424; GO:0030425; GO:0035011; GO:0035151; GO:0043025; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25516_c0_g1_i1	P20241	NRG_DROME	51.8	166	80	0	503	6	273	438	8.90E-45	181.4	NRG_DROME	reviewed	Neuroglian	Nrg CG1634	Drosophila melanogaster (Fruit fly)	1302	"axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"	axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0030424; GO:0030425; GO:0035011; GO:0035151; GO:0043025; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25516_c0_g1_i2	P20241	NRG_DROME	55	433	192	3	1298	6	7	438	1.10E-136	488	NRG_DROME	reviewed	Neuroglian	Nrg CG1634	Drosophila melanogaster (Fruit fly)	1302	"axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"	axon [GO:0030424]; bicellular tight junction [GO:0005923]; dendrite [GO:0030425]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0030424; GO:0030425; GO:0035011; GO:0035151; GO:0043025; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8338_c0_g1_i1	Q8NEJ9	NGDN_HUMAN	36.2	298	175	5	964	101	7	299	7.40E-27	122.9	NGDN_HUMAN	reviewed	Neuroguidin (Centromere accumulated nuclear protein 1) (CANu1) (EIF4E-binding protein)	NGDN C14orf120	Homo sapiens (Human)	315	"axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]"	"axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]"	RNA binding [GO:0003723]	GO:0000462; GO:0000775; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006417; GO:0030175; GO:0030424; GO:0030425; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25462_c0_g1_i1	Q8NEJ9	NGDN_HUMAN	100	75	0	0	225	1	64	138	9.20E-36	150.2	NGDN_HUMAN	reviewed	Neuroguidin (Centromere accumulated nuclear protein 1) (CANu1) (EIF4E-binding protein)	NGDN C14orf120	Homo sapiens (Human)	315	"axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]"	"axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]"	RNA binding [GO:0003723]	GO:0000462; GO:0000775; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006417; GO:0030175; GO:0030424; GO:0030425; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9341_c0_g1_i1	B0F2B4	NLGN4_MOUSE	40.6	165	84	3	556	95	239	400	1.10E-24	114.8	NLGN4_MOUSE	reviewed	Neuroligin 4-like (Neuroligin-4) (NL-4)	Nlgn4l Nl4* Nlgn4 Nlgn4x	Mus musculus (Mouse)	945	cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; male courtship behavior [GO:0008049]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; territorial aggressive behavior [GO:0002124]; vocalization behavior [GO:0071625]	cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]	neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]	GO:0002124; GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0008049; GO:0009986; GO:0021549; GO:0030425; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0098793	brainstem development [GO:0003360]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; male courtship behavior [GO:0008049]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; territorial aggressive behavior [GO:0002124]; vocalization behavior [GO:0071625]		NA	NA	NA	NA	NA	NA
TRINITY_DN34705_c0_g1_i1	Q9XTG1	NLGN1_CAEEL	58.3	48	20	0	149	6	140	187	1.50E-11	69.7	NLGN1_CAEEL	reviewed	Neuroligin-1	nlg-1 C40C9.5	Caenorhabditis elegans	798	axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neurotransmitter secretion [GO:0046929]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]	axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]	neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0009986; GO:0030424; GO:0030425; GO:0038023; GO:0042043; GO:0045202; GO:0046929; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neurotransmitter secretion [GO:0046929]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN40095_c0_g1_i1	Q8N2Q7	NLGN1_HUMAN	67.4	43	14	0	57	185	214	256	1.10E-10	67	NLGN1_HUMAN	reviewed	Neuroligin-1	NLGN1 KIAA1070	Homo sapiens (Human)	863	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]"	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]"	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	GO:0001540; GO:0002087; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007268; GO:0007399; GO:0007416; GO:0009897; GO:0009986; GO:0010841; GO:0014069; GO:0016080; GO:0016339; GO:0017146; GO:0023041; GO:0030165; GO:0030425; GO:0031175; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0042802; GO:0043083; GO:0043197; GO:0043198; GO:0043235; GO:0044877; GO:0045184; GO:0045202; GO:0045664; GO:0048488; GO:0048489; GO:0048511; GO:0048789; GO:0050804; GO:0050839; GO:0051491; GO:0051965; GO:0051968; GO:0060076; GO:0060291; GO:0060999; GO:0061002; GO:0071277; GO:0072553; GO:0089717; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098793; GO:0098794; GO:0098942; GO:0098985; GO:0099054; GO:0099055; GO:0099560; GO:0140058; GO:1900029; GO:1900244; GO:1902474; GO:1902533; GO:1904861; GO:1905520; GO:2000302; GO:2000310; GO:2000311; GO:2000463; GO:2000809	"AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuronal signal transduction [GO:0023041]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33112_c0_g1_i1	Q8N0W4	NLGNX_HUMAN	47.4	114	60	0	436	95	209	322	1.10E-22	107.8	NLGNX_HUMAN	reviewed	"Neuroligin-4, X-linked (Neuroligin X) (HNLX)"	NLGN4X KIAA1260 NLGN4 UNQ365/PRO701	Homo sapiens (Human)	816	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]"	cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016021; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]		NA	NA	NA	NA	NA	NA
TRINITY_DN38627_c0_g1_i1	Q8NFZ3	NLGNY_HUMAN	48.6	70	35	1	244	38	47	116	2.40E-11	69.3	NLGNY_HUMAN	reviewed	"Neuroligin-4, Y-linked (Neuroligin Y)"	NLGN4Y KIAA0951	Homo sapiens (Human)	816	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]"	cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]		NA	NA	NA	NA	NA	NA
TRINITY_DN1317_c3_g1_i1	Q20826	GLIT1_CAEEL	46.9	49	26	0	211	65	184	232	1.00E-07	57.4	GLIT1_CAEEL	reviewed	Neuroligin-like protein glit-1 (Gliotactin homolog) (Inactive esterase glit-1)	glit-1 F55D10.3	Caenorhabditis elegans	730	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; cellular response to paraquat [GO:0072756]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of response to oxidative stress [GO:1902883]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]	neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]	GO:0005887; GO:0007158; GO:0007268; GO:0009986; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0072756; GO:0097104; GO:0097105; GO:0098793; GO:1902883; GO:1903204	cellular response to paraquat [GO:0072756]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of response to oxidative stress [GO:1902883]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN20482_c0_g2_i1	P42675	NEUL_RABIT	54.4	103	45	2	366	61	600	701	8.00E-29	127.9	NEUL_RABIT	reviewed	"Neurolysin, mitochondrial (EC 3.4.24.16) (Microsomal endopeptidase) (MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)"	NLN	Oryctolagus cuniculus (Rabbit)	704	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN30449_c0_g1_i1	Q8IVL1	NAV2_HUMAN	45.9	109	47	5	317	6	872	973	1.90E-10	68.2	NAV2_HUMAN	reviewed	Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2)	NAV2 HELAD1 KIAA1419 POMFIL2 RAINB1 STEERIN2	Homo sapiens (Human)	2488	interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]	interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; heparin binding [GO:0008201]	GO:0003025; GO:0003678; GO:0005524; GO:0005614; GO:0005654; GO:0007399; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0021554; GO:0021563; GO:0021564; GO:0022008	glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i7	Q8IVL1	NAV2_HUMAN	47.6	905	366	24	2723	81	1668	2488	1.70E-193	677.9	NAV2_HUMAN	reviewed	Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2)	NAV2 HELAD1 KIAA1419 POMFIL2 RAINB1 STEERIN2	Homo sapiens (Human)	2488	interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]	interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; heparin binding [GO:0008201]	GO:0003025; GO:0003678; GO:0005524; GO:0005614; GO:0005654; GO:0007399; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0021554; GO:0021563; GO:0021564; GO:0022008	glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]		NA	NA	NA	NA	NA	NA
TRINITY_DN8845_c0_g1_i1	P36609	NCS2_CAEEL	65.8	117	40	0	353	3	35	151	3.50E-42	172.2	NCS2_CAEEL	reviewed	Neuronal calcium sensor 2 (NCS-2)	ncs-2 F10G8.5	Caenorhabditis elegans	190	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			blue	blue	NA	NA	NA	NA
TRINITY_DN2976_c0_g1_i1	Q08DM7	SEPT3_BOVIN	50	328	151	5	15	971	6	329	3.60E-90	333.2	SEPT3_BOVIN	reviewed	Neuronal-specific septin-3	SEPTIN3 SEPT3	Bos taurus (Bovine)	357	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0043005; GO:0060090; GO:0061640; GO:0098793; GO:0099569	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]		NA	NA	NA	NA	NA	NA
TRINITY_DN2976_c0_g1_i2	Q08DM7	SEPT3_BOVIN	50.3	304	138	5	15	899	6	305	3.10E-83	310.1	SEPT3_BOVIN	reviewed	Neuronal-specific septin-3	SEPTIN3 SEPT3	Bos taurus (Bovine)	357	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0043005; GO:0060090; GO:0061640; GO:0098793; GO:0099569	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]		NA	NA	NA	NA	NA	NA
TRINITY_DN39686_c0_g1_i1	P10776	NPAB_LOCMI	63	27	10	0	210	290	55	81	7.40E-06	52.4	NPAB_LOCMI	reviewed	Neuroparsin-A (NPA) [Cleaved into: Neuroparsin-B (NPB)]		Locusta migratoria (Migratory locust)	107	hormone activity [GO:0005179]; neuropeptide signaling pathway [GO:0007218]		hormone activity [GO:0005179]	GO:0005179; GO:0007218	neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN25547_c0_g1_i1	Q9U969	SWS_DROME	56.4	241	93	7	874	155	1071	1300	5.10E-66	252.7	SWS_DROME	reviewed	Neuropathy target esterase sws (Swiss cheese) (DSWS) (EC 3.1.1.5)	sws CG2212	Drosophila melanogaster (Fruit fly)	1425	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; protein kinase A catalytic subunit binding [GO:0034236]; ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; protein kinase A catalytic subunit binding [GO:0034236]	GO:0004622; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006643; GO:0006644; GO:0007272; GO:0007608; GO:0016021; GO:0016042; GO:0034236; GO:0034349; GO:0045494; GO:0046470; GO:0051402; GO:0061024; GO:0072657; GO:0102545; GO:2000480	ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN26841_c0_g1_i1	B4M709	SWS_DROVI	62.5	128	48	0	417	34	629	756	4.30E-39	162.2	SWS_DROVI	reviewed	Neuropathy target esterase sws (Swiss cheese) (EC 3.1.1.5)	sws GJ16892	Drosophila virilis (Fruit fly)	1483	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]	GO:0004622; GO:0005789; GO:0006643; GO:0007399; GO:0016021; GO:0016042; GO:0034349; GO:0046470; GO:0051402; GO:0061024; GO:0102545	glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]		NA	NA	NA	NA	NA	NA
TRINITY_DN33153_c0_g1_i1	B4M709	SWS_DROVI	36.6	484	237	8	5	1252	140	621	2.10E-81	304.3	SWS_DROVI	reviewed	Neuropathy target esterase sws (Swiss cheese) (EC 3.1.1.5)	sws GJ16892	Drosophila virilis (Fruit fly)	1483	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]	GO:0004622; GO:0005789; GO:0006643; GO:0007399; GO:0016021; GO:0016042; GO:0034349; GO:0046470; GO:0051402; GO:0061024; GO:0102545	glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]		NA	NA	NA	NA	NA	NA
TRINITY_DN33153_c0_g1_i2	B4H3U8	SWS_DROPE	48.8	209	105	2	5	628	142	349	6.70E-51	203	SWS_DROPE	reviewed	Neuropathy target esterase sws (Swiss cheese) (EC 3.1.1.5)	sws GL15243	Drosophila persimilis (Fruit fly)	1435	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; protein kinase A catalytic subunit binding [GO:0034236]; ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; protein kinase A catalytic subunit binding [GO:0034236]	GO:0004622; GO:0005789; GO:0005886; GO:0006643; GO:0007272; GO:0007608; GO:0016021; GO:0016042; GO:0034236; GO:0034349; GO:0045494; GO:0046470; GO:0051402; GO:0061024; GO:0072657; GO:0102545; GO:2000480	ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN33153_c0_g1_i2	B4H3U8	SWS_DROPE	37.1	186	109	2	733	1266	452	637	6.50E-30	133.3	SWS_DROPE	reviewed	Neuropathy target esterase sws (Swiss cheese) (EC 3.1.1.5)	sws GL15243	Drosophila persimilis (Fruit fly)	1435	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; protein kinase A catalytic subunit binding [GO:0034236]; ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; protein kinase A catalytic subunit binding [GO:0034236]	GO:0004622; GO:0005789; GO:0005886; GO:0006643; GO:0007272; GO:0007608; GO:0016021; GO:0016042; GO:0034236; GO:0034349; GO:0045494; GO:0046470; GO:0051402; GO:0061024; GO:0072657; GO:0102545; GO:2000480	ensheathment of neurons [GO:0007272]; glial cell apoptotic process [GO:0034349]; lipid catabolic process [GO:0016042]; membrane lipid metabolic process [GO:0006643]; membrane organization [GO:0061024]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; neuron apoptotic process [GO:0051402]; phosphatidylcholine metabolic process [GO:0046470]; photoreceptor cell maintenance [GO:0045494]; protein localization to membrane [GO:0072657]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN7576_c0_g1_i2	A1ZAX0	CCH1R_DROME	44.4	54	30	0	171	332	55	108	5.70E-05	48.5	CCH1R_DROME	reviewed	Neuropeptide CCHamide-1 receptor	CCHa1-R CG30106	Drosophila melanogaster (Fruit fly)	499	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; allatostatin receptor activity [GO:0008261]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	allatostatin receptor activity [GO:0008261]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016021	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN7576_c0_g1_i4	A1ZAX0	CCH1R_DROME	60.7	135	53	0	171	575	55	189	2.30E-41	170.2	CCH1R_DROME	reviewed	Neuropeptide CCHamide-1 receptor	CCHa1-R CG30106	Drosophila melanogaster (Fruit fly)	499	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; allatostatin receptor activity [GO:0008261]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	allatostatin receptor activity [GO:0008261]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016021	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN7576_c0_g1_i5	A1ZAX0	CCH1R_DROME	52.8	341	148	7	171	1163	55	392	6.60E-92	339.3	CCH1R_DROME	reviewed	Neuropeptide CCHamide-1 receptor	CCHa1-R CG30106	Drosophila melanogaster (Fruit fly)	499	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; allatostatin receptor activity [GO:0008261]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	allatostatin receptor activity [GO:0008261]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016021	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN27499_c0_g1_i1	Q4V622	CCH2R_DROME	59.7	72	29	0	219	4	101	172	5.50E-18	91.3	CCH2R_DROME	reviewed	Neuropeptide CCHamide-2 receptor	CCHa2-R CG14593	Drosophila melanogaster (Fruit fly)	489	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]		NA	NA	NA	NA	NA	NA
TRINITY_DN7775_c0_g1_i1	P23654	NRT_DROME	29.4	548	313	15	1665	109	337	839	8.50E-52	206.8	NRT_DROME	reviewed	Neurotactin	Nrt CG9704	Drosophila melanogaster (Fruit fly)	846	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007409; GO:0007411; GO:0007413; GO:0007417; GO:0016021; GO:0016323; GO:0030424	axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN7775_c0_g1_i2	P23654	NRT_DROME	29.4	548	313	15	1665	109	337	839	8.50E-52	206.8	NRT_DROME	reviewed	Neurotactin	Nrt CG9704	Drosophila melanogaster (Fruit fly)	846	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007409; GO:0007411; GO:0007413; GO:0007417; GO:0016021; GO:0016323; GO:0030424	axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN6657_c0_g1_i10	B7TB45	SPZ2_DROME	45.7	92	46	2	983	708	513	600	2.60E-16	88.2	SPZ2_DROME	reviewed	Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2)	NT1 DNT1 spz2 CG42576	Drosophila melanogaster (Fruit fly)	886	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN6657_c0_g1_i2	B7TB45	SPZ2_DROME	45.7	92	46	2	1041	766	513	600	2.80E-16	88.2	SPZ2_DROME	reviewed	Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2)	NT1 DNT1 spz2 CG42576	Drosophila melanogaster (Fruit fly)	886	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN6657_c0_g1_i5	B7TB45	SPZ2_DROME	45.7	92	46	2	975	700	513	600	2.60E-16	88.2	SPZ2_DROME	reviewed	Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2)	NT1 DNT1 spz2 CG42576	Drosophila melanogaster (Fruit fly)	886	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN6657_c0_g1_i8	B7TB45	SPZ2_DROME	33.7	175	97	5	180	701	444	600	3.30E-19	97.8	SPZ2_DROME	reviewed	Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2)	NT1 DNT1 spz2 CG42576	Drosophila melanogaster (Fruit fly)	886	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN6657_c0_g1_i9	B7TB45	SPZ2_DROME	46.4	97	48	2	79	369	503	595	3.10E-18	92.8	SPZ2_DROME	reviewed	Neurotrophin 1 (Neurotrophic factor 1) (Protein spaetzle 2) (Protein spatzle 2)	NT1 DNT1 spz2 CG42576	Drosophila melanogaster (Fruit fly)	886	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN37521_c0_g1_i1	Q923B3	NRIF1_MOUSE	100	101	0	0	3	305	675	775	5.20E-58	224.6	NRIF1_MOUSE	reviewed	Neurotrophin receptor-interacting factor 1 (Neurotrophin receptor-interacting factor) (Zinc finger protein 110)	Nrif1 Nrif Zfp110	Mus musculus (Mouse)	828	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; neurotrophin p75 receptor binding [GO:0005166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; extrinsic apoptotic signaling pathway [GO:0097191]; neuron apoptotic process [GO:0051402]; regulation of JNK cascade [GO:0046328]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cell apoptotic process [GO:1990009]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; neurotrophin p75 receptor binding [GO:0005166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0003682; GO:0005166; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0043565; GO:0046328; GO:0046872; GO:0051402; GO:0097191; GO:1990009; GO:1990837	extrinsic apoptotic signaling pathway [GO:0097191]; neuron apoptotic process [GO:0051402]; regulation of JNK cascade [GO:0046328]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cell apoptotic process [GO:1990009]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c1_g1_i1	Q4V8E9	NRIF1_RAT	46.9	81	43	0	247	5	706	786	1.20E-18	93.6	NRIF1_RAT	reviewed	Neurotrophin receptor-interacting factor 1 (Zinc finger protein 110)	Nrif1 Zfp110	Rattus norvegicus (Rat)	822	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; neurotrophin p75 receptor binding [GO:0005166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; extrinsic apoptotic signaling pathway [GO:0097191]; neuron apoptotic process [GO:0051402]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of JNK cascade [GO:0046328]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cell apoptotic process [GO:1990009]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; neurotrophin p75 receptor binding [GO:0005166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0003682; GO:0005166; GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0043565; GO:0046328; GO:0046872; GO:0051402; GO:0097191; GO:1900112; GO:1990009; GO:1990837	extrinsic apoptotic signaling pathway [GO:0097191]; neuron apoptotic process [GO:0051402]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of JNK cascade [GO:0046328]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cell apoptotic process [GO:1990009]		NA	NA	NA	NA	NA	NA
TRINITY_DN32014_c0_g1_i1	Q4V8E9	NRIF1_RAT	50.9	53	26	0	224	66	756	808	3.50E-10	65.5	NRIF1_RAT	reviewed	Neurotrophin receptor-interacting factor 1 (Zinc finger protein 110)	Nrif1 Zfp110	Rattus norvegicus (Rat)	822	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; neurotrophin p75 receptor binding [GO:0005166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; extrinsic apoptotic signaling pathway [GO:0097191]; neuron apoptotic process [GO:0051402]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of JNK cascade [GO:0046328]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cell apoptotic process [GO:1990009]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; neurotrophin p75 receptor binding [GO:0005166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0003682; GO:0005166; GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0043565; GO:0046328; GO:0046872; GO:0051402; GO:0097191; GO:1900112; GO:1990009; GO:1990837	extrinsic apoptotic signaling pathway [GO:0097191]; neuron apoptotic process [GO:0051402]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of JNK cascade [GO:0046328]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cell apoptotic process [GO:1990009]		blue	blue	NA	NA	NA	NA
TRINITY_DN13176_c0_g1_i2	Q5G268	NETR_NOMLE	35.7	389	213	12	7	1146	511	871	4.90E-62	240	NETR_NOMLE	reviewed	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	PRSS12	Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys)	875	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	exocytosis [GO:0006887]		NA	NA	NA	NA	NA	NA
TRINITY_DN13176_c0_g1_i3	Q5G268	NETR_NOMLE	37.5	272	146	10	141	929	615	871	7.20E-43	176	NETR_NOMLE	reviewed	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	PRSS12	Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys)	875	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	exocytosis [GO:0006887]		NA	NA	NA	NA	NA	NA
TRINITY_DN40069_c0_g1_i1	Q8BVW0	GANC_MOUSE	37.7	77	46	1	226	2	683	759	1.90E-09	62.8	GANC_MOUSE	reviewed	Neutral alpha-glucosidase C (EC 3.2.1.20)	Ganc	Mus musculus (Mouse)	898	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; glucose metabolic process [GO:0006006]"		"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0004558; GO:0006006; GO:0030246; GO:0032450	glucose metabolic process [GO:0006006]		blue	blue	NA	NA	NA	NA
TRINITY_DN36457_c0_g1_i1	P51912	AAAT_MOUSE	98.9	92	1	0	2	277	318	409	5.40E-46	184.5	AAAT_MOUSE	reviewed	Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5)	Slc1a5 Aaat Asct2 Slc1a7	Mus musculus (Mouse)	553	basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; L-serine transport [GO:0015825]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104]	basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]	GO:0005886; GO:0006868; GO:0009925; GO:0010585; GO:0015175; GO:0015183; GO:0015186; GO:0015194; GO:0015293; GO:0015825; GO:0016021; GO:0042470; GO:0046872; GO:0070207; GO:0140009; GO:0150104; GO:1903803	glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; L-serine transport [GO:0015825]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN33944_c0_g1_i1	Q15758	AAAT_HUMAN	100	151	0	0	455	3	347	497	2.40E-75	282.7	AAAT_HUMAN	reviewed	Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5)	SLC1A5 ASCT2 M7V1 RDR RDRC	Homo sapiens (Human)	541	basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618]; amino acid transport [GO:0006865]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104]	basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618]	GO:0001618; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0009925; GO:0010585; GO:0015171; GO:0015175; GO:0015183; GO:0015186; GO:0015194; GO:0015293; GO:0015804; GO:0016020; GO:0016021; GO:0038023; GO:0042470; GO:0046872; GO:0070062; GO:0070207; GO:0140009; GO:0150104; GO:1903803	amino acid transport [GO:0006865]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN36415_c0_g1_i1	Q15758	AAAT_HUMAN	100	105	0	0	315	1	225	329	2.60E-52	205.7	AAAT_HUMAN	reviewed	Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5)	SLC1A5 ASCT2 M7V1 RDR RDRC	Homo sapiens (Human)	541	basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618]; amino acid transport [GO:0006865]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104]	basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618]	GO:0001618; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0009925; GO:0010585; GO:0015171; GO:0015175; GO:0015183; GO:0015186; GO:0015194; GO:0015293; GO:0015804; GO:0016020; GO:0016021; GO:0038023; GO:0042470; GO:0046872; GO:0070062; GO:0070207; GO:0140009; GO:0150104; GO:1903803	amino acid transport [GO:0006865]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN931_c0_g1_i1	Q03017	CACT_DROME	38.7	253	137	4	944	219	221	466	9.00E-39	162.9	CACT_DROME	reviewed	NF-kappa-B inhibitor cactus	cact CG5848	Drosophila melanogaster (Fruit fly)	500	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; subsynaptic reticulum [GO:0071212]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; subsynaptic reticulum [GO:0071212]	NF-kappaB binding [GO:0051059]	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0009950; GO:0009953; GO:0019730; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059; GO:0071212	antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]		blue	blue	NA	NA	NA	NA
TRINITY_DN14297_c0_g1_i1	Q9NYR9	KBRS2_HUMAN	48.7	189	91	4	648	85	1	184	2.60E-39	163.7	KBRS2_HUMAN	reviewed	NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)	NKIRAS2 KBRAS2	Homo sapiens (Human)	191	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0007249	I-kappaB kinase/NF-kappaB signaling [GO:0007249]		blue	blue	NA	NA	NA	NA
TRINITY_DN14297_c0_g1_i2	Q9NYR9	KBRS2_HUMAN	48.7	189	91	4	648	85	1	184	3.40E-39	163.3	KBRS2_HUMAN	reviewed	NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)	NKIRAS2 KBRAS2	Homo sapiens (Human)	191	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0007249	I-kappaB kinase/NF-kappaB signaling [GO:0007249]		blue	blue	NA	NA	NA	NA
TRINITY_DN7976_c0_g1_i1	Q8BY02	NKRF_MOUSE	32.9	252	155	9	342	1082	445	687	5.20E-26	120.2	NKRF_MOUSE	reviewed	NF-kappa-B-repressing factor (NFkB-repressing factor) (Transcription factor NRF)	Nkrf Nrf	Mus musculus (Mouse)	690	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944	"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i10	B4PZ52	NFU1_DROYA	61.6	190	68	2	60	629	87	271	2.80E-58	226.9	NFU1_DROYA	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial"	GE15286	Drosophila yakuba (Fruit fly)	283	mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]	mitochondrion [GO:0005739]	iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]	GO:0005506; GO:0005739; GO:0016226; GO:0051536	iron-sulfur cluster assembly [GO:0016226]		blue	blue	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i11	B4PZ52	NFU1_DROYA	60	205	73	4	21	632	75	271	9.80E-59	228.4	NFU1_DROYA	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial"	GE15286	Drosophila yakuba (Fruit fly)	283	mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]	mitochondrion [GO:0005739]	iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]	GO:0005506; GO:0005739; GO:0016226; GO:0051536	iron-sulfur cluster assembly [GO:0016226]		blue	blue	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i17	B3MRT7	NFU1_DROAN	77.8	36	8	0	88	195	214	249	4.60E-10	65.1	NFU1_DROAN	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial"	GF20932	Drosophila ananassae (Fruit fly)	286	mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]	mitochondrion [GO:0005739]	iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]	GO:0005506; GO:0005739; GO:0016226; GO:0051536	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i2	B4PZ52	NFU1_DROYA	62.7	217	75	3	73	720	60	271	8.70E-69	263.5	NFU1_DROYA	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial"	GE15286	Drosophila yakuba (Fruit fly)	283	mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]	mitochondrion [GO:0005739]	iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]	GO:0005506; GO:0005739; GO:0016226; GO:0051536	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i36	B4PZ52	NFU1_DROYA	62.7	217	75	3	73	720	60	271	2.30E-69	263.8	NFU1_DROYA	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial"	GE15286	Drosophila yakuba (Fruit fly)	283	mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226]	mitochondrion [GO:0005739]	iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]	GO:0005506; GO:0005739; GO:0016226; GO:0051536	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN32860_c0_g1_i1	Q9UMS0	NFU1_HUMAN	100	129	0	0	1	387	117	245	2.80E-69	262.3	NFU1_HUMAN	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)"	NFU1 HIRIP5 CGI-33	Homo sapiens (Human)	254	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016226; GO:0051539; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i37	Q9UMS0	NFU1_HUMAN	60.5	157	57	2	82	552	55	206	4.50E-48	192.6	NFU1_HUMAN	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)"	NFU1 HIRIP5 CGI-33	Homo sapiens (Human)	254	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016226; GO:0051539; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN34986_c0_g1_i1	Q9QZ23	NFU1_MOUSE	56.8	74	32	0	273	52	168	241	8.50E-21	100.9	NFU1_MOUSE	reviewed	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5) (mHIRIP5)"	Nfu1 Hirip5	Mus musculus (Mouse)	255	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016226; GO:0051539; GO:0097428	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]		NA	NA	NA	NA	NA	NA
TRINITY_DN8894_c0_g2_i1	A0JMY5	NFXL1_XENLA	50	174	83	1	392	913	137	306	4.50E-52	206.8	NFXL1_XENLA	reviewed	NF-X1-type zinc finger protein NFXL1	nfxl1	Xenopus laevis (African clawed frog)	914	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0008270; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8894_c0_g1_i1	A0JMY5	NFXL1_XENLA	32.5	194	129	2	831	256	580	773	1.80E-25	118.6	NFXL1_XENLA	reviewed	NF-X1-type zinc finger protein NFXL1	nfxl1	Xenopus laevis (African clawed frog)	914	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0008270; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8894_c0_g1_i2	A0JMY5	NFXL1_XENLA	32.5	194	129	2	1080	505	580	773	2.10E-25	118.6	NFXL1_XENLA	reviewed	NF-X1-type zinc finger protein NFXL1	nfxl1	Xenopus laevis (African clawed frog)	914	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0008270; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4738_c0_g1_i1	Q8R151	ZNFX1_MOUSE	63	108	40	0	1	324	974	1081	1.90E-34	146.4	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN4738_c0_g1_i2	Q8R151	ZNFX1_MOUSE	62.1	87	33	0	62	322	995	1081	1.50E-26	120.2	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN4738_c0_g1_i3	Q8R151	ZNFX1_MOUSE	65.4	81	28	0	1	243	974	1054	1.70E-25	116.7	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN3821_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	43.2	81	40	1	29	253	331	411	2.80E-12	72.4	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i1	Q8R151	ZNFX1_MOUSE	32.6	353	206	9	1138	107	1573	1902	3.80E-37	157.1	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i10	Q8R151	ZNFX1_MOUSE	32.3	353	207	9	1138	107	1573	1902	2.20E-37	157.9	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i2	Q8R151	ZNFX1_MOUSE	32.3	353	207	9	1138	107	1573	1902	1.20E-38	162.2	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i3	Q8R151	ZNFX1_MOUSE	33.2	376	218	10	1207	107	1551	1902	2.40E-43	177.9	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		blue	blue	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i4	Q8R151	ZNFX1_MOUSE	45.9	170	86	3	604	107	1735	1902	4.50E-30	132.9	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i5	Q8R151	ZNFX1_MOUSE	44.7	170	88	3	604	107	1735	1902	3.00E-29	130.6	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		blue	blue	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i6	Q8R151	ZNFX1_MOUSE	44.7	170	88	3	604	107	1735	1902	5.00E-29	129.4	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i7	Q8R151	ZNFX1_MOUSE	45.3	170	87	3	604	107	1735	1902	9.80E-28	125.6	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN432_c0_g1_i8	Q8R151	ZNFX1_MOUSE	34.6	382	211	10	1225	107	1551	1902	6.70E-41	169.9	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN14710_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	100	104	0	0	2	313	580	683	3.20E-55	215.3	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN14710_c0_g1_i2	Q9P2E3	ZNFX1_HUMAN	95.5	67	3	0	67	267	617	683	1.60E-31	136.3	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN14710_c0_g1_i2	Q9P2E3	ZNFX1_HUMAN	100	28	0	0	2	85	493	520	3.30E-08	58.9	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN26405_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	64.6	79	25	1	2	229	600	678	1.00E-21	103.6	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN13143_c0_g1_i1	Q8R151	ZNFX1_MOUSE	34.4	96	57	3	273	4	468	563	1.10E-06	53.9	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN12289_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	42.3	71	37	1	204	4	437	507	1.00E-07	57	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN17636_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	40	90	50	2	266	6	1559	1647	5.00E-12	71.6	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN35029_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	100	79	0	0	2	238	417	495	3.80E-40	164.9	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN39203_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	100	70	0	0	211	2	341	410	1.20E-34	146.4	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN362_c0_g1_i1	Q8R151	ZNFX1_MOUSE	34.9	1314	769	31	381	4211	110	1373	3.10E-192	674.5	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN362_c0_g1_i2	Q8R151	ZNFX1_MOUSE	34.8	1171	676	26	381	3773	110	1232	3.90E-163	577.4	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN362_c0_g1_i3	Q9P2E3	ZNFX1_HUMAN	34.5	1326	764	32	414	4301	131	1382	2.10E-191	671.8	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN362_c0_g1_i5	Q9P2E3	ZNFX1_HUMAN	34.5	1326	764	32	414	4301	131	1382	9.40E-192	672.9	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN362_c0_g1_i7	Q8R151	ZNFX1_MOUSE	34.9	1314	769	31	381	4211	110	1373	4.00E-192	674.1	ZNFX1_MOUSE	reviewed	NFX1-type zinc finger-containing protein 1	Znfx1	Mus musculus (Mouse)	1909	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN28139_c0_g1_i1	Q9P2E3	ZNFX1_HUMAN	56.6	83	30	2	250	5	1160	1237	3.50E-15	82	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918	"nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heterochromatin assembly by small RNA [GO:0031048]"	nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000981; GO:0003723; GO:0004386; GO:0005634; GO:0008270; GO:0031048; GO:0031380	heterochromatin assembly by small RNA [GO:0031048]		NA	NA	NA	NA	NA	NA
TRINITY_DN3938_c0_g1_i1	Q9V3I8	OGG1_DROME	48.4	215	101	2	713	99	129	343	4.20E-58	226.1	OGG1_DROME	reviewed	N-glycosylase/DNA lyase (dOgg1) [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)]	Ogg1 CG1795	Drosophila melanogaster (Fruit fly)	343	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; nuclease activity [GO:0004518]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to oxidative stress [GO:0034599]; nucleotide-excision repair [GO:0006289]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; nuclease activity [GO:0004518]"	GO:0003684; GO:0004518; GO:0005634; GO:0005737; GO:0006284; GO:0006285; GO:0006289; GO:0034039; GO:0034599; GO:0140078	"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to oxidative stress [GO:0034599]; nucleotide-excision repair [GO:0006289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39329_c0_g1_i1	Q8NBF2	NHLC2_HUMAN	100	98	0	0	2	295	108	205	1.10E-52	206.8	NHLC2_HUMAN	reviewed	NHL repeat-containing protein 2	NHLRC2	Homo sapiens (Human)	726	cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; platelet degranulation [GO:0002576]	cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]		GO:0002576; GO:0005576; GO:0005829; GO:0031093	platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN26675_c0_g1_i1	Q8NBF2	NHLC2_HUMAN	100	68	0	0	206	3	433	500	3.50E-34	144.8	NHLC2_HUMAN	reviewed	NHL repeat-containing protein 2	NHLRC2	Homo sapiens (Human)	726	cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; platelet degranulation [GO:0002576]	cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]		GO:0002576; GO:0005576; GO:0005829; GO:0031093	platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN594_c0_g1_i2	Q8BZW8	NHLC2_MOUSE	44.4	629	318	13	108	1940	25	639	7.50E-146	519.2	NHLC2_MOUSE	reviewed	NHL repeat-containing protein 2	Nhlrc2	Mus musculus (Mouse)	725	cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN880_c0_g1_i1	Q6P8E9	NH2L1_XENTR	75	128	32	0	453	70	1	128	4.50E-49	195.7	NH2L1_XENTR	reviewed	NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein)	snu13 nhp2l1 TGas123b15.1 TNeu005n20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	128	"nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]"	nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	U4atac snRNA binding [GO:0030622]	GO:0000398; GO:0005634; GO:0005690; GO:0005730; GO:0030622; GO:0042254; GO:0046540; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28163_c0_g1_i1	Q5XH16	NH2L1_XENLA	55.7	88	37	2	263	3	31	117	4.50E-18	91.7	NH2L1_XENLA	reviewed	NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein)	snu13 nhp2l1	Xenopus laevis (African clawed frog)	128	"nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]"	nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	U4atac snRNA binding [GO:0030622]	GO:0000398; GO:0005634; GO:0005690; GO:0005730; GO:0030622; GO:0042254; GO:0046540; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39367_c0_g1_i1	Q3B8S0	NH2L1_BOVIN	100	128	0	0	52	435	1	128	7.40E-66	251.1	NH2L1_BOVIN	reviewed	"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]"	SNU13 NHP2L1	Bos taurus (Bovine)	128	"box C/D snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; ATPase binding [GO:0051117]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]"	box C/D snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	ATPase binding [GO:0051117]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000398; GO:0000470; GO:0000492; GO:0001651; GO:0003723; GO:0005634; GO:0005690; GO:0007338; GO:0030490; GO:0030621; GO:0030622; GO:0031428; GO:0032040; GO:0034511; GO:0034512; GO:0046540; GO:0051117; GO:0071005; GO:0071011	"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18420_c0_g1_i1	Q3B8S0	NH2L1_BOVIN	100	128	0	0	391	8	1	128	5.70E-66	251.5	NH2L1_BOVIN	reviewed	"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]"	SNU13 NHP2L1	Bos taurus (Bovine)	128	"box C/D snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; ATPase binding [GO:0051117]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]"	box C/D snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	ATPase binding [GO:0051117]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000398; GO:0000470; GO:0000492; GO:0001651; GO:0003723; GO:0005634; GO:0005690; GO:0007338; GO:0030490; GO:0030621; GO:0030622; GO:0031428; GO:0032040; GO:0034511; GO:0034512; GO:0046540; GO:0051117; GO:0071005; GO:0071011	"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18420_c0_g1_i2	Q3B8S0	NH2L1_BOVIN	100	87	0	0	268	8	42	128	2.00E-41	169.5	NH2L1_BOVIN	reviewed	"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]"	SNU13 NHP2L1	Bos taurus (Bovine)	128	"box C/D snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; ATPase binding [GO:0051117]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]"	box C/D snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	ATPase binding [GO:0051117]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000398; GO:0000470; GO:0000492; GO:0001651; GO:0003723; GO:0005634; GO:0005690; GO:0007338; GO:0030490; GO:0030621; GO:0030622; GO:0031428; GO:0032040; GO:0034511; GO:0034512; GO:0046540; GO:0051117; GO:0071005; GO:0071011	"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36514_c0_g1_i1	Q21568	NH2L1_CAEEL	74.2	128	33	0	403	20	1	128	1.40E-48	193.7	NH2L1_CAEEL	reviewed	NHP2-like protein 1 homolog	M28.5	Caenorhabditis elegans	128	"box C/D snoRNP complex [GO:0031428]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]"	box C/D snoRNP complex [GO:0031428]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	RNA binding [GO:0003723]	GO:0000398; GO:0000470; GO:0003723; GO:0030490; GO:0031428; GO:0032040; GO:0046540; GO:0071011	"maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34475_c0_g1_i1	Q21568	NH2L1_CAEEL	75	128	32	0	416	33	1	128	1.80E-48	193.4	NH2L1_CAEEL	reviewed	NHP2-like protein 1 homolog	M28.5	Caenorhabditis elegans	128	"box C/D snoRNP complex [GO:0031428]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]"	box C/D snoRNP complex [GO:0031428]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	RNA binding [GO:0003723]	GO:0000398; GO:0000470; GO:0003723; GO:0030490; GO:0031428; GO:0032040; GO:0046540; GO:0071011	"maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10457_c0_g1_i1	O60934	NBN_HUMAN	32.7	98	55	3	365	102	228	324	3.20E-06	52.8	NBN_HUMAN	reviewed	Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1)	NBN NBS NBS1 P95	Homo sapiens (Human)	754	"cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; blastocyst growth [GO:0001832]; cell cycle arrest [GO:0007050]; cell population proliferation [GO:0008283]; DNA damage checkpoint [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction in response to DNA damage [GO:0042770]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]; viral process [GO:0016032]"	"cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	damaged DNA binding [GO:0003684]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000784; GO:0001832; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005730; GO:0005829; GO:0006260; GO:0006302; GO:0006303; GO:0007050; GO:0007093; GO:0007095; GO:0008134; GO:0008283; GO:0016032; GO:0016233; GO:0016605; GO:0030174; GO:0030330; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042405; GO:0042770; GO:0045190; GO:0047485; GO:0050885; GO:0051321; GO:0090656; GO:0090737; GO:0097193; GO:1901796; GO:1904354	"blastocyst growth [GO:0001832]; cell cycle arrest [GO:0007050]; cell population proliferation [GO:0008283]; DNA damage checkpoint [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of signal transduction by p53 class mediator [GO:1901796]; signal transduction in response to DNA damage [GO:0042770]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26740_c0_g1_i1	Q969V3	NCLN_HUMAN	98.7	77	1	0	2	232	185	261	1.40E-36	152.9	NCLN_HUMAN	reviewed	Nicalin (Nicastrin-like protein)	NCLN	Homo sapiens (Human)	563	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991]		GO:0005789; GO:0009966; GO:0016020; GO:0016021; GO:0032991; GO:0043254; GO:0050821; GO:0061635	protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN6420_c0_g1_i1	Q8VCM8	NCLN_MOUSE	46.9	550	277	8	113	1723	9	556	4.10E-126	453.4	NCLN_MOUSE	reviewed	Nicalin (Nicastrin-like protein)	Ncln	Mus musculus (Mouse)	563	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]		GO:0005789; GO:0009966; GO:0016021; GO:0032991; GO:0043254; GO:0050821; GO:0061635	protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN33302_c0_g1_i2	P53184	PNC1_YEAST	34	209	114	5	285	890	4	195	3.40E-25	117.1	PNC1_YEAST	reviewed	Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase)	PNC1 YGL037C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	216	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; rDNA heterochromatin assembly [GO:0000183]; replicative cell aging [GO:0001302]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]"	metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]	GO:0000183; GO:0000781; GO:0001302; GO:0005634; GO:0005737; GO:0005777; GO:0006348; GO:0008936; GO:0019358; GO:0046872; GO:1904524	chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; rDNA heterochromatin assembly [GO:0000183]; replicative cell aging [GO:0001302]		NA	NA	1	NA	NA	NA
TRINITY_DN33302_c0_g1_i1	P53184	PNC1_YEAST	37.6	85	52	1	69	320	111	195	7.60E-07	54.7	PNC1_YEAST	reviewed	Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase)	PNC1 YGL037C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	216	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; rDNA heterochromatin assembly [GO:0000183]; replicative cell aging [GO:0001302]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]"	metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]	GO:0000183; GO:0000781; GO:0001302; GO:0005634; GO:0005737; GO:0005777; GO:0006348; GO:0008936; GO:0019358; GO:0046872; GO:1904524	chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; rDNA heterochromatin assembly [GO:0000183]; replicative cell aging [GO:0001302]		NA	NA	NA	NA	NA	NA
TRINITY_DN33302_c0_g1_i5	P53184	PNC1_YEAST	34	209	114	5	76	681	4	195	2.00E-25	117.5	PNC1_YEAST	reviewed	Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase)	PNC1 YGL037C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	216	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; rDNA heterochromatin assembly [GO:0000183]; replicative cell aging [GO:0001302]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777]"	metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]	GO:0000183; GO:0000781; GO:0001302; GO:0005634; GO:0005737; GO:0005777; GO:0006348; GO:0008936; GO:0019358; GO:0046872; GO:1904524	chromatin silencing at telomere [GO:0006348]; negative regulation of DNA amplification [GO:1904524]; nicotinate nucleotide salvage [GO:0019358]; rDNA heterochromatin assembly [GO:0000183]; replicative cell aging [GO:0001302]		NA	NA	NA	NA	NA	NA
TRINITY_DN4754_c0_g1_i2	Q99KQ4	NAMPT_MOUSE	43.2	176	83	4	558	46	324	487	9.50E-34	144.8	NAMPT_MOUSE	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Mus musculus (Mouse)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		brown	brown	NA	NA	NA	NA
TRINITY_DN4754_c0_g1_i7	Q99KQ4	NAMPT_MOUSE	47.7	480	233	7	1437	46	10	487	1.20E-126	454.9	NAMPT_MOUSE	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Mus musculus (Mouse)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN4754_c0_g1_i8	Q99KQ4	NAMPT_MOUSE	47.4	340	176	3	1046	30	53	390	3.10E-89	330.1	NAMPT_MOUSE	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Mus musculus (Mouse)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN18942_c0_g1_i1	Q99KQ4	NAMPT_MOUSE	49.1	293	142	3	1	858	175	467	5.20E-79	295.8	NAMPT_MOUSE	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Mus musculus (Mouse)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN18942_c0_g2_i1	Q99KQ4	NAMPT_MOUSE	55.6	162	61	2	1	456	12	172	3.00E-49	196.1	NAMPT_MOUSE	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Mus musculus (Mouse)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN35697_c0_g1_i1	Q52I78	NAMPT_PIG	55.7	483	196	5	44	1447	4	483	3.20E-156	553.1	NAMPT_PIG	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	NAMPT PBEF1	Sus scrofa (Pig)	491	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0009435; GO:0032922; GO:0047280	circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]		NA	NA	NA	NA	NA	NA
TRINITY_DN7104_c0_g2_i1	Q80Z29	NAMPT_RAT	46	265	141	2	25	816	186	449	4.40E-70	266.2	NAMPT_RAT	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Rattus norvegicus (Rat)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN7104_c0_g2_i2	Q52I78	NAMPT_PIG	56.7	141	50	2	61	453	10	149	1.50E-39	164.1	NAMPT_PIG	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	NAMPT PBEF1	Sus scrofa (Pig)	491	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0009435; GO:0032922; GO:0047280	circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]		NA	NA	NA	NA	NA	NA
TRINITY_DN7104_c0_g2_i3	Q80Z29	NAMPT_RAT	48.7	474	227	5	61	1440	10	481	7.40E-132	472.2	NAMPT_RAT	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Rattus norvegicus (Rat)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN7104_c0_g1_i2	Q80Z29	NAMPT_RAT	48.7	474	227	5	1513	134	10	481	7.30E-132	472.2	NAMPT_RAT	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Rattus norvegicus (Rat)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN7104_c0_g1_i3	Q80Z29	NAMPT_RAT	44.8	297	159	3	1012	134	186	481	7.20E-75	282.3	NAMPT_RAT	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	Nampt Pbef1	Rattus norvegicus (Rat)	491	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0009435; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthetic process [GO:0009435]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN4754_c0_g1_i3	P43490	NAMPT_HUMAN	46.9	162	82	2	531	58	321	482	2.60E-37	156.8	NAMPT_HUMAN	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin)	NAMPT PBEF PBEF1	Homo sapiens (Human)	491	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005829; GO:0005886; GO:0007165; GO:0007267; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0008284; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0034356; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070062; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33133_c0_g1_i1	P43490	NAMPT_HUMAN	100	234	0	0	703	2	1	234	2.10E-134	479.6	NAMPT_HUMAN	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin)	NAMPT PBEF PBEF1	Homo sapiens (Human)	491	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005829; GO:0005886; GO:0007165; GO:0007267; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0008284; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0034356; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070062; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32131_c0_g1_i1	P43490	NAMPT_HUMAN	100	80	0	0	241	2	382	461	1.60E-41	169.5	NAMPT_HUMAN	reviewed	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin)	NAMPT PBEF PBEF1	Homo sapiens (Human)	491	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0001774; GO:0004514; GO:0005125; GO:0005829; GO:0005886; GO:0007165; GO:0007267; GO:0007565; GO:0007568; GO:0007623; GO:0008144; GO:0008284; GO:0010507; GO:0014070; GO:0014916; GO:0016607; GO:0030054; GO:0032922; GO:0034356; GO:0042802; GO:0045944; GO:0047280; GO:0048661; GO:0051770; GO:0070062; GO:0070997; GO:0071479; GO:0090650; GO:1904646; GO:1905377; GO:2000773	aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; cellular response to ionizing radiation [GO:0071479]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; female pregnancy [GO:0007565]; microglial cell activation [GO:0001774]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lung blood pressure [GO:0014916]; response to D-galactose [GO:1905377]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN14820_c0_g1_i1	Q9EPA7	NMNA1_MOUSE	52.2	255	106	3	728	3	9	260	1.00E-67	258.1	NMNA1_MOUSE	reviewed	Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1)	Nmnat1 D4Cole1e Nmnat	Mus musculus (Mouse)	285	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:0043410; GO:0043524; GO:1901215; GO:1902511; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]		NA	NA	NA	NA	NA	NA
TRINITY_DN14820_c0_g1_i2	Q9EPA7	NMNA1_MOUSE	49.6	266	120	2	800	3	9	260	1.30E-66	254.6	NMNA1_MOUSE	reviewed	Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1)	Nmnat1 D4Cole1e Nmnat	Mus musculus (Mouse)	285	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:0043410; GO:0043524; GO:1901215; GO:1902511; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]		NA	NA	NA	NA	NA	NA
TRINITY_DN14820_c0_g1_i4	Q9EPA7	NMNA1_MOUSE	64.7	34	12	0	147	46	175	208	6.10E-05	47.8	NMNA1_MOUSE	reviewed	Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1)	Nmnat1 D4Cole1e Nmnat	Mus musculus (Mouse)	285	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:0043410; GO:0043524; GO:1901215; GO:1902511; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611]		NA	NA	NA	NA	NA	NA
TRINITY_DN26822_c0_g1_i1	Q9VQX4	PNCB_DROME	71.7	244	69	0	3	734	171	414	3.20E-98	359.4	PNCB_DROME	reviewed	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	Naprt CG3714	Drosophila melanogaster (Fruit fly)	555	cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872	NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN31666_c0_g1_i1	Q9VQX4	PNCB_DROME	69.6	92	28	0	276	1	457	548	2.80E-34	145.6	PNCB_DROME	reviewed	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	Naprt CG3714	Drosophila melanogaster (Fruit fly)	555	cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872	NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN31482_c0_g1_i1	Q9VQX4	PNCB_DROME	61.9	105	39	1	315	1	314	417	5.00E-30	131.7	PNCB_DROME	reviewed	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	Naprt CG3714	Drosophila melanogaster (Fruit fly)	555	cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872	NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN39786_c0_g1_i1	Q9VQX4	PNCB_DROME	50.7	69	34	0	207	1	192	260	2.00E-13	75.9	PNCB_DROME	reviewed	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	Naprt CG3714	Drosophila melanogaster (Fruit fly)	555	cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872	NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN1979_c0_g3_i1	Q05B89	NIF3L_BOVIN	44.6	336	174	6	1239	262	28	361	8.00E-69	262.7	NIF3L_BOVIN	reviewed	NIF3-like protein 1	NIF3L1	Bos taurus (Bovine)	377	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:1903507	negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]		NA	NA	NA	NA	NA	NA
TRINITY_DN1979_c0_g3_i2	Q05B89	NIF3L_BOVIN	44.3	352	184	6	1351	326	28	377	1.20E-73	278.9	NIF3L_BOVIN	reviewed	NIF3-like protein 1	NIF3L1	Bos taurus (Bovine)	377	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:1903507	negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]		NA	NA	NA	NA	NA	NA
TRINITY_DN223_c0_g1_i1	Q9Y2I6	NINL_HUMAN	36.8	152	84	5	437	3	185	331	6.90E-13	75.9	NINL_HUMAN	reviewed	Ninein-like protein	NINL KIAA0980 NLP	Homo sapiens (Human)	1382	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule anchoring at centrosome [GO:0034454]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]	calcium ion binding [GO:0005509]	GO:0000086; GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0010389; GO:0034454; GO:0045171; GO:0097711	ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule anchoring at centrosome [GO:0034454]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN223_c0_g1_i2	Q9Y2I6	NINL_HUMAN	36.8	152	84	5	437	3	185	331	6.70E-13	75.9	NINL_HUMAN	reviewed	Ninein-like protein	NINL KIAA0980 NLP	Homo sapiens (Human)	1382	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule anchoring at centrosome [GO:0034454]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]	calcium ion binding [GO:0005509]	GO:0000086; GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0010389; GO:0034454; GO:0045171; GO:0097711	ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule anchoring at centrosome [GO:0034454]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN1081_c0_g1_i3	Q9JHE8	NINJ2_RAT	30.8	117	79	2	83	433	14	128	3.10E-09	63.5	NINJ2_RAT	reviewed	Ninjurin-2 (Nerve injury-induced protein 2)	Ninj2	Rattus norvegicus (Rat)	144	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]	integral component of membrane [GO:0016021]		GO:0007155; GO:0016021; GO:0042246	cell adhesion [GO:0007155]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN25711_c0_g1_i1	Q6KCD5	NIPBL_MOUSE	51.2	285	135	3	850	2	1181	1463	4.00E-78	293.1	NIPBL_MOUSE	reviewed	Nipped-B-like protein (Delangin homolog) (SCC2 homolog)	Nipbl Scc2	Mus musculus (Mouse)	2798	"chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038]"	chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]	GO:0000122; GO:0000228; GO:0000785; GO:0000790; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006357; GO:0006974; GO:0007064; GO:0007076; GO:0007420; GO:0007507; GO:0007605; GO:0008022; GO:0019827; GO:0031065; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0034613; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045892; GO:0045944; GO:0045995; GO:0047485; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0070087; GO:0070550; GO:0071169; GO:0071481; GO:0071733; GO:0071921; GO:0090694; GO:1905406; GO:1990414; GO:1990841; GO:2001224	"brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3864_c0_g1_i1	Q9Y2I1	NISCH_HUMAN	39.8	442	255	4	126	1421	21	461	1.80E-80	301.6	NISCH_HUMAN	reviewed	Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein)	NISCH IRAS KIAA0975	Homo sapiens (Human)	1504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]	GO:0005178; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0048243; GO:0055037	"actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3864_c0_g1_i2	Q9Y2I1	NISCH_HUMAN	44.2	77	43	0	126	356	21	97	8.70E-14	78.2	NISCH_HUMAN	reviewed	Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein)	NISCH IRAS KIAA0975	Homo sapiens (Human)	1504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]	GO:0005178; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0048243; GO:0055037	"actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26370_c0_g1_i1	P39866	NIA2_PHAVU	45.1	71	39	0	213	1	230	300	3.20E-13	75.5	NIA2_PHAVU	reviewed	Nitrate reductase [NADH] 2 (NR-2) (EC 1.7.1.1)	NIA2 NR2	Phaseolus vulgaris (Kidney bean) (French bean)	890	FAD binding [GO:0071949]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase (NADH) activity [GO:0009703]; nitrate reductase (NADPH) activity [GO:0050464]; nitrate assimilation [GO:0042128]; nitric oxide biosynthetic process [GO:0006809]		FAD binding [GO:0071949]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase (NADH) activity [GO:0009703]; nitrate reductase (NADPH) activity [GO:0050464]	GO:0006809; GO:0009703; GO:0020037; GO:0030151; GO:0042128; GO:0043546; GO:0050464; GO:0071949	nitrate assimilation [GO:0042128]; nitric oxide biosynthetic process [GO:0006809]		NA	NA	NA	NA	NA	NA
TRINITY_DN37612_c0_g1_i1	Q27571	NOS_DROME	90.6	53	5	0	162	4	558	610	4.50E-25	114.8	NOS_DROME	reviewed	Nitric oxide synthase (EC 1.14.13.39) (dNOS)	Nos CG6713	Drosophila melanogaster (Fruit fly)	1349	"cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; arginine catabolic process [GO:0006527]; imaginal disc development [GO:0007444]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; nervous system development [GO:0007399]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of heart rate [GO:0002027]; regulation of organ growth [GO:0046620]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; synapse assembly [GO:0007416]"	cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	"calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0002027; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006809; GO:0007263; GO:0007399; GO:0007416; GO:0007444; GO:0008156; GO:0008285; GO:0009725; GO:0010181; GO:0012506; GO:0016491; GO:0016709; GO:0020037; GO:0031284; GO:0032496; GO:0046620; GO:0046872; GO:0050660; GO:0050661	arginine catabolic process [GO:0006527]; imaginal disc development [GO:0007444]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; nervous system development [GO:0007399]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of guanylate cyclase activity [GO:0031284]; regulation of heart rate [GO:0002027]; regulation of organ growth [GO:0046620]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN26329_c0_g1_i1	P29477	NOS2_MOUSE	100	104	0	0	2	313	522	625	1.30E-51	203.4	NOS2_MOUSE	reviewed	"Nitric oxide synthase, inducible (EC 1.14.13.39) (Inducible NO synthase) (Inducible NOS) (iNOS) (Macrophage NOS) (MAC-NOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)"	Nos2 Inosl	Mus musculus (Mouse)	1144	"cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; arginine binding [GO:0034618]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tetrahydrobiopterin binding [GO:0034617]; arginine catabolic process [GO:0006527]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; interleukin-6 production [GO:0032635]; interleukin-8 production [GO:0032637]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of killing of cells of other organism [GO:0051712]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801]"	cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	"actin binding [GO:0003779]; arginine binding [GO:0034618]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cAMP-dependent protein kinase regulator activity [GO:0008603]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; nitric-oxide synthase binding [GO:0050998]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tetrahydrobiopterin binding [GO:0034617]"	GO:0001666; GO:0003779; GO:0003958; GO:0004517; GO:0005516; GO:0005615; GO:0005634; GO:0005737; GO:0005777; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0006954; GO:0007263; GO:0007623; GO:0008013; GO:0008603; GO:0009617; GO:0009725; GO:0010181; GO:0010629; GO:0012506; GO:0016491; GO:0016709; GO:0018119; GO:0019901; GO:0020037; GO:0030863; GO:0031284; GO:0032310; GO:0032496; GO:0032635; GO:0032637; GO:0034617; GO:0034618; GO:0035690; GO:0042127; GO:0042177; GO:0042742; GO:0042802; GO:0042803; GO:0045296; GO:0045776; GO:0046872; GO:0048471; GO:0050660; GO:0050661; GO:0050796; GO:0050998; GO:0051712; GO:0051879; GO:0071222; GO:0071345; GO:0071346; GO:0071407; GO:1900015	arginine catabolic process [GO:0006527]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; interleukin-6 production [GO:0032635]; interleukin-8 production [GO:0032637]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of killing of cells of other organism [GO:0051712]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN3043_c0_g1_i1	Q26240	NOS_RHOPR	57.5	1165	455	10	27	3518	48	1173	0	1361.7	NOS_RHOPR	reviewed	"Nitric oxide synthase, salivary gland (NOS) (EC 1.14.13.39)"		Rhodnius prolixus (Triatomid bug)	1174	calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; nitric oxide biosynthetic process [GO:0006809]		calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]	GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0046872; GO:0050660; GO:0050661	nitric oxide biosynthetic process [GO:0006809]		blue	blue	NA	NA	NA	NA
TRINITY_DN36983_c0_g1_i1	Q3SWY5	NOSIP_BOVIN	100	90	0	0	63	332	1	90	2.40E-48	192.6	NOSIP_BOVIN	reviewed	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP)	NOSIP	Bos taurus (Bovine)	302	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005737; GO:0007275; GO:0061630	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN28118_c0_g1_i1	Q9D6T0	NOSIP_MOUSE	100	94	0	0	300	19	208	301	6.90E-47	187.6	NOSIP_MOUSE	reviewed	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP)	Nosip	Mus musculus (Mouse)	301	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005654; GO:0005737; GO:0007275; GO:0043086; GO:0051001; GO:0061630	multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]		NA	NA	NA	NA	NA	NA
TRINITY_DN33969_c0_g1_i1	Q9Y314	NOSIP_HUMAN	100	81	0	0	1	243	221	301	2.10E-39	162.5	NOSIP_HUMAN	reviewed	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP) (eNOS-interacting protein)	NOSIP CGI-25	Homo sapiens (Human)	301	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]; regulation of nitric-oxide synthase activity [GO:0050999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0043086; GO:0050999; GO:0051001; GO:0061630	multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]; regulation of nitric-oxide synthase activity [GO:0050999]		NA	NA	NA	NA	NA	NA
TRINITY_DN40859_c0_g1_i1	Q9Y314	NOSIP_HUMAN	98.6	72	1	0	2	217	135	206	2.80E-34	145.2	NOSIP_HUMAN	reviewed	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP) (eNOS-interacting protein)	NOSIP CGI-25	Homo sapiens (Human)	301	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]; regulation of nitric-oxide synthase activity [GO:0050999]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0043086; GO:0050999; GO:0051001; GO:0061630	multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]; regulation of nitric-oxide synthase activity [GO:0050999]		NA	NA	NA	NA	NA	NA
TRINITY_DN2180_c0_g2_i1	Q9VWV8	NOSIP_DROME	55.1	118	53	0	437	84	1	118	1.40E-33	144.1	NOSIP_DROME	reviewed	Nitric oxide synthase-interacting protein homolog	CG6179	Drosophila melanogaster (Fruit fly)	307	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0043086; GO:0051001; GO:0061630; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2180_c0_g1_i2	Q9VWV8	NOSIP_DROME	61.3	155	58	1	561	97	154	306	1.30E-47	191	NOSIP_DROME	reviewed	Nitric oxide synthase-interacting protein homolog	CG6179	Drosophila melanogaster (Fruit fly)	307	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0043086; GO:0051001; GO:0061630; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2444_c1_g1_i3	O76464	NFT1_DROME	50	198	95	2	219	812	35	228	7.80E-50	199.5	NFT1_DROME	reviewed	"Nitrilase and fragile histidine triad fusion protein NitFhit (NFT-1 protein) [Includes: Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (AP3A hydrolase) (AP3Aase) (Dinucleosidetriphosphatase); Nitrilase homolog (EC 3.5.-.-)]"	NitFhit CG7067	Drosophila melanogaster (Fruit fly)	460	"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139]"		"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0006139; GO:0016810; GO:0047710	nucleobase-containing compound metabolic process [GO:0006139]		NA	NA	NA	NA	NA	NA
TRINITY_DN2444_c1_g1_i1	O76463	NFT1_CAEEL	44.4	437	221	5	226	1512	17	439	9.10E-98	359	NFT1_CAEEL	reviewed	"Nitrilase and fragile histidine triad fusion protein NitFhit [Includes: Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase); Nitrilase homolog (EC 3.5.-.-)]"	nft-1 Y56A3A.13	Caenorhabditis elegans	440	"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139]"		"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0006139; GO:0016810; GO:0047710	nucleobase-containing compound metabolic process [GO:0006139]		NA	NA	NA	NA	NA	NA
TRINITY_DN2444_c1_g1_i2	O76463	NFT1_CAEEL	44.4	437	221	5	219	1505	17	439	9.10E-98	359	NFT1_CAEEL	reviewed	"Nitrilase and fragile histidine triad fusion protein NitFhit [Includes: Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase); Nitrilase homolog (EC 3.5.-.-)]"	nft-1 Y56A3A.13	Caenorhabditis elegans	440	"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139]"		"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0006139; GO:0016810; GO:0047710	nucleobase-containing compound metabolic process [GO:0006139]		NA	NA	NA	NA	NA	NA
TRINITY_DN37562_c0_g1_i1	Q54JM9	NIT2_DICDI	61.3	137	52	1	412	5	144	280	3.70E-46	185.7	NIT2_DICDI	reviewed	Nitrilase homolog 2 (EC 3.5.-.-)	nit2 DDB_G0287939	Dictyostelium discoideum (Slime mold)	328	omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]		omega-amidase activity [GO:0050152]	GO:0006107; GO:0006528; GO:0006541; GO:0050152	asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN11094_c0_g1_i1	Q5SZT7	NKAPL_MOUSE	55.1	78	35	0	236	3	258	335	1.20E-14	80.5	NKAPL_MOUSE	reviewed	NKAP-like protein	Nkapl	Mus musculus (Mouse)	395	nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154	cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1022_c0_g1_i1	P30415	NKTR_MOUSE	39.5	124	52	5	444	112	262	375	4.80E-06	52.8	NKTR_MOUSE	reviewed	NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR) (PPIase) (EC 5.2.1.8)	Nktr	Mus musculus (Mouse)	1453	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN268_c0_g1_i10	Q8R5A0	SMYD2_MOUSE	23	304	180	5	1361	453	18	268	1.00E-15	87	SMYD2_MOUSE	reviewed	N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (SET and MYND domain-containing protein 2)	Smyd2	Mus musculus (Mouse)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0016571; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975	"heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"		NA	NA	NA	NA	NA	NA
TRINITY_DN268_c0_g1_i13	Q8R5A0	SMYD2_MOUSE	23	304	180	5	1361	453	18	268	1.20E-15	87	SMYD2_MOUSE	reviewed	N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (SET and MYND domain-containing protein 2)	Smyd2	Mus musculus (Mouse)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0016571; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975	"heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"		NA	NA	NA	NA	NA	NA
TRINITY_DN268_c0_g1_i14	Q8R5A0	SMYD2_MOUSE	23	304	180	5	1361	453	18	268	1.40E-15	87	SMYD2_MOUSE	reviewed	N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (SET and MYND domain-containing protein 2)	Smyd2	Mus musculus (Mouse)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0016571; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975	"heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"		NA	NA	NA	NA	NA	NA
TRINITY_DN268_c0_g1_i6	Q8R5A0	SMYD2_MOUSE	23	304	180	5	1361	453	18	268	1.00E-15	87	SMYD2_MOUSE	reviewed	N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (SET and MYND domain-containing protein 2)	Smyd2	Mus musculus (Mouse)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0016571; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975	"heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"		NA	NA	NA	NA	NA	NA
TRINITY_DN268_c0_g1_i7	Q8R5A0	SMYD2_MOUSE	23	304	180	5	1361	453	18	268	9.20E-16	87	SMYD2_MOUSE	reviewed	N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (SET and MYND domain-containing protein 2)	Smyd2	Mus musculus (Mouse)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0016571; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975	"heart development [GO:0007507]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN7447_c0_g2_i4	Q5RGL7	SMY2B_DANRE	32.6	86	54	2	674	420	186	268	2.40E-06	54.3	SMY2B_DANRE	reviewed	N-lysine methyltransferase SMYD2-B (EC 2.1.1.-) (Histone methyltransferase SMYD2-B) (EC 2.1.1.354) (SET and MYND domain-containing protein 2B)	smyd2b si:dkey-121j17.3	Danio rerio (Zebrafish) (Brachydanio rerio)	434	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; heart contraction [GO:0060047]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0005634; GO:0005737; GO:0005829; GO:0007507; GO:0008285; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975; GO:0060047	"heart contraction [GO:0060047]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30173_c0_g1_i1	Q8XXY9	NODI_RALSO	92.3	117	9	0	352	2	128	244	1.30E-57	223.4	NODI_RALSO	reviewed	Nod factor export ATP-binding protein I (EC 7.6.2.-) (Nodulation ATP-binding protein I)	nodI RSc1974	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	321	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; transmembrane transporter activity [GO:0022857]; nodulation [GO:0009877]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857]	GO:0005524; GO:0005886; GO:0009877; GO:0016887; GO:0022857	nodulation [GO:0009877]		NA	NA	NA	NA	NA	NA
TRINITY_DN8468_c0_g1_i1	Q8XXY9	NODI_RALSO	82.6	86	14	1	256	2	3	88	5.70E-34	144.4	NODI_RALSO	reviewed	Nod factor export ATP-binding protein I (EC 7.6.2.-) (Nodulation ATP-binding protein I)	nodI RSc1974	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	321	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; transmembrane transporter activity [GO:0022857]; nodulation [GO:0009877]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857]	GO:0005524; GO:0005886; GO:0009877; GO:0016887; GO:0022857	nodulation [GO:0009877]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN2462_c0_g1_i1	Q6GQT9	NOMO1_MOUSE	38.9	314	184	4	925	2	83	394	4.60E-55	216.5	NOMO1_MOUSE	reviewed	Nodal modulator 1	Nomo1	Mus musculus (Mouse)	1214	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	carbohydrate binding [GO:0030246]	GO:0005789; GO:0016021; GO:0030246; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN2462_c0_g1_i2	Q6GQT9	NOMO1_MOUSE	42.7	368	203	4	1087	2	29	394	1.20E-81	305.1	NOMO1_MOUSE	reviewed	Nodal modulator 1	Nomo1	Mus musculus (Mouse)	1214	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	carbohydrate binding [GO:0030246]	GO:0005789; GO:0016021; GO:0030246; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN27446_c0_g1_i1	Q15155	NOMO1_HUMAN	100	128	0	0	384	1	26	153	5.50E-73	274.6	NOMO1_HUMAN	reviewed	Nodal modulator 1 (pM5 protein)	NOMO1 PM5	Homo sapiens (Human)	1222	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	carbohydrate binding [GO:0030246]	GO:0005789; GO:0016020; GO:0016021; GO:0030246			NA	NA	NA	NA	NA	NA
TRINITY_DN6991_c0_g1_i1	Q7KVS9	TRF41_DROME	50.3	143	67	2	2	421	400	541	3.80E-33	142.9	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN6991_c0_g1_i2	Q7KVS9	TRF41_DROME	50.3	143	67	2	2	421	400	541	3.40E-33	142.9	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN29878_c0_g1_i1	Q7KVS9	TRF41_DROME	68.5	89	28	0	1217	951	494	582	2.80E-28	127.9	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN19493_c0_g1_i1	Q7KVS9	TRF41_DROME	54.1	61	28	0	219	37	486	546	3.80E-13	75.1	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c1_g1_i2	Q7KVS9	TRF41_DROME	50	46	23	0	140	3	486	531	3.80E-07	55.1	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c1_g1_i3	Q7KVS9	TRF41_DROME	47.3	74	32	1	255	34	486	552	1.40E-11	70.5	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c0_g3_i1	Q7KVS9	TRF41_DROME	44.8	58	32	0	267	94	489	546	1.30E-09	63.5	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c0_g3_i2	Q7KVS9	TRF41_DROME	50.9	108	51	1	411	94	439	546	1.50E-23	110.5	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c0_g4_i2	Q7KVS9	TRF41_DROME	46.7	105	48	2	340	29	455	552	5.40E-19	95.1	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c0_g4_i3	Q7KVS9	TRF41_DROME	46.9	98	44	2	393	103	462	552	5.80E-17	88.6	TRF41_DROME	reviewed	Non-canonical poly(A) RNA polymerase protein Trf4-1 (EC 2.7.7.19) (Topoisomerase 1-related protein 4-1)	Trf4-1 CG11265	Drosophila melanogaster (Fruit fly)	1001	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005730; GO:0005737; GO:0006397; GO:0016853; GO:0031499; GO:0043630; GO:0046872; GO:0071044; GO:0071050	histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1170_c0_g1_i1	Q7KT91	C3390_DROME	46	237	102	1	633	1	47	283	4.60E-60	232.6	C3390_DROME	reviewed	Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45)	CG33090	Drosophila melanogaster (Fruit fly)	948	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]	GO:0004348; GO:0005886; GO:0005975; GO:0006680; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0046527	bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]		NA	NA	NA	NA	NA	NA
TRINITY_DN36962_c0_g1_i1	Q9HCG7	GBA2_HUMAN	100	66	0	0	200	3	577	642	2.60E-34	145.2	GBA2_HUMAN	reviewed	Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2)	GBA2 KIAA1605 SPG46 AD035	Homo sapiens (Human)	927	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0006687; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035	bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]		NA	NA	NA	NA	NA	NA
TRINITY_DN38068_c0_g1_i1	Q9HCG7	GBA2_HUMAN	100	81	0	0	1	243	809	889	7.10E-42	170.6	GBA2_HUMAN	reviewed	Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2)	GBA2 KIAA1605 SPG46 AD035	Homo sapiens (Human)	927	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0006687; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035	bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]		NA	NA	NA	NA	NA	NA
TRINITY_DN7069_c0_g1_i1	Q69ZF3	GBA2_MOUSE	55.1	454	191	4	69	1397	375	826	4.70E-141	502.7	GBA2_MOUSE	reviewed	Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2)	Gba2 Kiaa1605	Mus musculus (Mouse)	918	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005829; GO:0005975; GO:0006680; GO:0007417; GO:0008203; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035	carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]		NA	NA	NA	NA	NA	NA
TRINITY_DN7069_c0_g1_i2	Q5M868	GBA2_RAT	51.6	581	272	2	5	1720	311	891	2.30E-172	607.1	GBA2_RAT	reviewed	Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2)	Gba2	Rattus norvegicus (Rat)	912	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005829; GO:0005975; GO:0006680; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035	bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]		NA	NA	NA	NA	NA	NA
TRINITY_DN17905_c0_g1_i1	Q15233	NONO_HUMAN	99.4	166	1	0	536	39	131	296	7.60E-89	327.8	NONO_HUMAN	reviewed	"Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (55 kDa nuclear protein) (DNA-binding p52/p100 complex, 52 kDa subunit) (NMT55) (p54(nrb)) (p54nrb)"	NONO NRB54	Homo sapiens (Human)	471	"fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"	fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000398; GO:0000976; GO:0000978; GO:0001650; GO:0002218; GO:0003676; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006355; GO:0006397; GO:0007623; GO:0008380; GO:0016020; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0042802; GO:0045087; GO:0045892; GO:0070888; GO:0090575; GO:1903377	"activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17905_c0_g1_i2	Q15233	NONO_HUMAN	100	165	0	0	533	39	132	296	7.60E-89	327.8	NONO_HUMAN	reviewed	"Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (55 kDa nuclear protein) (DNA-binding p52/p100 complex, 52 kDa subunit) (NMT55) (p54(nrb)) (p54nrb)"	NONO NRB54	Homo sapiens (Human)	471	"fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"	fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000398; GO:0000976; GO:0000978; GO:0001650; GO:0002218; GO:0003676; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006355; GO:0006397; GO:0007623; GO:0008380; GO:0016020; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0042802; GO:0045087; GO:0045892; GO:0070888; GO:0090575; GO:1903377	"activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29095_c0_g1_i1	P29597	TYK2_HUMAN	98.4	122	2	0	366	1	993	1114	6.60E-68	257.7	TYK2_HUMAN	reviewed	Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2)	TYK2	Homo sapiens (Human)	1187	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; type 1 angiotensin receptor binding [GO:0031702]; cytokine-mediated signaling pathway [GO:0019221]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; interleukin-27-mediated signaling pathway [GO:0070106]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; type 1 angiotensin receptor binding [GO:0031702]	GO:0004713; GO:0004715; GO:0005131; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0016020; GO:0019221; GO:0031702; GO:0035556; GO:0035722; GO:0038155; GO:0060337; GO:0070062; GO:0070106	cytokine-mediated signaling pathway [GO:0019221]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; interleukin-27-mediated signaling pathway [GO:0070106]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; type I interferon signaling pathway [GO:0060337]		NA	NA	NA	NA	NA	NA
TRINITY_DN28949_c0_g1_i1	P32020	NLTP_MOUSE	100	80	0	0	243	4	27	106	3.00E-40	165.2	NLTP_MOUSE	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Mus musculus (Mouse)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006637; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0036042; GO:0042802; GO:0043065; GO:0043231; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN30079_c0_g1_i1	P22307	NLTP_HUMAN	100	52	0	0	207	52	496	547	1.80E-22	105.9	NLTP_HUMAN	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	SCP2	Homo sapiens (Human)	547	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; protein targeting to peroxisome [GO:0006625]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006694; GO:0006699; GO:0006701; GO:0008206; GO:0008526; GO:0015485; GO:0015914; GO:0016020; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033540; GO:0033814; GO:0036042; GO:0036109; GO:0043231; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373	alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; protein targeting to peroxisome [GO:0006625]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN39747_c0_g1_i1	P32020	NLTP_MOUSE	100	65	0	0	250	56	483	547	8.30E-30	130.6	NLTP_MOUSE	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Mus musculus (Mouse)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006637; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0036042; GO:0042802; GO:0043065; GO:0043231; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN37137_c0_g1_i1	P22307	NLTP_HUMAN	100	66	0	0	3	200	302	367	2.60E-34	145.2	NLTP_HUMAN	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	SCP2	Homo sapiens (Human)	547	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; protein targeting to peroxisome [GO:0006625]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006694; GO:0006699; GO:0006701; GO:0008206; GO:0008526; GO:0015485; GO:0015914; GO:0016020; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033540; GO:0033814; GO:0036042; GO:0036109; GO:0043231; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373	alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; protein targeting to peroxisome [GO:0006625]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN24509_c0_g1_i1	O62742	NLTP_RABIT	72.9	70	19	0	8	217	334	403	7.00E-22	104.4	NLTP_RABIT	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	SCP2	Oryctolagus cuniculus (Rabbit)	547	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylcholine transfer activity [GO:0120019]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; lipid transport [GO:0006869]	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylcholine transfer activity [GO:0120019]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]	GO:0003988; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0033814; GO:0050632; GO:0050633; GO:0120019; GO:0120020	bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN991_c0_g1_i1	P32020	NLTP_MOUSE	59.5	185	69	1	92	628	362	546	1.20E-52	208	NLTP_MOUSE	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Mus musculus (Mouse)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006637; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0036042; GO:0042802; GO:0043065; GO:0043231; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN991_c0_g1_i2	P11915	NLTP_RAT	63.2	546	191	4	61	1671	2	546	5.40E-192	672.2	NLTP_RAT	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Rattus norvegicus (Rat)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; cellular response to cholesterol [GO:0071397]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; response to estradiol [GO:0032355]; response to luteinizing hormone [GO:0034699]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032355; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0034699; GO:0036042; GO:0042802; GO:0043065; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0071397; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	aging [GO:0007568]; bile acid metabolic process [GO:0008206]; cellular response to cholesterol [GO:0071397]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; response to estradiol [GO:0032355]; response to luteinizing hormone [GO:0034699]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN991_c0_g1_i4	P32020	NLTP_MOUSE	59.7	186	69	1	107	646	361	546	7.10E-53	208.8	NLTP_MOUSE	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Mus musculus (Mouse)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006637; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0036042; GO:0042802; GO:0043065; GO:0043231; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN991_c0_g1_i6	P32020	NLTP_MOUSE	58.2	194	74	2	75	635	353	546	5.40E-53	209.1	NLTP_MOUSE	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Mus musculus (Mouse)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006637; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0036042; GO:0042802; GO:0043065; GO:0043231; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	acyl-CoA metabolic process [GO:0006637]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN28465_c0_g1_i1	P11915	NLTP_RAT	52.8	125	49	3	383	9	279	393	1.60E-27	123.6	NLTP_RAT	reviewed	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	Scp2 Scp-2	Rattus norvegicus (Rat)	547	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; aging [GO:0007568]; bile acid metabolic process [GO:0008206]; cellular response to cholesterol [GO:0071397]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; response to estradiol [GO:0032355]; response to luteinizing hormone [GO:0034699]; steroid biosynthetic process [GO:0006694]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial outer membrane [GO:0031315]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006694; GO:0006701; GO:0007031; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0019898; GO:0031315; GO:0032355; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0034699; GO:0036042; GO:0042802; GO:0043065; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0071397; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121	aging [GO:0007568]; bile acid metabolic process [GO:0008206]; cellular response to cholesterol [GO:0071397]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; response to estradiol [GO:0032355]; response to luteinizing hormone [GO:0034699]; steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN11101_c0_g1_i1	B5F731	RIHC_SALA4	25.9	220	124	5	85	738	120	302	6.40E-10	66.2	RIHC_SALA4	reviewed	Non-specific ribonucleoside hydrolase RihC (EC 3.2.-.-) (Purine/pyrimidine ribonucleoside hydrolase)	rihC SeAg_B0058	Salmonella agona (strain SL483)	306	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]"		"hydrolase activity, acting on glycosyl bonds [GO:0016798]"	GO:0006144; GO:0006206; GO:0016798	purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]		NA	NA	NA	NA	NA	NA
TRINITY_DN11101_c0_g1_i3	B5F731	RIHC_SALA4	25.9	220	124	5	85	738	120	302	6.00E-10	66.2	RIHC_SALA4	reviewed	Non-specific ribonucleoside hydrolase RihC (EC 3.2.-.-) (Purine/pyrimidine ribonucleoside hydrolase)	rihC SeAg_B0058	Salmonella agona (strain SL483)	306	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]"		"hydrolase activity, acting on glycosyl bonds [GO:0016798]"	GO:0006144; GO:0006206; GO:0016798	purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]		NA	NA	NA	NA	NA	NA
TRINITY_DN30997_c0_g1_i1	Q09225	NRF6_CAEEL	46.6	58	28	2	217	47	340	395	1.90E-07	56.2	NRF6_CAEEL	reviewed	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	nrf-6 C08B11.4	Caenorhabditis elegans	822	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"	integral component of membrane [GO:0016021]	"lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	lipid transport [GO:0006869]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN2493_c0_g1_i1	Q8IVI9	NOSTN_HUMAN	29.7	397	263	7	79	1245	38	426	5.10E-39	164.1	NOSTN_HUMAN	reviewed	Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer)	NOSTRIN	Homo sapiens (Human)	506	"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"	cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892; GO:0050999	"endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2493_c0_g1_i2	Q8IVI9	NOSTN_HUMAN	29.2	421	282	7	105	1343	14	426	1.90E-44	182.2	NOSTN_HUMAN	reviewed	Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer)	NOSTRIN	Homo sapiens (Human)	506	"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"	cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892; GO:0050999	"endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2493_c0_g1_i3	Q8IVI9	NOSTN_HUMAN	29.4	538	314	10	105	1688	14	495	2.10E-58	228.4	NOSTN_HUMAN	reviewed	Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer)	NOSTRIN	Homo sapiens (Human)	506	"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"	cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892; GO:0050999	"endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2493_c0_g1_i4	Q8IVI9	NOSTN_HUMAN	29.8	514	295	10	79	1590	38	495	7.30E-53	209.9	NOSTN_HUMAN	reviewed	Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer)	NOSTRIN	Homo sapiens (Human)	506	"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"	cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892; GO:0050999	"endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11619_c0_g1_i1	Q9FLX9	NLE1_ARATH	69.9	103	31	0	1	309	340	442	2.40E-39	162.5	NLE1_ARATH	reviewed	Notchless protein homolog	NLE1 At5g52820 MXC20.4	Arabidopsis thaliana (Mouse-ear cress)	473	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]; embryo sac development [GO:0009553]; ribosomal large subunit assembly [GO:0000027]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]		GO:0000027; GO:0005730; GO:0009553; GO:0080008	embryo sac development [GO:0009553]; ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN36599_c0_g1_i1	Q7ZXK9	NLE1_XENLA	76.2	122	29	0	1	366	355	476	1.00E-51	204.1	NLE1_XENLA	reviewed	Notchless protein homolog 1	nle1 nle	Xenopus laevis (African clawed frog)	476	nucleolus [GO:0005730]; Notch signaling pathway [GO:0007219]	nucleolus [GO:0005730]		GO:0005730; GO:0007219	Notch signaling pathway [GO:0007219]		blue	blue	NA	NA	NA	NA
TRINITY_DN38527_c0_g1_i1	A4II29	NRARP_XENTR	46	100	50	2	427	714	15	114	2.90E-17	90.9	NRARP_XENTR	reviewed	Notch-regulated ankyrin repeat-containing protein	nrarp	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	114	blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]			GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0045746; GO:0090263	blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]		blue	blue	NA	NA	NA	NA
TRINITY_DN2696_c0_g1_i7	P56941	NPC1_PIG	49.2	59	28	1	338	162	1063	1119	5.50E-08	58.5	NPC1_PIG	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Sus scrofa (Pig)	1277	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103	bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]		brown	brown	1	NA	NA	NA
TRINITY_DN1958_c0_g1_i2	O15118	NPC1_HUMAN	37.8	998	523	21	102	2990	25	959	1.30E-182	641.7	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN1958_c0_g1_i4	O15118	NPC1_HUMAN	37.3	816	417	19	3	2354	50	802	1.70E-135	485	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN1958_c0_g1_i6	O15118	NPC1_HUMAN	36.4	885	463	21	102	2645	25	846	7.20E-143	509.6	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN3245_c0_g2_i2	O15118	NPC1_HUMAN	34.9	172	108	4	54	557	1082	1253	2.80E-17	90.5	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN8183_c0_g1_i3	O15118	NPC1_HUMAN	59.5	232	94	0	698	3	580	811	7.40E-76	285	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN8183_c0_g1_i4	O35604	NPC1_MOUSE	59.2	120	49	0	380	21	686	805	2.60E-36	152.9	NPC1_MOUSE	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	Npc1	Mus musculus (Mouse)	1277	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015485; GO:0016020; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032367; GO:0033344; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN35713_c0_g1_i1	O15118	NPC1_HUMAN	100	87	0	0	261	1	829	915	1.30E-44	179.9	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN35844_c0_g1_i1	O15118	NPC1_HUMAN	100	84	0	0	3	254	1165	1248	4.90E-38	157.9	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN2696_c0_g1_i2	O35604	NPC1_MOUSE	55	180	79	1	1259	720	1077	1254	4.80E-44	180.3	NPC1_MOUSE	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	Npc1	Mus musculus (Mouse)	1277	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015485; GO:0016020; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032367; GO:0033344; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN2696_c0_g1_i3	P56941	NPC1_PIG	59.2	191	76	1	1301	729	1063	1251	2.10E-52	208	NPC1_PIG	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Sus scrofa (Pig)	1277	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103	bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2696_c0_g3_i1	O15118	NPC1_HUMAN	72.7	121	33	0	425	63	1137	1257	8.40E-41	167.9	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN2696_c0_g3_i2	O15118	NPC1_HUMAN	72.7	121	33	0	485	123	1137	1257	9.60E-41	167.9	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN12586_c0_g1_i1	P56941	NPC1_PIG	54.7	86	39	0	3	260	838	923	4.00E-19	95.1	NPC1_PIG	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Sus scrofa (Pig)	1277	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103	bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN19949_c0_g1_i1	P56941	NPC1_PIG	52.4	84	40	0	191	442	831	914	4.00E-19	95.9	NPC1_PIG	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Sus scrofa (Pig)	1277	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103	bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN17933_c0_g1_i1	O15118	NPC1_HUMAN	50.6	79	39	0	5	241	339	417	1.40E-16	86.7	NPC1_HUMAN	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Homo sapiens (Human)	1278	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN13689_c0_g1_i1	P56941	NPC1_PIG	53.5	213	88	2	1	636	1057	1259	3.00E-52	207.2	NPC1_PIG	reviewed	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	Sus scrofa (Pig)	1277	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103	bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN7497_c0_g1_i1	Q9VRC9	NPC1B_DROME	23.5	968	607	27	183	2825	314	1234	7.60E-48	194.1	NPC1B_DROME	reviewed	NPC intracellular cholesterol transporter 1 homolog 1b (Niemann-Pick type protein homolog 1b)	Npc1b CG12092	Drosophila melanogaster (Fruit fly)	1254	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007391; GO:0007417; GO:0007422; GO:0008203; GO:0016021; GO:0030299	central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]		NA	NA	NA	NA	NA	NA
TRINITY_DN7497_c0_g2_i1	Q9VRC9	NPC1B_DROME	24.8	616	393	13	1875	232	621	1234	2.10E-40	168.7	NPC1B_DROME	reviewed	NPC intracellular cholesterol transporter 1 homolog 1b (Niemann-Pick type protein homolog 1b)	Npc1b CG12092	Drosophila melanogaster (Fruit fly)	1254	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007391; GO:0007417; GO:0007422; GO:0008203; GO:0016021; GO:0030299	central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]		NA	NA	NA	NA	NA	NA
TRINITY_DN3245_c0_g2_i7	Q9VRC9	NPC1B_DROME	36.2	127	78	3	25	399	1112	1237	2.40E-16	87	NPC1B_DROME	reviewed	NPC intracellular cholesterol transporter 1 homolog 1b (Niemann-Pick type protein homolog 1b)	Npc1b CG12092	Drosophila melanogaster (Fruit fly)	1254	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007391; GO:0007417; GO:0007422; GO:0008203; GO:0016021; GO:0030299	central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]		NA	NA	NA	NA	NA	NA
TRINITY_DN25530_c0_g1_i1	Q9VRC9	NPC1B_DROME	47.9	71	36	1	4	213	1058	1128	1.70E-10	66.2	NPC1B_DROME	reviewed	NPC intracellular cholesterol transporter 1 homolog 1b (Niemann-Pick type protein homolog 1b)	Npc1b CG12092	Drosophila melanogaster (Fruit fly)	1254	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007391; GO:0007417; GO:0007422; GO:0008203; GO:0016021; GO:0030299	central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]		NA	NA	NA	NA	NA	NA
TRINITY_DN17933_c0_g1_i2	Q9VRC9	NPC1B_DROME	44.1	93	52	0	5	283	314	406	5.40E-17	88.2	NPC1B_DROME	reviewed	NPC intracellular cholesterol transporter 1 homolog 1b (Niemann-Pick type protein homolog 1b)	Npc1b CG12092	Drosophila melanogaster (Fruit fly)	1254	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007391; GO:0007417; GO:0007422; GO:0008203; GO:0016021; GO:0030299	central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]		NA	NA	NA	NA	NA	NA
TRINITY_DN34634_c0_g1_i1	P51688	SPHM_HUMAN	46.6	148	75	1	33	476	359	502	2.10E-35	150.2	SPHM_HUMAN	reviewed	N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)	SGSH HSS	Homo sapiens (Human)	502	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062	glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]		NA	NA	NA	NA	NA	NA
TRINITY_DN11502_c0_g1_i1	Q91044	NTRK3_CHICK	78.4	88	19	0	46	309	672	759	2.10E-38	159.5	NTRK3_CHICK	reviewed	NT-3 growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase) (Trk-C)	NTRK3 TRKC	Gallus gallus (Chicken)	827	axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of GTPase activity [GO:0090630]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian rhythm [GO:0007623]; heart development [GO:0007507]; lens fiber cell differentiation [GO:0070306]; mechanoreceptor differentiation [GO:0042490]; multicellular organism development [GO:0007275]; myelination in peripheral nervous system [GO:0022011]; negative regulation of protein phosphorylation [GO:0001933]; nervous system development [GO:0007399]; neuronal action potential propagation [GO:0019227]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of synapse assembly [GO:0051965]; regulation of MAPK cascade [GO:0043408]; regulation of protein kinase B signaling [GO:0051896]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000187; GO:0001933; GO:0002039; GO:0004714; GO:0005030; GO:0005524; GO:0005737; GO:0005887; GO:0007169; GO:0007275; GO:0007399; GO:0007507; GO:0007623; GO:0008284; GO:0010628; GO:0010976; GO:0014068; GO:0019227; GO:0022011; GO:0030335; GO:0030424; GO:0032148; GO:0033138; GO:0033674; GO:0042490; GO:0043065; GO:0043121; GO:0043235; GO:0043408; GO:0043410; GO:0048691; GO:0050927; GO:0051896; GO:0051965; GO:0070306; GO:0090630; GO:1990090; GO:2000251	activation of GTPase activity [GO:0090630]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian rhythm [GO:0007623]; heart development [GO:0007507]; lens fiber cell differentiation [GO:0070306]; mechanoreceptor differentiation [GO:0042490]; multicellular organism development [GO:0007275]; myelination in peripheral nervous system [GO:0022011]; negative regulation of protein phosphorylation [GO:0001933]; nervous system development [GO:0007399]; neuronal action potential propagation [GO:0019227]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of synapse assembly [GO:0051965]; regulation of MAPK cascade [GO:0043408]; regulation of protein kinase B signaling [GO:0051896]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN23236_c0_g2_i1	Q9EQC5	SCYL1_MOUSE	98.6	70	1	0	211	2	395	464	1.40E-33	142.9	SCYL1_MOUSE	reviewed	N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1)	Scyl1	Mus musculus (Mouse)	806	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0021522; GO:0030126; GO:0034613; GO:0048666	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33054_c0_g1_i1	Q9EQC5	SCYL1_MOUSE	100	69	0	0	3	209	326	394	2.80E-31	135.2	SCYL1_MOUSE	reviewed	N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1)	Scyl1	Mus musculus (Mouse)	806	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0021522; GO:0030126; GO:0034613; GO:0048666	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39034_c0_g1_i1	Q96KG9	SCYL1_HUMAN	100	92	0	0	277	2	293	384	9.30E-46	183.7	SCYL1_HUMAN	reviewed	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	Homo sapiens (Human)	808	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]	GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0016020; GO:0021522; GO:0030126; GO:0034613; GO:0045296; GO:0048666	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23236_c0_g1_i1	Q96KG9	SCYL1_HUMAN	100	118	0	0	355	2	347	464	9.90E-61	233.8	SCYL1_HUMAN	reviewed	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	Homo sapiens (Human)	808	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]	GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0016020; GO:0021522; GO:0030126; GO:0034613; GO:0045296; GO:0048666	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8936_c0_g1_i1	Q96KG9	SCYL1_HUMAN	55.7	359	159	0	1080	4	209	567	5.40E-110	399.1	SCYL1_HUMAN	reviewed	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	Homo sapiens (Human)	808	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]	GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0016020; GO:0021522; GO:0030126; GO:0034613; GO:0045296; GO:0048666	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8936_c0_g1_i2	Q96KG9	SCYL1_HUMAN	57.3	232	99	0	699	4	336	567	4.90E-70	265.8	SCYL1_HUMAN	reviewed	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	Homo sapiens (Human)	808	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]	GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0016020; GO:0021522; GO:0030126; GO:0034613; GO:0045296; GO:0048666	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8936_c0_g1_i3	Q28FH2	SCYL1_XENTR	56.3	126	55	0	384	7	436	561	5.70E-32	138.7	SCYL1_XENTR	reviewed	N-terminal kinase-like protein (SCY1-like protein 1)	scyl1 TEgg006d23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	827	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]		ATP binding [GO:0005524]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN29963_c0_g1_i1	Q9BV86	NTM1A_HUMAN	100	130	0	0	390	1	65	194	9.50E-73	273.9	NTM1A_HUMAN	reviewed	"N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (N-terminal RCC1 methyltransferase) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A) [Cleaved into: N-terminal Xaa-Pro-Lys N-methyltransferase 1, N-terminally processed]"	NTMT1 C9orf32 METTL11A NRMT NRMT1 AD-003	Homo sapiens (Human)	223	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-alanine methylation [GO:0018011]; N-terminal peptidyl-alanine trimethylation [GO:0018012]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-proline methylation [GO:0035568]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine methylation [GO:0035570]; N-terminal peptidyl-serine trimethylation [GO:0035573]; N-terminal protein amino acid methylation [GO:0006480]; spindle organization [GO:0007051]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006480; GO:0007051; GO:0007059; GO:0008168; GO:0008276; GO:0016571; GO:0018011; GO:0018012; GO:0018013; GO:0018016; GO:0035568; GO:0035570; GO:0035572; GO:0035573; GO:0042054; GO:0071885	chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-alanine methylation [GO:0018011]; N-terminal peptidyl-alanine trimethylation [GO:0018012]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-proline methylation [GO:0035568]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine methylation [GO:0035570]; N-terminal peptidyl-serine trimethylation [GO:0035573]; N-terminal protein amino acid methylation [GO:0006480]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN4339_c0_g1_i1	B1H2P7	NTM1A_XENTR	49.5	208	101	3	179	793	12	218	8.70E-54	212.2	NTM1A_XENTR	reviewed	N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A)	ntmt1 mettl11a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	224	cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-alanine methylation [GO:0018011]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-proline methylation [GO:0035568]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine methylation [GO:0035570]; N-terminal peptidyl-serine trimethylation [GO:0035573]; N-terminal protein amino acid methylation [GO:0006480]; spindle organization [GO:0007051]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]	GO:0005634; GO:0005737; GO:0006480; GO:0007051; GO:0007059; GO:0008168; GO:0008276; GO:0016571; GO:0018011; GO:0018013; GO:0018016; GO:0035568; GO:0035570; GO:0035572; GO:0035573; GO:0042054; GO:0071885	chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-alanine methylation [GO:0018011]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-proline methylation [GO:0035568]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine methylation [GO:0035570]; N-terminal peptidyl-serine trimethylation [GO:0035573]; N-terminal protein amino acid methylation [GO:0006480]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN10743_c0_g4_i1	Q9UKK6	NXT1_HUMAN	39	136	78	2	169	561	1	136	1.20E-21	105.1	NXT1_HUMAN	reviewed	NTF2-related export protein 1 (Protein p15)	NXT1	Homo sapiens (Human)	140	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	Ran GTPase binding [GO:0008536]	GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0008536; GO:0016607; GO:0044613	mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]		blue	blue	NA	NA	NA	NA
TRINITY_DN6_c0_g2_i1	O60285	NUAK1_HUMAN	54.8	323	142	1	146	1114	41	359	2.20E-96	354	NUAK1_HUMAN	reviewed	NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)	NUAK1 ARK5 KIAA0537 OMPHK1	Homo sapiens (Human)	661	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:1901796; GO:2000772	cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN6_c0_g2_i2	O60285	NUAK1_HUMAN	54.8	323	142	1	145	1113	41	359	2.20E-96	354	NUAK1_HUMAN	reviewed	NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)	NUAK1 ARK5 KIAA0537 OMPHK1	Homo sapiens (Human)	661	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:1901796; GO:2000772	cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN6_c0_g2_i4	O60285	NUAK1_HUMAN	58.6	157	65	0	146	616	41	197	1.90E-47	190.7	NUAK1_HUMAN	reviewed	NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)	NUAK1 ARK5 KIAA0537 OMPHK1	Homo sapiens (Human)	661	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:1901796; GO:2000772	cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN27848_c0_g1_i1	O60285	NUAK1_HUMAN	44.5	128	71	0	384	1	103	230	5.60E-28	125.2	NUAK1_HUMAN	reviewed	NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)	NUAK1 ARK5 KIAA0537 OMPHK1	Homo sapiens (Human)	661	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:1901796; GO:2000772	cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN34961_c0_g1_i1	Q66HE5	NUAK2_RAT	51.1	88	39	3	15	278	145	228	1.00E-15	84	NUAK2_RAT	reviewed	NUAK family SNF1-like kinase 2 (EC 2.7.11.1) (SNF1/AMP kinase-related kinase) (SNARK)	Nuak2	Rattus norvegicus (Rat)	630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006915; GO:0030036; GO:0035556; GO:0042149; GO:0043066	actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN26188_c0_g1_i1	Q09161	NCBP1_HUMAN	96.4	83	3	0	2	250	268	350	6.00E-44	177.6	NCBP1_HUMAN	reviewed	Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)	NCBP1 CBP80 NCBP	Homo sapiens (Human)	790	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005845; GO:0005846; GO:0006366; GO:0006368; GO:0006369; GO:0006370; GO:0006401; GO:0006405; GO:0006406; GO:0006446; GO:0008334; GO:0008380; GO:0008543; GO:0016070; GO:0030307; GO:0031047; GO:0031124; GO:0031442; GO:0034518; GO:0042795; GO:0045292; GO:0048026; GO:0050684; GO:0051168; GO:0098789; GO:1905216; GO:1990904	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33013_c0_g1_i1	Q09161	NCBP1_HUMAN	100	105	0	0	3	317	22	126	1.20E-52	206.8	NCBP1_HUMAN	reviewed	Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)	NCBP1 CBP80 NCBP	Homo sapiens (Human)	790	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005845; GO:0005846; GO:0006366; GO:0006368; GO:0006369; GO:0006370; GO:0006401; GO:0006405; GO:0006406; GO:0006446; GO:0008334; GO:0008380; GO:0008543; GO:0016070; GO:0030307; GO:0031047; GO:0031124; GO:0031442; GO:0034518; GO:0042795; GO:0045292; GO:0048026; GO:0050684; GO:0051168; GO:0098789; GO:1905216; GO:1990904	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32971_c0_g1_i1	Q09161	NCBP1_HUMAN	100	91	0	0	3	275	699	789	3.10E-46	185.3	NCBP1_HUMAN	reviewed	Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)	NCBP1 CBP80 NCBP	Homo sapiens (Human)	790	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005845; GO:0005846; GO:0006366; GO:0006368; GO:0006369; GO:0006370; GO:0006401; GO:0006405; GO:0006406; GO:0006446; GO:0008334; GO:0008380; GO:0008543; GO:0016070; GO:0030307; GO:0031047; GO:0031124; GO:0031442; GO:0034518; GO:0042795; GO:0045292; GO:0048026; GO:0050684; GO:0051168; GO:0098789; GO:1905216; GO:1990904	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7394_c0_g1_i1	B4JM29	NCBP1_DROGR	62.1	802	290	5	75	2444	1	800	1.30E-290	1000.3	NCBP1_DROGR	reviewed	Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)	Cbp80 GH24565	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	800	"nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]"	nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]	RNA cap binding [GO:0000339]	GO:0000339; GO:0005634; GO:0005846; GO:0006370; GO:0031047; GO:0045292; GO:0051028	"7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39946_c0_g1_i1	Q09161	NCBP1_HUMAN	100	67	0	0	2	202	212	278	1.60E-36	152.5	NCBP1_HUMAN	reviewed	Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)	NCBP1 CBP80 NCBP	Homo sapiens (Human)	790	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005845; GO:0005846; GO:0006366; GO:0006368; GO:0006369; GO:0006370; GO:0006401; GO:0006405; GO:0006406; GO:0006446; GO:0008334; GO:0008380; GO:0008543; GO:0016070; GO:0030307; GO:0031047; GO:0031124; GO:0031442; GO:0034518; GO:0042795; GO:0045292; GO:0048026; GO:0050684; GO:0051168; GO:0098789; GO:1905216; GO:1990904	"7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene silencing by RNA [GO:0031047]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4552_c0_g1_i1	Q5ZMC9	NDE1_CHICK	55.6	81	36	0	321	79	50	130	2.00E-15	83.2	NDE1_CHICK	reviewed	Nuclear distribution protein nudE homolog 1	NDE1 RCJMB04_2i10	Gallus gallus (Chicken)	342	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]	GO:0000132; GO:0000776; GO:0001764; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0016477; GO:0021987; GO:0031616; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:2000574	cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN4552_c0_g1_i2	Q9NXR1	NDE1_HUMAN	49.3	280	101	5	935	120	49	295	6.90E-53	209.1	NDE1_HUMAN	reviewed	Nuclear distribution protein nudE homolog 1 (NudE)	NDE1 NUDE	Homo sapiens (Human)	335	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]	GO:0000086; GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0010389; GO:0016020; GO:0016477; GO:0019904; GO:0021987; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:0097711; GO:2000574	cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN4552_c0_g1_i4	Q9NXR1	NDE1_HUMAN	50	264	108	3	890	120	49	295	6.10E-51	202.6	NDE1_HUMAN	reviewed	Nuclear distribution protein nudE homolog 1 (NudE)	NDE1 NUDE	Homo sapiens (Human)	335	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]	GO:0000086; GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0010389; GO:0016020; GO:0016477; GO:0019904; GO:0021987; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:0097711; GO:2000574	cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN31774_c0_g1_i1	Q9NXR1	NDE1_HUMAN	100	66	0	0	201	4	98	163	1.10E-27	123.2	NDE1_HUMAN	reviewed	Nuclear distribution protein nudE homolog 1 (NudE)	NDE1 NUDE	Homo sapiens (Human)	335	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]	GO:0000086; GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0010389; GO:0016020; GO:0016477; GO:0019904; GO:0021987; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:0097711; GO:2000574	cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN30862_c0_g1_i1	Q9GZM8	NDEL1_HUMAN	58.9	141	0	1	249	1	152	292	2.20E-30	132.5	NDEL1_HUMAN	reviewed	Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1)	NDEL1 EOPA MITAP1 NUDEL	Homo sapiens (Human)	345	axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]	alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]	GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0001833; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:1900029; GO:1904115; GO:1990138; GO:2000574	activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN30645_c0_g1_i1	Q9GZM8	NDEL1_HUMAN	100	90	0	0	270	1	87	176	3.30E-40	165.2	NDEL1_HUMAN	reviewed	Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1)	NDEL1 EOPA MITAP1 NUDEL	Homo sapiens (Human)	345	axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]	alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]	GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0001833; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:1900029; GO:1904115; GO:1990138; GO:2000574	activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN27898_c0_g1_i1	Q9UUJ6	NED1_SCHPO	49.4	77	39	0	231	1	357	433	4.00E-18	91.7	NED1_SCHPO	reviewed	Nuclear elongation and deformation protein 1	ned1 SPAC1952.13	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	656	cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; phosphatidate phosphatase activity [GO:0008195]; cellular lipid metabolic process [GO:0044255]; endoplasmic reticulum organization [GO:0007029]; fatty acid catabolic process [GO:0009062]; nuclear membrane organization [GO:0071763]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; phosphatidate phosphatase activity [GO:0008195]	GO:0000287; GO:0005634; GO:0005829; GO:0007029; GO:0008195; GO:0009062; GO:0019432; GO:0044255; GO:0071763	cellular lipid metabolic process [GO:0044255]; endoplasmic reticulum organization [GO:0007029]; fatty acid catabolic process [GO:0009062]; nuclear membrane organization [GO:0071763]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN2800_c0_g1_i2	Q5RDB4	NEMP1_PONAB	40.2	264	149	4	498	1271	145	405	4.00E-49	197.2	NEMP1_PONAB	reviewed	Nuclear envelope integral membrane protein 1	NEMP1 TMEM194A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	444	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]		GO:0005635; GO:0005637; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2800_c0_g1_i3	Q28EH9	NEMP1_XENTR	36.7	294	168	8	468	1313	121	408	7.30E-46	186.4	NEMP1_XENTR	reviewed	Nuclear envelope integral membrane protein 1	nemp1 tmem194a TTpA010p19.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	431	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; eye development [GO:0001654]	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]		GO:0001654; GO:0005635; GO:0005637; GO:0016021	eye development [GO:0001654]		NA	NA	NA	NA	NA	NA
TRINITY_DN25898_c0_g1_i1	Q3ZBP2	NEPR1_BOVIN	98.2	57	1	0	172	2	1	57	1.90E-27	122.5	NEPR1_BOVIN	reviewed	Nuclear envelope phosphatase-regulatory subunit 1 (Transmembrane protein 188)	CNEP1R1 TMEM188	Bos taurus (Bovine)	125	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]; lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]		GO:0005737; GO:0005829; GO:0006629; GO:0010867; GO:0016021; GO:0031965; GO:0034504; GO:0035307; GO:0071595	lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN4639_c0_g1_i1	Q5M8F7	NEPR1_XENTR	63.9	122	42	1	467	102	3	122	6.00E-36	152.1	NEPR1_XENTR	reviewed	Nuclear envelope phosphatase-regulatory subunit 1 (Transmembrane protein 188)	cnep1r1 tmem188 TEgg132c10.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	125	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]; lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]		GO:0005737; GO:0006629; GO:0010867; GO:0016021; GO:0031965; GO:0035307; GO:0071595	lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]		blue	blue	NA	NA	NA	NA
TRINITY_DN4639_c0_g1_i2	Q5M8F7	NEPR1_XENTR	59	78	30	1	319	86	3	78	2.70E-17	89.7	NEPR1_XENTR	reviewed	Nuclear envelope phosphatase-regulatory subunit 1 (Transmembrane protein 188)	cnep1r1 tmem188 TEgg132c10.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	125	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]; lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]		GO:0005737; GO:0006629; GO:0010867; GO:0016021; GO:0031965; GO:0035307; GO:0071595	lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]		blue	blue	NA	NA	NA	NA
TRINITY_DN3077_c0_g1_i1	Q9H7Z3	NRDE2_HUMAN	25.6	1094	710	26	30	3191	134	1163	5.10E-82	307.8	NRDE2_HUMAN	reviewed	Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog)	NRDE2 C14orf102	Homo sapiens (Human)	1164	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0016246; GO:0016607; GO:0031048; GO:0046833; GO:1902369	heterochromatin assembly by small RNA [GO:0031048]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]		NA	NA	NA	NA	NA	NA
TRINITY_DN3077_c0_g1_i2	Q80XC6	NRDE2_MOUSE	26.5	622	405	19	120	1943	588	1171	1.30E-35	152.9	NRDE2_MOUSE	reviewed	Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog)	Nrde2	Mus musculus (Mouse)	1172	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]; RNA processing [GO:0006396]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0006396; GO:0016246; GO:0016607; GO:0031048; GO:0046833; GO:1902369	heterochromatin assembly by small RNA [GO:0031048]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN32433_c0_g1_i1	O60524	NEMF_HUMAN	98.9	91	1	0	274	2	317	407	1.80E-41	169.5	NEMF_HUMAN	reviewed	Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1)	NEMF SDCCAG1	Homo sapiens (Human)	1076	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0043023; GO:0051168; GO:0072344; GO:1990112; GO:1990116	nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN27871_c0_g1_i1	O60524	NEMF_HUMAN	100	140	0	0	423	4	2	141	1.90E-74	279.6	NEMF_HUMAN	reviewed	Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1)	NEMF SDCCAG1	Homo sapiens (Human)	1076	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0043023; GO:0051168; GO:0072344; GO:1990112; GO:1990116	nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN28917_c0_g1_i1	Q9VBX1	NEMF_DROME	44.4	81	40	1	233	6	520	600	6.60E-14	77.8	NEMF_DROME	reviewed	Nuclear export mediator factor NEMF homolog (Protein Caliban)	Clbn CG11847	Drosophila melanogaster (Fruit fly)	992	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006611; GO:0043023; GO:0072344; GO:1902167; GO:1902231; GO:1990112; GO:1990116	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN35208_c0_g1_i1	Q9VBX1	NEMF_DROME	49.5	99	50	0	326	30	56	154	5.70E-23	108.2	NEMF_DROME	reviewed	Nuclear export mediator factor NEMF homolog (Protein Caliban)	Clbn CG11847	Drosophila melanogaster (Fruit fly)	992	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006611; GO:0043023; GO:0072344; GO:1902167; GO:1902231; GO:1990112; GO:1990116	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN5988_c1_g1_i1	Q9VBX1	NEMF_DROME	49	708	312	7	2114	90	2	693	8.00E-177	622.1	NEMF_DROME	reviewed	Nuclear export mediator factor NEMF homolog (Protein Caliban)	Clbn CG11847	Drosophila melanogaster (Fruit fly)	992	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006611; GO:0043023; GO:0072344; GO:1902167; GO:1902231; GO:1990112; GO:1990116	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN27078_c0_g1_i1	Q9VBX1	NEMF_DROME	60.6	160	63	0	481	2	509	668	6.70E-52	204.9	NEMF_DROME	reviewed	Nuclear export mediator factor NEMF homolog (Protein Caliban)	Clbn CG11847	Drosophila melanogaster (Fruit fly)	992	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006611; GO:0043023; GO:0072344; GO:1902167; GO:1902231; GO:1990112; GO:1990116	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]		NA	NA	NA	NA	NA	NA
TRINITY_DN30361_c0_g1_i1	Q08D88	NFIL3_BOVIN	50.6	83	41	0	549	301	47	129	2.50E-12	74.3	NFIL3_BOVIN	reviewed	Nuclear factor interleukin-3-regulated protein	NFIL3	Bos taurus (Bovine)	462	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0006955; GO:0007623; GO:0045892; GO:0045893	"circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30361_c0_g1_i2	Q08D88	NFIL3_BOVIN	50.6	83	41	0	956	708	47	129	3.70E-12	74.3	NFIL3_BOVIN	reviewed	Nuclear factor interleukin-3-regulated protein	NFIL3	Bos taurus (Bovine)	462	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0006955; GO:0007623; GO:0045892; GO:0045893	"circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30361_c0_g1_i3	Q08D88	NFIL3_BOVIN	50.6	83	41	0	1004	756	47	129	3.80E-12	74.3	NFIL3_BOVIN	reviewed	Nuclear factor interleukin-3-regulated protein	NFIL3	Bos taurus (Bovine)	462	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0006955; GO:0007623; GO:0045892; GO:0045893	"circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1145_c0_g1_i1	Q94527	NFKB1_DROME	38.9	357	188	9	1273	236	116	453	1.10E-54	215.7	NFKB1_DROME	reviewed	Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]	Rel CG11992	Drosophila melanogaster (Fruit fly)	971	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0002230; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:2000647	cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]		blue	blue	NA	NA	NA	NA
TRINITY_DN1145_c0_g1_i3	Q94527	NFKB1_DROME	38.9	357	188	9	1242	205	116	453	1.10E-54	215.7	NFKB1_DROME	reviewed	Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]	Rel CG11992	Drosophila melanogaster (Fruit fly)	971	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0002230; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:2000647	cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]		blue	blue	NA	NA	NA	NA
TRINITY_DN1145_c0_g1_i4	Q94527	NFKB1_DROME	38.9	357	188	9	1273	236	116	453	1.10E-54	215.7	NFKB1_DROME	reviewed	Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]	Rel CG11992	Drosophila melanogaster (Fruit fly)	971	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0002230; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:2000647	cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN1145_c0_g1_i5	Q94527	NFKB1_DROME	38.9	357	188	9	1242	205	116	453	1.10E-54	215.7	NFKB1_DROME	reviewed	Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]	Rel CG11992	Drosophila melanogaster (Fruit fly)	971	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0002230; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:2000647	cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN1145_c0_g1_i6	Q94527	NFKB1_DROME	38.9	352	185	9	1114	92	116	448	1.70E-54	214.9	NFKB1_DROME	reviewed	Nuclear factor NF-kappa-B p110 subunit (Rel-p110) (Relish protein) [Cleaved into: Nuclear factor NF-kappa-B p68 subunit (Rel-p68); Nuclear factor NF-kappa-B p49 subunit (Rel-p49)]	Rel CG11992	Drosophila melanogaster (Fruit fly)	971	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0002230; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005829; GO:0006955; GO:0006963; GO:0006964; GO:0006967; GO:0006974; GO:0009617; GO:0010628; GO:0034198; GO:0042742; GO:0042802; GO:0045087; GO:0045088; GO:0045089; GO:0045429; GO:0045944; GO:0048813; GO:0048935; GO:0050766; GO:0050829; GO:0051607; GO:0061057; GO:2000647	cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; dendrite morphogenesis [GO:0048813]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of stem cell proliferation [GO:2000647]; peptidoglycan recognition protein signaling pathway [GO:0061057]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i1	Q9WV30	NFAT5_MOUSE	49.7	330	145	7	772	1755	236	546	1.10E-73	279.3	NFAT5_MOUSE	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (Rel domain-containing transcription factor NFAT5) (T-cell transcription factor NFAT5)	Nfat5	Mus musculus (Mouse)	1534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i2	Q9WV30	NFAT5_MOUSE	49.7	330	145	7	460	1443	236	546	8.70E-74	279.3	NFAT5_MOUSE	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (Rel domain-containing transcription factor NFAT5) (T-cell transcription factor NFAT5)	Nfat5	Mus musculus (Mouse)	1534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i3	Q9WV30	NFAT5_MOUSE	49.7	330	145	7	460	1443	236	546	1.20E-73	278.9	NFAT5_MOUSE	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (Rel domain-containing transcription factor NFAT5) (T-cell transcription factor NFAT5)	Nfat5	Mus musculus (Mouse)	1534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i4	Q9WV30	NFAT5_MOUSE	49.7	330	145	7	772	1755	236	546	1.40E-73	278.9	NFAT5_MOUSE	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (Rel domain-containing transcription factor NFAT5) (T-cell transcription factor NFAT5)	Nfat5	Mus musculus (Mouse)	1534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i5	Q9WV30	NFAT5_MOUSE	49.7	330	145	7	460	1443	236	546	8.80E-74	279.3	NFAT5_MOUSE	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (Rel domain-containing transcription factor NFAT5) (T-cell transcription factor NFAT5)	Nfat5	Mus musculus (Mouse)	1534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	"calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription, DNA-templated [GO:0006351]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i6	D3ZGB1	NFAT5_RAT	42.6	460	223	15	772	2115	253	683	4.50E-72	274.6	NFAT5_RAT	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5)	Nfat5	Rattus norvegicus (Rat)	1548	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i9	D3ZGB1	NFAT5_RAT	42.6	460	223	15	460	1803	253	683	4.10E-72	274.6	NFAT5_RAT	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5)	Nfat5	Rattus norvegicus (Rat)	1548	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0001816; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006366; GO:0006970; GO:0008134; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i10	O94916	NFAT5_HUMAN	50	166	66	4	460	954	236	385	8.70E-33	142.5	NFAT5_HUMAN	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP)	NFAT5 KIAA0827 TONEBP	Homo sapiens (Human)	1531	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; excretion [GO:0007588]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001816; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006366; GO:0006970; GO:0007165; GO:0007588; GO:0008134; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; excretion [GO:0007588]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN186_c0_g1_i8	O94916	NFAT5_HUMAN	50	166	66	4	772	1266	236	385	1.10E-32	142.5	NFAT5_HUMAN	reviewed	Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP)	NFAT5 KIAA0827 TONEBP	Homo sapiens (Human)	1531	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; excretion [GO:0007588]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001816; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006366; GO:0006970; GO:0007165; GO:0007588; GO:0008134; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837	calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; excretion [GO:0007588]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN3645_c0_g1_i1	Q6P4R8	NFRKB_HUMAN	48.4	318	147	5	1316	363	363	663	6.00E-81	303.1	NFRKB_HUMAN	reviewed	Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G)	NFRKB INO80G	Homo sapiens (Human)	1299	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006366; GO:0006954; GO:0016579; GO:0031011	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN3645_c0_g1_i2	Q6P4R8	NFRKB_HUMAN	48.4	318	147	5	1322	369	363	663	6.00E-81	303.1	NFRKB_HUMAN	reviewed	Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G)	NFRKB INO80G	Homo sapiens (Human)	1299	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006366; GO:0006954; GO:0016579; GO:0031011	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN3644_c0_g1_i1	O77245	E75_METEN	91.1	416	36	1	2164	917	103	517	4.60E-207	722.6	E75_METEN	reviewed	Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3)	E75 NR1D3	Metapenaeus ensis (Greasyback shrimp) (Penaeus ensis)	606	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0008270; GO:0043565			blue	blue	NA	NA	NA	NA
TRINITY_DN33225_c0_g1_i1	G5EFF5	DAF12_CAEEL	68.3	82	26	0	246	1	112	193	4.20E-31	135.2	DAF12_CAEEL	reviewed	Nuclear hormone receptor family member daf-12 (Abnormal dauer formation protein 12)	daf-12 daf-20 mig-7 XL285 F11A1.3	Caenorhabditis elegans	753	"nucleus [GO:0005634]; (25S)-Delta(4)-dafachronate binding [GO:1902051]; (25S)-Delta(7)-dafachronate binding [GO:1902052]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; cholesterol homeostasis [GO:0042632]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; heat acclimation [GO:0010286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; male mating behavior [GO:0060179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dauer larval development [GO:0061066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dauer larval development [GO:0061065]; regulation of development, heterochronic [GO:0040034]; regulation of pharyngeal pumping [GO:0043051]"	nucleus [GO:0005634]	(25S)-Delta(4)-dafachronate binding [GO:1902051]; (25S)-Delta(7)-dafachronate binding [GO:1902052]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0003700; GO:0004879; GO:0005634; GO:0006629; GO:0006935; GO:0008270; GO:0008340; GO:0010286; GO:0030154; GO:0040024; GO:0040034; GO:0042632; GO:0043051; GO:0043565; GO:0045944; GO:0055088; GO:0060179; GO:0061065; GO:0061066; GO:1902051; GO:1902052	"cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; cholesterol homeostasis [GO:0042632]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; heat acclimation [GO:0010286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; male mating behavior [GO:0060179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dauer larval development [GO:0061066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dauer larval development [GO:0061065]; regulation of development, heterochronic [GO:0040034]; regulation of pharyngeal pumping [GO:0043051]"		NA	NA	1	NA	NA	NA
TRINITY_DN37856_c0_g1_i2	Q9XYB7	NHR8_CAEEL	48.5	68	33	1	6	209	17	82	2.20E-11	69.3	NHR8_CAEEL	reviewed	Nuclear hormone receptor family member nhr-8	nhr-8 F33D4.1	Caenorhabditis elegans	560	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0004879; GO:0005634; GO:0006629; GO:0008270; GO:0030154; GO:0042632; GO:0045944; GO:0055088	cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN28348_c0_g1_i1	P49867	FTZF1_BOMMO	70.8	178	38	3	565	41	74	240	1.90E-64	246.9	FTZF1_BOMMO	reviewed	Nuclear hormone receptor FTZ-F1 (BmFTZ-F1) (Nuclear receptor subfamily 5 group A member 3)	FTZ-F1 NR5A3	Bombyx mori (Silk moth)	534	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN31159_c0_g1_i1	P33244	FTZF1_DROME	63	235	87	0	810	106	792	1026	1.10E-84	314.7	FTZF1_DROME	reviewed	Nuclear hormone receptor FTZ-F1 (FTZ-F1 alpha) (Nuclear receptor subfamily 5 group A member 3)	ftz-f1 NR5A3 CG4059	Drosophila melanogaster (Fruit fly)	1027	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell death [GO:0008219]; dendrite morphogenesis [GO:0048813]; hormone-mediated signaling pathway [GO:0009755]; imaginal disc-derived leg morphogenesis [GO:0007480]; instar larval or pupal development [GO:0002165]; juvenile hormone mediated signaling pathway [GO:0035626]; lipid homeostasis [GO:0055088]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; neuron remodeling [GO:0016322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; pupation [GO:0035074]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]; response to hormone [GO:0009725]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000976; GO:0001228; GO:0002165; GO:0003677; GO:0003682; GO:0004879; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007480; GO:0007552; GO:0008134; GO:0008219; GO:0008270; GO:0009725; GO:0009755; GO:0009888; GO:0016319; GO:0016322; GO:0035073; GO:0035074; GO:0035075; GO:0035626; GO:0040034; GO:0045944; GO:0046982; GO:0048813; GO:0055088; GO:0090575	"cell death [GO:0008219]; dendrite morphogenesis [GO:0048813]; hormone-mediated signaling pathway [GO:0009755]; imaginal disc-derived leg morphogenesis [GO:0007480]; instar larval or pupal development [GO:0002165]; juvenile hormone mediated signaling pathway [GO:0035626]; lipid homeostasis [GO:0055088]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; neuron remodeling [GO:0016322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; pupation [GO:0035074]; regulation of development, heterochronic [GO:0040034]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to hormone [GO:0009725]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31159_c0_g1_i2	P33244	FTZF1_DROME	78.1	96	21	0	343	56	792	887	3.70E-40	165.6	FTZF1_DROME	reviewed	Nuclear hormone receptor FTZ-F1 (FTZ-F1 alpha) (Nuclear receptor subfamily 5 group A member 3)	ftz-f1 NR5A3 CG4059	Drosophila melanogaster (Fruit fly)	1027	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell death [GO:0008219]; dendrite morphogenesis [GO:0048813]; hormone-mediated signaling pathway [GO:0009755]; imaginal disc-derived leg morphogenesis [GO:0007480]; instar larval or pupal development [GO:0002165]; juvenile hormone mediated signaling pathway [GO:0035626]; lipid homeostasis [GO:0055088]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; neuron remodeling [GO:0016322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; pupation [GO:0035074]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]; response to hormone [GO:0009725]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000976; GO:0001228; GO:0002165; GO:0003677; GO:0003682; GO:0004879; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007480; GO:0007552; GO:0008134; GO:0008219; GO:0008270; GO:0009725; GO:0009755; GO:0009888; GO:0016319; GO:0016322; GO:0035073; GO:0035074; GO:0035075; GO:0035626; GO:0040034; GO:0045944; GO:0046982; GO:0048813; GO:0055088; GO:0090575	"cell death [GO:0008219]; dendrite morphogenesis [GO:0048813]; hormone-mediated signaling pathway [GO:0009755]; imaginal disc-derived leg morphogenesis [GO:0007480]; instar larval or pupal development [GO:0002165]; juvenile hormone mediated signaling pathway [GO:0035626]; lipid homeostasis [GO:0055088]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; neuron remodeling [GO:0016322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; pupation [GO:0035074]; regulation of development, heterochronic [GO:0040034]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to hormone [GO:0009725]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31159_c0_g1_i3	P33244	FTZF1_DROME	61.4	241	87	1	828	106	792	1026	7.90E-83	308.5	FTZF1_DROME	reviewed	Nuclear hormone receptor FTZ-F1 (FTZ-F1 alpha) (Nuclear receptor subfamily 5 group A member 3)	ftz-f1 NR5A3 CG4059	Drosophila melanogaster (Fruit fly)	1027	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell death [GO:0008219]; dendrite morphogenesis [GO:0048813]; hormone-mediated signaling pathway [GO:0009755]; imaginal disc-derived leg morphogenesis [GO:0007480]; instar larval or pupal development [GO:0002165]; juvenile hormone mediated signaling pathway [GO:0035626]; lipid homeostasis [GO:0055088]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; neuron remodeling [GO:0016322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; pupation [GO:0035074]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to ecdysone [GO:0035075]; response to hormone [GO:0009725]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000976; GO:0001228; GO:0002165; GO:0003677; GO:0003682; GO:0004879; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007480; GO:0007552; GO:0008134; GO:0008219; GO:0008270; GO:0009725; GO:0009755; GO:0009888; GO:0016319; GO:0016322; GO:0035073; GO:0035074; GO:0035075; GO:0035626; GO:0040034; GO:0045944; GO:0046982; GO:0048813; GO:0055088; GO:0090575	"cell death [GO:0008219]; dendrite morphogenesis [GO:0048813]; hormone-mediated signaling pathway [GO:0009755]; imaginal disc-derived leg morphogenesis [GO:0007480]; instar larval or pupal development [GO:0002165]; juvenile hormone mediated signaling pathway [GO:0035626]; lipid homeostasis [GO:0055088]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; neuron remodeling [GO:0016322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pupariation [GO:0035073]; pupation [GO:0035074]; regulation of development, heterochronic [GO:0040034]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]; response to hormone [GO:0009725]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38814_c0_g1_i1	Q05192	FTF1B_DROME	51.3	534	179	12	11	1420	292	808	6.80E-132	472.2	FTF1B_DROME	reviewed	Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1)	Hr39 FTZ-F1-beta FTZF1-beta NR5-beta-1 NR5B1 CG8676	Drosophila melanogaster (Fruit fly)	808	"nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]"	nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000976; GO:0000978; GO:0003682; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0009755; GO:0009888; GO:0035211; GO:0045944; GO:0060968; GO:0090575	"hormone-mediated signaling pathway [GO:0009755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene silencing [GO:0060968]; regulation of transcription, DNA-templated [GO:0006355]; spermathecum morphogenesis [GO:0035211]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25885_c0_g1_i1	Q24142	HR78_DROME	75	92	13	1	309	34	47	128	9.40E-35	147.5	HR78_DROME	reviewed	Nuclear hormone receptor HR78 (dHR78) (Nuclear receptor XR78E/F) (Nuclear receptor subfamily 2 group D member 1)	Hr78 Hr78D NR2D1 CG7199	Drosophila melanogaster (Fruit fly)	601	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; liquid clearance, open tracheal system [GO:0035002]; open tracheal system development [GO:0007424]; positive regulation of innate immune response [GO:0045089]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000790; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006355; GO:0006357; GO:0007424; GO:0008270; GO:0030154; GO:0035002; GO:0045089; GO:0048856; GO:0050829	"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; liquid clearance, open tracheal system [GO:0035002]; open tracheal system development [GO:0007424]; positive regulation of innate immune response [GO:0045089]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38905_c0_g1_i1	Q24143	HR96_DROME	46.6	266	125	2	827	81	456	721	3.80E-60	233.4	HR96_DROME	reviewed	Nuclear hormone receptor HR96 (dHR96) (Nuclear receptor subfamily 1 group J member 1)	Hr96 NR1J1 CG11783	Drosophila melanogaster (Fruit fly)	723	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0006629; GO:0008270; GO:0030154; GO:0042594; GO:0042632; GO:0045944; GO:0055088; GO:0070328; GO:0070873	cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN15357_c0_g1_i2	Q24143	HR96_DROME	63.1	65	24	0	234	40	523	587	1.20E-19	97.1	HR96_DROME	reviewed	Nuclear hormone receptor HR96 (dHR96) (Nuclear receptor subfamily 1 group J member 1)	Hr96 NR1J1 CG11783	Drosophila melanogaster (Fruit fly)	723	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0006629; GO:0008270; GO:0030154; GO:0042594; GO:0042632; GO:0045944; GO:0055088; GO:0070328; GO:0070873	cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN15357_c0_g1_i3	Q24143	HR96_DROME	44.8	181	89	1	552	43	477	657	8.10E-41	168.3	HR96_DROME	reviewed	Nuclear hormone receptor HR96 (dHR96) (Nuclear receptor subfamily 1 group J member 1)	Hr96 NR1J1 CG11783	Drosophila melanogaster (Fruit fly)	723	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0006629; GO:0008270; GO:0030154; GO:0042594; GO:0042632; GO:0045944; GO:0055088; GO:0070328; GO:0070873	cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]		NA	NA	NA	NA	NA	NA
TRINITY_DN6408_c0_g1_i1	Q24143	HR96_DROME	76.2	63	15	0	191	3	5	67	1.50E-24	113.2	HR96_DROME	reviewed	Nuclear hormone receptor HR96 (dHR96) (Nuclear receptor subfamily 1 group J member 1)	Hr96 NR1J1 CG11783	Drosophila melanogaster (Fruit fly)	723	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0006629; GO:0008270; GO:0030154; GO:0042594; GO:0042632; GO:0045944; GO:0055088; GO:0070328; GO:0070873	cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glycogen metabolic process [GO:0070873]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]; triglyceride homeostasis [GO:0070328]		blue	blue	NA	NA	NA	NA
TRINITY_DN4709_c0_g1_i1	Q8R3G1	PP1R8_MOUSE	54.3	348	135	7	3	1007	15	351	2.60E-91	337	PP1R8_MOUSE	reviewed	Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8)	Ppp1r8 Nipp1	Mus musculus (Mouse)	351	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]	GO:0003677; GO:0003729; GO:0004865; GO:0005654; GO:0005681; GO:0006397; GO:0007275; GO:0008283; GO:0008380; GO:0016607; GO:0019888; GO:0035308	cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN38697_c0_g1_i1	Q28147	PP1R8_BOVIN	100	99	0	0	297	1	123	221	1.10E-49	196.8	PP1R8_BOVIN	reviewed	Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8)	PPP1R8 NIPP1	Bos taurus (Bovine)	351	nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; mRNA processing [GO:0006397]; negative regulation of protein dephosphorylation [GO:0035308]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]	GO:0003677; GO:0003729; GO:0004865; GO:0005681; GO:0006397; GO:0008380; GO:0016607; GO:0035308	mRNA processing [GO:0006397]; negative regulation of protein dephosphorylation [GO:0035308]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN8611_c0_g1_i1	Q9LMT2	PAPS1_ARATH	57.5	106	44	1	320	3	172	276	3.60E-33	142.1	PAPS1_ARATH	reviewed	Nuclear poly(A) polymerase 1 (PAP(I)) (Poly(A) polymerase I) (EC 2.7.7.19) (Polynucleotide adenylyltransferase 1)	PAPS1 At1g17980 F2H15.20	Arabidopsis thaliana (Mouse-ear cress)	713	nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; flower development [GO:0009908]; leaf development [GO:0048366]; mRNA polyadenylation [GO:0006378]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; petal formation [GO:0048451]; RNA polyadenylation [GO:0043631]	nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006378; GO:0008285; GO:0009908; GO:0043631; GO:0045824; GO:0046872; GO:0048366; GO:0048451	flower development [GO:0009908]; leaf development [GO:0048366]; mRNA polyadenylation [GO:0006378]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; petal formation [GO:0048451]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN30144_c0_g1_i1	Q8VYW1	PAPS4_ARATH	61.3	75	29	0	3	227	206	280	1.40E-20	99.8	PAPS4_ARATH	reviewed	Nuclear poly(A) polymerase 4 (AtPAP(IV)) (PAP(IV)) (Poly(A) polymerase IV) (nPAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase 4)	PAPS4 NPAP At4g32850 T16I18.60	Arabidopsis thaliana (Mouse-ear cress)	741	nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006378; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN8418_c0_g1_i1	Q8R0G9	NU133_MOUSE	41.3	334	180	4	24	1013	828	1149	3.20E-65	250.4	NU133_MOUSE	reviewed	Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133)	Nup133	Mus musculus (Mouse)	1155	"condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]; RNA export from nucleus [GO:0006405]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]"	condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	structural constituent of nuclear pore [GO:0017056]	GO:0000940; GO:0000972; GO:0005643; GO:0006355; GO:0006405; GO:0006406; GO:0006606; GO:0006999; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031081; GO:0031965; GO:0048339; GO:0061053; GO:0072006	"mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]; RNA export from nucleus [GO:0006405]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35399_c0_g1_i1	P49790	NU153_HUMAN	26.6	515	289	17	1815	493	679	1178	7.00E-28	127.5	NU153_HUMAN	reviewed	Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153)	NUP153	Homo sapiens (Human)	1475	cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; tRNA export from nucleus [GO:0006409]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056]	GO:0003677; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0008139; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0042405; GO:0042802; GO:0043495; GO:0043657; GO:0044613; GO:0044615; GO:0046718; GO:0046832; GO:0046872; GO:0051292; GO:0060964; GO:0075732; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; tRNA export from nucleus [GO:0006409]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN8970_c0_g1_i2	Q640Z6	NU153_XENLA	40.4	193	94	6	907	1452	214	396	3.10E-20	101.3	NU153_XENLA	reviewed	Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153)	nup153	Xenopus laevis (African clawed frog)	1605	nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]	nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005643; GO:0015031; GO:0031965; GO:0046872; GO:0051028; GO:0051292	mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3248_c0_g1_i1	O75694	NU155_HUMAN	31.6	831	485	13	2349	94	564	1390	1.60E-109	398.7	NU155_HUMAN	reviewed	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	1391	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034	atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN3248_c0_g1_i11	O75694	NU155_HUMAN	34	1030	592	15	2915	72	280	1303	6.00E-159	563.1	NU155_HUMAN	reviewed	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	1391	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034	atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN3248_c0_g1_i4	O75694	NU155_HUMAN	33.8	1117	650	16	3195	94	280	1390	1.20E-171	605.5	NU155_HUMAN	reviewed	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	1391	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034	atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN3248_c0_g1_i5	O75694	NU155_HUMAN	38.2	1287	694	18	3647	72	23	1303	6.30E-246	852.4	NU155_HUMAN	reviewed	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	1391	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034	atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN3248_c0_g1_i6	O75694	NU155_HUMAN	37.8	1374	752	19	3927	94	23	1390	1.20E-258	894.8	NU155_HUMAN	reviewed	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	1391	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034	atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN3248_c0_g1_i7	O75694	NU155_HUMAN	31.6	744	427	12	2069	72	564	1303	8.20E-97	356.3	NU155_HUMAN	reviewed	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	1391	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0043657; GO:0044611; GO:0060964; GO:0075733; GO:0086014; GO:1900034	atrial cardiac muscle cell action potential [GO:0086014]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN2188_c0_g1_i1	Q12769	NU160_HUMAN	31.6	1406	864	33	102	4145	58	1423	4.70E-165	583.9	NU160_HUMAN	reviewed	Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160)	NUP160 KIAA0197 NUP120	Homo sapiens (Human)	1436	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031080; GO:0043657; GO:0060964; GO:0072006; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN27811_c0_g1_i1	Q12769	NU160_HUMAN	100	81	0	0	1	243	1050	1130	2.70E-41	168.7	NU160_HUMAN	reviewed	Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160)	NUP160 KIAA0197 NUP120	Homo sapiens (Human)	1436	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031080; GO:0043657; GO:0060964; GO:0072006; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN1343_c0_g1_i2	Q92621	NU205_HUMAN	31.9	1906	1154	39	5587	227	34	1914	2.30E-247	857.8	NU205_HUMAN	reviewed	Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205)	NUP205 C7orf14 KIAA0225	Homo sapiens (Human)	2012	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0006110; GO:0006406; GO:0006409; GO:0006913; GO:0006999; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0043657; GO:0044611; GO:0051292; GO:0060964; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN22974_c0_g1_i1	P35658	NU214_HUMAN	29.7	239	146	8	114	776	30	264	2.50E-17	90.9	NU214_HUMAN	reviewed	Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)	NUP214 CAIN CAN KIAA0023	Homo sapiens (Human)	2090	cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; host cell [GO:0043657]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]	GO:0000278; GO:0005049; GO:0005643; GO:0005654; GO:0005829; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006611; GO:0008139; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0043488; GO:0043657; GO:0046822; GO:0051726; GO:0060964; GO:0075733; GO:1900034; GO:1990876	intracellular transport of virus [GO:0075733]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN6028_c0_g1_i1	Q9UKX7	NUP50_HUMAN	59.3	118	45	2	56	406	351	466	6.10E-31	135.2	NUP50_HUMAN	reviewed	Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50)	NUP50 NPAP60L PRO1146	Homo sapiens (Human)	468	host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]		GO:0005643; GO:0005654; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043231; GO:0043657; GO:0060964; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN30764_c0_g1_i1	Q9UKX7	NUP50_HUMAN	100	83	0	0	1	249	353	435	5.50E-42	171	NUP50_HUMAN	reviewed	Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50)	NUP50 NPAP60L PRO1146	Homo sapiens (Human)	468	host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]		GO:0005643; GO:0005654; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043231; GO:0043657; GO:0060964; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN33725_c0_g1_i1	Q9BW27	NUP85_HUMAN	100	105	0	0	3	317	463	567	8.10E-54	210.7	NUP85_HUMAN	reviewed	Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1)	NUP85 NUP75 PCNT1	Homo sapiens (Human)	656	"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	structural constituent of nuclear pore [GO:0017056]	GO:0000777; GO:0005635; GO:0005654; GO:0005819; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0030032; GO:0031080; GO:0031965; GO:0043657; GO:0045893; GO:0048246; GO:0060964; GO:0072006; GO:0075733; GO:1900034	"intracellular transport of virus [GO:0075733]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3793_c0_g1_i1	Q6DK84	NUP85_XENTR	38.6	643	371	7	118	2016	24	652	9.50E-119	429.1	NUP85_XENTR	reviewed	Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85)	nup85	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	653	"nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"	nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]	structural constituent of nuclear pore [GO:0017056]	GO:0006406; GO:0006606; GO:0017056; GO:0031080; GO:0031965; GO:0045893; GO:0072006	"mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3793_c0_g1_i2	Q4QQS8	NUP85_RAT	37.9	182	100	3	262	792	69	242	5.50E-23	109.8	NUP85_RAT	reviewed	Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1)	Nup85 Pcnt1	Rattus norvegicus (Rat)	656	"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; chemotaxis [GO:0006935]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	structural constituent of nuclear pore [GO:0017056]	GO:0000777; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0006406; GO:0006606; GO:0006935; GO:0017056; GO:0030032; GO:0031080; GO:0031965; GO:0045893; GO:0048246; GO:0072006	"chemotaxis [GO:0006935]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2735_c0_g1_i1	Q9GYU8	NUP88_DROME	27.6	424	289	7	1569	316	270	681	1.00E-35	152.9	NUP88_DROME	reviewed	Nuclear pore complex protein Nup88 (88 kDa nuclear pore complex protein) (Nucleoporin Nup88) (Protein members only) (dNup88)	mbo Nup88 CG6819	Drosophila melanogaster (Fruit fly)	702	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]; antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]	GO:0000055; GO:0000056; GO:0000785; GO:0003682; GO:0005635; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056; GO:0019730; GO:0031965; GO:0031981; GO:0046826	antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN2735_c0_g1_i4	Q9GYU8	NUP88_DROME	27.6	424	289	7	1707	454	270	681	1.10E-35	152.9	NUP88_DROME	reviewed	Nuclear pore complex protein Nup88 (88 kDa nuclear pore complex protein) (Nucleoporin Nup88) (Protein members only) (dNup88)	mbo Nup88 CG6819	Drosophila melanogaster (Fruit fly)	702	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]; antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]	GO:0000055; GO:0000056; GO:0000785; GO:0003682; GO:0005635; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056; GO:0019730; GO:0031965; GO:0031981; GO:0046826	antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN2735_c0_g1_i6	Q9GYU8	NUP88_DROME	27.6	424	289	7	2203	950	270	681	1.40E-35	152.9	NUP88_DROME	reviewed	Nuclear pore complex protein Nup88 (88 kDa nuclear pore complex protein) (Nucleoporin Nup88) (Protein members only) (dNup88)	mbo Nup88 CG6819	Drosophila melanogaster (Fruit fly)	702	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]; antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]	GO:0000055; GO:0000056; GO:0000785; GO:0003682; GO:0005635; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056; GO:0019730; GO:0031965; GO:0031981; GO:0046826	antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN2735_c0_g1_i7	Q9GYU8	NUP88_DROME	27.6	424	289	7	1625	372	270	681	1.10E-35	152.9	NUP88_DROME	reviewed	Nuclear pore complex protein Nup88 (88 kDa nuclear pore complex protein) (Nucleoporin Nup88) (Protein members only) (dNup88)	mbo Nup88 CG6819	Drosophila melanogaster (Fruit fly)	702	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]; antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; structural constituent of nuclear pore [GO:0017056]	GO:0000055; GO:0000056; GO:0000785; GO:0003682; GO:0005635; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056; GO:0019730; GO:0031965; GO:0031981; GO:0046826	antimicrobial humoral response [GO:0019730]; mRNA export from nucleus [GO:0006406]; negative regulation of protein export from nucleus [GO:0046826]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN6949_c0_g1_i2	P49793	NUP98_RAT	39	372	218	4	30	1127	1330	1698	1.10E-73	278.5	NUP98_RAT	reviewed	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]	Nup98	Rattus norvegicus (Rat)	1816	"kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"	kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]	GO:0000776; GO:0003713; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0006606; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042277; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904	"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7630_c0_g1_i1	P49793	NUP98_RAT	29.1	234	137	5	710	27	1111	1321	2.20E-12	75.1	NUP98_RAT	reviewed	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]	Nup98	Rattus norvegicus (Rat)	1816	"kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"	kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]	GO:0000776; GO:0003713; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0006606; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042277; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904	"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7630_c0_g1_i6	P49793	NUP98_RAT	29.1	234	137	5	710	27	1111	1321	1.70E-12	75.1	NUP98_RAT	reviewed	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]	Nup98	Rattus norvegicus (Rat)	1816	"kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"	kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]	GO:0000776; GO:0003713; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0006606; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042277; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904	"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8223_c0_g1_i1	Q9VCH5	NUP98_DROME	50	94	43	3	329	60	191	284	7.60E-14	78.2	NUP98_DROME	reviewed	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (Nucleoporin Nup96) (Nup96)]	Nup98-96 Nup145 Nup98 CG10198	Drosophila melanogaster (Fruit fly)	1960	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]; chromatin DNA binding [GO:0031490]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; transcriptional activation by promoter-enhancer looping [GO:0071733]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]	chromatin DNA binding [GO:0031490]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]	GO:0000785; GO:0002230; GO:0005634; GO:0005643; GO:0005654; GO:0005700; GO:0005703; GO:0005704; GO:0005737; GO:0006405; GO:0006606; GO:0008236; GO:0010628; GO:0017056; GO:0030718; GO:0030838; GO:0031490; GO:0031965; GO:0034605; GO:0035075; GO:0035080; GO:0035167; GO:0036098; GO:0043922; GO:0044613; GO:0045944; GO:0046822; GO:0051028; GO:0060261; GO:0071390; GO:0071733; GO:1990841	cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN12834_c0_g1_i1	Q9VCH5	NUP98_DROME	54.7	179	78	1	1027	1563	873	1048	8.90E-48	193	NUP98_DROME	reviewed	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (Nucleoporin Nup96) (Nup96)]	Nup98-96 Nup145 Nup98 CG10198	Drosophila melanogaster (Fruit fly)	1960	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]; chromatin DNA binding [GO:0031490]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; transcriptional activation by promoter-enhancer looping [GO:0071733]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]	chromatin DNA binding [GO:0031490]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]	GO:0000785; GO:0002230; GO:0005634; GO:0005643; GO:0005654; GO:0005700; GO:0005703; GO:0005704; GO:0005737; GO:0006405; GO:0006606; GO:0008236; GO:0010628; GO:0017056; GO:0030718; GO:0030838; GO:0031490; GO:0031965; GO:0034605; GO:0035075; GO:0035080; GO:0035167; GO:0036098; GO:0043922; GO:0044613; GO:0045944; GO:0046822; GO:0051028; GO:0060261; GO:0071390; GO:0071733; GO:1990841	cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN12834_c0_g1_i6	Q9VCH5	NUP98_DROME	55.2	174	75	1	46	567	878	1048	1.40E-46	187.6	NUP98_DROME	reviewed	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (Nucleoporin Nup96) (Nup96)]	Nup98-96 Nup145 Nup98 CG10198	Drosophila melanogaster (Fruit fly)	1960	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]; chromatin DNA binding [GO:0031490]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; transcriptional activation by promoter-enhancer looping [GO:0071733]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome band [GO:0005704]; polytene chromosome puff [GO:0005703]	chromatin DNA binding [GO:0031490]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]	GO:0000785; GO:0002230; GO:0005634; GO:0005643; GO:0005654; GO:0005700; GO:0005703; GO:0005704; GO:0005737; GO:0006405; GO:0006606; GO:0008236; GO:0010628; GO:0017056; GO:0030718; GO:0030838; GO:0031490; GO:0031965; GO:0034605; GO:0035075; GO:0035080; GO:0035167; GO:0036098; GO:0043922; GO:0044613; GO:0045944; GO:0046822; GO:0051028; GO:0060261; GO:0071390; GO:0071733; GO:1990841	cellular response to ecdysone [GO:0071390]; cellular response to heat [GO:0034605]; germ-line stem cell population maintenance [GO:0030718]; heat shock-mediated polytene chromosome puffing [GO:0035080]; larval lymph gland hemopoiesis [GO:0035167]; male germ-line stem cell population maintenance [GO:0036098]; mRNA transport [GO:0051028]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; regulation of nucleocytoplasmic transport [GO:0046822]; response to ecdysone [GO:0035075]; RNA export from nucleus [GO:0006405]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN10644_c0_g1_i2	P37198	NUP62_HUMAN	40.6	187	107	2	49	600	326	511	3.30E-36	153.3	NUP62_HUMAN	reviewed	Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62)	NUP62	Homo sapiens (Human)	522	"annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; host cell [GO:0043657]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; intracellular transport of virus [GO:0075733]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"	annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; host cell [GO:0043657]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]	chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130]	GO:0000922; GO:0003682; GO:0005543; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005813; GO:0006110; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0007283; GO:0007569; GO:0008219; GO:0008285; GO:0009966; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0043407; GO:0043657; GO:0044613; GO:0044877; GO:0045742; GO:0045840; GO:0045893; GO:0046578; GO:0046580; GO:0046601; GO:0051425; GO:0051879; GO:0060236; GO:0060964; GO:0072686; GO:0075733; GO:0090543; GO:0098534; GO:1900034; GO:1903438; GO:1904781; GO:1990904	"cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; intracellular transport of virus [GO:0075733]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10987_c0_g1_i1	P11654	PO210_RAT	33.4	395	244	6	8	1177	952	1332	2.30E-45	184.5	PO210_RAT	reviewed	Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)	Nup210 Gp210 Pom210	Rattus norvegicus (Rat)	1886	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005789; GO:0015031; GO:0016021; GO:0017056; GO:0031965; GO:0051028; GO:0065003	mRNA transport [GO:0051028]; protein-containing complex assembly [GO:0065003]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN26835_c0_g1_i1	Q9UHQ1	NARF_HUMAN	100	130	0	0	2	391	285	414	3.10E-71	268.9	NARF_HUMAN	reviewed	Nuclear prelamin A recognition factor (Iron-only hydrogenase-like protein 2) (IOP2)	NARF	Homo sapiens (Human)	456	lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; lamin binding [GO:0005521]	lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	lamin binding [GO:0005521]	GO:0005521; GO:0005638; GO:0005652; GO:0005654; GO:0005730; GO:0031981			NA	NA	NA	NA	NA	NA
TRINITY_DN28705_c0_g1_i1	Q9UHQ1	NARF_HUMAN	100	132	0	0	399	4	113	244	8.20E-72	270.8	NARF_HUMAN	reviewed	Nuclear prelamin A recognition factor (Iron-only hydrogenase-like protein 2) (IOP2)	NARF	Homo sapiens (Human)	456	lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; lamin binding [GO:0005521]	lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	lamin binding [GO:0005521]	GO:0005521; GO:0005638; GO:0005652; GO:0005654; GO:0005730; GO:0031981			NA	NA	NA	NA	NA	NA
TRINITY_DN2614_c0_g1_i1	Q9VBP9	NPL4_DROME	50	666	278	6	63	2039	35	652	1.20E-188	661.4	NPL4_DROME	reviewed	Nuclear protein localization protein 4 homolog	Npl4 CG4673	Drosophila melanogaster (Fruit fly)	652	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586	cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2614_c0_g1_i3	Q9VBP9	NPL4_DROME	50.1	649	269	6	63	1988	35	635	1.10E-182	642.5	NPL4_DROME	reviewed	Nuclear protein localization protein 4 homolog	Npl4 CG4673	Drosophila melanogaster (Fruit fly)	652	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586	cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2614_c0_g1_i4	Q9VBP9	NPL4_DROME	50.1	665	277	6	63	2036	35	651	3.80E-188	660.6	NPL4_DROME	reviewed	Nuclear protein localization protein 4 homolog	Npl4 CG4673	Drosophila melanogaster (Fruit fly)	652	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0043130; GO:0043161; GO:0045879; GO:0046872; GO:0071795; GO:0098586	cellular response to virus [GO:0098586]; negative regulation of smoothened signaling pathway [GO:0045879]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21735_c0_g1_i1	P60670	NPL4_MOUSE	100	106	0	0	1	318	328	433	7.50E-60	230.7	NPL4_MOUSE	reviewed	Nuclear protein localization protein 4 homolog (Protein NPL4)	Nploc4 Kiaa1499 Npl4	Mus musculus (Mouse)	608	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030433; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0039536; GO:0042175; GO:0043130; GO:0044877; GO:0046872; GO:0051117	"Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27459_c0_g1_i1	Q8TAT6	NPL4_HUMAN	100	76	0	0	3	230	345	420	3.30E-41	168.3	NPL4_HUMAN	reviewed	Nuclear protein localization protein 4 homolog (Protein NPL4)	NPLOC4 KIAA1499 NPL4	Homo sapiens (Human)	608	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; error-free translesion synthesis [GO:0070987]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030433; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0039536; GO:0042175; GO:0043130; GO:0046872; GO:0070987	"error-free translesion synthesis [GO:0070987]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3576_c0_g1_i1	Q3B8C3	NR2CA_XENLA	44.5	128	67	2	395	12	13	136	5.50E-20	99	NR2CA_XENLA	reviewed	Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein homolog)	nr2c2ap tra16	Xenopus laevis (African clawed frog)	136	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN3576_c0_g1_i3	Q3B8C3	NR2CA_XENLA	44.5	128	67	2	395	12	13	136	5.40E-20	99	NR2CA_XENLA	reviewed	Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein homolog)	nr2c2ap tra16	Xenopus laevis (African clawed frog)	136	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN3576_c0_g1_i5	Q3B8C3	NR2CA_XENLA	44.5	128	67	2	395	12	13	136	5.30E-20	99	NR2CA_XENLA	reviewed	Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein homolog)	nr2c2ap tra16	Xenopus laevis (African clawed frog)	136	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN7607_c0_g1_i1	Q14686	NCOA6_HUMAN	49.1	106	51	2	96	410	53	156	1.30E-16	88.2	NCOA6_HUMAN	reviewed	"Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)"	NCOA6 AIB3 KIAA0181 RAP250 TRBP	Homo sapiens (Human)	2063	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; hormone receptor binding [GO:0051427]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; hormone receptor binding [GO:0051427]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019216; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0035097; GO:0043231; GO:0045893; GO:0045944; GO:0046965; GO:0046966; GO:0051427	"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7607_c0_g1_i2	Q14686	NCOA6_HUMAN	59.5	74	28	1	44	265	85	156	2.90E-14	80.1	NCOA6_HUMAN	reviewed	"Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)"	NCOA6 AIB3 KIAA0181 RAP250 TRBP	Homo sapiens (Human)	2063	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; hormone receptor binding [GO:0051427]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; hormone receptor binding [GO:0051427]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019216; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0035097; GO:0043231; GO:0045893; GO:0045944; GO:0046965; GO:0046966; GO:0051427	"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28840_c0_g1_i1	F1QLY4	RORAA_DANRE	96.7	61	2	0	20	202	1	61	1.20E-29	129.8	RORAA_DANRE	reviewed	Nuclear receptor ROR-alpha A (Retinoid-related orphan receptor alpha 2) (Retinoid-related orphan receptor-alpha A)	roraa rora2	Danio rerio (Zebrafish) (Brachydanio rerio)	468	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0007275; GO:0008270; GO:0010468; GO:0010628; GO:0043565; GO:0048511	multicellular organism development [GO:0007275]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3176_c0_g1_i1	F1QLY4	RORAA_DANRE	47.5	59	29	1	250	74	18	74	2.10E-11	70.5	RORAA_DANRE	reviewed	Nuclear receptor ROR-alpha A (Retinoid-related orphan receptor alpha 2) (Retinoid-related orphan receptor-alpha A)	roraa rora2	Danio rerio (Zebrafish) (Brachydanio rerio)	468	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0007275; GO:0008270; GO:0010468; GO:0010628; GO:0043565; GO:0048511	multicellular organism development [GO:0007275]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN32512_c0_g1_i1	Q14995	NR1D2_HUMAN	100	97	0	0	296	6	483	579	9.90E-46	183.7	NR1D2_HUMAN	reviewed	Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)	NR1D2	Homo sapiens (Human)	579	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014	"cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27307_c0_g1_i1	P43136	NR2F6_MOUSE	100	91	0	0	275	3	153	243	1.40E-46	186.4	NR2F6_MOUSE	reviewed	Nuclear receptor subfamily 2 group F member 6 (COUP transcription factor 3) (COUP-TF3) (V-erbA-related protein 2) (EAR-2)	Nr2f6 Ear-2 Ear2 Erbal2	Mus musculus (Mouse)	390	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0043153; GO:0043565; GO:0048666; GO:0048856; GO:0050965; GO:1990837	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35924_c0_g1_i1	O09017	NR2F6_RAT	98.5	67	1	0	3	203	243	309	2.00E-29	129	NR2F6_RAT	reviewed	Nuclear receptor subfamily 2 group F member 6 (COUPg) (Ovalbumin upstream promoter gamma nuclear receptor) (V-erbA-related protein 2) (EAR-2)	Nr2f6 Ear2 Erbal2	Rattus norvegicus (Rat)	390	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0043153; GO:0043565; GO:0048666; GO:0048856; GO:0050965; GO:1990837	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31955_c0_g1_i1	Q0V8F0	NR4A1_BOVIN	82.1	56	10	0	49	216	286	341	2.70E-21	102.1	NR4A1_BOVIN	reviewed	Nuclear receptor subfamily 4 group A member 1	NR4A1	Bos taurus (Bovine)	598	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; fat cell differentiation [GO:0045444]; negative regulation of cell cycle [GO:0045786]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of type B pancreatic cell proliferation [GO:0061469]; skeletal muscle cell differentiation [GO:0035914]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000978; GO:0001228; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006915; GO:0008270; GO:0031965; GO:0035259; GO:0035914; GO:0043065; GO:0043154; GO:0043565; GO:0045444; GO:0045786; GO:0045944; GO:0046982; GO:0061469; GO:0071376	apoptotic process [GO:0006915]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; fat cell differentiation [GO:0045444]; negative regulation of cell cycle [GO:0045786]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of type B pancreatic cell proliferation [GO:0061469]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN31955_c0_g1_i1	Q0V8F0	NR4A1_BOVIN	100	28	0	0	2	85	270	297	4.40E-11	68.2	NR4A1_BOVIN	reviewed	Nuclear receptor subfamily 4 group A member 1	NR4A1	Bos taurus (Bovine)	598	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; fat cell differentiation [GO:0045444]; negative regulation of cell cycle [GO:0045786]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of type B pancreatic cell proliferation [GO:0061469]; skeletal muscle cell differentiation [GO:0035914]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000978; GO:0001228; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006915; GO:0008270; GO:0031965; GO:0035259; GO:0035914; GO:0043065; GO:0043154; GO:0043565; GO:0045444; GO:0045786; GO:0045944; GO:0046982; GO:0061469; GO:0071376	apoptotic process [GO:0006915]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; fat cell differentiation [GO:0045444]; negative regulation of cell cycle [GO:0045786]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of type B pancreatic cell proliferation [GO:0061469]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN25556_c0_g1_i1	Q9UHY1	NRBP_HUMAN	100	150	0	0	1	450	197	346	4.00E-83	308.5	NRBP_HUMAN	reviewed	Nuclear receptor-binding protein	NRBP1 BCON3 NRBP	Homo sapiens (Human)	535	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005654; GO:0005737; GO:0005938; GO:0006367; GO:0006468; GO:0006888; GO:0012505; GO:0016020; GO:0030027; GO:0035556; GO:0042803	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN35400_c0_g1_i1	Q9Y0Y6	NRBP_DROME	44.6	166	92	0	79	576	401	566	1.70E-36	154.5	NRBP_DROME	reviewed	Nuclear receptor-binding protein homolog (MLF1-adaptor molecule)	Madm CG1098	Drosophila melanogaster (Fruit fly)	637	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005938; GO:0006468; GO:0006888; GO:0008361; GO:0009306; GO:0012505; GO:0035556; GO:0036335; GO:0042127; GO:0042803	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN35400_c0_g1_i2	Q9Y0Y6	NRBP_DROME	55.3	409	176	3	1	1206	158	566	1.20E-125	451.4	NRBP_DROME	reviewed	Nuclear receptor-binding protein homolog (MLF1-adaptor molecule)	Madm CG1098	Drosophila melanogaster (Fruit fly)	637	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005938; GO:0006468; GO:0006888; GO:0008361; GO:0009306; GO:0012505; GO:0035556; GO:0036335; GO:0042127; GO:0042803	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN11606_c1_g1_i1	Q1RMS5	NXF1_BOVIN	36.5	249	148	4	810	73	377	618	1.20E-37	158.3	NXF1_BOVIN	reviewed	Nuclear RNA export factor 1	NXF1	Bos taurus (Bovine)	620	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0016973	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]		NA	NA	NA	NA	NA	NA
TRINITY_DN1670_c0_g1_i1	Q5E9S2	NFYA_BOVIN	76.1	92	21	1	78	350	226	317	2.40E-30	133.3	NFYA_BOVIN	reviewed	Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)	NFYA	Bos taurus (Bovine)	341	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription from RNA polymerase II promoter in response to iron [GO:0010723]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"	CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0010723; GO:0016602; GO:0032993; GO:0045893; GO:0048511	"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter in response to iron [GO:0010723]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1670_c0_g1_i2	Q5E9S2	NFYA_BOVIN	76.1	92	21	1	78	350	226	317	2.60E-30	133.3	NFYA_BOVIN	reviewed	Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)	NFYA	Bos taurus (Bovine)	341	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription from RNA polymerase II promoter in response to iron [GO:0010723]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"	CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0010723; GO:0016602; GO:0032993; GO:0045893; GO:0048511	"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter in response to iron [GO:0010723]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1154_c0_g1_i1	Q6RG77	NFYB_HORSE	51.8	195	84	3	317	871	5	199	1.30E-41	171.8	NFYB_HORSE	reviewed	Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB)	NFYB	Equus caballus (Horse)	207	"CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]"	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0005634; GO:0016602; GO:0043565; GO:0045893; GO:0046982	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1154_c0_g1_i2	Q6RG77	NFYB_HORSE	47.8	205	87	4	114	698	5	199	3.80E-39	163.3	NFYB_HORSE	reviewed	Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB)	NFYB	Equus caballus (Horse)	207	"CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]"	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0005634; GO:0016602; GO:0043565; GO:0045893; GO:0046982	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1154_c0_g1_i3	Q6RG77	NFYB_HORSE	47.8	205	87	4	317	901	5	199	6.20E-39	162.9	NFYB_HORSE	reviewed	Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB)	NFYB	Equus caballus (Horse)	207	"CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]"	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0005634; GO:0016602; GO:0043565; GO:0045893; GO:0046982	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1154_c0_g1_i5	Q6RG77	NFYB_HORSE	51.8	195	84	3	114	668	5	199	7.90E-42	172.2	NFYB_HORSE	reviewed	Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB)	NFYB	Equus caballus (Horse)	207	"CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]"	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0005634; GO:0016602; GO:0043565; GO:0045893; GO:0046982	"positive regulation of transcription, DNA-templated [GO:0045893]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31099_c0_g1_i1	Q32KW0	NFYB_BOVIN	100	106	0	0	319	2	26	131	4.90E-51	201.4	NFYB_BOVIN	reviewed	Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB)	NFYB	Bos taurus (Bovine)	207	"CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]"	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]	GO:0005634; GO:0016602; GO:0043565; GO:0045893; GO:0046982	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2495_c0_g1_i1	Q5RA23	NFYC_PONAB	70	160	44	2	73	546	1	158	1.20E-53	211.1	NFYC_PONAB	reviewed	Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC)	NFYC	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	335	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0005634; GO:0046982			blue	blue	NA	NA	NA	NA
TRINITY_DN30264_c0_g1_i1	Q13952	NFYC_HUMAN	100	144	0	0	30	461	1	144	1.20E-74	280.4	NFYC_HUMAN	reviewed	Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC) (Transactivator HSM-1/2)	NFYC	Homo sapiens (Human)	458	"CCAAT-binding factor complex [GO:0016602]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; protein folding [GO:0006457]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	CCAAT-binding factor complex [GO:0016602]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006457; GO:0008134; GO:0016602; GO:0032993; GO:0045540; GO:0046982; GO:0090575	"protein folding [GO:0006457]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c4_g1_i1	Q9DBY8	NVL_MOUSE	42.3	614	304	9	1855	113	257	853	1.30E-128	462.2	NVL_MOUSE	reviewed	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	Nvl	Mus musculus (Mouse)	855	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c4_g1_i2	Q9DBY8	NVL_MOUSE	43.9	478	222	8	1459	113	393	853	4.70E-99	363.2	NVL_MOUSE	reviewed	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	Nvl	Mus musculus (Mouse)	855	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN37015_c0_g1_i1	O15381	NVL_HUMAN	100	90	0	0	271	2	271	360	1.10E-46	186.8	NVL_HUMAN	reviewed	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	NVL NVL2	Homo sapiens (Human)	856	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN38415_c0_g1_i1	O15381	NVL_HUMAN	100	98	0	0	296	3	654	751	1.70E-50	199.5	NVL_HUMAN	reviewed	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	NVL NVL2	Homo sapiens (Human)	856	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN27049_c0_g1_i1	O15381	NVL_HUMAN	68.1	69	22	0	2	208	287	355	1.50E-19	96.3	NVL_HUMAN	reviewed	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	NVL NVL2	Homo sapiens (Human)	856	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31455_c0_g1_i1	A2XGQ1	NUG2_ORYSI	65.8	73	25	0	222	4	200	272	3.10E-26	118.6	NUG2_ORYSI	reviewed	Nuclear/nucleolar GTPase 2	NUG2 OsI_11581	Oryza sativa subsp. indica (Rice)	535	nucleolus [GO:0005730]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]	nucleolus [GO:0005730]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]	GO:0005525; GO:0005730; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN16904_c0_g1_i1	Q02818	NUCB1_HUMAN	100	86	0	0	3	260	45	130	5.80E-42	171	NUCB1_HUMAN	reviewed	Nucleobindin-1 (CALNUC)	NUCB1 NUC	Homo sapiens (Human)	461	cis-Golgi network [GO:0005801]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; lumenal side of Golgi membrane [GO:0098547]; membrane [GO:0016020]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]; regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]	cis-Golgi network [GO:0005801]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; lumenal side of Golgi membrane [GO:0098547]; membrane [GO:0016020]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005615; GO:0005634; GO:0005769; GO:0005788; GO:0005791; GO:0005793; GO:0005798; GO:0005801; GO:0005802; GO:0007264; GO:0016020; GO:0032580; GO:0043687; GO:0044267; GO:0070062; GO:0072718; GO:0090498; GO:0098547; GO:1903533	cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]; regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN16904_c0_g1_i2	Q02819	NUCB1_MOUSE	96.1	76	3	0	3	230	54	129	3.30E-33	141.7	NUCB1_MOUSE	reviewed	Nucleobindin-1 (CALNUC)	Nucb1 Nuc Nucb	Mus musculus (Mouse)	459	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005791; GO:0005793; GO:0005794; GO:0005798; GO:0005801; GO:0005802; GO:0007264; GO:0032580; GO:0072718; GO:0090498; GO:0098547; GO:1903533	regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN1819_c0_g1_i5	Q02819	NUCB1_MOUSE	42.9	156	76	4	98	550	12	159	1.20E-19	98.2	NUCB1_MOUSE	reviewed	Nucleobindin-1 (CALNUC)	Nucb1 Nuc Nucb	Mus musculus (Mouse)	459	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005791; GO:0005793; GO:0005794; GO:0005798; GO:0005801; GO:0005802; GO:0007264; GO:0032580; GO:0072718; GO:0090498; GO:0098547; GO:1903533	regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN1819_c0_g1_i6	Q02819	NUCB1_MOUSE	42.9	156	76	4	98	550	12	159	1.70E-19	97.4	NUCB1_MOUSE	reviewed	Nucleobindin-1 (CALNUC)	Nucb1 Nuc Nucb	Mus musculus (Mouse)	459	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005791; GO:0005793; GO:0005794; GO:0005798; GO:0005801; GO:0005802; GO:0007264; GO:0032580; GO:0072718; GO:0090498; GO:0098547; GO:1903533	regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]		blue	blue	NA	NA	NA	NA
TRINITY_DN1819_c0_g1_i3	P80303	NUCB2_HUMAN	49.9	341	165	3	74	1087	3	340	4.60E-54	213.8	NUCB2_HUMAN	reviewed	Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1]	NUCB2 NEFA	Homo sapiens (Human)	420	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005615; GO:0005640; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0032099; GO:0070062	negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264]		blue	blue	NA	NA	NA	NA
TRINITY_DN31866_c0_g1_i1	P80303	NUCB2_HUMAN	100	80	0	0	242	3	50	129	4.00E-37	154.8	NUCB2_HUMAN	reviewed	Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1]	NUCB2 NEFA	Homo sapiens (Human)	420	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005615; GO:0005640; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0032099; GO:0070062	negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i10	Q3SYU1	NOC2L_BOVIN	42.6	530	295	4	1651	77	135	660	2.50E-124	447.6	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i12	Q3SYU1	NOC2L_BOVIN	37.3	75	47	0	497	273	473	547	2.00E-10	67.4	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i15	Q3SYU1	NOC2L_BOVIN	47.7	65	33	1	248	54	537	600	1.60E-09	63.2	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i16	Q3SYU1	NOC2L_BOVIN	37.7	77	48	0	298	68	473	549	2.60E-11	69.7	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i17	Q3SYU1	NOC2L_BOVIN	44.7	367	197	2	1153	68	184	549	8.70E-90	332	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i3	Q3SYU1	NOC2L_BOVIN	43.1	508	281	3	1745	237	135	639	3.10E-122	440.7	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i5	Q3SYU1	NOC2L_BOVIN	43	412	228	3	1223	3	135	544	2.10E-94	347.8	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i7	Q3SYU1	NOC2L_BOVIN	35.2	88	57	0	458	195	473	560	3.80E-11	69.7	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN1928_c0_g1_i8	Q3SYU1	NOC2L_BOVIN	42.6	530	295	4	1651	77	135	660	1.60E-124	448	NOC2L_BOVIN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Bos taurus (Bovine)	746	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN27771_c0_g1_i1	Q9Y3T9	NOC2L_HUMAN	100	85	0	0	257	3	516	600	1.20E-42	173.3	NOC2L_HUMAN	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L NIR	Homo sapiens (Human)	749	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002903; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:1901796; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN24274_c0_g1_i1	Q9WV70	NOC2L_MOUSE	99.3	139	1	0	417	1	351	489	1.60E-73	276.6	NOC2L_MOUSE	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	Noc2l Nir	Mus musculus (Mouse)	747	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002039; GO:0002903; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031493; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN24274_c0_g1_i2	Q9WV70	NOC2L_MOUSE	93.8	130	8	0	390	1	360	489	7.30E-65	247.7	NOC2L_MOUSE	reviewed	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	Noc2l Nir	Mus musculus (Mouse)	747	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002039; GO:0002903; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031493; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN28973_c0_g1_i1	Q8WTT2	NOC3L_HUMAN	100	79	0	0	237	1	518	596	1.10E-39	163.3	NOC3L_HUMAN	reviewed	Nucleolar complex protein 3 homolog (NOC3 protein homolog) (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)	NOC3L AD24 C10orf117 FAD24	Homo sapiens (Human)	800	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; fat cell differentiation [GO:0045444]	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0016607; GO:0045444	fat cell differentiation [GO:0045444]		NA	NA	NA	NA	NA	NA
TRINITY_DN1504_c0_g1_i1	Q5XGZ8	NOC3L_XENLA	37.8	680	379	11	355	2313	86	748	3.80E-95	350.9	NOC3L_XENLA	reviewed	Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)	noc3l	Xenopus laevis (African clawed frog)	795	nucleolus [GO:0005730]	nucleolus [GO:0005730]		GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN2084_c0_g1_i1	Q9BVI4	NOC4L_HUMAN	48.7	187	95	1	715	155	320	505	3.90E-40	166.4	NOC4L_HUMAN	reviewed	Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein)	NOC4L	Homo sapiens (Human)	516	integral component of membrane [GO:0016021]; Noc4p-Nop14p complex [GO:0030692]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	integral component of membrane [GO:0016021]; Noc4p-Nop14p complex [GO:0030692]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016021; GO:0030692; GO:0031965; GO:0032040	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN26885_c0_g1_i1	Q8SVJ8	NOG1_ENCCU	54.6	295	131	1	886	2	5	296	4.90E-88	325.9	NOG1_ENCCU	reviewed	Nucleolar GTP-binding protein 1	NOG1 ECU05_0800	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	528	nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]	GTP binding [GO:0005525]	GO:0005525; GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN36108_c0_g1_i1	Q9BZE4	NOG1_HUMAN	100	201	0	0	605	3	198	398	3.00E-110	399.1	NOG1_HUMAN	reviewed	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GTPBP4 CRFG NOG1	Homo sapiens (Human)	634	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29986_c0_g1_i1	Q9BZE4	NOG1_HUMAN	99.2	251	2	0	1	753	3	253	2.20E-142	506.1	NOG1_HUMAN	reviewed	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GTPBP4 CRFG NOG1	Homo sapiens (Human)	634	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1490_c0_g1_i1	Q9V411	NOG1_DROME	54.9	632	234	9	1832	9	1	605	1.60E-184	647.5	NOG1_DROME	reviewed	Nucleolar GTP-binding protein 1 (Novel nucleolar protein 1)	Non1 CG8801	Drosophila melanogaster (Fruit fly)	652	nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005730; GO:0007049; GO:0042254; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN30424_c0_g1_i1	Q75DA4	NOG2_ASHGO	71.8	78	22	0	3	236	293	370	3.00E-29	128.6	NOG2_ASHGO	reviewed	Nucleolar GTP-binding protein 2	NOG2 ABR120C	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	502	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; GTP binding [GO:0005525]; large ribosomal subunit rRNA binding [GO:0070180]; regulation of ribosomal subunit export from nucleus [GO:2000200]; ribosomal large subunit export from nucleus [GO:0000055]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	GTP binding [GO:0005525]; large ribosomal subunit rRNA binding [GO:0070180]	GO:0000055; GO:0005525; GO:0005654; GO:0005730; GO:0030687; GO:0070180; GO:2000200	regulation of ribosomal subunit export from nucleus [GO:2000200]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN23114_c1_g1_i1	Q13823	NOG2_HUMAN	72	75	21	0	28	252	195	269	1.60E-25	116.3	NOG2_HUMAN	reviewed	Nucleolar GTP-binding protein 2 (Autoantigen NGP-1)	GNL2 NGP1	Homo sapiens (Human)	731	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254	ribosome biogenesis [GO:0042254]		blue	blue	NA	NA	NA	NA
TRINITY_DN23114_c0_g1_i1	Q13823	NOG2_HUMAN	77.6	85	19	0	255	1	284	368	2.70E-36	152.1	NOG2_HUMAN	reviewed	Nucleolar GTP-binding protein 2 (Autoantigen NGP-1)	GNL2 NGP1	Homo sapiens (Human)	731	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254	ribosome biogenesis [GO:0042254]		blue	blue	NA	NA	NA	NA
TRINITY_DN5154_c0_g2_i1	Q5C9Z4	NOM1_HUMAN	43.9	253	124	6	6	764	309	543	1.10E-40	168.3	NOM1_HUMAN	reviewed	Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)	NOM1 C7orf3	Homo sapiens (Human)	860	nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0042274; GO:0048820	hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN5154_c0_g2_i2	Q5C9Z4	NOM1_HUMAN	62.2	45	17	0	85	219	499	543	7.50E-06	50.8	NOM1_HUMAN	reviewed	Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)	NOM1 C7orf3	Homo sapiens (Human)	860	nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0042274; GO:0048820	hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN5154_c0_g1_i1	Q5C9Z4	NOM1_HUMAN	37	308	174	4	1062	160	531	825	1.20E-51	205.3	NOM1_HUMAN	reviewed	Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)	NOM1 C7orf3	Homo sapiens (Human)	860	nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0042274; GO:0048820	hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN5154_c0_g1_i2	Q5C9Z4	NOM1_HUMAN	36.7	308	175	4	1062	160	531	825	1.20E-51	205.3	NOM1_HUMAN	reviewed	Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)	NOM1 C7orf3	Homo sapiens (Human)	860	nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0042274; GO:0048820	hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN4189_c0_g1_i1	O60287	NPA1P_HUMAN	26.5	505	331	15	3813	5279	1405	1885	2.00E-36	157.1	NPA1P_HUMAN	reviewed	Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog)	URB1 C21orf108 KIAA0539 NOP254 NPA1	Homo sapiens (Human)	2271	"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	fibrillar center [GO:0001650]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0000463; GO:0000466; GO:0001650; GO:0003723; GO:0005730	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2087_c0_g1_i1	Q7T0Q5	NOL10_XENLA	53.8	517	228	3	1626	91	7	517	1.50E-165	584.3	NOL10_XENLA	reviewed	Nucleolar protein 10	nol10	Xenopus laevis (African clawed frog)	689	nucleolus [GO:0005730]	nucleolus [GO:0005730]		GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN28665_c0_g1_i1	Q9BSC4	NOL10_HUMAN	56.8	81	35	0	243	1	319	399	5.70E-23	107.8	NOL10_HUMAN	reviewed	Nucleolar protein 10	NOL10	Homo sapiens (Human)	688	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31474_c0_g1_i1	Q9BSC4	NOL10_HUMAN	100	68	0	0	2	205	51	118	7.80E-34	143.7	NOL10_HUMAN	reviewed	Nucleolar protein 10	NOL10	Homo sapiens (Human)	688	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2343_c0_g1_i1	Q7S2L7	NOP12_NEUCR	50.9	53	23	1	1	150	372	424	6.50E-06	52.4	NOP12_NEUCR	reviewed	Nucleolar protein 12	nop-12 NCU09131	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	594	nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2343_c0_g1_i2	Q7S2L7	NOP12_NEUCR	50.9	53	23	1	1	150	372	424	6.60E-06	52.4	NOP12_NEUCR	reviewed	Nucleolar protein 12	nop-12 NCU09131	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	594	nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN2619_c0_g2_i1	P78316	NOP14_HUMAN	34.4	465	287	6	1450	86	398	854	1.70E-61	238.4	NOP14_HUMAN	reviewed	Nucleolar protein 14 (Nucleolar complex protein 14)	NOP14 C4orf9 NOL14 RES4-25	Homo sapiens (Human)	857	"90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"	90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0000447; GO:0000462; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0019899; GO:0030490; GO:0030515; GO:0030686; GO:0030692; GO:0032040; GO:0042274	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12036_c0_g1_i1	Q1RP77	NOP16_RAT	37.5	152	89	4	93	539	7	155	2.00E-15	84	NOP16_RAT	reviewed	Nucleolar protein 16 (Protein ZH1)	Nop16	Rattus norvegicus (Rat)	178	nucleolus [GO:0005730]; ribosomal large subunit biogenesis [GO:0042273]	nucleolus [GO:0005730]		GO:0005730; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]		blue	blue	NA	NA	NA	NA
TRINITY_DN36350_c0_g1_i1	O94818	NOL4_HUMAN	58.5	65	18	1	247	80	573	637	1.70E-11	70.9	NOL4_HUMAN	reviewed	Nucleolar protein 4 (Nucleolar-localized protein)	NOL4 NOLP HRIHFB2255	Homo sapiens (Human)	638	nucleolus [GO:0005730]; RNA binding [GO:0003723]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN14314_c0_g1_i1	O00567	NOP56_HUMAN	99.2	399	3	0	1231	35	33	431	8.60E-221	767.3	NOP56_HUMAN	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	Homo sapiens (Human)	594	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN14314_c0_g1_i2	O00567	NOP56_HUMAN	100	305	0	0	996	82	33	337	1.50E-167	590.1	NOP56_HUMAN	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	Homo sapiens (Human)	594	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN14314_c0_g1_i3	O00567	NOP56_HUMAN	100	388	0	0	1166	3	33	420	9.40E-217	753.8	NOP56_HUMAN	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	Homo sapiens (Human)	594	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN11096_c0_g1_i1	Q3SZ63	NOP56_BOVIN	72.7	176	45	1	7	525	263	438	5.50E-63	241.9	NOP56_BOVIN	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	Bos taurus (Bovine)	596	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0005737; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN40097_c0_g1_i1	Q9D6Z1	NOP56_MOUSE	100	164	0	0	1	492	92	255	1.10E-89	330.5	NOP56_MOUSE	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	Nop56 Nol5a	Mus musculus (Mouse)	580	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; histone methyltransferase binding [GO:1990226]; snoRNA binding [GO:0030515]; ribosome biogenesis [GO:0042254]	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	histone methyltransferase binding [GO:1990226]; snoRNA binding [GO:0030515]	GO:0001650; GO:0005654; GO:0005732; GO:0005737; GO:0030515; GO:0031428; GO:0032040; GO:0042254; GO:0070761; GO:1990226	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN37616_c0_g1_i1	Q3SZ63	NOP56_BOVIN	47.5	99	43	3	3	284	289	383	2.50E-14	79.3	NOP56_BOVIN	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	Bos taurus (Bovine)	596	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0005737; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5813_c0_g1_i1	Q3SZ63	NOP56_BOVIN	65.6	422	145	0	107	1372	4	425	1.60E-155	550.8	NOP56_BOVIN	reviewed	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	Bos taurus (Bovine)	596	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0005737; GO:0042254	ribosome biogenesis [GO:0042254]		blue	blue	NA	NA	NA	NA
TRINITY_DN37013_c0_g1_i1	O94514	NOP56_SCHPO	59.7	77	31	0	281	51	137	213	4.20E-22	105.1	NOP56_SCHPO	reviewed	Nucleolar protein 56 (Ribosome biosynthesis protein sik1)	nop56 sik1 SPBC646.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	497	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]	GO:0005634; GO:0005730; GO:0005732; GO:0006364; GO:0030515; GO:0030532; GO:0031428; GO:0032040	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN12523_c0_g1_i1	Q9P7S7	NOP58_SCHPO	67.4	89	28	1	269	3	142	229	3.00E-33	142.1	NOP58_SCHPO	reviewed	Nucleolar protein 58	nop58 SPAC23G3.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	508	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]	GO:0005634; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN14049_c0_g1_i1	Q9P7S7	NOP58_SCHPO	73.5	83	22	0	264	16	135	217	9.70E-32	137.1	NOP58_SCHPO	reviewed	Nucleolar protein 58	nop58 SPAC23G3.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	508	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]	GO:0005634; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040	rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN12523_c0_g2_i1	Q6DFW4	NOP58_MOUSE	75.9	112	27	0	2	337	254	365	9.30E-40	164.1	NOP58_MOUSE	reviewed	Nucleolar protein 58 (MSSP) (Nucleolar protein 5) (SIK-similar protein)	Nop58 Nol5	Mus musculus (Mouse)	536	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; ribosome biogenesis [GO:0042254]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0001094; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0015030; GO:0030515; GO:0031428; GO:0032040; GO:0042254; GO:0048254; GO:0051117; GO:0070761	ribosome biogenesis [GO:0042254]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN36253_c0_g1_i1	Q9Y2X3	NOP58_HUMAN	100	77	0	0	233	3	140	216	4.40E-41	167.9	NOP58_HUMAN	reviewed	Nucleolar protein 58 (Nucleolar protein 5)	NOP58 NOL5 NOP5 HSPC120	Homo sapiens (Human)	529	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761	rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN30400_c0_g1_i1	Q9Y2X3	NOP58_HUMAN	75.9	141	34	0	3	425	247	387	1.10E-53	210.7	NOP58_HUMAN	reviewed	Nucleolar protein 58 (Nucleolar protein 5)	NOP58 NOL5 NOP5 HSPC120	Homo sapiens (Human)	529	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761	rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		blue	blue	NA	NA	NA	NA
TRINITY_DN21356_c0_g1_i1	Q9Y2X3	NOP58_HUMAN	100	90	0	0	3	272	253	342	9.40E-43	173.7	NOP58_HUMAN	reviewed	Nucleolar protein 58 (Nucleolar protein 5)	NOP58 NOL5 NOP5 HSPC120	Homo sapiens (Human)	529	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761	rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN21356_c0_g1_i2	Q9Y2X3	NOP58_HUMAN	100	91	0	0	3	275	253	343	1.10E-43	176.8	NOP58_HUMAN	reviewed	Nucleolar protein 58 (Nucleolar protein 5)	NOP58 NOL5 NOP5 HSPC120	Homo sapiens (Human)	529	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761	rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3380_c0_g1_i1	Q8BMC4	NOP9_MOUSE	26.8	608	391	11	1749	4	57	636	2.20E-47	191.8	NOP9_MOUSE	reviewed	Nucleolar protein 9 (Pumilio domain-containing protein NOP9)	Nop9	Mus musculus (Mouse)	636	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]"	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]"	RNA binding [GO:0003723]	GO:0000056; GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005730; GO:0030686; GO:0030688	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]"		blue	blue	NA	NA	NA	NA
TRINITY_DN35187_c0_g1_i1	Q9NR30	DDX21_HUMAN	100	93	0	0	280	2	455	547	5.80E-48	191	DDX21_HUMAN	reviewed	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)	DDX21	Homo sapiens (Human)	783	"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]"	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0016020; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045815; GO:0051607; GO:0062176; GO:0097322	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; response to exogenous dsRNA [GO:0043330]; R-loop disassembly [GO:0062176]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29024_c0_g1_i1	Q9NR30	DDX21_HUMAN	59.1	88	36	0	266	3	460	547	2.40E-25	115.9	DDX21_HUMAN	reviewed	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)	DDX21	Homo sapiens (Human)	783	"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]"	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0016020; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045815; GO:0051607; GO:0062176; GO:0097322	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; response to exogenous dsRNA [GO:0043330]; R-loop disassembly [GO:0062176]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11095_c0_g1_i1	P31483	TIA1_HUMAN	46.3	307	153	6	137	1027	1	305	1.90E-75	284.3	TIA1_HUMAN	reviewed	Nucleolysin TIA-1 isoform p40 (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1)	TIA1	Homo sapiens (Human)	386	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008143; GO:0008543; GO:0010494; GO:0017148; GO:0035925; GO:0042036; GO:0048024; GO:0097165; GO:1903608; GO:1904037; GO:1990904	"apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10352_c0_g1_i1	P31483	TIA1_HUMAN	62.9	97	36	0	21	311	195	291	3.00E-32	139	TIA1_HUMAN	reviewed	Nucleolysin TIA-1 isoform p40 (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1)	TIA1	Homo sapiens (Human)	386	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR AU-rich region binding [GO:0035925]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008143; GO:0008543; GO:0010494; GO:0017148; GO:0035925; GO:0042036; GO:0048024; GO:0097165; GO:1903608; GO:1904037; GO:1990904	"apoptotic process [GO:0006915]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cytokine biosynthetic process [GO:0042036]; negative regulation of translation [GO:0017148]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8095_c0_g1_i1	Q6AXN4	NDC1_RAT	30.4	227	142	5	753	94	456	673	1.60E-18	95.9	NDC1_RAT	reviewed	Nucleoporin NDC1 (Transmembrane protein 48)	Ndc1 Tmem48	Rattus norvegicus (Rat)	673	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; structural constituent of nuclear pore [GO:0017056]; homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]	structural constituent of nuclear pore [GO:0017056]	GO:0005643; GO:0005737; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0016021; GO:0017056; GO:0031081; GO:0031965; GO:0051028; GO:0051292; GO:0070762	homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i12	Q6P6X9	NUP35_DANRE	37	332	168	10	459	1424	7	307	7.50E-41	169.9	NUP35_DANRE	reviewed	Nucleoporin NUP35 (35 kDa nucleoporin) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53)	nup35 nup53 zgc:65979	Danio rerio (Zebrafish) (Brachydanio rerio)	308	"nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]	phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]	GO:0003697; GO:0005543; GO:0006355; GO:0006607; GO:0006999; GO:0017056; GO:0031965; GO:0044613; GO:0044615; GO:0051028	"mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i13	Q6P6X9	NUP35_DANRE	37	332	168	10	861	1826	7	307	9.50E-41	169.9	NUP35_DANRE	reviewed	Nucleoporin NUP35 (35 kDa nucleoporin) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53)	nup35 nup53 zgc:65979	Danio rerio (Zebrafish) (Brachydanio rerio)	308	"nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]	phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]	GO:0003697; GO:0005543; GO:0006355; GO:0006607; GO:0006999; GO:0017056; GO:0031965; GO:0044613; GO:0044615; GO:0051028	"mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4585_c0_g1_i1	Q9VBU8	NUP37_DROME	27.8	317	221	7	1032	97	5	318	3.20E-28	127.5	NUP37_DROME	reviewed	Nucleoporin Nup37 (37 kDa nucleoporin)	Nup37 CG11875	Drosophila melanogaster (Fruit fly)	320	nuclear pore outer ring [GO:0031080]; mRNA transport [GO:0051028]; protein transport [GO:0015031]	nuclear pore outer ring [GO:0031080]		GO:0015031; GO:0031080; GO:0051028	mRNA transport [GO:0051028]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i2	P59235	NUP43_MOUSE	35.8	369	201	9	115	1116	7	374	4.00E-63	243.8	NUP43_MOUSE	reviewed	Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43)	Nup43	Mus musculus (Mouse)	380	condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]		GO:0000777; GO:0007049; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1075_c0_g1_i9	P59235	NUP43_MOUSE	35.8	369	201	9	115	1116	7	374	3.40E-63	243.8	NUP43_MOUSE	reviewed	Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43)	Nup43	Mus musculus (Mouse)	380	condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]		GO:0000777; GO:0007049; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1108_c0_g1_i12	Q7Z3B4	NUP54_HUMAN	31.8	308	206	3	1044	133	178	485	2.90E-39	164.1	NUP54_HUMAN	reviewed	Nucleoporin p54 (54 kDa nucleoporin)	NUP54	Homo sapiens (Human)	507	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of protein import into nucleus [GO:0042306]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0006110; GO:0006406; GO:0006409; GO:0006605; GO:0006607; GO:0006999; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0042306; GO:0042802; GO:0043657; GO:0044613; GO:0044877; GO:0060964; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of protein import into nucleus [GO:0042306]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN1108_c0_g1_i31	Q7Z3B4	NUP54_HUMAN	31.8	308	206	3	1121	210	178	485	3.10E-39	164.1	NUP54_HUMAN	reviewed	Nucleoporin p54 (54 kDa nucleoporin)	NUP54	Homo sapiens (Human)	507	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of protein import into nucleus [GO:0042306]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0006110; GO:0006406; GO:0006409; GO:0006605; GO:0006607; GO:0006999; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0042306; GO:0042802; GO:0043657; GO:0044613; GO:0044877; GO:0060964; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of protein import into nucleus [GO:0042306]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN1108_c0_g1_i7	Q7Z3B4	NUP54_HUMAN	29.9	314	207	3	1094	192	178	491	5.50E-33	143.3	NUP54_HUMAN	reviewed	Nucleoporin p54 (54 kDa nucleoporin)	NUP54	Homo sapiens (Human)	507	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of protein import into nucleus [GO:0042306]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0006110; GO:0006406; GO:0006409; GO:0006605; GO:0006607; GO:0006999; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0036228; GO:0042306; GO:0042802; GO:0043657; GO:0044613; GO:0044877; GO:0060964; GO:0075733; GO:1900034	intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein localization to nuclear inner membrane [GO:0036228]; protein sumoylation [GO:0016925]; protein targeting [GO:0006605]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of protein import into nucleus [GO:0042306]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN6178_c0_g1_i1	Q5U4Y8	SEH1_XENTR	60.9	353	105	3	1267	215	1	322	4.00E-131	469.5	SEH1_XENTR	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit seh1)	seh1l TGas096l04.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	360	condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0005198; GO:0005765; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0034629; GO:0035859; GO:0051028; GO:0051301; GO:0051315; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6178_c0_g1_i2	Q5U4Y8	SEH1_XENTR	66.6	323	105	2	1177	215	1	322	1.10E-135	484.6	SEH1_XENTR	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit seh1)	seh1l TGas096l04.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	360	condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0005198; GO:0005765; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0034629; GO:0035859; GO:0051028; GO:0051301; GO:0051315; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15221_c0_g1_i3	Q8R2U0	SEH1_MOUSE	100	87	0	0	261	1	138	224	1.90E-45	182.6	SEH1_MOUSE	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1)	Seh1l	Mus musculus (Mouse)	360	condensed chromosome kinetochore [GO:0000777]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0002534; GO:0005198; GO:0005765; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0032008; GO:0034198; GO:0034629; GO:0035859; GO:0050830; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN15221_c0_g1_i1	Q96EE3	SEH1_HUMAN	100	223	0	0	672	4	1	223	2.40E-130	466.1	SEH1_HUMAN	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein)	SEH1L SEC13L SEH1	Homo sapiens (Human)	360	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0002534; GO:0005198; GO:0005635; GO:0005765; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006999; GO:0007080; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0032008; GO:0034198; GO:0034629; GO:0035859; GO:0043657; GO:0050830; GO:0051301; GO:0051315; GO:0060964; GO:0061700; GO:0075733; GO:1900034; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN15221_c0_g1_i2	Q96EE3	SEH1_HUMAN	100	140	0	0	421	2	1	140	7.10E-80	297.7	SEH1_HUMAN	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein)	SEH1L SEC13L SEH1	Homo sapiens (Human)	360	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0002534; GO:0005198; GO:0005635; GO:0005765; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006999; GO:0007080; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0032008; GO:0034198; GO:0034629; GO:0035859; GO:0043657; GO:0050830; GO:0051301; GO:0051315; GO:0060964; GO:0061700; GO:0075733; GO:1900034; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN15221_c0_g1_i4	Q96EE3	SEH1_HUMAN	100	140	0	0	421	2	1	140	7.10E-80	297.7	SEH1_HUMAN	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein)	SEH1L SEC13L SEH1	Homo sapiens (Human)	360	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0002534; GO:0005198; GO:0005635; GO:0005765; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006999; GO:0007080; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0032008; GO:0034198; GO:0034629; GO:0035859; GO:0043657; GO:0050830; GO:0051301; GO:0051315; GO:0060964; GO:0061700; GO:0075733; GO:1900034; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN31748_c0_g1_i1	Q96EE3	SEH1_HUMAN	100	104	0	0	3	314	191	294	2.50E-55	215.7	SEH1_HUMAN	reviewed	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein)	SEH1L SEC13L SEH1	Homo sapiens (Human)	360	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; host cell [GO:0043657]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	structural molecule activity [GO:0005198]	GO:0000777; GO:0002534; GO:0005198; GO:0005635; GO:0005765; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006999; GO:0007080; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0032008; GO:0034198; GO:0034629; GO:0035859; GO:0043657; GO:0050830; GO:0051301; GO:0051315; GO:0060964; GO:0061700; GO:0075733; GO:1900034; GO:1904263	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; intracellular transport of virus [GO:0075733]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN8802_c0_g1_i1	P12270	TPR_HUMAN	37.9	190	89	13	29	541	2101	2280	2.50E-08	60.5	TPR_HUMAN	reviewed	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	TPR	Homo sapiens (Human)	2363	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; host cell [GO:0043657]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; intracellular transport of virus [GO:0075733]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; host cell [GO:0043657]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]	GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006110; GO:0006404; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0043657; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0060964; GO:0070840; GO:0070849; GO:0072686; GO:0075733; GO:0090267; GO:0090316; GO:1900034; GO:1901673	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; intracellular transport of virus [GO:0075733]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN8802_c0_g1_i2	P12270	TPR_HUMAN	37.5	192	93	12	29	553	2101	2282	3.00E-08	60.5	TPR_HUMAN	reviewed	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	TPR	Homo sapiens (Human)	2363	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; host cell [GO:0043657]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; intracellular transport of virus [GO:0075733]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; host cell [GO:0043657]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]	GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006110; GO:0006404; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0043657; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0060964; GO:0070840; GO:0070849; GO:0072686; GO:0075733; GO:0090267; GO:0090316; GO:1900034; GO:1901673	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; intracellular transport of virus [GO:0075733]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN5367_c0_g1_i1	P12270	TPR_HUMAN	38.3	94	58	0	491	210	527	620	2.60E-06	53.5	TPR_HUMAN	reviewed	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	TPR	Homo sapiens (Human)	2363	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; host cell [GO:0043657]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; intracellular transport of virus [GO:0075733]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; host cell [GO:0043657]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]	GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006110; GO:0006404; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0043657; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0060964; GO:0070840; GO:0070849; GO:0072686; GO:0075733; GO:0090267; GO:0090316; GO:1900034; GO:1901673	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; intracellular transport of virus [GO:0075733]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN6175_c0_g1_i1	Q5EE04	TPR_XENLA	25.9	586	362	10	1662	1	390	935	6.50E-17	90.5	TPR_XENLA	reviewed	Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein) (Fragment)	tpr	Xenopus laevis (African clawed frog)	1997	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]	chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]	GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006606; GO:0007094; GO:0010965; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673	cell division [GO:0051301]; cellular response to heat [GO:0034605]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]		NA	NA	NA	NA	NA	NA
TRINITY_DN14860_c0_g1_i1	Q6DKJ4	NXN_HUMAN	38.4	318	192	4	57	1004	120	435	1.90E-65	251.1	NXN_HUMAN	reviewed	Nucleoredoxin (EC 1.8.1.8)	NXN NRX	Homo sapiens (Human)	435	cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]	GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0047134; GO:0072359	cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN14860_c0_g1_i2	Q6DKJ4	NXN_HUMAN	39.2	181	109	1	57	599	120	299	2.60E-38	160.2	NXN_HUMAN	reviewed	Nucleoredoxin (EC 1.8.1.8)	NXN NRX	Homo sapiens (Human)	435	cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]	GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0047134; GO:0072359	cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN10501_c0_g2_i1	Q90380	NDK_COLLI	76.1	46	11	0	91	228	6	51	8.40E-13	73.9	NDK_COLLI	reviewed	Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6)		Columba livia (Rock dove)	153	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004550; GO:0005524; GO:0005737; GO:0005886; GO:0006183; GO:0006228; GO:0006241; GO:0046872	CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN1708_c0_g1_i1	Q6DI51	NDK6_DANRE	56.5	147	63	1	442	2	7	152	5.80E-44	178.7	NDK6_DANRE	reviewed	Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6)	nme6 ndpkz6	Danio rerio (Zebrafish) (Brachydanio rerio)	175	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004550; GO:0005524; GO:0005739; GO:0006183; GO:0006228; GO:0006241; GO:0030308; GO:0045839; GO:0046872	CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN1708_c0_g1_i2	Q6DI51	NDK6_DANRE	65	80	28	0	241	2	73	152	1.80E-26	120.2	NDK6_DANRE	reviewed	Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6)	nme6 ndpkz6	Danio rerio (Zebrafish) (Brachydanio rerio)	175	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004550; GO:0005524; GO:0005739; GO:0006183; GO:0006228; GO:0006241; GO:0030308; GO:0045839; GO:0046872	CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN37077_c0_g1_i1	O88425	NDK6_MOUSE	96.9	128	4	0	385	2	28	155	2.00E-67	256.1	NDK6_MOUSE	reviewed	Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6) (nm23-M6)	Nme6	Mus musculus (Mouse)	189	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228]	mitochondrion [GO:0005739]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004550; GO:0005524; GO:0005739; GO:0006183; GO:0006228; GO:0006241; GO:0030308; GO:0045839; GO:0046872	CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN715_c0_g1_i2	Q9QXL8	NDK7_MOUSE	60.2	103	35	2	368	63	296	393	8.80E-28	124.4	NDK7_MOUSE	reviewed	Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-M7)	Nme7	Mus musculus (Mouse)	395	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0003351; GO:0004550; GO:0005524; GO:0005576; GO:0005813; GO:0006183; GO:0006228; GO:0006241; GO:0007368; GO:0007420; GO:0036064; GO:0042073; GO:0046872; GO:0060830; GO:0060972; GO:1990830	brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN715_c0_g1_i1	Q9QXL7	NDK7_RAT	70.4	54	16	0	224	63	340	393	5.10E-17	88.2	NDK7_RAT	reviewed	Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-R7)	Nme7	Rattus norvegicus (Rat)	395	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0003351; GO:0004550; GO:0005524; GO:0005576; GO:0005813; GO:0006183; GO:0006228; GO:0006241; GO:0007368; GO:0007420; GO:0036064; GO:0042073; GO:0046872; GO:0060830; GO:0060972; GO:1990830	brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN715_c0_g1_i3	Q9QXL7	NDK7_RAT	59.8	82	27	2	305	63	317	393	2.20E-20	99.8	NDK7_RAT	reviewed	Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-R7)	Nme7	Rattus norvegicus (Rat)	395	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0003351; GO:0004550; GO:0005524; GO:0005576; GO:0005813; GO:0006183; GO:0006228; GO:0006241; GO:0007368; GO:0007420; GO:0036064; GO:0042073; GO:0046872; GO:0060830; GO:0060972; GO:1990830	brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN8207_c1_g1_i1	P15531	NDKA_HUMAN	100	127	0	0	382	2	1	127	2.00E-69	263.1	NDKA_HUMAN	reviewed	Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)	NME1 NDPKA NM23	Homo sapiens (Human)	152	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]	GO:0000287; GO:0000977; GO:0002762; GO:0003697; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005741; GO:0005813; GO:0005829; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007595; GO:0008285; GO:0010629; GO:0010976; GO:0014075; GO:0015949; GO:0016020; GO:0019215; GO:0019899; GO:0021766; GO:0032587; GO:0033574; GO:0035690; GO:0042802; GO:0042981; GO:0043015; GO:0043024; GO:0043388; GO:0048471; GO:0050679; GO:0051591; GO:0070062; GO:0071333; GO:0071398	cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN17411_c0_g1_i1	P15531	NDKA_HUMAN	67.6	68	22	0	205	2	11	78	2.00E-21	102.4	NDKA_HUMAN	reviewed	Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)	NME1 NDPKA NM23	Homo sapiens (Human)	152	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]	GO:0000287; GO:0000977; GO:0002762; GO:0003697; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005741; GO:0005813; GO:0005829; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007595; GO:0008285; GO:0010629; GO:0010976; GO:0014075; GO:0015949; GO:0016020; GO:0019215; GO:0019899; GO:0021766; GO:0032587; GO:0033574; GO:0035690; GO:0042802; GO:0042981; GO:0043015; GO:0043024; GO:0043388; GO:0048471; GO:0050679; GO:0051591; GO:0070062; GO:0071333; GO:0071398	cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN4881_c0_g1_i2	P15531	NDKA_HUMAN	75.3	146	36	0	440	3	5	150	2.40E-61	236.5	NDKA_HUMAN	reviewed	Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)	NME1 NDPKA NM23	Homo sapiens (Human)	152	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]	GO:0000287; GO:0000977; GO:0002762; GO:0003697; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005741; GO:0005813; GO:0005829; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007595; GO:0008285; GO:0010629; GO:0010976; GO:0014075; GO:0015949; GO:0016020; GO:0019215; GO:0019899; GO:0021766; GO:0032587; GO:0033574; GO:0035690; GO:0042802; GO:0042981; GO:0043015; GO:0043024; GO:0043388; GO:0048471; GO:0050679; GO:0051591; GO:0070062; GO:0071333; GO:0071398	cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		blue	blue	NA	NA	NA	NA
TRINITY_DN4881_c0_g1_i3	P15531	NDKA_HUMAN	77.7	112	25	0	415	80	5	116	3.50E-46	186	NDKA_HUMAN	reviewed	Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)	NME1 NDPKA NM23	Homo sapiens (Human)	152	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]	GO:0000287; GO:0000977; GO:0002762; GO:0003697; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005741; GO:0005813; GO:0005829; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007595; GO:0008285; GO:0010629; GO:0010976; GO:0014075; GO:0015949; GO:0016020; GO:0019215; GO:0019899; GO:0021766; GO:0032587; GO:0033574; GO:0035690; GO:0042802; GO:0042981; GO:0043015; GO:0043024; GO:0043388; GO:0048471; GO:0050679; GO:0051591; GO:0070062; GO:0071333; GO:0071398	cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; regulation of apoptotic process [GO:0042981]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		blue	blue	NA	NA	NA	NA
TRINITY_DN30603_c0_g1_i1	P15532	NDKA_MOUSE	100	61	0	0	185	3	1	61	2.70E-28	125.6	NDKA_MOUSE	reviewed	Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Metastasis inhibition factor NM23) (NDPK-A) (Tumor metastatic process-associated protein) (nm23-M1)	Nme1 Nm23	Mus musculus (Mouse)	152	centrosome [GO:0005813]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; protein kinase binding [GO:0019901]; ribosomal small subunit binding [GO:0043024]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; mammary gland development [GO:0030879]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]	centrosome [GO:0005813]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; enzyme binding [GO:0019899]; gamma-tubulin binding [GO:0043015]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; protein kinase binding [GO:0019901]; ribosomal small subunit binding [GO:0043024]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]	GO:0000287; GO:0000977; GO:0002762; GO:0003697; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0005882; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007595; GO:0010629; GO:0010976; GO:0014075; GO:0016020; GO:0019215; GO:0019899; GO:0019901; GO:0021766; GO:0030879; GO:0032587; GO:0033574; GO:0035690; GO:0042802; GO:0043015; GO:0043024; GO:0043209; GO:0043388; GO:0048471; GO:0050679; GO:0051591; GO:0071333; GO:0071398	cellular response to drug [GO:0035690]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; hippocampus development [GO:0021766]; lactation [GO:0007595]; mammary gland development [GO:0030879]; negative regulation of gene expression [GO:0010629]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of neuron projection development [GO:0010976]; response to amine [GO:0014075]; response to cAMP [GO:0051591]; response to testosterone [GO:0033574]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN8207_c0_g1_i1	P22392	NDKB_HUMAN	100	143	0	0	54	482	1	143	6.50E-79	294.7	NDKB_HUMAN	reviewed	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2)	NME2 NM23B	Homo sapiens (Human)	152	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; neutrophil degranulation [GO:0043312]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]	GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007155; GO:0007189; GO:0007229; GO:0008144; GO:0009142; GO:0010976; GO:0015949; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0034774; GO:0042802; GO:0042981; GO:0043066; GO:0043312; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0060416; GO:0070062; GO:0071333; GO:0071398; GO:0071944; GO:1904813	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; neutrophil degranulation [GO:0043312]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8207_c0_g1_i2	P22392	NDKB_HUMAN	100	143	0	0	67	495	1	143	6.60E-79	294.7	NDKB_HUMAN	reviewed	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2)	NME2 NM23B	Homo sapiens (Human)	152	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; neutrophil degranulation [GO:0043312]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]	GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007155; GO:0007189; GO:0007229; GO:0008144; GO:0009142; GO:0010976; GO:0015949; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0034774; GO:0042802; GO:0042981; GO:0043066; GO:0043312; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0060416; GO:0070062; GO:0071333; GO:0071398; GO:0071944; GO:1904813	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; neutrophil degranulation [GO:0043312]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10501_c0_g1_i1	P22392	NDKB_HUMAN	68.2	85	27	0	3	257	20	104	5.50E-29	127.9	NDKB_HUMAN	reviewed	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2)	NME2 NM23B	Homo sapiens (Human)	152	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; neutrophil degranulation [GO:0043312]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]	GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007155; GO:0007189; GO:0007229; GO:0008144; GO:0009142; GO:0010976; GO:0015949; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0034774; GO:0042802; GO:0042981; GO:0043066; GO:0043312; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0060416; GO:0070062; GO:0071333; GO:0071398; GO:0071944; GO:1904813	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; neutrophil degranulation [GO:0043312]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10501_c0_g1_i2	Q5RFH3	NDKB_PONAB	66.7	69	23	0	3	209	20	88	2.70E-21	102.1	NDKB_PONAB	reviewed	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3)	NME2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	152	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; UTP biosynthetic process [GO:0006228]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]	GO:0001726; GO:0003677; GO:0004550; GO:0004673; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007229; GO:0009142; GO:0030027; GO:0045893; GO:0045944; GO:0046872; GO:0051880; GO:0071944	"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; UTP biosynthetic process [GO:0006228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8207_c0_g1_i3	Q50KA8	NDKB_CANLF	98.8	80	1	0	2	241	64	143	4.60E-41	167.9	NDKB_CANLF	reviewed	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-C2)	NME2 NM23B	Canis lupus familiaris (Dog) (Canis familiaris)	152	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]	GO:0001726; GO:0003677; GO:0004550; GO:0004673; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007229; GO:0009142; GO:0030027; GO:0042981; GO:0045893; GO:0045944; GO:0046872; GO:0051880; GO:0071944	"CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8622_c0_g1_i1	P56597	NDK5_HUMAN	48.2	191	97	1	758	186	12	200	1.50E-51	204.5	NDK5_HUMAN	reviewed	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	NME5	Homo sapiens (Human)	212	cilium [GO:0005929]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]	cilium [GO:0005929]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]	nucleoside diphosphate kinase activity [GO:0004550]	GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0060271; GO:1902176	cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN1283_c0_g1_i2	Q4V8V2	NUD17_DANRE	41.1	309	161	8	117	1022	6	300	3.80E-56	220.3	NUD17_DANRE	reviewed	Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)	nudt17 zgc:114128	Danio rerio (Zebrafish) (Brachydanio rerio)	300	cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]	cytosol [GO:0005829]; peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]	GO:0005777; GO:0005829; GO:0006734; GO:0006742; GO:0016787; GO:0019677; GO:0035529; GO:0046872	NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]		NA	NA	1	NA	NA	NA
TRINITY_DN1283_c0_g1_i1	Q4V8V2	NUD17_DANRE	41.1	309	161	8	83	988	6	300	2.20E-56	221.1	NUD17_DANRE	reviewed	Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)	nudt17 zgc:114128	Danio rerio (Zebrafish) (Brachydanio rerio)	300	cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]	cytosol [GO:0005829]; peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]	GO:0005777; GO:0005829; GO:0006734; GO:0006742; GO:0016787; GO:0019677; GO:0035529; GO:0046872	NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]		NA	NA	NA	NA	NA	NA
TRINITY_DN1283_c0_g1_i5	Q4V8V2	NUD17_DANRE	41.1	309	161	8	8	913	6	300	2.00E-56	221.1	NUD17_DANRE	reviewed	Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)	nudt17 zgc:114128	Danio rerio (Zebrafish) (Brachydanio rerio)	300	cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]	cytosol [GO:0005829]; peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]	GO:0005777; GO:0005829; GO:0006734; GO:0006742; GO:0016787; GO:0019677; GO:0035529; GO:0046872	NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]		NA	NA	NA	NA	NA	NA
TRINITY_DN1283_c0_g1_i6	Q4V8V2	NUD17_DANRE	41.1	309	161	8	57	962	6	300	2.80E-56	220.7	NUD17_DANRE	reviewed	Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)	nudt17 zgc:114128	Danio rerio (Zebrafish) (Brachydanio rerio)	300	cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]	cytosol [GO:0005829]; peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]	GO:0005777; GO:0005829; GO:0006734; GO:0006742; GO:0016787; GO:0019677; GO:0035529; GO:0046872	NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]		NA	NA	NA	NA	NA	NA
TRINITY_DN236_c0_g1_i11	Q5ZL13	NUD19_CHICK	37.5	64	38	2	221	36	298	361	9.50E-05	47.4	NUD19_CHICK	reviewed	Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)	NUDT19 RCJMB04_8e7	Gallus gallus (Chicken)	378	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005777; GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN236_c0_g1_i12	Q5PQ50	NUD19_XENLA	38.8	369	189	10	1028	24	6	371	1.50E-62	241.5	NUD19_XENLA	reviewed	Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)	nudt19	Xenopus laevis (African clawed frog)	380	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005777; GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN236_c0_g1_i15	Q5ZL13	NUD19_CHICK	34.3	303	170	6	857	36	59	361	5.60E-43	176.4	NUD19_CHICK	reviewed	Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)	NUDT19 RCJMB04_8e7	Gallus gallus (Chicken)	378	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005777; GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN236_c0_g1_i3	Q5ZL13	NUD19_CHICK	34	303	171	6	857	36	59	361	3.60E-42	173.7	NUD19_CHICK	reviewed	Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)	NUDT19 RCJMB04_8e7	Gallus gallus (Chicken)	378	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005777; GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN236_c0_g1_i6	Q5PQ50	NUD19_XENLA	38.2	293	147	7	792	10	6	296	8.50E-48	192.2	NUD19_XENLA	reviewed	Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)	nudt19	Xenopus laevis (African clawed frog)	380	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	peroxisome [GO:0005777]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005777; GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5064_c0_g1_i1	Q8WV74	NUDT8_HUMAN	45.5	209	102	6	119	736	6	205	1.20E-32	141.7	NUDT8_HUMAN	reviewed	Nucleoside diphosphate-linked moiety X motif 8 (Nudix motif 8) (EC 3.6.1.-)	NUDT8	Homo sapiens (Human)	236	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN14708_c0_g1_i1	Q9W0T1	NU301_DROME	32	266	152	6	797	12	638	878	1.80E-25	117.9	NU301_DROME	reviewed	Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215)	E(bx) CG32346 CG7022 Nurf301	Drosophila melanogaster (Fruit fly)	2669	"nucleus [GO:0005634]; NURF complex [GO:0016589]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid differentiation [GO:0048515]"	nucleus [GO:0005634]; NURF complex [GO:0016589]	lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0035064; GO:0035073; GO:0035076; GO:0042766; GO:0045824; GO:0045893; GO:0046426; GO:0046872; GO:0048515; GO:0070577	"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30046_c0_g1_i1	Q9W0T1	NU301_DROME	52.3	218	88	4	656	6	1248	1450	2.70E-56	220.3	NU301_DROME	reviewed	Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215)	E(bx) CG32346 CG7022 Nurf301	Drosophila melanogaster (Fruit fly)	2669	"nucleus [GO:0005634]; NURF complex [GO:0016589]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid differentiation [GO:0048515]"	nucleus [GO:0005634]; NURF complex [GO:0016589]	lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0035064; GO:0035073; GO:0035076; GO:0042766; GO:0045824; GO:0045893; GO:0046426; GO:0046872; GO:0048515; GO:0070577	"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36444_c0_g1_i1	Q9W0T1	NU301_DROME	50	42	21	0	40	165	342	383	5.50E-06	51.2	NU301_DROME	reviewed	Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215)	E(bx) CG32346 CG7022 Nurf301	Drosophila melanogaster (Fruit fly)	2669	"nucleus [GO:0005634]; NURF complex [GO:0016589]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid differentiation [GO:0048515]"	nucleus [GO:0005634]; NURF complex [GO:0016589]	lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0035064; GO:0035073; GO:0035076; GO:0042766; GO:0045824; GO:0045893; GO:0046426; GO:0046872; GO:0048515; GO:0070577	"chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4564_c0_g1_i1	Q6NUA7	SIL1_XENLA	32.7	425	228	9	97	1338	63	440	6.00E-59	229.9	SIL1_XENLA	reviewed	Nucleotide exchange factor SIL1	sil1	Xenopus laevis (African clawed frog)	456	endoplasmic reticulum lumen [GO:0005788]; protein transport [GO:0015031]	endoplasmic reticulum lumen [GO:0005788]		GO:0005788; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2500_c0_g1_i1	Q503C8	NUDC1_DANRE	29.2	596	386	15	1760	27	8	585	4.00E-68	260.8	NUDC1_DANRE	reviewed	NudC domain-containing protein 1	nudcd1 zgc:110705	Danio rerio (Zebrafish) (Brachydanio rerio)	585	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN40808_c0_g1_i1	Q96RS6	NUDC1_HUMAN	100	67	0	0	1	201	423	489	3.70E-36	151.4	NUDC1_HUMAN	reviewed	NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66)	NUDCD1 CML66	Homo sapiens (Human)	583	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; immune system process [GO:0002376]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0002376; GO:0005654; GO:0005829	immune system process [GO:0002376]		NA	NA	NA	NA	NA	NA
TRINITY_DN40489_c0_g1_i1	Q9Y6R0	NUMBL_HUMAN	100	74	0	0	223	2	110	183	1.90E-38	159.1	NUMBL_HUMAN	reviewed	Numb-like protein (Numb-related protein) (Numb-R)	NUMBL	Homo sapiens (Human)	609	cytoplasm [GO:0005737]; adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]	cytoplasm [GO:0005737]		GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769	adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]		NA	NA	NA	NA	NA	NA
TRINITY_DN4259_c0_g1_i3	Q8BML2	OACYL_MOUSE	29.8	178	121	2	621	1154	496	669	6.90E-16	86.7	OACYL_MOUSE	reviewed	O-acyltransferase like protein (Protein oacyl)	Oacyl	Mus musculus (Mouse)	685	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0016021; GO:0016747			NA	NA	NA	NA	NA	NA
TRINITY_DN4259_c0_g1_i4	Q8BML2	OACYL_MOUSE	35.8	109	69	1	416	90	562	669	5.00E-11	68.9	OACYL_MOUSE	reviewed	O-acyltransferase like protein (Protein oacyl)	Oacyl	Mus musculus (Mouse)	685	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0016021; GO:0016747			NA	NA	NA	NA	NA	NA
TRINITY_DN4259_c0_g1_i7	Q8BML2	OACYL_MOUSE	30.1	163	110	2	390	878	496	654	7.00E-15	82.8	OACYL_MOUSE	reviewed	O-acyltransferase like protein (Protein oacyl)	Oacyl	Mus musculus (Mouse)	685	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0016021; GO:0016747			NA	NA	NA	NA	NA	NA
TRINITY_DN4259_c0_g1_i8	Q8BML2	OACYL_MOUSE	34.1	135	85	2	494	90	539	669	3.70E-11	69.7	OACYL_MOUSE	reviewed	O-acyltransferase like protein (Protein oacyl)	Oacyl	Mus musculus (Mouse)	685	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0016021; GO:0016747			NA	NA	NA	NA	NA	NA
TRINITY_DN4259_c0_g1_i9	Q8BML2	OACYL_MOUSE	26.8	138	98	1	34	447	463	597	1.30E-09	64.3	OACYL_MOUSE	reviewed	O-acyltransferase like protein (Protein oacyl)	Oacyl	Mus musculus (Mouse)	685	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0016021; GO:0016747			NA	NA	NA	NA	NA	NA
TRINITY_DN16851_c0_g1_i4	Q8BML2	OACYL_MOUSE	30.5	187	111	6	654	136	265	446	3.40E-09	64.3	OACYL_MOUSE	reviewed	O-acyltransferase like protein (Protein oacyl)	Oacyl	Mus musculus (Mouse)	685	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0016021; GO:0016747			NA	NA	NA	NA	NA	NA
TRINITY_DN3411_c0_g1_i1	Q7ZWM6	OLA1_XENLA	72.1	387	106	2	1162	8	3	389	1.20E-161	570.9	OLA1_XENLA	reviewed	Obg-like ATPase 1	ola1	Xenopus laevis (African clawed frog)	396	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN3411_c0_g2_i1	Q7ZWM6	OLA1_XENLA	72.1	387	106	2	107	1261	3	389	1.20E-161	570.9	OLA1_XENLA	reviewed	Obg-like ATPase 1	ola1	Xenopus laevis (African clawed frog)	396	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN40862_c0_g1_i1	Q2HJ33	OLA1_BOVIN	99	98	1	0	35	328	1	98	4.60E-52	204.9	OLA1_BOVIN	reviewed	Obg-like ATPase 1	OLA1	Bos taurus (Bovine)	396	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5308_c0_g1_i1	P38219	OLA1_YEAST	59.5	74	30	0	1	222	96	169	1.00E-16	87	OLA1_YEAST	reviewed	Obg-like ATPase 1	OLA1 YBR025C YBR0309	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	394	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5308_c0_g1_i2	P38219	OLA1_YEAST	59.5	74	30	0	1	222	96	169	9.40E-17	87	OLA1_YEAST	reviewed	Obg-like ATPase 1	OLA1 YBR025C YBR0309	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	394	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN38728_c0_g1_i1	Q5ZM25	OLA1_CHICK	65.2	112	39	0	30	365	17	128	8.40E-39	161	OLA1_CHICK	reviewed	Obg-like ATPase 1	OLA1 RCJMB04_3f20	Gallus gallus (Chicken)	396	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN30568_c0_g1_i1	Q2HJ33	OLA1_BOVIN	100	77	0	0	233	3	300	376	2.70E-38	158.7	OLA1_BOVIN	reviewed	Obg-like ATPase 1	OLA1	Bos taurus (Bovine)	396	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34850_c0_g1_i1	Q9NTK5	OLA1_HUMAN	100	120	0	0	362	3	91	210	1.00E-65	250.4	OLA1_HUMAN	reviewed	Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9)	OLA1 GTPBP9 PRO2455 PTD004	Homo sapiens (Human)	396	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; ATP metabolic process [GO:0046034]; platelet degranulation [GO:0002576]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0002576; GO:0005524; GO:0005525; GO:0005576; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0016020; GO:0016887; GO:0031093; GO:0043022; GO:0043023; GO:0045296; GO:0046034; GO:0046872; GO:0070062	ATP metabolic process [GO:0046034]; platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN12851_c0_g2_i1	Q9SA73	OLA1_ARATH	52.3	86	39	1	266	9	184	267	5.00E-20	98.2	OLA1_ARATH	reviewed	Obg-like ATPase 1 (Ribosome-binding ATPase YchF) (AtYchF1)	YchF1 At1g30580 T5I8.3	Arabidopsis thaliana (Mouse-ear cress)	394	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; defense response [GO:0006952]; negative regulation of response to salt stress [GO:1901001]; response to cadmium ion [GO:0046686]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006952; GO:0009506; GO:0009651; GO:0016887; GO:0043022; GO:0043023; GO:0046686; GO:0046872; GO:1901001	defense response [GO:0006952]; negative regulation of response to salt stress [GO:1901001]; response to cadmium ion [GO:0046686]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN12851_c0_g1_i1	Q9SA73	OLA1_ARATH	57	100	43	0	1	300	270	369	2.70E-27	122.5	OLA1_ARATH	reviewed	Obg-like ATPase 1 (Ribosome-binding ATPase YchF) (AtYchF1)	YchF1 At1g30580 T5I8.3	Arabidopsis thaliana (Mouse-ear cress)	394	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; defense response [GO:0006952]; negative regulation of response to salt stress [GO:1901001]; response to cadmium ion [GO:0046686]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006952; GO:0009506; GO:0009651; GO:0016887; GO:0043022; GO:0043023; GO:0046686; GO:0046872; GO:1901001	defense response [GO:0006952]; negative regulation of response to salt stress [GO:1901001]; response to cadmium ion [GO:0046686]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN12851_c0_g3_i1	B8BBN7	OLA1_ORYSI	67.2	134	43	1	407	6	18	150	1.40E-48	193.7	OLA1_ORYSI	reviewed	Obg-like ATPase 1 (Ribosome-binding ATPase YchF) (OsYchF1)	OsI_28170	Oryza sativa subsp. indica (Rice)	394	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of response to salt stress [GO:1901001]; response to salt stress [GO:0009651]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0003924; GO:0005524; GO:0005525; GO:0005829; GO:0005886; GO:0009651; GO:0016887; GO:0043022; GO:0043023; GO:0046872; GO:1900425; GO:1901001	negative regulation of defense response to bacterium [GO:1900425]; negative regulation of response to salt stress [GO:1901001]; response to salt stress [GO:0009651]		NA	NA	NA	NA	NA	NA
TRINITY_DN26210_c0_g1_i1	A8DYP0	OBSCN_DROME	52	50	24	0	83	232	1349	1398	7.20E-07	54.3	OBSCN_DROME	reviewed	Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)	Unc-89 CG33519	Drosophila melanogaster (Fruit fly)	4218	M band [GO:0031430]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]	M band [GO:0031430]; sarcomere [GO:0030017]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]	GO:0005085; GO:0005523; GO:0005524; GO:0006468; GO:0006936; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0030017; GO:0031430; GO:0036309; GO:0045214; GO:0046872; GO:0051015	adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]		brown	brown	NA	NA	NA	NA
TRINITY_DN1393_c0_g1_i3	A8DYP0	OBSCN_DROME	26.5	147	98	4	333	743	2647	2793	9.70E-05	49.3	OBSCN_DROME	reviewed	Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)	Unc-89 CG33519	Drosophila melanogaster (Fruit fly)	4218	M band [GO:0031430]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]	M band [GO:0031430]; sarcomere [GO:0030017]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]	GO:0005085; GO:0005523; GO:0005524; GO:0006468; GO:0006936; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0030017; GO:0031430; GO:0036309; GO:0045214; GO:0046872; GO:0051015	adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN15882_c1_g1_i1	A8DYP0	OBSCN_DROME	48.9	47	23	1	43	180	3794	3840	2.60E-06	52.4	OBSCN_DROME	reviewed	Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)	Unc-89 CG33519	Drosophila melanogaster (Fruit fly)	4218	M band [GO:0031430]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]	M band [GO:0031430]; sarcomere [GO:0030017]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]	GO:0005085; GO:0005523; GO:0005524; GO:0006468; GO:0006936; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0030017; GO:0031430; GO:0036309; GO:0045214; GO:0046872; GO:0051015	adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN37039_c0_g1_i1	Q9VCZ3	OCTB1_DROME	65.4	104	34	2	324	16	330	432	5.60E-32	138.3	OCTB1_DROME	reviewed	Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R)	Octbeta1R oa2 Oct-beta-1 CG6919	Drosophila melanogaster (Fruit fly)	508	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; octopamine receptor activity [GO:0004989]	GO:0004930; GO:0004935; GO:0004989; GO:0005887; GO:0007186; GO:0007188; GO:0007189; GO:0008227; GO:0016021; GO:0045886; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]		NA	NA	NA	NA	NA	NA
TRINITY_DN31305_c0_g1_i1	Q9VCZ3	OCTB1_DROME	64.2	81	29	0	243	1	109	189	5.30E-21	101.3	OCTB1_DROME	reviewed	Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R)	Octbeta1R oa2 Oct-beta-1 CG6919	Drosophila melanogaster (Fruit fly)	508	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; octopamine receptor activity [GO:0004989]	GO:0004930; GO:0004935; GO:0004989; GO:0005887; GO:0007186; GO:0007188; GO:0007189; GO:0008227; GO:0016021; GO:0045886; GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]		NA	NA	NA	NA	NA	NA
TRINITY_DN27485_c0_g1_i1	Q29AU6	RUMI_DROPS	49.2	63	32	0	25	213	340	402	1.70E-11	69.7	RUMI_DROPS	reviewed	O-glucosyltransferase rumi (EC 2.4.1.-)	rumi GA16050	Drosophila pseudoobscura pseudoobscura (Fruit fly)	409	endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; cell fate commitment [GO:0045165]; muscle tissue development [GO:0060537]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation in endoplasmic reticulum [GO:0033577]; protein O-linked glycosylation via serine [GO:0018242]; rhabdomere development [GO:0042052]	endoplasmic reticulum lumen [GO:0005788]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0005788; GO:0007219; GO:0018242; GO:0033577; GO:0035251; GO:0035252; GO:0042052; GO:0045165; GO:0045746; GO:0045747; GO:0046527; GO:0060537	cell fate commitment [GO:0045165]; muscle tissue development [GO:0060537]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation in endoplasmic reticulum [GO:0033577]; protein O-linked glycosylation via serine [GO:0018242]; rhabdomere development [GO:0042052]		NA	NA	NA	NA	NA	NA
TRINITY_DN27485_c0_g1_i2	Q16QY8	RUMI_AEDAE	56.8	400	166	3	95	1285	6	401	3.00E-134	479.9	RUMI_AEDAE	reviewed	O-glucosyltransferase rumi homolog (EC 2.4.1.-)	AAEL011121	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	402	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; UDP-glucosyltransferase activity [GO:0035251]; protein O-linked glycosylation via serine [GO:0018242]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	UDP-glucosyltransferase activity [GO:0035251]	GO:0005576; GO:0005788; GO:0018242; GO:0035251	protein O-linked glycosylation via serine [GO:0018242]		NA	NA	NA	NA	NA	NA
TRINITY_DN21968_c0_g1_i1	O06994	O16G1_BACSU	62.4	101	38	0	4	306	101	201	9.70E-36	150.6	O16G1_BACSU	reviewed	"Oligo-1,6-glucosidase 1 (EC 3.2.1.10) (Dextrin 6-alpha-D-glucanohydrolase) (Oligosaccharide alpha-1,6-glucosidase 1) (Sucrase-isomaltase 1) (Isomaltase 1)"	malL yvdL BSU34560	Bacillus subtilis (strain 168)	561	"cytoplasm [GO:0005737]; alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; oligo-1,6-glucosidase activity [GO:0004574]; oligosaccharide catabolic process [GO:0009313]"	cytoplasm [GO:0005737]	"alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; oligo-1,6-glucosidase activity [GO:0004574]"	GO:0004556; GO:0004574; GO:0005737; GO:0009313; GO:0046872	oligosaccharide catabolic process [GO:0009313]		NA	NA	NA	NA	NA	NA
TRINITY_DN37416_c0_g1_i1	Q8Y0V1	ORN_RALSO	91.5	82	7	0	246	1	119	200	2.30E-40	165.6	ORN_RALSO	reviewed	Oligoribonuclease (EC 3.1.-.-)	orn RSc0942 RS04464	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	219	cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	cytoplasm [GO:0005737]	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN38694_c0_g1_i1	Q8Y0V1	ORN_RALSO	91	78	7	0	236	3	21	98	2.10E-36	152.5	ORN_RALSO	reviewed	Oligoribonuclease (EC 3.1.-.-)	orn RSc0942 RS04464	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	219	cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	cytoplasm [GO:0005737]	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN4097_c0_g1_i1	Q9Y3B8	ORN_HUMAN	65.2	187	65	0	153	713	39	225	2.70E-68	260	ORN_HUMAN	reviewed	"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)"	REXO2 SFN SMFN CGI-114	Homo sapiens (Human)	237	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117]	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005634; GO:0005730; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0006139; GO:0008408; GO:0009117	nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117]		blue	blue	NA	NA	NA	NA
TRINITY_DN24928_c0_g1_i1	Q9Y3B8	ORN_HUMAN	98.8	169	2	0	509	3	48	216	1.90E-95	349.7	ORN_HUMAN	reviewed	"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)"	REXO2 SFN SMFN CGI-114	Homo sapiens (Human)	237	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117]	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005634; GO:0005730; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0006139; GO:0008408; GO:0009117	nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN24928_c0_g1_i2	Q9D8S4	ORN_MOUSE	100	126	0	0	380	3	91	216	5.10E-71	268.1	ORN_MOUSE	reviewed	"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)"	Rexo2 Smfn	Mus musculus (Mouse)	237	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; nucleobase-containing compound metabolic process [GO:0006139]	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005634; GO:0005730; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0006139; GO:0008408	nucleobase-containing compound metabolic process [GO:0006139]		NA	NA	NA	NA	NA	NA
TRINITY_DN714_c0_g1_i1	A2VE52	ORN_BOVIN	43.9	180	99	2	614	75	34	211	3.30E-38	160.2	ORN_BOVIN	reviewed	"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)"	REXO2	Bos taurus (Bovine)	237	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005730; GO:0005739; GO:0005758; GO:0005759; GO:0005925			blue	blue	NA	NA	NA	NA
TRINITY_DN714_c0_g1_i3	A2VE52	ORN_BOVIN	45.4	163	87	2	563	75	51	211	2.90E-34	146.7	ORN_BOVIN	reviewed	"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)"	REXO2	Bos taurus (Bovine)	237	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005730; GO:0005739; GO:0005758; GO:0005759; GO:0005925			NA	NA	NA	NA	NA	NA
TRINITY_DN714_c0_g1_i4	A2VE52	ORN_BOVIN	43.9	180	99	2	614	75	34	211	3.30E-38	160.2	ORN_BOVIN	reviewed	"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)"	REXO2	Bos taurus (Bovine)	237	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0003676; GO:0005730; GO:0005739; GO:0005758; GO:0005759; GO:0005925			NA	NA	NA	NA	NA	NA
TRINITY_DN38634_c0_g1_i1	Q9NRP0	OSTC_HUMAN	100	62	0	0	16	201	1	62	9.70E-29	126.7	OSTC_HUMAN	reviewed	Oligosaccharyltransferase complex subunit OSTC (Hydrophobic protein HSF-28)	OSTC DC2 HDCMD45P HSPC307	Homo sapiens (Human)	149	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0008250; GO:0016021; GO:0018279	protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN15087_c0_g2_i1	Q5M9B7	OSTCB_XENLA	100	79	0	0	238	2	58	136	1.60E-38	159.5	OSTCB_XENLA	reviewed	Oligosaccharyltransferase complex subunit ostc-B	ostc-b	Xenopus laevis (African clawed frog)	149	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0006486; GO:0008250; GO:0016021	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15087_c0_g1_i1	Q5M9B7	OSTCB_XENLA	100	75	0	0	227	3	50	124	2.90E-37	155.2	OSTCB_XENLA	reviewed	Oligosaccharyltransferase complex subunit ostc-B	ostc-b	Xenopus laevis (African clawed frog)	149	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0006486; GO:0008250; GO:0016021	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN14237_c0_g1_i1	Q5M9B7	OSTCB_XENLA	66.4	128	43	0	386	3	1	128	2.80E-47	189.5	OSTCB_XENLA	reviewed	Oligosaccharyltransferase complex subunit ostc-B	ostc-b	Xenopus laevis (African clawed frog)	149	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0006486; GO:0008250; GO:0016021	protein glycosylation [GO:0006486]		blue	blue	NA	NA	NA	NA
TRINITY_DN14237_c0_g1_i2	Q5M9B7	OSTCB_XENLA	66.2	148	50	0	517	74	1	148	3.60E-55	216.1	OSTCB_XENLA	reviewed	Oligosaccharyltransferase complex subunit ostc-B	ostc-b	Xenopus laevis (African clawed frog)	149	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]		GO:0006486; GO:0008250; GO:0016021	protein glycosylation [GO:0006486]		blue	blue	NA	NA	NA	NA
TRINITY_DN344_c0_g1_i1	Q4VBV9	NIT2_DANRE	61.5	273	104	1	1044	226	2	273	1.30E-103	377.9	NIT2_DANRE	reviewed	Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2)	nit2 zgc:109720	Danio rerio (Zebrafish) (Brachydanio rerio)	277	cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]	cytoplasm [GO:0005737]	omega-amidase activity [GO:0050152]	GO:0005737; GO:0006107; GO:0006528; GO:0006541; GO:0050152	asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN344_c0_g1_i2	Q4VBV9	NIT2_DANRE	61.5	273	104	1	1057	239	2	273	1.40E-103	377.9	NIT2_DANRE	reviewed	Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2)	nit2 zgc:109720	Danio rerio (Zebrafish) (Brachydanio rerio)	277	cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]	cytoplasm [GO:0005737]	omega-amidase activity [GO:0050152]	GO:0005737; GO:0006107; GO:0006528; GO:0006541; GO:0050152	asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	1	NA	NA
TRINITY_DN35623_c0_g1_i1	Q9NQR4	NIT2_HUMAN	97.7	176	4	0	2	529	94	269	2.10E-99	362.8	NIT2_HUMAN	reviewed	Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2)	NIT2 CUA002	Homo sapiens (Human)	276	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	omega-amidase activity [GO:0050152]	GO:0005576; GO:0005813; GO:0005829; GO:0006107; GO:0006528; GO:0006541; GO:0035580; GO:0043312; GO:0050152; GO:0070062; GO:1904724	asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]		NA	NA	NA	NA	NA	NA
TRINITY_DN13056_c0_g1_i4	P18743	ZO2_XENLA	41.8	55	32	0	120	284	103	157	9.60E-06	50.8	ZO2_XENLA	reviewed	Oocyte zinc finger protein XlCOF2 (Fragment)		Xenopus laevis (African clawed frog)	157	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i10	P18743	ZO2_XENLA	51.9	54	26	0	168	7	104	157	5.20E-09	62.4	ZO2_XENLA	reviewed	Oocyte zinc finger protein XlCOF2 (Fragment)		Xenopus laevis (African clawed frog)	157	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i9	P18743	ZO2_XENLA	50.9	57	28	0	177	7	101	157	8.10E-10	64.7	ZO2_XENLA	reviewed	Oocyte zinc finger protein XlCOF2 (Fragment)		Xenopus laevis (African clawed frog)	157	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i6	P18746	ZO26_XENLA	40	55	33	0	171	335	4	58	2.10E-07	56.6	ZO26_XENLA	reviewed	Oocyte zinc finger protein XlCOF26 (Fragment)		Xenopus laevis (African clawed frog)	196	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i7	P18746	ZO26_XENLA	50	70	35	0	20	229	11	80	1.40E-15	83.2	ZO26_XENLA	reviewed	Oocyte zinc finger protein XlCOF26 (Fragment)		Xenopus laevis (African clawed frog)	196	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i31	P18749	ZO6_XENLA	46.5	71	38	0	216	4	259	329	1.90E-14	80.1	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c0_g1_i3	P18749	ZO6_XENLA	43.1	109	62	0	379	53	345	453	1.00E-22	108.6	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c0_g1_i1	P18749	ZO6_XENLA	50	68	34	0	2	205	379	446	5.90E-13	74.3	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN14556_c0_g1_i5	P18749	ZO6_XENLA	51.5	68	33	0	8	211	228	295	1.20E-14	80.9	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN18497_c0_g1_i1	P18749	ZO6_XENLA	28.3	233	155	4	794	96	36	256	4.60E-24	113.2	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i19	P18749	ZO6_XENLA	48.4	122	57	2	86	451	323	438	5.60E-24	112.1	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i17	P18749	ZO6_XENLA	45.9	61	33	0	160	342	287	347	1.30E-09	63.9	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i6	P18749	ZO6_XENLA	45.9	61	33	0	160	342	287	347	7.70E-10	64.7	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i8	P18749	ZO6_XENLA	47.5	61	32	0	160	342	287	347	3.50E-10	65.9	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i1	P18749	ZO6_XENLA	43.7	71	40	0	214	2	259	329	1.70E-12	73.2	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i10	P18749	ZO6_XENLA	41.8	91	53	0	280	8	259	349	4.10E-18	92	ZO6_XENLA	reviewed	Oocyte zinc finger protein XlCOF6 (Fragment)		Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c1_g1_i3	P18750	ZO61_XENLA	40.7	59	35	0	261	85	8	66	5.10E-06	51.6	ZO61_XENLA	reviewed	Oocyte zinc finger protein XlCOF6.1 (Fragment)		Xenopus laevis (African clawed frog)	224	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3331_c7_g1_i1	P18750	ZO61_XENLA	51.8	199	96	0	918	322	26	224	3.80E-60	233.4	ZO61_XENLA	reviewed	Oocyte zinc finger protein XlCOF6.1 (Fragment)		Xenopus laevis (African clawed frog)	224	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i2	P18751	ZO71_XENLA	50.8	59	29	0	628	804	703	761	2.20E-10	67.8	ZO71_XENLA	reviewed	Oocyte zinc finger protein XlCOF7.1 (Fragment)		Xenopus laevis (African clawed frog)	898	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8943_c1_g1_i1	P18751	ZO71_XENLA	46.5	71	38	0	4	216	824	894	1.30E-13	76.6	ZO71_XENLA	reviewed	Oocyte zinc finger protein XlCOF7.1 (Fragment)		Xenopus laevis (African clawed frog)	898	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN33616_c0_g1_i1	P18753	ZO84_XENLA	51	153	70	1	462	4	280	427	3.40E-43	176	ZO84_XENLA	reviewed	Oocyte zinc finger protein XlCOF8.4 (Fragment)		Xenopus laevis (African clawed frog)	780	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c2_g1_i1	P18753	ZO84_XENLA	45.6	79	43	0	242	6	334	412	2.60E-15	82.4	ZO84_XENLA	reviewed	Oocyte zinc finger protein XlCOF8.4 (Fragment)		Xenopus laevis (African clawed frog)	780	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i5	P18753	ZO84_XENLA	52	75	36	0	5	229	323	397	2.20E-16	85.9	ZO84_XENLA	reviewed	Oocyte zinc finger protein XlCOF8.4 (Fragment)		Xenopus laevis (African clawed frog)	780	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13058_c1_g1_i1	P18753	ZO84_XENLA	50.9	57	28	0	174	4	316	372	1.70E-08	59.7	ZO84_XENLA	reviewed	Oocyte zinc finger protein XlCOF8.4 (Fragment)		Xenopus laevis (African clawed frog)	780	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27099_c0_g1_i1	P18753	ZO84_XENLA	50.3	149	74	0	452	6	270	418	4.60E-42	172.2	ZO84_XENLA	reviewed	Oocyte zinc finger protein XlCOF8.4 (Fragment)		Xenopus laevis (African clawed frog)	780	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17463_c0_g1_i1	P18753	ZO84_XENLA	43.6	110	58	2	52	369	327	436	6.30E-18	91.7	ZO84_XENLA	reviewed	Oocyte zinc finger protein XlCOF8.4 (Fragment)		Xenopus laevis (African clawed frog)	780	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3256_c0_g1_i4	Q9HD40	SPCS_HUMAN	51.9	81	39	0	75	317	1	81	1.80E-16	87	SPCS_HUMAN	reviewed	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Liver-pancreas antigen) (LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen) (SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein)	SEPSECS TRNP48	Homo sapiens (Human)	501	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteine metabolic process [GO:0016259]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]"	GO:0000049; GO:0001514; GO:0005634; GO:0005737; GO:0005829; GO:0016259; GO:0016785; GO:0097056	selenocysteine incorporation [GO:0001514]; selenocysteine metabolic process [GO:0016259]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]		NA	NA	NA	NA	NA	NA
TRINITY_DN3256_c0_g1_i1	Q28EN2	SPCS_XENTR	61.6	237	91	0	75	785	1	237	9.40E-81	302.4	SPCS_XENTR	reviewed	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (UGA suppressor tRNA-associated protein)	sepsecs TGas010o23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	506	"cytoplasm [GO:0005737]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"	cytoplasm [GO:0005737]	"transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]"	GO:0000049; GO:0001514; GO:0005737; GO:0016785; GO:0097056	selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]		NA	NA	NA	NA	NA	NA
TRINITY_DN3256_c0_g1_i1	Q28EN2	SPCS_XENTR	50.8	189	87	1	784	1332	271	459	2.60E-46	188	SPCS_XENTR	reviewed	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (UGA suppressor tRNA-associated protein)	sepsecs TGas010o23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	506	"cytoplasm [GO:0005737]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"	cytoplasm [GO:0005737]	"transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]"	GO:0000049; GO:0001514; GO:0005737; GO:0016785; GO:0097056	selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]		NA	NA	NA	NA	NA	NA
TRINITY_DN3256_c0_g1_i2	Q6P6M7	SPCS_MOUSE	63.6	44	16	0	271	402	38	81	1.10E-10	67.8	SPCS_MOUSE	reviewed	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (UGA suppressor tRNA-associated protein)	Sepsecs D5Ertd135e	Mus musculus (Mouse)	504	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]"	GO:0000049; GO:0001514; GO:0005634; GO:0005737; GO:0016785; GO:0097056	selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]		NA	NA	NA	NA	NA	NA
TRINITY_DN3256_c0_g1_i3	Q28EN2	SPCS_XENTR	57.5	459	189	1	75	1433	1	459	1.60E-150	534.3	SPCS_XENTR	reviewed	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (UGA suppressor tRNA-associated protein)	sepsecs TGas010o23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	506	"cytoplasm [GO:0005737]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"	cytoplasm [GO:0005737]	"transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]"	GO:0000049; GO:0001514; GO:0005737; GO:0016785; GO:0097056	selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]		blue	blue	NA	NA	NA	NA
TRINITY_DN10562_c0_g1_i1	Q28EN2	SPCS_XENTR	57.1	163	68	2	4	486	198	360	2.80E-45	183	SPCS_XENTR	reviewed	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (UGA suppressor tRNA-associated protein)	sepsecs TGas010o23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	506	"cytoplasm [GO:0005737]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"	cytoplasm [GO:0005737]	"transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]"	GO:0000049; GO:0001514; GO:0005737; GO:0016785; GO:0097056	selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]		NA	NA	NA	NA	NA	NA
TRINITY_DN11420_c1_g1_i5	Q9GV46	LUCB_OPLGR	26.9	234	133	7	727	101	138	358	6.40E-10	66.2	LUCB_OPLGR	reviewed	Oplophorus-luciferin 2-monooxygenase non-catalytic subunit		Oplophorus gracilirostris (Luminous shrimp)	359	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			black	black	NA	NA	NA	NA
TRINITY_DN11420_c1_g1_i4	Q9GV46	LUCB_OPLGR	27.1	336	195	12	1018	101	43	358	7.20E-20	99.8	LUCB_OPLGR	reviewed	Oplophorus-luciferin 2-monooxygenase non-catalytic subunit		Oplophorus gracilirostris (Luminous shrimp)	359	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	1	NA	NA	1
TRINITY_DN1816_c0_g1_i5	Q505D7	OPA3_MOUSE	51.3	76	33	1	1	228	18	89	1.60E-14	80.1	OPA3_MOUSE	reviewed	Optic atrophy 3 protein homolog	Opa3	Mus musculus (Mouse)	179	mitochondrion [GO:0005739]; bone development [GO:0060348]; fat cell differentiation [GO:0045444]; mitochondrion morphogenesis [GO:0070584]; neuromuscular process [GO:0050905]; regulation of growth [GO:0040008]; regulation of lipid metabolic process [GO:0019216]; visual perception [GO:0007601]	mitochondrion [GO:0005739]		GO:0005739; GO:0007601; GO:0019216; GO:0040008; GO:0045444; GO:0050905; GO:0060348; GO:0070584	bone development [GO:0060348]; fat cell differentiation [GO:0045444]; mitochondrion morphogenesis [GO:0070584]; neuromuscular process [GO:0050905]; regulation of growth [GO:0040008]; regulation of lipid metabolic process [GO:0019216]; visual perception [GO:0007601]		blue	blue	1	NA	NA	NA
TRINITY_DN1816_c0_g1_i3	Q1L9A2	OPA3_DANRE	40.6	133	75	1	1	399	18	146	1.50E-20	100.9	OPA3_DANRE	reviewed	Optic atrophy 3 protein homolog	opa3 si:dkey-12o15.3	Danio rerio (Zebrafish) (Brachydanio rerio)	157	mitochondrion [GO:0005739]; locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]		GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881	locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN1816_c0_g1_i7	Q1L9A2	OPA3_DANRE	40.6	133	75	1	1	399	18	146	1.90E-20	100.5	OPA3_DANRE	reviewed	Optic atrophy 3 protein homolog	opa3 si:dkey-12o15.3	Danio rerio (Zebrafish) (Brachydanio rerio)	157	mitochondrion [GO:0005739]; locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]		GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881	locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216]		blue	blue	NA	NA	NA	NA
TRINITY_DN9619_c0_g1_i2	Q0GBZ5	OX1R_BOVIN	33.3	87	54	1	326	66	293	375	3.60E-09	62.8	OX1R_BOVIN	reviewed	Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1)	HCRTR1	Bos taurus (Bovine)	425	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]	integral component of plasma membrane [GO:0005887]	G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0051480; GO:0070374	feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]		NA	NA	NA	NA	NA	NA
TRINITY_DN26645_c1_g1_i1	Q94AM1	OOPDA_ARATH	35.8	399	234	6	1262	117	385	778	2.60E-63	244.2	OOPDA_ARATH	reviewed	"Organellar oligopeptidase A, chloroplastic/mitochondrial (EC 3.4.24.70) (Thimet metalloendopeptidase 1) (Zincin-like metalloproteases family protein 1)"	OOP TOP1 At5g65620 K21L13.14	Arabidopsis thaliana (Mouse-ear cress)	791	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plastid [GO:0009536]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plastid [GO:0009536]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005759; GO:0005829; GO:0006508; GO:0006518; GO:0009507; GO:0009536; GO:0009570; GO:0046872	peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i25	Q9VCA2	ORCT_DROME	31.6	282	180	3	916	71	206	474	6.20E-36	152.9	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		brown	brown	1	NA	NA	NA
TRINITY_DN222_c0_g1_i28	Q9VCA2	ORCT_DROME	31.5	276	182	2	1061	234	206	474	6.30E-37	156.4	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		brown	brown	1	NA	NA	NA
TRINITY_DN222_c0_g1_i18	Q9VCA2	ORCT_DROME	31.6	282	186	2	916	71	200	474	2.30E-38	161	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i7	Q9VCA2	ORCT_DROME	31.9	276	181	2	1061	234	206	474	2.90E-37	157.5	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i2	Q9VCA2	ORCT_DROME	46.8	186	98	1	149	706	324	508	2.10E-37	157.5	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i5	Q9VCA2	ORCT_DROME	42.2	400	222	4	134	1333	118	508	1.80E-76	288.1	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i6	Q9VCA2	ORCT_DROME	38.5	530	301	9	287	1873	3	508	3.90E-90	334	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i8	Q9VCA2	ORCT_DROME	47.2	125	65	1	13	387	385	508	1.30E-21	104.4	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN6848_c0_g1_i1	Q9VCA2	ORCT_DROME	32.7	538	346	7	1669	62	4	527	2.40E-78	294.7	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN6848_c0_g1_i2	Q9VCA2	ORCT_DROME	33.6	518	328	7	1658	111	4	507	8.90E-78	292.7	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN30717_c0_g1_i1	Q9VCA2	ORCT_DROME	40.9	44	26	0	48	179	219	262	1.80E-05	49.7	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN12592_c0_g1_i1	Q9VCA2	ORCT_DROME	42.6	122	70	0	1	366	402	523	3.00E-24	112.8	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		blue	blue	NA	NA	NA	NA
TRINITY_DN7098_c0_g1_i2	Q9VCA2	ORCT_DROME	45.8	537	280	5	88	1680	2	533	9.50E-125	448.7	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN4956_c0_g1_i4	Q9VCA2	ORCT_DROME	42.4	59	34	0	71	247	204	262	2.40E-05	49.7	ORCT_DROME	reviewed	Organic cation transporter protein	Orct CG6331	Drosophila melanogaster (Fruit fly)	548	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0006915; GO:0016021; GO:0022857	apoptotic process [GO:0006915]; ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN818_c0_g1_i1	Q95R48	OCTL_DROME	46.6	58	31	0	28	201	426	483	1.80E-06	53.1	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN7934_c0_g1_i1	Q95R48	OCTL_DROME	45.5	77	42	0	15	245	327	403	6.20E-14	77.8	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN6848_c0_g1_i3	Q95R48	OCTL_DROME	31.9	335	216	2	1043	60	201	530	2.60E-46	187.6	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN6125_c0_g1_i1	Q95R48	OCTL_DROME	43.5	108	61	0	3	326	199	306	1.70E-20	100.1	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN19503_c0_g1_i1	Q95R48	OCTL_DROME	38.1	84	52	0	332	81	338	421	3.00E-07	56.2	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN4910_c0_g1_i6	Q95R48	OCTL_DROME	33.3	84	56	0	323	72	338	421	3.30E-05	49.3	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN4910_c0_g1_i7	Q95R48	OCTL_DROME	36.9	84	53	0	304	53	338	421	1.50E-06	53.9	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN4910_c0_g1_i8	Q95R48	OCTL_DROME	35.7	84	54	0	304	53	338	421	3.60E-06	52.4	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN4910_c0_g1_i9	Q95R48	OCTL_DROME	33.3	84	56	0	323	72	338	421	5.10E-05	48.9	OCTL_DROME	reviewed	Organic cation transporter-like protein	Orct2 CG13610	Drosophila melanogaster (Fruit fly)	567	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]	integral component of membrane [GO:0016021]	organic cation transmembrane transporter activity [GO:0015101]	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]		NA	NA	NA	NA	NA	NA
TRINITY_DN14152_c1_g1_i1	Q9CAT6	OCT1_ARATH	49.1	53	27	0	5	163	272	324	4.10E-06	51.6	OCT1_ARATH	reviewed	Organic cation/carnitine transporter 1 (AtOCT1)	OCT1 1-Oct At1g73220 T18K17.11	Arabidopsis thaliana (Mouse-ear cress)	539	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cadaverine transport [GO:0015839]; leaf senescence [GO:0010150]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]	GO:0005524; GO:0005886; GO:0010150; GO:0015226; GO:0015839; GO:0016021	cadaverine transport [GO:0015839]; leaf senescence [GO:0010150]		NA	NA	NA	NA	NA	NA
TRINITY_DN12388_c0_g1_i1	Q9JI69	ORC1_CRIGR	73.5	83	22	0	1	249	589	671	3.70E-30	131.7	ORC1_CRIGR	reviewed	Origin recognition complex subunit 1	ORC1 ORC1L	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	850	nuclear origin of replication recognition complex [GO:0005664]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]	nuclear origin of replication recognition complex [GO:0005664]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0005524; GO:0005664; GO:0006260; GO:0016887; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN8753_c0_g1_i1	Q32PJ3	ORC3_BOVIN	39.1	294	170	4	955	80	426	712	7.40E-53	209.1	ORC3_BOVIN	reviewed	Origin recognition complex subunit 3	ORC3 ORC3L	Bos taurus (Bovine)	712	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005664; GO:0006260; GO:0006275	DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8753_c0_g1_i2	Q32PJ3	ORC3_BOVIN	77.4	31	7	0	172	80	682	712	2.80E-08	59.7	ORC3_BOVIN	reviewed	Origin recognition complex subunit 3	ORC3 ORC3L	Bos taurus (Bovine)	712	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005664; GO:0006260; GO:0006275	DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8753_c0_g1_i5	Q32PJ3	ORC3_BOVIN	38.7	507	302	4	1594	80	213	712	1.40E-104	381.7	ORC3_BOVIN	reviewed	Origin recognition complex subunit 3	ORC3 ORC3L	Bos taurus (Bovine)	712	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005664; GO:0006260; GO:0006275	DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8753_c0_g1_i8	Q32PJ3	ORC3_BOVIN	38.8	320	187	4	1033	80	400	712	2.80E-59	230.7	ORC3_BOVIN	reviewed	Origin recognition complex subunit 3	ORC3 ORC3L	Bos taurus (Bovine)	712	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; nuclear origin of replication recognition complex [GO:0005664]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005664; GO:0006260; GO:0006275	DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN29373_c0_g1_i1	Q9WUV0	ORC5_MOUSE	99	96	1	0	3	290	311	406	4.60E-48	191.4	ORC5_MOUSE	reviewed	Origin recognition complex subunit 5	Orc5 Orc5l	Mus musculus (Mouse)	435	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]	GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1667_c0_g1_i1	O43913	ORC5_HUMAN	46	435	220	6	107	1405	11	432	4.40E-102	373.2	ORC5_HUMAN	reviewed	Origin recognition complex subunit 5	ORC5 ORC5L	Homo sapiens (Human)	435	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]"	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]	GO:0000082; GO:0000166; GO:0000784; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN25546_c0_g1_i1	Q9P0S3	ORML1_HUMAN	100	141	0	0	2	424	13	153	1.60E-77	290	ORML1_HUMAN	reviewed	ORM1-like protein 1 (Adoplin-1)	ORMDL1 HSPC202	Homo sapiens (Human)	153	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]		GO:0005783; GO:0005789; GO:0006672; GO:0016021; GO:0035339; GO:0090156; GO:1900060	cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]		NA	NA	NA	NA	NA	NA
TRINITY_DN19671_c1_g1_i1	Q5E972	ORML2_BOVIN	100	53	0	0	221	63	101	153	1.10E-22	106.7	ORML2_BOVIN	reviewed	ORM1-like protein 2	ORMDL2	Bos taurus (Bovine)	153	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]		GO:0005783; GO:0006672; GO:0016021; GO:0035339; GO:0090156; GO:1900060	cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]		NA	NA	NA	NA	NA	NA
TRINITY_DN9812_c0_g1_i1	Q9CQZ0	ORML2_MOUSE	68	147	47	0	107	547	7	153	8.00E-53	208.4	ORML2_MOUSE	reviewed	ORM1-like protein 2	Ormdl2	Mus musculus (Mouse)	153	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]		GO:0005783; GO:0006672; GO:0016021; GO:0035339; GO:0090156; GO:1900060	cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]		blue	blue	NA	NA	NA	NA
TRINITY_DN19671_c0_g1_i1	Q53FV1	ORML2_HUMAN	100	124	0	0	3	374	30	153	1.30E-65	250.4	ORML2_HUMAN	reviewed	ORM1-like protein 2 (Adoplin-2)	ORMDL2 HSPC160 MSTP095	Homo sapiens (Human)	153	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]		GO:0005783; GO:0006672; GO:0016021; GO:0035339; GO:0090156; GO:1900060	cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]		NA	NA	NA	NA	NA	NA
TRINITY_DN14319_c0_g1_i1	Q9CPZ6	ORML3_MOUSE	98.6	148	2	0	483	40	6	153	3.40E-80	298.9	ORML3_MOUSE	reviewed	ORM1-like protein 3	Ormdl3	Mus musculus (Mouse)	153	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; negative regulation of serine C-palmitoyltransferase activity [GO:1904221]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; regulation of sphingolipid biosynthetic process [GO:0090153]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]		GO:0002903; GO:0005783; GO:0006672; GO:0006940; GO:0010508; GO:0016021; GO:0035339; GO:0090153; GO:0090156; GO:1900060; GO:1900182; GO:1904221	cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; negative regulation of serine C-palmitoyltransferase activity [GO:1904221]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; regulation of sphingolipid biosynthetic process [GO:0090153]		NA	NA	NA	NA	NA	NA
TRINITY_DN14319_c0_g1_i2	Q9CPZ6	ORML3_MOUSE	100	107	0	0	360	40	47	153	2.30E-57	222.6	ORML3_MOUSE	reviewed	ORM1-like protein 3	Ormdl3	Mus musculus (Mouse)	153	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; negative regulation of serine C-palmitoyltransferase activity [GO:1904221]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; regulation of sphingolipid biosynthetic process [GO:0090153]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]		GO:0002903; GO:0005783; GO:0006672; GO:0006940; GO:0010508; GO:0016021; GO:0035339; GO:0090153; GO:0090156; GO:1900060; GO:1900182; GO:1904221	cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; negative regulation of serine C-palmitoyltransferase activity [GO:1904221]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; regulation of sphingolipid biosynthetic process [GO:0090153]		NA	NA	NA	NA	NA	NA
TRINITY_DN37099_c0_g1_i1	Q89RB7	OAT_BRADU	65.6	64	22	0	201	10	33	96	3.10E-19	95.1	OAT_BRADU	reviewed	Ornithine aminotransferase (OAT) (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)	rocD bll2855	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	404	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; L-proline biosynthetic process [GO:0055129]	cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005737; GO:0030170; GO:0042802; GO:0050155; GO:0055129	L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN12496_c0_g1_i1	P29758	OAT_MOUSE	97.6	371	9	0	1148	36	69	439	2.10E-216	752.7	OAT_MOUSE	reviewed	"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)"	Oat	Mus musculus (Mouse)	439	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129	arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN12496_c0_g1_i2	P29758	OAT_MOUSE	98.1	216	4	0	683	36	224	439	3.70E-120	432.2	OAT_MOUSE	reviewed	"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)"	Oat	Mus musculus (Mouse)	439	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129	arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN12496_c0_g1_i3	P29758	OAT_MOUSE	99.7	391	1	0	1208	36	49	439	2.50E-233	808.9	OAT_MOUSE	reviewed	"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)"	Oat	Mus musculus (Mouse)	439	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129	arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN2945_c0_g1_i1	Q9VW26	OAT_DROME	70.3	428	124	1	98	1372	4	431	7.90E-181	634.8	OAT_DROME	reviewed	"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)"	Oat CG8782	Drosophila melanogaster (Fruit fly)	431	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; ornithine metabolic process [GO:0006591]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005737; GO:0005739; GO:0005759; GO:0006591; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129	arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; ornithine metabolic process [GO:0006591]		NA	NA	NA	NA	NA	NA
TRINITY_DN11104_c0_g1_i1	P49724	OAT_DROAN	58.5	352	140	2	1066	11	82	427	8.00E-122	438.3	OAT_DROAN	reviewed	"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)"	Oat	Drosophila ananassae (Fruit fly)	432	mitochondrial matrix [GO:0005759]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; L-proline biosynthetic process [GO:0055129]	mitochondrial matrix [GO:0005759]	ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005759; GO:0030170; GO:0050155; GO:0055129	L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN30118_c0_g1_i1	P00860	DCOR_MOUSE	100	80	0	0	1	240	193	272	2.70E-41	168.7	DCOR_MOUSE	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	Odc1 Odc	Mus musculus (Mouse)	461	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN22229_c0_g1_i1	P11926	DCOR_HUMAN	96.2	79	3	0	2	238	41	119	9.40E-39	160.2	DCOR_HUMAN	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	ODC1	Homo sapiens (Human)	461	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006521; GO:0006595; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN22229_c0_g1_i2	P00860	DCOR_MOUSE	100	83	0	0	3	251	37	119	1.90E-42	172.6	DCOR_MOUSE	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	Odc1 Odc	Mus musculus (Mouse)	461	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN349_c0_g1_i1	P27117	DCOR_BOVIN	49.4	401	190	4	247	1410	19	419	5.90E-111	402.9	DCOR_BOVIN	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	ODC1 ODC	Bos taurus (Bovine)	461	cytoplasm [GO:0005737]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]	cytoplasm [GO:0005737]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0004586; GO:0005737; GO:0033387; GO:0042176; GO:0042803	putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]		blue	blue	NA	NA	NA	NA
TRINITY_DN349_c0_g1_i3	P00860	DCOR_MOUSE	47.7	258	130	2	247	1005	19	276	3.40E-64	246.9	DCOR_MOUSE	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	Odc1 Odc	Mus musculus (Mouse)	461	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN17484_c0_g1_i1	P11926	DCOR_HUMAN	100	179	0	0	539	3	237	415	9.90E-105	380.6	DCOR_HUMAN	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	ODC1	Homo sapiens (Human)	461	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006521; GO:0006595; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN17484_c0_g1_i2	P11926	DCOR_HUMAN	99.4	172	1	0	518	3	237	408	2.70E-99	362.5	DCOR_HUMAN	reviewed	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	ODC1	Homo sapiens (Human)	461	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006521; GO:0006595; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN10700_c0_g1_i1	P54369	OAZ1_MOUSE	51.9	79	36	1	325	555	116	194	3.20E-13	76.6	OAZ1_MOUSE	reviewed	Ornithine decarboxylase antizyme 1 (ODC-Az)	Oaz1 Oaz	Mus musculus (Mouse)	227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ornithine decarboxylase inhibitor activity [GO:0008073]; protein-containing complex binding [GO:0044877]; negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; ornithine decarboxylase inhibitor activity [GO:0008073]; protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005737; GO:0005829; GO:0006595; GO:0006596; GO:0008073; GO:0019899; GO:0044877; GO:0045732; GO:0090316; GO:1902268	negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]		blue	blue	NA	NA	NA	NA
TRINITY_DN17217_c1_g1_i1	P46873	OSM3_CAEEL	52.4	42	20	0	65	190	509	550	8.00E-05	47.4	OSM3_CAEEL	reviewed	Osmotic avoidance abnormal protein 3 (Kinesin-like protein osm-3)	osm-3 M02B7.3	Caenorhabditis elegans	699	"ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]"	ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030030; GO:0030425; GO:0032839; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0043025; GO:0043053; GO:0046626; GO:0048471; GO:0060271; GO:0061066; GO:0097730; GO:0098971; GO:1902856; GO:1902857; GO:1905515	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]		NA	NA	NA	NA	NA	NA
TRINITY_DN28271_c0_g1_i1	P46873	OSM3_CAEEL	55	80	35	1	242	6	255	334	1.70E-19	96.3	OSM3_CAEEL	reviewed	Osmotic avoidance abnormal protein 3 (Kinesin-like protein osm-3)	osm-3 M02B7.3	Caenorhabditis elegans	699	"ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]"	ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030030; GO:0030425; GO:0032839; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0043025; GO:0043053; GO:0046626; GO:0048471; GO:0060271; GO:0061066; GO:0097730; GO:0098971; GO:1902856; GO:1902857; GO:1905515	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]		NA	NA	NA	NA	NA	NA
TRINITY_DN35030_c0_g1_i1	P46873	OSM3_CAEEL	64.8	88	31	0	269	6	272	359	5.10E-25	114.8	OSM3_CAEEL	reviewed	Osmotic avoidance abnormal protein 3 (Kinesin-like protein osm-3)	osm-3 M02B7.3	Caenorhabditis elegans	699	"ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]"	ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"	GO:0003777; GO:0005524; GO:0005815; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030030; GO:0030425; GO:0032839; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0043025; GO:0043053; GO:0046626; GO:0048471; GO:0060271; GO:0061066; GO:0097730; GO:0098971; GO:1902856; GO:1902857; GO:1905515	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; cilium assembly [GO:0060271]; dauer entry [GO:0043053]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; positive regulation of dauer larval development [GO:0061066]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of insulin receptor signaling pathway [GO:0046626]		NA	NA	NA	NA	NA	NA
TRINITY_DN19028_c0_g1_i1	O35103	OMD_MOUSE	29.5	190	121	6	821	279	92	277	7.40E-11	69.7	OMD_MOUSE	reviewed	Osteomodulin (Keratan sulfate proteoglycan osteomodulin) (KSPG osteomodulin) (Osteoadherin) (OSAD)	Omd	Mus musculus (Mouse)	423	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; regulation of bone mineralization [GO:0030500]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0005615; GO:0007155; GO:0030500; GO:0031012; GO:0062023	cell adhesion [GO:0007155]; regulation of bone mineralization [GO:0030500]		NA	NA	NA	NA	NA	NA
TRINITY_DN3514_c0_g1_i1	Q9HC10	OTOF_HUMAN	51.6	517	237	4	2	1513	377	893	1.50E-151	537.7	OTOF_HUMAN	reviewed	Otoferlin (Fer-1-like protein 2)	OTOF FER1L2	Homo sapiens (Human)	1997	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025	membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN3514_c0_g1_i3	Q9HC10	OTOF_HUMAN	51.4	519	236	5	2	1519	377	892	7.50E-150	531.9	OTOF_HUMAN	reviewed	Otoferlin (Fer-1-like protein 2)	OTOF FER1L2	Homo sapiens (Human)	1997	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025	membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN3514_c0_g1_i4	Q9HC10	OTOF_HUMAN	72.1	86	23	1	2	256	377	462	2.90E-29	129	OTOF_HUMAN	reviewed	Otoferlin (Fer-1-like protein 2)	OTOF FER1L2	Homo sapiens (Human)	1997	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025	membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN1859_c0_g1_i1	Q9HC10	OTOF_HUMAN	64.1	256	85	4	776	21	1400	1652	1.10E-95	351.7	OTOF_HUMAN	reviewed	Otoferlin (Fer-1-like protein 2)	OTOF FER1L2	Homo sapiens (Human)	1997	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025	membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN1859_c0_g1_i2	Q5SPC5	OTOF_DANRE	66.5	606	194	5	1891	89	1391	1992	3.90E-254	879	OTOF_DANRE	reviewed	Otoferlin (Fer-1-like protein 2)	otof fer1l2 si:dkey-181f18.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1992	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0050885	neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN1859_c0_g1_i3	Q5SPC5	OTOF_DANRE	71.7	339	95	1	1102	89	1654	1992	9.80E-153	541.2	OTOF_DANRE	reviewed	Otoferlin (Fer-1-like protein 2)	otof fer1l2 si:dkey-181f18.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1992	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0050885	neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN3514_c0_g1_i2	Q9ESF1	OTOF_MOUSE	51.3	725	335	6	2	2125	376	1099	7.00E-218	758.4	OTOF_MOUSE	reviewed	Otoferlin (Fer-1-like protein 2) (Protein pachanga)	Otof Fer1l2	Mus musculus (Mouse)	1997	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]	GO:0000139; GO:0001964; GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0044877; GO:0045177; GO:0045178; GO:0048787	plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN3514_c0_g2_i1	Q9ESF1	OTOF_MOUSE	56.1	132	55	1	2	397	1121	1249	2.10E-37	156.8	OTOF_MOUSE	reviewed	Otoferlin (Fer-1-like protein 2) (Protein pachanga)	Otof Fer1l2	Mus musculus (Mouse)	1997	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]	GO:0000139; GO:0001964; GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0044877; GO:0045177; GO:0045178; GO:0048787	plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN3514_c0_g2_i2	Q9ESF1	OTOF_MOUSE	50.8	63	28	1	69	257	1190	1249	1.20E-10	67.4	OTOF_MOUSE	reviewed	Otoferlin (Fer-1-like protein 2) (Protein pachanga)	Otof Fer1l2	Mus musculus (Mouse)	1997	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]	GO:0000139; GO:0001964; GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0044877; GO:0045177; GO:0045178; GO:0048787	plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN38950_c0_g1_i1	Q3U2S4	OTUD5_MOUSE	100	115	0	0	347	3	288	402	9.70E-61	233.8	OTUD5_MOUSE	reviewed	OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA)	Otud5 DXImx46e Sfc7	Mus musculus (Mouse)	566	"cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; interleukin-21 production [GO:0032625]; interleukin-9 production [GO:0032638]; negative regulation of interleukin-17 production [GO:0032700]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; regulation of T-helper 17 type immune response [GO:2000316]; response to lipopolysaccharide [GO:0032496]; T-helper 17 cell lineage commitment [GO:0072540]"		cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0004843; GO:0008234; GO:0016579; GO:0031647; GO:0032496; GO:0032625; GO:0032638; GO:0032700; GO:0043161; GO:0043374; GO:0061578; GO:0070536; GO:0071108; GO:0072540; GO:0101005; GO:1990380; GO:2000316	"CD8-positive, alpha-beta T cell differentiation [GO:0043374]; interleukin-21 production [GO:0032625]; interleukin-9 production [GO:0032638]; negative regulation of interleukin-17 production [GO:0032700]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; regulation of T-helper 17 type immune response [GO:2000316]; response to lipopolysaccharide [GO:0032496]; T-helper 17 cell lineage commitment [GO:0072540]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33828_c0_g1_i1	Q96G74	OTUD5_HUMAN	100	84	0	0	254	3	324	407	1.70E-41	169.5	OTUD5_HUMAN	reviewed	OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA)	OTUD5	Homo sapiens (Human)	571	cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]	cytosol [GO:0005829]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0004843; GO:0005829; GO:0008234; GO:0016579; GO:0032480; GO:0032496; GO:0061578; GO:0070536; GO:0071108; GO:0101005; GO:1990380	negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN16091_c0_g1_i3	Q640H3	OTU5B_XENLA	55.2	145	56	2	423	13	262	405	3.80E-34	146	OTU5B_XENLA	reviewed	OTU domain-containing protein 5-B (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA)	otud5-b	Xenopus laevis (African clawed frog)	518	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]		cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:0032496; GO:0070536; GO:0071108	protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN16091_c0_g1_i4	Q640H3	OTU5B_XENLA	56	166	64	2	486	13	241	405	4.90E-42	172.2	OTU5B_XENLA	reviewed	OTU domain-containing protein 5-B (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA)	otud5-b	Xenopus laevis (African clawed frog)	518	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]		cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:0032496; GO:0070536; GO:0071108	protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN16905_c4_g1_i3	Q8TE49	OTU7A_HUMAN	53.4	133	48	4	213	608	99	218	5.40E-28	125.9	OTU7A_HUMAN	reviewed	OTU domain-containing protein 7A (EC 3.4.19.12) (Zinc finger protein Cezanne 2)	OTUD7A C15orf16 CEZANNE2 OTUD7	Homo sapiens (Human)	926	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947	negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]		NA	NA	NA	NA	NA	NA
TRINITY_DN16905_c4_g1_i4	Q8R554	OTU7A_MOUSE	43.8	251	121	6	44	766	296	536	1.30E-42	176	OTU7A_MOUSE	reviewed	OTU domain-containing protein 7A (EC 3.4.19.12) (Zinc finger protein Cezanne 2)	Otud7a Cezanne2 Otud7	Mus musculus (Mouse)	926	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0008234; GO:0008270; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947	negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]		NA	NA	NA	NA	NA	NA
TRINITY_DN16905_c4_g1_i2	Q6GQQ9	OTU7B_HUMAN	46.4	455	184	12	129	1457	44	450	8.00E-94	346.7	OTU7B_HUMAN	reviewed	OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)	OTUD7B ZA20D1	Homo sapiens (Human)	843	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000122; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380	adaptive immune response [GO:0002250]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]		NA	NA	NA	NA	NA	NA
TRINITY_DN9509_c0_g1_i1	O18638	OAF_DROVI	48.7	273	121	6	864	88	38	305	1.00E-67	258.5	OAF_DROVI	reviewed	Out at first protein	oaf	Drosophila virilis (Fruit fly)	305	multicellular organism development [GO:0007275]			GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN34166_c0_g1_i1	Q8QZR4	OAF_MOUSE	100	90	0	0	3	272	108	197	8.10E-47	187.2	OAF_MOUSE	reviewed	Out at first protein homolog	Oaf D9Ucla1	Mus musculus (Mouse)	282							NA	NA	NA	NA	NA	NA
TRINITY_DN35361_c0_g1_i1	Q96PU9	ODF3A_HUMAN	34.7	219	135	6	1	648	12	225	1.90E-23	111.7	ODF3A_HUMAN	reviewed	Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3) (Sperm tail protein SHIPPO 1) (Transcript induced in spermiogenesis protein 50)	ODF3 SHIPPO1 TISP50	Homo sapiens (Human)	254	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520]		GO:0001520; GO:0005737; GO:0005856; GO:0007275; GO:0007283; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN35361_c0_g1_i2	Q96PU9	ODF3A_HUMAN	34.6	243	149	7	1	714	12	249	5.30E-27	122.9	ODF3A_HUMAN	reviewed	Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3) (Sperm tail protein SHIPPO 1) (Transcript induced in spermiogenesis protein 50)	ODF3 SHIPPO1 TISP50	Homo sapiens (Human)	254	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520]		GO:0001520; GO:0005737; GO:0005856; GO:0007275; GO:0007283; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8476_c0_g1_i1	Q90WD8	OVCH2_BUFJA	34.8	132	78	5	386	3	74	201	1.80E-14	80.5	OVCH2_BUFJA	reviewed	Ovochymase-2 (EC 3.4.21.120) (Oviductal protease) (Oviductin)	OVCH2 OVTN	Bufo japonicus (Japanese toad)	974	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN9935_c0_g1_i4	P20740	OVOS_CHICK	45.6	68	36	1	88	288	212	279	1.80E-09	63.5	OVOS_CHICK	reviewed	Ovostatin (Ovomacroglobulin)		Gallus gallus (Chicken)	1473	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]	extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615			NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i13	P02789	TRFE_CHICK	35	103	54	5	95	394	19	111	2.30E-05	50.1	TRFE_CHICK	reviewed	Ovotransferrin (Allergen Gal d III) (Conalbumin) (Serum transferrin) (allergen Gal d 3)		Gallus gallus (Chicken)	705	early endosome [GO:0005769]; extracellular space [GO:0005615]; organomineral extracellular matrix [GO:1990377]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ferric iron binding [GO:0008199]; iron ion binding [GO:0005506]; acute-phase response [GO:0006953]; antibacterial humoral response [GO:0019731]; antimicrobial humoral response [GO:0019730]; extracellular sequestering of iron ion [GO:0006881]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]	early endosome [GO:0005769]; extracellular space [GO:0005615]; organomineral extracellular matrix [GO:1990377]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	ferric iron binding [GO:0008199]; iron ion binding [GO:0005506]	GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0006880; GO:0006881; GO:0006953; GO:0008199; GO:0019730; GO:0019731; GO:0032496; GO:0042493; GO:0055037; GO:1990377	acute-phase response [GO:0006953]; antibacterial humoral response [GO:0019731]; antimicrobial humoral response [GO:0019730]; extracellular sequestering of iron ion [GO:0006881]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN38695_c0_g1_i1	Q9NX31	OSER1_HUMAN	29.9	154	92	4	544	83	155	292	1.40E-07	58.9	OSER1_HUMAN	reviewed	Oxidative stress-responsive serine-rich protein 1 (Oxidative stress-responsive protein 1) (Peroxide-inducible transcript 1 protein)	OSER1 C20orf111 BM-038 HSPC168 HSPC207	Homo sapiens (Human)	292	cellular response to hydrogen peroxide [GO:0070301]			GO:0070301	cellular response to hydrogen peroxide [GO:0070301]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g2_i2	A1YER2	HTAI2_GORGO	50	132	63	1	84	470	16	147	4.50E-31	136	HTAI2_GORGO	reviewed	Oxidoreductase HTATIP2 (EC 1.1.1.-)	HTATIP2	Gorilla gorilla gorilla (Western lowland gorilla)	242	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]	GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0005829; GO:0006915; GO:0016491; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g2_i6	Q9Z2G9	HTAI2_MOUSE	49.4	156	71	2	196	657	87	236	5.90E-36	152.5	HTAI2_MOUSE	reviewed	Oxidoreductase HTATIP2 (EC 1.1.1.-)	Htatip2 Cc3 Tip30	Mus musculus (Mouse)	242	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	"NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0005829; GO:0006915; GO:0016620; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170; GO:0051287	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g2_i7	Q9Z2G9	HTAI2_MOUSE	49.4	156	71	2	240	701	87	236	6.30E-36	152.5	HTAI2_MOUSE	reviewed	Oxidoreductase HTATIP2 (EC 1.1.1.-)	Htatip2 Cc3 Tip30	Mus musculus (Mouse)	242	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	"NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0005829; GO:0006915; GO:0016620; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170; GO:0051287	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g2_i9	Q9Z2G9	HTAI2_MOUSE	45.8	227	112	3	84	749	16	236	1.10E-49	198.4	HTAI2_MOUSE	reviewed	Oxidoreductase HTATIP2 (EC 1.1.1.-)	Htatip2 Cc3 Tip30	Mus musculus (Mouse)	242	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]	"NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001525; GO:0004674; GO:0005635; GO:0005737; GO:0005829; GO:0006915; GO:0016620; GO:0030154; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170; GO:0051287	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]		NA	NA	NA	NA	NA	NA
TRINITY_DN5337_c0_g1_i11	J5JH35	OPS5_BEAB2	24.4	570	315	17	1694	12	85	547	2.80E-43	178.3	OPS5_BEAB2	reviewed	Oxidoreductase OpS5 (EC 1.-.-.-) (Laccase OpS5) (Oosporein biosynthesis protein 5)	OpS5 BBA_08183	Beauveria bassiana (strain ARSEF 2860) (White muscardine disease fungus) (Tritirachium shiotae)	590	copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; pathogenesis [GO:0009405]		copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]	GO:0005507; GO:0009405; GO:0016491	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN4460_c1_g1_i1	Q5R7Q6	OXLD1_PONAB	50	76	38	0	272	499	81	156	6.10E-15	82.4	OXLD1_PONAB	reviewed	Oxidoreductase-like domain-containing protein 1	OXLD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	159							blue	blue	NA	NA	NA	NA
TRINITY_DN28042_c0_g1_i1	A7ZI50	BETA_ECO24	67.5	40	13	0	47	166	493	532	4.90E-09	61.6	BETA_ECO24	reviewed	Oxygen-dependent choline dehydrogenase (CDH) (CHD) (EC 1.1.99.1) (Betaine aldehyde dehydrogenase) (BADH) (EC 1.2.1.8)	betA EcE24377A_0326	Escherichia coli O139:H28 (strain E24377A / ETEC)	556	betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]	GO:0008802; GO:0008812; GO:0019285; GO:0050660	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i6	A8AJN0	BETA_CITK8	70.7	41	12	0	65	187	492	532	4.10E-09	62	BETA_CITK8	reviewed	Oxygen-dependent choline dehydrogenase (CDH) (CHD) (EC 1.1.99.1) (Betaine aldehyde dehydrogenase) (BADH) (EC 1.2.1.8)	betA CKO_02584	Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696)	558	betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]	GO:0008802; GO:0008812; GO:0019285; GO:0050660	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN23399_c0_g1_i1	Q1QXE1	BETA1_CHRSD	60.5	86	30	1	329	72	455	536	5.10E-22	105.1	BETA1_CHRSD	reviewed	Oxygen-dependent choline dehydrogenase 1 (CDH 1) (CHD 1) (EC 1.1.99.1) (Betaine aldehyde dehydrogenase 1) (BADH 1) (EC 1.2.1.8)	betA1 betA Csal_1514	Chromohalobacter salexigens (strain ATCC BAA-138 / DSM 3043 / CIP 106854 / NCIMB 13768 / 1H11)	560	betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]	GO:0008802; GO:0008812; GO:0019285; GO:0050660	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN29139_c0_g1_i1	Q1QXE1	BETA1_CHRSD	63.5	63	23	0	4	192	474	536	1.80E-17	89.4	BETA1_CHRSD	reviewed	Oxygen-dependent choline dehydrogenase 1 (CDH 1) (CHD 1) (EC 1.1.99.1) (Betaine aldehyde dehydrogenase 1) (BADH 1) (EC 1.2.1.8)	betA1 betA Csal_1514	Chromohalobacter salexigens (strain ATCC BAA-138 / DSM 3043 / CIP 106854 / NCIMB 13768 / 1H11)	560	betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]		betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]	GO:0008802; GO:0008812; GO:0019285; GO:0050660	glycine betaine biosynthetic process from choline [GO:0019285]		NA	NA	NA	NA	NA	NA
TRINITY_DN1650_c0_g1_i1	Q9V3D2	HEM6_DROME	58.2	385	153	4	1239	100	9	390	3.40E-125	449.9	HEM6_DROME	reviewed	Oxygen-dependent coproporphyrinogen-III oxidase (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)	Coprox CG3433	Drosophila melanogaster (Fruit fly)	390	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]	GO:0004109; GO:0005737; GO:0005739; GO:0005758; GO:0006782; GO:0006783; GO:0042803	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN34531_c0_g1_i1	P36551	HEM6_HUMAN	100	149	0	0	3	449	299	447	2.70E-87	322.4	HEM6_HUMAN	reviewed	"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)"	CPOX CPO CPX	Homo sapiens (Human)	454	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]	GO:0004109; GO:0005212; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006782; GO:0006783; GO:0010039; GO:0010288; GO:0017085; GO:0042803; GO:0046685; GO:0051597	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597]		NA	NA	NA	NA	NA	NA
TRINITY_DN31137_c0_g1_i1	P36552	HEM6_MOUSE	94.8	155	8	0	465	1	206	360	3.30E-88	325.5	HEM6_MOUSE	reviewed	"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)"	Cpox Cpo	Mus musculus (Mouse)	443	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; sodium:potassium-exchanging ATPase activity [GO:0005391]; structural constituent of eye lens [GO:0005212]; heme biosynthetic process [GO:0006783]; potassium ion transport [GO:0006813]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	coproporphyrinogen oxidase activity [GO:0004109]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; sodium:potassium-exchanging ATPase activity [GO:0005391]; structural constituent of eye lens [GO:0005212]	GO:0004109; GO:0005212; GO:0005391; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006782; GO:0006783; GO:0006813; GO:0006814; GO:0010039; GO:0010288; GO:0016020; GO:0017085; GO:0042802; GO:0042803; GO:0046685; GO:0051597	heme biosynthetic process [GO:0006783]; potassium ion transport [GO:0006813]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN34708_c0_g1_i1	Q3B7Z2	OSBP1_MOUSE	71.6	116	33	0	349	2	419	534	3.50E-42	172.2	OSBP1_MOUSE	reviewed	Oxysterol-binding protein 1	Osbp Kiaa4220	Mus musculus (Mouse)	805	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015	intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]		NA	NA	NA	NA	NA	NA
TRINITY_DN3445_c0_g1_i1	P22059	OSBP1_HUMAN	64.6	209	71	2	123	743	92	299	2.40E-72	273.5	OSBP1_HUMAN	reviewed	Oxysterol-binding protein 1	OSBP OSBP1	Homo sapiens (Human)	807	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006699; GO:0008142; GO:0008289; GO:0015248; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015	bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]		NA	NA	NA	NA	NA	NA
TRINITY_DN3445_c0_g1_i2	P22059	OSBP1_HUMAN	62.1	219	72	2	123	779	92	299	7.20E-72	271.9	OSBP1_HUMAN	reviewed	Oxysterol-binding protein 1	OSBP OSBP1	Homo sapiens (Human)	807	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006699; GO:0008142; GO:0008289; GO:0015248; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015	bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]		NA	NA	NA	NA	NA	NA
TRINITY_DN30059_c0_g1_i1	P22059	OSBP1_HUMAN	53.5	129	60	0	28	414	679	807	3.20E-31	136.7	OSBP1_HUMAN	reviewed	Oxysterol-binding protein 1	OSBP OSBP1	Homo sapiens (Human)	807	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006699; GO:0008142; GO:0008289; GO:0015248; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015	bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]		NA	NA	NA	NA	NA	NA
TRINITY_DN3603_c0_g1_i1	Q91XL9	OSBL1_MOUSE	64.9	251	84	2	3	743	544	794	1.40E-98	360.9	OSBL1_MOUSE	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1 Orp1a Orp1l	Mus musculus (Mouse)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	NA	NA	NA	NA
TRINITY_DN3603_c0_g1_i2	Q8K4M9	OSBL1_RAT	51.6	455	168	5	3	1355	544	950	1.00E-132	474.9	OSBL1_RAT	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1	Rattus norvegicus (Rat)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	NA	NA	NA	NA
TRINITY_DN3603_c0_g1_i4	Q91XL9	OSBL1_MOUSE	64.9	251	84	2	3	743	544	794	1.70E-98	360.9	OSBL1_MOUSE	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1 Orp1a Orp1l	Mus musculus (Mouse)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	NA	NA	NA	NA
TRINITY_DN13350_c0_g1_i1	Q91XL9	OSBL1_MOUSE	42.2	320	175	4	77	1030	41	352	2.70E-69	263.8	OSBL1_MOUSE	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1 Orp1a Orp1l	Mus musculus (Mouse)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	NA	NA	NA	NA
TRINITY_DN13350_c0_g1_i3	Q8K4M9	OSBL1_RAT	35.1	522	297	8	55	1614	6	487	2.70E-84	314.3	OSBL1_RAT	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1	Rattus norvegicus (Rat)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	NA	NA	NA	NA
TRINITY_DN13350_c0_g1_i5	Q8K4M9	OSBL1_RAT	41.7	355	197	4	55	1113	6	352	1.50E-76	288.1	OSBL1_RAT	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1	Rattus norvegicus (Rat)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	NA	NA	NA	NA
TRINITY_DN3603_c0_g1_i3	Q91XL9	OSBL1_MOUSE	67.4	224	69	2	3	662	544	767	2.90E-90	332.8	OSBL1_MOUSE	reviewed	Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1)	Osbpl1a Orp1 Orp1a Orp1l	Mus musculus (Mouse)	950	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005768; GO:0005770; GO:0005829; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0044232			NA	NA	1	NA	NA	NA
TRINITY_DN909_c0_g1_i10	S4R1M9	OSB10_MOUSE	43.4	555	265	11	23	1654	242	758	5.80E-112	406.4	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i14	Q9BXB5	OSB10_HUMAN	50.9	222	106	3	46	708	537	756	4.40E-60	233	OSB10_HUMAN	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	OSBPL10 ORP10 OSBP9	Homo sapiens (Human)	764	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; phosphatidylserine acyl-chain remodeling [GO:0036150]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005829; GO:0005856; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0036150; GO:0043231	phosphatidylserine acyl-chain remodeling [GO:0036150]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i15	S4R1M9	OSB10_MOUSE	54.8	93	42	0	46	324	539	631	3.40E-25	115.9	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i16	S4R1M9	OSB10_MOUSE	46.1	89	17	2	299	565	388	445	7.40E-11	68.9	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i17	S4R1M9	OSB10_MOUSE	53.2	216	91	3	1	624	418	631	1.80E-61	237.3	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i18	Q9BXB5	OSB10_HUMAN	51.3	345	155	6	1	1008	416	756	6.50E-96	352.4	OSB10_HUMAN	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	OSBPL10 ORP10 OSBP9	Homo sapiens (Human)	764	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; phosphatidylserine acyl-chain remodeling [GO:0036150]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005829; GO:0005856; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0036150; GO:0043231	phosphatidylserine acyl-chain remodeling [GO:0036150]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i3	S4R1M9	OSB10_MOUSE	30.1	209	110	5	23	643	242	416	1.70E-06	54.7	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i5	S4R1M9	OSB10_MOUSE	54.8	93	42	0	46	324	539	631	7.60E-25	114.8	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i8	S4R1M9	OSB10_MOUSE	42.3	426	200	8	23	1270	242	631	6.80E-78	292.7	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN909_c0_g1_i9	S4R1M9	OSB10_MOUSE	53.2	216	91	3	1	624	418	631	1.00E-61	238	OSB10_MOUSE	reviewed	Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10)	Osbpl10 Orp10	Mus musculus (Mouse)	766	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; lipid metabolic process [GO:0006629]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005829; GO:0005856; GO:0006629; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN37653_c0_g1_i1	Q9BXB4	OSB11_HUMAN	100	71	0	0	3	215	502	572	6.00E-37	154.1	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005654; GO:0005794; GO:0005829; GO:0008289; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444	fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]		NA	NA	NA	NA	NA	NA
TRINITY_DN25640_c0_g1_i1	Q9H1P3	OSBL2_HUMAN	99.4	167	1	0	3	503	111	277	2.00E-99	362.8	OSBL2_HUMAN	reviewed	Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)	OSBPL2 KIAA0772 ORP2	Homo sapiens (Human)	480	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]	"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol transfer activity [GO:0008526]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"	GO:0005546; GO:0005811; GO:0005829; GO:0006699; GO:0007009; GO:0008289; GO:0008526; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0030301; GO:0031234; GO:0032367; GO:0032934; GO:0043231; GO:0051289; GO:0120020	bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN21272_c0_g1_i1	Q8BX94	OSBL2_MOUSE	100	111	0	0	1	333	192	302	5.60E-66	251.1	OSBL2_MOUSE	reviewed	Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)	Osbpl2	Mus musculus (Mouse)	484	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]	"cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol transfer activity [GO:0008526]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]"	GO:0005546; GO:0005811; GO:0005829; GO:0007009; GO:0008289; GO:0008526; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0030301; GO:0031234; GO:0032367; GO:0032934; GO:0043231; GO:0051289; GO:0120020	cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c0_g1_i1	Q9DBS9	OSBL3_MOUSE	60.7	56	22	0	101	268	470	525	1.50E-12	73.6	OSBL3_MOUSE	reviewed	Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3)	Osbpl3 Orp3	Mus musculus (Mouse)	855	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038			NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c0_g1_i2	Q9DBS9	OSBL3_MOUSE	54.9	237	100	3	2	709	598	828	2.20E-74	280.4	OSBL3_MOUSE	reviewed	Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3)	Osbpl3 Orp3	Mus musculus (Mouse)	855	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038			NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c0_g1_i3	Q8BXR9	OSBL6_MOUSE	57.1	387	158	4	150	1304	579	959	9.20E-131	468.4	OSBL6_MOUSE	reviewed	Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6)	Osbpl6	Mus musculus (Mouse)	959	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; regulation of cholesterol transport [GO:0032374]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031901; GO:0031965; GO:0032374; GO:0032934; GO:0043231; GO:0097038	regulation of cholesterol transport [GO:0032374]		NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c0_g1_i4	Q8BXR9	OSBL6_MOUSE	71.1	121	35	0	150	512	579	699	3.90E-43	176	OSBL6_MOUSE	reviewed	Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6)	Osbpl6	Mus musculus (Mouse)	959	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; regulation of cholesterol transport [GO:0032374]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031901; GO:0031965; GO:0032374; GO:0032934; GO:0043231; GO:0097038	regulation of cholesterol transport [GO:0032374]		NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c1_g1_i1	Q8BXR9	OSBL6_MOUSE	28.5	498	299	13	1568	132	31	490	1.00E-38	162.9	OSBL6_MOUSE	reviewed	Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6)	Osbpl6	Mus musculus (Mouse)	959	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; regulation of cholesterol transport [GO:0032374]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031901; GO:0031965; GO:0032374; GO:0032934; GO:0043231; GO:0097038	regulation of cholesterol transport [GO:0032374]		NA	NA	NA	NA	NA	NA
TRINITY_DN8108_c1_g1_i2	Q8BXR9	OSBL6_MOUSE	28.8	531	314	14	1518	4	31	523	5.30E-40	167.2	OSBL6_MOUSE	reviewed	Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6)	Osbpl6	Mus musculus (Mouse)	959	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; regulation of cholesterol transport [GO:0032374]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031901; GO:0031965; GO:0032374; GO:0032934; GO:0043231; GO:0097038	regulation of cholesterol transport [GO:0032374]		NA	NA	NA	NA	NA	NA
TRINITY_DN8571_c0_g2_i1	B9EJ86	OSBL8_MOUSE	60.3	199	60	4	107	652	128	324	6.40E-64	245.4	OSBL8_MOUSE	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	Osbpl8 Kiaa1451 Orp8	Mus musculus (Mouse)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN8571_c0_g2_i2	B9EJ86	OSBL8_MOUSE	59.4	207	65	4	107	676	128	332	1.40E-63	245	OSBL8_MOUSE	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	Osbpl8 Kiaa1451 Orp8	Mus musculus (Mouse)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN8571_c0_g1_i1	Q9BZF1	OSBL8_HUMAN	63.7	402	143	2	1712	516	376	777	7.70E-151	535.4	OSBL8_HUMAN	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	OSBPL8 KIAA1451 ORP8 OSBP10	Homo sapiens (Human)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN8571_c0_g1_i3	Q9BZF1	OSBL8_HUMAN	70.2	275	79	2	861	46	376	650	1.40E-113	410.6	OSBL8_HUMAN	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	OSBPL8 KIAA1451 ORP8 OSBP10	Homo sapiens (Human)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN8571_c0_g1_i4	Q9BZF1	OSBL8_HUMAN	63.7	402	143	2	1378	182	376	777	4.70E-151	535.8	OSBL8_HUMAN	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	OSBPL8 KIAA1451 ORP8 OSBP10	Homo sapiens (Human)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN27829_c0_g1_i1	Q9BZF1	OSBL8_HUMAN	100	107	0	0	1	321	192	298	4.20E-58	224.9	OSBL8_HUMAN	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	OSBPL8 KIAA1451 ORP8 OSBP10	Homo sapiens (Human)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN27313_c0_g1_i1	Q9BZF1	OSBL8_HUMAN	100	84	0	0	3	254	486	569	2.70E-44	178.7	OSBL8_HUMAN	reviewed	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	OSBPL8 KIAA1451 ORP8 OSBP10	Homo sapiens (Human)	889	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]		NA	NA	NA	NA	NA	NA
TRINITY_DN18875_c0_g1_i1	Q96SU4	OSBL9_HUMAN	81.9	94	17	0	282	1	3	96	4.00E-42	171.8	OSBL9_HUMAN	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9 ORP9 OSBP4	Homo sapiens (Human)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231	bile acid biosynthetic process [GO:0006699]		NA	NA	NA	NA	NA	NA
TRINITY_DN11032_c0_g2_i1	A2A8Z1	OSBL9_MOUSE	98.6	211	3	0	634	2	432	642	4.00E-129	461.8	OSBL9_MOUSE	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	Osbpl9 Orp9	Mus musculus (Mouse)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN11032_c0_g2_i2	A2A8Z1	OSBL9_MOUSE	99.5	211	1	0	634	2	432	642	1.40E-129	463.4	OSBL9_MOUSE	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	Osbpl9 Orp9	Mus musculus (Mouse)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN11032_c0_g1_i1	Q96SU4	OSBL9_HUMAN	100	123	0	0	371	3	348	470	2.20E-66	252.7	OSBL9_HUMAN	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9 ORP9 OSBP4	Homo sapiens (Human)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231	bile acid biosynthetic process [GO:0006699]		NA	NA	NA	NA	NA	NA
TRINITY_DN10400_c0_g1_i12	Q5R9W4	OSBL9_PONAB	64.9	388	133	3	101	1258	344	730	7.50E-149	528.5	OSBL9_PONAB	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	736	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lipid binding [GO:0008289]; lipid transport [GO:0006869]	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]	lipid binding [GO:0008289]	GO:0005794; GO:0006869; GO:0008289; GO:0031902	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN10400_c0_g1_i4	Q5R9W4	OSBL9_PONAB	71.6	74	20	1	101	319	344	417	7.50E-22	104.8	OSBL9_PONAB	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	736	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lipid binding [GO:0008289]; lipid transport [GO:0006869]	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]	lipid binding [GO:0008289]	GO:0005794; GO:0006869; GO:0008289; GO:0031902	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN10400_c0_g1_i5	Q96SU4	OSBL9_HUMAN	72.9	70	19	0	2	211	563	632	2.70E-27	122.5	OSBL9_HUMAN	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9 ORP9 OSBP4	Homo sapiens (Human)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231	bile acid biosynthetic process [GO:0006699]		NA	NA	NA	NA	NA	NA
TRINITY_DN10400_c0_g1_i7	Q96SU4	OSBL9_HUMAN	59.8	169	67	1	46	552	563	730	2.00E-54	213.8	OSBL9_HUMAN	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9 ORP9 OSBP4	Homo sapiens (Human)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231	bile acid biosynthetic process [GO:0006699]		NA	NA	NA	NA	NA	NA
TRINITY_DN10400_c0_g1_i9	Q5R9W4	OSBL9_PONAB	68.5	168	51	2	101	598	344	511	3.10E-63	243	OSBL9_PONAB	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	OSBPL9	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	736	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lipid binding [GO:0008289]; lipid transport [GO:0006869]	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]	lipid binding [GO:0008289]	GO:0005794; GO:0006869; GO:0008289; GO:0031902	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i11	A2A8Z1	OSBL9_MOUSE	42.9	56	29	1	105	263	114	169	7.50E-05	47.8	OSBL9_MOUSE	reviewed	Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)	Osbpl9 Orp9	Mus musculus (Mouse)	736	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]	lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005794; GO:0005829; GO:0008289; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN23559_c0_g1_i1	P55055	NR1H2_HUMAN	96.4	84	3	0	369	118	61	144	4.10E-44	178.7	NR1H2_HUMAN	reviewed	Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor)	NR1H2 LXRB NER UNR	Homo sapiens (Human)	460	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to nutrient levels [GO:0031667]; retinoic acid receptor signaling pathway [GO:0048384]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006367; GO:0006629; GO:0008270; GO:0010745; GO:0010867; GO:0010875; GO:0010884; GO:0010887; GO:0030154; GO:0031667; GO:0032270; GO:0032369; GO:0032376; GO:0034191; GO:0036151; GO:0042632; GO:0045723; GO:0045861; GO:0045892; GO:0045893; GO:0045944; GO:0046965; GO:0048384; GO:0048550; GO:0051006; GO:0051117; GO:0055088; GO:0060336; GO:0090108; GO:0090187; GO:0090340; GO:0120163; GO:1903573	"cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to nutrient levels [GO:0031667]; retinoic acid receptor signaling pathway [GO:0048384]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23559_c0_g1_i2	P55055	NR1H2_HUMAN	100	95	0	0	402	118	50	144	8.60E-53	207.6	NR1H2_HUMAN	reviewed	Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor)	NR1H2 LXRB NER UNR	Homo sapiens (Human)	460	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to nutrient levels [GO:0031667]; retinoic acid receptor signaling pathway [GO:0048384]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006367; GO:0006629; GO:0008270; GO:0010745; GO:0010867; GO:0010875; GO:0010884; GO:0010887; GO:0030154; GO:0031667; GO:0032270; GO:0032369; GO:0032376; GO:0034191; GO:0036151; GO:0042632; GO:0045723; GO:0045861; GO:0045892; GO:0045893; GO:0045944; GO:0046965; GO:0048384; GO:0048550; GO:0051006; GO:0051117; GO:0055088; GO:0060336; GO:0090108; GO:0090187; GO:0090340; GO:0120163; GO:1903573	"cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to nutrient levels [GO:0031667]; retinoic acid receptor signaling pathway [GO:0048384]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8283_c0_g1_i1	Q68FJ6	PK1IP_XENLA	41.5	323	182	4	81	1037	1	320	7.50E-70	265.8	PK1IP_XENLA	reviewed	p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like)	pak1ip1	Xenopus laevis (African clawed frog)	363	nucleolus [GO:0005730]; negative regulation of signal transduction [GO:0009968]; ribosomal large subunit biogenesis [GO:0042273]	nucleolus [GO:0005730]		GO:0005730; GO:0009968; GO:0042273	negative regulation of signal transduction [GO:0009968]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN22331_c0_g1_i2	Q0V8N6	P3_BOVIN	29.2	257	172	4	1065	313	193	445	2.20E-22	108.6	P3_BOVIN	reviewed	P3 protein (Solute carrier family 10 member 3)	SLC10A3	Bos taurus (Bovine)	477	integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]	integral component of membrane [GO:0016021]	bile acid:sodium symporter activity [GO:0008508]	GO:0008508; GO:0015721; GO:0016021; GO:0032526	bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]		blue	blue	NA	NA	NA	NA
TRINITY_DN22331_c0_g1_i3	Q0V8N6	P3_BOVIN	29.3	184	121	3	846	313	265	445	2.40E-13	77.8	P3_BOVIN	reviewed	P3 protein (Solute carrier family 10 member 3)	SLC10A3	Bos taurus (Bovine)	477	integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]	integral component of membrane [GO:0016021]	bile acid:sodium symporter activity [GO:0008508]	GO:0008508; GO:0015721; GO:0016021; GO:0032526	bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]		NA	NA	NA	NA	NA	NA
TRINITY_DN22331_c0_g1_i4	Q0V8N6	P3_BOVIN	29.2	257	172	4	1065	313	193	445	2.20E-22	108.6	P3_BOVIN	reviewed	P3 protein (Solute carrier family 10 member 3)	SLC10A3	Bos taurus (Bovine)	477	integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]	integral component of membrane [GO:0016021]	bile acid:sodium symporter activity [GO:0008508]	GO:0008508; GO:0015721; GO:0016021; GO:0032526	bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]		blue	blue	NA	NA	NA	NA
TRINITY_DN22331_c0_g1_i5	Q0V8N6	P3_BOVIN	30.1	229	154	3	708	28	230	454	2.10E-17	90.9	P3_BOVIN	reviewed	P3 protein (Solute carrier family 10 member 3)	SLC10A3	Bos taurus (Bovine)	477	integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]	integral component of membrane [GO:0016021]	bile acid:sodium symporter activity [GO:0008508]	GO:0008508; GO:0015721; GO:0016021; GO:0032526	bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526]		NA	NA	NA	NA	NA	NA
TRINITY_DN3614_c0_g1_i1	Q96ST3	SIN3A_HUMAN	70.2	121	22	2	401	721	87	207	1.20E-37	158.3	SIN3A_HUMAN	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	1273	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0021895; GO:0030516; GO:0031937; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1903351; GO:2000678	"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3614_c0_g1_i2	Q96ST3	SIN3A_HUMAN	53	185	61	4	311	829	34	204	3.50E-41	170.2	SIN3A_HUMAN	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	1273	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0021895; GO:0030516; GO:0031937; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1903351; GO:2000678	"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3614_c0_g1_i4	Q96ST3	SIN3A_HUMAN	53.2	188	62	4	311	838	34	207	1.40E-42	174.9	SIN3A_HUMAN	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	1273	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0021895; GO:0030516; GO:0031937; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1903351; GO:2000678	"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3614_c0_g1_i6	Q96ST3	SIN3A_HUMAN	51.6	188	59	5	311	820	34	207	7.00E-39	162.5	SIN3A_HUMAN	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	1273	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0021895; GO:0030516; GO:0031937; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1903351; GO:2000678	"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3614_c0_g1_i7	Q96ST3	SIN3A_HUMAN	72.9	118	24	1	401	730	87	204	5.80E-40	166	SIN3A_HUMAN	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	1273	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor inhibitor activity [GO:0140416]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0021895; GO:0030516; GO:0031937; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1903351; GO:2000678	"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30995_c0_g1_i1	Q62141	SIN3B_MOUSE	100	86	0	0	259	2	39	124	5.60E-45	181	SIN3B_MOUSE	reviewed	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)	Sin3b Kiaa0700	Mus musculus (Mouse)	1098	"autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; cardiac muscle tissue development [GO:0048738]; histone deacetylation [GO:0016575]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; skeletal muscle tissue development [GO:0007519]"	autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]	chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005737; GO:0007519; GO:0016575; GO:0016580; GO:0030849; GO:0045786; GO:0045892; GO:0048738	"cardiac muscle tissue development [GO:0048738]; histone deacetylation [GO:0016575]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; skeletal muscle tissue development [GO:0007519]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32118_c0_g1_i1	Q1LZF1	PAX6_BOVIN	88.5	52	6	0	2	157	14	65	4.10E-20	98.2	PAX6_BOVIN	reviewed	Paired box protein Pax-6 (Oculorhombin)	PAX6	Bos taurus (Bovine)	422	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activity [GO:0004842]; anatomical structure development [GO:0048856]; negative regulation of neurogenesis [GO:0050768]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activity [GO:0004842]"	GO:0000790; GO:0000978; GO:0000981; GO:0004842; GO:0006357; GO:0045893; GO:0048856; GO:0050768; GO:1904798	"anatomical structure development [GO:0048856]; negative regulation of neurogenesis [GO:0050768]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN478_c0_g1_i1	Q20390	PPT1_CAEEL	53.2	158	74	0	565	92	9	166	1.00E-49	198	PPT1_CAEEL	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	ppt-1 F44C4.5	Caenorhabditis elegans	298	intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790]; cellular protein catabolic process [GO:0044257]; mitochondrion organization [GO:0007005]; oviposition [GO:0018991]; post-embryonic development [GO:0009791]; protein depalmitoylation [GO:0002084]; receptor-mediated endocytosis [GO:0006898]	intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]	palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005764; GO:0006898; GO:0007005; GO:0008474; GO:0009791; GO:0016790; GO:0018991; GO:0043231; GO:0044257	cellular protein catabolic process [GO:0044257]; mitochondrion organization [GO:0007005]; oviposition [GO:0018991]; post-embryonic development [GO:0009791]; protein depalmitoylation [GO:0002084]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN478_c0_g1_i2	P50897	PPT1_HUMAN	60.5	271	106	1	917	108	32	302	1.20E-98	361.3	PPT1_HUMAN	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	PPT1 CLN1 PPT	Homo sapiens (Human)	306	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146	adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	1
TRINITY_DN478_c0_g1_i3	P50897	PPT1_HUMAN	60.8	273	105	1	926	108	32	302	1.50E-99	364.4	PPT1_HUMAN	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	PPT1 CLN1 PPT	Homo sapiens (Human)	306	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146	adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN478_c0_g1_i4	P50897	PPT1_HUMAN	62.9	143	51	1	434	6	32	172	1.90E-50	200.3	PPT1_HUMAN	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	PPT1 CLN1 PPT	Homo sapiens (Human)	306	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146	adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN18866_c0_g1_i1	P50897	PPT1_HUMAN	99.5	190	1	0	570	1	34	223	1.90E-109	396.4	PPT1_HUMAN	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	PPT1 CLN1 PPT	Homo sapiens (Human)	306	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146	adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN18866_c0_g1_i2	O88531	PPT1_MOUSE	97.2	179	5	0	538	2	34	212	4.60E-102	371.7	PPT1_MOUSE	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	Ppt1 Cln1 Ppt	Mus musculus (Mouse)	306	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular macromolecule catabolic process [GO:0044265]; cellular protein catabolic process [GO:0044257]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; visual perception [GO:0007601]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007040; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016042; GO:0016290; GO:0016790; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043005; GO:0043025; GO:0043066; GO:0043231; GO:0043524; GO:0044257; GO:0044265; GO:0045121; GO:0045202; GO:0048260; GO:0048549; GO:0120146	adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular macromolecule catabolic process [GO:0044265]; cellular protein catabolic process [GO:0044257]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN40484_c0_g1_i1	P50897	PPT1_HUMAN	100	73	0	0	241	23	234	306	1.10E-37	156.8	PPT1_HUMAN	reviewed	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)	PPT1 CLN1 PPT	Homo sapiens (Human)	306	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]	lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]	GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146	adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN200_c0_g1_i11	Q5E9H9	ABHDA_BOVIN	29.4	235	151	8	826	137	66	290	1.10E-22	109	ABHDA_BOVIN	reviewed	"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)"	ABHD10	Bos taurus (Bovine)	306	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; glucuronoside catabolic process [GO:0019391]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]"	GO:0004553; GO:0005739; GO:0005829; GO:0019391; GO:0102390	glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN200_c0_g1_i13	Q9NUJ1	ABHDA_HUMAN	30	237	156	5	798	94	66	294	4.10E-27	123.6	ABHDA_HUMAN	reviewed	"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)"	ABHD10	Homo sapiens (Human)	306	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; cellular glucuronidation [GO:0052695]; glucuronoside catabolic process [GO:0019391]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]"	GO:0004553; GO:0005739; GO:0005759; GO:0005829; GO:0019391; GO:0052695; GO:0102390	cellular glucuronidation [GO:0052695]; glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN200_c0_g1_i15	Q5E9H9	ABHDA_BOVIN	29.4	235	151	8	826	137	66	290	1.10E-22	109	ABHDA_BOVIN	reviewed	"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)"	ABHD10	Bos taurus (Bovine)	306	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; glucuronoside catabolic process [GO:0019391]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]"	GO:0004553; GO:0005739; GO:0005829; GO:0019391; GO:0102390	glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN200_c0_g1_i2	Q5E9H9	ABHDA_BOVIN	28.9	239	156	7	798	94	66	294	1.10E-23	112.1	ABHDA_BOVIN	reviewed	"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)"	ABHD10	Bos taurus (Bovine)	306	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; glucuronoside catabolic process [GO:0019391]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]"	GO:0004553; GO:0005739; GO:0005829; GO:0019391; GO:0102390	glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN200_c0_g1_i5	Q9NUJ1	ABHDA_HUMAN	29.5	193	127	4	666	94	109	294	5.50E-18	92.8	ABHDA_HUMAN	reviewed	"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)"	ABHD10	Homo sapiens (Human)	306	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; cellular glucuronidation [GO:0052695]; glucuronoside catabolic process [GO:0019391]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]"	GO:0004553; GO:0005739; GO:0005759; GO:0005829; GO:0019391; GO:0052695; GO:0102390	cellular glucuronidation [GO:0052695]; glucuronoside catabolic process [GO:0019391]		NA	NA	NA	NA	NA	NA
TRINITY_DN848_c0_g1_i1	A2VEY9	APP_DROME	62.2	333	122	2	1554	565	18	349	5.10E-121	436.4	APP_DROME	reviewed	Palmitoyltransferase app (EC 2.3.1.225) (Protein approximated)	app CG42318	Drosophila melanogaster (Fruit fly)	693	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; establishment of body hair or bristle planar orientation [GO:0048104]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; pattern specification process [GO:0007389]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0001737; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0007389; GO:0016021; GO:0016324; GO:0018230; GO:0018345; GO:0019706; GO:0045179; GO:0048104	establishment of body hair or bristle planar orientation [GO:0048104]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; pattern specification process [GO:0007389]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN25433_c0_g1_i1	Q7S7C5	PFA3_NEUCR	49.1	53	27	0	3	161	134	186	9.10E-11	67	PFA3_NEUCR	reviewed	Palmitoyltransferase pfa3 (EC 2.3.1.225) (Palmitoyltransferase 3) (Protein fatty acyltransferase 3)	ptr-3 pfa3 B13M13.170 NCU01267	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	622	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005774; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN28963_c0_g1_i1	Q6CPU8	PFA3_KLULA	56.4	55	24	0	195	31	103	157	5.50E-14	77.8	PFA3_KLULA	reviewed	Palmitoyltransferase PFA3 (EC 2.3.1.225) (Protein fatty acyltransferase 3)	PFA3 KLLA0E02068g	Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica)	325	"fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein palmitoylation [GO:0018345]; vacuole fusion, non-autophagic [GO:0042144]"	fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000329; GO:0016021; GO:0018345; GO:0019706; GO:0042144	"protein palmitoylation [GO:0018345]; vacuole fusion, non-autophagic [GO:0042144]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38792_c0_g1_i1	Q4WZL8	PFA3_ASPFU	57.4	68	22	1	208	26	130	197	9.60E-17	87	PFA3_ASPFU	reviewed	Palmitoyltransferase pfa3 (EC 2.3.1.225) (Protein fatty acyltransferase 3)	pfa3 AFUA_2G16480	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	548	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005774; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN13260_c0_g1_i1	Q4WZL8	PFA3_ASPFU	65	60	19	1	3	182	127	184	8.40E-18	90.5	PFA3_ASPFU	reviewed	Palmitoyltransferase pfa3 (EC 2.3.1.225) (Protein fatty acyltransferase 3)	pfa3 AFUA_2G16480	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	548	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005774; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN28215_c0_g1_i1	P0CS69	PFA4_CRYNB	58	50	21	0	51	200	92	141	2.90E-15	82	PFA4_CRYNB	reviewed	Palmitoyltransferase PFA4 (EC 2.3.1.225) (Protein S-acyltransferase) (PAT) (Protein fatty acyltransferase 4)	PFA4 CNBB1070	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	459	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein palmitoylation [GO:0018345]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005789; GO:0016021; GO:0018345; GO:0019706	protein palmitoylation [GO:0018345]		NA	NA	NA	NA	NA	NA
TRINITY_DN680_c0_g1_i1	Q4R690	ZDH13_MACFA	34.1	185	111	5	3666	3124	85	262	6.10E-13	78.6	ZDH13_MACFA	reviewed	Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 13) (DHHC-13)	ZDHHC13 QtsA-18740	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	622	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016409; GO:0019706; GO:0030659; GO:0030660			NA	NA	NA	NA	NA	NA
TRINITY_DN680_c0_g1_i4	Q4R690	ZDH13_MACFA	34.1	185	111	5	2341	1799	85	262	4.10E-13	78.6	ZDH13_MACFA	reviewed	Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 13) (DHHC-13)	ZDHHC13 QtsA-18740	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	622	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016409; GO:0019706; GO:0030659; GO:0030660			NA	NA	NA	NA	NA	NA
TRINITY_DN680_c0_g1_i5	Q4R690	ZDH13_MACFA	34.1	185	111	5	3383	2841	85	262	5.70E-13	78.6	ZDH13_MACFA	reviewed	Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 13) (DHHC-13)	ZDHHC13 QtsA-18740	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	622	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016409; GO:0019706; GO:0030659; GO:0030660			NA	NA	NA	NA	NA	NA
TRINITY_DN3143_c0_g1_i1	Q4R690	ZDH13_MACFA	36.4	176	95	5	514	8	94	259	2.40E-15	83.6	ZDH13_MACFA	reviewed	Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 13) (DHHC-13)	ZDHHC13 QtsA-18740	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	622	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016409; GO:0019706; GO:0030659; GO:0030660			NA	NA	NA	NA	NA	NA
TRINITY_DN3143_c0_g1_i2	Q4R690	ZDH13_MACFA	36.9	176	94	5	514	8	94	259	2.90E-16	86.7	ZDH13_MACFA	reviewed	Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 13) (DHHC-13)	ZDHHC13 QtsA-18740	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	622	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016409; GO:0019706; GO:0030659; GO:0030660			NA	NA	NA	NA	NA	NA
TRINITY_DN848_c0_g1_i2	Q8IZN3	ZDH14_HUMAN	59.6	337	125	3	1674	664	5	330	1.10E-121	438.7	ZDH14_HUMAN	reviewed	Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14)	ZDHHC14	Homo sapiens (Human)	488	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN32480_c0_g1_i1	Q8IZN3	ZDH14_HUMAN	63.2	68	21	1	221	30	150	217	7.00E-20	97.4	ZDH14_HUMAN	reviewed	Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14)	ZDHHC14	Homo sapiens (Human)	488	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN37999_c0_g1_i1	F1QXD3	ZDH15_DANRE	53.6	69	32	0	233	27	119	187	1.60E-19	96.3	ZH15B_DANRE	reviewed	Palmitoyltransferase ZDHHC15B (EC 2.3.1.225) (Acyltransferase ZDHHC15B) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15B)	zdhhc15b	Danio rerio (Zebrafish) (Brachydanio rerio)	332	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; postsynaptic density [GO:0014069]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]; dopaminergic neuron differentiation [GO:0071542]; forebrain development [GO:0030900]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to membrane [GO:0072657]; protein palmitoleylation [GO:0045234]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; postsynaptic density [GO:0014069]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005794; GO:0006612; GO:0008270; GO:0014069; GO:0016188; GO:0018230; GO:0019706; GO:0030173; GO:0030900; GO:0045234; GO:0071542; GO:0072657; GO:0140450	dopaminergic neuron differentiation [GO:0071542]; forebrain development [GO:0030900]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to membrane [GO:0072657]; protein palmitoleylation [GO:0045234]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188]		NA	NA	NA	NA	NA	NA
TRINITY_DN33155_c0_g1_i1	Q969W1	ZDH16_HUMAN	46.3	82	42	1	11	256	134	213	2.90E-06	52.4	ZDH16_HUMAN	reviewed	Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Abl-philin 2) (Zinc finger DHHC domain-containing protein 16) (DHHC-16)	ZDHHC16 APH2 UNQ2570/PRO6258	Homo sapiens (Human)	377	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN7243_c0_g1_i1	Q58CU4	ZDH16_BOVIN	75	60	15	0	19	198	144	203	2.10E-15	82.4	ZDH16_BOVIN	reviewed	Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 16) (DHHC-16)	ZDHHC16	Bos taurus (Bovine)	377	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN7243_c0_g1_i2	Q58CU4	ZDH16_BOVIN	71.8	39	11	0	19	135	144	182	2.40E-10	65.9	ZDH16_BOVIN	reviewed	Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 16) (DHHC-16)	ZDHHC16	Bos taurus (Bovine)	377	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN7243_c0_g1_i3	Q58CU4	ZDH16_BOVIN	71.8	39	11	0	19	135	144	182	2.10E-10	65.9	ZDH16_BOVIN	reviewed	Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 16) (DHHC-16)	ZDHHC16	Bos taurus (Bovine)	377	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN33934_c0_g1_i1	B8A4F0	ZD16A_DANRE	41.9	74	38	1	236	15	136	204	5.00E-08	58.2	ZD16A_DANRE	reviewed	Palmitoyltransferase ZDHHC16A (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 16A) (DHHC-16A)	zdhhc16a zdhhc16	Danio rerio (Zebrafish) (Brachydanio rerio)	387	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; cellular response to DNA damage stimulus [GO:0006974]; commitment of multipotent stem cells to neuronal lineage in forebrain [GO:0021898]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment [GO:0021899]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0001654; GO:0005789; GO:0005794; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537; GO:0021898; GO:0021899	cellular response to DNA damage stimulus [GO:0006974]; commitment of multipotent stem cells to neuronal lineage in forebrain [GO:0021898]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment [GO:0021899]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN7243_c0_g2_i1	Q8IUH5	ZDH17_HUMAN	61.5	96	37	0	5	292	419	514	1.20E-32	140.2	ZDH17_HUMAN	reviewed	Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17)	ZDHHC17 HIP14 HIP3 HYPH KIAA0946 HSPC294	Homo sapiens (Human)	632	aggresome [GO:0016235]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling receptor binding [GO:0005102]; axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]	aggresome [GO:0016235]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]	identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling receptor binding [GO:0005102]	GO:0000139; GO:0005102; GO:0005794; GO:0007409; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043123; GO:0043231; GO:0051386; GO:0070372	axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]		NA	NA	NA	NA	NA	NA
TRINITY_DN31206_c0_g1_i1	Q9NUE0	ZDH18_HUMAN	50	60	30	0	182	3	192	251	4.40E-12	71.6	ZDH18_HUMAN	reviewed	Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18)	ZDHHC18	Homo sapiens (Human)	388	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN35836_c0_g1_i1	Q9NUE0	ZDH18_HUMAN	100	146	0	0	2	439	108	253	2.50E-82	305.8	ZDH18_HUMAN	reviewed	Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18)	ZDHHC18	Homo sapiens (Human)	388	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN39753_c0_g1_i1	Q9JKR5	ZDHC2_RAT	76.7	86	20	0	4	261	112	197	1.30E-36	153.3	ZDHC2_RAT	reviewed	Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Acyltransferase ZDHHC2) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 2) (DHHC-2)	Zdhhc2 Srec	Rattus norvegicus (Rat)	366	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic vesicle maturation [GO:0016188]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006612; GO:0014069; GO:0016188; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0022407; GO:0042176; GO:0042803; GO:0048168; GO:0055038; GO:0072659; GO:0098837; GO:1900273; GO:1903076; GO:1903539; GO:1904719; GO:1905751	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic vesicle maturation [GO:0016188]		blue	blue	NA	NA	NA	NA
TRINITY_DN40546_c0_g1_i1	Q9JKR5	ZDHC2_RAT	62.3	61	23	0	2	184	125	185	6.40E-20	97.4	ZDHC2_RAT	reviewed	Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Acyltransferase ZDHHC2) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 2) (DHHC-2)	Zdhhc2 Srec	Rattus norvegicus (Rat)	366	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic vesicle maturation [GO:0016188]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006612; GO:0014069; GO:0016188; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0022407; GO:0042176; GO:0042803; GO:0048168; GO:0055038; GO:0072659; GO:0098837; GO:1900273; GO:1903076; GO:1903539; GO:1904719; GO:1905751	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic vesicle maturation [GO:0016188]		NA	NA	NA	NA	NA	NA
TRINITY_DN35768_c0_g1_i1	Q0VC89	ZDH20_BOVIN	92.6	95	7	0	285	1	110	204	4.50E-48	191.4	ZDH20_BOVIN	reviewed	Palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Acyltransferase ZDHHC20) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 20)	ZDHHC20	Bos taurus (Bovine)	365	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0008270; GO:0018230; GO:0019706; GO:0030173; GO:0048471	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN6370_c0_g1_i1	Q76IC6	ZDH23_RAT	26.9	387	214	9	125	1153	17	378	7.50E-29	129.8	ZDH23_RAT	reviewed	Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)	Zdhhc23 Nidd	Rattus norvegicus (Rat)	429	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN6370_c0_g1_i2	Q76IC6	ZDH23_RAT	26.9	387	214	9	125	1153	17	378	7.30E-29	129.8	ZDH23_RAT	reviewed	Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)	Zdhhc23 Nidd	Rattus norvegicus (Rat)	429	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN17031_c0_g1_i1	Q9NYG2	ZDHC3_HUMAN	94.9	79	4	0	250	14	126	204	1.60E-41	169.5	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17031_c0_g1_i2	Q9NYG2	ZDHC3_HUMAN	94.9	79	4	0	250	14	126	204	1.60E-41	169.5	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36560_c0_g1_i1	Q9NYG2	ZDHC3_HUMAN	76.2	63	15	0	3	191	135	197	2.50E-24	112.1	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5381_c1_g1_i1	Q9NYG2	ZDHC3_HUMAN	32.1	265	172	4	1131	349	38	298	1.40E-37	158.7	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5381_c1_g1_i12	Q9NYG2	ZDHC3_HUMAN	32.1	265	172	4	1158	376	38	298	1.40E-37	158.7	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5381_c1_g1_i3	Q9NYG2	ZDHC3_HUMAN	32.1	265	172	4	1076	294	38	298	1.40E-37	158.7	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5381_c1_g1_i5	Q9NYG2	ZDHC3_HUMAN	35.5	124	78	2	461	90	38	159	2.20E-17	90.5	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8481_c0_g1_i1	Q9NYG2	ZDHC3_HUMAN	64.9	205	71	1	7	618	74	278	9.50E-75	281.2	ZDHC3_HUMAN	reviewed	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	ZDHHC3 HSD49	Homo sapiens (Human)	299	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:1902685	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"		blue	blue	NA	NA	NA	NA
TRINITY_DN952_c0_g1_i3	E1BLT8	ZDHC5_BOVIN	48.4	64	33	0	99	290	12	75	1.80E-09	63.5	ZDHC5_BOVIN	reviewed	Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5)	ZDHHC5	Bos taurus (Bovine)	714	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005886; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030425; GO:0045335; GO:0062208; GO:1903078; GO:1905171	positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]		NA	NA	NA	NA	NA	NA
TRINITY_DN30866_c0_g1_i1	E1BLT8	ZDHC5_BOVIN	69.2	52	16	0	183	28	105	156	3.80E-18	91.7	ZDHC5_BOVIN	reviewed	Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5)	ZDHHC5	Bos taurus (Bovine)	714	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005886; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030425; GO:0045335; GO:0062208; GO:1903078; GO:1905171	positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]		NA	NA	NA	NA	NA	NA
TRINITY_DN39104_c0_g1_i1	Q9C0B5	ZDHC5_HUMAN	100	193	0	0	580	2	27	219	1.70E-110	399.8	ZDHC5_HUMAN	reviewed	Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375)	ZDHHC5 KIAA1748 ZNF375	Homo sapiens (Human)	715	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005886; GO:0016020; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030425; GO:0045335; GO:0062208; GO:1903078; GO:1905171	positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]		NA	NA	NA	NA	NA	NA
TRINITY_DN6190_c0_g1_i2	Q9H6R6	ZDHC6_HUMAN	45.3	393	195	9	1247	123	16	406	1.70E-92	341.3	ZDHC6_HUMAN	reviewed	Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Transmembrane protein H4) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) (Zinc finger protein 376)	ZDHHC6 ZNF376	Homo sapiens (Human)	413	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein acylation [GO:0043543]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010636; GO:0016021; GO:0016409; GO:0016747; GO:0018230; GO:0018345; GO:0019706; GO:0043543	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein acylation [GO:0043543]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN6190_c0_g1_i6	Q9H6R6	ZDHC6_HUMAN	42.5	214	110	5	662	57	16	228	1.50E-42	174.5	ZDHC6_HUMAN	reviewed	Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Transmembrane protein H4) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) (Zinc finger protein 376)	ZDHHC6 ZNF376	Homo sapiens (Human)	413	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein acylation [GO:0043543]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010636; GO:0016021; GO:0016409; GO:0016747; GO:0018230; GO:0018345; GO:0019706; GO:0043543	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein acylation [GO:0043543]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN6190_c0_g1_i8	Q9H6R6	ZDHC6_HUMAN	44.4	288	143	6	938	123	120	406	9.40E-61	235.3	ZDHC6_HUMAN	reviewed	Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Transmembrane protein H4) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) (Zinc finger protein 376)	ZDHHC6 ZNF376	Homo sapiens (Human)	413	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein acylation [GO:0043543]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010636; GO:0016021; GO:0016409; GO:0016747; GO:0018230; GO:0018345; GO:0019706; GO:0043543	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of mitochondrial fusion [GO:0010636]; protein acylation [GO:0043543]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN29034_c0_g1_i1	Q2THW8	ZDHC8_CANLF	67.2	67	22	0	13	213	89	155	1.90E-26	119.4	ZDHC8_CANLF	reviewed	Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8)	ZDHHC8	Canis lupus familiaris (Dog) (Canis familiaris)	765	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0010875; GO:0016021; GO:0018230; GO:0019706; GO:0031966	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]		NA	NA	NA	NA	NA	NA
TRINITY_DN952_c0_g1_i1	Q9ULC8	ZDHC8_HUMAN	64.4	239	85	0	102	818	13	251	9.10E-90	331.6	ZDHC8_HUMAN	reviewed	Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378)	ZDHHC8 KIAA1292 ZDHHCL1 ZNF378	Homo sapiens (Human)	765	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0005829; GO:0007626; GO:0010875; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0031966; GO:0034380; GO:1903078	high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]		NA	NA	NA	NA	NA	NA
TRINITY_DN952_c0_g1_i2	Q9ULC8	ZDHC8_HUMAN	64.3	238	85	0	102	815	13	250	8.80E-89	328.6	ZDHC8_HUMAN	reviewed	Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378)	ZDHHC8 KIAA1292 ZDHHCL1 ZNF378	Homo sapiens (Human)	765	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005794; GO:0005829; GO:0007626; GO:0010875; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0031966; GO:0034380; GO:1903078	high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]		NA	NA	NA	NA	NA	NA
TRINITY_DN38827_c0_g1_i1	Q504Q3	PAN2_HUMAN	100	148	0	0	444	1	961	1108	9.10E-80	297.4	PAN2_HUMAN	reviewed	PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2)	PAN2 KIAA0710 USP52	Homo sapiens (Human)	1202	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleus [GO:0005634]; PAN complex [GO:0031251]; P-body [GO:0000932]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0005829; GO:0006397; GO:0006508; GO:0010606; GO:0031251; GO:0046872	mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN932_c0_g1_i1	A1Z7K9	PAN2_DROME	42.3	1277	624	19	196	3864	22	1239	1.10E-269	931.4	PAN2_DROME	reviewed	PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2)	PAN2 CG8232	Drosophila melanogaster (Fruit fly)	1241	nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; proteolysis [GO:0006508]	nucleus [GO:0005634]; PAN complex [GO:0031251]; P-body [GO:0000932]	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0006508; GO:0010606; GO:0031251; GO:0046872	mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN18925_c0_g1_i1	Q640Q5	PAN3_MOUSE	54.3	427	167	7	1	1257	365	771	3.90E-123	443	PAN3_MOUSE	reviewed	PAN2-PAN3 deadenylation complex subunit Pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)	Pan3	Mus musculus (Mouse)	837	P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]	PAN complex [GO:0031251]; P-body [GO:0000932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]	GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004535; GO:0004672; GO:0005524; GO:0006397; GO:0006605; GO:0010606; GO:0031251; GO:0046872	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]		NA	NA	NA	NA	NA	NA
TRINITY_DN18925_c0_g1_i2	Q58A45	PAN3_HUMAN	56.9	144	59	1	1	423	419	562	2.80E-40	166.4	PAN3_HUMAN	reviewed	PAN2-PAN3 deadenylation complex subunit PAN3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)	PAN3	Homo sapiens (Human)	887	"cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	cytosol [GO:0005829]; PAN complex [GO:0031251]; P-body [GO:0000932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]	GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0005829; GO:0006397; GO:0006605; GO:0010606; GO:0031251; GO:0046872; GO:0090503	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18925_c0_g1_i3	Q58A45	PAN3_HUMAN	50.6	87	40	1	1	252	419	505	7.50E-18	91.3	PAN3_HUMAN	reviewed	PAN2-PAN3 deadenylation complex subunit PAN3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)	PAN3	Homo sapiens (Human)	887	"cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	cytosol [GO:0005829]; PAN complex [GO:0031251]; P-body [GO:0000932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]	GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0005829; GO:0006397; GO:0006605; GO:0010606; GO:0031251; GO:0046872; GO:0090503	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18925_c0_g1_i4	Q640Q5	PAN3_MOUSE	54.7	488	193	7	1	1440	365	832	7.80E-147	521.9	PAN3_MOUSE	reviewed	PAN2-PAN3 deadenylation complex subunit Pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)	Pan3	Mus musculus (Mouse)	837	P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]	PAN complex [GO:0031251]; P-body [GO:0000932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]	GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004535; GO:0004672; GO:0005524; GO:0006397; GO:0006605; GO:0010606; GO:0031251; GO:0046872	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]		NA	NA	NA	NA	NA	NA
TRINITY_DN18925_c0_g1_i5	Q640Q5	PAN3_MOUSE	53.1	354	138	7	1	1038	365	698	6.00E-96	352.4	PAN3_MOUSE	reviewed	PAN2-PAN3 deadenylation complex subunit Pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)	Pan3	Mus musculus (Mouse)	837	P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]	PAN complex [GO:0031251]; P-body [GO:0000932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]	GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004535; GO:0004672; GO:0005524; GO:0006397; GO:0006605; GO:0010606; GO:0031251; GO:0046872	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605]		NA	NA	NA	NA	NA	NA
TRINITY_DN40121_c0_g1_i1	Q4ZHW1	PTF1A_XENLA	40.8	98	40	5	349	98	156	249	4.70E-07	55.5	PTF1A_XENLA	reviewed	Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (Transcription factor Ptf1a/p48)	ptf1a	Xenopus laevis (African clawed frog)	270	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0009888; GO:0030902; GO:0031017; GO:0045893; GO:0046983; GO:0048384; GO:0048699	"exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10473_c0_g1_i4	Q64424	LIPR2_MYOCO	48.5	68	35	0	242	39	111	178	3.30E-13	75.5	LIPR2_MYOCO	reviewed	Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3)	PNLIPRP2	Myocastor coypus (Coypu) (Nutria)	470	extracellular space [GO:0005615]; membrane [GO:0016020]; 1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; galactolipid catabolic process [GO:0019376]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; triglyceride catabolic process [GO:0019433]	extracellular space [GO:0005615]; membrane [GO:0016020]	1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]	GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0009395; GO:0016020; GO:0019376; GO:0019433; GO:0034638; GO:0047372; GO:0047714; GO:0102549	galactolipid catabolic process [GO:0019376]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; triglyceride catabolic process [GO:0019433]		NA	NA	NA	NA	NA	NA
TRINITY_DN30990_c0_g1_i1	Q17RR3	LIPR3_HUMAN	49.6	115	55	2	83	424	140	252	1.10E-22	107.8	LIPR3_HUMAN	reviewed	Pancreatic lipase-related protein 3 (PL-RP3) (EC 3.1.1.3)	PNLIPRP3	Homo sapiens (Human)	467	extracellular space [GO:0005615]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005615; GO:0016042; GO:0016298	lipid catabolic process [GO:0016042]		brown	brown	1	NA	NA	NA
TRINITY_DN8631_c0_g1_i1	Q17RR3	LIPR3_HUMAN	34.1	170	78	7	529	107	189	353	1.40E-17	91.3	LIPR3_HUMAN	reviewed	Pancreatic lipase-related protein 3 (PL-RP3) (EC 3.1.1.3)	PNLIPRP3	Homo sapiens (Human)	467	extracellular space [GO:0005615]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005615; GO:0016042; GO:0016298	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN8631_c0_g1_i4	Q17RR3	LIPR3_HUMAN	53	66	29	1	239	42	189	252	8.90E-13	74.3	LIPR3_HUMAN	reviewed	Pancreatic lipase-related protein 3 (PL-RP3) (EC 3.1.1.3)	PNLIPRP3	Homo sapiens (Human)	467	extracellular space [GO:0005615]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular space [GO:0005615]	lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005615; GO:0016042; GO:0016298	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN35704_c0_g1_i1	P50903	LIPP_CAVPO	58	100	41	1	13	309	144	243	2.00E-25	116.3	LIPP_CAVPO	reviewed	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)	PNLIP	Cavia porcellus (Guinea pig)	465	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN40557_c0_g1_i1	P50903	LIPP_CAVPO	55.6	90	33	3	37	297	151	236	1.50E-17	90.5	LIPP_CAVPO	reviewed	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)	PNLIP	Cavia porcellus (Guinea pig)	465	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0046872	lipid catabolic process [GO:0016042]		brown	brown	NA	NA	NA	NA
TRINITY_DN21322_c0_g1_i1	Q02157	LIPP_RABIT	36	311	177	7	999	112	43	346	2.10E-43	177.9	LIPP_RABIT	reviewed	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)	PNLIP	Oryctolagus cuniculus (Rabbit)	465	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN21322_c0_g1_i2	Q02157	LIPP_RABIT	36	311	177	7	1208	321	43	346	2.40E-43	177.9	LIPP_RABIT	reviewed	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)	PNLIP	Oryctolagus cuniculus (Rabbit)	465	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0016042; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN22071_c0_g1_i1	Q9BZ23	PANK2_HUMAN	100	75	0	0	2	226	380	454	1.30E-37	156.4	PANK2_HUMAN	reviewed	"Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2)"	PANK2 C20orf48	Homo sapiens (Human)	570	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; aerobic respiration [GO:0009060]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion morphogenesis [GO:0070584]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0007286; GO:0009060; GO:0015937; GO:0015939; GO:0016310; GO:0019217; GO:0051881; GO:0070584; GO:0090207; GO:1904251	aerobic respiration [GO:0009060]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion morphogenesis [GO:0070584]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286]		NA	NA	NA	NA	NA	NA
TRINITY_DN28221_c0_g1_i1	Q9BZ23	PANK2_HUMAN	67.2	67	22	0	2	202	362	428	7.50E-21	100.5	PANK2_HUMAN	reviewed	"Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2)"	PANK2 C20orf48	Homo sapiens (Human)	570	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; aerobic respiration [GO:0009060]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion morphogenesis [GO:0070584]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]	GO:0004594; GO:0005524; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0007286; GO:0009060; GO:0015937; GO:0015939; GO:0016310; GO:0019217; GO:0051881; GO:0070584; GO:0090207; GO:1904251	aerobic respiration [GO:0009060]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion morphogenesis [GO:0070584]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286]		NA	NA	NA	NA	NA	NA
TRINITY_DN15309_c0_g1_i1	Q868Z9	PPN_DROME	36.4	341	187	6	962	3	1940	2271	5.60E-66	252.7	PPN_DROME	reviewed	Papilin	Ppn CG33103	Drosophila melanogaster (Fruit fly)	2898	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix structural constituent [GO:0005201]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]	extracellular matrix structural constituent [GO:0005201]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004222; GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0030198; GO:0031012	extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN15309_c0_g1_i2	Q868Z9	PPN_DROME	35.9	340	189	5	962	3	1941	2271	4.60E-68	259.6	PPN_DROME	reviewed	Papilin	Ppn CG33103	Drosophila melanogaster (Fruit fly)	2898	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular matrix structural constituent [GO:0005201]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]	extracellular matrix structural constituent [GO:0005201]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004222; GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0030198; GO:0031012	extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN903_c0_g1_i1	Q5ZLM0	CDC73_CHICK	52.7	93	43	1	357	82	151	243	8.30E-15	81.3	CDC73_CHICK	reviewed	Parafibromin (Cell division cycle protein 73 homolog)	CDC73 RCJMB04_5j4	Gallus gallus (Chicken)	531	Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]	Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleus [GO:0005634]	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134	cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN31896_c0_g1_i1	Q6P1J9	CDC73_HUMAN	100	130	0	0	3	392	365	494	1.60E-72	273.1	CDC73_HUMAN	reviewed	Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein)	CDC73 C1orf28 HRPT2	Homo sapiens (Human)	531	"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]"	"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000784; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:1904837; GO:2000134	beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN903_c0_g1_i2	Q6P1J9	CDC73_HUMAN	49	104	48	2	332	24	151	250	2.60E-15	82.8	CDC73_HUMAN	reviewed	Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein)	CDC73 C1orf28 HRPT2	Homo sapiens (Human)	531	"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]"	"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000784; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:1904837; GO:2000134	beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN903_c0_g2_i1	Q6P1J9	CDC73_HUMAN	56.3	380	147	8	1115	33	151	530	1.30E-103	377.9	CDC73_HUMAN	reviewed	Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein)	CDC73 C1orf28 HRPT2	Homo sapiens (Human)	531	"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]"	"Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000784; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:1904837; GO:2000134	beta-catenin-TCF complex assembly [GO:1904837]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]		blue	blue	NA	NA	NA	NA
TRINITY_DN19326_c0_g1_i1	Q86RN8	MYSP_RHIMP	49.6	141	71	0	453	31	433	573	1.60E-27	124	MYSP_RHIMP	reviewed	Paramyosin	PRM	Rhipicephalus microplus (Cattle tick) (Boophilus microplus)	873	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	motor activity [GO:0003774]	GO:0003774; GO:0016459; GO:0030016; GO:0032982			NA	NA	NA	NA	NA	NA
TRINITY_DN19326_c0_g1_i2	Q86RN8	MYSP_RHIMP	52.2	161	77	0	484	2	433	593	6.30E-35	148.7	MYSP_RHIMP	reviewed	Paramyosin	PRM	Rhipicephalus microplus (Cattle tick) (Boophilus microplus)	873	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; motor activity [GO:0003774]	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	motor activity [GO:0003774]	GO:0003774; GO:0016459; GO:0030016; GO:0032982			NA	NA	NA	NA	NA	NA
TRINITY_DN41051_c0_g1_i1	P35415	MYSP1_DROME	42.2	102	52	1	307	2	263	357	1.30E-13	77.4	MYSP1_DROME	reviewed	"Paramyosin, long form"	Prm CG5939	Drosophila melanogaster (Fruit fly)	879	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005856; GO:0005863; GO:0007498; GO:0016459; GO:0030239; GO:0031032; GO:0031430	actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]		NA	NA	NA	NA	NA	NA
TRINITY_DN19326_c0_g2_i2	P35415	MYSP1_DROME	59.8	174	68	1	112	633	705	876	9.70E-47	188.3	MYSP1_DROME	reviewed	"Paramyosin, long form"	Prm CG5939	Drosophila melanogaster (Fruit fly)	879	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005856; GO:0005863; GO:0007498; GO:0016459; GO:0030239; GO:0031032; GO:0031430	actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]		NA	NA	NA	NA	NA	NA
TRINITY_DN18313_c0_g1_i1	P35415	MYSP1_DROME	56.9	181	78	0	545	3	38	218	2.00E-42	173.7	MYSP1_DROME	reviewed	"Paramyosin, long form"	Prm CG5939	Drosophila melanogaster (Fruit fly)	879	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005856; GO:0005863; GO:0007498; GO:0016459; GO:0030239; GO:0031032; GO:0031430	actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]		NA	NA	NA	NA	NA	NA
TRINITY_DN19326_c0_g2_i1	P35416	MYSP2_DROME	55.4	242	106	1	3	728	398	637	1.00E-60	235	MYSP2_DROME	reviewed	"Paramyosin, short form (Miniparamyosin)"	Prm CG5939	Drosophila melanogaster (Fruit fly)	640	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459]; striated muscle myosin thick filament [GO:0005863]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005856; GO:0005863; GO:0007498; GO:0016459; GO:0030239; GO:0031032	actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]		NA	NA	NA	NA	NA	NA
TRINITY_DN25383_c0_g1_i1	Q9UQ90	SPG7_HUMAN	58.1	534	212	5	1588	5	165	692	1.40E-173	611.3	SPG7_HUMAN	reviewed	Paraplegin (EC 3.4.24.-) (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein)	SPG7 CAR CMAR PGN	Homo sapiens (Human)	795	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0006851; GO:0007005; GO:0007399; GO:0008053; GO:0008089; GO:0008233; GO:0008270; GO:0034982; GO:0042407; GO:0046902; GO:0051082; GO:0065003; GO:1902686; GO:1904115	anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]		NA	NA	NA	NA	NA	NA
TRINITY_DN39612_c0_g1_i1	Q9UQ90	SPG7_HUMAN	100	322	0	0	968	3	315	636	1.30E-179	630.2	SPG7_HUMAN	reviewed	Paraplegin (EC 3.4.24.-) (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein)	SPG7 CAR CMAR PGN	Homo sapiens (Human)	795	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0006851; GO:0007005; GO:0007399; GO:0008053; GO:0008089; GO:0008233; GO:0008270; GO:0034982; GO:0042407; GO:0046902; GO:0051082; GO:0065003; GO:1902686; GO:1904115	anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]		NA	NA	NA	NA	NA	NA
TRINITY_DN1285_c0_g1_i1	Q9UQ90	SPG7_HUMAN	40.7	86	48	1	3	260	700	782	1.10E-10	67.4	SPG7_HUMAN	reviewed	Paraplegin (EC 3.4.24.-) (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein)	SPG7 CAR CMAR PGN	Homo sapiens (Human)	795	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0006851; GO:0007005; GO:0007399; GO:0008053; GO:0008089; GO:0008233; GO:0008270; GO:0034982; GO:0042407; GO:0046902; GO:0051082; GO:0065003; GO:1902686; GO:1904115	anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]		blue	blue	NA	NA	NA	NA
TRINITY_DN1285_c0_g1_i2	Q9UQ90	SPG7_HUMAN	47.5	61	32	0	3	185	700	760	4.10E-10	65.5	SPG7_HUMAN	reviewed	Paraplegin (EC 3.4.24.-) (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein)	SPG7 CAR CMAR PGN	Homo sapiens (Human)	795	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0006851; GO:0007005; GO:0007399; GO:0008053; GO:0008089; GO:0008233; GO:0008270; GO:0034982; GO:0042407; GO:0046902; GO:0051082; GO:0065003; GO:1902686; GO:1904115	anterograde axonal transport [GO:0008089]; cristae formation [GO:0042407]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902]		NA	NA	NA	NA	NA	NA
TRINITY_DN39960_c0_g1_i1	Q3ULF4	SPG7_MOUSE	100	153	0	0	2	460	394	546	3.50E-82	305.4	SPG7_MOUSE	reviewed	Paraplegin (EC 3.4.24.-) (Spastic paraplegia 7 protein)	Spg7	Mus musculus (Mouse)	781	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; cell adhesion [GO:0007155]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of mitochondrial membrane permeability [GO:0046902]	axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0007005; GO:0007155; GO:0008053; GO:0008089; GO:0008270; GO:0030155; GO:0034982; GO:0042407; GO:0046902; GO:0065003; GO:1902686; GO:1904115	anterograde axonal transport [GO:0008089]; cell adhesion [GO:0007155]; cristae formation [GO:0042407]; mitochondrial fusion [GO:0008053]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of mitochondrial membrane permeability [GO:0046902]		NA	NA	NA	NA	NA	NA
TRINITY_DN35499_c0_g1_i1	Q99497	PARK7_HUMAN	53.2	188	86	2	79	642	1	186	1.40E-45	184.5	PARK7_HUMAN	reviewed	Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124)	PARK7	Homo sapiens (Human)	189	"adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]"	adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]	"androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein-containing complex binding [GO:0044877]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]"	GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0007005; GO:0007265; GO:0007338; GO:0008134; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016570; GO:0016605; GO:0016684; GO:0018323; GO:0019249; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033182; GO:0033234; GO:0033864; GO:0034599; GO:0035065; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061727; GO:0070062; GO:0070301; GO:0070491; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268	"activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9761_c0_g1_i1	Q5E946	PARK7_BOVIN	100	90	0	0	30	299	1	90	3.50E-43	175.3	PARK7_BOVIN	reviewed	Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124)	PARK7	Bos taurus (Bovine)	189	"cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; single fertilization [GO:0007338]"	cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]	androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein-containing complex binding [GO:0044877]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]	GO:0000785; GO:0002866; GO:0003713; GO:0003729; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0007005; GO:0007338; GO:0008233; GO:0008344; GO:0010273; GO:0010629; GO:0016532; GO:0016570; GO:0016605; GO:0018323; GO:0019900; GO:0019955; GO:0030073; GO:0031334; GO:0032091; GO:0032435; GO:0032757; GO:0033138; GO:0033182; GO:0033234; GO:0033864; GO:0034599; GO:0035065; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042803; GO:0043005; GO:0043523; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045340; GO:0045944; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051444; GO:0051583; GO:0051881; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061727; GO:0070301; GO:0070491; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:1900182; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902958; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903181; GO:1903197; GO:1903384; GO:1903427; GO:1903428; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001268	"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; single fertilization [GO:0007338]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9761_c0_g2_i1	Q99LX0	PARK7_MOUSE	100	96	0	0	30	317	1	96	4.20E-47	188.3	PARK7_MOUSE	reviewed	Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124)	Park7	Mus musculus (Mouse)	189	"axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]; androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]"	axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]	"androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein-containing complex binding [GO:0044877]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]"	GO:0000785; GO:0001933; GO:0001963; GO:0002866; GO:0003713; GO:0003723; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007338; GO:0008134; GO:0008233; GO:0008344; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016570; GO:0016605; GO:0016684; GO:0018323; GO:0019249; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032435; GO:0032757; GO:0033138; GO:0033182; GO:0033234; GO:0033864; GO:0034599; GO:0034614; GO:0035065; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042177; GO:0042542; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043005; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061727; GO:0061827; GO:0070301; GO:0070491; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902958; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903204; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1904782; GO:1905259; GO:1905516; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268	"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25959_c0_g1_i1	Q9NPB6	PAR6A_HUMAN	100	83	0	0	259	11	189	271	3.00E-38	158.7	PAR6A_HUMAN	reviewed	Partitioning defective 6 homolog alpha (PAR-6) (PAR-6 alpha) (PAR-6A) (PAR6C) (Tax interaction protein 40) (TIP-40)	PARD6A PAR6A	Homo sapiens (Human)	346	"apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; transcription factor binding [GO:0008134]; bicellular tight junction assembly [GO:0070830]; cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; transcription factor binding [GO:0008134]	GO:0001726; GO:0001933; GO:0005080; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0007179; GO:0008134; GO:0016032; GO:0016324; GO:0017048; GO:0030742; GO:0034451; GO:0045217; GO:0050714; GO:0051301; GO:0060071; GO:0060341; GO:0070830; GO:1904781	"bicellular tight junction assembly [GO:0070830]; cell-cell junction maintenance [GO:0045217]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8544_c0_g1_i4	Q9NPB6	PAR6A_HUMAN	43.8	96	52	2	299	15	1	95	6.20E-15	81.6	PAR6A_HUMAN	reviewed	Partitioning defective 6 homolog alpha (PAR-6) (PAR-6 alpha) (PAR-6A) (PAR6C) (Tax interaction protein 40) (TIP-40)	PARD6A PAR6A	Homo sapiens (Human)	346	"apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; transcription factor binding [GO:0008134]; bicellular tight junction assembly [GO:0070830]; cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; transcription factor binding [GO:0008134]	GO:0001726; GO:0001933; GO:0005080; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0007179; GO:0008134; GO:0016032; GO:0016324; GO:0017048; GO:0030742; GO:0034451; GO:0045217; GO:0050714; GO:0051301; GO:0060071; GO:0060341; GO:0070830; GO:1904781	"bicellular tight junction assembly [GO:0070830]; cell-cell junction maintenance [GO:0045217]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8544_c0_g1_i2	Q9BYG5	PAR6B_HUMAN	47.4	76	38	2	239	15	22	96	9.20E-13	74.3	PAR6B_HUMAN	reviewed	Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B)	PARD6B PAR6B	Homo sapiens (Human)	372	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]	GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007043; GO:0007098; GO:0007163; GO:0007409; GO:0016324; GO:0017048; GO:0030334; GO:0032991; GO:0051301; GO:0060341; GO:0065003; GO:0070062; GO:0070830	axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell-cell junction assembly [GO:0007043]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341]		NA	NA	NA	NA	NA	NA
TRINITY_DN8544_c0_g1_i1	Q9JK84	PAR6G_MOUSE	55.9	286	118	4	916	80	19	303	4.10E-75	283.1	PAR6G_MOUSE	reviewed	Partitioning defective 6 homolog gamma (PAR-6 gamma) (PAR6A)	Pard6g Par6g	Mus musculus (Mouse)	382	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]	GO:0005080; GO:0005634; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0017048; GO:0032991; GO:0051301; GO:0060341	cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341]		NA	NA	NA	NA	NA	NA
TRINITY_DN8544_c0_g1_i3	Q9JK84	PAR6G_MOUSE	55.2	281	118	4	901	80	24	303	1.40E-72	274.6	PAR6G_MOUSE	reviewed	Partitioning defective 6 homolog gamma (PAR-6 gamma) (PAR6A)	Pard6g Par6g	Mus musculus (Mouse)	382	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]	GO:0005080; GO:0005634; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0017048; GO:0032991; GO:0051301; GO:0060341	cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341]		NA	NA	NA	NA	NA	NA
TRINITY_DN3667_c0_g1_i1	Q2F5J3	PYM_BOMMO	44.1	195	100	4	48	623	1	189	9.20E-29	128.6	PYM_BOMMO	reviewed	Partner of Y14 and mago (Protein wibg homolog)	Pym wibg	Bombyx mori (Silk moth)	193	"cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]		GO:0000184; GO:0005737; GO:0035145; GO:1903259	"exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3667_c0_g1_i2	Q2F5J3	PYM_BOMMO	44.8	183	92	4	144	683	13	189	3.20E-27	123.6	PYM_BOMMO	reviewed	Partner of Y14 and mago (Protein wibg homolog)	Pym wibg	Bombyx mori (Silk moth)	193	"cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]		GO:0000184; GO:0005737; GO:0035145; GO:1903259	"exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3667_c0_g1_i3	Q2F5J3	PYM_BOMMO	44.8	183	92	4	120	659	13	189	3.10E-27	123.6	PYM_BOMMO	reviewed	Partner of Y14 and mago (Protein wibg homolog)	Pym wibg	Bombyx mori (Silk moth)	193	"cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]		GO:0000184; GO:0005737; GO:0035145; GO:1903259	"exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6645_c0_g1_i1	Q11186	PLPL2_CAEEL	42.9	56	32	0	8	175	211	266	3.30E-06	54.7	PLPL2_CAEEL	reviewed	Patanin-like phospholipase domain-containing protein atgl-1 (EC 3.1.1.3) (Adipose triglyceride lipase 1)	atgl-1 C05D11.7	Caenorhabditis elegans	621	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]	triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005737; GO:0005811; GO:0005886; GO:0016020; GO:0016021; GO:0019433; GO:0055088	lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]		NA	NA	NA	NA	NA	NA
TRINITY_DN7497_c0_g1_i3	Q0EEE2	PTHD3_MOUSE	26.7	131	93	1	1128	1520	345	472	4.50E-10	68.6	PTHD3_MOUSE	reviewed	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	Ptchd3	Mus musculus (Mouse)	906	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sperm midpiece [GO:0097225]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sperm midpiece [GO:0097225]		GO:0016020; GO:0016021; GO:0097225			NA	NA	NA	NA	NA	NA
TRINITY_DN7497_c0_g1_i4	Q0EEE2	PTHD3_MOUSE	22.3	565	388	12	1128	2747	345	883	2.20E-33	146	PTHD3_MOUSE	reviewed	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	Ptchd3	Mus musculus (Mouse)	906	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sperm midpiece [GO:0097225]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sperm midpiece [GO:0097225]		GO:0016020; GO:0016021; GO:0097225			NA	NA	NA	NA	NA	NA
TRINITY_DN7497_c0_g1_i5	Q0EEE2	PTHD3_MOUSE	26.7	131	93	1	1790	1398	345	472	4.50E-10	68.6	PTHD3_MOUSE	reviewed	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	Ptchd3	Mus musculus (Mouse)	906	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sperm midpiece [GO:0097225]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sperm midpiece [GO:0097225]		GO:0016020; GO:0016021; GO:0097225			NA	NA	NA	NA	NA	NA
TRINITY_DN11707_c0_g1_i1	Q9NB04	PATJ_DROME	64.9	285	82	4	5	841	549	821	1.70E-94	347.4	PATJ_DROME	reviewed	Patj homolog	Patj CG12021	Drosophila melanogaster (Fruit fly)	871	adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; subapical complex [GO:0035003]; myosin II light chain binding [GO:0032033]; protein kinase C binding [GO:0005080]; adherens junction maintenance [GO:0034334]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; cell-cell junction assembly [GO:0007043]; establishment of planar polarity [GO:0001736]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; pupal development [GO:0035209]	adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; subapical complex [GO:0035003]	myosin II light chain binding [GO:0032033]; protein kinase C binding [GO:0005080]	GO:0001736; GO:0002009; GO:0005080; GO:0005635; GO:0005737; GO:0005886; GO:0005912; GO:0005918; GO:0007043; GO:0008594; GO:0016324; GO:0016327; GO:0016332; GO:0016333; GO:0016334; GO:0032033; GO:0034332; GO:0034334; GO:0035003; GO:0035088; GO:0035209; GO:0035509; GO:0045176; GO:0045179; GO:0045494	adherens junction maintenance [GO:0034334]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; cell-cell junction assembly [GO:0007043]; establishment of planar polarity [GO:0001736]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; pupal development [GO:0035209]		NA	NA	NA	NA	NA	NA
TRINITY_DN5615_c0_g1_i1	A1ZAU8	PTRO_DROME	76	150	36	0	521	72	1481	1630	2.60E-66	253.1	PTRO_DROME	reviewed	Patronin (Short spindle protein 4)	Patronin l(2)k07433 ssp4 CG33130	Drosophila melanogaster (Fruit fly)	1630	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]	calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0005516; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0008017; GO:0030496; GO:0030507; GO:0031122; GO:0031175; GO:0035331; GO:0045167; GO:0051011; GO:0061867; GO:0120219	asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN6401_c0_g1_i1	A1ZAU8	PTRO_DROME	44	257	137	2	2	751	15	271	6.60E-61	235.7	PTRO_DROME	reviewed	Patronin (Short spindle protein 4)	Patronin l(2)k07433 ssp4 CG33130	Drosophila melanogaster (Fruit fly)	1630	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]	calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0005516; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0008017; GO:0030496; GO:0030507; GO:0031122; GO:0031175; GO:0035331; GO:0045167; GO:0051011; GO:0061867; GO:0120219	asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN6401_c0_g1_i2	A1ZAU8	PTRO_DROME	43.8	288	155	2	2	844	15	302	4.20E-69	263.1	PTRO_DROME	reviewed	Patronin (Short spindle protein 4)	Patronin l(2)k07433 ssp4 CG33130	Drosophila melanogaster (Fruit fly)	1630	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]	calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0005516; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0008017; GO:0030496; GO:0030507; GO:0031122; GO:0031175; GO:0035331; GO:0045167; GO:0051011; GO:0061867; GO:0120219	asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN6401_c0_g1_i3	A1ZAU8	PTRO_DROME	43.8	288	155	2	2	844	15	302	4.20E-69	263.1	PTRO_DROME	reviewed	Patronin (Short spindle protein 4)	Patronin l(2)k07433 ssp4 CG33130	Drosophila melanogaster (Fruit fly)	1630	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; spindle [GO:0005819]; subapical part of cell [GO:0120219]	calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0005516; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0008017; GO:0030496; GO:0030507; GO:0031122; GO:0031175; GO:0035331; GO:0045167; GO:0051011; GO:0061867; GO:0120219	asymmetric protein localization involved in cell fate determination [GO:0045167]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle asymmetry [GO:0061867]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN1151_c0_g1_i1	A1CFL2	PATE_ASPCL	57.9	76	31	1	82	306	293	368	1.50E-15	84	PATE_ASPCL	reviewed	Patulin synthase (EC 1.1.-.-) (Dehydrogenase patE) (Patulin synthesis protein E)	patE ACLA_093600	Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1)	628	"cell cortex [GO:0005938]; cell wall [GO:0005618]; extracellular region [GO:0005576]; vacuole [GO:0005773]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	cell cortex [GO:0005938]; cell wall [GO:0005618]; extracellular region [GO:0005576]; vacuole [GO:0005773]	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"	GO:0005576; GO:0005618; GO:0005773; GO:0005938; GO:0016614; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN4272_c0_g1_i1	Q9Y5B6	PAXB1_HUMAN	33.8	393	236	7	1232	99	519	902	1.40E-59	231.9	PAXB1_HUMAN	reviewed	PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1)	PAXBP1 C21orf66 GCFC GCFC1	Homo sapiens (Human)	917	cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]	cytosol [GO:0005829]; nucleus [GO:0005634]	RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000978; GO:0005634; GO:0005829; GO:0007517; GO:0008134; GO:0014842; GO:0031062; GO:0045944; GO:2000288	muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]		NA	NA	NA	NA	NA	NA
TRINITY_DN4272_c0_g1_i2	Q9Y5B6	PAXB1_HUMAN	34.7	337	197	6	1067	99	575	902	1.20E-54	215.3	PAXB1_HUMAN	reviewed	PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1)	PAXBP1 C21orf66 GCFC GCFC1	Homo sapiens (Human)	917	cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]	cytosol [GO:0005829]; nucleus [GO:0005634]	RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000978; GO:0005634; GO:0005829; GO:0007517; GO:0008134; GO:0014842; GO:0031062; GO:0045944; GO:2000288	muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]		NA	NA	NA	NA	NA	NA
TRINITY_DN4272_c0_g1_i3	Q9Y5B6	PAXB1_HUMAN	34.3	458	264	8	1388	99	454	902	2.00E-72	274.6	PAXB1_HUMAN	reviewed	PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1)	PAXBP1 C21orf66 GCFC GCFC1	Homo sapiens (Human)	917	cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]	cytosol [GO:0005829]; nucleus [GO:0005634]	RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000978; GO:0005634; GO:0005829; GO:0007517; GO:0008134; GO:0014842; GO:0031062; GO:0045944; GO:2000288	muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]		NA	NA	NA	NA	NA	NA
TRINITY_DN4272_c0_g1_i4	Q9Y5B6	PAXB1_HUMAN	33.7	282	164	6	902	99	630	902	4.90E-41	169.9	PAXB1_HUMAN	reviewed	PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1)	PAXBP1 C21orf66 GCFC GCFC1	Homo sapiens (Human)	917	cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]	cytosol [GO:0005829]; nucleus [GO:0005634]	RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000978; GO:0005634; GO:0005829; GO:0007517; GO:0008134; GO:0014842; GO:0031062; GO:0045944; GO:2000288	muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]		NA	NA	NA	NA	NA	NA
TRINITY_DN2097_c0_g1_i1	P49023	PAXI_HUMAN	48.1	532	171	8	711	2156	114	590	3.20E-136	487.3	PAXI_HUMAN	reviewed	Paxillin	PXN	Homo sapiens (Human)	591	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]; cell adhesion [GO:0007155]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; muscle contraction [GO:0006936]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]	GO:0001725; GO:0003712; GO:0005178; GO:0005829; GO:0005875; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0006936; GO:0007155; GO:0007165; GO:0007172; GO:0007179; GO:0008013; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0031625; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0046872; GO:0048010; GO:0051496; GO:0060396	cell adhesion [GO:0007155]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; muscle contraction [GO:0006936]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		blue	blue	NA	NA	NA	NA
TRINITY_DN25920_c0_g1_i1	P49023	PAXI_HUMAN	100	255	0	0	834	70	337	591	2.00E-165	582.8	PAXI_HUMAN	reviewed	Paxillin	PXN	Homo sapiens (Human)	591	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]; cell adhesion [GO:0007155]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; muscle contraction [GO:0006936]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]	GO:0001725; GO:0003712; GO:0005178; GO:0005829; GO:0005875; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0006936; GO:0007155; GO:0007165; GO:0007172; GO:0007179; GO:0008013; GO:0017166; GO:0019901; GO:0019903; GO:0030027; GO:0031625; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0046872; GO:0048010; GO:0051496; GO:0060396	cell adhesion [GO:0007155]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; muscle contraction [GO:0006936]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN26659_c0_g1_i1	Q5XIY8	PAXI1_DANRE	51	96	45	2	291	4	6	99	2.60E-20	99.4	PAXI1_DANRE	reviewed	PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)	paxip1 zgc:92593	Danio rerio (Zebrafish) (Brachydanio rerio)	943	nucleus [GO:0005634]; DNA repair [GO:0006281]	nucleus [GO:0005634]		GO:0005634; GO:0006281	DNA repair [GO:0006281]		blue	blue	NA	NA	NA	NA
TRINITY_DN12066_c0_g1_i1	Q90WJ3	PAXI1_XENLA	34.6	433	223	10	459	1739	775	1153	3.40E-61	237.7	PAXI1_XENLA	reviewed	PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) (SMAD wing for transcriptional activation) (Protein Swift)	paxip1 K14	Xenopus laevis (African clawed frog)	1256	nucleus [GO:0005634]; DNA repair [GO:0006281]	nucleus [GO:0005634]		GO:0005634; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN8021_c0_g1_i2	Q6P1Z5	PED1A_MOUSE	36.7	90	54	2	23	292	112	198	3.10E-12	72.4	PED1A_MOUSE	reviewed	PC-esterase domain-containing protein 1A (Protein FAM113A)	Pced1a Fam113a	Mus musculus (Mouse)	449							NA	NA	NA	NA	NA	NA
TRINITY_DN36255_c0_g1_i1	Q8BFV2	PCID2_MOUSE	58.3	139	58	0	2	418	258	396	4.60E-43	175.6	PCID2_MOUSE	reviewed	PCI domain-containing protein 2 (CSN12-like protein)	Pcid2	Mus musculus (Mouse)	399	"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]	GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0071033; GO:0090267; GO:2000117	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36255_c0_g1_i2	Q2TBN6	PCID2_BOVIN	57.5	73	31	0	27	245	333	405	5.70E-18	91.7	PCID2_BOVIN	reviewed	PCI domain-containing protein 2 (CSN12-like protein)	PCID2	Bos taurus (Bovine)	408	"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]	GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045893; GO:0048536; GO:0070390; GO:0071033; GO:0090267; GO:2000117	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35511_c0_g1_i1	Q8BFV2	PCID2_MOUSE	98.3	120	2	0	3	362	280	399	1.20E-60	233.8	PCID2_MOUSE	reviewed	PCI domain-containing protein 2 (CSN12-like protein)	Pcid2	Mus musculus (Mouse)	399	"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]	GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0071033; GO:0090267; GO:2000117	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20582_c0_g3_i1	Q2TBN6	PCID2_BOVIN	47.6	143	75	0	3	431	1	143	7.60E-31	134.8	PCID2_BOVIN	reviewed	PCI domain-containing protein 2 (CSN12-like protein)	PCID2	Bos taurus (Bovine)	408	"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]	GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045893; GO:0048536; GO:0070390; GO:0071033; GO:0090267; GO:2000117	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34029_c0_g1_i1	Q5JVF3	PCID2_HUMAN	100	71	0	0	1	213	329	399	7.80E-34	144.1	PCID2_HUMAN	reviewed	PCI domain-containing protein 2 (CSN12-like protein)	PCID2 HT004	Homo sapiens (Human)	399	"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]	GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0071033; GO:0090267; GO:2000117	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15331_c0_g2_i1	Q1RMA6	PARI_DANRE	35.8	109	69	1	329	3	152	259	2.80E-13	76.6	PARI_DANRE	reviewed	PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP)	parpbp pari zgc:136263	Danio rerio (Zebrafish) (Brachydanio rerio)	568	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:2000042	DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2589_c1_g1_i1	Q9W4Y2	PDFR_DROME	29.8	178	101	4	132	608	129	301	2.00E-12	74.3	PDFR_DROME	reviewed	PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF)	Pdfr gop Han CG13758	Drosophila melanogaster (Fruit fly)	669	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188]; peptide hormone binding [GO:0017046]	GO:0004948; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0008528; GO:0016021; GO:0017046; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0050850; GO:0055070; GO:0060086	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]		NA	NA	NA	NA	NA	NA
TRINITY_DN2589_c1_g1_i2	Q9W4Y2	PDFR_DROME	44.9	49	27	0	132	278	129	177	7.00E-06	52.4	PDFR_DROME	reviewed	PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF)	Pdfr gop Han CG13758	Drosophila melanogaster (Fruit fly)	669	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188]; peptide hormone binding [GO:0017046]	GO:0004948; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0008528; GO:0016021; GO:0017046; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0050850; GO:0055070; GO:0060086	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]		NA	NA	NA	NA	NA	NA
TRINITY_DN9178_c0_g1_i1	A1ZA47	ZASP_DROME	53.9	76	35	0	233	6	2004	2079	8.70E-22	104	ZASP_DROME	reviewed	PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)	Zasp52 Zasp CG30084	Drosophila melanogaster (Fruit fly)	2194	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]	GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061	actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]		blue	blue	NA	NA	NA	NA
TRINITY_DN38718_c0_g1_i1	A1ZA47	ZASP_DROME	53.1	130	60	1	2	388	11	140	4.30E-31	135.6	ZASP_DROME	reviewed	PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)	Zasp52 Zasp CG30084	Drosophila melanogaster (Fruit fly)	2194	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]	GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061	actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]		blue	blue	NA	NA	NA	NA
TRINITY_DN1689_c0_g1_i2	Q6NXB2	PDZ11_DANRE	54.5	77	35	0	401	631	62	138	3.40E-18	93.6	PDZ11_DANRE	reviewed	PDZ domain-containing protein 11	pdzd11 pdzk11 zgc:77536	Danio rerio (Zebrafish) (Brachydanio rerio)	142	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]	protein C-terminus binding [GO:0008022]	GO:0005829; GO:0005911; GO:0007269; GO:0008022; GO:0016323; GO:0045199; GO:0045202; GO:0098793; GO:1903361	maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]		NA	NA	NA	NA	NA	NA
TRINITY_DN1689_c0_g1_i5	Q6NXB2	PDZ11_DANRE	54.5	77	35	0	395	625	62	138	3.40E-18	93.6	PDZ11_DANRE	reviewed	PDZ domain-containing protein 11	pdzd11 pdzk11 zgc:77536	Danio rerio (Zebrafish) (Brachydanio rerio)	142	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]	protein C-terminus binding [GO:0008022]	GO:0005829; GO:0005911; GO:0007269; GO:0008022; GO:0016323; GO:0045199; GO:0045202; GO:0098793; GO:1903361	maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]		NA	NA	NA	NA	NA	NA
TRINITY_DN1689_c0_g1_i6	Q6NXB2	PDZ11_DANRE	55.6	81	36	0	46	288	58	138	2.00E-20	100.1	PDZ11_DANRE	reviewed	PDZ domain-containing protein 11	pdzd11 pdzk11 zgc:77536	Danio rerio (Zebrafish) (Brachydanio rerio)	142	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]	protein C-terminus binding [GO:0008022]	GO:0005829; GO:0005911; GO:0007269; GO:0008022; GO:0016323; GO:0045199; GO:0045202; GO:0098793; GO:1903361	maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]		blue	blue	NA	NA	NA	NA
TRINITY_DN1689_c0_g1_i7	Q6NXB2	PDZ11_DANRE	54.5	77	35	0	231	461	62	138	2.70E-18	93.6	PDZ11_DANRE	reviewed	PDZ domain-containing protein 11	pdzd11 pdzk11 zgc:77536	Danio rerio (Zebrafish) (Brachydanio rerio)	142	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; presynapse [GO:0098793]; synapse [GO:0045202]	protein C-terminus binding [GO:0008022]	GO:0005829; GO:0005911; GO:0007269; GO:0008022; GO:0016323; GO:0045199; GO:0045202; GO:0098793; GO:1903361	maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]		NA	NA	NA	NA	NA	NA
TRINITY_DN29592_c0_g1_i1	Q32LE7	PDZ11_BOVIN	100	68	0	0	1	204	73	140	1.50E-32	139.4	PDZ11_BOVIN	reviewed	PDZ domain-containing protein 11	PDZD11	Bos taurus (Bovine)	140	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; pore complex [GO:0046930]; presynapse [GO:0098793]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; pore complex assembly [GO:0046931]; protein localization to basolateral plasma membrane [GO:1903361]	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; pore complex [GO:0046930]; presynapse [GO:0098793]; synapse [GO:0045202]	protein C-terminus binding [GO:0008022]	GO:0005829; GO:0005911; GO:0005912; GO:0007269; GO:0008022; GO:0016323; GO:0045199; GO:0045202; GO:0046930; GO:0046931; GO:0098793; GO:1903361	maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; pore complex assembly [GO:0046931]; protein localization to basolateral plasma membrane [GO:1903361]		NA	NA	NA	NA	NA	NA
TRINITY_DN2672_c0_g1_i5	B9EJ80	PDZD8_MOUSE	24.4	1091	627	32	2978	111	92	1119	8.20E-53	210.7	PDZD8_MOUSE	reviewed	PDZ domain-containing protein 8	Pdzd8	Mus musculus (Mouse)	1147	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]	GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016021; GO:0022604; GO:0035556; GO:0044233; GO:0046872; GO:0051560; GO:1990456	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN2672_c0_g1_i9	Q8NEN9	PDZD8_HUMAN	33.1	350	193	7	1358	408	92	433	2.10E-41	171.8	PDZD8_HUMAN	reviewed	PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104)	PDZD8 PDZK8	Homo sapiens (Human)	1154	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]; viral process [GO:0016032]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]	GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016020; GO:0016021; GO:0016032; GO:0022604; GO:0035556; GO:0044233; GO:0046872; GO:0051560; GO:1990456	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN19135_c0_g1_i1	Q9QYC1	PCX1_MOUSE	42.1	107	54	1	397	77	1705	1803	1.30E-19	97.8	PCX1_MOUSE	reviewed	Pecanex-like protein 1 (Pecanex homolog protein 1)	Pcnx1 Kiaa0805 Pcnx Pcnxl1	Mus musculus (Mouse)	2344	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN19135_c0_g1_i2	Q9QYC1	PCX1_MOUSE	64.5	293	96	1	882	4	1705	1989	2.30E-110	400.2	PCX1_MOUSE	reviewed	Pecanex-like protein 1 (Pecanex homolog protein 1)	Pcnx1 Kiaa0805 Pcnx Pcnxl1	Mus musculus (Mouse)	2344	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN20630_c0_g1_i1	Q9H6A9	PCX3_HUMAN	91.9	99	8	0	297	1	1431	1529	1.50E-47	190.3	PCX3_HUMAN	reviewed	Pecanex-like protein 3 (Pecanex homolog protein 3)	PCNX3 PCNXL3	Homo sapiens (Human)	2034	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			yellow	yellow	NA	NA	NA	NA
TRINITY_DN11548_c0_g3_i1	Q5HZQ9	PCX4_XENLA	31.1	286	162	8	44	892	178	431	2.10E-19	98.2	PCX4_XENLA	reviewed	Pecanex-like protein 4 (Pecanex homolog protein 4)	pcnx4 pcnxl4	Xenopus laevis (African clawed frog)	1184	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5560_c0_g1_i1	Q8C2E4	PTCD1_MOUSE	30.8	653	406	10	1861	2	22	661	1.10E-67	259.6	PTCD1_MOUSE	reviewed	"Pentatricopeptide repeat-containing protein 1, mitochondrial"	Ptcd1	Mus musculus (Mouse)	695	mitochondrial matrix [GO:0005759]; tRNA binding [GO:0000049]; mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780]	mitochondrial matrix [GO:0005759]	tRNA binding [GO:0000049]	GO:0000049; GO:0005759; GO:0032543; GO:0042780	mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780]		NA	NA	NA	NA	NA	NA
TRINITY_DN5560_c0_g1_i2	Q8C2E4	PTCD1_MOUSE	30.8	653	406	10	1861	2	22	661	1.10E-67	259.6	PTCD1_MOUSE	reviewed	"Pentatricopeptide repeat-containing protein 1, mitochondrial"	Ptcd1	Mus musculus (Mouse)	695	mitochondrial matrix [GO:0005759]; tRNA binding [GO:0000049]; mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780]	mitochondrial matrix [GO:0005759]	tRNA binding [GO:0000049]	GO:0000049; GO:0005759; GO:0032543; GO:0042780	mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780]		NA	NA	NA	NA	NA	NA
TRINITY_DN25843_c0_g1_i1	Q8SQ41	PEPB_CANLF	58.3	48	14	1	177	52	343	390	1.20E-07	56.6	PEPB_CANLF	reviewed	Pepsin B (EC 3.4.23.2)	PGB PGNB	Canis lupus familiaris (Dog) (Canis familiaris)	390	extracellular region [GO:0005576]; aspartic-type endopeptidase activity [GO:0004190]; digestion [GO:0007586]	extracellular region [GO:0005576]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0005576; GO:0007586	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN4369_c0_g1_i2	Q93RZ5	PEPE_STRCO	58	50	21	0	86	235	182	231	3.30E-07	55.8	PEPE_STRCO	reviewed	Peptidase E (EC 3.4.13.21) (Alpha-aspartyl dipeptidase) (Asp-specific dipeptidase) (Dipeptidase E)	pepE SCO0575 SC5G5.07	Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)	243	cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	cytoplasm [GO:0005737]	dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236]	GO:0005737; GO:0008236; GO:0016805			NA	NA	NA	NA	NA	NA
TRINITY_DN38918_c0_g1_i1	Q2GBN7	RF1_NOVAD	89	91	10	0	275	3	192	282	4.10E-38	158.3	RF1_NOVAD	reviewed	Peptide chain release factor 1 (RF-1)	prfA Saro_0288	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	354	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN7963_c0_g1_i2	B8EI32	RF1_METSB	39.1	92	56	0	486	761	56	147	7.70E-14	79.3	RF1_METSB	reviewed	Peptide chain release factor 1 (RF-1)	prfA Msil_1564	Methylocella silvestris (strain DSM 15510 / CIP 108128 / LMG 27833 / NCIMB 13906 / BL2)	360	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN34296_c0_g1_i1	B2UDM7	RF1_RALPJ	98.6	70	1	0	213	4	278	347	4.90E-31	134.4	RF1_RALPJ	reviewed	Peptide chain release factor 1 (RF-1)	prfA Rpic_3146	Ralstonia pickettii (strain 12J)	360	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN8986_c0_g1_i1	A5V9C3	RF1_SPHWW	91.7	96	8	0	289	2	227	322	5.80E-43	174.5	RF1_SPHWW	reviewed	Peptide chain release factor 1 (RF-1)	prfA Swit_2530	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	360	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN8986_c0_g1_i2	A5V9C3	RF1_SPHWW	92.8	125	8	1	376	2	199	322	5.40E-57	221.5	RF1_SPHWW	reviewed	Peptide chain release factor 1 (RF-1)	prfA Swit_2530	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	360	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN7963_c0_g1_i1	Q2KI15	RF1ML_BOVIN	49.7	328	159	3	411	1391	54	376	2.70E-83	310.8	RF1ML_BOVIN	reviewed	"Peptide chain release factor 1-like, mitochondrial (Mitochondrial translational release factor 1-like)"	MTRF1L	Bos taurus (Bovine)	380	mitochondrion [GO:0005739]; translation release factor activity [GO:0003747]; mitochondrial translational termination [GO:0070126]	mitochondrion [GO:0005739]	translation release factor activity [GO:0003747]	GO:0003747; GO:0005739; GO:0070126	mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN10600_c0_g1_i1	B2U8V1	RF2_RALPJ	100	71	0	0	216	4	236	306	4.80E-34	144.4	RF2_RALPJ	reviewed	Peptide chain release factor 2 (RF-2)	prfB Rpic_0895	Ralstonia pickettii (strain 12J)	367	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN10600_c1_g1_i1	Q5NZU2	RF2_AROAE	81.8	66	12	0	202	5	237	302	9.40E-24	110.2	RF2_AROAE	reviewed	Peptide chain release factor 2 (RF-2)	prfB AZOSEA32970 ebA5809	Aromatoleum aromaticum (strain EbN1) (Azoarcus sp. (strain EbN1))	367	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"	cytoplasm [GO:0005737]	"translation release factor activity, codon specific [GO:0016149]"	GO:0005737; GO:0016149			NA	NA	NA	NA	NA	NA
TRINITY_DN3476_c0_g1_i1	Q9FUZ0	DEF1A_SOLLC	41.2	114	67	0	345	4	112	225	3.00E-16	86.3	DEF1A_SOLLC	reviewed	"Peptide deformylase 1A, chloroplastic (PDF 1A) (EC 3.5.1.88) (Polypeptide deformylase)"	PDF1A	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	277	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; translation [GO:0006412]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]	GO:0005739; GO:0006412; GO:0009507; GO:0009570; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872	co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN41030_c0_g1_i1	Q9HBH1	DEFM_HUMAN	100	52	0	0	170	15	192	243	1.20E-26	119.8	DEFM_HUMAN	reviewed	"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)"	PDF PDF1A	Homo sapiens (Human)	243	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]	GO:0005739; GO:0006412; GO:0008284; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872	co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3476_c0_g1_i2	Q9HBH1	DEFM_HUMAN	51.6	184	89	0	679	128	59	242	1.80E-49	197.6	DEFM_HUMAN	reviewed	"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)"	PDF PDF1A	Homo sapiens (Human)	243	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]	GO:0005739; GO:0006412; GO:0008284; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872	co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN3476_c0_g1_i3	Q9HBH1	DEFM_HUMAN	50	92	46	0	558	283	59	150	1.20E-17	91.7	DEFM_HUMAN	reviewed	"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)"	PDF PDF1A	Homo sapiens (Human)	243	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]	GO:0005739; GO:0006412; GO:0008284; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872	co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3476_c0_g1_i3	Q9HBH1	DEFM_HUMAN	48.4	62	32	0	313	128	181	242	6.40E-11	69.3	DEFM_HUMAN	reviewed	"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)"	PDF PDF1A	Homo sapiens (Human)	243	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]	GO:0005739; GO:0006412; GO:0008284; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872	co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN35500_c0_g1_i1	A4FYX5	MSRA_METM5	41.7	103	54	1	24	314	54	156	2.20E-17	90.5	MSRA_METM5	reviewed	Peptide methionine sulfoxide reductase MsrA (Protein-methionine-S-oxide reductase) (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase)	msrA MmarC5_1107	Methanococcus maripaludis (strain C5 / ATCC BAA-1333)	157	peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464]		peptide-methionine (S)-S-oxide reductase activity [GO:0008113]	GO:0006464; GO:0008113	cellular protein modification process [GO:0006464]		blue	blue	NA	NA	NA	NA
TRINITY_DN28811_c0_g1_i1	Q47EU6	MSRB_DECAR	56.5	46	20	0	143	6	10	55	8.20E-10	64.3	MSRB_DECAR	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB Daro_1889	Dechloromonas aromatica (strain RCB)	132	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN11248_c1_g1_i1	Q8UGX7	MSRB_AGRFC	56	75	32	1	1	222	27	101	1.40E-17	89.7	MSRB_AGRFC	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB Atu0908 AGR_C_1655	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	135	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i11	B0BYW4	MSRB_ACAM1	67.3	101	31	1	387	91	30	130	1.60E-37	157.1	MSRB_ACAM1	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB AM1_2115	Acaryochloris marina (strain MBIC 11017)	131	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i12	Q47EU6	MSRB_DECAR	58	50	21	0	238	89	7	56	2.30E-12	73.6	MSRB_DECAR	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB Daro_1889	Dechloromonas aromatica (strain RCB)	132	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i13	B0BYW4	MSRB_ACAM1	64.5	124	42	1	456	91	7	130	7.30E-44	178.7	MSRB_ACAM1	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB AM1_2115	Acaryochloris marina (strain MBIC 11017)	131	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i3	B8GMG5	MSRB_THISH	66.7	24	8	0	163	92	37	60	3.50E-05	48.9	MSRB_THISH	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB Tgr7_0705	Thioalkalivibrio sulfidiphilus (strain HL-EbGR7)	137	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i4	B0BYW4	MSRB_ACAM1	64.5	124	42	1	456	91	7	130	6.70E-44	178.7	MSRB_ACAM1	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB AM1_2115	Acaryochloris marina (strain MBIC 11017)	131	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i7	Q47EU6	MSRB_DECAR	58	50	21	0	238	89	7	56	2.30E-12	73.6	MSRB_DECAR	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB Daro_1889	Dechloromonas aromatica (strain RCB)	132	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN5714_c0_g1_i9	B0BYW4	MSRB_ACAM1	64.5	124	42	1	456	91	7	130	7.30E-44	178.7	MSRB_ACAM1	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB AM1_2115	Acaryochloris marina (strain MBIC 11017)	131	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN39204_c0_g1_i1	B0BYW4	MSRB_ACAM1	62.9	70	26	0	211	2	20	89	2.50E-19	95.5	MSRB_ACAM1	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB AM1_2115	Acaryochloris marina (strain MBIC 11017)	131	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN32235_c0_g1_i1	Q89EM9	MSRB_BRADU	61.1	95	37	0	302	18	45	139	1.00E-29	130.6	MSRB_BRADU	reviewed	Peptide methionine sulfoxide reductase MsrB (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase)	msrB blr7044	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	139	cytoplasm [GO:0005737]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN35116_c0_g1_i1	Q92RA4	MSRB1_RHIME	57.8	90	37	1	5	271	43	132	7.50E-26	117.9	MSRB1_RHIME	reviewed	Peptide methionine sulfoxide reductase MsrB 1 (EC 1.8.4.12) (Peptide-methionine (R)-S-oxide reductase 1)	msrB1 R00991 SMc00117	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	135	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]	GO:0006979; GO:0008270; GO:0030091; GO:0033743	protein repair [GO:0030091]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN6608_c0_g1_i1	P91679	PEPT1_DROME	54.2	48	20	1	168	25	307	352	3.90E-06	52	PEPT1_DROME	reviewed	Peptide transporter family 1 (Oligopeptide transporter 1) (Protein YIN)	yin opt1 CG44402	Drosophila melanogaster (Fruit fly)	743	integral component of plasma membrane [GO:0005887]; phagocytic vesicle membrane [GO:0030670]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; dipeptide transmembrane transport [GO:0035442]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]	integral component of plasma membrane [GO:0005887]; phagocytic vesicle membrane [GO:0030670]	dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]	GO:0005427; GO:0005887; GO:0006857; GO:0015031; GO:0030670; GO:0035442; GO:0035673; GO:0071916	dipeptide transmembrane transport [GO:0035442]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN26211_c0_g1_i1	Q503I8	NGLY1_DANRE	64.2	67	24	0	203	3	257	323	8.10E-23	107.1	NGLY1_DANRE	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	ngly1 zgc:110561	Danio rerio (Zebrafish) (Brachydanio rerio)	644	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN5918_c0_g1_i1	Q503I8	NGLY1_DANRE	52	254	117	2	757	2	271	521	1.20E-69	264.6	NGLY1_DANRE	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	ngly1 zgc:110561	Danio rerio (Zebrafish) (Brachydanio rerio)	644	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN5918_c0_g1_i2	Q503I8	NGLY1_DANRE	68.9	45	14	0	204	70	271	315	2.20E-14	79.3	NGLY1_DANRE	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	ngly1 zgc:110561	Danio rerio (Zebrafish) (Brachydanio rerio)	644	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN5918_c0_g1_i3	Q5ZJM3	NGLY1_CHICK	35	80	47	2	244	5	453	527	1.70E-05	50.1	NGLY1_CHICK	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	NGLY1 RCJMB04_17c15	Gallus gallus (Chicken)	651	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN5918_c0_g1_i4	Q503I8	NGLY1_DANRE	41.4	507	261	5	1441	2	24	521	2.50E-102	374	NGLY1_DANRE	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	ngly1 zgc:110561	Danio rerio (Zebrafish) (Brachydanio rerio)	644	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN5918_c0_g1_i5	Q503I8	NGLY1_DANRE	33.4	326	171	8	904	2	212	516	1.20E-40	169.1	NGLY1_DANRE	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	ngly1 zgc:110561	Danio rerio (Zebrafish) (Brachydanio rerio)	644	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN25448_c0_g1_i1	Q96IV0	NGLY1_HUMAN	98.7	76	1	0	3	230	316	391	4.70E-43	174.5	NGLY1_HUMAN	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (hPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	NGLY1 PNG1	Homo sapiens (Human)	654	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006515; GO:0006516; GO:0006517; GO:0046872	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN31744_c0_g1_i1	Q9JI78	NGLY1_MOUSE	100	104	0	0	314	3	269	372	2.60E-65	248.8	NGLY1_MOUSE	reviewed	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	Ngly1	Mus musculus (Mouse)	651	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872; GO:0062023	glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN147_c1_g1_i4	Q9V5E1	PAL1_DROME	39.9	469	245	13	1536	169	85	529	4.30E-84	313.5	PAL1_DROME	reviewed	Peptidyl-alpha-hydroxyglycine alpha-amidating lyase 1 (EC 4.3.2.5) (Peptidylamidoglycolate lyase 1) (dPAL1)	Pal1 CG12130	Drosophila melanogaster (Fruit fly)	541	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; courtship behavior [GO:0007619]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]	GO:0004504; GO:0004598; GO:0005576; GO:0005886; GO:0006518; GO:0007619; GO:0016021; GO:0043025; GO:0044719; GO:0046872	courtship behavior [GO:0007619]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]		NA	NA	NA	NA	NA	NA
TRINITY_DN147_c1_g1_i3	P12890	AMDB_XENLA	36.8	742	375	17	2267	69	55	711	3.50E-136	487.3	AMDB_XENLA	reviewed	Peptidyl-glycine alpha-amidating monooxygenase B (PAM-B) (Peptide C-terminal alpha-amidating enzyme II) (AE-II) (Peptidyl-glycine alpha-amidating monooxygenase II) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase B (PHM-B) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase B (EC 4.3.2.5) (Peptidylamidoglycolate lyase-B) (PAL-B)]	pam-b	Xenopus laevis (African clawed frog)	875	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; peptide metabolic process [GO:0006518]	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]	copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]	GO:0004504; GO:0004598; GO:0005507; GO:0006518; GO:0016021; GO:0030658	peptide metabolic process [GO:0006518]		NA	NA	NA	NA	NA	NA
TRINITY_DN147_c1_g1_i6	P12890	AMDB_XENLA	34.3	861	466	19	2715	196	55	836	4.80E-137	490.3	AMDB_XENLA	reviewed	Peptidyl-glycine alpha-amidating monooxygenase B (PAM-B) (Peptide C-terminal alpha-amidating enzyme II) (AE-II) (Peptidyl-glycine alpha-amidating monooxygenase II) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase B (PHM-B) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase B (EC 4.3.2.5) (Peptidylamidoglycolate lyase-B) (PAL-B)]	pam-b	Xenopus laevis (African clawed frog)	875	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; peptide metabolic process [GO:0006518]	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]	copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]	GO:0004504; GO:0004598; GO:0005507; GO:0006518; GO:0016021; GO:0030658	peptide metabolic process [GO:0006518]		NA	NA	NA	NA	NA	NA
TRINITY_DN12473_c1_g1_i1	O01404	PHM_DROME	56.5	313	131	4	1020	97	53	365	2.30E-102	373.6	PHM_DROME	reviewed	Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3)	Phm CG3832	Drosophila melanogaster (Fruit fly)	365	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	copper ion binding [GO:0005507]; peptidylglycine monooxygenase activity [GO:0004504]	GO:0004504; GO:0005507; GO:0005576; GO:0005615; GO:0006518; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719	memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]		NA	NA	NA	NA	NA	NA
TRINITY_DN147_c1_g1_i1	O01404	PHM_DROME	37.2	266	141	8	816	70	54	310	5.20E-41	169.9	PHM_DROME	reviewed	Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3)	Phm CG3832	Drosophila melanogaster (Fruit fly)	365	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	copper ion binding [GO:0005507]; peptidylglycine monooxygenase activity [GO:0004504]	GO:0004504; GO:0005507; GO:0005576; GO:0005615; GO:0006518; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719	memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]		NA	NA	NA	NA	NA	NA
TRINITY_DN13487_c0_g1_i1	P18253	CYPH_SCHPO	68.7	147	40	2	37	477	4	144	2.70E-53	209.5	CYPH_SCHPO	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (CPH) (Cyclosporin A-binding protein) (Rotamase)	ppi1 cyp2 SPBC28F2.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	162	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c2_g1_i1	P22011	PPIA_CANAL	64.9	74	26	0	3	224	89	162	3.00E-22	105.5	PPIA_CANAL	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (CPH) (Cyclosporin A-binding protein) (Rotamase)	CYP1 CAALFM_C702380CA CaJ7.0279 CaO19.13826 CaO19.6472	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	162	cytoplasm [GO:0005737]; fungal biofilm matrix [GO:0062040]; yeast-form cell wall [GO:0030445]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; fungal biofilm matrix [GO:0062040]; yeast-form cell wall [GO:0030445]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0030445; GO:0062040	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g3_i1	P22011	PPIA_CANAL	68.9	61	19	0	1	183	102	162	5.50E-20	97.8	PPIA_CANAL	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (CPH) (Cyclosporin A-binding protein) (Rotamase)	CYP1 CAALFM_C702380CA CaJ7.0279 CaO19.13826 CaO19.6472	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	162	cytoplasm [GO:0005737]; fungal biofilm matrix [GO:0062040]; yeast-form cell wall [GO:0030445]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; fungal biofilm matrix [GO:0062040]; yeast-form cell wall [GO:0030445]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0030445; GO:0062040	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN8789_c0_g1_i1	P21569	CYPH_MAIZE	71.8	156	44	0	472	5	2	157	5.80E-64	245	CYPH_MAIZE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYP ROT1	Zea mays (Maize)	172	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005829; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN8789_c0_g1_i2	P21569	CYPH_MAIZE	64	175	44	1	529	5	2	157	2.60E-60	233	CYPH_MAIZE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYP ROT1	Zea mays (Maize)	172	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005829; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN6032_c0_g1_i1	P21569	CYPH_MAIZE	70.9	172	48	1	26	541	3	172	1.50E-68	260.4	CYPH_MAIZE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYP ROT1	Zea mays (Maize)	172	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005829; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN21808_c0_g1_i1	P54985	PPIA_BLAGE	84.8	92	14	0	3	278	13	104	8.10E-42	170.6	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i10	P54985	PPIA_BLAGE	81.7	104	19	0	2	313	13	116	8.00E-46	184.1	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i5	P54985	PPIA_BLAGE	80.4	92	18	0	2	277	13	104	1.90E-38	159.5	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i7	P25007	PPIA_DROME	68.5	168	52	1	71	571	57	224	1.40E-64	247.3	PPIA_DROME	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	Cyp1 Cyp-1 CG9916	Drosophila melanogaster (Fruit fly)	227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i8	P25007	PPIA_DROME	70.5	132	39	0	3	398	93	224	4.30E-52	205.3	PPIA_DROME	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	Cyp1 Cyp-1 CG9916	Drosophila melanogaster (Fruit fly)	227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i9	P54985	PPIA_BLAGE	77.9	104	23	0	89	400	1	104	2.80E-43	176	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2884_c1_g1_i1	P54985	PPIA_BLAGE	82.4	74	13	0	3	224	33	106	7.90E-32	137.1	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g1_i1	P54985	PPIA_BLAGE	78.9	95	17	1	46	330	13	104	3.80E-38	158.7	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g1_i2	P54985	PPIA_BLAGE	84.5	84	13	0	76	327	21	104	2.90E-38	159.1	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN191_c0_g1_i4	P54985	PPIA_BLAGE	80.8	104	20	0	24	335	1	104	1.70E-46	186.4	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN31038_c0_g1_i1	P54985	PPIA_BLAGE	41.7	72	39	1	3	209	27	98	4.30E-11	68.2	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2218_c0_g1_i1	P54985	PPIA_BLAGE	32.5	163	95	7	567	106	6	162	1.70E-08	62	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2218_c0_g1_i2	P54985	PPIA_BLAGE	32.5	163	95	7	567	106	6	162	1.00E-08	62	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2218_c0_g1_i3	P54985	PPIA_BLAGE	32.5	163	95	7	567	106	6	162	1.50E-08	62	PPIA_BLAGE	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)	CYPA	Blattella germanica (German cockroach) (Blatta germanica)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN420_c0_g1_i1	Q39613	CYPH_CATRO	80.4	168	32	1	3	503	4	171	2.10E-78	293.1	CYPH_CATRO	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyp) (Cyclosporin A-binding protein) (Rotamase) (allergen Cat r 1)	PCKR1	Catharanthus roseus (Madagascar periwinkle) (Vinca rosea)	172	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of protein refolding [GO:0061083]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0061083	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of protein refolding [GO:0061083]		NA	NA	NA	NA	NA	NA
TRINITY_DN420_c0_g1_i2	Q39613	CYPH_CATRO	81	168	31	1	3	503	4	171	5.10E-77	288.5	CYPH_CATRO	reviewed	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyp) (Cyclosporin A-binding protein) (Rotamase) (allergen Cat r 1)	PCKR1	Catharanthus roseus (Madagascar periwinkle) (Vinca rosea)	172	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of protein refolding [GO:0061083]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0061083	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of protein refolding [GO:0061083]		red	red	NA	NA	NA	NA
TRINITY_DN40409_c0_g1_i1	P52012	PPIL2_CAEEL	57.6	118	47	2	1	354	303	417	1.10E-33	144.1	PPIL2_CAEEL	reviewed	Peptidyl-prolyl cis-trans isomerase 4 (PPIase 4) (EC 2.3.2.27) (EC 5.2.1.8) (Cyclophilin mog-6) (Cyclophilin-4) (Masculinization of germline protein 6) (RING-type E3 ubiquitin transferase isomerase 4) (Rotamase 4)	cyn-4 cyp-4 mog-6 F59E10.2	Caenorhabditis elegans	523	nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cell differentiation [GO:0030154]; feminization of hermaphroditic germ-line [GO:0040022]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]; sex differentiation [GO:0007548]	nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0007548; GO:0030154; GO:0034450; GO:0040022	cell differentiation [GO:0030154]; feminization of hermaphroditic germ-line [GO:0040022]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]; sex differentiation [GO:0007548]		NA	NA	NA	NA	NA	NA
TRINITY_DN27761_c0_g1_i1	P52015	CYP7_CAEEL	61.1	157	61	0	480	10	3	159	2.30E-53	209.9	CYP7_CAEEL	reviewed	Peptidyl-prolyl cis-trans isomerase 7 (PPIase 7) (EC 5.2.1.8) (Cyclophilin-7) (Rotamase 7)	cyn-7 cyp-7 Y75B12B.2	Caenorhabditis elegans	171	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN27344_c0_g1_i1	P52015	CYP7_CAEEL	73.2	164	44	0	494	3	4	167	6.90E-68	258.1	CYP7_CAEEL	reviewed	Peptidyl-prolyl cis-trans isomerase 7 (PPIase 7) (EC 5.2.1.8) (Cyclophilin-7) (Rotamase 7)	cyn-7 cyp-7 Y75B12B.2	Caenorhabditis elegans	171	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN583_c0_g1_i4	P17742	PPIA_MOUSE	100	164	0	0	522	31	1	164	9.90E-95	347.4	PPIA_MOUSE	reviewed	"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) (SP18) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]"	Ppia	Mus musculus (Mouse)	164	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000187; GO:0000413; GO:0001933; GO:0001934; GO:0003755; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006469; GO:0006915; GO:0016018; GO:0030168; GO:0030182; GO:0030593; GO:0030595; GO:0032148; GO:0032873; GO:0032991; GO:0034389; GO:0034599; GO:0035307; GO:0042118; GO:0043209; GO:0043231; GO:0045069; GO:0045070; GO:0050714; GO:0051092; GO:0060352; GO:0061944; GO:0070527; GO:1902176; GO:1904399; GO:2001233	activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]		NA	NA	NA	NA	NA	NA
TRINITY_DN583_c0_g1_i5	P62938	PPIA_CHLAE	98.2	165	3	0	518	24	1	165	2.20E-94	346.3	PPIA_CHLAE	reviewed	"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]"	PPIA CYPA	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	165	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000187; GO:0000413; GO:0001933; GO:0001934; GO:0003755; GO:0005178; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006469; GO:0006915; GO:0016018; GO:0030168; GO:0030593; GO:0030595; GO:0032148; GO:0032873; GO:0034599; GO:0035307; GO:0042118; GO:0045069; GO:0051092; GO:0060352; GO:0061944; GO:0070527; GO:1902176; GO:1904399; GO:2001233	activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]		NA	NA	NA	NA	NA	NA
TRINITY_DN27507_c0_g1_i1	P0C1H7	PPIA1_RHIO9	70.1	147	44	0	4	444	17	163	5.80E-56	218.4	PPIA1_RHIO9	reviewed	Peptidyl-prolyl cis-trans isomerase A1 (PPIase A1) (EC 5.2.1.8) (Cyclophilin A1) (Cyclosporin A-binding protein) (Rotamase A1)	cyp2 RO3G_12864	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	164	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN5803_c0_g1_i1	Q9TW32	PPIB_DICDI	74.7	166	42	0	525	28	32	197	5.90E-70	265	PPIB_DICDI	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B)	cypB cyp2 DDB_G0269120	Dictyostelium discoideum (Slime mold)	197	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005783; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN1611_c1_g1_i13	Q27774	PPIB_SCHJA	32.4	102	59	3	314	39	95	196	1.50E-05	50.8	PPIB_SCHJA	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin)		Schistosoma japonicum (Blood fluke)	213	endoplasmic reticulum lumen [GO:0005788]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005788; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN1611_c1_g1_i6	Q27774	PPIB_SCHJA	32.4	102	59	3	314	39	95	196	1.60E-05	50.8	PPIB_SCHJA	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin)		Schistosoma japonicum (Blood fluke)	213	endoplasmic reticulum lumen [GO:0005788]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005788; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN10301_c0_g1_i1	P24367	PPIB_CHICK	67.1	207	64	1	72	680	1	207	2.20E-76	287	PPIB_CHICK	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	PPIB	Gallus gallus (Chicken)	207	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005788; GO:0006457; GO:0016018; GO:0032991; GO:0042470; GO:0043231; GO:0061077; GO:1904027	chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		brown	brown	NA	NA	NA	NA
TRINITY_DN1213_c0_g1_i2	P24369	PPIB_MOUSE	98.9	186	2	0	581	24	31	216	3.10E-104	379	PPIB_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	Ppib	Mus musculus (Mouse)	216	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]	GO:0000413; GO:0003755; GO:0005654; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0061077; GO:0070063	bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN1213_c0_g1_i3	P23284	PPIB_HUMAN	100	186	0	0	581	24	31	216	7.40E-106	384.4	PPIB_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	PPIB CYPB	Homo sapiens (Human)	216	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006457; GO:0016018; GO:0016020; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070062; GO:0070063	bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN35872_c0_g1_i1	Q7S7Z6	PPIB_NEUCR	66.9	160	51	2	478	2	37	195	3.70E-56	219.2	PPIB_NEUCR	reviewed	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Rotamase B)	cpr2 18F11.170 NCU01200	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	285	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0016018; GO:0016021; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c1_g1_i1	P0C1I9	CYP11_RHIO9	64.8	54	19	0	117	278	123	176	3.00E-13	76.3	CYP11_RHIO9	reviewed	Peptidyl-prolyl cis-trans isomerase cyp11 (PPIase cyp11) (EC 5.2.1.8) (Cyclophilin cyp11) (Rotamase cyp11)	cyp11 RO3G_13323	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	338	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]		peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN12905_c0_g1_i1	Q9LPC7	CP18A_ARATH	63.7	146	53	0	440	3	1	146	2.50E-51	203	CP18A_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP18-1 (PPIase CYP18-1) (EC 5.2.1.8) (Cyclophilin of 18 kDa 1) (Cyclophilin-18-1)	CYP18-1 At1g01940 F22M8.7	Arabidopsis thaliana (Mouse-ear cress)	160	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i1	P34790	CP18C_ARATH	76.8	95	15	1	3	266	30	124	4.40E-37	154.8	CP18C_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP18-3 (PPIase CYP18-3) (EC 5.2.1.8) (Cyclophilin of 18 kDa 3) (Cyclosporin A-binding protein) (Rotamase cyclophilin-1)	CYP18-3 ROC1 At4g38740 T9A14.20	Arabidopsis thaliana (Mouse-ear cress)	172	"apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; de-etiolation [GO:0009704]; plant-type hypersensitive response [GO:0009626]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; red, far-red light phototransduction [GO:0009585]; regulation of protein phosphorylation [GO:0001932]; response to cadmium ion [GO:0046686]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]"	apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0001932; GO:0003755; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007165; GO:0009416; GO:0009585; GO:0009626; GO:0009704; GO:0009742; GO:0009785; GO:0016018; GO:0046686; GO:0048046	"blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; de-etiolation [GO:0009704]; plant-type hypersensitive response [GO:0009626]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; red, far-red light phototransduction [GO:0009585]; regulation of protein phosphorylation [GO:0001932]; response to cadmium ion [GO:0046686]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21578_c0_g1_i1	P34790	CP18C_ARATH	81.8	66	12	0	200	3	65	130	5.30E-27	120.9	CP18C_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP18-3 (PPIase CYP18-3) (EC 5.2.1.8) (Cyclophilin of 18 kDa 3) (Cyclosporin A-binding protein) (Rotamase cyclophilin-1)	CYP18-3 ROC1 At4g38740 T9A14.20	Arabidopsis thaliana (Mouse-ear cress)	172	"apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; de-etiolation [GO:0009704]; plant-type hypersensitive response [GO:0009626]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; red, far-red light phototransduction [GO:0009585]; regulation of protein phosphorylation [GO:0001932]; response to cadmium ion [GO:0046686]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]"	apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0001932; GO:0003755; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007165; GO:0009416; GO:0009585; GO:0009626; GO:0009704; GO:0009742; GO:0009785; GO:0016018; GO:0046686; GO:0048046	"blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; de-etiolation [GO:0009704]; plant-type hypersensitive response [GO:0009626]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; red, far-red light phototransduction [GO:0009585]; regulation of protein phosphorylation [GO:0001932]; response to cadmium ion [GO:0046686]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21578_c0_g1_i2	P34790	CP18C_ARATH	83.6	67	11	0	202	2	65	131	2.20E-28	125.6	CP18C_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP18-3 (PPIase CYP18-3) (EC 5.2.1.8) (Cyclophilin of 18 kDa 3) (Cyclosporin A-binding protein) (Rotamase cyclophilin-1)	CYP18-3 ROC1 At4g38740 T9A14.20	Arabidopsis thaliana (Mouse-ear cress)	172	"apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; de-etiolation [GO:0009704]; plant-type hypersensitive response [GO:0009626]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; red, far-red light phototransduction [GO:0009585]; regulation of protein phosphorylation [GO:0001932]; response to cadmium ion [GO:0046686]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]"	apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0001932; GO:0003755; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007165; GO:0009416; GO:0009585; GO:0009626; GO:0009704; GO:0009742; GO:0009785; GO:0016018; GO:0046686; GO:0048046	"blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; de-etiolation [GO:0009704]; plant-type hypersensitive response [GO:0009626]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; red, far-red light phototransduction [GO:0009585]; regulation of protein phosphorylation [GO:0001932]; response to cadmium ion [GO:0046686]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11062_c0_g1_i1	Q9SKQ0	CP19B_ARATH	79.3	169	35	0	516	10	4	172	1.00E-77	290.8	CP19B_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP19-2 (PPIase CYP19-2) (EC 5.2.1.8) (Cyclophilin of 19 kDa 2) (Cyclophilin-2) (Rotamase cyclophilin-6)	CYP19-2 CYP2 ROC6 At2g21130 F26H11.11	Arabidopsis thaliana (Mouse-ear cress)	174	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN35401_c0_g1_i1	Q8LDP4	CP19D_ARATH	65	143	50	0	4	432	57	199	3.40E-50	199.1	CP19D_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP19-4 (PPIase CYP19-4) (EC 5.2.1.8) (Cyclophilin of 19 kDa 4) (Cyclophilin-5) (Rotamase CYP19-4)	CYP19-4 CYP5 At2g29960 F23F1.12	Arabidopsis thaliana (Mouse-ear cress)	201	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; multivesicular body [GO:0005771]; peroxisome [GO:0005777]; secretory vesicle [GO:0099503]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of protein refolding [GO:0061083]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; multivesicular body [GO:0005771]; peroxisome [GO:0005777]; secretory vesicle [GO:0099503]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005576; GO:0005737; GO:0005771; GO:0005777; GO:0005783; GO:0005795; GO:0005829; GO:0006457; GO:0016018; GO:0016020; GO:0043231; GO:0061083; GO:0099503	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of protein refolding [GO:0061083]		NA	NA	NA	NA	NA	NA
TRINITY_DN27314_c0_g1_i1	Q9ZVJ4	CYP22_ARATH	69.8	172	51	1	517	2	28	198	3.70E-72	272.3	CYP22_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP22 (PPIase CYP22) (EC 5.2.1.8) (Cyclophilin of 22 kDa) (Cyclophilin-22)	CYP22 CYP22-1 At2g38730 T6A23.7	Arabidopsis thaliana (Mouse-ear cress)	199	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vacuole [GO:0005773]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005773; GO:0005829; GO:0005886; GO:0006457; GO:0016018; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN7673_c0_g1_i1	P0C1I8	CYP6_RHIO9	62.7	142	47	2	19	429	20	160	2.70E-44	179.5	CYP6_RHIO9	reviewed	Peptidyl-prolyl cis-trans isomerase cyp6 (PPIase cyp6) (EC 5.2.1.8) (Cyclophilin cyp6) (Rotamase cyp6)	cyp6 RO3G_10072	Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) (Mucormycosis agent) (Rhizopus arrhizus var. delemar)	176	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]		peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN29854_c0_g1_i1	Q8W4D0	CPY71_ARATH	67.6	213	65	2	645	19	416	628	2.90E-82	306.2	CPY71_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase CYP71 (PPIase CYP71) (EC 5.2.1.8) (Cyclophilin of 71 kDa) (Cyclophilin-71)	CYP71 At3g44600 F14L2.150	Arabidopsis thaliana (Mouse-ear cress)	631	nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; carpel development [GO:0048440]; leaf formation [GO:0010338]; leaf shaping [GO:0010358]; leaf vascular tissue pattern formation [GO:0010305]; meristem structural organization [GO:0009933]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of flower development [GO:0009909]; regulation of histone methylation [GO:0031060]; regulation of root meristem growth [GO:0010082]; sepal formation [GO:0048453]; stamen development [GO:0048443]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003682; GO:0003755; GO:0005634; GO:0009909; GO:0009933; GO:0010082; GO:0010305; GO:0010338; GO:0010358; GO:0031060; GO:0042393; GO:0048440; GO:0048443; GO:0048453	carpel development [GO:0048440]; leaf formation [GO:0010338]; leaf shaping [GO:0010358]; leaf vascular tissue pattern formation [GO:0010305]; meristem structural organization [GO:0009933]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of flower development [GO:0009909]; regulation of histone methylation [GO:0031060]; regulation of root meristem growth [GO:0010082]; sepal formation [GO:0048453]; stamen development [GO:0048443]		NA	NA	NA	NA	NA	NA
TRINITY_DN33017_c0_g1_i1	Q08752	PPID_HUMAN	100	96	0	0	289	2	52	147	1.90E-54	212.6	PPID_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D)	PPID CYP40 CYPD	Homo sapiens (Human)	370	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019076; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0045070; GO:0050714; GO:0051879; GO:0061077; GO:0065003; GO:0071492	apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN33017_c0_g1_i2	Q08752	PPID_HUMAN	98.7	76	1	0	230	3	52	127	7.40E-41	167.2	PPID_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D)	PPID CYP40 CYPD	Homo sapiens (Human)	370	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019076; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0045070; GO:0050714; GO:0051879; GO:0061077; GO:0065003; GO:0071492	apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN3550_c0_g1_i1	Q6DGG0	PPID_RAT	51.1	366	169	4	9	1103	13	369	2.40E-103	377.1	PPID_RAT	reviewed	Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D)	Ppid	Rattus norvegicus (Rat)	370	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006915; GO:0006979; GO:0008134; GO:0015031; GO:0016018; GO:0019899; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0043066; GO:0045070; GO:0050714; GO:0051879; GO:0051881; GO:0061077; GO:0065003; GO:0071492	apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN26102_c0_g1_i1	Q4HXF6	PPID_GIBZE	62.1	169	63	1	2	508	13	180	1.10E-55	217.6	PPID_GIBZE	reviewed	Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (Rotamase D)	CPR6 FGRRES_10352 FGSG_10352	Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)	372	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN5009_c0_g1_i1	Q4HXF6	PPID_GIBZE	58	162	62	4	15	500	14	169	5.70E-46	185.3	PPID_GIBZE	reviewed	Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (Rotamase D)	CPR6 FGRRES_10352 FGSG_10352	Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)	372	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005737; GO:0006457	protein folding [GO:0006457]		red	red	NA	NA	NA	NA
TRINITY_DN22964_c0_g1_i1	Q9UNP9	PPIE_HUMAN	90.2	133	0	1	362	3	122	254	4.70E-66	251.5	PPIE_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E)	PPIE CYP33	Homo sapiens (Human)	301	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; neutrophil degranulation [GO:0043312]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0000398; GO:0000413; GO:0003723; GO:0003729; GO:0003755; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006355; GO:0006457; GO:0008143; GO:0016018; GO:0016607; GO:0034774; GO:0043312; GO:0045070; GO:0071007; GO:0071013; GO:1904813	"mRNA splicing, via spliceosome [GO:0000398]; neutrophil degranulation [GO:0043312]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22964_c0_g1_i2	Q9UNP9	PPIE_HUMAN	90.2	133	0	1	362	3	122	254	4.70E-66	251.5	PPIE_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E)	PPIE CYP33	Homo sapiens (Human)	301	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; neutrophil degranulation [GO:0043312]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0000398; GO:0000413; GO:0003723; GO:0003729; GO:0003755; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006355; GO:0006457; GO:0008143; GO:0016018; GO:0016607; GO:0034774; GO:0043312; GO:0045070; GO:0071007; GO:0071013; GO:1904813	"mRNA splicing, via spliceosome [GO:0000398]; neutrophil degranulation [GO:0043312]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36831_c0_g1_i1	Q9UNP9	PPIE_HUMAN	100	74	0	0	223	2	61	134	5.90E-35	147.5	PPIE_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E)	PPIE CYP33	Homo sapiens (Human)	301	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; neutrophil degranulation [GO:0043312]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0000398; GO:0000413; GO:0003723; GO:0003729; GO:0003755; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006355; GO:0006457; GO:0008143; GO:0016018; GO:0016607; GO:0034774; GO:0043312; GO:0045070; GO:0071007; GO:0071013; GO:1904813	"mRNA splicing, via spliceosome [GO:0000398]; neutrophil degranulation [GO:0043312]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4454_c1_g1_i1	A4FV72	PPIE_BOVIN	63.7	171	61	1	94	606	1	170	1.10E-55	218	PPIE_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Rotamase E)	PPIE	Bos taurus (Bovine)	301	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]	GO:0000398; GO:0000413; GO:0003729; GO:0003755; GO:0005634; GO:0005737; GO:0006457; GO:0008143; GO:0016018; GO:0071007	"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4454_c1_g1_i2	A4FV72	PPIE_BOVIN	68	300	95	1	94	993	1	299	1.40E-120	434.5	PPIE_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Rotamase E)	PPIE	Bos taurus (Bovine)	301	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]	GO:0000398; GO:0000413; GO:0003729; GO:0003755; GO:0005634; GO:0005737; GO:0006457; GO:0008143; GO:0016018; GO:0071007	"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36222_c0_g1_i1	Q4G338	PPIE_HAECO	50.5	99	49	0	297	1	21	119	3.10E-23	109	PPIE_HAECO	reviewed	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophiline 33) (HcCYP) (Cyclophiline E) (Rotamase E)		Haemonchus contortus (Barber pole worm)	324	nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; peptide binding [GO:0042277]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; peptidyl-proline modification [GO:0018208]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	nucleus [GO:0005634]	DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; peptide binding [GO:0042277]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0000166; GO:0000413; GO:0003677; GO:0003723; GO:0003755; GO:0005634; GO:0006457; GO:0018208; GO:0042277	peptidyl-proline modification [GO:0018208]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		red	red	NA	NA	NA	NA
TRINITY_DN9202_c0_g1_i1	P30405	PPIF_HUMAN	100	127	0	0	382	2	75	201	4.60E-72	271.6	PPIF_HUMAN	reviewed	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Mitochondrial cyclophilin) (CyP-M) (Rotamase F)"	PPIF CYP3	Homo sapiens (Human)	207	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005743; GO:0005757; GO:0005759; GO:0006457; GO:0008637; GO:0010849; GO:0010939; GO:0016018; GO:0016020; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070266; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27128_c0_g1_i1	P30405	PPIF_HUMAN	69.8	169	51	0	535	29	38	206	4.70E-68	258.8	PPIF_HUMAN	reviewed	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Mitochondrial cyclophilin) (CyP-M) (Rotamase F)"	PPIF CYP3	Homo sapiens (Human)	207	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005743; GO:0005757; GO:0005759; GO:0006457; GO:0008637; GO:0010849; GO:0010939; GO:0016018; GO:0016020; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070266; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21808_c1_g1_i1	P30404	PPIF_BOVIN	65.7	70	24	0	214	5	124	193	2.90E-23	108.6	PPIF_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Rotamase F)"	PPIF CYP3	Bos taurus (Bovine)	208	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005757; GO:0005759; GO:0006457; GO:0006915; GO:0010849; GO:0016018; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26508_c9_g1_i1	P30404	PPIF_BOVIN	72.9	170	46	0	602	93	38	207	1.10E-73	277.7	PPIF_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Rotamase F)"	PPIF CYP3	Bos taurus (Bovine)	208	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005757; GO:0005759; GO:0006457; GO:0006915; GO:0010849; GO:0016018; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i4	P30404	PPIF_BOVIN	66.3	101	34	0	3	305	101	201	8.30E-35	147.5	PPIF_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Rotamase F)"	PPIF CYP3	Bos taurus (Bovine)	208	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005757; GO:0005759; GO:0006457; GO:0006915; GO:0010849; GO:0016018; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c0_g1_i6	P30404	PPIF_BOVIN	71.9	146	41	0	2	439	56	201	9.60E-61	234.2	PPIF_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Rotamase F)"	PPIF CYP3	Bos taurus (Bovine)	208	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005757; GO:0005759; GO:0006457; GO:0006915; GO:0010849; GO:0016018; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"apoptotic process [GO:0006915]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39530_c0_g1_i1	P48375	FKB12_DROME	77	87	20	0	265	5	10	96	1.60E-37	156.4	FKB12_DROME	reviewed	Peptidyl-prolyl cis-trans isomerase Fkbp12 (PPIase Fkbp12) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (Macrolide-binding protein) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	Fkbp12 FK506-bp2 CG11001	Drosophila melanogaster (Fruit fly)	108	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0005886; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]		blue	blue	NA	NA	NA	NA
TRINITY_DN25671_c0_g1_i1	P26883	FKB1A_MOUSE	100	85	0	0	323	69	24	108	2.60E-44	179.1	FKB1A_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase)	Fkbp1a Fkbp1	Mus musculus (Mouse)	108	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; Z disc [GO:0030018]; activin binding [GO:0048185]; enzyme binding [GO:0019899]; FK506 binding [GO:0005528]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; amyloid fibril formation [GO:1990000]; chaperone-mediated protein folding [GO:0061077]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; response to iron ion [GO:0010039]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; Z disc [GO:0030018]	activin binding [GO:0048185]; enzyme binding [GO:0019899]; FK506 binding [GO:0005528]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]	GO:0000413; GO:0003007; GO:0003755; GO:0005160; GO:0005528; GO:0005737; GO:0005829; GO:0006936; GO:0007183; GO:0010039; GO:0016020; GO:0016529; GO:0019221; GO:0019899; GO:0030018; GO:0030544; GO:0031000; GO:0031312; GO:0031398; GO:0032092; GO:0032515; GO:0032880; GO:0032925; GO:0033017; GO:0034713; GO:0042098; GO:0042802; GO:0043231; GO:0043679; GO:0044325; GO:0045202; GO:0046332; GO:0048185; GO:0050776; GO:0051209; GO:0055010; GO:0060314; GO:0060347; GO:0061077; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425	amyloid fibril formation [GO:1990000]; chaperone-mediated protein folding [GO:0061077]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; response to iron ion [GO:0010039]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]		NA	NA	NA	NA	NA	NA
TRINITY_DN13409_c0_g1_i1	P45878	FKBP2_MOUSE	100	134	0	0	1	402	7	140	5.00E-73	275	FKBP2_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)	Fkbp2 Fkbp13	Mus musculus (Mouse)	140	endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	endoplasmic reticulum membrane [GO:0005789]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005789			NA	NA	NA	NA	NA	NA
TRINITY_DN13409_c0_g2_i1	P26885	FKBP2_HUMAN	100	133	0	0	3	401	10	142	3.80E-73	275.4	FKBP2_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)	FKBP2 FKBP13	Homo sapiens (Human)	142	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005783; GO:0005789			NA	NA	NA	NA	NA	NA
TRINITY_DN1036_c0_g1_i1	P26885	FKBP2_HUMAN	54	63	28	1	88	276	1	62	7.60E-10	64.7	FKBP2_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)	FKBP2 FKBP13	Homo sapiens (Human)	142	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005783; GO:0005789			blue	blue	NA	NA	NA	NA
TRINITY_DN1036_c0_g1_i2	P26885	FKBP2_HUMAN	67.8	143	45	1	88	516	1	142	1.60E-50	200.7	FKBP2_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)	FKBP2 FKBP13	Homo sapiens (Human)	142	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005783; GO:0005789			NA	NA	NA	NA	NA	NA
TRINITY_DN1036_c0_g1_i3	P26885	FKBP2_HUMAN	67.9	140	44	1	88	507	1	139	8.40E-49	194.9	FKBP2_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)	FKBP2 FKBP13	Homo sapiens (Human)	142	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005783; GO:0005789			blue	blue	NA	NA	NA	NA
TRINITY_DN9083_c0_g2_i1	Q02790	FKBP4_HUMAN	100	153	0	0	459	1	66	218	3.40E-85	315.5	FKBP4_HUMAN	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	FKBP4 FKBP52	Homo sapiens (Human)	459	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex localization [GO:0031503]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000413; GO:0003723; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006457; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030674; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0051219; GO:0061077; GO:0070062; GO:1900034	androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein-containing complex localization [GO:0031503]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]		NA	NA	NA	NA	NA	NA
TRINITY_DN29856_c0_g1_i1	Q02790	FKBP4_HUMAN	100	83	0	0	3	251	215	297	4.00E-40	164.9	FKBP4_HUMAN	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	FKBP4 FKBP52	Homo sapiens (Human)	459	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex localization [GO:0031503]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000413; GO:0003723; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006457; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030674; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0051219; GO:0061077; GO:0070062; GO:1900034	androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein-containing complex localization [GO:0031503]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]		NA	NA	NA	NA	NA	NA
TRINITY_DN9083_c0_g1_i1	P30416	FKBP4_MOUSE	100	110	0	0	330	1	66	175	5.10E-59	228	FKBP4_MOUSE	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	Fkbp4 Fkpb52	Mus musculus (Mouse)	458	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; tau protein binding [GO:0048156]; androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex localization [GO:0031503]; reproductive structure development [GO:0048608]; steroid hormone receptor complex assembly [GO:0006463]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; tau protein binding [GO:0048156]	GO:0000413; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043005; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0048608; GO:0051219; GO:0061077	androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein-containing complex localization [GO:0031503]; protein peptidyl-prolyl isomerization [GO:0000413]; reproductive structure development [GO:0048608]; steroid hormone receptor complex assembly [GO:0006463]		NA	NA	NA	NA	NA	NA
TRINITY_DN1199_c0_g1_i1	Q9TRY0	FKBP4_BOVIN	49.2	439	211	3	165	1481	23	449	4.80E-115	416.4	FKBP4_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (FK506-binding protein 4) (FKBP-4) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	FKBP4	Bos taurus (Bovine)	459	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005634; GO:0005739; GO:0005829; GO:0005874; GO:0010977; GO:0031072; GO:0031111; GO:0044295; GO:0061077	chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]		NA	NA	NA	NA	NA	NA
TRINITY_DN1199_c0_g1_i2	Q9TRY0	FKBP4_BOVIN	47.1	471	227	4	102	1514	1	449	1.30E-115	418.3	FKBP4_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (FK506-binding protein 4) (FKBP-4) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	FKBP4	Bos taurus (Bovine)	459	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005634; GO:0005739; GO:0005829; GO:0005874; GO:0010977; GO:0031072; GO:0031111; GO:0044295; GO:0061077	chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]		NA	NA	NA	NA	NA	NA
TRINITY_DN20189_c0_g1_i1	Q9TRY0	FKBP4_BOVIN	51.7	410	197	1	130	1359	23	431	4.30E-117	423.3	FKBP4_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (FK506-binding protein 4) (FKBP-4) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	FKBP4	Bos taurus (Bovine)	459	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005634; GO:0005739; GO:0005829; GO:0005874; GO:0010977; GO:0031072; GO:0031111; GO:0044295; GO:0061077	chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]		NA	NA	NA	NA	NA	NA
TRINITY_DN20189_c0_g1_i2	Q9TRY0	FKBP4_BOVIN	52.4	401	190	1	130	1332	23	422	2.60E-116	420.6	FKBP4_BOVIN	reviewed	"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (FK506-binding protein 4) (FKBP-4) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]"	FKBP4	Bos taurus (Bovine)	459	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005634; GO:0005739; GO:0005829; GO:0005874; GO:0010977; GO:0031072; GO:0031111; GO:0044295; GO:0061077	chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]		blue	blue	NA	NA	NA	NA
TRINITY_DN26118_c0_g1_i1	Q13451	FKBP5_HUMAN	100	140	0	0	421	2	155	294	4.80E-78	291.6	FKBP5_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5) (FKBP-5) (FKBP54) (p54) (HSP90-binding immunophilin) (Rotamase)	FKBP5 AIG6 FKBP51	Homo sapiens (Human)	457	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005528; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0009617; GO:0016020; GO:0031072; GO:0061077; GO:0070062	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN30253_c0_g1_i1	Q14318	FKBP8_HUMAN	100	78	0	0	1	234	271	348	6.60E-37	154.1	FKBP8_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase)	FKBP8 FKBP38	Homo sapiens (Human)	412	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183]	GO:0001708; GO:0001933; GO:0003755; GO:0005739; GO:0005783; GO:0005829; GO:0006457; GO:0006915; GO:0007224; GO:0010468; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0044183; GO:0046872; GO:0097718	apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN18592_c0_g1_i1	Q14318	FKBP8_HUMAN	37.7	326	180	6	1065	118	91	403	1.80E-48	194.9	FKBP8_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase)	FKBP8 FKBP38	Homo sapiens (Human)	412	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183]	GO:0001708; GO:0001933; GO:0003755; GO:0005739; GO:0005783; GO:0005829; GO:0006457; GO:0006915; GO:0007224; GO:0010468; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0044183; GO:0046872; GO:0097718	apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]		blue	blue	NA	NA	NA	NA
TRINITY_DN15362_c0_g1_i1	Q13427	PPIG_HUMAN	100	109	0	0	328	2	74	182	2.80E-57	222.2	PPIG_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G)	PPIG	Homo sapiens (Human)	754	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN15362_c0_g1_i2	Q13427	PPIG_HUMAN	100	178	0	0	535	2	5	182	1.90E-103	376.3	PPIG_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G)	PPIG	Homo sapiens (Human)	754	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c1_g1_i3	Q13427	PPIG_HUMAN	68.5	124	39	0	74	445	3	126	1.30E-47	191.4	PPIG_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G)	PPIG	Homo sapiens (Human)	754	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c1_g1_i3	Q13427	PPIG_HUMAN	51.7	58	28	0	561	734	127	184	1.20E-08	62	PPIG_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G)	PPIG	Homo sapiens (Human)	754	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN325_c1_g1_i2	O55035	PPIG_RAT	63.7	182	66	0	74	619	3	184	2.20E-64	246.9	PPIG_RAT	reviewed	Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (Cyclophilin G) (Matrin cyclophilin) (Matrin-cyp) (Rotamase G)	Ppig	Rattus norvegicus (Rat)	752	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0006457; GO:0016018; GO:0016363; GO:0016607; GO:0043231	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		blue	blue	NA	NA	NA	NA
TRINITY_DN22398_c0_g1_i1	Q0P5D0	PPIH_BOVIN	100	177	0	0	43	573	1	177	2.90E-103	375.9	PPIH_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H)	PPIH	Bos taurus (Bovine)	177	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005681; GO:0005737; GO:0006397; GO:0006457; GO:0008380; GO:0016018; GO:0016607; GO:0043231	mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN22398_c0_g1_i2	Q0P5D0	PPIH_BOVIN	100	88	0	0	1	264	90	177	1.00E-48	193.7	PPIH_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H)	PPIH	Bos taurus (Bovine)	177	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005681; GO:0005737; GO:0006397; GO:0006457; GO:0008380; GO:0016018; GO:0016607; GO:0043231	mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN4985_c0_g1_i1	Q0P5D0	PPIH_BOVIN	77.2	171	39	0	595	83	7	177	3.90E-80	299.3	PPIH_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H)	PPIH	Bos taurus (Bovine)	177	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005681; GO:0005737; GO:0006397; GO:0006457; GO:0008380; GO:0016018; GO:0016607; GO:0043231	mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN28639_c0_g1_i1	P51752	MIP_COXBU	51.9	77	36	1	233	3	128	203	1.10E-15	83.6	MIP_COXBU	reviewed	Peptidyl-prolyl cis-trans isomerase Mip (PPIase) (EC 5.2.1.8) (Macrophage infectivity potentiator) (Rotamase)	mip CBU_0630	Coxiella burnetii (strain RSA 493 / Nine Mile phase I)	230	extracellular region [GO:0005576]; membrane [GO:0016020]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; pathogenesis [GO:0009405]; protein folding [GO:0006457]	extracellular region [GO:0005576]; membrane [GO:0016020]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005576; GO:0006457; GO:0009405; GO:0016020	pathogenesis [GO:0009405]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN5284_c0_g1_i1	Q5BIN5	PIN1_BOVIN	59.7	62	25	0	34	219	100	161	4.70E-13	75.1	PIN1_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)	PIN1	Bos taurus (Bovine)	163	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]	GO:0000413; GO:0001666; GO:0001934; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0008013; GO:0016607; GO:0016859; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0032091; GO:0032092; GO:0032465; GO:0032794; GO:0036064; GO:0042127; GO:0042177; GO:0043547; GO:0045944; GO:0050815; GO:0050816; GO:0050821; GO:0051443; GO:0060393; GO:0070373; GO:0090263; GO:1900180; GO:1902430; GO:2000146	cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]		red	red	NA	NA	NA	NA
TRINITY_DN29631_c0_g1_i1	Q5BIN5	PIN1_BOVIN	100	68	0	0	242	39	96	163	8.70E-32	137.1	PIN1_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)	PIN1	Bos taurus (Bovine)	163	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]	GO:0000413; GO:0001666; GO:0001934; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0008013; GO:0016607; GO:0016859; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0032091; GO:0032092; GO:0032465; GO:0032794; GO:0036064; GO:0042127; GO:0042177; GO:0043547; GO:0045944; GO:0050815; GO:0050816; GO:0050821; GO:0051443; GO:0060393; GO:0070373; GO:0090263; GO:1900180; GO:1902430; GO:2000146	cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN16134_c0_g1_i2	Q9Y237	PIN4_HUMAN	99.1	110	1	0	11	340	22	131	2.10E-58	226.1	PIN4_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (hPar14) (Parvulin-17) (Par17) (hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH) (hEPVH) (Rotamase Pin4)	PIN4	Homo sapiens (Human)	131	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]; bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]	bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0003677; GO:0003681; GO:0003690; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005819; GO:0006364; GO:0030684	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2548_c0_g1_i1	Q503Y7	PIN4_DANRE	82.4	102	18	0	41	346	27	128	1.40E-43	177.2	PIN4_DANRE	reviewed	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Rotamase Pin4)	pin4 zgc:110008	Danio rerio (Zebrafish) (Brachydanio rerio)	128	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]; DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]	DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003677; GO:0003755; GO:0005730; GO:0005737; GO:0005819; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN16134_c0_g1_i1	Q9CWW6	PIN4_MOUSE	100	108	0	0	17	340	24	131	1.30E-57	223.4	PIN4_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Rotamase Pin4)	Pin4	Mus musculus (Mouse)	131	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]; bent DNA binding [GO:0003681]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]	bent DNA binding [GO:0003681]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003681; GO:0003690; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005819; GO:0006364; GO:0030684	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN29424_c0_g1_i1	Q9LEK8	PIN1_DIGLA	60.7	56	18	1	209	42	65	116	3.80E-12	71.6	PIN1_DIGLA	reviewed	Peptidyl-prolyl cis-trans isomerase Pin1 (PPIase Pin1) (EC 5.2.1.8) (DlPar13) (Rotamase Pin1)	PARV12.8	Digitalis lanata (Grecian foxglove)	118	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN3294_c0_g1_i2	Q9SL42	PIN1_ARATH	74.2	62	16	0	70	255	58	119	1.00E-19	97.4	PIN1_ARATH	reviewed	Peptidyl-prolyl cis-trans isomerase Pin1 (PPIase Pin1) (EC 5.2.1.8) (PIN1At) (Rotamase Pin1)	PIN1 At2g18040 T27K22.9	Arabidopsis thaliana (Mouse-ear cress)	119	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; gravitropism [GO:0009630]; regulation of cell cycle [GO:0051726]; regulation of flower development [GO:0009909]; regulation of protein localization [GO:0032880]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0009506; GO:0009630; GO:0009909; GO:0032880; GO:0051726	gravitropism [GO:0009630]; regulation of cell cycle [GO:0051726]; regulation of flower development [GO:0009909]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN36281_c0_g1_i1	P73789	PPI2_SYNY3	55.7	88	38	1	279	16	84	170	1.10E-22	107.1	PPI2_SYNY3	reviewed	Peptidyl-prolyl cis-trans isomerase slr1251 (PPIase slr1251) (EC 5.2.1.8) (Rotamase slr1251)	slr1251	Synechocystis sp. (strain PCC 6803 / Kazusa)	171	cytoplasm [GO:0005737]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN39199_c0_g1_i1	P73789	PPI2_SYNY3	60	130	47	4	385	2	17	143	4.20E-36	152.1	PPI2_SYNY3	reviewed	Peptidyl-prolyl cis-trans isomerase slr1251 (PPIase slr1251) (EC 5.2.1.8) (Rotamase slr1251)	slr1251	Synechocystis sp. (strain PCC 6803 / Kazusa)	171	cytoplasm [GO:0005737]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN27640_c0_g1_i1	Q9D0W5	PPIL1_MOUSE	100	158	0	0	3	476	9	166	3.50E-93	342	PPIL1_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1)	Ppil1	Mus musculus (Mouse)	166	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718	"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2884_c0_g1_i1	Q5E992	PPIL1_BOVIN	74.5	161	41	0	581	99	3	163	3.10E-71	269.6	PPIL1_BOVIN	reviewed	Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1)	PPIL1	Bos taurus (Bovine)	166	"nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0016018; GO:0071007	"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1639_c0_g1_i1	Q9H2H8	PPIL3_HUMAN	75.8	153	37	0	460	2	1	153	6.80E-69	261.5	PPIL3_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3)	PPIL3	Homo sapiens (Human)	161	"catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	catalytic step 2 spliceosome [GO:0071013]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0006457; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33329_c0_g1_i1	Q9D6L8	PPIL3_MOUSE	99.2	118	1	0	24	377	1	118	1.20E-67	256.9	PPIL3_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (CYP10L) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3)	Ppil3 Cyp10l	Mus musculus (Mouse)	161	catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0006397; GO:0006457; GO:0008380; GO:0071013	mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN5186_c0_g1_i1	Q9CXG3	PPIL4_MOUSE	60.3	363	135	2	1333	266	1	361	7.00E-123	442.2	PPIL4_MOUSE	reviewed	Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)	Ppil4	Mus musculus (Mouse)	492	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]		NA	NA	NA	NA	NA	NA
TRINITY_DN38788_c0_g1_i1	Q8WUA2	PPIL4_HUMAN	66.7	63	21	0	48	236	1	63	3.70E-19	95.1	PPIL4_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)	PPIL4	Homo sapiens (Human)	492	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]		NA	NA	NA	NA	NA	NA
TRINITY_DN29365_c0_g1_i1	Q8WUA2	PPIL4_HUMAN	100	85	0	0	255	1	227	311	4.20E-45	181.4	PPIL4_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)	PPIL4	Homo sapiens (Human)	492	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]		NA	NA	NA	NA	NA	NA
TRINITY_DN21223_c0_g1_i1	Q8WUA2	PPIL4_HUMAN	64.4	135	44	2	420	19	207	338	1.50E-42	173.7	PPIL4_HUMAN	reviewed	Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)	PPIL4	Homo sapiens (Human)	492	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]		NA	NA	NA	NA	NA	NA
TRINITY_DN27677_c0_g1_i1	Q29RZ2	PPWD1_BOVIN	100	109	0	0	2	328	525	633	2.40E-61	235.7	PPWD1_BOVIN	reviewed	Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8)	PPWD1	Bos taurus (Bovine)	644	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0006397; GO:0008380; GO:0016018; GO:0016604; GO:0071013	mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1432_c0_g1_i1	Q29RZ2	PPWD1_BOVIN	62.3	604	225	1	1880	69	44	644	1.10E-236	820.8	PPWD1_BOVIN	reviewed	Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8)	PPWD1	Bos taurus (Bovine)	644	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0006397; GO:0008380; GO:0016018; GO:0016604; GO:0071013	mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN39899_c0_g1_i1	Q29RZ2	PPWD1_BOVIN	60.7	117	43	2	25	372	71	185	2.00E-35	149.8	PPWD1_BOVIN	reviewed	Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8)	PPWD1	Bos taurus (Bovine)	644	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0006397; GO:0008380; GO:0016018; GO:0016604; GO:0071013	mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN39490_c0_g1_i1	Q29RZ2	PPWD1_BOVIN	100	75	0	0	227	3	370	444	2.10E-35	149.1	PPWD1_BOVIN	reviewed	Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8)	PPWD1	Bos taurus (Bovine)	644	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0006397; GO:0008380; GO:0016018; GO:0016604; GO:0071013	mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN39519_c0_g1_i1	Q29RZ2	PPWD1_BOVIN	100	67	0	0	203	3	85	151	2.30E-33	142.1	PPWD1_BOVIN	reviewed	Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8)	PPWD1	Bos taurus (Bovine)	644	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0006397; GO:0008380; GO:0016018; GO:0016604; GO:0071013	mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN32485_c0_g1_i1	Q96BP3	PPWD1_HUMAN	100	71	0	0	3	215	459	529	3.30E-35	148.3	PPWD1_HUMAN	reviewed	Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8) (Spliceosome-associated cyclophilin)	PPWD1 KIAA0073	Homo sapiens (Human)	646	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0016018; GO:0016604; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25789_c0_g1_i1	P34222	PTH2_YEAST	62.2	37	14	0	134	24	172	208	1.10E-06	53.5	PTH2_YEAST	reviewed	Peptidyl-tRNA hydrolase 2 (PTH 2) (EC 3.1.1.29)	PTH2 YBL057C YBL0510 YBL0514	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	208	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	aminoacyl-tRNA hydrolase activity [GO:0004045]	GO:0004045; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]		NA	NA	NA	NA	NA	NA
TRINITY_DN30048_c0_g1_i1	Q8R2Y8	PTH2_MOUSE	53.3	184	70	4	657	121	9	181	6.60E-43	175.6	PTH2_MOUSE	reviewed	"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29)"	Ptrh2 Pth2	Mus musculus (Mouse)	181	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA hydrolase activity [GO:0004045]	GO:0004045; GO:0005739; GO:0005829; GO:0010629; GO:2000210; GO:2000811	negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]		blue	blue	NA	NA	NA	NA
TRINITY_DN32186_c0_g1_i1	Q9Y3E5	PTH2_HUMAN	100	128	0	0	3	386	52	179	2.20E-67	256.1	PTH2_HUMAN	reviewed	"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)"	PTRH2 BIT1 PTH2 CGI-147	Homo sapiens (Human)	179	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]	aminoacyl-tRNA hydrolase activity [GO:0004045]	GO:0004045; GO:0005739; GO:0005829; GO:0006915; GO:0010629; GO:0016020; GO:2000210; GO:2000811	apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210]		NA	NA	NA	NA	NA	NA
TRINITY_DN30705_c0_g1_i1	Q14197	ICT1_HUMAN	100	79	0	0	1	237	58	136	2.90E-40	165.2	ICT1_HUMAN	reviewed	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Digestion substraction 1) (DS-1) (Immature colon carcinoma transcript 1 protein) (Mitochondrial large ribosomal subunit protein mL62)"	MRPL58 DS1 ICT1	Homo sapiens (Human)	206	"mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]"	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"	GO:0004045; GO:0005739; GO:0005743; GO:0005759; GO:0005762; GO:0016150; GO:0070125; GO:0070126	mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1422_c0_g1_i1	Q8R035	ICT1_MOUSE	40.8	157	91	1	3	473	48	202	6.50E-26	119	ICT1_MOUSE	reviewed	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog)"	Mrpl58 Ict1	Mus musculus (Mouse)	206	"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]"	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"	GO:0004045; GO:0005739; GO:0005762; GO:0016150; GO:0070126	mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1422_c0_g1_i2	Q8R035	ICT1_MOUSE	39.7	156	92	1	3	470	48	201	8.30E-25	115.5	ICT1_MOUSE	reviewed	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog)"	Mrpl58 Ict1	Mus musculus (Mouse)	206	"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]"	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"	GO:0004045; GO:0005739; GO:0005762; GO:0016150; GO:0070126	mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1422_c0_g1_i3	Q8R035	ICT1_MOUSE	41.4	157	90	1	3	473	48	202	8.30E-27	122.1	ICT1_MOUSE	reviewed	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog)"	Mrpl58 Ict1	Mus musculus (Mouse)	206	"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]"	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"	GO:0004045; GO:0005739; GO:0005762; GO:0016150; GO:0070126	mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1422_c0_g1_i5	Q8R035	ICT1_MOUSE	41.4	157	90	1	3	473	48	202	6.90E-27	122.1	ICT1_MOUSE	reviewed	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog)"	Mrpl58 Ict1	Mus musculus (Mouse)	206	"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]"	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"	GO:0004045; GO:0005739; GO:0005762; GO:0016150; GO:0070126	mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN1422_c0_g1_i7	Q8R035	ICT1_MOUSE	40.8	157	91	1	3	473	48	202	2.60E-26	120.2	ICT1_MOUSE	reviewed	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog)"	Mrpl58 Ict1	Mus musculus (Mouse)	206	"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]"	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	"aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]"	GO:0004045; GO:0005739; GO:0005762; GO:0016150; GO:0070126	mitochondrial translational termination [GO:0070126]		NA	NA	NA	NA	NA	NA
TRINITY_DN34922_c0_g1_i1	P55201	BRPF1_HUMAN	100	81	0	0	245	3	509	589	3.00E-40	165.2	BRPF1_HUMAN	reviewed	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	BRPF1 BR140	Homo sapiens (Human)	1214	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0042393; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0070776; GO:1901796	"histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35452_c0_g1_i1	P55201	BRPF1_HUMAN	61.7	133	47	1	481	95	1082	1214	3.10E-41	169.9	BRPF1_HUMAN	reviewed	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	BRPF1 BR140	Homo sapiens (Human)	1214	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0042393; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0070776; GO:1901796	"histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16671_c0_g1_i1	P55201	BRPF1_HUMAN	54.8	124	44	3	419	48	509	620	3.30E-23	109.4	BRPF1_HUMAN	reviewed	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	BRPF1 BR140	Homo sapiens (Human)	1214	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0042393; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0070776; GO:1901796	"histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16671_c0_g1_i2	P55201	BRPF1_HUMAN	51.7	172	71	3	516	1	515	674	5.80E-33	142.1	BRPF1_HUMAN	reviewed	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	BRPF1 BR140	Homo sapiens (Human)	1214	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0042393; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0070776; GO:1901796	"histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16671_c0_g1_i4	P55201	BRPF1_HUMAN	51.7	172	68	4	507	1	515	674	1.20E-32	141.4	BRPF1_HUMAN	reviewed	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	BRPF1 BR140	Homo sapiens (Human)	1214	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0042393; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0070776; GO:1901796	"histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12305_c1_g1_i3	O95613	PCNT_HUMAN	26.4	216	127	6	652	17	3020	3207	2.00E-09	64.7	PCNT_HUMAN	reviewed	Pericentrin (Kendrin) (Pericentrin-B)	PCNT KIAA0402 PCNT2	Homo sapiens (Human)	3336	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]	calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]	GO:0000086; GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007052; GO:0007165; GO:0010389; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097711	ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN16019_c0_g1_i1	Q25637	PER_PERAM	44.3	176	97	1	1	528	405	579	6.60E-41	168.7	PER_PERAM	reviewed	Period circadian protein	per	Periplaneta americana (American cockroach) (Blatta americana)	893	"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"	nucleus [GO:0005634]		GO:0005634; GO:0006355; GO:0048511	"regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14397_c1_g1_i1	Q15269	PWP2_HUMAN	48.5	262	133	2	799	14	626	885	1.30E-63	244.6	PWP2_HUMAN	reviewed	Periodic tryptophan protein 2 homolog	PWP2 PWP2H	Homo sapiens (Human)	919	"nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]"	nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0006364; GO:0032040; GO:0034388	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18361_c0_g1_i1	Q24210	CSKP_DROME	84.7	111	17	0	14	346	744	854	2.90E-49	195.7	CSKP_DROME	reviewed	Peripheral plasma membrane protein CASK (dCASK) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase) (CAKI) (Camguk)	CASK Caki cmg CG6703	Drosophila melanogaster (Fruit fly)	898	neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; type I terminal bouton [GO:0061174]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]	neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; type I terminal bouton [GO:0061174]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005886; GO:0007269; GO:0007274; GO:0007298; GO:0007615; GO:0007616; GO:0007628; GO:0008049; GO:0008344; GO:0008582; GO:0016080; GO:0016081; GO:0031594; GO:0040011; GO:0040012; GO:0042043; GO:0046928; GO:0048149; GO:0048488; GO:0061174; GO:0072375; GO:1900073; GO:1900244; GO:2000331	adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]		NA	NA	NA	NA	NA	NA
TRINITY_DN37963_c0_g1_i1	Q01603	PERO_DROME	33	97	64	1	313	23	454	549	1.60E-09	63.5	PERO_DROME	reviewed	Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase)	Pxd HDC14047 PO CG3477	Drosophila melanogaster (Fruit fly)	690	egg chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]	egg chorion [GO:0042600]; extracellular region [GO:0005576]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872	eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN36988_c0_g1_i1	Q01603	PERO_DROME	50	72	36	0	4	219	567	638	1.50E-14	79.7	PERO_DROME	reviewed	Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase)	Pxd HDC14047 PO CG3477	Drosophila melanogaster (Fruit fly)	690	egg chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]	egg chorion [GO:0042600]; extracellular region [GO:0005576]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872	eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN31133_c0_g1_i1	Q01603	PERO_DROME	44.3	176	98	0	10	537	475	650	1.80E-40	167.2	PERO_DROME	reviewed	Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase)	Pxd HDC14047 PO CG3477	Drosophila melanogaster (Fruit fly)	690	egg chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]	egg chorion [GO:0042600]; extracellular region [GO:0005576]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872	eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN30240_c0_g1_i1	Q20616	SKPO1_CAEEL	46	150	71	4	3	452	469	608	4.40E-29	129	SKPO1_CAEEL	reviewed	Peroxidase skpo-1 (EC 1.11.1.7) (ShKT and peroxidase domain-containing protein 1)	skpo-1 F49E12.1	Caenorhabditis elegans	655	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; response to oxidative stress [GO:0006979]		heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0006979; GO:0008340; GO:0010629; GO:0020037; GO:0045087; GO:0046872; GO:0050830	defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN28426_c0_g1_i1	Q9VZZ4	PXDN_DROME	59.7	72	29	0	62	277	1099	1170	3.80E-23	108.6	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c1_g1_i1	Q9VZZ4	PXDN_DROME	60.7	117	44	1	403	59	1164	1280	1.40E-38	160.6	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN12677_c1_g1_i2	Q9VZZ4	PXDN_DROME	60.3	116	44	1	404	63	1164	1279	1.20E-37	157.5	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN10681_c0_g2_i1	Q9VZZ4	PXDN_DROME	50	42	21	0	75	200	1173	1214	3.40E-05	48.5	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN20014_c0_g1_i1	Q9VZZ4	PXDN_DROME	49.4	77	39	0	280	50	1005	1081	2.70E-19	95.9	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN39188_c0_g1_i1	Q9VZZ4	PXDN_DROME	38.1	105	56	4	327	37	779	882	1.90E-13	76.6	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN31079_c0_g1_i1	Q9VZZ4	PXDN_DROME	63.6	55	20	0	203	39	823	877	2.30E-15	82.8	PXDN_DROME	reviewed	Peroxidasin (EC 1.11.1.7)	Pxn CG12002	Drosophila melanogaster (Fruit fly)	1527	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN32560_c0_g1_i1	Q3UQ28	PXDN_MOUSE	60.4	53	21	0	161	3	704	756	1.60E-14	79.7	PXDN_MOUSE	reviewed	Peroxidasin homolog (EC 1.11.1.7)	Pxdn Kiaa0230	Mus musculus (Mouse)	1475	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023	collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN35630_c0_g1_i1	Q3UQ28	PXDN_MOUSE	74.4	43	11	0	412	284	978	1020	6.60E-15	82	PXDN_MOUSE	reviewed	Peroxidasin homolog (EC 1.11.1.7)	Pxdn Kiaa0230	Mus musculus (Mouse)	1475	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023	collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN35630_c0_g1_i1	Q3UQ28	PXDN_MOUSE	56.2	64	28	0	194	3	1017	1080	1.10E-12	74.7	PXDN_MOUSE	reviewed	Peroxidasin homolog (EC 1.11.1.7)	Pxdn Kiaa0230	Mus musculus (Mouse)	1475	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005201; GO:0005615; GO:0005783; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023	collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN25996_c0_g1_i1	Q1ENI8	PXDN_CAEEL	44.6	65	33	1	9	203	1103	1164	4.30E-09	61.6	PXDN1_CAEEL	reviewed	Peroxidasin homolog pxn-1 (EC 1.11.1.7)	pxn-1 ZK994.3	Caenorhabditis elegans	1285	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; muscle attachment [GO:0016203]; positive regulation of axon guidance [GO:1902669]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0016203; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0048679; GO:1902669	embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; muscle attachment [GO:0016203]; positive regulation of axon guidance [GO:1902669]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN19864_c0_g1_i1	A1KZ92	PXDNL_HUMAN	32	75	51	0	58	282	414	488	4.30E-06	52	PXDNL_HUMAN	reviewed	Peroxidasin-like protein (EC 1.11.1.7) (Cardiac peroxidase) (Vascular peroxidase 2) (polysomal ribonuclease 1) (PRM1)	PXDNL VPO2	Homo sapiens (Human)	1463	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004519; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0055114	hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN2161_c0_g1_i1	Q9V3P0	PRDX1_DROME	75.5	192	47	0	55	630	1	192	5.00E-85	315.5	PRDX1_DROME	reviewed	Peroxiredoxin 1 (EC 1.11.1.24) (Cytosolic thioredoxin peroxidase) (DPx-4783) (DmTPx-1) (Thioredoxin peroxidase) (Thioredoxin-dependent peroxiredoxin 1)	Jafrac1 TPX-1 CG1633	Drosophila melanogaster (Fruit fly)	194	cytosol [GO:0005829]; thioredoxin peroxidase activity [GO:0008379]; cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]	cytosol [GO:0005829]	thioredoxin peroxidase activity [GO:0008379]	GO:0005829; GO:0006979; GO:0007155; GO:0007281; GO:0008340; GO:0008354; GO:0008379; GO:0019430; GO:0042594; GO:0042744; GO:0045321; GO:0045454	cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]		blue	blue	NA	NA	NA	NA
TRINITY_DN1584_c0_g1_i1	P35700	PRDX1_MOUSE	100	199	0	0	645	49	1	199	9.10E-116	417.5	PRDX1_MOUSE	reviewed	Peroxiredoxin-1 (EC 1.11.1.24) (Macrophage 23 kDa stress protein) (Osteoblast-specific factor 3) (OSF-3) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1)	Prdx1 Msp23 Paga Tdpx2	Mus musculus (Mouse)	199	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear euchromatin [GO:0005719]; nucleolus [GO:0005730]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	heme binding [GO:0020037]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]	GO:0000302; GO:0004601; GO:0005634; GO:0005719; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005782; GO:0005829; GO:0006979; GO:0008283; GO:0008379; GO:0019430; GO:0020037; GO:0030101; GO:0032872; GO:0034101; GO:0042267; GO:0042744; GO:0042802; GO:0043209; GO:0045321; GO:0045454; GO:0051920; GO:1901222	cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]		NA	NA	NA	NA	NA	NA
TRINITY_DN1584_c0_g1_i2	Q06830	PRDX1_HUMAN	99.5	199	1	0	625	29	1	199	1.50E-115	416.8	PRDX1_HUMAN	reviewed	Peroxiredoxin-1 (EC 1.11.1.24) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1)	PRDX1 PAGA PAGB TDPX2	Homo sapiens (Human)	199	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; RNA binding [GO:0003723]; thioredoxin peroxidase activity [GO:0008379]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; RNA binding [GO:0003723]; thioredoxin peroxidase activity [GO:0008379]	GO:0001501; GO:0001895; GO:0003723; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006979; GO:0008283; GO:0008379; GO:0019430; GO:0030101; GO:0032872; GO:0034101; GO:0034599; GO:0042267; GO:0042470; GO:0042744; GO:0042802; GO:0045296; GO:0045321; GO:0045454; GO:0070062; GO:1901222	cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN2623_c0_g1_i1	Q6DV14	PRDX1_GEKJA	50.5	103	51	0	312	4	8	110	2.40E-26	119.4	PRDX1_GEKJA	reviewed	Peroxiredoxin-1 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 1)	PRDX1 GekBS014P	Gekko japonicus (Schlegel's Japanese gecko)	199	cytoplasm [GO:0005737]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]	cytoplasm [GO:0005737]	peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]	GO:0004601; GO:0005737; GO:0051920			NA	NA	NA	NA	NA	NA
TRINITY_DN2623_c0_g1_i2	Q6DV14	PRDX1_GEKJA	47.8	92	48	0	279	4	19	110	1.50E-22	106.7	PRDX1_GEKJA	reviewed	Peroxiredoxin-1 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 1)	PRDX1 GekBS014P	Gekko japonicus (Schlegel's Japanese gecko)	199	cytoplasm [GO:0005737]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]	cytoplasm [GO:0005737]	peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]	GO:0004601; GO:0005737; GO:0051920			NA	NA	NA	NA	NA	NA
TRINITY_DN31156_c0_g1_i1	P0CB50	PRDX1_CHICK	54.5	77	35	0	233	3	8	84	3.80E-19	95.1	PRDX1_CHICK	reviewed	Peroxiredoxin-1 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 1)	PRDX1	Gallus gallus (Chicken)	199	cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]	GO:0005634; GO:0005829; GO:0006979; GO:0008283; GO:0008379; GO:0019430; GO:0030101; GO:0032872; GO:0034101; GO:0042267; GO:0042744; GO:0042802; GO:0045321; GO:0045454; GO:1901222	cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN27247_c0_g1_i1	P32119	PRDX2_HUMAN	100	108	0	0	47	370	1	108	2.20E-58	226.1	PRDX2_HUMAN	reviewed	Peroxiredoxin-2 (EC 1.11.1.24) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)	PRDX2 NKEFB TDPX1	Homo sapiens (Human)	198	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; antioxidant activity [GO:0016209]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	antioxidant activity [GO:0016209]; thioredoxin peroxidase activity [GO:0008379]	GO:0000187; GO:0002536; GO:0005737; GO:0005829; GO:0006979; GO:0008379; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042744; GO:0042981; GO:0043066; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:0070062; GO:2001240	activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN37181_c0_g1_i1	P32119	PRDX2_HUMAN	100	94	0	0	3	284	105	198	1.10E-50	200.3	PRDX2_HUMAN	reviewed	Peroxiredoxin-2 (EC 1.11.1.24) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)	PRDX2 NKEFB TDPX1	Homo sapiens (Human)	198	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; antioxidant activity [GO:0016209]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	antioxidant activity [GO:0016209]; thioredoxin peroxidase activity [GO:0008379]	GO:0000187; GO:0002536; GO:0005737; GO:0005829; GO:0006979; GO:0008379; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042744; GO:0042981; GO:0043066; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:0070062; GO:2001240	activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN17025_c0_g1_i1	Q61171	PRDX2_MOUSE	100	198	0	0	634	41	1	198	3.80E-114	412.1	PRDX2_MOUSE	reviewed	Peroxiredoxin-2 (EC 1.11.1.24) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)	Prdx2 Tdpx1 Tpx	Mus musculus (Mouse)	198	cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]	GO:0000187; GO:0002536; GO:0004601; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0008430; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042743; GO:0042744; GO:0042981; GO:0043209; GO:0043524; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0048872; GO:2001237; GO:2001240	activation of MAPK activity [GO:0000187]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; homeostasis of number of cells [GO:0048872]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; leukocyte activation [GO:0045321]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell proliferation [GO:0042098]; thymus development [GO:0048538]		NA	NA	NA	NA	NA	NA
TRINITY_DN38704_c0_g1_i1	Q9XEX2	PRX2B_ARATH	60.4	53	21	0	161	3	28	80	4.10E-14	78.2	PRX2B_ARATH	reviewed	Peroxiredoxin-2B (EC 1.11.1.25) (Glutaredoxin-dependent peroxiredoxin) (Peroxiredoxin IIB) (Peroxiredoxin TPx1) (Thioredoxin peroxidase 2B) (Thioredoxin-dependent peroxidase 1)	PRXIIB TPX1 At1g65980 F12P19.14	Arabidopsis thaliana (Mouse-ear cress)	162	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; response to cadmium ion [GO:0046686]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	thioredoxin peroxidase activity [GO:0008379]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008379; GO:0009507; GO:0034599; GO:0042744; GO:0045454; GO:0046686	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN32580_c0_g1_i1	Q13162	PRDX4_HUMAN	99	105	1	0	1	315	59	163	1.70E-56	219.5	PRDX4_HUMAN	reviewed	Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)	PRDX4	Homo sapiens (Human)	271	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; smooth endoplasmic reticulum [GO:0005790]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; neutrophil degranulation [GO:0043312]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; smooth endoplasmic reticulum [GO:0005790]	thioredoxin peroxidase activity [GO:0008379]	GO:0005576; GO:0005634; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007252; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0034774; GO:0043312; GO:0045454; GO:0070062; GO:0072593; GO:1904813; GO:2000255	cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; neutrophil degranulation [GO:0043312]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN14086_c0_g1_i1	Q13162	PRDX4_HUMAN	75.4	224	53	1	770	105	48	271	2.30E-101	370.2	PRDX4_HUMAN	reviewed	Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)	PRDX4	Homo sapiens (Human)	271	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; smooth endoplasmic reticulum [GO:0005790]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; neutrophil degranulation [GO:0043312]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; smooth endoplasmic reticulum [GO:0005790]	thioredoxin peroxidase activity [GO:0008379]	GO:0005576; GO:0005634; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007252; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0034774; GO:0043312; GO:0045454; GO:0070062; GO:0072593; GO:1904813; GO:2000255	cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; neutrophil degranulation [GO:0043312]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN33028_c0_g1_i1	O08807	PRDX4_MOUSE	99.3	139	1	0	2	418	56	194	3.60E-78	292	PRDX4_MOUSE	reviewed	Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)	Prdx4	Mus musculus (Mouse)	274	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]	thioredoxin peroxidase activity [GO:0008379]	GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0045454; GO:0055114; GO:0072593; GO:2000255	cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN19617_c0_g2_i1	O08807	PRDX4_MOUSE	100	83	0	0	293	45	192	274	1.40E-44	179.9	PRDX4_MOUSE	reviewed	Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)	Prdx4	Mus musculus (Mouse)	274	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]	thioredoxin peroxidase activity [GO:0008379]	GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0045454; GO:0055114; GO:0072593; GO:2000255	cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN19617_c0_g1_i1	Q9BGI2	PRDX4_BOVIN	100	83	0	0	259	11	192	274	1.30E-44	179.9	PRDX4_BOVIN	reviewed	Peroxiredoxin-4 (EC 1.11.1.24) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin-dependent peroxiredoxin 4)	PRDX4	Bos taurus (Bovine)	274	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	thioredoxin peroxidase activity [GO:0008379]	GO:0005783; GO:0005829; GO:0006979; GO:0008379; GO:0045454	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN5432_c0_g1_i1	P30044	PRDX5_HUMAN	55.3	159	68	1	144	611	56	214	1.00E-45	184.9	PRDX5_HUMAN	reviewed	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)"	PRDX5 ACR1 SBBI10	Homo sapiens (Human)	214	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]	GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN37002_c0_g1_i1	P30044	PRDX5_HUMAN	100	91	0	0	3	275	58	148	1.30E-47	189.9	PRDX5_HUMAN	reviewed	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)"	PRDX5 ACR1 SBBI10	Homo sapiens (Human)	214	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]	GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN19167_c0_g1_i1	P30044	PRDX5_HUMAN	100	57	0	0	3	173	158	214	2.00E-25	115.9	PRDX5_HUMAN	reviewed	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)"	PRDX5 ACR1 SBBI10	Homo sapiens (Human)	214	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]	GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN15753_c0_g1_i1	P99029	PRDX5_MOUSE	99.1	109	1	0	329	3	46	154	1.00E-56	220.3	PRDX5_MOUSE	reviewed	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 2D-0014IV) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)"	Prdx5 Prdx6	Mus musculus (Mouse)	210	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]	GO:0001016; GO:0004601; GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070995; GO:0072541; GO:2001057	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN19167_c0_g1_i2	P99029	PRDX5_MOUSE	98.4	61	1	0	2	184	150	210	1.70E-27	122.9	PRDX5_MOUSE	reviewed	"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 2D-0014IV) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)"	Prdx5 Prdx6	Mus musculus (Mouse)	210	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; RNA polymerase III transcription regulatory region sequence-specific DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]	GO:0001016; GO:0004601; GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070995; GO:0072541; GO:2001057	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN3249_c0_g1_i1	A0JPD7	PXL2A_XENTR	47.5	198	100	3	675	91	22	218	7.20E-46	185.7	PXL2A_XENTR	reviewed	Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) (Redox-regulatory protein FAM213A)	prxl2a fam213a pamm	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	227	cytoplasm [GO:0005737]; antioxidant activity [GO:0016209]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]	antioxidant activity [GO:0016209]	GO:0005737; GO:0016209; GO:0055114	oxidation-reduction process [GO:0055114]		brown	brown	NA	NA	NA	NA
TRINITY_DN3249_c0_g1_i2	A0JPD7	PXL2A_XENTR	50	130	63	1	474	91	89	218	5.00E-32	139.8	PXL2A_XENTR	reviewed	Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) (Redox-regulatory protein FAM213A)	prxl2a fam213a pamm	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	227	cytoplasm [GO:0005737]; antioxidant activity [GO:0016209]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]	antioxidant activity [GO:0016209]	GO:0005737; GO:0016209; GO:0055114	oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN3051_c0_g1_i1	B8AKX6	GLO1_ORYSI	51.7	356	169	2	1182	115	3	355	4.10E-96	353.2	GLO1_ORYSI	reviewed	Peroxisomal (S)-2-hydroxy-acid oxidase GLO1 (EC 1.1.3.15) (Glycolate oxidase 1) (GOX 1) (OsGLO1) (Short chain alpha-hydroxy acid oxidase GLO1)	GLO1 OsI_13800	Oryza sativa subsp. indica (Rice)	369	peroxisome [GO:0005777]; FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]; modulation by virus of host process [GO:0019048]; oxidative photosynthetic carbon pathway [GO:0009854]; photorespiration [GO:0009853]; regulation of photosynthesis [GO:0010109]	peroxisome [GO:0005777]	FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]	GO:0005777; GO:0008891; GO:0009853; GO:0009854; GO:0010109; GO:0010181; GO:0019048; GO:0052852; GO:0052853; GO:0052854	modulation by virus of host process [GO:0019048]; oxidative photosynthetic carbon pathway [GO:0009854]; photorespiration [GO:0009853]; regulation of photosynthesis [GO:0010109]		blue	blue	NA	NA	NA	NA
TRINITY_DN3051_c0_g1_i3	B8AUI3	GLO3_ORYSI	52.8	267	123	3	840	40	4	267	8.80E-72	271.9	GLO3_ORYSI	reviewed	Peroxisomal (S)-2-hydroxy-acid oxidase GLO3 (EC 1.1.3.15) (Glycolate oxidase 3) (GOX 3) (OsGLO3) (Short chain alpha-hydroxy acid oxidase GLO3)	GLO3 H0215F08.7 OsI_17479	Oryza sativa subsp. indica (Rice)	367	peroxisome [GO:0005777]; FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]; modulation by virus of host process [GO:0019048]; oxidative photosynthetic carbon pathway [GO:0009854]; photorespiration [GO:0009853]; regulation of photosynthesis [GO:0010109]	peroxisome [GO:0005777]	FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]	GO:0005777; GO:0008891; GO:0009853; GO:0009854; GO:0010109; GO:0010181; GO:0019048; GO:0052852; GO:0052853; GO:0052854	modulation by virus of host process [GO:0019048]; oxidative photosynthetic carbon pathway [GO:0009854]; photorespiration [GO:0009853]; regulation of photosynthesis [GO:0010109]		NA	NA	NA	NA	NA	NA
TRINITY_DN3051_c0_g1_i2	B8B7C5	GLO5_ORYSI	52.7	93	44	0	352	74	3	95	4.40E-21	102.4	GLO5_ORYSI	reviewed	Peroxisomal (S)-2-hydroxy-acid oxidase GLO5 (EC 1.1.3.15) (Glycolate oxidase 5) (GOX 5) (OsGLO5) (Short chain alpha-hydroxy acid oxidase GLO5)	GLO5 OsI_24928	Oryza sativa subsp. indica (Rice)	369	peroxisome [GO:0005777]; FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]; modulation by virus of host process [GO:0019048]; oxidative photosynthetic carbon pathway [GO:0009854]; photorespiration [GO:0009853]; regulation of photosynthesis [GO:0010109]	peroxisome [GO:0005777]	FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]	GO:0005777; GO:0008891; GO:0009853; GO:0009854; GO:0010109; GO:0010181; GO:0019048; GO:0052852; GO:0052853; GO:0052854	modulation by virus of host process [GO:0019048]; oxidative photosynthetic carbon pathway [GO:0009854]; photorespiration [GO:0009853]; regulation of photosynthesis [GO:0010109]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c1_g1_i11	Q8HYL8	ACOX1_PHACI	45.4	656	344	5	2031	100	4	657	5.50E-162	572.8	ACOX1_PHACI	reviewed	Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase)	ACOX1	Phascolarctos cinereus (Koala)	661	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]	peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]	GO:0003997; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0019395; GO:0033540; GO:0071949	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c1_g1_i21	Q8HYL8	ACOX1_PHACI	46.6	521	266	3	1629	100	138	657	1.60E-136	488	ACOX1_PHACI	reviewed	Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase)	ACOX1	Phascolarctos cinereus (Koala)	661	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]	peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]	GO:0003997; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0019395; GO:0033540; GO:0071949	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c1_g1_i6	Q8HYL8	ACOX1_PHACI	46.6	521	266	3	1629	100	138	657	1.50E-136	488	ACOX1_PHACI	reviewed	Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase)	ACOX1	Phascolarctos cinereus (Koala)	661	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]	peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]	GO:0003997; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0019395; GO:0033540; GO:0071949	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN30132_c0_g1_i1	Q9R0H0	ACOX1_MOUSE	100	127	0	0	381	1	232	358	2.20E-66	252.7	ACOX1_MOUSE	reviewed	"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"	Acox1 Acox Paox	Mus musculus (Mouse)	661	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]	GO:0000038; GO:0003997; GO:0005504; GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0005829; GO:0006091; GO:0006629; GO:0006635; GO:0006693; GO:0007283; GO:0016401; GO:0016559; GO:0019395; GO:0030165; GO:0033540; GO:0042632; GO:0042803; GO:0047485; GO:0050660; GO:0050665; GO:0055088; GO:0071949	cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c1_g1_i17	Q3SZP5	ACOX1_BOVIN	46.2	582	299	4	1719	10	4	583	3.50E-141	503.4	ACOX1_BOVIN	reviewed	"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"	ACOX1	Bos taurus (Bovine)	660	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038]	peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0016401; GO:0019395; GO:0033540; GO:0050660; GO:0055088; GO:0071949	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN1423_c1_g1_i22	Q3SZP5	ACOX1_BOVIN	51.6	368	176	2	1166	66	4	370	2.90E-102	373.6	ACOX1_BOVIN	reviewed	"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"	ACOX1	Bos taurus (Bovine)	660	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038]	peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0016401; GO:0019395; GO:0033540; GO:0050660; GO:0055088; GO:0071949	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN24220_c0_g1_i2	O15254	ACOX3_HUMAN	45	591	316	5	27	1787	106	691	6.30E-143	509.2	ACOX3_HUMAN	reviewed	Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)	ACOX3 BRCOX PRCOX	Homo sapiens (Human)	700	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]	GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN32530_c0_g1_i1	Q9EPL9	ACOX3_MOUSE	98.6	73	1	0	1	219	409	481	1.50E-38	159.5	ACOX3_MOUSE	reviewed	Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)	Acox3	Mus musculus (Mouse)	700	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]	GO:0003997; GO:0005504; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]		NA	NA	NA	NA	NA	NA
TRINITY_DN28625_c0_g1_i1	O74941	PEX1_SCHPO	56.3	119	52	0	375	19	668	786	1.50E-35	150.2	PEX1_SCHPO	reviewed	Peroxisomal ATPase pex1 (Peroxin-1) (Peroxisome biogenesis protein pex1)	pex1 SPCC553.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	937	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005778; GO:0005829; GO:0007031; GO:0016558; GO:0016562; GO:0016887	"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38284_c0_g1_i1	P55100	ECHP_CAVPO	57.1	63	27	0	195	7	100	162	1.70E-15	82.8	ECHP_CAVPO	reviewed	"Peroxisomal bifunctional enzyme (PBE) (PBFE) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]"	EHHADH	Cavia porcellus (Guinea pig)	726	"peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; fatty acid beta-oxidation [GO:0006635]"	peroxisome [GO:0005777]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]"	GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635; GO:0016509; GO:0016863	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN22101_c0_g1_i1	Q6NYL3	ECHP_DANRE	57.6	85	36	0	9	263	78	162	1.30E-20	100.1	ECHP_DANRE	reviewed	"Peroxisomal bifunctional enzyme (PBE) (PBFE) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]"	ehhadh echd si:dkeyp-30d5.2 zgc:77526	Danio rerio (Zebrafish) (Brachydanio rerio)	718	"peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; fatty acid beta-oxidation [GO:0006635]"	peroxisome [GO:0005777]	"3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]"	GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635; GO:0016509; GO:0016863	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN1166_c0_g1_i11	A6H7C2	PEX3_BOVIN	32	253	163	4	870	133	49	299	1.40E-31	138.3	PEX3_BOVIN	reviewed	Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3)	PEX3	Bos taurus (Bovine)	373	integral component of peroxisomal membrane [GO:0005779]; protein-macromolecule adaptor activity [GO:0030674]; protein import into peroxisome membrane [GO:0045046]	integral component of peroxisomal membrane [GO:0005779]	protein-macromolecule adaptor activity [GO:0030674]	GO:0005779; GO:0030674; GO:0045046	protein import into peroxisome membrane [GO:0045046]		NA	NA	NA	NA	NA	NA
TRINITY_DN1166_c0_g1_i2	Q60HE1	PEX3_MACFA	30.9	356	203	7	1146	100	49	368	4.40E-41	170.2	PEX3_MACFA	reviewed	Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3)	PEX3 QnpA-14710	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	373	endoplasmic reticulum [GO:0005783]; integral component of peroxisomal membrane [GO:0005779]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; protein-lipid complex [GO:0032994]; lipid binding [GO:0008289]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]	endoplasmic reticulum [GO:0005783]; integral component of peroxisomal membrane [GO:0005779]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; protein-lipid complex [GO:0032994]	lipid binding [GO:0008289]	GO:0005654; GO:0005777; GO:0005779; GO:0005783; GO:0007031; GO:0008289; GO:0032994; GO:0045046	peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]		NA	NA	NA	NA	NA	NA
TRINITY_DN1166_c0_g1_i8	Q60HE1	PEX3_MACFA	30.9	356	203	7	1214	168	49	368	4.60E-41	170.2	PEX3_MACFA	reviewed	Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3)	PEX3 QnpA-14710	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	373	endoplasmic reticulum [GO:0005783]; integral component of peroxisomal membrane [GO:0005779]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; protein-lipid complex [GO:0032994]; lipid binding [GO:0008289]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]	endoplasmic reticulum [GO:0005783]; integral component of peroxisomal membrane [GO:0005779]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; protein-lipid complex [GO:0032994]	lipid binding [GO:0008289]	GO:0005654; GO:0005777; GO:0005779; GO:0005783; GO:0007031; GO:0008289; GO:0032994; GO:0045046	peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]		NA	NA	NA	NA	NA	NA
TRINITY_DN13247_c0_g1_i1	Q54CS8	PEX6_DICDI	75	140	33	1	433	20	952	1091	4.10E-59	228.8	PEX6_DICDI	reviewed	Peroxisomal biogenesis factor 6 (Peroxin-6)	pex6 DDB_G0292788	Dictyostelium discoideum (Slime mold)	1201	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0016558; GO:0016887	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN37707_c0_g1_i1	Q9ZPI6	AIM1_ARATH	57.3	89	38	0	17	283	85	173	3.60E-21	102.1	AIM1_ARATH	reviewed	Peroxisomal fatty acid beta-oxidation multifunctional protein AIM1 (Protein ABNORMAL INFLORESCENCE MERISTEM 1) (AtAIM1) [Includes: Enoyl-CoA hydratase/3-2-trans-enoyl-CoA isomerase/3-hydroxybutyryl-CoA epimerase (EC 4.2.1.17) (EC 5.1.2.3) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]	AIM1 At4g29010 F19B15.40	Arabidopsis thaliana (Mouse-ear cress)	721	cell wall [GO:0005618]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA epimerase activity [GO:0008692]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; fatty acid beta-oxidation [GO:0006635]; flower development [GO:0009908]; jasmonic acid biosynthetic process [GO:0009695]	cell wall [GO:0005618]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA epimerase activity [GO:0008692]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]	GO:0003729; GO:0003857; GO:0004165; GO:0004300; GO:0005618; GO:0005777; GO:0005886; GO:0006635; GO:0008017; GO:0008692; GO:0009506; GO:0009695; GO:0009908; GO:0018812	fatty acid beta-oxidation [GO:0006635]; flower development [GO:0009908]; jasmonic acid biosynthetic process [GO:0009695]		NA	NA	NA	NA	NA	NA
TRINITY_DN21698_c0_g1_i1	Q02207	FOX2_YEAST	63	92	34	0	2	277	101	192	2.30E-25	115.9	FOX2_YEAST	reviewed	Peroxisomal hydratase-dehydrogenase-epimerase (HDE) (Multifunctional beta-oxidation protein) (MFP) [Includes: 2-enoyl-CoA hydratase (EC 4.2.1.119); (3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12)]	FOX2 YKR009C YK108	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	900	peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; fatty acid beta-oxidation [GO:0006635]	peroxisome [GO:0005777]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]	GO:0003857; GO:0004300; GO:0005777; GO:0006635; GO:0016853; GO:0044594	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN5574_c0_g1_i3	Q02207	FOX2_YEAST	57.7	130	55	0	391	2	83	212	1.30E-35	150.6	FOX2_YEAST	reviewed	Peroxisomal hydratase-dehydrogenase-epimerase (HDE) (Multifunctional beta-oxidation protein) (MFP) [Includes: 2-enoyl-CoA hydratase (EC 4.2.1.119); (3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12)]	FOX2 YKR009C YK108	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	900	peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; fatty acid beta-oxidation [GO:0006635]	peroxisome [GO:0005777]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]	GO:0003857; GO:0004300; GO:0005777; GO:0006635; GO:0016853; GO:0044594	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN5574_c0_g1_i4	Q02207	FOX2_YEAST	56.3	135	59	0	405	1	91	225	7.10E-39	161.4	FOX2_YEAST	reviewed	Peroxisomal hydratase-dehydrogenase-epimerase (HDE) (Multifunctional beta-oxidation protein) (MFP) [Includes: 2-enoyl-CoA hydratase (EC 4.2.1.119); (3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12)]	FOX2 YKR009C YK108	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	900	peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; fatty acid beta-oxidation [GO:0006635]	peroxisome [GO:0005777]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]	GO:0003857; GO:0004300; GO:0005777; GO:0006635; GO:0016853; GO:0044594	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN5574_c0_g1_i5	Q02207	FOX2_YEAST	58.1	129	54	0	388	2	84	212	1.60E-35	150.2	FOX2_YEAST	reviewed	Peroxisomal hydratase-dehydrogenase-epimerase (HDE) (Multifunctional beta-oxidation protein) (MFP) [Includes: 2-enoyl-CoA hydratase (EC 4.2.1.119); (3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12)]	FOX2 YKR009C YK108	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	900	peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; fatty acid beta-oxidation [GO:0006635]	peroxisome [GO:0005777]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]	GO:0003857; GO:0004300; GO:0005777; GO:0006635; GO:0016853; GO:0044594	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN8240_c0_g1_i1	Q2T9J0	TYSD1_HUMAN	25	464	219	14	1380	13	215	557	3.30E-29	131.7	TYSD1_HUMAN	reviewed	"Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form]"	TYSND1	Homo sapiens (Human)	566	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein processing [GO:0016485]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]	GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006625; GO:0016020; GO:0016485; GO:0031998; GO:0042802	protein processing [GO:0016485]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998]		NA	NA	NA	NA	NA	NA
TRINITY_DN39502_c0_g1_i1	P41909	PXA1_YEAST	53.2	62	29	0	188	3	739	800	5.70E-13	74.3	PXA1_YEAST	reviewed	Peroxisomal long-chain fatty acid import protein 2 (Peroxisomal ABC transporter 1)	PXA1 PAL1 PAT2 SSH2 YPL147W LPI1W P2607	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	870	integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; fatty-acyl-CoA transport [GO:0015916]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760]	integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]	GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005779; GO:0006635; GO:0007031; GO:0015908; GO:0015910; GO:0015916; GO:0016887; GO:0042626; GO:0042758; GO:0042760	fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; fatty-acyl-CoA transport [GO:0015916]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760]		NA	NA	NA	NA	NA	NA
TRINITY_DN3378_c0_g1_i2	Q2KIY1	PXMP2_BOVIN	44.6	175	89	2	119	619	19	193	4.60E-36	152.9	PXMP2_BOVIN	reviewed	Peroxisomal membrane protein 2	PXMP2	Bos taurus (Bovine)	196	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]		GO:0005737; GO:0005778; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3378_c0_g1_i1	Q2KIY1	PXMP2_BOVIN	45.1	175	89	1	119	622	19	193	1.10E-37	158.3	PXMP2_BOVIN	reviewed	Peroxisomal membrane protein 2	PXMP2	Bos taurus (Bovine)	196	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]		GO:0005737; GO:0005778; GO:0016021			NA	NA	1	NA	NA	1
TRINITY_DN612_c3_g1_i1	O75381	PEX14_HUMAN	32.6	227	123	5	90	704	14	232	3.40E-16	87.4	PEX14_HUMAN	reviewed	Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14)	PEX14	Homo sapiens (Human)	377	"fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]"	fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	GO:0001650; GO:0003714; GO:0005102; GO:0005634; GO:0005777; GO:0005778; GO:0006625; GO:0007031; GO:0008017; GO:0016020; GO:0016021; GO:0016558; GO:0016560; GO:0016561; GO:0016567; GO:0032091; GO:0032991; GO:0034453; GO:0036250; GO:0042802; GO:0043433; GO:0044721; GO:0045892; GO:0047485; GO:0048487; GO:0065003; GO:1990429	"microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein-containing complex assembly [GO:0065003]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3871_c0_g2_i1	Q91XC9	PEX16_MOUSE	44.1	111	58	3	339	7	86	192	2.90E-14	79.7	PEX16_MOUSE	reviewed	Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16)	Pex16	Mus musculus (Mouse)	336	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	protein C-terminus binding [GO:0008022]	GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0005789; GO:0006625; GO:0007031; GO:0008022; GO:0016557; GO:0016558; GO:0022615; GO:0032581; GO:0045046; GO:0106101	ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615]		NA	NA	NA	NA	NA	NA
TRINITY_DN3871_c0_g2_i2	Q91XC9	PEX16_MOUSE	38.9	144	79	5	432	7	56	192	3.40E-15	82.8	PEX16_MOUSE	reviewed	Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16)	Pex16	Mus musculus (Mouse)	336	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	protein C-terminus binding [GO:0008022]	GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0005789; GO:0006625; GO:0007031; GO:0008022; GO:0016557; GO:0016558; GO:0022615; GO:0032581; GO:0045046; GO:0106101	ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615]		blue	blue	NA	NA	NA	NA
TRINITY_DN28655_c0_g1_i1	P51659	DHB4_HUMAN	100	81	0	0	2	244	187	267	1.50E-44	179.5	DHB4_HUMAN	reviewed	"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]"	HSD17B4 EDH17B4 SDR8C1	Homo sapiens (Human)	736	"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]"	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"	GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006699; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009	alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]		NA	NA	NA	NA	NA	NA
TRINITY_DN5072_c0_g1_i2	P51659	DHB4_HUMAN	70.7	116	34	0	87	434	1	116	3.70E-40	166	DHB4_HUMAN	reviewed	"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]"	HSD17B4 EDH17B4 SDR8C1	Homo sapiens (Human)	736	"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]"	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"	GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006699; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009	alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]		NA	NA	NA	NA	NA	NA
TRINITY_DN5072_c0_g1_i3	P51659	DHB4_HUMAN	53.4	747	334	7	87	2318	1	736	1.70E-225	783.9	DHB4_HUMAN	reviewed	"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]"	HSD17B4 EDH17B4 SDR8C1	Homo sapiens (Human)	736	"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]"	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"	GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006699; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009	alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]		NA	NA	NA	NA	NA	NA
TRINITY_DN16713_c0_g1_i1	P51659	DHB4_HUMAN	98.6	74	1	0	223	2	67	140	9.20E-36	150.2	DHB4_HUMAN	reviewed	"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]"	HSD17B4 EDH17B4 SDR8C1	Homo sapiens (Human)	736	"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]"	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"	GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006699; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009	alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]		NA	NA	NA	NA	NA	NA
TRINITY_DN16713_c0_g1_i2	P51660	DHB4_MOUSE	99.3	140	1	0	421	2	1	140	4.80E-73	275	DHB4_MOUSE	reviewed	"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]"	Hsd17b4 Edh17b4	Mus musculus (Mouse)	735	"mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]"	mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"	GO:0000038; GO:0003857; GO:0004300; GO:0004303; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0008209; GO:0008210; GO:0016508; GO:0016853; GO:0018812; GO:0033989; GO:0036111; GO:0036112; GO:0042802; GO:0042803; GO:0044594; GO:0060009	androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]		NA	NA	NA	NA	NA	NA
TRINITY_DN26343_c0_g1_i1	Q6QHF9	PAOX_HUMAN	100	67	0	0	221	21	445	511	7.20E-33	140.6	PAOX_HUMAN	reviewed	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase)	PAOX PAO UNQ1923/PRO4398	Homo sapiens (Human)	511	"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; protein targeting to peroxisome [GO:0006625]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]"	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]	"N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]"	GO:0005782; GO:0005829; GO:0006596; GO:0006598; GO:0006625; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307	polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; protein targeting to peroxisome [GO:0006625]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]		NA	NA	NA	NA	NA	NA
TRINITY_DN8434_c0_g1_i10	Q9D826	SOX_MOUSE	31.2	269	168	8	103	864	93	359	3.30E-28	127.1	SOX_MOUSE	reviewed	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	Pipox Pso	Mus musculus (Mouse)	390	peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]	peroxisome [GO:0005777]	L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]	GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114	L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN8434_c0_g1_i2	Q9D826	SOX_MOUSE	31.7	325	203	10	43	969	38	359	1.70E-36	154.8	SOX_MOUSE	reviewed	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	Pipox Pso	Mus musculus (Mouse)	390	peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]	peroxisome [GO:0005777]	L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]	GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114	L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN8434_c0_g1_i5	Q9D826	SOX_MOUSE	33.3	348	214	9	43	1041	38	382	7.30E-44	179.5	SOX_MOUSE	reviewed	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	Pipox Pso	Mus musculus (Mouse)	390	peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]	peroxisome [GO:0005777]	L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]	GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114	L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; oxidation-reduction process [GO:0055114]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN3547_c0_g1_i1	Q8BWN8	ACOT4_MOUSE	57.3	75	30	1	33	257	104	176	3.10E-18	92.4	ACOT4_MOUSE	reviewed	Peroxisomal succinyl-coenzyme A thioesterase (EC 3.1.2.3) (Acyl-coenzyme A thioesterase 4) (Acyl-CoA thioesterase 4) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib) (PTE-Ib)	Acot4 Pte1b Pte2b	Mus musculus (Mouse)	421	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; succinyl-CoA hydrolase activity [GO:0004778]	GO:0000038; GO:0001676; GO:0004778; GO:0005777; GO:0006104; GO:0006631; GO:0006637; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0044466; GO:0046459; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN33430_c0_g1_i2	Q8BWN8	ACOT4_MOUSE	47.4	230	108	4	110	793	3	221	8.00E-56	218.8	ACOT4_MOUSE	reviewed	Peroxisomal succinyl-coenzyme A thioesterase (EC 3.1.2.3) (Acyl-coenzyme A thioesterase 4) (Acyl-CoA thioesterase 4) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib) (PTE-Ib)	Acot4 Pte1b Pte2b	Mus musculus (Mouse)	421	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; succinyl-CoA hydrolase activity [GO:0004778]	GO:0000038; GO:0001676; GO:0004778; GO:0005777; GO:0006104; GO:0006631; GO:0006637; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0044466; GO:0046459; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN33430_c0_g1_i3	Q8BWN8	ACOT4_MOUSE	49.2	179	81	2	58	594	53	221	2.20E-45	183.7	ACOT4_MOUSE	reviewed	Peroxisomal succinyl-coenzyme A thioesterase (EC 3.1.2.3) (Acyl-coenzyme A thioesterase 4) (Acyl-CoA thioesterase 4) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib) (PTE-Ib)	Acot4 Pte1b Pte2b	Mus musculus (Mouse)	421	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	peroxisome [GO:0005777]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; succinyl-CoA hydrolase activity [GO:0004778]	GO:0000038; GO:0001676; GO:0004778; GO:0005777; GO:0006104; GO:0006631; GO:0006637; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0044466; GO:0046459; GO:0047617; GO:0052689	acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN15428_c0_g1_i1	O00628	PEX7_HUMAN	54.5	292	130	2	101	976	7	295	4.90E-94	345.9	PEX7_HUMAN	reviewed	Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)	PEX7 PTS2R	Homo sapiens (Human)	323	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]; endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]	GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803	endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN15428_c0_g1_i2	O00628	PEX7_HUMAN	54.7	265	117	2	101	895	7	268	4.10E-85	316.2	PEX7_HUMAN	reviewed	Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)	PEX7 PTS2R	Homo sapiens (Human)	323	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]; endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]	GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803	endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN15428_c0_g1_i3	O00628	PEX7_HUMAN	50.4	133	66	0	101	499	7	139	2.70E-36	153.3	PEX7_HUMAN	reviewed	Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)	PEX7 PTS2R	Homo sapiens (Human)	323	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]; endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]	GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803	endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN34186_c0_g1_i1	Q54WA3	PEX7_DICDI	48.6	72	37	0	3	218	185	256	9.30E-17	87	PEX7_DICDI	reviewed	Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)	pex7 DDB_G0279801	Dictyostelium discoideum (Slime mold)	316	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; peroxisome matrix targeting signal-2 binding [GO:0005053]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	peroxisome matrix targeting signal-2 binding [GO:0005053]	GO:0005053; GO:0005777; GO:0005782; GO:0005829; GO:0007031; GO:0016558	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]		NA	NA	NA	NA	NA	NA
TRINITY_DN10768_c0_g1_i1	Q99MZ7	PECR_MOUSE	52.9	278	122	5	888	76	6	281	4.40E-76	286.2	PECR_MOUSE	reviewed	Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38)	Pecr	Mus musculus (Mouse)	303	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]	GO:0005102; GO:0005739; GO:0005777; GO:0005778; GO:0019166; GO:0030497; GO:0033306; GO:0043231; GO:0055114	fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306]		blue	blue	NA	NA	NA	NA
TRINITY_DN10768_c0_g1_i2	Q99MZ7	PECR_MOUSE	52.7	279	123	5	891	76	5	281	3.50E-76	286.6	PECR_MOUSE	reviewed	Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38)	Pecr	Mus musculus (Mouse)	303	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]	GO:0005102; GO:0005739; GO:0005777; GO:0005778; GO:0019166; GO:0030497; GO:0033306; GO:0043231; GO:0055114	fatty acid elongation [GO:0030497]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306]		NA	NA	NA	NA	NA	NA
TRINITY_DN3507_c0_g1_i1	Q13608	PEX6_HUMAN	42.9	707	339	13	2204	126	315	970	1.20E-132	475.7	PEX6_HUMAN	reviewed	Peroxisome assembly factor 2 (PAF-2) (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)	PEX6 PXAAA1	Homo sapiens (Human)	980	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0044877; GO:0050821; GO:0097733	"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3507_c0_g1_i2	Q99LC9	PEX6_MOUSE	63.9	288	103	1	989	126	685	971	3.90E-100	366.3	PEX6_MOUSE	reviewed	Peroxisome assembly factor 2 (PAF-2) (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)	Pex6	Mus musculus (Mouse)	981	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0044877; GO:0050821; GO:0097733	"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29413_c0_g1_i1	Q13608	PEX6_HUMAN	100	89	0	0	4	270	746	834	8.40E-44	177.2	PEX6_HUMAN	reviewed	Peroxisome assembly factor 2 (PAF-2) (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)	PEX6 PXAAA1	Homo sapiens (Human)	980	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0044877; GO:0050821; GO:0097733	"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7364_c0_g1_i2	Q9ET67	PEX12_CRILO	37.5	168	93	5	60	530	152	318	5.70E-20	99	PEX12_CRILO	reviewed	Peroxisome assembly protein 12 (Peroxin-12)	PEX12	Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)	359	integral component of peroxisomal membrane [GO:0005779]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]	integral component of peroxisomal membrane [GO:0005779]	protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]	GO:0005779; GO:0007031; GO:0008022; GO:0008270; GO:0016558	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]		NA	NA	NA	NA	NA	NA
TRINITY_DN9342_c0_g1_i1	Q5BL07	PEX1_MOUSE	67	212	66	1	2	637	863	1070	3.10E-76	286.2	PEX1_MOUSE	reviewed	Peroxisome biogenesis factor 1 (Peroxin-1)	Pex1	Mus musculus (Mouse)	1284	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0008289; GO:0016558; GO:0016887; GO:0044877; GO:0060152	microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]		NA	NA	NA	NA	NA	NA
TRINITY_DN9342_c0_g1_i2	Q54GX5	PEX1_DICDI	77.5	138	31	0	2	415	888	1025	7.60E-59	228	PEX1_DICDI	reviewed	Peroxisome biogenesis factor 1 (Peroxin-1)	pex1 DDB_G0289867	Dictyostelium discoideum (Slime mold)	1227	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0007031; GO:0016558; GO:0016887	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]		NA	NA	NA	NA	NA	NA
TRINITY_DN7382_c0_g1_i1	Q06438	PEX2_CRIGR	33.6	280	167	5	906	100	15	286	2.60E-37	157.5	PEX2_CRIGR	reviewed	Peroxisome biogenesis factor 2 (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1) (PAF-1)	PEX2 PAF1 PMP35 PXMP3	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	304	Cdc73/Paf1 complex [GO:0016593]; integral component of peroxisomal membrane [GO:0005779]; metal ion binding [GO:0046872]; fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome organization [GO:0007031]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; very long-chain fatty acid metabolic process [GO:0000038]	Cdc73/Paf1 complex [GO:0016593]; integral component of peroxisomal membrane [GO:0005779]	metal ion binding [GO:0046872]	GO:0000038; GO:0000122; GO:0005779; GO:0006635; GO:0007031; GO:0016558; GO:0016593; GO:0031648; GO:0046872; GO:0048147; GO:0050680	fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome organization [GO:0007031]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; very long-chain fatty acid metabolic process [GO:0000038]		NA	NA	NA	NA	NA	NA
TRINITY_DN9342_c0_g1_i3	Q9FNP1	PEX1_ARATH	45.1	71	39	0	33	245	997	1067	4.30E-09	62	PEX1_ARATH	reviewed	Peroxisome biogenesis protein 1 (Peroxin-1) (AtPEX1)	PEX1 At5g08470 F8L15.15	Arabidopsis thaliana (Mouse-ear cress)	1130	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; fatty acid beta-oxidation [GO:0006635]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005778; GO:0005829; GO:0006635; GO:0007031; GO:0016558; GO:0016887	fatty acid beta-oxidation [GO:0006635]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]		NA	NA	NA	NA	NA	NA
TRINITY_DN1663_c0_g1_i1	Q5VV67	PPRC1_HUMAN	45	129	64	2	476	96	1537	1660	3.10E-23	110.2	PPRC1_HUMAN	reviewed	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC)	PPRC1 KIAA0595	Homo sapiens (Human)	1664	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0007005; GO:0008134; GO:0030374; GO:0045944; GO:0051091	mitochondrion organization [GO:0007005]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN1663_c0_g1_i3	Q5VV67	PPRC1_HUMAN	44.6	92	44	2	365	96	1574	1660	1.00E-11	71.2	PPRC1_HUMAN	reviewed	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC)	PPRC1 KIAA0595	Homo sapiens (Human)	1664	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0007005; GO:0008134; GO:0030374; GO:0045944; GO:0051091	mitochondrion organization [GO:0007005]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN4299_c0_g1_i1	Q8WY91	THAP4_HUMAN	46.8	47	21	1	141	13	5	51	1.50E-05	50.4	THAP4_HUMAN	reviewed	Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (THAP domain-containing protein 4)	THAP4 CGI-36 PP238	Homo sapiens (Human)	577	DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]	GO:0003677; GO:0006570; GO:0020037; GO:0042126; GO:0042802; GO:0046872; GO:0062213; GO:0070026	nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN4567_c0_g1_i10	Q2TBI2	THAP4_BOVIN	41.1	73	35	3	398	186	26	92	1.40E-06	54.3	THAP4_BOVIN	reviewed	Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (THAP domain-containing protein 4)	THAP4	Bos taurus (Bovine)	584	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]	GO:0003677; GO:0006570; GO:0042126; GO:0046872; GO:0062213; GO:0070026	nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN4567_c0_g1_i3	Q2TBI2	THAP4_BOVIN	38.8	98	51	4	473	186	2	92	4.70E-11	69.7	THAP4_BOVIN	reviewed	Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (THAP domain-containing protein 4)	THAP4	Bos taurus (Bovine)	584	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]	GO:0003677; GO:0006570; GO:0042126; GO:0046872; GO:0062213; GO:0070026	nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN4567_c0_g1_i8	Q2TBI2	THAP4_BOVIN	38.8	98	51	4	473	186	2	92	4.80E-11	69.7	THAP4_BOVIN	reviewed	Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (THAP domain-containing protein 4)	THAP4	Bos taurus (Bovine)	584	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]	GO:0003677; GO:0006570; GO:0042126; GO:0046872; GO:0062213; GO:0070026	nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570]		NA	NA	NA	NA	NA	NA
TRINITY_DN36080_c0_g1_i1	Q9DCM0	ETHE1_MOUSE	100	92	0	0	1	276	127	218	1.60E-50	199.5	ETHE1_MOUSE	reviewed	"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	Ethe1 Hsco	Mus musculus (Mouse)	254	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813	glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]		NA	NA	NA	NA	NA	NA
TRINITY_DN8423_c0_g1_i1	Q9DCM0	ETHE1_MOUSE	58	245	98	2	158	883	11	253	6.30E-81	302.4	ETHE1_MOUSE	reviewed	"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	Ethe1 Hsco	Mus musculus (Mouse)	254	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813	glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]		NA	NA	NA	NA	NA	NA
TRINITY_DN31443_c0_g1_i1	Q9DCM0	ETHE1_MOUSE	100	117	0	0	1	351	5	121	9.80E-61	233.8	ETHE1_MOUSE	reviewed	"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	Ethe1 Hsco	Mus musculus (Mouse)	254	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813	glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]		NA	NA	NA	NA	NA	NA
TRINITY_DN30255_c0_g1_i1	O95571	ETHE1_HUMAN	100	105	0	0	3	317	25	129	7.20E-55	214.2	ETHE1_HUMAN	reviewed	"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	ETHE1 HSCO	Homo sapiens (Human)	254	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070221; GO:0070813	"glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34292_c0_g1_i1	O95571	ETHE1_HUMAN	100	123	0	0	1	369	127	249	3.80E-71	268.5	ETHE1_HUMAN	reviewed	"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	ETHE1 HSCO	Homo sapiens (Human)	254	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070221; GO:0070813	"glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5399_c0_g1_i1	Q8WW12	PCNP_HUMAN	45.5	99	47	2	226	522	76	167	4.10E-12	73.2	PCNP_HUMAN	reviewed	PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein)	PCNP	Homo sapiens (Human)	178	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0007049; GO:0016567; GO:0016604; GO:0043161	cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5399_c0_g1_i2	Q8WW12	PCNP_HUMAN	45.5	99	47	2	213	509	76	167	4.00E-12	73.2	PCNP_HUMAN	reviewed	PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein)	PCNP	Homo sapiens (Human)	178	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0007049; GO:0016567; GO:0016604; GO:0043161	cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		blue	blue	NA	NA	NA	NA
TRINITY_DN5399_c0_g1_i3	Q8WW12	PCNP_HUMAN	45.5	99	47	2	232	528	76	167	4.10E-12	73.2	PCNP_HUMAN	reviewed	PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein)	PCNP	Homo sapiens (Human)	178	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0007049; GO:0016567; GO:0016604; GO:0043161	cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN12029_c0_g1_i7	Q5DTT2	PSD1_MOUSE	46.6	73	38	1	284	66	779	850	3.10E-12	72.4	PSD1_MOUSE	reviewed	PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)	Psd Efa6a Kiaa2011 Psd1	Mus musculus (Mouse)	1024	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]"	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]"	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]	GO:0005086; GO:0005543; GO:0014069; GO:0016021; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092	neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN12029_c0_g1_i9	Q5DTT2	PSD1_MOUSE	55.9	195	75	2	586	35	518	712	5.60E-55	216.1	PSD1_MOUSE	reviewed	PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)	Psd Efa6a Kiaa2011 Psd1	Mus musculus (Mouse)	1024	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]"	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]"	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]	GO:0005086; GO:0005543; GO:0014069; GO:0016021; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092	neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN12029_c0_g1_i6	Q9NYI0	PSD3_HUMAN	49.5	410	196	4	1531	332	581	989	1.60E-107	391.7	PSD3_HUMAN	reviewed	PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3)	PSD3 EFA6D EFA6R HCA67 KIAA0942	Homo sapiens (Human)	1048	postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; regulation of ARF protein signal transduction [GO:0032012]	postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0014069; GO:0032012; GO:0032587	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN12029_c0_g1_i3	Q2PFD7	PSD3_MOUSE	46	289	133	6	865	29	519	794	1.80E-60	234.6	PSD3_MOUSE	reviewed	PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3)	Psd3 Efa6d Kiaa0942	Mus musculus (Mouse)	1037	membrane [GO:0016020]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012]	membrane [GO:0016020]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]	GO:0005086; GO:0014069; GO:0016020; GO:0032011; GO:0032012; GO:0032587	ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN32584_c0_g1_i1	Q8NDX1	PSD4_HUMAN	100	123	0	0	372	4	617	739	1.30E-66	253.4	PSD4_HUMAN	reviewed	PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein)	PSD4 EFA6B TIC	Homo sapiens (Human)	1056	membrane [GO:0016020]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]; regulation of ARF protein signal transduction [GO:0032012]	membrane [GO:0016020]; ruffle membrane [GO:0032587]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]	GO:0005086; GO:0005543; GO:0016020; GO:0032012; GO:0032587	regulation of ARF protein signal transduction [GO:0032012]		NA	NA	NA	NA	NA	NA
TRINITY_DN8002_c0_g2_i1	Q17DK2	NAA25_AEDAE	40	275	153	5	51	857	52	320	1.70E-51	204.5	NAA25_AEDAE	reviewed	Phagocyte signaling-impaired protein (N-terminal acetyltransferase B complex subunit MDM20 homolog) (N-terminal acetyltransferase B complex subunit NAA25 homolog)	psidin AAEL004142	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	940	"lysosome [GO:0005764]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]"	lysosome [GO:0005764]		GO:0005764; GO:0006911; GO:0006955; GO:0045087	"immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9958_c0_g1_i1	Q9P1Y6	PHRF1_HUMAN	49.8	213	98	4	654	19	94	298	7.00E-51	202.2	PHRF1_HUMAN	reviewed	PHD and RING finger domain-containing protein 1	PHRF1 KIAA1542	Homo sapiens (Human)	1649	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]	GO:0006366; GO:0006397; GO:0016020; GO:0019904; GO:0046872; GO:0070063	mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]		blue	blue	NA	NA	NA	NA
TRINITY_DN26603_c0_g1_i1	Q9P1Y6	PHRF1_HUMAN	58.3	84	32	2	270	22	165	246	2.40E-22	105.9	PHRF1_HUMAN	reviewed	PHD and RING finger domain-containing protein 1	PHRF1 KIAA1542	Homo sapiens (Human)	1649	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]	GO:0006366; GO:0006397; GO:0016020; GO:0019904; GO:0046872; GO:0070063	mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN4901_c0_g2_i1	Q8WUB8	PHF10_HUMAN	38.5	288	128	5	1277	561	191	478	5.30E-54	213.4	PHF10_HUMAN	reviewed	PHD finger protein 10 (BRG1-associated factor 45a) (BAF45a) (XAP135)	PHF10 BAF45A	Homo sapiens (Human)	498	"npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005654; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071564	"negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4901_c0_g2_i2	Q8WUB8	PHF10_HUMAN	37.1	356	170	6	1466	561	123	478	3.60E-64	247.3	PHF10_HUMAN	reviewed	PHD finger protein 10 (BRG1-associated factor 45a) (BAF45a) (XAP135)	PHF10 BAF45A	Homo sapiens (Human)	498	"npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005654; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071564	"negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13690_c0_g1_i1	Q96QT6	PHF12_HUMAN	36.7	395	189	8	1047	1	12	391	1.10E-63	245.4	PHF12_HUMAN	reviewed	PHD finger protein 12 (PHD factor 1) (Pf1)	PHF12 KIAA1523	Homo sapiens (Human)	1004	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]	GO:0000122; GO:0001222; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006355; GO:0016580; GO:0017053; GO:0035091; GO:0045892; GO:0046872; GO:0070822	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN61_c0_g1_i1	O94880	PHF14_HUMAN	63	73	25	2	436	651	319	390	1.80E-21	104.4	PHF14_HUMAN	reviewed	PHD finger protein 14	PHF14 KIAA0783	Homo sapiens (Human)	888	MOZ/MORF histone acetyltransferase complex [GO:0070776]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	MOZ/MORF histone acetyltransferase complex [GO:0070776]	histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000122; GO:0006357; GO:0042393; GO:0043972; GO:0044154; GO:0046872; GO:0048286; GO:0070776; GO:2000584; GO:2000791	histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN61_c0_g1_i2	O94880	PHF14_HUMAN	65.1	186	61	4	436	990	319	501	1.90E-69	264.2	PHF14_HUMAN	reviewed	PHD finger protein 14	PHF14 KIAA0783	Homo sapiens (Human)	888	MOZ/MORF histone acetyltransferase complex [GO:0070776]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	MOZ/MORF histone acetyltransferase complex [GO:0070776]	histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000122; GO:0006357; GO:0042393; GO:0043972; GO:0044154; GO:0046872; GO:0048286; GO:0070776; GO:2000584; GO:2000791	histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN61_c0_g1_i3	O94880	PHF14_HUMAN	66.3	83	27	1	46	294	420	501	2.70E-27	122.5	PHF14_HUMAN	reviewed	PHD finger protein 14	PHF14 KIAA0783	Homo sapiens (Human)	888	MOZ/MORF histone acetyltransferase complex [GO:0070776]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	MOZ/MORF histone acetyltransferase complex [GO:0070776]	histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000122; GO:0006357; GO:0042393; GO:0043972; GO:0044154; GO:0046872; GO:0048286; GO:0070776; GO:2000584; GO:2000791	histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16675_c0_g2_i1	O94880	PHF14_HUMAN	54.8	73	29	1	1	207	740	812	6.50E-15	82	PHF14_HUMAN	reviewed	PHD finger protein 14	PHF14 KIAA0783	Homo sapiens (Human)	888	MOZ/MORF histone acetyltransferase complex [GO:0070776]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	MOZ/MORF histone acetyltransferase complex [GO:0070776]	histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0000122; GO:0006357; GO:0042393; GO:0043972; GO:0044154; GO:0046872; GO:0048286; GO:0070776; GO:2000584; GO:2000791	histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29837_c0_g1_i1	Q9CXG9	PHF19_MOUSE	55.2	67	29	1	549	749	508	573	8.20E-12	72.4	PHF19_MOUSE	reviewed	PHD finger protein 19 (Polycomb-like protein 3)	Phf19 Pcl3	Mus musculus (Mouse)	578	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0006325; GO:0006355; GO:0019827; GO:0035064; GO:0046872; GO:0048863; GO:0061087	"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29837_c0_g1_i2	Q9CXG9	PHF19_MOUSE	55.2	67	29	1	320	520	508	573	5.70E-12	72.4	PHF19_MOUSE	reviewed	PHD finger protein 19 (Polycomb-like protein 3)	Phf19 Pcl3	Mus musculus (Mouse)	578	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0006325; GO:0006355; GO:0019827; GO:0035064; GO:0046872; GO:0048863; GO:0061087	"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27171_c0_g1_i1	Q8CCJ9	P20L1_MOUSE	45.5	77	41	1	177	407	680	755	1.20E-15	84.3	P20L1_MOUSE	reviewed	PHD finger protein 20-like protein 1	Phf20l1	Mus musculus (Mouse)	1013	NSL complex [GO:0044545]; metal ion binding [GO:0046872]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]	NSL complex [GO:0044545]	metal ion binding [GO:0046872]	GO:0006357; GO:0016573; GO:0044545; GO:0046872	histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15307_c0_g1_i1	A2VE56	P20L1_BOVIN	49.2	59	29	1	210	34	8	65	2.40E-10	66.2	P20L1_BOVIN	reviewed	PHD finger protein 20-like protein 1	PHF20L1	Bos taurus (Bovine)	316	NSL complex [GO:0044545]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]	NSL complex [GO:0044545]		GO:0006357; GO:0016573; GO:0044545	histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15307_c0_g1_i2	Q4V9H5	P20L1_RAT	40.3	124	66	3	400	47	8	129	2.30E-18	93.6	P20L1_RAT	reviewed	PHD finger protein 20-like protein 1	Phf20l1	Rattus norvegicus (Rat)	1015	NSL complex [GO:0044545]; metal ion binding [GO:0046872]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]	NSL complex [GO:0044545]	metal ion binding [GO:0046872]	GO:0006357; GO:0016573; GO:0044545; GO:0046872	histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN21702_c0_g1_i1	Q7YZH1	RNO_DROME	83.8	74	12	0	1	222	350	423	1.30E-34	146.4	RNO_DROME	reviewed	PHD finger protein rhinoceros	rno CG7036	Drosophila melanogaster (Fruit fly)	3241	nucleus [GO:0005634]; metal ion binding [GO:0046872]; compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0042051; GO:0042059; GO:0046872	compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]		NA	NA	NA	NA	NA	NA
TRINITY_DN21702_c0_g3_i1	Q7YZH1	RNO_DROME	43.6	195	78	4	1	489	445	639	2.60E-33	143.3	RNO_DROME	reviewed	PHD finger protein rhinoceros	rno CG7036	Drosophila melanogaster (Fruit fly)	3241	nucleus [GO:0005634]; metal ion binding [GO:0046872]; compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0042051; GO:0042059; GO:0046872	compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]		NA	NA	NA	NA	NA	NA
TRINITY_DN21702_c0_g3_i2	Q7YZH1	RNO_DROME	44.7	266	104	5	1	669	445	710	4.40E-49	196.4	RNO_DROME	reviewed	PHD finger protein rhinoceros	rno CG7036	Drosophila melanogaster (Fruit fly)	3241	nucleus [GO:0005634]; metal ion binding [GO:0046872]; compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0042051; GO:0042059; GO:0046872	compound eye photoreceptor development [GO:0042051]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]		NA	NA	NA	NA	NA	NA
TRINITY_DN39539_c0_g1_i1	P0DI19	PHF5A_ARATH	92.7	110	8	0	413	84	1	110	2.80E-60	232.6	PHF5A_ARATH	reviewed	PHD finger-like domain-containing protein 5A	At2g30000 F23F1.8	Arabidopsis thaliana (Mouse-ear cress)	110	"precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; mRNA splicing, via spliceosome [GO:0000398]"	precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]		GO:0000398; GO:0005686; GO:0005689; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]"		red	red	NA	NA	NA	NA
TRINITY_DN7396_c0_g1_i1	Q7RTV0	PHF5A_HUMAN	97.3	110	3	0	421	92	1	110	1.10E-63	244.2	PHF5A_HUMAN	reviewed	PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b)	PHF5A	Homo sapiens (Human)	110	"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]"	nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]"		blue	blue	NA	NA	NA	NA
TRINITY_DN17842_c0_g1_i1	Q7RTV0	PHF5A_HUMAN	100	110	0	0	36	365	1	110	2.10E-65	249.6	PHF5A_HUMAN	reviewed	PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b)	PHF5A	Homo sapiens (Human)	110	"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]"	nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17842_c0_g1_i2	Q7RTV0	PHF5A_HUMAN	100	110	0	0	36	365	1	110	3.50E-65	248.8	PHF5A_HUMAN	reviewed	PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b)	PHF5A	Homo sapiens (Human)	110	"nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]"	nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26095_c0_g1_i1	Q9DCG6	PBLD1_MOUSE	49.3	71	35	1	56	268	23	92	6.70E-12	71.6	PBLD1_MOUSE	reviewed	Phenazine biosynthesis-like domain-containing protein 1 (EC 5.1.-.-)	Pbld1 Mawbp2 Pbld	Mus musculus (Mouse)	288	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; isomerase activity [GO:0016853]	GO:0005737; GO:0009058; GO:0010633; GO:0010719; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0050680; GO:0060392; GO:0060394	biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]		NA	NA	NA	NA	NA	NA
TRINITY_DN38109_c0_g1_i1	Q9W1V6	PPO3_DROME	53.3	75	35	0	239	15	371	445	2.40E-18	92.4	PPO3_DROME	reviewed	Phenoloxidase 3 (EC 1.14.18.1) (Diphenol oxidase A3) (Diphenoloxidase subunit A3) (Prophenoloxidase 59) (Tyrosinase A3)	PPO3 Dox-3 Dox-A3 proPO59 CG42640	Drosophila melanogaster (Fruit fly)	683	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]; dopamine metabolic process [GO:0042417]; melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	dopamine monooxygenase activity [GO:0036264]; L-DOPA monooxygenase activity [GO:0036263]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]	GO:0004503; GO:0005576; GO:0005737; GO:0035011; GO:0036263; GO:0036264; GO:0042417; GO:0042438; GO:0046872	dopamine metabolic process [GO:0042417]; melanin biosynthetic process [GO:0042438]; melanotic encapsulation of foreign target [GO:0035011]		blue	blue	NA	NA	NA	NA
TRINITY_DN12645_c0_g1_i2	O97366	PPAF1_HOLDI	39.6	202	115	5	676	77	104	300	8.90E-29	128.6	PPAF1_HOLDI	reviewed	Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]	PPAF1 PPAF-I	Holotrichia diomphalia (Korean black chafer)	365	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0008233; GO:0045087	innate immune response [GO:0045087]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN12645_c0_g1_i3	O97366	PPAF1_HOLDI	38.6	355	190	15	1121	90	28	365	7.40E-53	209.5	PPAF1_HOLDI	reviewed	Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]	PPAF1 PPAF-I	Holotrichia diomphalia (Korean black chafer)	365	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0008233; GO:0045087	innate immune response [GO:0045087]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN12645_c0_g1_i4	O97366	PPAF1_HOLDI	38.6	140	69	8	512	114	28	157	6.60E-16	85.9	PPAF1_HOLDI	reviewed	Phenoloxidase-activating factor 1 (EC 3.4.21.-) (Prophenoloxidase-activating factor I) (Serine protease PPAF-1) [Cleaved into: Phenoloxidase-activating factor 1 light chain; Phenoloxidase-activating factor 1 heavy chain]	PPAF1 PPAF-I	Holotrichia diomphalia (Korean black chafer)	365	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0008233; GO:0045087	innate immune response [GO:0045087]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN12474_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	41	290	167	3	12	872	123	411	2.70E-63	243.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN414_c7_g1_i1	Q9GRW0	PPAF2_HOLDI	45.5	101	54	1	1	303	255	354	4.30E-20	98.6	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN414_c10_g1_i1	Q9GRW0	PPAF2_HOLDI	58.5	41	16	1	1	120	352	392	4.70E-06	51.6	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN414_c0_g3_i1	Q9GRW0	PPAF2_HOLDI	34.6	156	83	6	442	2	72	217	5.50E-15	82.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN25436_c1_g1_i1	Q9GRW0	PPAF2_HOLDI	58	69	28	1	9	212	322	390	3.10E-17	88.6	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN24166_c0_g5_i1	Q9GRW0	PPAF2_HOLDI	44.9	138	72	3	13	420	126	261	3.50E-28	125.9	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN26464_c20_g1_i1	Q9GRW0	PPAF2_HOLDI	45.8	343	164	8	1137	160	65	402	2.40E-83	310.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN16541_c1_g1_i1	Q9GRW0	PPAF2_HOLDI	42.4	347	172	10	79	1059	54	392	1.60E-70	268.1	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c8_g1_i1	Q9GRW0	PPAF2_HOLDI	44.6	166	89	2	1	492	193	357	5.60E-36	152.1	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	54.2	48	21	1	3	143	355	402	1.90E-07	56.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i10	Q9GRW0	PPAF2_HOLDI	36.4	88	49	3	9	254	104	190	5.40E-08	58.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i15	Q9GRW0	PPAF2_HOLDI	44.3	318	163	7	6	932	90	402	1.10E-70	268.5	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i16	Q9GRW0	PPAF2_HOLDI	43.3	277	144	6	6	812	90	361	9.60E-59	228.4	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i2	Q9GRW0	PPAF2_HOLDI	45.5	268	141	4	11	805	137	402	4.90E-64	246.1	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i3	Q9GRW0	PPAF2_HOLDI	40.3	139	76	4	11	415	137	272	7.60E-23	108.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i5	Q9GRW0	PPAF2_HOLDI	39.6	139	72	5	6	398	90	224	4.30E-20	99	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i7	Q9GRW0	PPAF2_HOLDI	36.4	154	94	3	11	466	137	288	1.10E-22	107.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c0_g1_i8	Q9GRW0	PPAF2_HOLDI	54.2	48	21	1	3	143	355	402	1.90E-07	56.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c9_g1_i1	Q9GRW0	PPAF2_HOLDI	46.5	198	103	2	601	14	161	357	8.20E-47	188.3	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c2_g1_i1	Q9GRW0	PPAF2_HOLDI	42.2	344	175	8	137	1114	65	402	4.20E-74	280	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN16541_c14_g1_i1	Q9GRW0	PPAF2_HOLDI	35.5	121	66	4	3	344	88	203	1.40E-11	70.5	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN24901_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	54.7	75	34	0	229	5	285	359	4.60E-20	98.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN20584_c1_g1_i1	Q9GRW0	PPAF2_HOLDI	48.8	84	42	1	3	254	268	350	5.40E-16	84.7	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN1940_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	49.3	134	65	3	17	412	267	399	1.90E-33	143.7	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN544_c2_g1_i1	Q9GRW0	PPAF2_HOLDI	48.3	269	131	5	23	814	137	402	2.30E-69	263.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c1_g1_i1	Q9GRW0	PPAF2_HOLDI	51.5	130	59	2	381	4	251	380	7.30E-33	141.4	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c4_g1_i1	Q9GRW0	PPAF2_HOLDI	39.6	359	191	9	1076	51	65	414	3.20E-66	253.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	42.5	146	79	3	453	28	129	273	1.70E-28	127.1	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c0_g1_i2	Q9GRW0	PPAF2_HOLDI	42.5	146	79	3	453	28	129	273	8.30E-28	124.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c0_g1_i3	Q9GRW0	PPAF2_HOLDI	42.6	129	72	1	408	28	145	273	5.60E-24	112.5	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c9_g1_i1	Q9GRW0	PPAF2_HOLDI	54.1	74	34	0	23	244	284	357	6.10E-18	91.3	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c1_g2_i1	Q9GRW0	PPAF2_HOLDI	43.1	255	135	5	745	5	107	359	2.00E-55	217.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c7_g1_i1	Q9GRW0	PPAF2_HOLDI	46	187	97	3	3	554	201	386	2.80E-41	169.9	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c0_g4_i1	Q9GRW0	PPAF2_HOLDI	60.5	76	29	1	329	105	327	402	8.70E-19	94.4	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c0_g4_i2	Q9GRW0	PPAF2_HOLDI	60.5	76	29	1	329	105	327	402	8.70E-19	94.4	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c3_g1_i1	Q9GRW0	PPAF2_HOLDI	41.7	343	178	8	109	1086	65	402	2.20E-69	264.2	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN544_c8_g1_i1	Q9GRW0	PPAF2_HOLDI	40.5	358	187	8	71	1093	65	413	2.40E-68	260.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN24712_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	39.3	89	51	2	262	2	148	235	3.30E-13	75.5	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN40132_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	44.9	69	34	2	210	4	212	276	1.40E-07	56.6	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN21171_c1_g1_i1	Q9GRW0	PPAF2_HOLDI	30.8	130	64	5	56	391	65	186	3.70E-08	59.3	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN34225_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	60	70	27	1	225	19	333	402	1.80E-18	92.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN13700_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	56.8	118	46	3	5	346	284	400	2.20E-32	139.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN15843_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	40.2	306	171	4	404	1291	97	400	2.30E-63	244.6	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN23143_c1_g1_i1	Q9GRW0	PPAF2_HOLDI	44	91	50	1	273	1	256	345	1.60E-13	76.6	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN23143_c0_g1_i1	Q9GRW0	PPAF2_HOLDI	58.5	41	17	0	211	89	364	404	2.20E-07	55.8	PPAF2_HOLDI	reviewed	Phenoloxidase-activating factor 2 (45 KDa PPAF) (Hd-45) (Prophenoloxidase-activating factor II) (Serine protease-like PPAF-2) [Cleaved into: Phenoloxidase-activating factor 2 light chain; Phenoloxidase-activating factor 2 heavy chain]	PPAF2 PPAF-II	Holotrichia diomphalia (Korean black chafer)	415	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN3895_c0_g1_i1	Q8I6K0	PPAF3_HOLDI	46.1	102	46	4	19	300	83	183	4.40E-17	88.6	PPAF3_HOLDI	reviewed	Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]	PPAF3 PPAF-III	Holotrichia diomphalia (Korean black chafer)	351	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN1556_c0_g1_i1	Q8I6K0	PPAF3_HOLDI	42.6	169	83	7	67	564	89	246	1.10E-26	121.3	PPAF3_HOLDI	reviewed	Phenoloxidase-activating factor 3 (EC 3.4.21.-) (Prophenoloxidase-activating factor III) (Serine protease-like protein PPAF-3) [Cleaved into: Phenoloxidase-activating factor 3 light chain; Phenoloxidase-activating factor 3 heavy chain]	PPAF3 PPAF-III	Holotrichia diomphalia (Korean black chafer)	351	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; innate immune response [GO:0045087]	extracellular region [GO:0005576]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0045087; GO:0046872	innate immune response [GO:0045087]		blue	blue	NA	NA	NA	NA
TRINITY_DN36597_c0_g1_i1	O06837	STYD_PSEFL	62.7	83	31	0	250	2	225	307	1.50E-23	109.8	STYD_PSEFL	reviewed	Phenylacetaldehyde dehydrogenase (PAD) (EC 1.2.1.39)	styD	Pseudomonas fluorescens	502	phenylacetaldehyde dehydrogenase activity [GO:0008957]; styrene catabolic process [GO:0042207]		phenylacetaldehyde dehydrogenase activity [GO:0008957]	GO:0008957; GO:0042207	styrene catabolic process [GO:0042207]		NA	NA	NA	NA	NA	NA
TRINITY_DN11403_c0_g1_i1	Q54XS1	PH4H_DICDI	69.1	152	47	0	510	55	198	349	2.30E-58	226.5	PH4H_DICDI	reviewed	Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase)	pah DDB_G0278781	Dictyostelium discoideum (Slime mold)	441	identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; prephenate dehydratase activity [GO:0004664]; tetrahydrobiopterin binding [GO:0034617]; tryptophan 5-monooxygenase activity [GO:0004510]; asexual reproduction [GO:0019954]; L-phenylalanine biosynthetic process [GO:0009094]; L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571]		identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; prephenate dehydratase activity [GO:0004664]; tetrahydrobiopterin binding [GO:0034617]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004505; GO:0004510; GO:0004664; GO:0005506; GO:0006559; GO:0006571; GO:0009094; GO:0019954; GO:0034617; GO:0042802	asexual reproduction [GO:0019954]; L-phenylalanine biosynthetic process [GO:0009094]; L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571]		NA	NA	NA	NA	NA	NA
TRINITY_DN25703_c0_g1_i1	Q9Y285	SYFA_HUMAN	100	247	0	0	741	1	260	506	1.40E-144	513.5	SYFA_HUMAN	reviewed	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	FARSA FARS FARSL FARSLA	Homo sapiens (Human)	508	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006432; GO:0009328; GO:0016020; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN29137_c0_g1_i1	Q9Y285	SYFA_HUMAN	100	97	0	0	293	3	180	276	1.10E-52	206.8	SYFA_HUMAN	reviewed	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	FARSA FARS FARSL FARSLA	Homo sapiens (Human)	508	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006432; GO:0009328; GO:0016020; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN8330_c0_g1_i1	Q1JPX3	SYFA_DANRE	67.8	307	95	1	1	921	191	493	7.30E-127	454.9	SYFA_DANRE	reviewed	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	farsa farsla zgc:136506 zgc:158185	Danio rerio (Zebrafish) (Brachydanio rerio)	497	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN35867_c0_g1_i1	Q505J8	SYFA_RAT	98.5	198	2	1	3	593	265	462	1.30E-110	400.2	SYFA_RAT	reviewed	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	Farsa Farsla	Rattus norvegicus (Rat)	508	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN2179_c0_g1_i2	Q505J8	SYFA_RAT	58.9	492	194	4	56	1513	7	496	2.60E-169	596.7	SYFA_RAT	reviewed	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	Farsa Farsla	Rattus norvegicus (Rat)	508	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN2179_c0_g1_i3	Q505J8	SYFA_RAT	58.9	492	194	4	56	1513	7	496	2.60E-169	596.7	SYFA_RAT	reviewed	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	Farsa Farsla	Rattus norvegicus (Rat)	508	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]		NA	NA	NA	NA	NA	NA
TRINITY_DN14677_c0_g1_i1	Q9NSD9	SYFB_HUMAN	100	71	0	0	1	213	189	259	1.00E-36	153.3	SYFB_HUMAN	reviewed	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	FARSB FARSLB FRSB HSPC173	Homo sapiens (Human)	589	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006432; GO:0009328; GO:0016020; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN31536_c0_g1_i1	Q9NSD9	SYFB_HUMAN	100	101	0	0	303	1	2	102	1.60E-51	203	SYFB_HUMAN	reviewed	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	FARSB FARSLB FRSB HSPC173	Homo sapiens (Human)	589	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006432; GO:0009328; GO:0016020; GO:0051290	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN3081_c0_g1_i1	Q9VCA5	SYFB_DROME	48.7	595	280	5	1855	119	1	586	1.10E-166	588.2	SYFB_DROME	reviewed	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	beta-PheRS CG5706	Drosophila melanogaster (Fruit fly)	589	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0002161; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN3081_c0_g1_i2	Q9VCA5	SYFB_DROME	50.6	423	188	4	1276	56	1	418	6.10E-119	429.1	SYFB_DROME	reviewed	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	beta-PheRS CG5706	Drosophila melanogaster (Fruit fly)	589	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0002161; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN15304_c0_g2_i1	Q9VCA5	SYFB_DROME	72	93	26	0	282	4	106	198	5.00E-34	144.8	SYFB_DROME	reviewed	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	beta-PheRS CG5706	Drosophila melanogaster (Fruit fly)	589	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0002161; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN15304_c0_g1_i1	Q550D2	SYFB_DICDI	74.2	66	17	0	1	198	217	282	6.70E-22	104	SYFB_DICDI	reviewed	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	phesB pheS DDB_G0277303	Dictyostelium discoideum (Slime mold)	617	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN15541_c0_g1_i3	Q99M01	SYFM_MOUSE	55.9	290	127	1	93	962	162	450	1.50E-93	344.4	SYFM_MOUSE	reviewed	"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)"	Fars2 Fars1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN15541_c0_g1_i4	Q99M01	SYFM_MOUSE	51.1	454	188	4	131	1471	24	450	4.90E-128	459.5	SYFM_MOUSE	reviewed	"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)"	Fars2 Fars1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN15541_c0_g1_i5	Q99M01	SYFM_MOUSE	54.1	429	188	3	131	1396	24	450	4.10E-132	473	SYFM_MOUSE	reviewed	"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)"	Fars2 Fars1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN15541_c0_g1_i6	Q99M01	SYFM_MOUSE	51.3	277	127	2	131	940	24	299	4.30E-77	290	SYFM_MOUSE	reviewed	"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)"	Fars2 Fars1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN15541_c0_g1_i6	Q99M01	SYFM_MOUSE	58.9	95	38	1	951	1235	357	450	1.30E-25	119	SYFM_MOUSE	reviewed	"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)"	Fars2 Fars1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN3908_c0_g1_i1	Q9H2J4	PDCL3_HUMAN	60.2	128	47	2	473	99	113	239	1.20E-37	157.5	PDCL3_HUMAN	reviewed	Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1)	PDCL3 PhLP2A VIAF1	Homo sapiens (Human)	239	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]; protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]	protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0001525; GO:0001938; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0010628; GO:0030036; GO:0032991; GO:0034605; GO:0043184; GO:0044183; GO:0045766; GO:0048471; GO:0050730; GO:0050821; GO:0061077; GO:0097356; GO:1903645; GO:2000059	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]		blue	blue	NA	NA	NA	NA
TRINITY_DN27315_c0_g1_i1	Q9H2J4	PDCL3_HUMAN	100	74	0	0	223	2	124	197	4.00E-39	161.4	PDCL3_HUMAN	reviewed	Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1)	PDCL3 PhLP2A VIAF1	Homo sapiens (Human)	239	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]; protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]	protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0001525; GO:0001938; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0010628; GO:0030036; GO:0032991; GO:0034605; GO:0043184; GO:0044183; GO:0045766; GO:0048471; GO:0050730; GO:0050821; GO:0061077; GO:0097356; GO:1903645; GO:2000059	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]		NA	NA	NA	NA	NA	NA
TRINITY_DN32059_c0_g1_i1	Q8BVF2	PDCL3_MOUSE	98.5	66	1	0	201	4	127	192	3.80E-33	141.4	PDCL3_MOUSE	reviewed	Phosducin-like protein 3 (Viral IAP-associated factor 1) (VIAF-1)	Pdcl3 Viaf1	Mus musculus (Mouse)	240	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]; protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]	protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0001525; GO:0001938; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0006915; GO:0010628; GO:0030036; GO:0032991; GO:0034605; GO:0043184; GO:0044183; GO:0045766; GO:0048471; GO:0050730; GO:0050821; GO:0061077; GO:0097356; GO:1903645; GO:2000059	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]		NA	NA	NA	NA	NA	NA
TRINITY_DN24849_c0_g1_i1	Q5XHF3	PHR4B_XENLA	61.8	76	28	1	232	5	572	646	7.00E-15	80.9	PHR4B_XENLA	reviewed	Phosphatase and actin regulator 4-B	phactr4-b	Xenopus laevis (African clawed frog)	697	cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]; actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; lamellipodium [GO:0030027]	actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]	GO:0001755; GO:0001843; GO:0003779; GO:0005737; GO:0007266; GO:0008157; GO:0030027; GO:0030036; GO:0043085; GO:0048484; GO:0051726; GO:0061386; GO:0072542; GO:2001045	actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN36728_c0_g1_i1	P12234	MPCP_BOVIN	66.7	72	24	0	3	218	191	262	8.50E-23	107.1	MPCP_BOVIN	reviewed	"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)"	SLC25A3 PHC	Bos taurus (Bovine)	362	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]	GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0044877	phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN10383_c0_g1_i3	Q5R7W2	MPCP_PONAB	99.4	322	2	0	7	972	40	361	8.00E-185	647.5	MPCP_PONAB	reviewed	"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)"	SLC25A3 PHC	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	361	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; symporter activity [GO:0015293]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	symporter activity [GO:0015293]	GO:0005743; GO:0015293; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN10383_c0_g1_i4	Q8VEM8	MPCP_MOUSE	99.7	290	1	0	1	870	68	357	2.60E-166	585.9	MPCP_MOUSE	reviewed	"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)"	Slc25a3	Mus musculus (Mouse)	357	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]	GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877	phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN13368_c0_g1_i1	Q5R7W2	MPCP_PONAB	69.3	88	27	0	281	18	44	131	2.00E-30	132.9	MPCP_PONAB	reviewed	"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)"	SLC25A3 PHC	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	361	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; symporter activity [GO:0015293]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	symporter activity [GO:0015293]	GO:0005743; GO:0015293; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN9708_c6_g1_i1	Q5R7W2	MPCP_PONAB	69.3	361	100	1	81	1130	1	361	1.10E-143	511.1	MPCP_PONAB	reviewed	"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)"	SLC25A3 PHC	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	361	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; symporter activity [GO:0015293]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	symporter activity [GO:0015293]	GO:0005743; GO:0015293; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN25809_c0_g1_i1	Q2G607	PSTB_NOVAD	97.2	72	2	0	216	1	151	222	5.30E-33	141	PSTB_NOVAD	reviewed	Phosphate import ATP-binding protein PstB (EC 7.3.2.1) (ABC phosphate transporter) (Phosphate-transporting ATPase)	pstB Saro_2279	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	275	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; inorganic phosphate transmembrane transporter activity [GO:0005315]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; ATP binding [GO:0005524]; inorganic phosphate transmembrane transporter activity [GO:0005315]	GO:0005315; GO:0005524; GO:0005886; GO:0015415; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN25729_c0_g1_i1	O95674	CDS2_HUMAN	99	100	1	0	302	3	315	414	2.90E-53	208.8	CDS2_HUMAN	reviewed	Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)	CDS2	Homo sapiens (Human)	445	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005743; GO:0005783; GO:0005789; GO:0006655; GO:0016020; GO:0016021; GO:0016024; GO:0140042	CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN25277_c0_g1_i1	O95674	CDS2_HUMAN	99.4	181	1	0	3	545	120	300	1.90E-103	376.3	CDS2_HUMAN	reviewed	Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)	CDS2	Homo sapiens (Human)	445	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005743; GO:0005783; GO:0005789; GO:0006655; GO:0016020; GO:0016021; GO:0016024; GO:0140042	CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN25277_c0_g1_i2	O95674	CDS2_HUMAN	100	181	0	0	3	545	120	300	3.80E-104	378.6	CDS2_HUMAN	reviewed	Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)	CDS2	Homo sapiens (Human)	445	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005743; GO:0005783; GO:0005789; GO:0006655; GO:0016020; GO:0016021; GO:0016024; GO:0140042	CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN14202_c0_g2_i1	O49639	CDS2_ARATH	76.1	71	17	0	237	25	312	382	2.10E-25	115.9	CDS2_ARATH	reviewed	Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)	CDS2 At4g22340 T10I14.170	Arabidopsis thaliana (Mouse-ear cress)	423	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005789; GO:0016021; GO:0016024	CDP-diacylglycerol biosynthetic process [GO:0016024]		NA	NA	NA	NA	NA	NA
TRINITY_DN14202_c0_g1_i1	O49639	CDS2_ARATH	50	82	41	0	6	251	194	275	7.30E-21	100.9	CDS2_ARATH	reviewed	Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)	CDS2 At4g22340 T10I14.170	Arabidopsis thaliana (Mouse-ear cress)	423	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005789; GO:0016021; GO:0016024	CDP-diacylglycerol biosynthetic process [GO:0016024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5901_c0_g1_i1	Q6DJM2	TAM41_XENLA	53.8	173	77	2	2	514	17	188	5.60E-47	189.5	TAM41_XENLA	reviewed	"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)"	tamm41	Xenopus laevis (African clawed frog)	338	extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]	extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005743; GO:0016024; GO:0019898; GO:0031314; GO:0032049	cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5901_c0_g1_i1	Q6DJM2	TAM41_XENLA	43.7	103	58	0	520	828	233	335	3.10E-13	77.4	TAM41_XENLA	reviewed	"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)"	tamm41	Xenopus laevis (African clawed frog)	338	extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]	extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005743; GO:0016024; GO:0019898; GO:0031314; GO:0032049	cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]		NA	NA	NA	NA	NA	NA
TRINITY_DN5901_c0_g1_i2	Q3B7H2	TAM41_DANRE	50.2	321	156	3	2	958	17	335	1.80E-81	304.3	TAM41_DANRE	reviewed	"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)"	tamm41 zgc:123195	Danio rerio (Zebrafish) (Brachydanio rerio)	338	extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]	extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005743; GO:0016024; GO:0019898; GO:0031314; GO:0032049	cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]		NA	NA	NA	NA	NA	NA
TRINITY_DN26724_c0_g1_i1	P56079	CDS_DROME	63.8	425	144	3	134	1402	26	442	1.70E-156	553.9	CDS_DROME	reviewed	"Phosphatidate cytidylyltransferase, photoreceptor-specific (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase)"	Cds CdsA CG7962	Drosophila melanogaster (Fruit fly)	447	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	phosphatidate cytidylyltransferase activity [GO:0004605]	GO:0004605; GO:0005789; GO:0007291; GO:0007430; GO:0007601; GO:0007602; GO:0008610; GO:0010513; GO:0010868; GO:0010883; GO:0016021; GO:0016024; GO:0016056; GO:0043052	"CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]"		blue	blue	NA	NA	NA	NA
TRINITY_DN38185_c0_g1_i1	Q92539	LPIN2_HUMAN	97.6	82	2	0	249	4	671	752	7.00E-45	180.6	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i13	Q92539	LPIN2_HUMAN	33.3	1040	528	23	138	3209	1	890	2.60E-131	471.5	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i14	Q92539	LPIN2_HUMAN	31.3	973	506	22	22	2904	68	890	7.00E-107	390.2	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i15	Q92539	LPIN2_HUMAN	46.1	76	40	1	11	238	468	542	7.50E-16	85.9	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i15	Q92539	LPIN2_HUMAN	64	50	18	0	450	599	758	807	3.80E-12	73.6	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i3	Q92539	LPIN2_HUMAN	34.1	1041	504	27	142	3171	1	890	5.30E-132	473.8	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i5	Q92539	LPIN2_HUMAN	33.3	1040	528	23	142	3213	1	890	3.50E-131	471.1	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i6	Q92539	LPIN2_HUMAN	31.3	972	506	22	1	2880	69	890	2.00E-106	388.7	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i7	Q92539	LPIN2_HUMAN	34.1	1041	504	27	138	3167	1	890	5.30E-132	473.8	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i9	Q92539	LPIN2_HUMAN	24.4	352	110	8	50	673	468	807	5.10E-18	93.2	LPIN2_HUMAN	reviewed	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	Homo sapiens (Human)	896	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN32468_c0_g1_i1	Q9BQK8	LPIN3_HUMAN	36.1	83	48	2	2	241	733	813	6.60E-08	57.8	LPIN3_HUMAN	reviewed	Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like)	LPIN3 LIPN3L	Homo sapiens (Human)	851	endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN274_c0_g1_i2	Q9BQK8	LPIN3_HUMAN	57.8	102	43	0	351	656	703	804	2.10E-28	127.5	LPIN3_HUMAN	reviewed	Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like)	LPIN3 LIPN3L	Homo sapiens (Human)	851	endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005789; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944	cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]		NA	NA	NA	NA	NA	NA
TRINITY_DN5312_c0_g1_i1	Q7TSX5	SMS1_RAT	54.6	97	44	0	99	389	306	402	9.60E-28	124.8	SMS1_RAT	reviewed	Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23)	Sgms1 Mob Tmem23	Rattus norvegicus (Rat)	419	Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of gene expression [GO:0010628]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]	Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]	ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]	GO:0000138; GO:0002950; GO:0005887; GO:0006686; GO:0006915; GO:0006954; GO:0010628; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:0071222; GO:0071356; GO:2001237	apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of gene expression [GO:0010628]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]		NA	NA	NA	NA	NA	NA
TRINITY_DN5312_c0_g1_i2	Q7TSX5	SMS1_RAT	48.1	285	142	3	338	1183	121	402	1.00E-70	268.9	SMS1_RAT	reviewed	Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23)	Sgms1 Mob Tmem23	Rattus norvegicus (Rat)	419	Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of gene expression [GO:0010628]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]	Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]	ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]	GO:0000138; GO:0002950; GO:0005887; GO:0006686; GO:0006915; GO:0006954; GO:0010628; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:0071222; GO:0071356; GO:2001237	apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of gene expression [GO:0010628]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]		blue	blue	NA	NA	NA	NA
TRINITY_DN13048_c1_g2_i2	Q96S96	PEBP4_HUMAN	37.8	127	68	5	408	49	77	199	1.90E-16	87	PEBP4_HUMAN	reviewed	Phosphatidylethanolamine-binding protein 4 (PEBP-4) (hPEBP4) (Protein cousin-of-RKIP 1)	PEBP4 CORK1 UNQ1933/PRO4408	Homo sapiens (Human)	227	extracellular exosome [GO:0070062]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]		GO:0005764; GO:0070062			blue	blue	NA	NA	NA	NA
TRINITY_DN13048_c1_g2_i3	Q96S96	PEBP4_HUMAN	37.8	127	68	5	408	49	77	199	1.40E-16	87.4	PEBP4_HUMAN	reviewed	Phosphatidylethanolamine-binding protein 4 (PEBP-4) (hPEBP4) (Protein cousin-of-RKIP 1)	PEBP4 CORK1 UNQ1933/PRO4408	Homo sapiens (Human)	227	extracellular exosome [GO:0070062]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]		GO:0005764; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN13048_c1_g2_i4	Q96S96	PEBP4_HUMAN	37.8	127	68	5	459	100	77	199	2.10E-16	87	PEBP4_HUMAN	reviewed	Phosphatidylethanolamine-binding protein 4 (PEBP-4) (hPEBP4) (Protein cousin-of-RKIP 1)	PEBP4 CORK1 UNQ1933/PRO4408	Homo sapiens (Human)	227	extracellular exosome [GO:0070062]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]		GO:0005764; GO:0070062			blue	blue	NA	NA	NA	NA
TRINITY_DN34282_c0_g1_i1	Q8WUK0	PTPM1_HUMAN	100	66	0	0	3	200	24	89	7.70E-34	143.7	PTPM1_HUMAN	reviewed	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48)	PTPMT1 MOSP PLIP PNAS-129	Homo sapiens (Human)	201	"mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]"	mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004439; GO:0004725; GO:0005634; GO:0005743; GO:0008138; GO:0008962; GO:0032049; GO:2001242	cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]		NA	NA	NA	NA	NA	NA
TRINITY_DN34565_c0_g1_i1	Q8WUK0	PTPM1_HUMAN	100	68	0	0	206	3	105	172	1.10E-32	139.8	PTPM1_HUMAN	reviewed	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48)	PTPMT1 MOSP PLIP PNAS-129	Homo sapiens (Human)	201	"mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]"	mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004439; GO:0004725; GO:0005634; GO:0005743; GO:0008138; GO:0008962; GO:0032049; GO:2001242	cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]		NA	NA	NA	NA	NA	NA
TRINITY_DN4636_c0_g1_i6	Q8WUK0	PTPM1_HUMAN	31	126	51	2	376	107	58	183	1.10E-07	57.8	PTPM1_HUMAN	reviewed	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48)	PTPMT1 MOSP PLIP PNAS-129	Homo sapiens (Human)	201	"mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]"	mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004439; GO:0004725; GO:0005634; GO:0005743; GO:0008138; GO:0008962; GO:0032049; GO:2001242	cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]		NA	NA	NA	NA	NA	NA
TRINITY_DN4636_c0_g1_i1	Q86BN8	PTPM1_DROME	63.8	58	21	0	280	107	135	192	5.70E-14	78.2	PTPM1_DROME	reviewed	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16) (EC 3.1.3.48)	PTPMT1 Plip CG10371	Drosophila melanogaster (Fruit fly)	200	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0006655; GO:0008138; GO:0008962; GO:0016311	dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN4636_c0_g1_i2	Q86BN8	PTPM1_DROME	57.1	105	45	0	330	16	8	112	6.90E-32	138.3	PTPM1_DROME	reviewed	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16) (EC 3.1.3.48)	PTPMT1 Plip CG10371	Drosophila melanogaster (Fruit fly)	200	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0006655; GO:0008138; GO:0008962; GO:0016311	dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN4636_c0_g1_i3	Q86BN8	PTPM1_DROME	44	100	53	1	424	125	8	104	1.40E-18	94.4	PTPM1_DROME	reviewed	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16) (EC 3.1.3.48)	PTPMT1 Plip CG10371	Drosophila melanogaster (Fruit fly)	200	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0006655; GO:0008138; GO:0008962; GO:0016311	dephosphorylation [GO:0016311]; phosphatidylglycerol biosynthetic process [GO:0006655]		NA	NA	NA	NA	NA	NA
TRINITY_DN1146_c0_g1_i1	A8E7C5	SAC2_DANRE	48.6	622	274	10	13	1815	35	631	8.80E-164	578.6	SAC2_DANRE	reviewed	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	inpp5f sac2 si:dkey-192p21.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1120	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]		NA	NA	NA	NA	NA	NA
TRINITY_DN1146_c0_g1_i3	A8E7C5	SAC2_DANRE	50.1	493	227	4	58	1518	275	754	1.10E-142	508.8	SAC2_DANRE	reviewed	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	inpp5f sac2 si:dkey-192p21.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1120	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]		NA	NA	NA	NA	NA	NA
TRINITY_DN1146_c0_g1_i4	A8E7C5	SAC2_DANRE	46.2	758	349	13	13	2223	35	754	1.20E-186	655.2	SAC2_DANRE	reviewed	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	inpp5f sac2 si:dkey-192p21.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1120	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]		NA	NA	NA	NA	NA	NA
TRINITY_DN1146_c0_g1_i5	A8E7C5	SAC2_DANRE	46.2	758	349	13	13	2223	35	754	1.30E-186	655.2	SAC2_DANRE	reviewed	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	inpp5f sac2 si:dkey-192p21.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1120	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]		NA	NA	NA	NA	NA	NA
TRINITY_DN1146_c0_g1_i6	A8E7C5	SAC2_DANRE	50.1	493	227	4	58	1518	275	754	1.10E-142	508.8	SAC2_DANRE	reviewed	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	inpp5f sac2 si:dkey-192p21.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1120	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]		NA	NA	NA	NA	NA	NA
TRINITY_DN30388_c0_g1_i1	A8E7C5	SAC2_DANRE	72.7	44	12	0	323	192	524	567	2.70E-12	72.8	SAC2_DANRE	reviewed	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	inpp5f sac2 si:dkey-192p21.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1120	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]		NA	NA	NA	NA	NA	NA
TRINITY_DN8748_c0_g1_i1	P60483	PTEN_CANLF	63.8	69	25	0	47	253	1	69	5.50E-21	101.3	PTEN_CANLF	reviewed	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1	Canis lupus familiaris (Dog) (Canis familiaris)	403	"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]; anaphase-promoting complex binding [GO:0010997]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse maturation [GO:0060074]"	apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]	"anaphase-promoting complex binding [GO:0010997]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]"	GO:0001525; GO:0002902; GO:0004438; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007270; GO:0007417; GO:0007507; GO:0007611; GO:0008138; GO:0008284; GO:0008285; GO:0009898; GO:0010719; GO:0010975; GO:0010997; GO:0014065; GO:0016311; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0033032; GO:0033137; GO:0033555; GO:0035176; GO:0035749; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043220; GO:0043491; GO:0043542; GO:0045202; GO:0045475; GO:0045736; GO:0045792; GO:0046855; GO:0046856; GO:0048681; GO:0048738; GO:0048853; GO:0048870; GO:0050680; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990381; GO:2000060; GO:2000134; GO:2000463; GO:2000808	"adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse maturation [GO:0060074]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34654_c0_g1_i1	P60483	PTEN_CANLF	68.2	85	27	0	2	256	93	177	3.20E-29	128.6	PTEN_CANLF	reviewed	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1	Canis lupus familiaris (Dog) (Canis familiaris)	403	"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]; anaphase-promoting complex binding [GO:0010997]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse maturation [GO:0060074]"	apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]	"anaphase-promoting complex binding [GO:0010997]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]"	GO:0001525; GO:0002902; GO:0004438; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007270; GO:0007417; GO:0007507; GO:0007611; GO:0008138; GO:0008284; GO:0008285; GO:0009898; GO:0010719; GO:0010975; GO:0010997; GO:0014065; GO:0016311; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0033032; GO:0033137; GO:0033555; GO:0035176; GO:0035749; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043220; GO:0043491; GO:0043542; GO:0045202; GO:0045475; GO:0045736; GO:0045792; GO:0046855; GO:0046856; GO:0048681; GO:0048738; GO:0048853; GO:0048870; GO:0050680; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990381; GO:2000060; GO:2000134; GO:2000463; GO:2000808	"adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse maturation [GO:0060074]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31453_c0_g1_i1	P60483	PTEN_CANLF	98.9	93	1	0	279	1	1	93	3.70E-50	198.4	PTEN_CANLF	reviewed	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	PTEN MMAC1	Canis lupus familiaris (Dog) (Canis familiaris)	403	"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]; anaphase-promoting complex binding [GO:0010997]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse maturation [GO:0060074]"	apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]	"anaphase-promoting complex binding [GO:0010997]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]"	GO:0001525; GO:0002902; GO:0004438; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007270; GO:0007417; GO:0007507; GO:0007611; GO:0008138; GO:0008284; GO:0008285; GO:0009898; GO:0010719; GO:0010975; GO:0010997; GO:0014065; GO:0016311; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0033032; GO:0033137; GO:0033555; GO:0035176; GO:0035749; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043220; GO:0043491; GO:0043542; GO:0045202; GO:0045475; GO:0045736; GO:0045792; GO:0046855; GO:0046856; GO:0048681; GO:0048738; GO:0048853; GO:0048870; GO:0050680; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990381; GO:2000060; GO:2000134; GO:2000463; GO:2000808	"adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse maturation [GO:0060074]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11445_c0_g1_i1	Q4R6N0	TPTE2_MACFA	55.1	243	108	1	38	763	237	479	5.30E-75	282.3	TPTE2_MACFA	reviewed	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67)"	TPTE2 QtsA-17567	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	566	"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]"	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0000139; GO:0004725; GO:0005789; GO:0008138; GO:0016021; GO:0016314			NA	NA	NA	NA	NA	NA
TRINITY_DN11445_c0_g1_i3	Q4R6N0	TPTE2_MACFA	47.1	350	177	5	502	1527	130	479	5.60E-84	313.2	TPTE2_MACFA	reviewed	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67)"	TPTE2 QtsA-17567	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	566	"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]"	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0000139; GO:0004725; GO:0005789; GO:0008138; GO:0016021; GO:0016314			NA	NA	NA	NA	NA	NA
TRINITY_DN28863_c0_g1_i1	Q8NEB9	PK3C3_HUMAN	100	150	0	0	451	2	1	150	1.90E-88	326.2	PK3C3_HUMAN	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)	PIK3C3 VPS34	Homo sapiens (Human)	887	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]; toll-like receptor 9 signaling pathway [GO:0034162]"	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006497; GO:0006661; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0030670; GO:0032465; GO:0034162; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]; toll-like receptor 9 signaling pathway [GO:0034162]		NA	NA	NA	NA	NA	NA
TRINITY_DN38597_c0_g1_i1	Q8NEB9	PK3C3_HUMAN	77.9	77	17	0	232	2	610	686	6.60E-29	127.5	PK3C3_HUMAN	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)	PIK3C3 VPS34	Homo sapiens (Human)	887	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]; toll-like receptor 9 signaling pathway [GO:0034162]"	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006497; GO:0006661; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0030670; GO:0032465; GO:0034162; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]; toll-like receptor 9 signaling pathway [GO:0034162]		blue	blue	NA	NA	NA	NA
TRINITY_DN13211_c0_g1_i1	Q8NEB9	PK3C3_HUMAN	65.2	66	23	0	206	9	350	415	9.50E-16	83.6	PK3C3_HUMAN	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)	PIK3C3 VPS34	Homo sapiens (Human)	887	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]; toll-like receptor 9 signaling pathway [GO:0034162]"	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006497; GO:0006661; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0030670; GO:0032465; GO:0034162; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]; toll-like receptor 9 signaling pathway [GO:0034162]		blue	blue	NA	NA	NA	NA
TRINITY_DN3641_c0_g1_i1	O88763	PK3C3_RAT	60.6	325	125	1	968	3	3	327	4.70E-122	439.1	PK3C3_RAT	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3)	Pik3c3 Vps34	Rattus norvegicus (Rat)	887	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]"	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006468; GO:0006497; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0009267; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035004; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0045335; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]		NA	NA	NA	NA	NA	NA
TRINITY_DN3641_c0_g1_i2	O88763	PK3C3_RAT	60.6	325	123	2	962	3	3	327	8.80E-121	434.9	PK3C3_RAT	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3)	Pik3c3 Vps34	Rattus norvegicus (Rat)	887	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]"	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006468; GO:0006497; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0009267; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035004; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0045335; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]		NA	NA	NA	NA	NA	NA
TRINITY_DN7072_c0_g1_i1	Q6PF93	PK3C3_MOUSE	82.8	99	17	0	300	4	694	792	6.90E-47	187.6	PK3C3_MOUSE	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3)	Pik3c3 Vps34	Mus musculus (Mouse)	887	"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]"	"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0006468; GO:0006497; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0009267; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035004; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0045335; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]		blue	blue	NA	NA	NA	NA
TRINITY_DN7072_c0_g1_i2	Q6PF93	PK3C3_MOUSE	64.6	99	11	1	228	4	694	792	7.60E-30	130.6	PK3C3_MOUSE	reviewed	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3)	Pik3c3 Vps34	Mus musculus (Mouse)	887	"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]"	"autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0006468; GO:0006497; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0009267; GO:0016020; GO:0016236; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035004; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0045335; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of cytokinesis [GO:0032465]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]		NA	NA	NA	NA	NA	NA
TRINITY_DN26200_c0_g1_i1	P27986	P85A_HUMAN	100	89	0	0	2	268	328	416	1.60E-47	189.5	P85A_HUMAN	reviewed	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	PIK3R1 GRB1	Homo sapiens (Human)	724	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; axon guidance [GO:0007411]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; leukocyte migration [GO:0050900]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]"	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]"	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001678; GO:0001784; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0006606; GO:0006661; GO:0007173; GO:0007186; GO:0007411; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0014065; GO:0014068; GO:0016020; GO:0016032; GO:0019221; GO:0019903; GO:0030168; GO:0030183; GO:0030335; GO:0031295; GO:0032760; GO:0032869; GO:0033120; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0038095; GO:0038096; GO:0038128; GO:0042307; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048010; GO:0048015; GO:0048471; GO:0050821; GO:0050852; GO:0050900; GO:0051491; GO:0051497; GO:0051897; GO:0060396; GO:0120183; GO:1900103; GO:1903078; GO:1990578	axon guidance [GO:0007411]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; leukocyte migration [GO:0050900]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1215_c0_g1_i1	P26450	P85A_MOUSE	35.6	644	348	16	612	2474	118	717	6.50E-93	343.6	P85A_MOUSE	reviewed	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	Pik3r1	Mus musculus (Mouse)	724	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ErbB-3 class receptor binding [GO:0043125]; estrogen receptor binding [GO:0030331]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose metabolic process [GO:0006006]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of heart rate [GO:0010459]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of proteolysis [GO:0045861]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of gene expression [GO:0010628]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA splicing [GO:0033120]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to cAMP [GO:0051591]; response to endoplasmic reticulum stress [GO:0034976]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]"	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ErbB-3 class receptor binding [GO:0043125]; estrogen receptor binding [GO:0030331]; insulin binding [GO:0043559]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	GO:0001678; GO:0001784; GO:0001934; GO:0001953; GO:0005102; GO:0005158; GO:0005159; GO:0005161; GO:0005168; GO:0005516; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006006; GO:0006468; GO:0006606; GO:0007162; GO:0008022; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0010459; GO:0010592; GO:0010628; GO:0010656; GO:0014065; GO:0016020; GO:0016303; GO:0019901; GO:0019903; GO:0019904; GO:0022408; GO:0030183; GO:0030331; GO:0030335; GO:0030971; GO:0031625; GO:0032760; GO:0032868; GO:0032869; GO:0032991; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043005; GO:0043066; GO:0043125; GO:0043551; GO:0043559; GO:0043560; GO:0045663; GO:0045671; GO:0045776; GO:0045861; GO:0045944; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0048662; GO:0050821; GO:0051117; GO:0051219; GO:0051384; GO:0051491; GO:0051492; GO:0051497; GO:0051591; GO:0051965; GO:0060396; GO:0120183; GO:1900103; GO:1903076; GO:1990578	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose metabolic process [GO:0006006]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of heart rate [GO:0010459]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of proteolysis [GO:0045861]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of gene expression [GO:0010628]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA splicing [GO:0033120]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to cAMP [GO:0051591]; response to endoplasmic reticulum stress [GO:0034976]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN1215_c0_g1_i2	P26450	P85A_MOUSE	35.6	644	348	16	584	2446	118	717	6.40E-93	343.6	P85A_MOUSE	reviewed	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	Pik3r1	Mus musculus (Mouse)	724	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ErbB-3 class receptor binding [GO:0043125]; estrogen receptor binding [GO:0030331]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose metabolic process [GO:0006006]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of heart rate [GO:0010459]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of proteolysis [GO:0045861]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of gene expression [GO:0010628]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA splicing [GO:0033120]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to cAMP [GO:0051591]; response to endoplasmic reticulum stress [GO:0034976]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]"	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; ErbB-3 class receptor binding [GO:0043125]; estrogen receptor binding [GO:0030331]; insulin binding [GO:0043559]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	GO:0001678; GO:0001784; GO:0001934; GO:0001953; GO:0005102; GO:0005158; GO:0005159; GO:0005161; GO:0005168; GO:0005516; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006006; GO:0006468; GO:0006606; GO:0007162; GO:0008022; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0010459; GO:0010592; GO:0010628; GO:0010656; GO:0014065; GO:0016020; GO:0016303; GO:0019901; GO:0019903; GO:0019904; GO:0022408; GO:0030183; GO:0030331; GO:0030335; GO:0030971; GO:0031625; GO:0032760; GO:0032868; GO:0032869; GO:0032991; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043005; GO:0043066; GO:0043125; GO:0043551; GO:0043559; GO:0043560; GO:0045663; GO:0045671; GO:0045776; GO:0045861; GO:0045944; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0048662; GO:0050821; GO:0051117; GO:0051219; GO:0051384; GO:0051491; GO:0051492; GO:0051497; GO:0051591; GO:0051965; GO:0060396; GO:0120183; GO:1900103; GO:1903076; GO:1990578	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose metabolic process [GO:0006006]; growth hormone receptor signaling pathway [GO:0060396]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of heart rate [GO:0010459]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of proteolysis [GO:0045861]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of gene expression [GO:0010628]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA splicing [GO:0033120]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to cAMP [GO:0051591]; response to endoplasmic reticulum stress [GO:0034976]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN40070_c0_g1_i1	P23726	P85B_BOVIN	100	68	0	0	206	3	326	393	2.90E-36	151.8	P85B_BOVIN	reviewed	Phosphatidylinositol 3-kinase regulatory subunit beta (PI3-kinase regulatory subunit beta) (PI3K regulatory subunit beta) (PtdIns-3-kinase regulatory subunit beta) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta) (PI3-kinase subunit p85-beta) (PtdIns-3-kinase regulatory subunit p85-beta)	PIK3R2	Bos taurus (Bovine)	724	focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]	GO:0001678; GO:0005634; GO:0005925; GO:0005942; GO:0008134; GO:0008286; GO:0010506; GO:0014065; GO:0015031; GO:0030833; GO:0032869; GO:0034976; GO:0036312; GO:0042307; GO:0043551; GO:0045785; GO:0045944; GO:0046854; GO:0046935; GO:0046982; GO:0051492; GO:1903076	cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN36023_c0_g1_i1	O08908	P85B_MOUSE	99.1	113	1	0	341	3	311	423	6.60E-62	237.7	P85B_MOUSE	reviewed	Phosphatidylinositol 3-kinase regulatory subunit beta (PI3-kinase regulatory subunit beta) (PI3K regulatory subunit beta) (PtdIns-3-kinase regulatory subunit beta) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta) (PI3-kinase subunit p85-beta) (PtdIns-3-kinase regulatory subunit p85-beta)	Pik3r2	Mus musculus (Mouse)	722	focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of MAPK cascade [GO:0043409]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]	GO:0001678; GO:0001784; GO:0005634; GO:0005925; GO:0005942; GO:0008134; GO:0008286; GO:0010506; GO:0014065; GO:0015031; GO:0019903; GO:0030833; GO:0030971; GO:0032869; GO:0034976; GO:0036312; GO:0042307; GO:0043409; GO:0043551; GO:0045785; GO:0045944; GO:0046854; GO:0046935; GO:0046982; GO:0051492; GO:0090051; GO:1903076	cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of MAPK cascade [GO:0043409]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN39503_c0_g1_i1	P32871	PK3CA_BOVIN	65.2	92	31	1	1	276	879	969	3.70E-29	128.6	PK3CA_BOVIN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)"	PIK3CA	Bos taurus (Bovine)	1068	"cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; liver development [GO:0001889]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein kinase B signaling [GO:0043491]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]"	"cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001525; GO:0001889; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0010468; GO:0010592; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030027; GO:0030295; GO:0033138; GO:0035004; GO:0035005; GO:0036092; GO:0040014; GO:0043457; GO:0043491; GO:0043524; GO:0043560; GO:0044029; GO:0046854; GO:0046934; GO:0048015; GO:0048471; GO:0052742; GO:0052812; GO:0060612; GO:0071333; GO:0097009; GO:2000270; GO:2000653; GO:2000811	adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; liver development [GO:0001889]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein kinase B signaling [GO:0043491]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]		NA	NA	NA	NA	NA	NA
TRINITY_DN2047_c0_g1_i1	O00329	PK3CD_HUMAN	44.5	1043	555	13	310	3423	19	1042	1.50E-246	854.4	PK3CD_HUMAN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)"	PIK3CD	Homo sapiens (Human)	1044	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]"	GO:0001779; GO:0001816; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006661; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN2047_c0_g1_i2	O00329	PK3CD_HUMAN	44.5	1043	555	13	328	3441	19	1042	1.50E-246	854.4	PK3CD_HUMAN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)"	PIK3CD	Homo sapiens (Human)	1044	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]"	GO:0001779; GO:0001816; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006661; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]		blue	blue	NA	NA	NA	NA
TRINITY_DN26232_c0_g1_i1	O00329	PK3CD_HUMAN	100	96	0	0	290	3	609	704	1.20E-48	193.4	PK3CD_HUMAN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)"	PIK3CD	Homo sapiens (Human)	1044	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]"	GO:0001779; GO:0001816; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006661; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN40983_c0_g1_i1	O00329	PK3CD_HUMAN	100	91	0	0	3	275	746	836	5.70E-48	191	PK3CD_HUMAN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)"	PIK3CD	Homo sapiens (Human)	1044	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]"	GO:0001779; GO:0001816; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006661; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN30501_c0_g1_i1	O00329	PK3CD_HUMAN	100	128	0	0	385	2	839	966	1.00E-71	270.4	PK3CD_HUMAN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)"	PIK3CD	Homo sapiens (Human)	1044	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]"	GO:0001779; GO:0001816; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006661; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine-mediated signaling pathway [GO:0019221]; cytokine production [GO:0001816]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN25812_c0_g1_i1	P48736	PK3CG_HUMAN	100	81	0	0	1	243	906	986	2.20E-43	175.6	PK3CG_HUMAN	reviewed	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)"	PIK3CG	Homo sapiens (Human)	1102	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; cytokine production [GO:0001816]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001525; GO:0001816; GO:0002250; GO:0002407; GO:0002675; GO:0002679; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006661; GO:0006897; GO:0006954; GO:0007186; GO:0007204; GO:0010818; GO:0010897; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030168; GO:0030593; GO:0032252; GO:0033628; GO:0035004; GO:0035005; GO:0035747; GO:0036092; GO:0042098; GO:0042110; GO:0042802; GO:0043303; GO:0043406; GO:0045087; GO:0046854; GO:0046875; GO:0046934; GO:0048015; GO:0051897; GO:0052742; GO:0052812; GO:0055118; GO:0070527; GO:0071320; GO:0072672; GO:0097284; GO:1903169; GO:2000270	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; cytokine production [GO:0001816]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098]		NA	NA	NA	NA	NA	NA
TRINITY_DN24239_c0_g1_i1	P54677	PI4K_DICDI	58.6	99	37	1	285	1	992	1090	7.00E-28	124.4	PI4K_DICDI	reviewed	Phosphatidylinositol 4-kinase (PI4-kinase) (PtdIns-4-kinase) (EC 2.7.1.67) (PI4K-alpha)	pikD pik4 DDB_G0288485	Dictyostelium discoideum (Slime mold)	1180	cytoplasm [GO:0005737]; membrane [GO:0016020]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; membrane [GO:0016020]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0016020; GO:0031152; GO:0043327; GO:0046854; GO:0048015; GO:0052742	aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3971_c0_g1_i1	O02811	PI4KA_BOVIN	46.9	482	232	9	1471	56	390	857	3.80E-109	396.7	PI4KA_BOVIN	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	PI4KA PIK4CA	Bos taurus (Bovine)	2102	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0030660; GO:0046854; GO:0048015; GO:0052742	phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3971_c0_g1_i4	O02811	PI4KA_BOVIN	47.4	1978	984	21	5883	40	152	2102	0	1720.7	PI4KA_BOVIN	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	PI4KA PIK4CA	Bos taurus (Bovine)	2102	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0030660; GO:0046854; GO:0048015; GO:0052742	phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN34594_c0_g1_i1	O02811	PI4KA_BOVIN	98.2	110	2	0	3	332	1716	1825	9.60E-58	223.8	PI4KA_BOVIN	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	PI4KA PIK4CA	Bos taurus (Bovine)	2102	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0030660; GO:0046854; GO:0048015; GO:0052742	phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN7361_c0_g1_i3	O08662	PI4KA_RAT	44.8	125	67	2	373	2	22	145	3.80E-23	109.4	PI4KA_RAT	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	Pi4ka Pik4ca	Rattus norvegicus (Rat)	2096	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0016301; GO:0016310; GO:0030660; GO:0039694; GO:0044803; GO:0046786; GO:0046854; GO:0048015; GO:0052742	multi-organism membrane organization [GO:0044803]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN7361_c0_g1_i6	O08662	PI4KA_RAT	49.4	89	44	1	355	89	22	109	3.50E-18	92.8	PI4KA_RAT	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	Pi4ka Pik4ca	Rattus norvegicus (Rat)	2096	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0016301; GO:0016310; GO:0030660; GO:0039694; GO:0044803; GO:0046786; GO:0046854; GO:0048015; GO:0052742	multi-organism membrane organization [GO:0044803]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN28909_c0_g1_i1	P42356	PI4KA_HUMAN	100	88	0	0	266	3	1609	1696	1.60E-47	189.5	PI4KA_HUMAN	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha)	PI4KA PIK4 PIK4CA	Homo sapiens (Human)	2102	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006661; GO:0007165; GO:0016020; GO:0016301; GO:0016310; GO:0019034; GO:0030660; GO:0039694; GO:0044803; GO:0045296; GO:0046786; GO:0046854; GO:0048015; GO:0052742; GO:0070062	multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN19133_c0_g1_i1	P42356	PI4KA_HUMAN	100	199	0	0	598	2	1868	2066	1.80E-115	416.4	PI4KA_HUMAN	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha)	PI4KA PIK4 PIK4CA	Homo sapiens (Human)	2102	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006661; GO:0007165; GO:0016020; GO:0016301; GO:0016310; GO:0019034; GO:0030660; GO:0039694; GO:0044803; GO:0045296; GO:0046786; GO:0046854; GO:0048015; GO:0052742; GO:0070062	multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN39473_c0_g1_i1	P42356	PI4KA_HUMAN	100	66	0	0	200	3	1271	1336	7.20E-32	137.1	PI4KA_HUMAN	reviewed	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha)	PI4KA PIK4 PIK4CA	Homo sapiens (Human)	2102	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006661; GO:0007165; GO:0016020; GO:0016301; GO:0016310; GO:0019034; GO:0030660; GO:0039694; GO:0044803; GO:0045296; GO:0046786; GO:0046854; GO:0048015; GO:0052742; GO:0070062	multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN28681_c0_g1_i1	Q49GP3	PI4KB_DANRE	74.2	93	24	0	2	280	645	737	3.10E-36	152.9	PI4KB_DANRE	reviewed	Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67)	pi4kb pik4cb	Danio rerio (Zebrafish) (Brachydanio rerio)	835	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; semicircular canal development [GO:0060872]	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005524; GO:0005737; GO:0005741; GO:0016020; GO:0030867; GO:0046854; GO:0048015; GO:0052742; GO:0060872	phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; semicircular canal development [GO:0060872]		NA	NA	NA	NA	NA	NA
TRINITY_DN3042_c0_g2_i3	Q6PE18	P4K2A_DANRE	72.4	246	64	1	248	973	44	289	4.80E-106	386	P4K2A_DANRE	reviewed	Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha)	pi4k2a pi4kii si:ch211-197k17.1	Danio rerio (Zebrafish) (Brachydanio rerio)	447	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005739; GO:0005768; GO:0005802; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0030425; GO:0031224; GO:0031410; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3042_c0_g2_i4	Q6PE18	P4K2A_DANRE	65.2	417	125	5	283	1512	43	446	3.20E-159	563.1	P4K2A_DANRE	reviewed	Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha)	pi4k2a pi4kii si:ch211-197k17.1	Danio rerio (Zebrafish) (Brachydanio rerio)	447	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005739; GO:0005768; GO:0005802; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0030425; GO:0031224; GO:0031410; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3042_c0_g2_i8	Q6PE18	P4K2A_DANRE	66.2	411	125	3	248	1462	44	446	4.70E-163	575.9	P4K2A_DANRE	reviewed	Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha)	pi4k2a pi4kii si:ch211-197k17.1	Danio rerio (Zebrafish) (Brachydanio rerio)	447	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005739; GO:0005768; GO:0005802; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0030425; GO:0031224; GO:0031410; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN38197_c0_g1_i1	Q8CBQ5	P4K2B_MOUSE	96.7	180	6	0	541	2	258	437	2.00E-100	366.3	P4K2B_MOUSE	reviewed	Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta)	Pi4k2b	Mus musculus (Mouse)	469	endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]	endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0007030; GO:0007032; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3042_c0_g2_i2	Q28G26	P4K2B_XENTR	67.4	384	117	3	94	1227	109	490	1.70E-158	560.5	P4K2B_XENTR	reviewed	Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta)	pi4k2b TGas067g11.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	492	endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]	endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0007030; GO:0007032; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN3042_c0_g2_i5	Q28G26	P4K2B_XENTR	67.4	384	117	3	242	1375	109	490	1.90E-158	560.5	P4K2B_XENTR	reviewed	Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta)	pi4k2b TGas067g11.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	492	endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]	endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0007030; GO:0007032; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN13569_c0_g1_i1	Q8TCG2	P4K2B_HUMAN	94.2	104	6	0	1	312	100	203	2.70E-54	212.2	P4K2B_HUMAN	reviewed	Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA)	PI4K2B	Homo sapiens (Human)	481	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN13569_c0_g1_i2	Q8TCG2	P4K2B_HUMAN	98.7	153	2	0	1	459	100	252	1.80E-86	319.7	P4K2B_HUMAN	reviewed	Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA)	PI4K2B	Homo sapiens (Human)	481	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]	GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0046854	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN29512_c0_g1_i1	O00443	P3C2A_HUMAN	100	86	0	0	2	259	1172	1257	7.70E-47	187.2	P3C2A_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha)	PIK3C2A	Homo sapiens (Human)	1686	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0010508; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016477; GO:0030136; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0036092; GO:0046854; GO:0048008; GO:0048015; GO:0048268; GO:0052742; GO:0061024; GO:0070062; GO:0090050	cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]		NA	NA	NA	NA	NA	NA
TRINITY_DN28663_c0_g1_i1	O00443	P3C2A_HUMAN	100	69	0	0	1	207	1429	1497	6.40E-36	150.6	P3C2A_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha)	PIK3C2A	Homo sapiens (Human)	1686	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0010508; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016477; GO:0030136; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0036092; GO:0046854; GO:0048008; GO:0048015; GO:0048268; GO:0052742; GO:0061024; GO:0070062; GO:0090050	cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]		NA	NA	NA	NA	NA	NA
TRINITY_DN4860_c0_g1_i1	O00750	P3C2B_HUMAN	37.6	1262	708	21	92	3832	430	1626	1.10E-235	818.5	P3C2B_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)	PIK3C2B	Homo sapiens (Human)	1634	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0009267; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043491; GO:0046854; GO:0048015; GO:0052742; GO:1905037	autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein kinase B signaling [GO:0043491]		NA	NA	1	NA	NA	NA
TRINITY_DN4860_c0_g1_i2	O00750	P3C2B_HUMAN	46.4	125	66	1	122	493	1502	1626	4.10E-25	116.3	P3C2B_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)	PIK3C2B	Homo sapiens (Human)	1634	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0009267; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043491; GO:0046854; GO:0048015; GO:0052742; GO:1905037	autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein kinase B signaling [GO:0043491]		NA	NA	NA	NA	NA	NA
TRINITY_DN4860_c0_g1_i3	O00750	P3C2B_HUMAN	37.4	1304	733	22	329	4186	388	1626	3.70E-242	840.1	P3C2B_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)	PIK3C2B	Homo sapiens (Human)	1634	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0009267; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043491; GO:0046854; GO:0048015; GO:0052742; GO:1905037	autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein kinase B signaling [GO:0043491]		NA	NA	NA	NA	NA	NA
TRINITY_DN4860_c0_g1_i6	O00750	P3C2B_HUMAN	31.3	847	509	18	329	2821	388	1177	6.10E-116	420.2	P3C2B_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)	PIK3C2B	Homo sapiens (Human)	1634	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0009267; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043491; GO:0046854; GO:0048015; GO:0052742; GO:1905037	autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein kinase B signaling [GO:0043491]		NA	NA	NA	NA	NA	NA
TRINITY_DN4860_c0_g1_i7	O00750	P3C2B_HUMAN	36.3	1423	807	28	1089	5285	280	1626	3.20E-243	844	P3C2B_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)	PIK3C2B	Homo sapiens (Human)	1634	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0009267; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043491; GO:0046854; GO:0048015; GO:0052742; GO:1905037	autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; protein kinase B signaling [GO:0043491]		NA	NA	NA	NA	NA	NA
TRINITY_DN14929_c0_g1_i1	Q5F356	PI42A_CHICK	61.6	396	148	3	96	1280	8	400	9.00E-134	478.4	PI42A_CHICK	reviewed	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(5)P-4-kinase isoform 2-alpha)	PIP4K2A PIP5K2A RCJMB04_33l24	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0016309			blue	blue	NA	NA	NA	NA
TRINITY_DN14929_c0_g1_i2	Q5F356	PI42A_CHICK	60.2	405	148	4	96	1307	8	400	1.50E-131	471.1	PI42A_CHICK	reviewed	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(5)P-4-kinase isoform 2-alpha)	PIP4K2A PIP5K2A RCJMB04_33l24	Gallus gallus (Chicken)	405	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0016309			NA	NA	NA	NA	NA	NA
TRINITY_DN27886_c0_g1_i1	Q9H490	PIGU_HUMAN	100	80	0	0	240	1	347	426	2.50E-39	162.2	PIGU_HUMAN	reviewed	Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U)	PIGU CDC91L1 PSEC0205 UNQ3055/PRO9875	Homo sapiens (Human)	435	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0006506; GO:0016020; GO:0016255; GO:0034394; GO:0042765; GO:0046425	attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]		NA	NA	NA	NA	NA	NA
TRINITY_DN16643_c0_g1_i1	Q9H490	PIGU_HUMAN	41	439	243	5	1369	89	1	435	5.70E-86	319.7	PIGU_HUMAN	reviewed	Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U)	PIGU CDC91L1 PSEC0205 UNQ3055/PRO9875	Homo sapiens (Human)	435	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0006506; GO:0016020; GO:0016255; GO:0034394; GO:0042765; GO:0046425	attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]		NA	NA	NA	NA	NA	NA
TRINITY_DN34931_c0_g1_i1	P37287	PIGA_HUMAN	65.8	79	27	0	242	6	282	360	2.80E-22	105.5	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c1_g1_i1	P37287	PIGA_HUMAN	53.7	54	25	0	223	62	36	89	1.90E-12	73.2	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c1_g1_i2	P37287	PIGA_HUMAN	52.8	53	25	0	233	75	37	89	4.60E-11	68.6	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c1_g1_i3	P37287	PIGA_HUMAN	53.7	54	25	0	236	75	36	89	2.00E-12	73.2	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c0_g1_i1	P37287	PIGA_HUMAN	57.2	423	177	4	1347	85	33	453	7.10E-129	462.2	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5709_c0_g1_i2	P37287	PIGA_HUMAN	57.2	418	175	4	1332	85	38	453	7.90E-127	455.3	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN28206_c0_g1_i1	P37287	PIGA_HUMAN	100	102	0	0	3	308	34	135	2.30E-53	209.1	PIGA_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A)	PIGA	Homo sapiens (Human)	484	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0009893; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of metabolic process [GO:0009893]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN10155_c0_g1_i4	Q9CXR4	PIGC_MOUSE	31.2	266	171	3	108	872	13	277	4.80E-23	110.2	PIGC_MOUSE	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C)	Pigc	Mus musculus (Mouse)	297	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0006506; GO:0016021; GO:0017176	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN10155_c0_g1_i5	Q9CXR4	PIGC_MOUSE	33.1	278	174	3	108	908	13	289	4.70E-30	133.7	PIGC_MOUSE	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C)	Pigc	Mus musculus (Mouse)	297	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0006506; GO:0016021; GO:0017176	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN4899_c0_g1_i2	Q14442	PIGH_HUMAN	39.1	115	66	3	443	108	65	178	5.00E-14	79.7	PIGH_HUMAN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class H protein) (PIG-H)	PIGH	Homo sapiens (Human)	188	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; catalytic activity [GO:0003824]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; cellular protein modification process [GO:0006464]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]	catalytic activity [GO:0003824]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0003824; GO:0005783; GO:0005789; GO:0006464; GO:0006506; GO:0016254; GO:0017176	cellular protein modification process [GO:0006464]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]		NA	NA	NA	NA	NA	NA
TRINITY_DN4899_c0_g1_i3	Q32L89	PIGH_BOVIN	39.1	115	66	3	443	108	65	178	4.00E-14	79.7	PIGH_BOVIN	reviewed	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class H protein) (PIG-H)	PIGH	Bos taurus (Bovine)	188	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0006506; GO:0017176	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i4	Q9NCL8	PITP1_DICDI	46.8	47	25	0	188	48	175	221	6.60E-09	60.8	PITP1_DICDI	reviewed	Phosphatidylinositol transfer protein 1 (PtdIns transfer protein 1) (DdPITP1)	pitA DDB_G0290069	Dictyostelium discoideum (Slime mold)	264	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091; GO:0071944			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i6	Q9NCL8	PITP1_DICDI	51.2	43	21	0	176	48	179	221	1.80E-07	56.2	PITP1_DICDI	reviewed	Phosphatidylinositol transfer protein 1 (PtdIns transfer protein 1) (DdPITP1)	pitA DDB_G0290069	Dictyostelium discoideum (Slime mold)	264	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091; GO:0071944			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i9	Q9NCL8	PITP1_DICDI	48.8	80	41	0	445	206	175	254	2.60E-21	103.2	PITP1_DICDI	reviewed	Phosphatidylinositol transfer protein 1 (PtdIns transfer protein 1) (DdPITP1)	pitA DDB_G0290069	Dictyostelium discoideum (Slime mold)	264	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091; GO:0071944			NA	NA	NA	NA	NA	NA
TRINITY_DN802_c0_g1_i3	P48738	PIPNA_RABIT	62.1	235	73	7	772	89	1	226	6.30E-74	278.9	PIPNA_RABIT	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	PITPNA PITPN	Oryctolagus cuniculus (Rabbit)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; axonogenesis [GO:0007409]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0007409; GO:0008525; GO:0008526; GO:0031210; GO:0035091	axonogenesis [GO:0007409]		blue	blue	NA	NA	NA	NA
TRINITY_DN12779_c0_g1_i1	Q00169	PIPNA_HUMAN	100	130	0	0	390	1	140	269	5.00E-74	278.1	PIPNA_HUMAN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	PITPNA PITPN	Homo sapiens (Human)	270	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; axonogenesis [GO:0007409]; interleukin-12-mediated signaling pathway [GO:0035722]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005829; GO:0006629; GO:0007409; GO:0007601; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0035722; GO:0070062; GO:1901611	axonogenesis [GO:0007409]; interleukin-12-mediated signaling pathway [GO:0035722]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN12779_c0_g1_i2	P53810	PIPNA_MOUSE	100	131	0	0	396	4	139	269	3.90E-74	278.5	PIPNA_MOUSE	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	Pitpna Pitpn	Mus musculus (Mouse)	271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]; axonogenesis [GO:0007409]; phospholipid transport [GO:0015914]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]	fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]	GO:0000062; GO:0005543; GO:0005737; GO:0005829; GO:0007409; GO:0008289; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0031210; GO:0035091; GO:0043209; GO:0070540	axonogenesis [GO:0007409]; phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN11724_c0_g1_i1	Q00169	PIPNA_HUMAN	98.3	120	2	0	360	1	21	140	1.60E-66	253.1	PIPNA_HUMAN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	PITPNA PITPN	Homo sapiens (Human)	270	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; axonogenesis [GO:0007409]; interleukin-12-mediated signaling pathway [GO:0035722]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005829; GO:0006629; GO:0007409; GO:0007601; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0035722; GO:0070062; GO:1901611	axonogenesis [GO:0007409]; interleukin-12-mediated signaling pathway [GO:0035722]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11724_c0_g1_i2	P53810	PIPNA_MOUSE	99.3	137	1	0	414	4	4	140	3.40E-76	285.4	PIPNA_MOUSE	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	Pitpna Pitpn	Mus musculus (Mouse)	271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]; axonogenesis [GO:0007409]; phospholipid transport [GO:0015914]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]	fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]	GO:0000062; GO:0005543; GO:0005737; GO:0005829; GO:0007409; GO:0008289; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0031210; GO:0035091; GO:0043209; GO:0070540	axonogenesis [GO:0007409]; phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN9793_c0_g1_i2	P48738	PIPNA_RABIT	53.5	170	70	4	578	90	102	269	4.40E-42	173.3	PIPNA_RABIT	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	PITPNA PITPN	Oryctolagus cuniculus (Rabbit)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; axonogenesis [GO:0007409]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0007409; GO:0008525; GO:0008526; GO:0031210; GO:0035091	axonogenesis [GO:0007409]		NA	NA	NA	NA	NA	NA
TRINITY_DN9793_c0_g1_i2	P48738	PIPNA_RABIT	66.3	104	29	1	910	599	2	99	9.50E-37	155.6	PIPNA_RABIT	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	PITPNA PITPN	Oryctolagus cuniculus (Rabbit)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; axonogenesis [GO:0007409]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0007409; GO:0008525; GO:0008526; GO:0031210; GO:0035091	axonogenesis [GO:0007409]		NA	NA	NA	NA	NA	NA
TRINITY_DN9793_c0_g1_i1	Q2HJ54	PIPNA_BOVIN	58.5	277	99	6	899	90	2	269	7.50E-87	322	PIPNA_BOVIN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha) (Phosphatidylinositol-transfer protein 35 kDa isoform) (PI-TP 35 kda isoform)	PITPNA	Bos taurus (Bovine)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i1	Q2HJ54	PIPNA_BOVIN	58.2	55	17	1	227	63	14	62	3.30E-09	62.4	PIPNA_BOVIN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha) (Phosphatidylinositol-transfer protein 35 kDa isoform) (PI-TP 35 kda isoform)	PITPNA	Bos taurus (Bovine)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0008525; GO:0008526; GO:0031210; GO:0035091			brown	brown	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i10	Q2HJ54	PIPNA_BOVIN	50.7	201	92	3	769	185	67	266	5.30E-53	209.5	PIPNA_BOVIN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha) (Phosphatidylinositol-transfer protein 35 kDa isoform) (PI-TP 35 kda isoform)	PITPNA	Bos taurus (Bovine)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i7	Q2HJ54	PIPNA_BOVIN	59	78	26	1	243	10	14	85	4.50E-17	88.6	PIPNA_BOVIN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha) (Phosphatidylinositol-transfer protein 35 kDa isoform) (PI-TP 35 kda isoform)	PITPNA	Bos taurus (Bovine)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i8	Q2HJ54	PIPNA_BOVIN	53.3	272	114	4	982	185	2	266	8.90E-78	292	PIPNA_BOVIN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha) (Phosphatidylinositol-transfer protein 35 kDa isoform) (PI-TP 35 kda isoform)	PITPNA	Bos taurus (Bovine)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i2	Q2HJ54	PIPNA_BOVIN	54.7	232	92	4	725	48	2	226	1.40E-64	247.7	PIPNA_BOVIN	reviewed	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha) (Phosphatidylinositol-transfer protein 35 kDa isoform) (PI-TP 35 kda isoform)	PITPNA	Bos taurus (Bovine)	270	cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	1	NA	NA	NA
TRINITY_DN802_c0_g1_i8	P53811	PIPNB_MOUSE	69.5	105	26	1	414	100	1	99	3.20E-38	159.5	PIPNB_MOUSE	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta)	Pitpnb	Mus musculus (Mouse)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091	in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN19962_c1_g1_i1	P53811	PIPNB_MOUSE	100	72	0	0	216	1	8	79	1.50E-35	149.4	PIPNB_MOUSE	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta)	Pitpnb	Mus musculus (Mouse)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091	in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN21224_c0_g1_i1	P48739	PIPNB_HUMAN	100	85	0	0	3	257	168	252	9.20E-48	190.3	PIPNB_HUMAN	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta)	PITPNB	Homo sapiens (Human)	271	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; lipid metabolic process [GO:0006629]; nucleus organization [GO:0006997]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0000139; GO:0005737; GO:0005789; GO:0006629; GO:0006890; GO:0006997; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091	"lipid metabolic process [GO:0006629]; nucleus organization [GO:0006997]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN802_c0_g1_i10	Q9TR36	PIPNB_BOVIN	56	166	66	3	703	224	102	266	2.40E-46	187.2	PIPNB_BOVIN	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform)	PITPNB	Bos taurus (Bovine)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN802_c0_g1_i2	Q9TR36	PIPNB_BOVIN	60.6	274	94	5	1027	224	1	266	3.30E-91	336.7	PIPNB_BOVIN	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform)	PITPNB	Bos taurus (Bovine)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN802_c0_g1_i4	Q9TR36	PIPNB_BOVIN	55.3	300	94	5	1105	224	1	266	2.20E-88	327.4	PIPNB_BOVIN	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform)	PITPNB	Bos taurus (Bovine)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN19962_c0_g1_i1	Q9TR36	PIPNB_BOVIN	100	122	0	0	368	3	2	123	8.60E-68	257.3	PIPNB_BOVIN	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform)	PITPNB	Bos taurus (Bovine)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN1574_c0_g1_i3	Q9TR36	PIPNB_BOVIN	53.8	78	36	0	421	188	188	265	1.10E-20	101.3	PIPNB_BOVIN	reviewed	Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform)	PITPNB	Bos taurus (Bovine)	271	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005794; GO:0008525; GO:0008526; GO:0031210; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN3167_c0_g1_i1	A6QL88	SAC1_BOVIN	58.6	87	35	1	3	260	345	431	6.70E-22	104.4	SAC1_BOVIN	reviewed	Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)	SACM1L SAC1	Bos taurus (Bovine)	587	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856]	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]	GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0016791; GO:0032281; GO:0043812; GO:0046856; GO:0140268	phosphatidylinositol dephosphorylation [GO:0046856]		blue	blue	NA	NA	NA	NA
TRINITY_DN7088_c0_g1_i1	Q9ES21	SAC1_RAT	63.2	87	32	0	266	6	192	278	7.50E-29	127.5	SAC1_RAT	reviewed	Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)	Sacm1l Sac1	Rattus norvegicus (Rat)	587	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphatase activity [GO:0016791]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856]	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]	phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]	GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0016791; GO:0030176; GO:0032281; GO:0034593; GO:0043812; GO:0046856; GO:0140268	phosphatidylinositol dephosphorylation [GO:0046856]		blue	blue	NA	NA	NA	NA
TRINITY_DN2000_c0_g1_i10	Q9VI75	PICAL_DROME	54.5	253	76	7	6	755	210	426	4.30E-53	210.3	PICAL_DROME	reviewed	Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180)	lap CG2520	Drosophila melanogaster (Fruit fly)	468	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]	"1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]"	GO:0000149; GO:0005545; GO:0005546; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370	chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN2000_c0_g1_i3	Q9VI75	PICAL_DROME	53.9	245	72	7	6	701	210	426	5.50E-50	199.9	PICAL_DROME	reviewed	Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180)	lap CG2520	Drosophila melanogaster (Fruit fly)	468	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]	"1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]"	GO:0000149; GO:0005545; GO:0005546; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370	chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN2000_c0_g1_i4	Q9VI75	PICAL_DROME	54.5	253	70	7	6	737	210	426	1.20E-52	208.8	PICAL_DROME	reviewed	Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180)	lap CG2520	Drosophila melanogaster (Fruit fly)	468	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]	"1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]"	GO:0000149; GO:0005545; GO:0005546; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370	chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN2000_c0_g1_i6	Q9VI75	PICAL_DROME	52.8	235	75	6	6	656	210	426	1.60E-46	188.3	PICAL_DROME	reviewed	Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180)	lap CG2520	Drosophila melanogaster (Fruit fly)	468	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]	"1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]"	GO:0000149; GO:0005545; GO:0005546; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370	chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN2000_c0_g1_i8	Q9VI75	PICAL_DROME	52.2	253	72	8	6	725	210	426	1.20E-47	192.2	PICAL_DROME	reviewed	Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180)	lap CG2520	Drosophila melanogaster (Fruit fly)	468	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]"	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]	"1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]"	GO:0000149; GO:0005545; GO:0005546; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370	chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]		NA	NA	NA	NA	NA	NA
TRINITY_DN4644_c0_g1_i1	Q5R8I8	PISD_PONAB	47.8	347	173	3	1148	120	64	406	2.70E-89	330.5	PISD_PONAB	reviewed	"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]"	PISD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	409	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]	phosphatidylserine decarboxylase activity [GO:0004609]	GO:0004609; GO:0005634; GO:0006646; GO:0016540; GO:0031305	phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]		NA	NA	NA	NA	NA	NA
TRINITY_DN4644_c0_g1_i2	Q5R8I8	PISD_PONAB	47.8	347	173	3	1148	120	64	406	3.00E-89	330.5	PISD_PONAB	reviewed	"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]"	PISD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	409	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]	phosphatidylserine decarboxylase activity [GO:0004609]	GO:0004609; GO:0005634; GO:0006646; GO:0016540; GO:0031305	phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]		NA	NA	NA	NA	NA	NA
TRINITY_DN4644_c0_g1_i3	P27465	PISD_CRIGR	44.2	147	81	1	473	33	64	209	1.30E-28	128.3	PISD_CRIGR	reviewed	"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]"	Pisd PSSC	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	409	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]	phosphatidylserine decarboxylase activity [GO:0004609]	GO:0004609; GO:0005634; GO:0006646; GO:0016540; GO:0031305	phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]		NA	NA	NA	NA	NA	NA
TRINITY_DN35618_c0_g1_i1	Q8BSF4	PISD_MOUSE	95.5	111	5	0	3	335	228	338	5.90E-63	241.1	PISD_MOUSE	reviewed	"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]"	Pisd	Mus musculus (Mouse)	406	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	phosphatidylserine decarboxylase activity [GO:0004609]	GO:0004609; GO:0005634; GO:0005739; GO:0006646; GO:0016540; GO:0031305	phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]		NA	NA	NA	NA	NA	NA
TRINITY_DN15171_c0_g1_i3	Q6MG55	ABHGA_RAT	41.7	180	101	2	600	73	377	556	6.00E-34	145.6	ABHGA_RAT	reviewed	Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23)	Abhd16a Bat5	Rattus norvegicus (Rat)	558	integral component of membrane [GO:0016021]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0004620; GO:0006660; GO:0008474; GO:0016020; GO:0016021; GO:0047372; GO:0052651; GO:1905344	monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]		NA	NA	NA	NA	NA	NA
TRINITY_DN9121_c0_g1_i1	Q5ZM65	PTSS1_CHICK	49.4	176	89	0	733	206	246	421	2.40E-48	193.7	PTSS1_CHICK	reviewed	Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)	PTDSS1 RCJMB04_2p18	Gallus gallus (Chicken)	473	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN9121_c0_g1_i2	Q2KHY9	PTSS1_BOVIN	55.4	352	156	1	1324	269	50	400	2.20E-121	437.2	PTSS1_BOVIN	reviewed	Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)	PTDSS1	Bos taurus (Bovine)	473	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN24010_c0_g1_i1	Q2KHY9	PTSS1_BOVIN	100	96	0	0	288	1	53	148	3.80E-50	198.4	PTSS1_BOVIN	reviewed	Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)	PTDSS1	Bos taurus (Bovine)	473	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN24010_c0_g2_i1	P48651	PTSS1_HUMAN	100	244	0	0	1	732	144	387	3.40E-148	525.4	PTSS1_HUMAN	reviewed	Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)	PTDSS1 KIAA0024 PSSA	Homo sapiens (Human)	473	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]	GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN38292_c0_g1_i1	Q9BVG9	PTSS2_HUMAN	100	100	0	0	1	300	176	275	8.40E-61	233.8	PTSS2_HUMAN	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS2 PSS2	Homo sapiens (Human)	487	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]	GO:0003882; GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4571_c0_g1_i1	E1BYA3	PTSS2_CHICK	56	100	43	1	54	350	24	123	4.50E-25	115.5	PTSS2_CHICK	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS1	Gallus gallus (Chicken)	442	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4571_c0_g1_i2	E1BYA3	PTSS2_CHICK	54.8	405	179	3	54	1262	24	426	1.20E-141	504.6	PTSS2_CHICK	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS1	Gallus gallus (Chicken)	442	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4571_c0_g1_i3	E1BYA3	PTSS2_CHICK	70.1	67	17	1	34	225	157	223	1.60E-24	112.8	PTSS2_CHICK	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS1	Gallus gallus (Chicken)	442	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4571_c0_g1_i4	Q9BVG9	PTSS2_HUMAN	58.8	364	148	2	54	1139	46	409	8.40E-136	485	PTSS2_HUMAN	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS2 PSS2	Homo sapiens (Human)	487	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]	GO:0003882; GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4571_c0_g1_i5	E1BYA3	PTSS2_CHICK	55.9	102	44	1	54	356	24	125	9.50E-26	117.9	PTSS2_CHICK	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS1	Gallus gallus (Chicken)	442	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]	GO:0005789; GO:0006659; GO:0016021; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN4571_c0_g1_i7	Q9BVG9	PTSS2_HUMAN	60.5	200	78	1	54	650	46	245	3.60E-73	276.2	PTSS2_HUMAN	reviewed	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	PTDSS2 PSS2	Homo sapiens (Human)	487	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]	GO:0003882; GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740; GO:0106245	phosphatidylserine biosynthetic process [GO:0006659]		NA	NA	NA	NA	NA	NA
TRINITY_DN36566_c0_g1_i1	F1RQM2	AGM1_PIG	57.1	70	29	1	2	211	28	96	6.40E-15	80.9	AGM1_PIG	reviewed	Phosphoacetylglucosamine mutase (PAGM) (PGlcNAc mutase) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)	PGM3 AGM1	Sus scrofa (Pig)	542	magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004610; GO:0004614; GO:0005975; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097	carbohydrate metabolic process [GO:0005975]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN1539_c0_g1_i1	F1RQM2	AGM1_PIG	55.4	381	168	2	50	1189	1	380	2.70E-118	426.8	AGM1_PIG	reviewed	Phosphoacetylglucosamine mutase (PAGM) (PGlcNAc mutase) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)	PGM3 AGM1	Sus scrofa (Pig)	542	magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004610; GO:0004614; GO:0005975; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097	carbohydrate metabolic process [GO:0005975]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN16330_c0_g1_i1	Q18268	PDL1_CAEEL	65.1	63	22	0	255	67	96	158	4.10E-19	95.1	PDL1_CAEEL	reviewed	Phosphodiesterase delta-like protein	pdl-1 C27H5.1	Caenorhabditis elegans	159	cytoplasm [GO:0005737]; sensory perception of light stimulus [GO:0050953]	cytoplasm [GO:0005737]		GO:0005737; GO:0050953	sensory perception of light stimulus [GO:0050953]		NA	NA	NA	NA	NA	NA
TRINITY_DN26820_c0_g1_i1	B2U804	PCKG_RALPJ	99.4	167	1	0	2	502	211	377	3.80E-98	358.6	PCKG_RALPJ	reviewed	Phosphoenolpyruvate carboxykinase [GTP] (PEP carboxykinase) (PEPCK) (EC 4.1.1.32)	pckG Rpic_3739	Ralstonia pickettii (strain 12J)	622	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]	GO:0004613; GO:0005525; GO:0005737; GO:0006094; GO:0030145	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	NA
TRINITY_DN37145_c0_g1_i1	B2U804	PCKG_RALPJ	100	69	0	0	1	207	110	178	1.30E-33	142.9	PCKG_RALPJ	reviewed	Phosphoenolpyruvate carboxykinase [GTP] (PEP carboxykinase) (PEPCK) (EC 4.1.1.32)	pckG Rpic_3739	Ralstonia pickettii (strain 12J)	622	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]	GO:0004613; GO:0005525; GO:0005737; GO:0006094; GO:0030145	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	NA
TRINITY_DN35354_c0_g1_i1	B2U804	PCKG_RALPJ	92.6	68	5	0	1	204	480	547	9.80E-37	153.3	PCKG_RALPJ	reviewed	Phosphoenolpyruvate carboxykinase [GTP] (PEP carboxykinase) (PEPCK) (EC 4.1.1.32)	pckG Rpic_3739	Ralstonia pickettii (strain 12J)	622	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]	GO:0004613; GO:0005525; GO:0005737; GO:0006094; GO:0030145	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	NA
TRINITY_DN16842_c2_g1_i1	P20007	PCKG_DROME	68.4	95	29	1	283	2	129	223	8.60E-31	134	PCKG_DROME	reviewed	Phosphoenolpyruvate carboxykinase [GTP] (PEPCK) (EC 4.1.1.32)	Pepck ZDF4 CG17725	Drosophila melanogaster (Fruit fly)	647	cytosol [GO:0005829]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; cellular response to glucose stimulus [GO:0071333]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]	GO:0004613; GO:0005525; GO:0005739; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0033993; GO:0042594; GO:0046327; GO:0071333	cellular response to glucose stimulus [GO:0071333]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN16842_c1_g1_i1	P20007	PCKG_DROME	68.4	114	35	1	3	341	105	218	1.30E-38	160.2	PCKG_DROME	reviewed	Phosphoenolpyruvate carboxykinase [GTP] (PEPCK) (EC 4.1.1.32)	Pepck ZDF4 CG17725	Drosophila melanogaster (Fruit fly)	647	cytosol [GO:0005829]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; cellular response to glucose stimulus [GO:0071333]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]	GO:0004613; GO:0005525; GO:0005739; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0033993; GO:0042594; GO:0046327; GO:0071333	cellular response to glucose stimulus [GO:0071333]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN12457_c0_g1_i1	Q8BH04	PCKGM_MOUSE	98.6	222	3	0	666	1	176	397	4.20E-129	461.8	PCKGM_MOUSE	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	Pck2	Mus musculus (Mouse)	640	cytosol [GO:0005829]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005829; GO:0006090; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN12457_c0_g1_i2	Q8BH04	PCKGM_MOUSE	98.2	332	6	0	998	3	176	507	1.40E-200	699.9	PCKGM_MOUSE	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	Pck2	Mus musculus (Mouse)	640	cytosol [GO:0005829]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005829; GO:0006090; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN20166_c0_g1_i1	Q16822	PCKGM_HUMAN	66.2	80	27	0	6	245	491	570	1.10E-29	130.2	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN36657_c0_g1_i1	Q16822	PCKGM_HUMAN	98.8	84	1	0	2	253	87	170	2.40E-45	182.2	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN22399_c1_g1_i1	Q16822	PCKGM_HUMAN	62.3	77	29	0	236	6	501	577	2.00E-25	115.9	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN22399_c2_g1_i1	Q16822	PCKGM_HUMAN	67.2	64	21	0	195	4	478	541	6.40E-20	97.4	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN2132_c0_g1_i1	Q16822	PCKGM_HUMAN	68.6	609	188	2	203	2029	35	640	2.40E-263	909.4	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		blue	blue	NA	NA	NA	NA
TRINITY_DN2132_c0_g1_i2	Q16822	PCKGM_HUMAN	68.8	609	187	2	203	2029	35	640	8.70E-264	911	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		blue	blue	NA	NA	NA	NA
TRINITY_DN2132_c0_g1_i3	Q16822	PCKGM_HUMAN	68.5	616	191	2	214	2061	28	640	1.70E-264	913.3	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		blue	blue	NA	NA	NA	NA
TRINITY_DN2132_c0_g1_i4	Q16822	PCKGM_HUMAN	68.7	616	190	2	214	2061	28	640	6.10E-265	914.8	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		blue	blue	NA	NA	NA	NA
TRINITY_DN38482_c0_g1_i1	Q16822	PCKGM_HUMAN	63.9	36	13	0	23	130	590	625	1.10E-06	53.9	PCKGM_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	PCK2 PEPCK2	Homo sapiens (Human)	640	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]	GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN13830_c0_g1_i1	Q5R5J1	PCKGC_PONAB	58.8	68	28	0	3	206	165	232	2.70E-18	92	PCKGC_PONAB	reviewed	"Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32) (Serine-protein kinase PCK1) (EC 2.7.11.-)"	PCK1 PPCK1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	622	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; regulation of lipid biosynthetic process [GO:0046890]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]	GO:0004613; GO:0005525; GO:0005783; GO:0005829; GO:0006094; GO:0006107; GO:0018105; GO:0032869; GO:0043382; GO:0046872; GO:0046890; GO:0071333; GO:0106264	cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; regulation of lipid biosynthetic process [GO:0046890]		NA	NA	NA	NA	NA	NA
TRINITY_DN16842_c0_g1_i1	P35558	PCKGC_HUMAN	74.8	115	29	0	347	3	188	302	7.70E-50	197.6	PCKGC_HUMAN	reviewed	"Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32) (Serine-protein kinase PCK1) (EC 2.7.11.-)"	PCK1 PEPCK1	Homo sapiens (Human)	622	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]; aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to potassium ion starvation [GO:0051365]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of lipid biosynthetic process [GO:0046890]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	carboxylic acid binding [GO:0031406]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]	GO:0000287; GO:0004613; GO:0005525; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006006; GO:0006090; GO:0006094; GO:0006107; GO:0007568; GO:0014823; GO:0018105; GO:0019003; GO:0019543; GO:0030145; GO:0031406; GO:0032496; GO:0032868; GO:0032869; GO:0033993; GO:0042593; GO:0042594; GO:0043382; GO:0046327; GO:0046890; GO:0051365; GO:0061402; GO:0070062; GO:0070365; GO:0070741; GO:0071300; GO:0071320; GO:0071332; GO:0071333; GO:0071347; GO:0071356; GO:0071377; GO:0071456; GO:0071549; GO:0106264; GO:1904640	aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to potassium ion starvation [GO:0051365]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of lipid biosynthetic process [GO:0046890]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN2482_c0_g1_i1	O88588	PACS1_RAT	36.8	451	255	9	1394	60	530	956	1.10E-69	265.8	PACS1_RAT	reviewed	Phosphofurin acidic cluster sorting protein 1 (PACS-1)	Pacs1	Rattus norvegicus (Rat)	961	COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; cellular protein localization [GO:0034613]; positive regulation of protein binding [GO:0032092]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]	COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	ion channel binding [GO:0044325]	GO:0005794; GO:0030137; GO:0032092; GO:0034067; GO:0034613; GO:0044325; GO:0048471; GO:0072659	cellular protein localization [GO:0034613]; positive regulation of protein binding [GO:0032092]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN2482_c0_g1_i2	Q8K212	PACS1_MOUSE	36.8	451	255	9	1394	60	530	956	4.10E-69	263.8	PACS1_MOUSE	reviewed	Phosphofurin acidic cluster sorting protein 1 (PACS-1)	Pacs1	Mus musculus (Mouse)	961	COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; cellular protein localization [GO:0034613]; positive regulation of protein binding [GO:0032092]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]	COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	ion channel binding [GO:0044325]	GO:0005794; GO:0030137; GO:0032092; GO:0034067; GO:0034613; GO:0044325; GO:0048471; GO:0072659	cellular protein localization [GO:0034613]; positive regulation of protein binding [GO:0032092]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN8276_c0_g1_i1	P39671	PGM_RHIRD	75.8	182	44	0	22	567	210	391	6.90E-80	298.1	PGM_RHIRD	reviewed	Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase)	pgm exoC pscA	Rhizobium radiobacter (Agrobacterium tumefaciens) (Agrobacterium radiobacter)	542	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; glucose metabolic process [GO:0006006]		magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0006006	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN1850_c0_g1_i1	P39671	PGM_RHIRD	74.5	98	25	0	6	299	214	311	4.40E-38	158.3	PGM_RHIRD	reviewed	Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase)	pgm exoC pscA	Rhizobium radiobacter (Agrobacterium tumefaciens) (Agrobacterium radiobacter)	542	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; glucose metabolic process [GO:0006006]		magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0006006	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN39875_c0_g1_i1	P39671	PGM_RHIRD	70.6	163	48	0	490	2	1	163	6.90E-63	241.5	PGM_RHIRD	reviewed	Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase)	pgm exoC pscA	Rhizobium radiobacter (Agrobacterium tumefaciens) (Agrobacterium radiobacter)	542	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; glucose metabolic process [GO:0006006]		magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0006006	glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN711_c0_g1_i1	Q9VUY9	PGM_DROME	63	562	205	2	1753	71	1	560	6.00E-213	741.9	PGM_DROME	reviewed	Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase)	Pgm1 CG5165	Drosophila melanogaster (Fruit fly)	560	cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]	cytosol [GO:0005829]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005829; GO:0005975; GO:0005978; GO:0006006	carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]		blue	blue	NA	NA	NA	NA
TRINITY_DN23853_c0_g2_i1	Q9M4G4	PGMC_SOLTU	63.2	171	46	4	13	516	293	449	6.30E-56	218.4	PGMC_SOLTU	reviewed	"Phosphoglucomutase, cytoplasmic (PGM) (EC 5.4.2.2) (Glucose phosphomutase)"	PGM1 PGM I	Solanum tuberosum (Potato)	583	cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]	cytosol [GO:0005829]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005829; GO:0005975; GO:0006006	carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN20296_c0_g1_i1	Q08DP0	PGM1_BOVIN	100	72	0	0	218	3	336	407	8.10E-37	153.7	PGM1_BOVIN	reviewed	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)	PGM1	Bos taurus (Bovine)	562	cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]	cytosol [GO:0005829]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005829; GO:0005975; GO:0006006	carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN20296_c0_g1_i2	P36871	PGM1_HUMAN	100	77	0	0	233	3	331	407	4.10E-39	161.4	PGM1_HUMAN	reviewed	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)	PGM1	Homo sapiens (Human)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0005978; GO:0005980; GO:0006006; GO:0006094; GO:0006096; GO:0019388; GO:0043312; GO:0070062; GO:1904724; GO:1904813	carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN26410_c0_g1_i1	P36871	PGM1_HUMAN	100	69	0	0	209	3	465	533	5.20E-33	141	PGM1_HUMAN	reviewed	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)	PGM1	Homo sapiens (Human)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0005978; GO:0005980; GO:0006006; GO:0006094; GO:0006096; GO:0019388; GO:0043312; GO:0070062; GO:1904724; GO:1904813	carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN17957_c0_g1_i1	P36871	PGM1_HUMAN	100	179	0	0	1	537	140	318	1.10E-100	367.1	PGM1_HUMAN	reviewed	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)	PGM1	Homo sapiens (Human)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0005978; GO:0005980; GO:0006006; GO:0006094; GO:0006096; GO:0019388; GO:0043312; GO:0070062; GO:1904724; GO:1904813	carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN17957_c0_g1_i2	P36871	PGM1_HUMAN	100	134	0	0	1	402	140	273	1.20E-73	276.9	PGM1_HUMAN	reviewed	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)	PGM1	Homo sapiens (Human)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0005978; GO:0005980; GO:0006006; GO:0006094; GO:0006096; GO:0019388; GO:0043312; GO:0070062; GO:1904724; GO:1904813	carbohydrate metabolic process [GO:0005975]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN25846_c0_g1_i1	Q9D0F9	PGM1_MOUSE	100	86	0	0	258	1	449	534	1.50E-42	172.9	PGM1_MOUSE	reviewed	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1) (Phosphoglucomutase-2)	Pgm1 Pgm2	Mus musculus (Mouse)	562	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Z disc [GO:0030018]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Z disc [GO:0030018]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005737; GO:0005829; GO:0005975; GO:0006006; GO:0030018	carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]		NA	NA	NA	NA	NA	NA
TRINITY_DN25724_c0_g1_i1	Q96G03	PGM2_HUMAN	60	150	58	1	541	92	465	612	3.00E-48	193	PGM2_HUMAN	reviewed	Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7)	PGM2 MSTP006	Homo sapiens (Human)	612	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]	GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006098; GO:0008973; GO:0019388; GO:0034774; GO:0043312; GO:0046386; GO:0070062; GO:1904813	deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN27738_c0_g1_i1	P51903	PGK_CHICK	67.6	68	22	0	206	3	278	345	2.20E-20	99	PGK_CHICK	reviewed	Phosphoglycerate kinase (EC 2.7.2.3)	PGK	Gallus gallus (Chicken)	417	chromosome [GO:0005694]; cytosol [GO:0005829]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]; positive regulation of oxidative phosphorylation [GO:1903862]	chromosome [GO:0005694]; cytosol [GO:0005829]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]	GO:0004618; GO:0005524; GO:0005694; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0043531; GO:1903862	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]; positive regulation of oxidative phosphorylation [GO:1903862]		NA	NA	NA	NA	NA	NA
TRINITY_DN17665_c1_g1_i1	A5V9J6	PGK_SPHWW	91.9	74	6	0	3	224	167	240	1.80E-31	136	PGK_SPHWW	reviewed	Phosphoglycerate kinase (EC 2.7.2.3)	pgk Swit_2604	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	397	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]	GO:0004618; GO:0005524; GO:0005737; GO:0006096	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN33276_c0_g1_i1	P27362	PGK_PLAF7	72.6	62	17	0	259	74	355	416	1.00E-17	90.5	PGK_PLAF7	reviewed	Phosphoglycerate kinase (EC 2.7.2.3)	PGK PFI1105w	Plasmodium falciparum (isolate 3D7)	416	cytosol [GO:0005829]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; positive regulation of oxidative phosphorylation [GO:1903862]	cytosol [GO:0005829]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]	GO:0004618; GO:0005524; GO:0005829; GO:0006094; GO:0006096; GO:0043531; GO:1903862	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; positive regulation of oxidative phosphorylation [GO:1903862]		red	red	NA	NA	NA	NA
TRINITY_DN3259_c0_g1_i3	Q60HD8	PGK1_MACFA	75.9	270	65	0	889	80	147	416	1.20E-115	417.5	PGK1_MACFA	reviewed	Phosphoglycerate kinase 1 (EC 2.7.2.3)	PGK1 QccE-15495	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	417	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]	GO:0004618; GO:0005524; GO:0005737; GO:0006096	glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN3259_c0_g1_i4	P09411	PGK1_MOUSE	99.6	261	1	0	859	77	157	417	1.40E-148	526.9	PGK1_MOUSE	reviewed	Phosphoglycerate kinase 1 (EC 2.7.2.3)	Pgk1 Pgk-1	Mus musculus (Mouse)	417	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; carbohydrate metabolic process [GO:0005975]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]	GO:0004618; GO:0005524; GO:0005615; GO:0005737; GO:0005829; GO:0005975; GO:0006094; GO:0006096; GO:0016310; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0045121; GO:0047134; GO:0071456; GO:1903862	carbohydrate metabolic process [GO:0005975]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]		NA	NA	NA	NA	NA	NA
TRINITY_DN3259_c0_g1_i2	P00558	PGK1_HUMAN	100	261	0	0	859	77	157	417	8.10E-149	527.7	PGK1_HUMAN	reviewed	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1 PGKA MIG10 OK/SW-cl.110	Homo sapiens (Human)	417	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]	GO:0004618; GO:0005524; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0016020; GO:0016310; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0045121; GO:0047134; GO:0061621; GO:0070062; GO:0071456; GO:1903862	canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]		NA	NA	NA	NA	NA	NA
TRINITY_DN31813_c0_g1_i1	P00558	PGK1_HUMAN	76	125	30	0	2	376	163	287	2.30E-47	189.5	PGK1_HUMAN	reviewed	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1 PGKA MIG10 OK/SW-cl.110	Homo sapiens (Human)	417	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]	GO:0004618; GO:0005524; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0016020; GO:0016310; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0045121; GO:0047134; GO:0061621; GO:0070062; GO:0071456; GO:1903862	canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]		NA	NA	NA	NA	NA	NA
TRINITY_DN13513_c0_g2_i1	P18669	PGAM1_HUMAN	100	197	0	0	1	591	58	254	4.70E-112	405.2	PGAM1_HUMAN	reviewed	Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)	PGAM1 PGAMA CDABP0006	Homo sapiens (Human)	254	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]	GO:0004082; GO:0004619; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006094; GO:0006096; GO:0006110; GO:0016020; GO:0016787; GO:0019901; GO:0034774; GO:0043312; GO:0043456; GO:0045730; GO:0061621; GO:0070062; GO:1904813	canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]		NA	NA	NA	NA	NA	NA
TRINITY_DN13513_c0_g1_i1	P18669	PGAM1_HUMAN	100	210	0	0	1	630	45	254	7.60E-121	434.5	PGAM1_HUMAN	reviewed	Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)	PGAM1 PGAMA CDABP0006	Homo sapiens (Human)	254	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]	GO:0004082; GO:0004619; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006094; GO:0006096; GO:0006110; GO:0016020; GO:0016787; GO:0019901; GO:0034774; GO:0043312; GO:0043456; GO:0045730; GO:0061621; GO:0070062; GO:1904813	canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]		NA	NA	NA	NA	NA	NA
TRINITY_DN11236_c1_g1_i1	Q32KV0	PGAM2_BOVIN	68.4	79	25	0	257	21	58	136	7.10E-24	110.9	PGAM2_BOVIN	reviewed	Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2)	PGAM2	Bos taurus (Bovine)	253	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; glycolytic process [GO:0006096]		bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0006096; GO:0016787	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN11236_c0_g1_i2	Q32KV0	PGAM2_BOVIN	71.8	149	41	1	482	36	106	253	2.90E-55	216.1	PGAM2_BOVIN	reviewed	Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2)	PGAM2	Bos taurus (Bovine)	253	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; glycolytic process [GO:0006096]		bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0006096; GO:0016787	glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN22302_c0_g1_i1	Q32KV0	PGAM2_BOVIN	69.7	221	66	1	91	753	34	253	5.60E-83	308.9	PGAM2_BOVIN	reviewed	Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2)	PGAM2	Bos taurus (Bovine)	253	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; glycolytic process [GO:0006096]		bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0006096; GO:0016787	glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN22302_c0_g1_i3	Q32KV0	PGAM2_BOVIN	69.3	254	77	1	160	921	1	253	1.10E-98	361.3	PGAM2_BOVIN	reviewed	Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2)	PGAM2	Bos taurus (Bovine)	253	bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; glycolytic process [GO:0006096]		bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]	GO:0004082; GO:0004619; GO:0006096; GO:0016787	glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN11236_c0_g1_i1	O70250	PGAM2_MOUSE	71.4	56	16	0	203	36	198	253	1.10E-14	80.1	PGAM2_MOUSE	reviewed	Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M)	Pgam2	Mus musculus (Mouse)	253	"cytosol [GO:0005829]; nucleus [GO:0005634]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to inorganic substance [GO:0010035]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; phosphoglycerate mutase activity [GO:0004619]"	GO:0004082; GO:0004619; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0006941; GO:0007219; GO:0007283; GO:0010035; GO:0016787; GO:0042802; GO:0046538; GO:0046689	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to inorganic substance [GO:0010035]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN288_c0_g1_i12	Q8VD65	PI3R4_MOUSE	38.2	605	324	12	1788	79	551	1140	6.90E-102	372.9	PI3R4_MOUSE	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1)	Pik3r4 Vps15	Mus musculus (Mouse)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN288_c0_g1_i14	Q8VD65	PI3R4_MOUSE	40.7	827	436	14	2464	89	551	1358	1.50E-168	594.7	PI3R4_MOUSE	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1)	Pik3r4 Vps15	Mus musculus (Mouse)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN288_c0_g1_i3	Q8VD65	PI3R4_MOUSE	40.7	827	436	14	2466	91	551	1358	1.50E-168	594.7	PI3R4_MOUSE	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1)	Pik3r4 Vps15	Mus musculus (Mouse)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN288_c0_g1_i5	Q8VD65	PI3R4_MOUSE	46.5	312	155	4	957	46	1051	1358	1.00E-78	295	PI3R4_MOUSE	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1)	Pik3r4 Vps15	Mus musculus (Mouse)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN288_c0_g1_i7	Q8VD65	PI3R4_MOUSE	38.2	607	325	12	1805	90	551	1142	1.40E-102	375.2	PI3R4_MOUSE	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1)	Pik3r4 Vps15	Mus musculus (Mouse)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN288_c0_g1_i9	Q8VD65	PI3R4_MOUSE	38.2	607	325	12	1796	81	551	1142	8.20E-103	375.9	PI3R4_MOUSE	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1)	Pik3r4 Vps15	Mus musculus (Mouse)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016236; GO:0030242; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN13933_c0_g1_i3	Q99570	PI3R4_HUMAN	57.3	124	53	0	378	7	375	498	6.20E-30	132.1	PI3R4_HUMAN	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein)	PIK3R4 VPS15	Homo sapiens (Human)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006623; GO:0006661; GO:0015630; GO:0016020; GO:0016236; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034162; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]		blue	blue	NA	NA	NA	NA
TRINITY_DN2355_c2_g1_i29	Q99570	PI3R4_HUMAN	54.2	48	22	0	4	147	1093	1140	1.20E-08	60.8	PI3R4_HUMAN	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein)	PIK3R4 VPS15	Homo sapiens (Human)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006623; GO:0006661; GO:0015630; GO:0016020; GO:0016236; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034162; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]		NA	NA	NA	NA	NA	NA
TRINITY_DN2355_c2_g1_i30	Q99570	PI3R4_HUMAN	54.2	48	22	0	4	147	1093	1140	1.50E-08	60.8	PI3R4_HUMAN	reviewed	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein)	PIK3R4 VPS15	Homo sapiens (Human)	1358	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]"	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006623; GO:0006661; GO:0015630; GO:0016020; GO:0016236; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034162; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]		NA	NA	NA	NA	NA	NA
TRINITY_DN2977_c0_g1_i4	A2VBC4	PA1_POLPI	30	203	121	7	583	8	122	314	1.70E-14	81.3	PA1_POLPI	reviewed	Phospholipase A1 (EC 3.1.1.32) (allergen Poly p 1)		Polybia paulista (Neotropical social wasp) (Swarm-founding polistine wasp)	322	extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; triglyceride lipase activity [GO:0004806]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0008970; GO:0016042; GO:0044179; GO:0052739; GO:0052740	hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2977_c0_g1_i8	A2VBC4	PA1_POLPI	29.6	203	122	7	690	115	122	314	1.30E-14	81.6	PA1_POLPI	reviewed	Phospholipase A1 (EC 3.1.1.32) (allergen Poly p 1)		Polybia paulista (Neotropical social wasp) (Swarm-founding polistine wasp)	322	extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; triglyceride lipase activity [GO:0004806]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]	extracellular region [GO:0005576]	1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; triglyceride lipase activity [GO:0004806]	GO:0004806; GO:0005576; GO:0008970; GO:0016042; GO:0044179; GO:0052739; GO:0052740	hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2977_c0_g1_i1	Q06478	PA11_DOLMA	32.4	173	97	5	653	177	93	259	7.50E-14	79	PA11_DOLMA	reviewed	Phospholipase A1 1 (EC 3.1.1.32) (EC 3.1.1.4) (Allergen Dol m I) (allergen Dol m 1) (Fragment)		Dolichovespula maculata (Bald-faced hornet) (Vespula maculata)	317	"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]"	GO:0004623; GO:0004806; GO:0005576; GO:0008970; GO:0016042; GO:0052739; GO:0052740; GO:0102567; GO:0102568	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2977_c0_g1_i3	Q06478	PA11_DOLMA	32.4	173	97	5	744	268	93	259	8.60E-14	79	PA11_DOLMA	reviewed	Phospholipase A1 1 (EC 3.1.1.32) (EC 3.1.1.4) (Allergen Dol m I) (allergen Dol m 1) (Fragment)		Dolichovespula maculata (Bald-faced hornet) (Vespula maculata)	317	"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]"	GO:0004623; GO:0004806; GO:0005576; GO:0008970; GO:0016042; GO:0052739; GO:0052740; GO:0102567; GO:0102568	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2977_c0_g1_i5	Q06478	PA11_DOLMA	30.4	204	121	5	730	161	63	259	1.90E-16	88.2	PA11_DOLMA	reviewed	Phospholipase A1 1 (EC 3.1.1.32) (EC 3.1.1.4) (Allergen Dol m I) (allergen Dol m 1) (Fragment)		Dolichovespula maculata (Bald-faced hornet) (Vespula maculata)	317	"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]"	GO:0004623; GO:0004806; GO:0005576; GO:0008970; GO:0016042; GO:0052739; GO:0052740; GO:0102567; GO:0102568	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2977_c0_g1_i6	Q06478	PA11_DOLMA	30.4	204	121	5	616	47	63	259	1.70E-16	88.2	PA11_DOLMA	reviewed	Phospholipase A1 1 (EC 3.1.1.32) (EC 3.1.1.4) (Allergen Dol m I) (allergen Dol m 1) (Fragment)		Dolichovespula maculata (Bald-faced hornet) (Vespula maculata)	317	"extracellular region [GO:0005576]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]"	extracellular region [GO:0005576]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; triglyceride lipase activity [GO:0004806]"	GO:0004623; GO:0004806; GO:0005576; GO:0008970; GO:0016042; GO:0052739; GO:0052740; GO:0102567; GO:0102568	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN32016_c0_g1_i1	Q9Y263	PLAP_HUMAN	100	77	0	0	232	2	219	295	5.10E-42	171	PLAP_HUMAN	reviewed	Phospholipase A-2-activating protein (PLA2P) (PLAP)	PLAA PLAP	Homo sapiens (Human)	795	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]; phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]	phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]	GO:0005634; GO:0005737; GO:0006644; GO:0006693; GO:0006954; GO:0007165; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224	cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin recycling [GO:0010992]		NA	NA	NA	NA	NA	NA
TRINITY_DN26472_c0_g1_i1	Q9Y263	PLAP_HUMAN	100	85	0	0	257	3	332	416	4.70E-44	177.9	PLAP_HUMAN	reviewed	Phospholipase A-2-activating protein (PLA2P) (PLAP)	PLAA PLAP	Homo sapiens (Human)	795	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]; phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]	phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]	GO:0005634; GO:0005737; GO:0006644; GO:0006693; GO:0006954; GO:0007165; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224	cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin recycling [GO:0010992]		NA	NA	NA	NA	NA	NA
TRINITY_DN2630_c0_g1_i1	Q9Y263	PLAP_HUMAN	43.1	802	432	12	98	2458	3	795	8.70E-183	642.1	PLAP_HUMAN	reviewed	Phospholipase A-2-activating protein (PLA2P) (PLAP)	PLAA PLAP	Homo sapiens (Human)	795	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]; phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]	phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]	GO:0005634; GO:0005737; GO:0006644; GO:0006693; GO:0006954; GO:0007165; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224	cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin recycling [GO:0010992]		NA	NA	NA	NA	NA	NA
TRINITY_DN219_c0_g1_i3	Q8WU67	ABHD3_HUMAN	42.8	353	190	5	1037	3	32	380	3.70E-80	300.1	ABHD3_HUMAN	reviewed	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3)	ABHD3	Homo sapiens (Human)	409	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"	GO:0004623; GO:0005886; GO:0006656; GO:0008126; GO:0008970; GO:0016021; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568	cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]		NA	NA	NA	NA	NA	NA
TRINITY_DN219_c0_g1_i7	Q8WU67	ABHD3_HUMAN	42.8	353	190	5	1037	3	32	380	3.70E-80	300.1	ABHD3_HUMAN	reviewed	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3)	ABHD3	Homo sapiens (Human)	409	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"	GO:0004623; GO:0005886; GO:0006656; GO:0008126; GO:0008970; GO:0016021; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568	cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]		NA	NA	NA	NA	NA	NA
TRINITY_DN219_c0_g1_i4	Q91ZH7	ABHD3_MOUSE	40.1	354	201	5	1057	5	37	382	1.70E-72	274.6	ABHD3_MOUSE	reviewed	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3)	Abhd3 Labh3	Mus musculus (Mouse)	411	"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]"	integral component of membrane [GO:0016021]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"	GO:0004623; GO:0008126; GO:0008970; GO:0016021; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568	cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]		NA	NA	NA	NA	NA	NA
TRINITY_DN219_c0_g1_i6	Q91ZH7	ABHD3_MOUSE	40.1	354	201	5	1057	5	37	382	1.70E-72	274.6	ABHD3_MOUSE	reviewed	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3)	Abhd3 Labh3	Mus musculus (Mouse)	411	"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]"	integral component of membrane [GO:0016021]	"1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; short-chain carboxylesterase activity [GO:0034338]"	GO:0004623; GO:0008126; GO:0008970; GO:0016021; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740; GO:0102567; GO:0102568	cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine metabolic process [GO:0046470]		NA	NA	NA	NA	NA	NA
TRINITY_DN22710_c0_g1_i1	Q38882	PLDA1_ARATH	56.2	73	25	3	13	213	222	293	3.90E-12	71.6	PLDA1_ARATH	reviewed	Phospholipase D alpha 1 (AtPLDalpha1) (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (PLDalpha) (Phosphatidylcholine-hydrolyzing phospholipase D 1)	PLDALPHA1 PLD1 At3g15730 MSJ11.13	Arabidopsis thaliana (Mouse-ear cress)	810	"chloroplast [GO:0009507]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase activity [GO:0004620]; phospholipase D activity [GO:0004630]; abscisic acid-activated signaling pathway [GO:0009738]; ethylene-activated signaling pathway [GO:0009873]; fatty acid metabolic process [GO:0006631]; leaf shaping [GO:0010358]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; regulation of stomatal movement [GO:0010119]; response to abscisic acid [GO:0009737]; response to cadmium ion [GO:0046686]; seed germination [GO:0009845]"	chloroplast [GO:0009507]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]	"calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase activity [GO:0004620]; phospholipase D activity [GO:0004630]"	GO:0004620; GO:0004630; GO:0005096; GO:0005509; GO:0005546; GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0009395; GO:0009506; GO:0009507; GO:0009737; GO:0009738; GO:0009789; GO:0009845; GO:0009873; GO:0010119; GO:0010358; GO:0016020; GO:0030136; GO:0031966; GO:0046470; GO:0046686; GO:0070290	abscisic acid-activated signaling pathway [GO:0009738]; ethylene-activated signaling pathway [GO:0009873]; fatty acid metabolic process [GO:0006631]; leaf shaping [GO:0010358]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; regulation of stomatal movement [GO:0010119]; response to abscisic acid [GO:0009737]; response to cadmium ion [GO:0046686]; seed germination [GO:0009845]		NA	NA	NA	NA	NA	NA
TRINITY_DN35830_c0_g1_i1	Q43270	PLDA1_MAIZE	41.2	825	406	22	2366	81	4	812	1.00E-162	575.5	PLDA1_MAIZE	reviewed	Phospholipase D alpha 1 (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1)	PLD1	Zea mays (Maize)	812	plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]	plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005509; GO:0005886; GO:0009395; GO:0046470; GO:0070290	phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]		NA	NA	NA	NA	NA	NA
TRINITY_DN4970_c0_g1_i1	Q43270	PLDA1_MAIZE	51.8	282	119	6	811	5	459	736	2.20E-71	270.4	PLDA1_MAIZE	reviewed	Phospholipase D alpha 1 (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1)	PLD1	Zea mays (Maize)	812	plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]	plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005509; GO:0005886; GO:0009395; GO:0046470; GO:0070290	phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]		NA	NA	NA	NA	NA	NA
TRINITY_DN26653_c0_g1_i1	O04865	PLDA1_VIGUN	54.7	53	22	1	54	206	258	310	3.80E-10	65.1	PLDA1_VIGUN	reviewed	Phospholipase D alpha 1 (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1)	PLD1	Vigna unguiculata (Cowpea)	809	membrane [GO:0016020]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]	membrane [GO:0016020]	calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005509; GO:0016020; GO:0016042; GO:0046470; GO:0070290	lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN26653_c0_g1_i2	Q43007	PLDA1_ORYSJ	51.5	130	59	3	1	384	187	314	1.30E-29	130.6	PLDA1_ORYSJ	reviewed	Phospholipase D alpha 1 (PLD alpha 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D 1)	PLD1 Os01g0172400 LOC_Os01g07760 OsJ_00559	Oryza sativa subsp. japonica (Rice)	812	plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]	plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005509; GO:0005886; GO:0009395; GO:0046470; GO:0070290	phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]		NA	NA	NA	NA	NA	NA
TRINITY_DN1117_c1_g2_i1	P93733	PLDB1_ARATH	52.2	92	43	1	1	273	932	1023	9.70E-22	104	PLDB1_ARATH	reviewed	Phospholipase D beta 1 (AtPLDbeta1) (PLD beta 1) (PLDbeta) (EC 3.1.4.4)	PLDBETA1 At2g42010 T6D20.10	Arabidopsis thaliana (Mouse-ear cress)	1083	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; metal ion binding [GO:0046872]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]; defense response to bacterium, incompatible interaction [GO:0009816]; phospholipid catabolic process [GO:0009395]; response to cadmium ion [GO:0046686]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	"metal ion binding [GO:0046872]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]"	GO:0004630; GO:0005546; GO:0005737; GO:0005886; GO:0009395; GO:0009506; GO:0009816; GO:0046686; GO:0046872; GO:0070290	"defense response to bacterium, incompatible interaction [GO:0009816]; phospholipid catabolic process [GO:0009395]; response to cadmium ion [GO:0046686]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1117_c0_g1_i1	O23078	PLDB2_ARATH	36.1	812	436	18	2336	120	116	917	1.30E-132	475.3	PLDB2_ARATH	reviewed	Phospholipase D beta 2 (AtPLDbeta2) (PLD beta 2) (EC 3.1.4.4) (PLDdelta1)	PLDBETA2 At4g00240 A_IG005I10.13 F5I10.13	Arabidopsis thaliana (Mouse-ear cress)	927	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005509; GO:0005737; GO:0005886; GO:0009395; GO:0046470; GO:0070290	phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]		blue	blue	NA	NA	NA	NA
TRINITY_DN6133_c0_g1_i1	Q9T053	PLDG1_ARATH	49.6	119	58	1	28	384	364	480	1.90E-31	136.7	PLDG1_ARATH	reviewed	Phospholipase D gamma 1 (AtPLDgamma1) (PLD gamma 1) (EC 3.1.4.4) (Choline phosphatase) (Lecithinase D) (Lipophosphodiesterase II)	PLDGAMMA1 At4g11850 T26M18.60	Arabidopsis thaliana (Mouse-ear cress)	858	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]; embryo development ending in seed dormancy [GO:0009793]; innate immune response [GO:0045087]; membrane lipid metabolic process [GO:0006643]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]; response to aluminum ion [GO:0010044]; response to oxidative stress [GO:0006979]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]"	GO:0004630; GO:0005509; GO:0005546; GO:0005829; GO:0005886; GO:0006643; GO:0006979; GO:0009395; GO:0009793; GO:0010044; GO:0045087; GO:0046470; GO:0070290	embryo development ending in seed dormancy [GO:0009793]; innate immune response [GO:0045087]; membrane lipid metabolic process [GO:0006643]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]; response to aluminum ion [GO:0010044]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN22710_c0_g2_i1	Q9T053	PLDG1_ARATH	49.1	234	98	7	653	6	369	599	3.80E-50	199.5	PLDG1_ARATH	reviewed	Phospholipase D gamma 1 (AtPLDgamma1) (PLD gamma 1) (EC 3.1.4.4) (Choline phosphatase) (Lecithinase D) (Lipophosphodiesterase II)	PLDGAMMA1 At4g11850 T26M18.60	Arabidopsis thaliana (Mouse-ear cress)	858	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]; embryo development ending in seed dormancy [GO:0009793]; innate immune response [GO:0045087]; membrane lipid metabolic process [GO:0006643]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]; response to aluminum ion [GO:0010044]; response to oxidative stress [GO:0006979]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase D activity [GO:0004630]"	GO:0004630; GO:0005509; GO:0005546; GO:0005829; GO:0005886; GO:0006643; GO:0006979; GO:0009395; GO:0009793; GO:0010044; GO:0045087; GO:0046470; GO:0070290	embryo development ending in seed dormancy [GO:0009793]; innate immune response [GO:0045087]; membrane lipid metabolic process [GO:0006643]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid catabolic process [GO:0009395]; response to aluminum ion [GO:0010044]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN33883_c0_g1_i1	Q9M9W8	PLDZ2_ARATH	46.3	82	29	1	27	227	841	922	8.90E-13	73.9	PLDZ2_ARATH	reviewed	Phospholipase D zeta 2 (PLDzeta2) (EC 3.1.4.4) (Phospholipase D p2) (AtPLDp2) (Phospholipase D2 PHOX and PX-containing domain protein)	PLPZETA2 PLDP2 At3g05630 F18C1.10	Arabidopsis thaliana (Mouse-ear cress)	1046	plasma membrane [GO:0005886]; vacuole [GO:0005773]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; cellular response to nitrogen starvation [GO:0006995]; cellular response to phosphate starvation [GO:0016036]; galactolipid biosynthetic process [GO:0019375]; inositol lipid-mediated signaling [GO:0048017]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; regulation of vesicle-mediated transport [GO:0060627]; response to auxin [GO:0009733]; root development [GO:0048364]	plasma membrane [GO:0005886]; vacuole [GO:0005773]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005773; GO:0005886; GO:0006654; GO:0006995; GO:0008610; GO:0009395; GO:0009733; GO:0016036; GO:0019375; GO:0048017; GO:0048364; GO:0060627; GO:0070290	cellular response to nitrogen starvation [GO:0006995]; cellular response to phosphate starvation [GO:0016036]; galactolipid biosynthetic process [GO:0019375]; inositol lipid-mediated signaling [GO:0048017]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; regulation of vesicle-mediated transport [GO:0060627]; response to auxin [GO:0009733]; root development [GO:0048364]		NA	NA	NA	NA	NA	NA
TRINITY_DN12447_c0_g1_i1	O08684	PLD1_CRIGR	37.7	504	264	8	17	1510	58	517	8.90E-91	335.9	PLD1_CRIGR	reviewed	Phospholipase D1 (PLD 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1)	PLD1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1036	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]	GO:0000139; GO:0004630; GO:0005789; GO:0006654; GO:0016042; GO:0031902; GO:0035091; GO:0048017; GO:0048471; GO:0070290	inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]		NA	NA	NA	NA	NA	NA
TRINITY_DN12447_c0_g1_i5	O08684	PLD1_CRIGR	27.4	339	198	7	446	1444	58	354	4.00E-31	137.5	PLD1_CRIGR	reviewed	Phospholipase D1 (PLD 1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1)	PLD1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1036	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]	GO:0000139; GO:0004630; GO:0005789; GO:0006654; GO:0016042; GO:0031902; GO:0035091; GO:0048017; GO:0048471; GO:0070290	inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]		NA	NA	NA	NA	NA	NA
TRINITY_DN29859_c0_g1_i1	Q0V8L6	PLD2_BOVIN	51.7	327	150	4	992	12	606	924	6.40E-87	322.4	PLD2_BOVIN	reviewed	Phospholipase D2 (PLD 2) (EC 3.1.4.4) (Choline phosphatase 2) (Phosphatidylcholine-hydrolyzing phospholipase D2)	PLD2	Bos taurus (Bovine)	933	membrane [GO:0016020]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]	membrane [GO:0016020]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0006654; GO:0016020; GO:0016042; GO:0035091; GO:0048017; GO:0048870; GO:0070290	cell motility [GO:0048870]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]		NA	NA	NA	NA	NA	NA
TRINITY_DN29859_c0_g1_i2	Q0V8L6	PLD2_BOVIN	50.6	449	208	6	1355	12	489	924	3.40E-118	427.2	PLD2_BOVIN	reviewed	Phospholipase D2 (PLD 2) (EC 3.1.4.4) (Choline phosphatase 2) (Phosphatidylcholine-hydrolyzing phospholipase D2)	PLD2	Bos taurus (Bovine)	933	membrane [GO:0016020]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]	membrane [GO:0016020]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0006654; GO:0016020; GO:0016042; GO:0035091; GO:0048017; GO:0048870; GO:0070290	cell motility [GO:0048870]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]		NA	NA	NA	NA	NA	NA
TRINITY_DN38056_c0_g1_i1	O14939	PLD2_HUMAN	100	82	0	0	247	2	347	428	7.90E-41	167.2	PLD2_HUMAN	reviewed	Phospholipase D2 (PLD 2) (hPLD2) (EC 3.1.4.4) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)	PLD2	Homo sapiens (Human)	933	endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465]	endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005789; GO:0005886; GO:0006654; GO:0007010; GO:0007264; GO:0016042; GO:0035091; GO:0036465; GO:0038096; GO:0048017; GO:0048870; GO:0070290; GO:0098793	cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465]		NA	NA	NA	NA	NA	NA
TRINITY_DN26413_c0_g1_i1	P97813	PLD2_MOUSE	99	101	1	0	3	305	380	480	2.50E-52	205.7	PLD2_MOUSE	reviewed	Phospholipase D2 (PLD 2) (mPLD2) (EC 3.1.4.4) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)	Pld2	Mus musculus (Mouse)	933	brush border membrane [GO:0031526]; caveola [GO:0005901]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; protein kinase C binding [GO:0005080]; cell motility [GO:0048870]; G protein-coupled receptor internalization [GO:0002031]; inositol lipid-mediated signaling [GO:0048017]; neuron projection development [GO:0031175]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]	brush border membrane [GO:0031526]; caveola [GO:0005901]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; protein kinase C binding [GO:0005080]	GO:0001666; GO:0002031; GO:0004630; GO:0005080; GO:0005634; GO:0005789; GO:0005794; GO:0005886; GO:0005901; GO:0006654; GO:0006898; GO:0009395; GO:0014068; GO:0014070; GO:0030027; GO:0030335; GO:0031175; GO:0031526; GO:0035091; GO:0042383; GO:0042542; GO:0043306; GO:0043434; GO:0045785; GO:0048017; GO:0048260; GO:0048870; GO:0070290	cell motility [GO:0048870]; G protein-coupled receptor internalization [GO:0002031]; inositol lipid-mediated signaling [GO:0048017]; neuron projection development [GO:0031175]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]		NA	NA	NA	NA	NA	NA
TRINITY_DN28456_c0_g1_i1	P36969	GPX4_HUMAN	98.8	80	1	0	1	240	63	142	7.00E-42	170.6	GPX4_HUMAN	reviewed	Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)	GPX4	Homo sapiens (Human)	197	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]; aging [GO:0007568]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; glutathione metabolic process [GO:0006749]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; oxidation-reduction process [GO:0055114]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]	GO:0004601; GO:0004602; GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0005829; GO:0006325; GO:0006644; GO:0006749; GO:0006979; GO:0007275; GO:0007283; GO:0007568; GO:0008430; GO:0019369; GO:0019372; GO:0032355; GO:0032991; GO:0042759; GO:0042802; GO:0047066; GO:0050727; GO:0051258; GO:0055114; GO:0070062; GO:0110076	aging [GO:0007568]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; glutathione metabolic process [GO:0006749]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; oxidation-reduction process [GO:0055114]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN27709_c0_g1_i1	P36968	GPX4_PIG	68.6	86	27	0	258	1	63	148	1.00E-30	133.7	GPX4_PIG	reviewed	Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)	GPX4	Sus scrofa (Pig)	197	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; lipoxygenase pathway [GO:0019372]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]	GO:0004601; GO:0004602; GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0005829; GO:0006325; GO:0006979; GO:0007275; GO:0007283; GO:0019369; GO:0019372; GO:0032991; GO:0042802; GO:0047066; GO:0051258; GO:0110076	arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; lipoxygenase pathway [GO:0019372]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN16623_c0_g1_i1	O70325	GPX4_MOUSE	98.7	77	1	0	1	231	70	146	5.10E-42	171	GPX4_MOUSE	reviewed	Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)	Gpx4	Mus musculus (Mouse)	197	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]; aging [GO:0007568]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; glutathione metabolic process [GO:0006749]; lipoxygenase pathway [GO:0019372]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]	GO:0004601; GO:0004602; GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006325; GO:0006749; GO:0006979; GO:0007275; GO:0007283; GO:0007568; GO:0008430; GO:0019369; GO:0019372; GO:0032355; GO:0032991; GO:0042802; GO:0047066; GO:0050727; GO:0051258; GO:0110076	aging [GO:0007568]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; glutathione metabolic process [GO:0006749]; lipoxygenase pathway [GO:0019372]; multicellular organism development [GO:0007275]; negative regulation of ferroptosis [GO:0110076]; protein polymerization [GO:0051258]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN36570_c0_g1_i1	O14494	PLPP1_HUMAN	100	69	0	0	1	207	110	178	9.90E-37	153.3	PLPP1_HUMAN	reviewed	Phospholipid phosphatase 1 (EC 3.1.3.-) (EC 3.1.3.106) (EC 3.1.3.4) (EC 3.1.3.81) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a)	PLPP1 LPP1 PPAP2A	Homo sapiens (Human)	284	apical plasma membrane [GO:0016324]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ceramide-1-phosphate phosphatase activity [GO:0106235]; diacylglycerol diphosphate phosphatase activity [GO:0000810]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; androgen receptor signaling pathway [GO:0030521]; ceramide metabolic process [GO:0006672]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell population proliferation [GO:0008285]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of lipid metabolic process [GO:0019216]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]	apical plasma membrane [GO:0016324]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	ceramide-1-phosphate phosphatase activity [GO:0106235]; diacylglycerol diphosphate phosphatase activity [GO:0000810]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0000810; GO:0005886; GO:0005887; GO:0005901; GO:0006644; GO:0006670; GO:0006672; GO:0007165; GO:0007205; GO:0008195; GO:0008285; GO:0016020; GO:0016324; GO:0016791; GO:0019216; GO:0030148; GO:0030518; GO:0030521; GO:0042392; GO:0042577; GO:0045121; GO:0046839; GO:0070062; GO:0106235	androgen receptor signaling pathway [GO:0030521]; ceramide metabolic process [GO:0006672]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell population proliferation [GO:0008285]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of lipid metabolic process [GO:0019216]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]		NA	NA	NA	NA	NA	NA
TRINITY_DN398_c0_g1_i1	O14495	PLPP3_HUMAN	49.1	214	102	3	847	209	71	278	1.10E-49	198.4	PLPP3_HUMAN	reviewed	Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)	PLPP3 LPP3 PPAP2B	Homo sapiens (Human)	311	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion [GO:0044329]; canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration [GO:0044328]; canonical Wnt signaling pathway involved in positive regulation of wound healing [GO:0044330]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0016020; GO:0016021; GO:0016323; GO:0016791; GO:0030111; GO:0030148; GO:0033116; GO:0033631; GO:0034109; GO:0042392; GO:0042577; GO:0044328; GO:0044329; GO:0044330; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0060070; GO:0070971; GO:0106235; GO:1902068	"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion [GO:0044329]; canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration [GO:0044328]; canonical Wnt signaling pathway involved in positive regulation of wound healing [GO:0044330]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]"		NA	NA	NA	NA	NA	NA
TRINITY_DN398_c0_g1_i2	O14495	PLPP3_HUMAN	45.2	157	79	3	726	259	71	221	4.40E-31	136.3	PLPP3_HUMAN	reviewed	Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)	PLPP3 LPP3 PPAP2B	Homo sapiens (Human)	311	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion [GO:0044329]; canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration [GO:0044328]; canonical Wnt signaling pathway involved in positive regulation of wound healing [GO:0044330]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0016020; GO:0016021; GO:0016323; GO:0016791; GO:0030111; GO:0030148; GO:0033116; GO:0033631; GO:0034109; GO:0042392; GO:0042577; GO:0044328; GO:0044329; GO:0044330; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0060070; GO:0070971; GO:0106235; GO:1902068	"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion [GO:0044329]; canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration [GO:0044328]; canonical Wnt signaling pathway involved in positive regulation of wound healing [GO:0044330]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]"		NA	NA	NA	NA	NA	NA
TRINITY_DN398_c0_g1_i3	O14495	PLPP3_HUMAN	49.1	214	102	3	987	349	71	278	1.30E-49	198.4	PLPP3_HUMAN	reviewed	Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)	PLPP3 LPP3 PPAP2B	Homo sapiens (Human)	311	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion [GO:0044329]; canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration [GO:0044328]; canonical Wnt signaling pathway involved in positive regulation of wound healing [GO:0044330]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0016020; GO:0016021; GO:0016323; GO:0016791; GO:0030111; GO:0030148; GO:0033116; GO:0033631; GO:0034109; GO:0042392; GO:0042577; GO:0044328; GO:0044329; GO:0044330; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0060070; GO:0070971; GO:0106235; GO:1902068	"Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion [GO:0044329]; canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration [GO:0044328]; canonical Wnt signaling pathway involved in positive regulation of wound healing [GO:0044330]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9398_c0_g1_i1	Q66H88	PLPP6_RAT	36.2	149	94	1	599	153	132	279	7.40E-19	95.9	PLPP6_RAT	reviewed	Phospholipid phosphatase 6 (EC 3.1.3.-) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (Presqualene diphosphate phosphatase)	Plpp6 Ppapdc2	Rattus norvegicus (Rat)	293	integral component of membrane [GO:0016021]; membrane [GO:0016020]; lipid phosphatase activity [GO:0042577]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; phospholipid dephosphorylation [GO:0046839]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	lipid phosphatase activity [GO:0042577]; sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0016020; GO:0016021; GO:0042392; GO:0042577; GO:0046839	phospholipid dephosphorylation [GO:0046839]		blue	blue	NA	NA	NA	NA
TRINITY_DN6089_c0_g1_i1	O15162	PLS1_HUMAN	47.7	218	86	2	116	694	96	310	3.90E-57	223	PLS1_HUMAN	reviewed	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b)	PLSCR1	Homo sapiens (Human)	318	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"	GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:0070782; GO:1905820; GO:2000373	acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]		NA	NA	NA	NA	NA	NA
TRINITY_DN6089_c0_g1_i2	O15162	PLS1_HUMAN	52.3	218	101	1	116	769	96	310	2.90E-66	253.4	PLS1_HUMAN	reviewed	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b)	PLSCR1	Homo sapiens (Human)	318	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"	GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:0070782; GO:1905820; GO:2000373	acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]		blue	blue	NA	NA	NA	NA
TRINITY_DN26514_c0_g1_i1	O15162	PLS1_HUMAN	100	88	0	0	272	9	231	318	3.30E-48	191.8	PLS1_HUMAN	reviewed	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b)	PLSCR1	Homo sapiens (Human)	318	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"	GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:0070782; GO:1905820; GO:2000373	acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]		NA	NA	NA	NA	NA	NA
TRINITY_DN36598_c0_g1_i1	O15162	PLS1_HUMAN	100	143	0	0	430	2	79	221	2.60E-85	315.8	PLS1_HUMAN	reviewed	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b)	PLSCR1	Homo sapiens (Human)	318	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"	GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:0070782; GO:1905820; GO:2000373	acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]		NA	NA	NA	NA	NA	NA
TRINITY_DN11326_c0_g1_i1	O15162	PLS1_HUMAN	60.1	228	90	1	114	794	85	312	5.30E-84	312.4	PLS1_HUMAN	reviewed	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b)	PLSCR1	Homo sapiens (Human)	318	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]"	GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:0070782; GO:1905820; GO:2000373	acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288]		NA	NA	NA	NA	NA	NA
TRINITY_DN39885_c0_g1_i1	Q9JJ00	PLS1_MOUSE	100	96	0	0	313	26	233	328	5.70E-52	204.5	PLS1_MOUSE	reviewed	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (Transplantability-associated protein 1) (NOR1) (TRA1)	Plscr1 Tra1b Tras1	Mus musculus (Mouse)	328	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]"	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]"	GO:0000287; GO:0001228; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0008270; GO:0010628; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032091; GO:0032791; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:1905820; GO:2000373	acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]		NA	NA	NA	NA	NA	NA
TRINITY_DN27697_c0_g1_i1	Q9DCW2	PLS2_MOUSE	95.6	136	6	0	411	4	83	218	2.00E-76	286.2	PLS2_MOUSE	reviewed	Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2)	Plscr2	Mus musculus (Mouse)	307	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; cellular response to lipopolysaccharide [GO:0071222]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0005886; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0046872; GO:0070782; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]		NA	NA	NA	NA	NA	NA
TRINITY_DN11326_c0_g1_i2	Q3ZBG9	PLS2_BOVIN	59.9	227	90	1	114	791	67	293	2.80E-83	310.1	PLS2_BOVIN	reviewed	Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2)	PLSCR2	Bos taurus (Bovine)	293	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]	GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872	plasma membrane phospholipid scrambling [GO:0017121]		NA	NA	NA	NA	NA	NA
TRINITY_DN23675_c0_g1_i1	Q9NRY6	PLS3_HUMAN	95.9	73	3	0	44	262	223	295	9.70E-35	147.1	PLS3_HUMAN	reviewed	Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3)	PLSCR3	Homo sapiens (Human)	295	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124]	GO:0000287; GO:0005509; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006915; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0032049; GO:0032791; GO:0042593; GO:0042632; GO:0042981; GO:0043621; GO:0045340; GO:0048306; GO:0071222; GO:0090199	apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199]		NA	NA	NA	NA	NA	NA
TRINITY_DN23675_c0_g1_i2	Q9JIZ9	PLS3_MOUSE	98.5	67	1	0	44	244	224	290	1.50E-31	136.3	PLS3_MOUSE	reviewed	Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3)	Plscr3	Mus musculus (Mouse)	296	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124]	GO:0000287; GO:0005509; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006915; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0032049; GO:0032791; GO:0042593; GO:0042632; GO:0042981; GO:0043621; GO:0045340; GO:0048306; GO:0071222; GO:0090199	apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199]		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i3	P41233	ABCA1_MOUSE	50	90	44	1	250	516	862	951	2.50E-16	87	ABCA1_MOUSE	reviewed	Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	Mus musculus (Mouse)	2261	"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]	GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0007584; GO:0008035; GO:0008203; GO:0008320; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016020; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0032611; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0035690; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140115; GO:0140328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"		NA	NA	NA	NA	NA	NA
TRINITY_DN182_c0_g1_i5	P41233	ABCA1_MOUSE	50	90	44	1	284	550	862	951	2.70E-16	87	ABCA1_MOUSE	reviewed	Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	Mus musculus (Mouse)	2261	"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]	GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0007584; GO:0008035; GO:0008203; GO:0008320; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016020; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0032611; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0035690; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140115; GO:0140328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"		NA	NA	NA	NA	NA	NA
TRINITY_DN569_c0_g1_i1	P41233	ABCA1_MOUSE	27.9	1132	673	27	3261	10	105	1141	2.30E-96	355.5	ABCA1_MOUSE	reviewed	Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	Abca1 Abc1	Mus musculus (Mouse)	2261	"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]	GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0007584; GO:0008035; GO:0008203; GO:0008320; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016020; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0032611; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0035690; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140115; GO:0140328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10322_c0_g1_i1	O95477	ABCA1_HUMAN	61.8	102	37	1	343	38	2040	2139	1.00E-31	137.5	ABCA1_HUMAN	reviewed	Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)	ABCA1 ABC1 CERP	Homo sapiens (Human)	2261	"basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"	basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]	GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0007584; GO:0008035; GO:0008203; GO:0008320; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019216; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0032611; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0035690; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140115; GO:0140328	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to drug [GO:0035690]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta production [GO:0032611]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7257_c0_g1_i2	P70704	AT8A1_MOUSE	63.6	99	36	0	298	2	626	724	4.60E-30	131.7	AT8A1_MOUSE	reviewed	Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)	Atp8a1 Atpc1	Mus musculus (Mouse)	1164	chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; flippase activity [GO:0140327]; magnesium ion binding [GO:0000287]; transmembrane transporter activity [GO:0022857]; learning [GO:0007612]; lipid transport [GO:0006869]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transmembrane transport [GO:0055085]	chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; flippase activity [GO:0140327]; magnesium ion binding [GO:0000287]; transmembrane transporter activity [GO:0022857]	GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006869; GO:0007612; GO:0016887; GO:0022857; GO:0030285; GO:0030335; GO:0042584; GO:0043231; GO:0045332; GO:0055085; GO:0061092; GO:0140326; GO:0140327	learning [GO:0007612]; lipid transport [GO:0006869]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN32384_c0_g1_i1	C7EXK4	AT8A2_BOVIN	66.2	65	22	0	196	2	130	194	1.00E-17	90.1	AT8A2_BOVIN	reviewed	Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (P4-ATPase flippase complex alpha subunit ATP8A2)	ATP8A2	Bos taurus (Bovine)	1148	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]	GO:0000287; GO:0005524; GO:0005768; GO:0005794; GO:0005886; GO:0016021; GO:0090556; GO:0097381			NA	NA	NA	NA	NA	NA
TRINITY_DN36313_c0_g1_i1	P98198	AT8B2_HUMAN	55.1	78	33	1	234	7	773	850	6.60E-16	84.3	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN12387_c0_g1_i1	P98198	AT8B2_HUMAN	73.1	78	21	0	268	35	361	438	1.20E-26	120.2	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN32723_c0_g1_i1	P98198	AT8B2_HUMAN	100	81	0	0	246	4	775	855	1.60E-38	159.5	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN7257_c0_g1_i1	P98199	AT8B2_MOUSE	62	100	38	0	305	6	633	732	4.00E-29	128.6	AT8B2_MOUSE	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	Atp8b2	Mus musculus (Mouse)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN6399_c0_g1_i1	P98198	AT8B2_HUMAN	74.7	194	49	0	588	7	769	962	3.00E-78	292.7	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN4831_c0_g1_i5	P98198	AT8B2_HUMAN	72.5	40	11	0	981	862	150	189	2.00E-10	68.2	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		brown	brown	1	NA	NA	NA
TRINITY_DN4831_c0_g1_i1	P98198	AT8B2_HUMAN	65.4	240	82	1	721	2	51	289	3.40E-85	316.2	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN4831_c0_g1_i10	P98198	AT8B2_HUMAN	72.5	40	11	0	1088	969	150	189	2.20E-10	68.2	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN4831_c0_g1_i13	P98198	AT8B2_HUMAN	64.1	259	92	1	778	2	32	289	3.00E-90	333.2	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN4831_c0_g1_i14	P98198	AT8B2_HUMAN	65.2	158	55	0	508	35	32	189	1.20E-50	201.1	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN4831_c0_g1_i2	P98198	AT8B2_HUMAN	69	42	13	0	160	35	148	189	2.40E-11	68.9	AT8B2_HUMAN	reviewed	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	ATP8B2 ATPID KIAA1137	Homo sapiens (Human)	1209	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0034220; GO:0045332; GO:0140326	Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN14434_c0_g1_i1	Q9U280	TAT1_CAEEL	69.2	133	41	0	3	401	715	847	7.80E-46	184.5	TAT1_CAEEL	reviewed	Phospholipid-transporting ATPase tat-1 (EC 7.6.2.1)	tat-1 Y49E10.11	Caenorhabditis elegans	1139	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006897; GO:0007040; GO:0015914; GO:0016323; GO:0016324; GO:0031901; GO:0045332; GO:0055037; GO:0055038; GO:0060100; GO:0060101; GO:0140326	"endocytosis [GO:0006897]; lysosome organization [GO:0007040]; negative regulation of phagocytosis, engulfment [GO:0060101]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phagocytosis, engulfment [GO:0060100]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26790_c0_g1_i1	Q1W377	PMM_SOLLC	65.6	154	53	0	514	53	91	244	2.00E-60	233.4	PMM_SOLLC	reviewed	Phosphomannomutase (LePMM) (EC 5.4.2.8)	PMM	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	252	cytosol [GO:0005829]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	cytosol [GO:0005829]	phosphomannomutase activity [GO:0004615]	GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0045047	GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]		NA	NA	NA	NA	NA	NA
TRINITY_DN28455_c0_g1_i1	Q9UTJ2	PMM_SCHPO	50.5	95	44	1	1	276	149	243	5.40E-22	104.8	PMM_SCHPO	reviewed	Phosphomannomutase (PMM) (EC 5.4.2.8)	pmm1 SPAC1556.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	257	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	cytosol [GO:0005829]; nucleus [GO:0005634]	phosphomannomutase activity [GO:0004615]	GO:0004615; GO:0005634; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0045047	GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]		NA	NA	NA	NA	NA	NA
TRINITY_DN11268_c0_g1_i1	Q1W374	PMM_WHEAT	60.3	214	83	2	729	88	34	245	8.50E-75	281.6	PMM_WHEAT	reviewed	Phosphomannomutase (TaPMM) (EC 5.4.2.8)	PMM PMM-A1	Triticum aestivum (Wheat)	249	cytosol [GO:0005829]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	cytosol [GO:0005829]	phosphomannomutase activity [GO:0004615]	GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0045047	GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]		NA	NA	NA	NA	NA	NA
TRINITY_DN38578_c0_g1_i1	O15305	PMM2_HUMAN	100	168	0	0	3	506	58	225	3.80E-98	358.6	PMM2_HUMAN	reviewed	Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8)	PMM2	Homo sapiens (Human)	246	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]	GO:0004615; GO:0005654; GO:0005829; GO:0006013; GO:0006486; GO:0006487; GO:0009298; GO:0043025; GO:0045047; GO:0046872	GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]		NA	NA	NA	NA	NA	NA
TRINITY_DN12053_c0_g2_i1	Q944H0	PEAM2_ARATH	48.1	79	41	0	278	42	118	196	1.50E-17	90.1	PEAM2_ARATH	reviewed	Phosphomethylethanolamine N-methyltransferase (AtPMEAMT) (EC 2.1.1.-) (Phosphoethanolamine N-methyltransferase 2)	NMT2 PMEAMT At1g48600 T1N15.22/T1N15.23 T1N15_20	Arabidopsis thaliana (Mouse-ear cress)	491	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]	GO:0000234; GO:0003729; GO:0005737; GO:0006656; GO:0032259; GO:0052667	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]		NA	NA	NA	NA	NA	NA
TRINITY_DN9707_c0_g1_i10	Q944H0	PEAM2_ARATH	50.4	266	128	1	124	921	229	490	1.30E-75	284.6	PEAM2_ARATH	reviewed	Phosphomethylethanolamine N-methyltransferase (AtPMEAMT) (EC 2.1.1.-) (Phosphoethanolamine N-methyltransferase 2)	NMT2 PMEAMT At1g48600 T1N15.22/T1N15.23 T1N15_20	Arabidopsis thaliana (Mouse-ear cress)	491	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]	GO:0000234; GO:0003729; GO:0005737; GO:0006656; GO:0032259; GO:0052667	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]		NA	NA	NA	NA	NA	NA
TRINITY_DN9707_c0_g1_i5	Q944H0	PEAM2_ARATH	50.5	212	101	1	178	813	283	490	5.90E-59	229.2	PEAM2_ARATH	reviewed	Phosphomethylethanolamine N-methyltransferase (AtPMEAMT) (EC 2.1.1.-) (Phosphoethanolamine N-methyltransferase 2)	NMT2 PMEAMT At1g48600 T1N15.22/T1N15.23 T1N15_20	Arabidopsis thaliana (Mouse-ear cress)	491	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]	GO:0000234; GO:0003729; GO:0005737; GO:0006656; GO:0032259; GO:0052667	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]		NA	NA	NA	NA	NA	NA
TRINITY_DN31274_c0_g1_i1	Q944H0	PEAM2_ARATH	47.1	104	53	1	360	55	6	109	5.00E-21	102.4	PEAM2_ARATH	reviewed	Phosphomethylethanolamine N-methyltransferase (AtPMEAMT) (EC 2.1.1.-) (Phosphoethanolamine N-methyltransferase 2)	NMT2 PMEAMT At1g48600 T1N15.22/T1N15.23 T1N15_20	Arabidopsis thaliana (Mouse-ear cress)	491	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphomethylethanolamine N-methyltransferase activity [GO:0052667]	GO:0000234; GO:0003729; GO:0005737; GO:0006656; GO:0032259; GO:0052667	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]		NA	NA	NA	NA	NA	NA
TRINITY_DN2929_c0_g1_i1	Q2KIU2	PMVK_BOVIN	55.8	172	73	1	126	641	6	174	2.70E-48	193.7	PMVK_BOVIN	reviewed	Phosphomevalonate kinase (PMKase) (EC 2.7.4.2)	PMVK	Bos taurus (Bovine)	192	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]"	cytosol [GO:0005829]	ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]	GO:0004631; GO:0005524; GO:0005829; GO:0006695; GO:0019287	"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]"		NA	NA	NA	NA	NA	NA
TRINITY_DN326_c0_g1_i1	B8DKP2	PHNX_DESVM	43.9	271	152	0	903	91	7	277	8.40E-60	232.3	PHNX_DESVM	reviewed	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	phnX DvMF_0514	Desulfovibrio vulgaris (strain Miyazaki F / DSM 19637)	280	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]		magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]	GO:0000287; GO:0019700; GO:0050194	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN326_c0_g1_i2	A6V8P9	PHNX_PSEA7	43	256	146	0	858	91	17	272	8.80E-56	218.8	PHNX_PSEA7	reviewed	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	phnX PSPA7_4080	Pseudomonas aeruginosa (strain PA7)	275	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]		magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]	GO:0000287; GO:0019700; GO:0050194	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN326_c0_g1_i3	B8DKP2	PHNX_DESVM	43.9	271	152	0	903	91	7	277	1.40E-59	231.5	PHNX_DESVM	reviewed	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	phnX DvMF_0514	Desulfovibrio vulgaris (strain Miyazaki F / DSM 19637)	280	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]		magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]	GO:0000287; GO:0019700; GO:0050194	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN326_c0_g1_i5	A6V8P9	PHNX_PSEA7	43	256	146	0	858	91	17	272	8.90E-56	218.8	PHNX_PSEA7	reviewed	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	phnX PSPA7_4080	Pseudomonas aeruginosa (strain PA7)	275	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]		magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]	GO:0000287; GO:0019700; GO:0050194	organic phosphonate catabolic process [GO:0019700]		NA	NA	NA	NA	NA	NA
TRINITY_DN326_c0_g1_i6	B8DKP2	PHNX_DESVM	43.9	271	152	0	903	91	7	277	1.40E-59	231.5	PHNX_DESVM	reviewed	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	phnX DvMF_0514	Desulfovibrio vulgaris (strain Miyazaki F / DSM 19637)	280	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]		magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]	GO:0000287; GO:0019700; GO:0050194	organic phosphonate catabolic process [GO:0019700]		blue	blue	NA	NA	NA	NA
TRINITY_DN7566_c0_g1_i2	P40506	PPCS_YEAST	55.3	94	40	1	428	153	39	132	2.30E-20	100.1	PPCS_YEAST	reviewed	Phosphopantothenate--cysteine ligase CAB2 (EC 6.3.2.5) (Coenzyme A biosynthesis protein 2) (Phosphopantothenoylcysteine synthetase) (PPC synthetase)	CAB2 YIL083C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	365	CoA-synthesizing protein complex [GO:1990143]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phosphopantothenate--cysteine ligase activity [GO:0004632]; coenzyme A biosynthetic process [GO:0015937]	CoA-synthesizing protein complex [GO:1990143]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	phosphopantothenate--cysteine ligase activity [GO:0004632]	GO:0004632; GO:0005634; GO:0005737; GO:0015937; GO:1990143	coenzyme A biosynthetic process [GO:0015937]		NA	NA	1	NA	NA	NA
TRINITY_DN33580_c0_g1_i1	Q96CD2	COAC_HUMAN	97.4	78	2	0	236	3	64	141	2.60E-41	168.7	COAC_HUMAN	reviewed	Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC)	PPCDC COAC MDS018 UNQ9365/PRO34154	Homo sapiens (Human)	204	cytosol [GO:0005829]; phosphopantothenoylcysteine decarboxylase complex [GO:0071513]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; phosphopantothenoylcysteine decarboxylase complex [GO:0071513]	FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]	GO:0004633; GO:0005829; GO:0010181; GO:0015937; GO:0042802; GO:0071513	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN1900_c0_g1_i1	Q8BZB2	COAC_MOUSE	64	86	31	0	495	752	72	157	1.90E-30	134.4	COAC_MOUSE	reviewed	Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC)	Ppcdc Coac	Mus musculus (Mouse)	204	phosphopantothenoylcysteine decarboxylase complex [GO:0071513]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]	phosphopantothenoylcysteine decarboxylase complex [GO:0071513]	FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]	GO:0004633; GO:0010181; GO:0015937; GO:0042802; GO:0071513	coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN1900_c0_g1_i2	Q8BZB2	COAC_MOUSE	58.9	124	51	0	495	866	72	195	1.70E-41	171.4	COAC_MOUSE	reviewed	Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC)	Ppcdc Coac	Mus musculus (Mouse)	204	phosphopantothenoylcysteine decarboxylase complex [GO:0071513]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]	phosphopantothenoylcysteine decarboxylase complex [GO:0071513]	FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]	GO:0004633; GO:0010181; GO:0015937; GO:0042802; GO:0071513	coenzyme A biosynthetic process [GO:0015937]		blue	blue	NA	NA	NA	NA
TRINITY_DN25960_c0_g1_i1	Q14558	KPRA_HUMAN	100	270	0	0	812	3	13	282	6.50E-148	524.6	KPRA_HUMAN	reviewed	Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39)	PRPSAP1	Homo sapiens (Human)	356	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0004857; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0009165; GO:0042802	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN346_c0_g1_i1	Q5ZL26	KPRB_CHICK	70.2	359	102	2	1116	49	13	369	4.40E-137	489.2	KPRB_CHICK	reviewed	Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2)	PRPSAP2 RCJMB04_8b17	Gallus gallus (Chicken)	369	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009165	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN346_c0_g1_i4	Q5ZL26	KPRB_CHICK	69.7	360	103	3	1119	49	13	369	3.50E-134	479.6	KPRB_CHICK	reviewed	Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2)	PRPSAP2 RCJMB04_8b17	Gallus gallus (Chicken)	369	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009165	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN21187_c0_g1_i1	Q8R574	KPRB_MOUSE	100	133	0	0	400	2	43	175	1.30E-69	263.5	KPRB_MOUSE	reviewed	Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41)	Prpsap2	Mus musculus (Mouse)	369	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]	identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009165; GO:0032991; GO:0042802; GO:0060348	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN27968_c0_g1_i1	Q8XXC4	PUR2_RALSO	92.9	84	6	0	1	252	73	156	4.20E-37	154.8	PUR2_RALSO	reviewed	Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (GARS) (Glycinamide ribonucleotide synthetase) (Phosphoribosylglycinamide synthetase)	purD RSc2191 RS01408	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	422	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]	GO:0004637; GO:0005524; GO:0006189; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN6038_c0_g1_i1	Q9FDL5	PUR2_ZYMMO	70.9	79	23	0	252	16	226	304	1.50E-26	119.8	PUR2_ZYMMO	reviewed	Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (GARS) (Glycinamide ribonucleotide synthetase) (Phosphoribosylglycinamide synthetase)	purD ZMO0299	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	417	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]	GO:0004637; GO:0005524; GO:0006189; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c1_g2_i1	O66949	PUR2_AQUAE	56.2	48	21	0	228	85	88	135	1.40E-09	63.5	PUR2_AQUAE	reviewed	Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (GARS) (Glycinamide ribonucleotide synthetase) (Phosphoribosylglycinamide synthetase)	purD aq_742	Aquifex aeolicus (strain VF5)	424	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]	GO:0004637; GO:0005524; GO:0006189; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN8365_c0_g1_i1	Q986A5	PUR2_RHILO	55.8	43	18	1	86	214	53	94	7.20E-05	47.8	PUR2_RHILO	reviewed	Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (GARS) (Glycinamide ribonucleotide synthetase) (Phosphoribosylglycinamide synthetase)	purD mlr7447	Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))	425	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]	GO:0004637; GO:0005524; GO:0006189; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN32049_c0_g1_i1	B2S4W8	PUR5_BRUA1	52.8	89	39	1	262	5	150	238	1.60E-18	93.2	PUR5_BRUA1	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM BAbS19_I06840	Brucella abortus (strain S19)	359	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN37531_c0_g1_i1	Q2G9X9	PUR5_NOVAD	96.1	76	3	0	2	229	219	294	9.30E-36	150.2	PUR5_NOVAD	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM Saro_0899	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN10413_c0_g1_i1	Q2G9X9	PUR5_NOVAD	92.4	66	5	0	199	2	145	210	1.30E-28	126.3	PUR5_NOVAD	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM Saro_0899	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN10413_c0_g2_i1	Q1GSA2	PUR5_SPHAL	89.4	123	13	0	369	1	92	214	2.20E-58	226.1	PUR5_SPHAL	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM Sala_1757	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN4035_c0_g1_i1	Q8XW52	PUR5_RALSO	94.5	127	5	1	3	377	5	131	1.50E-62	240	PUR5_RALSO	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM RSc2623 RS00927	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	353	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	1
TRINITY_DN12749_c0_g1_i1	B0KBQ3	PUR5_THEP3	65.2	66	23	0	122	319	73	138	3.20E-20	99.4	PUR5_THEP3	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM Teth39_1711	Thermoanaerobacter pseudethanolicus (strain ATCC 33223 / 39E) (Clostridium thermohydrosulfuricum)	336	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN7452_c0_g1_i1	Q2N8X9	PUR5_ERYLH	82.9	76	13	0	230	3	220	295	7.60E-30	130.6	PUR5_ERYLH	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM ELI_08850	Erythrobacter litoralis (strain HTCC2594)	368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN28313_c0_g1_i1	Q2N8X9	PUR5_ERYLH	82.4	91	16	0	3	275	216	306	1.90E-35	149.4	PUR5_ERYLH	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM ELI_08850	Erythrobacter litoralis (strain HTCC2594)	368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN33446_c0_g1_i1	Q8XW52	PUR5_RALSO	93.9	165	10	0	498	4	137	301	9.60E-86	317.4	PUR5_RALSO	reviewed	Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase)	purM RSc2623 RS00927	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	353	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]	GO:0004641; GO:0005524; GO:0005737; GO:0006189	'de novo' IMP biosynthetic process [GO:0006189]		NA	NA	NA	NA	NA	NA
TRINITY_DN35791_c0_g1_i1	O15067	PUR4_HUMAN	60.3	78	29	1	236	3	1054	1129	1.40E-18	93.2	PUR4_HUMAN	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	PFAS KIAA0361	Homo sapiens (Human)	1338	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005829; GO:0006189; GO:0006541; GO:0009168; GO:0042493; GO:0046872; GO:0070062; GO:0097065	'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN34972_c0_g1_i1	O15067	PUR4_HUMAN	100	96	0	0	289	2	481	576	1.20E-51	203.4	PUR4_HUMAN	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	PFAS KIAA0361	Homo sapiens (Human)	1338	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005829; GO:0006189; GO:0006541; GO:0009168; GO:0042493; GO:0046872; GO:0070062; GO:0097065	'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i1	O15067	PUR4_HUMAN	47.8	364	173	6	1133	45	24	371	6.50E-86	319.3	PUR4_HUMAN	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	PFAS KIAA0361	Homo sapiens (Human)	1338	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005829; GO:0006189; GO:0006541; GO:0009168; GO:0042493; GO:0046872; GO:0070062; GO:0097065	'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i2	Q5SUR0	PUR4_MOUSE	52	914	401	12	2748	52	446	1336	1.30E-240	834.3	PUR4_MOUSE	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	Pfas Kiaa0361	Mus musculus (Mouse)	1337	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; response to drug [GO:0042493]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005737; GO:0006189; GO:0006541; GO:0009156; GO:0042493; GO:0046872; GO:0097065	'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; response to drug [GO:0042493]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i4	Q5SUR0	PUR4_MOUSE	53.8	1360	569	21	4080	52	20	1336	0	1306.2	PUR4_MOUSE	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	Pfas Kiaa0361	Mus musculus (Mouse)	1337	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; response to drug [GO:0042493]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005737; GO:0006189; GO:0006541; GO:0009156; GO:0042493; GO:0046872; GO:0097065	'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; response to drug [GO:0042493]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i6	O15067	PUR4_HUMAN	46.2	403	198	5	1230	52	944	1337	6.10E-92	339.3	PUR4_HUMAN	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	PFAS KIAA0361	Homo sapiens (Human)	1338	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005829; GO:0006189; GO:0006541; GO:0009168; GO:0042493; GO:0046872; GO:0070062; GO:0097065	'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN33340_c0_g1_i1	Q54JC8	PUR4_DICDI	71.4	70	19	1	213	7	369	438	3.20E-22	105.1	PUR4_DICDI	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	purL DDB_G0288145	Dictyostelium discoideum (Slime mold)	1355	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005737; GO:0006164; GO:0006189; GO:0006541; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i3	P35421	PUR4_DROME	49	339	168	3	1074	58	1018	1351	3.90E-87	323.2	PUR4_DROME	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Protein adenosine-2)	Pfas ade2 CG9127	Drosophila melanogaster (Fruit fly)	1354	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005737; GO:0006164; GO:0006189; GO:0006541; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i5	P35421	PUR4_DROME	48.4	62	29	1	243	58	1293	1351	3.50E-12	72.4	PUR4_DROME	reviewed	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Protein adenosine-2)	Pfas ade2 CG9127	Drosophila melanogaster (Fruit fly)	1354	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005737; GO:0006164; GO:0006189; GO:0006541; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN21022_c0_g1_i1	P08179	PUR3_ECOLI	57	93	40	0	5	283	46	138	9.40E-22	104	PUR3_ECOLI	reviewed	Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)	purN b2500 JW2485	Escherichia coli (strain K12)	212	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; cellular response to DNA damage stimulus [GO:0006974]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004644; GO:0005737; GO:0005829; GO:0006189; GO:0006974	'de novo' IMP biosynthetic process [GO:0006189]; cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN39080_c0_g1_i1	P15735	PHKG2_HUMAN	100	151	0	0	453	1	137	287	5.10E-86	318.2	PHKG2_HUMAN	reviewed	"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2)"	PHKG2	Homo sapiens (Human)	406	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0004674; GO:0004689; GO:0005516; GO:0005524; GO:0005829; GO:0005964; GO:0005977; GO:0005978; GO:0005980; GO:0006091; GO:0006468; GO:0019899; GO:0045819; GO:0050321	generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN15955_c0_g1_i1	P15735	PHKG2_HUMAN	100	77	0	0	232	2	323	399	1.70E-40	166	PHKG2_HUMAN	reviewed	"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2)"	PHKG2	Homo sapiens (Human)	406	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0004674; GO:0004689; GO:0005516; GO:0005524; GO:0005829; GO:0005964; GO:0005977; GO:0005978; GO:0005980; GO:0006091; GO:0006468; GO:0019899; GO:0045819; GO:0050321	generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1896_c0_g1_i1	P07934	PHKG1_MOUSE	70.4	54	16	0	46	207	128	181	1.50E-14	80.1	PHKG1_MOUSE	reviewed	"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26)"	Phkg1 Phkg	Mus musculus (Mouse)	388	phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]	phosphorylase kinase complex [GO:0005964]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]	GO:0004689; GO:0005516; GO:0005524; GO:0005964; GO:0005977; GO:0005978; GO:0006468; GO:0019899; GO:0050321	glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1896_c0_g1_i3	P13286	PHKG1_RAT	56.9	274	117	1	1	819	103	376	3.70E-86	319.7	PHKG1_RAT	reviewed	"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26)"	Phkg1 Phkg	Rattus norvegicus (Rat)	388	phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]	phosphorylase kinase complex [GO:0005964]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]	GO:0004689; GO:0005516; GO:0005524; GO:0005964; GO:0005977; GO:0005978; GO:0006468; GO:0019899; GO:0050321	glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN1896_c0_g1_i2	Q16816	PHKG1_HUMAN	67.1	79	26	0	1	237	103	181	2.50E-23	109.4	PHKG1_HUMAN	reviewed	"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHK-gamma-M) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26)"	PHKG1 PHKG	Homo sapiens (Human)	387	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]	GO:0004689; GO:0005516; GO:0005524; GO:0005829; GO:0005964; GO:0005975; GO:0005978; GO:0005980; GO:0019899; GO:0050321	carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]		NA	NA	NA	NA	NA	NA
TRINITY_DN26148_c0_g1_i1	Q93100	KPBB_HUMAN	100	73	0	0	219	1	509	581	2.10E-37	155.6	KPBB_HUMAN	reviewed	Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	PHKB	Homo sapiens (Human)	1093	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; generation of precursor metabolites and energy [GO:0006091]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005977; GO:0005980; GO:0006091; GO:0006468	generation of precursor metabolites and energy [GO:0006091]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN34950_c0_g1_i1	Q93100	KPBB_HUMAN	100	100	0	0	302	3	129	228	2.90E-53	208.8	KPBB_HUMAN	reviewed	Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	PHKB	Homo sapiens (Human)	1093	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; generation of precursor metabolites and energy [GO:0006091]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005977; GO:0005980; GO:0006091; GO:0006468	generation of precursor metabolites and energy [GO:0006091]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN4383_c0_g1_i1	Q3MHI4	PHAX_BOVIN	30.4	319	169	13	860	9	4	304	8.20E-22	105.9	PHAX_BOVIN	reviewed	Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein)	PHAX RNUXA	Bos taurus (Bovine)	394	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005813; GO:0006408; GO:0015030; GO:0015031	protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408]		blue	blue	NA	NA	NA	NA
TRINITY_DN40297_c0_g1_i1	B2U882	SERC_RALPJ	98.7	78	1	0	234	1	172	249	2.00E-41	169.1	SERC_RALPJ	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	serC Rpic_0773	Ralstonia pickettii (strain 12J)	378	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0008615; GO:0030170	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]		NA	NA	NA	NA	NA	NA
TRINITY_DN40545_c0_g1_i1	A6VZ92	SERC_MARMS	57.1	70	28	1	242	33	291	358	1.20E-15	83.6	SERC_MARMS	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	serC Mmwyl1_2859	Marinomonas sp. (strain MWYL1)	359	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0008615; GO:0030170	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]		NA	NA	NA	NA	NA	NA
TRINITY_DN9763_c0_g1_i1	C1D8N3	SERC_LARHH	52.6	211	99	1	2	634	28	237	1.00E-60	234.6	SERC_LARHH	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	serC LHK_01839	Laribacter hongkongensis (strain HLHK9)	359	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0008615; GO:0030170	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]		NA	NA	NA	NA	NA	NA
TRINITY_DN33366_c0_g1_i1	Q9Y617	SERC_HUMAN	100	137	0	0	411	1	113	249	6.70E-77	287.7	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0005829; GO:0006564; GO:0008615; GO:0030170; GO:0042802; GO:0070062	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]		NA	NA	NA	NA	NA	NA
TRINITY_DN14888_c0_g1_i1	Q5M819	SERB_RAT	53.2	139	65	0	485	69	85	223	6.00E-40	165.2	SERB_RAT	reviewed	Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase)	Psph	Rattus norvegicus (Rat)	225	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoserine phosphatase activity [GO:0004647]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoserine phosphatase activity [GO:0004647]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004647; GO:0005509; GO:0005737; GO:0006563; GO:0006564; GO:0009612; GO:0016311; GO:0016791; GO:0031667; GO:0033574; GO:0042802; GO:0042803; GO:0043005	dephosphorylation [GO:0016311]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN37954_c0_g1_i1	Q0P3Z2	PTER_DANRE	47.2	72	38	0	2	217	278	349	4.40E-14	78.2	PTER_DANRE	reviewed	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein)	pter si:ch211-261f3.2 zgc:153666	Danio rerio (Zebrafish) (Brachydanio rerio)	349	hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056]		hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]	GO:0008270; GO:0009056; GO:0016787	catabolic process [GO:0009056]		NA	NA	NA	NA	NA	NA
TRINITY_DN893_c0_g1_i1	Q0P3Z2	PTER_DANRE	52	348	164	2	2090	3133	4	348	5.80E-107	390.6	PTER_DANRE	reviewed	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein)	pter si:ch211-261f3.2 zgc:153666	Danio rerio (Zebrafish) (Brachydanio rerio)	349	hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056]		hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]	GO:0008270; GO:0009056; GO:0016787	catabolic process [GO:0009056]		NA	NA	NA	NA	NA	NA
TRINITY_DN893_c0_g1_i48	Q0P3Z2	PTER_DANRE	52	348	164	2	299	1342	4	348	2.60E-107	390.6	PTER_DANRE	reviewed	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein)	pter si:ch211-261f3.2 zgc:153666	Danio rerio (Zebrafish) (Brachydanio rerio)	349	hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056]		hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]	GO:0008270; GO:0009056; GO:0016787	catabolic process [GO:0009056]		NA	NA	NA	NA	NA	NA
TRINITY_DN39242_c0_g1_i1	Q7SZS2	PTER_XENLA	38.6	70	18	1	6	215	161	205	1.30E-07	56.6	PTER_XENLA	reviewed	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein)	pter	Xenopus laevis (African clawed frog)	349	"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056]"		"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"	GO:0008270; GO:0009056; GO:0016788	catabolic process [GO:0009056]		NA	NA	NA	NA	NA	NA
TRINITY_DN35823_c0_g1_i1	Q9TTF0	NR2E3_BOVIN	75	36	9	0	151	44	239	274	1.60E-08	59.7	NR2E3_BOVIN	reviewed	Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor)	NR2E3	Bos taurus (Bovine)	411	nuclear chromatin [GO:0000790]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000978; GO:0004879; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32604_c0_g1_i1	Q9TTF0	NR2E3_BOVIN	61.4	44	17	0	118	249	367	410	1.10E-08	60.8	NR2E3_BOVIN	reviewed	Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor)	NR2E3	Bos taurus (Bovine)	411	nuclear chromatin [GO:0000790]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0000978; GO:0004879; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35671_c0_g1_i1	Q5BJP9	PHYD1_RAT	55.2	221	98	1	1	660	70	290	5.70E-66	252.3	PHYD1_RAT	reviewed	Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-)	Phyhd1	Rattus norvegicus (Rat)	291	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN34288_c0_g1_i1	O35386	PAHX_MOUSE	100	125	0	0	2	376	141	265	1.80E-76	286.2	PAHX_MOUSE	reviewed	"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Lupus nephritis-associated peptide 1) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)"	Phyh Ln1 Lnap1 Pahx	Mus musculus (Mouse)	338	9+0 non-motile cilium [GO:0097731]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]	9+0 non-motile cilium [GO:0097731]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]	GO:0001561; GO:0003824; GO:0005739; GO:0005777; GO:0005782; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731	2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]		NA	NA	NA	NA	NA	NA
TRINITY_DN7328_c0_g1_i1	P57093	PAHX_RAT	58.9	331	132	4	1025	42	9	338	7.30E-110	398.7	PAHX_RAT	reviewed	"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)"	Phyh	Rattus norvegicus (Rat)	338	9+0 non-motile cilium [GO:0097731]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]	9+0 non-motile cilium [GO:0097731]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]	GO:0001561; GO:0003824; GO:0005739; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731	2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]		blue	blue	NA	NA	NA	NA
TRINITY_DN4568_c0_g1_i1	Q8LSN3	FYPP_PEA	67.1	255	71	2	768	4	20	261	1.10E-107	391	FYPP_PEA	reviewed	Phytochrome-associated serine/threonine-protein phosphatase (EC 3.1.3.16) (PsFyPP)	FYPP	Pisum sativum (Garden pea)	303	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4075_c0_g1_i2	P0DMW6	VKT3A_ACTEQ	42.1	57	31	1	831	1001	4	58	3.00E-09	64.3	VKT3A_ACTEQ	reviewed	PI-actitoxin-Aeq3a (PI-AITX-Aeq3a) (Kunitz-type proteinase inhibitor AEPI-I)		Actinia equina (Beadlet anemone)	59	extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]; nematocyst [GO:0042151]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0042151; GO:0090729			blue	blue	NA	NA	NA	NA
TRINITY_DN23640_c0_g2_i1	P16895	IELA_ANESU	47.8	46	23	1	139	2	2	46	1.20E-05	50.4	IELA_ANESU	reviewed	PI-actitoxin-Avd5a (PI-AITX-Avd5a) (Non-classical Kazal-type elastase inhibitor)		Anemonia sulcata (Mediterranean snakelocks sea anemone)	48	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			blue	blue	NA	NA	NA	NA
TRINITY_DN28494_c0_g1_i1	P16895	IELA_ANESU	53.2	47	22	0	43	183	2	48	2.10E-08	59.3	IELA_ANESU	reviewed	PI-actitoxin-Avd5a (PI-AITX-Avd5a) (Non-classical Kazal-type elastase inhibitor)		Anemonia sulcata (Mediterranean snakelocks sea anemone)	48	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN35682_c0_g1_i1	M9MSG8	PIEZO_DROME	45.9	294	146	4	871	5	425	710	7.00E-63	242.3	PIEZO_DROME	reviewed	Piezo-type mechanosensitive ion channel component	Piezo CG18103	Drosophila melanogaster (Fruit fly)	2551	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0007638; GO:0008381; GO:0016020; GO:0016021; GO:0042391; GO:0050982; GO:0071260; GO:0098655	cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN35682_c0_g1_i3	M9MSG8	PIEZO_DROME	45.8	319	160	4	946	5	400	710	1.30E-67	258.1	PIEZO_DROME	reviewed	Piezo-type mechanosensitive ion channel component	Piezo CG18103	Drosophila melanogaster (Fruit fly)	2551	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0007638; GO:0008381; GO:0016020; GO:0016021; GO:0042391; GO:0050982; GO:0071260; GO:0098655	cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN6170_c0_g1_i1	M9MSG8	PIEZO_DROME	72.2	54	15	0	267	106	2478	2531	1.80E-14	80.1	PIEZO_DROME	reviewed	Piezo-type mechanosensitive ion channel component	Piezo CG18103	Drosophila melanogaster (Fruit fly)	2551	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0007638; GO:0008381; GO:0016020; GO:0016021; GO:0042391; GO:0050982; GO:0071260; GO:0098655	cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN6416_c0_g1_i1	M9MSG8	PIEZO_DROME	53.1	143	66	1	444	869	1702	1844	1.20E-39	165.2	PIEZO_DROME	reviewed	Piezo-type mechanosensitive ion channel component	Piezo CG18103	Drosophila melanogaster (Fruit fly)	2551	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0007638; GO:0008381; GO:0016020; GO:0016021; GO:0042391; GO:0050982; GO:0071260; GO:0098655	cation transmembrane transport [GO:0098655]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; mechanosensory behavior [GO:0007638]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN21535_c0_g1_i1	Q92508	PIEZ1_HUMAN	100	67	0	0	213	13	2455	2521	7.60E-32	137.1	PIEZ1_HUMAN	reviewed	Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A)	PIEZO1 FAM38A KIAA0233	Homo sapiens (Human)	2521	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; regulation of membrane potential [GO:0042391]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0016020; GO:0016021; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260	cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN6170_c0_g1_i2	Q9H5I5	PIEZ2_HUMAN	44.3	619	324	8	1986	145	2146	2748	1.00E-148	528.9	PIEZ2_HUMAN	reviewed	Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B)	PIEZO2 C18orf30 C18orf58 FAM38B	Homo sapiens (Human)	2752	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016020; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260	cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]		NA	NA	NA	NA	NA	NA
TRINITY_DN13269_c0_g2_i1	Q8CD54	PIEZ2_MOUSE	42.1	145	74	3	439	17	1350	1488	2.20E-25	116.7	PIEZ2_MOUSE	reviewed	Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B)	Piezo2 Fam38b	Mus musculus (Mouse)	2822	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016020; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260	cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]		NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i10	Q6P3X8	PGBD2_HUMAN	29	138	95	2	368	778	348	483	5.30E-14	79.7	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i11	Q6P3X8	PGBD2_HUMAN	30.4	138	93	2	368	778	348	483	1.10E-14	82	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i14	Q6P3X8	PGBD2_HUMAN	27.3	139	97	3	368	781	348	483	1.40E-09	65.1	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i16	Q6P3X8	PGBD2_HUMAN	33	97	63	1	368	658	348	442	2.00E-09	64.3	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i17	Q6P3X8	PGBD2_HUMAN	25.7	280	169	9	368	1201	348	590	4.80E-20	100.5	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i18	Q6P3X8	PGBD2_HUMAN	28.7	195	134	3	368	949	348	538	3.10E-19	97.8	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i20	Q6P3X8	PGBD2_HUMAN	25.4	280	170	9	368	1201	348	590	1.40E-19	99	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i3	Q6P3X8	PGBD2_HUMAN	33.3	105	67	2	368	679	348	450	2.60E-09	63.9	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN6745_c0_g1_i9	Q6P3X8	PGBD2_HUMAN	33.3	78	50	1	368	601	348	423	9.10E-06	52	PGBD2_HUMAN	reviewed	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)	592	sequence-specific DNA binding [GO:0043565]		sequence-specific DNA binding [GO:0043565]	GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN4553_c0_g1_i1	Q96DM1	PGBD4_HUMAN	45.5	77	42	0	23	253	225	301	1.90E-14	79.7	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN3981_c0_g1_i4	Q96DM1	PGBD4_HUMAN	38.1	63	36	2	266	87	523	585	5.80E-05	49.3	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN3981_c0_g1_i7	Q96DM1	PGBD4_HUMAN	32.1	137	84	4	476	87	451	585	6.90E-14	79	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN36236_c0_g1_i1	Q96DM1	PGBD4_HUMAN	50	56	28	0	135	302	241	296	3.40E-11	69.3	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN35157_c0_g1_i1	Q96DM1	PGBD4_HUMAN	45.5	66	32	2	3	197	228	290	1.80E-09	62.8	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN35323_c0_g1_i1	Q96DM1	PGBD4_HUMAN	37	119	70	2	14	367	241	355	1.40E-18	94.7	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN722_c1_g2_i1	Q96DM1	PGBD4_HUMAN	32.9	544	343	13	682	2280	53	585	5.00E-76	287.3	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN17520_c0_g1_i2	Q96DM1	PGBD4_HUMAN	43.9	82	42	3	312	79	504	585	1.00E-09	64.3	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN17520_c0_g1_i3	Q96DM1	PGBD4_HUMAN	36.8	163	87	8	534	79	428	585	3.90E-16	86.3	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN17520_c0_g1_i5	Q96DM1	PGBD4_HUMAN	45.7	70	36	1	282	79	516	585	1.20E-09	63.9	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN34826_c0_g1_i1	Q96DM1	PGBD4_HUMAN	29.1	117	82	1	380	33	241	357	3.90E-10	65.9	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN33979_c0_g1_i1	Q96DM1	PGBD4_HUMAN	47.7	65	34	0	23	217	225	289	1.40E-11	70.1	PGBD4_HUMAN	reviewed	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)	585							NA	NA	NA	NA	NA	NA
TRINITY_DN28052_c0_g1_i1	A3KN33	EGFLA_BOVIN	47.1	70	37	0	6	215	787	856	8.60E-15	80.5	EGFLA_BOVIN	reviewed	"Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)"	EGFLAM	Bos taurus (Bovine)	1018	cell projection [GO:0042995]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]; calcium ion binding [GO:0005509]	cell projection [GO:0042995]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]	calcium ion binding [GO:0005509]	GO:0005509; GO:0042995; GO:0043083; GO:0048786			NA	NA	NA	NA	NA	NA
TRINITY_DN39980_c0_g1_i1	A3KN33	EGFLA_BOVIN	41.4	128	69	3	415	35	893	1015	5.30E-21	102.1	EGFLA_BOVIN	reviewed	"Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)"	EGFLAM	Bos taurus (Bovine)	1018	cell projection [GO:0042995]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]; calcium ion binding [GO:0005509]	cell projection [GO:0042995]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]	calcium ion binding [GO:0005509]	GO:0005509; GO:0042995; GO:0043083; GO:0048786			NA	NA	NA	NA	NA	NA
TRINITY_DN3082_c1_g1_i3	Q9CZX5	PINX1_MOUSE	41	229	106	5	99	779	4	205	1.10E-36	155.2	PINX1_MOUSE	reviewed	PIN2/TERF1-interacting telomerase inhibitor 1 (67-11-3 protein) (LPTS1) (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (TRF1-interacting protein 1)	Pinx1 Lpts	Mus musculus (Mouse)	332	"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]"	"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]"	protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]	GO:0000228; GO:0000776; GO:0000777; GO:0000781; GO:0000784; GO:0005654; GO:0005730; GO:0005819; GO:0007004; GO:0007080; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0051974; GO:0070034; GO:0070198; GO:1902570; GO:1904744; GO:1904751	"mitotic metaphase plate congression [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26173_c0_g1_i1	Q96BK5	PINX1_HUMAN	97.6	85	2	0	256	2	1	85	4.10E-43	174.9	PINX1_HUMAN	reviewed	PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1)	PINX1 LPTL LPTS	Homo sapiens (Human)	328	"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004]"	"chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]"	protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]	GO:0000228; GO:0000776; GO:0000777; GO:0000781; GO:0000784; GO:0005654; GO:0005730; GO:0005819; GO:0007004; GO:0007080; GO:0008285; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0051972; GO:0051974; GO:0070034; GO:0070198; GO:1902570; GO:1904357; GO:1904744; GO:1904751	"mitotic metaphase plate congression [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9847_c0_g2_i1	Q9H307	PININ_HUMAN	34.9	172	111	1	775	260	109	279	4.20E-05	50.4	PININ_HUMAN	reviewed	Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein)	PNN DRS MEMA	Homo sapiens (Human)	717	"catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]	GO:0000398; GO:0003677; GO:0003723; GO:0005198; GO:0005882; GO:0005886; GO:0005911; GO:0007155; GO:0016020; GO:0016607; GO:0030057; GO:0071013	"cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17452_c2_g1_i1	Q9NUJ7	PLCX1_HUMAN	44.1	59	33	0	221	45	43	101	4.90E-07	55.1	PLCX1_HUMAN	reviewed	PI-PLC X domain-containing protein 1	PLCXD1	Homo sapiens (Human)	323	cytoplasm [GO:0005737]; phosphoric diester hydrolase activity [GO:0008081]; lipid metabolic process [GO:0006629]	cytoplasm [GO:0005737]	phosphoric diester hydrolase activity [GO:0008081]	GO:0005737; GO:0006629; GO:0008081	lipid metabolic process [GO:0006629]		brown	brown	NA	NA	NA	NA
TRINITY_DN22969_c0_g1_i1	Q8CDF7	EXD1_MOUSE	28.9	346	221	6	1028	3	40	364	1.20E-32	142.5	EXD1_MOUSE	reviewed	piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1)	Exd1 Exdl1	Mus musculus (Mouse)	570	P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]	PET complex [GO:1990923]; P granule [GO:0043186]	protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:0090305; GO:1990923	gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]		NA	NA	NA	NA	NA	NA
TRINITY_DN12400_c0_g1_i1	A8D8P8	SIWI_BOMMO	48.2	85	44	0	10	264	377	461	1.10E-17	90.9	SIWI_BOMMO	reviewed	Piwi-like protein Siwi (EC 3.1.26.-)	Siwi	Bombyx mori (Silk moth)	899	cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; PET complex [GO:1990923]	endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]	GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923	cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN12400_c0_g1_i2	A8D8P8	SIWI_BOMMO	37.9	174	105	2	10	525	377	549	3.30E-31	136.3	SIWI_BOMMO	reviewed	Piwi-like protein Siwi (EC 3.1.26.-)	Siwi	Bombyx mori (Silk moth)	899	cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; PET complex [GO:1990923]	endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]	GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923	cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN16125_c0_g1_i1	A8D8P8	SIWI_BOMMO	38.9	175	96	2	19	528	101	269	3.50E-25	116.3	SIWI_BOMMO	reviewed	Piwi-like protein Siwi (EC 3.1.26.-)	Siwi	Bombyx mori (Silk moth)	899	cytoplasm [GO:0005737]; PET complex [GO:1990923]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; PET complex [GO:1990923]	endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; piRNA binding [GO:0034584]	GO:0000287; GO:0004521; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923	cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1361_c0_g1_i12	Q6ZH85	PIRL2_ORYSJ	46	100	53	1	10	309	203	301	2.10E-11	70.5	PIRL2_ORYSJ	reviewed	Plant intracellular Ras-group-related LRR protein 2 (Intracellular Ras-group-related LRR protein 2) (OsIRL2)	IRL2 Os02g0593600 LOC_Os02g38040 OJ1067_B01.5 OsJ_07347 OSJNBa0016G10.27	Oryza sativa subsp. japonica (Rice)	501							NA	NA	NA	NA	NA	NA
TRINITY_DN1361_c0_g1_i14	Q6ZH85	PIRL2_ORYSJ	46	100	53	1	10	309	203	301	1.60E-11	70.5	PIRL2_ORYSJ	reviewed	Plant intracellular Ras-group-related LRR protein 2 (Intracellular Ras-group-related LRR protein 2) (OsIRL2)	IRL2 Os02g0593600 LOC_Os02g38040 OJ1067_B01.5 OsJ_07347 OSJNBa0016G10.27	Oryza sativa subsp. japonica (Rice)	501							NA	NA	NA	NA	NA	NA
TRINITY_DN1361_c0_g1_i5	Q6ZH85	PIRL2_ORYSJ	46	100	53	1	10	309	203	301	1.90E-11	70.5	PIRL2_ORYSJ	reviewed	Plant intracellular Ras-group-related LRR protein 2 (Intracellular Ras-group-related LRR protein 2) (OsIRL2)	IRL2 Os02g0593600 LOC_Os02g38040 OJ1067_B01.5 OsJ_07347 OSJNBa0016G10.27	Oryza sativa subsp. japonica (Rice)	501							NA	NA	NA	NA	NA	NA
TRINITY_DN5778_c3_g1_i1	Q5G5E0	PIRL5_ARATH	30.2	159	102	5	780	313	254	406	1.90E-06	55.1	PIRL5_ARATH	reviewed	Plant intracellular Ras-group-related LRR protein 5	PIRL5 At2g17440 F5J6.20	Arabidopsis thaliana (Mouse-ear cress)	526	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]		GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN23531_c0_g1_i1	Q99KR8	FUCO2_MOUSE	93.6	78	5	0	14	247	25	102	2.10E-41	169.1	FUCO2_MOUSE	reviewed	Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2)	Fuca2	Mus musculus (Mouse)	461	extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617]	extracellular space [GO:0005615]; lysosome [GO:0005764]	alpha-L-fucosidase activity [GO:0004560]	GO:0004560; GO:0005615; GO:0005764; GO:0006004; GO:0009617; GO:0016139; GO:2000535	fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN31346_c0_g1_i1	P26262	KLKB1_MOUSE	56.9	65	28	0	3	197	564	628	2.10E-16	85.9	KLKB1_MOUSE	reviewed	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	Klkb1 Klk3 Pk	Mus musculus (Mouse)	638	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0051919	blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]		NA	NA	NA	NA	NA	NA
TRINITY_DN25733_c0_g1_i1	Q98SH2	AT2B1_CHICK	68.1	163	41	1	18	506	735	886	1.50E-54	213.8	AT2B1_CHICK	reviewed	Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)	ATP2B1 PMCA1	Gallus gallus (Chicken)	1205	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; regulation of cytosolic calcium ion concentration [GO:0051480]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"	GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0046872; GO:0051480	regulation of cytosolic calcium ion concentration [GO:0051480]		NA	NA	NA	NA	NA	NA
TRINITY_DN7787_c0_g1_i1	Q98SH2	AT2B1_CHICK	73.5	102	27	0	22	327	770	871	9.50E-34	144.1	AT2B1_CHICK	reviewed	Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)	ATP2B1 PMCA1	Gallus gallus (Chicken)	1205	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; regulation of cytosolic calcium ion concentration [GO:0051480]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"	GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0046872; GO:0051480	regulation of cytosolic calcium ion concentration [GO:0051480]		NA	NA	NA	NA	NA	NA
TRINITY_DN27462_c0_g1_i1	Q98SH2	AT2B1_CHICK	62.4	85	32	0	269	15	770	854	7.30E-25	114.4	AT2B1_CHICK	reviewed	Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)	ATP2B1 PMCA1	Gallus gallus (Chicken)	1205	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; regulation of cytosolic calcium ion concentration [GO:0051480]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]"	GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0046872; GO:0051480	regulation of cytosolic calcium ion concentration [GO:0051480]		NA	NA	NA	NA	NA	NA
TRINITY_DN35384_c0_g1_i1	P20020	AT2B1_HUMAN	68.2	409	125	5	1	1218	736	1142	5.50E-151	535.4	AT2B1_HUMAN	reviewed	Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)	ATP2B1 PMCA1	Homo sapiens (Human)	1220	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; aging [GO:0007568]; brain development [GO:0007420]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]"	GO:0001772; GO:0001818; GO:0003056; GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006874; GO:0007420; GO:0007568; GO:0008217; GO:0009409; GO:0009898; GO:0015085; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030501; GO:0032591; GO:0032809; GO:0034220; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0051481; GO:0051928; GO:0070062; GO:0071305; GO:0071386; GO:0098978; GO:0098982; GO:0099059; GO:1900076; GO:1903779; GO:1990034	aging [GO:0007568]; brain development [GO:0007420]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409]		NA	NA	NA	NA	NA	NA
TRINITY_DN30012_c0_g1_i1	G5E829	AT2B1_MOUSE	69.3	137	33	1	5	415	756	883	1.10E-45	184.1	AT2B1_MOUSE	reviewed	Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)	Atp2b1	Mus musculus (Mouse)	1220	"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; aging [GO:0007568]; brain development [GO:0007420]; calcium ion export [GO:1901660]; calcium ion export across plasma membrane [GO:1990034]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409]"	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]"	GO:0001772; GO:0001818; GO:0003056; GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0007420; GO:0007568; GO:0008217; GO:0009409; GO:0009898; GO:0015085; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030501; GO:0032590; GO:0032591; GO:0032809; GO:0043231; GO:0045121; GO:0045177; GO:0046872; GO:0051480; GO:0051481; GO:0051928; GO:0071305; GO:0071386; GO:0098978; GO:0098982; GO:0099059; GO:1900076; GO:1901660; GO:1905056; GO:1990034	aging [GO:0007568]; brain development [GO:0007420]; calcium ion export [GO:1901660]; calcium ion export across plasma membrane [GO:1990034]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409]		NA	NA	NA	NA	NA	NA
TRINITY_DN27310_c0_g1_i1	Q16720	AT2B3_HUMAN	72	261	73	0	3	785	746	1006	4.00E-102	372.5	AT2B3_HUMAN	reviewed	Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)	ATP2B3	Homo sapiens (Human)	1220	"extracellular vesicle [GO:1903561]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]"	extracellular vesicle [GO:1903561]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]"	GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0006874; GO:0015085; GO:0016021; GO:0019829; GO:0030165; GO:0034220; GO:0043231; GO:0046872; GO:0051480; GO:1903561; GO:1903779; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]		NA	NA	NA	NA	NA	NA
TRINITY_DN40759_c0_g1_i1	P23634	AT2B4_HUMAN	98.8	84	1	0	1	252	876	959	1.80E-40	166	AT2B4_HUMAN	reviewed	Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)	ATP2B4 ATP2B2 MXRA1	Homo sapiens (Human)	1241	"basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]"	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]	"ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]"	GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0010751; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0019829; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0033138; GO:0034220; GO:0036126; GO:0036487; GO:0043005; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048306; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0099059; GO:0140199; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145; GO:2000481	calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]		NA	NA	NA	NA	NA	NA
TRINITY_DN30811_c0_g1_i1	Q99LQ7	TM189_MOUSE	100	114	0	0	1	342	155	268	3.30E-69	261.9	PDES1_MOUSE	reviewed	Plasmanylethanolamine desaturase (EC 1.14.19.77) (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)	PEDS1 Pdes Tmem189	Mus musculus (Mouse)	271	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]	GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0016021; GO:0016491; GO:0050207	ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN16850_c0_g1_i1	A5PLL7	TM189_HUMAN	59.8	264	106	0	55	846	5	268	8.20E-91	335.1	PDES1_HUMAN	reviewed	Plasmanylethanolamine desaturase (EC 1.14.19.77) (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)	PEDS1 KUA PDES TMEM189	Homo sapiens (Human)	270	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]	GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0016021; GO:0016491; GO:0050207	ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN16850_c0_g2_i1	A5PLL7	TM189_HUMAN	100	100	0	0	3	302	67	166	1.50E-54	213	PDES1_HUMAN	reviewed	Plasmanylethanolamine desaturase (EC 1.14.19.77) (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)	PEDS1 KUA PDES TMEM189	Homo sapiens (Human)	270	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]	GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0016021; GO:0016491; GO:0050207	ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN25587_c0_g1_i1	Q8NC51	PAIRB_HUMAN	37.2	129	66	4	428	84	200	327	1.20E-09	64.7	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; PML body organization [GO:0030578]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016020; GO:0030578; GO:0032183; GO:0042981; GO:0043488; GO:0045296; GO:0048471; GO:0070062	PML body organization [GO:0030578]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]		blue	blue	NA	NA	NA	NA
TRINITY_DN7345_c0_g1_i1	Q9HBL7	PLRKT_HUMAN	49.6	135	68	0	91	495	6	140	1.10E-27	124.8	PLRKT_HUMAN	reviewed	Plasminogen receptor (KT) (Plg-R(KT))	PLGRKT C9orf46 AD025 MDS030	Homo sapiens (Human)	147	integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]	integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0006935; GO:0006954; GO:0010756	chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]		NA	NA	NA	NA	NA	NA
TRINITY_DN7345_c0_g1_i2	Q9HBL7	PLRKT_HUMAN	49.6	135	68	0	91	495	6	140	1.40E-27	124.4	PLRKT_HUMAN	reviewed	Plasminogen receptor (KT) (Plg-R(KT))	PLGRKT C9orf46 AD025 MDS030	Homo sapiens (Human)	147	integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]	integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0006935; GO:0006954; GO:0010756	chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]		NA	NA	NA	NA	NA	NA
TRINITY_DN2935_c0_g1_i3	Q14651	PLSI_HUMAN	46.5	226	121	0	726	49	5	230	5.60E-53	209.1	PLSI_HUMAN	reviewed	Plastin-1 (Intestine-specific plastin) (I-plastin)	PLS1	Homo sapiens (Human)	629	actin filament [GO:0005884]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; stereocilium [GO:0032420]; terminal web [GO:1990357]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; auditory receptor cell stereocilium organization [GO:0060088]; intestinal D-glucose absorption [GO:0001951]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of microvillus length [GO:0032532]; terminal web assembly [GO:1902896]; vestibular receptor cell stereocilium organization [GO:0060121]	actin filament [GO:0005884]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; stereocilium [GO:0032420]; terminal web [GO:1990357]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]	GO:0001951; GO:0005200; GO:0005509; GO:0005737; GO:0005884; GO:0005903; GO:0032420; GO:0032432; GO:0032532; GO:0040018; GO:0051015; GO:0051017; GO:0051639; GO:0060088; GO:0060121; GO:0070062; GO:1902896; GO:1903078; GO:1990357	actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; auditory receptor cell stereocilium organization [GO:0060088]; intestinal D-glucose absorption [GO:0001951]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of microvillus length [GO:0032532]; terminal web assembly [GO:1902896]; vestibular receptor cell stereocilium organization [GO:0060121]		NA	NA	NA	NA	NA	NA
TRINITY_DN2935_c0_g1_i2	P13796	PLSL_HUMAN	55.4	619	263	8	1913	87	7	622	4.60E-184	646	PLSL_HUMAN	reviewed	Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1)	LCP1 PLS2	Homo sapiens (Human)	627	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0035722; GO:0042802; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0070062; GO:0071803	actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]		NA	NA	NA	NA	NA	NA
TRINITY_DN26084_c0_g1_i1	P13796	PLSL_HUMAN	100	112	0	0	3	338	130	241	6.10E-60	231.1	PLSL_HUMAN	reviewed	Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1)	LCP1 PLS2	Homo sapiens (Human)	627	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0035722; GO:0042802; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0070062; GO:0071803	actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]		NA	NA	NA	NA	NA	NA
TRINITY_DN27364_c0_g1_i1	P13796	PLSL_HUMAN	99.7	381	1	0	1188	46	247	627	3.70E-221	768.5	PLSL_HUMAN	reviewed	Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1)	LCP1 PLS2	Homo sapiens (Human)	627	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0035722; GO:0042802; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0070062; GO:0071803	actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]		NA	NA	NA	NA	NA	NA
TRINITY_DN27926_c0_g1_i1	Q13093	PAFA_HUMAN	41.5	130	71	2	448	65	271	397	5.30E-22	105.5	PAFA_HUMAN	reviewed	Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2) (gVIIA-PLA2) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase)	PLA2G7 PAFAH	Homo sapiens (Human)	441	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; hydrolase activity, acting on ester bonds [GO:0016788]; phospholipid binding [GO:0005543]; lipid oxidation [GO:0034440]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine catabolic process [GO:0034638]; plasma lipoprotein particle oxidation [GO:0034441]; platelet activating factor catabolic process [GO:0062234]; platelet activating factor metabolic process [GO:0046469]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte chemotaxis [GO:0090026]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]	"1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; hydrolase activity, acting on ester bonds [GO:0016788]; phospholipid binding [GO:0005543]"	GO:0003847; GO:0005543; GO:0005576; GO:0005737; GO:0016788; GO:0034362; GO:0034364; GO:0034374; GO:0034440; GO:0034441; GO:0034638; GO:0046469; GO:0047499; GO:0050729; GO:0062234; GO:0090026	lipid oxidation [GO:0034440]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine catabolic process [GO:0034638]; plasma lipoprotein particle oxidation [GO:0034441]; platelet activating factor catabolic process [GO:0062234]; platelet activating factor metabolic process [GO:0046469]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte chemotaxis [GO:0090026]		NA	NA	NA	NA	NA	NA
TRINITY_DN14767_c0_g1_i1	Q28017	PAFA_BOVIN	35.7	154	87	4	2	439	101	250	2.20E-20	100.1	PAFA_BOVIN	reviewed	Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase)	PLA2G7	Bos taurus (Bovine)	444	high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine catabolic process [GO:0034638]; platelet activating factor catabolic process [GO:0062234]; platelet activating factor metabolic process [GO:0046469]	high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]	1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]	GO:0003847; GO:0034362; GO:0034364; GO:0034638; GO:0046469; GO:0047499; GO:0062234	phosphatidylcholine catabolic process [GO:0034638]; platelet activating factor catabolic process [GO:0062234]; platelet activating factor metabolic process [GO:0046469]		NA	NA	NA	NA	NA	NA
TRINITY_DN20897_c0_g1_i1	B0LSW3	LIS1_FELCA	99.5	219	1	0	9	665	128	346	2.10E-128	459.5	LIS1_FELCA	reviewed	Platelet-activating factor acetylhydrolase IB subunit beta (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha)	PAFAH1B1 LIS1	Felis catus (Cat) (Felis silvestris catus)	410	astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; synapse [GO:0045202]; dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]; acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; lipid catabolic process [GO:0016042]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]	astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; synapse [GO:0045202]	dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]	GO:0000132; GO:0000235; GO:0000776; GO:0001667; GO:0001675; GO:0001764; GO:0001961; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0005938; GO:0007097; GO:0007268; GO:0007281; GO:0007405; GO:0007611; GO:0008090; GO:0008344; GO:0009306; GO:0016042; GO:0019226; GO:0021540; GO:0021766; GO:0021819; GO:0030036; GO:0031023; GO:0031252; GO:0031514; GO:0031965; GO:0032420; GO:0036035; GO:0040019; GO:0042249; GO:0042802; GO:0043005; GO:0043025; GO:0043087; GO:0043622; GO:0045202; GO:0046329; GO:0047496; GO:0048471; GO:0048854; GO:0050885; GO:0051010; GO:0051012; GO:0051081; GO:0051219; GO:0051301; GO:0051661; GO:0060117; GO:0061003; GO:0070507; GO:0070840; GO:0090102; GO:0090176; GO:1904115; GO:2000574	acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; germ cell development [GO:0007281]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; lipid catabolic process [GO:0016042]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN27140_c0_g1_i1	P43033	LIS1_BOVIN	100	97	0	0	292	2	309	405	1.90E-54	212.6	LIS1_BOVIN	reviewed	Platelet-activating factor acetylhydrolase IB subunit beta (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha)	PAFAH1B1 LIS1 PAFAHA	Bos taurus (Bovine)	410	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; spindle [GO:0005819]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; phospholipase binding [GO:0043274]; cell differentiation [GO:0030154]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; lipid catabolic process [GO:0016042]; microtubule sliding [GO:0051012]; nervous system development [GO:0007399]; platelet activating factor metabolic process [GO:0046469]	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; spindle [GO:0005819]	dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; phospholipase binding [GO:0043274]	GO:0000132; GO:0005815; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0007399; GO:0008017; GO:0008201; GO:0016042; GO:0030154; GO:0031965; GO:0034452; GO:0043274; GO:0046469; GO:0051012; GO:0051301; GO:0070840	cell differentiation [GO:0030154]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; lipid catabolic process [GO:0016042]; microtubule sliding [GO:0051012]; nervous system development [GO:0007399]; platelet activating factor metabolic process [GO:0046469]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c1_g1_i1	Q8AXC7	PGFRA_TAKRU	54.5	55	22	1	9	173	620	671	2.10E-10	65.9	PGFRA_TAKRU	reviewed	Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor)	pdgfra	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	1062	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; chemotaxis [GO:0006935]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; platelet-derived growth factor alpha-receptor activity [GO:0005018]	GO:0005018; GO:0005524; GO:0005886; GO:0006935; GO:0007275; GO:0016021	chemotaxis [GO:0006935]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i5	Q8AXC7	PGFRA_TAKRU	21.9	448	295	17	230	1504	5	420	8.40E-09	63.9	PGFRA_TAKRU	reviewed	Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor)	pdgfra	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	1062	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; chemotaxis [GO:0006935]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; platelet-derived growth factor alpha-receptor activity [GO:0005018]	GO:0005018; GO:0005524; GO:0005886; GO:0006935; GO:0007275; GO:0016021	chemotaxis [GO:0006935]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN37191_c0_g1_i1	Q96S99	PKHF1_HUMAN	96.8	94	3	0	1	282	97	190	1.80E-49	196.1	PKHF1_HUMAN	reviewed	Pleckstrin homology domain-containing family F member 1 (PH domain-containing family F member 1) (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains) (Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15)	PLEKHF1 APPD LAPF ZFYVE15	Homo sapiens (Human)	279	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; apoptotic process [GO:0006915]; endosome organization [GO:0007032]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050]	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]	GO:0005634; GO:0005764; GO:0005765; GO:0006915; GO:0007032; GO:0010008; GO:0010314; GO:0010508; GO:0016050; GO:0032266; GO:0035091; GO:0046872; GO:0048471; GO:0070273; GO:0072659; GO:2001244	apoptotic process [GO:0006915]; endosome organization [GO:0007032]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN1972_c0_g1_i1	Q7ZUV1	PKHF2_DANRE	81	137	26	0	36	446	1	137	7.80E-63	241.5	PKHF2_DANRE	reviewed	Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2)	plekhf2 zgc:56073	Danio rerio (Zebrafish) (Brachydanio rerio)	247	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]	GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1972_c0_g1_i2	Q91WB4	PKHF2_MOUSE	69	239	72	1	36	746	1	239	1.50E-96	354.4	PKHF2_MOUSE	reviewed	Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2)	Plekhf2	Mus musculus (Mouse)	249	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]	GO:0005783; GO:0015031; GO:0030133; GO:0031901; GO:0035091; GO:0046872	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1972_c0_g1_i3	Q7ZUV1	PKHF2_DANRE	80.9	131	25	0	88	480	7	137	8.60E-60	231.5	PKHF2_DANRE	reviewed	Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2)	plekhf2 zgc:56073	Danio rerio (Zebrafish) (Brachydanio rerio)	247	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]	GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1972_c0_g1_i4	Q91WB4	PKHF2_MOUSE	68.7	233	71	1	88	780	7	239	1.60E-93	344.4	PKHF2_MOUSE	reviewed	Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2)	Plekhf2	Mus musculus (Mouse)	249	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]	GO:0005783; GO:0015031; GO:0030133; GO:0031901; GO:0035091; GO:0046872	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN36402_c0_g1_i1	Q9H8W4	PKHF2_HUMAN	100	129	0	0	2	388	80	208	3.50E-75	282	PKHF2_HUMAN	reviewed	Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2) (Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains) (EAPF) (PH and FYVE domain-containing protein 2) (Phafin-2) (Phafin2) (Zinc finger FYVE domain-containing protein 18)	PLEKHF2 ZFYVE18	Homo sapiens (Human)	249	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]	GO:0005783; GO:0015031; GO:0030133; GO:0031901; GO:0035091; GO:0046872	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i1	O94827	PKHG5_HUMAN	41.3	421	235	3	88	1317	325	744	2.20E-86	322	PKHG5_HUMAN	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)	PLEKHG5 KIAA0720	Homo sapiens (Human)	1062	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043065; GO:0043123; GO:0043542; GO:0048471; GO:0051056; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i10	O94827	PKHG5_HUMAN	41.3	421	235	3	88	1317	325	744	2.80E-86	321.6	PKHG5_HUMAN	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)	PLEKHG5 KIAA0720	Homo sapiens (Human)	1062	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043065; GO:0043123; GO:0043542; GO:0048471; GO:0051056; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i13	O94827	PKHG5_HUMAN	41.3	421	235	3	88	1317	325	744	2.90E-86	321.6	PKHG5_HUMAN	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)	PLEKHG5 KIAA0720	Homo sapiens (Human)	1062	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043065; GO:0043123; GO:0043542; GO:0048471; GO:0051056; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i2	O94827	PKHG5_HUMAN	41.3	421	235	3	88	1317	325	744	2.80E-86	321.6	PKHG5_HUMAN	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)	PLEKHG5 KIAA0720	Homo sapiens (Human)	1062	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043065; GO:0043123; GO:0043542; GO:0048471; GO:0051056; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i5	O94827	PKHG5_HUMAN	41.3	421	235	3	88	1317	325	744	2.10E-86	322	PKHG5_HUMAN	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)	PLEKHG5 KIAA0720	Homo sapiens (Human)	1062	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043065; GO:0043123; GO:0043542; GO:0048471; GO:0051056; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i11	Q6RFZ7	PKHG5_RAT	35.6	624	362	10	88	1893	305	910	3.70E-86	321.2	PKHG5_RAT	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)	Plekhg5 Tech	Rattus norvegicus (Rat)	1039	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN167_c0_g1_i7	Q6RFZ7	PKHG5_RAT	41.3	421	235	2	88	1317	305	724	5.60E-89	330.1	PKHG5_RAT	reviewed	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)	Plekhg5 Tech	Rattus norvegicus (Rat)	1039	"axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; Rho protein signal transduction [GO:0007266]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0099575	"endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	1
TRINITY_DN7463_c0_g1_i1	Q9D240	PKHJ1_MOUSE	34	147	85	3	91	531	1	135	4.20E-14	80.5	PKHJ1_MOUSE	reviewed	Pleckstrin homology domain-containing family J member 1 (PH domain-containing family J member 1) (Guanine nucleotide-releasing protein x)	Plekhj1 Gnrpx	Mus musculus (Mouse)	164	"cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]		GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0042147; GO:0055037	"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4304_c0_g1_i8	Q6ZWE6	PKHM3_HUMAN	40	65	38	1	235	44	676	740	3.00E-09	62.4	PKHM3_HUMAN	reviewed	Pleckstrin homology domain-containing family M member 3 (PH domain-containing family M member 3) (Differentiation associated protein)	PLEKHM3 DAPR PLEKHM1L	Homo sapiens (Human)	761	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872	myoblast differentiation [GO:0045445]		NA	NA	NA	NA	NA	NA
TRINITY_DN8652_c0_g1_i1	Q8BM47	PKHM3_MOUSE	40	280	159	1	1233	2045	455	734	3.90E-59	231.1	PKHM3_MOUSE	reviewed	Pleckstrin homology domain-containing family M member 3 (PH domain-containing family M member 3) (Differentiation-associated protein)	Plekhm3 Dapr	Mus musculus (Mouse)	761	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872	myoblast differentiation [GO:0045445]		blue	blue	NA	NA	NA	NA
TRINITY_DN8652_c0_g1_i2	Q8BM47	PKHM3_MOUSE	37.5	299	159	2	1233	2102	455	734	1.60E-55	219.2	PKHM3_MOUSE	reviewed	Pleckstrin homology domain-containing family M member 3 (PH domain-containing family M member 3) (Differentiation-associated protein)	Plekhm3 Dapr	Mus musculus (Mouse)	761	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]	GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872	myoblast differentiation [GO:0045445]		NA	NA	NA	NA	NA	NA
TRINITY_DN4392_c0_g1_i1	Q6PDH0	PHLB1_MOUSE	62.4	157	57	2	163	630	1214	1369	6.40E-54	212.2	PHLB1_MOUSE	reviewed	Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha)	Phldb1 Kiaa0638 Ll5a	Mus musculus (Mouse)	1371	basal cortex [GO:0045180]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]	basal cortex [GO:0045180]		GO:0010470; GO:0010717; GO:0045180; GO:0070507; GO:1904261	positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]		NA	NA	NA	NA	NA	NA
TRINITY_DN4392_c0_g1_i2	Q6PDH0	PHLB1_MOUSE	62.4	157	57	2	177	644	1214	1369	6.50E-54	212.2	PHLB1_MOUSE	reviewed	Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha)	Phldb1 Kiaa0638 Ll5a	Mus musculus (Mouse)	1371	basal cortex [GO:0045180]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]	basal cortex [GO:0045180]		GO:0010470; GO:0010717; GO:0045180; GO:0070507; GO:1904261	positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]		NA	NA	NA	NA	NA	NA
TRINITY_DN2775_c0_g1_i1	Q9JI55	PLEC_CRIGR	21.2	1074	606	42	4675	1871	3413	4385	1.80E-21	107.5	PLEC_CRIGR	reviewed	Plectin (PCN) (PLTN) (300 kDa intermediate filament-associated protein) (IFAP300) (Plectin-1) (Fragment)	PLEC PLEC1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	4473	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; midbody [GO:0030496]; actin binding [GO:0003779]; intermediate filament cytoskeleton organization [GO:0045104]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; midbody [GO:0030496]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0030496; GO:0045104	intermediate filament cytoskeleton organization [GO:0045104]		NA	NA	NA	NA	NA	NA
TRINITY_DN27680_c0_g1_i1	P30427	PLEC_RAT	65.5	194	66	1	2	580	192	385	6.60E-70	265	PLEC_RAT	reviewed	Plectin (PCN) (PLTN) (Plectin-1)	Plec Plec1	Rattus norvegicus (Rat)	4687	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; contractile fiber [GO:0043292]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; protein N-terminus binding [GO:0047485]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; female pregnancy [GO:0007565]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; response to nutrient [GO:0007584]; wound healing [GO:0042060]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; contractile fiber [GO:0043292]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; protein N-terminus binding [GO:0047485]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005200; GO:0005737; GO:0005856; GO:0005903; GO:0005925; GO:0007565; GO:0007584; GO:0008092; GO:0008307; GO:0009925; GO:0016020; GO:0016324; GO:0016528; GO:0030056; GO:0030506; GO:0030855; GO:0031581; GO:0042060; GO:0042383; GO:0043034; GO:0043292; GO:0045104; GO:0047485; GO:0048471	epithelial cell differentiation [GO:0030855]; female pregnancy [GO:0007565]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; response to nutrient [GO:0007584]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN2775_c0_g1_i2	P30427	PLEC_RAT	21.7	637	369	26	2789	1059	4033	4599	2.00E-14	83.2	PLEC_RAT	reviewed	Plectin (PCN) (PLTN) (Plectin-1)	Plec Plec1	Rattus norvegicus (Rat)	4687	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; contractile fiber [GO:0043292]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; protein N-terminus binding [GO:0047485]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; female pregnancy [GO:0007565]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; response to nutrient [GO:0007584]; wound healing [GO:0042060]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; contractile fiber [GO:0043292]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; protein N-terminus binding [GO:0047485]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005200; GO:0005737; GO:0005856; GO:0005903; GO:0005925; GO:0007565; GO:0007584; GO:0008092; GO:0008307; GO:0009925; GO:0016020; GO:0016324; GO:0016528; GO:0030056; GO:0030506; GO:0030855; GO:0031581; GO:0042060; GO:0042383; GO:0043034; GO:0043292; GO:0045104; GO:0047485; GO:0048471	epithelial cell differentiation [GO:0030855]; female pregnancy [GO:0007565]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; response to nutrient [GO:0007584]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN2798_c0_g1_i1	Q2KID6	PLRG1_BOVIN	54.4	371	127	5	105	1091	3	373	5.50E-110	399.1	PLRG1_BOVIN	reviewed	Pleiotropic regulator 1	PLRG1	Bos taurus (Bovine)	513	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2798_c0_g1_i2	Q2KID6	PLRG1_BOVIN	61.3	111	40	1	14	337	263	373	5.70E-34	144.8	PLRG1_BOVIN	reviewed	Pleiotropic regulator 1	PLRG1	Bos taurus (Bovine)	513	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40349_c0_g1_i1	O43660	PLRG1_HUMAN	100	77	0	0	2	232	416	492	9.10E-39	160.2	PLRG1_HUMAN	reviewed	Pleiotropic regulator 1	PLRG1	Homo sapiens (Human)	514	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005654; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7483_c0_g1_i1	Q2KID6	PLRG1_BOVIN	67.9	137	44	0	509	99	377	513	2.30E-58	226.5	PLRG1_BOVIN	reviewed	Pleiotropic regulator 1	PLRG1	Bos taurus (Bovine)	513	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19217_c1_g1_i1	Q922V4	PLRG1_MOUSE	100	107	0	0	2	322	263	369	6.40E-59	227.6	PLRG1_MOUSE	reviewed	Pleiotropic regulator 1	Plrg1	Mus musculus (Mouse)	513	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19217_c0_g1_i1	Q2KID6	PLRG1_BOVIN	100	73	0	0	219	1	220	292	5.60E-38	157.5	PLRG1_BOVIN	reviewed	Pleiotropic regulator 1	PLRG1	Bos taurus (Bovine)	513	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19217_c0_g1_i2	Q2KID6	PLRG1_BOVIN	100	73	0	0	219	1	220	292	5.60E-38	157.5	PLRG1_BOVIN	reviewed	Pleiotropic regulator 1	PLRG1	Bos taurus (Bovine)	513	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8731_c0_g1_i1	B0S5N4	PLXA3_DANRE	65.6	151	44	2	4	456	1421	1563	5.60E-51	201.8	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i10	B0S5N4	PLXA3_DANRE	31.8	1140	664	43	3317	9	182	1245	3.20E-153	544.3	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i13	B0S5N4	PLXA3_DANRE	32.2	912	543	30	2750	111	182	1050	2.10E-134	481.5	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i20	B0S5N4	PLXA3_DANRE	35.3	116	69	4	456	118	578	690	3.20E-14	79.7	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i21	B0S5N4	PLXA3_DANRE	31.7	1091	643	38	3249	88	182	1207	6.60E-151	536.6	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i9	B0S5N4	PLXA3_DANRE	33.7	731	426	25	2175	76	182	884	2.40E-112	407.9	PLXA3_DANRE	reviewed	Plexin A3	plxna3 si:dkey-7i23.3	Danio rerio (Zebrafish) (Brachydanio rerio)	1892	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0042802; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN12298_c1_g1_i1	Q6DE92	PXDC2_XENLA	64.6	79	28	0	48	284	144	222	1.90E-25	116.3	PXDC2_XENLA	reviewed	Plexin domain-containing protein 2	plxdc2	Xenopus laevis (African clawed frog)	513	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN12298_c1_g1_i2	Q6DE92	PXDC2_XENLA	54.4	125	56	1	10	381	98	222	1.70E-34	146.7	PXDC2_XENLA	reviewed	Plexin domain-containing protein 2	plxdc2	Xenopus laevis (African clawed frog)	513	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i13	Q6DE92	PXDC2_XENLA	42.9	338	181	7	36	1022	22	356	3.20E-71	270.4	PXDC2_XENLA	reviewed	Plexin domain-containing protein 2	plxdc2	Xenopus laevis (African clawed frog)	513	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i3	Q6DE92	PXDC2_XENLA	42	338	184	7	36	1022	22	356	2.30E-69	264.2	PXDC2_XENLA	reviewed	Plexin domain-containing protein 2	plxdc2	Xenopus laevis (African clawed frog)	513	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i21	Q6DE92	PXDC2_XENLA	42.3	338	183	7	36	1022	22	356	1.60E-70	268.1	PXDC2_XENLA	reviewed	Plexin domain-containing protein 2	plxdc2	Xenopus laevis (African clawed frog)	513	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	1	NA	NA	NA
TRINITY_DN12298_c0_g1_i1	Q6UX71	PXDC2_HUMAN	57.8	64	27	0	11	202	159	222	2.00E-16	85.9	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i1	Q6UX71	PXDC2_HUMAN	48.1	233	116	3	196	882	115	346	1.40E-58	228	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i11	Q6UX71	PXDC2_HUMAN	46.9	277	138	5	42	851	97	371	2.60E-69	263.8	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i12	Q6UX71	PXDC2_HUMAN	46.6	277	139	5	42	851	97	371	4.20E-68	260	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i14	Q6UX71	PXDC2_HUMAN	49.4	259	125	4	196	960	115	371	3.50E-68	260.4	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i15	Q6UX71	PXDC2_HUMAN	46.6	277	139	5	42	851	97	371	3.80E-68	260	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i18	Q6UX71	PXDC2_HUMAN	49.1	173	84	2	42	548	97	269	1.50E-42	174.1	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i19	Q6UX71	PXDC2_HUMAN	48.5	233	115	3	196	882	115	346	7.20E-60	232.3	PXDC2_HUMAN	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	PLXDC2 TEM7R UNQ2514/PRO6003	Homo sapiens (Human)	529	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i5	Q9DC11	PXDC2_MOUSE	44.3	115	59	3	5	340	259	371	7.40E-23	108.2	PXDC2_MOUSE	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	Plxdc2 Tem7r	Mus musculus (Mouse)	530	collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0062023			NA	NA	NA	NA	NA	NA
TRINITY_DN592_c0_g1_i9	Q9DC11	PXDC2_MOUSE	44.3	115	59	3	5	340	259	371	9.30E-23	108.2	PXDC2_MOUSE	reviewed	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	Plxdc2 Tem7r	Mus musculus (Mouse)	530	collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0062023			NA	NA	NA	NA	NA	NA
TRINITY_DN34119_c0_g1_i1	P70206	PLXA1_MOUSE	68.9	45	14	0	56	190	1297	1341	1.40E-11	69.7	PLXA1_MOUSE	reviewed	Plexin-A1 (Plex 1) (Plexin-1)	Plxna1 Kiaa4053	Mus musculus (Mouse)	1894	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014910; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:0060666; GO:0097485; GO:1902287; GO:1990138	dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN34119_c0_g1_i2	P70206	PLXA1_MOUSE	64.9	77	27	0	6	236	1265	1341	4.20E-21	101.7	PLXA1_MOUSE	reviewed	Plexin-A1 (Plex 1) (Plexin-1)	Plxna1 Kiaa4053	Mus musculus (Mouse)	1894	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014910; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:0060666; GO:0097485; GO:1902287; GO:1990138	dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i18	Q80UG2	PLXA4_MOUSE	33.1	332	199	8	1011	61	182	505	3.20E-43	177.2	PLXA4_MOUSE	reviewed	Plexin-A4	Plxna4 Kiaa1550	Mus musculus (Mouse)	1893	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007399; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0043087; GO:0048485; GO:0048812; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:1902287	anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]		NA	NA	NA	NA	NA	NA
TRINITY_DN32784_c0_g1_i1	Q9HCM2	PLXA4_HUMAN	83.8	179	29	0	5	541	1662	1840	6.30E-83	308.1	PLXA4_HUMAN	reviewed	Plexin-A4	PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003	Homo sapiens (Human)	1894	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0030334; GO:0043087; GO:0048485; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:1902287	anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]		NA	NA	NA	NA	NA	NA
TRINITY_DN31986_c0_g1_i1	Q80UG2	PLXA4_MOUSE	42.2	109	57	2	413	93	41	145	9.20E-17	88.2	PLXA4_MOUSE	reviewed	Plexin-A4	Plxna4 Kiaa1550	Mus musculus (Mouse)	1893	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007399; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0043087; GO:0048485; GO:0048812; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:1902287	anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]		NA	NA	NA	NA	NA	NA
TRINITY_DN27671_c0_g1_i1	Q9HCM2	PLXA4_HUMAN	73.1	67	18	0	202	2	1347	1413	3.90E-18	91.7	PLXA4_HUMAN	reviewed	Plexin-A4	PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003	Homo sapiens (Human)	1894	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0030334; GO:0043087; GO:0048485; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:1902287	anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i12	Q9V4A7	PLXB_DROME	30.5	1217	650	38	3460	203	217	1368	2.60E-145	518.1	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i16	Q9V4A7	PLXB_DROME	42.2	154	80	3	452	9	1234	1384	8.30E-24	112.5	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i2	Q9V4A7	PLXB_DROME	44.7	123	61	2	379	29	1234	1355	2.30E-19	97.4	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i6	Q9V4A7	PLXB_DROME	44.4	124	61	2	384	31	1234	1355	4.40E-19	96.7	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN17087_c0_g1_i8	Q9V4A7	PLXB_DROME	31	290	116	6	856	203	1091	1368	2.10E-26	121.3	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN5481_c0_g1_i2	Q9V4A7	PLXB_DROME	66.1	387	128	3	1	1155	1252	1637	1.70E-136	487.3	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN5481_c0_g1_i3	Q9V4A7	PLXB_DROME	58.6	827	292	11	1	2412	1252	2051	2.80E-263	909.4	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN26813_c0_g1_i1	Q9V4A7	PLXB_DROME	45.5	391	173	5	1205	33	529	879	1.10E-95	351.7	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN29135_c0_g1_i1	Q9V4A7	PLXB_DROME	64.9	74	23	1	224	3	1820	1890	2.30E-22	105.9	PLXB_DROME	reviewed	Plexin-B	PlexB CG17245	Drosophila melanogaster (Fruit fly)	2051	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN39931_c0_g1_i1	B2RXS4	PLXB2_MOUSE	100	108	0	0	2	325	1369	1476	5.70E-55	214.5	PLXB2_MOUSE	reviewed	Plexin-B2	Plxnb2	Mus musculus (Mouse)	1842	collagen-containing extracellular matrix [GO:0062023]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	collagen-containing extracellular matrix [GO:0062023]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	GO:0001843; GO:0001932; GO:0002116; GO:0005887; GO:0007156; GO:0007162; GO:0007405; GO:0007420; GO:0008360; GO:0010976; GO:0017154; GO:0030334; GO:0043087; GO:0045727; GO:0050772; GO:0062023; GO:0071526; GO:1902287; GO:1904861; GO:2001222	brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]		NA	NA	NA	NA	NA	NA
TRINITY_DN4700_c0_g1_i10	P54277	PMS1_HUMAN	37.8	444	256	9	81	1382	1	434	1.50E-72	275	PMS1_HUMAN	reviewed	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	PMS1 PMSL1	Homo sapiens (Human)	932	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]	GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN4700_c0_g1_i12	P54277	PMS1_HUMAN	43.7	323	177	4	81	1037	1	322	6.20E-69	262.7	PMS1_HUMAN	reviewed	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	PMS1 PMSL1	Homo sapiens (Human)	932	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]	GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN4700_c0_g1_i13	P54277	PMS1_HUMAN	33.7	359	218	9	116	1162	86	434	9.40E-47	189.1	PMS1_HUMAN	reviewed	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	PMS1 PMSL1	Homo sapiens (Human)	932	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]	GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN4700_c0_g1_i3	P54277	PMS1_HUMAN	52.6	135	64	0	81	485	1	135	1.50E-31	138.7	PMS1_HUMAN	reviewed	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	PMS1 PMSL1	Homo sapiens (Human)	932	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]	GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN38399_c0_g1_i1	P54277	PMS1_HUMAN	100	57	0	0	173	3	1	57	5.20E-22	104.4	PMS1_HUMAN	reviewed	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	PMS1 PMSL1	Homo sapiens (Human)	932	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]	mismatch repair complex [GO:0032300]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]	GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0042493	mismatch repair [GO:0006298]; response to drug [GO:0042493]		NA	NA	NA	NA	NA	NA
TRINITY_DN9799_c0_g1_i1	Q28I85	POC1A_XENTR	61.1	126	49	0	191	568	56	181	3.60E-44	179.5	POC1A_XENTR	reviewed	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	poc1a wdr51a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	441	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9799_c0_g1_i1	Q28I85	POC1A_XENTR	59	39	16	0	76	192	6	44	1.00E-06	55.1	POC1A_XENTR	reviewed	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	poc1a wdr51a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	441	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9799_c0_g1_i3	Q28I85	POC1A_XENTR	60.2	176	70	0	76	603	6	181	2.10E-63	243.4	POC1A_XENTR	reviewed	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	poc1a wdr51a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	441	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9799_c0_g1_i4	Q28I85	POC1A_XENTR	56.9	51	22	0	76	228	6	56	2.90E-11	69.3	POC1A_XENTR	reviewed	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	poc1a wdr51a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	441	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9799_c0_g1_i7	Q28I85	POC1A_XENTR	60.2	176	70	0	57	584	6	181	1.20E-63	244.2	POC1A_XENTR	reviewed	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	poc1a wdr51a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	441	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9799_c0_g1_i8	Q28I85	POC1A_XENTR	62.9	143	53	0	76	504	6	148	1.40E-51	204.1	POC1A_XENTR	reviewed	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	poc1a wdr51a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	441	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN29433_c0_g1_i1	F6ZT52	POC1B_XENTR	49.2	65	33	0	199	5	42	106	5.30E-11	67.8	POC1B_XENTR	reviewed	POC1 centriolar protein homolog B (WD repeat-containing protein 51B) (WD40 repeat protein Pix1)	poc1b wdr51b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	470	centriole [GO:0005814]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; centriole replication [GO:0007099]	centriole [GO:0005814]; cytoplasm [GO:0005737]		GO:0005737; GO:0005814; GO:0007099; GO:0030030	cell projection organization [GO:0030030]; centriole replication [GO:0007099]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c0_g1_i7	P11204	POL_EIAV9	25.7	144	104	2	287	718	941	1081	2.70E-06	54.7	POL_EIAV9	reviewed	Pol polyprotein [Cleaved into: Protease (Retropepsin) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	pol	Equine infectious anemia virus (isolate 1369) (EIAV)	1146	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; dUTP diphosphatase activity [GO:0004170]; exoribonuclease H activity [GO:0004533]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; dUTP diphosphatase activity [GO:0004170]; exoribonuclease H activity [GO:0004533]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]	GO:0000287; GO:0002134; GO:0003677; GO:0003964; GO:0004170; GO:0004190; GO:0004523; GO:0004533; GO:0006226; GO:0006310; GO:0008270; GO:0015074; GO:0044826; GO:0046081; GO:0046718; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		NA	NA	1	NA	NA	NA
TRINITY_DN4953_c0_g1_i1	P11204	POL_EIAV9	25.7	144	104	2	287	718	941	1081	1.40E-06	55.5	POL_EIAV9	reviewed	Pol polyprotein [Cleaved into: Protease (Retropepsin) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	pol	Equine infectious anemia virus (isolate 1369) (EIAV)	1146	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; dUTP diphosphatase activity [GO:0004170]; exoribonuclease H activity [GO:0004533]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; dUTP diphosphatase activity [GO:0004170]; exoribonuclease H activity [GO:0004533]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]	GO:0000287; GO:0002134; GO:0003677; GO:0003964; GO:0004170; GO:0004190; GO:0004523; GO:0004533; GO:0006226; GO:0006310; GO:0008270; GO:0015074; GO:0044826; GO:0046081; GO:0046718; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		NA	NA	NA	NA	NA	NA
TRINITY_DN4953_c0_g1_i9	P11204	POL_EIAV9	25.7	144	104	2	287	718	941	1081	2.60E-06	54.7	POL_EIAV9	reviewed	Pol polyprotein [Cleaved into: Protease (Retropepsin) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	pol	Equine infectious anemia virus (isolate 1369) (EIAV)	1146	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; dUTP diphosphatase activity [GO:0004170]; exoribonuclease H activity [GO:0004533]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; dUTP diphosphatase activity [GO:0004170]; exoribonuclease H activity [GO:0004533]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; UTP binding [GO:0002134]; zinc ion binding [GO:0008270]	GO:0000287; GO:0002134; GO:0003677; GO:0003964; GO:0004170; GO:0004190; GO:0004523; GO:0004533; GO:0006226; GO:0006310; GO:0008270; GO:0015074; GO:0044826; GO:0046081; GO:0046718; GO:0075713	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		NA	NA	NA	NA	NA	NA
TRINITY_DN26761_c0_g1_i1	P29675	SF3_HELAN	34.8	69	45	0	298	504	6	74	1.40E-08	61.2	SF3_HELAN	reviewed	Pollen-specific protein SF3	SF3	Helianthus annuus (Common sunflower)	219	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4255_c0_g1_i4	Q11208	PARP_SARPE	52.7	93	44	0	318	40	1	93	6.10E-25	115.9	PARP_SARPE	reviewed	Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase) (ADPRT) (Poly[ADP-ribose] synthase) (Protein ADP-ribosyltransferase) (EC 2.4.2.-)		Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	996	nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; protein ADP-ribosylation [GO:0006471]	nucleus [GO:0005634]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003950; GO:0005634; GO:0006471; GO:0008270; GO:0051287	protein ADP-ribosylation [GO:0006471]		NA	NA	NA	NA	NA	NA
TRINITY_DN4255_c0_g1_i5	Q11208	PARP_SARPE	41.9	332	166	7	954	1	1	319	4.60E-66	253.4	PARP_SARPE	reviewed	Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase) (ADPRT) (Poly[ADP-ribose] synthase) (Protein ADP-ribosyltransferase) (EC 2.4.2.-)		Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	996	nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; protein ADP-ribosylation [GO:0006471]	nucleus [GO:0005634]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003950; GO:0005634; GO:0006471; GO:0008270; GO:0051287	protein ADP-ribosylation [GO:0006471]		NA	NA	NA	NA	NA	NA
TRINITY_DN33641_c0_g1_i1	P09874	PARP1_HUMAN	100	125	0	0	2	376	659	783	5.00E-63	241.5	PARP1_HUMAN	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT PPOL	Homo sapiens (Human)	1014	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; R-SMAD binding [GO:0070412]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000715; GO:0000717; GO:0000723; GO:0000724; GO:0000784; GO:0000977; GO:0001228; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0033683; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070213; GO:0070412; GO:0070911; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1903827; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170	"apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4255_c0_g1_i2	P26446	PARP1_CHICK	59.8	87	35	0	413	673	6	92	3.10E-24	113.6	PARP1_CHICK	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT	Gallus gallus (Chicken)	1011	chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	chromosome [GO:0005694]; nucleolus [GO:0005730]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003950; GO:0005694; GO:0005730; GO:0006281; GO:0008270; GO:0018312; GO:0018424; GO:0030592; GO:0051287; GO:0070212; GO:0070213; GO:1905168; GO:1990404; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN40748_c0_g1_i1	P09874	PARP1_HUMAN	100	66	0	0	200	3	102	167	1.70E-33	142.5	PARP1_HUMAN	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT PPOL	Homo sapiens (Human)	1014	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; R-SMAD binding [GO:0070412]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000715; GO:0000717; GO:0000723; GO:0000724; GO:0000784; GO:0000977; GO:0001228; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0033683; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070213; GO:0070412; GO:0070911; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1903827; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170	"apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35838_c0_g1_i1	P09874	PARP1_HUMAN	100	173	0	0	2	520	821	993	7.90E-99	360.9	PARP1_HUMAN	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT PPOL	Homo sapiens (Human)	1014	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; R-SMAD binding [GO:0070412]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000715; GO:0000717; GO:0000723; GO:0000724; GO:0000784; GO:0000977; GO:0001228; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0033683; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070213; GO:0070412; GO:0070911; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1903827; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170	"apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35838_c0_g1_i2	Q9R152	PARP1_CRIGR	98.7	156	2	0	2	469	820	975	4.80E-87	321.6	PARP1_CRIGR	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1013	nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; site of DNA damage [GO:0090734]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003950; GO:0005730; GO:0006302; GO:0006471; GO:0006974; GO:0008270; GO:0010613; GO:0018312; GO:0018424; GO:0030592; GO:0051287; GO:0070212; GO:0070213; GO:0090734; GO:1905168; GO:1990404; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN39890_c0_g1_i1	P09874	PARP1_HUMAN	100	81	0	0	246	4	4	84	4.50E-44	177.9	PARP1_HUMAN	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT PPOL	Homo sapiens (Human)	1014	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; R-SMAD binding [GO:0070412]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000715; GO:0000717; GO:0000723; GO:0000724; GO:0000784; GO:0000977; GO:0001228; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0033683; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070213; GO:0070412; GO:0070911; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1903827; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170	"apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29639_c0_g1_i1	Q9R152	PARP1_CRIGR	61.4	376	125	4	1128	4	630	986	4.80E-125	449.1	PARP1_CRIGR	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1013	nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; site of DNA damage [GO:0090734]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003950; GO:0005730; GO:0006302; GO:0006471; GO:0006974; GO:0008270; GO:0010613; GO:0018312; GO:0018424; GO:0030592; GO:0051287; GO:0070212; GO:0070213; GO:0090734; GO:1905168; GO:1990404; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN29639_c0_g1_i2	P26446	PARP1_CHICK	60	60	23	1	180	1	927	985	4.30E-14	78.2	PARP1_CHICK	reviewed	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	PARP1 ADPRT	Gallus gallus (Chicken)	1011	chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	chromosome [GO:0005694]; nucleolus [GO:0005730]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003950; GO:0005694; GO:0005730; GO:0006281; GO:0008270; GO:0018312; GO:0018424; GO:0030592; GO:0051287; GO:0070212; GO:0070213; GO:1905168; GO:1990404; GO:1990966	ATP generation from poly-ADP-D-ribose [GO:1990966]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN31480_c0_g1_i1	Q9UGN5	PARP2_HUMAN	78.2	78	17	0	235	2	419	496	4.90E-32	137.9	PARP2_HUMAN	reviewed	Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	PARP2 ADPRT2 ADPRTL2	Homo sapiens (Human)	583	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]	GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0018312; GO:0030592; GO:0061051; GO:0070212; GO:0097191; GO:0140294; GO:1901215; GO:1990404	base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN27832_c0_g1_i1	Q9UGN5	PARP2_HUMAN	45.6	68	36	1	201	1	433	500	4.70E-10	64.7	PARP2_HUMAN	reviewed	Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	PARP2 ADPRT2 ADPRTL2	Homo sapiens (Human)	583	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]	GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0018312; GO:0030592; GO:0061051; GO:0070212; GO:0097191; GO:0140294; GO:1901215; GO:1990404	base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN5213_c0_g1_i1	Q5Z8Q9	PRP2A_ORYSJ	71.9	114	29	1	336	4	502	615	2.60E-42	172.6	PRP2A_ORYSJ	reviewed	Poly [ADP-ribose] polymerase 2-A (PARP-2-A) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase 2-A) (ADPRT-2-A) (Poly[ADP-ribose] synthase 2-A) (Protein ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	PARP2-A Os01g0351200 LOC_Os01g24940 B1051E10.55 P0463A02.25	Oryza sativa subsp. japonica (Rice)	660	nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; double-strand break repair [GO:0006302]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; nucleus [GO:0005634]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003677; GO:0003950; GO:0005634; GO:0005730; GO:0006302; GO:0070212; GO:1990404	double-strand break repair [GO:0006302]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN5213_c0_g2_i1	Q5Z8Q9	PRP2A_ORYSJ	72.8	114	28	1	336	4	502	615	2.00E-42	172.9	PRP2A_ORYSJ	reviewed	Poly [ADP-ribose] polymerase 2-A (PARP-2-A) (EC 2.4.2.30) (NAD(+) ADP-ribosyltransferase 2-A) (ADPRT-2-A) (Poly[ADP-ribose] synthase 2-A) (Protein ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	PARP2-A Os01g0351200 LOC_Os01g24940 B1051E10.55 P0463A02.25	Oryza sativa subsp. japonica (Rice)	660	nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; double-strand break repair [GO:0006302]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; nucleus [GO:0005634]	DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003677; GO:0003950; GO:0005634; GO:0005730; GO:0006302; GO:0070212; GO:1990404	double-strand break repair [GO:0006302]; protein poly-ADP-ribosylation [GO:0070212]		NA	NA	NA	NA	NA	NA
TRINITY_DN15442_c0_g1_i1	O95271	TNKS1_HUMAN	88.4	95	11	0	3	287	694	788	1.20E-45	183.3	TNKS1_HUMAN	reviewed	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	TNKS PARP5A PARPL TIN1 TINF1 TNKS1	Homo sapiens (Human)	1327	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]"	histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37058_c0_g1_i1	O95271	TNKS1_HUMAN	89.2	111	12	0	2	334	827	937	7.70E-55	214.2	TNKS1_HUMAN	reviewed	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	TNKS PARP5A PARPL TIN1 TINF1 TNKS1	Homo sapiens (Human)	1327	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]"	histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14554_c0_g1_i1	O95271	TNKS1_HUMAN	81.7	306	56	0	920	3	180	485	1.80E-147	523.5	TNKS1_HUMAN	reviewed	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	TNKS PARP5A PARPL TIN1 TINF1 TNKS1	Homo sapiens (Human)	1327	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]"	histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36387_c0_g1_i1	O95271	TNKS1_HUMAN	100	128	0	0	386	3	176	303	3.40E-70	265.4	TNKS1_HUMAN	reviewed	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	TNKS PARP5A PARPL TIN1 TINF1 TNKS1	Homo sapiens (Human)	1327	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]"	histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38555_c0_g1_i1	Q9H2K2	TNKS2_HUMAN	99.3	142	1	0	2	427	34	175	9.70E-79	293.9	TNKS2_HUMAN	reviewed	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2) (Tankyrase-like protein) (Tankyrase-related protein)	TNKS2 PARP5B TANK2 TNKL	Homo sapiens (Human)	1166	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0000139; GO:0000209; GO:0000242; GO:0000784; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33343_c0_g1_i1	Q9H2K2	TNKS2_HUMAN	100	94	0	0	283	2	222	315	2.00E-51	202.6	TNKS2_HUMAN	reviewed	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2) (Tankyrase-like protein) (Tankyrase-related protein)	TNKS2 PARP5B TANK2 TNKL	Homo sapiens (Human)	1166	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0000139; GO:0000209; GO:0000242; GO:0000784; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1925_c0_g1_i1	Q3UES3	TNKS2_MOUSE	32.5	154	83	5	1885	1469	95	242	6.00E-07	58.2	TNKS2_MOUSE	reviewed	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2)	Tnks2 Tank2	Mus musculus (Mouse)	1166	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]	GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0006471; GO:0016055; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1925_c0_g1_i2	Q3UES3	TNKS2_MOUSE	32.5	154	83	5	1683	1267	95	242	5.60E-07	58.2	TNKS2_MOUSE	reviewed	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2)	Tnks2 Tank2	Mus musculus (Mouse)	1166	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]	GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0006471; GO:0016055; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21707_c0_g1_i1	Q3UES3	TNKS2_MOUSE	46	63	34	0	221	33	86	148	1.50E-06	53.1	TNKS2_MOUSE	reviewed	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2)	Tnks2 Tank2	Mus musculus (Mouse)	1166	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]	GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0006471; GO:0016055; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18745_c0_g1_i1	P51003	PAPOA_HUMAN	99.6	242	1	0	738	13	38	279	8.80E-136	484.2	PAPOA_HUMAN	reviewed	Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha)	PAPOLA PAP	Homo sapiens (Human)	745	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0000287; GO:0000398; GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006369; GO:0006378; GO:0030145; GO:0031124; GO:0031440; GO:0043631	"mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38637_c0_g1_i1	P25500	PAPOA_BOVIN	100	51	0	0	153	1	304	354	5.20E-22	104.4	PAPOA_BOVIN	reviewed	Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha)	PAPOLA PAP	Bos taurus (Bovine)	739	nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631]	nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006378; GO:0030145; GO:0031440; GO:0043631	mRNA polyadenylation [GO:0006378]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4287_c0_g1_i1	Q9BWT3	PAPOG_HUMAN	63.5	446	158	3	1328	3	20	464	1.60E-165	583.9	PAPOG_HUMAN	reviewed	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	PAPOLG PAP2 PAPG	Homo sapiens (Human)	736	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4287_c0_g1_i3	Q9BWT3	PAPOG_HUMAN	63.5	446	158	3	1414	89	20	464	1.70E-165	583.9	PAPOG_HUMAN	reviewed	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	PAPOLG PAP2 PAPG	Homo sapiens (Human)	736	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN5955_c0_g1_i1	Q9BWT3	PAPOG_HUMAN	49.7	173	83	1	510	4	64	236	1.10E-44	181	PAPOG_HUMAN	reviewed	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	PAPOLG PAP2 PAPG	Homo sapiens (Human)	736	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN39520_c0_g1_i1	Q9BWT3	PAPOG_HUMAN	100	84	0	0	253	2	223	306	5.50E-45	181	PAPOG_HUMAN	reviewed	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	PAPOLG PAP2 PAPG	Homo sapiens (Human)	736	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4287_c0_g1_i2	Q6PCL9	PAPOG_MOUSE	59.5	523	204	5	1737	187	20	540	8.80E-177	621.7	PAPOG_MOUSE	reviewed	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	Papolg	Mus musculus (Mouse)	739	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016604; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN4287_c0_g1_i4	Q6PCL9	PAPOG_MOUSE	59.5	523	204	5	1737	187	20	540	6.70E-177	622.1	PAPOG_MOUSE	reviewed	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	Papolg	Mus musculus (Mouse)	739	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016604; GO:0043631; GO:0046872	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN1679_c0_g1_i1	O42617	PAP_CANAL	59.5	79	32	0	237	1	257	335	8.50E-24	110.5	PAP_CANAL	reviewed	Poly(A) polymerase PAPalpha (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha)	PAPALPHA PAP1 C5_01745W_B CaO19.10713	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	558	nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]; single-species biofilm formation on inanimate substrate [GO:0044011]	nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006397; GO:0031123; GO:0043631; GO:0044011; GO:0046872	mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]; single-species biofilm formation on inanimate substrate [GO:0044011]		NA	NA	NA	NA	NA	NA
TRINITY_DN9927_c0_g1_i2	O17087	GLD2_CAEEL	42.4	144	75	2	511	86	549	686	6.90E-24	112.8	GLD2_CAEEL	reviewed	Poly(A) RNA polymerase gld-2 (EC 2.7.7.19) (Defective in germ line development protein 2)	gld-2 ZC308.1	Caenorhabditis elegans	1113	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; RNA-directed RNA polymerase complex [GO:0031379]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic cell cycle [GO:0051321]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; nucleus organization [GO:0006997]; positive regulation of meiosis I [GO:0060903]; regulation of cell division [GO:0051302]; RNA polyadenylation [GO:0043631]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; RNA-directed RNA polymerase complex [GO:0031379]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0006378; GO:0006397; GO:0006997; GO:0009792; GO:0016779; GO:0031379; GO:0032991; GO:0043186; GO:0043631; GO:0046872; GO:0051302; GO:0051321; GO:0060903	embryo development ending in birth or egg hatching [GO:0009792]; meiotic cell cycle [GO:0051321]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; nucleus organization [GO:0006997]; positive regulation of meiosis I [GO:0060903]; regulation of cell division [GO:0051302]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN31438_c0_g1_i2	Q2HJ44	GLD2_BOVIN	100	82	0	0	246	1	248	329	3.60E-41	168.3	GLD2_BOVIN	reviewed	Poly(A) RNA polymerase GLD2 (EC 2.7.7.19) (PAP-associated domain-containing protein 4)	TENT2	Bos taurus (Bovine)	484	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0006378; GO:0006397; GO:0016779; GO:0034062; GO:0043489; GO:0043631; GO:0046872; GO:0070566; GO:0071044; GO:2000626	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489]		NA	NA	NA	NA	NA	NA
TRINITY_DN31438_c0_g1_i1	Q6PIY7	GLD2_HUMAN	100	95	0	0	340	56	248	342	2.40E-48	192.6	GLD2_HUMAN	reviewed	Poly(A) RNA polymerase GLD2 (hGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2) (Terminal uridylyltransferase 2) (TUTase 2)	TENT2 GLD2 PAPD4	Homo sapiens (Human)	484	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; 5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]	5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]	GO:0002244; GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006378; GO:0006397; GO:0016779; GO:0021766; GO:0030182; GO:0031380; GO:0034062; GO:0043489; GO:0043631; GO:0046872; GO:0060041; GO:0070566; GO:0071044; GO:1990603; GO:2000626	dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489]		NA	NA	NA	NA	NA	NA
TRINITY_DN9927_c0_g1_i1	Q9VD44	GLD2A_DROME	46.1	280	139	6	832	8	928	1200	5.40E-61	236.5	GLD2A_DROME	reviewed	Poly(A) RNA polymerase gld-2 homolog A (DmGLD2) (EC 2.7.7.19)	Gld2 CG5732	Drosophila melanogaster (Fruit fly)	1364	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; long-term memory [GO:0007616]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006378; GO:0006397; GO:0007616; GO:0016779; GO:0043005; GO:0043631; GO:0046872	long-term memory [GO:0007616]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i2	O46102	PAPD1_DROME	46.5	101	54	0	61	363	291	391	2.50E-18	93.2	PAPD1_DROME	reviewed	"Poly(A) RNA polymerase, mitochondrial (DmMTPAP) (EC 2.7.7.19)"	MTPAP CG11418	Drosophila melanogaster (Fruit fly)	612	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0036416; GO:0046872; GO:0097222; GO:1990817	mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN4743_c0_g1_i13	O46102	PAPD1_DROME	36.5	318	188	5	930	4	37	349	9.90E-46	185.7	PAPD1_DROME	reviewed	"Poly(A) RNA polymerase, mitochondrial (DmMTPAP) (EC 2.7.7.19)"	MTPAP CG11418	Drosophila melanogaster (Fruit fly)	612	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0036416; GO:0046872; GO:0097222; GO:1990817	mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN4743_c0_g1_i6	O46102	PAPD1_DROME	36.5	318	188	5	930	4	37	349	9.90E-46	185.7	PAPD1_DROME	reviewed	"Poly(A) RNA polymerase, mitochondrial (DmMTPAP) (EC 2.7.7.19)"	MTPAP CG11418	Drosophila melanogaster (Fruit fly)	612	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0036416; GO:0046872; GO:0097222; GO:1990817	mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN4743_c0_g1_i14	O46102	PAPD1_DROME	52.5	59	28	0	180	4	291	349	3.10E-10	65.9	PAPD1_DROME	reviewed	"Poly(A) RNA polymerase, mitochondrial (DmMTPAP) (EC 2.7.7.19)"	MTPAP CG11418	Drosophila melanogaster (Fruit fly)	612	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0036416; GO:0046872; GO:0097222; GO:1990817	mitochondrial mRNA polyadenylation [GO:0097222]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; tRNA stabilization [GO:0036416]		brown	brown	1	NA	NA	NA
TRINITY_DN5690_c0_g1_i13	Q9D0D3	PAPD1_MOUSE	44.7	85	46	1	68	322	340	423	7.10E-11	68.2	PAPD1_MOUSE	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase)"	Mtpap Papd1	Mus musculus (Mouse)	585	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i9	Q9D0D3	PAPD1_MOUSE	46.7	75	40	0	68	292	340	414	4.30E-10	65.5	PAPD1_MOUSE	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase)"	Mtpap Papd1	Mus musculus (Mouse)	585	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i11	Q9NVV4	PAPD1_HUMAN	40.5	173	94	2	3	509	324	491	1.90E-28	127.1	PAPD1_HUMAN	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	582	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i12	Q9NVV4	PAPD1_HUMAN	38.9	126	71	2	216	581	354	477	5.60E-16	86.7	PAPD1_HUMAN	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	582	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i14	Q9NVV4	PAPD1_HUMAN	38.9	126	71	2	216	581	354	477	5.10E-16	86.7	PAPD1_HUMAN	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	582	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i3	Q9NVV4	PAPD1_HUMAN	40	160	87	2	68	535	337	491	3.50E-25	116.3	PAPD1_HUMAN	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	582	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i4	Q9NVV4	PAPD1_HUMAN	46.3	82	44	0	3	248	324	405	1.10E-12	73.9	PAPD1_HUMAN	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	582	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN5690_c0_g1_i8	Q9NVV4	PAPD1_HUMAN	46.4	69	37	0	68	274	337	405	2.00E-09	63.2	PAPD1_HUMAN	reviewed	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	582	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005737; GO:0005739; GO:0006378; GO:0006397; GO:0016779; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN16888_c0_g1_i1	Q7ZU92	PARN_DANRE	38.2	400	220	11	1293	163	1	396	1.10E-59	232.3	PARN_DANRE	reviewed	Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Polyadenylate-specific ribonuclease)	parn zgc:56067	Danio rerio (Zebrafish) (Brachydanio rerio)	660	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0030097; GO:0043169; GO:0046872	hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]		blue	blue	NA	NA	NA	NA
TRINITY_DN16888_c0_g1_i2	Q7ZU92	PARN_DANRE	37.5	485	274	12	1819	440	1	481	2.50E-73	278.1	PARN_DANRE	reviewed	Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Polyadenylate-specific ribonuclease)	parn zgc:56067	Danio rerio (Zebrafish) (Brachydanio rerio)	660	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0030097; GO:0043169; GO:0046872	hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]		blue	blue	NA	NA	NA	NA
TRINITY_DN16888_c0_g1_i6	Q7ZU92	PARN_DANRE	37.5	485	274	12	1775	396	1	481	2.40E-73	278.1	PARN_DANRE	reviewed	Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Polyadenylate-specific ribonuclease)	parn zgc:56067	Danio rerio (Zebrafish) (Brachydanio rerio)	660	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0030097; GO:0043169; GO:0046872	hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]		blue	blue	NA	NA	NA	NA
TRINITY_DN962_c0_g1_i1	P57721	PCBP3_HUMAN	50.6	87	38	1	21	281	289	370	1.60E-15	83.6	PCBP3_HUMAN	reviewed	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"	GO:0001227; GO:0003690; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062; GO:1990829	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		blue	blue	NA	NA	NA	NA
TRINITY_DN962_c0_g1_i2	P57721	PCBP3_HUMAN	40.7	167	82	3	4	501	215	365	7.80E-20	98.6	PCBP3_HUMAN	reviewed	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"	GO:0001227; GO:0003690; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062; GO:1990829	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		NA	NA	NA	NA	NA	NA
TRINITY_DN962_c0_g1_i3	P57721	PCBP3_HUMAN	43.4	152	77	3	4	447	215	361	5.10E-20	99.8	PCBP3_HUMAN	reviewed	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"	GO:0001227; GO:0003690; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062; GO:1990829	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		NA	NA	NA	NA	NA	NA
TRINITY_DN962_c0_g1_i4	P57721	PCBP3_HUMAN	42	157	80	3	4	471	215	361	3.10E-20	100.5	PCBP3_HUMAN	reviewed	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"	GO:0001227; GO:0003690; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062; GO:1990829	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		NA	NA	NA	NA	NA	NA
TRINITY_DN962_c0_g1_i6	P57721	PCBP3_HUMAN	42.2	161	82	3	4	483	215	365	5.30E-21	102.4	PCBP3_HUMAN	reviewed	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"	GO:0001227; GO:0003690; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062; GO:1990829	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		NA	NA	NA	NA	NA	NA
TRINITY_DN962_c0_g1_i7	P57721	PCBP3_HUMAN	40.5	163	80	3	4	489	215	361	4.50E-19	96.7	PCBP3_HUMAN	reviewed	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]"	GO:0001227; GO:0003690; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062; GO:1990829	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]		NA	NA	NA	NA	NA	NA
TRINITY_DN26960_c0_g1_i1	Q8T6B9	PUF68_DROME	59.7	139	53	1	145	552	499	637	1.70E-37	157.5	PUF68_DROME	reviewed	Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog)	hfp pUf68 CG12085	Drosophila melanogaster (Fruit fly)	637	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013	"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1999_c0_g1_i1	Q8T6B9	PUF68_DROME	67.5	283	84	3	112	954	46	322	2.70E-99	363.6	PUF68_DROME	reviewed	Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog)	hfp pUf68 CG12085	Drosophila melanogaster (Fruit fly)	637	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013	"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1999_c0_g1_i10	Q8T6B9	PUF68_DROME	69.1	278	81	2	37	858	46	322	1.20E-101	371.3	PUF68_DROME	reviewed	Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog)	hfp pUf68 CG12085	Drosophila melanogaster (Fruit fly)	637	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013	"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1999_c0_g1_i4	Q8T6B9	PUF68_DROME	63	305	81	3	112	1014	46	322	5.90E-97	355.9	PUF68_DROME	reviewed	Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog)	hfp pUf68 CG12085	Drosophila melanogaster (Fruit fly)	637	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013	"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1999_c0_g1_i6	Q8T6B9	PUF68_DROME	68.3	278	81	3	112	927	46	322	3.40E-99	363.2	PUF68_DROME	reviewed	Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog)	hfp pUf68 CG12085	Drosophila melanogaster (Fruit fly)	637	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013	"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1999_c0_g1_i7	Q8T6B9	PUF68_DROME	68.3	278	81	3	79	894	46	322	3.30E-99	363.2	PUF68_DROME	reviewed	Poly(U)-binding-splicing factor half pint (Protein half pint) (68 kDa poly(U)-binding-splicing factor) (PUF60 homolog)	hfp pUf68 CG12085	Drosophila melanogaster (Fruit fly)	637	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0001558; GO:0003723; GO:0005634; GO:0006376; GO:0007275; GO:0007282; GO:0008285; GO:0032991; GO:0045926; GO:0048477; GO:0071011; GO:0071013	"alternative mRNA splicing, via spliceosome [GO:0000380]; cystoblast division [GO:0007282]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell growth [GO:0001558]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20698_c0_g2_i1	Q2HJG2	PUF60_BOVIN	100	222	0	0	682	17	68	289	4.20E-124	445.3	PUF60_BOVIN	reviewed	Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor)	PUF60	Bos taurus (Bovine)	530	"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0006376; GO:0006915	"alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20698_c0_g1_i1	Q2HJG2	PUF60_BOVIN	100	222	0	0	723	58	68	289	2.00E-124	446.4	PUF60_BOVIN	reviewed	Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor)	PUF60	Bos taurus (Bovine)	530	"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0006376; GO:0006915	"alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1999_c0_g1_i5	Q2HJG2	PUF60_BOVIN	69.5	105	32	0	77	391	181	285	5.90E-37	155.6	PUF60_BOVIN	reviewed	Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor)	PUF60	Bos taurus (Bovine)	530	"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0006376; GO:0006915	"alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23318_c0_g1_i2	Q3UEB3	PUF60_MOUSE	100	108	0	0	2	325	430	537	1.60E-52	206.5	PUF60_MOUSE	reviewed	Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor)	Puf60	Mus musculus (Mouse)	564	"cell junction [GO:0030054]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cell junction [GO:0030054]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0003677; GO:0003723; GO:0005654; GO:0006376; GO:0006915; GO:0030054; GO:0042802	"alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23318_c0_g1_i1	Q9UHX1	PUF60_HUMAN	100	130	0	0	2	391	425	554	7.80E-67	254.2	PUF60_HUMAN	reviewed	Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1)	PUF60 FIR ROBPI SIAHBP1	Homo sapiens (Human)	559	"cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cell junction [GO:0030054]; nucleoplasm [GO:0005654]	cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0005654; GO:0006376; GO:0006915; GO:0030054; GO:0042802; GO:0045296	"alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29732_c0_g1_i1	Q9VZ49	ENDOU_DROME	48.6	247	121	3	134	865	349	592	5.60E-58	226.1	ENDOU_DROME	reviewed	Poly(U)-specific endoribonuclease homolog (EC 3.1.-.-) (Protein endoU) (Uridylate-specific endoribonuclease homolog)	CG2145	Drosophila melanogaster (Fruit fly)	592	"extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	extracellular region [GO:0005576]	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005576; GO:0046872; GO:0090502	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1551_c0_g1_i1	Q9VZ49	ENDOU_DROME	46.5	114	58	2	374	42	477	590	1.00E-23	110.9	ENDOU_DROME	reviewed	Poly(U)-specific endoribonuclease homolog (EC 3.1.-.-) (Protein endoU) (Uridylate-specific endoribonuclease homolog)	CG2145	Drosophila melanogaster (Fruit fly)	592	"extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	extracellular region [GO:0005576]	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005576; GO:0046872; GO:0090502	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		black	black	1	NA	1	1
TRINITY_DN39961_c0_g1_i1	B1WBB4	ENDUB_XENLA	44.1	68	35	1	4	198	82	149	4.70E-07	54.7	ENDUB_XENLA	reviewed	Poly(U)-specific endoribonuclease-B (EC 3.1.-.-) (Protein endoU-B) (Uridylate-specific endoribonuclease-B) (XendoU-B)	endou-b	Xenopus laevis (African clawed frog)	292	nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	nucleus [GO:0005634]	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0005634; GO:0046872			black	black	1	NA	NA	1
TRINITY_DN40988_c0_g1_i1	P21187	PABP_DROME	59.2	71	29	0	1	213	313	383	1.70E-16	86.3	PABP_DROME	reviewed	Polyadenylate-binding protein (PABP) (Poly(A)-binding protein)	pAbp CG5119	Drosophila melanogaster (Fruit fly)	634	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; chemical synaptic transmission [GO:0007268]; dorsal/ventral pattern formation [GO:0009953]; male meiosis cytokinesis [GO:0007112]; male meiotic nuclear division [GO:0007140]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of neuron death [GO:1901215]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of compound eye photoreceptor development [GO:0045314]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0007112; GO:0007140; GO:0007268; GO:0007283; GO:0007289; GO:0008143; GO:0008266; GO:0009953; GO:0010494; GO:0045202; GO:0045314; GO:0045727; GO:0048477; GO:0048599; GO:0071011; GO:0071013; GO:1901215; GO:1990904	"chemical synaptic transmission [GO:0007268]; dorsal/ventral pattern formation [GO:0009953]; male meiosis cytokinesis [GO:0007112]; male meiotic nuclear division [GO:0007140]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of neuron death [GO:1901215]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of compound eye photoreceptor development [GO:0045314]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7918_c0_g2_i1	P61286	PABP1_BOVIN	100	156	0	0	469	2	245	400	2.70E-82	305.8	PABP1_BOVIN	reviewed	Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)	PABPC1 PABP1	Bos taurus (Bovine)	636	"catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0000184; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008022; GO:0008143; GO:0008266; GO:0008380; GO:0010494; GO:0030027; GO:0031047; GO:0031252; GO:0045070; GO:0060213; GO:0071013; GO:1900153; GO:1990904; GO:2000623	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7918_c0_g1_i1	P29341	PABP1_MOUSE	100	408	0	0	1226	3	3	410	3.60E-235	815.1	PABP1_MOUSE	reviewed	Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)	Pabpc1 Pabp1	Mus musculus (Mouse)	636	"catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0000184; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008022; GO:0008143; GO:0008266; GO:0008380; GO:0010494; GO:0030027; GO:0030425; GO:0031047; GO:0031252; GO:0036464; GO:0045070; GO:0045202; GO:0060213; GO:0071013; GO:1900153; GO:1990124; GO:1990904; GO:2000623	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18381_c0_g1_i1	P61286	PABP1_BOVIN	96.1	129	5	0	1	387	508	636	1.90E-60	233	PABP1_BOVIN	reviewed	Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)	PABPC1 PABP1	Bos taurus (Bovine)	636	"catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0000184; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008022; GO:0008143; GO:0008266; GO:0008380; GO:0010494; GO:0030027; GO:0031047; GO:0031252; GO:0045070; GO:0060213; GO:0071013; GO:1900153; GO:1990904; GO:2000623	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18381_c0_g1_i2	P61286	PABP1_BOVIN	96.1	129	5	0	1	387	508	636	1.90E-60	233	PABP1_BOVIN	reviewed	Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)	PABPC1 PABP1	Bos taurus (Bovine)	636	"catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0000184; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008022; GO:0008143; GO:0008266; GO:0008380; GO:0010494; GO:0030027; GO:0031047; GO:0031252; GO:0045070; GO:0060213; GO:0071013; GO:1900153; GO:1990904; GO:2000623	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25870_c0_g1_i1	F1QB54	PABPA_DANRE	65.3	75	26	0	241	17	541	615	1.20E-18	93.6	PABPA_DANRE	reviewed	Polyadenylate-binding protein 1A (PABP-1A) (Poly(A)-binding protein 1A)	pabpc1a	Danio rerio (Zebrafish) (Brachydanio rerio)	634	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006412; GO:0006417; GO:0007507; GO:0008143; GO:0008266; GO:0010494; GO:1990904	heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN32893_c0_g1_i1	F1QB54	PABPA_DANRE	67.6	74	24	0	10	231	542	615	2.40E-19	95.9	PABPA_DANRE	reviewed	Polyadenylate-binding protein 1A (PABP-1A) (Poly(A)-binding protein 1A)	pabpc1a	Danio rerio (Zebrafish) (Brachydanio rerio)	634	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006412; GO:0006417; GO:0007507; GO:0008143; GO:0008266; GO:0010494; GO:1990904	heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412]		red	red	NA	NA	NA	NA
TRINITY_DN204_c0_g2_i1	P20965	PABPA_XENLA	61.8	89	32	1	1	261	535	623	3.00E-20	99	PABPA_XENLA	reviewed	Polyadenylate-binding protein 1-A (PABP-1-A) (Poly(A)-binding protein 1-A) (xPABP1-A) (Cytoplasmic poly(A)-binding protein 1-A)	pabpc1-a pabp pabp1	Xenopus laevis (African clawed frog)	633	"cytoplasm [GO:0005737]; polysome [GO:0005844]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"	cytoplasm [GO:0005737]; polysome [GO:0005844]	eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]	GO:0005737; GO:0005844; GO:0006397; GO:0006412; GO:0006417; GO:0008143; GO:0031047; GO:0031370; GO:0043621; GO:0048255; GO:0060212; GO:0060213; GO:1900153	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"		red	red	NA	NA	NA	NA
TRINITY_DN18432_c0_g1_i1	P20965	PABPA_XENLA	76.9	65	15	0	198	4	532	596	4.10E-22	104.8	PABPA_XENLA	reviewed	Polyadenylate-binding protein 1-A (PABP-1-A) (Poly(A)-binding protein 1-A) (xPABP1-A) (Cytoplasmic poly(A)-binding protein 1-A)	pabpc1-a pabp pabp1	Xenopus laevis (African clawed frog)	633	"cytoplasm [GO:0005737]; polysome [GO:0005844]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"	cytoplasm [GO:0005737]; polysome [GO:0005844]	eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]	GO:0005737; GO:0005844; GO:0006397; GO:0006412; GO:0006417; GO:0008143; GO:0031047; GO:0031370; GO:0043621; GO:0048255; GO:0060212; GO:0060213; GO:1900153	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32356_c0_g1_i1	P20965	PABPA_XENLA	76.5	85	20	0	256	2	1	85	2.60E-31	136	PABPA_XENLA	reviewed	Polyadenylate-binding protein 1-A (PABP-1-A) (Poly(A)-binding protein 1-A) (xPABP1-A) (Cytoplasmic poly(A)-binding protein 1-A)	pabpc1-a pabp pabp1	Xenopus laevis (African clawed frog)	633	"cytoplasm [GO:0005737]; polysome [GO:0005844]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"	cytoplasm [GO:0005737]; polysome [GO:0005844]	eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]	GO:0005737; GO:0005844; GO:0006397; GO:0006412; GO:0006417; GO:0008143; GO:0031047; GO:0031370; GO:0043621; GO:0048255; GO:0060212; GO:0060213; GO:1900153	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37093_c0_g1_i1	Q6IP09	PABPB_XENLA	64.2	95	33	1	43	327	289	382	3.10E-27	122.5	PABPB_XENLA	reviewed	Polyadenylate-binding protein 1-B (PABP-1-B) (Poly(A)-binding protein 1-B) (xPABP1-B) (Cytoplasmic poly(A)-binding protein 1-B)	pabpc1-b	Xenopus laevis (African clawed frog)	633	"cytoplasm [GO:0005737]; polysome [GO:0005844]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"	cytoplasm [GO:0005737]; polysome [GO:0005844]	eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]	GO:0005737; GO:0005844; GO:0006397; GO:0006412; GO:0006417; GO:0008143; GO:0031047; GO:0031370; GO:0043621; GO:0048255; GO:0060212; GO:0060213; GO:1900153	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38735_c0_g1_i1	Q6IP09	PABPB_XENLA	65.3	124	38	1	474	103	509	627	1.60E-32	140.6	PABPB_XENLA	reviewed	Polyadenylate-binding protein 1-B (PABP-1-B) (Poly(A)-binding protein 1-B) (xPABP1-B) (Cytoplasmic poly(A)-binding protein 1-B)	pabpc1-b	Xenopus laevis (African clawed frog)	633	"cytoplasm [GO:0005737]; polysome [GO:0005844]; eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"	cytoplasm [GO:0005737]; polysome [GO:0005844]	eukaryotic initiation factor 4G binding [GO:0031370]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]	GO:0005737; GO:0005844; GO:0006397; GO:0006412; GO:0006417; GO:0008143; GO:0031047; GO:0031370; GO:0043621; GO:0048255; GO:0060212; GO:0060213; GO:1900153	"gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of translation [GO:0006417]; translation [GO:0006412]"		blue	blue	NA	NA	NA	NA
TRINITY_DN11608_c0_g1_i1	Q8CCS6	PABP2_MOUSE	99.2	129	1	0	125	511	142	270	9.90E-70	264.2	PABP2_MOUSE	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)	Pabpn1 Pab2 Pabp2	Mus musculus (Mouse)	302	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0016607; GO:0016973; GO:0042405; GO:0043621; GO:0070063; GO:0071222; GO:1904247; GO:1990904	cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]		NA	NA	NA	NA	NA	NA
TRINITY_DN11608_c0_g1_i2	Q28165	PABP2_BOVIN	100	140	0	0	125	544	146	285	7.50E-76	284.6	PABP2_BOVIN	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)	PABPN1 PAB2 PABP2	Bos taurus (Bovine)	306	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	protein self-association [GO:0043621]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0016607; GO:0042405; GO:0043621; GO:0070063; GO:0071222; GO:1904247; GO:1990904	cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]		NA	NA	NA	NA	NA	NA
TRINITY_DN3493_c0_g1_i1	Q6NVP7	PABP2_XENTR	70.5	139	32	3	315	713	137	272	1.70E-47	191	PABP2_XENTR	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)	pabpn1 TGas130l12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	296	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0003723; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0042405; GO:0045746; GO:0070063; GO:0071222; GO:0098508; GO:1904247; GO:1990904	cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]		blue	blue	NA	NA	NA	NA
TRINITY_DN3493_c0_g1_i2	Q6NVP7	PABP2_XENTR	68.7	150	38	3	315	746	137	283	1.10E-49	198.4	PABP2_XENTR	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)	pabpn1 TGas130l12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	296	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0003723; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0042405; GO:0045746; GO:0070063; GO:0071222; GO:0098508; GO:1904247; GO:1990904	cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]		NA	NA	NA	NA	NA	NA
TRINITY_DN3493_c0_g1_i3	Q6NVP7	PABP2_XENTR	69.9	146	35	3	315	734	137	279	1.40E-49	198	PABP2_XENTR	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)	pabpn1 TGas130l12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	296	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0003723; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0042405; GO:0045746; GO:0070063; GO:0071222; GO:0098508; GO:1904247; GO:1990904	cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]		blue	blue	NA	NA	NA	NA
TRINITY_DN28628_c0_g1_i1	Q6NVP7	PABP2_XENTR	58.8	80	33	0	25	264	156	235	3.30E-24	112.1	PABP2_XENTR	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)	pabpn1 TGas130l12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	296	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0003723; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0042405; GO:0045746; GO:0070063; GO:0071222; GO:0098508; GO:1904247; GO:1990904	cellular response to lipopolysaccharide [GO:0071222]; endothelial to hematopoietic transition [GO:0098508]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]		NA	NA	NA	NA	NA	NA
TRINITY_DN2841_c0_g1_i1	O14327	PAB2_SCHPO	52	102	49	0	1	306	25	126	9.90E-25	114	PAB2_SCHPO	reviewed	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Poly(A)-binding protein II) (PABII)	pab2 SPBC16E9.12c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	166	cytoplasm [GO:0005737]; Mei2 nuclear dot complex [GO:0033620]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear exosome focus [GO:1990251]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; poly(A) binding [GO:0008143]; homologous chromosome pairing at meiosis [GO:0007129]; mRNA catabolic process [GO:0006402]	cytoplasm [GO:0005737]; Mei2 nuclear dot complex [GO:0033620]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear exosome focus [GO:1990251]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]	poly(A) binding [GO:0008143]	GO:0000790; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005844; GO:0006402; GO:0007129; GO:0008143; GO:0016604; GO:0033620; GO:1990251	homologous chromosome pairing at meiosis [GO:0007129]; mRNA catabolic process [GO:0006402]		NA	NA	NA	NA	NA	NA
TRINITY_DN6960_c2_g1_i1	Q13310	PABP4_HUMAN	75.8	418	97	2	92	1336	1	417	1.70E-181	637.1	PABP4_HUMAN	reviewed	Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP)	PABPC4 APP1 PABP4	Homo sapiens (Human)	644	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904	blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN13731_c0_g1_i1	Q13310	PABP4_HUMAN	69.5	131	34	2	2	376	296	426	8.60E-42	171	PABP4_HUMAN	reviewed	Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP)	PABPC4 APP1 PABP4	Homo sapiens (Human)	644	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904	blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN29407_c0_g1_i1	Q13310	PABP4_HUMAN	97.8	46	1	0	61	198	571	616	3.90E-18	91.7	PABP4_HUMAN	reviewed	Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP)	PABPC4 APP1 PABP4	Homo sapiens (Human)	644	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904	blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26172_c0_g1_i1	Q9ZQA8	PABP7_ARATH	44.7	76	42	0	242	15	104	179	1.40E-13	76.6	PABP7_ARATH	reviewed	Polyadenylate-binding protein 7 (PABP-7) (Poly(A)-binding protein 7)	PAB7 At2g36660 F13K3.6	Arabidopsis thaliana (Mouse-ear cress)	609	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0008143; GO:0008266; GO:1990904	regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN68_c0_g1_i1	Q4WK03	PABP_ASPFU	62.8	199	71	1	596	9	45	243	2.50E-67	256.5	PABP_ASPFU	reviewed	"Polyadenylate-binding protein, cytoplasmic and nuclear (PABP) (Poly(A)-binding protein) (Polyadenylate tail-binding protein)"	pab1 AFUA_1G04190	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	753	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0008143; GO:0008266; GO:0010494; GO:0051028; GO:1990904	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN39093_c0_g1_i1	P31209	PABP_SCHPO	67.2	189	59	2	559	2	76	264	9.80E-69	261.2	PABP_SCHPO	reviewed	"Polyadenylate-binding protein, cytoplasmic and nuclear (PABP) (Poly(A)-binding protein) (Polyadenylate tail-binding protein)"	pab1 pabp SPAC57A7.04c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	653	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of poly(A)-specific ribonuclease activity [GO:0106247]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of poly(A)-specific ribonuclease activity [GO:0106248]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:0031124; GO:0051028; GO:0060211; GO:0060212; GO:0071014; GO:0106247; GO:0106248; GO:1904690; GO:1990904	mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of poly(A)-specific ribonuclease activity [GO:0106247]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of poly(A)-specific ribonuclease activity [GO:0106248]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]		NA	NA	NA	NA	NA	NA
TRINITY_DN38700_c0_g1_i1	P31209	PABP_SCHPO	69.3	166	51	0	500	3	76	241	3.60E-64	245.7	PABP_SCHPO	reviewed	"Polyadenylate-binding protein, cytoplasmic and nuclear (PABP) (Poly(A)-binding protein) (Polyadenylate tail-binding protein)"	pab1 pabp SPAC57A7.04c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	653	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of poly(A)-specific ribonuclease activity [GO:0106247]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of poly(A)-specific ribonuclease activity [GO:0106248]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:0031124; GO:0051028; GO:0060211; GO:0060212; GO:0071014; GO:0106247; GO:0106248; GO:1904690; GO:1990904	mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of poly(A)-specific ribonuclease activity [GO:0106247]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of poly(A)-specific ribonuclease activity [GO:0106248]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]		NA	NA	NA	NA	NA	NA
TRINITY_DN10670_c1_g1_i1	Q6P3E7	HDA10_MOUSE	56.9	58	25	0	1	174	99	156	3.20E-13	75.9	HDA10_MOUSE	reviewed	Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10)	Hdac10	Mus musculus (Mouse)	666	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006355; GO:0008270; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048	"DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10670_c1_g1_i1	Q6P3E7	HDA10_MOUSE	69	29	9	0	186	272	161	189	2.90E-06	52.8	HDA10_MOUSE	reviewed	Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10)	Hdac10	Mus musculus (Mouse)	666	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006355; GO:0008270; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048	"DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10670_c1_g1_i2	Q6P3E7	HDA10_MOUSE	59.8	102	41	0	1	306	99	200	1.90E-31	136.3	HDA10_MOUSE	reviewed	Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10)	Hdac10	Mus musculus (Mouse)	666	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006355; GO:0008270; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048	"DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8387_c2_g1_i2	Q9NQ11	AT132_HUMAN	34.9	439	257	10	1	1272	754	1178	3.40E-47	191.4	AT132_HUMAN	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	ATP13A2 PARK9	Homo sapiens (Human)	1180	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0012506; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN8387_c2_g1_i7	Q9NQ11	AT132_HUMAN	34.9	439	257	10	1	1272	754	1178	3.10E-47	191.4	AT132_HUMAN	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	ATP13A2 PARK9	Homo sapiens (Human)	1180	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0012506; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN3264_c0_g1_i1	Q9NQ11	AT132_HUMAN	66.9	142	47	0	3	428	838	979	6.40E-46	184.9	AT132_HUMAN	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	ATP13A2 PARK9	Homo sapiens (Human)	1180	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0012506; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN34542_c0_g1_i2	Q9CTG6	AT132_MOUSE	44.7	132	60	2	34	393	427	557	8.50E-21	101.3	AT132_MOUSE	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	Atp13a2	Mus musculus (Mouse)	1169	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0010628; GO:0010821; GO:0012506; GO:0016241; GO:0016243; GO:0016887; GO:0030133; GO:0031982; GO:0032585; GO:0033157; GO:0034599; GO:0043005; GO:0043025; GO:0046872; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0080025; GO:0097734; GO:1900180; GO:1902047; GO:1903543; GO:1903710; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN33039_c0_g1_i1	Q9NQ11	AT132_HUMAN	100	88	0	0	266	3	834	921	6.90E-43	174.1	AT132_HUMAN	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	ATP13A2 PARK9	Homo sapiens (Human)	1180	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0012506; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN31681_c0_g1_i1	Q9NQ11	AT132_HUMAN	100	77	0	0	233	3	620	696	7.70E-38	157.1	AT132_HUMAN	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	ATP13A2 PARK9	Homo sapiens (Human)	1180	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0012506; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN24966_c0_g1_i1	Q9CTG6	AT132_MOUSE	34.5	116	76	0	123	470	160	275	3.30E-14	79.7	AT132_MOUSE	reviewed	Polyamine-transporting ATPase 13A2 (EC 7.6.2.-)	Atp13a2	Mus musculus (Mouse)	1169	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0010628; GO:0010821; GO:0012506; GO:0016241; GO:0016243; GO:0016887; GO:0030133; GO:0031982; GO:0032585; GO:0033157; GO:0034599; GO:0043005; GO:0043025; GO:0046872; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0080025; GO:0097734; GO:1900180; GO:1902047; GO:1903543; GO:1903710; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1990938; GO:2000152	autophagosome-lysosome fusion [GO:0061909]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN26040_c0_g1_i1	Q32KX7	BMI1_BOVIN	100	125	0	0	55	429	1	125	5.40E-69	261.5	BMI1_BOVIN	reviewed	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)	BMI1 PCGF4	Bos taurus (Bovine)	326	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]	promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005737; GO:0006306; GO:0006342; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016604; GO:0021903; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0045814; GO:0048103; GO:0048704; GO:0051443; GO:0097027; GO:1990841; GO:2000011; GO:2001234	"brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24911_c0_g1_i1	Q32KX7	BMI1_BOVIN	43.3	67	37	1	216	16	162	227	3.70E-10	65.1	BMI1_BOVIN	reviewed	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)	BMI1 PCGF4	Bos taurus (Bovine)	326	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]	promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005737; GO:0006306; GO:0006342; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016604; GO:0021903; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0045814; GO:0048103; GO:0048704; GO:0051443; GO:0097027; GO:1990841; GO:2000011; GO:2001234	"brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24911_c0_g2_i1	Q32KX7	BMI1_BOVIN	70.1	107	32	0	51	371	6	112	5.10E-42	171.8	BMI1_BOVIN	reviewed	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)	BMI1 PCGF4	Bos taurus (Bovine)	326	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]	promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005737; GO:0006306; GO:0006342; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016604; GO:0021903; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0045814; GO:0048103; GO:0048704; GO:0051443; GO:0097027; GO:1990841; GO:2000011; GO:2001234	"brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17854_c0_g2_i1	Q32KX7	BMI1_BOVIN	74.7	99	25	0	322	26	6	104	1.30E-43	177.2	BMI1_BOVIN	reviewed	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)	BMI1 PCGF4	Bos taurus (Bovine)	326	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]	promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005737; GO:0006306; GO:0006342; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016604; GO:0021903; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0045814; GO:0048103; GO:0048704; GO:0051443; GO:0097027; GO:1990841; GO:2000011; GO:2001234	"brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21376_c0_g1_i1	Q640D5	BMI1B_XENLA	32.7	101	67	1	41	340	151	251	2.20E-11	70.5	BMI1B_XENLA	reviewed	Polycomb complex protein BMI-1-B (Polycomb group RING finger protein 4-B)	bmi1b pcgf4	Xenopus laevis (African clawed frog)	323	"PcG protein complex [GO:0031519]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; chromatin organization [GO:0006325]; negative regulation of gene expression, epigenetic [GO:0045814]"	PcG protein complex [GO:0031519]	metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0006325; GO:0031519; GO:0045814; GO:0046872; GO:1990841	"chromatin organization [GO:0006325]; negative regulation of gene expression, epigenetic [GO:0045814]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34484_c0_g1_i1	Q9BSM1	PCGF1_HUMAN	98.7	75	1	0	227	3	28	102	2.60E-38	158.7	PCGF1_HUMAN	reviewed	Polycomb group RING finger protein 1 (Nervous system Polycomb-1) (NSPc1) (RING finger protein 68)	PCGF1 NSPC1 RNF68	Homo sapiens (Human)	259	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; chromatin silencing [GO:0006342]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]	metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]	GO:0000122; GO:0005634; GO:0005654; GO:0006342; GO:0006355; GO:0008022; GO:0031519; GO:0035102; GO:0035518; GO:0036353; GO:0046872; GO:1990841	"chromatin silencing [GO:0006342]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21376_c0_g1_i2	P23798	PCGF2_MOUSE	36.1	83	52	1	11	256	142	224	5.70E-10	65.1	PCGF2_MOUSE	reviewed	Polycomb group RING finger protein 2 (DNA-binding protein Mel-18) (Melanoma nuclear protein 18) (RING finger protein 110) (Zinc finger protein 144) (Zfp-144)	Pcgf2 Mel-18 Mel18 Rnf110 Zfp144 Znf144	Mus musculus (Mouse)	342	nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; anterior/posterior pattern specification [GO:0009952]; cellular response to hydrogen peroxide [GO:0070301]; chromatin silencing [GO:0006342]; embryonic skeletal system development [GO:0048706]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of catalytic activity [GO:0050790]	nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0000122; GO:0000790; GO:0001701; GO:0001739; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006342; GO:0009952; GO:0016573; GO:0016604; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0048704; GO:0048706; GO:0050790; GO:0070301; GO:1990841; GO:2001234	anterior/posterior pattern specification [GO:0009952]; cellular response to hydrogen peroxide [GO:0070301]; chromatin silencing [GO:0006342]; embryonic skeletal system development [GO:0048706]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of catalytic activity [GO:0050790]		NA	NA	NA	NA	NA	NA
TRINITY_DN3438_c0_g3_i1	Q2KJ29	PCGF3_BOVIN	58.3	242	79	3	756	91	2	241	1.30E-74	281.2	PCGF3_BOVIN	reviewed	Polycomb group RING finger protein 3	PCGF3	Bos taurus (Bovine)	242	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]	metal ion binding [GO:0046872]	GO:0000805; GO:0005634; GO:0005654; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0060819	histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]; regulation of transcription by RNA polymerase II [GO:0006357]		pink	pink	NA	NA	NA	NA
TRINITY_DN3438_c0_g3_i2	Q2KJ29	PCGF3_BOVIN	57.1	154	46	2	483	82	2	155	8.30E-41	168.3	PCGF3_BOVIN	reviewed	Polycomb group RING finger protein 3	PCGF3	Bos taurus (Bovine)	242	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]	metal ion binding [GO:0046872]	GO:0000805; GO:0005634; GO:0005654; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0060819	histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]; regulation of transcription by RNA polymerase II [GO:0006357]		pink	pink	NA	NA	NA	NA
TRINITY_DN15178_c0_g1_i1	Q9V727	ASX_DROME	53.7	54	24	1	61	219	1237	1290	6.60E-08	58.5	ASX_DROME	reviewed	Polycomb protein Asx (Additional sex combs)	Asx CG8787	Drosophila melanogaster (Fruit fly)	1669	"chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of ubiquitin-specific protease activity [GO:2000152]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]	chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000785; GO:0001709; GO:0003677; GO:0003682; GO:0005634; GO:0007469; GO:0007475; GO:0009887; GO:0010468; GO:0035186; GO:0035517; GO:0035522; GO:0035800; GO:0045498; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:2000152	"animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of ubiquitin-specific protease activity [GO:2000152]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15178_c0_g1_i2	Q9V727	ASX_DROME	53.7	54	24	1	106	264	1237	1290	9.60E-08	58.2	ASX_DROME	reviewed	Polycomb protein Asx (Additional sex combs)	Asx CG8787	Drosophila melanogaster (Fruit fly)	1669	"chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of ubiquitin-specific protease activity [GO:2000152]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186]"	chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]	chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000785; GO:0001709; GO:0003677; GO:0003682; GO:0005634; GO:0007469; GO:0007475; GO:0009887; GO:0010468; GO:0035186; GO:0035517; GO:0035522; GO:0035800; GO:0045498; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:2000152	"animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of ubiquitin-specific protease activity [GO:2000152]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32053_c0_g1_i1	Q3SZ25	EED_BOVIN	100	119	0	0	357	1	312	430	1.30E-68	260	EED_BOVIN	reviewed	Polycomb protein EED	EED	Bos taurus (Bovine)	441	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]	GO:0000122; GO:0000978; GO:0001226; GO:0001739; GO:0003682; GO:0005829; GO:0006342; GO:0006349; GO:0035098; GO:0042802; GO:0045120; GO:0046976; GO:0061087; GO:1990830; GO:2000011	cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]		NA	NA	NA	NA	NA	NA
TRINITY_DN5525_c0_g1_i1	Q3SZ25	EED_BOVIN	61.3	119	44	1	46	396	322	440	1.30E-45	184.1	EED_BOVIN	reviewed	Polycomb protein EED	EED	Bos taurus (Bovine)	441	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]	GO:0000122; GO:0000978; GO:0001226; GO:0001739; GO:0003682; GO:0005829; GO:0006342; GO:0006349; GO:0035098; GO:0042802; GO:0045120; GO:0046976; GO:0061087; GO:1990830; GO:2000011	cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]		NA	NA	NA	NA	NA	NA
TRINITY_DN5525_c0_g1_i2	Q3SZ25	EED_BOVIN	67.1	146	46	1	20	451	295	440	5.00E-62	238.8	EED_BOVIN	reviewed	Polycomb protein EED	EED	Bos taurus (Bovine)	441	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]	GO:0000122; GO:0000978; GO:0001226; GO:0001739; GO:0003682; GO:0005829; GO:0006342; GO:0006349; GO:0035098; GO:0042802; GO:0045120; GO:0046976; GO:0061087; GO:1990830; GO:2000011	cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]		NA	NA	NA	NA	NA	NA
TRINITY_DN11323_c0_g1_i1	Q28DT7	EED_XENTR	60.3	242	93	2	103	822	21	261	3.20E-78	293.1	EED_XENTR	reviewed	Polycomb protein eed	eed tgas047c23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	438	ESC/E(Z) complex [GO:0035098]; chromatin silencing [GO:0006342]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]	ESC/E(Z) complex [GO:0035098]		GO:0000122; GO:0006342; GO:0035098; GO:0070734	chromatin silencing [GO:0006342]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN27059_c0_g1_i1	Q3SZ25	EED_BOVIN	100	169	0	0	508	2	92	260	1.20E-99	363.6	EED_BOVIN	reviewed	Polycomb protein EED	EED	Bos taurus (Bovine)	441	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]	GO:0000122; GO:0000978; GO:0001226; GO:0001739; GO:0003682; GO:0005829; GO:0006342; GO:0006349; GO:0035098; GO:0042802; GO:0045120; GO:0046976; GO:0061087; GO:1990830; GO:2000011	cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]		NA	NA	NA	NA	NA	NA
TRINITY_DN39768_c0_g1_i1	Q9VHA0	SCM_DROME	59.4	106	32	2	327	10	323	417	1.50E-26	120.2	SCM_DROME	reviewed	Polycomb protein Scm (Sex comb on midleg protein)	Scm CG9495	Drosophila melanogaster (Fruit fly)	877	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; PRC1 complex binding [GO:0140259]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; chromatin organization [GO:0006325]; compound eye development [GO:0048749]; gene silencing [GO:0016458]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; ovarian follicle cell stalk formation [GO:0030713]; ventral cord development [GO:0007419]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; PRC1 complex [GO:0035102]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; PRC1 complex binding [GO:0140259]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0005700; GO:0006325; GO:0007409; GO:0007419; GO:0008270; GO:0016458; GO:0022008; GO:0030708; GO:0030713; GO:0035102; GO:0042393; GO:0042802; GO:0045892; GO:0045926; GO:0048749; GO:0140259	"axonogenesis [GO:0007409]; chromatin organization [GO:0006325]; compound eye development [GO:0048749]; gene silencing [GO:0016458]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; ovarian follicle cell stalk formation [GO:0030713]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39018_c0_g1_i2	Q96GD3	SCMH1_HUMAN	30.6	304	155	5	32	778	357	659	1.90E-28	127.9	SCMH1_HUMAN	reviewed	Polycomb protein SCMH1 (Sex comb on midleg homolog 1)	SCMH1	Homo sapiens (Human)	660	"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"	chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0016458; GO:0042393; GO:0045892	"anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39018_c0_g1_i4	Q96GD3	SCMH1_HUMAN	30.4	303	155	5	188	931	358	659	2.40E-27	124.4	SCMH1_HUMAN	reviewed	Polycomb protein SCMH1 (Sex comb on midleg homolog 1)	SCMH1	Homo sapiens (Human)	660	"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"	chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0016458; GO:0042393; GO:0045892	"anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5138_c0_g1_i3	Q29L50	SMBT_DROPS	45.3	673	236	19	1	1644	338	1003	3.30E-153	544.3	SMBT_DROPS	reviewed	Polycomb protein Sfmbt (Scm-like with four MBT domain-containing protein 1)	Sfmbt GA14249	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1274	nucleus [GO:0005634]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]	nucleus [GO:0005634]	DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006342; GO:0007446; GO:0008270; GO:0035064	chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]		NA	NA	NA	NA	NA	NA
TRINITY_DN5138_c0_g1_i3	Q29L50	SMBT_DROPS	42.5	106	59	1	3024	3335	1163	1268	2.60E-17	92.8	SMBT_DROPS	reviewed	Polycomb protein Sfmbt (Scm-like with four MBT domain-containing protein 1)	Sfmbt GA14249	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1274	nucleus [GO:0005634]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]	nucleus [GO:0005634]	DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006342; GO:0007446; GO:0008270; GO:0035064	chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]		NA	NA	NA	NA	NA	NA
TRINITY_DN5138_c0_g1_i2	Q9VK33	SMBT_DROME	55.8	52	20	1	1	147	329	380	3.40E-08	59.7	SMBT_DROME	reviewed	Polycomb protein Sfmbt (Scm-like with four MBT domain-containing protein 1) (dSfmbt)	Sfmbt CG16975	Drosophila melanogaster (Fruit fly)	1220	"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]"	nucleus [GO:0005634]; PcG protein complex [GO:0031519]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003682; GO:0005634; GO:0006342; GO:0007446; GO:0008270; GO:0010629; GO:0031519; GO:0035064; GO:0042393; GO:0045892; GO:0048477	"chromatin silencing [GO:0006342]; imaginal disc growth [GO:0007446]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39643_c0_g1_i1	Q15022	SUZ12_HUMAN	100	121	0	0	3	365	442	562	2.70E-69	262.3	SUZ12_HUMAN	reviewed	Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog)	SUZ12 CHET9 JJAZ1 KIAA0160	Homo sapiens (Human)	739	"ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; histone H3-K27 methylation [GO:0070734]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]"	ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; sex chromatin [GO:0001739]	chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]	GO:0000122; GO:0000978; GO:0001226; GO:0001739; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0008284; GO:0016574; GO:0016604; GO:0031490; GO:0032993; GO:0035064; GO:0035098; GO:0042054; GO:0045596; GO:0045814; GO:0046872; GO:0070317; GO:0070734; GO:1990841	"histone H3-K27 methylation [GO:0070734]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33458_c0_g1_i1	Q6DC03	SZ12A_DANRE	69.5	128	37	2	381	1	412	538	6.50E-50	198	SZ12A_DANRE	reviewed	Polycomb protein suz12-A (Suppressor of zeste 12 protein homolog A)	suz12a suz12 suz12l zgc:100863	Danio rerio (Zebrafish) (Brachydanio rerio)	657	ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; histone methylation [GO:0016571]	ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]	GO:0005634; GO:0016571; GO:0031490; GO:0035098; GO:0046872	histone methylation [GO:0016571]		NA	NA	NA	NA	NA	NA
TRINITY_DN1720_c9_g1_i1	Q13563	PKD2_HUMAN	50.2	440	202	6	1471	188	489	923	4.20E-105	383.3	PKD2_HUMAN	reviewed	Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2)	PKD2 TRPP2	Homo sapiens (Human)	968	"basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cation channel complex [GO:0034703]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; phosphoprotein binding [GO:0051219]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; aorta development [GO:0035904]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell cycle arrest [GO:0007050]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to osmotic stress [GO:0071470]; cellular response to reactive oxygen species [GO:0034614]; centrosome duplication [GO:0051298]; cilium organization [GO:0044782]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; liver development [GO:0001889]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric cortex development [GO:0072214]; metanephric cortical collecting duct development [GO:0072219]; metanephric distal tubule development [GO:0072235]; metanephric mesenchyme development [GO:0072075]; metanephric part of ureteric bud development [GO:0035502]; metanephric S-shaped body morphogenesis [GO:0072284]; metanephric smooth muscle tissue development [GO:0072208]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neural tube development [GO:0021915]; placenta blood vessel development [GO:0060674]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of calcium ion import [GO:0090279]; regulation of cell population proliferation [GO:0042127]; release of sequestered calcium ion into cytosol [GO:0051209]; renal artery morphogenesis [GO:0061441]; renal tubule morphogenesis [GO:0061333]; sodium ion transmembrane transport [GO:0035725]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055]"	basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cation channel complex [GO:0034703]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]	actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; phosphoprotein binding [GO:0051219]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0001658; GO:0001889; GO:0001892; GO:0001947; GO:0002133; GO:0003127; GO:0005102; GO:0005244; GO:0005245; GO:0005248; GO:0005249; GO:0005261; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0005929; GO:0006816; GO:0007050; GO:0007259; GO:0007368; GO:0007507; GO:0008092; GO:0008285; GO:0009925; GO:0015271; GO:0016020; GO:0016055; GO:0021510; GO:0021915; GO:0022843; GO:0030027; GO:0030659; GO:0031514; GO:0031587; GO:0034614; GO:0034703; GO:0035502; GO:0035725; GO:0035904; GO:0036064; GO:0042127; GO:0042802; GO:0042803; GO:0042805; GO:0042994; GO:0043398; GO:0044325; GO:0044782; GO:0045180; GO:0045429; GO:0045737; GO:0045944; GO:0048763; GO:0050982; GO:0051117; GO:0051209; GO:0051219; GO:0051262; GO:0051289; GO:0051290; GO:0051298; GO:0051371; GO:0060170; GO:0060315; GO:0060674; GO:0061333; GO:0061441; GO:0070062; GO:0070588; GO:0071158; GO:0071277; GO:0071320; GO:0071458; GO:0071464; GO:0071470; GO:0071498; GO:0071556; GO:0071805; GO:0071910; GO:0072075; GO:0072164; GO:0072177; GO:0072208; GO:0072214; GO:0072218; GO:0072219; GO:0072235; GO:0072284; GO:0072686; GO:0090279; GO:0097730; GO:0098662; GO:0198738; GO:2000134	"aorta development [GO:0035904]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell-cell signaling by wnt [GO:0198738]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to osmotic stress [GO:0071470]; cellular response to reactive oxygen species [GO:0034614]; centrosome duplication [GO:0051298]; cilium organization [GO:0044782]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; liver development [GO:0001889]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric cortex development [GO:0072214]; metanephric cortical collecting duct development [GO:0072219]; metanephric distal tubule development [GO:0072235]; metanephric mesenchyme development [GO:0072075]; metanephric part of ureteric bud development [GO:0035502]; metanephric smooth muscle tissue development [GO:0072208]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neural tube development [GO:0021915]; placenta blood vessel development [GO:0060674]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of calcium ion import [GO:0090279]; regulation of cell population proliferation [GO:0042127]; release of sequestered calcium ion into cytosol [GO:0051209]; renal artery morphogenesis [GO:0061441]; renal tubule morphogenesis [GO:0061333]; sodium ion transmembrane transport [GO:0035725]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39640_c0_g1_i1	Q2HJC9	PQBP1_BOVIN	100	62	0	0	3	188	202	263	2.40E-29	129	PQBP1_BOVIN	reviewed	Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1)	PQBP1	Bos taurus (Bovine)	263	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]	double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]	GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005737; GO:0005829; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598	"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10947_c0_g1_i1	Q6PCT5	PQBP1_RAT	36.5	156	36	4	640	173	1	93	2.60E-12	73.9	PQBP1_RAT	reviewed	Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1)	Pqbp1	Rattus norvegicus (Rat)	263	"centrosome [GO:0005813]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; protein C-terminus binding [GO:0008022]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]"	centrosome [GO:0005813]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; protein C-terminus binding [GO:0008022]; ribonucleoprotein complex binding [GO:0043021]	GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0008022; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598; GO:0097546; GO:1902857	"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30549_c0_g1_i1	Q2HJC9	PQBP1_BOVIN	78.7	61	13	0	81	263	197	257	1.70E-22	106.7	PQBP1_BOVIN	reviewed	Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1)	PQBP1	Bos taurus (Bovine)	263	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]	double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]	GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005737; GO:0005829; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598	"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6782_c0_g1_i1	Q91VA6	PDIP2_MOUSE	66.5	197	61	2	169	753	62	255	2.20E-74	280.8	PDIP2_MOUSE	reviewed	Polymerase delta-interacting protein 2	Poldip2	Mus musculus (Mouse)	368	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584; GO:0070987	error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]		NA	NA	NA	NA	NA	NA
TRINITY_DN6782_c0_g1_i1	Q91VA6	PDIP2_MOUSE	81.5	119	22	0	750	1106	243	361	8.20E-53	209.1	PDIP2_MOUSE	reviewed	Polymerase delta-interacting protein 2	Poldip2	Mus musculus (Mouse)	368	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584; GO:0070987	error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]		NA	NA	NA	NA	NA	NA
TRINITY_DN6782_c0_g1_i2	Q91VA6	PDIP2_MOUSE	71.6	303	81	2	169	1071	62	361	1.20E-128	461.1	PDIP2_MOUSE	reviewed	Polymerase delta-interacting protein 2	Poldip2	Mus musculus (Mouse)	368	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584; GO:0070987	error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]		blue	blue	NA	NA	NA	NA
TRINITY_DN15339_c0_g1_i4	Q91VA6	PDIP2_MOUSE	99.1	316	3	0	950	3	44	359	1.80E-186	652.9	PDIP2_MOUSE	reviewed	Polymerase delta-interacting protein 2	Poldip2	Mus musculus (Mouse)	368	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584; GO:0070987	error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]		NA	NA	NA	NA	NA	NA
TRINITY_DN15339_c0_g1_i2	Q9Y2S7	PDIP2_HUMAN	100	147	0	0	444	4	48	194	9.10E-83	307.4	PDIP2_HUMAN	reviewed	Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein) (p38)	POLDIP2 PDIP38 POLD4 HSPC017	Homo sapiens (Human)	368	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0016242; GO:0042645; GO:0045931; GO:0070584; GO:0070987	error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]		NA	NA	NA	NA	NA	NA
TRINITY_DN15339_c0_g1_i3	Q9Y2S7	PDIP2_HUMAN	100	177	0	0	533	3	183	359	8.40E-104	377.5	PDIP2_HUMAN	reviewed	Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein) (p38)	POLDIP2 PDIP38 POLD4 HSPC017	Homo sapiens (Human)	368	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0016242; GO:0042645; GO:0045931; GO:0070584; GO:0070987	error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i1	E1BPN0	NOL9_BOVIN	24.4	537	319	19	800	2224	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i1	E1BPN0	NOL9_BOVIN	24.4	537	319	19	3941	2517	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i2	E1BPN0	NOL9_BOVIN	24.4	537	319	19	800	2224	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i2	E1BPN0	NOL9_BOVIN	24.4	537	319	19	3941	2517	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i3	E1BPN0	NOL9_BOVIN	24.4	537	319	19	800	2224	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i3	E1BPN0	NOL9_BOVIN	24.4	537	319	19	3941	2517	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i4	E1BPN0	NOL9_BOVIN	24.4	537	319	19	800	2224	132	643	9.00E-25	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i5	E1BPN0	NOL9_BOVIN	24.4	537	319	19	800	2224	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5788_c0_g2_i5	E1BPN0	NOL9_BOVIN	24.4	537	319	19	3941	2517	132	643	1.60E-24	117.1	NOL9_BOVIN	reviewed	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	NOL9	Bos taurus (Bovine)	694	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006396; GO:0051731	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16978_c0_g1_i1	O08912	GALT1_MOUSE	100	236	0	0	3	710	303	538	2.20E-144	512.7	GALT1_MOUSE	reviewed	Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]	Galnt1	Mus musculus (Mouse)	559	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0016021; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN16978_c0_g1_i2	Q10472	GALT1_HUMAN	100	110	0	0	3	332	303	412	5.20E-64	244.6	GALT1_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]	GALNT1	Homo sapiens (Human)	559	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0006493; GO:0016020; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN20877_c0_g1_i1	Q10472	GALT1_HUMAN	99.6	265	1	0	797	3	47	311	1.50E-152	540	GALT1_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]	GALNT1	Homo sapiens (Human)	559	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0006493; GO:0016020; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN20877_c1_g1_i1	O08912	GALT1_MOUSE	100	96	0	0	2	289	158	253	1.10E-49	196.8	GALT1_MOUSE	reviewed	Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]	Galnt1	Mus musculus (Mouse)	559	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0016021; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g3_i1	Q6WV20	GALT1_DROME	52.3	493	222	7	12	1460	108	597	5.40E-143	509.2	GALT1_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 1 (pp-GaNTase 1) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1)	Pgant1 GalNAc-T1 CG8182	Drosophila melanogaster (Fruit fly)	601	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN30328_c0_g1_i1	Q86SR1	GLT10_HUMAN	61.5	65	25	0	14	208	309	373	9.80E-23	107.1	GLT10_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	GALNT10	Homo sapiens (Human)	603	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN37457_c0_g1_i1	Q921L8	GLT11_MOUSE	95.2	124	6	0	372	1	206	329	7.00E-65	247.7	GLT11_MOUSE	reviewed	Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)	Galnt11	Mus musculus (Mouse)	608	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]		NA	NA	NA	NA	NA	NA
TRINITY_DN38981_c0_g1_i1	Q8NCW6	GLT11_HUMAN	39.5	253	118	7	699	19	1	244	3.10E-38	160.2	GLT11_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)	GALNT11	Homo sapiens (Human)	608	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]		NA	NA	NA	NA	NA	NA
TRINITY_DN38981_c0_g1_i4	Q8NCW6	GLT11_HUMAN	39.5	253	118	7	699	19	1	244	2.20E-38	160.6	GLT11_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)	GALNT11	Homo sapiens (Human)	608	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]		NA	NA	NA	NA	NA	NA
TRINITY_DN8720_c0_g1_i1	Q10471	GALT2_HUMAN	78.9	313	66	0	2	940	129	441	4.10E-154	545.4	GALT2_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GALNT2	Homo sapiens (Human)	571	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN38895_c0_g1_i1	Q10471	GALT2_HUMAN	100	89	0	0	269	3	244	332	3.90E-49	194.9	GALT2_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GALNT2	Homo sapiens (Human)	571	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN3331_c4_g1_i2	Q10471	GALT2_HUMAN	48.8	123	61	2	609	244	447	568	1.60E-29	131	GALT2_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GALNT2	Homo sapiens (Human)	571	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		brown	brown	1	NA	NA	NA
TRINITY_DN38828_c0_g1_i1	Q10471	GALT2_HUMAN	99.1	108	1	0	3	326	110	217	3.70E-54	211.8	GALT2_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GALNT2	Homo sapiens (Human)	571	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN35470_c0_g1_i1	Q10471	GALT2_HUMAN	100	104	0	0	1	312	348	451	8.20E-59	227.3	GALT2_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GALNT2	Homo sapiens (Human)	571	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN3331_c4_g1_i1	Q10471	GALT2_HUMAN	48.8	123	61	2	409	44	447	568	1.10E-29	131	GALT2_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GALNT2	Homo sapiens (Human)	571	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN25689_c0_g1_i1	P34678	GALT3_CAEEL	43.3	67	38	0	235	35	234	300	2.70E-09	62.4	GALT3_CAEEL	reviewed	Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (GalNAc-T1) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3) (pp-GaNTase 3)	gly-3 ZK688.8	Caenorhabditis elegans	612	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN28120_c0_g1_i1	P34678	GALT3_CAEEL	48.6	70	34	1	2	211	339	406	2.30E-17	89	GALT3_CAEEL	reviewed	Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (GalNAc-T1) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3) (pp-GaNTase 3)	gly-3 ZK688.8	Caenorhabditis elegans	612	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN10247_c0_g1_i1	P70419	GALT3_MOUSE	43	114	62	1	1	342	335	445	5.00E-25	115.2	GALT3_MOUSE	reviewed	Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)	Galnt3	Mus musculus (Mouse)	633	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0004653; GO:0005509; GO:0005794; GO:0016021; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN10247_c0_g1_i2	P70419	GALT3_MOUSE	43	114	62	1	1	342	335	445	6.50E-25	114.8	GALT3_MOUSE	reviewed	Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)	Galnt3	Mus musculus (Mouse)	633	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0004653; GO:0005509; GO:0005794; GO:0016021; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN32437_c0_g1_i1	Q9Y117	GALT3_DROME	31.7	145	55	3	50	352	429	573	2.40E-12	73.2	GALT3_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 3 (pp-GaNTase 3) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)	Pgant3 CG4445	Drosophila melanogaster (Fruit fly)	667	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; transferase activity, transferring glycosyl groups [GO:0016757]; cell-substrate adhesion [GO:0031589]; extracellular matrix constituent secretion [GO:0070278]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; protein O-linked glycosylation [GO:0006493]; regulation of cell adhesion mediated by integrin [GO:0033628]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0008376; GO:0009312; GO:0016021; GO:0016266; GO:0016757; GO:0030246; GO:0031589; GO:0033628; GO:0046872; GO:0070278	cell-substrate adhesion [GO:0031589]; extracellular matrix constituent secretion [GO:0070278]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; protein O-linked glycosylation [GO:0006493]; regulation of cell adhesion mediated by integrin [GO:0033628]		NA	NA	NA	NA	NA	NA
TRINITY_DN38981_c0_g1_i3	Q8MVS5	GLT35_DROME	48.4	531	254	6	1562	6	90	612	1.00E-147	525	GLT35_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 35A (EC 2.4.1.41) (Protein l(2)35Aa) (Protein-UDP acetylgalactosaminyltransferase 35A) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 35A) (pp-GaNTase 35A) (dGalNAc-T1)	Pgant35A CG7480	Drosophila melanogaster (Fruit fly)	632	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; open tracheal system development [GO:0007424]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0005795; GO:0006486; GO:0007424; GO:0008593; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; open tracheal system development [GO:0007424]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]		NA	NA	NA	NA	NA	NA
TRINITY_DN10247_c0_g1_i3	Q8I136	GALT4_CAEEL	50	98	45	2	43	333	308	402	7.70E-23	107.8	GALT4_CAEEL	reviewed	Polypeptide N-acetylgalactosaminyltransferase 4 (pp-GaNTase 4) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4)	gly-4 Y116F11B.12	Caenorhabditis elegans	589	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i1	Q6WV17	GALT5_DROME	44.9	118	41	1	99	452	537	630	1.80E-24	114.4	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i10	Q6WV17	GALT5_DROME	64.5	629	209	2	21	1865	2	630	3.10E-241	835.9	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i12	Q6WV17	GALT5_DROME	64.5	629	209	2	21	1865	2	630	3.40E-241	835.9	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i3	Q6WV17	GALT5_DROME	64.7	513	167	2	21	1517	2	514	4.00E-191	669.1	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i5	Q6WV17	GALT5_DROME	63.8	629	214	2	21	1865	2	630	3.90E-237	822.4	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i6	Q6WV17	GALT5_DROME	66.7	234	78	0	77	778	397	630	2.60E-99	363.2	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g2_i8	Q6WV17	GALT5_DROME	63.8	629	214	2	21	1865	2	630	4.70E-237	822	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g1_i1	Q6WV17	GALT5_DROME	72	50	14	0	10	159	349	398	4.30E-16	84.7	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN3316_c0_g1_i2	Q6WV17	GALT5_DROME	66.4	113	36	1	10	348	349	459	4.20E-43	175.3	GALT5_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	Pgant5 CG31651	Drosophila melanogaster (Fruit fly)	630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN30669_c0_g1_i1	Q9VUT6	GALT8_DROME	52.5	59	28	0	219	43	296	354	1.60E-13	76.3	GALT8_DROME	reviewed	Polypeptide N-acetylgalactosaminyltransferase 8 (pp-GaNTase 8) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 8) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8)	Pgant8 CG7297	Drosophila melanogaster (Fruit fly)	590	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c1_g1_i1	Q49A17	GLTL6_HUMAN	43.5	62	33	1	209	24	68	127	3.10E-06	52	GLTL6_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17)	GALNTL6 GALNT17	Homo sapiens (Human)	601	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c1_g1_i2	Q49A17	GLTL6_HUMAN	43.2	88	48	1	264	1	68	153	4.20E-16	85.1	GLTL6_HUMAN	reviewed	Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17)	GALNTL6 GALNT17	Homo sapiens (Human)	601	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	protein O-linked glycosylation via threonine [GO:0018243]		NA	NA	NA	NA	NA	NA
TRINITY_DN26840_c0_g1_i1	Q91WF7	FIG4_MOUSE	100	73	0	0	220	2	302	374	6.90E-36	150.6	FIG4_MOUSE	reviewed	"Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)"	Fig4 Kiaa0274 Sac3	Mus musculus (Mouse)	907	"endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]"	endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]	"phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]"	GO:0004438; GO:0005783; GO:0005794; GO:0005811; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0032288; GO:0034593; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046488; GO:0046856; GO:0048666; GO:0055037	locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN2687_c0_g1_i1	Q92562	FIG4_HUMAN	46.5	963	429	13	148	2979	7	902	3.00E-222	773.5	FIG4_HUMAN	reviewed	"Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)"	FIG4 KIAA0274 SAC3	Homo sapiens (Human)	907	"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]"	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]	"phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]"	GO:0000139; GO:0004438; GO:0005783; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037	locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN2687_c0_g1_i3	Q91WF7	FIG4_MOUSE	29.7	138	51	3	82	495	166	257	7.40E-07	55.5	FIG4_MOUSE	reviewed	"Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)"	Fig4 Kiaa0274 Sac3	Mus musculus (Mouse)	907	"endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]"	endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]	"phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol bisphosphate phosphatase activity [GO:0034593]"	GO:0004438; GO:0005783; GO:0005794; GO:0005811; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0032288; GO:0034593; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046488; GO:0046856; GO:0048666; GO:0055037	locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN26325_c0_g1_i1	Q92562	FIG4_HUMAN	100	102	0	0	2	307	78	179	4.30E-52	204.9	FIG4_HUMAN	reviewed	"Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)"	FIG4 KIAA0274 SAC3	Homo sapiens (Human)	907	"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]"	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]	"phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]"	GO:0000139; GO:0004438; GO:0005783; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037	locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN2294_c0_g1_i1	Q9VLP9	PORED_DROME	32.7	321	204	6	93	1025	8	326	2.70E-34	147.5	PORED_DROME	reviewed	Polyprenol reductase (EC 1.3.1.94)	CG7840	Drosophila melanogaster (Fruit fly)	326	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; polyprenol reductase activity [GO:0102389]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; polyprenol catabolic process [GO:0016095]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; polyprenol reductase activity [GO:0102389]	GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0016021; GO:0016095; GO:0019348; GO:0019408; GO:0102389	dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; polyprenol catabolic process [GO:0016095]		NA	NA	NA	NA	NA	NA
TRINITY_DN2294_c0_g1_i2	Q9VLP9	PORED_DROME	33	288	185	4	76	915	39	326	1.60E-33	144.8	PORED_DROME	reviewed	Polyprenol reductase (EC 1.3.1.94)	CG7840	Drosophila melanogaster (Fruit fly)	326	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; polyprenol reductase activity [GO:0102389]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; polyprenol catabolic process [GO:0016095]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; polyprenol reductase activity [GO:0102389]	GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0016021; GO:0016095; GO:0019348; GO:0019408; GO:0102389	dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; polyprenol catabolic process [GO:0016095]		NA	NA	NA	NA	NA	NA
TRINITY_DN34382_c0_g1_i1	Q8WN55	PTBP1_BOVIN	75	60	15	0	213	34	230	289	3.40E-19	95.1	PTBP1_BOVIN	reviewed	Polypyrimidine tract-binding protein 1 (PTB)	PTBP1	Bos taurus (Bovine)	531	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0006417; GO:0008380; GO:0043484; GO:0045595; GO:0048025; GO:0051148	"mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21343_c0_g1_i1	Q8WN55	PTBP1_BOVIN	100	128	0	0	386	3	171	298	2.60E-67	256.5	PTBP1_BOVIN	reviewed	Polypyrimidine tract-binding protein 1 (PTB)	PTBP1	Bos taurus (Bovine)	531	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0006417; GO:0008380; GO:0043484; GO:0045595; GO:0048025; GO:0051148	"mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21343_c0_g1_i1	Q8WN55	PTBP1_BOVIN	92	88	7	0	643	380	28	115	2.10E-37	157.1	PTBP1_BOVIN	reviewed	Polypyrimidine tract-binding protein 1 (PTB)	PTBP1	Bos taurus (Bovine)	531	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0006417; GO:0008380; GO:0043484; GO:0045595; GO:0048025; GO:0051148	"mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i2	P26599	PTBP1_HUMAN	59	554	171	9	71	1663	11	531	5.60E-165	582.4	PTBP1_HUMAN	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	PTBP1 PTB	Homo sapiens (Human)	531	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006417; GO:0008187; GO:0008380; GO:0008543; GO:0016020; GO:0016070; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	"fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i3	P26599	PTBP1_HUMAN	58	564	177	8	71	1711	11	531	1.70E-164	580.9	PTBP1_HUMAN	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	PTBP1 PTB	Homo sapiens (Human)	531	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006417; GO:0008187; GO:0008380; GO:0008543; GO:0016020; GO:0016070; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	"fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i4	P26599	PTBP1_HUMAN	57	284	85	5	22	846	276	531	3.80E-75	283.1	PTBP1_HUMAN	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	PTBP1 PTB	Homo sapiens (Human)	531	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006417; GO:0008187; GO:0008380; GO:0008543; GO:0016020; GO:0016070; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	"fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i6	P26599	PTBP1_HUMAN	59	554	166	9	71	1648	11	531	9.50E-165	581.6	PTBP1_HUMAN	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	PTBP1 PTB	Homo sapiens (Human)	531	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006417; GO:0008187; GO:0008380; GO:0008543; GO:0016020; GO:0016070; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	"fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21343_c0_g1_i2	P26599	PTBP1_HUMAN	100	136	0	0	410	3	28	163	6.70E-69	261.2	PTBP1_HUMAN	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	PTBP1 PTB	Homo sapiens (Human)	531	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006417; GO:0008187; GO:0008380; GO:0008543; GO:0016020; GO:0016070; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	"fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13686_c0_g1_i1	P26599	PTBP1_HUMAN	100	202	0	0	664	59	330	531	2.70E-112	406	PTBP1_HUMAN	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	PTBP1 PTB	Homo sapiens (Human)	531	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006417; GO:0008187; GO:0008380; GO:0008543; GO:0016020; GO:0016070; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	"fibroblast growth factor receptor signaling pathway [GO:0008543]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i1	Q00438	PTBP1_RAT	57.8	587	178	11	71	1747	11	555	6.50E-164	578.9	PTBP1_RAT	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (Pyrimidine-binding protein) (PYBP)	Ptbp1 Ptb Pybp Tbfii	Rattus norvegicus (Rat)	555	"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000381; GO:0000956; GO:0001069; GO:0003231; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0010976; GO:0032024; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0043565; GO:0044306; GO:0045595; GO:0045665; GO:0045727; GO:0045944; GO:0048025; GO:0051148; GO:0070886; GO:0070935; GO:0075522; GO:1904411	"3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i5	Q00438	PTBP1_RAT	55.9	594	194	11	71	1795	11	555	1.30E-164	581.3	PTBP1_RAT	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (Pyrimidine-binding protein) (PYBP)	Ptbp1 Ptb Pybp Tbfii	Rattus norvegicus (Rat)	555	"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000381; GO:0000956; GO:0001069; GO:0003231; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0010976; GO:0032024; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0043565; GO:0044306; GO:0045595; GO:0045665; GO:0045727; GO:0045944; GO:0048025; GO:0051148; GO:0070886; GO:0070935; GO:0075522; GO:1904411	"3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i7	Q00438	PTBP1_RAT	55.6	597	196	11	71	1810	11	555	7.90E-165	582	PTBP1_RAT	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (Pyrimidine-binding protein) (PYBP)	Ptbp1 Ptb Pybp Tbfii	Rattus norvegicus (Rat)	555	"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000381; GO:0000956; GO:0001069; GO:0003231; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0010976; GO:0032024; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0043565; GO:0044306; GO:0045595; GO:0045665; GO:0045727; GO:0045944; GO:0048025; GO:0051148; GO:0070886; GO:0070935; GO:0075522; GO:1904411	"3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN263_c0_g1_i8	Q00438	PTBP1_RAT	56.5	582	188	10	71	1732	11	555	4.50E-165	582.8	PTBP1_RAT	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (Pyrimidine-binding protein) (PYBP)	Ptbp1 Ptb Pybp Tbfii	Rattus norvegicus (Rat)	555	"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000381; GO:0000956; GO:0001069; GO:0003231; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0010976; GO:0032024; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0043565; GO:0044306; GO:0045595; GO:0045665; GO:0045727; GO:0045944; GO:0048025; GO:0051148; GO:0070886; GO:0070935; GO:0075522; GO:1904411	"3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13686_c0_g1_i2	Q00438	PTBP1_RAT	99	202	2	0	650	45	354	555	2.50E-110	399.4	PTBP1_RAT	reviewed	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (Pyrimidine-binding protein) (PYBP)	Ptbp1 Ptb Pybp Tbfii	Rattus norvegicus (Rat)	555	"cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000381; GO:0000956; GO:0001069; GO:0003231; GO:0003697; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0010976; GO:0032024; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0043565; GO:0044306; GO:0045595; GO:0045665; GO:0045727; GO:0045944; GO:0048025; GO:0051148; GO:0070886; GO:0070935; GO:0075522; GO:1904411	"3'-UTR-mediated mRNA stabilization [GO:0070935]; cardiac ventricle development [GO:0003231]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25563_c0_g1_i1	Q9UKA9	PTBP2_HUMAN	100	107	0	0	321	1	159	265	1.60E-54	213	PTBP2_HUMAN	reviewed	Polypyrimidine tract-binding protein 2 (Neural polypyrimidine tract-binding protein) (Neurally-enriched homolog of PTB) (PTB-like protein)	PTBP2 NPTB PTB PTBLP	Homo sapiens (Human)	531	growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; spinal cord development [GO:0021510]	growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0006376; GO:0006417; GO:0021510; GO:0021549; GO:0030426; GO:0033119; GO:0043025; GO:0043484; GO:2000177	cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; spinal cord development [GO:0021510]		NA	NA	NA	NA	NA	NA
TRINITY_DN19190_c0_g1_i1	Q8BHD7	PTBP3_MOUSE	100	70	0	0	2	211	340	409	5.30E-33	141	PTBP3_MOUSE	reviewed	Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)	Ptbp3 Rod1	Mus musculus (Mouse)	523	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0006397; GO:0006417; GO:0008380; GO:0033119; GO:0043249; GO:0043484; GO:0045595; GO:0048025	"erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19190_c0_g1_i2	O95758	PTBP3_HUMAN	100	107	0	0	5	325	370	476	6.70E-56	217.6	PTBP3_HUMAN	reviewed	Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)	PTBP3 ROD1	Homo sapiens (Human)	552	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0006417; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0043484; GO:0045595; GO:0048025	"anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16079_c0_g1_i1	O95758	PTBP3_HUMAN	98.5	68	1	0	3	206	73	140	1.60E-31	136	PTBP3_HUMAN	reviewed	Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)	PTBP3 ROD1	Homo sapiens (Human)	552	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0006417; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0043484; GO:0045595; GO:0048025	"anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38730_c0_g1_i1	A2VE01	CLP1_BOVIN	100	112	0	0	338	3	89	200	1.00E-59	230.3	CLP1_BOVIN	reviewed	Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1)	CLP1	Bos taurus (Bovine)	425	"cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; RNA processing [GO:0006396]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]	ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]	GO:0000214; GO:0005524; GO:0005634; GO:0005829; GO:0005849; GO:0006378; GO:0006388; GO:0006396; GO:0021695; GO:0030423; GO:0035087; GO:0046404; GO:0051731; GO:0051733; GO:0051736	"cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; RNA processing [GO:0006396]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29165_c0_g1_i1	B2U7R6	PNP_RALPJ	99.2	124	1	0	1	372	63	186	2.40E-65	249.2	PNP_RALPJ	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp Rpic_2219	Ralstonia pickettii (strain 12J)	724	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN14239_c0_g1_i1	Q1GVQ8	PNP_SPHAL	92.3	117	9	0	352	2	26	142	5.00E-57	221.5	PNP_SPHAL	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp Sala_0543	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	771	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN14239_c0_g1_i2	Q1GVQ8	PNP_SPHAL	88.6	79	9	0	238	2	64	142	2.80E-35	148.7	PNP_SPHAL	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp Sala_0543	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	771	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN4016_c0_g1_i1	Q1LPW7	PNP_CUPMC	97.6	123	3	0	370	2	404	526	8.70E-60	230.7	PNP_CUPMC	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp Rmet_0923	Cupriavidus metallidurans (strain ATCC 43123 / DSM 2839 / NBRC 102507 / CH34) (Ralstonia metallidurans)	725	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN3701_c0_g1_i1	A5VCY9	PNP_SPHWW	91.1	112	10	0	2	337	421	532	5.20E-51	201.4	PNP_SPHWW	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp Swit_3810	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	774	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN3701_c0_g2_i1	Q2G5F5	PNP_NOVAD	86	121	17	0	3	365	411	531	6.00E-53	208	PNP_NOVAD	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp Saro_2482	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	772	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN34293_c0_g1_i1	Q9PL77	PNP_CHLMU	57.6	132	51	1	21	416	396	522	5.50E-34	145.2	PNP_CHLMU	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp TC_0230	Chlamydia muridarum (strain MoPn / Nigg)	693	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN26335_c0_g1_i1	B2RIW6	PNP_PORG3	74	73	18	1	218	3	458	530	2.90E-23	108.6	PNP_PORG3	reviewed	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	pnp PGN_0792	Porphyromonas gingivalis (strain ATCC 33277 / DSM 20709 / CIP 103683 / JCM 12257 / NCTC 11834 / 2561)	743	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN30076_c0_g1_i1	Q8TCS8	PNPT1_HUMAN	100	142	0	0	426	1	78	219	1.10E-74	280.4	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN38970_c0_g1_i1	Q8TCS8	PNPT1_HUMAN	100	166	0	0	559	62	334	499	8.50E-91	334.3	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i1	Q8TCS8	PNPT1_HUMAN	55.8	660	288	4	78	2048	53	711	1.20E-208	728.4	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i2	Q8TCS8	PNPT1_HUMAN	56.9	708	301	4	78	2192	53	759	1.40E-230	800.8	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i5	Q8TCS8	PNPT1_HUMAN	55.8	659	287	4	185	2152	54	711	2.20E-208	727.2	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i7	Q8TCS8	PNPT1_HUMAN	55.8	659	287	4	185	2152	54	711	2.80E-208	727.2	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i8	Q8TCS8	PNPT1_HUMAN	57	707	300	4	185	2296	54	759	2.40E-230	800	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN30748_c0_g1_i1	Q8TCS8	PNPT1_HUMAN	100	75	0	0	227	3	701	775	1.20E-35	149.8	PNPT1_HUMAN	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN32555_c0_g1_i1	Q8K1R3	PNPT1_MOUSE	100	128	0	0	385	2	78	205	5.90E-67	254.6	PNPT1_MOUSE	reviewed	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)"	Pnpt1 Pnpase	Mus musculus (Mouse)	783	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000963; GO:0000964; GO:0000965; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:0097421; GO:2000627; GO:2000772	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA processing [GO:0000963]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i11	Q5K2P8	POLS2_MOUSE	31.1	299	161	9	1090	263	12	288	2.40E-25	118.2	POLS2_MOUSE	reviewed	Polyserase-2 (EC 3.4.21.-) (Polyserine protease 2) (Serine protease 36)	Prss36	Mus musculus (Mouse)	849	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005737; GO:0006508	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN23523_c0_g2_i1	Q5K2P8	POLS2_MOUSE	63	46	16	1	71	208	227	271	5.10E-09	61.2	POLS2_MOUSE	reviewed	Polyserase-2 (EC 3.4.21.-) (Polyserine protease 2) (Serine protease 36)	Prss36	Mus musculus (Mouse)	849	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005737; GO:0006508	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i8	Q5K2P8	POLS2_MOUSE	54.3	70	29	2	302	93	227	293	7.20E-15	81.3	POLS2_MOUSE	reviewed	Polyserase-2 (EC 3.4.21.-) (Polyserine protease 2) (Serine protease 36)	Prss36	Mus musculus (Mouse)	849	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005737; GO:0006508	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN40403_c0_g1_i1	P23398	UBIQP_STRPU	98.6	70	1	0	267	58	10	79	7.30E-32	137.5	UBIQP_STRPU	reviewed	Polyubiquitin [Cleaved into: Ubiquitin] (Fragment)		Strongylocentrotus purpuratus (Purple sea urchin)	133	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN6826_c0_g1_i1	Q8K4F2	LX15B_RAT	33.2	449	275	8	1316	6	233	668	5.30E-60	233.4	LX15B_RAT	reviewed	Polyunsaturated fatty acid lipoxygenase ALOX15B (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase B) (15-LOX-B) (EC 1.13.11.33) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-)	Alox15b	Rattus norvegicus (Rat)	677	"adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; linoleate 9S-lipoxygenase activity [GO:1990136]; lipid binding [GO:0008289]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; endocannabinoid signaling pathway [GO:0071926]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; phospholipid metabolic process [GO:0006644]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]"	adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; linoleate 9S-lipoxygenase activity [GO:1990136]; lipid binding [GO:0008289]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"	GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006629; GO:0006644; GO:0008285; GO:0008289; GO:0010744; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019898; GO:0034440; GO:0035360; GO:0036403; GO:0043651; GO:0045618; GO:0045786; GO:0045926; GO:0050473; GO:0051122; GO:0071926; GO:0090197; GO:1901696; GO:1990136; GO:2001303	arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; endocannabinoid signaling pathway [GO:0071926]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; phospholipid metabolic process [GO:0006644]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]		blue	blue	NA	NA	NA	NA
TRINITY_DN34000_c0_g1_i1	Q9HBU9	POPD2_HUMAN	39.7	63	37	1	204	19	126	188	2.80E-07	55.5	POPD2_HUMAN	reviewed	Popeye domain-containing protein 2 (Popeye protein 2)	POPDC2 POP2	Homo sapiens (Human)	364	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; heart development [GO:0007507]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcolemma [GO:0042383]	cAMP binding [GO:0030552]	GO:0002027; GO:0007507; GO:0007519; GO:0016020; GO:0016021; GO:0030552; GO:0042383; GO:0042391; GO:0051146	heart development [GO:0007507]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]		NA	NA	NA	NA	NA	NA
TRINITY_DN36625_c0_g1_i1	Q8YVU6	HEM3_NOSS1	54.8	73	31	1	237	19	52	122	5.50E-15	81.3	HEM3_NOSS1	reviewed	Porphobilinogen deaminase (PBG) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase)	hemC alr1878	Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576)	323	hydroxymethylbilane synthase activity [GO:0004418]; chlorophyll biosynthetic process [GO:0015995]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]		hydroxymethylbilane synthase activity [GO:0004418]	GO:0004418; GO:0006782; GO:0015995; GO:0018160	chlorophyll biosynthetic process [GO:0015995]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN26497_c0_g1_i1	P08397	HEM3_HUMAN	51.5	367	168	2	1267	167	5	361	8.20E-92	339	HEM3_HUMAN	reviewed	Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase)	HMBS PBGD UPS	Homo sapiens (Human)	361	cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	hydroxymethylbilane synthase activity [GO:0004418]	GO:0004418; GO:0005737; GO:0005829; GO:0006782; GO:0006783; GO:0018160	heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN37862_c0_g1_i1	P22907	HEM3_MOUSE	98.5	68	1	0	205	2	191	258	8.60E-33	140.2	HEM3_MOUSE	reviewed	Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase)	Hmbs Uros1	Mus musculus (Mouse)	361	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; amine binding [GO:0043176]; carboxylic acid binding [GO:0031406]; hydroxymethylbilane synthase activity [GO:0004418]; uroporphyrinogen-III synthase activity [GO:0004852]; heme biosynthetic process [GO:0006783]; liver development [GO:0001889]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to drug [GO:0042493]; tetrapyrrole biosynthetic process [GO:0033014]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	amine binding [GO:0043176]; carboxylic acid binding [GO:0031406]; hydroxymethylbilane synthase activity [GO:0004418]; uroporphyrinogen-III synthase activity [GO:0004852]	GO:0001889; GO:0004418; GO:0004852; GO:0005634; GO:0005737; GO:0005829; GO:0006778; GO:0006779; GO:0006782; GO:0006783; GO:0018160; GO:0030424; GO:0031406; GO:0033014; GO:0042493; GO:0043176; GO:0048471	heme biosynthetic process [GO:0006783]; liver development [GO:0001889]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to drug [GO:0042493]; tetrapyrrole biosynthetic process [GO:0033014]		NA	NA	NA	NA	NA	NA
TRINITY_DN18014_c0_g2_i1	P08397	HEM3_HUMAN	98.3	121	2	0	365	3	44	164	8.30E-63	240.7	HEM3_HUMAN	reviewed	Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase)	HMBS PBGD UPS	Homo sapiens (Human)	361	cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	hydroxymethylbilane synthase activity [GO:0004418]	GO:0004418; GO:0005737; GO:0005829; GO:0006782; GO:0006783; GO:0018160	heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN18014_c0_g1_i1	P22907	HEM3_MOUSE	100	151	0	0	453	1	44	194	9.30E-80	297.4	HEM3_MOUSE	reviewed	Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase)	Hmbs Uros1	Mus musculus (Mouse)	361	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; amine binding [GO:0043176]; carboxylic acid binding [GO:0031406]; hydroxymethylbilane synthase activity [GO:0004418]; uroporphyrinogen-III synthase activity [GO:0004852]; heme biosynthetic process [GO:0006783]; liver development [GO:0001889]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to drug [GO:0042493]; tetrapyrrole biosynthetic process [GO:0033014]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	amine binding [GO:0043176]; carboxylic acid binding [GO:0031406]; hydroxymethylbilane synthase activity [GO:0004418]; uroporphyrinogen-III synthase activity [GO:0004852]	GO:0001889; GO:0004418; GO:0004852; GO:0005634; GO:0005737; GO:0005829; GO:0006778; GO:0006779; GO:0006782; GO:0006783; GO:0018160; GO:0030424; GO:0031406; GO:0033014; GO:0042493; GO:0043176; GO:0048471	heme biosynthetic process [GO:0006783]; liver development [GO:0001889]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to drug [GO:0042493]; tetrapyrrole biosynthetic process [GO:0033014]		NA	NA	NA	NA	NA	NA
TRINITY_DN10317_c0_g1_i1	A6H7B8	PGAP2_BOVIN	49	198	101	0	720	127	14	211	4.60E-45	183	PGAP2_BOVIN	reviewed	Post-GPI attachment to proteins factor 2	PGAP2	Bos taurus (Bovine)	254	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005789; GO:0006506; GO:0016021	GPI anchor biosynthetic process [GO:0006506]		NA	NA	NA	NA	NA	NA
TRINITY_DN10317_c0_g1_i4	A6H7B8	PGAP2_BOVIN	48.1	156	81	0	594	127	56	211	1.10E-33	144.8	PGAP2_BOVIN	reviewed	Post-GPI attachment to proteins factor 2	PGAP2	Bos taurus (Bovine)	254	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005789; GO:0006506; GO:0016021	GPI anchor biosynthetic process [GO:0006506]		blue	blue	NA	NA	NA	NA
TRINITY_DN26915_c0_g1_i1	Q0VFE3	PGAP3_XENTR	44	293	163	1	997	119	15	306	6.20E-72	272.7	PGAP3_XENTR	reviewed	Post-GPI attachment to proteins factor 3 (PER1-like domain-containing protein 1)	pgap3 perld1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	316	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; hydrolase activity, acting on ester bonds [GO:0016788]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]	"hydrolase activity, acting on ester bonds [GO:0016788]"	GO:0000139; GO:0006505; GO:0006506; GO:0016021; GO:0016788; GO:0031227	GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]		blue	blue	NA	NA	NA	NA
TRINITY_DN15191_c0_g1_i1	P57789	KCNKA_HUMAN	45.3	64	34	1	225	37	223	286	4.60E-10	65.1	KCNKA_HUMAN	reviewed	Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit)	KCNK10 TREK2	Homo sapiens (Human)	538	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005267; GO:0005886; GO:0005887; GO:0007165; GO:0007613; GO:0022841; GO:0030322; GO:0034765; GO:0071805	memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322]		NA	NA	NA	NA	NA	NA
TRINITY_DN30971_c0_g1_i1	Q96T54	KCNKH_HUMAN	47.4	78	39	2	241	8	185	260	2.30E-11	69.3	KCNKH_HUMAN	reviewed	Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2) (TALK-2)	KCNK17 TALK2 TASK4 UNQ5816/PRO19634	Homo sapiens (Human)	332	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0022841; GO:0030322; GO:0034765; GO:0071805	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]		NA	NA	NA	NA	NA	NA
TRINITY_DN28959_c0_g1_i1	O35111	KCNK3_MOUSE	50.8	59	28	1	180	4	78	135	1.90E-10	66.2	KCNK3_MOUSE	reviewed	Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (Cardiac two pore background K(+) channel) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1) (cTBAK-1)	Kcnk3 Ctbak Task Task1	Mus musculus (Mouse)	409	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]	GO:0005216; GO:0005252; GO:0005886; GO:0005887; GO:0006813; GO:0007420; GO:0008022; GO:0022841; GO:0030322; GO:0034220; GO:0042493; GO:0044548; GO:0051481; GO:0071294; GO:0071456; GO:0071805; GO:0090102	brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to drug [GO:0042493]; stabilization of membrane potential [GO:0030322]		NA	NA	NA	NA	NA	NA
TRINITY_DN18059_c0_g1_i1	P17972	KCNAW_DROME	79	200	42	0	602	3	143	342	1.10E-88	327.4	KCNAW_DROME	reviewed	Potassium voltage-gated channel protein Shaw (Shaw2)	Shaw SHAW2 CG2822	Drosophila melanogaster (Fruit fly)	498	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN18059_c0_g1_i2	P17972	KCNAW_DROME	80.5	169	33	0	509	3	174	342	2.50E-71	269.6	KCNAW_DROME	reviewed	Potassium voltage-gated channel protein Shaw (Shaw2)	Shaw SHAW2 CG2822	Drosophila melanogaster (Fruit fly)	498	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN27410_c0_g1_i1	P17972	KCNAW_DROME	98.6	74	1	0	1	222	367	440	4.50E-35	148.7	KCNAW_DROME	reviewed	Potassium voltage-gated channel protein Shaw (Shaw2)	Shaw SHAW2 CG2822	Drosophila melanogaster (Fruit fly)	498	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN38350_c0_g1_i1	P22001	KCNA3_HUMAN	100	74	0	0	224	3	436	509	1.70E-37	156	KCNA3_HUMAN	reviewed	Potassium voltage-gated channel subfamily A member 3 (HGK5) (HLK3) (HPCN3) (Voltage-gated K(+) channel HuKIII) (Voltage-gated potassium channel subunit Kv1.3)	KCNA3 HGK5	Homo sapiens (Human)	575	axon [GO:0030424]; calyx of Held [GO:0044305]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	axon [GO:0030424]; calyx of Held [GO:0044305]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]	GO:0005244; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0015271; GO:0016021; GO:0030424; GO:0034765; GO:0044305; GO:0045121; GO:0051260; GO:0071805; GO:0099056	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN36416_c0_g1_i1	Q61923	KCNA6_MOUSE	49.3	67	34	0	203	3	396	462	2.80E-11	68.9	KCNA6_MOUSE	reviewed	Potassium voltage-gated channel subfamily A member 6 (MK1.6) (Voltage-gated potassium channel subunit Kv1.6)	Kcna6	Mus musculus (Mouse)	529	axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005887; GO:0008076; GO:0016021; GO:0030424; GO:0034705; GO:0034765; GO:0043679; GO:0051260; GO:0071805	potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN26416_c0_g1_i2	Q9TSZ3	KCNH2_CANLF	87.5	48	6	0	65	208	375	422	9.80E-19	94.4	KCNH2_CANLF	reviewed	Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1)	KCNH2 CERG ERG	Canis lupus familiaris (Dog) (Canis familiaris)	1158	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; cellular response to drug [GO:0035690]; membrane depolarization during action potential [GO:0086010]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]	C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]	GO:0005242; GO:0005249; GO:0005251; GO:0005887; GO:0009986; GO:0031625; GO:0035690; GO:0042391; GO:0042803; GO:0048471; GO:0055075; GO:0055131; GO:0060307; GO:0071805; GO:0086010; GO:0086091; GO:0097110; GO:0097623; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573	cellular response to drug [GO:0035690]; membrane depolarization during action potential [GO:0086010]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]		NA	NA	NA	NA	NA	NA
TRINITY_DN40590_c0_g1_i1	Q9PT84	KCNH6_CHICK	70.5	112	32	1	345	13	534	645	8.00E-39	161	KCNH6_CHICK	reviewed	Potassium voltage-gated channel subfamily H member 6 (Ether-a-go-go-related gene potassium channel) (ERG) (Eag-related protein) (Ether-a-go-go-related protein) (Voltage-gated potassium channel subunit Kv11.2)	KCNH6 ERG	Gallus gallus (Chicken)	1202	integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	integral component of plasma membrane [GO:0005887]	voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005887; GO:0034765; GO:0042391; GO:0071805	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN25234_c0_g1_i1	Q9NR82	KCNQ5_HUMAN	52.8	89	32	2	288	52	541	629	2.10E-16	86.3	KCNQ5_HUMAN	reviewed	Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5)	KCNQ5	Homo sapiens (Human)	932	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN14585_c0_g1_i2	Q9NR82	KCNQ5_HUMAN	63.5	241	86	1	11	727	156	396	3.60E-86	319.7	KCNQ5_HUMAN	reviewed	Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5)	KCNQ5	Homo sapiens (Human)	932	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN34615_c0_g1_i1	O60741	HCN1_HUMAN	63.6	44	15	1	162	31	196	238	5.00E-09	61.2	HCN1_HUMAN	reviewed	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1) (BCNG-1)	HCN1 BCNG1	Homo sapiens (Human)	890	axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]	axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0005222; GO:0005248; GO:0005249; GO:0005267; GO:0005886; GO:0005887; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0045176; GO:0046549; GO:0051289; GO:0071320; GO:0071805; GO:0098855	apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]		brown	brown	NA	NA	NA	NA
TRINITY_DN34615_c0_g1_i2	O60741	HCN1_HUMAN	63.6	44	15	1	162	31	196	238	4.20E-09	61.6	HCN1_HUMAN	reviewed	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1) (BCNG-1)	HCN1 BCNG1	Homo sapiens (Human)	890	axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]	axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0005222; GO:0005248; GO:0005249; GO:0005267; GO:0005886; GO:0005887; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0045176; GO:0046549; GO:0051289; GO:0071320; GO:0071805; GO:0098855	apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN39464_c0_g1_i1	Q9UL51	HCN2_HUMAN	81.4	70	13	0	5	214	410	479	1.70E-27	122.9	HCN2_HUMAN	reviewed	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2)	HCN2 BCNG2	Homo sapiens (Human)	889	HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0007267; GO:0008076; GO:0030552; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0098719; GO:0098855; GO:1990573	cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN37903_c0_g1_i1	Q9Y3Q4	HCN4_HUMAN	67.9	56	18	0	197	30	262	317	1.00E-15	83.6	HCN4_HUMAN	reviewed	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	HCN4	Homo sapiens (Human)	1203	HCN channel complex [GO:0098855]; intrinsic component of plasma membrane [GO:0031226]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248]; blood circulation [GO:0008015]; cation transport [GO:0006812]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; SA node cell action potential [GO:0086015]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	HCN channel complex [GO:0098855]; intrinsic component of plasma membrane [GO:0031226]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248]	GO:0002027; GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0006812; GO:0006936; GO:0008015; GO:0030552; GO:0031226; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0048471; GO:0055117; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086015; GO:0086041; GO:0086046; GO:0086091; GO:0098719; GO:0098855; GO:0098909; GO:1990573	blood circulation [GO:0008015]; cation transport [GO:0006812]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; SA node cell action potential [GO:0086015]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN22165_c0_g1_i1	Q9Y3Q4	HCN4_HUMAN	70.5	61	17	1	184	2	619	678	1.90E-17	89.4	HCN4_HUMAN	reviewed	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	HCN4	Homo sapiens (Human)	1203	HCN channel complex [GO:0098855]; intrinsic component of plasma membrane [GO:0031226]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248]; blood circulation [GO:0008015]; cation transport [GO:0006812]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; SA node cell action potential [GO:0086015]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	HCN channel complex [GO:0098855]; intrinsic component of plasma membrane [GO:0031226]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248]	GO:0002027; GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0006812; GO:0006936; GO:0008015; GO:0030552; GO:0031226; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0048471; GO:0055117; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086015; GO:0086041; GO:0086046; GO:0086091; GO:0098719; GO:0098855; GO:0098909; GO:1990573	blood circulation [GO:0008015]; cation transport [GO:0006812]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; SA node cell action potential [GO:0086015]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN31045_c0_g1_i1	P63682	KDPB_MYCBO	87	69	9	0	1	207	523	591	3.20E-27	121.7	KDPB_MYCBO	reviewed	Potassium-transporting ATPase ATP-binding subunit (EC 7.2.2.6) (ATP phosphohydrolase [potassium-transporting] B chain) (Potassium-binding and translocating subunit B) (Potassium-translocating ATPase B chain)	kdpB BQ2027_MB1059	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	709	"integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; potassium transmembrane transporter activity, phosphorylative mechanism [GO:0008556]"	integral component of plasma membrane [GO:0005887]	"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; potassium transmembrane transporter activity, phosphorylative mechanism [GO:0008556]"	GO:0000287; GO:0005524; GO:0005887; GO:0008556			NA	NA	NA	NA	NA	NA
TRINITY_DN4256_c0_g3_i1	O76924	ARI2_DROME	38.6	132	74	2	148	531	29	157	4.60E-15	82.8	ARI2_DROME	reviewed	Potential E3 ubiquitin-protein ligase ariadne-2 (EC 2.3.2.31) (Protein ariadne-2) (RING-type E3 ubiquitin transferase ariadne-2)	ari-2 ari2 TRIAD1 CG5709	Drosophila melanogaster (Fruit fly)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0032436; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4256_c0_g3_i2	O76924	ARI2_DROME	50	82	41	0	148	393	29	110	5.00E-15	82.4	ARI2_DROME	reviewed	Potential E3 ubiquitin-protein ligase ariadne-2 (EC 2.3.2.31) (Protein ariadne-2) (RING-type E3 ubiquitin transferase ariadne-2)	ari-2 ari2 TRIAD1 CG5709	Drosophila melanogaster (Fruit fly)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0032436; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4256_c0_g3_i3	O76924	ARI2_DROME	64.5	479	140	2	148	1503	29	504	5.80E-185	648.7	ARI2_DROME	reviewed	Potential E3 ubiquitin-protein ligase ariadne-2 (EC 2.3.2.31) (Protein ariadne-2) (RING-type E3 ubiquitin transferase ariadne-2)	ari-2 ari2 TRIAD1 CG5709	Drosophila melanogaster (Fruit fly)	509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0032436; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i4	Q9HBE1	PATZ1_HUMAN	46.2	52	25	1	1029	1184	356	404	1.30E-07	59.3	PATZ1_HUMAN	reviewed	"POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)"	PATZ1 PATZ RIAZ ZBTB19 ZNF278 ZSG	Homo sapiens (Human)	687	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0008584; GO:0030217; GO:0031625; GO:0045892; GO:0046872	"male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33128_c0_g1_i1	Q60636	PRDM1_MOUSE	52.6	156	64	1	690	223	113	258	1.30E-43	177.9	PRDM1_MOUSE	reviewed	PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)	Prdm1 Blimp1	Mus musculus (Mouse)	856	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001822; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0010629; GO:0030889; GO:0031665; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841	adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN33128_c0_g1_i2	Q60636	PRDM1_MOUSE	52.3	153	63	1	498	40	113	255	1.60E-43	177.2	PRDM1_MOUSE	reviewed	PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)	Prdm1 Blimp1	Mus musculus (Mouse)	856	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001822; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0010629; GO:0030889; GO:0031665; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841	adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN25245_c0_g1_i1	O75626	PRDM1_HUMAN	100	87	0	0	262	2	153	239	7.10E-48	190.7	PRDM1_HUMAN	reviewed	PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1)	PRDM1 BLIMP1	Homo sapiens (Human)	825	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001227; GO:0001763; GO:0001822; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841	adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN25245_c0_g1_i2	O75626	PRDM1_HUMAN	98.9	95	1	0	286	2	145	239	1.80E-52	206.1	PRDM1_HUMAN	reviewed	PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1)	PRDM1 BLIMP1	Homo sapiens (Human)	825	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001227; GO:0001763; GO:0001822; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841	adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN20517_c0_g1_i1	O75626	PRDM1_HUMAN	79.7	133	27	0	151	549	558	690	1.80E-64	246.9	PRDM1_HUMAN	reviewed	PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1)	PRDM1 BLIMP1	Homo sapiens (Human)	825	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001227; GO:0001763; GO:0001822; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841	adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN19127_c0_g1_i11	B4F6U4	PRD10_XENTR	46.5	269	140	2	864	67	624	891	2.60E-69	265.8	PRD10_XENTR	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	prdm10	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1173	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0045944; GO:0046872	methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN19127_c0_g1_i11	B4F6U4	PRD10_XENTR	31.5	419	254	10	2072	867	210	612	3.60E-42	175.6	PRD10_XENTR	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	prdm10	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1173	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0045944; GO:0046872	methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN19127_c0_g1_i12	B4F6U4	PRD10_XENTR	51.9	133	60	1	468	82	749	881	6.20E-35	148.7	PRD10_XENTR	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	prdm10	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1173	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0045944; GO:0046872	methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN19127_c0_g1_i13	B4F6U4	PRD10_XENTR	37.3	700	401	13	2106	67	210	891	2.70E-122	441.8	PRD10_XENTR	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	prdm10	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1173	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0045944; GO:0046872	methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN19127_c0_g1_i5	B4F6U4	PRD10_XENTR	50.7	140	65	1	489	82	742	881	5.90E-36	152.5	PRD10_XENTR	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	prdm10	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1173	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0045944; GO:0046872	methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN19127_c0_g1_i9	B4F6U4	PRD10_XENTR	39.9	233	128	5	785	108	210	437	1.10E-33	145.6	PRD10_XENTR	reviewed	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	prdm10	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1173	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0045944; GO:0046872	methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN18303_c0_g1_i1	E9Q8T2	PRD15_MOUSE	44.8	67	37	0	209	9	783	849	1.00E-12	73.6	PRD15_MOUSE	reviewed	PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15)	Prdm15	Mus musculus (Mouse)	1174	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; methylation [GO:0032259]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0010468; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035	methylation [GO:0032259]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]		NA	NA	NA	NA	NA	NA
TRINITY_DN15900_c0_g1_i1	E9Q8T2	PRD15_MOUSE	41.6	77	45	0	246	16	755	831	9.70E-15	80.5	PRD15_MOUSE	reviewed	PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15)	Prdm15	Mus musculus (Mouse)	1174	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; methylation [GO:0032259]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0010468; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035	methylation [GO:0032259]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]		NA	NA	NA	NA	NA	NA
TRINITY_DN15900_c0_g1_i2	E9Q8T2	PRD15_MOUSE	42.9	77	43	1	243	16	755	831	1.30E-14	80.1	PRD15_MOUSE	reviewed	PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15)	Prdm15	Mus musculus (Mouse)	1174	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; methylation [GO:0032259]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0005654; GO:0007275; GO:0008168; GO:0010468; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035	methylation [GO:0032259]; multicellular organism development [GO:0007275]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i16	Q9CXE0	PRDM5_MOUSE	45	111	51	1	21	323	447	557	1.20E-21	104.4	PRDM5_MOUSE	reviewed	PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5)	Prdm5	Mus musculus (Mouse)	599	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000278; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008168; GO:0016575; GO:0016604; GO:0043565; GO:0045892; GO:0046872; GO:0051567; GO:0070491; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18186_c0_g1_i1	Q5F433	PRAF3_CHICK	47.6	170	89	0	59	568	5	174	5.90E-38	159.1	PRAF3_CHICK	reviewed	PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5)	ARL6IP5 PRAF3 RCJMB04_3k9	Gallus gallus (Chicken)	188	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of transport [GO:0051051]; regulation of neurotransmitter uptake [GO:0051580]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0015813; GO:0016020; GO:0016021; GO:0051051; GO:0051580	L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of transport [GO:0051051]; regulation of neurotransmitter uptake [GO:0051580]		NA	NA	NA	NA	NA	NA
TRINITY_DN18186_c0_g1_i2	Q5F433	PRAF3_CHICK	47.6	170	89	0	59	568	5	174	5.80E-38	159.1	PRAF3_CHICK	reviewed	PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5)	ARL6IP5 PRAF3 RCJMB04_3k9	Gallus gallus (Chicken)	188	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of transport [GO:0051051]; regulation of neurotransmitter uptake [GO:0051580]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0015813; GO:0016020; GO:0016021; GO:0051051; GO:0051580	L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of transport [GO:0051051]; regulation of neurotransmitter uptake [GO:0051580]		blue	blue	NA	NA	NA	NA
TRINITY_DN18186_c0_g1_i3	Q5F433	PRAF3_CHICK	47.6	170	89	0	59	568	5	174	2.60E-38	160.2	PRAF3_CHICK	reviewed	PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5)	ARL6IP5 PRAF3 RCJMB04_3k9	Gallus gallus (Chicken)	188	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of transport [GO:0051051]; regulation of neurotransmitter uptake [GO:0051580]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0015813; GO:0016020; GO:0016021; GO:0051051; GO:0051580	L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of transport [GO:0051051]; regulation of neurotransmitter uptake [GO:0051580]		blue	blue	NA	NA	NA	NA
TRINITY_DN30326_c0_g1_i1	O75915	PRAF3_HUMAN	100	80	0	0	1	240	109	188	5.40E-37	154.5	PRAF3_HUMAN	reviewed	PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27)	ARL6IP5 DERP11 JWA PRA2 PRAF3 HSPC127	Homo sapiens (Human)	188	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of neurotransmitter uptake [GO:0051580]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0008631; GO:0010917; GO:0015813; GO:0016020; GO:0016021; GO:0032874; GO:0043065; GO:0043280; GO:0051051; GO:0051580	intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of neurotransmitter uptake [GO:0051580]		NA	NA	NA	NA	NA	NA
TRINITY_DN32134_c0_g1_i1	O75915	PRAF3_HUMAN	100	79	0	0	5	241	1	79	2.10E-38	159.1	PRAF3_HUMAN	reviewed	PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27)	ARL6IP5 DERP11 JWA PRA2 PRAF3 HSPC127	Homo sapiens (Human)	188	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of neurotransmitter uptake [GO:0051580]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0008631; GO:0010917; GO:0015813; GO:0016020; GO:0016021; GO:0032874; GO:0043065; GO:0043280; GO:0051051; GO:0051580	intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of neurotransmitter uptake [GO:0051580]		NA	NA	NA	NA	NA	NA
TRINITY_DN32134_c0_g1_i2	O75915	PRAF3_HUMAN	98.7	79	1	0	13	249	1	79	3.70E-38	158.3	PRAF3_HUMAN	reviewed	PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27)	ARL6IP5 DERP11 JWA PRA2 PRAF3 HSPC127	Homo sapiens (Human)	188	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of neurotransmitter uptake [GO:0051580]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0002037; GO:0005789; GO:0005856; GO:0005886; GO:0008631; GO:0010917; GO:0015813; GO:0016020; GO:0016021; GO:0032874; GO:0043065; GO:0043280; GO:0051051; GO:0051580	intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate transmembrane transport [GO:0015813]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of neurotransmitter uptake [GO:0051580]		NA	NA	NA	NA	NA	NA
TRINITY_DN39636_c0_g1_i1	Q9W1W9	PADC1_DROME	48.7	158	79	1	471	4	27	184	2.50E-36	153.3	PADC1_DROME	reviewed	PRADC1-like protein (PAP21-like protein)	CG9849	Drosophila melanogaster (Fruit fly)	196	extracellular region [GO:0005576]; muscle cell fate determination [GO:0007521]	extracellular region [GO:0005576]		GO:0005576; GO:0007521	muscle cell fate determination [GO:0007521]		blue	blue	NA	NA	NA	NA
TRINITY_DN1573_c0_g1_i1	Q9CWM4	PFD1_MOUSE	46.6	116	62	0	97	444	6	121	3.70E-22	106.3	PFD1_MOUSE	reviewed	Prefoldin subunit 1	Pfdn1	Mus musculus (Mouse)	122	cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; actin cytoskeleton organization [GO:0030036]; B cell activation [GO:0042113]; cerebellum development [GO:0021549]; protein folding [GO:0006457]; telencephalon development [GO:0021537]	cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]	protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0006457; GO:0016272; GO:0021537; GO:0021549; GO:0030036; GO:0042113; GO:0044183; GO:0051082	actin cytoskeleton organization [GO:0030036]; B cell activation [GO:0042113]; cerebellum development [GO:0021549]; protein folding [GO:0006457]; telencephalon development [GO:0021537]		blue	blue	NA	NA	NA	NA
TRINITY_DN1573_c0_g1_i2	Q9CWM4	PFD1_MOUSE	44.6	121	62	1	97	459	6	121	2.10E-20	100.5	PFD1_MOUSE	reviewed	Prefoldin subunit 1	Pfdn1	Mus musculus (Mouse)	122	cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; actin cytoskeleton organization [GO:0030036]; B cell activation [GO:0042113]; cerebellum development [GO:0021549]; protein folding [GO:0006457]; telencephalon development [GO:0021537]	cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]	protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0006457; GO:0016272; GO:0021537; GO:0021549; GO:0030036; GO:0042113; GO:0044183; GO:0051082	actin cytoskeleton organization [GO:0030036]; B cell activation [GO:0042113]; cerebellum development [GO:0021549]; protein folding [GO:0006457]; telencephalon development [GO:0021537]		blue	blue	NA	NA	NA	NA
TRINITY_DN4276_c0_g1_i1	A1A4P5	PFD2_BOVIN	53.4	131	58	1	95	478	24	154	1.70E-30	134	PFD2_BOVIN	reviewed	Prefoldin subunit 2	PFDN2	Bos taurus (Bovine)	154	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495	positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN27127_c0_g1_i1	Q9UHV9	PFD2_HUMAN	100	124	0	0	375	4	13	136	1.80E-60	233	PFD2_HUMAN	reviewed	Prefoldin subunit 2	PFDN2 PFD2 HSPC231	Homo sapiens (Human)	154	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495	positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN39860_c0_g1_i1	O70591	PFD2_MOUSE	99.1	106	1	0	320	3	23	128	1.90E-50	199.5	PFD2_MOUSE	reviewed	Prefoldin subunit 2	Pfdn2 Pfd2	Mus musculus (Mouse)	154	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495	positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN24042_c0_g1_i1	P61758	PFD3_HUMAN	100	166	0	0	500	3	10	175	1.60E-88	326.6	PFD3_HUMAN	reviewed	Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1)	VBP1 PFDN3	Homo sapiens (Human)	197	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; tubulin binding [GO:0015631]; microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]	tubulin binding [GO:0015631]	GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231	microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN3343_c0_g1_i1	P61758	PFD3_HUMAN	57.4	176	75	0	621	94	22	197	1.50E-55	217.6	PFD3_HUMAN	reviewed	Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1)	VBP1 PFDN3	Homo sapiens (Human)	197	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; tubulin binding [GO:0015631]; microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]	tubulin binding [GO:0015631]	GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231	microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		blue	blue	NA	NA	NA	NA
TRINITY_DN39272_c0_g1_i1	P61758	PFD3_HUMAN	53.6	84	38	1	22	273	105	187	4.70E-18	91.7	PFD3_HUMAN	reviewed	Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1)	VBP1 PFDN3	Homo sapiens (Human)	197	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; tubulin binding [GO:0015631]; microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]	tubulin binding [GO:0015631]	GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231	microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		red	red	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i2	Q9NQP4	PFD4_HUMAN	48.4	122	63	0	760	1125	12	133	2.10E-25	118.2	PFD4_HUMAN	reviewed	Prefoldin subunit 4 (Protein C-1)	PFDN4 PFD4	Homo sapiens (Human)	134	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN2444_c0_g1_i6	Q9NQP4	PFD4_HUMAN	48.4	122	63	0	760	1125	12	133	2.10E-25	118.2	PFD4_HUMAN	reviewed	Prefoldin subunit 4 (Protein C-1)	PFDN4 PFD4	Homo sapiens (Human)	134	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN19445_c0_g1_i1	Q9NQP4	PFD4_HUMAN	47.9	121	63	0	75	437	12	132	2.60E-26	119.8	PFD4_HUMAN	reviewed	Prefoldin subunit 4 (Protein C-1)	PFDN4 PFD4	Homo sapiens (Human)	134	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN19445_c0_g1_i5	Q9NQP4	PFD4_HUMAN	45.1	122	67	0	75	440	12	133	5.50E-24	112.1	PFD4_HUMAN	reviewed	Prefoldin subunit 4 (Protein C-1)	PFDN4 PFD4	Homo sapiens (Human)	134	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN19445_c0_g1_i7	Q9NQP4	PFD4_HUMAN	45.2	93	51	0	75	353	12	104	5.30E-17	88.6	PFD4_HUMAN	reviewed	Prefoldin subunit 4 (Protein C-1)	PFDN4 PFD4	Homo sapiens (Human)	134	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN3893_c0_g1_i1	Q99471	PFD5_HUMAN	51.7	143	69	0	570	142	3	145	3.50E-34	146.4	PFD5_HUMAN	reviewed	Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1)	PFDN5 MM1 PFD5	Homo sapiens (Human)	154	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006457; GO:0016272; GO:0045111; GO:0045892; GO:0051082; GO:0060041; GO:0090090	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		blue	blue	NA	NA	NA	NA
TRINITY_DN17958_c0_g2_i1	Q99471	PFD5_HUMAN	100	99	0	0	298	2	36	134	4.30E-49	194.9	PFD5_HUMAN	reviewed	Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1)	PFDN5 MM1 PFD5	Homo sapiens (Human)	154	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006457; GO:0016272; GO:0045111; GO:0045892; GO:0051082; GO:0060041; GO:0090090	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17958_c0_g1_i1	Q99471	PFD5_HUMAN	100	93	0	0	280	2	36	128	2.40E-46	185.7	PFD5_HUMAN	reviewed	Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1)	PFDN5 MM1 PFD5	Homo sapiens (Human)	154	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006457; GO:0016272; GO:0045111; GO:0045892; GO:0051082; GO:0060041; GO:0090090	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6986_c0_g1_i4	Q61838	PZP_MOUSE	20.5	229	162	6	905	219	1269	1477	5.50E-05	50.1	PZP_MOUSE	reviewed	Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit]	Pzp A2m	Mus musculus (Mouse)	1495	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]; embryo implantation [GO:0007566]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0044877; GO:0048403; GO:0048406; GO:0062023	embryo implantation [GO:0007566]		NA	NA	NA	NA	NA	NA
TRINITY_DN12767_c0_g1_i1	Q61838	PZP_MOUSE	33.9	112	71	3	30	362	1379	1488	1.40E-12	73.9	PZP_MOUSE	reviewed	Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit]	Pzp A2m	Mus musculus (Mouse)	1495	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]; embryo implantation [GO:0007566]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0044877; GO:0048403; GO:0048406; GO:0062023	embryo implantation [GO:0007566]		NA	NA	NA	NA	NA	NA
TRINITY_DN28277_c0_g1_i1	P20742	PZP_HUMAN	34.9	149	87	5	49	477	85	229	6.90E-17	88.6	PZP_HUMAN	reviewed	Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)	PZP CPAMD6	Homo sapiens (Human)	1482	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0007565; GO:0070062; GO:0072562	female pregnancy [GO:0007565]		NA	NA	NA	NA	NA	NA
TRINITY_DN39922_c0_g1_i1	Q9Y3B1	PLD3B_HUMAN	100	130	0	0	392	3	1	130	3.70E-71	268.9	PLD3B_HUMAN	reviewed	PRELI domain containing protein 3B (Protein slowmo homolog 2)	PRELID3B C20orf45 SLMO2 CGI-107	Homo sapiens (Human)	194	mitochondrial intermembrane space [GO:0005758]; phosphatidic acid transfer activity [GO:1990050]; phospholipid transport [GO:0015914]	mitochondrial intermembrane space [GO:0005758]	phosphatidic acid transfer activity [GO:1990050]	GO:0005758; GO:0015914; GO:1990050	phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN25974_c0_g1_i1	Q9Y255	PRLD1_HUMAN	100	103	0	0	1	309	1	103	4.90E-56	218	PRLD1_HUMAN	reviewed	"PRELI domain-containing protein 1, mitochondrial (25 kDa protein of relevant evolutionary and lymphoid interest) (Px19-like protein)"	PRELID1 PRELI CGI-106 SBBI12	Homo sapiens (Human)	219	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; immune response [GO:0006955]; intermembrane lipid transfer [GO:0120009]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of apoptotic process [GO:0042981]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]		GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0006955; GO:0007275; GO:0010917; GO:0010950; GO:0015914; GO:0032991; GO:0042981; GO:0043066; GO:0045580; GO:0051881; GO:0070234; GO:0090201; GO:0097035; GO:0120009; GO:1901857; GO:2001140	apoptotic process [GO:0006915]; immune response [GO:0006955]; intermembrane lipid transfer [GO:0120009]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of apoptotic process [GO:0042981]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580]		NA	NA	NA	NA	NA	NA
TRINITY_DN4334_c0_g1_i1	Q9C0J8	WDR33_HUMAN	58.8	80	33	0	183	422	43	122	6.40E-21	102.1	WDR33_HUMAN	reviewed	pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa)	WDR33 WDC146	Homo sapiens (Human)	1336	"collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"	collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006369; GO:0006378; GO:0006406; GO:0007283; GO:0031124	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4334_c0_g1_i2	Q9C0J8	WDR33_HUMAN	66.7	105	35	0	183	497	43	147	1.30E-37	157.5	WDR33_HUMAN	reviewed	pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa)	WDR33 WDC146	Homo sapiens (Human)	1336	"collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"	collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006369; GO:0006378; GO:0006406; GO:0007283; GO:0031124	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN79_c0_g1_i1	Q5U317	FIP1_RAT	36.1	208	118	3	749	171	94	301	2.70E-24	114	FIP1_RAT	reviewed	Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)	Fip1l1	Rattus norvegicus (Rat)	536	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005847; GO:0006378; GO:0098789	mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN79_c0_g1_i2	Q5U317	FIP1_RAT	37	189	104	3	652	131	94	282	3.40E-23	110.2	FIP1_RAT	reviewed	Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)	Fip1l1	Rattus norvegicus (Rat)	536	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005847; GO:0006378; GO:0098789	mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN21778_c0_g1_i1	Q6UN15	FIP1_HUMAN	100	69	0	0	3	209	139	207	5.00E-36	151	FIP1_HUMAN	reviewed	Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia)	FIP1L1 FIP1 RHE	Homo sapiens (Human)	594	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006406; GO:0031124; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1282_c0_g1_i1	Q6UN15	FIP1_HUMAN	50	58	28	1	248	75	137	193	1.10E-11	70.5	FIP1_HUMAN	reviewed	Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia)	FIP1L1 FIP1 RHE	Homo sapiens (Human)	594	"mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]"	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006406; GO:0031124; GO:0098789	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6824_c0_g1_i1	O94913	PCF11_HUMAN	32.9	246	149	3	762	40	1252	1486	6.00E-24	112.8	PCF11_HUMAN	reviewed	Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11)	PCF11 KIAA0824	Homo sapiens (Human)	1555	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]	GO:0000398; GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379; GO:0031124	"mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6824_c0_g1_i2	O94913	PCF11_HUMAN	33.2	241	145	3	805	98	1252	1481	1.40E-23	111.7	PCF11_HUMAN	reviewed	Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11)	PCF11 KIAA0824	Homo sapiens (Human)	1555	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]	GO:0000398; GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379; GO:0031124	"mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4604_c0_g1_i1	O94913	PCF11_HUMAN	49.4	162	70	2	597	112	17	166	2.30E-38	160.2	PCF11_HUMAN	reviewed	Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11)	PCF11 KIAA0824	Homo sapiens (Human)	1555	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]	GO:0000398; GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379; GO:0031124	"mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24604_c0_g2_i1	A5DDF4	PRP5_PICGU	67.9	81	26	0	244	2	376	456	3.20E-26	118.6	PRP5_PICGU	reviewed	Pre-mRNA-processing ATP-dependent RNA helicase PRP5 (EC 3.6.4.13)	PRP5 PGUG_01305	Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) (Yeast) (Candida guilliermondii)	862	nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; mRNA branch site recognition [GO:0000348]	nucleus [GO:0005634]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]	GO:0000348; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0008186	mRNA branch site recognition [GO:0000348]		NA	NA	NA	NA	NA	NA
TRINITY_DN32266_c0_g1_i1	Q4IP34	PRP5_GIBZE	60.6	71	27	1	214	2	589	658	2.00E-19	95.9	PRP5_GIBZE	reviewed	Pre-mRNA-processing ATP-dependent RNA helicase PRP5 (EC 3.6.4.13)	PRP5 FGRRES_01024 FGSG_01024	Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)	1207	nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN10896_c0_g1_i2	O60508	PRP17_HUMAN	60.5	38	14	1	113	226	543	579	9.60E-09	60.8	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33625_c0_g1_i1	O60508	PRP17_HUMAN	100	159	0	0	2	478	208	366	4.70E-90	331.6	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33550_c0_g1_i1	O60508	PRP17_HUMAN	100	133	0	0	400	2	72	204	1.10E-73	276.9	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40021_c0_g1_i1	O60508	PRP17_HUMAN	99	105	1	0	1	315	351	455	4.80E-59	228	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8810_c0_g2_i1	O60508	PRP17_HUMAN	58.9	73	30	0	1	219	282	354	1.70E-21	102.8	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8810_c0_g1_i1	O60508	PRP17_HUMAN	51.6	128	62	0	2	385	378	505	5.40E-36	151.8	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1289_c0_g1_i1	O60508	PRP17_HUMAN	66.1	551	182	4	109	1758	33	579	2.20E-228	793.1	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1289_c0_g1_i2	O60508	PRP17_HUMAN	66.1	551	182	4	109	1758	33	579	2.20E-228	793.1	PRP17_HUMAN	reviewed	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17)	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	579	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0071007; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		blue	blue	NA	NA	NA	NA
TRINITY_DN229_c0_g1_i1	Q1JPZ7	PRP39_DANRE	35	448	280	5	1540	215	256	698	5.30E-74	280	PRP39_DANRE	reviewed	Pre-mRNA-processing factor 39 (PRP39 homolog)	prpf39 si:dz261o22.3	Danio rerio (Zebrafish) (Brachydanio rerio)	752	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]		GO:0000243; GO:0000395; GO:0005685; GO:0071004	mRNA 5'-splice site recognition [GO:0000395]		NA	NA	NA	NA	NA	NA
TRINITY_DN229_c0_g1_i2	Q1JPZ7	PRP39_DANRE	32.6	481	280	6	1639	215	256	698	4.20E-69	263.8	PRP39_DANRE	reviewed	Pre-mRNA-processing factor 39 (PRP39 homolog)	prpf39 si:dz261o22.3	Danio rerio (Zebrafish) (Brachydanio rerio)	752	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]		GO:0000243; GO:0000395; GO:0005685; GO:0071004	mRNA 5'-splice site recognition [GO:0000395]		NA	NA	NA	NA	NA	NA
TRINITY_DN11962_c0_g1_i1	Q86UA1	PRP39_HUMAN	63.3	79	29	0	274	38	323	401	6.30E-26	117.9	PRP39_HUMAN	reviewed	Pre-mRNA-processing factor 39 (PRP39 homolog)	PRPF39	Homo sapiens (Human)	669	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]		GO:0000243; GO:0000395; GO:0005685; GO:0071004	mRNA 5'-splice site recognition [GO:0000395]		NA	NA	NA	NA	NA	NA
TRINITY_DN39721_c0_g1_i1	O94906	PRP6_HUMAN	100	141	0	0	3	425	434	574	2.60E-76	285.8	PRP6_HUMAN	reviewed	Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6 C20orf14	Homo sapiens (Human)	941	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35730_c0_g1_i1	O94906	PRP6_HUMAN	95.4	413	11	1	4	1218	210	622	5.40E-223	774.6	PRP6_HUMAN	reviewed	Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6 C20orf14	Homo sapiens (Human)	941	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28117_c0_g1_i1	O94906	PRP6_HUMAN	100	73	0	0	3	221	631	703	4.10E-33	141.4	PRP6_HUMAN	reviewed	Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6 C20orf14	Homo sapiens (Human)	941	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39553_c0_g1_i1	O94906	PRP6_HUMAN	100	150	0	0	452	3	770	919	1.90E-85	316.2	PRP6_HUMAN	reviewed	Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6 C20orf14	Homo sapiens (Human)	941	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26113_c0_g1_i1	Q2KJJ0	PRP6_BOVIN	95.7	69	3	0	1	207	369	437	2.40E-30	132.1	PRP6_BOVIN	reviewed	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6	Bos taurus (Bovine)	941	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30208_c0_g1_i1	Q2KJJ0	PRP6_BOVIN	100	61	0	0	185	3	1	61	7.00E-30	130.6	PRP6_BOVIN	reviewed	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6	Bos taurus (Bovine)	941	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36772_c0_g1_i1	Q2KJJ0	PRP6_BOVIN	59.1	66	27	0	3	200	443	508	3.60E-15	81.6	PRP6_BOVIN	reviewed	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6	Bos taurus (Bovine)	941	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36711_c0_g1_i1	Q2KJJ0	PRP6_BOVIN	100	67	0	0	203	3	131	197	6.60E-33	140.6	PRP6_BOVIN	reviewed	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	PRPF6	Bos taurus (Bovine)	941	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10727_c0_g1_i1	Q91YR7	PRP6_MOUSE	66.1	940	291	4	112	2856	1	937	0	1189.1	PRP6_MOUSE	reviewed	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	Prpf6	Mus musculus (Mouse)	941	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16981_c0_g1_i1	Q6P2Q9	PRP8_HUMAN	85	568	85	0	3	1706	513	1080	2.30E-304	1045.4	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16981_c0_g3_i1	Q6P2Q9	PRP8_HUMAN	86.5	913	123	0	2750	12	1083	1995	0	1679.8	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38907_c0_g1_i1	Q6P2Q9	PRP8_HUMAN	76.8	181	42	0	544	2	33	213	1.30E-83	310.5	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37819_c0_g1_i1	Q6P2Q9	PRP8_HUMAN	100	68	0	0	206	3	1881	1948	2.50E-32	138.7	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16885_c0_g1_i1	Q6P2Q9	PRP8_HUMAN	100	1197	0	0	3593	3	644	1840	0	2485.3	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16049_c0_g1_i1	Q6P2Q9	PRP8_HUMAN	100	516	0	0	2	1549	1820	2335	1.40E-305	1049.3	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN788_c1_g1_i1	Q6P2Q9	PRP8_HUMAN	99.8	645	1	0	1936	2	4	648	0	1348.6	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN788_c0_g1_i1	Q6P2Q9	PRP8_HUMAN	90.4	2313	220	1	278	7213	20	2332	0	4396.3	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN788_c0_g1_i2	Q6P2Q9	PRP8_HUMAN	78.9	426	89	1	278	1552	20	445	1.30E-208	727.2	PRP8_HUMAN	reviewed	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	2335	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16981_c0_g2_i1	Q99PV0	PRP8_MOUSE	68.5	279	88	0	839	3	2037	2315	1.00E-119	431	PRP8_MOUSE	reviewed	Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)	Prpf8 Prp8	Mus musculus (Mouse)	2335	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000398; GO:0005634; GO:0005682; GO:0008237; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39025_c0_g1_i1	Q8T295	PRP8_DICDI	70.7	82	24	0	247	2	393	474	1.20E-28	126.7	PRP8_DICDI	reviewed	Pre-mRNA-processing-splicing factor 8 homolog (Splicing factor Prp8)	prpf8 prp8 DDB_G0274229	Dictyostelium discoideum (Slime mold)	2327	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; spliceosomal tri-snRNP complex assembly [GO:0000244]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0005682; GO:0006397; GO:0008237; GO:0008380; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0070122; GO:0071013; GO:0097157	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; spliceosomal tri-snRNP complex assembly [GO:0000244]		NA	NA	NA	NA	NA	NA
TRINITY_DN31711_c0_g1_i1	Q9SSD2	PRP8A_ARATH	70.5	139	41	0	1	417	244	382	9.80E-55	214.2	PRP8A_ARATH	reviewed	Pre-mRNA-processing-splicing factor 8A (PRP8 homolog A) (AtPRP8A) (Protein ABNORMAL SUSPENSOR 2) (Protein EMBRYO DEFECTIVE 14) (Protein EMBRYO DEFECTIVE 177) (Protein EMBRYO DEFECTIVE 33) (Protein SUPPRESSOR OF OVEREXPRESSED FCA 81)	PRP8A EMB14 EMB177 EMB33 SOF81 SUS2 At1g80070 F18B13.15	Arabidopsis thaliana (Mouse-ear cress)	2359	"catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; U5 snRNP [GO:0005682]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000380; GO:0000398; GO:0005682; GO:0005739; GO:0008237; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0070122; GO:0071013; GO:0097157	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39219_c0_g1_i1	Q59W52	PRP28_CANAL	44.6	92	51	0	281	6	480	571	1.80E-18	93.2	PRP28_CANAL	reviewed	Pre-mRNA-splicing ATP-dependent RNA helicase PRP28 (EC 3.6.4.13)	PRP28 CAALFM_C111300CA CaO19.672 CaO19.8289	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	581	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31264_c0_g1_i1	Q2HJ41	PRP18_BOVIN	47.3	74	39	0	223	2	259	332	7.00E-15	80.9	PRP18_BOVIN	reviewed	Pre-mRNA-splicing factor 18 (PRP18 homolog)	PRPF18	Bos taurus (Bovine)	342	nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]	nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000350; GO:0005682; GO:0016607; GO:0046540; GO:0071021; GO:0071048	generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]		NA	NA	NA	NA	NA	NA
TRINITY_DN9909_c0_g1_i1	Q8BM39	PRP18_MOUSE	54.8	312	129	5	6	929	39	342	2.00E-85	317.4	PRP18_MOUSE	reviewed	Pre-mRNA-splicing factor 18 (PRP18 homolog)	Prpf18 Prp18	Mus musculus (Mouse)	342	membrane [GO:0016020]; nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; negative regulation of cellular protein metabolic process [GO:0032269]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]	membrane [GO:0016020]; nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000350; GO:0005682; GO:0016020; GO:0016607; GO:0032269; GO:0046540; GO:0071021; GO:0071048	generation of catalytic spliceosome for second transesterification step [GO:0000350]; negative regulation of cellular protein metabolic process [GO:0032269]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]		blue	blue	NA	NA	NA	NA
TRINITY_DN25548_c0_g1_i1	Q2HJ41	PRP18_BOVIN	100	82	0	0	3	248	254	335	6.60E-43	174.1	PRP18_BOVIN	reviewed	Pre-mRNA-splicing factor 18 (PRP18 homolog)	PRPF18	Bos taurus (Bovine)	342	nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]	nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000350; GO:0005682; GO:0016607; GO:0046540; GO:0071021; GO:0071048	generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]		NA	NA	NA	NA	NA	NA
TRINITY_DN27760_c0_g1_i1	Q8LB54	PRP38_ARATH	55.2	105	47	0	318	4	2	106	8.10E-30	131	PRP38_ARATH	reviewed	Pre-mRNA-splicing factor 38	PRP38 At2g40650 T7D17.17	Arabidopsis thaliana (Mouse-ear cress)	355	precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]		GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN22909_c0_g1_i1	Q0P5I6	PR38A_BOVIN	100	163	0	0	51	539	1	163	6.70E-93	341.3	PR38A_BOVIN	reviewed	Pre-mRNA-splicing factor 38A	PRPF38A	Bos taurus (Bovine)	312	"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000398; GO:0005634; GO:0005654; GO:0031965; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2122_c0_g1_i1	Q28H87	PR38A_XENTR	72.5	193	53	0	82	660	1	193	7.70E-81	301.6	PR38A_XENTR	reviewed	Pre-mRNA-splicing factor 38A	prpf38a TEgg055l14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	312	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000398; GO:0005634; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2122_c0_g1_i2	Q6DHU4	PR38A_DANRE	76.2	168	40	0	82	585	1	168	1.10E-73	277.7	PR38A_DANRE	reviewed	Pre-mRNA-splicing factor 38A	prpf38a zgc:92059	Danio rerio (Zebrafish) (Brachydanio rerio)	313	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000398; GO:0005634; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN425_c0_g1_i1	Q5VTL8	PR38B_HUMAN	79.3	145	30	0	48	482	42	186	4.60E-68	259.2	PR38B_HUMAN	reviewed	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	546	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN425_c0_g1_i2	Q5VTL8	PR38B_HUMAN	79.3	145	30	0	48	482	42	186	1.60E-68	260.4	PR38B_HUMAN	reviewed	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	546	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN425_c0_g1_i4	Q5VTL8	PR38B_HUMAN	74.1	158	41	0	48	521	42	199	7.40E-69	261.5	PR38B_HUMAN	reviewed	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	546	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN425_c0_g1_i5	Q5VTL8	PR38B_HUMAN	75.7	177	43	0	48	578	42	218	1.40E-80	300.4	PR38B_HUMAN	reviewed	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	546	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN26824_c0_g1_i1	Q5VTL8	PR38B_HUMAN	100	75	0	0	1	225	42	116	2.10E-38	160.2	PR38B_HUMAN	reviewed	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	546	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN26824_c0_g1_i1	Q5VTL8	PR38B_HUMAN	100	71	0	0	233	445	116	186	3.40E-36	152.9	PR38B_HUMAN	reviewed	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	546	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN37349_c0_g1_i1	Q20875	DHX15_CAEEL	48.3	116	56	3	1	339	596	710	5.10E-26	118.6	DHX15_CAEEL	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase ddx-15 (EC 3.6.4.13) (DEAH box protein 15)	ddx-15 F56D2.6	Caenorhabditis elegans	739	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0006364; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN36687_c0_g1_i1	Q8VY00	ESP3_ARATH	59.8	87	33	1	1	255	957	1043	1.30E-23	110.2	ESP3_ARATH	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH1 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP2) (Protein EMBRYO DEFECTIVE 2733) (Protein ENHANCED SILENCING PHENOTYPE 3)	ESP3 EMB2733 At1g32490 F5D14.27	Arabidopsis thaliana (Mouse-ear cress)	1044	membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA splicing [GO:0008380]	membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0016020; GO:0035194	mRNA processing [GO:0006397]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24284_c0_g1_i1	Q8VY00	ESP3_ARATH	77.3	185	42	0	6	560	404	588	5.00E-83	308.5	ESP3_ARATH	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH1 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP2) (Protein EMBRYO DEFECTIVE 2733) (Protein ENHANCED SILENCING PHENOTYPE 3)	ESP3 EMB2733 At1g32490 F5D14.27	Arabidopsis thaliana (Mouse-ear cress)	1044	membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA splicing [GO:0008380]	membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0016020; GO:0035194	mRNA processing [GO:0006397]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN8072_c0_g1_i1	F4IE66	PRP22_ARATH	59.1	115	47	0	366	22	331	445	6.50E-31	134.8	PRP22_ARATH	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH10 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP22) (Protein ROOT INITIATION DEFECTIVE 1)	RID1 At1g26370 T1K7.25	Arabidopsis thaliana (Mouse-ear cress)	717	nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0006397; GO:0008380; GO:0043484; GO:0045943	mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN39695_c0_g1_i1	F4K2E9	PRP16_ARATH	71.6	183	52	0	1	549	551	733	2.70E-73	276.2	PRP16_ARATH	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH7 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP16) (Protein CLUMSY VEIN) (Protein EMBRYO DEFECTIVE 3011) (Protein PSR1-INTERACTING PROTEIN 1)	CUV EMB3011 PINP1 At5g13010 T24H18_180	Arabidopsis thaliana (Mouse-ear cress)	1255	"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; defense response to fungus, incompatible interaction [GO:0009817]; embryo development ending in seed dormancy [GO:0009793]; gene expression [GO:0010467]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of RNA splicing [GO:0033120]; primary miRNA processing [GO:0031053]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]; root development [GO:0048364]; root hair elongation [GO:0048767]; xylem and phloem pattern formation [GO:0010051]"	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0008380; GO:0009793; GO:0009817; GO:0010051; GO:0010467; GO:0016246; GO:0031053; GO:0031334; GO:0033120; GO:0048364; GO:0048767	"defense response to fungus, incompatible interaction [GO:0009817]; embryo development ending in seed dormancy [GO:0009793]; gene expression [GO:0010467]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of RNA splicing [GO:0033120]; primary miRNA processing [GO:0031053]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]; root development [GO:0048364]; root hair elongation [GO:0048767]; xylem and phloem pattern formation [GO:0010051]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30093_c0_g1_i1	O43143	DHX15_HUMAN	100	244	0	0	3	734	552	795	2.90E-142	505.8	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26446_c0_g1_i1	O43143	DHX15_HUMAN	94.3	88	5	0	2	265	221	308	4.20E-40	164.9	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1416_c0_g1_i1	O43143	DHX15_HUMAN	83	481	80	1	1520	84	115	595	9.40E-231	800.8	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1416_c0_g1_i2	O43143	DHX15_HUMAN	82.7	202	35	0	692	87	593	794	2.10E-100	366.7	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1416_c0_g1_i3	O43143	DHX15_HUMAN	80.8	156	30	0	554	87	639	794	9.80E-75	281.2	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1416_c0_g1_i4	O43143	DHX15_HUMAN	83.2	680	112	1	2120	87	115	794	0	1161	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35429_c0_g1_i1	O43143	DHX15_HUMAN	100	389	0	0	49	1215	109	497	5.90E-214	744.6	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15859_c0_g1_i1	O43143	DHX15_HUMAN	100	103	0	0	1	309	110	212	2.90E-56	218.8	DHX15_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15)	DHX15 DBP1 DDX15	Homo sapiens (Human)	795	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0043279	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27682_c0_g1_i1	O60231	DHX16_HUMAN	70.8	274	80	0	3	824	573	846	5.40E-110	398.7	DHX16_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16)	DHX16 DBP2 DDX16 KIAA0577 PRP2	Homo sapiens (Human)	1041	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26944_c0_g1_i1	O60231	DHX16_HUMAN	100	108	0	0	1	324	880	987	2.50E-58	225.7	DHX16_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16)	DHX16 DBP2 DDX16 KIAA0577 PRP2	Homo sapiens (Human)	1041	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30785_c0_g1_i1	O60231	DHX16_HUMAN	100	102	0	0	3	308	654	755	1.30E-53	209.9	DHX16_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16)	DHX16 DBP2 DDX16 KIAA0577 PRP2	Homo sapiens (Human)	1041	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7079_c0_g1_i1	Q767K6	DHX16_PIG	62.7	166	61	1	603	106	880	1044	3.50E-58	226.1	DHX16_PIG	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16)	DHX16 DDX16	Sus scrofa (Pig)	1045	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15320_c0_g1_i1	Q9P774	PRP16_SCHPO	65.6	157	51	2	2	466	692	847	4.10E-54	212.2	PRP16_SCHPO	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase prp16 (EC 3.6.4.13)	prp16 SPBC1711.17 SPBC17G9.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1173	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type spliceosomal complex [GO:0005684]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type spliceosomal complex [GO:0005684]	3'-5' RNA helicase activity [GO:0034458]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0000350; GO:0000398; GO:0000790; GO:0003723; GO:0005524; GO:0005634; GO:0005681; GO:0005684; GO:0016887; GO:0034458; GO:0045292	"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3488_c1_g1_i1	Q92620	PRP16_HUMAN	80.4	219	43	0	3	659	535	753	6.50E-98	358.2	PRP16_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)	DHX38 DDX38 KIAA0224 PRP16	Homo sapiens (Human)	1227	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006405; GO:0006406; GO:0016020; GO:0031124; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24552_c0_g1_i1	Q92620	PRP16_HUMAN	100	113	0	0	339	1	532	644	2.00E-58	226.1	PRP16_HUMAN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)	DHX38 DDX38 KIAA0224 PRP16	Homo sapiens (Human)	1227	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006405; GO:0006406; GO:0016020; GO:0031124; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28300_c0_g1_i1	Q17R09	PRP16_BOVIN	83.2	149	25	0	6	452	766	914	8.70E-70	264.2	PRP16_BOVIN	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)	DHX38 PRP16	Bos taurus (Bovine)	1227	"catalytic step 2 spliceosome [GO:0071013]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8072_c0_g2_i1	Q10752	CDC28_SCHPO	49.2	246	120	4	755	18	414	654	9.20E-59	228.4	CDC28_SCHPO	reviewed	Pre-mRNA-splicing factor ATP-dependent RNA helicase-like protein cdc28 (EC 3.6.4.13) (Pre-mRNA-processing protein 8)	cdc28 prp8 SPBC19C2.01 SPBC21B10.01c SPBC874.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1055	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; generation of catalytic spliceosome for first transesterification step [GO:0000349]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000349; GO:0003723; GO:0003724; GO:0005524; GO:0005681	generation of catalytic spliceosome for first transesterification step [GO:0000349]		NA	NA	NA	NA	NA	NA
TRINITY_DN28166_c0_g1_i1	C8VBH3	CEF1_EMENI	69	184	43	1	511	2	4	187	2.30E-67	256.5	CEF1_EMENI	reviewed	Pre-mRNA-splicing factor cef1	cef1 AN10944	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	791	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]	GO:0003677; GO:0005681; GO:0005737; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN31664_c0_g1_i1	Q5B020	CWC15_EMENI	62.1	58	21	1	3	173	174	231	1.90E-14	79.3	CWC15_EMENI	reviewed	Pre-mRNA-splicing factor cwc15	cwc15 AN6110	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	232	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0045292; GO:0071013	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25573_c0_g1_i1	Q9NXE8	CWC25_HUMAN	50.3	161	62	3	553	74	1	144	2.90E-26	120.2	CWC25_HUMAN	reviewed	Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25)	CWC25 CCDC49	Homo sapiens (Human)	425	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684]		GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34555_c0_g1_i1	O94316	SN114_SCHPO	58	81	34	0	3	245	899	979	2.60E-21	102.4	SN114_SCHPO	reviewed	Pre-mRNA-splicing factor cwf10 (114 kDa U5 small nuclear ribonucleoprotein component homolog) (Complexed with cdc5 protein 10)	cwf10 snu114 spef2 SPBC215.12	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	984	"cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of heterochromatin domain assembly [GO:1902802]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	GO:0000244; GO:0000398; GO:0000974; GO:0003924; GO:0005525; GO:0005634; GO:0005681; GO:0005682; GO:0005829; GO:0030623; GO:0045292; GO:0046540; GO:0071007; GO:0071014; GO:1902802; GO:1990904	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of heterochromatin domain assembly [GO:1902802]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37554_c0_g1_i1	Q9ULR0	ISY1_HUMAN	100	146	0	0	440	3	37	182	7.40E-82	304.3	ISY1_HUMAN	reviewed	Pre-mRNA-splicing factor ISY1 homolog	ISY1 KIAA1160	Homo sapiens (Human)	285	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]	RNA binding [GO:0003723]	GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0006283; GO:0071006; GO:0071013; GO:0071014; GO:0071020	"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7237_c0_g1_i1	Q9ULR0	ISY1_HUMAN	66.7	105	34	1	353	42	35	139	6.10E-34	144.8	ISY1_HUMAN	reviewed	Pre-mRNA-splicing factor ISY1 homolog	ISY1 KIAA1160	Homo sapiens (Human)	285	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]	RNA binding [GO:0003723]	GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0006283; GO:0071006; GO:0071013; GO:0071014; GO:0071020	"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8628_c0_g2_i1	Q69ZQ2	ISY1_MOUSE	61.5	275	100	4	16	837	1	270	5.50E-79	295.8	ISY1_MOUSE	reviewed	Pre-mRNA-splicing factor ISY1 homolog	Isy1 Kiaa1160	Mus musculus (Mouse)	285	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]		GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0005634; GO:0071006; GO:0071013; GO:0071014; GO:0071020	"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34800_c0_g1_i1	P0CS48	PRP46_CRYNJ	68.8	93	29	0	281	3	159	251	2.70E-35	149.1	PRP46_CRYNJ	reviewed	Pre-mRNA-splicing factor PRP46 (Pre-mRNA-processing protein 46)	PRP46 CNG03060	Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) (Filobasidiella neoformans)	473	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; Prp19 complex [GO:0000974]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; Prp19 complex [GO:0000974]		GO:0000398; GO:0000974; GO:0005737; GO:0071013; GO:0080008	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31032_c0_g1_i1	O13615	PRP46_SCHPO	83.8	80	13	0	242	3	195	274	9.90E-36	150.2	PRP46_SCHPO	reviewed	Pre-mRNA-splicing factor prp5 (Complexed with cdc5 protein 1) (Pre-mRNA-processing protein 5)	prp5 cwf1 pi024 SPBP22H7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	473	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]		GO:0000398; GO:0000974; GO:0005634; GO:0005681; GO:0045292; GO:0071013; GO:0071014; GO:0080008	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2538_c0_g1_i1	Q4WP02	SPP2_ASPFU	33.3	135	71	4	382	741	193	323	8.00E-05	49.7	SPP2_ASPFU	reviewed	Pre-mRNA-splicing factor spp2	spp2 AFUA_4G07550	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	541	spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005681; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN29178_c0_g1_i1	Q9HCS7	SYF1_HUMAN	100	98	0	0	2	295	379	476	1.40E-52	206.5	SYF1_HUMAN	reviewed	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20949_c0_g1_i1	Q9HCS7	SYF1_HUMAN	99.3	138	1	0	416	3	480	617	1.70E-75	283.1	SYF1_HUMAN	reviewed	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20949_c0_g1_i2	Q9HCS7	SYF1_HUMAN	100	138	0	0	416	3	480	617	7.50E-76	284.3	SYF1_HUMAN	reviewed	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19055_c0_g1_i1	Q9HCS7	SYF1_HUMAN	50	178	80	1	521	15	189	366	7.80E-46	184.9	SYF1_HUMAN	reviewed	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22260_c0_g1_i1	Q9HCS7	SYF1_HUMAN	97.9	94	2	0	1	282	70	163	9.70E-51	200.3	SYF1_HUMAN	reviewed	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22260_c0_g1_i2	Q9HCS7	SYF1_HUMAN	100	95	0	0	1	285	70	164	7.20E-54	210.7	SYF1_HUMAN	reviewed	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6192_c0_g1_i1	Q9DCD2	SYF1_MOUSE	41	117	46	4	417	82	721	819	5.60E-11	68.9	SYF1_MOUSE	reviewed	Pre-mRNA-splicing factor SYF1 (XPA-binding protein 2)	Xab2 Syf1	Mus musculus (Mouse)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19055_c0_g2_i1	Q9DCD2	SYF1_MOUSE	55	271	116	3	796	2	374	644	2.50E-80	300.1	SYF1_MOUSE	reviewed	Pre-mRNA-splicing factor SYF1 (XPA-binding protein 2)	Xab2 Syf1	Mus musculus (Mouse)	855	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1511_c0_g1_i1	A1Z9G2	SYF1_DROME	65.6	669	228	1	2002	2	13	681	9.10E-271	934.1	SYF1_DROME	reviewed	Pre-mRNA-splicing factor syf1 homolog (Pre-mRNA-splicing factor fandango) (Protein faint sausage)	fand fas CG6197	Drosophila melanogaster (Fruit fly)	883	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; cardioblast cell fate determination [GO:0007510]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; Malpighian tubule morphogenesis [GO:0007443]; morphogenesis of an epithelium [GO:0002009]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000381; GO:0000398; GO:0000974; GO:0002009; GO:0005634; GO:0007443; GO:0007510; GO:0008380; GO:0071007; GO:0071011; GO:0071013; GO:0071014	"cardioblast cell fate determination [GO:0007510]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; Malpighian tubule morphogenesis [GO:0007443]; morphogenesis of an epithelium [GO:0002009]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1511_c0_g1_i2	A1Z9G2	SYF1_DROME	65.8	666	226	1	1993	2	16	681	8.90E-271	934.1	SYF1_DROME	reviewed	Pre-mRNA-splicing factor syf1 homolog (Pre-mRNA-splicing factor fandango) (Protein faint sausage)	fand fas CG6197	Drosophila melanogaster (Fruit fly)	883	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; cardioblast cell fate determination [GO:0007510]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; Malpighian tubule morphogenesis [GO:0007443]; morphogenesis of an epithelium [GO:0002009]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000381; GO:0000398; GO:0000974; GO:0002009; GO:0005634; GO:0007443; GO:0007510; GO:0008380; GO:0071007; GO:0071011; GO:0071013; GO:0071014	"cardioblast cell fate determination [GO:0007510]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; Malpighian tubule morphogenesis [GO:0007443]; morphogenesis of an epithelium [GO:0002009]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1511_c0_g1_i3	A1Z9G2	SYF1_DROME	67.4	607	196	1	1819	5	16	622	1.30E-249	863.6	SYF1_DROME	reviewed	Pre-mRNA-splicing factor syf1 homolog (Pre-mRNA-splicing factor fandango) (Protein faint sausage)	fand fas CG6197	Drosophila melanogaster (Fruit fly)	883	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; cardioblast cell fate determination [GO:0007510]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; Malpighian tubule morphogenesis [GO:0007443]; morphogenesis of an epithelium [GO:0002009]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000349; GO:0000381; GO:0000398; GO:0000974; GO:0002009; GO:0005634; GO:0007443; GO:0007510; GO:0008380; GO:0071007; GO:0071011; GO:0071013; GO:0071014	"cardioblast cell fate determination [GO:0007510]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; Malpighian tubule morphogenesis [GO:0007443]; morphogenesis of an epithelium [GO:0002009]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1212_c0_g1_i1	Q6DGP2	SYF2_DANRE	58.2	201	83	1	694	92	39	238	1.50E-58	227.6	SYF2_DANRE	reviewed	Pre-mRNA-splicing factor syf2	syf2 zgc:92835	Danio rerio (Zebrafish) (Brachydanio rerio)	238	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0005634; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1212_c0_g1_i2	Q6DGP2	SYF2_DANRE	56.4	218	94	1	745	92	22	238	3.10E-60	233.4	SYF2_DANRE	reviewed	Pre-mRNA-splicing factor syf2	syf2 zgc:92835	Danio rerio (Zebrafish) (Brachydanio rerio)	238	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0000398; GO:0000974; GO:0005634; GO:0071007; GO:0071013; GO:0071014	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN40324_c0_g1_i1	Q612R3	SYF2_CAEBR	48.1	52	27	0	223	68	182	233	1.70E-06	53.1	SYF2_CAEBR	reviewed	Pre-mRNA-splicing factor syf-2	syf-2 CBG16608	Caenorhabditis briggsae	233	catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]		GO:0000974; GO:0006397; GO:0008380; GO:0071013; GO:0071014	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		red	red	NA	NA	NA	NA
TRINITY_DN31229_c0_g1_i1	O95926	SYF2_HUMAN	100	79	0	0	263	27	165	243	6.10E-39	161	SYF2_HUMAN	reviewed	Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29)	SYF2 CBPIN GCIPIP	Homo sapiens (Human)	243	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0000974; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0007095; GO:0007369; GO:0008284; GO:0016607; GO:0048568; GO:0071007; GO:0071013; GO:0071014	"embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10094_c0_g1_i1	Q28XY0	FL2D_DROPS	60.2	181	68	2	988	458	143	323	4.40E-50	200.3	FL2D_DROPS	reviewed	Pre-mRNA-splicing regulator female-lethal(2)D	fl(2)d GA19508	Drosophila pseudoobscura pseudoobscura (Fruit fly)	560	"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]		GO:0000375; GO:0000381; GO:0005634; GO:0006397; GO:0007530; GO:0007548; GO:0030154; GO:0036396; GO:0048749; GO:0070868; GO:0080009	"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10094_c0_g1_i3	Q28XY0	FL2D_DROPS	63.8	105	35	1	763	458	219	323	9.00E-28	125.6	FL2D_DROPS	reviewed	Pre-mRNA-splicing regulator female-lethal(2)D	fl(2)d GA19508	Drosophila pseudoobscura pseudoobscura (Fruit fly)	560	"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]		GO:0000375; GO:0000381; GO:0005634; GO:0006397; GO:0007530; GO:0007548; GO:0030154; GO:0036396; GO:0048749; GO:0070868; GO:0080009	"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10094_c0_g1_i2	Q9Y091	FL2D_DROME	55.1	78	34	1	322	92	136	213	5.00E-15	82.8	FL2D_DROME	reviewed	Pre-mRNA-splicing regulator female-lethal(2)D (dFL(2)D)	fl(2)d CG6315	Drosophila melanogaster (Fruit fly)	536	"nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; female germ-line sex determination [GO:0019099]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]		GO:0000375; GO:0000381; GO:0005634; GO:0006397; GO:0007530; GO:0007539; GO:0007548; GO:0019099; GO:0030154; GO:0036396; GO:0048749; GO:0070868; GO:0080009	"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; female germ-line sex determination [GO:0019099]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32695_c0_g1_i1	Q7SXL7	FL2D_DANRE	100	84	0	0	3	254	135	218	1.30E-38	159.8	FL2D_DANRE	reviewed	Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein)	wtap ch211-195e3.2 zgc:66202	Danio rerio (Zebrafish) (Brachydanio rerio)	423	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]		GO:0000381; GO:0005634; GO:0005737; GO:0006397; GO:0007049; GO:0007275; GO:0008380; GO:0016607; GO:0036396; GO:0042981; GO:0080009	"cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3646_c0_g1_i1	Q9UI14	PRAF1_HUMAN	49.7	163	77	1	183	671	26	183	2.30E-38	160.6	PRAF1_HUMAN	reviewed	Prenylated Rab acceptor protein 1 (PRA1 family protein 1)	RABAC1 PRA1 PRAF1	Homo sapiens (Human)	185	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]	GO:0005794; GO:0005886; GO:0008021; GO:0008022; GO:0016020; GO:0016021; GO:0042802; GO:0070064			blue	blue	NA	NA	NA	NA
TRINITY_DN28143_c0_g1_i1	Q9UI14	PRAF1_HUMAN	100	118	0	0	1	354	20	137	2.00E-61	236.1	PRAF1_HUMAN	reviewed	Prenylated Rab acceptor protein 1 (PRA1 family protein 1)	RABAC1 PRA1 PRAF1	Homo sapiens (Human)	185	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]	GO:0005794; GO:0005886; GO:0008021; GO:0008022; GO:0016020; GO:0016021; GO:0042802; GO:0070064			NA	NA	NA	NA	NA	NA
TRINITY_DN32056_c0_g1_i1	Q9Z0S9	PRAF1_MOUSE	100	104	0	0	2	313	33	136	4.00E-53	208.4	PRAF1_MOUSE	reviewed	Prenylated Rab acceptor protein 1 (PRA1 family protein 1) (Prenylin)	Rabac1 Pra Pra1 Praf1	Mus musculus (Mouse)	185	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]	GO:0005794; GO:0005886; GO:0008021; GO:0008022; GO:0016021; GO:0042802; GO:0070064			NA	NA	NA	NA	NA	NA
TRINITY_DN3162_c1_g1_i2	Q9CQF9	PCYOX_MOUSE	45.9	133	72	0	298	696	33	165	8.80E-28	126.7	PCYOX_MOUSE	reviewed	Prenylcysteine oxidase (EC 1.8.3.5)	Pcyox1 Kiaa0908	Mus musculus (Mouse)	505	lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; ATPase-coupled chloride transmembrane transporter activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]	ATPase-coupled chloride transmembrane transporter activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]	GO:0001735; GO:0005764; GO:0005886; GO:0006821; GO:0008555; GO:0030327; GO:0030328; GO:0034361	chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]		NA	NA	NA	NA	NA	NA
TRINITY_DN3162_c1_g1_i4	Q9CQF9	PCYOX_MOUSE	42.2	251	144	1	298	1047	33	283	4.80E-53	209.9	PCYOX_MOUSE	reviewed	Prenylcysteine oxidase (EC 1.8.3.5)	Pcyox1 Kiaa0908	Mus musculus (Mouse)	505	lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; ATPase-coupled chloride transmembrane transporter activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]	ATPase-coupled chloride transmembrane transporter activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]	GO:0001735; GO:0005764; GO:0005886; GO:0006821; GO:0008555; GO:0030327; GO:0030328; GO:0034361	chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]		NA	NA	NA	NA	NA	NA
TRINITY_DN3162_c1_g1_i5	Q9UHG3	PCYOX_HUMAN	36.1	493	283	6	298	1752	33	501	1.30E-76	288.9	PCYOX_HUMAN	reviewed	Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase)	PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183	Homo sapiens (Human)	505	extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; ATPase-coupled chloride transmembrane transporter activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]	ATPase-coupled chloride transmembrane transporter activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]	GO:0001735; GO:0005764; GO:0005886; GO:0008555; GO:0030327; GO:0030328; GO:0034361; GO:0070062	prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]		NA	NA	NA	NA	NA	NA
TRINITY_DN11991_c0_g1_i1	H9JAQ7	TRIMR_BOMMO	29.4	177	120	2	708	193	1	177	5.90E-21	102.8	TRIMR_BOMMO	reviewed	Pre-piRNA 3'-exonuclease trimmer (EC 3.1.13.-) (PARN-like domain-containing protein 1 homolog) (BmPNLDC1)	PNLDC1	Bombyx mori (Silk moth)	532	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0003723; GO:0005739; GO:0005741; GO:0016021; GO:0031047; GO:0046872; GO:1990511	gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8308_c0_g1_i2	H9JAQ7	TRIMR_BOMMO	29.5	281	185	5	32	868	259	528	8.40E-30	132.5	TRIMR_BOMMO	reviewed	Pre-piRNA 3'-exonuclease trimmer (EC 3.1.13.-) (PARN-like domain-containing protein 1 homolog) (BmPNLDC1)	PNLDC1	Bombyx mori (Silk moth)	532	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0003723; GO:0005739; GO:0005741; GO:0016021; GO:0031047; GO:0046872; GO:1990511	gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8308_c0_g1_i3	H9JAQ7	TRIMR_BOMMO	29.5	281	185	5	32	868	259	528	7.90E-30	132.5	TRIMR_BOMMO	reviewed	Pre-piRNA 3'-exonuclease trimmer (EC 3.1.13.-) (PARN-like domain-containing protein 1 homolog) (BmPNLDC1)	PNLDC1	Bombyx mori (Silk moth)	532	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0003723; GO:0005739; GO:0005741; GO:0016021; GO:0031047; GO:0046872; GO:1990511	gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8308_c0_g1_i4	H9JAQ7	TRIMR_BOMMO	27.3	253	171	5	2	754	287	528	6.30E-21	102.8	TRIMR_BOMMO	reviewed	Pre-piRNA 3'-exonuclease trimmer (EC 3.1.13.-) (PARN-like domain-containing protein 1 homolog) (BmPNLDC1)	PNLDC1	Bombyx mori (Silk moth)	532	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0003723; GO:0005739; GO:0005741; GO:0016021; GO:0031047; GO:0046872; GO:1990511	gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8308_c0_g1_i8	H9JAQ7	TRIMR_BOMMO	29.5	281	185	5	32	868	259	528	8.40E-30	132.5	TRIMR_BOMMO	reviewed	Pre-piRNA 3'-exonuclease trimmer (EC 3.1.13.-) (PARN-like domain-containing protein 1 homolog) (BmPNLDC1)	PNLDC1	Bombyx mori (Silk moth)	532	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000175; GO:0003723; GO:0005739; GO:0005741; GO:0016021; GO:0031047; GO:0046872; GO:1990511	gene silencing by RNA [GO:0031047]; piRNA biosynthetic process [GO:1990511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4290_c0_g1_i1	Q5ZKM1	SPB1_CHICK	45	171	91	2	1	510	163	331	1.10E-34	147.9	SPB1_CHICK	reviewed	pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	FTSJ3 RCJMB04_10b6	Gallus gallus (Chicken)	832	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA 2'-O-methyltransferase activity [GO:0062105]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]"	RNA 2'-O-methyltransferase activity [GO:0062105]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0000453; GO:0000463; GO:0000466; GO:0001510; GO:0005730; GO:0008173; GO:0008650; GO:0016435; GO:0030687; GO:0030688; GO:0031167; GO:0062105	"enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3479_c0_g1_i1	Q9DBE9	SPB1_MOUSE	42.4	177	96	3	687	175	646	822	2.10E-24	114.4	SPB1_MOUSE	reviewed	pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	Ftsj3	Mus musculus (Mouse)	838	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA 2'-O-methyltransferase activity [GO:0062105]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]"	RNA 2'-O-methyltransferase activity [GO:0062105]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0000453; GO:0000463; GO:0000466; GO:0001510; GO:0005654; GO:0005730; GO:0008173; GO:0008650; GO:0016435; GO:0030687; GO:0030688; GO:0031167; GO:0062105	"enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1346_c0_g1_i1	Q756J5	ESF1_ASHGO	40.5	222	122	3	888	223	153	364	6.50E-40	166.4	ESF1_ASHGO	reviewed	Pre-rRNA-processing protein ESF1 (18S rRNA factor 1)	ESF1 AER259W	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	619	nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1346_c0_g1_i4	Q756J5	ESF1_ASHGO	40.2	224	122	3	894	223	153	364	1.90E-39	164.9	ESF1_ASHGO	reviewed	Pre-rRNA-processing protein ESF1 (18S rRNA factor 1)	ESF1 AER259W	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	619	nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1464_c0_g1_i1	O74362	ESF2_SCHPO	35	160	96	4	148	612	107	263	5.30E-21	102.8	ESF2_SCHPO	reviewed	Pre-rRNA-processing protein esf2 (18S rRNA factor 2)	esf2 SPBC28E12.05 SPBC3H7.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	334	"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; rRNA processing [GO:0006364]; small-subunit processome assembly [GO:0034462]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0034462	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; rRNA processing [GO:0006364]; small-subunit processome assembly [GO:0034462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1464_c0_g1_i2	O74362	ESF2_SCHPO	33.7	181	104	6	148	675	107	276	1.20E-20	101.7	ESF2_SCHPO	reviewed	Pre-rRNA-processing protein esf2 (18S rRNA factor 2)	esf2 SPBC28E12.05 SPBC3H7.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	334	"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; rRNA processing [GO:0006364]; small-subunit processome assembly [GO:0034462]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0034462	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; rRNA processing [GO:0006364]; small-subunit processome assembly [GO:0034462]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2098_c0_g1_i1	A7EI93	IPI1_SCLS1	31.4	175	103	6	82	588	1	164	1.70E-05	52.8	IPI1_SCLS1	reviewed	Pre-rRNA-processing protein ipi1	ipi1 SS1G_05035	Sclerotinia sclerotiorum (strain ATCC 18683 / 1980 / Ss-1) (White mold) (Whetzelinia sclerotiorum)	348	MLL1 complex [GO:0071339]; Rix1 complex [GO:0097344]; rRNA processing [GO:0006364]	MLL1 complex [GO:0071339]; Rix1 complex [GO:0097344]		GO:0006364; GO:0071339; GO:0097344	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN33434_c0_g1_i1	Q5ACM4	PNO1_CANAL	69.6	148	45	0	449	6	122	269	8.70E-54	211.1	PNO1_CANAL	reviewed	Pre-rRNA-processing protein PNO1	PNO1 CAALFM_CR10410CA CaO19.7618	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	276	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005737; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN30080_c0_g1_i1	Q2NL82	TSR1_HUMAN	100	135	0	0	407	3	651	785	2.50E-76	285.8	TSR1_HUMAN	reviewed	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	804	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30387_c0_g1_i1	Q5XGY1	TSR1_XENLA	56.9	130	52	1	2	379	659	788	7.70E-38	157.9	TSR1_XENLA	reviewed	Pre-rRNA-processing protein TSR1 homolog	tsr1	Xenopus laevis (African clawed frog)	815	nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]		GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN3266_c0_g1_i1	Q5XGY1	TSR1_XENLA	71	176	51	0	2	529	623	798	2.10E-73	276.9	TSR1_XENLA	reviewed	Pre-rRNA-processing protein TSR1 homolog	tsr1	Xenopus laevis (African clawed frog)	815	nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]		GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		blue	blue	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i2	Q2NL82	TSR1_HUMAN	38.3	379	210	6	1092	22	4	380	1.30E-56	221.9	TSR1_HUMAN	reviewed	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	804	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i3	Q2NL82	TSR1_HUMAN	35.7	258	161	3	767	3	4	259	1.40E-31	138.3	TSR1_HUMAN	reviewed	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	804	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i4	Q2NL82	TSR1_HUMAN	38.3	379	210	6	1092	22	4	380	1.30E-56	221.9	TSR1_HUMAN	reviewed	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	804	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i5	Q5XGY1	TSR1_XENLA	40.1	212	106	3	597	22	176	386	8.00E-34	145.2	TSR1_XENLA	reviewed	Pre-rRNA-processing protein TSR1 homolog	tsr1	Xenopus laevis (African clawed frog)	815	nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]		GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i6	Q2NL82	TSR1_HUMAN	38.3	379	210	6	1092	22	4	380	1.30E-56	221.9	TSR1_HUMAN	reviewed	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	804	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i7	Q2NL82	TSR1_HUMAN	38.3	379	210	6	1092	22	4	380	1.30E-56	221.9	TSR1_HUMAN	reviewed	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	804	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1085_c0_g1_i1	Q9VP47	TSR1_DROME	38.7	111	63	2	324	4	180	289	1.70E-12	73.6	TSR1_DROME	reviewed	Pre-rRNA-processing protein TSR1 homolog (Tsr1 ribosome assembly factor)	Tsr1 CG7338	Drosophila melanogaster (Fruit fly)	814	"nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]"	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003924; GO:0005525; GO:0005730; GO:0030688; GO:0034511	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26171_c0_g1_i1	Q9H300	PARL_HUMAN	100	74	0	0	222	1	292	365	5.10E-39	161	PARL_HUMAN	reviewed	"Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]"	PARL PSARL PRO2207	Homo sapiens (Human)	379	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion transmembrane transport [GO:0006851]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006508; GO:0006851; GO:0010821; GO:0016021; GO:0030162; GO:0033619; GO:1903214; GO:2000377	membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion transmembrane transport [GO:0006851]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN28212_c0_g1_i1	Q9H300	PARL_HUMAN	98.8	81	1	0	245	3	212	292	5.30E-37	154.5	PARL_HUMAN	reviewed	"Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]"	PARL PSARL PRO2207	Homo sapiens (Human)	379	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion transmembrane transport [GO:0006851]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006508; GO:0006851; GO:0010821; GO:0016021; GO:0030162; GO:0033619; GO:1903214; GO:2000377	membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion transmembrane transport [GO:0006851]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN1675_c0_g1_i1	Q9H300	PARL_HUMAN	50	282	126	3	148	975	98	370	1.20E-75	285	PARL_HUMAN	reviewed	"Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]"	PARL PSARL PRO2207	Homo sapiens (Human)	379	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion transmembrane transport [GO:0006851]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006508; GO:0006851; GO:0010821; GO:0016021; GO:0030162; GO:0033619; GO:1903214; GO:2000377	membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion transmembrane transport [GO:0006851]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN2337_c0_g1_i1	Q7ZVZ6	PREP_DANRE	49.4	988	476	6	240	3134	34	1020	2.40E-278	959.9	PREP_DANRE	reviewed	"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)"	pitrm1 zgc:55469	Danio rerio (Zebrafish) (Brachydanio rerio)	1023	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing [GO:0016485]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0016485; GO:0046872	protein processing [GO:0016485]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN27554_c0_g1_i1	Q5JRX3	PREP_HUMAN	100	68	0	0	2	205	867	934	2.00E-34	145.6	PREP_HUMAN	reviewed	"Presequence protease, mitochondrial (hPreP) (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) (Metalloprotease 1) (hMP1)"	PITRM1 KIAA1104 MP1 PREP	Homo sapiens (Human)	1037	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485	protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN26734_c0_g1_i1	Q5JRX3	PREP_HUMAN	100	94	0	0	282	1	182	275	4.20E-54	211.5	PREP_HUMAN	reviewed	"Presequence protease, mitochondrial (hPreP) (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) (Metalloprotease 1) (hMP1)"	PITRM1 KIAA1104 MP1 PREP	Homo sapiens (Human)	1037	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485	protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN35998_c0_g1_i1	Q5JRX3	PREP_HUMAN	100	107	0	0	3	323	72	178	5.90E-60	231.1	PREP_HUMAN	reviewed	"Presequence protease, mitochondrial (hPreP) (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) (Metalloprotease 1) (hMP1)"	PITRM1 KIAA1104 MP1 PREP	Homo sapiens (Human)	1037	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485	protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN847_c0_g1_i1	Q9NRD5	PICK1_HUMAN	64.1	370	129	1	259	1368	4	369	4.20E-134	479.6	PICK1_HUMAN	reviewed	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Homo sapiens (Human)	415	"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0016235; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090	"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN847_c0_g1_i10	Q9NRD5	PICK1_HUMAN	64.1	370	129	1	259	1368	4	369	4.20E-134	479.6	PICK1_HUMAN	reviewed	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Homo sapiens (Human)	415	"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0016235; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090	"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN847_c0_g1_i12	Q9NRD5	PICK1_HUMAN	64.1	370	129	1	259	1368	4	369	4.20E-134	479.6	PICK1_HUMAN	reviewed	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Homo sapiens (Human)	415	"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0016235; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090	"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN847_c0_g1_i13	Q9NRD5	PICK1_HUMAN	64.1	370	129	1	259	1368	4	369	4.20E-134	479.6	PICK1_HUMAN	reviewed	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Homo sapiens (Human)	415	"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0016235; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090	"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN847_c0_g1_i5	Q9NRD5	PICK1_HUMAN	61	213	83	0	2	640	157	369	3.30E-71	269.6	PICK1_HUMAN	reviewed	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Homo sapiens (Human)	415	"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0016235; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090	"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15258_c0_g1_i1	Q2T9M1	PICK1_BOVIN	55.2	67	30	0	201	1	155	221	7.20E-16	84	PICK1_BOVIN	reviewed	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Bos taurus (Bovine)	417	cytoskeleton [GO:0005856]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]	cytoskeleton [GO:0005856]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0002092; GO:0005856; GO:0014069; GO:0016020; GO:0019904; GO:0021782; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062	cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]		NA	NA	NA	NA	NA	NA
TRINITY_DN31756_c0_g1_i1	O43709	BUD23_HUMAN	99.6	249	1	0	1	747	33	281	4.10E-144	511.9	BUD23_HUMAN	reviewed	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)	BUD23 MERM1 WBSCR22 HUSSY-03 PP3381	Homo sapiens (Human)	281	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0016435; GO:0031167; GO:0046982; GO:0048471; GO:0070476; GO:2000234	chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN8968_c0_g2_i1	Q55DA6	BUD23_DICDI	57.3	75	31	1	1	225	146	219	1.20E-20	100.1	BUD23_DICDI	reviewed	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog)	DDB_G0269722	Dictyostelium discoideum (Slime mold)	287	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanine-N7)-methylation [GO:0070476]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0005654; GO:0005730; GO:0016435; GO:0048471; GO:0070476	rRNA (guanine-N7)-methylation [GO:0070476]		NA	NA	NA	NA	NA	NA
TRINITY_DN32423_c0_g1_i1	Q9CY21	BUD23_MOUSE	100	90	0	0	3	272	55	144	1.80E-49	196.1	BUD23_MOUSE	reviewed	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog) (rRNA methyltransferase and ribosome maturation factor)	Bud23 Wbscr22	Mus musculus (Mouse)	281	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0005654; GO:0005730; GO:0006325; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234	chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]		NA	NA	NA	NA	NA	NA
TRINITY_DN6513_c0_g1_i2	Q9CY21	BUD23_MOUSE	59.2	277	110	2	911	90	5	281	2.40E-90	333.6	BUD23_MOUSE	reviewed	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog) (rRNA methyltransferase and ribosome maturation factor)	Bud23 Wbscr22	Mus musculus (Mouse)	281	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0005654; GO:0005730; GO:0006325; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234	chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]		blue	blue	NA	NA	NA	NA
TRINITY_DN8968_c0_g1_i1	Q9CY21	BUD23_MOUSE	66.9	118	39	0	2	355	29	146	2.80E-42	172.6	BUD23_MOUSE	reviewed	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog) (rRNA methyltransferase and ribosome maturation factor)	Bud23 Wbscr22	Mus musculus (Mouse)	281	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0005654; GO:0005730; GO:0006325; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234	chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]		NA	NA	NA	NA	NA	NA
TRINITY_DN10270_c0_g1_i1	O61470	PSMD3_ANOGA	63.9	468	160	4	1486	95	34	496	4.30E-159	562.8	PSMD3_ANOGA	reviewed	Probable 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome subunit S3) (26S proteasome regulatory subunit RPN3) (Diphenol oxidase A2 component) (DOX-A2)	Dox-A2 AGAP009082	Anopheles gambiae (African malaria mosquito)	496	"proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0006511; GO:0008541; GO:0030234; GO:0042176	regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN10270_c0_g1_i3	O61470	PSMD3_ANOGA	63.9	468	160	4	1486	95	34	496	4.30E-159	562.8	PSMD3_ANOGA	reviewed	Probable 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome subunit S3) (26S proteasome regulatory subunit RPN3) (Diphenol oxidase A2 component) (DOX-A2)	Dox-A2 AGAP009082	Anopheles gambiae (African malaria mosquito)	496	"proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"proteasome regulatory particle, lid subcomplex [GO:0008541]"	enzyme regulator activity [GO:0030234]	GO:0006511; GO:0008541; GO:0030234; GO:0042176	regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN4643_c0_g1_i1	O17071	PRS10_CAEEL	65.5	287	99	0	873	13	118	404	3.30E-105	382.9	PRS10_CAEEL	reviewed	Probable 26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit rpt-4) (Proteasome regulatory particle ATPase-like protein 4)	rpt-4 F23F1.8	Caenorhabditis elegans	406	"cytosolic proteasome complex [GO:0031597]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]"	"cytosolic proteasome complex [GO:0031597]; nucleus [GO:0005634]; proteasome regulatory particle, base subcomplex [GO:0008540]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005634; GO:0008540; GO:0016887; GO:0030433; GO:0031597; GO:0031647; GO:0042802; GO:0043161; GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN588_c2_g1_i1	Q9V6Y3	RT16_DROME	61.6	125	44	1	444	82	5	129	1.80E-36	154.5	RT16_DROME	reviewed	"Probable 28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt)"	mRpS16 CG8338	Drosophila melanogaster (Fruit fly)	129	mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit [GO:0015935]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005763; GO:0006412; GO:0015935; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN1044_c0_g1_i1	Q9VY28	RT25_DROME	59.5	163	66	0	597	109	1	163	1.00E-57	224.6	RT25_DROME	reviewed	"Probable 28S ribosomal protein S25, mitochondrial (MRP-S25) (S25mt)"	mRpS25 CG14413	Drosophila melanogaster (Fruit fly)	167	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN8350_c0_g1_i1	Q9VVN2	RT26_DROME	34.9	209	131	3	102	713	15	223	1.60E-21	104.8	RT26_DROME	reviewed	"Probable 28S ribosomal protein S26, mitochondrial (MRP-S26) (S26mt)"	mRpS26 CG7354	Drosophila melanogaster (Fruit fly)	225	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005763; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN4199_c0_g1_i1	Q9VZD5	RT06_DROME	41.3	143	80	1	55	483	4	142	1.20E-32	141	RT06_DROME	reviewed	"Probable 28S ribosomal protein S6, mitochondrial (MRP-S6) (S6mt)"	mRpS6 CG15016	Drosophila melanogaster (Fruit fly)	147	mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial small ribosomal subunit [GO:0005763]	small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005763; GO:0006412; GO:0032543; GO:0070181	mitochondrial translation [GO:0032543]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN33047_c0_g1_i1	Q922K7	NOP2_MOUSE	68.3	82	26	0	15	260	337	418	5.60E-29	127.9	NOP2_MOUSE	reviewed	Probable 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)	Nop2 Nol1	Mus musculus (Mouse)	793	nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; blastocyst formation [GO:0001825]; maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	GO:0000027; GO:0000470; GO:0001510; GO:0001825; GO:0003723; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796	blastocyst formation [GO:0001825]; maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i3	Q9VA02	DHTK1_DROME	38.8	170	101	2	616	116	21	190	1.10E-30	135.2	DHTK1_DROME	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial (EC 1.2.4.2)"	CG1544	Drosophila melanogaster (Fruit fly)	919	mitochondrial membrane [GO:0031966]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrial membrane [GO:0031966]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN4930_c0_g1_i1	Q9VA02	DHTK1_DROME	64	356	128	0	1121	54	564	919	4.70E-133	475.7	DHTK1_DROME	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial (EC 1.2.4.2)"	CG1544	Drosophila melanogaster (Fruit fly)	919	mitochondrial membrane [GO:0031966]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrial membrane [GO:0031966]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN4930_c0_g1_i3	Q9VA02	DHTK1_DROME	67	318	105	0	1037	84	564	881	2.20E-124	446.8	DHTK1_DROME	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial (EC 1.2.4.2)"	CG1544	Drosophila melanogaster (Fruit fly)	919	mitochondrial membrane [GO:0031966]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrial membrane [GO:0031966]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i1	Q5R7H0	DHTK1_PONAB	50.8	482	231	3	1473	37	22	500	2.00E-143	510.8	DHTK1_PONAB	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	DHTKD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	919	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i10	Q5R7H0	DHTK1_PONAB	49.1	538	268	3	1607	3	22	556	1.30E-156	554.7	DHTK1_PONAB	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	DHTKD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	919	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i11	A2ATU0	DHTK1_MOUSE	69.8	53	16	0	248	90	214	266	4.10E-16	85.1	DHTK1_MOUSE	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	Dhtkd1 Kiaa1630	Mus musculus (Mouse)	921	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0002244; GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i6	Q5R7H0	DHTK1_PONAB	49.7	318	154	3	981	37	22	336	1.20E-83	311.6	DHTK1_PONAB	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	DHTKD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	919	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i7	Q4KLP0	DHTK1_RAT	54.3	289	132	0	869	3	268	556	2.60E-95	350.1	DHTK1_RAT	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	Dhtkd1	Rattus norvegicus (Rat)	920	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0002244; GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN17190_c0_g1_i8	Q5R7H0	DHTK1_PONAB	47.7	554	268	4	1655	3	22	556	4.70E-154	546.2	DHTK1_PONAB	reviewed	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	DHTKD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	919	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005739; GO:0006091; GO:0006096; GO:0006099; GO:0030976	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN18791_c2_g1_i1	Q84MB6	DIOX2_ARATH	40	90	51	2	304	38	210	297	1.60E-11	70.1	DIOX2_ARATH	reviewed	Probable 2-oxoglutarate-dependent dioxygenase At3g50210 (EC 1.14.11.-)	At3g50210 F11C1.50	Arabidopsis thaliana (Mouse-ear cress)	332	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN14445_c1_g1_i5	Q8H113	DIN11_ARATH	45.9	74	38	2	4	222	218	290	2.70E-11	69.3	DIN11_ARATH	reviewed	Probable 2-oxoglutarate-dependent dioxygenase DIN11 (EC 1.14.11.-) (Protein DARK-INDUCIBLE 11)	DIN11 At3g49620 T9C5.210	Arabidopsis thaliana (Mouse-ear cress)	357	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0046872; GO:0051213			NA	NA	NA	NA	NA	NA
TRINITY_DN12626_c0_g1_i1	P91119	PDE5_CAEEL	63.6	121	44	0	363	1	461	581	8.10E-42	171	PDE5_CAEEL	reviewed	"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)"	pde-5 C32E12.2	Caenorhabditis elegans	728	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004118; GO:0006935; GO:0007165; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555	chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN6549_c0_g1_i1	P91119	PDE5_CAEEL	62.5	80	30	0	248	9	577	656	8.80E-24	110.5	PDE5_CAEEL	reviewed	"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)"	pde-5 C32E12.2	Caenorhabditis elegans	728	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]"		"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004118; GO:0006935; GO:0007165; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555	chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN4616_c0_g1_i1	Q5TUE9	RM23_ANOGA	57.1	126	54	0	387	10	1	126	1.40E-35	150.6	RM23_ANOGA	reviewed	"Probable 39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23)"	mRpL23 AGAP010338	Anopheles gambiae (African malaria mosquito)	151	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN25644_c0_g1_i1	Q29MA5	RM24_DROPS	60.2	186	74	0	560	3	58	243	6.80E-64	245	RM24_DROPS	reviewed	"Probable 39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24)"	mRpL24 GA21365	Drosophila pseudoobscura pseudoobscura (Fruit fly)	247	mitochondrial large ribosomal subunit [GO:0005762]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005762; GO:0006412	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN25644_c0_g1_i2	Q9VMY1	RM24_DROME	56.3	103	45	0	374	66	58	160	3.50E-32	139	RM24_DROME	reviewed	"Probable 39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24)"	mRpL24 CG8849	Drosophila melanogaster (Fruit fly)	247	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543	mitochondrial translation [GO:0032543]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN3211_c0_g1_i1	Q9VCX3	RM45_DROME	53.3	306	122	4	966	97	61	361	3.70E-87	323.2	RM45_DROME	reviewed	"Probable 39S ribosomal protein L45, mitochondrial (L45mt) (MRP-L45)"	mRpL45 CG6949	Drosophila melanogaster (Fruit fly)	361	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005762; GO:0032543	mitochondrial translation [GO:0032543]		blue	blue	NA	NA	NA	NA
TRINITY_DN188_c0_g1_i1	P34439	HCDH1_CAEEL	56.1	82	36	0	332	87	216	297	1.10E-22	107.5	HCDH1_CAEEL	reviewed	Probable 3-hydroxyacyl-CoA dehydrogenase F54C8.1 (EC 1.1.1.35)	F54C8.1	Caenorhabditis elegans	298	mitochondrial matrix [GO:0005759]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]	GO:0003857; GO:0005759; GO:0006635; GO:0070403	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN37945_c0_g1_i1	Q9V8M5	3HIDH_DROME	51.7	58	28	0	185	12	204	261	6.00E-10	64.3	3HIDH_DROME	reviewed	"Probable 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)"	CG15093	Drosophila melanogaster (Fruit fly)	324	"mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; cellular amino acid metabolic process [GO:0006520]; valine catabolic process [GO:0006574]"	mitochondrion [GO:0005739]	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0006520; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287	cellular amino acid metabolic process [GO:0006520]; valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN28462_c0_g1_i1	Q1PEY5	HIBC2_ARATH	49.3	67	34	0	206	6	108	174	3.60E-11	68.6	HIBC2_ARATH	reviewed	Probable 3-hydroxyisobutyryl-CoA hydrolase 2 (EC 3.1.2.4)	At2g30650 T11J7.4	Arabidopsis thaliana (Mouse-ear cress)	378	peroxisome [GO:0005777]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]	peroxisome [GO:0005777]	3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]	GO:0003860; GO:0005777; GO:0006574	valine catabolic process [GO:0006574]		NA	NA	NA	NA	NA	NA
TRINITY_DN27804_c0_g1_i1	Q54P77	4CL1_DICDI	39.6	96	53	1	302	15	199	289	3.60E-14	79.3	4CL1_DICDI	reviewed	Probable 4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1)	4cl1 DDB_G0284831	Dictyostelium discoideum (Slime mold)	551	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009698; GO:0016207; GO:0016405	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN8430_c0_g1_i2	Q54P77	4CL1_DICDI	37.2	545	314	10	1686	100	12	544	3.60E-93	344	4CL1_DICDI	reviewed	Probable 4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1)	4cl1 DDB_G0284831	Dictyostelium discoideum (Slime mold)	551	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009698; GO:0016207; GO:0016405	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN7470_c0_g1_i1	Q54P79	4CL3_DICDI	45.2	250	135	2	3	746	295	544	1.50E-54	214.5	4CL3_DICDI	reviewed	Probable 4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3)	4cl3 DDB_G0284743	Dictyostelium discoideum (Slime mold)	551	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009698; GO:0016207; GO:0016405	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN32653_c0_g1_i1	Q54P79	4CL3_DICDI	35.1	111	72	0	52	384	241	351	1.30E-13	77.4	4CL3_DICDI	reviewed	Probable 4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3)	4cl3 DDB_G0284743	Dictyostelium discoideum (Slime mold)	551	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; phenylpropanoid metabolic process [GO:0009698]		4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]	GO:0005524; GO:0009698; GO:0016207; GO:0016405	phenylpropanoid metabolic process [GO:0009698]		NA	NA	NA	NA	NA	NA
TRINITY_DN34644_c0_g1_i1	Q86AD9	THIL1_DICDI	51.5	68	33	0	3	206	239	306	1.00E-12	73.6	THIL1_DICDI	reviewed	Probable acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)	DDB_G0271544	Dictyostelium discoideum (Slime mold)	414	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]; ergosterol biosynthetic process [GO:0006696]; fatty acid beta-oxidation [GO:0006635]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]	GO:0003985; GO:0003988; GO:0005739; GO:0005777; GO:0005829; GO:0006635; GO:0006696; GO:0046872	ergosterol biosynthetic process [GO:0006696]; fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN27564_c0_g1_i1	P58798	ARPC4_CAEEL	50.8	120	59	0	360	1	35	154	8.20E-26	117.9	ARPC4_CAEEL	reviewed	Probable actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)	arx-6 C35D10.16	Caenorhabditis elegans	169	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; epithelial cell migration [GO:0010631]; morphogenesis of embryonic epithelium [GO:0016331]	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005885; GO:0010631; GO:0016331; GO:0030041; GO:0034314	actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; epithelial cell migration [GO:0010631]; morphogenesis of embryonic epithelium [GO:0016331]		NA	NA	NA	NA	NA	NA
TRINITY_DN7953_c0_g1_i1	P34275	IVD_CAEEL	54.5	198	90	0	9	602	201	398	5.50E-55	215.7	IVD_CAEEL	reviewed	Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)	acdh-6 C02D5.1	Caenorhabditis elegans	408	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]		flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN37014_c0_g1_i1	P34275	IVD_CAEEL	62.7	83	30	1	246	1	177	259	4.70E-25	114.8	IVD_CAEEL	reviewed	Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)	acdh-6 C02D5.1	Caenorhabditis elegans	408	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]		flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN38870_c0_g1_i1	P34275	IVD_CAEEL	59.1	110	45	0	2	331	87	196	1.50E-32	140.2	IVD_CAEEL	reviewed	Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)	acdh-6 C02D5.1	Caenorhabditis elegans	408	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]		flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN4630_c0_g1_i1	P34275	IVD_CAEEL	56.3	277	120	1	949	122	122	398	2.80E-87	323.6	IVD_CAEEL	reviewed	Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)	acdh-6 C02D5.1	Caenorhabditis elegans	408	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]		flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN4630_c0_g1_i2	P34275	IVD_CAEEL	56.1	319	139	1	1075	122	80	398	9.30E-102	371.7	IVD_CAEEL	reviewed	Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)	acdh-6 C02D5.1	Caenorhabditis elegans	408	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]		flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		blue	blue	NA	NA	NA	NA
TRINITY_DN4630_c0_g1_i3	P34275	IVD_CAEEL	56.3	277	120	1	949	122	122	398	2.90E-87	323.6	IVD_CAEEL	reviewed	Probable acyl-CoA dehydrogenase 6 (Probable isovaleryl-CoA dehydrogenase) (IVD) (EC 1.3.8.4)	acdh-6 C02D5.1	Caenorhabditis elegans	408	flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]		flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0006552; GO:0008470; GO:0050660	leucine catabolic process [GO:0006552]		NA	NA	NA	NA	NA	NA
TRINITY_DN34095_c0_g1_i1	P63428	ACDP_MYCBO	72.5	80	22	0	240	1	212	291	1.00E-29	130.2	ACDP_MYCBO	reviewed	Probable acyl-CoA dehydrogenase fadE25 (EC 1.3.99.-)	fadE25 acd BQ2027_MB3302C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	389	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]		acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN33288_c0_g1_i1	P63428	ACDP_MYCBO	63.5	74	24	2	219	1	123	194	5.40E-17	87.8	ACDP_MYCBO	reviewed	Probable acyl-CoA dehydrogenase fadE25 (EC 1.3.99.-)	fadE25 acd BQ2027_MB3302C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	389	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]		acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN29049_c0_g1_i1	Q86S40	ADPGK_CAEEL	28.5	221	148	7	727	80	274	489	1.60E-12	74.7	ADPGK_CAEEL	reviewed	Probable ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147)	C50D2.7	Caenorhabditis elegans	502	extracellular region [GO:0005576]; ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872]; glycolytic process [GO:0006096]	extracellular region [GO:0005576]	ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872]	GO:0005576; GO:0006096; GO:0043843; GO:0046872	glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN39389_c0_g1_i1	Q0WQQ1	AGD15_ARATH	60	65	26	0	27	221	36	100	2.50E-17	89	AGD15_ARATH	reviewed	Probable ADP-ribosylation factor GTPase-activating protein AGD15 (ARF GAP AGD15) (Protein ARF-GAP DOMAIN 15) (AtAGD15)	AGD15 At3g17660 MKP6.22	Arabidopsis thaliana (Mouse-ear cress)	232	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]		GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN25668_c0_g1_i1	Q8H100	AGD8_ARATH	55.1	78	35	0	241	8	20	97	3.40E-23	108.6	AGD8_ARATH	reviewed	Probable ADP-ribosylation factor GTPase-activating protein AGD8 (ARF GAP AGD8) (Protein ARF-GAP DOMAIN 8) (AtAGD8)	AGD8 At4g17890 T6K21.1	Arabidopsis thaliana (Mouse-ear cress)	413	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0005829; GO:0046872; GO:0048205	COPI coating of Golgi vesicle [GO:0048205]		NA	NA	NA	NA	NA	NA
TRINITY_DN30216_c0_g1_i1	Q9FIQ0	AGD9_ARATH	50	80	38	1	242	3	6	83	6.40E-19	94.4	AGD9_ARATH	reviewed	Probable ADP-ribosylation factor GTPase-activating protein AGD9 (ARF GAP AGD9) (Protein ARF-GAP DOMAIN 9) (AtAGD9)	AGD9 At5g46750 MZA15.17	Arabidopsis thaliana (Mouse-ear cress)	402	Golgi membrane [GO:0000139]; plastid [GO:0009536]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; response to abscisic acid [GO:0009737]	Golgi membrane [GO:0000139]; plastid [GO:0009536]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0009536; GO:0009737; GO:0046872; GO:0048205	COPI coating of Golgi vesicle [GO:0048205]; response to abscisic acid [GO:0009737]		NA	NA	NA	NA	NA	NA
TRINITY_DN28762_c0_g1_i1	Q54MJ7	ALAM_DICDI	50	68	34	0	2	205	466	533	9.30E-17	87	ALAM_DICDI	reviewed	"Probable alanine aminotransferase, mitochondrial (ALT) (EC 2.6.1.2) (Glutamate pyruvate transaminase) (GPT) (Glutamic--alanine transaminase) (Glutamic--pyruvic transaminase)"	gpt DDB_G0285899	Dictyostelium discoideum (Slime mold)	534	mitochondrial matrix [GO:0005759]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]	mitochondrial matrix [GO:0005759]	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0005759; GO:0009058; GO:0030170; GO:0042853	biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]		NA	NA	NA	NA	NA	NA
TRINITY_DN15278_c0_g1_i1	Q7XH05	ALDO1_ORYSJ	50	62	29	2	208	23	1198	1257	7.60E-08	57.4	ALDO1_ORYSJ	reviewed	Probable aldehyde oxidase 1 (AO-1) (EC 1.2.3.1)	Os10g0138100 LOC_Os10g04860 OsJ_30665 OSJNAa0087H07.7	Oryza sativa subsp. japonica (Rice)	1358	"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]"	GO:0004031; GO:0005506; GO:0009055; GO:0009688; GO:0009851; GO:0051537; GO:0071949; GO:0102797; GO:0102798	abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]		NA	NA	NA	NA	NA	NA
TRINITY_DN19333_c0_g1_i1	B2UG65	ALLC_RALPJ	99	101	1	0	1	303	27	127	3.30E-57	221.9	ALLC_RALPJ	reviewed	Probable allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	alc Rpic_3472	Ralstonia pickettii (strain 12J)	336	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN19333_c0_g1_i2	B2UG65	ALLC_RALPJ	100	101	0	0	1	303	27	127	2.00E-57	222.6	ALLC_RALPJ	reviewed	Probable allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	alc Rpic_3472	Ralstonia pickettii (strain 12J)	336	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037; GO:0006144	allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]		NA	NA	NA	NA	NA	NA
TRINITY_DN7698_c0_g1_i1	Q8N6M5	ALLC_HUMAN	51.6	91	44	0	3	275	39	129	3.20E-22	105.5	ALLC_HUMAN	reviewed	Probable allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	ALLC	Homo sapiens (Human)	391	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]		allantoicase activity [GO:0004037]	GO:0000256; GO:0004037	allantoin catabolic process [GO:0000256]		NA	NA	NA	NA	NA	NA
TRINITY_DN29256_c0_g1_i1	Q9Z3R8	AGLA_RHIME	75.8	66	16	0	51	248	14	79	4.30E-26	118.2	AGLA_RHIME	reviewed	Probable alpha-glucosidase (EC 3.2.1.20)	aglA R00698 SMc03064	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	551	maltose alpha-glucosidase activity [GO:0032450]		maltose alpha-glucosidase activity [GO:0032450]	GO:0032450			NA	NA	NA	NA	NA	NA
TRINITY_DN30137_c0_g1_i1	Q8NDH3	PEPL1_HUMAN	62.1	522	196	2	1594	35	1	522	3.70E-185	649.4	PEPL1_HUMAN	reviewed	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	NPEPL1 KIAA1974	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005634; GO:0005737; GO:0030145; GO:0070006			blue	blue	NA	NA	NA	NA
TRINITY_DN24529_c0_g1_i1	Q6NSR8	PEPL1_MOUSE	100	124	0	0	1	372	359	482	1.40E-68	260	PEPL1_MOUSE	reviewed	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	Npepl1	Mus musculus (Mouse)	524	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN32729_c0_g1_i1	Q6NSR8	PEPL1_MOUSE	100	185	0	0	556	2	174	358	5.10E-104	378.3	PEPL1_MOUSE	reviewed	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	Npepl1	Mus musculus (Mouse)	524	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN32309_c0_g1_i1	Q8NDH3	PEPL1_HUMAN	57.1	56	22	1	172	5	256	309	8.10E-10	63.9	PEPL1_HUMAN	reviewed	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	NPEPL1 KIAA1974	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005634; GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN32508_c0_g1_i1	Q8NDH3	PEPL1_HUMAN	100	97	0	0	291	1	229	325	2.60E-51	202.2	PEPL1_HUMAN	reviewed	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	NPEPL1 KIAA1974	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005634; GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN30013_c0_g1_i1	Q8NDH3	PEPL1_HUMAN	64.2	81	29	0	8	250	312	392	1.50E-21	103.2	PEPL1_HUMAN	reviewed	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	NPEPL1 KIAA1974	Homo sapiens (Human)	523	cytoplasm [GO:0005737]; nucleus [GO:0005634]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005634; GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN838_c0_g1_i4	Q9LQ10	1A110_ARATH	29.7	185	121	2	222	758	160	341	4.00E-20	100.1	1A110_ARATH	reviewed	Probable aminotransferase ACS10 (EC 2.6.1.-)	ACS10 At1g62960 F16P17.11	Arabidopsis thaliana (Mouse-ear cress)	557	pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 1-aminocyclopropane-1-carboxylate biosynthetic process [GO:0042218]		pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0008483; GO:0030170; GO:0042218	1-aminocyclopropane-1-carboxylate biosynthetic process [GO:0042218]		NA	NA	NA	NA	NA	NA
TRINITY_DN5418_c0_g1_i2	Q3E9A0	ANTR6_ARATH	37.7	61	36	1	157	339	430	488	1.50E-05	50.4	ANTR6_ARATH	reviewed	"Probable anion transporter 6, chloroplastic (Phosphate transporter PHT4;5)"	ANTR6 PHT4;5 At5g20380 F5O24.270	Arabidopsis thaliana (Mouse-ear cress)	517	chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; plastid [GO:0009536]; inorganic phosphate transmembrane transporter activity [GO:0005315]; defense response [GO:0006952]	chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; plastid [GO:0009536]	inorganic phosphate transmembrane transporter activity [GO:0005315]	GO:0005315; GO:0006952; GO:0009536; GO:0016021; GO:0031969	defense response [GO:0006952]		NA	NA	NA	NA	NA	NA
TRINITY_DN5418_c0_g1_i3	Q3E9A0	ANTR6_ARATH	42.6	61	33	1	157	339	430	488	2.10E-07	56.6	ANTR6_ARATH	reviewed	"Probable anion transporter 6, chloroplastic (Phosphate transporter PHT4;5)"	ANTR6 PHT4;5 At5g20380 F5O24.270	Arabidopsis thaliana (Mouse-ear cress)	517	chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; plastid [GO:0009536]; inorganic phosphate transmembrane transporter activity [GO:0005315]; defense response [GO:0006952]	chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; plastid [GO:0009536]	inorganic phosphate transmembrane transporter activity [GO:0005315]	GO:0005315; GO:0006952; GO:0009536; GO:0016021; GO:0031969	defense response [GO:0006952]		NA	NA	NA	NA	NA	NA
TRINITY_DN5418_c0_g1_i4	Q3E9A0	ANTR6_ARATH	47.8	46	24	0	157	294	430	475	1.60E-06	53.5	ANTR6_ARATH	reviewed	"Probable anion transporter 6, chloroplastic (Phosphate transporter PHT4;5)"	ANTR6 PHT4;5 At5g20380 F5O24.270	Arabidopsis thaliana (Mouse-ear cress)	517	chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; plastid [GO:0009536]; inorganic phosphate transmembrane transporter activity [GO:0005315]; defense response [GO:0006952]	chloroplast membrane [GO:0031969]; integral component of membrane [GO:0016021]; plastid [GO:0009536]	inorganic phosphate transmembrane transporter activity [GO:0005315]	GO:0005315; GO:0006952; GO:0009536; GO:0016021; GO:0031969	defense response [GO:0006952]		NA	NA	NA	NA	NA	NA
TRINITY_DN36186_c0_g1_i1	Q9VXN4	SYRC_DROME	62.3	122	46	0	380	15	183	304	3.00E-39	162.5	SYRC_DROME	reviewed	"Probable arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase)"	ArgRS Aats-arg CG9020	Drosophila melanogaster (Fruit fly)	665	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005737; GO:0005829; GO:0006420; GO:0017101	arginyl-tRNA aminoacylation [GO:0006420]		NA	NA	NA	NA	NA	NA
TRINITY_DN961_c0_g1_i1	Q0P5H7	SYRM_BOVIN	42.7	483	268	5	1517	81	101	578	6.50E-101	369.4	SYRM_BOVIN	reviewed	"Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	RARS2 RARSL	Bos taurus (Bovine)	578	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006420; GO:0032543	arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN961_c0_g1_i5	Q0P5H7	SYRM_BOVIN	37	557	268	5	1739	81	101	578	2.20E-92	341.3	SYRM_BOVIN	reviewed	"Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	RARS2 RARSL	Bos taurus (Bovine)	578	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]	GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006420; GO:0032543	arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]		brown	brown	NA	NA	NA	NA
TRINITY_DN6029_c0_g1_i1	B7XHQ4	SYDC_ENTBH	65.3	118	41	0	7	360	357	474	9.50E-43	174.1	SYDC_ENTBH	reviewed	"Probable aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	EBI_21705	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	474	cytoplasm [GO:0005737]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; aspartyl-tRNA aminoacylation [GO:0006422]	cytoplasm [GO:0005737]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]	GO:0004815; GO:0005524; GO:0005737; GO:0006422	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN36953_c0_g1_i1	B7XHQ4	SYDC_ENTBH	64.4	149	53	0	449	3	148	296	3.10E-51	202.6	SYDC_ENTBH	reviewed	"Probable aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	EBI_21705	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	474	cytoplasm [GO:0005737]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; aspartyl-tRNA aminoacylation [GO:0006422]	cytoplasm [GO:0005737]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]	GO:0004815; GO:0005524; GO:0005737; GO:0006422	aspartyl-tRNA aminoacylation [GO:0006422]		NA	NA	NA	NA	NA	NA
TRINITY_DN3616_c0_g1_i1	Q1MTN8	ACL4_SCHPO	28.7	404	197	11	1215	67	2	335	1.20E-26	122.5	ACL4_SCHPO	reviewed	Probable assembly chaperone of rpl4	SPBC16D10.01c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	336	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN38036_c0_g1_i1	P0A9U5	YBIT_ECO57	68	75	24	0	235	11	437	511	2.00E-25	115.9	YBIT_ECO57	reviewed	Probable ATP-binding protein YbiT	ybiT Z1042 ECs0897	Escherichia coli O157:H7	530	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN28159_c0_g1_i1	P0A9U5	YBIT_ECO57	82.2	107	19	0	3	323	145	251	1.20E-47	190.3	YBIT_ECO57	reviewed	Probable ATP-binding protein YbiT	ybiT Z1042 ECs0897	Escherichia coli O157:H7	530	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN36655_c0_g1_i1	P63390	YHES_ECO57	62.1	66	25	0	13	210	145	210	8.60E-20	97.1	YHES_ECO57	reviewed	Probable ATP-binding protein YheS	yheS Z4713 ECs4203	Escherichia coli O157:H7	637	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN29322_c0_g1_i1	P44808	Y658_HAEIN	80.6	72	14	0	216	1	152	223	1.20E-29	129.8	YHES_HAEIN	reviewed	Probable ATP-binding protein YheS	yheS HI_0658	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	638	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN5347_c0_g1_i1	P63390	YHES_ECO57	53	66	31	0	5	202	415	480	4.40E-13	74.7	YHES_ECO57	reviewed	Probable ATP-binding protein YheS	yheS Z4713 ECs4203	Escherichia coli O157:H7	637	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN25827_c0_g1_i1	P63390	YHES_ECO57	48.5	68	35	0	6	209	147	214	2.00E-16	85.9	YHES_ECO57	reviewed	Probable ATP-binding protein YheS	yheS Z4713 ECs4203	Escherichia coli O157:H7	637	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN2539_c0_g1_i1	Q86B47	Y8611_DROME	63	73	27	0	219	1	348	420	2.10E-20	99.4	Y8611_DROME	reviewed	Probable ATP-dependent RNA helicase CG8611 (EC 3.6.4.13)	CG8611	Drosophila melanogaster (Fruit fly)	975	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN35378_c0_g1_i1	Q55CP6	DDX1_DICDI	77.8	72	16	0	264	49	1	72	2.30E-25	115.9	DDX1_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx1 (EC 3.6.4.13) (DEAD box protein 1)	ddx1 DDB_G0269966	Dictyostelium discoideum (Slime mold)	765	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]	nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0003682; GO:0003712; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0008143; GO:0032508; GO:0033677	DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]		NA	NA	NA	NA	NA	NA
TRINITY_DN33164_c0_g1_i1	Q13206	DDX10_HUMAN	98.9	89	1	0	1	267	167	255	7.50E-45	180.6	DDX10_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10)	DDX10	Homo sapiens (Human)	875	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; anterior head development [GO:0097065]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0097065	anterior head development [GO:0097065]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1726_c0_g1_i1	Q5ZJF6	DDX10_CHICK	43.3	723	330	6	2024	78	22	738	7.80E-153	542.3	DDX10_CHICK	reviewed	Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10)	DDX10 RCJMB04_18j24	Gallus gallus (Chicken)	875	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN11776_c0_g1_i1	Q54CE0	DDX17_DICDI	53.6	97	45	0	316	26	484	580	1.90E-26	119.8	DDX17_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx17 (EC 3.6.4.13) (DEAD box protein 17)	ddx17 DDB_G0293168	Dictyostelium discoideum (Slime mold)	785	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:1990904	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15757_c0_g2_i1	Q92841	DDX17_HUMAN	100	141	0	0	1	423	282	422	2.00E-76	286.2	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39306_c0_g1_i1	Q92841	DDX17_HUMAN	47.6	82	38	1	248	18	179	260	8.30E-14	77.4	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c5_g1_i1	Q92841	DDX17_HUMAN	48.9	45	23	0	135	1	405	449	1.20E-05	50.1	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c0_g1_i1	Q92841	DDX17_HUMAN	60.4	139	23	1	421	5	442	548	2.10E-41	169.9	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c0_g1_i3	Q92841	DDX17_HUMAN	76.1	276	66	0	905	78	167	442	2.50E-124	446.4	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c0_g1_i4	Q92841	DDX17_HUMAN	77.5	382	86	0	1150	5	167	548	4.10E-180	632.1	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c0_g1_i5	Q92841	DDX17_HUMAN	76.7	382	89	0	1150	5	167	548	3.80E-178	625.5	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		blue	blue	NA	NA	NA	NA
TRINITY_DN11012_c0_g1_i6	Q92841	DDX17_HUMAN	78.2	317	69	0	1021	71	167	483	3.00E-150	532.7	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11012_c0_g1_i8	Q92841	DDX17_HUMAN	74.7	79	20	0	307	71	405	483	2.50E-30	132.9	DDX17_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Homo sapiens (Human)	729	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13598_c0_g2_i1	Q9BUQ8	DDX23_HUMAN	65.5	145	49	1	442	11	664	808	3.70E-49	195.7	DDX23_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)	DDX23	Homo sapiens (Human)	820	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0046540; GO:0062176; GO:0070062; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1931_c0_g1_i1	Q9BUQ8	DDX23_HUMAN	79.4	383	78	1	1230	85	438	820	6.50E-176	618.2	DDX23_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)	DDX23	Homo sapiens (Human)	820	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0046540; GO:0062176; GO:0070062; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33481_c0_g1_i1	Q9BUQ8	DDX23_HUMAN	100	277	0	0	918	88	544	820	1.20E-156	553.9	DDX23_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)	DDX23	Homo sapiens (Human)	820	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0046540; GO:0062176; GO:0070062; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33481_c0_g1_i1	Q9BUQ8	DDX23_HUMAN	95.7	23	1	0	988	920	520	542	2.20E-04	48.1	DDX23_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)	DDX23	Homo sapiens (Human)	820	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0046540; GO:0062176; GO:0070062; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2876_c0_g2_i1	Q5RC67	DDX23_PONAB	61.4	220	85	0	663	4	243	462	1.40E-75	284.3	DDX23_PONAB	reviewed	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (DEAD box protein 23)	DDX23	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	820	chromatin [GO:0000785]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]	chromatin [GO:0000785]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0000785; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0062176	mRNA processing [GO:0006397]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN33756_c0_g1_i1	Q5RC67	DDX23_PONAB	91.7	145	12	0	437	3	266	410	9.60E-74	277.3	DDX23_PONAB	reviewed	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (DEAD box protein 23)	DDX23	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	820	chromatin [GO:0000785]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]	chromatin [GO:0000785]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0000785; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0062176	mRNA processing [GO:0006397]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24035_c0_g1_i1	Q54TJ4	DDX27_DICDI	55	109	49	0	2	328	277	385	2.10E-28	126.3	DDX27_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx27 (EC 3.6.4.13) (DEAD box protein 27)	ddx27 DDB_G0281711	Dictyostelium discoideum (Slime mold)	783	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31873_c0_g1_i1	Q54TJ4	DDX27_DICDI	66.1	59	20	0	6	182	194	252	7.60E-15	80.9	DDX27_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx27 (EC 3.6.4.13) (DEAD box protein 27)	ddx27 DDB_G0281711	Dictyostelium discoideum (Slime mold)	783	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN8663_c0_g1_i1	Q921N6	DDX27_MOUSE	62.9	210	78	0	630	1	175	384	2.20E-71	270.4	DDX27_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	Ddx27	Mus musculus (Mouse)	760	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN8663_c0_g1_i2	Q921N6	DDX27_MOUSE	63.3	210	77	0	630	1	175	384	7.20E-72	271.9	DDX27_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	Ddx27	Mus musculus (Mouse)	760	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN27267_c0_g1_i1	Q96GQ7	DDX27_HUMAN	96.9	130	4	0	2	391	459	588	3.50E-59	228.8	DDX27_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	DDX27 cPERP-F RHLP HSPC259 PP3241	Homo sapiens (Human)	796	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN17568_c0_g1_i1	Q96GQ7	DDX27_HUMAN	41.8	280	157	2	6	836	467	743	3.40E-43	176.8	DDX27_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	DDX27 cPERP-F RHLP HSPC259 PP3241	Homo sapiens (Human)	796	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN30518_c0_g1_i1	Q96GQ7	DDX27_HUMAN	100	146	0	0	440	3	257	402	1.50E-77	290	DDX27_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	DDX27 cPERP-F RHLP HSPC259 PP3241	Homo sapiens (Human)	796	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN28607_c0_g1_i1	Q54QS3	DDX3_DICDI	38.5	78	48	0	2	235	559	636	5.40E-15	81.3	DDX3_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx3 (EC 3.6.4.13) (DEAD box protein 3)	ddx3 DDB_G0283661	Dictyostelium discoideum (Slime mold)	712	nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0005634; GO:0043186			NA	NA	NA	NA	NA	NA
TRINITY_DN36268_c0_g1_i1	Q869P0	DDX31_DICDI	51.7	89	43	0	286	20	606	694	8.80E-23	107.5	DDX31_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx31 (EC 3.6.4.13) (DEAD box protein 31)	ddx31 DDB_G0271708	Dictyostelium discoideum (Slime mold)	908	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN12581_c0_g1_i1	Q9H8H2	DDX31_HUMAN	58.8	85	35	0	12	266	555	639	3.80E-25	115.2	DDX31_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX31 (EC 3.6.4.13) (DEAD box protein 31) (Helicain)	DDX31	Homo sapiens (Human)	851	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0042254; GO:0043231	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN24556_c0_g2_i1	Q3MSQ8	DDX4_PELLE	49.4	87	44	0	261	1	568	654	2.10E-20	99.4	DDX4_PELLE	reviewed	Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog)	ddx4 vlg	Pelophylax lessonae (Pool frog) (Rana lessonae)	724	pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	pi-body [GO:0071546]; piP-body [GO:0071547]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007141; GO:0007275; GO:0007283; GO:0010529; GO:0016887; GO:0031047; GO:0034587; GO:0043046; GO:0048477; GO:0071546; GO:0071547; GO:1990511	DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6211_c0_g2_i1	Q91VN6	DDX41_MOUSE	62.3	302	111	1	3	908	142	440	2.90E-104	379.8	DDX41_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41)	Ddx41	Mus musculus (Mouse)	622	"catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005783; GO:0008283; GO:0030154; GO:0035458; GO:0045944; GO:0046872; GO:0051607; GO:0071013	"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23219_c0_g1_i1	Q9UJV9	DDX41_HUMAN	100	422	0	0	2	1267	146	567	7.50E-244	844	DDX41_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) (DEAD box protein abstrakt homolog)	DDX41 ABS	Homo sapiens (Human)	622	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005783; GO:0005829; GO:0006915; GO:0008283; GO:0016020; GO:0030154; GO:0032481; GO:0035458; GO:0045944; GO:0046872; GO:0051607; GO:0071013	"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10214_c0_g1_i1	Q4TVV3	DDX46_DANRE	61.9	699	240	7	2137	89	198	886	3.50E-242	839.3	DDX46_DANRE	reviewed	Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46)	ddx46	Danio rerio (Zebrafish) (Brachydanio rerio)	1018	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621]"	Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007420; GO:0015030; GO:0016607; GO:0031017; GO:0045621; GO:0045648; GO:0048546; GO:0060216; GO:0072576; GO:1902038	"brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32728_c0_g1_i1	Q7L014	DDX46_HUMAN	70.2	84	24	1	3	254	949	1031	4.70E-25	115.2	DDX46_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog)	DDX46 KIAA0801	Homo sapiens (Human)	1031	"Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0015030; GO:0016020; GO:0016607	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10214_c0_g1_i2	Q7L014	DDX46_HUMAN	59.8	82	33	0	331	86	749	830	1.50E-19	97.1	DDX46_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog)	DDX46 KIAA0801	Homo sapiens (Human)	1031	"Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0015030; GO:0016020; GO:0016607	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36036_c0_g1_i1	Q7L014	DDX46_HUMAN	100	91	0	0	273	1	364	454	1.50E-48	193	DDX46_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog)	DDX46 KIAA0801	Homo sapiens (Human)	1031	"Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0015030; GO:0016020; GO:0016607	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN90_c2_g1_i1	Q9CWX9	DDX47_MOUSE	67.1	407	130	1	1266	46	18	420	2.10E-153	543.5	DDX47_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)	Ddx47	Mus musculus (Mouse)	455	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN23364_c0_g1_i1	Q9H0S4	DDX47_HUMAN	98.7	231	3	0	3	695	24	254	2.40E-122	439.5	DDX47_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)	DDX47	Homo sapiens (Human)	455	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016020	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN7416_c0_g1_i1	Q9CWX9	DDX47_MOUSE	65.4	133	45	1	399	1	282	413	2.00E-41	169.9	DDX47_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)	Ddx47	Mus musculus (Mouse)	455	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN30882_c0_g1_i1	Q9H0S4	DDX47_HUMAN	100	146	0	0	2	439	265	410	2.20E-78	292.7	DDX47_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)	DDX47	Homo sapiens (Human)	455	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016020	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN33998_c0_g1_i1	Q29S22	DDX47_BOVIN	100	75	0	0	1	225	301	375	1.20E-35	149.8	DDX47_BOVIN	reviewed	Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)	DDX47	Bos taurus (Bovine)	457	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN40355_c0_g1_i1	Q9Y6V7	DDX49_HUMAN	98.1	107	2	0	1	321	14	120	3.30E-55	215.3	DDX49_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49)	DDX49	Homo sapiens (Human)	483	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364; GO:0030307; GO:0044357	positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1931_c1_g1_i2	Q4FZF3	DDX49_MOUSE	56.6	419	176	4	1313	69	8	424	5.00E-122	439.5	DDX49_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49)	Ddx49	Mus musculus (Mouse)	480	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0030307; GO:0044357	positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN24382_c0_g1_i1	Q9Y6V7	DDX49_HUMAN	100	78	0	0	236	3	279	356	5.10E-37	154.5	DDX49_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49)	DDX49	Homo sapiens (Human)	483	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364; GO:0030307; GO:0044357	positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN29786_c0_g1_i1	Q9Y6V7	DDX49_HUMAN	100	90	0	0	3	272	281	370	1.40E-43	176.4	DDX49_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49)	DDX49	Homo sapiens (Human)	483	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364; GO:0030307; GO:0044357	positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN15757_c0_g1_i1	P17844	DDX5_HUMAN	100	52	0	0	51	206	406	457	1.60E-23	109.4	DDX5_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)	DDX5 G17P1 HELR HLR1	Homo sapiens (Human)	614	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0009299; GO:0016020; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15757_c0_g1_i2	P17844	DDX5_HUMAN	100	353	0	0	3	1061	105	457	3.60E-207	721.8	DDX5_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)	DDX5 G17P1 HELR HLR1	Homo sapiens (Human)	614	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0009299; GO:0016020; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27608_c0_g1_i1	Q9Y2R4	DDX52_HUMAN	100	110	0	0	3	332	437	546	4.60E-60	231.5	DDX52_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)	DDX52 ROK1 HUSSY-19	Homo sapiens (Human)	599	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0030490	maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN28650_c0_g1_i1	Q9Y2R4	DDX52_HUMAN	56.3	158	1	1	2	271	289	446	2.10E-34	146	DDX52_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)	DDX52 ROK1 HUSSY-19	Homo sapiens (Human)	599	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0030490	maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5095_c0_g2_i2	Q8K301	DDX52_MOUSE	56.9	448	188	2	1426	92	150	595	4.40E-144	513.1	DDX52_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)	Ddx52 Rok1	Mus musculus (Mouse)	598	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030490	maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN5095_c0_g1_i2	Q8K301	DDX52_MOUSE	56.9	448	188	2	431	1765	150	595	4.40E-144	513.1	DDX52_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)	Ddx52 Rok1	Mus musculus (Mouse)	598	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0030490	maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN29227_c0_g1_i1	Q9NY93	DDX56_HUMAN	100	75	0	0	226	2	24	98	7.70E-35	147.1	DDX56_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)	DDX56 DDX21 NOH61	Homo sapiens (Human)	547	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020	positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN22837_c0_g1_i1	Q9NY93	DDX56_HUMAN	100	82	0	0	3	248	110	191	1.40E-37	156.4	DDX56_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)	DDX56 DDX21 NOH61	Homo sapiens (Human)	547	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020	positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN24724_c0_g1_i1	Q9NY93	DDX56_HUMAN	100	72	0	0	1	216	235	306	1.10E-33	143.3	DDX56_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)	DDX56 DDX21 NOH61	Homo sapiens (Human)	547	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020	positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN252_c0_g1_i1	Q9D0R4	DDX56_MOUSE	46.7	552	273	6	1729	113	2	545	5.00E-132	473	DDX56_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 56)	Ddx56 D11Ertd619e Noh61	Mus musculus (Mouse)	546	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976	positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN29317_c0_g1_i1	Q9D0R4	DDX56_MOUSE	100	72	0	0	217	2	435	506	2.80E-34	145.2	DDX56_MOUSE	reviewed	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 56)	Ddx56 D11Ertd619e Noh61	Mus musculus (Mouse)	546	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976	positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN24885_c0_g1_i1	P26196	DDX6_HUMAN	98.3	299	5	0	2	898	61	359	2.50E-161	569.3	DDX6_HUMAN	reviewed	Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)	DDX6 HLR2 RCK	Homo sapiens (Human)	483	adherens junction [GO:0005912]; chromatoid body [GO:0033391]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; sperm annulus [GO:0097227]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; spermatid differentiation [GO:0048515]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]	adherens junction [GO:0005912]; chromatoid body [GO:0033391]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; sperm annulus [GO:0097227]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000792; GO:0000932; GO:0001520; GO:0003723; GO:0003724; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005912; GO:0010494; GO:0016020; GO:0016442; GO:0017148; GO:0019074; GO:0019827; GO:0019904; GO:0033391; GO:0033962; GO:0034063; GO:0036464; GO:0043928; GO:0045296; GO:0045665; GO:0048471; GO:0048515; GO:0061830; GO:0097227; GO:1905618	exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; spermatid differentiation [GO:0048515]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN37463_c0_g1_i1	Q5ZKB9	DDX6_CHICK	100	128	0	0	385	2	314	441	2.60E-70	265.8	DDX6_CHICK	reviewed	Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (DEAD box protein 6)	DDX6 RCJMB04_11n24	Gallus gallus (Chicken)	483	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA helicase activity [GO:0003724]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA helicase activity [GO:0003724]	GO:0000932; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0010494; GO:0016442; GO:0017148; GO:0019074; GO:0019827; GO:0019904; GO:0033962; GO:0034063; GO:0045665; GO:1905618	negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3946_c0_g1_i1	Q54E49	DDX6_DICDI	75.3	401	99	0	1259	57	21	421	1.40E-178	627.1	DDX6_DICDI	reviewed	Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6)	ddx6 DDB_G0291804	Dictyostelium discoideum (Slime mold)	423	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]	GO:0000932; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0006397; GO:0010494; GO:0033962; GO:0034063	mRNA processing [GO:0006397]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN15714_c0_g1_i1	Q04217	DHR1_YEAST	60.6	66	26	0	8	205	731	796	4.30E-16	84.7	DHR1_YEAST	reviewed	Probable ATP-dependent RNA helicase DHR1 (EC 3.6.4.13) (DEAH box RNA helicase DHR1) (Extracellular mutant protein 16)	ECM16 DHR1 YMR128W YM9553.04	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1267	"90S preribosome [GO:0030686]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosome biogenesis [GO:0042254]; rRNA methylation [GO:0031167]"	90S preribosome [GO:0030686]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0030686; GO:0031167; GO:0032040; GO:0042254	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosome biogenesis [GO:0042254]; rRNA methylation [GO:0031167]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7235_c0_g1_i2	Q14147	DHX34_HUMAN	44.9	1165	590	17	3519	106	3	1142	3.20E-255	883.2	DHX34_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34)	DHX34 DDX34 KIAA0134	Homo sapiens (Human)	1143	"membrane [GO:0016020]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	membrane [GO:0016020]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:0016020; GO:2000623	"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40559_c0_g1_i1	Q9DBV3	DHX34_MOUSE	98.8	82	1	0	250	5	296	377	3.40E-39	161.8	DHX34_MOUSE	reviewed	Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34)	Dhx34 Ddx34 Kiaa0134	Mus musculus (Mouse)	1145	"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:2000623	"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27567_c0_g1_i1	Q9H5Z1	DHX35_HUMAN	59.7	196	78	1	587	3	35	230	2.60E-61	236.5	DHX35_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35)	DHX35 C20orf15 DDX35	Homo sapiens (Human)	703	"catalytic step 2 spliceosome [GO:0071013]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16996_c0_g1_i1	Q9H5Z1	DHX35_HUMAN	50.6	89	41	2	5	265	300	387	1.40E-14	80.1	DHX35_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35)	DHX35 C20orf15 DDX35	Homo sapiens (Human)	703	"catalytic step 2 spliceosome [GO:0071013]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34066_c0_g1_i1	Q9H5Z1	DHX35_HUMAN	52.5	139	65	1	3	419	400	537	1.60E-33	143.7	DHX35_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35)	DHX35 C20orf15 DDX35	Homo sapiens (Human)	703	"catalytic step 2 spliceosome [GO:0071013]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3524_c0_g1_i1	Q8IY37	DHX37_HUMAN	39.6	240	138	5	64	780	920	1153	2.90E-43	177.2	DHX37_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37)	DHX37 DDX37 KIAA1517	Homo sapiens (Human)	1157	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]; brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007420; GO:0031965; GO:0034511; GO:0042254; GO:0042255; GO:2000020	"brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37248_c0_g1_i1	Q8IY37	DHX37_HUMAN	95.9	123	5	0	369	1	297	419	6.90E-57	221.1	DHX37_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37)	DHX37 DDX37 KIAA1517	Homo sapiens (Human)	1157	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]; brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007420; GO:0031965; GO:0034511; GO:0042254; GO:0042255; GO:2000020	"brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33026_c0_g1_i1	Q8IX18	DHX40_HUMAN	100	68	0	0	205	2	81	148	1.10E-32	139.8	DHX40_HUMAN	reviewed	Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40) (Protein PAD)	DHX40 DDX40 ARG147	Homo sapiens (Human)	779	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN3524_c0_g1_i2	O46072	KZ_DROME	50.7	963	428	12	145	2952	243	1185	6.50E-249	862.1	KZ_DROME	reviewed	Probable ATP-dependent RNA helicase kurz (EC 3.6.4.13)	kz CG3228	Drosophila melanogaster (Fruit fly)	1192	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000462; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005730	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6917_c0_g1_i1	Q03319	PRH1_SCHPO	40.4	89	48	2	254	3	336	424	2.30E-11	69.3	PRH1_SCHPO	reviewed	Probable ATP-dependent RNA helicase prh1 (EC 3.6.4.13)	prh1 SPAC2G11.11c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	719	nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase I [GO:0045943]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006397; GO:0042254; GO:0045943	mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase I [GO:0045943]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i1	B3P3W1	SPNE_DROER	25	703	415	20	1927	29	628	1288	1.30E-45	186	SPNE_DROER	reviewed	Probable ATP-dependent RNA helicase spindle-E (EC 3.6.4.13) (Homeless)	spn-E hls GG16958	Drosophila erecta (Fruit fly)	1432	"nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; chromatin silencing [GO:0006342]; dorsal appendage formation [GO:0046843]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic chromosome condensation [GO:0007076]; negative regulation of transposition, DNA-mediated [GO:0000335]; oocyte karyosome formation [GO:0030717]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte maturation [GO:0001556]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0000335; GO:0001556; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0006342; GO:0007076; GO:0007283; GO:0007294; GO:0007317; GO:0008298; GO:0009949; GO:0009951; GO:0030423; GO:0030717; GO:0030720; GO:0043186; GO:0046843; GO:0060213	"chromatin silencing [GO:0006342]; dorsal appendage formation [GO:0046843]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic chromosome condensation [GO:0007076]; negative regulation of transposition, DNA-mediated [GO:0000335]; oocyte karyosome formation [GO:0030717]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte maturation [GO:0001556]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i7	B3P3W1	SPNE_DROER	24.8	694	410	20	1907	36	628	1279	1.20E-43	179.5	SPNE_DROER	reviewed	Probable ATP-dependent RNA helicase spindle-E (EC 3.6.4.13) (Homeless)	spn-E hls GG16958	Drosophila erecta (Fruit fly)	1432	"nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; chromatin silencing [GO:0006342]; dorsal appendage formation [GO:0046843]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic chromosome condensation [GO:0007076]; negative regulation of transposition, DNA-mediated [GO:0000335]; oocyte karyosome formation [GO:0030717]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte maturation [GO:0001556]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0000335; GO:0001556; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0006342; GO:0007076; GO:0007283; GO:0007294; GO:0007317; GO:0008298; GO:0009949; GO:0009951; GO:0030423; GO:0030717; GO:0030720; GO:0043186; GO:0046843; GO:0060213	"chromatin silencing [GO:0006342]; dorsal appendage formation [GO:0046843]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic chromosome condensation [GO:0007076]; negative regulation of transposition, DNA-mediated [GO:0000335]; oocyte karyosome formation [GO:0030717]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte maturation [GO:0001556]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17907_c0_g2_i1	B4PRJ9	SPNE_DROYA	54.1	74	30	1	225	16	112	185	5.20E-15	81.3	SPNE_DROYA	reviewed	Probable ATP-dependent RNA helicase spindle-E (EC 3.6.4.13) (Homeless)	spn-E hls GE24344	Drosophila yakuba (Fruit fly)	1436	"nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; chromatin silencing [GO:0006342]; dorsal appendage formation [GO:0046843]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic chromosome condensation [GO:0007076]; negative regulation of transposition, DNA-mediated [GO:0000335]; oocyte karyosome formation [GO:0030717]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte maturation [GO:0001556]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0000335; GO:0001556; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0006342; GO:0007076; GO:0007283; GO:0007294; GO:0007317; GO:0008298; GO:0009949; GO:0009951; GO:0030423; GO:0030717; GO:0030720; GO:0043186; GO:0046843; GO:0060213	"chromatin silencing [GO:0006342]; dorsal appendage formation [GO:0046843]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; mitotic chromosome condensation [GO:0007076]; negative regulation of transposition, DNA-mediated [GO:0000335]; oocyte karyosome formation [GO:0030717]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte maturation [GO:0001556]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of pole plasm oskar mRNA localization [GO:0007317]; spermatogenesis [GO:0007283]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7671_c0_g1_i1	Q9IA79	BI1_PAROL	56.3	142	60	1	518	99	96	237	9.70E-41	167.9	BI1_PAROL	reviewed	Probable Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein homolog) (Transmembrane BAX inhibitor motif-containing protein 6)	tmbim6 tegt	Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)	237	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0006915; GO:0006986; GO:0016021; GO:0043066	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]		blue	blue	NA	NA	NA	NA
TRINITY_DN9421_c1_g1_i6	Q8WSF3	FDL_DROME	48.5	132	68	0	450	55	261	392	1.60E-34	147.1	FDL_DROME	reviewed	Probable beta-hexosaminidase fdl (EC 3.2.1.52) (Protein fused lobes)	fdl CG8824	Drosophila melanogaster (Fruit fly)	660	late endosome [GO:0005770]; plasma membrane [GO:0005886]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]	late endosome [GO:0005770]; plasma membrane [GO:0005886]	beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005770; GO:0005886; GO:0005975; GO:0006491; GO:0006517; GO:0007420; GO:0016063; GO:0016231; GO:0102148	brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]		brown	brown	1	NA	NA	NA
TRINITY_DN9421_c1_g1_i1	Q8WSF3	FDL_DROME	48.6	181	93	0	544	2	261	441	3.20E-50	199.5	FDL_DROME	reviewed	Probable beta-hexosaminidase fdl (EC 3.2.1.52) (Protein fused lobes)	fdl CG8824	Drosophila melanogaster (Fruit fly)	660	late endosome [GO:0005770]; plasma membrane [GO:0005886]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]	late endosome [GO:0005770]; plasma membrane [GO:0005886]	beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005770; GO:0005886; GO:0005975; GO:0006491; GO:0006517; GO:0007420; GO:0016063; GO:0016231; GO:0102148	brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]		NA	NA	NA	NA	NA	NA
TRINITY_DN40785_c0_g1_i1	Q8WSF3	FDL_DROME	50	90	45	0	2	271	315	404	3.60E-26	118.6	FDL_DROME	reviewed	Probable beta-hexosaminidase fdl (EC 3.2.1.52) (Protein fused lobes)	fdl CG8824	Drosophila melanogaster (Fruit fly)	660	late endosome [GO:0005770]; plasma membrane [GO:0005886]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]	late endosome [GO:0005770]; plasma membrane [GO:0005886]	beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005770; GO:0005886; GO:0005975; GO:0006491; GO:0006517; GO:0007420; GO:0016063; GO:0016231; GO:0102148	brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]		NA	NA	NA	NA	NA	NA
TRINITY_DN18912_c0_g1_i1	Q8WSF3	FDL_DROME	48.5	97	50	0	78	368	296	392	1.40E-26	120.6	FDL_DROME	reviewed	Probable beta-hexosaminidase fdl (EC 3.2.1.52) (Protein fused lobes)	fdl CG8824	Drosophila melanogaster (Fruit fly)	660	late endosome [GO:0005770]; plasma membrane [GO:0005886]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]	late endosome [GO:0005770]; plasma membrane [GO:0005886]	beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005770; GO:0005886; GO:0005975; GO:0006491; GO:0006517; GO:0007420; GO:0016063; GO:0016231; GO:0102148	brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]		brown	brown	NA	NA	NA	NA
TRINITY_DN18912_c0_g1_i2	Q8WSF3	FDL_DROME	49.5	97	49	0	78	368	296	392	3.80E-27	122.5	FDL_DROME	reviewed	Probable beta-hexosaminidase fdl (EC 3.2.1.52) (Protein fused lobes)	fdl CG8824	Drosophila melanogaster (Fruit fly)	660	late endosome [GO:0005770]; plasma membrane [GO:0005886]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]	late endosome [GO:0005770]; plasma membrane [GO:0005886]	beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]	GO:0004563; GO:0005770; GO:0005886; GO:0005975; GO:0006491; GO:0006517; GO:0007420; GO:0016063; GO:0016231; GO:0102148	brain development [GO:0007420]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; rhodopsin biosynthetic process [GO:0016063]		NA	NA	NA	NA	NA	NA
TRINITY_DN1239_c0_g1_i1	O95671	ASML_HUMAN	50.7	207	95	3	716	111	7	211	1.10E-50	201.8	ASML_HUMAN	reviewed	Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]	ASMTL	Homo sapiens (Human)	621	cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]	GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0047429	methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN1239_c0_g1_i3	O95671	ASML_HUMAN	50.7	207	95	3	702	97	7	211	1.10E-50	201.8	ASML_HUMAN	reviewed	Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]	ASMTL	Homo sapiens (Human)	621	cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]	GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0047429	methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN1239_c0_g1_i4	O95671	ASML_HUMAN	50.5	182	83	3	627	97	32	211	5.90E-44	179.1	ASML_HUMAN	reviewed	Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]	ASMTL	Homo sapiens (Human)	621	cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]	GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0047429	methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN1239_c0_g1_i6	O95671	ASML_HUMAN	50.5	182	83	3	641	111	32	211	6.00E-44	179.1	ASML_HUMAN	reviewed	Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]	ASMTL	Homo sapiens (Human)	621	cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]	GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0047429	methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]		NA	NA	NA	NA	NA	NA
TRINITY_DN39334_c0_g1_i1	Q60048	CADA_LISMN	65.5	84	28	1	1	249	570	653	1.10E-21	103.6	CADA_LISMN	reviewed	Probable cadmium-transporting ATPase (EC 7.2.2.21) (Cadmium-efflux ATPase)	cadA	Listeria monocytogenes	711	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; metal ion transport [GO:0030001]; response to cadmium ion [GO:0046686]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0016021; GO:0019829; GO:0030001; GO:0046686; GO:0046872	metal ion transport [GO:0030001]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN28656_c0_g1_i1	Q60048	CADA_LISMN	64.5	93	32	1	284	9	551	643	9.20E-25	114	CADA_LISMN	reviewed	Probable cadmium-transporting ATPase (EC 7.2.2.21) (Cadmium-efflux ATPase)	cadA	Listeria monocytogenes	711	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; metal ion transport [GO:0030001]; response to cadmium ion [GO:0046686]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0016021; GO:0019829; GO:0030001; GO:0046686; GO:0046872	metal ion transport [GO:0030001]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i10	Q86IC9	CAMT1_DICDI	44.9	89	48	1	132	398	19	106	1.30E-11	71.6	CAMT1_DICDI	reviewed	Probable caffeoyl-CoA O-methyltransferase 1 (EC 2.1.1.104) (O-methyltransferase 5)	omt5 DDB_G0275499	Dictyostelium discoideum (Slime mold)	230	caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]		caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0008757; GO:0032259; GO:0042409; GO:0046872	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN5731_c1_g1_i9	Q86IC9	CAMT1_DICDI	50.5	208	101	2	132	752	19	225	1.60E-50	201.1	CAMT1_DICDI	reviewed	Probable caffeoyl-CoA O-methyltransferase 1 (EC 2.1.1.104) (O-methyltransferase 5)	omt5 DDB_G0275499	Dictyostelium discoideum (Slime mold)	230	caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]		caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0008757; GO:0032259; GO:0042409; GO:0046872	methylation [GO:0032259]		blue	blue	NA	NA	NA	NA
TRINITY_DN33218_c0_g1_i1	Q8SRK8	KAPC_ENCCU	47.3	129	67	1	2	385	89	217	1.90E-28	126.7	KAPC_ENCCU	reviewed	Probable cAMP-dependent protein kinase catalytic subunit (EC 2.7.11.11)	ECU07_0520	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	322	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]		AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004679; GO:0004691; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN26847_c0_g1_i1	Q8SS96	KC11_ENCCU	54.6	194	88	0	6	587	71	264	2.00E-58	226.9	KC11_ENCCU	reviewed	Probable casein kinase I homolog ECU03_0910 (EC 2.7.11.1)	ECU03_0910	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	304	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; DNA repair [GO:0006281]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN14740_c0_g1_i2	Q5XF89	AT133_MOUSE	38.4	125	68	3	72	425	592	714	2.00E-16	87	AT133_MOUSE	reviewed	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-)	Atp13a3 Gm542	Mus musculus (Mouse)	1219	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN14740_c0_g1_i4	Q5XF89	AT133_MOUSE	39.5	147	80	3	72	491	592	736	5.10E-23	109	AT133_MOUSE	reviewed	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-)	Atp13a3 Gm542	Mus musculus (Mouse)	1219	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN35834_c0_g1_i1	Q5XF89	AT133_MOUSE	58.6	237	92	1	30	722	280	516	4.70E-71	269.2	AT133_MOUSE	reviewed	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-)	Atp13a3 Gm542	Mus musculus (Mouse)	1219	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN36168_c0_g1_i1	Q5XF89	AT133_MOUSE	56.6	113	49	0	3	341	671	783	2.20E-31	136.3	AT133_MOUSE	reviewed	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-)	Atp13a3 Gm542	Mus musculus (Mouse)	1219	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN5892_c0_g1_i1	Q9H7F0	AT133_HUMAN	40.7	1222	639	19	140	3631	9	1202	4.80E-233	809.7	AT133_HUMAN	reviewed	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-) (ATPase family homolog up-regulated in senescence cells 1)	ATP13A3 AFURS1	Homo sapiens (Human)	1226	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0006812; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN27457_c0_g1_i1	Q9H7F0	AT133_HUMAN	48.5	134	56	3	61	435	286	415	2.20E-25	116.7	AT133_HUMAN	reviewed	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-) (ATPase family homolog up-regulated in senescence cells 1)	ATP13A3 AFURS1	Homo sapiens (Human)	1226	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0006812; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN34542_c0_g1_i1	Q4VNC0	AT135_HUMAN	55	60	27	0	73	252	430	489	7.20E-12	71.2	AT135_HUMAN	reviewed	Probable cation-transporting ATPase 13A5 (EC 7.2.2.-) (P5-ATPase isoform 5)	ATP13A5 UNQ488/PRO1004	Homo sapiens (Human)	1218	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0034220; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]		NA	NA	NA	NA	NA	NA
TRINITY_DN7352_c0_g1_i1	Q8SWM6	CDC5_ENCCU	76.5	115	27	0	24	368	135	249	8.40E-47	187.6	CDC5_ENCCU	reviewed	Probable cell cycle serine/threonine-protein kinase CDC5 homolog (EC 2.7.11.21)	CDC5 ECU01_0630	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	472	cytoplasm [GO:0005737]; spindle pole body [GO:0005816]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; spindle pole body [GO:0005816]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005816; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN38650_c0_g1_i1	Q8SR85	CDC71_ENCCU	69.5	82	25	0	249	4	198	279	3.30E-26	118.6	CDC71_ENCCU	reviewed	Probable cell division control protein 7 homolog 1 (EC 2.7.11.1)	CDC7-1 ECU08_1960	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	351	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0046872; GO:0051301; GO:0051321	cell division [GO:0051301]; meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN30609_c0_g1_i1	Q8SRF5	Y823_ENCCU	56.9	195	84	0	636	52	12	206	2.40E-57	223.4	Y823_ENCCU	reviewed	Probable cell division protein kinase ECU08_0230 (EC 2.7.11.22)	ECU08_0230	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	265	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]	nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0004693; GO:0005524; GO:0005634; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN40583_c0_g1_i1	Q8KG79	CLPB1_CHLTE	78.8	80	17	0	240	1	198	277	3.90E-32	138.3	CLPB1_CHLTE	reviewed	Probable chaperone protein ClpB 1	clpB1 CT0089	Chlorobaculum tepidum (strain ATCC 49652 / DSM 12025 / NBRC 103806 / TLS) (Chlorobium tepidum)	438	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN14381_c0_g2_i1	Q9W092	CHIT2_DROME	43.7	375	186	8	91	1176	33	395	6.30E-86	319.7	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	x	black	black	1	NA	1	1
TRINITY_DN17711_c0_g1_i5	Q9W092	CHIT2_DROME	40.8	397	198	10	1297	173	14	395	9.20E-75	282.3	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	x	black	black	1	NA	1	1
TRINITY_DN20559_c0_g1_i1	Q9W092	CHIT2_DROME	47.5	181	90	2	551	9	43	218	8.40E-46	184.9	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38173_c0_g1_i1	Q9W092	CHIT2_DROME	33.8	71	30	1	176	15	358	428	2.00E-05	49.3	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17711_c0_g1_i3	Q9W092	CHIT2_DROME	41.6	397	195	10	1297	173	14	395	2.00E-77	291.2	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17711_c0_g1_i4	Q9W092	CHIT2_DROME	41.9	399	191	10	1297	173	14	395	5.80E-77	289.7	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	1
TRINITY_DN32922_c0_g1_i1	Q9W092	CHIT2_DROME	50.5	206	98	1	47	652	39	244	5.30E-60	232.3	CHIT2_DROME	reviewed	Probable chitinase 2 (EC 3.2.1.14)	Cht2 CG2054	Drosophila melanogaster (Fruit fly)	484	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0006032; GO:0008061; GO:0008362; GO:0008363; GO:0018990; GO:0040003; GO:0042060	"chitin-based cuticle development [GO:0040003]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; chitin catabolic process [GO:0006032]; ecdysis, chitin-based cuticle [GO:0018990]; larval chitin-based cuticle development [GO:0008363]; polysaccharide catabolic process [GO:0000272]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26275_c0_g1_i1	Q7G8Y3	ISW2_ORYSJ	72.3	137	38	0	413	3	519	655	6.80E-53	208	ISW2_ORYSJ	reviewed	Probable chromatin-remodeling complex ATPase chain (EC 3.6.4.-) (ISW2-like) (Sucrose nonfermenting protein 2 homolog)	Os01g0367900 LOC_Os01g27040 B1329D01.23 OsJ_01780 P0043B10.9 P0560B06.13 P0784G04.20	Oryza sativa subsp. japonica (Rice)	1107	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome positioning [GO:0016584]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0008094; GO:0016584; GO:0031491; GO:0043044	ATP-dependent chromatin remodeling [GO:0043044]; nucleosome positioning [GO:0016584]		NA	NA	NA	NA	NA	NA
TRINITY_DN22960_c0_g2_i1	P34574	CLH_CAEEL	63.7	91	33	0	3	275	699	789	5.10E-28	124.8	CLH_CAEEL	reviewed	Probable clathrin heavy chain 1	chc-1 T20G5.1	Caenorhabditis elegans	1681	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; apical protein localization [GO:0045176]; cortical actin cytoskeleton organization [GO:0030866]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]	clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005938; GO:0006886; GO:0006898; GO:0008104; GO:0008340; GO:0009792; GO:0009898; GO:0016324; GO:0030130; GO:0030132; GO:0030139; GO:0030866; GO:0031410; GO:0032051; GO:0045176; GO:0045334; GO:0071439; GO:0072686; GO:2000370	apical protein localization [GO:0045176]; cortical actin cytoskeleton organization [GO:0030866]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; intracellular protein transport [GO:0006886]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN2111_c0_g1_i2	Q9V3D6	CPSF2_DROME	50.9	759	347	9	2291	84	1	756	4.60E-218	759.2	CPSF2_DROME	reviewed	Probable cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit)	Cpsf100 CG1957	Drosophila melanogaster (Fruit fly)	756	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]	GO:0003723; GO:0005847; GO:0006378; GO:0006398; GO:0098789	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]		NA	NA	NA	NA	NA	NA
TRINITY_DN12547_c0_g1_i1	Q2PZI1	D19L1_HUMAN	39.5	438	243	4	1387	101	248	672	3.80E-79	297	D19L1_HUMAN	reviewed	Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1)	DPY19L1 GA0500 KIAA0877	Homo sapiens (Human)	675	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]		NA	NA	NA	NA	NA	NA
TRINITY_DN26555_c0_g1_i1	Q6ZPD9	D19L3_HUMAN	33.2	265	167	5	1035	256	200	459	3.00E-25	117.5	D19L3_HUMAN	reviewed	Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)	DPY19L3	Homo sapiens (Human)	716	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005637; GO:0016021; GO:0018406	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]		NA	NA	NA	NA	NA	NA
TRINITY_DN26492_c0_g1_i1	Q6ZPD9	D19L3_HUMAN	51.8	168	77	2	550	50	549	713	1.20E-44	181	D19L3_HUMAN	reviewed	Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)	DPY19L3	Homo sapiens (Human)	716	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005637; GO:0016021; GO:0018406	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]		NA	NA	NA	NA	NA	NA
TRINITY_DN26492_c0_g1_i2	Q6ZPD9	D19L3_HUMAN	76.2	63	15	0	252	64	549	611	2.50E-21	102.4	D19L3_HUMAN	reviewed	Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)	DPY19L3	Homo sapiens (Human)	716	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005637; GO:0016021; GO:0018406	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]		NA	NA	NA	NA	NA	NA
TRINITY_DN34781_c0_g1_i1	P9WPS2	CTPV_MYCTO	60.6	104	41	0	3	314	291	394	1.30E-27	123.6	CTPV_MYCTO	reviewed	Probable copper-exporting P-type ATPase V (EC 7.2.2.8) (Cu(+)-exporting ATPase)	ctpV MT0997	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	770	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN36947_c0_g1_i1	P73241	ATCS_SYNY3	50.7	71	34	1	214	2	356	425	1.10E-09	63.5	ATCS_SYNY3	reviewed	Probable copper-transporting ATPase PacS (EC 7.2.2.8)	pacS sll1920	Synechocystis sp. (strain PCC 6803 / Kazusa)	745	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper ion import [GO:0015677]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; copper ion binding [GO:0005507]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]"	GO:0005507; GO:0005524; GO:0005886; GO:0015677; GO:0016021; GO:0043682	copper ion import [GO:0015677]		NA	NA	NA	NA	NA	NA
TRINITY_DN3057_c0_g1_i1	P37279	ATCS_SYNE7	62.7	110	41	0	334	5	256	365	2.70E-31	136	ATCS_SYNE7	reviewed	Probable copper-transporting ATPase PacS (EC 7.2.2.8)	pacS Synpcc7942_1570 sed0002	Synechococcus elongatus (strain PCC 7942 / FACHB-805) (Anacystis nidulans R2)	747	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872	copper ion transport [GO:0006825]		NA	NA	NA	NA	NA	NA
TRINITY_DN10467_c0_g1_i1	O74351	NFS1_SCHPO	67.3	269	87	1	819	13	103	370	1.10E-103	377.9	NFS1_SCHPO	reviewed	"Probable cysteine desulfurase, mitochondrial (EC 2.8.1.7)"	SPBC21D10.11c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	501	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; tRNA wobble position uridine thiolation [GO:0002143]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]	GO:0002143; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0016226; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051536	[2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; tRNA wobble position uridine thiolation [GO:0002143]		NA	NA	NA	NA	NA	NA
TRINITY_DN34133_c0_g1_i1	Q9SUL1	RD19C_ARATH	52.9	68	32	0	216	13	129	196	2.60E-14	79	RD19C_ARATH	reviewed	Probable cysteine protease RD19C (EC 3.4.22.-) (RD19-like protein 2)	RD19C RDL2 At4g16190 dl4135w	Arabidopsis thaliana (Mouse-ear cress)	373	extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; vacuole [GO:0005773]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; vacuole [GO:0005773]	cysteine-type endopeptidase activity [GO:0004197]	GO:0000323; GO:0004197; GO:0005615; GO:0005764; GO:0005773; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN11658_c0_g1_i1	Q9HA77	SYCM_HUMAN	47.4	114	59	1	395	57	94	207	1.30E-23	110.9	SYCM_HUMAN	reviewed	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	CARS2 OK/SW-cl.10	Homo sapiens (Human)	564	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN11658_c0_g1_i2	Q9HA77	SYCM_HUMAN	64.1	39	14	0	129	13	94	132	6.10E-08	57.8	SYCM_HUMAN	reviewed	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	CARS2 OK/SW-cl.10	Homo sapiens (Human)	564	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN11658_c0_g1_i3	Q6DJ95	SYCM_XENTR	48.4	186	85	2	614	60	34	209	7.10E-45	182.2	SYCM_XENTR	reviewed	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	cars2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	572	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN11658_c0_g1_i4	Q6DJ95	SYCM_XENTR	48.4	186	85	2	614	60	34	209	7.70E-45	182.2	SYCM_XENTR	reviewed	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	cars2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	572	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN4457_c0_g1_i2	Q6DJ95	SYCM_XENTR	45.3	316	168	4	946	2	217	528	6.40E-70	265.8	SYCM_XENTR	reviewed	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	cars2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	572	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN4457_c0_g1_i3	Q6PA41	SYCM_XENLA	34.6	133	84	2	400	2	399	528	5.30E-11	68.9	SYCM_XENLA	reviewed	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	cars2	Xenopus laevis (African clawed frog)	572	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]	GO:0004817; GO:0005524; GO:0005759; GO:0006423; GO:0046872	cysteinyl-tRNA aminoacylation [GO:0006423]		NA	NA	NA	NA	NA	NA
TRINITY_DN4607_c0_g1_i3	P53703	CCHL_CAEEL	65.2	115	39	1	439	780	66	180	1.80E-39	164.9	CCHL_CAEEL	reviewed	Probable cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome-c-type synthase)	cchl-1 T06D8.6	Caenorhabditis elegans	280	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	cytochrome c-heme linkage [GO:0018063]		NA	NA	NA	NA	NA	NA
TRINITY_DN4607_c0_g1_i3	P53703	CCHL_CAEEL	66.3	83	26	2	764	1006	175	257	5.40E-28	126.7	CCHL_CAEEL	reviewed	Probable cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome-c-type synthase)	cchl-1 T06D8.6	Caenorhabditis elegans	280	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]	GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872	cytochrome c-heme linkage [GO:0018063]		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c0_g1_i1	Q9VE00	C12A4_DROME	39.5	233	123	5	753	94	306	533	6.70E-39	162.5	C12A4_DROME	reviewed	"Probable cytochrome P450 12a4, mitochondrial (EC 1.14.-.-) (CYPXIIA4)"	Cyp12a4 CG6042	Drosophila melanogaster (Fruit fly)	536	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; response to insecticide [GO:0017085]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0017085; GO:0020037; GO:0031966	response to insecticide [GO:0017085]		NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i10	Q9VE01	C12A5_DROME	42.9	140	69	3	473	87	392	531	9.10E-26	118.2	C12A5_DROME	reviewed	"Probable cytochrome P450 12a5, mitochondrial (EC 1.14.-.-) (CYPXIIA5)"	Cyp12a5 CG11821	Drosophila melanogaster (Fruit fly)	536	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037; GO:0031966			NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i11	Q9VE01	C12A5_DROME	36.1	438	261	7	1361	87	100	531	8.00E-67	256.1	C12A5_DROME	reviewed	"Probable cytochrome P450 12a5, mitochondrial (EC 1.14.-.-) (CYPXIIA5)"	Cyp12a5 CG11821	Drosophila melanogaster (Fruit fly)	536	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037; GO:0031966			NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i2	Q9VE01	C12A5_DROME	40.5	227	121	4	734	87	308	531	2.50E-41	170.6	C12A5_DROME	reviewed	"Probable cytochrome P450 12a5, mitochondrial (EC 1.14.-.-) (CYPXIIA5)"	Cyp12a5 CG11821	Drosophila melanogaster (Fruit fly)	536	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037; GO:0031966			NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i5	Q9VE01	C12A5_DROME	33.7	520	322	10	1601	87	20	531	1.10E-67	259.2	C12A5_DROME	reviewed	"Probable cytochrome P450 12a5, mitochondrial (EC 1.14.-.-) (CYPXIIA5)"	Cyp12a5 CG11821	Drosophila melanogaster (Fruit fly)	536	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037; GO:0031966			NA	NA	NA	NA	NA	NA
TRINITY_DN16015_c0_g1_i1	Q9VVR9	C12C1_DROME	52.1	71	34	0	240	28	372	442	4.40E-15	81.6	C12C1_DROME	reviewed	"Probable cytochrome P450 12c1, mitochondrial (EC 1.14.-.-) (CYPXIIC1)"	Cyp12c1 CG4120	Drosophila melanogaster (Fruit fly)	524	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037; GO:0031966			NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c0_g1_i9	Q9V6D6	CP301_DROME	36.2	130	80	1	480	100	421	550	3.00E-21	103.2	CP301_DROME	reviewed	"Probable cytochrome P450 301a1, mitochondrial (EC 1.14.-.-) (CYPCCCIA1)"	Cyp301a1 CG8587	Drosophila melanogaster (Fruit fly)	553	"mitochondrial membrane [GO:0031966]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; tergite morphogenesis [GO:0007490]"	mitochondrial membrane [GO:0031966]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0007490; GO:0016705; GO:0020037; GO:0031966	tergite morphogenesis [GO:0007490]		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c0_g1_i4	Q9V5L3	C49A1_DROME	33.6	131	85	1	396	4	205	333	1.10E-18	95.1	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c0_g1_i6	Q9V5L3	C49A1_DROME	31	464	291	7	1337	6	96	550	1.60E-65	251.9	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c0_g1_i8	Q9V5L3	C49A1_DROME	34.2	284	171	4	818	6	270	550	2.40E-44	180.6	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN13471_c0_g1_i2	Q9V5L3	C49A1_DROME	35.9	223	134	3	738	94	361	582	8.30E-32	139	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN13471_c0_g1_i4	Q9V5L3	C49A1_DROME	30.5	554	335	13	1635	94	39	582	2.80E-65	251.1	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i14	Q9V5L3	C49A1_DROME	30	330	204	9	993	43	80	395	1.70E-34	148.3	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN8316_c0_g1_i4	Q9V5L3	C49A1_DROME	30.1	292	178	8	882	43	118	395	2.50E-31	137.5	C49A1_DROME	reviewed	Probable cytochrome P450 49a1 (EC 1.14.-.-) (CYPXLIXA1)	Cyp49a1 CG18377	Drosophila melanogaster (Fruit fly)	589	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN10758_c0_g1_i2	Q9VB31	C6A18_DROME	58.1	62	26	0	91	276	425	486	1.90E-14	80.1	C6A18_DROME	reviewed	Probable cytochrome P450 6a18 (EC 1.14.-.-) (CYPVIA18)	Cyp6a18 CG13977	Drosophila melanogaster (Fruit fly)	507	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN11777_c0_g1_i1	Q9V771	C6A23_DROME	34.7	170	108	3	554	54	180	349	8.80E-19	95.1	C6A23_DROME	reviewed	Probable cytochrome P450 6a23 (EC 1.14.-.-) (CYPVIA23)	Cyp6a23 CG10242	Drosophila melanogaster (Fruit fly)	502	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	endoplasmic reticulum membrane [GO:0005789]	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c0_g1_i3	Q09660	CC44_CAEEL	40.9	66	37	1	199	2	132	195	1.50E-05	49.7	CC44_CAEEL	reviewed	Probable cytochrome P450 CYP44 (EC 1.14.-.-)	cyp-44A1 ccp-44 cyp44 ZK177.5	Caenorhabditis elegans	489	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN30298_c0_g1_i1	Q09660	CC44_CAEEL	39.5	76	42	2	12	239	408	479	6.00E-09	61.2	CC44_CAEEL	reviewed	Probable cytochrome P450 CYP44 (EC 1.14.-.-)	cyp-44A1 ccp-44 cyp44 ZK177.5	Caenorhabditis elegans	489	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN22956_c0_g1_i1	B2UAK8	AMPA_RALPJ	98.8	83	1	0	251	3	315	397	6.90E-40	164.1	AMPA_RALPJ	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA Rpic_2679	Ralstonia pickettii (strain 12J)	502	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i8	Q1I5F9	AMPA_PSEE4	47.8	92	48	0	276	1	227	318	2.10E-18	92.8	AMPA_PSEE4	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA PSEEN4443	Pseudomonas entomophila (strain L48)	497	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN26953_c0_g1_i1	Q11HH5	AMPA_CHESB	64.8	91	32	0	280	8	325	415	1.20E-29	130.2	AMPA_CHESB	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA Meso_1756	Chelativorans sp. (strain BNC1)	495	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN31928_c0_g1_i1	Q6A9W5	AMPA_CUTAK	68.2	66	21	0	203	6	331	396	4.00E-18	91.7	AMPA_CUTAK	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA PPA0694	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	508	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN2140_c0_g1_i1	Q9A7M9	AMPA_CAUVC	74.7	79	20	0	3	239	308	386	5.10E-29	127.9	AMPA_CAUVC	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA CC_1692	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	493	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN5447_c0_g1_i1	A4VNZ7	AMPA_PSEU5	48.9	92	47	0	276	1	226	317	2.10E-18	92.8	AMPA_PSEU5	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA PST_3058	Pseudomonas stutzeri (strain A1501)	496	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	1	NA	NA	NA
TRINITY_DN28170_c0_g1_i1	B2I6L3	AMPA_XYLF2	63.8	69	25	0	208	2	313	381	6.80E-17	87.4	AMPA_XYLF2	reviewed	Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)	pepA XfasM23_0098	Xylella fastidiosa (strain M23)	491	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN32778_c0_g1_i1	Q54F30	NARF_DICDI	49.2	59	23	2	10	165	394	452	8.30E-09	60.8	NARF_DICDI	reviewed	Probable cytosolic Fe-S cluster assembly factor narfl	narfl DDB_G0291149	Dictyostelium discoideum (Slime mold)	522	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"	CIA complex [GO:0097361]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"	GO:0016226; GO:0046872; GO:0051539; GO:0097361	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN1979_c0_g2_i1	O76071	CIAO1_HUMAN	66	326	110	1	1073	99	8	333	2.40E-135	483.4	CIAO1_HUMAN	reviewed	Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39)	CIAO1 CIA1 WDR39	Homo sapiens (Human)	339	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]		GO:0005737; GO:0006357; GO:0007059; GO:0008284; GO:0016226; GO:0071817; GO:0097361; GO:0097428	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31461_c0_g1_i1	O76071	CIAO1_HUMAN	100	291	0	0	1	873	30	320	7.30E-182	637.5	CIAO1_HUMAN	reviewed	Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39)	CIAO1 CIA1 WDR39	Homo sapiens (Human)	339	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357]	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]		GO:0005737; GO:0006357; GO:0007059; GO:0008284; GO:0016226; GO:0071817; GO:0097361; GO:0097428	chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2234_c0_g1_i1	Q9VWA2	DCTD_DROME	69.5	59	18	0	35	211	22	80	2.50E-19	95.5	DCTD_DROME	reviewed	Probable deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	CG6951	Drosophila melanogaster (Fruit fly)	203	dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]		dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270]	GO:0004132; GO:0006226; GO:0006231; GO:0008270	dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]		NA	NA	NA	NA	NA	NA
TRINITY_DN39095_c0_g1_i1	O94337	DHYS_SCHPO	67.7	65	18	1	29	214	193	257	3.40E-19	95.1	DHYS_SCHPO	reviewed	Probable deoxyhypusine synthase (DHS) (EC 2.5.1.46)	SPBC1271.04c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	350	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; deoxyhypusine synthase activity [GO:0034038]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; regulation of cytoplasmic translation [GO:2000765]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	deoxyhypusine synthase activity [GO:0034038]	GO:0005634; GO:0005737; GO:0005829; GO:0008612; GO:0034038; GO:2000765	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; regulation of cytoplasmic translation [GO:2000765]		NA	NA	NA	NA	NA	NA
TRINITY_DN32898_c0_g1_i1	Q9VSF4	DHYS_DROME	70.4	169	50	0	509	3	119	287	8.00E-72	271.2	DHYS_DROME	reviewed	Probable deoxyhypusine synthase (DHS) (EC 2.5.1.46)	CG8005	Drosophila melanogaster (Fruit fly)	368	cytoplasm [GO:0005737]; deoxyhypusine synthase activity [GO:0034038]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]	cytoplasm [GO:0005737]	deoxyhypusine synthase activity [GO:0034038]	GO:0005737; GO:0008612; GO:0034038	peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]		NA	NA	NA	NA	NA	NA
TRINITY_DN26209_c0_g1_i1	Q2KHT8	DIM1_BOVIN	52.8	72	34	0	217	2	148	219	1.60E-13	76.3	DIM1_BOVIN	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	DIMT1 DIMT1L	Bos taurus (Bovine)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN3210_c0_g1_i1	Q9D0D4	DIM1_MOUSE	74.5	286	73	0	907	50	27	312	2.20E-122	440.3	DIM1_MOUSE	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	Dimt1 Dimt1l	Mus musculus (Mouse)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN3210_c0_g1_i2	Q9D0D4	DIM1_MOUSE	61.3	62	24	0	235	50	251	312	1.10E-14	80.5	DIM1_MOUSE	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	Dimt1 Dimt1l	Mus musculus (Mouse)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN3210_c0_g1_i3	Q9D0D4	DIM1_MOUSE	74.5	286	73	0	907	50	27	312	2.10E-122	440.3	DIM1_MOUSE	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	Dimt1 Dimt1l	Mus musculus (Mouse)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN3210_c0_g1_i4	Q9D0D4	DIM1_MOUSE	74.5	286	73	0	907	50	27	312	2.20E-122	440.3	DIM1_MOUSE	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	Dimt1 Dimt1l	Mus musculus (Mouse)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN21609_c0_g1_i1	Q9UNQ2	DIM1_HUMAN	52.4	84	39	1	260	9	60	142	1.10E-16	87	DIM1_HUMAN	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	DIMT1 DIMT1L HUSSY-05	Homo sapiens (Human)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN21197_c0_g1_i1	Q9UNQ2	DIM1_HUMAN	100	247	0	0	743	3	17	263	8.50E-139	494.2	DIM1_HUMAN	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	DIMT1 DIMT1L HUSSY-05	Homo sapiens (Human)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN21197_c0_g1_i2	Q9D0D4	DIM1_MOUSE	99	196	2	0	590	3	17	212	1.50E-106	386.7	DIM1_MOUSE	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	Dimt1 Dimt1l	Mus musculus (Mouse)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN5572_c0_g1_i1	Q2KHT8	DIM1_BOVIN	73.2	71	19	0	227	15	115	185	1.80E-23	109.4	DIM1_BOVIN	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	DIMT1 DIMT1L	Bos taurus (Bovine)	313	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN3210_c0_g1_i5	Q9VAQ5	DIM1_DROME	54.1	133	43	1	518	120	1	115	5.70E-34	145.6	DIM1_DROME	reviewed	"Probable dimethyladenosine transferase (EC 2.1.1.183) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	CG11837	Drosophila melanogaster (Fruit fly)	306	"mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; rRNA methylation [GO:0031167]"	mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005730; GO:0005759; GO:0031167; GO:0052909	rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN37176_c0_g1_i1	C4JHY5	DAPB_UNCRE	51.2	82	36	3	2	238	784	864	7.20E-13	74.3	DAPB_UNCRE	reviewed	Probable dipeptidyl-aminopeptidase B (DPAP B) (EC 3.4.14.5)	DAPB UREG_01410	Uncinocarpus reesii (strain UAMH 1704)	914	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]	aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005774; GO:0008236; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN861_c0_g1_i10	Q9VUM0	MSH6_DROME	44.3	97	51	1	485	204	1091	1187	3.60E-19	96.7	MSH6_DROME	reviewed	Probable DNA mismatch repair protein Msh6	Msh6 CG7003	Drosophila melanogaster (Fruit fly)	1190	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008630; GO:0030983; GO:0032300; GO:0032301; GO:0036297; GO:0043570; GO:0045910	DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]		NA	NA	NA	NA	NA	NA
TRINITY_DN861_c0_g1_i16	Q9VUM0	MSH6_DROME	43.3	97	51	2	484	206	1091	1187	4.40E-17	91.3	MSH6_DROME	reviewed	Probable DNA mismatch repair protein Msh6	Msh6 CG7003	Drosophila melanogaster (Fruit fly)	1190	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008630; GO:0030983; GO:0032300; GO:0032301; GO:0036297; GO:0043570; GO:0045910	DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]		NA	NA	NA	NA	NA	NA
TRINITY_DN861_c0_g1_i17	Q9VUM0	MSH6_DROME	67.4	46	15	0	138	1	1091	1136	1.40E-13	79.3	MSH6_DROME	reviewed	Probable DNA mismatch repair protein Msh6	Msh6 CG7003	Drosophila melanogaster (Fruit fly)	1190	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008630; GO:0030983; GO:0032300; GO:0032301; GO:0036297; GO:0043570; GO:0045910	DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]		NA	NA	NA	NA	NA	NA
TRINITY_DN861_c0_g1_i6	Q9VUM0	MSH6_DROME	43.3	97	52	1	485	204	1091	1187	1.50E-18	94.4	MSH6_DROME	reviewed	Probable DNA mismatch repair protein Msh6	Msh6 CG7003	Drosophila melanogaster (Fruit fly)	1190	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]	mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]	ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; mismatched DNA binding [GO:0030983]	GO:0000400; GO:0000710; GO:0005524; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008630; GO:0030983; GO:0032300; GO:0032301; GO:0036297; GO:0043570; GO:0045910	DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; pyrimidine dimer repair [GO:0006290]		NA	NA	NA	NA	NA	NA
TRINITY_DN2131_c0_g1_i1	Q9VQY9	PSF2_DROME	52.5	80	38	0	79	318	39	118	1.50E-20	100.1	PSF2_DROME	reviewed	Probable DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	Psf2 CG18013	Drosophila melanogaster (Fruit fly)	203	"CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]		GO:0000727; GO:0000811; GO:0005634; GO:0006270; GO:0006271; GO:0030261; GO:0031298; GO:0032508; GO:0032784; GO:0071162	"chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2131_c0_g1_i2	Q9VQY9	PSF2_DROME	55.1	118	53	0	87	440	1	118	1.70E-33	144.4	PSF2_DROME	reviewed	Probable DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	Psf2 CG18013	Drosophila melanogaster (Fruit fly)	203	"CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]		GO:0000727; GO:0000811; GO:0005634; GO:0006270; GO:0006271; GO:0030261; GO:0031298; GO:0032508; GO:0032784; GO:0071162	"chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2131_c0_g1_i2	Q9VQY9	PSF2_DROME	53.3	60	28	0	485	664	119	178	7.00E-11	69.3	PSF2_DROME	reviewed	Probable DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	Psf2 CG18013	Drosophila melanogaster (Fruit fly)	203	"CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]		GO:0000727; GO:0000811; GO:0005634; GO:0006270; GO:0006271; GO:0030261; GO:0031298; GO:0032508; GO:0032784; GO:0071162	"chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2131_c0_g1_i3	Q9VQY9	PSF2_DROME	54.5	178	81	0	87	620	1	178	5.40E-53	209.1	PSF2_DROME	reviewed	Probable DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	Psf2 CG18013	Drosophila melanogaster (Fruit fly)	203	"CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]		GO:0000727; GO:0000811; GO:0005634; GO:0006270; GO:0006271; GO:0030261; GO:0031298; GO:0032508; GO:0032784; GO:0071162	"chromosome condensation [GO:0030261]; DNA duplex unwinding [GO:0032508]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated transcription, elongation [GO:0032784]"		blue	blue	NA	NA	NA	NA
TRINITY_DN20573_c0_g1_i1	Q55BP5	TOP2_DICDI	61.7	60	23	0	12	191	403	462	5.70E-16	84.3	TOP2_DICDI	reviewed	Probable DNA topoisomerase 2 (EC 5.6.2.2) (DNA topoisomerase II)	top2 topB DDB_G0270418	Dictyostelium discoideum (Slime mold)	1521	"chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; DNA topological change [GO:0006265]; mitotic DNA integrity checkpoint [GO:0044774]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]"	chromosome [GO:0005694]; nucleus [GO:0005634]	"ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]"	GO:0000712; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0005694; GO:0006265; GO:0044774; GO:0046872	DNA topological change [GO:0006265]; mitotic DNA integrity checkpoint [GO:0044774]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN39996_c0_g1_i1	Q9P7X8	RPA2_SCHPO	67.1	76	25	0	256	29	465	540	1.80E-27	122.9	RPA2_SCHPO	reviewed	Probable DNA-directed RNA polymerase I subunit RPA2 (EC 2.7.7.6) (DNA-directed RNA polymerase I polypeptide 2) (RNA polymerase I subunit 2)	rpa2 SPBP23A10.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1174	RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase I [GO:0006360]	RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005736; GO:0006360; GO:0032549; GO:0046872	transcription by RNA polymerase I [GO:0006360]		NA	NA	NA	NA	NA	NA
TRINITY_DN29668_c0_g1_i1	Q9W3V8	ALG8_DROME	69.3	101	31	0	323	21	15	115	6.20E-35	148.3	ALG8_DROME	reviewed	"Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase) (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Protein xiantuan)"	xit CG4542	Drosophila melanogaster (Fruit fly)	511	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; apical constriction involved in gastrulation [GO:0003384]; germ-band extension [GO:0007377]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]"	GO:0003384; GO:0005783; GO:0005789; GO:0006486; GO:0006487; GO:0006490; GO:0007377; GO:0016021; GO:0042283	apical constriction involved in gastrulation [GO:0003384]; germ-band extension [GO:0007377]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN16892_c0_g1_i1	Q6P8H8	ALG8_MOUSE	47.3	205	106	1	7	615	314	518	1.70E-47	190.7	ALG8_MOUSE	reviewed	"Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	Alg8 Gm1089	Mus musculus (Mouse)	526	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]"	GO:0000033; GO:0005789; GO:0006487; GO:0006490; GO:0016021; GO:0018279; GO:0042283	oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN16892_c0_g1_i2	Q6P8H8	ALG8_MOUSE	43.6	172	95	1	53	562	347	518	1.00E-35	151.4	ALG8_MOUSE	reviewed	"Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	Alg8 Gm1089	Mus musculus (Mouse)	526	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]"	GO:0000033; GO:0005789; GO:0006487; GO:0006490; GO:0016021; GO:0018279; GO:0042283	oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN35427_c0_g1_i1	Q54QG6	ALG6_DICDI	54.8	93	39	2	280	2	31	120	2.90E-23	109	ALG6_DICDI	reviewed	"Probable dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	alg6 DDB_G0283841	Dictyostelium discoideum (Slime mold)	518	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]"	GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0042281	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN3385_c2_g1_i1	Q9VH78	ALG12_DROME	49.4	476	240	1	2215	791	1	476	2.10E-135	484.6	ALG12_DROME	reviewed	"Probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog)"	Alg12 CG8412	Drosophila melanogaster (Fruit fly)	678	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006486; GO:0006487; GO:0006488; GO:0016021; GO:0052824; GO:0052917	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN3385_c2_g1_i3	Q9VH78	ALG12_DROME	49.4	476	240	1	2042	618	1	476	1.90E-135	484.6	ALG12_DROME	reviewed	"Probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog)"	Alg12 CG8412	Drosophila melanogaster (Fruit fly)	678	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity [GO:0052824]; dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0052917]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006486; GO:0006487; GO:0006488; GO:0016021; GO:0052824; GO:0052917	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN34676_c0_g1_i1	G5EDB2	MADD3_CAEEL	61.1	72	28	0	223	8	708	779	2.00E-21	102.8	MADD3_CAEEL	reviewed	Probable dual specificity protein kinase madd-3 (EC 2.7.11.-) (Muscle arm development defective protein 3)	madd-3 tag-172 E02H4.3	Caenorhabditis elegans	887	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN426_c0_g1_i1	Q54T76	DUSP4_DICDI	29.2	130	68	5	406	74	265	389	4.00E-08	59.7	DUSP4_DICDI	reviewed	Probable dual specificity protein phosphatase DDB_G0281963 (EC 3.1.3.16) (EC 3.1.3.48)	DDB_G0281963	Dictyostelium discoideum (Slime mold)	394	nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0006470; GO:0008138	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN426_c0_g1_i4	Q54T76	DUSP4_DICDI	47.7	44	22	1	205	74	347	389	5.80E-05	48.9	DUSP4_DICDI	reviewed	Probable dual specificity protein phosphatase DDB_G0281963 (EC 3.1.3.16) (EC 3.1.3.48)	DDB_G0281963	Dictyostelium discoideum (Slime mold)	394	nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0006470; GO:0008138	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN28454_c0_g1_i1	Q84RR0	ARI7_ARATH	67.8	59	17	1	5	175	268	326	1.30E-20	99.8	ARI7_ARATH	reviewed	Probable E3 ubiquitin-protein ligase ARI7 (EC 2.3.2.31) (ARIADNE-like protein ARI7) (Protein ariadne homolog 7) (RING-type E3 ubiquitin transferase ARI7)	ARI7 At2g31510 T9H9.3	Arabidopsis thaliana (Mouse-ear cress)	562	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5888_c0_g1_i1	Q86UW9	DTX2_HUMAN	48.4	258	121	4	850	86	371	619	3.70E-64	247.3	DTX2_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2)	DTX2 KIAA1528 RNF58	Homo sapiens (Human)	622	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0031965; GO:0061630	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN5888_c0_g1_i3	Q86UW9	DTX2_HUMAN	48.4	258	121	4	850	86	371	619	3.20E-64	247.3	DTX2_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2)	DTX2 KIAA1528 RNF58	Homo sapiens (Human)	622	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0031965; GO:0061630	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN12665_c0_g1_i2	Q15751	HERC1_HUMAN	39.1	87	45	2	1626	1862	4282	4368	5.90E-06	54.3	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN12665_c0_g1_i3	Q15751	HERC1_HUMAN	41	78	38	2	1626	1835	4282	4359	1.30E-05	53.1	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c0_g1_i4	Q15751	HERC1_HUMAN	65.4	625	212	1	1947	85	4236	4860	2.60E-235	816.2	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	1	NA	NA	NA
TRINITY_DN36298_c0_g1_i1	Q15751	HERC1_HUMAN	56.7	67	29	0	75	275	4222	4288	2.20E-15	82.8	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c0_g2_i1	Q15751	HERC1_HUMAN	69.6	135	36	1	412	23	4084	4218	2.40E-50	199.5	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c0_g1_i1	Q15751	HERC1_HUMAN	64.6	1034	355	4	3156	85	3828	4860	0	1354	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c0_g1_i3	Q15751	HERC1_HUMAN	67.9	901	285	1	2775	85	3960	4860	0	1263.1	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c0_g1_i7	Q15751	HERC1_HUMAN	65.8	558	187	1	1746	85	4303	4860	4.20E-208	726.5	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN19870_c0_g1_i1	Q15751	HERC1_HUMAN	65.6	64	21	1	193	5	696	759	3.00E-21	102.1	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN19870_c0_g1_i2	Q15751	HERC1_HUMAN	65.9	126	42	1	379	5	634	759	2.90E-48	192.6	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN19870_c0_g1_i3	Q15751	HERC1_HUMAN	54.8	73	33	0	220	2	634	706	1.10E-15	83.6	HERC1_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	HERC1	Homo sapiens (Human)	4861	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN17409_c0_g3_i1	Q9VR91	HERC2_DROME	30.7	150	87	5	486	43	1420	1554	2.10E-11	70.5	HERC2_DROME	reviewed	Probable E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	HERC2 CG11734	Drosophila melanogaster (Fruit fly)	4912	centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]	centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005737; GO:0005814; GO:0016567; GO:0046872; GO:0061630	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN30825_c0_g1_i1	Q15034	HERC3_HUMAN	38.5	104	46	4	301	20	285	380	1.50E-09	63.5	HERC3_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC3 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 3) (HECT-type E3 ubiquitin transferase HERC3)	HERC3 KIAA0032	Homo sapiens (Human)	1050	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005829; GO:0031410			NA	NA	NA	NA	NA	NA
TRINITY_DN30825_c0_g1_i2	Q15034	HERC3_HUMAN	41.3	104	51	3	325	20	285	380	6.40E-14	78.2	HERC3_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC3 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 3) (HECT-type E3 ubiquitin transferase HERC3)	HERC3 KIAA0032	Homo sapiens (Human)	1050	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005829; GO:0031410			NA	NA	NA	NA	NA	NA
TRINITY_DN37394_c0_g1_i1	Q5PQN1	HERC4_RAT	49.5	105	53	0	17	331	128	232	1.50E-21	103.6	HERC4_RAT	reviewed	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	Herc4	Rattus norvegicus (Rat)	1057	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; fibrillar center [GO:0001650]	ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154; GO:0045879	cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN30465_c0_g1_i1	Q5GLZ8	HERC4_HUMAN	45.7	70	38	0	215	6	710	779	6.70E-12	70.9	HERC4_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	HERC4 KIAA1593	Homo sapiens (Human)	1057	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; fibrillar center [GO:0001650]	ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154; GO:0045879	cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6396_c0_g2_i1	Q5PQN1	HERC4_RAT	40.7	371	205	5	1	1077	458	825	3.30E-67	256.9	HERC4_RAT	reviewed	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	Herc4	Rattus norvegicus (Rat)	1057	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; fibrillar center [GO:0001650]	ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154; GO:0045879	cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6396_c0_g1_i1	Q6PAV2	HERC4_MOUSE	55.4	204	90	1	612	4	831	1034	4.60E-61	235.7	HERC4_MOUSE	reviewed	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	Herc4	Mus musculus (Mouse)	1057	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; fibrillar center [GO:0001650]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630	cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6396_c0_g1_i2	Q5PQN1	HERC4_RAT	63.4	145	52	1	435	4	890	1034	1.80E-49	196.8	HERC4_RAT	reviewed	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	Herc4	Rattus norvegicus (Rat)	1057	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; fibrillar center [GO:0001650]	ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154; GO:0045879	cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN36460_c0_g1_i1	Q2MJS2	I2BPL_MACMU	53.6	192	66	5	626	87	613	793	1.30E-39	164.5	I2BPL_MACMU	reviewed	Probable E3 ubiquitin-protein ligase IRF2BPL (EC 2.3.2.27) (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like)	IRF2BPL EAP1	Macaca mulatta (Rhesus macaque)	794	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]	GO:0000122; GO:0003714; GO:0005634; GO:0006357; GO:0045944; GO:0046543; GO:0046872; GO:0061630	development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27288_c0_g1_i1	Q9H000	MKRN2_HUMAN	98.7	76	1	0	229	2	264	339	3.90E-42	171.4	MKRN2_HUMAN	reviewed	Probable E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2)	MKRN2 RNF62 HSPC070	Homo sapiens (Human)	416	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0003723; GO:0016567; GO:0046872; GO:0061630	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN38188_c0_g1_i1	Q9ERV1	MKRN2_MOUSE	100	81	0	0	1	243	294	374	2.20E-43	175.6	MKRN2_MOUSE	reviewed	Probable E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-2)	Mkrn2	Mus musculus (Mouse)	416	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0016567; GO:0046872; GO:0061630	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN35462_c0_g1_i1	Q9ERV1	MKRN2_MOUSE	48.6	249	122	4	2	748	146	388	2.50E-71	270.4	MKRN2_MOUSE	reviewed	Probable E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-2)	Mkrn2	Mus musculus (Mouse)	416	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0016567; GO:0046872; GO:0061630	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN35462_c0_g1_i2	Q9DD48	MKRN2_SERQU	55.1	69	28	2	78	284	320	385	1.20E-16	87.8	MKRN2_SERQU	reviewed	Probable E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-2) (Zinc finger protein YGHLC3HC4)	mkrn2 yghl2 yghlc3hc4	Seriola quinqueradiata (Five-ray yellowtail)	423	metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; transferase activity [GO:0016740]	GO:0007399; GO:0016567; GO:0016740; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; nervous system development [GO:0007399]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN25400_c0_g1_i1	Q6T486	RBRA_DICDI	65.1	86	30	0	3	260	270	355	1.10E-31	137.1	RBRA_DICDI	reviewed	Probable E3 ubiquitin-protein ligase rbrA (EC 2.3.2.31) (Ariadne-like ubiquitin ligase)	rbrA DDB_G0286961	Dictyostelium discoideum (Slime mold)	520	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; sporulation resulting in formation of a cellular spore [GO:0030435]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0030435; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; sporulation resulting in formation of a cellular spore [GO:0030435]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4804_c0_g1_i1	A4IIY1	R144A_XENTR	50.6	249	112	2	893	180	18	266	2.10E-72	275	R144A_XENTR	reviewed	Probable E3 ubiquitin-protein ligase RNF144A (EC 2.3.2.31) (RING finger protein 144A)	rnf144a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	292	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0005794; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN33549_c0_g1_i1	P94132	ETFD_ACIAD	71.8	78	20	2	239	9	12	88	5.00E-24	111.3	ETFD_ACIAD	reviewed	Probable electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	etfD ACIAD1680	Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)	570	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]"	GO:0004174; GO:0046872; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN30632_c0_g1_i1	P94132	ETFD_ACIAD	63.8	218	78	1	4	654	135	352	4.60E-80	298.9	ETFD_ACIAD	reviewed	Probable electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)	etfD ACIAD1680	Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)	570	"4 iron, 4 sulfur cluster binding [GO:0051539]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]"	GO:0004174; GO:0046872; GO:0051539			NA	NA	NA	NA	NA	NA
TRINITY_DN2453_c0_g1_i1	Q9VL18	EF1D_DROME	54.2	253	112	3	113	865	5	255	1.10E-47	191.8	EF1D_DROME	reviewed	Probable elongation factor 1-delta (EF-1-delta)	eEF1delta CG4912	Drosophila melanogaster (Fruit fly)	256	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414	translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN2453_c0_g1_i2	Q9VL18	EF1D_DROME	51.4	251	97	3	113	790	5	255	3.20E-41	170.2	EF1D_DROME	reviewed	Probable elongation factor 1-delta (EF-1-delta)	eEF1delta CG4912	Drosophila melanogaster (Fruit fly)	256	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]	guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414	translational elongation [GO:0006414]		blue	blue	NA	NA	NA	NA
TRINITY_DN28804_c0_g1_i1	Q11174	CHIT_CAEEL	47.1	70	37	0	2	211	129	198	7.20E-14	77.4	CHIT_CAEEL	reviewed	Probable endochitinase (EC 3.2.1.14)	cht-1 C04F6.3	Caenorhabditis elegans	617	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]; response to fungus [GO:0009620]	extracellular region [GO:0005576]	chitinase activity [GO:0004568]; chitin binding [GO:0008061]	GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061; GO:0009620	chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]; response to fungus [GO:0009620]		NA	NA	NA	NA	NA	NA
TRINITY_DN24822_c0_g1_i1	A6LB99	END4_PARD8	53.2	62	29	0	70	255	184	245	4.50E-15	81.6	END4_PARD8	reviewed	Probable endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV)	nfo BDI_1200	Parabacteroides distasonis (strain ATCC 8503 / DSM 20701 / CIP 104284 / JCM 5825 / NCTC 11152)	281	deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]		deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0006281; GO:0008270; GO:0008833	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN24822_c0_g1_i2	C0QMG1	END4_DESAH	52.9	119	56	0	1	357	126	244	4.70E-34	145.2	END4_DESAH	reviewed	Probable endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV)	nfo HRM2_34030	Desulfobacterium autotrophicum (strain ATCC 43914 / DSM 3382 / HRM2)	279	deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]		deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0006281; GO:0008270; GO:0008833	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN36645_c0_g1_i1	Q52995	ECHH_RHIME	86.2	87	12	0	3	263	94	180	6.40E-36	151	ECHH_RHIME	reviewed	Probable enoyl-CoA hydratase (EC 4.2.1.17)	fadB1 R00366 SMc01153	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	257	enoyl-CoA hydratase activity [GO:0004300]; fatty acid metabolic process [GO:0006631]		enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN29225_c0_g1_i1	P64017	ECHA8_MYCBO	65.7	105	35	1	3	317	52	155	4.60E-33	141.7	ECHA8_MYCBO	reviewed	Probable enoyl-CoA hydratase echA8 (EC 4.2.1.17)	echA8 BQ2027_MB1099C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	257	enoyl-CoA hydratase activity [GO:0004300]; fatty acid metabolic process [GO:0006631]		enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN38434_c0_g1_i1	P64017	ECHA8_MYCBO	82.6	92	16	0	10	285	93	184	5.20E-36	151.4	ECHA8_MYCBO	reviewed	Probable enoyl-CoA hydratase echA8 (EC 4.2.1.17)	echA8 BQ2027_MB1099C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	257	enoyl-CoA hydratase activity [GO:0004300]; fatty acid metabolic process [GO:0006631]		enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN18307_c0_g1_i1	P64017	ECHA8_MYCBO	70.3	128	38	0	2	385	58	185	1.30E-42	173.7	ECHA8_MYCBO	reviewed	Probable enoyl-CoA hydratase echA8 (EC 4.2.1.17)	echA8 BQ2027_MB1099C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	257	enoyl-CoA hydratase activity [GO:0004300]; fatty acid metabolic process [GO:0006631]		enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN18307_c0_g1_i2	P64017	ECHA8_MYCBO	69.5	128	39	0	2	385	58	185	1.30E-42	173.7	ECHA8_MYCBO	reviewed	Probable enoyl-CoA hydratase echA8 (EC 4.2.1.17)	echA8 BQ2027_MB1099C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	257	enoyl-CoA hydratase activity [GO:0004300]; fatty acid metabolic process [GO:0006631]		enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0006631	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN34190_c0_g1_i1	Q1ZXF1	ECHM_DICDI	65.5	142	48	1	10	435	60	200	1.20E-47	190.7	ECHM_DICDI	reviewed	"Probable enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)"	echs1 DDB_G0285071	Dictyostelium discoideum (Slime mold)	277	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0005739; GO:0005759; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN24503_c0_g1_i1	O17214	FUMH_CAEEL	66.5	251	84	0	3	755	150	400	2.80E-89	329.7	FUMH_CAEEL	reviewed	"Probable fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	fum-1 H14A12.2	Caenorhabditis elegans	501	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0004333; GO:0005739; GO:0005759; GO:0006099; GO:0006106; GO:0006108; GO:0045239	fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN28202_c0_g1_i1	O17214	FUMH_CAEEL	79.2	72	15	0	1	216	343	414	5.90E-24	110.9	FUMH_CAEEL	reviewed	"Probable fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	fum-1 H14A12.2	Caenorhabditis elegans	501	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]	fumarate hydratase activity [GO:0004333]	GO:0004333; GO:0005739; GO:0005759; GO:0006099; GO:0006106; GO:0006108; GO:0045239	fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3415_c0_g2_i1	Q98KK0	BODG_RHILO	39.6	101	53	2	309	7	146	238	2.80E-13	76.3	BODG_RHILO	reviewed	"Probable gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	mll1440	Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))	383	cytoplasm [GO:0005737]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; carnitine biosynthetic process [GO:0045329]	cytoplasm [GO:0005737]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]	GO:0005506; GO:0005737; GO:0008336; GO:0045329	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN14805_c0_g1_i1	B0G172	PGTB2_DICDI	55.9	68	30	0	1	204	204	271	1.50E-19	96.3	PGTB2_DICDI	reviewed	Probable geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)	rabggtb DDB_G0290671	Dictyostelium discoideum (Slime mold)	339	Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]	Rab-protein geranylgeranyltransferase complex [GO:0005968]	Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]	GO:0004663; GO:0005968; GO:0008270; GO:0017137; GO:0018342; GO:0018344	protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]		NA	NA	NA	NA	NA	NA
TRINITY_DN13441_c0_g1_i1	P51531	SMCA2_HUMAN	96.6	87	3	0	262	2	393	479	6.00E-31	134.4	SMCA2_HUMAN	reviewed	Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)	SMARCA2 BAF190B BRM SNF2A SNF2L2	Homo sapiens (Human)	1590	"intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]"	intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000790; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008285; GO:0016514; GO:0030308; GO:0042393; GO:0043044; GO:0043231; GO:0045111; GO:0045892; GO:0045893; GO:0045944; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30034_c0_g1_i1	P51531	SMCA2_HUMAN	99.2	125	1	0	1	375	809	933	8.90E-68	257.3	SMCA2_HUMAN	reviewed	Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)	SMARCA2 BAF190B BRM SNF2A SNF2L2	Homo sapiens (Human)	1590	"intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]"	intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000790; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008285; GO:0016514; GO:0030308; GO:0042393; GO:0043044; GO:0043231; GO:0045111; GO:0045892; GO:0045893; GO:0045944; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6963_c0_g1_i1	Q9VAI0	GNA1_DROME	51.3	189	89	3	111	671	5	192	5.70E-49	195.7	GNA1_DROME	reviewed	Probable glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase)	Gnpnat CG1969	Drosophila melanogaster (Fruit fly)	219	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]	glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]	GO:0004343; GO:0005783; GO:0005793; GO:0005794; GO:0006048; GO:0008080; GO:0048029	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN6963_c0_g1_i2	Q9VAI0	GNA1_DROME	51.3	189	89	3	102	662	5	192	5.60E-49	195.7	GNA1_DROME	reviewed	Probable glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase)	Gnpnat CG1969	Drosophila melanogaster (Fruit fly)	219	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]	glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]	GO:0004343; GO:0005783; GO:0005793; GO:0005794; GO:0006048; GO:0008080; GO:0048029	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN4029_c0_g1_i10	Q90218	GLRK_ANAPL	24	388	277	8	1388	258	69	449	4.90E-25	117.9	GLRK_ANAPL	reviewed	Probable glutamate receptor (Kainate-binding protein)	KBP	Anas platyrhynchos (Mallard) (Anas boschas)	487	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]	GO:0004970; GO:0016021; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN4029_c0_g1_i16	Q90218	GLRK_ANAPL	24.6	289	206	5	1002	160	69	353	5.10E-20	100.9	GLRK_ANAPL	reviewed	Probable glutamate receptor (Kainate-binding protein)	KBP	Anas platyrhynchos (Mallard) (Anas boschas)	487	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]	GO:0004970; GO:0016021; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN4029_c0_g1_i2	Q90218	GLRK_ANAPL	24.6	289	206	5	1002	160	69	353	5.10E-20	100.9	GLRK_ANAPL	reviewed	Probable glutamate receptor (Kainate-binding protein)	KBP	Anas platyrhynchos (Mallard) (Anas boschas)	487	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]	GO:0004970; GO:0016021; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN4029_c0_g1_i3	Q90218	GLRK_ANAPL	24	388	277	8	1388	258	69	449	4.90E-25	117.9	GLRK_ANAPL	reviewed	Probable glutamate receptor (Kainate-binding protein)	KBP	Anas platyrhynchos (Mallard) (Anas boschas)	487	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]	integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	ionotropic glutamate receptor activity [GO:0004970]	GO:0004970; GO:0016021; GO:0045211			NA	NA	NA	NA	NA	NA
TRINITY_DN29150_c0_g1_i1	O13775	SYEC_SCHPO	68.8	64	20	0	196	5	202	265	2.80E-20	98.6	SYEC_SCHPO	reviewed	"Probable glutamate--tRNA ligase, cytoplasmic (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)"	gus1 ers1 SPAC17A5.15c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	716	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamine-tRNA ligase activity [GO:0004819]; cytoplasmic translation [GO:0002181]; glutaminyl-tRNA aminoacylation [GO:0006425]; glutamyl-tRNA aminoacylation [GO:0006424]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; nucleus [GO:0005634]; polysome [GO:0005844]	ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamine-tRNA ligase activity [GO:0004819]	GO:0002181; GO:0004818; GO:0004819; GO:0005524; GO:0005634; GO:0005829; GO:0005844; GO:0006424; GO:0006425; GO:0010494; GO:0017102	cytoplasmic translation [GO:0002181]; glutaminyl-tRNA aminoacylation [GO:0006425]; glutamyl-tRNA aminoacylation [GO:0006424]		NA	NA	NA	NA	NA	NA
TRINITY_DN5794_c0_g1_i1	Q9CXJ1	SYEM_MOUSE	62.7	134	49	1	404	6	5	138	2.90E-39	162.9	SYEM_MOUSE	reviewed	"Probable glutamate--tRNA ligase, mitochondrial (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)"	Ears2 Kiaa1970	Mus musculus (Mouse)	523	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]; tRNA aminoacylation for mitochondrial protein translation [GO:0070127]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004818; GO:0005524; GO:0005739; GO:0005759; GO:0006424; GO:0008270; GO:0050561; GO:0070127	glutamyl-tRNA aminoacylation [GO:0006424]; tRNA aminoacylation for mitochondrial protein translation [GO:0070127]		NA	NA	NA	NA	NA	NA
TRINITY_DN343_c0_g1_i1	Q9Y105	SYQ_DROME	59.7	774	302	6	83	2377	5	777	2.30E-273	943	SYQ_DROME	reviewed	Probable glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase)	GlnRS Aats-gln CG10506	Drosophila melanogaster (Fruit fly)	778	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; dendrite morphogenesis [GO:0048813]; glutaminyl-tRNA aminoacylation [GO:0006425]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]	GO:0004819; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0017101; GO:0048813	dendrite morphogenesis [GO:0048813]; glutaminyl-tRNA aminoacylation [GO:0006425]		blue	blue	NA	NA	NA	NA
TRINITY_DN29068_c0_g1_i1	Q8SR10	SYQ_ENCCU	64.1	78	28	0	2	235	225	302	2.90E-24	112.1	SYQ_ENCCU	reviewed	Probable glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)	ECU10_1460	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	697	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; glutaminyl-tRNA aminoacylation [GO:0006425]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]	GO:0004819; GO:0005524; GO:0005737; GO:0006425	glutaminyl-tRNA aminoacylation [GO:0006425]		NA	NA	NA	NA	NA	NA
TRINITY_DN37651_c0_g1_i1	Q9Y7Y8	SYQ_SCHPO	56.9	72	31	0	2	217	342	413	4.20E-14	78.2	SYQ_SCHPO	reviewed	Probable glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)	qrs1 SPBC342.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	811	cytosol [GO:0005829]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; cytoplasmic translation [GO:0002181]; glutaminyl-tRNA aminoacylation [GO:0006425]	cytosol [GO:0005829]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]	GO:0002181; GO:0004819; GO:0005524; GO:0005829; GO:0006425	cytoplasmic translation [GO:0002181]; glutaminyl-tRNA aminoacylation [GO:0006425]		NA	NA	NA	NA	NA	NA
TRINITY_DN36850_c0_g1_i1	A9CSU5	SYQ_ENTBH	81.2	133	24	1	404	6	371	502	3.10E-61	235.7	SYQ_ENTBH	reviewed	Probable glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)	EBI_22570	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	691	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]	GO:0004819; GO:0005524; GO:0005737; GO:0006418	tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN5631_c0_g2_i1	Q20772	GCDH_CAEEL	65	203	71	0	6	614	206	408	1.60E-75	283.9	GCDH_CAEEL	reviewed	"Probable glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	F54D5.7	Caenorhabditis elegans	409	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7941_c0_g1_i1	Q20772	GCDH_CAEEL	53.7	41	19	0	92	214	22	62	1.30E-05	50.4	GCDH_CAEEL	reviewed	"Probable glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	F54D5.7	Caenorhabditis elegans	409	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7941_c0_g1_i2	Q20772	GCDH_CAEEL	45	60	25	1	27	206	13	64	9.60E-07	53.9	GCDH_CAEEL	reviewed	"Probable glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	F54D5.7	Caenorhabditis elegans	409	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN7941_c0_g1_i3	Q20772	GCDH_CAEEL	44.8	58	24	1	27	200	13	62	9.50E-06	50.8	GCDH_CAEEL	reviewed	"Probable glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	F54D5.7	Caenorhabditis elegans	409	mitochondrial matrix [GO:0005759]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]		NA	NA	NA	NA	NA	NA
TRINITY_DN28989_c0_g1_i1	Q9D7B7	GPX8_MOUSE	100	81	0	0	245	3	32	112	2.70E-41	168.7	GPX8_MOUSE	reviewed	Probable glutathione peroxidase 8 (GPx-8) (GSHPx-8) (EC 1.11.1.9)	Gpx8	Mus musculus (Mouse)	209	integral component of membrane [GO:0016021]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]	integral component of membrane [GO:0016021]	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]	GO:0004601; GO:0004602; GO:0006979; GO:0016021	response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN3744_c0_g1_i1	Q5U583	GPX8B_XENLA	47.5	179	89	3	52	579	24	200	5.60E-37	156	GPX8B_XENLA	reviewed	Probable glutathione peroxidase 8-B (GPx-8-B) (GSHPx-8-B) (EC 1.11.1.9)	gpx8-b	Xenopus laevis (African clawed frog)	209	integral component of membrane [GO:0016021]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]	integral component of membrane [GO:0016021]	glutathione peroxidase activity [GO:0004602]	GO:0004602; GO:0006979; GO:0016021	response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i1	E1BBQ2	GP158_BOVIN	35.5	107	58	4	471	163	262	361	1.60E-13	77.8	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i10	E1BBQ2	GP158_BOVIN	26.9	201	122	8	750	172	178	361	5.80E-14	81.3	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i11	E1BBQ2	GP158_BOVIN	26.9	201	122	8	741	163	178	361	5.90E-14	81.3	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i12	E1BBQ2	GP158_BOVIN	26.9	201	122	8	750	172	178	361	5.90E-14	81.3	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i13	E1BBQ2	GP158_BOVIN	26.9	201	122	8	741	163	178	361	5.80E-14	81.3	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i2	E1BBQ2	GP158_BOVIN	26.9	201	122	8	741	163	178	361	5.80E-14	81.3	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i3	E1BBQ2	GP158_BOVIN	24.3	189	116	9	581	39	178	347	1.60E-05	53.1	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN681_c0_g1_i9	E1BBQ2	GP158_BOVIN	26.9	201	122	8	750	172	178	361	5.80E-14	81.3	GP158_BOVIN	reviewed	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3972_c0_g1_i2	Q9VXD9	MTH1_DROME	30.6	121	79	3	363	7	335	452	1.70E-06	55.5	MTH1_DROME	reviewed	Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1)	mthl1 CG4521	Drosophila melanogaster (Fruit fly)	676	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016021; GO:0042594; GO:0043519; GO:0048383; GO:0070252	actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN27122_c0_g1_i1	Q9VXD9	MTH1_DROME	36.8	193	103	7	673	122	416	598	3.30E-20	100.1	MTH1_DROME	reviewed	Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1)	mthl1 CG4521	Drosophila melanogaster (Fruit fly)	676	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016021; GO:0042594; GO:0043519; GO:0048383; GO:0070252	actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN5897_c0_g1_i2	Q9VXD9	MTH1_DROME	24.8	411	237	20	1073	3	61	453	2.60E-12	75.1	MTH1_DROME	reviewed	Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1)	mthl1 CG4521	Drosophila melanogaster (Fruit fly)	676	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016021; GO:0042594; GO:0043519; GO:0048383; GO:0070252	actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN27812_c0_g1_i1	P9WPZ0	Y1496_MYCTO	74	77	20	0	232	2	115	191	8.80E-26	117.1	Y1496_MYCTO	reviewed	Probable GTPase MT1543 (EC 3.6.-.-)	MT1543	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	334	ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]		ATP binding [GO:0005524]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005524; GO:0005525			NA	NA	NA	NA	NA	NA
TRINITY_DN37601_c0_g1_i1	Q86YR7	MF2L2_HUMAN	50	60	30	0	26	205	278	337	1.40E-09	63.2	MF2L2_HUMAN	reviewed	Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2)	MCF2L2 DRG KIAA0861	Homo sapiens (Human)	1114	guanyl-nucleotide exchange factor activity [GO:0005085]		guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085			NA	NA	NA	NA	NA	NA
TRINITY_DN278_c0_g1_i3	Q7Z333	SETX_HUMAN	25.2	763	452	27	2445	355	1593	2302	2.10E-38	162.9	SETX_HUMAN	reviewed	Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)	SETX ALS4 KIAA0625 SCAR1	Homo sapiens (Human)	2677	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18933_c0_g1_i1	Q6DFV5	HELZ_MOUSE	36.8	296	176	7	306	1175	159	449	4.30E-44	180.3	HELZ_MOUSE	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-)	Helz Kiaa0054	Mus musculus (Mouse)	1964	cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0035194; GO:0043186; GO:0046872	post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN18933_c0_g2_i1	P42694	HELZ_HUMAN	61.3	623	216	6	3	1829	456	1067	1.10E-216	754.2	HELZ_HUMAN	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein)	HELZ DRHC KIAA0054	Homo sapiens (Human)	1942	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0035194; GO:0043186; GO:0046872	post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN18933_c0_g2_i2	P42694	HELZ_HUMAN	48.4	221	106	3	3	665	456	668	1.10E-52	208	HELZ_HUMAN	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein)	HELZ DRHC KIAA0054	Homo sapiens (Human)	1942	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0035194; GO:0043186; GO:0046872	post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN18933_c0_g2_i3	P42694	HELZ_HUMAN	56	300	124	3	3	902	456	747	3.80E-91	336.3	HELZ_HUMAN	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein)	HELZ DRHC KIAA0054	Homo sapiens (Human)	1942	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0035194; GO:0043186; GO:0046872	post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN18933_c0_g3_i1	P42694	HELZ_HUMAN	67.3	52	17	0	79	234	1061	1112	1.90E-14	79.7	HELZ_HUMAN	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein)	HELZ DRHC KIAA0054	Homo sapiens (Human)	1942	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0035194; GO:0043186; GO:0046872	post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN29177_c0_g1_i1	P42694	HELZ_HUMAN	100	95	0	0	2	286	699	793	2.00E-51	202.6	HELZ_HUMAN	reviewed	Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein)	HELZ DRHC KIAA0054	Homo sapiens (Human)	1942	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0035194; GO:0043186; GO:0046872	post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN28243_c0_g1_i1	P56521	HDA19_MAIZE	72.5	80	21	1	257	18	146	224	5.00E-30	131.3	HDA19_MAIZE	reviewed	Probable histone deacetylase 19 (EC 3.5.1.98) (RPD3 homolog)		Zea mays (Maize)	513	nucleus [GO:0005634]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	nucleus [GO:0005634]	NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]	GO:0005634; GO:0032041			NA	NA	NA	NA	NA	NA
TRINITY_DN8214_c0_g1_i2	Q9NQW5	PRDM7_HUMAN	46.3	67	35	1	228	31	229	295	3.50E-09	62.4	PRDM7_HUMAN	reviewed	Probable histone-lysine N-methyltransferase PRDM7 (EC 2.1.1.-) (PR domain zinc finger protein 7) (PR domain-containing protein 7)	PRDM7 PFM4	Homo sapiens (Human)	492	"chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; nucleus [GO:0005634]	histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]	GO:0005634; GO:0005694; GO:0006355; GO:0010468; GO:0010845; GO:0042054; GO:0042800; GO:0046975; GO:0080182	"histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8214_c0_g1_i4	Q9NQW5	PRDM7_HUMAN	47.1	68	34	2	253	53	229	295	8.50E-09	61.2	PRDM7_HUMAN	reviewed	Probable histone-lysine N-methyltransferase PRDM7 (EC 2.1.1.-) (PR domain zinc finger protein 7) (PR domain-containing protein 7)	PRDM7 PFM4	Homo sapiens (Human)	492	"chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; nucleus [GO:0005634]	histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]	GO:0005634; GO:0005694; GO:0006355; GO:0010468; GO:0010845; GO:0042054; GO:0042800; GO:0046975; GO:0080182	"histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"		brown	brown	1	NA	NA	NA
TRINITY_DN838_c0_g1_i7	Q4AC99	1A1L2_HUMAN	39	249	151	1	77	823	308	555	1.90E-51	204.5	1A1L2_HUMAN	reviewed	Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2 (ACC synthase-like protein 2)	ACCSL	Homo sapiens (Human)	568	catalytic activity [GO:0003824]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]		catalytic activity [GO:0003824]; pyridoxal phosphate binding [GO:0030170]	GO:0003824; GO:0009058; GO:0030170	biosynthetic process [GO:0009058]		NA	NA	NA	NA	NA	NA
TRINITY_DN26394_c0_g1_i1	O14306	YE8A_SCHPO	38	71	43	1	1	210	917	987	5.40E-07	54.7	YE8A_SCHPO	reviewed	Probable inositol polyphosphate 5-phosphatase C9G1.10c (EC 3.1.3.-)	SPAC9G1.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1191	"actin cortical patch [GO:0030479]; cell division site [GO:0032153]; cell tip [GO:0051286]; cytosol [GO:0005829]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; inositol lipid-mediated signaling [GO:0048017]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]"	actin cortical patch [GO:0030479]; cell division site [GO:0032153]; cell tip [GO:0051286]; cytosol [GO:0005829]	"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]"	GO:0004439; GO:0005829; GO:0030479; GO:0032153; GO:0046855; GO:0046856; GO:0048017; GO:0051286	inositol lipid-mediated signaling [GO:0048017]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN5692_c0_g1_i1	Q9VWH4	IDH3A_DROME	79.4	170	35	0	604	95	208	377	1.10E-73	278.1	IDH3A_DROME	reviewed	"Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)"	Idh3a l(1)G0156 CG12233	Drosophila melanogaster (Fruit fly)	377	mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN5692_c0_g1_i2	Q9VWH4	IDH3A_DROME	83.1	260	44	0	874	95	118	377	5.90E-123	441.8	IDH3A_DROME	reviewed	"Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)"	Idh3a l(1)G0156 CG12233	Drosophila melanogaster (Fruit fly)	377	mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN5153_c0_g1_i3	Q9VWH4	IDH3A_DROME	60.2	83	31	1	238	480	17	99	6.30E-18	92	IDH3A_DROME	reviewed	"Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)"	Idh3a l(1)G0156 CG12233	Drosophila melanogaster (Fruit fly)	377	mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287	isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN40701_c0_g1_i1	B7XK16	SYIC_ENTBH	78.7	89	19	0	28	294	574	662	2.00E-35	149.4	SYIC_ENTBH	reviewed	"Probable isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	EBI_22873	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	953	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]	GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0006428	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN6378_c0_g1_i1	Q54YD4	SYIC_DICDI	60.3	73	29	0	227	9	691	763	1.10E-20	100.1	SYIC_DICDI	reviewed	"Probable isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	ileS DDB_G0278293	Dictyostelium discoideum (Slime mold)	1067	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005829; GO:0006428	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN6378_c0_g3_i1	Q54YD4	SYIC_DICDI	66.4	304	102	0	9	920	385	688	5.40E-127	455.3	SYIC_DICDI	reviewed	"Probable isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	ileS DDB_G0278293	Dictyostelium discoideum (Slime mold)	1067	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005829; GO:0006428	isoleucyl-tRNA aminoacylation [GO:0006428]		NA	NA	NA	NA	NA	NA
TRINITY_DN29443_c0_g1_i1	Q15652	JHD2C_HUMAN	98.6	71	1	0	7	219	1840	1910	8.60E-39	160.2	JHD2C_HUMAN	reviewed	Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8)	JMJD1C JHDM2C KIAA1380 TRIP8	Homo sapiens (Human)	2540	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; blood coagulation [GO:0007596]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006355; GO:0006357; GO:0007596; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0046966; GO:0051213	"blood coagulation [GO:0007596]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6377_c0_g1_i1	B7XHP6	SYLC_ENTBH	67.8	115	33	2	351	19	3	117	1.00E-36	154.1	SYLC_ENTBH	reviewed	"Probable leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	EBI_21702	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	860	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN34981_c0_g1_i1	B7XHP6	SYLC_ENTBH	67.6	74	24	0	11	232	129	202	1.90E-28	125.9	SYLC_ENTBH	reviewed	"Probable leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	EBI_21702	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	860	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	1	NA	NA	NA
TRINITY_DN12584_c0_g1_i1	C4V8L1	SYLC_NOSCE	68.3	104	33	0	312	1	504	607	2.10E-39	162.9	SYLC_NOSCE	reviewed	"Probable leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	NCER_100842	Nosema ceranae (strain BRL01) (Microsporidian parasite)	884	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; regulation of TORC1 signaling [GO:1903432]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005737; GO:0006429; GO:1903432	leucyl-tRNA aminoacylation [GO:0006429]; regulation of TORC1 signaling [GO:1903432]		NA	NA	NA	NA	NA	NA
TRINITY_DN31300_c0_g1_i1	Q8SRS8	SYLC_ENCCU	62	92	34	1	4	279	373	463	1.30E-26	120.2	SYLC_ENCCU	reviewed	"Probable leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	ECU06_0280	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	874	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0004823; GO:0005524; GO:0005737; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN16292_c0_g1_i1	Q15031	SYLM_HUMAN	51.2	82	38	1	96	335	625	706	1.60E-15	83.6	SYLM_HUMAN	reviewed	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS2 KIAA0028	Homo sapiens (Human)	903	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006429; GO:0032543	leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16292_c0_g1_i2	Q8VDC0	SYLM_MOUSE	40.2	219	114	3	19	633	292	507	1.90E-39	164.1	SYLM_MOUSE	reviewed	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	Lars2	Mus musculus (Mouse)	902	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006429; GO:0032543	leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN16292_c0_g1_i3	Q5RDP4	SYLM_PONAB	44.1	415	218	4	19	1224	293	706	1.30E-99	364.8	SYLM_PONAB	reviewed	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	903	mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	mitochondrial matrix [GO:0005759]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005759; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN16292_c0_g1_i4	Q5RDP4	SYLM_PONAB	43.9	415	219	4	19	1224	293	706	4.90E-99	362.8	SYLM_PONAB	reviewed	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	LARS2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	903	mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]	mitochondrial matrix [GO:0005759]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005759; GO:0006429	leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN16292_c0_g1_i5	Q8VDC0	SYLM_MOUSE	43.8	274	137	3	19	798	292	562	2.30E-61	237.3	SYLM_MOUSE	reviewed	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	Lars2	Mus musculus (Mouse)	902	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006429; GO:0032543	leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN29437_c0_g1_i1	Q8RXU4	THA1_ARATH	55.2	96	42	1	3	290	158	252	7.40E-22	104.4	THA1_ARATH	reviewed	Probable low-specificity L-threonine aldolase 1 (EC 4.1.2.48) (Threonine aldolase 1)	THA1 At1g08630 F22O13.11	Arabidopsis thaliana (Mouse-ear cress)	358	cytosol [GO:0005829]; L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]; glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]	cytosol [GO:0005829]	L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]	GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732	glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]		NA	NA	NA	NA	NA	NA
TRINITY_DN9513_c0_g1_i1	Q8RXU4	THA1_ARATH	43.6	349	182	3	1145	105	6	341	1.40E-80	301.6	THA1_ARATH	reviewed	Probable low-specificity L-threonine aldolase 1 (EC 4.1.2.48) (Threonine aldolase 1)	THA1 At1g08630 F22O13.11	Arabidopsis thaliana (Mouse-ear cress)	358	cytosol [GO:0005829]; L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]; glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]	cytosol [GO:0005829]	L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]	GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732	glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3390_c0_g1_i1	Q9FPH3	THA2_ARATH	41.5	354	190	4	647	1699	7	346	2.90E-71	271.2	THA2_ARATH	reviewed	Probable low-specificity L-threonine aldolase 2 (EC 4.1.2.48) (Threonine aldolase 2)	THA2 At3g04520 T27C4.17	Arabidopsis thaliana (Mouse-ear cress)	355	cytosol [GO:0005829]; L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]; glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]	cytosol [GO:0005829]	L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]	GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732	glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]		blue	blue	NA	NA	NA	NA
TRINITY_DN33913_c0_g1_i1	C0LGV0	Y5487_ARATH	49.3	69	34	1	9	212	706	774	2.80E-10	65.5	Y5487_ARATH	reviewed	Probable LRR receptor-like serine/threonine-protein kinase At5g48740 (EC 2.7.11.1)	At5g48740 K24G6.7	Arabidopsis thaliana (Mouse-ear cress)	895	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN37549_c0_g1_i1	O49445	LRK72_ARATH	47.1	68	35	1	205	5	452	519	3.50E-10	65.1	LRK72_ARATH	reviewed	Probable L-type lectin-domain containing receptor kinase VII.2 (Arabidopsis thaliana lectin-receptor kinase d) (AthlecRK-d) (LecRK-VII.2) (EC 2.7.11.1)	LECRK72 LECRKD At4g28350 F20O9.40	Arabidopsis thaliana (Mouse-ear cress)	681	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to oomycetes [GO:0002229]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]	GO:0002229; GO:0004675; GO:0005524; GO:0005886; GO:0006952; GO:0016021; GO:0030246; GO:0042742	defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to oomycetes [GO:0002229]		NA	NA	NA	NA	NA	NA
TRINITY_DN1433_c0_g1_i1	Q9V6L0	KDM4B_DROME	67.4	86	25	1	1	249	280	365	1.80E-28	129	KDM4B_DROME	reviewed	Probable lysine-specific demethylase 4B (EC 1.14.11.66) (Probable JmjC domain-containing histone demethylation protein 3B) (Probable [histone H3]-trimethyl-L-lysine(9) demethylase 4B)	Kdm4B CG33182	Drosophila melanogaster (Fruit fly)	590	"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]"	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]	GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544	"chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11946_c0_g1_i1	A9CS74	SYKC_ENTBH	74.1	81	21	0	245	3	357	437	5.00E-27	121.3	SYKC_ENTBH	reviewed	"Probable lysine--tRNA ligase, cytoplasmic (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)"	EBI_25548	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	518	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN34527_c0_g1_i1	A9CS74	SYKC_ENTBH	76	100	24	0	11	310	417	516	1.80E-38	159.8	SYKC_ENTBH	reviewed	"Probable lysine--tRNA ligase, cytoplasmic (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)"	EBI_25548	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	518	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN11383_c0_g1_i1	C4V8R9	SYKC_NOSCE	69.5	128	39	0	387	4	158	285	3.90E-50	198.7	SYKC_NOSCE	reviewed	"Probable lysine--tRNA ligase, cytoplasmic (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)"	NCER_100909	Nosema ceranae (strain BRL01) (Microsporidian parasite)	514	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN11383_c1_g1_i1	A9CS74	SYKC_ENTBH	69.8	149	45	0	1	447	164	312	8.20E-58	224.6	SYKC_ENTBH	reviewed	"Probable lysine--tRNA ligase, cytoplasmic (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)"	EBI_25548	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	518	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]; lysyl-tRNA aminoacylation [GO:0006430]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430	lysyl-tRNA aminoacylation [GO:0006430]		NA	NA	NA	NA	NA	NA
TRINITY_DN2194_c1_g1_i1	P13080	MALT_AEDAE	48.1	104	46	2	1	288	174	277	1.10E-19	97.4	MALT_AEDAE	reviewed	Probable maltase (EC 3.2.1.20)	MAL1 MAL I AAEL000392	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	579	maltose alpha-glucosidase activity [GO:0032450]		maltose alpha-glucosidase activity [GO:0032450]	GO:0032450			NA	NA	NA	NA	NA	NA
TRINITY_DN37078_c0_g1_i1	P90747	AT131_CAEEL	54.3	70	32	0	214	5	930	999	4.60E-13	74.7	AT131_CAEEL	reviewed	Probable manganese-transporting ATPase catp-8 (EC 7.2.2.-) (Cation transporting ATPase 8)	catp-8 C10C6.6	Caenorhabditis elegans	1178	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005789; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN4352_c1_g3_i1	P90747	AT131_CAEEL	49.4	79	40	0	3	239	938	1016	1.10E-15	83.6	AT131_CAEEL	reviewed	Probable manganese-transporting ATPase catp-8 (EC 7.2.2.-) (Cation transporting ATPase 8)	catp-8 C10C6.6	Caenorhabditis elegans	1178	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005789; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]		NA	NA	NA	NA	NA	NA
TRINITY_DN39784_c0_g1_i1	P34650	MPI_CAEEL	48.1	81	39	2	3	242	247	325	1.20E-15	83.6	MPI_CAEEL	reviewed	Probable mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI)	ZK632.4	Caenorhabditis elegans	416	cytosol [GO:0005829]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486]	cytosol [GO:0005829]	mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]	GO:0000032; GO:0004476; GO:0005829; GO:0005975; GO:0006486; GO:0008270; GO:0009298	carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN37443_c0_g1_i1	Q09582	METH_CAEEL	57.9	145	57	2	441	7	1108	1248	7.40E-43	174.9	METH_CAEEL	reviewed	Probable methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)	metr-1 R03D7.1	Caenorhabditis elegans	1249	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]	cytosol [GO:0005829]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]		NA	NA	NA	NA	NA	NA
TRINITY_DN34094_c0_g1_i1	Q8SQW5	SYMC_ENCCU	78	59	13	0	181	5	2	60	2.40E-22	105.5	SYMC_ENCCU	reviewed	"Probable methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	ECU11_0890	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	550	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]	GO:0004825; GO:0005524; GO:0005737; GO:0006431	methionyl-tRNA aminoacylation [GO:0006431]		NA	NA	1	NA	NA	NA
TRINITY_DN3105_c0_g1_i1	Q9V9A7	MCCB_DROME	83.7	135	22	0	407	3	153	287	4.30E-60	231.9	MCCB_DROME	reviewed	"Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2 l(2)04524 CG3267	Drosophila melanogaster (Fruit fly)	578	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202	leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]		NA	NA	NA	NA	NA	NA
TRINITY_DN3105_c0_g1_i2	Q9V9A7	MCCB_DROME	80	165	33	0	497	3	123	287	8.40E-74	277.7	MCCB_DROME	reviewed	"Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2 l(2)04524 CG3267	Drosophila melanogaster (Fruit fly)	578	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202	leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]		NA	NA	NA	NA	NA	NA
TRINITY_DN3105_c0_g1_i3	Q9V9A7	MCCB_DROME	80.6	165	32	0	497	3	123	287	2.90E-74	279.3	MCCB_DROME	reviewed	"Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2 l(2)04524 CG3267	Drosophila melanogaster (Fruit fly)	578	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202	leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]		NA	NA	NA	NA	NA	NA
TRINITY_DN32676_c0_g1_i1	Q9V9A7	MCCB_DROME	70.1	177	53	0	3	533	117	293	2.30E-69	263.1	MCCB_DROME	reviewed	"Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2 l(2)04524 CG3267	Drosophila melanogaster (Fruit fly)	578	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202	leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]		NA	NA	NA	NA	NA	NA
TRINITY_DN28481_c0_g1_i1	Q9V9A7	MCCB_DROME	74.1	147	38	0	3	443	347	493	2.90E-62	239.2	MCCB_DROME	reviewed	"Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)"	Mccc2 l(2)04524 CG3267	Drosophila melanogaster (Fruit fly)	578	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]	methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202	leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563]		NA	NA	NA	NA	NA	NA
TRINITY_DN36889_c0_g1_i1	Q75HE6	MTHR_ORYSJ	57.1	105	36	1	296	9	152	256	4.20E-28	125.2	MTHR_ORYSJ	reviewed	Probable methylenetetrahydrofolate reductase (EC 1.5.1.20)	Os03g0815200 LOC_Os03g60090 OSJNBa0024F18.2 OSJNBb0042K11.1	Oryza sativa subsp. japonica (Rice)	594	cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]	FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]	GO:0004489; GO:0005829; GO:0006730; GO:0009086; GO:0035999; GO:0071949	methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN6037_c0_g1_i1	Q54I10	MMSA_DICDI	53	132	62	0	2	397	333	464	3.00E-37	156	MMSA_DICDI	reviewed	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	mmsdh aldh6 DDB_G0289085	Dictyostelium discoideum (Slime mold)	528	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN6037_c0_g2_i1	Q7QC84	MMSA_ANOGA	64.9	111	39	0	333	1	220	330	1.20E-36	153.7	MMSA_ANOGA	reviewed	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	AGAP002499	Anopheles gambiae (African malaria mosquito)	521	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN3356_c0_g1_i1	Q7QC84	MMSA_ANOGA	80.8	52	10	0	212	57	131	182	2.50E-19	95.5	MMSA_ANOGA	reviewed	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	AGAP002499	Anopheles gambiae (African malaria mosquito)	521	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN3356_c0_g1_i2	Q7QC84	MMSA_ANOGA	70.6	507	148	1	1611	94	15	521	1.30E-206	720.7	MMSA_ANOGA	reviewed	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	AGAP002499	Anopheles gambiae (African malaria mosquito)	521	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		blue	blue	NA	NA	NA	NA
TRINITY_DN3356_c0_g1_i3	Q7QC84	MMSA_ANOGA	71.7	392	111	0	1269	94	130	521	1.00E-161	571.6	MMSA_ANOGA	reviewed	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	AGAP002499	Anopheles gambiae (African malaria mosquito)	521	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN3356_c0_g1_i3	Q7QC84	MMSA_ANOGA	66.4	116	38	1	1675	1331	15	130	1.00E-36	156.4	MMSA_ANOGA	reviewed	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	AGAP002499	Anopheles gambiae (African malaria mosquito)	521	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrion [GO:0005739]	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN181_c0_g1_i1	Q7PS09	MTNB_ANOGA	61.1	113	44	0	342	4	14	126	9.50E-33	141.7	MTNB_ANOGA	reviewed	Probable methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109)	AGAP000470	Anopheles gambiae (African malaria mosquito)	231	cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytoplasm [GO:0005737]	methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0019284; GO:0019509; GO:0046570	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN181_c0_g1_i5	Q7PS09	MTNB_ANOGA	59.9	227	89	1	791	117	3	229	5.70E-72	272.7	MTNB_ANOGA	reviewed	Probable methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109)	AGAP000470	Anopheles gambiae (African malaria mosquito)	231	cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytoplasm [GO:0005737]	methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0019284; GO:0019509; GO:0046570	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]		NA	NA	NA	NA	NA	NA
TRINITY_DN38226_c0_g1_i1	Q13395	TARB1_HUMAN	68.4	57	18	0	2	172	1558	1614	1.40E-15	83.2	TARB1_HUMAN	reviewed	Probable methyltransferase TARBP1 (EC 2.1.1.-) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185)	TARBP1 TRM3 TRP185	Homo sapiens (Human)	1621	nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]	RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]	GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN12102_c0_g1_i3	Q13395	TARB1_HUMAN	27.9	348	234	7	1124	117	1067	1409	2.90E-30	134.8	TARB1_HUMAN	reviewed	Probable methyltransferase TARBP1 (EC 2.1.1.-) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185)	TARBP1 TRM3 TRP185	Homo sapiens (Human)	1621	nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]	RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]	GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN12102_c0_g1_i4	Q13395	TARB1_HUMAN	34.7	554	338	10	1732	122	1067	1613	5.00E-81	303.9	TARB1_HUMAN	reviewed	Probable methyltransferase TARBP1 (EC 2.1.1.-) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185)	TARBP1 TRM3 TRP185	Homo sapiens (Human)	1621	nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]	RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]	GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN39719_c0_g1_i1	P0A9U1	YBHF_ECOLI	48.8	84	43	0	260	9	446	529	6.90E-19	94.4	YBHF_ECOLI	reviewed	Probable multidrug ABC transporter ATP-binding protein YbhF	ybhF b0794 JW5104	Escherichia coli (strain K12)	578	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]	GO:0005524; GO:0005886; GO:0015562; GO:0016887; GO:1990961	xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i10	P91660	L259_DROME	59.3	59	24	0	132	308	1228	1286	2.80E-13	76.3	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i12	P91660	L259_DROME	59.3	59	24	0	132	308	1228	1286	4.30E-13	76.3	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i12	P91660	L259_DROME	67.4	43	14	0	335	463	1288	1330	6.50E-09	62.4	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i3	P91660	L259_DROME	59.3	59	24	0	132	308	1228	1286	3.90E-13	76.3	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i3	P91660	L259_DROME	70.2	47	12	1	335	475	1288	1332	3.40E-09	63.2	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN13173_c0_g1_i8	P91660	L259_DROME	70.2	47	12	1	56	196	1288	1332	2.10E-09	62.8	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN36559_c0_g1_i1	P91660	L259_DROME	35.5	107	69	0	3	323	295	401	5.80E-15	81.6	L259_DROME	reviewed	Probable multidrug resistance-associated protein lethal(2)03659 (Wunen region A protein)	l(2)03659 CG8799	Drosophila melanogaster (Fruit fly)	1374	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]	GO:0005524; GO:0007275; GO:0008514; GO:0015562; GO:0015711; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN34448_c0_g1_i1	Q8SS35	Y4A0_ENCCU	51.8	112	49	1	23	343	121	232	6.00E-26	118.2	Y4A0_ENCCU	reviewed	Probable myosin heavy chain ECU04_1000	ECU04_1000	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1649	myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	myosin complex [GO:0016459]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0016459; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN6792_c0_g1_i1	Q8SS35	Y4A0_ENCCU	52.7	91	43	0	2	274	579	669	6.10E-22	104.8	Y4A0_ENCCU	reviewed	Probable myosin heavy chain ECU04_1000	ECU04_1000	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1649	myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	myosin complex [GO:0016459]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0016459; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN3750_c0_g1_i1	Q8SS35	Y4A0_ENCCU	60.9	128	46	1	379	8	388	515	3.70E-37	155.6	Y4A0_ENCCU	reviewed	Probable myosin heavy chain ECU04_1000	ECU04_1000	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1649	myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	myosin complex [GO:0016459]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0016459; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN16783_c0_g1_i1	P35449	NHX9_CAEEL	54.3	127	57	1	6	386	357	482	2.20E-34	146.7	NHX9_CAEEL	reviewed	Probable Na(+)/H(+) antiporter nhx-9 (Na(+)-H(+) exchanger protein 9)	nhx-9 ZK822.3	Caenorhabditis elegans	667	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0006814; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719	potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN16783_c0_g1_i4	P35449	NHX9_CAEEL	45.9	181	92	3	6	533	357	536	1.00E-38	162.2	NHX9_CAEEL	reviewed	Probable Na(+)/H(+) antiporter nhx-9 (Na(+)-H(+) exchanger protein 9)	nhx-9 ZK822.3	Caenorhabditis elegans	667	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0006814; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719	potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN25915_c0_g1_i1	O45293	GALT8_CAEEL	44.7	76	41	1	228	1	287	361	5.00E-13	74.7	GALT8_CAEEL	reviewed	Probable N-acetylgalactosaminyltransferase 8 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 8) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8) (pp-GaNTase 8)	gly-8 Y66A7A.6	Caenorhabditis elegans	421	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"metal ion binding [GO:0046872]; Notch binding [GO:0005112]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0005112; GO:0005794; GO:0006486; GO:0008593; GO:0016021; GO:0016757; GO:0046872	protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]		NA	NA	NA	NA	NA	NA
TRINITY_DN25915_c0_g1_i2	O45293	GALT8_CAEEL	44.7	76	41	1	228	1	287	361	5.00E-13	74.7	GALT8_CAEEL	reviewed	Probable N-acetylgalactosaminyltransferase 8 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 8) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8) (pp-GaNTase 8)	gly-8 Y66A7A.6	Caenorhabditis elegans	421	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"metal ion binding [GO:0046872]; Notch binding [GO:0005112]; transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0000139; GO:0005112; GO:0005794; GO:0006486; GO:0008593; GO:0016021; GO:0016757; GO:0046872	protein glycosylation [GO:0006486]; regulation of Notch signaling pathway [GO:0008593]		NA	NA	NA	NA	NA	NA
TRINITY_DN359_c0_g1_i1	Q9NHD5	SAN_DROME	80.6	155	30	0	553	89	3	157	1.30E-71	270.8	SAN_DROME	reviewed	Probable N-acetyltransferase san (EC 2.3.1.258) (N-epsilon-acetyltransferase san) (EC 2.3.1.-) (Protein atado) (Protein separation anxiety)	san span CG12352	Drosophila melanogaster (Fruit fly)	184	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248]	N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0000278; GO:0004596; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0016573; GO:0031248; GO:0031415	histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474]		NA	NA	NA	NA	NA	NA
TRINITY_DN36280_c0_g1_i1	Q52JK6	VIP2_NICBE	59.7	72	29	0	10	225	425	496	1.20E-19	96.7	VIP2_NICBE	reviewed	Probable NOT transcription complex subunit VIP2 (Protein VIRE2 INTERACTING PROTEIN2) (NbVIP2) (Fragment)	VIP2	Nicotiana benthamiana	603	"CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]"	CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]		GO:0005634; GO:0006355; GO:0015074; GO:0030015	"DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3955_c0_g1_i2	P31396	HR3_DROME	53.5	228	104	2	26	709	257	482	4.00E-65	249.6	HR3_DROME	reviewed	Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4)	Hr3 Hr46 CG11823	Drosophila melanogaster (Fruit fly)	487	"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]"	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0004879; GO:0005634; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944	"metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3955_c0_g1_i3	P31396	HR3_DROME	64.3	115	41	0	62	406	281	395	6.10E-38	158.3	HR3_DROME	reviewed	Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4)	Hr3 Hr46 CG11823	Drosophila melanogaster (Fruit fly)	487	"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]"	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0004879; GO:0005634; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944	"metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3955_c0_g1_i1	P49868	HR3_GALME	48.4	91	46	1	21	293	461	550	7.60E-17	88.2	HR3_GALME	reviewed	Probable nuclear hormone receptor HR3 (gHR3) (Nuclear receptor subfamily 1 group F member 4)	HR3 NR1F4	Galleria mellonella (Greater wax moth)	557	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN27971_c0_g1_i1	Q08882	HR3_MANSE	92.5	107	8	0	323	3	89	195	4.40E-53	208.4	HR3_MANSE	reviewed	Probable nuclear hormone receptor HR3 (mHR3) (Nuclear receptor subfamily 1 group F member 4)	HR3 NR1F4	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	548	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0008270; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN25714_c0_g1_i1	P49869	HR38_DROME	95.3	85	4	0	12	266	738	822	1.30E-44	179.9	HR38_DROME	reviewed	Probable nuclear hormone receptor HR38 (dHR38) (Nuclear receptor subfamily 4 group A member 4)	Hr38 NR4A4 CG1864	Drosophila melanogaster (Fruit fly)	1073	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; core promoter sequence-specific DNA binding [GO:0001046]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	core promoter sequence-specific DNA binding [GO:0001046]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]	GO:0000977; GO:0000978; GO:0001046; GO:0004879; GO:0005102; GO:0005634; GO:0005667; GO:0005737; GO:0008270; GO:0035259; GO:0042335; GO:0043565; GO:0045944; GO:0046982; GO:0048082; GO:0071376	cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]		NA	NA	NA	NA	NA	NA
TRINITY_DN9300_c0_g1_i1	Q54N72	NOG1_DICDI	69.9	272	82	0	818	3	3	274	5.30E-113	408.7	NOG1_DICDI	reviewed	Probable nucleolar GTP-binding protein 1	nog1 DDB_G0285465	Dictyostelium discoideum (Slime mold)	674	nucleolus [GO:0005730]; GTP binding [GO:0005525]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	GTP binding [GO:0005525]	GO:0005525; GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN37487_c0_g1_i1	O80763	NRX1_ARATH	49.3	67	31	3	198	1	347	411	4.30E-11	68.2	NRX1_ARATH	reviewed	Probable nucleoredoxin 1 (AtNrx1) (EC 1.8.1.8)	At1g60420 T13D8.29	Arabidopsis thaliana (Mouse-ear cress)	578	cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; regulation of pollen tube growth [GO:0080092]; response to cadmium ion [GO:0046686]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein-disulfide reductase activity [GO:0047134]	GO:0005634; GO:0005829; GO:0009860; GO:0010183; GO:0046686; GO:0047134; GO:0080092	pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; regulation of pollen tube growth [GO:0080092]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN38784_c0_g1_i2	A5WUX7	CL065_DANRE	56.9	72	31	0	218	3	31	102	9.80E-16	84.3	CL065_DANRE	reviewed	"Probable peptide chain release factor C12orf65 homolog, mitochondrial"	si:ch211-275j6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	156	mitochondrial large ribosomal subunit [GO:0005762]; translation release factor activity [GO:0003747]	mitochondrial large ribosomal subunit [GO:0005762]	translation release factor activity [GO:0003747]	GO:0003747; GO:0005762			NA	NA	NA	NA	NA	NA
TRINITY_DN33414_c0_g1_i1	P91268	PGAL_CAEEL	50	56	28	0	32	199	157	212	9.20E-09	60.5	PGAL_CAEEL	reviewed	Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1 (EC 4.3.2.5) (Probable peptidylamidoglycolate lyase) (PAL)	pgal-1 F21F3.1	Caenorhabditis elegans	350	extracellular region [GO:0005576]; membrane [GO:0016020]; metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]; peptide metabolic process [GO:0006518]	extracellular region [GO:0005576]; membrane [GO:0016020]	metal ion binding [GO:0046872]; peptidylamidoglycolate lyase activity [GO:0004598]	GO:0004598; GO:0005576; GO:0006518; GO:0016020; GO:0046872	peptide metabolic process [GO:0006518]		NA	NA	NA	NA	NA	NA
TRINITY_DN6402_c0_g1_i1	O97067	PTH2_DROME	53	100	47	0	331	630	73	172	6.60E-23	109	PTH2_DROME	reviewed	Probable peptidyl-tRNA hydrolase 2 (PTH 2) (EC 3.1.1.29)	CG1307	Drosophila melanogaster (Fruit fly)	186	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA hydrolase activity [GO:0004045]	GO:0004045; GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN2830_c0_g1_i1	Q7KML2	ACOX1_DROME	50	668	320	6	98	2080	9	669	8.50E-179	628.6	ACOX1_DROME	reviewed	Probable peroxisomal acyl-coenzyme A oxidase 1 (EC 1.3.3.6)	CG5009	Drosophila melanogaster (Fruit fly)	669	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]	peroxisome [GO:0005777]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006635; GO:0006693; GO:0009062; GO:0019395; GO:0033540; GO:0050660; GO:0050665; GO:0055088; GO:0071949	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN8330_c0_g2_i1	Q8SRG9	SYFA_ENCCU	60	305	101	2	27	923	185	474	1.50E-108	394	SYFA_ENCCU	reviewed	Probable phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)	ECU07_1660	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	475	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0006432	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN5289_c0_g1_i1	Q8SS40	SYFB_ENCCU	51.9	81	33	2	2	235	96	173	8.50E-16	84	SYFB_ENCCU	reviewed	Probable phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	ECU04_0900	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	557	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0006432	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN33769_c0_g1_i1	C4VA52	SYFB_NOSCE	41.1	95	54	1	287	3	1	93	1.10E-12	73.9	SYFB_NOSCE	reviewed	Probable phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	NCER_101490	Nosema ceranae (strain BRL01) (Microsporidian parasite)	504	phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0006432; GO:0009328	phenylalanyl-tRNA aminoacylation [GO:0006432]		NA	NA	NA	NA	NA	NA
TRINITY_DN15541_c0_g1_i2	O16129	SYFM_DROME	52.3	130	62	0	146	535	20	149	3.60E-33	143.3	SYFM_DROME	reviewed	"Probable phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)"	PheRS-m Aats-phe Aats-phe-m Pts CG13348	Drosophila melanogaster (Fruit fly)	453	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN30718_c0_g1_i1	O49299	PGMC1_ARATH	69.2	78	18	1	221	6	86	163	2.60E-22	105.5	PGMC1_ARATH	reviewed	"Probable phosphoglucomutase, cytoplasmic 1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)"	At1g23190 F26F24.1 T26J12.5	Arabidopsis thaliana (Mouse-ear cress)	583	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; response to cadmium ion [GO:0046686]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006006; GO:0046686	carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN23853_c0_g1_i1	O49299	PGMC1_ARATH	56.8	74	31	1	234	13	488	560	4.60E-15	81.6	PGMC1_ARATH	reviewed	"Probable phosphoglucomutase, cytoplasmic 1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)"	At1g23190 F26F24.1 T26J12.5	Arabidopsis thaliana (Mouse-ear cress)	583	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; response to cadmium ion [GO:0046686]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006006; GO:0046686	carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN691_c3_g1_i1	Q9Y2G3	AT11B_HUMAN	51.6	254	118	3	138	896	19	268	1.80E-66	254.2	AT11B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)	ATP11B ATPIF ATPIR KIAA0956	Homo sapiens (Human)	1177	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326	aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN691_c3_g1_i2	Q9Y2G3	AT11B_HUMAN	51.6	254	118	3	63	821	19	268	2.10E-66	253.8	AT11B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)	ATP11B ATPIF ATPIR KIAA0956	Homo sapiens (Human)	1177	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326	aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN385_c0_g1_i3	Q9Y2G3	AT11B_HUMAN	40.9	809	425	13	5	2317	278	1071	5.70E-157	556.2	AT11B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)	ATP11B ATPIF ATPIR KIAA0956	Homo sapiens (Human)	1177	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326	aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN385_c0_g1_i5	Q9Y2G3	AT11B_HUMAN	45.3	616	290	11	5	1747	278	881	4.00E-137	490	AT11B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)	ATP11B ATPIF ATPIR KIAA0956	Homo sapiens (Human)	1177	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326	aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN385_c0_g1_i4	Q9N0Z4	AT11B_RABIT	43.8	541	257	10	5	1522	270	798	5.60E-108	392.9	AT11B_RABIT	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B) (RING finger-binding protein) (Fragment)	ATP11B	Oryctolagus cuniculus (Rabbit)	1169	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid transport [GO:0015914]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; recycling endosome membrane [GO:0055038]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005794; GO:0015914; GO:0016021; GO:0055038; GO:0140326	phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN385_c0_g1_i6	Q9N0Z4	AT11B_RABIT	51.9	106	49	1	287	598	693	798	1.30E-23	111.3	AT11B_RABIT	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B) (RING finger-binding protein) (Fragment)	ATP11B	Oryctolagus cuniculus (Rabbit)	1169	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid transport [GO:0015914]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; recycling endosome membrane [GO:0055038]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005794; GO:0015914; GO:0016021; GO:0055038; GO:0140326	phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN39846_c0_g1_i1	Q9N0Z4	AT11B_RABIT	100	109	0	0	327	1	75	183	4.70E-57	221.5	AT11B_RABIT	reviewed	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B) (RING finger-binding protein) (Fragment)	ATP11B	Oryctolagus cuniculus (Rabbit)	1169	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid transport [GO:0015914]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; recycling endosome membrane [GO:0055038]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005794; GO:0015914; GO:0016021; GO:0055038; GO:0140326	phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN385_c0_g1_i2	P98196	AT11A_HUMAN	58.6	70	29	0	58	267	840	909	5.40E-18	91.7	AT11A_HUMAN	reviewed	Probable phospholipid-transporting ATPase IH (EC 7.6.2.1) (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A)	ATP11A ATPIH ATPIS KIAA1021	Homo sapiens (Human)	1134	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005765; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0016020; GO:0016021; GO:0035579; GO:0043231; GO:0043312; GO:0045332; GO:0055037; GO:0070821; GO:0140326	neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]		NA	NA	1	NA	NA	NA
TRINITY_DN14705_c0_g1_i1	O75110	ATP9A_HUMAN	100	80	0	0	242	3	676	755	2.10E-41	169.1	ATP9A_HUMAN	reviewed	Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A)	ATP9A ATPIIA KIAA0611	Homo sapiens (Human)	1047	"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]	GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0031901; GO:0045332; GO:0048471; GO:0055037; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37696_c0_g1_i1	O75110	ATP9A_HUMAN	66.2	77	26	0	1	231	334	410	7.50E-23	107.5	ATP9A_HUMAN	reviewed	Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A)	ATP9A ATPIIA KIAA0611	Homo sapiens (Human)	1047	"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]	GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0031901; GO:0045332; GO:0048471; GO:0055037; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37233_c0_g1_i1	O70228	ATP9A_MOUSE	98.6	71	1	0	214	2	346	416	1.10E-33	143.3	ATP9A_MOUSE	reviewed	Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A)	Atp9a	Mus musculus (Mouse)	1047	"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]	GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0031901; GO:0045332; GO:0048471; GO:0055037; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32163_c0_g1_i1	O70228	ATP9A_MOUSE	100	72	0	0	221	6	150	221	9.90E-35	146.7	ATP9A_MOUSE	reviewed	Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A)	Atp9a	Mus musculus (Mouse)	1047	"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]	GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0031901; GO:0045332; GO:0048471; GO:0055037; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15436_c0_g1_i1	O43861	ATP9B_HUMAN	69.9	83	25	0	2	250	838	920	3.60E-25	115.2	ATP9B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	ATP9B ATPIIB NEO1L HUSSY-20	Homo sapiens (Human)	1147	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0048471; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36700_c0_g1_i1	O43861	ATP9B_HUMAN	56.2	80	33	1	21	260	623	700	1.50E-18	93.2	ATP9B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	ATP9B ATPIIB NEO1L HUSSY-20	Homo sapiens (Human)	1147	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0048471; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29958_c0_g1_i1	O43861	ATP9B_HUMAN	99	97	0	1	3	293	773	868	1.90E-49	196.1	ATP9B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	ATP9B ATPIIB NEO1L HUSSY-20	Homo sapiens (Human)	1147	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0048471; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29504_c0_g1_i1	O43861	ATP9B_HUMAN	98.5	68	1	0	1	204	439	506	9.50E-32	136.7	ATP9B_HUMAN	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	ATP9B ATPIIB NEO1L HUSSY-20	Homo sapiens (Human)	1147	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0048471; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2478_c0_g1_i2	F1Q4S1	ATP9B_DANRE	67.9	914	275	5	2826	139	210	1123	0	1207.2	ATP9B_DANRE	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	atp9b	Danio rerio (Zebrafish) (Brachydanio rerio)	1125	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2478_c0_g1_i3	F1Q4S1	ATP9B_DANRE	68.1	910	272	5	2814	139	214	1123	0	1206	ATP9B_DANRE	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	atp9b	Danio rerio (Zebrafish) (Brachydanio rerio)	1125	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2478_c0_g1_i4	F1Q4S1	ATP9B_DANRE	67	1041	323	7	3201	139	84	1123	0	1356.7	ATP9B_DANRE	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	atp9b	Danio rerio (Zebrafish) (Brachydanio rerio)	1125	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2478_c0_g1_i6	F1Q4S1	ATP9B_DANRE	45.9	61	31	1	371	195	84	144	3.30E-07	56.2	ATP9B_DANRE	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	atp9b	Danio rerio (Zebrafish) (Brachydanio rerio)	1125	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2478_c0_g1_i7	F1Q4S1	ATP9B_DANRE	67	1041	323	7	3201	139	84	1123	0	1356.7	ATP9B_DANRE	reviewed	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	atp9b	Danio rerio (Zebrafish) (Brachydanio rerio)	1125	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4831_c0_g1_i9	Q8TF62	AT8B4_HUMAN	76.5	51	12	0	154	2	220	270	2.20E-18	92.4	AT8B4_HUMAN	reviewed	Probable phospholipid-transporting ATPase IM (EC 7.6.2.1) (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4)	ATP8B4 KIAA1939	Homo sapiens (Human)	1192	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0035579; GO:0043312; GO:0045332; GO:0070821; GO:0140326	Golgi organization [GO:0007030]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN26293_c0_g1_i1	P40527	ATC7_YEAST	46.3	54	29	0	195	34	744	797	3.70E-07	55.1	ATC7_YEAST	reviewed	Probable phospholipid-transporting ATPase NEO1 (EC 7.6.2.1)	NEO1 YIL048W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1151	"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vacuole organization [GO:0007033]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000139; GO:0000287; GO:0005524; GO:0005768; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0007033; GO:0010008; GO:0015031; GO:0016021; GO:0045332; GO:0140326	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vacuole organization [GO:0007033]"		NA	NA	1	NA	NA	NA
TRINITY_DN28595_c0_g1_i1	O60312	AT10A_HUMAN	52.8	72	33	1	1	213	1009	1080	1.20E-13	76.6	AT10A_HUMAN	reviewed	Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A)	ATP10A ATP10C ATPVA ATPVC KIAA0566	Homo sapiens (Human)	1499	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0008360; GO:0016021; GO:0034220; GO:0045332; GO:0140326	ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN27391_c0_g1_i1	O60312	AT10A_HUMAN	67.5	77	25	0	2	232	845	921	4.80E-24	111.3	AT10A_HUMAN	reviewed	Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A)	ATP10A ATP10C ATPVA ATPVC KIAA0566	Homo sapiens (Human)	1499	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0008360; GO:0016021; GO:0034220; GO:0045332; GO:0140326	ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN12018_c0_g1_i1	O54827	AT10A_MOUSE	69.6	112	34	0	338	3	1012	1123	2.40E-40	166	AT10A_MOUSE	reviewed	Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (P-locus fat-associated ATPase) (P4-ATPase flippase complex alpha subunit ATP10A)	Atp10a Atpc5 Pfatp	Mus musculus (Mouse)	1508	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0045332; GO:0140326	phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN39746_c0_g1_i1	O94823	AT10B_HUMAN	57.1	70	28	1	22	225	877	946	3.80E-16	85.1	AT10B_HUMAN	reviewed	Probable phospholipid-transporting ATPase VB (EC 7.6.2.1) (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B)	ATP10B ATPVB KIAA0715	Homo sapiens (Human)	1461	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0030659; GO:0045332; GO:0140326	phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN35488_c0_g1_i1	Q9P241	AT10D_HUMAN	59.2	179	72	1	576	43	48	226	5.20E-53	209.5	AT10D_HUMAN	reviewed	Probable phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D)	ATP10D ATPVD KIAA1487	Homo sapiens (Human)	1426	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0016021; GO:0034220; GO:0045332; GO:0140326	cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN33966_c0_g1_i1	Q8K2X1	AT10D_MOUSE	60.3	68	27	0	3	206	395	462	5.40E-19	94.7	AT10D_MOUSE	reviewed	Probable phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D)	Atp10d	Mus musculus (Mouse)	1416	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; cation transport [GO:0006812]; phospholipid translocation [GO:0045332]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005789; GO:0005886; GO:0006812; GO:0016021; GO:0045332; GO:0140326	cation transport [GO:0006812]; phospholipid translocation [GO:0045332]		blue	blue	NA	NA	NA	NA
TRINITY_DN3360_c0_g1_i7	Q9M8D3	PUR4_ARATH	52.5	61	29	0	350	168	1194	1254	2.20E-11	70.1	PUR4_ARATH	reviewed	"Probable phosphoribosylformylglycinamidine synthase, chloroplastic/mitochondrial (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)"	At1g74260 F1O17.7	Arabidopsis thaliana (Mouse-ear cress)	1407	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; microgametogenesis [GO:0055046]; pollen development [GO:0009555]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005739; GO:0006189; GO:0006541; GO:0009507; GO:0009555; GO:0009570; GO:0046872; GO:0055046	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; microgametogenesis [GO:0055046]; pollen development [GO:0009555]		NA	NA	NA	NA	NA	NA
TRINITY_DN40789_c0_g1_i1	Q9M8D3	PUR4_ARATH	57.7	78	31	1	254	27	1326	1403	3.20E-21	102.1	PUR4_ARATH	reviewed	"Probable phosphoribosylformylglycinamidine synthase, chloroplastic/mitochondrial (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)"	At1g74260 F1O17.7	Arabidopsis thaliana (Mouse-ear cress)	1407	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; microgametogenesis [GO:0055046]; pollen development [GO:0009555]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]	GO:0004642; GO:0005524; GO:0005739; GO:0006189; GO:0006541; GO:0009507; GO:0009555; GO:0009570; GO:0046872; GO:0055046	'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; microgametogenesis [GO:0055046]; pollen development [GO:0009555]		NA	NA	NA	NA	NA	NA
TRINITY_DN5102_c0_g1_i1	Q9W391	KPBA_DROME	59.9	197	66	2	649	98	1051	1247	5.10E-64	245.7	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN5102_c0_g1_i2	Q9W391	KPBA_DROME	62.9	197	69	1	676	98	1051	1247	1.50E-69	264.2	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN5102_c0_g1_i3	Q9W391	KPBA_DROME	62.2	479	151	6	1456	98	773	1247	7.50E-158	558.5	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN5102_c0_g1_i4	Q9W391	KPBA_DROME	53.4	118	51	1	439	98	1130	1247	2.30E-31	136.7	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g2_i1	Q9W391	KPBA_DROME	88.5	26	3	0	91	168	1	26	2.50E-05	49.3	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g2_i2	Q9W391	KPBA_DROME	69.4	134	41	0	3	404	358	491	1.40E-46	187.2	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g2_i3	Q9W391	KPBA_DROME	68.1	715	213	6	91	2223	1	704	3.90E-275	948.7	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g2_i4	Q9W391	KPBA_DROME	41	188	98	5	6	557	526	704	4.40E-27	122.9	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g2_i5	Q9W391	KPBA_DROME	69.7	715	202	6	91	2223	1	704	8.70E-283	974.2	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN10221_c0_g2_i6	Q9W391	KPBA_DROME	62.7	59	22	0	49	225	357	415	1.90E-14	79.7	KPBA_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	CG7766	Drosophila melanogaster (Fruit fly)	1247	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN985_c0_g1_i1	Q9VLS1	KPBB_DROME	68.8	720	211	2	2259	100	36	741	1.10E-293	1010.4	KPBB_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	CG8475	Drosophila melanogaster (Fruit fly)	1093	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN985_c0_g1_i2	Q9VLS1	KPBB_DROME	60.4	1073	388	7	3245	93	36	1093	0	1268.8	KPBB_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	CG8475	Drosophila melanogaster (Fruit fly)	1093	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN985_c0_g1_i3	Q9VLS1	KPBB_DROME	67.5	400	116	2	1206	7	356	741	1.10E-154	547.7	KPBB_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	CG8475	Drosophila melanogaster (Fruit fly)	1093	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN985_c0_g1_i4	Q9VLS1	KPBB_DROME	61.6	1073	376	6	3248	93	36	1093	0	1302.7	KPBB_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	CG8475	Drosophila melanogaster (Fruit fly)	1093	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN985_c0_g1_i5	Q9VLS1	KPBB_DROME	66.7	408	122	2	2139	916	358	751	1.40E-154	548.1	KPBB_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	CG8475	Drosophila melanogaster (Fruit fly)	1093	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN985_c0_g1_i5	Q9VLS1	KPBB_DROME	45.9	303	142	4	938	93	792	1093	3.10E-64	248.1	KPBB_DROME	reviewed	Probable phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	CG8475	Drosophila melanogaster (Fruit fly)	1093	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; glycogen metabolic process [GO:0005977]	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005964; GO:0005977	glycogen metabolic process [GO:0005977]		NA	NA	NA	NA	NA	NA
TRINITY_DN15802_c0_g1_i1	Q9VAN0	SERC_DROME	57.7	265	112	0	493	1287	99	363	8.30E-87	322.4	SERC_DROME	reviewed	Probable phosphoserine aminotransferase (PSAT) (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase)	CG11899	Drosophila melanogaster (Fruit fly)	364	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0030170	L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN15802_c0_g1_i1	Q9VAN0	SERC_DROME	54.4	103	46	1	102	407	5	107	4.00E-25	117.5	SERC_DROME	reviewed	Probable phosphoserine aminotransferase (PSAT) (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase)	CG11899	Drosophila melanogaster (Fruit fly)	364	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0030170	L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN15802_c0_g1_i2	Q9VAN0	SERC_DROME	57.7	359	152	0	102	1178	5	363	6.20E-121	435.6	SERC_DROME	reviewed	Probable phosphoserine aminotransferase (PSAT) (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase)	CG11899	Drosophila melanogaster (Fruit fly)	364	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0030170	L-serine biosynthetic process [GO:0006564]		blue	blue	NA	NA	NA	NA
TRINITY_DN15802_c0_g1_i3	P91856	SERC_CAEEL	61.7	94	36	0	102	383	10	103	9.50E-27	121.3	SERC_CAEEL	reviewed	Probable phosphoserine aminotransferase (PSAT) (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase)	F26H9.5	Caenorhabditis elegans	370	cytoplasm [GO:0005737]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]	cytoplasm [GO:0005737]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0006564; GO:0030170	L-serine biosynthetic process [GO:0006564]		NA	NA	NA	NA	NA	NA
TRINITY_DN6622_c0_g1_i1	P54679	PMA1_DICDI	64.2	67	24	0	202	2	711	777	1.90E-16	85.9	PMA1_DICDI	reviewed	Probable plasma membrane ATPase (EC 7.1.2.1) (PAT2) (Proton pump)	patB DDB_G0282817	Dictyostelium discoideum (Slime mold)	1058	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; pathogen-containing vacuole [GO:0140220]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton export across plasma membrane [GO:0120029]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]"	integral component of membrane [GO:0016021]; membrane [GO:0016020]; pathogen-containing vacuole [GO:0140220]; plasma membrane [GO:0005886]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005524; GO:0005886; GO:0008553; GO:0016020; GO:0016021; GO:0016887; GO:0046872; GO:0051453; GO:0120029; GO:0140220; GO:1902600	proton export across plasma membrane [GO:0120029]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN28106_c0_g1_i1	Q9VTE5	PFD2_DROME	56.1	57	25	0	16	186	27	83	2.20E-12	72.4	PFD2_DROME	reviewed	Probable prefoldin subunit 2	Pfdn2 l(3)01239 CG6302	Drosophila melanogaster (Fruit fly)	143	cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; establishment or maintenance of neuroblast polarity [GO:0045196]; protein folding [GO:0006457]	cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]	protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0006457; GO:0016272; GO:0044183; GO:0045196; GO:0051082	establishment or maintenance of neuroblast polarity [GO:0045196]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN6783_c0_g3_i1	Q9LZQ9	DEAH2_ARATH	65.5	232	75	1	11	691	67	298	9.90E-84	311.2	DEAH2_ARATH	reviewed	Probable pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH2 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP43)	At3g62310 T12C14_10	Arabidopsis thaliana (Mouse-ear cress)	726	cytosol [GO:0005829]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005681; GO:0005730; GO:0005829; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN6783_c0_g2_i1	O22899	PRP43_ARATH	65.4	286	95	1	859	2	311	592	5.30E-108	392.1	PRP43_ARATH	reviewed	Probable pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH3 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP43)	At2g47250 T08I13.9	Arabidopsis thaliana (Mouse-ear cress)	729	chloroplast envelope [GO:0009941]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	chloroplast envelope [GO:0009941]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0009941	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN6783_c0_g1_i1	O22899	PRP43_ARATH	56.8	125	54	0	384	10	590	714	8.00E-40	164.5	PRP43_ARATH	reviewed	Probable pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH3 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP43)	At2g47250 T08I13.9	Arabidopsis thaliana (Mouse-ear cress)	729	chloroplast envelope [GO:0009941]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	chloroplast envelope [GO:0009941]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0009941	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN4024_c0_g1_i1	P34498	MOG1_CAEEL	47.3	182	95	1	41	583	442	623	5.20E-46	185.7	MOG1_CAEEL	reviewed	Probable pre-mRNA-splicing factor ATP-dependent RNA helicase mog-1 (EC 3.6.4.13) (Masculinization of germline protein 1) (Sex determination protein mog-1)	mog-1 K03H1.2	Caenorhabditis elegans	1131	"spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; feminization of hermaphroditic germ-line [GO:0040022]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0040022	"feminization of hermaphroditic germ-line [GO:0040022]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36806_c0_g1_i1	P34498	MOG1_CAEEL	78.6	70	15	0	1	210	843	912	1.80E-25	115.9	MOG1_CAEEL	reviewed	Probable pre-mRNA-splicing factor ATP-dependent RNA helicase mog-1 (EC 3.6.4.13) (Masculinization of germline protein 1) (Sex determination protein mog-1)	mog-1 K03H1.2	Caenorhabditis elegans	1131	"spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; feminization of hermaphroditic germ-line [GO:0040022]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0040022	"feminization of hermaphroditic germ-line [GO:0040022]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37721_c0_g1_i1	O45244	DHX16_CAEEL	75.3	174	43	0	6	527	369	542	3.00E-77	289.3	DHX16_CAEEL	reviewed	Probable pre-mRNA-splicing factor ATP-dependent RNA helicase mog-4 (EC 3.6.4.13) (Masculinization of germline protein 4) (Sex determination protein mog-4)	mog-4 C04H5.6	Caenorhabditis elegans	1008	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; developmental growth [GO:0048589]; embryonic body morphogenesis [GO:0010172]; feminization of hermaphroditic germ-line [GO:0040022]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0006397; GO:0007281; GO:0008380; GO:0010172; GO:0040022; GO:0048589	developmental growth [GO:0048589]; embryonic body morphogenesis [GO:0010172]; feminization of hermaphroditic germ-line [GO:0040022]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g2_i10	Q7L3T8	SYPM_HUMAN	46.9	175	92	1	818	297	292	466	4.10E-41	169.9	SYPM_HUMAN	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	PARS2	Homo sapiens (Human)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g2_i3	Q7L3T8	SYPM_HUMAN	51.7	87	42	0	307	47	292	378	1.90E-23	109.8	SYPM_HUMAN	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	PARS2	Homo sapiens (Human)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g2_i4	Q7L3T8	SYPM_HUMAN	46.9	175	92	1	711	190	292	466	2.70E-41	170.2	SYPM_HUMAN	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	PARS2	Homo sapiens (Human)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g2_i5	Q7L3T8	SYPM_HUMAN	46.9	175	92	1	735	214	292	466	2.80E-41	170.2	SYPM_HUMAN	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	PARS2	Homo sapiens (Human)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g2_i8	Q7L3T8	SYPM_HUMAN	41.6	89	51	1	453	190	378	466	4.20E-10	66.2	SYPM_HUMAN	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	PARS2	Homo sapiens (Human)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g1_i2	O74765	SYPM_SCHPO	46.8	141	61	2	524	904	86	226	5.70E-28	126.3	SYPM_SCHPO	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	SPBC24C6.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	425	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; mitochondrial translation [GO:0032543]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433; GO:0032543	mitochondrial translation [GO:0032543]; prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g1_i4	O74765	SYPM_SCHPO	48.9	139	58	1	47	424	88	226	7.30E-34	144.8	SYPM_SCHPO	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	SPBC24C6.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	425	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; mitochondrial translation [GO:0032543]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433; GO:0032543	mitochondrial translation [GO:0032543]; prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g1_i6	Q5M7W7	SYPM_RAT	45.3	254	135	2	211	963	19	271	1.30E-59	231.5	SYPM_RAT	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	Pars2	Rattus norvegicus (Rat)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g1_i7	Q5M7W7	SYPM_RAT	42.1	254	129	3	211	921	19	271	5.80E-52	206.1	SYPM_RAT	reviewed	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	Pars2	Rattus norvegicus (Rat)	475	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN36113_c0_g1_i1	Q9Y7T8	PSB3_SCHPO	55.2	87	39	0	1	261	60	146	5.50E-24	111.3	PSB3_SCHPO	reviewed	Probable proteasome subunit beta type-3 (EC 3.4.25.1)	pup3 SPCC63.12c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	204	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161; GO:0045842	positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN5830_c0_g1_i1	Q6P7G6	BRK1A_XENLA	74.3	74	19	0	178	399	1	74	9.30E-25	114.8	BRK1A_XENLA	reviewed	Probable protein BRICK1-A	brk1-a	Xenopus laevis (African clawed frog)	75	cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]	cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]	protein-containing complex binding [GO:0044877]	GO:0005856; GO:0007015; GO:0031209; GO:0044877	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN5830_c0_g1_i3	Q6P7G6	BRK1A_XENLA	74.3	74	19	0	149	370	1	74	8.80E-25	114.8	BRK1A_XENLA	reviewed	Probable protein BRICK1-A	brk1-a	Xenopus laevis (African clawed frog)	75	cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]	cytoskeleton [GO:0005856]; SCAR complex [GO:0031209]	protein-containing complex binding [GO:0044877]	GO:0005856; GO:0007015; GO:0031209; GO:0044877	actin filament organization [GO:0007015]		blue	blue	NA	NA	NA	NA
TRINITY_DN809_c0_g1_i1	Q8VZN9	P2C11_ARATH	50.9	57	27	1	441	611	125	180	1.60E-08	61.2	P2C11_ARATH	reviewed	Probable protein phosphatase 2C 11 (AtPP2C11) (EC 3.1.3.16)	At1g43900 F28H19.16 F9C16.6	Arabidopsis thaliana (Mouse-ear cress)	371	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005829; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN29417_c0_g1_i1	Q9M9W9	P2C34_ARATH	50.8	65	32	0	201	7	254	318	6.30E-12	70.9	P2C34_ARATH	reviewed	Probable protein phosphatase 2C 34 (AtPP2C34) (EC 3.1.3.16)	At3g05640 F18C1.9	Arabidopsis thaliana (Mouse-ear cress)	358	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of growth [GO:0045926]; protein dephosphorylation [GO:0006470]; regulation of microtubule binding [GO:1904526]; response to water deprivation [GO:0009414]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005829; GO:0005886; GO:0006470; GO:0009414; GO:0045926; GO:0046872; GO:1904526	negative regulation of growth [GO:0045926]; protein dephosphorylation [GO:0006470]; regulation of microtubule binding [GO:1904526]; response to water deprivation [GO:0009414]		red	red	NA	NA	NA	NA
TRINITY_DN809_c0_g2_i2	Q0DBU3	P2C56_ORYSJ	37.9	116	53	5	627	938	152	260	2.90E-06	54.3	P2C56_ORYSJ	reviewed	Probable protein phosphatase 2C 56 (OsPP2C56) (EC 3.1.3.16)	Os06g0526800 Os06g0526950 LOC_Os06g33549 OsJ_020684 OSJNBa0043B22.28 P0001B01.8	Oryza sativa subsp. japonica (Rice)	352	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]		magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN32383_c0_g1_i1	A0DSB3	PP2C6_PARTE	45.9	109	54	3	325	2	170	274	5.20E-19	95.1	PP2C6_PARTE	reviewed	Probable protein phosphatase 2C 6 (PP2C 6) (EC 3.1.3.16)	GSPATT00019634001	Paramecium tetraurelia	295	membrane [GO:0016020]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	membrane [GO:0016020]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0016020; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN36092_c0_g1_i1	P49596	PP2C2_CAEEL	62.2	320	120	1	1046	87	1	319	1.20E-115	417.9	PP2C2_CAEEL	reviewed	Probable protein phosphatase 2C T23F11.1 (PP2C) (EC 3.1.3.16)	ppm-2 T23F11.1	Caenorhabditis elegans	356	presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of axon extension [GO:0030517]; positive regulation of synapse assembly [GO:0051965]	presynaptic active zone [GO:0048786]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]	GO:0004722; GO:0004724; GO:0030517; GO:0031625; GO:0046872; GO:0048786; GO:0051965	negative regulation of axon extension [GO:0030517]; positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN30623_c0_g1_i1	P49596	PP2C2_CAEEL	50.8	120	51	1	362	3	154	265	3.00E-28	125.9	PP2C2_CAEEL	reviewed	Probable protein phosphatase 2C T23F11.1 (PP2C) (EC 3.1.3.16)	ppm-2 T23F11.1	Caenorhabditis elegans	356	presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of axon extension [GO:0030517]; positive regulation of synapse assembly [GO:0051965]	presynaptic active zone [GO:0048786]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]	GO:0004722; GO:0004724; GO:0030517; GO:0031625; GO:0046872; GO:0048786; GO:0051965	negative regulation of axon extension [GO:0030517]; positive regulation of synapse assembly [GO:0051965]		NA	NA	NA	NA	NA	NA
TRINITY_DN19525_c0_g1_i1	Q3EBC2	ZDHC5_ARATH	54.1	61	28	0	233	51	158	218	2.10E-07	56.2	ZDHC5_ARATH	reviewed	Probable protein S-acyltransferase 17 (EC 2.3.1.225) (Probable palmitoyltransferase At3g04970) (Zinc finger DHHC domain-containing protein At3g04970)	PAT17 At3g04970 T9J14.8	Arabidopsis thaliana (Mouse-ear cress)	397	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706; GO:0030659	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]		red	red	NA	NA	NA	NA
TRINITY_DN31947_c0_g1_i1	Q9M1K5	ZDH13_ARATH	51.9	54	26	0	170	9	142	195	1.40E-10	66.6	ZDH13_ARATH	reviewed	Probable protein S-acyltransferase 4 (EC 2.3.1.225) (Probable palmitoyltransferase At3g56930) (Zinc finger DHHC domain-containing protein At3g56930)	PAT04 At3g56930 F24I3.10	Arabidopsis thaliana (Mouse-ear cress)	477	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; root hair [GO:0035618]; trans-Golgi network transport vesicle [GO:0030140]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]; root hair elongation [GO:0048767]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; root hair [GO:0035618]; trans-Golgi network transport vesicle [GO:0030140]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0019706; GO:0030140; GO:0035618; GO:0048767	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]; root hair elongation [GO:0048767]		NA	NA	NA	NA	NA	NA
TRINITY_DN28617_c0_g1_i1	Q54DU9	TP4AA_DICDI	48.3	87	42	2	1	255	70	155	1.90E-16	86.3	TP4AA_DICDI	reviewed	Probable protein tyrosine phosphatase type IVA A (EC 3.1.3.48)	DDB_G0292024	Dictyostelium discoideum (Slime mold)	166	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0008138; GO:0016020			red	red	NA	NA	NA	NA
TRINITY_DN40804_c0_g1_i1	Q9URZ1	PIMT_SCHPO	61.2	67	19	1	1	201	58	117	7.70E-13	73.9	PIMT_SCHPO	reviewed	Probable protein-L-isoaspartate O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	pcm2 SPAC869.08	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	230	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; cellular detoxification [GO:1990748]; protein repair [GO:0030091]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005634; GO:0005737; GO:0005829; GO:0030091; GO:1990748	cellular detoxification [GO:1990748]; protein repair [GO:0030091]		NA	NA	NA	NA	NA	NA
TRINITY_DN6446_c0_g1_i1	P52899	ODPA_CAEEL	63	54	20	0	220	59	26	79	6.20E-13	75.1	ODPA_CAEEL	reviewed	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	T05H10.6	Caenorhabditis elegans	397	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005739; GO:0005967; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN6446_c0_g1_i2	P52899	ODPA_CAEEL	63	54	20	0	229	68	26	79	1.10E-12	74.3	ODPA_CAEEL	reviewed	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	T05H10.6	Caenorhabditis elegans	397	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005739; GO:0005967; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		blue	blue	NA	NA	NA	NA
TRINITY_DN6446_c0_g1_i3	P52899	ODPA_CAEEL	70	200	60	0	602	3	26	225	1.90E-77	290.4	ODPA_CAEEL	reviewed	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	T05H10.6	Caenorhabditis elegans	397	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005739; GO:0005967; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN38670_c0_g1_i1	Q54E21	RFC2_DICDI	54	239	109	1	5	721	22	259	4.10E-69	262.7	RFC2_DICDI	reviewed	Probable replication factor C subunit 2 (Activator 1 subunit 2)	rfc2 DDB_G0291868	Dictyostelium discoideum (Slime mold)	338	DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; leading strand elongation [GO:0006272]	DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006272; GO:0006281; GO:0031391	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; leading strand elongation [GO:0006272]		NA	NA	NA	NA	NA	NA
TRINITY_DN25464_c0_g1_i1	Q54ST4	RFC5_DICDI	61.2	80	31	0	243	4	38	117	4.30E-23	108.2	RFC5_DICDI	reviewed	Probable replication factor C subunit 5 (Activator 1 subunit 5)	rfc5 DDB_G0282235	Dictyostelium discoideum (Slime mold)	347	DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA clamp loader activity [GO:0003689]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; leading strand elongation [GO:0006272]	DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006272; GO:0006281; GO:0016887; GO:0031391	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; leading strand elongation [GO:0006272]		NA	NA	NA	NA	NA	NA
TRINITY_DN10778_c0_g1_i2	Q9VB98	Y5521_DROME	42.9	226	93	10	654	55	343	558	1.50E-34	147.9	Y5521_DROME	reviewed	Probable Rho GTPase-activating protein CG5521	CG5521	Drosophila melanogaster (Fruit fly)	1958	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0005737; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN5114_c0_g1_i1	Q8SSF6	RLP24_ENCCU	62.3	69	26	0	210	4	1	69	7.20E-21	100.9	RLP24_ENCCU	reviewed	Probable ribosome biogenesis protein RLP24	RPL24 ECU02_0810	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	155	ribosome [GO:0005840]	ribosome [GO:0005840]		GO:0005840			NA	NA	NA	NA	NA	NA
TRINITY_DN9036_c0_g1_i1	Q3SZ12	RLP24_BOVIN	65.4	159	54	1	73	549	1	158	2.60E-56	219.9	RLP24_BOVIN	reviewed	Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1)	RSL24D1	Bos taurus (Bovine)	163	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0022625; GO:1902626	assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN33310_c0_g1_i1	Q7ZTZ2	RLP24_DANRE	64.3	112	40	0	362	27	1	112	5.40E-39	161.8	RLP24_DANRE	reviewed	Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1)	rsl24d1 zgc:56202	Danio rerio (Zebrafish) (Brachydanio rerio)	161	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022625; GO:1902626	assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN40384_c0_g1_i1	Q9UHA3	RLP24_HUMAN	100	120	0	0	362	3	13	132	2.40E-62	239.2	RLP24_HUMAN	reviewed	Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like)	RSL24D1 C15orf15 RPL24L My024	Homo sapiens (Human)	163	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0022625; GO:1902626	assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN6933_c0_g1_i1	Q9VKB4	RPF1_DROME	58.2	311	112	6	79	981	92	394	3.90E-84	313.2	RPF1_DROME	reviewed	Probable ribosome production factor 1 (Ribosome biogenesis protein RPF1)	CG6712	Drosophila melanogaster (Fruit fly)	394	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0006364; GO:0019843; GO:0030687; GO:0042254	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN956_c0_g1_i4	Q6J5K9	ARMI_DROME	29.3	423	247	11	46	1236	279	675	2.10E-32	142.5	ARMI_DROME	reviewed	Probable RNA helicase armi (EC 3.6.4.13) (Protein armitage)	armi CG11513	Drosophila melanogaster (Fruit fly)	1188	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; P granule [GO:0043186]; synapse [GO:0045202]; Yb body [GO:0070725]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; dorsal appendage formation [GO:0046843]; embryonic axis specification [GO:0000578]; germarium-derived egg chamber formation [GO:0007293]; long-term memory [GO:0007616]; microtubule organizing center organization [GO:0031023]; negative regulation of DNA damage checkpoint [GO:2000002]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; pole plasm protein localization [GO:0007318]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA interference [GO:0016246]; small RNA loading onto RISC [GO:0070922]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; P granule [GO:0043186]; synapse [GO:0045202]; Yb body [GO:0070725]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000578; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0007293; GO:0007318; GO:0007616; GO:0016246; GO:0030424; GO:0030425; GO:0031023; GO:0032574; GO:0035194; GO:0043025; GO:0043186; GO:0045202; GO:0046843; GO:0048477; GO:0070725; GO:0070922; GO:1990511; GO:2000002	"dorsal appendage formation [GO:0046843]; embryonic axis specification [GO:0000578]; germarium-derived egg chamber formation [GO:0007293]; long-term memory [GO:0007616]; microtubule organizing center organization [GO:0031023]; negative regulation of DNA damage checkpoint [GO:2000002]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; pole plasm protein localization [GO:0007318]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA interference [GO:0016246]; small RNA loading onto RISC [GO:0070922]"		NA	NA	NA	NA	NA	NA
TRINITY_DN956_c0_g1_i4	Q6J5K9	ARMI_DROME	44	75	40	1	2257	2475	691	765	2.30E-10	69.3	ARMI_DROME	reviewed	Probable RNA helicase armi (EC 3.6.4.13) (Protein armitage)	armi CG11513	Drosophila melanogaster (Fruit fly)	1188	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; P granule [GO:0043186]; synapse [GO:0045202]; Yb body [GO:0070725]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; dorsal appendage formation [GO:0046843]; embryonic axis specification [GO:0000578]; germarium-derived egg chamber formation [GO:0007293]; long-term memory [GO:0007616]; microtubule organizing center organization [GO:0031023]; negative regulation of DNA damage checkpoint [GO:2000002]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; pole plasm protein localization [GO:0007318]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA interference [GO:0016246]; small RNA loading onto RISC [GO:0070922]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; P granule [GO:0043186]; synapse [GO:0045202]; Yb body [GO:0070725]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0000578; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0007293; GO:0007318; GO:0007616; GO:0016246; GO:0030424; GO:0030425; GO:0031023; GO:0032574; GO:0035194; GO:0043025; GO:0043186; GO:0045202; GO:0046843; GO:0048477; GO:0070725; GO:0070922; GO:1990511; GO:2000002	"dorsal appendage formation [GO:0046843]; embryonic axis specification [GO:0000578]; germarium-derived egg chamber formation [GO:0007293]; long-term memory [GO:0007616]; microtubule organizing center organization [GO:0031023]; negative regulation of DNA damage checkpoint [GO:2000002]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; pole plasm protein localization [GO:0007318]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA interference [GO:0016246]; small RNA loading onto RISC [GO:0070922]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38954_c0_g1_i1	Q86U06	RBM23_HUMAN	100	193	0	0	582	4	140	332	1.30E-105	383.6	RBM23_HUMAN	reviewed	Probable RNA-binding protein 23 (CAPER beta) (CAPERbeta) (RNA-binding motif protein 23) (RNA-binding region-containing protein 4) (Splicing factor SF2)	RBM23 RNPC4 PP239	Homo sapiens (Human)	439	"membrane [GO:0016020]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"	membrane [GO:0016020]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016020; GO:0045893; GO:0048024	"mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18599_c0_g1_i4	P86049	RBM46_MOUSE	56.8	308	130	3	1274	357	6	312	2.20E-97	357.5	RBM46_MOUSE	reviewed	Probable RNA-binding protein 46 (RNA-binding motif protein 46)	Rbm46	Mus musculus (Mouse)	533	nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]	nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0001829; GO:0003723; GO:0003729; GO:0005634; GO:0048255	mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]		NA	NA	NA	NA	NA	NA
TRINITY_DN18599_c0_g1_i5	P86049	RBM46_MOUSE	56.8	308	130	3	1274	357	6	312	2.20E-97	357.5	RBM46_MOUSE	reviewed	Probable RNA-binding protein 46 (RNA-binding motif protein 46)	Rbm46	Mus musculus (Mouse)	533	nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]	nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0001829; GO:0003723; GO:0003729; GO:0005634; GO:0048255	mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]		NA	NA	NA	NA	NA	NA
TRINITY_DN18599_c0_g1_i7	P86049	RBM46_MOUSE	56.8	308	130	3	1243	326	6	312	2.20E-97	357.5	RBM46_MOUSE	reviewed	Probable RNA-binding protein 46 (RNA-binding motif protein 46)	Rbm46	Mus musculus (Mouse)	533	nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]	nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0001829; GO:0003723; GO:0003729; GO:0005634; GO:0048255	mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]		NA	NA	NA	NA	NA	NA
TRINITY_DN18599_c0_g1_i1	P86049	RBM46_MOUSE	56.8	308	130	3	1295	378	6	312	2.20E-97	357.5	RBM46_MOUSE	reviewed	Probable RNA-binding protein 46 (RNA-binding motif protein 46)	Rbm46	Mus musculus (Mouse)	533	nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]	nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0001829; GO:0003723; GO:0003729; GO:0005634; GO:0048255	mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829]		brown	brown	1	NA	NA	NA
TRINITY_DN841_c0_g1_i1	Q5HZM1	EIF1A_XENLA	47.5	158	79	1	588	127	1	158	8.80E-32	138.7	EIF1A_XENLA	reviewed	Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)	eif1ad	Xenopus laevis (African clawed frog)	169	nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]	nucleus [GO:0005634]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN841_c0_g1_i2	Q5HZM1	EIF1A_XENLA	47.5	158	79	1	588	127	1	158	1.10E-31	138.3	EIF1A_XENLA	reviewed	Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)	eif1ad	Xenopus laevis (African clawed frog)	169	nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]	nucleus [GO:0005634]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN841_c0_g1_i3	Q5HZM1	EIF1A_XENLA	47.5	158	79	1	588	127	1	158	8.30E-32	138.7	EIF1A_XENLA	reviewed	Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)	eif1ad	Xenopus laevis (African clawed frog)	169	nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]	nucleus [GO:0005634]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN29354_c0_g1_i1	Q5RKI6	EIF1A_RAT	95.6	91	4	0	275	3	14	104	3.10E-46	185.3	EIF1A_RAT	reviewed	Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)	Eif1ad	Rattus norvegicus (Rat)	167	nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]	nucleus [GO:0005634]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN5613_c0_g2_i1	Q95SX7	RTBS_DROME	34.7	75	48	1	227	3	582	655	3.00E-05	48.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5613_c0_g1_i2	Q95SX7	RTBS_DROME	36.9	84	52	1	253	2	565	647	9.00E-06	50.8	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5613_c0_g1_i3	Q95SX7	RTBS_DROME	40	105	62	1	316	2	544	647	6.00E-12	71.6	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN44_c0_g1_i10	Q95SX7	RTBS_DROME	27.6	116	71	3	44	352	614	729	1.20E-05	51.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN44_c0_g1_i5	Q95SX7	RTBS_DROME	22.3	215	143	7	3	581	617	829	7.50E-06	52.4	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		blue	blue	NA	NA	NA	NA
TRINITY_DN70_c1_g1_i23	Q95SX7	RTBS_DROME	25	432	310	6	1650	394	440	870	1.80E-27	126.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	1
TRINITY_DN70_c1_g1_i26	Q95SX7	RTBS_DROME	25	432	310	6	2082	3338	440	870	1.70E-27	126.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28017_c0_g1_i1	Q95SX7	RTBS_DROME	35.2	71	38	1	4	192	613	683	2.80E-05	48.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN467_c0_g1_i11	Q95SX7	RTBS_DROME	29.5	441	286	8	19	1293	407	838	2.40E-39	165.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN467_c0_g1_i22	Q95SX7	RTBS_DROME	29.8	326	214	9	1006	1947	310	632	2.40E-23	112.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN467_c0_g1_i25	Q95SX7	RTBS_DROME	31.7	319	204	5	19	945	407	721	1.50E-32	141.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN467_c0_g1_i7	Q95SX7	RTBS_DROME	31.1	257	164	7	1207	1947	379	632	1.40E-23	112.8	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15465_c2_g1_i1	Q95SX7	RTBS_DROME	37.4	91	49	2	293	36	572	659	1.40E-09	63.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32807_c0_g1_i1	Q95SX7	RTBS_DROME	41.1	73	37	1	24	224	613	685	9.80E-07	53.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN845_c0_g1_i1	Q95SX7	RTBS_DROME	30.1	395	252	10	1131	1	379	767	5.00E-39	164.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN845_c0_g1_i33	Q95SX7	RTBS_DROME	29.6	392	252	10	1131	10	379	764	2.60E-37	158.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5158_c1_g1_i1	Q95SX7	RTBS_DROME	42.6	68	38	1	204	1	582	648	5.90E-07	54.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9151_c1_g1_i4	Q95SX7	RTBS_DROME	33.6	107	61	3	30	323	582	687	1.90E-09	63.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8253_c0_g1_i1	Q95SX7	RTBS_DROME	42.3	78	42	2	250	17	595	669	1.30E-06	53.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5401_c0_g1_i1	Q95SX7	RTBS_DROME	39.4	71	43	0	215	3	513	583	1.90E-06	52.8	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16943_c0_g1_i10	Q95SX7	RTBS_DROME	44.8	58	31	1	218	48	500	557	9.50E-06	51.6	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16943_c0_g1_i11	Q95SX7	RTBS_DROME	48.9	47	24	0	188	48	511	557	4.90E-05	48.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16943_c0_g1_i12	Q95SX7	RTBS_DROME	44.8	58	31	1	218	48	500	557	9.50E-06	51.6	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16943_c0_g1_i15	Q95SX7	RTBS_DROME	33.7	98	64	1	293	3	494	591	7.50E-06	51.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16943_c0_g1_i2	Q95SX7	RTBS_DROME	34.8	92	59	1	275	3	500	591	2.40E-06	53.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16943_c0_g1_i4	Q95SX7	RTBS_DROME	37	81	51	0	245	3	511	591	2.90E-07	55.8	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15128_c0_g1_i1	Q95SX7	RTBS_DROME	33.3	117	77	1	44	391	442	558	7.30E-12	71.6	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3962_c0_g1_i1	Q95SX7	RTBS_DROME	48.9	45	23	0	952	1086	513	557	2.80E-05	51.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3962_c0_g1_i3	Q95SX7	RTBS_DROME	48.9	45	23	0	1017	1151	513	557	3.00E-05	51.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3962_c0_g1_i4	Q95SX7	RTBS_DROME	48.9	45	23	0	1017	1151	513	557	3.00E-05	51.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN695_c0_g1_i12	Q95SX7	RTBS_DROME	27.8	381	244	10	71	1135	481	856	2.90E-24	115.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN695_c0_g1_i14	Q95SX7	RTBS_DROME	28.9	308	188	10	71	916	481	783	3.40E-19	97.4	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN695_c0_g1_i15	Q95SX7	RTBS_DROME	24.3	882	580	26	1230	3698	4	856	1.20E-32	144.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN695_c0_g1_i2	Q95SX7	RTBS_DROME	28	346	216	11	177	1136	456	794	1.40E-18	95.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN695_c0_g1_i4	Q95SX7	RTBS_DROME	27.4	361	229	11	10	1014	441	794	1.60E-18	95.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14949_c1_g1_i1	Q95SX7	RTBS_DROME	40.3	67	39	1	218	18	502	567	2.20E-05	49.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40315_c0_g1_i1	Q95SX7	RTBS_DROME	36.3	113	71	1	11	346	489	601	3.60E-13	75.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13049_c0_g1_i1	Q95SX7	RTBS_DROME	25	424	289	12	176	1375	268	686	1.30E-15	85.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13049_c0_g1_i3	Q95SX7	RTBS_DROME	25	424	289	12	176	1375	268	686	3.40E-16	87.8	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13049_c0_g1_i4	Q95SX7	RTBS_DROME	25	424	289	12	129	1328	268	686	1.20E-15	85.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13049_c0_g1_i6	Q95SX7	RTBS_DROME	25	424	289	12	176	1375	268	686	1.50E-16	89	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13049_c0_g1_i7	Q95SX7	RTBS_DROME	25	424	289	12	129	1328	268	686	1.50E-16	89	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11552_c1_g1_i3	Q95SX7	RTBS_DROME	37.2	121	73	2	3	359	484	603	6.60E-15	82	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10774_c1_g1_i1	Q95SX7	RTBS_DROME	41.8	67	38	1	227	30	501	567	5.00E-05	48.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34297_c0_g1_i1	Q95SX7	RTBS_DROME	35.4	79	44	2	18	233	614	692	5.20E-05	48.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32719_c0_g1_i1	Q95SX7	RTBS_DROME	36.5	96	60	1	376	89	565	659	1.70E-10	67	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20173_c0_g1_i1	Q95SX7	RTBS_DROME	40	75	44	1	12	236	582	655	4.70E-06	51.6	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11113_c0_g3_i1	Q95SX7	RTBS_DROME	37.3	83	51	1	7	252	476	558	5.80E-10	64.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11113_c0_g3_i2	Q95SX7	RTBS_DROME	34.9	83	53	1	7	252	476	558	1.30E-09	63.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10252_c0_g1_i1	Q95SX7	RTBS_DROME	36.7	79	43	2	33	248	614	692	1.00E-06	53.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1742_c0_g2_i11	Q95SX7	RTBS_DROME	29.8	429	266	9	47	1252	415	835	2.60E-43	177.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g2_i17	Q95SX7	RTBS_DROME	30.1	432	267	9	47	1261	415	838	9.80E-45	183	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g1_i1	Q95SX7	RTBS_DROME	28.4	486	317	9	1762	374	361	838	1.30E-44	183	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g1_i10	Q95SX7	RTBS_DROME	28.4	486	317	9	1762	374	361	838	1.30E-44	183	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g1_i14	Q95SX7	RTBS_DROME	28.4	486	317	9	1762	374	361	838	1.20E-44	183	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g1_i17	Q95SX7	RTBS_DROME	28.4	486	317	9	1762	374	361	838	1.30E-44	183	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	1	NA
TRINITY_DN1742_c0_g1_i20	Q95SX7	RTBS_DROME	28.6	486	316	9	1762	374	361	838	3.60E-45	184.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g1_i30	Q95SX7	RTBS_DROME	27.9	488	321	9	1481	87	361	840	6.40E-43	177.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1742_c0_g1_i37	Q95SX7	RTBS_DROME	28.6	486	316	9	1762	374	361	838	3.60E-45	184.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23158_c0_g1_i1	Q95SX7	RTBS_DROME	40.6	64	38	0	225	34	539	602	1.30E-06	53.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN23158_c0_g1_i2	Q95SX7	RTBS_DROME	37.5	72	45	0	249	34	531	602	1.70E-06	53.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14196_c0_g1_i1	Q95SX7	RTBS_DROME	40.8	76	39	1	21	230	613	688	3.20E-07	55.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN990_c0_g1_i15	Q95SX7	RTBS_DROME	31.2	410	254	8	1556	381	440	839	7.00E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN990_c0_g1_i21	Q95SX7	RTBS_DROME	31.2	410	254	8	1581	406	440	839	7.10E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN990_c0_g1_i23	Q95SX7	RTBS_DROME	25.2	828	523	25	2746	443	48	839	9.80E-43	177.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN990_c0_g1_i35	Q95SX7	RTBS_DROME	31.2	410	254	8	1654	479	440	839	7.40E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN990_c0_g1_i36	Q95SX7	RTBS_DROME	31.2	410	254	8	1626	451	440	839	7.30E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN990_c0_g1_i4	Q95SX7	RTBS_DROME	31.2	410	254	8	1422	247	440	839	6.70E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN467_c0_g1_i4	Q95SX7	RTBS_DROME	28.1	538	353	12	1006	2544	310	838	1.50E-41	172.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	1
TRINITY_DN845_c0_g1_i11	Q95SX7	RTBS_DROME	30.1	395	252	10	1131	1	379	767	6.60E-39	164.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	1	NA	NA	NA
TRINITY_DN845_c0_g1_i27	Q95SX7	RTBS_DROME	28.1	274	171	9	779	9	572	836	1.80E-17	91.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN845_c0_g1_i28	Q95SX7	RTBS_DROME	28.1	274	171	9	1210	440	572	836	4.70E-17	90.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		yellow	yellow	1	NA	NA	NA
TRINITY_DN695_c0_g1_i1	Q95SX7	RTBS_DROME	27.8	381	244	10	71	1135	481	856	2.90E-24	115.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	1	NA	NA	NA
TRINITY_DN695_c0_g1_i11	Q95SX7	RTBS_DROME	24.3	882	580	26	1336	3804	4	856	1.20E-32	144.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN695_c0_g1_i13	Q95SX7	RTBS_DROME	24.2	665	428	22	60	1901	155	794	1.10E-17	93.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	1
TRINITY_DN39227_c0_g1_i1	Q95SX7	RTBS_DROME	37.5	80	49	1	242	6	479	558	1.80E-05	49.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2484_c0_g1_i19	Q95SX7	RTBS_DROME	31.3	332	209	6	1400	444	511	836	2.50E-33	144.8	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2484_c0_g1_i27	Q95SX7	RTBS_DROME	32.6	279	172	5	823	17	511	783	2.90E-29	130.6	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN695_c0_g1_i3	Q95SX7	RTBS_DROME	27.8	381	244	10	71	1135	481	856	2.60E-24	115.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN695_c0_g1_i6	Q95SX7	RTBS_DROME	27.8	381	244	10	71	1135	481	856	2.90E-24	115.5	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	1
TRINITY_DN695_c0_g1_i8	Q95SX7	RTBS_DROME	24.3	882	580	26	1336	3804	4	856	1.20E-32	144.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN10268_c1_g1_i4	Q95SX7	RTBS_DROME	31.5	108	68	2	43	366	546	647	4.70E-05	48.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		yellow	yellow	1	NA	NA	1
TRINITY_DN1742_c0_g2_i10	Q95SX7	RTBS_DROME	30.1	432	267	9	47	1261	415	838	8.10E-45	183	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	1	NA	NA	1
TRINITY_DN1742_c0_g1_i24	Q95SX7	RTBS_DROME	28.4	486	317	9	1478	90	361	838	7.60E-44	179.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	1	NA	NA	1
TRINITY_DN990_c0_g1_i10	Q95SX7	RTBS_DROME	31.2	410	254	8	1626	451	440	839	7.30E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	1	NA
TRINITY_DN990_c0_g1_i11	Q95SX7	RTBS_DROME	25.2	828	523	25	2746	443	48	839	9.80E-43	177.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN990_c0_g1_i19	Q95SX7	RTBS_DROME	31.2	410	254	8	1626	451	440	839	7.30E-42	173.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN990_c0_g1_i20	Q95SX7	RTBS_DROME	25.2	828	523	25	2601	298	48	839	9.40E-43	177.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN318_c0_g1_i20	Q95SX7	RTBS_DROME	29.9	468	285	11	1769	459	385	840	3.60E-43	177.9	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN318_c0_g1_i4	Q95SX7	RTBS_DROME	27.4	680	422	21	2342	459	181	840	2.70E-44	182.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN318_c0_g1_i9	Q95SX7	RTBS_DROME	30.3	468	283	11	1769	459	385	840	7.90E-45	183.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN4696_c0_g1_i2	Q95SX7	RTBS_DROME	39.1	92	55	1	279	4	565	655	3.20E-10	68.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10551_c0_g2_i7	Q95SX7	RTBS_DROME	26.2	225	138	6	141	758	583	798	3.30E-13	77	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17919_c0_g2_i1	Q95SX7	RTBS_DROME	38.7	106	64	1	173	487	498	603	2.60E-14	80.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17919_c0_g3_i2	Q95SX7	RTBS_DROME	38.7	75	45	1	3	224	501	575	4.90E-08	58.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN358_c1_g1_i19	Q95SX7	RTBS_DROME	32.7	312	187	8	1032	142	484	787	3.60E-34	147.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN358_c1_g1_i25	Q95SX7	RTBS_DROME	32.7	312	187	8	917	27	484	787	3.20E-34	147.1	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN358_c1_g1_i9	Q95SX7	RTBS_DROME	32.4	145	96	2	877	446	484	627	1.90E-15	84.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN318_c0_g1_i10	Q95SX7	RTBS_DROME	30.3	468	283	11	1769	459	385	840	7.70E-45	183.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN318_c0_g1_i19	Q95SX7	RTBS_DROME	27.4	680	422	21	2342	459	181	840	2.70E-44	182.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN318_c0_g1_i7	Q95SX7	RTBS_DROME	30.3	468	283	11	1769	459	385	840	7.60E-45	183.7	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN318_c0_g1_i8	Q95SX7	RTBS_DROME	27.4	680	422	21	2342	459	181	840	2.70E-44	182.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30002_c0_g1_i1	Q95SX7	RTBS_DROME	37.9	87	41	2	331	89	581	660	2.30E-09	63.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN9900_c0_g1_i1	Q95SX7	RTBS_DROME	30.7	153	94	3	191	622	572	721	1.60E-11	71.2	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8988_c2_g1_i2	Q95SX7	RTBS_DROME	41.2	68	39	1	13	216	582	648	6.60E-07	54.3	RTBS_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	RTase	Drosophila melanogaster (Fruit fly)	906	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8253_c0_g1_i2	Q9NBX4	RTXE_DROME	35.6	90	51	2	444	193	594	682	3.00E-06	53.1	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8253_c0_g1_i3	Q9NBX4	RTXE_DROME	41.6	77	42	2	442	212	594	667	2.30E-06	53.5	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5401_c0_g1_i2	Q9NBX4	RTXE_DROME	37.5	64	40	0	215	24	512	575	4.60E-06	51.6	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	NA	NA	NA	NA
TRINITY_DN3638_c0_g1_i1	Q9NBX4	RTXE_DROME	42.4	66	37	1	30	224	488	553	6.30E-07	54.7	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN11552_c1_g1_i1	Q9NBX4	RTXE_DROME	42.4	66	35	2	18	209	488	552	3.30E-06	52	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11552_c1_g1_i2	Q9NBX4	RTXE_DROME	32.2	121	70	5	29	382	492	603	1.60E-06	54.3	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i1	Q9NBX4	RTXE_DROME	27.8	381	258	8	165	1289	293	662	3.30E-19	98.6	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i10	Q9NBX4	RTXE_DROME	40.1	152	90	1	10	465	512	662	4.80E-19	97.4	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i11	Q9NBX4	RTXE_DROME	40.1	152	90	1	10	465	512	662	4.40E-19	97.4	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i15	Q9NBX4	RTXE_DROME	27.8	381	258	8	165	1289	293	662	3.10E-19	98.6	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i16	Q9NBX4	RTXE_DROME	40.1	152	90	1	10	465	512	662	2.30E-19	97.4	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i17	Q9NBX4	RTXE_DROME	37.7	175	107	2	47	568	489	662	7.70E-20	99	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i3	Q9NBX4	RTXE_DROME	40.1	152	90	1	10	465	512	662	4.80E-19	97.4	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3726_c0_g1_i8	Q9NBX4	RTXE_DROME	40.1	152	90	1	10	465	512	662	2.30E-19	97.4	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i15	Q9NBX4	RTXE_DROME	29.1	320	205	7	5	925	524	834	1.30E-24	115.9	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i19	Q9NBX4	RTXE_DROME	22.5	879	600	23	141	2681	5	834	1.20E-35	153.7	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20180_c0_g1_i26	Q9NBX4	RTXE_DROME	29.1	320	205	7	5	925	524	834	1.30E-24	115.9	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		blue	blue	NA	NA	NA	NA
TRINITY_DN14196_c0_g1_i2	Q9NBX4	RTXE_DROME	39.2	74	42	1	21	233	612	685	5.90E-07	54.7	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	NA	NA	NA	NA
TRINITY_DN3072_c0_g1_i1	Q9NBX4	RTXE_DROME	37	81	50	1	75	314	472	552	3.00E-09	62.8	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10925_c0_g1_i1	Q9NBX4	RTXE_DROME	26.9	312	210	9	4	903	564	869	8.30E-21	102.8	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10925_c0_g1_i2	Q9NBX4	RTXE_DROME	26.9	312	210	9	4	903	564	869	8.30E-21	102.8	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	NA	NA	NA	NA
TRINITY_DN25489_c0_g1_i1	Q9NBX4	RTXE_DROME	41.3	75	41	1	2	217	606	680	1.80E-07	56.2	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN925_c1_g1_i16	Q9NBX4	RTXE_DROME	25.3	553	383	13	2201	591	296	834	1.80E-30	136	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN925_c1_g1_i18	Q9NBX4	RTXE_DROME	25.3	553	383	13	2172	562	296	834	1.80E-30	136	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN925_c1_g1_i9	Q9NBX4	RTXE_DROME	25.3	553	383	13	2183	573	296	834	1.80E-30	136	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16494_c0_g1_i2	Q9NBX4	RTXE_DROME	31.1	103	68	2	1	300	492	594	1.80E-05	50.1	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12117_c0_g1_i1	Q9NBX4	RTXE_DROME	40.7	81	47	1	240	1	488	568	4.30E-08	58.5	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	NA	NA	NA	NA
TRINITY_DN31020_c0_g1_i1	Q9NBX4	RTXE_DROME	35.7	84	53	1	268	20	474	557	6.00E-07	55.1	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		brown	brown	1	NA	NA	NA
TRINITY_DN18803_c0_g1_i1	Q9NBX4	RTXE_DROME	36.2	141	75	4	432	46	548	685	4.50E-10	65.9	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8919_c0_g1_i2	Q9NBX4	RTXE_DROME	36.4	77	40	2	1	204	624	700	5.00E-06	52.4	RTXE_DROME	reviewed	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	X-element\ORF2 ORF2	Drosophila melanogaster (Fruit fly)	908	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0006313	"transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27807_c0_g1_i1	Q99848	EBP2_HUMAN	100	84	0	0	252	1	92	175	3.20E-37	155.2	EBP2_HUMAN	reviewed	Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40)	EBNA1BP2 EBP2	Homo sapiens (Human)	306	"nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	"nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN35342_c0_g1_i1	Q9V9Z9	EBP2_DROME	52.1	167	77	2	160	654	18	183	6.40E-37	156.4	EBP2_DROME	reviewed	Probable rRNA-processing protein EBP2 homolog	CG1542	Drosophila melanogaster (Fruit fly)	307	"nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	"nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273	ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN29669_c0_g1_i1	Q27522	METK5_CAEEL	56.6	76	33	0	229	2	267	342	8.60E-16	84	METK5_CAEEL	reviewed	Probable S-adenosylmethionine synthase 5 (AdoMet synthase 5) (EC 2.5.1.6) (Methionine adenosyltransferase 5) (MAT 5)	sams-5 tag-32 T13A10.11	Caenorhabditis elegans	404	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN35891_c0_g1_i1	Q9H3G5	CPVL_HUMAN	100	71	0	0	213	1	178	248	3.30E-35	148.3	CPVL_HUMAN	reviewed	"Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP)"	CPVL VLP PSEC0124 UNQ197/PRO223	Homo sapiens (Human)	476	extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]	extracellular exosome [GO:0070062]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN5094_c0_g1_i1	O18391	KRAK_DROME	32.7	294	194	4	1221	349	35	327	4.60E-44	180.3	KRAK_DROME	reviewed	Probable serine hydrolase (EC 3.1.-.-) (Kraken protein)	kraken CG3943	Drosophila melanogaster (Fruit fly)	331	carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]; digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]		carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]	GO:0007275; GO:0007586; GO:0009636; GO:0016787; GO:0052689	digestion [GO:0007586]; multicellular organism development [GO:0007275]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN554_c0_g1_i5	Q54HH2	SRR_DICDI	46.2	234	123	3	1175	477	9	240	3.90E-54	213.8	SRR_DICDI	reviewed	Probable serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)	srr DDB_G0289463	Dictyostelium discoideum (Slime mold)	324	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; D-serine biosynthetic process [GO:0070179]; D-serine catabolic process [GO:0036088]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005524; GO:0005737; GO:0006563; GO:0006565; GO:0008721; GO:0018114; GO:0018249; GO:0030170; GO:0030378; GO:0036088; GO:0042866; GO:0070179	D-serine biosynthetic process [GO:0070179]; D-serine catabolic process [GO:0036088]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]		NA	NA	NA	NA	NA	NA
TRINITY_DN554_c0_g1_i6	Q54HH2	SRR_DICDI	43.8	315	172	5	1056	115	9	319	2.10E-67	257.7	SRR_DICDI	reviewed	Probable serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)	srr DDB_G0289463	Dictyostelium discoideum (Slime mold)	324	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; D-serine biosynthetic process [GO:0070179]; D-serine catabolic process [GO:0036088]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005524; GO:0005737; GO:0006563; GO:0006565; GO:0008721; GO:0018114; GO:0018249; GO:0030170; GO:0030378; GO:0036088; GO:0042866; GO:0070179	D-serine biosynthetic process [GO:0070179]; D-serine catabolic process [GO:0036088]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]		NA	NA	NA	NA	NA	NA
TRINITY_DN5016_c0_g1_i2	Q54DK3	CDC7_DICDI	56.9	51	22	0	248	400	998	1048	1.00E-05	51.6	CDC7_DICDI	reviewed	Probable serine/threonine-protein kinase cdc7 (EC 2.7.11.1) (Cell division control protein 7)	cdc7 DDB_G0292152	Dictyostelium discoideum (Slime mold)	1061	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; double-strand break repair via break-induced replication [GO:0000727]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000727; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0046872	double-strand break repair via break-induced replication [GO:0000727]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN37556_c0_g1_i1	Q55F45	Y8642_DICDI	41.8	55	31	1	26	190	771	824	2.90E-07	55.5	Y8642_DICDI	reviewed	Probable serine/threonine-protein kinase DDB_G0268642 (EC 2.7.11.1)	DDB_G0268642	Dictyostelium discoideum (Slime mold)	1078	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN29935_c0_g1_i1	Q54BC9	DYRK2_DICDI	50	122	61	0	373	8	708	829	2.30E-31	136.3	DYRK2_DICDI	reviewed	Probable serine/threonine-protein kinase dyrk2 (EC 2.7.12.1) (Dual specificity tyrosine-phosphorylation-regulated kinase 2)	dyrk2 DDB_G0293750	Dictyostelium discoideum (Slime mold)	915	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005856; GO:0018105; GO:0018107	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]		NA	NA	NA	NA	NA	NA
TRINITY_DN30115_c0_g1_i1	B7XHR6	KIN1_ENTBH	73	100	27	0	329	30	185	284	4.90E-38	158.3	KIN1_ENTBH	reviewed	Probable serine/threonine-protein kinase KIN1 homolog (EC 2.7.11.1)	KIN1 EBI_21713	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	595	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006887	exocytosis [GO:0006887]		NA	NA	NA	NA	NA	NA
TRINITY_DN7111_c0_g1_i1	Q8SW92	KIN28_ENCCU	57.1	119	51	0	384	28	92	210	3.40E-38	159.1	KIN28_ENCCU	reviewed	Probable serine/threonine-protein kinase KIN28 homolog (EC 2.7.11.23)	KIN28 ECU02_1450	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	308	transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]	transcription factor TFIIK complex [GO:0070985]	ATP binding [GO:0005524]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0005524; GO:0007049; GO:0008353; GO:0051301; GO:0070985	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN7111_c0_g1_i2	Q8SW92	KIN28_ENCCU	59.4	133	54	0	404	6	92	224	2.10E-46	186.4	KIN28_ENCCU	reviewed	Probable serine/threonine-protein kinase KIN28 homolog (EC 2.7.11.23)	KIN28 ECU02_1450	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	308	transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]	transcription factor TFIIK complex [GO:0070985]	ATP binding [GO:0005524]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0005524; GO:0007049; GO:0008353; GO:0051301; GO:0070985	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN37218_c0_g1_i1	Q8SSE7	ATR_ENCCU	68.6	70	22	0	212	3	1643	1712	9.70E-25	113.6	ATR_ENCCU	reviewed	Probable serine/threonine-protein kinase MEC1 homolog (EC 2.7.11.1) (ATR homolog) (DNA-damage checkpoint kinase MEC1 homolog)	MEC1 ECU02_1130	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	1805	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0006281; GO:0006325; GO:0051321	chromatin organization [GO:0006325]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]		NA	NA	1	NA	NA	NA
TRINITY_DN25678_c0_g1_i1	Q54QV3	YAKA_DICDI	63.1	111	41	0	2	334	328	438	2.20E-38	159.5	YAKA_DICDI	reviewed	Probable serine/threonine-protein kinase yakA (EC 2.7.12.1)	yakA dagB DDB_G0283605	Dictyostelium discoideum (Slime mold)	1458	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; chemotaxis [GO:0006935]; hyperosmotic response [GO:0006972]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gene expression [GO:0010468]; response to curcumin [GO:1904643]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; signal transduction [GO:0007165]; sorocarp development [GO:0030587]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006935; GO:0006972; GO:0006979; GO:0007165; GO:0008277; GO:0010225; GO:0010468; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0019933; GO:0030587; GO:0031152; GO:0051409; GO:1904643	aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; chemotaxis [GO:0006935]; hyperosmotic response [GO:0006972]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to curcumin [GO:1904643]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; signal transduction [GO:0007165]; sorocarp development [GO:0030587]		NA	NA	NA	NA	NA	NA
TRINITY_DN1970_c0_g1_i1	Q5M8Y1	SPCS2_XENTR	49.2	183	93	0	644	96	16	198	1.80E-48	194.1	SPCS2_XENTR	reviewed	Probable signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit)	spcs2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	201	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		blue	blue	NA	NA	NA	NA
TRINITY_DN37520_c0_g1_i1	Q9VLV5	RUXE_DROME	71.4	91	26	0	40	312	1	91	2.20E-31	136.3	RUXE_DROME	reviewed	Probable small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)	SmE CG18591	Drosophila melanogaster (Fruit fly)	94	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0030532; GO:0046540; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3835_c0_g1_i1	Q9VU02	SMD1_DROME	79.2	96	20	0	680	393	1	96	4.30E-37	156.4	SMD1_DROME	reviewed	Probable small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1)	SmD1 snRNP69D CG10753	Drosophila melanogaster (Fruit fly)	124	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0030532; GO:0034715; GO:0034719; GO:0071011; GO:0071013; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		blue	blue	NA	NA	NA	NA
TRINITY_DN18102_c0_g1_i1	Q9VN12	NCKXH_DROME	75.6	86	21	0	2	259	461	546	1.10E-27	123.6	NCKXH_DROME	reviewed	Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090)	CG1090	Drosophila melanogaster (Fruit fly)	633	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"	GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN18102_c0_g1_i2	Q9VN12	NCKXH_DROME	68.8	64	20	0	2	193	461	524	2.80E-15	82.4	NCKXH_DROME	reviewed	Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090)	CG1090	Drosophila melanogaster (Fruit fly)	633	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"	GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN40814_c0_g1_i1	Q9VN12	NCKXH_DROME	73.6	91	24	0	3	275	536	626	3.60E-34	145.2	NCKXH_DROME	reviewed	Probable sodium/potassium/calcium exchanger CG1090 (Na(+)/K(+)/Ca(2+)-exchange protein CG1090)	CG1090	Drosophila melanogaster (Fruit fly)	633	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"	GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g1_i10	Q8MNV0	SPAST_CAEEL	40	75	45	0	65	289	267	341	8.10E-07	54.7	SPAST_CAEEL	reviewed	Probable spastin homolog spas-1 (EC 5.6.1.1)	spas-1 C24B5.2	Caenorhabditis elegans	512	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; nucleus localization [GO:0051647]; oogenesis [GO:0048477]; positive regulation of microtubule depolymerization [GO:0031117]; vulval development [GO:0040025]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0001578; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0005874; GO:0007019; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0031117; GO:0031122; GO:0032991; GO:0040025; GO:0042802; GO:0048471; GO:0048477; GO:0051013; GO:0051647	cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; nucleus localization [GO:0051647]; oogenesis [GO:0048477]; positive regulation of microtubule depolymerization [GO:0031117]; vulval development [GO:0040025]		NA	NA	NA	NA	NA	NA
TRINITY_DN38089_c0_g1_i1	Q8RXF1	SF3A1_ARATH	59.7	62	25	0	9	194	190	251	3.90E-17	88.2	SF3A1_ARATH	reviewed	Probable splicing factor 3A subunit 1	At1g14650 T5E21.13	Arabidopsis thaliana (Mouse-ear cress)	785	"catalytic step 2 spliceosome [GO:0071013]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005684; GO:0005686; GO:0071004; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2082_c0_g1_i1	Q09511	RSP4_CAEEL	65.9	91	31	0	109	381	10	100	1.50E-31	137.1	RSP4_CAEEL	reviewed	"Probable splicing factor, arginine/serine-rich 4 (CeSC35) (RNA-binding protein srp-2)"	rsp-4 srp-2 EEED8.7	Caenorhabditis elegans	196	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0007275; GO:0016607; GO:0045292	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26442_c0_g1_i1	Q18409	RSP6_CAEEL	44.2	52	29	0	201	46	4	55	5.00E-08	58.2	RSP6_CAEEL	reviewed	"Probable splicing factor, arginine/serine-rich 6 (CeSRp20) (RNA-binding protein srp-1)"	rsp-6 srp-1 C33H5.12	Caenorhabditis elegans	179	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gonad development [GO:0008406]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of DNA-templated transcription, termination [GO:0031554]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0007275; GO:0008380; GO:0008406; GO:0016607; GO:0030154; GO:0031554; GO:0045292	"cell differentiation [GO:0030154]; gonad development [GO:0008406]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of DNA-templated transcription, termination [GO:0031554]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3304_c0_g1_i1	O01159	RSP7_CAEEL	40.4	260	142	5	49	804	8	262	5.40E-45	183	RSP7_CAEEL	reviewed	"Probable splicing factor, arginine/serine-rich 7 (p54)"	rsp-7 D2089.1	Caenorhabditis elegans	452	"nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3304_c0_g1_i2	O01159	RSP7_CAEEL	40.4	260	142	5	49	804	8	262	5.50E-45	183	RSP7_CAEEL	reviewed	"Probable splicing factor, arginine/serine-rich 7 (p54)"	rsp-7 D2089.1	Caenorhabditis elegans	452	"nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4480_c0_g1_i1	P42315	SCOA_BACSU	65.6	90	31	0	271	2	121	210	3.40E-29	128.6	SCOA_BACSU	reviewed	Probable succinyl-CoA:3-ketoacid coenzyme A transferase subunit A (EC 2.8.3.5) (Succinyl-CoA:3-oxoacid CoA-transferase) (OXCT A)	scoA yxjD BSU38990 N15K	Bacillus subtilis (strain 168)	238	3-oxoacid CoA-transferase activity [GO:0008260]; acetate CoA-transferase activity [GO:0008775]; CoA-transferase activity [GO:0008410]		3-oxoacid CoA-transferase activity [GO:0008260]; acetate CoA-transferase activity [GO:0008775]; CoA-transferase activity [GO:0008410]	GO:0008260; GO:0008410; GO:0008775			NA	NA	NA	NA	NA	NA
TRINITY_DN311_c0_g3_i1	Q54J66	SYTC1_DICDI	62.5	64	24	0	193	2	121	184	1.80E-19	96.3	SYTC1_DICDI	reviewed	"Probable threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)"	thrS1 DDB_G0288267	Dictyostelium discoideum (Slime mold)	710	cytoplasm [GO:0005737]; phagocytic vesicle [GO:0045335]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; phagocytic vesicle [GO:0045335]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0006418; GO:0006435; GO:0045335	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN35490_c0_g1_i1	B7XIA1	SYTC_ENTBH	72.1	204	57	0	2	613	213	416	4.60E-90	332	SYTC_ENTBH	reviewed	"Probable threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)"	EBI_22768	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	634	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]	GO:0004829; GO:0005524; GO:0005737; GO:0006435	threonyl-tRNA aminoacylation [GO:0006435]		NA	NA	NA	NA	NA	NA
TRINITY_DN34139_c0_g1_i1	B7XIA1	SYTC_ENTBH	71.4	105	30	0	317	3	418	522	3.60E-38	158.7	SYTC_ENTBH	reviewed	"Probable threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)"	EBI_22768	Enterocytozoon bieneusi (strain H348) (Microsporidian parasite)	634	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]	GO:0004829; GO:0005524; GO:0005737; GO:0006435	threonyl-tRNA aminoacylation [GO:0006435]		NA	NA	NA	NA	NA	NA
TRINITY_DN27080_c0_g1_i1	Q9W1G0	TALDO_DROME	53.2	62	29	0	4	189	270	331	2.80E-10	65.5	TALDO_DROME	reviewed	Probable transaldolase (EC 2.2.1.2)	Taldo Tal CG2827	Drosophila melanogaster (Fruit fly)	331	"cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0009052	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11141_c0_g1_i1	B9L8T4	Y626_NAUPA	29.6	247	160	6	756	28	1	237	3.60E-20	100.5	Y626_NAUPA	reviewed	Probable transcriptional regulatory protein NAMH_0626	NAMH_0626	Nautilia profundicola (strain ATCC BAA-1463 / DSM 18972 / AmH)	238	"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	DNA binding [GO:0003677]	GO:0003677; GO:0005737; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9946_c0_g1_i1	P56287	EI2BE_SCHPO	36.7	90	55	2	736	470	220	308	9.50E-08	58.9	EI2BE_SCHPO	reviewed	Probable translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	tif225 SPAC8C9.15c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	678	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]	guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0002183; GO:0003743; GO:0005085; GO:0005829; GO:0005851; GO:0016779; GO:0031369	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN9946_c0_g1_i4	P56287	EI2BE_SCHPO	36.7	90	55	2	732	466	220	308	9.50E-08	58.9	EI2BE_SCHPO	reviewed	Probable translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	tif225 SPAC8C9.15c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	678	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]	guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0002183; GO:0003743; GO:0005085; GO:0005829; GO:0005851; GO:0016779; GO:0031369	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN26658_c1_g1_i1	P56287	EI2BE_SCHPO	37.3	150	85	3	112	561	18	158	3.60E-19	96.7	EI2BE_SCHPO	reviewed	Probable translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	tif225 SPAC8C9.15c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	678	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]	guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0002183; GO:0003743; GO:0005085; GO:0005829; GO:0005851; GO:0016779; GO:0031369	cytoplasmic translational initiation [GO:0002183]		NA	NA	NA	NA	NA	NA
TRINITY_DN9803_c0_g1_i1	Q9VK89	TRM1_DROME	52.6	171	73	2	3	491	217	387	7.80E-48	191.4	TRM1_DROME	reviewed	"Probable tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)"	CG6388	Drosophila melanogaster (Fruit fly)	578	nucleus [GO:0005634]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA N2-guanine methylation [GO:0002940]	nucleus [GO:0005634]	tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]	GO:0000049; GO:0002940; GO:0004809; GO:0005634	tRNA N2-guanine methylation [GO:0002940]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i12	Q8IYL2	TRM44_HUMAN	44.2	486	232	6	2012	3364	265	746	3.10E-119	431.4	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i13	Q8IYL2	TRM44_HUMAN	42.8	320	158	2	1178	2062	340	659	7.20E-74	280	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i14	Q8IYL2	TRM44_HUMAN	44.2	486	232	6	993	2345	265	746	2.20E-119	431.4	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i15	Q8IYL2	TRM44_HUMAN	44.4	399	193	4	993	2114	265	659	1.30E-97	359	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i16	Q8IYL2	TRM44_HUMAN	44.4	399	193	4	977	2098	265	659	7.30E-98	359.8	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i2	Q8IYL2	TRM44_HUMAN	43	407	197	4	145	1260	340	746	7.10E-96	352.4	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN3651_c0_g2_i6	Q8IYL2	TRM44_HUMAN	43	407	197	4	1178	2293	340	746	1.30E-95	352.4	TRM44_HUMAN	reviewed	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	TRMT44 C4orf23 METTL19	Homo sapiens (Human)	757	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]	GO:0005737; GO:0016300; GO:0030488; GO:0046872	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN32343_c0_g1_i1	O22145	OSGP2_ARATH	53.6	56	26	0	3	170	369	424	1.40E-11	69.7	OSGP2_ARATH	reviewed	"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (Glycoprotease 1) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein GCP1) (tRNA threonylcarbamoyladenosine biosynthesis protein GCP1)"	GCP1 At2g45270 F4L23.22	Arabidopsis thaliana (Mouse-ear cress)	480	EKC/KEOPS complex [GO:0000408]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; embryo development ending in seed dormancy [GO:0009793]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	EKC/KEOPS complex [GO:0000408]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0000408; GO:0002949; GO:0005739; GO:0005743; GO:0009793; GO:0046872; GO:0061711	embryo development ending in seed dormancy [GO:0009793]; tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN8403_c0_g2_i1	Q4V7F3	OSGP2_RAT	52.2	92	36	2	24	275	9	100	2.70E-18	92.4	OSGP2_RAT	reviewed	"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein Osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein Osgepl1)"	Osgepl1	Rattus norvegicus (Rat)	414	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0000408; GO:0002949; GO:0005739; GO:0046872; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN8403_c0_g1_i1	Q32LQ3	OSGP2_DANRE	46.7	212	110	1	388	1023	189	397	4.10E-52	206.8	OSGP2_DANRE	reviewed	"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein osgepl1)"	osgepl1 si:dz72b14.6	Danio rerio (Zebrafish) (Brachydanio rerio)	404	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0000408; GO:0002949; GO:0005739; GO:0046872; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN8403_c0_g1_i1	Q32LQ3	OSGP2_DANRE	55.5	110	49	0	2	331	82	191	5.40E-28	126.7	OSGP2_DANRE	reviewed	"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein osgepl1)"	osgepl1 si:dz72b14.6	Danio rerio (Zebrafish) (Brachydanio rerio)	404	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0000408; GO:0002949; GO:0005739; GO:0046872; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN8403_c0_g1_i2	Q32LQ3	OSGP2_DANRE	49.8	319	157	1	2	958	82	397	2.00E-88	327.4	OSGP2_DANRE	reviewed	"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein osgepl1)"	osgepl1 si:dz72b14.6	Danio rerio (Zebrafish) (Brachydanio rerio)	404	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0000408; GO:0002949; GO:0005739; GO:0046872; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN6650_c0_g1_i1	Q8WWH5	TRUB1_HUMAN	50.4	258	120	5	78	830	54	310	1.40E-59	231.5	TRUB1_HUMAN	reviewed	Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-)	TRUB1 PUS4	Homo sapiens (Human)	349	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005739; GO:0005829; GO:0006400; GO:0009982; GO:1990481	mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]		blue	blue	NA	NA	NA	NA
TRINITY_DN15146_c0_g1_i1	Q54E29	THG1_DICDI	44.4	261	139	2	889	107	2	256	7.00E-65	250	THG1_DICDI	reviewed	Probable tRNA(His) guanylyltransferase (EC 2.7.7.79) (tRNA-histidine guanylyltransferase)	thg1 DDB_G0291830	Dictyostelium discoideum (Slime mold)	256	cytosol [GO:0005829]; 3'-5' RNA polymerase activity [GO:0097748]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; tRNA guanylyltransferase activity [GO:0008193]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytosol [GO:0005829]	3'-5' RNA polymerase activity [GO:0097748]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; tRNA guanylyltransferase activity [GO:0008193]	GO:0000287; GO:0005525; GO:0005829; GO:0006400; GO:0008033; GO:0008193; GO:0097748	tRNA modification [GO:0006400]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN13695_c0_g1_i1	Q21279	TTL15_CAEEL	42.1	430	226	8	8	1264	96	513	6.10E-95	349.4	TTL15_CAEEL	reviewed	Probable tubulin polyglutamylase ttll-15 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 15)	ttll-15 K07C5.7	Caenorhabditis elegans	513	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cellular protein modification process [GO:0006464]; oviposition [GO:0018991]		ATP binding [GO:0005524]; ligase activity [GO:0016874]	GO:0005524; GO:0006464; GO:0016874; GO:0018991	cellular protein modification process [GO:0006464]; oviposition [GO:0018991]		NA	NA	NA	NA	NA	NA
TRINITY_DN2585_c0_g1_i1	Q9W3C0	UTP11_DROME	34.9	258	142	6	835	77	1	237	1.40E-21	105.1	UTP11_DROME	reviewed	Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11)	CG1789	Drosophila melanogaster (Fruit fly)	237	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]; translation [GO:0006412]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0005730; GO:0006364; GO:0006412; GO:0032040	rRNA processing [GO:0006364]; translation [GO:0006412]		blue	blue	NA	NA	NA	NA
TRINITY_DN2585_c0_g1_i2	Q9W3C0	UTP11_DROME	34.9	258	142	6	835	77	1	237	1.80E-21	104.8	UTP11_DROME	reviewed	Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11)	CG1789	Drosophila melanogaster (Fruit fly)	237	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]; translation [GO:0006412]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0005730; GO:0006364; GO:0006412; GO:0032040	rRNA processing [GO:0006364]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN35862_c0_g1_i1	Q1ZXK3	LSM3_DICDI	61.2	85	29	2	254	12	7	91	2.30E-21	102.8	LSM3_DICDI	reviewed	Probable U6 snRNA-associated Sm-like protein LSm3	lsm3 DDB_G0277107	Dictyostelium discoideum (Slime mold)	97	"catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; nucleolus [GO:0005730]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; small nucleolar ribonucleoprotein complex [GO:0005732]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"	catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; nucleolus [GO:0005730]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; small nucleolar ribonucleoprotein complex [GO:0005732]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	RNA binding [GO:0003723]	GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005688; GO:0005730; GO:0005732; GO:0033962; GO:0046540; GO:0071011; GO:0071013; GO:1990726	"mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"		red	red	NA	NA	NA	NA
TRINITY_DN32905_c0_g1_i1	P70398	USP9X_MOUSE	33.8	145	81	4	1	402	2343	2483	4.10E-08	59.7	USP9X_MOUSE	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets homolog) (Fat facets protein-related, X-linked) (Ubiquitin carboxyl-terminal hydrolase FAM) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	Usp9x Fafl Fam	Mus musculus (Mouse)	2559	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0001701; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0009791; GO:0016477; GO:0016579; GO:0021698; GO:0021766; GO:0030426; GO:0030509; GO:0031625; GO:0042752; GO:0045177; GO:0048511; GO:0048675; GO:0050821; GO:0050856; GO:0051301; GO:0070410; GO:0071560; GO:0071947; GO:0101005; GO:1901537; GO:1990138; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN31037_c0_g1_i1	P70398	USP9X_MOUSE	41.9	241	131	4	2	712	1254	1489	2.50E-42	173.7	USP9X_MOUSE	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets homolog) (Fat facets protein-related, X-linked) (Ubiquitin carboxyl-terminal hydrolase FAM) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	Usp9x Fafl Fam	Mus musculus (Mouse)	2559	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0001701; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0009791; GO:0016477; GO:0016579; GO:0021698; GO:0021766; GO:0030426; GO:0030509; GO:0031625; GO:0042752; GO:0045177; GO:0048511; GO:0048675; GO:0050821; GO:0050856; GO:0051301; GO:0070410; GO:0071560; GO:0071947; GO:0101005; GO:1901537; GO:1990138; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN209_c1_g1_i1	Q93008	USP9X_HUMAN	85.6	118	17	0	2	355	358	475	3.40E-55	215.7	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	1	NA	NA	NA
TRINITY_DN209_c1_g1_i2	Q93008	USP9X_HUMAN	85.6	180	26	0	2	541	358	537	2.50E-87	322.8	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN1917_c0_g1_i1	Q93008	USP9X_HUMAN	36.4	77	49	0	305	75	219	295	7.60E-09	61.6	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		blue	blue	NA	NA	NA	NA
TRINITY_DN1917_c0_g1_i3	Q93008	USP9X_HUMAN	36.4	77	49	0	304	74	219	295	7.60E-09	61.6	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN23596_c0_g1_i1	Q93008	USP9X_HUMAN	98.5	66	1	0	201	4	1649	1714	1.90E-32	139	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN36091_c0_g1_i1	Q93008	USP9X_HUMAN	100	91	0	0	1	273	756	846	4.80E-47	188	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN30022_c0_g1_i1	Q93008	USP9X_HUMAN	55.3	333	142	4	989	3	1950	2279	5.00E-94	345.9	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN38668_c0_g1_i1	Q93008	USP9X_HUMAN	68.2	195	62	0	586	2	712	906	6.60E-78	291.6	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN38640_c0_g1_i1	Q93008	USP9X_HUMAN	59.8	249	86	3	3	710	1508	1755	3.40E-84	312.8	USP9X_HUMAN	reviewed	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	2554	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN32269_c0_g1_i1	Q3UQI9	MINY4_MOUSE	42.5	73	41	1	12	230	560	631	4.60E-11	68.2	MINY4_MOUSE	reviewed	Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4)	Mindy4 Fam188b	Mus musculus (Mouse)	744	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]		cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:1990380			NA	NA	NA	NA	NA	NA
TRINITY_DN34185_c0_g1_i1	Q0VA42	MINY4_XENTR	53.1	64	30	0	196	5	643	706	1.20E-14	80.1	MINY4_XENTR	reviewed	Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4)	mindy4 fam188b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	746	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]		cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:1990380			NA	NA	NA	NA	NA	NA
TRINITY_DN31656_c0_g1_i1	Q9FMM0	UBC18_ARATH	53.7	95	44	0	49	333	45	139	2.10E-28	126.3	UBC18_ARATH	reviewed	Probable ubiquitin-conjugating enzyme E2 18 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 18) (Ubiquitin carrier protein 18)	UBC18 At5g42990 MBD2.19	Arabidopsis thaliana (Mouse-ear cress)	161	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0061631	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN31656_c0_g1_i2	Q9FMM0	UBC18_ARATH	68.7	67	21	0	51	251	73	139	6.80E-24	110.9	UBC18_ARATH	reviewed	Probable ubiquitin-conjugating enzyme E2 18 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 18) (Ubiquitin carrier protein 18)	UBC18 At5g42990 MBD2.19	Arabidopsis thaliana (Mouse-ear cress)	161	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0061631	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN28233_c0_g1_i1	Q9C8X7	UBC31_ARATH	47.3	74	38	1	9	227	38	111	5.60E-17	87.8	UBC31_ARATH	reviewed	Probable ubiquitin-conjugating enzyme E2 31 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 31) (Ubiquitin carrier protein 31)	UBC31 At1g36340 F7F23.6	Arabidopsis thaliana (Mouse-ear cress)	154	nucleus [GO:0005634]; vacuole [GO:0005773]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; vacuole [GO:0005773]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0005773; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN39625_c0_g1_i1	P34477	UBC7_CAEEL	60.9	92	35	1	276	4	26	117	2.40E-30	132.5	UBC7_CAEEL	reviewed	Probable ubiquitin-conjugating enzyme E2 7 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 7) (Ubiquitin carrier protein 7) (Ubiquitin-protein ligase 7)	ubc-7 F58A4.10	Caenorhabditis elegans	164	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0006511; GO:0043161; GO:0061631	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN39283_c0_g1_i1	Q5UQ88	UBC3_MIMIV	54	87	37	1	259	8	1273	1359	9.20E-24	110.5	UBC3_MIMIV	reviewed	Probable ubiquitin-conjugating enzyme E2 R521 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R521) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	MIMI_R521	Acanthamoeba polyphaga mimivirus (APMV)	1441	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0005524; GO:0016021; GO:0061631			NA	NA	NA	NA	NA	NA
TRINITY_DN15259_c0_g1_i1	Q1JPX4	UB2WB_DANRE	97.7	43	1	0	129	1	96	138	2.30E-18	92.4	UB2WB_DANRE	reviewed	Probable ubiquitin-conjugating enzyme E2 W-B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W-B) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (Ubiquitin carrier protein W-B) (Ubiquitin-protein ligase W-B)	ube2wb zgc:136503	Danio rerio (Zebrafish) (Brachydanio rerio)	151	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0043161; GO:0061631; GO:0071218	cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN15259_c0_g1_i1	Q1JPX4	UB2WB_DANRE	94.1	34	2	0	227	126	37	70	1.40E-12	73.2	UB2WB_DANRE	reviewed	Probable ubiquitin-conjugating enzyme E2 W-B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W-B) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (Ubiquitin carrier protein W-B) (Ubiquitin-protein ligase W-B)	ube2wb zgc:136503	Danio rerio (Zebrafish) (Brachydanio rerio)	151	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0043161; GO:0061631; GO:0071218	cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN25697_c0_g1_i1	Q8T191	UGGG_DICDI	60.3	146	57	1	1	438	1490	1634	9.70E-50	197.6	UGGG_DICDI	reviewed	Probable UDP-glucose:glycoprotein glucosyltransferase A (EC 2.4.1.-) (Developmental gene 1109 protein)	ggtA DG1109 DDB_G0274103	Dictyostelium discoideum (Slime mold)	1681	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]; sorocarp development [GO:0030587]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0030587; GO:0051082; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]; sorocarp development [GO:0030587]		NA	NA	NA	NA	NA	NA
TRINITY_DN37875_c0_g1_i1	Q18493	UAP1_CAEEL	50	114	57	0	8	349	302	415	4.30E-27	122.1	UAP1_CAEEL	reviewed	Probable UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23)	C36A4.4	Caenorhabditis elegans	484	cytoplasm [GO:0005737]; uridylyltransferase activity [GO:0070569]	cytoplasm [GO:0005737]	uridylyltransferase activity [GO:0070569]	GO:0005737; GO:0070569			NA	NA	NA	NA	NA	NA
TRINITY_DN38910_c0_g1_i1	Q86AX3	HUTU_DICDI	58	112	47	0	359	24	127	238	8.00E-34	144.4	HUTU_DICDI	reviewed	Probable urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	uroc1 DDB_G0277727	Dictyostelium discoideum (Slime mold)	672	urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		urocanate hydratase activity [GO:0016153]	GO:0006548; GO:0016153; GO:0019556; GO:0019557	histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN5405_c0_g2_i1	Q86KU2	SYVC_DICDI	66	106	36	0	318	1	141	246	2.30E-38	159.5	SYVC_DICDI	reviewed	"Probable valine--tRNA ligase, cytoplasmic (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	valS1 DDB_G0277733	Dictyostelium discoideum (Slime mold)	1072	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006438; GO:0031012	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN3112_c0_g2_i1	Q86KU2	SYVC_DICDI	59.8	184	63	3	1	522	484	666	1.70E-61	236.9	SYVC_DICDI	reviewed	"Probable valine--tRNA ligase, cytoplasmic (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	valS1 DDB_G0277733	Dictyostelium discoideum (Slime mold)	1072	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006438; GO:0031012	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN36257_c0_g1_i1	C4V924	SYVC_NOSCE	58	100	37	2	300	10	52	149	1.70E-24	113.2	SYVC_NOSCE	reviewed	"Probable valine--tRNA ligase, cytoplasmic (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	NCER_101032	Nosema ceranae (strain BRL01) (Microsporidian parasite)	883	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN40656_c0_g1_i1	Q8SS27	SYVC_ENCCU	57.8	154	61	4	2	457	492	643	3.80E-44	179.1	SYVC_ENCCU	reviewed	"Probable valine--tRNA ligase, cytoplasmic (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	ECU04_1140	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	921	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	1	NA	NA	NA
TRINITY_DN38956_c0_g1_i1	Q9N5Y2	TECR_CAEEL	56.2	162	68	2	481	2	48	208	5.50E-46	185.3	TECR_CAEEL	reviewed	Probable very-long-chain enoyl-CoA reductase art-1 (EC 1.3.1.93)	art-1 C15F1.6	Caenorhabditis elegans	308	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]	GO:0005789; GO:0016021; GO:0016491; GO:0042761; GO:0102758	very long-chain fatty acid biosynthetic process [GO:0042761]		blue	blue	NA	NA	NA	NA
TRINITY_DN29982_c0_g1_i1	Q19546	WRN_CAEEL	66.1	56	19	0	190	23	499	554	5.50E-17	87.8	WRN_CAEEL	reviewed	Probable Werner syndrome ATP-dependent helicase homolog 1 (EC 3.6.4.12)	wrn-1 F18C5.2	Caenorhabditis elegans	1056	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]	GO:0000723; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006259; GO:0006268; GO:0006281; GO:0006310; GO:0008340; GO:0009378; GO:0010212; GO:0010259; GO:0032508; GO:0035861; GO:0043138; GO:0044806	determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN34063_c0_g1_i1	Q19546	WRN_CAEEL	50.8	65	32	0	220	26	476	540	4.70E-16	84.7	WRN_CAEEL	reviewed	Probable Werner syndrome ATP-dependent helicase homolog 1 (EC 3.6.4.12)	wrn-1 F18C5.2	Caenorhabditis elegans	1056	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]	GO:0000723; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006259; GO:0006268; GO:0006281; GO:0006310; GO:0008340; GO:0009378; GO:0010212; GO:0010259; GO:0032508; GO:0035861; GO:0043138; GO:0044806	determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN38027_c0_g1_i1	A8P5H7	AMPP1_COPC7	56	125	44	2	364	2	448	565	5.30E-33	141.7	AMPP1_COPC7	reviewed	Probable Xaa-Pro aminopeptidase P (AMPP) (Aminopeptidase P) (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Prolidase)	AMPP CC1G_05499	Coprinopsis cinerea (strain Okayama-7 / 130 / ATCC MYA-4618 / FGSC 9003) (Inky cap fungus) (Hormographiella aspergillata)	622	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]		metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0046872; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i20	B6QG01	AMPP1_TALMQ	42.7	579	317	8	1774	56	48	617	6.70E-129	462.6	AMPP1_TALMQ	reviewed	Probable Xaa-Pro aminopeptidase P (AMPP) (Aminopeptidase P) (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Prolidase)	ampp PMAA_083920	Talaromyces marneffei (strain ATCC 18224 / CBS 334.59 / QM 7333) (Penicillium marneffei)	657	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]		metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0046872; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i7	B6QG01	AMPP1_TALMQ	55.3	159	67	3	523	56	460	617	2.40E-42	173.3	AMPP1_TALMQ	reviewed	Probable Xaa-Pro aminopeptidase P (AMPP) (Aminopeptidase P) (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Prolidase)	ampp PMAA_083920	Talaromyces marneffei (strain ATCC 18224 / CBS 334.59 / QM 7333) (Penicillium marneffei)	657	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]		metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0046872; GO:0070006			NA	NA	NA	NA	NA	NA
TRINITY_DN40196_c0_g1_i1	Q54QU8	Y3629_DICDI	45.7	116	62	1	345	1	183	298	1.40E-22	107.1	Y3629_DICDI	reviewed	Probable zinc transporter protein DDB_G0283629	DDB_G0283629	Dictyostelium discoideum (Slime mold)	543	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005886; GO:0006829; GO:0016021; GO:0046872; GO:0071577	zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2600_c0_g1_i7	Q54F34	Y1141_DICDI	54.8	42	19	0	63	188	485	526	4.10E-06	52	Y1141_DICDI	reviewed	Probable zinc transporter protein DDB_G0291141	DDB_G0291141	Dictyostelium discoideum (Slime mold)	770	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; metal ion binding [GO:0046872]; zinc ion transport [GO:0006829]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cation transmembrane transporter activity [GO:0008324]; metal ion binding [GO:0046872]	GO:0005794; GO:0006829; GO:0008324; GO:0016021; GO:0046872	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN23203_c0_g2_i1	P49935	CATH_MOUSE	100	109	0	0	2	328	93	201	3.50E-60	231.9	CATH_MOUSE	reviewed	Pro-cathepsin H (Cathepsin B3) (Cathepsin BA) [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]	Ctsh	Mus musculus (Mouse)	333	acrosomal vesicle [GO:0001669]; alveolar lamellar body [GO:0097208]; axoneme [GO:0005930]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; outer dense fiber [GO:0001520]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; kininogen binding [GO:0030984]; peptidase activator activity involved in apoptotic process [GO:0016505]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]; bradykinin catabolic process [GO:0010815]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]	acrosomal vesicle [GO:0001669]; alveolar lamellar body [GO:0097208]; axoneme [GO:0005930]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; outer dense fiber [GO:0001520]	aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; kininogen binding [GO:0030984]; peptidase activator activity involved in apoptotic process [GO:0016505]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]	GO:0001520; GO:0001656; GO:0001669; GO:0001913; GO:0002764; GO:0004175; GO:0004177; GO:0004197; GO:0004252; GO:0005615; GO:0005764; GO:0005829; GO:0005930; GO:0006508; GO:0008233; GO:0008234; GO:0008284; GO:0008656; GO:0010628; GO:0010634; GO:0010813; GO:0010815; GO:0010952; GO:0016505; GO:0030108; GO:0030335; GO:0030984; GO:0031638; GO:0031648; GO:0032526; GO:0033619; GO:0036464; GO:0043066; GO:0043129; GO:0043231; GO:0043621; GO:0044877; GO:0045766; GO:0051603; GO:0060448; GO:0070324; GO:0070371; GO:0097067; GO:0097208; GO:2001235	bradykinin catabolic process [GO:0010815]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN23203_c0_g1_i1	P09668	CATH_HUMAN	100	102	0	0	2	307	95	196	5.70E-57	221.1	CATH_HUMAN	reviewed	Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]	CTSH CPSB	Homo sapiens (Human)	335	alveolar lamellar body [GO:0097208]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; bradykinin catabolic process [GO:0010815]; cellular protein metabolic process [GO:0044267]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]	alveolar lamellar body [GO:0097208]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]	GO:0001656; GO:0001913; GO:0002250; GO:0002764; GO:0004175; GO:0004177; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0006508; GO:0008233; GO:0008234; GO:0008284; GO:0008656; GO:0010628; GO:0010634; GO:0010813; GO:0010815; GO:0010952; GO:0019882; GO:0030108; GO:0030335; GO:0031638; GO:0031648; GO:0032526; GO:0033619; GO:0034774; GO:0036464; GO:0043066; GO:0043129; GO:0043231; GO:0043312; GO:0044267; GO:0045766; GO:0051603; GO:0060448; GO:0062023; GO:0070062; GO:0070324; GO:0070371; GO:0097067; GO:0097208; GO:0097486; GO:1904724; GO:1904813; GO:2001235	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; bradykinin catabolic process [GO:0010815]; cellular protein metabolic process [GO:0044267]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN33452_c0_g1_i1	P09668	CATH_HUMAN	61.8	55	20	1	182	18	279	332	7.00E-14	77.4	CATH_HUMAN	reviewed	Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]	CTSH CPSB	Homo sapiens (Human)	335	alveolar lamellar body [GO:0097208]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; bradykinin catabolic process [GO:0010815]; cellular protein metabolic process [GO:0044267]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]	alveolar lamellar body [GO:0097208]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]	GO:0001656; GO:0001913; GO:0002250; GO:0002764; GO:0004175; GO:0004177; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0006508; GO:0008233; GO:0008234; GO:0008284; GO:0008656; GO:0010628; GO:0010634; GO:0010813; GO:0010815; GO:0010952; GO:0019882; GO:0030108; GO:0030335; GO:0031638; GO:0031648; GO:0032526; GO:0033619; GO:0034774; GO:0036464; GO:0043066; GO:0043129; GO:0043231; GO:0043312; GO:0044267; GO:0045766; GO:0051603; GO:0060448; GO:0062023; GO:0070062; GO:0070324; GO:0070371; GO:0097067; GO:0097208; GO:0097486; GO:1904724; GO:1904813; GO:2001235	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; bradykinin catabolic process [GO:0010815]; cellular protein metabolic process [GO:0044267]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]		NA	NA	NA	NA	NA	NA
TRINITY_DN25470_c0_g1_i1	P07154	CATL1_RAT	59.2	130	53	0	392	3	87	216	1.50E-41	170.2	CATL1_RAT	reviewed	Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Cyclic protein 2) (CP-2) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]	Ctsl Ctsl1	Rattus norvegicus (Rat)	334	"apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; multivesicular body [GO:0005771]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; collagen binding [GO:0005518]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; fusion of virus membrane with host endosome membrane [GO:0039654]; hair follicle morphogenesis [GO:0031069]; immune response [GO:0006955]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]; zymogen activation [GO:0031638]"	apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; multivesicular body [GO:0005771]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vacuole [GO:0005773]	aminopeptidase activity [GO:0004177]; collagen binding [GO:0005518]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]	GO:0001968; GO:0002250; GO:0004175; GO:0004177; GO:0004197; GO:0005518; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005771; GO:0005773; GO:0005886; GO:0005902; GO:0006508; GO:0006590; GO:0006955; GO:0007154; GO:0007283; GO:0008234; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0010839; GO:0014070; GO:0016324; GO:0016485; GO:0016540; GO:0016807; GO:0019065; GO:0021675; GO:0030574; GO:0030984; GO:0031069; GO:0031410; GO:0031638; GO:0034230; GO:0034698; GO:0039654; GO:0042277; GO:0042393; GO:0042583; GO:0043005; GO:0043204; GO:0043373; GO:0043394; GO:0044877; GO:0046697; GO:0046718; GO:0048002; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0060309; GO:0097067; GO:0097655; GO:1990834; GO:2000249	"adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; fusion of virus membrane with host endosome membrane [GO:0039654]; hair follicle morphogenesis [GO:0031069]; immune response [GO:0006955]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]; zymogen activation [GO:0031638]"	xx	black	black	1	NA	NA	1
TRINITY_DN3050_c0_g2_i1	P07154	CATL1_RAT	57.1	98	38	3	20	304	114	210	2.60E-25	115.9	CATL1_RAT	reviewed	Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Cyclic protein 2) (CP-2) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]	Ctsl Ctsl1	Rattus norvegicus (Rat)	334	"apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; multivesicular body [GO:0005771]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; collagen binding [GO:0005518]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; fusion of virus membrane with host endosome membrane [GO:0039654]; hair follicle morphogenesis [GO:0031069]; immune response [GO:0006955]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]; zymogen activation [GO:0031638]"	apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; multivesicular body [GO:0005771]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vacuole [GO:0005773]	aminopeptidase activity [GO:0004177]; collagen binding [GO:0005518]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]	GO:0001968; GO:0002250; GO:0004175; GO:0004177; GO:0004197; GO:0005518; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005771; GO:0005773; GO:0005886; GO:0005902; GO:0006508; GO:0006590; GO:0006955; GO:0007154; GO:0007283; GO:0008234; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0010839; GO:0014070; GO:0016324; GO:0016485; GO:0016540; GO:0016807; GO:0019065; GO:0021675; GO:0030574; GO:0030984; GO:0031069; GO:0031410; GO:0031638; GO:0034230; GO:0034698; GO:0039654; GO:0042277; GO:0042393; GO:0042583; GO:0043005; GO:0043204; GO:0043373; GO:0043394; GO:0044877; GO:0046697; GO:0046718; GO:0048002; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0060309; GO:0097067; GO:0097655; GO:1990834; GO:2000249	"adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; fusion of virus membrane with host endosome membrane [GO:0039654]; hair follicle morphogenesis [GO:0031069]; immune response [GO:0006955]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; thyroid hormone generation [GO:0006590]; viral entry into host cell [GO:0046718]; zymogen activation [GO:0031638]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39111_c0_g1_i1	P06797	CATL1_MOUSE	100	254	0	0	3	764	81	334	7.30E-152	537.7	CATL1_MOUSE	reviewed	Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) (p39 cysteine proteinase) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]	Ctsl Ctsl1	Mus musculus (Mouse)	334	"apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; hair follicle morphogenesis [GO:0031069]; immune response [GO:0006955]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; thyroid hormone generation [GO:0006590]; zymogen activation [GO:0031638]"	apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]	aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]	GO:0004175; GO:0004177; GO:0004197; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005773; GO:0005902; GO:0006508; GO:0006590; GO:0006955; GO:0007154; GO:0007283; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0010839; GO:0014070; GO:0016324; GO:0016540; GO:0016807; GO:0021675; GO:0030574; GO:0030984; GO:0031069; GO:0031410; GO:0031638; GO:0034230; GO:0034698; GO:0042277; GO:0042393; GO:0042583; GO:0043005; GO:0043204; GO:0043373; GO:0044877; GO:0046697; GO:0048002; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0060309; GO:0062023	"antigen processing and presentation of peptide antigen [GO:0048002]; autophagic cell death [GO:0048102]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; hair follicle morphogenesis [GO:0031069]; immune response [GO:0006955]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]; thyroid hormone generation [GO:0006590]; zymogen activation [GO:0031638]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28241_c0_g1_i1	P07711	CATL1_HUMAN	100	137	0	0	413	3	128	264	6.70E-77	287.7	CATL1_HUMAN	reviewed	Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]	CTSL CTSL1	Homo sapiens (Human)	333	"apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; extracellular matrix disassembly [GO:0022617]; fusion of virus membrane with host endosome membrane [GO:0039654]; immune response [GO:0006955]; macrophage apoptotic process [GO:0071888]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of keratinocyte differentiation [GO:0045616]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]; zymogen activation [GO:0031638]"	apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; histone binding [GO:0042393]; proteoglycan binding [GO:0043394]; serpin family protein binding [GO:0097655]	GO:0001968; GO:0002224; GO:0002250; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005771; GO:0005886; GO:0006508; GO:0006955; GO:0008234; GO:0016324; GO:0016540; GO:0019065; GO:0019882; GO:0019886; GO:0022617; GO:0030574; GO:0031638; GO:0034230; GO:0036021; GO:0039654; GO:0042393; GO:0042583; GO:0043202; GO:0043373; GO:0043394; GO:0045616; GO:0046718; GO:0048002; GO:0051603; GO:0060309; GO:0062023; GO:0070062; GO:0071888; GO:0097067; GO:0097655	"adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; extracellular matrix disassembly [GO:0022617]; fusion of virus membrane with host endosome membrane [GO:0039654]; immune response [GO:0006955]; macrophage apoptotic process [GO:0071888]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of keratinocyte differentiation [GO:0045616]; toll-like receptor signaling pathway [GO:0002224]; viral entry into host cell [GO:0046718]; zymogen activation [GO:0031638]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38421_c0_g1_i1	Q9GL24	CATL1_CANLF	65.3	72	24	1	224	9	112	182	4.10E-21	101.7	CATL1_CANLF	reviewed	Procathepsin L (EC 3.4.22.15) (Cathepsin L1) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]	CTSL CTSL1	Canis lupus familiaris (Dog) (Canis familiaris)	333	"apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; antigen processing and presentation of peptide antigen [GO:0048002]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; immune response [GO:0006955]; protein autoprocessing [GO:0016540]; proteolysis involved in cellular protein catabolic process [GO:0051603]; zymogen activation [GO:0031638]"	apical plasma membrane [GO:0016324]; chromaffin granule [GO:0042583]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]	GO:0004175; GO:0004197; GO:0005615; GO:0005764; GO:0006955; GO:0016324; GO:0016540; GO:0030574; GO:0031638; GO:0034230; GO:0042583; GO:0043373; GO:0048002; GO:0051603; GO:0060309	"antigen processing and presentation of peptide antigen [GO:0048002]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; enkephalin processing [GO:0034230]; immune response [GO:0006955]; protein autoprocessing [GO:0016540]; proteolysis involved in cellular protein catabolic process [GO:0051603]; zymogen activation [GO:0031638]"		NA	NA	NA	NA	NA	NA
TRINITY_DN851_c0_g1_i1	P21902	PCE_TACTR	34.3	359	200	13	232	1242	26	370	3.00E-41	171	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN851_c0_g1_i10	P21902	PCE_TACTR	34.8	359	198	13	232	1242	26	370	6.10E-42	173.3	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN851_c0_g1_i2	P21902	PCE_TACTR	38.4	219	118	8	1	627	159	370	1.30E-30	134.8	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN851_c0_g1_i5	P21902	PCE_TACTR	34.3	359	200	13	232	1242	26	370	3.90E-41	170.6	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN3625_c0_g1_i1	P21902	PCE_TACTR	34.8	256	149	4	845	102	125	370	1.90E-36	154.5	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN9489_c0_g1_i1	P21902	PCE_TACTR	40.7	86	41	3	25	252	126	211	3.40E-10	65.5	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN13507_c0_g1_i1	P21902	PCE_TACTR	44	84	38	3	233	6	127	209	2.80E-11	68.9	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i13	P21902	PCE_TACTR	25.6	313	207	6	1177	269	74	370	7.70E-24	113.2	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i3	P21902	PCE_TACTR	28.8	243	154	4	973	269	139	370	1.70E-25	118.2	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN5090_c0_g1_i1	P21902	PCE_TACTR	29.2	260	138	10	884	177	137	374	9.30E-19	95.9	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i11	P21902	PCE_TACTR	32.4	296	174	5	977	114	93	370	3.40E-34	147.1	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i12	P21902	PCE_TACTR	33.4	296	170	7	974	114	93	370	2.50E-35	151.4	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i13	P21902	PCE_TACTR	33.4	296	170	7	974	114	93	370	1.50E-35	152.1	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i14	P21902	PCE_TACTR	33.1	296	172	6	977	114	93	370	1.30E-34	149.1	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i6	P21902	PCE_TACTR	32.8	296	172	6	974	114	93	370	9.30E-35	149.4	PCE_TACTR	reviewed	Proclotting enzyme (EC 3.4.21.86) [Cleaved into: Proclotting enzyme light chain; Proclotting enzyme heavy chain]		Tachypleus tridentatus (Japanese horseshoe crab)	375	extracellular region [GO:0005576]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]	extracellular region [GO:0005576]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236; GO:0016485; GO:0030133; GO:0042381; GO:0046872	hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i11	Q9UKZ9	PCOC2_HUMAN	31.5	92	56	2	70	345	59	143	2.70E-07	56.6	PCOC2_HUMAN	reviewed	Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2) (PCPE-2) (Procollagen C-proteinase enhancer 2)	PCOLCE2 PCPE2 UNQ250/PRO287	Homo sapiens (Human)	415	extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830]	extracellular region [GO:0005576]	collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]	GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]		NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i20	Q9UKZ9	PCOC2_HUMAN	30	120	75	3	687	1046	33	143	2.40E-07	58.2	PCOC2_HUMAN	reviewed	Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2) (PCPE-2) (Procollagen C-proteinase enhancer 2)	PCOLCE2 PCPE2 UNQ250/PRO287	Homo sapiens (Human)	415	extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830]	extracellular region [GO:0005576]	collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]	GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]		NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i24	Q9UKZ9	PCOC2_HUMAN	30	120	75	3	440	799	33	143	1.90E-07	58.2	PCOC2_HUMAN	reviewed	Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2) (PCPE-2) (Procollagen C-proteinase enhancer 2)	PCOLCE2 PCPE2 UNQ250/PRO287	Homo sapiens (Human)	415	extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830]	extracellular region [GO:0005576]	collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]	GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]		NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i8	Q9UKZ9	PCOC2_HUMAN	30	120	75	3	653	1012	33	143	2.30E-07	58.2	PCOC2_HUMAN	reviewed	Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2) (PCPE-2) (Procollagen C-proteinase enhancer 2)	PCOLCE2 PCPE2 UNQ250/PRO287	Homo sapiens (Human)	415	extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830]	extracellular region [GO:0005576]	collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]	GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]		NA	NA	NA	NA	NA	NA
TRINITY_DN30154_c0_g1_i1	Q9VTH0	PLOD_DROME	75.9	83	20	0	250	2	630	712	1.30E-34	146.7	PLOD_DROME	reviewed	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase (Procollagen lysyl hydroxylase) (EC 1.14.11.4)"	Plod CG6199	Drosophila melanogaster (Fruit fly)	721	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; growth of a germarium-derived egg chamber [GO:0007295]; peptidyl-lysine hydroxylation [GO:0017185]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0005506; GO:0005615; GO:0005783; GO:0007295; GO:0008475; GO:0017185; GO:0031418; GO:0033823; GO:0048471; GO:0050211	growth of a germarium-derived egg chamber [GO:0007295]; peptidyl-lysine hydroxylation [GO:0017185]		NA	NA	NA	NA	NA	NA
TRINITY_DN21858_c0_g1_i1	Q9VTH0	PLOD_DROME	78.3	83	18	0	251	3	636	718	8.40E-38	157.1	PLOD_DROME	reviewed	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase (Procollagen lysyl hydroxylase) (EC 1.14.11.4)"	Plod CG6199	Drosophila melanogaster (Fruit fly)	721	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; growth of a germarium-derived egg chamber [GO:0007295]; peptidyl-lysine hydroxylation [GO:0017185]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0005506; GO:0005615; GO:0005783; GO:0007295; GO:0008475; GO:0017185; GO:0031418; GO:0033823; GO:0048471; GO:0050211	growth of a germarium-derived egg chamber [GO:0007295]; peptidyl-lysine hydroxylation [GO:0017185]		NA	NA	NA	NA	NA	NA
TRINITY_DN36673_c0_g1_i1	Q02809	PLOD1_HUMAN	98.8	81	1	0	3	245	629	709	3.10E-45	181.8	PLOD1_HUMAN	reviewed	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)"	PLOD1 LLH PLOD	Homo sapiens (Human)	727	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0008475; GO:0008544; GO:0017185; GO:0030867; GO:0031418; GO:0070062; GO:1902494	epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN37197_c0_g1_i1	Q9R0E2	PLOD1_MOUSE	100	81	0	0	3	245	582	662	1.30E-43	176.4	PLOD1_MOUSE	reviewed	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)"	Plod1 Plod	Mus musculus (Mouse)	728	catalytic complex [GO:1902494]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; rough endoplasmic reticulum membrane [GO:0030867]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptide binding [GO:0042277]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	catalytic complex [GO:1902494]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; rough endoplasmic reticulum membrane [GO:0030867]	ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptide binding [GO:0042277]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001666; GO:0005783; GO:0008198; GO:0008475; GO:0008544; GO:0017185; GO:0030867; GO:0031418; GO:0042277; GO:0062023; GO:1902494	epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN31088_c0_g1_i1	Q9R0B9	PLOD2_MOUSE	98.9	87	1	0	262	2	541	627	2.40E-48	192.2	PLOD2_MOUSE	reviewed	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2)"	Plod2	Mus musculus (Mouse)	737	endoplasmic reticulum [GO:0005783]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]	endoplasmic reticulum [GO:0005783]; rough endoplasmic reticulum membrane [GO:0030867]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0005506; GO:0005783; GO:0008475; GO:0017185; GO:0030867; GO:0031418; GO:0046947	hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]		NA	NA	NA	NA	NA	NA
TRINITY_DN22282_c0_g1_i1	Q95ND4	EGF_FELCA	45.3	75	40	1	20	241	335	409	8.50E-14	77.8	EGF_FELCA	reviewed	Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor]	EGF	Felis catus (Cat) (Felis silvestris catus)	1210	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	integral component of membrane [GO:0016021]	calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]	GO:0005509; GO:0008083; GO:0016021; GO:0043388; GO:0045740; GO:0046425	positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]		NA	NA	NA	NA	NA	NA
TRINITY_DN37940_c0_g1_i1	Q8T938	PROF_BRABE	42.9	63	36	0	13	201	59	121	4.00E-12	71.6	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26925_c2_g1_i1	Q6QEJ7	PROF_APIME	48.4	62	32	0	5	190	65	126	3.30E-11	68.9	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			blue	blue	NA	NA	NA	NA
TRINITY_DN26925_c0_g1_i1	Q8T938	PROF_BRABE	39.3	89	53	1	264	1	1	89	1.20E-12	73.9	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN39041_c0_g1_i1	Q6QEJ7	PROF_APIME	40.2	92	55	0	278	3	26	117	1.20E-13	77	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19138_c0_g1_i1	Q6QEJ7	PROF_APIME	46.9	98	52	0	1	294	12	109	1.30E-18	93.6	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i1	Q6QEJ7	PROF_APIME	44.9	98	53	1	291	1	6	103	1.10E-15	84	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i13	Q6QEJ7	PROF_APIME	45.7	116	62	1	357	13	6	121	9.20E-22	104.4	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i15	Q6QEJ7	PROF_APIME	45.7	116	62	1	357	13	6	121	3.50E-21	102.4	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i4	Q6QEJ7	PROF_APIME	46.6	116	61	1	357	13	6	121	3.20E-22	105.9	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i5	Q6QEJ7	PROF_APIME	46.6	116	61	1	357	13	6	121	3.20E-22	105.9	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i8	Q6QEJ7	PROF_APIME	46.6	116	61	1	357	13	6	121	3.20E-22	105.9	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c2_g1_i1	Q8T938	PROF_BRABE	37.5	112	70	0	6	341	10	121	1.50E-18	94	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c4_g1_i1	Q8T938	PROF_BRABE	38.2	102	63	0	24	329	20	121	5.00E-17	88.6	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN23181_c0_g2_i1	Q68HB4	PROF_BOMMO	37.7	69	43	0	2	208	33	101	2.60E-08	58.9	PROF_BOMMO	reviewed	Profilin		Bombyx mori (Silk moth)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN23181_c0_g1_i1	Q6QEJ7	PROF_APIME	41.2	102	60	0	1	306	25	126	6.70E-16	84.7	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN23181_c0_g1_i2	Q6QEJ7	PROF_APIME	41.7	103	60	0	6	314	24	126	1.50E-18	93.6	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c0_g1_i1	Q68HB4	PROF_BOMMO	50	62	31	0	268	83	65	126	3.20E-11	68.9	PROF_BOMMO	reviewed	Profilin		Bombyx mori (Silk moth)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c0_g1_i2	Q8T938	PROF_BRABE	44.2	52	29	0	253	98	70	121	1.60E-07	56.6	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c0_g1_i3	Q68HB4	PROF_BOMMO	51.6	62	30	0	268	83	65	126	3.80E-12	72	PROF_BOMMO	reviewed	Profilin		Bombyx mori (Silk moth)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c0_g1_i4	Q68HB4	PROF_BOMMO	41.8	91	53	0	318	46	36	126	2.60E-15	82.8	PROF_BOMMO	reviewed	Profilin		Bombyx mori (Silk moth)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c0_g1_i5	Q8T938	PROF_BRABE	38.1	84	52	0	349	98	38	121	1.70E-12	73.6	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c0_g1_i8	Q8T938	PROF_BRABE	44.2	52	29	0	253	98	70	121	1.60E-07	56.6	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN21323_c1_g1_i1	Q6QEJ7	PROF_APIME	38.3	94	58	0	6	287	33	126	6.70E-14	78.2	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c7_g1_i1	Q8T938	PROF_BRABE	39.7	63	38	0	192	4	20	82	1.30E-07	56.6	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c6_g1_i1	Q8T938	PROF_BRABE	38.8	121	73	1	1	360	1	121	2.90E-19	96.3	PROF_BRABE	reviewed	Profilin		Branchiostoma belcheri (Amphioxus)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c0_g1_i1	Q6QEJ7	PROF_APIME	42.2	102	59	0	2	307	25	126	5.40E-20	98.6	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c0_g1_i3	Q6QEJ7	PROF_APIME	42.2	102	59	0	2	307	25	126	5.40E-20	98.6	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c0_g1_i4	Q6QEJ7	PROF_APIME	42.2	102	59	0	2	307	25	126	4.20E-20	99	PROF_APIME	reviewed	Profilin		Apis mellifera (Honeybee)	126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN19138_c0_g1_i2	Q941H7	PROF_LITCN	35.1	74	46	2	13	228	19	92	4.10E-07	55.1	PROF_LITCN	reviewed	Profilin (Minor allergen Lit c 1) (allergen Lit c 1)		Litchi chinensis (Lychee)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN25384_c7_g1_i1	P25843	PROF_DROME	44.4	126	69	1	462	88	1	126	3.80E-27	122.9	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN5133_c8_g1_i1	P25843	PROF_DROME	45	111	60	1	74	403	1	111	9.50E-23	107.8	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN26925_c1_g1_i1	P25843	PROF_DROME	42.9	56	32	0	232	65	66	121	3.00E-08	58.9	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i10	P25843	PROF_DROME	43.8	121	67	1	372	13	1	121	1.00E-23	111.3	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i14	P25843	PROF_DROME	43.8	121	67	1	372	13	1	121	1.30E-23	110.9	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i2	P25843	PROF_DROME	43.8	121	67	1	372	13	1	121	1.20E-23	110.9	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i6	P25843	PROF_DROME	43.8	121	67	1	372	13	1	121	1.20E-23	110.9	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c0_g1_i9	P25843	PROF_DROME	43.8	121	67	1	372	13	1	121	5.20E-24	112.1	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN27794_c0_g1_i1	P25843	PROF_DROME	55.6	126	56	0	465	88	1	126	8.40E-37	154.8	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c4_g1_i1	P25843	PROF_DROME	42.3	104	59	1	39	347	1	104	5.00E-20	98.6	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16683_c1_g1_i1	P25843	PROF_DROME	43	86	48	1	21	275	2	87	1.40E-14	80.1	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN16683_c0_g1_i1	P25843	PROF_DROME	39.7	126	75	1	40	414	1	126	3.40E-24	112.8	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN22293_c0_g1_i1	P25843	PROF_DROME	41.3	121	70	1	363	4	1	121	5.20E-23	108.6	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN22293_c0_g1_i2	P25843	PROF_DROME	41.3	121	70	1	363	4	1	121	1.00E-23	110.9	PROF_DROME	reviewed	Profilin (Protein chickadee)	chic chi CG9553	Drosophila melanogaster (Fruit fly)	126	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]	actin monomer binding [GO:0003785]	GO:0000281; GO:0000902; GO:0000915; GO:0003785; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007300; GO:0007391; GO:0007420; GO:0007436; GO:0007488; GO:0016322; GO:0030041; GO:0030717; GO:0032507; GO:0035019; GO:0035193; GO:0036098; GO:0042060; GO:0042989; GO:0043005; GO:0045451; GO:0048471; GO:0048680; GO:0048842; GO:0051491	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actomyosin contractile ring assembly [GO:0000915]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; dorsal closure [GO:0007391]; histoblast morphogenesis [GO:0007488]; larval central nervous system remodeling [GO:0035193]; larval salivary gland morphogenesis [GO:0007436]; maintenance of protein location in cell [GO:0032507]; male germ-line stem cell population maintenance [GO:0036098]; mitotic cytokinesis [GO:0000281]; neuron remodeling [GO:0016322]; oocyte karyosome formation [GO:0030717]; ovarian nurse cell to oocyte transport [GO:0007300]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of axon regeneration [GO:0048680]; positive regulation of filopodium assembly [GO:0051491]; sequestering of actin monomers [GO:0042989]; somatic stem cell population maintenance [GO:0035019]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN39041_c1_g1_i1	P49232	PROF1_WHEAT	36.6	82	51	1	249	7	45	126	2.10E-12	72.8	PROF1_WHEAT	reviewed	Profilin-1	PRO1	Triticum aestivum (Wheat)	131	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; actin monomer binding [GO:0003785]; sequestering of actin monomers [GO:0042989]	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005856; GO:0005938; GO:0042989	sequestering of actin monomers [GO:0042989]		NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c3_g1_i1	Q9T0M8	PROF2_PARJU	39.6	101	60	1	395	96	24	124	2.30E-16	86.7	PROF2_PARJU	reviewed	Profilin-2 (Pollen allergen Par j 3.0102) (allergen Par j 3.0102)	PRO2	Parietaria judaica (Pellitory-of-the-wall) (Parietaria diffusa)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN16843_c5_g1_i1	Q9M7N0	PROF3_HEVBR	45.3	64	34	1	234	46	63	126	5.80E-12	71.2	PROF3_HEVBR	reviewed	Profilin-3 (Pollen allergen Hev b 8.0201) (allergen Hev b 8.0201)		Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c3_g1_i1	Q9M7N0	PROF3_HEVBR	38.9	126	71	3	214	573	1	126	4.80E-21	102.8	PROF3_HEVBR	reviewed	Profilin-3 (Pollen allergen Hev b 8.0201) (allergen Hev b 8.0201)		Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c3_g1_i1	Q9M7N0	PROF3_HEVBR	48.6	37	19	0	166	56	91	127	5.30E-04	46.2	PROF3_HEVBR	reviewed	Profilin-3 (Pollen allergen Hev b 8.0201) (allergen Hev b 8.0201)		Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN17834_c5_g1_i1	Q9M7N0	PROF3_HEVBR	39.2	125	70	3	448	92	1	125	1.90E-19	97.1	PROF3_HEVBR	reviewed	Profilin-3 (Pollen allergen Hev b 8.0201) (allergen Hev b 8.0201)		Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN1672_c1_g1_i1	Q9M7N0	PROF3_HEVBR	38.3	94	56	2	276	1	19	112	3.60E-13	75.5	PROF3_HEVBR	reviewed	Profilin-3 (Pollen allergen Hev b 8.0201) (allergen Hev b 8.0201)		Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	131	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN26828_c0_g1_i1	Q8N4S7	PAQR4_HUMAN	35.8	271	147	5	320	1117	16	264	1.80E-37	158.3	PAQR4_HUMAN	reviewed	Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV)	PAQR4	Homo sapiens (Human)	273	integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]	integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0016021; GO:0038023			NA	NA	NA	NA	NA	NA
TRINITY_DN26828_c0_g1_i2	Q8N4S7	PAQR4_HUMAN	38.2	254	147	4	320	1066	16	264	1.30E-40	168.7	PAQR4_HUMAN	reviewed	Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV)	PAQR4	Homo sapiens (Human)	273	integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]	integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0016021; GO:0038023			NA	NA	NA	NA	NA	NA
TRINITY_DN26104_c0_g1_i1	Q5ZIV5	PDC10_CHICK	100	110	0	0	332	3	97	206	2.20E-54	212.6	PDC10_CHICK	reviewed	Programmed cell death protein 10	PDCD10 RCJMB04_23e18	Gallus gallus (Chicken)	212	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; wound healing, spreading of cells [GO:0044319]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]	GO:0000139; GO:0001525; GO:0005829; GO:0005886; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0033138; GO:0036481; GO:0042803; GO:0043066; GO:0043406; GO:0044319; GO:0045747; GO:0047485; GO:0050821; GO:0051683; GO:0090051; GO:0090168; GO:0090316; GO:1903588; GO:1990830	"angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26104_c0_g1_i2	Q9BUL8	PDC10_HUMAN	100	116	0	0	351	4	97	212	7.80E-58	224.2	PDC10_HUMAN	reviewed	Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15)	PDCD10 CCM3 TFAR15	Homo sapiens (Human)	212	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; response to hydrogen peroxide [GO:0042542]; wound healing, spreading of cells [GO:0044319]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]	GO:0000139; GO:0001525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0033138; GO:0036481; GO:0042542; GO:0042803; GO:0043066; GO:0043406; GO:0044319; GO:0045747; GO:0047485; GO:0050821; GO:0051683; GO:0070062; GO:0071902; GO:0090051; GO:0090168; GO:0090316; GO:1903588; GO:1990830	"angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; response to hydrogen peroxide [GO:0042542]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3420_c0_g1_i1	Q6PHH3	PD10A_DANRE	51.1	174	80	2	578	57	39	207	2.70E-39	163.3	PD10A_DANRE	reviewed	Programmed cell death protein 10-A	pdcd10a pdcd10 si:ch211-167c22.5	Danio rerio (Zebrafish) (Brachydanio rerio)	210	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; chordate embryonic development [GO:0043009]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; vasculature development [GO:0001944]	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]		GO:0000139; GO:0001525; GO:0001568; GO:0001944; GO:0003007; GO:0005886; GO:0006915; GO:0007507; GO:0043009; GO:0048514	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; chordate embryonic development [GO:0043009]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; vasculature development [GO:0001944]		brown	brown	NA	NA	NA	NA
TRINITY_DN3420_c0_g1_i3	Q6PHH3	PD10A_DANRE	48.6	146	70	2	559	122	39	179	6.40E-30	132.1	PD10A_DANRE	reviewed	Programmed cell death protein 10-A	pdcd10a pdcd10 si:ch211-167c22.5	Danio rerio (Zebrafish) (Brachydanio rerio)	210	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; chordate embryonic development [GO:0043009]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; vasculature development [GO:0001944]	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]		GO:0000139; GO:0001525; GO:0001568; GO:0001944; GO:0003007; GO:0005886; GO:0006915; GO:0007507; GO:0043009; GO:0048514	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; chordate embryonic development [GO:0043009]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; vasculature development [GO:0001944]		blue	blue	NA	NA	NA	NA
TRINITY_DN5976_c0_g1_i1	P46718	PDCD2_MOUSE	45.8	356	170	7	74	1126	1	338	4.20E-82	306.6	PDCD2_MOUSE	reviewed	Programmed cell death protein 2 (Zinc finger protein Rp-8)	Pdcd2 Rp8	Mus musculus (Mouse)	343	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0006919; GO:0019899; GO:0043065; GO:0046872; GO:1901532; GO:1902035	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]		NA	NA	NA	NA	NA	NA
TRINITY_DN5976_c0_g1_i4	P46718	PDCD2_MOUSE	52.8	123	53	1	74	442	1	118	6.40E-31	135.2	PDCD2_MOUSE	reviewed	Programmed cell death protein 2 (Zinc finger protein Rp-8)	Pdcd2 Rp8	Mus musculus (Mouse)	343	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0006919; GO:0019899; GO:0043065; GO:0046872; GO:1901532; GO:1902035	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]		NA	NA	NA	NA	NA	NA
TRINITY_DN6491_c0_g1_i1	Q5ZID2	PDD2L_CHICK	33.7	202	119	8	791	1381	179	370	7.40E-17	90.1	PDD2L_CHICK	reviewed	Programmed cell death protein 2-like	PDCD2L RCJMB04_27n18	Gallus gallus (Chicken)	379	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6491_c0_g1_i5	Q5ZID2	PDD2L_CHICK	32.8	204	120	8	791	1387	179	370	1.60E-16	89	PDD2L_CHICK	reviewed	Programmed cell death protein 2-like	PDCD2L RCJMB04_27n18	Gallus gallus (Chicken)	379	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN25389_c0_g1_i1	P12815	PDCD6_MOUSE	60.9	169	66	0	306	812	22	190	8.20E-59	228.8	PDCD6_MOUSE	reviewed	Programmed cell death protein 6 (ALG-257) (Apoptosis-linked gene 2 protein) (ALG-2) (PMP41)	Pdcd6 Alg2	Mus musculus (Mouse)	191	COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]	COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0070971; GO:1902527; GO:1990756	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]		blue	blue	NA	NA	NA	NA
TRINITY_DN31942_c0_g1_i1	O75340	PDCD6_HUMAN	97.6	83	0	1	243	1	107	189	5.10E-40	164.5	PDCD6_HUMAN	reviewed	Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)	PDCD6 ALG2	Homo sapiens (Human)	191	COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]	COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0070062; GO:0070971; GO:0097190; GO:1902527; GO:1990756	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]		NA	NA	NA	NA	NA	NA
TRINITY_DN33861_c0_g1_i1	O75340	PDCD6_HUMAN	100	173	0	0	553	35	19	191	7.60E-100	364.4	PDCD6_HUMAN	reviewed	Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)	PDCD6 ALG2	Homo sapiens (Human)	191	COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]	COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0070062; GO:0070971; GO:0097190; GO:1902527; GO:1990756	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]		NA	NA	NA	NA	NA	NA
TRINITY_DN18874_c0_g1_i1	P67778	PHB_MOUSE	100	154	0	0	464	3	47	200	8.70E-81	300.8	PHB_MOUSE	reviewed	Prohibitin (B-cell receptor-associated protein 32) (BAP 32)	Phb	Mus musculus (Mouse)	272	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extrinsic component of mitochondrial outer membrane [GO:0031315]; extrinsic component of presynaptic active zone membrane [GO:0098891]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; proteinase activated receptor binding [GO:0031871]; transcription corepressor activity [GO:0003714]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; animal organ regeneration [GO:0031100]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; immunoglobulin production [GO:0002377]; interleukin-17 production [GO:0032620]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle atresia [GO:0001552]; ovarian follicle development [GO:0001541]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; RIG-I signaling pathway [GO:0039529]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extrinsic component of mitochondrial outer membrane [GO:0031315]; extrinsic component of presynaptic active zone membrane [GO:0098891]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; proteinase activated receptor binding [GO:0031871]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001541; GO:0001552; GO:0001850; GO:0001851; GO:0002377; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005769; GO:0005886; GO:0005887; GO:0006355; GO:0007005; GO:0007202; GO:0008022; GO:0008285; GO:0009986; GO:0010628; GO:0010942; GO:0010944; GO:0014069; GO:0016575; GO:0019899; GO:0023035; GO:0030061; GO:0030308; GO:0031100; GO:0031315; GO:0031871; GO:0032620; GO:0035632; GO:0035902; GO:0039529; GO:0042113; GO:0042177; GO:0042493; GO:0042826; GO:0043066; GO:0043209; GO:0043434; GO:0044830; GO:0045471; GO:0045745; GO:0045892; GO:0045893; GO:0045917; GO:0046718; GO:0046982; GO:0048661; GO:0050821; GO:0050847; GO:0051897; GO:0060766; GO:0070373; GO:0070374; GO:0071354; GO:0071897; GO:0072538; GO:0098891; GO:0098978; GO:0098982; GO:0140374; GO:1901224; GO:1990051; GO:2000323	"activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; animal organ regeneration [GO:0031100]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; immunoglobulin production [GO:0002377]; interleukin-17 production [GO:0032620]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle atresia [GO:0001552]; ovarian follicle development [GO:0001541]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; RIG-I signaling pathway [GO:0039529]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15326_c0_g1_i1	P67778	PHB_MOUSE	99.5	215	1	0	646	2	45	259	7.50E-107	387.9	PHB_MOUSE	reviewed	Prohibitin (B-cell receptor-associated protein 32) (BAP 32)	Phb	Mus musculus (Mouse)	272	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extrinsic component of mitochondrial outer membrane [GO:0031315]; extrinsic component of presynaptic active zone membrane [GO:0098891]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; proteinase activated receptor binding [GO:0031871]; transcription corepressor activity [GO:0003714]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; animal organ regeneration [GO:0031100]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; immunoglobulin production [GO:0002377]; interleukin-17 production [GO:0032620]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle atresia [GO:0001552]; ovarian follicle development [GO:0001541]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; RIG-I signaling pathway [GO:0039529]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extrinsic component of mitochondrial outer membrane [GO:0031315]; extrinsic component of presynaptic active zone membrane [GO:0098891]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; proteinase activated receptor binding [GO:0031871]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001541; GO:0001552; GO:0001850; GO:0001851; GO:0002377; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005769; GO:0005886; GO:0005887; GO:0006355; GO:0007005; GO:0007202; GO:0008022; GO:0008285; GO:0009986; GO:0010628; GO:0010942; GO:0010944; GO:0014069; GO:0016575; GO:0019899; GO:0023035; GO:0030061; GO:0030308; GO:0031100; GO:0031315; GO:0031871; GO:0032620; GO:0035632; GO:0035902; GO:0039529; GO:0042113; GO:0042177; GO:0042493; GO:0042826; GO:0043066; GO:0043209; GO:0043434; GO:0044830; GO:0045471; GO:0045745; GO:0045892; GO:0045893; GO:0045917; GO:0046718; GO:0046982; GO:0048661; GO:0050821; GO:0050847; GO:0051897; GO:0060766; GO:0070373; GO:0070374; GO:0071354; GO:0071897; GO:0072538; GO:0098891; GO:0098978; GO:0098982; GO:0140374; GO:1901224; GO:1990051; GO:2000323	"activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; animal organ regeneration [GO:0031100]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; immunoglobulin production [GO:0002377]; interleukin-17 production [GO:0032620]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle atresia [GO:0001552]; ovarian follicle development [GO:0001541]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; RIG-I signaling pathway [GO:0039529]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15326_c0_g1_i2	P67778	PHB_MOUSE	99.1	212	2	0	636	1	45	256	1.20E-104	380.6	PHB_MOUSE	reviewed	Prohibitin (B-cell receptor-associated protein 32) (BAP 32)	Phb	Mus musculus (Mouse)	272	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extrinsic component of mitochondrial outer membrane [GO:0031315]; extrinsic component of presynaptic active zone membrane [GO:0098891]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; proteinase activated receptor binding [GO:0031871]; transcription corepressor activity [GO:0003714]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; animal organ regeneration [GO:0031100]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; immunoglobulin production [GO:0002377]; interleukin-17 production [GO:0032620]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle atresia [GO:0001552]; ovarian follicle development [GO:0001541]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; RIG-I signaling pathway [GO:0039529]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extrinsic component of mitochondrial outer membrane [GO:0031315]; extrinsic component of presynaptic active zone membrane [GO:0098891]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; proteinase activated receptor binding [GO:0031871]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001541; GO:0001552; GO:0001850; GO:0001851; GO:0002377; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005769; GO:0005886; GO:0005887; GO:0006355; GO:0007005; GO:0007202; GO:0008022; GO:0008285; GO:0009986; GO:0010628; GO:0010942; GO:0010944; GO:0014069; GO:0016575; GO:0019899; GO:0023035; GO:0030061; GO:0030308; GO:0031100; GO:0031315; GO:0031871; GO:0032620; GO:0035632; GO:0035902; GO:0039529; GO:0042113; GO:0042177; GO:0042493; GO:0042826; GO:0043066; GO:0043209; GO:0043434; GO:0044830; GO:0045471; GO:0045745; GO:0045892; GO:0045893; GO:0045917; GO:0046718; GO:0046982; GO:0048661; GO:0050821; GO:0050847; GO:0051897; GO:0060766; GO:0070373; GO:0070374; GO:0071354; GO:0071897; GO:0072538; GO:0098891; GO:0098978; GO:0098982; GO:0140374; GO:1901224; GO:1990051; GO:2000323	"activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; animal organ regeneration [GO:0031100]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; immunoglobulin production [GO:0002377]; interleukin-17 production [GO:0032620]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle atresia [GO:0001552]; ovarian follicle development [GO:0001541]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; response to peptide hormone [GO:0043434]; RIG-I signaling pathway [GO:0039529]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11105_c0_g1_i1	Q54GI9	PHB1_DICDI	62.1	153	58	0	11	469	75	227	7.10E-49	194.9	PHB1_DICDI	reviewed	"Prohibitin-1, mitochondrial"	phbA DDB_G0290123	Dictyostelium discoideum (Slime mold)	271	mitochondrial inner membrane [GO:0005743]	mitochondrial inner membrane [GO:0005743]		GO:0005743			NA	NA	NA	NA	NA	NA
TRINITY_DN9114_c0_g1_i1	Q5ZMN3	PHB2_CHICK	61	200	77	1	603	7	43	242	1.10E-62	241.1	PHB2_CHICK	reviewed	Prohibitin-2	PHB2 RCJMB04_1i23	Gallus gallus (Chicken)	301	cell surface [GO:0009986]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; mitophagy [GO:0000423]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein homodimerization activity [GO:0042803]	GO:0000423; GO:0005634; GO:0005737; GO:0005743; GO:0005886; GO:0009986; GO:0016363; GO:0035632; GO:0042803	mitophagy [GO:0000423]		NA	NA	NA	NA	NA	NA
TRINITY_DN11099_c0_g1_i1	Q2HJ97	PHB2_BOVIN	59.9	187	75	0	563	3	61	247	2.00E-58	226.9	PHB2_BOVIN	reviewed	Prohibitin-2	PHB2	Bos taurus (Bovine)	299	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005743; GO:0005886; GO:0007202; GO:0009986; GO:0016363; GO:0016477; GO:0023035; GO:0032991; GO:0035632; GO:0042113; GO:0042803; GO:0046625; GO:0098800; GO:1900208; GO:1901224; GO:1904959; GO:1990051	activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]		NA	NA	NA	NA	NA	NA
TRINITY_DN11007_c0_g2_i1	Q2HJ97	PHB2_BOVIN	69.6	135	40	1	146	547	1	135	1.40E-49	197.6	PHB2_BOVIN	reviewed	Prohibitin-2	PHB2	Bos taurus (Bovine)	299	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005743; GO:0005886; GO:0007202; GO:0009986; GO:0016363; GO:0016477; GO:0023035; GO:0032991; GO:0035632; GO:0042113; GO:0042803; GO:0046625; GO:0098800; GO:1900208; GO:1901224; GO:1904959; GO:1990051	activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]		NA	NA	NA	NA	NA	NA
TRINITY_DN11007_c0_g2_i2	Q2HJ97	PHB2_BOVIN	69.8	298	89	1	146	1036	1	298	5.00E-114	412.5	PHB2_BOVIN	reviewed	Prohibitin-2	PHB2	Bos taurus (Bovine)	299	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005743; GO:0005886; GO:0007202; GO:0009986; GO:0016363; GO:0016477; GO:0023035; GO:0032991; GO:0035632; GO:0042113; GO:0042803; GO:0046625; GO:0098800; GO:1900208; GO:1901224; GO:1904959; GO:1990051	activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]		blue	blue	NA	NA	NA	NA
TRINITY_DN11007_c0_g1_i2	Q2HJ97	PHB2_BOVIN	73.6	246	64	1	737	3	1	246	2.50E-97	356.7	PHB2_BOVIN	reviewed	Prohibitin-2	PHB2	Bos taurus (Bovine)	299	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005743; GO:0005886; GO:0007202; GO:0009986; GO:0016363; GO:0016477; GO:0023035; GO:0032991; GO:0035632; GO:0042113; GO:0042803; GO:0046625; GO:0098800; GO:1900208; GO:1901224; GO:1904959; GO:1990051	activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; immunoglobulin production [GO:0002377]; mitophagy [GO:0000423]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]		NA	NA	NA	NA	NA	NA
TRINITY_DN15312_c0_g2_i1	Q99623	PHB2_HUMAN	99.6	238	1	0	740	27	1	238	1.70E-123	443.4	PHB2_HUMAN	reviewed	Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)	PHB2 BAP REA	Homo sapiens (Human)	299	"axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; amide binding [GO:0033218]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; immunoglobulin production [GO:0002377]; induction by virus of host autophagy [GO:0039520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]"	axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]	amide binding [GO:0033218]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006606; GO:0006851; GO:0007005; GO:0007062; GO:0007202; GO:0008022; GO:0009611; GO:0009986; GO:0014069; GO:0016363; GO:0016477; GO:0023035; GO:0030331; GO:0030424; GO:0031536; GO:0032991; GO:0033147; GO:0033218; GO:0033600; GO:0035632; GO:0039520; GO:0039529; GO:0042113; GO:0042802; GO:0042803; GO:0043066; GO:0043433; GO:0045892; GO:0046625; GO:0046982; GO:0047485; GO:0048786; GO:0050821; GO:0051091; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098978; GO:0098982; GO:0140374; GO:1900208; GO:1901224; GO:1902808; GO:1904959; GO:1990051	"activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; immunoglobulin production [GO:0002377]; induction by virus of host autophagy [GO:0039520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15312_c0_g2_i2	Q99623	PHB2_HUMAN	99.5	221	1	0	689	27	18	238	1.50E-113	410.2	PHB2_HUMAN	reviewed	Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)	PHB2 BAP REA	Homo sapiens (Human)	299	"axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; amide binding [GO:0033218]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; immunoglobulin production [GO:0002377]; induction by virus of host autophagy [GO:0039520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]"	axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]	amide binding [GO:0033218]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006606; GO:0006851; GO:0007005; GO:0007062; GO:0007202; GO:0008022; GO:0009611; GO:0009986; GO:0014069; GO:0016363; GO:0016477; GO:0023035; GO:0030331; GO:0030424; GO:0031536; GO:0032991; GO:0033147; GO:0033218; GO:0033600; GO:0035632; GO:0039520; GO:0039529; GO:0042113; GO:0042802; GO:0042803; GO:0043066; GO:0043433; GO:0045892; GO:0046625; GO:0046982; GO:0047485; GO:0048786; GO:0050821; GO:0051091; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098978; GO:0098982; GO:0140374; GO:1900208; GO:1901224; GO:1902808; GO:1904959; GO:1990051	"activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; immunoglobulin production [GO:0002377]; induction by virus of host autophagy [GO:0039520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15312_c0_g1_i1	Q99623	PHB2_HUMAN	100	103	0	0	2	310	196	298	1.00E-45	183.7	PHB2_HUMAN	reviewed	Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)	PHB2 BAP REA	Homo sapiens (Human)	299	"axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; amide binding [GO:0033218]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; immunoglobulin production [GO:0002377]; induction by virus of host autophagy [GO:0039520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]"	axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]	amide binding [GO:0033218]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]	GO:0000423; GO:0002377; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006606; GO:0006851; GO:0007005; GO:0007062; GO:0007202; GO:0008022; GO:0009611; GO:0009986; GO:0014069; GO:0016363; GO:0016477; GO:0023035; GO:0030331; GO:0030424; GO:0031536; GO:0032991; GO:0033147; GO:0033218; GO:0033600; GO:0035632; GO:0039520; GO:0039529; GO:0042113; GO:0042802; GO:0042803; GO:0043066; GO:0043433; GO:0045892; GO:0046625; GO:0046982; GO:0047485; GO:0048786; GO:0050821; GO:0051091; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098978; GO:0098982; GO:0140374; GO:1900208; GO:1901224; GO:1902808; GO:1904959; GO:1990051	"activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; immunoglobulin production [GO:0002377]; induction by virus of host autophagy [GO:0039520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34270_c0_g1_i1	P85831	PROH4_APIME	60.7	28	11	0	40	123	54	81	6.00E-05	47.8	PROH4_APIME	reviewed	Prohormone-4 [Cleaved into: Brain peptide IDLSRFYGHFNT; Brain peptide IDLSRFYGHFN; Brain peptide IDLSRFYGHF; Brain peptide DLSRFYGHFNT; Brain peptide DLSRFYGHFN; Brain peptide DLSRFYGHF]		Apis mellifera (Honeybee)	202	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN38194_c0_g1_i1	Q14005	IL16_HUMAN	100	96	0	0	3	290	1220	1315	7.90E-48	190.7	IL16_HUMAN	reviewed	Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)]	IL16	Homo sapiens (Human)	1332	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]; viral process [GO:0016032]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006955; GO:0016032; GO:0016607; GO:0019221; GO:0030595; GO:0032730; GO:0032735; GO:0032755; GO:0042609; GO:0050729; GO:0050930; GO:0051924; GO:0090543; GO:1902565	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN40766_c0_g1_i1	Q14005	IL16_HUMAN	100	78	0	0	235	2	1119	1196	3.90E-37	154.8	IL16_HUMAN	reviewed	Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)]	IL16	Homo sapiens (Human)	1332	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]; viral process [GO:0016032]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006955; GO:0016032; GO:0016607; GO:0019221; GO:0030595; GO:0032730; GO:0032735; GO:0032755; GO:0042609; GO:0050729; GO:0050930; GO:0051924; GO:0090543; GO:1902565	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN35407_c0_g1_i1	Q0V8R5	IL16_BOVIN	42.3	265	121	6	3351	4136	379	614	1.30E-42	177.2	IL16_BOVIN	reviewed	Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)]	IL16	Bos taurus (Bovine)	627	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]	GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0030595; GO:0042609; GO:0050930	induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]		NA	NA	NA	NA	NA	NA
TRINITY_DN17242_c0_g1_i3	Q8SPN2	PKR1_BOVIN	29.3	133	83	4	1	381	78	205	4.00E-07	55.8	PKR1_BOVIN	reviewed	Prokineticin receptor 1 (PK-R1) (G-protein coupled receptor 73) (G-protein coupled receptor ZAQ)	PROKR1 GPR73 PKR1	Bos taurus (Bovine)	393	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of plasma membrane [GO:0005887]	G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]	GO:0004930; GO:0004983; GO:0005887; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1812_c0_g1_i1	Q9HCU5	PREB_HUMAN	32.7	275	169	9	893	93	142	408	3.00E-29	131.3	PREB_HUMAN	reviewed	Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12)	PREB SEC12	Homo sapiens (Human)	417	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]	GO:0000139; GO:0003400; GO:0003677; GO:0005085; GO:0005090; GO:0005096; GO:0005634; GO:0005789; GO:0006888; GO:0009306; GO:0016020; GO:0030176; GO:0032527; GO:0036498; GO:0048208; GO:0051020; GO:0070971	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400]		NA	NA	NA	NA	NA	NA
TRINITY_DN24521_c0_g1_i1	O01377	PCNA_BOMMO	75.4	260	63	1	221	997	1	260	1.70E-111	404.1	PCNA_BOMMO	reviewed	Proliferating cell nuclear antigen (PCNA) (Cyclin)	PCNA	Bombyx mori (Silk moth)	260	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]; DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA polymerase processivity factor activity [GO:0030337]	GO:0003677; GO:0005634; GO:0006260; GO:0006275; GO:0030337	DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]		blue	blue	NA	NA	NA	NA
TRINITY_DN29862_c0_g1_i1	P12004	PCNA_HUMAN	100	261	0	0	799	17	1	261	1.00E-143	510.8	PCNA_HUMAN	reviewed	Proliferating cell nuclear antigen (PCNA) (Cyclin)	PCNA	Homo sapiens (Human)	261	"centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell differentiation [GO:0030855]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; protein ubiquitination [GO:0016567]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]; viral process [GO:0016032]"	"centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]"	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]	GO:0000083; GO:0000122; GO:0000307; GO:0000701; GO:0000723; GO:0000784; GO:0000785; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0006298; GO:0006977; GO:0007507; GO:0008022; GO:0016032; GO:0016567; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032201; GO:0032355; GO:0032405; GO:0033683; GO:0034644; GO:0035035; GO:0042276; GO:0042769; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0070987; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990	"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell differentiation [GO:0030855]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; protein ubiquitination [GO:0016567]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14890_c0_g1_i1	P17918	PCNA_MOUSE	100	160	0	0	480	1	99	258	7.10E-86	317.8	PCNA_MOUSE	reviewed	Proliferating cell nuclear antigen (PCNA) (Cyclin)	Pcna	Mus musculus (Mouse)	261	"centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; response to lipid [GO:0033993]; translesion synthesis [GO:0019985]"	centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000307; GO:0000701; GO:0000785; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0007507; GO:0008022; GO:0008134; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0033993; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990	"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; response to lipid [GO:0033993]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32561_c0_g1_i1	P17918	PCNA_MOUSE	100	104	0	0	32	343	1	104	2.80E-52	205.7	PCNA_MOUSE	reviewed	Proliferating cell nuclear antigen (PCNA) (Cyclin)	Pcna	Mus musculus (Mouse)	261	"centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; response to lipid [GO:0033993]; translesion synthesis [GO:0019985]"	centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000307; GO:0000701; GO:0000785; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0007507; GO:0008022; GO:0008134; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0033993; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990	"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; response to lipid [GO:0033993]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27603_c0_g1_i1	Q6AYD3	PA2G4_RAT	59.2	76	28	1	220	2	78	153	4.40E-17	88.2	PA2G4_RAT	reviewed	Proliferation-associated protein 2G4	Pa2g4	Rattus norvegicus (Rat)	394	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892	"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25459_c0_g1_i1	Q6AYD3	PA2G4_RAT	57.7	381	160	1	96	1235	5	385	3.80E-118	426.4	PA2G4_RAT	reviewed	Proliferation-associated protein 2G4	Pa2g4	Rattus norvegicus (Rat)	394	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892	"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30376_c0_g1_i1	Q9UQ80	PA2G4_HUMAN	50.8	124	60	1	372	1	243	365	1.20E-27	124	PA2G4_HUMAN	reviewed	Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1)	PA2G4 EBP1	Homo sapiens (Human)	394	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]	GO:0003676; GO:0003714; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0043312; GO:0045597; GO:0045892; GO:0070062	"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"		red	red	NA	NA	NA	NA
TRINITY_DN22940_c0_g1_i1	Q9UQ80	PA2G4_HUMAN	100	359	0	0	1079	3	1	359	6.50E-204	711.1	PA2G4_HUMAN	reviewed	Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1)	PA2G4 EBP1	Homo sapiens (Human)	394	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]	GO:0003676; GO:0003714; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0043312; GO:0045597; GO:0045892; GO:0070062	"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36306_c0_g1_i1	Q04499	PROD_DROME	67.3	248	80	1	1	741	434	681	3.20E-97	356.3	PROD_DROME	reviewed	"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Protein sluggish-A)"	slgA slg CG1417	Drosophila melanogaster (Fruit fly)	681	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; aggressive behavior [GO:0002118]; glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]	GO:0002118; GO:0004657; GO:0005739; GO:0005759; GO:0006537; GO:0006562; GO:0007626; GO:0010133; GO:0042331; GO:0071949	aggressive behavior [GO:0002118]; glutamate biosynthetic process [GO:0006537]; locomotory behavior [GO:0007626]; phototaxis [GO:0042331]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]		NA	NA	NA	NA	NA	NA
TRINITY_DN14445_c1_g1_i7	A0A411L030	BUAE_ASPBU	28.5	151	59	4	102	407	139	289	1.10E-08	61.6	BUAE_ASPBU	reviewed	Proline hydroxylase buaE (EC 1.14.11.-) (2-oxoglutarate-dependent dioxygenase buaE) (Burnettramic acids biosynthesis cluster protein E)	buaE	Aspergillus burnettii	319	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; antibiotic biosynthetic process [GO:0017000]		dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0017000; GO:0046872; GO:0051213	antibiotic biosynthetic process [GO:0017000]		NA	NA	NA	NA	NA	NA
TRINITY_DN2781_c0_g1_i2	Q92733	PRCC_HUMAN	36.6	355	166	7	981	88	139	491	1.90E-25	118.6	PRCC_HUMAN	reviewed	Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein)	PRCC TPRC	Homo sapiens (Human)	491	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0000398; GO:0005634; GO:0005654; GO:0007093; GO:0016607	"mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g1_i1	B0THP0	SYP_HELMI	38.9	113	61	2	283	618	3	108	9.20E-15	82	SYP_HELMI	reviewed	Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)	proS Helmi_21980 HM1_2267	Heliobacterium modesticaldum (strain ATCC 51547 / Ice1)	575	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0002161; GO:0004827; GO:0005524; GO:0005737; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6515_c0_g1_i3	B0THP0	SYP_HELMI	32.7	98	58	2	283	573	3	93	5.00E-07	56.2	SYP_HELMI	reviewed	Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)	proS Helmi_21980 HM1_2267	Heliobacterium modesticaldum (strain ATCC 51547 / Ice1)	575	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0002161; GO:0004827; GO:0005524; GO:0005737; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN28679_c0_g1_i1	B2UCU9	SYP_RALPJ	100	68	0	0	3	206	417	484	1.60E-34	146	SYP_RALPJ	reviewed	Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)	proS Rpic_3061	Ralstonia pickettii (strain 12J)	574	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0002161; GO:0004827; GO:0005524; GO:0005737; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	1
TRINITY_DN38112_c0_g1_i1	Q6A7L9	SYP_CUTAK	100	75	0	0	225	1	106	180	2.20E-37	155.6	SYP_CUTAK	reviewed	Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)	proS PPA1499	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	585	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0002161; GO:0004827; GO:0005524; GO:0005737; GO:0006433	prolyl-tRNA aminoacylation [GO:0006433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6811_c0_g1_i2	Q07954	LRP1_HUMAN	42.3	137	71	2	402	16	854	990	1.60E-25	117.1	LRP1_HUMAN	reviewed	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	LRP1 A2MR APR	Homo sapiens (Human)	4544	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic Golgi apparatus [GO:0150051]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic Golgi apparatus [GO:0150051]; receptor complex [GO:0043235]	alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005634; GO:0005765; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150051; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN37097_c0_g1_i2	Q6JHU8	P3H1_CHICK	51.9	241	112	3	772	53	457	694	4.10E-63	243	P3H1_CHICK	reviewed	Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Leucine- and proline-enriched proteoglycan 1 homolog) (Leprecan-1 homolog)	P3H1 LEPRE1	Gallus gallus (Chicken)	725	endoplasmic reticulum [GO:0005783]; protein-containing complex [GO:0032991]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of post-translational protein modification [GO:1901874]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708]	endoplasmic reticulum [GO:0005783]; protein-containing complex [GO:0032991]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]	GO:0005506; GO:0005783; GO:0019797; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:1901874; GO:1904027	bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of post-translational protein modification [GO:1901874]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708]		NA	NA	NA	NA	NA	NA
TRINITY_DN37097_c0_g1_i1	Q6JHU7	P3H2_CHICK	50	62	31	0	235	50	620	681	8.60E-13	74.3	P3H2_CHICK	reviewed	Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1)	P3H2 LEPREL1	Gallus gallus (Chicken)	694	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]	GO:0005506; GO:0005604; GO:0005654; GO:0005783; GO:0005794; GO:0008285; GO:0016529; GO:0019511; GO:0019797; GO:0031418; GO:0032963	collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24430_c0_g1_i2	Q6DE73	OGFD1_XENLA	33.9	127	71	4	370	20	336	459	7.50E-11	68.6	OGFD1_XENLA	reviewed	Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase)	ogfod1	Xenopus laevis (African clawed frog)	511	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]	GO:0005506; GO:0005634; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063	cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN4999_c0_g2_i4	Q5R4R3	OGFD1_PONAB	42.9	492	228	5	238	1572	36	521	1.00E-107	392.1	OGFD1_PONAB	reviewed	Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase)	OGFOD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	542	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]	GO:0005506; GO:0005634; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063	cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN4999_c0_g2_i6	Q5R4R3	OGFD1_PONAB	43.8	484	217	5	40	1350	46	521	2.50E-107	390.6	OGFD1_PONAB	reviewed	Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase)	OGFOD1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	542	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]	GO:0005506; GO:0005634; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063	cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN4999_c0_g2_i7	Q6DE73	OGFD1_XENLA	43.4	113	59	3	60	386	400	511	2.60E-17	89.7	OGFD1_XENLA	reviewed	Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase)	ogfod1	Xenopus laevis (African clawed frog)	511	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]	GO:0005506; GO:0005634; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063	cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN14337_c1_g1_i15	F4JAU3	P4H2_ARATH	37	81	30	1	249	70	158	238	1.40E-09	63.5	P4H2_ARATH	reviewed	Prolyl 4-hydroxylase 2 (AtP4H-2) (AtP4H2) (EC 1.14.11.2)	P4H2 At3g06300 F24P17.24	Arabidopsis thaliana (Mouse-ear cress)	299	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; root hair cell development [GO:0080147]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]	GO:0000137; GO:0000139; GO:0004656; GO:0005506; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0016021; GO:0018401; GO:0031418; GO:0080147	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; root hair cell development [GO:0080147]		NA	NA	NA	NA	NA	NA
TRINITY_DN17815_c1_g1_i1	Q60715	P4HA1_MOUSE	100	138	0	0	2	415	397	534	1.50E-80	300.1	P4HA1_MOUSE	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4ha1	Mus musculus (Mouse)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN17815_c0_g1_i1	P54001	P4HA1_RAT	97.5	81	2	0	245	3	376	456	5.40E-42	171	P4HA1_RAT	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4ha1 P4ha	Rattus norvegicus (Rat)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN14337_c1_g1_i10	P13674	P4HA1_HUMAN	41.1	168	86	2	598	95	379	533	6.30E-35	149.1	P4HA1_HUMAN	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4HA1 P4HA	Homo sapiens (Human)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN14337_c1_g1_i11	P13674	P4HA1_HUMAN	41.1	168	86	2	598	95	379	533	8.50E-35	148.7	P4HA1_HUMAN	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4HA1 P4HA	Homo sapiens (Human)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN14337_c1_g1_i14	P13674	P4HA1_HUMAN	41.1	168	86	2	598	95	379	533	8.30E-35	148.7	P4HA1_HUMAN	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4HA1 P4HA	Homo sapiens (Human)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN3571_c0_g1_i1	P13674	P4HA1_HUMAN	46.2	550	259	9	1703	60	16	530	5.10E-137	489.6	P4HA1_HUMAN	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4HA1 P4HA	Homo sapiens (Human)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN3571_c0_g1_i2	P13674	P4HA1_HUMAN	48	529	259	8	1640	60	16	530	1.60E-140	501.1	P4HA1_HUMAN	reviewed	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	P4HA1 P4HA	Homo sapiens (Human)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]	"identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN22795_c0_g1_i1	Q5ZLK5	P4HA2_CHICK	94.2	103	6	0	1	309	424	526	2.20E-56	219.2	P4HA2_CHICK	reviewed	"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)"	P4HA2 RCJMB04_5l17	Gallus gallus (Chicken)	534	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN14337_c1_g1_i18	Q75UG4	P4HA3_BOVIN	41.7	235	124	4	799	98	320	542	1.10E-44	181.8	P4HA3_BOVIN	reviewed	"Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3)"	P4HA3	Bos taurus (Bovine)	544	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	"iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]		NA	NA	NA	NA	NA	NA
TRINITY_DN34456_c0_g1_i1	Q86AS5	PPCE_DICDI	65.2	112	39	0	342	7	555	666	4.30E-37	155.2	PPCE_DICDI	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (POase) (Post-proline cleaving enzyme)	prep dpoA DDB_G0274387	Dictyostelium discoideum (Slime mold)	760	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; regulation of gene expression [GO:0010468]; regulation of signal transduction [GO:0009966]; response to lithium ion [GO:0010226]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005737; GO:0005829; GO:0006508; GO:0009966; GO:0010226; GO:0010468; GO:0070012	proteolysis [GO:0006508]; regulation of gene expression [GO:0010468]; regulation of signal transduction [GO:0009966]; response to lithium ion [GO:0010226]		NA	NA	NA	NA	NA	NA
TRINITY_DN28376_c0_g1_i1	Q9QUR6	PPCE_MOUSE	99.1	107	1	0	321	1	415	521	7.10E-58	224.2	PPCE_MOUSE	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	Prep Pep	Mus musculus (Mouse)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0019538; GO:0042277; GO:0070012	protein metabolic process [GO:0019538]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN33965_c0_g1_i1	Q06903	PPCE_AERHY	61.2	85	33	0	8	262	452	536	3.50E-23	108.6	PPCE_AERHY	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)		Aeromonas hydrophila	690	serine-type endopeptidase activity [GO:0004252]		serine-type endopeptidase activity [GO:0004252]	GO:0004252			NA	NA	NA	NA	NA	NA
TRINITY_DN28726_c0_g1_i1	P48147	PPCE_HUMAN	100	77	0	0	2	232	536	612	3.00E-42	171.8	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN40044_c0_g1_i1	P48147	PPCE_HUMAN	100	99	0	0	298	2	99	197	1.70E-53	209.5	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN36508_c0_g1_i1	P48147	PPCE_HUMAN	100	80	0	0	3	242	321	400	1.20E-41	169.9	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN36595_c0_g1_i1	P48147	PPCE_HUMAN	98.8	81	1	0	245	3	1	81	1.80E-43	176	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN24140_c0_g1_i1	P48147	PPCE_HUMAN	100	74	0	0	2	223	637	710	1.10E-37	156.8	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN24140_c0_g1_i2	P48147	PPCE_HUMAN	100	69	0	0	2	208	637	705	7.90E-34	143.7	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN38801_c0_g1_i1	Q06903	PPCE_AERHY	57.2	180	75	1	35	568	400	579	1.60E-49	197.2	PPCE_AERHY	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)		Aeromonas hydrophila	690	serine-type endopeptidase activity [GO:0004252]		serine-type endopeptidase activity [GO:0004252]	GO:0004252			NA	NA	NA	NA	NA	NA
TRINITY_DN787_c0_g1_i1	P48147	PPCE_HUMAN	57.9	477	198	3	1033	2457	235	710	1.30E-165	585.1	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN787_c0_g1_i1	P48147	PPCE_HUMAN	56.1	289	122	3	186	1037	3	291	4.00E-95	350.9	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN787_c0_g1_i2	Q9XTA2	PPCE_BOVIN	66.2	80	27	0	34	273	628	707	5.30E-25	115.2	PPCE_BOVIN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP	Bos taurus (Bovine)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005737; GO:0005829; GO:0070012			NA	NA	NA	NA	NA	NA
TRINITY_DN787_c0_g1_i3	P48147	PPCE_HUMAN	56.1	289	122	3	186	1037	3	291	2.30E-95	350.5	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN787_c0_g1_i4	P48147	PPCE_HUMAN	59	624	253	3	186	2051	3	625	4.50E-230	798.9	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN787_c0_g1_i5	P48147	PPCE_HUMAN	59.7	708	279	4	186	2291	3	710	5.50E-264	911.8	PPCE_HUMAN	reviewed	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	PREP PEP	Homo sapiens (Human)	710	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN2721_c0_g1_i1	Q3UUY6	PROM2_MOUSE	21.8	545	367	16	1577	18	97	607	4.20E-19	97.8	PROM2_MOUSE	reviewed	Prominin-2 (PROM-2) (Prominin-like protein 2) (mPROML2)	Prom2 Proml2	Mus musculus (Mouse)	835	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]	cholesterol binding [GO:0015485]	GO:0001934; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016323; GO:0016324; GO:0031346; GO:0031410; GO:0031528; GO:0042995; GO:0043087; GO:0044393; GO:0048550; GO:0060170; GO:0071914; GO:2001287	negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN2721_c0_g1_i2	Q3UUY6	PROM2_MOUSE	26	192	131	4	751	194	97	283	9.60E-07	55.8	PROM2_MOUSE	reviewed	Prominin-2 (PROM-2) (Prominin-like protein 2) (mPROML2)	Prom2 Proml2	Mus musculus (Mouse)	835	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]	cholesterol binding [GO:0015485]	GO:0001934; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016323; GO:0016324; GO:0031346; GO:0031410; GO:0031528; GO:0042995; GO:0043087; GO:0044393; GO:0048550; GO:0060170; GO:0071914; GO:2001287	negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN2721_c0_g1_i3	Q3UUY6	PROM2_MOUSE	24.6	236	165	6	778	92	97	326	1.20E-07	58.9	PROM2_MOUSE	reviewed	Prominin-2 (PROM-2) (Prominin-like protein 2) (mPROML2)	Prom2 Proml2	Mus musculus (Mouse)	835	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]	cholesterol binding [GO:0015485]	GO:0001934; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016323; GO:0016324; GO:0031346; GO:0031410; GO:0031528; GO:0042995; GO:0043087; GO:0044393; GO:0048550; GO:0060170; GO:0071914; GO:2001287	negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN35933_c0_g1_i1	P77495	PRPE_ECOLI	70.1	87	26	0	264	4	92	178	8.30E-28	124	PRPE_ECOLI	reviewed	Propionate--CoA ligase (EC 6.2.1.17) (Propionyl-CoA synthetase)	prpE yahU b0335 JW0326	Escherichia coli (strain K12)	628	"ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; propionate catabolic process, 2-methylcitrate cycle [GO:0019629]"		ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0005524; GO:0019629; GO:0050218	"propionate catabolic process, 2-methylcitrate cycle [GO:0019629]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN35785_c0_g1_i1	P55912	PRPE_SALTY	69.8	116	35	0	352	5	213	328	1.20E-42	173.7	PRPE_SALTY	reviewed	Propionate--CoA ligase (EC 6.2.1.17) (Propionyl-CoA synthetase)	prpE STM0371	Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)	628	"ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; propionate catabolic process, 2-methylcitrate cycle [GO:0019629]"		ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0005524; GO:0019629; GO:0050218	"propionate catabolic process, 2-methylcitrate cycle [GO:0019629]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN5663_c0_g5_i1	Q5LUF3	PCCA_RUEPO	76.3	139	29	1	429	13	231	365	2.40E-53	209.5	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN5663_c0_g1_i1	Q5LUF3	PCCA_RUEPO	73.1	160	43	0	483	4	109	268	9.10E-65	247.7	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN5663_c0_g1_i2	Q5LUF3	PCCA_RUEPO	67.7	334	98	2	984	1	109	438	7.10E-125	448.4	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN5663_c0_g1_i3	Q5LUF3	PCCA_RUEPO	64.5	155	49	1	447	1	284	438	3.40E-51	202.6	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN29205_c0_g1_i1	Q5LUF3	PCCA_RUEPO	65.5	116	40	0	348	1	1	116	3.60E-37	155.6	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN16478_c0_g1_i1	Q5LUF3	PCCA_RUEPO	60.7	140	55	0	421	2	41	180	3.50E-44	179.1	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN38398_c0_g1_i1	Q5LUF3	PCCA_RUEPO	63.8	80	29	0	6	245	15	94	1.00E-22	107.1	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN39449_c0_g1_i1	Q5LUF3	PCCA_RUEPO	74.7	95	24	0	287	3	1	95	3.00E-33	142.5	PCCA_RUEPO	reviewed	Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)	pccA SPO1101	Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)	681	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0016042; GO:0019541; GO:0046872	lipid catabolic process [GO:0016042]; propionate metabolic process [GO:0019541]		NA	NA	NA	NA	NA	NA
TRINITY_DN28686_c0_g1_i1	Q19842	PCCA_CAEEL	55.8	95	42	0	286	2	65	159	1.40E-20	100.1	PCCA_CAEEL	reviewed	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	pcca-1 F27D9.5	Caenorhabditis elegans	724	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0016421; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN7122_c0_g1_i10	Q91ZA3	PCCA_MOUSE	60.2	718	285	1	42	2195	8	724	3.40E-247	855.9	PCCA_MOUSE	reviewed	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	Pcca	Mus musculus (Mouse)	724	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0016421; GO:0019899; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN7122_c0_g1_i11	Q91ZA3	PCCA_MOUSE	69	467	144	1	42	1442	8	473	1.60E-187	657.1	PCCA_MOUSE	reviewed	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	Pcca	Mus musculus (Mouse)	724	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0016421; GO:0019899; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN7122_c0_g1_i18	Q91ZA3	PCCA_MOUSE	68.5	346	108	1	42	1079	8	352	5.70E-132	472.2	PCCA_MOUSE	reviewed	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	Pcca	Mus musculus (Mouse)	724	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0016421; GO:0019899; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN7122_c0_g1_i2	Q91ZA3	PCCA_MOUSE	62.9	672	249	0	247	2262	53	724	3.90E-246	852.4	PCCA_MOUSE	reviewed	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	Pcca	Mus musculus (Mouse)	724	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0016421; GO:0019899; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN7122_c0_g1_i6	Q91ZA3	PCCA_MOUSE	68.4	348	109	1	42	1085	8	354	1.90E-132	473.8	PCCA_MOUSE	reviewed	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	Pcca	Mus musculus (Mouse)	724	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0016421; GO:0019899; GO:0046872	lipid catabolic process [GO:0016042]		NA	NA	NA	NA	NA	NA
TRINITY_DN801_c0_g1_i1	Q3J4E3	PCCB_RHOS4	75	76	19	0	230	3	383	458	3.00E-26	118.6	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN801_c0_g1_i2	Q3J4E3	PCCB_RHOS4	72.9	218	57	1	649	2	283	500	4.20E-89	328.9	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN801_c0_g1_i3	Q3J4E3	PCCB_RHOS4	73.4	218	56	1	649	2	283	500	5.40E-89	328.6	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN801_c0_g1_i4	Q3J4E3	PCCB_RHOS4	68.6	102	30	1	301	2	399	500	1.80E-34	146.4	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN5928_c0_g1_i1	Q3J4E3	PCCB_RHOS4	84.9	172	26	0	3	518	59	230	5.30E-79	295	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN5928_c0_g2_i1	Q3J4E3	PCCB_RHOS4	75	80	20	0	3	242	26	105	2.80E-30	132.1	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN5928_c0_g2_i2	Q3J4E3	PCCB_RHOS4	84	119	19	0	15	371	71	189	2.70E-53	209.1	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN5928_c0_g2_i3	Q3J4E3	PCCB_RHOS4	80.5	164	32	0	3	494	26	189	1.10E-73	277.3	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN29063_c0_g1_i1	Q3J4E3	PCCB_RHOS4	82.5	63	11	0	190	2	1	63	4.40E-22	104.8	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN31016_c0_g1_i1	P53003	PCCB_SACEN	72.2	72	20	0	1	216	321	392	8.20E-26	117.1	PCCB_SACEN	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB SACE_3398	Saccharopolyspora erythraea (strain ATCC 11635 / DSM 40517 / JCM 4748 / NBRC 13426 / NCIMB 8594 / NRRL 2338)	546	acetyl-CoA carboxylase complex [GO:0009317]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; fatty acid biosynthetic process [GO:0006633]	acetyl-CoA carboxylase complex [GO:0009317]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0003989; GO:0004658; GO:0005524; GO:0006633; GO:0009317	fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN27290_c0_g1_i1	Q3J4E3	PCCB_RHOS4	72.1	61	17	0	1	183	450	510	6.20E-21	100.9	PCCB_RHOS4	reviewed	Propionyl-CoA carboxylase beta chain (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase)	pccB RHOS4_07730 RSP_2189	Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158)	510	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]		ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN4271_c0_g1_i1	P79384	PCCB_PIG	80.3	507	98	1	147	1661	33	539	3.40E-239	828.9	PCCB_PIG	reviewed	"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)"	PCCB	Sus scrofa (Pig)	539	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005759; GO:0019626	short-chain fatty acid catabolic process [GO:0019626]		blue	blue	NA	NA	NA	NA
TRINITY_DN34728_c0_g1_i1	Q99MN9	PCCB_MOUSE	98.8	84	1	0	255	4	446	529	4.30E-42	171.4	PCCB_MOUSE	reviewed	"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)"	Pccb	Mus musculus (Mouse)	541	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759			NA	NA	NA	NA	NA	NA
TRINITY_DN40956_c0_g1_i1	P05166	PCCB_HUMAN	99.5	187	1	0	564	4	249	435	1.60E-105	383.3	PCCB_HUMAN	reviewed	"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)"	PCCB	Homo sapiens (Human)	539	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768]; short-chain fatty acid catabolic process [GO:0019626]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006768; GO:0019626	biotin metabolic process [GO:0006768]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN25879_c0_g1_i1	P05166	PCCB_HUMAN	99.4	158	1	0	475	2	61	218	5.40E-86	318.2	PCCB_HUMAN	reviewed	"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)"	PCCB	Homo sapiens (Human)	539	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768]; short-chain fatty acid catabolic process [GO:0019626]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006768; GO:0019626	biotin metabolic process [GO:0006768]; short-chain fatty acid catabolic process [GO:0019626]		NA	NA	NA	NA	NA	NA
TRINITY_DN15474_c0_g1_i1	O93209	POL_FFV	35.1	77	50	0	23	253	931	1007	4.40E-08	58.5	POL_FFV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Feline foamy virus (FFV) (Feline syncytial virus)	1156	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN10068_c0_g1_i1	O93209	POL_FFV	29.9	144	100	1	64	495	865	1007	7.10E-14	79.7	POL_FFV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Feline foamy virus (FFV) (Feline syncytial virus)	1156	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN10068_c0_g1_i10	O93209	POL_FFV	32.1	84	57	0	452	703	924	1007	6.70E-08	60.1	POL_FFV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Feline foamy virus (FFV) (Feline syncytial virus)	1156	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN10068_c0_g1_i10	O93209	POL_FFV	35.1	77	50	0	115	345	931	1007	1.50E-07	58.9	POL_FFV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Feline foamy virus (FFV) (Feline syncytial virus)	1156	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN10068_c0_g1_i12	O93209	POL_FFV	35.1	77	50	0	115	345	931	1007	9.40E-08	58.9	POL_FFV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Feline foamy virus (FFV) (Feline syncytial virus)	1156	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN10068_c0_g1_i2	O93209	POL_FFV	29.9	144	100	1	64	495	865	1007	7.10E-14	79.7	POL_FFV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Feline foamy virus (FFV) (Feline syncytial virus)	1156	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		brown	brown	NA	NA	NA	NA
TRINITY_DN33891_c0_g1_i1	P14350	POL_FOAMV	27.1	258	179	5	886	119	777	1027	3.10E-17	90.9	POL_FOAMV	reviewed	Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]	pol	Human spumaretrovirus (SFVcpz(hu)) (Human foamy virus)	1143	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]	host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]	aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0042802; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]		NA	NA	NA	NA	NA	NA
TRINITY_DN38152_c0_g1_i1	P29122	PCSK6_HUMAN	54.9	51	23	0	224	72	347	397	1.50E-09	63.2	PCSK6_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4)	PCSK6 PACE4	Homo sapiens (Human)	969	"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; serine-type endopeptidase activity [GO:0004252]; cornification [GO:0070268]; determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]"	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007354; GO:0007368; GO:0008201; GO:0009100; GO:0009986; GO:0016020; GO:0016485; GO:0016486; GO:0030510; GO:0032455; GO:0032902; GO:0032940; GO:0048406; GO:0051004; GO:0062023; GO:0070268	"cornification [GO:0070268]; determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26891_c0_g1_i1	Q16549	PCSK7_HUMAN	100	272	0	0	2	817	200	471	1.60E-162	573.2	PCSK7_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7)	PCSK7 LPC PC7 PC8 SPC7	Homo sapiens (Human)	785	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0016486; GO:0030173	peptide hormone processing [GO:0016486]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN20478_c0_g1_i3	Q16549	PCSK7_HUMAN	60.6	208	76	3	618	1229	130	335	1.60E-65	251.5	PCSK7_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7)	PCSK7 LPC PC7 PC8 SPC7	Homo sapiens (Human)	785	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0016486; GO:0030173	peptide hormone processing [GO:0016486]; protein processing [GO:0016485]		brown	brown	1	NA	NA	NA
TRINITY_DN20478_c0_g1_i2	Q16549	PCSK7_HUMAN	41.6	399	195	8	3	1193	339	701	3.60E-75	283.9	PCSK7_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7)	PCSK7 LPC PC7 PC8 SPC7	Homo sapiens (Human)	785	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0016486; GO:0030173	peptide hormone processing [GO:0016486]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN20478_c0_g1_i6	Q16549	PCSK7_HUMAN	49.9	585	274	9	618	2354	130	701	1.10E-154	548.9	PCSK7_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7)	PCSK7 LPC PC7 PC8 SPC7	Homo sapiens (Human)	785	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0016486; GO:0030173	peptide hormone processing [GO:0016486]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN20478_c0_g1_i8	Q16549	PCSK7_HUMAN	66.7	222	67	4	13	666	162	380	5.00E-80	298.9	PCSK7_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7)	PCSK7 LPC PC7 PC8 SPC7	Homo sapiens (Human)	785	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0016486; GO:0030173	peptide hormone processing [GO:0016486]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN7141_c0_g1_i1	Q9V7U0	RESIL_DROME	51.7	58	27	1	183	10	345	401	7.50E-08	57.8	RESIL_DROME	reviewed	Pro-resilin	resilin CG15920	Drosophila melanogaster (Fruit fly)	620	chitin-based extracellular matrix [GO:0062129]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]; chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]; chitin-based cuticle development [GO:0040003]	chitin-based extracellular matrix [GO:0062129]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-carbohydrate complex [GO:0032992]	chitin binding [GO:0008061]; extracellular matrix constituent conferring elasticity [GO:0030023]; structural constituent of chitin-based larval cuticle [GO:0008010]; structural constituent of cuticle [GO:0042302]	GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302; GO:0062129	chitin-based cuticle development [GO:0040003]		NA	NA	NA	NA	NA	NA
TRINITY_DN2030_c0_g1_i1	O13035	SAP_CHICK	24.5	478	245	16	2299	1019	64	476	9.00E-27	124	SAP_CHICK	reviewed	Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A; Saposin-B; Saposin-C; Saposin-D]	PSAP	Gallus gallus (Chicken)	518	extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]	extracellular space [GO:0005615]; lysosome [GO:0005764]		GO:0005615; GO:0005764; GO:0006665; GO:0007193; GO:0019216	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]		blue	blue	NA	NA	NA	NA
TRINITY_DN3662_c0_g1_i1	Q7ZUC7	PGES2_DANRE	44.7	284	140	5	104	940	103	374	6.50E-68	259.2	PGES2_DANRE	reviewed	Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2)	ptges2 pges2 ptgesl	Danio rerio (Zebrafish) (Brachydanio rerio)	377	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]; prostaglandin biosynthetic process [GO:0001516]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0000139; GO:0001516; GO:0005739; GO:0009055; GO:0015035; GO:0016021; GO:0016829; GO:0020037; GO:0043295; GO:0050220	prostaglandin biosynthetic process [GO:0001516]		blue	blue	NA	NA	NA	NA
TRINITY_DN40915_c0_g1_i1	Q9H7Z7	PGES2_HUMAN	100	73	0	0	221	3	73	145	5.30E-36	151	PGES2_HUMAN	reviewed	Prostaglandin E synthase 2 (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) (EC 5.3.99.3) [Cleaved into: Prostaglandin E synthase 2 truncated form]	PTGES2 C9orf15 PGES2	Homo sapiens (Human)	377	"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]; cyclooxygenase pathway [GO:0019371]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	DNA binding [GO:0003677]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0009055; GO:0015035; GO:0016021; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0043295; GO:0043312; GO:0045893; GO:0048471; GO:0050220	"cyclooxygenase pathway [GO:0019371]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29719_c0_g1_i1	Q9H7Z7	PGES2_HUMAN	100	74	0	0	224	3	221	294	1.60E-37	156	PGES2_HUMAN	reviewed	Prostaglandin E synthase 2 (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) (EC 5.3.99.3) [Cleaved into: Prostaglandin E synthase 2 truncated form]	PTGES2 C9orf15 PGES2	Homo sapiens (Human)	377	"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]; cyclooxygenase pathway [GO:0019371]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	DNA binding [GO:0003677]; electron transfer activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0009055; GO:0015035; GO:0016021; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0043295; GO:0043312; GO:0045893; GO:0048471; GO:0050220	"cyclooxygenase pathway [GO:0019371]; neutrophil degranulation [GO:0043312]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1392_c0_g1_i11	Q8MJ08	PE2R4_BOVIN	29.2	281	158	4	22	750	66	343	1.00E-22	109	PE2R4_BOVIN	reviewed	Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor)	PTGER4	Bos taurus (Bovine)	492	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; prostaglandin E receptor activity [GO:0004957]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to prostaglandin E stimulus [GO:0071380]; inflammatory response [GO:0006954]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	prostaglandin E receptor activity [GO:0004957]	GO:0004957; GO:0005886; GO:0006954; GO:0007188; GO:0007189; GO:0007204; GO:0016021; GO:0033624; GO:0050728; GO:0071380; GO:2000420	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to prostaglandin E stimulus [GO:0071380]; inflammatory response [GO:0006954]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; positive regulation of cytosolic calcium ion concentration [GO:0007204]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i1	P05980	PGFS1_BOVIN	41.3	332	181	6	27	1007	1	323	1.50E-62	241.5	PGFS1_BOVIN	reviewed	Prostaglandin F synthase 1 (PGF 1) (PGF synthase 1) (PGFS1) (EC 1.1.1.188) (Prostaglandin F synthase I) (PGFSI) (Prostaglandin-D2 11 reductase 1)		Bos taurus (Bovine)	323	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin-F synthase activity [GO:0047017]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; C21-steroid hormone metabolic process [GO:0008207]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin-F synthase activity [GO:0047017]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]	GO:0001516; GO:0004032; GO:0005496; GO:0005829; GO:0006693; GO:0008106; GO:0008202; GO:0008207; GO:0016229; GO:0016491; GO:0032052; GO:0036131; GO:0042448; GO:0044597; GO:0044598; GO:0047017; GO:0047023; GO:0047086	C21-steroid hormone metabolic process [GO:0008207]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN3546_c0_g1_i5	P05980	PGFS1_BOVIN	42.4	304	167	4	27	923	1	301	4.90E-60	233	PGFS1_BOVIN	reviewed	Prostaglandin F synthase 1 (PGF 1) (PGF synthase 1) (PGFS1) (EC 1.1.1.188) (Prostaglandin F synthase I) (PGFSI) (Prostaglandin-D2 11 reductase 1)		Bos taurus (Bovine)	323	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin-F synthase activity [GO:0047017]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; C21-steroid hormone metabolic process [GO:0008207]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin-F synthase activity [GO:0047017]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]	GO:0001516; GO:0004032; GO:0005496; GO:0005829; GO:0006693; GO:0008106; GO:0008202; GO:0008207; GO:0016229; GO:0016491; GO:0032052; GO:0036131; GO:0042448; GO:0044597; GO:0044598; GO:0047017; GO:0047023; GO:0047086	C21-steroid hormone metabolic process [GO:0008207]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN35737_c0_g1_i1	Q05769	PGH2_MOUSE	100	72	0	0	2	217	257	328	7.30E-38	157.1	PGH2_MOUSE	reviewed	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein)	Ptgs2 Cox-2 Cox2 Pghs-b Tis10	Mus musculus (Mouse)	604	"caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; keratinocyte differentiation [GO:0030216]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]	"enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]"	GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005783; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008284; GO:0008285; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0010942; GO:0016702; GO:0019233; GO:0019371; GO:0019899; GO:0020037; GO:0030216; GO:0030282; GO:0030728; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034097; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042127; GO:0042307; GO:0042493; GO:0042633; GO:0042803; GO:0043005; GO:0043065; GO:0043066; GO:0043154; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0097756; GO:0150077; GO:1902219; GO:1990776	"aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; keratinocyte differentiation [GO:0030216]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33745_c0_g1_i1	Q05769	PGH2_MOUSE	100	145	0	0	436	2	425	569	1.30E-78	293.5	PGH2_MOUSE	reviewed	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein)	Ptgs2 Cox-2 Cox2 Pghs-b Tis10	Mus musculus (Mouse)	604	"caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; keratinocyte differentiation [GO:0030216]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]	"enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]"	GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005783; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008284; GO:0008285; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0010942; GO:0016702; GO:0019233; GO:0019371; GO:0019899; GO:0020037; GO:0030216; GO:0030282; GO:0030728; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034097; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042127; GO:0042307; GO:0042493; GO:0042633; GO:0042803; GO:0043005; GO:0043065; GO:0043066; GO:0043154; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0097756; GO:0150077; GO:1902219; GO:1990776	"aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; keratinocyte differentiation [GO:0030216]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]"		NA	NA	NA	NA	NA	NA
TRINITY_DN308_c0_g1_i1	O62698	PGH2_BOVIN	51.8	554	260	6	1708	56	19	568	6.70E-175	615.5	PGH2_BOVIN	reviewed	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)	PTGS2 COX2	Bos taurus (Bovine)	604	endoplasmic reticulum membrane [GO:0005789]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; dioxygenase activity [GO:0051213]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; cellular response to interleukin-1 [GO:0071347]; cyclooxygenase pathway [GO:0019371]; inflammatory response [GO:0006954]; meiotic spindle organization [GO:0000212]; ovarian cumulus expansion [GO:0001550]; positive regulation of embryonic development [GO:0040019]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of neuroinflammatory response [GO:0150077]; response to oxidative stress [GO:0006979]	endoplasmic reticulum membrane [GO:0005789]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]	dioxygenase activity [GO:0051213]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0000212; GO:0001516; GO:0001550; GO:0001934; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005789; GO:0006954; GO:0006979; GO:0008217; GO:0019371; GO:0020037; GO:0040019; GO:0046872; GO:0051213; GO:0071347; GO:0150077; GO:1900195; GO:1904146	cellular response to interleukin-1 [GO:0071347]; cyclooxygenase pathway [GO:0019371]; inflammatory response [GO:0006954]; meiotic spindle organization [GO:0000212]; ovarian cumulus expansion [GO:0001550]; positive regulation of embryonic development [GO:0040019]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of neuroinflammatory response [GO:0150077]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN39393_c0_g1_i1	P35354	PGH2_HUMAN	95.7	94	4	0	3	284	136	229	1.60E-48	193	PGH2_HUMAN	reviewed	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)	PTGS2 COX2	Homo sapiens (Human)	604	"caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; cytokine-mediated signaling pathway [GO:0019221]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]	"enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]"	GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008285; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0016702; GO:0019221; GO:0019233; GO:0019371; GO:0019372; GO:0019899; GO:0020037; GO:0030282; GO:0030728; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034356; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042307; GO:0042493; GO:0042633; GO:0042759; GO:0042803; GO:0043005; GO:0043065; GO:0043154; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050727; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0097756; GO:0150077; GO:1902219; GO:1990776	"aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; cytokine-mediated signaling pathway [GO:0019221]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]"		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i2	Q28719	PTGR1_RABIT	50.8	252	121	2	94	846	1	250	1.80E-64	247.7	PTGR1_RABIT	reviewed	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (ADRAB-F) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	PTGR1 LTB4DH	Oryctolagus cuniculus (Rabbit)	349	cytoplasm [GO:0005737]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0097257; GO:2001302	leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i5	Q28719	PTGR1_RABIT	48.3	333	162	5	94	1086	1	325	1.70E-86	321.2	PTGR1_RABIT	reviewed	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (ADRAB-F) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	PTGR1 LTB4DH	Oryctolagus cuniculus (Rabbit)	349	cytoplasm [GO:0005737]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0097257; GO:2001302	leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i11	Q29073	PTGR1_PIG	52.9	104	47	2	1182	1487	146	249	4.50E-20	100.9	PTGR1_PIG	reviewed	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	PTGR1 LTB4DH	Sus scrofa (Pig)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0005829; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0097257; GO:2001302	leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN8219_c0_g1_i1	Q9EQZ5	PTGR1_CAVPO	49.3	337	159	6	66	1070	1	327	1.20E-83	311.6	PTGR1_CAVPO	reviewed	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	Ptgr1 Ltb4dh	Cavia porcellus (Guinea pig)	329	cytoplasm [GO:0005737]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0097257; GO:2001302	leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN13592_c0_g1_i3	Q3SZJ4	PTGR1_BOVIN	43.4	76	39	1	5	220	1	76	2.10E-08	60.1	PTGR1_BOVIN	reviewed	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	PTGR1 LTB4DH	Bos taurus (Bovine)	329	cytoplasm [GO:0005737]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0097257; GO:2001302	leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]		NA	NA	NA	NA	NA	NA
TRINITY_DN7315_c0_g1_i1	Q14914	PTGR1_HUMAN	43.9	57	31	1	230	63	193	249	2.00E-06	52.8	PTGR1_HUMAN	reviewed	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	PTGR1 LTB4DH	Homo sapiens (Human)	329	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0006691; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0070062; GO:0097257; GO:0097327; GO:2001302	leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327]		NA	NA	NA	NA	NA	NA
TRINITY_DN9845_c0_g1_i1	Q9DB60	PXL2B_MOUSE	46.4	166	89	0	2	499	17	182	5.70E-36	152.5	PXL2B_MOUSE	reviewed	Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Peroxiredoxin-like 2B)	Prxl2b Fam213b	Mus musculus (Mouse)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-F synthase activity [GO:0047017]; thioredoxin peroxidase activity [GO:0008379]; oxidation-reduction process [GO:0055114]; prostaglandin biosynthetic process [GO:0001516]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; myelin sheath [GO:0043209]	"antioxidant activity [GO:0016209]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-F synthase activity [GO:0047017]; thioredoxin peroxidase activity [GO:0008379]"	GO:0001516; GO:0005737; GO:0005783; GO:0005829; GO:0008379; GO:0016209; GO:0016616; GO:0043209; GO:0047017; GO:0055114	oxidation-reduction process [GO:0055114]; prostaglandin biosynthetic process [GO:0001516]		NA	NA	NA	NA	NA	NA
TRINITY_DN35194_c0_g1_i1	P84755	IPK2_CENMR	48	50	24	2	195	49	2	50	3.70E-05	48.5	IPK2_CENMR	reviewed	Protease inhibitor 2 (CmPI-II) (Protease inhibitor-II)		Cenchritis muricatus (Beaded periwinkle)	50	serine-type endopeptidase inhibitor activity [GO:0004867]		serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867			NA	NA	NA	NA	NA	NA
TRINITY_DN23073_c0_g1_i1	Q16186	ADRM1_HUMAN	100	94	0	0	283	2	297	390	2.80E-45	182.2	ADRM1_HUMAN	reviewed	Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein) (Gp110) (Adhesion-regulating molecule 1) (ARM-1) (Proteasome regulatory particle non-ATPase 13) (hRpn13) (Rpn13 homolog)	ADRM1 GP110	Homo sapiens (Human)	407	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; protein deubiquitination [GO:0016579]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]	GO:0000502; GO:0002020; GO:0005654; GO:0005829; GO:0005886; GO:0006368; GO:0006511; GO:0008541; GO:0016579; GO:0043130; GO:0043248; GO:0061133; GO:0070628	proteasome assembly [GO:0043248]; protein deubiquitination [GO:0016579]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4932_c0_g1_i1	Q7ZXD6	ADM1B_XENLA	53.3	120	52	3	2	358	264	380	2.00E-24	113.6	ADM1B_XENLA	reviewed	Proteasomal ubiquitin receptor ADRM1-B	adrm1-b	Xenopus laevis (African clawed frog)	404	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	endopeptidase activator activity [GO:0061133]	GO:0000502; GO:0005634; GO:0005737; GO:0043248; GO:0061133	proteasome assembly [GO:0043248]		blue	blue	NA	NA	NA	NA
TRINITY_DN30803_c0_g1_i1	Q06323	PSME1_HUMAN	100	86	0	0	3	260	107	192	5.70E-42	171	PSME1_HUMAN	reviewed	Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha)	PSME1 IFI5111	Homo sapiens (Human)	249	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]	endopeptidase activator activity [GO:0061133]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0008537; GO:0010950; GO:0010972; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:2000045	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32800_c0_g1_i1	P97371	PSME1_MOUSE	100	83	0	0	251	3	105	187	2.10E-41	169.1	PSME1_MOUSE	reviewed	Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha)	Psme1	Mus musculus (Mouse)	249	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; antigen processing and presentation of exogenous antigen [GO:0019884]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]		GO:0005654; GO:0005737; GO:0008537; GO:0010950; GO:0019884; GO:0061136; GO:2000045	antigen processing and presentation of exogenous antigen [GO:0019884]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]		NA	NA	NA	NA	NA	NA
TRINITY_DN19284_c0_g1_i1	Q9UL46	PSME2_HUMAN	100	86	0	0	3	260	91	176	4.00E-43	174.9	PSME2_HUMAN	reviewed	Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta)	PSME2	Homo sapiens (Human)	239	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]	endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0008537; GO:0010950; GO:0010972; GO:0016020; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0035722; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:2000045	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19284_c0_g1_i2	Q9UL46	PSME2_HUMAN	100	86	0	0	3	260	91	176	4.00E-43	174.9	PSME2_HUMAN	reviewed	Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta)	PSME2	Homo sapiens (Human)	239	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]	endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0008537; GO:0010950; GO:0010972; GO:0016020; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0035722; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:2000045	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40574_c0_g1_i1	P61289	PSME3_HUMAN	100	69	0	0	1	207	35	103	1.60E-34	146	PSME3_HUMAN	reviewed	Proteasome activator complex subunit 3 (11S regulator complex subunit gamma) (REG-gamma) (Activator of multicatalytic protease subunit 3) (Ki nuclear autoantigen) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	PSME3	Homo sapiens (Human)	254	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]	endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]	GO:0000165; GO:0000209; GO:0000502; GO:0002039; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006521; GO:0006915; GO:0007049; GO:0008537; GO:0010950; GO:0010972; GO:0016020; GO:0016032; GO:0016579; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061133; GO:0061136; GO:0061418; GO:0070498; GO:0090090; GO:0090263; GO:0097371; GO:1901990; GO:1902036; GO:2000045; GO:2001237	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4849_c0_g1_i1	Q5F3J5	PSME3_CHICK	53.3	242	110	3	809	90	14	254	8.50E-72	271.9	PSME3_CHICK	reviewed	Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	PSME3 RCJMB04_15e19 RCJMB04_5i13	Gallus gallus (Chicken)	254	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]	endopeptidase activator activity [GO:0061133]	GO:0005654; GO:0005737; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:2000045	positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]		blue	blue	NA	NA	NA	NA
TRINITY_DN4849_c0_g1_i2	Q5F3J5	PSME3_CHICK	53.7	242	110	2	812	90	14	254	1.60E-73	277.7	PSME3_CHICK	reviewed	Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	PSME3 RCJMB04_15e19 RCJMB04_5i13	Gallus gallus (Chicken)	254	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]	endopeptidase activator activity [GO:0061133]	GO:0005654; GO:0005737; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:2000045	positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]		blue	blue	NA	NA	NA	NA
TRINITY_DN4849_c0_g2_i1	Q5F3J5	PSME3_CHICK	53.3	242	110	3	109	828	14	254	8.50E-72	271.9	PSME3_CHICK	reviewed	Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	PSME3 RCJMB04_15e19 RCJMB04_5i13	Gallus gallus (Chicken)	254	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]	endopeptidase activator activity [GO:0061133]	GO:0005654; GO:0005737; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:2000045	positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]		NA	NA	NA	NA	NA	NA
TRINITY_DN18324_c0_g1_i1	Q5F3J5	PSME3_CHICK	100	116	0	0	410	63	139	254	8.20E-59	227.6	PSME3_CHICK	reviewed	Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	PSME3 RCJMB04_15e19 RCJMB04_5i13	Gallus gallus (Chicken)	254	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]	endopeptidase activator activity [GO:0061133]	GO:0005654; GO:0005737; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:2000045	positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]		NA	NA	NA	NA	NA	NA
TRINITY_DN18324_c0_g1_i2	Q5F3J5	PSME3_CHICK	100	122	0	0	428	63	133	254	9.80E-63	240.7	PSME3_CHICK	reviewed	Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	PSME3 RCJMB04_15e19 RCJMB04_5i13	Gallus gallus (Chicken)	254	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]	endopeptidase activator activity [GO:0061133]	GO:0005654; GO:0005737; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:2000045	positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]		NA	NA	NA	NA	NA	NA
TRINITY_DN2543_c1_g1_i1	Q5XGC5	PSMG2_XENTR	39.5	248	134	6	164	862	15	261	7.30E-41	169.5	PSMG2_XENTR	reviewed	Proteasome assembly chaperone 2	psmg2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	261	cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome assembly [GO:0043248]	cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0043248; GO:0051131	chaperone-mediated protein complex assembly [GO:0051131]; proteasome assembly [GO:0043248]		NA	NA	NA	NA	NA	NA
TRINITY_DN31387_c0_g1_i1	Q969U7	PSMG2_HUMAN	100	59	0	0	34	210	1	59	3.30E-27	121.7	PSMG2_HUMAN	reviewed	Proteasome assembly chaperone 2 (PAC-2) (Hepatocellular carcinoma-susceptibility protein 3) (Tumor necrosis factor superfamily member 5-induced protein 1)	PSMG2 HCCA3 PAC2 TNFSF5IP1	Homo sapiens (Human)	264	chaperone complex [GO:0101031]; cytosol [GO:0005829]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; chaperone-mediated protein complex assembly [GO:0051131]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; proteasome assembly [GO:0043248]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; nucleus [GO:0005634]	molecular adaptor activity [GO:0060090]	GO:0005634; GO:0005829; GO:0007094; GO:0043066; GO:0043248; GO:0051131; GO:0060090; GO:0101031	chaperone-mediated protein complex assembly [GO:0051131]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; proteasome assembly [GO:0043248]		NA	NA	NA	NA	NA	NA
TRINITY_DN9122_c0_g1_i1	Q6L0W3	PSA_PICTO	48.1	52	27	0	38	193	6	57	3.40E-05	48.5	PSA_PICTO	reviewed	Proteasome subunit alpha (20S proteasome alpha subunit) (Proteasome core protein PsmA)	psmA PTO0804	Picrophilus torridus (strain ATCC 700027 / DSM 9790 / JCM 10055 / NBRC 100828)	234	"cytoplasm [GO:0005737]; proteasome core complex, alpha-subunit complex [GO:0019773]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytoplasm [GO:0005737]; proteasome core complex, alpha-subunit complex [GO:0019773]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005737; GO:0006511; GO:0010498; GO:0019773	proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN16326_c0_g1_i1	Q3T0X5	PSA1_BOVIN	100	74	0	0	3	224	100	173	3.30E-38	158.3	PSA1_BOVIN	reviewed	Proteasome subunit alpha type-1	PSMA1	Bos taurus (Bovine)	263	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]	GO:0001530; GO:0002376; GO:0002862; GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN16326_c0_g1_i2	Q3T0X5	PSA1_BOVIN	100	70	0	0	2	211	104	173	1.10E-35	149.8	PSA1_BOVIN	reviewed	Proteasome subunit alpha type-1	PSMA1	Bos taurus (Bovine)	263	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]	GO:0001530; GO:0002376; GO:0002862; GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN9100_c0_g1_i1	Q3T0X5	PSA1_BOVIN	94.9	59	3	0	40	216	1	59	1.20E-24	113.2	PSA1_BOVIN	reviewed	Proteasome subunit alpha type-1	PSMA1	Bos taurus (Bovine)	263	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]	GO:0001530; GO:0002376; GO:0002862; GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN40023_c0_g1_i1	Q27562	PSA1_DICDI	63.9	72	26	0	9	224	103	174	4.90E-21	101.3	PSA1_DICDI	reviewed	Proteasome subunit alpha type-1 (Proteasome subunit C2)	psmA1 prtC DDB_G0282363	Dictyostelium discoideum (Slime mold)	248	"nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]	GO:0004175; GO:0005634; GO:0005839; GO:0006508; GO:0006511; GO:0008233; GO:0010498; GO:0010499; GO:0019773; GO:0043161; GO:0045335	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN7743_c0_g2_i1	Q3T0Y5	PSA2_BOVIN	100	234	0	0	766	65	1	234	4.10E-131	468.8	PSA2_BOVIN	reviewed	Proteasome subunit alpha type-2	PSMA2	Bos taurus (Bovine)	234	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0000932; GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN7743_c0_g1_i1	P49722	PSA2_MOUSE	100	234	0	0	722	21	1	234	3.80E-131	468.8	PSA2_MOUSE	reviewed	Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)	Psma2 Lmpc3	Mus musculus (Mouse)	234	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0000932; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN7877_c0_g1_i1	P24495	PSA2_XENLA	82.1	234	42	0	48	749	1	234	3.30E-107	389.4	PSA2_XENLA	reviewed	Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (xC3) (Proteasome component C3)	psma2	Xenopus laevis (African clawed frog)	234	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"		GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773	ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN7599_c0_g1_i1	O23708	PSA2A_ARATH	75.5	151	37	0	456	4	85	235	1.20E-61	237.3	PSA2A_ARATH	reviewed	Proteasome subunit alpha type-2-A (20S proteasome alpha subunit B-1) (Proteasome component 3)	PAB1 PRC3 At1g16470 F3O9.27	Arabidopsis thaliana (Mouse-ear cress)	235	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to zinc ion [GO:0010043]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0004175; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010043; GO:0010498; GO:0010499; GO:0019773; GO:0022626; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN7599_c0_g2_i1	O23708	PSA2A_ARATH	62.4	85	31	1	256	2	3	86	3.40E-22	105.5	PSA2A_ARATH	reviewed	Proteasome subunit alpha type-2-A (20S proteasome alpha subunit B-1) (Proteasome component 3)	PAB1 PRC3 At1g16470 F3O9.27	Arabidopsis thaliana (Mouse-ear cress)	235	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to zinc ion [GO:0010043]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0004175; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010043; GO:0010498; GO:0010499; GO:0019773; GO:0022626; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN31654_c0_g1_i1	Q58DU5	PSA3_BOVIN	100	90	0	0	88	357	1	90	6.50E-44	177.9	PSA3_BOVIN	reviewed	Proteasome subunit alpha type-3	PSMA3	Bos taurus (Bovine)	255	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN10143_c0_g1_i1	Q58DU5	PSA3_BOVIN	100	100	0	0	301	2	1	100	3.80E-49	195.3	PSA3_BOVIN	reviewed	Proteasome subunit alpha type-3	PSMA3	Bos taurus (Bovine)	255	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN15870_c1_g2_i1	Q58DU5	PSA3_BOVIN	92.3	26	2	0	162	239	8	33	6.20E-06	51.2	PSA3_BOVIN	reviewed	Proteasome subunit alpha type-3	PSMA3	Bos taurus (Bovine)	255	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN32015_c0_g1_i1	Q9LSU0	PSA3_ORYSJ	58.8	97	38	2	1	288	132	227	4.20E-25	115.2	PSA3_ORYSJ	reviewed	Proteasome subunit alpha type-3 (20S proteasome alpha subunit G) (20S proteasome subunit alpha-7)	PAG1 Os01g0811100 LOC_Os01g59600 OsJ_03826 P0425G02.8 P0468B07.45	Oryza sativa subsp. japonica (Rice)	249	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN12634_c0_g1_i1	O23715	PSA3_ARATH	63.3	60	22	0	180	1	1	60	9.40E-16	83.6	PSA3_ARATH	reviewed	Proteasome subunit alpha type-3 (20S proteasome alpha subunit G-1) (DiDi 17A-2a) (Proteasome component 8) (Proteasome subunit alpha type-7)	PAG1 PRC8 At2g27020 T20P8.7	Arabidopsis thaliana (Mouse-ear cress)	249	"apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]"	"apoplast [GO:0048046]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0004175; GO:0005634; GO:0005737; GO:0005773; GO:0005774; GO:0005777; GO:0005829; GO:0005839; GO:0009409; GO:0010498; GO:0010499; GO:0019773; GO:0043161; GO:0046686; GO:0048046	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]		NA	NA	NA	NA	NA	NA
TRINITY_DN1450_c0_g1_i1	P25788	PSA3_HUMAN	66.3	255	85	1	960	199	1	255	7.10E-99	362.1	PSA3_HUMAN	reviewed	Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3 HC8 PSC8	Homo sapiens (Human)	255	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045202; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1450_c0_g1_i3	P25788	PSA3_HUMAN	66.3	255	85	1	960	199	1	255	7.10E-99	362.1	PSA3_HUMAN	reviewed	Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3 HC8 PSC8	Homo sapiens (Human)	255	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045202; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8449_c0_g1_i1	P25788	PSA3_HUMAN	98.6	138	2	0	1	414	98	235	1.70E-75	283.1	PSA3_HUMAN	reviewed	Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3 HC8 PSC8	Homo sapiens (Human)	255	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045202; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8449_c0_g1_i2	P25788	PSA3_HUMAN	100	138	0	0	1	414	98	235	3.40E-76	285.4	PSA3_HUMAN	reviewed	Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3 HC8 PSC8	Homo sapiens (Human)	255	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"	endopeptidase activity [GO:0004175]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045202; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8353_c0_g1_i1	Q3ZCK9	PSA4_BOVIN	100	226	0	0	679	2	1	226	8.30E-126	451.1	PSA4_BOVIN	reviewed	Proteasome subunit alpha type-4	PSMA4	Bos taurus (Bovine)	261	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000932; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN8353_c0_g1_i2	Q3ZCK9	PSA4_BOVIN	90	180	10	2	523	2	49	226	1.20E-84	313.9	PSA4_BOVIN	reviewed	Proteasome subunit alpha type-4	PSMA4	Bos taurus (Bovine)	261	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000932; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN5584_c0_g1_i1	Q3ZCK9	PSA4_BOVIN	74.4	238	61	0	88	801	1	238	3.80E-99	362.8	PSA4_BOVIN	reviewed	Proteasome subunit alpha type-4	PSMA4	Bos taurus (Bovine)	261	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000932; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN8353_c0_g2_i1	Q9R1P0	PSA4_MOUSE	100	159	0	0	479	3	68	226	2.70E-85	315.8	PSA4_MOUSE	reviewed	Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	Psma4	Mus musculus (Mouse)	261	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0000932; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161; GO:0043231	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN33001_c0_g1_i1	O81148	PSA4A_ARATH	73	141	38	0	425	3	1	141	7.80E-56	218	PSA4A_ARATH	reviewed	Proteasome subunit alpha type-4-A (20S proteasome alpha subunit C-1) (Proteasome 27 kDa subunit) (Proteasome component 9) (Proteasome subunit alpha type-3)	PAC1 PRC9 PRS1 At3g22110 MKA23.2	Arabidopsis thaliana (Mouse-ear cress)	250	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; vacuole [GO:0005773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to cadmium ion [GO:0046686]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; vacuole [GO:0005773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0004175; GO:0005634; GO:0005737; GO:0005739; GO:0005773; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0022626; GO:0043161; GO:0046686	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN1473_c0_g1_i1	Q95083	PSA5_DROME	92	75	6	0	225	1	1	75	2.90E-31	135.6	PSA5_DROME	reviewed	Proteasome subunit alpha type-5	Prosalpha5 ProsMA5 CG10938	Drosophila melanogaster (Fruit fly)	244	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; circadian rhythm [GO:0007623]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0007623; GO:0008063; GO:0010498; GO:0010499; GO:0019773; GO:0043161	circadian rhythm [GO:0007623]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN1473_c0_g1_i2	Q95083	PSA5_DROME	92	75	6	0	225	1	1	75	2.90E-31	135.6	PSA5_DROME	reviewed	Proteasome subunit alpha type-5	Prosalpha5 ProsMA5 CG10938	Drosophila melanogaster (Fruit fly)	244	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; circadian rhythm [GO:0007623]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0000502; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0007623; GO:0008063; GO:0010498; GO:0010499; GO:0019773; GO:0043161	circadian rhythm [GO:0007623]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN10542_c0_g2_i1	Q5E987	PSA5_BOVIN	100	70	0	0	212	3	2	71	4.50E-32	137.9	PSA5_BOVIN	reviewed	Proteasome subunit alpha type-5	PSMA5	Bos taurus (Bovine)	241	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN10542_c0_g1_i1	Q5E987	PSA5_BOVIN	100	75	0	0	225	1	1	75	2.50E-35	149.1	PSA5_BOVIN	reviewed	Proteasome subunit alpha type-5	PSMA5	Bos taurus (Bovine)	241	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN13369_c0_g2_i1	Q2YDE4	PSA6_BOVIN	100	77	0	0	231	1	170	246	2.10E-35	149.1	PSA6_BOVIN	reviewed	Proteasome subunit alpha type-6	PSMA6	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0005844; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0043161; GO:0051059; GO:0051092	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN13369_c0_g1_i2	Q2YDE4	PSA6_BOVIN	100	160	0	0	482	3	1	160	1.90E-90	333.2	PSA6_BOVIN	reviewed	Proteasome subunit alpha type-6	PSMA6	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0005844; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0043161; GO:0051059; GO:0051092	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN13369_c0_g1_i3	Q2YDE4	PSA6_BOVIN	100	160	0	0	482	3	1	160	1.10E-90	334	PSA6_BOVIN	reviewed	Proteasome subunit alpha type-6	PSMA6	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0005844; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0043161; GO:0051059; GO:0051092	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN1297_c0_g1_i1	Q2YDE4	PSA6_BOVIN	70.7	246	72	0	752	15	1	246	7.40E-96	351.7	PSA6_BOVIN	reviewed	Proteasome subunit alpha type-6	PSMA6	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0005844; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0043161; GO:0051059; GO:0051092	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN22744_c0_g1_i1	Q2YDE4	PSA6_BOVIN	70.2	131	39	0	394	2	1	131	3.70E-46	185.7	PSA6_BOVIN	reviewed	Proteasome subunit alpha type-6	PSMA6	Bos taurus (Bovine)	246	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0005844; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0043161; GO:0051059; GO:0051092	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN25486_c0_g1_i1	Q9XG77	PSA6_TOBAC	57.3	157	67	0	471	1	8	164	3.20E-47	189.5	PSA6_TOBAC	reviewed	Proteasome subunit alpha type-6 (20S proteasome alpha subunit A) (20S proteasome subunit alpha-1)	PAA1 PSA1	Nicotiana tabacum (Common tobacco)	246	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]	GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN13369_c0_g1_i4	Q9QUM9	PSA6_MOUSE	100	160	0	0	482	3	1	160	2.40E-90	332.8	PSA6_MOUSE	reviewed	Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	Psma6	Mus musculus (Mouse)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000502; GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0005844; GO:0007519; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN28192_c0_g1_i1	Q9QUM9	PSA6_MOUSE	100	114	0	0	2	343	63	176	6.00E-63	241.1	PSA6_MOUSE	reviewed	Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	Psma6	Mus musculus (Mouse)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]"	endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0000502; GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0005844; GO:0007519; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN32793_c0_g1_i1	P34120	PSA7_DICDI	64.8	196	68	1	589	2	3	197	8.40E-71	268.1	PSA7_DICDI	reviewed	Proteasome subunit alpha type-7 (Proteasome component DD5)	psmA7 prdE DDB_G0272831	Dictyostelium discoideum (Slime mold)	250	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]	GO:0004175; GO:0005634; GO:0005737; GO:0005839; GO:0006508; GO:0008233; GO:0010498; GO:0010499; GO:0019773; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN9467_c0_g1_i1	Q9PTW9	PSA7_CARAU	77	235	54	0	60	764	2	236	8.10E-101	368.2	PSA7_CARAU	reviewed	Proteasome subunit alpha type-7 (Proteasome subunit alpha 4)	psma7	Carassius auratus (Goldfish)	251	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"		GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773	ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN2773_c0_g1_i3	Q9Z2U0	PSA7_MOUSE	100	234	0	0	77	778	1	234	1.40E-128	460.3	PSA7_MOUSE	reviewed	Proteasome subunit alpha type-7 (Proteasome subunit RC6-1)	Psma7	Mus musculus (Mouse)	248	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]	GO:0000502; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0042802; GO:0043161; GO:0098794	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN2773_c0_g1_i2	O14818	PSA7_HUMAN	100	234	0	0	77	778	1	234	4.20E-128	458.8	PSA7_HUMAN	reviewed	Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7 HSPC	Homo sapiens (Human)	248	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:0098794; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2773_c0_g1_i4	O14818	PSA7_HUMAN	94.8	174	8	1	17	538	62	234	2.70E-86	319.3	PSA7_HUMAN	reviewed	Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7 HSPC	Homo sapiens (Human)	248	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0042802; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:0098794; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13475_c0_g1_i1	O82531	PSB1_PETHY	55.7	97	43	0	293	3	64	160	1.10E-25	117.1	PSB1_PETHY	reviewed	Proteasome subunit beta type-1 (EC 3.4.25.1) (20S proteasome alpha subunit F) (20S proteasome subunit beta-6)	PBF1	Petunia hybrida (Petunia)	223	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0019774; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN8313_c0_g2_i1	O09061	PSB1_MOUSE	99.6	236	1	0	1	708	5	240	5.40E-133	474.9	PSB1_MOUSE	reviewed	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	Psmb1	Mus musculus (Mouse)	240	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN8313_c0_g1_i1	P20618	PSB1_HUMAN	100	241	0	0	6	728	1	241	3.20E-136	485.7	PSB1_HUMAN	reviewed	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1 PSC5	Homo sapiens (Human)	241	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3709_c0_g1_i1	P40304	PSB1_DROME	53.5	226	102	2	104	772	10	235	2.30E-63	243.8	PSB1_DROME	reviewed	Proteasome subunit beta type-1 (EC 3.4.25.1) (Proteasome 26 kDa subunit)	Prosbeta6 l(3)73Ai PROS-26 Pros26 CG4097	Drosophila melanogaster (Fruit fly)	235	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; circadian rhythm [GO:0007623]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0007623; GO:0008063; GO:0010498; GO:0010499; GO:0019774; GO:0043161	circadian rhythm [GO:0007623]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN40343_c0_g1_i1	P49721	PSB2_HUMAN	100	69	0	0	2	208	133	201	1.90E-33	142.5	PSB2_HUMAN	reviewed	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	PSMB2	Homo sapiens (Human)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010243; GO:0010498; GO:0010499; GO:0010972; GO:0014070; GO:0016020; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29514_c0_g1_i1	Q9R1P3	PSB2_MOUSE	100	71	0	0	1	213	131	201	1.10E-34	146.7	PSB2_MOUSE	reviewed	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	Psmb2	Mus musculus (Mouse)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010243; GO:0010498; GO:0010499; GO:0014070; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]		NA	NA	NA	NA	NA	NA
TRINITY_DN17276_c0_g1_i1	Q9R1P3	PSB2_MOUSE	52.6	192	90	1	698	123	1	191	1.20E-50	201.4	PSB2_MOUSE	reviewed	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	Psmb2	Mus musculus (Mouse)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010243; GO:0010498; GO:0010499; GO:0014070; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]		blue	blue	NA	NA	NA	NA
TRINITY_DN12869_c0_g1_i1	P49721	PSB2_HUMAN	100	94	0	0	3	284	24	117	8.30E-50	197.2	PSB2_HUMAN	reviewed	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	PSMB2	Homo sapiens (Human)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010243; GO:0010498; GO:0010499; GO:0010972; GO:0014070; GO:0016020; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12869_c0_g1_i2	P49721	PSB2_HUMAN	100	94	0	0	3	284	24	117	8.30E-50	197.2	PSB2_HUMAN	reviewed	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	PSMB2	Homo sapiens (Human)	201	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010243; GO:0010498; GO:0010499; GO:0010972; GO:0014070; GO:0016020; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11686_c0_g1_i10	O73817	PSB3_ONCMY	68.5	178	56	0	535	2	1	178	1.60E-71	270.4	PSB3_ONCMY	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	psmb3	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	205	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		blue	blue	NA	NA	NA	NA
TRINITY_DN11686_c0_g1_i14	O73817	PSB3_ONCMY	68.4	177	56	0	532	2	2	178	5.50E-71	268.9	PSB3_ONCMY	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	psmb3	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	205	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	1
TRINITY_DN11686_c0_g1_i16	O73817	PSB3_ONCMY	68.4	177	56	0	532	2	2	178	7.40E-71	268.9	PSB3_ONCMY	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	psmb3	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	205	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN11686_c0_g1_i5	O73817	PSB3_ONCMY	68.4	177	56	0	532	2	2	178	7.40E-71	268.9	PSB3_ONCMY	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	psmb3	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	205	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN27914_c0_g1_i1	O73817	PSB3_ONCMY	67.5	80	26	0	11	250	94	173	3.90E-27	121.7	PSB3_ONCMY	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	psmb3	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	205	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN23279_c0_g1_i1	P33672	PSB3_BOVIN	65.6	90	31	0	2	271	13	102	2.00E-29	129.4	PSB3_BOVIN	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	Bos taurus (Bovine)	205	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN15647_c0_g1_i1	P49720	PSB3_HUMAN	100	146	0	0	438	1	1	146	5.70E-80	298.1	PSB3_HUMAN	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	Homo sapiens (Human)	205	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15647_c0_g1_i2	Q9R1P1	PSB3_MOUSE	99.3	148	1	0	445	2	1	148	3.10E-81	302.4	PSB3_MOUSE	reviewed	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	Psmb3	Mus musculus (Mouse)	205	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0030163; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]		NA	NA	NA	NA	NA	NA
TRINITY_DN22741_c0_g1_i1	Q3T108	PSB4_BOVIN	43.2	139	62	3	42	419	9	143	8.40E-27	121.3	PSB4_BOVIN	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1)	PSMB4	Bos taurus (Bovine)	264	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]	GO:0001530; GO:0002862; GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0036064; GO:0043161	negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN30486_c0_g1_i1	Q7DLR9	PSB4_ARATH	55.5	119	53	0	7	363	102	220	5.70E-35	148.3	PSB4_ARATH	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (20S proteasome beta subunit G-1) (Proteasome component H) (Proteasome subunit beta type-7)	PBG1 PRCH At1g56450 F13N6.3	Arabidopsis thaliana (Mouse-ear cress)	246	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to cadmium ion [GO:0046686]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0022626; GO:0043161; GO:0046686	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN33636_c0_g1_i1	P28070	PSB4_HUMAN	100	71	0	0	214	2	115	185	3.90E-36	151.4	PSB4_HUMAN	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3)	PSMB4 PROS26	Homo sapiens (Human)	264	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0001530; GO:0002223; GO:0002479; GO:0002862; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0036064; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31598_c0_g1_i1	P99026	PSB4_MOUSE	100	146	0	0	1	438	31	176	3.10E-80	298.9	PSB4_MOUSE	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (Low molecular mass protein 3) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3)	Psmb4 Lmp3	Mus musculus (Mouse)	264	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0001530; GO:0002862; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0036064; GO:0043161	negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN35013_c0_g1_i1	P28024	PSB4_XENLA	51.4	72	35	0	6	221	19	90	1.10E-17	90.1	PSB4_XENLA	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment)	psmb4	Xenopus laevis (African clawed frog)	242	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN29687_c1_g1_i1	P28024	PSB4_XENLA	47.8	247	114	5	102	827	6	242	5.90E-65	249.2	PSB4_XENLA	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment)	psmb4	Xenopus laevis (African clawed frog)	242	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN19861_c1_g1_i1	P28024	PSB4_XENLA	52.9	87	37	1	63	311	23	109	2.00E-20	99.8	PSB4_XENLA	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment)	psmb4	Xenopus laevis (African clawed frog)	242	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN35876_c0_g1_i1	P34067	PSB4_RAT	43.8	73	41	0	3	221	113	185	6.50E-13	74.3	PSB4_RAT	reviewed	Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (RN3)	Psmb4	Rattus norvegicus (Rat)	263	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0001530; GO:0002862; GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0036064; GO:0043161	negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN3433_c0_g1_i1	Q32KL2	PSB5_BOVIN	68.6	207	65	0	790	170	53	259	2.30E-84	313.9	PSB5_BOVIN	reviewed	Proteasome subunit beta type-5 (EC 3.4.25.1)	PSMB5	Bos taurus (Bovine)	263	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979]"	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005839; GO:0006979; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN22715_c0_g1_i1	Q32KL2	PSB5_BOVIN	69.8	63	19	0	192	4	111	173	5.70E-21	100.9	PSB5_BOVIN	reviewed	Proteasome subunit beta type-5 (EC 3.4.25.1)	PSMB5	Bos taurus (Bovine)	263	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979]"	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005839; GO:0006979; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN7896_c0_g1_i1	P28074	PSB5_HUMAN	100	193	0	0	3	581	71	263	1.50E-107	390.2	PSB5_HUMAN	reviewed	Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X)	PSMB5 LMPX MB1 X	Homo sapiens (Human)	263	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to oxidative stress [GO:0006979]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0006508; GO:0006521; GO:0006979; GO:0008233; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to oxidative stress [GO:0006979]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7896_c0_g2_i1	O55234	PSB5_MOUSE	100	188	0	0	3	566	77	264	2.80E-105	382.5	PSB5_MOUSE	reviewed	Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit X)	Psmb5	Mus musculus (Mouse)	264	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979]"	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0006508; GO:0006979; GO:0008233; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN33615_c0_g1_i1	O23717	PSB5A_ARATH	61.6	219	76	3	20	676	46	256	5.20E-72	272.3	PSB5A_ARATH	reviewed	Proteasome subunit beta type-5-A (EC 3.4.25.1) (20S proteasome beta subunit E-1) (Proteasome component E) (Proteasome epsilon-1 chain)	PBE1 PRCE At1g13060 F3F19.8	Arabidopsis thaliana (Mouse-ear cress)	274	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	1	NA	NA	NA
TRINITY_DN26912_c0_g1_i1	Q9LIP2	PSB5B_ARATH	53.6	84	39	0	1	252	64	147	5.50E-21	101.3	PSB5B_ARATH	reviewed	Proteasome subunit beta type-5-B (EC 3.4.25.1) (20S proteasome beta subunit E-2) (Proteasome epsilon-2 chain)	PBE2 At3g26340 F20C19.6	Arabidopsis thaliana (Mouse-ear cress)	273	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161	proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		NA	NA	NA	NA	NA	NA
TRINITY_DN7896_c1_g2_i1	P28063	PSB8_MOUSE	100	205	0	0	655	41	72	276	2.80E-117	422.5	PSB8_MOUSE	reviewed	Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i)	Psmb8 Lmp7 Mc13	Mus musculus (Mouse)	276	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; antigen processing and presentation [GO:0019882]; fat cell differentiation [GO:0045444]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0019882; GO:0043161; GO:0045444; GO:0052548; GO:1990111	antigen processing and presentation [GO:0019882]; fat cell differentiation [GO:0045444]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN364_c0_g1_i1	P28063	PSB8_MOUSE	53.1	81	38	0	247	5	164	244	3.80E-19	95.1	PSB8_MOUSE	reviewed	Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i)	Psmb8 Lmp7 Mc13	Mus musculus (Mouse)	276	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; antigen processing and presentation [GO:0019882]; fat cell differentiation [GO:0045444]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0019882; GO:0043161; GO:0045444; GO:0052548; GO:1990111	antigen processing and presentation [GO:0019882]; fat cell differentiation [GO:0045444]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]		NA	NA	NA	NA	NA	NA
TRINITY_DN7896_c1_g1_i1	P28062	PSB8_HUMAN	100	210	0	0	669	40	67	276	1.10E-121	437.2	PSB8_HUMAN	reviewed	Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein)	PSMB8 LMP7 PSMB5i RING10 Y2	Homo sapiens (Human)	276	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; fat cell differentiation [GO:0045444]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]"	endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019774; GO:0031145; GO:0031146; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045444; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0060337; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1990111	"anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; fat cell differentiation [GO:0045444]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9200_c0_g1_i1	Q58576	PAN_METJA	99.1	106	1	0	320	3	251	356	1.20E-52	206.8	PAN_METJA	reviewed	Proteasome-activating nucleotidase (PAN) (Proteasomal ATPase) (Proteasome regulatory ATPase) (Proteasome regulatory particle)	pan MJ1176	Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)	430	cytoplasm [GO:0005737]; proteasome-activating nucleotidase complex [GO:0022623]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; CTPase activity [GO:0043273]; GTPase activity [GO:0003924]; proteasomal protein catabolic process [GO:0010498]; protein unfolding [GO:0043335]	cytoplasm [GO:0005737]; proteasome-activating nucleotidase complex [GO:0022623]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; CTPase activity [GO:0043273]; GTPase activity [GO:0003924]	GO:0003924; GO:0005524; GO:0005737; GO:0010498; GO:0016887; GO:0022623; GO:0043273; GO:0043335	proteasomal protein catabolic process [GO:0010498]; protein unfolding [GO:0043335]		NA	NA	NA	NA	NA	NA
TRINITY_DN39995_c0_g1_i1	P11171	41_HUMAN	100	92	0	0	277	2	339	430	8.30E-47	187.2	EPB41_HUMAN	reviewed	Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1) (Erythrocyte membrane protein band 4.1)	EPB41 E41P	Homo sapiens (Human)	864	basolateral plasma membrane [GO:0016323]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731]; 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport [GO:0051924]; regulation of cell shape [GO:0008360]; regulation of intestinal absorption [GO:1904478]	basolateral plasma membrane [GO:0016323]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731]	1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005516; GO:0005545; GO:0005829; GO:0005856; GO:0005886; GO:0007049; GO:0008022; GO:0008360; GO:0009898; GO:0014069; GO:0014731; GO:0016323; GO:0016604; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030866; GO:0031032; GO:0032092; GO:0032991; GO:0045171; GO:0047485; GO:0051219; GO:0051301; GO:0051924; GO:0065003; GO:0072686; GO:0099738; GO:1904478; GO:1904778	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport [GO:0051924]; regulation of cell shape [GO:0008360]; regulation of intestinal absorption [GO:1904478]		NA	NA	NA	NA	NA	NA
TRINITY_DN34851_c0_g1_i1	P48193	41_MOUSE	100	80	0	0	242	3	415	494	1.10E-42	173.3	EPB41_MOUSE	reviewed	Protein 4.1 (P4.1) (4.1R) (Band 4.1) (Erythrocyte membrane protein band 4.1)	Epb41 Epb4.1 Kiaa4056	Mus musculus (Mouse)	858	actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport [GO:0051924]; regulation of cell shape [GO:0008360]; regulation of intestinal absorption [GO:1904478]	actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005516; GO:0005545; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007049; GO:0008022; GO:0008360; GO:0009898; GO:0014069; GO:0015629; GO:0016020; GO:0016323; GO:0016604; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030866; GO:0031032; GO:0032092; GO:0032991; GO:0045171; GO:0047485; GO:0051219; GO:0051301; GO:0051924; GO:0065003; GO:0072686; GO:0099738; GO:1904478; GO:1904778	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport [GO:0051924]; regulation of cell shape [GO:0008360]; regulation of intestinal absorption [GO:1904478]		NA	NA	NA	NA	NA	NA
TRINITY_DN1909_c0_g1_i1	Q9V8R9	41_DROME	55.5	137	47	6	90	491	1569	1694	1.40E-24	114.4	EPB41_DROME	reviewed	Protein 4.1 homolog (Protein coracle)	cora CG11949	Drosophila melanogaster (Fruit fly)	1698	"cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; actin binding [GO:0003779]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; adult somatic muscle development [GO:0007527]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; protein targeting to membrane [GO:0006612]; regulation of tube size, open tracheal system [GO:0035151]"	cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]	actin binding [GO:0003779]; structural molecule activity [GO:0005198]	GO:0003015; GO:0003779; GO:0005198; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0006612; GO:0007391; GO:0007527; GO:0009792; GO:0031032; GO:0035151; GO:0035321; GO:0045216; GO:0060857; GO:0061343	"actomyosin structure organization [GO:0031032]; adult somatic muscle development [GO:0007527]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; protein targeting to membrane [GO:0006612]; regulation of tube size, open tracheal system [GO:0035151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1322_c0_g1_i1	Q9V8R9	41_DROME	67.4	341	108	2	47	1066	29	367	8.00E-130	464.9	EPB41_DROME	reviewed	Protein 4.1 homolog (Protein coracle)	cora CG11949	Drosophila melanogaster (Fruit fly)	1698	"cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; actin binding [GO:0003779]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; adult somatic muscle development [GO:0007527]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; protein targeting to membrane [GO:0006612]; regulation of tube size, open tracheal system [GO:0035151]"	cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]	actin binding [GO:0003779]; structural molecule activity [GO:0005198]	GO:0003015; GO:0003779; GO:0005198; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0006612; GO:0007391; GO:0007527; GO:0009792; GO:0031032; GO:0035151; GO:0035321; GO:0045216; GO:0060857; GO:0061343	"actomyosin structure organization [GO:0031032]; adult somatic muscle development [GO:0007527]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; protein targeting to membrane [GO:0006612]; regulation of tube size, open tracheal system [GO:0035151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1322_c0_g1_i4	Q9V8R9	41_DROME	73.4	241	62	1	79	801	129	367	1.20E-98	360.9	EPB41_DROME	reviewed	Protein 4.1 homolog (Protein coracle)	cora CG11949	Drosophila melanogaster (Fruit fly)	1698	"cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]; actin binding [GO:0003779]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; adult somatic muscle development [GO:0007527]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; protein targeting to membrane [GO:0006612]; regulation of tube size, open tracheal system [GO:0035151]"	cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; smooth septate junction [GO:0005920]	actin binding [GO:0003779]; structural molecule activity [GO:0005198]	GO:0003015; GO:0003779; GO:0005198; GO:0005856; GO:0005886; GO:0005918; GO:0005920; GO:0006612; GO:0007391; GO:0007527; GO:0009792; GO:0031032; GO:0035151; GO:0035321; GO:0045216; GO:0060857; GO:0061343	"actomyosin structure organization [GO:0031032]; adult somatic muscle development [GO:0007527]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; protein targeting to membrane [GO:0006612]; regulation of tube size, open tracheal system [GO:0035151]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9953_c0_g1_i1	Q9D2V5	AAR2_MOUSE	43.8	162	89	1	586	107	10	171	6.50E-37	155.6	AAR2_MOUSE	reviewed	Protein AAR2 homolog (AAR2 splicing factor homolog)	Aar2	Mus musculus (Mouse)	384	spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244]	spliceosomal complex [GO:0005681]		GO:0000244; GO:0005681	spliceosomal tri-snRNP complex assembly [GO:0000244]		NA	NA	NA	NA	NA	NA
TRINITY_DN8389_c0_g1_i2	Q8K4F5	ABHDB_MOUSE	39.5	167	95	4	546	46	146	306	7.90E-29	128.6	ABHDB_MOUSE	reviewed	Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog)	Abhd11 Wbscr21	Mus musculus (Mouse)	307	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]	mitochondrion [GO:0005739]	hydrolase activity [GO:0016787]	GO:0005739; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN8389_c0_g1_i4	Q8K4F5	ABHDB_MOUSE	40.6	271	152	5	858	46	45	306	2.60E-53	210.7	ABHDB_MOUSE	reviewed	Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog)	Abhd11 Wbscr21	Mus musculus (Mouse)	307	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]	mitochondrion [GO:0005739]	hydrolase activity [GO:0016787]	GO:0005739; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN37302_c0_g1_i1	Q8K4F5	ABHDB_MOUSE	100	75	0	0	228	4	169	243	2.70E-35	148.7	ABHDB_MOUSE	reviewed	Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog)	Abhd11 Wbscr21	Mus musculus (Mouse)	307	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]	mitochondrion [GO:0005739]	hydrolase activity [GO:0016787]	GO:0005739; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN30121_c0_g1_i1	Q6IRP4	ABHDD_XENLA	43.3	150	79	4	448	5	85	230	1.20E-26	120.9	ABHDD_XENLA	reviewed	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	abhd13	Xenopus laevis (African clawed frog)	336	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN4374_c0_g1_i1	Q7L211	ABHDD_HUMAN	44.8	319	171	3	101	1057	10	323	3.10E-74	280.4	ABHDD_HUMAN	reviewed	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	ABHD13 C13orf6	Homo sapiens (Human)	337	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0008474; GO:0016020; GO:0016021; GO:0032839	protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN4374_c0_g1_i2	Q7L211	ABHDD_HUMAN	44.7	253	133	4	101	853	10	257	7.70E-54	212.6	ABHDD_HUMAN	reviewed	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	ABHD13 C13orf6	Homo sapiens (Human)	337	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0008474; GO:0016020; GO:0016021; GO:0032839	protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN4374_c0_g1_i5	Q7L211	ABHDD_HUMAN	44.8	319	171	3	101	1057	10	323	3.10E-74	280.4	ABHDD_HUMAN	reviewed	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	ABHD13 C13orf6	Homo sapiens (Human)	337	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0008474; GO:0016020; GO:0016021; GO:0032839	protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN4374_c0_g1_i7	Q7L211	ABHDD_HUMAN	44.7	253	133	4	101	853	10	257	7.50E-54	212.6	ABHDD_HUMAN	reviewed	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	ABHD13 C13orf6	Homo sapiens (Human)	337	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0008474; GO:0016020; GO:0016021; GO:0032839	protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN26606_c0_g1_i1	Q7L211	ABHDD_HUMAN	100	139	0	0	2	418	105	243	4.40E-76	285	ABHDD_HUMAN	reviewed	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	ABHD13 C13orf6	Homo sapiens (Human)	337	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]	dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0008474; GO:0016020; GO:0016021; GO:0032839	protein depalmitoylation [GO:0002084]		NA	NA	NA	NA	NA	NA
TRINITY_DN27887_c0_g1_i3	Q5I0C4	ABHEA_RAT	44.4	90	48	2	266	3	104	193	5.00E-11	68.6	ABHEA_RAT	reviewed	Protein ABHD14A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14A) (Abhydrolase domain-containing protein 14A)	Abhd14a	Rattus norvegicus (Rat)	242	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0005737; GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN27887_c0_g1_i4	Q96IU4	ABHEB_HUMAN	41	61	36	0	217	35	91	151	1.80E-05	50.1	ABHEB_HUMAN	reviewed	Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B)	ABHD14B CIB	Homo sapiens (Human)	210	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016787; GO:0045944; GO:0050427; GO:0070062	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN1255_c0_g1_i1	Q5R816	ABHEB_PONAB	40.7	209	114	4	383	988	2	207	2.50E-38	161	ABHEB_PONAB	reviewed	Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B)	ABHD14B CIB	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	210	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005737; GO:0016787			blue	blue	NA	NA	NA	NA
TRINITY_DN1255_c0_g1_i2	Q5R816	ABHEB_PONAB	40.7	162	86	4	196	660	2	160	6.00E-25	115.9	ABHEB_PONAB	reviewed	Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B)	ABHD14B CIB	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	210	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005737; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN1255_c0_g1_i4	Q5R816	ABHEB_PONAB	40.7	209	114	4	175	780	2	207	2.10E-38	161	ABHEB_PONAB	reviewed	Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B)	ABHD14B CIB	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	210	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	hydrolase activity [GO:0016787]	GO:0005634; GO:0005737; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN15171_c0_g1_i5	Q80YU0	ABHGB_MOUSE	52.5	59	28	0	247	71	270	328	3.80E-11	68.6	ABHGB_MOUSE	reviewed	Protein ABHD16B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 16B) (Abhydrolase domain-containing protein 16B)	Abhd16b	Mus musculus (Mouse)	474	membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]	membrane [GO:0016020]	acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0004620; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651	monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]		brown	brown	NA	NA	NA	NA
TRINITY_DN2299_c0_g1_i1	Q8C1A9	ABD18_MOUSE	45.3	492	235	7	1572	103	3	462	1.50E-122	441.4	ABD18_MOUSE	reviewed	Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18)	Abhd18	Mus musculus (Mouse)	464	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN2299_c0_g1_i2	Q8C1A9	ABD18_MOUSE	42.7	522	235	8	1662	103	3	462	1.50E-117	424.9	ABD18_MOUSE	reviewed	Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18)	Abhd18	Mus musculus (Mouse)	464	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN44_c2_g1_i1	Q24174	ABRU_DROME	47.1	138	63	2	115	528	79	206	1.20E-26	122.9	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN44_c2_g1_i2	Q24174	ABRU_DROME	47.1	138	63	2	115	528	79	206	1.20E-26	122.9	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN44_c2_g1_i3	Q24174	ABRU_DROME	47.1	138	63	2	115	528	79	206	1.20E-26	122.9	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11302_c0_g1_i1	Q24174	ABRU_DROME	47	117	60	2	117	467	76	190	1.40E-23	110.9	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8322_c0_g1_i1	Q24174	ABRU_DROME	45.9	109	59	0	109	435	79	187	5.40E-24	113.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8322_c0_g1_i2	Q24174	ABRU_DROME	45.9	109	59	0	109	435	79	187	5.10E-24	113.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		blue	blue	NA	NA	NA	NA
TRINITY_DN12347_c0_g1_i1	Q24174	ABRU_DROME	66.1	112	38	0	61	396	76	187	2.70E-39	162.9	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10755_c0_g1_i1	Q24174	ABRU_DROME	45	109	60	0	497	171	79	187	1.20E-24	114.8	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2621_c0_g2_i1	Q24174	ABRU_DROME	52.3	109	52	0	64	390	79	187	8.60E-29	128.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32895_c0_g1_i1	Q24174	ABRU_DROME	36.7	109	69	0	47	373	79	187	8.60E-19	94.7	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33041_c0_g1_i1	Q24174	ABRU_DROME	57.3	110	47	0	333	4	78	187	6.30E-33	141.4	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5518_c0_g1_i1	Q24174	ABRU_DROME	40.5	121	72	0	1633	1271	80	200	2.40E-19	98.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28190_c0_g1_i1	Q24174	ABRU_DROME	42.2	109	63	0	415	89	79	187	1.20E-22	107.8	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1666_c0_g1_i1	Q24174	ABRU_DROME	44	109	61	0	131	457	79	187	6.20E-24	113.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1666_c0_g1_i2	Q24174	ABRU_DROME	44	109	61	0	131	457	79	187	5.20E-24	113.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1666_c0_g1_i3	Q24174	ABRU_DROME	44	109	61	0	131	457	79	187	6.10E-24	113.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1666_c0_g1_i4	Q24174	ABRU_DROME	44	109	61	0	131	457	79	187	6.70E-24	113.6	ABRU_DROME	reviewed	Protein abrupt (Protein clueless)	ab clu CG43860	Drosophila melanogaster (Fruit fly)	904	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007298; GO:0007423; GO:0008039; GO:0016198; GO:0016203; GO:0016319; GO:0046872; GO:0048813	"axon choice point recognition [GO:0016198]; border follicle cell migration [GO:0007298]; dendrite morphogenesis [GO:0048813]; muscle attachment [GO:0016203]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; synaptic target recognition [GO:0008039]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9932_c0_g1_i1	Q17A75	FICD_AEDAE	63.4	273	100	0	897	79	184	456	3.60E-99	362.8	FICD_AEDAE	reviewed	Protein adenylyltransferase Fic (EC 2.7.7.n1) (De-AMPylase Fic) (EC 3.1.4.-)	AAEL005383	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	499	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein adenylyltransferase activity [GO:0070733]	GO:0005524; GO:0016021; GO:0016787; GO:0018117; GO:0070733	protein adenylylation [GO:0018117]		NA	NA	NA	NA	NA	NA
TRINITY_DN9932_c0_g1_i2	Q17A75	FICD_AEDAE	62.3	268	101	0	882	79	189	456	8.20E-96	351.7	FICD_AEDAE	reviewed	Protein adenylyltransferase Fic (EC 2.7.7.n1) (De-AMPylase Fic) (EC 3.1.4.-)	AAEL005383	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	499	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein adenylyltransferase activity [GO:0070733]	GO:0005524; GO:0016021; GO:0016787; GO:0018117; GO:0070733	protein adenylylation [GO:0018117]		NA	NA	NA	NA	NA	NA
TRINITY_DN32829_c0_g1_i1	A8MR89	AEL1_ARATH	47.1	102	54	0	3	308	52	153	2.60E-21	102.8	AEL1_ARATH	reviewed	Protein AE7-like 1 (MIP18 family protein At3g50845)	AEL1 At3g50845 F18B3	Arabidopsis thaliana (Mouse-ear cress)	154	iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]			GO:0016226; GO:0106035	iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]		NA	NA	NA	NA	NA	NA
TRINITY_DN31233_c0_g1_i1	O54826	AF10_MOUSE	100	114	0	0	344	3	99	212	1.30E-65	250	AF10_MOUSE	reviewed	Protein AF-10	Mllt10 Af10	Mus musculus (Mouse)	1068	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]	GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN35558_c0_g1_i1	P55197	AF10_HUMAN	75.9	195	37	1	119	703	19	203	3.50E-91	336.7	AF10_HUMAN	reviewed	Protein AF-10 (ALL1-fused gene from chromosome 10 protein)	MLLT10 AF10	Homo sapiens (Human)	1068	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]	GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN16327_c0_g1_i2	A7RRG3	AKTIP_NEMVE	52.9	187	84	2	26	577	42	227	7.10E-57	221.9	AKTIP_NEMVE	reviewed	Protein AKTIP homolog (Fused toes protein homolog)	v1g232160	Nematostella vectensis (Starlet sea anemone)	297							NA	NA	NA	NA	NA	NA
TRINITY_DN33633_c0_g1_i1	B4LFQ9	SHEP_DROVI	73.4	177	47	0	1106	576	237	413	3.00E-69	263.8	SHEP_DROVI	reviewed	Protein alan shepard	shep GJ12205	Drosophila virilis (Fruit fly)	595	ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; response to gravity [GO:0009629]	ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0003723; GO:0009629; GO:1990904	response to gravity [GO:0009629]		NA	NA	NA	NA	NA	NA
TRINITY_DN6016_c0_g1_i2	Q9M2U3	ALPL_ARATH	25.1	179	124	4	1175	657	68	242	4.70E-08	60.8	ALPL_ARATH	reviewed	Protein ALP1-like (EC 3.1.-.-)	At3g55350 T22E16.10	Arabidopsis thaliana (Mouse-ear cress)	406	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3586_c0_g1_i3	Q9M2U3	ALPL_ARATH	37.5	112	55	4	9	305	214	323	1.70E-11	70.1	ALPL_ARATH	reviewed	Protein ALP1-like (EC 3.1.-.-)	At3g55350 T22E16.10	Arabidopsis thaliana (Mouse-ear cress)	406	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i12	Q9M2U3	ALPL_ARATH	31.1	167	101	5	1	459	190	356	2.10E-14	80.9	ALPL_ARATH	reviewed	Protein ALP1-like (EC 3.1.-.-)	At3g55350 T22E16.10	Arabidopsis thaliana (Mouse-ear cress)	406	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i33	Q9M2U3	ALPL_ARATH	31.4	159	95	5	1	435	190	348	1.70E-14	80.5	ALPL_ARATH	reviewed	Protein ALP1-like (EC 3.1.-.-)	At3g55350 T22E16.10	Arabidopsis thaliana (Mouse-ear cress)	406	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15309_c0_g2_i1	P00978	AMBP_BOVIN	50	72	33	1	30	245	228	296	3.40E-15	82	AMBP_BOVIN	reviewed	Protein AMBP [Cleaved into: Alpha-1-microglobulin; Inter-alpha-trypsin inhibitor light chain (ITI-LC) (BI-14) (Bikunin) (Cumulus extracellular matrix-stabilizing factor) (ESF) (HI-30); Trypstatin]	AMBP ITIL	Bos taurus (Bovine)	352	cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; IgA binding [GO:0019862]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]; protein-chromophore linkage [GO:0018298]	cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	heme binding [GO:0020037]; IgA binding [GO:0019862]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0005886; GO:0009986; GO:0018298; GO:0019862; GO:0020037; GO:0042803	protein-chromophore linkage [GO:0018298]		NA	NA	NA	NA	NA	NA
TRINITY_DN30040_c0_g1_i1	Q9VD92	ARCH_DROME	47.5	162	66	3	538	59	12	156	4.60E-35	149.4	ARCH_DROME	reviewed	Protein archease-like	Archease CG6353	Drosophila melanogaster (Fruit fly)	156	"tRNA-splicing ligase complex [GO:0072669]; metal ion binding [GO:0046872]; positive regulation of axon regeneration [GO:0048680]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	tRNA-splicing ligase complex [GO:0072669]	metal ion binding [GO:0046872]	GO:0006388; GO:0046872; GO:0048680; GO:0072669	"positive regulation of axon regeneration [GO:0048680]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30949_c0_g1_i1	Q9VD92	ARCH_DROME	44.6	74	39	2	261	46	83	156	5.90E-10	64.7	ARCH_DROME	reviewed	Protein archease-like	Archease CG6353	Drosophila melanogaster (Fruit fly)	156	"tRNA-splicing ligase complex [GO:0072669]; metal ion binding [GO:0046872]; positive regulation of axon regeneration [GO:0048680]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	tRNA-splicing ligase complex [GO:0072669]	metal ion binding [GO:0046872]	GO:0006388; GO:0046872; GO:0048680; GO:0072669	"positive regulation of axon regeneration [GO:0048680]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		red	red	NA	NA	NA	NA
TRINITY_DN48_c1_g2_i2	Q9VGR2	NDUF7_DROME	47.8	113	57	1	403	71	324	436	1.30E-21	104.8	NDUF7_DROME	reviewed	"Protein arginine methyltransferase NDUFAF7 homolog, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7 homolog) (Protein midA homolog)"	CG17726	Drosophila melanogaster (Fruit fly)	437	mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mitochondrial respiratory chain complex I assembly [GO:0032981]	mitochondrion [GO:0005739]	protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]	GO:0005739; GO:0032981; GO:0035243	mitochondrial respiratory chain complex I assembly [GO:0032981]		blue	blue	NA	NA	NA	NA
TRINITY_DN48_c1_g2_i4	Q08BY0	NDUF7_DANRE	48.8	377	187	5	1249	125	20	392	1.90E-100	367.9	NDUF7_DANRE	reviewed	"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)"	ndufaf7 zgc:153989	Danio rerio (Zebrafish) (Brachydanio rerio)	422	"mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]"	mitochondrion [GO:0005739]	protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]	GO:0005739; GO:0019918; GO:0032981; GO:0035243; GO:0043009	"chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27371_c0_g1_i1	A8IEF3	ANM1_CHLRE	59.1	154	62	1	477	16	46	198	2.00E-48	193.4	ANM1_CHLRE	reviewed	Protein arginine N-methyltransferase 1 (EC 2.1.1.-)	PRMT1 CHLREDRAFT_205758	Chlamydomonas reinhardtii (Chlamydomonas smithii)	345	motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-arginine N-methyltransferase activity [GO:0016274]	motile cilium [GO:0031514]; nucleus [GO:0005634]	protein-arginine N-methyltransferase activity [GO:0016274]	GO:0005634; GO:0016274; GO:0031514			NA	NA	NA	NA	NA	NA
TRINITY_DN9707_c0_g1_i13	Q9JIF0	ANM1_MOUSE	100	302	0	0	1	906	70	371	3.60E-179	628.6	ANM1_MOUSE	reviewed	Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1)	Prmt1 Hrmt1l2 Mrmt1	Mus musculus (Mouse)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; [cytochrome c]-arginine N-methyltransferase activity [GO:0016275]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; snoRNP binding [GO:0030519]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; liver regeneration [GO:0097421]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine omega-N-methylation [GO:0035247]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	[cytochrome c]-arginine N-methyltransferase activity [GO:0016275]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; S-adenosyl-L-methionine binding [GO:1904047]; snoRNP binding [GO:0030519]	GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0008469; GO:0016020; GO:0016274; GO:0016275; GO:0016571; GO:0018216; GO:0019899; GO:0019919; GO:0030519; GO:0031175; GO:0032991; GO:0034709; GO:0035241; GO:0035242; GO:0035247; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046985; GO:0048273; GO:0051260; GO:0097421; GO:1900745; GO:1904047	"histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; liver regeneration [GO:0097421]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine omega-N-methylation [GO:0035247]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9707_c0_g1_i15	Q63009	ANM1_RAT	100	343	0	0	3	1031	11	353	4.80E-204	711.4	ANM1_RAT	reviewed	Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1)	Prmt1 Hrmt1l2	Rattus norvegicus (Rat)	353	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; [cytochrome c]-arginine N-methyltransferase activity [GO:0016275]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snoRNP binding [GO:0030519]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; liver regeneration [GO:0097421]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine omega-N-methylation [GO:0035247]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	[cytochrome c]-arginine N-methyltransferase activity [GO:0016275]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snoRNP binding [GO:0030519]	GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0008469; GO:0008757; GO:0016020; GO:0016274; GO:0016275; GO:0016571; GO:0018216; GO:0019899; GO:0019919; GO:0030519; GO:0031175; GO:0032991; GO:0034709; GO:0035241; GO:0035242; GO:0035247; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046985; GO:0048273; GO:0051260; GO:0097421; GO:1900745; GO:1904047	"histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; liver regeneration [GO:0097421]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine omega-N-methylation [GO:0035247]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9707_c0_g1_i9	Q99873	ANM1_HUMAN	75.6	332	81	0	31	1026	40	371	2.10E-149	530	ANM1_HUMAN	reviewed	Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4)	PRMT1 HMT2 HRMT1L2 IR1B4	Homo sapiens (Human)	371	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0006977; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0016274; GO:0016571; GO:0018216; GO:0019899; GO:0031175; GO:0034709; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046985; GO:0048273; GO:0051260; GO:1900745; GO:1904047	"cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26577_c0_g1_i1	Q8GWT4	ANM15_ARATH	56	75	30	1	2	217	536	610	5.90E-19	94.4	ANM15_ARATH	reviewed	Protein arginine N-methyltransferase 1.5 (AtPMRT15) (AtPMRT5) (EC 2.1.1.319) (Shk1 kinase-binding protein 1 homolog)	PMRT15 PMRT5 SKB1 At4g31120 F6E21.40	Arabidopsis thaliana (Mouse-ear cress)	642	"cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; protein methyltransferase activity [GO:0008276]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; positive regulation of vernalization response [GO:0010220]; regulation of flower development [GO:0009909]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleus [GO:0005634]	histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein methyltransferase activity [GO:0008276]	GO:0005634; GO:0005829; GO:0006355; GO:0008276; GO:0008469; GO:0009909; GO:0010220; GO:0034969; GO:0035242; GO:0043985	"histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; positive regulation of vernalization response [GO:0010220]; regulation of flower development [GO:0009909]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37742_c0_g1_i1	P55345	ANM2_HUMAN	100	147	0	0	443	3	114	260	4.80E-81	301.6	ANM2_HUMAN	reviewed	Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)	PRMT2 HMT1 HRMT1L1	Homo sapiens (Human)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134	"developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1780_c1_g1_i1	P55345	ANM2_HUMAN	40.1	287	162	4	116	970	99	377	5.80E-54	213.4	ANM2_HUMAN	reviewed	Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)	PRMT2 HMT1 HRMT1L1	Homo sapiens (Human)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134	"developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1780_c1_g1_i2	P55345	ANM2_HUMAN	39.5	276	157	4	68	889	110	377	2.80E-50	201.1	ANM2_HUMAN	reviewed	Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)	PRMT2 HMT1 HRMT1L1	Homo sapiens (Human)	433	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134	"developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15248_c0_g1_i1	D9IVE5	ANM2_XENLA	43.5	62	34	1	284	99	23	83	2.60E-07	57	ANM2_XENLA	reviewed	Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)	prmt2	Xenopus laevis (African clawed frog)	432	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of androgen receptor signaling pathway [GO:0060765]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	estrogen receptor binding [GO:0030331]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]	GO:0005634; GO:0005737; GO:0008469; GO:0016571; GO:0030331; GO:0032088; GO:0035242; GO:0043065; GO:0045892; GO:0045893; GO:0048588; GO:0060765; GO:2000134	"developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of androgen receptor signaling pathway [GO:0060765]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39023_c0_g1_i1	O60678	ANM3_HUMAN	100	75	0	0	226	2	313	387	1.70E-37	156	ANM3_HUMAN	reviewed	Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)	PRMT3 HRMT1L3	Homo sapiens (Human)	531	cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; ribosome binding [GO:0043022]; negative regulation of protein ubiquitination [GO:0031397]; protein methylation [GO:0006479]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; ribosome binding [GO:0043022]	GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0016274; GO:0031397; GO:0043022; GO:0046872	negative regulation of protein ubiquitination [GO:0031397]; protein methylation [GO:0006479]		NA	NA	NA	NA	NA	NA
TRINITY_DN40045_c0_g1_i1	Q922H1	ANM3_MOUSE	100	109	0	0	328	2	258	366	3.20E-53	208.8	ANM3_MOUSE	reviewed	Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)	Prmt3 Hrmt1l3	Mus musculus (Mouse)	532	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; modified amino acid binding [GO:0072341]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; modified amino acid binding [GO:0072341]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]	GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0016274; GO:0018216; GO:0019919; GO:0031397; GO:0035242; GO:0043022; GO:0046872; GO:0060997; GO:0072341	"dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4114_c0_g1_i1	O70467	ANM3_RAT	42	502	265	9	90	1526	30	528	5.40E-101	369.8	ANM3_RAT	reviewed	Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)	Prmt3 Hrmt1l3	Rattus norvegicus (Rat)	528	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; modified amino acid binding [GO:0072341]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; modified amino acid binding [GO:0072341]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0008757; GO:0016274; GO:0018216; GO:0019919; GO:0031397; GO:0035242; GO:0043022; GO:0046872; GO:0060997; GO:0072341	"dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30198_c0_g1_i1	O14744	ANM5_HUMAN	57.2	208	83	4	637	23	281	485	3.00E-60	233	ANM5_HUMAN	reviewed	"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]"	PRMT5 HRMT1L5 IBP72 JBP1 SKB1	Homo sapiens (Human)	637	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein heterodimerization activity [GO:0046982]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]	GO:0000387; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4645_c0_g1_i1	O14744	ANM5_HUMAN	65.9	378	127	1	1220	93	260	637	2.40E-146	520	ANM5_HUMAN	reviewed	"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]"	PRMT5 HRMT1L5 IBP72 JBP1 SKB1	Homo sapiens (Human)	637	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein heterodimerization activity [GO:0046982]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]	GO:0000387; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30483_c0_g1_i1	O14744	ANM5_HUMAN	100	113	0	0	341	3	277	389	1.10E-59	230.3	ANM5_HUMAN	reviewed	"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]"	PRMT5 HRMT1L5 IBP72 JBP1 SKB1	Homo sapiens (Human)	637	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein heterodimerization activity [GO:0046982]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]	GO:0000387; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19470_c0_g1_i1	Q8CIG8	ANM5_MOUSE	100	135	0	0	3	407	370	504	1.00E-72	273.9	ANM5_MOUSE	reviewed	Protein arginine N-methyltransferase 5 (Prmt5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)	Prmt5 Jbp1 Skb1	Mus musculus (Mouse)	637	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein methylation [GO:0006479]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000387; GO:0002039; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0006479; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0032991; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0044877; GO:0045596; GO:0046982; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:1904992	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein methylation [GO:0006479]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19470_c0_g2_i1	Q8CIG8	ANM5_MOUSE	99.4	168	1	0	3	506	370	537	4.00E-95	348.6	ANM5_MOUSE	reviewed	Protein arginine N-methyltransferase 5 (Prmt5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)	Prmt5 Jbp1 Skb1	Mus musculus (Mouse)	637	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein methylation [GO:0006479]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000387; GO:0002039; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0006479; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0032991; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0044877; GO:0045596; GO:0046982; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:1904992	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein methylation [GO:0006479]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36225_c0_g1_i1	A7YW45	ANM5_BOVIN	100	117	0	0	353	3	501	617	1.50E-69	263.1	ANM5_BOVIN	reviewed	Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)	PRMT5 SKB1	Bos taurus (Bovine)	637	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; methyl-CpG binding [GO:0008327]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleus [GO:0005634]	E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; methyl-CpG binding [GO:0008327]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; transcription corepressor activity [GO:0003714]	GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1064_c0_g1_i1	A7YW45	ANM5_BOVIN	43	214	116	3	631	2	13	224	7.60E-41	168.7	ANM5_BOVIN	reviewed	Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)	PRMT5 SKB1	Bos taurus (Bovine)	637	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; methyl-CpG binding [GO:0008327]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; transcription corepressor activity [GO:0003714]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleus [GO:0005634]	E-box binding [GO:0070888]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; methyl-CpG binding [GO:0008327]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; transcription corepressor activity [GO:0003714]	GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161	"circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"		blue	blue	NA	NA	NA	NA
TRINITY_DN29013_c0_g1_i1	Q96LA8	ANM6_HUMAN	100	86	0	0	2	259	59	144	2.00E-42	172.6	ANM6_HUMAN	reviewed	Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 6) (Histone-arginine N-methyltransferase PRMT6)	PRMT6 HRMT1L6	Homo sapiens (Human)	375	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; base-excision repair [GO:0006284]; cellular senescence [GO:0090398]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; viral process [GO:0016032]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone-arginine N-methyltransferase activity [GO:0008469]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]	GO:0000122; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0008469; GO:0010821; GO:0016032; GO:0016274; GO:0016571; GO:0019919; GO:0031064; GO:0034970; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045652; GO:0045892; GO:0051572; GO:0070611; GO:0070612; GO:0090398; GO:1901796	"base-excision repair [GO:0006284]; cellular senescence [GO:0090398]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26663_c0_g1_i1	Q6NWG4	ANM6_DANRE	44.1	347	181	7	160	1182	4	343	8.60E-70	265.8	ANM6_DANRE	reviewed	Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6)	prmt6	Danio rerio (Zebrafish) (Brachydanio rerio)	349	"chromatin [GO:0000785]; nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246]"	chromatin [GO:0000785]; nucleus [GO:0005634]	histone-arginine N-methyltransferase activity [GO:0008469]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000785; GO:0005634; GO:0006281; GO:0008469; GO:0008757; GO:0010629; GO:0019919; GO:0034970; GO:0035241; GO:0035242; GO:0035246; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0051572; GO:0070611; GO:0070612	"DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7000_c0_g1_i1	Q6P2P2	ANM9_HUMAN	30.9	392	166	5	1151	21	83	384	1.80E-39	164.9	ANM9_HUMAN	reviewed	Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320)	PRMT9 PRMT10	Homo sapiens (Human)	845	cytoplasm [GO:0005737]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]	protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]	GO:0005737; GO:0006397; GO:0016274; GO:0035241; GO:0035243	mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN7000_c0_g1_i4	Q6P2P2	ANM9_HUMAN	43.3	208	112	2	884	270	83	287	9.50E-36	152.1	ANM9_HUMAN	reviewed	Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320)	PRMT9 PRMT10	Homo sapiens (Human)	845	cytoplasm [GO:0005737]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]	protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]	GO:0005737; GO:0006397; GO:0016274; GO:0035241; GO:0035243	mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN18512_c0_g1_i1	Q7XTS3	AGO3_ORYSJ	46.7	60	30	1	4	177	800	859	5.40E-07	54.7	AGO3_ORYSJ	reviewed	Protein argonaute 3 (OsAGO3)	AGO3 Os04g0615800 LOC_Os04g52550 OSJNBa0008M17.12	Oryza sativa subsp. japonica (Rice)	1109	nucleic acid binding [GO:0003676]; gene silencing by RNA [GO:0031047]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0031047	gene silencing by RNA [GO:0031047]		NA	NA	NA	NA	NA	NA
TRINITY_DN30123_c0_g1_i1	Q9UL18	AGO1_HUMAN	90	90	9	0	290	21	753	842	1.30E-42	173.3	AGO1_HUMAN	reviewed	Protein argonaute-1 (Argonaute1) (hAgo1) (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1) (eIF-2C 1) (eIF2C 1) (Putative RNA-binding protein Q99)	AGO1 EIF2C1	Homo sapiens (Human)	857	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]	GO:0000932; GO:0000956; GO:0000978; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0007223; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016442; GO:0016525; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0045652; GO:0045944; GO:0060964; GO:0070578; GO:0090502; GO:1901224; GO:1990904	"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30123_c0_g1_i1	Q9UL18	AGO1_HUMAN	100	20	0	0	60	1	830	849	9.10E-04	44.3	AGO1_HUMAN	reviewed	Protein argonaute-1 (Argonaute1) (hAgo1) (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1) (eIF-2C 1) (eIF2C 1) (Putative RNA-binding protein Q99)	AGO1 EIF2C1	Homo sapiens (Human)	857	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]	GO:0000932; GO:0000956; GO:0000978; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0007223; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016442; GO:0016525; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0045652; GO:0045944; GO:0060964; GO:0070578; GO:0090502; GO:1901224; GO:1990904	"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10238_c0_g1_i1	Q9UL18	AGO1_HUMAN	52.6	95	44	1	82	363	6	100	5.40E-25	115.2	AGO1_HUMAN	reviewed	Protein argonaute-1 (Argonaute1) (hAgo1) (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1) (eIF-2C 1) (eIF2C 1) (Putative RNA-binding protein Q99)	AGO1 EIF2C1	Homo sapiens (Human)	857	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]	GO:0000932; GO:0000956; GO:0000978; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0007223; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016442; GO:0016525; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0045652; GO:0045944; GO:0060964; GO:0070578; GO:0090502; GO:1901224; GO:1990904	"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN797_c0_g1_i5	Q9UL18	AGO1_HUMAN	74.8	305	71	1	921	25	191	495	4.90E-136	485.3	AGO1_HUMAN	reviewed	Protein argonaute-1 (Argonaute1) (hAgo1) (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1) (eIF-2C 1) (eIF2C 1) (Putative RNA-binding protein Q99)	AGO1 EIF2C1	Homo sapiens (Human)	857	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]	GO:0000932; GO:0000956; GO:0000978; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0007223; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016442; GO:0016525; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0045652; GO:0045944; GO:0060964; GO:0070578; GO:0090502; GO:1901224; GO:1990904	"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24534_c0_g1_i1	Q6QME8	AGO2_BOVIN	100	83	0	0	249	1	720	802	7.00E-45	180.6	AGO2_BOVIN	reviewed	Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)	AGO2 EIF2C2	Bos taurus (Bovine)	860	"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"	GO:0000340; GO:0000932; GO:0005634; GO:0005844; GO:0005845; GO:0006355; GO:0016442; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0070551; GO:0070578; GO:1990904	"miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21314_c0_g1_i2	Q6DCX2	AGO2_XENLA	36.5	340	202	7	997	2	156	489	6.70E-57	222.6	AGO2_XENLA	reviewed	Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)	ago2 eif2c2	Xenopus laevis (African clawed frog)	862	"mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"	GO:0000340; GO:0000932; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153	"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN797_c0_g1_i1	Q6DCX2	AGO2_XENLA	77	405	66	1	1245	31	485	862	1.80E-181	636.7	AGO2_XENLA	reviewed	Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)	ago2 eif2c2	Xenopus laevis (African clawed frog)	862	"mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"	GO:0000340; GO:0000932; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153	"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN797_c0_g1_i2	Q6DCX2	AGO2_XENLA	76.5	694	136	1	2112	31	196	862	0	1096.6	AGO2_XENLA	reviewed	Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)	ago2 eif2c2	Xenopus laevis (African clawed frog)	862	"mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"	GO:0000340; GO:0000932; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153	"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN797_c0_g1_i3	Q6DCX2	AGO2_XENLA	79.4	97	20	0	295	5	490	586	2.80E-40	165.6	AGO2_XENLA	reviewed	Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)	ago2 eif2c2	Xenopus laevis (African clawed frog)	862	"mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"	GO:0000340; GO:0000932; GO:0005845; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:1900153	"gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN797_c0_g1_i4	Q6QME8	AGO2_BOVIN	82.1	224	40	0	702	31	637	860	2.10E-106	386.7	AGO2_BOVIN	reviewed	Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)	AGO2 EIF2C2	Bos taurus (Bovine)	860	"mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]; miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA 7-methylguanosine cap binding [GO:0000340]; siRNA binding [GO:0035197]"	GO:0000340; GO:0000932; GO:0005634; GO:0005844; GO:0005845; GO:0006355; GO:0016442; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0070551; GO:0070578; GO:1990904	"miRNA mediated inhibition of translation [GO:0035278]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of translational initiation [GO:0045947]; pre-miRNA processing [GO:0031054]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9167_c0_g1_i1	Q9UKV8	AGO2_HUMAN	53.1	337	151	4	1117	119	515	848	1.40E-98	361.3	AGO2_HUMAN	reviewed	Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)	AGO2 EIF2C2	Homo sapiens (Human)	859	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]"	GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904	"gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4812_c0_g1_i4	Q9UKV8	AGO2_HUMAN	42.3	854	449	20	47	2533	12	846	2.00E-182	641	AGO2_HUMAN	reviewed	Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)	AGO2 EIF2C2	Homo sapiens (Human)	859	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]"	GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904	"gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28516_c0_g1_i1	Q9UKV8	AGO2_HUMAN	100	123	0	0	370	2	497	619	2.40E-65	249.2	AGO2_HUMAN	reviewed	Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)	AGO2 EIF2C2	Homo sapiens (Human)	859	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]"	GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904	"gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4812_c0_g1_i7	Q6T5B7	AGO3_BOVIN	52.1	284	133	3	7	849	471	754	1.60E-76	287.7	AGO3_BOVIN	reviewed	Protein argonaute-3 (Argonaute3) (EC 3.1.26.n2) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3)	AGO3 EIF2C3	Bos taurus (Bovine)	861	"P-body [GO:0000932]; RISC complex [GO:0016442]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; regulation of stem cell proliferation [GO:0072091]"	P-body [GO:0000932]; RISC complex [GO:0016442]	"endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]"	GO:0000932; GO:0004521; GO:0006402; GO:0016442; GO:0035198; GO:0035278; GO:0046872; GO:0072091; GO:0090624	miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; regulation of stem cell proliferation [GO:0072091]		NA	NA	NA	NA	NA	NA
TRINITY_DN4812_c0_g1_i1	Q9H9G7	AGO3_HUMAN	55.2	353	155	3	41	1090	468	820	1.40E-106	387.9	AGO3_HUMAN	reviewed	Protein argonaute-3 (Argonaute3) (hAgo3) (EC 3.1.26.n2) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3)	AGO3 EIF2C3	Homo sapiens (Human)	860	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of stem cell proliferation [GO:0072091]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"	GO:0000794; GO:0000932; GO:0003723; GO:0003725; GO:0003727; GO:0004521; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0007223; GO:0010501; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0031054; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0036464; GO:0045652; GO:0046872; GO:0070578; GO:0072091; GO:0090624; GO:1901224	"miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of stem cell proliferation [GO:0072091]; RNA secondary structure unwinding [GO:0010501]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25660_c0_g1_i1	Q5ZMW0	AGO4_CHICK	100	130	0	0	3	392	140	269	1.40E-71	270	AGO4_CHICK	reviewed	Protein argonaute-4 (Argonaute4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4)	AGO4 EIF2C4 RCJMB04_1a17	Gallus gallus (Chicken)	794	P-body [GO:0000932]; RISC complex [GO:0016442]; miRNA binding [GO:0035198]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]	P-body [GO:0000932]; RISC complex [GO:0016442]	miRNA binding [GO:0035198]	GO:0000932; GO:0006402; GO:0016442; GO:0035198; GO:0035278	miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]		NA	NA	NA	NA	NA	NA
TRINITY_DN25949_c0_g1_i1	Q5ZMW0	AGO4_CHICK	97.1	69	2	0	207	1	599	667	2.70E-34	145.2	AGO4_CHICK	reviewed	Protein argonaute-4 (Argonaute4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4)	AGO4 EIF2C4 RCJMB04_1a17	Gallus gallus (Chicken)	794	P-body [GO:0000932]; RISC complex [GO:0016442]; miRNA binding [GO:0035198]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]	P-body [GO:0000932]; RISC complex [GO:0016442]	miRNA binding [GO:0035198]	GO:0000932; GO:0006402; GO:0016442; GO:0035198; GO:0035278	miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]		NA	NA	NA	NA	NA	NA
TRINITY_DN12695_c0_g1_i1	Q5R6Z9	DCR1C_PONAB	40	400	212	10	66	1250	1	377	9.80E-74	279.3	DCR1C_PONAB	reviewed	Protein artemis (EC 3.1.-.-) (DNA cross-link repair 1C protein)	DCLRE1C	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	692	nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; adaptive immune response [GO:0002250]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]	GO:0002250; GO:0004519; GO:0004527; GO:0005634; GO:0006281; GO:0006310; GO:0070419	adaptive immune response [GO:0002250]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN13175_c0_g1_i3	Q9VPF0	ATK_DROME	24.7	636	422	9	2778	964	260	869	2.00E-42	176	ATK_DROME	reviewed	Protein artichoke	atk CG5195	Drosophila melanogaster (Fruit fly)	1535	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]		GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]		NA	NA	NA	NA	NA	NA
TRINITY_DN13175_c0_g1_i5	Q9VPF0	ATK_DROME	32.7	113	76	0	389	51	405	517	4.50E-07	55.8	ATK_DROME	reviewed	Protein artichoke	atk CG5195	Drosophila melanogaster (Fruit fly)	1535	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]		GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]		brown	brown	NA	NA	NA	NA
TRINITY_DN21639_c0_g1_i1	Q9VPF0	ATK_DROME	24.7	223	156	6	239	898	574	787	2.60E-05	51.2	ATK_DROME	reviewed	Protein artichoke	atk CG5195	Drosophila melanogaster (Fruit fly)	1535	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]		GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]		NA	NA	NA	NA	NA	NA
TRINITY_DN38745_c0_g1_i1	Q9VPF0	ATK_DROME	30.5	167	108	4	35	523	480	642	7.90E-12	72	ATK_DROME	reviewed	Protein artichoke	atk CG5195	Drosophila melanogaster (Fruit fly)	1535	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]		GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]		NA	NA	NA	NA	NA	NA
TRINITY_DN2524_c0_g1_i1	Q5MK24	ARV1_ARATH	36.1	122	72	2	124	477	2	121	4.80E-11	70.1	ARV1_ARATH	reviewed	Protein ARV 1 (AtArv1p)	ARV1 At1g01020 T25K16.2	Arabidopsis thaliana (Mouse-ear cress)	245	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular sterol transport [GO:0032366]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005794; GO:0006665; GO:0016021; GO:0016125; GO:0032366; GO:0032541; GO:0097036	intracellular sterol transport [GO:0032366]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]		NA	NA	NA	NA	NA	NA
TRINITY_DN2524_c0_g1_i2	Q5MK24	ARV1_ARATH	36.1	122	69	2	124	468	2	121	8.10E-11	69.3	ARV1_ARATH	reviewed	Protein ARV 1 (AtArv1p)	ARV1 At1g01020 T25K16.2	Arabidopsis thaliana (Mouse-ear cress)	245	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular sterol transport [GO:0032366]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005794; GO:0006665; GO:0016021; GO:0016125; GO:0032366; GO:0032541; GO:0097036	intracellular sterol transport [GO:0032366]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]		NA	NA	NA	NA	NA	NA
TRINITY_DN21913_c0_g1_i1	Q96CP6	ASTRA_HUMAN	100	94	0	0	2	283	78	171	4.10E-49	194.9	ASTRA_HUMAN	reviewed	Protein Aster-A (GRAM domain-containing protein 1A)	GRAMD1A KIAA1533	Homo sapiens (Human)	724	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]	GO:0005776; GO:0005829; GO:0005886; GO:0006914; GO:0015485; GO:0016021; GO:0031227; GO:0031234; GO:0031410; GO:0044232; GO:0071397; GO:0120020; GO:0140268	autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]		NA	NA	NA	NA	NA	NA
TRINITY_DN21913_c0_g1_i2	Q96CP6	ASTRA_HUMAN	100	94	0	0	2	283	78	171	4.10E-49	194.9	ASTRA_HUMAN	reviewed	Protein Aster-A (GRAM domain-containing protein 1A)	GRAMD1A KIAA1533	Homo sapiens (Human)	724	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]	GO:0005776; GO:0005829; GO:0005886; GO:0006914; GO:0015485; GO:0016021; GO:0031227; GO:0031234; GO:0031410; GO:0044232; GO:0071397; GO:0120020; GO:0140268	autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]		NA	NA	NA	NA	NA	NA
TRINITY_DN1724_c0_g1_i1	Q80TI0	ASTRB_MOUSE	29.6	358	220	9	688	1692	373	721	7.30E-36	153.7	ASTRB_MOUSE	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	Gramd1b Kiaa1201	Mus musculus (Mouse)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN1724_c0_g1_i2	Q80TI0	ASTRB_MOUSE	29.6	358	220	9	359	1363	373	721	6.00E-36	153.7	ASTRB_MOUSE	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	Gramd1b Kiaa1201	Mus musculus (Mouse)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN1724_c0_g1_i3	Q80TI0	ASTRB_MOUSE	29.6	358	220	9	16	1020	373	721	3.70E-36	154.1	ASTRB_MOUSE	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	Gramd1b Kiaa1201	Mus musculus (Mouse)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN6130_c0_g1_i1	Q3KR37	ASTRB_HUMAN	49.5	218	100	2	657	4	26	233	6.40E-56	219.2	ASTRB_HUMAN	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	GRAMD1B KIAA1201 UNQ3032/PRO9834	Homo sapiens (Human)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN6130_c0_g1_i2	Q3KR37	ASTRB_HUMAN	48.5	198	92	2	656	63	26	213	2.20E-48	194.1	ASTRB_HUMAN	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	GRAMD1B KIAA1201 UNQ3032/PRO9834	Homo sapiens (Human)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN24738_c0_g1_i1	Q3KR37	ASTRB_HUMAN	100	151	0	0	1	453	70	220	1.10E-85	317	ASTRB_HUMAN	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	GRAMD1B KIAA1201 UNQ3032/PRO9834	Homo sapiens (Human)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN6464_c0_g1_i1	Q3KR37	ASTRB_HUMAN	34.7	173	111	2	317	832	373	544	1.00E-24	115.5	ASTRB_HUMAN	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	GRAMD1B KIAA1201 UNQ3032/PRO9834	Homo sapiens (Human)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN6464_c0_g1_i2	Q3KR37	ASTRB_HUMAN	34.7	173	111	2	305	820	373	544	9.90E-25	115.5	ASTRB_HUMAN	reviewed	Protein Aster-B (GRAM domain-containing protein 1B)	GRAMD1B KIAA1201 UNQ3032/PRO9834	Homo sapiens (Human)	738	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]		NA	NA	NA	NA	NA	NA
TRINITY_DN1367_c0_g1_i1	Q9U516	ASTER_MANSE	72.4	105	27	1	332	18	4	106	4.00E-40	165.6	ASTER_MANSE	reviewed	Protein Asterix		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	108	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN36977_c0_g1_i1	Q9Y284	ASTER_HUMAN	100	86	0	0	2	259	2	87	1.30E-44	179.9	ASTER_HUMAN	reviewed	Protein Asterix (WD repeat domain 83 opposite strand) (WDR83 opposite strand)	WDR83OS C19orf56 CGI-140 My006 PTD008	Homo sapiens (Human)	106	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN625_c0_g1_i2	Q9VPW1	ASTE_DROME	33	349	178	7	94	1008	1	337	2.80E-43	177.9	ASTE_DROME	reviewed	Protein asteroid	ast CG4426	Drosophila melanogaster (Fruit fly)	854	compound eye morphogenesis [GO:0001745]; compound eye photoreceptor fate commitment [GO:0001752]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; larval somatic muscle development [GO:0007526]			GO:0001745; GO:0001752; GO:0007476; GO:0007526; GO:0008586	compound eye morphogenesis [GO:0001745]; compound eye photoreceptor fate commitment [GO:0001752]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; larval somatic muscle development [GO:0007526]		NA	NA	NA	NA	NA	NA
TRINITY_DN625_c0_g1_i3	Q9VPW1	ASTE_DROME	29.8	282	142	7	92	805	68	337	5.90E-26	120.2	ASTE_DROME	reviewed	Protein asteroid	ast CG4426	Drosophila melanogaster (Fruit fly)	854	compound eye morphogenesis [GO:0001745]; compound eye photoreceptor fate commitment [GO:0001752]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; larval somatic muscle development [GO:0007526]			GO:0001745; GO:0001752; GO:0007476; GO:0007526; GO:0008586	compound eye morphogenesis [GO:0001745]; compound eye photoreceptor fate commitment [GO:0001752]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; larval somatic muscle development [GO:0007526]		NA	NA	NA	NA	NA	NA
TRINITY_DN6916_c0_g1_i1	Q8NAA4	A16L2_HUMAN	47.3	93	48	1	2	277	526	618	6.10E-20	98.2	A16L2_HUMAN	reviewed	Protein Atg16l2 (APG16-like 2) (Autophagy-related protein 16-2) (WD repeat-containing protein 80)	ATG16L2 WDR80	Homo sapiens (Human)	619	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0000045; GO:0000421; GO:0005654; GO:0005829; GO:0015031; GO:0039689	autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4208_c0_g1_i3	Q8ML92	AVE_DROME	51.6	91	43	1	263	535	12	101	3.20E-20	100.1	AVE_DROME	reviewed	Protein aveugle	ave CG30476	Drosophila melanogaster (Fruit fly)	106	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; scaffold protein binding [GO:0097110]; circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]	scaffold protein binding [GO:0097110]	GO:0001751; GO:0001754; GO:0005737; GO:0005829; GO:0007169; GO:0007173; GO:0007601; GO:0007623; GO:0009898; GO:0042675; GO:0046579; GO:0070374; GO:0097110	circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN4208_c0_g1_i6	Q8ML92	AVE_DROME	54	87	39	1	200	460	16	101	2.90E-20	100.1	AVE_DROME	reviewed	Protein aveugle	ave CG30476	Drosophila melanogaster (Fruit fly)	106	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; scaffold protein binding [GO:0097110]; circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]	scaffold protein binding [GO:0097110]	GO:0001751; GO:0001754; GO:0005737; GO:0005829; GO:0007169; GO:0007173; GO:0007601; GO:0007623; GO:0009898; GO:0042675; GO:0046579; GO:0070374; GO:0097110	circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN4208_c0_g1_i7	Q8ML92	AVE_DROME	51.6	91	43	1	222	494	12	101	3.00E-20	100.1	AVE_DROME	reviewed	Protein aveugle	ave CG30476	Drosophila melanogaster (Fruit fly)	106	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; scaffold protein binding [GO:0097110]; circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]	scaffold protein binding [GO:0097110]	GO:0001751; GO:0001754; GO:0005737; GO:0005829; GO:0007169; GO:0007173; GO:0007601; GO:0007623; GO:0009898; GO:0042675; GO:0046579; GO:0070374; GO:0097110	circadian rhythm [GO:0007623]; compound eye cone cell differentiation [GO:0042675]; compound eye photoreceptor cell differentiation [GO:0001751]; epidermal growth factor receptor signaling pathway [GO:0007173]; eye photoreceptor cell differentiation [GO:0001754]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN591_c0_g1_i1	Q502P7	BANP_DANRE	52.9	153	68	1	1753	1295	174	322	4.70E-41	171	BANP_DANRE	reviewed	Protein BANP	banp zgc:111954	Danio rerio (Zebrafish) (Brachydanio rerio)	508	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN591_c0_g1_i2	Q502P7	BANP_DANRE	52.9	153	68	1	1753	1295	174	322	4.70E-41	171	BANP_DANRE	reviewed	Protein BANP	banp zgc:111954	Danio rerio (Zebrafish) (Brachydanio rerio)	508	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]		blue	blue	NA	NA	NA	NA
TRINITY_DN591_c0_g1_i3	Q502P7	BANP_DANRE	52.9	153	68	1	1166	708	174	322	3.40E-41	171	BANP_DANRE	reviewed	Protein BANP	banp zgc:111954	Danio rerio (Zebrafish) (Brachydanio rerio)	508	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN591_c0_g1_i5	Q502P7	BANP_DANRE	52.9	153	68	1	1454	996	174	322	4.00E-41	171	BANP_DANRE	reviewed	Protein BANP	banp zgc:111954	Danio rerio (Zebrafish) (Brachydanio rerio)	508	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN591_c0_g1_i6	Q502P7	BANP_DANRE	52.9	153	68	1	1915	1457	174	322	5.10E-41	171	BANP_DANRE	reviewed	Protein BANP	banp zgc:111954	Danio rerio (Zebrafish) (Brachydanio rerio)	508	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN591_c0_g1_i8	Q502P7	BANP_DANRE	52.9	153	68	1	3339	2881	174	322	8.20E-41	171	BANP_DANRE	reviewed	Protein BANP	banp zgc:111954	Danio rerio (Zebrafish) (Brachydanio rerio)	508	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006325; GO:0007049; GO:0034504; GO:0042177	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]		NA	NA	NA	NA	NA	NA
TRINITY_DN32760_c0_g1_i1	M9NDE3	BARK_DROME	42.3	300	152	4	51	890	1705	2003	6.60E-64	245.7	BARK_DROME	reviewed	Protein bark beetle (Protein anakonda)	bark aka CG3921	Drosophila melanogaster (Fruit fly)	3123	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]"	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]	carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005886; GO:0005912; GO:0005918; GO:0005923; GO:0016021; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274	"cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32760_c0_g1_i3	M9NDE3	BARK_DROME	43.4	937	483	12	51	2780	1705	2621	5.10E-229	795.8	BARK_DROME	reviewed	Protein bark beetle (Protein anakonda)	bark aka CG3921	Drosophila melanogaster (Fruit fly)	3123	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]"	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]	carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005886; GO:0005912; GO:0005918; GO:0005923; GO:0016021; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274	"cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3244_c0_g1_i2	Q9VFR0	BCCIP_DROME	36.7	259	157	3	851	81	41	294	5.30E-46	186.4	BCCIP_DROME	reviewed	Protein BCCIP homolog	CG9286	Drosophila melanogaster (Fruit fly)	297	centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]	centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]	kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]	GO:0000079; GO:0000132; GO:0005813; GO:0006974; GO:0007052; GO:0015631; GO:0019207; GO:0019887; GO:0034453; GO:0045859; GO:0090307; GO:0097431	cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]		blue	blue	NA	NA	NA	NA
TRINITY_DN3244_c0_g1_i6	Q9VFR0	BCCIP_DROME	36.8	258	156	3	848	81	42	294	2.70E-46	187.2	BCCIP_DROME	reviewed	Protein BCCIP homolog	CG9286	Drosophila melanogaster (Fruit fly)	297	centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]	centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]	kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]	GO:0000079; GO:0000132; GO:0005813; GO:0006974; GO:0007052; GO:0015631; GO:0019207; GO:0019887; GO:0034453; GO:0045859; GO:0090307; GO:0097431	cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]		NA	NA	NA	NA	NA	NA
TRINITY_DN10224_c0_g1_i1	P16568	BICD_DROME	34	259	140	5	740	3	375	615	3.00E-27	123.6	BICD_DROME	reviewed	Protein bicaudal D	BicD CG6605	Drosophila melanogaster (Fruit fly)	782	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]; cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]	clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007293; GO:0007294; GO:0007309; GO:0007312; GO:0008093; GO:0008103; GO:0008298; GO:0017137; GO:0030100; GO:0032050; GO:0033365; GO:0034452; GO:0048477; GO:0048488; GO:0050658; GO:0051028; GO:0070507; GO:0070727; GO:0070840; GO:0072393; GO:0098793; GO:2000302; GO:2000370	cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN10224_c0_g1_i2	P16568	BICD_DROME	40.7	150	80	2	522	94	375	522	9.70E-20	98.2	BICD_DROME	reviewed	Protein bicaudal D	BicD CG6605	Drosophila melanogaster (Fruit fly)	782	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]; cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]	clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007293; GO:0007294; GO:0007309; GO:0007312; GO:0008093; GO:0008103; GO:0008298; GO:0017137; GO:0030100; GO:0032050; GO:0033365; GO:0034452; GO:0048477; GO:0048488; GO:0050658; GO:0051028; GO:0070507; GO:0070727; GO:0070840; GO:0072393; GO:0098793; GO:2000302; GO:2000370	cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN5791_c0_g1_i1	P16568	BICD_DROME	56.3	261	114	0	783	1	38	298	1.60E-59	231.1	BICD_DROME	reviewed	Protein bicaudal D	BicD CG6605	Drosophila melanogaster (Fruit fly)	782	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]; cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]	clathrin heavy chain binding [GO:0032050]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007293; GO:0007294; GO:0007309; GO:0007312; GO:0008093; GO:0008103; GO:0008298; GO:0017137; GO:0030100; GO:0032050; GO:0033365; GO:0034452; GO:0048477; GO:0048488; GO:0050658; GO:0051028; GO:0070507; GO:0070727; GO:0070840; GO:0072393; GO:0098793; GO:2000302; GO:2000370	cellular macromolecule localization [GO:0070727]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived oocyte fate determination [GO:0007294]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; mRNA transport [GO:0051028]; oocyte axis specification [GO:0007309]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein localization to organelle [GO:0033365]; regulation of endocytosis [GO:0030100]; regulation of microtubule cytoskeleton organization [GO:0070507]; RNA transport [GO:0050658]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN29680_c1_g1_i1	Q24207	BOULE_DROME	51.4	142	53	2	18	437	24	151	2.50E-31	136.7	BOULE_DROME	reviewed	Protein boule	bol CG4760	Drosophila melanogaster (Fruit fly)	228	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; multicellular organism development [GO:0007275]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]	GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0007275; GO:0007283; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935	3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; multicellular organism development [GO:0007275]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN37001_c0_g1_i1	Q9VQU9	BOWEL_DROME	80.7	83	16	0	130	378	220	302	1.10E-36	154.1	BOWEL_DROME	reviewed	Protein bowel (Brother of odd with entrails limited)	bowl CG10021	Drosophila melanogaster (Fruit fly)	744	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007362; GO:0007366; GO:0007442; GO:0007480; GO:0009880; GO:0016348; GO:0035220; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7281_c0_g1_i1	Q9VQU9	BOWEL_DROME	86.5	155	21	0	442	906	221	375	1.70E-82	307.8	BOWEL_DROME	reviewed	Protein bowel (Brother of odd with entrails limited)	bowl CG10021	Drosophila melanogaster (Fruit fly)	744	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007362; GO:0007366; GO:0007442; GO:0007480; GO:0009880; GO:0016348; GO:0035220; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7281_c0_g1_i2	Q9VQU9	BOWEL_DROME	86.5	155	21	0	352	816	221	375	1.60E-82	307.8	BOWEL_DROME	reviewed	Protein bowel (Brother of odd with entrails limited)	bowl CG10021	Drosophila melanogaster (Fruit fly)	744	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007362; GO:0007366; GO:0007442; GO:0007480; GO:0009880; GO:0016348; GO:0035220; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; periodic partitioning by pair rule gene [GO:0007366]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; terminal region determination [GO:0007362]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39043_c0_g1_i1	Q9W0K7	BAB1_DROME	51.2	121	59	0	84	446	98	218	1.50E-32	141	BAB1_DROME	reviewed	Protein bric-a-brac 1	bab1 bab CG9097	Drosophila melanogaster (Fruit fly)	977	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092	"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35535_c0_g1_i1	Q9W0K7	BAB1_DROME	37.7	106	66	0	3	320	106	211	4.50E-16	85.5	BAB1_DROME	reviewed	Protein bric-a-brac 1	bab1 bab CG9097	Drosophila melanogaster (Fruit fly)	977	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092	"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6575_c0_g1_i1	Q9W0K7	BAB1_DROME	38	108	67	0	130	453	104	211	2.10E-19	98.6	BAB1_DROME	reviewed	Protein bric-a-brac 1	bab1 bab CG9097	Drosophila melanogaster (Fruit fly)	977	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092	"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7783_c0_g1_i1	Q9W0K7	BAB1_DROME	49.5	97	48	1	52	342	116	211	1.70E-21	104	BAB1_DROME	reviewed	Protein bric-a-brac 1	bab1 bab CG9097	Drosophila melanogaster (Fruit fly)	977	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092	"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37985_c0_g1_i1	Q9W0K7	BAB1_DROME	57.3	117	50	0	2	352	104	220	5.10E-36	151.8	BAB1_DROME	reviewed	Protein bric-a-brac 1	bab1 bab CG9097	Drosophila melanogaster (Fruit fly)	977	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0007548; GO:0046660; GO:0048070; GO:0048071; GO:0048086; GO:0048092	"eye-antennal disc morphogenesis [GO:0007455]; female sex differentiation [GO:0046660]; leg disc morphogenesis [GO:0007478]; negative regulation of developmental pigmentation [GO:0048086]; negative regulation of male pigmentation [GO:0048092]; regulation of developmental pigmentation [GO:0048070]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8136_c0_g1_i1	Q9W0K4	BAB2_DROME	66.7	114	36	2	392	51	198	309	4.70E-40	166	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26718_c0_g1_i1	Q9W0K4	BAB2_DROME	50.4	113	56	0	394	56	196	308	2.70E-31	136.3	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN175_c0_g1_i1	Q9W0K4	BAB2_DROME	35.9	142	91	0	12	437	166	307	3.50E-23	110.9	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	1	NA	NA	NA
TRINITY_DN147_c3_g1_i1	Q9W0K4	BAB2_DROME	52.3	128	61	0	578	195	181	308	1.20E-35	151.4	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN175_c0_g1_i3	Q9W0K4	BAB2_DROME	35.9	142	91	0	12	437	166	307	3.90E-23	110.9	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN175_c0_g1_i4	Q9W0K4	BAB2_DROME	35.9	142	91	0	12	437	166	307	4.30E-23	110.9	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN175_c0_g1_i5	Q9W0K4	BAB2_DROME	35.9	142	91	0	12	437	166	307	4.70E-23	110.9	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14864_c0_g1_i3	Q9W0K4	BAB2_DROME	51.8	114	55	0	1575	1234	197	310	1.50E-29	132.5	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1560_c0_g1_i1	Q9W0K4	BAB2_DROME	44.9	156	72	4	113	571	163	307	7.90E-24	113.2	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1560_c0_g1_i2	Q9W0K4	BAB2_DROME	44.9	156	72	4	865	1323	163	307	1.60E-23	112.8	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10169_c0_g1_i1	Q9W0K4	BAB2_DROME	57.3	96	41	0	306	19	213	308	7.30E-28	124.4	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14009_c0_g1_i1	Q9W0K4	BAB2_DROME	49.2	120	60	1	426	67	193	311	1.20E-29	131	BAB2_DROME	reviewed	Protein bric-a-brac 2	bab2 BtbII CG9102	Drosophila melanogaster (Fruit fly)	1067	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]	GO:0003680; GO:0003700; GO:0005634; GO:0005700; GO:0006355; GO:0006357; GO:0007455; GO:0007478; GO:0061040; GO:2000736	"eye-antennal disc morphogenesis [GO:0007455]; female gonad morphogenesis [GO:0061040]; leg disc morphogenesis [GO:0007478]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16599_c0_g1_i1	Q91VR8	BRK1_MOUSE	100	74	0	0	1	222	2	75	1.20E-34	146.7	BRK1_MOUSE	reviewed	Protein BRICK1 (BRK1)	Brk1	Mus musculus (Mouse)	75	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]	GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0031334; GO:0042802; GO:0044877; GO:0048365; GO:0048870; GO:2000601	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]		NA	NA	NA	NA	NA	NA
TRINITY_DN16599_c0_g1_i2	Q91VR8	BRK1_MOUSE	95.1	41	2	0	1	123	2	42	4.60E-15	82	BRK1_MOUSE	reviewed	Protein BRICK1 (BRK1)	Brk1	Mus musculus (Mouse)	75	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]	GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0031334; GO:0042802; GO:0044877; GO:0048365; GO:0048870; GO:2000601	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]		NA	NA	NA	NA	NA	NA
TRINITY_DN16599_c0_g1_i2	Q91VR8	BRK1_MOUSE	97.2	36	1	0	180	287	40	75	3.10E-11	69.3	BRK1_MOUSE	reviewed	Protein BRICK1 (BRK1)	Brk1	Mus musculus (Mouse)	75	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]	GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0031334; GO:0042802; GO:0044877; GO:0048365; GO:0048870; GO:2000601	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]		NA	NA	NA	NA	NA	NA
TRINITY_DN16599_c0_g1_i3	Q91VR8	BRK1_MOUSE	100	74	0	0	1	222	2	75	9.30E-35	147.1	BRK1_MOUSE	reviewed	Protein BRICK1 (BRK1)	Brk1	Mus musculus (Mouse)	75	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]	GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0031334; GO:0042802; GO:0044877; GO:0048365; GO:0048870; GO:2000601	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein-containing complex assembly [GO:0031334]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]		NA	NA	NA	NA	NA	NA
TRINITY_DN3197_c0_g1_i2	Q9VIL0	BRUN_DROME	33	1084	486	17	140	3145	1	926	7.20E-163	576.2	BRUN_DROME	reviewed	Protein brunelleschi (NIK- and IKBKB-binding protein)	brun bru CG2478	Drosophila melanogaster (Fruit fly)	1320	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]		GO:0000212; GO:0000916; GO:0005737; GO:0005794; GO:0005802; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0030008; GO:0036063; GO:0043087; GO:0048137; GO:0048193; GO:1990071	actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]		NA	NA	NA	NA	NA	NA
TRINITY_DN3197_c0_g1_i4	Q9VIL0	BRUN_DROME	33	724	270	7	140	2089	1	583	2.70E-108	394.4	BRUN_DROME	reviewed	Protein brunelleschi (NIK- and IKBKB-binding protein)	brun bru CG2478	Drosophila melanogaster (Fruit fly)	1320	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]		GO:0000212; GO:0000916; GO:0005737; GO:0005794; GO:0005802; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0030008; GO:0036063; GO:0043087; GO:0048137; GO:0048193; GO:1990071	actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]		NA	NA	NA	NA	NA	NA
TRINITY_DN3197_c0_g1_i7	Q9VIL0	BRUN_DROME	41.3	109	61	2	140	460	1	108	9.90E-20	98.2	BRUN_DROME	reviewed	Protein brunelleschi (NIK- and IKBKB-binding protein)	brun bru CG2478	Drosophila melanogaster (Fruit fly)	1320	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]		GO:0000212; GO:0000916; GO:0005737; GO:0005794; GO:0005802; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0030008; GO:0036063; GO:0043087; GO:0048137; GO:0048193; GO:1990071	actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]		NA	NA	NA	NA	NA	NA
TRINITY_DN10747_c0_g1_i1	Q9VIL0	BRUN_DROME	35.1	333	179	4	990	103	987	1319	2.20E-50	201.1	BRUN_DROME	reviewed	Protein brunelleschi (NIK- and IKBKB-binding protein)	brun bru CG2478	Drosophila melanogaster (Fruit fly)	1320	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]	acroblast [GO:0036063]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]		GO:0000212; GO:0000916; GO:0005737; GO:0005794; GO:0005802; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0030008; GO:0036063; GO:0043087; GO:0048137; GO:0048193; GO:1990071	actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]		NA	NA	NA	NA	NA	NA
TRINITY_DN8034_c0_g1_i1	P53348	BTG1_BOVIN	100	134	0	0	3	404	23	156	1.50E-73	276.6	BTG1_BOVIN	reviewed	Protein BTG1 (B-cell translocation gene 1 protein) (Myocardial vascular inhibition factor) (VIF)	BTG1	Bos taurus (Bovine)	171	cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	enzyme binding [GO:0019899]	GO:0005634; GO:0005737; GO:0008285; GO:0019899; GO:0045603; GO:0045766; GO:0045930; GO:2000271	negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]		NA	NA	NA	NA	NA	NA
TRINITY_DN173_c0_g2_i1	P53348	BTG1_BOVIN	53.2	126	56	2	72	446	6	129	9.20E-31	134.8	BTG1_BOVIN	reviewed	Protein BTG1 (B-cell translocation gene 1 protein) (Myocardial vascular inhibition factor) (VIF)	BTG1	Bos taurus (Bovine)	171	cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	enzyme binding [GO:0019899]	GO:0005634; GO:0005737; GO:0008285; GO:0019899; GO:0045603; GO:0045766; GO:0045930; GO:2000271	negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]		blue	blue	NA	NA	NA	NA
TRINITY_DN10900_c0_g2_i1	P78543	BTG2_HUMAN	100	128	0	0	2	385	24	151	3.00E-71	268.9	BTG2_HUMAN	reviewed	Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3)	BTG2 PC3	Homo sapiens (Human)	158	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006479; GO:0006974; GO:0006977; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0014070; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0045930; GO:0051602; GO:0060213; GO:0070062; GO:2000178	"anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10900_c0_g1_i1	Q04211	BTG2_MOUSE	100	90	0	0	7	276	44	133	1.40E-49	196.4	BTG2_MOUSE	reviewed	Protein BTG2 (BTG family member 2) (NGF-inducible protein TIS21)	Btg2 Tis21	Mus musculus (Mouse)	158	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0006479; GO:0006974; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0014070; GO:0017148; GO:0021542; GO:0021954; GO:0030182; GO:0031175; GO:0035914; GO:0043066; GO:0043434; GO:0043524; GO:0045930; GO:0051602; GO:0060213; GO:2000178	anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN14156_c0_g1_i1	Q2NKU3	BUD31_BOVIN	100	141	0	0	2	424	4	144	1.20E-82	307	BUD31_BOVIN	reviewed	Protein BUD31 homolog (Protein G10 homolog)	BUD31	Bos taurus (Bovine)	144	"nuclear chromatin [GO:0000790]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]"	nuclear chromatin [GO:0000790]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]	GO:0000398; GO:0000790; GO:0005681; GO:0030374; GO:0035257; GO:0071007; GO:2000825	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14156_c0_g1_i2	Q2NKU3	BUD31_BOVIN	100	87	0	0	3	263	58	144	5.40E-49	194.5	BUD31_BOVIN	reviewed	Protein BUD31 homolog (Protein G10 homolog)	BUD31	Bos taurus (Bovine)	144	"nuclear chromatin [GO:0000790]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]"	nuclear chromatin [GO:0000790]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]	GO:0000398; GO:0000790; GO:0005681; GO:0030374; GO:0035257; GO:0071007; GO:2000825	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]"		NA	NA	NA	NA	NA	NA
TRINITY_DN552_c1_g1_i1	Q962X9	BUD31_BRABE	90.3	144	14	0	1	432	1	144	1.10E-76	287.3	BUD31_BRABE	reviewed	Protein BUD31 homolog (Protein G10 homolog)		Branchiostoma belcheri (Amphioxus)	144	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN120_c0_g1_i1	Q65WT0	BD31B_ORYSJ	59.9	137	54	1	6	416	10	145	9.40E-48	191	BD31B_ORYSJ	reviewed	Protein BUD31 homolog 2 (Protein G10 homolog 2)	Os05g0446300 LOC_Os05g37390 OsJ_18724 P0615D12.15	Oryza sativa subsp. japonica (Rice)	145	"spliceosomal complex [GO:0005681]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]		GO:0000398; GO:0005681	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN617_c0_g1_i2	Q24522	BUN1_DROME	67.3	49	16	0	160	306	65	113	9.60E-10	64.7	BUN1_DROME	reviewed	"Protein bunched, class 1/class 3/D/E isoforms (Protein shortsighted)"	bun shs CG42281	Drosophila melanogaster (Fruit fly)	219	cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; ovarian follicle cell migration [GO:0007297]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; tissue regeneration [GO:0042246]	cytosol [GO:0005829]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]	GO:0001751; GO:0002052; GO:0003700; GO:0005634; GO:0005829; GO:0007297; GO:0007304; GO:0008284; GO:0008340; GO:0009996; GO:0016319; GO:0030307; GO:0036335; GO:0042246; GO:0042803; GO:0043066; GO:0046843	chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; ovarian follicle cell migration [GO:0007297]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN617_c0_g1_i1	Q24523	BUN2_DROME	68.1	69	22	0	140	346	1156	1224	1.20E-16	87.8	BUN2_DROME	reviewed	"Protein bunched, class 2/F/G isoform (Protein shortsighted)"	bun shs CG42281	Drosophila melanogaster (Fruit fly)	1331	cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; ovarian follicle cell migration [GO:0007297]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; tissue regeneration [GO:0042246]	cytosol [GO:0005829]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]	GO:0001751; GO:0002052; GO:0003700; GO:0005634; GO:0005829; GO:0007297; GO:0007304; GO:0008284; GO:0008340; GO:0009996; GO:0016319; GO:0030307; GO:0036335; GO:0042246; GO:0042803; GO:0043066; GO:0046843	chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; ovarian follicle cell migration [GO:0007297]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN8370_c0_g1_i1	Q9NQ89	CL004_HUMAN	63.1	103	38	0	393	85	448	550	2.20E-32	139.8	CL004_HUMAN	reviewed	Protein C12orf4	C12orf4	Homo sapiens (Human)	552	cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304]	cytoplasm [GO:0005737]		GO:0005737; GO:0043304	regulation of mast cell degranulation [GO:0043304]		blue	blue	NA	NA	NA	NA
TRINITY_DN4883_c0_g1_i1	D4A770	CL004_RAT	38.9	193	106	2	551	3	145	335	1.70E-27	124	CL004_RAT	reviewed	Protein C12orf4 homolog		Rattus norvegicus (Rat)	552	cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304]	cytoplasm [GO:0005737]		GO:0005737; GO:0043304	regulation of mast cell degranulation [GO:0043304]		blue	blue	NA	NA	NA	NA
TRINITY_DN8462_c0_g2_i1	Q6AY71	CH037_RAT	45.2	104	57	0	47	358	107	210	2.00E-23	110.2	CH037_RAT	reviewed	Protein C8orf37 homolog		Rattus norvegicus (Rat)	210	ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; photoreceptor cell morphogenesis [GO:0008594]	ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]		GO:0001917; GO:0005737; GO:0005829; GO:0008594; GO:0097546	photoreceptor cell morphogenesis [GO:0008594]		NA	NA	NA	NA	NA	NA
TRINITY_DN13159_c0_g1_i1	Q2L6K8	CNPY4_DANRE	41.9	198	103	4	630	55	22	213	1.30E-34	147.9	CNPY4_DANRE	reviewed	Protein canopy 4	cnpy4	Danio rerio (Zebrafish) (Brachydanio rerio)	217	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN1722_c1_g2_i1	Q9QXT0	CNPY2_MOUSE	34.4	154	97	1	669	208	22	171	6.90E-23	109.4	CNPY2_MOUSE	reviewed	Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein ZSIG9) (Transmembrane protein 4)	Cnpy2 Msap Tmem4 Zsig9	Mus musculus (Mouse)	182	endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]	endoplasmic reticulum [GO:0005783]		GO:0005783; GO:0010629; GO:0010988; GO:0045716	negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]		blue	blue	NA	NA	NA	NA
TRINITY_DN30666_c0_g1_i1	Q9Y2B0	CNPY2_HUMAN	100	70	0	0	213	4	22	91	5.60E-35	147.5	CNPY2_HUMAN	reviewed	Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)	CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426	Homo sapiens (Human)	182	endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]	endoplasmic reticulum [GO:0005783]		GO:0005783; GO:0010629; GO:0010988; GO:0045716	negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]		NA	NA	NA	NA	NA	NA
TRINITY_DN36240_c0_g1_i1	Q0P5N1	CNPY3_BOVIN	100	75	0	0	31	255	99	173	1.10E-37	156.8	CNPY3_BOVIN	reviewed	Protein canopy homolog 3	CNPY3	Bos taurus (Bovine)	282	endoplasmic reticulum [GO:0005783]; signaling receptor binding [GO:0005102]; innate immune response [GO:0045087]	endoplasmic reticulum [GO:0005783]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005783; GO:0045087	innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN12510_c0_g2_i1	Q96RK0	CIC_HUMAN	72.1	43	12	0	200	72	239	281	2.00E-13	75.9	CIC_HUMAN	reviewed	Protein capicua homolog	CIC KIAA0306	Homo sapiens (Human)	1608	"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]"	intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000122; GO:0000790; GO:0000981; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286	"brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; social behavior [GO:0035176]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12510_c0_g1_i1	Q96RK0	CIC_HUMAN	42.5	80	40	2	1430	1651	140	219	4.50E-07	57.8	CIC_HUMAN	reviewed	Protein capicua homolog	CIC KIAA0306	Homo sapiens (Human)	1608	"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]"	intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000122; GO:0000790; GO:0000981; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286	"brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; social behavior [GO:0035176]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7160_c0_g1_i1	Q924A2	CIC_MOUSE	37.6	210	106	6	625	2	2226	2412	1.70E-21	104.8	CIC_MOUSE	reviewed	Protein capicua homolog	Cic Kiaa0306	Mus musculus (Mouse)	2510	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286	"brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; social behavior [GO:0035176]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7160_c0_g1_i3	Q924A2	CIC_MOUSE	37.6	210	106	6	625	2	2226	2412	1.60E-21	104.8	CIC_MOUSE	reviewed	Protein capicua homolog	Cic Kiaa0306	Mus musculus (Mouse)	2510	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286	"brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; social behavior [GO:0035176]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2193_c0_g1_i1	Q1ECZ4	CASC3_DANRE	40.4	99	55	1	524	240	208	306	5.10E-13	75.9	CASC3_DANRE	reviewed	Protein CASC3 (Cancer susceptibility candidate gene 3 protein homolog) (Metastatic lymph node protein 51 homolog) (DrMLN51) (Protein MLN 51 homolog)	casc3 mln51	Danio rerio (Zebrafish) (Brachydanio rerio)	754	"cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]"	cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]	RNA binding [GO:0003723]	GO:0000184; GO:0000398; GO:0003723; GO:0005634; GO:0006417; GO:0010494; GO:0016607; GO:0030425; GO:0035145; GO:0048471; GO:0051028; GO:0071006	"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6856_c0_g1_i1	O16053	CDV3_DROYA	40	110	48	5	320	6	3	99	2.10E-06	53.5	CDV3_DROYA	reviewed	Protein CDV3 homolog (Protein anon-2C9)	GE14456	Drosophila yakuba (Fruit fly)	268							blue	blue	NA	NA	NA	NA
TRINITY_DN8576_c0_g1_i3	Q90773	CEPU1_CHICK	25.2	270	193	6	202	1005	42	304	7.90E-18	93.6	CEPU1_CHICK	reviewed	Protein CEPU-1		Gallus gallus (Chicken)	353	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]		GO:0005886; GO:0007155; GO:0031225	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN36232_c0_g1_i1	Q96SW2	CRBN_HUMAN	97.5	80	2	0	1	240	360	439	3.70E-43	174.9	CRBN_HUMAN	reviewed	Protein cereblon	CRBN AD-006	Homo sapiens (Human)	442	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ion channel binding [GO:0044325]; metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0016020; GO:0016567; GO:0031333; GO:0031334; GO:0031464; GO:0034766; GO:0043161; GO:0044325; GO:0046872; GO:0048471	negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1428_c0_g2_i1	Q96SW2	CRBN_HUMAN	38.2	437	246	12	2557	1268	17	436	1.80E-69	265.8	CRBN_HUMAN	reviewed	Protein cereblon	CRBN AD-006	Homo sapiens (Human)	442	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ion channel binding [GO:0044325]; metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0016020; GO:0016567; GO:0031333; GO:0031334; GO:0031464; GO:0034766; GO:0043161; GO:0044325; GO:0046872; GO:0048471	negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1428_c0_g2_i1	Q96SW2	CRBN_HUMAN	39.2	401	222	10	1	1182	51	436	3.30E-66	255	CRBN_HUMAN	reviewed	Protein cereblon	CRBN AD-006	Homo sapiens (Human)	442	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ion channel binding [GO:0044325]; metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0016020; GO:0016567; GO:0031333; GO:0031334; GO:0031464; GO:0034766; GO:0043161; GO:0044325; GO:0046872; GO:0048471	negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN21661_c0_g1_i1	P14921	ETS1_HUMAN	100	138	0	0	448	35	304	441	2.10E-79	296.2	ETS1_HUMAN	reviewed	Protein C-ets-1 (p54)	ETS1 EWSR2	Homo sapiens (Human)	441	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; cellular response to hydrogen peroxide [GO:0070301]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; hypothalamus development [GO:0021854]; immune response [GO:0006955]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; pituitary gland development [GO:0021983]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of apoptotic process [GO:0042981]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to laminar fluid shear stress [GO:0034616]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0006955; GO:0007565; GO:0008134; GO:0008284; GO:0008285; GO:0009612; GO:0010595; GO:0010628; GO:0010715; GO:0021854; GO:0021983; GO:0030154; GO:0030578; GO:0032355; GO:0034616; GO:0035035; GO:0042802; GO:0042981; GO:0043536; GO:0044849; GO:0045648; GO:0045765; GO:0045766; GO:0045786; GO:0045893; GO:0045944; GO:0046677; GO:0048870; GO:0050728; GO:0050729; GO:0051272; GO:0060055; GO:0070301; GO:0070555; GO:1902895; GO:1904996	"angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; cellular response to hydrogen peroxide [GO:0070301]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; hypothalamus development [GO:0021854]; immune response [GO:0006955]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; pituitary gland development [GO:0021983]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of apoptotic process [GO:0042981]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to laminar fluid shear stress [GO:0034616]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21661_c0_g1_i2	P14921	ETS1_HUMAN	100	137	0	0	471	61	304	440	1.80E-78	293.1	ETS1_HUMAN	reviewed	Protein C-ets-1 (p54)	ETS1 EWSR2	Homo sapiens (Human)	441	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; cellular response to hydrogen peroxide [GO:0070301]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; hypothalamus development [GO:0021854]; immune response [GO:0006955]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; pituitary gland development [GO:0021983]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of apoptotic process [GO:0042981]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to laminar fluid shear stress [GO:0034616]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0006955; GO:0007565; GO:0008134; GO:0008284; GO:0008285; GO:0009612; GO:0010595; GO:0010628; GO:0010715; GO:0021854; GO:0021983; GO:0030154; GO:0030578; GO:0032355; GO:0034616; GO:0035035; GO:0042802; GO:0042981; GO:0043536; GO:0044849; GO:0045648; GO:0045765; GO:0045766; GO:0045786; GO:0045893; GO:0045944; GO:0046677; GO:0048870; GO:0050728; GO:0050729; GO:0051272; GO:0060055; GO:0070301; GO:0070555; GO:1902895; GO:1904996	"angiogenesis involved in wound healing [GO:0060055]; cell differentiation [GO:0030154]; cell motility [GO:0048870]; cellular response to hydrogen peroxide [GO:0070301]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; hypothalamus development [GO:0021854]; immune response [GO:0006955]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; pituitary gland development [GO:0021983]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of apoptotic process [GO:0042981]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to laminar fluid shear stress [GO:0034616]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5067_c0_g1_i1	Q7YU81	CHN_DROME	40.7	243	122	4	958	1626	303	543	6.00E-44	180.3	CHN_DROME	reviewed	Protein charlatan	chn CG11798	Drosophila melanogaster (Fruit fly)	1214	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; eye development [GO:0001654]; larval somatic muscle development [GO:0007526]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001654; GO:0001700; GO:0005634; GO:0006357; GO:0007422; GO:0007423; GO:0007458; GO:0007526; GO:0042683; GO:0043565; GO:0045944; GO:0046872; GO:0048813	dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; eye development [GO:0001654]; larval somatic muscle development [GO:0007526]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]		blue	blue	NA	NA	NA	NA
TRINITY_DN34804_c0_g1_i1	Q9ZV43	CHR8_ARATH	68.4	98	31	0	2	295	773	870	1.30E-37	156.8	CHR8_ARATH	reviewed	Protein CHROMATIN REMODELING 8 (AtCHR8) (AtCSB) (EC 3.6.4.-)	CHR8 CSB ERCC6 RAD26 RAD54 At2g18760 MSF3.14	Arabidopsis thaliana (Mouse-ear cress)	1187	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to gamma radiation [GO:0010332]; transcription-coupled nucleotide-excision repair [GO:0006283]	nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006281; GO:0006283; GO:0006974; GO:0008094; GO:0010332	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to gamma radiation [GO:0010332]; transcription-coupled nucleotide-excision repair [GO:0006283]		NA	NA	NA	NA	NA	NA
TRINITY_DN14486_c2_g1_i1	Q9DFZ4	CHUR_XENLA	47.8	113	58	1	414	76	1	112	1.20E-27	124.4	CHUR_XENLA	reviewed	Protein Churchill	churc1 chch	Xenopus laevis (African clawed frog)	112	"zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]"		zinc ion binding [GO:0008270]	GO:0007275; GO:0008270; GO:0045893	"multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]"		brown	brown	NA	NA	NA	NA
TRINITY_DN39026_c0_g1_i1	O80990	CIA1_ARATH	51.5	132	56	4	12	389	111	240	2.20E-35	149.8	CIA1_ARATH	reviewed	Protein CIA1 (Cytosolic iron-sulfur protein assembly 1) (Protein EMBRYO DEFECTIVE 1345)	CIA1 EMB1345 At2g26060 T19L18.13	Arabidopsis thaliana (Mouse-ear cress)	352	CIA complex [GO:0097361]; nucleus [GO:0005634]; iron-sulfur cluster assembly [GO:0016226]	CIA complex [GO:0097361]; nucleus [GO:0005634]		GO:0005634; GO:0016226; GO:0097361	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN3766_c0_g1_i3	Q80U30	CL16A_MOUSE	52.6	133	57	3	77	457	244	376	2.90E-29	129.8	CL16A_MOUSE	reviewed	Protein CLEC16A	Clec16a Kiaa0350	Mus musculus (Mouse)	1036	cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096]	cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0006914; GO:0008333; GO:0009267; GO:0016021; GO:0016197; GO:0017137; GO:0031982; GO:0032435; GO:0036020; GO:1901096; GO:1901097; GO:1901098; GO:1901525; GO:1904263; GO:1904766	autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096]		NA	NA	NA	NA	NA	NA
TRINITY_DN30897_c0_g1_i1	Q2KHT3	CL16A_HUMAN	97.6	82	0	1	1	240	158	239	6.50E-40	164.1	CL16A_HUMAN	reviewed	Protein CLEC16A (C-type lectin domain family 16 member A)	CLEC16A KIAA0350	Homo sapiens (Human)	1053	cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096]	cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0006914; GO:0008333; GO:0009267; GO:0016021; GO:0016197; GO:0017137; GO:0031982; GO:0032435; GO:0036020; GO:1901096; GO:1901097; GO:1901098; GO:1901525; GO:1904263; GO:1904766	autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096]		NA	NA	NA	NA	NA	NA
TRINITY_DN39132_c0_g1_i1	Q54GS1	CL16A_DICDI	53.3	92	43	0	5	280	112	203	3.10E-23	109	CL16A_DICDI	reviewed	Protein CLEC16A homolog	DDB_G0289943	Dictyostelium discoideum (Slime mold)	1550	endolysosome membrane [GO:0036020]; integral component of membrane [GO:0016021]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]	endolysosome membrane [GO:0036020]; integral component of membrane [GO:0016021]	Rab GTPase binding [GO:0017137]	GO:0006914; GO:0008333; GO:0016021; GO:0016197; GO:0017137; GO:0036020; GO:1901096	autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]		NA	NA	NA	NA	NA	NA
TRINITY_DN3766_c0_g1_i1	Q9VEV4	CL16A_DROME	64.9	308	76	2	1	828	94	401	1.60E-107	390.6	CL16A_DROME	reviewed	Protein CLEC16A homolog (Endosomal maturation defective protein)	ema CG12753	Drosophila melanogaster (Fruit fly)	1067	autophagosome membrane [GO:0000421]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]	autophagosome membrane [GO:0000421]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000421; GO:0005770; GO:0005794; GO:0006914; GO:0008333; GO:0016021; GO:0016197; GO:0017137; GO:0031902; GO:0036020; GO:1901096	autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]		NA	NA	NA	NA	NA	NA
TRINITY_DN3766_c0_g1_i2	Q9VEV4	CL16A_DROME	89.7	78	8	0	1	234	94	171	4.40E-33	141.7	CL16A_DROME	reviewed	Protein CLEC16A homolog (Endosomal maturation defective protein)	ema CG12753	Drosophila melanogaster (Fruit fly)	1067	autophagosome membrane [GO:0000421]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]	autophagosome membrane [GO:0000421]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]	Rab GTPase binding [GO:0017137]	GO:0000139; GO:0000421; GO:0005770; GO:0005794; GO:0006914; GO:0008333; GO:0016021; GO:0016197; GO:0017137; GO:0031902; GO:0036020; GO:1901096	autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]		NA	NA	NA	NA	NA	NA
TRINITY_DN6023_c0_g1_i1	B3NRK6	CLP1_DROER	55.4	56	25	0	168	1	7	62	1.90E-09	63.2	CLP1_DROER	reviewed	Protein CLP1 homolog	cbc GG22488	Drosophila erecta (Fruit fly)	423	"mRNA cleavage factor complex [GO:0005849]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; mRNA 3'-end processing [GO:0031124]; regulation of RNA splicing [GO:0043484]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage factor complex [GO:0005849]; tRNA-intron endonuclease complex [GO:0000214]	ATP binding [GO:0005524]	GO:0000214; GO:0005524; GO:0005849; GO:0006388; GO:0031124; GO:0043484	"mRNA 3'-end processing [GO:0031124]; regulation of RNA splicing [GO:0043484]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4975_c0_g1_i1	Q7QJW7	CLP1_ANOGA	59.4	367	142	3	1275	181	61	422	3.40E-127	456.4	CLP1_ANOGA	reviewed	Protein CLP1 homolog	cbc AGAP007701	Anopheles gambiae (African malaria mosquito)	423	"mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; mRNA polyadenylation [GO:0006378]; RNA processing [GO:0006396]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]	GO:0005524; GO:0005634; GO:0005849; GO:0006378; GO:0006388; GO:0006396; GO:0051731	"mRNA polyadenylation [GO:0006378]; RNA processing [GO:0006396]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29697_c0_g1_i1	Q5ZJH7	CNPD1_CHICK	36.5	296	174	5	71	922	15	308	9.00E-43	176.4	CNPD1_CHICK	reviewed	Protein CNPPD1	CNPPD1 RCJMB04_3a20	Gallus gallus (Chicken)	439	integral component of membrane [GO:0016021]; protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	integral component of membrane [GO:0016021]	protein kinase binding [GO:0019901]	GO:0000079; GO:0016021; GO:0019901	regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]		blue	blue	NA	NA	NA	NA
TRINITY_DN3228_c0_g2_i1	Q96RY5	CRML_HUMAN	65	40	14	0	221	340	163	202	2.50E-08	59.7	CRML_HUMAN	reviewed	Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein)	CRAMP1 C16orf34 CRAMP1L HN1L KIAA1426	Homo sapiens (Human)	1269	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0003677; GO:0003682; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN15319_c0_g1_i1	Q9VC61	CRERF_DROME	66.5	254	72	6	1117	383	500	749	1.80E-69	264.6	CRERF_DROME	reviewed	Protein CREBRF homolog (Protein Repressed by Tor)	REPTOR CG13624	Drosophila melanogaster (Fruit fly)	755	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; TORC1 signaling [GO:0038202]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006986; GO:0038202; GO:0042594; GO:0045893; GO:0045944; GO:0046982	"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; TORC1 signaling [GO:0038202]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14703_c0_g1_i1	O88668	CREG1_MOUSE	44.8	172	93	1	627	112	47	216	6.50E-43	176	CREG1_MOUSE	reviewed	Protein CREG1 (Cellular repressor of E1A-stimulated genes 1)	Creg1 Creg	Mus musculus (Mouse)	220	"extracellular space [GO:0005615]; transcription regulator complex [GO:0005667]; transcription factor binding [GO:0008134]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular space [GO:0005615]; transcription regulator complex [GO:0005667]	transcription factor binding [GO:0008134]	GO:0005615; GO:0005667; GO:0006355; GO:0008134; GO:0040008	"regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN14703_c0_g1_i3	O88668	CREG1_MOUSE	44.8	172	93	1	650	135	47	216	6.70E-43	176	CREG1_MOUSE	reviewed	Protein CREG1 (Cellular repressor of E1A-stimulated genes 1)	Creg1 Creg	Mus musculus (Mouse)	220	"extracellular space [GO:0005615]; transcription regulator complex [GO:0005667]; transcription factor binding [GO:0008134]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular space [GO:0005615]; transcription regulator complex [GO:0005667]	transcription factor binding [GO:0008134]	GO:0005615; GO:0005667; GO:0006355; GO:0008134; GO:0040008	"regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1813_c0_g1_i1	P17886	CRN_DROME	63.5	668	238	1	150	2135	3	670	4.40E-263	908.7	CRN_DROME	reviewed	Protein crooked neck	crn CG3193	Drosophila melanogaster (Fruit fly)	702	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; axon ensheathment [GO:0008366]; glial cell migration [GO:0008347]; Malpighian tubule morphogenesis [GO:0007443]; mRNA splicing, via spliceosome [GO:0000398]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000381; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005829; GO:0007438; GO:0007443; GO:0008347; GO:0008366; GO:0016607; GO:0071007; GO:0071011; GO:0071013; GO:0071014	"axon ensheathment [GO:0008366]; glial cell migration [GO:0008347]; Malpighian tubule morphogenesis [GO:0007443]; mRNA splicing, via spliceosome [GO:0000398]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8641_c0_g1_i2	P17886	CRN_DROME	59.2	71	29	0	215	3	53	123	5.40E-17	87.8	CRN_DROME	reviewed	Protein crooked neck	crn CG3193	Drosophila melanogaster (Fruit fly)	702	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; axon ensheathment [GO:0008366]; glial cell migration [GO:0008347]; Malpighian tubule morphogenesis [GO:0007443]; mRNA splicing, via spliceosome [GO:0000398]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000245; GO:0000381; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005829; GO:0007438; GO:0007443; GO:0008347; GO:0008366; GO:0016607; GO:0071007; GO:0071011; GO:0071013; GO:0071014	"axon ensheathment [GO:0008366]; glial cell migration [GO:0008347]; Malpighian tubule morphogenesis [GO:0007443]; mRNA splicing, via spliceosome [GO:0000398]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37906_c0_g1_i1	P10040	CRB_DROME	37.2	86	45	5	1	246	394	474	2.00E-07	56.2	CRB_DROME	reviewed	Protein crumbs (95F)	crb CG6383	Drosophila melanogaster (Fruit fly)	2146	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]"	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]	GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007399; GO:0007424; GO:0007435; GO:0007443; GO:0008284; GO:0016021; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032391; GO:0032435; GO:0032880; GO:0033157; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036	"adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26453_c0_g1_i1	Q80YA8	CRUM2_MOUSE	47	66	33	2	14	211	117	180	6.90E-09	60.8	CRUM2_MOUSE	reviewed	Protein crumbs homolog 2 (crumbs2) (Crumbs-like protein 2)	Crb2	Mus musculus (Mouse)	1282	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; circulatory system development [GO:0072359]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]	GO:0001707; GO:0001756; GO:0005509; GO:0005886; GO:0007157; GO:0010470; GO:0010718; GO:0010951; GO:0014028; GO:0016021; GO:0016324; GO:0019828; GO:0030513; GO:0032991; GO:0044877; GO:0045197; GO:0045199; GO:0055111; GO:0072359	circulatory system development [GO:0072359]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756]		NA	NA	NA	NA	NA	NA
TRINITY_DN11260_c0_g1_i3	B4MLE8	CUE_DROWI	39.6	106	48	4	25	297	381	485	4.30E-15	82.4	CUE_DROWI	reviewed	Protein cueball	cue GK17203	Drosophila willistoni (Fruit fly)	651	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oogenesis [GO:0048477]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; spermatogenesis [GO:0007283]; triglyceride homeostasis [GO:0070328]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007283; GO:0016021; GO:0045938; GO:0048477; GO:0070328	"oogenesis [GO:0048477]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; spermatogenesis [GO:0007283]; triglyceride homeostasis [GO:0070328]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23057_c0_g2_i1	O60888	CUTA_HUMAN	100	71	0	0	2	214	87	157	6.90E-33	140.6	CUTA_HUMAN	reviewed	Protein CutA (Acetylcholinesterase-associated protein) (Brain acetylcholinesterase putative membrane anchor)	CUTA ACHAP C6orf82	Homo sapiens (Human)	179	extracellular exosome [GO:0070062]; membrane [GO:0016020]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; protein localization [GO:0008104]; response to metal ion [GO:0010038]	extracellular exosome [GO:0070062]; membrane [GO:0016020]	copper ion binding [GO:0005507]; enzyme binding [GO:0019899]	GO:0005507; GO:0008104; GO:0010038; GO:0016020; GO:0019899; GO:0070062	protein localization [GO:0008104]; response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN23057_c0_g1_i1	Q9CQ89	CUTA_MOUSE	100	96	0	0	3	290	63	158	3.00E-47	188.7	CUTA_MOUSE	reviewed	Protein CutA (Brain acetylcholinesterase putative membrane anchor)	Cuta	Mus musculus (Mouse)	177	membrane [GO:0016020]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; protein localization [GO:0008104]; response to metal ion [GO:0010038]	membrane [GO:0016020]	copper ion binding [GO:0005507]; enzyme binding [GO:0019899]	GO:0005507; GO:0008104; GO:0010038; GO:0016020; GO:0019899	protein localization [GO:0008104]; response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i10	Q66KY3	CUTA_XENLA	61.5	130	47	2	486	106	22	151	1.10E-37	157.9	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i11	Q66KY3	CUTA_XENLA	61.5	130	47	2	509	129	22	151	4.90E-38	159.1	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i13	Q66KY3	CUTA_XENLA	61.5	130	47	2	509	129	22	151	4.90E-38	159.1	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i14	Q66KY3	CUTA_XENLA	61.5	130	47	2	486	106	22	151	4.80E-38	159.1	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		blue	blue	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i3	Q66KY3	CUTA_XENLA	61.5	130	47	2	486	106	22	151	4.70E-38	159.1	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i7	Q66KY3	CUTA_XENLA	61.5	130	47	2	509	129	22	151	1.10E-37	157.9	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN2395_c0_g1_i8	Q66KY3	CUTA_XENLA	61.5	130	47	2	486	106	22	151	7.40E-38	158.3	CUTA_XENLA	reviewed	Protein CutA homolog	cuta	Xenopus laevis (African clawed frog)	151	response to metal ion [GO:0010038]			GO:0010038	response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN36138_c0_g1_i1	Q9V3B6	CWC15_DROME	74.2	66	17	0	281	84	1	66	5.70E-21	101.7	CWC15_DROME	reviewed	Protein CWC15 homolog	c12.1 CG12135	Drosophila melanogaster (Fruit fly)	259	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0045292; GO:0071011; GO:0071013	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31279_c0_g1_i1	Q6IQU4	CWC15_DANRE	94.1	68	4	0	206	3	1	68	1.70E-27	122.9	CWC15_DANRE	reviewed	Protein CWC15 homolog	cwc15 zgc:86607	Danio rerio (Zebrafish) (Brachydanio rerio)	243	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0045292; GO:0071007; GO:0071013	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8615_c0_g1_i1	Q6NUB2	CW15A_XENLA	67.6	74	21	2	88	300	155	228	3.80E-21	102.4	CW15A_XENLA	reviewed	Protein CWC15 homolog A	cwc15-a	Xenopus laevis (African clawed frog)	228	"nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0071007	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31643_c0_g1_i1	Q24292	DS_DROME	36.6	82	51	1	11	256	908	988	2.90E-06	52.4	DS_DROME	reviewed	Protein dachsous (Adherin)	ds CG17941	Drosophila melanogaster (Fruit fly)	3503	"apicolateral plasma membrane [GO:0016327]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apicolateral plasma membrane [GO:0016327]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0001736; GO:0005509; GO:0005886; GO:0007156; GO:0007560; GO:0016021; GO:0016327; GO:0030054; GO:0035331; GO:0035332; GO:0042067; GO:0060071; GO:0090251; GO:0098609	"cell-cell adhesion [GO:0098609]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16973_c0_g1_i1	Q9P219	DAPLE_HUMAN	36.9	122	72	3	72	422	400	521	4.90E-07	55.8	DAPLE_HUMAN	reviewed	Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2)	CCDC88C DAPLE KIAA1509	Homo sapiens (Human)	2028	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]	GO:0001932; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005737; GO:0005813; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031098; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043621; GO:0051959; GO:0090090	apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN16973_c0_g1_i2	Q9P219	DAPLE_HUMAN	44.5	209	111	3	3	614	313	521	8.20E-32	138.7	DAPLE_HUMAN	reviewed	Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2)	CCDC88C DAPLE KIAA1509	Homo sapiens (Human)	2028	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]	GO:0001932; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005737; GO:0005813; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031098; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043621; GO:0051959; GO:0090090	apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN23100_c0_g1_i1	Q9P219	DAPLE_HUMAN	31.7	189	128	1	658	92	843	1030	8.10E-17	89	DAPLE_HUMAN	reviewed	Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2)	CCDC88C DAPLE KIAA1509	Homo sapiens (Human)	2028	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]	GO:0001932; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005737; GO:0005813; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031098; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043621; GO:0051959; GO:0090090	apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1887_c0_g1_i3	P11420	DA_DROME	46.2	275	95	6	184	849	363	637	1.30E-45	184.9	DA_DROME	reviewed	Protein daughterless	da CG5102	Drosophila melanogaster (Fruit fly)	710	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0030707; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0050821; GO:0061101; GO:0061382; GO:0061525	"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1887_c0_g1_i4	P11420	DA_DROME	57.5	113	48	0	25	363	500	612	3.60E-26	119	DA_DROME	reviewed	Protein daughterless	da CG5102	Drosophila melanogaster (Fruit fly)	710	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0030707; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0050821; GO:0061101; GO:0061382; GO:0061525	"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1887_c0_g1_i5	P11420	DA_DROME	46.2	277	96	6	57	728	361	637	1.70E-46	187.6	DA_DROME	reviewed	Protein daughterless	da CG5102	Drosophila melanogaster (Fruit fly)	710	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0007400; GO:0007423; GO:0008134; GO:0008407; GO:0030237; GO:0030707; GO:0035019; GO:0042803; GO:0043425; GO:0043565; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0048477; GO:0048663; GO:0050821; GO:0061101; GO:0061382; GO:0061525	"chaeta morphogenesis [GO:0008407]; female sex determination [GO:0030237]; hindgut development [GO:0061525]; Malpighian tubule tip cell differentiation [GO:0061382]; neuroblast fate determination [GO:0007400]; neuroendocrine cell differentiation [GO:0061101]; neuron fate commitment [GO:0048663]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1405_c0_g1_i1	Q8NFT6	DBF4B_HUMAN	28.3	321	195	9	3360	2452	35	338	8.10E-22	107.8	DBF4B_HUMAN	reviewed	Protein DBF4 homolog B (Activator of S phase kinase-like protein 1) (ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1)	DBF4B ASKL1 DRF1	Homo sapiens (Human)	615	aggresome [GO:0016235]; cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0016235; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987	cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]		NA	NA	NA	NA	NA	NA
TRINITY_DN1405_c0_g1_i2	Q8NFT6	DBF4B_HUMAN	28.3	321	195	9	3340	2432	35	338	8.10E-22	107.8	DBF4B_HUMAN	reviewed	Protein DBF4 homolog B (Activator of S phase kinase-like protein 1) (ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1)	DBF4B ASKL1 DRF1	Homo sapiens (Human)	615	aggresome [GO:0016235]; cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0016235; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987	cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]		NA	NA	NA	NA	NA	NA
TRINITY_DN8058_c0_g1_i1	Q7ZYA7	DDI2_XENLA	46	63	34	0	68	256	16	78	3.70E-10	66.2	DDI2_XENLA	reviewed	Protein DDI1 homolog 2 (EC 3.4.23.-)	ddi2	Xenopus laevis (African clawed frog)	393	chromosome [GO:0005694]; cytosol [GO:0005829]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]	chromosome [GO:0005694]; cytosol [GO:0005829]	aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]	GO:0004190; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0072711; GO:0097752	cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN8058_c0_g1_i5	A2ADY9	DDI2_MOUSE	53.9	384	154	4	68	1165	16	394	3.00E-101	370.5	DDI2_MOUSE	reviewed	Protein DDI1 homolog 2 (EC 3.4.23.-)	Ddi2	Mus musculus (Mouse)	399	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]	GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752	cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN8058_c0_g1_i6	Q6TH22	DDI2_DANRE	65.5	267	88	1	66	866	143	405	1.50E-90	334.7	DDI2_DANRE	reviewed	Protein DDI1 homolog 2 (EC 3.4.23.-)	ddi2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	chromosome [GO:0005694]; cytosol [GO:0005829]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]	chromosome [GO:0005694]; cytosol [GO:0005829]	aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]	GO:0004190; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0072711; GO:0097752	cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN34522_c0_g1_i1	Q24573	DRI_DROME	69.8	53	15	1	173	18	372	424	5.00E-13	74.7	DRI_DROME	reviewed	Protein dead ringer (Protein retained)	retn dri CG5403	Drosophila melanogaster (Fruit fly)	911	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; embryonic pattern specification [GO:0009880]; gliogenesis [GO:0042063]; male courtship behavior [GO:0008049]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of female receptivity [GO:0045924]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000977; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0007411; GO:0007431; GO:0007517; GO:0008049; GO:0009880; GO:0009952; GO:0042063; GO:0045893; GO:0045924; GO:0048477; GO:0048813; GO:0070491	"anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; embryonic pattern specification [GO:0009880]; gliogenesis [GO:0042063]; male courtship behavior [GO:0008049]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of female receptivity [GO:0045924]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15125_c0_g1_i1	Q26263	DPN_DROME	69.5	59	18	0	32	208	43	101	4.50E-18	91.7	DPN_DROME	reviewed	Protein deadpan	dpn CG8704	Drosophila melanogaster (Fruit fly)	435	"nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; dosage compensation [GO:0007549]; larval locomotory behavior [GO:0008345]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuroblast proliferation [GO:0002052]; R7 cell fate commitment [GO:0007465]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination, establishment of X:A ratio [GO:0007540]"	nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007465; GO:0007540; GO:0007549; GO:0008344; GO:0008345; GO:0009952; GO:0010629; GO:0014019; GO:0043565; GO:0045840; GO:0046983; GO:0050767; GO:1902692; GO:1990837	"adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; dosage compensation [GO:0007549]; larval locomotory behavior [GO:0008345]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuroblast proliferation [GO:0002052]; R7 cell fate commitment [GO:0007465]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination, establishment of X:A ratio [GO:0007540]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15125_c0_g1_i2	Q26263	DPN_DROME	68.9	61	19	0	44	226	41	101	1.30E-18	93.6	DPN_DROME	reviewed	Protein deadpan	dpn CG8704	Drosophila melanogaster (Fruit fly)	435	"nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; dosage compensation [GO:0007549]; larval locomotory behavior [GO:0008345]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuroblast proliferation [GO:0002052]; R7 cell fate commitment [GO:0007465]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination, establishment of X:A ratio [GO:0007540]"	nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007465; GO:0007540; GO:0007549; GO:0008344; GO:0008345; GO:0009952; GO:0010629; GO:0014019; GO:0043565; GO:0045840; GO:0046983; GO:0050767; GO:1902692; GO:1990837	"adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; dosage compensation [GO:0007549]; larval locomotory behavior [GO:0008345]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuroblast proliferation [GO:0002052]; R7 cell fate commitment [GO:0007465]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sex determination, establishment of X:A ratio [GO:0007540]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33290_c0_g1_i1	P07713	DECA_DROME	37.3	249	117	7	2	685	282	512	6.20E-35	149.1	DECA_DROME	reviewed	Protein decapentaplegic (Protein DPP-C)	dpp CG9885	Drosophila melanogaster (Fruit fly)	588	"cell leading edge [GO:0031252]; cytoneme [GO:0035230]; dense core granule lumen [GO:0098898]; extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; collagen binding [GO:0005518]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; morphogen activity [GO:0016015]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; amnioserosa formation [GO:0007378]; anterior Malpighian tubule development [GO:0061327]; BMP signaling pathway [GO:0030509]; cardioblast differentiation [GO:0010002]; cell chemotaxis involved in Malpighian tubule morphogenesis [GO:0061352]; chorion-containing eggshell formation [GO:0007304]; compound eye morphogenesis [GO:0001745]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectodermal cell fate specification [GO:0001715]; embryonic hindgut morphogenesis [GO:0048619]; epithelial cell migration, open tracheal system [GO:0007427]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; fusion cell fate specification [GO:0035156]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; genital disc sexually dimorphic development [GO:0035263]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; hemocyte development [GO:0007516]; hindgut morphogenesis [GO:0007442]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; labial disc development [GO:0035217]; larval lymph gland hemocyte differentiation [GO:0035168]; lymph gland development [GO:0048542]; male germ-line stem cell population maintenance [GO:0036098]; Malpighian tubule morphogenesis [GO:0007443]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; mesoderm development [GO:0007498]; negative regulation of gene expression [GO:0010629]; negative regulation of salivary gland boundary specification [GO:0045705]; ovarian follicle cell development [GO:0030707]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of muscle organ development [GO:0048636]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; regulation of cell shape [GO:0008360]; regulation of imaginal disc growth [GO:0045570]; regulation of stem cell differentiation [GO:2000736]; regulation of tube diameter, open tracheal system [GO:0035158]; SMAD protein signal transduction [GO:0060395]; spectrosome organization [GO:0030721]; wing and notum subfield formation [GO:0035309]; wing disc pattern formation [GO:0035222]; zygotic specification of dorsal/ventral axis [GO:0007352]"	cell leading edge [GO:0031252]; cytoneme [GO:0035230]; dense core granule lumen [GO:0098898]; extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; collagen binding [GO:0005518]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; morphogen activity [GO:0016015]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]	GO:0001715; GO:0001745; GO:0005125; GO:0005518; GO:0005615; GO:0007281; GO:0007304; GO:0007313; GO:0007352; GO:0007378; GO:0007391; GO:0007427; GO:0007442; GO:0007443; GO:0007444; GO:0007455; GO:0007458; GO:0007474; GO:0007476; GO:0007498; GO:0007507; GO:0007516; GO:0008083; GO:0008201; GO:0008354; GO:0008360; GO:0008586; GO:0009950; GO:0009953; GO:0010002; GO:0010628; GO:0010629; GO:0010862; GO:0016015; GO:0030509; GO:0030707; GO:0030718; GO:0030721; GO:0031252; GO:0035156; GO:0035158; GO:0035168; GO:0035214; GO:0035215; GO:0035217; GO:0035222; GO:0035224; GO:0035230; GO:0035263; GO:0035309; GO:0036098; GO:0036099; GO:0042078; GO:0042803; GO:0045464; GO:0045570; GO:0045572; GO:0045595; GO:0045705; GO:0046843; GO:0046982; GO:0048018; GO:0048542; GO:0048619; GO:0048636; GO:0060323; GO:0060391; GO:0060395; GO:0061320; GO:0061327; GO:0061352; GO:0070700; GO:0098898; GO:2000736	"amnioserosa formation [GO:0007378]; anterior Malpighian tubule development [GO:0061327]; BMP signaling pathway [GO:0030509]; cardioblast differentiation [GO:0010002]; cell chemotaxis involved in Malpighian tubule morphogenesis [GO:0061352]; chorion-containing eggshell formation [GO:0007304]; compound eye morphogenesis [GO:0001745]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; ectodermal cell fate specification [GO:0001715]; embryonic hindgut morphogenesis [GO:0048619]; epithelial cell migration, open tracheal system [GO:0007427]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; fusion cell fate specification [GO:0035156]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; genital disc sexually dimorphic development [GO:0035263]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; hemocyte development [GO:0007516]; hindgut morphogenesis [GO:0007442]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; labial disc development [GO:0035217]; larval lymph gland hemocyte differentiation [GO:0035168]; lymph gland development [GO:0048542]; male germ-line stem cell population maintenance [GO:0036098]; Malpighian tubule morphogenesis [GO:0007443]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; mesoderm development [GO:0007498]; negative regulation of gene expression [GO:0010629]; negative regulation of salivary gland boundary specification [GO:0045705]; ovarian follicle cell development [GO:0030707]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of muscle organ development [GO:0048636]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; regulation of cell shape [GO:0008360]; regulation of imaginal disc growth [GO:0045570]; regulation of stem cell differentiation [GO:2000736]; regulation of tube diameter, open tracheal system [GO:0035158]; SMAD protein signal transduction [GO:0060395]; spectrosome organization [GO:0030721]; wing and notum subfield formation [GO:0035309]; wing disc pattern formation [GO:0035222]; zygotic specification of dorsal/ventral axis [GO:0007352]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3416_c0_g1_i1	Q23985	DTX_DROME	47.9	167	78	4	599	123	46	211	1.90E-38	160.6	DTX_DROME	reviewed	Protein deltex (Probable E3 ubiquitin-protein ligase deltex) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase deltex)	dx CG3929	Drosophila melanogaster (Fruit fly)	738	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; negative regulation of Notch signaling pathway [GO:0045746]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein ubiquitination [GO:0016567]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0006897; GO:0007219; GO:0007220; GO:0008270; GO:0016567; GO:0017124; GO:0035220; GO:0045746; GO:0045747; GO:0061630	endocytosis [GO:0006897]; negative regulation of Notch signaling pathway [GO:0045746]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein ubiquitination [GO:0016567]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN3416_c0_g1_i2	Q23985	DTX_DROME	44.5	191	95	5	738	190	46	233	3.00E-38	160.2	DTX_DROME	reviewed	Protein deltex (Probable E3 ubiquitin-protein ligase deltex) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase deltex)	dx CG3929	Drosophila melanogaster (Fruit fly)	738	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; negative regulation of Notch signaling pathway [GO:0045746]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein ubiquitination [GO:0016567]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0006897; GO:0007219; GO:0007220; GO:0008270; GO:0016567; GO:0017124; GO:0035220; GO:0045746; GO:0045747; GO:0061630	endocytosis [GO:0006897]; negative regulation of Notch signaling pathway [GO:0045746]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; protein ubiquitination [GO:0016567]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN13710_c0_g1_i2	P48608	DIA_DROME	38.6	500	291	7	49	1533	594	1082	2.50E-67	258.1	DIA_DROME	reviewed	Protein diaphanous	dia CG1768	Drosophila melanogaster (Fruit fly)	1091	"apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actomyosin structure organization [GO:0110020]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]"	apical part of cell [GO:0045177]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]	"actin binding [GO:0003779]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rho GTPase binding [GO:0017048]"	GO:0000281; GO:0000915; GO:0003383; GO:0003779; GO:0005546; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0007110; GO:0007111; GO:0007279; GO:0007349; GO:0007424; GO:0007435; GO:0007605; GO:0008104; GO:0009306; GO:0012506; GO:0016476; GO:0017048; GO:0030589; GO:0030838; GO:0031532; GO:0032154; GO:0032507; GO:0032991; GO:0035011; GO:0045010; GO:0045177; GO:0045448; GO:0051225; GO:0051489; GO:0090303; GO:0097320; GO:0106036; GO:0110020	"actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actomyosin contractile ring assembly [GO:0000915]; apical constriction [GO:0003383]; assembly of apicomedial cortex actomyosin [GO:0106036]; cellularization [GO:0007349]; maintenance of protein location in cell [GO:0032507]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; melanotic encapsulation of foreign target [GO:0035011]; mitotic cell cycle, embryonic [GO:0045448]; mitotic cytokinesis [GO:0000281]; open tracheal system development [GO:0007424]; plasma membrane tubulation [GO:0097320]; pole cell formation [GO:0007279]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of wound healing [GO:0090303]; protein localization [GO:0008104]; protein secretion [GO:0009306]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actomyosin structure organization [GO:0110020]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; spindle assembly [GO:0051225]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27382_c0_g1_i1	O60610	DIAP1_HUMAN	100	69	0	0	209	3	403	471	5.50E-35	147.5	DIAP1_HUMAN	reviewed	Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1)	DIAPH1 DIAP1	Homo sapiens (Human)	1272	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; ion channel binding [GO:0044325]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]	actin binding [GO:0003779]; ion channel binding [GO:0044325]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]	GO:0003723; GO:0003779; GO:0005102; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0007605; GO:0008360; GO:0017048; GO:0030036; GO:0030041; GO:0030335; GO:0030667; GO:0032587; GO:0032886; GO:0035372; GO:0043312; GO:0044325; GO:0051279; GO:0051493; GO:0071420; GO:0072686; GO:0101003; GO:2000145	actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN14876_c0_g1_i1	F1M775	DIAP1_RAT	34.7	438	265	10	1420	143	83	511	2.90E-62	241.1	DIAP1_RAT	reviewed	Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1) (mDIA1)	Diaph1 Diap1	Rattus norvegicus (Rat)	1265	brush border [GO:0005903]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; profilin binding [GO:0005522]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; neuron projection development [GO:0031175]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]	brush border [GO:0005903]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; profilin binding [GO:0005522]; Rho GTPase binding [GO:0017048]	GO:0003779; GO:0005522; GO:0005634; GO:0005737; GO:0005815; GO:0005903; GO:0007010; GO:0007420; GO:0007605; GO:0008360; GO:0017048; GO:0030036; GO:0030041; GO:0030335; GO:0031175; GO:0032587; GO:0032886; GO:0035372; GO:0042802; GO:0043005; GO:0044325; GO:0051279; GO:0051493; GO:0071420; GO:0072686	actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; neuron projection development [GO:0031175]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN18354_c0_g2_i1	Q3TDN0	DISP1_MOUSE	38.5	769	414	14	2229	1	258	993	5.30E-144	513.1	DISP1_MOUSE	reviewed	Protein dispatched homolog 1 (Mdispa)	Disp1 Disp Dispa Icb Icbins	Mus musculus (Mouse)	1521	integral component of membrane [GO:0016021]; peptide transmembrane transporter activity [GO:1904680]; determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]	integral component of membrane [GO:0016021]	peptide transmembrane transporter activity [GO:1904680]	GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016021; GO:0060539; GO:1904680	determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]		NA	NA	NA	NA	NA	NA
TRINITY_DN38635_c0_g1_i1	Q6R5J2	DISP1_DANRE	55.5	128	57	0	3	386	1002	1129	1.10E-32	141.4	DISP1_DANRE	reviewed	Protein dispatched homolog 1 (Protein chameleon)	disp1 con	Danio rerio (Zebrafish) (Brachydanio rerio)	1464	integral component of membrane [GO:0016021]; adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]	integral component of membrane [GO:0016021]		GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016021; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839	adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN4587_c0_g1_i1	Q6UXH1	CREL2_HUMAN	45.8	271	142	3	1140	328	25	290	5.50E-59	229.9	CREL2_HUMAN	reviewed	Protein disulfide isomerase CRELD2 (EC 5.3.4.1) (Cysteine-rich with EGF-like domain protein 2)	CRELD2 UNQ185/PRO211	Homo sapiens (Human)	353	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005509; GO:0005615; GO:0005783; GO:0005794			NA	NA	NA	NA	NA	NA
TRINITY_DN25900_c0_g1_i1	Q67IX6	PDI14_ORYSJ	61	77	27	3	246	19	406	480	2.30E-19	95.9	PDI14_ORYSJ	reviewed	Protein disulfide isomerase-like 1-4 (OsPDIL1-4) (EC 5.3.4.1) (Protein disulfide isomerase-like 2-1) (OsPDIL2-1)	PDIL1-4 PDIL2-1 Os02g0100100 LOC_Os02g01010 OsJ_04977 OSJNOa183H18.2	Oryza sativa subsp. japonica (Rice)	563	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; vacuolar membrane [GO:0005774]; protein disulfide isomerase activity [GO:0003756]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; vacuolar membrane [GO:0005774]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005774; GO:0005783; GO:0005788; GO:0005829; GO:0006457; GO:0034976	protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		red	red	NA	NA	NA	NA
TRINITY_DN1153_c0_g1_i3	P54399	PDI_DROME	58.6	490	200	2	1523	63	7	496	2.70E-166	586.6	PDI_DROME	reviewed	Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1)	Pdi CG6988	Drosophila melanogaster (Fruit fly)	496	cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0012505; GO:0015037; GO:0043025; GO:0045169; GO:0048471; GO:0060187; GO:0070732			blue	blue	NA	NA	NA	NA
TRINITY_DN1153_c0_g1_i4	P54399	PDI_DROME	58.8	495	198	2	1544	63	7	496	3.00E-168	593.2	PDI_DROME	reviewed	Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1)	Pdi CG6988	Drosophila melanogaster (Fruit fly)	496	cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0012505; GO:0015037; GO:0043025; GO:0045169; GO:0048471; GO:0060187; GO:0070732			blue	blue	NA	NA	NA	NA
TRINITY_DN13395_c2_g1_i1	P54399	PDI_DROME	63.9	147	53	0	444	4	282	428	4.80E-52	205.3	PDI_DROME	reviewed	Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1)	Pdi CG6988	Drosophila melanogaster (Fruit fly)	496	cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	cell pole [GO:0060187]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fusome [GO:0045169]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; spindle envelope [GO:0070732]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0012505; GO:0015037; GO:0043025; GO:0045169; GO:0048471; GO:0060187; GO:0070732			NA	NA	NA	NA	NA	NA
TRINITY_DN39090_c0_g1_i1	P29828	PDI_MEDSA	54	50	23	0	99	248	395	444	1.30E-09	63.5	PDI_MEDSA	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1)	PDI	Medicago sativa (Alfalfa)	512	endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788			NA	NA	NA	NA	NA	NA
TRINITY_DN9626_c0_g2_i1	P09103	PDIA1_MOUSE	100	483	0	0	1449	1	9	491	1.40E-281	969.5	PDIA1_MOUSE	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Endoplasmic reticulum resident protein 59) (ER protein 59) (ERp59) (Prolyl 4-hydroxylase subunit beta) (p55)	P4hb Pdia1	Mus musculus (Mouse)	509	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein-containing complex binding [GO:0044877]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	GO:0003756; GO:0003779; GO:0004656; GO:0005178; GO:0005783; GO:0005788; GO:0005793; GO:0005829; GO:0005856; GO:0006457; GO:0009897; GO:0015037; GO:0016222; GO:0018401; GO:0019899; GO:0030027; GO:0032991; GO:0034663; GO:0034976; GO:0042470; GO:0044877; GO:0045785; GO:0046598; GO:0046982; GO:0071456; GO:0098761; GO:1900026; GO:1902175	cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN9626_c0_g1_i1	P07237	PDIA1_HUMAN	100	466	0	0	1425	28	14	479	2.30E-273	942.2	PDIA1_HUMAN	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)	P4HB ERBA2L PDI PDIA1 PO4DB	Homo sapiens (Human)	508	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cellular protein metabolic process [GO:0044267]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; chylomicron assembly [GO:0034378]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]; very-low-density lipoprotein particle assembly [GO:0034379]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0003779; GO:0004656; GO:0005178; GO:0005576; GO:0005783; GO:0005788; GO:0005793; GO:0005829; GO:0005856; GO:0005925; GO:0006457; GO:0009897; GO:0015037; GO:0016222; GO:0018401; GO:0019899; GO:0030027; GO:0032991; GO:0034378; GO:0034379; GO:0034663; GO:0034976; GO:0035722; GO:0038155; GO:0042470; GO:0043687; GO:0044267; GO:0045785; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:0098761; GO:1900026; GO:1902175	cellular protein metabolic process [GO:0044267]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; chylomicron assembly [GO:0034378]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN28673_c0_g1_i1	P05307	PDIA1_BOVIN	56.4	78	30	2	240	7	364	437	1.60E-18	93.2	PDIA1_BOVIN	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)	P4HB PDIA1	Bos taurus (Bovine)	510	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]	procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0006457; GO:0009897; GO:0018401; GO:0034976; GO:0042470; GO:0046982	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN28157_c0_g1_i1	P05307	PDIA1_BOVIN	45.6	57	28	1	176	15	374	430	8.70E-10	63.9	PDIA1_BOVIN	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)	P4HB PDIA1	Bos taurus (Bovine)	510	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]	procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	GO:0003756; GO:0004656; GO:0005783; GO:0005788; GO:0006457; GO:0009897; GO:0018401; GO:0034976; GO:0042470; GO:0046982	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN15898_c0_g1_i1	Q8R4U2	PDIA1_CRIGR	73.3	60	16	0	93	272	51	110	2.30E-20	99.4	PDIA1_CRIGR	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Prolyl 4-hydroxylase subunit beta) (p58)	P4HB PDIA1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	509	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	GO:0003756; GO:0005783; GO:0005788; GO:0005886; GO:0042470; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN15898_c0_g1_i2	Q8R4U2	PDIA1_CRIGR	71.9	57	16	0	93	263	51	107	1.70E-17	89.7	PDIA1_CRIGR	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Prolyl 4-hydroxylase subunit beta) (p58)	P4HB PDIA1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	509	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	GO:0003756; GO:0005783; GO:0005788; GO:0005886; GO:0042470; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN15898_c1_g1_i1	Q8R4U2	PDIA1_CRIGR	50.6	176	84	1	2	520	96	271	9.30E-47	188	PDIA1_CRIGR	reviewed	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Prolyl 4-hydroxylase subunit beta) (p58)	P4HB PDIA1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	509	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]	GO:0003756; GO:0005783; GO:0005788; GO:0005886; GO:0042470; GO:0046982			NA	NA	NA	NA	NA	NA
TRINITY_DN13395_c1_g1_i1	Q17770	PDI2_CAEEL	59.1	115	47	0	5	349	364	478	4.00E-35	149.1	PDI2_CAEEL	reviewed	Protein disulfide-isomerase 2 (EC 5.3.4.1) (PDI 1) (Prolyl 4-hydroxylase subunit beta-2)	pdi-2 C07A12.4	Caenorhabditis elegans	493	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; endoplasmic reticulum unfolded protein response [GO:0030968]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein deglutathionylation [GO:0080058]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222]	protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003756; GO:0003810; GO:0005783; GO:0005788; GO:0006457; GO:0016222; GO:0018401; GO:0030968; GO:0034976; GO:0043412; GO:0055114; GO:0080058	endoplasmic reticulum unfolded protein response [GO:0030968]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein deglutathionylation [GO:0080058]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN13395_c1_g1_i2	Q17770	PDI2_CAEEL	58.7	126	52	0	5	382	364	489	4.10E-36	152.1	PDI2_CAEEL	reviewed	Protein disulfide-isomerase 2 (EC 5.3.4.1) (PDI 1) (Prolyl 4-hydroxylase subunit beta-2)	pdi-2 C07A12.4	Caenorhabditis elegans	493	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; endoplasmic reticulum unfolded protein response [GO:0030968]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein deglutathionylation [GO:0080058]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; procollagen-proline 4-dioxygenase complex [GO:0016222]	protein disulfide isomerase activity [GO:0003756]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003756; GO:0003810; GO:0005783; GO:0005788; GO:0006457; GO:0016222; GO:0018401; GO:0030968; GO:0034976; GO:0043412; GO:0055114; GO:0080058	endoplasmic reticulum unfolded protein response [GO:0030968]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein deglutathionylation [GO:0080058]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN2331_c0_g2_i1	P27773	PDIA3_MOUSE	100	121	0	0	365	3	350	470	1.90E-67	256.1	PDIA3_MOUSE	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)	Pdia3 Erp Erp60 Grp58	Mus musculus (Mouse)	505	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; TAP complex [GO:0042825]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; peptidase activity [GO:0008233]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cellular response to interleukin-7 [GO:0098761]; cellular response to vitamin D [GO:0071305]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; TAP complex [GO:0042825]	identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; peptidase activity [GO:0008233]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase (glutathione) activity [GO:0019153]	GO:0001669; GO:0003756; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005783; GO:0005788; GO:0005790; GO:0005886; GO:0006457; GO:0008233; GO:0009986; GO:0015037; GO:0016324; GO:0019153; GO:0034976; GO:0042288; GO:0042470; GO:0042802; GO:0042824; GO:0042825; GO:0043209; GO:0071305; GO:0098761; GO:1903334; GO:2001238	cellular response to interleukin-7 [GO:0098761]; cellular response to vitamin D [GO:0071305]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN19026_c0_g1_i1	P30101	PDIA3_HUMAN	100	83	0	0	2	250	15	97	5.50E-42	171	PDIA3_HUMAN	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)	PDIA3 ERP57 ERP60 GRP58	Homo sapiens (Human)	505	"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; recycling endosome membrane [GO:0055038]; cysteine-type endopeptidase activity [GO:0004197]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; phospholipase C activity [GO:0004629]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]"	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; recycling endosome membrane [GO:0055038]	cysteine-type endopeptidase activity [GO:0004197]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; phospholipase C activity [GO:0004629]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0002474; GO:0002479; GO:0003723; GO:0003756; GO:0004197; GO:0004629; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0015036; GO:0015037; GO:0034975; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0045335; GO:0055038; GO:0070062; GO:0098761; GO:2001238	"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19026_c0_g2_i1	P27773	PDIA3_MOUSE	100	82	0	0	2	247	16	97	2.10E-41	169.1	PDIA3_MOUSE	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)	Pdia3 Erp Erp60 Grp58	Mus musculus (Mouse)	505	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; TAP complex [GO:0042825]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; peptidase activity [GO:0008233]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cellular response to interleukin-7 [GO:0098761]; cellular response to vitamin D [GO:0071305]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; TAP complex [GO:0042825]	identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; peptidase activity [GO:0008233]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase (glutathione) activity [GO:0019153]	GO:0001669; GO:0003756; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005783; GO:0005788; GO:0005790; GO:0005886; GO:0006457; GO:0008233; GO:0009986; GO:0015037; GO:0016324; GO:0019153; GO:0034976; GO:0042288; GO:0042470; GO:0042802; GO:0042824; GO:0042825; GO:0043209; GO:0071305; GO:0098761; GO:1903334; GO:2001238	cellular response to interleukin-7 [GO:0098761]; cellular response to vitamin D [GO:0071305]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN2331_c0_g1_i1	Q4VIT4	PDIA3_CHLAE	98.4	129	2	0	387	1	350	478	8.00E-72	270.8	PDIA3_CHLAE	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)	PDIA3 ERP57	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	505	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0005788; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN25900_c0_g1_i2	Q4VIT4	PDIA3_CHLAE	61.4	57	20	1	189	19	388	442	2.80E-13	75.5	PDIA3_CHLAE	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)	PDIA3 ERP57	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	505	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0005788; GO:0042470			NA	NA	NA	NA	NA	NA
TRINITY_DN3900_c0_g1_i1	Q8JG64	PDIA3_CHICK	47.5	259	126	8	761	3	13	267	3.30E-53	209.9	PDIA3_CHICK	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	Gallus gallus (Chicken)	505	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]	identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0098761; GO:2001238	cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		blue	blue	NA	NA	NA	NA
TRINITY_DN35388_c0_g1_i1	Q8JG64	PDIA3_CHICK	63.9	97	33	2	18	302	357	453	2.10E-30	132.9	PDIA3_CHICK	reviewed	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	PDIA3 ERP57 GRP58	Gallus gallus (Chicken)	505	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]	identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0098761; GO:2001238	cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		blue	blue	NA	NA	NA	NA
TRINITY_DN12482_c0_g1_i1	P13667	PDIA4_HUMAN	99.5	193	1	0	580	2	417	609	1.20E-108	393.7	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN26920_c0_g1_i1	P13667	PDIA4_HUMAN	61.1	90	35	0	271	2	181	270	7.50E-27	120.9	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN33104_c0_g1_i1	P13667	PDIA4_HUMAN	54.5	66	30	0	208	11	526	591	6.20E-18	90.9	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN13395_c0_g1_i2	P13667	PDIA4_HUMAN	99.6	227	1	0	1	681	66	292	3.50E-131	468.8	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN1055_c0_g1_i1	P13667	PDIA4_HUMAN	45.7	599	303	17	1846	89	56	645	1.20E-137	491.9	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN1055_c0_g1_i2	P13667	PDIA4_HUMAN	45.1	443	224	15	1384	89	211	645	4.70E-93	343.6	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN1055_c0_g1_i2	P13667	PDIA4_HUMAN	63.2	95	32	2	1670	1392	177	270	3.60E-24	114.8	PDIA4_HUMAN	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	PDIA4 ERP70 ERP72	Homo sapiens (Human)	645	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]	GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0061077	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN27494_c0_g1_i1	P08003	PDIA4_MOUSE	100	144	0	0	432	1	471	614	1.10E-80	300.4	PDIA4_MOUSE	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	Pdia4 Cai Erp72	Mus musculus (Mouse)	638	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0009986; GO:0015037; GO:0034663; GO:0034976; GO:0042470; GO:0061077; GO:1903334	chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN13395_c0_g1_i1	P08003	PDIA4_MOUSE	100	113	0	0	3	341	173	285	3.00E-62	238.8	PDIA4_MOUSE	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	Pdia4 Cai Erp72	Mus musculus (Mouse)	638	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0009986; GO:0015037; GO:0034663; GO:0034976; GO:0042470; GO:0061077; GO:1903334	chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN25480_c0_g1_i1	P08003	PDIA4_MOUSE	100	126	0	0	379	2	49	174	6.70E-69	261.2	PDIA4_MOUSE	reviewed	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	Pdia4 Cai Erp72	Mus musculus (Mouse)	638	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0009986; GO:0015037; GO:0034663; GO:0034976; GO:0042470; GO:0061077; GO:1903334	chaperone-mediated protein folding [GO:0061077]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN2592_c0_g1_i1	Q2KIL5	PDIA5_BOVIN	48.9	131	61	3	5	382	261	390	7.10E-28	124.8	PDIA5_BOVIN	reviewed	Protein disulfide-isomerase A5 (EC 5.3.4.1)	PDIA5	Bos taurus (Bovine)	521	endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum lumen [GO:0005788]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0015037			blue	blue	NA	NA	NA	NA
TRINITY_DN4168_c0_g1_i1	Q921X9	PDIA5_MOUSE	37.3	252	139	8	857	120	262	500	1.10E-36	155.2	PDIA5_MOUSE	reviewed	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	Pdia5 Pdir	Mus musculus (Mouse)	517	endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum lumen [GO:0005788]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0015037			blue	blue	NA	NA	NA	NA
TRINITY_DN11567_c0_g1_i1	Q15084	PDIA6_HUMAN	99.2	132	1	0	3	398	146	277	5.30E-71	268.1	PDIA6_HUMAN	reviewed	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)	PDIA6 ERP5 P5 TXNDC7	Homo sapiens (Human)	440	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cellular protein metabolic process [GO:0044267]; IRE1-mediated unfolded protein response [GO:0036498]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006457; GO:0015037; GO:0034663; GO:0036498; GO:0042470; GO:0043687; GO:0044267; GO:0070062	cellular protein metabolic process [GO:0044267]; IRE1-mediated unfolded protein response [GO:0036498]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN12922_c1_g1_i1	Q15084	PDIA6_HUMAN	100	79	0	0	239	3	16	94	5.30E-42	171	PDIA6_HUMAN	reviewed	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)	PDIA6 ERP5 P5 TXNDC7	Homo sapiens (Human)	440	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cellular protein metabolic process [GO:0044267]; IRE1-mediated unfolded protein response [GO:0036498]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006457; GO:0015037; GO:0034663; GO:0036498; GO:0042470; GO:0043687; GO:0044267; GO:0070062	cellular protein metabolic process [GO:0044267]; IRE1-mediated unfolded protein response [GO:0036498]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11567_c0_g2_i1	Q922R8	PDIA6_MOUSE	98.4	122	2	0	1	366	144	265	8.90E-65	247.3	PDIA6_MOUSE	reviewed	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Thioredoxin domain-containing protein 7)	Pdia6 Txndc7	Mus musculus (Mouse)	440	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0015037; GO:0030168; GO:0034663; GO:0042470; GO:0070527	platelet activation [GO:0030168]; platelet aggregation [GO:0070527]		NA	NA	NA	NA	NA	NA
TRINITY_DN9127_c0_g1_i1	Q11067	PDIA6_CAEEL	36.5	63	40	0	18	206	25	87	2.40E-07	55.8	PDIA6_CAEEL	reviewed	Protein disulfide-isomerase A6 homolog (EC 5.3.4.1)	pdi-6 tag-320 B0403.4	Caenorhabditis elegans	440	endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; endoplasmic reticulum unfolded protein response [GO:0030968]	endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0030968	endoplasmic reticulum unfolded protein response [GO:0030968]		blue	blue	NA	NA	NA	NA
TRINITY_DN6003_c1_g1_i1	Q9V438	PDIA6_DROME	75.9	79	19	0	241	5	157	235	3.50E-32	138.7	PDIA6_DROME	reviewed	Protein disulfide-isomerase A6 homolog (EC 5.3.4.1) (Calcium-binding protein 1) (DmCaBP1)	CaBP1 CG5809	Drosophila melanogaster (Fruit fly)	433	cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]	cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0005788; GO:0006909; GO:0009986; GO:0012505; GO:0015037; GO:2000427	phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]		blue	blue	NA	NA	NA	NA
TRINITY_DN15595_c0_g1_i1	Q9V438	PDIA6_DROME	65.6	93	32	0	279	1	11	103	9.20E-33	140.6	PDIA6_DROME	reviewed	Protein disulfide-isomerase A6 homolog (EC 5.3.4.1) (Calcium-binding protein 1) (DmCaBP1)	CaBP1 CG5809	Drosophila melanogaster (Fruit fly)	433	cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]	cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0005788; GO:0006909; GO:0009986; GO:0012505; GO:0015037; GO:2000427	phagocytosis [GO:0006909]; positive regulation of apoptotic cell clearance [GO:2000427]		blue	blue	NA	NA	NA	NA
TRINITY_DN21478_c0_g1_i1	Q6GNG3	TMX3_XENLA	60	55	20	1	81	239	48	102	5.20E-15	81.6	TMX3_XENLA	reviewed	Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3)	tmx3 txndc10	Xenopus laevis (African clawed frog)	452	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005789; GO:0016021			brown	brown	NA	NA	NA	NA
TRINITY_DN21478_c0_g1_i2	Q6GNG3	TMX3_XENLA	39.8	221	126	4	57	713	9	224	2.00E-39	164.1	TMX3_XENLA	reviewed	Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3)	tmx3 txndc10	Xenopus laevis (African clawed frog)	452	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN31048_c0_g1_i1	Q50KB1	SEP2_EMIHU	54.4	68	28	2	199	5	11	78	1.00E-13	77	SEP2_EMIHU	reviewed	Protein disulfide-isomerase-like protein EhSep2	2-Sep	Emiliania huxleyi (Pontosphaera huxleyi)	223	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0005788			NA	NA	NA	NA	NA	NA
TRINITY_DN31766_c0_g1_i1	Q9MAH3	DJ1B_ARATH	57.5	40	17	0	151	32	396	435	1.50E-05	49.7	DJ1B_ARATH	reviewed	Protein DJ-1 homolog B (AtDJ1B)	DJ1B At1g53280 F12M16.18	Arabidopsis thaliana (Mouse-ear cress)	438	"chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; nucleus [GO:0005634]; glyoxalase III activity [GO:0019172]; protein deglycase activity [GO:0036524]; guanine deglycation, glyoxal removal [GO:0106046]; protein deglycation, glyoxal removal [GO:0036529]"	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; nucleus [GO:0005634]	glyoxalase III activity [GO:0019172]; protein deglycase activity [GO:0036524]	GO:0005634; GO:0005829; GO:0009507; GO:0009570; GO:0019172; GO:0036524; GO:0036529; GO:0106046	"guanine deglycation, glyoxal removal [GO:0106046]; protein deglycation, glyoxal removal [GO:0036529]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13536_c0_g1_i1	Q8BL99	DOP1_MOUSE	48.1	79	41	0	6	242	2006	2084	1.30E-14	80.5	DOP1_MOUSE	reviewed	Protein dopey-1	Dop1a D9Ertd809e Dopey1	Mus musculus (Mouse)	2399	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN13536_c0_g1_i2	Q8BL99	DOP1_MOUSE	51.9	79	38	0	6	242	2006	2084	2.40E-16	86.3	DOP1_MOUSE	reviewed	Protein dopey-1	Dop1a D9Ertd809e Dopey1	Mus musculus (Mouse)	2399	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN13536_c0_g1_i3	Q5JWR5	DOP1_HUMAN	60	45	18	0	6	140	2054	2098	1.20E-07	57.4	DOP1_HUMAN	reviewed	Protein dopey-1	DOP1A DOPEY1 KIAA1117	Homo sapiens (Human)	2465	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3202_c0_g1_i3	Q5JWR5	DOP1_HUMAN	57.4	296	125	1	903	16	1	295	7.70E-95	348.6	DOP1_HUMAN	reviewed	Protein dopey-1	DOP1A DOPEY1 KIAA1117	Homo sapiens (Human)	2465	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3202_c0_g1_i5	Q5JWR5	DOP1_HUMAN	57.4	296	125	1	903	16	1	295	7.80E-95	348.6	DOP1_HUMAN	reviewed	Protein dopey-1	DOP1A DOPEY1 KIAA1117	Homo sapiens (Human)	2465	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i17	Q5JWR5	DOP1_HUMAN	37.5	208	104	6	298	846	1895	2101	1.10E-21	105.5	DOP1_HUMAN	reviewed	Protein dopey-1	DOP1A DOPEY1 KIAA1117	Homo sapiens (Human)	2465	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN3202_c0_g1_i1	A1ZBE8	DOP1_DROME	24.8	844	513	20	2560	125	230	983	1.00E-45	186.8	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3202_c0_g1_i2	A1ZBE8	DOP1_DROME	31.3	1067	610	21	3229	125	8	983	3.10E-124	448	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3202_c0_g1_i4	A1ZBE8	DOP1_DROME	31.3	1067	610	21	3229	125	8	983	3.10E-124	448	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i10	A1ZBE8	DOP1_DROME	51	196	90	2	419	988	2094	2289	6.80E-45	183	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i12	Q292H2	DOP1_DROPS	31.2	224	133	3	6	638	2098	2313	2.10E-21	104	DOP1_DROPS	reviewed	Protein dopey-1 homolog	GA13490	Drosophila pseudoobscura pseudoobscura (Fruit fly)	2629	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i14	Q292H2	DOP1_DROPS	58.2	67	26	1	82	276	2123	2189	8.70E-14	78.2	DOP1_DROPS	reviewed	Protein dopey-1 homolog	GA13490	Drosophila pseudoobscura pseudoobscura (Fruit fly)	2629	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i14	Q292H2	DOP1_DROPS	27.4	157	103	2	6	443	2098	2254	3.80E-09	62.8	DOP1_DROPS	reviewed	Protein dopey-1 homolog	GA13490	Drosophila pseudoobscura pseudoobscura (Fruit fly)	2629	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i2	A1ZBE8	DOP1_DROME	53.3	214	94	2	127	750	2094	2307	1.50E-53	211.1	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i20	A1ZBE8	DOP1_DROME	51.6	153	68	2	419	859	2094	2246	1.00E-32	142.1	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i23	A1ZBE8	DOP1_DROME	51.3	195	89	2	423	989	2095	2289	1.50E-44	181.8	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i3	A1ZBE8	DOP1_DROME	50.3	165	78	1	491	973	2119	2283	2.30E-35	151	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i30	Q292H2	DOP1_DROPS	52.2	67	32	0	82	282	2258	2324	6.70E-12	72	DOP1_DROPS	reviewed	Protein dopey-1 homolog	GA13490	Drosophila pseudoobscura pseudoobscura (Fruit fly)	2629	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i7	A1ZBE8	DOP1_DROME	49.1	165	80	1	491	973	2119	2283	9.70E-34	145.6	DOP1_DROME	reviewed	Protein dopey-1 homolog	CG15099	Drosophila melanogaster (Fruit fly)	2599	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN38977_c0_g1_i1	Q9Y3R5	DOP2_HUMAN	100	44	0	0	202	71	3	46	3.90E-17	88.2	DOP2_HUMAN	reviewed	Protein dopey-2	DOP1B C21orf5 DOPEY2 KIAA0933	Homo sapiens (Human)	2298	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; cognition [GO:0050890]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0007029; GO:0007275; GO:0015031; GO:0050890; GO:0070062	cognition [GO:0050890]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN38977_c0_g1_i1	Q9Y3R5	DOP2_HUMAN	96.2	26	1	0	78	1	162	187	3.10E-06	52	DOP2_HUMAN	reviewed	Protein dopey-2	DOP1B C21orf5 DOPEY2 KIAA0933	Homo sapiens (Human)	2298	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; cognition [GO:0050890]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0007029; GO:0007275; GO:0015031; GO:0050890; GO:0070062	cognition [GO:0050890]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2487_c0_g1_i22	Q642P2	DOP2_XENLA	52.9	70	30	1	11	220	1774	1840	7.00E-12	71.2	DOP2_XENLA	reviewed	Protein dopey-2	dop1b dopey2	Xenopus laevis (African clawed frog)	2270	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN13647_c0_g1_i1	Q642P2	DOP2_XENLA	60.4	48	19	0	11	154	1787	1834	1.00E-08	60.5	DOP2_XENLA	reviewed	Protein dopey-2	dop1b dopey2	Xenopus laevis (African clawed frog)	2270	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]		GO:0000139; GO:0005829; GO:0006895; GO:0015031	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN20399_c0_g1_i1	Q9NYP3	DONS_HUMAN	43.4	143	73	4	439	26	349	488	1.30E-22	107.5	DONS_HUMAN	reviewed	Protein downstream neighbor of Son (B17)	DONSON C21orf60	Homo sapiens (Human)	566	nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint [GO:0007095]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]	nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]		GO:0000077; GO:0005634; GO:0005657; GO:0006260; GO:0007095; GO:0007275; GO:0030894; GO:0033260; GO:0048478	DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint [GO:0007095]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN40837_c0_g1_i1	Q9VNA8	DONS_DROME	66.7	69	23	0	34	240	245	313	6.10E-21	101.3	DONS_DROME	reviewed	Protein downstream neighbor of son homolog (Protein humpty dumpty)	hd CG2669	Drosophila melanogaster (Fruit fly)	568	nucleus [GO:0005634]; cell division [GO:0051301]; eggshell chorion gene amplification [GO:0007307]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0007307; GO:0033260; GO:0051301	cell division [GO:0051301]; eggshell chorion gene amplification [GO:0007307]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]		NA	NA	NA	NA	NA	NA
TRINITY_DN40837_c0_g1_i2	Q9VNA8	DONS_DROME	66.7	69	23	0	34	240	245	313	5.90E-21	101.3	DONS_DROME	reviewed	Protein downstream neighbor of son homolog (Protein humpty dumpty)	hd CG2669	Drosophila melanogaster (Fruit fly)	568	nucleus [GO:0005634]; cell division [GO:0051301]; eggshell chorion gene amplification [GO:0007307]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]	nucleus [GO:0005634]		GO:0005634; GO:0007275; GO:0007307; GO:0033260; GO:0051301	cell division [GO:0051301]; eggshell chorion gene amplification [GO:0007307]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1279_c3_g1_i1	Q9VJQ5	NC2B_DROME	73.3	120	32	0	469	110	8	127	3.80E-46	186	NC2B_DROME	reviewed	Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (dNC2)	NC2beta Dr1 CG4185	Drosophila melanogaster (Fruit fly)	183	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]	core promoter sequence-specific DNA binding [GO:0001046]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001046; GO:0003714; GO:0005634; GO:0005671; GO:0006338; GO:0008134; GO:0016573; GO:0017025; GO:0017054; GO:0042766; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0051123	"chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1279_c3_g1_i3	Q9VJQ5	NC2B_DROME	71.8	124	35	0	481	110	4	127	2.90E-46	186.4	NC2B_DROME	reviewed	Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (dNC2)	NC2beta Dr1 CG4185	Drosophila melanogaster (Fruit fly)	183	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]	core promoter sequence-specific DNA binding [GO:0001046]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001046; GO:0003714; GO:0005634; GO:0005671; GO:0006338; GO:0008134; GO:0016573; GO:0017025; GO:0017054; GO:0042766; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0051123	"chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33590_c0_g1_i1	Q5ZMV3	NC2B_CHICK	100	124	0	0	372	1	1	124	3.70E-62	238.8	NC2B_CHICK	reviewed	Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein)	DR1 RCJMB04_1b9	Gallus gallus (Chicken)	176	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; RNA polymerase II transcription regulator complex [GO:0090575]; core promoter sequence-specific DNA binding [GO:0001046]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; RNA polymerase II transcription regulator complex [GO:0090575]	core promoter sequence-specific DNA binding [GO:0001046]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001046; GO:0003714; GO:0005671; GO:0006338; GO:0016251; GO:0017025; GO:0017054; GO:0043966; GO:0045944; GO:0046982; GO:0051123; GO:0090575	chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]		NA	NA	NA	NA	NA	NA
TRINITY_DN26579_c0_g1_i1	Q6YKA8	DRK_DROSI	85.3	211	31	0	101	733	1	211	1.70E-108	393.7	DRK_DROSI	reviewed	Protein E(sev)2B (Downstream of receptor kinase) (Protein enhancer of sevenless 2B) (SH2-SH3 adapter protein drk)	drk E(sev)2B	Drosophila simulans (Fruit fly)	211	"plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; sevenless binding [GO:0005118]; signaling receptor complex adaptor activity [GO:0030159]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; insulin receptor signaling pathway [GO:0008286]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; sevenless binding [GO:0005118]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001784; GO:0005118; GO:0005154; GO:0005886; GO:0007173; GO:0007265; GO:0007426; GO:0007427; GO:0007476; GO:0007605; GO:0007614; GO:0008022; GO:0008286; GO:0008293; GO:0008355; GO:0008543; GO:0030159; GO:0030707; GO:0032991; GO:0045500; GO:0045793; GO:0048010; GO:0048260; GO:0070374; GO:0098793; GO:1904263	"epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; insulin receptor signaling pathway [GO:0008286]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26579_c0_g1_i2	Q6YKA8	DRK_DROSI	71.9	32	9	0	101	196	1	32	4.50E-05	48.5	DRK_DROSI	reviewed	Protein E(sev)2B (Downstream of receptor kinase) (Protein enhancer of sevenless 2B) (SH2-SH3 adapter protein drk)	drk E(sev)2B	Drosophila simulans (Fruit fly)	211	"plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; sevenless binding [GO:0005118]; signaling receptor complex adaptor activity [GO:0030159]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; insulin receptor signaling pathway [GO:0008286]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; sevenless binding [GO:0005118]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001784; GO:0005118; GO:0005154; GO:0005886; GO:0007173; GO:0007265; GO:0007426; GO:0007427; GO:0007476; GO:0007605; GO:0007614; GO:0008022; GO:0008286; GO:0008293; GO:0008355; GO:0008543; GO:0030159; GO:0030707; GO:0032991; GO:0045500; GO:0045793; GO:0048010; GO:0048260; GO:0070374; GO:0098793; GO:1904263	"epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; insulin receptor signaling pathway [GO:0008286]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3425_c0_g1_i1	Q07139	ECT2_MOUSE	33.9	351	222	7	1104	70	102	448	1.30E-49	198.7	ECT2_MOUSE	reviewed	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	Ect2 mKIAA4037	Mus musculus (Mouse)	913	"bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]"	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0017048; GO:0030496; GO:0030676; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043547; GO:0045666; GO:0045859; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3425_c0_g1_i3	Q9H8V3	ECT2_HUMAN	37	389	231	7	1156	2	124	502	1.10E-62	242.3	ECT2_HUMAN	reviewed	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	ECT2	Homo sapiens (Human)	914	"bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007186; GO:0007399; GO:0015031; GO:0016604; GO:0030496; GO:0030676; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8948_c0_g1_i1	Q9H8V3	ECT2_HUMAN	56.1	155	68	0	543	79	511	665	3.70E-46	186	ECT2_HUMAN	reviewed	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	ECT2	Homo sapiens (Human)	914	"bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007186; GO:0007399; GO:0015031; GO:0016604; GO:0030496; GO:0030676; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8948_c0_g1_i2	Q9H8V3	ECT2_HUMAN	49.1	293	144	2	885	10	511	799	1.50E-76	287.7	ECT2_HUMAN	reviewed	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	ECT2	Homo sapiens (Human)	914	"bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007186; GO:0007399; GO:0015031; GO:0016604; GO:0030496; GO:0030676; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14209_c0_g1_i1	Q8WYP5	ELYS_HUMAN	35.2	330	202	5	4	987	645	964	1.10E-51	205.3	ELYS_HUMAN	reviewed	Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1)	AHCTF1 ELYS TMBS62 MSTP108	Homo sapiens (Human)	2266	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000777; GO:0003677; GO:0003700; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0007049; GO:0015031; GO:0016363; GO:0031965; GO:0032465; GO:0051028; GO:0051292; GO:0051301; GO:0070062	cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN35654_c0_g1_i2	Q8T4F7	ENA_DROME	54.9	71	30	1	102	314	912	980	8.20E-10	64.7	ENA_DROME	reviewed	Protein enabled	ena enb CG15112	Drosophila melanogaster (Fruit fly)	980	"axon [GO:0030424]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; subsynaptic reticulum [GO:0071212]; actin binding [GO:0003779]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; filopodium assembly [GO:0046847]; formation of a compartment boundary [GO:0060288]; germ-band shortening [GO:0007390]; gonad morphogenesis [GO:0035262]; head involution [GO:0008258]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of cell migration [GO:0030335]; positive regulation of cell projection organization [GO:0031346]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; subsynaptic reticulum organization [GO:1990255]; suture of dorsal opening [GO:0007396]"	axon [GO:0030424]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; subsynaptic reticulum [GO:0071212]	actin binding [GO:0003779]; SH3 domain binding [GO:0017124]	GO:0003382; GO:0003779; GO:0005829; GO:0005856; GO:0007015; GO:0007298; GO:0007303; GO:0007390; GO:0007391; GO:0007396; GO:0007409; GO:0007411; GO:0008258; GO:0010591; GO:0017124; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0030425; GO:0031252; GO:0031346; GO:0032433; GO:0032956; GO:0035262; GO:0045886; GO:0046847; GO:0048749; GO:0048813; GO:0051489; GO:0051491; GO:0060288; GO:0071212; GO:1990255	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; filopodium assembly [GO:0046847]; formation of a compartment boundary [GO:0060288]; germ-band shortening [GO:0007390]; gonad morphogenesis [GO:0035262]; head involution [GO:0008258]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of cell migration [GO:0030335]; positive regulation of cell projection organization [GO:0031346]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; subsynaptic reticulum organization [GO:1990255]; suture of dorsal opening [GO:0007396]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30719_c0_g1_i1	Q8N8S7	ENAH_HUMAN	78.2	110	24	0	380	51	3	112	2.60E-47	189.5	ENAH_HUMAN	reviewed	Protein enabled homolog	ENAH MENA	Homo sapiens (Human)	591	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]	actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358	actin polymerization-dependent cell motility [GO:0070358]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]		NA	NA	NA	NA	NA	NA
TRINITY_DN30719_c0_g1_i2	Q8N8S7	ENAH_HUMAN	78.6	112	24	0	386	51	1	112	1.10E-48	194.1	ENAH_HUMAN	reviewed	Protein enabled homolog	ENAH MENA	Homo sapiens (Human)	591	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]	actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358	actin polymerization-dependent cell motility [GO:0070358]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]		blue	blue	NA	NA	NA	NA
TRINITY_DN24149_c0_g1_i2	P49257	LMAN1_HUMAN	96.6	118	4	0	355	2	75	192	8.10E-63	240.7	LMAN1_HUMAN	reviewed	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)	LMAN1 ERGIC53 F5F8D	Homo sapiens (Human)	510	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0018279; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0048208; GO:0051082; GO:0062023; GO:0070062; GO:1903215	blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN154_c0_g1_i1	P49257	LMAN1_HUMAN	57.5	320	131	2	1024	80	42	361	1.20E-96	354.8	LMAN1_HUMAN	reviewed	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)	LMAN1 ERGIC53 F5F8D	Homo sapiens (Human)	510	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0018279; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0048208; GO:0051082; GO:0062023; GO:0070062; GO:1903215	blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN154_c0_g1_i2	P49257	LMAN1_HUMAN	48.6	490	221	10	1529	90	42	510	8.50E-115	415.6	LMAN1_HUMAN	reviewed	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)	LMAN1 ERGIC53 F5F8D	Homo sapiens (Human)	510	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0018279; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0048208; GO:0051082; GO:0062023; GO:0070062; GO:1903215	blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN30494_c0_g1_i1	P49257	LMAN1_HUMAN	100	110	0	0	331	2	169	278	2.40E-61	235.7	LMAN1_HUMAN	reviewed	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)	LMAN1 ERGIC53 F5F8D	Homo sapiens (Human)	510	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0018279; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0048208; GO:0051082; GO:0062023; GO:0070062; GO:1903215	blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN24149_c0_g1_i1	Q9D0F3	LMAN1_MOUSE	100	93	0	0	280	2	108	200	9.60E-51	200.3	LMAN1_MOUSE	reviewed	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1) (p58)	Lman1 Ergic53	Mus musculus (Mouse)	517	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; sarcomere [GO:0030017]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of organelle organization [GO:0010638]; protein transport [GO:0015031]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; sarcomere [GO:0030017]	identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0007029; GO:0007030; GO:0010638; GO:0015031; GO:0016021; GO:0030017; GO:0030134; GO:0033116; GO:0042802; GO:0043231; GO:0044220; GO:0046872; GO:0062023	endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of organelle organization [GO:0010638]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN25450_c0_g1_i1	P18491	EMC_DROME	54.8	73	31	1	29	241	23	95	1.30E-14	80.1	EMC_DROME	reviewed	Protein extra-macrochaetae	emc CG1007	Drosophila melanogaster (Fruit fly)	199	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian regulation of gene expression [GO:0032922]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007368; GO:0007391; GO:0007458; GO:0007476; GO:0007494; GO:0007530; GO:0008258; GO:0008407; GO:0008586; GO:0030154; GO:0030381; GO:0032922; GO:0042675; GO:0043392; GO:0045466; GO:0045892; GO:0046552; GO:0046843; GO:0046982; GO:0048056; GO:0061525	"cell differentiation [GO:0030154]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian regulation of gene expression [GO:0032922]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36942_c0_g1_i1	P18491	EMC_DROME	46.7	60	29	1	20	190	22	81	1.50E-07	56.6	EMC_DROME	reviewed	Protein extra-macrochaetae	emc CG1007	Drosophila melanogaster (Fruit fly)	199	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian regulation of gene expression [GO:0032922]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007368; GO:0007391; GO:0007458; GO:0007476; GO:0007494; GO:0007530; GO:0008258; GO:0008407; GO:0008586; GO:0030154; GO:0030381; GO:0032922; GO:0042675; GO:0043392; GO:0045466; GO:0045892; GO:0046552; GO:0046843; GO:0046982; GO:0048056; GO:0061525	"cell differentiation [GO:0030154]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian regulation of gene expression [GO:0032922]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]"		blue	blue	NA	NA	NA	NA
TRINITY_DN16974_c0_g1_i1	A0A1F4	EYS_DROME	25	1304	675	37	3509	57	1013	2166	6.20E-102	374	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i10	A0A1F4	EYS_DROME	50.4	284	132	3	130	981	137	411	9.10E-88	325.9	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i11	A0A1F4	EYS_DROME	54.3	197	84	2	82	672	221	411	4.20E-67	256.9	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i12	A0A1F4	EYS_DROME	54.3	197	84	2	134	724	221	411	7.50E-67	256.1	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i7	A0A1F4	EYS_DROME	52.1	165	74	1	123	617	221	380	7.10E-55	215.3	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c1_g1_i9	A0A1F4	EYS_DROME	54.3	197	84	2	123	713	221	411	4.30E-67	256.9	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]		NA	NA	NA	NA	NA	NA
TRINITY_DN37206_c0_g1_i1	B8JI71	EYS_DANRE	42.1	76	44	0	271	44	679	754	1.60E-13	76.6	EYS_DANRE	reviewed	Protein eyes shut homolog	eys	Danio rerio (Zebrafish) (Brachydanio rerio)	2904	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; interphotoreceptor matrix [GO:0033165]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; actin filament organization [GO:0007015]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; response to stimulus [GO:0050896]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; interphotoreceptor matrix [GO:0033165]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0005112; GO:0005509; GO:0005737; GO:0005856; GO:0005929; GO:0007015; GO:0007601; GO:0033165; GO:0035845; GO:0045494; GO:0046549; GO:0050896	actin filament organization [GO:0007015]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; response to stimulus [GO:0050896]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN21633_c0_g1_i1	Q5T9C2	F102A_HUMAN	62.9	116	41	2	893	552	38	153	2.40E-31	137.5	F102A_HUMAN	reviewed	Protein FAM102A (Early estrogen-induced gene 1 protein)	FAM102A C9orf132 EEIG1	Homo sapiens (Human)	384							NA	NA	NA	NA	NA	NA
TRINITY_DN21633_c0_g1_i2	Q5T9C2	F102A_HUMAN	62.2	119	43	2	661	311	38	156	3.60E-32	139.8	F102A_HUMAN	reviewed	Protein FAM102A (Early estrogen-induced gene 1 protein)	FAM102A C9orf132 EEIG1	Homo sapiens (Human)	384							NA	NA	NA	NA	NA	NA
TRINITY_DN38641_c0_g1_i1	Q5T9C2	F102A_HUMAN	99	100	1	0	302	3	54	153	9.10E-55	213.8	F102A_HUMAN	reviewed	Protein FAM102A (Early estrogen-induced gene 1 protein)	FAM102A C9orf132 EEIG1	Homo sapiens (Human)	384							NA	NA	NA	NA	NA	NA
TRINITY_DN15412_c0_g1_i1	Q6AYT4	F122A_RAT	34.6	269	103	11	954	157	15	213	5.00E-20	100.1	F122A_RAT	reviewed	Protein FAM122A	Fam122a	Rattus norvegicus (Rat)	286	protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]		protein serine/threonine phosphatase inhibitor activity [GO:0004865]	GO:0004865; GO:0030307; GO:0032436	positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]		NA	NA	NA	NA	NA	NA
TRINITY_DN7595_c0_g1_i1	Q9P2D6	F135A_HUMAN	31.6	253	156	5	1277	537	172	413	1.70E-25	118.6	F135A_HUMAN	reviewed	Protein FAM135A	FAM135A KIAA1411	Homo sapiens (Human)	1515	cellular lipid metabolic process [GO:0044255]			GO:0044255	cellular lipid metabolic process [GO:0044255]		NA	NA	NA	NA	NA	NA
TRINITY_DN7595_c0_g2_i1	Q5RA75	F135A_PONAB	62.8	296	107	2	928	41	803	1095	6.20E-108	392.1	F135A_PONAB	reviewed	Protein FAM135A	FAM135A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	1095							NA	NA	NA	NA	NA	NA
TRINITY_DN7595_c0_g2_i2	Q641I1	F135B_XENLA	61.7	316	117	2	988	41	1065	1376	2.90E-113	411	F135B_XENLA	reviewed	Protein FAM135B	fam135b	Xenopus laevis (African clawed frog)	1376							NA	NA	NA	NA	NA	NA
TRINITY_DN7595_c0_g2_i3	Q641I1	F135B_XENLA	61.7	316	117	2	988	41	1065	1376	1.50E-113	411	F135B_XENLA	reviewed	Protein FAM135B	fam135b	Xenopus laevis (African clawed frog)	1376							NA	NA	NA	NA	NA	NA
TRINITY_DN1080_c0_g1_i1	O94988	FA13A_HUMAN	37.1	213	102	6	199	765	772	976	3.00E-22	107.1	FA13A_HUMAN	reviewed	Protein FAM13A	FAM13A FAM13A1 KIAA0914	Homo sapiens (Human)	1023	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1080_c0_g1_i2	O94988	FA13A_HUMAN	33.3	433	219	19	886	2025	561	976	9.10E-34	146.7	FA13A_HUMAN	reviewed	Protein FAM13A	FAM13A FAM13A1 KIAA0914	Homo sapiens (Human)	1023	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1080_c0_g1_i3	O94988	FA13A_HUMAN	33.3	433	219	19	501	1640	561	976	7.40E-34	146.7	FA13A_HUMAN	reviewed	Protein FAM13A	FAM13A FAM13A1 KIAA0914	Homo sapiens (Human)	1023	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8216_c0_g1_i1	Q6UXP7	F151B_HUMAN	38	187	106	4	2	559	85	262	6.50E-24	112.5	F151B_HUMAN	reviewed	Protein FAM151B	FAM151B UNQ9217/PRO28685	Homo sapiens (Human)	276							NA	NA	NA	NA	NA	NA
TRINITY_DN17234_c0_g1_i1	A0JPG1	F16B1_XENLA	30.7	765	464	15	169	2346	1	738	3.00E-81	304.7	F16B1_XENLA	reviewed	Protein FAM160B1	fam160b1	Xenopus laevis (African clawed frog)	744							NA	NA	NA	NA	NA	NA
TRINITY_DN17234_c0_g1_i6	A0JNG7	F16B1_BOVIN	41.7	132	75	1	252	647	630	759	4.80E-21	102.8	F16B1_BOVIN	reviewed	Protein FAM160B1	FAM160B1	Bos taurus (Bovine)	765							NA	NA	NA	NA	NA	NA
TRINITY_DN17234_c0_g1_i2	Q80YR2	F16B2_MOUSE	33.3	180	116	3	169	708	1	176	1.80E-17	91.3	F16B2_MOUSE	reviewed	Protein FAM160B2 (Retinoic acid-induced protein 16)	Fam160b2 Rai16	Mus musculus (Mouse)	744							NA	NA	NA	NA	NA	NA
TRINITY_DN17234_c0_g1_i5	Q86V87	F16B2_HUMAN	35.8	109	67	2	169	495	1	106	8.00E-09	62	F16B2_HUMAN	reviewed	Protein FAM160B2 (Retinoic acid-induced protein 16)	FAM160B2 RAI16 FP13191	Homo sapiens (Human)	743							NA	NA	NA	NA	NA	NA
TRINITY_DN6300_c0_g1_i1	Q96KS9	F167A_HUMAN	34.7	199	97	6	604	89	21	213	1.50E-17	91.3	F167A_HUMAN	reviewed	Protein FAM167A	FAM167A C8orf13	Homo sapiens (Human)	214							blue	blue	NA	NA	NA	NA
TRINITY_DN359_c1_g3_i1	Q8N128	F177A_HUMAN	43.8	96	48	3	185	469	49	139	3.40E-15	84	F177A_HUMAN	reviewed	Protein FAM177A1	FAM177A1 C14orf24	Homo sapiens (Human)	213							NA	NA	NA	NA	NA	NA
TRINITY_DN359_c1_g3_i3	Q8N128	F177A_HUMAN	43.8	96	48	3	185	469	49	139	3.20E-15	84	F177A_HUMAN	reviewed	Protein FAM177A1	FAM177A1 C14orf24	Homo sapiens (Human)	213							NA	NA	NA	NA	NA	NA
TRINITY_DN15450_c0_g1_i4	Q4R6P1	F200A_MACFA	50.8	59	29	0	194	18	265	323	6.60E-09	60.8	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN31637_c0_g1_i1	Q4R6P1	F200A_MACFA	49.5	103	48	1	5	313	271	369	2.10E-20	99.8	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN13436_c0_g1_i1	Q8TCP9	F200A_HUMAN	40.7	59	35	0	22	198	71	129	2.20E-07	55.8	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			brown	brown	NA	NA	NA	NA
TRINITY_DN13436_c0_g1_i2	Q8TCP9	F200A_HUMAN	39	59	36	0	22	198	71	129	1.50E-06	53.1	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i1	Q8TCP9	F200A_HUMAN	40.9	137	79	2	407	3	419	555	1.20E-19	98.2	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i6	Q4R6P1	F200A_MACFA	48.8	121	61	1	492	133	260	380	3.80E-26	119.4	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i7	Q8TCP9	F200A_HUMAN	40.9	137	80	1	410	3	419	555	6.70E-21	102.1	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8009_c0_g1_i5	Q4R6P1	F200A_MACFA	50.7	75	33	1	12	224	265	339	3.90E-16	85.1	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i4	Q4R6P1	F200A_MACFA	29.2	281	175	7	123	914	300	573	1.30E-21	105.5	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c0_g1_i9	Q4R6P1	F200A_MACFA	27.7	274	174	7	1	771	307	573	1.30E-17	92	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4165_c6_g1_i4	Q4R6P1	F200A_MACFA	42	100	53	1	14	298	265	364	3.90E-11	69.3	F200A_MACFA	reviewed	Protein FAM200A	FAM200A QtsA-17507	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN7279_c0_g4_i1	Q8TCP9	F200A_HUMAN	53.7	67	31	0	221	21	297	363	5.70E-14	77.8	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN7279_c0_g4_i2	Q8TCP9	F200A_HUMAN	53.4	88	41	0	284	21	276	363	6.80E-20	97.8	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN23242_c1_g1_i1	Q8TCP9	F200A_HUMAN	49.3	67	34	0	212	12	494	560	6.30E-11	67.8	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN12806_c1_g1_i1	Q8TCP9	F200A_HUMAN	56.1	57	23	2	206	36	516	570	3.20E-08	59.3	F200A_HUMAN	reviewed	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)	573	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN1975_c0_g2_i2	P0CF97	F200B_HUMAN	42.2	64	37	0	71	262	345	408	7.80E-09	61.2	F200B_HUMAN	reviewed	Protein FAM200B	FAM200B C4orf53	Homo sapiens (Human)	657							NA	NA	NA	NA	NA	NA
TRINITY_DN1975_c0_g2_i3	P0CF97	F200B_HUMAN	40.6	64	38	0	71	262	345	408	1.30E-08	60.5	F200B_HUMAN	reviewed	Protein FAM200B	FAM200B C4orf53	Homo sapiens (Human)	657							NA	NA	NA	NA	NA	NA
TRINITY_DN14580_c0_g1_i1	P0CF97	F200B_HUMAN	48.3	118	61	0	358	5	350	467	9.40E-27	120.9	F200B_HUMAN	reviewed	Protein FAM200B	FAM200B C4orf53	Homo sapiens (Human)	657							NA	NA	NA	NA	NA	NA
TRINITY_DN37_c0_g1_i2	Q96KR6	F210B_HUMAN	37.9	169	63	2	772	1278	65	191	4.30E-19	97.4	F210B_HUMAN	reviewed	"Protein FAM210B, mitochondrial"	FAM210B C20orf108 PSEC0265	Homo sapiens (Human)	192	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648]	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0005739; GO:0005741; GO:0016021; GO:0031224; GO:0043249; GO:0045648; GO:0071392	cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648]		NA	NA	NA	NA	NA	NA
TRINITY_DN37_c0_g1_i3	Q96KR6	F210B_HUMAN	64.2	53	19	0	702	860	139	191	6.00E-12	73.2	F210B_HUMAN	reviewed	"Protein FAM210B, mitochondrial"	FAM210B C20orf108 PSEC0265	Homo sapiens (Human)	192	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648]	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0005739; GO:0005741; GO:0016021; GO:0031224; GO:0043249; GO:0045648; GO:0071392	cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648]		NA	NA	NA	NA	NA	NA
TRINITY_DN3263_c0_g1_i1	Q1LV22	F214A_DANRE	58	219	68	6	166	783	781	988	1.10E-57	224.9	F214A_DANRE	reviewed	Protein FAM214A	fam214a si:dkey-266j9.3	Danio rerio (Zebrafish) (Brachydanio rerio)	989							NA	NA	NA	NA	NA	NA
TRINITY_DN3263_c0_g1_i3	Q1LV22	F214A_DANRE	48.2	311	116	9	2659	3546	708	988	6.80E-64	247.7	F214A_DANRE	reviewed	Protein FAM214A	fam214a si:dkey-266j9.3	Danio rerio (Zebrafish) (Brachydanio rerio)	989							NA	NA	NA	NA	NA	NA
TRINITY_DN3263_c0_g1_i4	Q1LV22	F214A_DANRE	48.2	311	116	9	2633	3520	708	988	6.80E-64	247.7	F214A_DANRE	reviewed	Protein FAM214A	fam214a si:dkey-266j9.3	Danio rerio (Zebrafish) (Brachydanio rerio)	989							NA	NA	NA	NA	NA	NA
TRINITY_DN3263_c0_g1_i6	Q5FW46	F214A_XENTR	48.3	323	126	11	1669	2583	646	945	2.00E-65	252.3	F214A_XENTR	reviewed	Protein FAM214A	fam214a TGas096p02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	946							NA	NA	NA	NA	NA	NA
TRINITY_DN32889_c0_g1_i1	Q5FW46	F214A_XENTR	36.7	207	120	5	689	96	23	227	2.00E-29	131	F214A_XENTR	reviewed	Protein FAM214A	fam214a TGas096p02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	946							NA	NA	NA	NA	NA	NA
TRINITY_DN451_c0_g1_i1	A6QR31	FA32A_BOVIN	51.9	108	48	1	88	411	9	112	2.00E-14	80.5	FA32A_BOVIN	reviewed	Protein FAM32A (Ovarian tumor associated gene 12) (OTAG-12)	FAM32A OTAG12	Bos taurus (Bovine)	112	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0006915; GO:0007049	apoptotic process [GO:0006915]; cell cycle [GO:0007049]		blue	blue	NA	NA	NA	NA
TRINITY_DN451_c0_g1_i2	A6QR31	FA32A_BOVIN	80.5	41	8	0	81	203	72	112	7.70E-14	77.8	FA32A_BOVIN	reviewed	Protein FAM32A (Ovarian tumor associated gene 12) (OTAG-12)	FAM32A OTAG12	Bos taurus (Bovine)	112	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0006915; GO:0007049	apoptotic process [GO:0006915]; cell cycle [GO:0007049]		blue	blue	NA	NA	NA	NA
TRINITY_DN39991_c0_g1_i1	A6QR31	FA32A_BOVIN	100	60	0	0	239	60	53	112	8.50E-27	120.6	FA32A_BOVIN	reviewed	Protein FAM32A (Ovarian tumor associated gene 12) (OTAG-12)	FAM32A OTAG12	Bos taurus (Bovine)	112	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0006915; GO:0007049	apoptotic process [GO:0006915]; cell cycle [GO:0007049]		NA	NA	NA	NA	NA	NA
TRINITY_DN28638_c0_g1_i1	A6QR31	FA32A_BOVIN	49	51	26	0	7	159	58	108	2.10E-06	52.8	FA32A_BOVIN	reviewed	Protein FAM32A (Ovarian tumor associated gene 12) (OTAG-12)	FAM32A OTAG12	Bos taurus (Bovine)	112	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005730; GO:0006915; GO:0007049	apoptotic process [GO:0006915]; cell cycle [GO:0007049]		red	red	NA	NA	NA	NA
TRINITY_DN12003_c0_g1_i1	Q9VAY7	FAM50_DROME	47.6	170	83	3	13	516	193	358	5.30E-37	155.6	FAM50_DROME	reviewed	Protein FAM50 homolog	CG12259	Drosophila melanogaster (Fruit fly)	359	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN6817_c0_g1_i1	Q7PYQ5	FAM50_ANOGA	68.7	83	26	0	679	927	1	83	8.00E-23	109.4	FAM50_ANOGA	reviewed	Protein FAM50 homolog	AGAP002062	Anopheles gambiae (African malaria mosquito)	358	nucleus [GO:0005634]; chromatin organization [GO:0006325]	nucleus [GO:0005634]		GO:0005634; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN6817_c0_g1_i2	Q7PYQ5	FAM50_ANOGA	68.7	83	26	0	679	927	1	83	8.00E-23	109.4	FAM50_ANOGA	reviewed	Protein FAM50 homolog	AGAP002062	Anopheles gambiae (African malaria mosquito)	358	nucleus [GO:0005634]; chromatin organization [GO:0006325]	nucleus [GO:0005634]		GO:0005634; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN4974_c0_g2_i1	Q9VAY7	FAM50_DROME	78.4	194	42	0	672	91	165	358	1.50E-88	327.4	FAM50_DROME	reviewed	Protein FAM50 homolog	CG12259	Drosophila melanogaster (Fruit fly)	359	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN4974_c0_g1_i1	Q14320	FA50A_HUMAN	99.2	131	1	0	396	4	155	285	1.60E-58	226.9	FA50A_HUMAN	reviewed	Protein FAM50A (Protein HXC-26) (Protein XAP-5)	FAM50A DXS9928E HXC26 XAP5	Homo sapiens (Human)	339	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]; spermatogenesis [GO:0007283]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0007283	chromatin organization [GO:0006325]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN28831_c0_g1_i1	Q9WV03	FA50A_MOUSE	100	78	0	0	234	1	209	286	5.40E-39	161	FA50A_MOUSE	reviewed	Protein FAM50A (Protein XAP-5)	Fam50a D0HXS9928E Xap5	Mus musculus (Mouse)	339	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin organization [GO:0006325]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN27426_c0_g1_i1	Q9Y247	FA50B_HUMAN	81.2	80	15	0	19	258	140	219	3.60E-28	125.2	FA50B_HUMAN	reviewed	Protein FAM50B (Protein XAP-5-like)	FAM50B X5L	Homo sapiens (Human)	325	nucleus [GO:0005634]; chromatin organization [GO:0006325]	nucleus [GO:0005634]		GO:0005634; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN1553_c0_g1_i1	Q5EA89	FA76A_BOVIN	48.6	325	147	7	1099	128	1	306	2.50E-73	277.3	FA76A_BOVIN	reviewed	Protein FAM76A	FAM76A	Bos taurus (Bovine)	307	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1553_c0_g1_i2	Q5EA89	FA76A_BOVIN	45.2	73	35	2	297	82	119	187	3.10E-07	55.8	FA76A_BOVIN	reviewed	Protein FAM76A	FAM76A	Bos taurus (Bovine)	307	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			blue	blue	NA	NA	NA	NA
TRINITY_DN1553_c0_g1_i3	Q5EA89	FA76A_BOVIN	47.6	332	147	8	1120	128	1	306	2.30E-71	270.8	FA76A_BOVIN	reviewed	Protein FAM76A	FAM76A	Bos taurus (Bovine)	307	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1553_c0_g1_i4	Q5EA89	FA76A_BOVIN	35.4	192	109	4	670	128	119	306	5.20E-18	92.8	FA76A_BOVIN	reviewed	Protein FAM76A	FAM76A	Bos taurus (Bovine)	307	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN30052_c0_g1_i1	Q5HYJ3	FA76B_HUMAN	100	85	0	0	255	1	5	89	2.60E-47	188.7	FA76B_HUMAN	reviewed	Protein FAM76B	FAM76B	Homo sapiens (Human)	339	nuclear speck [GO:0016607]	nuclear speck [GO:0016607]		GO:0016607			NA	NA	NA	NA	NA	NA
TRINITY_DN33638_c0_g1_i1	Q3UVG3	F91A1_MOUSE	97.8	93	2	0	3	281	42	134	2.20E-47	189.1	F91A1_MOUSE	reviewed	Protein FAM91A1	Fam91a1 D15Ertd621e Kiaa0493	Mus musculus (Mouse)	837	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2656_c0_g1_i1	Q6TEP1	F91A1_DANRE	69.9	123	37	0	394	26	3	125	2.50E-44	179.5	F91A1_DANRE	reviewed	Protein FAM91A1	fam91a1 si:dkey-5e12.2 zgc:63609	Danio rerio (Zebrafish) (Brachydanio rerio)	831	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2656_c0_g1_i10	Q3UVG3	F91A1_MOUSE	49.3	876	360	14	2587	47	4	824	8.20E-221	768.5	F91A1_MOUSE	reviewed	Protein FAM91A1	Fam91a1 D15Ertd621e Kiaa0493	Mus musculus (Mouse)	837	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2656_c0_g1_i12	Q3UVG3	F91A1_MOUSE	55.5	548	210	8	1877	300	124	659	9.00E-161	568.5	F91A1_MOUSE	reviewed	Protein FAM91A1	Fam91a1 D15Ertd621e Kiaa0493	Mus musculus (Mouse)	837	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN39648_c0_g1_i1	Q658Y4	F91A1_HUMAN	100	118	0	0	2	355	204	321	1.60E-63	243	F91A1_HUMAN	reviewed	Protein FAM91A1	FAM91A1	Homo sapiens (Human)	838	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN31073_c0_g1_i1	Q3UVG3	F91A1_MOUSE	100	75	0	0	225	1	373	447	1.20E-35	149.8	F91A1_MOUSE	reviewed	Protein FAM91A1	Fam91a1 D15Ertd621e Kiaa0493	Mus musculus (Mouse)	837	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN4599_c0_g1_i2	Q3TJZ6	FA98A_MOUSE	44.1	315	170	3	1003	62	6	315	2.80E-66	253.8	FA98A_MOUSE	reviewed	Protein FAM98A	Fam98a	Mus musculus (Mouse)	515	tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]	tRNA-splicing ligase complex [GO:0072669]	protein methyltransferase activity [GO:0008276]	GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029	lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]		NA	NA	NA	NA	NA	NA
TRINITY_DN4599_c0_g1_i4	Q8NCA5	FA98A_HUMAN	46.2	143	71	3	568	143	6	143	1.90E-22	107.5	FA98A_HUMAN	reviewed	Protein FAM98A	FAM98A	Homo sapiens (Human)	518	tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]	tRNA-splicing ligase complex [GO:0072669]	protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]	GO:0003723; GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029	lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]		NA	NA	NA	NA	NA	NA
TRINITY_DN2543_c0_g1_i12	Q8CG73	FTM_MOUSE	26.2	206	128	5	222	824	27	213	6.90E-06	53.1	FTM_MOUSE	reviewed	Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein)	Rpgrip1l Ftm Nphp8	Mus musculus (Mouse)	1264	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]; telencephalon development [GO:0021537]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]	thromboxane A2 receptor binding [GO:0031870]	GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035108; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515	brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN2543_c0_g1_i6	Q8CG73	FTM_MOUSE	26.2	206	128	5	297	899	27	213	7.40E-06	53.1	FTM_MOUSE	reviewed	Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein)	Rpgrip1l Ftm Nphp8	Mus musculus (Mouse)	1264	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]; telencephalon development [GO:0021537]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]	thromboxane A2 receptor binding [GO:0031870]	GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035108; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515	brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN0_c10_g1_i1	P49356	FNTB_HUMAN	53.3	424	196	1	1362	91	12	433	1.90E-134	480.7	FNTB_HUMAN	reviewed	Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta)	FNTB	Homo sapiens (Human)	437	cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965]	protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]	GO:0004660; GO:0005829; GO:0005875; GO:0005965; GO:0008270; GO:0018342; GO:0018343; GO:0022400	protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; regulation of rhodopsin mediated signaling pathway [GO:0022400]		blue	blue	NA	NA	NA	NA
TRINITY_DN36219_c0_g1_i1	P49355	FNTB_BOVIN	52.9	306	138	3	3	902	99	404	1.30E-93	344.4	FNTB_BOVIN	reviewed	Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta)	FNTB	Bos taurus (Bovine)	437	protein farnesyltransferase complex [GO:0005965]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060]	protein farnesyltransferase complex [GO:0005965]	farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]	GO:0004311; GO:0004660; GO:0005965; GO:0008270; GO:0008285; GO:0018342; GO:0018343; GO:0042060; GO:0048146	negative regulation of cell population proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN11683_c0_g1_i1	P49354	FNTA_HUMAN	99.5	218	1	0	655	2	39	256	9.70E-126	450.7	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN11683_c0_g1_i2	P49354	FNTA_HUMAN	98.1	209	4	0	628	2	48	256	3.40E-120	432.2	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN11683_c0_g2_i1	Q61239	FNTA_MOUSE	100	114	0	0	342	1	144	257	7.80E-63	240.7	FNTA_MOUSE	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	Fnta	Mus musculus (Mouse)	377	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; negative regulation of apoptotic process [GO:0043066]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; response to cytokine [GO:0034097]; response to inorganic substance [GO:0010035]; response to organic cyclic compound [GO:0014070]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005875; GO:0005953; GO:0005965; GO:0008017; GO:0008284; GO:0010035; GO:0014070; GO:0018343; GO:0018344; GO:0030548; GO:0030971; GO:0034097; GO:0043014; GO:0043066; GO:0045213; GO:0045787; GO:0051770; GO:0051771; GO:0090044; GO:0090045	negative regulation of apoptotic process [GO:0043066]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; response to cytokine [GO:0034097]; response to inorganic substance [GO:0010035]; response to organic cyclic compound [GO:0014070]		NA	NA	NA	NA	NA	NA
TRINITY_DN3428_c0_g1_i2	P49354	FNTA_HUMAN	52.1	328	148	4	104	1078	45	366	4.10E-95	349.7	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	1
TRINITY_DN3428_c0_g1_i3	P49354	FNTA_HUMAN	52.1	328	148	4	121	1095	45	366	5.40E-95	349.4	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN3428_c0_g1_i4	P49354	FNTA_HUMAN	59.1	171	69	1	104	616	45	214	2.30E-55	216.9	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN3428_c0_g1_i5	P49354	FNTA_HUMAN	58.1	172	71	1	121	636	45	215	1.30E-54	214.5	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN3428_c0_g1_i6	P49354	FNTA_HUMAN	58.1	172	71	1	104	619	45	215	1.20E-54	214.5	FNTA_HUMAN	reviewed	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	FNTA	Homo sapiens (Human)	379	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]	acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN9220_c0_g1_i1	Q9BKZ9	FEH1_CAEEL	80	55	11	0	9	173	409	463	2.20E-21	102.8	FEH1_CAEEL	reviewed	Protein Fe65 homolog	feh-1 Y54F10AM.2	Caenorhabditis elegans	665	"actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]"	actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]	GO:0001540; GO:0002119; GO:0005634; GO:0005737; GO:0005884; GO:0006355; GO:0007631; GO:0008134; GO:0009792	"embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9220_c0_g1_i2	Q9BKZ9	FEH1_CAEEL	46.1	284	112	7	9	824	409	663	1.30E-60	235	FEH1_CAEEL	reviewed	Protein Fe65 homolog	feh-1 Y54F10AM.2	Caenorhabditis elegans	665	"actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]"	actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]	GO:0001540; GO:0002119; GO:0005634; GO:0005737; GO:0005884; GO:0006355; GO:0007631; GO:0008134; GO:0009792	"embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9220_c0_g1_i3	Q9BKZ9	FEH1_CAEEL	44.6	184	89	5	39	554	481	663	2.10E-36	154.1	FEH1_CAEEL	reviewed	Protein Fe65 homolog	feh-1 Y54F10AM.2	Caenorhabditis elegans	665	"actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]"	actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]	GO:0001540; GO:0002119; GO:0005634; GO:0005737; GO:0005884; GO:0006355; GO:0007631; GO:0008134; GO:0009792	"embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3852_c0_g1_i1	Q6P9Z4	FEM1A_DANRE	33.1	625	392	11	171	2015	9	617	3.60E-86	320.9	FEM1A_DANRE	reviewed	Protein fem-1 homolog A (FEM1a) (FEM1-alpha)	fem1a zgc:63483	Danio rerio (Zebrafish) (Brachydanio rerio)	617	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; negative regulation of inflammatory response [GO:0050728]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005737; GO:0006511; GO:0016567; GO:0050728; GO:0051438	negative regulation of inflammatory response [GO:0050728]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN24673_c0_g1_i5	Q6P9Z4	FEM1A_DANRE	46.7	368	170	9	77	1171	273	617	5.20E-80	299.7	FEM1A_DANRE	reviewed	Protein fem-1 homolog A (FEM1a) (FEM1-alpha)	fem1a zgc:63483	Danio rerio (Zebrafish) (Brachydanio rerio)	617	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; negative regulation of inflammatory response [GO:0050728]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005737; GO:0006511; GO:0016567; GO:0050728; GO:0051438	negative regulation of inflammatory response [GO:0050728]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31566_c0_g1_i1	Q9BSK4	FEM1A_HUMAN	96.5	114	4	0	344	3	139	252	3.40E-58	225.3	FEM1A_HUMAN	reviewed	Protein fem-1 homolog A (FEM1a) (FEM1-alpha) (Prostaglandin E receptor 4-associated protein)	FEM1A EPRAP	Homo sapiens (Human)	669	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; EP4 subtype prostaglandin E2 receptor binding [GO:0031867]; negative regulation of inflammatory response [GO:0050728]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]	EP4 subtype prostaglandin E2 receptor binding [GO:0031867]	GO:0000151; GO:0005829; GO:0006511; GO:0016567; GO:0031867; GO:0043687; GO:0050728; GO:0051438	negative regulation of inflammatory response [GO:0050728]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3088_c0_g1_i1	Q5ZM55	FEM1B_CHICK	49.3	683	289	3	2182	137	1	627	1.90E-184	647.5	FEM1B_CHICK	reviewed	Protein fem-1 homolog B (FEM1b) (FEM1-beta)	FEM1B RCJMB04_3b14	Gallus gallus (Chicken)	627	cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:2000001	apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]		blue	blue	NA	NA	NA	NA
TRINITY_DN33749_c0_g1_i1	Q9UK73	FEM1B_HUMAN	98.9	88	1	0	264	1	84	171	1.80E-45	183	FEM1B_HUMAN	reviewed	Protein fem-1 homolog B (FEM1b) (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha) (F1A-alpha)	FEM1B F1AA KIAA0396	Homo sapiens (Human)	627	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	death receptor binding [GO:0005123]	GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0016567; GO:0043687; GO:0051438; GO:0060442; GO:0060743; GO:1902041; GO:2000001	apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]		NA	NA	NA	NA	NA	NA
TRINITY_DN33749_c0_g1_i2	Q9UK73	FEM1B_HUMAN	99.3	144	1	0	432	1	28	171	3.70E-78	292	FEM1B_HUMAN	reviewed	Protein fem-1 homolog B (FEM1b) (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha) (F1A-alpha)	FEM1B F1AA KIAA0396	Homo sapiens (Human)	627	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	death receptor binding [GO:0005123]	GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0016567; GO:0043687; GO:0051438; GO:0060442; GO:0060743; GO:1902041; GO:2000001	apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]		NA	NA	NA	NA	NA	NA
TRINITY_DN29655_c0_g1_i1	Q9UK73	FEM1B_HUMAN	100	121	0	0	364	2	451	571	6.10E-66	251.1	FEM1B_HUMAN	reviewed	Protein fem-1 homolog B (FEM1b) (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha) (F1A-alpha)	FEM1B F1AA KIAA0396	Homo sapiens (Human)	627	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	death receptor binding [GO:0005123]	GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0016567; GO:0043687; GO:0051438; GO:0060442; GO:0060743; GO:1902041; GO:2000001	apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]		NA	NA	NA	NA	NA	NA
TRINITY_DN24673_c0_g1_i2	Q8CEF1	FEM1C_MOUSE	54.4	638	269	7	10	1923	1	616	2.60E-190	666.8	FEM1C_MOUSE	reviewed	Protein fem-1 homolog C (FEM1c) (FEM1-gamma)	Fem1c Kiaa1785	Mus musculus (Mouse)	617	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005654; GO:0005829; GO:0006511; GO:0016567	protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24673_c0_g1_i3	Q8CEF1	FEM1C_MOUSE	70.1	214	64	0	10	651	1	214	7.30E-84	311.6	FEM1C_MOUSE	reviewed	Protein fem-1 homolog C (FEM1c) (FEM1-gamma)	Fem1c Kiaa1785	Mus musculus (Mouse)	617	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005654; GO:0005829; GO:0006511; GO:0016567	protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24673_c0_g1_i4	Q8CEF1	FEM1C_MOUSE	56.2	73	32	0	10	228	1	73	4.10E-16	85.1	FEM1C_MOUSE	reviewed	Protein fem-1 homolog C (FEM1c) (FEM1-gamma)	Fem1c Kiaa1785	Mus musculus (Mouse)	617	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005654; GO:0005829; GO:0006511; GO:0016567	protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1946_c0_g1_i1	A3FEM2	FEV_DANRE	71.1	45	13	0	24	158	112	156	1.30E-10	66.6	FEV_DANRE	reviewed	Protein FEV (Protein Pet-1)	fev pet1 zgc:158720	Danio rerio (Zebrafish) (Brachydanio rerio)	235	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell differentiation [GO:0030154]; hematopoietic stem cell differentiation [GO:0060218]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007399; GO:0030154; GO:0060218	"cell differentiation [GO:0030154]; hematopoietic stem cell differentiation [GO:0060218]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36083_c0_g1_i1	Q8L3Z8	FZR2_ARATH	72.2	227	62	1	686	9	249	475	1.60E-94	347.1	FZR2_ARATH	reviewed	Protein FIZZY-RELATED 2 (Cell cycle switch protein CCS52A1)	FZR2 CCS52A1 CDH1-2 At4g22910 F7H19.90	Arabidopsis thaliana (Mouse-ear cress)	483	anaphase-promoting complex [GO:0005680]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA endoreduplication [GO:0042023]; multidimensional cell growth [GO:0009825]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; protein ubiquitination [GO:0016567]; trichome branching [GO:0010091]	anaphase-promoting complex [GO:0005680]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005680; GO:0009825; GO:0010091; GO:0010997; GO:0016567; GO:0031145; GO:0042023; GO:0051301; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA endoreduplication [GO:0042023]; multidimensional cell growth [GO:0009825]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; protein ubiquitination [GO:0016567]; trichome branching [GO:0010091]		NA	NA	NA	NA	NA	NA
TRINITY_DN26950_c0_g1_i1	Q9JJ28	FLII_MOUSE	66.7	69	23	0	1	207	131	199	5.90E-21	100.9	FLII_MOUSE	reviewed	Protein flightless-1 homolog	Flii Fli1 Fliih	Mus musculus (Mouse)	1271	"actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; multicellular organism development [GO:0007275]; myofibril assembly [GO:0030239]"	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005903; GO:0005925; GO:0007275; GO:0008154; GO:0015629; GO:0030036; GO:0030239; GO:0034451; GO:0051014; GO:0051015; GO:0051016	actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; multicellular organism development [GO:0007275]; myofibril assembly [GO:0030239]		blue	blue	NA	NA	NA	NA
TRINITY_DN1293_c0_g1_i1	Q8BP78	F10C1_MOUSE	69.3	189	47	1	2	535	127	315	2.70E-46	187.2	F10C1_MOUSE	reviewed	Protein FRA10AC1 homolog	Fra10ac1	Mus musculus (Mouse)	315	nucleus [GO:0005634]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	nucleus [GO:0005634]	phosphatase activity [GO:0016791]	GO:0005634; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN1293_c0_g1_i2	Q8BP78	F10C1_MOUSE	69.3	189	47	1	2	535	127	315	3.20E-46	187.2	F10C1_MOUSE	reviewed	Protein FRA10AC1 homolog	Fra10ac1	Mus musculus (Mouse)	315	nucleus [GO:0005634]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	nucleus [GO:0005634]	phosphatase activity [GO:0016791]	GO:0005634; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN1293_c0_g1_i5	Q8BP78	F10C1_MOUSE	69.3	189	47	1	2	535	127	315	8.30E-46	187.2	F10C1_MOUSE	reviewed	Protein FRA10AC1 homolog	Fra10ac1	Mus musculus (Mouse)	315	nucleus [GO:0005634]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	nucleus [GO:0005634]	phosphatase activity [GO:0016791]	GO:0005634; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	1
TRINITY_DN6384_c0_g1_i1	Q9VT28	FRY_DROME	52.3	266	118	2	6	800	1312	1569	4.50E-72	272.7	FRY_DROME	reviewed	Protein furry	fry CG32045	Drosophila melanogaster (Fruit fly)	3479	"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"	apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]		GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013	"antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3018_c0_g1_i1	Q9VT28	FRY_DROME	46.3	328	111	12	878	21	2670	2974	7.20E-52	205.7	FRY_DROME	reviewed	Protein furry	fry CG32045	Drosophila melanogaster (Fruit fly)	3479	"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"	apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]		GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013	"antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3341_c0_g1_i1	Q9VT28	FRY_DROME	72.6	208	52	1	21	629	368	575	2.20E-79	296.6	FRY_DROME	reviewed	Protein furry	fry CG32045	Drosophila melanogaster (Fruit fly)	3479	"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"	apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]		GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013	"antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14865_c0_g1_i1	Q9VT28	FRY_DROME	63.2	144	52	1	429	1	1727	1870	5.20E-48	191.8	FRY_DROME	reviewed	Protein furry	fry CG32045	Drosophila melanogaster (Fruit fly)	3479	"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"	apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; site of polarized growth [GO:0030427]		GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013	"antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14896_c0_g1_i4	Q9BT04	FUZZY_HUMAN	46.6	163	75	4	96	569	12	167	5.10E-30	132.5	FUZZY_HUMAN	reviewed	Protein fuzzy homolog	FUZ FY	Homo sapiens (Human)	418	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314]; negative regulation of neural crest formation [GO:0090301]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]		GO:0001736; GO:0001843; GO:0001942; GO:0005737; GO:0005856; GO:0008285; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0030336; GO:0042995; GO:0045724; GO:0048704; GO:0060271; GO:0070062; GO:0090090; GO:0090301; GO:1905515; GO:2000314	cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314]; negative regulation of neural crest formation [GO:0090301]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14896_c0_g1_i8	Q9BT04	FUZZY_HUMAN	45	220	109	4	96	740	12	224	1.30E-42	174.9	FUZZY_HUMAN	reviewed	Protein fuzzy homolog	FUZ FY	Homo sapiens (Human)	418	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314]; negative regulation of neural crest formation [GO:0090301]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]		GO:0001736; GO:0001843; GO:0001942; GO:0005737; GO:0005856; GO:0008285; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0030336; GO:0042995; GO:0045724; GO:0048704; GO:0060271; GO:0070062; GO:0090090; GO:0090301; GO:1905515; GO:2000314	cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314]; negative regulation of neural crest formation [GO:0090301]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10448_c0_g1_i1	Q8SY33	GAWKY_DROME	33.6	143	70	6	2	382	294	427	1.50E-06	53.9	GAWKY_DROME	reviewed	Protein Gawky	gw GW182 CG31992	Drosophila melanogaster (Fruit fly)	1384	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RNA binding [GO:0003723]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing by miRNA [GO:0035195]; locomotor rhythm [GO:0045475]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing [GO:0016441]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]	RNA binding [GO:0003723]	GO:0000932; GO:0001700; GO:0003723; GO:0005654; GO:0005737; GO:0006402; GO:0010629; GO:0016441; GO:0016442; GO:0032880; GO:0035195; GO:0035278; GO:0045475; GO:0060213	embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing by miRNA [GO:0035195]; locomotor rhythm [GO:0045475]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing [GO:0016441]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN15695_c0_g1_i1	Q8SY33	GAWKY_DROME	37.3	276	125	10	900	109	793	1032	2.30E-21	104.4	GAWKY_DROME	reviewed	Protein Gawky	gw GW182 CG31992	Drosophila melanogaster (Fruit fly)	1384	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RNA binding [GO:0003723]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing by miRNA [GO:0035195]; locomotor rhythm [GO:0045475]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing [GO:0016441]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]	RNA binding [GO:0003723]	GO:0000932; GO:0001700; GO:0003723; GO:0005654; GO:0005737; GO:0006402; GO:0010629; GO:0016441; GO:0016442; GO:0032880; GO:0035195; GO:0035278; GO:0045475; GO:0060213	embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing by miRNA [GO:0035195]; locomotor rhythm [GO:0045475]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing [GO:0016441]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN15695_c0_g1_i2	Q8SY33	GAWKY_DROME	35.6	225	107	8	717	73	793	989	2.70E-12	73.9	GAWKY_DROME	reviewed	Protein Gawky	gw GW182 CG31992	Drosophila melanogaster (Fruit fly)	1384	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RNA binding [GO:0003723]; embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing by miRNA [GO:0035195]; locomotor rhythm [GO:0045475]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing [GO:0016441]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]	RNA binding [GO:0003723]	GO:0000932; GO:0001700; GO:0003723; GO:0005654; GO:0005737; GO:0006402; GO:0010629; GO:0016441; GO:0016442; GO:0032880; GO:0035195; GO:0035278; GO:0045475; GO:0060213	embryonic development via the syncytial blastoderm [GO:0001700]; gene silencing by miRNA [GO:0035195]; locomotor rhythm [GO:0045475]; miRNA mediated inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of gene expression [GO:0010629]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing [GO:0016441]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN737_c0_g1_i1	Q292F9	GDAP2_DROPS	56.2	292	105	4	892	86	251	542	1.10E-87	324.7	GDAP2_DROPS	reviewed	Protein GDAP2 homolog	GA15091	Drosophila pseudoobscura pseudoobscura (Fruit fly)	542							NA	NA	NA	NA	NA	NA
TRINITY_DN737_c0_g1_i2	Q7JUR6	GDAP2_DROME	64.4	216	77	0	733	86	325	540	7.70E-81	302	GDAP2_DROME	reviewed	Protein GDAP2 homolog	Gdap2 CG18812	Drosophila melanogaster (Fruit fly)	540							NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c2_g1_i1	Q01820	GCL_DROME	42	443	227	5	211	1449	54	496	5.60E-95	349.7	GCL_DROME	reviewed	Protein germ cell-less	gcl CG8411	Drosophila melanogaster (Fruit fly)	569	"cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription by RNA polymerase III [GO:0016480]; negative regulation of transcription, DNA-templated [GO:0045892]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"	cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000209; GO:0005634; GO:0005635; GO:0005643; GO:0005938; GO:0007278; GO:0007279; GO:0007281; GO:0007315; GO:0016480; GO:0031234; GO:0031463; GO:0034399; GO:0043161; GO:0045892; GO:0120177; GO:1990756	"germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase III [GO:0016480]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c2_g1_i2	Q01820	GCL_DROME	43.7	135	71	2	93	482	362	496	2.60E-27	123.6	GCL_DROME	reviewed	Protein germ cell-less	gcl CG8411	Drosophila melanogaster (Fruit fly)	569	"cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription by RNA polymerase III [GO:0016480]; negative regulation of transcription, DNA-templated [GO:0045892]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"	cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000209; GO:0005634; GO:0005635; GO:0005643; GO:0005938; GO:0007278; GO:0007279; GO:0007281; GO:0007315; GO:0016480; GO:0031234; GO:0031463; GO:0034399; GO:0043161; GO:0045892; GO:0120177; GO:1990756	"germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase III [GO:0016480]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c2_g1_i3	Q01820	GCL_DROME	44.4	126	67	1	93	461	362	487	4.40E-27	122.9	GCL_DROME	reviewed	Protein germ cell-less	gcl CG8411	Drosophila melanogaster (Fruit fly)	569	"cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription by RNA polymerase III [GO:0016480]; negative regulation of transcription, DNA-templated [GO:0045892]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"	cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000209; GO:0005634; GO:0005635; GO:0005643; GO:0005938; GO:0007278; GO:0007279; GO:0007281; GO:0007315; GO:0016480; GO:0031234; GO:0031463; GO:0034399; GO:0043161; GO:0045892; GO:0120177; GO:1990756	"germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase III [GO:0016480]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c2_g1_i4	Q01820	GCL_DROME	41.8	478	243	7	162	1502	23	496	5.90E-100	366.3	GCL_DROME	reviewed	Protein germ cell-less	gcl CG8411	Drosophila melanogaster (Fruit fly)	569	"cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription by RNA polymerase III [GO:0016480]; negative regulation of transcription, DNA-templated [GO:0045892]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"	cell cortex [GO:0005938]; Cul3-RING ubiquitin ligase complex [GO:0031463]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000209; GO:0005634; GO:0005635; GO:0005643; GO:0005938; GO:0007278; GO:0007279; GO:0007281; GO:0007315; GO:0016480; GO:0031234; GO:0031463; GO:0034399; GO:0043161; GO:0045892; GO:0120177; GO:1990756	"germ cell development [GO:0007281]; negative regulation of torso signaling pathway [GO:0120177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase III [GO:0016480]; pole cell fate determination [GO:0007278]; pole cell formation [GO:0007279]; pole plasm assembly [GO:0007315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5684_c0_g2_i2	P13360	GLAS_DROME	38.2	76	47	0	250	23	425	500	8.50E-10	64.3	GLAS_DROME	reviewed	Protein glass	gl CG7672	Drosophila melanogaster (Fruit fly)	604	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37377_c0_g1_i1	P13360	GLAS_DROME	48.3	89	46	0	283	17	425	513	1.10E-20	100.5	GLAS_DROME	reviewed	Protein glass	gl CG7672	Drosophila melanogaster (Fruit fly)	604	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i3	P13360	GLAS_DROME	36.1	122	78	0	494	859	449	570	4.50E-20	100.1	GLAS_DROME	reviewed	Protein glass	gl CG7672	Drosophila melanogaster (Fruit fly)	604	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36293_c0_g1_i1	P13360	GLAS_DROME	91	67	6	0	201	1	487	553	1.90E-32	139	GLAS_DROME	reviewed	Protein glass	gl CG7672	Drosophila melanogaster (Fruit fly)	604	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24346_c0_g1_i1	P13360	GLAS_DROME	46.2	52	25	1	191	36	467	515	3.40E-07	55.5	GLAS_DROME	reviewed	Protein glass	gl CG7672	Drosophila melanogaster (Fruit fly)	604	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24346_c0_g1_i3	P13360	GLAS_DROME	46.2	52	25	1	191	36	467	515	5.80E-07	55.1	GLAS_DROME	reviewed	Protein glass	gl CG7672	Drosophila melanogaster (Fruit fly)	604	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40689_c0_g1_i1	Q8BUV8	GP107_MOUSE	100	83	0	0	252	4	404	486	2.80E-41	168.7	GP107_MOUSE	reviewed	Protein GPR107	Gpr107 Kiaa1624	Mus musculus (Mouse)	551	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583]	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	clathrin heavy chain binding [GO:0032050]	GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030136; GO:0032050; GO:0072583	clathrin-dependent endocytosis [GO:0072583]		NA	NA	NA	NA	NA	NA
TRINITY_DN12267_c0_g1_i2	Q8BUV8	GP107_MOUSE	43.4	553	269	11	23	1636	14	537	9.30E-113	409.1	GP107_MOUSE	reviewed	Protein GPR107	Gpr107 Kiaa1624	Mus musculus (Mouse)	551	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583]	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	clathrin heavy chain binding [GO:0032050]	GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030136; GO:0032050; GO:0072583	clathrin-dependent endocytosis [GO:0072583]		NA	NA	NA	NA	NA	NA
TRINITY_DN39877_c0_g1_i1	Q8BUV8	GP107_MOUSE	100	108	0	0	2	325	250	357	4.70E-57	221.5	GP107_MOUSE	reviewed	Protein GPR107	Gpr107 Kiaa1624	Mus musculus (Mouse)	551	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583]	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	clathrin heavy chain binding [GO:0032050]	GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030136; GO:0032050; GO:0072583	clathrin-dependent endocytosis [GO:0072583]		NA	NA	NA	NA	NA	NA
TRINITY_DN15372_c0_g1_i1	Q91WD0	GP108_MOUSE	99.3	137	1	0	413	3	328	464	1.60E-73	276.6	GP108_MOUSE	reviewed	Protein GPR108 (Lung seven transmembrane receptor 2)	Gpr108 Lustr2	Mus musculus (Mouse)	569	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005794; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN15372_c0_g2_i1	Q9NPR9	GP108_HUMAN	98.7	224	3	0	673	2	302	525	1.10E-121	437.2	GP108_HUMAN	reviewed	Protein GPR108 (Lung seven transmembrane receptor 2)	GPR108 LUSTR2	Homo sapiens (Human)	543	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005794; GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4517_c1_g1_i1	P16371	GROU_DROME	91.3	333	29	0	1130	132	398	730	1.50E-185	650.2	GROU_DROME	reviewed	Protein groucho (Enhancer of split m9/10 protein) (E(spl)m9/10)	gro E(spl)m9/m10 CG8384	Drosophila melanogaster (Fruit fly)	730	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; CRD domain binding [GO:0071906]; HMG box domain binding [GO:0071837]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Toll signaling pathway [GO:0045751]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; sex determination, primary response to X:A ratio [GO:0007541]; torso signaling pathway [GO:0008293]; Wnt signaling pathway [GO:0016055]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	CRD domain binding [GO:0071906]; HMG box domain binding [GO:0071837]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0007173; GO:0007399; GO:0007541; GO:0008134; GO:0008293; GO:0008543; GO:0016055; GO:0030154; GO:0032991; GO:0045751; GO:0045892; GO:0070491; GO:0071837; GO:0071906; GO:0090090	"cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Toll signaling pathway [GO:0045751]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; sex determination, primary response to X:A ratio [GO:0007541]; torso signaling pathway [GO:0008293]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4517_c1_g1_i2	P16371	GROU_DROME	91.3	333	29	0	1082	84	398	730	1.10E-185	650.6	GROU_DROME	reviewed	Protein groucho (Enhancer of split m9/10 protein) (E(spl)m9/10)	gro E(spl)m9/m10 CG8384	Drosophila melanogaster (Fruit fly)	730	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; CRD domain binding [GO:0071906]; HMG box domain binding [GO:0071837]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Toll signaling pathway [GO:0045751]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; sex determination, primary response to X:A ratio [GO:0007541]; torso signaling pathway [GO:0008293]; Wnt signaling pathway [GO:0016055]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	CRD domain binding [GO:0071906]; HMG box domain binding [GO:0071837]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0007173; GO:0007399; GO:0007541; GO:0008134; GO:0008293; GO:0008543; GO:0016055; GO:0030154; GO:0032991; GO:0045751; GO:0045892; GO:0070491; GO:0071837; GO:0071906; GO:0090090	"cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Toll signaling pathway [GO:0045751]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; sex determination, primary response to X:A ratio [GO:0007541]; torso signaling pathway [GO:0008293]; Wnt signaling pathway [GO:0016055]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10828_c0_g1_i1	A1Z6E0	GUS_DROME	70.3	276	77	4	186	1007	7	279	1.00E-116	421.4	GUS_DROME	reviewed	Protein gustavus	gus CG2944	Drosophila melanogaster (Fruit fly)	279	cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]	cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449	cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN10828_c0_g1_i2	A1Z6E0	GUS_DROME	70.2	282	79	4	58	897	1	279	5.80E-119	428.7	GUS_DROME	reviewed	Protein gustavus	gus CG2944	Drosophila melanogaster (Fruit fly)	279	cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]	cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]		GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449	cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN2172_c0_g1_i1	Q3ZCU0	GVQW3_HUMAN	51.4	107	52	0	378	58	7	113	7.00E-25	115.2	GVQW3_HUMAN	reviewed	Protein GVQW3 (GVQW motif-containing protein 3)	GVQW3	Homo sapiens (Human)	254							NA	NA	NA	NA	NA	NA
TRINITY_DN2172_c0_g1_i2	Q3ZCU0	GVQW3_HUMAN	37.3	225	125	3	1116	442	7	215	9.10E-29	129.4	GVQW3_HUMAN	reviewed	Protein GVQW3 (GVQW motif-containing protein 3)	GVQW3	Homo sapiens (Human)	254							NA	NA	NA	NA	NA	NA
TRINITY_DN7362_c0_g1_i1	P42944	GZF3_YEAST	52.5	61	27	2	182	3	126	185	1.80E-09	62.8	GZF3_YEAST	reviewed	Protein GZF3	GZF3 YJL110C J0806	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	551	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitrogen catabolite repression of transcription [GO:0090295]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0008270; GO:0043565; GO:0045944; GO:0051457; GO:0090295	maintenance of protein location in nucleus [GO:0051457]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitrogen catabolite repression of transcription [GO:0090295]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN40217_c0_g1_i1	P14003	HAIR_DROME	60	40	16	0	186	67	33	72	5.60E-06	51.2	HAIR_DROME	reviewed	Protein hairy	h CG6494	Drosophila melanogaster (Fruit fly)	337	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; cell morphogenesis [GO:0000902]; membrane organization [GO:0061024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; periodic partitioning by pair rule gene [GO:0007366]; posterior head segmentation [GO:0035289]; regulation of cellular metabolic process [GO:0031323]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; salivary gland morphogenesis [GO:0007435]; trunk segmentation [GO:0035290]; tube morphogenesis [GO:0035239]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000902; GO:0000978; GO:0000981; GO:0001227; GO:0001666; GO:0003677; GO:0005634; GO:0006357; GO:0007366; GO:0007399; GO:0007424; GO:0007435; GO:0008134; GO:0009952; GO:0031323; GO:0035239; GO:0035289; GO:0035290; GO:0045892; GO:0046983; GO:0050767; GO:0061024; GO:0070888	"anterior/posterior pattern specification [GO:0009952]; cell morphogenesis [GO:0000902]; membrane organization [GO:0061024]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; open tracheal system development [GO:0007424]; periodic partitioning by pair rule gene [GO:0007366]; posterior head segmentation [GO:0035289]; regulation of cellular metabolic process [GO:0031323]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; salivary gland morphogenesis [GO:0007435]; trunk segmentation [GO:0035290]; tube morphogenesis [GO:0035239]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32744_c0_g1_i1	P17276	PH4H_DROME	62.3	53	20	0	236	78	398	450	1.40E-11	70.1	PH4H_DROME	reviewed	Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase)	Hn pah Tph CG7399	Drosophila melanogaster (Fruit fly)	452	iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]		iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427	eye pigment biosynthetic process [GO:0006726]; long-term memory [GO:0007616]; L-phenylalanine catabolic process [GO:0006559]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]		NA	NA	NA	NA	NA	NA
TRINITY_DN32744_c0_g1_i2	P17276	PH4H_DROME	68.4	440	135	3	1385	78	11	450	2.50E-182	639.8	PH4H_DROME	reviewed	Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase)	Hn pah Tph CG7399	Drosophila melanogaster (Fruit fly)	452	iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]		iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427	eye pigment biosynthetic process [GO:0006726]; long-term memory [GO:0007616]; L-phenylalanine catabolic process [GO:0006559]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]		NA	NA	NA	NA	NA	NA
TRINITY_DN32744_c0_g1_i3	P17276	PH4H_DROME	75.2	218	54	0	731	78	233	450	2.20E-97	356.7	PH4H_DROME	reviewed	Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase)	Hn pah Tph CG7399	Drosophila melanogaster (Fruit fly)	452	iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]		iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427	eye pigment biosynthetic process [GO:0006726]; long-term memory [GO:0007616]; L-phenylalanine catabolic process [GO:0006559]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]		NA	NA	NA	NA	NA	NA
TRINITY_DN9540_c0_g1_i1	Q9VBG6	HGH1_DROME	31.5	200	132	1	595	11	6	205	2.70E-17	90.5	HGH1_DROME	reviewed	Protein HGH1 homolog	CG6073	Drosophila melanogaster (Fruit fly)	369							NA	NA	NA	NA	NA	NA
TRINITY_DN7327_c0_g1_i1	Q8R1F6	HID1_MOUSE	71.7	336	84	1	975	1	151	486	6.90E-142	505	HID1_MOUSE	reviewed	Protein HID1 (HID1 domain-containing protein) (Protein hid-1 homolog)	Hid1	Mus musculus (Mouse)	788	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]		GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0090498			NA	NA	NA	NA	NA	NA
TRINITY_DN7327_c0_g1_i2	Q8R1F6	HID1_MOUSE	69.8	486	130	2	1407	1	1	486	1.40E-204	713.8	HID1_MOUSE	reviewed	Protein HID1 (HID1 domain-containing protein) (Protein hid-1 homolog)	Hid1	Mus musculus (Mouse)	788	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]		GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0090498			NA	NA	NA	NA	NA	NA
TRINITY_DN7327_c0_g1_i4	Q8R1F6	HID1_MOUSE	69.8	394	102	2	1131	1	93	486	2.90E-162	572.8	HID1_MOUSE	reviewed	Protein HID1 (HID1 domain-containing protein) (Protein hid-1 homolog)	Hid1	Mus musculus (Mouse)	788	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]		GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0090498			NA	NA	NA	NA	NA	NA
TRINITY_DN6391_c0_g1_i1	Q61666	HIRA_MOUSE	63	311	107	5	917	3	1	309	1.90E-122	440.3	HIRA_MOUSE	reviewed	Protein HIRA (TUP1-like enhancer of split protein 1)	Hira Tuple1	Mus musculus (Mouse)	1015	"HIR complex [GO:0000417]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; DNA replication-independent nucleosome assembly [GO:0006336]; gastrulation [GO:0007369]; mitotic sister chromatid segregation [GO:0000070]; muscle cell differentiation [GO:0042692]; osteoblast differentiation [GO:0001649]; regulation of chromatin silencing [GO:0031935]; transcription, DNA-templated [GO:0006351]"	HIR complex [GO:0000417]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; protein-containing complex [GO:0032991]	histone binding [GO:0042393]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]	GO:0000070; GO:0000417; GO:0000790; GO:0001085; GO:0001649; GO:0003714; GO:0005654; GO:0006336; GO:0006351; GO:0007369; GO:0016605; GO:0031935; GO:0032991; GO:0042393; GO:0042692	"DNA replication-independent nucleosome assembly [GO:0006336]; gastrulation [GO:0007369]; mitotic sister chromatid segregation [GO:0000070]; muscle cell differentiation [GO:0042692]; osteoblast differentiation [GO:0001649]; regulation of chromatin silencing [GO:0031935]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN427_c0_g1_i10	Q02645	HTS_DROME	53.1	456	196	5	1376	60	18	472	2.30E-135	483.8	HTS_DROME	reviewed	Protein hu-li tai shao (Adducin-like protein)	hts CG9325	Drosophila melanogaster (Fruit fly)	1156	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]	actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793	"actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"		NA	NA	NA	NA	NA	NA
TRINITY_DN427_c0_g1_i11	Q02645	HTS_DROME	53	659	273	11	2111	192	18	658	4.90E-190	666	HTS_DROME	reviewed	Protein hu-li tai shao (Adducin-like protein)	hts CG9325	Drosophila melanogaster (Fruit fly)	1156	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]	actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793	"actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"		NA	NA	NA	NA	NA	NA
TRINITY_DN427_c0_g1_i3	Q02645	HTS_DROME	55.8	588	240	6	2185	473	18	602	3.60E-188	659.8	HTS_DROME	reviewed	Protein hu-li tai shao (Adducin-like protein)	hts CG9325	Drosophila melanogaster (Fruit fly)	1156	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]	actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793	"actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"		NA	NA	NA	NA	NA	NA
TRINITY_DN427_c0_g1_i6	Q02645	HTS_DROME	55.8	588	240	6	2122	410	18	602	3.50E-188	659.8	HTS_DROME	reviewed	Protein hu-li tai shao (Adducin-like protein)	hts CG9325	Drosophila melanogaster (Fruit fly)	1156	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]	actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793	"actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"		NA	NA	NA	NA	NA	NA
TRINITY_DN427_c0_g1_i7	Q02645	HTS_DROME	55.8	588	240	6	1907	195	18	602	3.20E-188	659.8	HTS_DROME	reviewed	Protein hu-li tai shao (Adducin-like protein)	hts CG9325	Drosophila melanogaster (Fruit fly)	1156	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]	actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793	"actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation, actin assembly [GO:0008302]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27954_c0_g1_i1	F4I893	ILA_ARATH	53.6	97	45	0	292	2	1916	2012	9.00E-23	107.5	ILA_ARATH	reviewed	Protein ILITYHIA	ILA At1g64790 F13O11.10	Arabidopsis thaliana (Mouse-ear cress)	2696	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; defense response to bacterium [GO:0042742]; induced systemic resistance [GO:0009682]; innate immune response [GO:0045087]; positive regulation of kinase activity [GO:0033674]; regulation of translation [GO:0006417]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]	GO:0005634; GO:0005829; GO:0006417; GO:0009682; GO:0019887; GO:0019901; GO:0033674; GO:0042742; GO:0043022; GO:0045087	defense response to bacterium [GO:0042742]; induced systemic resistance [GO:0009682]; innate immune response [GO:0045087]; positive regulation of kinase activity [GO:0033674]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN4058_c0_g1_i1	Q5BL31	ILRUN_DANRE	52.6	196	90	2	653	69	2	195	3.60E-54	213	ILRUN_DANRE	reviewed	Protein ILRUN	ilrun zgc:101577	Danio rerio (Zebrafish) (Brachydanio rerio)	283	nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]	nucleus [GO:0005634]; phagophore assembly site [GO:0000407]	ubiquitin binding [GO:0043130]	GO:0000407; GO:0005634; GO:0016236; GO:0043130; GO:0045087	innate immune response [GO:0045087]; macroautophagy [GO:0016236]		NA	NA	NA	NA	NA	NA
TRINITY_DN4058_c0_g1_i2	Q5BL31	ILRUN_DANRE	53.2	171	77	2	583	74	2	170	2.50E-46	186.8	ILRUN_DANRE	reviewed	Protein ILRUN	ilrun zgc:101577	Danio rerio (Zebrafish) (Brachydanio rerio)	283	nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]	nucleus [GO:0005634]; phagophore assembly site [GO:0000407]	ubiquitin binding [GO:0043130]	GO:0000407; GO:0005634; GO:0016236; GO:0043130; GO:0045087	innate immune response [GO:0045087]; macroautophagy [GO:0016236]		NA	NA	NA	NA	NA	NA
TRINITY_DN24561_c0_g1_i2	Q9VVT2	INDY1_DROME	57	121	52	0	393	31	76	196	7.40E-33	141.4	INDY1_DROME	reviewed	Protein I'm not dead yet (INDY transporter protein) (drIndy)	Indy CG3979	Drosophila melanogaster (Fruit fly)	590	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]	GO:0005886; GO:0005887; GO:0006848; GO:0008340; GO:0010889; GO:0015137; GO:0015141; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0050833; GO:0098656	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]		NA	NA	NA	NA	NA	NA
TRINITY_DN13482_c0_g1_i3	Q9VVT2	INDY1_DROME	49.4	87	44	0	282	22	66	152	1.70E-18	93.2	INDY1_DROME	reviewed	Protein I'm not dead yet (INDY transporter protein) (drIndy)	Indy CG3979	Drosophila melanogaster (Fruit fly)	590	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]	GO:0005886; GO:0005887; GO:0006848; GO:0008340; GO:0010889; GO:0015137; GO:0015141; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0050833; GO:0098656	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]		NA	NA	NA	NA	NA	NA
TRINITY_DN13482_c0_g1_i4	Q9VVT2	INDY1_DROME	49.4	87	44	0	269	9	66	152	1.20E-18	93.6	INDY1_DROME	reviewed	Protein I'm not dead yet (INDY transporter protein) (drIndy)	Indy CG3979	Drosophila melanogaster (Fruit fly)	590	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]	GO:0005886; GO:0005887; GO:0006848; GO:0008340; GO:0010889; GO:0015137; GO:0015141; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0050833; GO:0098656	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]		NA	NA	NA	NA	NA	NA
TRINITY_DN13482_c0_g1_i5	Q9VVT2	INDY1_DROME	45.3	64	35	0	1	192	89	152	5.90E-11	67.8	INDY1_DROME	reviewed	Protein I'm not dead yet (INDY transporter protein) (drIndy)	Indy CG3979	Drosophila melanogaster (Fruit fly)	590	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]	GO:0005886; GO:0005887; GO:0006848; GO:0008340; GO:0010889; GO:0015137; GO:0015141; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0050833; GO:0098656	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]		NA	NA	NA	NA	NA	NA
TRINITY_DN13482_c0_g1_i8	Q9VVT2	INDY1_DROME	46.9	64	34	0	1	192	89	152	9.10E-12	70.5	INDY1_DROME	reviewed	Protein I'm not dead yet (INDY transporter protein) (drIndy)	Indy CG3979	Drosophila melanogaster (Fruit fly)	590	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	citrate transmembrane transporter activity [GO:0015137]; pyruvate transmembrane transporter activity [GO:0050833]; succinate transmembrane transporter activity [GO:0015141]	GO:0005886; GO:0005887; GO:0006848; GO:0008340; GO:0010889; GO:0015137; GO:0015141; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0050833; GO:0098656	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]		NA	NA	NA	NA	NA	NA
TRINITY_DN11005_c0_g2_i1	Q642J4	IMPCT_DANRE	46.5	301	136	3	987	160	9	309	4.60E-67	256.5	IMPCT_DANRE	reviewed	Protein IMPACT (Imprinted and ancient gene protein homolog)	impact zgc:103672	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; polysome [GO:0005844]; polysome binding [GO:1905538]; protein kinase inhibitor activity [GO:0004860]; ribosome binding [GO:0043022]; cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]	cytoplasm [GO:0005737]; polysome [GO:0005844]	polysome binding [GO:1905538]; protein kinase inhibitor activity [GO:0004860]; ribosome binding [GO:0043022]	GO:0000122; GO:0001933; GO:0004860; GO:0005737; GO:0005844; GO:0031333; GO:0031953; GO:0034198; GO:0042149; GO:0043022; GO:0045666; GO:0060548; GO:0060733; GO:0070301; GO:0071264; GO:0071468; GO:0071494; GO:0072755; GO:0097201; GO:1905538; GO:1990138; GO:1990253	cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]		NA	NA	NA	NA	NA	NA
TRINITY_DN11005_c0_g2_i2	Q642J4	IMPCT_DANRE	57.8	147	62	0	600	160	163	309	1.80E-41	171.4	IMPCT_DANRE	reviewed	Protein IMPACT (Imprinted and ancient gene protein homolog)	impact zgc:103672	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasm [GO:0005737]; polysome [GO:0005844]; polysome binding [GO:1905538]; protein kinase inhibitor activity [GO:0004860]; ribosome binding [GO:0043022]; cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]	cytoplasm [GO:0005737]; polysome [GO:0005844]	polysome binding [GO:1905538]; protein kinase inhibitor activity [GO:0004860]; ribosome binding [GO:0043022]	GO:0000122; GO:0001933; GO:0004860; GO:0005737; GO:0005844; GO:0031333; GO:0031953; GO:0034198; GO:0042149; GO:0043022; GO:0045666; GO:0060548; GO:0060733; GO:0070301; GO:0071264; GO:0071468; GO:0071494; GO:0072755; GO:0097201; GO:1905538; GO:1990138; GO:1990253	cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]		NA	NA	NA	NA	NA	NA
TRINITY_DN33311_c0_g1_i1	O13997	YIH1_SCHPO	52.3	65	29	1	3	191	199	263	1.10E-11	70.1	YIH1_SCHPO	reviewed	Protein IMPACT homolog	yih1 SPAC27E2.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	280	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; actin binding [GO:0003779]; polysome binding [GO:1905538]; protein kinase inhibitor activity [GO:0004860]; ribosome binding [GO:0043022]; cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of cytoplasmic translation in response to stress [GO:1990497]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]	actin binding [GO:0003779]; polysome binding [GO:1905538]; protein kinase inhibitor activity [GO:0004860]; ribosome binding [GO:0043022]	GO:0001933; GO:0003779; GO:0004860; GO:0005634; GO:0005737; GO:0005844; GO:0034198; GO:0043022; GO:0060548; GO:0060733; GO:0070301; GO:0071264; GO:0071468; GO:0072755; GO:1905538; GO:1990497	cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of cytoplasmic translation in response to stress [GO:1990497]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]		NA	NA	NA	NA	NA	NA
TRINITY_DN15210_c0_g2_i2	Q3HNM7	INSC_MOUSE	40.1	257	150	3	817	53	285	539	9.70E-43	175.3	INSC_MOUSE	reviewed	Protein inscuteable homolog (Minsc)	Insc	Mus musculus (Mouse)	579	apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647]	apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000132; GO:0005886; GO:0007399; GO:0008093; GO:0008356; GO:0009786; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991; GO:0045176; GO:0045179	apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN15210_c0_g2_i4	Q3HNM7	INSC_MOUSE	39.7	219	128	3	703	53	323	539	7.40E-34	145.6	INSC_MOUSE	reviewed	Protein inscuteable homolog (Minsc)	Insc	Mus musculus (Mouse)	579	apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647]	apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000132; GO:0005886; GO:0007399; GO:0008093; GO:0008356; GO:0009786; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991; GO:0045176; GO:0045179	apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN15210_c0_g1_i1	Q3HNM7	INSC_MOUSE	45.7	129	66	3	8	391	454	579	2.90E-22	106.3	INSC_MOUSE	reviewed	Protein inscuteable homolog (Minsc)	Insc	Mus musculus (Mouse)	579	apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647]	apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000132; GO:0005886; GO:0007399; GO:0008093; GO:0008356; GO:0009786; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991; GO:0045176; GO:0045179	apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647]		NA	NA	NA	NA	NA	NA
TRINITY_DN19622_c0_g1_i2	Q9ULD6	INTU_HUMAN	28.6	378	218	14	1086	43	36	391	5.10E-21	103.6	INTU_HUMAN	reviewed	Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6)	INTU KIAA1284 PDZD6 PDZK6	Homo sapiens (Human)	942	cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192]	cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]		GO:0001736; GO:0005737; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0016192; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0036064; GO:0042733; GO:0043587; GO:0044458; GO:0045880; GO:0051782; GO:0060021; GO:0060173; GO:0060271; GO:1905515	cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN35911_c0_g1_i1	Q297K8	JAGN_DROPS	50.8	197	92	1	88	663	1	197	5.90E-47	189.1	JAGN_DROPS	reviewed	Protein jagunal	jagn GA10683	Drosophila pseudoobscura pseudoobscura (Fruit fly)	197	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; endoplasmic reticulum organization [GO:0007029]; establishment of ER localization [GO:0051686]; exocytosis [GO:0006887]; oocyte growth [GO:0001555]; vitellogenesis [GO:0007296]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0001555; GO:0005789; GO:0006887; GO:0007029; GO:0007296; GO:0008407; GO:0016021; GO:0022416; GO:0051686	chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; endoplasmic reticulum organization [GO:0007029]; establishment of ER localization [GO:0051686]; exocytosis [GO:0006887]; oocyte growth [GO:0001555]; vitellogenesis [GO:0007296]		blue	blue	NA	NA	NA	NA
TRINITY_DN3254_c0_g1_i4	Q5F363	JARD2_CHICK	42.7	171	98	0	185	697	542	712	3.90E-40	166.4	JARD2_CHICK	reviewed	Protein Jumonji (Jumonji/ARID domain-containing protein 2)	JARID2 JMJ RCJMB04_32g20	Gallus gallus (Chicken)	1233	"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; multicellular organism development [GO:0007275]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; stem cell differentiation [GO:0048863]"	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]	GO:0003677; GO:0003682; GO:0005634; GO:0006338; GO:0007275; GO:0031061; GO:0032452; GO:0034721; GO:0035097; GO:0045892; GO:0048863; GO:0051574	"chromatin remodeling [GO:0006338]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; multicellular organism development [GO:0007275]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3117_c0_g1_i1	B4M5X4	KIBRA_DROVI	32	297	183	8	55	912	532	820	8.30E-22	105.9	KIBRA_DROVI	reviewed	Protein kibra	Kibra GJ10664	Drosophila virilis (Fruit fly)	1276	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; positive regulation of hippo signaling [GO:0035332]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]		GO:0005737; GO:0016324; GO:0035332	positive regulation of hippo signaling [GO:0035332]		NA	NA	NA	NA	NA	NA
TRINITY_DN25906_c0_g1_i1	P34102	PK3_DICDI	47.5	122	55	1	1	339	572	693	3.70E-28	125.6	PK3_DICDI	reviewed	Protein kinase 3 (PK3) (EC 2.7.11.1)	pkgC DDB_G0286125	Dictyostelium discoideum (Slime mold)	910	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN7448_c0_g1_i1	Q25378	KPC1_LYTPI	75.4	183	43	1	51	599	13	193	8.90E-86	317.8	KPC1_LYTPI	reviewed	Protein kinase C (EC 2.7.11.13)	PKC1	Lytechinus pictus (Painted sea urchin)	658	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]		ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; zinc ion binding [GO:0008270]	GO:0004698; GO:0005524; GO:0008270; GO:0035556	intracellular signal transduction [GO:0035556]		NA	NA	NA	NA	NA	NA
TRINITY_DN3357_c0_g1_i1	P13678	KPC3_DROME	62.5	736	246	7	88	2259	1	718	3.00E-267	922.5	KPC3_DROME	reviewed	Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F)	Pkc98E Pkc3 CG1954	Drosophila melanogaster (Fruit fly)	739	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007616; GO:0008285; GO:0009950; GO:0018105; GO:0034389; GO:0035556; GO:0045471; GO:0046872	dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]		NA	NA	NA	NA	NA	NA
TRINITY_DN3357_c0_g1_i2	P13678	KPC3_DROME	58.5	340	126	4	88	1083	1	333	1.20E-115	418.3	KPC3_DROME	reviewed	Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F)	Pkc98E Pkc3 CG1954	Drosophila melanogaster (Fruit fly)	739	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007616; GO:0008285; GO:0009950; GO:0018105; GO:0034389; GO:0035556; GO:0045471; GO:0046872	dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]		NA	NA	NA	NA	NA	NA
TRINITY_DN3357_c0_g1_i3	P13678	KPC3_DROME	47.1	121	62	1	88	450	1	119	1.50E-28	127.5	KPC3_DROME	reviewed	Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F)	Pkc98E Pkc3 CG1954	Drosophila melanogaster (Fruit fly)	739	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007616; GO:0008285; GO:0009950; GO:0018105; GO:0034389; GO:0035556; GO:0045471; GO:0046872	dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to ethanol [GO:0045471]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i1	O13154	PACN2_CHICK	46	457	207	9	1400	102	5	445	2.20E-102	374.8	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i1	O13154	PACN2_CHICK	51.9	185	89	0	2046	1492	5	189	4.40E-50	201.1	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i2	O13154	PACN2_CHICK	47.1	450	226	6	1442	102	5	445	3.70E-105	384	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i2	O13154	PACN2_CHICK	51.9	185	89	0	2088	1534	5	189	4.40E-50	201.1	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i3	O13154	PACN2_CHICK	46.5	452	207	8	1385	102	5	445	2.30E-104	381.3	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i3	O13154	PACN2_CHICK	51.9	185	89	0	2031	1477	5	189	4.30E-50	201.1	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i4	O13154	PACN2_CHICK	46.6	455	226	7	1457	102	5	445	4.60E-103	377.1	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN190_c0_g1_i4	O13154	PACN2_CHICK	51.9	185	89	0	2103	1549	5	189	4.50E-50	201.1	PACN2_CHICK	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Focal adhesion protein of 52 kDa) (FAP52)	PACSIN2	Gallus gallus (Chicken)	448	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006897; GO:0007010; GO:0008092; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0045806; GO:0055038; GO:0070300; GO:0070836; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN27256_c0_g1_i1	Q9WVE8	PACN2_MOUSE	100	82	0	0	2	247	8	89	2.90E-43	175.3	PACN2_MOUSE	reviewed	Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II) (SdpII)	Pacsin2	Mus musculus (Mouse)	486	caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]	caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]	cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005911; GO:0007010; GO:0007165; GO:0008092; GO:0008289; GO:0016607; GO:0019898; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0036010; GO:0042802; GO:0043231; GO:0045806; GO:0048858; GO:0055038; GO:0070300; GO:0070836; GO:0072584; GO:0097320	actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN33931_c0_g1_i1	Q7LZQ8	KPCB_XENLA	95.7	94	4	0	283	2	558	651	9.80E-51	200.3	KPCB_XENLA	reviewed	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	prkcb prkcb1	Xenopus laevis (African clawed frog)	671	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006915; GO:0008270; GO:0016020; GO:0030374; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0043123; GO:0050681; GO:0050853	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40207_c0_g1_i1	P05126	KPCB_BOVIN	100	73	0	0	2	220	332	404	3.40E-35	148.3	KPCB_BOVIN	reviewed	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	PRKCB PRKCB1	Bos taurus (Bovine)	671	calyx of Held [GO:0044305]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]	calyx of Held [GO:0044305]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spectrin [GO:0008091]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006816; GO:0006874; GO:0006915; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0018105; GO:0030374; GO:0030949; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0071322; GO:0099171; GO:2000300	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7395_c0_g2_i1	P05126	KPCB_BOVIN	100	178	0	0	1	534	382	559	1.70E-104	379.8	KPCB_BOVIN	reviewed	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	PRKCB PRKCB1	Bos taurus (Bovine)	671	calyx of Held [GO:0044305]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]	calyx of Held [GO:0044305]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spectrin [GO:0008091]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006816; GO:0006874; GO:0006915; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0018105; GO:0030374; GO:0030949; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0071322; GO:0099171; GO:2000300	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15256_c0_g1_i1	P05126	KPCB_BOVIN	100	113	0	0	2	340	43	155	6.60E-70	264.2	KPCB_BOVIN	reviewed	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	PRKCB PRKCB1	Bos taurus (Bovine)	671	calyx of Held [GO:0044305]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]	calyx of Held [GO:0044305]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spectrin [GO:0008091]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006816; GO:0006874; GO:0006915; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0018105; GO:0030374; GO:0030949; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0071322; GO:0099171; GO:2000300	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10895_c0_g1_i1	P28867	KPCD_MOUSE	56.9	51	22	0	165	13	230	280	3.30E-14	78.6	KPCD_MOUSE	reviewed	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	Prkcd Pkcd	Mus musculus (Mouse)	674	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; TIR domain binding [GO:0070976]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphorylation [GO:0042325]; response to oxidative stress [GO:0006979]; termination of signal transduction [GO:0023021]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; TIR domain binding [GO:0070976]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006979; GO:0007049; GO:0008047; GO:0016020; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030837; GO:0032079; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0035307; GO:0035556; GO:0042100; GO:0042119; GO:0042307; GO:0042325; GO:0042742; GO:0043065; GO:0043406; GO:0043407; GO:0043410; GO:0043560; GO:0046326; GO:0046627; GO:0046777; GO:0046872; GO:0048471; GO:0050732; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphorylation [GO:0042325]; response to oxidative stress [GO:0006979]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN21093_c0_g1_i1	P28867	KPCD_MOUSE	100	73	0	0	221	3	493	565	6.00E-40	164.1	KPCD_MOUSE	reviewed	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	Prkcd Pkcd	Mus musculus (Mouse)	674	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; TIR domain binding [GO:0070976]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphorylation [GO:0042325]; response to oxidative stress [GO:0006979]; termination of signal transduction [GO:0023021]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; TIR domain binding [GO:0070976]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006979; GO:0007049; GO:0008047; GO:0016020; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030837; GO:0032079; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0035307; GO:0035556; GO:0042100; GO:0042119; GO:0042307; GO:0042325; GO:0042742; GO:0043065; GO:0043406; GO:0043407; GO:0043410; GO:0043560; GO:0046326; GO:0046627; GO:0046777; GO:0046872; GO:0048471; GO:0050732; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphorylation [GO:0042325]; response to oxidative stress [GO:0006979]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN13602_c0_g1_i1	Q05655	KPCD_HUMAN	100	146	0	0	440	3	442	587	2.10E-84	312.8	KPCD_HUMAN	reviewed	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	Homo sapiens (Human)	676	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0007049; GO:0007165; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0035556; GO:0035578; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043312; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN7395_c1_g1_i1	Q05655	KPCD_HUMAN	97.6	123	3	0	1	369	377	499	1.10E-65	250.4	KPCD_HUMAN	reviewed	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD	Homo sapiens (Human)	676	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0002223; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0007049; GO:0007165; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030168; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032613; GO:0032615; GO:0032930; GO:0032956; GO:0034351; GO:0035307; GO:0035556; GO:0035578; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043312; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0060333; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN33339_c0_g1_i1	P24723	KPCL_HUMAN	100	299	0	0	900	4	324	622	1.60E-176	619.8	KPCL_HUMAN	reviewed	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL	Homo sapiens (Human)	683	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0010744; GO:0018105; GO:0019899; GO:0030168; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:1903078; GO:2000810	intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30016_c0_g1_i1	P24723	KPCL_HUMAN	100	138	0	0	417	4	163	300	7.50E-84	310.8	KPCL_HUMAN	reviewed	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL	Homo sapiens (Human)	683	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0010744; GO:0018105; GO:0019899; GO:0030168; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:1903078; GO:2000810	intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN25759_c0_g1_i1	Q90XF2	KPCI_DANRE	100	127	0	0	383	3	323	449	2.10E-72	272.7	KPCI_DANRE	reviewed	Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota)	prkci hal	Danio rerio (Zebrafish) (Brachydanio rerio)	588	cytosol [GO:0005829]; intrinsic component of plasma membrane [GO:0031226]; nucleus [GO:0005634]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein serine/threonine kinase activity [GO:0004674]; adherens junction maintenance [GO:0034334]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cell projection assembly [GO:0030031]; cell-cell junction maintenance [GO:0045217]; cell-cell junction organization [GO:0045216]; digestive tract mesoderm development [GO:0007502]; digestive tract morphogenesis [GO:0048546]; dorsal motor nucleus of vagus nerve development [GO:0021744]; embryonic heart tube development [GO:0035050]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; generation of neurons [GO:0048699]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesodermal cell migration [GO:0008078]; morphogenesis of a polarized epithelium [GO:0001738]; neural tube formation [GO:0001841]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; odontogenesis [GO:0042476]; peptidyl-serine phosphorylation [GO:0018105]; photoreceptor cell outer segment organization [GO:0035845]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; ventricular system development [GO:0021591]	cytosol [GO:0005829]; intrinsic component of plasma membrane [GO:0031226]; nucleus [GO:0005634]; zonula adherens [GO:0005915]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein serine/threonine kinase activity [GO:0004674]	GO:0000132; GO:0001738; GO:0001841; GO:0004674; GO:0004698; GO:0005524; GO:0005543; GO:0005634; GO:0005829; GO:0005915; GO:0007097; GO:0007405; GO:0007420; GO:0007502; GO:0007507; GO:0008078; GO:0016332; GO:0018105; GO:0021591; GO:0021744; GO:0030031; GO:0031226; GO:0034332; GO:0034334; GO:0035050; GO:0035556; GO:0035778; GO:0035845; GO:0042476; GO:0045199; GO:0045216; GO:0045217; GO:0046872; GO:0048546; GO:0048699; GO:0060041; GO:0060042	adherens junction maintenance [GO:0034334]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cell-cell junction maintenance [GO:0045217]; cell-cell junction organization [GO:0045216]; cell projection assembly [GO:0030031]; digestive tract mesoderm development [GO:0007502]; digestive tract morphogenesis [GO:0048546]; dorsal motor nucleus of vagus nerve development [GO:0021744]; embryonic heart tube development [GO:0035050]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; generation of neurons [GO:0048699]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesodermal cell migration [GO:0008078]; morphogenesis of a polarized epithelium [GO:0001738]; neural tube formation [GO:0001841]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; odontogenesis [GO:0042476]; peptidyl-serine phosphorylation [GO:0018105]; photoreceptor cell outer segment organization [GO:0035845]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN34549_c0_g1_i1	Q04759	KPCT_HUMAN	100	90	0	0	270	1	202	291	2.10E-50	199.1	KPCT_HUMAN	reviewed	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT	Homo sapiens (Human)	706	"aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of cell growth [GO:0001558]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]; T cell receptor signaling pathway [GO:0050852]"	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0016235; GO:0018105; GO:0030168; GO:0032212; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0038095; GO:0042102; GO:0045652; GO:0046627; GO:0046872; GO:0050852; GO:0050870; GO:0051092; GO:0051973; GO:0060326; GO:0070233; GO:0090330; GO:1904355; GO:2000318; GO:2000570	"axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; regulation of cell growth [GO:0001558]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24307_c0_g1_i1	Q02111	KPCT_MOUSE	100	88	0	0	2	265	437	524	4.60E-47	188	KPCT_MOUSE	reviewed	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	Prkcq Pkcq	Mus musculus (Mouse)	707	"aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; immunological synapse [GO:0001772]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; cell chemotaxis [GO:0060326]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]"	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; immunological synapse [GO:0001772]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0001772; GO:0002376; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006355; GO:0006468; GO:0006509; GO:0006954; GO:0010389; GO:0016020; GO:0016235; GO:0018105; GO:0031594; GO:0032212; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0042102; GO:0042307; GO:0042383; GO:0046627; GO:0046872; GO:0050714; GO:0050870; GO:0051092; GO:0051491; GO:0051496; GO:0051973; GO:0060326; GO:0070233; GO:0090330; GO:1904355; GO:2000318; GO:2000570	"cell chemotaxis [GO:0060326]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24307_c0_g2_i1	Q04759	KPCT_HUMAN	99.5	188	1	0	3	566	421	608	6.80E-112	404.4	KPCT_HUMAN	reviewed	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT	Homo sapiens (Human)	706	"aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of cell growth [GO:0001558]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]; T cell receptor signaling pathway [GO:0050852]"	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0016235; GO:0018105; GO:0030168; GO:0032212; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0038095; GO:0042102; GO:0045652; GO:0046627; GO:0046872; GO:0050852; GO:0050870; GO:0051092; GO:0051973; GO:0060326; GO:0070233; GO:0090330; GO:1904355; GO:2000318; GO:2000570	"axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; regulation of cell growth [GO:0001558]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7395_c0_g1_i1	P05130	KPC1_DROME	78.1	360	74	1	8	1087	322	676	2.40E-167	589.7	KPC1_DROME	reviewed	"Protein kinase C, brain isozyme (PKC) (EC 2.7.11.13) (dPKC53E(BR))"	Pkc53E PKC1 CG6622	Drosophila melanogaster (Fruit fly)	679	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein phosphorylation [GO:0006468]; regulation of hemocyte proliferation [GO:0035206]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase C activity [GO:0004697]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005886; GO:0006468; GO:0008270; GO:0018105; GO:0035206; GO:0035556; GO:2000370	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; protein phosphorylation [GO:0006468]; regulation of hemocyte proliferation [GO:0035206]		NA	NA	NA	NA	NA	NA
TRINITY_DN16217_c0_g2_i1	Q9ULU4	PKCB1_HUMAN	62.1	58	19	1	411	247	1026	1083	4.40E-16	85.9	PKCB1_HUMAN	reviewed	Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)	ZMYND8 KIAA1125 PRKCBP1 RACK7	Homo sapiens (Human)	1186	"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952	"modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16217_c0_g2_i2	Q9ULU4	PKCB1_HUMAN	62.1	58	19	1	348	184	1026	1083	3.80E-16	85.9	PKCB1_HUMAN	reviewed	Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)	ZMYND8 KIAA1125 PRKCBP1 RACK7	Homo sapiens (Human)	1186	"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952	"modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38770_c0_g1_i1	Q9ULU4	PKCB1_HUMAN	50.7	213	104	1	256	894	83	294	7.30E-68	258.8	PKCB1_HUMAN	reviewed	Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)	ZMYND8 KIAA1125 PRKCBP1 RACK7	Homo sapiens (Human)	1186	"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952	"modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31549_c0_g1_i1	Q62919	NELL1_RAT	41.1	107	57	2	9	323	366	468	1.10E-18	94	NELL1_RAT	reviewed	Protein kinase C-binding protein NELL1 (NEL-like protein 1)	Nell1	Rattus norvegicus (Rat)	810	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; cell differentiation [GO:0030154]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]	GO:0005080; GO:0005509; GO:0005615; GO:0005635; GO:0005737; GO:0008201; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0042802; GO:0043065; GO:0045667; GO:0045669; GO:0045778; GO:0048471; GO:1903363	cell differentiation [GO:0030154]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]		NA	NA	NA	NA	NA	NA
TRINITY_DN40801_c0_g1_i1	Q92832	NELL1_HUMAN	55.7	70	31	0	1	210	113	182	5.00E-18	91.3	NELL1_HUMAN	reviewed	Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1)	NELL1 NRP1	Homo sapiens (Human)	810	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]; cell differentiation [GO:0030154]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of osteoblast proliferation [GO:0033689]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]	GO:0005080; GO:0005509; GO:0005576; GO:0005635; GO:0005737; GO:0007399; GO:0008201; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0045669; GO:0048471; GO:1903363	cell differentiation [GO:0030154]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of osteoblast proliferation [GO:0033689]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN12094_c0_g1_i2	P18431	SGG_DROME	83.7	300	49	0	3	902	15	314	1.00E-146	520.8	SGG_DROME	reviewed	Protein kinase shaggy (EC 2.7.11.1) (Protein zeste-white 3)	sgg gsk3 zw3 CG2621	Drosophila melanogaster (Fruit fly)	514	axon [GO:0030424]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; fusome [GO:0045169]; mitotic spindle [GO:0072686]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell planar polarity [GO:0090163]; female meiotic nuclear division [GO:0007143]; habituation [GO:0046959]; heart development [GO:0007507]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; locomotor rhythm [GO:0045475]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; olfactory learning [GO:0008355]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein phosphorylation [GO:0006468]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein import into nucleus [GO:0042306]; regulation of proteolysis [GO:0030162]; response to anesthetic [GO:0072347]; rhythmic behavior [GO:0007622]; segment polarity determination [GO:0007367]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; spindle organization [GO:0007051]; synaptic growth at neuromuscular junction [GO:0051124]; wing and notum subfield formation [GO:0035309]	axon [GO:0030424]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; fusome [GO:0045169]; mitotic spindle [GO:0072686]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0003382; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0007051; GO:0007143; GO:0007165; GO:0007367; GO:0007507; GO:0007622; GO:0007623; GO:0008355; GO:0008407; GO:0008587; GO:0009649; GO:0022416; GO:0030162; GO:0030424; GO:0030589; GO:0030707; GO:0031594; GO:0032436; GO:0035019; GO:0035293; GO:0035309; GO:0035324; GO:0042306; GO:0042752; GO:0043508; GO:0045169; GO:0045475; GO:0045842; GO:0045879; GO:0045886; GO:0046627; GO:0046959; GO:0048477; GO:0051124; GO:0070507; GO:0070884; GO:0072347; GO:0072686; GO:0090090; GO:0090163; GO:1903052; GO:2000060	chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; chitin-based larval cuticle pattern formation [GO:0035293]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell planar polarity [GO:0090163]; female meiotic nuclear division [GO:0007143]; habituation [GO:0046959]; heart development [GO:0007507]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; locomotor rhythm [GO:0045475]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; olfactory learning [GO:0008355]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein phosphorylation [GO:0006468]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein import into nucleus [GO:0042306]; regulation of proteolysis [GO:0030162]; response to anesthetic [GO:0072347]; rhythmic behavior [GO:0007622]; segment polarity determination [GO:0007367]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; spindle organization [GO:0007051]; synaptic growth at neuromuscular junction [GO:0051124]; wing and notum subfield formation [GO:0035309]		NA	NA	NA	NA	NA	NA
TRINITY_DN4267_c0_g1_i1	B4J4Y2	KTU_DROGR	31.1	392	245	9	1680	541	21	399	9.90E-45	183	KTU_DROGR	reviewed	"Protein kintoun (Dynein assembly factor 2, axonemal homolog) (PP1-interacting protein 20)"	Nop17l Ppi20 GH21580	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	893	cytoplasm [GO:0005737]; protein phosphatase 1 binding [GO:0008157]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]	cytoplasm [GO:0005737]	protein phosphatase 1 binding [GO:0008157]	GO:0005737; GO:0008157; GO:0060285; GO:0070286	axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]		NA	NA	NA	NA	NA	NA
TRINITY_DN2785_c0_g1_i1	Q9VNE2	PKRA_DROME	49.6	339	167	2	1022	6	50	384	9.70E-93	341.7	PKRA_DROME	reviewed	Protein krasavietz (Eukaryotic translation initiation factor 5C domain-containing protein) (Decp) (eIF5C domain-containing protein) (Protein extra bases)	kra ecp eIF-5C exba CG2922	Drosophila melanogaster (Fruit fly)	422	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuronal cell body [GO:0043025]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]; axon midline choice point recognition [GO:0016199]; behavioral response to ethanol [GO:0048149]; long-term memory [GO:0007616]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of filopodium assembly [GO:0051491]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuronal cell body [GO:0043025]	ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation initiation factor binding [GO:0031369]	GO:0005737; GO:0007616; GO:0016199; GO:0017148; GO:0030175; GO:0030424; GO:0030707; GO:0031369; GO:0043022; GO:0043024; GO:0043025; GO:0044295; GO:0048149; GO:0048477; GO:0051491	axon midline choice point recognition [GO:0016199]; behavioral response to ethanol [GO:0048149]; long-term memory [GO:0007616]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; positive regulation of filopodium assembly [GO:0051491]		NA	NA	NA	NA	NA	NA
TRINITY_DN4784_c0_g1_i1	Q0V8M0	KRI1_BOVIN	41.7	247	126	5	1481	750	358	589	4.20E-39	164.1	KRI1_BOVIN	reviewed	Protein KRI1 homolog	KRI1	Bos taurus (Bovine)	705	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"	90S preribosome [GO:0030686]; nucleolus [GO:0005730]		GO:0000447; GO:0005730; GO:0030686	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4784_c0_g1_i2	Q0V8M0	KRI1_BOVIN	41.7	247	126	5	1481	750	358	589	4.20E-39	164.1	KRI1_BOVIN	reviewed	Protein KRI1 homolog	KRI1	Bos taurus (Bovine)	705	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"	90S preribosome [GO:0030686]; nucleolus [GO:0005730]		GO:0000447; GO:0005730; GO:0030686	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4472_c0_g1_i1	Q0V8M0	KRI1_BOVIN	25.2	313	191	9	160	999	8	310	7.20E-08	59.7	KRI1_BOVIN	reviewed	Protein KRI1 homolog	KRI1	Bos taurus (Bovine)	705	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"	90S preribosome [GO:0030686]; nucleolus [GO:0005730]		GO:0000447; GO:0005730; GO:0030686	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5684_c0_g2_i1	Q01871	KRUP_EUSPL	51	51	25	0	220	68	8	58	9.50E-10	64.3	KRUP_EUSPL	reviewed	Protein krueppel (Fragment)	Kr	Euscelis plebejus (Leafhopper)	74	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; segmentation [GO:0035282]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0035282; GO:0046872	segmentation [GO:0035282]		NA	NA	NA	NA	NA	NA
TRINITY_DN38348_c0_g1_i1	Q25515	KRUP_MANSE	39.3	61	34	1	195	13	1	58	2.90E-07	55.8	KRUP_MANSE	reviewed	Protein krueppel (Fragment)	Kr	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	76	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; segmentation [GO:0035282]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0035282; GO:0046872	segmentation [GO:0035282]		NA	NA	NA	NA	NA	NA
TRINITY_DN9376_c0_g2_i1	Q25515	KRUP_MANSE	55.7	70	30	1	1	210	4	72	5.30E-18	91.3	KRUP_MANSE	reviewed	Protein krueppel (Fragment)	Kr	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	76	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; segmentation [GO:0035282]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0035282; GO:0046872	segmentation [GO:0035282]		NA	NA	NA	NA	NA	NA
TRINITY_DN3068_c0_g1_i1	Q0P457	KTI12_DANRE	51.3	275	133	1	55	879	1	274	1.10E-77	291.6	KTI12_DANRE	reviewed	Protein KTI12 homolog	kti12 si:dkey-77f17.5 zgc:153393	Danio rerio (Zebrafish) (Brachydanio rerio)	275	Elongator holoenzyme complex [GO:0033588]; ATP binding [GO:0005524]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]	Elongator holoenzyme complex [GO:0033588]	ATP binding [GO:0005524]	GO:0002098; GO:0005524; GO:0006357; GO:0033588	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN3068_c0_g1_i2	Q0P457	KTI12_DANRE	51.3	275	133	1	55	879	1	274	3.80E-78	293.1	KTI12_DANRE	reviewed	Protein KTI12 homolog	kti12 si:dkey-77f17.5 zgc:153393	Danio rerio (Zebrafish) (Brachydanio rerio)	275	Elongator holoenzyme complex [GO:0033588]; ATP binding [GO:0005524]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]	Elongator holoenzyme complex [GO:0033588]	ATP binding [GO:0005524]	GO:0002098; GO:0005524; GO:0006357; GO:0033588	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN7360_c0_g1_i1	P24156	L2CC_DROME	75.1	269	67	0	100	906	3	271	4.50E-113	409.1	L2CC_DROME	reviewed	Protein l(2)37Cc	l(2)37Cc CG10691	Drosophila melanogaster (Fruit fly)	276	membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]	membrane [GO:0016020]; mitochondrion [GO:0005739]		GO:0005739; GO:0007275; GO:0016020; GO:0071456	cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN4727_c0_g1_i1	Q7KRY7	LAP4_DROME	62.4	338	122	2	2	1015	125	457	1.60E-114	414.1	SCRIB_DROME	reviewed	Protein lap4 (Protein scribble) (Protein smell-impaired)	scrib smi vart CG5462	Drosophila melanogaster (Fruit fly)	1851	"adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"	adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]		GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005912; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008285; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0042048; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794	"anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4727_c0_g1_i2	Q7KRY7	LAP4_DROME	43.1	949	418	17	2	2554	125	1049	2.70E-177	624	SCRIB_DROME	reviewed	Protein lap4 (Protein scribble) (Protein smell-impaired)	scrib smi vart CG5462	Drosophila melanogaster (Fruit fly)	1851	"adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"	adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]		GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005912; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008285; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0042048; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794	"anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1610_c0_g1_i1	Q7KRY7	LAP4_DROME	58.1	217	88	2	76	723	1237	1451	1.70E-63	244.2	SCRIB_DROME	reviewed	Protein lap4 (Protein scribble) (Protein smell-impaired)	scrib smi vart CG5462	Drosophila melanogaster (Fruit fly)	1851	"adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"	adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]		GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005912; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008285; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0042048; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794	"anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1610_c0_g1_i2	Q7KRY7	LAP4_DROME	59.4	239	93	3	3	716	1216	1451	1.50E-70	267.7	SCRIB_DROME	reviewed	Protein lap4 (Protein scribble) (Protein smell-impaired)	scrib smi vart CG5462	Drosophila melanogaster (Fruit fly)	1851	"adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"	adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]		GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005912; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008285; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0042048; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794	"anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell-cell adhesion [GO:0098609]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of endocytosis [GO:0030100]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3754_c0_g1_i3	P82147	L2EFL_DROME	30.7	150	92	4	90	512	8	154	5.70E-11	69.3	L2EFL_DROME	reviewed	Protein lethal(2)essential for life (Protein Efl21)	l(2)efl CG4533	Drosophila melanogaster (Fruit fly)	187	perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]	perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]	unfolded protein binding [GO:0051082]	GO:0007275; GO:0009408; GO:0010998; GO:0030018; GO:0042026; GO:0045214; GO:0048471; GO:0051082; GO:0061077	chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN3754_c0_g1_i4	P82147	L2EFL_DROME	41	78	45	1	320	553	78	154	1.40E-10	68.2	L2EFL_DROME	reviewed	Protein lethal(2)essential for life (Protein Efl21)	l(2)efl CG4533	Drosophila melanogaster (Fruit fly)	187	perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]	perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]	unfolded protein binding [GO:0051082]	GO:0007275; GO:0009408; GO:0010998; GO:0030018; GO:0042026; GO:0045214; GO:0048471; GO:0051082; GO:0061077	chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN3861_c0_g2_i1	Q32L53	LFG1_BOVIN	43.8	233	130	1	120	818	134	365	2.00E-49	197.6	LFG1_BOVIN	reviewed	Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit)	GRINA LFG1 NMDARA1	Bos taurus (Bovine)	366	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	ion channel binding [GO:0044325]	GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236	endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]		NA	NA	NA	NA	NA	NA
TRINITY_DN3861_c0_g2_i2	Q32L53	LFG1_BOVIN	42.9	126	72	0	120	497	134	259	5.00E-22	105.9	LFG1_BOVIN	reviewed	Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit)	GRINA LFG1 NMDARA1	Bos taurus (Bovine)	366	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	ion channel binding [GO:0044325]	GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236	endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]		NA	NA	NA	NA	NA	NA
TRINITY_DN39172_c0_g1_i1	Q32L53	LFG1_BOVIN	44	84	45	1	14	265	281	362	4.20E-10	65.5	LFG1_BOVIN	reviewed	Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit)	GRINA LFG1 NMDARA1	Bos taurus (Bovine)	366	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	ion channel binding [GO:0044325]	GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236	endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]		NA	NA	NA	NA	NA	NA
TRINITY_DN31850_c0_g1_i1	Q9ESF4	LFG1_MOUSE	47.5	80	40	1	263	24	264	341	2.10E-13	76.3	LFG1_MOUSE	reviewed	Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit)	Grina Lag Lfg1 Nmdara1	Mus musculus (Mouse)	345	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	ion channel binding [GO:0044325]	GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236	endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]		NA	NA	NA	NA	NA	NA
TRINITY_DN33381_c0_g1_i1	Q7Z429	LFG1_HUMAN	100	65	0	0	258	64	307	371	6.20E-28	124.4	LFG1_HUMAN	reviewed	Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3)	GRINA LFG1 NMDARA1 TMBIM3	Homo sapiens (Human)	371	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	ion channel binding [GO:0044325]	GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236	endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]		NA	NA	NA	NA	NA	NA
TRINITY_DN36057_c0_g1_i1	O88407	LFG2_RAT	40.2	251	131	4	103	801	66	315	1.40E-39	164.9	LFG2_RAT	reviewed	Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35)	Faim2 Lfg Lfg2 Nmp35	Rattus norvegicus (Rat)	316	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]		GO:0002931; GO:0005783; GO:0005794; GO:0006915; GO:0007417; GO:0016020; GO:0016021; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:1902042; GO:2001234	apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]		NA	NA	NA	NA	NA	NA
TRINITY_DN36057_c0_g1_i2	O88407	LFG2_RAT	40.2	251	131	4	112	810	66	315	1.40E-39	164.9	LFG2_RAT	reviewed	Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35)	Faim2 Lfg Lfg2 Nmp35	Rattus norvegicus (Rat)	316	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]		GO:0002931; GO:0005783; GO:0005794; GO:0006915; GO:0007417; GO:0016020; GO:0016021; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:1902042; GO:2001234	apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]		blue	blue	NA	NA	NA	NA
TRINITY_DN30050_c0_g1_i1	O88407	LFG2_RAT	46.2	221	115	1	728	78	92	312	1.20E-49	198.4	LFG2_RAT	reviewed	Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35)	Faim2 Lfg Lfg2 Nmp35	Rattus norvegicus (Rat)	316	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]		GO:0002931; GO:0005783; GO:0005794; GO:0006915; GO:0007417; GO:0016020; GO:0016021; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:1902042; GO:2001234	apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]		blue	blue	NA	NA	NA	NA
TRINITY_DN37530_c0_g1_i1	Q969X1	LFG3_HUMAN	100	142	0	0	1	426	80	221	2.60E-71	269.2	LFG3_HUMAN	reviewed	Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1)	TMBIM1 LFG3 RECS1 PP1201 PSEC0158	Homo sapiens (Human)	311	endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; death receptor binding [GO:0005123]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; neutrophil degranulation [GO:0043312]; positive regulation of blood vessel remodeling [GO:2000504]	endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	death receptor binding [GO:0005123]	GO:0005123; GO:0005765; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0035579; GO:0043086; GO:0043231; GO:0043312; GO:0070062; GO:1902042; GO:1902045; GO:1903077; GO:2000504	negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; neutrophil degranulation [GO:0043312]; positive regulation of blood vessel remodeling [GO:2000504]		NA	NA	NA	NA	NA	NA
TRINITY_DN26660_c0_g1_i1	Q8BJZ3	LFG3_MOUSE	100	69	0	0	3	209	241	309	2.40E-33	142.1	LFG3_MOUSE	reviewed	Protein lifeguard 3 (Responsive to centrifugal force and shear stress gene 1 protein) (Protein RECS1) (Transmembrane BAX inhibitor motif-containing protein 1)	Tmbim1 Lfg3 Recs1	Mus musculus (Mouse)	309	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; death receptor binding [GO:0005123]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of blood vessel remodeling [GO:2000504]; regulation of calcium-mediated signaling [GO:0050848]	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	death receptor binding [GO:0005123]	GO:0005123; GO:0005765; GO:0005794; GO:0010008; GO:0016021; GO:0043086; GO:0043231; GO:0050848; GO:1902042; GO:1902045; GO:1903077; GO:2000504	negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of blood vessel remodeling [GO:2000504]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN26660_c0_g1_i2	Q8BJZ3	LFG3_MOUSE	95.6	68	3	0	3	206	242	309	5.90E-32	137.5	LFG3_MOUSE	reviewed	Protein lifeguard 3 (Responsive to centrifugal force and shear stress gene 1 protein) (Protein RECS1) (Transmembrane BAX inhibitor motif-containing protein 1)	Tmbim1 Lfg3 Recs1	Mus musculus (Mouse)	309	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; death receptor binding [GO:0005123]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of blood vessel remodeling [GO:2000504]; regulation of calcium-mediated signaling [GO:0050848]	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	death receptor binding [GO:0005123]	GO:0005123; GO:0005765; GO:0005794; GO:0010008; GO:0016021; GO:0043086; GO:0043231; GO:0050848; GO:1902042; GO:1902045; GO:1903077; GO:2000504	negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of blood vessel remodeling [GO:2000504]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN6681_c0_g1_i1	Q9SA63	LFG4_ARATH	46.8	62	24	2	7	183	187	242	1.60E-06	53.1	LFG4_ARATH	reviewed	Protein LIFEGUARD 4 (AtLFG4)	LFG4 At1g03070 F10O3.11	Arabidopsis thaliana (Mouse-ear cress)	247	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN34359_c0_g1_i1	Q9HC24	LFG4_HUMAN	100	67	0	0	202	2	1	67	2.00E-29	129	LFG4_HUMAN	reviewed	Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein)	TMBIM4 GAAP LFG4 CGI-119	Homo sapiens (Human)	238	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005795; GO:0006915; GO:0016021; GO:0043066; GO:0050848	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN2941_c0_g1_i1	Q9DA39	LFG4_MOUSE	49.1	212	108	0	111	746	10	221	2.80E-48	193.7	LFG4_MOUSE	reviewed	Protein lifeguard 4 (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein)	Tmbim4 Lfg4	Mus musculus (Mouse)	238	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005795; GO:0006915; GO:0016021; GO:0043066; GO:0050848	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]		blue	blue	NA	NA	NA	NA
TRINITY_DN10351_c0_g1_i1	O17583	LIN10_CAEEL	72.2	396	93	2	409	1545	587	982	3.40E-156	553.1	LIN10_CAEEL	reviewed	Protein lin-10 (Abnormal cell lineage protein 10)	lin-10 C09H6.2	Caenorhabditis elegans	982	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852	chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN10351_c0_g1_i2	O17583	LIN10_CAEEL	72.2	396	93	2	365	1501	587	982	3.30E-156	553.1	LIN10_CAEEL	reviewed	Protein lin-10 (Abnormal cell lineage protein 10)	lin-10 C09H6.2	Caenorhabditis elegans	982	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852	chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN10351_c0_g1_i4	O17583	LIN10_CAEEL	72.2	396	93	2	297	1433	587	982	3.10E-156	553.1	LIN10_CAEEL	reviewed	Protein lin-10 (Abnormal cell lineage protein 10)	lin-10 C09H6.2	Caenorhabditis elegans	982	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852	chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN10351_c0_g1_i5	O17583	LIN10_CAEEL	60	65	26	0	294	488	587	651	1.30E-13	79	LIN10_CAEEL	reviewed	Protein lin-10 (Abnormal cell lineage protein 10)	lin-10 C09H6.2	Caenorhabditis elegans	982	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852	chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN10351_c0_g1_i7	O17583	LIN10_CAEEL	72.2	396	93	2	294	1430	587	982	3.10E-156	553.1	LIN10_CAEEL	reviewed	Protein lin-10 (Abnormal cell lineage protein 10)	lin-10 C09H6.2	Caenorhabditis elegans	982	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852	chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2239_c0_g1_i1	Q6X4M3	LIN52_ONCMY	54.4	103	45	1	143	445	9	111	2.80E-22	106.7	LIN52_ONCMY	reviewed	Protein lin-52 homolog (12.5 kDa retinal tissue protein) (Rtp12.5)	lin52	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	112	"DRM complex [GO:0070176]; multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]"	DRM complex [GO:0070176]		GO:0006351; GO:0007275; GO:0070176	"multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7602_c0_g1_i1	Q0IHV2	LIN54_XENTR	52.1	48	23	0	85	228	681	728	7.80E-07	54.7	LIN54_XENTR	reviewed	Protein lin-54 homolog	lin54	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	741	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0005634; GO:0006355; GO:0007049; GO:0046872	"cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7602_c0_g1_i2	Q571G4	LIN54_MOUSE	43.8	64	33	1	85	276	689	749	1.20E-06	53.9	LIN54_MOUSE	reviewed	Protein lin-54 homolog	Lin54 Kiaa2037	Mus musculus (Mouse)	749	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0005634; GO:0006355; GO:0007049; GO:0046872	"cell cycle [GO:0007049]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26251_c0_g1_i1	Q0P5F3	LIN7C_BOVIN	100	78	0	0	236	3	1	78	7.40E-36	150.6	LIN7C_BOVIN	reviewed	Protein lin-7 homolog C (Lin-7C)	LIN7C	Bos taurus (Bovine)	197	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]	L27 domain binding [GO:0097016]	GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0043005; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361	exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2456_c0_g1_i1	Q0P5F3	LIN7C_BOVIN	82.8	180	31	0	542	3	1	180	1.90E-80	300.1	LIN7C_BOVIN	reviewed	Protein lin-7 homolog C (Lin-7C)	LIN7C	Bos taurus (Bovine)	197	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]	L27 domain binding [GO:0097016]	GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0043005; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361	exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN32944_c0_g1_i1	Q5TKA1	LIN9_HUMAN	50.4	526	216	10	1665	103	53	538	7.80E-136	485.7	LIN9_HUMAN	reviewed	Protein lin-9 homolog (HuLin-9) (hLin-9) (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein)	LIN9 BARA TGS	Homo sapiens (Human)	542	"nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]	DNA binding [GO:0003677]	GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0007049; GO:0017053; GO:0051726; GO:0071897	"cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32944_c0_g1_i2	Q5TKA1	LIN9_HUMAN	51.9	511	216	10	1620	103	53	538	6.90E-137	489.2	LIN9_HUMAN	reviewed	Protein lin-9 homolog (HuLin-9) (hLin-9) (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein)	LIN9 BARA TGS	Homo sapiens (Human)	542	"nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]	DNA binding [GO:0003677]	GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0007049; GO:0017053; GO:0051726; GO:0071897	"cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1137_c0_g1_i1	Q9V4Z9	LINES_DROME	49.5	107	52	1	409	89	633	737	1.70E-20	100.5	LINES_DROME	reviewed	Protein lines	lin CG11770	Drosophila melanogaster (Fruit fly)	858	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007367; GO:0007440; GO:0007442; GO:0008544; GO:0009880; GO:0009946; GO:0016055; GO:0035220; GO:0035277; GO:0045944; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1137_c0_g1_i4	Q9V4Z9	LINES_DROME	52.7	226	99	2	1033	374	633	856	5.90E-56	219.5	LINES_DROME	reviewed	Protein lines	lin CG11770	Drosophila melanogaster (Fruit fly)	858	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007367; GO:0007440; GO:0007442; GO:0008544; GO:0009880; GO:0009946; GO:0016055; GO:0035220; GO:0035277; GO:0045944; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN1137_c0_g1_i5	Q9V4Z9	LINES_DROME	49.5	107	52	1	356	36	633	737	9.00E-21	101.3	LINES_DROME	reviewed	Protein lines	lin CG11770	Drosophila melanogaster (Fruit fly)	858	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007367; GO:0007440; GO:0007442; GO:0008544; GO:0009880; GO:0009946; GO:0016055; GO:0035220; GO:0035277; GO:0045944; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1137_c0_g1_i6	Q9V4Z9	LINES_DROME	52.7	226	99	2	864	205	633	856	5.00E-56	219.5	LINES_DROME	reviewed	Protein lines	lin CG11770	Drosophila melanogaster (Fruit fly)	858	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007367; GO:0007440; GO:0007442; GO:0008544; GO:0009880; GO:0009946; GO:0016055; GO:0035220; GO:0035277; GO:0045944; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN204_c0_g1_i1	Q9V4Z9	LINES_DROME	40.5	148	87	1	495	55	437	584	3.80E-26	120.6	LINES_DROME	reviewed	Protein lines	lin CG11770	Drosophila melanogaster (Fruit fly)	858	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0007367; GO:0007440; GO:0007442; GO:0008544; GO:0009880; GO:0009946; GO:0016055; GO:0035220; GO:0035277; GO:0045944; GO:0048617; GO:0048619	"embryonic foregut morphogenesis [GO:0048617]; embryonic hindgut morphogenesis [GO:0048619]; embryonic pattern specification [GO:0009880]; epidermis development [GO:0008544]; foregut morphogenesis [GO:0007440]; hindgut morphogenesis [GO:0007442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal axis specification [GO:0009946]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN741_c0_g1_i1	Q290X3	LIG_DROPS	34.7	236	109	15	782	120	1071	1276	6.00E-13	76.3	LIG_DROPS	reviewed	Protein lingerer	lig GA21277	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1327	cytoplasm [GO:0005737]; behavior [GO:0007610]; copulation [GO:0007620]	cytoplasm [GO:0005737]		GO:0005737; GO:0007610; GO:0007620	behavior [GO:0007610]; copulation [GO:0007620]		blue	blue	NA	NA	NA	NA
TRINITY_DN741_c0_g1_i2	Q290X3	LIG_DROPS	37.2	218	116	14	746	120	1071	1276	1.10E-14	82	LIG_DROPS	reviewed	Protein lingerer	lig GA21277	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1327	cytoplasm [GO:0005737]; behavior [GO:0007610]; copulation [GO:0007620]	cytoplasm [GO:0005737]		GO:0005737; GO:0007610; GO:0007620	behavior [GO:0007610]; copulation [GO:0007620]		blue	blue	NA	NA	NA	NA
TRINITY_DN741_c0_g2_i1	Q290X3	LIG_DROPS	37.2	218	116	14	30	656	1071	1276	1.10E-14	82	LIG_DROPS	reviewed	Protein lingerer	lig GA21277	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1327	cytoplasm [GO:0005737]; behavior [GO:0007610]; copulation [GO:0007620]	cytoplasm [GO:0005737]		GO:0005737; GO:0007610; GO:0007620	behavior [GO:0007610]; copulation [GO:0007620]		NA	NA	NA	NA	NA	NA
TRINITY_DN741_c0_g2_i2	Q290X3	LIG_DROPS	34.7	236	109	15	30	692	1071	1276	6.00E-13	76.3	LIG_DROPS	reviewed	Protein lingerer	lig GA21277	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1327	cytoplasm [GO:0005737]; behavior [GO:0007610]; copulation [GO:0007620]	cytoplasm [GO:0005737]		GO:0005737; GO:0007610; GO:0007620	behavior [GO:0007610]; copulation [GO:0007620]		NA	NA	NA	NA	NA	NA
TRINITY_DN35971_c0_g1_i1	Q7ZX75	LMBRL_XENLA	67.1	79	26	0	238	2	55	133	8.10E-22	105.1	LMBRL_XENLA	reviewed	Protein LMBR1L	lmbr1l	Xenopus laevis (African clawed frog)	483	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0006897; GO:0016021; GO:0016055; GO:0090090	endocytosis [GO:0006897]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3160_c0_g1_i2	Q9D1E5	LMBRL_MOUSE	45.1	346	172	5	6	1043	142	469	3.40E-63	243.8	LMBRL_MOUSE	reviewed	Protein LMBR1L (Lipocalin-1-interacting membrane receptor) (LIMR) (Uteroglobin receptor)	Lmbr1l D15Ertd735e Kiaa1174	Mus musculus (Mouse)	489	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005789; GO:0005886; GO:0005887; GO:0006898; GO:0007165; GO:0016055; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090	hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3594_c0_g1_i1	Q6NVR8	LS14A_XENTR	39.5	124	48	7	407	87	295	408	8.00E-09	62	LS14A_XENTR	reviewed	Protein LSM14 homolog A (RNA-associated protein 55A) (RAP55A)	lsm14a rap55a	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	469	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; messenger ribonucleoprotein complex [GO:1990124]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; messenger ribonucleoprotein complex [GO:1990124]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]	DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0007275; GO:0010494; GO:0017148; GO:0017151; GO:0033962; GO:0034063; GO:1990124; GO:1990904	multicellular organism development [GO:0007275]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063]		blue	blue	NA	NA	NA	NA
TRINITY_DN18517_c0_g1_i1	Q5U3J8	LTV1_DANRE	38.3	94	52	2	401	138	65	158	6.40E-08	58.5	LTV1_DANRE	reviewed	Protein LTV1 homolog	ltv1 zgc:103432	Danio rerio (Zebrafish) (Brachydanio rerio)	469	"cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"		GO:0000056; GO:0005634; GO:0005829; GO:0030688; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN939_c0_g1_i1	Q6NSQ7	LTV1_MOUSE	32.9	444	227	13	51	1367	4	381	7.40E-41	169.9	LTV1_MOUSE	reviewed	Protein LTV1 homolog	Ltv1	Mus musculus (Mouse)	470	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"		GO:0000056; GO:0005634; GO:0005654; GO:0005829; GO:0030688; GO:0042274	ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN30226_c0_g1_i1	Q3ZBV3	MGN_BOVIN	100	64	0	0	193	2	1	64	5.70E-31	134.4	MGN_BOVIN	reviewed	Protein mago nashi homolog	MAGOH	Bos taurus (Bovine)	146	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0000184; GO:0000381; GO:0003723; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0035145; GO:0051028; GO:0071013	"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24405_c1_g1_i1	Q3ZBV3	MGN_BOVIN	69.4	124	1	1	36	296	1	124	6.80E-39	161	MGN_BOVIN	reviewed	Protein mago nashi homolog	MAGOH	Bos taurus (Bovine)	146	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0000184; GO:0000381; GO:0003723; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0035145; GO:0051028; GO:0071013	"mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3098_c0_g1_i2	P49029	MGN_CAEEL	75	68	16	1	218	15	4	70	1.40E-22	106.7	MGN_CAEEL	reviewed	Protein mago nashi homolog (Ce-mago)	mag-1 R09B3.5	Caenorhabditis elegans	152	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; multicellular organism development [GO:0007275]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; oogenesis [GO:0048477]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]		GO:0007275; GO:0008380; GO:0035145; GO:0048477; GO:0071013; GO:0071048	multicellular organism development [GO:0007275]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; oogenesis [GO:0048477]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN38688_c0_g1_i1	P49029	MGN_CAEEL	75.6	131	32	0	394	2	9	139	1.40E-54	213.8	MGN_CAEEL	reviewed	Protein mago nashi homolog (Ce-mago)	mag-1 R09B3.5	Caenorhabditis elegans	152	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; multicellular organism development [GO:0007275]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; oogenesis [GO:0048477]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]		GO:0007275; GO:0008380; GO:0035145; GO:0048477; GO:0071013; GO:0071048	multicellular organism development [GO:0007275]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; oogenesis [GO:0048477]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24405_c0_g1_i1	Q0VC92	MGN2_BOVIN	100	87	0	0	262	2	36	122	1.10E-43	176.8	MGN2_BOVIN	reviewed	Protein mago nashi homolog 2	MAGOHB MAGOH2	Bos taurus (Bovine)	148	"catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]	GO:0000184; GO:0000398; GO:0003723; GO:0005634; GO:0008380; GO:0035145; GO:0051028; GO:0071005; GO:0071006; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3098_c0_g1_i1	Q0VC92	MGN2_BOVIN	88.7	142	16	0	428	3	3	144	1.40E-70	266.9	MGN2_BOVIN	reviewed	Protein mago nashi homolog 2	MAGOHB MAGOH2	Bos taurus (Bovine)	148	"catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]	GO:0000184; GO:0000398; GO:0003723; GO:0005634; GO:0008380; GO:0035145; GO:0051028; GO:0071005; GO:0071006; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19329_c0_g2_i2	Q9W2F2	DCAF1_DROME	34.6	344	170	6	90	1106	111	404	9.30E-47	189.1	DCAF1_DROME	reviewed	Protein mahjong (DDB1- and CUL4-associated factor-like 1) (VPRBP-like protein)	mahj CG10080	Drosophila melanogaster (Fruit fly)	1544	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; cell competition in a multicellular organism [GO:0035212]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]		GO:0005634; GO:0016567; GO:0035212; GO:0080008	cell competition in a multicellular organism [GO:0035212]; protein ubiquitination [GO:0016567]		brown	brown	NA	NA	NA	NA
TRINITY_DN14091_c0_g1_i1	Q9W2F2	DCAF1_DROME	51.4	105	50	1	3	317	840	943	2.20E-22	106.3	DCAF1_DROME	reviewed	Protein mahjong (DDB1- and CUL4-associated factor-like 1) (VPRBP-like protein)	mahj CG10080	Drosophila melanogaster (Fruit fly)	1544	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; cell competition in a multicellular organism [GO:0035212]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]		GO:0005634; GO:0016567; GO:0035212; GO:0080008	cell competition in a multicellular organism [GO:0035212]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN31512_c0_g1_i1	Q1RML7	MAK16_BOVIN	100	67	0	0	203	3	119	185	6.40E-28	124	MAK16_BOVIN	reviewed	Protein MAK16 homolog	MAK16	Bos taurus (Bovine)	298	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN4792_c0_g2_i1	Q6P7N1	MAK16_XENTR	63	92	34	0	361	86	106	197	2.20E-23	109.8	MAK16_XENTR	reviewed	Protein MAK16 homolog (MAK16-like protein)	mak16 mak16l	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	300	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN8233_c0_g2_i1	Q55DJ3	MAK16_DICDI	68.2	88	26	1	266	3	7	92	8.00E-31	134	MAK16_DICDI	reviewed	Protein MAK16 homolog (MAK16-like protein)	mak16l mak16 DDB_G0269642	Dictyostelium discoideum (Slime mold)	309	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; ribosomal large subunit biogenesis [GO:0042273]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687; GO:0042273	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN4792_c0_g1_i1	Q66L33	MK16A_XENLA	71.7	99	27	1	295	2	1	99	2.60E-38	159.5	MK16A_XENLA	reviewed	Protein MAK16 homolog A (MAK16-like protein A)	mak16-a mak16l-a	Xenopus laevis (African clawed frog)	301	nucleolus [GO:0005730]	nucleolus [GO:0005730]		GO:0005730			blue	blue	NA	NA	NA	NA
TRINITY_DN8233_c0_g1_i1	Q7ZYG5	MK16B_XENLA	52.1	71	34	0	239	27	124	194	3.70E-11	68.6	MK16B_XENLA	reviewed	Protein MAK16 homolog B (MAK16-like protein B)	mak16-b mak16l-b	Xenopus laevis (African clawed frog)	304	nucleolus [GO:0005730]	nucleolus [GO:0005730]		GO:0005730			red	red	NA	NA	NA	NA
TRINITY_DN694_c0_g1_i2	P49283	MVL_DROME	63.3	515	178	6	1787	267	42	553	6.60E-178	625.5	MVL_DROME	reviewed	Protein Malvolio	Mvl CG3671	Drosophila melanogaster (Fruit fly)	596	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]	GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0005887; GO:0010038; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076; GO:0070838	copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN694_c0_g1_i3	P49283	MVL_DROME	63.3	515	178	6	1787	267	42	553	6.60E-178	625.5	MVL_DROME	reviewed	Protein Malvolio	Mvl CG3671	Drosophila melanogaster (Fruit fly)	596	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]	GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0005887; GO:0010038; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076; GO:0070838	copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN694_c0_g1_i4	P49283	MVL_DROME	63.3	515	178	6	1787	267	42	553	6.60E-178	625.5	MVL_DROME	reviewed	Protein Malvolio	Mvl CG3671	Drosophila melanogaster (Fruit fly)	596	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cadmium ion transmembrane transporter activity [GO:0015086]; copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293]	GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0005887; GO:0010038; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076; GO:0070838	copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; divalent metal ion transport [GO:0070838]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; response to metal ion [GO:0010038]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN36593_c0_g1_i1	Q9VZH2	MAS_DROME	88.9	54	6	0	102	263	992	1045	1.20E-23	110.2	MAS_DROME	reviewed	Protein masquerade	mas c-SPH79 SPH79 CG15002	Drosophila melanogaster (Fruit fly)	1047	axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]	axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]		GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007417; GO:0007422; GO:0010976; GO:0016203; GO:0030424; GO:0043025; GO:0061564; GO:0106030	axon development [GO:0061564]; central nervous system development [GO:0007417]; muscle attachment [GO:0016203]; neuron projection fasciculation [GO:0106030]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN867_c0_g1_i1	P52162	MAX_CHICK	65	103	20	3	388	80	1	87	1.80E-25	117.1	MAX_CHICK	reviewed	Protein max (Myc-associated factor X)	MAX	Gallus gallus (Chicken)	160	"MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]"	GO:0000790; GO:0001227; GO:0003700; GO:0005634; GO:0032993; GO:0045944; GO:0046983; GO:0070888; GO:0071339; GO:0090575	positive regulation of transcription by RNA polymerase II [GO:0045944]		brown	brown	NA	NA	NA	NA
TRINITY_DN35694_c0_g1_i1	P61245	MAX_FELCA	99.2	124	1	0	372	1	1	124	6.30E-61	234.6	MAX_FELCA	reviewed	Protein max (Myc-associated factor X)	MAX	Felis catus (Cat) (Felis silvestris catus)	160	"dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]"	GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0030425; GO:0045944; GO:0046983; GO:0071339; GO:0090575	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN867_c0_g1_i3	P28574	MAX_MOUSE	45	100	38	1	280	32	57	156	2.20E-12	73.2	MAX_MOUSE	reviewed	Protein max (Myc-associated factor X) (Myc-binding novel HLH/LZ protein) (Protein myn)	Max Myn	Mus musculus (Mouse)	160	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0009267; GO:0010629; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0046983; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070888; GO:0071339; GO:0071375; GO:0090575; GO:1990837	"cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN867_c0_g1_i4	P28574	MAX_MOUSE	51.7	172	50	4	496	32	1	156	3.10E-32	139.8	MAX_MOUSE	reviewed	Protein max (Myc-associated factor X) (Myc-binding novel HLH/LZ protein) (Protein myn)	Max Myn	Mus musculus (Mouse)	160	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0009267; GO:0010629; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0046983; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070888; GO:0071339; GO:0071375; GO:0090575; GO:1990837	"cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN867_c0_g1_i5	P28574	MAX_MOUSE	54.1	172	60	4	538	32	1	156	2.90E-36	153.3	MAX_MOUSE	reviewed	Protein max (Myc-associated factor X) (Myc-binding novel HLH/LZ protein) (Protein myn)	Max Myn	Mus musculus (Mouse)	160	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0009267; GO:0010629; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0046983; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070888; GO:0071339; GO:0071375; GO:0090575; GO:1990837	"cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19955_c0_g2_i1	Q5RHY1	MCM10_DANRE	31.8	211	121	5	594	1	153	353	7.10E-23	109.4	MCM10_DANRE	reviewed	Protein MCM10 homolog	mcm10 si:ch211-206k18.2	Danio rerio (Zebrafish) (Brachydanio rerio)	833	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0003688; GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0031298; GO:0046872	cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN19955_c0_g2_i2	Q5RHY1	MCM10_DANRE	32.1	187	108	4	611	90	153	333	8.90E-21	102.4	MCM10_DANRE	reviewed	Protein MCM10 homolog	mcm10 si:ch211-206k18.2	Danio rerio (Zebrafish) (Brachydanio rerio)	833	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0003688; GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0031298; GO:0046872	cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN19955_c0_g1_i1	Q28E45	MCM10_XENTR	32.2	227	116	8	661	20	356	557	1.30E-18	94.7	MCM10_XENTR	reviewed	Protein MCM10 homolog	mcm10 TEgg053h10.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	845	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0003688; GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0031298; GO:0046872	cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]		NA	NA	NA	NA	NA	NA
TRINITY_DN15502_c0_g1_i1	Q9VS24	MELT_DROME	56.3	327	109	8	1001	87	669	983	6.60E-96	352.8	MELT_DROME	reviewed	Protein melted	melt CG8624	Drosophila melanogaster (Fruit fly)	994	plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]	GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0009966; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263	cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN15502_c0_g1_i3	Q9VS24	MELT_DROME	56.9	181	55	5	596	87	815	983	3.00E-50	199.9	MELT_DROME	reviewed	Protein melted	melt CG8624	Drosophila melanogaster (Fruit fly)	994	plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]	GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0009966; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263	cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN15502_c0_g1_i4	Q9VS24	MELT_DROME	56.3	327	109	8	1001	87	669	983	6.40E-96	352.8	MELT_DROME	reviewed	Protein melted	melt CG8624	Drosophila melanogaster (Fruit fly)	994	plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]	GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0009966; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263	cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN9454_c0_g1_i1	Q9VS24	MELT_DROME	33.5	379	213	5	1078	2	120	479	1.40E-42	175.3	MELT_DROME	reviewed	Protein melted	melt CG8624	Drosophila melanogaster (Fruit fly)	994	plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]	GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0009966; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263	cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN9454_c0_g1_i6	Q9VS24	MELT_DROME	38	447	237	6	1279	2	52	479	2.60E-66	254.2	MELT_DROME	reviewed	Protein melted	melt CG8624	Drosophila melanogaster (Fruit fly)	994	plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-5-phosphate binding [GO:0010314]; cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]	GO:0001708; GO:0005886; GO:0006629; GO:0009267; GO:0009966; GO:0010314; GO:0031323; GO:0035091; GO:0043433; GO:0045464; GO:0046628; GO:1904263	cell fate specification [GO:0001708]; cellular response to starvation [GO:0009267]; lipid metabolic process [GO:0006629]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of TORC1 signaling [GO:1904263]; R8 cell fate specification [GO:0045464]; regulation of cellular metabolic process [GO:0031323]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN8232_c0_g1_i2	Q0KHY3	MESH_DROME	53.3	214	97	2	644	3	131	341	9.00E-63	241.5	MESH_DROME	reviewed	Protein mesh	mesh CG31004	Drosophila melanogaster (Fruit fly)	1454	apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]; cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]	apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]		GO:0005615; GO:0005920; GO:0007160; GO:0007275; GO:0016021; GO:0016327; GO:0090528	cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]		NA	NA	NA	NA	NA	NA
TRINITY_DN8232_c0_g1_i1	Q0KHY3	MESH_DROME	49	145	73	1	475	41	131	274	2.20E-37	156.8	MESH_DROME	reviewed	Protein mesh	mesh CG31004	Drosophila melanogaster (Fruit fly)	1454	apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]; cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]	apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]		GO:0005615; GO:0005920; GO:0007160; GO:0007275; GO:0016021; GO:0016327; GO:0090528	cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]		brown	brown	1	NA	NA	NA
TRINITY_DN10349_c0_g1_i1	H9JIQ1	MESH_BOMMO	44.1	118	66	0	75	428	512	629	4.10E-24	112.5	MESH_BOMMO	reviewed	Protein mesh		Bombyx mori (Silk moth)	1583	integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; septate junction [GO:0005918]; cell-matrix adhesion [GO:0007160]	integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; septate junction [GO:0005918]		GO:0005918; GO:0007160; GO:0016021; GO:0016328	cell-matrix adhesion [GO:0007160]		NA	NA	NA	NA	NA	NA
TRINITY_DN10349_c0_g1_i2	H9JIQ1	MESH_BOMMO	46.5	157	84	0	1	471	473	629	1.70E-39	163.7	MESH_BOMMO	reviewed	Protein mesh		Bombyx mori (Silk moth)	1583	integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; septate junction [GO:0005918]; cell-matrix adhesion [GO:0007160]	integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; septate junction [GO:0005918]		GO:0005918; GO:0007160; GO:0016021; GO:0016328	cell-matrix adhesion [GO:0007160]		NA	NA	NA	NA	NA	NA
TRINITY_DN26973_c0_g1_i2	H9JIQ1	MESH_BOMMO	48.1	648	320	9	44	1963	626	1265	4.50E-187	656	MESH_BOMMO	reviewed	Protein mesh		Bombyx mori (Silk moth)	1583	integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; septate junction [GO:0005918]; cell-matrix adhesion [GO:0007160]	integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; septate junction [GO:0005918]		GO:0005918; GO:0007160; GO:0016021; GO:0016328	cell-matrix adhesion [GO:0007160]		NA	NA	NA	NA	NA	NA
TRINITY_DN38591_c0_g1_i1	Q0KHY3	MESH_DROME	63.5	148	54	0	445	2	338	485	1.10E-53	210.7	MESH_DROME	reviewed	Protein mesh	mesh CG31004	Drosophila melanogaster (Fruit fly)	1454	apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]; cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]	apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; smooth septate junction [GO:0005920]		GO:0005615; GO:0005920; GO:0007160; GO:0007275; GO:0016021; GO:0016327; GO:0090528	cell-matrix adhesion [GO:0007160]; multicellular organism development [GO:0007275]; smooth septate junction assembly [GO:0090528]		NA	NA	NA	NA	NA	NA
TRINITY_DN8917_c5_g1_i1	Q9VEZ3	MSPS_DROME	55.5	528	224	2	81	1661	1	518	9.70E-151	535	MSPS_DROME	reviewed	Protein mini spindles	msps CG5000	Drosophila melanogaster (Fruit fly)	2042	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; tubulin binding [GO:0015631]; axon guidance [GO:0007411]; bicoid mRNA localization [GO:0045450]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum organization [GO:0007029]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; establishment or maintenance of neuroblast polarity [GO:0045196]; female meiotic nuclear division [GO:0007143]; microtubule polymerization [GO:0046785]; mitotic cell cycle [GO:0000278]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; positive regulation of microtubule nucleation [GO:0090063]; pronuclear fusion [GO:0007344]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; tubulin binding [GO:0015631]	GO:0000022; GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0005737; GO:0005813; GO:0007029; GO:0007052; GO:0007143; GO:0007344; GO:0007411; GO:0008017; GO:0015631; GO:0016325; GO:0030951; GO:0031122; GO:0035371; GO:0045196; GO:0045450; GO:0046785; GO:0048477; GO:0051298; GO:0061863; GO:0090063	axon guidance [GO:0007411]; bicoid mRNA localization [GO:0045450]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum organization [GO:0007029]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; establishment or maintenance of neuroblast polarity [GO:0045196]; female meiotic nuclear division [GO:0007143]; microtubule polymerization [GO:0046785]; mitotic cell cycle [GO:0000278]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; positive regulation of microtubule nucleation [GO:0090063]; pronuclear fusion [GO:0007344]		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i14	Q1L908	MSTO1_DANRE	29.7	590	374	12	1811	123	1	576	1.80E-61	238.8	MSTO1_DANRE	reviewed	Protein misato homolog 1	msto1 si:dkey-263h23.5 zgc:55470	Danio rerio (Zebrafish) (Brachydanio rerio)	591	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]		GO:0000002; GO:0000070; GO:0005737; GO:0005741; GO:0048311; GO:0090307	mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c0_g1_i19	Q1L908	MSTO1_DANRE	30.1	572	359	12	2326	692	1	558	8.40E-61	236.9	MSTO1_DANRE	reviewed	Protein misato homolog 1	msto1 si:dkey-263h23.5 zgc:55470	Danio rerio (Zebrafish) (Brachydanio rerio)	591	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]		GO:0000002; GO:0000070; GO:0005737; GO:0005741; GO:0048311; GO:0090307	mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN37255_c0_g1_i1	Q9BUK6	MSTO1_HUMAN	100	80	0	0	241	2	1	80	8.60E-42	170.6	MSTO1_HUMAN	reviewed	Protein misato homolog 1	MSTO1 LST005 SLTP005	Homo sapiens (Human)	570	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]		GO:0000002; GO:0000070; GO:0005737; GO:0005741; GO:0007005; GO:0048311; GO:0090307	mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]		NA	NA	NA	NA	NA	NA
TRINITY_DN6379_c0_g1_i1	B3DIY3	MMS22_DANRE	27.4	340	205	11	202	1158	29	347	2.50E-15	84.7	MMS22_DANRE	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	mms22l zgc:194596	Danio rerio (Zebrafish) (Brachydanio rerio)	1240	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		GO:0000724; GO:0031297; GO:0043596	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN6379_c0_g1_i9	B3DIY3	MMS22_DANRE	27.4	340	205	11	205	1161	29	347	2.50E-15	84.7	MMS22_DANRE	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	mms22l zgc:194596	Danio rerio (Zebrafish) (Brachydanio rerio)	1240	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		GO:0000724; GO:0031297; GO:0043596	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN1710_c0_g1_i12	E1C2Z0	MMS22_CHICK	27.4	901	575	25	2521	8	356	1240	6.10E-67	257.3	MMS22_CHICK	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	MMS22L	Gallus gallus (Chicken)	1243	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		GO:0000724; GO:0031297; GO:0043596	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN1710_c0_g1_i5	E1C2Z0	MMS22_CHICK	27.2	883	567	24	2520	61	356	1225	1.70E-64	249.2	MMS22_CHICK	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	MMS22L	Gallus gallus (Chicken)	1243	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		GO:0000724; GO:0031297; GO:0043596	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN1710_c0_g1_i8	E1C2Z0	MMS22_CHICK	33.1	281	171	6	897	97	405	682	2.60E-33	144.1	MMS22_CHICK	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	MMS22L	Gallus gallus (Chicken)	1243	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		GO:0000724; GO:0031297; GO:0043596	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN1710_c0_g1_i9	E1C2Z0	MMS22_CHICK	32.7	272	156	6	887	144	474	742	2.80E-28	127.9	MMS22_CHICK	reviewed	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	MMS22L	Gallus gallus (Chicken)	1243	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	nuclear replication fork [GO:0043596]		GO:0000724; GO:0031297; GO:0043596	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		NA	NA	NA	NA	NA	NA
TRINITY_DN14844_c0_g1_i10	Q9VLT1	MON2_DROME	56	389	151	3	111	1265	16	388	4.60E-114	412.9	MON2_DROME	reviewed	Protein MON2 homolog	mon2 CG8683	Drosophila melanogaster (Fruit fly)	1684	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; cytoskeletal regulatory protein binding [GO:0005519]; actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]	cytoskeletal regulatory protein binding [GO:0005519]	GO:0005519; GO:0005768; GO:0005794; GO:0007318; GO:0015031; GO:0031532	actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN14844_c0_g1_i11	Q9VLT1	MON2_DROME	56.4	1255	467	12	111	3791	16	1218	0	1330.5	MON2_DROME	reviewed	Protein MON2 homolog	mon2 CG8683	Drosophila melanogaster (Fruit fly)	1684	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; cytoskeletal regulatory protein binding [GO:0005519]; actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]	cytoskeletal regulatory protein binding [GO:0005519]	GO:0005519; GO:0005768; GO:0005794; GO:0007318; GO:0015031; GO:0031532	actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN14844_c0_g1_i2	Q9VLT1	MON2_DROME	56.6	1125	408	12	89	3379	146	1218	0	1200.3	MON2_DROME	reviewed	Protein MON2 homolog	mon2 CG8683	Drosophila melanogaster (Fruit fly)	1684	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; cytoskeletal regulatory protein binding [GO:0005519]; actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]	cytoskeletal regulatory protein binding [GO:0005519]	GO:0005519; GO:0005768; GO:0005794; GO:0007318; GO:0015031; GO:0031532	actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN14844_c0_g1_i5	Q9VLT1	MON2_DROME	58.1	284	86	3	150	950	951	1218	2.40E-85	317	MON2_DROME	reviewed	Protein MON2 homolog	mon2 CG8683	Drosophila melanogaster (Fruit fly)	1684	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; cytoskeletal regulatory protein binding [GO:0005519]; actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]	cytoskeletal regulatory protein binding [GO:0005519]	GO:0005519; GO:0005768; GO:0005794; GO:0007318; GO:0015031; GO:0031532	actin cytoskeleton reorganization [GO:0031532]; pole plasm protein localization [GO:0007318]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN14844_c0_g1_i6	Q29L43	MON2_DROPS	58.6	169	70	0	111	617	14	182	6.90E-47	188.7	MON2_DROPS	reviewed	Protein MON2 homolog	mon2 GA16450	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1701	protein transport [GO:0015031]			GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN38580_c0_g1_i1	Q7Z3U7	MON2_HUMAN	100	66	0	0	3	200	774	839	8.50E-33	140.2	MON2_HUMAN	reviewed	Protein MON2 homolog (Protein SF21)	MON2 KIAA1040 SF21	Homo sapiens (Human)	1717	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]		GO:0005829; GO:0006895; GO:0015031; GO:0070062	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN28974_c0_g1_i1	Q7Z3U7	MON2_HUMAN	100	104	0	0	1	312	86	189	1.20E-49	196.8	MON2_HUMAN	reviewed	Protein MON2 homolog (Protein SF21)	MON2 KIAA1040 SF21	Homo sapiens (Human)	1717	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]		GO:0005829; GO:0006895; GO:0015031; GO:0070062	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN14844_c0_g1_i7	Q7Z3U7	MON2_HUMAN	62	50	19	0	68	217	138	187	6.50E-09	61.2	MON2_HUMAN	reviewed	Protein MON2 homolog (Protein SF21)	MON2 KIAA1040 SF21	Homo sapiens (Human)	1717	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]		GO:0005829; GO:0006895; GO:0015031; GO:0070062	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5948_c0_g1_i5	Q8BZ20	PAR12_MOUSE	39.1	92	54	2	581	309	598	688	9.90E-13	75.1	PAR12_MOUSE	reviewed	Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)	Parp12 Zc3hdc1	Mus musculus (Mouse)	711	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404	protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]		NA	NA	NA	NA	NA	NA
TRINITY_DN10641_c0_g1_i1	Q3ULW8	PARP3_MOUSE	54.6	249	101	4	3	725	286	530	6.30E-66	252.3	PARP3_MOUSE	reviewed	Protein mono-ADP-ribosyltransferase PARP3 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) (Poly [ADP-ribose] polymerase 3) (PARP-3) (Poly[ADP-ribose] synthase 3) (pADPRT-3)	Parp3 Adprt3	Mus musculus (Mouse)	533	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]	GO:0000723; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006471; GO:0016604; GO:0030592; GO:0035861; GO:0045829; GO:0051106; GO:0060236; GO:0070212; GO:0070213; GO:0140289; GO:0140294; GO:1905662; GO:1990166; GO:1990404; GO:2001034	DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN28361_c0_g1_i1	A6PVC2	TTLL8_HUMAN	49	51	26	0	182	334	39	89	4.70E-08	58.9	TTLL8_HUMAN	reviewed	Protein monoglycylase TTLL8 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 8)	TTLL8	Homo sapiens (Human)	850	"axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; protein polyglycylation [GO:0018094]"	axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0070735; GO:0070736	protein polyglycylation [GO:0018094]		NA	NA	NA	NA	NA	NA
TRINITY_DN4929_c0_g1_i1	P42003	MAD_DROME	77.2	473	80	5	75	1490	10	455	2.60E-193	676.4	MAD_DROME	reviewed	Protein mothers against dpp	Mad CG12399	Drosophila melanogaster (Fruit fly)	455	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc morphogenesis [GO:0007560]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001102; GO:0001227; GO:0001228; GO:0001745; GO:0003713; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0007179; GO:0007419; GO:0007476; GO:0007480; GO:0007488; GO:0007507; GO:0007560; GO:0008134; GO:0008586; GO:0009653; GO:0030154; GO:0030509; GO:0030707; GO:0030718; GO:0031625; GO:0035019; GO:0035290; GO:0042078; GO:0043565; GO:0045464; GO:0045595; GO:0045705; GO:0045887; GO:0045944; GO:0046872; GO:0048100; GO:0060395; GO:0060799; GO:0070411; GO:0071144; GO:0090571; GO:1904398; GO:2000134	anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc morphogenesis [GO:0007560]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN4929_c0_g1_i2	P42003	MAD_DROME	76.9	247	52	2	42	782	214	455	1.40E-108	394	MAD_DROME	reviewed	Protein mothers against dpp	Mad CG12399	Drosophila melanogaster (Fruit fly)	455	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc morphogenesis [GO:0007560]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001102; GO:0001227; GO:0001228; GO:0001745; GO:0003713; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0007179; GO:0007419; GO:0007476; GO:0007480; GO:0007488; GO:0007507; GO:0007560; GO:0008134; GO:0008586; GO:0009653; GO:0030154; GO:0030509; GO:0030707; GO:0030718; GO:0031625; GO:0035019; GO:0035290; GO:0042078; GO:0043565; GO:0045464; GO:0045595; GO:0045705; GO:0045887; GO:0045944; GO:0046872; GO:0048100; GO:0060395; GO:0060799; GO:0070411; GO:0071144; GO:0090571; GO:1904398; GO:2000134	anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; compound eye morphogenesis [GO:0001745]; germ-line stem cell division [GO:0042078]; germ-line stem cell population maintenance [GO:0030718]; heart development [GO:0007507]; histoblast morphogenesis [GO:0007488]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc morphogenesis [GO:0007560]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; positive regulation of neuromuscular junction development [GO:1904398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R8 cell fate specification [GO:0045464]; regulation of cell differentiation [GO:0045595]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification [GO:0060799]; trunk segmentation [GO:0035290]; ventral cord development [GO:0007419]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN11016_c0_g1_i1	Q66GV0	MPV17_XENLA	46.1	178	94	2	54	584	1	177	2.00E-40	167.2	MPV17_XENLA	reviewed	Protein Mpv17	mpv17	Xenopus laevis (African clawed frog)	177	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4611_c0_g1_i1	Q4V3E2	MRG2_ARATH	60	40	16	0	235	116	60	99	3.70E-06	52.8	MRG2_ARATH	reviewed	Protein MRG2 (MRG family protein 2) (Morf Related Gene 2)	MRG2 At1g02740 F22D16.25	Arabidopsis thaliana (Mouse-ear cress)	327	"histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; euchromatin binding [GO:1990188]; histone acetylation [GO:0016573]; histone H4 acetylation [GO:0043967]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; regulation of transcription, DNA-templated [GO:0006355]"	histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]	euchromatin binding [GO:1990188]	GO:0000123; GO:0005634; GO:0006355; GO:0016573; GO:0043967; GO:0048510; GO:1990188	"histone acetylation [GO:0016573]; histone H4 acetylation [GO:0043967]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28779_c0_g1_i1	Q923Z3	MTO1_MOUSE	99	97	1	0	2	292	25	121	1.40E-52	206.5	MTO1_MOUSE	reviewed	"Protein MTO1 homolog, mitochondrial"	Mto1	Mus musculus (Mouse)	669	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005739; GO:0030488; GO:0050660; GO:0070899	mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5832_c0_g1_i1	Q923Z3	MTO1_MOUSE	83.1	71	12	0	250	38	42	112	3.20E-29	128.6	MTO1_MOUSE	reviewed	"Protein MTO1 homolog, mitochondrial"	Mto1	Mus musculus (Mouse)	669	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005739; GO:0030488; GO:0050660; GO:0070899	mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5832_c0_g1_i3	Q5RB71	MTO1_PONAB	57.5	610	241	9	1814	3	43	640	1.60E-194	680.6	MTO1_PONAB	reviewed	"Protein MTO1 homolog, mitochondrial"	MTO1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	692	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005739; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5832_c0_g1_i4	Q5RB71	MTO1_PONAB	57.5	610	241	9	1814	3	43	640	1.20E-194	681	MTO1_PONAB	reviewed	"Protein MTO1 homolog, mitochondrial"	MTO1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	692	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005739; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN39952_c0_g1_i1	Q9Y2Z2	MTO1_HUMAN	100	87	0	0	262	2	446	532	9.80E-45	180.3	MTO1_HUMAN	reviewed	"Protein MTO1 homolog, mitochondrial"	MTO1 CGI-02	Homo sapiens (Human)	717	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; RNA binding [GO:0003723]; mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; RNA binding [GO:0003723]	GO:0002098; GO:0003723; GO:0005739; GO:0030488; GO:0050660; GO:0070899	mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN4013_c0_g1_i1	Q8R1S4	MTSS1_MOUSE	48.1	264	120	5	1662	922	99	362	2.30E-38	161.8	MTSS1_MOUSE	reviewed	Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)	Mtss1 Mim	Mus musculus (Mouse)	759	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]		NA	NA	NA	NA	NA	NA
TRINITY_DN4013_c0_g1_i2	Q8R1S4	MTSS1_MOUSE	48.1	264	120	5	1508	768	99	362	2.10E-38	161.8	MTSS1_MOUSE	reviewed	Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)	Mtss1 Mim	Mus musculus (Mouse)	759	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]		NA	NA	NA	NA	NA	NA
TRINITY_DN4013_c0_g1_i6	Q8R1S4	MTSS1_MOUSE	48.1	264	120	5	1729	989	99	362	2.40E-38	161.8	MTSS1_MOUSE	reviewed	Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)	Mtss1 Mim	Mus musculus (Mouse)	759	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]		NA	NA	NA	NA	NA	NA
TRINITY_DN4013_c0_g1_i8	Q8R1S4	MTSS1_MOUSE	48.1	264	120	5	1621	881	99	362	2.20E-38	161.8	MTSS1_MOUSE	reviewed	Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)	Mtss1 Mim	Mus musculus (Mouse)	759	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]		NA	NA	NA	NA	NA	NA
TRINITY_DN4013_c0_g1_i11	O43312	MTSS1_HUMAN	53.8	117	39	3	1227	922	242	358	6.70E-06	53.5	MTSS1_HUMAN	reviewed	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	MTSS1 KIAA0429 MIM	Homo sapiens (Human)	755	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]	actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN4013_c0_g1_i3	O43312	MTSS1_HUMAN	53.8	117	39	3	1294	989	242	358	7.10E-06	53.5	MTSS1_HUMAN	reviewed	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	MTSS1 KIAA0429 MIM	Homo sapiens (Human)	755	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]	actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1783_c0_g1_i1	Q66IM5	NATD1_XENTR	48.4	95	45	2	114	392	15	107	4.40E-19	95.9	NATD1_XENTR	reviewed	Protein NATD1 (N-acetyltransferase domain-containing protein 1)	natd1 gtlf3b TEgg042j15.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	109							blue	blue	NA	NA	NA	NA
TRINITY_DN28784_c0_g1_i1	Q92597	NDRG1_HUMAN	98.3	119	2	0	2	358	37	155	1.20E-66	253.4	NDRG1_HUMAN	reviewed	Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42)	NDRG1 CAP43 DRG1 RTP	Homo sapiens (Human)	394	"adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]"	adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]	GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0007165; GO:0008017; GO:0008285; GO:0010038; GO:0015630; GO:0017137; GO:0030330; GO:0032287; GO:0042981; GO:0043015; GO:0045296; GO:0045576; GO:0048471; GO:0055038; GO:0070062; GO:0071456; GO:0098978; GO:0099173	"cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14736_c0_g1_i1	Q9UGV2	NDRG3_HUMAN	100	100	0	0	1	300	31	130	1.40E-55	216.5	NDRG3_HUMAN	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein)	NDRG3	Homo sapiens (Human)	375	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]		GO:0005737; GO:0007165; GO:0007283; GO:0030154; GO:0030308; GO:0070062	cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3014_c0_g1_i1	A7MB28	NDRG3_BOVIN	43.1	153	79	2	496	62	3	155	2.30E-30	133.7	NDRG3_BOVIN	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein)	NDRG3	Bos taurus (Bovine)	375	cytoplasm [GO:0005737]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]		GO:0005737; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3014_c0_g1_i2	Q5RA95	NDRG3_PONAB	40.7	246	130	4	727	17	3	241	3.10E-49	196.8	NDRG3_PONAB	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein)	NDRG3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	375	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN3014_c0_g1_i3	A7MB28	NDRG3_BOVIN	39.3	346	185	6	1197	214	3	341	3.80E-65	250.4	NDRG3_BOVIN	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein)	NDRG3	Bos taurus (Bovine)	375	cytoplasm [GO:0005737]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]		GO:0005737; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3014_c0_g1_i5	A7MB28	NDRG3_BOVIN	42.8	152	79	2	435	4	3	154	2.10E-30	133.7	NDRG3_BOVIN	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein)	NDRG3	Bos taurus (Bovine)	375	cytoplasm [GO:0005737]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]		GO:0005737; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3014_c0_g1_i6	A7MB28	NDRG3_BOVIN	37.7	355	204	5	1096	62	3	350	1.10E-63	245.4	NDRG3_BOVIN	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein)	NDRG3	Bos taurus (Bovine)	375	cytoplasm [GO:0005737]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]		GO:0005737; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN14736_c0_g2_i1	Q9QYF9	NDRG3_MOUSE	100	73	0	0	2	220	57	129	4.30E-38	157.9	NDRG3_MOUSE	reviewed	Protein NDRG3 (N-myc downstream-regulated gene 3 protein) (Protein Ndr3)	Ndrg3 Ndr3	Mus musculus (Mouse)	375	cytoplasm [GO:0005737]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]		GO:0005737; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN34718_c0_g1_i1	X2JAU8	NWK_DROME	53.1	98	35	3	406	128	517	608	1.30E-22	107.5	NWK_DROME	reviewed	Protein nervous wreck (Nwk)	nwk CG43479	Drosophila melanogaster (Fruit fly)	1075	"axon [GO:0030424]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]"	axon [GO:0030424]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]	"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]"	GO:0001881; GO:0005543; GO:0005546; GO:0005737; GO:0007274; GO:0008021; GO:0008582; GO:0030424; GO:0030833; GO:0031594; GO:0042734; GO:0043325; GO:0044803; GO:0045886; GO:0055037; GO:2000601	multi-organism membrane organization [GO:0044803]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; receptor recycling [GO:0001881]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic growth at neuromuscular junction [GO:0008582]		NA	NA	NA	NA	NA	NA
TRINITY_DN621_c0_g2_i2	Q9VIP0	NESD_DROME	23.4	496	310	12	283	1605	33	513	3.70E-24	114.8	NESD_DROME	reviewed	Protein nessun dorma	nesd CG10722	Drosophila melanogaster (Fruit fly)	602	centralspindlin complex [GO:0097149]; female germline ring canal [GO:0035324]; fusome [GO:0045169]; intercellular bridge [GO:0045171]; male germline ring canal [GO:0035323]; midbody [GO:0030496]; carbohydrate binding [GO:0030246]; female germline ring canal stabilization [GO:0008335]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]	centralspindlin complex [GO:0097149]; female germline ring canal [GO:0035324]; fusome [GO:0045169]; intercellular bridge [GO:0045171]; male germline ring canal [GO:0035323]; midbody [GO:0030496]	carbohydrate binding [GO:0030246]	GO:0007112; GO:0007283; GO:0008335; GO:0030246; GO:0030496; GO:0035323; GO:0035324; GO:0045169; GO:0045171; GO:0097149	female germline ring canal stabilization [GO:0008335]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN621_c0_g2_i5	Q9VIP0	NESD_DROME	24.4	427	260	9	283	1416	33	445	5.70E-22	107.5	NESD_DROME	reviewed	Protein nessun dorma	nesd CG10722	Drosophila melanogaster (Fruit fly)	602	centralspindlin complex [GO:0097149]; female germline ring canal [GO:0035324]; fusome [GO:0045169]; intercellular bridge [GO:0045171]; male germline ring canal [GO:0035323]; midbody [GO:0030496]; carbohydrate binding [GO:0030246]; female germline ring canal stabilization [GO:0008335]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]	centralspindlin complex [GO:0097149]; female germline ring canal [GO:0035324]; fusome [GO:0045169]; intercellular bridge [GO:0045171]; male germline ring canal [GO:0035323]; midbody [GO:0030496]	carbohydrate binding [GO:0030246]	GO:0007112; GO:0007283; GO:0008335; GO:0030246; GO:0030496; GO:0035323; GO:0035324; GO:0045169; GO:0045171; GO:0097149	female germline ring canal stabilization [GO:0008335]; male meiosis cytokinesis [GO:0007112]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2374_c0_g1_i1	P29503	NEUR_DROME	42.8	680	285	11	158	1894	76	752	1.30E-146	521.5	NEUR_DROME	reviewed	Protein neuralized	neur neu CG11988	Drosophila melanogaster (Fruit fly)	754	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0007419; GO:0007422; GO:0007423; GO:0007476; GO:0007498; GO:0007616; GO:0008104; GO:0008270; GO:0008356; GO:0016360; GO:0030718; GO:0035204; GO:0045314; GO:0045747; GO:0045807; GO:0046532; GO:0048471; GO:0048749; GO:0061630; GO:1901981	asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN2374_c0_g1_i2	P29503	NEUR_DROME	42.7	656	276	10	105	1781	100	752	3.10E-142	506.9	NEUR_DROME	reviewed	Protein neuralized	neur neu CG11988	Drosophila melanogaster (Fruit fly)	754	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0007419; GO:0007422; GO:0007423; GO:0007476; GO:0007498; GO:0007616; GO:0008104; GO:0008270; GO:0008356; GO:0016360; GO:0030718; GO:0035204; GO:0045314; GO:0045747; GO:0045807; GO:0046532; GO:0048471; GO:0048749; GO:0061630; GO:1901981	asymmetric cell division [GO:0008356]; compound eye development [GO:0048749]; germ-line stem cell population maintenance [GO:0030718]; imaginal disc-derived wing morphogenesis [GO:0007476]; long-term memory [GO:0007616]; mesoderm development [GO:0007498]; negative regulation of lamellocyte differentiation [GO:0035204]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; regulation of compound eye photoreceptor development [GO:0045314]; regulation of photoreceptor cell differentiation [GO:0046532]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN4084_c0_g1_i1	Q9VXK0	NIPSN_DROME	61.5	257	97	1	111	881	19	273	1.30E-93	344.7	NIPSN_DROME	reviewed	Protein NipSnap	Nipsnap CG9212	Drosophila melanogaster (Fruit fly)	273	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN4084_c0_g1_i1	Q9VXK0	NIPSN_DROME	72.9	48	13	0	947	1090	226	273	2.70E-14	81.3	NIPSN_DROME	reviewed	Protein NipSnap	Nipsnap CG9212	Drosophila melanogaster (Fruit fly)	273	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN32031_c0_g1_i1	Q9BPW8	NIPS1_HUMAN	98.6	71	1	0	216	4	161	231	1.00E-36	153.3	NIPS1_HUMAN	reviewed	Protein NipSnap homolog 1 (NipSnap1)	NIPSNAP1	Homo sapiens (Human)	284	mitochondrion [GO:0005739]; synaptic membrane [GO:0097060]; neurotransmitter binding [GO:0042165]; sensory perception of pain [GO:0019233]	mitochondrion [GO:0005739]; synaptic membrane [GO:0097060]	neurotransmitter binding [GO:0042165]	GO:0005739; GO:0019233; GO:0042165; GO:0097060	sensory perception of pain [GO:0019233]		NA	NA	NA	NA	NA	NA
TRINITY_DN31827_c0_g1_i1	Q9BPW8	NIPS1_HUMAN	85.7	70	10	0	249	40	215	284	5.40E-29	127.9	NIPS1_HUMAN	reviewed	Protein NipSnap homolog 1 (NipSnap1)	NIPSNAP1	Homo sapiens (Human)	284	mitochondrion [GO:0005739]; synaptic membrane [GO:0097060]; neurotransmitter binding [GO:0042165]; sensory perception of pain [GO:0019233]	mitochondrion [GO:0005739]; synaptic membrane [GO:0097060]	neurotransmitter binding [GO:0042165]	GO:0005739; GO:0019233; GO:0042165; GO:0097060	sensory perception of pain [GO:0019233]		NA	NA	NA	NA	NA	NA
TRINITY_DN6522_c0_g1_i2	Q5DU56	NLRC3_MOUSE	27.4	354	202	15	453	1406	131	465	7.10E-10	67	NLRC3_MOUSE	reviewed	Protein NLRC3	Nlrc3	Mus musculus (Mouse)	1064	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN6522_c0_g1_i4	Q5DU56	NLRC3_MOUSE	28.5	228	134	10	290	916	248	465	1.60E-05	52	NLRC3_MOUSE	reviewed	Protein NLRC3	Nlrc3	Mus musculus (Mouse)	1064	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN20025_c0_g1_i1	Q5DU56	NLRC3_MOUSE	92.3	26	2	0	228	151	4	29	8.20E-08	57.4	NLRC3_MOUSE	reviewed	Protein NLRC3	Nlrc3	Mus musculus (Mouse)	1064	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]		blue	blue	NA	NA	NA	NA
TRINITY_DN20025_c0_g1_i2	Q5DU56	NLRC3_MOUSE	92.3	26	2	0	253	176	4	29	9.00E-08	57.4	NLRC3_MOUSE	reviewed	Protein NLRC3	Nlrc3	Mus musculus (Mouse)	1064	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]		NA	NA	NA	NA	NA	NA
TRINITY_DN29908_c0_g1_i1	Q9GRX4	NONA_DROLR	50	232	116	0	6	701	282	513	1.10E-62	241.5	NONA_DROLR	reviewed	Protein no-on-transient A	nonA	Drosophila littoralis (Fruit fly)	698	RNA binding [GO:0003723]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		RNA binding [GO:0003723]	GO:0003723; GO:0007601; GO:0050896	response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN3911_c0_g1_i2	Q0WP01	PTR9_ARATH	31.9	113	70	2	64	402	19	124	3.20E-07	56.6	PTR9_ARATH	reviewed	Protein NRT1/ PTR FAMILY 5.10 (AtNPF5.10)	NPF5.10 At1g22540 F12K8.12	Arabidopsis thaliana (Mouse-ear cress)	557	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; oligopeptide transport [GO:0006857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006857; GO:0016021; GO:0022857	oligopeptide transport [GO:0006857]		NA	NA	NA	NA	NA	NA
TRINITY_DN38584_c0_g1_i1	Q7Q968	NTAQ1_ANOGA	51.6	62	30	0	227	42	14	75	4.90E-16	85.5	NTAQ1_ANOGA	reviewed	Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (Protein tungus)	tun AGAP004865	Anopheles gambiae (African malaria mosquito)	211	cytosol [GO:0005829]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]; cellular protein modification process [GO:0006464]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]	GO:0005634; GO:0005829; GO:0006464; GO:0008418; GO:0070773	cellular protein modification process [GO:0006464]		NA	NA	NA	NA	NA	NA
TRINITY_DN38584_c0_g1_i2	B4J8A0	NTAQ1_DROGR	58.7	189	77	1	657	94	8	196	2.10E-66	253.8	NTAQ1_DROGR	reviewed	Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (Protein tungus)	tun GH21323	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	205	protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]		protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]	GO:0008418; GO:0070773			NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i1	P16554	NUMB_DROME	60.5	362	104	7	1751	729	35	378	6.70E-109	396.4	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i10	P16554	NUMB_DROME	81.5	54	10	0	283	122	184	237	2.80E-19	96.3	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i11	P16554	NUMB_DROME	79.4	209	37	2	748	122	35	237	1.40E-93	344.4	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i12	P16554	NUMB_DROME	81.4	204	37	1	733	122	35	237	3.30E-95	349.7	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i14	P16554	NUMB_DROME	61.3	357	104	6	1736	729	35	378	1.60E-110	401.7	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i15	P16554	NUMB_DROME	57.7	381	106	8	1817	729	35	378	4.90E-107	390.2	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i16	P16554	NUMB_DROME	59.3	381	100	8	1817	729	35	378	1.90E-111	404.8	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i17	P16554	NUMB_DROME	58.5	376	106	7	1802	729	35	378	1.50E-108	395.2	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i21	P16554	NUMB_DROME	62.2	362	98	7	1751	729	35	378	1.90E-113	411.4	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i4	P16554	NUMB_DROME	60.1	376	100	7	1802	729	35	378	4.40E-113	410.2	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i5	P16554	NUMB_DROME	63	357	98	6	1736	729	35	378	6.00E-115	416.4	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i6	P16554	NUMB_DROME	63	357	98	6	1399	392	35	378	4.90E-115	416.4	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN864_c0_g1_i9	P16554	NUMB_DROME	62.2	362	98	7	1414	392	35	378	1.60E-113	411.4	NUMB_DROME	reviewed	Protein numb	numb CG3779	Drosophila melanogaster (Fruit fly)	556	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]	basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; Notch binding [GO:0005112]	GO:0001920; GO:0005112; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0007405; GO:0007406; GO:0008104; GO:0008347; GO:0009786; GO:0010629; GO:0014019; GO:0016360; GO:0034613; GO:0035050; GO:0035883; GO:0042694; GO:0045035; GO:0045178; GO:0045746; GO:0045807; GO:0050767; GO:0051642; GO:0051960; GO:0055059; GO:0061320; GO:0061382; GO:1902692	asymmetric neuroblast division [GO:0055059]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; enteroendocrine cell differentiation [GO:0035883]; glial cell migration [GO:0008347]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of receptor recycling [GO:0001920]; neuroblast development [GO:0014019]; neuroblast proliferation [GO:0007405]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]		NA	NA	NA	NA	NA	NA
TRINITY_DN33255_c0_g1_i1	Q08DS3	OSR1_BOVIN	100	123	0	0	425	57	145	267	6.30E-70	264.6	OSR1_BOVIN	reviewed	Protein odd-skipped-related 1	OSR1 ODD1	Bos taurus (Bovine)	267	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation involved in kidney development [GO:0072111]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; gonad development [GO:0008406]; heart development [GO:0007507]; intermediate mesoderm development [GO:0048389]; mesangial cell development [GO:0072143]; mesonephric duct morphogenesis [GO:0072180]; metanephric cap mesenchymal cell proliferation involved in metanephros development [GO:0090094]; metanephric epithelium development [GO:0072207]; metanephric glomerulus vasculature development [GO:0072239]; metanephric interstitial fibroblast development [GO:0072259]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule development [GO:0072234]; metanephric smooth muscle tissue development [GO:0072208]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of nephron tubule epithelial cell differentiation [GO:0072183]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; pattern specification involved in metanephros development [GO:0072268]; positive regulation of bone mineralization [GO:0030501]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; renal vesicle progenitor cell differentiation [GO:0072184]; roof of mouth development [GO:0060021]; specification of anterior mesonephric tubule identity [GO:0072168]; specification of posterior mesonephric tubule identity [GO:0072169]; stem cell differentiation [GO:0048863]; ureter urothelium development [GO:0072190]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000122; GO:0000977; GO:0001655; GO:0001657; GO:0002062; GO:0005634; GO:0007507; GO:0008406; GO:0030501; GO:0035115; GO:0035116; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043066; GO:0045944; GO:0046872; GO:0048389; GO:0048793; GO:0048863; GO:0050679; GO:0060021; GO:0071300; GO:0072075; GO:0072111; GO:0072143; GO:0072162; GO:0072168; GO:0072169; GO:0072180; GO:0072183; GO:0072184; GO:0072190; GO:0072207; GO:0072208; GO:0072234; GO:0072239; GO:0072259; GO:0072268; GO:0090094; GO:1905408; GO:2000543; GO:2000650	cell proliferation involved in kidney development [GO:0072111]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; gonad development [GO:0008406]; heart development [GO:0007507]; intermediate mesoderm development [GO:0048389]; mesangial cell development [GO:0072143]; mesonephric duct morphogenesis [GO:0072180]; metanephric cap mesenchymal cell proliferation involved in metanephros development [GO:0090094]; metanephric epithelium development [GO:0072207]; metanephric glomerulus vasculature development [GO:0072239]; metanephric interstitial fibroblast development [GO:0072259]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule development [GO:0072234]; metanephric smooth muscle tissue development [GO:0072208]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of nephron tubule epithelial cell differentiation [GO:0072183]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; pattern specification involved in metanephros development [GO:0072268]; positive regulation of bone mineralization [GO:0030501]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; renal vesicle progenitor cell differentiation [GO:0072184]; roof of mouth development [GO:0060021]; specification of anterior mesonephric tubule identity [GO:0072168]; specification of posterior mesonephric tubule identity [GO:0072169]; stem cell differentiation [GO:0048863]; ureteric bud development [GO:0001657]; ureter urothelium development [GO:0072190]; urogenital system development [GO:0001655]		NA	NA	NA	NA	NA	NA
TRINITY_DN35529_c0_g1_i1	Q5SWX8	ODR4_HUMAN	28.9	488	281	18	1496	114	1	449	5.10E-32	140.6	ODR4_HUMAN	reviewed	Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1)	ODR4 C1orf27 TTG1 TTG1A	Homo sapiens (Human)	454	integral component of membrane [GO:0016021]; protein localization [GO:0008104]	integral component of membrane [GO:0016021]		GO:0008104; GO:0016021	protein localization [GO:0008104]		NA	NA	NA	NA	NA	NA
TRINITY_DN29746_c0_g1_i1	O60502	OGA_HUMAN	100	212	0	0	1	636	127	338	1.70E-124	446.4	OGA_HUMAN	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT)	OGA HEXC KIAA0679 MEA5 MGEA5	Homo sapiens (Human)	916	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016032; GO:0016231; GO:0102166; GO:0102167; GO:0102571	glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN34652_c0_g1_i1	O60502	OGA_HUMAN	99.4	161	1	0	483	1	190	350	1.00E-92	340.5	OGA_HUMAN	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT)	OGA HEXC KIAA0679 MEA5 MGEA5	Homo sapiens (Human)	916	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016032; GO:0016231; GO:0102166; GO:0102167; GO:0102571	glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN39_c0_g1_i1	Q9EQQ9	OGA_MOUSE	41.9	129	66	3	39	422	542	662	3.10E-23	109.8	OGA_MOUSE	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)	Oga Hexc Kiaa0679 Mgea5	Mus musculus (Mouse)	916	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]	GO:0004402; GO:0005634; GO:0005739; GO:0005829; GO:0006044; GO:0006517; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571	dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN39_c0_g1_i2	Q8VIJ5	OGA_RAT	33.2	395	225	9	39	1217	542	899	9.20E-56	219.2	OGA_RAT	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)	Oga Hexc Mea5 Mgea5	Rattus norvegicus (Rat)	916	mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]	GO:0004402; GO:0005634; GO:0005739; GO:0006044; GO:0006517; GO:0006612; GO:0007568; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0048545; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571	aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]		NA	NA	NA	NA	NA	NA
TRINITY_DN39_c0_g1_i3	Q9EQQ9	OGA_MOUSE	38.5	148	79	4	39	479	542	678	1.60E-22	108.6	OGA_MOUSE	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)	Oga Hexc Kiaa0679 Mgea5	Mus musculus (Mouse)	916	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]	GO:0004402; GO:0005634; GO:0005739; GO:0005829; GO:0006044; GO:0006517; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571	dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN39_c0_g1_i4	Q8VIJ5	OGA_RAT	34.7	377	225	8	39	1163	542	899	5.00E-59	229.9	OGA_RAT	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)	Oga Hexc Mea5 Mgea5	Rattus norvegicus (Rat)	916	mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]	GO:0004402; GO:0005634; GO:0005739; GO:0006044; GO:0006517; GO:0006612; GO:0007568; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0048545; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571	aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]		NA	NA	NA	NA	NA	NA
TRINITY_DN1156_c0_g1_i2	Q9EQQ9	OGA_MOUSE	53.6	401	164	7	1259	102	38	431	1.40E-118	427.9	OGA_MOUSE	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)	Oga Hexc Kiaa0679 Mgea5	Mus musculus (Mouse)	916	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]	GO:0004402; GO:0005634; GO:0005739; GO:0005829; GO:0006044; GO:0006517; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571	dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN38245_c0_g1_i1	Q9EQQ9	OGA_MOUSE	98.5	67	1	0	1	201	49	115	1.70E-33	142.5	OGA_MOUSE	reviewed	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)	Oga Hexc Kiaa0679 Mgea5	Mus musculus (Mouse)	916	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; histone acetyltransferase activity [GO:0004402]	GO:0004402; GO:0005634; GO:0005739; GO:0005829; GO:0006044; GO:0006517; GO:0006612; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571	dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN38293_c0_g1_i1	Q5E9Q1	PGLT1_BOVIN	100	75	0	0	3	227	221	295	1.20E-38	159.8	PGLT1_BOVIN	reviewed	Protein O-glucosyltransferase 1 (EC 2.4.1.376) (CAP10-like 46 kDa protein) (KTEL motif-containing protein 1) (O-glucosyltransferase Rumi homolog) (Rumi) (Protein O-xylosyltransferase) (EC 2.4.2.63)	POGLUT1 CLP46 KTELC1	Bos taurus (Bovine)	392	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; axial mesoderm development [GO:0048318]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0001756; GO:0005788; GO:0005829; GO:0006493; GO:0007369; GO:0010470; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537	axial mesoderm development [GO:0048318]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756]		NA	NA	NA	NA	NA	NA
TRINITY_DN4348_c0_g1_i1	Q6UW63	PLGT2_HUMAN	54.5	246	111	1	3	740	258	502	1.80E-73	277.3	PLGT2_HUMAN	reviewed	Protein O-glucosyltransferase 2 (EC 2.4.1.-) (Endoplasmic reticulum resident protein 58) (ER protein 58) (ERp58) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-)	POGLUT2 EP58 KDELC1 UNQ1910/PRO4357	Homo sapiens (Human)	502	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0005654; GO:0005788; GO:0005829; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527	protein O-linked glycosylation via serine [GO:0018242]		NA	NA	NA	NA	NA	NA
TRINITY_DN4348_c0_g1_i2	Q6UW63	PLGT2_HUMAN	58.9	107	44	0	3	323	258	364	4.20E-30	132.1	PLGT2_HUMAN	reviewed	Protein O-glucosyltransferase 2 (EC 2.4.1.-) (Endoplasmic reticulum resident protein 58) (ER protein 58) (ERp58) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-)	POGLUT2 EP58 KDELC1 UNQ1910/PRO4357	Homo sapiens (Human)	502	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0005654; GO:0005788; GO:0005829; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527	protein O-linked glycosylation via serine [GO:0018242]		NA	NA	NA	NA	NA	NA
TRINITY_DN4348_c0_g1_i3	Q6UW63	PLGT2_HUMAN	51	143	69	1	77	505	361	502	1.70E-36	154.1	PLGT2_HUMAN	reviewed	Protein O-glucosyltransferase 2 (EC 2.4.1.-) (Endoplasmic reticulum resident protein 58) (ER protein 58) (ERp58) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-)	POGLUT2 EP58 KDELC1 UNQ1910/PRO4357	Homo sapiens (Human)	502	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0005654; GO:0005788; GO:0005829; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527	protein O-linked glycosylation via serine [GO:0018242]		NA	NA	NA	NA	NA	NA
TRINITY_DN4348_c0_g1_i4	Q6UW63	PLGT2_HUMAN	51.1	262	111	2	3	788	258	502	5.30E-71	269.2	PLGT2_HUMAN	reviewed	Protein O-glucosyltransferase 2 (EC 2.4.1.-) (Endoplasmic reticulum resident protein 58) (ER protein 58) (ERp58) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-)	POGLUT2 EP58 KDELC1 UNQ1910/PRO4357	Homo sapiens (Human)	502	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0005654; GO:0005788; GO:0005829; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527	protein O-linked glycosylation via serine [GO:0018242]		NA	NA	NA	NA	NA	NA
TRINITY_DN27152_c0_g1_i1	Q7Z4H8	PLGT3_HUMAN	99.1	106	1	0	1	318	296	401	8.60E-56	217.2	PLGT3_HUMAN	reviewed	Protein O-glucosyltransferase 3 (EC 2.4.1.-) (KDEL motif-containing protein 2) (Protein O-xylosyltransferase POGLUT3) (EC 2.4.2.-)	POGLUT3 KDELC2 UNQ1904/PRO4350	Homo sapiens (Human)	507	endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242]	endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]	glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0005788; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527	protein O-linked glycosylation via serine [GO:0018242]		NA	NA	NA	NA	NA	NA
TRINITY_DN29546_c0_g1_i1	Q5EAB6	PMGT1_BOVIN	71.2	73	21	0	219	1	369	441	1.50E-27	122.9	PMGT1_BOVIN	reviewed	"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)"	POMGNT1	Bos taurus (Bovine)	660	integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	acetylglucosaminyltransferase activity [GO:0008375]; manganese ion binding [GO:0030145]	GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN2655_c0_g1_i1	Q95JJ0	SG196_MACFA	42.2	187	101	5	816	1361	34	218	1.70E-36	155.2	SG196_MACFA	reviewed	Protein O-mannose kinase (POMK) (EC 2.7.1.183) (Protein kinase-like protein SgK196) (Sugen kinase 196)	POMK SGK196 QtsA-17014	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	350	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; carbohydrate phosphorylation [GO:0046835]; protein O-linked glycosylation [GO:0006493]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]"	GO:0004672; GO:0005524; GO:0005789; GO:0006493; GO:0016021; GO:0016773; GO:0019200; GO:0046835	carbohydrate phosphorylation [GO:0046835]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN11274_c0_g1_i1	Q9VTK2	POMT1_DROME	52	694	327	4	2112	40	191	881	1.50E-220	767.3	POMT1_DROME	reviewed	Protein O-mannosyltransferase 1 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 1) (dPOMT1) (Protein rotated abdomen)	rt POMT1 CG6097	Drosophila melanogaster (Fruit fly)	886	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; regulation of synaptic activity [GO:0060025]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; specification of segmental identity, abdomen [GO:0007385]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005783; GO:0005789; GO:0007385; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0060025	"lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; regulation of synaptic activity [GO:0060025]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; specification of segmental identity, abdomen [GO:0007385]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22128_c0_g1_i1	Q2LZ62	POMT1_DROPS	85	20	3	0	2	61	517	536	6.30E-05	47.8	POMT1_DROPS	reviewed	Protein O-mannosyltransferase 1 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 1) (Protein rotated abdomen)	rt GA19350	Drosophila pseudoobscura pseudoobscura (Fruit fly)	908	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; regulation of synaptic activity [GO:0060025]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; specification of segmental identity, abdomen [GO:0007385]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005783; GO:0005789; GO:0007385; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0045214; GO:0060025	"lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; regulation of synaptic activity [GO:0060025]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; specification of segmental identity, abdomen [GO:0007385]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11408_c0_g1_i1	Q9W5D4	POMT2_DROME	55.6	54	18	1	204	43	655	702	2.40E-10	65.9	POMT2_DROME	reviewed	Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2) (DmPOMT2) (dPOMT2) (Protein twisted)	tw Pomt2 CG12311	Drosophila melanogaster (Fruit fly)	765	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005783; GO:0005789; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]		NA	NA	NA	NA	NA	NA
TRINITY_DN11408_c0_g1_i2	Q9W5D4	POMT2_DROME	50	42	15	1	191	66	655	690	3.80E-05	48.5	POMT2_DROME	reviewed	Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2) (DmPOMT2) (dPOMT2) (Protein twisted)	tw Pomt2 CG12311	Drosophila melanogaster (Fruit fly)	765	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005783; GO:0005789; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]		NA	NA	NA	NA	NA	NA
TRINITY_DN3748_c0_g1_i1	Q9W5D4	POMT2_DROME	38.5	200	66	3	1	453	549	740	6.30E-28	125.2	POMT2_DROME	reviewed	Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2) (DmPOMT2) (dPOMT2) (Protein twisted)	tw Pomt2 CG12311	Drosophila melanogaster (Fruit fly)	765	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005783; GO:0005789; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]		NA	NA	NA	NA	NA	NA
TRINITY_DN3748_c0_g1_i2	Q9W5D4	POMT2_DROME	43.3	224	71	4	1	531	526	740	1.40E-42	174.1	POMT2_DROME	reviewed	Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2) (DmPOMT2) (dPOMT2) (Protein twisted)	tw Pomt2 CG12311	Drosophila melanogaster (Fruit fly)	765	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005783; GO:0005789; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]		NA	NA	NA	NA	NA	NA
TRINITY_DN17118_c0_g1_i2	Q8IUR5	TMTC1_HUMAN	46.9	64	33	1	63	254	310	372	3.30E-09	62.4	TMTC1_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	TMTC1 ARG99	Homo sapiens (Human)	882	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0006396; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN7688_c0_g1_i1	Q3UV71	TMTC1_MOUSE	56.3	71	30	1	74	283	35	105	1.40E-14	80.5	TMTC1_MOUSE	reviewed	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	Tmtc1	Mus musculus (Mouse)	942	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005739; GO:0005783; GO:0006396; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN17118_c0_g1_i1	Q3UV71	TMTC1_MOUSE	44.9	78	40	2	14	241	356	432	5.00E-10	65.1	TMTC1_MOUSE	reviewed	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	Tmtc1	Mus musculus (Mouse)	942	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005739; GO:0005783; GO:0006396; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]		brown	brown	1	NA	NA	NA
TRINITY_DN23049_c0_g1_i1	Q3UV71	TMTC1_MOUSE	45.2	73	30	2	192	1	473	544	1.30E-06	53.5	TMTC1_MOUSE	reviewed	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	Tmtc1	Mus musculus (Mouse)	942	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005739; GO:0005783; GO:0006396; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN38336_c0_g1_i1	Q6DCD5	TMTC2_XENLA	60.5	43	17	0	91	219	780	822	1.30E-05	50.1	TMTC2_XENLA	reviewed	Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 2)	tmtc2	Xenopus laevis (African clawed frog)	836	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]		brown	brown	NA	NA	NA	NA
TRINITY_DN21577_c0_g1_i1	Q6ZXV5	TMTC3_HUMAN	53.3	60	26	1	248	69	324	381	4.90E-09	61.6	TMTC3_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Protein SMILE) (Transmembrane and TPR repeat-containing protein 3)	TMTC3	Homo sapiens (Human)	915	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0034976; GO:0035269; GO:1901800	positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN21577_c0_g1_i2	Q6ZXV5	TMTC3_HUMAN	51.7	60	27	1	248	69	324	381	7.10E-08	57.8	TMTC3_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Protein SMILE) (Transmembrane and TPR repeat-containing protein 3)	TMTC3	Homo sapiens (Human)	915	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0034976; GO:0035269; GO:1901800	positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN34268_c0_g1_i1	Q7K4B6	TMTC3_DROME	67.9	81	26	0	3	245	636	716	3.20E-26	118.6	TMTC3_DROME	reviewed	Protein O-mannosyl-transferase Tmtc3 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 3)	Tmtc3 CG4050	Drosophila melanogaster (Fruit fly)	926	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN31857_c0_g1_i1	Q7K4B6	TMTC3_DROME	68.2	132	42	0	486	91	761	892	4.70E-46	185.7	TMTC3_DROME	reviewed	Protein O-mannosyl-transferase Tmtc3 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 3)	Tmtc3 CG4050	Drosophila melanogaster (Fruit fly)	926	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269	protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN687_c0_g1_i1	Q5T4D3	TMTC4_HUMAN	43.2	315	140	9	922	35	43	337	1.40E-58	228	TMTC4_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)	TMTC4	Homo sapiens (Human)	741	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584	endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN687_c0_g1_i2	Q5T4D3	TMTC4_HUMAN	44.9	356	161	7	1121	99	43	378	3.30E-78	293.5	TMTC4_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)	TMTC4	Homo sapiens (Human)	741	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584	endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN687_c0_g1_i3	Q5T4D3	TMTC4_HUMAN	46.2	411	185	8	1234	47	43	432	3.70E-94	346.7	TMTC4_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)	TMTC4	Homo sapiens (Human)	741	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584	endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN687_c0_g1_i4	Q5T4D3	TMTC4_HUMAN	44.5	292	127	7	1028	198	43	314	1.60E-58	228	TMTC4_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)	TMTC4	Homo sapiens (Human)	741	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584	endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN687_c0_g1_i4	Q5T4D3	TMTC4_HUMAN	61.7	47	18	0	187	47	386	432	2.00E-08	61.6	TMTC4_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)	TMTC4	Homo sapiens (Human)	741	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584	endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN687_c0_g1_i5	Q5T4D3	TMTC4_HUMAN	46.2	65	35	0	293	99	314	378	4.10E-12	72.4	TMTC4_HUMAN	reviewed	Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)	TMTC4	Homo sapiens (Human)	741	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584	endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN33787_c0_g1_i1	Q7PRB5	OPI10_ANOGA	55.9	204	82	4	58	657	1	200	1.30E-59	231.1	OPI10_ANOGA	reviewed	Protein OPI10 homolog	AGAP002426	Anopheles gambiae (African malaria mosquito)	201	cytosol [GO:0005829]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; nuclear import signal receptor activity [GO:0061608]; protein import into nucleus [GO:0006606]	cytosol [GO:0005829]; nucleus [GO:0005634]	Hsp70 protein binding [GO:0030544]; nuclear import signal receptor activity [GO:0061608]	GO:0005634; GO:0005829; GO:0006606; GO:0030544; GO:0061608	protein import into nucleus [GO:0006606]		blue	blue	NA	NA	NA	NA
TRINITY_DN33787_c0_g1_i2	Q7PRB5	OPI10_ANOGA	65	60	21	0	58	237	1	60	3.40E-17	89	OPI10_ANOGA	reviewed	Protein OPI10 homolog	AGAP002426	Anopheles gambiae (African malaria mosquito)	201	cytosol [GO:0005829]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; nuclear import signal receptor activity [GO:0061608]; protein import into nucleus [GO:0006606]	cytosol [GO:0005829]; nucleus [GO:0005634]	Hsp70 protein binding [GO:0030544]; nuclear import signal receptor activity [GO:0061608]	GO:0005634; GO:0005829; GO:0006606; GO:0030544; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN13582_c0_g1_i1	Q96SN7	ORAI2_HUMAN	100	130	0	0	6	395	36	165	7.40E-65	247.7	ORAI2_HUMAN	reviewed	Protein orai-2 (CAP-binding protein complex-interacting protein 2) (Transmembrane protein 142B)	ORAI2 C7orf19 CBCIP2 TMEM142B PP1729	Homo sapiens (Human)	254	growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; store-operated calcium channel activity [GO:0015279]; store-operated calcium entry [GO:0002115]	growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0015279; GO:0016020; GO:0016021; GO:0030426	store-operated calcium entry [GO:0002115]		NA	NA	NA	NA	NA	NA
TRINITY_DN762_c0_g1_i1	Q8BH10	ORAI2_MOUSE	50	248	83	5	88	795	32	250	7.70E-46	185.7	ORAI2_MOUSE	reviewed	Protein orai-2 (Transmembrane protein 142B)	Orai2 Tmem142b	Mus musculus (Mouse)	250	growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; store-operated calcium channel activity [GO:0015279]; store-operated calcium entry [GO:0002115]	growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0015279; GO:0016020; GO:0016021; GO:0030426	store-operated calcium entry [GO:0002115]		blue	blue	NA	NA	NA	NA
TRINITY_DN3108_c0_g1_i1	Q8K2C7	OS9_MOUSE	51.2	172	77	3	556	62	104	275	1.40E-45	184.1	OS9_MOUSE	reviewed	Protein OS-9	Os9	Mus musculus (Mouse)	672	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	carbohydrate binding [GO:0030246]; protease binding [GO:0002020]	GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:0034976; GO:1904153	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3108_c0_g1_i3	Q8K2C7	OS9_MOUSE	50.6	156	71	2	456	7	104	259	7.00E-43	174.9	OS9_MOUSE	reviewed	Protein OS-9	Os9	Mus musculus (Mouse)	672	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	carbohydrate binding [GO:0030246]; protease binding [GO:0002020]	GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:0034976; GO:1904153	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3108_c0_g1_i4	Q8K2C7	OS9_MOUSE	50	88	40	2	313	62	188	275	4.30E-15	82	OS9_MOUSE	reviewed	Protein OS-9	Os9	Mus musculus (Mouse)	672	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	carbohydrate binding [GO:0030246]; protease binding [GO:0002020]	GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:0034976; GO:1904153	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32747_c0_g1_i1	Q27421	OSP_DROME	82.3	62	11	0	187	2	81	142	3.80E-27	121.7	OSP_DROME	reviewed	Protein outspread	osp CG3479	Drosophila melanogaster (Fruit fly)	1566	actin cytoskeleton [GO:0015629]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]	actin cytoskeleton [GO:0015629]	actin filament binding [GO:0051015]	GO:0007015; GO:0015629; GO:0051015	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN8146_c0_g1_i1	P10383	OTU_DROME	29.9	411	213	7	1410	304	18	395	5.00E-47	190.3	OTU_DROME	reviewed	Protein ovarian tumor locus	otu CG12743	Drosophila melanogaster (Fruit fly)	853	cytosol [GO:0005829]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; female germ-line sex determination [GO:0019099]; germ cell development [GO:0007281]; oogenesis [GO:0048477]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of stem cell differentiation [GO:2000738]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0007281; GO:0016579; GO:0019099; GO:0032877; GO:0048477; GO:2000738	female germ-line sex determination [GO:0019099]; germ cell development [GO:0007281]; oogenesis [GO:0048477]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of stem cell differentiation [GO:2000738]; protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i21	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i21	P17193	DPOL_HPBDW	24.1	224	162	4	8304	7651	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i27	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i27	P17193	DPOL_HPBDW	24.1	224	162	4	8489	7836	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i3	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i3	P17193	DPOL_HPBDW	24.1	224	162	4	8303	7650	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i31	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i31	P17193	DPOL_HPBDW	24.1	224	162	4	8304	7651	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i32	P17193	DPOL_HPBDW	24.1	224	162	4	1172	519	391	612	4.30E-11	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		brown	brown	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i9	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	7.80E-11	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c2_g1_i16	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	3.40E-11	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		brown	brown	1	NA	NA	1
TRINITY_DN1_c2_g1_i25	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	1	NA	NA	1
TRINITY_DN1_c2_g1_i25	P17193	DPOL_HPBDW	24.1	224	162	4	8303	7650	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	1	NA	NA	1
TRINITY_DN1_c2_g1_i33	P17193	DPOL_HPBDW	24.1	224	162	4	2405	3058	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	1	NA	NA	NA
TRINITY_DN1_c2_g1_i33	P17193	DPOL_HPBDW	24.1	224	162	4	8304	7651	391	612	1.20E-10	72.4	DPOL_HPBDW	reviewed	Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	P	Duck hepatitis B virus (isolate white Shanghai duck S31) (DHBV)	788	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]		DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872	DNA replication [GO:0006260]		NA	NA	1	NA	NA	NA
TRINITY_DN11467_c0_g1_i1	B5DF93	PATL1_RAT	35.2	307	180	7	1266	391	399	701	3.10E-33	144.4	PATL1_RAT	reviewed	Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b)	Patl1	Rattus norvegicus (Rat)	770	CCR4-NOT complex [GO:0030014]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; P-body assembly [GO:0033962]	CCR4-NOT complex [GO:0030014]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]	poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0000290; GO:0000932; GO:0003723; GO:0008266; GO:0016605; GO:0016607; GO:0030014; GO:0033962; GO:0034046	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; P-body assembly [GO:0033962]		NA	NA	NA	NA	NA	NA
TRINITY_DN13784_c0_g1_i1	Q9BVG4	PBDC1_HUMAN	53.6	138	64	0	547	134	21	158	3.20E-37	156.8	PBDC1_HUMAN	reviewed	Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1)	PBDC1 CXorf26	Homo sapiens (Human)	233							blue	blue	NA	NA	NA	NA
TRINITY_DN519_c0_g1_i1	P40797	PNUT_DROME	72	425	111	4	1290	37	116	539	3.80E-142	506.1	PNUT_DROME	reviewed	Protein peanut	pnut CG8705	Drosophila melanogaster (Fruit fly)	539	apical plasma membrane [GO:0016324]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]	apical plasma membrane [GO:0016324]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; contractile ring [GO:0070938]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]	GO:0000281; GO:0003779; GO:0003924; GO:0005525; GO:0005739; GO:0005886; GO:0005940; GO:0006915; GO:0007349; GO:0008017; GO:0015630; GO:0016324; GO:0031105; GO:0031625; GO:0032153; GO:0032154; GO:0034613; GO:0042803; GO:0043065; GO:0045171; GO:0045572; GO:0060090; GO:0060271; GO:0061640; GO:0070938	apoptotic process [GO:0006915]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of imaginal disc growth [GO:0045572]		NA	NA	NA	NA	NA	NA
TRINITY_DN33839_c0_g1_i1	P18490	PCX_DROME	51.6	93	45	0	91	369	1	93	1.60E-21	103.6	PCX_DROME	reviewed	Protein pecanex	pcx CG3443	Drosophila melanogaster (Fruit fly)	3413	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; endoplasmic reticulum organization [GO:0007029]; nervous system development [GO:0007399]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]		GO:0005783; GO:0007029; GO:0007399; GO:0016021; GO:0030154	cell differentiation [GO:0030154]; endoplasmic reticulum organization [GO:0007029]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN24106_c0_g1_i1	P48612	PELO_DROME	54.5	88	40	0	1	264	151	238	4.40E-21	101.7	PELO_DROME	reviewed	Protein pelota (EC 3.1.-.-)	pelo CG3959	Drosophila melanogaster (Fruit fly)	395	"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"	cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	GO:0000212; GO:0001745; GO:0004519; GO:0005634; GO:0005737; GO:0007141; GO:0008315; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:1990533	"compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31541_c0_g1_i1	P48612	PELO_DROME	56.5	92	40	0	277	2	163	254	1.40E-22	106.7	PELO_DROME	reviewed	Protein pelota (EC 3.1.-.-)	pelo CG3959	Drosophila melanogaster (Fruit fly)	395	"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"	cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	GO:0000212; GO:0001745; GO:0004519; GO:0005634; GO:0005737; GO:0007141; GO:0008315; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:1990533	"compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38679_c2_g1_i1	P48612	PELO_DROME	63	281	104	0	849	7	1	281	5.10E-101	369	PELO_DROME	reviewed	Protein pelota (EC 3.1.-.-)	pelo CG3959	Drosophila melanogaster (Fruit fly)	395	"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"	cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	GO:0000212; GO:0001745; GO:0004519; GO:0005634; GO:0005737; GO:0007141; GO:0008315; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:1990533	"compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"		blue	blue	NA	NA	NA	NA
TRINITY_DN29524_c0_g1_i1	Q5ZK01	PELO_CHICK	47.8	69	36	0	208	2	179	247	7.70E-13	73.9	PELO_CHICK	reviewed	Protein pelota homolog (EC 3.1.-.-)	PELO RCJMB04_14b4	Gallus gallus (Chicken)	385	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	GO:0004519; GO:0005634; GO:0005737; GO:0007049; GO:0032790; GO:0046872; GO:0051301; GO:0070481; GO:0070651; GO:0070966; GO:0071025	"cell cycle [GO:0007049]; cell division [GO:0051301]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30527_c0_g1_i1	Q58DV0	PELO_BOVIN	100	116	0	0	350	3	47	162	4.80E-60	231.5	PELO_BOVIN	reviewed	Protein pelota homolog (EC 3.1.-.-)	PELO	Bos taurus (Bovine)	385	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	GO:0004519; GO:0005634; GO:0005737; GO:0032790; GO:0046872; GO:0070481; GO:0070651; GO:0070966; GO:0071025	"nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30214_c0_g1_i1	Q8LGF7	PEX4_ARATH	54.9	91	41	0	3	275	23	113	4.70E-26	118.2	PEX4_ARATH	reviewed	Protein PEROXIN-4 (AtPEX4) (E2 ubiquitin-conjugating enzyme 21) (Probable ubiquitin-conjugating enzyme E2 21) (EC 2.3.2.23) (Ubiquitin carrier protein 21)	PEX4 UBC21 At5g25760 F18A17.10	Arabidopsis thaliana (Mouse-ear cress)	157	nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; fatty acid beta-oxidation [GO:0006635]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005778; GO:0006635; GO:0007031; GO:0016558; GO:0016567; GO:0061631	fatty acid beta-oxidation [GO:0006635]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		red	red	NA	NA	NA	NA
TRINITY_DN39730_c0_g1_i1	Q96T49	PP16B_HUMAN	100	75	0	0	227	3	135	209	2.00E-38	159.1	PP16B_HUMAN	reviewed	Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (hTIMAP)	PPP1R16B ANKRD4 KIAA0823	Homo sapiens (Human)	567	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670]	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]	GO:0001938; GO:0005634; GO:0005886; GO:0008157; GO:0014066; GO:0016607; GO:0017020; GO:0019888; GO:0035304; GO:0035307; GO:0035308; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589; GO:1903670	establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670]		NA	NA	NA	NA	NA	NA
TRINITY_DN4312_c0_g1_i1	Q95N27	PP16B_BOVIN	54.1	259	119	0	1176	400	61	319	2.70E-76	287.3	PP16B_BOVIN	reviewed	Protein phosphatase 1 regulatory inhibitor subunit 16B (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (bTIMAP)	PPP1R16B	Bos taurus (Bovine)	568	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670]	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005886; GO:0008157; GO:0014066; GO:0016607; GO:0017020; GO:0019888; GO:0035304; GO:0035307; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589; GO:1903670	establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670]		blue	blue	NA	NA	NA	NA
TRINITY_DN4529_c0_g1_i1	Q9BZL4	PP12C_HUMAN	29.4	194	113	3	120	632	95	287	9.80E-14	79	PP12C_HUMAN	reviewed	Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85)	PPP1R12C LENG3 MBS85	Homo sapiens (Human)	782	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]	GO:0004857; GO:0005737; GO:0005856; GO:0007165; GO:0019208; GO:0019901	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7301_c0_g1_i1	Q96C90	PP14B_HUMAN	36.3	91	51	3	198	470	51	134	5.00E-06	52.8	PP14B_HUMAN	reviewed	Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein)	PPP1R14B PLCB3N PNG	Homo sapiens (Human)	147	cytoplasm [GO:0005737]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; innate immune response [GO:0045087]; regulation of phosphorylation [GO:0042325]	cytoplasm [GO:0005737]	protein serine/threonine phosphatase inhibitor activity [GO:0004865]	GO:0004865; GO:0005737; GO:0042325; GO:0045087	innate immune response [GO:0045087]; regulation of phosphorylation [GO:0042325]		NA	NA	NA	NA	NA	NA
TRINITY_DN7301_c0_g1_i2	Q96C90	PP14B_HUMAN	36.3	91	51	3	212	484	51	134	5.10E-06	52.8	PP14B_HUMAN	reviewed	Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein)	PPP1R14B PLCB3N PNG	Homo sapiens (Human)	147	cytoplasm [GO:0005737]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; innate immune response [GO:0045087]; regulation of phosphorylation [GO:0042325]	cytoplasm [GO:0005737]	protein serine/threonine phosphatase inhibitor activity [GO:0004865]	GO:0004865; GO:0005737; GO:0042325; GO:0045087	innate immune response [GO:0045087]; regulation of phosphorylation [GO:0042325]		NA	NA	NA	NA	NA	NA
TRINITY_DN33321_c0_g1_i1	Q923M0	PP16A_MOUSE	35.4	79	49	2	322	86	247	323	5.20E-08	58.5	PP16A_MOUSE	reviewed	Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase targeting subunit 3)	Ppp1r16a Mypt3	Mus musculus (Mouse)	524	cytosol [GO:0005829]; plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; regulation of protein dephosphorylation [GO:0035304]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]	GO:0005829; GO:0005886; GO:0008157; GO:0017020; GO:0019888; GO:0035304	regulation of protein dephosphorylation [GO:0035304]		NA	NA	NA	NA	NA	NA
TRINITY_DN1851_c0_g1_i2	Q6IR70	PPR21_XENLA	27	777	519	13	115	2340	9	772	1.80E-52	209.1	PPR21_XENLA	reviewed	Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1)	ppp1r21 ccdc128 klraq1	Xenopus laevis (African clawed frog)	776	early endosome [GO:0005769]	early endosome [GO:0005769]		GO:0005769			NA	NA	NA	NA	NA	NA
TRINITY_DN1851_c0_g1_i1	Q6IR70	PPR21_XENLA	26.5	737	494	13	115	2220	9	732	1.70E-44	182.6	PPR21_XENLA	reviewed	Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1)	ppp1r21 ccdc128 klraq1	Xenopus laevis (African clawed frog)	776	early endosome [GO:0005769]	early endosome [GO:0005769]		GO:0005769			NA	NA	1	NA	NA	NA
TRINITY_DN2712_c0_g1_i1	Q1L994	PPR37_DANRE	41.5	482	250	6	1456	17	164	615	2.90E-98	361.3	PPR37_DANRE	reviewed	Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68)	ppp1r37 lrrc68 si:ch211-234g24.1	Danio rerio (Zebrafish) (Brachydanio rerio)	919	protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]		protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0010923	negative regulation of phosphatase activity [GO:0010923]		NA	NA	NA	NA	NA	NA
TRINITY_DN7476_c0_g1_i2	Q0VCR4	PPR3C_BOVIN	38	213	117	8	457	1080	55	257	4.60E-31	137.1	PPR3C_BOVIN	reviewed	Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG)	PPP1R3C PPP1R5	Bos taurus (Bovine)	318	protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]	protein phosphatase type 1 complex [GO:0000164]	glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]	GO:0000164; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:2001069	glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]		blue	blue	NA	NA	NA	NA
TRINITY_DN35359_c0_g1_i1	Q32PL1	PP1R7_DANRE	62.8	290	108	0	945	76	55	344	1.50E-97	357.8	PP1R7_DANRE	reviewed	Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22)	ppp1r7 sds22 zgc:123325	Danio rerio (Zebrafish) (Brachydanio rerio)	345	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN36003_c0_g1_i1	Q5RFS7	PP1R7_PONAB	98.9	183	2	0	589	41	178	360	2.30E-94	346.3	PP1R7_PONAB	reviewed	Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22)	PPP1R7 SDS22	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	360	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN30074_c0_g1_i1	P45969	SDS22_CAEEL	50.5	105	52	0	318	4	81	185	4.20E-22	105.5	SDS22_CAEEL	reviewed	Protein phosphatase 1 regulatory subunit SDS22 homolog	sds-22 T09A5.9	Caenorhabditis elegans	326	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN39356_c0_g1_i1	P35815	PPM1B_RAT	49	49	24	1	193	47	212	259	5.10E-05	48.1	PPM1B_RAT	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Rattus norvegicus (Rat)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN25272_c0_g1_i1	O75688	PPM1B_HUMAN	100	104	0	0	1	312	197	300	5.90E-57	221.1	PPM1B_HUMAN	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	PPM1B PP2CB	Homo sapiens (Human)	479	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN27778_c0_g1_i1	P36993	PPM1B_MOUSE	100	88	0	0	264	1	105	192	1.60E-47	189.5	PPM1B_MOUSE	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Mus musculus (Mouse)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN35989_c0_g1_i1	P36993	PPM1B_MOUSE	98.1	103	2	0	31	339	1	103	2.00E-55	216.1	PPM1B_MOUSE	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Mus musculus (Mouse)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN34076_c0_g1_i1	O62830	PPM1B_BOVIN	50	96	40	3	2	283	169	258	2.10E-14	79.7	PPM1B_BOVIN	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	PPM1B	Bos taurus (Bovine)	484	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN701_c0_g1_i1	P35815	PPM1B_RAT	62.2	376	136	2	1255	137	1	373	2.10E-135	483.8	PPM1B_RAT	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Rattus norvegicus (Rat)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN701_c0_g1_i2	P35815	PPM1B_RAT	62.2	376	136	2	1221	103	1	373	2.00E-135	483.8	PPM1B_RAT	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Rattus norvegicus (Rat)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN701_c0_g1_i3	P35815	PPM1B_RAT	60.2	399	147	3	1381	194	1	390	1.60E-136	487.6	PPM1B_RAT	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Rattus norvegicus (Rat)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN701_c0_g1_i4	P35815	PPM1B_RAT	62.2	376	136	2	1196	78	1	373	1.50E-135	484.2	PPM1B_RAT	reviewed	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	Ppm1b Pp2c2 Pppm1b	Rattus norvegicus (Rat)	390	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; N-terminal protein myristoylation [GO:0006499]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]		blue	blue	NA	NA	NA	NA
TRINITY_DN10693_c0_g1_i1	O15297	PPM1D_HUMAN	51.2	291	126	4	533	1393	99	377	4.40E-77	290.4	PPM1D_HUMAN	reviewed	Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)	PPM1D WIP1	Homo sapiens (Human)	605	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005829; GO:0006306; GO:0006342; GO:0006367; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019	"cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		blue	blue	NA	NA	NA	NA
TRINITY_DN12306_c0_g1_i1	Q8WY54	PPM1E_HUMAN	51.7	89	42	1	6	272	363	450	3.10E-22	105.5	PPM1E_HUMAN	reviewed	Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA)	PPM1E CAMKN KIAA1072 POPX1	Homo sapiens (Human)	755	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006469; GO:0032991; GO:0035690; GO:0035970; GO:0046872; GO:0051496	cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]		blue	blue	NA	NA	NA	NA
TRINITY_DN12312_c0_g1_i1	P49593	PPM1F_HUMAN	34.6	243	148	2	699	1	39	280	3.50E-33	143.3	PPM1F_HUMAN	reviewed	Protein phosphatase 1F (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase) (CaM-kinase phosphatase) (CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog) (hFem-2)	PPM1F KIAA0015 POPX2	Homo sapiens (Human)	454	"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to drug [GO:0035690]; histone dephosphorylation [GO:0016576]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cellular protein localization [GO:1903827]"	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006469; GO:0008138; GO:0010628; GO:0010634; GO:0010811; GO:0016576; GO:0030335; GO:0032991; GO:0033137; GO:0033192; GO:0035690; GO:0035970; GO:0043280; GO:0044387; GO:0045892; GO:0045927; GO:0046872; GO:0048471; GO:0050921; GO:0051224; GO:0051496; GO:0051894; GO:0070262; GO:0097193; GO:1903827; GO:2000048	"cellular response to drug [GO:0035690]; histone dephosphorylation [GO:0016576]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cellular protein localization [GO:1903827]"		blue	blue	NA	NA	NA	NA
TRINITY_DN37987_c0_g1_i1	P79126	PPM1G_BOVIN	50	68	34	0	204	1	398	465	9.50E-16	83.6	PPM1G_BOVIN	reviewed	Protein phosphatase 1G (EC 3.1.3.16) (Magnesium-dependent calcium inhibitable phosphatase) (MCPP) (Protein phosphatase 1B) (Protein phosphatase 2C isoform gamma) (PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma)	PPM1G PPM1C	Bos taurus (Bovine)	543	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle arrest [GO:0007050]; peptidyl-threonine dephosphorylation [GO:0035970]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005737; GO:0007050; GO:0016020; GO:0035970; GO:0046872	cell cycle arrest [GO:0007050]; peptidyl-threonine dephosphorylation [GO:0035970]		NA	NA	NA	NA	NA	NA
TRINITY_DN36035_c0_g1_i1	O15355	PPM1G_HUMAN	98.9	95	1	0	1	285	384	478	1.00E-47	190.3	PPM1G_HUMAN	reviewed	Protein phosphatase 1G (EC 3.1.3.16) (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma) (PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma)	PPM1G PPM1C	Homo sapiens (Human)	546	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle arrest [GO:0007050]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0007050; GO:0016020; GO:0035970; GO:0046872	cell cycle arrest [GO:0007050]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN27231_c0_g1_i1	Q9ULR3	PPM1H_HUMAN	41.6	149	68	4	70	516	1	130	1.20E-17	91.3	PPM1H_HUMAN	reviewed	Protein phosphatase 1H (EC 3.1.3.16)	PPM1H ARHCL1 KIAA1157 URCC2	Homo sapiens (Human)	514	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004721; GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005737; GO:0042802			NA	NA	NA	NA	NA	NA
TRINITY_DN7836_c0_g1_i1	Q641Y6	PPM1J_RAT	49.9	351	155	4	1394	393	150	496	2.20E-93	344.4	PPM1J_RAT	reviewed	Protein phosphatase 1J (EC 3.1.3.16) (Protein phosphatase 2C isoform zeta) (PP2C-zeta)	Ppm1j Ppp2cz	Rattus norvegicus (Rat)	504	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]		magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0006470	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1918_c0_g1_i1	Q6ING9	PPM1K_XENLA	50.7	146	69	2	566	129	223	365	3.70E-33	142.9	PPM1K_XENLA	reviewed	"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)"	ppm1k	Xenopus laevis (African clawed frog)	373	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1918_c0_g1_i2	Q6ING9	PPM1K_XENLA	53.8	130	59	1	518	129	237	365	5.90E-33	143.7	PPM1K_XENLA	reviewed	"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)"	ppm1k	Xenopus laevis (African clawed frog)	373	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1918_c0_g1_i2	Q6ING9	PPM1K_XENLA	43.8	185	98	2	1144	602	61	243	5.00E-32	140.6	PPM1K_XENLA	reviewed	"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)"	ppm1k	Xenopus laevis (African clawed frog)	373	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1918_c0_g1_i3	Q8BXN7	PPM1K_MOUSE	46.4	319	169	1	1097	147	41	359	7.50E-75	282.7	PPM1K_MOUSE	reviewed	"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)"	Ppm1k Pp2cm	Mus musculus (Mouse)	372	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005739; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1918_c0_g1_i4	Q6ING9	PPM1K_XENLA	44.4	178	93	2	612	91	61	236	1.90E-32	141.4	PPM1K_XENLA	reviewed	"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)"	ppm1k	Xenopus laevis (African clawed frog)	373	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN809_c0_g2_i1	A5PJZ2	PPM1L_BOVIN	50.5	188	92	1	627	1190	163	349	4.30E-50	200.3	PPM1L_BOVIN	reviewed	Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon)	PPM1L PP2CE	Bos taurus (Bovine)	360	integral component of membrane [GO:0016021]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	integral component of membrane [GO:0016021]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN40869_c0_g1_i1	Q96MI6	PPM1M_HUMAN	100	76	0	0	1	228	94	169	9.00E-39	160.2	PPM1M_HUMAN	reviewed	Protein phosphatase 1M (EC 3.1.3.16) (Protein phosphatase 2C isoform eta) (PP2C-eta) (PP2CE)	PPM1M PPM1E	Homo sapiens (Human)	270	nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0005634; GO:0006470; GO:0030145	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN15137_c0_g1_i1	P11845	IPP2_RABIT	39.9	143	65	4	371	3	7	148	5.70E-14	78.6	IPP2_RABIT	reviewed	Protein phosphatase inhibitor 2 (IPP-2)	PPP1R2 IPP2	Oryctolagus cuniculus (Rabbit)	205	protein phosphatase type 1 complex [GO:0000164]; skeletal muscle myofibril [GO:0098723]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; glycogen metabolic process [GO:0005977]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of signal transduction [GO:0009966]	protein phosphatase type 1 complex [GO:0000164]; skeletal muscle myofibril [GO:0098723]	protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]	GO:0000164; GO:0004864; GO:0005977; GO:0008157; GO:0009966; GO:0032515; GO:0098723	glycogen metabolic process [GO:0005977]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of signal transduction [GO:0009966]		blue	blue	NA	NA	NA	NA
TRINITY_DN438_c0_g1_i1	Q8BVQ5	PPME1_MOUSE	52.3	390	163	7	1217	69	13	386	1.10E-104	381.7	PPME1_MOUSE	reviewed	Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89)	Ppme1 Pme1	Mus musculus (Mouse)	386	protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482]		protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]	GO:0006482; GO:0019901; GO:0019903; GO:0051721; GO:0051722; GO:0051723	protein demethylation [GO:0006482]		NA	NA	NA	NA	NA	NA
TRINITY_DN438_c0_g1_i2	Q8BVQ5	PPME1_MOUSE	53.1	377	154	7	1295	186	13	373	9.30E-102	372.1	PPME1_MOUSE	reviewed	Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89)	Ppme1 Pme1	Mus musculus (Mouse)	386	protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482]		protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]	GO:0006482; GO:0019901; GO:0019903; GO:0051721; GO:0051722; GO:0051723	protein demethylation [GO:0006482]		NA	NA	NA	NA	NA	NA
TRINITY_DN438_c0_g1_i4	Q8BVQ5	PPME1_MOUSE	53.1	377	154	7	1298	189	13	373	9.30E-102	372.1	PPME1_MOUSE	reviewed	Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89)	Ppme1 Pme1	Mus musculus (Mouse)	386	protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482]		protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]	GO:0006482; GO:0019901; GO:0019903; GO:0051721; GO:0051722; GO:0051723	protein demethylation [GO:0006482]		NA	NA	NA	NA	NA	NA
TRINITY_DN27662_c0_g1_i1	Q9Y570	PPME1_HUMAN	100	76	0	0	2	229	65	140	1.10E-36	153.3	PPME1_HUMAN	reviewed	Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89)	PPME1 PME1 PP2593 PRO0750	Homo sapiens (Human)	386	nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; G2/M transition of mitotic cell cycle [GO:0000086]; protein demethylation [GO:0006482]	nucleoplasm [GO:0005654]	cadherin binding [GO:0045296]; protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]	GO:0000086; GO:0004864; GO:0005654; GO:0006482; GO:0019888; GO:0019901; GO:0019903; GO:0045296; GO:0051721; GO:0051722; GO:0051723	G2/M transition of mitotic cell cycle [GO:0000086]; protein demethylation [GO:0006482]		NA	NA	NA	NA	NA	NA
TRINITY_DN32674_c0_g1_i1	Q58DN4	PPME1_BOVIN	100	107	0	0	323	3	136	242	7.40E-55	214.2	PPME1_BOVIN	reviewed	Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89)	PPME1 PME1	Bos taurus (Bovine)	380	protein C-terminal methylesterase activity [GO:0051722]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein demethylation [GO:0006482]		protein C-terminal methylesterase activity [GO:0051722]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]	GO:0006482; GO:0051721; GO:0051722; GO:0051723	protein demethylation [GO:0006482]		NA	NA	NA	NA	NA	NA
TRINITY_DN5311_c0_g1_i2	P36872	2ABA_DROME	85	421	63	0	25	1287	58	478	1.90E-218	759.6	2ABA_DROME	reviewed	Protein phosphatase PP2A 55 kDa regulatory subunit (PR55) (Protein phosphatase PP2A regulatory subunit B) (Protein twins)	tws aar Pp2A-85F CG6235	Drosophila melanogaster (Fruit fly)	499	cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; centrosome cycle [GO:0007098]; circadian rhythm [GO:0007623]; imaginal disc pattern formation [GO:0007447]; maintenance of neuroblast polarity [GO:0045201]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of centriole replication [GO:0046599]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; sensory organ development [GO:0007423]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000278; GO:0005634; GO:0005829; GO:0006470; GO:0007091; GO:0007098; GO:0007406; GO:0007423; GO:0007447; GO:0007623; GO:0019888; GO:0030071; GO:0045201; GO:0045880; GO:0046599; GO:0050821; GO:0070262; GO:0090263	centrosome cycle [GO:0007098]; circadian rhythm [GO:0007623]; imaginal disc pattern formation [GO:0007447]; maintenance of neuroblast polarity [GO:0045201]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of centriole replication [GO:0046599]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; sensory organ development [GO:0007423]		blue	blue	NA	NA	NA	NA
TRINITY_DN8962_c0_g1_i1	Q6NN85	SSH_DROME	57.6	170	68	2	66	575	403	568	5.40E-44	181.4	SSH_DROME	reviewed	Protein phosphatase Slingshot (EC 3.1.3.16) (EC 3.1.3.48)	ssh CG6238	Drosophila melanogaster (Fruit fly)	1045	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; inactivation of MAPK activity [GO:0000188]; mitotic cell cycle [GO:0000278]; mushroom body development [GO:0016319]; negative regulation of actin filament polymerization [GO:0030837]; nuclear migration [GO:0007097]; protein dephosphorylation [GO:0006470]; regulation of actin filament polymerization [GO:0030833]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0000278; GO:0000902; GO:0003779; GO:0004721; GO:0004725; GO:0005737; GO:0005856; GO:0006470; GO:0007097; GO:0007409; GO:0008064; GO:0008138; GO:0010591; GO:0016319; GO:0030036; GO:0030833; GO:0030837; GO:0045177; GO:0048749; GO:0050770	actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; inactivation of MAPK activity [GO:0000188]; mitotic cell cycle [GO:0000278]; mushroom body development [GO:0016319]; negative regulation of actin filament polymerization [GO:0030837]; nuclear migration [GO:0007097]; protein dephosphorylation [GO:0006470]; regulation of actin filament polymerization [GO:0030833]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591]		NA	NA	NA	NA	NA	NA
TRINITY_DN8962_c0_g1_i2	Q6NN85	SSH_DROME	63.2	318	109	3	78	1019	255	568	4.80E-105	384.4	SSH_DROME	reviewed	Protein phosphatase Slingshot (EC 3.1.3.16) (EC 3.1.3.48)	ssh CG6238	Drosophila melanogaster (Fruit fly)	1045	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; inactivation of MAPK activity [GO:0000188]; mitotic cell cycle [GO:0000278]; mushroom body development [GO:0016319]; negative regulation of actin filament polymerization [GO:0030837]; nuclear migration [GO:0007097]; protein dephosphorylation [GO:0006470]; regulation of actin filament polymerization [GO:0030833]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000188; GO:0000278; GO:0000902; GO:0003779; GO:0004721; GO:0004725; GO:0005737; GO:0005856; GO:0006470; GO:0007097; GO:0007409; GO:0008064; GO:0008138; GO:0010591; GO:0016319; GO:0030036; GO:0030833; GO:0030837; GO:0045177; GO:0048749; GO:0050770	actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell morphogenesis [GO:0000902]; compound eye development [GO:0048749]; inactivation of MAPK activity [GO:0000188]; mitotic cell cycle [GO:0000278]; mushroom body development [GO:0016319]; negative regulation of actin filament polymerization [GO:0030837]; nuclear migration [GO:0007097]; protein dephosphorylation [GO:0006470]; regulation of actin filament polymerization [GO:0030833]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591]		blue	blue	NA	NA	NA	NA
TRINITY_DN16992_c0_g1_i2	Q9V9A8	PHTF_DROME	30.4	184	110	6	131	664	484	655	8.80E-10	65.5	PHTF_DROME	reviewed	Protein phtf	phtf CG3268	Drosophila melanogaster (Fruit fly)	880	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN16992_c0_g1_i4	Q9V9A8	PHTF_DROME	30.4	184	110	6	44	577	484	655	2.00E-10	67.4	PHTF_DROME	reviewed	Protein phtf	phtf CG3268	Drosophila melanogaster (Fruit fly)	880	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN27246_c0_g1_i2	Q9V9A8	PHTF_DROME	53.1	49	23	0	88	234	1	49	1.50E-06	55.5	PHTF_DROME	reviewed	Protein phtf	phtf CG3268	Drosophila melanogaster (Fruit fly)	880	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN27246_c0_g1_i1	Q8CB19	PHTF2_MOUSE	36.8	182	98	3	103	648	8	172	1.20E-23	112.5	PHTF2_MOUSE	reviewed	Protein PHTF2	Phtf2	Mus musculus (Mouse)	747	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; DNA binding [GO:0003677]	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005783			NA	NA	NA	NA	NA	NA
TRINITY_DN35304_c0_g1_i1	Q5ZKN3	PHTF2_CHICK	95.7	69	3	0	207	1	32	100	6.70E-33	140.6	PHTF2_CHICK	reviewed	Protein PHTF2	PHTF2 RCJMB04_9p2	Gallus gallus (Chicken)	752	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; DNA binding [GO:0003677]	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005783			NA	NA	NA	NA	NA	NA
TRINITY_DN3438_c0_g2_i1	Q24118	PIGE_DROME	39.4	490	266	8	1550	144	433	912	1.70E-88	328.2	PIGE_DROME	reviewed	Protein pigeon (Protein linotte)	pigeon lio CG10739	Drosophila melanogaster (Fruit fly)	915	trans-Golgi network [GO:0005802]; positive regulation of amyloid-beta formation [GO:1902004]	trans-Golgi network [GO:0005802]		GO:0005802; GO:1902004	positive regulation of amyloid-beta formation [GO:1902004]		NA	NA	NA	NA	NA	NA
TRINITY_DN11073_c0_g1_i1	Q9VPW8	PINO_DROME	43.9	139	71	3	50	460	60	193	2.60E-27	123.6	PINO_DROME	reviewed	Protein pinocchio	Pino smi21F CG4710	Drosophila melanogaster (Fruit fly)	249	olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]			GO:0007608; GO:0042048	olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]		blue	blue	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i10	Q90941	PB1_CHICK	35.4	1281	714	21	3794	162	58	1294	7.50E-215	749.2	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]	RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0003677; GO:0003682; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i11	Q90941	PB1_CHICK	29.8	917	495	19	2728	95	818	1624	1.50E-95	352.4	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]	RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0003677; GO:0003682; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i12	Q90941	PB1_CHICK	34.9	1291	720	20	3836	162	58	1294	3.40E-215	750.4	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]	RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0003677; GO:0003682; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i13	Q90941	PB1_CHICK	35.3	1281	719	20	3806	162	58	1294	2.30E-216	754.2	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]	RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0003677; GO:0003682; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i14	Q90941	PB1_CHICK	29.8	917	495	19	2728	95	818	1624	1.50E-95	352.4	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]	RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0003677; GO:0003682; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i19	Q90941	PB1_CHICK	35	1291	715	21	3824	162	58	1294	1.40E-213	745	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]	RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0003677; GO:0003682; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]		NA	NA	NA	NA	NA	NA
TRINITY_DN36304_c0_g1_i1	Q86U86	PB1_HUMAN	100	73	0	0	2	220	227	299	1.70E-34	146	PB1_HUMAN	reviewed	Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)	PBRM1 BAF180 PB1	Homo sapiens (Human)	1689	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0000228; GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0006338; GO:0008285; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i1	Q86U86	PB1_HUMAN	31.7	271	171	5	1234	458	1164	1432	4.90E-30	133.7	PB1_HUMAN	reviewed	Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)	PBRM1 BAF180 PB1	Homo sapiens (Human)	1689	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0000228; GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0006338; GO:0008285; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN970_c0_g1_i2	Q86U86	PB1_HUMAN	31.7	271	171	5	923	147	1164	1432	3.60E-30	133.7	PB1_HUMAN	reviewed	Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)	PBRM1 BAF180 PB1	Homo sapiens (Human)	1689	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]	GO:0000228; GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0006338; GO:0008285; GO:0016586; GO:0043044; GO:0070577	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN2242_c0_g1_i1	Q9V579	PREL_DROME	49.1	161	80	1	639	157	12	170	5.10E-41	169.5	PREL_DROME	reviewed	Protein preli-like	prel CG8806	Drosophila melanogaster (Fruit fly)	236	mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; dendrite morphogenesis [GO:0048813]; mitochondrion morphogenesis [GO:0070584]; phospholipid transport [GO:0015914]	mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	phosphatidic acid transfer activity [GO:1990050]	GO:0005739; GO:0005758; GO:0015914; GO:0030061; GO:0048813; GO:0070584; GO:1990050	dendrite morphogenesis [GO:0048813]; mitochondrion morphogenesis [GO:0070584]; phospholipid transport [GO:0015914]		blue	blue	NA	NA	NA	NA
TRINITY_DN2242_c0_g1_i2	Q9V579	PREL_DROME	50	50	25	0	210	61	121	170	3.10E-09	62	PREL_DROME	reviewed	Protein preli-like	prel CG8806	Drosophila melanogaster (Fruit fly)	236	mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; dendrite morphogenesis [GO:0048813]; mitochondrion morphogenesis [GO:0070584]; phospholipid transport [GO:0015914]	mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	phosphatidic acid transfer activity [GO:1990050]	GO:0005739; GO:0005758; GO:0015914; GO:0030061; GO:0048813; GO:0070584; GO:1990050	dendrite morphogenesis [GO:0048813]; mitochondrion morphogenesis [GO:0070584]; phospholipid transport [GO:0015914]		NA	NA	NA	NA	NA	NA
TRINITY_DN5600_c0_g1_i1	A3KPW7	PTAR1_DANRE	35	320	183	6	1238	324	4	313	6.50E-49	196.4	PTAR1_DANRE	reviewed	Protein prenyltransferase alpha subunit repeat-containing protein 1	ptar1 si:ch211-117c19.3	Danio rerio (Zebrafish) (Brachydanio rerio)	426	cytoplasm [GO:0005737]; protein prenyltransferase activity [GO:0008318]; protein prenylation [GO:0018342]	cytoplasm [GO:0005737]	protein prenyltransferase activity [GO:0008318]	GO:0005737; GO:0008318; GO:0018342	protein prenylation [GO:0018342]		NA	NA	NA	NA	NA	NA
TRINITY_DN6284_c0_g1_i1	Q292U2	PRIC1_DROPS	54.4	79	36	0	13	249	651	729	1.00E-22	107.1	PRIC1_DROPS	reviewed	Protein prickle	pk GA10748	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1353	plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]	plasma membrane [GO:0005886]	zinc ion binding [GO:0008270]	GO:0001736; GO:0005886; GO:0007164; GO:0008270; GO:0009948	anterior/posterior axis specification [GO:0009948]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]		blue	blue	NA	NA	NA	NA
TRINITY_DN39276_c0_g1_i1	Q96M27	PRRC1_HUMAN	100	69	0	0	209	3	226	294	1.10E-30	133.3	PRRC1_HUMAN	reviewed	Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1)	PRRC1	Homo sapiens (Human)	445	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; identical protein binding [GO:0042802]; protein kinase A regulatory subunit binding [GO:0034237]; activation of protein kinase A activity [GO:0034199]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	identical protein binding [GO:0042802]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0005737; GO:0005794; GO:0034199; GO:0034237; GO:0042802	activation of protein kinase A activity [GO:0034199]		NA	NA	NA	NA	NA	NA
TRINITY_DN11028_c0_g1_i1	Q5XJA3	PRRC1_DANRE	43.2	287	147	5	942	97	157	432	2.40E-56	220.7	PRRC1_DANRE	reviewed	Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1) (Protein misty somites)	prrc1 mys zgc:103484	Danio rerio (Zebrafish) (Brachydanio rerio)	435	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; protein kinase A regulatory subunit binding [GO:0034237]; activation of protein kinase A activity [GO:0034199]; epithelial structure maintenance [GO:0010669]; somite specification [GO:0001757]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	protein kinase A regulatory subunit binding [GO:0034237]	GO:0001757; GO:0005737; GO:0005794; GO:0010669; GO:0034199; GO:0034237	activation of protein kinase A activity [GO:0034199]; epithelial structure maintenance [GO:0010669]; somite specification [GO:0001757]		blue	blue	NA	NA	NA	NA
TRINITY_DN3489_c0_g1_i1	P48634	PRC2A_HUMAN	62	79	30	0	500	264	17	95	9.80E-22	104.8	PRC2A_HUMAN	reviewed	Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2)	PRRC2A BAT2 G2	Homo sapiens (Human)	2157	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062	cell differentiation [GO:0030154]		NA	NA	NA	NA	NA	NA
TRINITY_DN3489_c0_g1_i2	P48634	PRC2A_HUMAN	62	79	30	0	562	326	17	95	1.10E-21	104.8	PRC2A_HUMAN	reviewed	Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2)	PRRC2A BAT2 G2	Homo sapiens (Human)	2157	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062	cell differentiation [GO:0030154]		NA	NA	NA	NA	NA	NA
TRINITY_DN3489_c0_g1_i3	P48634	PRC2A_HUMAN	62	79	30	0	532	296	17	95	1.00E-21	104.8	PRC2A_HUMAN	reviewed	Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2)	PRRC2A BAT2 G2	Homo sapiens (Human)	2157	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062	cell differentiation [GO:0030154]		NA	NA	NA	NA	NA	NA
TRINITY_DN2891_c0_g1_i1	Q0IHU9	PRUN2_XENTR	53	198	93	0	167	760	94	291	5.50E-60	232.6	PRUN2_XENTR	reviewed	Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1)	Prune2 Bmcc1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	316	cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]	cytoplasm [GO:0005737]	exopolyphosphatase activity [GO:0004309]	GO:0004309; GO:0005737; GO:0006798; GO:0006915	apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]		blue	blue	NA	NA	NA	NA
TRINITY_DN27412_c0_g1_i1	Q0IHU9	PRUN2_XENTR	66.7	48	16	0	54	197	126	173	1.60E-13	76.3	PRUN2_XENTR	reviewed	Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1)	Prune2 Bmcc1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	316	cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]	cytoplasm [GO:0005737]	exopolyphosphatase activity [GO:0004309]	GO:0004309; GO:0005737; GO:0006798; GO:0006915	apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]		NA	NA	NA	NA	NA	NA
TRINITY_DN5205_c0_g1_i1	A1Z9A8	PTCD3_DROME	57.1	91	39	0	93	365	37	127	7.20E-26	118.2	PTCD3_DROME	reviewed	"Protein PTCD3 homolog, mitochondrial"	CG4679	Drosophila melanogaster (Fruit fly)	652	mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	mitochondrion [GO:0005739]; ribosome [GO:0005840]	ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024	mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1803_c0_g1_i1	A1Z9A8	PTCD3_DROME	39.1	443	264	4	1438	119	207	646	8.00E-93	342.4	PTCD3_DROME	reviewed	"Protein PTCD3 homolog, mitochondrial"	CG4679	Drosophila melanogaster (Fruit fly)	652	mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	mitochondrion [GO:0005739]; ribosome [GO:0005840]	ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024	mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN1803_c0_g1_i5	A1Z9A8	PTCD3_DROME	44.2	120	67	0	407	48	207	326	8.30E-27	121.3	PTCD3_DROME	reviewed	"Protein PTCD3 homolog, mitochondrial"	CG4679	Drosophila melanogaster (Fruit fly)	652	mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	mitochondrion [GO:0005739]; ribosome [GO:0005840]	ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024	mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN6673_c0_g2_i1	P20054	PYR1_DICDI	71.2	118	34	0	24	377	401	518	6.30E-45	181.4	PYR1_DICDI	reviewed	Protein PYR1-3 [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	pyr1-3 DDB_G0276335	Dictyostelium discoideum (Slime mold)	2225	cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]	cytoplasm [GO:0005737]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0006207; GO:0006541; GO:0006807; GO:0016597; GO:0044205; GO:0046872	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN16923_c0_g1_i1	O93937	PYR1_EMENI	55	200	83	2	37	618	1011	1209	1.90E-59	230.3	PYR1_EMENI	reviewed	Protein pyrABCN [Includes: Glutamine-dependent carbamoyl-phosphate (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2)]	pyrABCN AN0565	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	2275	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; negative regulation of pyrimidine nucleobase metabolic process [GO:0045984]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; metal ion binding [GO:0046872]	GO:0003922; GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005829; GO:0006207; GO:0006228; GO:0006520; GO:0006541; GO:0006807; GO:0016021; GO:0016597; GO:0019240; GO:0044205; GO:0045984; GO:0046872	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; negative regulation of pyrimidine nucleobase metabolic process [GO:0045984]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN36986_c0_g1_i1	Q9P258	RCC2_HUMAN	100	148	0	0	1	444	195	342	4.10E-83	308.5	RCC2_HUMAN	reviewed	Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa)	RCC2 KIAA1470 TD60	Homo sapiens (Human)	522	"chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]"	"chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]"	guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0003723; GO:0005085; GO:0005730; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0048365; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]		NA	NA	NA	NA	NA	NA
TRINITY_DN33214_c0_g1_i1	Q6NYE2	RCC2_DANRE	49.8	424	205	3	86	1333	66	489	2.40E-121	437.2	RCC2_DANRE	reviewed	Protein RCC2 homolog	rcc2 zgc:77115	Danio rerio (Zebrafish) (Brachydanio rerio)	495	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]; cell cycle [GO:0007049]; cell division [GO:0051301]; neural crest cell migration [GO:0001755]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]"		GO:0000775; GO:0001755; GO:0005730; GO:0005737; GO:0005819; GO:0005886; GO:0007049; GO:0030496; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; neural crest cell migration [GO:0001755]		blue	blue	NA	NA	NA	NA
TRINITY_DN37136_c0_g1_i1	Q9C7E7	RDM16_ARATH	50.8	63	29	2	233	48	661	722	4.90E-08	58.2	RDM16_ARATH	reviewed	Protein RDM16 (Pre-mRNA-splicing factor RDM16) (Protein RNA-directed DNA methylation 16)	RDM16 At1g28060 F13K9.16	Arabidopsis thaliana (Mouse-ear cress)	786	"nucleoplasm [GO:0005654]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; embryo development ending in seed dormancy [GO:0009793]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA methylation [GO:0044030]"	nucleoplasm [GO:0005654]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		GO:0000398; GO:0005654; GO:0006397; GO:0009793; GO:0044030; GO:0046540	"embryo development ending in seed dormancy [GO:0009793]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA methylation [GO:0044030]"		red	red	NA	NA	NA	NA
TRINITY_DN26922_c0_g1_i1	Q13123	RED_HUMAN	100	148	0	0	1	444	113	260	1.40E-75	283.5	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6536_c0_g1_i1	Q13123	RED_HUMAN	55	218	80	4	83	715	1	207	9.20E-29	128.6	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38121_c0_g1_i1	Q13123	RED_HUMAN	100	104	0	0	314	3	442	545	6.10E-54	211.1	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1453_c0_g1_i2	Q13123	RED_HUMAN	56.6	122	48	2	408	43	433	549	1.20E-33	144.8	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1453_c0_g1_i3	Q13123	RED_HUMAN	60.2	108	38	2	419	96	433	535	5.50E-31	136	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1453_c0_g1_i4	Q13123	RED_HUMAN	58.6	116	43	2	360	13	433	543	1.60E-32	141	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1453_c0_g1_i5	Q13123	RED_HUMAN	60.2	108	38	2	419	96	433	535	5.50E-31	136	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6309_c0_g1_i1	Q13123	RED_HUMAN	57.4	136	56	2	39	443	203	337	1.20E-33	144.4	RED_HUMAN	reviewed	Protein Red (Cytokine IK) (IK factor) (Protein RER)	IK RED RER	Homo sapiens (Human)	557	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	GO:0000278; GO:0000381; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016032; GO:0016607; GO:0034501; GO:0042802; GO:0071005	"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1875_c0_g1_i1	Q24629	REF2P_DROSI	33.8	154	86	5	550	134	29	181	6.00E-12	72.8	REF2P_DROSI	reviewed	Protein ref(2)P (Refractory to sigma P)	ref(2)P	Drosophila simulans (Fruit fly)	599	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; selective autophagy [GO:0061912]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005737; GO:0008270; GO:0061912	selective autophagy [GO:0061912]		blue	blue	NA	NA	NA	NA
TRINITY_DN1875_c0_g1_i2	Q24629	REF2P_DROSI	32.7	153	93	5	562	134	29	181	1.40E-11	71.6	REF2P_DROSI	reviewed	Protein ref(2)P (Refractory to sigma P)	ref(2)P	Drosophila simulans (Fruit fly)	599	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; selective autophagy [GO:0061912]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005737; GO:0008270; GO:0061912	selective autophagy [GO:0061912]		NA	NA	NA	NA	NA	NA
TRINITY_DN39320_c0_g1_i1	O15258	RER1_HUMAN	100	159	0	0	1	477	38	196	7.80E-88	324.3	RER1_HUMAN	reviewed	Protein RER1	RER1	Homo sapiens (Human)	196	"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; acetylcholine receptor binding [GO:0033130]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]"	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]	acetylcholine receptor binding [GO:0033130]	GO:0005783; GO:0005793; GO:0005794; GO:0005886; GO:0006621; GO:0006890; GO:0009986; GO:0030173; GO:0033130; GO:0071340; GO:1903078	"positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8366_c0_g1_i1	Q9CQU3	RER1_MOUSE	96.3	163	6	0	513	25	34	196	2.90E-85	315.8	RER1_MOUSE	reviewed	Protein RER1	Rer1	Mus musculus (Mouse)	196	"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; acetylcholine receptor binding [GO:0033130]; neuromuscular junction development [GO:0007528]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]"	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]	acetylcholine receptor binding [GO:0033130]	GO:0005783; GO:0005793; GO:0005794; GO:0005886; GO:0006621; GO:0006890; GO:0007528; GO:0009986; GO:0030173; GO:0033130; GO:0071340; GO:1903078	"neuromuscular junction development [GO:0007528]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3505_c0_g1_i1	Q9CQU3	RER1_MOUSE	66.5	179	58	1	90	626	16	192	1.20E-65	251.1	RER1_MOUSE	reviewed	Protein RER1	Rer1	Mus musculus (Mouse)	196	"cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; acetylcholine receptor binding [GO:0033130]; neuromuscular junction development [GO:0007528]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]"	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]	acetylcholine receptor binding [GO:0033130]	GO:0005783; GO:0005793; GO:0005794; GO:0005886; GO:0006621; GO:0006890; GO:0007528; GO:0009986; GO:0030173; GO:0033130; GO:0071340; GO:1903078	"neuromuscular junction development [GO:0007528]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3505_c0_g1_i2	A5PJ65	RER1_BOVIN	65.4	179	62	0	60	596	14	192	1.80E-66	253.8	RER1_BOVIN	reviewed	Protein RER1	RER1	Bos taurus (Bovine)	196	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3505_c0_g1_i3	A5PJ65	RER1_BOVIN	66.3	181	58	1	111	644	12	192	2.10E-65	250.4	RER1_BOVIN	reviewed	Protein RER1	RER1	Bos taurus (Bovine)	196	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0016021			NA	NA	1	NA	NA	NA
TRINITY_DN31885_c0_g1_i1	P52879	RER1_CAEEL	53.7	67	31	0	207	7	106	172	1.50E-12	73.2	RER1_CAEEL	reviewed	Protein RER1 homolog	rer-1 F46C5.8	Caenorhabditis elegans	191	"endoplasmic reticulum [GO:0005783]; integral component of Golgi membrane [GO:0030173]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endoplasmic reticulum [GO:0005783]; integral component of Golgi membrane [GO:0030173]		GO:0005783; GO:0006621; GO:0006890; GO:0015031; GO:0030173	"protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28326_c0_g1_i1	O48671	RER1B_ARATH	44.7	103	54	1	1	300	65	167	2.70E-22	105.9	RER1B_ARATH	reviewed	Protein RER1B (AtRER1B)	RER1B At2g21600 F2G1.13	Arabidopsis thaliana (Mouse-ear cress)	195	"cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]		GO:0005783; GO:0005794; GO:0005801; GO:0006621; GO:0006890; GO:0030173	"protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i1	P43125	RDGB_DROME	59	754	286	6	2418	166	514	1247	4.20E-259	895.6	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i14	P43125	RDGB_DROME	60.9	92	35	1	277	2	724	814	1.50E-26	120.6	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i15	P43125	RDGB_DROME	67.7	440	133	2	1479	166	815	1247	3.60E-176	619.4	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i17	P43125	RDGB_DROME	57.4	893	341	11	2796	166	378	1247	2.50E-276	953	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i2	P43125	RDGB_DROME	56.9	901	341	11	2820	166	378	1247	1.70E-275	950.3	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i3	P43125	RDGB_DROME	45.2	389	186	8	1209	85	378	753	8.40E-67	255.8	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i5	P43125	RDGB_DROME	43.2	250	131	3	831	85	514	753	1.10E-49	198.4	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i7	P43125	RDGB_DROME	44.3	397	186	8	1233	85	378	753	5.50E-66	253.1	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2347_c0_g1_i9	P43125	RDGB_DROME	66.5	534	167	3	1761	166	724	1247	1.20E-211	737.6	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5809_c0_g1_i1	P43125	RDGB_DROME	68.5	279	86	1	1024	188	5	281	4.00E-119	429.5	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5809_c0_g1_i2	P43125	RDGB_DROME	68.2	283	88	1	1036	188	1	281	1.20E-120	434.5	RDGB_DROME	reviewed	Protein retinal degeneration B (Probable calcium transporter rdgB)	rdgB CG11111	Drosophila melanogaster (Fruit fly)	1259	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; subrhabdomeral cisterna [GO:0016029]	metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0007601; GO:0007602; GO:0007603; GO:0007608; GO:0008525; GO:0008526; GO:0015914; GO:0016021; GO:0016029; GO:0016056; GO:0016059; GO:0031210; GO:0035091; GO:0046488; GO:0046872; GO:0070300; GO:0071482; GO:1990050	"calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; deactivation of rhodopsin mediated signaling [GO:0016059]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33698_c0_g1_i1	P20350	RHOM_DROME	67.1	76	25	0	244	17	164	239	1.10E-23	110.2	RHOM_DROME	reviewed	Protein rhomboid (EC 3.4.21.105) (Protein veinlet)	rho Ve CG1004	Drosophila melanogaster (Fruit fly)	355	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; serine-type endopeptidase activity [GO:0004252]; axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; protein processing [GO:0016485]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]"	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]	serine-type endopeptidase activity [GO:0004252]	GO:0000281; GO:0001742; GO:0001752; GO:0004252; GO:0005737; GO:0005794; GO:0007391; GO:0007409; GO:0007420; GO:0007436; GO:0007438; GO:0007474; GO:0007476; GO:0007479; GO:0008586; GO:0010628; GO:0010629; GO:0016021; GO:0016485; GO:0030173; GO:0031902; GO:0035160; GO:0035202; GO:0035225; GO:0035311; GO:0038004; GO:0042058; GO:0042327; GO:0042749; GO:0043703; GO:0045177; GO:0048149; GO:0048865; GO:0061331; GO:0090317	"axonogenesis [GO:0007409]; behavioral response to ethanol [GO:0048149]; brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; determination of genital disc primordium [GO:0035225]; dorsal closure [GO:0007391]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; larval salivary gland morphogenesis [GO:0007436]; leg disc proximal/distal pattern formation [GO:0007479]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; mitotic cytokinesis [GO:0000281]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular protein transport [GO:0090317]; oenocyte development [GO:0007438]; oenocyte differentiation [GO:0001742]; photoreceptor cell fate determination [GO:0043703]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphorylation [GO:0042327]; protein processing [GO:0016485]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; stem cell fate commitment [GO:0048865]; tracheal pit formation in open tracheal system [GO:0035202]; wing cell fate specification [GO:0035311]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10167_c0_g1_i1	Q9VVE2	ROGDI_DROME	48.4	258	128	2	181	954	15	267	7.70E-61	235.7	ROGDI_DROME	reviewed	Protein rogdi	rogdi CG7725	Drosophila melanogaster (Fruit fly)	268	axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; behavioral response to ethanol [GO:0048149]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]	axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]		GO:0005634; GO:0005635; GO:0007035; GO:0008021; GO:0030424; GO:0030425; GO:0032502; GO:0043204; GO:0043291; GO:0048149	behavioral response to ethanol [GO:0048149]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	1
TRINITY_DN10167_c0_g1_i2	Q9VVE2	ROGDI_DROME	48.4	258	128	2	185	958	15	267	7.70E-61	235.7	ROGDI_DROME	reviewed	Protein rogdi	rogdi CG7725	Drosophila melanogaster (Fruit fly)	268	axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; behavioral response to ethanol [GO:0048149]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]	axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]		GO:0005634; GO:0005635; GO:0007035; GO:0008021; GO:0030424; GO:0030425; GO:0032502; GO:0043204; GO:0043291; GO:0048149	behavioral response to ethanol [GO:0048149]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN10167_c0_g1_i4	Q7ZVT5	ROGDI_DANRE	40.5	74	41	1	185	406	12	82	1.10E-07	58.2	ROGDI_DANRE	reviewed	Protein rogdi homolog	rogdi zgc:55665	Danio rerio (Zebrafish) (Brachydanio rerio)	284	axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; developmental process [GO:0032502]; vacuolar acidification [GO:0007035]	axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]		GO:0005634; GO:0005635; GO:0007035; GO:0008021; GO:0030424; GO:0030425; GO:0032502; GO:0043204; GO:0043291	developmental process [GO:0032502]; vacuolar acidification [GO:0007035]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN6585_c0_g3_i2	Q6AYG0	RRNAD_RAT	25.5	251	104	5	48	785	2	174	4.60E-13	76.6	RRNAD_RAT	reviewed	Protein RRNAD1	Rrnad1	Rattus norvegicus (Rat)	475	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN6585_c0_g3_i3	Q6AYG0	RRNAD_RAT	25.5	251	104	5	40	777	2	174	5.90E-13	76.3	RRNAD_RAT	reviewed	Protein RRNAD1	Rrnad1	Rattus norvegicus (Rat)	475	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN7857_c0_g1_i1	Q96FB5	RRNAD_HUMAN	40.3	290	160	6	4	870	185	462	7.40E-49	195.7	RRNAD_HUMAN	reviewed	Protein RRNAD1 (Ribosomal RNA adenine dimethylase domain-containing protein 1)	RRNAD1 C1orf66 CGI-41	Homo sapiens (Human)	475	"integral component of membrane [GO:0016021]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	integral component of membrane [GO:0016021]	"rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN7999_c0_g1_i1	A4V8B4	SAV1_RAT	36.4	398	212	9	1387	242	1	373	1.60E-53	211.8	SAV1_RAT	reviewed	Protein salvador homolog 1 (45 kDa WW domain protein) (rWW45)	Sav1 Ww45	Rattus norvegicus (Rat)	387	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-1 adrenergic receptor binding [GO:0031697]; identical protein binding [GO:0042802]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of organ growth [GO:0046620]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-1 adrenergic receptor binding [GO:0031697]; identical protein binding [GO:0042802]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]	GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0007165; GO:0030159; GO:0030216; GO:0030425; GO:0031697; GO:0035329; GO:0042802; GO:0043065; GO:0043113; GO:0045600; GO:0046332; GO:0046620; GO:0050680; GO:0050821; GO:0051091; GO:0060044; GO:0060412; GO:0060487; GO:0060575; GO:0070699; GO:2000036	apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of organ growth [GO:0046620]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN1095_c2_g1_i4	P45843	SCRT_DROME	45.8	539	267	3	3	1616	95	609	1.60E-137	491.1	SCRT_DROME	reviewed	Protein scarlet	st CG4314	Drosophila melanogaster (Fruit fly)	666	integral component of pigment granule membrane [GO:0090740]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; eye pigment precursor transport [GO:0006856]; ommochrome biosynthetic process [GO:0006727]	integral component of pigment granule membrane [GO:0090740]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0015842; GO:0016887; GO:0031409; GO:0042626; GO:0090740; GO:0098793	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; eye pigment precursor transport [GO:0006856]; ommochrome biosynthetic process [GO:0006727]		NA	NA	1	NA	NA	NA
TRINITY_DN1095_c2_g1_i7	P45843	SCRT_DROME	44.9	595	302	4	3	1781	95	665	1.10E-148	528.5	SCRT_DROME	reviewed	Protein scarlet	st CG4314	Drosophila melanogaster (Fruit fly)	666	integral component of pigment granule membrane [GO:0090740]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; eye pigment precursor transport [GO:0006856]; ommochrome biosynthetic process [GO:0006727]	integral component of pigment granule membrane [GO:0090740]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0015842; GO:0016887; GO:0031409; GO:0042626; GO:0090740; GO:0098793	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; eye pigment precursor transport [GO:0006856]; ommochrome biosynthetic process [GO:0006727]		NA	NA	NA	NA	NA	NA
TRINITY_DN1095_c2_g1_i9	P45843	SCRT_DROME	48.3	344	164	2	224	1255	36	365	1.30E-87	325.1	SCRT_DROME	reviewed	Protein scarlet	st CG4314	Drosophila melanogaster (Fruit fly)	666	integral component of pigment granule membrane [GO:0090740]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; eye pigment precursor transport [GO:0006856]; ommochrome biosynthetic process [GO:0006727]	integral component of pigment granule membrane [GO:0090740]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0015842; GO:0016887; GO:0031409; GO:0042626; GO:0090740; GO:0098793	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; eye pigment precursor transport [GO:0006856]; ommochrome biosynthetic process [GO:0006727]		NA	NA	NA	NA	NA	NA
TRINITY_DN10833_c0_g1_i1	Q8VYP0	SCO11_ARATH	50.5	95	46	1	314	30	238	331	4.70E-22	105.1	SCO11_ARATH	reviewed	"Protein SCO1 homolog 1, mitochondrial (Homolog of the copper chaperone SCO1 member 1) (HCC1)"	HCC1 SCO1-1 At3g08950 T16O11.9	Arabidopsis thaliana (Mouse-ear cress)	334	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; copper ion binding [GO:0005507]; embryo development ending in seed dormancy [GO:0009793]; mitochondrial cytochrome c oxidase assembly [GO:0033617]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	copper ion binding [GO:0005507]	GO:0005507; GO:0005739; GO:0005743; GO:0009793; GO:0016021; GO:0033617	embryo development ending in seed dormancy [GO:0009793]; mitochondrial cytochrome c oxidase assembly [GO:0033617]		NA	NA	NA	NA	NA	NA
TRINITY_DN11460_c0_g1_i1	O75880	SCO1_HUMAN	50.4	244	116	2	810	94	56	299	7.30E-69	262.3	SCO1_HUMAN	reviewed	"Protein SCO1 homolog, mitochondrial"	SCO1 SCOD1	Homo sapiens (Human)	301	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper ion binding [GO:0005507]; cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]	copper ion binding [GO:0005507]	GO:0005507; GO:0005739; GO:0006825; GO:0006878; GO:0030016; GO:0031305; GO:0033617; GO:1901799	cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]		NA	NA	NA	NA	NA	NA
TRINITY_DN30331_c0_g1_i1	O75880	SCO1_HUMAN	100	115	0	0	3	347	146	260	1.60E-63	243	SCO1_HUMAN	reviewed	"Protein SCO1 homolog, mitochondrial"	SCO1 SCOD1	Homo sapiens (Human)	301	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper ion binding [GO:0005507]; cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]	copper ion binding [GO:0005507]	GO:0005507; GO:0005739; GO:0006825; GO:0006878; GO:0030016; GO:0031305; GO:0033617; GO:1901799	cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]		NA	NA	NA	NA	NA	NA
TRINITY_DN33708_c0_g1_i1	O43819	SCO2_HUMAN	100	139	0	0	1	417	114	252	1.50E-79	296.6	SCO2_HUMAN	reviewed	"Protein SCO2 homolog, mitochondrial"	SCO2	Homo sapiens (Human)	266	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; eye development [GO:0001654]; in utero embryonic development [GO:0001701]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; oxidation-reduction process [GO:0055114]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myofibril [GO:0030016]	copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0001654; GO:0001701; GO:0003012; GO:0005507; GO:0005739; GO:0005759; GO:0006825; GO:0006878; GO:0014823; GO:0015035; GO:0022904; GO:0030016; GO:0031305; GO:0033617; GO:0055114	cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; eye development [GO:0001654]; in utero embryonic development [GO:0001701]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; oxidation-reduction process [GO:0055114]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]		NA	NA	NA	NA	NA	NA
TRINITY_DN31136_c0_g1_i1	Q8VCL2	SCO2_MOUSE	100	74	0	0	1	222	148	221	8.20E-37	153.7	SCO2_MOUSE	reviewed	"Protein SCO2 homolog, mitochondrial"	Sco2	Mus musculus (Mouse)	255	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; eye development [GO:0001654]; in utero embryonic development [GO:0001701]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; respiratory chain complex IV assembly [GO:0008535]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]	copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0001654; GO:0001701; GO:0003012; GO:0005507; GO:0005739; GO:0006825; GO:0006878; GO:0008535; GO:0014823; GO:0015035; GO:0022904; GO:0030016; GO:0031305; GO:0033617; GO:0055070	cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; eye development [GO:0001654]; in utero embryonic development [GO:0001701]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; respiratory chain complex IV assembly [GO:0008535]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]		NA	NA	NA	NA	NA	NA
TRINITY_DN731_c0_g1_i1	Q4H4B6	SCRIB_DANRE	27.4	226	107	4	684	172	1403	1626	3.60E-06	53.5	SCRIB_DANRE	reviewed	Protein scribble homolog (Scribble1)	scrib llk scrb1	Danio rerio (Zebrafish) (Brachydanio rerio)	1724	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuron migration [GO:0001764]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; vasculature development [GO:0001944]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]	protein heterodimerization activity [GO:0046982]	GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0030027; GO:0030054; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045202; GO:0045930; GO:0046982; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097120; GO:0097475; GO:0098609; GO:0098793; GO:0098887; GO:0098968	"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; vasculature development [GO:0001944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN731_c0_g1_i2	Q4H4B6	SCRIB_DANRE	27.4	226	107	4	1045	533	1403	1626	5.40E-06	53.5	SCRIB_DANRE	reviewed	Protein scribble homolog (Scribble1)	scrib llk scrb1	Danio rerio (Zebrafish) (Brachydanio rerio)	1724	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuron migration [GO:0001764]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; vasculature development [GO:0001944]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]	protein heterodimerization activity [GO:0046982]	GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0030027; GO:0030054; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045202; GO:0045930; GO:0046982; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097120; GO:0097475; GO:0098609; GO:0098793; GO:0098887; GO:0098968	"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; vasculature development [GO:0001944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7870_c0_g1_i1	Q9VTH4	SCLLA_DROME	28.7	108	76	1	241	564	145	251	3.30E-09	63.5	SCLLA_DROME	reviewed	Protein scylla (Protein regulated in development and DNA damage response 2) (REDD-2)	scyl CG7590	Drosophila melanogaster (Fruit fly)	280	cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]		GO:0005737; GO:0006915; GO:0006979; GO:0008219; GO:0008258; GO:0009968; GO:0032006; GO:0032504; GO:0045926	apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN7870_c0_g1_i2	Q9VTH4	SCLLA_DROME	28.7	108	76	1	241	564	145	251	3.40E-09	63.5	SCLLA_DROME	reviewed	Protein scylla (Protein regulated in development and DNA damage response 2) (REDD-2)	scyl CG7590	Drosophila melanogaster (Fruit fly)	280	cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]		GO:0005737; GO:0006915; GO:0006979; GO:0008219; GO:0008258; GO:0009968; GO:0032006; GO:0032504; GO:0045926	apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN18893_c0_g1_i1	Q9VTH4	SCLLA_DROME	33.7	104	65	2	282	590	152	252	8.60E-08	58.9	SCLLA_DROME	reviewed	Protein scylla (Protein regulated in development and DNA damage response 2) (REDD-2)	scyl CG7590	Drosophila melanogaster (Fruit fly)	280	cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]		GO:0005737; GO:0006915; GO:0006979; GO:0008219; GO:0008258; GO:0009968; GO:0032006; GO:0032504; GO:0045926	apoptotic process [GO:0006915]; cell death [GO:0008219]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN1984_c0_g1_i2	Q7KKH3	SDA1_DROME	57.1	77	33	0	1	231	636	712	7.40E-15	81.3	SDA1_DROME	reviewed	Protein SDA1 homolog (Mystery protein 45A)	Mys45A CG8070	Drosophila melanogaster (Fruit fly)	712	nucleolus [GO:0005730]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]		GO:0000055; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN33814_c0_g1_i1	Q7KKH3	SDA1_DROME	52.2	92	44	0	1	276	358	449	2.30E-20	99.4	SDA1_DROME	reviewed	Protein SDA1 homolog (Mystery protein 45A)	Mys45A CG8070	Drosophila melanogaster (Fruit fly)	712	nucleolus [GO:0005730]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]		GO:0000055; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21796_c0_g1_i1	Q9NVU7	SDA1_HUMAN	96	173	7	0	3	521	79	251	7.70E-86	317.8	SDA1_HUMAN	reviewed	Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA)	SDAD1 NUC130	Homo sapiens (Human)	687	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000055; GO:0005654; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21796_c0_g1_i2	Q9NVU7	SDA1_HUMAN	95	161	8	0	1	483	91	251	2.10E-77	289.7	SDA1_HUMAN	reviewed	Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA)	SDAD1 NUC130	Homo sapiens (Human)	687	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000055; GO:0005654; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN34809_c0_g1_i1	Q9NVU7	SDA1_HUMAN	100	96	0	0	3	290	362	457	2.10E-48	192.6	SDA1_HUMAN	reviewed	Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA)	SDAD1 NUC130	Homo sapiens (Human)	687	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000055; GO:0005654; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2903_c0_g1_i1	A5D7C2	SDA1_BOVIN	46.1	395	187	5	1188	4	254	622	6.80E-77	289.3	SDA1_BOVIN	reviewed	Protein SDA1 homolog (SDA1 domain-containing protein 1)	SDAD1	Bos taurus (Bovine)	688	nucleolus [GO:0005730]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]		GO:0000055; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1984_c0_g1_i1	Q6NV26	SDA1_DANRE	54	63	27	1	13	195	620	682	4.90E-10	65.1	SDA1_DANRE	reviewed	Protein SDA1 homolog (SDA1 domain-containing protein 1)	sdad1	Danio rerio (Zebrafish) (Brachydanio rerio)	682	nucleolus [GO:0005730]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]		GO:0000055; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN1984_c0_g1_i3	Q6NV26	SDA1_DANRE	54	63	27	1	13	195	620	682	4.80E-10	65.1	SDA1_DANRE	reviewed	Protein SDA1 homolog (SDA1 domain-containing protein 1)	sdad1	Danio rerio (Zebrafish) (Brachydanio rerio)	682	nucleolus [GO:0005730]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]		GO:0000055; GO:0005730; GO:0030036; GO:0042273	actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2126_c0_g1_i1	Q5XIQ5	SDA1_RAT	62.2	222	84	0	752	87	5	226	2.50E-73	276.9	SDA1_RAT	reviewed	Protein SDA1 homolog (SDA1 domain-containing protein 1)	Sdad1	Rattus norvegicus (Rat)	686	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000055; GO:0005654; GO:0005730; GO:0030036; GO:0042273; GO:1990830	actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4566_c1_g1_i1	Q3ZCC9	SEC13_BOVIN	57.2	159	63	4	10	474	152	309	1.10E-48	194.5	SEC13_BOVIN	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1)	SEC13 SEC13L1	Bos taurus (Bovine)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0000776; GO:0005198; GO:0005654; GO:0005765; GO:0005789; GO:0005829; GO:0030127; GO:0031080; GO:0032527; GO:0042802; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263	COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]		blue	blue	NA	NA	NA	NA
TRINITY_DN3932_c0_g1_i1	Q5XFW8	SEC13_RAT	64.3	196	66	2	585	1	1	193	2.70E-72	273.1	SEC13_RAT	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1)	Sec13 Sec13l1	Rattus norvegicus (Rat)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005635; GO:0005643; GO:0005765; GO:0005789; GO:0005829; GO:0006888; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263	COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]		blue	blue	NA	NA	NA	NA
TRINITY_DN13804_c0_g1_i1	Q9D1M0	SEC13_MOUSE	100	176	0	0	3	530	8	183	4.00E-106	385.2	SEC13_MOUSE	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	Sec13 Sec13l1	Mus musculus (Mouse)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0043231; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263	COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN4566_c1_g1_i2	Q9D1M0	SEC13_MOUSE	50.9	116	52	4	10	345	152	266	2.90E-25	115.9	SEC13_MOUSE	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	Sec13 Sec13l1	Mus musculus (Mouse)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0043231; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263	COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN24246_c1_g1_i1	P55735	SEC13_HUMAN	100	184	0	0	72	623	1	184	1.40E-110	400.2	SEC13_HUMAN	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	SEC13 D3S1231E SEC13A SEC13L1 SEC13R	Homo sapiens (Human)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0002474; GO:0005198; GO:0005635; GO:0005654; GO:0005765; GO:0005789; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006886; GO:0012507; GO:0016032; GO:0019083; GO:0019886; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0042802; GO:0043231; GO:0043657; GO:0048208; GO:0060964; GO:0061700; GO:0070062; GO:0075733; GO:0090110; GO:0090114; GO:1900034; GO:1904263	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; intracellular protein transport [GO:0006886]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN24246_c0_g1_i1	P55735	SEC13_HUMAN	98.6	146	2	0	438	1	177	322	7.90E-84	310.8	SEC13_HUMAN	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	SEC13 D3S1231E SEC13A SEC13L1 SEC13R	Homo sapiens (Human)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0002474; GO:0005198; GO:0005635; GO:0005654; GO:0005765; GO:0005789; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006886; GO:0012507; GO:0016032; GO:0019083; GO:0019886; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0042802; GO:0043231; GO:0043657; GO:0048208; GO:0060964; GO:0061700; GO:0070062; GO:0075733; GO:0090110; GO:0090114; GO:1900034; GO:1904263	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; intracellular protein transport [GO:0006886]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN24246_c0_g1_i2	P55735	SEC13_HUMAN	96.4	112	4	0	418	83	177	288	3.70E-62	238.8	SEC13_HUMAN	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	SEC13 D3S1231E SEC13A SEC13L1 SEC13R	Homo sapiens (Human)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0002474; GO:0005198; GO:0005635; GO:0005654; GO:0005765; GO:0005789; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006886; GO:0012507; GO:0016032; GO:0019083; GO:0019886; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0042802; GO:0043231; GO:0043657; GO:0048208; GO:0060964; GO:0061700; GO:0070062; GO:0075733; GO:0090110; GO:0090114; GO:1900034; GO:1904263	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; intracellular protein transport [GO:0006886]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]		NA	NA	NA	NA	NA	NA
TRINITY_DN24246_c0_g1_i3	Q9D1M0	SEC13_MOUSE	99.3	146	1	0	438	1	177	322	7.10E-85	314.3	SEC13_MOUSE	reviewed	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	Sec13 Sec13l1	Mus musculus (Mouse)	322	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0000139; GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0043231; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263	COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN2629_c0_g1_i1	P53997	SET_DROME	60.6	165	49	3	3	479	83	237	5.70E-50	198.7	SET_DROME	reviewed	Protein SET	Set CG4299	Drosophila melanogaster (Fruit fly)	269	nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0006334; GO:0042393	nucleosome assembly [GO:0006334]		NA	NA	NA	NA	NA	NA
TRINITY_DN10351_c1_g1_i1	Q01105	SET_HUMAN	100	137	0	0	3	413	106	242	6.30E-74	278.9	SET_HUMAN	reviewed	Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I)	SET	Homo sapiens (Human)	290	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]	GO:0003677; GO:0003682; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0016032; GO:0019888; GO:0032991; GO:0035067; GO:0042393; GO:0043488; GO:0043524; GO:0045892; GO:0048471	"DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10351_c1_g1_i2	Q01105	SET_HUMAN	100	137	0	0	3	413	106	242	6.30E-74	278.9	SET_HUMAN	reviewed	Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I)	SET	Homo sapiens (Human)	290	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]	GO:0003677; GO:0003682; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0016032; GO:0019888; GO:0032991; GO:0035067; GO:0042393; GO:0043488; GO:0043524; GO:0045892; GO:0048471	"DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i3	Q9VIQ9	SICK_DROME	36.9	293	105	5	1269	616	1068	1355	2.50E-29	131.3	SICK_DROME	reviewed	Protein sickie	sick sickie CG34343	Drosophila melanogaster (Fruit fly)	2197	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; actin filament organization [GO:0007015]; axonogenesis [GO:0007409]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; nervous system development [GO:0007399]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0007015; GO:0007399; GO:0007409; GO:0016887; GO:0045087; GO:0050829	actin filament organization [GO:0007015]; axonogenesis [GO:0007409]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g1_i9	Q9VIQ9	SICK_DROME	47.1	174	62	2	1062	616	1187	1355	1.40E-29	132.1	SICK_DROME	reviewed	Protein sickie	sick sickie CG34343	Drosophila melanogaster (Fruit fly)	2197	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; actin filament organization [GO:0007015]; axonogenesis [GO:0007409]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; nervous system development [GO:0007399]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0007015; GO:0007399; GO:0007409; GO:0016887; GO:0045087; GO:0050829	actin filament organization [GO:0007015]; axonogenesis [GO:0007409]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g2_i1	O97394	SDK_DROME	74	96	24	1	6	293	2130	2224	4.70E-32	138.7	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i1	O97394	SDK_DROME	53.8	589	263	3	25	1764	1336	1924	3.50E-183	642.9	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i10	O97394	SDK_DROME	54.4	1571	679	13	30	4658	503	2063	0	1644.4	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i2	O97394	SDK_DROME	54.1	1579	679	14	30	4682	503	2063	0	1635.5	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i3	O97394	SDK_DROME	55.2	1570	666	14	30	4655	503	2063	0	1642.1	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i5	O97394	SDK_DROME	55.2	1209	522	8	1	3567	716	1924	0	1316.2	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i7	O97394	SDK_DROME	55.5	1562	666	13	30	4631	503	2063	0	1651	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i8	O97394	SDK_DROME	47.4	114	60	0	121	462	926	1039	4.40E-25	115.9	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN121_c0_g1_i1	O97394	SDK_DROME	20.6	330	238	9	1184	252	1513	1837	1.10E-07	60.1	SDK_DROME	reviewed	Protein sidekick	sdk CG5227	Drosophila melanogaster (Fruit fly)	2224	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]		GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]		NA	NA	NA	NA	NA	NA
TRINITY_DN2824_c0_g1_i9	Q8AV58	SDK1_CHICK	47	66	33	1	49	246	859	922	1.50E-07	57	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	identical protein binding [GO:0042802]	GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0042802; GO:0045202	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN5130_c0_g1_i1	Q24524	SING_DROME	62.3	491	178	4	1569	115	23	512	8.30E-185	648.3	SING_DROME	reviewed	Protein singed	sn CG1536	Drosophila melanogaster (Fruit fly)	512	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN18322_c0_g1_i1	Q24524	SING_DROME	48.5	66	34	0	203	6	78	143	2.10E-15	82.4	SING_DROME	reviewed	Protein singed	sn CG1536	Drosophila melanogaster (Fruit fly)	512	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN26059_c0_g1_i1	Q9VGY6	SKEL1_DROME	56.9	65	27	1	207	16	93	157	7.00E-17	87.4	SKEL1_DROME	reviewed	"Protein Skeletor, isoforms B/C"	Skeletor CG43161	Drosophila melanogaster (Fruit fly)	784	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]; dopamine beta-monooxygenase activity [GO:0004500]; catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819]	dopamine beta-monooxygenase activity [GO:0004500]	GO:0004500; GO:0005634; GO:0005700; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006584; GO:0006997; GO:0051225; GO:0051301; GO:0051321	catecholamine metabolic process [GO:0006584]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN9074_c0_g1_i1	Q9V3U9	SLMO_DROME	53.4	191	85	1	90	662	1	187	7.10E-58	225.3	SLMO_DROME	reviewed	Protein slowmo	slmo kisir CG9131	Drosophila melanogaster (Fruit fly)	215	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; germarium-derived oocyte differentiation [GO:0030706]; larval locomotory behavior [GO:0008345]; multicellular organism development [GO:0007275]; peristalsis [GO:0030432]; phospholipid transport [GO:0015914]; spermatogenesis [GO:0007283]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	phosphatidic acid transfer activity [GO:1990050]	GO:0005739; GO:0005758; GO:0007275; GO:0007283; GO:0008345; GO:0015914; GO:0030432; GO:0030706; GO:1990050	germarium-derived oocyte differentiation [GO:0030706]; larval locomotory behavior [GO:0008345]; multicellular organism development [GO:0007275]; peristalsis [GO:0030432]; phospholipid transport [GO:0015914]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN9074_c0_g1_i2	Q9V3U9	SLMO_DROME	55.6	153	68	0	90	548	1	153	2.20E-50	200.3	SLMO_DROME	reviewed	Protein slowmo	slmo kisir CG9131	Drosophila melanogaster (Fruit fly)	215	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; germarium-derived oocyte differentiation [GO:0030706]; larval locomotory behavior [GO:0008345]; multicellular organism development [GO:0007275]; peristalsis [GO:0030432]; phospholipid transport [GO:0015914]; spermatogenesis [GO:0007283]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	phosphatidic acid transfer activity [GO:1990050]	GO:0005739; GO:0005758; GO:0007275; GO:0007283; GO:0008345; GO:0015914; GO:0030432; GO:0030706; GO:1990050	germarium-derived oocyte differentiation [GO:0030706]; larval locomotory behavior [GO:0008345]; multicellular organism development [GO:0007275]; peristalsis [GO:0030432]; phospholipid transport [GO:0015914]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6742_c0_g1_i1	Q5PRF9	SMAG2_HUMAN	36.7	196	93	8	1	570	474	644	2.20E-17	90.5	SMAG2_HUMAN	reviewed	Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B)	SAMD4B SMAUG2	Homo sapiens (Human)	694	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of mRNA stability [GO:0043488]	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]	GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0017148; GO:0030371; GO:0043488	negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of mRNA stability [GO:0043488]		NA	NA	NA	NA	NA	NA
TRINITY_DN11237_c0_g1_i1	B0W730	SMG8_CULQU	50	242	113	4	736	20	645	881	1.20E-63	244.6	SMG8_CULQU	reviewed	Protein SMG8 (Protein smg-8 homolog)	CPIJ003128	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	912	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"			GO:0000184	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9445_c0_g1_i1	Q0VA04	SMG8_XENTR	61.1	36	14	0	3	110	237	272	4.00E-05	48.5	SMG8_XENTR	reviewed	Protein smg8 (Protein smg-8 homolog)	smg8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	915	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]"			GO:0000184; GO:0045859	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6696_c0_g1_i1	Q2YDD2	SMG9_BOVIN	37.1	286	175	2	936	79	161	441	9.70E-44	179.5	SMG9_BOVIN	reviewed	Protein SMG9	SMG9	Bos taurus (Bovine)	520	"brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"			GO:0000184; GO:0001654; GO:0007420; GO:0007507	"brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6696_c0_g1_i2	Q2YDD2	SMG9_BOVIN	36.3	364	206	3	1411	383	161	519	2.50E-55	218.4	SMG9_BOVIN	reviewed	Protein SMG9	SMG9	Bos taurus (Bovine)	520	"brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"			GO:0000184; GO:0001654; GO:0007420; GO:0007507	"brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29785_c0_g1_i1	Q9QX47	SON_MOUSE	39.8	118	64	2	519	184	2319	2435	5.40E-19	95.9	SON_MOUSE	reviewed	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	Son Nrebp	Mus musculus (Mouse)	2444	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN719_c0_g1_i1	Q9QX47	SON_MOUSE	44	159	75	5	529	80	2160	2313	5.30E-23	109.8	SON_MOUSE	reviewed	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	Son Nrebp	Mus musculus (Mouse)	2444	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN719_c0_g1_i2	Q9QX47	SON_MOUSE	53.7	123	55	1	534	172	2314	2436	6.80E-33	142.1	SON_MOUSE	reviewed	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	Son Nrebp	Mus musculus (Mouse)	2444	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN719_c0_g1_i3	Q9QX47	SON_MOUSE	48.2	282	130	6	984	172	2160	2436	2.10E-63	244.6	SON_MOUSE	reviewed	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	Son Nrebp	Mus musculus (Mouse)	2444	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN719_c0_g1_i4	Q9QX47	SON_MOUSE	50.7	146	63	4	594	172	2295	2436	3.20E-33	144.4	SON_MOUSE	reviewed	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	Son Nrebp	Mus musculus (Mouse)	2444	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN719_c0_g1_i4	Q9QX47	SON_MOUSE	44	159	75	5	1081	632	2160	2313	3.90E-23	110.9	SON_MOUSE	reviewed	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	Son Nrebp	Mus musculus (Mouse)	2444	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10_c0_g1_i2	P26675	SOS_DROME	48.9	280	133	3	1	840	184	453	8.50E-61	235.3	SOS_DROME	reviewed	Protein son of sevenless	Sos CG7793	Drosophila melanogaster (Fruit fly)	1596	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; rhabdomere microvillus membrane [GO:0035997]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon midline choice point recognition [GO:0016199]; defense response to virus [GO:0051607]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; photoreceptor cell fate determination [GO:0043703]; positive regulation of cell size [GO:0045793]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; small GTPase mediated signal transduction [GO:0007264]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; rhabdomere microvillus membrane [GO:0035997]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]	GO:0003677; GO:0005088; GO:0005829; GO:0007173; GO:0007264; GO:0007426; GO:0007427; GO:0007465; GO:0007480; GO:0008293; GO:0008543; GO:0016199; GO:0030676; GO:0031234; GO:0035022; GO:0035997; GO:0043703; GO:0045500; GO:0045793; GO:0046579; GO:0046982; GO:0048010; GO:0051607; GO:2000134	"axon midline choice point recognition [GO:0016199]; defense response to virus [GO:0051607]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; photoreceptor cell fate determination [GO:0043703]; positive regulation of cell size [GO:0045793]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; R7 cell fate commitment [GO:0007465]; sevenless signaling pathway [GO:0045500]; small GTPase mediated signal transduction [GO:0007264]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29954_c0_g1_i1	Q9VZX1	SPZ5_DROME	57.7	52	22	0	273	118	333	384	1.10E-14	80.9	SPZ5_DROME	reviewed	Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5)	spz5 DNT1 NT2 CG9972	Drosophila melanogaster (Fruit fly)	387	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0002225; GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN29954_c0_g1_i2	Q9VZX1	SPZ5_DROME	47.7	111	52	3	447	118	279	384	1.80E-23	110.5	SPZ5_DROME	reviewed	Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5)	spz5 DNT1 NT2 CG9972	Drosophila melanogaster (Fruit fly)	387	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0002225; GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN29954_c0_g1_i3	Q9VZX1	SPZ5_DROME	40.3	129	72	2	504	118	261	384	5.50E-23	109	SPZ5_DROME	reviewed	Protein spaetzle 5 (Neurotrophic factor 2) (Protein spatzle 5)	spz5 DNT1 NT2 CG9972	Drosophila melanogaster (Fruit fly)	387	extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]; axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; Toll binding [GO:0005121]	GO:0002225; GO:0005121; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0008045; GO:0008063; GO:0008083; GO:0008592; GO:0010941; GO:0021556; GO:0031637; GO:0045087; GO:0048018	axon guidance [GO:0007411]; central nervous system formation [GO:0021556]; innate immune response [GO:0045087]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; regulation of cell death [GO:0010941]; regulation of neuronal synaptic plasticity in response to neurotrophin [GO:0031637]; regulation of Toll signaling pathway [GO:0008592]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN19578_c0_g1_i2	P98068	SPAN_STRPU	50.7	67	33	0	6	206	172	238	7.60E-13	73.9	SPAN_STRPU	reviewed	Protein SpAN (EC 3.4.24.-)	SPAN	Strongylocentrotus purpuratus (Purple sea urchin)	616	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]		metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1263_c0_g1_i1	Q9VN45	SPART_DROME	37.6	165	103	0	710	216	360	524	7.00E-26	119.4	SPART_DROME	reviewed	Protein spartin	spartin CG12001	Drosophila melanogaster (Fruit fly)	553	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	Rab GTPase binding [GO:0017137]	GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301	cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]		NA	NA	NA	NA	NA	NA
TRINITY_DN1263_c0_g1_i2	Q9VN45	SPART_DROME	32.9	213	143	0	854	216	312	524	1.50E-28	128.3	SPART_DROME	reviewed	Protein spartin	spartin CG12001	Drosophila melanogaster (Fruit fly)	553	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	Rab GTPase binding [GO:0017137]	GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301	cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]		NA	NA	NA	NA	NA	NA
TRINITY_DN1263_c0_g1_i3	Q9VN45	SPART_DROME	32.9	213	143	0	848	210	312	524	1.50E-28	128.3	SPART_DROME	reviewed	Protein spartin	spartin CG12001	Drosophila melanogaster (Fruit fly)	553	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	Rab GTPase binding [GO:0017137]	GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301	cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]		NA	NA	NA	NA	NA	NA
TRINITY_DN1263_c0_g1_i4	Q9VN45	SPART_DROME	37.6	165	103	0	704	210	360	524	6.90E-26	119.4	SPART_DROME	reviewed	Protein spartin	spartin CG12001	Drosophila melanogaster (Fruit fly)	553	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; Rab GTPase binding [GO:0017137]; cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]	early endosome [GO:0005769]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	Rab GTPase binding [GO:0017137]	GO:0002092; GO:0005769; GO:0005811; GO:0005886; GO:0007399; GO:0017137; GO:0030514; GO:0042734; GO:0043195; GO:0045886; GO:0051301	cell division [GO:0051301]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; positive regulation of receptor internalization [GO:0002092]		NA	NA	NA	NA	NA	NA
TRINITY_DN26661_c0_g1_i1	Q6NRW2	SPDLB_XENLA	29.4	245	169	1	1	723	215	459	7.60E-21	102.4	SPDLB_XENLA	reviewed	Protein Spindly-B (Coiled-coil domain-containing protein 99-B) (Spindle apparatus coiled-coil domain-containing protein 1-B)	spdl1-b ccdc99-b	Xenopus laevis (African clawed frog)	610	condensed chromosome outer kinetochore [GO:0000940]; nucleus [GO:0005634]; spindle pole [GO:0000922]; kinetochore binding [GO:0043515]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]	condensed chromosome outer kinetochore [GO:0000940]; nucleus [GO:0005634]; spindle pole [GO:0000922]	kinetochore binding [GO:0043515]	GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0007080; GO:0007094; GO:0034501; GO:0043515; GO:0051301	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]		NA	NA	NA	NA	NA	NA
TRINITY_DN9969_c0_g1_i1	Q9GQQ0	SPIN_DROME	52.3	499	228	4	192	1682	96	586	1.40E-139	498	SPIN_DROME	reviewed	Protein spinster (Protein benchwarmer) (Protein diphthong)	spin bnch CG8428	Drosophila melanogaster (Fruit fly)	605	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; transmembrane transporter activity [GO:0022857]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0016021; GO:0022857; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0098793	cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN9969_c0_g1_i4	Q9GQQ0	SPIN_DROME	59.2	304	115	3	192	1100	96	391	2.50E-95	350.5	SPIN_DROME	reviewed	Protein spinster (Protein benchwarmer) (Protein diphthong)	spin bnch CG8428	Drosophila melanogaster (Fruit fly)	605	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; transmembrane transporter activity [GO:0022857]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0016021; GO:0022857; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0098793	cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN9969_c0_g1_i6	Q9GQQ0	SPIN_DROME	41.4	198	115	1	4	594	396	593	2.20E-36	154.1	SPIN_DROME	reviewed	Protein spinster (Protein benchwarmer) (Protein diphthong)	spin bnch CG8428	Drosophila melanogaster (Fruit fly)	605	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; transmembrane transporter activity [GO:0022857]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0016021; GO:0022857; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0098793	cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN26249_c0_g1_i1	Q9H2V7	SPNS1_HUMAN	100	152	0	0	3	458	68	219	3.70E-84	312	SPNS1_HUMAN	reviewed	Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1)	SPNS1 SPIN1 PP20300	Homo sapiens (Human)	528	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]	transmembrane transporter activity [GO:0022857]	GO:0005743; GO:0005765; GO:0006869; GO:0016021; GO:0022857	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN28941_c0_g1_i1	Q9U1K1	SPIR_DROME	61.3	75	29	0	41	265	703	777	2.20E-23	109.4	SPIR_DROME	reviewed	Protein spire	spir p150-Spir CG10076	Drosophila melanogaster (Fruit fly)	1020	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament-based process [GO:0030029]; actin nucleation [GO:0045010]; chorion-containing eggshell formation [GO:0007304]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; pole plasm RNA localization [GO:0007316]; protein transport [GO:0015031]; regulation of cytoskeleton organization [GO:0051493]; vesicle-mediated transport [GO:0016192]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; microtubule binding [GO:0008017]	GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007304; GO:0007315; GO:0007316; GO:0008017; GO:0015031; GO:0016192; GO:0030029; GO:0030036; GO:0030041; GO:0030659; GO:0030717; GO:0036089; GO:0040038; GO:0045010; GO:0045451; GO:0046907; GO:0048193; GO:0048471; GO:0048477; GO:0051295; GO:0051493; GO:0051639	actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; chorion-containing eggshell formation [GO:0007304]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; pole plasm assembly [GO:0007315]; pole plasm oskar mRNA localization [GO:0045451]; pole plasm RNA localization [GO:0007316]; protein transport [GO:0015031]; regulation of cytoskeleton organization [GO:0051493]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3473_c0_g1_i1	Q8SX83	SPEN_DROME	59.9	167	67	0	13	513	5393	5559	5.10E-49	195.7	SPEN_DROME	reviewed	Protein split ends	spen CG18497	Drosophila melanogaster (Fruit fly)	5560	"nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; mRNA splicing, via spliceosome [GO:0000398]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]"	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0000398; GO:0003676; GO:0003723; GO:0005634; GO:0006355; GO:0007173; GO:0007379; GO:0007400; GO:0007403; GO:0007411; GO:0007422; GO:0008586; GO:0035222; GO:0035321; GO:0048106; GO:0048749; GO:0050832; GO:0090263	"axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; mRNA splicing, via spliceosome [GO:0000398]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1052_c0_g1_i1	Q8SX83	SPEN_DROME	60.6	254	100	0	764	3	549	802	2.50E-92	340.1	SPEN_DROME	reviewed	Protein split ends	spen CG18497	Drosophila melanogaster (Fruit fly)	5560	"nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; mRNA splicing, via spliceosome [GO:0000398]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]"	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0000398; GO:0003676; GO:0003723; GO:0005634; GO:0006355; GO:0007173; GO:0007379; GO:0007400; GO:0007403; GO:0007411; GO:0007422; GO:0008586; GO:0035222; GO:0035321; GO:0048106; GO:0048749; GO:0050832; GO:0090263	"axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; mRNA splicing, via spliceosome [GO:0000398]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1052_c0_g1_i3	Q8SX83	SPEN_DROME	51.6	254	80	1	635	3	549	802	7.90E-71	268.5	SPEN_DROME	reviewed	Protein split ends	spen CG18497	Drosophila melanogaster (Fruit fly)	5560	"nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; mRNA splicing, via spliceosome [GO:0000398]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]"	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0000398; GO:0003676; GO:0003723; GO:0005634; GO:0006355; GO:0007173; GO:0007379; GO:0007400; GO:0007403; GO:0007411; GO:0007422; GO:0008586; GO:0035222; GO:0035321; GO:0048106; GO:0048749; GO:0050832; GO:0090263	"axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; mRNA splicing, via spliceosome [GO:0000398]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2163_c0_g2_i1	Q8MQW8	SPRI_DROME	31.8	459	286	11	1325	3	1168	1617	1.80E-44	182.2	SPRI_DROME	reviewed	Protein sprint (SH2 poly-proline-containing Ras-interactor protein)	spri CG33175 CG34414	Drosophila melanogaster (Fruit fly)	1789	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]	GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688	axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2163_c0_g2_i2	Q8MQW8	SPRI_DROME	46.9	143	76	0	583	155	1414	1556	5.10E-29	129.4	SPRI_DROME	reviewed	Protein sprint (SH2 poly-proline-containing Ras-interactor protein)	spri CG33175 CG34414	Drosophila melanogaster (Fruit fly)	1789	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]	GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688	axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2163_c0_g2_i4	Q8MQW8	SPRI_DROME	31.1	395	249	9	1288	155	1168	1556	3.30E-35	151.4	SPRI_DROME	reviewed	Protein sprint (SH2 poly-proline-containing Ras-interactor protein)	spri CG33175 CG34414	Drosophila melanogaster (Fruit fly)	1789	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]	GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688	axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2163_c0_g2_i5	Q8MQW8	SPRI_DROME	43.5	207	113	2	620	3	1414	1617	2.90E-38	160.2	SPRI_DROME	reviewed	Protein sprint (SH2 poly-proline-containing Ras-interactor protein)	spri CG33175 CG34414	Drosophila melanogaster (Fruit fly)	1789	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]	GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688	axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2261_c0_g1_i1	O43610	SPY3_HUMAN	42.2	154	77	2	537	103	112	262	3.70E-32	140.2	SPY3_HUMAN	reviewed	Protein sprouty homolog 3 (Spry-3)	SPRY3	Homo sapiens (Human)	288	cytosol [GO:0005829]; membrane [GO:0016020]; animal organ development [GO:0048513]; axon development [GO:0061564]; multicellular organism development [GO:0007275]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]	cytosol [GO:0005829]; membrane [GO:0016020]		GO:0005829; GO:0007275; GO:0016020; GO:0040037; GO:0043407; GO:0046580; GO:0048513; GO:0061564	animal organ development [GO:0048513]; axon development [GO:0061564]; multicellular organism development [GO:0007275]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]		NA	NA	NA	NA	NA	NA
TRINITY_DN26518_c0_g1_i1	Q8IMP6	SPT2_DROME	56.9	65	28	0	203	9	500	564	7.20E-12	70.9	SPT2_DROME	reviewed	Protein SPT2 homolog	CG5815	Drosophila melanogaster (Fruit fly)	581	"nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]"	nucleolus [GO:0005730]	DNA binding [GO:0003677]; histone binding [GO:0042393]	GO:0003677; GO:0005730; GO:0006334; GO:0006355; GO:0010847; GO:0042393; GO:0043486	"histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30595_c0_g1_i1	Q62280	SSXT_MOUSE	51.1	90	42	2	61	327	1	89	5.90E-15	81.6	SSXT_MOUSE	reviewed	Protein SSXT (Protein SYT) (Synovial sarcoma-associated Ss18-alpha)	Ss18 Ssxt Syt	Mus musculus (Mouse)	418	"npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; nuclear receptor transcription coactivator activity [GO:0030374]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to drug [GO:0042493]"	npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	nuclear receptor transcription coactivator activity [GO:0030374]	GO:0000226; GO:0000902; GO:0005634; GO:0007010; GO:0016514; GO:0030374; GO:0035556; GO:0042493; GO:0045893; GO:0045944; GO:0048013; GO:0071564; GO:0097150	"cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to drug [GO:0042493]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2675_c0_g1_i2	Q2M146	ST7_DROPS	76.2	538	95	1	1601	87	4	541	7.30E-230	798.1	ST7_DROPS	reviewed	Protein ST7 homolog	GA17575	Drosophila pseudoobscura pseudoobscura (Fruit fly)	541	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN38370_c0_g1_i1	Q9ZT71	STA1_ARATH	56.2	80	35	0	2	241	695	774	1.60E-15	83.2	STA1_ARATH	reviewed	Protein STABILIZED1 (Pre-mRNA processing factor 6-like protein) (Protein EMBRYO DEFECTIVE 2770)	STA1 EMB2770 At4g03430 F9H3.5	Arabidopsis thaliana (Mouse-ear cress)	1029	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; gene silencing by RNA-directed DNA methylation [GO:0080188]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of primary miRNA processing [GO:2000636]; response to cold [GO:0009409]; seed germination [GO:0009845]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0009409; GO:0009845; GO:0015030; GO:0046540; GO:0071013; GO:0080188; GO:2000630; GO:2000636	"gene silencing by RNA-directed DNA methylation [GO:0080188]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of primary miRNA processing [GO:2000636]; response to cold [GO:0009409]; seed germination [GO:0009845]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3595_c0_g1_i1	Q9ZT71	STA1_ARATH	50.4	125	62	0	1	375	850	974	2.40E-31	136.3	STA1_ARATH	reviewed	Protein STABILIZED1 (Pre-mRNA processing factor 6-like protein) (Protein EMBRYO DEFECTIVE 2770)	STA1 EMB2770 At4g03430 F9H3.5	Arabidopsis thaliana (Mouse-ear cress)	1029	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; gene silencing by RNA-directed DNA methylation [GO:0080188]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of primary miRNA processing [GO:2000636]; response to cold [GO:0009409]; seed germination [GO:0009845]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0009409; GO:0009845; GO:0015030; GO:0046540; GO:0071013; GO:0080188; GO:2000630; GO:2000636	"gene silencing by RNA-directed DNA methylation [GO:0080188]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of primary miRNA processing [GO:2000636]; response to cold [GO:0009409]; seed germination [GO:0009845]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i2	P42519	STAR_DROME	33.9	127	77	3	613	245	423	546	3.70E-15	84.3	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i2	P42519	STAR_DROME	37.1	97	54	3	1358	1080	443	536	6.80E-09	63.5	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i3	P42519	STAR_DROME	33.9	127	77	3	608	240	423	546	2.50E-15	84.3	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i4	P42519	STAR_DROME	33.9	127	77	3	613	245	423	546	3.70E-15	84.3	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i4	P42519	STAR_DROME	37.1	97	54	3	1358	1080	443	536	6.80E-09	63.5	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i5	P42519	STAR_DROME	33.9	127	77	3	613	245	423	546	2.70E-15	84.3	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		brown	brown	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i7	P42519	STAR_DROME	33.9	127	77	3	580	212	423	546	3.60E-15	84.3	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i7	P42519	STAR_DROME	37.1	97	54	3	1325	1047	443	536	6.60E-09	63.5	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i9	P42519	STAR_DROME	33.9	127	77	3	580	212	423	546	3.60E-15	84.3	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c0_g2_i9	P42519	STAR_DROME	37.1	97	54	3	1325	1047	443	536	6.60E-09	63.5	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0042749; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; regulation of circadian sleep/wake cycle [GO:0042749]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN38243_c0_g1_i1	Q24212	STNB_DROME	81.6	76	14	0	228	1	790	865	5.60E-32	137.9	STNB_DROME	reviewed	Protein stoned-B (Stn-B) (StonedB)	stnB CG12473	Drosophila melanogaster (Fruit fly)	1262	clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; regulation of endocytosis [GO:0030100]; regulation of synaptic vesicle endocytosis [GO:1900242]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]	clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]	clathrin adaptor activity [GO:0035615]; scaffold protein binding [GO:0097110]	GO:0007268; GO:0008021; GO:0016192; GO:0030100; GO:0030136; GO:0030139; GO:0031410; GO:0035615; GO:0043231; GO:0048488; GO:0048489; GO:0048786; GO:0097110; GO:0099504; GO:1900242	chemical synaptic transmission [GO:0007268]; regulation of endocytosis [GO:0030100]; regulation of synaptic vesicle endocytosis [GO:1900242]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN6752_c0_g1_i1	A8JUV0	SBNO_DROME	48.8	164	73	3	81	551	351	510	5.20E-28	125.9	SBNO_DROME	reviewed	Protein strawberry notch	sno CG44436	Drosophila melanogaster (Fruit fly)	1653	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0007219; GO:0008587; GO:0031490; GO:0042393; GO:0042461; GO:0045747; GO:0045944; GO:0048190	"imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6752_c0_g1_i3	A8JUV0	SBNO_DROME	65.7	543	175	3	81	1688	351	889	1.80E-203	710.3	SBNO_DROME	reviewed	Protein strawberry notch	sno CG44436	Drosophila melanogaster (Fruit fly)	1653	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0007219; GO:0008587; GO:0031490; GO:0042393; GO:0042461; GO:0045747; GO:0045944; GO:0048190	"imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40194_c0_g1_i1	A8JUV0	SBNO_DROME	54.1	85	39	0	257	3	638	722	4.60E-18	91.7	SBNO_DROME	reviewed	Protein strawberry notch	sno CG44436	Drosophila melanogaster (Fruit fly)	1653	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0007219; GO:0008587; GO:0031490; GO:0042393; GO:0042461; GO:0045747; GO:0045944; GO:0048190	"imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29674_c0_g1_i1	A8JUV0	SBNO_DROME	63.4	552	181	3	82	1680	1101	1650	5.20E-198	692.2	SBNO_DROME	reviewed	Protein strawberry notch	sno CG44436	Drosophila melanogaster (Fruit fly)	1653	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0007219; GO:0008587; GO:0031490; GO:0042393; GO:0042461; GO:0045747; GO:0045944; GO:0048190	"imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29674_c0_g1_i2	A8JUV0	SBNO_DROME	64.8	528	165	3	82	1608	1101	1626	1.70E-195	683.7	SBNO_DROME	reviewed	Protein strawberry notch	sno CG44436	Drosophila melanogaster (Fruit fly)	1653	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0007219; GO:0008587; GO:0031490; GO:0042393; GO:0042461; GO:0045747; GO:0045944; GO:0048190	"imaginal disc-derived wing margin morphogenesis [GO:0008587]; Notch signaling pathway [GO:0007219]; photoreceptor cell development [GO:0042461]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; wing disc dorsal/ventral pattern formation [GO:0048190]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30042_c0_g1_i1	Q5F371	SBNO1_CHICK	100	88	0	0	267	4	871	958	1.30E-41	169.9	SBNO1_CHICK	reviewed	Protein strawberry notch homolog 1	SBNO1 RCJMB04_30k7	Gallus gallus (Chicken)	1239	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0031490; GO:0042393	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17873_c0_g1_i1	A3KN83	SBNO1_HUMAN	100	362	0	0	1086	1	335	696	1.50E-208	726.5	SBNO1_HUMAN	reviewed	Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3)	SBNO1 MOP3	Homo sapiens (Human)	1393	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0031490; GO:0042393	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17873_c0_g1_i2	A3KN83	SBNO1_HUMAN	100	362	0	0	1086	1	335	696	1.50E-208	726.5	SBNO1_HUMAN	reviewed	Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3)	SBNO1 MOP3	Homo sapiens (Human)	1393	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0031490; GO:0042393	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37292_c0_g1_i1	Q9Y2G9	SBNO2_HUMAN	100	91	0	0	2	274	339	429	1.40E-46	186.4	SBNO2_HUMAN	reviewed	Protein strawberry notch homolog 2	SBNO2 KIAA0963	Homo sapiens (Human)	1366	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0002281; GO:0005634; GO:0006355; GO:0030282; GO:0030316; GO:0031490; GO:0042393; GO:0045892; GO:0045944; GO:0050727; GO:0061430; GO:0071222; GO:0071348; GO:0071354; GO:0072675; GO:1990830	"bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6688_c0_g1_i1	P25991	SUF_DROME	44.4	205	90	3	648	97	559	760	7.40E-38	158.7	SUF_DROME	reviewed	Protein suppressor of forked	su(f) CG17170	Drosophila melanogaster (Fruit fly)	765	mRNA cleavage stimulating factor complex [GO:0005848]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; RNA 3'-end processing [GO:0031123]	mRNA cleavage stimulating factor complex [GO:0005848]; nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005848; GO:0006397; GO:0031123; GO:1903220	mRNA processing [GO:0006397]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; RNA 3'-end processing [GO:0031123]		NA	NA	NA	NA	NA	NA
TRINITY_DN6688_c0_g1_i2	P25991	SUF_DROME	40.9	115	55	1	402	97	646	760	6.30E-15	82	SUF_DROME	reviewed	Protein suppressor of forked	su(f) CG17170	Drosophila melanogaster (Fruit fly)	765	mRNA cleavage stimulating factor complex [GO:0005848]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; RNA 3'-end processing [GO:0031123]	mRNA cleavage stimulating factor complex [GO:0005848]; nucleus [GO:0005634]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005848; GO:0006397; GO:0031123; GO:1903220	mRNA processing [GO:0006397]; positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO:1903220]; RNA 3'-end processing [GO:0031123]		NA	NA	NA	NA	NA	NA
TRINITY_DN3656_c0_g3_i1	P08970	SUHW_DROME	45.8	48	26	0	17	160	413	460	4.40E-06	51.6	SUHW_DROME	reviewed	Protein suppressor of hairy wing	su(Hw) CG8573	Drosophila melanogaster (Fruit fly)	941	"chromatin [GO:0000785]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization to euchromatin [GO:1905632]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]"	chromatin [GO:0000785]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000785; GO:0000790; GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005700; GO:0006325; GO:0006357; GO:0031936; GO:0035075; GO:0043035; GO:0043565; GO:0045892; GO:0046872; GO:1905632; GO:1990188	"chromatin organization [GO:0006325]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization to euchromatin [GO:1905632]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7174_c0_g1_i1	P22293	SUS_DROME	54.9	102	42	3	1373	1675	325	423	9.60E-27	123.2	SUS_DROME	reviewed	Protein suppressor of sable	su(sable) su(s) CG6222	Drosophila melanogaster (Fruit fly)	1325	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear RNA surveillance [GO:0071027]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005700; GO:0045892; GO:0046872; GO:0071027	"negative regulation of transcription, DNA-templated [GO:0045892]; nuclear RNA surveillance [GO:0071027]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8532_c0_g1_i1	P12297	SUWA_DROME	33.4	308	172	4	958	134	220	527	9.70E-24	112.5	SUWA_DROME	reviewed	Protein suppressor of white apricot	su(w[a]) su(wa) CG3019	Drosophila melanogaster (Fruit fly)	963	nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA 5'-splice site recognition [GO:0000395]	nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0000395; GO:0003723; GO:0016607	mRNA 5'-splice site recognition [GO:0000395]		NA	NA	NA	NA	NA	NA
TRINITY_DN8532_c0_g1_i2	P12297	SUWA_DROME	30.1	409	207	8	1171	89	220	597	5.20E-24	113.6	SUWA_DROME	reviewed	Protein suppressor of white apricot	su(w[a]) su(wa) CG3019	Drosophila melanogaster (Fruit fly)	963	nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA 5'-splice site recognition [GO:0000395]	nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0000395; GO:0003723; GO:0016607	mRNA 5'-splice site recognition [GO:0000395]		blue	blue	NA	NA	NA	NA
TRINITY_DN33626_c0_g1_i1	Q2TXA2	SYM1_ASPOR	32.7	159	101	4	654	187	11	166	4.50E-18	93.2	SYM1_ASPOR	reviewed	Protein sym1	sym1 AO090010000224	Aspergillus oryzae (strain ATCC 42149 / RIB 40) (Yellow koji mold)	173	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN593_c9_g1_i1	A7S6Y0	SYS1_NEMVE	48	152	78	1	568	113	1	151	1.50E-38	161	SYS1_NEMVE	reviewed	Protein SYS1 homolog	sys1 v1g229542	Nematostella vectensis (Starlet sea anemone)	157	cytosol [GO:0005829]; integral component of Golgi membrane [GO:0030173]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; Golgi to plasma membrane protein transport [GO:0043001]; protein localization to Golgi apparatus [GO:0034067]	cytosol [GO:0005829]; integral component of Golgi membrane [GO:0030173]; trans-Golgi network [GO:0005802]		GO:0005802; GO:0005829; GO:0006895; GO:0030173; GO:0034067; GO:0043001	Golgi to endosome transport [GO:0006895]; Golgi to plasma membrane protein transport [GO:0043001]; protein localization to Golgi apparatus [GO:0034067]		blue	blue	NA	NA	NA	NA
TRINITY_DN37884_c0_g1_i1	Q9HCD6	TANC2_HUMAN	37	92	57	1	366	91	1099	1189	3.70E-06	52.8	TANC2_HUMAN	reviewed	"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)"	TANC2 KIAA1148 KIAA1636	Homo sapiens (Human)	1990	axon [GO:0030424]; dendritic spine [GO:0043197]; dense core granule cytoskeletal transport [GO:0099519]; in utero embryonic development [GO:0001701]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]	axon [GO:0030424]; dendritic spine [GO:0043197]		GO:0001701; GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0099519	dense core granule cytoskeletal transport [GO:0099519]; in utero embryonic development [GO:0001701]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]		NA	NA	NA	NA	NA	NA
TRINITY_DN25505_c0_g1_i1	Q9VED0	TAPT1_DROME	58.4	279	105	2	109	915	46	323	2.60E-89	330.1	TAPT1_DROME	reviewed	Protein TAPT1 homolog	CG7218	Drosophila melanogaster (Fruit fly)	676	ciliary basal body [GO:0036064]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; positive regulation of cilium assembly [GO:0045724]	ciliary basal body [GO:0036064]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0030176; GO:0035437; GO:0036064; GO:0045724	maintenance of protein localization in endoplasmic reticulum [GO:0035437]; positive regulation of cilium assembly [GO:0045724]		NA	NA	NA	NA	NA	NA
TRINITY_DN2005_c0_g1_i1	Q6UWH6	TX261_HUMAN	50	176	81	2	542	21	24	194	1.90E-39	163.7	TX261_HUMAN	reviewed	Protein TEX261	TEX261 UNQ1882/PRO4325	Homo sapiens (Human)	196	COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; COPII adaptor activity [GO:0097020]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	COPII adaptor activity [GO:0097020]	GO:0006888; GO:0030134; GO:0030173; GO:0030176; GO:0097020	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN2005_c0_g1_i2	Q6UWH6	TX261_HUMAN	49.7	149	64	3	461	21	55	194	1.30E-30	134.4	TX261_HUMAN	reviewed	Protein TEX261	TEX261 UNQ1882/PRO4325	Homo sapiens (Human)	196	COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; COPII adaptor activity [GO:0097020]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	COPII adaptor activity [GO:0097020]	GO:0006888; GO:0030134; GO:0030173; GO:0030176; GO:0097020	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN2613_c0_g1_i1	Q92734	TFG_HUMAN	53.7	177	75	2	117	647	5	174	9.80E-41	168.3	TFG_HUMAN	reviewed	Protein TFG (TRK-fused gene protein)	TFG	Homo sapiens (Human)	400	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]	identical protein binding [GO:0042802]	GO:0000139; GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN2613_c0_g1_i2	Q92734	TFG_HUMAN	55.2	174	73	3	117	635	5	174	1.60E-40	167.5	TFG_HUMAN	reviewed	Protein TFG (TRK-fused gene protein)	TFG	Homo sapiens (Human)	400	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]	identical protein binding [GO:0042802]	GO:0000139; GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		blue	blue	NA	NA	NA	NA
TRINITY_DN21857_c0_g2_i1	Q92734	TFG_HUMAN	100	84	0	0	252	1	1	84	1.30E-40	166.8	TFG_HUMAN	reviewed	Protein TFG (TRK-fused gene protein)	TFG	Homo sapiens (Human)	400	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]	identical protein binding [GO:0042802]	GO:0000139; GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN21857_c0_g1_i1	Q92734	TFG_HUMAN	100	84	0	0	252	1	1	84	9.30E-41	167.2	TFG_HUMAN	reviewed	Protein TFG (TRK-fused gene protein)	TFG	Homo sapiens (Human)	400	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]	identical protein binding [GO:0042802]	GO:0000139; GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN24126_c0_g1_i1	P49021	TIM_DROME	40	175	99	2	56	565	780	953	1.10E-26	121.7	TIM_DROME	reviewed	Protein timeless	tim CG3234	Drosophila melanogaster (Fruit fly)	1398	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; cellular response to light stimulus [GO:0071482]; circadian behavior [GO:0048512]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; copulation [GO:0007620]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; negative phototaxis [GO:0046957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; photoperiodism [GO:0009648]; positive regulation of phagocytosis [GO:0050766]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of phagocytosis [GO:0050764]; regulation of protein import into nucleus [GO:0042306]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; rhythmic behavior [GO:0007622]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replication fork protection complex [GO:0031298]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]	GO:0000076; GO:0000122; GO:0000228; GO:0000790; GO:0003053; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0007617; GO:0007620; GO:0007622; GO:0007623; GO:0008062; GO:0008134; GO:0009648; GO:0009649; GO:0031298; GO:0042306; GO:0042749; GO:0043111; GO:0045187; GO:0045475; GO:0046957; GO:0046982; GO:0048471; GO:0048478; GO:0048512; GO:0050764; GO:0050766; GO:0060086; GO:0071482; GO:2000678	"cellular response to light stimulus [GO:0071482]; circadian behavior [GO:0048512]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; copulation [GO:0007620]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; negative phototaxis [GO:0046957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; photoperiodism [GO:0009648]; positive regulation of phagocytosis [GO:0050766]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of phagocytosis [GO:0050764]; regulation of protein import into nucleus [GO:0042306]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; rhythmic behavior [GO:0007622]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20745_c0_g1_i1	P49021	TIM_DROME	43.7	231	129	1	715	26	552	782	1.10E-45	184.9	TIM_DROME	reviewed	Protein timeless	tim CG3234	Drosophila melanogaster (Fruit fly)	1398	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; cellular response to light stimulus [GO:0071482]; circadian behavior [GO:0048512]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; copulation [GO:0007620]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; negative phototaxis [GO:0046957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; photoperiodism [GO:0009648]; positive regulation of phagocytosis [GO:0050766]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of phagocytosis [GO:0050764]; regulation of protein import into nucleus [GO:0042306]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; rhythmic behavior [GO:0007622]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replication fork protection complex [GO:0031298]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]	GO:0000076; GO:0000122; GO:0000228; GO:0000790; GO:0003053; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0007617; GO:0007620; GO:0007622; GO:0007623; GO:0008062; GO:0008134; GO:0009648; GO:0009649; GO:0031298; GO:0042306; GO:0042749; GO:0043111; GO:0045187; GO:0045475; GO:0046957; GO:0046982; GO:0048471; GO:0048478; GO:0048512; GO:0050764; GO:0050766; GO:0060086; GO:0071482; GO:2000678	"cellular response to light stimulus [GO:0071482]; circadian behavior [GO:0048512]; circadian regulation of heart rate [GO:0003053]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; copulation [GO:0007620]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; eclosion rhythm [GO:0008062]; entrainment of circadian clock [GO:0009649]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; negative phototaxis [GO:0046957]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; photoperiodism [GO:0009648]; positive regulation of phagocytosis [GO:0050766]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of phagocytosis [GO:0050764]; regulation of protein import into nucleus [GO:0042306]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; rhythmic behavior [GO:0007622]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27547_c0_g1_i1	Q9U3V5	TIPT_DROME	58.2	79	29	3	277	47	539	615	1.40E-12	73.6	TIPT_DROME	reviewed	Protein tiptop	tio CG12630	Drosophila melanogaster (Fruit fly)	1024	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007380; GO:0046872; GO:0048730; GO:0048749; GO:0061330	"compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39947_c0_g1_i1	Q9U3V5	TIPT_DROME	50	86	31	1	106	327	252	337	1.20E-15	84	TIPT_DROME	reviewed	Protein tiptop	tio CG12630	Drosophila melanogaster (Fruit fly)	1024	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007380; GO:0046872; GO:0048730; GO:0048749; GO:0061330	"compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26216_c0_g1_i1	Q54HT1	TIRA_DICDI	49	51	21	1	155	3	450	495	5.20E-06	51.2	TIRA_DICDI	reviewed	Protein tirA (EC 3.2.2.6) (TIR domain-containing protein A)	tirA DDB_G0289237	Dictyostelium discoideum (Slime mold)	1336	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; asexual reproduction [GO:0019954]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]"		"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0006952; GO:0007165; GO:0019954; GO:0032496; GO:0042742; GO:0050135; GO:0061809	asexual reproduction [GO:0019954]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30191_c0_g1_i1	Q61471	TOB1_MOUSE	60.1	158	61	1	1220	747	1	156	2.80E-52	207.6	TOB1_MOUSE	reviewed	Protein Tob1 (Transducer of erbB-2 1)	Tob1 Tob Trob	Mus musculus (Mouse)	362	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0005737; GO:0008285; GO:0010468; GO:0017148; GO:0030014; GO:0030514; GO:0030971; GO:0045668; GO:0046332; GO:0060212; GO:0060213; GO:0060390; GO:1900153	"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]"		blue	blue	NA	NA	NA	NA
TRINITY_DN27456_c0_g1_i1	P50616	TOB1_HUMAN	100	121	0	0	46	408	1	121	8.20E-67	254.2	TOB1_HUMAN	reviewed	Protein Tob1 (Transducer of erbB-2 1)	TOB1 TOB TROB1	Homo sapiens (Human)	345	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0005737; GO:0008285; GO:0010468; GO:0017148; GO:0030014; GO:0030514; GO:0030971; GO:0045668; GO:0046332; GO:0060212; GO:0060213; GO:0060390; GO:1900153	"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27602_c0_g1_i1	Q14106	TOB2_HUMAN	98.1	104	2	0	2	313	44	147	3.20E-55	215.3	TOB2_HUMAN	reviewed	Protein Tob2 (Protein Tob4) (Transducer of erbB-2 2)	TOB2 KIAA1663 TOB4 TROB2	Homo sapiens (Human)	344	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; female gamete generation [GO:0007292]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0007292; GO:0008285; GO:0010468; GO:0042809; GO:0045671; GO:0045778	female gamete generation [GO:0007292]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN21083_c0_g1_i1	Q9JM55	TOB2_MOUSE	100	93	0	0	280	2	1	93	3.00E-48	192.2	TOB2_MOUSE	reviewed	Protein Tob2 (Transducer of erbB-2 2)	Tob2	Mus musculus (Mouse)	345	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0010468; GO:0042809; GO:0045671; GO:0045778	negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN104_c0_g2_i1	P08953	TOLL_DROME	29.5	991	629	21	2874	16	66	1024	8.30E-111	403.3	TOLL_DROME	reviewed	Protein toll (EC 3.2.2.6)	Tl CG5490	Drosophila melanogaster (Fruit fly)	1097	"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; virion binding [GO:0046790]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]"	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; virion binding [GO:0046790]"	GO:0002224; GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009597; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0035212; GO:0038023; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046790; GO:0050135; GO:0050830; GO:0061760; GO:0061809; GO:0070976; GO:1902875	antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]		NA	NA	NA	NA	NA	NA
TRINITY_DN104_c0_g1_i1	P08953	TOLL_DROME	32.5	799	493	15	2384	105	236	1027	1.70E-102	375.6	TOLL_DROME	reviewed	Protein toll (EC 3.2.2.6)	Tl CG5490	Drosophila melanogaster (Fruit fly)	1097	"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; virion binding [GO:0046790]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]"	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; virion binding [GO:0046790]"	GO:0002224; GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009597; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0035212; GO:0038023; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046790; GO:0050135; GO:0050830; GO:0061760; GO:0061809; GO:0070976; GO:1902875	antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063]		blue	blue	NA	NA	NA	NA
TRINITY_DN26292_c0_g1_i1	Q24119	TRH_DROME	73.4	64	17	0	1	192	358	421	4.10E-23	108.2	TRH_DROME	reviewed	Protein trachealess	trh CG6883	Drosophila melanogaster (Fruit fly)	1022	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; appendage development [GO:0048736]; epithelial cell fate determination, open tracheal system [GO:0007425]; epithelial tube formation [GO:0072175]; Malpighian tubule morphogenesis [GO:0007443]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007424; GO:0007425; GO:0007431; GO:0007435; GO:0007443; GO:0035202; GO:0035277; GO:0043565; GO:0045944; GO:0046982; GO:0048736; GO:0072175	"appendage development [GO:0048736]; epithelial cell fate determination, open tracheal system [GO:0007425]; epithelial tube formation [GO:0072175]; Malpighian tubule morphogenesis [GO:0007443]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28268_c0_g1_i1	P42282	TTKA_DROME	47.4	95	50	0	44	328	22	116	9.00E-20	97.8	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28268_c0_g1_i2	P42282	TTKA_DROME	48.6	107	55	0	17	337	10	116	7.30E-25	114.8	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27119_c0_g1_i2	P42282	TTKA_DROME	57.3	124	53	0	413	42	3	126	1.90E-38	161	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27119_c0_g1_i3	P42282	TTKA_DROME	59.3	59	21	1	172	5	3	61	1.50E-13	77.8	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1035_c0_g1_i1	P42282	TTKA_DROME	61.5	117	43	2	593	243	4	118	5.90E-34	146	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1035_c0_g1_i2	P42282	TTKA_DROME	61.5	117	43	2	593	243	4	118	9.30E-34	145.2	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1035_c0_g1_i3	P42282	TTKA_DROME	61.5	117	43	2	593	243	4	118	6.50E-34	146	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1035_c0_g1_i4	P42282	TTKA_DROME	61.5	117	43	2	593	243	4	118	5.50E-34	146	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1035_c0_g1_i5	P42282	TTKA_DROME	61.5	117	43	2	593	243	4	118	7.20E-34	145.6	TTKA_DROME	reviewed	"Protein tramtrack, alpha isoform (Repressor protein fushi tarazu) (Tramtrack p88)"	ttk FTZ-F2 CG1856	Drosophila melanogaster (Fruit fly)	813	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; POZ domain binding [GO:0031208]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007173; GO:0007422; GO:0007426; GO:0008360; GO:0016476; GO:0017053; GO:0030707; GO:0031208; GO:0035001; GO:0035147; GO:0035151; GO:0035883; GO:0040003; GO:0042675; GO:0042682; GO:0042803; GO:0043388; GO:0045500; GO:0045677; GO:0045892; GO:0045944; GO:0046533; GO:0046843; GO:0046872; GO:0048053; GO:0048626; GO:0048750; GO:0060446; GO:1903688	"branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; chitin-based cuticle development [GO:0040003]; compound eye cone cell differentiation [GO:0042675]; compound eye corneal lens morphogenesis [GO:0048750]; dorsal appendage formation [GO:0046843]; dorsal trunk growth, open tracheal system [GO:0035001]; enteroendocrine cell differentiation [GO:0035883]; epidermal growth factor receptor signaling pathway [GO:0007173]; myoblast fate specification [GO:0048626]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 development [GO:0048053]; regulation of cell shape [GO:0008360]; regulation of compound eye cone cell fate specification [GO:0042682]; regulation of embryonic cell shape [GO:0016476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tube size, open tracheal system [GO:0035151]; sevenless signaling pathway [GO:0045500]; tracheal outgrowth, open tracheal system [GO:0007426]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34116_c0_g1_i1	Q9SRI1	SC13A_ARATH	52.3	153	72	1	457	2	7	159	2.70E-43	176.4	SC13A_ARATH	reviewed	Protein transport protein SEC13 homolog A (SEC13-like protein A)	SEC13A At3g01340 T22N4.3	Arabidopsis thaliana (Mouse-ear cress)	302	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; nuclear pore outer ring [GO:0031080]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; protein transport [GO:0015031]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; nuclear pore outer ring [GO:0031080]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005783; GO:0005829; GO:0015031; GO:0030127; GO:0031080; GO:0090114	COPII-coated vesicle budding [GO:0090114]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1731_c0_g1_i1	O15027	SC16A_HUMAN	39	428	244	5	1252	2	1426	1847	5.40E-80	300.1	SC16A_HUMAN	reviewed	Protein transport protein Sec16A (SEC16 homolog A) (p250)	SEC16A KIAA0310 SEC16 SEC16L	Homo sapiens (Human)	2357	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]		GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659	autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN1731_c0_g1_i2	O15027	SC16A_HUMAN	37.5	467	264	7	1372	2	1399	1847	1.60E-80	302	SC16A_HUMAN	reviewed	Protein transport protein Sec16A (SEC16 homolog A) (p250)	SEC16A KIAA0310 SEC16 SEC16L	Homo sapiens (Human)	2357	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]		GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659	autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN1731_c0_g1_i3	O15027	SC16A_HUMAN	37.5	467	264	7	1372	2	1399	1847	1.50E-80	302	SC16A_HUMAN	reviewed	Protein transport protein Sec16A (SEC16 homolog A) (p250)	SEC16A KIAA0310 SEC16 SEC16L	Homo sapiens (Human)	2357	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]		GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659	autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN28535_c0_g1_i1	O15027	SC16A_HUMAN	100	87	0	0	2	262	1677	1763	6.60E-46	184.1	SC16A_HUMAN	reviewed	Protein transport protein Sec16A (SEC16 homolog A) (p250)	SEC16A KIAA0310 SEC16 SEC16L	Homo sapiens (Human)	2357	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]		GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659	autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762]		NA	NA	NA	NA	NA	NA
TRINITY_DN15476_c0_g2_i1	Q2HB00	SEC23_CHAGB	59.8	132	52	1	3	398	639	769	9.30E-39	161	SEC23_CHAGB	reviewed	Protein transport protein SEC23	SEC23 CHGG_02604	Chaetomium globosum (strain ATCC 6205 / CBS 148.51 / DSM 1962 / NBRC 6347 / NRRL 1970) (Soil fungus)	773	COPII vesicle coat [GO:0030127]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; COPII-coated vesicle budding [GO:0090114]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	zinc ion binding [GO:0008270]	GO:0000139; GO:0005789; GO:0006886; GO:0008270; GO:0030127; GO:0090114	COPII-coated vesicle budding [GO:0090114]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN15476_c0_g1_i1	Q4PE39	SEC23_USTMA	72.6	95	26	0	291	7	518	612	3.50E-33	142.1	SEC23_USTMA	reviewed	Protein transport protein SEC23	SEC23 UMAG_01624	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	773	COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0006886; GO:0008270; GO:0030127; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN7915_c0_g1_i1	Q8SQX2	SEC23_ENCCU	45.1	71	39	0	2	214	573	643	1.50E-14	79.7	SEC23_ENCCU	reviewed	Protein transport protein SEC23	SEC23 ECU11_0790	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	707	COPII vesicle coat [GO:0030127]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; COPII-coated vesicle budding [GO:0090114]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	zinc ion binding [GO:0008270]	GO:0000139; GO:0005789; GO:0006886; GO:0008270; GO:0030127; GO:0090114	COPII-coated vesicle budding [GO:0090114]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN16674_c0_g1_i2	Q15436	SC23A_HUMAN	99.2	239	2	0	2	718	469	707	1.50E-135	483.4	SC23A_HUMAN	reviewed	Protein transport protein Sec23A (hSec23A) (SEC23-related protein A)	SEC23A	Homo sapiens (Human)	765	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0002474; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0019898; GO:0030127; GO:0048208; GO:0048471; GO:0070971; GO:0072659; GO:0090110	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1421_c0_g1_i3	Q5ZK03	SC23A_CHICK	65.6	424	142	4	2318	1056	345	767	1.10E-163	578.6	SC23A_CHICK	reviewed	Protein transport protein Sec23A (SEC23-related protein A)	SEC23A RCJMB04_14a13	Gallus gallus (Chicken)	767	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN1421_c0_g1_i5	Q5ZK03	SC23A_CHICK	65.6	424	142	4	1530	268	345	767	7.10E-164	578.6	SC23A_CHICK	reviewed	Protein transport protein Sec23A (SEC23-related protein A)	SEC23A RCJMB04_14a13	Gallus gallus (Chicken)	767	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN1421_c0_g1_i6	Q5ZK03	SC23A_CHICK	65.6	424	142	4	1351	89	345	767	8.20E-164	578.2	SC23A_CHICK	reviewed	Protein transport protein Sec23A (SEC23-related protein A)	SEC23A RCJMB04_14a13	Gallus gallus (Chicken)	767	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		blue	blue	NA	NA	NA	NA
TRINITY_DN1421_c0_g1_i7	Q5ZK03	SC23A_CHICK	73.3	30	8	0	178	89	738	767	8.20E-06	50.8	SC23A_CHICK	reviewed	Protein transport protein Sec23A (SEC23-related protein A)	SEC23A RCJMB04_14a13	Gallus gallus (Chicken)	767	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		blue	blue	NA	NA	NA	NA
TRINITY_DN32887_c0_g1_i1	A2VDL8	SC23A_BOVIN	100	111	0	0	2	334	348	458	7.40E-58	224.2	SC23A_BOVIN	reviewed	Protein transport protein Sec23A (SEC23-related protein A)	SEC23A	Bos taurus (Bovine)	768	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0019898; GO:0030127; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN16674_c0_g1_i1	Q01405	SC23A_MOUSE	99.2	239	2	0	2	718	469	707	2.50E-135	482.6	SC23A_MOUSE	reviewed	Protein transport protein Sec23A (SEC23-related protein A)	Sec23a Sec23 Sec23r	Mus musculus (Mouse)	765	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0019898; GO:0030127; GO:0030134; GO:0048471; GO:0070971; GO:0072659; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN30206_c0_g1_i1	Q15437	SC23B_HUMAN	100	278	0	0	3	836	457	734	4.00E-161	568.5	SC23B_HUMAN	reviewed	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	Homo sapiens (Human)	767	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012505; GO:0030127; GO:0048471; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN29435_c0_g1_i1	Q15437	SC23B_HUMAN	100	80	0	0	241	2	364	443	5.90E-41	167.5	SC23B_HUMAN	reviewed	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	Homo sapiens (Human)	767	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012505; GO:0030127; GO:0048471; GO:0070971; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN39926_c0_g1_i1	O95486	SC24A_HUMAN	100	83	0	0	3	251	633	715	1.60E-41	169.5	SC24A_HUMAN	reviewed	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	Homo sapiens (Human)	1093	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cholesterol homeostasis [GO:0042632]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000149; GO:0002474; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0030127; GO:0042632; GO:0045714; GO:0048208; GO:0050714; GO:0070971; GO:0090110	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]		NA	NA	NA	NA	NA	NA
TRINITY_DN31173_c0_g1_i1	O95487	SC24B_HUMAN	98.9	186	2	0	2	559	665	850	3.10E-101	369	SC24B_HUMAN	reviewed	Protein transport protein Sec24B (SEC24-related protein B)	SEC24B	Homo sapiens (Human)	1268	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000149; GO:0001843; GO:0002474; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0021747; GO:0030127; GO:0035909; GO:0048208; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]		NA	NA	NA	NA	NA	NA
TRINITY_DN6427_c0_g1_i1	O95487	SC24B_HUMAN	52.9	770	357	4	123	2426	501	1266	5.20E-241	835.5	SC24B_HUMAN	reviewed	Protein transport protein Sec24B (SEC24-related protein B)	SEC24B	Homo sapiens (Human)	1268	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000149; GO:0001843; GO:0002474; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0021747; GO:0030127; GO:0035909; GO:0048208; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]		NA	NA	NA	NA	NA	NA
TRINITY_DN36038_c0_g1_i1	P53992	SC24C_HUMAN	46.2	130	70	0	485	96	965	1094	4.50E-30	132.5	SC24C_HUMAN	reviewed	Protein transport protein Sec24C (SEC24-related protein C)	SEC24C KIAA0079	Homo sapiens (Human)	1094	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000149; GO:0001701; GO:0002474; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0030127; GO:0048208; GO:0070971; GO:0090110	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; in utero embryonic development [GO:0001701]		blue	blue	NA	NA	NA	NA
TRINITY_DN13467_c0_g1_i1	Q9SFU0	SC24A_ARATH	53.6	69	32	0	210	4	407	475	4.40E-16	84.7	SC24A_ARATH	reviewed	Protein transport protein Sec24-like At3g07100	At3g07100 T1B9.25	Arabidopsis thaliana (Mouse-ear cress)	1038	COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; ER body organization [GO:0080119]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; male gamete generation [GO:0048232]; negative regulation of DNA endoreduplication [GO:0032876]; regulation of cell size [GO:0008361]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000149; GO:0005789; GO:0006886; GO:0007029; GO:0007030; GO:0008270; GO:0008361; GO:0030127; GO:0032876; GO:0048232; GO:0070971; GO:0080119; GO:0090110	COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; ER body organization [GO:0080119]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; male gamete generation [GO:0048232]; negative regulation of DNA endoreduplication [GO:0032876]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN31189_c0_g1_i1	O94979	SC31A_HUMAN	100	69	0	0	2	208	223	291	6.00E-34	144.1	SC31A_HUMAN	reviewed	Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein)	SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334	Homo sapiens (Human)	1220	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; vesicle coat [GO:0030120]; calcium-dependent protein binding [GO:0048306]; structural molecule activity [GO:0005198]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; IRE1-mediated unfolded protein response [GO:0036498]; response to calcium ion [GO:0051592]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; vesicle coat [GO:0030120]	calcium-dependent protein binding [GO:0048306]; structural molecule activity [GO:0005198]	GO:0000139; GO:0002474; GO:0005198; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0007029; GO:0012507; GO:0019886; GO:0030120; GO:0030127; GO:0030134; GO:0036498; GO:0043231; GO:0048208; GO:0048306; GO:0048471; GO:0051592; GO:0070971; GO:0090110; GO:0090114	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; IRE1-mediated unfolded protein response [GO:0036498]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN5092_c0_g1_i1	Q7SYD5	SC31A_DANRE	41.7	254	123	4	701	3	190	439	5.60E-55	215.7	SC31A_DANRE	reviewed	Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A)	sec31a sec31l1 sec31p	Danio rerio (Zebrafish) (Brachydanio rerio)	1254	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; digestive system development [GO:0055123]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]	structural molecule activity [GO:0005198]	GO:0000139; GO:0001889; GO:0005198; GO:0005789; GO:0006886; GO:0006888; GO:0007029; GO:0030127; GO:0030134; GO:0055123; GO:0070971; GO:0090110; GO:0090114	COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; digestive system development [GO:0055123]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]		NA	NA	NA	NA	NA	NA
TRINITY_DN1537_c0_g1_i1	P38379	SC61A_PYRSA	77.8	135	30	0	3	407	45	179	6.50E-56	218	SC61A_PYRSA	reviewed	Protein transport protein Sec61 subunit alpha		Pyrenomonas salina	494	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0015031; GO:0016021	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN8018_c0_g2_i1	Q54XK2	SC61A_DICDI	64.7	85	30	0	257	3	233	317	1.40E-24	113.2	SC61A_DICDI	reviewed	Protein transport protein Sec61 subunit alpha (Secretory 61 complex subunit alpha)	sec61a DDB_G0278885	Dictyostelium discoideum (Slime mold)	475	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0015450; GO:0016021; GO:0031204; GO:0043022	"posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1537_c0_g2_i1	Q54XK2	SC61A_DICDI	75.3	97	24	0	291	1	220	316	2.00E-35	149.4	SC61A_DICDI	reviewed	Protein transport protein Sec61 subunit alpha (Secretory 61 complex subunit alpha)	sec61a DDB_G0278885	Dictyostelium discoideum (Slime mold)	475	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0015450; GO:0016021; GO:0031204; GO:0043022	"posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1537_c0_g3_i1	Q54XK2	SC61A_DICDI	69.8	149	45	0	509	63	318	466	7.30E-57	221.5	SC61A_DICDI	reviewed	Protein transport protein Sec61 subunit alpha (Secretory 61 complex subunit alpha)	sec61a DDB_G0278885	Dictyostelium discoideum (Slime mold)	475	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0015450; GO:0016021; GO:0031204; GO:0043022	"posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6288_c0_g1_i1	Q54XK2	SC61A_DICDI	45.6	79	43	0	3	239	35	113	1.00E-13	77	SC61A_DICDI	reviewed	Protein transport protein Sec61 subunit alpha (Secretory 61 complex subunit alpha)	sec61a DDB_G0278885	Dictyostelium discoideum (Slime mold)	475	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0015450; GO:0016021; GO:0031204; GO:0043022	"posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17339_c0_g1_i1	Q5EA68	S61A1_BOVIN	100	74	0	0	255	34	403	476	6.70E-35	147.5	S61A1_BOVIN	reviewed	Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)	SEC61A1	Bos taurus (Bovine)	476	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047	"posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24894_c0_g1_i1	P38377	S61A1_CANLF	100	100	0	0	303	4	93	192	7.40E-49	194.1	S61A1_CANLF	reviewed	Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)	SEC61A1	Canis lupus familiaris (Dog) (Canis familiaris)	476	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047	"posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24894_c0_g1_i2	P38377	S61A1_CANLF	100	163	0	0	489	1	31	193	2.50E-86	319.3	S61A1_CANLF	reviewed	Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)	SEC61A1	Canis lupus familiaris (Dog) (Canis familiaris)	476	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047	"posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8900_c0_g1_i1	Q5EA68	S61A1_BOVIN	100	261	0	0	1	783	216	476	6.40E-143	508.1	S61A1_BOVIN	reviewed	Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)	SEC61A1	Bos taurus (Bovine)	476	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047	"posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8900_c0_g1_i2	Q5EA68	S61A1_BOVIN	100	261	0	0	1	783	216	476	6.40E-143	508.1	S61A1_BOVIN	reviewed	Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)	SEC61A1	Bos taurus (Bovine)	476	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047	"posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8018_c0_g1_i1	Q5NVM7	S61A2_PONAB	69.4	121	37	0	2	364	344	464	8.20E-41	167.9	S61A2_PONAB	reviewed	Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2)	SEC61A2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	476	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0015031; GO:0016021	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN25574_c1_g1_i1	Q98SN8	S61A2_ONCMY	96.5	171	6	0	3	515	25	195	1.60E-88	326.6	S61A2_ONCMY	reviewed	Protein transport protein Sec61 subunit alpha isoform B	sec61ab	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	476	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0015031; GO:0016021	protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN32874_c2_g1_i1	Q98SN8	S61A2_ONCMY	87.1	280	35	1	928	89	198	476	6.90E-138	491.5	S61A2_ONCMY	reviewed	Protein transport protein Sec61 subunit alpha isoform B	sec61ab	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	476	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0015031; GO:0016021	protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN20254_c0_g1_i1	Q90ZM2	S61A1_DANRE	87.9	66	8	0	199	2	92	157	1.90E-24	112.5	S61A1_DANRE	reviewed	Protein transport protein Sec61 subunit alpha-like 1	sec61al1 sec61a sec61aa	Danio rerio (Zebrafish) (Brachydanio rerio)	476	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; habenula development [GO:0021986]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0008320; GO:0016021; GO:0021986; GO:0031204; GO:0039019; GO:0043022	"habenula development [GO:0021986]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1540_c0_g1_i1	Q9NDM2	GUTR1_DROME	28.5	137	92	2	207	614	30	161	8.50E-07	55.5	GUTR1_DROME	reviewed	Protein trapped in endoderm-1	Tre1 CG3171	Drosophila melanogaster (Fruit fly)	392	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234	ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]		blue	blue	NA	NA	NA	NA
TRINITY_DN36726_c0_g1_i1	Q7KRW1	TRC8_DROME	70.8	72	21	0	224	9	591	662	2.30E-26	119	TRC8_DROME	reviewed	Protein TRC8 homolog	Trc8 CG2304	Drosophila melanogaster (Fruit fly)	809	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ERAD pathway [GO:0036503]; negative regulation of growth [GO:0045926]; protein ubiquitination [GO:0016567]; ventral midline development [GO:0007418]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005783; GO:0005789; GO:0007418; GO:0008270; GO:0012505; GO:0016021; GO:0016567; GO:0036503; GO:0045926; GO:0061630	ERAD pathway [GO:0036503]; negative regulation of growth [GO:0045926]; protein ubiquitination [GO:0016567]; ventral midline development [GO:0007418]		NA	NA	NA	NA	NA	NA
TRINITY_DN18176_c0_g1_i1	Q05024	TRI1_YEAST	38.2	68	41	1	616	819	126	192	6.00E-07	56.6	TRI1_YEAST	reviewed	Protein TRI1	TRI1 YMR233W YM9959.15	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	226	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN18176_c0_g1_i3	Q05024	TRI1_YEAST	38.2	68	41	1	585	788	126	192	5.80E-07	56.6	TRI1_YEAST	reviewed	Protein TRI1	TRI1 YMR233W YM9959.15	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	226	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN18176_c0_g1_i4	Q05024	TRI1_YEAST	38.2	68	41	1	517	720	126	192	5.30E-07	56.6	TRI1_YEAST	reviewed	Protein TRI1	TRI1 YMR233W YM9959.15	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	226	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN18176_c0_g1_i6	Q05024	TRI1_YEAST	38.2	68	41	1	570	773	126	192	5.70E-07	56.6	TRI1_YEAST	reviewed	Protein TRI1	TRI1 YMR233W YM9959.15	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	226	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN18176_c0_g1_i7	Q05024	TRI1_YEAST	38.2	68	41	1	437	640	126	192	4.90E-07	56.6	TRI1_YEAST	reviewed	Protein TRI1	TRI1 YMR233W YM9959.15	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	226	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]		GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN1827_c0_g1_i1	Q27237	TID_DROME	64	86	30	1	157	411	55	140	4.70E-22	105.5	TID_DROME	reviewed	"Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID50) (TID56)"	l(2)tid CG5504	Drosophila melanogaster (Fruit fly)	520	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; regulation of apoptotic process [GO:0042981]; response to heat [GO:0009408]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]	GO:0005113; GO:0005524; GO:0005739; GO:0005741; GO:0005829; GO:0006457; GO:0007005; GO:0007275; GO:0009408; GO:0031072; GO:0042981; GO:0045879; GO:0046872; GO:0051082	mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; regulation of apoptotic process [GO:0042981]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN1827_c0_g1_i2	Q27237	TID_DROME	64.6	65	23	0	157	351	55	119	9.40E-17	87.8	TID_DROME	reviewed	"Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID50) (TID56)"	l(2)tid CG5504	Drosophila melanogaster (Fruit fly)	520	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; regulation of apoptotic process [GO:0042981]; response to heat [GO:0009408]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]	GO:0005113; GO:0005524; GO:0005739; GO:0005741; GO:0005829; GO:0006457; GO:0007005; GO:0007275; GO:0009408; GO:0031072; GO:0042981; GO:0045879; GO:0046872; GO:0051082	mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; regulation of apoptotic process [GO:0042981]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN1827_c0_g1_i3	Q27237	TID_DROME	64.6	65	23	0	157	351	55	119	9.40E-17	87.8	TID_DROME	reviewed	"Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID50) (TID56)"	l(2)tid CG5504	Drosophila melanogaster (Fruit fly)	520	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; regulation of apoptotic process [GO:0042981]; response to heat [GO:0009408]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]	GO:0005113; GO:0005524; GO:0005739; GO:0005741; GO:0005829; GO:0006457; GO:0007005; GO:0007275; GO:0009408; GO:0031072; GO:0042981; GO:0045879; GO:0046872; GO:0051082	mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; regulation of apoptotic process [GO:0042981]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN38565_c0_g1_i1	Q93096	TP4A1_HUMAN	100	117	0	0	1	351	57	173	1.40E-65	250	TP4A1_HUMAN	reviewed	Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (PTP(CAAXI)) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1)	PTP4A1 PRL1 PTPCAAX1	Homo sapiens (Human)	173	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005819; GO:0007049; GO:0007275; GO:0008138; GO:0009898; GO:0030335	cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]		NA	NA	NA	NA	NA	NA
TRINITY_DN39236_c0_g1_i1	Q93096	TP4A1_HUMAN	64.5	169	57	2	587	87	6	173	4.50E-57	222.6	TP4A1_HUMAN	reviewed	Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (PTP(CAAXI)) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1)	PTP4A1 PRL1 PTPCAAX1	Homo sapiens (Human)	173	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005819; GO:0007049; GO:0007275; GO:0008138; GO:0009898; GO:0030335	cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]		blue	blue	NA	NA	NA	NA
TRINITY_DN28490_c0_g1_i1	Q93096	TP4A1_HUMAN	100	62	0	0	188	3	1	62	2.10E-29	129	TP4A1_HUMAN	reviewed	Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (PTP(CAAXI)) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1)	PTP4A1 PRL1 PTPCAAX1	Homo sapiens (Human)	173	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005819; GO:0007049; GO:0007275; GO:0008138; GO:0009898; GO:0030335	cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]		NA	NA	NA	NA	NA	NA
TRINITY_DN18713_c0_g1_i1	Q12974	TP4A2_HUMAN	81.4	167	0	1	37	444	1	167	1.90E-73	276.6	TP4A2_HUMAN	reviewed	Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2)	PTP4A2 PRL2 PTPCAAX2 BM-008	Homo sapiens (Human)	167	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN18713_c0_g1_i2	Q12974	TP4A2_HUMAN	100	120	0	0	3	362	48	167	1.20E-68	260.4	TP4A2_HUMAN	reviewed	Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2)	PTP4A2 PRL2 PTPCAAX2 BM-008	Homo sapiens (Human)	167	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN18713_c0_g1_i3	Q12974	TP4A2_HUMAN	100	120	0	0	3	362	48	167	1.20E-68	260.4	TP4A2_HUMAN	reviewed	Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2)	PTP4A2 PRL2 PTPCAAX2 BM-008	Homo sapiens (Human)	167	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; post-translational protein modification [GO:0043687]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0043687	post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN2201_c0_g1_i1	Q9VCE9	UBS3A_DROME	43.5	754	332	12	75	2072	1	748	1.00E-168	595.1	UBS3A_DROME	reviewed	Protein UBASH3A homolog	CG13604	Drosophila melanogaster (Fruit fly)	751	cytosol [GO:0005829]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	cytosol [GO:0005829]	phosphatase activity [GO:0016791]	GO:0005829; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN2201_c0_g1_i2	Q9VCE9	UBS3A_DROME	45.6	195	101	3	336	917	555	745	1.10E-47	191.8	UBS3A_DROME	reviewed	Protein UBASH3A homolog	CG13604	Drosophila melanogaster (Fruit fly)	751	cytosol [GO:0005829]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	cytosol [GO:0005829]	phosphatase activity [GO:0016791]	GO:0005829; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN2201_c0_g1_i2	Q9VCE9	UBS3A_DROME	50.3	151	60	5	75	485	1	150	2.80E-30	134	UBS3A_DROME	reviewed	Protein UBASH3A homolog	CG13604	Drosophila melanogaster (Fruit fly)	751	cytosol [GO:0005829]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	cytosol [GO:0005829]	phosphatase activity [GO:0016791]	GO:0005829; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN2201_c0_g1_i4	Q9VCE9	UBS3A_DROME	56.5	207	87	2	75	689	1	206	4.40E-63	242.7	UBS3A_DROME	reviewed	Protein UBASH3A homolog	CG13604	Drosophila melanogaster (Fruit fly)	751	cytosol [GO:0005829]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	cytosol [GO:0005829]	phosphatase activity [GO:0016791]	GO:0005829; GO:0016311; GO:0016791	dephosphorylation [GO:0016311]		NA	NA	NA	NA	NA	NA
TRINITY_DN3549_c0_g1_i3	Q4KUS2	UN13A_MOUSE	66	1097	347	8	3355	107	617	1701	0	1441.8	UN13A_MOUSE	reviewed	Protein unc-13 homolog A (Munc13-1)	Unc13a	Mus musculus (Mouse)	1712	"axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; amyloid-beta metabolic process [GO:0050435]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	axon [GO:0030424]; calyx of Held [GO:0044305]; excitatory synapse [GO:0060076]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin-1 binding [GO:0017075]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0010807; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030424; GO:0030507; GO:0030672; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035556; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0047485; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098831; GO:0099011; GO:0099525; GO:1900451; GO:1902991; GO:1903861	"amyloid-beta metabolic process [GO:0050435]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3549_c0_g1_i1	O14795	UN13B_HUMAN	68.5	1063	303	7	3226	107	532	1585	0	1442.6	UN13B_HUMAN	reviewed	Protein unc-13 homolog B (Munc13-2) (munc13)	UNC13B UNC13	Homo sapiens (Human)	1591	"calyx of Held [GO:0044305]; cytosol [GO:0005829]; early phagosome [GO:0032009]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; syntaxin-1 binding [GO:0017075]; acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; glutamate secretion [GO:0014047]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; phagosome maturation [GO:0090382]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	calyx of Held [GO:0044305]; cytosol [GO:0005829]; early phagosome [GO:0032009]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; syntaxin-1 binding [GO:0017075]	GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007269; GO:0007528; GO:0010808; GO:0014047; GO:0016020; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0017137; GO:0019992; GO:0030672; GO:0030742; GO:0031594; GO:0031914; GO:0032009; GO:0035249; GO:0035556; GO:0042734; GO:0043065; GO:0043195; GO:0044305; GO:0048172; GO:0048786; GO:0050714; GO:0060384; GO:0060478; GO:0061789; GO:0071333; GO:0090382; GO:0097151; GO:0097470; GO:0098831; GO:0099011; GO:0099525; GO:1900426	"acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; glutamate secretion [GO:0014047]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; phagosome maturation [GO:0090382]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28099_c0_g1_i1	Q9H3U1	UN45A_HUMAN	100	96	0	0	289	2	684	779	7.40E-46	184.1	UN45A_HUMAN	reviewed	Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1)	UNC45A SMAP1	Homo sapiens (Human)	944	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]	cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]	GO:0005794; GO:0005829; GO:0007517; GO:0016607; GO:0030154; GO:0045296; GO:0048471; GO:0051879; GO:0061077	cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517]		NA	NA	NA	NA	NA	NA
TRINITY_DN4847_c0_g1_i1	Q8IWX7	UN45B_HUMAN	38.9	906	537	9	80	2755	3	905	1.40E-179	631.7	UN45B_HUMAN	reviewed	Protein unc-45 homolog B (Unc-45B) (SMUNC45)	UNC45B CMYA4 UNC45	Homo sapiens (Human)	931	cytosol [GO:0005829]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]	cytosol [GO:0005829]	Hsp90 protein binding [GO:0051879]	GO:0002088; GO:0005829; GO:0007517; GO:0030154; GO:0051879; GO:0061077	cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]		NA	NA	NA	NA	NA	NA
TRINITY_DN29877_c0_g1_i1	Q9CQ61	UNC50_MOUSE	99.2	120	1	0	1	360	131	250	2.40E-62	239.2	UNC50_MOUSE	reviewed	Protein unc-50 homolog (Periodontal ligament-specific protein 22) (PDLs22)	Unc50	Mus musculus (Mouse)	259	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nuclear inner membrane [GO:0005637]; RNA binding [GO:0003723]; cell surface receptor signaling pathway [GO:0007166]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nuclear inner membrane [GO:0005637]	RNA binding [GO:0003723]	GO:0000139; GO:0003723; GO:0005637; GO:0005794; GO:0007166; GO:0015031; GO:0030173	cell surface receptor signaling pathway [GO:0007166]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN38971_c0_g1_i1	Q53HI1	UNC50_HUMAN	100	86	0	0	261	4	43	128	1.30E-44	179.9	UNC50_HUMAN	reviewed	Protein unc-50 homolog (Periodontal ligament-specific protein 22) (PDLs22) (Protein GMH1 homolog) (hGMH1) (Uncoordinated-like protein)	UNC50 UNCL HSD-23 HSD23	Homo sapiens (Human)	259	integral component of Golgi membrane [GO:0030173]; nuclear inner membrane [GO:0005637]; RNA binding [GO:0003723]; protein transport [GO:0015031]	integral component of Golgi membrane [GO:0030173]; nuclear inner membrane [GO:0005637]	RNA binding [GO:0003723]	GO:0003723; GO:0005637; GO:0015031; GO:0030173	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2968_c0_g1_i1	Q9VHN5	UNC50_DROME	54	187	85	1	72	632	89	274	1.90E-50	200.7	UNC50_DROME	reviewed	Protein unc-50 homolog (Uncoordinated-like protein)	CG9773	Drosophila melanogaster (Fruit fly)	275	integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031]	integral component of Golgi membrane [GO:0030173]		GO:0015031; GO:0030173	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2968_c0_g1_i2	Q9VHN5	UNC50_DROME	61.1	108	41	1	3	326	90	196	5.40E-30	131.7	UNC50_DROME	reviewed	Protein unc-50 homolog (Uncoordinated-like protein)	CG9773	Drosophila melanogaster (Fruit fly)	275	integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031]	integral component of Golgi membrane [GO:0030173]		GO:0015031; GO:0030173	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2968_c0_g1_i3	Q9VHN5	UNC50_DROME	59.6	250	100	1	180	929	26	274	7.20E-80	298.9	UNC50_DROME	reviewed	Protein unc-50 homolog (Uncoordinated-like protein)	CG9773	Drosophila melanogaster (Fruit fly)	275	integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031]	integral component of Golgi membrane [GO:0030173]		GO:0015031; GO:0030173	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5706_c0_g1_i4	Q9P2D8	UNC79_HUMAN	52.4	313	137	5	1004	84	2267	2573	2.70E-87	323.6	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5706_c0_g1_i5	Q9P2D8	UNC79_HUMAN	52.6	270	116	5	873	82	2267	2530	8.60E-74	278.5	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5706_c0_g1_i6	Q9P2D8	UNC79_HUMAN	50.7	377	162	9	1125	37	2267	2633	1.00E-95	351.7	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN27789_c0_g1_i1	Q9P2D8	UNC79_HUMAN	46.9	143	72	2	202	630	2004	2142	1.30E-29	131.3	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5860_c0_g1_i1	Q9P2D8	UNC79_HUMAN	33.2	1371	721	26	81	3881	1	1280	2.20E-209	731.1	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5860_c0_g1_i7	Q9P2D8	UNC79_HUMAN	33.4	1371	718	26	63	3863	1	1280	5.10E-211	736.5	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5860_c0_g1_i8	Q9P2D8	UNC79_HUMAN	33	1170	638	22	33	3377	202	1280	1.60E-179	631.7	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN5860_c0_g1_i9	Q9P2D8	UNC79_HUMAN	36.1	147	46	3	63	359	1	147	1.80E-14	80.5	UNC79_HUMAN	reviewed	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)	2635	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i13	Q5SPF7	UN93A_DANRE	51.6	91	44	0	53	325	281	371	5.40E-22	105.1	UN93A_DANRE	reviewed	Protein unc-93 homolog A (Unc-93A)	unc93a si:dkey-14a7.1	Danio rerio (Zebrafish) (Brachydanio rerio)	465	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN16923_c0_g2_i1	P07259	PYR1_YEAST	56.7	231	100	0	1	693	1170	1400	3.90E-69	262.7	PYR1_YEAST	reviewed	Protein URA2 [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2)]	URA2 YJL130C J0686	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	2214	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; negative regulation of pyrimidine nucleobase metabolic process [GO:0045984]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006207; GO:0006228; GO:0006541; GO:0006807; GO:0016021; GO:0016597; GO:0019240; GO:0044205; GO:0045984; GO:0046872	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; negative regulation of pyrimidine nucleobase metabolic process [GO:0045984]; nitrogen compound metabolic process [GO:0006807]; UTP biosynthetic process [GO:0006228]		NA	NA	NA	NA	NA	NA
TRINITY_DN10018_c0_g1_i1	A7T0W1	UXT_NEMVE	44.4	135	72	2	513	115	13	146	1.40E-22	107.8	UXT_NEMVE	reviewed	Protein UXT homolog	v1g140887	Nematostella vectensis (Starlet sea anemone)	159	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; beta-tubulin binding [GO:0048487]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	beta-tubulin binding [GO:0048487]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0000785; GO:0003712; GO:0003714; GO:0005634; GO:0006357; GO:0006457; GO:0016272; GO:0016592; GO:0045944; GO:0048487; GO:0051082	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11983_c1_g1_i1	Q5ZIW5	VAC14_CHICK	47.1	87	44	1	44	298	386	472	3.90E-14	79	VAC14_CHICK	reviewed	Protein VAC14 homolog	VAC14 RCJMB04_23c3	Gallus gallus (Chicken)	780	endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; vacuolar membrane [GO:0005774]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]	endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; vacuolar membrane [GO:0005774]		GO:0000306; GO:0005774; GO:0006661; GO:0010008; GO:0033674; GO:0070772	phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]		NA	NA	NA	NA	NA	NA
TRINITY_DN11983_c1_g2_i1	Q68F38	VAC14_XENLA	54	337	152	3	1092	85	3	337	4.10E-103	376.3	VAC14_XENLA	reviewed	Protein VAC14 homolog	vac14	Xenopus laevis (African clawed frog)	782	endosome membrane [GO:0010008]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661]	endosome membrane [GO:0010008]; PAS complex [GO:0070772]		GO:0006661; GO:0010008; GO:0070772	phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN12106_c1_g1_i1	Q68F38	VAC14_XENLA	57.5	247	101	1	63	791	523	769	2.10E-71	270.8	VAC14_XENLA	reviewed	Protein VAC14 homolog	vac14	Xenopus laevis (African clawed frog)	782	endosome membrane [GO:0010008]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661]	endosome membrane [GO:0010008]; PAS complex [GO:0070772]		GO:0006661; GO:0010008; GO:0070772	phosphatidylinositol biosynthetic process [GO:0006661]		NA	NA	NA	NA	NA	NA
TRINITY_DN12106_c1_g1_i2	Q66L58	VAC14_DANRE	57.7	248	101	2	87	818	512	759	4.80E-71	269.6	VAC14_DANRE	reviewed	Protein VAC14 homolog	vac14 zgc:100945	Danio rerio (Zebrafish) (Brachydanio rerio)	771	endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; vacuolar membrane [GO:0005774]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]	endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; vacuolar membrane [GO:0005774]		GO:0000306; GO:0005774; GO:0006661; GO:0010008; GO:0033674; GO:0070772	phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]		NA	NA	NA	NA	NA	NA
TRINITY_DN3665_c0_g1_i2	Q9NHV9	VAV_DROME	37.4	182	100	3	968	444	21	195	2.20E-26	121.3	VAV_DROME	reviewed	Protein vav (DroVav) (dVAV)	Vav CG7893	Drosophila melanogaster (Fruit fly)	793	cytosol [GO:0005829]; metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]	GO:0001745; GO:0005088; GO:0005829; GO:0007173; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0016477; GO:0030676; GO:0031532; GO:0035011; GO:0035556; GO:0042059; GO:0046872; GO:0048010; GO:0070374; GO:0072499; GO:0090630; GO:1903391; GO:2000251	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN3665_c0_g1_i2	Q9NHV9	VAV_DROME	26.6	124	61	4	343	5	152	256	3.10E-04	47.8	VAV_DROME	reviewed	Protein vav (DroVav) (dVAV)	Vav CG7893	Drosophila melanogaster (Fruit fly)	793	cytosol [GO:0005829]; metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]	GO:0001745; GO:0005088; GO:0005829; GO:0007173; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0016477; GO:0030676; GO:0031532; GO:0035011; GO:0035556; GO:0042059; GO:0046872; GO:0048010; GO:0070374; GO:0072499; GO:0090630; GO:1903391; GO:2000251	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN3665_c0_g1_i3	Q9NHV9	VAV_DROME	32.6	276	139	6	811	5	21	256	9.20E-34	145.6	VAV_DROME	reviewed	Protein vav (DroVav) (dVAV)	Vav CG7893	Drosophila melanogaster (Fruit fly)	793	cytosol [GO:0005829]; metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]	GO:0001745; GO:0005088; GO:0005829; GO:0007173; GO:0007298; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007424; GO:0007520; GO:0016477; GO:0030676; GO:0031532; GO:0035011; GO:0035556; GO:0042059; GO:0046872; GO:0048010; GO:0070374; GO:0072499; GO:0090630; GO:1903391; GO:2000251	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; compound eye morphogenesis [GO:0001745]; dorsal closure [GO:0007391]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; myoblast fusion [GO:0007520]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of adherens junction organization [GO:1903391]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN21047_c0_g1_i1	Q17320	WHITE_CERCA	43.5	92	49	2	47	316	588	678	1.50E-14	80.5	WHITE_CERCA	reviewed	Protein white	W	Ceratitis capitata (Mediterranean fruit fly) (Tephritis capitata)	679	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN37135_c0_g1_i1	Q16928	WHITE_ANOAL	39	41	25	0	76	198	340	380	3.80E-05	48.9	WHITE_ANOAL	reviewed	Protein white	W	Anopheles albimanus (New world malaria mosquito)	709	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0016021; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN24546_c0_g1_i1	P10090	WHITE_DROME	62.8	172	64	0	621	106	206	377	1.80E-57	223.8	WHITE_DROME	reviewed	Protein white	w CG2759	Drosophila melanogaster (Fruit fly)	687	"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]"	cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN4129_c1_g3_i2	P10090	WHITE_DROME	40.4	146	86	1	76	513	541	685	8.60E-25	115.2	WHITE_DROME	reviewed	Protein white	w CG2759	Drosophila melanogaster (Fruit fly)	687	"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]"	cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN4129_c1_g3_i3	P10090	WHITE_DROME	38.8	361	201	4	127	1191	339	685	4.60E-68	260	WHITE_DROME	reviewed	Protein white	w CG2759	Drosophila melanogaster (Fruit fly)	687	"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]"	cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN24056_c0_g1_i1	Q27256	WHITE_ANOGA	61	59	23	0	2	178	199	257	3.10E-13	75.5	WHITE_ANOGA	reviewed	Protein white	w AGAP000553	Anopheles gambiae (African malaria mosquito)	695	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN24056_c0_g1_i2	Q27256	WHITE_ANOGA	76.5	34	8	0	93	194	224	257	9.50E-08	57.4	WHITE_ANOGA	reviewed	Protein white	w AGAP000553	Anopheles gambiae (African malaria mosquito)	695	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN24056_c0_g1_i3	Q27256	WHITE_ANOGA	76.5	34	8	0	94	195	224	257	9.50E-08	57.4	WHITE_ANOGA	reviewed	Protein white	w AGAP000553	Anopheles gambiae (African malaria mosquito)	695	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN24056_c0_g2_i1	Q17320	WHITE_CERCA	65.1	83	29	0	20	268	242	324	3.30E-24	112.5	WHITE_CERCA	reviewed	Protein white	W	Ceratitis capitata (Mediterranean fruit fly) (Tephritis capitata)	679	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN24056_c0_g2_i2	Q05360	WHITE_LUCCU	60.2	103	41	0	20	328	240	342	2.90E-30	132.5	WHITE_LUCCU	reviewed	Protein white	W	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	677	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN7568_c0_g1_i1	Q16928	WHITE_ANOAL	38.3	81	29	2	60	239	72	152	8.00E-09	60.8	WHITE_ANOAL	reviewed	Protein white	W	Anopheles albimanus (New world malaria mosquito)	709	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0016021; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN1095_c2_g1_i1	P10090	WHITE_DROME	51.1	137	67	0	98	508	251	387	2.50E-42	173.3	WHITE_DROME	reviewed	Protein white	w CG2759	Drosophila melanogaster (Fruit fly)	687	"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]"	cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN1095_c2_g1_i11	P10090	WHITE_DROME	35.5	279	177	2	109	939	409	686	4.90E-50	199.9	WHITE_DROME	reviewed	Protein white	w CG2759	Drosophila melanogaster (Fruit fly)	687	"cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]"	cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	"amine transmembrane transporter activity [GO:0005275]; ATPase activity [GO:0016887]; ATPase-coupled 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ATPase-coupled guanine transmembrane transporter activity [GO:0008558]; ATP binding [GO:0005524]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]"	GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015842; GO:0016887; GO:0031409; GO:0031410; GO:0042332; GO:0042401; GO:0042441; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN40437_c0_g1_i1	Q05360	WHITE_LUCCU	39.8	98	36	4	32	277	37	127	6.90E-09	61.2	WHITE_LUCCU	reviewed	Protein white	W	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	677	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; pigment binding [GO:0031409]	integral component of membrane [GO:0016021]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; pigment binding [GO:0031409]	GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0042626			NA	NA	NA	NA	NA	NA
TRINITY_DN18341_c0_g1_i1	Q3LHL9	WGE_DROME	46	87	37	1	21	251	1185	1271	5.30E-16	85.1	WGE_DROME	reviewed	Protein winged eye	wge CG31151	Drosophila melanogaster (Fruit fly)	1658	chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]	chromatin [GO:0000785]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0000785; GO:0003682; GO:0005634; GO:0007560; GO:0030154	cell differentiation [GO:0030154]; imaginal disc morphogenesis [GO:0007560]		NA	NA	NA	NA	NA	NA
TRINITY_DN32716_c0_g1_i1	Q9W517	WAPL_DROME	52.5	278	131	1	833	3	1137	1414	9.30E-76	285.8	WAPL_DROME	reviewed	Protein wings apart-like (Protein parallel sister chromatids)	wapl pasc CG3707	Drosophila melanogaster (Fruit fly)	1741	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; chromatin organization [GO:0006325]; meiotic chromosome segregation [GO:0045132]; mitotic cohesin unloading [GO:0061781]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; sister chromatid cohesion [GO:0007062]	nucleus [GO:0005634]; polytene chromosome [GO:0005700]		GO:0005634; GO:0005700; GO:0006325; GO:0007062; GO:0045132; GO:0060623; GO:0061781; GO:0071922	chromatin organization [GO:0006325]; meiotic chromosome segregation [GO:0045132]; mitotic cohesin unloading [GO:0061781]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN25484_c0_g1_i1	P49340	WNT1_BOMMO	47.1	102	50	1	360	55	174	271	1.20E-24	114	WNT1_BOMMO	reviewed	Protein Wnt-1	WNT-1	Bombyx mori (Silk moth)	392	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0007275; GO:0016055	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24028_c0_g1_i1	Q5E9U6	WNT16_BOVIN	38.5	91	49	1	97	348	56	146	1.70E-12	73.9	WNT16_BOVIN	reviewed	Protein Wnt-16	WNT16	Bos taurus (Bovine)	362	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0007275; GO:0016055	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN28568_c0_g1_i1	Q92048	WNT2_DANRE	59.2	76	26	2	217	2	273	347	1.00E-21	103.6	WNT2_DANRE	reviewed	Protein Wnt-2	wnt2 wnt-2	Danio rerio (Zebrafish) (Brachydanio rerio)	350	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; hepatocyte proliferation [GO:0072574]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; neuron differentiation [GO:0030182]; swim bladder development [GO:0048794]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	GO:0001889; GO:0005109; GO:0005125; GO:0005615; GO:0007275; GO:0030182; GO:0045165; GO:0048794; GO:0060070; GO:0072574	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; hepatocyte proliferation [GO:0072574]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; neuron differentiation [GO:0030182]; swim bladder development [GO:0048794]		NA	NA	NA	NA	NA	NA
TRINITY_DN18719_c0_g1_i2	P28465	WNT2_DROME	54.7	212	77	4	598	8	93	300	6.00E-59	228.8	WNT2_DROME	reviewed	Protein Wnt-2 (dWnt-2)	Wnt2 Wnt-2 CG1916	Drosophila melanogaster (Fruit fly)	352	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]; axon extension [GO:0048675]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; germ-line stem-cell niche homeostasis [GO:0060250]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; open tracheal system development [GO:0007424]; positive regulation of JNK cascade [GO:0046330]; segment polarity determination [GO:0007367]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0007367; GO:0007424; GO:0007517; GO:0016055; GO:0030182; GO:0045165; GO:0046330; GO:0048675; GO:0060070; GO:0060250	axon extension [GO:0048675]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; germ-line stem-cell niche homeostasis [GO:0060250]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; open tracheal system development [GO:0007424]; positive regulation of JNK cascade [GO:0046330]; segment polarity determination [GO:0007367]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN32216_c0_g1_i1	P56705	WNT4_HUMAN	64.4	59	21	0	211	35	293	351	6.60E-20	97.4	WNT4_HUMAN	reviewed	Protein Wnt-4	WNT4 UNQ426/PRO864	Homo sapiens (Human)	351	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via MAPK cascade [GO:0038030]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; Wnt signaling pathway [GO:0016055]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714]	GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0016055; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0038030; GO:0040037; GO:0042445; GO:0043547; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234	"adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via MAPK cascade [GO:0038030]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10890_c1_g1_i1	P49338	WNT4_XENLA	84.8	33	5	0	67	165	198	230	4.30E-11	68.9	WNT4_XENLA	reviewed	Protein Wnt-4 (XWnt-4)	wnt4	Xenopus laevis (African clawed frog)	351	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0009880; GO:0016055; GO:0039018; GO:0039020; GO:0072013	embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]		brown	brown	NA	NA	NA	NA
TRINITY_DN10890_c1_g1_i2	P49338	WNT4_XENLA	55.3	76	34	0	268	41	223	298	4.20E-19	95.1	WNT4_XENLA	reviewed	Protein Wnt-4 (XWnt-4)	wnt4	Xenopus laevis (African clawed frog)	351	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0009880; GO:0016055; GO:0039018; GO:0039020; GO:0072013	embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]		brown	brown	NA	NA	NA	NA
TRINITY_DN10890_c1_g1_i4	P49338	WNT4_XENLA	59.6	109	44	0	67	393	198	306	1.40E-34	147.1	WNT4_XENLA	reviewed	Protein Wnt-4 (XWnt-4)	wnt4	Xenopus laevis (African clawed frog)	351	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0009880; GO:0016055; GO:0039018; GO:0039020; GO:0072013	embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN34915_c0_g1_i1	P31286	WNT5A_XENLA	70.7	58	17	0	201	28	323	380	3.90E-22	104.8	WNT5A_XENLA	reviewed	Protein Wnt-5a (XWnt-5a)	wnt5a	Xenopus laevis (African clawed frog)	380	"extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; frizzled binding [GO:0005109]; Wnt-protein binding [GO:0017147]; anterior/posterior axis specification, embryo [GO:0008595]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; dorsal/ventral axis specification [GO:0009950]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Spemann organizer formation [GO:0060061]"	extracellular region [GO:0005576]; protein-containing complex [GO:0032991]	frizzled binding [GO:0005109]; Wnt-protein binding [GO:0017147]	GO:0005109; GO:0005576; GO:0008595; GO:0009950; GO:0017147; GO:0032991; GO:0042074; GO:0045944; GO:0060061; GO:0060070; GO:0090090	"anterior/posterior axis specification, embryo [GO:0008595]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; dorsal/ventral axis specification [GO:0009950]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Spemann organizer formation [GO:0060061]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28147_c0_g1_i2	P28145	WNT6_THUTH	53.8	39	18	0	119	235	79	117	1.20E-06	53.5	WNT6_THUTH	reviewed	Protein Wnt-6 (Fragment)	wnt6	Thunnus thynnus (Atlantic bluefin tuna) (Scomber thynnus)	117	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0007275; GO:0016055	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN18571_c0_g1_i1	Q1KYK4	WNT7A_AOTTR	76.6	47	11	0	105	245	303	349	4.60E-20	98.2	WNT7A_AOTTR	reviewed	Protein Wnt-7a	WNT7A	Aotus trivirgatus (Three-striped night monkey) (Douroucouli)	349	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0007275; GO:0016055	multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN18571_c0_g1_i2	P56706	WNT7B_HUMAN	88.9	99	11	0	1	297	251	349	6.10E-51	201.1	WNT7B_HUMAN	reviewed	Protein Wnt-7b	WNT7B	Homo sapiens (Human)	349	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular metabolic process [GO:0044237]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; in utero embryonic development [GO:0001701]; inner medullary collecting duct development [GO:0072061]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	GO:0001701; GO:0003338; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007257; GO:0016055; GO:0016332; GO:0021871; GO:0022009; GO:0030182; GO:0030324; GO:0030666; GO:0032364; GO:0032536; GO:0042592; GO:0044237; GO:0045165; GO:0045669; GO:0046330; GO:0048018; GO:0048144; GO:0048568; GO:0048812; GO:0050808; GO:0051384; GO:0060070; GO:0060425; GO:0060428; GO:0060482; GO:0060535; GO:0060560; GO:0060669; GO:0060710; GO:0061180; GO:0070062; GO:0070307; GO:0071300; GO:0072053; GO:0072054; GO:0072060; GO:0072061; GO:0072089; GO:0072205; GO:0072207; GO:0072236	activation of JUN kinase activity [GO:0007257]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular metabolic process [GO:0044237]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; inner medullary collecting duct development [GO:0072061]; in utero embryonic development [GO:0001701]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN25233_c0_g1_i1	Q3L254	WNT7B_CHICK	59.6	94	36	2	279	1	67	159	1.30E-26	120.2	WNT7B_CHICK	reviewed	Protein Wnt-7b	WNT7B	Gallus gallus (Chicken)	349	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	GO:0005109; GO:0005125; GO:0005615; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]		NA	NA	NA	NA	NA	NA
TRINITY_DN18719_c0_g1_i1	P28047	WNT7B_MOUSE	52.5	282	129	4	844	5	20	298	2.00E-79	297.4	WNT7B_MOUSE	reviewed	Protein Wnt-7b	Wnt7b Wnt-7b	Mus musculus (Mouse)	349	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; activation of JUN kinase activity [GO:0007257]; anatomical structure regression [GO:0060033]; angiogenesis [GO:0001525]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular metabolic process [GO:0044237]; central nervous system vasculogenesis [GO:0022009]; chemoattraction of dopaminergic neuron axon [GO:0036516]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; in utero embryonic development [GO:0001701]; inner medullary collecting duct development [GO:0072061]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung-associated mesenchyme development [GO:0060484]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; smooth muscle cell differentiation [GO:0051145]; stem cell development [GO:0048864]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	GO:0001525; GO:0001701; GO:0001944; GO:0003338; GO:0005109; GO:0005125; GO:0005615; GO:0005737; GO:0005788; GO:0005886; GO:0007257; GO:0008284; GO:0009986; GO:0010628; GO:0016055; GO:0016332; GO:0021846; GO:0021871; GO:0022009; GO:0030182; GO:0030324; GO:0031175; GO:0032364; GO:0032536; GO:0036516; GO:0042475; GO:0042592; GO:0044237; GO:0045165; GO:0045669; GO:0045879; GO:0046330; GO:0048018; GO:0048568; GO:0048812; GO:0048864; GO:0050768; GO:0050808; GO:0051145; GO:0060033; GO:0060070; GO:0060425; GO:0060428; GO:0060482; GO:0060484; GO:0060535; GO:0060560; GO:0060669; GO:0060710; GO:0072053; GO:0072054; GO:0072060; GO:0072061; GO:0072205; GO:0072207; GO:0072236; GO:1902262; GO:1902379; GO:1904938	activation of JUN kinase activity [GO:0007257]; anatomical structure regression [GO:0060033]; angiogenesis [GO:0001525]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular metabolic process [GO:0044237]; central nervous system vasculogenesis [GO:0022009]; chemoattraction of dopaminergic neuron axon [GO:0036516]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; inner medullary collecting duct development [GO:0072061]; in utero embryonic development [GO:0001701]; lobar bronchus development [GO:0060482]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; smooth muscle cell differentiation [GO:0051145]; stem cell development [GO:0048864]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN40566_c0_g1_i1	B4J2W3	WLS_DROGR	50	116	52	2	3	350	153	262	2.20E-28	126.3	WLS_DROGR	reviewed	Protein wntless	wls GH16661	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	562	cell projection [GO:0042995]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; intrinsic component of endosome membrane [GO:0031302]; intrinsic component of Golgi membrane [GO:0031228]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Wnt-protein binding [GO:0017147]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; Golgi to plasma membrane protein transport [GO:0043001]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; positive regulation of protein secretion [GO:0050714]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of intracellular protein transport [GO:0033157]; segment polarity determination [GO:0007367]; trans-synaptic signalling via exosome [GO:0099157]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055]	cell projection [GO:0042995]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; intrinsic component of endosome membrane [GO:0031302]; intrinsic component of Golgi membrane [GO:0031228]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	Wnt-protein binding [GO:0017147]	GO:0001745; GO:0005769; GO:0005771; GO:0005887; GO:0007367; GO:0007480; GO:0008587; GO:0016055; GO:0017147; GO:0030177; GO:0030285; GO:0031227; GO:0031228; GO:0031302; GO:0031594; GO:0033157; GO:0035017; GO:0042734; GO:0042995; GO:0043001; GO:0045211; GO:0050714; GO:0061355; GO:0061357; GO:0070062; GO:0099056; GO:0099157	compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; Golgi to plasma membrane protein transport [GO:0043001]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; positive regulation of protein secretion [GO:0050714]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of intracellular protein transport [GO:0033157]; segment polarity determination [GO:0007367]; trans-synaptic signalling via exosome [GO:0099157]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN39315_c0_g1_i1	Q6DJR2	WWC2_XENTR	41.8	244	132	3	706	5	75	318	1.90E-42	174.1	WWC2_XENTR	reviewed	Protein WWC2 (WW domain-containing protein 2)	wwc2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1171							NA	NA	NA	NA	NA	NA
TRINITY_DN16549_c0_g1_i2	F1QC45	XRP2_DANRE	45.1	328	172	5	990	25	49	374	1.50E-73	278.1	XRP2_DANRE	reviewed	Protein XRP2	rp2	Danio rerio (Zebrafish) (Brachydanio rerio)	376	cilium [GO:0005929]; periciliary membrane compartment [GO:1990075]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; cell morphogenesis [GO:0000902]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; post-Golgi vesicle-mediated transport [GO:0006892]; pronephros development [GO:0048793]; protein transport [GO:0015031]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]	cilium [GO:0005929]; periciliary membrane compartment [GO:1990075]	GTPase activator activity [GO:0005096]; GTP binding [GO:0005525]	GO:0000902; GO:0001947; GO:0005096; GO:0005525; GO:0005929; GO:0006892; GO:0010842; GO:0015031; GO:0035845; GO:0042461; GO:0045494; GO:0048793; GO:0060041; GO:0061371; GO:1990075	cell morphogenesis [GO:0000902]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; post-Golgi vesicle-mediated transport [GO:0006892]; pronephros development [GO:0048793]; protein transport [GO:0015031]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN16549_c0_g1_i4	Q9EPK2	XRP2_MOUSE	54.6	152	68	1	890	438	1	152	3.80E-46	186.8	XRP2_MOUSE	reviewed	Protein XRP2	Rp2 Rp2h	Mus musculus (Mouse)	347	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0000902; GO:0005096; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006892; GO:0015031; GO:0016604; GO:0031410; GO:0036064; GO:1990075	cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN29487_c0_g1_i1	O75695	XRP2_HUMAN	100	70	0	0	210	1	37	106	2.70E-37	155.2	XRP2_HUMAN	reviewed	Protein XRP2	RP2	Homo sapiens (Human)	350	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; unfolded protein binding [GO:0051082]; cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein folding [GO:0006457]; protein transport [GO:0015031]; visual perception [GO:0007601]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0000902; GO:0005096; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006457; GO:0006892; GO:0007601; GO:0015031; GO:0016604; GO:0031410; GO:0036064; GO:0051082; GO:0070062; GO:1990075	cell morphogenesis [GO:0000902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein folding [GO:0006457]; protein transport [GO:0015031]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN27915_c0_g1_i1	O95070	YIF1A_HUMAN	100	95	0	0	1	285	156	250	2.30E-44	179.1	YIF1A_HUMAN	reviewed	Protein YIF1A (54TMp) (YIP1-interacting factor homolog A)	YIF1A 54TM HYIF1P YIF1	Homo sapiens (Human)	293	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]		GO:0005789; GO:0005793; GO:0006888; GO:0015031; GO:0030134; GO:0030173; GO:0033116; GO:0036498	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN35772_c0_g1_i1	O95070	YIF1A_HUMAN	100	70	0	0	3	212	49	118	1.30E-34	146.4	YIF1A_HUMAN	reviewed	Protein YIF1A (54TMp) (YIP1-interacting factor homolog A)	YIF1A 54TM HYIF1P YIF1	Homo sapiens (Human)	293	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]		GO:0005789; GO:0005793; GO:0006888; GO:0015031; GO:0030134; GO:0030173; GO:0033116; GO:0036498	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN40084_c0_g1_i1	Q91XB7	YIF1A_MOUSE	100	80	0	0	1	240	168	247	1.30E-35	149.8	YIF1A_MOUSE	reviewed	Protein YIF1A (YIP1-interacting factor homolog A)	Yif1a	Mus musculus (Mouse)	293	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]		GO:0005789; GO:0005793; GO:0006888; GO:0015031; GO:0030134; GO:0030173; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN18909_c0_g1_i1	Q5BJH7	YIF1B_HUMAN	100	93	0	0	279	1	66	158	2.40E-49	195.7	YIF1B_HUMAN	reviewed	Protein YIF1B (YIP1-interacting factor homolog B)	YIF1B PP4519 UNQ3073/PRO9905	Homo sapiens (Human)	314	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein targeting to membrane [GO:0006612]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006612; GO:0006888; GO:0030134; GO:0030173; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein targeting to membrane [GO:0006612]		NA	NA	NA	NA	NA	NA
TRINITY_DN2651_c0_g1_i1	Q4FZQ0	YF1BB_XENLA	54	248	111	2	840	103	53	299	9.90E-71	268.9	YF1BB_XENLA	reviewed	Protein YIF1B-B (YIP1-interacting factor homolog B-B)	yif1b-b	Xenopus laevis (African clawed frog)	300	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0016021; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2651_c0_g1_i3	Q4FZQ0	YF1BB_XENLA	54	248	111	2	840	103	53	299	9.80E-71	268.9	YF1BB_XENLA	reviewed	Protein YIF1B-B (YIP1-interacting factor homolog B-B)	yif1b-b	Xenopus laevis (African clawed frog)	300	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0016021; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2651_c0_g1_i4	Q4FZQ0	YF1BB_XENLA	54	248	111	2	840	103	53	299	9.80E-71	268.9	YF1BB_XENLA	reviewed	Protein YIF1B-B (YIP1-interacting factor homolog B-B)	yif1b-b	Xenopus laevis (African clawed frog)	300	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0016021; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN2651_c0_g1_i5	Q4FZQ0	YF1BB_XENLA	54	248	111	2	840	103	53	299	9.80E-71	268.9	YF1BB_XENLA	reviewed	Protein YIF1B-B (YIP1-interacting factor homolog B-B)	yif1b-b	Xenopus laevis (African clawed frog)	300	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0016021; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN33525_c0_g1_i1	Q9Y548	YIPF1_HUMAN	100	91	0	0	1	273	165	255	1.20E-45	183.3	YIPF1_HUMAN	reviewed	Protein YIPF1 (YIP1 family member 1)	YIPF1	Homo sapiens (Human)	306	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; Rab GTPase binding [GO:0017137]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005794; GO:0005797; GO:0005802; GO:0016021; GO:0016192; GO:0017137; GO:0030133; GO:0031902	vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3526_c0_g1_i1	Q91VU1	YIPF1_MOUSE	45.4	260	131	3	51	809	44	299	1.30E-60	234.6	YIPF1_MOUSE	reviewed	Protein YIPF1 (YIP1 family member 1)	Yipf1	Mus musculus (Mouse)	306	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; Rab GTPase binding [GO:0017137]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	Rab GTPase binding [GO:0017137]	GO:0000138; GO:0005794; GO:0005797; GO:0005802; GO:0016021; GO:0016192; GO:0017137; GO:0030133; GO:0031902	vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10429_c0_g1_i1	Q28CH8	YIPF6_XENTR	56.4	195	84	1	120	704	30	223	1.20E-62	241.1	YIPF6_XENTR	reviewed	Protein YIPF6 (YIP1 family member 6)	yipf6 TGas105o14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	233	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]		GO:0000138; GO:0000139; GO:0005797; GO:0005802; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN37806_c0_g1_i1	Q96EC8	YIPF6_HUMAN	100	156	0	0	1	468	41	196	6.50E-84	311.2	YIPF6_HUMAN	reviewed	Protein YIPF6 (YIP1 family member 6)	YIPF6	Homo sapiens (Human)	236	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; intestinal epithelial cell development [GO:0060576]	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	identical protein binding [GO:0042802]	GO:0000138; GO:0000139; GO:0005783; GO:0005797; GO:0005801; GO:0005802; GO:0016021; GO:0030134; GO:0042802; GO:0060576	intestinal epithelial cell development [GO:0060576]		NA	NA	NA	NA	NA	NA
TRINITY_DN26966_c0_g1_i1	Q2YDI3	YPEL2_BOVIN	94.9	118	6	0	422	69	2	119	7.40E-63	241.9	YPEL2_BOVIN	reviewed	Protein yippee-like 2	YPEL2	Bos taurus (Bovine)	119	nucleolus [GO:0005730]; metal ion binding [GO:0046872]	nucleolus [GO:0005730]	metal ion binding [GO:0046872]	GO:0005730; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11925_c0_g1_i1	A6QPH8	YPEL3_BOVIN	100	119	0	0	386	30	1	119	4.30E-68	258.5	YPEL3_BOVIN	reviewed	Protein yippee-like 3	YPEL3	Bos taurus (Bovine)	119	nucleolus [GO:0005730]; metal ion binding [GO:0046872]	nucleolus [GO:0005730]	metal ion binding [GO:0046872]	GO:0005730; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11925_c0_g1_i2	A6QPH8	YPEL3_BOVIN	100	119	0	0	386	30	1	119	4.30E-68	258.5	YPEL3_BOVIN	reviewed	Protein yippee-like 3	YPEL3	Bos taurus (Bovine)	119	nucleolus [GO:0005730]; metal ion binding [GO:0046872]	nucleolus [GO:0005730]	metal ion binding [GO:0046872]	GO:0005730; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1676_c0_g1_i7	Q47688	YKFC_ECOLI	23.4	244	150	9	802	107	15	233	1.40E-05	53.1	YKFC_ECOLI	reviewed	Protein YkfC	ykfC b0258 JW5813	Escherichia coli (strain K12)	381							NA	NA	NA	NA	NA	NA
TRINITY_DN1676_c0_g1_i2	Q47688	YKFC_ECOLI	23.8	244	149	9	802	107	15	233	7.70E-07	57.4	YKFC_ECOLI	reviewed	Protein YkfC	ykfC b0258 JW5813	Escherichia coli (strain K12)	381							brown	brown	1	NA	NA	NA
TRINITY_DN4744_c0_g1_i1	A4Z945	ZBED8_BOVIN	45.8	107	57	1	97	417	75	180	1.00E-19	97.8	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i10	A4Z945	ZBED8_BOVIN	46.4	140	75	0	10	429	83	222	1.70E-30	133.7	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i11	A4Z945	ZBED8_BOVIN	45.5	88	48	0	293	556	75	162	1.40E-16	87.8	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i13	Q8IZ13	ZBED8_HUMAN	41.4	181	106	0	8	550	42	222	2.50E-34	146.7	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i19	Q8IZ13	ZBED8_HUMAN	44.9	167	90	1	83	583	58	222	5.00E-33	142.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i2	A4Z945	ZBED8_BOVIN	45.9	148	80	0	293	736	75	222	5.00E-30	132.9	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i4	A4Z945	ZBED8_BOVIN	45.5	88	48	0	252	515	75	162	1.30E-16	87.8	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i8	A4Z945	ZBED8_BOVIN	47.3	148	78	0	97	540	75	222	1.80E-32	140.6	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i9	Q8IZ13	ZBED8_HUMAN	43.2	125	69	1	83	457	58	180	1.80E-22	107.1	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g2_i2	Q8IZ13	ZBED8_HUMAN	51.5	97	47	0	1	291	174	270	8.80E-23	107.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2908_c1_g2_i3	Q8IZ13	ZBED8_HUMAN	52.4	82	39	0	367	122	88	169	2.80E-18	92.8	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2908_c1_g2_i4	Q8IZ13	ZBED8_HUMAN	41.7	96	55	1	341	54	106	200	7.10E-16	84.7	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2908_c4_g1_i1	Q8IZ13	ZBED8_HUMAN	40.6	244	144	1	4	732	27	270	1.60E-49	197.6	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2908_c1_g3_i1	Q8IZ13	ZBED8_HUMAN	44.7	85	47	0	263	9	88	172	3.60E-15	82	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN16345_c0_g1_i1	Q8IZ13	ZBED8_HUMAN	41.4	87	46	2	333	82	472	556	5.50E-13	75.1	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN16345_c0_g1_i2	Q8IZ13	ZBED8_HUMAN	41.4	87	46	2	333	82	472	556	4.30E-13	75.9	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN27757_c0_g1_i1	A4Z945	ZBED8_BOVIN	44.7	114	63	0	350	9	294	407	8.90E-25	114.4	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN8524_c0_g1_i1	A4Z945	ZBED8_BOVIN	42.4	139	78	1	458	48	95	233	2.50E-24	113.2	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN7908_c2_g1_i1	A4Z945	ZBED8_BOVIN	37.7	69	36	2	3	203	523	586	4.00E-05	48.5	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN17360_c0_g2_i1	Q8IZ13	ZBED8_HUMAN	41	61	36	0	23	205	139	199	1.60E-07	56.2	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN17360_c0_g1_i1	A4Z945	ZBED8_BOVIN	43.1	102	56	1	9	314	71	170	1.90E-15	83.2	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN17399_c0_g1_i1	A4Z945	ZBED8_BOVIN	42.9	56	32	0	195	28	74	129	3.60E-07	55.5	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN17399_c0_g1_i2	Q8IZ13	ZBED8_HUMAN	34.9	106	69	0	345	28	24	129	8.00E-13	74.7	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN28742_c0_g1_i1	A4Z945	ZBED8_BOVIN	56.1	107	47	0	321	1	91	197	2.50E-26	119.4	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN19646_c0_g1_i1	Q8IZ13	ZBED8_HUMAN	49.2	63	32	0	6	194	286	348	1.30E-12	73.6	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN7704_c0_g1_i1	A4Z945	ZBED8_BOVIN	52.5	162	77	0	40	525	74	235	2.10E-43	176.8	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN7704_c0_g1_i2	A4Z945	ZBED8_BOVIN	53.7	162	75	0	40	525	74	235	2.50E-44	179.9	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i1	A4Z945	ZBED8_BOVIN	50.9	55	27	0	165	1	172	226	1.60E-08	60.5	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i10	A4Z945	ZBED8_BOVIN	45.9	74	40	0	234	13	149	222	2.00E-12	72.8	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i11	A4Z945	ZBED8_BOVIN	49.3	71	36	0	213	1	156	226	1.60E-13	76.3	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i2	A4Z945	ZBED8_BOVIN	48.1	108	56	0	333	10	125	232	4.30E-23	109	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i3	A4Z945	ZBED8_BOVIN	49	98	50	0	306	13	125	222	1.90E-20	100.1	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i4	A4Z945	ZBED8_BOVIN	46.4	84	45	0	261	10	149	232	2.80E-15	82.4	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i5	A4Z945	ZBED8_BOVIN	48.2	83	43	0	258	10	150	232	2.30E-14	79.3	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i6	A4Z945	ZBED8_BOVIN	47.8	67	35	0	201	1	160	226	2.90E-12	72	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i7	A4Z945	ZBED8_BOVIN	49	98	50	0	306	13	125	222	4.90E-21	102.1	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN6851_c0_g1_i8	Q8IZ13	ZBED8_HUMAN	48.8	84	43	0	313	62	125	208	3.30E-17	89.4	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN13727_c0_g1_i1	Q8IZ13	ZBED8_HUMAN	46.3	134	71	1	3	404	95	227	1.10E-29	131	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN19247_c0_g2_i1	Q8IZ13	ZBED8_HUMAN	34	94	56	3	3	275	243	333	3.70E-07	55.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN7279_c0_g3_i1	A4Z945	ZBED8_BOVIN	49.2	120	59	1	364	5	291	408	1.00E-23	110.9	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN7279_c0_g2_i1	A4Z945	ZBED8_BOVIN	50	54	27	0	170	9	317	370	3.10E-08	58.9	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN3521_c0_g1_i1	A4Z945	ZBED8_BOVIN	38	442	269	3	125	1444	2	440	2.20E-86	322	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN3521_c0_g1_i2	A4Z945	ZBED8_BOVIN	36.6	599	357	6	125	1903	2	583	9.50E-108	392.5	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN3521_c0_g1_i3	A4Z945	ZBED8_BOVIN	36.4	599	358	6	1895	117	2	583	1.60E-107	391.7	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5759_c0_g1_i1	A4Z945	ZBED8_BOVIN	37.3	118	74	0	364	11	174	291	1.70E-19	97.1	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5759_c0_g1_i3	A4Z945	ZBED8_BOVIN	39	82	50	0	279	34	174	255	1.70E-11	70.1	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5759_c0_g1_i5	A4Z945	ZBED8_BOVIN	38.1	118	73	0	364	11	174	291	1.30E-19	97.4	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			yellow	yellow	NA	NA	NA	NA
TRINITY_DN9751_c1_g1_i1	Q8IZ13	ZBED8_HUMAN	42.5	73	40	1	3	221	516	586	2.90E-10	65.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN9751_c1_g1_i2	Q8IZ13	ZBED8_HUMAN	55.6	45	20	0	3	137	516	560	2.00E-08	59.3	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN27798_c0_g1_i1	A4Z945	ZBED8_BOVIN	47.1	68	36	0	37	240	127	194	4.50E-10	65.1	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN10538_c4_g1_i1	A4Z945	ZBED8_BOVIN	46.3	67	35	1	29	229	508	573	2.60E-09	62.4	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN9548_c0_g1_i1	A4Z945	ZBED8_BOVIN	44.9	78	42	1	25	255	513	590	1.70E-10	66.6	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN626_c0_g1_i2	A4Z945	ZBED8_BOVIN	48.6	70	36	0	224	15	339	408	1.80E-13	76.3	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			yellow	yellow	1	NA	NA	NA
TRINITY_DN626_c0_g1_i9	A4Z945	ZBED8_BOVIN	46.9	49	26	0	161	15	360	408	4.90E-06	52.4	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			yellow	yellow	1	NA	NA	NA
TRINITY_DN16645_c0_g1_i1	Q8IZ13	ZBED8_HUMAN	45.6	329	178	1	985	2	2	330	4.80E-79	296.2	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c2_g1_i1	Q8IZ13	ZBED8_HUMAN	38.3	214	124	5	15	641	376	586	4.60E-32	139.4	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c1_g1_i1	Q8IZ13	ZBED8_HUMAN	40	60	34	1	249	70	518	575	4.20E-05	48.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c1_g1_i2	Q8IZ13	ZBED8_HUMAN	39.7	78	43	2	254	27	518	593	4.50E-07	55.1	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c1_g1_i4	Q8IZ13	ZBED8_HUMAN	38.2	68	40	1	320	117	518	583	2.80E-06	52.8	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c1_g1_i5	Q8IZ13	ZBED8_HUMAN	39.7	78	43	2	251	24	518	593	3.40E-07	55.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i10	Q8IZ13	ZBED8_HUMAN	35.9	170	102	3	2	496	407	574	3.30E-23	109.8	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i12	Q8IZ13	ZBED8_HUMAN	41.1	265	151	2	3	782	295	559	9.90E-53	208.4	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i14	Q8IZ13	ZBED8_HUMAN	35.1	134	82	2	185	571	426	559	1.60E-15	84.3	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i2	Q8IZ13	ZBED8_HUMAN	34.2	155	95	3	2	445	407	561	4.00E-20	99.4	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i4	Q8IZ13	ZBED8_HUMAN	50	134	67	0	3	404	295	428	7.30E-32	139	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i4	Q8IZ13	ZBED8_HUMAN	36.9	122	71	2	373	726	469	588	4.30E-16	86.7	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i5	Q8IZ13	ZBED8_HUMAN	35.9	184	111	3	2	538	407	588	7.10E-27	122.1	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i7	A4Z945	ZBED8_BOVIN	52.3	111	53	0	3	335	295	405	3.70E-25	115.5	ZBED8_BOVIN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3	Bos taurus (Bovine)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i8	Q8IZ13	ZBED8_HUMAN	34.1	123	76	2	185	538	426	548	6.80E-13	75.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i9	Q8IZ13	ZBED8_HUMAN	40.4	267	152	3	3	782	295	561	1.50E-51	204.5	ZBED8_HUMAN	reviewed	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)	594	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN29163_c0_g1_i1	Q7Z7L7	ZER1_HUMAN	100	70	0	0	1	210	658	727	2.70E-37	155.2	ZER1_HUMAN	reviewed	Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein)	ZER1 C9orf60 ZYG ZYG11BL	Homo sapiens (Human)	766	Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	Cul2-RING ubiquitin ligase complex [GO:0031462]		GO:0006515; GO:0031462; GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2648_c0_g1_i1	Q9W0E8	ZER1_DROME	46.4	780	357	10	2295	64	38	792	2.50E-182	640.6	ZER1_DROME	reviewed	Protein zer-1 homolog (Zyg-11 homolog B-like protein)	CG12084	Drosophila melanogaster (Fruit fly)	793	Cul2-RING ubiquitin ligase complex [GO:0031462]	Cul2-RING ubiquitin ligase complex [GO:0031462]		GO:0031462			NA	NA	NA	NA	NA	NA
TRINITY_DN2648_c0_g1_i3	Q9W0E8	ZER1_DROME	46.7	780	356	9	2298	64	38	792	5.30E-185	649.4	ZER1_DROME	reviewed	Protein zer-1 homolog (Zyg-11 homolog B-like protein)	CG12084	Drosophila melanogaster (Fruit fly)	793	Cul2-RING ubiquitin ligase complex [GO:0031462]	Cul2-RING ubiquitin ligase complex [GO:0031462]		GO:0031462			NA	NA	NA	NA	NA	NA
TRINITY_DN3782_c0_g1_i3	P56873	ZNRD2_MOUSE	54.5	77	35	0	100	330	9	85	1.20E-20	100.9	ZNRD2_MOUSE	reviewed	Protein ZNRD2 (Autoantigen p27 homolog) (Protein C184L) (Sjoegren syndrome/scleroderma autoantigen 1 homolog) (Zinc ribbon domain-containing protein 2)	Znrd2 C184l Sssca1	Mus musculus (Mouse)	199	identical protein binding [GO:0042802]		identical protein binding [GO:0042802]	GO:0042802			NA	NA	NA	NA	NA	NA
TRINITY_DN26056_c0_g1_i1	O60232	ZNRD2_HUMAN	100	69	0	0	3	209	1	69	2.10E-34	145.6	ZNRD2_HUMAN	reviewed	Protein ZNRD2 (Autoantigen p27) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2)	ZNRD2 SSSCA1	Homo sapiens (Human)	199	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]			GO:0000278; GO:0051301	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN3782_c0_g1_i1	O60232	ZNRD2_HUMAN	36.2	199	117	2	100	696	9	197	3.90E-25	116.7	ZNRD2_HUMAN	reviewed	Protein ZNRD2 (Autoantigen p27) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2)	ZNRD2 SSSCA1	Homo sapiens (Human)	199	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]			GO:0000278; GO:0051301	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]		blue	blue	NA	NA	NA	NA
TRINITY_DN8632_c1_g1_i1	Q3UFS0	ZY11B_MOUSE	37.6	739	427	10	2251	53	15	725	6.80E-126	453	ZY11B_MOUSE	reviewed	Protein zyg-11 homolog B	Zyg11b Kiaa1730	Mus musculus (Mouse)	744	Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	Cul2-RING ubiquitin ligase complex [GO:0031462]		GO:0006515; GO:0031462; GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN8632_c1_g1_i2	Q3UFS0	ZY11B_MOUSE	37.6	739	427	10	2251	53	15	725	5.30E-126	453.4	ZY11B_MOUSE	reviewed	Protein zyg-11 homolog B	Zyg11b Kiaa1730	Mus musculus (Mouse)	744	Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	Cul2-RING ubiquitin ligase complex [GO:0031462]		GO:0006515; GO:0031462; GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i1	Q9VZU2	HHAT_DROME	38	129	76	1	47	433	304	428	2.20E-20	100.1	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i10	Q9VZU2	HHAT_DROME	42.6	47	27	0	47	187	304	350	2.00E-05	49.7	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i2	Q9VZU2	HHAT_DROME	39.2	120	69	1	47	406	304	419	8.10E-20	99	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i4	Q9VZU2	HHAT_DROME	40	125	70	1	47	406	304	428	3.10E-19	96.3	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i5	Q9VZU2	HHAT_DROME	40.7	113	67	0	47	385	304	416	6.20E-21	102.8	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i6	Q9VZU2	HHAT_DROME	39.5	124	70	1	47	403	304	427	1.80E-19	97.1	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN2_c5_g1_i9	Q9VZU2	HHAT_DROME	40.5	116	68	1	47	391	304	419	2.10E-20	100.9	HHAT_DROME	reviewed	Protein-cysteine N-palmitoyltransferase Rasp (EC 2.3.1.-) (Protein central missing) (Protein sightless) (Protein skinny hedgehog)	rasp cmn sit ski CG11495	Drosophila melanogaster (Fruit fly)	500	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005783; GO:0005829; GO:0007224; GO:0007225; GO:0007367; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345; GO:0038004; GO:0046843; GO:0048100	dorsal appendage formation [GO:0046843]; epidermal growth factor receptor ligand maturation [GO:0038004]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; patched ligand maturation [GO:0007225]; protein palmitoylation [GO:0018345]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc anterior/posterior pattern formation [GO:0048100]		NA	NA	NA	NA	NA	NA
TRINITY_DN26610_c0_g1_i1	P21981	TGM2_MOUSE	100	149	0	0	1	447	271	419	6.00E-87	321.2	TGM2_MOUSE	reviewed	Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase-2) (TGase-2)	Tgm2	Mus musculus (Mouse)	686	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; transaminase activity [GO:0008483]; apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; branching involved in salivary gland morphogenesis [GO:0060445]; G protein-coupled receptor signaling pathway [GO:0007186]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peptide cross-linking [GO:0018149]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of smooth muscle cell proliferation [GO:0048661]; salivary gland cavitation [GO:0060662]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; transaminase activity [GO:0008483]	GO:0001974; GO:0003810; GO:0005509; GO:0005525; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0007186; GO:0007200; GO:0008483; GO:0016020; GO:0018149; GO:0018153; GO:0019904; GO:0031012; GO:0031226; GO:0032471; GO:0042802; GO:0043065; GO:0043123; GO:0043277; GO:0045785; GO:0048661; GO:0050729; GO:0051482; GO:0051561; GO:0060445; GO:0060662; GO:0062023	apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; branching involved in salivary gland morphogenesis [GO:0060445]; G protein-coupled receptor signaling pathway [GO:0007186]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peptide cross-linking [GO:0018149]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of smooth muscle cell proliferation [GO:0048661]; salivary gland cavitation [GO:0060662]		NA	NA	NA	NA	NA	NA
TRINITY_DN29737_c1_g1_i1	Q9GLK0	TGM1_CANLF	38.3	81	48	1	1	243	453	531	4.90E-12	71.6	TGM1_CANLF	reviewed	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	TGM1	Canis lupus familiaris (Dog) (Canis familiaris)	815	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]	membrane [GO:0016020]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0010838; GO:0016020; GO:0018149; GO:0031424; GO:0045787; GO:0046872	keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]		NA	NA	NA	NA	NA	NA
TRINITY_DN27955_c0_g1_i1	A2VDP2	PCMD1_BOVIN	100	82	0	0	246	1	38	119	3.80E-43	174.9	PCMD1_BOVIN	reviewed	Protein-L-isoaspartate O-methyltransferase domain-containing protein 1	PCMTD1	Bos taurus (Bovine)	356	cytoplasm [GO:0005737]; membrane [GO:0016020]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]; membrane [GO:0016020]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN4649_c0_g1_i1	A2VDP2	PCMD1_BOVIN	75.8	33	8	0	190	92	71	103	5.50E-06	51.6	PCMD1_BOVIN	reviewed	Protein-L-isoaspartate O-methyltransferase domain-containing protein 1	PCMTD1	Bos taurus (Bovine)	356	cytoplasm [GO:0005737]; membrane [GO:0016020]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]; membrane [GO:0016020]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN4649_c0_g1_i2	A2VDP2	PCMD1_BOVIN	69.9	103	31	0	400	92	1	103	2.30E-36	153.3	PCMD1_BOVIN	reviewed	Protein-L-isoaspartate O-methyltransferase domain-containing protein 1	PCMTD1	Bos taurus (Bovine)	356	cytoplasm [GO:0005737]; membrane [GO:0016020]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]; membrane [GO:0016020]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737; GO:0016020			NA	NA	NA	NA	NA	NA
TRINITY_DN4649_c0_g1_i4	A2VDP2	PCMD1_BOVIN	52.4	309	139	4	1122	211	1	306	1.00E-85	318.5	PCMD1_BOVIN	reviewed	Protein-L-isoaspartate O-methyltransferase domain-containing protein 1	PCMTD1	Bos taurus (Bovine)	356	cytoplasm [GO:0005737]; membrane [GO:0016020]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]; membrane [GO:0016020]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737; GO:0016020			blue	blue	NA	NA	NA	NA
TRINITY_DN28951_c0_g1_i1	Q92047	PIMT_DANRE	51	100	47	1	295	2	117	216	2.40E-20	99.4	PIMT_DANRE	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	pcmt	Danio rerio (Zebrafish) (Brachydanio rerio)	228	cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN821_c0_g1_i3	Q5F3N1	PIMT_CHICK	62.8	223	83	0	794	126	1	223	9.30E-77	288.5	PIMT_CHICK	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	PCMT1 RCJMB04_11o11	Gallus gallus (Chicken)	228	cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN821_c0_g1_i4	Q5F3N1	PIMT_CHICK	62.8	223	83	0	794	126	1	223	9.00E-77	288.5	PIMT_CHICK	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	PCMT1 RCJMB04_11o11	Gallus gallus (Chicken)	228	cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN821_c0_g1_i5	Q5F3N1	PIMT_CHICK	62.8	223	83	0	796	128	1	223	1.20E-76	288.1	PIMT_CHICK	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	PCMT1 RCJMB04_11o11	Gallus gallus (Chicken)	228	cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN821_c0_g1_i6	Q5F3N1	PIMT_CHICK	62.8	223	83	0	796	128	1	223	1.20E-76	288.1	PIMT_CHICK	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	PCMT1 RCJMB04_11o11	Gallus gallus (Chicken)	228	cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	cytoplasm [GO:0005737]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN18706_c0_g1_i1	P23506	PIMT_MOUSE	99	99	1	0	1	297	129	227	3.50E-52	205.3	PIMT_MOUSE	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	Pcmt1	Mus musculus (Mouse)	227	basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; protein methylation [GO:0006479]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]	basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0004719; GO:0005615; GO:0005737; GO:0005829; GO:0006479; GO:0008757; GO:0010667; GO:0016323; GO:0031526; GO:0043005; GO:0043204; GO:0046498; GO:0046500	negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; protein methylation [GO:0006479]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]		NA	NA	NA	NA	NA	NA
TRINITY_DN18706_c0_g1_i2	P22061	PIMT_HUMAN	99.5	205	1	0	2	616	23	227	6.10E-117	421.4	PIMT_HUMAN	reviewed	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	PCMT1	Homo sapiens (Human)	227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; protein methylation [GO:0006479]; protein repair [GO:0030091]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]	cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0030091; GO:0045296; GO:0070062; GO:1903561	protein methylation [GO:0006479]; protein repair [GO:0030091]		NA	NA	NA	NA	NA	NA
TRINITY_DN6263_c0_g1_i2	Q8C436	MT21D_MOUSE	46.4	211	107	4	717	91	16	222	4.00E-40	166.8	MT21D_MOUSE	reviewed	Protein-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase)	Vcpkmt Gm71 Mettl21d	Mus musculus (Mouse)	228	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]	ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023; GO:0032780; GO:0032991; GO:0051117	negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN9943_c0_g1_i1	F1QWK4	MCA3B_DANRE	53.4	58	24	1	177	4	1548	1602	1.50E-08	59.7	MCA3B_DANRE	reviewed	Protein-methionine sulfoxide oxidase mical3b (EC 1.14.13.225) (Molecule interacting with CasL protein 3B) (MICAL-3B)	mical3b	Danio rerio (Zebrafish) (Brachydanio rerio)	1673	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]"	GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0006887; GO:0007010; GO:0016709; GO:0017137; GO:0030042; GO:0046872; GO:0055114; GO:0071949	actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN5549_c1_g1_i2	O12947	ICMT_XENLA	50.9	273	130	3	818	3	1	270	1.30E-70	268.1	ICMT_XENLA	reviewed	Protein-S-isoprenylcysteine O-methyltransferase (EC 2.1.1.100) (Farnesyl cysteine carboxyl methyltransferase) (FCMT) (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase) (PPMT) (Prenylcysteine carboxyl methyltransferase) (pcCMT)	icmt	Xenopus laevis (African clawed frog)	288	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671]	GO:0004671; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN39525_c0_g1_i1	Q14289	FAK2_HUMAN	100	114	0	0	344	3	526	639	1.80E-62	239.6	FAK2_HUMAN	reviewed	Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK)	PTK2B FAK2 PYK2 RAFTK	Homo sapiens (Human)	1009	"apical dendrite [GO:0097440]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase binding [GO:0043423]; ATP binding [GO:0005524]; calmodulin-dependent protein kinase activity [GO:0004683]; NMDA glutamate receptor activity [GO:0004972]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein C-terminus binding [GO:0008022]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel endothelial cell migration [GO:0043534]; bone resorption [GO:0045453]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; glial cell proliferation [GO:0014009]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-2-mediated signaling pathway [GO:0038110]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of potassium ion transport [GO:0043267]; neuron projection development [GO:0031175]; oocyte maturation [GO:0001556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of establishment of cell polarity [GO:2000114]; regulation of inositol trisphosphate biosynthetic process [GO:0032960]; regulation of macrophage chemotaxis [GO:0010758]; regulation of NMDA receptor activity [GO:2000310]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to osmotic stress [GO:0006970]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; stress fiber assembly [GO:0043149]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	apical dendrite [GO:0097440]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]	3-phosphoinositide-dependent protein kinase binding [GO:0043423]; ATP binding [GO:0005524]; calmodulin-dependent protein kinase activity [GO:0004683]; NMDA glutamate receptor activity [GO:0004972]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0001525; GO:0001556; GO:0001666; GO:0001954; GO:0002040; GO:0002250; GO:0002315; GO:0004683; GO:0004713; GO:0004715; GO:0004972; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0005938; GO:0006468; GO:0006915; GO:0006968; GO:0006970; GO:0007165; GO:0007166; GO:0007169; GO:0007172; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008284; GO:0008285; GO:0008360; GO:0009612; GO:0009725; GO:0009749; GO:0010226; GO:0010595; GO:0010656; GO:0010752; GO:0010758; GO:0010976; GO:0014009; GO:0014069; GO:0017146; GO:0018108; GO:0030027; GO:0030154; GO:0030155; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0030502; GO:0030838; GO:0031175; GO:0031234; GO:0031625; GO:0032960; GO:0033209; GO:0035235; GO:0035902; GO:0038083; GO:0038110; GO:0042127; GO:0042220; GO:0042493; GO:0042542; GO:0042976; GO:0043025; GO:0043066; GO:0043149; GO:0043197; GO:0043267; GO:0043423; GO:0043507; GO:0043524; GO:0043534; GO:0043552; GO:0044297; GO:0044877; GO:0045087; GO:0045121; GO:0045429; GO:0045453; GO:0045471; GO:0045638; GO:0045727; GO:0045766; GO:0045860; GO:0046330; GO:0046777; GO:0048010; GO:0048041; GO:0048167; GO:0048471; GO:0050731; GO:0050848; GO:0051000; GO:0051279; GO:0051591; GO:0051592; GO:0051968; GO:0060291; GO:0060292; GO:0065003; GO:0070098; GO:0070374; GO:0071300; GO:0071498; GO:0086100; GO:0090630; GO:0097440; GO:0098978; GO:2000058; GO:2000060; GO:2000114; GO:2000249; GO:2000310; GO:2000463; GO:2000538; GO:2000573	"activation of GTPase activity [GO:0090630]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel endothelial cell migration [GO:0043534]; bone resorption [GO:0045453]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; glial cell proliferation [GO:0014009]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-2-mediated signaling pathway [GO:0038110]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of potassium ion transport [GO:0043267]; neuron projection development [GO:0031175]; oocyte maturation [GO:0001556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell growth [GO:0030307]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; protein-containing complex assembly [GO:0065003]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of establishment of cell polarity [GO:2000114]; regulation of inositol trisphosphate biosynthetic process [GO:0032960]; regulation of macrophage chemotaxis [GO:0010758]; regulation of NMDA receptor activity [GO:2000310]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to osmotic stress [GO:0006970]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; stress fiber assembly [GO:0043149]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3243_c0_g1_i1	Q9VYB7	TPST_DROME	66.6	311	104	0	239	1171	58	368	2.80E-126	453.4	TPST_DROME	reviewed	Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase)	Tpst Tango13 CG32632	Drosophila melanogaster (Fruit fly)	499	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0009306; GO:0016021	peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN33196_c0_g1_i1	O60704	TPST2_HUMAN	100	125	0	0	378	4	44	168	5.80E-67	254.6	TPST2_HUMAN	reviewed	Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2)	TPST2	Homo sapiens (Human)	377	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478]		NA	NA	NA	NA	NA	NA
TRINITY_DN13483_c0_g2_i1	O88856	TPST2_MOUSE	98.8	169	2	0	1	507	181	349	3.60E-96	352.1	TPST2_MOUSE	reviewed	Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2)	Tpst2 D5ucla3	Mus musculus (Mouse)	376	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; peptidyl-tyrosine sulfation [GO:0006478]; prevention of polyspermy [GO:0060468]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0007342; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0060468	fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; peptidyl-tyrosine sulfation [GO:0006478]; prevention of polyspermy [GO:0060468]		NA	NA	NA	NA	NA	NA
TRINITY_DN13483_c0_g1_i1	O60704	TPST2_HUMAN	100	189	0	0	1	567	182	370	2.40E-109	396	TPST2_HUMAN	reviewed	Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2)	TPST2	Homo sapiens (Human)	377	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478]		NA	NA	NA	NA	NA	NA
TRINITY_DN31506_c0_g1_i1	O88856	TPST2_MOUSE	96.8	95	3	0	2	286	41	135	1.70E-47	189.5	TPST2_MOUSE	reviewed	Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2)	Tpst2 D5ucla3	Mus musculus (Mouse)	376	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; peptidyl-tyrosine sulfation [GO:0006478]; prevention of polyspermy [GO:0060468]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0007342; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0060468	fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; peptidyl-tyrosine sulfation [GO:0006478]; prevention of polyspermy [GO:0060468]		NA	NA	NA	NA	NA	NA
TRINITY_DN3165_c0_g1_i1	Q5R537	THRB_PONAB	45	60	26	2	33	191	371	430	5.60E-07	54.7	THRB_PONAB	reviewed	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	623	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; acute-phase response [GO:0006953]; blood coagulation [GO:0007596]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005509; GO:0005576; GO:0006953; GO:0007596	acute-phase response [GO:0006953]; blood coagulation [GO:0007596]		blue	blue	NA	NA	NA	NA
TRINITY_DN23540_c0_g2_i1	Q9UN75	PCDAC_HUMAN	38.9	72	39	1	1	201	246	317	2.70E-07	55.5	PCDAC_HUMAN	reviewed	Protocadherin alpha-12 (PCDH-alpha-12)	PCDHA12	Homo sapiens (Human)	941	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]		NA	NA	NA	NA	NA	NA
TRINITY_DN33741_c0_g1_i1	Q6PB90	PCDBE_MOUSE	42.5	80	46	0	243	4	200	279	4.60E-12	71.6	PCDBE_MOUSE	reviewed	Protocadherin beta-14 (PCDH-beta-14)	Pcdhb14	Mus musculus (Mouse)	796	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]		blue	blue	NA	NA	NA	NA
TRINITY_DN7706_c0_g1_i1	Q14517	FAT1_HUMAN	32	241	141	9	710	3	3210	3432	2.70E-17	90.5	FAT1_HUMAN	reviewed	"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"	FAT1 CDHF7 FAT	Homo sapiens (Human)	4588	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609	actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]		NA	NA	NA	NA	NA	NA
TRINITY_DN23540_c0_g1_i1	Q14517	FAT1_HUMAN	51	96	47	0	298	11	727	822	1.20E-20	100.5	FAT1_HUMAN	reviewed	"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"	FAT1 CDHF7 FAT	Homo sapiens (Human)	4588	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609	actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]		NA	NA	NA	NA	NA	NA
TRINITY_DN35612_c0_g1_i1	Q14517	FAT1_HUMAN	35.2	159	94	5	468	1	3293	3445	6.60E-15	82	FAT1_HUMAN	reviewed	"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"	FAT1 CDHF7 FAT	Homo sapiens (Human)	4588	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609	actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]		NA	NA	NA	NA	NA	NA
TRINITY_DN9487_c0_g1_i1	Q9NYQ8	FAT2_HUMAN	32.1	78	51	1	292	59	1660	1735	5.80E-05	48.5	FAT2_HUMAN	reviewed	Protocadherin Fat 2 (hFat2) (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1)	FAT2 CDHF8 KIAA0811 MEGF1	Homo sapiens (Human)	4349	adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005794; GO:0005886; GO:0005912; GO:0007156; GO:0010631; GO:0016021; GO:0031589; GO:0070062; GO:0098609	cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]		NA	NA	NA	NA	NA	NA
TRINITY_DN33603_c0_g1_i2	O88277	FAT2_RAT	32.9	231	132	8	55	729	741	954	4.40E-19	96.7	FAT2_RAT	reviewed	Protocadherin Fat 2 (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1)	Fat2 Fath2 Megf1	Rattus norvegicus (Rat)	4351	adherens junction [GO:0005912]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005794; GO:0005886; GO:0005912; GO:0007156; GO:0010631; GO:0016021; GO:0031589; GO:0098609	cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]		NA	NA	NA	NA	NA	NA
TRINITY_DN30736_c0_g1_i1	Q6V0I7	FAT4_HUMAN	45.5	99	49	3	3	287	2257	2354	3.20E-11	69.3	FAT4_HUMAN	reviewed	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	FAT4 CDHF14 FATJ Nbla00548	Homo sapiens (Human)	4981	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609	cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]		NA	NA	NA	NA	NA	NA
TRINITY_DN9487_c0_g1_i2	Q96JQ0	PCD16_HUMAN	36.8	87	52	1	268	17	2599	2685	3.30E-07	55.8	PCD16_HUMAN	reviewed	Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1)	DCHS1 CDH19 CDH25 FIB1 KIAA1773 PCDH16	Homo sapiens (Human)	3298	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; multicellular organism development [GO:0007275]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007157; GO:0007275; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0021915; GO:0022008; GO:0034332; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072137; GO:0072659; GO:0090102; GO:0098742	adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; multicellular organism development [GO:0007275]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i14	Q39617	POR_CHLRE	42.9	84	46	1	21	266	131	214	1.30E-10	67	POR_CHLRE	reviewed	"Protochlorophyllide reductase, chloroplastic (PCR) (EC 1.3.1.33) (NADPH-protochlorophyllide oxidoreductase) (POR)"	PORA LPCR-1	Chlamydomonas reinhardtii (Chlamydomonas smithii)	397	chloroplast [GO:0009507]; protochlorophyllide reductase activity [GO:0016630]; chlorophyll biosynthetic process [GO:0015995]; photosynthesis [GO:0015979]	chloroplast [GO:0009507]	protochlorophyllide reductase activity [GO:0016630]	GO:0009507; GO:0015979; GO:0015995; GO:0016630	chlorophyll biosynthetic process [GO:0015995]; photosynthesis [GO:0015979]		NA	NA	NA	NA	NA	NA
TRINITY_DN4489_c1_g1_i2	Q8CFY5	COX10_MOUSE	48.9	225	90	4	352	987	196	408	7.50E-50	199.1	COX10_MOUSE	reviewed	"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)"	Cox10	Mus musculus (Mouse)	443	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]	GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006783; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069	aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN4489_c1_g1_i3	Q8CFY5	COX10_MOUSE	48.6	212	84	4	352	948	196	395	8.50E-46	185.7	COX10_MOUSE	reviewed	"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)"	Cox10	Mus musculus (Mouse)	443	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]	GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006783; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069	aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN4489_c0_g1_i1	Q8CFY5	COX10_MOUSE	66	50	17	0	333	184	301	350	1.00E-12	74.7	COX10_MOUSE	reviewed	"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)"	Cox10	Mus musculus (Mouse)	443	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]	GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006783; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069	aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]		blue	blue	NA	NA	NA	NA
TRINITY_DN4489_c0_g1_i2	Q8CFY5	COX10_MOUSE	59.4	293	119	0	1029	151	142	434	2.20E-90	334.3	COX10_MOUSE	reviewed	"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)"	Cox10	Mus musculus (Mouse)	443	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]	GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006783; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069	aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN4489_c0_g1_i3	Q8CFY5	COX10_MOUSE	45.1	71	26	2	324	151	364	434	1.50E-05	50.4	COX10_MOUSE	reviewed	"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)"	Cox10	Mus musculus (Mouse)	443	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]	GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006783; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069	aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN1182_c0_g1_i1	B7Z0W9	OTOP_DROME	57.5	299	125	1	915	19	1158	1454	1.80E-97	357.5	OTOP_DROME	reviewed	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	OtopLc CG42265	Drosophila melanogaster (Fruit fly)	1576	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN1182_c0_g1_i2	B7Z0W9	OTOP_DROME	79.3	58	12	0	374	201	1383	1440	2.80E-22	106.7	OTOP_DROME	reviewed	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	OtopLc CG42265	Drosophila melanogaster (Fruit fly)	1576	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN1182_c0_g1_i3	B7Z0W9	OTOP_DROME	48.3	656	270	12	1911	19	843	1454	2.40E-154	547.4	OTOP_DROME	reviewed	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	OtopLc CG42265	Drosophila melanogaster (Fruit fly)	1576	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN1182_c0_g1_i6	B7Z0W9	OTOP_DROME	48	281	117	6	861	88	843	1117	3.10E-54	213.8	OTOP_DROME	reviewed	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	OtopLc CG42265	Drosophila melanogaster (Fruit fly)	1576	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN36616_c0_g1_i1	B7Z0W9	OTOP_DROME	43.6	101	57	0	53	355	1351	1451	2.40E-20	99.8	OTOP_DROME	reviewed	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	OtopLc CG42265	Drosophila melanogaster (Fruit fly)	1576	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN38055_c0_g1_i1	B7Z0W9	OTOP_DROME	52.4	42	20	0	70	195	1163	1204	6.90E-08	57.8	OTOP_DROME	reviewed	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	OtopLc CG42265	Drosophila melanogaster (Fruit fly)	1576	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN2507_c0_g2_i1	Q3UHK1	MYCT_MOUSE	35	103	67	0	409	101	496	598	1.90E-11	72.4	MYCT_MOUSE	reviewed	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	Slc2a13	Mus musculus (Mouse)	637	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]	ATPase binding [GO:0051117]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transmembrane transporter activity [GO:0005365]; protease binding [GO:0002020]	GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005887; GO:0015798; GO:0016020; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0071944; GO:0097450; GO:1902004	myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]		NA	NA	NA	NA	NA	NA
TRINITY_DN2507_c0_g2_i3	Q3UHK1	MYCT_MOUSE	34	103	68	0	412	104	496	598	1.30E-10	69.7	MYCT_MOUSE	reviewed	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	Slc2a13	Mus musculus (Mouse)	637	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]	ATPase binding [GO:0051117]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transmembrane transporter activity [GO:0005365]; protease binding [GO:0002020]	GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005887; GO:0015798; GO:0016020; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0071944; GO:0097450; GO:1902004	myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]		NA	NA	NA	NA	NA	NA
TRINITY_DN1561_c0_g1_i2	Q96QE2	MYCT_HUMAN	45.3	415	214	5	1409	201	78	491	9.10E-95	349	MYCT_HUMAN	reviewed	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	SLC2A13	Homo sapiens (Human)	648	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transport across blood-brain barrier [GO:0150104]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transmembrane transporter activity [GO:0005365]; protease binding [GO:0002020]	GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005886; GO:0005887; GO:0015798; GO:0016020; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0071944; GO:0097450; GO:0150104; GO:1902004	myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transport across blood-brain barrier [GO:0150104]		NA	NA	1	NA	NA	NA
TRINITY_DN1561_c0_g1_i2	Q96QE2	MYCT_HUMAN	56.2	80	35	0	240	1	523	602	6.20E-19	97.1	MYCT_HUMAN	reviewed	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	SLC2A13	Homo sapiens (Human)	648	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transport across blood-brain barrier [GO:0150104]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transmembrane transporter activity [GO:0005365]; protease binding [GO:0002020]	GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005886; GO:0005887; GO:0015798; GO:0016020; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0071944; GO:0097450; GO:0150104; GO:1902004	myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transport across blood-brain barrier [GO:0150104]		NA	NA	1	NA	NA	NA
TRINITY_DN1561_c0_g1_i1	Q96QE2	MYCT_HUMAN	46.9	527	267	5	1548	1	78	602	9.50E-130	465.3	MYCT_HUMAN	reviewed	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	SLC2A13	Homo sapiens (Human)	648	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transport across blood-brain barrier [GO:0150104]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transmembrane transporter activity [GO:0005365]; protease binding [GO:0002020]	GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005886; GO:0005887; GO:0015798; GO:0016020; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0071944; GO:0097450; GO:0150104; GO:1902004	myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transport across blood-brain barrier [GO:0150104]		blue	blue	NA	NA	NA	NA
TRINITY_DN35906_c0_g1_i1	Q4KL91	S36A4_XENLA	40.3	457	252	6	1468	146	45	496	5.50E-82	306.6	S36A4_XENLA	reviewed	Proton-coupled amino acid transporter 4 (Proton/amino acid transporter 4) (Solute carrier family 36 member 4)	slc36a4 pat4	Xenopus laevis (African clawed frog)	522	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006865; GO:0015293; GO:0016021	amino acid transport [GO:0006865]		NA	NA	NA	NA	NA	NA
TRINITY_DN126_c0_g1_i1	Q7ZWG6	PCFT_DANRE	29.4	235	159	3	1042	341	232	460	1.80E-16	89	PCFT_DANRE	reviewed	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	slc46a1 hcp1 pcft zgc:56400	Danio rerio (Zebrafish) (Brachydanio rerio)	481	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	folic acid binding [GO:0005542]; transmembrane transporter activity [GO:0022857]	GO:0005542; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN126_c0_g1_i2	Q7ZWG6	PCFT_DANRE	34.2	161	106	0	823	341	300	460	3.70E-16	87	PCFT_DANRE	reviewed	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	slc46a1 hcp1 pcft zgc:56400	Danio rerio (Zebrafish) (Brachydanio rerio)	481	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	folic acid binding [GO:0005542]; transmembrane transporter activity [GO:0022857]	GO:0005542; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN126_c0_g1_i5	Q7ZWG6	PCFT_DANRE	30	434	277	8	1609	341	43	460	2.70E-39	164.9	PCFT_DANRE	reviewed	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	slc46a1 hcp1 pcft zgc:56400	Danio rerio (Zebrafish) (Brachydanio rerio)	481	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	folic acid binding [GO:0005542]; transmembrane transporter activity [GO:0022857]	GO:0005542; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN40948_c0_g1_i1	P10911	MCF2_HUMAN	47.4	95	43	3	408	136	724	815	3.80E-16	85.9	MCF2_HUMAN	reviewed	Proto-oncogene DBL (Proto-oncogene MCF-2) [Cleaved into: MCF2-transforming protein; DBL-transforming protein]	MCF2 DBL	Homo sapiens (Human)	925	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005829; GO:0005856; GO:0007186; GO:0016020; GO:0016358; GO:0035556; GO:0043065; GO:0050771; GO:0051056; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN7659_c0_g1_i4	P06240	LCK_MOUSE	26.8	168	107	6	52	537	273	430	4.00E-05	49.7	LCK_MOUSE	reviewed	Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK)	Lck Lsk-t	Mus musculus (Mouse)	509	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]; antigen binding [GO:0003823]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein antigen binding [GO:1990405]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular zinc ion homeostasis [GO:0006882]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of uterine smooth muscle contraction [GO:0070474]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of T cell receptor signaling pathway [GO:0050856]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to metal ion [GO:0010038]; T cell differentiation [GO:0030217]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]"	antigen binding [GO:0003823]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein antigen binding [GO:1990405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]	GO:0000242; GO:0001772; GO:0001784; GO:0003823; GO:0004713; GO:0004715; GO:0004722; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006882; GO:0006919; GO:0007166; GO:0007169; GO:0008022; GO:0009612; GO:0010038; GO:0010628; GO:0018108; GO:0019901; GO:0019903; GO:0030139; GO:0030154; GO:0030217; GO:0031234; GO:0034116; GO:0038083; GO:0042127; GO:0042169; GO:0042493; GO:0042531; GO:0042542; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043548; GO:0044877; GO:0045087; GO:0045121; GO:0045588; GO:0045589; GO:0046777; GO:0050853; GO:0050856; GO:0050870; GO:0051117; GO:0051209; GO:0070474; GO:0098978; GO:0099091; GO:1903039; GO:1990405; GO:2001244	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular zinc ion homeostasis [GO:0006882]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of uterine smooth muscle contraction [GO:0070474]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of T cell receptor signaling pathway [GO:0050856]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to metal ion [GO:0010038]; T cell differentiation [GO:0030217]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN37712_c0_g1_i1	P12931	SRC_HUMAN	98.7	77	1	0	2	232	99	175	1.40E-39	162.9	SRC_HUMAN	reviewed	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC SRC1	Homo sapiens (Human)	536	"actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; estrogen receptor binding [GO:0030331]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell population proliferation [GO:0042127]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]"	"actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]"	ATPase binding [GO:0051117]; ATP binding [GO:0005524]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; estrogen receptor binding [GO:0030331]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]	GO:0001545; GO:0002102; GO:0002223; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005102; GO:0005158; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005886; GO:0005901; GO:0005925; GO:0007049; GO:0007155; GO:0007165; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007186; GO:0007229; GO:0007411; GO:0008022; GO:0008283; GO:0009612; GO:0009615; GO:0010447; GO:0010632; GO:0010634; GO:0010907; GO:0010954; GO:0014068; GO:0014069; GO:0014911; GO:0016032; GO:0016236; GO:0016301; GO:0018105; GO:0018108; GO:0019899; GO:0019900; GO:0020037; GO:0022407; GO:0030054; GO:0030154; GO:0030168; GO:0030331; GO:0030900; GO:0031234; GO:0031295; GO:0031333; GO:0031625; GO:0031648; GO:0031667; GO:0031954; GO:0032148; GO:0032211; GO:0032587; GO:0032869; GO:0033146; GO:0033625; GO:0034332; GO:0034446; GO:0035306; GO:0035556; GO:0035635; GO:0036035; GO:0036120; GO:0038083; GO:0038096; GO:0038128; GO:0042127; GO:0042169; GO:0042476; GO:0042493; GO:0043005; GO:0043065; GO:0043066; GO:0043114; GO:0043149; GO:0043154; GO:0043393; GO:0043406; GO:0043552; GO:0044325; GO:0045056; GO:0045087; GO:0045121; GO:0045124; GO:0045296; GO:0045453; GO:0045737; GO:0045747; GO:0045892; GO:0045893; GO:0046628; GO:0046777; GO:0046875; GO:0048010; GO:0048011; GO:0048013; GO:0048041; GO:0048471; GO:0048477; GO:0050715; GO:0050731; GO:0050847; GO:0050900; GO:0051057; GO:0051117; GO:0051219; GO:0051385; GO:0051602; GO:0051895; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060444; GO:0060491; GO:0060576; GO:0070062; GO:0070102; GO:0070301; GO:0070374; GO:0070555; GO:0070700; GO:0070851; GO:0071222; GO:0071253; GO:0071375; GO:0071393; GO:0071398; GO:0071456; GO:0071498; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:0097110; GO:0098609; GO:0098978; GO:0099091; GO:1900182; GO:1903997; GO:2000386; GO:2000394; GO:2000573; GO:2000588; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286	"activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell population proliferation [GO:0042127]; regulation of cell projection assembly [GO:0060491]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6319_c0_g1_i1	P56602	PPOX_BOVIN	41.3	472	265	4	81	1475	1	467	6.50E-96	352.8	PPOX_BOVIN	reviewed	Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4)	PPOX	Bos taurus (Bovine)	477	intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]	GO:0004729; GO:0005739; GO:0006782; GO:0006783; GO:0016491; GO:0031304	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN38351_c0_g1_i1	Q6KF82	PHCY1_HOMAM	60.4	53	21	0	203	45	130	182	5.80E-13	74.3	PHCY1_HOMAM	reviewed	Pseudohemocyanin-1 (Fragment)	phc-1	Homarus americanus (American lobster)	684	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	NA	NA	NA	1
TRINITY_DN1066_c0_g1_i1	Q6KF82	PHCY1_HOMAM	57	93	34	1	264	4	517	609	6.10E-23	107.8	PHCY1_HOMAM	reviewed	Pseudohemocyanin-1 (Fragment)	phc-1	Homarus americanus (American lobster)	684	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	NA	NA	NA	1
TRINITY_DN930_c0_g1_i2	Q6KF82	PHCY1_HOMAM	60	100	38	2	345	49	582	680	1.20E-26	120.6	PHCY1_HOMAM	reviewed	Pseudohemocyanin-1 (Fragment)	phc-1	Homarus americanus (American lobster)	684	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	1	NA	1	1
TRINITY_DN24645_c0_g1_i1	Q6KF81	PHCY2_HOMAM	63.2	76	28	0	1	228	308	383	7.00E-23	107.5	PHCY2_HOMAM	reviewed	Pseudohemocyanin-2 (Fragment)	phc-2	Homarus americanus (American lobster)	681	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN930_c0_g1_i1	Q6KF81	PHCY2_HOMAM	57.9	76	30	2	273	49	604	678	4.00E-17	88.6	PHCY2_HOMAM	reviewed	Pseudohemocyanin-2 (Fragment)	phc-2	Homarus americanus (American lobster)	681	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	NA	NA	NA	1
TRINITY_DN930_c0_g1_i4	Q6KF81	PHCY2_HOMAM	58.9	73	28	2	263	48	604	675	5.10E-17	88.2	PHCY2_HOMAM	reviewed	Pseudohemocyanin-2 (Fragment)	phc-2	Homarus americanus (American lobster)	681	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	1	NA	1	1
TRINITY_DN1066_c0_g1_i2	Q6KF81	PHCY2_HOMAM	57.6	92	33	1	261	4	515	606	3.50E-23	108.6	PHCY2_HOMAM	reviewed	Pseudohemocyanin-2 (Fragment)	phc-2	Homarus americanus (American lobster)	681	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	1	NA	1	1
TRINITY_DN1685_c0_g1_i1	Q6KF81	PHCY2_HOMAM	52.6	274	128	1	10	825	220	493	6.70E-84	312	PHCY2_HOMAM	reviewed	Pseudohemocyanin-2 (Fragment)	phc-2	Homarus americanus (American lobster)	681	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			black	black	NA	NA	NA	1
TRINITY_DN32245_c0_g1_i1	A6TL60	PSUG_ALKMQ	48.5	68	33	1	201	4	234	301	2.20E-09	62.4	PSUG_ALKMQ	reviewed	Pseudouridine-5'-phosphate glycosidase (PsiMP glycosidase) (EC 4.2.1.70)	psuG Amet_0703	Alkaliphilus metalliredigens (strain QYMF)	307	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridylate synthase activity [GO:0004730]; nucleobase catabolic process [GO:0046113]"		"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridylate synthase activity [GO:0004730]"	GO:0004730; GO:0016798; GO:0046113; GO:0046872	nucleobase catabolic process [GO:0046113]		NA	NA	NA	NA	NA	NA
TRINITY_DN18817_c0_g1_i1	Q9USY1	YOW5_SCHPO	59	212	85	2	1	630	59	270	4.30E-62	239.2	YOW5_SCHPO	reviewed	Pseudouridine-metabolizing bifunctional protein C1861.05 [Includes: Pseudouridine-5'-phosphate glycosidase (PsiMP glycosidase) (EC 4.2.1.70); Pseudouridine kinase (EC 2.7.1.83)]	SPBC1861.05	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	747	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225]; pseudouridylate synthase activity [GO:0004730]; pseudouridine synthesis [GO:0001522]; pyrimidine nucleoside metabolic process [GO:0006213]"	cytoplasm [GO:0005737]	"ATP binding [GO:0005524]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225]; pseudouridylate synthase activity [GO:0004730]"	GO:0001522; GO:0004730; GO:0005524; GO:0005737; GO:0006213; GO:0016798; GO:0046872; GO:0050225	pseudouridine synthesis [GO:0001522]; pyrimidine nucleoside metabolic process [GO:0006213]		NA	NA	NA	NA	NA	NA
TRINITY_DN5098_c0_g1_i1	Q91VU7	PUS7_MOUSE	44	75	39	1	366	142	110	181	1.50E-08	60.8	PUS7_MOUSE	reviewed	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	Pus7 Kiaa1897	Mus musculus (Mouse)	660	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]		blue	blue	NA	NA	NA	NA
TRINITY_DN9897_c0_g4_i1	Q91VU7	PUS7_MOUSE	46.6	326	167	5	78	1043	184	506	7.50E-79	295.8	PUS7_MOUSE	reviewed	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	Pus7 Kiaa1897	Mus musculus (Mouse)	660	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN9897_c0_g2_i1	Q91VU7	PUS7_MOUSE	41.7	115	63	2	338	6	219	333	2.10E-15	83.2	PUS7_MOUSE	reviewed	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	Pus7 Kiaa1897	Mus musculus (Mouse)	660	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN9897_c0_g1_i1	Q96PZ0	PUS7_HUMAN	37.5	160	99	1	165	644	500	658	7.80E-27	122.1	PUS7_HUMAN	reviewed	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	PUS7 KIAA1897	Homo sapiens (Human)	661	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN9897_c0_g3_i1	Q91VU7	PUS7_MOUSE	34.5	333	174	4	1	996	358	647	2.50E-51	204.1	PUS7_MOUSE	reviewed	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	Pus7 Kiaa1897	Mus musculus (Mouse)	660	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN4902_c0_g1_i1	Q8K2A1	GULP1_MOUSE	60.7	183	72	0	64	612	10	192	1.70E-57	224.2	GULP1_MOUSE	reviewed	PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP)	Gulp1 Ced6	Mus musculus (Mouse)	304	"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]"	cytoplasm [GO:0005737]		GO:0005737; GO:0006869; GO:0006911; GO:0006915	"apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36272_c0_g1_i1	P39736	BX42_DROME	48.1	79	39	1	291	55	1	77	2.60E-15	82.8	BX42_DROME	reviewed	Puff-specific protein Bx42	Bx42 CG8264	Drosophila melanogaster (Fruit fly)	547	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; DNA binding [GO:0003677]; embryonic development via the syncytial blastoderm [GO:0001700]; eye-antennal disc development [GO:0035214]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]	DNA binding [GO:0003677]	GO:0000398; GO:0000974; GO:0001700; GO:0003677; GO:0035214; GO:0071011; GO:0071013	"embryonic development via the syncytial blastoderm [GO:0001700]; eye-antennal disc development [GO:0035214]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN920_c0_g1_i1	P39736	BX42_DROME	60.3	468	166	6	1450	83	88	547	1.20E-131	471.5	BX42_DROME	reviewed	Puff-specific protein Bx42	Bx42 CG8264	Drosophila melanogaster (Fruit fly)	547	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]; DNA binding [GO:0003677]; embryonic development via the syncytial blastoderm [GO:0001700]; eye-antennal disc development [GO:0035214]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; Prp19 complex [GO:0000974]	DNA binding [GO:0003677]	GO:0000398; GO:0000974; GO:0001700; GO:0003677; GO:0035214; GO:0071011; GO:0071013	"embryonic development via the syncytial blastoderm [GO:0001700]; eye-antennal disc development [GO:0035214]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24115_c0_g1_i1	Q2VB19	PUM1_CHICK	100	128	0	0	3	386	820	947	4.50E-67	255	PUM1_CHICK	reviewed	Pumilio homolog 1	PUM1 RCJMB04_1f11	Gallus gallus (Chicken)	1189	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]	GO:0000932; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0061157; GO:1900246; GO:2000637	adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN18932_c0_g2_i1	Q14671	PUM1_HUMAN	100	214	0	0	642	1	953	1166	3.70E-122	438.7	PUM1_HUMAN	reviewed	Pumilio homolog 1 (HsPUM) (Pumilio-1)	PUM1 KIAA0099 PUMH1	Homo sapiens (Human)	1186	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637	adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN18932_c0_g2_i2	Q14671	PUM1_HUMAN	99.5	209	1	0	627	1	958	1166	4.90E-119	428.3	PUM1_HUMAN	reviewed	Pumilio homolog 1 (HsPUM) (Pumilio-1)	PUM1 KIAA0099 PUMH1	Homo sapiens (Human)	1186	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637	adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN18932_c0_g1_i1	Q8TB72	PUM2_HUMAN	99.4	315	0	1	940	2	752	1066	1.40E-178	626.7	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN8757_c0_g2_i1	Q8TB72	PUM2_HUMAN	80.3	376	63	4	31	1146	689	1057	1.20E-169	597.4	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN8757_c0_g2_i2	Q8TB72	PUM2_HUMAN	76.1	397	63	5	31	1209	689	1057	4.80E-166	585.5	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN8757_c0_g2_i3	Q8TB72	PUM2_HUMAN	77.2	391	63	4	31	1191	689	1057	3.90E-168	592.4	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN8757_c0_g2_i4	Q8TB72	PUM2_HUMAN	81.6	370	63	3	31	1128	689	1057	9.30E-172	604.4	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN32824_c0_g1_i1	Q8TB72	PUM2_HUMAN	97.5	81	0	1	238	2	805	885	2.70E-38	158.7	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN39171_c0_g1_i1	E3WDQ9	PUM2_XENLA	60	190	75	1	9	578	872	1060	1.20E-60	234.2	PUM2_XENLA	reviewed	Pumilio homolog 2 (Pumilio-2)	pum2	Xenopus laevis (African clawed frog)	1173	P-body [GO:0000932]; RNA binding [GO:0003723]; regulation of translation [GO:0006417]	P-body [GO:0000932]	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0006417	regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN34757_c0_g1_i1	Q8TB72	PUM2_HUMAN	49.8	231	113	2	690	4	738	967	8.10E-59	228.4	PUM2_HUMAN	reviewed	Pumilio homolog 2 (Pumilio-2)	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	1066	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN13919_c0_g1_i1	Q15397	PUM3_HUMAN	100	88	0	0	264	1	322	409	1.50E-45	183	PUM3_HUMAN	reviewed	Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8)	PUM3 cPERP-C KIAA0020 PUF-A XTP5	Homo sapiens (Human)	648	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835	regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN13919_c0_g1_i2	Q15397	PUM3_HUMAN	100	122	0	0	366	1	322	443	2.00E-64	246.1	PUM3_HUMAN	reviewed	Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8)	PUM3 cPERP-C KIAA0020 PUF-A XTP5	Homo sapiens (Human)	648	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835	regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN32692_c0_g1_i1	Q15397	PUM3_HUMAN	38	523	313	7	1628	87	126	646	2.60E-99	364.4	PUM3_HUMAN	reviewed	Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8)	PUM3 cPERP-C KIAA0020 PUF-A XTP5	Homo sapiens (Human)	648	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835	regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]		NA	NA	NA	NA	NA	NA
TRINITY_DN33588_c0_g1_i1	P55786	PSA_HUMAN	100	126	0	0	379	2	386	511	7.40E-70	264.2	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN36331_c0_g1_i1	P55786	PSA_HUMAN	40.9	127	74	1	9	389	113	238	1.50E-17	90.5	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN9907_c1_g1_i1	Q11011	PSA_MOUSE	57.6	872	367	2	2706	100	41	912	3.20E-295	1015.8	PSA_MOUSE	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	Npepps Psa	Mus musculus (Mouse)	920	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN9907_c1_g1_i2	Q11011	PSA_MOUSE	51.9	322	154	1	1062	100	591	912	1.20E-85	318.2	PSA_MOUSE	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	Npepps Psa	Mus musculus (Mouse)	920	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN22434_c0_g1_i1	P55786	PSA_HUMAN	100	113	0	0	2	340	713	825	2.20E-57	222.6	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN29408_c0_g1_i1	P55786	PSA_HUMAN	100	73	0	0	221	3	560	632	3.40E-35	148.3	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN34192_c0_g1_i1	P55786	PSA_HUMAN	60.9	64	25	0	203	12	153	216	2.50E-17	89	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN39792_c0_g1_i1	P55786	PSA_HUMAN	93.4	229	0	1	687	1	176	389	4.20E-124	445.3	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN39792_c0_g1_i2	P55786	PSA_HUMAN	100	214	0	0	642	1	176	389	8.50E-127	454.1	PSA_HUMAN	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	NPEPPS PSA	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN2510_c2_g1_i4	P16425	Y2R2_DROME	26.3	365	245	10	2420	1374	441	797	1.10E-18	97.1	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2859_c0_g1_i1	P16425	Y2R2_DROME	26.8	261	170	9	1356	601	438	686	2.20E-10	68.6	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2859_c0_g1_i10	P16425	Y2R2_DROME	26.8	261	170	9	1355	600	438	686	2.20E-10	68.6	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2859_c0_g1_i11	P16425	Y2R2_DROME	26.9	238	161	8	726	40	438	671	2.00E-10	67.8	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2859_c0_g1_i6	P16425	Y2R2_DROME	26.8	261	170	9	1215	460	438	686	2.00E-10	68.6	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2859_c0_g1_i8	P16425	Y2R2_DROME	27.1	229	155	7	849	187	447	671	5.00E-10	66.6	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2859_c0_g1_i9	P16425	Y2R2_DROME	27	252	164	8	849	118	447	686	1.70E-10	68.2	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	NA	NA	NA	NA
TRINITY_DN2510_c2_g1_i2	P16425	Y2R2_DROME	26.3	365	245	10	2434	1388	441	797	1.10E-18	97.1	Y2R2_DROME	reviewed	Putative 115 kDa protein in type-1 retrotransposable element R1DM (ORF 2) (Putative 115 kDa protein in type I retrotransposable element R1DM)	R1A1-element\ORF2	Drosophila melanogaster (Fruit fly)	1021							NA	NA	1	NA	NA	NA
TRINITY_DN11082_c0_g1_i4	O96838	FYV1_DROME	29.2	271	135	7	1228	425	699	915	4.10E-21	104	FYV1_DROME	reviewed	Putative 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (Type III PIP kinase) (PIPkin-III)	fab1 CG6355	Drosophila melanogaster (Fruit fly)	1809	endosome [GO:0005768]; endosome membrane [GO:0010008]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular signal transduction [GO:0035556]; phosphatidylinositol phosphorylation [GO:0046854]	endosome [GO:0005768]; endosome membrane [GO:0010008]; vesicle membrane [GO:0012506]	1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]	GO:0000285; GO:0005524; GO:0005768; GO:0008270; GO:0008333; GO:0010008; GO:0012506; GO:0016308; GO:0035556; GO:0046854; GO:0097352	autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular signal transduction [GO:0035556]; phosphatidylinositol phosphorylation [GO:0046854]		NA	NA	NA	NA	NA	NA
TRINITY_DN37473_c0_g1_i1	Q9I702	BAUC_PSEAE	62.8	86	32	0	2	259	215	300	8.30E-25	114	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN37133_c0_g1_i1	Q9I702	BAUC_PSEAE	72.6	95	25	1	1	282	230	324	5.00E-31	134.8	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN37143_c0_g1_i1	Q9I702	BAUC_PSEAE	70.7	75	22	0	6	230	342	416	1.30E-24	113.2	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN17642_c0_g2_i1	Q9I702	BAUC_PSEAE	69.8	63	19	0	196	8	117	179	3.90E-22	104.8	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN17642_c0_g1_i1	Q9I702	BAUC_PSEAE	64.8	71	25	0	213	1	117	187	5.50E-22	104.4	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN983_c0_g1_i1	Q9I702	BAUC_PSEAE	62.5	72	27	0	217	2	231	302	2.00E-19	95.9	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN983_c0_g2_i1	Q9I702	BAUC_PSEAE	60.3	68	27	0	204	1	211	278	7.80E-18	90.5	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN2255_c0_g1_i1	Q9I702	BAUC_PSEAE	66.3	83	28	0	257	9	105	187	4.70E-28	124.8	BAUC_PSEAE	reviewed	Putative 3-oxopropanoate dehydrogenase (EC 1.2.1.-)	bauC PA0130	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	497	malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]	GO:0004491; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019483	beta-alanine biosynthetic process [GO:0019483]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]		NA	NA	NA	NA	NA	NA
TRINITY_DN1439_c0_g1_i3	Q05184	PHT4_PSEPU	27.3	172	118	3	1428	913	37	201	1.20E-10	69.7	PHT4_PSEPU	reviewed	"Putative 4,5-dihydroxyphthalate dehydrogenase (DHP dehydrogenase) (EC 1.-.-.-)"	pht4	Pseudomonas putida (Arthrobacter siderocapsulatus)	410	oxidoreductase activity [GO:0016491]; phthalate catabolic process [GO:0046239]		oxidoreductase activity [GO:0016491]	GO:0016491; GO:0046239	phthalate catabolic process [GO:0046239]		NA	NA	NA	NA	NA	NA
TRINITY_DN1439_c0_g1_i6	Q05184	PHT4_PSEPU	27.3	172	118	3	1366	851	37	201	1.10E-10	69.7	PHT4_PSEPU	reviewed	"Putative 4,5-dihydroxyphthalate dehydrogenase (DHP dehydrogenase) (EC 1.-.-.-)"	pht4	Pseudomonas putida (Arthrobacter siderocapsulatus)	410	oxidoreductase activity [GO:0016491]; phthalate catabolic process [GO:0046239]		oxidoreductase activity [GO:0016491]	GO:0016491; GO:0046239	phthalate catabolic process [GO:0046239]		NA	NA	NA	NA	NA	NA
TRINITY_DN1439_c0_g1_i8	Q05184	PHT4_PSEPU	27.3	172	118	3	1531	1016	37	201	1.20E-10	69.7	PHT4_PSEPU	reviewed	"Putative 4,5-dihydroxyphthalate dehydrogenase (DHP dehydrogenase) (EC 1.-.-.-)"	pht4	Pseudomonas putida (Arthrobacter siderocapsulatus)	410	oxidoreductase activity [GO:0016491]; phthalate catabolic process [GO:0046239]		oxidoreductase activity [GO:0016491]	GO:0016491; GO:0046239	phthalate catabolic process [GO:0046239]		NA	NA	NA	NA	NA	NA
TRINITY_DN29004_c0_g1_i1	O31826	YNGI_BACSU	65.2	69	24	0	2	208	386	454	5.40E-22	104.4	YNGI_BACSU	reviewed	Putative acyl-CoA synthetase YngI (EC 6.2.1.-)	yngI BSU18250	Bacillus subtilis (strain 168)	549	ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]		ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]	GO:0005524; GO:0006631; GO:0031956	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN26768_c0_g1_i1	O53871	Y0859_MYCTU	54.7	86	39	0	2	259	288	373	4.80E-20	98.2	Y0859_MYCTU	reviewed	Putative acyltransferase Rv0859 (EC 2.3.1.-)	fadA Rv0859	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	403	cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]	cell wall [GO:0005618]; plasma membrane [GO:0005886]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003985; GO:0003988; GO:0005618; GO:0005886; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN29759_c0_g1_i1	O53871	Y0859_MYCTU	56.6	99	42	1	12	305	289	387	1.30E-21	103.6	Y0859_MYCTU	reviewed	Putative acyltransferase Rv0859 (EC 2.3.1.-)	fadA Rv0859	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	403	cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]	cell wall [GO:0005618]; plasma membrane [GO:0005886]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003985; GO:0003988; GO:0005618; GO:0005886; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN7167_c0_g1_i1	O53871	Y0859_MYCTU	77.6	67	15	0	203	3	324	390	1.90E-24	112.5	Y0859_MYCTU	reviewed	Putative acyltransferase Rv0859 (EC 2.3.1.-)	fadA Rv0859	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	403	cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]	cell wall [GO:0005618]; plasma membrane [GO:0005886]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]	GO:0003985; GO:0003988; GO:0005618; GO:0005886; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN21300_c0_g1_i1	O34660	ALDH4_BACSU	47.7	65	34	0	205	11	429	493	5.30E-14	77.8	ALDH4_BACSU	reviewed	Putative aldehyde dehydrogenase DhaS (EC 1.2.1.3)	dhaS BSU19310	Bacillus subtilis (strain 168)	495	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; cellular aldehyde metabolic process [GO:0006081]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0006081; GO:0043878	cellular aldehyde metabolic process [GO:0006081]		NA	NA	NA	NA	NA	NA
TRINITY_DN33359_c0_g1_i1	O34660	ALDH4_BACSU	53.8	65	30	0	5	199	261	325	3.20E-16	85.1	ALDH4_BACSU	reviewed	Putative aldehyde dehydrogenase DhaS (EC 1.2.1.3)	dhaS BSU19310	Bacillus subtilis (strain 168)	495	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; cellular aldehyde metabolic process [GO:0006081]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0006081; GO:0043878	cellular aldehyde metabolic process [GO:0006081]		NA	NA	NA	NA	NA	NA
TRINITY_DN40392_c0_g1_i1	Q49Z69	ALD1_STAS1	47.4	114	57	2	397	62	358	470	1.40E-23	110.5	ALD1_STAS1	reviewed	Putative aldehyde dehydrogenase SSP0762 (EC 1.2.1.3)	SSP0762	Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41)	475	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0043878			NA	NA	NA	NA	NA	NA
TRINITY_DN40067_c0_g1_i1	P39616	ALDH2_BACSU	55.6	99	44	0	5	301	168	266	2.60E-25	115.9	ALDH2_BACSU	reviewed	Putative aldehyde dehydrogenase YwdH (EC 1.2.1.3)	ywdH BSU37960 ipa-58r	Bacillus subtilis (strain 168)	456	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; cellular aldehyde metabolic process [GO:0006081]		aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0006081; GO:0043878	cellular aldehyde metabolic process [GO:0006081]		NA	NA	NA	NA	NA	NA
TRINITY_DN30205_c0_g1_i1	Q9A8Z4	Y1201_CAUVC	72.2	72	20	0	3	218	30	101	9.90E-27	120.2	Y1201_CAUVC	reviewed	Putative aldolase class 2 protein CC_1201	CC_1201	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	257	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27624_c0_g1_i1	Q9A8Z4	Y1201_CAUVC	27.2	202	95	4	695	222	15	208	7.80E-11	69.3	Y1201_CAUVC	reviewed	Putative aldolase class 2 protein CC_1201	CC_1201	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	257	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27624_c0_g1_i2	Q9A8Z4	Y1201_CAUVC	33.3	204	125	5	830	222	15	208	2.50E-21	104.4	Y1201_CAUVC	reviewed	Putative aldolase class 2 protein CC_1201	CC_1201	Caulobacter vibrioides (strain ATCC 19089 / CB15) (Caulobacter crescentus)	257	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN25447_c0_g1_i1	Q27245	YH24_CAEEL	49.7	306	150	1	910	5	84	389	2.10E-78	293.9	YH24_CAEEL	reviewed	Putative aminopeptidase W07G4.4 (EC 3.4.11.-)	lap-2 W07G4.4	Caenorhabditis elegans	522	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0030145; GO:0070006			blue	blue	NA	NA	NA	NA
TRINITY_DN18384_c0_g1_i2	Q9J5H7	V024_FOWPN	27.3	150	82	3	35	415	210	355	1.30E-07	57.8	V024_FOWPN	reviewed	Putative ankyrin repeat protein FPV024	FPV024	Fowlpox virus (strain NVSL) (FPV)	596							NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i20	Q9J4Z5	V245_FOWPN	28.1	260	161	7	241	972	37	286	3.60E-14	80.9	V245_FOWPN	reviewed	Putative ankyrin repeat protein FPV245	FPV245	Fowlpox virus (strain NVSL) (FPV)	436							NA	NA	NA	NA	NA	NA
TRINITY_DN6950_c0_g1_i1	Q8Q0U0	Y045_METMA	39.7	174	98	2	18	518	178	351	4.30E-28	125.9	Y045_METMA	reviewed	Putative ankyrin repeat protein MM_0045	MM_0045	Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88) (Methanosarcina frisia)	360							NA	NA	NA	NA	NA	NA
TRINITY_DN6950_c0_g1_i2	Q8Q0U0	Y045_METMA	39.7	174	98	2	18	518	178	351	7.30E-28	125.2	Y045_METMA	reviewed	Putative ankyrin repeat protein MM_0045	MM_0045	Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88) (Methanosarcina frisia)	360							NA	NA	NA	NA	NA	NA
TRINITY_DN26391_c0_g1_i1	Q8Q0U0	Y045_METMA	38.6	70	43	0	5	214	214	283	1.50E-08	59.7	Y045_METMA	reviewed	Putative ankyrin repeat protein MM_0045	MM_0045	Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88) (Methanosarcina frisia)	360							NA	NA	NA	NA	NA	NA
TRINITY_DN22314_c0_g2_i1	Q8Q0U0	Y045_METMA	32.8	180	118	3	542	3	167	343	9.50E-19	95.1	Y045_METMA	reviewed	Putative ankyrin repeat protein MM_0045	MM_0045	Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88) (Methanosarcina frisia)	360							NA	NA	NA	NA	NA	NA
TRINITY_DN4529_c0_g1_i3	Q1RK13	Y220_RICBR	33.1	148	94	3	146	589	447	589	3.60E-12	73.6	Y220_RICBR	reviewed	Putative ankyrin repeat protein RBE_0220	RBE_0220	Rickettsia bellii (strain RML369-C)	826							NA	NA	NA	NA	NA	NA
TRINITY_DN14948_c0_g1_i1	Q4UMH6	Y381_RICFE	26.7	191	121	4	148	711	723	897	1.80E-11	71.2	Y381_RICFE	reviewed	Putative ankyrin repeat protein RF_0381	RF_0381	Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)	1179	guanosine tetraphosphate metabolic process [GO:0015969]			GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]		NA	NA	NA	NA	NA	NA
TRINITY_DN38621_c0_g1_i1	Q6R7C4	IAP4_OSHVF	41.8	55	32	0	844	680	291	345	7.80E-07	56.2	IAP4_OSHVF	reviewed	Putative apoptosis inhibitor ORF106	ORF106	Ostreid herpesvirus 1 (isolate France) (OsHV-1) (Pacific oyster herpesvirus)	465	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN17688_c3_g1_i2	Q9W141	ATPK_DROME	66.4	107	34	1	64	378	1	107	2.70E-40	166.4	ATPK_DROME	reviewed	"Putative ATP synthase subunit f, mitochondrial"	ATPsynF CG4692	Drosophila melanogaster (Fruit fly)	107	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"		GO:0000276; GO:0005739; GO:0005753; GO:0042776; GO:1902600	mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		blue	blue	NA	NA	NA	NA
TRINITY_DN17688_c3_g1_i1	Q9W141	ATPK_DROME	68.7	67	19	1	64	258	1	67	1.30E-23	110.5	ATPK_DROME	reviewed	"Putative ATP synthase subunit f, mitochondrial"	ATPsynF CG4692	Drosophila melanogaster (Fruit fly)	107	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"		GO:0000276; GO:0005739; GO:0005753; GO:0042776; GO:1902600	mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]		NA	NA	1	NA	NA	NA
TRINITY_DN3648_c0_g1_i2	P46441	N2B_HAEIR	54	287	127	3	9	869	183	464	1.80E-85	317.4	N2B_HAEIR	reviewed	Putative ATPase N2B (HFN2B)		Haematobia irritans (Horn fly) (Conops irritans)	464	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN3648_c0_g1_i3	P46441	N2B_HAEIR	54	287	127	3	9	869	183	464	1.80E-85	317.4	N2B_HAEIR	reviewed	Putative ATPase N2B (HFN2B)		Haematobia irritans (Horn fly) (Conops irritans)	464	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN3648_c0_g1_i4	P46441	N2B_HAEIR	54	287	127	3	9	869	183	464	1.80E-85	317.4	N2B_HAEIR	reviewed	Putative ATPase N2B (HFN2B)		Haematobia irritans (Horn fly) (Conops irritans)	464	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN3648_c0_g1_i1	P46441	N2B_HAEIR	54	287	127	3	9	869	183	464	1.80E-85	317.4	N2B_HAEIR	reviewed	Putative ATPase N2B (HFN2B)		Haematobia irritans (Horn fly) (Conops irritans)	464	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	1	NA	NA	NA
TRINITY_DN26152_c0_g1_i1	A8WK63	RECQ1_CAEBR	61.7	81	31	0	245	3	339	419	1.20E-23	110.2	RECQ1_CAEBR	reviewed	Putative ATP-dependent DNA helicase Q1 (EC 3.6.4.12)	CBG24191	Caenorhabditis briggsae	618	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN12165_c0_g1_i12	A8WK63	RECQ1_CAEBR	47.9	73	35	1	219	10	394	466	6.60E-13	74.7	RECQ1_CAEBR	reviewed	Putative ATP-dependent DNA helicase Q1 (EC 3.6.4.12)	CBG24191	Caenorhabditis briggsae	618	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0032508; GO:0036310; GO:0043138	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]		NA	NA	NA	NA	NA	NA
TRINITY_DN24556_c0_g1_i1	P24346	DDX3_XENLA	60	110	44	0	11	340	341	450	3.00E-33	142.5	DDX3_XENLA	reviewed	Putative ATP-dependent RNA helicase an3 (EC 3.6.4.13)	an3	Xenopus laevis (African clawed frog)	697	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0010494; GO:0030027; GO:0031252; GO:0061702; GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]		NA	NA	NA	NA	NA	NA
TRINITY_DN2896_c0_g1_i1	P24346	DDX3_XENLA	77.3	304	54	1	1	912	330	618	1.20E-131	471.1	DDX3_XENLA	reviewed	Putative ATP-dependent RNA helicase an3 (EC 3.6.4.13)	an3	Xenopus laevis (African clawed frog)	697	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0010494; GO:0030027; GO:0031252; GO:0061702; GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]		NA	NA	NA	NA	NA	NA
TRINITY_DN5974_c0_g2_i1	P16381	DDX3L_MOUSE	74.4	82	21	0	2	247	309	390	1.70E-30	132.9	DDX3L_MOUSE	reviewed	Putative ATP-dependent RNA helicase Pl10 (EC 3.6.4.13)	D1Pas1 Pl10	Mus musculus (Mouse)	660	nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007275; GO:0007276; GO:0007283; GO:0030154; GO:0043186	cell differentiation [GO:0030154]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7416_c0_g2_i1	P34580	DDX47_CAEEL	63.6	231	84	0	703	11	44	274	5.90E-81	302	DDX47_CAEEL	reviewed	Putative ATP-dependent RNA helicase T26G10.1 (EC 3.6.4.13)	T26G10.1	Caenorhabditis elegans	489	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN6492_c0_g1_i1	Q2QRX6	DRTS_ORYSJ	74.2	93	24	0	37	315	371	463	1.20E-38	160.2	DRTS_ORYSJ	reviewed	Putative bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) [Includes: Dihydrofolate reductase (EC 1.5.1.3); Thymidylate synthase (EC 2.1.1.45)]	Os12g0446900 LOC_Os12g26060	Oryza sativa subsp. japonica (Rice)	494	cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	dihydrofolate reductase activity [GO:0004146]; thymidylate synthase activity [GO:0004799]	GO:0004146; GO:0004799; GO:0005739; GO:0005829; GO:0006231; GO:0006730; GO:0032259; GO:0046654	dTMP biosynthetic process [GO:0006231]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN6492_c0_g1_i2	Q2QRX6	DRTS_ORYSJ	73.3	105	28	0	3	317	359	463	1.20E-44	180.3	DRTS_ORYSJ	reviewed	Putative bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) [Includes: Dihydrofolate reductase (EC 1.5.1.3); Thymidylate synthase (EC 2.1.1.45)]	Os12g0446900 LOC_Os12g26060	Oryza sativa subsp. japonica (Rice)	494	cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	dihydrofolate reductase activity [GO:0004146]; thymidylate synthase activity [GO:0004799]	GO:0004146; GO:0004799; GO:0005739; GO:0005829; GO:0006231; GO:0006730; GO:0032259; GO:0046654	dTMP biosynthetic process [GO:0006231]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4629_c0_g3_i1	Q41420	CALM3_SOLTU	81.2	32	6	0	310	215	84	115	1.00E-08	60.8	CALM3_SOLTU	reviewed	Putative calmodulin-3 (CaM-3) (Fragment)	PCM3	Solanum tuberosum (Potato)	124	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]	GO:0005509; GO:0019722	calcium-mediated signaling [GO:0019722]		NA	NA	NA	NA	NA	NA
TRINITY_DN7612_c0_g1_i1	Q27504	CAH3_CAEEL	42.9	77	40	1	19	249	158	230	3.90E-11	68.6	CAH3_CAEEL	reviewed	Putative carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase 3)	cah-3 K05G3.3	Caenorhabditis elegans	246	plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]	plasma membrane [GO:0005886]	carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005886; GO:0006730; GO:0008270; GO:0016836	one-carbon metabolic process [GO:0006730]		blue	blue	NA	NA	NA	NA
TRINITY_DN1631_c0_g1_i1	Q556J6	Y4007_DICDI	42.9	112	56	3	4	324	99	207	1.50E-18	93.6	Y4007_DICDI	reviewed	Putative cyclin-dependent serine/threonine-protein kinase DDB_G0272797/DDB_G0274007 (EC 2.7.11.22)	DDB_G0272797; DDB_G0274007	Dictyostelium discoideum (Slime mold)	680	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]	GO:0000083; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN2489_c0_g1_i1	Q9VN93	CPR1_DROME	67.2	67	22	0	10	210	547	613	1.20E-23	110.2	CPR1_DROME	reviewed	Putative cysteine proteinase CG12163 (EC 3.4.22.-)	CG12163	Drosophila melanogaster (Fruit fly)	614	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0045169; GO:0051603; GO:0098595	proteolysis involved in cellular protein catabolic process [GO:0051603]		blue	blue	NA	NA	NA	NA
TRINITY_DN2489_c0_g1_i2	Q9VN93	CPR1_DROME	73.6	53	14	0	2	160	561	613	1.70E-20	99.4	CPR1_DROME	reviewed	Putative cysteine proteinase CG12163 (EC 3.4.22.-)	CG12163	Drosophila melanogaster (Fruit fly)	614	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular space [GO:0005615]; fusome [GO:0045169]; lysosome [GO:0005764]; perivitelline space [GO:0098595]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0045169; GO:0051603; GO:0098595	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN13414_c0_g1_i1	O17624	C13B1_CAEEL	29.3	116	75	1	480	154	22	137	6.80E-07	55.5	C13B1_CAEEL	reviewed	Putative cytochrome P450 cyp-13B1 (EC 1.14.-.-)	cyp-13B1 F02C12.5	Caenorhabditis elegans	510	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN13414_c0_g1_i2	O17624	C13B1_CAEEL	27.3	150	101	2	433	5	22	170	6.00E-10	65.5	C13B1_CAEEL	reviewed	Putative cytochrome P450 cyp-13B1 (EC 1.14.-.-)	cyp-13B1 F02C12.5	Caenorhabditis elegans	510	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"		"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016705; GO:0020037			NA	NA	NA	NA	NA	NA
TRINITY_DN22021_c0_g1_i1	Q6P1N9	TATD1_HUMAN	60.2	128	49	1	268	651	5	130	1.60E-38	161.4	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22021_c0_g1_i10	Q6P1N9	TATD1_HUMAN	60.1	163	63	1	363	851	5	165	5.90E-51	202.6	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22021_c0_g1_i3	Q6P1N9	TATD1_HUMAN	60.2	128	49	1	268	651	5	130	1.60E-38	161.4	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22021_c0_g1_i6	Q6P1N9	TATD1_HUMAN	60.1	163	63	1	132	620	5	165	4.40E-51	202.6	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22021_c0_g1_i8	Q6P1N9	TATD1_HUMAN	60.1	163	63	1	268	756	5	165	5.30E-51	202.6	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22021_c0_g2_i1	Q6P1N9	TATD1_HUMAN	62.7	126	45	1	3	380	172	295	1.60E-40	167.2	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN22021_c0_g2_i2	Q6P1N9	TATD1_HUMAN	58.2	134	46	2	3	404	172	295	1.30E-37	157.5	TATD1_HUMAN	reviewed	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein)	TATDN1 CDA11	Homo sapiens (Human)	297	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	nucleoplasm [GO:0005654]	"3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"	GO:0005654; GO:0008296; GO:0016888; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19586_c0_g1_i1	C4JQN7	DPEP2_UNCRE	64.7	85	30	0	259	5	243	327	4.90E-25	114.8	DPEP2_UNCRE	reviewed	Putative dipeptidase UREG_03382 (EC 3.4.13.19)	UREG_03382	Uncinocarpus reesii (strain UAMH 1704)	453	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]	integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]	GO:0016021; GO:0046872; GO:0070573			NA	NA	NA	NA	NA	NA
TRINITY_DN11426_c0_g2_i2	P83102	DYRK3_DROME	94.2	69	4	0	1	207	352	420	7.50E-30	131.3	DYRK3_DROME	reviewed	Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog (EC 2.7.12.1)	Dyrk3 CG40478	Drosophila melanogaster (Fruit fly)	828	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0018105; GO:0018107	peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN9705_c0_g1_i1	Q8N806	UBR7_HUMAN	42.3	409	215	8	105	1289	15	416	5.10E-84	313.2	UBR7_HUMAN	reviewed	Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7)	UBR7 C14orf130	Homo sapiens (Human)	425	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0061630			blue	blue	NA	NA	NA	NA
TRINITY_DN9705_c0_g1_i2	Q8N806	UBR7_HUMAN	43.2	310	157	7	105	992	15	319	4.30E-64	246.5	UBR7_HUMAN	reviewed	Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7)	UBR7 C14orf130	Homo sapiens (Human)	425	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0061630			blue	blue	NA	NA	NA	1
TRINITY_DN6761_c0_g1_i1	Q2TAQ1	ELP1_XENLA	45.3	139	76	0	417	1	11	149	7.40E-31	136	ELP1_XENLA	reviewed	Putative elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein)	elp1 ikbkap	Xenopus laevis (African clawed frog)	1170	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]		GO:0002098; GO:0005634; GO:0005737; GO:0033588	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN16893_c0_g1_i1	Q2TAQ1	ELP1_XENLA	32.2	338	203	9	135	1082	351	684	1.50E-33	145.2	ELP1_XENLA	reviewed	Putative elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein)	elp1 ikbkap	Xenopus laevis (African clawed frog)	1170	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]		GO:0002098; GO:0005634; GO:0005737; GO:0033588	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN34994_c0_g1_i1	O34893	YNGF_BACSU	57.8	64	26	1	25	213	91	154	8.20E-10	63.9	YNGF_BACSU	reviewed	Putative enoyl-CoA hydratase/isomerase YngF	yngF BSU18220	Bacillus subtilis (strain 168)	260	enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]		enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0006635	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN16636_c0_g1_i1	Q89703	POL_CSVMV	42.6	68	39	0	9	212	286	353	3.50E-11	68.6	POL_CSVMV	reviewed	Putative enzymatic polyprotein [Includes: Protease (PR) (EC 3.4.23.-); Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]	ORF 3	Cassava vein mosaic virus (CsVMV)	652	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0046872	DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN347_c0_g1_i10	Q04164	SAS_DROME	25.5	106	79	0	11	328	1424	1529	1.10E-06	55.5	SAS_DROME	reviewed	Putative epidermal cell surface receptor (Stranded at second protein)	sas CG2507	Drosophila melanogaster (Fruit fly)	1693	apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; instar larval development [GO:0002168]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165]	apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]	heparin binding [GO:0008201]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]	GO:0002168; GO:0005178; GO:0005887; GO:0007155; GO:0007165; GO:0007411; GO:0008201; GO:0016324; GO:0031012; GO:0038023; GO:0060548	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; instar larval development [GO:0002168]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN35627_c0_g1_i1	Q04164	SAS_DROME	44.6	65	34	2	196	5	752	815	1.60E-11	69.7	SAS_DROME	reviewed	Putative epidermal cell surface receptor (Stranded at second protein)	sas CG2507	Drosophila melanogaster (Fruit fly)	1693	apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; instar larval development [GO:0002168]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165]	apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]	heparin binding [GO:0008201]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]	GO:0002168; GO:0005178; GO:0005887; GO:0007155; GO:0007165; GO:0007411; GO:0008201; GO:0016324; GO:0031012; GO:0038023; GO:0060548	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; instar larval development [GO:0002168]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37088_c0_g1_i1	O16580	GLCM1_CAEEL	51.1	47	22	1	140	3	270	316	9.10E-05	47.4	GLCM1_CAEEL	reviewed	Putative glucosylceramidase 1 (EC 3.2.1.45)	gba-1 C33C12.3	Caenorhabditis elegans	523	glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; glucosylceramide catabolic process [GO:0006680]		glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]	GO:0004348; GO:0006680; GO:0016787	glucosylceramide catabolic process [GO:0006680]		NA	NA	NA	NA	NA	NA
TRINITY_DN6591_c0_g1_i1	G5ECR8	GLCM3_CAEEL	43.1	202	109	4	58	657	320	517	1.40E-40	167.9	GLCM3_CAEEL	reviewed	Putative glucosylceramidase 3 (EC 3.2.1.45)	gba-3 F11E6.1	Caenorhabditis elegans	522	glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; glucosylceramide catabolic process [GO:0006680]		glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]	GO:0004348; GO:0006680; GO:0016787	glucosylceramide catabolic process [GO:0006680]		NA	NA	NA	NA	NA	NA
TRINITY_DN36172_c0_g1_i1	G5ECR8	GLCM3_CAEEL	53.8	143	64	1	4	432	301	441	1.90E-40	166.8	GLCM3_CAEEL	reviewed	Putative glucosylceramidase 3 (EC 3.2.1.45)	gba-3 F11E6.1	Caenorhabditis elegans	522	glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; glucosylceramide catabolic process [GO:0006680]		glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]	GO:0004348; GO:0006680; GO:0016787	glucosylceramide catabolic process [GO:0006680]		NA	NA	NA	NA	NA	NA
TRINITY_DN11491_c0_g1_i1	Q9C102	GLT1_SCHPO	75.8	66	16	0	213	16	1193	1258	3.10E-25	115.2	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i10	Q9C102	GLT1_SCHPO	57.3	1026	430	6	130	3195	527	1548	0	1157.5	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i12	Q9C102	GLT1_SCHPO	57.3	131	56	0	80	472	366	496	1.00E-41	171	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i2	Q9C102	GLT1_SCHPO	55.2	286	126	2	90	947	221	504	7.90E-89	328.6	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i5	Q9C102	GLT1_SCHPO	54.2	1505	653	12	90	4562	221	1702	0	1588.2	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i7	Q9C102	GLT1_SCHPO	56.2	89	38	1	46	312	1615	1702	1.80E-24	113.2	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN3253_c0_g1_i9	Q9C102	GLT1_SCHPO	53.5	1551	678	14	5	4597	175	1702	0	1606.3	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN21539_c0_g1_i1	Q9C102	GLT1_SCHPO	78.7	94	20	0	287	6	977	1070	1.60E-37	156.4	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN40825_c0_g1_i1	Q9C102	GLT1_SCHPO	77.6	67	15	0	6	206	1045	1111	2.20E-23	109	GLT1_SCHPO	reviewed	Putative glutamate synthase [NADPH] (EC 1.4.1.13) (NADPH-GOGAT)	glt1 SPAPB1E7.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	2111	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]"	GO:0004355; GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0015930; GO:0016040; GO:0016491; GO:0019676; GO:0036267; GO:0050660; GO:0051538; GO:0097054	ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; invasive filamentous growth [GO:0036267]; L-glutamate biosynthetic process [GO:0097054]		NA	NA	NA	NA	NA	NA
TRINITY_DN2755_c0_g1_i4	Q19013	GLS2_CAEEL	76.7	43	10	0	622	750	404	446	2.80E-13	77.4	GLS2_CAEEL	reviewed	Putative glutaminase 2 (GLS) (EC 3.5.1.2) (L-glutamine amidohydrolase)	glna-2 DH11.1	Caenorhabditis elegans	605	mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]	mitochondrion [GO:0005739]	glutaminase activity [GO:0004359]	GO:0004359; GO:0005739; GO:0006537; GO:0006543	glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]		NA	NA	NA	NA	NA	NA
TRINITY_DN830_c0_g1_i1	Q5ZI66	CHAC2_CHICK	76.3	59	12	1	713	537	1	57	4.20E-22	106.7	CHAC2_CHICK	reviewed	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	chac2 RCJMB04_29n19	Gallus gallus (Chicken)	186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006751; GO:0061928	glutathione catabolic process [GO:0006751]		NA	NA	NA	NA	NA	NA
TRINITY_DN830_c0_g1_i2	Q5ZI66	CHAC2_CHICK	66.1	56	19	0	710	543	1	56	2.80E-18	94	CHAC2_CHICK	reviewed	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	chac2 RCJMB04_29n19	Gallus gallus (Chicken)	186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006751; GO:0061928	glutathione catabolic process [GO:0006751]		NA	NA	NA	NA	NA	NA
TRINITY_DN830_c0_g1_i3	Q5ZI66	CHAC2_CHICK	47.4	116	59	1	419	78	53	168	4.50E-24	112.5	CHAC2_CHICK	reviewed	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	chac2 RCJMB04_29n19	Gallus gallus (Chicken)	186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006751; GO:0061928	glutathione catabolic process [GO:0006751]		NA	NA	NA	NA	NA	NA
TRINITY_DN830_c0_g1_i4	Q5ZI66	CHAC2_CHICK	57.6	170	68	2	581	78	1	168	3.80E-53	209.5	CHAC2_CHICK	reviewed	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	chac2 RCJMB04_29n19	Gallus gallus (Chicken)	186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006751; GO:0061928	glutathione catabolic process [GO:0006751]		NA	NA	NA	NA	NA	NA
TRINITY_DN830_c0_g1_i5	Q9CQG1	CHAC2_MOUSE	51.7	178	84	1	645	112	1	176	1.20E-44	181.4	CHAC2_MOUSE	reviewed	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	Chac2	Mus musculus (Mouse)	178	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006751; GO:0061928	glutathione catabolic process [GO:0006751]		blue	blue	NA	NA	NA	NA
TRINITY_DN830_c0_g2_i1	Q5ZI66	CHAC2_CHICK	48.7	113	56	1	2	334	56	168	2.30E-24	113.2	CHAC2_CHICK	reviewed	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	chac2 RCJMB04_29n19	Gallus gallus (Chicken)	186	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006751; GO:0061928	glutathione catabolic process [GO:0006751]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i10	A0JPE9	GLPK5_DANRE	48.2	508	258	1	268	1776	1	508	4.90E-146	519.6	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i11	A0JPE9	GLPK5_DANRE	43.1	204	107	1	3	614	184	378	1.50E-46	188.3	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i11	A0JPE9	GLPK5_DANRE	43.2	148	78	2	515	940	361	508	1.70E-26	121.7	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i13	A0JPE9	GLPK5_DANRE	47.4	173	91	0	82	600	184	356	2.10E-47	190.3	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i16	A0JPE9	GLPK5_DANRE	46.5	508	237	2	268	1686	1	508	3.10E-137	490.3	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i17	A0JPE9	GLPK5_DANRE	49.2	307	156	0	264	1184	55	361	6.20E-91	335.9	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i4	A0JPE9	GLPK5_DANRE	48.2	508	258	1	196	1704	1	508	4.70E-146	519.6	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i6	A0JPE9	GLPK5_DANRE	48.2	508	258	1	193	1701	1	508	4.70E-146	519.6	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN445_c0_g1_i9	A0JPE9	GLPK5_DANRE	49.2	307	156	0	261	1181	55	361	6.20E-91	335.9	GLPK5_DANRE	reviewed	Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5)	gk5 zgc:152983	Danio rerio (Zebrafish) (Brachydanio rerio)	510	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	mitochondrion [GO:0005739]	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	glycerol-3-phosphate biosynthetic process [GO:0046167]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN1024_c0_g1_i1	Q9SL56	GLPT5_ARATH	25.5	447	268	13	1355	189	23	462	1.70E-21	105.9	GLPT5_ARATH	reviewed	Putative glycerol-3-phosphate transporter 5 (G-3-P transporter 5) (Glycerol-3-phosphate permease 5) (AtG3Pp5) (G-3-P permease 5)	At2g13100 T17A11.9	Arabidopsis thaliana (Mouse-ear cress)	493	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0055062	carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]		blue	blue	NA	NA	NA	NA
TRINITY_DN1024_c0_g1_i2	Q9SL56	GLPT5_ARATH	25.5	447	268	13	1355	189	23	462	1.90E-21	105.9	GLPT5_ARATH	reviewed	Putative glycerol-3-phosphate transporter 5 (G-3-P transporter 5) (Glycerol-3-phosphate permease 5) (AtG3Pp5) (G-3-P permease 5)	At2g13100 T17A11.9	Arabidopsis thaliana (Mouse-ear cress)	493	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0055062	carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]		blue	blue	NA	NA	NA	NA
TRINITY_DN7574_c0_g2_i1	Q10179	SYG_SCHPO	60.7	89	35	0	5	271	328	416	1.00E-26	120.6	SYG_SCHPO	reviewed	Putative glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS)	grs1 SPAC3F10.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	652	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; cytoplasmic translation [GO:0002181]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; mitochondrial translation [GO:0032543]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0002181; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006426; GO:0015966; GO:0016740; GO:0032543; GO:0046983; GO:0070150	cytoplasmic translation [GO:0002181]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; mitochondrial translation [GO:0032543]		NA	NA	NA	NA	NA	NA
TRINITY_DN561_c0_g1_i2	Q8T4E1	GPI8_DROME	78.5	274	59	0	1165	344	42	315	4.40E-130	466.1	GPI8_DROME	reviewed	Putative GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol glycan anchor biosynthesis protein class K)	PIG-K CG4406	Drosophila melanogaster (Fruit fly)	355	GPI-anchor transamidase complex [GO:0042765]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]	GPI-anchor transamidase complex [GO:0042765]	GPI-anchor transamidase activity [GO:0003923]	GO:0003923; GO:0016255; GO:0034394; GO:0042765	attachment of GPI anchor to protein [GO:0016255]; protein localization to cell surface [GO:0034394]		blue	blue	NA	NA	NA	NA
TRINITY_DN8393_c0_g1_i2	Q6DCC6	GTPB6_XENLA	37.7	501	275	8	682	2109	39	527	1.90E-77	292	GTPB6_XENLA	reviewed	Putative GTP-binding protein 6	gtpbp6	Xenopus laevis (African clawed frog)	527	GTP binding [GO:0005525]; metal ion binding [GO:0046872]		GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0005525; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8393_c0_g1_i3	Q6DCC6	GTPB6_XENLA	39.1	202	119	3	522	1121	328	527	1.70E-32	141.7	GTPB6_XENLA	reviewed	Putative GTP-binding protein 6	gtpbp6	Xenopus laevis (African clawed frog)	527	GTP binding [GO:0005525]; metal ion binding [GO:0046872]		GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0005525; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8393_c0_g1_i3	Q6DCC6	GTPB6_XENLA	39.2	166	78	1	91	519	151	316	3.00E-24	114.4	GTPB6_XENLA	reviewed	Putative GTP-binding protein 6	gtpbp6	Xenopus laevis (African clawed frog)	527	GTP binding [GO:0005525]; metal ion binding [GO:0046872]		GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0005525; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN30427_c0_g1_i1	O43824	GTPB6_HUMAN	100	113	0	0	340	2	301	413	3.40E-58	225.3	GTPB6_HUMAN	reviewed	Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like)	GTPBP6 PGPL	Homo sapiens (Human)	516	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]	GO:0005525; GO:0005737; GO:0043022; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN32341_c0_g1_i1	P23249	MOV10_MOUSE	98.7	79	1	0	3	239	480	558	7.20E-39	160.6	MOV10_MOUSE	reviewed	Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein)	Mov10 Gb110	Mus musculus (Mouse)	1004	"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; viral replication complex [GO:0019034]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; P granule [GO:0043186]; viral replication complex [GO:0019034]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0019034; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0150011	"3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11250_c0_g1_i1	Q1LXK4	M10B1_DANRE	44.8	669	335	10	97	2037	357	1013	1.90E-159	564.3	M10B1_DANRE	reviewed	Putative helicase mov-10-B.1 (EC 3.6.4.13)	mov10b.1 si:dkeyp-38g6.2	Danio rerio (Zebrafish) (Brachydanio rerio)	1013	cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; P-body [GO:0000932]; P granule [GO:0043186]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0032574; GO:0035194; GO:0035279; GO:0043186	mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN11250_c0_g1_i3	Q1LXK4	M10B1_DANRE	44.8	669	335	10	97	2037	357	1013	1.90E-159	564.3	M10B1_DANRE	reviewed	Putative helicase mov-10-B.1 (EC 3.6.4.13)	mov10b.1 si:dkeyp-38g6.2	Danio rerio (Zebrafish) (Brachydanio rerio)	1013	cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; P-body [GO:0000932]; P granule [GO:0043186]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0032574; GO:0035194; GO:0035279; GO:0043186	mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; post-transcriptional gene silencing by RNA [GO:0035194]		NA	NA	NA	NA	NA	NA
TRINITY_DN11250_c0_g1_i4	Q1LXK4	M10B1_DANRE	47.6	225	106	3	3	641	789	1013	1.00E-51	204.9	M10B1_DANRE	reviewed	Putative helicase mov-10-B.1 (EC 3.6.4.13)	mov10b.1 si:dkeyp-38g6.2	Danio rerio (Zebrafish) (Brachydanio rerio)	1013	cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; P-body [GO:0000932]; P granule [GO:0043186]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0032574; GO:0035194; GO:0035279; GO:0043186	mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; post-transcriptional gene silencing by RNA [GO:0035194]		blue	blue	NA	NA	NA	NA
TRINITY_DN1468_c0_g1_i1	Q8R1F5	HYI_MOUSE	42.4	262	145	3	867	97	4	264	3.30E-53	210.3	HYI_MOUSE	reviewed	Putative hydroxypyruvate isomerase (EC 5.3.1.22)	Hyi	Mus musculus (Mouse)	277	hydroxypyruvate isomerase activity [GO:0008903]; glyoxylate metabolic process [GO:0046487]		hydroxypyruvate isomerase activity [GO:0008903]	GO:0008903; GO:0046487	glyoxylate metabolic process [GO:0046487]		NA	NA	NA	NA	NA	NA
TRINITY_DN1468_c0_g1_i4	Q8R1F5	HYI_MOUSE	42.4	262	145	3	869	99	4	264	5.60E-53	209.5	HYI_MOUSE	reviewed	Putative hydroxypyruvate isomerase (EC 5.3.1.22)	Hyi	Mus musculus (Mouse)	277	hydroxypyruvate isomerase activity [GO:0008903]; glyoxylate metabolic process [GO:0046487]		hydroxypyruvate isomerase activity [GO:0008903]	GO:0008903; GO:0046487	glyoxylate metabolic process [GO:0046487]		NA	NA	NA	NA	NA	NA
TRINITY_DN1468_c0_g1_i5	Q8R1F5	HYI_MOUSE	42.4	262	145	3	867	97	4	264	5.60E-53	209.5	HYI_MOUSE	reviewed	Putative hydroxypyruvate isomerase (EC 5.3.1.22)	Hyi	Mus musculus (Mouse)	277	hydroxypyruvate isomerase activity [GO:0008903]; glyoxylate metabolic process [GO:0046487]		hydroxypyruvate isomerase activity [GO:0008903]	GO:0008903; GO:0046487	glyoxylate metabolic process [GO:0046487]		NA	NA	NA	NA	NA	NA
TRINITY_DN1468_c0_g1_i8	Q8R1F5	HYI_MOUSE	42	262	146	3	867	97	4	264	2.80E-52	207.2	HYI_MOUSE	reviewed	Putative hydroxypyruvate isomerase (EC 5.3.1.22)	Hyi	Mus musculus (Mouse)	277	hydroxypyruvate isomerase activity [GO:0008903]; glyoxylate metabolic process [GO:0046487]		hydroxypyruvate isomerase activity [GO:0008903]	GO:0008903; GO:0046487	glyoxylate metabolic process [GO:0046487]		NA	NA	NA	NA	NA	NA
TRINITY_DN18173_c0_g1_i1	O61369	PICO_DROAN	45.5	66	34	1	263	72	398	463	2.70E-07	55.8	PICO_DROAN	reviewed	Putative inorganic phosphate cotransporter	Picot	Drosophila ananassae (Fruit fly)	483	integral component of membrane [GO:0016021]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]	GO:0006814; GO:0015114; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN10041_c0_g1_i1	O61369	PICO_DROAN	34.2	79	50	1	69	305	212	288	7.30E-05	48.1	PICO_DROAN	reviewed	Putative inorganic phosphate cotransporter	Picot	Drosophila ananassae (Fruit fly)	483	integral component of membrane [GO:0016021]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]	GO:0006814; GO:0015114; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN10041_c0_g1_i4	O61369	PICO_DROAN	35.4	79	49	1	69	305	212	288	1.20E-06	54.3	PICO_DROAN	reviewed	Putative inorganic phosphate cotransporter	Picot	Drosophila ananassae (Fruit fly)	483	integral component of membrane [GO:0016021]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]	GO:0006814; GO:0015114; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN10041_c0_g1_i7	O61369	PICO_DROAN	34.2	79	50	1	69	305	212	288	1.50E-05	50.4	PICO_DROAN	reviewed	Putative inorganic phosphate cotransporter	Picot	Drosophila ananassae (Fruit fly)	483	integral component of membrane [GO:0016021]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]	GO:0006814; GO:0015114; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6581_c0_g1_i1	O61369	PICO_DROAN	38.8	116	69	1	351	4	239	352	3.60E-16	85.9	PICO_DROAN	reviewed	Putative inorganic phosphate cotransporter	Picot	Drosophila ananassae (Fruit fly)	483	integral component of membrane [GO:0016021]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]	GO:0006814; GO:0015114; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6581_c0_g1_i2	O61369	PICO_DROAN	48.2	56	27	1	191	24	239	292	1.60E-05	49.7	PICO_DROAN	reviewed	Putative inorganic phosphate cotransporter	Picot	Drosophila ananassae (Fruit fly)	483	integral component of membrane [GO:0016021]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]	GO:0006814; GO:0015114; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN14521_c0_g1_i3	Q9V7S5	PICO_DROME	34.9	504	309	6	206	1708	36	523	1.10E-83	312.4	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g2_i1	Q9V7S5	PICO_DROME	45.1	443	236	5	126	1442	37	476	4.40E-107	389.8	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g2_i3	Q9V7S5	PICO_DROME	47	462	238	5	145	1518	37	495	3.60E-119	430.3	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g2_i6	Q9V7S5	PICO_DROME	45	240	128	3	145	858	37	274	4.60E-50	199.9	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g1_i2	Q9V7S5	PICO_DROME	47.2	462	237	5	1611	238	37	495	2.70E-119	430.6	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g1_i3	Q9V7S5	PICO_DROME	49.5	289	143	2	1098	238	208	495	1.50E-83	311.2	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g1_i5	Q9V7S5	PICO_DROME	45.5	462	245	5	1611	238	37	495	1.70E-113	411.4	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN28227_c0_g1_i1	Q9V7S5	PICO_DROME	39.9	188	106	2	44	601	332	514	1.10E-31	138.3	PICO_DROME	reviewed	Putative inorganic phosphate cotransporter	Picot CG8098	Drosophila melanogaster (Fruit fly)	529	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphate ion transmembrane transporter activity [GO:0015114]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN33488_c0_g1_i1	Q25197	HTK7_HYDVU	50.6	87	37	2	243	1	1119	1205	1.40E-16	86.7	HTK7_HYDVU	reviewed	Putative insulin-like peptide receptor (EC 2.7.10.1)	HTK7	Hydra vulgaris (Hydra) (Hydra attenuata)	1477	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0043548; GO:0043560; GO:0046777; GO:0046872	protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN18382_c0_g2_i1	Q10490	SYLC_SCHPO	51.1	137	66	1	434	24	503	638	1.50E-39	163.7	SYLC_SCHPO	reviewed	"Putative leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	lrs1 SPAC26F1.13c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1111	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; cytoplasmic translation [GO:0002181]; leucyl-tRNA aminoacylation [GO:0006429]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0002181; GO:0004823; GO:0005524; GO:0005829; GO:0006429	cytoplasmic translation [GO:0002181]; leucyl-tRNA aminoacylation [GO:0006429]		NA	NA	NA	NA	NA	NA
TRINITY_DN4260_c0_g1_i1	Q0VFH3	LIPT2_XENTR	60.4	111	43	1	424	95	111	221	5.10E-34	145.6	LIPT2_XENTR	reviewed	"Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)"	lipt2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	239	mitochondrion [GO:0005739]; ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249]	mitochondrion [GO:0005739]	ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]	GO:0005739; GO:0009249; GO:0016874; GO:0033819; GO:0102555; GO:2000376	positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN4260_c0_g1_i2	Q9VN27	LIPT2_DROME	54.6	108	48	1	400	77	7	113	4.70E-24	112.5	LIPT2_DROME	reviewed	"Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)"	CG9804	Drosophila melanogaster (Fruit fly)	234	mitochondrion [GO:0005739]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; protein lipoylation [GO:0009249]	mitochondrion [GO:0005739]	lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]	GO:0005739; GO:0009249; GO:0033819; GO:0102555	protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN4260_c0_g1_i3	Q29R99	LIPT2_DANRE	57.2	208	85	2	727	107	13	217	9.30E-65	248.4	LIPT2_DANRE	reviewed	"Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)"	lipt2 zgc:136925	Danio rerio (Zebrafish) (Brachydanio rerio)	224	mitochondrion [GO:0005739]; ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249]	mitochondrion [GO:0005739]	ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]	GO:0005739; GO:0009249; GO:0016874; GO:0033819; GO:0102555; GO:2000376	positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249]		NA	NA	NA	NA	NA	NA
TRINITY_DN10315_c0_g1_i1	P0C860	MS3L2_HUMAN	29.2	346	213	9	1016	69	93	436	1.20E-23	112.1	MS3L2_HUMAN	reviewed	Putative male-specific lethal-3 protein-like 2 (MSL3-like 2) (Male-specific lethal-3 homolog 2) (Male-specific lethal-3 homolog pseudogene 1)	MSL3P1 MSL3L2	Homo sapiens (Human)	447	histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]	histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]		GO:0000123; GO:0006342; GO:0016573; GO:0016575; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0072487	chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]		NA	NA	NA	NA	NA	NA
TRINITY_DN3715_c0_g1_i1	P94493	YNCC_BACSU	23.9	439	308	9	1359	91	36	464	2.60E-14	81.6	YNCC_BACSU	reviewed	Putative metabolite transport protein YncC	yncC BSU17630	Bacillus subtilis (strain 168)	471	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN3715_c0_g1_i3	P94493	YNCC_BACSU	22.5	293	208	8	936	91	180	464	2.40E-06	54.7	YNCC_BACSU	reviewed	Putative metabolite transport protein YncC	yncC BSU17630	Bacillus subtilis (strain 168)	471	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN2507_c0_g2_i6	C0SPB2	YWTG_BACSU	26.3	392	261	11	1255	110	63	436	1.30E-23	112.8	YWTG_BACSU	reviewed	Putative metabolite transport protein YwtG	ywtG BSU35830	Bacillus subtilis (strain 168)	457	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN2507_c0_g2_i8	C0SPB2	YWTG_BACSU	25.7	405	273	11	1294	110	50	436	1.50E-21	106.3	YWTG_BACSU	reviewed	Putative metabolite transport protein YwtG	ywtG BSU35830	Bacillus subtilis (strain 168)	457	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN489_c0_g1_i7	Q55EX9	Y8948_DICDI	32.3	220	132	6	870	220	21	226	3.50E-23	110.5	Y8948_DICDI	reviewed	Putative methyltransferase DDB_G0268948 (EC 2.1.1.-)	DDB_G0268948	Dictyostelium discoideum (Slime mold)	263	phagocytic vesicle [GO:0045335]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]	phagocytic vesicle [GO:0045335]	methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259; GO:0045335	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN735_c0_g1_i1	A6NDL7	MT21E_HUMAN	32	128	81	4	340	714	88	212	9.90E-08	59.3	MT21E_HUMAN	reviewed	Putative methyltransferase-like protein 21E pseudogene (EC 2.1.1.-)	METTL21EP METTL21CP1	Homo sapiens (Human)	271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023	peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN735_c0_g1_i2	A6NDL7	MT21E_HUMAN	32	128	81	4	245	619	88	212	9.00E-08	59.3	MT21E_HUMAN	reviewed	Putative methyltransferase-like protein 21E pseudogene (EC 2.1.1.-)	METTL21EP METTL21CP1	Homo sapiens (Human)	271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023	peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN735_c0_g1_i3	A6NDL7	MT21E_HUMAN	32	128	81	4	229	603	88	212	8.80E-08	59.3	MT21E_HUMAN	reviewed	Putative methyltransferase-like protein 21E pseudogene (EC 2.1.1.-)	METTL21EP METTL21CP1	Homo sapiens (Human)	271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023	peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN1662_c0_g1_i1	Q28Y14	ASPG1_DROPS	61.3	313	117	3	138	1064	51	363	2.90E-104	380.2	ASPG1_DROPS	reviewed	Putative N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase GA14866 (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain]	GA14866	Drosophila pseudoobscura pseudoobscura (Fruit fly)	388	lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein deglycosylation [GO:0006517]	lysosome [GO:0005764]	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]	GO:0003948; GO:0005764; GO:0006517; GO:0008233	protein deglycosylation [GO:0006517]		blue	blue	NA	NA	NA	NA
TRINITY_DN1662_c0_g1_i2	Q28Y14	ASPG1_DROPS	60.6	236	92	1	75	779	128	363	8.70E-77	288.5	ASPG1_DROPS	reviewed	Putative N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase GA14866 (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain]	GA14866	Drosophila pseudoobscura pseudoobscura (Fruit fly)	388	lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein deglycosylation [GO:0006517]	lysosome [GO:0005764]	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]	GO:0003948; GO:0005764; GO:0006517; GO:0008233	protein deglycosylation [GO:0006517]		NA	NA	NA	NA	NA	NA
TRINITY_DN37913_c0_g1_i1	Q9VJB6	CADN2_DROME	58.1	62	19	1	237	52	299	353	5.10E-13	74.7	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i10	Q9VJB6	CADN2_DROME	44.9	69	38	0	77	283	1412	1480	1.20E-14	80.5	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i2	Q9VJB6	CADN2_DROME	44.9	69	38	0	77	283	1412	1480	1.60E-14	80.1	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c0_g1_i4	Q9VJB6	CADN2_DROME	46.4	69	37	0	77	283	1412	1480	4.20E-15	82	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN29201_c0_g1_i1	Q9VJB6	CADN2_DROME	43	121	69	0	3	365	695	815	1.60E-21	103.6	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN37397_c0_g1_i1	Q9VJB6	CADN2_DROME	41.1	90	53	0	274	5	707	796	7.50E-16	84.3	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN27743_c0_g1_i1	Q9VJB6	CADN2_DROME	44.6	74	40	1	13	231	711	784	5.60E-11	68.2	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN11495_c0_g1_i1	Q9VJB6	CADN2_DROME	58.5	82	34	0	284	39	266	347	9.20E-23	107.5	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN11495_c0_g1_i2	Q9VJB6	CADN2_DROME	58.5	82	34	0	313	68	266	347	1.00E-22	107.5	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN1443_c1_g1_i1	Q9VJB6	CADN2_DROME	48.2	56	28	1	95	262	658	712	3.20E-05	49.3	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		brown	brown	NA	NA	NA	NA
TRINITY_DN1443_c1_g1_i5	Q9VJB6	CADN2_DROME	48.4	64	32	1	54	245	650	712	1.40E-07	57	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN10263_c0_g3_i1	Q9VJB6	CADN2_DROME	60.2	83	33	0	34	282	264	346	1.50E-23	110.2	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN10263_c0_g2_i1	Q9VJB6	CADN2_DROME	58.8	80	33	0	30	269	267	346	5.70E-20	98.2	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN6167_c0_g1_i3	Q9VJB6	CADN2_DROME	40.5	126	73	1	33	404	1239	1364	1.80E-18	93.6	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN16701_c0_g1_i1	Q9VJB6	CADN2_DROME	66.2	77	26	0	233	3	270	346	5.30E-23	108.2	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN31412_c0_g1_i1	Q9VJB6	CADN2_DROME	55	100	44	1	302	3	304	402	1.50E-25	116.7	CADN2_DROME	reviewed	Putative neural-cadherin 2 (Cadherin-N2) (dN2-cadherin)	CadN2 CG42829 CG7527	Drosophila melanogaster (Fruit fly)	1799	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007156; GO:0016318; GO:0016339; GO:0016342; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048846; GO:0098742	axon extension involved in axon guidance [GO:0048846]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]		NA	NA	NA	NA	NA	NA
TRINITY_DN6595_c0_g1_i1	Q9VZS6	NSMA_DROME	32.2	432	232	6	1334	186	2	421	3.90E-58	227.3	NSMA_DROME	reviewed	Putative neutral sphingomyelinase (EC 3.1.4.12)	nSMase CG12034	Drosophila melanogaster (Fruit fly)	442	caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin metabolic process [GO:0006684]	caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; sphingomyelin phosphodiesterase activity [GO:0004767]	GO:0004620; GO:0004767; GO:0005783; GO:0005901; GO:0006684; GO:0016020; GO:0016021; GO:0030149; GO:0046513; GO:0046872; GO:0071944	ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin metabolic process [GO:0006684]		NA	NA	NA	NA	NA	NA
TRINITY_DN6595_c0_g1_i2	Q9VZS6	NSMA_DROME	30	464	232	7	1430	186	2	421	5.30E-53	210.3	NSMA_DROME	reviewed	Putative neutral sphingomyelinase (EC 3.1.4.12)	nSMase CG12034	Drosophila melanogaster (Fruit fly)	442	caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin metabolic process [GO:0006684]	caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; sphingomyelin phosphodiesterase activity [GO:0004767]	GO:0004620; GO:0004767; GO:0005783; GO:0005901; GO:0006684; GO:0016020; GO:0016021; GO:0030149; GO:0046513; GO:0046872; GO:0071944	ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin metabolic process [GO:0006684]		NA	NA	NA	NA	NA	NA
TRINITY_DN6935_c0_g1_i1	Q6AZB8	HARB1_DANRE	37.9	66	41	0	22	219	118	183	4.40E-06	51.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN33602_c0_g1_i1	Q96MB7	HARB1_HUMAN	47.1	104	54	1	379	71	197	300	9.10E-20	97.8	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN26804_c0_g1_i1	Q96MB7	HARB1_HUMAN	36.2	301	180	6	139	1020	17	312	1.00E-43	179.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24243_c0_g1_i1	Q96MB7	HARB1_HUMAN	42.5	219	121	3	660	7	17	231	2.50E-38	160.6	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24243_c0_g1_i2	Q96MB7	HARB1_HUMAN	40.9	237	132	4	714	7	2	231	9.60E-39	161.8	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24243_c0_g1_i3	Q6AZB8	HARB1_DANRE	39.7	214	125	3	648	16	17	229	9.50E-33	141.7	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24243_c0_g1_i6	Q96MB7	HARB1_HUMAN	40.9	237	132	4	714	7	2	231	3.00E-39	163.7	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24243_c0_g1_i7	Q6AZB8	HARB1_DANRE	39	213	126	3	632	3	17	228	1.30E-31	137.9	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7682_c0_g1_i4	Q6AZB8	HARB1_DANRE	35.2	327	210	2	1045	68	23	348	1.60E-49	198.7	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7682_c0_g1_i5	Q6AZB8	HARB1_DANRE	35.2	327	210	2	1043	66	23	348	2.10E-49	198.4	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN7682_c0_g1_i6	Q6AZB8	HARB1_DANRE	35.2	327	210	2	517	1494	23	348	1.60E-49	198.7	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3913_c0_g1_i1	Q6AZB8	HARB1_DANRE	47.8	46	24	0	202	65	152	197	1.10E-06	53.9	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3913_c0_g1_i3	Q6AZB8	HARB1_DANRE	41.2	160	92	2	553	77	152	310	1.30E-28	127.9	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3913_c0_g1_i7	Q6AZB8	HARB1_DANRE	40.7	123	71	2	428	63	152	273	1.00E-18	94.7	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3913_c0_g1_i8	Q6AZB8	HARB1_DANRE	50	46	23	0	202	65	152	197	1.70E-07	56.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3913_c0_g1_i9	Q6AZB8	HARB1_DANRE	50	46	23	0	202	65	152	197	1.70E-07	56.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4063_c0_g1_i17	Q96MB7	HARB1_HUMAN	32.7	324	194	8	191	1111	16	332	4.30E-37	157.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4063_c0_g1_i18	Q96MB7	HARB1_HUMAN	32.6	328	198	7	158	1093	12	332	4.20E-37	157.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4063_c0_g1_i3	Q96MB7	HARB1_HUMAN	30.6	248	153	6	181	876	88	332	7.20E-27	122.9	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4063_c0_g1_i5	Q96MB7	HARB1_HUMAN	32.6	328	198	7	119	1054	12	332	4.10E-37	157.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4063_c0_g1_i8	Q96MB7	HARB1_HUMAN	32.7	324	194	8	133	1053	16	332	4.10E-37	157.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN10023_c1_g1_i1	Q6AZB8	HARB1_DANRE	25.1	251	170	4	800	57	67	302	2.40E-15	84.3	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15769_c0_g1_i1	Q17QR8	HARB1_BOVIN	39.7	73	43	1	9	224	199	271	5.20E-08	58.2	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g2_i1	Q96MB7	HARB1_HUMAN	51.6	64	31	0	205	14	23	86	1.90E-09	62.8	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g3_i1	B0BN95	HARB1_RAT	47.6	145	75	1	434	3	23	167	5.80E-30	132.1	HARB1_RAT	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	Harbi1	Rattus norvegicus (Rat)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i10	Q96MB7	HARB1_HUMAN	50	58	29	0	236	63	29	86	4.40E-07	55.5	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i2	Q96MB7	HARB1_HUMAN	50	64	32	0	254	63	23	86	9.40E-08	57.8	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i3	Q96MB7	HARB1_HUMAN	50	64	32	0	254	63	23	86	1.60E-07	57	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i5	Q96MB7	HARB1_HUMAN	51.6	64	31	0	254	63	23	86	2.20E-08	59.7	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15325_c0_g1_i7	Q96MB7	HARB1_HUMAN	50	58	29	0	236	63	29	86	5.70E-07	55.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22926_c0_g1_i1	Q6AZB8	HARB1_DANRE	38.7	191	117	0	177	749	23	213	2.70E-29	130.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN22926_c0_g1_i3	Q6AZB8	HARB1_DANRE	38.7	191	117	0	177	749	23	213	2.70E-29	130.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3586_c0_g1_i1	Q6AZB8	HARB1_DANRE	34.8	141	90	1	4	426	134	272	2.30E-19	96.7	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3586_c0_g1_i2	Q6AZB8	HARB1_DANRE	42.7	96	55	0	4	291	134	229	7.20E-15	81.3	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1785_c0_g1_i2	Q96MB7	HARB1_HUMAN	43	300	167	2	24	923	12	307	1.80E-59	231.1	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1785_c0_g1_i4	Q17QR8	HARB1_BOVIN	43.2	176	100	0	232	759	132	307	1.20E-37	158.3	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1785_c0_g1_i5	Q6AZB8	HARB1_DANRE	40.9	247	145	1	51	788	71	317	9.80E-51	201.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN125_c1_g1_i1	Q6AZB8	HARB1_DANRE	40.7	118	70	0	506	859	135	252	1.80E-19	98.2	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN125_c1_g1_i2	Q6AZB8	HARB1_DANRE	40.7	118	70	0	507	860	135	252	2.30E-19	97.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4853_c0_g1_i1	Q6AZB8	HARB1_DANRE	32.3	282	185	3	978	142	30	308	1.00E-39	165.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4853_c0_g1_i2	Q6AZB8	HARB1_DANRE	33.6	235	150	3	837	142	77	308	1.50E-33	144.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3008_c0_g1_i2	Q6AZB8	HARB1_DANRE	31.2	333	218	5	989	3	24	349	6.50E-39	162.9	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3008_c0_g1_i4	Q6AZB8	HARB1_DANRE	33	188	123	2	994	431	24	208	1.40E-25	118.6	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i14	Q17QR8	HARB1_BOVIN	34.4	212	126	5	153	779	103	304	7.00E-27	122.9	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	1
TRINITY_DN958_c0_g1_i18	B0BN95	HARB1_RAT	36.4	88	46	3	619	882	103	180	1.10E-07	58.9	HARB1_RAT	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	Harbi1	Rattus norvegicus (Rat)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i21	Q96MB7	HARB1_HUMAN	34.1	217	130	4	188	829	103	309	6.20E-28	126.3	HARB1_HUMAN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1 C11orf77	Homo sapiens (Human)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i31	Q17QR8	HARB1_BOVIN	34.4	212	126	5	414	1040	103	304	8.80E-27	122.9	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i34	Q17QR8	HARB1_BOVIN	34.4	212	126	5	188	814	103	304	7.20E-27	122.9	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN958_c0_g1_i7	Q17QR8	HARB1_BOVIN	32.7	205	123	6	9	614	103	295	2.90E-23	110.2	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8683_c0_g1_i1	B0BN95	HARB1_RAT	34.3	309	183	6	70	987	11	302	2.20E-41	171.4	HARB1_RAT	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	Harbi1	Rattus norvegicus (Rat)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8683_c0_g1_i6	B0BN95	HARB1_RAT	34.3	309	183	6	70	987	11	302	2.20E-41	171.4	HARB1_RAT	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	Harbi1	Rattus norvegicus (Rat)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8683_c0_g1_i7	Q6AZB8	HARB1_DANRE	37.9	153	86	2	5	454	157	303	1.10E-22	108.2	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8683_c0_g1_i8	Q6AZB8	HARB1_DANRE	35.2	281	171	3	159	992	31	303	1.70E-41	171.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8683_c0_g1_i9	Q6AZB8	HARB1_DANRE	35.2	281	171	3	159	992	31	303	1.70E-41	171.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15269_c0_g1_i1	Q17QR8	HARB1_BOVIN	32.9	70	47	0	216	7	169	238	5.10E-05	48.9	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN759_c0_g1_i1	Q6AZB8	HARB1_DANRE	33.3	300	186	8	1090	215	15	308	9.40E-34	146	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN759_c0_g1_i5	Q6AZB8	HARB1_DANRE	33.3	300	186	8	1090	215	15	308	9.50E-34	146	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN759_c0_g1_i8	Q6AZB8	HARB1_DANRE	33.2	274	171	6	1012	215	39	308	2.40E-31	137.9	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i1	Q6AZB8	HARB1_DANRE	37.5	333	205	2	1006	17	17	349	2.10E-56	221.1	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i10	Q6AZB8	HARB1_DANRE	38.3	334	199	3	1028	42	17	348	2.60E-60	234.2	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i11	Q6AZB8	HARB1_DANRE	43.7	103	58	0	428	120	17	119	4.70E-14	79.3	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i2	Q6AZB8	HARB1_DANRE	37.1	143	90	0	456	28	17	159	2.20E-17	90.5	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i4	Q6AZB8	HARB1_DANRE	41.2	182	107	0	625	80	17	198	1.80E-32	141	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i8	Q6AZB8	HARB1_DANRE	40.4	285	169	1	927	76	17	301	1.40E-54	214.9	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i9	Q6AZB8	HARB1_DANRE	37.5	333	204	3	1003	17	17	349	7.00E-55	216.1	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4439_c0_g1_i2	Q6AZB8	HARB1_DANRE	45.1	102	56	0	89	394	94	195	2.00E-19	97.1	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4439_c0_g1_i6	Q6AZB8	HARB1_DANRE	32.6	141	56	1	89	511	94	195	1.60E-13	77.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34038_c0_g1_i1	Q17QR8	HARB1_BOVIN	35.8	246	151	4	165	884	63	307	1.40E-37	158.3	HARB1_BOVIN	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	HARBI1	Bos taurus (Bovine)	349	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN9375_c0_g1_i2	Q6AZB8	HARB1_DANRE	32.8	195	128	3	584	9	140	334	1.10E-21	104.8	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1302_c0_g1_i5	Q6AZB8	HARB1_DANRE	42.3	78	45	0	295	62	17	94	4.50E-09	62.4	HARB1_DANRE	reviewed	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	harbi1 zgc:91866	Danio rerio (Zebrafish) (Brachydanio rerio)	349	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005737; GO:0046872			brown	brown	1	NA	NA	NA
TRINITY_DN236_c0_g1_i13	P91148	NDX7_CAEEL	32.4	145	93	2	489	55	60	199	4.20E-13	76.6	NDX7_CAEEL	reviewed	Putative nudix hydrolase 7 (EC 3.6.1.-)	ndx-7 C43E11.7	Caenorhabditis elegans	295	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]		hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0016787; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1816_c0_g1_i6	Q9VCG3	OPA32_DROME	41.5	135	76	1	3	407	16	147	3.30E-23	109.8	OPA32_DROME	reviewed	Putative OPA3-like protein CG13603	CG13601	Drosophila melanogaster (Fruit fly)	255	mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]		GO:0005739; GO:0019216	regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN1816_c0_g1_i9	Q9VCG3	OPA32_DROME	48.6	74	35	1	3	224	16	86	6.20E-14	78.2	OPA32_DROME	reviewed	Putative OPA3-like protein CG13603	CG13601	Drosophila melanogaster (Fruit fly)	255	mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]		GO:0005739; GO:0019216	regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN25618_c0_g1_i1	A4FUF0	GLYR1_BOVIN	100	71	0	0	1	213	375	445	1.10E-33	143.3	GLYR1_BOVIN	reviewed	Putative oxidoreductase GLYR1 (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60)	GLYR1 NP60	Bos taurus (Bovine)	553	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491]; oxidoreductase activity [GO:0016491]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491]; oxidoreductase activity [GO:0016491]	GO:0000786; GO:0003677; GO:0005654; GO:0005829; GO:0016491; GO:0031491; GO:0035064; GO:0035066; GO:0042393; GO:0045944; GO:0050661; GO:0051287	positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN7093_c0_g1_i1	Q7Q161	GLYR1_ANOGA	50.2	564	200	9	1551	91	7	566	1.40E-144	514.6	GLYR1_ANOGA	reviewed	Putative oxidoreductase GLYR1 homolog (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60 homolog)	AGAP009949	Anopheles gambiae (African malaria mosquito)	566	"NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"		"NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0016616; GO:0050661; GO:0051287			blue	blue	NA	NA	NA	NA
TRINITY_DN3294_c0_g1_i1	P54353	DOD_DROME	63.3	166	57	2	94	579	1	166	5.80E-51	202.2	DOD_DROME	reviewed	Putative peptidyl-prolyl cis-trans isomerase dodo (PPIase dodo) (EC 5.2.1.8) (Rotamase dodo)	dod CG17051	Drosophila melanogaster (Fruit fly)	166	cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; positive regulation of protein ubiquitination [GO:0031398]; regulation of locomotor rhythm [GO:1904059]	cytosol [GO:0005829]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]	GO:0003755; GO:0005634; GO:0005829; GO:0008134; GO:0031398; GO:1904059	positive regulation of protein ubiquitination [GO:0031398]; regulation of locomotor rhythm [GO:1904059]		blue	blue	NA	NA	NA	NA
TRINITY_DN85_c0_g1_i1	Q3SZ85	PTRD1_BOVIN	55.3	123	53	2	111	473	18	140	4.10E-30	132.9	PTRD1_BOVIN	reviewed	Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1)	PTRHD1	Bos taurus (Bovine)	140	aminoacyl-tRNA hydrolase activity [GO:0004045]		aminoacyl-tRNA hydrolase activity [GO:0004045]	GO:0004045			NA	NA	NA	NA	NA	NA
TRINITY_DN85_c0_g1_i2	Q3SZ85	PTRD1_BOVIN	55.3	123	53	2	91	453	18	140	4.00E-30	132.9	PTRD1_BOVIN	reviewed	Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1)	PTRHD1	Bos taurus (Bovine)	140	aminoacyl-tRNA hydrolase activity [GO:0004045]		aminoacyl-tRNA hydrolase activity [GO:0004045]	GO:0004045			blue	blue	NA	NA	NA	NA
TRINITY_DN7364_c0_g1_i1	Q19189	PEX12_CAEEL	31.3	265	162	6	22	768	62	322	1.90E-24	114.4	PEX12_CAEEL	reviewed	Putative peroxisome assembly protein 12 (Peroxin-12)	prx-12 F08B12.2	Caenorhabditis elegans	359	integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; nematode larval development [GO:0002119]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]	integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]	protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002119; GO:0004842; GO:0005779; GO:0006513; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:1990429	nematode larval development [GO:0002119]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN26775_c0_g1_i1	Q09891	ATCX_SCHPO	52.9	70	33	0	221	12	832	901	2.80E-14	79	ATCX_SCHPO	reviewed	Putative phospholipid-transporting ATPase C24B11.12c (EC 7.6.2.1)	SPAC24B11.12c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1402	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycolipid floppase activity [GO:0034202]; magnesium ion binding [GO:0000287]; glycolipid translocation [GO:0034203]; phospholipid translocation [GO:0045332]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; glycolipid floppase activity [GO:0034202]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0034202; GO:0034203; GO:0045332; GO:0140326; GO:1990531	glycolipid translocation [GO:0034203]; phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN30892_c0_g1_i1	O36028	ATCZ_SCHPO	50	80	40	0	254	15	842	921	3.40E-15	82	ATCZ_SCHPO	reviewed	Putative phospholipid-transporting ATPase C4F10.16c (EC 7.6.2.1)	SPAC4F10.16c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1367	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]	ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0045332; GO:0140326; GO:1990531	phospholipid translocation [GO:0045332]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c0_g1_i1	A8Y236	GLT10_CAEBR	49.4	616	287	12	1919	120	13	619	9.80E-169	595.1	GLT10_CAEBR	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	gly-10 CBG22373	Caenorhabditis briggsae	629	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c0_g1_i2	A8Y236	GLT10_CAEBR	51.8	407	178	9	1842	652	13	411	1.30E-109	398.7	GLT10_CAEBR	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	gly-10 CBG22373	Caenorhabditis briggsae	629	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c0_g1_i2	A8Y236	GLT10_CAEBR	41	183	101	3	650	120	438	619	5.30E-39	164.1	GLT10_CAEBR	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	gly-10 CBG22373	Caenorhabditis briggsae	629	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c0_g1_i3	A8Y236	GLT10_CAEBR	51.8	407	178	9	1842	652	13	411	9.90E-110	399.1	GLT10_CAEBR	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	gly-10 CBG22373	Caenorhabditis briggsae	629	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN2371_c0_g1_i3	A8Y236	GLT10_CAEBR	41	183	101	3	650	120	438	619	5.40E-39	164.1	GLT10_CAEBR	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	gly-10 CBG22373	Caenorhabditis briggsae	629	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN9003_c0_g1_i1	A8Y236	GLT10_CAEBR	54.5	99	44	1	33	329	125	222	1.20E-23	110.5	GLT10_CAEBR	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	gly-10 CBG22373	Caenorhabditis briggsae	629	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN4540_c0_g1_i1	Q8MRC9	GALT9_DROME	73.9	372	97	0	3	1118	176	547	2.90E-175	615.9	GALT9_DROME	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9)	Pgant9 CG30463	Drosophila melanogaster (Fruit fly)	650	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872	multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN4540_c0_g1_i2	Q8MRC9	GALT9_DROME	77.2	372	85	0	3	1118	176	547	6.50E-183	641.3	GALT9_DROME	reviewed	Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9)	Pgant9 CG30463	Drosophila melanogaster (Fruit fly)	650	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872	multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]		NA	NA	NA	NA	NA	NA
TRINITY_DN10293_c0_g1_i1	Q54NJ4	DHX15_DICDI	64.8	179	62	1	534	1	75	253	3.90E-61	235.7	DHX15_DICDI	reviewed	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase dhx15 (EC 3.6.4.13) (DEAH box protein 15)	dhx15 prp43 DDB_G0285213	Dictyostelium discoideum (Slime mold)	727	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24284_c0_g2_i1	Q54MH3	DHX16_DICDI	75.3	194	48	0	583	2	703	896	8.90E-83	307.8	DHX16_DICDI	reviewed	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16)	dhx16 DDB_G0285937	Dictyostelium discoideum (Slime mold)	1106	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN10293_c0_g2_i1	O17438	DHX15_STRPU	58.9	280	103	3	3	806	97	376	1.10E-86	321.2	DHX15_STRPU	reviewed	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase PRP1 (EC 3.6.4.13) (Fragment)	PRP1	Strongylocentrotus purpuratus (Purple sea urchin)	455	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]	GO:0003724; GO:0005524; GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN40126_c0_g1_i1	Q10057	PDI1_SCHPO	60.3	63	25	0	203	15	354	416	1.20E-17	90.1	PDI1_SCHPO	reviewed	Putative protein disulfide-isomerase C1F5.02 (EC 5.3.4.1)	SPAC1F5.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	492	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0034975; GO:0034976	protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN16706_c0_g1_i2	P83099	KPC4_DROME	44.4	54	30	0	212	51	304	357	1.70E-05	49.7	KPC4_DROME	reviewed	Putative protein kinase C delta type homolog (EC 2.7.11.13)	Pkcdelta CG10524	Drosophila melanogaster (Fruit fly)	671	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	1	NA	NA	NA
TRINITY_DN16420_c0_g1_i1	P83099	KPC4_DROME	68.5	168	52	1	510	10	127	294	1.00E-66	254.6	KPC4_DROME	reviewed	Putative protein kinase C delta type homolog (EC 2.7.11.13)	Pkcdelta CG10524	Drosophila melanogaster (Fruit fly)	671	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN16420_c0_g1_i2	P83099	KPC4_DROME	68.5	168	52	1	510	10	127	294	9.30E-67	254.6	KPC4_DROME	reviewed	Putative protein kinase C delta type homolog (EC 2.7.11.13)	Pkcdelta CG10524	Drosophila melanogaster (Fruit fly)	671	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN16706_c0_g1_i1	P83099	KPC4_DROME	52.3	88	42	0	265	2	304	391	2.80E-18	92.4	KPC4_DROME	reviewed	Putative protein kinase C delta type homolog (EC 2.7.11.13)	Pkcdelta CG10524	Drosophila melanogaster (Fruit fly)	671	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN278_c0_g1_i2	Q98TR3	RENT1_TAKRU	45	80	44	0	396	157	799	878	8.70E-11	68.2	RENT1_TAKRU	reviewed	Putative regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1)	rent1	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	1097	"P-body [GO:0000932]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	P-body [GO:0000932]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000932; GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0008270	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN169_c0_g2_i1	P0DKH2	RI2BC_ARATH	52.6	78	37	0	3	236	27	104	1.20E-17	90.1	RI2BC_ARATH	reviewed	Putative ribonucleoside-diphosphate reductase small chain B (Ribonucleoside-diphosphate reductase R2B subunit) (Ribonucleotide reductase small subunit B)	RNR2B RNR2B-1 At5g40942 MMG1.4	Arabidopsis thaliana (Mouse-ear cress)	158	oxidoreductase activity [GO:0016491]; deoxyribonucleotide biosynthetic process [GO:0009263]		oxidoreductase activity [GO:0016491]	GO:0009263; GO:0016491	deoxyribonucleotide biosynthetic process [GO:0009263]		NA	NA	NA	NA	NA	NA
TRINITY_DN30202_c0_g1_i1	Q54SY2	NVL_DICDI	53.1	179	79	1	6	527	577	755	1.50E-52	207.2	NVL_DICDI	reviewed	Putative ribosome biogenesis ATPase nvl (Nuclear valosin-containing protein-like)	nvl DDB_G0282181	Dictyostelium discoideum (Slime mold)	867	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5131_c0_g1_i1	B0UYH6	RPAP2_DANRE	27.6	312	193	9	51	935	18	313	2.00E-15	84.7	RPAP2_DANRE	reviewed	Putative RNA polymerase II subunit B1 CTD phosphatase rpap2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2)	rpap2 si:dkey-63k7.3	Danio rerio (Zebrafish) (Brachydanio rerio)	601	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0005634; GO:0005737; GO:0008420; GO:0009301; GO:0016591; GO:0043175; GO:0046872; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]		NA	NA	NA	NA	NA	NA
TRINITY_DN36801_c0_g1_i1	Q8NDT2	RB15B_HUMAN	100	116	0	0	2	349	327	442	8.90E-62	237.3	RB15B_HUMAN	reviewed	Putative RNA-binding protein 15B (One-twenty two protein 3) (HsOTT3) (HuOTT3) (RNA-binding motif protein 15B)	RBM15B OTT3	Homo sapiens (Human)	890	"nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; viral process [GO:0016032]"	nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0001510; GO:0003676; GO:0003723; GO:0005634; GO:0005635; GO:0005654; GO:0006406; GO:0009048; GO:0016032; GO:0016607; GO:0036396	"dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33219_c0_g1_i1	Q9NQ29	LUC7L_HUMAN	100	100	0	0	300	1	31	130	3.50E-51	201.8	LUC7L_HUMAN	reviewed	Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89)	LUC7L LUC7L1	Homo sapiens (Human)	371	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]; mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]	GO:0003729; GO:0005685; GO:0006376; GO:0042802; GO:0045843; GO:0050733; GO:0071004	mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]		NA	NA	NA	NA	NA	NA
TRINITY_DN2310_c0_g1_i1	Q9NQ29	LUC7L_HUMAN	72.3	220	61	0	2	661	24	243	3.10E-86	319.7	LUC7L_HUMAN	reviewed	Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89)	LUC7L LUC7L1	Homo sapiens (Human)	371	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]; mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]	GO:0003729; GO:0005685; GO:0006376; GO:0042802; GO:0045843; GO:0050733; GO:0071004	mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]		NA	NA	NA	NA	NA	NA
TRINITY_DN37367_c0_g1_i1	Q9NQ29	LUC7L_HUMAN	100	156	0	0	2	469	90	245	3.70E-77	288.9	LUC7L_HUMAN	reviewed	Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89)	LUC7L LUC7L1	Homo sapiens (Human)	371	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]; mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]	GO:0003729; GO:0005685; GO:0006376; GO:0042802; GO:0045843; GO:0050733; GO:0071004	mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]		NA	NA	NA	NA	NA	NA
TRINITY_DN33241_c0_g1_i1	Q9Y383	LC7L2_HUMAN	100	209	0	0	679	53	32	240	2.10E-112	406.4	LC7L2_HUMAN	reviewed	Putative RNA-binding protein Luc7-like 2	LUC7L2 CGI-59 CGI-74	Homo sapiens (Human)	392	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004	mRNA splice site selection [GO:0006376]		NA	NA	NA	NA	NA	NA
TRINITY_DN2310_c0_g1_i2	Q9Y383	LC7L2_HUMAN	73.6	216	57	0	2	649	24	239	2.40E-86	320.1	LC7L2_HUMAN	reviewed	Putative RNA-binding protein Luc7-like 2	LUC7L2 CGI-59 CGI-74	Homo sapiens (Human)	392	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004	mRNA splice site selection [GO:0006376]		blue	blue	NA	NA	NA	NA
TRINITY_DN40946_c0_g1_i1	A6NIE9	PRS29_HUMAN	44.6	74	35	2	3	221	218	286	7.10E-07	54.3	PRS29_HUMAN	reviewed	Putative serine protease 29 (EC 3.4.21.-) (Implantation serine proteinase 2-like protein) (ISP2-like protein)	PRSS29P ISP2	Homo sapiens (Human)	313	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508	proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN18670_c0_g1_i1	P90893	YM9I_CAEEL	36.6	454	273	7	1411	89	59	510	5.50E-82	306.6	YM9I_CAEEL	reviewed	Putative serine protease F56F10.1 (EC 3.4.-.-)	F56F10.1	Caenorhabditis elegans	540	membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508]	membrane raft [GO:0045121]	dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]	GO:0006508; GO:0008236; GO:0008239; GO:0045087; GO:0045121	innate immune response [GO:0045087]; proteolysis [GO:0006508]		blue	blue	NA	NA	NA	NA
TRINITY_DN40137_c0_g1_i1	O43930	PRKY_HUMAN	53.2	77	35	1	7	237	131	206	3.20E-15	82	PRKY_HUMAN	reviewed	Putative serine/threonine-protein kinase PRKY (EC 2.7.11.1)	PRKY	Homo sapiens (Human)	277	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004691; GO:0005524; GO:0005952; GO:0006468; GO:0007165; GO:0018105	peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5993_c0_g1_i1	Q6ZNB5	TRC2L_HUMAN	45.5	112	58	1	11	337	1	112	5.80E-23	110.9	TRC2L_HUMAN	reviewed	Putative short transient receptor potential channel 2-like protein (TrpC2-like protein)		Homo sapiens (Human)	142	nucleolus [GO:0005730]; damaged DNA binding [GO:0003684]; single strand break repair [GO:0000012]	nucleolus [GO:0005730]	damaged DNA binding [GO:0003684]	GO:0000012; GO:0003684; GO:0005730	single strand break repair [GO:0000012]		NA	NA	NA	NA	NA	NA
TRINITY_DN5574_c0_g1_i1	P96825	Y0148_MYCTU	58.8	80	33	0	241	2	132	211	1.80E-21	102.8	Y0148_MYCTU	reviewed	Putative short-chain type dehydrogenase/reductase Rv0148 (EC 1.1.1.-)	Rv0148	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	286	cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; protein pupylation [GO:0070490]	cell wall [GO:0005618]; plasma membrane [GO:0005886]	oxidoreductase activity [GO:0016491]	GO:0005618; GO:0005886; GO:0016491; GO:0070490	protein pupylation [GO:0070490]		NA	NA	NA	NA	NA	NA
TRINITY_DN6904_c0_g1_i1	Q9NVC3	S38A7_HUMAN	39.5	291	169	5	1	855	118	407	7.10E-50	199.1	S38A7_HUMAN	reviewed	Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7)	SLC38A7 SNAT7	Homo sapiens (Human)	462	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]	amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]	GO:0003333; GO:0005290; GO:0005313; GO:0006814; GO:0015171; GO:0015179; GO:0015180; GO:0015182; GO:0015183; GO:0015186; GO:0015190; GO:0015191; GO:0015194; GO:0016021; GO:0030424; GO:0043025	amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6904_c0_g1_i2	A7E3U5	S38A7_BOVIN	41.2	240	136	4	573	1280	173	411	1.20E-44	182.2	S38A7_BOVIN	reviewed	Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7)	SLC38A7 SNAT7	Bos taurus (Bovine)	463	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]	amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]	GO:0003333; GO:0005290; GO:0005313; GO:0006814; GO:0015171; GO:0015179; GO:0015180; GO:0015182; GO:0015183; GO:0015186; GO:0015190; GO:0015191; GO:0015194; GO:0016021; GO:0030424; GO:0043025	amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6904_c0_g1_i2	A7E3U5	S38A7_BOVIN	42.9	70	40	0	325	534	48	117	1.70E-09	65.5	S38A7_BOVIN	reviewed	Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7)	SLC38A7 SNAT7	Bos taurus (Bovine)	463	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]	amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]	GO:0003333; GO:0005290; GO:0005313; GO:0006814; GO:0015171; GO:0015179; GO:0015180; GO:0015182; GO:0015183; GO:0015186; GO:0015190; GO:0015191; GO:0015194; GO:0016021; GO:0030424; GO:0043025	amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN6904_c0_g1_i3	Q9NVC3	S38A7_HUMAN	39.5	397	231	6	349	1521	56	449	6.10E-76	286.6	S38A7_HUMAN	reviewed	Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7)	SLC38A7 SNAT7	Homo sapiens (Human)	462	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]	amino acid transmembrane transporter activity [GO:0015171]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]	GO:0003333; GO:0005290; GO:0005313; GO:0006814; GO:0015171; GO:0015179; GO:0015180; GO:0015182; GO:0015183; GO:0015186; GO:0015190; GO:0015191; GO:0015194; GO:0016021; GO:0030424; GO:0043025	amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN33256_c0_g1_i1	P83740	SC5A6_DROME	62.3	130	48	1	389	3	96	225	3.30E-33	142.5	SC5A6_DROME	reviewed	Putative sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter)	CG32669	Drosophila melanogaster (Fruit fly)	604	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN40653_c0_g1_i1	P83740	SC5A6_DROME	41.4	70	40	1	232	26	271	340	7.00E-08	57.8	SC5A6_DROME	reviewed	Putative sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter)	CG32669	Drosophila melanogaster (Fruit fly)	604	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN18715_c0_g1_i2	P83740	SC5A6_DROME	41.7	60	35	0	37	216	388	447	3.80E-05	48.5	SC5A6_DROME	reviewed	Putative sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter)	CG32669	Drosophila melanogaster (Fruit fly)	604	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN38587_c0_g1_i1	P83740	SC5A6_DROME	48.1	106	53	1	1	312	286	391	1.40E-21	103.6	SC5A6_DROME	reviewed	Putative sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter)	CG32669	Drosophila melanogaster (Fruit fly)	604	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN30156_c0_g1_i1	P0CL84	ST3L2_HUMAN	99.2	121	1	0	377	15	14	134	5.40E-65	248.1	ST3L2_HUMAN	reviewed	Putative STAG3-like protein 2 (Stromal antigen 3-like protein 2)	STAG3L2	Homo sapiens (Human)	134	chromatin [GO:0000785]; cohesin complex [GO:0008278]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; cohesin complex [GO:0008278]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	GO:0000785; GO:0003682; GO:0005634; GO:0007062; GO:0008278	sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN12751_c0_g1_i1	O34940	YVRE_BACSU	34	100	58	2	99	398	89	180	5.50E-11	68.9	YVRE_BACSU	reviewed	Putative sugar lactone lactonase YvrE (EC 3.1.1.-)	yvrE BSU33200	Bacillus subtilis (strain 168)	292	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; gluconolactonase activity [GO:0004341]; L-ascorbic acid biosynthetic process [GO:0019853]	cytoplasm [GO:0005737]	calcium ion binding [GO:0005509]; gluconolactonase activity [GO:0004341]	GO:0004341; GO:0005509; GO:0005737; GO:0019853	L-ascorbic acid biosynthetic process [GO:0019853]		NA	NA	NA	NA	NA	NA
TRINITY_DN27637_c0_g1_i1	O53176	Y2449_MYCTU	58.4	89	37	0	3	269	70	158	6.00E-21	101.3	Y2449_MYCTU	reviewed	Putative trans-acting enoyl reductase Rv2449c (EC 1.3.1.-)	Rv2449c	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	419	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	oxidoreductase activity [GO:0016491]	GO:0005886; GO:0009247; GO:0016021; GO:0016491	glycolipid biosynthetic process [GO:0009247]		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i5	A2VDT4	OVOL1_BOVIN	38.5	52	31	1	505	660	143	193	3.80E-05	50.1	OVOL1_BOVIN	reviewed	Putative transcription factor Ovo-like 1	OVOL1	Bos taurus (Bovine)	267	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; skin development [GO:0043588]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0001227; GO:0001228; GO:0001822; GO:0005634; GO:0007283; GO:0007498; GO:0009913; GO:0043565; GO:0043588; GO:0045892; GO:0046872; GO:0051729; GO:1901994; GO:2000647	"epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; skin development [GO:0043588]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14997_c0_g1_i1	P40656	SOX14_DROME	75.3	81	20	0	3	245	170	250	4.00E-29	128.3	SOX14_DROME	reviewed	Putative transcription factor SOX-14	Sox14 CG3090	Drosophila melanogaster (Fruit fly)	669	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0009653; GO:0016322; GO:0030154; GO:0043565; GO:0048813; GO:1904799; GO:1904801	"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14997_c0_g1_i2	P40656	SOX14_DROME	72.4	87	24	0	3	263	170	256	2.70E-31	135.6	SOX14_DROME	reviewed	Putative transcription factor SOX-14	Sox14 CG3090	Drosophila melanogaster (Fruit fly)	669	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0009653; GO:0016322; GO:0030154; GO:0043565; GO:0048813; GO:1904799; GO:1904801	"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38848_c0_g1_i1	P40656	SOX14_DROME	72.9	85	23	0	1	255	172	256	9.10E-32	137.1	SOX14_DROME	reviewed	Putative transcription factor SOX-14	Sox14 CG3090	Drosophila melanogaster (Fruit fly)	669	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007552; GO:0008301; GO:0009653; GO:0016322; GO:0030154; GO:0043565; GO:0048813; GO:1904799; GO:1904801	"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; metamorphosis [GO:0007552]; neuron remodeling [GO:0016322]; positive regulation of neuron remodeling [GO:1904801]; regulation of neuron remodeling [GO:1904799]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35524_c0_g1_i1	B8JMH0	CAF17_DANRE	34.6	347	172	9	1075	98	42	354	4.40E-47	190.3	CAF17_DANRE	reviewed	"Putative transferase CAF17 homolog, mitochondrial (EC 2.1.-.-) (Iron-sulfur cluster assembly factor homolog)"	iba57 ch1073-162b20.1	Danio rerio (Zebrafish) (Brachydanio rerio)	354	mitochondrial matrix [GO:0005759]; transferase activity [GO:0016740]; heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226]	mitochondrial matrix [GO:0005759]	transferase activity [GO:0016740]	GO:0005759; GO:0006783; GO:0016226; GO:0016740	heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN37065_c0_g1_i1	Q6C8Y7	CAF17_YARLI	56.6	53	23	0	3	161	246	298	1.30E-11	70.1	CAF17_YARLI	reviewed	"Putative transferase CAF17, mitochondrial (EC 2.1.-.-)"	CAF17 YALI0D15774g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	479	mitochondrial matrix [GO:0005759]; transferase activity [GO:0016740]; iron-sulfur cluster assembly [GO:0016226]	mitochondrial matrix [GO:0005759]	transferase activity [GO:0016740]	GO:0005759; GO:0016226; GO:0016740	iron-sulfur cluster assembly [GO:0016226]		NA	NA	NA	NA	NA	NA
TRINITY_DN5982_c0_g1_i1	Q9UET6	TRM7_HUMAN	54.8	73	29	2	15	221	88	160	1.90E-13	76.3	TRM7_HUMAN	reviewed	Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1)	FTSJ1 JM23	Homo sapiens (Human)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]	GO:0001510; GO:0002128; GO:0002181; GO:0005737; GO:0005829; GO:0006400; GO:0008173; GO:0008175; GO:0009020; GO:0030488; GO:0052666	cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]		NA	NA	NA	NA	NA	NA
TRINITY_DN1715_c0_g1_i1	Q9UET6	TRM7_HUMAN	66.2	281	91	1	3	845	9	285	3.10E-105	383.3	TRM7_HUMAN	reviewed	Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1)	FTSJ1 JM23	Homo sapiens (Human)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]	GO:0001510; GO:0002128; GO:0002181; GO:0005737; GO:0005829; GO:0006400; GO:0008173; GO:0008175; GO:0009020; GO:0030488; GO:0052666	cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]		NA	NA	NA	NA	NA	NA
TRINITY_DN39977_c0_g1_i1	Q9UET6	TRM7_HUMAN	100	136	0	0	1	408	65	200	2.00E-73	276.2	TRM7_HUMAN	reviewed	Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1)	FTSJ1 JM23	Homo sapiens (Human)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]	GO:0001510; GO:0002128; GO:0002181; GO:0005737; GO:0005829; GO:0006400; GO:0008173; GO:0008175; GO:0009020; GO:0030488; GO:0052666	cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]		NA	NA	NA	NA	NA	NA
TRINITY_DN8373_c0_g1_i1	Q27974	AUXI_BOVIN	60.3	116	44	2	4	345	788	903	1.70E-35	150.2	AUXI_BOVIN	reviewed	Putative tyrosine-protein phosphatase auxilin (EC 3.1.3.48) (DnaJ homolog subfamily C member 6)	DNAJC6	Bos taurus (Bovine)	910	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; protein domain specific binding [GO:0019904]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982]	clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; protein domain specific binding [GO:0019904]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]	GO:0004725; GO:0005737; GO:0006898; GO:0014069; GO:0016191; GO:0017124; GO:0019904; GO:0030276; GO:0031982; GO:0032050; GO:0043231; GO:0072318; GO:0072583; GO:0098793	clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]		NA	NA	NA	NA	NA	NA
TRINITY_DN39565_c0_g1_i1	Q9VUV9	U520_DROME	52	100	46	1	2	295	570	669	1.80E-21	103.2	U520_DROME	reviewed	Putative U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab)	l(3)72Ab CG5931	Drosophila melanogaster (Fruit fly)	2142	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0007283; GO:0007419; GO:0008380; GO:0030532; GO:0071011; GO:0071013	"mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"		NA	NA	1	NA	NA	NA
TRINITY_DN2458_c0_g2_i1	Q9VUV9	U520_DROME	79.8	262	51	1	782	3	761	1022	7.40E-117	421.4	U520_DROME	reviewed	Putative U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab)	l(3)72Ab CG5931	Drosophila melanogaster (Fruit fly)	2142	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0007283; GO:0007419; GO:0008380; GO:0030532; GO:0071011; GO:0071013	"mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39534_c0_g1_i1	Q9VUV9	U520_DROME	77.8	153	34	0	6	464	1644	1796	3.10E-70	265.8	U520_DROME	reviewed	Putative U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab)	l(3)72Ab CG5931	Drosophila melanogaster (Fruit fly)	2142	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0007283; GO:0007419; GO:0008380; GO:0030532; GO:0071011; GO:0071013	"mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38716_c0_g1_i1	Q9VUV9	U520_DROME	63.7	146	53	0	441	4	1644	1789	1.70E-57	223.4	U520_DROME	reviewed	Putative U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab)	l(3)72Ab CG5931	Drosophila melanogaster (Fruit fly)	2142	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0007283; GO:0007419; GO:0008380; GO:0030532; GO:0071011; GO:0071013	"mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8315_c0_g1_i6	Q6P8X6	UBP50_MOUSE	29.4	330	198	9	923	3	43	360	2.40E-28	127.9	UBP50_MOUSE	reviewed	Putative ubiquitin carboxyl-terminal hydrolase 50 (EC 3.4.19.12) (Deubiquitinating enzyme 50) (Ubiquitin thioesterase 50) (Ubiquitin-specific-processing protease 50)	Usp50	Mus musculus (Mouse)	390	cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; midbody [GO:0030496]; postsynaptic density [GO:0014069]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-like protein-specific protease activity [GO:0019783]; endosome organization [GO:0007032]; nuclear speck organization [GO:0035063]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; midbody [GO:0030496]; postsynaptic density [GO:0014069]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-like protein-specific protease activity [GO:0019783]	GO:0004843; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0019783; GO:0019897; GO:0030496; GO:0031313; GO:0032731; GO:0032741; GO:0035063; GO:0043197; GO:0070536; GO:0071108; GO:1900227; GO:2001056	endosome organization [GO:0007032]; nuclear speck organization [GO:0035063]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2951_c0_g1_i1	O14262	YFP5_SCHPO	27.3	194	128	5	690	127	26	212	7.60E-18	92.4	YFP5_SCHPO	reviewed	Putative uncharacterized hydrolase C7D4.05 (EC 3.-.-.-)	SPAC7D4.05	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	228	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatase activity [GO:0016791]	cytosol [GO:0005829]; nucleus [GO:0005634]	phosphatase activity [GO:0016791]	GO:0005634; GO:0005829; GO:0016791			NA	NA	NA	NA	NA	NA
TRINITY_DN2799_c0_g1_i1	Q9UT59	YKJ7_SCHPO	43.4	145	71	6	1233	808	1	137	1.60E-18	95.5	YKJ7_SCHPO	reviewed	Putative uncharacterized oxidoreductase C513.07 (EC 1.1.1.-)	SPAC513.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	336	"cytosol [GO:0005829]; nucleus [GO:0005634]; methylglyoxal reductase (NADPH-dependent) activity [GO:0043892]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; cellular detoxification of methylglyoxal [GO:0140041]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"methylglyoxal reductase (NADPH-dependent) activity [GO:0043892]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005634; GO:0005829; GO:0016491; GO:0016616; GO:0043892; GO:0140041	cellular detoxification of methylglyoxal [GO:0140041]		blue	blue	NA	NA	NA	NA
TRINITY_DN2799_c0_g1_i2	Q9UT59	YKJ7_SCHPO	38.5	291	153	12	1232	405	1	280	9.20E-35	149.4	YKJ7_SCHPO	reviewed	Putative uncharacterized oxidoreductase C513.07 (EC 1.1.1.-)	SPAC513.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	336	"cytosol [GO:0005829]; nucleus [GO:0005634]; methylglyoxal reductase (NADPH-dependent) activity [GO:0043892]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; cellular detoxification of methylglyoxal [GO:0140041]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"methylglyoxal reductase (NADPH-dependent) activity [GO:0043892]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005634; GO:0005829; GO:0016491; GO:0016616; GO:0043892; GO:0140041	cellular detoxification of methylglyoxal [GO:0140041]		blue	blue	NA	NA	NA	NA
TRINITY_DN7253_c0_g2_i1	Q8TGM7	ART2_YEAST	70.7	41	12	0	437	315	16	56	2.20E-09	63.5	ART2_YEAST	reviewed	Putative uncharacterized protein ART2 (Antisense to ribosomal RNA transcript protein 2)	ART2 YLR154W-A YLR154W-C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	61							blue	blue	NA	NA	NA	NA
TRINITY_DN40970_c0_g1_i1	Q58730	Y1334_METJA	53.7	54	25	0	177	16	2	55	9.50E-11	67	Y1334_METJA	reviewed	Putative UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (Alpha-D-glucosyl-1-phosphate uridylyltransferase) (UDP-glucose pyrophosphorylase) (UDPGP) (Uridine diphosphoglucose pyrophosphorylase)	MJ1334	Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)	283	UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; biosynthetic process [GO:0009058]; UDP-glucose metabolic process [GO:0006011]		UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]	GO:0003983; GO:0006011; GO:0009058	biosynthetic process [GO:0009058]; UDP-glucose metabolic process [GO:0006011]		NA	NA	NA	NA	NA	NA
TRINITY_DN6799_c0_g1_i3	Q55FG3	VP13C_DICDI	22.2	225	148	4	601	5	143	366	6.20E-11	69.3	VP13C_DICDI	reviewed	Putative vacuolar protein sorting-associated protein 13C (Developmental gene 1038 protein)	tipC DG1038 vps13 vps13C DDB_G0267422	Dictyostelium discoideum (Slime mold)	3848	extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; autophagosome assembly [GO:0000045]; culmination involved in sorocarp development [GO:0031154]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]		GO:0000045; GO:0005794; GO:0006623; GO:0016236; GO:0019898; GO:0031154; GO:0045053; GO:0045324	autophagosome assembly [GO:0000045]; culmination involved in sorocarp development [GO:0031154]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN30773_c0_g1_i1	P98163	YL_DROME	27.7	166	83	6	54	515	197	337	7.40E-09	62.4	YL_DROME	reviewed	Putative vitellogenin receptor (Protein yolkless) (YL)	yl CG1372	Drosophila melanogaster (Fruit fly)	1984	coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]; oogenesis [GO:0048477]	coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]	GO:0005509; GO:0005886; GO:0008196; GO:0016021; GO:0030135; GO:0031410; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN6633_c0_g2_i1	P0CG31	Z286B_HUMAN	34.2	73	45	1	242	24	239	308	8.70E-07	54.3	Z286B_HUMAN	reviewed	Putative zinc finger protein 286B	ZNF286B ZNF286C ZNF286L	Homo sapiens (Human)	522	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14356_c0_g1_i1	Q6ZN08	ZNF66_HUMAN	47.5	141	74	0	9	431	378	518	3.80E-33	142.5	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5269_c0_g1_i1	Q6ZN08	ZNF66_HUMAN	42.7	82	42	2	398	153	315	391	9.10E-12	72.8	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5269_c0_g1_i2	Q6ZN08	ZNF66_HUMAN	42.7	82	42	2	398	153	315	391	7.90E-12	72.8	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g3_i1	Q6ZN08	ZNF66_HUMAN	47.4	116	59	2	346	5	434	549	9.40E-23	107.8	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7304_c0_g1_i1	Q6ZN08	ZNF66_HUMAN	52.5	141	67	0	20	442	198	338	6.30E-42	171.8	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		brown	brown	1	NA	NA	NA
TRINITY_DN7304_c0_g2_i1	Q6ZN08	ZNF66_HUMAN	51.8	141	68	0	454	32	198	338	4.00E-41	169.1	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c2_g1_i1	Q6ZN08	ZNF66_HUMAN	55.4	65	29	0	200	6	426	490	6.50E-17	87.4	ZNF66_HUMAN	reviewed	Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)	ZNF66 ZNF66P	Homo sapiens (Human)	573	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i2	Q6ZMV8	ZN730_HUMAN	58.8	80	33	0	368	129	399	478	1.90E-22	106.7	ZN730_HUMAN	reviewed	Putative zinc finger protein 730	ZNF730	Homo sapiens (Human)	503	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i5	Q6ZMV8	ZN730_HUMAN	57	100	43	0	316	17	399	498	6.80E-29	127.9	ZN730_HUMAN	reviewed	Putative zinc finger protein 730	ZNF730	Homo sapiens (Human)	503	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17290_c0_g1_i1	A6NDX5	ZN840_HUMAN	60.5	38	15	0	116	3	348	385	1.10E-07	57	ZN840_HUMAN	reviewed	Putative zinc finger protein 840 (Zinc finger protein 840 pseudogene)	ZNF840P C20orf157 ZNF840	Homo sapiens (Human)	716	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34738_c0_g1_i1	Q8BX57	PXK_MOUSE	100	104	0	0	314	3	228	331	1.30E-56	219.9	PXK_MOUSE	reviewed	"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)"	Pxk	Mus musculus (Mouse)	582	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]	GO:0003779; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0042391; GO:0043271; GO:0050804	inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN13073_c0_g1_i1	Q8BX57	PXK_MOUSE	39.2	311	188	1	14	943	134	444	5.80E-62	239.6	PXK_MOUSE	reviewed	"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)"	Pxk	Mus musculus (Mouse)	582	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]	GO:0003779; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0042391; GO:0043271; GO:0050804	inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN13073_c0_g1_i2	Q8BX57	PXK_MOUSE	39.6	445	267	2	48	1379	1	444	1.20E-94	348.6	PXK_MOUSE	reviewed	"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)"	Pxk	Mus musculus (Mouse)	582	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]	GO:0003779; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0042391; GO:0043271; GO:0050804	inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN13073_c0_g1_i3	Q8BX57	PXK_MOUSE	39.5	311	187	1	72	1001	134	444	7.20E-63	242.7	PXK_MOUSE	reviewed	"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)"	Pxk	Mus musculus (Mouse)	582	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]	GO:0003779; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0042391; GO:0043271; GO:0050804	inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]		NA	NA	NA	NA	NA	NA
TRINITY_DN35235_c0_g1_i1	Q8QZR3	EST2A_MOUSE	45.5	55	27	1	187	32	76	130	2.00E-06	52.8	EST2A_MOUSE	reviewed	Pyrethroid hydrolase Ces2a (EC 3.1.1.88) (Carboxylic ester hydrolase 2A) (EC 3.1.1.-) (carboxylesterase 2A)	Ces2a Ces6	Mus musculus (Mouse)	558	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; trans-permethrin hydrolase activity [GO:0102209]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	carboxylic ester hydrolase activity [GO:0052689]; sterol esterase activity [GO:0004771]; trans-permethrin hydrolase activity [GO:0102209]; triglyceride lipase activity [GO:0004806]	GO:0004771; GO:0004806; GO:0005615; GO:0005783; GO:0006486; GO:0016042; GO:0052689; GO:0102209	lipid catabolic process [GO:0016042]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN1148_c0_g1_i1	Q68FS6	PYRD1_RAT	53.1	490	214	4	1495	74	9	498	1.10E-143	511.5	PYRD1_RAT	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-)	Pyroxd1	Rattus norvegicus (Rat)	498	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]	oxidoreductase activity [GO:0016491]	GO:0005634; GO:0005737; GO:0016491; GO:0030017; GO:0034599	cellular response to oxidative stress [GO:0034599]		NA	NA	NA	NA	NA	NA
TRINITY_DN1148_c0_g1_i2	Q68FS6	PYRD1_RAT	53.1	490	214	4	1512	91	9	498	1.10E-143	511.5	PYRD1_RAT	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-)	Pyroxd1	Rattus norvegicus (Rat)	498	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]	oxidoreductase activity [GO:0016491]	GO:0005634; GO:0005737; GO:0016491; GO:0030017; GO:0034599	cellular response to oxidative stress [GO:0034599]		NA	NA	NA	NA	NA	NA
TRINITY_DN1148_c0_g1_i3	Q68FS6	PYRD1_RAT	53.1	490	214	4	1530	109	9	498	1.50E-143	511.1	PYRD1_RAT	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-)	Pyroxd1	Rattus norvegicus (Rat)	498	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]	oxidoreductase activity [GO:0016491]	GO:0005634; GO:0005737; GO:0016491; GO:0030017; GO:0034599	cellular response to oxidative stress [GO:0034599]		NA	NA	NA	NA	NA	NA
TRINITY_DN9749_c0_g1_i1	Q8N2H3	PYRD2_HUMAN	57.8	365	154	0	1121	27	212	576	8.00E-120	431.8	PYRD2_HUMAN	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-)	PYROXD2 C10orf33	Homo sapiens (Human)	581	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0007005; GO:0016491	mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN26269_c0_g1_i1	Q68FT3	PYRD2_RAT	56.5	62	27	0	187	2	494	555	7.20E-16	84	PYRD2_RAT	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-)	Pyroxd2	Rattus norvegicus (Rat)	581	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0007005; GO:0016491	mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN2476_c0_g1_i1	Q8N2H3	PYRD2_HUMAN	69	71	22	0	45	257	34	104	2.80E-23	109.4	PYRD2_HUMAN	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-)	PYROXD2 C10orf33	Homo sapiens (Human)	581	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0007005; GO:0016491	mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN2476_c0_g1_i4	Q3MHH6	PYRD2_BOVIN	52.3	172	81	1	45	557	34	205	7.30E-46	185.3	PYRD2_BOVIN	reviewed	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-)	PYROXD2	Bos taurus (Bovine)	581	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0007005; GO:0016491	mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN35898_c0_g1_i1	Q8W1X2	PDXK_ARATH	64.3	129	46	0	388	2	37	165	2.40E-44	179.5	PDXK_ARATH	reviewed	"Pyridoxal kinase (EC 2.7.1.35) (Protein SALT OVERLY SENSITIVE 4) (Pyridoxal kinase-like protein SOS4) (Pyridoxine kinase) [Cleaved into: Pyridoxal kinase, N-terminally processed]"	PK PDXK SOS4 At5g37850 K18L3_10	Arabidopsis thaliana (Mouse-ear cress)	309	chloroplast [GO:0009507]; cytosol [GO:0005829]; plastid [GO:0009536]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; hyperosmotic salinity response [GO:0042538]; pyridoxal 5'-phosphate salvage [GO:0009443]; pyridoxine biosynthetic process [GO:0008615]; trichoblast differentiation [GO:0010054]	chloroplast [GO:0009507]; cytosol [GO:0005829]; plastid [GO:0009536]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]	GO:0005524; GO:0005829; GO:0008478; GO:0008615; GO:0009443; GO:0009507; GO:0009536; GO:0010054; GO:0042538; GO:0046872	hyperosmotic salinity response [GO:0042538]; pyridoxal 5'-phosphate salvage [GO:0009443]; pyridoxine biosynthetic process [GO:0008615]; trichoblast differentiation [GO:0010054]		NA	NA	NA	NA	NA	NA
TRINITY_DN1127_c0_g1_i1	O00764	PDXK_HUMAN	53.1	305	131	3	176	1054	6	310	1.30E-82	308.1	PDXK_HUMAN	reviewed	Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)	PDXK C21orf124 C21orf97 PKH PNK PRED79	Homo sapiens (Human)	312	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; ATP binding [GO:0005524]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; pyridoxal kinase activity [GO:0008478]; pyridoxal phosphate binding [GO:0030170]; sodium ion binding [GO:0031402]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; pyridoxal 5'-phosphate salvage [GO:0009443]; vitamin B6 metabolic process [GO:0042816]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]	ATP binding [GO:0005524]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; pyridoxal kinase activity [GO:0008478]; pyridoxal phosphate binding [GO:0030170]; sodium ion binding [GO:0031402]; zinc ion binding [GO:0008270]	GO:0000287; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0008478; GO:0009443; GO:0030170; GO:0030955; GO:0031402; GO:0031403; GO:0034774; GO:0035580; GO:0042803; GO:0042816; GO:0043312; GO:0070062	neutrophil degranulation [GO:0043312]; pyridoxal 5'-phosphate salvage [GO:0009443]; vitamin B6 metabolic process [GO:0042816]		blue	blue	NA	NA	NA	NA
TRINITY_DN41081_c0_g1_i1	O00764	PDXK_HUMAN	98.8	82	1	0	247	2	103	184	7.20E-42	170.6	PDXK_HUMAN	reviewed	Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)	PDXK C21orf124 C21orf97 PKH PNK PRED79	Homo sapiens (Human)	312	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; ATP binding [GO:0005524]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; pyridoxal kinase activity [GO:0008478]; pyridoxal phosphate binding [GO:0030170]; sodium ion binding [GO:0031402]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; pyridoxal 5'-phosphate salvage [GO:0009443]; vitamin B6 metabolic process [GO:0042816]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]	ATP binding [GO:0005524]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; pyridoxal kinase activity [GO:0008478]; pyridoxal phosphate binding [GO:0030170]; sodium ion binding [GO:0031402]; zinc ion binding [GO:0008270]	GO:0000287; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0008478; GO:0009443; GO:0030170; GO:0030955; GO:0031402; GO:0031403; GO:0034774; GO:0035580; GO:0042803; GO:0042816; GO:0043312; GO:0070062	neutrophil degranulation [GO:0043312]; pyridoxal 5'-phosphate salvage [GO:0009443]; vitamin B6 metabolic process [GO:0042816]		NA	NA	NA	NA	NA	NA
TRINITY_DN7287_c0_g1_i14	Q91XF0	PNPO_MOUSE	64.8	108	38	0	386	63	33	140	2.70E-36	153.3	PNPO_MOUSE	reviewed	Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)	Pnpo	Mus musculus (Mouse)	261	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]	GO:0004733; GO:0005654; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823	pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]		NA	NA	NA	NA	NA	NA
TRINITY_DN7287_c0_g1_i15	Q9NVS9	PNPO_HUMAN	57.8	237	95	3	1218	514	28	261	2.50E-75	284.3	PNPO_HUMAN	reviewed	Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)	PNPO	Homo sapiens (Human)	261	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]; vitamin B6 metabolic process [GO:0042816]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]	GO:0004733; GO:0005654; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042816; GO:0042823	pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]; vitamin B6 metabolic process [GO:0042816]		blue	blue	NA	NA	NA	NA
TRINITY_DN7287_c0_g1_i5	Q9NVS9	PNPO_HUMAN	52.5	261	95	4	1290	514	28	261	3.90E-71	270.4	PNPO_HUMAN	reviewed	Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)	PNPO	Homo sapiens (Human)	261	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]; vitamin B6 metabolic process [GO:0042816]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]	GO:0004733; GO:0005654; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042816; GO:0042823	pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]; vitamin B6 metabolic process [GO:0042816]		NA	NA	NA	NA	NA	NA
TRINITY_DN5680_c0_g1_i1	Q9VSL3	SEPIA_DROME	45.3	232	114	3	133	813	5	228	1.20E-52	208.4	SEPIA_DROME	reviewed	Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia)	se CG6781	Drosophila melanogaster (Fruit fly)	243	"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]"	cytoplasm [GO:0005737]	"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]"	GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114	eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]		blue	blue	NA	NA	NA	NA
TRINITY_DN7256_c0_g1_i1	Q9VSL3	SEPIA_DROME	46.5	226	108	4	675	13	3	220	2.00E-50	200.7	SEPIA_DROME	reviewed	Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia)	se CG6781	Drosophila melanogaster (Fruit fly)	243	"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]"	cytoplasm [GO:0005737]	"glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]"	GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114	eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]		blue	blue	NA	NA	NA	NA
TRINITY_DN30432_c0_g1_i1	P17817	P5CR_SOYBN	60.7	56	22	0	170	3	167	222	7.20E-12	70.9	P5CR_SOYBN	reviewed	Pyrroline-5-carboxylate reductase (P5C reductase) (P5CR) (EC 1.5.1.2)		Glycine max (Soybean) (Glycine hispida)	274	cytoplasm [GO:0005737]; pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]	cytoplasm [GO:0005737]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005737; GO:0055129	L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN38217_c0_g1_i1	P32322	P5CR1_HUMAN	100	66	0	0	201	4	194	259	3.90E-30	131.3	P5CR1_HUMAN	reviewed	"Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2)"	PYCR1	Homo sapiens (Human)	319	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005739; GO:0005759; GO:0006561; GO:0008652; GO:0034599; GO:0042802; GO:0051881; GO:0055129; GO:1903206	cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN30129_c0_g1_i1	Q922Q4	P5CR2_MOUSE	100	88	0	0	2	265	159	246	2.20E-44	179.1	P5CR2_MOUSE	reviewed	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	Pycr2	Mus musculus (Mouse)	320	mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	mitochondrion [GO:0005739]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i3	Q17QJ7	P5CR2_BOVIN	45.7	267	143	1	877	83	2	268	2.00E-58	228	P5CR2_BOVIN	reviewed	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	Bos taurus (Bovine)	320	mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	mitochondrion [GO:0005739]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]		NA	NA	NA	NA	NA	NA
TRINITY_DN9062_c0_g1_i4	Q17QJ7	P5CR2_BOVIN	52.2	178	85	0	616	83	91	268	1.30E-44	181	P5CR2_BOVIN	reviewed	Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)	PYCR2	Bos taurus (Bovine)	320	mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	mitochondrion [GO:0005739]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0055129	cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]		NA	NA	NA	NA	NA	NA
TRINITY_DN25794_c0_g1_i2	Q53H96	P5CR3_HUMAN	46.1	267	141	3	972	172	10	273	4.00E-62	240	P5CR3_HUMAN	reviewed	Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein)	PYCR3 PYCRL	Homo sapiens (Human)	274	cytosol [GO:0005829]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; L-proline biosynthetic process [GO:0055129]	cytosol [GO:0005829]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005829; GO:0008652; GO:0055129	cellular amino acid biosynthetic process [GO:0008652]; L-proline biosynthetic process [GO:0055129]		NA	NA	NA	NA	NA	NA
TRINITY_DN28167_c0_g1_i1	Q9KWU4	PYC_BACSU	56.7	60	25	1	177	1	6	65	1.70E-10	66.2	PYC_BACSU	reviewed	Pyruvate carboxylase (EC 6.4.1.1) (Pyruvic carboxylase) (PYC)	pyc pycA ylaP BSU14860	Bacillus subtilis (strain 168)	1148	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0006090; GO:0006094; GO:0009374; GO:0046872	gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090]		NA	NA	NA	NA	NA	NA
TRINITY_DN3647_c0_g3_i1	Q58626	PYCA_METJA	60	65	26	0	2	196	198	262	3.60E-18	91.7	PYCA_METJA	reviewed	Pyruvate carboxylase subunit A (EC 6.4.1.1) (Pyruvic carboxylase A)	pycA MJ1229	Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)	501	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0006094; GO:0046872	gluconeogenesis [GO:0006094]		NA	NA	NA	NA	NA	1
TRINITY_DN8069_c0_g1_i1	Q29RK2	PYC_BOVIN	71.2	900	258	1	152	2851	20	918	0	1331.6	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN8069_c0_g1_i4	Q29RK2	PYC_BOVIN	73.6	121	32	0	91	453	660	780	1.60E-50	200.3	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN15800_c0_g1_i1	Q29RK2	PYC_BOVIN	62.9	70	26	0	1	210	77	146	3.30E-19	95.1	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10229_c0_g1_i1	Q05920	PYC_MOUSE	69.1	175	54	0	2	526	224	398	2.70E-70	266.2	PYC_MOUSE	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	Pc Pcx	Mus musculus (Mouse)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; oxaloacetate metabolic process [GO:0006107]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of phospholipid biosynthetic process [GO:0071073]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0031406; GO:0042802; GO:0044791; GO:0044794; GO:0046872; GO:0071073	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; oxaloacetate metabolic process [GO:0006107]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of phospholipid biosynthetic process [GO:0071073]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN4961_c0_g1_i1	Q29RK2	PYC_BOVIN	54.3	94	43	0	375	94	951	1044	7.60E-27	121.3	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN4961_c0_g1_i2	Q29RK2	PYC_BOVIN	59.4	229	92	1	719	33	951	1178	1.50E-76	287.3	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN18304_c0_g1_i1	Q29RK2	PYC_BOVIN	63.6	280	102	0	2	841	549	828	4.80E-98	359	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN18304_c0_g2_i1	Q29RK2	PYC_BOVIN	73.3	90	24	0	12	281	835	924	1.30E-34	146.7	PYC_BOVIN	reviewed	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	PC	Bos taurus (Bovine)	1178	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]		NA	NA	NA	NA	NA	NA
TRINITY_DN35701_c0_g1_i1	A7MB35	ODPA_BOVIN	100	70	0	0	212	3	46	115	5.10E-36	151	ODPA_BOVIN	reviewed	"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)"	PDHA1	Bos taurus (Bovine)	390	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0045254	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6446_c0_g2_i1	P35486	ODPA_MOUSE	100	87	0	0	263	3	125	211	2.00E-45	182.6	ODPA_MOUSE	reviewed	"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)"	Pdha1 Pdha-1	Mus musculus (Mouse)	390	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; pyruvate dehydrogenase activity [GO:0004738]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; pyruvate dehydrogenase activity [GO:0004738]	GO:0004738; GO:0004739; GO:0005730; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0043209; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN39554_c0_g1_i1	P08559	ODPA_HUMAN	100	92	0	0	2	277	114	205	2.60E-48	192.2	ODPA_HUMAN	reviewed	"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)"	PDHA1 PHE1A	Homo sapiens (Human)	390	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0034604; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN39554_c0_g1_i2	P08559	ODPA_HUMAN	100	66	0	0	38	235	140	205	2.00E-33	142.5	ODPA_HUMAN	reviewed	"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)"	PDHA1 PHE1A	Homo sapiens (Human)	390	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0034604; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN4556_c0_g1_i1	O66113	ODPB_ZYMMO	78.6	131	28	0	394	2	284	414	1.30E-53	210.3	ODPB_ZYMMO	reviewed	Pyruvate dehydrogenase E1 component subunit beta (EC 1.2.4.1)	pdhB pdhAbeta ZMO1605	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	462	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN33547_c0_g1_i1	O66113	ODPB_ZYMMO	77.5	71	16	0	213	1	1	71	2.10E-25	115.9	ODPB_ZYMMO	reviewed	Pyruvate dehydrogenase E1 component subunit beta (EC 1.2.4.1)	pdhB pdhAbeta ZMO1605	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	462	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN9355_c0_g1_i1	O66113	ODPB_ZYMMO	82.6	276	48	0	831	4	140	415	7.40E-131	468	ODPB_ZYMMO	reviewed	Pyruvate dehydrogenase E1 component subunit beta (EC 1.2.4.1)	pdhB pdhAbeta ZMO1605	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	462	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN9355_c0_g1_i2	O66113	ODPB_ZYMMO	82.5	114	20	0	345	4	170	283	1.90E-53	209.5	ODPB_ZYMMO	reviewed	Pyruvate dehydrogenase E1 component subunit beta (EC 1.2.4.1)	pdhB pdhAbeta ZMO1605	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	462	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN9355_c0_g1_i3	O66113	ODPB_ZYMMO	82.3	277	49	0	831	1	140	416	9.70E-131	467.6	ODPB_ZYMMO	reviewed	Pyruvate dehydrogenase E1 component subunit beta (EC 1.2.4.1)	pdhB pdhAbeta ZMO1605	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	462	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN9355_c0_g1_i4	O66113	ODPB_ZYMMO	83.3	72	12	0	217	2	140	211	3.10E-28	125.2	ODPB_ZYMMO	reviewed	Pyruvate dehydrogenase E1 component subunit beta (EC 1.2.4.1)	pdhB pdhAbeta ZMO1605	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	462	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0006086; GO:0006096	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN15378_c0_g1_i1	P49432	ODPB_RAT	100	91	0	0	2	274	257	347	3.70E-47	188.3	ODPB_RAT	reviewed	"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)"	Pdhb	Rattus norvegicus (Rat)	359	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0045254	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN15378_c0_g2_i1	P11177	ODPB_HUMAN	100	310	0	0	1	930	38	347	6.60E-181	634.4	ODPB_HUMAN	reviewed	"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)"	PDHB PHE1B	Homo sapiens (Human)	359	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN15378_c0_g2_i2	Q9D051	ODPB_MOUSE	97.7	301	7	0	1	903	47	347	1.90E-172	606.3	ODPB_MOUSE	reviewed	"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)"	Pdhb	Mus musculus (Mouse)	359	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004739; GO:0005654; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3039_c0_g1_i1	P11966	ODPB_BOVIN	71.3	331	95	0	1085	93	29	359	8.90E-140	498	ODPB_BOVIN	reviewed	"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)"	PDHB	Bos taurus (Bovine)	359	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]	GO:0004739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0045254	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN3039_c0_g1_i2	Q9D051	ODPB_MOUSE	76.6	158	36	1	565	92	18	174	1.50E-66	253.8	ODPB_MOUSE	reviewed	"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)"	Pdhb	Mus musculus (Mouse)	359	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099]	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004739; GO:0005654; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0045254; GO:0061732	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6054_c0_g1_i1	O46504	PDPR_BOVIN	41.8	545	286	9	81	1688	332	854	4.60E-125	449.9	PDPR_BOVIN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR	Bos taurus (Bovine)	878	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN6054_c0_g1_i10	O46504	PDPR_BOVIN	39.8	846	468	13	255	2756	38	854	9.30E-181	635.6	PDPR_BOVIN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR	Bos taurus (Bovine)	878	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN6054_c0_g1_i12	O46504	PDPR_BOVIN	39.2	836	467	13	286	2757	48	854	2.60E-175	617.5	PDPR_BOVIN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR	Bos taurus (Bovine)	878	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN6054_c0_g1_i6	O46504	PDPR_BOVIN	42.4	118	66	2	255	602	38	155	7.60E-20	99	PDPR_BOVIN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR	Bos taurus (Bovine)	878	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]	mitochondrial matrix [GO:0005759]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN5587_c0_g1_i1	Q8NCN5	PDPR_HUMAN	43.5	833	451	7	291	2780	40	855	1.20E-207	724.9	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005739; GO:0005759; GO:0010510; GO:0016491	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]		NA	NA	NA	NA	NA	NA
TRINITY_DN5587_c0_g1_i2	Q8NCN5	PDPR_HUMAN	39.4	606	348	6	291	2102	40	628	6.60E-131	469.9	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005739; GO:0005759; GO:0010510; GO:0016491	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]		NA	NA	NA	NA	NA	NA
TRINITY_DN5587_c0_g1_i2	Q8NCN5	PDPR_HUMAN	56.2	201	87	1	2101	2700	655	855	7.00E-64	247.3	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005739; GO:0005759; GO:0010510; GO:0016491	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]		NA	NA	NA	NA	NA	NA
TRINITY_DN7938_c0_g1_i1	P22439	ODPX_BOVIN	56.2	89	39	0	7	273	47	135	2.40E-22	105.9	ODPX_BOVIN	reviewed	Pyruvate dehydrogenase protein X component (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein) (E3BP) (proX)	PDHX PDX1	Bos taurus (Bovine)	501	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]	"pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005739; GO:0005759; GO:0016746; GO:0034604; GO:0045254			blue	blue	NA	NA	NA	NA
TRINITY_DN7073_c0_g1_i1	P22439	ODPX_BOVIN	50.3	167	79	1	501	13	291	457	1.40E-39	164.1	ODPX_BOVIN	reviewed	Pyruvate dehydrogenase protein X component (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein) (E3BP) (proX)	PDHX PDX1	Bos taurus (Bovine)	501	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]	"pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0005739; GO:0005759; GO:0016746; GO:0034604; GO:0045254			blue	blue	NA	NA	NA	NA
TRINITY_DN33607_c0_g1_i1	O44006	KPYK_EIMTE	76.3	169	40	0	2	508	231	399	7.60E-70	264.6	KPYK_EIMTE	reviewed	Pyruvate kinase (PK) (EC 2.7.1.40)	PYK	Eimeria tenella (Coccidian parasite)	531	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]		ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0004743; GO:0005524; GO:0016301; GO:0030955			NA	NA	NA	NA	NA	NA
TRINITY_DN30148_c0_g1_i1	Q8K9M3	KPYK_BUCAP	69.5	95	29	0	3	287	243	337	2.80E-29	129	KPYK_BUCAP	reviewed	Pyruvate kinase (PK) (EC 2.7.1.40)	pykA BUsg_311	Buchnera aphidicola subsp. Schizaphis graminum (strain Sg)	481	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]		ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0004743; GO:0005524; GO:0016301; GO:0030955			NA	NA	NA	NA	NA	NA
TRINITY_DN26613_c0_g1_i1	O44006	KPYK_EIMTE	60.2	113	42	1	335	6	42	154	3.00E-35	149.1	KPYK_EIMTE	reviewed	Pyruvate kinase (PK) (EC 2.7.1.40)	PYK	Eimeria tenella (Coccidian parasite)	531	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]		ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0004743; GO:0005524; GO:0016301; GO:0030955			NA	NA	NA	NA	NA	NA
TRINITY_DN16632_c0_g1_i1	O62619	KPYK_DROME	66.9	529	169	2	182	1768	11	533	1.00E-201	704.5	KPYK_DROME	reviewed	Pyruvate kinase (PK) (EC 2.7.1.40)	PyK CG7070	Drosophila melanogaster (Fruit fly)	533	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006090; GO:0006096; GO:0009744; GO:0016301; GO:0030955; GO:0042593; GO:0043186	glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]		NA	NA	NA	NA	NA	NA
TRINITY_DN16632_c0_g1_i3	O62619	KPYK_DROME	67.1	529	168	2	182	1768	11	533	3.60E-202	706.1	KPYK_DROME	reviewed	Pyruvate kinase (PK) (EC 2.7.1.40)	PyK CG7070	Drosophila melanogaster (Fruit fly)	533	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006090; GO:0006096; GO:0009744; GO:0016301; GO:0030955; GO:0042593; GO:0043186	glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]		pink	pink	NA	NA	NA	NA
TRINITY_DN16632_c0_g1_i4	O62619	KPYK_DROME	67.1	529	168	2	182	1768	11	533	3.60E-202	706.1	KPYK_DROME	reviewed	Pyruvate kinase (PK) (EC 2.7.1.40)	PyK CG7070	Drosophila melanogaster (Fruit fly)	533	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006090; GO:0006096; GO:0009744; GO:0016301; GO:0030955; GO:0042593; GO:0043186	glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]		NA	NA	NA	NA	NA	NA
TRINITY_DN13529_c0_g1_i5	P14618	KPYM_HUMAN	100	333	0	0	2	1000	161	493	6.60E-187	654.4	KPYM_HUMAN	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	PKM OIP3 PK2 PK3 PKM2	Homo sapiens (Human)	531	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001666; GO:0001889; GO:0003723; GO:0003729; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0006754; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0016301; GO:0023026; GO:0030955; GO:0031100; GO:0031982; GO:0032869; GO:0034774; GO:0042802; GO:0042866; GO:0043312; GO:0043403; GO:0043531; GO:0045296; GO:0061621; GO:0062023; GO:0070062; GO:0070324; GO:1902912; GO:1903561; GO:1903672; GO:1904813; GO:2000767	animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN1681_c0_g2_i1	P14618	KPYM_HUMAN	100	148	0	0	446	3	19	166	3.70E-81	302	KPYM_HUMAN	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	PKM OIP3 PK2 PK3 PKM2	Homo sapiens (Human)	531	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001666; GO:0001889; GO:0003723; GO:0003729; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0006754; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0016301; GO:0023026; GO:0030955; GO:0031100; GO:0031982; GO:0032869; GO:0034774; GO:0042802; GO:0042866; GO:0043312; GO:0043403; GO:0043531; GO:0045296; GO:0061621; GO:0062023; GO:0070062; GO:0070324; GO:1902912; GO:1903561; GO:1903672; GO:1904813; GO:2000767	animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN13529_c0_g1_i2	Q5NVN0	KPYM_PONAB	98.8	249	3	0	2	748	161	409	4.90E-134	478.4	KPYM_PONAB	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme)	PKM PKM2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	531	nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]	nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0003729; GO:0004743; GO:0005524; GO:0005634; GO:0005791; GO:0016301; GO:0030955; GO:1903672; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]		NA	NA	NA	NA	NA	NA
TRINITY_DN13529_c0_g1_i4	P52480	KPYM_MOUSE	99.7	337	1	0	2	1012	161	497	6.10E-188	657.9	KPYM_MOUSE	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme)	Pkm Pk3 Pkm2 Pykm	Mus musculus (Mouse)	531	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001889; GO:0001917; GO:0003729; GO:0004743; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006006; GO:0006096; GO:0006754; GO:0012501; GO:0016301; GO:0030955; GO:0031100; GO:0032869; GO:0042802; GO:0042866; GO:0043209; GO:0043403; GO:0043531; GO:0062023; GO:0070324; GO:1902912; GO:1903672; GO:2000767	animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN13529_c0_g1_i6	P11979	KPYM_FELCA	98	249	5	0	2	748	161	409	1.90E-133	476.5	KPYM_FELCA	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme)	PKM PKM2	Felis catus (Cat) (Felis silvestris catus)	531	cytoplasm [GO:0005737]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]	GO:0000287; GO:0003729; GO:0004743; GO:0005524; GO:0005634; GO:0005737; GO:0005791; GO:0006096; GO:0016301; GO:0030955; GO:0032869; GO:1903672; GO:2000767	cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]		NA	NA	NA	NA	NA	NA
TRINITY_DN13529_c0_g1_i7	P11980	KPYM_RAT	96.6	89	3	0	2	268	409	497	4.60E-42	171.4	KPYM_RAT	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme)	Pkm Pkm2 Pykm	Rattus norvegicus (Rat)	531	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001666; GO:0001889; GO:0001917; GO:0003729; GO:0004743; GO:0005524; GO:0005634; GO:0005737; GO:0005791; GO:0005829; GO:0005929; GO:0006006; GO:0006096; GO:0006754; GO:0007584; GO:0009629; GO:0010033; GO:0012501; GO:0014870; GO:0016301; GO:0030955; GO:0031100; GO:0032868; GO:0032869; GO:0042802; GO:0042866; GO:0043403; GO:0043531; GO:0070324; GO:1902912; GO:1903672; GO:2000767	animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN1681_c0_g1_i1	P52480	KPYM_MOUSE	100	154	0	0	464	3	13	166	6.40E-84	311.2	KPYM_MOUSE	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme)	Pkm Pk3 Pkm2 Pykm	Mus musculus (Mouse)	531	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001889; GO:0001917; GO:0003729; GO:0004743; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006006; GO:0006096; GO:0006754; GO:0012501; GO:0016301; GO:0030955; GO:0031100; GO:0032869; GO:0042802; GO:0042866; GO:0043209; GO:0043403; GO:0043531; GO:0062023; GO:0070324; GO:1902912; GO:1903672; GO:2000767	animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; skeletal muscle tissue regeneration [GO:0043403]		NA	NA	NA	NA	NA	NA
TRINITY_DN5682_c0_g1_i1	Q6DF96	QTRT2_XENLA	48.3	89	46	0	2	268	318	406	7.70E-21	100.9	QTRT2_XENLA	reviewed	Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1)	qtrt2 qtrtd1	Xenopus laevis (African clawed frog)	415	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005737; GO:0005739; GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]		NA	NA	NA	NA	NA	NA
TRINITY_DN2692_c0_g1_i1	B7Q5K1	QTRT2_IXOSC	38	216	128	2	735	91	33	243	2.70E-34	147.1	QTRT2_IXOSC	reviewed	Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1)	ISCW021855	Ixodes scapularis (Black-legged tick) (Deer tick)	394	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005737; GO:0008479; GO:0046872; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]		NA	NA	NA	NA	NA	NA
TRINITY_DN2692_c0_g1_i3	B7Q5K1	QTRT2_IXOSC	34.5	293	184	3	899	24	33	318	4.20E-42	173.3	QTRT2_IXOSC	reviewed	Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1)	ISCW021855	Ixodes scapularis (Black-legged tick) (Deer tick)	394	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005737; GO:0008479; GO:0046872; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]		NA	NA	NA	NA	NA	NA
TRINITY_DN4253_c0_g1_i1	Q9VPY8	TGT_DROME	60.3	390	153	2	66	1235	7	394	2.70E-137	490	TGT_DROME	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	Tgt CG4947	Drosophila melanogaster (Fruit fly)	427	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005737; GO:0006400; GO:0008479; GO:0046872; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN5362_c0_g1_i1	O94460	TGT_SCHPO	60	55	22	0	29	193	248	302	3.00E-13	75.5	TGT_SCHPO	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	SPAC1687.19c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	404	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005829; GO:0006400; GO:0008479; GO:0046872; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	1	NA	NA	NA
TRINITY_DN5362_c0_g1_i2	O94460	TGT_SCHPO	52.5	80	35	1	3	242	226	302	1.20E-16	87	TGT_SCHPO	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	SPAC1687.19c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	404	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005829; GO:0006400; GO:0008479; GO:0046872; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN13430_c0_g1_i1	Q9JMA2	TGT_MOUSE	100	77	0	0	1	231	237	313	6.30E-40	164.1	TGT_MOUSE	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	Qtrt1 Tgt Tgut	Mus musculus (Mouse)	403	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005737; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN29023_c0_g1_i1	Q9BXR0	TGT_HUMAN	100	81	0	0	2	244	210	290	8.50E-43	173.7	TGT_HUMAN	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	QTRT1 TGT TGUT	Homo sapiens (Human)	403	mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN20034_c0_g2_i1	Q4QQY7	TGT_XENLA	59.4	128	51	1	385	2	21	147	1.10E-41	170.6	TGT_XENLA	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	qtrt1	Xenopus laevis (African clawed frog)	396	mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]	mitochondrial outer membrane [GO:0005741]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]		NA	NA	NA	NA	NA	NA
TRINITY_DN20034_c0_g1_i1	Q4QR99	TGT_RAT	56.6	182	75	2	545	3	196	374	4.30E-55	215.7	TGT_RAT	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	Qtrt1	Rattus norvegicus (Rat)	403	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005737; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN30478_c0_g1_i1	Q9JMA2	TGT_MOUSE	100	81	0	0	1	243	157	237	5.40E-42	171	TGT_MOUSE	reviewed	Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	Qtrt1 Tgt Tgut	Mus musculus (Mouse)	403	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005737; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN10394_c0_g1_i1	Q5T6V5	QSPP_HUMAN	47.4	285	148	1	50	904	5	287	1.60E-70	267.7	QSPP_HUMAN	reviewed	Queuosine salvage protein	C9orf64	Homo sapiens (Human)	341	tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]			GO:0006400; GO:0101030	tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN40694_c0_g1_i1	Q08257	QOR_HUMAN	100	75	0	0	228	4	7	81	1.70E-37	156	QOR_HUMAN	reviewed	Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)	CRYZ	Homo sapiens (Human)	329	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; zinc ion binding [GO:0008270]	GO:0003730; GO:0003960; GO:0005829; GO:0007601; GO:0008270; GO:0042178; GO:0042802; GO:0051289; GO:0070062; GO:0070402	protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN31961_c0_g1_i1	Q08257	QOR_HUMAN	98.9	88	1	0	1	264	94	181	4.10E-43	174.9	QOR_HUMAN	reviewed	Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)	CRYZ	Homo sapiens (Human)	329	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; zinc ion binding [GO:0008270]	GO:0003730; GO:0003960; GO:0005829; GO:0007601; GO:0008270; GO:0042178; GO:0042802; GO:0051289; GO:0070062; GO:0070402	protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN27117_c0_g1_i1	Q08257	QOR_HUMAN	52.2	322	149	2	1095	142	7	327	4.20E-87	323.2	QOR_HUMAN	reviewed	Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)	CRYZ	Homo sapiens (Human)	329	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; zinc ion binding [GO:0008270]	GO:0003730; GO:0003960; GO:0005829; GO:0007601; GO:0008270; GO:0042178; GO:0042802; GO:0051289; GO:0070062; GO:0070402	protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178]		NA	NA	NA	NA	NA	NA
TRINITY_DN3370_c0_g2_i1	Q3UNZ8	QORL2_MOUSE	38.7	341	207	1	1263	241	11	349	1.30E-63	245.4	QORL2_MOUSE	reviewed	Quinone oxidoreductase-like protein 2 (EC 1.-.-.-) (Zeta-crystallin homolog 2)	Cryzl2	Mus musculus (Mouse)	350	mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]	mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0005739; GO:0016491			blue	blue	NA	NA	NA	NA
TRINITY_DN34732_c0_g1_i1	A7RK30	QORL2_NEMVE	36.6	93	59	0	8	286	160	252	1.80E-12	73.2	QORL2_NEMVE	reviewed	Quinone oxidoreductase-like protein 2 homolog (EC 1.-.-.-)	v1g238856	Nematostella vectensis (Starlet sea anemone)	365	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN41057_c0_g1_i1	Q15032	R3HD1_HUMAN	98.9	94	1	0	3	284	126	219	1.30E-47	189.9	R3HD1_HUMAN	reviewed	R3H domain-containing protein 1	R3HDM1 KIAA0029 R3HDM	Homo sapiens (Human)	1099	RNA binding [GO:0003723]		RNA binding [GO:0003723]	GO:0003723			NA	NA	NA	NA	NA	NA
TRINITY_DN21617_c0_g1_i1	Q15032	R3HD1_HUMAN	53.7	149	65	2	330	776	137	281	4.40E-37	156.4	R3HD1_HUMAN	reviewed	R3H domain-containing protein 1	R3HDM1 KIAA0029 R3HDM	Homo sapiens (Human)	1099	RNA binding [GO:0003723]		RNA binding [GO:0003723]	GO:0003723			NA	NA	NA	NA	NA	NA
TRINITY_DN21617_c0_g1_i2	A0JNC2	R3HD2_BOVIN	39.8	249	133	4	330	1046	138	379	3.30E-38	160.6	R3HD2_BOVIN	reviewed	R3H domain-containing protein 2	R3HDM2	Bos taurus (Bovine)	989	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN21617_c0_g1_i3	A0JNC2	R3HD2_BOVIN	39.1	261	139	5	330	1073	138	391	3.90E-39	163.7	R3HD2_BOVIN	reviewed	R3H domain-containing protein 2	R3HDM2	Bos taurus (Bovine)	989	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1492_c0_g1_i1	Q2KIL7	R3HD4_BOVIN	36.6	112	71	0	414	79	159	270	7.00E-14	79	R3HD4_BOVIN	reviewed	R3H domain-containing protein 4	R3HDM4	Bos taurus (Bovine)	272	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1492_c0_g1_i5	Q96D70	R3HD4_HUMAN	27.9	251	139	5	816	103	45	266	8.30E-18	92.8	R3HD4_HUMAN	reviewed	R3H domain-containing protein 4	R3HDM4 C19orf22	Homo sapiens (Human)	268	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1492_c0_g1_i7	Q4VBF2	R3HD4_MOUSE	39.7	73	44	0	321	103	189	261	2.10E-08	60.1	R3HD4_MOUSE	reviewed	R3H domain-containing protein 4	R3hdm4	Mus musculus (Mouse)	262	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN36261_c0_g1_i1	P50396	GDIA_MOUSE	31.1	90	16	1	2	271	273	316	2.00E-05	49.7	GDIA_MOUSE	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1)	Gdi1 Rabgdia	Mus musculus (Mouse)	447	axon [GO:0030424]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043005; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051592; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17254_c0_g1_i1	Q7YQM0	GDIA_PONPY	66.4	443	145	2	1431	106	1	440	4.00E-175	615.9	GDIA_PONPY	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1)	GDI1 RABGDIA	Pongo pygmaeus (Bornean orangutan)	447	Golgi apparatus [GO:0005794]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]	Golgi apparatus [GO:0005794]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]	GO:0005093; GO:0005096; GO:0005794; GO:0015031; GO:0032482; GO:0050771; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]		blue	blue	NA	NA	NA	NA
TRINITY_DN17588_c0_g1_i3	P50396	GDIA_MOUSE	99.1	447	4	0	1347	7	1	447	3.90E-262	904.8	GDIA_MOUSE	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1)	Gdi1 Rabgdia	Mus musculus (Mouse)	447	axon [GO:0030424]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043005; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051592; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; response to calcium ion [GO:0051592]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN26869_c0_g1_i1	P31150	GDIA_HUMAN	100	130	0	0	22	411	1	130	3.20E-71	268.9	GDIA_HUMAN	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4)	GDI1 GDIL OPHN2 RABGDIA XAP4	Homo sapiens (Human)	447	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005092; GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051056; GO:0051592; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN21396_c0_g1_i1	P31150	GDIA_HUMAN	57.6	66	25	1	279	82	105	167	9.50E-14	77.4	GDIA_HUMAN	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4)	GDI1 GDIL OPHN2 RABGDIA XAP4	Homo sapiens (Human)	447	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005092; GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051056; GO:0051592; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN21396_c0_g1_i2	P31150	GDIA_HUMAN	56.5	92	37	1	276	1	105	193	1.90E-22	106.3	GDIA_HUMAN	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4)	GDI1 GDIL OPHN2 RABGDIA XAP4	Homo sapiens (Human)	447	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005092; GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051056; GO:0051592; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17588_c0_g1_i1	P31150	GDIA_HUMAN	100	354	0	0	1068	7	94	447	4.70E-207	721.5	GDIA_HUMAN	reviewed	Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4)	GDI1 GDIL OPHN2 RABGDIA XAP4	Homo sapiens (Human)	447	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]	GO:0005092; GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0015031; GO:0016192; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051056; GO:0051592; GO:0090315	negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10488_c0_g1_i1	P50395	GDIB_HUMAN	54	272	123	1	2	817	159	428	1.50E-88	327.4	GDIB_HUMAN	reviewed	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2 RABGDIB	Homo sapiens (Human)	445	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137; GO:0031982; GO:0034774; GO:0035578; GO:0043312; GO:0051056; GO:0070062	neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11755_c0_g1_i1	P50395	GDIB_HUMAN	100	445	0	0	1352	18	1	445	1.70E-260	899.4	GDIB_HUMAN	reviewed	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2 RABGDIB	Homo sapiens (Human)	445	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137; GO:0031982; GO:0034774; GO:0035578; GO:0043312; GO:0051056; GO:0070062	neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11755_c0_g1_i2	P50395	GDIB_HUMAN	98.4	445	7	0	1352	18	1	445	3.90E-257	888.3	GDIB_HUMAN	reviewed	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2 RABGDIB	Homo sapiens (Human)	445	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137; GO:0031982; GO:0034774; GO:0035578; GO:0043312; GO:0051056; GO:0070062	neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11755_c0_g1_i4	P50395	GDIB_HUMAN	98.9	445	5	0	1352	18	1	445	1.60E-258	892.9	GDIB_HUMAN	reviewed	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2 RABGDIB	Homo sapiens (Human)	445	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137; GO:0031982; GO:0034774; GO:0035578; GO:0043312; GO:0051056; GO:0070062	neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN606_c0_g1_i1	A2AWA9	RBGP1_MOUSE	48.3	982	463	15	3099	199	106	1057	3.30E-227	790	RBGP1_MOUSE	reviewed	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	Rabgap1 Kiaa4104	Mus musculus (Mouse)	1064	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN606_c0_g1_i2	A2AWA9	RBGP1_MOUSE	46.6	984	445	15	2971	65	106	1024	1.00E-214	748.4	RBGP1_MOUSE	reviewed	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	Rabgap1 Kiaa4104	Mus musculus (Mouse)	1064	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN606_c0_g1_i3	A2AWA9	RBGP1_MOUSE	43.5	200	103	4	668	81	106	299	1.20E-34	148.3	RBGP1_MOUSE	reviewed	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	Rabgap1 Kiaa4104	Mus musculus (Mouse)	1064	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN606_c0_g1_i4	A2AWA9	RBGP1_MOUSE	46.6	1018	463	16	3207	199	106	1057	7.30E-222	772.3	RBGP1_MOUSE	reviewed	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	Rabgap1 Kiaa4104	Mus musculus (Mouse)	1064	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN606_c0_g1_i5	A2AWA9	RBGP1_MOUSE	48.4	948	445	14	2863	65	106	1024	4.70E-220	766.1	RBGP1_MOUSE	reviewed	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	Rabgap1 Kiaa4104	Mus musculus (Mouse)	1064	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN33437_c0_g1_i1	Q9Y3P9	RBGP1_HUMAN	100	81	0	0	245	3	588	668	7.20E-42	170.6	RBGP1_HUMAN	reviewed	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	RABGAP1 HSPC094	Homo sapiens (Human)	1069	centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; tubulin binding [GO:0015631]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; tubulin binding [GO:0015631]	GO:0005096; GO:0005813; GO:0005829; GO:0005875; GO:0006886; GO:0007049; GO:0015631; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN32779_c0_g1_i1	A6H6A9	RBG1L_MOUSE	98.3	117	2	0	351	1	345	461	2.60E-61	235.7	RBG1L_MOUSE	reviewed	Rab GTPase-activating protein 1-like	Rabgap1l Hhl Kiaa0471	Mus musculus (Mouse)	815	cilium [GO:0005929]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; megakaryocyte development [GO:0035855]; regulation of protein localization [GO:0032880]	cilium [GO:0005929]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0005929; GO:0006886; GO:0006897; GO:0017137; GO:0032880; GO:0035855; GO:0090630	activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; megakaryocyte development [GO:0035855]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN38249_c0_g1_i1	Q5R372	RBG1L_HUMAN	100	75	0	0	227	3	609	683	9.00E-39	160.2	RBG1L_HUMAN	reviewed	Rab GTPase-activating protein 1-like	RABGAP1L HHL KIAA0471	Homo sapiens (Human)	815	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0006886; GO:0006897; GO:0017137; GO:0032880; GO:0090630	activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN40871_c0_g1_i1	Q5R372	RBG1L_HUMAN	100	73	0	0	296	78	498	570	1.50E-38	159.8	RBG1L_HUMAN	reviewed	Rab GTPase-activating protein 1-like	RABGAP1L HHL KIAA0471	Homo sapiens (Human)	815	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0006886; GO:0006897; GO:0017137; GO:0032880; GO:0090630	activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN4943_c0_g1_i1	Q9QZD5	RAE2_MOUSE	39.1	279	158	7	812	9	306	583	8.70E-52	205.3	RAE2_MOUSE	reviewed	Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2) (REP-2)	Chml Rep2	Mus musculus (Mouse)	621	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0017137; GO:0018344	intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4943_c0_g1_i2	Q9QZD5	RAE2_MOUSE	39.6	250	141	6	825	103	306	554	6.50E-47	189.1	RAE2_MOUSE	reviewed	Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2) (REP-2)	Chml Rep2	Mus musculus (Mouse)	621	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0017137; GO:0018344	intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2238_c0_g1_i1	Q3LGD4	RFP4A_DANRE	30.7	267	178	3	877	98	354	620	1.70E-16	88.2	RFP4A_DANRE	reviewed	Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A)	rab11fip4a rab11fip4	Danio rerio (Zebrafish) (Brachydanio rerio)	621	cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]	cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]	ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0005509; GO:0005768; GO:0007049; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038	cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN1266_c0_g1_i1	Q80UJ7	RB3GP_MOUSE	43.5	1021	477	16	61	2946	1	980	5.20E-227	789.3	RB3GP_MOUSE	reviewed	Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP)	Rab3gap1 Kiaa0066 Rab3gap	Mus musculus (Mouse)	981	cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005096; GO:0005737; GO:0005794; GO:0005811; GO:0007420; GO:0010628; GO:0010807; GO:0017112; GO:0017137; GO:0021854; GO:0032483; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0048489; GO:0050821; GO:0060079; GO:0060325; GO:0061646; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786	brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN1266_c0_g1_i2	Q80UJ7	RB3GP_MOUSE	41.3	92	54	0	61	336	1	92	2.60E-15	83.2	RB3GP_MOUSE	reviewed	Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP)	Rab3gap1 Kiaa0066 Rab3gap	Mus musculus (Mouse)	981	cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489]	cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005096; GO:0005737; GO:0005794; GO:0005811; GO:0007420; GO:0010628; GO:0010807; GO:0017112; GO:0017137; GO:0021854; GO:0032483; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0048489; GO:0050821; GO:0060079; GO:0060325; GO:0061646; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786	brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN32536_c0_g1_i1	Q15042	RB3GP_HUMAN	100	68	0	0	204	1	715	782	6.60E-33	140.6	RB3GP_HUMAN	reviewed	Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP)	RAB3GAP1 KIAA0066 RAB3GAP	Homo sapiens (Human)	981	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]	GO:0005085; GO:0005096; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0007420; GO:0010628; GO:0017137; GO:0021854; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0060079; GO:0060325; GO:0061646; GO:0070062; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786	brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN446_c0_g1_i2	Q5U1Z0	RBGPR_RAT	35.6	1418	777	30	4203	124	43	1382	3.00E-210	734.2	RBGPR_RAT	reviewed	Rab3 GTPase-activating protein non-catalytic subunit (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit)	Rab3gap2	Rattus norvegicus (Rat)	1386	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005737; GO:0005886; GO:0017137; GO:0030234; GO:0032991; GO:0043087; GO:0097051; GO:1903061; GO:1903373; GO:2000786	establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN446_c0_g1_i3	Q5U1Z0	RBGPR_RAT	35.6	1418	777	30	4203	124	43	1382	2.90E-210	734.2	RBGPR_RAT	reviewed	Rab3 GTPase-activating protein non-catalytic subunit (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit)	Rab3gap2	Rattus norvegicus (Rat)	1386	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005737; GO:0005886; GO:0017137; GO:0030234; GO:0032991; GO:0043087; GO:0097051; GO:1903061; GO:1903373; GO:2000786	establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN30346_c0_g1_i1	Q9H2M9	RBGPR_HUMAN	100	66	0	0	2	199	126	191	1.40E-32	139.4	RBGPR_HUMAN	reviewed	Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit)	RAB3GAP2 KIAA0839	Homo sapiens (Human)	1393	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0017137; GO:0030234; GO:0032991; GO:0043087; GO:0097051; GO:1903061; GO:1903373; GO:2000786	establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN653_c0_g1_i1	O18973	RABX5_BOVIN	35.3	490	295	10	144	1577	10	489	1.10E-73	279.6	RABX5_BOVIN	reviewed	Rab5 GDP/GTP exchange factor (Rabex-5)	RABGEF1 RABEX5	Bos taurus (Bovine)	492	early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031]	early endosome [GO:0005769]; recycling endosome [GO:0055037]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005769; GO:0006897; GO:0008270; GO:0015031; GO:0055037	endocytosis [GO:0006897]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN653_c0_g1_i2	O18973	RABX5_BOVIN	30.1	183	116	5	144	671	10	187	1.00E-12	75.5	RABX5_BOVIN	reviewed	Rab5 GDP/GTP exchange factor (Rabex-5)	RABGEF1 RABEX5	Bos taurus (Bovine)	492	early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031]	early endosome [GO:0005769]; recycling endosome [GO:0055037]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005769; GO:0006897; GO:0008270; GO:0015031; GO:0055037	endocytosis [GO:0006897]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN24358_c0_g1_i1	Q9JM13	RABX5_MOUSE	100	93	0	0	1	279	250	342	5.80E-48	191	RABX5_MOUSE	reviewed	Rab5 GDP/GTP exchange factor (Rabex-5)	Rabgef1 Rabex5	Mus musculus (Mouse)	491	cytosol [GO:0005829]; early endosome [GO:0005769]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; vesicle [GO:0031982]; DNA binding [GO:0003677]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]	cytosol [GO:0005829]; early endosome [GO:0005769]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; vesicle [GO:0031982]	DNA binding [GO:0003677]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0001933; GO:0002686; GO:0003677; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006897; GO:0008270; GO:0017112; GO:0017137; GO:0031982; GO:0032715; GO:0033004; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0055037; GO:0060368; GO:0061630; GO:1900235	endocytosis [GO:0006897]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]		NA	NA	NA	NA	NA	NA
TRINITY_DN24358_c0_g1_i2	Q9JM13	RABX5_MOUSE	100	89	0	0	1	267	250	338	7.50E-45	180.6	RABX5_MOUSE	reviewed	Rab5 GDP/GTP exchange factor (Rabex-5)	Rabgef1 Rabex5	Mus musculus (Mouse)	491	cytosol [GO:0005829]; early endosome [GO:0005769]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; vesicle [GO:0031982]; DNA binding [GO:0003677]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]	cytosol [GO:0005829]; early endosome [GO:0005769]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; vesicle [GO:0031982]	DNA binding [GO:0003677]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0001933; GO:0002686; GO:0003677; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006897; GO:0008270; GO:0017112; GO:0017137; GO:0031982; GO:0032715; GO:0033004; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0055037; GO:0060368; GO:0061630; GO:1900235	endocytosis [GO:0006897]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]		NA	NA	NA	NA	NA	NA
TRINITY_DN12170_c0_g1_i1	Q2T9P3	RGP1_BOVIN	45.3	190	99	3	5	562	84	272	1.50E-40	167.5	RGP1_BOVIN	reviewed	RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog)	RGP1	Bos taurus (Bovine)	394	"cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]	Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005829; GO:0016020; GO:0017112; GO:0017137; GO:0032991; GO:0034066; GO:0042147; GO:0043547; GO:1903363	"negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"		blue	blue	NA	NA	NA	NA
TRINITY_DN12170_c0_g1_i2	Q2T9P3	RGP1_BOVIN	45.4	174	90	3	5	514	84	256	5.80E-37	155.6	RGP1_BOVIN	reviewed	RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog)	RGP1	Bos taurus (Bovine)	394	"cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]	Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0005829; GO:0016020; GO:0017112; GO:0017137; GO:0032991; GO:0034066; GO:0042147; GO:0043547; GO:1903363	"negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6983_c0_g1_i1	Q810B6	ANFY1_MOUSE	49.3	860	400	6	2588	72	325	1169	1.10E-230	801.2	ANFY1_MOUSE	reviewed	Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)	Ankfy1 Ankhzn Kiaa1255	Mus musculus (Mouse)	1169	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]	metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]	GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0017137; GO:0030904; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0090160; GO:1901981	"endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36719_c0_g1_i1	Q3YEC7	RABL6_HUMAN	100	74	0	0	224	3	12	85	4.30E-38	157.9	RABL6_HUMAN	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)	RABL6 C9orf86 PARF	Homo sapiens (Human)	729	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN677_c0_g1_i1	Q3YEC7	RABL6_HUMAN	60.7	295	115	1	1354	473	1	295	2.60E-99	364	RABL6_HUMAN	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)	RABL6 C9orf86 PARF	Homo sapiens (Human)	729	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN677_c0_g1_i3	Q3YEC7	RABL6_HUMAN	54.6	326	116	2	1447	473	1	295	1.30E-93	345.1	RABL6_HUMAN	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)	RABL6 C9orf86 PARF	Homo sapiens (Human)	729	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN677_c0_g1_i5	Q3YEC7	RABL6_HUMAN	54.1	229	73	2	1399	716	1	198	2.60E-62	241.1	RABL6_HUMAN	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)	RABL6 C9orf86 PARF	Homo sapiens (Human)	729	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN677_c0_g1_i5	Q3YEC7	RABL6_HUMAN	74.5	47	12	0	671	531	200	246	8.60E-13	76.6	RABL6_HUMAN	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)	RABL6 C9orf86 PARF	Homo sapiens (Human)	729	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN677_c0_g1_i7	Q3YEC7	RABL6_HUMAN	65.6	160	52	2	528	52	1	158	5.20E-52	205.7	RABL6_HUMAN	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)	RABL6 C9orf86 PARF	Homo sapiens (Human)	729	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			blue	blue	NA	NA	NA	NA
TRINITY_DN26271_c0_g1_i1	Q5U3K5	RABL6_MOUSE	100	110	0	0	331	2	55	164	7.10E-61	234.2	RABL6_MOUSE	reviewed	Rab-like protein 6 (GTP-binding protein Parf) (Rab-like protein 1) (RBEL1)	Rabl6 Parf	Mus musculus (Mouse)	725	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN21129_c0_g1_i1	P54644	KRAC_DICDI	53.9	76	34	1	230	3	111	185	2.00E-15	82.8	KRAC_DICDI	reviewed	RAC family serine/threonine-protein kinase homolog (EC 2.7.11.1)	pkbA akt dagA DDB_G0268620	Dictyostelium discoideum (Slime mold)	444	"cell cortex [GO:0005938]; cell leading edge [GO:0031252]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; bleb assembly [GO:0032060]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Ras protein signal transduction [GO:0046580]; peptidyl-serine phosphorylation [GO:0018105]; phagosome maturation [GO:0090382]; phosphatidylinositol-mediated signaling [GO:0048015]; polyphosphate-mediated signaling [GO:0110094]; positive regulation of macropinocytosis [GO:1905303]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of protein kinase activity [GO:0045859]; response to differentiation-inducing factor 1 [GO:1903013]; response to hydrogen peroxide [GO:0042542]"	cell cortex [GO:0005938]; cell leading edge [GO:0031252]	"ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]"	GO:0000281; GO:0004674; GO:0004691; GO:0005524; GO:0005547; GO:0005938; GO:0006468; GO:0007163; GO:0018105; GO:0019887; GO:0030010; GO:0031036; GO:0031154; GO:0031252; GO:0032060; GO:0032147; GO:0035556; GO:0042542; GO:0043327; GO:0044351; GO:0045859; GO:0046580; GO:0048015; GO:0050765; GO:0050920; GO:0090382; GO:0110094; GO:1903013; GO:1905303	activation of protein kinase activity [GO:0032147]; bleb assembly [GO:0032060]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Ras protein signal transduction [GO:0046580]; peptidyl-serine phosphorylation [GO:0018105]; phagosome maturation [GO:0090382]; phosphatidylinositol-mediated signaling [GO:0048015]; polyphosphate-mediated signaling [GO:0110094]; positive regulation of macropinocytosis [GO:1905303]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of protein kinase activity [GO:0045859]; response to differentiation-inducing factor 1 [GO:1903013]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN36008_c0_g1_i2	Q8INB9	AKT1_DROME	74.5	235	60	0	706	2	259	493	2.60E-106	386.3	AKT1_DROME	reviewed	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Akt) (Protein kinase B) (PKB)	Akt1 CG4006	Drosophila melanogaster (Fruit fly)	611	"cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0018105; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:1901215; GO:1903688	"apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34929_c0_g1_i1	P31749	AKT1_HUMAN	99.3	137	1	0	412	2	228	364	1.00E-77	290.4	AKT1_HUMAN	reviewed	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC	Homo sapiens (Human)	480	"cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase B activity [GO:0032148]; activation-induced cell death of T cells [GO:0006924]; aging [GO:0007568]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; hyaluronan metabolic process [GO:0030212]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell size [GO:0045792]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; translation [GO:0006412]"	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]	"14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001649; GO:0001893; GO:0001934; GO:0001938; GO:0002042; GO:0004672; GO:0004674; GO:0004712; GO:0005080; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005978; GO:0005979; GO:0006006; GO:0006412; GO:0006417; GO:0006468; GO:0006469; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006974; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0007249; GO:0007281; GO:0007568; GO:0008283; GO:0008284; GO:0008286; GO:0008637; GO:0008643; GO:0009408; GO:0010507; GO:0010628; GO:0010629; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010918; GO:0010951; GO:0010975; GO:0014065; GO:0015630; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0021510; GO:0030027; GO:0030030; GO:0030154; GO:0030163; GO:0030212; GO:0030235; GO:0030307; GO:0030334; GO:0031018; GO:0031234; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032091; GO:0032094; GO:0032148; GO:0032270; GO:0032287; GO:0032436; GO:0032794; GO:0032869; GO:0032991; GO:0033138; GO:0034405; GO:0034614; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0038061; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043066; GO:0043154; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045737; GO:0045742; GO:0045746; GO:0045792; GO:0045861; GO:0045893; GO:0045907; GO:0045944; GO:0046326; GO:0046329; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048661; GO:0050999; GO:0051000; GO:0051091; GO:0051146; GO:0051721; GO:0051898; GO:0060079; GO:0060416; GO:0060644; GO:0060709; GO:0060716; GO:0070141; GO:0071260; GO:0071276; GO:0071356; GO:0071364; GO:0071380; GO:0071407; GO:0071456; GO:0071889; GO:0071901; GO:0072655; GO:0072656; GO:0090201; GO:0097011; GO:0097194; GO:0098794; GO:0100002; GO:0140052; GO:1900087; GO:1900182; GO:1901215; GO:1901796; GO:1902176; GO:1903038; GO:1903078; GO:1903721; GO:1990090; GO:1990418; GO:2000010; GO:2000402; GO:2001240	"activation-induced cell death of T cells [GO:0006924]; activation of protein kinase B activity [GO:0032148]; aging [GO:0007568]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaluronan metabolic process [GO:0030212]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell size [GO:0045792]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32665_c0_g1_i1	P31749	AKT1_HUMAN	100	90	0	0	272	3	135	224	4.40E-45	181.4	AKT1_HUMAN	reviewed	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC	Homo sapiens (Human)	480	"cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase B activity [GO:0032148]; activation-induced cell death of T cells [GO:0006924]; aging [GO:0007568]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; hyaluronan metabolic process [GO:0030212]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell size [GO:0045792]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; translation [GO:0006412]"	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]	"14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]"	GO:0001649; GO:0001893; GO:0001934; GO:0001938; GO:0002042; GO:0004672; GO:0004674; GO:0004712; GO:0005080; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005978; GO:0005979; GO:0006006; GO:0006412; GO:0006417; GO:0006468; GO:0006469; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006974; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0007249; GO:0007281; GO:0007568; GO:0008283; GO:0008284; GO:0008286; GO:0008637; GO:0008643; GO:0009408; GO:0010507; GO:0010628; GO:0010629; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010918; GO:0010951; GO:0010975; GO:0014065; GO:0015630; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0021510; GO:0030027; GO:0030030; GO:0030154; GO:0030163; GO:0030212; GO:0030235; GO:0030307; GO:0030334; GO:0031018; GO:0031234; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032091; GO:0032094; GO:0032148; GO:0032270; GO:0032287; GO:0032436; GO:0032794; GO:0032869; GO:0032991; GO:0033138; GO:0034405; GO:0034614; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0038061; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043066; GO:0043154; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045737; GO:0045742; GO:0045746; GO:0045792; GO:0045861; GO:0045893; GO:0045907; GO:0045944; GO:0046326; GO:0046329; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048661; GO:0050999; GO:0051000; GO:0051091; GO:0051146; GO:0051721; GO:0051898; GO:0060079; GO:0060416; GO:0060644; GO:0060709; GO:0060716; GO:0070141; GO:0071260; GO:0071276; GO:0071356; GO:0071364; GO:0071380; GO:0071407; GO:0071456; GO:0071889; GO:0071901; GO:0072655; GO:0072656; GO:0090201; GO:0097011; GO:0097194; GO:0098794; GO:0100002; GO:0140052; GO:1900087; GO:1900182; GO:1901215; GO:1901796; GO:1902176; GO:1903038; GO:1903078; GO:1903721; GO:1990090; GO:1990418; GO:2000010; GO:2000402; GO:2001240	"activation-induced cell death of T cells [GO:0006924]; activation of protein kinase B activity [GO:0032148]; aging [GO:0007568]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaluronan metabolic process [GO:0030212]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell size [GO:0045792]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21129_c0_g2_i1	P47197	AKT2_RAT	58.3	127	53	0	8	388	234	360	7.20E-44	177.9	AKT2_RAT	reviewed	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)	Akt2	Rattus norvegicus (Rat)	481	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; sarcoplasmic reticulum [GO:0016529]; vesicle [GO:0031982]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of RNA splicing [GO:0033119]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signal transduction [GO:0009967]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; retinal rod cell apoptotic process [GO:0097473]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; sarcoplasmic reticulum [GO:0016529]; vesicle [GO:0031982]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001666; GO:0001934; GO:0004672; GO:0004674; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0006468; GO:0006970; GO:0008284; GO:0008286; GO:0008643; GO:0009967; GO:0010628; GO:0010748; GO:0010765; GO:0010907; GO:0010918; GO:0014850; GO:0016529; GO:0018105; GO:0030335; GO:0031340; GO:0031667; GO:0031982; GO:0032000; GO:0032287; GO:0032587; GO:0032593; GO:0032868; GO:0032869; GO:0032870; GO:0032991; GO:0033119; GO:0033138; GO:0035556; GO:0043066; GO:0043154; GO:0043231; GO:0043491; GO:0045429; GO:0045725; GO:0045944; GO:0046326; GO:0046872; GO:0050927; GO:0065002; GO:0071407; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:2000147	activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of RNA splicing [GO:0033119]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signal transduction [GO:0009967]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; retinal rod cell apoptotic process [GO:0097473]		NA	NA	NA	NA	NA	NA
TRINITY_DN40287_c0_g1_i1	Q60823	AKT2_MOUSE	99.3	141	1	0	425	3	198	338	6.70E-80	297.7	AKT2_MOUSE	reviewed	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)	Akt2	Mus musculus (Mouse)	481	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; sarcoplasmic reticulum [GO:0016529]; vesicle [GO:0031982]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of RNA splicing [GO:0033119]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signal transduction [GO:0009967]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; retinal rod cell apoptotic process [GO:0097473]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; sarcoplasmic reticulum [GO:0016529]; vesicle [GO:0031982]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001934; GO:0004672; GO:0004674; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0006468; GO:0008284; GO:0008286; GO:0008643; GO:0009967; GO:0010628; GO:0010748; GO:0010765; GO:0010907; GO:0010918; GO:0016529; GO:0018105; GO:0030335; GO:0031340; GO:0031982; GO:0032000; GO:0032287; GO:0032587; GO:0032593; GO:0032868; GO:0032869; GO:0032991; GO:0033119; GO:0033138; GO:0035556; GO:0043066; GO:0043154; GO:0043231; GO:0043491; GO:0045429; GO:0045725; GO:0045944; GO:0046326; GO:0046872; GO:0050927; GO:0065002; GO:0071407; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:2000147	activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of RNA splicing [GO:0033119]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signal transduction [GO:0009967]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; retinal rod cell apoptotic process [GO:0097473]		NA	NA	NA	NA	NA	NA
TRINITY_DN25859_c0_g1_i1	P47197	AKT2_RAT	54.4	147	67	0	1	441	228	374	5.40E-48	191.8	AKT2_RAT	reviewed	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)	Akt2	Rattus norvegicus (Rat)	481	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; sarcoplasmic reticulum [GO:0016529]; vesicle [GO:0031982]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of RNA splicing [GO:0033119]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signal transduction [GO:0009967]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; retinal rod cell apoptotic process [GO:0097473]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; sarcoplasmic reticulum [GO:0016529]; vesicle [GO:0031982]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001666; GO:0001934; GO:0004672; GO:0004674; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0006468; GO:0006970; GO:0008284; GO:0008286; GO:0008643; GO:0009967; GO:0010628; GO:0010748; GO:0010765; GO:0010907; GO:0010918; GO:0014850; GO:0016529; GO:0018105; GO:0030335; GO:0031340; GO:0031667; GO:0031982; GO:0032000; GO:0032287; GO:0032587; GO:0032593; GO:0032868; GO:0032869; GO:0032870; GO:0032991; GO:0033119; GO:0033138; GO:0035556; GO:0043066; GO:0043154; GO:0043231; GO:0043491; GO:0045429; GO:0045725; GO:0045944; GO:0046326; GO:0046872; GO:0050927; GO:0065002; GO:0071407; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:2000147	activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of RNA splicing [GO:0033119]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signal transduction [GO:0009967]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; retinal rod cell apoptotic process [GO:0097473]		NA	NA	NA	NA	NA	NA
TRINITY_DN14414_c0_g1_i1	Q6NUQ1	RINT1_HUMAN	48.6	144	73	1	49	480	302	444	4.80E-35	149.1	RINT1_HUMAN	reviewed	RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1)	RINT1	Homo sapiens (Human)	792	"cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]		GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0007049; GO:0015031; GO:0060628; GO:0070939; GO:1902504	"cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		brown	brown	1	NA	NA	NA
TRINITY_DN14414_c0_g1_i11	Q6NUQ1	RINT1_HUMAN	45.5	202	96	3	49	630	302	497	4.60E-45	183	RINT1_HUMAN	reviewed	RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1)	RINT1	Homo sapiens (Human)	792	"cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]		GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0007049; GO:0015031; GO:0060628; GO:0070939; GO:1902504	"cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14414_c0_g1_i13	Q8BZ36	RINT1_MOUSE	48.9	264	131	2	46	828	301	563	2.30E-66	253.8	RINT1_MOUSE	reviewed	RAD50-interacting protein 1 (RAD50 interactor 1) (RINT-1)	Rint1	Mus musculus (Mouse)	792	"Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]		GO:0005783; GO:0005789; GO:0006890; GO:0007049; GO:0015031; GO:0060628; GO:0070939; GO:1902504	"cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14414_c0_g1_i5	Q8BZ36	RINT1_MOUSE	48.9	264	131	2	46	828	301	563	2.30E-66	253.8	RINT1_MOUSE	reviewed	RAD50-interacting protein 1 (RAD50 interactor 1) (RINT-1)	Rint1	Mus musculus (Mouse)	792	"Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]		GO:0005783; GO:0005789; GO:0006890; GO:0007049; GO:0015031; GO:0060628; GO:0070939; GO:1902504	"cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29081_c0_g1_i1	Q6VTH5	RSPH1_CYPCA	40.3	72	43	0	2	217	42	113	3.20E-14	78.6	RSPH1_CYPCA	reviewed	Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein)	rsph1 msap tsga2	Cyprinus carpio (Common carp)	218	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]		GO:0005737; GO:0005856; GO:0007275; GO:0007283; GO:0030154; GO:0031514; GO:0051321	cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8470_c0_g1_i1	A4IGH2	RSAD1_DANRE	43	393	182	5	20	1192	73	425	9.10E-80	298.9	RSAD1_DANRE	reviewed	"Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone)"	rsad1	Danio rerio (Zebrafish) (Brachydanio rerio)	444	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]"	GO:0004109; GO:0005737; GO:0005739; GO:0006779; GO:0046872; GO:0051539	porphyrin-containing compound biosynthetic process [GO:0006779]		NA	NA	NA	NA	NA	NA
TRINITY_DN40648_c0_g1_i1	Q32LP2	RADI_BOVIN	100	100	0	0	1	300	54	153	3.20E-52	205.3	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		NA	NA	NA	NA	NA	NA
TRINITY_DN37365_c0_g1_i1	Q32LP2	RADI_BOVIN	81.7	82	15	0	248	3	148	229	2.50E-34	145.6	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		NA	NA	NA	NA	NA	NA
TRINITY_DN11723_c0_g2_i3	Q32LP2	RADI_BOVIN	84.5	316	48	1	1071	127	1	316	2.40E-156	553.1	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		blue	blue	NA	NA	NA	NA
TRINITY_DN11723_c0_g2_i4	Q32LP2	RADI_BOVIN	85.1	316	46	1	1071	127	1	316	2.60E-158	559.7	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		blue	blue	NA	NA	NA	NA
TRINITY_DN11723_c0_g2_i5	Q32LP2	RADI_BOVIN	78	82	18	0	339	94	1	82	1.20E-30	134.4	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		NA	NA	NA	NA	NA	NA
TRINITY_DN32489_c0_g1_i1	Q32LP2	RADI_BOVIN	99.3	136	1	0	409	2	165	300	8.80E-77	287.3	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		NA	NA	NA	NA	NA	NA
TRINITY_DN34020_c0_g1_i1	Q32LP2	RADI_BOVIN	100	66	0	0	3	200	150	215	1.60E-31	136	RADI_BOVIN	reviewed	Radixin	RDX	Bos taurus (Bovine)	583	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]		NA	NA	NA	NA	NA	NA
TRINITY_DN38765_c0_g1_i2	Q9PU45	RADI_CHICK	24.1	290	159	5	39	731	7	294	3.80E-15	83.6	RADI_CHICK	reviewed	Radixin	RDX	Gallus gallus (Chicken)	583	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament capping [GO:0051693]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0051693	actin filament capping [GO:0051693]		NA	NA	NA	NA	NA	NA
TRINITY_DN5921_c0_g1_i1	P11346	KRAF1_DROME	51	151	72	1	131	583	142	290	1.70E-35	151	KRAF1_DROME	reviewed	Raf homolog serine/threonine-protein kinase Raf (D-Raf) (dRAF-1) (EC 2.7.11.1) (Protein pole-hole)	Raf ph phl CG2845	Drosophila melanogaster (Fruit fly)	739	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; compound eye photoreceptor development [GO:0042051]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; protein autophosphorylation [GO:0046777]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000186; GO:0002168; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0007265; GO:0007283; GO:0007298; GO:0007362; GO:0007369; GO:0007427; GO:0007430; GO:0007465; GO:0007472; GO:0007474; GO:0007476; GO:0007552; GO:0007623; GO:0008069; GO:0008284; GO:0008293; GO:0008543; GO:0009267; GO:0016242; GO:0019900; GO:0030641; GO:0035171; GO:0035309; GO:0040014; GO:0042051; GO:0042386; GO:0042461; GO:0045500; GO:0046530; GO:0046534; GO:0046777; GO:0046843; GO:0046872; GO:0048010; GO:0070371; GO:0070374; GO:2001234	"activation of MAPKK activity [GO:0000186]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; compound eye photoreceptor development [GO:0042051]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; protein autophosphorylation [GO:0046777]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5921_c0_g1_i2	P11346	KRAF1_DROME	51	151	72	1	131	583	142	290	1.90E-35	151	KRAF1_DROME	reviewed	Raf homolog serine/threonine-protein kinase Raf (D-Raf) (dRAF-1) (EC 2.7.11.1) (Protein pole-hole)	Raf ph phl CG2845	Drosophila melanogaster (Fruit fly)	739	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; compound eye photoreceptor development [GO:0042051]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; protein autophosphorylation [GO:0046777]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000186; GO:0002168; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0007265; GO:0007283; GO:0007298; GO:0007362; GO:0007369; GO:0007427; GO:0007430; GO:0007465; GO:0007472; GO:0007474; GO:0007476; GO:0007552; GO:0007623; GO:0008069; GO:0008284; GO:0008293; GO:0008543; GO:0009267; GO:0016242; GO:0019900; GO:0030641; GO:0035171; GO:0035309; GO:0040014; GO:0042051; GO:0042386; GO:0042461; GO:0045500; GO:0046530; GO:0046534; GO:0046777; GO:0046843; GO:0046872; GO:0048010; GO:0070371; GO:0070374; GO:2001234	"activation of MAPKK activity [GO:0000186]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; compound eye photoreceptor development [GO:0042051]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; protein autophosphorylation [GO:0046777]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39635_c0_g1_i1	A7E3S4	RAF1_BOVIN	75.7	70	16	1	3	212	433	501	3.60E-24	111.7	RAF1_BOVIN	reviewed	RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1)	RAF1	Bos taurus (Bovine)	648	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; activation of adenylate cyclase activity [GO:0007190]; activation of MAPKK activity [GO:0000186]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]	GO:0000186; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007190; GO:0008285; GO:0016607; GO:0017016; GO:0030154; GO:0030878; GO:0031143; GO:0031333; GO:0033138; GO:0035019; GO:0035556; GO:0035773; GO:0035994; GO:0042802; GO:0045104; GO:0045944; GO:0046872; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:1902042	activation of adenylate cyclase activity [GO:0007190]; activation of MAPKK activity [GO:0000186]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]		NA	NA	NA	NA	NA	NA
TRINITY_DN9283_c0_g1_i1	Q9JHS3	LTOR2_MOUSE	100	102	0	0	51	356	24	125	4.20E-51	201.8	LTOR2_MOUSE	reviewed	Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (Roadblock domain-containing protein 3)	Lamtor2 Mapbpip Robld3	Mus musculus (Mouse)	125	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; activation of MAPKK activity [GO:0000186]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; positive regulation of TOR signaling [GO:0032008]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]	guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]	GO:0000186; GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0010761; GO:0032008; GO:0034613; GO:0060090; GO:0071230; GO:0071986; GO:0150116; GO:1902414	activation of MAPKK activity [GO:0000186]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; positive regulation of TOR signaling [GO:0032008]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]		NA	NA	NA	NA	NA	NA
TRINITY_DN9283_c0_g1_i2	Q9JHS3	LTOR2_MOUSE	100	125	0	0	72	446	1	125	1.60E-63	243.4	LTOR2_MOUSE	reviewed	Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (Roadblock domain-containing protein 3)	Lamtor2 Mapbpip Robld3	Mus musculus (Mouse)	125	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; activation of MAPKK activity [GO:0000186]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; positive regulation of TOR signaling [GO:0032008]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]	guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]	GO:0000186; GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0010761; GO:0032008; GO:0034613; GO:0060090; GO:0071230; GO:0071986; GO:0150116; GO:1902414	activation of MAPKK activity [GO:0000186]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; positive regulation of TOR signaling [GO:0032008]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]		NA	NA	NA	NA	NA	NA
TRINITY_DN9283_c0_g2_i1	Q3T132	LTOR2_BOVIN	100	125	0	0	25	399	1	125	6.90E-64	244.6	LTOR2_BOVIN	reviewed	Ragulator complex protein LAMTOR2 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2)	LAMTOR2	Bos taurus (Bovine)	125	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; activation of MAPKK activity [GO:0000186]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; positive regulation of TOR signaling [GO:0032008]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]	guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]	GO:0000186; GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0010761; GO:0032008; GO:0034613; GO:0060090; GO:0071230; GO:0071986; GO:0150116; GO:1902414	activation of MAPKK activity [GO:0000186]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; positive regulation of TOR signaling [GO:0032008]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]		NA	NA	NA	NA	NA	NA
TRINITY_DN5327_c0_g1_i3	Q6DEG4	LTOR2_DANRE	69.6	125	38	0	78	452	1	125	2.30E-45	183.3	LTOR2_DANRE	reviewed	Ragulator complex protein LAMTOR2 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2)	lamtor2 zgc:100811	Danio rerio (Zebrafish) (Brachydanio rerio)	125	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]	guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]	GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0032008; GO:0034613; GO:0060090; GO:0071230; GO:0071986	cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN5327_c0_g1_i2	Q63ZJ2	LTR2A_XENLA	64.6	99	31	2	78	371	1	96	3.50E-27	122.5	LTR2A_XENLA	reviewed	Ragulator complex protein LAMTOR2-A (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2-A) (Roadblock domain-containing protein 3)	lamtor2-a robld3	Xenopus laevis (African clawed frog)	125	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]	guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]	GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0032008; GO:0034613; GO:0060090; GO:0071230; GO:0071986	cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]		NA	NA	NA	NA	NA	NA
TRINITY_DN10778_c0_g1_i1	Q6GYP7	RGPA1_MOUSE	41	293	131	9	759	1	360	650	4.50E-42	172.9	RGPA1_MOUSE	reviewed	Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating RapGAP domain-like 1) (Tuberin-like protein 1) (p240)	Ralgapa1 Garnl1 Kiaa0884 Tulip1	Mus musculus (Mouse)	2035	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0005634; GO:0005737; GO:0006355; GO:0046982; GO:0051056; GO:0090630	"activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN339_c0_g1_i1	Q86X10	RLGPB_HUMAN	42.6	458	213	12	1312	8	1041	1471	1.50E-80	301.6	RLGPB_HUMAN	reviewed	Ral GTPase-activating protein subunit beta (p170)	RALGAPB KIAA1219	Homo sapiens (Human)	1494	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0046982; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN339_c0_g1_i2	Q86X10	RLGPB_HUMAN	39.4	1598	758	36	4552	8	1	1471	3.00E-290	1000	RLGPB_HUMAN	reviewed	Ral GTPase-activating protein subunit beta (p170)	RALGAPB KIAA1219	Homo sapiens (Human)	1494	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0046982; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN339_c0_g1_i3	Q86X10	RLGPB_HUMAN	39.4	1616	747	39	4591	8	1	1471	5.10E-290	999.2	RLGPB_HUMAN	reviewed	Ral GTPase-activating protein subunit beta (p170)	RALGAPB KIAA1219	Homo sapiens (Human)	1494	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0046982; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN339_c0_g1_i4	Q86X10	RLGPB_HUMAN	35.9	767	365	16	2397	274	1	699	1.50E-123	445.3	RLGPB_HUMAN	reviewed	Ral GTPase-activating protein subunit beta (p170)	RALGAPB KIAA1219	Homo sapiens (Human)	1494	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0046982; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN26866_c0_g1_i1	Q60695	RGL1_MOUSE	100	88	0	0	1	264	286	373	3.10E-43	175.3	RGL1_MOUSE	reviewed	Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1)	Rgl1 Rgl	Mus musculus (Mouse)	768	Ral guanyl-nucleotide exchange factor activity [GO:0008321]; small GTPase mediated signal transduction [GO:0007264]		Ral guanyl-nucleotide exchange factor activity [GO:0008321]	GO:0007264; GO:0008321	small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3698_c0_g1_i1	Q9NZL6	RGL1_HUMAN	37.8	748	399	17	2224	122	15	743	8.30E-116	419.5	RGL1_HUMAN	reviewed	Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1)	RGL1 KIAA0959 RGL	Homo sapiens (Human)	768	cytosol [GO:0005829]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]; regulation of lipid metabolic process [GO:0019216]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	Ral guanyl-nucleotide exchange factor activity [GO:0008321]	GO:0005829; GO:0007264; GO:0008321; GO:0019216	regulation of lipid metabolic process [GO:0019216]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN25403_c0_g1_i1	Q9PT60	RBP1A_XENLA	49.3	136	67	2	554	150	315	449	4.00E-24	112.8	RBP1A_XENLA	reviewed	RalA-binding protein 1-A (RalBP1-A) (Ral-interacting protein 1-A) (RIP1-A) (XRLIP2) (XRLIP76-A)	ralbp1-a rlip	Xenopus laevis (African clawed frog)	655	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; actin cytoskeleton organization [GO:0030036]; gastrulation with mouth forming second [GO:0001702]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]	GO:0001702; GO:0005096; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017160; GO:0030036	actin cytoskeleton organization [GO:0030036]; gastrulation with mouth forming second [GO:0001702]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN25969_c0_g1_i1	Q9PT60	RBP1A_XENLA	52.8	108	51	0	9	332	199	306	1.50E-26	120.2	RBP1A_XENLA	reviewed	RalA-binding protein 1-A (RalBP1-A) (Ral-interacting protein 1-A) (RIP1-A) (XRLIP2) (XRLIP76-A)	ralbp1-a rlip	Xenopus laevis (African clawed frog)	655	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; actin cytoskeleton organization [GO:0030036]; gastrulation with mouth forming second [GO:0001702]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]	GO:0001702; GO:0005096; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017160; GO:0030036	actin cytoskeleton organization [GO:0030036]; gastrulation with mouth forming second [GO:0001702]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN10859_c1_g2_i1	Q96D71	REPS1_HUMAN	58.1	93	39	0	368	646	279	371	2.50E-25	117.1	REPS1_HUMAN	reviewed	RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1)	REPS1	Homo sapiens (Human)	796	clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]	GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0016197; GO:0017124; GO:0061024	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN10859_c1_g2_i2	Q96D71	REPS1_HUMAN	59.2	49	20	0	368	514	279	327	1.60E-11	71.2	REPS1_HUMAN	reviewed	RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1)	REPS1	Homo sapiens (Human)	796	clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]	GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0016197; GO:0017124; GO:0061024	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN39176_c0_g1_i1	P46060	RAGP1_HUMAN	100	88	0	0	2	265	38	125	1.20E-42	173.3	RAGP1_HUMAN	reviewed	Ran GTPase-activating protein 1 (RanGAP1)	RANGAP1 KIAA1835 SD	Homo sapiens (Human)	587	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0000777; GO:0003723; GO:0005096; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008536; GO:0016235; GO:0016925; GO:0030425; GO:0031625; GO:0031965; GO:0043231; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0072686; GO:0090630; GO:1904115; GO:1904117; GO:1990723	activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37569_c0_g1_i1	P46060	RAGP1_HUMAN	100	74	0	0	223	2	153	226	6.90E-36	150.6	RAGP1_HUMAN	reviewed	Ran GTPase-activating protein 1 (RanGAP1)	RANGAP1 KIAA1835 SD	Homo sapiens (Human)	587	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0000777; GO:0003723; GO:0005096; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008536; GO:0016235; GO:0016925; GO:0030425; GO:0031625; GO:0031965; GO:0043231; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0072686; GO:0090630; GO:1904115; GO:1904117; GO:1990723	activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN16517_c0_g1_i2	P46060	RAGP1_HUMAN	56.6	242	105	0	729	4	23	264	5.10E-70	265.8	RAGP1_HUMAN	reviewed	Ran GTPase-activating protein 1 (RanGAP1)	RANGAP1 KIAA1835 SD	Homo sapiens (Human)	587	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0000777; GO:0003723; GO:0005096; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008536; GO:0016235; GO:0016925; GO:0030425; GO:0031625; GO:0031965; GO:0043231; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0072686; GO:0090630; GO:1904115; GO:1904117; GO:1990723	activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8115_c0_g1_i1	Q9BYM8	HOIL1_HUMAN	59.6	47	19	0	221	81	438	484	1.90E-15	83.2	HOIL1_HUMAN	reviewed	RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)	RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4	Homo sapiens (Human)	510	cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cytoplasmic sequestering of protein [GO:0051220]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0007249; GO:0010803; GO:0016032; GO:0032088; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0050852; GO:0051092; GO:0051220; GO:0060546; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:2001238	cytoplasmic sequestering of protein [GO:0051220]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		blue	blue	NA	NA	NA	NA
TRINITY_DN8115_c0_g1_i2	Q9BYM8	HOIL1_HUMAN	59.6	47	19	0	252	112	438	484	2.10E-15	83.2	HOIL1_HUMAN	reviewed	RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)	RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4	Homo sapiens (Human)	510	cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cytoplasmic sequestering of protein [GO:0051220]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0007249; GO:0010803; GO:0016032; GO:0032088; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0050852; GO:0051092; GO:0051220; GO:0060546; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:2001238	cytoplasmic sequestering of protein [GO:0051220]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN8115_c0_g1_i3	Q9BYM8	HOIL1_HUMAN	60.3	73	29	0	237	19	438	510	6.00E-28	124.8	HOIL1_HUMAN	reviewed	RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)	RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4	Homo sapiens (Human)	510	cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cytoplasmic sequestering of protein [GO:0051220]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0007249; GO:0010803; GO:0016032; GO:0032088; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0050852; GO:0051092; GO:0051220; GO:0060546; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:2001238	cytoplasmic sequestering of protein [GO:0051220]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN24817_c0_g1_i1	P43487	RANG_HUMAN	100	94	0	0	2	283	32	125	1.40E-49	196.4	RANG_HUMAN	reviewed	Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1)	RANBP1	Homo sapiens (Human)	201	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]	GO:0005092; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0007165; GO:0008536; GO:0016032; GO:0045296; GO:0046604; GO:0046907	intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN40487_c0_g1_i1	Q3T0M7	RANG_BOVIN	100	87	0	0	3	263	29	115	8.20E-44	177.2	RANG_BOVIN	reviewed	Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1)	RANBP1	Bos taurus (Bovine)	206	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; spindle organization [GO:0007051]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]	GO:0005096; GO:0005634; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0007051; GO:0008536; GO:0046604; GO:0046907	intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; spindle organization [GO:0007051]		NA	NA	NA	NA	NA	NA
TRINITY_DN31082_c0_g1_i1	Q3T0M7	RANG_BOVIN	65.7	67	23	0	203	3	45	111	3.70E-20	98.2	RANG_BOVIN	reviewed	Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1)	RANBP1	Bos taurus (Bovine)	206	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; spindle organization [GO:0007051]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]	GO:0005096; GO:0005634; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0007051; GO:0008536; GO:0046604; GO:0046907	intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; spindle organization [GO:0007051]		blue	blue	NA	NA	NA	NA
TRINITY_DN6297_c0_g1_i1	F1PBJ0	RPGF2_CANLF	48.6	957	450	14	2897	102	62	1001	3.90E-244	846.3	RPGF2_CANLF	reviewed	Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1)	RAPGEF2 NRAPGEP PDZGEF1	Canis lupus familiaris (Dog) (Canis familiaris)	1498	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; cAMP binding [GO:0030552]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; ventricular system development [GO:0021591]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	beta-1 adrenergic receptor binding [GO:0031697]; cAMP binding [GO:0030552]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]	GO:0001568; GO:0001764; GO:0005088; GO:0005096; GO:0005737; GO:0005770; GO:0005886; GO:0005911; GO:0007186; GO:0007218; GO:0008285; GO:0010976; GO:0017034; GO:0019933; GO:0021591; GO:0021884; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN29959_c0_g1_i1	Q8TEU7	RPGF6_HUMAN	97.1	104	3	0	314	3	252	355	4.60E-54	211.5	RPGF6_HUMAN	reviewed	Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2) (PDZ-GEF2) (RA-GEF-2)	RAPGEF6 PDZGEF2	Homo sapiens (Human)	1601	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]	GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]	GO:0005085; GO:0005813; GO:0005829; GO:0005886; GO:0007265; GO:0016324; GO:0017016; GO:0030033; GO:0030139; GO:0030742; GO:0043087; GO:0043547; GO:0070300; GO:0072659	microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN12980_c0_g1_i1	Q5ZMV8	RPGP2_CHICK	73.6	72	19	0	216	1	314	385	2.90E-26	118.6	RPGP2_CHICK	reviewed	Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4)	RAP1GAP2 GARNL4 RCJMB04_1a20	Gallus gallus (Chicken)	730	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]		blue	blue	NA	NA	NA	NA
TRINITY_DN96_c0_g1_i6	P52306	GDS1_HUMAN	33.5	609	397	7	2175	355	1	603	1.20E-87	325.9	GDS1_HUMAN	reviewed	Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein)	RAP1GDS1	Homo sapiens (Human)	607	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005739; GO:0005783; GO:0005829; GO:0014829; GO:0031034; GO:0032471; GO:0043547; GO:0051561; GO:0070062	myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829]		NA	NA	NA	NA	NA	NA
TRINITY_DN96_c0_g1_i7	P52306	GDS1_HUMAN	34.7	530	339	6	1938	355	79	603	1.60E-78	295.4	GDS1_HUMAN	reviewed	Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein)	RAP1GDS1	Homo sapiens (Human)	607	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005739; GO:0005783; GO:0005829; GO:0014829; GO:0031034; GO:0032471; GO:0043547; GO:0051561; GO:0070062	myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829]		NA	NA	NA	NA	NA	NA
TRINITY_DN7598_c2_g1_i12	P50904	RASA1_RAT	44.6	766	382	10	2271	7	138	872	3.40E-176	620.2	RASA1_RAT	reviewed	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	Rasa1 Rasa	Rattus norvegicus (Rat)	1038	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]	GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001934; GO:0001953; GO:0005096; GO:0005102; GO:0005161; GO:0005829; GO:0005886; GO:0007155; GO:0007162; GO:0007165; GO:0008134; GO:0016020; GO:0019900; GO:0030036; GO:0030539; GO:0030833; GO:0030971; GO:0031965; GO:0032868; GO:0036120; GO:0042493; GO:0043066; GO:0043422; GO:0043524; GO:0043547; GO:0044325; GO:0044344; GO:0044877; GO:0046326; GO:0046580; GO:0048146; GO:0048514; GO:0050731; GO:0051020; GO:0071364; GO:0090630; GO:1990782	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN7598_c2_g1_i14	P50904	RASA1_RAT	45.8	746	383	9	2214	7	138	872	1.40E-179	631.3	RASA1_RAT	reviewed	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	Rasa1 Rasa	Rattus norvegicus (Rat)	1038	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]	GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001934; GO:0001953; GO:0005096; GO:0005102; GO:0005161; GO:0005829; GO:0005886; GO:0007155; GO:0007162; GO:0007165; GO:0008134; GO:0016020; GO:0019900; GO:0030036; GO:0030539; GO:0030833; GO:0030971; GO:0031965; GO:0032868; GO:0036120; GO:0042493; GO:0043066; GO:0043422; GO:0043524; GO:0043547; GO:0044325; GO:0044344; GO:0044877; GO:0046326; GO:0046580; GO:0048146; GO:0048514; GO:0050731; GO:0051020; GO:0071364; GO:0090630; GO:1990782	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN7598_c2_g1_i2	P50904	RASA1_RAT	47.1	446	197	8	1356	43	138	552	4.00E-106	386.7	RASA1_RAT	reviewed	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	Rasa1 Rasa	Rattus norvegicus (Rat)	1038	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]	GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001934; GO:0001953; GO:0005096; GO:0005102; GO:0005161; GO:0005829; GO:0005886; GO:0007155; GO:0007162; GO:0007165; GO:0008134; GO:0016020; GO:0019900; GO:0030036; GO:0030539; GO:0030833; GO:0030971; GO:0031965; GO:0032868; GO:0036120; GO:0042493; GO:0043066; GO:0043422; GO:0043524; GO:0043547; GO:0044325; GO:0044344; GO:0044877; GO:0046326; GO:0046580; GO:0048146; GO:0048514; GO:0050731; GO:0051020; GO:0071364; GO:0090630; GO:1990782	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN29998_c0_g1_i1	P20936	RASA1_HUMAN	66.1	56	19	0	63	230	919	974	5.00E-15	81.6	RASA1_HUMAN	reviewed	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	RASA1 GAP RASA	Homo sapiens (Human)	1047	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]	GO:0000165; GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0046580; GO:0048013; GO:0048514; GO:0051020; GO:0051252	blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]		brown	brown	NA	NA	NA	NA
TRINITY_DN29998_c0_g1_i3	P20936	RASA1_HUMAN	51.5	132	59	2	3	386	910	1040	7.30E-30	131.7	RASA1_HUMAN	reviewed	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	RASA1 GAP RASA	Homo sapiens (Human)	1047	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]	GO:0000165; GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0046580; GO:0048013; GO:0048514; GO:0051020; GO:0051252	blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN26995_c0_g1_i1	P58069	RASA2_MOUSE	96.1	76	3	0	230	3	371	446	5.00E-37	154.5	RASA2_MOUSE	reviewed	Ras GTPase-activating protein 2 (GAP1m)	Rasa2	Mus musculus (Mouse)	847	plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]	plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0005096; GO:0005543; GO:0005886; GO:0035556; GO:0046580; GO:0046872	intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]		NA	NA	NA	NA	NA	NA
TRINITY_DN28958_c0_g1_i1	Q60790	RASA3_MOUSE	100	114	0	0	2	343	548	661	4.70E-60	231.5	RASA3_MOUSE	reviewed	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (GapIII) (Ins P4-binding protein)	Rasa3	Mus musculus (Mouse)	834	intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to heat [GO:0034605]; negative regulation of Ras protein signal transduction [GO:0046580]	intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]	calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0015278; GO:0031235; GO:0034605; GO:0046580; GO:0046872	cellular response to heat [GO:0034605]; negative regulation of Ras protein signal transduction [GO:0046580]		NA	NA	NA	NA	NA	NA
TRINITY_DN34352_c0_g1_i1	Q14644	RASA3_HUMAN	100	104	0	0	2	313	584	687	4.20E-55	214.9	RASA3_HUMAN	reviewed	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein)	RASA3	Homo sapiens (Human)	834	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]	calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000165; GO:0005096; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0046580; GO:0046872	MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN924_c0_g1_i1	Q14644	RASA3_HUMAN	40.5	163	97	0	82	570	657	819	3.10E-32	140.2	RASA3_HUMAN	reviewed	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein)	RASA3	Homo sapiens (Human)	834	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]	calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000165; GO:0005096; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0046580; GO:0046872	MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN924_c0_g1_i2	Q14644	RASA3_HUMAN	50	74	37	0	2	223	289	362	1.30E-13	77	RASA3_HUMAN	reviewed	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein)	RASA3	Homo sapiens (Human)	834	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]	calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000165; GO:0005096; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0046580; GO:0046872	MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN924_c0_g1_i3	Q14644	RASA3_HUMAN	48.6	533	272	1	2	1600	289	819	4.80E-148	526.2	RASA3_HUMAN	reviewed	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein)	RASA3	Homo sapiens (Human)	834	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]	calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000165; GO:0005096; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0046580; GO:0046872	MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37184_c0_g1_i1	Q14644	RASA3_HUMAN	99	97	1	0	294	4	444	540	5.20E-47	188	RASA3_HUMAN	reviewed	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein)	RASA3	Homo sapiens (Human)	834	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]	calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000165; GO:0005096; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0046580; GO:0046872	MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2703_c0_g1_i1	Q8T498	GAP2_DROME	41.2	478	235	12	80	1438	356	812	4.50E-82	307	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2703_c0_g1_i2	Q8T498	GAP2_DROME	41.5	564	280	13	287	1891	270	812	1.10E-101	372.5	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i1	Q8T498	GAP2_DROME	48	737	287	13	85	2109	153	855	2.50E-176	621.3	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i2	Q8T498	GAP2_DROME	48	737	287	13	85	2109	153	855	2.50E-176	621.3	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i3	Q8T498	GAP2_DROME	47.4	703	280	11	82	2013	187	858	1.50E-166	588.6	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i4	Q8T498	GAP2_DROME	47.4	703	280	11	82	2013	187	858	1.40E-166	588.6	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i5	Q8T498	GAP2_DROME	47.6	700	277	11	82	2004	187	855	8.00E-167	589.7	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i6	Q8T498	GAP2_DROME	47.7	747	295	13	35	2089	143	855	8.60E-177	622.9	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i7	Q8T498	GAP2_DROME	47.7	747	295	13	35	2089	143	855	8.70E-177	622.9	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4926_c0_g1_i8	Q8T498	GAP2_DROME	47.6	700	277	11	82	2004	187	855	7.90E-167	589.7	GAP2_DROME	reviewed	Ras GTPase-activating protein raskol	raskol CG42684	Drosophila melanogaster (Fruit fly)	1580	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; GTPase activator activity [GO:0005096]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165; GO:0016324; GO:0045179; GO:0046580	negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15430_c0_g1_i1	Q9JKF1	IQGA1_MOUSE	100	130	0	0	391	2	103	232	5.30E-71	268.1	IQGA1_MOUSE	reviewed	Ras GTPase-activating-like protein IQGAP1	Iqgap1	Mus musculus (Mouse)	1657	"axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]"	axon [GO:0030424]; cell-cell junction [GO:0005911]; cell leading edge [GO:0031252]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005874; GO:0005886; GO:0005911; GO:0005925; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016328; GO:0016477; GO:0017016; GO:0017048; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030864; GO:0031234; GO:0031252; GO:0031267; GO:0032956; GO:0032991; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043406; GO:0043410; GO:0043539; GO:0044344; GO:0044548; GO:0044877; GO:0045121; GO:0045860; GO:0048008; GO:0048365; GO:0051015; GO:0051019; GO:0051894; GO:0060090; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]		NA	NA	NA	NA	NA	NA
TRINITY_DN15430_c0_g1_i2	P46940	IQGA1_HUMAN	99.2	130	1	0	391	2	103	232	4.00E-71	268.5	IQGA1_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP1 (p195)	IQGAP1 KIAA0051	Homo sapiens (Human)	1657	"actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"	actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]	"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016032; GO:0016328; GO:0016477; GO:0017016; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043410; GO:0043539; GO:0044548; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051015; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30102_c0_g1_i1	P46940	IQGA1_HUMAN	100	145	0	0	3	437	946	1090	9.70E-74	277.3	IQGA1_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP1 (p195)	IQGAP1 KIAA0051	Homo sapiens (Human)	1657	"actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"	actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]	"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016032; GO:0016328; GO:0016477; GO:0017016; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043410; GO:0043539; GO:0044548; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051015; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29133_c0_g1_i1	P46940	IQGA1_HUMAN	100	74	0	0	224	3	1176	1249	1.40E-36	152.9	IQGA1_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP1 (p195)	IQGAP1 KIAA0051	Homo sapiens (Human)	1657	"actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"	actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]	"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016032; GO:0016328; GO:0016477; GO:0017016; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043410; GO:0043539; GO:0044548; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051015; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN40518_c0_g1_i1	P46940	IQGA1_HUMAN	100	81	0	0	3	245	5	85	1.10E-42	173.3	IQGA1_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP1 (p195)	IQGAP1 KIAA0051	Homo sapiens (Human)	1657	"actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"	actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]	"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016032; GO:0016328; GO:0016477; GO:0017016; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043410; GO:0043539; GO:0044548; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051015; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN34785_c0_g1_i1	P46940	IQGA1_HUMAN	100	79	0	0	1	237	840	918	3.90E-37	154.8	IQGA1_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP1 (p195)	IQGAP1 KIAA0051	Homo sapiens (Human)	1657	"actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"	actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]	"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016032; GO:0016328; GO:0016477; GO:0017016; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043410; GO:0043539; GO:0044548; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051015; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN26795_c0_g1_i1	Q13576	IQGA2_HUMAN	41.9	105	61	0	8	322	1353	1457	2.90E-15	82.8	IQGA2_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP2	IQGAP2	Homo sapiens (Human)	1575	"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; neutrophil degranulation [GO:0043312]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]"	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]"	GO:0003779; GO:0005095; GO:0005096; GO:0005516; GO:0005547; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007165; GO:0009986; GO:0015629; GO:0017016; GO:0017048; GO:0030027; GO:0030175; GO:0030667; GO:0032956; GO:0034314; GO:0043312; GO:0048365; GO:0051015; GO:0070062; GO:0070493; GO:0071933; GO:2000249	Arp2/3 complex-mediated actin nucleation [GO:0034314]; neutrophil degranulation [GO:0043312]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN3943_c0_g1_i1	Q3UQ44	IQGA2_MOUSE	44.2	208	116	0	53	676	1023	1230	6.10E-51	202.2	IQGA2_MOUSE	reviewed	Ras GTPase-activating-like protein IQGAP2	Iqgap2	Mus musculus (Mouse)	1575	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; thrombin-activated receptor signaling pathway [GO:0070493]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]	"actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]"	GO:0005096; GO:0005516; GO:0005547; GO:0005737; GO:0005874; GO:0005902; GO:0009986; GO:0017016; GO:0017048; GO:0030027; GO:0030175; GO:0032956; GO:0034314; GO:0048365; GO:0051015; GO:0070493; GO:0071933; GO:2000249	Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN36041_c0_g1_i1	Q13576	IQGA2_HUMAN	100	242	0	0	727	2	12	253	3.30E-135	482.3	IQGA2_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP2	IQGAP2	Homo sapiens (Human)	1575	"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; neutrophil degranulation [GO:0043312]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]"	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; Rho GTPase binding [GO:0017048]"	GO:0003779; GO:0005095; GO:0005096; GO:0005516; GO:0005547; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007165; GO:0009986; GO:0015629; GO:0017016; GO:0017048; GO:0030027; GO:0030175; GO:0030667; GO:0032956; GO:0034314; GO:0043312; GO:0048365; GO:0051015; GO:0070062; GO:0070493; GO:0071933; GO:2000249	Arp2/3 complex-mediated actin nucleation [GO:0034314]; neutrophil degranulation [GO:0043312]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]		NA	NA	NA	NA	NA	NA
TRINITY_DN3943_c0_g1_i3	Q86VI3	IQGA3_HUMAN	37.8	987	562	13	62	2983	113	1060	1.10E-163	578.9	IQGA3_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP3	IQGAP3	Homo sapiens (Human)	1631	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]	GO:0000082; GO:0000187; GO:0005096; GO:0005516; GO:0005737; GO:0005829; GO:0005911; GO:0007265; GO:0008361; GO:0010628; GO:0010629; GO:0016328; GO:0017016; GO:0032956; GO:0033601; GO:0048365; GO:0051015; GO:0070371; GO:0070856; GO:0071310	activation of MAPK activity [GO:0000187]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN3943_c0_g1_i4	Q86VI3	IQGA3_HUMAN	41.2	1325	727	13	26	3961	16	1301	1.30E-270	934.5	IQGA3_HUMAN	reviewed	Ras GTPase-activating-like protein IQGAP3	IQGAP3	Homo sapiens (Human)	1631	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; Rac GTPase binding [GO:0048365]; Ras GTPase binding [GO:0017016]	GO:0000082; GO:0000187; GO:0005096; GO:0005516; GO:0005737; GO:0005829; GO:0005911; GO:0007265; GO:0008361; GO:0010628; GO:0010629; GO:0016328; GO:0017016; GO:0032956; GO:0033601; GO:0048365; GO:0051015; GO:0070371; GO:0070856; GO:0071310	activation of MAPK activity [GO:0000187]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]		NA	NA	NA	NA	NA	NA
TRINITY_DN40157_c0_g1_i1	Q86YV0	RASL3_HUMAN	100	84	0	0	253	2	229	312	2.20E-46	185.7	RASL3_HUMAN	reviewed	RAS protein activator like-3	RASAL3	Homo sapiens (Human)	1011	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]	GO:0000165; GO:0005096; GO:0005737; GO:0005829; GO:0005938; GO:0016020; GO:0042802; GO:0046580; GO:0051142; GO:0070062; GO:0098562	MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]		NA	NA	NA	NA	NA	NA
TRINITY_DN3035_c0_g1_i1	Q15404	RSU1_HUMAN	61.4	241	92	1	79	801	1	240	6.10E-82	305.4	RSU1_HUMAN	reviewed	Ras suppressor protein 1 (RSP-1) (Rsu-1)	RSU1 RSP1	Homo sapiens (Human)	277	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]		GO:0005829; GO:0005925; GO:0007165; GO:0010811; GO:0043547; GO:0070062	positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN32909_c0_g1_i1	Q15404	RSU1_HUMAN	100	223	0	0	11	679	1	223	1.70E-122	439.9	RSU1_HUMAN	reviewed	Ras suppressor protein 1 (RSP-1) (Rsu-1)	RSU1 RSP1	Homo sapiens (Human)	277	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]		GO:0005829; GO:0005925; GO:0007165; GO:0010811; GO:0043547; GO:0070062	positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN29857_c0_g1_i1	Q70E73	RAPH1_HUMAN	51.4	212	99	2	3	638	255	462	1.20E-53	211.1	RAPH1_HUMAN	reviewed	Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1)	RAPH1 ALS2CR18 ALS2CR9 KIAA1681 LPD PREL2 RMO1	Homo sapiens (Human)	1250	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; axon extension [GO:0048675]; signal transduction [GO:0007165]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]		GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675	axon extension [GO:0048675]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30405_c0_g1_i1	Q6DHR3	RG1BA_DANRE	44.8	203	98	4	621	25	25	217	8.00E-40	165.2	RG1BA_DANRE	reviewed	Ras-GEF domain-containing family member 1B-A	rasgef1ba rasgef1b si:dkey-18e17.1	Danio rerio (Zebrafish) (Brachydanio rerio)	514	Ras guanyl-nucleotide exchange factor activity [GO:0005088]; small GTPase mediated signal transduction [GO:0007264]		Ras guanyl-nucleotide exchange factor activity [GO:0005088]	GO:0005088; GO:0007264	small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN13442_c0_g2_i1	P01122	RHO_APLCA	90.1	192	19	0	119	694	1	192	1.70E-97	357.1	RHO_APLCA	reviewed	Ras-like GTP-binding protein RHO	RHO	Aplysia californica (California sea hare)	192	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007264	small GTPase mediated signal transduction [GO:0007264]		blue	blue	NA	NA	NA	NA
TRINITY_DN13442_c0_g2_i2	P01122	RHO_APLCA	90.1	192	19	0	100	675	1	192	9.70E-98	357.8	RHO_APLCA	reviewed	Ras-like GTP-binding protein RHO	RHO	Aplysia californica (California sea hare)	192	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007264	small GTPase mediated signal transduction [GO:0007264]		blue	blue	NA	NA	NA	NA
TRINITY_DN13442_c0_g2_i3	P01122	RHO_APLCA	90.1	192	19	0	411	986	1	192	1.80E-97	357.5	RHO_APLCA	reviewed	Ras-like GTP-binding protein RHO	RHO	Aplysia californica (California sea hare)	192	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007264	small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN10580_c1_g1_i1	P48148	RHO1_DROME	71.8	71	20	0	3	215	103	173	5.00E-23	107.8	RHO1_DROME	reviewed	Ras-like GTP-binding protein Rho1	Rho1 CG8416	Drosophila melanogaster (Fruit fly)	192	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell projection [GO:0042995]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actomyosin structure organization [GO:0110020]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; small GTPase mediated signal transduction [GO:0007264]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cell-cell contact zone [GO:0044291]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]	GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007163; GO:0007264; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016324; GO:0016328; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030865; GO:0030866; GO:0030950; GO:0031410; GO:0031532; GO:0031982; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0042995; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:0110020; GO:1901739; GO:1903475; GO:1904059	"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellularization [GO:0007349]; cellular protein localization [GO:0034613]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actomyosin structure organization [GO:0110020]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; small GTPase mediated signal transduction [GO:0007264]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23468_c0_g1_i2	P41925	RYL2_YARLI	53.5	99	46	0	351	55	1	99	1.90E-24	113.2	RYL2_YARLI	reviewed	Ras-like GTP-binding protein RYL2	RYL2 YALI0A04367g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	209	endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0012505	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN11109_c2_g1_i1	B3M185	RAS1_DROAN	90.8	163	15	0	76	564	1	163	5.80E-79	295	RAS1_DROAN	reviewed	Ras-like protein 1 (EC 3.6.5.2)	Ras85D GF16057	Drosophila ananassae (Fruit fly)	189	"membrane [GO:0016020]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein serine/threonine kinase activator activity [GO:0043539]; activation of MAPKKK activity [GO:0000185]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; chorion-containing eggshell pattern formation [GO:0030381]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal closure, spreading of leading edge cells [GO:0007395]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte migration [GO:0035099]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; intestinal stem cell homeostasis [GO:0036335]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; Malpighian tubule development [GO:0072002]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; myoblast fate specification [GO:0048626]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell fate determination [GO:0043703]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; stem cell fate commitment [GO:0048865]; stem cell proliferation [GO:0072089]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; trachea development [GO:0060438]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	membrane [GO:0016020]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0000165; GO:0000185; GO:0001710; GO:0002168; GO:0003924; GO:0005525; GO:0005886; GO:0007173; GO:0007265; GO:0007298; GO:0007309; GO:0007362; GO:0007395; GO:0007422; GO:0007426; GO:0007427; GO:0007430; GO:0007455; GO:0007474; GO:0007479; GO:0008293; GO:0008340; GO:0008543; GO:0008586; GO:0008594; GO:0009267; GO:0010629; GO:0016020; GO:0016242; GO:0016318; GO:0030381; GO:0035088; GO:0035099; GO:0035169; GO:0035170; GO:0035208; GO:0036335; GO:0040014; GO:0043539; GO:0043703; GO:0045500; GO:0045793; GO:0046534; GO:0046673; GO:0048010; GO:0048626; GO:0048865; GO:0051607; GO:0060438; GO:0070374; GO:0072002; GO:0072089; GO:1904263; GO:2001234	"activation of MAPKKK activity [GO:0000185]; border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; chorion-containing eggshell pattern formation [GO:0030381]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal closure, spreading of leading edge cells [GO:0007395]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye-antennal disc morphogenesis [GO:0007455]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemocyte migration [GO:0035099]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; intestinal stem cell homeostasis [GO:0036335]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; Malpighian tubule development [GO:0072002]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; myoblast fate specification [GO:0048626]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell fate determination [GO:0043703]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; stem cell fate commitment [GO:0048865]; stem cell proliferation [GO:0072089]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; trachea development [GO:0060438]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1017_c0_g2_i1	P04388	RAS2_DROME	74.3	187	47	1	617	60	6	192	1.10E-74	281.2	RAS2_DROME	reviewed	Ras-like protein 2 (EC 3.6.5.2)	Ras64B ras2 CG1167	Drosophila melanogaster (Fruit fly)	192	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]	plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0019003	Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN1017_c0_g1_i1	P04388	RAS2_DROME	69.4	49	15	0	1844	1698	127	175	2.10E-11	72.4	RAS2_DROME	reviewed	Ras-like protein 2 (EC 3.6.5.2)	Ras64B ras2 CG1167	Drosophila melanogaster (Fruit fly)	192	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]	plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0019003	Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN25471_c0_g1_i1	Q6P0U3	RSLBB_DANRE	33.3	210	127	4	792	199	9	217	1.80E-23	111.3	RSLBB_DANRE	reviewed	Ras-like protein family member 11B (EC 3.6.5.2)	rasl11b	Danio rerio (Zebrafish) (Brachydanio rerio)	244	membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mesendoderm development [GO:0048382]; signal transduction [GO:0007165]	membrane [GO:0016020]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0007165; GO:0016020; GO:0048382	mesendoderm development [GO:0048382]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN17_c0_g4_i1	P62998	RAC1_BOVIN	100	192	0	0	628	53	1	192	2.00E-110	399.8	RAC1_BOVIN	reviewed	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1)	RAC1	Bos taurus (Bovine)	192	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]	GO:0001764; GO:0001934; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016020; GO:0016601; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030334; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042470; GO:0042995; GO:0043197; GO:0043231; GO:0043652; GO:0048870; GO:0051022; GO:0071526; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN17_c0_g4_i2	P62998	RAC1_BOVIN	100	192	0	0	628	53	1	192	2.00E-110	399.8	RAC1_BOVIN	reviewed	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1)	RAC1	Bos taurus (Bovine)	192	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]	GO:0001764; GO:0001934; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016020; GO:0016601; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030334; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042470; GO:0042995; GO:0043197; GO:0043231; GO:0043652; GO:0048870; GO:0051022; GO:0071526; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN29232_c0_g1_i1	P62998	RAC1_BOVIN	74	104	27	0	1	312	51	154	8.80E-45	180.6	RAC1_BOVIN	reviewed	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1)	RAC1	Bos taurus (Bovine)	192	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]	GO:0001764; GO:0001934; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016020; GO:0016601; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030334; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042470; GO:0042995; GO:0043197; GO:0043231; GO:0043652; GO:0048870; GO:0051022; GO:0071526; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN1543_c0_g1_i1	P62998	RAC1_BOVIN	72	189	53	0	133	699	4	192	1.00E-78	294.7	RAC1_BOVIN	reviewed	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1)	RAC1	Bos taurus (Bovine)	192	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]	GO:0001764; GO:0001934; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016020; GO:0016601; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030334; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042470; GO:0042995; GO:0043197; GO:0043231; GO:0043652; GO:0048870; GO:0051022; GO:0071526; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN1543_c0_g1_i2	P62998	RAC1_BOVIN	72	189	53	0	110	676	4	192	7.80E-79	295	RAC1_BOVIN	reviewed	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1)	RAC1	Bos taurus (Bovine)	192	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]	GO:0001764; GO:0001934; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016020; GO:0016601; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030334; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042470; GO:0042995; GO:0043197; GO:0043231; GO:0043652; GO:0048870; GO:0051022; GO:0071526; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; neuron migration [GO:0001764]; positive regulation of protein phosphorylation [GO:0001934]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN17_c0_g1_i1	P15153	RAC2_HUMAN	100	192	0	0	627	52	1	192	6.00E-110	398.3	RAC2_HUMAN	reviewed	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	Homo sapiens (Human)	192	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; cell redox homeostasis [GO:0045454]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0003924; GO:0005525; GO:0005635; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007015; GO:0007163; GO:0007165; GO:0007186; GO:0008045; GO:0008284; GO:0008360; GO:0010310; GO:0010592; GO:0010810; GO:0016601; GO:0019887; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030670; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042129; GO:0042995; GO:0043231; GO:0043304; GO:0043652; GO:0045453; GO:0045454; GO:0051056; GO:0051897; GO:0060263; GO:0060753; GO:0070062; GO:0071593; GO:0090023; GO:1902622; GO:1903955	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; cell redox homeostasis [GO:0045454]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN17_c1_g1_i1	Q9TU25	RAC2_BOVIN	98.8	82	1	0	248	3	13	94	1.10E-42	173.3	RAC2_BOVIN	reviewed	Ras-related C3 botulinum toxin substrate 2 (p21-Rac2)	RAC2	Bos taurus (Bovine)	192	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0003924; GO:0005525; GO:0005635; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007186; GO:0008045; GO:0008284; GO:0008360; GO:0010592; GO:0010810; GO:0016601; GO:0019887; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042129; GO:0042995; GO:0043231; GO:0043304; GO:0043652; GO:0060263; GO:0060753; GO:0071593; GO:0090023; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]		NA	NA	NA	NA	NA	NA
TRINITY_DN17_c0_g3_i1	Q05144	RAC2_MOUSE	100	83	0	0	290	42	110	192	9.40E-41	167.2	RAC2_MOUSE	reviewed	Ras-related C3 botulinum toxin substrate 2 (Protein EN-7) (p21-Rac2)	Rac2	Mus musculus (Mouse)	192	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0003924; GO:0005525; GO:0005635; GO:0005737; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005938; GO:0006935; GO:0007015; GO:0007163; GO:0007186; GO:0008045; GO:0008284; GO:0008360; GO:0010592; GO:0010810; GO:0016020; GO:0016601; GO:0019887; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042129; GO:0042995; GO:0043231; GO:0043304; GO:0043652; GO:0045453; GO:0060263; GO:0060753; GO:0071593; GO:0090023; GO:1902622	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]		NA	NA	NA	NA	NA	NA
TRINITY_DN39318_c0_g1_i1	Q9HB90	RRAGC_HUMAN	100	97	0	0	293	3	226	322	1.60E-48	193	RRAGC_HUMAN	reviewed	Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929)	RRAGC	Homo sapiens (Human)	399	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]	GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006351; GO:0006915; GO:0007050; GO:0007264; GO:0008380; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16910_c0_g2_i1	Q9HB90	RRAGC_HUMAN	56.5	62	27	0	4	189	58	119	2.60E-13	75.5	RRAGC_HUMAN	reviewed	Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929)	RRAGC	Homo sapiens (Human)	399	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]	GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006351; GO:0006915; GO:0007050; GO:0007264; GO:0008380; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16910_c0_g1_i1	Q9HB90	RRAGC_HUMAN	58.2	177	65	3	508	2	212	387	6.00E-49	195.3	RRAGC_HUMAN	reviewed	Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929)	RRAGC	Homo sapiens (Human)	399	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]	GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006351; GO:0006915; GO:0007050; GO:0007264; GO:0008380; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40569_c0_g1_i1	Q9HB90	RRAGC_HUMAN	99	104	1	0	314	3	144	247	2.30E-53	209.1	RRAGC_HUMAN	reviewed	Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929)	RRAGC	Homo sapiens (Human)	399	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]	GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006351; GO:0006915; GO:0007050; GO:0007264; GO:0008380; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131	"apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TORC1 signaling [GO:1903432]; regulation of TOR signaling [GO:0032006]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4447_c0_g1_i1	Q9NQL2	RRAGD_HUMAN	76	342	70	3	162	1151	30	371	2.20E-142	506.9	RRAGD_HUMAN	reviewed	Ras-related GTP-binding protein D (Rag D) (RagD) (EC 3.6.5.-)	RRAGD	Homo sapiens (Human)	400	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; protein heterodimerization activity [GO:0046982]	GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0005829; GO:0007050; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032008; GO:0034448; GO:0034613; GO:0046982; GO:0051020; GO:0071230; GO:0071233; GO:1904263; GO:1990131; GO:1990253	cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]		NA	NA	NA	NA	NA	NA
TRINITY_DN25641_c0_g1_i1	Q03206	RAC1_CAEEL	57.2	166	59	1	83	544	4	169	4.20E-50	199.1	RAC1_CAEEL	reviewed	Ras-related protein ced-10 (CErac1) (Cell death protein 10) (Cell-corpse engulfment protein ced-10) (Ras-related protein rac-1)	ced-10 rac-1 C09G12.8	Caenorhabditis elegans	191	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; chemorepulsion of axon [GO:0061643]; cortical cytoskeleton organization [GO:0030865]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; negative regulation of microtubule polymerization [GO:0031115]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dorsal/ventral axon guidance [GO:1905815]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; small GTPase mediated signal transduction [GO:0007264]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0000132; GO:0001764; GO:0002119; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006915; GO:0007015; GO:0007163; GO:0007264; GO:0007369; GO:0008045; GO:0008360; GO:0009898; GO:0010171; GO:0010172; GO:0016021; GO:0016477; GO:0019901; GO:0030036; GO:0030334; GO:0030865; GO:0030950; GO:0031103; GO:0031115; GO:0031410; GO:0031982; GO:0032228; GO:0032956; GO:0033563; GO:0038007; GO:0042995; GO:0043005; GO:0043025; GO:0043231; GO:0043652; GO:0045138; GO:0048598; GO:0048812; GO:0048846; GO:0050764; GO:0061643; GO:0070986; GO:0097628; GO:1901076; GO:1903356; GO:1905815	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; chemorepulsion of axon [GO:0061643]; cortical cytoskeleton organization [GO:0030865]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; negative regulation of microtubule polymerization [GO:0031115]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dorsal/ventral axon guidance [GO:1905815]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; small GTPase mediated signal transduction [GO:0007264]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3790_c0_g1_i1	O14807	RASM_HUMAN	75.3	166	41	0	54	551	4	169	3.30E-71	269.2	RASM_HUMAN	reviewed	Ras-related protein M-Ras (EC 3.6.5.2) (Ras-related protein R-Ras3)	MRAS RRAS3	Homo sapiens (Human)	208	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; Ras protein signal transduction [GO:0007265]	plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0007275; GO:0007517; GO:0019003; GO:0030036; GO:0030742; GO:1990830	actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c0_g1_i1	P22125	RAB1_DIPOM	80	170	34	0	511	2	1	170	1.70E-73	276.9	RAB1_DIPOM	reviewed	Ras-related protein ORAB-1		Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)	202	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c0_g1_i4	P22125	RAB1_DIPOM	78.8	170	36	0	511	2	1	170	1.40E-72	273.9	RAB1_DIPOM	reviewed	Ras-related protein ORAB-1		Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)	202	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c0_g1_i5	P22125	RAB1_DIPOM	80.6	170	33	0	511	2	1	170	6.80E-75	281.6	RAB1_DIPOM	reviewed	Ras-related protein ORAB-1		Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)	202	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4205_c0_g1_i1	Q4UB16	RAB1_THEAN	52.4	82	39	0	295	50	19	100	1.10E-17	90.5	RAB1_THEAN	reviewed	Ras-related protein Rab-1 (Small GTP-binding protein rab1)	rab1 TA18180	Theileria annulata	220	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN6849_c1_g1_i1	P61026	RAB10_HUMAN	100	157	0	0	472	2	1	157	1.10E-86	320.5	RAB10_HUMAN	reviewed	Ras-related protein Rab-10 (EC 3.6.5.2)	RAB10	Homo sapiens (Human)	200	adherens junction [GO:0005912]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cadherin binding involved in cell-cell adhesion [GO:0098641]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; establishment of protein localization to membrane [GO:0090150]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	adherens junction [GO:0005912]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]	cadherin binding involved in cell-cell adhesion [GO:0098641]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0005929; GO:0006893; GO:0006904; GO:0007409; GO:0008021; GO:0009306; GO:0016192; GO:0016197; GO:0017157; GO:0019003; GO:0019882; GO:0030659; GO:0030667; GO:0030670; GO:0030859; GO:0031489; GO:0032593; GO:0032869; GO:0043001; GO:0043312; GO:0045055; GO:0045200; GO:0048471; GO:0055037; GO:0055038; GO:0070062; GO:0070382; GO:0071782; GO:0071786; GO:0072659; GO:0090150; GO:0097051; GO:0098641; GO:1903361	antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; establishment of protein localization to membrane [GO:0090150]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN35444_c0_g1_i1	Q5ZIT5	RAB10_CHICK	87	185	23	1	554	3	1	185	7.00E-88	324.7	RAB10_CHICK	reviewed	Ras-related protein Rab-10 (EC 3.6.5.2)	RAB10 RCJMB04_23k10	Gallus gallus (Chicken)	200	cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005929; GO:0006893; GO:0006904; GO:0007409; GO:0008021; GO:0009306; GO:0016192; GO:0016197; GO:0017157; GO:0019003; GO:0030670; GO:0030859; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0048471; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:1903361	axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN28112_c0_g1_i1	Q94148	RAB10_CAEEL	58.1	74	31	0	229	8	17	90	4.20E-20	98.2	RAB10_CAEEL	reviewed	Ras-related protein Rab-10 (Rab-10) (EC 3.6.5.2)	rab-10 T23H2.5	Caenorhabditis elegans	201	"axon [GO:0030424]; dense core granule [GO:0031045]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; ankyrin repeat binding [GO:0071532]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; cellular response to insulin stimulus [GO:0032869]; endocytic recycling [GO:0032456]; negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902647]; positive regulation of establishment of protein localization [GO:1904951]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; receptor recycling [GO:0001881]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]"	axon [GO:0030424]; dense core granule [GO:0031045]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]	ankyrin repeat binding [GO:0071532]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0001881; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005794; GO:0005797; GO:0005886; GO:0006904; GO:0008021; GO:0009306; GO:0017157; GO:0030424; GO:0031045; GO:0031901; GO:0031902; GO:0032456; GO:0032593; GO:0032794; GO:0032869; GO:0043025; GO:0055037; GO:0055038; GO:0071532; GO:0072659; GO:1902647; GO:1904951	"cellular response to insulin stimulus [GO:0032869]; endocytic recycling [GO:0032456]; negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902647]; positive regulation of establishment of protein localization [GO:1904951]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; receptor recycling [GO:0001881]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]"		NA	NA	NA	NA	NA	NA
TRINITY_DN90_c0_g3_i2	Q5ZJN2	RB11A_CHICK	84.4	205	29	1	95	700	1	205	2.50E-91	336.7	RB11A_CHICK	reviewed	Ras-related protein Rab-11A	RAB11A RCJMB04_16p4	Gallus gallus (Chicken)	216	"axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"	axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]	GO:0000922; GO:0003924; GO:0005525; GO:0005768; GO:0005771; GO:0005802; GO:0005828; GO:0006887; GO:0007080; GO:0008017; GO:0010634; GO:0010796; GO:0010971; GO:0030133; GO:0030424; GO:0030659; GO:0030953; GO:0031175; GO:0031489; GO:0032154; GO:0032402; GO:0032465; GO:0032991; GO:0034451; GO:0036258; GO:0045335; GO:0045773; GO:0048471; GO:0055037; GO:0055038; GO:0060627; GO:0070062; GO:0072594; GO:0090307; GO:0098837; GO:0098887; GO:0098978; GO:0150093; GO:1990182	"amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"		blue	blue	NA	NA	NA	NA
TRINITY_DN90_c0_g3_i3	Q5ZJN2	RB11A_CHICK	85.1	215	31	1	95	739	1	214	5.80E-98	359	RB11A_CHICK	reviewed	Ras-related protein Rab-11A	RAB11A RCJMB04_16p4	Gallus gallus (Chicken)	216	"axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"	axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]	GO:0000922; GO:0003924; GO:0005525; GO:0005768; GO:0005771; GO:0005802; GO:0005828; GO:0006887; GO:0007080; GO:0008017; GO:0010634; GO:0010796; GO:0010971; GO:0030133; GO:0030424; GO:0030659; GO:0030953; GO:0031175; GO:0031489; GO:0032154; GO:0032402; GO:0032465; GO:0032991; GO:0034451; GO:0036258; GO:0045335; GO:0045773; GO:0048471; GO:0055037; GO:0055038; GO:0060627; GO:0070062; GO:0072594; GO:0090307; GO:0098837; GO:0098887; GO:0098978; GO:0150093; GO:1990182	"amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13583_c0_g1_i1	P62490	RB11A_CANLF	100	196	0	0	53	640	1	196	6.30E-106	384.8	RB11A_CANLF	reviewed	Ras-related protein Rab-11A (Rab-11)	RAB11A RAB11	Canis lupus familiaris (Dog) (Canis familiaris)	216	"axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein localization to plasma membrane [GO:0072659]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"	axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]	GO:0000922; GO:0003924; GO:0005525; GO:0005768; GO:0005771; GO:0005802; GO:0005828; GO:0006887; GO:0007080; GO:0008017; GO:0010634; GO:0010796; GO:0010971; GO:0019904; GO:0030133; GO:0030424; GO:0030659; GO:0030953; GO:0031175; GO:0031489; GO:0032154; GO:0032402; GO:0032465; GO:0032991; GO:0034451; GO:0036258; GO:0045335; GO:0045773; GO:0048471; GO:0055037; GO:0055038; GO:0060627; GO:0070062; GO:0070382; GO:0072594; GO:0072659; GO:0090307; GO:0098837; GO:0098887; GO:0098978; GO:0150093; GO:1990182	"amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein localization to plasma membrane [GO:0072659]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13583_c0_g1_i2	P62490	RB11A_CANLF	100	175	0	0	53	577	1	175	5.00E-94	345.1	RB11A_CANLF	reviewed	Ras-related protein Rab-11A (Rab-11)	RAB11A RAB11	Canis lupus familiaris (Dog) (Canis familiaris)	216	"axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein localization to plasma membrane [GO:0072659]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"	axon [GO:0030424]; centriolar satellite [GO:0034451]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]	GO:0000922; GO:0003924; GO:0005525; GO:0005768; GO:0005771; GO:0005802; GO:0005828; GO:0006887; GO:0007080; GO:0008017; GO:0010634; GO:0010796; GO:0010971; GO:0019904; GO:0030133; GO:0030424; GO:0030659; GO:0030953; GO:0031175; GO:0031489; GO:0032154; GO:0032402; GO:0032465; GO:0032991; GO:0034451; GO:0036258; GO:0045335; GO:0045773; GO:0048471; GO:0055037; GO:0055038; GO:0060627; GO:0070062; GO:0070382; GO:0072594; GO:0072659; GO:0090307; GO:0098837; GO:0098887; GO:0098978; GO:0150093; GO:1990182	"amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein localization to plasma membrane [GO:0072659]; regulation of cytokinesis [GO:0032465]; regulation of multivesicular body size [GO:0010796]; regulation of vesicle-mediated transport [GO:0060627]"		NA	NA	NA	NA	NA	NA
TRINITY_DN282_c0_g1_i1	Q3MHP2	RB11B_BOVIN	100	179	0	0	2	538	23	201	1.10E-95	350.5	RB11B_BOVIN	reviewed	Ras-related protein Rab-11B	RAB11B	Bos taurus (Bovine)	218	"endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"	endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001881; GO:0003924; GO:0005525; GO:0005768; GO:0006887; GO:0008021; GO:0019003; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135	"cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"		NA	NA	NA	NA	NA	NA
TRINITY_DN282_c0_g1_i2	Q3MHP2	RB11B_BOVIN	100	201	0	0	6	608	1	201	2.00E-109	396.4	RB11B_BOVIN	reviewed	Ras-related protein Rab-11B	RAB11B	Bos taurus (Bovine)	218	"endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"	endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001881; GO:0003924; GO:0005525; GO:0005768; GO:0006887; GO:0008021; GO:0019003; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135	"cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32934_c0_g1_i1	Q3MHP2	RB11B_BOVIN	77.2	180	41	0	39	578	3	182	3.10E-75	282.7	RB11B_BOVIN	reviewed	Ras-related protein Rab-11B	RAB11B	Bos taurus (Bovine)	218	"endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"	endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001881; GO:0003924; GO:0005525; GO:0005768; GO:0006887; GO:0008021; GO:0019003; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135	"cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1089_c0_g2_i1	Q3MHP2	RB11B_BOVIN	67.3	162	52	1	487	2	3	163	8.80E-58	224.6	RB11B_BOVIN	reviewed	Ras-related protein Rab-11B	RAB11B	Bos taurus (Bovine)	218	"endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"	endosome [GO:0005768]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001881; GO:0003924; GO:0005525; GO:0005768; GO:0006887; GO:0008021; GO:0019003; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135	"cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22116_c0_g1_i1	F1PTE3	RAB13_CANLF	55.8	154	68	0	3	464	13	166	2.80E-47	189.5	RAB13_CANLF	reviewed	Ras-related protein Rab-13	RAB13	Canis lupus familiaris (Dog) (Canis familiaris)	203	bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; Golgi vesicle fusion to target membrane [GO:0048210]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; trans-Golgi network to recycling endosome transport [GO:0044795]; vesicle docking involved in exocytosis [GO:0006904]	bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005802; GO:0005886; GO:0005923; GO:0006904; GO:0008021; GO:0009306; GO:0010737; GO:0016328; GO:0017157; GO:0030027; GO:0030139; GO:0030140; GO:0030659; GO:0030866; GO:0031175; GO:0031410; GO:0032456; GO:0032593; GO:0032869; GO:0035767; GO:0043005; GO:0044795; GO:0048210; GO:0055037; GO:0055038; GO:0070830; GO:0072659; GO:0097368; GO:1902463	bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; Golgi vesicle fusion to target membrane [GO:0048210]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; trans-Golgi network to recycling endosome transport [GO:0044795]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN12075_c0_g1_i1	Q5ZKU5	RAB14_CHICK	100	189	0	0	1	567	11	199	1.30E-91	337	RAB14_CHICK	reviewed	Ras-related protein Rab-14	RAB14 RCJMB04_9b24	Gallus gallus (Chicken)	215	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006895; GO:0008543; GO:0012505; GO:0019003; GO:0031489; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090387	defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN12075_c0_g1_i2	Q5ZKU5	RAB14_CHICK	100	189	0	0	1	567	11	199	1.30E-91	337	RAB14_CHICK	reviewed	Ras-related protein Rab-14	RAB14 RCJMB04_9b24	Gallus gallus (Chicken)	215	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006895; GO:0008543; GO:0012505; GO:0019003; GO:0031489; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090387	defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN294_c0_g1_i1	Q5ZKU5	RAB14_CHICK	82.1	207	37	0	627	7	1	207	8.60E-93	341.3	RAB14_CHICK	reviewed	Ras-related protein Rab-14	RAB14 RCJMB04_9b24	Gallus gallus (Chicken)	215	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006895; GO:0008543; GO:0012505; GO:0019003; GO:0031489; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090387	defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]		blue	blue	NA	NA	NA	NA
TRINITY_DN13481_c0_g1_i1	P35293	RAB18_MOUSE	99.5	206	1	0	621	4	1	206	6.50E-116	417.9	RAB18_MOUSE	reviewed	Ras-related protein Rab-18	Rab18	Mus musculus (Mouse)	206	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001654; GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0034389; GO:0045202; GO:0051170; GO:0071782; GO:0071786	brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]		NA	NA	NA	NA	NA	NA
TRINITY_DN13481_c0_g1_i2	P35293	RAB18_MOUSE	99.5	206	1	0	621	4	1	206	6.50E-116	417.9	RAB18_MOUSE	reviewed	Ras-related protein Rab-18	Rab18	Mus musculus (Mouse)	206	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001654; GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0034389; GO:0045202; GO:0051170; GO:0071782; GO:0071786	brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]		NA	NA	NA	NA	NA	NA
TRINITY_DN35340_c0_g1_i1	Q5EB77	RAB18_RAT	75.1	205	49	2	88	696	2	206	2.40E-83	310.1	RAB18_RAT	reviewed	Ras-related protein Rab-18	Rab18	Rattus norvegicus (Rat)	206	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001654; GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0034389; GO:0045202; GO:0051170; GO:0071782; GO:0071786	brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]		blue	blue	NA	NA	NA	NA
TRINITY_DN13431_c0_g1_i1	P34139	RAB1A_DICDI	55.9	59	23	1	3	179	65	120	4.50E-09	62	RAB1A_DICDI	reviewed	Ras-related protein Rab-1A	rab1A rabA DDB_G0283757	Dictyostelium discoideum (Slime mold)	202	endomembrane system [GO:0012505]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; extracellular matrix [GO:0031012]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0012505; GO:0031012; GO:0140220	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN6849_c0_g1_i1	P62822	RAB1A_CANLF	100	138	0	0	415	2	1	138	2.90E-75	282.3	RAB1A_CANLF	reviewed	Ras-related protein Rab-1A	RAB1A RAB1	Canis lupus familiaris (Dog) (Canis familiaris)	205	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005783; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0019068; GO:0030252; GO:0032402; GO:0032637; GO:0034446; GO:0042470; GO:0042742; GO:0047496; GO:0070382; GO:0090110; GO:1903020	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN6849_c0_g1_i2	P62822	RAB1A_CANLF	100	138	0	0	415	2	1	138	2.90E-75	282.3	RAB1A_CANLF	reviewed	Ras-related protein Rab-1A	RAB1A RAB1	Canis lupus familiaris (Dog) (Canis familiaris)	205	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005783; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0019068; GO:0030252; GO:0032402; GO:0032637; GO:0034446; GO:0042470; GO:0042742; GO:0047496; GO:0070382; GO:0090110; GO:1903020	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN36611_c0_g1_i1	P62822	RAB1A_CANLF	96	174	7	0	56	577	1	174	4.60E-92	338.6	RAB1A_CANLF	reviewed	Ras-related protein Rab-1A	RAB1A RAB1	Canis lupus familiaris (Dog) (Canis familiaris)	205	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005783; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0019068; GO:0030252; GO:0032402; GO:0032637; GO:0034446; GO:0042470; GO:0042742; GO:0047496; GO:0070382; GO:0090110; GO:1903020	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]		blue	blue	NA	NA	NA	NA
TRINITY_DN31324_c0_g1_i1	P62822	RAB1A_CANLF	97.5	81	2	0	245	3	2	82	2.30E-40	165.6	RAB1A_CANLF	reviewed	Ras-related protein Rab-1A	RAB1A RAB1	Canis lupus familiaris (Dog) (Canis familiaris)	205	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; exocytic vesicle [GO:0070382]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005783; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0019068; GO:0030252; GO:0032402; GO:0032637; GO:0034446; GO:0042470; GO:0042742; GO:0047496; GO:0070382; GO:0090110; GO:1903020	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; interleukin-8 production [GO:0032637]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]		NA	NA	NA	NA	NA	NA
TRINITY_DN29855_c0_g1_i1	Q54NU2	RAB1D_DICDI	55.2	96	43	0	30	317	6	101	2.20E-27	122.9	RAB1D_DICDI	reviewed	Ras-related protein Rab-1D	rab1D DDB_G0284985	Dictyostelium discoideum (Slime mold)	204	endomembrane system [GO:0012505]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0012505; GO:0045335	intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN31169_c0_g1_i1	P55745	RAB21_CANLF	100	129	0	0	434	48	19	147	2.60E-71	269.2	RAB21_CANLF	reviewed	Ras-related protein Rab-21	RAB21	Canis lupus familiaris (Dog) (Canis familiaris)	223	cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; Ras protein signal transduction [GO:0007265]	cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005886; GO:0007265; GO:0015031; GO:0019003; GO:0030659; GO:0031901; GO:0032154; GO:0032482; GO:0043005; GO:0050821	protein stabilization [GO:0050821]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN32661_c0_g1_i1	Q6AXT5	RAB21_RAT	68.1	210	66	1	112	741	14	222	9.10E-81	301.6	RAB21_RAT	reviewed	Ras-related protein Rab-21	Rab21	Rattus norvegicus (Rat)	223	axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157]	axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005769; GO:0005789; GO:0005802; GO:0006886; GO:0008089; GO:0009898; GO:0012505; GO:0012506; GO:0017157; GO:0019003; GO:0030516; GO:0030659; GO:0032154; GO:0032482; GO:0032580; GO:0043005; GO:0045202; GO:0048260; GO:0050775; GO:0050821; GO:0098559; GO:1904115; GO:2000643	anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157]		blue	blue	NA	NA	NA	NA
TRINITY_DN26948_c0_g1_i1	Q9UL26	RB22A_HUMAN	100	112	0	0	25	360	1	112	2.00E-61	236.1	RB22A_HUMAN	reviewed	Ras-related protein Rab-22A (Rab-22)	RAB22A RAB22	Homo sapiens (Human)	194	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0012505; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0070062; GO:0097494	endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494]		NA	NA	NA	NA	NA	NA
TRINITY_DN38601_c0_g1_i1	Q9ULC3	RAB23_HUMAN	58.6	70	25	2	4	210	44	110	5.80E-16	84.3	RAB23_HUMAN	reviewed	Ras-related protein Rab-23	RAB23 HSPC137	Homo sapiens (Human)	237	autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; signal transduction [GO:0007165]	autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0007165; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094	autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN6810_c0_g1_i1	Q969Q5	RAB24_HUMAN	56.9	144	61	1	461	33	4	147	2.90E-43	176.4	RAB24_HUMAN	reviewed	Ras-related protein Rab-24	RAB24	Homo sapiens (Human)	203	autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005776; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0012505; GO:0030139; GO:0030667; GO:0043312	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN6810_c0_g1_i2	Q969Q5	RAB24_HUMAN	54.7	181	81	1	680	141	4	184	7.40E-53	208.8	RAB24_HUMAN	reviewed	Ras-related protein Rab-24	RAB24	Homo sapiens (Human)	203	autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005776; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0012505; GO:0030139; GO:0030667; GO:0043312	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]		blue	blue	NA	NA	NA	NA
TRINITY_DN28380_c0_g1_i1	P35290	RAB24_MOUSE	100	66	0	0	3	200	24	89	3.80E-33	141.4	RAB24_MOUSE	reviewed	Ras-related protein Rab-24 (Rab-16)	Rab24	Mus musculus (Mouse)	203	autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; membrane [GO:0016020]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; membrane [GO:0016020]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0012505; GO:0016020; GO:0030139	autophagy [GO:0006914]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN3633_c0_g1_i1	Q9ULW5	RAB26_HUMAN	70	207	59	1	669	49	50	253	6.80E-78	292	RAB26_HUMAN	reviewed	Ras-related protein Rab-26	RAB26	Homo sapiens (Human)	256	anchored component of synaptic vesicle membrane [GO:0098993]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intrinsic component of plasma membrane [GO:0031226]; secretory granule membrane [GO:0030667]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; exocrine system development [GO:0035272]; Golgi to plasma membrane protein transport [GO:0043001]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]	anchored component of synaptic vesicle membrane [GO:0098993]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intrinsic component of plasma membrane [GO:0031226]; secretory granule membrane [GO:0030667]	GMP binding [GO:0019002]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0017157; GO:0019002; GO:0030667; GO:0031226; GO:0035272; GO:0043001; GO:0045055; GO:0098993	exocrine system development [GO:0035272]; Golgi to plasma membrane protein transport [GO:0043001]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]		NA	NA	NA	NA	NA	NA
TRINITY_DN3633_c0_g1_i7	Q9VP48	RAB26_DROME	73.8	187	48	1	618	61	191	377	3.60E-74	279.3	RAB26_DROME	reviewed	Ras-related protein Rab-26	Rab26 CG34410	Drosophila melanogaster (Fruit fly)	388	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intrinsic component of plasma membrane [GO:0031226]; recycling endosome [GO:0055037]; synapse [GO:0045202]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intrinsic component of plasma membrane [GO:0031226]; recycling endosome [GO:0055037]; synapse [GO:0045202]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0015031; GO:0016192; GO:0017157; GO:0031226; GO:0031982; GO:0032482; GO:0045202; GO:0055037	protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3440_c0_g1_i1	Q4LE85	RB27A_PIG	55.2	105	47	0	63	377	117	221	5.00E-25	115.5	RB27A_PIG	reviewed	Ras-related protein Rab-27A (EC 3.6.5.2)	RAB27A	Sus scrofa (Pig)	221	dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]	dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0001750; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0006605; GO:0007596; GO:0010628; GO:0019003; GO:0019882; GO:0030141; GO:0030318; GO:0030425; GO:0031489; GO:0032402; GO:0032585; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0045921; GO:0050766; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182	antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]		NA	NA	NA	NA	NA	NA
TRINITY_DN3440_c0_g1_i2	Q4LE85	RB27A_PIG	65.4	217	71	1	112	750	5	221	1.00E-76	288.1	RB27A_PIG	reviewed	Ras-related protein Rab-27A (EC 3.6.5.2)	RAB27A	Sus scrofa (Pig)	221	dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]	dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0001750; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0006605; GO:0007596; GO:0010628; GO:0019003; GO:0019882; GO:0030141; GO:0030318; GO:0030425; GO:0031489; GO:0032402; GO:0032585; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0045921; GO:0050766; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182	antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]		NA	NA	NA	NA	NA	NA
TRINITY_DN34285_c0_g1_i1	P51159	RB27A_HUMAN	100	190	0	0	41	610	1	190	9.20E-107	387.5	RB27A_HUMAN	reviewed	Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram)	RAB27A RAB27	Homo sapiens (Human)	221	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; specific granule lumen [GO:0035580]; Weibel-Palade body [GO:0033093]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]; synaptic vesicle transport [GO:0048489]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; specific granule lumen [GO:0035580]; Weibel-Palade body [GO:0033093]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]	GO:0001750; GO:0003924; GO:0005525; GO:0005576; GO:0005764; GO:0005770; GO:0005794; GO:0005829; GO:0006605; GO:0006887; GO:0007596; GO:0010628; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0030667; GO:0031489; GO:0032400; GO:0032402; GO:0032585; GO:0033093; GO:0033162; GO:0035580; GO:0036257; GO:0042470; GO:0043312; GO:0043316; GO:0043320; GO:0045921; GO:0048489; GO:0050766; GO:0070062; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182	antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN34130_c0_g1_i1	Q3SWY9	RAB28_BOVIN	45.3	75	41	0	227	3	39	113	2.40E-15	82.4	RAB28_BOVIN	reviewed	Ras-related protein Rab-28	RAB28	Bos taurus (Bovine)	221	ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; toxin transport [GO:1901998]	ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0019003; GO:0035253; GO:0036064; GO:1901998	toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN12699_c0_g1_i1	P61105	RAB2A_CANLF	79.8	188	37	1	575	15	1	188	6.30E-82	305.1	RAB2A_CANLF	reviewed	Ras-related protein Rab-2A	RAB2A RAB2	Canis lupus familiaris (Dog) (Canis familiaris)	212	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0015031; GO:0016192; GO:0019003; GO:0033116; GO:0042470	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11556_c0_g1_i1	P61105	RAB2A_CANLF	100	169	0	0	508	2	30	198	3.10E-92	339	RAB2A_CANLF	reviewed	Ras-related protein Rab-2A	RAB2A RAB2	Canis lupus familiaris (Dog) (Canis familiaris)	212	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0015031; GO:0016192; GO:0019003; GO:0033116; GO:0042470	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11556_c0_g1_i2	P61105	RAB2A_CANLF	100	198	0	0	595	2	1	198	5.70E-110	398.3	RAB2A_CANLF	reviewed	Ras-related protein Rab-2A	RAB2A RAB2	Canis lupus familiaris (Dog) (Canis familiaris)	212	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0015031; GO:0016192; GO:0019003; GO:0033116; GO:0042470	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11556_c0_g1_i3	P53994	RAB2A_MOUSE	100	119	0	0	398	42	94	212	7.70E-62	237.7	RAB2A_MOUSE	reviewed	Ras-related protein Rab-2A	Rab2a Rab2	Mus musculus (Mouse)	212	anchored component of synaptic vesicle membrane [GO:0098993]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	anchored component of synaptic vesicle membrane [GO:0098993]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006886; GO:0007030; GO:0016020; GO:0016192; GO:0019003; GO:0033116; GO:0042470; GO:0043025; GO:0048471; GO:0098993	Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11556_c0_g2_i1	P61105	RAB2A_CANLF	94	50	3	0	152	3	1	50	8.40E-21	100.5	RAB2A_CANLF	reviewed	Ras-related protein Rab-2A	RAB2A RAB2	Canis lupus familiaris (Dog) (Canis familiaris)	212	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0015031; GO:0016192; GO:0019003; GO:0033116; GO:0042470	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN11556_c1_g1_i1	Q90965	RAB2A_CHICK	89.2	213	22	1	729	91	1	212	6.60E-105	381.7	RAB2A_CHICK	reviewed	Ras-related protein Rab-2A	RAB2A RAB2	Gallus gallus (Chicken)	212	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0007030; GO:0015031; GO:0016192; GO:0019003; GO:0033116	Golgi organization [GO:0007030]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN27281_c0_g1_i1	P36409	RAB2A_DICDI	61	118	46	0	55	408	2	119	2.20E-40	166.4	RAB2A_DICDI	reviewed	Ras-related protein Rab-2A	rab2A rab2 DDB_G0292268	Dictyostelium discoideum (Slime mold)	207	contractile vacuolar membrane [GO:0031164]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell death [GO:0008219]; phagocytosis [GO:0006909]; response to osmotic stress [GO:0006970]; sorocarp development [GO:0030587]	contractile vacuolar membrane [GO:0031164]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0005886; GO:0006909; GO:0006970; GO:0008219; GO:0030587; GO:0031164; GO:0140220	cell death [GO:0008219]; phagocytosis [GO:0006909]; response to osmotic stress [GO:0006970]; sorocarp development [GO:0030587]		NA	NA	NA	NA	NA	NA
TRINITY_DN32156_c0_g1_i1	P59279	RAB2B_MOUSE	98.6	72	1	0	1	216	139	210	9.70E-35	146.7	RAB2B_MOUSE	reviewed	Ras-related protein Rab-2B	Rab2b	Mus musculus (Mouse)	216	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0005886; GO:0015031; GO:0016192; GO:0045921; GO:0098793	positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN35435_c0_g1_i1	P25228	RAB3_DROME	86.9	213	26	2	16	648	8	220	1.40E-103	377.1	RAB3_DROME	reviewed	Ras-related protein Rab-3	Rab3 CG7576	Drosophila melanogaster (Fruit fly)	220	cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006904; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0017157; GO:0031410; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0048172; GO:0048786; GO:0048789; GO:0048790; GO:0072659	cytoskeletal matrix organization at active zone [GO:0048789]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN15985_c0_g1_i1	Q17QB7	RAB30_BOVIN	67.6	204	59	3	73	675	2	201	7.40E-72	271.9	RAB30_BOVIN	reviewed	Ras-related protein Rab-30	RAB30	Bos taurus (Bovine)	203	cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]	cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0031985; GO:0032482	Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]		NA	NA	NA	NA	NA	NA
TRINITY_DN19121_c0_g2_i1	Q921E2	RAB31_MOUSE	100	95	0	0	1	285	26	120	4.70E-53	208	RAB31_MOUSE	reviewed	Ras-related protein Rab-31	Rab31	Mus musculus (Mouse)	194	"cytoplasm [GO:0005737]; early endosome [GO:0005769]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]"	cytoplasm [GO:0005737]; early endosome [GO:0005769]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001891; GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0006886; GO:0012505; GO:0019003; GO:0031623; GO:0032588; GO:0032869; GO:0036186; GO:0043001; GO:0045055; GO:0045335; GO:0048193; GO:0060100; GO:0090382	"cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19121_c0_g1_i1	Q13636	RAB31_HUMAN	100	115	0	0	1	345	26	140	3.20E-64	245.4	RAB31_HUMAN	reviewed	Ras-related protein Rab-31 (Ras-related protein Rab-22B)	RAB31 RAB22B	Homo sapiens (Human)	194	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]"	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001891; GO:0003924; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0012505; GO:0019003; GO:0030667; GO:0031623; GO:0031901; GO:0032588; GO:0032869; GO:0036186; GO:0043001; GO:0043312; GO:0045055; GO:0045335; GO:0060100; GO:0090382	"cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3091_c0_g1_i2	Q13637	RAB32_HUMAN	67.5	209	65	2	696	70	20	225	8.60E-78	292.4	RAB32_HUMAN	reviewed	Ras-related protein Rab-32	RAB32	Homo sapiens (Human)	225	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]	AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232	antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3091_c0_g1_i4	Q13637	RAB32_HUMAN	67.5	209	65	2	604	1230	20	225	8.70E-78	292.4	RAB32_HUMAN	reviewed	Ras-related protein Rab-32	RAB32	Homo sapiens (Human)	225	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]	AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232	antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN19487_c0_g1_i1	Q13637	RAB32_HUMAN	69.2	107	33	0	325	5	22	128	1.20E-36	153.7	RAB32_HUMAN	reviewed	Ras-related protein Rab-32	RAB32	Homo sapiens (Human)	225	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]	AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232	antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN19487_c0_g1_i2	Q13637	RAB32_HUMAN	69.2	78	24	0	347	114	22	99	1.70E-25	116.7	RAB32_HUMAN	reviewed	Ras-related protein Rab-32	RAB32	Homo sapiens (Human)	225	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]	AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232	antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN25434_c0_g1_i1	Q14088	RB33A_HUMAN	100	146	0	0	438	1	51	196	9.60E-82	303.9	RB33A_HUMAN	reviewed	Ras-related protein Rab-33A (Small GTP-binding protein S10)	RAB33A RABS10	Homo sapiens (Human)	237	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005886; GO:0019882; GO:0032482	antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482]		NA	NA	NA	NA	NA	NA
TRINITY_DN38123_c0_g1_i1	Q9H082	RB33B_HUMAN	100	102	0	0	2	307	117	218	3.20E-55	215.3	RB33B_HUMAN	reviewed	Ras-related protein Rab-33B	RAB33B	Homo sapiens (Human)	229	"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]"	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005796; GO:0006891; GO:0015031; GO:0032482; GO:0034067; GO:0048705; GO:1903358; GO:1903434; GO:2000156	"autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29679_c0_g1_i1	Q9H082	RB33B_HUMAN	70.1	197	59	0	92	682	14	210	1.40E-76	287.7	RB33B_HUMAN	reviewed	Ras-related protein Rab-33B	RAB33B	Homo sapiens (Human)	229	"endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]"	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005796; GO:0006891; GO:0015031; GO:0032482; GO:0034067; GO:0048705; GO:1903358; GO:1903434; GO:2000156	"autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34072_c0_g1_i1	Q64008	RAB34_MOUSE	100	78	0	0	2	235	64	141	2.20E-40	165.6	RAB34_MOUSE	reviewed	Ras-related protein Rab-34 (Ras-related homolog) (Ras-related protein Rab-39) (Ras-related protein Rah)	Rab34 Rab39 Rah Rah1	Mus musculus (Mouse)	259	cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; guanyl nucleotide binding [GO:0019001]; Ral GTPase binding [GO:0017160]; antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; cellular response to glucose stimulus [GO:0071333]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein secretion [GO:0050714]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]	cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; ruffle [GO:0001726]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; guanyl nucleotide binding [GO:0019001]; Ral GTPase binding [GO:0017160]	GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005795; GO:0005929; GO:0006897; GO:0007041; GO:0017160; GO:0019001; GO:0019882; GO:0030030; GO:0030670; GO:0030742; GO:0031410; GO:0031982; GO:0031985; GO:0032418; GO:0043001; GO:0045335; GO:0045880; GO:0048471; GO:0050714; GO:0071333; GO:0072659; GO:0090382; GO:0090385; GO:1900426; GO:1905171	antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; cellular response to glucose stimulus [GO:0071333]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein secretion [GO:0050714]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN27186_c0_g1_i1	Q9BZG1	RAB34_HUMAN	69.7	99	30	0	299	3	49	147	7.20E-39	161	RAB34_HUMAN	reviewed	Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah)	RAB34 RAB39 RAH	Homo sapiens (Human)	259	cilium [GO:0005929]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; Ral GTPase binding [GO:0017160]; antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosome localization [GO:0032418]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]	cilium [GO:0005929]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; Ral GTPase binding [GO:0017160]	GO:0003924; GO:0005525; GO:0005794; GO:0005795; GO:0005929; GO:0006897; GO:0017160; GO:0019882; GO:0030030; GO:0030670; GO:0030742; GO:0031982; GO:0031985; GO:0032418; GO:0043001; GO:0045335; GO:0045880; GO:0048471; GO:0070062; GO:0072659; GO:0090382; GO:0090385	antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosome localization [GO:0032418]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN3775_c0_g1_i1	Q15286	RAB35_HUMAN	73.1	201	54	0	94	696	1	201	3.60E-79	296.2	RAB35_HUMAN	reviewed	Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C)	RAB35 RAB1C RAY	Homo sapiens (Human)	201	"anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]"	anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000281; GO:0003924; GO:0005525; GO:0005546; GO:0005829; GO:0005886; GO:0005905; GO:0008104; GO:0010008; GO:0015031; GO:0016197; GO:0019003; GO:0019882; GO:0030665; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0048227; GO:0055038; GO:0070062; GO:0098993; GO:1990090	antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]		blue	blue	NA	NA	NA	NA
TRINITY_DN36151_c0_g1_i1	Q15286	RAB35_HUMAN	100	72	0	0	219	4	22	93	2.20E-34	145.6	RAB35_HUMAN	reviewed	Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C)	RAB35 RAB1C RAY	Homo sapiens (Human)	201	"anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]"	anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	"GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000281; GO:0003924; GO:0005525; GO:0005546; GO:0005829; GO:0005886; GO:0005905; GO:0008104; GO:0010008; GO:0015031; GO:0016197; GO:0019003; GO:0019882; GO:0030665; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0048227; GO:0055038; GO:0070062; GO:0098993; GO:1990090	antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]		NA	NA	NA	NA	NA	NA
TRINITY_DN3633_c0_g1_i3	Q9JKM7	RAB37_MOUSE	69.5	151	46	0	501	49	69	219	5.80E-58	225.3	RAB37_MOUSE	reviewed	Ras-related protein Rab-37	Rab37	Mus musculus (Mouse)	223	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0015031; GO:0030141	protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN36792_c0_g1_i1	Q96AX2	RAB37_HUMAN	97.5	80	2	0	3	242	35	114	4.30E-39	161.4	RAB37_HUMAN	reviewed	Ras-related protein Rab-37	RAB37	Homo sapiens (Human)	223	azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]	azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0005886; GO:0015031; GO:0035577; GO:0035579; GO:0043312	neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN16325_c2_g1_i1	Q96DA2	RB39B_HUMAN	56	193	85	0	604	26	1	193	1.30E-64	247.7	RB39B_HUMAN	reviewed	Ras-related protein Rab-39B	RAB39B	Homo sapiens (Human)	213	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0031982; GO:0032482; GO:0043005; GO:0050808	autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN32949_c0_g1_i1	Q17QU4	RB39B_BOVIN	100	74	0	0	3	224	22	95	2.80E-37	155.2	RB39B_BOVIN	reviewed	Ras-related protein Rab-39B	RAB39B	Bos taurus (Bovine)	213	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0032482; GO:0043005; GO:0050808	autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN24101_c0_g1_i1	Q96S21	RB40C_HUMAN	74.2	151	39	0	601	149	79	229	6.80E-62	238.4	RB40C_HUMAN	reviewed	Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3)	RAB40C RARL RASL8C	Homo sapiens (Human)	281	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0019003; GO:0035556; GO:0048471; GO:0072659	intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN24101_c0_g1_i2	Q96S21	RB40C_HUMAN	70.6	221	63	1	805	149	9	229	5.10E-91	335.9	RB40C_HUMAN	reviewed	Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3)	RAB40C RARL RASL8C	Homo sapiens (Human)	281	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0019003; GO:0035556; GO:0048471; GO:0072659	intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN24101_c0_g1_i4	Q96S21	RB40C_HUMAN	71.5	179	51	0	685	149	51	229	4.00E-75	282.7	RB40C_HUMAN	reviewed	Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3)	RAB40C RARL RASL8C	Homo sapiens (Human)	281	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0019003; GO:0035556; GO:0048471; GO:0072659	intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN699_c0_g1_i1	Q86YS6	RAB43_HUMAN	66.9	118	39	0	117	470	12	129	1.70E-43	177.9	RAB43_HUMAN	reviewed	Ras-related protein Rab-43 (Ras-related protein Rab-41)	RAB43 RAB41	Homo sapiens (Human)	212	"endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"	endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007030; GO:0012505; GO:0019068; GO:0030670; GO:0032588; GO:0035526; GO:0045335; GO:0070062; GO:0071346; GO:0090382; GO:1901998	"autophagosome assembly [GO:0000045]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"		NA	NA	NA	NA	NA	NA
TRINITY_DN699_c0_g1_i2	Q86YS6	RAB43_HUMAN	55.6	198	87	1	117	710	12	208	2.00E-59	230.7	RAB43_HUMAN	reviewed	Ras-related protein Rab-43 (Ras-related protein Rab-41)	RAB43 RAB41	Homo sapiens (Human)	212	"endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"	endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007030; GO:0012505; GO:0019068; GO:0030670; GO:0032588; GO:0035526; GO:0045335; GO:0070062; GO:0071346; GO:0090382; GO:1901998	"autophagosome assembly [GO:0000045]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38652_c0_g1_i1	Q86YS6	RAB43_HUMAN	36.4	165	100	3	123	614	20	180	5.60E-19	96.3	RAB43_HUMAN	reviewed	Ras-related protein Rab-43 (Ras-related protein Rab-41)	RAB43 RAB41	Homo sapiens (Human)	212	"endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"	endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000045; GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007030; GO:0012505; GO:0019068; GO:0030670; GO:0032588; GO:0035526; GO:0045335; GO:0070062; GO:0071346; GO:0090382; GO:1901998	"autophagosome assembly [GO:0000045]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"		blue	blue	NA	NA	NA	NA
TRINITY_DN38425_c0_g1_i1	Q2TBH7	RAB4A_BOVIN	100	73	0	0	10	228	1	73	3.80E-37	154.8	RAB4A_BOVIN	reviewed	Ras-related protein Rab-4A	RAB4A	Bos taurus (Bovine)	218	early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0015031; GO:0019003; GO:0019882; GO:0030100; GO:0031901; GO:0032482; GO:0032593; GO:0048471; GO:0055038; GO:0070062; GO:0098837	antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN32320_c0_g1_i1	P61017	RAB4B_CANLF	63.1	103	38	0	320	12	9	111	4.50E-36	151.8	RAB4B_CANLF	reviewed	Ras-related protein Rab-4B	RAB4B	Canis lupus familiaris (Dog) (Canis familiaris)	213	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0030100; GO:0032482; GO:0032593	protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN30061_c0_g1_i1	Q91ZR1	RAB4B_MOUSE	99	192	2	0	55	630	1	192	2.90E-103	375.9	RAB4B_MOUSE	reviewed	Ras-related protein Rab-4B	Rab4b Rab4	Mus musculus (Mouse)	213	anchored component of synaptic vesicle membrane [GO:0098993]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; glucose import [GO:0046323]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	anchored component of synaptic vesicle membrane [GO:0098993]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0005768; GO:0005886; GO:0015031; GO:0030100; GO:0032482; GO:0032593; GO:0046323; GO:0048471; GO:0055037; GO:0098993	glucose import [GO:0046323]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN30031_c0_g1_i1	Q68EK7	RAB4B_DANRE	71.3	108	31	0	334	11	3	110	1.70E-44	179.9	RAB4B_DANRE	reviewed	Ras-related protein Rab-4B	rab4b zgc:101015	Danio rerio (Zebrafish) (Brachydanio rerio)	213	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0030100; GO:0032482; GO:0032593	protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN742_c0_g1_i1	Q68EK7	RAB4B_DANRE	85.1	194	29	0	583	2	1	194	1.80E-84	313.5	RAB4B_DANRE	reviewed	Ras-related protein Rab-4B	rab4b zgc:101015	Danio rerio (Zebrafish) (Brachydanio rerio)	213	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0030100; GO:0032482; GO:0032593	protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN742_c0_g1_i2	Q68EK7	RAB4B_DANRE	81	126	24	0	379	2	69	194	3.40E-44	179.5	RAB4B_DANRE	reviewed	Ras-related protein Rab-4B	rab4b zgc:101015	Danio rerio (Zebrafish) (Brachydanio rerio)	213	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0030100; GO:0032482; GO:0032593	protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN742_c0_g1_i2	Q68EK7	RAB4B_DANRE	93.8	32	2	0	468	373	1	32	1.90E-10	67.4	RAB4B_DANRE	reviewed	Ras-related protein Rab-4B	rab4b zgc:101015	Danio rerio (Zebrafish) (Brachydanio rerio)	213	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0030100; GO:0032482; GO:0032593	protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN23894_c0_g1_i1	Q0IIG7	RAB5A_BOVIN	100	141	0	0	425	3	11	151	5.80E-76	284.6	RAB5A_BOVIN	reviewed	Ras-related protein Rab-5A (EC 3.6.5.2)	RAB5A	Bos taurus (Bovine)	215	actin cytoskeleton [GO:0015629]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; melanosome [GO:0042470]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; ruffle [GO:0001726]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; amyloid-beta clearance by transcytosis [GO:0150093]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; regulation of endocytosis [GO:0030100]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465]; viral RNA genome replication [GO:0039694]	actin cytoskeleton [GO:0015629]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; melanosome [GO:0042470]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; ruffle [GO:0001726]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0001726; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006909; GO:0008021; GO:0012505; GO:0015629; GO:0019003; GO:0030100; GO:0030136; GO:0030139; GO:0030424; GO:0030425; GO:0030670; GO:0032009; GO:0036465; GO:0039694; GO:0042470; GO:0043195; GO:0045022; GO:0045121; GO:0045335; GO:0045921; GO:0048169; GO:0051036; GO:0051489; GO:0098559; GO:0098842; GO:0098993; GO:0150093; GO:2000286; GO:2000300	amyloid-beta clearance by transcytosis [GO:0150093]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; regulation of endocytosis [GO:0030100]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN40040_c0_g1_i1	M0RC99	RAB5A_RAT	59.4	101	38	1	1	303	22	119	1.30E-27	123.6	RAB5A_RAT	reviewed	Ras-related protein Rab-5A (EC 3.6.5.2) (Small GTP-binding protein rab5)	Rab5a	Rattus norvegicus (Rat)	215	actin cytoskeleton [GO:0015629]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; somatodendritic compartment [GO:0036477]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; zymogen granule membrane [GO:0042589]; GDP binding [GO:0019003]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl nucleotide binding [GO:0019001]; amyloid-beta clearance by transcytosis [GO:0150093]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; regulation of endocytosis [GO:0030100]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; viral RNA genome replication [GO:0039694]	actin cytoskeleton [GO:0015629]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; somatodendritic compartment [GO:0036477]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; zymogen granule membrane [GO:0042589]	GDP binding [GO:0019003]; GDP-dissociation inhibitor binding [GO:0051021]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; guanyl nucleotide binding [GO:0019001]	GO:0001726; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006909; GO:0007032; GO:0008021; GO:0010008; GO:0012505; GO:0014911; GO:0015629; GO:0016192; GO:0019001; GO:0019003; GO:0030100; GO:0030139; GO:0030424; GO:0030425; GO:0030670; GO:0032009; GO:0032991; GO:0036465; GO:0036477; GO:0039694; GO:0042470; GO:0042589; GO:0043005; GO:0043025; GO:0043195; GO:0043679; GO:0045022; GO:0045121; GO:0045335; GO:0045921; GO:0048169; GO:0048471; GO:0048661; GO:0051021; GO:0051036; GO:0051489; GO:0055037; GO:0098559; GO:0098842; GO:0098993; GO:0150093; GO:2000286; GO:2000300	amyloid-beta clearance by transcytosis [GO:0150093]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; regulation of endocytosis [GO:0030100]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN90_c0_g3_i1	P61020	RAB5B_HUMAN	78.2	165	36	0	128	622	21	185	7.90E-69	261.5	RAB5B_HUMAN	reviewed	Ras-related protein Rab-5B	RAB5B	Homo sapiens (Human)	215	anchored component of synaptic vesicle membrane [GO:0098993]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]	anchored component of synaptic vesicle membrane [GO:0098993]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0012505; GO:0016020; GO:0019003; GO:0019882; GO:0030100; GO:0030139; GO:0030667; GO:0030742; GO:0031901; GO:0042470; GO:0043231; GO:0043312; GO:0048227; GO:0070062; GO:0098993	antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]		blue	blue	NA	NA	NA	NA
TRINITY_DN35012_c0_g1_i1	Q5ZHW4	RAB5B_CHICK	72	100	27	1	301	2	21	119	2.10E-35	149.4	RAB5B_CHICK	reviewed	Ras-related protein Rab-5B	RAB5B RCJMB04_32j11	Gallus gallus (Chicken)	215	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]	GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0012505; GO:0019003; GO:0019882; GO:0030100; GO:0030139; GO:0030742; GO:0031901; GO:0043231; GO:0048227; GO:0070062	antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN90_c0_g4_i1	Q58DS9	RAB5C_BOVIN	100	126	0	0	379	2	6	131	1.20E-67	256.9	RAB5C_BOVIN	reviewed	Ras-related protein Rab-5C	RAB5C	Bos taurus (Bovine)	216	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0010008; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0042470	endocytic recycling [GO:0032456]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN90_c0_g2_i1	Q58DS9	RAB5C_BOVIN	89.5	76	7	1	3	227	6	81	5.30E-31	134.4	RAB5C_BOVIN	reviewed	Ras-related protein Rab-5C	RAB5C	Bos taurus (Bovine)	216	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0010008; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0042470	endocytic recycling [GO:0032456]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN23468_c0_g1_i3	Q58DS9	RAB5C_BOVIN	54.7	86	39	0	312	55	30	115	3.80E-21	102.4	RAB5C_BOVIN	reviewed	Ras-related protein Rab-5C	RAB5C	Bos taurus (Bovine)	216	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0010008; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0042470	endocytic recycling [GO:0032456]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN282_c1_g1_i1	O18334	RAB6_DROME	88.5	208	22	2	10	633	3	208	1.90E-96	354.4	RAB6_DROME	reviewed	Ras-related protein Rab6 (Protein warthog)	Rab6 wrt CG6601	Drosophila melanogaster (Fruit fly)	208	"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0001745; GO:0001881; GO:0003779; GO:0003924; GO:0005525; GO:0005764; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0012505; GO:0016192; GO:0031410; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0050832; GO:0060078	"axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN282_c1_g1_i2	O18334	RAB6_DROME	88.5	208	22	2	706	83	3	208	1.00E-96	354.4	RAB6_DROME	reviewed	Ras-related protein Rab6 (Protein warthog)	Rab6 wrt CG6601	Drosophila melanogaster (Fruit fly)	208	"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]	actin binding [GO:0003779]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0001745; GO:0001881; GO:0003779; GO:0003924; GO:0005525; GO:0005764; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0012505; GO:0016192; GO:0031410; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0050832; GO:0060078	"axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9504_c0_g1_i1	Q1KME6	RAB6A_CHICK	99.3	143	1	0	429	1	1	143	1.00E-75	283.9	RAB6A_CHICK	reviewed	Ras-related protein Rab-6A	RAB6A	Gallus gallus (Chicken)	208	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0018125; GO:0019882; GO:0019904; GO:0031489; GO:0034067; GO:0034498; GO:0042147; GO:0070381	"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9504_c0_g1_i2	P20340	RAB6A_HUMAN	100	143	0	0	429	1	1	143	3.50E-76	285.4	RAB6A_HUMAN	reviewed	Ras-related protein Rab-6A (Rab-6)	RAB6A RAB6	Homo sapiens (Human)	208	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; minus-end-directed organelle transport along microtubule [GO:0072385]; neutrophil degranulation [GO:0043312]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0016020; GO:0016032; GO:0018125; GO:0019882; GO:0019904; GO:0030667; GO:0031410; GO:0031489; GO:0032588; GO:0034067; GO:0034498; GO:0042147; GO:0043312; GO:0070062; GO:0070381; GO:0072385	"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; minus-end-directed organelle transport along microtubule [GO:0072385]; neutrophil degranulation [GO:0043312]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25498_c0_g1_i1	H9BW96	RAB7_EPICO	81.8	154	27	1	31	492	1	153	5.00E-71	268.5	RAB7_EPICO	reviewed	Ras-related protein rab7	rab7	Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)	207	cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; viral process [GO:0016032]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005765; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0010008; GO:0016032; GO:0016042; GO:0031902; GO:0045022; GO:0045732; GO:0048524	early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32862_c0_g1_i1	P18067	RAB7A_CANLF	85.4	205	30	0	88	702	1	205	1.10E-99	364.4	RAB7A_CANLF	reviewed	Ras-related protein Rab-7a	RAB7A RAB7	Canis lupus familiaris (Dog) (Canis familiaris)	207	anchored component of synaptic vesicle membrane [GO:0098993]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]	anchored component of synaptic vesicle membrane [GO:0098993]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005811; GO:0005829; GO:0007174; GO:0008333; GO:0015031; GO:0016042; GO:0030670; GO:0031902; GO:0032419; GO:0033162; GO:0045022; GO:0045335; GO:0061724; GO:0070382; GO:0090383; GO:0090385; GO:0098993	early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN16853_c0_g1_i1	P51149	RAB7A_HUMAN	100	207	0	0	651	31	1	207	9.00E-117	421	RAB7A_HUMAN	reviewed	Ras-related protein Rab-7a	RAB7A RAB7	Homo sapiens (Human)	207	"autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; retromer complex binding [GO:1905394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intercellular transport [GO:1902586]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]"	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; retromer complex binding [GO:1905394]	GO:0000045; GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005770; GO:0005811; GO:0005829; GO:0005886; GO:0006622; GO:0006897; GO:0007174; GO:0008333; GO:0010008; GO:0015031; GO:0016042; GO:0019003; GO:0019076; GO:0019886; GO:0022615; GO:0030667; GO:0030670; GO:0031902; GO:0032419; GO:0033162; GO:0042147; GO:0043312; GO:0045022; GO:0045335; GO:0045732; GO:0048524; GO:0061724; GO:0070062; GO:0090382; GO:0090383; GO:0090385; GO:1902586; GO:1903542; GO:1903543; GO:1905366; GO:1905394	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intercellular transport [GO:1902586]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16853_c0_g1_i3	P51149	RAB7A_HUMAN	100	207	0	0	651	31	1	207	9.00E-117	421	RAB7A_HUMAN	reviewed	Ras-related protein Rab-7a	RAB7A RAB7	Homo sapiens (Human)	207	"autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; retromer complex binding [GO:1905394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intercellular transport [GO:1902586]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]"	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; retromer complex binding [GO:1905394]	GO:0000045; GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005770; GO:0005811; GO:0005829; GO:0005886; GO:0006622; GO:0006897; GO:0007174; GO:0008333; GO:0010008; GO:0015031; GO:0016042; GO:0019003; GO:0019076; GO:0019886; GO:0022615; GO:0030667; GO:0030670; GO:0031902; GO:0032419; GO:0033162; GO:0042147; GO:0043312; GO:0045022; GO:0045335; GO:0045732; GO:0048524; GO:0061724; GO:0070062; GO:0090382; GO:0090383; GO:0090385; GO:1902586; GO:1903542; GO:1903543; GO:1905366; GO:1905394	"antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intercellular transport [GO:1902586]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33784_c0_g1_i1	Q95UJ0	RAB7A_PAROT	52.7	55	26	0	190	26	48	102	5.60E-11	67.8	RAB7A_PAROT	reviewed	Ras-related protein Rab-7a	Rab7a Rab7	Paramecium octaurelia	206	autophagosome membrane [GO:0000421]; extrinsic component of lysosome membrane [GO:0032419]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]	autophagosome membrane [GO:0000421]; extrinsic component of lysosome membrane [GO:0032419]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000421; GO:0003924; GO:0005525; GO:0005811; GO:0016042; GO:0030670; GO:0031902; GO:0032419; GO:0045335; GO:0061724; GO:0090382; GO:0090383	lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]		NA	NA	NA	NA	NA	NA
TRINITY_DN34275_c0_g1_i1	O14966	RAB7L_HUMAN	100	83	0	0	10	258	1	83	9.80E-42	170.2	RAB7L_HUMAN	reviewed	Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29)	RAB29 RAB7L1	Homo sapiens (Human)	203	"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]; viral RNA genome replication [GO:0039694]"	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]	dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]	GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0017137; GO:0019003; GO:0019894; GO:0020003; GO:0032438; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1901998; GO:1903441; GO:1905279	"Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]; viral RNA genome replication [GO:0039694]"		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c0_g2_i1	P61007	RAB8A_CANLF	98.4	185	3	0	557	3	1	185	4.70E-100	365.2	RAB8A_CANLF	reviewed	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A MEL RAB8	Canis lupus familiaris (Dog) (Canis familiaris)	207	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]	GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0017137; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031489; GO:0032456; GO:0032869; GO:0036064; GO:0043197; GO:0045335; GO:0048210; GO:0055038; GO:0060271; GO:0070382; GO:0072659; GO:0097546; GO:0097730; GO:0098969	autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c0_g2_i2	P61007	RAB8A_CANLF	98.2	167	3	0	503	3	1	167	1.50E-89	330.1	RAB8A_CANLF	reviewed	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A MEL RAB8	Canis lupus familiaris (Dog) (Canis familiaris)	207	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]	GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0017137; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031489; GO:0032456; GO:0032869; GO:0036064; GO:0043197; GO:0045335; GO:0048210; GO:0055038; GO:0060271; GO:0070382; GO:0072659; GO:0097546; GO:0097730; GO:0098969	autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN30556_c0_g1_i1	P61007	RAB8A_CANLF	94.8	172	9	0	518	3	1	172	2.50E-90	332.8	RAB8A_CANLF	reviewed	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A MEL RAB8	Canis lupus familiaris (Dog) (Canis familiaris)	207	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; dendritic spine [GO:0043197]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]	GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0017137; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031489; GO:0032456; GO:0032869; GO:0036064; GO:0043197; GO:0045335; GO:0048210; GO:0055038; GO:0060271; GO:0070382; GO:0072659; GO:0097546; GO:0097730; GO:0098969	autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN888_c1_g1_i1	Q2HJI8	RAB8B_BOVIN	100	78	0	0	236	3	1	78	4.80E-39	161.4	RAB8B_BOVIN	reviewed	Ras-related protein Rab-8B	RAB8B	Bos taurus (Bovine)	207	phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031; GO:0019003; GO:0030670; GO:0045335	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN8528_c0_g1_i1	Q2HJI8	RAB8B_BOVIN	56.9	123	52	1	371	3	1	122	2.10E-35	149.8	RAB8B_BOVIN	reviewed	Ras-related protein Rab-8B	RAB8B	Bos taurus (Bovine)	207	phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031; GO:0019003; GO:0030670; GO:0045335	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN29537_c0_g1_i1	Q2HJI8	RAB8B_BOVIN	69.6	46	14	0	36	173	63	108	2.90E-13	75.5	RAB8B_BOVIN	reviewed	Ras-related protein Rab-8B	RAB8B	Bos taurus (Bovine)	207	phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031; GO:0019003; GO:0030670; GO:0045335	protein transport [GO:0015031]		brown	brown	NA	NA	NA	NA
TRINITY_DN30422_c0_g1_i1	Q92930	RAB8B_HUMAN	100	83	0	0	2	250	87	169	1.40E-40	166.4	RAB8B_HUMAN	reviewed	Ras-related protein Rab-8B	RAB8B	Homo sapiens (Human)	207	cell tip [GO:0051286]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]; antigen processing and presentation [GO:0019882]; cell-substrate junction organization [GO:0150115]; cellular response to insulin stimulus [GO:0032869]; Golgi vesicle fusion to target membrane [GO:0048210]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	cell tip [GO:0051286]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]	GO:0003924; GO:0005102; GO:0005525; GO:0005654; GO:0005768; GO:0005778; GO:0005886; GO:0006904; GO:0008021; GO:0009306; GO:0016604; GO:0017157; GO:0019003; GO:0019882; GO:0030140; GO:0030670; GO:0030911; GO:0031346; GO:0032869; GO:0043231; GO:0045046; GO:0045335; GO:0048210; GO:0048471; GO:0051286; GO:0051461; GO:0055038; GO:0070062; GO:0072659; GO:0150115	antigen processing and presentation [GO:0019882]; cell-substrate junction organization [GO:0150115]; cellular response to insulin stimulus [GO:0032869]; Golgi vesicle fusion to target membrane [GO:0048210]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN7879_c0_g1_i4	P20791	RAB8B_DICDI	34.1	179	105	6	92	625	16	182	6.70E-21	102.4	RAB8B_DICDI	reviewed	Ras-related protein Rab-8B (GTP-binding protein SAS2)	rab8B sas2 sasB DDB_G0276399	Dictyostelium discoideum (Slime mold)	203	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; protein secretion [GO:0009306]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0006904; GO:0009306; GO:0016339; GO:0017157; GO:0031157	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; protein secretion [GO:0009306]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN90_c0_g1_i1	P24408	RAB9A_CANLF	63.3	188	66	2	80	634	3	190	2.40E-67	256.9	RAB9A_CANLF	reviewed	Ras-related protein Rab-9A	RAB9A RAB9	Canis lupus familiaris (Dog) (Canis familiaris)	201	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; negative regulation by host of symbiont molecular function [GO:0052405]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030670; GO:0032482; GO:0032880; GO:0042147; GO:0042470; GO:0042802; GO:0045335; GO:0045921; GO:0052405	"negative regulation by host of symbiont molecular function [GO:0052405]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26023_c0_g1_i1	P24408	RAB9A_CANLF	100	70	0	0	2	211	92	161	1.10E-35	149.8	RAB9A_CANLF	reviewed	Ras-related protein Rab-9A	RAB9A RAB9	Canis lupus familiaris (Dog) (Canis familiaris)	201	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; negative regulation by host of symbiont molecular function [GO:0052405]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030670; GO:0032482; GO:0032880; GO:0042147; GO:0042470; GO:0042802; GO:0045335; GO:0045921; GO:0052405	"negative regulation by host of symbiont molecular function [GO:0052405]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6488_c0_g1_i1	Q39222	RAA1B_ARATH	52.9	121	56	1	35	397	11	130	2.40E-31	136.3	RAA1B_ARATH	reviewed	Ras-related protein RABA1b (AtRABA1b) (Ras-related protein Rab11) (AtRab11)	RABA1B RAB11 At1g16920 F6I1.7	Arabidopsis thaliana (Mouse-ear cress)	216	endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; hyperosmotic salinity response [GO:0042538]; intracellular protein transport [GO:0006886]; regulation of vesicle-mediated transport [GO:0060627]	endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0005773; GO:0005774; GO:0005886; GO:0006886; GO:0012505; GO:0042538; GO:0060627	hyperosmotic salinity response [GO:0042538]; intracellular protein transport [GO:0006886]; regulation of vesicle-mediated transport [GO:0060627]		NA	NA	NA	NA	NA	NA
TRINITY_DN1089_c0_g1_i1	Q39222	RAA1B_ARATH	66.4	125	41	1	421	47	7	130	4.20E-40	165.6	RAA1B_ARATH	reviewed	Ras-related protein RABA1b (AtRABA1b) (Ras-related protein Rab11) (AtRab11)	RABA1B RAB11 At1g16920 F6I1.7	Arabidopsis thaliana (Mouse-ear cress)	216	endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; hyperosmotic salinity response [GO:0042538]; intracellular protein transport [GO:0006886]; regulation of vesicle-mediated transport [GO:0060627]	endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005634; GO:0005773; GO:0005774; GO:0005886; GO:0006886; GO:0012505; GO:0042538; GO:0060627	hyperosmotic salinity response [GO:0042538]; intracellular protein transport [GO:0006886]; regulation of vesicle-mediated transport [GO:0060627]		NA	NA	NA	NA	NA	NA
TRINITY_DN34852_c0_g1_i1	O04486	RAA2A_ARATH	48.9	88	43	1	45	302	64	151	6.60E-21	101.3	RAA2A_ARATH	reviewed	Ras-related protein RABA2a (AtRABA2a) (Ras-related protein Rab11C) (AtRab11C)	RABA2A RAB11C At1g09630 F21M12.2	Arabidopsis thaliana (Mouse-ear cress)	217	cell plate [GO:0009504]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytokinesis by cell plate formation [GO:0000911]; protein transport [GO:0015031]	cell plate [GO:0009504]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000911; GO:0003924; GO:0005525; GO:0005576; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0009504; GO:0010008; GO:0015031	cytokinesis by cell plate formation [GO:0000911]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN5038_c0_g1_i1	Q9ZRE2	RABD1_ARATH	63	108	40	0	331	8	3	110	1.70E-36	153.3	RABD1_ARATH	reviewed	Ras-related protein RABD1 (AtRABD1) (Ras-related protein ATFP8)	RABD1 ATFP8 At3g11730 F26K24.2	Arabidopsis thaliana (Mouse-ear cress)	205	endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin XI tail binding [GO:0080115]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; myosin XI tail binding [GO:0080115]	GO:0000139; GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0006888; GO:0012505; GO:0030742; GO:0032588; GO:0080115	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN26882_c0_g1_i1	Q9CB01	RABF1_ARATH	56.9	102	44	0	45	350	35	136	4.60E-29	128.6	RABF1_ARATH	reviewed	Ras-related protein RABF1 (AtRABF1) (Ras-related protein Ara-6) (Ras-related protein Rab5C) (AtRab5C)	RABF1 ARA-6 RAB5C At3g54840 F28P10.180	Arabidopsis thaliana (Mouse-ear cress)	202	cytoplasmic side of endosome membrane [GO:0010009]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]	cytoplasmic side of endosome membrane [GO:0010009]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0010009; GO:0012505; GO:0031901; GO:0045022	early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN23468_c0_g1_i1	Q9SN68	RAF2B_ARATH	42.3	189	106	1	674	108	7	192	6.10E-35	149.1	RAF2B_ARATH	reviewed	Ras-related protein RABF2b (AtRABF2b) (Ras-related protein Ara-7) (Ras-related protein Rab5B) (AtRab5B)	RABF2B ARA-7 RAB5B At4g19640 F24J7.190	Arabidopsis thaliana (Mouse-ear cress)	200	cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; intracellular organelle [GO:0043229]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; late endosome to vacuole transport [GO:0045324]; vacuole organization [GO:0007033]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; intracellular organelle [GO:0043229]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005886; GO:0006886; GO:0007033; GO:0012505; GO:0030139; GO:0031901; GO:0032585; GO:0043229; GO:0045324	intracellular protein transport [GO:0006886]; late endosome to vacuole transport [GO:0045324]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN23468_c0_g1_i4	Q9SN68	RAF2B_ARATH	42.6	176	98	1	635	108	20	192	1.80E-32	141	RAF2B_ARATH	reviewed	Ras-related protein RABF2b (AtRABF2b) (Ras-related protein Ara-7) (Ras-related protein Rab5B) (AtRab5B)	RABF2B ARA-7 RAB5B At4g19640 F24J7.190	Arabidopsis thaliana (Mouse-ear cress)	200	cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; intracellular organelle [GO:0043229]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; late endosome to vacuole transport [GO:0045324]; vacuole organization [GO:0007033]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; intracellular organelle [GO:0043229]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005886; GO:0006886; GO:0007033; GO:0012505; GO:0030139; GO:0031901; GO:0032585; GO:0043229; GO:0045324	intracellular protein transport [GO:0006886]; late endosome to vacuole transport [GO:0045324]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN11738_c0_g1_i1	Q9SMR4	RAH1C_ARATH	41.7	84	44	1	31	282	39	117	1.20E-13	77	RAH1C_ARATH	reviewed	Ras-related protein RABH1c (AtRABH1c)	RABH1C At4g39890 T5J17.60	Arabidopsis thaliana (Mouse-ear cress)	214	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0042147	"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30829_c0_g1_i1	Q9LFT9	RAH1E_ARATH	78.4	139	30	0	418	2	29	167	9.20E-58	224.2	RAH1E_ARATH	reviewed	Ras-related protein RABH1e (AtRABH1e)	RABH1E At5g10260 F18D22.30	Arabidopsis thaliana (Mouse-ear cress)	207	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0042147	"intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17_c0_g2_i1	P40792	RAC1_DROME	88.5	192	22	0	713	138	1	192	3.70E-100	365.9	RAC1_DROME	reviewed	Ras-related protein Rac1	Rac1 RacA CG2248	Drosophila melanogaster (Fruit fly)	192	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal fasciculation [GO:0007413]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell morphogenesis [GO:0000902]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; dendrite development [GO:0016358]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of myotube cell migration [GO:0110125]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of adherens junction organization [GO:1903391]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; small GTPase mediated signal transduction [GO:0007264]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]; vesicle [GO:0031982]	GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0000902; GO:0001726; GO:0001954; GO:0002433; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007254; GO:0007264; GO:0007298; GO:0007390; GO:0007391; GO:0007394; GO:0007395; GO:0007411; GO:0007413; GO:0007419; GO:0007422; GO:0007424; GO:0007426; GO:0007435; GO:0007516; GO:0007520; GO:0007613; GO:0008045; GO:0008078; GO:0008258; GO:0008347; GO:0008360; GO:0009611; GO:0010593; GO:0016028; GO:0016199; GO:0016203; GO:0016358; GO:0019897; GO:0019901; GO:0030032; GO:0030036; GO:0030865; GO:0030866; GO:0031175; GO:0031410; GO:0031532; GO:0031982; GO:0032147; GO:0032794; GO:0032956; GO:0035010; GO:0035011; GO:0035099; GO:0035212; GO:0035320; GO:0042052; GO:0042995; GO:0043231; GO:0043652; GO:0045773; GO:0046330; GO:0046664; GO:0046843; GO:0048010; GO:0048615; GO:0048675; GO:0048747; GO:0048812; GO:0048814; GO:0050770; GO:0050807; GO:0050975; GO:0051017; GO:0051450; GO:0051491; GO:0051963; GO:0071902; GO:0071907; GO:0090303; GO:0097206; GO:0110125; GO:1902669; GO:1903391; GO:1903688; GO:1904059	"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell morphogenesis [GO:0000902]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; dendrite development [GO:0016358]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of myotube cell migration [GO:0110125]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of adherens junction organization [GO:1903391]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; small GTPase mediated signal transduction [GO:0007264]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]"		blue	blue	NA	NA	NA	NA
TRINITY_DN20646_c0_g1_i1	P11233	RALA_HUMAN	99.4	179	1	0	537	1	1	179	5.70E-95	348.2	RALA_HUMAN	reviewed	Ras-related protein Ral-A (EC 3.6.5.2)	RALA RAL	Homo sapiens (Human)	206	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; exocytosis [GO:0006887]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane organization [GO:0061024]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]	GO:0001843; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007049; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031532; GO:0031625; GO:0031755; GO:0032154; GO:0035722; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0061024; GO:0070062; GO:0090543	actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; exocytosis [GO:0006887]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane organization [GO:0061024]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN20646_c0_g1_i3	P11233	RALA_HUMAN	99.4	179	1	0	537	1	1	179	5.70E-95	348.2	RALA_HUMAN	reviewed	Ras-related protein Ral-A (EC 3.6.5.2)	RALA RAL	Homo sapiens (Human)	206	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; exocytosis [GO:0006887]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane organization [GO:0061024]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]	GO:0001843; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007049; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031532; GO:0031625; GO:0031755; GO:0032154; GO:0035722; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0061024; GO:0070062; GO:0090543	actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; exocytosis [GO:0006887]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane organization [GO:0061024]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1771_c0_g1_i1	P48555	RALA_DROME	83.1	177	30	0	645	115	2	178	3.00E-78	293.5	RALA_DROME	reviewed	Ras-related protein Ral-a (EC 3.6.5.2)	Rala CG2849	Drosophila melanogaster (Fruit fly)	201	cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]	cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; PDZ domain binding [GO:0030165]	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0007298; GO:0007464; GO:0019003; GO:0022604; GO:0030165; GO:0032154; GO:0045087; GO:0045824; GO:0046329; GO:0050829; GO:0090543	border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN1771_c0_g1_i2	P48555	RALA_DROME	82.5	200	35	0	762	163	2	201	1.20E-88	328.2	RALA_DROME	reviewed	Ras-related protein Ral-a (EC 3.6.5.2)	Rala CG2849	Drosophila melanogaster (Fruit fly)	201	cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]	cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; PDZ domain binding [GO:0030165]	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0007298; GO:0007464; GO:0019003; GO:0022604; GO:0030165; GO:0032154; GO:0045087; GO:0045824; GO:0046329; GO:0050829; GO:0090543	border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN27980_c0_g1_i1	Q9JIW9	RALB_MOUSE	100	145	0	0	1	435	32	176	3.50E-76	285.4	RALB_MOUSE	reviewed	Ras-related protein Ral-B (EC 3.6.5.2)	Ralb	Mus musculus (Mouse)	206	midbody [GO:0030496]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]	midbody [GO:0030496]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]	GO:0001928; GO:0001934; GO:0003924; GO:0005525; GO:0005886; GO:0006915; GO:0007049; GO:0007265; GO:0009267; GO:0019003; GO:0030496; GO:0031625; GO:0032091; GO:0032092; GO:0051117; GO:0051301; GO:0060178; GO:0071360; GO:0071902; GO:2000786	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]		NA	NA	NA	NA	NA	NA
TRINITY_DN28469_c0_g1_i1	P11234	RALB_HUMAN	99.2	132	1	0	399	4	10	141	6.10E-67	254.6	RALB_HUMAN	reviewed	Ras-related protein Ral-B (EC 3.6.5.2)	RALB	Homo sapiens (Human)	206	extracellular exosome [GO:0070062]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]; signal transduction [GO:0007165]	extracellular exosome [GO:0070062]; midbody [GO:0030496]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]	GO:0001928; GO:0001934; GO:0003924; GO:0005525; GO:0005886; GO:0006915; GO:0007049; GO:0007165; GO:0007265; GO:0009267; GO:0019003; GO:0030496; GO:0031625; GO:0032091; GO:0032092; GO:0051117; GO:0051301; GO:0060178; GO:0070062; GO:0071360; GO:0071902; GO:2000786	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN22409_c0_g1_i1	Q18246	RAP1_CAEEL	96.5	57	2	0	173	3	1	57	2.40E-24	112.5	RAP1_CAEEL	reviewed	Ras-related protein Rap-1 (EC 3.6.5.2)	rap-1 C27B7.8	Caenorhabditis elegans	188	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to cAMP [GO:0071320]; collagen and cuticulin-based cuticle development [GO:0040002]; epidermis development [GO:0008544]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]	plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0008544; GO:0019003; GO:0032486; GO:0040002; GO:0071320; GO:2000301	cellular response to cAMP [GO:0071320]; collagen and cuticulin-based cuticle development [GO:0040002]; epidermis development [GO:0008544]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]		blue	blue	NA	NA	NA	NA
TRINITY_DN22409_c1_g1_i1	P08645	RAP1_DROME	87	77	10	0	1	231	31	107	3.10E-31	135.2	RAP1_DROME	reviewed	Ras-related protein Rap1 (EC 3.6.5.2) (Rap1 GTPase) (Ras-like protein 3)	Rap1 R RAP ras3 CG1956	Drosophila melanogaster (Fruit fly)	184	"cell leading edge [GO:0031252]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; adherens junction assembly [GO:0034333]; border follicle cell migration [GO:0007298]; cellular response to cAMP [GO:0071320]; dorsal closure [GO:0007391]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; ommatidial rotation [GO:0016318]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of smoothened signaling pathway [GO:0045880]; R7 cell fate commitment [GO:0007465]; Rap protein signal transduction [GO:0032486]; regulation of embryonic cell shape [GO:0016476]; substrate-dependent cell migration, cell extension [GO:0006930]; torso signaling pathway [GO:0008293]; visual perception [GO:0007601]"	cell leading edge [GO:0031252]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0006930; GO:0007298; GO:0007391; GO:0007465; GO:0007601; GO:0008293; GO:0016318; GO:0016476; GO:0019003; GO:0019901; GO:0022409; GO:0030718; GO:0031252; GO:0032486; GO:0034333; GO:0035099; GO:0035317; GO:0035331; GO:0045874; GO:0045880; GO:0070374; GO:0071320; GO:2000301	"adherens junction assembly [GO:0034333]; border follicle cell migration [GO:0007298]; cellular response to cAMP [GO:0071320]; dorsal closure [GO:0007391]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; negative regulation of hippo signaling [GO:0035331]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; ommatidial rotation [GO:0016318]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of smoothened signaling pathway [GO:0045880]; R7 cell fate commitment [GO:0007465]; Rap protein signal transduction [GO:0032486]; regulation of embryonic cell shape [GO:0016476]; substrate-dependent cell migration, cell extension [GO:0006930]; torso signaling pathway [GO:0008293]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10722_c1_g1_i1	P62833	RAP1A_BOVIN	98.7	77	1	0	21	251	1	77	8.40E-38	157.1	RAP1A_BOVIN	reviewed	Ras-related protein Rap-1A (EC 3.6.5.2) (GTP-binding protein smg p21A)	RAP1A	Bos taurus (Bovine)	184	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]	GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0010976; GO:0017034; GO:0030054; GO:0032045; GO:0032486; GO:0038180; GO:0043005; GO:0043547; GO:0044877; GO:0045860; GO:0048471; GO:0061028; GO:0070374; GO:0071320; GO:0072659; GO:0098696; GO:0098978; GO:1901888; GO:1990090; GO:2000301; GO:2001214	cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]		NA	NA	NA	NA	NA	NA
TRINITY_DN10722_c1_g1_i2	P62833	RAP1A_BOVIN	98.4	184	3	0	21	572	1	184	1.00E-99	364	RAP1A_BOVIN	reviewed	Ras-related protein Rap-1A (EC 3.6.5.2) (GTP-binding protein smg p21A)	RAP1A	Bos taurus (Bovine)	184	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]	GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0010976; GO:0017034; GO:0030054; GO:0032045; GO:0032486; GO:0038180; GO:0043005; GO:0043547; GO:0044877; GO:0045860; GO:0048471; GO:0061028; GO:0070374; GO:0071320; GO:0072659; GO:0098696; GO:0098978; GO:1901888; GO:1990090; GO:2000301; GO:2001214	cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]		NA	NA	NA	NA	NA	NA
TRINITY_DN10722_c1_g1_i3	P62833	RAP1A_BOVIN	98.7	77	1	0	21	251	1	77	8.40E-38	157.1	RAP1A_BOVIN	reviewed	Ras-related protein Rap-1A (EC 3.6.5.2) (GTP-binding protein smg p21A)	RAP1A	Bos taurus (Bovine)	184	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]	GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0010976; GO:0017034; GO:0030054; GO:0032045; GO:0032486; GO:0038180; GO:0043005; GO:0043547; GO:0044877; GO:0045860; GO:0048471; GO:0061028; GO:0070374; GO:0071320; GO:0072659; GO:0098696; GO:0098978; GO:1901888; GO:1990090; GO:2000301; GO:2001214	cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]		NA	NA	NA	NA	NA	NA
TRINITY_DN11682_c0_g1_i1	Q7ZXH7	RAP1B_XENLA	41.5	142	80	3	2	421	23	163	3.40E-23	109.4	RAP1B_XENLA	reviewed	Ras-related protein Rap-1b (EC 3.6.5.2)	rap1b	Xenopus laevis (African clawed frog)	184	cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486]	cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0030054; GO:0032486	Rap protein signal transduction [GO:0032486]		blue	blue	NA	NA	NA	NA
TRINITY_DN32670_c1_g1_i1	Q6TEN1	RAP1B_DANRE	89.2	185	18	2	89	640	1	184	5.20E-87	322	RAP1B_DANRE	reviewed	Ras-related protein Rap-1b (EC 3.6.5.2)	rap1b si:dkey-31f5.4	Danio rerio (Zebrafish) (Brachydanio rerio)	184	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; MAP kinase kinase activity [GO:0004708]; cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; MAP kinase kinase activity [GO:0004708]	GO:0001756; GO:0003428; GO:0003924; GO:0004708; GO:0005525; GO:0005829; GO:0005886; GO:0005911; GO:0007507; GO:0019003; GO:0032486; GO:0032525; GO:0060026; GO:0060536; GO:0071320; GO:2000301	cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]		blue	blue	NA	NA	NA	NA
TRINITY_DN10722_c0_g2_i1	P61223	RAP1B_BOVIN	100	184	0	0	572	21	1	184	7.30E-101	367.9	RAP1B_BOVIN	reviewed	Ras-related protein Rap-1b (EC 3.6.5.2) (GTP-binding protein smg p21B)	RAP1B	Bos taurus (Bovine)	184	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0005911; GO:0016020; GO:0019003; GO:0032486; GO:0061028; GO:0071320; GO:1901888; GO:2000114; GO:2000301	cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114]		NA	NA	NA	NA	NA	NA
TRINITY_DN10722_c0_g1_i1	P61223	RAP1B_BOVIN	100	184	0	0	572	21	1	184	4.80E-101	368.6	RAP1B_BOVIN	reviewed	Ras-related protein Rap-1b (EC 3.6.5.2) (GTP-binding protein smg p21B)	RAP1B	Bos taurus (Bovine)	184	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0005911; GO:0016020; GO:0019003; GO:0032486; GO:0061028; GO:0071320; GO:1901888; GO:2000114; GO:2000301	cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114]		NA	NA	NA	NA	NA	NA
TRINITY_DN6961_c0_g1_i1	Q06AU2	RAP2A_PIG	70.9	179	50	1	194	730	1	177	7.70E-68	258.5	RAP2A_PIG	reviewed	Ras-related protein Rap-2a (EC 3.6.5.2)	RAP2A	Sus scrofa (Pig)	183	bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of protein tyrosine kinase activity [GO:0061097]	bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein domain specific binding [GO:0019904]	GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0005923; GO:0019003; GO:0019904; GO:0030336; GO:0030496; GO:0031532; GO:0031954; GO:0032486; GO:0034613; GO:0044291; GO:0045121; GO:0046328; GO:0048814; GO:0055038; GO:0061097; GO:0070062; GO:0070527	actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of protein tyrosine kinase activity [GO:0061097]		blue	blue	NA	NA	NA	NA
TRINITY_DN25621_c0_g1_i1	P10114	RAP2A_HUMAN	100	94	0	0	284	3	1	94	1.60E-46	186.4	RAP2A_HUMAN	reviewed	Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30)	RAP2A	Homo sapiens (Human)	183	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; cellular response to drug [GO:0035690]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0001934; GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0019003; GO:0030033; GO:0030336; GO:0030496; GO:0031532; GO:0031954; GO:0032486; GO:0034613; GO:0035690; GO:0045184; GO:0046328; GO:0048814; GO:0055037; GO:0055038; GO:0072659	actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; cellular response to drug [GO:0035690]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]		NA	NA	NA	NA	NA	NA
TRINITY_DN32873_c0_g1_i1	P10114	RAP2A_HUMAN	100	104	0	0	1	312	20	123	2.50E-52	205.7	RAP2A_HUMAN	reviewed	Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30)	RAP2A	Homo sapiens (Human)	183	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; cellular response to drug [GO:0035690]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0001934; GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0019003; GO:0030033; GO:0030336; GO:0030496; GO:0031532; GO:0031954; GO:0032486; GO:0034613; GO:0035690; GO:0045184; GO:0046328; GO:0048814; GO:0055037; GO:0055038; GO:0072659	actin cytoskeleton reorganization [GO:0031532]; cellular protein localization [GO:0034613]; cellular response to drug [GO:0035690]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]		NA	NA	NA	NA	NA	NA
TRINITY_DN25785_c0_g1_i1	P40392	RIC1_ORYSJ	67.1	164	54	0	62	553	4	167	1.00E-59	231.1	RIC1_ORYSJ	reviewed	Ras-related protein RIC1	RIC1 Os01g0558600 LOC_Os01g37800 B1064G04.9 B1144D11.31 OsJ_02222	Oryza sativa subsp. japonica (Rice)	202	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN21259_c0_g1_i1	P10301	RRAS_HUMAN	99.3	134	1	0	2	403	47	180	1.60E-70	266.5	RRAS_HUMAN	reviewed	Ras-related protein R-Ras (EC 3.6.5.-) (p23)	RRAS	Homo sapiens (Human)	218	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]	GO:0002521; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0007265; GO:0010595; GO:0019003; GO:0030336; GO:0044877; GO:0045766; GO:0051896; GO:0060325; GO:0070062; GO:0070372; GO:1904906; GO:2001214	face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vasculogenesis [GO:2001214]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]		NA	NA	NA	NA	NA	NA
TRINITY_DN21259_c1_g1_i1	P10833	RRAS_MOUSE	100	121	0	0	50	412	40	160	1.90E-63	243	RRAS_MOUSE	reviewed	Ras-related protein R-Ras (EC 3.6.5.-) (p23)	Rras	Mus musculus (Mouse)	218	cytosol [GO:0005829]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex binding [GO:0044877]	GO:0002521; GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0007265; GO:0010595; GO:0019003; GO:0030336; GO:0044877; GO:0045766; GO:0051896; GO:0060325; GO:0070372; GO:1904906; GO:2001214	face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of vasculogenesis [GO:2001214]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]		NA	NA	NA	NA	NA	NA
TRINITY_DN26934_c0_g1_i1	P62070	RRAS2_HUMAN	100	183	0	0	3	551	22	204	1.10E-101	370.5	RRAS2_HUMAN	reviewed	Ras-related protein R-Ras2 (EC 3.6.5.-) (Ras-like protein TC21) (Teratocarcinoma oncogene)	RRAS2 TC21	Homo sapiens (Human)	204	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0001649; GO:0003924; GO:0005525; GO:0005783; GO:0005886; GO:0005925; GO:0007265; GO:0016020; GO:0019003; GO:0030335; GO:0070062; GO:1901214	osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g2_i2	O57415	RREB1_CHICK	51.4	37	18	0	5	115	92	128	1.90E-06	52.8	RREB1_CHICK	reviewed	Ras-responsive element-binding protein 1 (RREB-1)	RREB1	Gallus gallus (Chicken)	1615	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3765_c0_g1_i1	Q5JS13	RGPS1_HUMAN	44.4	527	237	13	1609	89	67	557	4.60E-100	366.7	RGPS1_HUMAN	reviewed	Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2) (RalGEF 2) (RalA exchange factor RalGPS1)	RALGPS1 KIAA0351 RALGEF2	Homo sapiens (Human)	557	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]; intracellular signal transduction [GO:0035556]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]	GO:0005085; GO:0005737; GO:0005886; GO:0007264; GO:0008321; GO:0032485; GO:0035556	intracellular signal transduction [GO:0035556]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3765_c0_g1_i2	Q5JS13	RGPS1_HUMAN	45.6	551	244	13	1681	89	43	557	3.10E-109	397.5	RGPS1_HUMAN	reviewed	Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2) (RalGEF 2) (RalA exchange factor RalGPS1)	RALGPS1 KIAA0351 RALGEF2	Homo sapiens (Human)	557	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]; intracellular signal transduction [GO:0035556]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]	GO:0005085; GO:0005737; GO:0005886; GO:0007264; GO:0008321; GO:0032485; GO:0035556	intracellular signal transduction [GO:0035556]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3765_c0_g1_i3	Q5JS13	RGPS1_HUMAN	45.6	551	244	13	1681	89	43	557	3.10E-109	397.5	RGPS1_HUMAN	reviewed	Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2) (RalGEF 2) (RalA exchange factor RalGPS1)	RALGPS1 KIAA0351 RALGEF2	Homo sapiens (Human)	557	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]; intracellular signal transduction [GO:0035556]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]	GO:0005085; GO:0005737; GO:0005886; GO:0007264; GO:0008321; GO:0032485; GO:0035556	intracellular signal transduction [GO:0035556]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN10812_c0_g1_i5	Q9NYW8	RBAK_HUMAN	55.1	89	40	0	66	332	589	677	5.00E-22	105.1	RBAK_HUMAN	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769)	RBAK ZNF769	Homo sapiens (Human)	714	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29258_c0_g1_i1	Q9NYW8	RBAK_HUMAN	54.4	79	36	0	291	55	317	395	7.00E-21	101.3	RBAK_HUMAN	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769)	RBAK ZNF769	Homo sapiens (Human)	714	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11917_c0_g2_i1	Q9NYW8	RBAK_HUMAN	46.2	117	63	0	362	12	307	423	1.10E-25	117.5	RBAK_HUMAN	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769)	RBAK ZNF769	Homo sapiens (Human)	714	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3413_c0_g1_i1	Q9NYW8	RBAK_HUMAN	51.9	79	38	0	239	3	595	673	2.50E-18	92.4	RBAK_HUMAN	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769)	RBAK ZNF769	Homo sapiens (Human)	714	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g3_i1	Q9NYW8	RBAK_HUMAN	55.8	77	34	0	296	66	329	405	8.70E-18	90.9	RBAK_HUMAN	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769)	RBAK ZNF769	Homo sapiens (Human)	714	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c0_g1_i2	Q9NYW8	RBAK_HUMAN	55.3	76	34	0	90	317	617	692	1.60E-17	90.1	RBAK_HUMAN	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769)	RBAK ZNF769	Homo sapiens (Human)	714	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i7	Q8BQC8	RBAK_MOUSE	57.3	96	41	0	135	422	328	423	1.40E-25	117.5	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i7	Q8BQC8	RBAK_MOUSE	43.4	83	43	2	1	246	314	393	6.20E-10	65.5	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i9	Q8BQC8	RBAK_MOUSE	57.3	96	41	0	151	438	328	423	1.40E-25	117.5	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i9	Q8BQC8	RBAK_MOUSE	55.8	52	23	0	2	157	337	388	6.50E-10	65.5	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i1	Q8BQC8	RBAK_MOUSE	39.1	156	88	2	3	449	293	448	6.90E-20	98.6	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i1	Q8BQC8	RBAK_MOUSE	52.4	82	39	0	247	492	294	375	2.00E-19	97.1	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1848_c0_g1_i6	Q8BQC8	RBAK_MOUSE	50	96	48	0	4	291	297	392	1.40E-20	100.1	RBAK_MOUSE	reviewed	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	Rbak Znf769	Mus musculus (Mouse)	711	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13893_c0_g1_i1	Q8NDN9	RCBT1_HUMAN	54.9	428	193	0	92	1375	2	429	3.20E-139	496.5	RCBT1_HUMAN	reviewed	RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1)	RCBTB1 CLLD7 E4.5	Homo sapiens (Human)	531	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006325; GO:0007049	cell cycle [GO:0007049]; chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN25647_c0_g1_i1	Q8NDN9	RCBT1_HUMAN	100	84	0	0	252	1	225	308	1.10E-42	173.3	RCBT1_HUMAN	reviewed	RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1)	RCBTB1 CLLD7 E4.5	Homo sapiens (Human)	531	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006325; GO:0007049	cell cycle [GO:0007049]; chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN27003_c0_g1_i1	Q6NXM2	RCBT1_MOUSE	100	70	0	0	213	4	191	260	8.70E-36	150.2	RCBT1_MOUSE	reviewed	RCC1 and BTB domain-containing protein 1 (Regulator of chromosome condensation and BTB domain-containing protein 1)	Rcbtb1	Mus musculus (Mouse)	531	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0006325; GO:0007049	cell cycle [GO:0007049]; chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN21244_c0_g1_i1	O95199	RCBT2_HUMAN	100	104	0	0	314	3	226	329	1.30E-56	219.9	RCBT2_HUMAN	reviewed	RCC1 and BTB domain-containing protein 2 (Chromosome condensation 1-like) (CHC1-L) (RCC1-like G exchanging factor) (Regulator of chromosome condensation and BTB domain-containing protein 2)	RCBTB2 CHC1L RLG	Homo sapiens (Human)	551	acrosomal vesicle [GO:0001669]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]	acrosomal vesicle [GO:0001669]	Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0001669; GO:0005087			NA	NA	NA	NA	NA	NA
TRINITY_DN21244_c0_g1_i2	O95199	RCBT2_HUMAN	98.7	76	1	0	229	2	226	301	8.10E-40	163.7	RCBT2_HUMAN	reviewed	RCC1 and BTB domain-containing protein 2 (Chromosome condensation 1-like) (CHC1-L) (RCC1-like G exchanging factor) (Regulator of chromosome condensation and BTB domain-containing protein 2)	RCBTB2 CHC1L RLG	Homo sapiens (Human)	551	acrosomal vesicle [GO:0001669]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]	acrosomal vesicle [GO:0001669]	Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0001669; GO:0005087			NA	NA	NA	NA	NA	NA
TRINITY_DN34945_c0_g1_i1	Q99LJ7	RCBT2_MOUSE	100	71	0	0	215	3	200	270	1.00E-36	153.3	RCBT2_MOUSE	reviewed	RCC1 and BTB domain-containing protein 2 (Chromosome condensation 1-like) (Regulator of chromosome condensation and BTB domain-containing protein 2)	Rcbtb2 Chc1l	Mus musculus (Mouse)	551	acrosomal vesicle [GO:0001669]	acrosomal vesicle [GO:0001669]		GO:0001669			NA	NA	NA	NA	NA	NA
TRINITY_DN6455_c0_g1_i1	Q8BTU7	RCCD1_MOUSE	48.4	93	48	0	488	210	156	248	3.40E-21	103.2	RCCD1_MOUSE	reviewed	RCC1 domain-containing protein 1	Rccd1	Mus musculus (Mouse)	377	chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325]	chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005694; GO:0005829; GO:0005886; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN6455_c0_g1_i2	Q8BTU7	RCCD1_MOUSE	53.4	58	27	0	383	210	191	248	6.80E-12	72	RCCD1_MOUSE	reviewed	RCC1 domain-containing protein 1	Rccd1	Mus musculus (Mouse)	377	chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325]	chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005694; GO:0005829; GO:0005886; GO:0006325	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN7388_c0_g1_i1	Q9CYF5	RCC1L_MOUSE	49.1	287	145	1	908	48	176	461	9.50E-84	312.4	RCC1L_MOUSE	reviewed	RCC1-like G exchanging factor-like protein (RCC1-like) (Williams-Beuren syndrome chromosomal region 16 protein homolog)	Rcc1l Wbscr16	Mus musculus (Mouse)	461	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]	GO:0005085; GO:0005087; GO:0005739; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613	mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]		NA	NA	NA	NA	NA	NA
TRINITY_DN7388_c0_g1_i2	Q9CYF5	RCC1L_MOUSE	37.1	423	201	5	1127	48	41	461	8.10E-79	295.8	RCC1L_MOUSE	reviewed	RCC1-like G exchanging factor-like protein (RCC1-like) (Williams-Beuren syndrome chromosomal region 16 protein homolog)	Rcc1l Wbscr16	Mus musculus (Mouse)	461	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]	GO:0005085; GO:0005087; GO:0005739; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613	mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]		NA	NA	NA	NA	NA	NA
TRINITY_DN7388_c0_g1_i3	Q9CYF5	RCC1L_MOUSE	44.3	424	224	5	1292	48	41	461	1.30E-106	388.3	RCC1L_MOUSE	reviewed	RCC1-like G exchanging factor-like protein (RCC1-like) (Williams-Beuren syndrome chromosomal region 16 protein homolog)	Rcc1l Wbscr16	Mus musculus (Mouse)	461	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	guanyl-nucleotide exchange factor activity [GO:0005085]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; rRNA binding [GO:0019843]	GO:0005085; GO:0005087; GO:0005739; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613	mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]		blue	blue	NA	NA	NA	NA
TRINITY_DN32037_c0_g1_i1	O54963	REST_RAT	48	50	26	0	11	160	276	325	2.20E-10	65.9	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40672_c0_g1_i1	O54963	REST_RAT	43.2	74	42	0	5	226	252	325	7.20E-14	77.8	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i16	O54963	REST_RAT	37.3	67	42	0	578	778	264	330	8.20E-10	65.9	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37151_c0_g1_i1	O54963	REST_RAT	35.7	115	72	1	14	352	273	387	3.30E-19	95.9	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40316_c0_g1_i1	O54963	REST_RAT	51.9	52	25	0	177	22	272	323	5.00E-12	71.2	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37064_c0_g1_i1	O54963	REST_RAT	48.8	80	41	0	251	12	275	354	5.50E-19	94.7	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40949_c0_g1_i1	O54963	REST_RAT	47.5	59	31	0	56	232	273	331	2.90E-13	75.5	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11782_c0_g3_i1	O54963	REST_RAT	48.1	52	27	0	176	21	275	326	6.40E-10	64.3	REST_RAT	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	Rest Nrsf	Rattus norvegicus (Rat)	1069	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0030182; GO:0032348; GO:0032991; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043565; GO:0043922; GO:0044877; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2497_c0_g1_i2	Q2EI20	REST_DANRE	32.9	73	49	0	402	620	329	401	4.80E-08	59.7	REST_DANRE	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	rest nrsf	Danio rerio (Zebrafish) (Brachydanio rerio)	855	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000381; GO:0000977; GO:0000981; GO:0001666; GO:0001764; GO:0005634; GO:0005737; GO:0006357; GO:0007626; GO:0010629; GO:0014043; GO:0021610; GO:0021754; GO:0021785; GO:0042551; GO:0045666; GO:0045667; GO:0045879; GO:0045892; GO:0046872; GO:0060831; GO:0097475	"branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28531_c0_g1_i1	Q2EI20	REST_DANRE	44.2	77	42	1	1	231	263	338	1.10E-16	87	REST_DANRE	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	rest nrsf	Danio rerio (Zebrafish) (Brachydanio rerio)	855	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000381; GO:0000977; GO:0000981; GO:0001666; GO:0001764; GO:0005634; GO:0005737; GO:0006357; GO:0007626; GO:0010629; GO:0014043; GO:0021610; GO:0021754; GO:0021785; GO:0042551; GO:0045666; GO:0045667; GO:0045879; GO:0045892; GO:0046872; GO:0060831; GO:0097475	"branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28136_c0_g1_i1	Q2EI20	REST_DANRE	41.3	46	27	0	49	186	351	396	7.20E-07	54.3	REST_DANRE	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor)	rest nrsf	Danio rerio (Zebrafish) (Brachydanio rerio)	855	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000381; GO:0000977; GO:0000981; GO:0001666; GO:0001764; GO:0005634; GO:0005737; GO:0006357; GO:0007626; GO:0010629; GO:0014043; GO:0021610; GO:0021754; GO:0021785; GO:0042551; GO:0045666; GO:0045667; GO:0045879; GO:0045892; GO:0046872; GO:0060831; GO:0097475	"branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7695_c0_g1_i2	Q13127	REST_HUMAN	43.1	109	61	1	440	117	301	409	7.00E-24	112.1	REST_HUMAN	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor)	REST NRSF XBR	Homo sapiens (Human)	1097	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i1	Q13127	REST_HUMAN	43.9	82	46	0	130	375	274	355	1.80E-17	90.5	REST_HUMAN	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor)	REST NRSF XBR	Homo sapiens (Human)	1097	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i10	Q13127	REST_HUMAN	40	150	88	2	542	985	263	412	7.50E-35	149.4	REST_HUMAN	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor)	REST NRSF XBR	Homo sapiens (Human)	1097	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2608_c0_g1_i8	Q13127	REST_HUMAN	46.4	84	45	0	490	741	272	355	5.40E-19	96.3	REST_HUMAN	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor)	REST NRSF XBR	Homo sapiens (Human)	1097	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36449_c0_g1_i1	Q13127	REST_HUMAN	100	78	0	0	3	236	278	355	1.60E-43	176	REST_HUMAN	reviewed	RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor)	REST NRSF XBR	Homo sapiens (Human)	1097	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0001227; GO:0001666; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008134; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0035690; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0070933; GO:0071257; GO:0071385; GO:0097150; GO:0099563; GO:1902459; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5684_c0_g1_i1	Q2EI21	RESTA_XENLA	48.2	56	29	0	390	223	298	353	6.10E-11	68.9	RESTA_XENLA	reviewed	RE1-silencing transcription factor A (Neural-restrictive silencer factor A)	rest-a nrsf-a	Xenopus laevis (African clawed frog)	1501	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0000381; GO:0001666; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i14	Q9PVG3	RESTB_XENLA	44.8	96	48	1	578	865	272	362	3.10E-18	94	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i17	Q9PVG3	RESTB_XENLA	44.8	96	48	1	136	423	272	362	1.50E-18	94	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14959_c0_g1_i1	Q9PVG3	RESTB_XENLA	45	60	33	0	56	235	271	330	2.60E-09	62.4	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6575_c0_g1_i2	Q9PVG3	RESTB_XENLA	38.3	115	67	2	1276	1617	295	406	6.40E-22	107.1	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33317_c0_g1_i1	Q9PVG3	RESTB_XENLA	44	75	41	1	27	248	305	379	2.10E-16	86.3	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28087_c0_g1_i1	Q9PVG3	RESTB_XENLA	40.6	64	32	1	287	114	259	322	6.00E-10	65.5	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36443_c0_g1_i1	Q9PVG3	RESTB_XENLA	47.4	78	41	0	30	263	274	351	2.80E-15	82.4	RESTB_XENLA	reviewed	RE1-silencing transcription factor B (Neural-restrictive silencer factor B) (Fragment)	rest-b nrsf-b	Xenopus laevis (African clawed frog)	529	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000381; GO:0000981; GO:0001666; GO:0005634; GO:0005737; GO:0043065; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0046872	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16075_c0_g1_i1	Q6NYD1	ROMO1_DANRE	70	80	22	1	334	95	3	80	1.30E-25	118.2	ROMO1_DANRE	reviewed	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	romo1 zgc:73345	Danio rerio (Zebrafish) (Brachydanio rerio)	80	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0042742; GO:0045039; GO:2000379	cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]		NA	NA	NA	NA	NA	NA
TRINITY_DN16075_c0_g1_i3	Q6NYD1	ROMO1_DANRE	70	80	22	1	334	95	3	80	1.20E-25	117.9	ROMO1_DANRE	reviewed	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	romo1 zgc:73345	Danio rerio (Zebrafish) (Brachydanio rerio)	80	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0042742; GO:0045039; GO:2000379	cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]		NA	NA	NA	NA	NA	NA
TRINITY_DN16075_c0_g1_i4	Q6NYD1	ROMO1_DANRE	70	80	22	1	334	95	3	80	7.60E-26	118.2	ROMO1_DANRE	reviewed	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	romo1 zgc:73345	Danio rerio (Zebrafish) (Brachydanio rerio)	80	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0042742; GO:0045039; GO:2000379	cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]		blue	blue	NA	NA	NA	NA
TRINITY_DN9399_c0_g1_i1	Q3SZV8	ROMO1_BOVIN	100	79	0	0	19	255	1	79	8.20E-40	164.1	ROMO1_BOVIN	reviewed	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	ROMO1	Bos taurus (Bovine)	79	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0045039; GO:0050829; GO:0050830; GO:0051838; GO:0061844; GO:2000379	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]		NA	NA	NA	NA	NA	NA
TRINITY_DN9399_c0_g1_i2	Q3SZV8	ROMO1_BOVIN	100	73	0	0	1	219	7	79	1.40E-36	153.3	ROMO1_BOVIN	reviewed	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	ROMO1	Bos taurus (Bovine)	79	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]		GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0045039; GO:0050829; GO:0050830; GO:0051838; GO:0061844; GO:2000379	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]		NA	NA	NA	NA	NA	NA
TRINITY_DN11622_c0_g2_i1	B2RZ37	REEP5_RAT	97.7	128	3	0	3	386	30	157	2.80E-69	262.3	REEP5_RAT	reviewed	Receptor expression-enhancing protein 5 (Polyposis locus protein 1 homolog)	Reep5 Dp1	Rattus norvegicus (Rat)	189	endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]	endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]		GO:0016021; GO:0071782			NA	NA	NA	NA	NA	NA
TRINITY_DN17685_c0_g1_i3	Q5RE33	REEP5_PONAB	57.4	162	69	0	586	101	11	172	1.60E-52	207.2	REEP5_PONAB	reviewed	Receptor expression-enhancing protein 5 (Polyposis locus protein 1 homolog)	REEP5 DP1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	189	endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]	endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]		GO:0016021; GO:0071782			blue	blue	NA	NA	NA	NA
TRINITY_DN11622_c0_g1_i1	Q00765	REEP5_HUMAN	100	149	0	0	1	447	22	170	4.90E-81	301.6	REEP5_HUMAN	reviewed	Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2)	REEP5 C5orf18 DP1 TB2	Homo sapiens (Human)	189	endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]	endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]		GO:0016021; GO:0071782			NA	NA	NA	NA	NA	NA
TRINITY_DN17685_c0_g1_i1	Q66IF1	REEP6_DANRE	56.8	139	60	0	511	95	39	177	7.30E-45	182.2	REEP6_DANRE	reviewed	Receptor expression-enhancing protein 6	reep6 zgc:101529	Danio rerio (Zebrafish) (Brachydanio rerio)	208	clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]	clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0010842; GO:0016021; GO:0030665; GO:0060059	embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]		blue	blue	NA	NA	NA	NA
TRINITY_DN17685_c0_g1_i2	Q66IF1	REEP6_DANRE	56.8	139	60	0	511	95	39	177	7.10E-45	182.2	REEP6_DANRE	reviewed	Receptor expression-enhancing protein 6	reep6 zgc:101529	Danio rerio (Zebrafish) (Brachydanio rerio)	208	clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]	clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0010842; GO:0016021; GO:0030665; GO:0060059	embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]		NA	NA	NA	NA	NA	NA
TRINITY_DN24725_c1_g1_i1	Q9ERK0	RIPK4_MOUSE	27.4	215	131	4	820	203	532	730	1.20E-14	82	RIPK4_MOUSE	reviewed	Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-associated protein kinase) (PKC-regulated protein kinase)	Ripk4 Ankrd3 Pkk	Mus musculus (Mouse)	786	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	cytoplasm [GO:0005737]; membrane [GO:0016020]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0051092	morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]		NA	NA	NA	NA	NA	NA
TRINITY_DN7113_c0_g1_i1	Q9ERK0	RIPK4_MOUSE	35.6	163	100	2	610	122	592	749	3.30E-15	83.6	RIPK4_MOUSE	reviewed	Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-associated protein kinase) (PKC-regulated protein kinase)	Ripk4 Ankrd3 Pkk	Mus musculus (Mouse)	786	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	cytoplasm [GO:0005737]; membrane [GO:0016020]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0051092	morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]		NA	NA	NA	NA	NA	NA
TRINITY_DN16975_c0_g1_i1	A8WVM4	RME6_CAEBR	28.7	129	78	4	708	355	261	386	2.20E-08	61.2	RME6_CAEBR	reviewed	Receptor-mediated endocytosis protein 6	rme-6 CBG04130	Caenorhabditis briggsae	1104	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; membrane [GO:0016020]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005829; GO:0006897; GO:0007165; GO:0016020; GO:0030136; GO:0032794; GO:0051223	endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36368_c0_g1_i1	Q7JQ32	GC76C_DROME	75.9	79	18	1	31	264	981	1059	1.20E-29	130.2	GC76C_DROME	reviewed	Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)	Gyc76C CG42636	Drosophila melanogaster (Fruit fly)	1525	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10732_c0_g1_i2	Q7JQ32	GC76C_DROME	30.5	344	212	7	974	9	26	364	4.10E-44	180.3	GC76C_DROME	reviewed	Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)	Gyc76C CG42636	Drosophila melanogaster (Fruit fly)	1525	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10732_c0_g1_i6	Q7JQ32	GC76C_DROME	29.8	349	216	7	998	9	26	364	1.20E-43	178.7	GC76C_DROME	reviewed	Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)	Gyc76C CG42636	Drosophila melanogaster (Fruit fly)	1525	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35458_c0_g1_i2	Q7JQ32	GC76C_DROME	40.8	184	101	4	554	3	712	887	6.10E-31	135.6	GC76C_DROME	reviewed	Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)	Gyc76C CG42636	Drosophila melanogaster (Fruit fly)	1525	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872	"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i1	P18433	PTPRA_HUMAN	30.7	521	345	8	1526	3	244	761	5.40E-67	256.9	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i2	P18433	PTPRA_HUMAN	30.3	521	347	8	1526	3	244	761	3.50E-66	254.2	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i4	P18433	PTPRA_HUMAN	30.3	521	347	8	1526	3	244	761	1.20E-66	255.8	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i6	P18433	PTPRA_HUMAN	30.9	521	344	8	1526	3	244	761	2.20E-68	261.5	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i7	P18433	PTPRA_HUMAN	39.7	257	147	3	761	15	244	500	1.10E-48	195.3	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i8	P18433	PTPRA_HUMAN	31.3	521	342	8	1526	3	244	761	9.80E-69	262.7	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN40454_c0_g1_i1	P18433	PTPRA_HUMAN	100	70	0	0	3	212	578	647	1.20E-37	156.4	PTPRA_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	PTPRA PTPA PTPRL2	Homo sapiens (Human)	802	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685	axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN25542_c0_g1_i1	P18052	PTPRA_MOUSE	100	134	0	0	403	2	404	537	8.00E-75	280.8	PTPRA_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)	Ptpra Lrp Ptpa	Mus musculus (Mouse)	829	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	protein-containing complex binding [GO:0044877]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005886; GO:0005925; GO:0006468; GO:0006470; GO:0008286; GO:0016021; GO:0043231; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0098685	insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN29729_c0_g1_i1	P23467	PTPRB_HUMAN	46.3	255	128	3	2	751	1710	1960	7.10E-62	238.8	PTPRB_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP)	PTPRB PTPB	Homo sapiens (Human)	1997	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001525; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0016311; GO:0035579; GO:0043235; GO:0043312; GO:0045296; GO:0070821; GO:1990264	angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]		blue	blue	NA	NA	NA	NA
TRINITY_DN614_c0_g1_i1	P06800	PTPRC_MOUSE	28.2	607	376	17	2083	425	620	1220	9.60E-60	233.4	PTPRC_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (Lymphocyte antigen 5) (Ly-5) (T200) (CD antigen CD45)	Ptprc Ly-5	Mus musculus (Mouse)	1293	bleb [GO:0032059]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of gene expression [GO:0010468]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]	bleb [GO:0032059]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]	GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002711; GO:0002923; GO:0002925; GO:0004725; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016021; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045582; GO:0045588; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050732; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070373; GO:0070374; GO:0071944; GO:0098857; GO:1903615; GO:1905451; GO:2000473; GO:2000648; GO:2001236; GO:2001238	activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of gene expression [GO:0010468]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]		blue	blue	NA	NA	NA	NA
TRINITY_DN31175_c0_g1_i1	P08575	PTPRC_HUMAN	100	120	0	0	3	362	788	907	8.00E-66	250.8	PTPRC_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)	PTPRC CD45	Homo sapiens (Human)	1306	bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016021; GO:0016032; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0042110; GO:0043312; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045588; GO:0045860; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070062; GO:0070373; GO:0070374; GO:0098857; GO:1903615; GO:1903979; GO:1904155; GO:1905451; GO:2000473; GO:2000648; GO:2001238	activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN28695_c0_g1_i1	P08575	PTPRC_HUMAN	100	103	0	0	310	2	679	781	6.90E-58	224.2	PTPRC_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)	PTPRC CD45	Homo sapiens (Human)	1306	bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016021; GO:0016032; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0042110; GO:0043312; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045588; GO:0045860; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070062; GO:0070373; GO:0070374; GO:0098857; GO:1903615; GO:1903979; GO:1904155; GO:1905451; GO:2000473; GO:2000648; GO:2001238	activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN27056_c0_g1_i1	P08575	PTPRC_HUMAN	100	65	0	0	17	211	1012	1076	4.00E-33	141.4	PTPRC_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)	PTPRC CD45	Homo sapiens (Human)	1306	bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016021; GO:0016032; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0042110; GO:0043312; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045588; GO:0045860; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070062; GO:0070373; GO:0070374; GO:0098857; GO:1903615; GO:1903979; GO:1904155; GO:1905451; GO:2000473; GO:2000648; GO:2001238	activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; neutrophil degranulation [GO:0043312]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN15749_c0_g1_i2	P23468	PTPRD_HUMAN	38.6	83	46	2	234	1	1782	1864	2.90E-10	65.9	PTPRD_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	PTPRD	Homo sapiens (Human)	1912	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0050775; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098978; GO:0099545; GO:0099560	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]		NA	NA	NA	NA	NA	NA
TRINITY_DN26739_c0_g1_i1	P23468	PTPRD_HUMAN	86.7	75	10	0	226	2	1684	1758	3.60E-35	148.3	PTPRD_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	PTPRD	Homo sapiens (Human)	1912	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0050775; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098978; GO:0099545; GO:0099560	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]		NA	NA	NA	NA	NA	NA
TRINITY_DN30916_c0_g1_i1	P23468	PTPRD_HUMAN	79.6	103	21	0	2	310	1575	1677	4.50E-41	168.3	PTPRD_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	PTPRD	Homo sapiens (Human)	1912	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0050775; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098978; GO:0099545; GO:0099560	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]		NA	NA	NA	NA	NA	NA
TRINITY_DN38781_c0_g1_i1	P23468	PTPRD_HUMAN	76.5	243	55	1	47	775	1315	1555	5.20E-115	415.2	PTPRD_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	PTPRD	Homo sapiens (Human)	1912	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0050775; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098978; GO:0099545; GO:0099560	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]		NA	NA	NA	NA	NA	NA
TRINITY_DN36563_c0_g1_i1	P49446	PTPRE_MOUSE	93.8	81	5	0	244	2	590	670	2.80E-38	159.1	PTPRE_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48)	Ptpre Ptpe	Mus musculus (Mouse)	699	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0042802; GO:0046627	negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]		NA	NA	NA	NA	NA	NA
TRINITY_DN36563_c0_g1_i1	P49446	PTPRE_MOUSE	85.2	27	4	0	315	235	205	231	1.90E-07	56.6	PTPRE_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48)	Ptpre Ptpe	Mus musculus (Mouse)	699	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0042802; GO:0046627	negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]		NA	NA	NA	NA	NA	NA
TRINITY_DN31904_c0_g1_i1	P10586	PTPRF_HUMAN	33.3	90	54	3	301	32	414	497	1.70E-05	50.1	PTPRF_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)	PTPRF LAR	Homo sapiens (Human)	1907	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein-containing complex binding [GO:0044877]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121	cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]		NA	NA	NA	NA	NA	NA
TRINITY_DN15749_c1_g1_i1	E9Q0N2	PTPRH_MOUSE	44.7	94	49	1	1	273	834	927	1.70E-15	83.2	PTPRH_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase H (R-PTP-H) (EC 3.1.3.48) (Stomach cancer-associated protein tyrosine phosphatase 1) (SAP-1)	Ptprh SAP-1	Mus musculus (Mouse)	971	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]	cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005737; GO:0005902; GO:0006470; GO:0016021; GO:0016324; GO:0031528; GO:0045296; GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN5850_c0_g1_i1	Q15262	PTPRK_HUMAN	34	592	343	15	1887	130	887	1436	9.20E-101	369.4	PTPRK_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	PTPRK PTPK	Homo sapiens (Human)	1439	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	adherens junction [GO:0005912]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030217; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5850_c0_g1_i2	Q15262	PTPRK_HUMAN	35.1	573	343	15	1830	130	887	1436	4.70E-102	373.6	PTPRK_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	PTPRK PTPK	Homo sapiens (Human)	1439	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	adherens junction [GO:0005912]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030217; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30091_c0_g1_i1	O02695	PTPR2_MACNE	73.2	257	69	0	11	781	713	969	9.40E-112	404.4	PTPR2_MACNE	reviewed	Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (M1851) [Cleaved into: IA-2beta60]	PTPRN2	Macaca nemestrina (Pig-tailed macaque)	1013	integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein tyrosine phosphatase activity [GO:0004725]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]	integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0006629; GO:0007269; GO:0016021; GO:0030667; GO:0030672; GO:0035773	insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]		NA	NA	NA	NA	NA	NA
TRINITY_DN3183_c0_g1_i1	Q15256	PTPRR_HUMAN	34.2	292	180	6	915	49	375	657	2.20E-45	184.5	PTPRR_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1)	PTPRR ECPTP PTPRQ	Homo sapiens (Human)	657	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein dephosphorylation [GO:0006470]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001701; GO:0004725; GO:0005001; GO:0005615; GO:0005829; GO:0005886; GO:0006470; GO:0010633; GO:0016021; GO:0019901; GO:0030054; GO:0038128; GO:0048471; GO:0070373	ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN3183_c0_g1_i2	Q15256	PTPRR_HUMAN	36	100	64	0	348	49	558	657	3.10E-14	80.9	PTPRR_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1)	PTPRR ECPTP PTPRQ	Homo sapiens (Human)	657	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein dephosphorylation [GO:0006470]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001701; GO:0004725; GO:0005001; GO:0005615; GO:0005829; GO:0005886; GO:0006470; GO:0010633; GO:0016021; GO:0019901; GO:0030054; GO:0038128; GO:0048471; GO:0070373	ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN15749_c0_g1_i1	Q92729	PTPRU_HUMAN	46.2	65	34	1	198	7	1039	1103	2.50E-10	66.2	PTPRU_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Pancreatic carcinoma phosphatase 2) (PCP-2) (Protein-tyrosine phosphatase J) (PTP-J) (hPTP-J) (Protein-tyrosine phosphatase pi) (PTP pi) (Protein-tyrosine phosphatase receptor omicron) (PTP-RO) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi)	PTPRU FMI PCP2 PTPRO	Homo sapiens (Human)	1446	cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0007155; GO:0007185; GO:0008013; GO:0008285; GO:0030154; GO:0030336; GO:0031100; GO:0034109; GO:0034394; GO:0051384; GO:0090090; GO:2000049	animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i20	B9EKR1	PTPRZ_MOUSE	30.4	404	249	9	506	1642	1722	2118	1.70E-44	182.2	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i29	B9EKR1	PTPRZ_MOUSE	28	543	344	14	577	2106	1722	2250	8.50E-51	203.4	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i4	B9EKR1	PTPRZ_MOUSE	28	543	344	14	506	2035	1722	2250	8.20E-51	203.4	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i7	B9EKR1	PTPRZ_MOUSE	30.4	404	249	9	518	1654	1722	2118	1.70E-44	182.2	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i8	B9EKR1	PTPRZ_MOUSE	31.2	384	232	9	566	1642	1742	2118	6.10E-44	180.3	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i9	B9EKR1	PTPRZ_MOUSE	28	543	344	14	518	2047	1722	2250	8.30E-51	203.4	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c1_g2_i1	Q6DDH2	RMI1_XENLA	42	200	114	2	1051	458	16	215	1.10E-36	155.6	RMI1_XENLA	reviewed	RecQ-mediated genome instability protein 1	rmi1	Xenopus laevis (African clawed frog)	557	nucleus [GO:0005634]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]	nucleus [GO:0005634]	nucleotide binding [GO:0000166]	GO:0000166; GO:0005634; GO:0006260	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1268_c1_g2_i2	Q6DDH2	RMI1_XENLA	42	200	114	2	1031	438	16	215	1.10E-36	155.6	RMI1_XENLA	reviewed	RecQ-mediated genome instability protein 1	rmi1	Xenopus laevis (African clawed frog)	557	nucleus [GO:0005634]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]	nucleus [GO:0005634]	nucleotide binding [GO:0000166]	GO:0000166; GO:0005634; GO:0006260	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i2	D4AU31	SWNK_ARTBC	35.2	105	60	3	428	114	56	152	7.60E-08	58.5	SWNK_ARTBC	reviewed	Reducing polyketide synthase swnK (EC 2.3.1.-) (Swainsonine biosynthesis gene cluster protein K)	swnK ARB_07844	Arthroderma benhamiae (strain ATCC MYA-4681 / CBS 112371) (Trichophyton mentagrophytes)	2567	"ligase activity [GO:0016874]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; methylation [GO:0032259]"		"ligase activity [GO:0016874]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]"	GO:0008168; GO:0016491; GO:0016746; GO:0016874; GO:0031177; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i12	P58751	RELN_RAT	40.2	410	219	10	63	1247	2986	3384	3.20E-80	300.4	RELN_RAT	reviewed	Reelin (EC 3.4.21.-)	Reln	Rattus norvegicus (Rat)	3462	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; thyroid hormone metabolic process [GO:0042403]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007612; GO:0007613; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0010468; GO:0010976; GO:0014068; GO:0014070; GO:0016358; GO:0016477; GO:0017085; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021769; GO:0021800; GO:0021819; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032570; GO:0032793; GO:0035176; GO:0035418; GO:0038026; GO:0042403; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051412; GO:0051602; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0070542; GO:0071549; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; thyroid hormone metabolic process [GO:0042403]; ventral spinal cord development [GO:0021517]"		brown	brown	1	NA	NA	NA
TRINITY_DN4978_c0_g1_i17	P58751	RELN_RAT	41.8	459	241	10	63	1394	2986	3433	3.50E-99	363.6	RELN_RAT	reviewed	Reelin (EC 3.4.21.-)	Reln	Rattus norvegicus (Rat)	3462	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; thyroid hormone metabolic process [GO:0042403]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007612; GO:0007613; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0010468; GO:0010976; GO:0014068; GO:0014070; GO:0016358; GO:0016477; GO:0017085; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021769; GO:0021800; GO:0021819; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032570; GO:0032793; GO:0035176; GO:0035418; GO:0038026; GO:0042403; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051412; GO:0051602; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0070542; GO:0071549; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; thyroid hormone metabolic process [GO:0042403]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i19	P78509	RELN_HUMAN	62.2	45	17	0	80	214	3383	3427	2.20E-11	69.3	RELN_HUMAN	reviewed	Reelin (EC 3.4.21.-)	RELN	Homo sapiens (Human)	3460	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0032793; GO:0038026; GO:0043005; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19946_c0_g1_i1	O93574	RELN_CHICK	39.7	156	92	2	512	48	533	687	5.10E-30	132.5	RELN_CHICK	reviewed	Reelin (EC 3.4.21.-) (Fragment)	RELN	Gallus gallus (Chicken)	3209	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0008236; GO:0010001; GO:0018108; GO:0021511; GO:0021517; GO:0021800; GO:0030425; GO:0043005; GO:0045860; GO:0046872; GO:0048265; GO:0051057; GO:0070325	axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i16	O93574	RELN_CHICK	36.9	1121	646	18	87	3314	2076	3180	5.70E-222	772.7	RELN_CHICK	reviewed	Reelin (EC 3.4.21.-) (Fragment)	RELN	Gallus gallus (Chicken)	3209	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0008236; GO:0010001; GO:0018108; GO:0021511; GO:0021517; GO:0021800; GO:0030425; GO:0043005; GO:0045860; GO:0046872; GO:0048265; GO:0051057; GO:0070325	axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i7	O93574	RELN_CHICK	37	825	462	15	81	2426	2371	3180	9.60E-158	558.9	RELN_CHICK	reviewed	Reelin (EC 3.4.21.-) (Fragment)	RELN	Gallus gallus (Chicken)	3209	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0008236; GO:0010001; GO:0018108; GO:0021511; GO:0021517; GO:0021800; GO:0030425; GO:0043005; GO:0045860; GO:0046872; GO:0048265; GO:0051057; GO:0070325	axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]		NA	NA	NA	NA	NA	NA
TRINITY_DN39689_c0_g1_i1	Q60841	RELN_MOUSE	46.4	84	38	3	265	23	361	440	3.40E-13	75.5	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19946_c0_g2_i1	Q60841	RELN_MOUSE	58	50	20	1	79	228	948	996	4.20E-12	71.6	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i1	Q60841	RELN_MOUSE	35.3	711	400	19	2	2095	1439	2102	3.60E-113	410.6	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i11	Q60841	RELN_MOUSE	38	874	480	21	2	2581	1439	2264	9.50E-164	578.9	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i13	Q60841	RELN_MOUSE	36.6	2470	1397	55	2	7135	1039	3432	0	1571.6	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i21	Q60841	RELN_MOUSE	37.4	2062	1158	44	69	6059	1439	3432	0	1369.4	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4978_c0_g1_i4	Q60841	RELN_MOUSE	36	2515	1397	56	2	7270	1039	3432	0	1550	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19047_c0_g1_i1	Q60841	RELN_MOUSE	41.4	157	86	4	679	1143	633	785	1.30E-22	109	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19047_c0_g1_i2	Q60841	RELN_MOUSE	32.5	354	219	9	24	1043	438	785	3.00E-39	164.1	RELN_MOUSE	reviewed	Reelin (EC 3.4.21.-) (Reeler protein)	Reln Rl	Mus musculus (Mouse)	3461	"axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007612; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010468; GO:0010976; GO:0014068; GO:0016358; GO:0016477; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021800; GO:0021819; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0043025; GO:0043204; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0062023; GO:0070325; GO:0070326; GO:0090129; GO:0097107; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density assembly [GO:0097107]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12751_c0_g1_i3	Q6TLF6	RGN_DANRE	43.5	115	63	1	2	346	181	293	1.40E-22	107.5	RGN_DANRE	reviewed	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)	rgn zgc:92078	Danio rerio (Zebrafish) (Brachydanio rerio)	295	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]	GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848	cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN12751_c0_g1_i5	Q6TLF6	RGN_DANRE	42.2	199	109	3	135	731	101	293	1.50E-38	161.4	RGN_DANRE	reviewed	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)	rgn zgc:92078	Danio rerio (Zebrafish) (Brachydanio rerio)	295	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]	GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848	cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN29117_c0_g1_i1	Q6TLF6	RGN_DANRE	45	120	61	2	2	358	171	286	6.80E-25	114.8	RGN_DANRE	reviewed	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)	rgn zgc:92078	Danio rerio (Zebrafish) (Brachydanio rerio)	295	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]	GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848	cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN2169_c1_g1_i2	Q9I923	RGN_CHICK	45.5	235	116	3	769	68	74	297	1.30E-52	208	RGN_CHICK	reviewed	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)	RGN	Gallus gallus (Chicken)	299	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]	GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848	cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]		NA	NA	NA	NA	NA	NA
TRINITY_DN5426_c0_g1_i1	Q9NQG5	RPR1B_HUMAN	57.7	156	65	1	12	479	170	324	1.80E-37	157.1	RPR1B_HUMAN	reviewed	Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor)	RPRD1B C20orf77 CREPT	Homo sapiens (Human)	326	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]"	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0005634; GO:0005654; GO:0008284; GO:0010564; GO:0016591; GO:0031124; GO:0042795; GO:0042802; GO:0045944; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN6721_c0_g1_i1	Q9NQG5	RPR1B_HUMAN	57.6	118	49	1	68	421	1	117	2.70E-33	143.3	RPR1B_HUMAN	reviewed	Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor)	RPRD1B C20orf77 CREPT	Homo sapiens (Human)	326	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]"	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0005634; GO:0005654; GO:0008284; GO:0010564; GO:0016591; GO:0031124; GO:0042795; GO:0042802; GO:0045944; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN1773_c0_g1_i2	P18754	RCC1_HUMAN	46.9	371	188	5	207	1307	5	370	6.40E-87	322.8	RCC1_HUMAN	reviewed	Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1)	RCC1 CHC1	Homo sapiens (Human)	421	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032]	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]	GO:0000082; GO:0000785; GO:0000790; GO:0000794; GO:0003682; GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007059; GO:0007088; GO:0008536; GO:0016032; GO:0031291; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673	cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1773_c0_g1_i4	P18754	RCC1_HUMAN	47.5	385	193	5	207	1349	5	384	1.70E-92	341.3	RCC1_HUMAN	reviewed	Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1)	RCC1 CHC1	Homo sapiens (Human)	421	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032]	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]	GO:0000082; GO:0000785; GO:0000790; GO:0000794; GO:0003682; GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007059; GO:0007088; GO:0008536; GO:0016032; GO:0031291; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673	cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1773_c0_g1_i1	P25171	RCC1_DROME	42.4	85	48	1	50	304	303	386	7.40E-12	71.2	RCC1_DROME	reviewed	Regulator of chromosome condensation (Chromatin-binding protein Bj1) (Regulator of chromosome condensation 1 ortholog)	Rcc1 Bj1 CG10480	Drosophila melanogaster (Fruit fly)	547	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; cell cycle [GO:0007049]; cell division [GO:0051301]; central nervous system development [GO:0007417]; NLS-bearing protein import into nucleus [GO:0006607]; Ran protein signal transduction [GO:0031291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; regulation of neurogenesis [GO:0050767]; regulation of nucleocytoplasmic transport [GO:0046822]; ventral cord development [GO:0007419]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0000790; GO:0000793; GO:0003682; GO:0005087; GO:0005634; GO:0005737; GO:0006607; GO:0007049; GO:0007346; GO:0007417; GO:0007419; GO:0031291; GO:0046822; GO:0050767; GO:0051301; GO:1901673	cell cycle [GO:0007049]; cell division [GO:0051301]; central nervous system development [GO:0007417]; NLS-bearing protein import into nucleus [GO:0006607]; Ran protein signal transduction [GO:0031291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; regulation of neurogenesis [GO:0050767]; regulation of nucleocytoplasmic transport [GO:0046822]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN1773_c0_g1_i3	P25171	RCC1_DROME	40.6	69	40	1	50	256	303	370	1.80E-06	53.5	RCC1_DROME	reviewed	Regulator of chromosome condensation (Chromatin-binding protein Bj1) (Regulator of chromosome condensation 1 ortholog)	Rcc1 Bj1 CG10480	Drosophila melanogaster (Fruit fly)	547	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; cell cycle [GO:0007049]; cell division [GO:0051301]; central nervous system development [GO:0007417]; NLS-bearing protein import into nucleus [GO:0006607]; Ran protein signal transduction [GO:0031291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; regulation of neurogenesis [GO:0050767]; regulation of nucleocytoplasmic transport [GO:0046822]; ventral cord development [GO:0007419]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0000790; GO:0000793; GO:0003682; GO:0005087; GO:0005634; GO:0005737; GO:0006607; GO:0007049; GO:0007346; GO:0007417; GO:0007419; GO:0031291; GO:0046822; GO:0050767; GO:0051301; GO:1901673	cell cycle [GO:0007049]; cell division [GO:0051301]; central nervous system development [GO:0007417]; NLS-bearing protein import into nucleus [GO:0006607]; Ran protein signal transduction [GO:0031291]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; regulation of neurogenesis [GO:0050767]; regulation of nucleocytoplasmic transport [GO:0046822]; ventral cord development [GO:0007419]		NA	NA	NA	NA	NA	NA
TRINITY_DN39825_c0_g1_i1	Q8VE37	RCC1_MOUSE	100	68	0	0	1	204	78	145	5.00E-33	141	RCC1_MOUSE	reviewed	Regulator of chromosome condensation (Chromosome condensation protein 1)	Rcc1 Chc1	Mus musculus (Mouse)	421	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]	GO:0000082; GO:0000785; GO:0000790; GO:0000794; GO:0003682; GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007059; GO:0007088; GO:0008536; GO:0031291; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673	cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN30356_c0_g1_i1	Q9JL25	RGS1_MOUSE	100	68	0	0	204	1	70	137	8.60E-33	140.2	RGS1_MOUSE	reviewed	Regulator of G-protein signaling 1 (RGS1)	Rgs1	Mus musculus (Mouse)	209	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]	GO:0001965; GO:0005096; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0008277; GO:0009617; GO:0009968; GO:0031234; GO:0043547; GO:0061737	G protein-coupled receptor signaling pathway [GO:0007186]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31497_c0_g1_i1	Q08116	RGS1_HUMAN	100	75	0	0	226	2	83	157	6.30E-37	154.1	RGS1_HUMAN	reviewed	Regulator of G-protein signaling 1 (RGS1) (B-cell activation protein BL34) (Early response protein 1R20)	RGS1 1R20 BL34 IER1	Homo sapiens (Human)	209	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0001965; GO:0003924; GO:0005096; GO:0005516; GO:0005829; GO:0005886; GO:0006955; GO:0007165; GO:0007186; GO:0007193; GO:0008277; GO:0009617; GO:0009968; GO:0031234; GO:0043547; GO:0061737	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN40510_c0_g1_i1	Q9CQE5	RGS10_MOUSE	100	67	0	0	1	201	41	107	6.10E-31	134	RGS10_MOUSE	reviewed	Regulator of G-protein signaling 10 (RGS10)	Rgs10	Mus musculus (Mouse)	181	axon terminus [GO:0043679]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to amphetamine [GO:0001975]	axon terminus [GO:0043679]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]	GO:0001965; GO:0001975; GO:0005096; GO:0005634; GO:0005829; GO:0007213; GO:0008277; GO:0009968; GO:0043025; GO:0043197; GO:0043547; GO:0043679	G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to amphetamine [GO:0001975]		NA	NA	NA	NA	NA	NA
TRINITY_DN26544_c0_g1_i1	O43566	RGS14_HUMAN	100	69	0	0	1	207	49	117	1.00E-33	143.3	RGS14_HUMAN	reviewed	Regulator of G-protein signaling 14 (RGS14)	RGS14	Homo sapiens (Human)	566	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922]	GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000278; GO:0000922; GO:0001965; GO:0003924; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005886; GO:0006913; GO:0006979; GO:0007051; GO:0007059; GO:0007186; GO:0007612; GO:0007616; GO:0008017; GO:0008277; GO:0008542; GO:0010070; GO:0014069; GO:0016604; GO:0016605; GO:0019901; GO:0030159; GO:0030425; GO:0031914; GO:0032794; GO:0035556; GO:0043197; GO:0043407; GO:0043620; GO:0045744; GO:0048008; GO:0050769; GO:0051301; GO:0060291; GO:0070373; GO:0098978	cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070]		NA	NA	NA	NA	NA	NA
TRINITY_DN38519_c0_g1_i1	O15492	RGS16_HUMAN	100	67	0	0	2	202	49	115	5.50E-32	137.5	RGS16_HUMAN	reviewed	Regulator of G-protein signaling 16 (RGS16) (A28-RGS14P) (Retinal-specific RGS) (RGS-r) (hRGS-r) (Retinally abundant regulator of G-protein signaling)	RGS16 RGSR	Homo sapiens (Human)	202	cytoplasm [GO:0005737]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005516; GO:0005737; GO:0005886; GO:0007186; GO:0007601; GO:0008277; GO:0009968; GO:0031224; GO:0043547	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN31116_c0_g1_i1	Q9CX84	RGS19_MOUSE	100	121	0	0	365	3	94	214	3.40E-64	245.4	RGS19_MOUSE	reviewed	Regulator of G-protein signaling 19 (RGS19)	Rgs19	Mus musculus (Mouse)	216	brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; membrane [GO:0016020]; membrane raft [GO:0045121]; G-protein alpha-subunit binding [GO:0001965]; negative regulation of signal transduction [GO:0009968]	brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; membrane [GO:0016020]; membrane raft [GO:0045121]	G-protein alpha-subunit binding [GO:0001965]	GO:0001965; GO:0005737; GO:0005903; GO:0009968; GO:0016020; GO:0030136; GO:0045121	negative regulation of signal transduction [GO:0009968]		NA	NA	NA	NA	NA	NA
TRINITY_DN26261_c0_g1_i1	P49795	RGS19_HUMAN	100	137	0	0	3	413	81	217	6.10E-73	274.6	RGS19_HUMAN	reviewed	Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP)	RGS19 GAIP GNAI3IP	Homo sapiens (Human)	217	brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to ethanol [GO:0045471]; small GTPase mediated signal transduction [GO:0007264]	brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activity [GO:0003924]	GO:0001965; GO:0003924; GO:0005794; GO:0005886; GO:0005903; GO:0006914; GO:0007186; GO:0007264; GO:0009968; GO:0016020; GO:0030136; GO:0045121; GO:0045471	autophagy [GO:0006914]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to ethanol [GO:0045471]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN29661_c0_g1_i1	O08849	RGS2_MOUSE	43.2	190	97	3	100	660	29	210	1.10E-32	141.7	RGS2_MOUSE	reviewed	Regulator of G-protein signaling 2 (RGS2)	Rgs2	Mus musculus (Mouse)	211	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-tubulin binding [GO:0048487]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-tubulin binding [GO:0048487]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]	GO:0001965; GO:0001975; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007049; GO:0007186; GO:0007283; GO:0007420; GO:0008277; GO:0009898; GO:0010519; GO:0010614; GO:0010976; GO:0017148; GO:0030728; GO:0043005; GO:0043407; GO:0043951; GO:0045471; GO:0045744; GO:0048487; GO:0050873; GO:0055119; GO:0060087; GO:0060135; GO:0060452; GO:0061052; GO:0140194; GO:1900924	brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN35360_c0_g1_i1	O76081	RGS20_HUMAN	69.5	141	43	0	554	132	239	379	2.90E-53	209.9	RGS20_HUMAN	reviewed	Regulator of G-protein signaling 20 (RGS20) (Gz-selective GTPase-activating protein) (G(z)GAP) (Gz-GAP) (Regulator of G-protein signaling Z1) (Regulator of Gz-selective protein signaling 1)	RGS20 RGSZ1 ZGAP1	Homo sapiens (Human)	388	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005802; GO:0005886; GO:0007186; GO:0008277; GO:0009968	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN3601_c0_g1_i3	P49758	RGS6_HUMAN	49.5	198	100	0	123	716	259	456	5.90E-52	205.7	RGS6_HUMAN	reviewed	Regulator of G-protein signaling 6 (RGS6) (S914)	RGS6	Homo sapiens (Human)	472	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0019898; GO:0035556; GO:0043547	G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		NA	NA	NA	NA	NA	NA
TRINITY_DN3601_c0_g1_i2	P49803	RGS7_RAT	59.3	457	176	4	12	1367	6	457	3.60E-157	556.2	RGS7_RAT	reviewed	Regulator of G-protein signaling 7 (RGS7)	Rgs7	Rattus norvegicus (Rat)	477	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; brain development [GO:0007420]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic membrane potential [GO:0060078]; response to amphetamine [GO:0001975]; response to cold [GO:0009409]; response to ethanol [GO:0045471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]	GO:0001965; GO:0001975; GO:0005096; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007420; GO:0008277; GO:0009409; GO:0009968; GO:0031681; GO:0032991; GO:0035556; GO:0043547; GO:0044292; GO:0045121; GO:0045211; GO:0045471; GO:0060078; GO:0098793; GO:0098978; GO:1901381	brain development [GO:0007420]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic membrane potential [GO:0060078]; response to amphetamine [GO:0001975]; response to cold [GO:0009409]; response to ethanol [GO:0045471]		blue	blue	NA	NA	NA	NA
TRINITY_DN3601_c0_g1_i4	O46470	RGS7_BOVIN	58.9	467	180	5	12	1397	6	465	1.40E-158	560.8	RGS7_BOVIN	reviewed	Regulator of G-protein signaling 7 (RGS7)	RGS7	Bos taurus (Bovine)	469	cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0005886; GO:0007186; GO:0009968; GO:0031681; GO:0035556	G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]		blue	blue	NA	NA	NA	NA
TRINITY_DN3601_c0_g1_i5	P49802	RGS7_HUMAN	59.3	457	176	4	12	1367	6	457	2.10E-157	557	RGS7_HUMAN	reviewed	Regulator of G-protein signaling 7 (RGS7)	RGS7	Homo sapiens (Human)	495	cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005829; GO:0005886; GO:0006457; GO:0007186; GO:0009968; GO:0031681; GO:0035556; GO:0043547	G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN369_c0_g1_i1	P57771	RGS8_HUMAN	32.1	131	76	4	405	19	43	162	7.80E-06	52	RGS8_HUMAN	reviewed	Regulator of G-protein signaling 8 (RGS8)	RGS8	Homo sapiens (Human)	180	dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of dopamine receptor signaling pathway [GO:0060159]	dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005886; GO:0007186; GO:0007213; GO:0009968; GO:0030425; GO:0031234; GO:0032809; GO:0043204; GO:0043547; GO:0045202; GO:0060159	G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of dopamine receptor signaling pathway [GO:0060159]		NA	NA	NA	NA	NA	NA
TRINITY_DN37751_c0_g1_i1	Q6GLX4	R9BPB_XENLA	46.4	56	30	0	46	213	20	75	2.90E-07	55.5	R9BPB_XENLA	reviewed	Regulator of G-protein signaling 9-binding protein B (RGS9-anchoring protein B)	rgs9bp-b	Xenopus laevis (African clawed frog)	251	integral component of membrane [GO:0016021]; negative regulation of signal transduction [GO:0009968]	integral component of membrane [GO:0016021]		GO:0009968; GO:0016021	negative regulation of signal transduction [GO:0009968]		NA	NA	NA	NA	NA	NA
TRINITY_DN1991_c0_g1_i2	Q9VCX1	RGS_DROME	37.2	521	302	9	1635	118	781	1291	2.00E-77	291.6	RGS_DROME	reviewed	Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco)	loco CG5248	Drosophila melanogaster (Fruit fly)	1541	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]	GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0050832; GO:0055059; GO:0060857	"asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1991_c0_g1_i3	Q9VCX1	RGS_DROME	50.7	223	103	3	820	164	781	1000	9.20E-50	198.7	RGS_DROME	reviewed	Regulator of G-protein signaling loco (RGS) (Locomotion defects protein) (Loco)	loco CG5248	Drosophila melanogaster (Fruit fly)	1541	"apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]"	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]	GO:0000578; GO:0001965; GO:0003015; GO:0005092; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006979; GO:0007049; GO:0007186; GO:0007303; GO:0007310; GO:0007419; GO:0008069; GO:0008277; GO:0009408; GO:0009786; GO:0010001; GO:0016324; GO:0019991; GO:0030866; GO:0032291; GO:0042594; GO:0045179; GO:0050832; GO:0055059; GO:0060857	"asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of glial blood-brain barrier [GO:0060857]; glial cell differentiation [GO:0010001]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16851_c0_g1_i1	Q9XVW1	RHY1_CAEEL	24.4	373	229	11	1145	108	143	489	8.20E-09	63.2	RHY1_CAEEL	reviewed	Regulator of hypoxia-inducible factor 1	rhy-1 W07A12.7	Caenorhabditis elegans	502	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; negative regulation of cellular response to hypoxia [GO:1900038]; response to hypoxia [GO:0001666]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"	GO:0001666; GO:0005789; GO:0016021; GO:0016747; GO:0048471; GO:1900038	negative regulation of cellular response to hypoxia [GO:1900038]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN1898_c0_g1_i3	Q32KL4	RMD1_BOVIN	38	208	127	1	702	79	109	314	9.50E-40	165.2	RMD1_BOVIN	reviewed	Regulator of microtubule dynamics protein 1 (RMD-1) (Protein FAM82B)	RMDN1 FAM82B	Bos taurus (Bovine)	317	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle pole [GO:0000922]		GO:0000922; GO:0005737; GO:0005874			NA	NA	NA	NA	NA	NA
TRINITY_DN1883_c1_g1_i2	Q4G069	RMD1_RAT	46.9	228	120	1	304	984	83	310	3.40E-53	210.3	RMD1_RAT	reviewed	Regulator of microtubule dynamics protein 1 (RMD-1) (Protein FAM82B)	Rmdn1 Fam82b	Rattus norvegicus (Rat)	310	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]	microtubule binding [GO:0008017]	GO:0005737; GO:0005876; GO:0008017; GO:0097431			NA	NA	NA	NA	NA	NA
TRINITY_DN1898_c0_g1_i1	Q5EAU9	RMD3_XENLA	41.1	224	129	1	795	124	222	442	1.80E-42	174.5	RMD3_XENLA	reviewed	Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C)	rmdn3 fam82a2 fam82c	Xenopus laevis (African clawed frog)	463	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]		GO:0000922; GO:0005634; GO:0005741; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1898_c0_g1_i2	Q5EAU9	RMD3_XENLA	41.1	224	129	1	795	124	222	442	3.60E-42	174.1	RMD3_XENLA	reviewed	Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C)	rmdn3 fam82a2 fam82c	Xenopus laevis (African clawed frog)	463	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]		GO:0000922; GO:0005634; GO:0005741; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1898_c0_g1_i4	Q5EAU9	RMD3_XENLA	41	217	125	1	774	124	229	442	4.00E-41	170.6	RMD3_XENLA	reviewed	Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C)	rmdn3 fam82a2 fam82c	Xenopus laevis (African clawed frog)	463	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]		GO:0000922; GO:0005634; GO:0005741; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3055_c2_g1_i2	Q8VC42	RMC1_MOUSE	43.2	361	180	5	14	1081	308	648	1.60E-70	268.1	RMC1_MOUSE	reviewed	Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1)	Rmc1 Mic1 Wdr98	Mus musculus (Mouse)	657	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]		GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	autophagy [GO:0006914]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN35642_c0_g1_i1	Q8VC42	RMC1_MOUSE	37.8	238	142	3	2	709	61	294	2.80E-46	186.8	RMC1_MOUSE	reviewed	Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1)	Rmc1 Mic1 Wdr98	Mus musculus (Mouse)	657	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]		GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	autophagy [GO:0006914]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN35642_c0_g1_i2	Q8VC42	RMC1_MOUSE	35.6	104	65	1	35	340	191	294	5.20E-14	78.6	RMC1_MOUSE	reviewed	Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1)	Rmc1 Mic1 Wdr98	Mus musculus (Mouse)	657	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]		GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	autophagy [GO:0006914]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN3055_c2_g1_i1	Q96DM3	RMC1_HUMAN	55.7	115	51	0	49	393	534	648	1.10E-27	124.4	RMC1_HUMAN	reviewed	Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1) (WD repeat-containing protein 98)	RMC1 C18orf8 MIC1 WDR98	Homo sapiens (Human)	657	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]		GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	autophagy [GO:0006914]; regulation of autophagy [GO:0010506]		NA	NA	NA	NA	NA	NA
TRINITY_DN40249_c0_g1_i1	Q92900	RENT1_HUMAN	98.7	79	1	0	237	1	262	340	1.10E-39	163.3	RENT1_HUMAN	reviewed	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1)	UPF1 KIAA0221 RENT1	Homo sapiens (Human)	1129	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0009048; GO:0016032; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39600_c0_g1_i1	Q92900	RENT1_HUMAN	100	94	0	0	1	282	659	752	3.40E-48	191.8	RENT1_HUMAN	reviewed	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1)	UPF1 KIAA0221 RENT1	Homo sapiens (Human)	1129	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0009048; GO:0016032; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38402_c0_g1_i1	Q92900	RENT1_HUMAN	100	73	0	0	219	1	478	550	2.40E-36	152.1	RENT1_HUMAN	reviewed	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1)	UPF1 KIAA0221 RENT1	Homo sapiens (Human)	1129	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0009048; GO:0016032; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31361_c0_g1_i1	Q92900	RENT1_HUMAN	99.5	211	1	0	2	634	781	991	9.20E-118	424.1	RENT1_HUMAN	reviewed	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1)	UPF1 KIAA0221 RENT1	Homo sapiens (Human)	1129	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0009048; GO:0016032; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27159_c0_g1_i1	Q9EPU0	RENT1_MOUSE	100	135	0	0	407	3	73	207	5.40E-79	294.7	RENT1_MOUSE	reviewed	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (mUpf1)	Upf1 Rent1	Mus musculus (Mouse)	1124	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]"	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006449; GO:0008270; GO:0009048; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0048471; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6490_c0_g1_i1	Q9VYS3	RENT1_DROME	68.1	1058	273	10	3099	97	1	1050	0	1428.3	RENT1_DROME	reviewed	Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-)	Upf1 CG1559	Drosophila melanogaster (Fruit fly)	1180	"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuronal ribonucleoprotein granule [GO:0071598]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000624]"	cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuronal ribonucleoprotein granule [GO:0071598]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0008270; GO:0071456; GO:0071598; GO:1990124; GO:2000624	"cellular response to hypoxia [GO:0071456]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000624]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39499_c0_g1_i1	Q9HEH1	RENT1_NEUCR	59	78	32	0	236	3	611	688	4.10E-18	91.7	RENT1_NEUCR	reviewed	Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-)	2E4.130 NCU04242	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	1093	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0008270	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN602_c0_g1_i1	Q9FJR0	RENT1_ARATH	50.6	166	67	2	474	4	773	932	3.10E-41	169.5	RENT1_ARATH	reviewed	Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-) (ATP-dependent helicase UPF1)	UPF1 LBA1 At5g47010 MQD22.15	Arabidopsis thaliana (Mouse-ear cress)	1254	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000932; GO:0003677; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0009506; GO:0009611; GO:0009863; GO:0009867; GO:0010182; GO:0042742; GO:0048571	"defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11349_c0_g1_i1	Q9FJR0	RENT1_ARATH	75.9	116	27	1	373	26	788	902	1.70E-42	173.3	RENT1_ARATH	reviewed	Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-) (ATP-dependent helicase UPF1)	UPF1 LBA1 At5g47010 MQD22.15	Arabidopsis thaliana (Mouse-ear cress)	1254	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000932; GO:0003677; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0009506; GO:0009611; GO:0009863; GO:0009867; GO:0010182; GO:0042742; GO:0048571	"defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11349_c0_g3_i1	Q9FJR0	RENT1_ARATH	68.4	247	78	0	744	4	126	372	2.50E-106	386.3	RENT1_ARATH	reviewed	Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-) (ATP-dependent helicase UPF1)	UPF1 LBA1 At5g47010 MQD22.15	Arabidopsis thaliana (Mouse-ear cress)	1254	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000932; GO:0003677; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0009506; GO:0009611; GO:0009863; GO:0009867; GO:0010182; GO:0042742; GO:0048571	"defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11349_c0_g2_i1	Q9FJR0	RENT1_ARATH	73.9	283	74	0	2	850	478	760	4.20E-121	435.6	RENT1_ARATH	reviewed	Regulator of nonsense transcripts 1 homolog (EC 3.6.4.-) (ATP-dependent helicase UPF1)	UPF1 LBA1 At5g47010 MQD22.15	Arabidopsis thaliana (Mouse-ear cress)	1254	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270]	GO:0000184; GO:0000932; GO:0003677; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0009506; GO:0009611; GO:0009863; GO:0009867; GO:0010182; GO:0042742; GO:0048571	"defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; long-day photoperiodism [GO:0048571]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to wounding [GO:0009611]; salicylic acid mediated signaling pathway [GO:0009863]; sugar mediated signaling pathway [GO:0010182]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40109_c0_g1_i1	Q9HAU5	RENT2_HUMAN	100	72	0	0	217	2	603	674	7.40E-35	147.1	RENT2_HUMAN	reviewed	Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2)	UPF2 KIAA1408 RENT2	Homo sapiens (Human)	1272	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471	"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1197_c0_g1_i1	A2AT37	RENT2_MOUSE	47.3	1151	568	10	3540	109	144	1262	4.00E-261	902.9	RENT2_MOUSE	reviewed	Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (Upf2)	Upf2	Mus musculus (Mouse)	1269	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471	"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11824_c0_g1_i1	B0S733	REN3A_DANRE	53.7	177	76	2	742	212	35	205	2.90E-44	180.3	REN3A_DANRE	reviewed	Regulator of nonsense transcripts 3A (Up-frameshift suppressor 3 homolog A)	upf3a si:dkey-21o13.6	Danio rerio (Zebrafish) (Brachydanio rerio)	452	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0003723; GO:0005730; GO:0005737; GO:0042162; GO:0045727; GO:0051028	"mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11824_c0_g1_i2	B0S733	REN3A_DANRE	53.7	177	76	2	1167	637	35	205	4.40E-44	180.3	REN3A_DANRE	reviewed	Regulator of nonsense transcripts 3A (Up-frameshift suppressor 3 homolog A)	upf3a si:dkey-21o13.6	Danio rerio (Zebrafish) (Brachydanio rerio)	452	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0003723; GO:0005730; GO:0005737; GO:0042162; GO:0045727; GO:0051028	"mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11824_c0_g1_i3	B0S733	REN3A_DANRE	53.7	177	76	2	1099	569	35	205	4.20E-44	180.3	REN3A_DANRE	reviewed	Regulator of nonsense transcripts 3A (Up-frameshift suppressor 3 homolog A)	upf3a si:dkey-21o13.6	Danio rerio (Zebrafish) (Brachydanio rerio)	452	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0003723; GO:0005730; GO:0005737; GO:0042162; GO:0045727; GO:0051028	"mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i4	A4K436	RTEL1_BOVIN	37.2	709	348	11	919	2982	336	968	5.80E-125	450.3	RTEL1_BOVIN	reviewed	Regulator of telomere elongation helicase 1 (EC 3.6.4.12)	RTEL1	Bos taurus (Bovine)	1216	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomeric loop disassembly [GO:0090657]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomeric loop disassembly [GO:0090657]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i4	A4K436	RTEL1_BOVIN	48	319	160	3	2	943	17	334	1.40E-78	296.2	RTEL1_BOVIN	reviewed	Regulator of telomere elongation helicase 1 (EC 3.6.4.12)	RTEL1	Bos taurus (Bovine)	1216	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomeric loop disassembly [GO:0090657]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomeric loop disassembly [GO:0090657]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i7	A4K436	RTEL1_BOVIN	37.1	708	347	11	6	2066	338	968	2.00E-124	448	RTEL1_BOVIN	reviewed	Regulator of telomere elongation helicase 1 (EC 3.6.4.12)	RTEL1	Bos taurus (Bovine)	1216	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomeric loop disassembly [GO:0090657]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomeric loop disassembly [GO:0090657]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i11	Q16X92	RTEL1_AEDAE	48.4	830	391	13	2	2416	17	834	1.50E-218	761.1	RTEL1_AEDAE	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AAEL008960	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1010	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i13	Q16X92	RTEL1_AEDAE	48.4	830	391	13	2	2416	17	834	1.50E-218	761.1	RTEL1_AEDAE	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AAEL008960	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1010	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i15	Q16X92	RTEL1_AEDAE	48.3	698	341	10	255	2324	149	834	6.80E-187	656	RTEL1_AEDAE	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AAEL008960	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1010	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i15	Q16X92	RTEL1_AEDAE	64.5	62	21	1	2	184	17	78	1.50E-13	80.1	RTEL1_AEDAE	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AAEL008960	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1010	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i6	Q16X92	RTEL1_AEDAE	48.3	698	341	10	255	2324	149	834	6.80E-187	656	RTEL1_AEDAE	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AAEL008960	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1010	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN817_c0_g1_i6	Q16X92	RTEL1_AEDAE	64.5	62	21	1	2	184	17	78	1.50E-13	80.1	RTEL1_AEDAE	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AAEL008960	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1010	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN6872_c0_g1_i2	Q7QEI1	RTEL1_ANOGA	41	83	43	1	38	286	572	648	1.20E-11	70.9	RTEL1_ANOGA	reviewed	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	AGAP000634	Anopheles gambiae (African malaria mosquito)	991	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomeric loop disassembly [GO:0090657]"	nucleus [GO:0005634]	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]"	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomeric loop disassembly [GO:0090657]		NA	NA	NA	NA	NA	NA
TRINITY_DN4963_c0_g1_i1	Q8K4Q0	RPTOR_MOUSE	41.3	341	150	8	1	909	512	840	6.30E-57	222.6	RPTOR_MOUSE	reviewed	Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein)	Rptor Raptor	Mus musculus (Mouse)	1335	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]	14-3-3 protein binding [GO:0071889]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010506; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087	cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN4963_c0_g1_i3	Q8K4Q0	RPTOR_MOUSE	35.6	848	433	19	1	2283	512	1333	3.70E-131	471.1	RPTOR_MOUSE	reviewed	Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein)	Rptor Raptor	Mus musculus (Mouse)	1335	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]	14-3-3 protein binding [GO:0071889]; protein-containing complex binding [GO:0044877]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010506; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087	cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN1376_c0_g1_i1	Q5VYX0	RNLS_HUMAN	46.3	348	174	6	1086	64	1	342	5.50E-84	312.8	RNLS_HUMAN	reviewed	Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C)	RNLS C10orf59	Homo sapiens (Human)	342	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]"	GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0034356; GO:0045776; GO:0051379; GO:0055114; GO:0070404; GO:0071871; GO:0097621; GO:1902074	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1376_c0_g1_i3	Q5VYX0	RNLS_HUMAN	46.8	344	170	6	1098	88	1	338	2.10E-83	310.8	RNLS_HUMAN	reviewed	Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C)	RNLS C10orf59	Homo sapiens (Human)	342	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]"	GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0034356; GO:0045776; GO:0051379; GO:0055114; GO:0070404; GO:0071871; GO:0097621; GO:1902074	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1376_c0_g1_i7	Q5VYX0	RNLS_HUMAN	47.7	197	99	3	590	3	1	194	7.70E-46	185.3	RNLS_HUMAN	reviewed	Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C)	RNLS C10orf59	Homo sapiens (Human)	342	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]"	GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0034356; GO:0045776; GO:0051379; GO:0055114; GO:0070404; GO:0071871; GO:0097621; GO:1902074	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1376_c0_g1_i8	Q5VYX0	RNLS_HUMAN	46.5	344	171	6	1098	88	1	338	3.60E-83	310.1	RNLS_HUMAN	reviewed	Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C)	RNLS C10orf59	Homo sapiens (Human)	342	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]"	GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0034356; GO:0045776; GO:0051379; GO:0055114; GO:0070404; GO:0071871; GO:0097621; GO:1902074	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN4049_c0_g1_i1	A1RSA2	RFCS1_PYRIL	48	125	54	3	351	4	4	126	5.30E-22	105.1	RFCS1_PYRIL	reviewed	Replication factor C small subunit 1 (RFC small subunit 1) (Clamp loader small subunit 1)	rfcS1 Pisl_0656	Pyrobaculum islandicum (strain DSM 4184 / JCM 9189 / GEO3)	329	DNA replication factor C complex [GO:0005663]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; DNA replication [GO:0006260]	DNA replication factor C complex [GO:0005663]	ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]	GO:0003689; GO:0005524; GO:0005663; GO:0006260	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN4450_c0_g1_i1	P35251	RFC1_HUMAN	60.3	282	109	2	6	842	641	922	4.30E-94	345.9	RFC1_HUMAN	reviewed	Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit)	RFC1 RFC140	Homo sapiens (Human)	1148	"cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]	GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0005730; GO:0005737; GO:0006261; GO:0006283; GO:0006296; GO:0006297; GO:0007004; GO:0008047; GO:0019904; GO:0019985; GO:0031391; GO:0032201; GO:0033683; GO:0042276; GO:0042769; GO:0043565; GO:0045893; GO:0061860; GO:0070062; GO:0070987; GO:0090618	"DNA clamp unloading [GO:0090618]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4450_c0_g1_i2	P35600	RFC1_DROME	63.5	74	26	1	6	227	477	549	4.50E-18	91.7	RFC1_DROME	reviewed	Replication factor C subunit 1 (Activator 1 140 kDa subunit) (Activator 1 subunit 1) (Germline transcription factor 1) (Replication factor C large subunit)	Gnf1 CG1119	Drosophila melanogaster (Fruit fly)	986	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; dendrite morphogenesis [GO:0048813]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]	GO:0003677; GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006281; GO:0048813	dendrite morphogenesis [GO:0048813]; DNA repair [GO:0006281]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN29083_c0_g1_i1	Q2R2B4	RFC1_ORYSJ	62.1	58	21	1	31	201	537	594	5.20E-15	81.3	RFC1_ORYSJ	reviewed	Replication factor C subunit 1 (OsRFC1) (Activator 1 large subunit) (Activator 1 subunit 1)	RFC1 Os11g0572100 LOC_Os11g36390	Oryza sativa subsp. japonica (Rice)	1021	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of chromatin silencing [GO:0031935]; regulation of histone H3-K9 methylation [GO:0051570]; resolution of meiotic recombination intermediates [GO:0000712]; response to abscisic acid [GO:0009737]	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]	GO:0000712; GO:0003677; GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006281; GO:0009737; GO:0031935; GO:0051570	DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of chromatin silencing [GO:0031935]; regulation of histone H3-K9 methylation [GO:0051570]; resolution of meiotic recombination intermediates [GO:0000712]; response to abscisic acid [GO:0009737]		NA	NA	NA	NA	NA	NA
TRINITY_DN24481_c1_g1_i1	P35250	RFC2_HUMAN	100	117	0	0	382	32	238	354	2.70E-64	245.7	RFC2_HUMAN	reviewed	Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40)	RFC2	Homo sapiens (Human)	354	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24481_c0_g1_i1	Q9WUK4	RFC2_MOUSE	100	235	0	0	1	705	104	338	8.70E-133	474.2	RFC2_MOUSE	reviewed	Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40)	Rfc2	Mus musculus (Mouse)	349	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0017116; GO:0019899; GO:0031390; GO:1900264	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3277_c0_g1_i2	P35250	RFC2_HUMAN	70.9	103	30	0	389	81	250	352	6.00E-39	161.8	RFC2_HUMAN	reviewed	Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40)	RFC2	Homo sapiens (Human)	354	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		yellow	yellow	NA	NA	NA	NA
TRINITY_DN38761_c0_g1_i1	P35250	RFC2_HUMAN	100	230	0	0	2	691	18	247	5.30E-127	454.9	RFC2_HUMAN	reviewed	Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40)	RFC2	Homo sapiens (Human)	354	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3277_c0_g1_i1	Q641W4	RFC2_RAT	75.3	336	83	0	1088	81	12	347	6.80E-146	518.5	RFC2_RAT	reviewed	Replication factor C subunit 2 (Activator 1 subunit C2)	Rfc2	Rattus norvegicus (Rat)	349	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0017116; GO:0019899; GO:0031390; GO:1900264	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]		NA	NA	NA	NA	NA	NA
TRINITY_DN28123_c0_g1_i1	Q9CAM7	RFC2_ARATH	59.2	71	29	0	12	224	46	116	2.00E-19	95.9	RFC2_ARATH	reviewed	Replication factor C subunit 2 (AtRFC2) (Activator 1 subunit 2) (Protein EMBRYO DEFECTIVE 2811)	RFC2 EMB2811 At1g63160 F16M19.6	Arabidopsis thaliana (Mouse-ear cress)	333	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN25674_c0_g1_i1	Q9FXM3	RFC2_ORYSJ	53.6	125	55	2	20	385	70	194	4.70E-32	138.7	RFC2_ORYSJ	reviewed	Replication factor C subunit 2 (OsRFC2) (Activator 1 subunit 2)	RFC2 Os12g0176500 LOC_Os12g07720 OsJ_35406	Oryza sativa subsp. japonica (Rice)	339	DNA replication factor C complex [GO:0005663]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]	DNA replication factor C complex [GO:0005663]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0005730; GO:0006261; GO:0006281; GO:0016887	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN18759_c0_g1_i1	P40348	RFC2_YEAST	58.3	72	29	1	217	2	29	99	5.20E-20	97.8	RFC2_YEAST	reviewed	Replication factor C subunit 2 (Replication factor C2) (Activator 1 41 kDa subunit)	RFC2 YJR068W J1808	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	353	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; DNA-dependent DNA replication [GO:0006261]; leading strand elongation [GO:0006272]; mismatch repair [GO:0006298]; sister chromatid cohesion [GO:0007062]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000076; GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006272; GO:0006281; GO:0006298; GO:0007062; GO:0016887; GO:0031389; GO:0031390; GO:0031391	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; leading strand elongation [GO:0006272]; mismatch repair [GO:0006298]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN3980_c0_g1_i1	Q8R323	RFC3_MOUSE	72.3	130	36	0	391	2	1	130	1.60E-51	203.8	RFC3_MOUSE	reviewed	Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)	Rfc3	Mus musculus (Mouse)	356	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]	GO:0003689; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0017116; GO:0031390; GO:0046683; GO:1900264	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]		NA	NA	NA	NA	NA	NA
TRINITY_DN7437_c0_g1_i1	Q2TBV1	RFC3_BOVIN	66.7	186	62	0	3	560	169	354	2.00E-67	256.9	RFC3_BOVIN	reviewed	Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)	RFC3	Bos taurus (Bovine)	356	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]	GO:0003689; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0017116; GO:0031390; GO:0046683; GO:1900264	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]		NA	NA	NA	NA	NA	NA
TRINITY_DN34080_c0_g1_i1	Q8R323	RFC3_MOUSE	98.6	69	1	0	308	102	13	81	4.80E-35	148.3	RFC3_MOUSE	reviewed	Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)	Rfc3	Mus musculus (Mouse)	356	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]	GO:0003689; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0017116; GO:0031390; GO:0046683; GO:1900264	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]		NA	NA	NA	NA	NA	NA
TRINITY_DN34080_c0_g1_i1	Q8R323	RFC3_MOUSE	100	36	0	0	109	2	79	114	2.00E-12	73.2	RFC3_MOUSE	reviewed	Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)	Rfc3	Mus musculus (Mouse)	356	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]	GO:0003689; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0017116; GO:0031390; GO:0046683; GO:1900264	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]		NA	NA	NA	NA	NA	NA
TRINITY_DN25708_c0_g1_i1	O14003	RFC3_SCHPO	58.6	133	49	2	400	2	69	195	1.20E-35	150.6	RFC3_SCHPO	reviewed	Replication factor C subunit 3 (Replication factor C3)	rfc3 SPAC27E2.10c SPAPJ698.01c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	342	Ctf18 RFC-like complex [GO:0031390]; cytosol [GO:0005829]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nuclear chromatin [GO:0000790]; nuclear DNA replication factor C complex [GO:0043599]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; DNA clamp unloader activity [GO:0061860]; DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-dependent DNA replication [GO:0006261]; mitotic DNA replication leading strand elongation [GO:1903460]; UV-damage excision repair [GO:0070914]	Ctf18 RFC-like complex [GO:0031390]; cytosol [GO:0005829]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nuclear chromatin [GO:0000790]; nuclear DNA replication factor C complex [GO:0043599]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]	ATP binding [GO:0005524]; DNA clamp unloader activity [GO:0061860]	GO:0000790; GO:0005524; GO:0005634; GO:0005663; GO:0005829; GO:0006261; GO:0006271; GO:0006281; GO:0031389; GO:0031390; GO:0031391; GO:0043599; GO:0061860; GO:0070914; GO:1903460	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]; mitotic DNA replication leading strand elongation [GO:1903460]; UV-damage excision repair [GO:0070914]		NA	NA	NA	NA	NA	NA
TRINITY_DN9530_c0_g1_i1	P38629	RFC3_YEAST	52.8	125	44	4	8	340	12	135	1.20E-26	120.6	RFC3_YEAST	reviewed	Replication factor C subunit 3 (Replication factor C3) (Activator 1 40 kDa subunit)	RFC3 YNL290W N0533	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	340	Ctf18 RFC-like complex [GO:0031390]; cytosol [GO:0005829]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; leading strand elongation [GO:0006272]; mismatch repair [GO:0006298]	Ctf18 RFC-like complex [GO:0031390]; cytosol [GO:0005829]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0005829; GO:0006261; GO:0006272; GO:0006281; GO:0006298; GO:0007049; GO:0016887; GO:0031389; GO:0031390; GO:0031391	cell cycle [GO:0007049]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; leading strand elongation [GO:0006272]; mismatch repair [GO:0006298]		NA	NA	NA	NA	NA	NA
TRINITY_DN19223_c0_g1_i1	P35249	RFC4_HUMAN	72.6	197	52	2	591	7	31	227	2.80E-76	286.2	RFC4_HUMAN	reviewed	Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37)	RFC4	Homo sapiens (Human)	363	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0031391; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34138_c0_g1_i1	Q8SQM0	RFC4_ENCCU	54.9	142	54	3	13	408	34	175	1.10E-34	147.5	RFC4_ENCCU	reviewed	Replication factor C subunit 4 (Replication factor C4)	RFC4 ECU09_1330	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	309	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA replication [GO:0006260]	nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0003677; GO:0005524; GO:0005634; GO:0006260; GO:0007049; GO:0016887	cell cycle [GO:0007049]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN33676_c0_g1_i1	P40937	RFC5_HUMAN	99.2	236	2	0	1	708	105	340	1.30E-128	460.3	RFC5_HUMAN	reviewed	Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36)	RFC5	Homo sapiens (Human)	340	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2248_c0_g1_i1	P40937	RFC5_HUMAN	70.2	322	96	0	1431	466	19	340	1.20E-134	481.5	RFC5_HUMAN	reviewed	Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36)	RFC5	Homo sapiens (Human)	340	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28217_c0_g1_i1	P40937	RFC5_HUMAN	94.5	91	5	0	2	274	78	168	2.70E-42	172.2	RFC5_HUMAN	reviewed	Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36)	RFC5	Homo sapiens (Human)	340	"Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0016887; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0032508; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264; GO:1901796	"DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23350_c0_g1_i1	Q9BWE0	REPI1_HUMAN	100	73	0	0	219	1	472	544	9.20E-41	166.8	REPI1_HUMAN	reviewed	Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464)	REPIN1 RIP60 ZNF464	Homo sapiens (Human)	567	chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]	chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005654; GO:0005664; GO:0005694; GO:0006260; GO:0006357; GO:0043035; GO:0046872	DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6566_c0_g1_i2	Q5RC43	RFA2_PONAB	27.6	293	160	9	920	93	11	268	4.80E-23	110.2	RFA2_PONAB	reviewed	Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2)	RPA2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	270	DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]	DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]	damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]	GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0010569; GO:0016605; GO:0034502; GO:2000001	base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN18921_c0_g1_i1	Q8VEE4	RFA1_MOUSE	100	77	0	0	2	232	200	276	1.50E-38	159.5	RFA1_MOUSE	reviewed	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1)	Rpa1	Mus musculus (Mouse)	623	condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; positive regulation of cell population proliferation [GO:0008284]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000723; GO:0000724; GO:0000793; GO:0000794; GO:0000800; GO:0001673; GO:0001701; GO:0003682; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006974; GO:0007004; GO:0008284; GO:0016605; GO:0030097; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0048873; GO:0051276; GO:0051321; GO:0090734; GO:0098505	base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; positive regulation of cell population proliferation [GO:0008284]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN18921_c0_g1_i2	Q8VEE4	RFA1_MOUSE	100	76	0	0	3	230	201	276	4.50E-38	157.9	RFA1_MOUSE	reviewed	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1)	Rpa1	Mus musculus (Mouse)	623	condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; positive regulation of cell population proliferation [GO:0008284]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000723; GO:0000724; GO:0000793; GO:0000794; GO:0000800; GO:0001673; GO:0001701; GO:0003682; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006974; GO:0007004; GO:0008284; GO:0016605; GO:0030097; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0048873; GO:0051276; GO:0051321; GO:0090734; GO:0098505	base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; positive regulation of cell population proliferation [GO:0008284]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN1184_c0_g2_i1	Q5ZJJ2	RFA1_CHICK	45.8	614	315	6	103	1908	5	612	2.50E-153	543.9	RFA1_CHICK	reviewed	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1)	RPA1 RCJMB04_17l6	Gallus gallus (Chicken)	614	DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0051321; GO:0090734; GO:0098505	base-excision repair [GO:0006284]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN1184_c0_g1_i1	Q5ZJJ2	RFA1_CHICK	46.6	579	292	5	1796	93	40	612	3.20E-148	526.9	RFA1_CHICK	reviewed	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1)	RPA1 RCJMB04_17l6	Gallus gallus (Chicken)	614	DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]	damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0051321; GO:0090734; GO:0098505	base-excision repair [GO:0006284]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]		blue	blue	NA	NA	NA	NA
TRINITY_DN40976_c0_g1_i1	Q24492	RFA1_DROME	45.8	72	39	0	221	6	169	240	1.20E-12	73.6	RFA1_DROME	reviewed	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) (DmRPA1)	RpA-70 RPA1 CG9633	Drosophila melanogaster (Fruit fly)	603	DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006289; GO:0007004; GO:0043047; GO:0043565; GO:0046872; GO:0051321	DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN31726_c0_g1_i1	P27694	RFA1_HUMAN	100	124	0	0	421	50	267	390	8.40E-67	254.2	RFA1_HUMAN	reviewed	"Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed]"	RPA1 REPA1 RPA70	Homo sapiens (Human)	616	"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"	"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]"	damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000082; GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006283; GO:0006284; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006297; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0019985; GO:0032201; GO:0033683; GO:0034502; GO:0036297; GO:0042276; GO:0042769; GO:0043047; GO:0043565; GO:0046872; GO:0051321; GO:0070987; GO:0090734; GO:0098505; GO:1900034; GO:1901796	"base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1600_c0_g1_i1	Q7T293	SDE2_DANRE	46.2	156	83	1	827	363	40	195	3.30E-23	110.5	SDE2_DANRE	reviewed	Replication stress response regulator SDE2	sde2 zgc:112095	Danio rerio (Zebrafish) (Brachydanio rerio)	467	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006260; GO:0007049; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]		blue	blue	NA	NA	NA	NA
TRINITY_DN4717_c0_g1_i1	Q0VCR1	RTF2_BOVIN	40.9	301	163	6	97	978	1	293	1.30E-47	191.8	RTF2_BOVIN	reviewed	Replication termination factor 2 (RTF2) (Replication termination factor 2 domain-containing protein 1)	RTF2 RTFDC1	Bos taurus (Bovine)	299	nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]	nucleus [GO:0005634]; replication fork [GO:0005657]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005657; GO:0071171; GO:0072711; GO:0097752; GO:1902979	cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]		NA	NA	NA	NA	NA	NA
TRINITY_DN25527_c0_g1_i1	Q9BY42	RTF2_HUMAN	100	76	0	0	49	276	1	76	1.10E-38	160.2	RTF2_HUMAN	reviewed	Replication termination factor 2 (RTF2) (Replication termination factor 2 domain-containing protein 1)	RTF2 C20orf43 RTFDC1 AD-007 CDA05 HSPC164 HSPC169	Homo sapiens (Human)	306	nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]	nucleus [GO:0005634]; replication fork [GO:0005657]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005657; GO:0071171; GO:0072711; GO:0097752; GO:1902979	cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]		NA	NA	NA	NA	NA	NA
TRINITY_DN39963_c0_g1_i1	Q9BY42	RTF2_HUMAN	100	87	0	0	56	316	1	87	4.40E-44	178.3	RTF2_HUMAN	reviewed	Replication termination factor 2 (RTF2) (Replication termination factor 2 domain-containing protein 1)	RTF2 C20orf43 RTFDC1 AD-007 CDA05 HSPC164 HSPC169	Homo sapiens (Human)	306	nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]	nucleus [GO:0005634]; replication fork [GO:0005657]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005657; GO:0071171; GO:0072711; GO:0097752; GO:1902979	cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]; site-specific DNA replication termination at RTS1 barrier [GO:0071171]		NA	NA	NA	NA	NA	NA
TRINITY_DN21430_c0_g1_i1	A5D9C6	MAF1_BOVIN	100	70	0	0	18	227	1	70	3.00E-34	145.2	MAF1_BOVIN	reviewed	Repressor of RNA polymerase III transcription MAF1 homolog	MAF1	Bos taurus (Bovine)	260	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase III core binding [GO:0000994]; negative regulation of transcription by RNA polymerase III [GO:0016480]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA polymerase III core binding [GO:0000994]	GO:0000994; GO:0005634; GO:0005737; GO:0016480	negative regulation of transcription by RNA polymerase III [GO:0016480]		NA	NA	NA	NA	NA	NA
TRINITY_DN21430_c0_g1_i2	A5D9C6	MAF1_BOVIN	100	68	0	0	3	206	3	70	3.90E-33	141.4	MAF1_BOVIN	reviewed	Repressor of RNA polymerase III transcription MAF1 homolog	MAF1	Bos taurus (Bovine)	260	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase III core binding [GO:0000994]; negative regulation of transcription by RNA polymerase III [GO:0016480]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA polymerase III core binding [GO:0000994]	GO:0000994; GO:0005634; GO:0005737; GO:0016480	negative regulation of transcription by RNA polymerase III [GO:0016480]		NA	NA	NA	NA	NA	NA
TRINITY_DN19994_c0_g2_i1	Q9H063	MAF1_HUMAN	100	165	0	0	495	1	69	233	3.60E-93	342	MAF1_HUMAN	reviewed	Repressor of RNA polymerase III transcription MAF1 homolog	MAF1	Homo sapiens (Human)	256	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]	GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0043231; GO:0048471; GO:0050811; GO:0060077	negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]		NA	NA	NA	NA	NA	NA
TRINITY_DN19994_c0_g1_i1	Q9D0U6	MAF1_MOUSE	98.8	162	2	0	492	7	69	230	7.50E-91	334.3	MAF1_MOUSE	reviewed	Repressor of RNA polymerase III transcription MAF1 homolog	Maf1	Mus musculus (Mouse)	258	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]	GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0043231; GO:0048471; GO:0050811; GO:0060077	negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]		NA	NA	NA	NA	NA	NA
TRINITY_DN8898_c0_g1_i1	Q9H063	MAF1_HUMAN	51.4	247	113	3	795	55	1	240	1.40E-63	244.6	MAF1_HUMAN	reviewed	Repressor of RNA polymerase III transcription MAF1 homolog	MAF1	Homo sapiens (Human)	256	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]	GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0043231; GO:0048471; GO:0050811; GO:0060077	negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]		blue	blue	NA	NA	NA	NA
TRINITY_DN8898_c0_g1_i2	Q9H063	MAF1_HUMAN	50.3	187	91	1	615	55	56	240	5.90E-48	192.2	MAF1_HUMAN	reviewed	Repressor of RNA polymerase III transcription MAF1 homolog	MAF1	Homo sapiens (Human)	256	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]	GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0043231; GO:0048471; GO:0050811; GO:0060077	negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]		NA	NA	NA	NA	NA	NA
TRINITY_DN7640_c0_g1_i2	Q8CI78	RMND1_MOUSE	41.7	312	151	5	1016	90	162	445	3.20E-56	221.1	RMND1_MOUSE	reviewed	Required for meiotic nuclear division protein 1 homolog	Rmnd1	Mus musculus (Mouse)	450	mitochondrion [GO:0005739]; positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412]	mitochondrion [GO:0005739]		GO:0005739; GO:0006412; GO:0070131	positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN7640_c0_g1_i4	Q9NWS8	RMND1_HUMAN	41.6	303	149	4	989	90	167	444	5.10E-56	220.3	RMND1_HUMAN	reviewed	Required for meiotic nuclear division protein 1 homolog	RMND1 C6orf96	Homo sapiens (Human)	449	mitochondrion [GO:0005739]; positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412]	mitochondrion [GO:0005739]		GO:0005739; GO:0006412; GO:0070131	positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN19749_c0_g1_i1	Q9BUV8	RAB5I_HUMAN	53.6	56	26	0	170	3	23	78	2.50E-12	72.8	RCAF1_HUMAN	reviewed	Respirasome Complex Assembly Factor 1 (Rab5-interacting protein) (RIP5)	RAB5IF C20orf24 RCAF1 PNAS-11	Homo sapiens (Human)	137	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respirasome assembly [GO:0097250]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]		GO:0005746; GO:0016021; GO:0097250	mitochondrial respirasome assembly [GO:0097250]		NA	NA	NA	NA	NA	NA
TRINITY_DN13783_c0_g1_i1	Q9CQT9	RAB5I_MOUSE	98.2	114	2	0	353	12	16	129	5.80E-61	234.6	RCAF1_MOUSE	reviewed	Respirasome Complex Assembly Factor 1 (RCAF1) (Rab5-interacting protein) (RIP5)	Rab5if Rcaf1	Mus musculus (Mouse)	129	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; mitochondrial respirasome assembly [GO:0097250]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]		GO:0005739; GO:0005746; GO:0016021; GO:0097250	mitochondrial respirasome assembly [GO:0097250]		NA	NA	NA	NA	NA	NA
TRINITY_DN13783_c0_g1_i2	Q9CQT9	RAB5I_MOUSE	98.2	114	2	0	353	12	16	129	5.80E-61	234.6	RCAF1_MOUSE	reviewed	Respirasome Complex Assembly Factor 1 (RCAF1) (Rab5-interacting protein) (RIP5)	Rab5if Rcaf1	Mus musculus (Mouse)	129	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; mitochondrial respirasome assembly [GO:0097250]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]		GO:0005739; GO:0005746; GO:0016021; GO:0097250	mitochondrial respirasome assembly [GO:0097250]		NA	NA	NA	NA	NA	NA
TRINITY_DN26687_c3_g1_i1	Q9CQT9	RAB5I_MOUSE	57.9	107	45	0	378	58	23	129	1.70E-34	147.1	RCAF1_MOUSE	reviewed	Respirasome Complex Assembly Factor 1 (RCAF1) (Rab5-interacting protein) (RIP5)	Rab5if Rcaf1	Mus musculus (Mouse)	129	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; mitochondrial respirasome assembly [GO:0097250]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]		GO:0005739; GO:0005746; GO:0016021; GO:0097250	mitochondrial respirasome assembly [GO:0097250]		blue	blue	NA	NA	NA	NA
TRINITY_DN28018_c0_g1_i1	Q59E36	RCOR_DROME	71.3	157	45	0	497	27	92	248	6.20E-60	231.9	RCOR_DROME	reviewed	REST corepressor (CoREST)	CoRest CG33525	Drosophila melanogaster (Fruit fly)	590	"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription by RNA polymerase II [GO:0006357]"	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005667; GO:0006357; GO:0016575; GO:0017053; GO:0045892; GO:0061086; GO:0090309; GO:2000619	"histone deacetylation [GO:0016575]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26903_c0_g1_i1	Q9P2K3	RCOR3_HUMAN	98.8	84	1	0	253	2	29	112	1.10E-45	183.3	RCOR3_HUMAN	reviewed	REST corepressor 3	RCOR3 KIAA1343	Homo sapiens (Human)	495	"histone deacetylase complex [GO:0000118]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	histone deacetylase complex [GO:0000118]; transcription regulator complex [GO:0005667]	transcription corepressor activity [GO:0003714]	GO:0000118; GO:0003714; GO:0005667; GO:0006357; GO:0016575; GO:0045892	"histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5197_c0_g1_i1	Q9VJE5	CL190_DROME	35.7	157	90	3	528	79	187	339	1.60E-16	89	CL190_DROME	reviewed	Restin homolog (Cytoplasmic linker protein 190) (Microtubule-binding protein 190) (d-CLIP-190)	CLIP-190 CG5020	Drosophila melanogaster (Fruit fly)	1690	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]; cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]	GO:0000776; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005875; GO:0005876; GO:0007349; GO:0008017; GO:0030424; GO:0031122; GO:0035371; GO:0044295; GO:0045169; GO:0051010; GO:0070854	cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]		NA	NA	NA	NA	NA	NA
TRINITY_DN5197_c0_g1_i2	Q9VJE5	CL190_DROME	35.7	157	90	3	528	79	187	339	1.60E-16	89	CL190_DROME	reviewed	Restin homolog (Cytoplasmic linker protein 190) (Microtubule-binding protein 190) (d-CLIP-190)	CLIP-190 CG5020	Drosophila melanogaster (Fruit fly)	1690	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]; cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]	GO:0000776; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005875; GO:0005876; GO:0007349; GO:0008017; GO:0030424; GO:0031122; GO:0035371; GO:0044295; GO:0045169; GO:0051010; GO:0070854	cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]		NA	NA	NA	NA	NA	NA
TRINITY_DN5197_c0_g1_i3	Q9VJE5	CL190_DROME	42.6	61	33	1	255	79	279	339	7.90E-06	51.2	CL190_DROME	reviewed	Restin homolog (Cytoplasmic linker protein 190) (Microtubule-binding protein 190) (d-CLIP-190)	CLIP-190 CG5020	Drosophila melanogaster (Fruit fly)	1690	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]; cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]	GO:0000776; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005875; GO:0005876; GO:0007349; GO:0008017; GO:0030424; GO:0031122; GO:0035371; GO:0044295; GO:0045169; GO:0051010; GO:0070854	cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]		NA	NA	NA	NA	NA	NA
TRINITY_DN2382_c0_g1_i1	Q9VJE5	CL190_DROME	39.6	273	107	4	940	125	111	326	1.30E-45	185.3	CL190_DROME	reviewed	Restin homolog (Cytoplasmic linker protein 190) (Microtubule-binding protein 190) (d-CLIP-190)	CLIP-190 CG5020	Drosophila melanogaster (Fruit fly)	1690	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]; cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]	GO:0000776; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005875; GO:0005876; GO:0007349; GO:0008017; GO:0030424; GO:0031122; GO:0035371; GO:0044295; GO:0045169; GO:0051010; GO:0070854	cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]		blue	blue	NA	NA	NA	NA
TRINITY_DN2382_c0_g1_i2	Q9VJE5	CL190_DROME	36.9	333	135	7	976	2	111	376	7.80E-46	186	CL190_DROME	reviewed	Restin homolog (Cytoplasmic linker protein 190) (Microtubule-binding protein 190) (d-CLIP-190)	CLIP-190 CG5020	Drosophila melanogaster (Fruit fly)	1690	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]; cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; myosin VI heavy chain binding [GO:0070854]	GO:0000776; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005875; GO:0005876; GO:0007349; GO:0008017; GO:0030424; GO:0031122; GO:0035371; GO:0044295; GO:0045169; GO:0051010; GO:0070854	cellularization [GO:0007349]; cytoplasmic microtubule organization [GO:0031122]		blue	blue	NA	NA	NA	NA
TRINITY_DN33037_c0_g1_i1	Q15293	RCN1_HUMAN	98.8	86	1	0	258	1	33	118	4.00E-43	174.9	RCN1_HUMAN	reviewed	Reticulocalbin-1	RCN1 RCN	Homo sapiens (Human)	331	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005783; GO:0005788; GO:0043687; GO:0044267	cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]		NA	NA	NA	NA	NA	NA
TRINITY_DN29995_c0_g1_i1	Q05186	RCN1_MOUSE	100	159	0	0	523	47	167	325	6.70E-90	331.3	RCN1_MOUSE	reviewed	Reticulocalbin-1	Rcn1 Rca1 Rcn	Mus musculus (Mouse)	325	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	calcium ion binding [GO:0005509]	GO:0001701; GO:0005509; GO:0005783; GO:0005788; GO:0043010	camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701]		NA	NA	NA	NA	NA	NA
TRINITY_DN7158_c0_g1_i1	Q8K0T0	RTN1_MOUSE	48.4	217	99	2	739	113	562	773	3.80E-54	213	RTN1_MOUSE	reviewed	Reticulon-1 (Neuroendocrine-specific protein)	Rtn1 Nsp	Mus musculus (Mouse)	780	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; smooth endoplasmic reticulum [GO:0005790]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; smooth endoplasmic reticulum [GO:0005790]		GO:0000139; GO:0005783; GO:0005789; GO:0005790; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN23430_c0_g1_i1	Q5RBL9	RTN3_PONAB	100	100	0	0	3	302	44	143	7.00E-47	187.6	RTN3_PONAB	reviewed	Reticulon-3	RTN3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	236	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005789; GO:0006915; GO:0016021; GO:0016192	apoptotic process [GO:0006915]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN23430_c0_g1_i2	Q5RBL9	RTN3_PONAB	98.8	82	1	0	3	248	44	125	2.00E-36	152.5	RTN3_PONAB	reviewed	Reticulon-3	RTN3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	236	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005789; GO:0006915; GO:0016021; GO:0016192	apoptotic process [GO:0006915]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN39066_c0_g1_i1	Q9NQC3	RTN4_HUMAN	97.1	172	5	0	15	530	1001	1172	4.80E-83	308.5	RTN4_HUMAN	reviewed	Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)	RTN4 KIAA0886 NOGO My043 SP1507	Homo sapiens (Human)	1192	cell junction [GO:0030054]; cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]	cell junction [GO:0030054]; cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030176; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0042995; GO:0043025; GO:0045296; GO:0045766; GO:0050771; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0120078; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213	apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]		NA	NA	NA	NA	NA	NA
TRINITY_DN5933_c0_g1_i1	Q4W4Z2	RT4I1_CAEEL	37.1	240	142	5	806	96	18	251	2.50E-29	131.3	RT4I1_CAEEL	reviewed	"Reticulon-4-interacting protein 1, mitochondrial (EC 1.-.-.-)"	rad-8 F56H1.6	Caenorhabditis elegans	366	mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; innate immune response [GO:0045087]; multicellular organism reproduction [GO:0032504]; positive regulation of growth rate [GO:0040010]; regulation of multicellular organism growth [GO:0040014]; reproduction [GO:0000003]; response to oxidative stress [GO:0006979]; response to oxygen levels [GO:0070482]; response to superoxide [GO:0000303]; response to UV [GO:0009411]	mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]	GO:0000003; GO:0000303; GO:0005739; GO:0006979; GO:0009411; GO:0009792; GO:0016491; GO:0032504; GO:0040010; GO:0040014; GO:0045087; GO:0050829; GO:0070482	defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; innate immune response [GO:0045087]; multicellular organism reproduction [GO:0032504]; positive regulation of growth rate [GO:0040010]; regulation of multicellular organism growth [GO:0040014]; reproduction [GO:0000003]; response to oxidative stress [GO:0006979]; response to oxygen levels [GO:0070482]; response to superoxide [GO:0000303]; response to UV [GO:0009411]		blue	blue	NA	NA	NA	NA
TRINITY_DN39487_c0_g1_i1	P52785	GUC2E_MOUSE	50.9	57	28	0	3	173	759	815	8.00E-11	67.4	GUC2E_MOUSE	reviewed	Retinal guanylyl cyclase 1 (Guanylate cyclase 2E) (Guanylyl cyclase GC-E) (EC 4.6.1.2)	Gucy2e Guc2e	Mus musculus (Mouse)	1108	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]	GO:0001653; GO:0001750; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0016021; GO:0019934; GO:0042622; GO:0042802; GO:0042803; GO:0044877	cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN30435_c0_g1_i1	O55057	PDE6D_MOUSE	79.2	144	30	0	68	499	7	150	1.20E-63	244.2	PDE6D_MOUSE	reviewed	"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta)"	Pde6d	Mus musculus (Mouse)	150	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601]"	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]"	GO:0005095; GO:0005737; GO:0005829; GO:0005856; GO:0007601; GO:0007602; GO:0017137; GO:0030659; GO:0031410; GO:0042995; GO:0047555	phototransduction [GO:0007602]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN40107_c0_g1_i1	Q95142	PDE6D_BOVIN	57.9	76	31	1	228	4	15	90	8.70E-19	94	PDE6D_BOVIN	reviewed	"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta)"	PDE6D	Bos taurus (Bovine)	150	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; photoreceptor outer segment membrane [GO:0042622]; GTPase inhibitor activity [GO:0005095]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; photoreceptor outer segment membrane [GO:0042622]	GTPase inhibitor activity [GO:0005095]	GO:0005095; GO:0005737; GO:0005829; GO:0005856; GO:0007601; GO:0030659; GO:0031410; GO:0042622; GO:0050896	response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN34022_c0_g1_i1	O55057	PDE6D_MOUSE	100	45	0	0	2	136	106	150	3.10E-17	88.6	PDE6D_MOUSE	reviewed	"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta)"	Pde6d	Mus musculus (Mouse)	150	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601]"	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]"	GO:0005095; GO:0005737; GO:0005829; GO:0005856; GO:0007601; GO:0007602; GO:0017137; GO:0030659; GO:0031410; GO:0042995; GO:0047555	phototransduction [GO:0007602]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN40722_c0_g1_i1	O43924	PDE6D_HUMAN	100	80	0	0	243	4	28	107	3.20E-42	171.8	PDE6D_HUMAN	reviewed	"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17)"	PDE6D PDED	Homo sapiens (Human)	150	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]	GO:0005095; GO:0005737; GO:0005829; GO:0005856; GO:0005929; GO:0007601; GO:0017137; GO:0030659; GO:0031410; GO:0050896	response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN39802_c0_g1_i1	O35600	ABCA4_MOUSE	60.7	84	33	0	252	1	1954	2037	2.80E-23	109	ABCA4_MOUSE	reviewed	Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter)	Abca4 Abcr	Mus musculus (Mouse)	2310	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; photoreceptor outer segment [GO:0001750]	ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]	GO:0001750; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0050896; GO:0090555; GO:0140326; GO:0140327; GO:0140347	lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN25006_c0_g1_i1	O35600	ABCA4_MOUSE	62.4	101	38	0	5	307	1059	1159	6.70E-32	137.9	ABCA4_MOUSE	reviewed	Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter)	Abca4 Abcr	Mus musculus (Mouse)	2310	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; photoreceptor outer segment [GO:0001750]	ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]	GO:0001750; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0050896; GO:0090555; GO:0140326; GO:0140327; GO:0140347	lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN28463_c0_g1_i1	P78363	ABCA4_HUMAN	61.3	62	24	0	19	204	1954	2015	3.10E-14	78.6	ABCA4_HUMAN	reviewed	Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein)	ABCA4 ABCR	Homo sapiens (Human)	2273	"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; transporter activity [GO:0005215]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]"	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]	ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; transporter activity [GO:0005215]	GO:0001523; GO:0005215; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0007603; GO:0016020; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0055085; GO:0090555; GO:0097381; GO:0140326; GO:0140327; GO:0140347	"lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39975_c0_g1_i1	P78363	ABCA4_HUMAN	60.4	101	38	1	2	304	2064	2162	7.70E-30	131	ABCA4_HUMAN	reviewed	Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein)	ABCA4 ABCR	Homo sapiens (Human)	2273	"endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; transporter activity [GO:0005215]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]"	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]	ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; transporter activity [GO:0005215]	GO:0001523; GO:0005215; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0007603; GO:0016020; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0055085; GO:0090555; GO:0097381; GO:0140326; GO:0140327; GO:0140347	"lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12303_c3_g1_i1	Q9VPH8	RBBP5_DROME	67.8	482	147	6	1750	329	1	482	1.20E-189	664.5	RBBP5_DROME	reviewed	Retinoblastoma-binding protein 5 homolog	Rbbp5 CG5585	Drosophila melanogaster (Fruit fly)	489	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]		GO:0044665; GO:0044666; GO:0048188; GO:0051568	histone H3-K4 methylation [GO:0051568]		NA	NA	NA	NA	NA	NA
TRINITY_DN30027_c0_g1_i1	P10276	RARA_HUMAN	98	101	2	0	2	304	85	185	4.10E-55	214.9	RARA_HUMAN	reviewed	Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)	RARA NR1B1	Homo sapiens (Human)	462	"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; alpha-actinin binding [GO:0051393]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; mRNA 5'-UTR binding [GO:0048027]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase B binding [GO:0043422]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; hormone-mediated signaling pathway [GO:0009755]; limb development [GO:0060173]; liver development [GO:0001889]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of binding [GO:0051099]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein phosphorylation [GO:0006468]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]"	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	"alpha-actinin binding [GO:0051393]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; mRNA 5'-UTR binding [GO:0048027]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase B binding [GO:0043422]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000900; GO:0000977; GO:0000978; GO:0000981; GO:0001657; GO:0001843; GO:0001889; GO:0001972; GO:0002068; GO:0003148; GO:0003417; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006367; GO:0006468; GO:0007165; GO:0007281; GO:0007283; GO:0007565; GO:0008134; GO:0008144; GO:0008270; GO:0008284; GO:0008285; GO:0009755; GO:0009986; GO:0015629; GO:0019899; GO:0019904; GO:0021766; GO:0030154; GO:0030425; GO:0030850; GO:0030853; GO:0031076; GO:0031490; GO:0031641; GO:0032355; GO:0032526; GO:0032689; GO:0032720; GO:0032736; GO:0032753; GO:0032754; GO:0032991; GO:0033189; GO:0034097; GO:0035264; GO:0042826; GO:0043066; GO:0043277; GO:0043422; GO:0044323; GO:0045471; GO:0045630; GO:0045666; GO:0045787; GO:0045892; GO:0045893; GO:0045944; GO:0048027; GO:0048167; GO:0048384; GO:0048471; GO:0051018; GO:0051099; GO:0051393; GO:0055012; GO:0060010; GO:0060173; GO:0060324; GO:0060534; GO:0060591; GO:0061037; GO:0071222; GO:0071391; GO:1990837	"apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; hormone-mediated signaling pathway [GO:0009755]; limb development [GO:0060173]; liver development [GO:0001889]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of binding [GO:0051099]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; protein phosphorylation [GO:0006468]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1799_c0_g1_i1	Q5I7G2	RXR_LYMST	73.4	342	81	3	1091	78	97	432	8.60E-142	505	RXR_LYMST	reviewed	Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR)	RXR	Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	436	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0007275; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1799_c0_g1_i2	Q5I7G2	RXR_LYMST	68.2	368	81	3	1169	78	97	432	7.20E-139	495.4	RXR_LYMST	reviewed	Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR)	RXR	Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	436	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0007275; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1799_c0_g1_i3	Q5I7G2	RXR_LYMST	78.2	197	43	0	668	78	236	432	9.90E-87	321.2	RXR_LYMST	reviewed	Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR)	RXR	Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	436	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0007275; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1799_c0_g1_i4	Q5I7G2	RXR_LYMST	76.7	202	47	0	683	78	231	432	9.10E-88	324.7	RXR_LYMST	reviewed	Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR)	RXR	Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	436	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0007275; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN1799_c0_g1_i5	Q5I7G2	RXR_LYMST	74.5	337	81	2	1076	78	97	432	2.00E-143	510.4	RXR_LYMST	reviewed	Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR)	RXR	Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	436	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0007275; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN23717_c0_g1_i1	P28704	RXRB_MOUSE	97	134	0	1	404	3	367	496	1.10E-66	253.8	RXRB_MOUSE	reviewed	Retinoic acid receptor RXR-beta (MHC class I regulatory element-binding protein H-2RIIBP) (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta)	Rxrb Nr2b2	Mus musculus (Mouse)	520	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D receptor binding [GO:0042809]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; ventricular cardiac muscle cell differentiation [GO:0055012]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D receptor binding [GO:0042809]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0001228; GO:0001701; GO:0001893; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0030375; GO:0031641; GO:0032526; GO:0042809; GO:0042974; GO:0043565; GO:0044323; GO:0044877; GO:0045893; GO:0045944; GO:0046966; GO:0048384; GO:0048856; GO:0055012; GO:0060038; GO:0071300; GO:0090575; GO:1990837	"anatomical structure development [GO:0048856]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; ventricular cardiac muscle cell differentiation [GO:0055012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23717_c0_g1_i2	P28704	RXRB_MOUSE	100	146	0	0	440	3	351	496	5.80E-79	294.7	RXRB_MOUSE	reviewed	Retinoic acid receptor RXR-beta (MHC class I regulatory element-binding protein H-2RIIBP) (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta)	Rxrb Nr2b2	Mus musculus (Mouse)	520	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D receptor binding [GO:0042809]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; ventricular cardiac muscle cell differentiation [GO:0055012]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D receptor binding [GO:0042809]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0001228; GO:0001701; GO:0001893; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0030375; GO:0031641; GO:0032526; GO:0042809; GO:0042974; GO:0043565; GO:0044323; GO:0044877; GO:0045893; GO:0045944; GO:0046966; GO:0048384; GO:0048856; GO:0055012; GO:0060038; GO:0071300; GO:0090575; GO:1990837	"anatomical structure development [GO:0048856]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; ventricular cardiac muscle cell differentiation [GO:0055012]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38726_c0_g1_i1	Q5TJF7	RXRB_CANLF	96.9	97	3	0	1	291	183	279	2.20E-51	202.6	RXRB_CANLF	reviewed	Retinoic acid receptor RXR-beta (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta)	RXRB NR2B2	Canis lupus familiaris (Dog) (Canis familiaris)	533	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; RNA polymerase II transcription regulator complex [GO:0090575]; nuclear receptor activity [GO:0004879]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; RNA polymerase II transcription regulator complex [GO:0090575]	nuclear receptor activity [GO:0004879]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0000790; GO:0000978; GO:0003707; GO:0004879; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0032526; GO:0044323; GO:0045944; GO:0048384; GO:0048856; GO:0090575	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]		NA	NA	NA	NA	NA	NA
TRINITY_DN35213_c0_g1_i1	Q920A5	RISC_MOUSE	47.5	80	42	0	250	11	165	244	2.40E-16	85.9	RISC_MOUSE	reviewed	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	Scpep1 Risc	Mus musculus (Mouse)	452	cytosol [GO:0005829]; extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular region [GO:0005576]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005576; GO:0005829; GO:0042573; GO:0045776; GO:0097755	negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN35910_c0_g1_i1	Q9HB40	RISC_HUMAN	47.2	123	64	1	367	2	40	162	1.30E-28	127.1	RISC_HUMAN	reviewed	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	SCPEP1 RISC SCP1 MSTP034 UNQ265/PRO302	Homo sapiens (Human)	452	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005829; GO:0042573; GO:0045776; GO:0070062; GO:0097755	negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN9237_c0_g1_i1	Q920A6	RISC_RAT	45.6	450	224	8	85	1404	8	446	2.60E-105	384	RISC_RAT	reviewed	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	Scpep1 Risc	Rattus norvegicus (Rat)	452	cytosol [GO:0005829]; extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular region [GO:0005576]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005576; GO:0005829; GO:0042573; GO:0045776; GO:0097755	negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]		blue	blue	NA	NA	NA	NA
TRINITY_DN33089_c0_g1_i1	Q9HB40	RISC_HUMAN	100	107	0	0	323	3	140	246	3.90E-56	218.4	RISC_HUMAN	reviewed	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	SCPEP1 RISC SCP1 MSTP034 UNQ265/PRO302	Homo sapiens (Human)	452	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005829; GO:0042573; GO:0045776; GO:0070062; GO:0097755	negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN32147_c0_g1_i1	Q920A5	RISC_MOUSE	99.5	186	1	0	560	3	105	290	1.10E-103	377.1	RISC_MOUSE	reviewed	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	Scpep1 Risc	Mus musculus (Mouse)	452	cytosol [GO:0005829]; extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular region [GO:0005576]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005576; GO:0005829; GO:0042573; GO:0045776; GO:0097755	negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN38644_c0_g1_i1	Q9HB40	RISC_HUMAN	98.7	76	1	0	1	228	34	109	2.50E-41	168.7	RISC_HUMAN	reviewed	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	SCPEP1 RISC SCP1 MSTP034 UNQ265/PRO302	Homo sapiens (Human)	452	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005829; GO:0042573; GO:0045776; GO:0070062; GO:0097755	negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; retinoic acid metabolic process [GO:0042573]		NA	NA	NA	NA	NA	NA
TRINITY_DN19393_c0_g1_i2	Q9QYF1	RDH11_MOUSE	52.8	72	33	1	151	366	27	97	1.80E-12	73.6	RDH11_MOUSE	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (Cell line MC/9.IL4-derived protein 1) (M42C60) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short-chain aldehyde dehydrogenase) (SCALD)	Rdh11 Arsdr1 Mdt1 Psdr1	Mus musculus (Mouse)	316	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; adaptation of rhodopsin mediated signaling [GO:0016062]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]	aldehyde dehydrogenase (NADP+) activity [GO:0033721]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0016021; GO:0016062; GO:0033721; GO:0042572; GO:0042574; GO:0052650; GO:0110095	adaptation of rhodopsin mediated signaling [GO:0016062]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g1_i5	Q8TC12	RDH11_HUMAN	53	117	54	1	352	2	52	167	3.90E-25	115.5	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN7913_c0_g1_i1	Q8TC12	RDH11_HUMAN	45.7	258	129	4	796	23	31	277	7.90E-56	218.8	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN7913_c0_g1_i2	Q8TC12	RDH11_HUMAN	49.5	200	96	2	630	31	31	225	1.60E-46	187.6	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN14913_c0_g1_i1	Q8TC12	RDH11_HUMAN	49.3	75	34	1	265	41	107	177	4.40E-13	75.1	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN14913_c0_g1_i2	Q8TC12	RDH11_HUMAN	50.7	75	33	1	265	41	107	177	5.20E-14	78.2	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g2_i1	Q8TC12	RDH11_HUMAN	58	131	53	2	60	452	52	180	1.70E-33	143.7	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		brown	brown	NA	NA	NA	NA
TRINITY_DN36561_c0_g1_i1	Q8TC12	RDH11_HUMAN	99.6	248	1	0	745	2	26	273	1.60E-140	500	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN1256_c0_g1_i1	Q8TC12	RDH11_HUMAN	34.4	334	190	8	1076	102	3	316	7.70E-33	142.9	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN1256_c0_g1_i2	Q8TC12	RDH11_HUMAN	35	311	179	7	1007	102	20	316	6.40E-34	146.4	RDH11_HUMAN	reviewed	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN10853_c0_g1_i1	Q8BYK4	RDH12_MOUSE	43.6	117	64	1	17	367	200	314	3.00E-20	99.8	RDH12_MOUSE	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300)	Rdh12	Mus musculus (Mouse)	316	photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	photoreceptor inner segment [GO:0001917]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN10853_c0_g1_i4	Q8BYK4	RDH12_MOUSE	48.3	89	44	1	17	283	200	286	3.60E-17	89	RDH12_MOUSE	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300)	Rdh12	Mus musculus (Mouse)	316	photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	photoreceptor inner segment [GO:0001917]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN8051_c0_g1_i1	Q96NR8	RDH12_HUMAN	48	294	146	4	346	1215	23	313	9.90E-69	262.3	RDH12_HUMAN	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2)	RDH12 SDR7C2	Homo sapiens (Human)	316	endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i12	P59837	RDH12_BOVIN	46.1	308	158	5	76	999	17	316	1.20E-64	248.4	RDH12_BOVIN	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300) (Double substrate specificity short-chain dehydrogenase/reductase 2)	RDH12 DSSDR2	Bos taurus (Bovine)	316	photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	photoreceptor inner segment [GO:0001917]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i2	P59837	RDH12_BOVIN	46.1	308	158	5	76	999	17	316	9.30E-65	248.8	RDH12_BOVIN	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300) (Double substrate specificity short-chain dehydrogenase/reductase 2)	RDH12 DSSDR2	Bos taurus (Bovine)	316	photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	photoreceptor inner segment [GO:0001917]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i4	P59837	RDH12_BOVIN	47.8	274	137	4	37	858	49	316	1.30E-59	231.5	RDH12_BOVIN	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300) (Double substrate specificity short-chain dehydrogenase/reductase 2)	RDH12 DSSDR2	Bos taurus (Bovine)	316	photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	photoreceptor inner segment [GO:0001917]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i8	P59837	RDH12_BOVIN	46.1	308	158	5	76	999	17	316	7.80E-64	245.7	RDH12_BOVIN	reviewed	Retinol dehydrogenase 12 (EC 1.1.1.300) (Double substrate specificity short-chain dehydrogenase/reductase 2)	RDH12 DSSDR2	Bos taurus (Bovine)	316	photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	photoreceptor inner segment [GO:0001917]	NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]	GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0110095	cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g1_i3	Q8CEE7	RDH13_MOUSE	48.9	131	59	4	462	85	161	288	8.70E-21	102.4	RDH13_MOUSE	reviewed	Retinol dehydrogenase 13 (EC 1.1.1.300)	Rdh13	Mus musculus (Mouse)	334	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g1_i3	Q8CEE7	RDH13_MOUSE	47.9	94	49	0	749	468	28	121	2.50E-15	84.3	RDH13_MOUSE	reviewed	Retinol dehydrogenase 13 (EC 1.1.1.300)	Rdh13	Mus musculus (Mouse)	334	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]		NA	NA	NA	NA	NA	NA
TRINITY_DN27711_c0_g1_i1	Q8NBN7	RDH13_HUMAN	50.9	112	53	2	7	342	122	231	1.40E-22	107.1	RDH13_HUMAN	reviewed	Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)	RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430	Homo sapiens (Human)	331	mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	mitochondrial inner membrane [GO:0005743]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]		NA	NA	NA	NA	NA	NA
TRINITY_DN33170_c0_g1_i1	Q8NBN7	RDH13_HUMAN	59.1	237	90	4	113	811	13	246	6.60E-71	268.9	RDH13_HUMAN	reviewed	Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)	RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430	Homo sapiens (Human)	331	mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	mitochondrial inner membrane [GO:0005743]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]		NA	NA	NA	NA	NA	NA
TRINITY_DN2171_c0_g1_i1	Q8NBN7	RDH13_HUMAN	51.4	317	153	1	1038	91	3	319	4.30E-86	319.7	RDH13_HUMAN	reviewed	Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)	RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430	Homo sapiens (Human)	331	mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	mitochondrial inner membrane [GO:0005743]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g1_i7	Q17QW3	RDH14_BOVIN	46	163	83	5	665	183	177	336	3.20E-25	117.5	RDH14_BOVIN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300)	RDH14	Bos taurus (Bovine)	336	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol metabolic process [GO:0042572]	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001750; GO:0005783; GO:0042572; GO:0052650	retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g1_i7	Q17QW3	RDH14_BOVIN	35.4	99	51	2	922	665	41	139	9.30E-09	62.8	RDH14_BOVIN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300)	RDH14	Bos taurus (Bovine)	336	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol metabolic process [GO:0042572]	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001750; GO:0005783; GO:0042572; GO:0052650	retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g1_i1	Q17QW3	RDH14_BOVIN	46	163	83	5	665	183	177	336	2.80E-25	117.5	RDH14_BOVIN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300)	RDH14	Bos taurus (Bovine)	336	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol metabolic process [GO:0042572]	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001750; GO:0005783; GO:0042572; GO:0052650	retinol metabolic process [GO:0042572]		NA	NA	1	NA	NA	NA
TRINITY_DN8539_c0_g1_i1	Q17QW3	RDH14_BOVIN	33.7	86	44	2	883	665	54	139	2.70E-04	47.8	RDH14_BOVIN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300)	RDH14	Bos taurus (Bovine)	336	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol metabolic process [GO:0042572]	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001750; GO:0005783; GO:0042572; GO:0052650	retinol metabolic process [GO:0042572]		NA	NA	1	NA	NA	NA
TRINITY_DN29632_c0_g1_i1	Q17QW3	RDH14_BOVIN	40.3	293	156	6	213	1049	45	332	6.00E-46	186.4	RDH14_BOVIN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300)	RDH14	Bos taurus (Bovine)	336	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol metabolic process [GO:0042572]	endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001750; GO:0005783; GO:0042572; GO:0052650	retinol metabolic process [GO:0042572]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i3	Q9HBH5	RDH14_HUMAN	50.6	233	112	3	117	812	104	334	3.70E-51	203.4	RDH14_HUMAN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)	RDH14 PAN2 SDR7C4 UNQ529/PRO1072	Homo sapiens (Human)	336	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001649; GO:0005634; GO:0005765; GO:0005783; GO:0005789; GO:0016020; GO:0052650	osteoblast differentiation [GO:0001649]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i6	Q9HBH5	RDH14_HUMAN	46.1	141	74	2	298	717	195	334	6.00E-24	112.8	RDH14_HUMAN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)	RDH14 PAN2 SDR7C4 UNQ529/PRO1072	Homo sapiens (Human)	336	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001649; GO:0005634; GO:0005765; GO:0005783; GO:0005789; GO:0016020; GO:0052650	osteoblast differentiation [GO:0001649]		NA	NA	NA	NA	NA	NA
TRINITY_DN21391_c0_g1_i6	Q9HBH5	RDH14_HUMAN	58.4	89	36	1	24	290	104	191	3.40E-19	97.1	RDH14_HUMAN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)	RDH14 PAN2 SDR7C4 UNQ529/PRO1072	Homo sapiens (Human)	336	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001649; GO:0005634; GO:0005765; GO:0005783; GO:0005789; GO:0016020; GO:0052650	osteoblast differentiation [GO:0001649]		NA	NA	NA	NA	NA	NA
TRINITY_DN39941_c0_g1_i1	Q9HBH5	RDH14_HUMAN	45.7	188	91	4	594	46	153	334	5.80E-32	139	RDH14_HUMAN	reviewed	Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)	RDH14 PAN2 SDR7C4 UNQ529/PRO1072	Homo sapiens (Human)	336	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001649; GO:0005634; GO:0005765; GO:0005783; GO:0005789; GO:0016020; GO:0052650	osteoblast differentiation [GO:0001649]		NA	NA	NA	NA	NA	NA
TRINITY_DN203_c0_g1_i2	Q9VD09	PINTA_DROME	36.6	257	156	3	951	181	19	268	1.80E-44	181.4	PINTA_DROME	reviewed	Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent)	pinta CG13848	Drosophila melanogaster (Fruit fly)	273	phosphatidylinositol bisphosphate binding [GO:1902936]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]		phosphatidylinositol bisphosphate binding [GO:1902936]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]	GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841; GO:1902936	phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN8726_c0_g1_i4	P04323	POL3_DROME	28	701	449	17	2733	742	243	924	9.00E-65	250.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN8726_c0_g1_i5	P04323	POL3_DROME	23.8	403	262	10	1851	742	534	924	1.60E-16	89.4	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6902_c0_g1_i10	P04323	POL3_DROME	41.8	79	44	2	670	906	168	244	9.50E-07	55.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6902_c0_g1_i11	P04323	POL3_DROME	41.8	79	44	2	625	861	168	244	9.00E-07	55.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6902_c0_g1_i18	P04323	POL3_DROME	44.3	79	42	2	625	861	168	244	2.80E-08	60.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6902_c0_g1_i9	P04323	POL3_DROME	44.3	79	42	2	623	859	168	244	2.80E-08	60.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN19332_c3_g1_i1	P04323	POL3_DROME	40.4	57	34	0	196	26	573	629	1.90E-06	52.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN5438_c0_g1_i2	P04323	POL3_DROME	38.5	96	59	0	522	235	365	460	3.10E-18	93.2	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN5438_c0_g1_i5	P04323	POL3_DROME	39.6	96	58	0	3	290	365	460	8.10E-19	95.1	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN5438_c0_g1_i8	P04323	POL3_DROME	39.6	96	58	0	3	290	365	460	8.40E-19	95.1	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN15120_c0_g1_i2	P04323	POL3_DROME	43.2	192	104	3	574	2	363	550	1.10E-35	151.4	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN15120_c0_g1_i3	P04323	POL3_DROME	45.9	98	48	3	292	2	457	550	1.10E-13	78.2	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3437_c0_g1_i3	P04323	POL3_DROME	21.8	532	357	16	1549	32	406	904	8.00E-20	100.1	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN39364_c0_g1_i1	P04323	POL3_DROME	44.6	56	31	0	229	62	568	623	2.50E-09	62.4	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN14533_c0_g1_i1	P04323	POL3_DROME	43.3	263	142	3	831	52	302	560	6.80E-52	205.7	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN14533_c0_g1_i4	P04323	POL3_DROME	38.7	199	119	2	663	76	302	500	3.00E-34	146.7	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		yellow	yellow	1	NA	NA	1
TRINITY_DN10634_c0_g1_i2	P04323	POL3_DROME	26.2	450	287	12	2361	1045	208	623	2.30E-36	155.6	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10634_c0_g1_i4	P04323	POL3_DROME	39.4	94	52	3	471	190	535	623	1.10E-07	58.9	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10634_c0_g1_i6	P04323	POL3_DROME	38.3	94	53	3	1326	1045	535	623	1.00E-06	56.6	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6866_c1_g1_i1	P04323	POL3_DROME	45.3	53	25	1	289	131	575	623	6.40E-05	48.1	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6866_c1_g1_i3	P04323	POL3_DROME	45.3	53	25	1	289	131	575	623	6.40E-05	48.1	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1355_c0_g1_i1	P04323	POL3_DROME	45.6	79	43	0	1654	1418	553	631	1.40E-11	72.8	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN1355_c0_g1_i10	P04323	POL3_DROME	44.3	79	44	0	344	108	553	631	1.10E-11	70.9	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1355_c0_g1_i15	P04323	POL3_DROME	47.5	61	32	0	673	491	553	613	4.40E-09	63.2	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1355_c0_g1_i9	P04323	POL3_DROME	47.5	61	32	0	374	192	553	613	2.50E-09	63.2	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6222_c0_g1_i1	P04323	POL3_DROME	39.7	68	41	0	19	222	572	639	9.50E-09	61.2	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6222_c0_g1_i3	P04323	POL3_DROME	39.7	68	41	0	365	162	572	639	9.50E-09	61.2	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN13272_c0_g1_i1	P04323	POL3_DROME	36.8	117	63	5	371	39	529	640	4.80E-08	58.9	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN13272_c0_g1_i2	P04323	POL3_DROME	41.4	111	56	4	359	39	535	640	2.60E-10	66.6	POL3_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1058	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN19713_c0_g1_i1	P20825	POL2_DROME	48.7	113	52	2	327	4	245	356	2.80E-25	115.9	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		brown	brown	1	NA	NA	NA
TRINITY_DN3764_c0_g1_i5	P20825	POL2_DROME	39	77	46	1	535	765	174	249	2.30E-06	54.3	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN3764_c0_g1_i2	P20825	POL2_DROME	39	77	46	1	358	588	174	249	3.00E-06	53.5	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3764_c0_g1_i9	P20825	POL2_DROME	39	77	46	1	358	588	174	249	1.80E-06	54.3	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1238_c0_g1_i1	P20825	POL2_DROME	50.7	69	34	0	46	252	297	365	2.90E-14	79	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		brown	brown	1	NA	NA	NA
TRINITY_DN1238_c0_g1_i2	P20825	POL2_DROME	50	60	30	0	46	225	297	356	1.60E-11	69.7	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN12841_c0_g1_i4	P20825	POL2_DROME	39.5	81	49	0	245	3	376	456	9.70E-11	68.6	POL2_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1059	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN36_c0_g1_i2	P10394	POL4_DROME	43.5	62	33	1	1	186	676	735	7.00E-05	50.4	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10489_c0_g1_i10	P10394	POL4_DROME	25.3	221	153	5	640	2	328	544	7.90E-16	85.5	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10489_c0_g1_i5	P10394	POL4_DROME	25.5	141	95	4	478	74	328	464	3.40E-07	57	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3406_c0_g1_i1	P10394	POL4_DROME	24.4	123	83	2	1415	1065	314	432	8.90E-05	50.1	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3406_c0_g1_i6	P10394	POL4_DROME	23.3	232	166	3	784	113	314	541	1.30E-16	88.6	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1910_c0_g2_i1	P10394	POL4_DROME	24.3	506	330	14	1577	114	264	734	6.30E-30	133.7	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN10634_c0_g1_i3	P10394	POL4_DROME	23.5	221	158	3	744	103	329	545	2.00E-14	81.3	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3353_c1_g1_i10	P10394	POL4_DROME	44.7	161	89	0	869	387	574	734	1.50E-33	144.8	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		brown	brown	1	NA	NA	NA
TRINITY_DN6866_c0_g1_i1	P10394	POL4_DROME	27.3	154	110	1	507	52	367	520	2.10E-10	67.8	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6866_c0_g1_i11	P10394	POL4_DROME	24.5	392	260	11	1206	64	329	695	8.50E-22	106.7	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6866_c0_g1_i12	P10394	POL4_DROME	23.2	207	151	2	934	338	338	544	4.50E-12	73.6	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6866_c0_g1_i2	P10394	POL4_DROME	25.1	350	236	9	1098	64	367	695	1.40E-19	99	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6866_c0_g1_i6	P10394	POL4_DROME	24	379	256	10	1167	64	338	695	5.60E-20	100.1	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN7515_c1_g1_i4	P10394	POL4_DROME	25.2	413	271	11	1277	75	348	734	1.90E-24	115.2	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN7515_c1_g1_i8	P10394	POL4_DROME	24.5	437	286	13	160	1431	329	734	9.80E-25	116.3	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3353_c1_g1_i12	P10394	POL4_DROME	44.7	161	89	0	869	387	574	734	1.50E-33	144.8	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3353_c1_g1_i5	P10394	POL4_DROME	44.7	161	89	0	869	387	574	734	1.50E-33	144.8	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3353_c1_g1_i6	P10394	POL4_DROME	44.7	161	89	0	749	267	574	734	1.30E-33	144.8	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3353_c1_g1_i8	P10394	POL4_DROME	44.7	161	89	0	869	387	574	734	1.50E-33	144.8	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10523_c0_g2_i1	P10394	POL4_DROME	24.5	200	143	2	157	732	345	544	4.10E-13	77	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10523_c0_g2_i2	P10394	POL4_DROME	24.7	174	129	1	122	637	371	544	1.40E-12	75.1	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10523_c0_g3_i1	P10394	POL4_DROME	26.2	130	94	1	596	213	415	544	6.70E-09	62.4	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10523_c0_g5_i1	P10394	POL4_DROME	32.7	107	70	1	111	425	414	520	2.80E-10	66.6	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN13234_c0_g1_i1	P10394	POL4_DROME	43.4	76	42	1	73	300	621	695	1.30E-11	70.5	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN13234_c0_g1_i3	P10394	POL4_DROME	43.4	76	42	1	73	300	621	695	1.00E-11	70.9	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN13234_c0_g1_i4	P10394	POL4_DROME	40.7	91	51	2	73	345	621	708	1.80E-12	73.6	POL4_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	POL ORF3	Drosophila melanogaster (Fruit fly)	1237	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN15599_c0_g1_i4	P10401	POLY_DROME	37.2	121	62	3	334	2	417	533	9.20E-11	67.8	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN15599_c0_g1_i5	P10401	POLY_DROME	36.8	155	83	4	441	10	417	567	1.90E-16	87	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN15599_c0_g1_i6	P10401	POLY_DROME	37.2	86	44	2	231	4	417	502	1.60E-06	53.1	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN22968_c2_g1_i1	P10401	POLY_DROME	31.8	66	45	0	207	10	371	436	4.80E-05	48.1	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10489_c0_g1_i15	P10401	POLY_DROME	28	485	306	12	1541	162	144	610	6.60E-43	176.8	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10489_c0_g1_i4	P10401	POLY_DROME	29.7	276	172	5	868	77	345	610	3.00E-26	120.6	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN13341_c0_g1_i1	P10401	POLY_DROME	33.1	151	82	4	3	419	411	554	1.20E-12	74.3	POLY_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1035	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]		endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN28896_c0_g1_i1	Q8I7P9	POL5_DROME	35.8	106	61	2	347	30	465	563	1.60E-09	63.9	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i1	Q8I7P9	POL5_DROME	33.8	225	132	4	716	75	338	556	8.20E-22	105.5	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i2	Q8I7P9	POL5_DROME	34.6	130	79	3	429	40	411	534	4.10E-10	66.2	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i6	Q8I7P9	POL5_DROME	31.8	211	127	5	674	75	352	556	1.60E-15	84.7	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i7	Q8I7P9	POL5_DROME	32.7	211	125	5	674	75	352	556	1.00E-17	92.4	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i7	Q8I7P9	POL5_DROME	30.7	140	84	3	640	1026	352	489	2.90E-04	47.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i8	Q8I7P9	POL5_DROME	32.7	211	125	4	674	75	352	556	1.30E-17	92	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5438_c0_g1_i11	Q8I7P9	POL5_DROME	52.2	69	29	1	207	1	315	379	4.10E-14	78.2	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17790_c0_g2_i1	Q8I7P9	POL5_DROME	29.8	94	66	0	285	4	277	370	3.00E-10	65.9	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7639_c0_g1_i10	Q8I7P9	POL5_DROME	31.7	249	156	4	10	717	196	443	1.80E-24	114.4	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7639_c0_g1_i15	Q8I7P9	POL5_DROME	30.1	166	113	2	921	430	196	360	5.90E-12	73.2	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7639_c0_g1_i4	Q8I7P9	POL5_DROME	32.1	249	155	4	10	717	196	443	1.70E-25	117.9	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7639_c0_g1_i8	Q8I7P9	POL5_DROME	33.1	172	112	2	511	2	196	366	1.50E-20	100.9	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3131_c1_g1_i11	Q8I7P9	POL5_DROME	45.3	53	29	0	298	140	502	554	9.70E-07	55.5	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		brown	brown	NA	NA	NA	NA
TRINITY_DN3131_c1_g1_i9	Q8I7P9	POL5_DROME	45.3	53	29	0	310	152	502	554	5.10E-07	55.5	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		brown	brown	NA	NA	NA	NA
TRINITY_DN40237_c0_g1_i1	Q8I7P9	POL5_DROME	40.6	64	33	1	37	213	139	202	3.70E-10	65.1	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2086_c1_g1_i13	Q8I7P9	POL5_DROME	36.5	96	57	1	1580	1293	465	556	3.80E-09	64.7	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN3131_c1_g1_i6	Q8I7P9	POL5_DROME	45.3	53	29	0	328	486	502	554	2.00E-06	54.3	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		brown	brown	1	NA	NA	NA
TRINITY_DN18092_c0_g1_i1	Q8I7P9	POL5_DROME	29.7	145	89	3	406	5	354	496	4.20E-07	55.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18092_c0_g1_i2	Q8I7P9	POL5_DROME	28.3	145	91	2	406	5	354	496	1.40E-05	50.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6481_c0_g2_i2	Q8I7P9	POL5_DROME	28.1	555	343	16	1671	139	243	785	7.60E-42	173.3	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6481_c0_g2_i4	Q8I7P9	POL5_DROME	32.9	343	203	7	1342	377	243	579	5.30E-38	160.2	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5527_c1_g1_i4	Q8I7P9	POL5_DROME	31.4	271	169	4	15	794	301	565	4.40E-27	123.2	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5527_c1_g1_i5	Q8I7P9	POL5_DROME	31.8	214	133	3	2	610	287	498	3.90E-20	99.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5527_c1_g1_i9	Q8I7P9	POL5_DROME	30.3	390	252	6	7	1137	183	565	9.80E-41	169.1	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12815_c0_g1_i1	Q8I7P9	POL5_DROME	35	80	47	2	86	316	277	354	4.70E-06	52	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4479_c0_g1_i1	Q8I7P9	POL5_DROME	32.4	145	86	3	3	404	355	498	1.70E-07	57.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4479_c0_g1_i4	Q8I7P9	POL5_DROME	31	145	88	3	3	404	355	498	2.00E-05	50.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4479_c0_g1_i6	Q8I7P9	POL5_DROME	33.1	145	85	3	3	404	355	498	7.50E-08	58.9	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4479_c0_g1_i7	Q8I7P9	POL5_DROME	31	145	88	3	3	404	355	498	2.00E-05	50.8	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4479_c0_g1_i8	Q8I7P9	POL5_DROME	31.7	145	87	3	3	404	355	498	9.10E-06	52	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1620_c0_g1_i1	Q8I7P9	POL5_DROME	30.2	431	280	7	1764	3011	132	556	7.80E-49	198	POL5_DROME	reviewed	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	pol	Drosophila melanogaster (Fruit fly)	1003	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4204_c1_g1_i2	Q94HW2	POLR1_ARATH	29.6	446	265	18	1391	144	1018	1444	1.60E-32	142.1	POLR1_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]	RE1 RF12 RF28 At1g58889 R18I; RE1 At1g59265 T4M14.18	Arabidopsis thaliana (Mouse-ear cress)	1466	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN935_c0_g1_i1	Q94HW2	POLR1_ARATH	29.1	470	278	20	1680	2993	998	1444	2.00E-35	152.9	POLR1_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]	RE1 RF12 RF28 At1g58889 R18I; RE1 At1g59265 T4M14.18	Arabidopsis thaliana (Mouse-ear cress)	1466	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN935_c0_g1_i3	Q94HW2	POLR1_ARATH	29.1	470	278	20	1683	2996	998	1444	2.00E-35	152.9	POLR1_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]	RE1 RF12 RF28 At1g58889 R18I; RE1 At1g59265 T4M14.18	Arabidopsis thaliana (Mouse-ear cress)	1466	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN935_c0_g1_i4	Q94HW2	POLR1_ARATH	29.1	470	278	20	36	1349	998	1444	7.10E-36	153.3	POLR1_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]	RE1 RF12 RF28 At1g58889 R18I; RE1 At1g59265 T4M14.18	Arabidopsis thaliana (Mouse-ear cress)	1466	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN6129_c0_g1_i2	Q94HW2	POLR1_ARATH	33.1	145	89	4	496	83	998	1141	5.00E-16	85.9	POLR1_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]	RE1 RF12 RF28 At1g58889 R18I; RE1 At1g59265 T4M14.18	Arabidopsis thaliana (Mouse-ear cress)	1466	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4204_c1_g1_i6	Q9ZT94	POLR2_ARATH	32.9	213	127	7	1404	805	1001	1210	1.10E-20	102.8	POLR2_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]	RE2 At4g02960 T4I9.16	Arabidopsis thaliana (Mouse-ear cress)	1456	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4204_c1_g1_i8	Q9ZT94	POLR2_ARATH	31.4	239	144	8	1033	368	1001	1236	1.00E-20	102.4	POLR2_ARATH	reviewed	Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]	RE2 At4g02960 T4I9.16	Arabidopsis thaliana (Mouse-ear cress)	1456	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN12591_c0_g1_i1	P10978	POLX_TOBAC	37.8	82	48	1	31	267	511	592	1.90E-07	56.6	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN12591_c0_g1_i2	P10978	POLX_TOBAC	48.8	43	22	0	60	188	550	592	3.10E-05	48.9	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN12591_c0_g1_i4	P10978	POLX_TOBAC	41.9	74	40	1	10	222	519	592	2.90E-07	55.8	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN12591_c0_g1_i6	P10978	POLX_TOBAC	38.3	94	55	1	109	381	499	592	4.40E-10	65.9	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i11	P10978	POLX_TOBAC	55.8	43	19	0	245	117	550	592	7.50E-07	54.3	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i17	P10978	POLX_TOBAC	38.3	94	55	1	648	376	499	592	9.20E-10	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i20	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i23	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i28	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i29	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i4	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i5	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i6	P10978	POLX_TOBAC	38.3	94	55	1	800	528	499	592	1.10E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i7	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i8	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN580_c0_g1_i9	P10978	POLX_TOBAC	38.3	94	55	1	953	681	499	592	1.30E-09	65.5	POLX_TOBAC	reviewed	Retrovirus-related Pol polyprotein from transposon TNT 1-94 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]		Nicotiana tabacum (Common tobacco)	1328	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1786_c0_g1_i1	Q03277	PO11_BRACO	26.3	99	73	0	361	65	408	506	1.90E-06	54.3	PO11_BRACO	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Bradysia coprophila (Dark-winged fungus gnat) (Sciara coprophila)	1004	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1786_c0_g1_i2	Q03277	PO11_BRACO	26.3	99	73	0	361	65	408	506	2.30E-06	54.3	PO11_BRACO	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Bradysia coprophila (Dark-winged fungus gnat) (Sciara coprophila)	1004	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			blue	blue	NA	NA	NA	NA
TRINITY_DN17597_c0_g1_i3	Q03277	PO11_BRACO	33	100	67	0	378	79	405	504	2.50E-07	56.6	PO11_BRACO	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Bradysia coprophila (Dark-winged fungus gnat) (Sciara coprophila)	1004	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			blue	blue	NA	NA	NA	NA
TRINITY_DN5158_c0_g1_i9	Q03270	PO12_NASVI	33.3	84	46	3	316	83	3	82	7.60E-05	48.1	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN21590_c1_g1_i3	Q03270	PO12_NASVI	37.3	83	44	3	58	291	3	82	8.80E-07	54.3	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN765_c0_g1_i10	Q03270	PO12_NASVI	28.1	146	95	4	1089	1505	3	145	7.50E-07	57.4	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			brown	brown	NA	NA	NA	NA
TRINITY_DN765_c0_g1_i4	Q03270	PO12_NASVI	28.1	146	95	4	1089	1505	3	145	7.50E-07	57.4	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g1_i10	Q03270	PO12_NASVI	24.6	187	108	6	316	816	3	176	1.30E-05	52	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g1_i14	Q03270	PO12_NASVI	24.6	187	108	6	104	604	3	176	1.10E-05	52	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g1_i16	Q03270	PO12_NASVI	24.6	187	108	6	393	893	3	176	2.10E-05	52	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g1_i17	Q03270	PO12_NASVI	24.6	187	108	6	316	816	3	176	1.30E-05	52	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1345_c0_g1_i7	Q03270	PO12_NASVI	24.6	187	108	6	285	785	3	176	1.30E-05	52	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN765_c0_g1_i17	Q03270	PO12_NASVI	28.1	146	95	4	2086	2502	3	145	7.00E-07	57.8	PO12_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1 2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	410	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	1	NA	NA	NA
TRINITY_DN447_c1_g1_i37	Q05118	PO23_POPJA	29.8	104	73	0	450	139	8	111	2.90E-09	63.5	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			yellow	yellow	NA	NA	NA	NA
TRINITY_DN5133_c1_g1_i1	Q03278	PO21_NASVI	26.6	158	111	1	682	224	428	585	2.20E-06	54.3	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4584_c0_g1_i2	Q05118	PO23_POPJA	29.4	153	92	3	875	1303	26	172	7.50E-05	50.8	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN4584_c0_g1_i3	Q05118	PO23_POPJA	29.4	153	92	3	922	1350	26	172	7.60E-05	50.8	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN2776_c0_g2_i2	Q03278	PO21_NASVI	51.9	54	24	1	124	285	512	563	1.30E-05	50.4	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i16	Q03278	PO21_NASVI	32.6	92	61	1	413	138	512	602	3.40E-08	59.7	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i17	Q03278	PO21_NASVI	29.4	85	59	1	392	138	519	602	2.30E-05	50.1	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i18	Q03278	PO21_NASVI	31.5	92	62	1	413	138	512	602	8.30E-07	55.1	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i6	Q03278	PO21_NASVI	28.7	143	82	3	413	42	512	653	3.40E-08	59.7	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN208_c0_g1_i7	Q03278	PO21_NASVI	32.6	92	61	1	417	142	512	602	2.60E-08	60.1	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3924_c0_g2_i14	Q05118	PO23_POPJA	27.7	188	108	7	2134	1637	25	206	4.70E-07	58.2	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1949_c1_g1_i1	Q03274	PO22_POPJA	28.7	129	84	3	1	363	152	280	1.00E-06	54.7	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1949_c1_g1_i12	Q03274	PO22_POPJA	29.5	129	83	3	1	363	152	280	5.50E-07	55.5	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1949_c1_g1_i13	Q03274	PO22_POPJA	38.2	76	45	2	1	222	152	227	2.70E-06	53.1	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1949_c1_g1_i7	Q03274	PO22_POPJA	35.5	76	48	1	1	225	152	227	6.90E-07	54.7	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN1949_c1_g1_i9	Q03274	PO22_POPJA	29.5	129	83	3	1	363	152	280	5.90E-07	55.5	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN16176_c0_g1_i5	Q05118	PO23_POPJA	33	91	61	0	147	419	21	111	2.30E-09	63.5	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN16176_c0_g1_i6	Q05118	PO23_POPJA	33.3	84	56	0	147	398	21	104	1.90E-07	57	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			yellow	yellow	NA	NA	NA	NA
TRINITY_DN999_c0_g1_i39	Q03274	PO22_POPJA	32.8	180	111	4	839	318	75	250	9.70E-14	79	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN999_c0_g1_i54	Q03274	PO22_POPJA	32.2	180	112	4	752	231	75	250	2.20E-12	74.3	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN15623_c0_g1_i3	Q05118	PO23_POPJA	27.5	153	97	2	98	526	26	174	2.50E-07	57.4	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN5133_c1_g1_i2	Q03278	PO21_NASVI	26.6	158	111	1	944	486	428	585	3.00E-06	54.3	PO21_NASVI	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Nasonia vitripennis (Parasitic wasp)	1025	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519; GO:0046872			brown	brown	1	NA	NA	NA
TRINITY_DN3924_c0_g2_i2	Q05118	PO23_POPJA	27.7	188	108	7	2134	1637	25	206	7.60E-07	58.2	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	1	NA	1	1
TRINITY_DN1949_c1_g1_i16	Q03274	PO22_POPJA	29.5	129	83	3	1	363	152	280	6.00E-07	55.5	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			brown	brown	1	NA	NA	NA
TRINITY_DN999_c0_g1_i21	Q03274	PO22_POPJA	32.2	115	74	1	397	65	69	183	3.30E-05	49.7	PO22_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	711	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			brown	brown	1	NA	NA	NA
TRINITY_DN4473_c1_g1_i2	Q05118	PO23_POPJA	25.4	189	119	5	751	242	25	210	9.70E-07	55.8	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN4473_c1_g1_i5	Q05118	PO23_POPJA	24.9	189	120	5	953	444	25	210	4.50E-06	53.9	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN4473_c1_g1_i6	Q05118	PO23_POPJA	25.4	189	119	5	953	444	25	210	2.30E-06	55.8	PO23_POPJA	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Popillia japonica (Japanese beetle)	606	endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]		endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964; GO:0004519			NA	NA	NA	NA	NA	NA
TRINITY_DN35636_c0_g1_i1	Q6NW40	RGMB_HUMAN	36.6	202	109	3	9	560	195	395	1.30E-27	124.8	RGMB_HUMAN	reviewed	RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON)	RGMB	Homo sapiens (Human)	437	"anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; BMP signaling pathway [GO:0030509]; cell adhesion [GO:0007155]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]"	anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]	GO:0005793; GO:0005886; GO:0007155; GO:0007165; GO:0015026; GO:0030509; GO:0042802; GO:0045121; GO:0045893; GO:0046658	"BMP signaling pathway [GO:0030509]; cell adhesion [GO:0007155]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19948_c0_g1_i1	P52565	GDIR1_HUMAN	100	129	0	0	422	36	76	204	3.30E-71	268.9	GDIR1_HUMAN	reviewed	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA GDIA1	Homo sapiens (Human)	204	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0005094; GO:0005096; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0035023; GO:0043066; GO:0048365; GO:0050771; GO:0050772; GO:0051056; GO:0070062; GO:0071526; GO:2000249	negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN19948_c0_g2_i1	P19803	GDIR1_BOVIN	100	87	0	0	261	1	77	163	1.60E-44	179.5	GDIR1_BOVIN	reviewed	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA	Bos taurus (Bovine)	204	cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0001772; GO:0005094; GO:0005096; GO:0005829; GO:0007266; GO:0016020; GO:0048365; GO:0071526	Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN2184_c0_g1_i1	P52565	GDIR1_HUMAN	51.8	164	74	3	558	70	32	191	4.00E-40	166.4	GDIR1_HUMAN	reviewed	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA GDIA1	Homo sapiens (Human)	204	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0005094; GO:0005096; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0035023; GO:0043066; GO:0048365; GO:0050771; GO:0050772; GO:0051056; GO:0070062; GO:0071526; GO:2000249	negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]		blue	blue	NA	NA	NA	NA
TRINITY_DN2184_c0_g1_i2	P52565	GDIR1_HUMAN	53.1	175	77	3	622	101	32	202	1.30E-47	191.4	GDIR1_HUMAN	reviewed	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA GDIA1	Homo sapiens (Human)	204	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0005094; GO:0005096; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0035023; GO:0043066; GO:0048365; GO:0050771; GO:0050772; GO:0051056; GO:0070062; GO:0071526; GO:2000249	negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]		blue	blue	NA	NA	NA	NA
TRINITY_DN2184_c0_g1_i3	P52565	GDIR1_HUMAN	53.1	175	77	3	624	103	32	202	1.30E-47	191.4	GDIR1_HUMAN	reviewed	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA GDIA1	Homo sapiens (Human)	204	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0005094; GO:0005096; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0035023; GO:0043066; GO:0048365; GO:0050771; GO:0050772; GO:0051056; GO:0070062; GO:0071526; GO:2000249	negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]		blue	blue	NA	NA	NA	NA
TRINITY_DN2184_c0_g1_i4	P52565	GDIR1_HUMAN	53.1	175	77	3	628	107	32	202	7.50E-48	192.2	GDIR1_HUMAN	reviewed	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA GDIA1	Homo sapiens (Human)	204	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0005094; GO:0005096; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0035023; GO:0043066; GO:0048365; GO:0050771; GO:0050772; GO:0051056; GO:0070062; GO:0071526; GO:2000249	negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]		blue	blue	NA	NA	NA	NA
TRINITY_DN26038_c0_g1_i1	Q61599	GDIR2_MOUSE	100	95	0	0	287	3	69	163	2.40E-49	195.7	GDIR2_MOUSE	reviewed	Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (D4) (Rho-GDI beta)	Arhgdib Gdid4	Mus musculus (Mouse)	200	cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; cellular response to redox state [GO:0071461]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0003924; GO:0005094; GO:0005096; GO:0005829; GO:0007266; GO:0016020; GO:0035023; GO:0048365; GO:0071461; GO:1901164; GO:2000249	cellular response to redox state [GO:0071461]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN24746_c0_g1_i1	Q9TU03	GDIR2_BOVIN	84.3	70	10	1	1	210	9	77	3.40E-24	111.7	GDIR2_BOVIN	reviewed	Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (D4-GDP-dissociation inhibitor) (D4-GDI) (Ly-GDI) (Rho-GDI beta)	ARHGDIB GDID4	Bos taurus (Bovine)	200	cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0005094; GO:0005096; GO:0005829; GO:0007266; GO:0016020; GO:0035023; GO:0048365; GO:2000249	regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN35751_c0_g1_i1	P52566	GDIR2_HUMAN	100	91	0	0	3	275	78	168	1.10E-46	186.8	GDIR2_HUMAN	reviewed	Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Ly-GDI) (Rho-GDI beta)	ARHGDIB GDIA2 GDID4 RAP1GN1	Homo sapiens (Human)	201	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; cellular response to redox state [GO:0071461]; multicellular organism development [GO:0007275]; negative regulation of cell adhesion [GO:0007162]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0003924; GO:0005094; GO:0005096; GO:0005737; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0007275; GO:0016020; GO:0031410; GO:0035023; GO:0048365; GO:0051056; GO:0070062; GO:0071461; GO:1901164; GO:2000249	cellular response to redox state [GO:0071461]; multicellular organism development [GO:0007275]; negative regulation of cell adhesion [GO:0007162]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN2740_c0_g1_i1	Q8IWW6	RHG12_HUMAN	31.6	522	285	14	1477	83	340	846	3.00E-61	237.7	RHG12_HUMAN	reviewed	Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12)	ARHGAP12	Homo sapiens (Human)	846	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic cup [GO:0001891]	GTPase activator activity [GO:0005096]	GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0005829; GO:0006911; GO:0007015; GO:0007165; GO:0043087; GO:0051056; GO:0051058	"actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2740_c0_g1_i2	Q8IWW6	RHG12_HUMAN	34.6	393	220	10	1192	83	468	846	4.80E-52	208	RHG12_HUMAN	reviewed	Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12)	ARHGAP12	Homo sapiens (Human)	846	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic cup [GO:0001891]	GTPase activator activity [GO:0005096]	GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0005829; GO:0006911; GO:0007015; GO:0007165; GO:0043087; GO:0051056; GO:0051058	"actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3339_c0_g1_i2	Q8C0D4	RHG12_MOUSE	33.3	105	56	2	2021	1749	1	105	2.80E-06	55.5	RHG12_MOUSE	reviewed	Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12)	Arhgap12	Mus musculus (Mouse)	838	"cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]	GTPase activator activity [GO:0005096]	GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0006911; GO:0007015; GO:0007165; GO:0043087; GO:0051058	"actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9123_c0_g1_i1	Q3UIA2	RHG17_MOUSE	28.1	210	139	4	615	1	3	205	3.70E-18	93.2	RHG17_MOUSE	reviewed	Rho GTPase-activating protein 17 (Neuron-associated developmentally-regulated protein) (Nadrin) (Rho-type GTPase-activating protein 17)	Arhgap17	Mus musculus (Mouse)	846	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0007015; GO:0007165; GO:0017124; GO:0017156; GO:0032956; GO:0035020; GO:0048365	actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN11624_c1_g2_i3	Q8N392	RHG18_HUMAN	35.6	298	173	5	481	1374	258	536	7.10E-41	169.9	RHG18_HUMAN	reviewed	Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18)	ARHGAP18	Homo sapiens (Human)	663	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]	GO:0001726; GO:0005096; GO:0005737; GO:0005829; GO:0005881; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0045296; GO:0051056; GO:2000145	regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN11624_c1_g2_i5	Q8N392	RHG18_HUMAN	35.9	290	167	5	49	918	266	536	2.40E-40	167.5	RHG18_HUMAN	reviewed	Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18)	ARHGAP18	Homo sapiens (Human)	663	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]	GO:0001726; GO:0005096; GO:0005737; GO:0005829; GO:0005881; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0045296; GO:0051056; GO:2000145	regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN4206_c0_g1_i1	Q9VX32	RG190_DROME	41.8	165	74	1	83	511	764	928	6.80E-34	145.2	RG190_DROME	reviewed	Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)	RhoGAPp190 CG32555	Drosophila melanogaster (Fruit fly)	1561	cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]	GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770	defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN4206_c0_g1_i2	Q9VX32	RG190_DROME	48.5	165	85	0	83	577	764	928	2.40E-43	176.8	RG190_DROME	reviewed	Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)	RhoGAPp190 CG32555	Drosophila melanogaster (Fruit fly)	1561	cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]	GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770	defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN1535_c0_g1_i1	Q9VX32	RG190_DROME	63.6	129	47	0	69	455	2	130	2.10E-47	189.9	RG190_DROME	reviewed	Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)	RhoGAPp190 CG32555	Drosophila melanogaster (Fruit fly)	1561	cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; semaphorin receptor binding [GO:0030215]	GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770	defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i2	Q6REY9	RHG20_RAT	34.2	202	123	5	1440	838	354	546	6.20E-19	97.1	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i3	Q6REY9	RHG20_RAT	34.2	202	123	5	1503	901	354	546	6.40E-19	97.1	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i4	Q6REY9	RHG20_RAT	33.9	189	119	4	769	206	363	546	4.10E-18	93.6	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i5	Q6REY9	RHG20_RAT	33.9	189	119	4	812	249	363	546	4.80E-18	93.2	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i6	Q6REY9	RHG20_RAT	34.2	202	123	5	1560	958	354	546	6.60E-19	97.1	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i7	Q6REY9	RHG20_RAT	34.2	202	123	5	1518	916	354	546	6.50E-19	97.1	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN201_c0_g1_i8	Q6REY9	RHG20_RAT	34.2	202	123	5	1638	1036	354	546	7.00E-19	97.1	RHG20_RAT	reviewed	Rho GTPase-activating protein 20 (RA and RhoGAP domain-containing protein) (RARhoGAP) (Rho-type GTPase-activating protein 20)	Arhgap20	Rattus norvegicus (Rat)	1182	GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; Rho GTPase binding [GO:0017048]	GO:0005096; GO:0007165; GO:0017048; GO:0035023	regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32749_c0_g1_i1	Q9P2F6	RHG20_HUMAN	37.8	410	238	9	1205	9	84	487	1.50E-68	261.9	RHG20_HUMAN	reviewed	Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20)	ARHGAP20 KIAA1391	Homo sapiens (Human)	1191	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38234_c0_g1_i1	P42331	RHG25_HUMAN	98.6	71	1	0	213	1	202	272	7.30E-35	147.1	RHG25_HUMAN	reviewed	Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25)	ARHGAP25 KIAA0053	Homo sapiens (Human)	645	"cytosol [GO:0005829]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; phagocytic cup [GO:0001891]	GTPase activator activity [GO:0005096]	GO:0001891; GO:0005096; GO:0005829; GO:0006911; GO:0007015; GO:0007165; GO:0051056; GO:0051058; GO:0090630	"actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7492_c0_g1_i1	Q9UNA1	RHG26_HUMAN	49.5	208	102	3	2	622	295	500	1.10E-49	198	RHG26_HUMAN	reviewed	Rho GTPase-activating protein 26 (GTPase regulator associated with focal adhesion kinase) (Oligophrenin-1-like protein) (Rho-type GTPase-activating protein 26)	ARHGAP26 GRAF KIAA0621 OPHN1L	Homo sapiens (Human)	814	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]	GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]	GO:0005096; GO:0005543; GO:0005829; GO:0005856; GO:0005925; GO:0007165; GO:0007399; GO:0030036; GO:0051056	actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38824_c0_g1_i1	P59281	RHG39_MOUSE	51.9	133	62	1	2	400	698	828	2.10E-38	160.2	RHG39_MOUSE	reviewed	Rho GTPase-activating protein 39	Arhgap39 D15Wsu169e Kiaa1688	Mus musculus (Mouse)	1107	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0005737; GO:0005856; GO:0007165; GO:0098794; GO:0098978; GO:0099173	postsynapse organization [GO:0099173]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38824_c0_g1_i2	Q9C0H5	RHG39_HUMAN	53	351	153	3	2	1051	705	1044	4.80E-103	375.9	RHG39_HUMAN	reviewed	Rho GTPase-activating protein 39	ARHGAP39 KIAA1688	Homo sapiens (Human)	1083	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173	postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38824_c0_g1_i3	Q9C0H5	RHG39_HUMAN	58.2	201	83	1	44	643	844	1044	1.20E-59	231.1	RHG39_HUMAN	reviewed	Rho GTPase-activating protein 39	ARHGAP39 KIAA1688	Homo sapiens (Human)	1083	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173	postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		brown	brown	NA	NA	NA	NA
TRINITY_DN33062_c0_g1_i1	Q3TBD2	HMHA1_MOUSE	98.8	166	2	0	2	499	694	859	4.00E-92	338.6	HMHA1_MOUSE	reviewed	Rho GTPase-activating protein 45 (Minor histocompatibility protein HA-1)	Arhgap45 Hmha1	Mus musculus (Mouse)	1116	cytoplasm [GO:0005737]; ruffle membrane [GO:0032587]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; ruffle membrane [GO:0032587]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0032587; GO:0035556; GO:0046872; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]		NA	NA	NA	NA	NA	NA
TRINITY_DN5489_c0_g1_i1	Q92619	HMHA1_HUMAN	40	795	377	15	2161	2	215	984	2.10E-129	464.5	HMHA1_HUMAN	reviewed	Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1 (mHag HA-1)]	ARHGAP45 HMHA1 KIAA0223	Homo sapiens (Human)	1136	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; neutrophil degranulation [GO:0043312]; regulation of small GTPase mediated signal transduction [GO:0051056]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005576; GO:0005829; GO:0016020; GO:0032587; GO:0034774; GO:0035556; GO:0035578; GO:0043312; GO:0046872; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; neutrophil degranulation [GO:0043312]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN20797_c0_g1_i1	Q92619	HMHA1_HUMAN	100	88	0	0	1	264	679	766	5.50E-48	191	HMHA1_HUMAN	reviewed	Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1 (mHag HA-1)]	ARHGAP45 HMHA1 KIAA0223	Homo sapiens (Human)	1136	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; neutrophil degranulation [GO:0043312]; regulation of small GTPase mediated signal transduction [GO:0051056]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005576; GO:0005829; GO:0016020; GO:0032587; GO:0034774; GO:0035556; GO:0035578; GO:0043312; GO:0046872; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; neutrophil degranulation [GO:0043312]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN20797_c0_g1_i2	Q92619	HMHA1_HUMAN	94	200	0	1	1	564	679	878	2.80E-102	372.5	HMHA1_HUMAN	reviewed	Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1 (mHag HA-1)]	ARHGAP45 HMHA1 KIAA0223	Homo sapiens (Human)	1136	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; neutrophil degranulation [GO:0043312]; regulation of small GTPase mediated signal transduction [GO:0051056]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005576; GO:0005829; GO:0016020; GO:0032587; GO:0034774; GO:0035556; GO:0035578; GO:0043312; GO:0046872; GO:0051056; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; neutrophil degranulation [GO:0043312]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN19242_c0_g1_i1	O54834	RHG06_MOUSE	69.4	72	22	0	1	216	423	494	1.40E-21	103.2	RHG06_MOUSE	reviewed	Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1)	Arhgap6	Mus musculus (Mouse)	987	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005737; GO:0005829; GO:0007015; GO:0007165; GO:0007202; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0043087; GO:0043274; GO:0043547; GO:0048041; GO:0051497; GO:0051895	actin filament organization [GO:0007015]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5983_c0_g1_i5	Q96QB1	RHG07_HUMAN	47.3	480	225	12	1489	68	932	1389	3.90E-104	380.2	RHG07_HUMAN	reviewed	Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein) (DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12)	DLC1 ARHGAP7 KIAA1723 STARD12	Homo sapiens (Human)	1528	caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169]; actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169]	GO:0001843; GO:0003007; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005901; GO:0005925; GO:0006915; GO:0006919; GO:0007165; GO:0008285; GO:0008289; GO:0008360; GO:0021575; GO:0030036; GO:0030336; GO:0030864; GO:0030900; GO:0032587; GO:0032956; GO:0035023; GO:0035024; GO:0035307; GO:0042169; GO:0045121; GO:0048041; GO:0051056; GO:0051497; GO:0051895; GO:1900119	actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30324_c0_g1_i1	Q9CXP4	RHG08_MOUSE	64.3	84	30	0	2	253	63	146	8.70E-27	120.6	RHG08_MOUSE	reviewed	Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8)	Arhgap8	Mus musculus (Mouse)	425	GTPase activator activity [GO:0005096]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN11624_c1_g1_i1	Q8T0G4	CONU_DROME	37.4	131	69	5	104	478	14	137	2.30E-06	54.3	CONU_DROME	reviewed	Rho GTPase-activating protein conundrum	conu CG17082	Drosophila melanogaster (Fruit fly)	629	apical cortex [GO:0045179]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030054; GO:0030833; GO:0032956; GO:0034260; GO:0043547; GO:0045179; GO:0051056	negative regulation of GTPase activity [GO:0034260]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN11624_c1_g2_i4	Q8T0G4	CONU_DROME	35.5	166	104	2	529	1026	308	470	9.40E-22	105.9	CONU_DROME	reviewed	Rho GTPase-activating protein conundrum	conu CG17082	Drosophila melanogaster (Fruit fly)	629	apical cortex [GO:0045179]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030054; GO:0030833; GO:0032956; GO:0034260; GO:0043547; GO:0045179; GO:0051056	negative regulation of GTPase activity [GO:0034260]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37527_c0_g1_i1	Q92888	ARHG1_HUMAN	100	73	0	0	220	2	531	603	6.80E-36	150.6	ARHG1_HUMAN	reviewed	Rho guanine nucleotide exchange factor 1 (115 kDa guanine nucleotide exchange factor) (p115-RhoGEF) (p115RhoGEF) (Sub1.5)	ARHGEF1	Homo sapiens (Human)	912	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; RNA binding [GO:0003723]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; RNA binding [GO:0003723]	GO:0001664; GO:0003723; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007266; GO:0043065; GO:0051056	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN9813_c0_g1_i2	O15013	ARHGA_HUMAN	29.8	486	304	12	13	1398	744	1216	1.30E-57	226.1	ARHGA_HUMAN	reviewed	Rho guanine nucleotide exchange factor 10	ARHGEF10 KIAA0294	Homo sapiens (Human)	1369	centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]	centrosome [GO:0005813]; cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]		NA	NA	NA	NA	NA	NA
TRINITY_DN9813_c0_g1_i3	O15013	ARHGA_HUMAN	23.7	300	198	10	13	846	744	1034	5.60E-15	83.2	ARHGA_HUMAN	reviewed	Rho guanine nucleotide exchange factor 10	ARHGEF10 KIAA0294	Homo sapiens (Human)	1369	centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]	centrosome [GO:0005813]; cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]		NA	NA	NA	NA	NA	NA
TRINITY_DN1648_c0_g1_i3	Q9ES67	ARHGB_RAT	36.2	149	80	3	113	529	311	454	7.50E-17	89	ARHGB_RAT	reviewed	Rho guanine nucleotide exchange factor 11 (RhoGEF glutamate transport modulator GTRAP48)	Arhgef11	Rattus norvegicus (Rat)	1527	"cytoplasm [GO:0005737]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurotransmitter levels [GO:0001505]; Rho protein signal transduction [GO:0007266]"	cytoplasm [GO:0005737]; membrane [GO:0016020]	G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001505; GO:0001664; GO:0005089; GO:0005096; GO:0005737; GO:0007186; GO:0007266; GO:0016020; GO:0045893	"G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurotransmitter levels [GO:0001505]; Rho protein signal transduction [GO:0007266]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1957_c0_g2_i1	Q9NZN5	ARHGC_HUMAN	47.6	370	185	6	157	1260	761	1123	5.60E-83	309.7	ARHGC_HUMAN	reviewed	Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF)	ARHGEF12 KIAA0382 LARG	Homo sapiens (Human)	1544	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0001664; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0043065; GO:0051056; GO:0070062	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]		blue	blue	NA	NA	NA	NA
TRINITY_DN13943_c0_g1_i1	Q5VV41	ARHGG_HUMAN	41.9	496	263	9	1635	166	227	703	1.90E-98	361.3	ARHGG_HUMAN	reviewed	Rho guanine nucleotide exchange factor 16 (Ephexin-4)	ARHGEF16 EPHEXIN4 NBR	Homo sapiens (Human)	709	cytosol [GO:0005829]; cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005829; GO:0007186; GO:0017048; GO:0030165; GO:0030971; GO:0043065; GO:0045296; GO:0051056; GO:0060326; GO:0090630; GO:1903078	activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN34395_c0_g1_i1	Q96PE2	ARHGH_HUMAN	49.2	189	96	0	3	569	1750	1938	3.90E-51	202.6	ARHGH_HUMAN	reviewed	Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4)	ARHGEF17 KIAA0337 TEM4	Homo sapiens (Human)	2063	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0043065; GO:0051056	actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN38538_c0_g1_i1	Q96PE2	ARHGH_HUMAN	37.7	416	248	4	1215	1	1052	1467	1.60E-65	251.5	ARHGH_HUMAN	reviewed	Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4)	ARHGEF17 KIAA0337 TEM4	Homo sapiens (Human)	2063	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0043065; GO:0051056	actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g1_i10	Q9NXL2	ARH38_HUMAN	31.4	188	118	5	617	81	61	246	9.90E-13	75.5	ARH38_HUMAN	reviewed	Rho guanine nucleotide exchange factor 38	ARHGEF38	Homo sapiens (Human)	777	cytoplasm [GO:0005737]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	cytoplasm [GO:0005737]	Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005089; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN41095_c0_g1_i1	Q15052	ARHG6_HUMAN	82.7	81	14	0	244	2	660	740	1.50E-28	126.3	ARHG6_HUMAN	reviewed	Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6)	ARHGEF6 COOL2 KIAA0006 PIXA	Homo sapiens (Human)	776	cytosol [GO:0005829]; lamellipodium [GO:0030027]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; apoptotic process [GO:0006915]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; lamellipodium [GO:0030027]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0005085; GO:0005089; GO:0005096; GO:0005829; GO:0006915; GO:0007186; GO:0007254; GO:0030027; GO:0030032; GO:0043065; GO:0051056	apoptotic process [GO:0006915]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN2121_c0_g1_i3	O55043	ARHG7_RAT	39.8	641	328	13	91	1860	9	642	4.00E-119	430.3	ARHG7_RAT	reviewed	Rho guanine nucleotide exchange factor 7 (Beta-Pix) (PAK-interacting exchange factor beta)	Arhgef7 Pak3bp Pixb	Rattus norvegicus (Rat)	646	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of GTP binding [GO:1904424]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322]	guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]	GO:0000322; GO:0001726; GO:0002244; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007030; GO:0007264; GO:0019901; GO:0030027; GO:0030032; GO:0030426; GO:0032092; GO:0032991; GO:0043005; GO:0043025; GO:0043065; GO:0043547; GO:0043615; GO:0060124; GO:0098974; GO:0098982; GO:0099140; GO:1904424	astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of GTP binding [GO:1904424]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN2121_c0_g1_i1	Q9ES28	ARHG7_MOUSE	40.4	554	280	10	79	1602	162	711	3.60E-108	393.7	ARHG7_MOUSE	reviewed	Rho guanine nucleotide exchange factor 7 (Beta-Pix) (PAK-interacting exchange factor beta) (p85SPR)	Arhgef7 Kiaa0142 Pak3bp	Mus musculus (Mouse)	862	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of GTP binding [GO:1904424]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322]	guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]	GO:0000322; GO:0001726; GO:0002244; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007030; GO:0007264; GO:0019901; GO:0030027; GO:0030032; GO:0030426; GO:0032092; GO:0032991; GO:0043005; GO:0043025; GO:0043065; GO:0043547; GO:0043615; GO:0060124; GO:0098974; GO:0098982; GO:0099140; GO:1904424	astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of GTP binding [GO:1904424]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN16414_c0_g1_i1	O77819	ROCK1_RABIT	49.2	949	442	11	121	2892	10	943	3.80E-230	799.7	ROCK1_RABIT	reviewed	"Rho-associated protein kinase 1 (EC 2.7.11.1) (Corneal epithelial Rho-associated-Ser/Thr kinase 1) (HEBM1) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (cAMP-dependent protein kinase ROCK-I) (CePKA) (p160 ROCK-1) (p160ROCK)"	ROCK1	Oryctolagus cuniculus (Rabbit)	1354	bleb [GO:0032059]; centriole [GO:0005814]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; myoblast migration [GO:0051451]; positive regulation of focal adhesion assembly [GO:0051894]; protein phosphorylation [GO:0006468]; regulation of cell migration [GO:0030334]; regulation of microtubule cytoskeleton organization [GO:0070507]; Rho protein signal transduction [GO:0007266]	bleb [GO:0032059]; centriole [GO:0005814]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0001726; GO:0004674; GO:0005524; GO:0005814; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0007266; GO:0017049; GO:0030027; GO:0030036; GO:0030334; GO:0032059; GO:0046872; GO:0051451; GO:0051894; GO:0070507	actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; myoblast migration [GO:0051451]; positive regulation of focal adhesion assembly [GO:0051894]; protein phosphorylation [GO:0006468]; regulation of cell migration [GO:0030334]; regulation of microtubule cytoskeleton organization [GO:0070507]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN26935_c0_g1_i1	Q13464	ROCK1_HUMAN	100	82	0	0	248	3	317	398	8.60E-43	173.7	ROCK1_HUMAN	reviewed	"Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)"	ROCK1	Homo sapiens (Human)	1354	bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000139; GO:0000281; GO:0001726; GO:0003180; GO:0003383; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005737; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0006939; GO:0007159; GO:0007165; GO:0007186; GO:0007249; GO:0007266; GO:0010494; GO:0010506; GO:0010508; GO:0010613; GO:0010628; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0019828; GO:0022614; GO:0030027; GO:0030036; GO:0030155; GO:0030334; GO:0030866; GO:0031032; GO:0031175; GO:0032059; GO:0032060; GO:0032091; GO:0032956; GO:0034774; GO:0035509; GO:0043312; GO:0043410; GO:0043524; GO:0045616; GO:0045664; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048598; GO:0050321; GO:0050900; GO:0050901; GO:0051045; GO:0051451; GO:0051492; GO:0051893; GO:0051894; GO:0061157; GO:0070168; GO:0070507; GO:0071559; GO:0072518; GO:0072659; GO:0097746; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1901888; GO:1902003; GO:1902430; GO:1902992; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN29891_c0_g1_i1	Q13464	ROCK1_HUMAN	100	268	0	0	2	805	55	322	5.20E-158	558.1	ROCK1_HUMAN	reviewed	"Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)"	ROCK1	Homo sapiens (Human)	1354	bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000139; GO:0000281; GO:0001726; GO:0003180; GO:0003383; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005737; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0006939; GO:0007159; GO:0007165; GO:0007186; GO:0007249; GO:0007266; GO:0010494; GO:0010506; GO:0010508; GO:0010613; GO:0010628; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0019828; GO:0022614; GO:0030027; GO:0030036; GO:0030155; GO:0030334; GO:0030866; GO:0031032; GO:0031175; GO:0032059; GO:0032060; GO:0032091; GO:0032956; GO:0034774; GO:0035509; GO:0043312; GO:0043410; GO:0043524; GO:0045616; GO:0045664; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048598; GO:0050321; GO:0050900; GO:0050901; GO:0051045; GO:0051451; GO:0051492; GO:0051893; GO:0051894; GO:0061157; GO:0070168; GO:0070507; GO:0071559; GO:0072518; GO:0072659; GO:0097746; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1901888; GO:1902003; GO:1902430; GO:1902992; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN16414_c0_g1_i3	O75116	ROCK2_HUMAN	61.6	172	64	1	70	579	7	178	1.20E-54	214.5	ROCK2_HUMAN	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	ROCK2 KIAA0619	Homo sapiens (Human)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2633_c0_g1_i1	O75116	ROCK2_HUMAN	50.1	343	155	5	34	1047	1019	1350	4.30E-84	313.2	ROCK2_HUMAN	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	ROCK2 KIAA0619	Homo sapiens (Human)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2633_c0_g1_i2	O75116	ROCK2_HUMAN	50.1	343	155	5	34	1047	1019	1350	4.30E-84	313.2	ROCK2_HUMAN	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	ROCK2 KIAA0619	Homo sapiens (Human)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2633_c0_g1_i3	O75116	ROCK2_HUMAN	50.1	343	155	5	34	1047	1019	1350	4.10E-84	313.2	ROCK2_HUMAN	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	ROCK2 KIAA0619	Homo sapiens (Human)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN30011_c0_g1_i1	O75116	ROCK2_HUMAN	100	138	0	0	1	414	123	260	7.20E-79	294.3	ROCK2_HUMAN	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	ROCK2 KIAA0619	Homo sapiens (Human)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN26144_c0_g1_i1	P70336	ROCK2_MOUSE	98.8	82	1	0	246	1	139	220	7.60E-44	177.2	ROCK2_MOUSE	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	Rock2	Mus musculus (Mouse)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]	GO:0000281; GO:0001843; GO:0001934; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0008625; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030036; GO:0030335; GO:0030866; GO:0031032; GO:0031616; GO:0031644; GO:0032723; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0048813; GO:0051246; GO:0051298; GO:0051496; GO:0061157; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2723_c0_g1_i1	Q28021	ROCK2_BOVIN	42.3	52	28	1	371	216	370	419	9.20E-06	51.6	ROCK2_BOVIN	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	ROCK2	Bos taurus (Bovine)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]	GO:0000281; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006939; GO:0007266; GO:0010825; GO:0017049; GO:0018107; GO:0030036; GO:0030866; GO:0031032; GO:0032956; GO:0042752; GO:0046872; GO:0048511; GO:0048598; GO:0072518; GO:1901888	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]		blue	blue	NA	NA	NA	NA
TRINITY_DN32390_c0_g1_i1	P70336	ROCK2_MOUSE	100	84	0	0	253	2	354	437	5.40E-45	181	ROCK2_MOUSE	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	Rock2	Mus musculus (Mouse)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]	GO:0000281; GO:0001843; GO:0001934; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0008625; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030036; GO:0030335; GO:0030866; GO:0031032; GO:0031616; GO:0031644; GO:0032723; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0048813; GO:0051246; GO:0051298; GO:0051496; GO:0061157; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN29405_c0_g1_i1	P70336	ROCK2_MOUSE	100	81	0	0	3	245	1142	1222	4.20E-42	171.4	ROCK2_MOUSE	reviewed	"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)"	Rock2	Mus musculus (Mouse)	1388	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]	GO:0000281; GO:0001843; GO:0001934; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0008625; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030036; GO:0030335; GO:0030866; GO:0031032; GO:0031616; GO:0031644; GO:0032723; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0048813; GO:0051246; GO:0051298; GO:0051496; GO:0061157; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]		NA	NA	NA	NA	NA	NA
TRINITY_DN38774_c0_g1_i1	A8WVU9	ROCK_CAEBR	42.4	165	91	3	496	11	116	279	2.20E-32	140.2	ROCK_CAEBR	reviewed	Rho-associated protein kinase let-502 (EC 2.7.11.1) (Lethal protein 502) (Rho-binding kinase let-502)	let-502 CBG03960	Caenorhabditis briggsae	1194	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of cell junction assembly [GO:1901888]; Rho protein signal transduction [GO:0007266]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]	GO:0000281; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0007266; GO:0017049; GO:0018107; GO:0030866; GO:0031032; GO:0032154; GO:0046872; GO:0048477; GO:0048598; GO:0072518; GO:1901888	actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of cell junction assembly [GO:1901888]; Rho protein signal transduction [GO:0007266]		NA	NA	NA	NA	NA	NA
TRINITY_DN29904_c0_g1_i1	Q19821	RHOM1_CAEEL	36	350	199	8	95	1108	4	340	3.10E-48	194.1	RHOM1_CAEEL	reviewed	Rhomboid-related protein 1 (EC 3.4.21.105)	rom-1 F26F4.3	Caenorhabditis elegans	356	integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; positive regulation of vulval development [GO:0040026]	integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0016021; GO:0040026	positive regulation of vulval development [GO:0040026]		NA	NA	NA	NA	NA	NA
TRINITY_DN29904_c0_g1_i2	Q19821	RHOM1_CAEEL	36	350	199	8	73	1086	4	340	4.00E-48	193.7	RHOM1_CAEEL	reviewed	Rhomboid-related protein 1 (EC 3.4.21.105)	rom-1 F26F4.3	Caenorhabditis elegans	356	integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; positive regulation of vulval development [GO:0040026]	integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0016021; GO:0040026	positive regulation of vulval development [GO:0040026]		NA	NA	NA	NA	NA	NA
TRINITY_DN29904_c0_g1_i3	Q19821	RHOM1_CAEEL	36	350	199	8	76	1089	4	340	4.00E-48	193.7	RHOM1_CAEEL	reviewed	Rhomboid-related protein 1 (EC 3.4.21.105)	rom-1 F26F4.3	Caenorhabditis elegans	356	integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; positive regulation of vulval development [GO:0040026]	integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0016021; GO:0040026	positive regulation of vulval development [GO:0040026]		NA	NA	NA	NA	NA	NA
TRINITY_DN12239_c0_g1_i2	Q19821	RHOM1_CAEEL	37.4	107	67	0	4	324	231	337	3.40E-15	82.8	RHOM1_CAEEL	reviewed	Rhomboid-related protein 1 (EC 3.4.21.105)	rom-1 F26F4.3	Caenorhabditis elegans	356	integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; positive regulation of vulval development [GO:0040026]	integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0016021; GO:0040026	positive regulation of vulval development [GO:0040026]		NA	NA	NA	NA	NA	NA
TRINITY_DN24331_c0_g1_i1	Q9NX52	RHBL2_HUMAN	39.5	167	75	3	471	1	40	190	6.00E-25	115.5	RHBL2_HUMAN	reviewed	"Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) (Rhomboid-like protein 2) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)]"	RHBDL2	Homo sapiens (Human)	303	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2273_c0_g1_i2	Q8TEB9	RHBL4_HUMAN	38.8	263	158	1	799	11	3	262	4.70E-43	176.4	RHBL4_HUMAN	reviewed	Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)	RHBDD1 RHBDL4 HSD-50 HSD50	Homo sapiens (Human)	315	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0030176; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211	"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2273_c0_g1_i3	Q8TEB9	RHBL4_HUMAN	39.8	254	150	1	772	11	12	262	3.60E-43	176.8	RHBL4_HUMAN	reviewed	Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)	RHBDD1 RHBDL4 HSD-50 HSD50	Homo sapiens (Human)	315	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0030176; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211	"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18319_c0_g1_i1	O94844	RHBT1_HUMAN	39.9	283	164	2	328	1176	398	674	8.60E-54	212.6	RHBT1_HUMAN	reviewed	Rho-related BTB domain-containing protein 1	RHOBTB1 KIAA0740	Homo sapiens (Human)	696	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0019901; GO:0030036; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042995; GO:0043231; GO:0043652; GO:0051056	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN18319_c0_g2_i1	O94844	RHBT1_HUMAN	65.4	237	78	2	729	19	5	237	6.20E-87	322	RHBT1_HUMAN	reviewed	Rho-related BTB domain-containing protein 1	RHOBTB1 KIAA0740	Homo sapiens (Human)	696	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0019901; GO:0030036; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042995; GO:0043231; GO:0043652; GO:0051056	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN18319_c0_g1_i2	Q91V93	RHBT2_MOUSE	37.9	285	171	2	485	1339	411	689	2.20E-53	211.5	RHBT2_MOUSE	reviewed	Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein homolog)	Rhobtb2 Dbc2	Mus musculus (Mouse)	728	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0019901; GO:0030036; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042995; GO:0043231; GO:0043652	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN33652_c0_g1_i1	Q3ZBW5	RHOB_BOVIN	100	159	0	0	478	2	22	180	9.80E-88	323.9	RHOB_BOVIN	reviewed	Rho-related GTP-binding protein RhoB	RHOB	Bos taurus (Bovine)	196	cleavage furrow [GO:0032154]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]	cleavage furrow [GO:0032154]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000281; GO:0001525; GO:0003924; GO:0005525; GO:0005634; GO:0006915; GO:0007155; GO:0007264; GO:0015031; GO:0030154; GO:0031902; GO:0032154; GO:0043065; GO:0070301; GO:0071479	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN2038_c0_g1_i1	Q1RMJ6	RHOC_BOVIN	56.4	117	50	1	356	6	3	118	3.90E-34	145.6	RHOC_BOVIN	reviewed	Rho-related GTP-binding protein RhoC	RHOC ARHC	Bos taurus (Bovine)	193	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030036; GO:0030865; GO:0031334; GO:0031410; GO:0031982; GO:0032154; GO:0032420; GO:0032956; GO:0042995; GO:0043005; GO:0043231; GO:0043297; GO:0044319; GO:1902766	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13228_c0_g1_i1	Q1RMJ6	RHOC_BOVIN	100	180	0	0	540	1	1	180	3.30E-101	369	RHOC_BOVIN	reviewed	Rho-related GTP-binding protein RhoC	RHOC ARHC	Bos taurus (Bovine)	193	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030036; GO:0030865; GO:0031334; GO:0031410; GO:0031982; GO:0032154; GO:0032420; GO:0032956; GO:0042995; GO:0043005; GO:0043231; GO:0043297; GO:0044319; GO:1902766	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13228_c0_g2_i1	Q1RMJ6	RHOC_BOVIN	100	193	0	0	622	44	1	193	1.70E-109	396.7	RHOC_BOVIN	reviewed	Rho-related GTP-binding protein RhoC	RHOC ARHC	Bos taurus (Bovine)	193	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030036; GO:0030865; GO:0031334; GO:0031410; GO:0031982; GO:0032154; GO:0032420; GO:0032956; GO:0042995; GO:0043005; GO:0043231; GO:0043297; GO:0044319; GO:1902766	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36989_c0_g1_i1	Q3SZA1	RHOF_BOVIN	100	111	0	0	2	334	40	150	4.20E-61	235	RHOF_BOVIN	reviewed	Rho-related GTP-binding protein RhoF	RHOF	Bos taurus (Bovine)	215	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030036; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042995; GO:0043231	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN24951_c0_g1_i1	P84097	RHOG_CRICR	100	189	0	0	56	622	1	189	4.50E-109	395.2	RHOG_CRICR	reviewed	Rho-related GTP-binding protein RhoG	RHOG ARHG	Cricetus cricetus (Black-bellied hamster)	191	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078]; small GTPase mediated signal transduction [GO:0007264]	plasma membrane [GO:0005886]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005886; GO:0007264; GO:0060326; GO:0090630; GO:1903078	activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN40281_c0_g1_i1	Q15669	RHOH_HUMAN	100	108	0	0	1	324	1	108	5.50E-58	224.6	RHOH_HUMAN	reviewed	Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein)	RHOH ARHH TTF	Homo sapiens (Human)	191	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; GTP binding [GO:0005525]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]	GO:0001772; GO:0003924; GO:0005095; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006355; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016601; GO:0017048; GO:0019210; GO:0019901; GO:0030031; GO:0030036; GO:0030217; GO:0030865; GO:0031410; GO:0031982; GO:0032956; GO:0042995; GO:0043124; GO:0043231; GO:0043652; GO:0045576; GO:0045582; GO:0051056; GO:1902622	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10922_c0_g1_i1	Q9EQT3	RHOU_MOUSE	78.6	117	25	0	353	3	53	169	6.50E-53	208	RHOU_MOUSE	reviewed	Rho-related GTP-binding protein RhoU (Rho GTPase-like protein ARHU) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1)	Rhou Arhu G28k Wrch1	Mus musculus (Mouse)	261	cell projection [GO:0042995]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]	cell projection [GO:0042995]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006897; GO:0007010; GO:0008360; GO:0016477; GO:0016601; GO:0030031; GO:0030036; GO:0032488; GO:0042995; GO:0046872	actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN7275_c0_g1_i1	Q14B46	RTKN2_MOUSE	32	325	199	9	1112	186	127	445	3.50E-35	150.6	RTKN2_MOUSE	reviewed	Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1)	Rtkn2 Plekhk1	Mus musculus (Mouse)	604	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243	hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2951_c0_g1_i2	Q94915	REG2_DROME	35	243	149	4	735	34	8	250	2.20E-39	164.1	REG2_DROME	reviewed	Rhythmically expressed gene 2 protein (dREG-2)	Reg-2 CG3200	Drosophila melanogaster (Fruit fly)	260	hydrolase activity [GO:0016787]		hydrolase activity [GO:0016787]	GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i12	Q8R1Q9	RBSK_MOUSE	50.5	95	47	0	295	11	75	169	1.50E-19	97.1	RBSK_MOUSE	reviewed	Ribokinase (RK) (EC 2.7.1.15)	Rbks Rbsk	Mus musculus (Mouse)	323	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005737; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i14	Q9H477	RBSK_HUMAN	78.2	55	12	0	444	280	18	72	8.70E-18	91.7	RBSK_HUMAN	reviewed	Ribokinase (RK) (EC 2.7.1.15)	RBKS RBSK	Homo sapiens (Human)	322	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i15	Q9H477	RBSK_HUMAN	56	293	127	1	962	90	30	322	4.20E-80	299.7	RBSK_HUMAN	reviewed	Ribokinase (RK) (EC 2.7.1.15)	RBKS RBSK	Homo sapiens (Human)	322	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i2	Q9H477	RBSK_HUMAN	61.6	151	58	0	550	98	18	168	2.70E-45	183.3	RBSK_HUMAN	reviewed	Ribokinase (RK) (EC 2.7.1.15)	RBKS RBSK	Homo sapiens (Human)	322	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i4	Q9H477	RBSK_HUMAN	57.7	305	127	1	998	90	18	322	4.80E-87	322.8	RBSK_HUMAN	reviewed	Ribokinase (RK) (EC 2.7.1.15)	RBKS RBSK	Homo sapiens (Human)	322	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i7	Q9H477	RBSK_HUMAN	72.1	43	12	0	310	182	30	72	5.40E-11	68.6	RBSK_HUMAN	reviewed	Ribokinase (RK) (EC 2.7.1.15)	RBKS RBSK	Homo sapiens (Human)	322	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN3296_c0_g1_i8	Q9H477	RBSK_HUMAN	78.2	55	12	0	438	274	18	72	8.60E-18	91.7	RBSK_HUMAN	reviewed	Ribokinase (RK) (EC 2.7.1.15)	RBKS RBSK	Homo sapiens (Human)	322	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN13734_c0_g1_i4	Q5HZJ0	RNC_MOUSE	61.3	194	67	4	722	153	1159	1348	3.10E-61	236.5	RNC_MOUSE	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III)	Drosha Etohi2 Rn3 Rnasen	Mus musculus (Mouse)	1373	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003725; GO:0004521; GO:0004525; GO:0005634; GO:0005730; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN13734_c0_g1_i5	Q5HZJ0	RNC_MOUSE	61.3	119	43	2	509	153	1233	1348	6.40E-36	152.1	RNC_MOUSE	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III)	Drosha Etohi2 Rn3 Rnasen	Mus musculus (Mouse)	1373	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003725; GO:0004521; GO:0004525; GO:0005634; GO:0005730; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN37439_c0_g1_i1	Q9NRR4	RNC_HUMAN	100	100	0	0	1	300	1004	1103	2.20E-53	209.1	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN8379_c0_g1_i1	Q9NRR4	RNC_HUMAN	55	131	58	1	55	447	991	1120	9.60E-37	154.5	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN8379_c0_g1_i3	Q9NRR4	RNC_HUMAN	74.6	169	43	0	3	509	890	1058	4.20E-72	272.3	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN8379_c0_g1_i4	Q9NRR4	RNC_HUMAN	65.9	232	78	1	3	698	890	1120	1.00E-88	327.8	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN13032_c0_g1_i1	Q9NRR4	RNC_HUMAN	54	163	72	1	84	563	589	751	6.40E-46	185.3	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN13032_c0_g1_i2	Q9NRR4	RNC_HUMAN	55.6	252	109	1	38	784	500	751	5.90E-82	305.4	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN13734_c0_g1_i2	Q9NRR4	RNC_HUMAN	66	97	32	1	364	74	1234	1329	1.90E-32	140.2	RNC_HUMAN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	1374	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]		NA	NA	NA	NA	NA	NA
TRINITY_DN2532_c0_g1_i2	O70338	RNH1_MOUSE	34.5	296	171	3	977	108	3	281	1.10E-43	178.7	RNH1_MOUSE	reviewed	Ribonuclease H1 (RNase H1) (EC 3.1.26.4)	Rnaseh1 Rnh1	Mus musculus (Mouse)	285	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA replication [GO:0006264]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	mitochondrion [GO:0005739]; nucleus [GO:0005634]	magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0000287; GO:0003676; GO:0004523; GO:0005634; GO:0005739; GO:0006264; GO:0043137; GO:0090502	"DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA replication [GO:0006264]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2532_c0_g1_i1	O60930	RNH1_HUMAN	47.6	145	76	0	542	108	138	282	7.50E-36	152.9	RNH1_HUMAN	reviewed	Ribonuclease H1 (RNase H1) (EC 3.1.26.4) (Ribonuclease H type II)	RNASEH1 RNH1	Homo sapiens (Human)	286	"cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0000287; GO:0003676; GO:0003723; GO:0004523; GO:0004540; GO:0005737; GO:0006401; GO:0043137; GO:0090502	"DNA replication, removal of RNA primer [GO:0043137]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18705_c0_g1_i1	Q54D13	RNH2A_DICDI	47.4	57	25	1	157	2	19	75	7.70E-06	50.8	RNH2A_DICDI	reviewed	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4)	rnaseh2A DDB_G0292584	Dictyostelium discoideum (Slime mold)	289	"ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA metabolic process [GO:0016070]"	ribonuclease H2 complex [GO:0032299]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0004523; GO:0006298; GO:0016070; GO:0032299; GO:0043137; GO:0046872	"DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA metabolic process [GO:0016070]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39707_c0_g1_i1	O75792	RNH2A_HUMAN	100	72	0	0	218	3	198	269	2.70E-37	155.2	RNH2A_HUMAN	reviewed	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)	RNASEH2A RNASEHI RNHIA	Homo sapiens (Human)	299	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]	metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872	"DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24814_c0_g1_i1	O75792	RNH2A_HUMAN	100	116	0	0	350	3	77	192	2.00E-58	226.1	RNH2A_HUMAN	reviewed	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)	RNASEH2A RNASEHI RNHIA	Homo sapiens (Human)	299	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]	metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872	"DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40547_c0_g1_i1	Q9SEZ6	RNH2A_ARATH	41.6	89	40	2	237	7	121	209	2.20E-11	69.3	RNH2A_ARATH	reviewed	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)	At2g25100 F13D4.60	Arabidopsis thaliana (Mouse-ear cress)	296	"ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]"	ribonuclease H2 complex [GO:0032299]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0004523; GO:0006298; GO:0032299; GO:0043137; GO:0046872	"DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33679_c0_g1_i1	Q9CWY8	RNH2A_MOUSE	51.3	273	132	1	94	909	1	273	4.00E-78	293.1	RNH2A_MOUSE	reviewed	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)	Rnaseh2a Rnasehi	Mus musculus (Mouse)	301	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0004523; GO:0005654; GO:0005829; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872	"DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37917_c0_g1_i1	Q5HZP1	RNH2B_XENLA	32.4	139	85	4	2	397	41	177	1.90E-15	83.6	RNH2B_XENLA	reviewed	Ribonuclease H2 subunit B (RNase H2 subunit B) (Ribonuclease HI subunit B)	rnaseh2b	Xenopus laevis (African clawed frog)	306	nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA catabolic process [GO:0006401]	nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]		GO:0005634; GO:0006401; GO:0032299	RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN13425_c0_g1_i1	Q8MSF5	RNK_DROME	51.6	93	45	0	404	126	1	93	1.90E-21	103.6	RNK_DROME	reviewed	Ribonuclease kappa (RNase K) (RNase kappa) (EC 3.1.-.-)	RNASEK l(2)NC110 CG40127	Drosophila melanogaster (Fruit fly)	95	integral component of membrane [GO:0016021]; endoribonuclease activity [GO:0004521]; cellular response to virus [GO:0098586]	integral component of membrane [GO:0016021]	endoribonuclease activity [GO:0004521]	GO:0004521; GO:0016021; GO:0098586	cellular response to virus [GO:0098586]		NA	NA	NA	NA	NA	NA
TRINITY_DN13425_c0_g1_i2	Q8MSF5	RNK_DROME	47.3	93	49	0	404	126	1	93	1.70E-17	90.5	RNK_DROME	reviewed	Ribonuclease kappa (RNase K) (RNase kappa) (EC 3.1.-.-)	RNASEK l(2)NC110 CG40127	Drosophila melanogaster (Fruit fly)	95	integral component of membrane [GO:0016021]; endoribonuclease activity [GO:0004521]; cellular response to virus [GO:0098586]	integral component of membrane [GO:0016021]	endoribonuclease activity [GO:0004521]	GO:0004521; GO:0016021; GO:0098586	cellular response to virus [GO:0098586]		NA	NA	NA	NA	NA	NA
TRINITY_DN2922_c0_g1_i1	Q8MKW7	RNZ_DROME	39.1	258	98	4	1	774	75	273	9.00E-41	168.7	RNZ_DROME	reviewed	"Ribonuclease Z, mitochondrial (RNase Z) (EC 3.1.26.11) (Juvenile hormone-inducible protein 1) (dRNAse Z) (tRNA 3 endonuclease) (DmeZ) (tRNase Z)"	RNaseZ JhI-1 CG3298	Drosophila melanogaster (Fruit fly)	766	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; nuclear tRNA 3'-trailer cleavage, endonucleolytic [GO:1902375]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-trailer cleavage, endonucleolytic [GO:0034414]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]"	GO:0001558; GO:0005634; GO:0005739; GO:0005829; GO:0006388; GO:0007419; GO:0016891; GO:0030307; GO:0034414; GO:0036093; GO:0042780; GO:0042781; GO:0045727; GO:0046872; GO:0072684; GO:0140040; GO:1902375	"germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; nuclear tRNA 3'-trailer cleavage, endonucleolytic [GO:1902375]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-trailer cleavage, endonucleolytic [GO:0034414]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2922_c0_g1_i2	Q8MKW7	RNZ_DROME	62.7	75	28	0	1	225	75	149	1.20E-22	107.1	RNZ_DROME	reviewed	"Ribonuclease Z, mitochondrial (RNase Z) (EC 3.1.26.11) (Juvenile hormone-inducible protein 1) (dRNAse Z) (tRNA 3 endonuclease) (DmeZ) (tRNase Z)"	RNaseZ JhI-1 CG3298	Drosophila melanogaster (Fruit fly)	766	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; nuclear tRNA 3'-trailer cleavage, endonucleolytic [GO:1902375]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-trailer cleavage, endonucleolytic [GO:0034414]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]"	GO:0001558; GO:0005634; GO:0005739; GO:0005829; GO:0006388; GO:0007419; GO:0016891; GO:0030307; GO:0034414; GO:0036093; GO:0042780; GO:0042781; GO:0045727; GO:0046872; GO:0072684; GO:0140040; GO:1902375	"germ cell proliferation [GO:0036093]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; nuclear tRNA 3'-trailer cleavage, endonucleolytic [GO:1902375]; positive regulation of cell growth [GO:0030307]; positive regulation of translation [GO:0045727]; regulation of cell growth [GO:0001558]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-trailer cleavage, endonucleolytic [GO:0034414]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; ventral cord development [GO:0007419]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13601_c0_g1_i2	Q99575	POP1_HUMAN	39.2	176	103	1	534	19	92	267	8.10E-26	118.6	POP1_HUMAN	reviewed	Ribonucleases P/MRP protein subunit POP1 (hPOP1) (EC 3.1.26.5)	POP1 KIAA0061	Homo sapiens (Human)	1024	"extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease MRP activity [GO:0000171]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA 5'-leader removal [GO:0001682]; tRNA catabolic process [GO:0016078]; tRNA processing [GO:0008033]"	extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]	ribonuclease MRP activity [GO:0000171]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]	GO:0000171; GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204; GO:0090502	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA 5'-leader removal [GO:0001682]; tRNA catabolic process [GO:0016078]; tRNA processing [GO:0008033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38932_c0_g1_i1	Q9UW15	RIR1_NEUCR	55.6	90	40	0	1	270	249	338	9.30E-27	120.6	RIR1_NEUCR	reviewed	Ribonucleoside-diphosphate reductase large chain (EC 1.17.4.1) (Ribonucleotide reductase large subunit)	rnr-1 B2A19.30 NCU03539	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	929	"ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"	ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0005971; GO:0006260; GO:0009263	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN3978_c0_g1_i1	Q8SR37	RIR1_ENCCU	70.8	137	40	0	417	7	599	735	1.70E-51	203.4	RIR1_ENCCU	reviewed	Ribonucleoside-diphosphate reductase large chain (EC 1.17.4.1) (Ribonucleotide reductase)	ECU10_0920	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	768	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0006260; GO:0009263	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN2313_c0_g1_i1	P21672	RIR3_YEAST	55.6	268	117	1	807	4	336	601	3.20E-83	309.7	RIR3_YEAST	reviewed	Ribonucleoside-diphosphate reductase large chain 2 (EC 1.17.4.1) (Ribonucleotide reductase DNA damage-inducible regulatory subunit 2) (Ribonucleotide reductase R1 subunit 2) (Ribonucleotide reductase large subunit 2)	RNR3 DIN1 YIL066C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	869	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; regulation of cellular respiration [GO:0043457]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0005737; GO:0005739; GO:0005971; GO:0006260; GO:0009263; GO:0043457	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; regulation of cellular respiration [GO:0043457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2313_c0_g1_i4	P21672	RIR3_YEAST	40.3	268	74	2	555	4	336	601	1.70E-46	187.2	RIR3_YEAST	reviewed	Ribonucleoside-diphosphate reductase large chain 2 (EC 1.17.4.1) (Ribonucleotide reductase DNA damage-inducible regulatory subunit 2) (Ribonucleotide reductase R1 subunit 2) (Ribonucleotide reductase large subunit 2)	RNR3 DIN1 YIL066C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	869	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; regulation of cellular respiration [GO:0043457]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0005737; GO:0005739; GO:0005971; GO:0006260; GO:0009263; GO:0043457	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; regulation of cellular respiration [GO:0043457]		NA	NA	NA	NA	NA	NA
TRINITY_DN2949_c0_g1_i1	P23921	RIR1_HUMAN	77.8	802	168	1	2487	82	1	792	0	1295	RIR1_HUMAN	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	RRM1 RR1	Homo sapiens (Human)	792	"cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0015949; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2949_c0_g1_i2	P07742	RIR1_MOUSE	76.8	811	166	2	2505	82	1	792	0	1293.5	RIR1_MOUSE	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	Rrm1	Mus musculus (Mouse)	792	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0017076; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2949_c0_g1_i4	P23921	RIR1_HUMAN	71.6	796	155	2	2286	82	7	792	0	1150.2	RIR1_HUMAN	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	RRM1 RR1	Homo sapiens (Human)	792	"cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0015949; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2949_c0_g1_i5	P07742	RIR1_MOUSE	76.9	805	164	2	2487	82	7	792	0	1285	RIR1_MOUSE	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	Rrm1	Mus musculus (Mouse)	792	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0017076; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN2949_c0_g1_i8	P23921	RIR1_HUMAN	77.9	796	166	1	2469	82	7	792	0	1286.6	RIR1_HUMAN	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	RRM1 RR1	Homo sapiens (Human)	792	"cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0015949; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN36235_c0_g1_i1	P07742	RIR1_MOUSE	100	176	0	0	1	528	423	598	1.10E-100	367.1	RIR1_MOUSE	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	Rrm1	Mus musculus (Mouse)	792	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0017076; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN11132_c0_g1_i1	P23921	RIR1_HUMAN	100	72	0	0	2	217	229	300	2.60E-35	148.7	RIR1_HUMAN	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	RRM1 RR1	Homo sapiens (Human)	792	"cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0015949; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN11132_c0_g2_i1	P23921	RIR1_HUMAN	99.5	771	4	0	55	2367	1	771	0	1551.6	RIR1_HUMAN	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	RRM1 RR1	Homo sapiens (Human)	792	"cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"	cell projection [GO:0042995]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0015949; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0061731; GO:0097718	cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]		NA	NA	NA	NA	NA	NA
TRINITY_DN6295_c0_g1_i1	P50648	RIR1_PLAF4	68	206	64	1	635	18	560	763	2.10E-77	290	RIR1_PLAF4	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleotide reductase R1 subunit)	RNR1	Plasmodium falciparum (isolate Dd2)	806	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0006260; GO:0009263	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN6295_c0_g2_i1	P50648	RIR1_PLAF4	67.1	426	134	1	1278	1	125	544	4.00E-176	619	RIR1_PLAF4	reviewed	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleotide reductase R1 subunit)	RNR1	Plasmodium falciparum (isolate Dd2)	806	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0006260; GO:0009263	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1173_c0_g2_i1	O15910	RIR2_TRYBB	68.7	326	99	3	11	985	14	337	4.50E-130	465.7	RIR2_TRYBB	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase R2 subunit) (Ribonucleotide reductase small subunit)	RNR2 NRDB	Trypanosoma brucei brucei	337	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1173_c0_g2_i2	O15910	RIR2_TRYBB	64.1	326	99	4	11	940	14	337	1.10E-117	424.5	RIR2_TRYBB	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase R2 subunit) (Ribonucleotide reductase small subunit)	RNR2 NRDB	Trypanosoma brucei brucei	337	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN4187_c0_g1_i1	P42170	RIR2_CAEEL	51.7	149	70	2	1	441	202	350	2.30E-32	140.2	RIR2_CAEEL	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	rnr-2 C03C10.3	Caenorhabditis elegans	381	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; embryo development ending in birth or egg hatching [GO:0009792]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0009263; GO:0009792; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; embryo development ending in birth or egg hatching [GO:0009792]		NA	NA	NA	NA	NA	NA
TRINITY_DN4187_c0_g1_i1	P42170	RIR2_CAEEL	41.5	41	24	0	357	479	323	363	0.0017	44.3	RIR2_CAEEL	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	rnr-2 C03C10.3	Caenorhabditis elegans	381	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; embryo development ending in birth or egg hatching [GO:0009792]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0009263; GO:0009792; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; embryo development ending in birth or egg hatching [GO:0009792]		NA	NA	NA	NA	NA	NA
TRINITY_DN4187_c0_g1_i2	Q8SRR2	RIR2_ENCCU	43.3	157	78	4	39	503	173	320	1.30E-24	114.4	RIR2_ENCCU	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	ECU06_0730	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	325	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1417_c0_g1_i5	Q8SRR2	RIR2_ENCCU	69.2	159	47	1	524	48	158	314	1.60E-60	233.8	RIR2_ENCCU	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	ECU06_0730	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	325	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1417_c0_g1_i6	Q8SRR2	RIR2_ENCCU	63.9	310	108	3	982	56	8	314	5.90E-114	412.1	RIR2_ENCCU	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	ECU06_0730	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	325	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN169_c0_g1_i1	Q8SRR2	RIR2_ENCCU	61.2	307	114	4	3	917	22	325	8.60E-104	378.3	RIR2_ENCCU	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	ECU06_0730	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	325	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN27301_c0_g1_i1	Q8SRR2	RIR2_ENCCU	60.3	68	26	1	9	209	258	325	9.60E-17	87	RIR2_ENCCU	reviewed	Ribonucleoside-diphosphate reductase small chain (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	ECU06_0730	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	325	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"		"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1173_c0_g1_i1	Q9LSD0	RIR2C_ARATH	65.8	196	63	1	3	578	137	332	4.20E-75	282.3	RIR2C_ARATH	reviewed	Ribonucleoside-diphosphate reductase small chain C (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase TSO2 subunit) (Ribonucleotide reductase small subunit C)	TSO2 At3g27060 MOJ10.13	Arabidopsis thaliana (Mouse-ear cress)	332	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; multicellular organism development [GO:0007275]; programmed cell death [GO:0012501]; regulation of cell cycle [GO:0051726]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005634; GO:0005737; GO:0006260; GO:0006281; GO:0007275; GO:0009263; GO:0012501; GO:0046872; GO:0051726	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; multicellular organism development [GO:0007275]; programmed cell death [GO:0012501]; regulation of cell cycle [GO:0051726]		NA	NA	NA	NA	NA	NA
TRINITY_DN27154_c0_g1_i1	Q9Z6S5	RIR1_CHLPN	75.2	153	38	0	459	1	424	576	6.20E-66	251.5	RIR1_CHLPN	reviewed	Ribonucleoside-diphosphate reductase subunit alpha (EC 1.17.4.1) (Ribonucleotide reductase)	nrdA CPn_0984 CP_0872 CpB1021	Chlamydia pneumoniae (Chlamydophila pneumoniae)	1044	"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; DNA replication [GO:0006260]"		"ATP binding [GO:0005524]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005524; GO:0006260	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN33182_c0_g1_i1	P79733	RIR2_DANRE	69.1	385	107	3	59	1189	6	386	2.80E-150	533.1	RIR2_DANRE	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)	rrm2 r2	Danio rerio (Zebrafish) (Brachydanio rerio)	386	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1417_c0_g2_i1	P79733	RIR2_DANRE	70.7	133	38	1	400	2	65	196	5.40E-50	198.4	RIR2_DANRE	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)	rrm2 r2	Danio rerio (Zebrafish) (Brachydanio rerio)	386	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0009263; GO:0046872	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN22959_c0_g1_i1	P31350	RIR2_HUMAN	97.6	164	4	0	494	3	50	213	8.90E-92	337.4	RIR2_HUMAN	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)	RRM2 RR2	Homo sapiens (Human)	389	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; negative regulation of G0 to G1 transition [GO:0070317]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000083; GO:0004748; GO:0005829; GO:0005971; GO:0006260; GO:0008199; GO:0009263; GO:0015949; GO:0042803; GO:0051290; GO:0070317	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; negative regulation of G0 to G1 transition [GO:0070317]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN22959_c0_g1_i2	P31350	RIR2_HUMAN	99.4	164	1	0	494	3	50	213	6.20E-93	341.3	RIR2_HUMAN	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)	RRM2 RR2	Homo sapiens (Human)	389	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; negative regulation of G0 to G1 transition [GO:0070317]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000083; GO:0004748; GO:0005829; GO:0005971; GO:0006260; GO:0008199; GO:0009263; GO:0015949; GO:0042803; GO:0051290; GO:0070317	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; negative regulation of G0 to G1 transition [GO:0070317]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN35633_c0_g1_i1	P31350	RIR2_HUMAN	100	229	0	0	701	15	161	389	1.10E-130	467.2	RIR2_HUMAN	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)	RRM2 RR2	Homo sapiens (Human)	389	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; negative regulation of G0 to G1 transition [GO:0070317]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	cytosol [GO:0005829]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0000083; GO:0004748; GO:0005829; GO:0005971; GO:0006260; GO:0008199; GO:0009263; GO:0015949; GO:0042803; GO:0051290; GO:0070317	deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; negative regulation of G0 to G1 transition [GO:0070317]; nucleobase-containing small molecule interconversion [GO:0015949]; protein heterotetramerization [GO:0051290]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]		NA	NA	NA	NA	NA	NA
TRINITY_DN1417_c0_g1_i7	P48592	RIR2_DROME	59.4	165	65	2	495	4	70	233	9.70E-52	204.5	RIR2_DROME	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	RnrS CG8975	Drosophila melanogaster (Fruit fly)	393	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0006919; GO:0009263; GO:0046872	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	1	NA	NA	NA
TRINITY_DN1417_c0_g1_i1	P48592	RIR2_DROME	63	327	114	4	994	26	70	393	2.90E-113	409.8	RIR2_DROME	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	RnrS CG8975	Drosophila melanogaster (Fruit fly)	393	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0006919; GO:0009263; GO:0046872	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN1417_c0_g1_i8	P48592	RIR2_DROME	64.3	325	113	3	986	18	70	393	2.00E-114	413.7	RIR2_DROME	reviewed	Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small subunit)	RnrS CG8975	Drosophila melanogaster (Fruit fly)	393	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]"	cytosol [GO:0005829]	"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0004748; GO:0005829; GO:0006260; GO:0006919; GO:0009263; GO:0046872	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN27193_c0_g1_i1	P49247	RPIA_HUMAN	98.7	154	2	0	464	3	81	234	1.20E-82	307	RPIA_HUMAN	reviewed	Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase)	RPIA RPI	Homo sapiens (Human)	311	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; ribose phosphate metabolic process [GO:0019693]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; ribose-5-phosphate isomerase activity [GO:0004751]	GO:0004751; GO:0005829; GO:0006014; GO:0006098; GO:0009052; GO:0019693; GO:0042802; GO:0043231; GO:0048029	"D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; ribose phosphate metabolic process [GO:0019693]"		NA	NA	NA	NA	NA	NA
TRINITY_DN564_c0_g1_i1	Q3T186	RPIA_BOVIN	61.4	236	91	0	160	867	25	260	2.60E-79	297	RPIA_BOVIN	reviewed	Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase) (Fragment)	RPIA	Bos taurus (Bovine)	264	"intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	intracellular membrane-bounded organelle [GO:0043231]	ribose-5-phosphate isomerase activity [GO:0004751]	GO:0004751; GO:0006014; GO:0009052; GO:0043231	"D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN564_c0_g1_i2	Q3T186	RPIA_BOVIN	61.4	236	91	0	90	797	25	260	3.10E-79	296.6	RPIA_BOVIN	reviewed	Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase) (Fragment)	RPIA	Bos taurus (Bovine)	264	"intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	intracellular membrane-bounded organelle [GO:0043231]	ribose-5-phosphate isomerase activity [GO:0004751]	GO:0004751; GO:0006014; GO:0009052; GO:0043231	"D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		blue	blue	NA	NA	NA	NA
TRINITY_DN16994_c0_g1_i1	Q8UDA9	KPRS_AGRFC	83.9	112	18	0	2	337	45	156	1.30E-49	196.8	KPRS_AGRFC	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs prsA Atu2218 AGR_C_4031	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	310	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN16994_c0_g2_i1	Q92N73	KPRS_RHIME	87.5	72	9	0	2	217	62	133	1.20E-29	129.8	KPRS_RHIME	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs prsA R02348 SMc02686	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	310	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN33190_c0_g1_i1	Q0C5A1	KPRS_HYPNA	60.6	94	37	0	282	1	34	127	3.30E-27	122.1	KPRS_HYPNA	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs HNE_0362	Hyphomonas neptunium (strain ATCC 15444)	312	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN35136_c0_g1_i1	Q8Y2E1	KPRS_RALSO	98.6	70	1	0	1	210	199	268	6.80E-33	140.6	KPRS_RALSO	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs prsA RSc0395 RS03363	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	316	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN33739_c0_g1_i1	Q8YIG1	KPRS_BRUME	85	107	16	0	6	326	27	133	1.80E-45	183	KPRS_BRUME	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs BMEI0483	Brucella melitensis biotype 1 (strain 16M / ATCC 23456 / NCTC 10094)	310	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN1618_c0_g1_i1	Q8Y2E1	KPRS_RALSO	98.1	157	3	0	1	471	28	184	5.10E-81	301.6	KPRS_RALSO	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs prsA RSc0395 RS03363	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	316	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN1618_c0_g1_i2	Q8Y2E1	KPRS_RALSO	85.4	151	22	0	1	453	34	184	5.30E-67	255	KPRS_RALSO	reviewed	Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase)	prs prsA RSc0395 RS03363	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	316	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN408_c0_g1_i1	Q2HJ58	PRPS1_BOVIN	87.7	317	39	0	134	1084	1	317	8.00E-160	564.7	PRPS1_BOVIN	reviewed	Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)	PRPS1	Bos taurus (Bovine)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		blue	blue	NA	NA	NA	NA
TRINITY_DN408_c0_g1_i2	Q2HJ58	PRPS1_BOVIN	89	318	35	0	134	1087	1	318	4.30E-162	572.4	PRPS1_BOVIN	reviewed	Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)	PRPS1	Bos taurus (Bovine)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		blue	blue	NA	NA	NA	NA
TRINITY_DN17993_c0_g1_i1	Q2HJ58	PRPS1_BOVIN	100	186	0	0	559	2	1	186	1.00E-102	374	PRPS1_BOVIN	reviewed	Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)	PRPS1	Bos taurus (Bovine)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN17993_c0_g1_i2	Q2HJ58	PRPS1_BOVIN	100	186	0	0	559	2	1	186	1.00E-102	374	PRPS1_BOVIN	reviewed	Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)	PRPS1	Bos taurus (Bovine)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN17993_c1_g1_i1	Q2HJ58	PRPS1_BOVIN	86.1	151	0	1	394	5	168	318	1.60E-64	246.5	PRPS1_BOVIN	reviewed	Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)	PRPS1	Bos taurus (Bovine)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0042803	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN346_c0_g1_i3	O94413	KPR2_SCHPO	57.6	59	25	0	214	38	3	61	3.20E-10	65.9	KPR2_SCHPO	reviewed	Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 2)	SPCC1620.06c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	321	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; fungal-type cell wall organization [GO:0031505]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribose phosphate diphosphokinase complex [GO:0002189]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0005829; GO:0006015; GO:0006164; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0031505	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; fungal-type cell wall organization [GO:0031505]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156]		NA	NA	NA	NA	NA	NA
TRINITY_DN30860_c0_g1_i1	P11908	PRPS2_HUMAN	99.3	141	1	0	4	426	1	141	1.00E-72	273.9	PRPS2_HUMAN	reviewed	Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II)	PRPS2	Homo sapiens (Human)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0006167; GO:0009116; GO:0009165; GO:0016208; GO:0016301; GO:0019003; GO:0030246; GO:0031100; GO:0042802; GO:0042803; GO:0043531	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN38404_c0_g1_i1	P11908	PRPS2_HUMAN	98.7	78	1	0	2	235	232	309	2.80E-35	148.7	PRPS2_HUMAN	reviewed	Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II)	PRPS2	Homo sapiens (Human)	318	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0006167; GO:0009116; GO:0009165; GO:0016208; GO:0016301; GO:0019003; GO:0030246; GO:0031100; GO:0042802; GO:0042803; GO:0043531	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN6966_c0_g1_i1	Q8BVY0	RL1D1_MOUSE	31.3	259	157	6	230	997	23	263	3.60E-28	127.5	RL1D1_MOUSE	reviewed	Ribosomal L1 domain-containing protein 1	Rsl1d1	Mus musculus (Mouse)	452	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]	90S preribosome [GO:0030686]; nucleolus [GO:0005730]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]	GO:0000470; GO:0003723; GO:0003730; GO:0005730; GO:0030686; GO:0032880; GO:0042981; GO:0048027; GO:2000772	maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN27945_c0_g1_i1	Q9H6W3	RIOX1_HUMAN	98.9	89	1	0	2	268	340	428	3.30E-48	191.8	RIOX1_HUMAN	reviewed	Ribosomal oxygenase 1 (60S ribosomal protein L8 histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66) (Myc-associated protein with JmjC domain) (Nucleolar protein 66) (hsNO66) (Ribosomal oxygenase NO66) (ROX)	RIOX1 C14orf169 MAPJD NO66	Homo sapiens (Human)	641	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]	GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0016706; GO:0032453; GO:0034720; GO:0045668; GO:0045892; GO:0051864; GO:0070544	"histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4733_c0_g1_i1	A3KP59	RIOX1_DANRE	51.9	447	214	1	1440	100	96	541	3.50E-142	506.9	RIOX1_DANRE	reviewed	Ribosomal oxygenase 1 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66)	riox1 no66 zgc:162967	Danio rerio (Zebrafish) (Brachydanio rerio)	544	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]	GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0016706; GO:0032453; GO:0034720; GO:0045668; GO:0045892; GO:0051864; GO:0070544	"histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34444_c0_g1_i1	Q8IUF8	RIOX2_HUMAN	100	137	0	0	2	412	163	299	3.00E-77	288.9	RIOX2_HUMAN	reviewed	Ribosomal oxygenase 2 (60S ribosomal protein L27a histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA) (EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) (Mineral dust-induced gene protein) (Nucleolar protein 52) (Ribosomal oxygenase MINA) (ROX)	RIOX2 MDIG MINA MINA53 NO52	Homo sapiens (Human)	465	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0016706; GO:0032453; GO:0034720; GO:0042254; GO:0042802; GO:0046872; GO:0051864; GO:0070544	histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN26098_c0_g1_i1	Q8CD15	RIOX2_MOUSE	60.3	58	23	0	1	174	141	198	8.20E-15	80.5	RIOX2_MOUSE	reviewed	Ribosomal oxygenase 2 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA) (EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen)	Riox2 Mina Mina53	Mus musculus (Mouse)	465	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell population proliferation [GO:0008283]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; regulation of cell population proliferation [GO:0042127]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0008283; GO:0016706; GO:0032453; GO:0034720; GO:0042127; GO:0042254; GO:0042802; GO:0046872; GO:0051864; GO:0070544	cell population proliferation [GO:0008283]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; regulation of cell population proliferation [GO:0042127]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN36878_c0_g1_i1	P48166	RL36A_CAEEL	71.7	60	17	0	184	5	18	77	5.60E-16	84.3	RL36A_CAEEL	reviewed	Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41)	rpl-36.A rpl-41 C09H10.2	Caenorhabditis elegans	105	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26743_c0_g1_i1	P48166	RL36A_CAEEL	67.8	90	29	0	275	6	16	105	2.00E-29	129.4	RL36A_CAEEL	reviewed	Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41)	rpl-36.A rpl-41 C09H10.2	Caenorhabditis elegans	105	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN23246_c1_g1_i1	P48166	RL36A_CAEEL	59.3	81	33	0	116	358	25	105	6.90E-20	98.2	RL36A_CAEEL	reviewed	Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41)	rpl-36.A rpl-41 C09H10.2	Caenorhabditis elegans	105	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21199_c0_g1_i1	P48166	RL36A_CAEEL	70.5	88	25	1	261	1	1	88	9.30E-28	124	RL36A_CAEEL	reviewed	Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41)	rpl-36.A rpl-41 C09H10.2	Caenorhabditis elegans	105	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN21199_c0_g1_i2	P48166	RL36A_CAEEL	70.5	88	25	1	261	1	1	88	2.90E-28	125.9	RL36A_CAEEL	reviewed	Ribosomal protein rpl-36.A (60S ribosomal protein L44) (L41)	rpl-36.A rpl-41 C09H10.2	Caenorhabditis elegans	105	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0006412; GO:0022625	translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN34434_c0_g1_i1	Q15418	KS6A1_HUMAN	100	210	0	0	2	631	85	294	1.90E-118	426.4	KS6A1_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	RPS6KA1 MAPKAPK1A RSK1	Homo sapiens (Human)	735	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944; GO:0072574; GO:2000491	cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN34434_c0_g1_i2	Q15418	KS6A1_HUMAN	100	71	0	0	2	214	85	155	2.10E-34	145.6	KS6A1_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	RPS6KA1 MAPKAPK1A RSK1	Homo sapiens (Human)	735	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944; GO:0072574; GO:2000491	cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN39965_c0_g1_i1	Q15418	KS6A1_HUMAN	51.4	70	34	0	4	213	159	228	1.10E-14	80.1	KS6A1_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	RPS6KA1 MAPKAPK1A RSK1	Homo sapiens (Human)	735	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944; GO:0072574; GO:2000491	cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5010_c0_g1_i1	Q9WUT3	KS6A2_MOUSE	80.8	281	52	2	845	6	79	358	6.10E-133	474.9	KS6A2_MOUSE	reviewed	Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)	Rps6ka2 Mapkapk1c Rsk3	Mus musculus (Mouse)	733	cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]	cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001556; GO:0002035; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0006468; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0018105; GO:0035556; GO:0043065; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687	brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]		blue	blue	NA	NA	NA	NA
TRINITY_DN10009_c0_g1_i1	P51812	KS6A3_HUMAN	83.9	149	24	0	1	447	488	636	1.30E-70	266.9	KS6A3_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	Homo sapiens (Human)	740	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0018105; GO:0019901; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]		blue	blue	NA	NA	NA	NA
TRINITY_DN37780_c0_g1_i1	P51812	KS6A3_HUMAN	100	83	0	0	1	249	182	264	1.20E-44	179.9	KS6A3_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2	Homo sapiens (Human)	740	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0018105; GO:0019901; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN35363_c0_g1_i1	Q5F3L1	KS6A5_CHICK	57.7	182	66	3	538	2	470	643	3.30E-55	216.1	KS6A5_CHICK	reviewed	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1)	RPS6KA5 RCJMB04_14g1	Gallus gallus (Chicken)	789	nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0035556	intracellular signal transduction [GO:0035556]		NA	NA	NA	NA	NA	NA
TRINITY_DN10525_c0_g2_i1	Q5F3L1	KS6A5_CHICK	81.5	162	29	1	1	486	111	271	3.70E-74	278.9	KS6A5_CHICK	reviewed	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1)	RPS6KA5 RCJMB04_14g1	Gallus gallus (Chicken)	789	nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0035556	intracellular signal transduction [GO:0035556]		NA	NA	NA	NA	NA	NA
TRINITY_DN33925_c0_g1_i1	Q8C050	KS6A5_MOUSE	41	105	52	3	7	321	285	379	3.00E-13	76.3	KS6A5_MOUSE	reviewed	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RLSK)	Rps6ka5 Msk1	Mus musculus (Mouse)	863	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0016572; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0043990; GO:0045892; GO:0045944; GO:0051092; GO:0070498	"histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30431_c0_g1_i1	O75582	KS6A5_HUMAN	100	178	0	0	535	2	104	281	5.60E-100	364.8	KS6A5_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL)	RPS6KA5 MSK1	Homo sapiens (Human)	802	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001818; GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007173; GO:0007411; GO:0016572; GO:0032793; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0043990; GO:0045892; GO:0045944; GO:0051092; GO:0070498	"axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10525_c0_g1_i1	O75582	KS6A5_HUMAN	71.4	70	20	0	213	4	288	357	3.80E-23	108.2	KS6A5_HUMAN	reviewed	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL)	RPS6KA5 MSK1	Homo sapiens (Human)	802	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001818; GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007173; GO:0007411; GO:0016572; GO:0032793; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0043990; GO:0045892; GO:0045944; GO:0051092; GO:0070498	"axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32066_c0_g1_i1	Q6TJY3	KS6B1_BOVIN	48	98	49	1	5	292	200	297	1.80E-23	109.8	KS6B1_BOVIN	reviewed	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1)	RPS6KB1	Bos taurus (Bovine)	527	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0006417; GO:0006468; GO:0006915; GO:0007049; GO:0014065; GO:0018105; GO:0031929; GO:0032869; GO:0035556; GO:0043005; GO:0043066; GO:0044539; GO:0045202; GO:0071363	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN31507_c0_g1_i1	Q6TJY3	KS6B1_BOVIN	100	74	0	0	222	1	141	214	1.40E-36	152.9	KS6B1_BOVIN	reviewed	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1)	RPS6KB1	Bos taurus (Bovine)	527	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0006417; GO:0006468; GO:0006915; GO:0007049; GO:0014065; GO:0018105; GO:0031929; GO:0032869; GO:0035556; GO:0043005; GO:0043066; GO:0044539; GO:0045202; GO:0071363	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN35441_c0_g1_i1	Q6TJY3	KS6B1_BOVIN	99.1	106	1	0	1	318	211	316	2.00E-60	232.6	KS6B1_BOVIN	reviewed	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1)	RPS6KB1	Bos taurus (Bovine)	527	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0006417; GO:0006468; GO:0006915; GO:0007049; GO:0014065; GO:0018105; GO:0031929; GO:0032869; GO:0035556; GO:0043005; GO:0043066; GO:0044539; GO:0045202; GO:0071363	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN32973_c0_g1_i1	Q6TJY3	KS6B1_BOVIN	78.5	265	57	0	1	795	130	394	2.60E-125	449.5	KS6B1_BOVIN	reviewed	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1)	RPS6KB1	Bos taurus (Bovine)	527	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0006417; GO:0006468; GO:0006915; GO:0007049; GO:0014065; GO:0018105; GO:0031929; GO:0032869; GO:0035556; GO:0043005; GO:0043066; GO:0044539; GO:0045202; GO:0071363	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]		blue	blue	NA	NA	NA	NA
TRINITY_DN39084_c0_g1_i1	Q9UBS0	KS6B2_HUMAN	98.7	76	1	0	2	229	160	235	3.10E-39	161.8	KS6B2_HUMAN	reviewed	Ribosomal protein S6 kinase beta-2 (S6K-beta-2) (S6K2) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 2) (P70S6K2) (p70-S6K 2) (S6 kinase-related kinase) (SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta) (S6K-beta) (p70 S6 kinase beta) (p70 S6K-beta) (p70 S6KB) (p70-beta)	RPS6KB2 STK14B	Homo sapiens (Human)	482	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; intracellular signal transduction [GO:0035556]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0006468; GO:0007165; GO:0031929; GO:0035556; GO:0042277; GO:0043491; GO:0045948	intracellular signal transduction [GO:0035556]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN39084_c0_g1_i2	Q9UBS0	KS6B2_HUMAN	100	134	0	0	2	403	160	293	4.30E-76	285	KS6B2_HUMAN	reviewed	Ribosomal protein S6 kinase beta-2 (S6K-beta-2) (S6K2) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 2) (P70S6K2) (p70-S6K 2) (S6 kinase-related kinase) (SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta) (S6K-beta) (p70 S6 kinase beta) (p70 S6K-beta) (p70 S6KB) (p70-beta)	RPS6KB2 STK14B	Homo sapiens (Human)	482	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; intracellular signal transduction [GO:0035556]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0006468; GO:0007165; GO:0031929; GO:0035556; GO:0042277; GO:0043491; GO:0045948	intracellular signal transduction [GO:0035556]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN6972_c0_g2_i1	Q8BLK9	KS6C1_MOUSE	32.4	216	122	5	647	3	828	1020	1.90E-23	112.5	KS6C1_MOUSE	reviewed	Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase)	Rps6kc1	Mus musculus (Mouse)	1056	early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	early endosome [GO:0005769]; membrane [GO:0016020]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005769; GO:0016020; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN6972_c0_g1_i1	Q96S38	KS6C1_HUMAN	34.3	175	112	2	241	762	233	405	1.10E-16	88.6	KS6C1_HUMAN	reviewed	Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein)	RPS6KC1 RPK118	Homo sapiens (Human)	1066	early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]	early endosome [GO:0005769]; membrane [GO:0016020]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30374_c0_g1_i1	Q96S38	KS6C1_HUMAN	27.4	208	127	5	933	352	13	210	6.20E-17	89.7	KS6C1_HUMAN	reviewed	Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein)	RPS6KC1 RPK118	Homo sapiens (Human)	1066	early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]	early endosome [GO:0005769]; membrane [GO:0016020]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN636_c0_g1_i1	Q96LW2	KS6R_HUMAN	40.4	285	167	3	349	1200	83	365	5.60E-58	226.5	KS6R_HUMAN	reviewed	Ribosomal protein S6 kinase-related protein (EC 2.7.11.1) (Sugen kinase 494)	RSKR SGK494	Homo sapiens (Human)	410	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN636_c0_g1_i3	Q96LW2	KS6R_HUMAN	40.4	285	167	3	349	1200	83	365	1.20E-57	226.1	KS6R_HUMAN	reviewed	Ribosomal protein S6 kinase-related protein (EC 2.7.11.1) (Sugen kinase 494)	RSKR SGK494	Homo sapiens (Human)	410	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN39776_c0_g1_i1	B2UGQ0	RLME_RALPJ	100	91	0	0	53	325	1	91	7.50E-47	187.6	RLME_RALPJ	reviewed	Ribosomal RNA large subunit methyltransferase E (EC 2.1.1.166) (23S rRNA Um2552 methyltransferase) (rRNA (uridine-2'-O-)-methyltransferase)	rlmE ftsJ rrmJ Rpic_2030	Ralstonia pickettii (strain 12J)	221	cytoplasm [GO:0005737]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	cytoplasm [GO:0005737]	rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0005737; GO:0008650			yellow	yellow	NA	NA	NA	NA
TRINITY_DN37068_c0_g1_i1	P56183	RRP1_MOUSE	100	71	0	0	213	1	24	94	8.70E-36	150.2	RRP1_MOUSE	reviewed	Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein)	Rrp1 Nnp1	Mus musculus (Mouse)	494	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; rRNA processing [GO:0006364]"	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]"		GO:0005634; GO:0005730; GO:0006364; GO:0030687; GO:0030688	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN3984_c0_g1_i5	Q14684	RRP1B_HUMAN	33.5	331	194	5	1334	405	12	337	8.40E-44	179.5	RRP1B_HUMAN	reviewed	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)	RRP1B KIAA0179	Homo sapiens (Human)	758	"cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]; viral process [GO:0016032]"	"cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]"	RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0010923; GO:0016032; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586	apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]; viral process [GO:0016032]		blue	blue	NA	NA	NA	NA
TRINITY_DN3984_c0_g1_i6	Q14684	RRP1B_HUMAN	32.3	331	199	6	2361	1429	12	337	8.10E-42	173.7	RRP1B_HUMAN	reviewed	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)	RRP1B KIAA0179	Homo sapiens (Human)	758	"cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]; viral process [GO:0016032]"	"cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]"	RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0010923; GO:0016032; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586	apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2778_c0_g2_i1	A6QNR1	RRP36_BOVIN	35.2	145	71	4	546	130	35	162	9.20E-12	72	RRP36_BOVIN	reviewed	Ribosomal RNA processing protein 36 homolog	RRP36	Bos taurus (Bovine)	246	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cleavage involved in rRNA processing [GO:0000469]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000469; GO:0005654; GO:0005730; GO:0006364; GO:0042274	cleavage involved in rRNA processing [GO:0000469]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN5572_c0_g2_i1	Q121Q5	RSMA_POLSJ	47.4	57	30	0	2	172	237	293	1.20E-06	53.5	RSMA_POLSJ	reviewed	"Ribosomal RNA small subunit methyltransferase A (EC 2.1.1.182) (16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase) (16S rRNA dimethyladenosine transferase) (16S rRNA dimethylase) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase)"	rsmA ksgA Bpro_4861	Polaromonas sp. (strain JS666 / ATCC BAA-500)	330	"cytoplasm [GO:0005737]; 16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase activity [GO:0052908]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	cytoplasm [GO:0005737]	"16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase activity [GO:0052908]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005737; GO:0052908			NA	NA	NA	NA	NA	NA
TRINITY_DN16274_c1_g1_i1	Q92979	NEP1_HUMAN	100	97	0	0	2	292	102	198	5.00E-50	198	NEP1_HUMAN	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	EMG1 C2F	Homo sapiens (Human)	244	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN16274_c0_g1_i1	O35130	NEP1_MOUSE	100	226	0	0	1	678	19	244	8.60E-128	457.6	NEP1_MOUSE	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	Emg1 C2f Grcc2f	Mus musculus (Mouse)	244	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0005654; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN16274_c0_g1_i2	O35130	NEP1_MOUSE	98.7	226	3	0	1	678	19	244	2.10E-126	453	NEP1_MOUSE	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	Emg1 C2f Grcc2f	Mus musculus (Mouse)	244	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0005654; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN5140_c0_g1_i2	O35130	NEP1_MOUSE	59.7	233	94	0	899	201	11	243	9.40E-77	288.5	NEP1_MOUSE	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	Emg1 C2f Grcc2f	Mus musculus (Mouse)	244	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0005654; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN5140_c0_g1_i6	O35130	NEP1_MOUSE	59.7	233	94	0	884	186	11	243	9.30E-77	288.5	NEP1_MOUSE	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	Emg1 C2f Grcc2f	Mus musculus (Mouse)	244	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0005654; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]		NA	NA	NA	NA	NA	NA
TRINITY_DN5140_c0_g1_i7	O35130	NEP1_MOUSE	66.7	135	45	0	793	389	109	243	3.00E-49	196.8	NEP1_MOUSE	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	Emg1 C2f Grcc2f	Mus musculus (Mouse)	244	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0005654; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]		brown	brown	1	NA	NA	NA
TRINITY_DN30868_c0_g1_i1	Q92979	NEP1_HUMAN	58.7	126	52	0	3	380	52	177	2.20E-34	146.4	NEP1_HUMAN	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)	EMG1 C2F	Homo sapiens (Human)	244	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0001824; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475	blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31953_c0_g1_i1	Q9P8P7	NEP1_CANAX	64	75	27	0	243	19	86	160	5.60E-23	107.8	NEP1_CANAX	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine-N1)-methyltransferase)	NEP1	Candida albicans (Yeast)	267	nucleolus [GO:0005730]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]	rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0005730; GO:0019843; GO:0042254; GO:0070037	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN5140_c0_g1_i5	Q9W4J5	NEP1_DROME	55.3	103	45	1	389	84	8	110	2.20E-23	110.2	NEP1_DROME	reviewed	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine-N1)-methyltransferase) (Ribosome biogenesis protein NEP1)	CG3527	Drosophila melanogaster (Fruit fly)	252	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; defense response to bacterium [GO:0042742]; rRNA base methylation [GO:0070475]; rRNA methylation [GO:0031167]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	GO:0005730; GO:0019843; GO:0031167; GO:0032040; GO:0042742; GO:0070037; GO:0070475	defense response to bacterium [GO:0042742]; rRNA base methylation [GO:0070475]; rRNA methylation [GO:0031167]		NA	NA	1	NA	NA	NA
TRINITY_DN2266_c0_g1_i1	Q9Y3A4	RRP7A_HUMAN	36.2	218	127	5	679	50	6	219	6.90E-29	129	RRP7A_HUMAN	reviewed	Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14)	RRP7A CGI-96	Homo sapiens (Human)	280	CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]	CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456]	RNA binding [GO:0003723]	GO:0000028; GO:0001825; GO:0003723; GO:0005654; GO:0005737; GO:0006364; GO:0032545; GO:0034456	blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN14857_c0_g1_i1	Q9DB85	RRP8_MOUSE	44.3	122	61	2	414	761	215	335	1.30E-20	101.7	RRP8_MOUSE	reviewed	Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1 homolog)	Rrp8	Mus musculus (Mouse)	457	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]; methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]; cellular response to glucose starvation [GO:0042149]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; positive regulation of cell cycle arrest [GO:0071158]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]	methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]	GO:0000183; GO:0005654; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008168; GO:0032259; GO:0033553; GO:0035064; GO:0042149; GO:0046015; GO:0071158; GO:0072332	cellular response to glucose starvation [GO:0042149]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; positive regulation of cell cycle arrest [GO:0071158]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN30300_c0_g1_i2	Q07844	RIX7_YEAST	66.2	228	75	1	689	12	503	730	8.20E-83	308.1	RIX7_YEAST	reviewed	Ribosome biogenesis ATPase RIX7	RIX7 YLL034C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	837	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]"	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005730; GO:0016887; GO:0030687; GO:0042254; GO:0042273; GO:0051973; GO:1990275	positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN13271_c0_g1_i1	B4GIU9	BOP1_DROPE	56.1	66	29	0	207	10	443	508	6.50E-18	90.9	BOP1_DROPE	reviewed	Ribosome biogenesis protein BOP1 homolog	GL17224	Drosophila persimilis (Fruit fly)	785	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of hemocyte proliferation [GO:0035206]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	ribonucleoprotein complex binding [GO:0043021]	GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0030687; GO:0035206; GO:0043021	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of hemocyte proliferation [GO:0035206]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6179_c0_g1_i2	Q3SZZ0	BRX1_BOVIN	58	264	108	2	866	84	53	316	2.10E-87	323.9	BRX1_BOVIN	reviewed	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)	BRIX1 BRIX BXDC2	Bos taurus (Bovine)	353	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosomal large subunit assembly [GO:0000027]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000027; GO:0005654; GO:0005730	ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN13634_c0_g2_i1	Q3SZZ0	BRX1_BOVIN	56.2	73	31	1	217	2	116	188	9.80E-19	93.6	BRX1_BOVIN	reviewed	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)	BRIX1 BRIX BXDC2	Bos taurus (Bovine)	353	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosomal large subunit assembly [GO:0000027]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		GO:0000027; GO:0005654; GO:0005730	ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN17546_c0_g1_i1	Q8TDN6	BRX1_HUMAN	100	233	0	0	3	701	35	267	2.00E-137	489.6	BRX1_HUMAN	reviewed	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)	BRIX1 BRIX BXDC2	Homo sapiens (Human)	353	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ribosomal large subunit assembly [GO:0000027]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000027; GO:0003723; GO:0005654; GO:0005730	ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN17546_c0_g1_i2	Q8TDN6	BRX1_HUMAN	98.9	190	2	0	3	572	35	224	2.40E-109	396	BRX1_HUMAN	reviewed	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)	BRIX1 BRIX BXDC2	Homo sapiens (Human)	353	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ribosomal large subunit assembly [GO:0000027]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000027; GO:0003723; GO:0005654; GO:0005730	ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN17546_c0_g1_i3	Q8TDN6	BRX1_HUMAN	98.9	190	2	0	3	572	35	224	2.40E-109	396	BRX1_HUMAN	reviewed	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)	BRIX1 BRIX BXDC2	Homo sapiens (Human)	353	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ribosomal large subunit assembly [GO:0000027]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000027; GO:0003723; GO:0005654; GO:0005730	ribosomal large subunit assembly [GO:0000027]		NA	NA	NA	NA	NA	NA
TRINITY_DN13634_c0_g1_i1	Q8UVY2	BRX1_XENLA	53.2	62	29	0	191	6	45	106	2.60E-14	79	BRX1_XENLA	reviewed	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2) (Bx24)	brix1 brix bxdc2	Xenopus laevis (African clawed frog)	339	nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]		GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN1000_c0_g1_i1	Q8BK35	NOP53_MOUSE	27.7	509	290	15	5	1504	42	481	4.90E-14	80.9	NOP53_MOUSE	reviewed	Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein)	Nop53 Gltscr2 Pict1	Mus musculus (Mouse)	484	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]	5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]	GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0014067; GO:0031333; GO:0032435; GO:0032436; GO:0033553; GO:0039535; GO:0042802; GO:0042981; GO:0043231; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173	cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN29525_c0_g1_i1	Q9NZM5	NOP53_HUMAN	100	73	0	0	224	6	406	478	7.30E-33	140.6	NOP53_HUMAN	reviewed	Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1) (PICT-1) (p60)	NOP53 GLT GLTSCR2 PICT1	Homo sapiens (Human)	478	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]; viral process [GO:0016032]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723]	GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0014067; GO:0016032; GO:0031333; GO:0032435; GO:0032436; GO:0039535; GO:0042802; GO:0042981; GO:0043231; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173	cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1000_c0_g1_i2	Q9NZM5	NOP53_HUMAN	53.4	73	34	0	171	389	403	475	1.10E-12	74.7	NOP53_HUMAN	reviewed	Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1) (PICT-1) (p60)	NOP53 GLT GLTSCR2 PICT1	Homo sapiens (Human)	478	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]; viral process [GO:0016032]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723]	GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0014067; GO:0016032; GO:0031333; GO:0032435; GO:0032436; GO:0039535; GO:0042802; GO:0042981; GO:0043231; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173	cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN35672_c0_g1_i1	Q4P3S7	NSA2_USTMA	73	89	24	0	1	267	172	260	1.10E-33	143.7	NSA2_USTMA	reviewed	Ribosome biogenesis protein NSA2	NSA2 UMAG_11787	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	262	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN33988_c0_g1_i1	P0CQ61	NSA2_CRYNB	78.9	128	27	0	386	3	1	128	3.30E-49	195.7	NSA2_CRYNB	reviewed	Ribosome biogenesis protein NSA2	NSA2 CNBM1180	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	254	nucleolus [GO:0005730]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]		GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN12576_c0_g1_i1	Q54GN8	NSA2_DICDI	62.1	58	22	0	62	235	1	58	2.80E-11	68.9	NSA2_DICDI	reviewed	Ribosome biogenesis protein NSA2 homolog	nsa2 DDB_G0290031	Dictyostelium discoideum (Slime mold)	260	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN12576_c0_g1_i3	Q54GN8	NSA2_DICDI	62.1	58	22	0	50	223	1	58	1.20E-11	70.1	NSA2_DICDI	reviewed	Ribosome biogenesis protein NSA2 homolog	nsa2 DDB_G0290031	Dictyostelium discoideum (Slime mold)	260	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN16159_c0_g1_i2	Q3SX11	NSA2_BOVIN	77.3	260	59	0	97	876	1	260	4.40E-111	402.5	NSA2_BOVIN	reviewed	Ribosome biogenesis protein NSA2 homolog (TGF-beta-inducible nuclear protein 1)	NSA2 TINP1	Bos taurus (Bovine)	260	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN16159_c0_g1_i3	Q3SX11	NSA2_BOVIN	77.3	260	59	0	97	876	1	260	6.20E-111	402.1	NSA2_BOVIN	reviewed	Ribosome biogenesis protein NSA2 homolog (TGF-beta-inducible nuclear protein 1)	NSA2 TINP1	Bos taurus (Bovine)	260	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		blue	blue	NA	NA	NA	NA
TRINITY_DN35683_c0_g1_i1	Q3SX11	NSA2_BOVIN	97.7	260	6	0	39	818	1	260	8.60E-135	481.1	NSA2_BOVIN	reviewed	Ribosome biogenesis protein NSA2 homolog (TGF-beta-inducible nuclear protein 1)	NSA2 TINP1	Bos taurus (Bovine)	260	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN12576_c0_g2_i1	Q3SX11	NSA2_BOVIN	74.3	179	46	0	2	538	82	260	3.20E-75	282.7	NSA2_BOVIN	reviewed	Ribosome biogenesis protein NSA2 homolog (TGF-beta-inducible nuclear protein 1)	NSA2 TINP1	Bos taurus (Bovine)	260	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"		GO:0000460; GO:0000470; GO:0005730; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]		NA	NA	NA	NA	NA	NA
TRINITY_DN7665_c0_g1_i2	Q9JJA4	WDR12_MOUSE	50.4	115	57	0	346	2	245	359	1.50E-31	137.1	WDR12_MOUSE	reviewed	Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12)	Wdr12 MNCb-5414	Mus musculus (Mouse)	423	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]"	ribonucleoprotein complex binding [GO:0043021]	GO:0000463; GO:0000466; GO:0005634; GO:0005654; GO:0005730; GO:0007219; GO:0030687; GO:0043021; GO:0051726; GO:0070545	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24737_c0_g1_i1	Q9JJA4	WDR12_MOUSE	100	72	0	0	216	1	254	325	9.40E-38	156.8	WDR12_MOUSE	reviewed	Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12)	Wdr12 MNCb-5414	Mus musculus (Mouse)	423	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]"	ribonucleoprotein complex binding [GO:0043021]	GO:0000463; GO:0000466; GO:0005634; GO:0005654; GO:0005730; GO:0007219; GO:0030687; GO:0043021; GO:0051726; GO:0070545	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7665_c0_g1_i1	B4JPT9	WDR12_DROGR	45.3	232	116	2	743	48	1	221	9.30E-54	211.8	WDR12_DROGR	reviewed	Ribosome biogenesis protein WDR12 homolog	GH13339	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	419	"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]"	ribonucleoprotein complex binding [GO:0043021]	GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0070545	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7665_c0_g1_i3	B7PY76	WDR12_IXOSC	42.4	375	205	4	1114	2	2	369	8.00E-86	318.9	WDR12_IXOSC	reviewed	Ribosome biogenesis protein WDR12 homolog	ISCW009002	Ixodes scapularis (Black-legged tick) (Deer tick)	425	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	ribonucleoprotein complex binding [GO:0043021]	GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0030687; GO:0043021	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2225_c0_g1_i2	Q2KIH4	RRS1_BOVIN	44.9	292	152	5	1077	223	4	293	2.60E-57	224.2	RRS1_BOVIN	reviewed	Ribosome biogenesis regulatory protein homolog	RRS1	Bos taurus (Bovine)	365	"condensed nuclear chromosome [GO:0000794]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]"	"condensed nuclear chromosome [GO:0000794]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	5S rRNA binding [GO:0008097]	GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0005730; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]"		blue	blue	NA	NA	NA	NA
TRINITY_DN16162_c0_g1_i1	A5D8M6	SBDS_XENLA	62	242	91	1	160	882	3	244	1.10E-77	291.6	SBDS_XENLA	reviewed	Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog)	sbds	Xenopus laevis (African clawed frog)	250	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ribosome binding [GO:0043022]; hematopoietic progenitor cell differentiation [GO:0002244]; mature ribosome assembly [GO:0042256]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ribosome binding [GO:0043022]	GO:0000922; GO:0002244; GO:0005654; GO:0005730; GO:0005737; GO:0042256; GO:0043022	hematopoietic progenitor cell differentiation [GO:0002244]; mature ribosome assembly [GO:0042256]		blue	blue	NA	NA	NA	NA
TRINITY_DN33152_c0_g1_i1	Q23202	SBDS_CAEEL	63.1	65	24	0	1	195	1	65	1.80E-17	89.4	SBDS_CAEEL	reviewed	Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog)	sbds-1 W06E11.4	Caenorhabditis elegans	253	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; mature ribosome assembly [GO:0042256]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0042256	mature ribosome assembly [GO:0042256]		NA	NA	NA	NA	NA	NA
TRINITY_DN36156_c0_g1_i1	Q9Y3A5	SBDS_HUMAN	100	166	0	0	54	551	1	166	2.50E-87	322.8	SBDS_HUMAN	reviewed	Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein)	SBDS CGI-97	Homo sapiens (Human)	250	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000922; GO:0001833; GO:0002244; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539	bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN17052_c0_g1_i1	Q9H9Y2	RPF1_HUMAN	100	144	0	0	3	434	166	309	4.80E-81	301.6	RPF1_HUMAN	reviewed	Ribosome production factor 1 (Brix domain-containing protein 5) (Ribosome biogenesis protein RPF1)	RPF1 BXDC5	Homo sapiens (Human)	349	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0006364; GO:0019843; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN17052_c0_g1_i2	Q9H9Y2	RPF1_HUMAN	100	121	0	0	3	365	189	309	1.20E-66	253.4	RPF1_HUMAN	reviewed	Ribosome production factor 1 (Brix domain-containing protein 5) (Ribosome biogenesis protein RPF1)	RPF1 BXDC5	Homo sapiens (Human)	349	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0006364; GO:0019843; GO:0030687	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN28800_c0_g1_i1	Q7VMI2	YCHF_HAEDU	70.1	87	26	0	1	261	6	92	9.00E-27	120.6	YCHF_HAEDU	reviewed	Ribosome-binding ATPase YchF	ychF engD HD_0995	Haemophilus ducreyi (strain 35000HP / ATCC 700724)	363	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN16908_c0_g1_i1	Q7VMI2	YCHF_HAEDU	67.7	65	21	0	10	204	67	131	1.40E-19	96.3	YCHF_HAEDU	reviewed	Ribosome-binding ATPase YchF	ychF engD HD_0995	Haemophilus ducreyi (strain 35000HP / ATCC 700724)	363	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5867_c0_g1_i1	P0ABU3	YCHF_ECO57	63	54	20	0	164	3	1	54	9.00E-13	73.9	YCHF_ECO57	reviewed	Ribosome-binding ATPase YchF	ychF engD Z1974 ECs1708	Escherichia coli O157:H7	363	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN30917_c0_g1_i1	Q7VMI2	YCHF_HAEDU	82.8	64	11	0	200	9	74	137	7.20E-24	110.5	YCHF_HAEDU	reviewed	Ribosome-binding ATPase YchF	ychF engD HD_0995	Haemophilus ducreyi (strain 35000HP / ATCC 700724)	363	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0016887; GO:0043022; GO:0043023; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27542_c0_g1_i1	P53295	RBG2_YEAST	54.7	64	29	0	235	44	305	368	1.90E-15	82.8	RBG2_YEAST	reviewed	Ribosome-interacting GTPase 2 (GTP-binding protein RBG2)	RBG2 GIR1 YGR173W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	368	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]; positive regulation of cellular response to amino acid starvation [GO:1903833]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]	GO:0002181; GO:0005525; GO:0005737; GO:1903833	cytoplasmic translation [GO:0002181]; positive regulation of cellular response to amino acid starvation [GO:1903833]		NA	NA	NA	NA	NA	NA
TRINITY_DN3330_c0_g1_i3	A8FK24	RRF_CAMJ8	25.1	179	129	3	617	90	8	184	1.40E-06	55.5	RRF_CAMJ8	reviewed	Ribosome-recycling factor (RRF) (Ribosome-releasing factor)	frr C8J_0212	Campylobacter jejuni subsp. jejuni serotype O:6 (strain 81116 / NCTC 11828)	185	cytoplasm [GO:0005737]; translational termination [GO:0006415]	cytoplasm [GO:0005737]		GO:0005737; GO:0006415	translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN3330_c0_g1_i5	A8FK24	RRF_CAMJ8	25.1	179	129	3	628	101	8	184	1.80E-06	55.1	RRF_CAMJ8	reviewed	Ribosome-recycling factor (RRF) (Ribosome-releasing factor)	frr C8J_0212	Campylobacter jejuni subsp. jejuni serotype O:6 (strain 81116 / NCTC 11828)	185	cytoplasm [GO:0005737]; translational termination [GO:0006415]	cytoplasm [GO:0005737]		GO:0005737; GO:0006415	translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN3330_c0_g1_i6	A8FK24	RRF_CAMJ8	25.1	179	129	3	568	41	8	184	1.30E-06	55.5	RRF_CAMJ8	reviewed	Ribosome-recycling factor (RRF) (Ribosome-releasing factor)	frr C8J_0212	Campylobacter jejuni subsp. jejuni serotype O:6 (strain 81116 / NCTC 11828)	185	cytoplasm [GO:0005737]; translational termination [GO:0006415]	cytoplasm [GO:0005737]		GO:0005737; GO:0006415	translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN2009_c0_g1_i2	Q8R2Q4	RRF2M_MOUSE	50.1	712	338	9	245	2350	70	774	8.40E-183	642.1	RRF2M_MOUSE	reviewed	"Ribosome-releasing factor 2, mitochondrial (RRF2mt) (Elongation factor G 2, mitochondrial) (EF-G2mt) (mEF-G 2)"	Gfm2 Efg2	Mus musculus (Mouse)	779	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0032543; GO:0032790	mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790]		NA	NA	NA	NA	NA	NA
TRINITY_DN2009_c0_g1_i4	Q8R2Q4	RRF2M_MOUSE	45.8	613	315	9	35	1843	169	774	7.20E-137	489.2	RRF2M_MOUSE	reviewed	"Ribosome-releasing factor 2, mitochondrial (RRF2mt) (Elongation factor G 2, mitochondrial) (EF-G2mt) (mEF-G 2)"	Gfm2 Efg2	Mus musculus (Mouse)	779	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790]	mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0032543; GO:0032790	mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790]		NA	NA	NA	NA	NA	NA
TRINITY_DN36363_c0_g1_i1	Q969S9	RRF2M_HUMAN	100	77	0	0	231	1	137	213	9.10E-39	160.2	RRF2M_HUMAN	reviewed	"Ribosome-releasing factor 2, mitochondrial (RRF2mt) (Elongation factor G 2, mitochondrial) (EF-G2mt) (mEF-G 2) (Elongation factor G2) (hEFG2)"	GFM2 EFG2 MSTP027	Homo sapiens (Human)	779	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]; ribosome disassembly [GO:0032790]; translational elongation [GO:0006414]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0006414; GO:0032543; GO:0032790; GO:0070126	mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]; ribosome disassembly [GO:0032790]; translational elongation [GO:0006414]		NA	NA	NA	NA	NA	NA
TRINITY_DN17830_c0_g1_i1	P65761	RPE_MYCBO	67.1	85	28	0	255	1	35	119	6.10E-28	124.4	RPE_MYCBO	reviewed	Ribulose-phosphate 3-epimerase (EC 5.1.3.1)	rpe BQ2027_MB1443	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	229	metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]		metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]	GO:0004750; GO:0006098; GO:0019323; GO:0046872	pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN13799_c0_g1_i1	Q755M2	RPE_ASHGO	61.6	86	33	0	6	263	121	206	5.10E-25	114.8	RPE_ASHGO	reviewed	Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Pentose-5-phosphate 3-epimerase) (PPE) (RPE)	RPE1 AFL208C	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	239	"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytosol [GO:0005829]	metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]	GO:0004750; GO:0005829; GO:0009052; GO:0019323; GO:0044262; GO:0046872	"cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39576_c0_g1_i1	Q96AT9	RPE_HUMAN	100	118	0	0	362	9	111	228	5.80E-64	244.6	RPE_HUMAN	reviewed	Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase)	RPE HUSSY-17	Homo sapiens (Human)	228	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]	GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0019323; GO:0042802; GO:0042803; GO:0044262; GO:0046872; GO:0070062	"carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2422_c0_g1_i1	Q8VEE0	RPE_MOUSE	66.7	210	69	1	5	631	5	214	3.70E-78	292.7	RPE_MOUSE	reviewed	Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-epimerase)	Rpe	Mus musculus (Mouse)	228	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]	GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0019323; GO:0030246; GO:0042802; GO:0042803; GO:0043231; GO:0044262; GO:0046872; GO:0048029	"carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27134_c0_g1_i1	P40117	RPE1_CUPNH	72.1	68	14	1	22	225	17	79	2.20E-21	102.4	RPE1_CUPNH	reviewed	Ribulose-phosphate 3-epimerase 1 (EC 5.1.3.1)	rpe1 cbbE2 cbbEC cfxE H16_B1391	Cupriavidus necator (strain ATCC 17699 / H16 / DSM 428 / Stanier 337) (Ralstonia eutropha)	241	metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; reductive pentose-phosphate cycle [GO:0019253]		metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]	GO:0004750; GO:0006098; GO:0019253; GO:0019323; GO:0046872	pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; reductive pentose-phosphate cycle [GO:0019253]		NA	NA	NA	NA	NA	NA
TRINITY_DN3555_c0_g1_i1	Q70JS2	KELC_ANOST	67.2	125	39	1	116	484	46	170	4.70E-39	162.9	KELC_ANOST	reviewed	Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein]	kel	Anopheles stephensi (Indo-Pakistan malaria mosquito)	1499	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN3555_c0_g1_i1	Q70JS2	KELC_ANOST	75	60	15	0	507	686	170	229	9.00E-22	105.5	KELC_ANOST	reviewed	Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein]	kel	Anopheles stephensi (Indo-Pakistan malaria mosquito)	1499	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN3555_c0_g1_i2	Q70JS2	KELC_ANOST	72.5	590	160	1	116	1879	46	635	7.80E-256	884.4	KELC_ANOST	reviewed	Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein]	kel	Anopheles stephensi (Indo-Pakistan malaria mosquito)	1499	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN3555_c0_g1_i3	Q70JS2	KELC_ANOST	69.6	184	54	1	116	661	46	229	2.80E-68	260	KELC_ANOST	reviewed	Ring canal kelch homolog (Kelch-like protein 1) [Cleaved into: Kelch short protein]	kel	Anopheles stephensi (Indo-Pakistan malaria mosquito)	1499	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i10	Q96PM5	ZN363_HUMAN	44.6	74	41	0	108	329	10	83	1.60E-15	84.3	ZN363_HUMAN	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)	RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363	Homo sapiens (Human)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987	error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i4	Q96PM5	ZN363_HUMAN	47.3	55	29	0	322	486	29	83	2.30E-11	70.9	ZN363_HUMAN	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)	RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363	Homo sapiens (Human)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987	error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38119_c0_g1_i1	Q96PM5	ZN363_HUMAN	100	74	0	0	223	2	12	85	8.40E-42	170.2	ZN363_HUMAN	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)	RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363	Homo sapiens (Human)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987	error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i11	Q9CR50	ZN363_MOUSE	46.8	233	122	2	304	1002	23	253	6.10E-70	266.2	ZN363_MOUSE	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)	Rchy1 Arnip Chimp Zfp363 Znf363	Mus musculus (Mouse)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i12	Q9CR50	ZN363_MOUSE	47.5	244	126	2	114	845	12	253	2.10E-74	280.8	ZN363_MOUSE	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)	Rchy1 Arnip Chimp Zfp363 Znf363	Mus musculus (Mouse)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i16	Q9CR50	ZN363_MOUSE	46.6	206	108	2	304	921	23	226	8.60E-62	238.8	ZN363_MOUSE	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)	Rchy1 Arnip Chimp Zfp363 Znf363	Mus musculus (Mouse)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i5	Q9CR50	ZN363_MOUSE	47.3	150	77	2	15	464	79	226	5.50E-43	175.3	ZN363_MOUSE	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)	Rchy1 Arnip Chimp Zfp363 Znf363	Mus musculus (Mouse)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9138_c0_g1_i7	Q9CR50	ZN363_MOUSE	47.5	217	112	2	114	764	12	226	2.80E-66	253.4	ZN363_MOUSE	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)	Rchy1 Arnip Chimp Zfp363 Znf363	Mus musculus (Mouse)	261	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11064_c0_g1_i2	Q96DX4	RSPRY_HUMAN	62.3	472	174	2	1548	133	101	568	2.20E-172	607.1	RSPRY_HUMAN	reviewed	RING finger and SPRY domain-containing protein 1	RSPRY1 KIAA1972 UNQ328/PRO444	Homo sapiens (Human)	576	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN11064_c0_g1_i3	Q96DX4	RSPRY_HUMAN	62.1	66	22	1	237	40	238	300	2.90E-15	82.4	RSPRY_HUMAN	reviewed	RING finger and SPRY domain-containing protein 1	RSPRY1 KIAA1972 UNQ328/PRO444	Homo sapiens (Human)	576	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN11064_c0_g1_i4	Q96DX4	RSPRY_HUMAN	59.9	242	94	1	815	90	101	339	1.40E-75	284.6	RSPRY_HUMAN	reviewed	RING finger and SPRY domain-containing protein 1	RSPRY1 KIAA1972 UNQ328/PRO444	Homo sapiens (Human)	576	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN21155_c0_g1_i1	Q96DX4	RSPRY_HUMAN	100	208	0	0	625	2	159	366	2.50E-115	416	RSPRY_HUMAN	reviewed	RING finger and SPRY domain-containing protein 1	RSPRY1 KIAA1972 UNQ328/PRO444	Homo sapiens (Human)	576	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN21155_c0_g1_i2	Q8BVR6	RSPRY_MOUSE	99.2	122	1	0	367	2	159	280	2.70E-61	235.7	RSPRY_MOUSE	reviewed	RING finger and SPRY domain-containing protein 1	Rspry1 Kiaa1972	Mus musculus (Mouse)	576	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603	proteolysis involved in cellular protein catabolic process [GO:0051603]		NA	NA	NA	NA	NA	NA
TRINITY_DN2127_c0_g1_i1	Q3UF64	RNFT2_MOUSE	39.3	150	90	1	536	90	296	445	3.20E-30	133.3	RNFT2_MOUSE	reviewed	RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118)	Rnft2 Tmem118	Mus musculus (Mouse)	445	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]	integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]	GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2127_c0_g1_i2	Q3UF64	RNFT2_MOUSE	35.5	276	177	1	914	90	170	445	2.50E-50	200.7	RNFT2_MOUSE	reviewed	RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118)	Rnft2 Tmem118	Mus musculus (Mouse)	445	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]	integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]	GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN90_c1_g1_i1	Q32NQ8	RNF10_XENLA	39.3	521	297	10	225	1760	95	605	3.50E-88	327.4	RNF10_XENLA	reviewed	RING finger protein 10	rnf10	Xenopus laevis (African clawed frog)	756	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0045944; GO:0046872	negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]		blue	blue	NA	NA	NA	NA
TRINITY_DN32125_c0_g1_i1	Q8N5U6	RNF10_HUMAN	100	111	0	0	336	4	175	285	2.40E-64	245.7	RNF10_HUMAN	reviewed	RING finger protein 10	RNF10 KIAA0262 RIE2	Homo sapiens (Human)	811	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]	GO:0000976; GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0045893; GO:0045944; GO:0046872; GO:0051865; GO:0061630	"negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4880_c0_g1_i1	Q5SWK7	RN145_MOUSE	45.9	320	172	1	69	1028	257	575	3.60E-73	276.9	RN145_MOUSE	reviewed	RING finger protein 145 (EC 2.3.2.27)	Rnf145	Mus musculus (Mouse)	663	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0012505; GO:0016021; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN4880_c0_g2_i2	Q96MT1	RN145_HUMAN	27.5	273	156	7	872	90	5	247	7.70E-15	82.8	RN145_HUMAN	reviewed	RING finger protein 145 (EC 2.3.2.27)	RNF145	Homo sapiens (Human)	663	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0012505; GO:0016021; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN30257_c0_g1_i1	E9QHE3	RN207_DANRE	34.2	120	79	0	377	18	439	558	4.70E-17	89	RN207_DANRE	reviewed	RING finger protein 207	rnf207b rnf207	Danio rerio (Zebrafish) (Brachydanio rerio)	634	cytoplasm [GO:0005737]; Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]	cytoplasm [GO:0005737]	Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0030544; GO:0055117; GO:0086019; GO:1901207; GO:1903762; GO:1903954	cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]		NA	NA	NA	NA	NA	NA
TRINITY_DN30257_c0_g1_i2	A0JNG4	RN207_BOVIN	36.5	156	98	1	482	15	365	519	2.60E-22	106.7	RN207_BOVIN	reviewed	RING finger protein 207	RNF207	Bos taurus (Bovine)	556	cytoplasm [GO:0005737]; Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0030544			NA	NA	NA	NA	NA	NA
TRINITY_DN30743_c0_g1_i1	E9QHE3	RN207_DANRE	58	112	47	0	5	340	112	223	5.60E-37	154.8	RN207_DANRE	reviewed	RING finger protein 207	rnf207b rnf207	Danio rerio (Zebrafish) (Brachydanio rerio)	634	cytoplasm [GO:0005737]; Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]	cytoplasm [GO:0005737]	Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0030544; GO:0055117; GO:0086019; GO:1901207; GO:1903762; GO:1903954	cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]		NA	NA	NA	NA	NA	NA
TRINITY_DN30743_c0_g1_i2	E9QHE3	RN207_DANRE	56.8	44	19	0	5	136	112	155	7.90E-10	63.9	RN207_DANRE	reviewed	RING finger protein 207	rnf207b rnf207	Danio rerio (Zebrafish) (Brachydanio rerio)	634	cytoplasm [GO:0005737]; Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]	cytoplasm [GO:0005737]	Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0030544; GO:0055117; GO:0086019; GO:1901207; GO:1903762; GO:1903954	cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]		NA	NA	NA	NA	NA	NA
TRINITY_DN30743_c0_g1_i3	E9QHE3	RN207_DANRE	60.2	98	39	0	5	298	112	209	1.00E-32	141	RN207_DANRE	reviewed	RING finger protein 207	rnf207b rnf207	Danio rerio (Zebrafish) (Brachydanio rerio)	634	cytoplasm [GO:0005737]; Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]	cytoplasm [GO:0005737]	Hsp70 protein binding [GO:0030544]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0030544; GO:0055117; GO:0086019; GO:1901207; GO:1903762; GO:1903954	cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]		NA	NA	NA	NA	NA	NA
TRINITY_DN2755_c0_g1_i7	Q9H0X6	RN208_HUMAN	42.9	49	24	1	649	783	142	190	1.90E-05	51.6	RN208_HUMAN	reviewed	RING finger protein 208	RNF208	Homo sapiens (Human)	261	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005829; GO:0046872; GO:0051865	protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN2755_c0_g1_i8	Q9H0X6	RN208_HUMAN	42.9	49	24	1	662	796	142	190	1.90E-05	51.6	RN208_HUMAN	reviewed	RING finger protein 208	RNF208	Homo sapiens (Human)	261	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005829; GO:0046872; GO:0051865	protein autoubiquitination [GO:0051865]		NA	NA	NA	NA	NA	NA
TRINITY_DN4004_c0_g1_i1	O94941	RNF37_HUMAN	29.6	362	216	6	1276	218	2	333	1.80E-33	145.2	RNF37_HUMAN	reviewed	RING finger protein 37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RNF37) (U-box domain-containing protein 5) (UbcM4-interacting protein 5) (hUIP5) (Ubiquitin-conjugating enzyme 7-interacting protein 5)	UBOX5 KIAA0860 RNF37 UBCE7IP5 UIP5	Homo sapiens (Human)	541	focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]	focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0005634; GO:0005654; GO:0005925; GO:0016604; GO:0031625; GO:0034450; GO:0046872; GO:0061630	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN4004_c0_g1_i2	O94941	RNF37_HUMAN	29	324	196	5	1177	218	40	333	2.70E-27	124.8	RNF37_HUMAN	reviewed	RING finger protein 37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RNF37) (U-box domain-containing protein 5) (UbcM4-interacting protein 5) (hUIP5) (Ubiquitin-conjugating enzyme 7-interacting protein 5)	UBOX5 KIAA0860 RNF37 UBCE7IP5 UIP5	Homo sapiens (Human)	541	focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]	focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0005634; GO:0005654; GO:0005925; GO:0016604; GO:0031625; GO:0034450; GO:0046872; GO:0061630	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN3919_c0_g1_i1	Q7L0R7	RNF44_HUMAN	44.4	72	29	3	235	50	351	421	9.80E-12	70.5	RNF44_HUMAN	reviewed	RING finger protein 44	RNF44 KIAA1100	Homo sapiens (Human)	432	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN40651_c0_g1_i1	Q03601	NHL1_CAEEL	48.2	56	28	1	90	257	36	90	8.20E-10	64.3	NHL1_CAEEL	reviewed	RING finger protein nhl-1	nhl-1 F54G8.4	Caenorhabditis elegans	974	metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630	negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN36910_c0_g1_i1	Q03601	NHL1_CAEEL	60	40	16	0	21	140	78	117	1.70E-08	60.5	NHL1_CAEEL	reviewed	RING finger protein nhl-1	nhl-1 F54G8.4	Caenorhabditis elegans	974	metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630	negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN11153_c0_g1_i1	Q03601	NHL1_CAEEL	52.7	273	127	2	190	1005	703	974	1.70E-84	314.3	NHL1_CAEEL	reviewed	RING finger protein nhl-1	nhl-1 F54G8.4	Caenorhabditis elegans	974	metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630	negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN11153_c0_g1_i2	Q03601	NHL1_CAEEL	52.2	203	95	2	190	795	703	904	3.70E-58	226.5	NHL1_CAEEL	reviewed	RING finger protein nhl-1	nhl-1 F54G8.4	Caenorhabditis elegans	974	metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630	negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3302_c0_g1_i1	Q9C0B0	UNK_HUMAN	34.4	253	135	10	33	770	501	729	1.10E-11	72	UNK_HUMAN	reviewed	RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5)	UNK KIAA1753 ZC3H5 ZC3HDC5	Homo sapiens (Human)	810	cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764]	cytoplasm [GO:0005737]; polysome [GO:0005844]	metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]	GO:0001764; GO:0003723; GO:0005737; GO:0005844; GO:0046872; GO:0048667; GO:1905538; GO:1990715; GO:2000766	cell morphogenesis involved in neuron differentiation [GO:0048667]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764]		NA	NA	NA	NA	NA	NA
TRINITY_DN39009_c0_g1_i1	Q54K33	RBX1_DICDI	81.4	102	19	0	393	88	3	104	5.30E-51	201.8	RBX1_DICDI	reviewed	RING-box protein 1	rbx1 DDB_G0287629	Dictyostelium discoideum (Slime mold)	104	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031461; GO:0061630; GO:0097602	protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN18525_c1_g1_i1	Q9W5E1	RBX1A_DROME	86.8	91	11	1	5	277	5	94	9.10E-41	167.2	RBX1A_DROME	reviewed	RING-box protein 1A (Regulator of cullins 1a) (dRbx1)	Roc1a CG16982	Drosophila melanogaster (Fruit fly)	108	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; smoothened signaling pathway [GO:0007224]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007224; GO:0008270; GO:0008283; GO:0016567; GO:0019005; GO:0031461; GO:0031462; GO:0031463; GO:0032436; GO:0045879; GO:0046627; GO:0061630; GO:0080008; GO:0090090; GO:0097602; GO:1904801	cell population proliferation [GO:0008283]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; smoothened signaling pathway [GO:0007224]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN23437_c1_g1_i1	Q9W5E1	RBX1A_DROME	88.4	69	8	0	31	237	14	82	5.00E-32	137.9	RBX1A_DROME	reviewed	RING-box protein 1A (Regulator of cullins 1a) (dRbx1)	Roc1a CG16982	Drosophila melanogaster (Fruit fly)	108	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; smoothened signaling pathway [GO:0007224]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007224; GO:0008270; GO:0008283; GO:0016567; GO:0019005; GO:0031461; GO:0031462; GO:0031463; GO:0032436; GO:0045879; GO:0046627; GO:0061630; GO:0080008; GO:0090090; GO:0097602; GO:1904801	cell population proliferation [GO:0008283]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; smoothened signaling pathway [GO:0007224]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2319_c0_g1_i1	Q9W5E1	RBX1A_DROME	91.9	111	6	2	478	146	1	108	4.90E-56	218.8	RBX1A_DROME	reviewed	RING-box protein 1A (Regulator of cullins 1a) (dRbx1)	Roc1a CG16982	Drosophila melanogaster (Fruit fly)	108	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; smoothened signaling pathway [GO:0007224]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007224; GO:0008270; GO:0008283; GO:0016567; GO:0019005; GO:0031461; GO:0031462; GO:0031463; GO:0032436; GO:0045879; GO:0046627; GO:0061630; GO:0080008; GO:0090090; GO:0097602; GO:1904801	cell population proliferation [GO:0008283]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; smoothened signaling pathway [GO:0007224]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN6533_c0_g1_i1	Q9UBF6	RBX2_HUMAN	96.9	32	1	0	182	87	27	58	1.20E-12	73.9	RBX2_HUMAN	reviewed	RING-box protein 2 (Rbx2) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein)	RNF7 RBX2 ROC2 SAG	Homo sapiens (Human)	113	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0031461; GO:0031466; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0097602	post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6533_c0_g1_i2	Q9UBF6	RBX2_HUMAN	65.5	87	30	0	359	99	27	113	4.10E-28	125.9	RBX2_HUMAN	reviewed	RING-box protein 2 (Rbx2) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein)	RNF7 RBX2 ROC2 SAG	Homo sapiens (Human)	113	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0031461; GO:0031466; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0097602	post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN12351_c0_g2_i1	Q9UBF6	RBX2_HUMAN	94.5	110	6	0	381	52	4	113	5.80E-59	228	RBX2_HUMAN	reviewed	RING-box protein 2 (Rbx2) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein)	RNF7 RBX2 ROC2 SAG	Homo sapiens (Human)	113	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0031461; GO:0031466; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0097602	post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN12351_c0_g1_i1	Q9WTZ1	RBX2_MOUSE	99.1	113	1	0	379	41	1	113	1.40E-65	250	RBX2_MOUSE	reviewed	RING-box protein 2 (Rbx2) (RING finger protein 7) (Sensitive to apoptosis gene protein)	Rnf7 Rbx2 Sag	Mus musculus (Mouse)	113	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; cerebral cortex radially oriented cell migration [GO:0021799]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006919; GO:0008270; GO:0008631; GO:0008637; GO:0016567; GO:0021799; GO:0021942; GO:0031461; GO:0031466; GO:0043066; GO:0045116; GO:0061630; GO:0061663; GO:0097602	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; cerebral cortex radially oriented cell migration [GO:0021799]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1733_c0_g1_i1	O13959	RBX1_SCHPO	59.3	86	32	1	309	61	15	100	7.40E-29	127.9	RBX1_SCHPO	reviewed	RING-box protein pip1 (RING-box protein 1) (Pop-interacting protein 1)	pip1 SPAC23H4.18c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	107	CLRC complex [GO:0043494]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; heterochromatin assembly [GO:0031507]; histone H3-K14 ubiquitination [GO:0140373]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	CLRC complex [GO:0043494]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]	cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0031146; GO:0031461; GO:0031507; GO:0043224; GO:0043494; GO:0061630; GO:0097602; GO:0140373	heterochromatin assembly [GO:0031507]; histone H3-K14 ubiquitination [GO:0140373]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21392_c1_g1_i1	Q13356	PPIL2_HUMAN	100	94	0	0	284	3	284	377	3.60E-53	208.4	PPIL2_HUMAN	reviewed	RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2)	PPIL2	Homo sapiens (Human)	520	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0050900; GO:0061630; GO:0072659	leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN3556_c0_g1_i1	Q13356	PPIL2_HUMAN	53.2	528	231	8	1675	116	1	520	3.40E-149	530	PPIL2_HUMAN	reviewed	RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2)	PPIL2	Homo sapiens (Human)	520	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0050900; GO:0061630; GO:0072659	leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN3556_c0_g1_i2	Q13356	PPIL2_HUMAN	53.2	528	231	8	1653	94	1	520	3.30E-149	530	PPIL2_HUMAN	reviewed	RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2)	PPIL2	Homo sapiens (Human)	520	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0050900; GO:0061630; GO:0072659	leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN35850_c0_g1_i1	Q9D787	PPIL2_MOUSE	100	93	0	0	2	280	240	332	1.40E-49	196.4	PPIL2_MOUSE	reviewed	RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase)	Ppil2	Mus musculus (Mouse)	521	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0003755; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0072659	protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN38768_c0_g1_i1	Q9D787	PPIL2_MOUSE	100	74	0	0	223	2	114	187	6.90E-36	150.6	PPIL2_MOUSE	reviewed	RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase)	Ppil2	Mus musculus (Mouse)	521	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0003755; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0072659	protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN738_c0_g1_i1	Q7SXR1	TRBP2_DANRE	49.3	73	37	0	350	132	139	211	1.70E-12	73.9	TRBP2_DANRE	reviewed	RISC-loading complex subunit tarbp2	tarbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	346	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]	GO:0003725; GO:0005737; GO:0006417; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0035197; GO:0035198; GO:0035280; GO:0042803; GO:0046782; GO:0070578; GO:0070883; GO:0090065; GO:1903798	miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]		NA	NA	NA	NA	NA	NA
TRINITY_DN738_c0_g1_i2	Q7SXR1	TRBP2_DANRE	42	205	105	3	675	100	139	342	1.00E-33	145.2	TRBP2_DANRE	reviewed	RISC-loading complex subunit tarbp2	tarbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	346	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]	GO:0003725; GO:0005737; GO:0006417; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0035197; GO:0035198; GO:0035280; GO:0042803; GO:0046782; GO:0070578; GO:0070883; GO:0090065; GO:1903798	miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]		NA	NA	NA	NA	NA	NA
TRINITY_DN738_c0_g1_i3	Q7SXR1	TRBP2_DANRE	40.5	215	114	3	735	100	139	342	7.50E-35	149.1	TRBP2_DANRE	reviewed	RISC-loading complex subunit tarbp2	tarbp2	Danio rerio (Zebrafish) (Brachydanio rerio)	346	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]	cytoplasm [GO:0005737]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]	GO:0003725; GO:0005737; GO:0006417; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0035197; GO:0035198; GO:0035280; GO:0042803; GO:0046782; GO:0070578; GO:0070883; GO:0090065; GO:1903798	miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of translation [GO:0006417]; regulation of viral transcription [GO:0046782]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]		NA	NA	NA	NA	NA	NA
TRINITY_DN38810_c0_g1_i1	Q4R3J0	RTCA_MACFA	49.5	333	161	3	1002	19	32	362	1.60E-87	324.3	RTCA_MACFA	reviewed	RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1)	RTCA RTCD1 QtsA-16663	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	366	nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963]	GO:0003963; GO:0005524; GO:0005654; GO:0006396	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN40586_c0_g1_i1	Q2KHX8	RCL1_BOVIN	65.7	67	23	0	21	221	7	73	7.00E-20	97.4	RCL1_BOVIN	reviewed	RNA 3'-terminal phosphate cyclase-like protein	RCL1	Bos taurus (Bovine)	373	"nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]"	nucleolus [GO:0005730]	endoribonuclease activity [GO:0004521]	GO:0000479; GO:0004521; GO:0005730	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23193_c0_g1_i1	Q9Y2P8	RCL1_HUMAN	100	103	0	0	311	3	260	362	4.60E-54	211.5	RCL1_HUMAN	reviewed	RNA 3'-terminal phosphate cyclase-like protein	RCL1 RNAC RPC2 RPCL1 RTC2 HSPC338	Homo sapiens (Human)	373	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	endoribonuclease activity [GO:0004521]	GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730; GO:0006364	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23193_c0_g1_i2	Q2KHX8	RCL1_BOVIN	98.2	114	2	0	344	3	249	362	1.80E-59	229.6	RCL1_BOVIN	reviewed	RNA 3'-terminal phosphate cyclase-like protein	RCL1	Bos taurus (Bovine)	373	"nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]"	nucleolus [GO:0005730]	endoribonuclease activity [GO:0004521]	GO:0000479; GO:0004521; GO:0005730	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38873_c0_g1_i1	Q9JJT0	RCL1_MOUSE	100	74	0	0	6	227	1	74	3.50E-35	148.3	RCL1_MOUSE	reviewed	RNA 3'-terminal phosphate cyclase-like protein	Rcl1 Rnac	Mus musculus (Mouse)	373	"nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]"	nucleolus [GO:0005730]	endoribonuclease activity [GO:0004521]	GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005730; GO:0006364	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8876_c0_g1_i1	Q9JJT0	RCL1_MOUSE	52.5	381	157	7	1228	104	8	370	1.00E-105	385.2	RCL1_MOUSE	reviewed	RNA 3'-terminal phosphate cyclase-like protein	Rcl1 Rnac	Mus musculus (Mouse)	373	"nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]"	nucleolus [GO:0005730]	endoribonuclease activity [GO:0004521]	GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005730; GO:0006364	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5044_c0_g1_i1	Q9NWB1	RFOX1_HUMAN	87.5	88	11	0	213	476	112	199	4.60E-37	156.4	RFOX1_HUMAN	reviewed	RNA binding protein fox-1 homolog 1 (Ataxin-2-binding protein 1) (Fox-1 homolog A) (Hexaribonucleotide-binding protein 1)	RBFOX1 A2BP A2BP1 FOX1 HRNBP1	Homo sapiens (Human)	397	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear stress granule [GO:0097165]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; mRNA binding [GO:0003729]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear stress granule [GO:0097165]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	mRNA binding [GO:0003729]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005802; GO:0006397; GO:0007399; GO:0008022; GO:0008380; GO:0010494; GO:0050658; GO:0097165	"mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5044_c0_g1_i2	Q7ZT82	RFX1L_DANRE	84	94	15	0	241	522	143	236	6.00E-38	158.7	RFX1L_DANRE	reviewed	RNA binding protein fox-1 homolog 1-like (Ataxin 2-binding protein 1-like) (Fox-1 homolog-like protein 1)	rbfox1l a2bp1l fox1 fox1l si:ch211-57k11.1	Danio rerio (Zebrafish) (Brachydanio rerio)	382	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cardiac muscle fiber development [GO:0048739]; heart process [GO:0003015]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; skeletal muscle fiber development [GO:0048741]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003015; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0043484; GO:0048739; GO:0048741	"cardiac muscle fiber development [GO:0048739]; heart process [GO:0003015]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; skeletal muscle fiber development [GO:0048741]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5044_c0_g1_i3	Q7ZT82	RFX1L_DANRE	84.4	96	15	0	216	503	143	238	1.80E-38	161	RFX1L_DANRE	reviewed	RNA binding protein fox-1 homolog 1-like (Ataxin 2-binding protein 1-like) (Fox-1 homolog-like protein 1)	rbfox1l a2bp1l fox1 fox1l si:ch211-57k11.1	Danio rerio (Zebrafish) (Brachydanio rerio)	382	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cardiac muscle fiber development [GO:0048739]; heart process [GO:0003015]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; skeletal muscle fiber development [GO:0048741]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003015; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0043484; GO:0048739; GO:0048741	"cardiac muscle fiber development [GO:0048739]; heart process [GO:0003015]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; skeletal muscle fiber development [GO:0048741]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39621_c0_g1_i1	P87115	NAT10_SCHPO	65	180	63	0	3	542	256	435	5.10E-64	245.4	NAT10_SCHPO	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase)	nat10 SPAC20G8.09c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1033	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; tRNA N-acetyltransferase activity [GO:0051392]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; tRNA N-acetyltransferase activity [GO:0051392]	GO:0000049; GO:0005524; GO:0005634; GO:0005730; GO:0030686; GO:0051391; GO:0051392; GO:1904812; GO:1990883	rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN40578_c0_g1_i1	Q55EJ3	NAT10_DICDI	63.4	82	27	1	239	3	491	572	8.60E-24	110.5	NAT10_DICDI	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase)	nat10 DDB_G0268868	Dictyostelium discoideum (Slime mold)	1057	nucleolus [GO:0005730]; ATP binding [GO:0005524]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0005524; GO:0005730; GO:0051391; GO:1904812; GO:1990883	rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN15111_c0_g1_i1	P53914	NAT10_YEAST	78.9	71	15	0	215	3	98	168	3.10E-25	115.2	NAT10_YEAST	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (Killer toxin-resistance protein 33) (Ribosomal RNA cytidine acetyltransferase 1)	KRE33 NAT10 RRA1 YNL132W N1216 N1858	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1056	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; snoRNA binding [GO:0030515]; tRNA binding [GO:0000049]; mRNA modification [GO:0016556]; ribosomal small subunit biogenesis [GO:0042274]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]"	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; snoRNA binding [GO:0030515]; tRNA binding [GO:0000049]	GO:0000049; GO:0005524; GO:0005730; GO:0016556; GO:0030515; GO:0030686; GO:0030688; GO:0042274; GO:0051391; GO:1904812; GO:1990883	mRNA modification [GO:0016556]; ribosomal small subunit biogenesis [GO:0042274]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN30083_c0_g1_i1	Q8K224	NAT10_MOUSE	58.6	249	100	2	3	743	355	602	1.30E-73	277.7	NAT10_MOUSE	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	Nat10 Kiaa1709	Mus musculus (Mouse)	1024	midbody [GO:0030496]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]	midbody [GO:0030496]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0005524; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN3582_c0_g2_i1	Q8K224	NAT10_MOUSE	52.1	933	431	8	3	2765	73	1001	9.80E-260	897.9	NAT10_MOUSE	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	Nat10 Kiaa1709	Mus musculus (Mouse)	1024	midbody [GO:0030496]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]	midbody [GO:0030496]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0005524; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN33621_c0_g1_i1	Q9H0A0	NAT10_HUMAN	100	171	0	0	516	4	82	252	1.70E-93	343.2	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN20948_c0_g1_i1	Q9H0A0	NAT10_HUMAN	65.1	126	43	1	379	2	235	359	2.60E-38	159.5	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN20948_c0_g2_i1	Q9H0A0	NAT10_HUMAN	54	100	46	0	4	303	80	179	8.00E-27	120.9	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN34673_c0_g1_i1	Q9H0A0	NAT10_HUMAN	60	60	24	0	4	183	698	757	9.80E-16	83.6	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN28541_c0_g1_i1	Q9H0A0	NAT10_HUMAN	100	80	0	0	242	3	362	441	4.40E-36	151.4	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN39938_c0_g1_i1	Q9H0A0	NAT10_HUMAN	99.3	145	1	0	2	436	488	632	3.10E-80	298.9	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN39388_c0_g1_i1	Q9H0A0	NAT10_HUMAN	100	90	0	0	1	270	259	348	2.10E-42	172.6	NAT10_HUMAN	reviewed	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	NAT10 ALP KIAA1709	Homo sapiens (Human)	1025	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]		NA	NA	NA	NA	NA	NA
TRINITY_DN29213_c0_g1_i1	Q1HFZ0	NSUN2_MOUSE	100	94	0	0	282	1	105	198	3.10E-49	195.3	NSUN2_MOUSE	reviewed	RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)	Nsun2 D13Wsu123e Misu	Mus musculus (Mouse)	757	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]	methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0007286; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:0080009; GO:2000736	cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN27243_c0_g1_i1	Q1HFZ0	NSUN2_MOUSE	100	101	0	0	305	3	269	369	5.00E-53	208	NSUN2_MOUSE	reviewed	RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)	Nsun2 D13Wsu123e Misu	Mus musculus (Mouse)	757	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]	methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0007286; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:0080009; GO:2000736	cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN32684_c0_g1_i1	Q08J23	NSUN2_HUMAN	99.4	334	2	0	2	1003	109	442	1.90E-200	699.5	NSUN2_HUMAN	reviewed	RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203) (tRNA methyltransferase 4 homolog) (hTrm4)	NSUN2 SAKI TRM4	Homo sapiens (Human)	767	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006400; GO:0007286; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:0080009; GO:2000736	cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN33353_c0_g1_i1	Q5ZLV4	NSUN2_CHICK	44.4	171	76	3	18	473	177	347	1.20E-37	157.5	NSUN2_CHICK	reviewed	RNA cytosine-C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)	NSUN2 RCJMB04_4l11	Gallus gallus (Chicken)	796	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]	methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0036416; GO:0062152; GO:0070062; GO:0080009; GO:2000736	mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN27321_c0_g1_i2	Q8N1G1	REXO1_HUMAN	61.6	146	56	0	479	42	1073	1218	3.10E-49	196.1	REXO1_HUMAN	reviewed	RNA exonuclease 1 homolog (EC 3.1.-.-) (Elongin-A-binding protein 1) (EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1)	REXO1 ELOABP1 KIAA1138 TCEB3BP1	Homo sapiens (Human)	1221	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604			NA	NA	NA	NA	NA	NA
TRINITY_DN11320_c0_g1_i1	Q7TT28	REXO1_MOUSE	38.1	252	140	6	486	1211	965	1210	1.50E-37	158.7	REXO1_MOUSE	reviewed	RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1)	Rexo1 Kiaa1138 Tceb3bp1	Mus musculus (Mouse)	1213	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604			NA	NA	NA	NA	NA	NA
TRINITY_DN27321_c0_g1_i1	Q7TT28	REXO1_MOUSE	61.9	84	32	0	270	19	1065	1148	1.80E-22	106.3	REXO1_MOUSE	reviewed	RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1)	Rexo1 Kiaa1138 Tceb3bp1	Mus musculus (Mouse)	1213	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604			NA	NA	NA	NA	NA	NA
TRINITY_DN28786_c0_g1_i1	Q757I9	REXO4_ASHGO	63.8	58	21	0	187	14	114	171	2.00E-14	79.3	REXO4_ASHGO	reviewed	RNA exonuclease 4 (EC 3.1.-.-)	REX4 AER024W	Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)	285	nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0006364; GO:0008408	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1895_c0_g2_i1	Q6PAQ4	REXO4_MOUSE	54.7	53	24	0	321	163	366	418	5.60E-10	65.1	REXO4_MOUSE	reviewed	RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog)	Rexo4 Gm111 Pmc2 Xpmc2h	Mus musculus (Mouse)	432	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; rRNA processing [GO:0006364]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]	GO:0000726; GO:0000737; GO:0000738; GO:0003690; GO:0003697; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0008408; GO:0016607	"DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35549_c0_g1_i1	Q9GZR2	REXO4_HUMAN	100	71	0	0	2	214	246	316	2.20E-34	145.6	REXO4_HUMAN	reviewed	RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2)	REXO4 PMC2 XPMC2H	Homo sapiens (Human)	422	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0000726; GO:0000737; GO:0000738; GO:0003690; GO:0003697; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006364; GO:0008408; GO:0016607	"DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1895_c0_g1_i1	Q91560	REXO4_XENLA	46.2	186	93	4	543	1	133	316	7.10E-29	129	REXO4_XENLA	reviewed	RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein)	rexo4 xpmc2	Xenopus laevis (African clawed frog)	421	nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634; GO:0006364; GO:0008408	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN3351_c0_g1_i1	Q96IC2	REXO5_HUMAN	50.4	123	59	1	1	369	261	381	1.40E-25	118.6	REXO5_HUMAN	reviewed	RNA exonuclease 5 (EC 3.1.-.-) (Exonuclease NEF-sp)	REXO5 44M2.3	Homo sapiens (Human)	774	extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]	exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	GO:0003723; GO:0004527; GO:0005634; GO:0005730; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN33793_c0_g1_i1	O60306	AQR_HUMAN	44.1	195	106	3	597	19	14	207	4.10E-39	162.9	AQR_HUMAN	reviewed	RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160)	AQR KIAA0560	Homo sapiens (Human)	1485	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0006283; GO:0016020; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN956_c0_g1_i3	Q9BXT6	M10L1_HUMAN	48.6	498	245	6	2995	4461	681	1176	4.70E-123	444.5	M10L1_HUMAN	reviewed	RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1)	MOV10L1	Homo sapiens (Human)	1211	cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007275; GO:0007281; GO:0007283; GO:0034587; GO:0035194; GO:0043046; GO:0043186; GO:0071546	DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN40695_c0_g1_i1	Q86W50	MET16_HUMAN	100	74	0	0	2	223	52	125	9.60E-38	156.8	MET16_HUMAN	reviewed	RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346)	METTL16 METT10D	Homo sapiens (Human)	562	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]	GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049; GO:1905869	"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9333_c0_g1_i1	Q5ZIA0	MET16_CHICK	32.8	204	122	4	659	93	179	382	3.00E-21	103.6	MET16_CHICK	reviewed	RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346)	METTL16 METT10D RCJMB04_28o5	Gallus gallus (Chicken)	558	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]	GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049	"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9333_c0_g2_i1	Q6GR37	MET16_XENLA	48	179	81	2	772	239	3	170	2.20E-40	167.5	MET16_XENLA	reviewed	RNA N6-adenosine-methyltransferase mettl16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346)	mettl16 mett10d	Xenopus laevis (African clawed frog)	547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]	GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0061157; GO:0080009; GO:0120048; GO:0120049	"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"		NA	NA	NA	NA	NA	NA
TRINITY_DN708_c0_g1_i1	O00472	ELL2_HUMAN	29.6	253	140	8	31	768	30	251	5.40E-19	96.3	ELL2_HUMAN	reviewed	RNA polymerase II elongation factor ELL2	ELL2	Homo sapiens (Human)	640	nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368]	nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]		GO:0005654; GO:0006368; GO:0008023; GO:0042795	snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN35733_c0_g1_i1	Q7TSG2	CTDP1_MOUSE	57.4	47	20	0	442	302	672	718	2.70E-10	66.6	CTDP1_MOUSE	reviewed	RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase)	Ctdp1 Fcp1	Mus musculus (Mouse)	960	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]	RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]	GO:0000922; GO:0001096; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0051233; GO:0051301; GO:0061052; GO:0070940	cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN8208_c0_g1_i1	Q9CY97	SSU72_MOUSE	100	119	0	0	3	359	76	194	3.00E-66	252.3	SSU72_MOUSE	reviewed	RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16)	Ssu72	Mus musculus (Mouse)	194	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0005654; GO:0005829; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]		NA	NA	NA	NA	NA	NA
TRINITY_DN8208_c0_g1_i2	Q9NP77	SSU72_HUMAN	100	143	0	0	3	431	52	194	6.40E-81	301.2	SSU72_HUMAN	reviewed	RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16)	SSU72 HSPC182 PNAS-120	Homo sapiens (Human)	194	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0005654; GO:0005829; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]		NA	NA	NA	NA	NA	NA
TRINITY_DN7138_c0_g1_i1	Q17QI2	SSU72_BOVIN	73	115	31	0	422	78	48	162	1.80E-45	183.3	SSU72_BOVIN	reviewed	RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16)	SSU72	Bos taurus (Bovine)	194	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0005829; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]		NA	NA	NA	NA	NA	NA
TRINITY_DN7138_c0_g1_i2	Q17QI2	SSU72_BOVIN	70.1	147	44	0	541	101	48	194	1.70E-56	220.3	SSU72_BOVIN	reviewed	RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16)	SSU72	Bos taurus (Bovine)	194	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0005829; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]		blue	blue	NA	NA	NA	NA
TRINITY_DN1996_c0_g1_i11	Q3T1I9	RPAP1_RAT	31.7	726	435	15	15	2108	321	1013	6.90E-82	307	RPAP1_RAT	reviewed	RNA polymerase II-associated protein 1	Rpap1	Rattus norvegicus (Rat)	1400	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1996_c0_g1_i5	Q3T1I9	RPAP1_RAT	29.5	1058	665	24	15	3092	321	1329	2.00E-99	365.5	RPAP1_RAT	reviewed	RNA polymerase II-associated protein 1	Rpap1	Rattus norvegicus (Rat)	1400	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1996_c0_g1_i6	Q3T1I9	RPAP1_RAT	31.7	726	435	15	15	2108	321	1013	6.90E-82	307	RPAP1_RAT	reviewed	RNA polymerase II-associated protein 1	Rpap1	Rattus norvegicus (Rat)	1400	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1996_c0_g1_i7	Q3T1I9	RPAP1_RAT	29.6	1058	664	24	15	3092	321	1329	8.80E-100	366.7	RPAP1_RAT	reviewed	RNA polymerase II-associated protein 1	Rpap1	Rattus norvegicus (Rat)	1400	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN1996_c0_g1_i8	Q3T1I9	RPAP1_RAT	29.5	985	615	23	15	2873	321	1258	1.20E-90	336.3	RPAP1_RAT	reviewed	RNA polymerase II-associated protein 1	Rpap1	Rattus norvegicus (Rat)	1400	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006366	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN26494_c0_g1_i1	B2RS91	RRN3_MOUSE	43.5	260	138	5	904	146	344	601	4.50E-49	196.4	RRN3_MOUSE	reviewed	RNA polymerase I-specific transcription initiation factor RRN3	Rrn3	Mus musculus (Mouse)	656	"nucleolus [GO:0005730]; RNA polymerase binding [GO:0070063]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; DNA-templated transcription, initiation [GO:0006352]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	nucleolus [GO:0005730]	RNA polymerase binding [GO:0070063]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]	GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005730; GO:0006352; GO:0006361; GO:0007000; GO:0007028; GO:0008283; GO:0010976; GO:0042254; GO:0045893; GO:0048872; GO:0070063; GO:1902254; GO:2000142	"cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; DNA-templated transcription, initiation [GO:0006352]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35556_c0_g1_i1	Q9NYV6	RRN3_HUMAN	100	88	0	0	3	266	477	564	2.60E-45	182.2	RRN3_HUMAN	reviewed	RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA)	RRN3 TIFIA	Homo sapiens (Human)	651	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]	GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0008283; GO:0010976; GO:0042254; GO:0045893; GO:0048872; GO:1902254; GO:2000142	"cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39751_c0_g1_i1	Q6PD62	CTR9_HUMAN	100	94	0	0	284	3	598	691	1.20E-48	193.4	CTR9_HUMAN	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	CTR9 KIAA0155 SH2BP1	Homo sapiens (Human)	1173	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]	GO:0000122; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005654; GO:0006355; GO:0006366; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0035327; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:1900364; GO:2000653; GO:2001162; GO:2001168	"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4864_c0_g1_i1	Q6PD62	CTR9_HUMAN	70.7	174	51	0	609	88	4	177	7.70E-65	248.4	CTR9_HUMAN	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	CTR9 KIAA0155 SH2BP1	Homo sapiens (Human)	1173	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]	GO:0000122; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005654; GO:0006355; GO:0006366; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0035327; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:1900364; GO:2000653; GO:2001162; GO:2001168	"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4864_c0_g1_i2	Q6PD62	CTR9_HUMAN	73.5	204	54	0	612	1	4	207	1.10E-82	307.8	CTR9_HUMAN	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	CTR9 KIAA0155 SH2BP1	Homo sapiens (Human)	1173	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]	GO:0000122; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005654; GO:0006355; GO:0006366; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0035327; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:1900364; GO:2000653; GO:2001162; GO:2001168	"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38412_c0_g1_i1	Q6PD62	CTR9_HUMAN	98.9	94	1	0	282	1	649	742	2.90E-47	188.7	CTR9_HUMAN	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	CTR9 KIAA0155 SH2BP1	Homo sapiens (Human)	1173	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]	GO:0000122; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005654; GO:0006355; GO:0006366; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0035327; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:1900364; GO:2000653; GO:2001162; GO:2001168	"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7184_c0_g1_i1	Q6DEU9	CTR9_XENTR	69.2	52	16	0	58	213	791	842	1.70E-13	77.4	CTR9_XENTR	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	ctr9 sh2bp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1172	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0001711; GO:0006355; GO:0006368; GO:0016593; GO:0016607; GO:0019827; GO:0035327; GO:0045638; GO:0051569; GO:0051571; GO:0080182; GO:2001162	"endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7184_c0_g1_i2	Q6DEU9	CTR9_XENTR	69.4	412	126	0	1	1236	431	842	1.30E-170	600.9	CTR9_XENTR	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	ctr9 sh2bp1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1172	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0001711; GO:0006355; GO:0006368; GO:0016593; GO:0016607; GO:0019827; GO:0035327; GO:0045638; GO:0051569; GO:0051571; GO:0080182; GO:2001162	"endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7184_c0_g1_i3	Q6PD62	CTR9_HUMAN	69.6	312	95	0	1	936	431	742	3.60E-132	472.6	CTR9_HUMAN	reviewed	RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1)	CTR9 KIAA0155 SH2BP1	Homo sapiens (Human)	1173	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]	GO:0000122; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005654; GO:0006355; GO:0006366; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0035327; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:1900364; GO:2000653; GO:2001162; GO:2001168	"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26523_c0_g1_i1	Q62018	CTR9_MOUSE	100	131	0	0	1	393	489	619	4.60E-75	281.6	CTR9_MOUSE	reviewed	"RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1) (Tetratricopeptide repeat-containing, SH2-binding phosphoprotein of 150 kDa) (TPR-containing, SH2-binding phosphoprotein of 150 kDa) (p150TSP)"	Ctr9 Kiaa0155 Sh2bp1	Mus musculus (Mouse)	1173	"Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"	Cdc73/Paf1 complex [GO:0016593]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]	GO:0000122; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005634; GO:0005654; GO:0006355; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0035327; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:1900364; GO:2000653; GO:2001162; GO:2001168	"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26886_c0_g1_i1	Q8WVC0	LEO1_HUMAN	98.3	117	2	0	354	4	393	509	5.80E-61	234.6	LEO1_HUMAN	reviewed	RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein)	LEO1 RDL	Homo sapiens (Human)	666	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; beta-catenin-TCF complex assembly [GO:1904837]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0001650; GO:0001711; GO:0005634; GO:0005654; GO:0005813; GO:0006366; GO:0006368; GO:0006378; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0031442; GO:0032968; GO:0033523; GO:0045638; GO:1904837; GO:1990269	beta-catenin-TCF complex assembly [GO:1904837]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN3190_c0_g1_i1	Q8WVC0	LEO1_HUMAN	66.2	269	86	3	86	883	354	620	3.40E-94	346.3	LEO1_HUMAN	reviewed	RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein)	LEO1 RDL	Homo sapiens (Human)	666	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; beta-catenin-TCF complex assembly [GO:1904837]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0001650; GO:0001711; GO:0005634; GO:0005654; GO:0005813; GO:0006366; GO:0006368; GO:0006378; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0031442; GO:0032968; GO:0033523; GO:0045638; GO:1904837; GO:1990269	beta-catenin-TCF complex assembly [GO:1904837]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN949_c0_g2_i1	Q9W261	RTF1_DROME	57.6	257	108	1	88	858	424	679	4.90E-78	293.1	RTF1_DROME	reviewed	RNA polymerase-associated protein Rtf1 (dRtf1)	Rtf1 CG10955	Drosophila melanogaster (Fruit fly)	775	"Cdc73/Paf1 complex [GO:0016593]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; Notch signaling pathway [GO:0007219]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	Cdc73/Paf1 complex [GO:0016593]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	DNA binding [GO:0003677]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0000785; GO:0003677; GO:0005634; GO:0007219; GO:0016593; GO:0035327; GO:0045893; GO:0045944; GO:0051571; GO:1905437; GO:1990269	"Notch signaling pathway [GO:0007219]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN949_c0_g2_i2	Q9W261	RTF1_DROME	57.6	257	108	1	88	858	424	679	5.00E-78	293.1	RTF1_DROME	reviewed	RNA polymerase-associated protein Rtf1 (dRtf1)	Rtf1 CG10955	Drosophila melanogaster (Fruit fly)	775	"Cdc73/Paf1 complex [GO:0016593]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; Notch signaling pathway [GO:0007219]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	Cdc73/Paf1 complex [GO:0016593]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	DNA binding [GO:0003677]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0000785; GO:0003677; GO:0005634; GO:0007219; GO:0016593; GO:0035327; GO:0045893; GO:0045944; GO:0051571; GO:1905437; GO:1990269	"Notch signaling pathway [GO:0007219]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12552_c0_g1_i1	Q8VCZ8	RUSD1_MOUSE	43.7	229	125	3	1003	326	3	230	1.50E-44	181.8	RUSD1_MOUSE	reviewed	RNA pseudouridylate synthase domain-containing protein 1 (Ribosomal large subunit pseudouridine synthase C-like protein)	Rpusd1 Rlucl	Mus musculus (Mouse)	306	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]		pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000455; GO:0003723; GO:0009982	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]		NA	NA	NA	NA	NA	NA
TRINITY_DN27546_c0_g1_i1	Q9CQE8	RTRAF_MOUSE	47.1	210	107	2	633	4	1	206	1.10E-49	198	RTRAF_MOUSE	reviewed	"RNA transcription, translation and transport factor protein"	RTRAF	Mus musculus (Mouse)	244	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006469; GO:0042802; GO:0045944; GO:0048471; GO:0072669; GO:0072686	"negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		blue	blue	NA	NA	NA	NA
TRINITY_DN27300_c0_g1_i1	Q9Y224	RTRAF_HUMAN	100	69	0	0	3	209	9	77	2.40E-38	158.7	RTRAF_HUMAN	reviewed	"RNA transcription, translation and transport factor protein (CLE7 homolog) (CLE) (hCLE)"	RTRAF C14orf166 CGI-99	Homo sapiens (Human)	244	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA transport [GO:0050658]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006469; GO:0016032; GO:0042802; GO:0045944; GO:0048471; GO:0050658; GO:0072669; GO:0072686	"negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA transport [GO:0050658]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39337_c0_g1_i1	O75319	DUS11_HUMAN	60.3	73	29	0	1	219	158	230	1.20E-21	103.2	DUS11_HUMAN	reviewed	RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1)	DUSP11 PIR1	Homo sapiens (Human)	377	"fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]"	fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]"	GO:0001650; GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0005654; GO:0006396; GO:0006470; GO:0008138; GO:0016070; GO:0016607; GO:0016791; GO:0045171; GO:0098507; GO:0098519	polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN35099_c0_g1_i1	Q5U5Q3	MEX3C_HUMAN	100	92	0	0	279	4	283	374	1.20E-45	183.3	MEX3C_HUMAN	reviewed	RNA-binding E3 ubiquitin-protein ligase MEX3C (EC 2.3.2.27) (RING finger and KH domain-containing protein 2) (RING finger protein 194) (RING-type E3 ubiquitin transferase MEX3C)	MEX3C RKHD2 RNF194 BM-013	Homo sapiens (Human)	659	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0003415; GO:0003723; GO:0005634; GO:0005737; GO:0045598; GO:0046872; GO:0061630; GO:0097009	chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598]		NA	NA	NA	NA	NA	NA
TRINITY_DN37923_c0_g1_i1	P38159	RBMX_HUMAN	100	87	0	0	3	263	7	93	9.10E-43	173.7	RBMX_HUMAN	reviewed	"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]"	RBMX HNRPG RBMXP1	Homo sapiens (Human)	391	"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA metabolic process [GO:0016070]; transcription by RNA polymerase II [GO:0006366]"	catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000381; GO:0000398; GO:0000978; GO:0001649; GO:0003682; GO:0003723; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0005719; GO:0006366; GO:0006509; GO:0016020; GO:0016070; GO:0019904; GO:0032991; GO:0042802; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347; GO:1990904	"cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA metabolic process [GO:0016070]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28926_c0_g1_i1	Q9Y388	RBMX2_HUMAN	85.1	74	11	0	225	4	32	105	1.90E-33	142.5	RBMX2_HUMAN	reviewed	"RNA-binding motif protein, X-linked 2"	RBMX2 CGI-79	Homo sapiens (Human)	322	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005686; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24236_c0_g1_i1	Q3ZBP3	RBMS1_BOVIN	100	149	0	0	1	447	74	222	3.20E-80	298.9	RBMS1_BOVIN	reviewed	"RNA-binding motif, single-stranded-interacting protein 1"	RBMS1	Bos taurus (Bovine)	403	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; DNA replication [GO:0006260]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006260; GO:0008143; GO:0008266; GO:1990904	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN24236_c0_g1_i2	Q91W59	RBMS1_MOUSE	98.8	170	2	0	50	559	53	222	3.10E-93	342.4	RBMS1_MOUSE	reviewed	"RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1)"	Rbms1 Mssp Mssp1	Mus musculus (Mouse)	403	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; DNA replication [GO:0006260]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006260; GO:0008143; GO:0008266; GO:1990904	DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN378_c0_g1_i1	P98175	RBM10_HUMAN	52.2	67	32	0	357	157	128	194	4.60E-13	75.9	RBM10_HUMAN	reviewed	RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1)	RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122	Homo sapiens (Human)	930	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0000122; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0008285; GO:0016607; GO:0032991; GO:0034393; GO:0035198; GO:0042802; GO:0046872; GO:0048025; GO:0070935	"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1656_c0_g1_i1	P98175	RBM10_HUMAN	44.4	302	139	11	992	117	646	928	2.30E-49	197.6	RBM10_HUMAN	reviewed	RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1)	RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122	Homo sapiens (Human)	930	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0000122; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0008285; GO:0016607; GO:0032991; GO:0034393; GO:0035198; GO:0042802; GO:0046872; GO:0048025; GO:0070935	"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN41107_c0_g1_i1	Q5EA36	RBM14_BOVIN	97.2	71	2	0	3	215	68	138	5.30E-33	141	RBM14_BOVIN	reviewed	RNA-binding protein 14 (RNA-binding motif protein 14)	RBM14	Bos taurus (Bovine)	669	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; centriole assembly [GO:0098534]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0045087; GO:0098534	centriole assembly [GO:0098534]; innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN8608_c0_g1_i1	Q5EA36	RBM14_BOVIN	41.6	154	80	4	566	1021	2	147	1.60E-19	98.6	RBM14_BOVIN	reviewed	RNA-binding protein 14 (RNA-binding motif protein 14)	RBM14	Bos taurus (Bovine)	669	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; centriole assembly [GO:0098534]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0045087; GO:0098534	centriole assembly [GO:0098534]; innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN30359_c0_g1_i1	Q9BX46	RBM24_HUMAN	85.1	67	10	0	204	4	11	77	6.40E-28	124	RBM24_HUMAN	reviewed	RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding region-containing protein 6)	RBM24 RNPC6	Homo sapiens (Human)	236	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; sequence-specific mRNA binding [GO:1990825]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; endocardial cushion development [GO:0003197]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; RNA splicing [GO:0008380]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; sequence-specific mRNA binding [GO:1990825]	GO:0000381; GO:0003197; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0006974; GO:0008380; GO:0010830; GO:0010831; GO:0030154; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0061157; GO:0061158; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; endocardial cushion development [GO:0003197]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30992_c0_g1_i1	P49756	RBM25_HUMAN	100	109	0	0	2	328	83	191	6.80E-56	217.6	RBM25_HUMAN	reviewed	RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)	RBM25 RNPC7	Homo sapiens (Human)	843	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4417_c0_g1_i3	P49756	RBM25_HUMAN	43	207	112	4	742	125	84	285	8.40E-34	145.6	RBM25_HUMAN	reviewed	RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)	RBM25 RNPC7	Homo sapiens (Human)	843	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4417_c0_g1_i4	P49756	RBM25_HUMAN	42.3	213	117	4	677	42	84	291	5.90E-34	146	RBM25_HUMAN	reviewed	RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)	RBM25 RNPC7	Homo sapiens (Human)	843	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4417_c0_g1_i6	P49756	RBM25_HUMAN	42.7	211	115	4	757	128	84	289	6.50E-34	146	RBM25_HUMAN	reviewed	RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)	RBM25 RNPC7	Homo sapiens (Human)	843	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36543_c0_g1_i1	B2RY56	RBM25_MOUSE	100	108	0	0	325	2	73	180	1.50E-55	216.5	RBM25_MOUSE	reviewed	RNA-binding protein 25 (RNA-binding motif protein 25)	Rbm25	Mus musculus (Mouse)	838	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005737; GO:0006397; GO:0006915; GO:0008380; GO:0016607; GO:0042981	"apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33209_c0_g1_i1	Q2T9I5	RBM26_XENLA	70.5	44	11	1	167	42	330	373	1.20E-12	73.9	RBM26_XENLA	reviewed	RNA-binding protein 26 (RNA-binding motif protein 26)	rbm26	Xenopus laevis (African clawed frog)	1059	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]		metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0010923; GO:0046872	mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]		NA	NA	NA	NA	NA	NA
TRINITY_DN7421_c0_g1_i1	Q9NW13	RBM28_HUMAN	44.6	267	145	2	799	5	330	595	8.90E-53	208.8	RBM28_HUMAN	reviewed	RNA-binding protein 28 (RNA-binding motif protein 28)	RBM28	Homo sapiens (Human)	759	nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN36541_c0_g1_i1	O89086	RBM3_MOUSE	100	70	0	0	210	1	8	77	2.70E-34	145.2	RBM3_MOUSE	reviewed	RNA-binding protein 3 (RNA-binding motif protein 3)	Rbm3	Mus musculus (Mouse)	153	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of translation [GO:0006417]; response to cold [GO:0009409]; translation [GO:0006412]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006412; GO:0006417; GO:0009409; GO:0030425; GO:0035196; GO:0043023; GO:0045727; GO:0048026	"positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of translation [GO:0006417]; response to cold [GO:0009409]; translation [GO:0006412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20786_c0_g1_i1	Q14498	RBM39_HUMAN	100	200	0	0	1	600	129	328	7.40E-109	394.4	RBM39_HUMAN	reviewed	RNA-binding protein 39 (CAPER alpha) (CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1)	RBM39 HCC1 RNPC2	Homo sapiens (Human)	530	"centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0003723; GO:0005654; GO:0006396; GO:0006397; GO:0008380; GO:0015630; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733	"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20786_c0_g2_i1	Q14498	RBM39_HUMAN	100	115	0	0	377	33	416	530	1.90E-62	239.6	RBM39_HUMAN	reviewed	RNA-binding protein 39 (CAPER alpha) (CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1)	RBM39 HCC1 RNPC2	Homo sapiens (Human)	530	"centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0003723; GO:0005654; GO:0006396; GO:0006397; GO:0008380; GO:0015630; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733	"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20786_c0_g1_i2	Q5RC80	RBM39_PONAB	100	273	0	0	1	819	129	401	5.00E-148	525	RBM39_PONAB	reviewed	RNA-binding protein 39 (RNA-binding motif protein 39)	RBM39	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	524	"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0048024	"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1220_c0_g1_i1	Q5RC80	RBM39_PONAB	68.7	386	96	4	1152	61	139	521	7.30E-143	508.4	RBM39_PONAB	reviewed	RNA-binding protein 39 (RNA-binding motif protein 39)	RBM39	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	524	"nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0048024	"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8060_c0_g1_i2	Q8CFD1	RBM45_RAT	45.7	94	50	1	103	381	8	101	2.30E-18	93.2	RBM45_RAT	reviewed	RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RNA-binding motif protein 45)	Rbm45 Drb1 Drbp1	Rattus norvegicus (Rat)	476	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0007399; GO:0030154; GO:0042802; GO:1990904	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		blue	blue	NA	NA	NA	NA
TRINITY_DN28818_c0_g1_i1	Q9BQ04	RBM4B_HUMAN	100	68	0	0	205	2	1	68	3.50E-33	141.7	RBM4B_HUMAN	reviewed	RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30)	RBM4B RBM30	Homo sapiens (Human)	359	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0007623; GO:0008270; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153; GO:0045292	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8608_c0_g1_i4	Q9BQ04	RBM4B_HUMAN	30.5	190	94	2	239	808	3	154	1.20E-15	85.5	RBM4B_HUMAN	reviewed	RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30)	RBM4B RBM30	Homo sapiens (Human)	359	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0007623; GO:0008270; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153; GO:0045292	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1656_c0_g1_i2	Q1RMU5	RBM5_BOVIN	43.1	313	135	10	1031	111	540	815	2.90E-50	200.7	RBM5_BOVIN	reviewed	RNA-binding protein 5 (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5)	RBM5 LUCA15	Bos taurus (Bovine)	815	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0006915; GO:0043065; GO:0046872	"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN378_c0_g1_i4	A4IGK4	RBM5_XENTR	45	131	62	4	423	34	96	217	4.60E-22	105.9	RBM5_XENTR	reviewed	RNA-binding protein 5 (RNA-binding motif protein 5)	rbm5 TGas113j08.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	838	"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0043065; GO:0046872	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32738_c0_g1_i2	Q6P0F4	RBM7_DANRE	53.8	91	39	3	918	649	5	93	4.10E-19	97.1	RBM7_DANRE	reviewed	RNA-binding protein 7 (RNA-binding motif protein 7)	rbm7 zgc:77304	Danio rerio (Zebrafish) (Brachydanio rerio)	252	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; axonogenesis [GO:0007409]; cerebellar Purkinje cell layer structural organization [GO:0021693]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0007409; GO:0021693	"axonogenesis [GO:0007409]; cerebellar Purkinje cell layer structural organization [GO:0021693]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5735_c0_g1_i2	Q27294	CAZ_DROME	57.4	101	42	1	362	60	114	213	3.70E-29	129.4	CAZ_DROME	reviewed	RNA-binding protein cabeza (P19) (Sarcoma-associated RNA-binding fly homolog)	caz SARFH CG3606	Drosophila melanogaster (Fruit fly)	399	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0000398; GO:0003682; GO:0003712; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006367; GO:0008344; GO:0008345; GO:0045887; GO:0046872; GO:0048749; GO:0051124; GO:0071013	"adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29898_c0_g1_i1	Q01844	EWS_HUMAN	100	78	0	0	3	236	381	458	2.90E-40	165.2	EWS_HUMAN	reviewed	RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein)	EWSR1 EWS	Homo sapiens (Human)	656	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003723; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006355; GO:0042802; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25134_c0_g1_i1	Q28009	FUS_BOVIN	100	77	0	0	233	3	290	366	2.40E-39	162.2	FUS_BOVIN	reviewed	RNA-binding protein FUS (Protein pigpen)	FUS	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003723; GO:0005634; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25134_c0_g1_i2	Q28009	FUS_BOVIN	100	77	0	0	233	3	290	366	2.40E-39	162.2	FUS_BOVIN	reviewed	RNA-binding protein FUS (Protein pigpen)	FUS	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003723; GO:0005634; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26614_c0_g1_i1	Q9BJZ5	FUSIL_DROME	68.4	117	34	2	207	548	366	482	2.20E-38	160.2	FUSIL_DROME	reviewed	RNA-binding protein fusilli	fus CG8205	Drosophila melanogaster (Fruit fly)	967	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0043484; GO:1990904	mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN15989_c0_g1_i1	Q9BJZ5	FUSIL_DROME	71.8	103	27	1	1	309	548	648	2.20E-36	152.9	FUSIL_DROME	reviewed	RNA-binding protein fusilli	fus CG8205	Drosophila melanogaster (Fruit fly)	967	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0043484; GO:1990904	mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN35492_c0_g1_i1	Q94901	LARK_DROME	50.5	220	98	3	688	47	1	215	2.60E-53	210.3	LARK_DROME	reviewed	RNA-binding protein lark	lark CG8597	Drosophila melanogaster (Fruit fly)	352	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000278; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0007303; GO:0007562; GO:0007623; GO:0008062; GO:0008104; GO:0008270; GO:0009792; GO:0016607; GO:0030036; GO:0042752; GO:0045292; GO:0045475; GO:0045804; GO:0045995; GO:0071011; GO:0071013; GO:2000767	"actin cytoskeleton organization [GO:0030036]; circadian rhythm [GO:0007623]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; eclosion [GO:0007562]; eclosion rhythm [GO:0008062]; embryo development ending in birth or egg hatching [GO:0009792]; locomotor rhythm [GO:0045475]; mitotic cell cycle [GO:0000278]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of eclosion [GO:0045804]; positive regulation of cytoplasmic translation [GO:2000767]; protein localization [GO:0008104]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39665_c0_g1_i1	Q6ZN04	MEX3B_HUMAN	85.1	174	22	3	754	239	63	234	2.50E-77	290	MEX3B_HUMAN	reviewed	RNA-binding protein MEX3B (RING finger and KH domain-containing protein 3) (RING finger protein 195)	MEX3B KIAA2009 RKHD3 RNF195	Homo sapiens (Human)	569	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	calcium ion binding [GO:0005509]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005509; GO:0005654; GO:0005829; GO:0006468; GO:0046777	protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN36348_c0_g1_i1	Q86XN8	MEX3D_HUMAN	49.5	95	33	2	313	74	557	651	5.00E-17	89.4	MEX3D_HUMAN	reviewed	RNA-binding protein MEX3D (RING finger and KH domain-containing protein 1) (RING finger protein 193) (TINO)	MEX3D KIAA2031 RKHD1 RNF193	Homo sapiens (Human)	651	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0010609; GO:0035925; GO:0046872; GO:0048471; GO:0061157	mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]		NA	NA	NA	NA	NA	NA
TRINITY_DN36348_c0_g1_i2	Q86XN8	MEX3D_HUMAN	49.5	95	33	2	270	509	557	651	5.00E-17	89.4	MEX3D_HUMAN	reviewed	RNA-binding protein MEX3D (RING finger and KH domain-containing protein 1) (RING finger protein 193) (TINO)	MEX3D KIAA2031 RKHD1 RNF193	Homo sapiens (Human)	651	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0010609; GO:0035925; GO:0046872; GO:0048471; GO:0061157	mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]		NA	NA	NA	NA	NA	NA
TRINITY_DN39377_c0_g1_i1	Q96DH6	MSI2H_HUMAN	53.9	76	33	2	14	235	21	96	2.50E-14	79.3	MSI2H_HUMAN	reviewed	RNA-binding protein Musashi homolog 2 (Musashi-2)	MSI2	Homo sapiens (Human)	328	cytoplasm [GO:0005737]; polysome [GO:0005844]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; stem cell development [GO:0048864]	cytoplasm [GO:0005737]; polysome [GO:0005844]	identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005844; GO:0008266; GO:0042802; GO:0048864	stem cell development [GO:0048864]		NA	NA	NA	NA	NA	NA
TRINITY_DN39128_c0_g1_i1	Q9VVE5	MSIR6_DROME	83.1	83	14	0	251	3	30	112	2.00E-36	152.9	MSIR6_DROME	reviewed	RNA-binding protein Musashi homolog Rbp6	Rbp6 RRM6 CG32169	Drosophila melanogaster (Fruit fly)	369	cytoplasm [GO:0005737]; polysome [GO:0005844]; poly(U) RNA binding [GO:0008266]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]	cytoplasm [GO:0005737]; polysome [GO:0005844]	poly(U) RNA binding [GO:0008266]; single-stranded RNA binding [GO:0003727]	GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864	stem cell development [GO:0048864]		NA	NA	NA	NA	NA	NA
TRINITY_DN40233_c0_g1_i1	Q9VVE5	MSIR6_DROME	47.4	78	41	0	259	26	119	196	1.20E-13	77	MSIR6_DROME	reviewed	RNA-binding protein Musashi homolog Rbp6	Rbp6 RRM6 CG32169	Drosophila melanogaster (Fruit fly)	369	cytoplasm [GO:0005737]; polysome [GO:0005844]; poly(U) RNA binding [GO:0008266]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]	cytoplasm [GO:0005737]; polysome [GO:0005844]	poly(U) RNA binding [GO:0008266]; single-stranded RNA binding [GO:0003727]	GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864	stem cell development [GO:0048864]		NA	NA	NA	NA	NA	NA
TRINITY_DN29814_c0_g1_i1	Q9VVE5	MSIR6_DROME	56.9	204	83	3	684	85	17	219	1.60E-61	237.7	MSIR6_DROME	reviewed	RNA-binding protein Musashi homolog Rbp6	Rbp6 RRM6 CG32169	Drosophila melanogaster (Fruit fly)	369	cytoplasm [GO:0005737]; polysome [GO:0005844]; poly(U) RNA binding [GO:0008266]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]	cytoplasm [GO:0005737]; polysome [GO:0005844]	poly(U) RNA binding [GO:0008266]; single-stranded RNA binding [GO:0003727]	GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864	stem cell development [GO:0048864]		NA	NA	NA	NA	NA	NA
TRINITY_DN2438_c0_g2_i1	Q3T042	NOB1_BOVIN	47.9	192	86	4	13	570	229	412	9.40E-41	168.3	NOB1_BOVIN	reviewed	RNA-binding protein NOB1 (EC 3.1.-.-)	NOB1	Bos taurus (Bovine)	413	"nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490]"	"nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]	GO:0000469; GO:0004521; GO:0005634; GO:0030490; GO:0030688; GO:0046872	cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN386_c0_g2_i1	P51513	NOVA1_HUMAN	55.8	104	43	2	243	551	399	500	1.10E-20	101.7	NOVA1_HUMAN	reviewed	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Onconeural ventral antigen 1) (Paraneoplastic Ri antigen) (Ventral neuron-specific protein 1)	NOVA1	Homo sapiens (Human)	507	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; chemical synaptic transmission [GO:0007268]; locomotory behavior [GO:0007626]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006396; GO:0007268; GO:0007626; GO:0008380; GO:0010468; GO:0043231; GO:0045202; GO:0051252; GO:0120163	"chemical synaptic transmission [GO:0007268]; locomotory behavior [GO:0007626]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN386_c0_g1_i1	Q2PFW9	NOVA1_MACFA	47.1	274	99	5	1186	368	23	251	4.50E-55	216.9	NOVA1_MACFA	reviewed	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)	NOVA1 QflA-17531 QtsA-14227	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	483	"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN386_c0_g1_i2	Q2PFW9	NOVA1_MACFA	52.8	246	98	4	1102	368	23	251	3.30E-60	233.8	NOVA1_MACFA	reviewed	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)	NOVA1 QflA-17531 QtsA-14227	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	483	"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN386_c0_g1_i3	Q2PFW9	NOVA1_MACFA	46.4	280	98	5	1204	368	23	251	7.70E-55	216.1	NOVA1_MACFA	reviewed	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)	NOVA1 QflA-17531 QtsA-14227	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	483	"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN386_c0_g1_i4	Q2PFW9	NOVA1_MACFA	53.8	240	99	4	1084	368	23	251	1.90E-60	234.6	NOVA1_MACFA	reviewed	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)	NOVA1 QflA-17531 QtsA-14227	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	483	"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634	"mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2057_c0_g1_i2	Q6DDB9	PNO1_XENTR	61.9	63	22	1	183	1	41	103	3.00E-15	82.8	PNO1_XENTR	reviewed	RNA-binding protein PNO1	pno1 TTpA007f20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	236	nucleolus [GO:0005730]; RNA binding [GO:0003723]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730			NA	NA	NA	NA	NA	NA
TRINITY_DN2057_c0_g1_i3	A7RP64	PNO1_NEMVE	65.9	211	67	3	719	93	31	238	9.50E-74	278.5	PNO1_NEMVE	reviewed	RNA-binding protein pno1	pno1 v1g199995	Nematostella vectensis (Starlet sea anemone)	238	nucleolus [GO:0005730]; RNA binding [GO:0003723]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730			blue	blue	NA	NA	NA	NA
TRINITY_DN2057_c0_g1_i4	A7RP64	PNO1_NEMVE	65.9	211	67	3	719	93	31	238	9.40E-74	278.5	PNO1_NEMVE	reviewed	RNA-binding protein pno1	pno1 v1g199995	Nematostella vectensis (Starlet sea anemone)	238	nucleolus [GO:0005730]; RNA binding [GO:0003723]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	GO:0003723; GO:0005730			blue	blue	NA	NA	NA	NA
TRINITY_DN33976_c0_g1_i1	Q9NRX1	PNO1_HUMAN	100	115	0	0	347	3	61	175	5.80E-61	234.6	PNO1_HUMAN	reviewed	RNA-binding protein PNO1 (Partner of NOB1)	PNO1	Homo sapiens (Human)	252	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN6819_c0_g1_i1	Q7KMJ6	NITO_DROME	56.6	479	151	11	1427	93	20	475	3.50E-115	416.8	NITO_DROME	reviewed	RNA-binding protein spenito	nito CG2910	Drosophila melanogaster (Fruit fly)	793	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003676; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737	"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33032_c0_g1_i1	Q7KMJ6	NITO_DROME	55.8	156	66	2	110	574	615	768	3.00E-38	159.8	NITO_DROME	reviewed	RNA-binding protein spenito	nito CG2910	Drosophila melanogaster (Fruit fly)	793	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003676; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737	"cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2052_c0_g1_i1	Q08473	SQD_DROME	65.9	223	71	2	98	766	8	225	1.50E-75	284.3	SQD_DROME	reviewed	RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)	sqd hrp40 CG16901	Drosophila melanogaster (Fruit fly)	344	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837	"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26539_c1_g1_i1	Q08473	SQD_DROME	66.5	221	68	2	735	73	8	222	1.10E-76	288.1	SQD_DROME	reviewed	RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)	sqd hrp40 CG16901	Drosophila melanogaster (Fruit fly)	344	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837	"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19129_c0_g1_i2	Q08473	SQD_DROME	88.9	27	3	0	224	304	57	83	1.40E-07	57	SQD_DROME	reviewed	RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)	sqd hrp40 CG16901	Drosophila melanogaster (Fruit fly)	344	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; precatalytic spliceosome [GO:0071011]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0043565; GO:0045451; GO:0048477; GO:0071011; GO:0071013; GO:1990837	"dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17526_c0_g1_i1	A6QR16	RNPS1_BOVIN	100	77	0	0	283	53	169	245	5.90E-40	164.5	RNPS1_BOVIN	reviewed	RNA-binding protein with serine-rich domain 1	RNPS1	Bos taurus (Bovine)	305	"ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0008380; GO:0016607; GO:0043065; GO:0048025; GO:0061574	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34024_c0_g1_i1	A6QR16	RNPS1_BOVIN	100	86	0	0	83	340	161	246	2.80E-45	182.6	RNPS1_BOVIN	reviewed	RNA-binding protein with serine-rich domain 1	RNPS1	Bos taurus (Bovine)	305	"ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0008380; GO:0016607; GO:0043065; GO:0048025; GO:0061574	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN122_c0_g1_i1	Q3KPW1	RNP1B_XENLA	57.9	95	36	2	402	124	137	229	1.10E-25	118.2	RNP1B_XENLA	reviewed	RNA-binding protein with serine-rich domain 1-B	rnps1-b	Xenopus laevis (African clawed frog)	283	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN40463_c0_g1_i1	Q96LT9	RNPC3_HUMAN	100	73	0	0	219	1	136	208	4.70E-37	154.5	RNPC3_HUMAN	reviewed	RNA-binding region-containing protein 3 (RNA-binding motif protein 40) (RNA-binding protein 40) (U11/U12 small nuclear ribonucleoprotein 65 kDa protein) (U11/U12 snRNP 65 kDa protein) (U11/U12-65K)	RNPC3 KIAA1839 RBM40 RNP SNRNP65	Homo sapiens (Human)	517	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]	pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]	GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0008380; GO:0030626; GO:0097157	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3892_c0_g1_i1	F1Q8J0	RNPC3_DANRE	35.2	486	276	12	92	1474	24	495	1.10E-58	229.2	RNPC3_DANRE	reviewed	RNA-binding region-containing protein 3 (RNA-binding protein 40)	rnpc3	Danio rerio (Zebrafish) (Brachydanio rerio)	505	"U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]"	U12-type spliceosomal complex [GO:0005689]	pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]	GO:0000398; GO:0001889; GO:0005689; GO:0030626; GO:0031016; GO:0048565; GO:0097157	"digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3892_c0_g1_i2	F1Q8J0	RNPC3_DANRE	36.8	486	268	12	92	1474	24	495	1.10E-58	229.2	RNPC3_DANRE	reviewed	RNA-binding region-containing protein 3 (RNA-binding protein 40)	rnpc3	Danio rerio (Zebrafish) (Brachydanio rerio)	505	"U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]"	U12-type spliceosomal complex [GO:0005689]	pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]	GO:0000398; GO:0001889; GO:0005689; GO:0030626; GO:0031016; GO:0048565; GO:0097157	"digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4711_c8_g1_i1	P21329	RTJK_DROFU	52.2	46	22	0	3	140	615	660	3.70E-05	48.9	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			blue	blue	NA	NA	NA	NA
TRINITY_DN37079_c0_g1_i1	P21328	RTJK_DROME	41.5	65	32	1	2	178	618	682	1.20E-05	50.1	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			blue	blue	NA	NA	NA	NA
TRINITY_DN8043_c1_g1_i1	P21328	RTJK_DROME	44.3	79	32	2	3	209	607	683	1.30E-07	56.6	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			blue	blue	NA	NA	NA	NA
TRINITY_DN8043_c1_g1_i2	P21328	RTJK_DROME	48.1	54	28	0	3	164	607	660	4.00E-06	51.6	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN2578_c0_g1_i12	P21329	RTJK_DROFU	30.6	209	134	5	33	629	550	757	4.20E-13	76.6	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	NA	NA	NA	NA
TRINITY_DN2578_c0_g1_i15	P21329	RTJK_DROFU	33	224	148	2	132	800	438	660	1.50E-22	108.2	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN2578_c0_g1_i2	P21329	RTJK_DROFU	30	213	130	6	33	629	550	757	5.40E-13	76.3	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	NA	NA	NA	NA
TRINITY_DN2578_c0_g1_i6	P21328	RTJK_DROME	30	203	140	2	2	607	459	660	1.10E-15	85.1	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN9239_c0_g2_i1	P21329	RTJK_DROFU	26.8	362	219	13	990	1	437	784	4.70E-18	93.6	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN3703_c0_g2_i3	P21329	RTJK_DROFU	34.3	143	76	5	398	9	584	721	1.40E-10	67.4	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN2330_c0_g1_i26	P21328	RTJK_DROME	22.1	890	609	28	3748	1250	6	868	4.80E-27	125.6	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN12999_c0_g3_i1	P21328	RTJK_DROME	48.3	58	30	0	12	185	607	664	6.60E-07	54.3	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			brown	brown	NA	NA	NA	NA
TRINITY_DN12972_c0_g1_i1	P21328	RTJK_DROME	33.3	69	46	0	239	33	608	676	9.40E-05	47.4	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN12972_c0_g1_i4	P21328	RTJK_DROME	32.2	90	49	2	251	6	608	693	4.40E-05	48.5	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN12972_c0_g1_i6	P21328	RTJK_DROME	32.6	86	46	2	237	4	612	693	1.80E-05	49.7	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN12972_c0_g1_i7	P21328	RTJK_DROME	32.2	90	49	2	249	4	608	693	5.70E-05	48.1	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN3596_c0_g1_i11	P21328	RTJK_DROME	28.9	308	194	5	65	928	383	685	1.30E-23	112.1	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			blue	blue	NA	NA	NA	NA
TRINITY_DN3596_c0_g1_i14	P21328	RTJK_DROME	27.4	339	215	7	334	1284	356	685	2.30E-23	111.7	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	NA	NA	NA	NA
TRINITY_DN3596_c0_g1_i15	P21328	RTJK_DROME	28.9	308	194	5	37	900	383	685	3.30E-24	114	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			brown	brown	NA	NA	NA	NA
TRINITY_DN3596_c0_g1_i2	P21328	RTJK_DROME	29.3	304	198	5	51	914	383	685	7.50E-24	112.8	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	NA	NA	NA	NA
TRINITY_DN3596_c0_g1_i3	P21328	RTJK_DROME	28.9	308	194	5	37	900	383	685	9.60E-24	112.5	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	NA	NA	NA	1
TRINITY_DN3596_c0_g1_i8	P21328	RTJK_DROME	27.8	335	219	7	334	1284	356	685	5.00E-23	110.5	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	NA	NA	NA	NA
TRINITY_DN5789_c0_g1_i14	P21328	RTJK_DROME	23.3	387	254	12	1078	14	310	685	3.20E-17	91.7	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN5789_c0_g1_i17	P21328	RTJK_DROME	23.5	387	253	12	1078	14	310	685	1.40E-17	92.8	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN27079_c0_g1_i1	P21328	RTJK_DROME	32.2	118	66	3	5	328	579	692	5.50E-08	58.5	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			brown	brown	NA	NA	NA	NA
TRINITY_DN33003_c0_g1_i1	P21329	RTJK_DROFU	34.5	84	42	3	11	238	638	716	2.20E-06	53.1	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN2423_c0_g1_i1	P21329	RTJK_DROFU	30.2	248	148	8	711	31	445	688	2.00E-15	84.3	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN18711_c0_g1_i1	P21329	RTJK_DROFU	39.4	66	33	2	1	177	618	683	6.50E-05	47.8	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN10551_c0_g2_i3	P21328	RTJK_DROME	28	350	223	10	12	986	439	784	1.30E-23	112.1	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN10551_c0_g2_i4	P21328	RTJK_DROME	30.2	169	109	3	34	513	616	784	4.60E-12	72.8	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN10551_c0_g2_i6	P21328	RTJK_DROME	28.8	347	224	10	12	986	439	784	4.70E-26	120.2	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN2578_c0_g1_i3	P21329	RTJK_DROFU	30.2	321	212	6	132	1061	438	757	1.10E-26	122.5	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	1	NA	NA	NA
TRINITY_DN2330_c0_g1_i2	P21328	RTJK_DROME	22.1	890	609	28	3748	1250	6	868	4.80E-27	125.6	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	1	NA	NA	NA
TRINITY_DN11075_c0_g1_i3	P21329	RTJK_DROFU	42.3	78	44	1	237	4	584	660	1.30E-06	53.5	RTJK_DROFU	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	jockey\pol pol	Drosophila funebris (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			yellow	yellow	1	NA	NA	NA
TRINITY_DN5789_c0_g1_i1	P21328	RTJK_DROME	23.5	387	253	12	1078	14	310	685	1.40E-17	92.8	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	1	NA	NA	NA
TRINITY_DN12846_c0_g1_i8	P21328	RTJK_DROME	24	416	286	10	1288	2463	455	864	1.30E-17	94	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN17524_c0_g1_i1	P21328	RTJK_DROME	37.1	89	47	4	250	5	601	687	1.90E-05	49.7	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN9326_c0_g3_i1	P21328	RTJK_DROME	41.5	65	37	1	6	200	598	661	5.00E-07	54.7	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN9326_c0_g1_i4	P21328	RTJK_DROME	26.1	287	188	10	3	812	594	873	1.10E-18	95.5	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN9326_c0_g1_i5	P21328	RTJK_DROME	32.4	142	81	4	3	398	594	730	1.60E-12	74.3	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	NA	NA	NA	NA
TRINITY_DN12846_c0_g1_i3	P21328	RTJK_DROME	24	416	286	10	1288	2463	455	864	1.30E-17	94	RTJK_DROME	reviewed	RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)	pol	Drosophila melanogaster (Fruit fly)	916	RNA-directed DNA polymerase activity [GO:0003964]		RNA-directed DNA polymerase activity [GO:0003964]	GO:0003964			NA	NA	1	NA	NA	NA
TRINITY_DN11648_c0_g1_i1	C1E9Y5	RTCB_MICCC	78.2	499	108	1	6	1502	16	513	4.40E-233	808.5	RTCB_MICCC	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	MICPUN_59883	Micromonas commoda (strain RCC299 / NOUM17 / CCMP2709) (Picoplanktonic green alga)	513	"tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]	GO:0003972; GO:0005525; GO:0006388; GO:0046872; GO:0072669	"tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14327_c0_g1_i2	Q5E9T9	RTCB_BOVIN	100	370	0	0	1	1110	136	505	8.90E-215	747.3	RTCB_BOVIN	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	RTCB	Bos taurus (Bovine)	505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]	GO:0000971; GO:0001701; GO:0001890; GO:0003972; GO:0005525; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006388; GO:0017166; GO:0046872; GO:0072669	"in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33150_c0_g1_i1	Q9VIW7	RTCB_DROME	47.5	80	39	2	23	259	84	161	4.40E-13	75.1	RTCB_DROME	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	RtcB CG9987	Drosophila melanogaster (Fruit fly)	506	"nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; positive regulation of tRNA processing [GO:2000237]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]	GO:0000971; GO:0003972; GO:0005525; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:2000237	"positive regulation of tRNA processing [GO:2000237]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20467_c0_g1_i1	Q5E9T9	RTCB_BOVIN	100	79	0	0	1	237	74	152	5.80E-41	167.5	RTCB_BOVIN	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	RTCB	Bos taurus (Bovine)	505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]	GO:0000971; GO:0001701; GO:0001890; GO:0003972; GO:0005525; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006388; GO:0017166; GO:0046872; GO:0072669	"in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20467_c0_g2_i1	Q9Y3I0	RTCB_HUMAN	100	118	0	0	2	355	23	140	6.60E-65	247.7	RTCB_HUMAN	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	RTCB C22orf28 HSPC117	Homo sapiens (Human)	505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]	GO:0000971; GO:0001701; GO:0001890; GO:0003723; GO:0003972; GO:0005525; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006388; GO:0017166; GO:0043231; GO:0046872; GO:0072669	"in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2267_c0_g1_i1	Q9VIW7	RTCB_DROME	86.8	506	67	0	1608	91	1	506	2.30E-264	912.5	RTCB_DROME	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	RtcB CG9987	Drosophila melanogaster (Fruit fly)	506	"nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; positive regulation of tRNA processing [GO:2000237]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]	GO:0000971; GO:0003972; GO:0005525; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:2000237	"positive regulation of tRNA processing [GO:2000237]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		blue	blue	NA	NA	NA	NA
TRINITY_DN14327_c0_g1_i1	Q99LF4	RTCB_MOUSE	100	310	0	0	2	931	196	505	7.40E-178	624.4	RTCB_MOUSE	reviewed	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase) (Focal adhesion-associated protein) (FAAP)	Rtcb D10Wsu52e	Mus musculus (Mouse)	505	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]	GO:0000971; GO:0001701; GO:0001890; GO:0003972; GO:0005525; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006388; GO:0017166; GO:0043231; GO:0046872; GO:0072669	"in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3219_c0_g1_i1	Q6NUC6	RC3H1_XENLA	71.4	455	125	3	79	1431	1	454	2.70E-183	643.3	RC3H1_XENLA	reviewed	Roquin-1 (EC 2.3.2.27) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1)	rc3h1	Xenopus laevis (African clawed frog)	1114	"cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to interleukin-1 [GO:0071347]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of T cell proliferation [GO:0042129]"	cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]	double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0003725; GO:0003730; GO:0004842; GO:0010494; GO:0010608; GO:0035613; GO:0042129; GO:0046872; GO:0061014; GO:0061158; GO:0071347	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to interleukin-1 [GO:0071347]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of T cell proliferation [GO:0042129]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2407_c0_g1_i1	Q5TC82	RC3H1_HUMAN	33.3	75	45	3	28	252	2	71	2.50E-05	49.3	RC3H1_HUMAN	reviewed	Roquin-1 (Roquin) (EC 2.3.2.27) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) (RING finger protein 198)	RC3H1 KIAA2025 RNF198	Homo sapiens (Human)	1133	"cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]	double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0006511; GO:0008270; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0061630; GO:0071347; GO:1901224; GO:2000320; GO:2000628	"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17956_c0_g1_i2	Q9HCK4	ROBO2_HUMAN	34.7	75	43	3	218	3	242	313	4.50E-06	51.6	ROBO2_HUMAN	reviewed	Roundabout homolog 2	ROBO2 KIAA1568	Homo sapiens (Human)	1378	axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]	GO:0001656; GO:0001657; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021510; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035481; GO:0035904; GO:0042802; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062	aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4900_c0_g1_i2	Q7TPD3	ROBO2_MOUSE	38	829	466	19	3937	1514	31	832	5.00E-140	500.7	ROBO2_MOUSE	reviewed	Roundabout homolog 2	Robo2 Kiaa1568	Mus musculus (Mouse)	1470	axolemma [GO:0030673]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	axolemma [GO:0030673]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]	GO:0001656; GO:0001657; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0007156; GO:0007411; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0035481; GO:0035904; GO:0042802; GO:0050772; GO:0050925; GO:0060412	aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2997_c0_g1_i2	Q9W704	RIPA_XENLA	36.9	244	116	12	115	798	1	222	2.20E-24	114.4	RIPA_XENLA	reviewed	RPA-interacting protein A (RPA-interacting protein alpha) (XRIPalpha)	rpain-a rip-a	Xenopus laevis (African clawed frog)	226	nucleus [GO:0005634]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN2997_c0_g1_i1	Q5M782	RIPB_XENLA	50	84	34	3	115	363	1	77	1.30E-12	75.5	RIPB_XENLA	reviewed	RPA-interacting protein B	rpain-b rip-b	Xenopus laevis (African clawed frog)	220	nucleus [GO:0005634]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8992_c0_g1_i1	P22087	FBRL_HUMAN	99.6	229	1	0	730	44	93	321	5.60E-128	458.4	FBRL_HUMAN	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin)	FBL FIB1 FLRN	Homo sapiens (Human)	321	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000494; GO:0001094; GO:0001649; GO:0001650; GO:0001651; GO:0001652; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0008649; GO:0015030; GO:0016020; GO:0031167; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070062; GO:1990258; GO:1990259	box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN8992_c0_g1_i2	P22087	FBRL_HUMAN	100	219	0	0	700	44	103	321	1.50E-121	436.8	FBRL_HUMAN	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin)	FBL FIB1 FLRN	Homo sapiens (Human)	321	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000494; GO:0001094; GO:0001649; GO:0001650; GO:0001651; GO:0001652; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0008649; GO:0015030; GO:0016020; GO:0031167; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070062; GO:1990258; GO:1990259	box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN8992_c0_g1_i3	P22087	FBRL_HUMAN	100	219	0	0	700	44	103	321	1.50E-121	436.8	FBRL_HUMAN	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin)	FBL FIB1 FLRN	Homo sapiens (Human)	321	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000494; GO:0001094; GO:0001649; GO:0001650; GO:0001651; GO:0001652; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0008649; GO:0015030; GO:0016020; GO:0031167; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070062; GO:1990258; GO:1990259	box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN8992_c0_g1_i4	P22087	FBRL_HUMAN	100	219	0	0	700	44	103	321	1.50E-121	436.8	FBRL_HUMAN	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin)	FBL FIB1 FLRN	Homo sapiens (Human)	321	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000494; GO:0001094; GO:0001649; GO:0001650; GO:0001651; GO:0001652; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0008649; GO:0015030; GO:0016020; GO:0031167; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070062; GO:1990258; GO:1990259	box C/D snoRNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]		NA	NA	NA	NA	NA	NA
TRINITY_DN35965_c0_g1_i1	Q8I1F4	FBRL_DROER	81.4	236	44	0	814	107	109	344	1.50E-111	404.1	FBRL_DROER	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase)	Fib GG20072	Drosophila erecta (Fruit fly)	345	Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; methylation [GO:0032259]; rRNA processing [GO:0006364]	Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]	GO:0001651; GO:0003723; GO:0006364; GO:0008168; GO:0015030; GO:0032259	methylation [GO:0032259]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN7924_c0_g1_i1	Q8SR42	FBRL_ENCCU	60.2	216	86	0	3	650	58	273	1.70E-72	273.9	FBRL_ENCCU	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase)	NOP1 ECU10_0820	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	291	nucleolus [GO:0005730]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; methylation [GO:0032259]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0006364; GO:0008168; GO:0032259	methylation [GO:0032259]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN10446_c0_g1_i1	P22232	FBRL_XENLA	70.8	243	64	1	788	60	87	322	7.30E-99	361.7	FBRL_XENLA	reviewed	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin)	fbl	Xenopus laevis (African clawed frog)	323	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0031167; GO:1990258; GO:1990259	histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN5483_c0_g1_i2	O74835	RRP5_SCHPO	28.1	633	404	16	1808	6	30	643	1.00E-52	209.5	RRP5_SCHPO	reviewed	rRNA biogenesis protein rrp5 (Ribosomal RNA-processing protein 5) (U3 small nucleolar RNA-associated protein rrp5) (U3 snoRNA-associated protein rrp5)	rrp5 SPCC1183.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1690	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005730; GO:0006364; GO:0006397; GO:0030515; GO:0032040; GO:0042134	mRNA processing [GO:0006397]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN15368_c0_g1_i1	Q6IN84	MRM1_HUMAN	39.7	229	121	6	855	181	88	303	4.70E-32	139.8	MRM1_HUMAN	reviewed	"rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)"	MRM1	Homo sapiens (Human)	353	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]	GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0070039	rRNA 2'-O-methylation [GO:0000451]		NA	NA	NA	NA	NA	NA
TRINITY_DN15368_c0_g1_i2	Q6IN84	MRM1_HUMAN	39.7	229	121	6	821	147	88	303	5.90E-32	139.4	MRM1_HUMAN	reviewed	"rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)"	MRM1	Homo sapiens (Human)	353	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]	GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0070039	rRNA 2'-O-methylation [GO:0000451]		NA	NA	NA	NA	NA	NA
TRINITY_DN41082_c0_g1_i1	Q9UI43	MRM2_HUMAN	100	79	0	0	3	239	47	125	2.50E-39	162.2	MRM2_HUMAN	reviewed	"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (16S rRNA (uridine(1369)-2'-O)-methyltransferase) (16S rRNA [Um1369] 2'-O-methyltransferase) (Protein ftsJ homolog 2)"	MRM2 FJH1 FTSJ2	Homo sapiens (Human)	246	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0000451; GO:0001510; GO:0005730; GO:0005739; GO:0005759; GO:0006364; GO:0008173; GO:0008650; GO:0031167	RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN1684_c0_g1_i1	Q9VDT6	MRM2_DROME	53.1	228	107	0	795	112	15	242	6.30E-59	229.2	MRM2_DROME	reviewed	"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (rRNA (uridine-2'-O)-methyltransferase)"	CG11447	Drosophila melanogaster (Fruit fly)	250	mitochondrion [GO:0005739]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; RNA methylation [GO:0001510]	mitochondrion [GO:0005739]	RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0001510; GO:0005739; GO:0008173; GO:0008650	RNA methylation [GO:0001510]		NA	NA	NA	NA	NA	NA
TRINITY_DN1684_c0_g1_i3	Q9VDT6	MRM2_DROME	53.1	228	107	0	795	112	15	242	2.80E-59	230.3	MRM2_DROME	reviewed	"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (rRNA (uridine-2'-O)-methyltransferase)"	CG11447	Drosophila melanogaster (Fruit fly)	250	mitochondrion [GO:0005739]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; RNA methylation [GO:0001510]	mitochondrion [GO:0005739]	RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0001510; GO:0005739; GO:0008173; GO:0008650	RNA methylation [GO:0001510]		NA	NA	NA	NA	NA	NA
TRINITY_DN1684_c0_g1_i4	Q9VDT6	MRM2_DROME	47.3	150	75	1	549	112	93	242	5.80E-28	126.3	MRM2_DROME	reviewed	"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (rRNA (uridine-2'-O)-methyltransferase)"	CG11447	Drosophila melanogaster (Fruit fly)	250	mitochondrion [GO:0005739]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; RNA methylation [GO:0001510]	mitochondrion [GO:0005739]	RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0001510; GO:0005739; GO:0008173; GO:0008650	RNA methylation [GO:0001510]		NA	NA	NA	NA	NA	NA
TRINITY_DN1684_c0_g1_i4	Q9VDT6	MRM2_DROME	59.8	97	37	1	799	509	15	109	5.00E-24	113.2	MRM2_DROME	reviewed	"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (rRNA (uridine-2'-O)-methyltransferase)"	CG11447	Drosophila melanogaster (Fruit fly)	250	mitochondrion [GO:0005739]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; RNA methylation [GO:0001510]	mitochondrion [GO:0005739]	RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	GO:0001510; GO:0005739; GO:0008173; GO:0008650	RNA methylation [GO:0001510]		NA	NA	NA	NA	NA	NA
TRINITY_DN9425_c0_g1_i1	Q5ND52	MRM3_MOUSE	30.4	437	257	11	1428	142	7	404	6.20E-40	166.8	MRM3_MOUSE	reviewed	"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)"	Mrm3 Rnmtl1	Mus musculus (Mouse)	418	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]	GO:0003723; GO:0005739; GO:0042802; GO:0070039			NA	NA	NA	NA	NA	NA
TRINITY_DN5165_c0_g1_i1	Q9NRN9	METL5_HUMAN	55.6	169	72	1	3	509	43	208	1.60E-50	200.7	METL5_HUMAN	reviewed	rRNA N6-adenosine-methyltransferase METTL5 (EC 2.1.1.-) (Methyltransferase-like protein 5)	METTL5 DC3 HSPC133	Homo sapiens (Human)	209	cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863]	cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]	nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0003676; GO:0005634; GO:0008988; GO:0031167; GO:0042995; GO:0045727; GO:0048863; GO:0098793; GO:0098794; GO:1904047	positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863]		NA	NA	NA	NA	NA	NA
TRINITY_DN7512_c0_g1_i1	Q6DCD7	ZCHC4_XENLA	45.9	122	64	2	50	415	260	379	1.40E-27	124.8	ZCHC4_XENLA	reviewed	rRNA N6-adenosine-methyltransferase ZCCHC4 (EC 2.1.1.-) (Zinc finger CCHC domain-containing protein 4)	zcchc4	Xenopus laevis (African clawed frog)	489	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; zinc ion binding [GO:0008270]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0031167; GO:0045727; GO:1904047	positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]		NA	NA	NA	NA	NA	NA
TRINITY_DN2015_c0_g1_i1	Q32PD0	FCF1_BOVIN	67	191	62	1	906	337	1	191	3.20E-72	273.5	FCF1_BOVIN	reviewed	rRNA-processing protein FCF1 homolog	FCF1	Bos taurus (Bovine)	198	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0005730; GO:0006364; GO:0032040	rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN7419_c0_g1_i1	Q32PD0	FCF1_BOVIN	79.2	96	20	0	350	63	96	191	1.10E-40	167.2	FCF1_BOVIN	reviewed	rRNA-processing protein FCF1 homolog	FCF1	Bos taurus (Bovine)	198	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0005730; GO:0006364; GO:0032040	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN24122_c0_g1_i1	Q32PD0	FCF1_BOVIN	94.3	106	6	0	26	343	50	155	6.10E-55	214.5	FCF1_BOVIN	reviewed	rRNA-processing protein FCF1 homolog	FCF1	Bos taurus (Bovine)	198	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0005730; GO:0006364; GO:0032040	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN24122_c0_g1_i2	Q9CTH6	FCF1_MOUSE	96	149	6	0	26	472	50	198	8.60E-82	304.3	FCF1_MOUSE	reviewed	rRNA-processing protein FCF1 homolog	Fcf1	Mus musculus (Mouse)	198	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000447; GO:0000480; GO:0005730; GO:0032040	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3500_c0_g1_i1	Q9CX11	UTP23_MOUSE	40	185	105	3	774	226	1	181	3.90E-34	146.7	UTP23_MOUSE	reviewed	rRNA-processing protein UTP23 homolog	Utp23	Mus musculus (Mouse)	249	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]	GO:0000480; GO:0003730; GO:0005730; GO:0032040; GO:0048027; GO:0070181	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]"		blue	blue	NA	NA	NA	NA
TRINITY_DN10849_c0_g1_i1	Q96T51	RUFY1_HUMAN	47.5	61	31	1	5	187	642	701	3.30E-11	68.6	RUFY1_HUMAN	reviewed	RUN and FYVE domain-containing protein 1 (FYVE-finger protein EIP1) (La-binding protein 1) (Rab4-interacting protein) (Zinc finger FYVE domain-containing protein 12)	RUFY1 RABIP4 ZFYVE12	Homo sapiens (Human)	708	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]	identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]	GO:0005737; GO:0005768; GO:0005829; GO:0006661; GO:0006897; GO:0007264; GO:0008289; GO:0015031; GO:0016607; GO:0017124; GO:0030100; GO:0031901; GO:0042169; GO:0042802; GO:0043231; GO:0046872	endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN3720_c0_g1_i1	Q8R4C2	RUFY2_MOUSE	40.5	74	36	2	948	736	515	583	3.80E-09	63.9	RUFY2_MOUSE	reviewed	RUN and FYVE domain-containing protein 2 (Leucine zipper FYVE-finger protein) (LZ-FYVE)	Rufy2 Kiaa1537	Mus musculus (Mouse)	606	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0017124; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4522_c0_g1_i1	Q8WXA3	RUFY2_HUMAN	49.7	318	150	4	1098	163	87	400	4.70E-69	263.1	RUFY2_HUMAN	reviewed	RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related)	RUFY2 KIAA1537 RABIP4R	Homo sapiens (Human)	606	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872	regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN4522_c0_g1_i3	Q8WXA3	RUFY2_HUMAN	42.9	522	277	5	1558	44	87	604	6.70E-101	369.4	RUFY2_HUMAN	reviewed	RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related)	RUFY2 KIAA1537 RABIP4R	Homo sapiens (Human)	606	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872	regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN3720_c0_g1_i2	Q8WXA3	RUFY2_HUMAN	32.6	135	82	2	1073	669	471	596	3.00E-12	75.5	RUFY2_HUMAN	reviewed	RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related)	RUFY2 KIAA1537 RABIP4R	Homo sapiens (Human)	606	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872	regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN3720_c0_g1_i3	Q8WXA3	RUFY2_HUMAN	31.1	122	75	2	1101	736	471	583	2.70E-08	62.4	RUFY2_HUMAN	reviewed	RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related)	RUFY2 KIAA1537 RABIP4R	Homo sapiens (Human)	606	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872	regulation of endocytosis [GO:0030100]		NA	NA	NA	NA	NA	NA
TRINITY_DN4304_c0_g1_i1	Q92622	RUBIC_HUMAN	33.8	284	154	7	852	31	402	661	7.90E-17	90.1	RUBIC_HUMAN	reviewed	Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron)	RUBCN KIAA0226	Homo sapiens (Human)	972	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; phosphatidylinositol phosphate binding [GO:1901981]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	phosphatidylinositol phosphate binding [GO:1901981]	GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:0071985; GO:1901097; GO:1901981	autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909]		NA	NA	NA	NA	NA	NA
TRINITY_DN4304_c0_g1_i2	Q92622	RUBIC_HUMAN	36.5	565	323	9	1723	62	402	941	5.80E-83	310.5	RUBIC_HUMAN	reviewed	Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron)	RUBCN KIAA0226	Homo sapiens (Human)	972	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; phosphatidylinositol phosphate binding [GO:1901981]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	phosphatidylinositol phosphate binding [GO:1901981]	GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:0071985; GO:1901097; GO:1901981	autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909]		NA	NA	NA	NA	NA	NA
TRINITY_DN39234_c0_g1_i1	Q96C34	RUND1_HUMAN	100	75	0	0	2	226	463	537	2.20E-37	155.6	RUND1_HUMAN	reviewed	RUN domain-containing protein 1	RUNDC1 LP5161	Homo sapiens (Human)	613	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN19482_c0_g1_i1	Q96C34	RUND1_HUMAN	55.8	77	34	0	19	249	470	546	6.00E-17	88.2	RUND1_HUMAN	reviewed	RUN domain-containing protein 1	RUNDC1 LP5161	Homo sapiens (Human)	613	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN9589_c0_g1_i1	Q0VDN7	RUND1_MOUSE	37.4	227	122	5	622	2	41	267	7.60E-27	123.2	RUND1_MOUSE	reviewed	RUN domain-containing protein 1	Rundc1	Mus musculus (Mouse)	615	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN11684_c0_g1_i4	Q9Y265	RUVB1_HUMAN	100	275	0	0	3	827	115	389	9.50E-155	547.4	RUVB1_HUMAN	reviewed	RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha)	RUVBL1 INO80H NMP238 TIP49 TIP49A	Homo sapiens (Human)	456	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0000492; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016579; GO:0016887; GO:0017025; GO:0031011; GO:0034080; GO:0035267; GO:0040008; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0051117; GO:0051301; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:1904837; GO:1904874; GO:1990904	beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11684_c0_g2_i1	Q9Y265	RUVB1_HUMAN	100	91	0	0	1	273	96	186	7.70E-45	180.6	RUVB1_HUMAN	reviewed	RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha)	RUVBL1 INO80H NMP238 TIP49 TIP49A	Homo sapiens (Human)	456	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0000492; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016579; GO:0016887; GO:0017025; GO:0031011; GO:0034080; GO:0035267; GO:0040008; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0051117; GO:0051301; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:1904837; GO:1904874; GO:1990904	beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN25679_c0_g1_i1	Q9Y265	RUVB1_HUMAN	100	90	0	0	271	2	1	90	3.70E-41	168.7	RUVB1_HUMAN	reviewed	RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha)	RUVBL1 INO80H NMP238 TIP49 TIP49A	Homo sapiens (Human)	456	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0000492; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016579; GO:0016887; GO:0017025; GO:0031011; GO:0034080; GO:0035267; GO:0040008; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0051117; GO:0051301; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:1904837; GO:1904874; GO:1990904	beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN20723_c0_g1_i1	P60122	RUVB1_MOUSE	100	151	0	0	454	2	176	326	2.90E-81	302.4	RUVB1_MOUSE	reviewed	RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (DNA helicase p50) (Pontin 52) (TIP49a)	Ruvbl1 Tip49 Tip49a	Mus musculus (Mouse)	456	cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 3'-5' DNA helicase activity [GO:0043138]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of plasminogen activation [GO:0010756]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	3'-5' DNA helicase activity [GO:0043138]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0000492; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007049; GO:0010756; GO:0016363; GO:0016573; GO:0016887; GO:0017025; GO:0031011; GO:0032991; GO:0035267; GO:0040008; GO:0043138; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0051117; GO:0051301; GO:0071339; GO:0090263; GO:0097255; GO:1990904; GO:2000269	box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of plasminogen activation [GO:0010756]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN99_c0_g1_i1	Q9DE26	RUVB1_XENLA	75.2	367	90	1	20	1117	25	391	9.80E-155	547.7	RUVB1_XENLA	reviewed	RuvB-like 1 (EC 3.6.4.12) (Pontin)	ruvbl1	Xenopus laevis (African clawed frog)	456	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]	GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255	DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN11684_c0_g1_i5	Q9DE26	RUVB1_XENLA	77.6	456	102	0	89	1456	1	456	7.30E-201	701.4	RUVB1_XENLA	reviewed	RuvB-like 1 (EC 3.6.4.12) (Pontin)	ruvbl1	Xenopus laevis (African clawed frog)	456	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]	GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255	DNA recombination [GO:0006310]; DNA repair [GO:0006281]		blue	blue	NA	NA	NA	NA
TRINITY_DN11684_c0_g1_i6	Q9DE26	RUVB1_XENLA	86.5	333	45	0	89	1087	1	333	2.20E-162	573.2	RUVB1_XENLA	reviewed	RuvB-like 1 (EC 3.6.4.12) (Pontin)	ruvbl1	Xenopus laevis (African clawed frog)	456	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]	GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255	DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN33314_c0_g1_i1	Q2TBU9	RUVB2_BOVIN	80.9	94	18	0	1	282	18	111	6.10E-37	154.5	RUVB2_BOVIN	reviewed	RuvB-like 2 (EC 3.6.4.12)	RUVBL2	Bos taurus (Bovine)	463	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]	GO:0000492; GO:0000812; GO:0003678; GO:0005524; GO:0005634; GO:0005737; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0016573; GO:0031011; GO:0035267; GO:0043139; GO:0043967; GO:0043968; GO:0071339; GO:0097255	box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN21758_c0_g1_i1	Q9Y230	RUVB2_HUMAN	99.2	123	1	0	2	370	257	379	5.00E-63	241.5	RUVB2_HUMAN	reviewed	RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta)	RUVBL2 INO80J TIP48 TIP49B CGI-46	Homo sapiens (Human)	463	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]	GO:0000492; GO:0000812; GO:0000978; GO:0000979; GO:0001094; GO:0003678; GO:0003714; GO:0005524; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0006457; GO:0008013; GO:0016020; GO:0016363; GO:0016573; GO:0017025; GO:0031011; GO:0031490; GO:0034644; GO:0035066; GO:0035267; GO:0040008; GO:0042802; GO:0042803; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045944; GO:0051082; GO:0051117; GO:0070062; GO:0071169; GO:0071339; GO:0071392; GO:0071733; GO:0071899; GO:0090090; GO:0097255; GO:1904874; GO:1990904	box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN21758_c0_g1_i2	Q9WTM5	RUVB2_MOUSE	99.2	131	1	0	2	394	257	387	2.10E-67	256.1	RUVB2_MOUSE	reviewed	RuvB-like 2 (EC 3.6.4.12) (p47 protein)	Ruvbl2	Mus musculus (Mouse)	463	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]	GO:0000492; GO:0000812; GO:0000978; GO:0000979; GO:0001094; GO:0003678; GO:0003714; GO:0005524; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0008013; GO:0016573; GO:0017025; GO:0031011; GO:0031490; GO:0034644; GO:0035066; GO:0035267; GO:0042802; GO:0042803; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045944; GO:0051117; GO:0071169; GO:0071339; GO:0071392; GO:0071733; GO:0071899; GO:0090090; GO:0097255; GO:1990904	box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN975_c0_g1_i1	Q9WTM5	RUVB2_MOUSE	74.5	137	35	0	412	2	2	138	6.30E-49	194.9	RUVB2_MOUSE	reviewed	RuvB-like 2 (EC 3.6.4.12) (p47 protein)	Ruvbl2	Mus musculus (Mouse)	463	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]	GO:0000492; GO:0000812; GO:0000978; GO:0000979; GO:0001094; GO:0003678; GO:0003714; GO:0005524; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0008013; GO:0016573; GO:0017025; GO:0031011; GO:0031490; GO:0034644; GO:0035066; GO:0035267; GO:0042802; GO:0042803; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045944; GO:0051117; GO:0071169; GO:0071339; GO:0071392; GO:0071733; GO:0071899; GO:0090090; GO:0097255; GO:1990904	box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN12174_c1_g1_i1	Q9WTM5	RUVB2_MOUSE	100	128	0	0	385	2	1	128	2.60E-62	239.2	RUVB2_MOUSE	reviewed	RuvB-like 2 (EC 3.6.4.12) (p47 protein)	Ruvbl2	Mus musculus (Mouse)	463	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]	GO:0000492; GO:0000812; GO:0000978; GO:0000979; GO:0001094; GO:0003678; GO:0003714; GO:0005524; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0008013; GO:0016573; GO:0017025; GO:0031011; GO:0031490; GO:0034644; GO:0035066; GO:0035267; GO:0042802; GO:0042803; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045944; GO:0051117; GO:0071169; GO:0071339; GO:0071392; GO:0071733; GO:0071899; GO:0090090; GO:0097255; GO:1990904	box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]		NA	NA	NA	NA	NA	NA
TRINITY_DN6441_c0_g1_i1	Q9DE27	RUVB2_XENLA	78.1	128	28	0	386	3	263	390	2.90E-53	209.1	RUVB2_XENLA	reviewed	RuvB-like 2 (EC 3.6.4.12) (Reptin)	ruvbl2	Xenopus laevis (African clawed frog)	462	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]	GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255	DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN11684_c0_g1_i3	Q9V3K3	RUVB2_DROME	80.6	139	27	0	3	419	250	388	1.30E-59	230.3	RUVB2_DROME	reviewed	RuvB-like helicase 2 (EC 3.6.4.12) (Dreptin) (Drep) (Reptin)	rept CG9750	Drosophila melanogaster (Fruit fly)	481	histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; transcription corepressor activity [GO:0003714]; box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]	histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; transcription corepressor activity [GO:0003714]	GO:0000123; GO:0000492; GO:0000812; GO:0003678; GO:0003714; GO:0005524; GO:0005634; GO:0006281; GO:0006338; GO:0006342; GO:0006357; GO:0007480; GO:0010629; GO:0016573; GO:0031011; GO:0035072; GO:0035267; GO:0042127; GO:0043139; GO:0043486; GO:0090090; GO:0097255; GO:1901838	box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; DNA repair [GO:0006281]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN5963_c0_g1_i1	Q9CQK7	RWDD1_MOUSE	44.2	240	125	4	827	117	1	234	3.40E-39	163.7	RWDD1_MOUSE	reviewed	RWD domain-containing protein 1 (DRG family-regulatory protein 2) (IH1)	Rwdd1 Dfrp2	Mus musculus (Mouse)	243	cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]	cytoplasm [GO:0005737]; polysome [GO:0005844]		GO:0002181; GO:0005737; GO:0005844; GO:0007569; GO:0030521; GO:0034599; GO:0071394; GO:2000825	androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]		blue	blue	NA	NA	NA	NA
TRINITY_DN5963_c0_g1_i2	Q9CQK7	RWDD1_MOUSE	46.2	145	75	2	542	117	90	234	2.70E-21	104.4	RWDD1_MOUSE	reviewed	RWD domain-containing protein 1 (DRG family-regulatory protein 2) (IH1)	Rwdd1 Dfrp2	Mus musculus (Mouse)	243	cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]	cytoplasm [GO:0005737]; polysome [GO:0005844]		GO:0002181; GO:0005737; GO:0005844; GO:0007569; GO:0030521; GO:0034599; GO:0071394; GO:2000825	androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]		NA	NA	NA	NA	NA	NA
TRINITY_DN5963_c0_g1_i2	Q9CQK7	RWDD1_MOUSE	41.7	96	50	2	915	628	1	90	7.30E-11	69.7	RWDD1_MOUSE	reviewed	RWD domain-containing protein 1 (DRG family-regulatory protein 2) (IH1)	Rwdd1 Dfrp2	Mus musculus (Mouse)	243	cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]	cytoplasm [GO:0005737]; polysome [GO:0005844]		GO:0002181; GO:0005737; GO:0005844; GO:0007569; GO:0030521; GO:0034599; GO:0071394; GO:2000825	androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]		NA	NA	NA	NA	NA	NA
TRINITY_DN14674_c0_g1_i1	P25931	RYAR_DROME	55.8	104	45	1	567	259	304	407	1.70E-25	117.5	RYAR_DROME	reviewed	RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)	RYa-R NepYr CG5811	Drosophila melanogaster (Fruit fly)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0004983; GO:0005886; GO:0007166; GO:0007186; GO:0008188; GO:0016021	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN14674_c0_g1_i2	P25931	RYAR_DROME	55.8	104	45	1	26	334	304	407	1.60E-25	117.5	RYAR_DROME	reviewed	RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)	RYa-R NepYr CG5811	Drosophila melanogaster (Fruit fly)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0004983; GO:0005886; GO:0007166; GO:0007186; GO:0008188; GO:0016021	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN14674_c0_g1_i4	P25931	RYAR_DROME	55.8	104	45	1	26	334	304	407	2.40E-25	117.5	RYAR_DROME	reviewed	RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)	RYa-R NepYr CG5811	Drosophila melanogaster (Fruit fly)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0004983; GO:0005886; GO:0007166; GO:0007186; GO:0008188; GO:0016021	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN36964_c0_g1_i1	P25931	RYAR_DROME	64.9	77	27	0	1	231	159	235	7.20E-20	97.4	RYAR_DROME	reviewed	RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)	RYa-R NepYr CG5811	Drosophila melanogaster (Fruit fly)	464	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0004983; GO:0005886; GO:0007166; GO:0007186; GO:0008188; GO:0016021	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i22	D8VNS7	FCNV1_CERRY	48.3	178	85	4	738	208	130	301	1.80E-43	177.6	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i29	D8VNS7	FCNV1_CERRY	44.9	214	111	4	735	97	130	337	4.80E-49	196.1	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			blue	blue	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i30	D8VNS7	FCNV1_CERRY	45.3	214	110	4	735	97	130	337	1.30E-49	198	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN30749_c1_g1_i1	D8VNS7	FCNV1_CERRY	53.7	67	31	0	3	203	179	245	9.20E-14	77	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g1_i1	D8VNS7	FCNV1_CERRY	53.3	75	34	1	3	224	218	292	7.80E-19	94	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g1_i7	D8VNS7	FCNV1_CERRY	51.1	90	43	1	3	269	218	307	5.90E-21	101.3	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i1	D8VNS7	FCNV1_CERRY	50	184	86	3	149	697	123	301	1.20E-46	188	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i5	D8VNS7	FCNV1_CERRY	51.2	166	75	3	6	500	141	301	3.40E-43	176	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i8	D8VNS7	FCNV1_CERRY	52	150	69	2	1	447	154	301	7.10E-40	164.9	FCNV1_CERRY	reviewed	Ryncolin-1		Cerberus rynchops (Dog-faced water snake)	345	extracellular region [GO:0005576]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	toxin activity [GO:0090729]	GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN881_c0_g1_i1	Q9BY12	SCAPE_HUMAN	51.9	106	48	1	342	34	98	203	3.10E-24	114.8	SCAPE_HUMAN	reviewed	S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)	SCAPER KIAA1454 ZNF291 MSTP063	Homo sapiens (Human)	1400	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN4995_c0_g1_i1	Q9BY12	SCAPE_HUMAN	46.1	102	51	3	48	344	747	847	3.40E-13	76.3	SCAPE_HUMAN	reviewed	S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)	SCAPER KIAA1454 ZNF291 MSTP063	Homo sapiens (Human)	1400	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN4995_c0_g1_i2	Q9BY12	SCAPE_HUMAN	36.2	578	335	13	48	1700	747	1317	3.50E-79	297.4	SCAPE_HUMAN	reviewed	S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)	SCAPER KIAA1454 ZNF291 MSTP063	Homo sapiens (Human)	1400	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN27748_c0_g1_i1	P39450	FRMA_PHODP	85.6	153	22	0	1	459	217	369	1.20E-77	290.4	FRMA_PHODP	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Alcohol dehydrogenase class-3) (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	frmA	Photobacterium damsela subsp. piscicida (Pasteurella piscicida)	369	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	1
TRINITY_DN28515_c0_g1_i1	A7ZIA4	FRMA_ECO24	100	67	0	0	202	2	96	162	2.60E-34	145.2	FRMA_ECO24	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Alcohol dehydrogenase class-3) (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	frmA EcE24377A_0381	Escherichia coli O139:H28 (strain E24377A / ETEC)	369	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN4937_c0_g1_i1	A7ZIA4	FRMA_ECO24	93.5	155	10	0	467	3	31	185	6.50E-84	311.2	FRMA_ECO24	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Alcohol dehydrogenase class-3) (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	frmA EcE24377A_0381	Escherichia coli O139:H28 (strain E24377A / ETEC)	369	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]	cytoplasm [GO:0005737]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN4446_c0_g1_i1	P32771	FADH_YEAST	27.8	212	128	7	682	104	38	243	1.50E-10	68.6	FADH_YEAST	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Alcohol dehydrogenase SFA) (EC 1.1.1.1) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (FLD) (GSH-FDH) (EC 1.1.1.-)	SFA1 SFA YDL168W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	386	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; hydroxymethylfurfural reductase (NADH) activity [GO:0033833]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; amino acid catabolic process to alcohol via Ehrlich pathway [GO:0000947]; ethanol oxidation [GO:0006069]; formaldehyde catabolic process [GO:0046294]; furaldehyde metabolic process [GO:0033859]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	"alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; hydroxymethylfurfural reductase (NADH) activity [GO:0033833]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]"	GO:0000947; GO:0004022; GO:0004024; GO:0005737; GO:0005739; GO:0005829; GO:0006069; GO:0008270; GO:0033833; GO:0033859; GO:0046294; GO:0051903	amino acid catabolic process to alcohol via Ehrlich pathway [GO:0000947]; ethanol oxidation [GO:0006069]; formaldehyde catabolic process [GO:0046294]; furaldehyde metabolic process [GO:0033859]		NA	NA	NA	NA	NA	NA
TRINITY_DN1174_c0_g1_i1	P45382	FADH_PARDE	84	94	15	0	24	305	261	354	6.20E-43	174.5	FADH_PARDE	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	flhA	Paracoccus denitrificans	375	S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]		S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN29544_c0_g1_i1	P45382	FADH_PARDE	72.1	111	25	1	316	2	233	343	5.70E-44	177.9	FADH_PARDE	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	flhA	Paracoccus denitrificans	375	S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]		S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN5992_c0_g1_i1	P45382	FADH_PARDE	74	127	27	1	2	364	215	341	3.30E-51	202.2	FADH_PARDE	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	flhA	Paracoccus denitrificans	375	S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]		S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN348_c0_g1_i1	P45382	FADH_PARDE	82.4	125	21	1	382	11	64	188	2.70E-56	219.2	FADH_PARDE	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	flhA	Paracoccus denitrificans	375	S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]		S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN348_c0_g1_i2	P45382	FADH_PARDE	80.4	148	28	1	443	3	64	211	4.10E-64	245.4	FADH_PARDE	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	flhA	Paracoccus denitrificans	375	S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]		S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN348_c0_g2_i1	P45382	FADH_PARDE	87.1	70	8	1	209	3	71	140	1.10E-30	133.3	FADH_PARDE	reviewed	S-(hydroxymethyl)glutathione dehydrogenase (EC 1.1.1.284) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-)	flhA	Paracoccus denitrificans	375	S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]		S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]	GO:0006069; GO:0008270; GO:0051903	ethanol oxidation [GO:0006069]		NA	NA	NA	NA	NA	NA
TRINITY_DN18865_c0_g1_i1	Q497V5	SRBD1_MOUSE	33.5	319	186	8	1055	123	191	491	7.90E-41	169.5	SRBD1_MOUSE	reviewed	S1 RNA-binding domain-containing protein 1	Srbd1	Mus musculus (Mouse)	982	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]		mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0006139; GO:0006412	nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN18865_c0_g1_i2	Q497V5	SRBD1_MOUSE	33.6	333	195	8	979	5	191	505	2.40E-44	181	SRBD1_MOUSE	reviewed	S1 RNA-binding domain-containing protein 1	Srbd1	Mus musculus (Mouse)	982	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]		mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0006139; GO:0006412	nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN2192_c0_g1_i1	Q8NBX0	SCPDL_HUMAN	41.8	423	235	6	116	1372	8	423	2.70E-83	310.8	SCPDL_HUMAN	reviewed	Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-)	SCCPDH CGI-49	Homo sapiens (Human)	429	extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576]	extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	oxidoreductase activity [GO:0016491]	GO:0002576; GO:0005576; GO:0005634; GO:0005739; GO:0005811; GO:0005886; GO:0009247; GO:0016020; GO:0016491; GO:0030496; GO:0031093	glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576]		blue	blue	NA	NA	NA	NA
TRINITY_DN1057_c0_g1_i2	Q5R5C9	SCPDL_PONAB	34.3	233	148	2	788	93	196	424	1.00E-33	145.2	SCPDL_PONAB	reviewed	Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-)	SCCPDH	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	429	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			blue	blue	NA	NA	NA	NA
TRINITY_DN40833_c0_g1_i1	Q8NBX0	SCPDL_HUMAN	100	80	0	0	2	241	87	166	1.60E-41	169.5	SCPDL_HUMAN	reviewed	Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-)	SCCPDH CGI-49	Homo sapiens (Human)	429	extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576]	extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	oxidoreductase activity [GO:0016491]	GO:0002576; GO:0005576; GO:0005634; GO:0005739; GO:0005811; GO:0005886; GO:0009247; GO:0016020; GO:0016491; GO:0030496; GO:0031093	glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN11063_c0_g1_i11	Q9NZJ4	SACS_HUMAN	45.5	88	48	0	54	317	115	202	1.70E-16	87.8	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11063_c0_g1_i12	Q9NZJ4	SACS_HUMAN	47.1	87	46	0	54	314	115	201	7.00E-18	91.7	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11063_c0_g1_i13	Q9NZJ4	SACS_HUMAN	45.5	88	48	0	54	317	115	202	1.70E-16	87.8	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11063_c0_g1_i15	Q9NZJ4	SACS_HUMAN	44.1	93	52	0	54	332	115	207	4.30E-16	85.5	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i1	Q9NZJ4	SACS_HUMAN	42.3	137	63	2	113	487	96	228	1.30E-23	112.1	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i10	Q9NZJ4	SACS_HUMAN	37.4	257	146	4	142	882	94	345	8.30E-40	165.6	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i11	Q9NZJ4	SACS_HUMAN	45.2	124	68	0	148	519	96	219	6.10E-26	119	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i12	Q9NZJ4	SACS_HUMAN	43.2	139	63	2	142	522	94	228	1.90E-25	117.5	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i13	Q9NZJ4	SACS_HUMAN	37.6	255	144	4	113	847	96	345	7.40E-40	166	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i2	Q9NZJ4	SACS_HUMAN	38.5	257	143	4	142	882	94	345	2.00E-41	171	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i3	Q9NZJ4	SACS_HUMAN	37.2	282	157	5	142	942	94	370	2.50E-43	177.6	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i5	Q9NZJ4	SACS_HUMAN	38.1	257	144	4	142	882	94	345	1.80E-41	171.4	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i7	Q9NZJ4	SACS_HUMAN	41	117	53	2	116	430	116	228	6.10E-18	92	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN116_c0_g1_i9	Q9NZJ4	SACS_HUMAN	43.3	141	62	3	107	493	94	228	7.50E-26	118.6	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN10142_c0_g1_i1	Q9NZJ4	SACS_HUMAN	62	50	19	0	239	90	152	201	2.60E-14	79.3	SACS_HUMAN	reviewed	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	SACS KIAA0730	Homo sapiens (Human)	4579	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]		brown	brown	NA	NA	NA	NA
TRINITY_DN23068_c0_g1_i1	O43865	SAHH2_HUMAN	99.3	138	1	0	1	414	393	530	1.00E-75	283.9	SAHH2_HUMAN	reviewed	S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2) (AdoHcyase 2)	AHCYL1 DCAL IRBIT XPVKONA	Homo sapiens (Human)	530	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of cardiac conduction [GO:1903779]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0006915; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0044233; GO:0051592; GO:0070062; GO:1903779; GO:1990456	angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of cardiac conduction [GO:1903779]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN23068_c0_g1_i2	O43865	SAHH2_HUMAN	100	417	0	0	1	1251	114	530	2.30E-248	859	SAHH2_HUMAN	reviewed	S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2) (AdoHcyase 2)	AHCYL1 DCAL IRBIT XPVKONA	Homo sapiens (Human)	530	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of cardiac conduction [GO:1903779]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0006915; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0044233; GO:0051592; GO:0070062; GO:1903779; GO:1990456	angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of cardiac conduction [GO:1903779]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353]		NA	NA	NA	NA	NA	NA
TRINITY_DN4155_c0_g1_i1	P91931	DCAM_DROME	44.2	120	60	2	84	443	104	216	1.90E-23	110.5	DCAM_DROME	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	SamDC CG5029	Drosophila melanogaster (Fruit fly)	347	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN4155_c0_g1_i2	P91931	DCAM_DROME	45.5	242	123	3	32	757	106	338	1.50E-56	221.1	DCAM_DROME	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	SamDC CG5029	Drosophila melanogaster (Fruit fly)	347	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN4155_c0_g1_i3	P91931	DCAM_DROME	50	320	150	4	17	976	29	338	2.70E-82	307	DCAM_DROME	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	SamDC CG5029	Drosophila melanogaster (Fruit fly)	347	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN4155_c0_g1_i4	P91931	DCAM_DROME	45.5	244	124	3	334	1065	104	338	2.50E-57	224.2	DCAM_DROME	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	SamDC CG5029	Drosophila melanogaster (Fruit fly)	347	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN4155_c0_g1_i4	P91931	DCAM_DROME	64.9	77	26	1	17	247	29	104	1.90E-17	91.7	DCAM_DROME	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	SamDC CG5029	Drosophila melanogaster (Fruit fly)	347	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN37652_c0_g1_i1	P50243	DCAM_BOVIN	100	73	0	0	3	221	220	292	4.30E-38	157.9	DCAM_BOVIN	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	AMD1	Bos taurus (Bovine)	334	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0019810	S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN30553_c0_g1_i1	P50243	DCAM_BOVIN	39.8	103	51	3	6	311	188	280	3.90E-16	85.5	DCAM_BOVIN	reviewed	S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]	AMD1	Bos taurus (Bovine)	334	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0019810	S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN37581_c0_g1_i1	P0DMN7	DCAM1_MOUSE	100	84	0	0	2	253	32	115	6.90E-40	164.1	DCAM1_MOUSE	reviewed	S-adenosylmethionine decarboxylase proenzyme 1 (AdoMetDC 1) (SAMDC 1) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase 1 alpha chain; S-adenosylmethionine decarboxylase 1 beta chain]	Amd1	Mus musculus (Mouse)	334	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; identical protein binding [GO:0042802]; putrescine binding [GO:0019810]; in utero embryonic development [GO:0001701]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]	adenosylmethionine decarboxylase activity [GO:0004014]; identical protein binding [GO:0042802]; putrescine binding [GO:0019810]	GO:0001701; GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0019810; GO:0042802	in utero embryonic development [GO:0001701]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN26226_c0_g1_i1	A5VBQ3	METK_SPHWW	84.1	69	11	0	208	2	94	162	2.90E-28	125.2	METK_SPHWW	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK Swit_3373	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	402	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN3584_c0_g1_i1	B2UD22	METK_RALPJ	98.8	83	1	0	249	1	207	289	1.60E-41	169.5	METK_RALPJ	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK Rpic_0036	Ralstonia pickettii (strain 12J)	396	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN3584_c0_g2_i1	Q6A8H3	METK_CUTAK	100	87	0	0	263	3	237	323	1.30E-44	179.9	METK_CUTAK	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK PPA1193	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	397	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN6694_c0_g1_i1	Q5NQV7	METK_ZYMMO	83.1	124	21	0	373	2	209	332	4.60E-56	218.4	METK_ZYMMO	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK ZMO0273	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	391	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN6694_c0_g2_i1	Q2N5U2	METK_ERYLH	81.2	96	18	0	291	4	217	312	1.20E-38	160.2	METK_ERYLH	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK ELI_14285	Erythrobacter litoralis (strain HTCC2594)	403	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN6262_c1_g1_i1	A6T2Z1	METK_JANMA	89.9	69	7	0	208	2	92	160	1.40E-30	132.9	METK_JANMA	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK mma_3198	Janthinobacterium sp. (strain Marseille) (Minibacterium massiliensis)	387	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN6262_c0_g1_i1	B2UD22	METK_RALPJ	98.6	71	1	0	2	214	29	99	1.40E-33	142.9	METK_RALPJ	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase)	metK Rpic_0036	Ralstonia pickettii (strain 12J)	396	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478]	GO:0000287; GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN435_c0_g1_i1	P40320	METK_DROME	73.4	402	101	2	65	1258	5	404	1.00E-177	624.4	METK_DROME	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	Sam-S M(2)21AB SamS CG2674	Drosophila melanogaster (Fruit fly)	408	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0008340; GO:0046872	determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		blue	blue	NA	NA	NA	NA
TRINITY_DN435_c0_g1_i2	P40320	METK_DROME	73.3	296	79	0	484	1371	109	404	4.80E-133	476.1	METK_DROME	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	Sam-S M(2)21AB SamS CG2674	Drosophila melanogaster (Fruit fly)	408	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0008340; GO:0046872	determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN435_c0_g1_i2	P40320	METK_DROME	71.9	146	35	2	65	490	5	148	9.90E-54	212.6	METK_DROME	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	Sam-S M(2)21AB SamS CG2674	Drosophila melanogaster (Fruit fly)	408	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0008340; GO:0046872	determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN435_c0_g1_i3	P40320	METK_DROME	73.4	402	101	2	65	1258	5	404	8.50E-177	621.3	METK_DROME	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	Sam-S M(2)21AB SamS CG2674	Drosophila melanogaster (Fruit fly)	408	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0008340; GO:0046872	determination of adult lifespan [GO:0008340]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN21809_c0_g1_i1	P93254	METK_MESCR	78.5	135	25	2	1	402	217	348	5.40E-55	214.9	METK_MESCR	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	METK	Mesembryanthemum crystallinum (Common ice plant) (Cryophytum crystallinum)	392	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN4186_c0_g2_i1	B0LXM0	METK_WHEAT	75.2	141	31	2	425	6	212	349	2.40E-56	219.5	METK_WHEAT	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	SAMS	Triticum aestivum (Wheat)	396	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN27109_c0_g1_i1	A8HYU5	METK_CHLRE	75.9	158	37	1	490	17	175	331	8.30E-66	251.1	METK_CHLRE	reviewed	S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT)	METM CHLREDRAFT_182408	Chlamydomonas reinhardtii (Chlamydomonas smithii)	390	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN21809_c0_g2_i1	A9NUH8	METK1_PICSI	76.6	77	14	1	8	226	96	172	5.00E-26	117.9	METK1_PICSI	reviewed	S-adenosylmethionine synthase 1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1)	METK1	Picea sitchensis (Sitka spruce) (Pinus sitchensis)	393	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN27540_c0_g1_i1	Q9FVG7	METK2_PINCO	75	160	40	0	39	518	4	163	2.20E-64	246.5	METK2_PINCO	reviewed	S-adenosylmethionine synthase 2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2)	SAMS2	Pinus contorta (Shore pine) (Lodgepole pine)	393	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN4186_c0_g1_i1	Q94FA5	METK4_BRAJU	71	169	46	1	498	1	4	172	1.40E-63	243.8	METK4_BRAJU	reviewed	S-adenosylmethionine synthase 4 (AdoMet synthase 4) (EC 2.5.1.6) (Methionine adenosyltransferase 4) (MAT 4)	MSAMS4	Brassica juncea (Indian mustard) (Sinapis juncea)	390	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005737; GO:0006556; GO:0006730; GO:0046872	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN9989_c0_g1_i1	Q9LUT2	METK4_ARATH	75	76	19	0	48	275	3	78	3.50E-29	128.6	METK4_ARATH	reviewed	S-adenosylmethionine synthase 4 (AdoMet synthase 4) (EC 2.5.1.6) (Methionine adenosyltransferase 4) (MAT 4)	METK4 MTO3 SAMS3 At3g17390 MGD8.23	Arabidopsis thaliana (Mouse-ear cress)	393	cell wall [GO:0005618]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; mRNA binding [GO:0003729]; lignin biosynthetic process [GO:0009809]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; response to cold [GO:0009409]; S-adenosylmethionine biosynthetic process [GO:0006556]	cell wall [GO:0005618]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; mRNA binding [GO:0003729]	GO:0003729; GO:0004478; GO:0005524; GO:0005618; GO:0005730; GO:0005829; GO:0005886; GO:0006555; GO:0006556; GO:0006730; GO:0009409; GO:0009506; GO:0009809; GO:0046872	lignin biosynthetic process [GO:0009809]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; response to cold [GO:0009409]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN11470_c0_g1_i2	Q3THS6	METK2_MOUSE	100	362	0	0	1128	43	1	362	1.10E-209	730.3	METK2_MOUSE	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2)	Mat2a	Mus musculus (Mouse)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; circadian rhythm [GO:0007623]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to hormone [GO:0009725]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0007623; GO:0009725; GO:0016597; GO:0034214; GO:0042493; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0051591; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; circadian rhythm [GO:0007623]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to hormone [GO:0009725]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN11470_c0_g1_i6	Q3THS6	METK2_MOUSE	100	395	0	0	1189	5	1	395	1.80E-231	802.7	METK2_MOUSE	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2)	Mat2a	Mus musculus (Mouse)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; circadian rhythm [GO:0007623]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to hormone [GO:0009725]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0007623; GO:0009725; GO:0016597; GO:0034214; GO:0042493; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0051591; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; circadian rhythm [GO:0007623]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to hormone [GO:0009725]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN15093_c0_g1_i1	P31153	METK2_HUMAN	51.1	92	45	0	276	1	82	173	3.70E-21	102.1	METK2_HUMAN	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)	MAT2A AMS2 MATA2	Homo sapiens (Human)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0032259; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN11470_c0_g1_i1	P31153	METK2_HUMAN	100	107	0	0	363	43	256	362	5.10E-56	218.4	METK2_HUMAN	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)	MAT2A AMS2 MATA2	Homo sapiens (Human)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0032259; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN11470_c0_g1_i3	P31153	METK2_HUMAN	100	395	0	0	1189	5	1	395	2.40E-231	802.4	METK2_HUMAN	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)	MAT2A AMS2 MATA2	Homo sapiens (Human)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0032259; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN11470_c0_g1_i4	P31153	METK2_HUMAN	100	140	0	0	424	5	256	395	1.20E-77	290.4	METK2_HUMAN	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)	MAT2A AMS2 MATA2	Homo sapiens (Human)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0032259; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN11470_c0_g1_i5	P31153	METK2_HUMAN	100	362	0	0	1128	43	1	362	1.40E-209	729.9	METK2_HUMAN	reviewed	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)	MAT2A AMS2 MATA2	Homo sapiens (Human)	395	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0032259; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c0_g1_i4	Q9NWH9	SLTM_HUMAN	42.7	82	42	1	1026	781	20	96	1.90E-09	65.1	SLTM_HUMAN	reviewed	SAFB-like transcription modulator (Modulator of estrogen-induced transcription)	SLTM MET	Homo sapiens (Human)	1034	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684	apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c0_g1_i5	Q9NWH9	SLTM_HUMAN	42.7	82	42	1	909	664	20	96	1.70E-09	65.1	SLTM_HUMAN	reviewed	SAFB-like transcription modulator (Modulator of estrogen-induced transcription)	SLTM MET	Homo sapiens (Human)	1034	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684	apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN33819_c0_g1_i1	Q9NWH9	SLTM_HUMAN	100	67	0	0	41	241	383	449	1.20E-30	133.3	SLTM_HUMAN	reviewed	SAFB-like transcription modulator (Modulator of estrogen-induced transcription)	SLTM MET	Homo sapiens (Human)	1034	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684	apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38396_c0_g1_i1	Q9NWH9	SLTM_HUMAN	100	72	0	0	216	1	6	77	3.80E-31	134.8	SLTM_HUMAN	reviewed	SAFB-like transcription modulator (Modulator of estrogen-induced transcription)	SLTM MET	Homo sapiens (Human)	1034	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684	apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35216_c0_g1_i1	Q96ES7	SGF29_HUMAN	100	59	0	0	225	49	235	293	2.20E-29	129	SGF29_HUMAN	reviewed	SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29)	SGF29 CCDC101	Homo sapiens (Human)	293	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]	enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]	GO:0000124; GO:0005671; GO:0016573; GO:0019899; GO:0035064; GO:0043966; GO:0047485; GO:0070461; GO:0071169	establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]		NA	NA	NA	NA	NA	NA
TRINITY_DN35058_c0_g1_i1	Q9DA08	SGF29_MOUSE	100	67	0	0	247	47	227	293	5.50E-34	144.4	SGF29_MOUSE	reviewed	SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29)	Sgf29 Ccdc101	Mus musculus (Mouse)	293	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]	enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]	GO:0000124; GO:0005634; GO:0005671; GO:0016573; GO:0019899; GO:0035064; GO:0043966; GO:0047485; GO:0070461	histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]		NA	NA	NA	NA	NA	NA
TRINITY_DN8885_c0_g1_i1	P0C606	SGF29_RAT	48.9	284	138	1	941	111	10	293	4.60E-73	276.6	SGF29_RAT	reviewed	SAGA-associated factor 29 (rSGF29) (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29)	Sgf29 Ccdc101	Rattus norvegicus (Rat)	293	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]	enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]	GO:0000124; GO:0005634; GO:0005671; GO:0016573; GO:0019899; GO:0035064; GO:0043966; GO:0047485; GO:0070461	histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]		NA	NA	NA	NA	NA	NA
TRINITY_DN38236_c0_g1_i1	P0A391	NAHF_PSEPU	79.1	67	14	0	6	206	220	286	9.70E-24	110.2	NAHF_PSEPU	reviewed	Salicylaldehyde dehydrogenase (EC 1.2.1.65)	nahF	Pseudomonas putida (Arthrobacter siderocapsulatus)	483	salicylaldehyde dehydrogenase activity [GO:0018485]; aromatic compound catabolic process [GO:0019439]		salicylaldehyde dehydrogenase activity [GO:0018485]	GO:0018485; GO:0019439	aromatic compound catabolic process [GO:0019439]		NA	NA	NA	NA	NA	NA
TRINITY_DN33519_c0_g1_i1	Q14BN4	SLMAP_HUMAN	100	98	0	0	2	295	37	134	1.30E-53	209.9	SLMAP_HUMAN	reviewed	Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)	SLMAP KIAA1601 SLAP UNQ1847/PRO3577	Homo sapiens (Human)	828	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]		GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]		NA	NA	NA	NA	NA	NA
TRINITY_DN1630_c0_g1_i2	Q14BN4	SLMAP_HUMAN	73.5	136	34	1	558	157	3	138	2.00E-55	216.9	SLMAP_HUMAN	reviewed	Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)	SLMAP KIAA1601 SLAP UNQ1847/PRO3577	Homo sapiens (Human)	828	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]		GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]		NA	NA	NA	NA	NA	NA
TRINITY_DN1630_c0_g1_i3	Q14BN4	SLMAP_HUMAN	63.5	271	87	2	917	141	3	273	2.70E-89	330.1	SLMAP_HUMAN	reviewed	Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)	SLMAP KIAA1601 SLAP UNQ1847/PRO3577	Homo sapiens (Human)	828	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]		GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]		NA	NA	NA	NA	NA	NA
TRINITY_DN1630_c0_g1_i4	Q14BN4	SLMAP_HUMAN	61.4	207	70	1	731	141	67	273	1.80E-61	237.7	SLMAP_HUMAN	reviewed	Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)	SLMAP KIAA1601 SLAP UNQ1847/PRO3577	Homo sapiens (Human)	828	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]		GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]		NA	NA	NA	NA	NA	NA
TRINITY_DN1630_c0_g1_i4	Q14BN4	SLMAP_HUMAN	72.6	62	17	0	901	716	3	64	2.90E-19	97.4	SLMAP_HUMAN	reviewed	Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)	SLMAP KIAA1601 SLAP UNQ1847/PRO3577	Homo sapiens (Human)	828	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]		GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]		NA	NA	NA	NA	NA	NA
TRINITY_DN30974_c0_g1_i1	P70083	AT2A1_MAKNI	80	95	18	1	285	4	269	363	2.10E-37	156	AT2A1_MAKNI	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) (SR Ca(2+)-ATPase 1) (EC 7.2.2.10) (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	atp2a1	Makaira nigricans (Atlantic blue marlin)	996	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transport [GO:0006816]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; regulation of striated muscle contraction [GO:0006942]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum membrane [GO:0005789]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]"	GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005789; GO:0005793; GO:0006816; GO:0006942; GO:0016020; GO:0016021; GO:0016529; GO:0016887; GO:0031448; GO:0031673; GO:0031674; GO:0033017; GO:0045988; GO:0048471; GO:1990036	calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transport [GO:0006816]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; regulation of striated muscle contraction [GO:0006942]		NA	NA	NA	NA	NA	NA
TRINITY_DN26224_c0_g1_i1	O55143	AT2A2_MOUSE	100	83	0	0	250	2	560	642	1.50E-42	172.9	AT2A2_MOUSE	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	Atp2a2	Mus musculus (Mouse)	1044	"apical ectoplasmic specialization [GO:0061831]; calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection [GO:0120025]; protein-containing complex [GO:0032991]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; lutropin-choriogonadotropic hormone receptor binding [GO:0031775]; protein C-terminus binding [GO:0008022]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; S100 protein binding [GO:0044548]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular calcium ion homeostasis [GO:0006874]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER-nucleus signaling pathway [GO:0006984]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; organelle organization [GO:0006996]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of muscle contraction [GO:0006937]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; skeletal muscle contraction [GO:0003009]; T-tubule organization [GO:0033292]; transition between fast and slow fiber [GO:0014883]"	apical ectoplasmic specialization [GO:0061831]; calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection [GO:0120025]; protein-containing complex [GO:0032991]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; lutropin-choriogonadotropic hormone receptor binding [GO:0031775]; protein C-terminus binding [GO:0008022]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; S100 protein binding [GO:0044548]"	GO:0002026; GO:0003009; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006937; GO:0006984; GO:0006996; GO:0008022; GO:0008553; GO:0010882; GO:0012506; GO:0014801; GO:0014883; GO:0014898; GO:0016020; GO:0016529; GO:0016887; GO:0019899; GO:0031234; GO:0031775; GO:0032469; GO:0032470; GO:0032496; GO:0032991; GO:0033017; GO:0033292; GO:0034599; GO:0034605; GO:0043434; GO:0044325; GO:0044548; GO:0045822; GO:0048471; GO:0055119; GO:0061831; GO:0070296; GO:0070588; GO:0086036; GO:0086039; GO:0090534; GO:0097470; GO:0098909; GO:0120025; GO:1900121; GO:1903233; GO:1903515; GO:1990036	calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular calcium ion homeostasis [GO:0006874]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER-nucleus signaling pathway [GO:0006984]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; organelle organization [GO:0006996]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of muscle contraction [GO:0006937]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN33659_c0_g1_i1	P16615	AT2A2_HUMAN	100	68	0	0	206	3	345	412	1.60E-34	146	AT2A2_HUMAN	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A2 ATP2B	Homo sapiens (Human)	1042	"apical ectoplasmic specialization [GO:0061831]; calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection [GO:0120025]; platelet dense tubular network membrane [GO:0031095]; protein-containing complex [GO:0032991]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; lutropin-choriogonadotropic hormone receptor binding [GO:0031775]; protein C-terminus binding [GO:0008022]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; S100 protein binding [GO:0044548]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epidermis development [GO:0008544]; ER-nucleus signaling pathway [GO:0006984]; ion transmembrane transport [GO:0034220]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; organelle organization [GO:0006996]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of heart rate [GO:0010460]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; skeletal muscle contraction [GO:0003009]; T-tubule organization [GO:0033292]; transition between fast and slow fiber [GO:0014883]"	apical ectoplasmic specialization [GO:0061831]; calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection [GO:0120025]; platelet dense tubular network membrane [GO:0031095]; protein-containing complex [GO:0032991]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; lutropin-choriogonadotropic hormone receptor binding [GO:0031775]; protein C-terminus binding [GO:0008022]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; S100 protein binding [GO:0044548]"	GO:0002026; GO:0003009; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005789; GO:0005887; GO:0006874; GO:0006984; GO:0006996; GO:0007155; GO:0008022; GO:0008544; GO:0008553; GO:0010460; GO:0010882; GO:0012506; GO:0014801; GO:0014883; GO:0014898; GO:0016020; GO:0016529; GO:0016887; GO:0019899; GO:0031095; GO:0031234; GO:0031775; GO:0032469; GO:0032470; GO:0032496; GO:0032991; GO:0033017; GO:0033292; GO:0034220; GO:0034599; GO:0034605; GO:0034976; GO:0044325; GO:0044548; GO:0045822; GO:0048471; GO:0055119; GO:0061831; GO:0070296; GO:0070588; GO:0086036; GO:0086039; GO:0090534; GO:0097470; GO:0098909; GO:0120025; GO:1900121; GO:1903233; GO:1903515; GO:1903779; GO:1990036	calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epidermis development [GO:0008544]; ER-nucleus signaling pathway [GO:0006984]; ion transmembrane transport [GO:0034220]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; organelle organization [GO:0006996]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of heart rate [GO:0010460]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN40047_c0_g1_i1	Q00779	AT2A2_FELCA	100	98	0	0	295	2	283	380	9.40E-49	193.7	AT2A2_FELCA	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A2	Felis catus (Cat) (Felis silvestris catus)	997	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0010882; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588; GO:0086039	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]		NA	NA	NA	NA	NA	NA
TRINITY_DN38116_c0_g1_i1	O46674	AT2A2_CANLF	100	75	0	0	2	226	84	158	6.60E-34	144.1	AT2A2_CANLF	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A2	Canis lupus familiaris (Dog) (Canis familiaris)	997	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0010882; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588; GO:0086039	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]		NA	NA	NA	NA	NA	NA
TRINITY_DN6335_c0_g1_i1	O46674	AT2A2_CANLF	99.2	119	1	0	2	358	696	814	1.90E-59	229.6	AT2A2_CANLF	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A2	Canis lupus familiaris (Dog) (Canis familiaris)	997	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0010882; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588; GO:0086039	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]		NA	NA	NA	NA	NA	NA
TRINITY_DN6335_c0_g1_i4	O46674	AT2A2_CANLF	100	86	0	0	2	259	696	781	2.00E-39	162.5	AT2A2_CANLF	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A2	Canis lupus familiaris (Dog) (Canis familiaris)	997	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0010882; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588; GO:0086039	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]		NA	NA	NA	NA	NA	NA
TRINITY_DN31071_c0_g1_i1	O46674	AT2A2_CANLF	100	76	0	0	1	228	27	102	6.60E-34	144.1	AT2A2_CANLF	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A2	Canis lupus familiaris (Dog) (Canis familiaris)	997	"integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]"	integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0006874; GO:0008553; GO:0010882; GO:0016021; GO:0016887; GO:0033017; GO:0046872; GO:0070588; GO:0086039	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]		NA	NA	NA	NA	NA	NA
TRINITY_DN34835_c0_g1_i1	O55143	AT2A2_MOUSE	100	142	0	0	428	3	420	561	3.10E-77	288.9	AT2A2_MOUSE	reviewed	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	Atp2a2	Mus musculus (Mouse)	1044	"apical ectoplasmic specialization [GO:0061831]; calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection [GO:0120025]; protein-containing complex [GO:0032991]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; lutropin-choriogonadotropic hormone receptor binding [GO:0031775]; protein C-terminus binding [GO:0008022]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; S100 protein binding [GO:0044548]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular calcium ion homeostasis [GO:0006874]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER-nucleus signaling pathway [GO:0006984]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; organelle organization [GO:0006996]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of muscle contraction [GO:0006937]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; skeletal muscle contraction [GO:0003009]; T-tubule organization [GO:0033292]; transition between fast and slow fiber [GO:0014883]"	apical ectoplasmic specialization [GO:0061831]; calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane bounded cell projection [GO:0120025]; protein-containing complex [GO:0032991]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle membrane [GO:0012506]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; lutropin-choriogonadotropic hormone receptor binding [GO:0031775]; protein C-terminus binding [GO:0008022]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; S100 protein binding [GO:0044548]"	GO:0002026; GO:0003009; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006937; GO:0006984; GO:0006996; GO:0008022; GO:0008553; GO:0010882; GO:0012506; GO:0014801; GO:0014883; GO:0014898; GO:0016020; GO:0016529; GO:0016887; GO:0019899; GO:0031234; GO:0031775; GO:0032469; GO:0032470; GO:0032496; GO:0032991; GO:0033017; GO:0033292; GO:0034599; GO:0034605; GO:0043434; GO:0044325; GO:0044548; GO:0045822; GO:0048471; GO:0055119; GO:0061831; GO:0070296; GO:0070588; GO:0086036; GO:0086039; GO:0090534; GO:0097470; GO:0098909; GO:0120025; GO:1900121; GO:1903233; GO:1903515; GO:1990036	calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular calcium ion homeostasis [GO:0006874]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER-nucleus signaling pathway [GO:0006984]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; organelle organization [GO:0006996]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of muscle contraction [GO:0006937]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN15584_c0_g1_i1	Q93084	AT2A3_HUMAN	100	98	0	0	297	4	290	387	1.80E-47	189.5	AT2A3_HUMAN	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	ATP2A3	Homo sapiens (Human)	999	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN27723_c0_g1_i1	Q93084	AT2A3_HUMAN	99.2	132	1	0	2	397	12	143	2.30E-66	252.7	AT2A3_HUMAN	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	ATP2A3	Homo sapiens (Human)	999	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN39766_c0_g1_i1	Q93084	AT2A3_HUMAN	100	103	0	0	1	309	95	197	2.60E-49	195.7	AT2A3_HUMAN	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	ATP2A3	Homo sapiens (Human)	999	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN12931_c0_g1_i1	Q64518	AT2A3_MOUSE	99.2	236	2	0	2	709	679	914	6.90E-130	464.5	AT2A3_MOUSE	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	Atp2a3	Mus musculus (Mouse)	999	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of receptor binding [GO:1900121]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0032469; GO:0033017; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:1900121; GO:1903515	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of receptor binding [GO:1900121]		NA	NA	NA	NA	NA	NA
TRINITY_DN12931_c0_g1_i2	Q64518	AT2A3_MOUSE	98.7	77	1	0	2	232	679	755	1.50E-33	142.9	AT2A3_MOUSE	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	Atp2a3	Mus musculus (Mouse)	999	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of receptor binding [GO:1900121]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0032469; GO:0033017; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:1900121; GO:1903515	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of receptor binding [GO:1900121]		NA	NA	NA	NA	NA	NA
TRINITY_DN12931_c0_g1_i3	Q93084	AT2A3_HUMAN	100	236	0	0	2	709	679	914	1.40E-130	466.8	AT2A3_HUMAN	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	ATP2A3	Homo sapiens (Human)	999	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN35295_c0_g1_i1	Q93084	AT2A3_HUMAN	98.5	68	1	0	2	205	648	715	4.30E-32	137.9	AT2A3_HUMAN	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	ATP2A3	Homo sapiens (Human)	999	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN40089_c0_g1_i1	Q64518	AT2A3_MOUSE	100	69	0	0	1	207	570	638	8.40E-36	150.2	AT2A3_MOUSE	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	Atp2a3	Mus musculus (Mouse)	999	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of receptor binding [GO:1900121]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0032469; GO:0033017; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:1900121; GO:1903515	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of receptor binding [GO:1900121]		NA	NA	NA	NA	NA	NA
TRINITY_DN40423_c0_g1_i1	Q93084	AT2A3_HUMAN	100	83	0	0	252	4	571	653	4.60E-44	177.9	AT2A3_HUMAN	reviewed	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3)	ATP2A3	Homo sapiens (Human)	999	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calcium ion transmembrane transporter activity [GO:0015085]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008553; GO:0008656; GO:0015085; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN16527_c0_g1_i1	Q99LB7	SARDH_MOUSE	57.6	278	116	2	832	2	596	872	1.10E-89	331.3	SARDH_MOUSE	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)"	Sardh	Mus musculus (Mouse)	919	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053	sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN16527_c0_g1_i3	Q64380	SARDH_RAT	52.9	140	65	1	441	25	596	735	2.30E-35	149.8	SARDH_RAT	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)"	Sardh	Rattus norvegicus (Rat)	919	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053	choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN18332_c0_g1_i1	Q99LB7	SARDH_MOUSE	64.7	116	40	1	346	2	64	179	3.40E-38	159.1	SARDH_MOUSE	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)"	Sardh	Mus musculus (Mouse)	919	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053	sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN31416_c0_g1_i1	Q99LB7	SARDH_MOUSE	49.4	77	39	0	45	275	396	472	2.60E-19	95.9	SARDH_MOUSE	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)"	Sardh	Mus musculus (Mouse)	919	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053	sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN40725_c0_g1_i1	Q9UL12	SARDH_HUMAN	59.1	93	36	2	6	278	375	467	1.10E-25	117.1	SARDH_HUMAN	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	918	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053	choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]		NA	NA	NA	NA	NA	NA
TRINITY_DN37741_c0_g1_i1	Q9UL12	SARDH_HUMAN	48.4	91	47	0	276	4	651	741	5.40E-22	104.8	SARDH_HUMAN	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	918	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053	choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]		NA	NA	NA	NA	NA	NA
TRINITY_DN34888_c0_g1_i1	Q9UL12	SARDH_HUMAN	74	73	19	0	6	224	745	817	6.10E-25	114.8	SARDH_HUMAN	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	918	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053	choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]		NA	NA	NA	NA	NA	NA
TRINITY_DN34888_c0_g1_i2	Q9UL12	SARDH_HUMAN	65.2	132	45	1	6	401	745	875	7.30E-45	182.2	SARDH_HUMAN	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	918	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053	choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]		NA	NA	NA	NA	NA	NA
TRINITY_DN34888_c0_g1_i2	Q9UL12	SARDH_HUMAN	56.1	155	60	3	749	303	745	897	4.90E-41	169.5	SARDH_HUMAN	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	918	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053	choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]		NA	NA	NA	NA	NA	NA
TRINITY_DN39584_c0_g1_i1	Q9UL12	SARDH_HUMAN	68	128	41	0	413	30	363	490	2.80E-54	212.6	SARDH_HUMAN	reviewed	"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	918	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0042426; GO:1901053	choline catabolic process [GO:0042426]; sarcosine catabolic process [GO:1901053]		NA	NA	NA	NA	NA	NA
TRINITY_DN39706_c0_g1_i1	Q15424	SAFB1_HUMAN	100	80	0	0	241	2	401	480	2.30E-40	165.6	SAFB1_HUMAN	reviewed	Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein)	SAFB HAP HET SAFB1	Homo sapiens (Human)	915	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; hormone metabolic process [GO:0042445]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000978; GO:0003682; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0030520; GO:0040008; GO:0042445; GO:0043565; GO:0045944; GO:0050684	chromatin organization [GO:0006325]; hormone metabolic process [GO:0042445]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16605_c3_g1_i1	D3YXK2	SAFB1_MOUSE	42.4	66	38	0	284	87	3	68	5.10E-05	48.5	SAFB1_MOUSE	reviewed	Scaffold attachment factor B1 (SAF-B1)	Safb Safb1	Mus musculus (Mouse)	937	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; hormone metabolic process [GO:0042445]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000978; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0030520; GO:0040008; GO:0042445; GO:0043565; GO:0045944; GO:0050684	hormone metabolic process [GO:0042445]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN25655_c0_g1_i1	Q14151	SAFB2_HUMAN	100	101	0	0	304	2	396	496	2.70E-51	202.2	SAFB2_HUMAN	reviewed	Scaffold attachment factor B2 (SAF-B2)	SAFB2 KIAA0138	Homo sapiens (Human)	953	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062	regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]		NA	NA	NA	NA	NA	NA
TRINITY_DN565_c0_g1_i1	Q14151	SAFB2_HUMAN	72.8	81	22	0	337	95	406	486	3.10E-28	126.7	SAFB2_HUMAN	reviewed	Scaffold attachment factor B2 (SAF-B2)	SAFB2 KIAA0138	Homo sapiens (Human)	953	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062	regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]		NA	NA	NA	NA	NA	NA
TRINITY_DN565_c0_g1_i3	Q14151	SAFB2_HUMAN	75	76	19	0	229	2	406	481	1.20E-27	124.4	SAFB2_HUMAN	reviewed	Scaffold attachment factor B2 (SAF-B2)	SAFB2 KIAA0138	Homo sapiens (Human)	953	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062	regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]		NA	NA	NA	NA	NA	NA
TRINITY_DN565_c0_g1_i5	Q14151	SAFB2_HUMAN	75	84	21	0	366	115	406	489	4.10E-31	136.3	SAFB2_HUMAN	reviewed	Scaffold attachment factor B2 (SAF-B2)	SAFB2 KIAA0138	Homo sapiens (Human)	953	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062	regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]		NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i15	Q6R2W3	SCND3_HUMAN	38.3	94	57	1	81	362	855	947	2.60E-11	69.7	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN4744_c0_g1_i18	Q6R2W3	SCND3_HUMAN	36.4	129	81	1	3	389	820	947	2.90E-16	86.3	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN26786_c0_g1_i1	Q6R2W3	SCND3_HUMAN	43	114	65	0	343	2	816	929	3.20E-20	99.4	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN8009_c0_g1_i2	Q6R2W3	SCND3_HUMAN	50	58	29	0	177	350	1038	1095	1.80E-09	63.5	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN8009_c0_g1_i6	Q6R2W3	SCND3_HUMAN	50	58	29	0	161	334	1038	1095	1.70E-09	63.5	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN1975_c0_g2_i1	Q6R2W3	SCND3_HUMAN	36.8	68	43	0	71	274	1018	1085	3.00E-08	59.3	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN9548_c0_g1_i2	Q6R2W3	SCND3_HUMAN	47.3	93	48	1	7	282	1233	1325	3.80E-13	75.5	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN9548_c0_g1_i3	Q6R2W3	SCND3_HUMAN	48.4	93	47	1	7	282	1233	1325	9.00E-15	80.9	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN7772_c0_g1_i1	Q6R2W3	SCND3_HUMAN	43.1	295	160	5	45	920	818	1107	7.70E-65	248.8	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		brown	brown	NA	NA	NA	NA
TRINITY_DN38182_c0_g1_i1	Q6R2W3	SCND3_HUMAN	73.9	69	18	0	2	208	1045	1113	2.20E-23	109	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN36635_c0_g1_i1	Q6R2W3	SCND3_HUMAN	45.4	108	55	1	331	8	1018	1121	3.60E-20	99	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN5710_c0_g1_i1	Q6R2W3	SCND3_HUMAN	54.3	81	37	0	25	267	1245	1325	2.20E-16	86.3	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		blue	blue	NA	NA	NA	NA
TRINITY_DN29714_c0_g1_i1	Q6R2W3	SCND3_HUMAN	54.7	75	34	0	32	256	1245	1319	1.00E-14	80.5	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		blue	blue	NA	NA	NA	NA
TRINITY_DN4625_c0_g1_i1	Q6R2W3	SCND3_HUMAN	43.4	76	43	0	243	16	1250	1325	4.50E-13	75.1	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		blue	blue	NA	NA	NA	NA
TRINITY_DN9548_c0_g1_i4	Q6R2W3	SCND3_HUMAN	50	78	39	0	31	264	1248	1325	4.20E-14	78.6	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN9548_c0_g1_i5	Q6R2W3	SCND3_HUMAN	48.4	93	47	1	2	277	1233	1325	3.40E-14	79	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN9548_c0_g1_i6	Q6R2W3	SCND3_HUMAN	47.1	68	36	0	60	263	1258	1325	2.60E-08	59.3	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN20029_c0_g1_i1	Q6R2W3	SCND3_HUMAN	42.2	90	52	0	40	309	816	905	3.60E-14	79	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN14063_c0_g2_i1	Q6R2W3	SCND3_HUMAN	33	94	60	2	11	289	1230	1321	3.00E-06	52.8	SCND3_HUMAN	reviewed	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	1325	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN14895_c0_g2_i1	Q60417	SCRB1_CRIGR	42.6	94	54	0	3	284	323	416	1.90E-20	100.9	SCRB1_CRIGR	reviewed	Scavenger receptor class B member 1 (SRB1) (HaSR-BI) (SR-BI)	SCARB1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	509	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]	GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508	adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]		NA	NA	NA	NA	NA	NA
TRINITY_DN7972_c0_g1_i1	P97943	SCRB1_RAT	33.6	425	256	9	177	1442	16	417	2.50E-64	248.1	SCRB1_RAT	reviewed	Scavenger receptor class B member 1 (SRB1) (SR-BI)	Scarb1	Rattus norvegicus (Rat)	509	"caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; identical protein binding [GO:0042802]; lipid transporter activity [GO:0005319]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; adhesion of symbiont to host [GO:0044406]; androgen biosynthetic process [GO:0006702]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipid transport [GO:0006869]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phagocytosis, recognition [GO:0006910]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; steroid biosynthetic process [GO:0006694]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]"	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; identical protein binding [GO:0042802]; lipid transporter activity [GO:0005319]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]	GO:0001530; GO:0001540; GO:0001786; GO:0001875; GO:0001935; GO:0005319; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0006694; GO:0006702; GO:0006707; GO:0006869; GO:0006910; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0016021; GO:0030169; GO:0030301; GO:0031528; GO:0032497; GO:0033344; GO:0034185; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0042802; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050764; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508	"adhesion of symbiont to host [GO:0044406]; androgen biosynthetic process [GO:0006702]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipid transport [GO:0006869]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phagocytosis, recognition [GO:0006910]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; steroid biosynthetic process [GO:0006694]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14895_c0_g1_i1	O18824	SCRB1_BOVIN	36.3	113	69	2	353	18	154	264	1.30E-17	90.9	SCRB1_BOVIN	reviewed	Scavenger receptor class B member 1 (SRB1) (SR-BI)	SCARB1	Bos taurus (Bovine)	509	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]	GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508	adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]		NA	NA	NA	NA	NA	NA
TRINITY_DN14895_c0_g1_i2	O18824	SCRB1_BOVIN	37.5	253	155	2	773	18	14	264	1.00E-47	191.8	SCRB1_BOVIN	reviewed	Scavenger receptor class B member 1 (SRB1) (SR-BI)	SCARB1	Bos taurus (Bovine)	509	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]	GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508	adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]		NA	NA	NA	NA	NA	NA
TRINITY_DN13196_c0_g1_i1	Q5VUG0	SMBT2_HUMAN	32.6	641	378	17	61	1893	38	654	3.90E-83	311.2	SMBT2_HUMAN	reviewed	Scm-like with four MBT domains protein 2 (Scm-like with 4 MBT domains protein 2)	SFMBT2 KIAA1617	Homo sapiens (Human)	894	"aggresome [GO:0016235]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]"	aggresome [GO:0016235]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]	GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0010629; GO:0016235; GO:0016604; GO:0016607; GO:0042393; GO:0043231; GO:0045892	"negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4256_c0_g1_i4	P0DPU3	TX14A_SCODE	46	552	290	8	1736	93	28	575	4.90E-138	493	TX14A_SCODE	reviewed	Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]		Scolopendra dehaani (Thai centipede) (Scolopendra subspinipes dehaani)	577	extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]	extracellular region [GO:0005576]	glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]	GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729	glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]		NA	NA	NA	NA	NA	NA
TRINITY_DN40248_c0_g1_i1	P0DPU3	TX14A_SCODE	47.1	70	37	0	212	3	462	531	8.70E-12	70.5	TX14A_SCODE	reviewed	Scoloptoxin SSD14 (SLPTX-SSD14) (Toxin-SSD14) [Cleaved into: SLPTX-SSD14 subunit alpha; SLPTX-SSD14 subunit beta]		Scolopendra dehaani (Thai centipede) (Scolopendra subspinipes dehaani)	577	extracellular region [GO:0005576]; glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]; glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]	extracellular region [GO:0005576]	glutathione hydrolase activity [GO:0036374]; toxin activity [GO:0090729]	GO:0005576; GO:0006751; GO:0036374; GO:0044179; GO:0090729	glutathione catabolic process [GO:0006751]; hemolysis in other organism [GO:0044179]		NA	NA	NA	NA	NA	NA
TRINITY_DN40368_c0_g1_i1	Q2PC93	SSPO_CHICK	56.8	37	16	0	88	198	1615	1651	1.30E-06	53.5	SSPO_CHICK	reviewed	SCO-spondin	SSPO	Gallus gallus (Chicken)	5255	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0031012	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN7563_c0_g1_i1	Q2PC93	SSPO_CHICK	41.7	84	46	2	286	44	1650	1733	4.10E-10	65.9	SSPO_CHICK	reviewed	SCO-spondin	SSPO	Gallus gallus (Chicken)	5255	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0031012	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	1
TRINITY_DN7563_c0_g1_i2	Q2PC93	SSPO_CHICK	41.7	84	46	2	286	44	1650	1733	3.20E-10	65.9	SSPO_CHICK	reviewed	SCO-spondin	SSPO	Gallus gallus (Chicken)	5255	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0031012	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN4149_c0_g2_i1	Q8CFE4	SCYL2_MOUSE	54.7	636	275	3	71	1972	1	625	1.10E-203	711.4	SCYL2_MOUSE	reviewed	SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa)	Scyl2 Cvak104 D10Ertd802e	Mus musculus (Mouse)	930	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]	GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370	brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]		NA	NA	NA	NA	NA	NA
TRINITY_DN4149_c0_g2_i2	Q8CFE4	SCYL2_MOUSE	54.9	632	272	3	71	1960	1	621	1.60E-203	710.7	SCYL2_MOUSE	reviewed	SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa)	Scyl2 Cvak104 D10Ertd802e	Mus musculus (Mouse)	930	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]	GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370	brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]		NA	NA	NA	NA	NA	NA
TRINITY_DN27694_c0_g1_i1	Q8WVM8	SCFD1_HUMAN	100	88	0	0	1	264	25	112	6.10E-47	187.6	SCFD1_HUMAN	reviewed	Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2)	SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23	Homo sapiens (Human)	642	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0006904; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0048208; GO:0051223; GO:0060628; GO:1901998; GO:1902902	"cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35467_c0_g1_i1	Q8WVM8	SCFD1_HUMAN	100	201	0	0	1	603	120	320	3.70E-108	392.1	SCFD1_HUMAN	reviewed	Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2)	SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23	Homo sapiens (Human)	642	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0006904; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0048208; GO:0051223; GO:0060628; GO:1901998; GO:1902902	"cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39268_c0_g1_i1	Q8WVM8	SCFD1_HUMAN	99	97	1	0	296	6	350	446	1.90E-44	179.5	SCFD1_HUMAN	reviewed	Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2)	SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23	Homo sapiens (Human)	642	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0006904; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0048208; GO:0051223; GO:0060628; GO:1901998; GO:1902902	"cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2420_c0_g1_i1	Q8WVM8	SCFD1_HUMAN	55.2	640	262	11	46	1926	13	640	5.00E-194	679.1	SCFD1_HUMAN	reviewed	Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2)	SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23	Homo sapiens (Human)	642	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0006904; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0048208; GO:0051223; GO:0060628; GO:1901998; GO:1902902	"cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33441_c0_g1_i1	Q62991	SCFD1_RAT	99	105	1	0	1	315	524	628	2.50E-55	215.7	SCFD1_RAT	reviewed	Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2) (Vesicle transport-related protein Ra410)	Scfd1 Ra410 Sly1 Stxbp1l2	Rattus norvegicus (Rat)	637	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle [GO:0005798]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0006904; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0051223; GO:0060628; GO:1901998; GO:1902902	"cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28731_c0_g1_i1	Q54IJ1	SCFD1_DICDI	55.2	58	23	2	173	9	278	335	2.00E-09	62.8	SCFD1_DICDI	reviewed	Sec1 family domain-containing protein 1 homolog	scfd1 DDB_G0288719	Dictyostelium discoideum (Slime mold)	673	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; syntaxin binding [GO:0019905]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]	syntaxin binding [GO:0019905]	GO:0000139; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006904; GO:0016192; GO:0019905; GO:0032580	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5173_c0_g1_i3	Q8BTY8	SCFD2_MOUSE	35.2	640	382	12	97	1956	14	640	1.50E-97	358.6	SCFD2_MOUSE	reviewed	Sec1 family domain-containing protein 2 (Neuronal Sec1) (Syntaxin-binding protein 1-like 1)	Scfd2 Stxbp1l1	Mus musculus (Mouse)	684	plasma membrane [GO:0005886]; secretory granule [GO:0030141]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	plasma membrane [GO:0005886]; secretory granule [GO:0030141]	syntaxin binding [GO:0019905]	GO:0005886; GO:0006886; GO:0006904; GO:0016192; GO:0019905; GO:0030141	intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5173_c0_g1_i5	Q8BTY8	SCFD2_MOUSE	34.3	562	336	12	97	1722	14	562	4.50E-77	290.4	SCFD2_MOUSE	reviewed	Sec1 family domain-containing protein 2 (Neuronal Sec1) (Syntaxin-binding protein 1-like 1)	Scfd2 Stxbp1l1	Mus musculus (Mouse)	684	plasma membrane [GO:0005886]; secretory granule [GO:0030141]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	plasma membrane [GO:0005886]; secretory granule [GO:0030141]	syntaxin binding [GO:0019905]	GO:0005886; GO:0006886; GO:0006904; GO:0016192; GO:0019905; GO:0030141	intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN834_c0_g1_i1	Q92503	S14L1_HUMAN	54	729	310	6	37	2202	1	711	6.10E-220	765.4	S14L1_HUMAN	reviewed	SEC14-like protein 1	SEC14L1 SEC14L	Homo sapiens (Human)	715	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	RIG-I binding [GO:0039552]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087	choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]		NA	NA	NA	NA	NA	NA
TRINITY_DN834_c0_g1_i2	Q92503	S14L1_HUMAN	52.2	763	304	8	37	2298	1	711	6.00E-218	758.8	S14L1_HUMAN	reviewed	SEC14-like protein 1	SEC14L1 SEC14L	Homo sapiens (Human)	715	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	RIG-I binding [GO:0039552]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087	choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]		NA	NA	NA	NA	NA	NA
TRINITY_DN834_c0_g1_i3	Q92503	S14L1_HUMAN	65.3	118	41	0	37	390	1	118	6.40E-39	161.8	S14L1_HUMAN	reviewed	SEC14-like protein 1	SEC14L1 SEC14L	Homo sapiens (Human)	715	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	RIG-I binding [GO:0039552]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087	choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]		NA	NA	NA	NA	NA	NA
TRINITY_DN37839_c0_g1_i1	Q92503	S14L1_HUMAN	96.7	91	3	0	2	274	222	312	1.30E-47	189.9	S14L1_HUMAN	reviewed	SEC14-like protein 1	SEC14L1 SEC14L	Homo sapiens (Human)	715	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	RIG-I binding [GO:0039552]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087	choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]		NA	NA	NA	NA	NA	NA
TRINITY_DN33713_c0_g1_i1	A8Y5H7	S14L1_MOUSE	100	91	0	0	3	275	235	325	7.90E-50	197.2	S14L1_MOUSE	reviewed	SEC14-like protein 1	Sec14l1 Kiaa4251	Mus musculus (Mouse)	715	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	RIG-I binding [GO:0039552]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087	choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]		NA	NA	NA	NA	NA	NA
TRINITY_DN4040_c0_g1_i2	O76054	S14L2_HUMAN	43.5	395	207	6	195	1358	7	392	1.60E-93	344.7	S14L2_HUMAN	reviewed	SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (hTAP) (Squalene transfer protein) (Supernatant protein factor) (SPF)	SEC14L2 C22orf6 KIAA1186 KIAA1658	Homo sapiens (Human)	403	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431]	GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008431; GO:0045540; GO:0045893; GO:0070062	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1077_c0_g1_i1	Q803W1	SCRN3_DANRE	52.4	420	182	8	109	1338	3	414	2.40E-113	410.6	SCRN3_DANRE	reviewed	Secernin-3	scrn3 zgc:55430	Danio rerio (Zebrafish) (Brachydanio rerio)	417	cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]		cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]	GO:0016805; GO:0070004			NA	NA	NA	NA	NA	NA
TRINITY_DN1077_c0_g1_i2	Q803W1	SCRN3_DANRE	51.3	421	186	8	109	1341	3	414	1.20E-109	398.3	SCRN3_DANRE	reviewed	Secernin-3	scrn3 zgc:55430	Danio rerio (Zebrafish) (Brachydanio rerio)	417	cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]		cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]	GO:0016805; GO:0070004			NA	NA	NA	NA	NA	NA
TRINITY_DN33589_c0_g1_i1	Q7YRN1	SFRP4_MACMU	56.5	69	30	0	210	4	9	77	3.70E-15	81.6	SFRP4_MACMU	reviewed	Secreted frizzled-related protein 4 (sFRP-4)	SFRP4	Macaca mulatta (Rhesus macaque)	346	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; regulation of BMP signaling pathway [GO:0030510]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	Wnt-protein binding [GO:0017147]	GO:0005615; GO:0005737; GO:0017147; GO:0030154; GO:0030510; GO:0060070; GO:0060349; GO:0090090; GO:2000051	bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; regulation of BMP signaling pathway [GO:0030510]		NA	NA	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i9	P0CV25	RLR78_PLAVT	37.3	75	47	0	1321	1097	29	103	1.30E-05	53.1	RLR78_PLAVT	reviewed	Secreted RxLR effector protein 78	RXLR78	Plasmopara viticola (Downy mildew of grapevine) (Botrytis viticola)	113	extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell [GO:0043657]		GO:0005576; GO:0009405; GO:0043657	pathogenesis [GO:0009405]		NA	NA	1	NA	NA	NA
TRINITY_DN739_c0_g1_i16	P0CV25	RLR78_PLAVT	37.3	75	47	0	729	505	29	103	1.40E-05	53.1	RLR78_PLAVT	reviewed	Secreted RxLR effector protein 78	RXLR78	Plasmopara viticola (Downy mildew of grapevine) (Botrytis viticola)	113	extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell [GO:0043657]		GO:0005576; GO:0009405; GO:0043657	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i19	P0CV25	RLR78_PLAVT	37.3	75	47	0	1723	1499	29	103	1.60E-05	53.1	RLR78_PLAVT	reviewed	Secreted RxLR effector protein 78	RXLR78	Plasmopara viticola (Downy mildew of grapevine) (Botrytis viticola)	113	extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell [GO:0043657]		GO:0005576; GO:0009405; GO:0043657	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i2	P0CV25	RLR78_PLAVT	37.3	75	47	0	1324	1100	29	103	1.30E-05	53.1	RLR78_PLAVT	reviewed	Secreted RxLR effector protein 78	RXLR78	Plasmopara viticola (Downy mildew of grapevine) (Botrytis viticola)	113	extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell [GO:0043657]		GO:0005576; GO:0009405; GO:0043657	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i20	P0CV25	RLR78_PLAVT	37.3	75	47	0	1725	1501	29	103	2.10E-05	53.1	RLR78_PLAVT	reviewed	Secreted RxLR effector protein 78	RXLR78	Plasmopara viticola (Downy mildew of grapevine) (Botrytis viticola)	113	extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell [GO:0043657]		GO:0005576; GO:0009405; GO:0043657	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN739_c0_g1_i7	P0CV25	RLR78_PLAVT	37.3	75	47	0	1323	1099	29	103	1.80E-05	53.1	RLR78_PLAVT	reviewed	Secreted RxLR effector protein 78	RXLR78	Plasmopara viticola (Downy mildew of grapevine) (Botrytis viticola)	113	extracellular region [GO:0005576]; host cell [GO:0043657]; pathogenesis [GO:0009405]	extracellular region [GO:0005576]; host cell [GO:0043657]		GO:0005576; GO:0009405; GO:0043657	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN35161_c0_g1_i1	P23811	SCTR_RAT	44.4	81	42	2	172	408	277	356	2.20E-11	70.1	SCTR_RAT	reviewed	Secretin receptor (SCT-R)	Sctr	Rattus norvegicus (Rat)	449	cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; secretin receptor activity [GO:0015055]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; renal water absorption [GO:0070295]; response to nutrient levels [GO:0031667]	cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; secretin receptor activity [GO:0015055]	GO:0002024; GO:0005881; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007420; GO:0008528; GO:0009992; GO:0015055; GO:0016021; GO:0017046; GO:0031667; GO:0032098; GO:0042277; GO:0043950; GO:0048167; GO:0050996; GO:0070295	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; renal water absorption [GO:0070295]; response to nutrient levels [GO:0031667]		NA	NA	NA	NA	NA	NA
TRINITY_DN3626_c0_g1_i1	Q9UGK8	SRGEF_HUMAN	40.8	238	131	6	102	803	16	247	3.10E-34	147.1	SRGEF_HUMAN	reviewed	Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein)	SERGEF DELGEF GNEFR	Homo sapiens (Human)	458	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709	negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3626_c0_g1_i2	Q9UGK8	SRGEF_HUMAN	40.8	238	130	6	102	800	16	247	3.10E-34	147.1	SRGEF_HUMAN	reviewed	Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein)	SERGEF DELGEF GNEFR	Homo sapiens (Human)	458	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709	negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3626_c0_g1_i3	Q9UGK8	SRGEF_HUMAN	40	407	211	11	102	1283	16	402	1.20E-64	248.8	SRGEF_HUMAN	reviewed	Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein)	SERGEF DELGEF GNEFR	Homo sapiens (Human)	458	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Ran guanyl-nucleotide exchange factor activity [GO:0005087]	GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709	negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN146_c0_g1_i1	O15126	SCAM1_HUMAN	58.7	109	44	1	379	56	116	224	4.40E-30	132.5	SCAM1_HUMAN	reviewed	Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)	SCAMP1 SCAMP	Homo sapiens (Human)	338	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]		GO:0000139; GO:0005794; GO:0005802; GO:0005886; GO:0006892; GO:0015031; GO:0016021; GO:0030136; GO:0030672; GO:0032588; GO:0035579; GO:0042589; GO:0043312; GO:0055038	neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN146_c0_g1_i2	O15126	SCAM1_HUMAN	55	211	87	4	708	88	116	322	2.10E-53	210.7	SCAM1_HUMAN	reviewed	Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)	SCAMP1 SCAMP	Homo sapiens (Human)	338	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]		GO:0000139; GO:0005794; GO:0005802; GO:0005886; GO:0006892; GO:0015031; GO:0016021; GO:0030136; GO:0030672; GO:0032588; GO:0035579; GO:0042589; GO:0043312; GO:0055038	neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN146_c0_g1_i3	O15126	SCAM1_HUMAN	55	211	90	3	717	88	116	322	3.90E-55	216.5	SCAM1_HUMAN	reviewed	Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)	SCAMP1 SCAMP	Homo sapiens (Human)	338	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]		GO:0000139; GO:0005794; GO:0005802; GO:0005886; GO:0006892; GO:0015031; GO:0016021; GO:0030136; GO:0030672; GO:0032588; GO:0035579; GO:0042589; GO:0043312; GO:0055038	neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN32972_c0_g1_i1	O15126	SCAM1_HUMAN	100	107	0	0	3	323	127	233	8.50E-59	227.3	SCAM1_HUMAN	reviewed	Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)	SCAMP1 SCAMP	Homo sapiens (Human)	338	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]		GO:0000139; GO:0005794; GO:0005802; GO:0005886; GO:0006892; GO:0015031; GO:0016021; GO:0030136; GO:0030672; GO:0032588; GO:0035579; GO:0042589; GO:0043312; GO:0055038	neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN16489_c0_g1_i1	Q9ERN0	SCAM2_MOUSE	99	102	1	0	31	336	107	208	9.70E-58	223.8	SCAM2_MOUSE	reviewed	Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2)	Scamp2	Mus musculus (Mouse)	329	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; protein transport [GO:0015031]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]		GO:0000139; GO:0005794; GO:0015031; GO:0016021; GO:0030133; GO:0032588; GO:0043231; GO:0055038	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN39823_c0_g1_i1	O15127	SCAM2_HUMAN	100	147	0	0	443	3	107	253	4.50E-85	315.1	SCAM2_HUMAN	reviewed	Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2)	SCAMP2	Homo sapiens (Human)	329	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]		GO:0000139; GO:0005794; GO:0006892; GO:0015031; GO:0016021; GO:0030133; GO:0032588; GO:0043231; GO:0055038; GO:0070062	post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN27742_c0_g1_i1	O14828	SCAM3_HUMAN	97.9	97	2	0	3	293	176	272	6.80E-47	187.6	SCAM3_HUMAN	reviewed	Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3)	SCAMP3 C1orf3 PROPIN1	Homo sapiens (Human)	347	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; ubiquitin protein ligase binding [GO:0031625]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]	ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005794; GO:0006892; GO:0015031; GO:0016021; GO:0031625; GO:0032588; GO:0043231; GO:0055038; GO:0070062	post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN32696_c0_g1_i1	O35609	SCAM3_MOUSE	100	61	0	0	28	210	121	181	2.80E-31	135.2	SCAM3_MOUSE	reviewed	Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3)	Scamp3	Mus musculus (Mouse)	349	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; ubiquitin protein ligase binding [GO:0031625]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]	ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005794; GO:0006886; GO:0010033; GO:0015031; GO:0016021; GO:0031625; GO:0032526; GO:0032588; GO:0043231; GO:0055038	intracellular protein transport [GO:0006886]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]		NA	NA	NA	NA	NA	NA
TRINITY_DN9128_c0_g1_i2	Q9UHJ6	SHPK_HUMAN	34.9	312	177	5	162	1034	13	319	3.30E-48	193.7	SHPK_HUMAN	reviewed	Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein)	SHPK CARKL	Homo sapiens (Human)	478	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; sedoheptulokinase activity [GO:0050277]; carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; sedoheptulokinase activity [GO:0050277]"	GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0016773; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353	"carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9128_c0_g1_i3	Q9UHJ6	SHPK_HUMAN	34.9	312	177	5	162	1034	13	319	3.30E-48	193.7	SHPK_HUMAN	reviewed	Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein)	SHPK CARKL	Homo sapiens (Human)	478	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; sedoheptulokinase activity [GO:0050277]; carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; sedoheptulokinase activity [GO:0050277]"	GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0016773; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353	"carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2534_c0_g1_i1	Q6DKE2	DVL3_XENLA	69.3	101	30	1	630	328	1	100	5.00E-35	149.4	DVL3_XENLA	reviewed	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	dvl3	Xenopus laevis (African clawed frog)	717	cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]	beta-catenin binding [GO:0008013]	GO:0005737; GO:0007275; GO:0008013; GO:0016055; GO:0032053; GO:0035556; GO:0060271	ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2534_c0_g1_i2	B1WAP7	DVL3_XENTR	75.9	54	13	0	232	71	1	54	2.30E-19	96.3	DVL3_XENTR	reviewed	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	dvl3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	713	cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]	cytosol [GO:0005829]	beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]	GO:0005109; GO:0005829; GO:0008013; GO:0032053; GO:0035556; GO:0060070; GO:0060271; GO:0090179	canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]		NA	NA	NA	NA	NA	NA
TRINITY_DN2534_c0_g1_i3	Q6DKE2	DVL3_XENLA	59.4	143	43	3	435	49	1	142	9.40E-39	161.4	DVL3_XENLA	reviewed	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	dvl3	Xenopus laevis (African clawed frog)	717	cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]	beta-catenin binding [GO:0008013]	GO:0005737; GO:0007275; GO:0008013; GO:0016055; GO:0032053; GO:0035556; GO:0060271	ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24077_c0_g1_i1	Q92997	DVL3_HUMAN	100	85	0	0	2	256	410	494	6.10E-44	177.6	DVL3_HUMAN	reviewed	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	DVL3 KIAA0208	Homo sapiens (Human)	716	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]; beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; response to drug [GO:0042493]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]	beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]	GO:0000790; GO:0001934; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0035556; GO:0035567; GO:0038031; GO:0042493; GO:0043507; GO:0043547; GO:0045893; GO:0045944; GO:0048365; GO:0050821; GO:0060070; GO:0060071; GO:0090090; GO:0090179; GO:0150012; GO:1903827; GO:1904886	"beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; response to drug [GO:0042493]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9806_c0_g1_i1	B1WAP7	DVL3_XENTR	70.6	303	76	6	1	900	239	531	1.50E-116	420.6	DVL3_XENTR	reviewed	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	dvl3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	713	cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]	cytosol [GO:0005829]	beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]	GO:0005109; GO:0005829; GO:0008013; GO:0032053; GO:0035556; GO:0060070; GO:0060271; GO:0090179	canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]		NA	NA	NA	NA	NA	NA
TRINITY_DN30506_c0_g1_i1	Q92997	DVL3_HUMAN	100	69	0	0	1	207	256	324	1.90E-32	139	DVL3_HUMAN	reviewed	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	DVL3 KIAA0208	Homo sapiens (Human)	716	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]; beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; response to drug [GO:0042493]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]	beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]	GO:0000790; GO:0001934; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0035556; GO:0035567; GO:0038031; GO:0042493; GO:0043507; GO:0043547; GO:0045893; GO:0045944; GO:0048365; GO:0050821; GO:0060070; GO:0060071; GO:0090090; GO:0090179; GO:0150012; GO:1903827; GO:1904886	"beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; response to drug [GO:0042493]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		NA	NA	NA	NA	NA	NA
TRINITY_DN287_c0_g1_i1	P20482	CNC_DROME	56.1	214	71	3	225	800	1096	1308	4.60E-54	213	CNC_DROME	reviewed	Segmentation protein cap'n'collar	cnc CG43286	Drosophila melanogaster (Fruit fly)	1383	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]	DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003700; GO:0005634; GO:0005703; GO:0005737; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045893; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465	"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]"		NA	NA	NA	NA	NA	NA
TRINITY_DN287_c0_g1_i2	P20482	CNC_DROME	56.1	214	71	3	118	693	1096	1308	5.30E-54	212.6	CNC_DROME	reviewed	Segmentation protein cap'n'collar	cnc CG43286	Drosophila melanogaster (Fruit fly)	1383	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]	DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003700; GO:0005634; GO:0005703; GO:0005737; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045893; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465	"blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2494_c0_g1_i1	Q5E9P6	BSCL2_BOVIN	41.5	135	75	1	94	486	123	257	1.40E-21	104.4	BSCL2_BOVIN	reviewed	Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog)	BSCL2	Bos taurus (Bovine)	394	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]		GO:0005789; GO:0005811; GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995; GO:0140042	fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]		NA	NA	NA	NA	NA	NA
TRINITY_DN2494_c0_g1_i2	Q5E9P6	BSCL2_BOVIN	45.8	225	120	2	161	829	33	257	1.10E-49	198.7	BSCL2_BOVIN	reviewed	Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog)	BSCL2	Bos taurus (Bovine)	394	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]		GO:0005789; GO:0005811; GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995; GO:0140042	fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]		NA	NA	NA	NA	NA	NA
TRINITY_DN2494_c0_g1_i3	Q5E9P6	BSCL2_BOVIN	48.5	68	35	0	94	297	123	190	1.50E-10	67	BSCL2_BOVIN	reviewed	Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog)	BSCL2	Bos taurus (Bovine)	394	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]		GO:0005789; GO:0005811; GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995; GO:0140042	fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]		NA	NA	NA	NA	NA	NA
TRINITY_DN2494_c0_g1_i4	Q5E9P6	BSCL2_BOVIN	43.7	135	76	0	94	498	123	257	3.30E-26	120.2	BSCL2_BOVIN	reviewed	Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog)	BSCL2	Bos taurus (Bovine)	394	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]		GO:0005789; GO:0005811; GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995; GO:0140042	fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]		NA	NA	NA	NA	NA	NA
TRINITY_DN29516_c0_g1_i1	Q0VC82	SPS1_BOVIN	100	88	0	0	2	265	208	295	1.70E-44	179.5	SPS1_BOVIN	reviewed	"Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1)"	SEPHS1	Bos taurus (Bovine)	392	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]; selenocysteine biosynthetic process [GO:0016260]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]"	GO:0004756; GO:0005524; GO:0005737; GO:0005886; GO:0016260; GO:0031965; GO:0042803; GO:0046872; GO:0046982	selenocysteine biosynthetic process [GO:0016260]		NA	NA	NA	NA	NA	NA
TRINITY_DN29100_c0_g1_i1	Q8BH69	SPS1_MOUSE	100	91	0	0	276	4	123	213	1.70E-45	183	SPS1_MOUSE	reviewed	"Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1)"	Sephs1 Sps1	Mus musculus (Mouse)	392	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]; selenocysteine biosynthetic process [GO:0016260]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]"	GO:0004756; GO:0005524; GO:0005737; GO:0005886; GO:0016260; GO:0031965; GO:0042802; GO:0042803; GO:0046872; GO:0046982	selenocysteine biosynthetic process [GO:0016260]		NA	NA	NA	NA	NA	NA
TRINITY_DN29831_c0_g1_i1	Q0VC82	SPS1_BOVIN	95.5	292	13	0	2	877	100	391	9.70E-158	557.4	SPS1_BOVIN	reviewed	"Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1)"	SEPHS1	Bos taurus (Bovine)	392	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]; selenocysteine biosynthetic process [GO:0016260]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]"	GO:0004756; GO:0005524; GO:0005737; GO:0005886; GO:0016260; GO:0031965; GO:0042803; GO:0046872; GO:0046982	selenocysteine biosynthetic process [GO:0016260]		NA	NA	NA	NA	NA	NA
TRINITY_DN35523_c0_g1_i1	Q99611	SPS2_HUMAN	100	331	0	0	1	993	118	448	6.70E-179	627.9	SPS2_HUMAN	reviewed	"Selenide, water dikinase 2 (EC 2.7.9.3) (Selenium donor protein 2) (Selenophosphate synthase 2)"	SEPHS2 SPS2	Homo sapiens (Human)	448	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]"	GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0005829; GO:0016259; GO:0016260; GO:0046872	selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259]		NA	NA	NA	NA	NA	NA
TRINITY_DN3400_c0_g1_i1	A2VDS1	SCLY_BOVIN	50	296	137	3	3	857	64	359	1.40E-76	287.7	SCLY_BOVIN	reviewed	Selenocysteine lyase (EC 4.4.1.16)	SCLY	Bos taurus (Bovine)	437	cytosol [GO:0005829]; selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]	cytosol [GO:0005829]	selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]	GO:0005829; GO:0009000; GO:0016740			NA	NA	NA	NA	NA	NA
TRINITY_DN3400_c0_g1_i2	A2VDS1	SCLY_BOVIN	53	264	113	3	3	761	64	327	9.40E-73	275	SCLY_BOVIN	reviewed	Selenocysteine lyase (EC 4.4.1.16)	SCLY	Bos taurus (Bovine)	437	cytosol [GO:0005829]; selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]	cytosol [GO:0005829]	selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]	GO:0005829; GO:0009000; GO:0016740			NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i1	Q26473	SEM1A_SCHAM	49.3	710	306	12	2174	90	60	730	2.10E-185	650.6	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i10	Q26473	SEM1A_SCHAM	50.4	677	274	10	1952	90	60	730	1.50E-182	641	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i2	Q26473	SEM1A_SCHAM	45.6	125	59	4	452	90	611	730	1.70E-16	87.4	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i3	Q26473	SEM1A_SCHAM	34.9	324	158	11	1016	90	445	730	4.80E-37	156.8	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i4	Q26473	SEM1A_SCHAM	51.5	615	241	7	1778	90	60	669	5.00E-177	622.5	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i5	Q26473	SEM1A_SCHAM	52.4	63	26	1	278	90	611	669	3.30E-11	69.3	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i6	Q26473	SEM1A_SCHAM	50.3	648	273	9	2000	90	60	669	5.40E-180	632.5	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN5146_c0_g1_i7	Q26473	SEM1A_SCHAM	34	262	125	8	842	90	445	669	1.20E-31	138.7	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN674_c0_g1_i2	Q26473	SEM1A_SCHAM	48.8	168	81	4	570	76	14	179	4.80E-41	169.1	SEM1A_SCHAM	reviewed	Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)	SEMA-1A FAS4	Schistocerca americana (American grasshopper)	730	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]	semaphorin receptor binding [GO:0030215]	GO:0007399; GO:0016021; GO:0030154; GO:0030215	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN674_c0_g1_i1	Q24322	SEM1A_DROME	47.5	781	366	13	2366	90	59	817	1.70E-188	661	SEM1A_DROME	reviewed	Semaphorin-1A (Semaphorin-I) (Sema I)	Sema1a Dsema-I Sema-1a CG18405	Drosophila melanogaster (Fruit fly)	899	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell size [GO:0045792]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance [GO:2000305]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005615; GO:0005886; GO:0007411; GO:0007416; GO:0008039; GO:0008045; GO:0008201; GO:0016021; GO:0016199; GO:0030215; GO:0030335; GO:0045499; GO:0045792; GO:0048813; GO:0048843; GO:0050919; GO:0071526; GO:2000305	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell size [GO:0045792]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance [GO:2000305]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN21792_c0_g1_i1	Q24323	SEM2A_DROME	80	120	24	0	2	361	244	363	4.40E-56	218.4	SEM2A_DROME	reviewed	Semaphorin-2A (Semaphorin-II) (Sema II)	Sema2a Sema-2a CG4700	Drosophila melanogaster (Fruit fly)	724	cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; dendrite guidance [GO:0070983]; drinking behavior [GO:0042756]; flight behavior [GO:0007629]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory bulb axon guidance [GO:0071678]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synaptic target inhibition [GO:0016201]; visual behavior [GO:0007632]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005576; GO:0005615; GO:0005829; GO:0007411; GO:0007629; GO:0007632; GO:0012505; GO:0016201; GO:0030215; GO:0030335; GO:0030534; GO:0042756; GO:0045499; GO:0048843; GO:0050919; GO:0070983; GO:0071526; GO:0071678; GO:0097374	adult behavior [GO:0030534]; axon guidance [GO:0007411]; dendrite guidance [GO:0070983]; drinking behavior [GO:0042756]; flight behavior [GO:0007629]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory bulb axon guidance [GO:0071678]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synaptic target inhibition [GO:0016201]; visual behavior [GO:0007632]		NA	NA	NA	NA	NA	NA
TRINITY_DN5580_c0_g2_i1	Q60519	SEM5B_MOUSE	55.3	76	34	0	276	49	587	662	4.10E-22	105.1	SEM5B_MOUSE	reviewed	Semaphorin-5B (Semaphorin-G) (Sema G)	Sema5b Kiaa1445 Semag SemG	Mus musculus (Mouse)	1093	integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	integral component of membrane [GO:0016021]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0007411; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526; GO:0097485; GO:1990138	axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]		NA	NA	NA	NA	NA	NA
TRINITY_DN31595_c0_g1_i1	P86905	SNMP1_APIME	41	61	34	1	3	185	37	95	2.50E-09	62.4	SNMP1_APIME	reviewed	Sensory neuron membrane protein 1		Apis mellifera (Honeybee)	520	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007608; GO:0016021; GO:0050896	response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		blue	blue	NA	NA	NA	NA
TRINITY_DN18718_c0_g1_i1	Q7Q6R1	SNMP2_ANOGA	36.5	85	54	0	2	256	31	115	2.80E-12	72.4	SNMP2_ANOGA	reviewed	Sensory neuron membrane protein 2	SCRB16 AGAP005716	Anopheles gambiae (African malaria mosquito)	577	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007608; GO:0016021; GO:0050896	response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		blue	blue	NA	NA	NA	NA
TRINITY_DN16862_c0_g2_i1	B2RFN2	SNMP2_HELVI	36	114	65	2	405	82	72	183	2.00E-12	73.6	SNMP2_HELVI	reviewed	Sensory neuron membrane protein 2 (HvirSNMP-2)	snmp2	Heliothis virescens (Tobacco budworm moth)	520	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007608; GO:0016021; GO:0050896	response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN31880_c0_g1_i1	Q9GZR1	SENP6_HUMAN	100	85	0	0	256	2	668	752	3.90E-43	174.9	SENP6_HUMAN	reviewed	Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6)	SENP6 KIAA0797 SSP1 SUSP1 FKSG6	Homo sapiens (Human)	1112	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	SUMO-specific endopeptidase activity [GO:0070139]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234	protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]		NA	NA	NA	NA	NA	NA
TRINITY_DN131_c0_g2_i1	A7MBJ2	SENP7_BOVIN	38.5	317	155	5	1179	229	771	1047	1.40E-53	212.2	SENP7_BOVIN	reviewed	Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7)	SENP7 SUSP2	Bos taurus (Bovine)	1047	cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	SUMO-specific endopeptidase activity [GO:0070139]	GO:0005634; GO:0005737; GO:0016926; GO:0070139	protein desumoylation [GO:0016926]		NA	NA	NA	NA	NA	NA
TRINITY_DN907_c0_g1_i2	P60330	ESPL1_MOUSE	40.6	239	129	5	1066	1773	1887	2115	2.90E-42	174.9	ESPL1_MOUSE	reviewed	Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)	Espl1 Esp1 Kiaa0165	Mus musculus (Mouse)	2118	centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0000070; GO:0000212; GO:0000278; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0007059; GO:0007127; GO:0008233; GO:0008234; GO:0045143; GO:0051307; GO:0072686	chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]		NA	NA	NA	NA	NA	NA
TRINITY_DN907_c0_g1_i3	Q14674	ESPL1_HUMAN	39.1	128	66	4	457	834	2002	2119	6.80E-16	86.3	ESPL1_HUMAN	reviewed	Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)	ESPL1 ESP1 KIAA0165	Homo sapiens (Human)	2120	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; catalytic activity [GO:0003824]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	catalytic activity [GO:0003824]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686	apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]		NA	NA	NA	NA	NA	NA
TRINITY_DN907_c0_g1_i4	P60330	ESPL1_MOUSE	40.6	239	129	5	825	1532	1887	2115	2.50E-42	174.9	ESPL1_MOUSE	reviewed	Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)	Espl1 Esp1 Kiaa0165	Mus musculus (Mouse)	2118	centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]	GO:0000070; GO:0000212; GO:0000278; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0007059; GO:0007127; GO:0008233; GO:0008234; GO:0045143; GO:0051307; GO:0072686	chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]		NA	NA	NA	NA	NA	NA
TRINITY_DN7333_c0_g1_i1	Q64105	SPRE_MOUSE	42	257	137	5	846	91	12	261	6.10E-44	179.5	SPRE_MOUSE	reviewed	Sepiapterin reductase (SPR) (EC 1.1.1.153)	Spr	Mus musculus (Mouse)	261	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein homodimerization activity [GO:0042803]; sepiapterin reductase activity [GO:0004757]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dopamine metabolic process [GO:0042417]; L-phenylalanine metabolic process [GO:0006558]; nitric oxide biosynthetic process [GO:0006809]; norepinephrine metabolic process [GO:0042415]; pteridine metabolic process [GO:0019889]; regulation of multicellular organism growth [GO:0040014]; response to organic substance [GO:0010033]; serotonin metabolic process [GO:0042428]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrobiopterin metabolic process [GO:0046146]; voluntary musculoskeletal movement [GO:0050882]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	protein homodimerization activity [GO:0042803]; sepiapterin reductase activity [GO:0004757]	GO:0004757; GO:0005654; GO:0005739; GO:0005829; GO:0006558; GO:0006729; GO:0006809; GO:0010033; GO:0019889; GO:0040014; GO:0042415; GO:0042417; GO:0042428; GO:0042803; GO:0046146; GO:0048667; GO:0050882	cell morphogenesis involved in neuron differentiation [GO:0048667]; dopamine metabolic process [GO:0042417]; L-phenylalanine metabolic process [GO:0006558]; nitric oxide biosynthetic process [GO:0006809]; norepinephrine metabolic process [GO:0042415]; pteridine metabolic process [GO:0019889]; regulation of multicellular organism growth [GO:0040014]; response to organic substance [GO:0010033]; serotonin metabolic process [GO:0042428]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrobiopterin metabolic process [GO:0046146]; voluntary musculoskeletal movement [GO:0050882]		NA	NA	NA	NA	NA	1
TRINITY_DN870_c0_g1_i1	Q8R536	SPRE_MERUN	42.7	255	142	3	763	2	3	254	1.20E-45	184.9	SPRE_MERUN	reviewed	Sepiapterin reductase (SPR) (EC 1.1.1.153) (Benzil reductase ((S)-benzoin forming)) (EC 1.1.1.320)	SPR	Meriones unguiculatus (Mongolian jird) (Gerbillus unguiculatus)	262	cytoplasm [GO:0005737]; benzil reductase [(S)-benzoin-forming] activity [GO:0102306]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729]	cytoplasm [GO:0005737]	benzil reductase [(S)-benzoin-forming] activity [GO:0102306]; sepiapterin reductase activity [GO:0004757]	GO:0004757; GO:0005737; GO:0006729; GO:0102306	tetrahydrobiopterin biosynthetic process [GO:0006729]		NA	NA	NA	NA	NA	NA
TRINITY_DN9259_c0_g1_i1	P42207	SEPT1_DROME	74.9	299	75	0	1080	184	7	305	1.10E-136	488	SEPT1_DROME	reviewed	Septin-1 (DIFF6 protein homolog) (Protein innocent bystander)	Sep1 Diff6 iby CG1403	Drosophila melanogaster (Fruit fly)	361	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; regulation of exocytosis [GO:0017157]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]	GO:0003924; GO:0005525; GO:0005940; GO:0007349; GO:0008021; GO:0015630; GO:0017157; GO:0031105; GO:0031625; GO:0032153; GO:0034613; GO:0042803; GO:0043065; GO:0060090; GO:0061640	cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; regulation of exocytosis [GO:0017157]		blue	blue	NA	NA	NA	NA
TRINITY_DN38054_c0_g1_i1	Q8WYJ6	SEPT1_HUMAN	100	80	0	0	242	3	207	286	4.50E-42	171.4	SEPT1_HUMAN	reviewed	Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24)	SEPTIN1 DIFF6 PNUTL3 SEPT1	Homo sapiens (Human)	367	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005815; GO:0005940; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0034613; GO:0042802; GO:0060090; GO:0061640	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]		NA	NA	NA	NA	NA	NA
TRINITY_DN29983_c0_g1_i1	Q8WYJ6	SEPT1_HUMAN	100	203	0	0	3	611	9	211	1.70E-113	409.8	SEPT1_HUMAN	reviewed	Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24)	SEPTIN1 DIFF6 PNUTL3 SEPT1	Homo sapiens (Human)	367	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005815; GO:0005940; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0034613; GO:0042802; GO:0060090; GO:0061640	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]		NA	NA	NA	NA	NA	NA
TRINITY_DN40093_c0_g1_i1	A2VE99	SEP11_BOVIN	100	127	0	0	3	383	73	199	4.50E-67	255	SEP11_BOVIN	reviewed	Septin-11	SEPTIN11 SEPT11	Bos taurus (Bovine)	425	axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0030424; GO:0031105; GO:0032153; GO:0034613; GO:0043197; GO:0060090; GO:0061640	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]		NA	NA	NA	NA	NA	NA
TRINITY_DN8334_c0_g1_i1	P54359	SEPT2_DROME	77.1	96	22	0	290	3	224	319	1.60E-40	166.4	SEPT2_DROME	reviewed	Septin-2	Sep2 CG4173	Drosophila melanogaster (Fruit fly)	419	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]	GO:0000281; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007349; GO:0007444; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042803; GO:0051726; GO:0060090; GO:0061640	cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]		blue	blue	NA	NA	NA	NA
TRINITY_DN3213_c0_g1_i1	P54359	SEPT2_DROME	80.6	67	13	0	9	209	12	78	3.50E-26	118.2	SEPT2_DROME	reviewed	Septin-2	Sep2 CG4173	Drosophila melanogaster (Fruit fly)	419	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]	GO:0000281; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007349; GO:0007444; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042803; GO:0051726; GO:0060090; GO:0061640	cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]		blue	blue	NA	NA	NA	NA
TRINITY_DN1534_c0_g1_i1	P54359	SEPT2_DROME	77.9	154	34	0	3	464	74	227	2.40E-67	256.1	SEPT2_DROME	reviewed	Septin-2	Sep2 CG4173	Drosophila melanogaster (Fruit fly)	419	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]	GO:0000281; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007349; GO:0007444; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042803; GO:0051726; GO:0060090; GO:0061640	cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]		blue	blue	NA	NA	NA	NA
TRINITY_DN37082_c0_g1_i1	Q15019	SEPT2_HUMAN	100	250	0	0	752	3	73	322	4.00E-142	505.4	SEPT2_HUMAN	reviewed	Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5)	SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2	Homo sapiens (Human)	361	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; neuron projection development [GO:0031175]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]	cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0000145; GO:0000777; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0008021; GO:0015629; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0031175; GO:0032153; GO:0032154; GO:0032391; GO:0034613; GO:0042802; GO:0045171; GO:0045296; GO:0048471; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730	cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; neuron projection development [GO:0031175]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN37082_c0_g1_i2	Q15019	SEPT2_HUMAN	100	316	0	0	950	3	7	322	3.60E-182	638.6	SEPT2_HUMAN	reviewed	Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5)	SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2	Homo sapiens (Human)	361	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; neuron projection development [GO:0031175]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]	cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0000145; GO:0000777; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0008021; GO:0015629; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0031175; GO:0032153; GO:0032154; GO:0032391; GO:0034613; GO:0042802; GO:0045171; GO:0045296; GO:0048471; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730	cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; neuron projection development [GO:0031175]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN19954_c0_g1_i1	O43236	SEPT4_HUMAN	69.7	99	30	0	1	297	324	422	2.40E-36	152.5	SEPT4_HUMAN	reviewed	Septin-4 (Apoptosis-related protein in the TGF-beta signaling pathway) (ARTS) (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2) (hCDCREL-2) (Cerebral protein 7) (Peanut-like protein 2)	SEPTIN4 ARTS C17orf47 PNUTL2 SEP4 SEPT4 hucep-7	Homo sapiens (Human)	478	cell division site [GO:0032153]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatogenesis [GO:0007283]	cell division site [GO:0032153]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]	GO:0000287; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005940; GO:0006915; GO:0007283; GO:0008021; GO:0015630; GO:0017157; GO:0030154; GO:0031105; GO:0031398; GO:0032153; GO:0034613; GO:0042802; GO:0042981; GO:0043065; GO:0060090; GO:0061640; GO:0097227; GO:2001244	apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN19954_c0_g2_i1	P28661	SEPT4_MOUSE	66.3	190	64	0	571	2	122	311	4.30E-74	278.9	SEPT4_MOUSE	reviewed	Septin-4 (Brain protein H5) (Peanut-like protein 2)	Septin4 Pnutl2 Sept4	Mus musculus (Mouse)	478	cell division site [GO:0032153]; cell projection [GO:0042995]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of exocytosis [GO:0017157]; sperm capacitation [GO:0048240]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]	cell division site [GO:0032153]; cell projection [GO:0042995]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; synaptic vesicle [GO:0008021]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]	GO:0000287; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005940; GO:0007286; GO:0007420; GO:0008021; GO:0015630; GO:0017157; GO:0030382; GO:0031105; GO:0031398; GO:0031514; GO:0032153; GO:0034613; GO:0036126; GO:0042802; GO:0042995; GO:0043065; GO:0043209; GO:0048240; GO:0060090; GO:0061640; GO:0097227; GO:2001244	brain development [GO:0007420]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of exocytosis [GO:0017157]; spermatid development [GO:0007286]; sperm capacitation [GO:0048240]; sperm mitochondrion organization [GO:0030382]		NA	NA	NA	NA	NA	NA
TRINITY_DN25517_c0_g1_i1	Q14141	SEPT6_HUMAN	100	137	0	0	412	2	83	219	3.20E-71	268.9	SEPT6_HUMAN	reviewed	Septin-6	SEPTIN6 KIAA0128 SEP2 SEPT6	Homo sapiens (Human)	434	axon terminus [GO:0043679]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin collar [GO:0032173]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; spermatogenesis [GO:0007283]; viral process [GO:0016032]	axon terminus [GO:0043679]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin collar [GO:0032173]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0000281; GO:0000777; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007283; GO:0008021; GO:0015630; GO:0016032; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0032173; GO:0034613; GO:0043679; GO:0060090; GO:0060271; GO:0061640; GO:0097227	cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; spermatogenesis [GO:0007283]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN519_c0_g1_i3	O55131	SEPT7_MOUSE	71.7	329	84	3	1287	325	23	350	4.60E-140	499.2	SEPT7_MOUSE	reviewed	Septin-7 (CDC10 protein homolog)	Septin7 Cdc10 Sept7	Mus musculus (Mouse)	436	axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0000281; GO:0000777; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0015630; GO:0016020; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0034613; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0097730; GO:0098978; GO:0099173; GO:1902857	cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]		NA	NA	1	NA	NA	NA
TRINITY_DN8175_c0_g1_i2	O55131	SEPT7_MOUSE	99.7	331	1	0	1077	85	20	350	5.70E-192	671.4	SEPT7_MOUSE	reviewed	Septin-7 (CDC10 protein homolog)	Septin7 Cdc10 Sept7	Mus musculus (Mouse)	436	axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0000281; GO:0000777; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0015630; GO:0016020; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0034613; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0097730; GO:0098978; GO:0099173; GO:1902857	cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; dendritic spine morphogenesis [GO:0060997]; mitotic cytokinesis [GO:0000281]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8175_c0_g1_i3	Q6Q137	SEPT7_BOVIN	100	333	0	0	1083	85	19	351	3.90E-193	675.2	SEPT7_BOVIN	reviewed	Septin-7 (CDC10 protein homolog)	SEPTIN7 CDC10 SEPT7	Bos taurus (Bovine)	437	axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0000777; GO:0003924; GO:0005525; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032153; GO:0032154; GO:0034613; GO:0060090; GO:0060271; GO:0061640	cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN27620_c0_g1_i1	Q9UHD8	SEPT9_HUMAN	95.8	95	4	0	287	3	480	574	1.40E-47	189.9	SEPT9_HUMAN	reviewed	Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1)	SEPTIN9 KIAA0991 MSF SEPT9	Homo sapiens (Human)	586	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]	cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0001725; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005930; GO:0005940; GO:0015629; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0045296; GO:0048471; GO:0060090; GO:0061640; GO:0097730; GO:1902857	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]		NA	NA	NA	NA	NA	NA
TRINITY_DN12562_c0_g1_i1	Q9UHD8	SEPT9_HUMAN	100	213	0	0	1	639	273	485	7.60E-120	431	SEPT9_HUMAN	reviewed	Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1)	SEPTIN9 KIAA0991 MSF SEPT9	Homo sapiens (Human)	586	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]	cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; molecular adaptor activity [GO:0060090]	GO:0001725; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005930; GO:0005940; GO:0015629; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0045296; GO:0048471; GO:0060090; GO:0061640; GO:0097730; GO:1902857	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]		NA	NA	NA	NA	NA	NA
TRINITY_DN2312_c0_g1_i2	Q9Y103	TFP11_DROME	50.6	81	38	2	97	333	1	81	6.90E-13	75.1	TFP11_DROME	reviewed	Septin-interacting protein 1 (Septin and tuftelin-interacting protein 1) (STIP-1)	sip1 stip-1 CG7238	Drosophila melanogaster (Fruit fly)	839	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex disassembly [GO:0000390]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]	nucleic acid binding [GO:0003676]	GO:0000390; GO:0000398; GO:0003676; GO:0005681; GO:0005737; GO:0071008; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex disassembly [GO:0000390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2822_c0_g1_i2	Q13501	SQSTM_HUMAN	36.4	214	109	8	763	152	236	432	2.10E-11	71.2	SQSTM_HUMAN	reviewed	Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)	SQSTM1 ORCA OSIL	Homo sapiens (Human)	440	aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; immune system process [GO:0002376]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511]	aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]	enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000407; GO:0000422; GO:0000423; GO:0000932; GO:0001934; GO:0002376; GO:0002931; GO:0004674; GO:0005080; GO:0005654; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006511; GO:0006914; GO:0006915; GO:0007005; GO:0007032; GO:0008104; GO:0008270; GO:0010821; GO:0016197; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030971; GO:0031397; GO:0031625; GO:0035255; GO:0035556; GO:0035973; GO:0042169; GO:0042802; GO:0043065; GO:0043066; GO:0043122; GO:0043130; GO:0043231; GO:0044753; GO:0044754; GO:0044877; GO:0045944; GO:0046578; GO:0061635; GO:0061912; GO:0070062; GO:0070498; GO:0070530; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719	aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; immune system process [GO:0002376]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN698_c0_g1_i1	P83095	LACTB_BOVIN	59.5	126	49	1	486	115	109	234	7.40E-38	159.5	LACTB_BOVIN	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	LACTB	Bos taurus (Bovine)	556	mitochondrion [GO:0005739]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]	peptidase activity [GO:0008233]	GO:0005739; GO:0006508; GO:0006629; GO:0008233; GO:0019216	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		blue	blue	NA	NA	NA	1
TRINITY_DN698_c0_g1_i2	P83095	LACTB_BOVIN	63.7	91	31	1	381	115	144	234	5.50E-27	122.1	LACTB_BOVIN	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	LACTB	Bos taurus (Bovine)	556	mitochondrion [GO:0005739]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]	peptidase activity [GO:0008233]	GO:0005739; GO:0006508; GO:0006629; GO:0008233; GO:0019216	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN698_c0_g1_i3	Q9EP89	LACTB_MOUSE	45.6	228	107	4	738	100	322	547	2.50E-50	201.4	LACTB_MOUSE	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	Lactb Lact1	Mus musculus (Mouse)	551	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN698_c0_g1_i3	Q9EP89	LACTB_MOUSE	58.3	103	43	0	1034	726	105	207	1.00E-30	136.3	LACTB_MOUSE	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	Lactb Lact1	Mus musculus (Mouse)	551	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN698_c0_g1_i5	P83095	LACTB_BOVIN	36.2	207	49	2	729	115	109	234	4.20E-27	124	LACTB_BOVIN	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	LACTB	Bos taurus (Bovine)	556	mitochondrion [GO:0005739]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]	peptidase activity [GO:0008233]	GO:0005739; GO:0006508; GO:0006629; GO:0008233; GO:0019216	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN698_c0_g1_i7	P83095	LACTB_BOVIN	59.5	126	49	1	486	115	109	234	7.40E-38	159.5	LACTB_BOVIN	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	LACTB	Bos taurus (Bovine)	556	mitochondrion [GO:0005739]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	mitochondrion [GO:0005739]	peptidase activity [GO:0008233]	GO:0005739; GO:0006508; GO:0006629; GO:0008233; GO:0019216	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		blue	blue	NA	NA	NA	NA
TRINITY_DN698_c0_g1_i8	Q9EP89	LACTB_MOUSE	47.1	255	118	4	819	100	295	547	5.10E-60	232.6	LACTB_MOUSE	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	Lactb Lact1	Mus musculus (Mouse)	551	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN27938_c0_g1_i1	P83111	LACTB_HUMAN	100	131	0	0	394	2	99	229	3.10E-71	268.9	LACTB_HUMAN	reviewed	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	LACTB MRPL56 UNQ843/PRO1781	Homo sapiens (Human)	547	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN19198_c0_g1_i1	P52712	CBPX_ORYSJ	65.4	78	27	0	236	3	115	192	3.30E-23	108.6	CBPX_ORYSJ	reviewed	Serine carboxypeptidase-like (EC 3.4.16.-)	CBP31 Os07g0479300 LOC_Os07g29620 P0434A03.108-1 P0640E12.147-1	Oryza sativa subsp. japonica (Rice)	429	endoplasmic reticulum membrane [GO:0005789]; peroxisome [GO:0005777]; vacuole [GO:0005773]; serine-type carboxypeptidase activity [GO:0004185]	endoplasmic reticulum membrane [GO:0005789]; peroxisome [GO:0005777]; vacuole [GO:0005773]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005773; GO:0005777; GO:0005789			NA	NA	NA	NA	NA	NA
TRINITY_DN7853_c0_g1_i3	Q8R238	SDSL_MOUSE	39.1	317	136	2	40	819	9	325	5.40E-55	216.1	SDSL_MOUSE	reviewed	Serine dehydratase-like (EC 4.3.1.17) (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (SDH)	Sdsl Sds	Mus musculus (Mouse)	329	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; isoleucine biosynthetic process [GO:0009097]; threonine catabolic process [GO:0006567]; threonine metabolic process [GO:0006566]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]	GO:0003941; GO:0004794; GO:0005739; GO:0006566; GO:0006567; GO:0009097; GO:0042802	isoleucine biosynthetic process [GO:0009097]; threonine catabolic process [GO:0006567]; threonine metabolic process [GO:0006566]		NA	NA	NA	NA	NA	NA
TRINITY_DN7853_c0_g1_i5	Q8R238	SDSL_MOUSE	45.4	141	76	1	71	490	185	325	3.90E-27	122.9	SDSL_MOUSE	reviewed	Serine dehydratase-like (EC 4.3.1.17) (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (SDH)	Sdsl Sds	Mus musculus (Mouse)	329	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; isoleucine biosynthetic process [GO:0009097]; threonine catabolic process [GO:0006567]; threonine metabolic process [GO:0006566]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]	GO:0003941; GO:0004794; GO:0005739; GO:0006566; GO:0006567; GO:0009097; GO:0042802	isoleucine biosynthetic process [GO:0009097]; threonine catabolic process [GO:0006567]; threonine metabolic process [GO:0006566]		NA	NA	NA	NA	NA	NA
TRINITY_DN7853_c0_g1_i6	Q96GA7	SDSL_HUMAN	47.8	251	131	0	43	795	10	260	2.60E-62	240.4	SDSL_HUMAN	reviewed	Serine dehydratase-like (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (Serine dehydratase 2) (SDH 2) (EC 4.3.1.17)	SDSL	Homo sapiens (Human)	329	cytosol [GO:0005829]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]; threonine metabolic process [GO:0006566]	cytosol [GO:0005829]	identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]	GO:0003941; GO:0004794; GO:0005829; GO:0006566; GO:0006567; GO:0009097; GO:0019518; GO:0030170; GO:0042802	isoleucine biosynthetic process [GO:0009097]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]; threonine metabolic process [GO:0006566]		NA	NA	NA	NA	NA	NA
TRINITY_DN2463_c0_g1_i1	Q9H4I8	SEHL2_HUMAN	29.3	307	186	9	963	91	13	304	8.10E-29	129.4	SEHL2_HUMAN	reviewed	Serine hydrolase-like protein 2 (EC 3.1.-.-)	SERHL2 SERHL	Homo sapiens (Human)	314	cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]	cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	hydrolase activity [GO:0016787]	GO:0005777; GO:0016787; GO:0031410; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN2463_c0_g1_i2	Q9H4I8	SEHL2_HUMAN	29.3	307	186	9	963	91	13	304	8.20E-29	129.4	SEHL2_HUMAN	reviewed	Serine hydrolase-like protein 2 (EC 3.1.-.-)	SERHL2 SERHL	Homo sapiens (Human)	314	cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]	cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	hydrolase activity [GO:0016787]	GO:0005777; GO:0016787; GO:0031410; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN38916_c0_g1_i1	Q6AAU3	GLYA_CUTAK	98.6	72	1	0	2	217	180	251	7.40E-35	147.1	GLYA_CUTAK	reviewed	Serine hydroxymethyltransferase (SHMT) (Serine methylase) (EC 2.1.2.1)	glyA PPA0369	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	491	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN31240_c0_g1_i1	A5V5D1	GLYA_SPHWW	86.5	148	20	0	1	444	204	351	1.10E-69	263.8	GLYA_SPHWW	reviewed	Serine hydroxymethyltransferase (SHMT) (Serine methylase) (EC 2.1.2.1)	glyA Swit_1131	Sphingomonas wittichii (strain RW1 / DSM 6014 / JCM 10273)	438	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	1
TRINITY_DN36165_c0_g1_i1	B2U7G7	GLYA_RALPJ	99	104	1	0	314	3	271	374	1.80E-50	199.5	GLYA_RALPJ	reviewed	Serine hydroxymethyltransferase (SHMT) (Serine methylase) (EC 2.1.2.1)	glyA Rpic_0678	Ralstonia pickettii (strain 12J)	415	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN1399_c0_g1_i1	Q2G646	GLYA_NOVAD	96.2	133	5	0	1	399	176	308	7.70E-70	264.2	GLYA_NOVAD	reviewed	Serine hydroxymethyltransferase (SHMT) (Serine methylase) (EC 2.1.2.1)	glyA Saro_2240	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	436	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN31760_c0_g1_i1	Q8Y1G1	GLYA1_RALSO	100	75	0	0	228	4	198	272	5.80E-38	157.5	GLYA1_RALSO	reviewed	Serine hydroxymethyltransferase 1 (SHMT 1) (Serine methylase 1) (EC 2.1.2.1)	glyA1 RSc0729 RS05124	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	415	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN11745_c0_g1_i1	O23254	GLYC4_ARATH	60.5	248	87	2	3	716	187	433	3.50E-81	302.8	GLYC4_ARATH	reviewed	Serine hydroxymethyltransferase 4 (AtSHMT4) (EC 2.1.2.1) (Glycine hydroxymethyltransferase 4) (Serine methylase 4)	SHM4 SHMT4 At4g13930 dl3005c FCAALL.160	Arabidopsis thaliana (Mouse-ear cress)	471	cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; one-carbon metabolic process [GO:0006730]; response to cadmium ion [GO:0046686]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]	GO:0004372; GO:0005829; GO:0005886; GO:0006544; GO:0006565; GO:0006730; GO:0007623; GO:0008270; GO:0009506; GO:0016597; GO:0019264; GO:0030170; GO:0035999; GO:0046653; GO:0046655; GO:0046686; GO:0050897; GO:0070905; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; one-carbon metabolic process [GO:0006730]; response to cadmium ion [GO:0046686]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN11745_c0_g2_i1	O23254	GLYC4_ARATH	72.6	168	46	0	8	511	16	183	1.60E-64	246.9	GLYC4_ARATH	reviewed	Serine hydroxymethyltransferase 4 (AtSHMT4) (EC 2.1.2.1) (Glycine hydroxymethyltransferase 4) (Serine methylase 4)	SHM4 SHMT4 At4g13930 dl3005c FCAALL.160	Arabidopsis thaliana (Mouse-ear cress)	471	cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; one-carbon metabolic process [GO:0006730]; response to cadmium ion [GO:0046686]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]	amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]	GO:0004372; GO:0005829; GO:0005886; GO:0006544; GO:0006565; GO:0006730; GO:0007623; GO:0008270; GO:0009506; GO:0016597; GO:0019264; GO:0030170; GO:0035999; GO:0046653; GO:0046655; GO:0046686; GO:0050897; GO:0070905; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; circadian rhythm [GO:0007623]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; one-carbon metabolic process [GO:0006730]; response to cadmium ion [GO:0046686]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN5237_c0_g1_i1	Q9SVM4	GLYC5_ARATH	46.6	73	39	0	239	21	357	429	2.10E-12	72.8	GLYC5_ARATH	reviewed	Serine hydroxymethyltransferase 5 (AtSHMT5) (EC 2.1.2.1) (Glycine hydroxymethyltransferase 5) (Protein EMBRYO SAC DEVELOPMENT ARREST 36) (Protein EMBRYO SAC DEVELOPMENT ARREST 37) (Serine methylase 5)	SHM5 EDA36 EDA37 SHMT5 At4g13890 F18A5.280	Arabidopsis thaliana (Mouse-ear cress)	470	cytosol [GO:0005829]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; one-carbon metabolic process [GO:0006730]; polar nucleus fusion [GO:0010197]; pollen development [GO:0009555]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]	amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]	GO:0004372; GO:0005829; GO:0006544; GO:0006565; GO:0006730; GO:0008270; GO:0009555; GO:0010197; GO:0016597; GO:0019264; GO:0030170; GO:0035999; GO:0046653; GO:0046655; GO:0050897; GO:0070905; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; one-carbon metabolic process [GO:0006730]; polar nucleus fusion [GO:0010197]; pollen development [GO:0009555]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN37436_c0_g1_i1	O62585	GLYC_ENCCU	52.1	73	35	0	222	4	112	184	1.40E-15	83.2	GLYC_ENCCU	reviewed	"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT-1 ECU01_0190; SHMT-2 ECU01_1420	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	460	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN7045_c0_g1_i1	Q6FUP6	GLYC_CANGA	55.8	138	55	3	18	413	211	348	3.20E-34	146	GLYC_CANGA	reviewed	"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHM2 CAGL0F01749g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	469	cytoplasm [GO:0005737]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	cytoplasm [GO:0005737]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005737; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN24308_c0_g1_i2	P50431	GLYC_MOUSE	96.7	121	4	0	364	2	75	195	9.50E-67	253.8	GLYC_MOUSE	reviewed	"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	Shmt1 Shmt	Mus musculus (Mouse)	478	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0004372; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006231; GO:0006544; GO:0006545; GO:0006563; GO:0006565; GO:0006730; GO:0008270; GO:0008732; GO:0009113; GO:0016597; GO:0017148; GO:0019264; GO:0030170; GO:0035999; GO:0036094; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051289; GO:0070905; GO:1904482; GO:1990830	cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN30001_c0_g1_i1	P34896	GLYC_HUMAN	100	93	0	0	282	4	174	266	4.80E-50	198	GLYC_HUMAN	reviewed	"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT1	Homo sapiens (Human)	483	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0004372; GO:0005634; GO:0005654; GO:0005829; GO:0006231; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0008270; GO:0008732; GO:0009113; GO:0016597; GO:0017148; GO:0019264; GO:0030170; GO:0035999; GO:0036094; GO:0042802; GO:0042803; GO:0045329; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051289; GO:0070062; GO:0070905; GO:1904482; GO:1990830	carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN1379_c0_g1_i1	P34896	GLYC_HUMAN	62.5	461	170	2	1462	89	22	482	5.70E-169	595.5	GLYC_HUMAN	reviewed	"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT1	Homo sapiens (Human)	483	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0004372; GO:0005634; GO:0005654; GO:0005829; GO:0006231; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0008270; GO:0008732; GO:0009113; GO:0016597; GO:0017148; GO:0019264; GO:0030170; GO:0035999; GO:0036094; GO:0042802; GO:0042803; GO:0045329; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051289; GO:0070062; GO:0070905; GO:1904482; GO:1990830	carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN13846_c0_g1_i1	P34897	GLYM_HUMAN	100	399	0	0	1199	3	45	443	1.60E-232	806.2	GLYM_HUMAN	reviewed	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT2	Homo sapiens (Human)	504	"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN13846_c0_g1_i2	Q9CZN7	GLYM_MOUSE	100	136	0	0	410	3	308	443	1.00E-72	273.9	GLYM_MOUSE	reviewed	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	Shmt2	Mus musculus (Mouse)	504	"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006545; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051262; GO:0051289; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN13846_c0_g1_i3	P34897	GLYM_HUMAN	97.2	252	7	0	758	3	192	443	3.30E-138	492.3	GLYM_HUMAN	reviewed	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT2	Homo sapiens (Human)	504	"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN33762_c0_g1_i1	P34899	GLYM_PEA	68.2	343	109	0	1032	4	109	451	6.80E-142	505	GLYM_PEA	reviewed	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"		Pisum sativum (Garden pea)	518	mitochondrion [GO:0005739]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]	mitochondrion [GO:0005739]	glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]	GO:0004372; GO:0005739; GO:0019264; GO:0030170; GO:0035999	glycine biosynthetic process from serine [GO:0019264]; tetrahydrofolate interconversion [GO:0035999]		NA	NA	NA	NA	NA	NA
TRINITY_DN2247_c0_g1_i1	P34897	GLYM_HUMAN	78	200	44	0	1	600	87	286	5.60E-92	338.6	GLYM_HUMAN	reviewed	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT2	Homo sapiens (Human)	504	"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN2247_c0_g1_i2	P34897	GLYM_HUMAN	72.1	384	106	1	1	1152	87	469	6.40E-165	581.6	GLYM_HUMAN	reviewed	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT2	Homo sapiens (Human)	504	"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0050897; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482	cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]		NA	NA	NA	NA	NA	NA
TRINITY_DN22123_c0_g1_i1	Q9QZI8	SERC1_MOUSE	98.8	85	1	0	255	1	214	298	5.70E-42	171	SERC1_MOUSE	reviewed	Serine incorporator 1 (Axotomy-induced glyco/Golgi protein 2) (Membrane protein TMS-2) (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)	Serinc1 Aigp2 Tde1l Tde2 Tms2	Mus musculus (Mouse)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222	membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN6786_c0_g1_i1	Q9NRX5	SERC1_HUMAN	50.7	469	210	7	1512	121	1	453	4.90E-120	433	SERC1_HUMAN	reviewed	Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)	SERINC1 KIAA1253 TDE1L TDE2 UNQ396/PRO732	Homo sapiens (Human)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222	membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]		blue	blue	NA	NA	NA	NA
TRINITY_DN6786_c0_g1_i3	Q9NRX5	SERC1_HUMAN	49.4	484	211	7	1563	121	1	453	1.10E-119	431.8	SERC1_HUMAN	reviewed	Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)	SERINC1 KIAA1253 TDE1L TDE2 UNQ396/PRO732	Homo sapiens (Human)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222	membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN28708_c0_g1_i1	Q9NRX5	SERC1_HUMAN	100	94	0	0	282	1	30	123	3.40E-48	191.8	SERC1_HUMAN	reviewed	Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)	SERINC1 KIAA1253 TDE1L TDE2 UNQ396/PRO732	Homo sapiens (Human)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222	membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN25737_c0_g1_i1	Q3MHV9	SERC1_BOVIN	98.7	76	1	0	296	69	378	453	1.50E-38	159.8	SERC1_BOVIN	reviewed	Serine incorporator 1 (Tumor differentially expressed protein 2)	SERINC1 TDE2	Bos taurus (Bovine)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005789; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021	phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN32937_c0_g1_i1	Q3MHV9	SERC1_BOVIN	100	70	0	0	211	2	137	206	2.50E-35	148.7	SERC1_BOVIN	reviewed	Serine incorporator 1 (Tumor differentially expressed protein 2)	SERINC1 TDE2	Bos taurus (Bovine)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005789; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021	phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN32937_c0_g1_i2	Q3MHV9	SERC1_BOVIN	100	77	0	0	232	2	137	213	5.90E-38	157.5	SERC1_BOVIN	reviewed	Serine incorporator 1 (Tumor differentially expressed protein 2)	SERINC1 TDE2	Bos taurus (Bovine)	453	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005789; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021	phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i1	A4FUZ5	SERC3_BOVIN	38.5	192	111	5	1562	996	14	201	2.20E-28	128.6	SERC3_BOVIN	reviewed	Serine incorporator 3	SERINC3	Bos taurus (Bovine)	472	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i1	A4FUZ5	SERC3_BOVIN	29.6	291	185	6	1039	206	188	471	5.50E-24	114	SERC3_BOVIN	reviewed	Serine incorporator 3	SERINC3	Bos taurus (Bovine)	472	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i14	A4FUZ5	SERC3_BOVIN	33.4	470	286	11	1570	206	14	471	1.80E-59	231.9	SERC3_BOVIN	reviewed	Serine incorporator 3	SERINC3	Bos taurus (Bovine)	472	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i4	A4FUZ5	SERC3_BOVIN	31.8	214	128	4	814	206	265	471	3.10E-21	104	SERC3_BOVIN	reviewed	Serine incorporator 3	SERINC3	Bos taurus (Bovine)	472	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i8	A4FUZ5	SERC3_BOVIN	36.8	136	80	2	598	206	337	471	2.40E-16	87.4	SERC3_BOVIN	reviewed	Serine incorporator 3	SERINC3	Bos taurus (Bovine)	472	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN31239_c0_g1_i1	Q9QZI9	SERC3_MOUSE	100	288	0	0	2	865	26	313	2.20E-162	572.8	SERC3_MOUSE	reviewed	Serine incorporator 3 (Axotomy-induced glyco/Golgi protein 1) (AIGP-1) (Axotomy-induced glycoprotein 1) (Membrane protein TMS-1) (Tumor differentially expressed protein 1)	Serinc3 Aigp1 Diff33 Tde1 Tms1	Mus musculus (Mouse)	472	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005794; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i15	Q9QZI9	SERC3_MOUSE	36.8	247	147	7	1279	551	14	255	1.00E-31	139.4	SERC3_MOUSE	reviewed	Serine incorporator 3 (Axotomy-induced glyco/Golgi protein 1) (AIGP-1) (Axotomy-induced glycoprotein 1) (Membrane protein TMS-1) (Tumor differentially expressed protein 1)	Serinc3 Aigp1 Diff33 Tde1 Tms1	Mus musculus (Mouse)	472	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005794; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i18	Q9QZI9	SERC3_MOUSE	36.4	283	170	8	1361	528	14	291	2.70E-38	161.4	SERC3_MOUSE	reviewed	Serine incorporator 3 (Axotomy-induced glyco/Golgi protein 1) (AIGP-1) (Axotomy-induced glycoprotein 1) (Membrane protein TMS-1) (Tumor differentially expressed protein 1)	Serinc3 Aigp1 Diff33 Tde1 Tms1	Mus musculus (Mouse)	472	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005794; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i5	Q9QZI9	SERC3_MOUSE	36.8	247	147	7	1120	392	14	255	9.10E-32	139.4	SERC3_MOUSE	reviewed	Serine incorporator 3 (Axotomy-induced glyco/Golgi protein 1) (AIGP-1) (Axotomy-induced glycoprotein 1) (Membrane protein TMS-1) (Tumor differentially expressed protein 1)	Serinc3 Aigp1 Diff33 Tde1 Tms1	Mus musculus (Mouse)	472	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005794; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN37598_c0_g1_i1	Q9QZI9	SERC3_MOUSE	100	92	0	0	2	277	381	472	1.30E-48	193.4	SERC3_MOUSE	reviewed	Serine incorporator 3 (Axotomy-induced glyco/Golgi protein 1) (AIGP-1) (Axotomy-induced glycoprotein 1) (Membrane protein TMS-1) (Tumor differentially expressed protein 1)	Serinc3 Aigp1 Diff33 Tde1 Tms1	Mus musculus (Mouse)	472	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0000139; GO:0005794; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0045087; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN38207_c0_g1_i1	Q13530	SERC3_HUMAN	100	97	0	0	1	291	377	473	1.40E-49	196.8	SERC3_HUMAN	reviewed	Serine incorporator 3 (Tumor differentially expressed protein 1)	SERINC3 DIFF33 TDE1 SBBI99	Homo sapiens (Human)	473	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]; viral process [GO:0016032]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0016032; GO:0045087; GO:0048471; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c0_g1_i9	Q13530	SERC3_HUMAN	29.6	287	174	8	1018	206	198	472	2.20E-23	111.3	SERC3_HUMAN	reviewed	Serine incorporator 3 (Tumor differentially expressed protein 1)	SERINC3 DIFF33 TDE1 SBBI99	Homo sapiens (Human)	473	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]; viral process [GO:0016032]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0016032; GO:0045087; GO:0048471; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30041_c0_g1_i1	Q13530	SERC3_HUMAN	100	218	0	0	655	2	81	298	1.30E-122	440.3	SERC3_HUMAN	reviewed	Serine incorporator 3 (Tumor differentially expressed protein 1)	SERINC3 DIFF33 TDE1 SBBI99	Homo sapiens (Human)	473	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]; viral process [GO:0016032]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]		GO:0000139; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0009597; GO:0016020; GO:0016021; GO:0016032; GO:0045087; GO:0048471; GO:0051607; GO:1902237	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN40643_c0_g1_i1	P83748	PRS30_RAT	64.6	48	16	1	179	36	220	266	5.80E-12	71.2	PRS30_RAT	reviewed	Serine protease 30 (EC 3.4.21.-) (Distal intestinal serine protease) (Transmembrane serine protease 1) (TMSP-1) (Transmembrane serine protease 8)	Prss30 Disp Tmprss8 Tmsp-1 Tmsp1	Rattus norvegicus (Rat)	304	anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; proteolysis [GO:0006508]; sodium ion transport [GO:0006814]	anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]	GO:0004252; GO:0005615; GO:0006508; GO:0006814; GO:0017080; GO:0046658	proteolysis [GO:0006508]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12645_c0_g1_i1	Q8VIF2	PRS42_MOUSE	45.3	53	26	2	266	108	261	310	3.40E-05	48.9	PRS42_MOUSE	reviewed	Serine protease 42 (EC 3.4.21.-) (Testis serine protease 2)	Prss42 Tessp2	Mus musculus (Mouse)	335	anchored component of plasma membrane [GO:0046658]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]	anchored component of plasma membrane [GO:0046658]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0007281; GO:0007283; GO:0046658	germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN35250_c0_g1_i1	Q402U7	PRS44_MOUSE	68.1	47	14	1	42	182	294	339	6.30E-11	67.8	PRS44_MOUSE	reviewed	Serine protease 44 (EC 3.4.21.-) (Testis serine protease 4) (TESSP-4) (Testis-specific serine protease 4)	Prss44 Tessp4	Mus musculus (Mouse)	372	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0007281; GO:0007283; GO:0016021	germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN12966_c1_g1_i1	B7YZU2	LINT_DROME	33.1	148	80	4	32	439	1468	1608	2.30E-14	80.1	LINT_DROME	reviewed	Serine protease filzig (EC 3.4.21.-) (Lumens interrupted)	flz lint CG8213	Drosophila melanogaster (Fruit fly)	1693	"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]"	integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595	"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i5	B7YZU2	LINT_DROME	32.5	197	119	4	844	260	1505	1689	7.00E-20	99.4	LINT_DROME	reviewed	Serine protease filzig (EC 3.4.21.-) (Lumens interrupted)	flz lint CG8213	Drosophila melanogaster (Fruit fly)	1693	"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]"	integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595	"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i6	B7YZU2	LINT_DROME	31.8	195	123	3	844	260	1505	1689	1.20E-19	98.6	LINT_DROME	reviewed	Serine protease filzig (EC 3.4.21.-) (Lumens interrupted)	flz lint CG8213	Drosophila melanogaster (Fruit fly)	1693	"integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]"	integral component of membrane [GO:0016021]; perivitelline space [GO:0098595]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0006508; GO:0016021; GO:0035149; GO:0060439; GO:0098595	"lumen formation, open tracheal system [GO:0035149]; proteolysis [GO:0006508]; trachea morphogenesis [GO:0060439]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40448_c0_g1_i1	Q9VB68	GRASS_DROME	42.9	84	44	1	11	250	262	345	6.20E-12	71.2	GRASS_DROME	reviewed	Serine protease grass (EC 3.4.21.-) (Gram-positive specific serine protease)	grass c-SP1 CG5896	Drosophila melanogaster (Fruit fly)	377	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0002804; GO:0004252; GO:0005509; GO:0005576; GO:0006508; GO:0006963; GO:0045087; GO:0045752; GO:0050830; GO:0050832	defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of Toll signaling pathway [GO:0045752]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN33417_c0_g1_i1	Q9VFC2	SP88E_DROME	35.5	358	203	8	48	1058	73	423	8.90E-55	215.7	SP88E_DROME	reviewed	Serine protease inhibitor 88Ea (Serpin 88Ea)	Spn88Ea Spn5 CG18525	Drosophila melanogaster (Fruit fly)	427	extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002376; GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0042438; GO:0045751; GO:0045824; GO:0045861; GO:0048526	imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]	x	brown	brown	NA	NA	NA	NA
TRINITY_DN33417_c0_g1_i3	Q9VFC2	SP88E_DROME	30.4	293	179	6	132	953	48	334	2.00E-34	147.9	SP88E_DROME	reviewed	Serine protease inhibitor 88Ea (Serpin 88Ea)	Spn88Ea Spn5 CG18525	Drosophila melanogaster (Fruit fly)	427	extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002376; GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0042438; GO:0045751; GO:0045824; GO:0045861; GO:0048526	imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]	x	brown	brown	NA	NA	NA	NA
TRINITY_DN33417_c0_g1_i2	Q9VFC2	SP88E_DROME	35.9	387	216	9	132	1229	48	423	3.60E-60	233.8	SP88E_DROME	reviewed	Serine protease inhibitor 88Ea (Serpin 88Ea)	Spn88Ea Spn5 CG18525	Drosophila melanogaster (Fruit fly)	427	extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002376; GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0042438; GO:0045751; GO:0045824; GO:0045861; GO:0048526	imaginal disc-derived wing expansion [GO:0048526]; immune system process [GO:0002376]; melanin biosynthetic process [GO:0042438]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteolysis [GO:0045861]; negative regulation of Toll signaling pathway [GO:0045751]		NA	NA	NA	NA	NA	NA
TRINITY_DN168_c0_g1_i2	O96790	DPGN_DIPMA	37.3	268	141	7	781	41	27	288	9.00E-39	162.2	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)	minus	Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]	x	black	black	NA	NA	1	1
TRINITY_DN168_c0_g1_i1	O96790	DPGN_DIPMA	41.2	160	71	5	488	60	192	345	4.60E-23	109.4	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]	x	black	black	1	NA	NA	1
TRINITY_DN882_c0_g1_i5	O96790	DPGN_DIPMA	31.1	370	199	11	1061	3	15	345	8.40E-37	156.4	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]		NA	NA	NA	NA	NA	NA
TRINITY_DN26527_c0_g1_i1	O96790	DPGN_DIPMA	40.8	71	32	2	221	33	277	345	3.50E-07	55.5	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]		blue	blue	NA	NA	NA	NA
TRINITY_DN8336_c0_g1_i1	O96790	DPGN_DIPMA	33	218	128	5	75	683	77	291	2.60E-28	127.1	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]		NA	NA	NA	NA	NA	NA
TRINITY_DN19137_c3_g1_i1	O96790	DPGN_DIPMA	41.2	80	39	1	2	217	251	330	8.60E-10	63.9	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]		NA	NA	NA	NA	NA	NA
TRINITY_DN168_c0_g1_i4	O96790	DPGN_DIPMA	36.2	218	117	6	662	60	133	345	9.20E-29	128.6	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0050819	negative regulation of coagulation [GO:0050819]		NA	NA	NA	NA	NA	NA
TRINITY_DN21704_c0_g2_i1	Q17800	SVH1_CAEEL	47.8	69	34	1	240	34	879	945	1.60E-13	76.6	SVH1_CAEEL	reviewed	Serine protease svh-1 (EC 3.4.21.-) (HGF/MSP/plasminogen-like protein svh-1) (Suppressor of vhp-1 deletion lethality protein svh-1)	svh-1 C07G1.1	Caenorhabditis elegans	951	extracellular space [GO:0005615]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; axon regeneration [GO:0031103]; larval development [GO:0002164]; positive regulation of gonad development [GO:1905941]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pharyngeal pumping [GO:1903746]; protein destabilization [GO:0031648]	extracellular space [GO:0005615]; membrane [GO:0016020]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0002164; GO:0004252; GO:0005044; GO:0005615; GO:0016020; GO:0031103; GO:0031648; GO:0043410; GO:1903746; GO:1905941	axon regeneration [GO:0031103]; larval development [GO:0002164]; positive regulation of gonad development [GO:1905941]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pharyngeal pumping [GO:1903746]; protein destabilization [GO:0031648]		blue	blue	NA	NA	NA	NA
TRINITY_DN33592_c0_g1_i1	Q05319	STUB_DROME	46.7	92	49	0	357	82	691	782	1.40E-22	107.1	STUB_DROME	reviewed	Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]	Sb Sb-sbd CG4316	Drosophila melanogaster (Fruit fly)	787	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017	actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]		black	black	1	NA	1	1
TRINITY_DN1021_c0_g1_i12	Q05319	STUB_DROME	31.5	238	149	5	970	269	555	782	9.90E-26	119	STUB_DROME	reviewed	Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]	Sb Sb-sbd CG4316	Drosophila melanogaster (Fruit fly)	787	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017	actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]		NA	NA	NA	NA	NA	NA
TRINITY_DN1021_c0_g1_i8	Q05319	STUB_DROME	33.1	239	145	6	973	269	555	782	1.20E-27	125.9	STUB_DROME	reviewed	Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]	Sb Sb-sbd CG4316	Drosophila melanogaster (Fruit fly)	787	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017	actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]		blue	blue	NA	NA	NA	NA
TRINITY_DN554_c0_g1_i3	Q2PGG3	SRR_ARATH	45.7	232	123	2	699	4	12	240	1.30E-55	218	SRR_ARATH	reviewed	Serine racemase (AtSR) (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)	SR SR1 At4g11640 T5C23.70	Arabidopsis thaliana (Mouse-ear cress)	331	ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; serine family amino acid metabolic process [GO:0009069]		ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005524; GO:0006563; GO:0008721; GO:0009069; GO:0018114; GO:0030170; GO:0030378; GO:0042866; GO:0043621; GO:0070178; GO:0070179	D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; serine family amino acid metabolic process [GO:0009069]		NA	NA	NA	NA	NA	NA
TRINITY_DN554_c0_g1_i7	Q9QZX7	SRR_MOUSE	43.9	255	133	7	852	100	79	327	1.30E-51	204.9	SRR_MOUSE	reviewed	Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17)	Srr	Mus musculus (Mouse)	339	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005886; GO:0006563; GO:0007420; GO:0007568; GO:0008721; GO:0009069; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042493; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0043278; GO:0045177; GO:0070178; GO:0070179	aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]		NA	NA	NA	NA	NA	NA
TRINITY_DN25693_c0_g1_i1	Q5ZMJ9	SRRM1_CHICK	100	115	0	0	347	3	1	115	2.60E-59	229.2	SRRM1_CHICK	reviewed	Serine/arginine repetitive matrix protein 1	SRRM1 RCJMB04_1m21	Gallus gallus (Chicken)	888	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]		GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN526_c0_g1_i2	Q5ZMJ9	SRRM1_CHICK	75.7	70	17	0	646	437	7	76	1.20E-23	111.7	SRRM1_CHICK	reviewed	Serine/arginine repetitive matrix protein 1	SRRM1 RCJMB04_1m21	Gallus gallus (Chicken)	888	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]		GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN526_c0_g1_i4	Q5ZMJ9	SRRM1_CHICK	78.7	75	16	0	661	437	2	76	2.40E-27	124	SRRM1_CHICK	reviewed	Serine/arginine repetitive matrix protein 1	SRRM1 RCJMB04_1m21	Gallus gallus (Chicken)	888	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleus [GO:0005634]		GO:0005634; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN526_c0_g1_i3	Q8IYB3	SRRM1_HUMAN	68.5	54	17	0	249	88	78	131	2.60E-14	80.1	SRRM1_HUMAN	reviewed	Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein)	SRRM1 SRM160	Homo sapiens (Human)	904	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0008380; GO:0016363; GO:0016607; GO:0031124; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN526_c0_g1_i5	Q8IYB3	SRRM1_HUMAN	66.7	57	19	0	258	88	75	131	9.90E-15	80.9	SRRM1_HUMAN	reviewed	Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein)	SRRM1 SRM160	Homo sapiens (Human)	904	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0008380; GO:0016363; GO:0016607; GO:0031124; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN526_c0_g1_i6	Q8IYB3	SRRM1_HUMAN	74	131	33	1	480	88	2	131	2.90E-49	196.4	SRRM1_HUMAN	reviewed	Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein)	SRRM1 SRM160	Homo sapiens (Human)	904	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0008380; GO:0016363; GO:0016607; GO:0031124; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		blue	blue	NA	NA	NA	NA
TRINITY_DN526_c0_g1_i7	Q8IYB3	SRRM1_HUMAN	70.4	54	16	0	249	88	78	131	1.80E-14	80.9	SRRM1_HUMAN	reviewed	Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein)	SRRM1 SRM160	Homo sapiens (Human)	904	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0008380; GO:0016363; GO:0016607; GO:0031124; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33823_c0_g1_i1	Q9LHP2	SL30A_ARATH	40.4	89	42	1	235	2	17	105	1.70E-11	69.7	SL30A_ARATH	reviewed	Serine/arginine-rich SC35-like splicing factor SCL30A (At-SCL30A) (AtSCL30A) (SC35-like splicing factor 30A) (Serine/arginine-rich splicing factor 30A)	SCL30A At3g13570 K20M4.1	Arabidopsis thaliana (Mouse-ear cress)	262	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005737; GO:0005829; GO:0008380; GO:0016607; GO:0045292	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31845_c0_g1_i1	Q0VCY7	SRSF1_BOVIN	100	65	0	0	1	195	120	184	3.60E-33	141.7	SRSF1_BOVIN	reviewed	"Serine/arginine-rich splicing factor 1 (Splicing factor, arginine/serine-rich 1)"	SRSF1 SFRS1	Bos taurus (Bovine)	248	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000381; GO:0000395; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0016607; GO:0045292; GO:0051028	"mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30087_c0_g1_i1	Q05519	SRS11_HUMAN	100	92	0	0	1	276	39	130	7.00E-46	184.1	SRS11_HUMAN	reviewed	"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)"	SRSF11 SFRS11	Homo sapiens (Human)	484	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0031124; GO:0042802	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN862_c0_g1_i1	Q7SXP4	SRS1A_DANRE	77.8	90	19	1	13	282	122	210	3.90E-36	152.1	SRS1A_DANRE	reviewed	"Serine/arginine-rich splicing factor 1A (Splicing factor, arginine/serine-rich 1) (Splicing factor, arginine/serine-rich 1A)"	srsf1a sfrs1a sfrs1l zgc:66146	Danio rerio (Zebrafish) (Brachydanio rerio)	257	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0016607; GO:0045292	"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30294_c0_g1_i1	Q6NYA0	SRS1B_DANRE	83.3	78	12	1	3	233	17	94	2.40E-32	139	SRS1B_DANRE	reviewed	"Serine/arginine-rich splicing factor 1B (Splicing factor, arginine/serine-rich 1) (Splicing factor, arginine/serine-rich 1B)"	srsf1b sfrs1 sfrs1b zgc:111894 zgc:65898 zgc:76897	Danio rerio (Zebrafish) (Brachydanio rerio)	245	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0016607; GO:0045292	"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28261_c0_g1_i1	Q3MHR5	SRSF2_BOVIN	100	69	0	0	85	291	1	69	1.60E-34	146.7	SRSF2_BOVIN	reviewed	"Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)"	SRSF2 SFRS2	Bos taurus (Bovine)	221	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0036002; GO:0045292	"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18666_c0_g1_i1	Q3SZR8	SRSF3_BOVIN	99	99	1	0	352	56	1	99	3.00E-55	215.7	SRSF3_BOVIN	reviewed	"Serine/arginine-rich splicing factor 3 (Splicing factor, arginine/serine-rich 3)"	SRSF3 SFRS3	Bos taurus (Bovine)	164	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	phospholipase binding [GO:0043274]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0043274; GO:0045292; GO:0048024; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18666_c0_g1_i2	Q3SZR8	SRSF3_BOVIN	100	99	0	0	352	56	1	99	4.90E-56	218.4	SRSF3_BOVIN	reviewed	"Serine/arginine-rich splicing factor 3 (Splicing factor, arginine/serine-rich 3)"	SRSF3 SFRS3	Bos taurus (Bovine)	164	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	phospholipase binding [GO:0043274]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0043274; GO:0045292; GO:0048024; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29645_c0_g1_i1	Q3SZR8	SRSF3_BOVIN	74.7	87	21	1	100	360	8	93	6.00E-31	135.2	SRSF3_BOVIN	reviewed	"Serine/arginine-rich splicing factor 3 (Splicing factor, arginine/serine-rich 3)"	SRSF3 SFRS3	Bos taurus (Bovine)	164	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	phospholipase binding [GO:0043274]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016607; GO:0043274; GO:0045292; GO:0048024; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"		blue	blue	NA	NA	NA	NA
TRINITY_DN289_c0_g1_i3	Q08170	SRSF4_HUMAN	67.4	95	31	0	1	285	85	179	1.10E-28	127.1	SRSF4_HUMAN	reviewed	"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)"	SRSF4 SFRS4 SRP75	Homo sapiens (Human)	494	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]	GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0031124; GO:0032868; GO:0045292; GO:0048025; GO:1990825	"mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g1_i7	Q08170	SRSF4_HUMAN	69.7	89	27	0	1	267	85	173	5.20E-30	131.3	SRSF4_HUMAN	reviewed	"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)"	SRSF4 SFRS4 SRP75	Homo sapiens (Human)	494	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]	GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0031124; GO:0032868; GO:0045292; GO:0048025; GO:1990825	"mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15348_c0_g1_i1	Q08170	SRSF4_HUMAN	100	86	0	0	304	47	100	185	3.60E-43	175.3	SRSF4_HUMAN	reviewed	"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)"	SRSF4 SFRS4 SRP75	Homo sapiens (Human)	494	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]	GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0031124; GO:0032868; GO:0045292; GO:0048025; GO:1990825	"mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30977_c0_g1_i1	Q08170	SRSF4_HUMAN	100	92	0	0	279	4	1	92	8.10E-48	190.7	SRSF4_HUMAN	reviewed	"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)"	SRSF4 SFRS4 SRP75	Homo sapiens (Human)	494	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]	GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0031124; GO:0032868; GO:0045292; GO:0048025; GO:1990825	"mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17655_c0_g2_i1	Q13243	SRSF5_HUMAN	100	76	0	0	270	43	1	76	2.00E-38	159.5	SRSF5_HUMAN	reviewed	"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)"	SRSF5 HRS SFRS5 SRP40	Homo sapiens (Human)	272	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0032869; GO:0033120; GO:0043422; GO:0045292; GO:0051726; GO:0097421	"cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17655_c0_g1_i1	Q13243	SRSF5_HUMAN	100	76	0	0	270	43	1	76	2.20E-38	159.5	SRSF5_HUMAN	reviewed	"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)"	SRSF5 HRS SFRS5 SRP40	Homo sapiens (Human)	272	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0032869; GO:0033120; GO:0043422; GO:0045292; GO:0051726; GO:0097421	"cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31028_c0_g1_i1	Q13243	SRSF5_HUMAN	100	70	0	0	1	210	112	181	5.20E-33	141	SRSF5_HUMAN	reviewed	"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)"	SRSF5 HRS SFRS5 SRP40	Homo sapiens (Human)	272	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0032869; GO:0033120; GO:0043422; GO:0045292; GO:0051726; GO:0097421	"cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31028_c0_g1_i2	Q13243	SRSF5_HUMAN	98.3	60	1	0	57	236	122	181	8.20E-27	120.6	SRSF5_HUMAN	reviewed	"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)"	SRSF5 HRS SFRS5 SRP40	Homo sapiens (Human)	272	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0032869; GO:0033120; GO:0043422; GO:0045292; GO:0051726; GO:0097421	"cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell cycle [GO:0051726]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15348_c0_g2_i1	Q13247	SRSF6_HUMAN	98.9	87	1	0	266	6	110	196	4.10E-43	174.9	SRSF6_HUMAN	reviewed	"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)"	SRSF6 SFRS6 SRP55	Homo sapiens (Human)	344	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell death [GO:0060548]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006376; GO:0006405; GO:0006406; GO:0010837; GO:0016607; GO:0031124; GO:0032868; GO:0036002; GO:0045292; GO:0045617; GO:0048025; GO:0060501; GO:0060548; GO:0061041; GO:2000675	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell death [GO:0060548]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN255_c0_g2_i1	Q3T106	SRSF7_BOVIN	40.7	108	59	1	500	192	12	119	1.80E-17	90.9	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN255_c0_g2_i2	Q3T106	SRSF7_BOVIN	40.7	108	59	1	444	136	12	119	1.20E-17	91.3	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN255_c0_g2_i3	Q3T106	SRSF7_BOVIN	40.7	108	59	1	460	152	12	119	1.60E-17	90.9	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN255_c0_g2_i4	Q3T106	SRSF7_BOVIN	40.7	108	59	1	447	139	12	119	1.60E-17	90.9	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40269_c0_g1_i1	Q3T106	SRSF7_BOVIN	100	124	0	0	441	70	1	124	2.80E-71	269.2	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22147_c0_g1_i1	Q3T106	SRSF7_BOVIN	56.3	158	24	3	97	567	10	123	6.20E-40	165.6	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22147_c0_g1_i2	Q3T106	SRSF7_BOVIN	82	61	11	0	97	279	10	70	6.40E-24	112.1	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22147_c0_g1_i4	Q3T106	SRSF7_BOVIN	76.5	115	24	2	97	438	10	122	2.30E-45	183.3	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i1	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	75	341	38	126	1.30E-30	134	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i10	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	11	277	38	126	1.70E-30	134.4	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i2	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	374	108	38	126	1.20E-30	134	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i4	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	808	542	38	126	1.70E-30	134.8	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i4	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	100	366	38	126	3.80E-30	133.7	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i8	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	100	366	38	126	1.40E-30	134	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3374_c0_g1_i9	Q8BL97	SRSF7_MOUSE	70.8	89	26	0	294	28	38	126	1.90E-30	133.3	SRSF7_MOUSE	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	Srsf7 Sfrs7	Mus musculus (Mouse)	267	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31789_c0_g1_i1	Q3T106	SRSF7_BOVIN	100	124	0	0	436	65	1	124	3.70E-71	268.9	SRSF7_BOVIN	reviewed	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	SRSF7 SFRS7	Bos taurus (Bovine)	235	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14109_c0_g1_i1	Q13242	SRSF9_HUMAN	100	105	0	0	1	315	105	209	1.50E-55	216.5	SRSF9_HUMAN	reviewed	"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)"	SRSF9 SFRS9 SRP30C	Homo sapiens (Human)	221	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA export from nucleus [GO:0006405]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0009636; GO:0016607; GO:0019904; GO:0031124; GO:0043279; GO:0045292; GO:0048025	"mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14109_c0_g1_i2	Q13242	SRSF9_HUMAN	100	93	0	0	44	322	117	209	1.00E-48	193.7	SRSF9_HUMAN	reviewed	"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)"	SRSF9 SFRS9 SRP30C	Homo sapiens (Human)	221	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA export from nucleus [GO:0006405]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0009636; GO:0016607; GO:0019904; GO:0031124; GO:0043279; GO:0045292; GO:0048025	"mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14109_c0_g1_i3	Q9D0B0	SRSF9_MOUSE	100	105	0	0	1	315	106	210	1.50E-55	216.5	SRSF9_MOUSE	reviewed	"Serine/arginine-rich splicing factor 9 (Splicing factor, arginine/serine-rich 9)"	Srsf9 Sfrs9	Mus musculus (Mouse)	222	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0009636; GO:0016607; GO:0019904; GO:0043279; GO:0045292; GO:0048025	"mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26877_c0_g1_i1	Q852Q2	OSK1_ORYSJ	73.3	187	50	0	561	1	56	242	2.10E-81	303.1	OSK1_ORYSJ	reviewed	Serine/threonine protein kinase OSK1 (OsK1) (EC 2.7.11.1) (SUCROSE NON-FERMENTING-1 related protein kinase 1A) (SNF1-related kinase 1A) (SnRK1A)	OSK1 SNRK1A LOC_Os05g45420 Os05g0530500 OJ1131_E09.11 OSNPB_050530500	Oryza sativa subsp. japonica (Rice)	505	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0035556	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN19085_c0_g2_i1	Q8LF36	2A5T_ARATH	62.1	203	77	0	3	611	235	437	7.40E-72	271.6	2A5T_ARATH	reviewed	"Serine/threonine protein phosphatase 2A 57 kDa regulatory subunit B' theta isoform (AtB' theta) (PP2A, B' subunit, theta isoform)"	B'THETA At1g13460 T6J4.19	Arabidopsis thaliana (Mouse-ear cress)	492	cytosol [GO:0005829]; peroxisome [GO:0005777]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; brassinosteroid mediated signaling pathway [GO:0009742]; negative regulation of brassinosteroid mediated signaling pathway [GO:1900458]; positive regulation of fatty acid beta-oxidation [GO:0032000]	cytosol [GO:0005829]; peroxisome [GO:0005777]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005777; GO:0005829; GO:0009742; GO:0019888; GO:0032000; GO:1900458	brassinosteroid mediated signaling pathway [GO:0009742]; negative regulation of brassinosteroid mediated signaling pathway [GO:1900458]; positive regulation of fatty acid beta-oxidation [GO:0032000]		NA	NA	NA	NA	NA	NA
TRINITY_DN36292_c0_g1_i1	Q8WUJ0	STYX_HUMAN	100	102	0	0	3	308	96	197	2.50E-52	205.7	STYX_HUMAN	reviewed	Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase STYX) (Phosphoserine/threonine/tyrosine interaction protein)	STYX	Homo sapiens (Human)	223	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; F-box domain binding [GO:1990444]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; MAPK export from nucleus [GO:0045204]; negative regulation of catalytic activity [GO:0043086]; negative regulation of protein binding [GO:0032091]; negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062026]; regulation of ERK1 and ERK2 cascade [GO:0070372]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	F-box domain binding [GO:1990444]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]	GO:0001691; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0032091; GO:0043086; GO:0045204; GO:0062026; GO:0070372; GO:1990444	MAPK export from nucleus [GO:0045204]; negative regulation of catalytic activity [GO:0043086]; negative regulation of protein binding [GO:0032091]; negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062026]; regulation of ERK1 and ERK2 cascade [GO:0070372]		NA	NA	NA	NA	NA	NA
TRINITY_DN444_c0_g1_i1	Q5U593	STYXB_XENLA	51.4	146	71	0	632	195	35	180	2.60E-37	157.1	STYXB_XENLA	reviewed	Serine/threonine/tyrosine-interacting protein B (Inactive tyrosine-protein phosphatase STYX-B)	styx-b	Xenopus laevis (African clawed frog)	223	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]		protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0008138			blue	blue	NA	NA	NA	NA
TRINITY_DN444_c0_g1_i1	Q5U593	STYXB_XENLA	65.1	43	15	0	774	646	20	62	5.70E-08	59.7	STYXB_XENLA	reviewed	Serine/threonine/tyrosine-interacting protein B (Inactive tyrosine-protein phosphatase STYX-B)	styx-b	Xenopus laevis (African clawed frog)	223	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]		protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0008138			blue	blue	NA	NA	NA	NA
TRINITY_DN444_c0_g1_i2	Q5U593	STYXB_XENLA	60.2	161	64	0	677	195	20	180	5.10E-53	209.1	STYXB_XENLA	reviewed	Serine/threonine/tyrosine-interacting protein B (Inactive tyrosine-protein phosphatase STYX-B)	styx-b	Xenopus laevis (African clawed frog)	223	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]		protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0008138			blue	blue	NA	NA	NA	NA
TRINITY_DN1132_c3_g1_i3	Q5VZP5	DUS27_HUMAN	46.2	156	79	2	557	93	133	284	2.70E-28	127.1	STYL2_HUMAN	reviewed	Serine/threonine/tyrosine-interacting-like protein 2 (Inactive dual specificity phosphatase 27)	STYXL2 DUSP27	Homo sapiens (Human)	1158	sarcomere [GO:0030017]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	sarcomere [GO:0030017]	protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0008138; GO:0030017			NA	NA	NA	NA	NA	NA
TRINITY_DN6074_c0_g1_i1	Q7SY52	STK10_DANRE	64.3	154	55	0	462	1	111	264	1.00E-57	224.2	STK10_DANRE	reviewed	Serine/threonine-protein kinase 10 (EC 2.7.11.1)	stk10 zgc:63495	Danio rerio (Zebrafish) (Brachydanio rerio)	974	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005886; GO:0007049; GO:0042803; GO:0046777; GO:2000401	cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]		blue	blue	NA	NA	NA	NA
TRINITY_DN39169_c0_g1_i1	O94804	STK10_HUMAN	100	157	0	0	1	471	110	266	4.30E-88	325.1	STK10_HUMAN	reviewed	Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase)	STK10 LOK	Homo sapiens (Human)	968	extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; lymphocyte aggregation [GO:0071593]; neutrophil degranulation [GO:0043312]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of lymphocyte migration [GO:2000401]	extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007049; GO:0035579; GO:0042802; GO:0042803; GO:0043312; GO:0046777; GO:0070062; GO:0071593; GO:2000401	cell cycle [GO:0007049]; lymphocyte aggregation [GO:0071593]; neutrophil degranulation [GO:0043312]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of lymphocyte migration [GO:2000401]		NA	NA	NA	NA	NA	NA
TRINITY_DN31277_c0_g1_i1	O55098	STK10_MOUSE	100	81	0	0	3	245	176	256	5.00E-43	174.5	STK10_MOUSE	reviewed	Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase)	Stk10 Lok	Mus musculus (Mouse)	966	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; lymphocyte aggregation [GO:0071593]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005886; GO:0007049; GO:0042802; GO:0042803; GO:0046777; GO:0071593; GO:2000401	cell cycle [GO:0007049]; lymphocyte aggregation [GO:0071593]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]		NA	NA	NA	NA	NA	NA
TRINITY_DN36044_c0_g1_i1	O88697	STK16_MOUSE	98.2	113	2	0	3	341	158	270	4.00E-59	228.4	STK16_MOUSE	reviewed	Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Embryo-derived protein kinase) (Edpk) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase Krct) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2)	Stk16 Edpk Krct Mpsk1 Pkl12 Tsf1	Mus musculus (Mouse)	305	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005798; GO:0005829; GO:0006468; GO:0016020; GO:0045944; GO:0046777; GO:0048471; GO:0071560	cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN4346_c0_g1_i13	P57760	STK16_RAT	40.7	297	167	4	1153	263	6	293	7.10E-61	236.1	STK16_RAT	reviewed	Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2)	Stk16 Mpsk1 Tsf1	Rattus norvegicus (Rat)	305	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005798; GO:0005829; GO:0006468; GO:0016020; GO:0045944; GO:0046777; GO:0048471; GO:0071560	cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN4346_c0_g1_i8	P57760	STK16_RAT	40.7	297	167	4	1149	259	6	293	7.10E-61	236.1	STK16_RAT	reviewed	Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2)	Stk16 Mpsk1 Tsf1	Rattus norvegicus (Rat)	305	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005798; GO:0005829; GO:0006468; GO:0016020; GO:0045944; GO:0046777; GO:0048471; GO:0071560	cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		blue	blue	NA	NA	NA	NA
TRINITY_DN31220_c0_g1_i1	Q9UEE5	ST17A_HUMAN	100	233	0	0	1	699	110	342	5.80E-129	461.5	ST17A_HUMAN	reviewed	Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1)	STK17A DRAK1	Homo sapiens (Human)	414	nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005886; GO:0006468; GO:0006915; GO:0016607; GO:0035556; GO:0043065; GO:2000271; GO:2000377	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN24650_c0_g1_i1	Q9GM70	ST17A_RABIT	47.6	42	22	0	1	126	172	213	1.10E-06	53.5	ST17A_RABIT	reviewed	Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) (rDRAK1)	STK17A DRAK1	Oryctolagus cuniculus (Rabbit)	397	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; regulation of reactive oxygen species metabolic process [GO:2000377]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0006915; GO:0035556; GO:0043065; GO:2000377	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN3613_c0_g1_i2	Q9GM70	ST17A_RABIT	48.9	92	46	1	106	378	231	322	5.90E-18	93.6	ST17A_RABIT	reviewed	Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) (rDRAK1)	STK17A DRAK1	Oryctolagus cuniculus (Rabbit)	397	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; regulation of reactive oxygen species metabolic process [GO:2000377]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0006915; GO:0035556; GO:0043065; GO:2000377	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; regulation of reactive oxygen species metabolic process [GO:2000377]		NA	NA	NA	NA	NA	NA
TRINITY_DN32933_c0_g1_i1	O94768	ST17B_HUMAN	100	66	0	0	3	200	32	97	7.90E-31	133.7	ST17B_HUMAN	reviewed	Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2)	STK17B DRAK2	Homo sapiens (Human)	372	actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005793; GO:0005886; GO:0006468; GO:0006915; GO:0015629; GO:0035556; GO:0043065; GO:0046777; GO:2000271	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN33045_c0_g1_i1	O94768	ST17B_HUMAN	100	168	0	0	505	2	122	289	5.10E-87	321.6	ST17B_HUMAN	reviewed	Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2)	STK17B DRAK2	Homo sapiens (Human)	372	actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005793; GO:0005886; GO:0006468; GO:0006915; GO:0015629; GO:0035556; GO:0043065; GO:0046777; GO:2000271	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN39287_c0_g1_i1	Q9Y6E0	STK24_HUMAN	100	283	0	0	850	2	27	309	8.30E-162	570.9	STK24_HUMAN	reviewed	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	Homo sapiens (Human)	443	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0008631; GO:0009267; GO:0016020; GO:0030336; GO:0042542; GO:0045296; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194	cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN39493_c0_g1_i1	Q9Y6E0	STK24_HUMAN	60.4	96	37	1	289	5	145	240	9.60E-30	130.6	STK24_HUMAN	reviewed	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	STK24 MST3 STK3	Homo sapiens (Human)	443	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0008631; GO:0009267; GO:0016020; GO:0030336; GO:0042542; GO:0045296; GO:0046777; GO:0046872; GO:0048679; GO:0070062; GO:0097194	cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38146_c0_g1_i1	Q9Z2W1	STK25_MOUSE	100	72	0	0	218	3	1	72	1.20E-33	143.3	STK25_MOUSE	reviewed	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	Mus musculus (Mouse)	426	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN7221_c0_g2_i1	Q9Z2W1	STK25_MOUSE	82.1	279	49	1	157	990	13	291	7.00E-130	465.3	STK25_MOUSE	reviewed	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	Mus musculus (Mouse)	426	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN7221_c0_g2_i2	Q9Z2W1	STK25_MOUSE	81.3	284	52	1	76	924	8	291	1.80E-130	467.2	STK25_MOUSE	reviewed	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	Stk25 Sok1	Mus musculus (Mouse)	426	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN21641_c0_g1_i1	O00506	STK25_HUMAN	100	208	0	0	2	625	12	219	7.70E-117	421	STK25_HUMAN	reviewed	Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	Homo sapiens (Human)	426	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168	establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN26097_c0_g1_i1	Q9P289	STK26_HUMAN	100	112	0	0	338	3	15	126	9.80E-58	223.8	STK26_HUMAN	reviewed	Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK)	STK26 MASK MST4	Homo sapiens (Human)	416	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0006468; GO:0006915; GO:0009267; GO:0012506; GO:0016020; GO:0016324; GO:0030033; GO:0030336; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0046777; GO:0048471; GO:0070062; GO:0071944; GO:1903205	apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN40357_c0_g1_i1	Q9P289	STK26_HUMAN	98.8	81	1	0	244	2	131	211	3.30E-39	161.8	STK26_HUMAN	reviewed	Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK)	STK26 MASK MST4	Homo sapiens (Human)	416	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0006468; GO:0006915; GO:0009267; GO:0012506; GO:0016020; GO:0016324; GO:0030033; GO:0030336; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0046777; GO:0048471; GO:0070062; GO:0071944; GO:1903205	apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN32877_c0_g1_i1	Q9JJX8	ST32B_MOUSE	60.2	98	39	0	327	34	143	240	2.20E-29	130.6	ST32B_MOUSE	reviewed	Serine/threonine-protein kinase 32B (EC 2.7.11.1)	Stk32b Stk32	Mus musculus (Mouse)	414	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN32877_c0_g1_i1	Q9JJX8	ST32B_MOUSE	60.9	92	36	0	593	318	1	92	8.60E-26	118.6	ST32B_MOUSE	reviewed	Serine/threonine-protein kinase 32B (EC 2.7.11.1)	Stk32b Stk32	Mus musculus (Mouse)	414	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN32877_c0_g1_i3	Q9JJX8	ST32B_MOUSE	63.5	74	27	0	282	61	145	218	8.50E-23	107.5	ST32B_MOUSE	reviewed	Serine/threonine-protein kinase 32B (EC 2.7.11.1)	Stk32b Stk32	Mus musculus (Mouse)	414	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		blue	blue	NA	NA	NA	NA
TRINITY_DN32877_c0_g1_i2	Q8QZV4	ST32C_MOUSE	63.6	228	83	0	714	31	85	312	3.30E-83	309.7	ST32C_MOUSE	reviewed	Serine/threonine-protein kinase 32C (EC 2.7.11.1)	Stk32c Pkek MNCb-1563	Mus musculus (Mouse)	488	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN32877_c0_g1_i4	Q8QZV4	ST32C_MOUSE	63.6	228	83	0	714	31	85	312	3.30E-83	309.7	ST32C_MOUSE	reviewed	Serine/threonine-protein kinase 32C (EC 2.7.11.1)	Stk32c Pkek MNCb-1563	Mus musculus (Mouse)	488	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		blue	blue	NA	NA	NA	NA
TRINITY_DN32877_c0_g1_i6	Q8QZV4	ST32C_MOUSE	62.6	227	85	0	711	31	86	312	5.90E-82	305.4	ST32C_MOUSE	reviewed	Serine/threonine-protein kinase 32C (EC 2.7.11.1)	Stk32c Pkek MNCb-1563	Mus musculus (Mouse)	488	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		blue	blue	NA	NA	NA	NA
TRINITY_DN29391_c0_g1_i1	Q69ZM6	STK36_MOUSE	67.7	127	41	0	3	383	94	220	4.30E-49	195.3	STK36_MOUSE	reviewed	Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog)	Stk36 Kiaa1278	Mus musculus (Mouse)	1316	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]	GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0007228; GO:0007420; GO:0008134; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271	brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]		NA	NA	NA	NA	NA	NA
TRINITY_DN16963_c0_g1_i1	A2VDV2	STK38_BOVIN	99.7	320	1	0	962	3	53	372	1.40E-186	653.3	STK38_BOVIN	reviewed	Serine/threonine-protein kinase 38 (EC 2.7.11.1)	STK38	Bos taurus (Bovine)	465	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0035556; GO:0043407; GO:0046872	intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN40683_c0_g1_i1	Q9Y2H1	ST38L_HUMAN	100	61	0	0	1	183	198	258	7.20E-31	134	ST38L_HUMAN	reviewed	Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2)	STK38L KIAA0965 NDR2	Homo sapiens (Human)	464	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0015629; GO:0016020; GO:0018105; GO:0035556; GO:0051128	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128]		NA	NA	NA	NA	NA	NA
TRINITY_DN28090_c0_g1_i1	Q9Y2H1	ST38L_HUMAN	100	80	0	0	242	3	374	453	8.30E-43	173.7	ST38L_HUMAN	reviewed	Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2)	STK38L KIAA0965 NDR2	Homo sapiens (Human)	464	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0015629; GO:0016020; GO:0018105; GO:0035556; GO:0051128	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128]		NA	NA	NA	NA	NA	NA
TRINITY_DN26671_c0_g1_i1	Q5E9L6	STK4_BOVIN	100	232	0	0	697	2	21	252	1.30E-133	476.9	STK4_BOVIN	reviewed	Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)]	STK4 MST1	Bos taurus (Bovine)	487	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; primitive hemopoiesis [GO:0060215]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]	GO:0000287; GO:0000902; GO:0001569; GO:0001841; GO:0003157; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007417; GO:0008134; GO:0008285; GO:0016604; GO:0018105; GO:0023014; GO:0030216; GO:0031098; GO:0032092; GO:0032147; GO:0032991; GO:0033138; GO:0035329; GO:0042803; GO:0045600; GO:0046621; GO:0046777; GO:0050821; GO:0060215; GO:0060706; GO:0060800; GO:0090090; GO:0097284; GO:1902043; GO:1904237	"activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; primitive hemopoiesis [GO:0060215]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN642_c0_g1_i1	A4K2W5	STK4_AOTNA	82.9	246	42	0	738	1	13	258	3.30E-122	439.1	STK4_AOTNA	reviewed	Serine/threonine-protein kinase 4 (EC 2.7.11.1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)]	STK4	Aotus nancymaae (Ma's night monkey)	487	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0007165; GO:0046872	apoptotic process [GO:0006915]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36853_c0_g1_i1	Q7T0B0	STK40_XENTR	69.1	94	28	1	370	89	241	333	1.20E-29	130.6	STK40_XENTR	reviewed	Serine/threonine-protein kinase 40 (EC 2.7.11.1) (Serine/threonine-protein kinase lyk4)	stk40	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	443	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN26068_c0_g1_i1	P51566	AFC1_ARATH	55.8	95	41	1	6	290	281	374	2.90E-26	119	AFC1_ARATH	reviewed	Serine/threonine-protein kinase AFC1 (EC 2.7.12.1)	AFC1 AME2 At3g53570 F4P12_270	Arabidopsis thaliana (Mouse-ear cress)	467	"ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; regulation of transcription, DNA-templated [GO:0006355]"		ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004712; GO:0005524; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36008_c0_g1_i1	Q17941	AKT1_CAEEL	73.2	71	19	0	246	34	184	254	5.20E-23	108.2	AKT1_CAEEL	reviewed	Serine/threonine-protein kinase akt-1 (EC 2.7.11.1) (Protein kinase B akt-1) (PKB akt-1)	akt-1 C12D8.10	Caenorhabditis elegans	541	"axon [GO:0030424]; cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to salt [GO:1902074]"	axon [GO:0030424]; cytoplasmic side of plasma membrane [GO:0009898]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]	"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]"	GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005547; GO:0006468; GO:0006935; GO:0007635; GO:0008286; GO:0008340; GO:0008582; GO:0009898; GO:0018105; GO:0018107; GO:0030424; GO:0030425; GO:0035556; GO:0042771; GO:0043025; GO:0045087; GO:0046872; GO:1902074	chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN30593_c0_g1_i1	P10398	ARAF_HUMAN	100	121	0	0	364	2	26	146	8.60E-68	257.3	ARAF_HUMAN	reviewed	Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks)	ARAF ARAF1 PKS PKS2	Homo sapiens (Human)	606	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular protein modification process [GO:0006464]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005739; GO:0005829; GO:0006464; GO:0032006; GO:0032434; GO:0033138; GO:0043066; GO:0046872	cellular protein modification process [GO:0006464]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN8346_c0_g1_i2	Q9JKK8	ATR_MOUSE	55.7	79	35	0	5	241	2242	2320	4.80E-17	88.6	ATR_MOUSE	reviewed	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)	Atr Kiaa4069	Mus musculus (Mouse)	2635	"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; establishment of RNA localization to telomere [GO:0097694]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; replicative senescence [GO:0090399]; telomere maintenance [GO:0000723]"	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000723; GO:0001741; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006281; GO:0006468; GO:0006974; GO:0007566; GO:0008156; GO:0016605; GO:0018105; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0043393; GO:0043517; GO:0046777; GO:0051276; GO:0070198; GO:0071480; GO:0090399; GO:0097694; GO:1904884	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; establishment of RNA localization to telomere [GO:0097694]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; replicative senescence [GO:0090399]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8346_c0_g1_i4	Q9JKK8	ATR_MOUSE	62.9	251	93	0	5	757	2242	2492	2.80E-92	339.7	ATR_MOUSE	reviewed	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)	Atr Kiaa4069	Mus musculus (Mouse)	2635	"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; establishment of RNA localization to telomere [GO:0097694]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; replicative senescence [GO:0090399]; telomere maintenance [GO:0000723]"	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000723; GO:0001741; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006281; GO:0006468; GO:0006974; GO:0007566; GO:0008156; GO:0016605; GO:0018105; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0043393; GO:0043517; GO:0046777; GO:0051276; GO:0070198; GO:0071480; GO:0090399; GO:0097694; GO:1904884	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; establishment of RNA localization to telomere [GO:0097694]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; replicative senescence [GO:0090399]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8346_c0_g1_i1	Q13535	ATR_HUMAN	51.7	58	28	0	142	315	2587	2644	8.60E-10	64.7	ATR_HUMAN	reviewed	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)	ATR FRP1	Homo sapiens (Human)	2644	"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000723; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006260; GO:0006281; GO:0006974; GO:0007275; GO:0008156; GO:0016605; GO:0018105; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0036297; GO:0042493; GO:0043517; GO:0046777; GO:0070198; GO:0071480; GO:0090399; GO:0097694; GO:0097695; GO:1900034; GO:1901796; GO:1904884	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39632_c0_g1_i1	Q13535	ATR_HUMAN	97.8	93	2	0	1	279	2470	2562	1.40E-49	196.4	ATR_HUMAN	reviewed	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)	ATR FRP1	Homo sapiens (Human)	2644	"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000723; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006260; GO:0006281; GO:0006974; GO:0007275; GO:0008156; GO:0016605; GO:0018105; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0036297; GO:0042493; GO:0043517; GO:0046777; GO:0070198; GO:0071480; GO:0090399; GO:0097694; GO:0097695; GO:1900034; GO:1901796; GO:1904884	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34077_c0_g1_i1	Q13535	ATR_HUMAN	54.5	55	25	0	182	18	2292	2346	9.80E-12	70.5	ATR_HUMAN	reviewed	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)	ATR FRP1	Homo sapiens (Human)	2644	"chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000723; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006260; GO:0006281; GO:0006974; GO:0007275; GO:0008156; GO:0016605; GO:0018105; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0036297; GO:0042493; GO:0043517; GO:0046777; GO:0070198; GO:0071480; GO:0090399; GO:0097694; GO:0097695; GO:1900034; GO:1901796; GO:1904884	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8346_c0_g1_i3	Q9DE14	ATR_XENLA	61.1	396	147	3	5	1171	2259	2654	5.20E-141	502.3	ATR_XENLA	reviewed	Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)	atr	Xenopus laevis (African clawed frog)	2654	PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]	PML body [GO:0016605]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]	GO:0003677; GO:0004674; GO:0005524; GO:0006281; GO:0016605; GO:0018105; GO:0046982	DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i1	Q9Z265	CHK2_MOUSE	41.1	418	231	8	101	1318	77	491	8.60E-79	295.8	CHK2_MOUSE	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)	Chek2 Chk2 Rad53	Mus musculus (Mouse)	546	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0035690; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i2	Q9Z265	CHK2_MOUSE	39.5	463	256	9	101	1426	77	536	9.00E-82	305.8	CHK2_MOUSE	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)	Chek2 Chk2 Rad53	Mus musculus (Mouse)	546	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0035690; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i3	Q9Z265	CHK2_MOUSE	41.1	418	231	8	101	1318	77	491	9.80E-79	295.8	CHK2_MOUSE	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)	Chek2 Chk2 Rad53	Mus musculus (Mouse)	546	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0035690; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i7	Q9Z265	CHK2_MOUSE	37.8	286	166	6	101	931	77	359	2.60E-42	174.1	CHK2_MOUSE	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)	Chek2 Chk2 Rad53	Mus musculus (Mouse)	546	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0035690; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i8	Q9Z265	CHK2_MOUSE	39.5	463	256	9	101	1426	77	536	9.10E-82	305.8	CHK2_MOUSE	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)	Chek2 Chk2 Rad53	Mus musculus (Mouse)	546	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0035690; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3135_c0_g1_i9	Q9Z265	CHK2_MOUSE	41.1	418	231	8	101	1318	77	491	9.90E-79	295.8	CHK2_MOUSE	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)	Chek2 Chk2 Rad53	Mus musculus (Mouse)	546	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0000781; GO:0001302; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0035690; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7372_c0_g1_i1	A8XJW8	CST1_CAEBR	59.1	132	54	0	400	5	126	257	4.30E-39	162.2	CST1_CAEBR	reviewed	Serine/threonine-protein kinase cst-1 (EC 2.7.11.1) [Cleaved into: Serine/threonine-protein kinase cst-1 37kDa subunit; Serine/threonine-protein kinase cst-1 18kDa subunit]	cst-1 CBG14395	Caenorhabditis briggsae	494	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; determination of adult lifespan [GO:0008340]; muscle fiber development [GO:0048747]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0008340; GO:0023014; GO:0031098; GO:0032147; GO:0048747	activation of protein kinase activity [GO:0032147]; determination of adult lifespan [GO:0008340]; muscle fiber development [GO:0048747]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN31577_c0_g1_i1	Q05609	CTR1_ARATH	37.7	69	43	0	3	209	649	717	2.10E-10	65.9	CTR1_ARATH	reviewed	Serine/threonine-protein kinase CTR1 (EC 2.7.11.1) (Protein CONSTITUTIVE TRIPLE RESPONSE1)	CTR1 At5g03730 F17C15_150	Arabidopsis thaliana (Mouse-ear cress)	821	endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182]	endoplasmic reticulum membrane [GO:0005789]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0001666; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005789; GO:0009686; GO:0009723; GO:0009744; GO:0009750; GO:0009873; GO:0010105; GO:0010182; GO:0046777; GO:0048510; GO:2000035; GO:2000069	ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i1	Q15139	KPCD1_HUMAN	57.7	787	258	10	2266	113	102	882	3.90E-251	869	KPCD1_HUMAN	reviewed	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	PRKD1 PKD PKD1 PRKCM	Homo sapiens (Human)	912	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; negative regulation of endocytosis [GO:0045806]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007165; GO:0007229; GO:0007265; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0030148; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042802; GO:0043123; GO:0043536; GO:0043552; GO:0045087; GO:0045669; GO:0045766; GO:0045806; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0051092; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028; GO:2001044	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; negative regulation of endocytosis [GO:0045806]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i2	Q62101	KPCD1_MOUSE	68.8	443	125	5	1450	149	440	878	3.00E-172	607.1	KPCD1_MOUSE	reviewed	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	Prkd1 Pkcm Pkd Prkcm	Mus musculus (Mouse)	918	autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	autophagosome membrane [GO:0000421]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i2	Q62101	KPCD1_MOUSE	43.4	346	162	5	2471	1533	100	444	1.90E-73	278.9	KPCD1_MOUSE	reviewed	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	Prkd1 Pkcm Pkd Prkcm	Mus musculus (Mouse)	918	autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	autophagosome membrane [GO:0000421]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i5	Q62101	KPCD1_MOUSE	68.8	443	125	5	1450	149	440	878	2.90E-172	607.1	KPCD1_MOUSE	reviewed	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	Prkd1 Pkcm Pkd Prkcm	Mus musculus (Mouse)	918	autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	autophagosome membrane [GO:0000421]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i5	Q62101	KPCD1_MOUSE	42.6	345	131	6	2366	1533	100	444	3.50E-69	264.6	KPCD1_MOUSE	reviewed	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	Prkd1 Pkcm Pkd Prkcm	Mus musculus (Mouse)	918	autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	autophagosome membrane [GO:0000421]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN34446_c0_g1_i1	Q9BZL6	KPCD2_HUMAN	100	72	0	0	2	217	134	205	1.90E-38	159.1	KPCD2_HUMAN	reviewed	Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2)	PRKD2 PKD2 HSPC187	Homo sapiens (Human)	878	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:1901727; GO:1902533; GO:2000573; GO:2001028	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN26407_c0_g1_i1	Q9BZL6	KPCD2_HUMAN	98.6	69	1	0	208	2	244	312	1.10E-35	149.8	KPCD2_HUMAN	reviewed	Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2)	PRKD2 PKD2 HSPC187	Homo sapiens (Human)	878	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:1901727; GO:1902533; GO:2000573; GO:2001028	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN40570_c0_g1_i1	Q9BZL6	KPCD2_HUMAN	100	80	0	0	242	3	694	773	8.30E-43	173.7	KPCD2_HUMAN	reviewed	Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2)	PRKD2 PKD2 HSPC187	Homo sapiens (Human)	878	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:1901727; GO:1902533; GO:2000573; GO:2001028	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN24330_c0_g1_i1	Q9BZL6	KPCD2_HUMAN	100	187	0	0	561	1	527	713	6.30E-102	371.3	KPCD2_HUMAN	reviewed	Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2)	PRKD2 PKD2 HSPC187	Homo sapiens (Human)	878	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:1901727; GO:1902533; GO:2000573; GO:2001028	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i6	Q8K1Y2	KPCD3_MOUSE	59.4	774	256	12	2371	158	110	861	7.20E-256	884.8	KPCD3_MOUSE	reviewed	Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (nPKC-nu)	Prkd3 Prkcn	Mus musculus (Mouse)	889	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase D signaling [GO:0089700]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]	GO:0004698; GO:0005524; GO:0005654; GO:0005829; GO:0016020; GO:0016301; GO:0046872; GO:0089700	protein kinase D signaling [GO:0089700]		NA	NA	NA	NA	NA	NA
TRINITY_DN26240_c0_g1_i1	O94806	KPCD3_HUMAN	100	71	0	0	214	2	564	634	2.10E-34	145.6	KPCD3_HUMAN	reviewed	Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu)	PRKD3 EPK2 PRKCN	Homo sapiens (Human)	890	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]	GO:0004697; GO:0004698; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700	protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i3	O94806	KPCD3_HUMAN	52.7	207	68	3	658	62	110	294	4.00E-55	216.1	KPCD3_HUMAN	reviewed	Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu)	PRKD3 EPK2 PRKCN	Homo sapiens (Human)	890	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]	GO:0004697; GO:0004698; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700	protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN19416_c0_g1_i4	O94806	KPCD3_HUMAN	68.8	109	33	1	506	183	110	218	6.20E-40	165.2	KPCD3_HUMAN	reviewed	Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu)	PRKD3 EPK2 PRKCN	Homo sapiens (Human)	890	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]	GO:0004697; GO:0004698; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700	protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]		NA	NA	NA	NA	NA	NA
TRINITY_DN5482_c0_g1_i1	Q9JLM8	DCLK1_MOUSE	52.8	489	193	6	1425	73	214	702	2.40E-129	463.8	DCLK1_MOUSE	reviewed	Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1)	Dclk1 Dcamkl1 Dclk	Mus musculus (Mouse)	756	postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; response to virus [GO:0009615]	postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0001764; GO:0004672; GO:0004674; GO:0005524; GO:0007409; GO:0007420; GO:0009615; GO:0014069; GO:0018105; GO:0021952; GO:0030900; GO:0035556; GO:0048675; GO:0048812; GO:0048813; GO:1900181	axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN36933_c0_g1_i1	Q8BWQ5	DCLK3_MOUSE	48.5	97	40	2	278	3	670	761	4.30E-20	98.6	DCLK3_MOUSE	reviewed	Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (CLICK-I and II-related) (CLr) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)	Dclk3 Dcamkl3	Mus musculus (Mouse)	790	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0035556; GO:1900181	intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN35847_c0_g1_i1	P49762	DOA_DROME	76.8	284	55	1	1	819	475	758	5.00E-132	471.9	DOA_DROME	reviewed	Serine/threonine-protein kinase Doa (EC 2.7.12.1) (Protein darkener of apricot)	Doa CG42320	Drosophila melanogaster (Fruit fly)	832	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000381; GO:0002225; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006468; GO:0007350; GO:0007399; GO:0007548; GO:0007601; GO:0009306; GO:0010508; GO:0016301; GO:0018993; GO:0042051; GO:0045752; GO:0046777; GO:0048749; GO:0050896; GO:2000255	"blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31436_c0_g1_i1	P49762	DOA_DROME	59.1	88	36	0	15	278	629	716	1.50E-27	123.2	DOA_DROME	reviewed	Serine/threonine-protein kinase Doa (EC 2.7.12.1) (Protein darkener of apricot)	Doa CG42320	Drosophila melanogaster (Fruit fly)	832	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000381; GO:0002225; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006468; GO:0007350; GO:0007399; GO:0007548; GO:0007601; GO:0009306; GO:0010508; GO:0016301; GO:0018993; GO:0042051; GO:0045752; GO:0046777; GO:0048749; GO:0050896; GO:2000255	"blastoderm segmentation [GO:0007350]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; negative regulation of male germ cell proliferation [GO:2000255]; nervous system development [GO:0007399]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of autophagy [GO:0010508]; positive regulation of Toll signaling pathway [GO:0045752]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to stimulus [GO:0050896]; sex differentiation [GO:0007548]; somatic sex determination [GO:0018993]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3419_c0_g1_i1	Q9W1B0	GEK_DROME	78.9	289	59	1	2	862	66	354	4.20E-137	488.8	GEK_DROME	reviewed	Serine/threonine-protein kinase Genghis Khan (EC 2.7.11.1)	gek CG4012	Drosophila melanogaster (Fruit fly)	1637	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008039; GO:0008154; GO:0018107; GO:0030424; GO:0030426; GO:0030833; GO:0031032; GO:0035556; GO:0046872	actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN29535_c0_g1_i1	Q9W1B0	GEK_DROME	82.5	63	11	0	28	216	990	1052	7.50E-27	120.6	GEK_DROME	reviewed	Serine/threonine-protein kinase Genghis Khan (EC 2.7.11.1)	gek CG4012	Drosophila melanogaster (Fruit fly)	1637	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008039; GO:0008154; GO:0018107; GO:0030424; GO:0030426; GO:0030833; GO:0031032; GO:0035556; GO:0046872	actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN13201_c0_g1_i1	Q9W1B0	GEK_DROME	51.2	84	39	2	19	267	1493	1575	4.60E-16	85.9	GEK_DROME	reviewed	Serine/threonine-protein kinase Genghis Khan (EC 2.7.11.1)	gek CG4012	Drosophila melanogaster (Fruit fly)	1637	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008039; GO:0008154; GO:0018107; GO:0030424; GO:0030426; GO:0030833; GO:0031032; GO:0035556; GO:0046872	actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN1298_c0_g1_i1	Q9W1B0	GEK_DROME	55	209	93	1	49	672	1099	1307	1.00E-61	238	GEK_DROME	reviewed	Serine/threonine-protein kinase Genghis Khan (EC 2.7.11.1)	gek CG4012	Drosophila melanogaster (Fruit fly)	1637	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008039; GO:0008154; GO:0018107; GO:0030424; GO:0030426; GO:0030833; GO:0031032; GO:0035556; GO:0046872	actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN1298_c0_g1_i2	Q9W1B0	GEK_DROME	50.7	71	35	0	49	261	1099	1169	8.50E-12	70.9	GEK_DROME	reviewed	Serine/threonine-protein kinase Genghis Khan (EC 2.7.11.1)	gek CG4012	Drosophila melanogaster (Fruit fly)	1637	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008039; GO:0008154; GO:0018107; GO:0030424; GO:0030426; GO:0030833; GO:0031032; GO:0035556; GO:0046872	actin polymerization or depolymerization [GO:0008154]; actomyosin structure organization [GO:0031032]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of actin filament polymerization [GO:0030833]; synaptic target recognition [GO:0008039]		NA	NA	NA	NA	NA	NA
TRINITY_DN28912_c0_g1_i1	Q8C0P0	GWL_MOUSE	62.4	101	33	1	289	2	103	203	3.00E-31	135.6	GWL_MOUSE	reviewed	Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L)	Mastl Gw Gwl	Mus musculus (Mouse)	865	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]	GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0016301; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721; GO:0051726; GO:1904668	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]		NA	NA	NA	NA	NA	NA
TRINITY_DN32247_c0_g1_i1	D2HXI8	GWL_AILME	100	70	0	0	2	211	124	193	6.20E-34	144.1	GWL_AILME	reviewed	Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L)	MASTL GW GWL PANDA_017354	Ailuropoda melanoleuca (Giant panda)	882	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]	GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0032154; GO:0032515; GO:0051301; GO:0051721	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]		NA	NA	NA	NA	NA	NA
TRINITY_DN36205_c0_g1_i1	Q96GX5	GWL_HUMAN	79	81	16	1	2	244	723	802	1.60E-33	142.9	GWL_HUMAN	reviewed	Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L)	MASTL GW GWL THC2	Homo sapiens (Human)	879	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]	GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0016301; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721; GO:0051726; GO:1904668	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]		NA	NA	NA	NA	NA	NA
TRINITY_DN16467_c0_g1_i1	O61661	CHK1_DROME	70.4	142	42	0	428	3	96	237	5.70E-63	241.5	CHK1_DROME	reviewed	Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes)	grp CG17161	Drosophila melanogaster (Fruit fly)	512	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle arrest [GO:0007050]; cellularization [GO:0007349]; centrosome separation [GO:0051299]; DNA damage checkpoint [GO:0000077]; embryonic development via the syncytial blastoderm [GO:0001700]; imaginal disc development [GO:0007444]; intracellular signal transduction [GO:0035556]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; spindle assembly [GO:0051225]; wound healing [GO:0042060]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0001700; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007050; GO:0007093; GO:0007348; GO:0007349; GO:0007444; GO:0009314; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299	cell cycle arrest [GO:0007050]; cellularization [GO:0007349]; centrosome separation [GO:0051299]; DNA damage checkpoint [GO:0000077]; embryonic development via the syncytial blastoderm [GO:0001700]; imaginal disc development [GO:0007444]; intracellular signal transduction [GO:0035556]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; spindle assembly [GO:0051225]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN1868_c0_g1_i1	O61661	CHK1_DROME	40.4	255	128	6	1	696	259	512	3.20E-35	150.2	CHK1_DROME	reviewed	Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes)	grp CG17161	Drosophila melanogaster (Fruit fly)	512	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle arrest [GO:0007050]; cellularization [GO:0007349]; centrosome separation [GO:0051299]; DNA damage checkpoint [GO:0000077]; embryonic development via the syncytial blastoderm [GO:0001700]; imaginal disc development [GO:0007444]; intracellular signal transduction [GO:0035556]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; spindle assembly [GO:0051225]; wound healing [GO:0042060]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0001700; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007050; GO:0007093; GO:0007348; GO:0007349; GO:0007444; GO:0009314; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299	cell cycle arrest [GO:0007050]; cellularization [GO:0007349]; centrosome separation [GO:0051299]; DNA damage checkpoint [GO:0000077]; embryonic development via the syncytial blastoderm [GO:0001700]; imaginal disc development [GO:0007444]; intracellular signal transduction [GO:0035556]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; response to radiation [GO:0009314]; spindle assembly [GO:0051225]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN39154_c0_g1_i1	Q0V7M1	KPSH1_BOVIN	100	129	0	0	3	389	142	270	1.40E-68	260	KPSH1_BOVIN	reviewed	Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1)	PSKH1	Bos taurus (Bovine)	424	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005815; GO:0005886; GO:0007368; GO:0007507; GO:0016607	determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]		NA	NA	NA	NA	NA	NA
TRINITY_DN34089_c0_g1_i1	Q0V7M1	KPSH1_BOVIN	63.9	144	52	0	434	3	161	304	3.50E-52	205.7	KPSH1_BOVIN	reviewed	Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1)	PSKH1	Bos taurus (Bovine)	424	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005815; GO:0005886; GO:0007368; GO:0007507; GO:0016607	determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]		NA	NA	NA	NA	NA	NA
TRINITY_DN13847_c0_g1_i1	Q8TF76	HASP_HUMAN	44.1	261	141	3	872	99	530	788	8.10E-56	218.8	HASP_HUMAN	reviewed	Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)	HASPIN GSG2	Homo sapiens (Human)	798	"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007064; GO:0035556; GO:0071459; GO:0072354; GO:2000751	"histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13847_c0_g1_i3	Q8TF76	HASP_HUMAN	44.1	236	129	2	797	99	553	788	9.00E-53	208.8	HASP_HUMAN	reviewed	Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)	HASPIN GSG2	Homo sapiens (Human)	798	"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007064; GO:0035556; GO:0071459; GO:0072354; GO:2000751	"histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36877_c0_g1_i1	Q01919	KIN4_YEAST	58.5	94	39	0	287	6	93	186	2.90E-26	119	KIN4_YEAST	reviewed	Serine/threonine-protein kinase KIN4 (EC 2.7.11.1)	KIN4 KIN3 KIN31 YOR233W O5220	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	800	cell cortex [GO:0005938]; cellular bud neck [GO:0005935]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole body [GO:0005816]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; mitotic spindle orientation checkpoint [GO:0031578]; protein localization to spindle pole body [GO:0071988]; protein phosphorylation [GO:0006468]	cell cortex [GO:0005938]; cellular bud neck [GO:0005935]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole body [GO:0005816]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005816; GO:0005935; GO:0005938; GO:0006468; GO:0031578; GO:0035556; GO:0071988	intracellular signal transduction [GO:0035556]; mitotic spindle orientation checkpoint [GO:0031578]; protein localization to spindle pole body [GO:0071988]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN9628_c0_g1_i4	O95835	LATS1_HUMAN	74.1	379	89	4	2	1114	708	1085	8.30E-163	574.7	LATS1_HUMAN	reviewed	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	LATS1 WARTS	Homo sapiens (Human)	1130	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:2000058	cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN38514_c0_g1_i1	O95835	LATS1_HUMAN	100	98	0	0	1	294	654	751	1.20E-46	186.8	LATS1_HUMAN	reviewed	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	LATS1 WARTS	Homo sapiens (Human)	1130	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:2000058	cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]		NA	NA	NA	NA	NA	NA
TRINITY_DN36155_c0_g1_i1	Q9NRM7	LATS2_HUMAN	58.9	95	38	1	1	285	720	813	1.40E-26	120.2	LATS2_HUMAN	reviewed	Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)	LATS2 KPM	Homo sapiens (Human)	1088	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0090090	cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]		NA	NA	NA	NA	NA	NA
TRINITY_DN5775_c0_g1_i1	Q8IWU2	LMTK2_HUMAN	36.6	276	157	7	5	811	194	458	2.00E-43	178.7	LMTK2_HUMAN	reviewed	Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2)	LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2	Homo sapiens (Human)	1503	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine kinase activity [GO:0004674]; axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]	ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine kinase activity [GO:0004674]	GO:0001881; GO:0004674; GO:0004864; GO:0005524; GO:0005769; GO:0005794; GO:0005829; GO:0005887; GO:0006468; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0016021; GO:0018105; GO:0018107; GO:0018108; GO:0030426; GO:0032456; GO:0033572; GO:0033674; GO:0043025; GO:0043235; GO:0045022; GO:0046777; GO:0048471; GO:0055037; GO:0070853	axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN5775_c0_g1_i2	Q8IWU2	LMTK2_HUMAN	37.7	252	144	6	5	739	194	439	3.50E-43	176.8	LMTK2_HUMAN	reviewed	Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2)	LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2	Homo sapiens (Human)	1503	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine kinase activity [GO:0004674]; axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]	ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine kinase activity [GO:0004674]	GO:0001881; GO:0004674; GO:0004864; GO:0005524; GO:0005769; GO:0005794; GO:0005829; GO:0005887; GO:0006468; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0016021; GO:0018105; GO:0018107; GO:0018108; GO:0030426; GO:0032456; GO:0033572; GO:0033674; GO:0043025; GO:0043235; GO:0045022; GO:0046777; GO:0048471; GO:0055037; GO:0070853	axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; multicellular organism development [GO:0007275]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN36383_c0_g1_i1	P20794	MAK_HUMAN	77.2	101	23	0	3	305	105	205	4.30E-44	178.3	MAK_HUMAN	reviewed	Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase)	MAK	Homo sapiens (Human)	623	axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; transcription coactivator activity [GO:0003713]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; multicellular organism development [GO:0007275]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; transcription coactivator activity [GO:0003713]	GO:0001750; GO:0001917; GO:0003713; GO:0004672; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0007275; GO:0007283; GO:0010468; GO:0030154; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:1902856	cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; multicellular organism development [GO:0007275]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN21349_c0_g1_i1	Q05512	MARK2_MOUSE	100	72	0	0	245	30	705	776	1.70E-36	152.9	MARK2_MOUSE	reviewed	Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (mPar-1b)	Mark2 Emk	Mus musculus (Mouse)	776	actin filament [GO:0005884]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]	actin filament [GO:0005884]; basal cortex [GO:0045180]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0001764; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005884; GO:0005886; GO:0006468; GO:0008289; GO:0010976; GO:0016020; GO:0016055; GO:0016328; GO:0018105; GO:0030010; GO:0030425; GO:0035556; GO:0045180; GO:0045197; GO:0046777; GO:0047485; GO:0048156; GO:0050321; GO:0050770; GO:0051493; GO:0061564; GO:0070507; GO:0071963; GO:0097427; GO:1904526	axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21835_c0_g1_i1	Q7KZI7	MARK2_HUMAN	100	189	0	0	2	568	176	364	5.40E-109	394.8	MARK2_HUMAN	reviewed	Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b)	MARK2 EMK1	Homo sapiens (Human)	788	actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0000422; GO:0001764; GO:0003723; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005884; GO:0005886; GO:0006468; GO:0008289; GO:0010976; GO:0016020; GO:0016055; GO:0016328; GO:0018105; GO:0018107; GO:0030010; GO:0030295; GO:0030425; GO:0032147; GO:0035556; GO:0045197; GO:0045296; GO:0046777; GO:0048156; GO:0050321; GO:0050770; GO:0051493; GO:0051646; GO:0061564; GO:0070507; GO:0071963; GO:0097427; GO:1904526	activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN21349_c0_g1_i2	Q7KZI7	MARK2_HUMAN	91.9	111	9	0	362	30	678	788	4.20E-54	211.8	MARK2_HUMAN	reviewed	Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b)	MARK2 EMK1	Homo sapiens (Human)	788	actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0000422; GO:0001764; GO:0003723; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005884; GO:0005886; GO:0006468; GO:0008289; GO:0010976; GO:0016020; GO:0016055; GO:0016328; GO:0018105; GO:0018107; GO:0030010; GO:0030295; GO:0030425; GO:0032147; GO:0035556; GO:0045197; GO:0045296; GO:0046777; GO:0048156; GO:0050321; GO:0050770; GO:0051493; GO:0051646; GO:0061564; GO:0070507; GO:0071963; GO:0097427; GO:1904526	activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN6889_c0_g1_i1	Q23356	MIG15_CAEEL	85.1	168	25	0	504	1	117	284	7.70E-83	307.8	MIG15_CAEEL	reviewed	Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15)	mig-15 ZC504.4	Caenorhabditis elegans	1096	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000003; GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0023014; GO:0030334; GO:0031098; GO:0032147; GO:0032228; GO:0033563; GO:0048812	"activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3025_c0_g1_i1	Q23356	MIG15_CAEEL	69	394	111	4	1154	6	703	1096	4.80E-157	555.8	MIG15_CAEEL	reviewed	Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15)	mig-15 ZC504.4	Caenorhabditis elegans	1096	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000003; GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0023014; GO:0030334; GO:0031098; GO:0032147; GO:0032228; GO:0033563; GO:0048812	"activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3025_c0_g1_i2	Q23356	MIG15_CAEEL	68.3	394	114	4	1154	6	703	1096	1.10E-156	554.7	MIG15_CAEEL	reviewed	Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15)	mig-15 ZC504.4	Caenorhabditis elegans	1096	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000003; GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0023014; GO:0030334; GO:0031098; GO:0032147; GO:0032228; GO:0033563; GO:0048812	"activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3025_c0_g1_i3	Q23356	MIG15_CAEEL	66.5	406	118	5	1190	6	698	1096	3.50E-156	552.7	MIG15_CAEEL	reviewed	Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15)	mig-15 ZC504.4	Caenorhabditis elegans	1096	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000003; GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0023014; GO:0030334; GO:0031098; GO:0032147; GO:0032228; GO:0033563; GO:0048812	"activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28540_c0_g1_i1	Q5VT25	MRCKA_HUMAN	100	96	0	0	1	288	192	287	4.30E-54	211.5	MRCKA_HUMAN	reviewed	Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha)	CDC42BPA KIAA0451	Homo sapiens (Human)	1732	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	actomyosin [GO:0042641]; cell-cell junction [GO:0005911]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0035556; GO:0042641; GO:0042802; GO:0070062	actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN12237_c0_g1_i1	P42345	MTOR_HUMAN	91.2	80	7	0	6	245	2296	2375	2.50E-39	162.2	MTOR_HUMAN	reviewed	Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	Homo sapiens (Human)	2549	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001933; GO:0001934; GO:0001938; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0005979; GO:0006112; GO:0006207; GO:0006468; GO:0007040; GO:0007050; GO:0007281; GO:0007420; GO:0007569; GO:0007584; GO:0007616; GO:0008361; GO:0008542; GO:0009267; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0014042; GO:0014736; GO:0014823; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019901; GO:0019904; GO:0021510; GO:0030163; GO:0030425; GO:0030838; GO:0031397; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0031998; GO:0032095; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035176; GO:0035264; GO:0038202; GO:0042060; GO:0042220; GO:0042752; GO:0042802; GO:0043022; GO:0043025; GO:0043087; GO:0043200; GO:0043276; GO:0043278; GO:0043610; GO:0045335; GO:0045429; GO:0045670; GO:0045727; GO:0045792; GO:0045945; GO:0046777; GO:0046889; GO:0048255; GO:0048511; GO:0048661; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051897; GO:0055013; GO:0060048; GO:0060135; GO:0060252; GO:0060999; GO:0061051; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0090335; GO:0090559; GO:0098978; GO:0099524; GO:1900034; GO:1901216; GO:1901838; GO:1903691; GO:1904000; GO:1904056; GO:1904058; GO:1904059; GO:1904193; GO:1904197; GO:1904206; GO:1904213; GO:1904690; GO:1990253	"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9048_c0_g1_i1	P42345	MTOR_HUMAN	55.1	635	273	5	1969	86	802	1431	1.30E-194	681	MTOR_HUMAN	reviewed	Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	Homo sapiens (Human)	2549	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001933; GO:0001934; GO:0001938; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0005979; GO:0006112; GO:0006207; GO:0006468; GO:0007040; GO:0007050; GO:0007281; GO:0007420; GO:0007569; GO:0007584; GO:0007616; GO:0008361; GO:0008542; GO:0009267; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0014042; GO:0014736; GO:0014823; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019901; GO:0019904; GO:0021510; GO:0030163; GO:0030425; GO:0030838; GO:0031397; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0031998; GO:0032095; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035176; GO:0035264; GO:0038202; GO:0042060; GO:0042220; GO:0042752; GO:0042802; GO:0043022; GO:0043025; GO:0043087; GO:0043200; GO:0043276; GO:0043278; GO:0043610; GO:0045335; GO:0045429; GO:0045670; GO:0045727; GO:0045792; GO:0045945; GO:0046777; GO:0046889; GO:0048255; GO:0048511; GO:0048661; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051897; GO:0055013; GO:0060048; GO:0060135; GO:0060252; GO:0060999; GO:0061051; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0090335; GO:0090559; GO:0098978; GO:0099524; GO:1900034; GO:1901216; GO:1901838; GO:1903691; GO:1904000; GO:1904056; GO:1904058; GO:1904059; GO:1904193; GO:1904197; GO:1904206; GO:1904213; GO:1904690; GO:1990253	"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9048_c0_g1_i2	P42345	MTOR_HUMAN	54.4	739	323	7	2197	2	802	1533	1.00E-227	791.2	MTOR_HUMAN	reviewed	Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	Homo sapiens (Human)	2549	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001933; GO:0001934; GO:0001938; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0005979; GO:0006112; GO:0006207; GO:0006468; GO:0007040; GO:0007050; GO:0007281; GO:0007420; GO:0007569; GO:0007584; GO:0007616; GO:0008361; GO:0008542; GO:0009267; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0014042; GO:0014736; GO:0014823; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019901; GO:0019904; GO:0021510; GO:0030163; GO:0030425; GO:0030838; GO:0031397; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0031998; GO:0032095; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035176; GO:0035264; GO:0038202; GO:0042060; GO:0042220; GO:0042752; GO:0042802; GO:0043022; GO:0043025; GO:0043087; GO:0043200; GO:0043276; GO:0043278; GO:0043610; GO:0045335; GO:0045429; GO:0045670; GO:0045727; GO:0045792; GO:0045945; GO:0046777; GO:0046889; GO:0048255; GO:0048511; GO:0048661; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051897; GO:0055013; GO:0060048; GO:0060135; GO:0060252; GO:0060999; GO:0061051; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0090335; GO:0090559; GO:0098978; GO:0099524; GO:1900034; GO:1901216; GO:1901838; GO:1903691; GO:1904000; GO:1904056; GO:1904058; GO:1904059; GO:1904193; GO:1904197; GO:1904206; GO:1904213; GO:1904690; GO:1990253	"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9048_c0_g1_i3	P42345	MTOR_HUMAN	55	634	273	5	1883	3	802	1430	1.80E-193	677.2	MTOR_HUMAN	reviewed	Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	Homo sapiens (Human)	2549	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001933; GO:0001934; GO:0001938; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0005979; GO:0006112; GO:0006207; GO:0006468; GO:0007040; GO:0007050; GO:0007281; GO:0007420; GO:0007569; GO:0007584; GO:0007616; GO:0008361; GO:0008542; GO:0009267; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0014042; GO:0014736; GO:0014823; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019901; GO:0019904; GO:0021510; GO:0030163; GO:0030425; GO:0030838; GO:0031397; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0031998; GO:0032095; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035176; GO:0035264; GO:0038202; GO:0042060; GO:0042220; GO:0042752; GO:0042802; GO:0043022; GO:0043025; GO:0043087; GO:0043200; GO:0043276; GO:0043278; GO:0043610; GO:0045335; GO:0045429; GO:0045670; GO:0045727; GO:0045792; GO:0045945; GO:0046777; GO:0046889; GO:0048255; GO:0048511; GO:0048661; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051897; GO:0055013; GO:0060048; GO:0060135; GO:0060252; GO:0060999; GO:0061051; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0090335; GO:0090559; GO:0098978; GO:0099524; GO:1900034; GO:1901216; GO:1901838; GO:1903691; GO:1904000; GO:1904056; GO:1904058; GO:1904059; GO:1904193; GO:1904197; GO:1904206; GO:1904213; GO:1904690; GO:1990253	"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; lysosome organization [GO:0007040]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2883_c0_g1_i12	A1Z7T0	PKN_DROME	45.3	117	46	4	97	402	148	261	2.50E-12	73.2	PKN_DROME	reviewed	Serine/threonine-protein kinase N (EC 2.7.11.13) (Protein kinase related to PKN)	Pkn Dpkn CG2049	Drosophila melanogaster (Fruit fly)	1190	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0007391; GO:0007472; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0031532; GO:0032154; GO:0035556; GO:0045179; GO:0046777; GO:0090303; GO:1901648	actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN2883_c0_g1_i13	A1Z7T0	PKN_DROME	43.8	96	36	4	73	315	169	261	5.60E-07	55.1	PKN_DROME	reviewed	Serine/threonine-protein kinase N (EC 2.7.11.13) (Protein kinase related to PKN)	Pkn Dpkn CG2049	Drosophila melanogaster (Fruit fly)	1190	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0007391; GO:0007472; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0031532; GO:0032154; GO:0035556; GO:0045179; GO:0046777; GO:0090303; GO:1901648	actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN2883_c0_g1_i7	A1Z7T0	PKN_DROME	54.7	53	22	1	73	231	169	219	2.20E-05	49.7	PKN_DROME	reviewed	Serine/threonine-protein kinase N (EC 2.7.11.13) (Protein kinase related to PKN)	Pkn Dpkn CG2049	Drosophila melanogaster (Fruit fly)	1190	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0007391; GO:0007472; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0031532; GO:0032154; GO:0035556; GO:0045179; GO:0046777; GO:0090303; GO:1901648	actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN34247_c0_g1_i1	A1Z7T0	PKN_DROME	90.5	179	17	0	3	539	965	1143	5.60E-95	348.2	PKN_DROME	reviewed	Serine/threonine-protein kinase N (EC 2.7.11.13) (Protein kinase related to PKN)	Pkn Dpkn CG2049	Drosophila melanogaster (Fruit fly)	1190	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]	apical cortex [GO:0045179]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0007391; GO:0007472; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0031532; GO:0032154; GO:0035556; GO:0045179; GO:0046777; GO:0090303; GO:1901648	actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of actomyosin contractile ring localization [GO:1901648]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN23174_c0_g1_i1	Q16512	PKN1_HUMAN	100	138	0	0	2	415	715	852	3.00E-77	288.9	PKN1_HUMAN	reviewed	Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)	PKN1 PAK1 PKN PRK1 PRKCL1	Homo sapiens (Human)	942	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; GTP-Rho binding [GO:0017049]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; activation of JUN kinase activity [GO:0007257]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; histone H3-T11 phosphorylation [GO:0035407]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; GTP-Rho binding [GO:0017049]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]	GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0004672; GO:0004674; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006357; GO:0006468; GO:0006469; GO:0006972; GO:0007165; GO:0007257; GO:0010631; GO:0017049; GO:0018105; GO:0030374; GO:0030496; GO:0030889; GO:0032154; GO:0032991; GO:0035402; GO:0035407; GO:0035556; GO:0042393; GO:0042826; GO:0048365; GO:0048536; GO:0050681; GO:2000145	activation of JUN kinase activity [GO:0007257]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; histone H3-T11 phosphorylation [GO:0035407]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]		NA	NA	NA	NA	NA	NA
TRINITY_DN2883_c0_g1_i10	O08874	PKN2_RAT	54.8	42	19	0	73	198	152	193	2.20E-05	49.7	PKN2_RAT	reviewed	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (Cardiolipin-activated protein kinase Pak2) (PKN gamma) (Protease-activated kinase 2) (PAK-2) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) (p140 kinase)	Pkn2 Pak2 Prk2 Prkcl2	Rattus norvegicus (Rat)	985	apical junction complex [GO:0043296]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]	apical junction complex [GO:0043296]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase binding [GO:0070063]	GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0010631; GO:0016301; GO:0017049; GO:0018105; GO:0030027; GO:0030030; GO:0030496; GO:0032154; GO:0032467; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:2000145	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]		NA	NA	NA	NA	NA	NA
TRINITY_DN2883_c0_g1_i15	A7MBL8	PKN2_DANRE	46.2	117	57	3	52	402	110	220	4.20E-15	82.4	PKN2_DANRE	reviewed	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	pkn2 prk2 prkcl2 zgc:153916	Danio rerio (Zebrafish) (Brachydanio rerio)	977	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0007049; GO:0007155; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0032154; GO:0035556; GO:0051301	cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN2883_c0_g1_i2	A7MBL8	PKN2_DANRE	45	120	60	3	87	446	107	220	6.00E-15	82	PKN2_DANRE	reviewed	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	pkn2 prk2 prkcl2 zgc:153916	Danio rerio (Zebrafish) (Brachydanio rerio)	977	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; GTP-Rho binding [GO:0017049]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0007049; GO:0007155; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0032154; GO:0035556; GO:0051301	cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN29675_c0_g1_i1	P51954	NEK1_MOUSE	58.6	268	104	2	5129	4347	55	322	2.10E-82	309.7	NEK1_MOUSE	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1)	Nek1	Mus musculus (Mouse)	1203	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006974; GO:0007049; GO:0007283; GO:0010212; GO:0016301; GO:0034451; GO:0035264; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:2000001	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38722_c0_g1_i1	P51954	NEK1_MOUSE	55.8	120	52	1	6	365	99	217	3.00E-36	152.5	NEK1_MOUSE	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1)	Nek1	Mus musculus (Mouse)	1203	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006974; GO:0007049; GO:0007283; GO:0010212; GO:0016301; GO:0034451; GO:0035264; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:2000001	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28921_c0_g1_i1	Q96PY6	NEK1_HUMAN	59.4	101	40	1	300	1	105	205	1.00E-29	130.6	NEK1_HUMAN	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	NEK1 KIAA1901	Homo sapiens (Human)	1258	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36210_c0_g1_i1	Q96PY6	NEK1_HUMAN	52.1	117	56	0	19	369	100	216	5.60E-30	131.7	NEK1_HUMAN	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	NEK1 KIAA1901	Homo sapiens (Human)	1258	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27368_c0_g1_i1	Q96PY6	NEK1_HUMAN	42.1	95	53	1	302	18	108	200	6.30E-19	94.7	NEK1_HUMAN	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	NEK1 KIAA1901	Homo sapiens (Human)	1258	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32171_c0_g1_i1	Q96PY6	NEK1_HUMAN	98.1	54	1	0	163	2	104	157	4.80E-24	111.3	NEK1_HUMAN	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	NEK1 KIAA1901	Homo sapiens (Human)	1258	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32171_c0_g1_i1	Q96PY6	NEK1_HUMAN	92	25	2	0	227	153	50	74	5.90E-06	51.2	NEK1_HUMAN	reviewed	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	NEK1 KIAA1901	Homo sapiens (Human)	1258	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32140_c0_g1_i1	P51955	NEK2_HUMAN	61.7	47	18	0	193	333	186	232	2.00E-10	66.6	NEK2_HUMAN	reviewed	Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1)	NEK2 NEK2A NLK1	Homo sapiens (Human)	445	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0000070; GO:0000086; GO:0000278; GO:0000776; GO:0000777; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007059; GO:0007088; GO:0010389; GO:0019903; GO:0030496; GO:0032212; GO:0032991; GO:0043392; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051973; GO:0051988; GO:0090307; GO:0097711; GO:1903126; GO:1904355	blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN34691_c0_g1_i1	P51956	NEK3_HUMAN	100	91	0	0	1	273	109	199	7.20E-51	200.7	NEK3_HUMAN	reviewed	Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3)	NEK3	Homo sapiens (Human)	506	axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; mitotic cell cycle [GO:0000278]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of tubulin deacetylation [GO:0090043]	axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030010; GO:0030424; GO:0046872; GO:0048812; GO:0051301; GO:0090043	cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; mitotic cell cycle [GO:0000278]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of tubulin deacetylation [GO:0090043]		NA	NA	NA	NA	NA	NA
TRINITY_DN26600_c0_g1_i1	Q9R0A5	NEK3_MOUSE	34.8	207	117	3	39	614	47	250	2.10E-33	144.1	NEK3_MOUSE	reviewed	Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3)	Nek3	Mus musculus (Mouse)	511	axon [GO:0030424]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of tubulin deacetylation [GO:0090043]	axon [GO:0030424]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007049; GO:0030010; GO:0030424; GO:0046872; GO:0048812; GO:0051301; GO:0090043	cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of tubulin deacetylation [GO:0090043]		NA	NA	NA	NA	NA	NA
TRINITY_DN26855_c0_g1_i1	Q8RX66	NEK3_ARATH	41	178	90	3	499	5	72	247	1.10E-33	144.4	NEK3_ARATH	reviewed	Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (NimA-related protein kinase 3) (AtNek3)	NEK3 At5g28290 T8M17.60	Arabidopsis thaliana (Mouse-ear cress)	568	cortical microtubule [GO:0055028]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; microtubule-based process [GO:0007017]	cortical microtubule [GO:0055028]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0007017; GO:0055028	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13120_c0_g1_i1	Q9Z1J2	NEK4_MOUSE	61.5	143	55	0	6	434	95	237	4.30E-50	198.7	NEK4_MOUSE	reviewed	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2)	Nek4 Stk2	Mus musculus (Mouse)	792	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]"	ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17952_c0_g1_i1	P51957	NEK4_HUMAN	29.9	157	94	3	172	600	120	274	1.30E-15	85.1	NEK4_HUMAN	reviewed	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2)	NEK4 STK2	Homo sapiens (Human)	841	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]"	ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17952_c0_g1_i2	P51957	NEK4_HUMAN	29.9	157	94	3	120	548	120	274	1.20E-15	85.1	NEK4_HUMAN	reviewed	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2)	NEK4 STK2	Homo sapiens (Human)	841	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]"	ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38968_c0_g1_i1	Q6P3R8	NEK5_HUMAN	60.5	114	42	1	15	356	92	202	5.00E-36	151.8	NEK5_HUMAN	reviewed	Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5)	NEK5	Homo sapiens (Human)	708	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0046872; GO:0051155; GO:2001056	positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155]		NA	NA	NA	NA	NA	NA
TRINITY_DN21402_c0_g1_i1	Q9ES70	NEK6_MOUSE	99.2	118	1	0	1	354	170	287	1.90E-67	256.1	NEK6_MOUSE	reviewed	Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6)	Nek6	Mus musculus (Mouse)	313	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0000922; GO:0001222; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007059; GO:0016607; GO:0018105; GO:0019894; GO:0019901; GO:0030071; GO:0031625; GO:0032991; GO:0033613; GO:0034451; GO:0043231; GO:0046777; GO:0051301	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]		NA	NA	NA	NA	NA	NA
TRINITY_DN21402_c0_g1_i2	Q9ES70	NEK6_MOUSE	100	76	0	0	1	228	212	287	1.70E-42	172.6	NEK6_MOUSE	reviewed	Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6)	Nek6	Mus musculus (Mouse)	313	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0000922; GO:0001222; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007059; GO:0016607; GO:0018105; GO:0019894; GO:0019901; GO:0030071; GO:0031625; GO:0032991; GO:0033613; GO:0034451; GO:0043231; GO:0046777; GO:0051301	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]		NA	NA	NA	NA	NA	NA
TRINITY_DN26741_c0_g1_i1	Q9ES70	NEK6_MOUSE	100	131	0	0	395	3	27	157	1.50E-70	266.5	NEK6_MOUSE	reviewed	Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6)	Nek6	Mus musculus (Mouse)	313	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0000922; GO:0001222; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007059; GO:0016607; GO:0018105; GO:0019894; GO:0019901; GO:0030071; GO:0031625; GO:0032991; GO:0033613; GO:0034451; GO:0043231; GO:0046777; GO:0051301	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071]		NA	NA	NA	NA	NA	NA
TRINITY_DN34650_c0_g1_i1	Q9HC98	NEK6_HUMAN	40.6	69	39	1	212	6	146	212	2.90E-10	65.5	NEK6_HUMAN	reviewed	Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512)	NEK6	Homo sapiens (Human)	313	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear envelope disassembly [GO:0007077]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; spindle assembly [GO:0051225]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0000922; GO:0001222; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006468; GO:0006915; GO:0007059; GO:0007077; GO:0007346; GO:0016607; GO:0018105; GO:0019894; GO:0019901; GO:0030071; GO:0031625; GO:0032991; GO:0033613; GO:0034451; GO:0043123; GO:0043231; GO:0046777; GO:0051225; GO:0051301; GO:2000772	apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear envelope disassembly [GO:0007077]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN2706_c0_g1_i12	Q8TDX7	NEK7_HUMAN	84.2	215	34	0	1585	941	87	301	2.70E-108	394	NEK7_HUMAN	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	NEK7	Homo sapiens (Human)	302	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN2706_c0_g1_i2	Q8TDX7	NEK7_HUMAN	80.5	277	54	0	1708	878	25	301	1.00E-132	475.3	NEK7_HUMAN	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	NEK7	Homo sapiens (Human)	302	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN2706_c0_g1_i4	Q8TDX7	NEK7_HUMAN	84.2	215	34	0	1522	878	87	301	2.60E-108	394	NEK7_HUMAN	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	NEK7	Homo sapiens (Human)	302	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN2706_c0_g1_i7	Q8TDX7	NEK7_HUMAN	80.5	277	54	0	1771	941	25	301	1.10E-132	475.3	NEK7_HUMAN	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	NEK7	Homo sapiens (Human)	302	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN20811_c0_g1_i1	Q8TDX7	NEK7_HUMAN	99.6	272	1	0	818	3	13	284	4.30E-160	565.1	NEK7_HUMAN	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	NEK7	Homo sapiens (Human)	302	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN20811_c0_g1_i2	Q8TDX7	NEK7_HUMAN	100	272	0	0	818	3	13	284	1.90E-160	566.2	NEK7_HUMAN	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	NEK7	Homo sapiens (Human)	302	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN20811_c1_g1_i1	Q9ES74	NEK7_MOUSE	100	70	0	0	213	4	88	157	7.30E-35	147.1	NEK7_MOUSE	reviewed	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	Nek7	Mus musculus (Mouse)	302	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006468; GO:0032212; GO:0046872; GO:0051973; GO:1904355	positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2801_c0_g1_i1	D3ZGQ5	NEK8_RAT	57.7	182	77	0	718	173	105	286	1.10E-57	224.9	NEK8_RAT	reviewed	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8)	Nek8 Jck	Rattus norvegicus (Rat)	698	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546	animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]		NA	NA	NA	NA	NA	NA
TRINITY_DN2801_c0_g1_i2	D3ZGQ5	NEK8_RAT	57.7	182	77	0	718	173	105	286	1.10E-57	224.9	NEK8_RAT	reviewed	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8)	Nek8 Jck	Rattus norvegicus (Rat)	698	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546	animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]		NA	NA	NA	NA	NA	NA
TRINITY_DN2801_c0_g1_i5	D3ZGQ5	NEK8_RAT	53.7	287	132	1	1033	173	1	286	9.30E-89	328.6	NEK8_RAT	reviewed	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8)	Nek8 Jck	Rattus norvegicus (Rat)	698	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546	animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]		NA	NA	NA	NA	NA	NA
TRINITY_DN2801_c0_g1_i4	Q86SG6	NEK8_HUMAN	55.7	273	120	1	1033	215	1	272	1.60E-88	327.8	NEK8_HUMAN	reviewed	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a)	NEK8 JCK NEK12A	Homo sapiens (Human)	692	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546	animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]		NA	NA	NA	NA	NA	NA
TRINITY_DN2801_c0_g1_i7	Q86SG6	NEK8_HUMAN	46	272	90	2	859	215	1	272	4.30E-63	243	NEK8_HUMAN	reviewed	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a)	NEK8 JCK NEK12A	Homo sapiens (Human)	692	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546	animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]		NA	NA	NA	NA	NA	NA
TRINITY_DN598_c0_g1_i1	O01775	NEKL2_CAEEL	42.2	116	61	1	350	3	119	228	2.30E-21	103.2	NEKL2_CAEEL	reviewed	Serine/threonine-protein kinase nekl-2 (EC 2.7.11.1) (Never in mitosis A kinase-like 2) (NimA-kinase-like 2)	nekl-2 ZC581.1	Caenorhabditis elegans	357	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; molting cycle [GO:0042303]; multicellular organism development [GO:0007275]; positive regulation of endocytosis [GO:0045807]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0007275; GO:0042303; GO:0045807; GO:0046872	molting cycle [GO:0042303]; multicellular organism development [GO:0007275]; positive regulation of endocytosis [GO:0045807]		NA	NA	NA	NA	NA	NA
TRINITY_DN35800_c0_g1_i1	G5EFM9	NEKL3_CAEEL	58.7	92	37	1	6	281	145	235	7.10E-25	114.4	NEKL3_CAEEL	reviewed	Serine/threonine-protein kinase nekl-3 (EC 2.7.11.1) (Molting protein MLT-1) (Never in mitosis A kinase-like 3) (NimA kinase-like 3)	nekl-3 mlt-1 F19H6.1	Caenorhabditis elegans	302	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; gonad development [GO:0008406]; molting cycle [GO:0042303]; multicellular organism growth [GO:0035264]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0008406; GO:0016324; GO:0035264; GO:0042303; GO:0046872	gonad development [GO:0008406]; molting cycle [GO:0042303]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN39646_c0_g1_i1	G5EFM9	NEKL3_CAEEL	55.9	127	53	2	384	10	122	247	1.80E-34	146.7	NEKL3_CAEEL	reviewed	Serine/threonine-protein kinase nekl-3 (EC 2.7.11.1) (Molting protein MLT-1) (Never in mitosis A kinase-like 3) (NimA kinase-like 3)	nekl-3 mlt-1 F19H6.1	Caenorhabditis elegans	302	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; gonad development [GO:0008406]; molting cycle [GO:0042303]; multicellular organism growth [GO:0035264]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0008406; GO:0016324; GO:0035264; GO:0042303; GO:0046872	gonad development [GO:0008406]; molting cycle [GO:0042303]; multicellular organism growth [GO:0035264]		NA	NA	NA	NA	NA	NA
TRINITY_DN33911_c0_g1_i1	Q8IY84	NIM1_HUMAN	62	179	67	1	539	3	98	275	5.70E-60	231.9	NIM1_HUMAN	reviewed	Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase)	NIM1K NIM1	Homo sapiens (Human)	436	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0035556; GO:0042149	cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN34752_c0_g1_i1	E1BMN8	NLK_BOVIN	65.7	140	47	1	1	420	396	534	4.00E-48	192.6	NLK_BOVIN	reviewed	Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase)	NLK	Bos taurus (Bovine)	534	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0016055; GO:0046872; GO:0050821	protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24847_c0_g1_i1	E1BMN8	NLK_BOVIN	79.7	143	29	0	69	497	252	394	7.90E-64	244.6	NLK_BOVIN	reviewed	Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase)	NLK	Bos taurus (Bovine)	534	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0016055; GO:0046872; GO:0050821	protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24847_c0_g1_i2	E1BMN8	NLK_BOVIN	76.8	112	26	0	46	381	283	394	4.00E-47	188.7	NLK_BOVIN	reviewed	Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase)	NLK	Bos taurus (Bovine)	534	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0016055; GO:0046872; GO:0050821	protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN24847_c0_g1_i3	E1BMN8	NLK_BOVIN	83.9	174	28	0	3	524	221	394	4.00E-82	305.4	NLK_BOVIN	reviewed	Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase)	NLK	Bos taurus (Bovine)	534	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]; protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; metal ion binding [GO:0046872]	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0016055; GO:0046872; GO:0050821	protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN36699_c0_g1_i1	O95747	OXSR1_HUMAN	51.6	93	39	1	279	19	158	250	4.60E-21	101.7	OXSR1_HUMAN	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 KIAA1101 OSR1	Homo sapiens (Human)	527	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction by trans-phosphorylation [GO:0023016]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0006979; GO:0007231; GO:0010820; GO:0018107; GO:0019901; GO:0023016; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0046777; GO:0070062; GO:0071476; GO:1901017; GO:1990869	cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction by trans-phosphorylation [GO:0023016]		NA	NA	NA	NA	NA	NA
TRINITY_DN26432_c0_g1_i1	Q863I2	OXSR1_PIG	61.6	73	28	0	1	219	245	317	5.20E-20	97.8	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction by trans-phosphorylation [GO:0023016]	cytosol [GO:0005829]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0007231; GO:0010820; GO:0018107; GO:0019901; GO:0023016; GO:0035556; GO:0038146; GO:0042802; GO:0046777	chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction by trans-phosphorylation [GO:0023016]		NA	NA	NA	NA	NA	NA
TRINITY_DN34722_c0_g1_i1	O95747	OXSR1_HUMAN	100	81	0	0	243	1	100	180	7.30E-39	160.6	OXSR1_HUMAN	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 KIAA1101 OSR1	Homo sapiens (Human)	527	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction by trans-phosphorylation [GO:0023016]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0006979; GO:0007231; GO:0010820; GO:0018107; GO:0019901; GO:0023016; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0046777; GO:0070062; GO:0071476; GO:1901017; GO:1990869	cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction by trans-phosphorylation [GO:0023016]		NA	NA	NA	NA	NA	NA
TRINITY_DN6393_c3_g1_i1	Q08E52	PAK1_BOVIN	100	126	0	0	378	1	342	467	1.60E-69	263.1	PAK1_BOVIN	reviewed	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	Bos taurus (Bovine)	544	actin filament [GO:0005884]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060]	actin filament [GO:0005884]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]	GO:0001726; GO:0001934; GO:0004674; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0016477; GO:0023014; GO:0030335; GO:0031098; GO:0031116; GO:0031532; GO:0032147; GO:0032587; GO:0032991; GO:0033138; GO:0033148; GO:0042060; GO:0043507; GO:0046777; GO:0048012; GO:0048365; GO:0048754; GO:0050770; GO:0051496; GO:0060244; GO:0071437	actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN35346_c0_g1_i1	Q08E52	PAK1_BOVIN	60.5	299	117	1	904	11	240	538	1.60E-97	357.5	PAK1_BOVIN	reviewed	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	PAK1	Bos taurus (Bovine)	544	actin filament [GO:0005884]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060]	actin filament [GO:0005884]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]	GO:0001726; GO:0001934; GO:0004674; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0016477; GO:0023014; GO:0030335; GO:0031098; GO:0031116; GO:0031532; GO:0032147; GO:0032587; GO:0032991; GO:0033138; GO:0033148; GO:0042060; GO:0043507; GO:0046777; GO:0048012; GO:0048365; GO:0048754; GO:0050770; GO:0051496; GO:0060244; GO:0071437	actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060]		blue	blue	NA	NA	NA	NA
TRINITY_DN6573_c0_g1_i1	Q29502	PAK2_RABIT	37.3	193	74	5	83	613	1	162	2.50E-21	104	PAK2_RABIT	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) (p21-activated protein kinase I) (PAKI) [Cleaved into: PAK-2p27; PAK-2p34]	PAK2	Oryctolagus cuniculus (Rabbit)	524	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]	GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005911; GO:0014069; GO:0016020; GO:0016301; GO:0018105; GO:0019901; GO:0030296; GO:0034333; GO:0042802; GO:0043065; GO:0046777; GO:0048365; GO:0048471; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0097194; GO:0098978; GO:0150105; GO:2001238; GO:2001271	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN6573_c0_g1_i3	Q29502	PAK2_RABIT	46.3	162	71	4	83	520	1	162	8.50E-29	128.6	PAK2_RABIT	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) (p21-activated protein kinase I) (PAKI) [Cleaved into: PAK-2p27; PAK-2p34]	PAK2	Oryctolagus cuniculus (Rabbit)	524	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]	GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005911; GO:0014069; GO:0016020; GO:0016301; GO:0018105; GO:0019901; GO:0030296; GO:0034333; GO:0042802; GO:0043065; GO:0046777; GO:0048365; GO:0048471; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0097194; GO:0098978; GO:0150105; GO:2001238; GO:2001271	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN5837_c0_g1_i1	Q29502	PAK2_RABIT	42	443	196	6	1152	4	74	515	2.10E-79	297.7	PAK2_RABIT	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) (p21-activated protein kinase I) (PAKI) [Cleaved into: PAK-2p27; PAK-2p34]	PAK2	Oryctolagus cuniculus (Rabbit)	524	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]	GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005911; GO:0014069; GO:0016020; GO:0016301; GO:0018105; GO:0019901; GO:0030296; GO:0034333; GO:0042802; GO:0043065; GO:0046777; GO:0048365; GO:0048471; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0097194; GO:0098978; GO:0150105; GO:2001238; GO:2001271	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN5837_c0_g1_i3	Q29502	PAK2_RABIT	47.4	443	214	5	1278	4	74	515	1.20E-99	365.2	PAK2_RABIT	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) (p21-activated protein kinase I) (PAKI) [Cleaved into: PAK-2p27; PAK-2p34]	PAK2	Oryctolagus cuniculus (Rabbit)	524	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]	GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005911; GO:0014069; GO:0016020; GO:0016301; GO:0018105; GO:0019901; GO:0030296; GO:0034333; GO:0042802; GO:0043065; GO:0046777; GO:0048365; GO:0048471; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0097194; GO:0098978; GO:0150105; GO:2001238; GO:2001271	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; execution phase of apoptosis [GO:0097194]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN6393_c0_g1_i5	Q13177	PAK2_HUMAN	69.5	174	53	0	579	58	323	496	4.30E-69	262.3	PAK2_HUMAN	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)]	PAK2	Homo sapiens (Human)	524	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]	GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006469; GO:0006915; GO:0007165; GO:0014069; GO:0016310; GO:0018105; GO:0019901; GO:0023014; GO:0030296; GO:0031098; GO:0031267; GO:0031295; GO:0032147; GO:0034333; GO:0035722; GO:0038095; GO:0040008; GO:0042802; GO:0043066; GO:0045296; GO:0046777; GO:0048010; GO:0048365; GO:0048471; GO:0050690; GO:0050731; GO:0050770; GO:0050852; GO:0051493; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0098978; GO:0150105; GO:2001238; GO:2001271	activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	x	brown	brown	NA	NA	NA	NA
TRINITY_DN29252_c0_g1_i1	Q13177	PAK2_HUMAN	100	82	0	0	246	1	56	137	2.10E-41	169.1	PAK2_HUMAN	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)]	PAK2	Homo sapiens (Human)	524	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]	GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006469; GO:0006915; GO:0007165; GO:0014069; GO:0016310; GO:0018105; GO:0019901; GO:0023014; GO:0030296; GO:0031098; GO:0031267; GO:0031295; GO:0032147; GO:0034333; GO:0035722; GO:0038095; GO:0040008; GO:0042802; GO:0043066; GO:0045296; GO:0046777; GO:0048010; GO:0048365; GO:0048471; GO:0050690; GO:0050731; GO:0050770; GO:0050852; GO:0051493; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0098978; GO:0150105; GO:2001238; GO:2001271	activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN6393_c0_g1_i4	Q13177	PAK2_HUMAN	67.6	204	66	0	669	58	321	524	4.70E-78	292.4	PAK2_HUMAN	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)]	PAK2	Homo sapiens (Human)	524	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]	GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006469; GO:0006915; GO:0007165; GO:0014069; GO:0016310; GO:0018105; GO:0019901; GO:0023014; GO:0030296; GO:0031098; GO:0031267; GO:0031295; GO:0032147; GO:0034333; GO:0035722; GO:0038095; GO:0040008; GO:0042802; GO:0043066; GO:0045296; GO:0046777; GO:0048010; GO:0048365; GO:0048471; GO:0050690; GO:0050731; GO:0050770; GO:0050852; GO:0051493; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0098978; GO:0150105; GO:2001238; GO:2001271	activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN26628_c0_g1_i1	Q13177	PAK2_HUMAN	100	100	0	0	300	1	277	376	1.30E-48	193.4	PAK2_HUMAN	reviewed	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)]	PAK2	Homo sapiens (Human)	524	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]	GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006469; GO:0006915; GO:0007165; GO:0014069; GO:0016310; GO:0018105; GO:0019901; GO:0023014; GO:0030296; GO:0031098; GO:0031267; GO:0031295; GO:0032147; GO:0034333; GO:0035722; GO:0038095; GO:0040008; GO:0042802; GO:0043066; GO:0045296; GO:0046777; GO:0048010; GO:0048365; GO:0048471; GO:0050690; GO:0050731; GO:0050770; GO:0050852; GO:0051493; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0098978; GO:0150105; GO:2001238; GO:2001271	activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN6393_c0_g1_i2	O75914	PAK3_HUMAN	67.3	257	84	0	840	70	298	554	5.70E-99	362.1	PAK3_HUMAN	reviewed	Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3)	PAK3 OPHN3	Homo sapiens (Human)	559	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; synapse organization [GO:0050808]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; SH3 domain binding [GO:0017124]	GO:0002223; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007409; GO:0010763; GO:0016358; GO:0017048; GO:0017124; GO:0023014; GO:0030833; GO:0031098; GO:0031295; GO:0032147; GO:0043525; GO:0046872; GO:0048013; GO:0050770; GO:0050808; GO:0050852; GO:0060997; GO:0061003; GO:0071407; GO:2000573	activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; synapse organization [GO:0050808]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN38626_c0_g1_i1	O75914	PAK3_HUMAN	82.4	278	49	0	892	59	279	556	3.80E-133	475.7	PAK3_HUMAN	reviewed	Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3)	PAK3 OPHN3	Homo sapiens (Human)	559	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; synapse organization [GO:0050808]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; SH3 domain binding [GO:0017124]	GO:0002223; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007409; GO:0010763; GO:0016358; GO:0017048; GO:0017124; GO:0023014; GO:0030833; GO:0031098; GO:0031295; GO:0032147; GO:0043525; GO:0046872; GO:0048013; GO:0050770; GO:0050808; GO:0050852; GO:0060997; GO:0061003; GO:0071407; GO:2000573	activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated protein kinase signaling cascade [GO:0031098]; synapse organization [GO:0050808]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN26581_c0_g1_i1	Q9VXE5	PAKM_DROME	92.7	179	13	0	1	537	410	588	1.60E-94	346.7	PAKM_DROME	reviewed	Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)	mbt CG18582	Drosophila melanogaster (Fruit fly)	639	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]	GO:0000187; GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0017048; GO:0018105; GO:0023014; GO:0031098; GO:0032147; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:2000047	activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN26581_c0_g1_i2	Q9VXE5	PAKM_DROME	93.4	122	8	0	28	393	467	588	6.90E-63	241.1	PAKM_DROME	reviewed	Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)	mbt CG18582	Drosophila melanogaster (Fruit fly)	639	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]	GO:0000187; GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0017048; GO:0018105; GO:0023014; GO:0031098; GO:0032147; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:2000047	activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN6573_c0_g1_i2	Q17850	PK1_CAEEL	46	87	42	2	80	325	3	89	2.90E-13	76.3	PK1_CAEEL	reviewed	Serine/threonine-protein kinase pak-1 (EC 2.7.11.1) (CePAK) (p21-activated kinase 1) (PAK1)	pak-1 C09B8.7	Caenorhabditis elegans	572	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; gonad morphogenesis [GO:0035262]; hemidesmosome assembly [GO:0031581]; inductive cell migration [GO:0040039]; motor neuron axon guidance [GO:0008045]; nematode larval development [GO:0002119]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0002119; GO:0004672; GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0008045; GO:0010172; GO:0016020; GO:0016021; GO:0016477; GO:0023014; GO:0030056; GO:0030424; GO:0031098; GO:0031581; GO:0032147; GO:0035262; GO:0040039; GO:0043025; GO:0043204; GO:0048598; GO:0050770	activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; gonad morphogenesis [GO:0035262]; hemidesmosome assembly [GO:0031581]; inductive cell migration [GO:0040039]; motor neuron axon guidance [GO:0008045]; nematode larval development [GO:0002119]; regulation of axonogenesis [GO:0050770]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN23493_c0_g1_i19	A8WYE4	PAR1_CAEBR	89.2	74	8	0	35	256	1015	1088	4.40E-34	145.2	PAR1_CAEBR	reviewed	Serine/threonine-protein kinase par-1 (EC 2.7.11.1)	par-1 CBG04756	Caenorhabditis briggsae	1088	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism development [GO:0007275]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005938; GO:0007275; GO:0035556; GO:0046872; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN4232_c0_g1_i1	Q05652	KPEL_DROME	43.5	322	165	7	55	999	189	500	6.30E-59	229.6	KPEL_DROME	reviewed	Serine/threonine-protein kinase pelle (EC 2.7.11.1)	pll CG5974	Drosophila melanogaster (Fruit fly)	501	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; antifungal innate immune response [GO:0061760]; apoptotic process [GO:0006915]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal/ventral asymmetry [GO:0048262]; dorsal/ventral pattern formation [GO:0009953]; hemocyte proliferation [GO:0035172]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]	GO:0002804; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007352; GO:0007526; GO:0008063; GO:0009953; GO:0019221; GO:0019904; GO:0035172; GO:0035332; GO:0035556; GO:0045087; GO:0045732; GO:0046777; GO:0048262; GO:0061760; GO:2000060	antifungal innate immune response [GO:0061760]; apoptotic process [GO:0006915]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal/ventral asymmetry [GO:0048262]; dorsal/ventral pattern formation [GO:0009953]; hemocyte proliferation [GO:0035172]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352]		NA	NA	NA	NA	NA	NA
TRINITY_DN19367_c0_g1_i1	Q9N0P9	PIM1_BOVIN	57.7	71	29	1	1	210	86	156	8.00E-13	73.9	PIM1_BOVIN	reviewed	Serine/threonine-protein kinase pim-1 (EC 2.7.11.1)	PIM1	Bos taurus (Bovine)	313	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular detoxification [GO:1990748]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]	GO:0004674; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0008134; GO:0022898; GO:0030145; GO:0043024; GO:0043066; GO:0043433; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:0090336; GO:1902033; GO:1905062; GO:1990748	"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular detoxification [GO:1990748]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30777_c0_g1_i1	P11309	PIM1_HUMAN	100	290	0	0	1	870	24	313	1.10E-174	613.6	PIM1_HUMAN	reviewed	Serine/threonine-protein kinase pim-1 (EC 2.7.11.1)	PIM1	Homo sapiens (Human)	313	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular detoxification [GO:1990748]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan metabolic process [GO:0030212]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]	GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007275; GO:0008134; GO:0019221; GO:0022898; GO:0030145; GO:0030212; GO:0043024; GO:0043066; GO:0043433; GO:0043539; GO:0045737; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:0071902; GO:0090336; GO:1902033; GO:1905062; GO:1990748	"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular detoxification [GO:1990748]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan metabolic process [GO:0030212]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25303_c1_g1_i1	Q62070	PIM2_MOUSE	100	70	0	0	1	210	248	317	2.40E-38	158.7	PIM2_MOUSE	reviewed	Serine/threonine-protein kinase pim-2 (EC 2.7.11.1)	Pim2 Pim-2	Mus musculus (Mouse)	370	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007346; GO:0008285; GO:0008637; GO:0010508; GO:0016239; GO:0032091; GO:0043066; GO:0043123; GO:0045893; GO:0046777; GO:0050821	"apoptotic mitochondrial changes [GO:0008637]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25303_c0_g1_i1	Q9P1W9	PIM2_HUMAN	100	206	0	0	3	620	75	280	1.00E-124	447.2	PIM2_HUMAN	reviewed	Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h)	PIM2	Homo sapiens (Human)	311	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]; response to virus [GO:0009615]"	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0007346; GO:0008285; GO:0009615; GO:0010508; GO:0043066; GO:0043123; GO:0045893; GO:0046777; GO:0050821	"apoptotic process [GO:0006915]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]; response to virus [GO:0009615]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31980_c0_g1_i1	Q86V86	PIM3_HUMAN	100	105	0	0	1	315	161	265	4.80E-59	228	PIM3_HUMAN	reviewed	Serine/threonine-protein kinase pim-3 (EC 2.7.11.1)	PIM3	Homo sapiens (Human)	326	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0043066; GO:0046777; GO:0061179	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN17491_c0_g1_i1	P58750	PIM3_MOUSE	100	154	0	0	2	463	132	285	2.30E-89	329.3	PIM3_MOUSE	reviewed	Serine/threonine-protein kinase pim-3 (EC 2.7.11.1)	Pim3	Mus musculus (Mouse)	326	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; histone phosphorylation [GO:0016572]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0016572; GO:0043066; GO:0046777; GO:0061179	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; histone phosphorylation [GO:0016572]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN36406_c0_g1_i1	Q91822	PIM3_XENLA	55.3	275	117	5	1101	280	30	299	1.00E-85	318.9	PIM3_XENLA	reviewed	Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Pim-1)	pim3 pim1	Xenopus laevis (African clawed frog)	323	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0043066	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]		NA	NA	NA	NA	NA	NA
TRINITY_DN38562_c0_g1_i1	Q9PU85	PIM3_COTJA	60.2	261	99	4	112	891	35	291	8.90E-87	322	PIM3_COTJA	reviewed	Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim)	PIM3 PIM-3	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	323	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0043066	negative regulation of apoptotic process [GO:0043066]		blue	blue	NA	NA	NA	NA
TRINITY_DN4949_c0_g1_i2	Q9BXM7	PINK1_HUMAN	43.1	364	183	8	1045	2124	203	546	9.90E-64	246.5	PINK1_HUMAN	reviewed	"Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1)"	PINK1	Homo sapiens (Human)	581	"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine/threonine kinase activity [GO:0004674]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0000422; GO:0000785; GO:0001934; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0016020; GO:0016236; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030424; GO:0030426; GO:0031307; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0042981; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051091; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:1900407; GO:1901727; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903147; GO:1903202; GO:1903204; GO:1903214; GO:1903298; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904783; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243	"activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein-containing complex assembly [GO:0043254]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4250_c0_g1_i1	Q9VPC0	KP58_DROME	84.5	116	18	0	1	348	542	657	2.90E-52	205.7	KP58_DROME	reviewed	Serine/threonine-protein kinase PITSLRE (EC 2.7.11.22) (Cell division cycle 2-like)	Pitslre CG4268	Drosophila melanogaster (Fruit fly)	952	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]	nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]	GO:0002225; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0007049; GO:0007346; GO:0010468; GO:0045752	cell cycle [GO:0007049]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN9541_c0_g1_i3	Q9KIG4	PK1_STRTO	35.6	90	51	3	370	101	128	210	3.60E-05	49.7	PK1_STRTO	reviewed	Serine/threonine-protein kinase PK-1 (stoPK-1) (EC 2.7.11.1)	spk1	Streptomyces toyocaensis	641	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN39624_c0_g1_i1	Q01577	PKPA_PHYB8	52	179	85	1	535	2	61	239	3.50E-52	206.1	PKPA_PHYB8	reviewed	Serine/threonine-protein kinase pkpA (EC 2.7.11.1)	pkpA	Phycomyces blakesleeanus (strain ATCC 8743b / DSM 1359 / FGSC 10004 / NBRC 33097 / NRRL 1555)	613	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524			NA	NA	1	NA	NA	NA
TRINITY_DN7906_c0_g1_i1	P70032	PLK1_XENLA	75.9	145	35	0	2	436	128	272	1.80E-64	246.5	PLK1_XENLA	reviewed	Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1)	plk1 plx1	Xenopus laevis (African clawed frog)	598	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; centrosome cycle [GO:0007098]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte maturation [GO:0001556]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000086; GO:0000122; GO:0000278; GO:0000281; GO:0000776; GO:0001556; GO:0001578; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007098; GO:0008017; GO:0019901; GO:0030496; GO:0043066; GO:0051233; GO:0071168; GO:0072425; GO:1904668	centrosome cycle [GO:0007098]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte maturation [GO:0001556]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]		NA	NA	NA	NA	NA	NA
TRINITY_DN33227_c0_g1_i1	Q07832	PLK1_MOUSE	62.4	101	37	1	303	1	166	265	4.90E-32	138.3	PLK1_MOUSE	reviewed	Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13)	Plk1 Plk	Mus musculus (Mouse)	603	"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome outer kinetochore [GO:0000942]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to organelle [GO:0033365]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; synaptonemal complex disassembly [GO:0070194]"	"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]"	anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000775; GO:0000776; GO:0000780; GO:0000785; GO:0000795; GO:0000922; GO:0000942; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005876; GO:0006468; GO:0007094; GO:0007098; GO:0007346; GO:0008017; GO:0010800; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0033365; GO:0034451; GO:0040038; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0070194; GO:0071168; GO:0072425; GO:0090435; GO:0097431; GO:1901673; GO:1904668; GO:1904776	centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to organelle [GO:0033365]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; synaptonemal complex disassembly [GO:0070194]		NA	NA	NA	NA	NA	NA
TRINITY_DN40775_c0_g1_i1	P53350	PLK1_HUMAN	80	70	14	0	7	216	499	568	8.80E-28	123.6	PLK1_HUMAN	reviewed	Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13)	PLK1 PLK	Homo sapiens (Human)	603	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194]; ubiquitin-dependent protein catabolic process [GO:0006511]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]	anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000785; GO:0000795; GO:0000922; GO:0000942; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006468; GO:0006511; GO:0007062; GO:0007077; GO:0007094; GO:0007098; GO:0007346; GO:0008017; GO:0010389; GO:0010800; GO:0010997; GO:0015630; GO:0016301; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031145; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0051726; GO:0070194; GO:0071168; GO:0072425; GO:0090435; GO:0097431; GO:0097711; GO:1900182; GO:1901673; GO:1901990; GO:1902749; GO:1904668; GO:1904776	anaphase-promoting complex-dependent catabolic process [GO:0031145]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN15115_c0_g1_i1	Q9H4B4	PLK3_HUMAN	100	111	0	0	334	2	150	260	2.20E-62	239.2	PLK3_HUMAN	reviewed	Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase)	PLK3 CNK FNK PRK	Homo sapiens (Human)	646	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G1/S transition checkpoint [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000122; GO:0000278; GO:0000302; GO:0000922; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005813; GO:0006468; GO:0006915; GO:0006970; GO:0006974; GO:0006977; GO:0007093; GO:0007113; GO:0009314; GO:0030425; GO:0031122; GO:0032465; GO:0043025; GO:0043066; GO:0043491; GO:0044819; GO:0051302; GO:0090166; GO:0090316; GO:1901796; GO:1904716; GO:2000777	"apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G1/S transition checkpoint [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15115_c0_g1_i2	Q9H4B4	PLK3_HUMAN	100	111	0	0	334	2	150	260	2.20E-62	239.2	PLK3_HUMAN	reviewed	Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase)	PLK3 CNK FNK PRK	Homo sapiens (Human)	646	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G1/S transition checkpoint [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000122; GO:0000278; GO:0000302; GO:0000922; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005813; GO:0006468; GO:0006915; GO:0006970; GO:0006974; GO:0006977; GO:0007093; GO:0007113; GO:0009314; GO:0030425; GO:0031122; GO:0032465; GO:0043025; GO:0043066; GO:0043491; GO:0044819; GO:0051302; GO:0090166; GO:0090316; GO:1901796; GO:1904716; GO:2000777	"apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G1/S transition checkpoint [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28924_c0_g1_i1	O00444	PLK4_HUMAN	100	79	0	0	239	3	47	125	7.60E-41	167.2	PLK4_HUMAN	reviewed	Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak)	PLK4 SAK STK18	Homo sapiens (Human)	970	centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; XY body [GO:0001741]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; trophoblast giant cell differentiation [GO:0060707]	centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; XY body [GO:0001741]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]	GO:0000086; GO:0000278; GO:0000922; GO:0001741; GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007099; GO:0010389; GO:0032154; GO:0032465; GO:0042802; GO:0046601; GO:0060707; GO:0097711; GO:0098535; GO:0098536	centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; trophoblast giant cell differentiation [GO:0060707]		NA	NA	NA	NA	NA	NA
TRINITY_DN27569_c0_g1_i1	Q6PAD2	PLK4_XENLA	38.3	347	189	9	80	1093	563	893	1.40E-44	181.8	PLK4_XENLA	reviewed	Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase Sak)	plk4 sak	Xenopus laevis (African clawed frog)	944	centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; positive regulation of centriole replication [GO:0046601]	centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005730; GO:0005737; GO:0005814; GO:0007099; GO:0046601; GO:0098535; GO:0098536	centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; positive regulation of centriole replication [GO:0046601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11138_c0_g1_i2	O97143	PLK4_DROME	63.4	224	81	1	9	680	8	230	8.10E-78	291.6	PLK4_DROME	reviewed	Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase SAK)	SAK CG7186	Drosophila melanogaster (Fruit fly)	769	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; positive regulation of protein catabolic process [GO:0045732]; protein autophosphorylation [GO:0046777]; regulation of centriole replication [GO:0046599]; regulation of cytokinesis [GO:0032465]; regulation of protein stability [GO:0031647]; sperm axoneme assembly [GO:0007288]; syncytial blastoderm mitotic cell cycle [GO:0035186]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]	GO:0000278; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0007099; GO:0007140; GO:0007288; GO:0031647; GO:0032465; GO:0035186; GO:0042802; GO:0045732; GO:0046599; GO:0046777	centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; positive regulation of protein catabolic process [GO:0045732]; protein autophosphorylation [GO:0046777]; regulation of centriole replication [GO:0046599]; regulation of cytokinesis [GO:0032465]; regulation of protein stability [GO:0031647]; sperm axoneme assembly [GO:0007288]; syncytial blastoderm mitotic cell cycle [GO:0035186]		NA	NA	NA	NA	NA	NA
TRINITY_DN11138_c0_g1_i3	Q16W24	PLK4_AEDAE	56.7	298	122	2	9	884	4	300	2.60E-91	337	PLK4_AEDAE	reviewed	Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase SAK)	SAK AAEL009360	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	769	centriole [GO:0005814]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]	centriole [GO:0005814]; cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005814; GO:0007099	centriole replication [GO:0007099]		NA	NA	NA	NA	NA	NA
TRINITY_DN34507_c0_g1_i1	Q07538	PRP4_SCHPO	63.9	72	24	1	1	216	286	355	6.20E-21	100.9	PRP4_SCHPO	reviewed	Serine/threonine-protein kinase prp4 (EC 2.7.11.1)	prp4 SPCC777.14	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	477	"nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; protein phosphorylation [GO:0006468]"	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0045292; GO:0070317; GO:1905746	"mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; protein phosphorylation [GO:0006468]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4772_c0_g1_i1	Q08DZ2	PRP4B_BOVIN	68.8	215	67	0	691	47	794	1008	1.10E-87	324.3	PRP4B_BOVIN	reviewed	Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog)	PRPF4B	Bos taurus (Bovine)	1008	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0018105; GO:0018107	mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN4772_c0_g1_i2	Q08DZ2	PRP4B_BOVIN	68.8	215	67	0	691	47	794	1008	1.10E-87	324.3	PRP4B_BOVIN	reviewed	Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog)	PRPF4B	Bos taurus (Bovine)	1008	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0018105; GO:0018107	mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN4772_c0_g1_i3	Q08DZ2	PRP4B_BOVIN	68.8	215	67	0	722	78	794	1008	1.10E-87	324.3	PRP4B_BOVIN	reviewed	Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog)	PRPF4B	Bos taurus (Bovine)	1008	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0018105; GO:0018107	mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN4772_c0_g1_i4	Q08DZ2	PRP4B_BOVIN	68.8	215	67	0	722	78	794	1008	1.10E-87	324.3	PRP4B_BOVIN	reviewed	Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog)	PRPF4B	Bos taurus (Bovine)	1008	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0018105; GO:0018107	mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN36469_c0_g1_i1	Q08DZ2	PRP4B_BOVIN	71	62	18	0	7	192	846	907	2.20E-20	99	PRP4B_BOVIN	reviewed	Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog)	PRPF4B	Bos taurus (Bovine)	1008	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005681; GO:0006397; GO:0008380; GO:0018105; GO:0018107	mRNA processing [GO:0006397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN35863_c0_g1_i1	Q54VD8	RIO1_DICDI	56.7	67	29	0	203	3	289	355	9.50E-16	83.6	RIO1_DICDI	reviewed	Serine/threonine-protein kinase rio1 (EC 2.7.11.1) (EC 3.6.3.-)	rio1 DDB_G0280431	Dictyostelium discoideum (Slime mold)	574	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; protein phosphorylation [GO:0006468]"	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0016787; GO:0030490; GO:0030688; GO:0046872	maturation of SSU-rRNA [GO:0030490]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN37808_c0_g1_i1	Q922Q2	RIOK1_MOUSE	68.7	83	26	0	254	6	285	367	1.60E-28	126.3	RIOK1_MOUSE	reviewed	Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1)	Riok1	Mus musculus (Mouse)	567	"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]"	"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:2000234	maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN2611_c0_g2_i1	Q54T05	RIO2_DICDI	66.3	92	31	0	287	12	95	186	6.00E-32	137.9	RIO2_DICDI	reviewed	Serine/threonine-protein kinase rio2 (EC 2.7.11.1)	rio2 DDB_G0282099	Dictyostelium discoideum (Slime mold)	522	"cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; protein phosphorylation [GO:0006468]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0030490; GO:0030688; GO:0046872	maturation of SSU-rRNA [GO:0030490]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2611_c0_g1_i1	Q54T05	RIO2_DICDI	63.2	95	35	0	345	61	193	287	2.10E-29	129.8	RIO2_DICDI	reviewed	Serine/threonine-protein kinase rio2 (EC 2.7.11.1)	rio2 DDB_G0282099	Dictyostelium discoideum (Slime mold)	522	"cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; protein phosphorylation [GO:0006468]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0030490; GO:0030688; GO:0046872	maturation of SSU-rRNA [GO:0030490]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN28021_c0_g1_i1	Q9BVS4	RIOK2_HUMAN	100	110	0	0	1	330	208	317	2.30E-59	229.2	RIOK2_HUMAN	reviewed	Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)	RIOK2 RIO2	Homo sapiens (Human)	552	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:2000208; GO:2000234	cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN32766_c0_g1_i1	Q9BVS4	RIOK2_HUMAN	99.4	171	1	0	513	1	40	210	1.40E-95	350.1	RIOK2_HUMAN	reviewed	Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)	RIOK2 RIO2	Homo sapiens (Human)	552	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:2000208; GO:2000234	cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN34493_c0_g1_i1	Q9CQS5	RIOK2_MOUSE	98.2	163	3	0	23	511	1	163	1.20E-86	320.5	RIOK2_MOUSE	reviewed	Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)	Riok2	Mus musculus (Mouse)	547	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:2000208; GO:2000234	maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN1840_c0_g1_i1	Q9CQS5	RIOK2_MOUSE	64.1	334	116	3	85	1077	1	333	9.00E-119	428.3	RIOK2_MOUSE	reviewed	Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)	Riok2	Mus musculus (Mouse)	547	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:2000208; GO:2000234	maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]		NA	NA	NA	NA	NA	NA
TRINITY_DN4536_c0_g1_i1	Q9DBU3	RIOK3_MOUSE	41.1	209	111	6	617	3	13	213	3.60E-30	133.7	RIOK3_MOUSE	reviewed	Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3)	Riok3	Mus musculus (Mouse)	519	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786	cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]		NA	NA	NA	NA	NA	NA
TRINITY_DN21693_c0_g1_i2	Q9DBU3	RIOK3_MOUSE	100	142	0	0	426	1	288	429	6.30E-78	291.2	RIOK3_MOUSE	reviewed	Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3)	Riok3	Mus musculus (Mouse)	519	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786	cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]		NA	NA	NA	NA	NA	NA
TRINITY_DN7962_c0_g1_i1	O14730	RIOK3_HUMAN	56.3	238	99	1	780	82	242	479	2.70E-74	280	RIOK3_HUMAN	reviewed	Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog)	RIOK3 SUDD	Homo sapiens (Human)	519	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786	cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]		NA	NA	NA	NA	NA	NA
TRINITY_DN21693_c0_g1_i1	O14730	RIOK3_HUMAN	98.7	157	2	0	473	3	288	444	5.70E-88	324.7	RIOK3_HUMAN	reviewed	Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog)	RIOK3 SUDD	Homo sapiens (Human)	519	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]"	ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786	cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]		NA	NA	NA	NA	NA	NA
TRINITY_DN13858_c0_g1_i1	Q7ZTW4	SGK1_DANRE	66.9	154	51	0	4	465	94	247	1.60E-58	226.9	SGK1_DANRE	reviewed	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	sgk1 sgk wu:fc20a09	Danio rerio (Zebrafish) (Brachydanio rerio)	433	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0006915; GO:0006954; GO:0015459; GO:0018105; GO:0035556; GO:0048812	apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN36466_c0_g1_i1	O00141	SGK1_HUMAN	100	96	0	0	290	3	201	296	9.60E-54	210.3	SGK1_HUMAN	reviewed	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK	Homo sapiens (Human)	431	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; ion transmembrane transport [GO:0034220]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0034220; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; ion transmembrane transport [GO:0034220]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN27262_c0_g1_i1	A7MB74	SGK1_BOVIN	100	148	0	0	446	3	151	298	4.60E-87	321.6	SGK1_BOVIN	reviewed	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK	Bos taurus (Bovine)	431	endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]	endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005739; GO:0005789; GO:0005886; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN31360_c0_g1_i1	O00141	SGK1_HUMAN	98.7	79	1	0	237	1	74	152	9.60E-36	150.2	SGK1_HUMAN	reviewed	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK	Homo sapiens (Human)	431	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; ion transmembrane transport [GO:0034220]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0034220; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; ion transmembrane transport [GO:0034220]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN23161_c0_g1_i1	Q6GPN6	SGK1A_XENLA	75.3	77	18	1	2	232	247	322	1.00E-29	130.2	SGK1A_XENLA	reviewed	Serine/threonine-protein kinase Sgk1-A (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1-A)	sgk1-a sgk-a	Xenopus laevis (African clawed frog)	434	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005783; GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN31914_c0_g1_i1	Q9ERE3	SGK3_MOUSE	55.4	139	60	2	2	415	237	374	3.90E-40	165.6	SGK3_MOUSE	reviewed	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)	Sgk3 Cisk Sgkl	Mus musculus (Mouse)	496	cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005769; GO:0015459; GO:0018105; GO:0031410; GO:0035091; GO:0035556; GO:0043231; GO:0055037; GO:2001240	intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN4238_c0_g1_i2	Q6P4S6	SIK3_MOUSE	28.6	377	213	14	8	1123	286	611	9.70E-17	89.4	SIK3_MOUSE	reviewed	Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK)	Sik3 Kiaa0999 Qsk	Mus musculus (Mouse)	1311	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0035556; GO:0048705; GO:0050321; GO:0060351; GO:1904263; GO:1904515	cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705]		NA	NA	NA	NA	NA	NA
TRINITY_DN37683_c0_g1_i1	Q9Y2K2	SIK3_HUMAN	100	110	0	0	332	3	80	189	1.80E-56	219.5	SIK3_HUMAN	reviewed	Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK)	SIK3 KIAA0999 QSK L19	Homo sapiens (Human)	1321	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0050321; GO:1904263; GO:1904515	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN30311_c0_g1_i1	Q6P4S6	SIK3_MOUSE	70	230	69	0	742	53	32	261	9.90E-95	347.8	SIK3_MOUSE	reviewed	Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK)	Sik3 Kiaa0999 Qsk	Mus musculus (Mouse)	1311	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0035556; GO:0048705; GO:0050321; GO:0060351; GO:1904263; GO:1904515	cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705]		NA	NA	NA	NA	NA	NA
TRINITY_DN4238_c0_g1_i1	Q6NSM8	SIK3_DANRE	31.8	289	149	11	14	871	339	582	7.00E-15	83.2	SIK3_DANRE	reviewed	Serine/threonine-protein kinase SIK3 homolog (EC 2.7.11.1) (Serine/threonine-protein kinase QSK homolog)	zgc:66101	Danio rerio (Zebrafish) (Brachydanio rerio)	1187	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0050321	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2849_c0_g1_i1	Q8BKX6	SMG1_MOUSE	32	3676	2136	71	299	10687	132	3658	0	1668.3	SMG1_MOUSE	reviewed	Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1)	Smg1 Kiaa0421	Mus musculus (Mouse)	3658	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TORC1 signaling [GO:0038202]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010507; GO:0016242; GO:0018105; GO:0031931; GO:0031932; GO:0032204; GO:0038202; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:2001020	"DNA repair [GO:0006281]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TORC1 signaling [GO:0038202]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29274_c0_g1_i1	Q96Q15	SMG1_HUMAN	100	81	0	0	2	244	976	1056	1.30E-40	166.4	SMG1_HUMAN	reviewed	Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein)	SMG1 ATX KIAA0421 LIP	Homo sapiens (Human)	3661	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TORC1 signaling [GO:0038202]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0010507; GO:0016242; GO:0018105; GO:0031931; GO:0031932; GO:0032204; GO:0038202; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:2001020	"DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TORC1 signaling [GO:0038202]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40993_c0_g1_i1	P06784	STE7_YEAST	54.5	66	28	2	5	199	310	374	3.10E-11	68.6	STE7_YEAST	reviewed	Serine/threonine-protein kinase STE7 (EC 2.7.12.2)	STE7 YDL159W D1525	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	515	"cytoplasm [GO:0005737]; mating projection tip [GO:0043332]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; cell wall integrity MAPK cascade [GO:0000196]; invasive growth in response to glucose limitation [GO:0001403]; pheromone response MAPK cascade [GO:0071507]; protein phosphorylation [GO:0006468]; pseudohyphal growth [GO:0007124]; regulation of transposition, RNA-mediated [GO:0010525]; signal transduction involved in filamentous growth [GO:0001402]"	cytoplasm [GO:0005737]; mating projection tip [GO:0043332]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine/threonine kinase activity [GO:0004674]	GO:0000187; GO:0000196; GO:0001402; GO:0001403; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0006468; GO:0007124; GO:0010525; GO:0043332; GO:0071507	"activation of MAPK activity [GO:0000187]; cell wall integrity MAPK cascade [GO:0000196]; invasive growth in response to glucose limitation [GO:0001403]; pheromone response MAPK cascade [GO:0071507]; protein phosphorylation [GO:0006468]; pseudohyphal growth [GO:0007124]; regulation of transposition, RNA-mediated [GO:0010525]; signal transduction involved in filamentous growth [GO:0001402]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2720_c0_g1_i1	Q91604	STK11_XENLA	72.7	110	30	0	66	395	47	156	7.50E-40	164.9	STK11_XENLA	reviewed	Serine/threonine-protein kinase stk11 (EC 2.7.11.1) (Liver kinase B1 homolog) (lkb1) (Serine/threonine-protein kinase XEEK1)	stk11 eek1	Xenopus laevis (African clawed frog)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006974; GO:0007049; GO:0010212; GO:0016020; GO:0030010; GO:0030295; GO:0030308; GO:0042593; GO:0046777; GO:0046872; GO:0072332	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN2720_c0_g1_i3	Q91604	STK11_XENLA	72.4	98	27	0	66	359	47	144	4.70E-34	145.2	STK11_XENLA	reviewed	Serine/threonine-protein kinase stk11 (EC 2.7.11.1) (Liver kinase B1 homolog) (lkb1) (Serine/threonine-protein kinase XEEK1)	stk11 eek1	Xenopus laevis (African clawed frog)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006974; GO:0007049; GO:0010212; GO:0016020; GO:0030010; GO:0030295; GO:0030308; GO:0042593; GO:0046777; GO:0046872; GO:0072332	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN2720_c0_g1_i4	Q91604	STK11_XENLA	71.9	89	25	0	66	332	47	135	4.10E-28	125.6	STK11_XENLA	reviewed	Serine/threonine-protein kinase stk11 (EC 2.7.11.1) (Liver kinase B1 homolog) (lkb1) (Serine/threonine-protein kinase XEEK1)	stk11 eek1	Xenopus laevis (African clawed frog)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006974; GO:0007049; GO:0010212; GO:0016020; GO:0030010; GO:0030295; GO:0030308; GO:0042593; GO:0046777; GO:0046872; GO:0072332	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN2720_c0_g1_i5	Q91604	STK11_XENLA	68.5	89	28	0	66	332	47	135	1.70E-26	120.2	STK11_XENLA	reviewed	Serine/threonine-protein kinase stk11 (EC 2.7.11.1) (Liver kinase B1 homolog) (lkb1) (Serine/threonine-protein kinase XEEK1)	stk11 eek1	Xenopus laevis (African clawed frog)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006974; GO:0007049; GO:0010212; GO:0016020; GO:0030010; GO:0030295; GO:0030308; GO:0042593; GO:0046777; GO:0046872; GO:0072332	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN2720_c0_g1_i6	Q91604	STK11_XENLA	75.3	81	20	0	66	308	47	127	3.60E-27	122.1	STK11_XENLA	reviewed	Serine/threonine-protein kinase stk11 (EC 2.7.11.1) (Liver kinase B1 homolog) (lkb1) (Serine/threonine-protein kinase XEEK1)	stk11 eek1	Xenopus laevis (African clawed frog)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006974; GO:0007049; GO:0010212; GO:0016020; GO:0030010; GO:0030295; GO:0030308; GO:0042593; GO:0046777; GO:0046872; GO:0072332	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell growth [GO:0030308]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; response to ionizing radiation [GO:0010212]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN35723_c0_g1_i1	Q0KHQ5	TAO_DROME	82.9	140	24	0	426	7	114	253	9.40E-66	250.8	TAO_DROME	reviewed	Serine/threonine-protein kinase Tao (EC 2.7.11.1)	Tao Tao-1 CG14217	Drosophila melanogaster (Fruit fly)	1039	axon [GO:0030424]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; central complex development [GO:0048036]; intestinal stem cell homeostasis [GO:0036335]; MAPK cascade [GO:0000165]; mushroom body development [GO:0016319]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of endocytosis [GO:0045807]; positive regulation of hippo signaling [GO:0035332]; protein phosphorylation [GO:0006468]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]	axon [GO:0030424]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; spindle [GO:0005819]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0001894; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0016020; GO:0016319; GO:0023014; GO:0030424; GO:0030514; GO:0030707; GO:0031098; GO:0032147; GO:0035094; GO:0035332; GO:0036335; GO:0042220; GO:0043204; GO:0045178; GO:0045471; GO:0045807; GO:0045886; GO:0046621; GO:0048036; GO:0048812	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; central complex development [GO:0048036]; intestinal stem cell homeostasis [GO:0036335]; MAPK cascade [GO:0000165]; mushroom body development [GO:0016319]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of endocytosis [GO:0045807]; positive regulation of hippo signaling [GO:0035332]; protein phosphorylation [GO:0006468]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; tissue homeostasis [GO:0001894]		blue	blue	NA	NA	NA	NA
TRINITY_DN27772_c0_g1_i1	Q9H2K8	TAOK3_HUMAN	100	158	0	0	476	3	134	291	8.80E-89	327.4	TAOK3_HUMAN	reviewed	Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3)	TAOK3 DPK JIK KDS MAP3K18	Homo sapiens (Human)	898	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740]	GO:0000165; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0023014; GO:0031098; GO:0032147; GO:0032874; GO:0043507; GO:0046329; GO:0046330; GO:0046777; GO:0048812	activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]		NA	NA	NA	NA	NA	NA
TRINITY_DN165_c0_g1_i3	Q6DFJ6	TBK1_XENLA	41.5	609	331	8	2275	455	1	586	6.20E-122	439.9	TBK1_XENLA	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1)	tbk1	Xenopus laevis (African clawed frog)	725	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087	innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN165_c0_g1_i4	Q6DFJ6	TBK1_XENLA	41.5	609	331	8	2275	455	1	586	4.70E-122	440.3	TBK1_XENLA	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1)	tbk1	Xenopus laevis (African clawed frog)	725	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087	innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN165_c0_g1_i5	Q6DFJ6	TBK1_XENLA	41.5	609	331	8	2275	455	1	586	4.80E-122	440.3	TBK1_XENLA	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1)	tbk1	Xenopus laevis (African clawed frog)	725	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087	innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN37633_c0_g1_i1	Q9UHD2	TBK1_HUMAN	100	135	0	0	1	405	97	231	2.80E-75	282.3	TBK1_HUMAN	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)	TBK1 NAK	Homo sapiens (Human)	729	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; cellular response to cytokine stimulus [GO:0071345]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon production [GO:0032606]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0002218; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010008; GO:0016032; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032480; GO:0032481; GO:0032606; GO:0032727; GO:0032728; GO:0033138; GO:0035666; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:0071345; GO:1901214; GO:1904417	activation of innate immune response [GO:0002218]; cellular response to cytokine stimulus [GO:0071345]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type I interferon production [GO:0032481]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon production [GO:0032606]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN37590_c0_g1_i1	Q9UHD2	TBK1_HUMAN	100	74	0	0	222	1	26	99	1.10E-36	153.3	TBK1_HUMAN	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)	TBK1 NAK	Homo sapiens (Human)	729	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; cellular response to cytokine stimulus [GO:0071345]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon production [GO:0032606]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0002218; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010008; GO:0016032; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032480; GO:0032481; GO:0032606; GO:0032727; GO:0032728; GO:0033138; GO:0035666; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:0071345; GO:1901214; GO:1904417	activation of innate immune response [GO:0002218]; cellular response to cytokine stimulus [GO:0071345]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type I interferon production [GO:0032481]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon production [GO:0032606]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN165_c0_g1_i1	Q9WUN2	TBK1_MOUSE	39	633	340	9	2344	455	1	590	7.80E-120	433	TBK1_MOUSE	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1)	Tbk1	Mus musculus (Mouse)	729	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0002218; GO:0003676; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0010468; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0031323; GO:0032479; GO:0032727; GO:0032728; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:1904417	activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN165_c0_g1_i2	Q9WUN2	TBK1_MOUSE	39	633	340	9	2344	455	1	590	5.90E-120	433.3	TBK1_MOUSE	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1)	Tbk1	Mus musculus (Mouse)	729	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0002218; GO:0003676; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0010468; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0031323; GO:0032479; GO:0032727; GO:0032728; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:1904417	activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN165_c0_g1_i9	Q9WUN2	TBK1_MOUSE	39	633	340	9	2344	455	1	590	6.10E-120	433.3	TBK1_MOUSE	reviewed	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1)	Tbk1	Mus musculus (Mouse)	729	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]	GO:0002218; GO:0003676; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0010468; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0031323; GO:0032479; GO:0032727; GO:0032728; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:1904417	activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]		NA	NA	NA	NA	NA	NA
TRINITY_DN30800_c0_g1_i1	Q6FRZ9	ATM_CANGA	66.2	71	23	1	7	219	2556	2625	2.40E-20	99	ATM_CANGA	reviewed	Serine/threonine-protein kinase TEL1 (EC 2.7.11.1) (ATM homolog) (DNA-damage checkpoint kinase TEL1) (Telomere length regulation protein 1)	TEL1 CAGL0H04609g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	2763	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone phosphorylation [GO:0016572]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]"	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]"	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000077; GO:0000723; GO:0000781; GO:0004674; GO:0005524; GO:0005634; GO:0006281; GO:0010212; GO:0016572	DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; histone phosphorylation [GO:0016572]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]		NA	NA	NA	NA	NA	NA
TRINITY_DN32853_c0_g1_i3	Q59H18	TNI3K_HUMAN	44.1	247	107	6	768	58	596	821	6.70E-46	185.7	TNI3K_HUMAN	reviewed	Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase)	TNNI3K CARK	Homo sapiens (Human)	835	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]	GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779	bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]		NA	NA	NA	NA	NA	NA
TRINITY_DN16202_c0_g1_i1	Q59H18	TNI3K_HUMAN	28.6	189	116	6	639	91	1	176	8.10E-09	62.4	TNI3K_HUMAN	reviewed	Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase)	TNNI3K CARK	Homo sapiens (Human)	835	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]	GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779	bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]		NA	NA	NA	NA	NA	NA
TRINITY_DN32853_c0_g1_i4	Q5GIG6	TNI3K_MOUSE	67.2	119	39	0	758	402	595	713	1.80E-43	177.6	TNI3K_MOUSE	reviewed	Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)	Tnni3k Cark	Mus musculus (Mouse)	834	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]	GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779	bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]		NA	NA	NA	NA	NA	NA
TRINITY_DN34587_c0_g1_i1	Q9VK45	TOR_DROME	74.3	70	17	1	211	2	2299	2367	3.20E-22	105.1	TOR_DROME	reviewed	Serine/threonine-protein kinase Tor (EC 2.7.11.1) (Target of rapamycin)	Tor CG5092	Drosophila melanogaster (Fruit fly)	2470	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; apical protein localization [GO:0045176]; autophagy [GO:0006914]; cellular response to nutrient [GO:0031670]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; endocytic recycling [GO:0032456]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; gonad development [GO:0008406]; insulin receptor signaling pathway [GO:0008286]; lamellocyte differentiation [GO:0035171]; larval midgut cell programmed cell death [GO:0035096]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell size [GO:0045793]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to drug [GO:2001023]; regulation of terminal button organization [GO:2000331]; terminal branching, open tracheal system [GO:0007430]; TORC1 signaling [GO:0038202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	ATP binding [GO:0005524]; chromatin DNA binding [GO:0031490]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]	GO:0001558; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006914; GO:0007430; GO:0008286; GO:0008340; GO:0008406; GO:0010507; GO:0016242; GO:0031490; GO:0031670; GO:0031931; GO:0031932; GO:0032456; GO:0035096; GO:0035171; GO:0035264; GO:0038202; GO:0043066; GO:0043621; GO:0044877; GO:0045176; GO:0045793; GO:0045887; GO:0045945; GO:0046628; GO:0048010; GO:0048142; GO:0048813; GO:0051729; GO:0051897; GO:0090070; GO:0090303; GO:1901799; GO:1902669; GO:2000331; GO:2000377; GO:2001023	"apical protein localization [GO:0045176]; autophagy [GO:0006914]; cellular response to nutrient [GO:0031670]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; endocytic recycling [GO:0032456]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; gonad development [GO:0008406]; insulin receptor signaling pathway [GO:0008286]; lamellocyte differentiation [GO:0035171]; larval midgut cell programmed cell death [GO:0035096]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of macroautophagy [GO:0016242]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell size [GO:0045793]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to drug [GO:2001023]; regulation of terminal button organization [GO:2000331]; terminal branching, open tracheal system [GO:0007430]; TORC1 signaling [GO:0038202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26803_c0_g1_i1	Q39238	TSL_ARATH	54.4	90	41	0	1	270	398	487	9.40E-19	94	TSL_ARATH	reviewed	Serine/threonine-protein kinase TOUSLED (EC 2.7.11.1)	TOUSLED TSL At5g20930 F22D1.100	Arabidopsis thaliana (Mouse-ear cress)	688	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]; regulation of RNA interference [GO:1900368]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]	GO:0001672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007059; GO:0018105; GO:0035556; GO:0042802; GO:1900368	chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]; regulation of RNA interference [GO:1900368]		NA	NA	NA	NA	NA	NA
TRINITY_DN5603_c0_g1_i1	Q86UE8	TLK2_HUMAN	79.5	127	26	0	3	383	614	740	8.50E-58	224.2	TLK2_HUMAN	reviewed	Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2)	TLK2	Homo sapiens (Human)	772	intermediate filament [GO:0005882]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672]	intermediate filament [GO:0005882]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]	GO:0001672; GO:0004674; GO:0005524; GO:0005634; GO:0005882; GO:0006325; GO:0006468; GO:0006974; GO:0007049; GO:0007059; GO:0010507; GO:0018105; GO:0032435; GO:0035556; GO:0042802; GO:0048471; GO:0071480	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672]		NA	NA	NA	NA	NA	NA
TRINITY_DN2719_c0_g1_i1	Q1ECX4	TLK2_DANRE	69	155	34	1	1	465	361	501	3.90E-57	222.2	TLK2_DANRE	reviewed	Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2)	tlk2 zgc:136697	Danio rerio (Zebrafish) (Brachydanio rerio)	697	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0001672; GO:0004674; GO:0005524; GO:0005634; GO:0007059; GO:0018105; GO:0035556	chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]		NA	NA	NA	NA	NA	NA
TRINITY_DN2719_c0_g1_i2	Q1ECX4	TLK2_DANRE	75.9	141	34	0	1	423	361	501	2.60E-60	232.6	TLK2_DANRE	reviewed	Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2)	tlk2 zgc:136697	Danio rerio (Zebrafish) (Brachydanio rerio)	697	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]	nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0001672; GO:0004674; GO:0005524; GO:0005634; GO:0007059; GO:0018105; GO:0035556	chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; regulation of chromatin assembly or disassembly [GO:0001672]		NA	NA	NA	NA	NA	NA
TRINITY_DN198_c0_g1_i2	Q2LZZ7	TRC_DROPS	74.4	481	95	3	60	1502	1	453	1.10E-207	724.2	TRC_DROPS	reviewed	Serine/threonine-protein kinase tricornered (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like) (Serine/threonine-protein kinase tricorner)	trc GA21227	Drosophila pseudoobscura pseudoobscura (Fruit fly)	458	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0051012; GO:0070451; GO:0070593; GO:0150013	antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN198_c0_g1_i3	Q2LZZ7	TRC_DROPS	76.2	466	90	3	94	1488	8	453	4.20E-207	722.2	TRC_DROPS	reviewed	Serine/threonine-protein kinase tricornered (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like) (Serine/threonine-protein kinase tricorner)	trc GA21227	Drosophila pseudoobscura pseudoobscura (Fruit fly)	458	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0051012; GO:0070451; GO:0070593; GO:0150013	antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN198_c0_g1_i4	Q2LZZ7	TRC_DROPS	76	471	95	3	60	1472	1	453	3.70E-208	725.7	TRC_DROPS	reviewed	Serine/threonine-protein kinase tricornered (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like) (Serine/threonine-protein kinase tricorner)	trc GA21227	Drosophila pseudoobscura pseudoobscura (Fruit fly)	458	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0051012; GO:0070451; GO:0070593; GO:0150013	antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN198_c0_g1_i5	Q2LZZ7	TRC_DROPS	77.9	456	90	3	94	1458	8	453	1.10E-207	724.2	TRC_DROPS	reviewed	Serine/threonine-protein kinase tricornered (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like) (Serine/threonine-protein kinase tricorner)	trc GA21227	Drosophila pseudoobscura pseudoobscura (Fruit fly)	458	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]	axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell hair [GO:0070451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0051012; GO:0070451; GO:0070593; GO:0150013	antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3040_c0_g1_i1	Q4V7Q6	ULK3_XENLA	45.9	481	246	3	69	1508	1	468	1.10E-119	431.8	ULK3_XENLA	reviewed	Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3)	ulk3	Xenopus laevis (African clawed frog)	468	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy [GO:0006914]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0006914; GO:0045879; GO:0045880; GO:0046777	autophagy [GO:0006914]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]		NA	NA	NA	NA	NA	NA
TRINITY_DN23938_c0_g1_i1	Q6PHR2	ULK3_HUMAN	100	160	0	0	3	482	38	197	5.30E-89	328.2	ULK3_HUMAN	reviewed	Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3)	ULK3	Homo sapiens (Human)	472	ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; fibroblast activation [GO:0072537]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; smoothened signaling pathway [GO:0007224]	ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000407; GO:0004674; GO:0005524; GO:0005737; GO:0006914; GO:0007224; GO:0045879; GO:0045880; GO:0046777; GO:0072537; GO:0090398; GO:0097542	autophagy [GO:0006914]; cellular senescence [GO:0090398]; fibroblast activation [GO:0072537]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN23938_c0_g1_i2	Q6PHR2	ULK3_HUMAN	100	169	0	0	2	508	29	197	3.40E-94	345.5	ULK3_HUMAN	reviewed	Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3)	ULK3	Homo sapiens (Human)	472	ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; fibroblast activation [GO:0072537]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; smoothened signaling pathway [GO:0007224]	ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000407; GO:0004674; GO:0005524; GO:0005737; GO:0006914; GO:0007224; GO:0045879; GO:0045880; GO:0046777; GO:0072537; GO:0090398; GO:0097542	autophagy [GO:0006914]; cellular senescence [GO:0090398]; fibroblast activation [GO:0072537]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN14917_c0_g3_i1	Q23023	UNC51_CAEEL	43.9	230	119	4	390	1079	637	856	2.60E-41	171	UNC51_CAEEL	reviewed	Serine/threonine-protein kinase unc-51 (EC 2.7.11.1) (Uncoordinated protein 51)	unc-51 Y60A3A.1	Caenorhabditis elegans	856	axon [GO:0030424]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0006914; GO:0007409; GO:0007411; GO:0008340; GO:0008361; GO:0009792; GO:0012501; GO:0016477; GO:0030424; GO:0030516; GO:0032880; GO:0040014; GO:0040024; GO:0043005; GO:0043025; GO:0043277; GO:0045138; GO:0046777; GO:0046872	apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN14917_c0_g2_i1	Q23023	UNC51_CAEEL	66.9	254	76	2	872	114	38	284	1.50E-89	330.9	UNC51_CAEEL	reviewed	Serine/threonine-protein kinase unc-51 (EC 2.7.11.1) (Uncoordinated protein 51)	unc-51 Y60A3A.1	Caenorhabditis elegans	856	axon [GO:0030424]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0006914; GO:0007409; GO:0007411; GO:0008340; GO:0008361; GO:0009792; GO:0012501; GO:0016477; GO:0030424; GO:0030516; GO:0032880; GO:0040014; GO:0040024; GO:0043005; GO:0043025; GO:0043277; GO:0045138; GO:0046777; GO:0046872	apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN10564_c0_g1_i2	Q80X41	VRK1_MOUSE	93.2	132	9	0	550	155	87	218	5.00E-67	255.4	VRK1_MOUSE	reviewed	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1)	Vrk1	Mus musculus (Mouse)	440	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0007049; GO:0018105; GO:0019901; GO:0031493; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166	cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN10564_c0_g1_i2	Q80X41	VRK1_MOUSE	96.9	64	2	0	194	3	206	269	5.50E-34	145.6	VRK1_MOUSE	reviewed	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1)	Vrk1	Mus musculus (Mouse)	440	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0007049; GO:0018105; GO:0019901; GO:0031493; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166	cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN410_c0_g1_i1	Q7ZUS1	VRK1_DANRE	51.4	354	165	4	1144	98	10	361	2.50E-98	360.5	VRK1_DANRE	reviewed	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1)	vrk1 zgc:56266	Danio rerio (Zebrafish) (Brachydanio rerio)	425	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0007049; GO:0018105; GO:0051301; GO:0090166	cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]		blue	blue	NA	NA	NA	NA
TRINITY_DN410_c0_g1_i2	Q7ZUS1	VRK1_DANRE	50.4	381	176	6	1927	800	10	382	1.10E-98	362.5	VRK1_DANRE	reviewed	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1)	vrk1 zgc:56266	Danio rerio (Zebrafish) (Brachydanio rerio)	425	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0007049; GO:0018105; GO:0051301; GO:0090166	cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]		NA	NA	NA	NA	NA	NA
TRINITY_DN10564_c0_g1_i1	Q99986	VRK1_HUMAN	100	195	0	0	585	1	87	281	4.70E-116	418.3	VRK1_HUMAN	reviewed	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1)	VRK1	Homo sapiens (Human)	396	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic nuclear envelope reassembly [GO:0007084]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0007077; GO:0007084; GO:0018105; GO:0019901; GO:0031493; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166	cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic nuclear envelope reassembly [GO:0007084]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN9628_c0_g1_i1	Q9VA38	WARTS_DROME	91.2	34	3	0	75	176	788	821	9.60E-11	67	WARTS_DROME	reviewed	Serine/threonine-protein kinase Warts (EC 2.7.11.1)	wts CG12072	Drosophila melanogaster (Fruit fly)	1105	apicomedial cortex [GO:0106037]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; imaginal disc growth [GO:0007446]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of microfilament motor activity [GO:0120080]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein import into nucleus [GO:0042308]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipophagy [GO:1904504]; R8 cell fate specification [GO:0045464]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of organ growth [GO:0046620]; response to ionizing radiation [GO:0010212]; stem cell proliferation [GO:0072089]	apicomedial cortex [GO:0106037]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0001708; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0007298; GO:0007406; GO:0007424; GO:0007446; GO:0008285; GO:0008360; GO:0010212; GO:0018105; GO:0035329; GO:0035556; GO:0042308; GO:0042771; GO:0043065; GO:0045464; GO:0045571; GO:0046620; GO:0046872; GO:0048814; GO:0060253; GO:0072089; GO:0090090; GO:0106037; GO:0120080; GO:1904504	border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; imaginal disc growth [GO:0007446]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of microfilament motor activity [GO:0120080]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein import into nucleus [GO:0042308]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipophagy [GO:1904504]; R8 cell fate specification [GO:0045464]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of organ growth [GO:0046620]; response to ionizing radiation [GO:0010212]; stem cell proliferation [GO:0072089]		NA	NA	NA	NA	NA	NA
TRINITY_DN29275_c0_g1_i1	Q9H4A3	WNK1_HUMAN	100	77	0	0	3	233	232	308	2.70E-38	158.7	WNK1_HUMAN	reviewed	Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1)	WNK1 HSN2 KDP KIAA0344 PRKWNK1	Homo sapiens (Human)	2382	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]	GO:0002028; GO:0004672; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0010766; GO:0010820; GO:0010923; GO:0016020; GO:0018105; GO:0018107; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0023016; GO:0030295; GO:0032414; GO:0033633; GO:0034115; GO:0034260; GO:0035556; GO:0038116; GO:0048666; GO:0050794; GO:0050801; GO:0050852; GO:0090263; GO:0097022; GO:1903038; GO:1903288; GO:1904062; GO:1990869; GO:2000651	cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN39904_c0_g1_i1	Q9H4A3	WNK1_HUMAN	100	159	0	0	2	478	303	461	2.20E-87	322.8	WNK1_HUMAN	reviewed	Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1)	WNK1 HSN2 KDP KIAA0344 PRKWNK1	Homo sapiens (Human)	2382	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase activity [GO:0004674]	GO:0002028; GO:0004672; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0010766; GO:0010820; GO:0010923; GO:0016020; GO:0018105; GO:0018107; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0023016; GO:0030295; GO:0032414; GO:0033633; GO:0034115; GO:0034260; GO:0035556; GO:0038116; GO:0048666; GO:0050794; GO:0050801; GO:0050852; GO:0090263; GO:0097022; GO:1903038; GO:1903288; GO:1904062; GO:1990869; GO:2000651	cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN345_c0_g1_i1	Q80XP9	WNK3_MOUSE	66.4	336	110	1	1203	196	135	467	9.60E-130	464.9	WNK3_MOUSE	reviewed	Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3)	Wnk3	Mus musculus (Mouse)	1757	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0006884; GO:0007231; GO:0010765; GO:0010766; GO:0010800; GO:0018107; GO:0019869; GO:0019870; GO:0032414; GO:0035556; GO:0035633; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090188; GO:0090279; GO:1903078; GO:1903288; GO:1904062; GO:2000651	cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062]		NA	NA	NA	NA	NA	NA
TRINITY_DN345_c0_g1_i2	Q80XP9	WNK3_MOUSE	63.7	364	129	1	1093	2	135	495	1.90E-132	473.8	WNK3_MOUSE	reviewed	Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3)	Wnk3	Mus musculus (Mouse)	1757	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0006884; GO:0007231; GO:0010765; GO:0010766; GO:0010800; GO:0018107; GO:0019869; GO:0019870; GO:0032414; GO:0035556; GO:0035633; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090188; GO:0090279; GO:1903078; GO:1903288; GO:1904062; GO:2000651	cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062]		NA	NA	NA	NA	NA	NA
TRINITY_DN33628_c0_g1_i1	O75460	ERN1_HUMAN	100	126	0	0	1	378	598	723	1.10E-68	260.4	ERN1_HUMAN	reviewed	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	ERN1 IRE1	Homo sapiens (Human)	977	"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]"	AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0001935; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006402; GO:0006468; GO:0007050; GO:0007257; GO:0016241; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990332; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31272_c0_g1_i1	O75460	ERN1_HUMAN	100	82	0	0	3	248	74	155	1.90E-42	172.6	ERN1_HUMAN	reviewed	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	ERN1 IRE1	Homo sapiens (Human)	977	"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]"	AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0001935; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006402; GO:0006468; GO:0007050; GO:0007257; GO:0016241; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990332; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN638_c0_g1_i2	Q9EQY0	ERN1_MOUSE	56.3	398	168	3	670	1845	564	961	2.00E-130	468	ERN1_MOUSE	reviewed	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	Ern1 Ire1	Mus musculus (Mouse)	977	"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"	AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006468; GO:0007050; GO:0007257; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN638_c0_g1_i3	Q9EQY0	ERN1_MOUSE	41.5	950	461	21	223	2847	32	961	3.30E-182	640.6	ERN1_MOUSE	reviewed	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	Ern1 Ire1	Mus musculus (Mouse)	977	"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"	AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006468; GO:0007050; GO:0007257; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN638_c0_g1_i6	Q9EQY0	ERN1_MOUSE	56.3	398	168	3	344	1519	564	961	1.40E-130	468	ERN1_MOUSE	reviewed	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	Ern1 Ire1	Mus musculus (Mouse)	977	"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"	AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006468; GO:0007050; GO:0007257; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN638_c0_g1_i7	Q9EQY0	ERN1_MOUSE	41.8	941	467	20	223	2835	32	961	3.00E-183	644	ERN1_MOUSE	reviewed	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	Ern1 Ire1	Mus musculus (Mouse)	977	"AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"	AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006468; GO:0007050; GO:0007257; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33090_c0_g1_i1	Q6GLQ4	PP1RA_XENLA	31.1	148	80	3	2	439	399	526	3.10E-08	60.1	PP1RA_XENLA	reviewed	Serine/threonine-protein phosphatase 1 regulatory subunit 10	ppp1r10	Xenopus laevis (African clawed frog)	819	nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN37207_c0_g1_i1	P63151	2ABA_HUMAN	100	125	0	0	378	4	65	189	5.20E-68	258.1	2ABA_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha)	PPP2R2A	Homo sapiens (Human)	447	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278]"	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]	protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; tau protein binding [GO:0048156]	GO:0000086; GO:0000159; GO:0000184; GO:0005654; GO:0005829; GO:0006470; GO:0007084; GO:0019888; GO:0043278; GO:0044877; GO:0048156; GO:0051721; GO:0070262; GO:0098978	"G2/M transition of mitotic cell cycle [GO:0000086]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14087_c0_g1_i1	P63151	2ABA_HUMAN	99.5	202	1	0	606	1	192	393	1.10E-115	417.2	2ABA_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha)	PPP2R2A	Homo sapiens (Human)	447	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278]"	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]	protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; tau protein binding [GO:0048156]	GO:0000086; GO:0000159; GO:0000184; GO:0005654; GO:0005829; GO:0006470; GO:0007084; GO:0019888; GO:0043278; GO:0044877; GO:0048156; GO:0051721; GO:0070262; GO:0098978	"G2/M transition of mitotic cell cycle [GO:0000086]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26751_c0_g1_i1	Q66LE6	2ABD_HUMAN	99.1	117	1	0	353	3	66	182	1.10E-62	240.4	2ABD_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta)	PPP2R2D KIAA1541	Homo sapiens (Human)	453	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000278; GO:0005829; GO:0010458; GO:0019888; GO:0051301; GO:0070262	cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]		NA	NA	NA	NA	NA	NA
TRINITY_DN33335_c0_g1_i1	Q66LE6	2ABD_HUMAN	100	119	0	0	357	1	226	344	4.30E-64	245	2ABD_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta)	PPP2R2D KIAA1541	Homo sapiens (Human)	453	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000278; GO:0005829; GO:0010458; GO:0019888; GO:0051301; GO:0070262	cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]		NA	NA	NA	NA	NA	NA
TRINITY_DN5311_c0_g1_i1	Q66LE6	2ABD_HUMAN	83.7	263	43	0	25	813	11	273	1.90E-129	463.4	2ABD_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta)	PPP2R2D KIAA1541	Homo sapiens (Human)	453	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000278; GO:0005829; GO:0010458; GO:0019888; GO:0051301; GO:0070262	cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]		blue	blue	NA	NA	NA	NA
TRINITY_DN39712_c0_g1_i1	Q15172	2A5A_HUMAN	99.1	107	1	0	323	3	310	416	1.10E-55	216.9	2A5A_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha)	PPP2R5A	Homo sapiens (Human)	486	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]"	kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000775; GO:0004721; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007165; GO:0016020; GO:0019888; GO:0019900; GO:0030018; GO:0031430; GO:0031952; GO:0035307; GO:0072542; GO:0090219; GO:1903077	negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN19085_c0_g1_i1	Q15172	2A5A_HUMAN	51.3	76	34	1	230	3	117	189	2.00E-17	89.4	2A5A_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha)	PPP2R5A	Homo sapiens (Human)	486	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]"	kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000775; GO:0004721; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007165; GO:0016020; GO:0019888; GO:0019900; GO:0030018; GO:0031430; GO:0031952; GO:0035307; GO:0072542; GO:0090219; GO:1903077	negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN27406_c0_g1_i1	Q15172	2A5A_HUMAN	98.6	142	2	0	18	443	67	208	1.80E-75	283.1	2A5A_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha)	PPP2R5A	Homo sapiens (Human)	486	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]"	kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000775; GO:0004721; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007165; GO:0016020; GO:0019888; GO:0019900; GO:0030018; GO:0031430; GO:0031952; GO:0035307; GO:0072542; GO:0090219; GO:1903077	negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31251_c0_g1_i1	Q28647	2A5B_RABIT	98.7	79	1	0	253	17	390	468	3.20E-37	155.2	2A5B_RABIT	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B56-beta) (PP2A B subunit isoform PR61-beta) (PP2A B subunit isoform R5-beta)	PPP2R5B	Oryctolagus cuniculus (Rabbit)	500	nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; signal transduction [GO:0007165]	nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005634; GO:0007165; GO:0019888	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN17153_c0_g1_i1	Q15173	2A5B_HUMAN	55	80	36	0	242	3	227	306	4.50E-20	98.2	2A5B_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B56-beta) (PP2A B subunit isoform PR61-beta) (PP2A B subunit isoform R5-beta)	PPP2R5B	Homo sapiens (Human)	497	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; cellular response to growth factor stimulus [GO:0071363]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein autophosphorylation [GO:0031952]; regulation of signaling receptor activity [GO:0010469]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0010469; GO:0010976; GO:0014066; GO:0019888; GO:0031334; GO:0031952; GO:0036498; GO:0045944; GO:0050730; GO:0051091; GO:0051388; GO:0051898; GO:0070317; GO:0071158; GO:0071363; GO:0072542	cellular response to growth factor stimulus [GO:0071363]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein autophosphorylation [GO:0031952]; regulation of signaling receptor activity [GO:0010469]		NA	NA	NA	NA	NA	NA
TRINITY_DN12649_c0_g1_i2	Q6PD28	2A5B_MOUSE	92.4	158	12	0	3	476	229	386	5.80E-80	298.1	2A5B_MOUSE	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B56-beta) (PP2A B subunit isoform PR61-beta) (PP2A B subunit isoform R5-beta)	Ppp2r5b	Mus musculus (Mouse)	497	cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; cellular response to growth factor stimulus [GO:0071363]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase activator activity [GO:0072542]	GO:0000159; GO:0001932; GO:0005634; GO:0005829; GO:0006470; GO:0007165; GO:0010469; GO:0010976; GO:0031334; GO:0031952; GO:0045944; GO:0050730; GO:0051091; GO:0051388; GO:0070317; GO:0071158; GO:0071363; GO:0072542	cellular response to growth factor stimulus [GO:0071363]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12649_c1_g1_i1	Q6PD28	2A5B_MOUSE	100	76	0	0	3	230	232	307	8.40E-37	153.7	2A5B_MOUSE	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B56-beta) (PP2A B subunit isoform PR61-beta) (PP2A B subunit isoform R5-beta)	Ppp2r5b	Mus musculus (Mouse)	497	cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; cellular response to growth factor stimulus [GO:0071363]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase activator activity [GO:0072542]	GO:0000159; GO:0001932; GO:0005634; GO:0005829; GO:0006470; GO:0007165; GO:0010469; GO:0010976; GO:0031334; GO:0031952; GO:0045944; GO:0050730; GO:0051091; GO:0051388; GO:0070317; GO:0071158; GO:0071363; GO:0072542	cellular response to growth factor stimulus [GO:0071363]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN27610_c0_g1_i1	Q14738	2A5D_HUMAN	56.5	154	67	0	3	464	282	435	1.90E-51	203.4	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN21739_c0_g1_i1	Q14738	2A5D_HUMAN	97.7	129	3	0	13	399	114	242	1.50E-68	260	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12649_c0_g1_i1	Q14738	2A5D_HUMAN	100	216	0	0	3	650	274	489	2.20E-122	439.5	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12649_c0_g1_i3	Q14738	2A5D_HUMAN	99.1	216	2	0	3	650	274	489	8.30E-122	437.6	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN35563_c0_g1_i1	Q14738	2A5D_HUMAN	63.6	44	16	0	237	106	557	600	4.80E-06	52	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN13300_c0_g1_i1	Q14738	2A5D_HUMAN	80.5	456	87	1	1371	10	67	522	3.30E-217	755.7	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN13300_c0_g1_i2	Q14738	2A5D_HUMAN	81.4	442	80	1	1329	10	81	522	8.40E-212	737.6	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN13300_c0_g1_i3	Q14738	2A5D_HUMAN	81.4	442	80	1	1329	10	81	522	1.10E-211	737.3	2A5D_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	602	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0010801; GO:0019888; GO:0031952; GO:0035307; GO:0072542	negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN6394_c0_g1_i1	A4FV68	2A5E_BOVIN	81.1	445	82	2	1622	294	11	455	1.10E-210	734.2	2A5E_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PP2A B subunit isoform B'-epsilon) (PP2A B subunit isoform B56-epsilon) (PP2A B subunit isoform PR61-epsilon) (PP2A B subunit isoform R5-epsilon)	PPP2R5E	Bos taurus (Bovine)	467	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase activator activity [GO:0072542]	GO:0000159; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0031952; GO:0072542	protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		blue	blue	NA	NA	NA	NA
TRINITY_DN27269_c0_g1_i1	A4FV68	2A5E_BOVIN	100	69	0	0	3	209	100	168	1.20E-34	146.4	2A5E_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PP2A B subunit isoform B'-epsilon) (PP2A B subunit isoform B56-epsilon) (PP2A B subunit isoform PR61-epsilon) (PP2A B subunit isoform R5-epsilon)	PPP2R5E	Bos taurus (Bovine)	467	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase activator activity [GO:0072542]	GO:0000159; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0031952; GO:0072542	protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN24973_c0_g1_i2	Q60996	2A5G_MOUSE	95.4	152	7	0	23	478	23	174	1.50E-80	300.1	2A5G_MOUSE	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-alpha-3) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma)	Ppp2r5c	Mus musculus (Mouse)	524	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"	protein phosphatase activator activity [GO:0072542]	GO:0000159; GO:0000775; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006470; GO:0007165; GO:0008285; GO:0031952; GO:0043161; GO:0072542	negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN24973_c0_g1_i1	Q28651	2A5G_RABIT	95.4	152	7	0	23	478	23	174	2.00E-80	299.7	2A5G_RABIT	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma)	PPP2R5C	Oryctolagus cuniculus (Rabbit)	524	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; signal transduction [GO:0007165]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000775; GO:0005634; GO:0007165; GO:0019888	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN23321_c0_g1_i1	Q13362	2A5G_HUMAN	100	189	0	0	568	2	202	390	1.20E-105	383.6	2A5G_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29)	PPP2R5C KIAA0044	Homo sapiens (Human)	524	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"	protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000775; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006470; GO:0006977; GO:0007165; GO:0008285; GO:0014066; GO:0019888; GO:0031952; GO:0042771; GO:0043161; GO:0051898; GO:0072542	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4303_c1_g1_i1	P30153	2AAA_HUMAN	70.8	48	11	1	138	4	341	388	9.40E-10	63.9	2AAA_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)	PPP2R1A	Homo sapiens (Human)	589	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]"	protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000086; GO:0000159; GO:0000184; GO:0000188; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007084; GO:0007143; GO:0008287; GO:0008380; GO:0010033; GO:0010389; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0097711; GO:0098978; GO:1903538; GO:1990405; GO:2001241	"apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4303_c0_g1_i1	P30153	2AAA_HUMAN	79.6	240	49	0	3	722	189	428	4.60E-105	382.1	2AAA_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)	PPP2R1A	Homo sapiens (Human)	589	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]"	protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000086; GO:0000159; GO:0000184; GO:0000188; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007084; GO:0007143; GO:0008287; GO:0008380; GO:0010033; GO:0010389; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0097711; GO:0098978; GO:1903538; GO:1990405; GO:2001241	"apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"		blue	blue	NA	NA	NA	NA
TRINITY_DN39817_c0_g1_i1	P30153	2AAA_HUMAN	100	233	0	0	699	1	194	426	1.70E-125	449.9	2AAA_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)	PPP2R1A	Homo sapiens (Human)	589	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]"	protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000086; GO:0000159; GO:0000184; GO:0000188; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007084; GO:0007143; GO:0008287; GO:0008380; GO:0010033; GO:0010389; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0097711; GO:0098978; GO:1903538; GO:1990405; GO:2001241	"apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37972_c0_g1_i1	P30154	2AAB_HUMAN	100	69	0	0	209	3	216	284	4.10E-30	131.3	2AAB_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta)	PPP2R1B	Homo sapiens (Human)	601	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005737; GO:0006470; GO:0008287; GO:0019888; GO:0045121; GO:0060561; GO:0070062; GO:2001241	apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN29088_c0_g1_i1	P30154	2AAB_HUMAN	100	91	0	0	3	275	288	378	3.90E-44	178.3	2AAB_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta)	PPP2R1B	Homo sapiens (Human)	601	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005737; GO:0006470; GO:0008287; GO:0019888; GO:0045121; GO:0060561; GO:0070062; GO:2001241	apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN37335_c0_g1_i1	Q7TNP2	2AAB_MOUSE	100	73	0	0	3	221	342	414	1.40E-33	142.9	2AAB_MOUSE	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta)	Ppp2r1b	Mus musculus (Mouse)	601	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; synapse [GO:0045202]; protein phosphatase regulator activity [GO:0019888]; apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; synapse [GO:0045202]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005737; GO:0006470; GO:0008287; GO:0019888; GO:0045121; GO:0045202; GO:0060561; GO:0098978; GO:2001241	apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN6199_c0_g1_i1	Q28717	PTPA_RABIT	55.2	299	134	0	123	1019	23	321	1.00E-98	362.1	PTPA_RABIT	reviewed	"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')"	PTPA PPP2R4	Oryctolagus cuniculus (Rabbit)	323	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]	GO:0000159; GO:0003755; GO:0005524; GO:0005634; GO:0005737; GO:0008160; GO:0019888; GO:0032515; GO:0032516; GO:0035307; GO:0035308; GO:0042803; GO:0043666; GO:0051721	negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN39504_c0_g1_i1	P58389	PTPA_MOUSE	100	89	0	0	3	269	133	221	6.20E-47	187.6	PTPA_MOUSE	reviewed	"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')"	Ptpa Ppp2r4	Mus musculus (Mouse)	323	calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666]	calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]	GO:0000159; GO:0003755; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0008160; GO:0016887; GO:0019888; GO:0032515; GO:0032516; GO:0034704; GO:0035307; GO:0035308; GO:0042803; GO:0043065; GO:0043666; GO:0051721	mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN29411_c0_g1_i1	P0CQ01	PTPA1_CRYNB	40.4	57	34	0	27	197	197	253	4.10E-06	51.6	PTPA1_CRYNB	reviewed	Serine/threonine-protein phosphatase 2A activator 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase PTPA-1) (PPIase PTPA-1) (Rotamase PTPA-1) (Phosphotyrosyl phosphatase activator 1)	RRD1 CNBK2750	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	362	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphatase activator activity [GO:0019211]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphatase activator activity [GO:0019211]	GO:0003755; GO:0005634; GO:0005737; GO:0019211			NA	NA	NA	NA	NA	NA
TRINITY_DN40383_c0_g1_i1	P0CQ03	PTPA2_CRYNB	56.2	64	25	1	228	37	164	224	3.60E-14	78.6	PTPA2_CRYNB	reviewed	Serine/threonine-protein phosphatase 2A activator 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase PTPA-2) (PPIase PTPA-2) (Rotamase PTPA-2) (Phosphotyrosyl phosphatase activator 2)	RRD2 CNBL1550	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	382	cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphatase activator activity [GO:0019211]	cytoplasm [GO:0005737]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphatase activator activity [GO:0019211]	GO:0003755; GO:0005737; GO:0019211			NA	NA	NA	NA	NA	NA
TRINITY_DN42_c0_g1_i1	G5EGK8	PP2A_CAEEL	61.1	296	115	0	910	23	23	318	1.50E-116	420.6	PP2A_CAEEL	reviewed	Serine/threonine-protein phosphatase 2A catalytic subunit (PP2A) (EC 3.1.3.16)	let-92 F38H4.9	Caenorhabditis elegans	318	axon [GO:0030424]; axonal growth cone [GO:0044295]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein phosphatase type 2A complex [GO:0000159]; DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; centrosome separation [GO:0051299]; meiotic spindle disassembly [GO:0051229]; mitotic centrosome separation [GO:0007100]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; pronuclear envelope synthesis [GO:0018985]	axon [GO:0030424]; axonal growth cone [GO:0044295]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein phosphatase type 2A complex [GO:0000159]	DEAD/H-box RNA helicase binding [GO:0017151]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0000159; GO:0004721; GO:0005737; GO:0005813; GO:0007052; GO:0007084; GO:0007100; GO:0017151; GO:0018985; GO:0030424; GO:0043025; GO:0043204; GO:0044295; GO:0046872; GO:0051229; GO:0051299	centrosome separation [GO:0051299]; meiotic spindle disassembly [GO:0051229]; mitotic centrosome separation [GO:0007100]; mitotic nuclear envelope reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; pronuclear envelope synthesis [GO:0018985]		NA	NA	NA	NA	NA	NA
TRINITY_DN4568_c1_g1_i1	P67774	PP2AA_BOVIN	76.3	291	65	1	11	883	23	309	7.80E-139	494.6	PP2AA_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)	PPP2CA	Bos taurus (Bovine)	309	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]"	GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000159; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008022; GO:0010719; GO:0035970; GO:0045121; GO:0046872; GO:0046982; GO:0050811; GO:0051321; GO:0071902	meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]		NA	NA	NA	NA	NA	NA
TRINITY_DN161_c0_g2_i1	P67774	PP2AA_BOVIN	93.5	309	20	0	1026	100	1	309	2.40E-177	622.9	PP2AA_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)	PPP2CA	Bos taurus (Bovine)	309	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]"	GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000159; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008022; GO:0010719; GO:0035970; GO:0045121; GO:0046872; GO:0046982; GO:0050811; GO:0051321; GO:0071902	meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]		blue	blue	NA	NA	NA	NA
TRINITY_DN10559_c0_g1_i1	P67774	PP2AA_BOVIN	100	309	0	0	31	957	1	309	1.20E-188	660.2	PP2AA_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)	PPP2CA	Bos taurus (Bovine)	309	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]"	GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000159; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008022; GO:0010719; GO:0035970; GO:0045121; GO:0046872; GO:0046982; GO:0050811; GO:0051321; GO:0071902	meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]		NA	NA	NA	NA	NA	NA
TRINITY_DN10559_c0_g1_i2	P67774	PP2AA_BOVIN	100	309	0	0	31	957	1	309	1.20E-188	660.2	PP2AA_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)	PPP2CA	Bos taurus (Bovine)	309	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]"	GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000159; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008022; GO:0010719; GO:0035970; GO:0045121; GO:0046872; GO:0046982; GO:0050811; GO:0051321; GO:0071902	meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of protein serine/threonine kinase activity [GO:0071902]		NA	NA	NA	NA	NA	NA
TRINITY_DN6203_c0_g1_i1	P48463	PP2AA_CHICK	72.1	290	80	1	4	870	20	309	2.70E-134	479.6	PP2AA_CHICK	reviewed	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)	PPP2CA	Gallus gallus (Chicken)	309	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic mitochondrial changes [GO:0008637]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; response to antibiotic [GO:0046677]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]"	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000159; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005737; GO:0008637; GO:0010468; GO:0034976; GO:0042542; GO:0043161; GO:0046677; GO:0046872; GO:0046982	apoptotic mitochondrial changes [GO:0008637]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; response to antibiotic [GO:0046677]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]		NA	NA	NA	NA	NA	NA
TRINITY_DN10305_c0_g1_i1	Q06190	P2R3A_HUMAN	62.9	428	151	5	1552	281	695	1118	7.20E-154	545.4	P2R3A_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B)	PPP2R3A PPP2R3	Homo sapiens (Human)	1150	protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell motility involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	protein phosphatase type 2A complex [GO:0000159]	calcium ion binding [GO:0005509]; protein-macromolecule adaptor activity [GO:0030674]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263	eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell motility involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]		NA	NA	NA	NA	NA	NA
TRINITY_DN10305_c0_g1_i2	Q06190	P2R3A_HUMAN	79.2	48	10	0	191	48	979	1026	8.10E-17	87.4	P2R3A_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B)	PPP2R3A PPP2R3	Homo sapiens (Human)	1150	protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell motility involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	protein phosphatase type 2A complex [GO:0000159]	calcium ion binding [GO:0005509]; protein-macromolecule adaptor activity [GO:0030674]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263	eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell motility involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]		NA	NA	NA	NA	NA	NA
TRINITY_DN26390_c0_g1_i1	Q9Y5P8	P2R3B_HUMAN	100	87	0	0	264	4	356	442	1.80E-46	186	P2R3B_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit)	PPP2R3B PPP2R3L	Homo sapiens (Human)	575	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; cell cycle arrest [GO:0007050]; protein dephosphorylation [GO:0006470]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005509; GO:0005634; GO:0005654; GO:0006470; GO:0007050; GO:0019888	cell cycle arrest [GO:0007050]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN38050_c0_g1_i1	Q5E9G1	P2R3C_BOVIN	65.9	88	30	0	2	265	162	249	1.30E-25	116.7	P2R3C_BOVIN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	PPP2R3C	Bos taurus (Bovine)	453	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	metal ion binding [GO:0046872]	GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900	activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN5485_c0_g1_i1	Q969Q6	P2R3C_HUMAN	72.6	456	119	2	85	1452	1	450	1.70E-192	673.7	P2R3C_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C)	PPP2R3C C14orf10 G5PR	Homo sapiens (Human)	453	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	metal ion binding [GO:0046872]	GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900	activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN5485_c0_g1_i2	Q969Q6	P2R3C_HUMAN	72.6	456	119	2	85	1452	1	450	1.70E-192	673.7	P2R3C_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C)	PPP2R3C C14orf10 G5PR	Homo sapiens (Human)	453	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	metal ion binding [GO:0046872]	GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900	activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN24813_c0_g1_i1	Q969Q6	P2R3C_HUMAN	100	401	0	0	2	1204	53	453	3.40E-233	808.5	P2R3C_HUMAN	reviewed	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C)	PPP2R3C C14orf10 G5PR	Homo sapiens (Human)	453	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	metal ion binding [GO:0046872]	GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900	activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN31406_c0_g1_i1	Q12705	PP2B_SCHPO	58.8	80	32	1	245	6	93	171	1.10E-21	103.6	PP2B_SCHPO	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit (EC 3.1.3.16)	ppb1 SPBC1346.01c SPBP4H10.04	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	554	"calcineurin complex [GO:0005955]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic actomyosin contractile ring [GO:0110085]; mitotic actomyosin contractile ring, intermediate layer [GO:0120105]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; calcineurin-mediated signaling [GO:0097720]; cellular response to calcium ion [GO:0071277]; fungal-type cell wall organization [GO:0031505]; fungal-type cell wall organization or biogenesis [GO:0071852]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; positive regulation of mitotic actomyosin contractile ring contraction [GO:1903473]; positive regulation of mitotic division septum assembly [GO:0140281]; regulation of cell shape [GO:0008360]"	"calcineurin complex [GO:0005955]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic actomyosin contractile ring [GO:0110085]; mitotic actomyosin contractile ring, intermediate layer [GO:0120105]"	calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0004723; GO:0005516; GO:0005737; GO:0005829; GO:0005955; GO:0008360; GO:0031505; GO:0032153; GO:0033192; GO:0046872; GO:0071277; GO:0071852; GO:0097720; GO:0110085; GO:0120105; GO:0140281; GO:1903473; GO:1905949	calcineurin-mediated signaling [GO:0097720]; cellular response to calcium ion [GO:0071277]; fungal-type cell wall organization [GO:0031505]; fungal-type cell wall organization or biogenesis [GO:0071852]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; positive regulation of mitotic actomyosin contractile ring contraction [GO:1903473]; positive regulation of mitotic division septum assembly [GO:0140281]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN16757_c0_g1_i1	Q0G819	PP2B_CAEEL	70.6	102	30	0	306	1	300	401	1.50E-36	153.3	PP2B_CAEEL	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit (EC 3.1.3.16) (Abnormal chemotaxis protein 6) (Calmodulin-dependent calcineurin subunit A)	tax-6 cna-1 C02F4.2	Caenorhabditis elegans	542	axon [GO:0030424]; calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; phosphoprotein phosphatase activity [GO:0004721]; calcineurin-mediated signaling [GO:0097720]; calcium-mediated signaling [GO:0019722]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; hyperosmotic response [GO:0006972]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of growth rate [GO:0040010]; positive regulation of multicellular organism growth [GO:0040018]; protein dephosphorylation [GO:0006470]; protein localization to non-motile cilium [GO:0097499]; regulation of gene expression [GO:0010468]; response to alkaline pH [GO:0010446]; response to hermaphrodite contact [GO:0034606]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; vulval location [GO:0034608]	axon [GO:0030424]; calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; perikaryon [GO:0043204]	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0005509; GO:0005516; GO:0005634; GO:0005737; GO:0005955; GO:0006470; GO:0006897; GO:0006935; GO:0006972; GO:0007635; GO:0008340; GO:0008355; GO:0010446; GO:0010468; GO:0019722; GO:0030424; GO:0030425; GO:0033192; GO:0034606; GO:0034608; GO:0040010; GO:0040018; GO:0040024; GO:0040040; GO:0042048; GO:0043025; GO:0043052; GO:0043204; GO:0070262; GO:0097499; GO:0097720; GO:0097730	calcineurin-mediated signaling [GO:0097720]; calcium-mediated signaling [GO:0019722]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; hyperosmotic response [GO:0006972]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of growth rate [GO:0040010]; positive regulation of multicellular organism growth [GO:0040018]; protein dephosphorylation [GO:0006470]; protein localization to non-motile cilium [GO:0097499]; regulation of gene expression [GO:0010468]; response to alkaline pH [GO:0010446]; response to hermaphrodite contact [GO:0034606]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; vulval location [GO:0034608]		NA	NA	NA	NA	NA	NA
TRINITY_DN6912_c0_g1_i1	Q7YSW8	PP2BA_DICDI	67.6	74	24	0	230	9	310	383	2.80E-24	112.1	PP2BA_DICDI	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit (EC 3.1.3.16) (Calcineurin subunit A)	canA DDB_G0276883	Dictyostelium discoideum (Slime mold)	623	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; protein dephosphorylation [GO:0006470]; regulation of sorocarp development [GO:0031156]; response to cation stress [GO:0043157]; response to differentiation-inducing factor 1 [GO:1903013]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005516; GO:0005737; GO:0005955; GO:0006470; GO:0031149; GO:0031156; GO:0033192; GO:0043157; GO:0044671; GO:0046872; GO:0097720; GO:1903013	calcineurin-mediated signaling [GO:0097720]; protein dephosphorylation [GO:0006470]; regulation of sorocarp development [GO:0031156]; response to cation stress [GO:0043157]; response to differentiation-inducing factor 1 [GO:1903013]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149]		NA	NA	NA	NA	NA	NA
TRINITY_DN15068_c0_g1_i1	Q7YSW8	PP2BA_DICDI	71.2	59	17	0	221	45	230	288	5.20E-20	97.8	PP2BA_DICDI	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit (EC 3.1.3.16) (Calcineurin subunit A)	canA DDB_G0276883	Dictyostelium discoideum (Slime mold)	623	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; protein dephosphorylation [GO:0006470]; regulation of sorocarp development [GO:0031156]; response to cation stress [GO:0043157]; response to differentiation-inducing factor 1 [GO:1903013]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005516; GO:0005737; GO:0005955; GO:0006470; GO:0031149; GO:0031156; GO:0033192; GO:0043157; GO:0044671; GO:0046872; GO:0097720; GO:1903013	calcineurin-mediated signaling [GO:0097720]; protein dephosphorylation [GO:0006470]; regulation of sorocarp development [GO:0031156]; response to cation stress [GO:0043157]; response to differentiation-inducing factor 1 [GO:1903013]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149]		NA	NA	NA	NA	NA	NA
TRINITY_DN14487_c0_g1_i2	Q9VXF1	PP2B3_DROME	90.9	439	36	1	1838	534	124	562	5.20E-238	825.1	PP2B3_DROME	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit 3 (EC 3.1.3.16) (Calmodulin-dependent calcineurin A3 subunit)	CanA-14F CnnA14D CG9819	Drosophila melanogaster (Fruit fly)	584	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005516; GO:0005737; GO:0005955; GO:0030431; GO:0033192; GO:0046872; GO:0097720	calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN14487_c0_g1_i3	Q9VXF1	PP2B3_DROME	90.9	439	36	1	1855	551	124	562	5.30E-238	825.1	PP2B3_DROME	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit 3 (EC 3.1.3.16) (Calmodulin-dependent calcineurin A3 subunit)	CanA-14F CnnA14D CG9819	Drosophila melanogaster (Fruit fly)	584	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005516; GO:0005737; GO:0005955; GO:0030431; GO:0033192; GO:0046872; GO:0097720	calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]		blue	blue	NA	NA	NA	NA
TRINITY_DN14487_c0_g1_i4	Q9VXF1	PP2B3_DROME	90.4	439	40	1	1819	509	124	562	2.30E-238	826.2	PP2B3_DROME	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit 3 (EC 3.1.3.16) (Calmodulin-dependent calcineurin A3 subunit)	CanA-14F CnnA14D CG9819	Drosophila melanogaster (Fruit fly)	584	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005516; GO:0005737; GO:0005955; GO:0030431; GO:0033192; GO:0046872; GO:0097720	calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN14487_c1_g1_i1	P48452	PP2BA_BOVIN	100	70	0	0	3	212	65	134	5.10E-36	151	PP2BA_BOVIN	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)	PPP3CA	Bos taurus (Bovine)	521	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470]; response to calcium ion [GO:0051592]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0005516; GO:0005737; GO:0005829; GO:0005955; GO:0006470; GO:0016311; GO:0030018; GO:0033173; GO:0033192; GO:0042383; GO:0043197; GO:0046872; GO:0051592; GO:0097720	calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN14487_c1_g2_i1	P63328	PP2BA_MOUSE	95.1	370	8	1	2	1081	145	514	6.50E-204	711.1	PP2BA_MOUSE	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha)	Ppp3ca Calna	Mus musculus (Mouse)	521	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; dephosphorylation [GO:0016311]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; Z disc [GO:0030018]	ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000082; GO:0001975; GO:0004721; GO:0004722; GO:0004723; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0007420; GO:0007568; GO:0008144; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0016018; GO:0016311; GO:0019722; GO:0019899; GO:0030018; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0036057; GO:0042383; GO:0043197; GO:0044877; GO:0045202; GO:0045785; GO:0045807; GO:0045944; GO:0046676; GO:0046872; GO:0046983; GO:0048741; GO:0050774; GO:0050804; GO:0051091; GO:0051117; GO:0051592; GO:0060079; GO:0070262; GO:0071333; GO:0097720; GO:0098685; GO:0098978; GO:0099170; GO:1903244; GO:1903799; GO:1905205	aging [GO:0007568]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; dephosphorylation [GO:0016311]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883]		NA	NA	NA	NA	NA	NA
TRINITY_DN32326_c0_g1_i1	P16298	PP2BB_HUMAN	100	75	0	0	3	227	321	395	1.80E-39	162.5	PP2BB_HUMAN	reviewed	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta)	PPP3CB CALNA2 CALNB CNA2	Homo sapiens (Human)	524	"calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007223; GO:0007507; GO:0007612; GO:0007613; GO:0016311; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035774; GO:0038095; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0050796; GO:0097720; GO:0098978; GO:1900242	"axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16263_c0_g1_i1	P48454	PP2BC_HUMAN	99	102	1	0	309	4	60	161	4.90E-56	218	PP2BC_HUMAN	reviewed	"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)"	PPP3CC CALNA3 CNA3	Homo sapiens (Human)	512	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynaptic cytosol [GO:0099523]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynaptic cytosol [GO:0099523]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0005516; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0007420; GO:0033173; GO:0033192; GO:0046872; GO:0097720; GO:0098978; GO:0099523; GO:1900244; GO:1900740	brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN15068_c0_g2_i1	P48455	PP2BC_MOUSE	68.5	111	35	0	3	335	264	374	4.50E-40	165.2	PP2BC_MOUSE	reviewed	"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)"	Ppp3cc Calnc	Mus musculus (Mouse)	513	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]; regulation of synaptic vesicle endocytosis [GO:1900242]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0005516; GO:0005737; GO:0005955; GO:0006470; GO:0007420; GO:0033173; GO:0033192; GO:0046872; GO:0097720; GO:0098793; GO:0098978; GO:0099523; GO:1900242; GO:1900244	brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]; regulation of synaptic vesicle endocytosis [GO:1900242]		NA	NA	NA	NA	NA	NA
TRINITY_DN37623_c0_g1_i1	P48454	PP2BC_HUMAN	100	133	0	0	401	3	170	302	1.70E-77	289.7	PP2BC_HUMAN	reviewed	"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)"	PPP3CC CALNA3 CNA3	Homo sapiens (Human)	512	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynaptic cytosol [GO:0099523]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynaptic cytosol [GO:0099523]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0005516; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0007420; GO:0033173; GO:0033192; GO:0046872; GO:0097720; GO:0098978; GO:0099523; GO:1900244; GO:1900740	brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN27053_c0_g1_i1	P48454	PP2BC_HUMAN	100	195	0	0	2	586	313	507	3.40E-106	385.6	PP2BC_HUMAN	reviewed	"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)"	PPP3CC CALNA3 CNA3	Homo sapiens (Human)	512	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynaptic cytosol [GO:0099523]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynaptic cytosol [GO:0099523]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0005516; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0007420; GO:0033173; GO:0033192; GO:0046872; GO:0097720; GO:0098978; GO:0099523; GO:1900244; GO:1900740	brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN15374_c0_g2_i1	A6H772	PP4C_BOVIN	100	281	0	0	48	890	1	281	4.70E-168	591.7	PP4C_BOVIN	reviewed	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16)	PPP4C	Bos taurus (Bovine)	307	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein phosphorylation [GO:0006468]; regulation of double-strand break repair via homologous recombination [GO:0010569]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0006468; GO:0010569; GO:0030289; GO:0046872	protein phosphorylation [GO:0006468]; regulation of double-strand break repair via homologous recombination [GO:0010569]		NA	NA	NA	NA	NA	NA
TRINITY_DN15374_c0_g1_i1	A6H772	PP4C_BOVIN	100	307	0	0	48	968	1	307	3.00E-184	645.6	PP4C_BOVIN	reviewed	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16)	PPP4C	Bos taurus (Bovine)	307	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein phosphorylation [GO:0006468]; regulation of double-strand break repair via homologous recombination [GO:0010569]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0006468; GO:0010569; GO:0030289; GO:0046872	protein phosphorylation [GO:0006468]; regulation of double-strand break repair via homologous recombination [GO:0010569]		NA	NA	NA	NA	NA	NA
TRINITY_DN38752_c0_g1_i1	Q6IP91	PP4C_XENLA	76.8	297	59	1	895	5	4	290	8.60E-141	501.1	PP4C_XENLA	reviewed	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16)	ppp4c	Xenopus laevis (African clawed frog)	307	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0005634; GO:0005737; GO:0005815; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN161_c0_g1_i1	A9JRC7	PP4CB_DANRE	93.2	307	21	0	937	17	1	307	4.70E-173	608.6	PP4CB_DANRE	reviewed	Serine/threonine-protein phosphatase 4 catalytic subunit B (PP4C-B) (EC 3.1.3.16)	ppp4cb zgc:172126	Danio rerio (Zebrafish) (Brachydanio rerio)	307	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of BMP signaling pathway [GO:0030513]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0005737; GO:0005815; GO:0009953; GO:0030513; GO:0046872; GO:0048264	determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of BMP signaling pathway [GO:0030513]		blue	blue	NA	NA	NA	NA
TRINITY_DN19874_c2_g1_i1	A9JRC7	PP4CB_DANRE	95.9	49	2	0	2	148	153	201	1.30E-21	103.2	PP4CB_DANRE	reviewed	Serine/threonine-protein phosphatase 4 catalytic subunit B (PP4C-B) (EC 3.1.3.16)	ppp4cb zgc:172126	Danio rerio (Zebrafish) (Brachydanio rerio)	307	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of BMP signaling pathway [GO:0030513]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0005737; GO:0005815; GO:0009953; GO:0030513; GO:0046872; GO:0048264	determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of BMP signaling pathway [GO:0030513]		NA	NA	NA	NA	NA	NA
TRINITY_DN64_c0_g1_i1	Q8TF05	PP4R1_HUMAN	52.8	316	149	0	1294	2241	614	929	2.10E-90	335.1	PP4R1_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 1	PPP4R1 MEG1 PP4R1	Homo sapiens (Human)	950	protein phosphatase 4 complex [GO:0030289]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	protein phosphatase 4 complex [GO:0030289]; protein serine/threonine phosphatase complex [GO:0008287]	protein phosphatase regulator activity [GO:0019888]	GO:0006468; GO:0006470; GO:0007165; GO:0008287; GO:0019888; GO:0030289	protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38337_c0_g1_i1	Q8TF05	PP4R1_HUMAN	100	68	0	0	1	204	195	262	4.10E-35	147.9	PP4R1_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 1	PPP4R1 MEG1 PP4R1	Homo sapiens (Human)	950	protein phosphatase 4 complex [GO:0030289]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	protein phosphatase 4 complex [GO:0030289]; protein serine/threonine phosphatase complex [GO:0008287]	protein phosphatase regulator activity [GO:0019888]	GO:0006468; GO:0006470; GO:0007165; GO:0008287; GO:0019888; GO:0030289	protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7521_c0_g1_i1	Q8TF05	PP4R1_HUMAN	59.3	167	67	1	1	498	169	335	2.00E-54	213.8	PP4R1_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 1	PPP4R1 MEG1 PP4R1	Homo sapiens (Human)	950	protein phosphatase 4 complex [GO:0030289]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	protein phosphatase 4 complex [GO:0030289]; protein serine/threonine phosphatase complex [GO:0008287]	protein phosphatase regulator activity [GO:0019888]	GO:0006468; GO:0006470; GO:0007165; GO:0008287; GO:0019888; GO:0030289	protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4610_c0_g1_i1	Q9W2U4	PP4R2_DROME	39.9	158	93	1	798	331	4	161	4.80E-32	139.8	PP4R2_DROME	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PPP4R2-related protein)	PPP4R2r CG2890	Drosophila melanogaster (Fruit fly)	609	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; protein dephosphorylation [GO:0006470]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]"	protein phosphatase regulator activity [GO:0019888]	GO:0000278; GO:0000775; GO:0005634; GO:0005737; GO:0006470; GO:0019888; GO:0030289; GO:0045879	mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN4610_c0_g1_i2	Q9W2U4	PP4R2_DROME	39.9	158	93	1	849	382	4	161	5.10E-32	139.8	PP4R2_DROME	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PPP4R2-related protein)	PPP4R2r CG2890	Drosophila melanogaster (Fruit fly)	609	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; protein dephosphorylation [GO:0006470]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]"	protein phosphatase regulator activity [GO:0019888]	GO:0000278; GO:0000775; GO:0005634; GO:0005737; GO:0006470; GO:0019888; GO:0030289; GO:0045879	mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i1	Q9VFS5	PP4R3_DROME	52	75	36	0	623	399	568	642	1.50E-16	87.8	PP4R3_DROME	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3 (PP4R3) (Protein falafel)	flfl CG9351	Drosophila melanogaster (Fruit fly)	980	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]"		GO:0000775; GO:0005634; GO:0005737; GO:0006281; GO:0016020; GO:0030289; GO:0045175; GO:0055059	asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN492_c0_g1_i4	Q9VFS5	PP4R3_DROME	47.5	99	47	2	291	1	568	663	7.70E-19	94.4	PP4R3_DROME	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3 (PP4R3) (Protein falafel)	flfl CG9351	Drosophila melanogaster (Fruit fly)	980	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]"		GO:0000775; GO:0005634; GO:0005737; GO:0006281; GO:0016020; GO:0030289; GO:0045175; GO:0055059	asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]		blue	blue	NA	NA	NA	NA
TRINITY_DN937_c0_g2_i1	Q9VFS5	PP4R3_DROME	81	174	33	0	5	526	12	185	2.00E-81	303.1	PP4R3_DROME	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3 (PP4R3) (Protein falafel)	flfl CG9351	Drosophila melanogaster (Fruit fly)	980	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]"		GO:0000775; GO:0005634; GO:0005737; GO:0006281; GO:0016020; GO:0030289; GO:0045175; GO:0055059	asymmetric neuroblast division [GO:0055059]; basal protein localization [GO:0045175]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN25314_c0_g1_i1	Q6IN85	P4R3A_HUMAN	100	110	0	0	333	4	28	137	1.10E-56	220.3	P4R3A_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1)	PPP4R3A KIAA2010 PP4R3A SMEK1 MSTP033	Homo sapiens (Human)	833	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005815; GO:0005829; GO:0016607			NA	NA	NA	NA	NA	NA
TRINITY_DN25314_c0_g1_i2	Q6IN85	P4R3A_HUMAN	100	120	0	0	363	4	18	137	3.40E-64	245.4	P4R3A_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1)	PPP4R3A KIAA2010 PP4R3A SMEK1 MSTP033	Homo sapiens (Human)	833	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005815; GO:0005829; GO:0016607			NA	NA	NA	NA	NA	NA
TRINITY_DN8908_c0_g1_i1	Q7ZX60	P4R3A_XENLA	70.6	102	27	1	311	6	251	349	1.60E-33	143.3	P4R3A_XENLA	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3-A (SMEK homolog 2-A)	ppp4r3b-a smek2-a	Xenopus laevis (African clawed frog)	820							NA	NA	NA	NA	NA	NA
TRINITY_DN8908_c0_g1_i2	Q7ZX60	P4R3A_XENLA	67.4	92	27	1	278	3	250	338	5.40E-27	122.1	P4R3A_XENLA	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3-A (SMEK homolog 2-A)	ppp4r3b-a smek2-a	Xenopus laevis (African clawed frog)	820							NA	NA	NA	NA	NA	NA
TRINITY_DN8908_c0_g1_i3	Q7ZX60	P4R3A_XENLA	65.9	185	60	1	586	32	227	408	3.20E-64	246.1	P4R3A_XENLA	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3-A (SMEK homolog 2-A)	ppp4r3b-a smek2-a	Xenopus laevis (African clawed frog)	820							NA	NA	NA	NA	NA	NA
TRINITY_DN27718_c0_g1_i1	Q5MIZ7	P4R3B_HUMAN	99.2	121	1	0	6	368	32	152	2.10E-61	236.1	P4R3B_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2)	PPP4R3B KIAA1387 PP4R3B SMEK2	Homo sapiens (Human)	849	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of lipid metabolic process [GO:0019216]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]		GO:0005654; GO:0005737; GO:0005813; GO:0006470; GO:0016607; GO:0019216; GO:0030289; GO:0045722	positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN23428_c0_g1_i1	Q5MIZ7	P4R3B_HUMAN	100	76	0	0	228	1	39	114	3.80E-37	154.8	P4R3B_HUMAN	reviewed	Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2)	PPP4R3B KIAA1387 PP4R3B SMEK2	Homo sapiens (Human)	849	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of lipid metabolic process [GO:0019216]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]		GO:0005654; GO:0005737; GO:0005813; GO:0006470; GO:0016607; GO:0019216; GO:0030289; GO:0045722	positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of lipid metabolic process [GO:0019216]		NA	NA	NA	NA	NA	NA
TRINITY_DN13880_c0_g1_i1	Q9NES8	PPP5_CAEEL	69.5	246	75	0	6	743	235	480	4.60E-108	392.1	PPP5_CAEEL	reviewed	Serine/threonine-protein phosphatase 5 (EC 3.1.3.16)	pph-5 Y39B6A.2	Caenorhabditis elegans	496	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of exocytosis [GO:0045920]; protein localization to organelle [GO:0033365]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004721; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0032991; GO:0033365; GO:0045920; GO:0046872; GO:0051879; GO:0072686	negative regulation of exocytosis [GO:0045920]; protein localization to organelle [GO:0033365]		NA	NA	NA	NA	NA	NA
TRINITY_DN33250_c0_g1_i1	Q84K11	PPP5_SOLLC	67.6	148	48	0	4	447	380	527	1.50E-53	210.3	PPP5_SOLLC	reviewed	Serine/threonine-protein phosphatase 5 (EC 3.1.3.16) (LePP5)	PP5	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	556	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005789; GO:0005829; GO:0016021; GO:0016607; GO:0031965; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN38893_c0_g1_i1	Q84K11	PPP5_SOLLC	74.7	75	19	0	1	225	297	371	2.90E-29	128.6	PPP5_SOLLC	reviewed	Serine/threonine-protein phosphatase 5 (EC 3.1.3.16) (LePP5)	PP5	Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	556	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005789; GO:0005829; GO:0016021; GO:0016607; GO:0031965; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13880_c0_g1_i2	P53041	PPP5_HUMAN	65.4	52	18	0	72	227	299	350	5.50E-14	78.2	PPP5_HUMAN	reviewed	Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)	PPP5C PPP5	Homo sapiens (Human)	499	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0044877; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324	"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37456_c0_g1_i1	P53041	PPP5_HUMAN	100	110	0	0	1	330	348	457	2.90E-62	238.8	PPP5_HUMAN	reviewed	Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)	PPP5C PPP5	Homo sapiens (Human)	499	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0044877; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324	"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20015_c0_g1_i1	P53041	PPP5_HUMAN	100	106	0	0	3	320	237	342	1.10E-58	226.9	PPP5_HUMAN	reviewed	Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)	PPP5C PPP5	Homo sapiens (Human)	499	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0044877; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324	"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20015_c0_g1_i2	P53041	PPP5_HUMAN	100	106	0	0	3	320	237	342	1.10E-58	226.9	PPP5_HUMAN	reviewed	Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)	PPP5C PPP5	Homo sapiens (Human)	499	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0044877; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324	"cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15179_c0_g1_i1	Q9CQR6	PPP6_MOUSE	78.2	293	64	0	3	881	13	305	1.60E-145	516.9	PPP6_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16)	Ppp6c	Mus musculus (Mouse)	305	cytosol [GO:0005829]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0007049; GO:0045087; GO:0046872	cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN15179_c0_g1_i2	Q9CQR6	PPP6_MOUSE	80.4	92	18	0	3	278	13	104	7.30E-40	164.5	PPP6_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16)	Ppp6c	Mus musculus (Mouse)	305	cytosol [GO:0005829]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0007049; GO:0045087; GO:0046872	cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN23286_c0_g1_i1	O00743	PPP6_HUMAN	100	69	0	0	2	208	208	276	2.00E-37	155.6	PPP6_HUMAN	reviewed	"Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]"	PPP6C PPP6	Homo sapiens (Human)	305	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000082; GO:0000139; GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208	COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN23286_c0_g1_i2	O00743	PPP6_HUMAN	100	98	0	0	2	295	208	305	6.70E-55	214.2	PPP6_HUMAN	reviewed	"Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]"	PPP6C PPP6	Homo sapiens (Human)	305	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000082; GO:0000139; GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208	COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN23063_c0_g1_i1	O00743	PPP6_HUMAN	100	178	0	0	535	2	29	206	4.80E-107	388.3	PPP6_HUMAN	reviewed	"Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]"	PPP6C PPP6	Homo sapiens (Human)	305	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000082; GO:0000139; GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208	COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN23063_c0_g1_i2	O00743	PPP6_HUMAN	100	192	0	0	577	2	15	206	2.70E-116	419.1	PPP6_HUMAN	reviewed	"Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]"	PPP6C PPP6	Homo sapiens (Human)	305	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000082; GO:0000139; GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208	COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN2380_c0_g1_i1	Q505D1	ANR28_MOUSE	30.3	264	163	4	853	83	222	471	4.20E-23	110.5	ANR28_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	Ankrd28	Mus musculus (Mouse)	1053	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2380_c0_g1_i2	Q505D1	ANR28_MOUSE	30.3	264	163	4	853	83	222	471	4.30E-23	110.2	ANR28_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	Ankrd28	Mus musculus (Mouse)	1053	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN2380_c0_g1_i3	Q505D1	ANR28_MOUSE	30.2	265	164	4	856	83	221	471	6.80E-23	109.8	ANR28_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	Ankrd28	Mus musculus (Mouse)	1053	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN135_c0_g1_i1	O15084	ANR28_HUMAN	30.8	682	438	14	2064	76	9	675	7.90E-69	263.5	ANR28_HUMAN	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	ANKRD28 KIAA0379	Homo sapiens (Human)	1053	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]		GO:0000139; GO:0005654; GO:0005829; GO:0048208	COPII vesicle coating [GO:0048208]		NA	NA	NA	NA	NA	NA
TRINITY_DN1118_c0_g1_i1	Q5F478	ANR44_CHICK	24	775	533	16	211	2436	45	796	1.40E-21	107.1	ANR44_CHICK	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)	ANKRD44 RCJMB04_2g14	Gallus gallus (Chicken)	990							NA	NA	NA	NA	NA	NA
TRINITY_DN1118_c0_g1_i6	Q5F478	ANR44_CHICK	24	775	533	16	211	2436	45	796	1.40E-21	107.1	ANR44_CHICK	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)	ANKRD44 RCJMB04_2g14	Gallus gallus (Chicken)	990							NA	NA	NA	NA	NA	NA
TRINITY_DN1118_c0_g1_i7	Q5F478	ANR44_CHICK	24	775	533	16	211	2436	45	796	9.90E-22	107.1	ANR44_CHICK	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)	ANKRD44 RCJMB04_2g14	Gallus gallus (Chicken)	990							NA	NA	NA	NA	NA	NA
TRINITY_DN1118_c0_g1_i9	Q5F478	ANR44_CHICK	24	775	533	16	211	2436	45	796	9.90E-22	107.1	ANR44_CHICK	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)	ANKRD44 RCJMB04_2g14	Gallus gallus (Chicken)	990							NA	NA	NA	NA	NA	NA
TRINITY_DN7905_c0_g2_i4	Q5F478	ANR44_CHICK	28.1	146	94	5	710	297	209	351	6.50E-09	62.8	ANR44_CHICK	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)	ANKRD44 RCJMB04_2g14	Gallus gallus (Chicken)	990							NA	NA	NA	NA	NA	NA
TRINITY_DN36920_c0_g1_i1	Q5F478	ANR44_CHICK	43.7	71	39	1	9	221	142	211	3.90E-07	55.1	ANR44_CHICK	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)	ANKRD44 RCJMB04_2g14	Gallus gallus (Chicken)	990							NA	NA	NA	NA	NA	NA
TRINITY_DN3847_c0_g1_i13	Q502K3	ANR52_DANRE	23.6	275	167	8	1109	285	133	364	4.70E-07	57.4	ANR52_DANRE	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)	ankrd52 zgc:112069	Danio rerio (Zebrafish) (Brachydanio rerio)	1071							NA	NA	NA	NA	NA	NA
TRINITY_DN38541_c0_g1_i1	Q9UPN7	PP6R1_HUMAN	100	110	0	0	332	3	96	205	5.80E-55	214.5	PP6R1_HUMAN	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 1 (SAPS domain family member 1)	PPP6R1 KIAA1115 PP6R1 SAPS1	Homo sapiens (Human)	881	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; Rho GTPase binding [GO:0017048]; COPII vesicle coating [GO:0048208]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; Rho GTPase binding [GO:0017048]	GO:0000139; GO:0005634; GO:0005829; GO:0017048; GO:0019888; GO:0019903; GO:0043666; GO:0048208	COPII vesicle coating [GO:0048208]; regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN34034_c0_g1_i1	Q9UPN7	PP6R1_HUMAN	100	75	0	0	2	226	369	443	5.70E-38	157.5	PP6R1_HUMAN	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 1 (SAPS domain family member 1)	PPP6R1 KIAA1115 PP6R1 SAPS1	Homo sapiens (Human)	881	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; Rho GTPase binding [GO:0017048]; COPII vesicle coating [GO:0048208]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; Rho GTPase binding [GO:0017048]	GO:0000139; GO:0005634; GO:0005829; GO:0017048; GO:0019888; GO:0019903; GO:0043666; GO:0048208	COPII vesicle coating [GO:0048208]; regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN27541_c0_g1_i1	O75170	PP6R2_HUMAN	100	98	0	0	2	295	109	206	4.20E-49	194.9	PP6R2_HUMAN	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2)	PPP6R2 KIAA0685 PP6R2 SAPS2	Homo sapiens (Human)	966	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043231; GO:0043666	regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN644_c0_g1_i1	Q922D4	PP6R3_MOUSE	38.7	763	378	17	2715	514	1	702	6.40E-118	426.8	PP6R3_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)	Ppp6r3 D19Ertd703e Kiaa1558 Pp6r3 Saps3	Mus musculus (Mouse)	844	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666	regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN644_c0_g1_i3	Q922D4	PP6R3_MOUSE	42	583	291	10	2910	1195	1	547	1.20E-114	416	PP6R3_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)	Ppp6r3 D19Ertd703e Kiaa1558 Pp6r3 Saps3	Mus musculus (Mouse)	844	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666	regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN644_c0_g1_i4	Q922D4	PP6R3_MOUSE	42	583	291	10	2826	1111	1	547	1.20E-114	416	PP6R3_MOUSE	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)	Ppp6r3 D19Ertd703e Kiaa1558 Pp6r3 Saps3	Mus musculus (Mouse)	844	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666	regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN644_c0_g1_i2	Q5H9R7	PP6R3_HUMAN	37.7	796	401	18	2811	514	1	731	2.50E-117	424.9	PP6R3_HUMAN	reviewed	Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL)	PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3	Homo sapiens (Human)	873	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; COPII vesicle coating [GO:0048208]; regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0000139; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666; GO:0048208	COPII vesicle coating [GO:0048208]; regulation of phosphoprotein phosphatase activity [GO:0043666]		NA	NA	NA	NA	NA	NA
TRINITY_DN26578_c0_g1_i1	P48462	PP1B_DROME	72.3	296	78	1	925	50	7	302	1.30E-131	470.7	PP1B_DROME	reviewed	Serine/threonine-protein phosphatase beta isoform (EC 3.1.3.16) (Protein flap wing)	flw PP1-9C PP1-BETA-9C CG2096	Drosophila melanogaster (Fruit fly)	330	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; beta-catenin destruction complex disassembly [GO:1904886]; cell adhesion [GO:0007155]; chromosome segregation [GO:0007059]; circadian rhythm [GO:0007623]; female germline ring canal formation [GO:0007301]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesoderm development [GO:0007498]; negative regulation of JNK cascade [GO:0046329]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actomyosin contractile ring contraction [GO:0031991]; striated muscle tissue development [GO:0014706]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0007059; GO:0007155; GO:0007300; GO:0007301; GO:0007312; GO:0007476; GO:0007498; GO:0007623; GO:0014706; GO:0017018; GO:0031991; GO:0045879; GO:0046329; GO:0046872; GO:0090263; GO:1904886	beta-catenin destruction complex disassembly [GO:1904886]; cell adhesion [GO:0007155]; chromosome segregation [GO:0007059]; circadian rhythm [GO:0007623]; female germline ring canal formation [GO:0007301]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesoderm development [GO:0007498]; negative regulation of JNK cascade [GO:0046329]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; ovarian nurse cell to oocyte transport [GO:0007300]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actomyosin contractile ring contraction [GO:0031991]; striated muscle tissue development [GO:0014706]		NA	NA	NA	NA	NA	NA
TRINITY_DN32178_c0_g1_i1	Q60EX6	BSL1_ORYSJ	68.4	57	18	0	3	173	765	821	2.50E-16	85.5	BSL1_ORYSJ	reviewed	Serine/threonine-protein phosphatase BSL1 homolog (EC 3.1.3.16) (BSU1-like protein 1 homolog)	BSL1 Os05g0144400 LOC_Os05g05240 OJ1607_F09.10	Oryza sativa subsp. japonica (Rice)	883	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; brassinosteroid mediated signaling pathway [GO:0009742]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0009742; GO:0046872	brassinosteroid mediated signaling pathway [GO:0009742]		NA	NA	NA	NA	NA	NA
TRINITY_DN20978_c0_g1_i1	Q9LR78	BSU1_ARATH	51.7	87	41	1	268	8	507	592	8.90E-22	104	BSU1_ARATH	reviewed	Serine/threonine-protein phosphatase BSU1 (EC 3.1.3.16) (Bri1 suppressor protein 1)	BSU1 At1g03445 F21B7.7	Arabidopsis thaliana (Mouse-ear cress)	793	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; brassinosteroid mediated signaling pathway [GO:0009742]; positive regulation of brassinosteroid mediated signaling pathway [GO:1900459]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0005886; GO:0009742; GO:0032880; GO:0046872; GO:1900459	brassinosteroid mediated signaling pathway [GO:0009742]; positive regulation of brassinosteroid mediated signaling pathway [GO:1900459]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN10440_c0_g1_i1	P22198	PP1_MAIZE	56.9	304	113	2	932	21	16	301	8.60E-104	378.3	PP1_MAIZE	reviewed	Serine/threonine-protein phosphatase PP1 (EC 3.1.3.16)	PP1	Zea mays (Maize)	316	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN25687_c0_g1_i1	P22198	PP1_MAIZE	62.3	276	103	1	847	23	26	301	1.00E-106	387.9	PP1_MAIZE	reviewed	Serine/threonine-protein phosphatase PP1 (EC 3.1.3.16)	PP1	Zea mays (Maize)	316	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN585_c0_g1_i1	Q9UW86	PP1_NEUCR	78	300	66	0	933	34	1	300	2.30E-149	529.6	PP1_NEUCR	reviewed	Serine/threonine-protein phosphatase PP1 (EC 3.1.3.16) (Phosphoprotein phosphatase 1)	pph-3 ppp-1 NCU00043	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	308	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; chromosome segregation [GO:0007059]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0004722; GO:0005634; GO:0005737; GO:0007059; GO:0007346; GO:0046872; GO:0051726; GO:0072357	chromosome segregation [GO:0007059]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN30686_c0_g1_i1	O82733	PP17_ARATH	65.9	261	89	0	15	797	34	294	1.60E-109	397.1	PP17_ARATH	reviewed	Serine/threonine-protein phosphatase PP1 isozyme 7 (EC 3.1.3.16) (Type one protein phosphatase 7)	TOPP7 TOPP6 At5g43380 MWF20.7	Arabidopsis thaliana (Mouse-ear cress)	331	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN28253_c0_g1_i1	O82734	PP18_ARATH	58.6	29	12	0	158	72	185	213	5.90E-06	51.2	PP18_ARATH	reviewed	Serine/threonine-protein phosphatase PP1 isozyme 8 (EC 3.1.3.16) (Type one protein phosphatase 8)	TOPP8 At5g27840 T1G16.170	Arabidopsis thaliana (Mouse-ear cress)	324	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; pollen tube growth [GO:0009860]; root hair cell tip growth [GO:0048768]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0009860; GO:0046872; GO:0048768	pollen tube growth [GO:0009860]; root hair cell tip growth [GO:0048768]		NA	NA	NA	NA	NA	NA
TRINITY_DN8564_c0_g1_i1	P23880	PP12_SCHPO	42.2	154	81	2	4	465	48	193	2.90E-31	136.3	PP12_SCHPO	reviewed	Serine/threonine-protein phosphatase PP1-2 (EC 3.1.3.16) (Suppressor protein SDS21)	sds21 SPCC31H12.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	322	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0000790; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0007049; GO:0007059; GO:0007346; GO:0046872; GO:0051301; GO:0051726; GO:0072357; GO:2000784	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]		blue	blue	NA	NA	NA	NA
TRINITY_DN13131_c0_g1_i1	P23880	PP12_SCHPO	62.5	288	107	1	4	864	18	305	1.10E-108	394.4	PP12_SCHPO	reviewed	Serine/threonine-protein phosphatase PP1-2 (EC 3.1.3.16) (Suppressor protein SDS21)	sds21 SPCC31H12.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	322	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0000790; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0007049; GO:0007059; GO:0007346; GO:0046872; GO:0051301; GO:0051726; GO:0072357; GO:2000784	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN6136_c0_g1_i1	P23880	PP12_SCHPO	69	290	89	1	1	867	6	295	2.90E-123	443	PP12_SCHPO	reviewed	Serine/threonine-protein phosphatase PP1-2 (EC 3.1.3.16) (Suppressor protein SDS21)	sds21 SPCC31H12.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	322	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0000790; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0007049; GO:0007059; GO:0007346; GO:0046872; GO:0051301; GO:0051726; GO:0072357; GO:2000784	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c1_g3_i1	Q3T0E7	PP1A_BOVIN	100	161	0	0	37	519	1	161	2.90E-93	342.4	PP1A_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)	PPP1CA	Bos taurus (Bovine)	330	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0030324; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0048754; GO:0051301; GO:0072357; GO:0098641; GO:2001241	branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c2_g3_i1	Q3T0E7	PP1A_BOVIN	100	177	0	0	2	532	154	330	6.00E-105	381.3	PP1A_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)	PPP1CA	Bos taurus (Bovine)	330	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0030324; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0048754; GO:0051301; GO:0072357; GO:0098641; GO:2001241	branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c0_g2_i1	Q3T0E7	PP1A_BOVIN	92.7	329	20	2	1076	102	1	329	1.60E-184	646.7	PP1A_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)	PPP1CA	Bos taurus (Bovine)	330	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0030324; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0048754; GO:0051301; GO:0072357; GO:0098641; GO:2001241	branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]		blue	blue	NA	NA	NA	NA
TRINITY_DN3636_c1_g2_i1	Q3T0E7	PP1A_BOVIN	100	129	0	0	2	388	202	330	3.10E-74	278.9	PP1A_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)	PPP1CA	Bos taurus (Bovine)	330	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0030324; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0048754; GO:0051301; GO:0072357; GO:0098641; GO:2001241	branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN5954_c0_g1_i1	P62137	PP1A_MOUSE	100	154	0	0	4	465	1	154	7.30E-88	324.3	PP1A_MOUSE	reviewed	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)	Ppp1ca Ppp1a	Mus musculus (Mouse)	330	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular process [GO:0009987]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translation [GO:0006417]; response to lead ion [GO:0010288]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]"	cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021]	GO:0000164; GO:0000784; GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005977; GO:0005979; GO:0005981; GO:0006417; GO:0006470; GO:0007049; GO:0008157; GO:0009987; GO:0010288; GO:0016311; GO:0016791; GO:0030324; GO:0032922; GO:0042587; GO:0042752; GO:0043005; GO:0043021; GO:0043025; GO:0043153; GO:0043197; GO:0043204; GO:0044877; GO:0046872; GO:0048754; GO:0051301; GO:0072357; GO:0098641; GO:0098793; GO:0098794; GO:0098978; GO:2001241	branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular process [GO:0009987]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translation [GO:0006417]; response to lead ion [GO:0010288]		NA	NA	NA	NA	NA	NA
TRINITY_DN585_c0_g2_i1	Q627N3	GLC7B_CAEBR	80.4	296	58	0	912	25	6	301	1.70E-149	530	GLC7B_CAEBR	reviewed	Serine/threonine-protein phosphatase PP1-beta (EC 3.1.3.16) (Glc seven-like phosphatase 2)	gsp-2 CBG00598	Caenorhabditis briggsae	333	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell division [GO:0051301]; chromatin organization [GO:0006325]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; peptidyl-serine dephosphorylation [GO:0070262]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005694; GO:0005737; GO:0006325; GO:0007275; GO:0031965; GO:0046872; GO:0051301; GO:0051321; GO:0070262	cell division [GO:0051301]; chromatin organization [GO:0006325]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; peptidyl-serine dephosphorylation [GO:0070262]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c0_g1_i1	Q6GQL2	PP1B_XENLA	92.5	319	24	0	991	35	1	319	2.10E-180	632.9	PP1B_XENLA	reviewed	Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16)	ppp1cb	Xenopus laevis (African clawed frog)	327	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; cell cycle [GO:0007049]; cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]	metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]	GO:0005634; GO:0005737; GO:0005977; GO:0007049; GO:0030155; GO:0046872; GO:0050115; GO:0051301; GO:0072357	cell cycle [GO:0007049]; cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]		blue	blue	NA	NA	NA	NA
TRINITY_DN3636_c0_g1_i2	Q6GQL2	PP1B_XENLA	93.6	140	9	0	505	86	1	140	5.30E-74	278.5	PP1B_XENLA	reviewed	Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16)	ppp1cb	Xenopus laevis (African clawed frog)	327	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; cell cycle [GO:0007049]; cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]	metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]	GO:0005634; GO:0005737; GO:0005977; GO:0007049; GO:0030155; GO:0046872; GO:0050115; GO:0051301; GO:0072357	cell cycle [GO:0007049]; cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c2_g2_i1	Q3SWW9	PP1B_BOVIN	100	70	0	0	26	235	1	70	2.30E-34	145.6	PP1B_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16) (EC 3.1.3.53)	PPP1CB	Bos taurus (Bovine)	327	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0072357	cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c2_g2_i2	Q3SWW9	PP1B_BOVIN	100	327	0	0	26	1006	1	327	3.50E-199	695.3	PP1B_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16) (EC 3.1.3.53)	PPP1CB	Bos taurus (Bovine)	327	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0072357	cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c2_g1_i1	Q3SWW9	PP1B_BOVIN	100	100	0	0	2	301	99	198	9.60E-57	220.3	PP1B_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16) (EC 3.1.3.53)	PPP1CB	Bos taurus (Bovine)	327	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]"	metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000784; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0072357	cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]		NA	NA	NA	NA	NA	NA
TRINITY_DN27575_c0_g1_i1	P36873	PP1G_HUMAN	100	157	0	0	29	499	1	157	2.20E-90	332.8	PP1G_HUMAN	reviewed	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)	PPP1CC	Homo sapiens (Human)	323	cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]	cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]	GO:0000164; GO:0000777; GO:0003723; GO:0004721; GO:0004722; GO:0005521; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005925; GO:0005977; GO:0006470; GO:0007049; GO:0008022; GO:0008157; GO:0016607; GO:0016791; GO:0019901; GO:0019904; GO:0030182; GO:0030496; GO:0032154; GO:0032922; GO:0032991; GO:0042752; GO:0043153; GO:0043197; GO:0044877; GO:0046822; GO:0046872; GO:0047485; GO:0051301; GO:0060252; GO:0072357; GO:0098793	cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]		NA	NA	NA	NA	NA	NA
TRINITY_DN31602_c0_g1_i1	P61287	PP1G_BOVIN	100	176	0	0	1	528	139	314	8.10E-105	380.9	PP1G_BOVIN	reviewed	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)	PPP1CC	Bos taurus (Bovine)	323	"cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; U12-type spliceosomal complex [GO:0005689]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; mRNA splicing, via spliceosome [GO:0000398]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]"	cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; U12-type spliceosomal complex [GO:0005689]	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0000398; GO:0000777; GO:0004722; GO:0005689; GO:0005730; GO:0005739; GO:0005977; GO:0006470; GO:0007049; GO:0016607; GO:0016791; GO:0030496; GO:0032154; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0051301; GO:0072357	"cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; mRNA splicing, via spliceosome [GO:0000398]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3636_c1_g1_i1	P36874	PP1GA_XENLA	100	105	0	0	3	317	27	131	1.60E-57	223	PP1GA_XENLA	reviewed	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit A (PP-1G-A) (xPP1-gamma1) (EC 3.1.3.16)	ppp1cc-a ppp1cc	Xenopus laevis (African clawed frog)	323	cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein phosphatase type 1 complex [GO:0000164]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; mitotic nuclear envelope reassembly [GO:0007084]; protein dephosphorylation [GO:0006470]	cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein phosphatase type 1 complex [GO:0000164]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0000777; GO:0004722; GO:0005730; GO:0005739; GO:0005977; GO:0006470; GO:0007084; GO:0016020; GO:0016607; GO:0030496; GO:0032154; GO:0046872; GO:0051301	cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; mitotic nuclear envelope reassembly [GO:0007084]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN28_c0_g1_i1	P32945	PPQ1_YEAST	52.3	130	61	1	403	14	286	414	4.80E-35	148.7	PPQ1_YEAST	reviewed	Serine/threonine-protein phosphatase PPQ (EC 3.1.3.16)	PPQ1 SAL6 YPL179W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	549	cytoplasm [GO:0005737]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion [GO:0090029]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004721; GO:0004722; GO:0004724; GO:0005634; GO:0005737; GO:0006470; GO:0046872; GO:0090029	negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion [GO:0090029]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN161_c1_g1_i1	P49576	PPX1_PARTE	46.2	119	61	2	355	8	35	153	5.70E-24	111.7	PPX1_PARTE	reviewed	Serine/threonine-protein phosphatase PP-X homolog 1 (EC 3.1.3.16)	Ppx1 GSPATT00019262001	Paramecium tetraurelia	303	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]		metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]	GO:0004721; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g1_i1	P26686	SRR55_DROME	57.5	134	39	1	79	426	1	134	1.50E-32	141.7	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g1_i2	P26686	SRR55_DROME	57.5	134	39	1	79	426	1	134	1.10E-32	141	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g1_i4	P26686	SRR55_DROME	62.4	189	53	1	79	591	1	189	2.20E-57	223.4	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g1_i8	P26686	SRR55_DROME	77.1	70	16	0	79	288	1	70	4.00E-25	115.5	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g2_i1	P26686	SRR55_DROME	84.7	72	11	0	3	218	121	192	3.80E-28	125.2	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN289_c0_g2_i2	P26686	SRR55_DROME	83.6	61	10	0	22	204	132	192	4.30E-21	101.7	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1721_c0_g2_i1	P26686	SRR55_DROME	75.7	74	18	0	52	273	1	74	5.90E-27	121.3	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1721_c0_g2_i2	P26686	SRR55_DROME	55.7	61	27	0	52	234	1	61	2.80E-12	72.4	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12856_c0_g1_i1	P26686	SRR55_DROME	81.7	71	13	0	250	38	4	74	1.20E-26	120.2	SRR55_DROME	reviewed	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	B52 E(Dfd) RS55 SR55 CG10851	Drosophila melanogaster (Fruit fly)	376	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37119_c0_g1_i1	P21549	SPYA_HUMAN	53.4	88	41	0	265	2	114	201	3.70E-23	108.6	SPYA_HUMAN	reviewed	Serine--pyruvate aminotransferase (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)	AGXT AGT1 SPAT	Homo sapiens (Human)	392	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]; cellular nitrogen compound metabolic process [GO:0034641]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; protein targeting to peroxisome [GO:0006625]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]	GO:0004760; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0007219; GO:0008453; GO:0008483; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0034641; GO:0042802; GO:0042803; GO:0042853; GO:0042866; GO:0043231; GO:0043621; GO:0046487; GO:0046724; GO:0051384; GO:0051591	"cellular nitrogen compound metabolic process [GO:0034641]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; protein targeting to peroxisome [GO:0006625]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c0_g1_i1	P31030	SPYA_RABIT	51.6	217	105	0	735	85	10	226	5.60E-62	239.2	SPYA_RABIT	reviewed	Serine--pyruvate aminotransferase (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)	AGXT AGT1	Oryctolagus cuniculus (Rabbit)	392	peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine-pyruvate transaminase activity [GO:0004760]	peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine-pyruvate transaminase activity [GO:0004760]	GO:0004760; GO:0005777; GO:0008453; GO:0042803; GO:0043621			NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c0_g1_i2	P31030	SPYA_RABIT	51.2	246	120	0	739	2	10	255	1.90E-70	267.3	SPYA_RABIT	reviewed	Serine--pyruvate aminotransferase (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)	AGXT AGT1	Oryctolagus cuniculus (Rabbit)	392	peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine-pyruvate transaminase activity [GO:0004760]	peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine-pyruvate transaminase activity [GO:0004760]	GO:0004760; GO:0005777; GO:0008453; GO:0042803; GO:0043621			NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c0_g1_i3	P31030	SPYA_RABIT	49.6	226	114	0	762	85	1	226	5.60E-62	239.2	SPYA_RABIT	reviewed	Serine--pyruvate aminotransferase (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)	AGXT AGT1	Oryctolagus cuniculus (Rabbit)	392	peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine-pyruvate transaminase activity [GO:0004760]	peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine-pyruvate transaminase activity [GO:0004760]	GO:0004760; GO:0005777; GO:0008453; GO:0042803; GO:0043621			NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c0_g1_i4	P09139	SPYA_RAT	47.6	275	144	0	826	2	3	277	9.10E-71	268.5	SPYA_RAT	reviewed	"Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)"	Agxt Agt1	Rattus norvegicus (Rat)	414	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]	GO:0004760; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0007219; GO:0008453; GO:0008483; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042802; GO:0042803; GO:0042853; GO:0042866; GO:0043621; GO:0046487; GO:0046724; GO:0051384; GO:0051591	"glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c0_g1_i5	P09139	SPYA_RAT	48	246	128	0	822	85	3	248	2.00E-62	240.7	SPYA_RAT	reviewed	"Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)"	Agxt Agt1	Rattus norvegicus (Rat)	414	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]	GO:0004760; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0007219; GO:0008453; GO:0008483; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042802; GO:0042803; GO:0042853; GO:0042866; GO:0043621; GO:0046487; GO:0046724; GO:0051384; GO:0051591	"glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; pyruvate biosynthetic process [GO:0042866]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6201_c0_g1_i6	P41689	SPYA_FELCA	49	255	130	0	766	2	23	277	8.60E-71	268.5	SPYA_FELCA	reviewed	"Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)"	AGXT AGT1	Felis catus (Cat) (Felis silvestris catus)	414	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]	GO:0004760; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0008453; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042803; GO:0042853; GO:0043621	"glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21560_c0_g1_i1	Q5E959	STRAP_BOVIN	100	164	0	0	52	543	1	164	2.30E-93	342.8	STRAP_BOVIN	reviewed	Serine-threonine kinase receptor-associated protein	STRAP	Bos taurus (Bovine)	350	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN21560_c0_g1_i2	Q5E959	STRAP_BOVIN	98.8	82	1	0	162	407	83	164	7.00E-42	171.4	STRAP_BOVIN	reviewed	Serine-threonine kinase receptor-associated protein	STRAP	Bos taurus (Bovine)	350	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN21560_c0_g1_i2	Q5E959	STRAP_BOVIN	88.9	45	5	0	52	186	1	45	8.60E-16	84.7	STRAP_BOVIN	reviewed	Serine-threonine kinase receptor-associated protein	STRAP	Bos taurus (Bovine)	350	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN21560_c0_g1_i3	Q5E959	STRAP_BOVIN	100	153	0	0	1	459	12	164	6.10E-87	321.2	STRAP_BOVIN	reviewed	Serine-threonine kinase receptor-associated protein	STRAP	Bos taurus (Bovine)	350	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN316_c0_g1_i1	Q5ZL33	STRAP_CHICK	64.2	313	111	1	46	984	1	312	2.40E-121	436.8	STRAP_CHICK	reviewed	Serine-threonine kinase receptor-associated protein	STRAP RCJMB04_7p19	Gallus gallus (Chicken)	350	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN36330_c0_g1_i1	Q9Y3F4	STRAP_HUMAN	100	127	0	0	383	3	205	331	2.00E-70	266.2	STRAP_HUMAN	reviewed	Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD)	STRAP MAWD UNRIP	Homo sapiens (Human)	350	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0003723; GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN33354_c0_g1_i1	Q9Z1Z2	STRAP_MOUSE	100	85	0	0	3	257	245	329	1.70E-46	186	STRAP_MOUSE	reviewed	Serine-threonine kinase receptor-associated protein (UNR-interacting protein)	Strap Unrip	Mus musculus (Mouse)	350	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]	GO:0000122; GO:0000387; GO:0003723; GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i1	A3CTP4	SYS_METMJ	23.9	268	174	6	861	97	166	416	3.70E-08	60.5	SYS_METMJ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS Memar_0811	Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i10	A3CTP4	SYS_METMJ	23.9	268	174	6	861	97	166	416	3.70E-08	60.5	SYS_METMJ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS Memar_0811	Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i11	A3CTP4	SYS_METMJ	23.9	268	174	6	861	97	166	416	3.70E-08	60.5	SYS_METMJ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS Memar_0811	Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i13	A3CTP4	SYS_METMJ	23.9	268	174	6	861	97	166	416	3.70E-08	60.5	SYS_METMJ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS Memar_0811	Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i16	Q2GKS1	SYS_ANAPZ	30.2	96	62	2	483	205	334	427	1.30E-05	51.2	SYS_ANAPZ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS APH_0427	Anaplasma phagocytophilum (strain HZ)	428	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i6	A3CTP4	SYS_METMJ	23.9	268	174	6	861	97	166	416	3.70E-08	60.5	SYS_METMJ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS Memar_0811	Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3191_c0_g1_i7	A3CTP4	SYS_METMJ	23.9	268	174	6	861	97	166	416	3.70E-08	60.5	SYS_METMJ	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS Memar_0811	Methanoculleus marisnigri (strain ATCC 35101 / DSM 1498 / JR1)	425	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN25657_c0_g1_i1	Q8SS48	SYS_ENCCU	58.6	237	97	1	4	714	184	419	5.60E-82	305.4	SYS_ENCCU	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	ECU04_0750	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	429	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0006434; GO:0097056	selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN26756_c0_g1_i1	Q6A5P0	SYS_CUTAK	98.6	71	1	0	213	1	354	424	1.90E-35	149.1	SYS_CUTAK	reviewed	Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)	serS PPA2219	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	424	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]	GO:0004828; GO:0005524; GO:0005737; GO:0006434; GO:0016260; GO:0097056	selenocysteine biosynthetic process [GO:0016260]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN235_c0_g1_i2	Q6DRC0	SYSC_DANRE	51.3	573	184	6	1826	117	1	481	3.50E-152	540	SYSC_DANRE	reviewed	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS)"	sars1 sars	Danio rerio (Zebrafish) (Brachydanio rerio)	515	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cerebellum vasculature development [GO:0061300]; negative regulation of angiogenesis [GO:0016525]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; regulation of vasculature development [GO:1901342]; seryl-tRNA aminoacylation [GO:0006434]; vasculature development [GO:0001944]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0000122; GO:0000978; GO:0001525; GO:0001569; GO:0001944; GO:0004828; GO:0005524; GO:0005634; GO:0005829; GO:0006434; GO:0016525; GO:0061300; GO:1901342; GO:1903671; GO:1904046	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cerebellum vasculature development [GO:0061300]; negative regulation of angiogenesis [GO:0016525]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; regulation of vasculature development [GO:1901342]; seryl-tRNA aminoacylation [GO:0006434]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN235_c0_g1_i1	P26638	SYSC_MOUSE	59.8	505	194	6	1556	63	1	503	9.60E-167	588.2	SYSC_MOUSE	reviewed	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	Sars1 Sars Sers	Mus musculus (Mouse)	512	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0000122; GO:0000978; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006434; GO:0016525; GO:0019899; GO:0042803; GO:0097056; GO:1904046	negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		blue	blue	NA	NA	NA	NA
TRINITY_DN10794_c0_g1_i1	Q4R4U9	SYSC_MACFA	98.6	296	4	0	891	4	193	488	1.50E-169	596.7	SYSC_MACFA	reviewed	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	SARS1 SARS QccE-14020	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]	GO:0000122; GO:0000978; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0006434; GO:0016525; GO:0097056; GO:1904046	negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN10794_c0_g1_i2	Q4R4U9	SYSC_MACFA	99.3	296	2	0	891	4	193	488	2.90E-170	599	SYSC_MACFA	reviewed	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	SARS1 SARS QccE-14020	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	514	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]	GO:0000122; GO:0000978; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0006434; GO:0016525; GO:0097056; GO:1904046	negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN26692_c0_g1_i1	Q39230	SYSC_ARATH	56.9	232	92	4	680	3	177	406	2.60E-73	276.6	SYSC_ARATH	reviewed	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	At5g27470 F21A20_180	Arabidopsis thaliana (Mouse-ear cress)	451	cytosol [GO:0005829]; plastid [GO:0009536]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; response to cadmium ion [GO:0046686]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytosol [GO:0005829]; plastid [GO:0009536]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0004828; GO:0005524; GO:0005829; GO:0006434; GO:0009536; GO:0046686; GO:0097056	response to cadmium ion [GO:0046686]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN30365_c0_g1_i1	Q39230	SYSC_ARATH	57.7	272	101	4	800	3	149	412	4.80E-87	322.4	SYSC_ARATH	reviewed	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	At5g27470 F21A20_180	Arabidopsis thaliana (Mouse-ear cress)	451	cytosol [GO:0005829]; plastid [GO:0009536]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; response to cadmium ion [GO:0046686]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytosol [GO:0005829]; plastid [GO:0009536]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0004828; GO:0005524; GO:0005829; GO:0006434; GO:0009536; GO:0046686; GO:0097056	response to cadmium ion [GO:0046686]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN5932_c0_g1_i11	Q9JJL8	SYSM_MOUSE	47	349	181	4	399	1439	147	493	2.50E-87	324.3	SYSM_MOUSE	reviewed	"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	Sars2 Sarsm	Mus musculus (Mouse)	518	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158; GO:0097056	mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN5932_c0_g1_i22	Q9NP81	SYSM_HUMAN	43.6	236	130	3	420	1121	154	388	9.50E-50	199.5	SYSM_HUMAN	reviewed	"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	SARS2 SARSM	Homo sapiens (Human)	518	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006434; GO:0070158; GO:0097056	mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN5932_c0_g1_i22	Q9NP81	SYSM_HUMAN	55.6	108	47	1	1130	1453	387	493	1.60E-28	129	SYSM_HUMAN	reviewed	"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	SARS2 SARSM	Homo sapiens (Human)	518	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006434; GO:0070158; GO:0097056	mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN5932_c0_g1_i3	Q9JJL8	SYSM_MOUSE	49.8	251	123	3	127	876	245	493	1.30E-65	251.5	SYSM_MOUSE	reviewed	"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	Sars2 Sarsm	Mus musculus (Mouse)	518	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158; GO:0097056	mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]		NA	NA	NA	NA	NA	NA
TRINITY_DN3047_c0_g1_i1	Q92079	TRFE_GADMO	50.5	103	44	5	3	302	27	125	3.10E-18	92.4	TRFE_GADMO	reviewed	Serotransferrin (Fragment)	tf	Gadus morhua (Atlantic cod)	642	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN37883_c0_g1_i1	Q921I1	TRFE_MOUSE	100	83	0	0	3	251	181	263	3.80E-46	184.9	TRFE_MOUSE	reviewed	Serotransferrin (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin)	Tf Trf	Mus musculus (Mouse)	697	"apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; dense body [GO:0097433]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle [GO:0031982]; vesicle coat [GO:0030120]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]; actin filament organization [GO:0007015]; activation of JUN kinase activity [GO:0007257]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; response to bacterium [GO:0009617]; SMAD protein signal transduction [GO:0060395]"	apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; dense body [GO:0097433]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; vesicle [GO:0031982]; vesicle coat [GO:0030120]	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]	GO:0005576; GO:0005604; GO:0005615; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0005905; GO:0006826; GO:0006879; GO:0007015; GO:0007257; GO:0008198; GO:0008199; GO:0009617; GO:0009925; GO:0009986; GO:0016020; GO:0016324; GO:0019731; GO:0030120; GO:0030139; GO:0030316; GO:0031232; GO:0031410; GO:0031643; GO:0031982; GO:0034756; GO:0034986; GO:0042327; GO:0045178; GO:0045780; GO:0045893; GO:0048260; GO:0048471; GO:0051286; GO:0055037; GO:0060395; GO:0070371; GO:0070447; GO:0071281; GO:0097433; GO:1990459; GO:1990712; GO:2000147	"actin filament organization [GO:0007015]; activation of JUN kinase activity [GO:0007257]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; response to bacterium [GO:0009617]; SMAD protein signal transduction [GO:0060395]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2714_c0_g1_i1	P80426	TRFE1_SALSA	24.1	348	190	8	254	1156	21	341	1.50E-15	85.5	TRFE1_SALSA	reviewed	Serotransferrin-1 (Serotransferrin I) (STF I) (sTF1) (Siderophilin I)	tf1	Salmo salar (Atlantic salmon)	690	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN2714_c0_g1_i4	P80426	TRFE1_SALSA	24.1	348	190	8	578	1480	21	341	1.90E-15	85.5	TRFE1_SALSA	reviewed	Serotransferrin-1 (Serotransferrin I) (STF I) (sTF1) (Siderophilin I)	tf1	Salmo salar (Atlantic salmon)	690	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN6756_c0_g1_i1	P50452	SPB8_HUMAN	50.6	89	43	1	6	272	278	365	5.00E-20	98.2	SPB8_HUMAN	reviewed	Serpin B8 (Cytoplasmic antiproteinase 2) (CAP-2) (CAP2) (Peptidase inhibitor 8) (PI-8)	SERPINB8 PI8	Homo sapiens (Human)	374	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0005737; GO:0005829; GO:0010951; GO:0062023; GO:0070062; GO:0090136	epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951]		NA	NA	NA	NA	NA	NA
TRINITY_DN5340_c0_g1_i1	Q53KS8	SPZ2A_ORYSJ	42.9	91	47	1	261	4	326	416	5.90E-10	64.7	SPZ2A_ORYSJ	reviewed	Serpin-Z2A (OrysaZ2a)	Os11g0239000 LOC_Os11g13530	Oryza sativa subsp. japonica (Rice)	424	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]	extracellular space [GO:0005615]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0010951	negative regulation of endopeptidase activity [GO:0010951]		blue	blue	NA	NA	NA	NA
TRINITY_DN4038_c1_g1_i1	Q5TUF1	SRRT_ANOGA	70.7	58	17	0	237	64	589	646	6.50E-19	94.7	SRRT_ANOGA	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AGAP010382	Anopheles gambiae (African malaria mosquito)	967	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0016604; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c1_g1_i12	Q5TUF1	SRRT_ANOGA	68.6	194	45	2	547	2	518	707	1.10E-67	257.7	SRRT_ANOGA	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AGAP010382	Anopheles gambiae (African malaria mosquito)	967	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0016604; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c1_g1_i3	Q5TUF1	SRRT_ANOGA	70.2	57	17	0	186	16	543	599	1.20E-15	83.6	SRRT_ANOGA	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AGAP010382	Anopheles gambiae (African malaria mosquito)	967	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0016604; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c1_g1_i4	Q5TUF1	SRRT_ANOGA	78.8	104	22	0	375	64	543	646	1.20E-45	183.7	SRRT_ANOGA	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AGAP010382	Anopheles gambiae (African malaria mosquito)	967	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0016604; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c1_g1_i5	Q5TUF1	SRRT_ANOGA	57.7	123	36	2	334	2	589	707	6.90E-29	128.3	SRRT_ANOGA	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AGAP010382	Anopheles gambiae (African malaria mosquito)	967	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0016604; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4038_c1_g1_i6	Q5TUF1	SRRT_ANOGA	66.3	169	41	2	472	2	543	707	9.80E-56	217.6	SRRT_ANOGA	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AGAP010382	Anopheles gambiae (African malaria mosquito)	967	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0016604; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN1602_c0_g1_i1	Q17FR9	SRRT_AEDAE	57.4	68	26	1	98	292	133	200	7.00E-13	74.7	SRRT_AEDAE	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AAEL003287	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	937	nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN1602_c0_g1_i3	Q17FR9	SRRT_AEDAE	69.7	66	20	0	98	295	133	198	1.90E-20	99.8	SRRT_AEDAE	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AAEL003287	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	937	nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN1602_c0_g1_i4	Q17FR9	SRRT_AEDAE	57.4	68	26	1	98	292	133	200	7.00E-13	74.7	SRRT_AEDAE	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2 homolog)	Ars2 AAEL003287	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	937	nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]	nucleoplasm [GO:0005654]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005654; GO:0006397; GO:0031053	mRNA processing [GO:0006397]; primary miRNA processing [GO:0031053]		NA	NA	NA	NA	NA	NA
TRINITY_DN19670_c0_g1_i1	Q5R539	SRRT_PONAB	100	129	0	0	389	3	400	528	3.80E-72	271.9	SRRT_PONAB	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2)	SRRT ARS2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	871	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]	GO:0003677; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0031053; GO:0097150	"mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19670_c0_g1_i2	Q5R539	SRRT_PONAB	100	141	0	0	424	2	400	540	9.10E-80	297.4	SRRT_PONAB	reviewed	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2)	SRRT ARS2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	871	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]	GO:0003677; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0031053; GO:0097150	"mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1867_c0_g1_i2	Q8BH49	SESQ1_MOUSE	52.3	132	63	0	912	517	1	132	3.60E-36	153.7	SESQ1_MOUSE	reviewed	Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1)	Pheta1 Fam109a	Mus musculus (Mouse)	266	"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	protein homodimerization activity [GO:0042803]	GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037	"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1867_c0_g1_i1	Q8N4B1	SESQ1_HUMAN	55.9	59	26	0	690	514	69	127	1.10E-11	72	SESQ1_HUMAN	reviewed	Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1)	PHETA1 FAM109A	Homo sapiens (Human)	249	"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	protein homodimerization activity [GO:0042803]	GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037	"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1867_c0_g1_i3	Q8N4B1	SESQ1_HUMAN	53.5	127	59	0	894	514	1	127	2.70E-36	154.1	SESQ1_HUMAN	reviewed	Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1)	PHETA1 FAM109A	Homo sapiens (Human)	249	"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	protein homodimerization activity [GO:0042803]	GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037	"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14991_c0_g1_i1	Q9W1K5	SESN_DROME	45.3	128	70	0	2	385	50	177	3.00E-30	133.7	SESN_DROME	reviewed	Sestrin homolog (dSesn)	Sesn CG11299	Drosophila melanogaster (Fruit fly)	497	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to reactive oxygen species [GO:1901031]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]"	GO:0000422; GO:0005634; GO:0005737; GO:0010259; GO:0016239; GO:0016684; GO:0030308; GO:0070728; GO:0071230; GO:0071233; GO:1901031; GO:1904262; GO:1990253; GO:2000377	autophagy of mitochondrion [GO:0000422]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to reactive oxygen species [GO:1901031]		NA	NA	NA	NA	NA	NA
TRINITY_DN14991_c0_g1_i2	Q9W1K5	SESN_DROME	29.6	469	218	8	2	1147	50	493	8.30E-51	202.6	SESN_DROME	reviewed	Sestrin homolog (dSesn)	Sesn CG11299	Drosophila melanogaster (Fruit fly)	497	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to reactive oxygen species [GO:1901031]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]"	GO:0000422; GO:0005634; GO:0005737; GO:0010259; GO:0016239; GO:0016684; GO:0030308; GO:0070728; GO:0071230; GO:0071233; GO:1901031; GO:1904262; GO:1990253; GO:2000377	autophagy of mitochondrion [GO:0000422]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of response to reactive oxygen species [GO:1901031]		NA	NA	NA	NA	NA	NA
TRINITY_DN30682_c0_g1_i1	Q9CYP7	SESN3_MOUSE	47.1	68	33	1	241	47	145	212	2.80E-14	79	SESN3_MOUSE	reviewed	Sestrin-3	Sesn3	Mus musculus (Mouse)	492	"cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203]"	cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; nucleus [GO:0005634]	"leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]"	GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0032868; GO:0034198; GO:0038203; GO:0042149; GO:0042593; GO:0046626; GO:0051896; GO:0061700; GO:0070728; GO:0071230; GO:0071233; GO:1901031; GO:1904262; GO:1990253	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN32045_c0_g1_i1	Q8IYR2	SMYD4_HUMAN	35.2	108	60	2	70	393	71	168	5.30E-10	65.5	SMYD4_HUMAN	reviewed	SET and MYND domain-containing protein 4 (EC 2.1.1.-)	SMYD4 KIAA1936	Homo sapiens (Human)	804	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]		metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259; GO:0046872	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN10453_c0_g1_i3	Q8BTK5	SMYD4_MOUSE	34.4	273	140	6	777	22	92	346	6.00E-28	126.7	SMYD4_MOUSE	reviewed	SET and MYND domain-containing protein 4 (EC 2.1.1.-)	Smyd4 Kiaa1936	Mus musculus (Mouse)	799	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]		metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259; GO:0046872	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN4816_c0_g1_i1	Q5ZIZ2	SMYD5_CHICK	58.5	381	158	0	141	1283	30	410	1.50E-128	461.1	SMYD5_CHICK	reviewed	SET and MYND domain-containing protein 5 (EC 2.1.1.-)	SMYD5 RCJMB04_22j23	Gallus gallus (Chicken)	420	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]		metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259; GO:0046872	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN29555_c0_g1_i1	Q3TYX3	SMYD5_MOUSE	99	96	1	0	2	289	154	249	1.90E-49	196.1	SMYD5_MOUSE	reviewed	SET and MYND domain-containing protein 5 (EC 2.1.1.-) (Protein NN8-4AG) (Retinoic acid-induced protein 15)	Smyd5 Rai15	Mus musculus (Mouse)	416	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]		metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259; GO:0046872	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN38403_c0_g1_i1	Q6GMV2	SMYD5_HUMAN	100	89	0	0	2	268	229	317	5.60E-48	191	SMYD5_HUMAN	reviewed	SET and MYND domain-containing protein 5 (EC 2.1.1.-) (Protein NN8-4AG) (Retinoic acid-induced protein 15)	SMYD5 RAI15	Homo sapiens (Human)	418	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]		metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259; GO:0046872	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN33091_c0_g1_i1	P58467	SETD4_MOUSE	40.6	303	167	5	65	958	4	298	6.20E-49	196.1	SETD4_MOUSE	reviewed	SET domain-containing protein 4 (EC 2.1.1.-)	Setd4 ORF21	Mus musculus (Mouse)	439	cytosol [GO:0005829]; nucleus [GO:0005634]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005634; GO:0005829; GO:0016279; GO:0018023; GO:0018026	peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]		NA	NA	NA	NA	NA	NA
TRINITY_DN989_c0_g1_i1	Q8NE22	SETD9_HUMAN	36.3	295	151	9	908	108	13	298	1.40E-41	171.8	SETD9_HUMAN	reviewed	SET domain-containing protein 9 (EC 2.1.1.-)	SETD9 C5orf35	Homo sapiens (Human)	299	nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]	nucleoplasm [GO:0005654]	lysine N-methyltransferase activity [GO:0016278]	GO:0005654; GO:0016278; GO:0032259; GO:1901796	methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN989_c0_g1_i5	Q8NE22	SETD9_HUMAN	42.1	114	60	2	449	108	191	298	1.40E-17	91.7	SETD9_HUMAN	reviewed	SET domain-containing protein 9 (EC 2.1.1.-)	SETD9 C5orf35	Homo sapiens (Human)	299	nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]	nucleoplasm [GO:0005654]	lysine N-methyltransferase activity [GO:0016278]	GO:0005654; GO:0016278; GO:0032259; GO:1901796	methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN989_c0_g1_i6	Q8NE22	SETD9_HUMAN	41.2	177	97	3	638	108	129	298	1.20E-32	142.1	SETD9_HUMAN	reviewed	SET domain-containing protein 9 (EC 2.1.1.-)	SETD9 C5orf35	Homo sapiens (Human)	299	nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]	nucleoplasm [GO:0005654]	lysine N-methyltransferase activity [GO:0016278]	GO:0005654; GO:0016278; GO:0032259; GO:1901796	methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]		NA	NA	NA	NA	NA	NA
TRINITY_DN13420_c0_g1_i3	P83501	MSTAB_DROME	28.9	440	261	17	1514	279	33	448	2.90E-33	144.8	MSTAB_DROME	reviewed	"SET domain-containing protein SmydA-8, isoform B (EC 2.1.1.-)"	SmydA-8 msta CG33548	Drosophila melanogaster (Fruit fly)	448	nuclear chromatin [GO:0000790]; histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]	nuclear chromatin [GO:0000790]	histone deacetylase binding [GO:0042826]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000790; GO:0008757; GO:0010629; GO:0034968; GO:0042826	histone lysine methylation [GO:0034968]; negative regulation of gene expression [GO:0010629]		NA	NA	NA	NA	NA	NA
TRINITY_DN2315_c0_g1_i1	Q94545	ASH2_DROME	65.4	162	54	2	67	552	277	436	1.70E-62	240.4	ASH2_DROME	reviewed	"Set1/Ash2 histone methyltransferase complex subunit ASH2 (Absent, small, or homeotic discs protein 2)"	ash2 CG6677	Drosophila melanogaster (Fruit fly)	556	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0002168; GO:0003677; GO:0005634; GO:0005700; GO:0005703; GO:0006357; GO:0007420; GO:0007444; GO:0007474; GO:0007476; GO:0010628; GO:0010629; GO:0019899; GO:0033128; GO:0035075; GO:0035209; GO:0044665; GO:0044666; GO:0046872; GO:0048096; GO:0048188; GO:0048813; GO:0051568; GO:0051571	brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]		NA	NA	NA	NA	NA	NA
TRINITY_DN2315_c0_g1_i2	Q94545	ASH2_DROME	52.3	442	173	10	74	1336	12	436	3.20E-128	459.9	ASH2_DROME	reviewed	"Set1/Ash2 histone methyltransferase complex subunit ASH2 (Absent, small, or homeotic discs protein 2)"	ash2 CG6677	Drosophila melanogaster (Fruit fly)	556	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0002168; GO:0003677; GO:0005634; GO:0005700; GO:0005703; GO:0006357; GO:0007420; GO:0007444; GO:0007474; GO:0007476; GO:0010628; GO:0010629; GO:0019899; GO:0033128; GO:0035075; GO:0035209; GO:0044665; GO:0044666; GO:0046872; GO:0048096; GO:0048188; GO:0048813; GO:0051568; GO:0051571	brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]		NA	NA	NA	NA	NA	NA
TRINITY_DN2315_c0_g1_i4	Q94545	ASH2_DROME	54.4	559	223	12	74	1708	12	552	4.90E-172	605.9	ASH2_DROME	reviewed	"Set1/Ash2 histone methyltransferase complex subunit ASH2 (Absent, small, or homeotic discs protein 2)"	ash2 CG6677	Drosophila melanogaster (Fruit fly)	556	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0002168; GO:0003677; GO:0005634; GO:0005700; GO:0005703; GO:0006357; GO:0007420; GO:0007444; GO:0007474; GO:0007476; GO:0010628; GO:0010629; GO:0019899; GO:0033128; GO:0035075; GO:0035209; GO:0044665; GO:0044666; GO:0046872; GO:0048096; GO:0048188; GO:0048813; GO:0051568; GO:0051571	brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]		blue	blue	NA	NA	NA	NA
TRINITY_DN2315_c0_g1_i5	Q94545	ASH2_DROME	52.3	453	185	12	74	1393	12	446	1.90E-129	464.2	ASH2_DROME	reviewed	"Set1/Ash2 histone methyltransferase complex subunit ASH2 (Absent, small, or homeotic discs protein 2)"	ash2 CG6677	Drosophila melanogaster (Fruit fly)	556	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0002168; GO:0003677; GO:0005634; GO:0005700; GO:0005703; GO:0006357; GO:0007420; GO:0007444; GO:0007474; GO:0007476; GO:0010628; GO:0010629; GO:0019899; GO:0033128; GO:0035075; GO:0035209; GO:0044665; GO:0044666; GO:0046872; GO:0048096; GO:0048188; GO:0048813; GO:0051568; GO:0051571	brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc development [GO:0007444]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]		NA	NA	NA	NA	NA	NA
TRINITY_DN38110_c0_g1_i1	Q9UBL3	ASH2L_HUMAN	100	72	0	0	218	3	541	612	1.10E-38	159.8	ASH2L_HUMAN	reviewed	Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein)	ASH2L ASH2L1	Homo sapiens (Human)	628	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627]	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005654; GO:0005719; GO:0006974; GO:0008013; GO:0008284; GO:0030097; GO:0035097; GO:0043627; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0048188; GO:0051568; GO:0071339; GO:1904837; GO:1990188	beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN34544_c0_g1_i1	Q9UBL3	ASH2L_HUMAN	98.9	89	1	0	3	269	321	409	3.90E-49	194.9	ASH2L_HUMAN	reviewed	Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein)	ASH2L ASH2L1	Homo sapiens (Human)	628	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627]	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005654; GO:0005719; GO:0006974; GO:0008013; GO:0008284; GO:0030097; GO:0035097; GO:0043627; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0048188; GO:0051568; GO:0071339; GO:1904837; GO:1990188	beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN33051_c0_g1_i1	Q9UBL3	ASH2L_HUMAN	100	76	0	0	230	3	414	489	2.60E-41	168.7	ASH2L_HUMAN	reviewed	Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein)	ASH2L ASH2L1	Homo sapiens (Human)	628	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627]	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005634; GO:0005654; GO:0005719; GO:0006974; GO:0008013; GO:0008284; GO:0030097; GO:0035097; GO:0043627; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0048188; GO:0051568; GO:0071339; GO:1904837; GO:1990188	beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN227_c0_g1_i1	O97018	SXL_CHRRU	54.1	196	79	1	705	118	76	260	1.80E-57	224.2	SXL_CHRRU	reviewed	Sex-lethal homolog	SXL	Chrysomya rufifacies (Hairy maggot blowfly) (Lucilia rufifacies)	307	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0000380; GO:0003723; GO:0005634; GO:0007530; GO:1990904	"alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]"		blue	blue	NA	NA	NA	NA
TRINITY_DN227_c0_g1_i2	O97018	SXL_CHRRU	57	186	79	1	675	118	76	260	5.40E-59	229.2	SXL_CHRRU	reviewed	Sex-lethal homolog	SXL	Chrysomya rufifacies (Hairy maggot blowfly) (Lucilia rufifacies)	307	"nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]"	nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	GO:0000380; GO:0003723; GO:0005634; GO:0007530; GO:1990904	"alternative mRNA splicing, via spliceosome [GO:0000380]; sex determination [GO:0007530]"		blue	blue	NA	NA	NA	NA
TRINITY_DN36715_c0_g1_i1	Q9R0P3	ESTD_MOUSE	98.8	85	1	0	255	1	58	142	1.90E-45	182.6	ESTD_MOUSE	reviewed	S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase 10) (Esterase D) (Sid 478)	Esd Es10 Sid478	Mus musculus (Mouse)	282	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	"carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; S-formylglutathione hydrolase activity [GO:0018738]"	GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0052689	formaldehyde catabolic process [GO:0046294]		NA	NA	NA	NA	NA	NA
TRINITY_DN3829_c0_g1_i1	Q08E20	ESTD_BOVIN	69.5	118	36	0	2	355	55	172	2.60E-48	192.6	ESTD_BOVIN	reviewed	S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D)	ESD	Bos taurus (Bovine)	282	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]	GO:0005829; GO:0018738; GO:0031410; GO:0046294; GO:0052689	formaldehyde catabolic process [GO:0046294]		blue	blue	NA	NA	NA	NA
TRINITY_DN30119_c0_g1_i1	Q6PD21	SHB_MOUSE	55.4	56	25	0	295	462	388	443	1.90E-10	67.4	SHB_MOUSE	reviewed	SH2 domain-containing adapter protein B	Shb	Mus musculus (Mouse)	503	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	phosphotyrosine residue binding [GO:0001784]	GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006469; GO:0006915; GO:0030097; GO:0030154; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN6790_c0_g1_i1	Q5SQS7	SH24B_HUMAN	50.6	81	39	1	309	67	351	430	1.10E-16	87.8	SH24B_HUMAN	reviewed	SH2 domain-containing protein 4B	SH2D4B	Homo sapiens (Human)	431	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6790_c0_g1_i2	A6X942	SH24B_MOUSE	54.9	142	63	1	102	527	290	430	8.50E-39	161.8	SH24B_MOUSE	reviewed	SH2 domain-containing protein 4B	Sh2d4b	Mus musculus (Mouse)	431	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6790_c0_g1_i4	A6X942	SH24B_MOUSE	54.9	142	63	1	492	67	290	430	8.00E-39	161.8	SH24B_MOUSE	reviewed	SH2 domain-containing protein 4B	Sh2d4b	Mus musculus (Mouse)	431	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN3997_c0_g1_i3	Q9NRF2	SH2B1_HUMAN	35.2	122	70	3	592	251	287	407	1.40E-13	79	SH2B1_HUMAN	reviewed	"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B)"	SH2B1 KIAA1299 SH2B	Homo sapiens (Human)	756	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0005068; GO:0005634; GO:0005829; GO:0005886; GO:0007596; GO:0030032; GO:0035556; GO:0045840; GO:0060391; GO:2000278	blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN3997_c0_g1_i4	Q91ZM2	SH2B1_MOUSE	49.1	175	61	3	769	275	469	625	4.60E-37	156.8	SH2B1_MOUSE	reviewed	"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B) (SH2-B PH domain-containing signaling mediator 1)"	Sh2b1 Sh2bpsm1	Mus musculus (Mouse)	756	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001726; GO:0005068; GO:0005634; GO:0005829; GO:0005886; GO:0030032; GO:0035556; GO:0045840; GO:0060391; GO:2000278	intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN3997_c0_g1_i1	Q9JID9	SH2B2_MOUSE	30.2	500	308	13	1666	269	17	509	1.00E-52	209.5	SH2B2_MOUSE	reviewed	SH2B adapter protein 2 (Adapter protein with pleckstrin homology and Src homology 2 domains) (SH2 and PH domain-containing adapter protein APS)	Sh2b2 Aps	Mus musculus (Mouse)	621	actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; actin cytoskeleton organization [GO:0030036]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; brown fat cell differentiation [GO:0050873]; cytokine-mediated signaling pathway [GO:0019221]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of glucose import [GO:0046325]; nervous system development [GO:0007399]; regulation of immune response [GO:0050776]; regulation of metabolic process [GO:0019222]; regulation of Ras protein signal transduction [GO:0046578]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001725; GO:0001726; GO:0001922; GO:0005068; GO:0005737; GO:0005884; GO:0005886; GO:0007399; GO:0008286; GO:0019221; GO:0019222; GO:0030036; GO:0035556; GO:0035591; GO:0042169; GO:0042593; GO:0042802; GO:0046325; GO:0046578; GO:0050776; GO:0050851; GO:0050853; GO:0050873	actin cytoskeleton organization [GO:0030036]; antigen receptor-mediated signaling pathway [GO:0050851]; B-1 B cell homeostasis [GO:0001922]; B cell receptor signaling pathway [GO:0050853]; brown fat cell differentiation [GO:0050873]; cytokine-mediated signaling pathway [GO:0019221]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of glucose import [GO:0046325]; nervous system development [GO:0007399]; regulation of immune response [GO:0050776]; regulation of metabolic process [GO:0019222]; regulation of Ras protein signal transduction [GO:0046578]		NA	NA	NA	NA	NA	NA
TRINITY_DN3531_c0_g1_i1	Q9NFP5	SH3BG_DROME	51.5	103	44	1	527	237	1	103	5.30E-21	102.4	SH3BG_DROME	reviewed	SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein)	Sh3beta SH3BGR CG8582	Drosophila melanogaster (Fruit fly)	158	SH3 domain binding [GO:0017124]		SH3 domain binding [GO:0017124]	GO:0017124			blue	blue	NA	NA	NA	NA
TRINITY_DN3531_c0_g1_i2	Q9NFP5	SH3BG_DROME	51.5	103	44	1	487	197	1	103	4.90E-21	102.4	SH3BG_DROME	reviewed	SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein)	Sh3beta SH3BGR CG8582	Drosophila melanogaster (Fruit fly)	158	SH3 domain binding [GO:0017124]		SH3 domain binding [GO:0017124]	GO:0017124			NA	NA	NA	NA	NA	NA
TRINITY_DN3531_c0_g1_i3	Q9NFP5	SH3BG_DROME	51.5	103	44	1	686	396	1	103	6.90E-21	102.4	SH3BG_DROME	reviewed	SH3 domain-binding glutamic acid-rich protein homolog (SH3BGR protein)	Sh3beta SH3BGR CG8582	Drosophila melanogaster (Fruit fly)	158	SH3 domain binding [GO:0017124]		SH3 domain binding [GO:0017124]	GO:0017124			NA	NA	NA	NA	NA	NA
TRINITY_DN8098_c0_g1_i1	Q9V785	3BP5H_DROME	51.3	279	118	5	1549	746	33	304	3.70E-59	230.7	3BP5H_DROME	reviewed	SH3 domain-binding protein 5 homolog (Protein parcase)	pcs CG7761	Drosophila melanogaster (Fruit fly)	477	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; SH3 domain binding [GO:0017124]; anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of protein tyrosine kinase activity [GO:0061099]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; SH3 domain binding [GO:0017124]	GO:0004860; GO:0005737; GO:0005886; GO:0007301; GO:0007498; GO:0007517; GO:0009952; GO:0017112; GO:0017124; GO:0035556; GO:0042694; GO:0048644; GO:0061099	anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of protein tyrosine kinase activity [GO:0061099]		NA	NA	NA	NA	NA	NA
TRINITY_DN8098_c0_g1_i2	Q9V785	3BP5H_DROME	62.9	62	23	0	274	89	33	94	1.40E-14	80.1	3BP5H_DROME	reviewed	SH3 domain-binding protein 5 homolog (Protein parcase)	pcs CG7761	Drosophila melanogaster (Fruit fly)	477	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; SH3 domain binding [GO:0017124]; anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of protein tyrosine kinase activity [GO:0061099]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; SH3 domain binding [GO:0017124]	GO:0004860; GO:0005737; GO:0005886; GO:0007301; GO:0007498; GO:0007517; GO:0009952; GO:0017112; GO:0017124; GO:0035556; GO:0042694; GO:0048644; GO:0061099	anterior/posterior pattern specification [GO:0009952]; female germline ring canal formation [GO:0007301]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; muscle cell fate specification [GO:0042694]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of protein tyrosine kinase activity [GO:0061099]		NA	NA	NA	NA	NA	NA
TRINITY_DN4452_c0_g1_i1	A4IH82	3BP5L_XENTR	50.2	251	102	2	1813	1064	66	294	2.10E-53	211.8	3BP5L_XENTR	reviewed	SH3 domain-binding protein 5-like (SH3BP-5-like)	sh3bp5l	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	373	cytoplasm [GO:0005737]; protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]	cytoplasm [GO:0005737]	protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]	GO:0004860; GO:0005737; GO:0017112; GO:0035556; GO:0061099	intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c0_g1_i1	Q8R550	SH3K1_MOUSE	31.2	433	220	9	1975	758	2	383	1.30E-45	186	SH3K1_MOUSE	reviewed	"SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes)"	Sh3kbp1 Ruk Seta	Mus musculus (Mouse)	709	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]	SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005856; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202; GO:0050871	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN1395_c0_g1_i2	Q8R550	SH3K1_MOUSE	30.9	450	216	10	2026	758	2	383	3.10E-45	184.9	SH3K1_MOUSE	reviewed	"SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes)"	Sh3kbp1 Ruk Seta	Mus musculus (Mouse)	709	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]	SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005856; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202; GO:0050871	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN2339_c0_g1_i2	A1ZAY1	DLISH_DROME	58.1	236	77	4	130	837	32	245	3.40E-70	266.5	DLISH_DROME	reviewed	SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)	Dlish CG10933	Drosophila melanogaster (Fruit fly)	355	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]; cadherin binding [GO:0045296]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]	cadherin binding [GO:0045296]	GO:0001736; GO:0005737; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219	establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]		NA	NA	NA	NA	NA	NA
TRINITY_DN2339_c0_g1_i3	A1ZAY1	DLISH_DROME	56.5	269	93	5	31	837	1	245	1.80E-76	287.3	DLISH_DROME	reviewed	SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)	Dlish CG10933	Drosophila melanogaster (Fruit fly)	355	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]; cadherin binding [GO:0045296]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]	cadherin binding [GO:0045296]	GO:0001736; GO:0005737; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219	establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]		NA	NA	NA	NA	NA	NA
TRINITY_DN2339_c0_g1_i4	A1ZAY1	DLISH_DROME	65.3	98	25	2	31	303	1	96	8.70E-27	120.9	DLISH_DROME	reviewed	SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)	Dlish CG10933	Drosophila melanogaster (Fruit fly)	355	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]; cadherin binding [GO:0045296]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]	cadherin binding [GO:0045296]	GO:0001736; GO:0005737; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219	establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]		NA	NA	NA	NA	NA	NA
TRINITY_DN28903_c0_g1_i1	Q6P7W2	SHKB1_MOUSE	100	56	0	0	218	51	390	445	8.60E-26	117.1	SHKB1_MOUSE	reviewed	SH3KBP1-binding protein 1 (SETA-binding protein 1)	Shkbp1 Sb1	Mus musculus (Mouse)	704	lysosome [GO:0005764]; identical protein binding [GO:0042802]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260]	lysosome [GO:0005764]	identical protein binding [GO:0042802]	GO:0005764; GO:0042802; GO:0045742; GO:0051260	positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN32965_c0_g1_i1	Q8TBC3	SHKB1_HUMAN	100	285	0	0	1	855	289	573	8.00E-165	580.9	SHKB1_HUMAN	reviewed	SH3KBP1-binding protein 1 (SETA-binding protein 1)	SHKBP1 SB1 PP203	Homo sapiens (Human)	707	lysosome [GO:0005764]; identical protein binding [GO:0042802]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260]	lysosome [GO:0005764]	identical protein binding [GO:0042802]	GO:0005764; GO:0042802; GO:0045742; GO:0051260	positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN28141_c0_g1_i1	Q8TBC3	SHKB1_HUMAN	100	121	0	0	364	2	14	134	7.30E-67	254.2	SHKB1_HUMAN	reviewed	SH3KBP1-binding protein 1 (SETA-binding protein 1)	SHKBP1 SB1 PP203	Homo sapiens (Human)	707	lysosome [GO:0005764]; identical protein binding [GO:0042802]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260]	lysosome [GO:0005764]	identical protein binding [GO:0042802]	GO:0005764; GO:0042802; GO:0045742; GO:0051260	positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN30187_c0_g1_i1	Q8VZD5	KSG5_ARATH	69.6	313	93	2	1	936	73	384	9.10E-130	464.5	KSG5_ARATH	reviewed	Shaggy-related protein kinase epsilon (EC 2.7.11.1) (ASK-epsilon) (Shaggy-related protein kinase 13) (AtSK13)	ASK5 SK13 At5g14640 T15N1.130	Arabidopsis thaliana (Mouse-ear cress)	410	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; hyperosmotic response [GO:0006972]; protein autophosphorylation [GO:0046777]; response to salt stress [GO:0009651]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006972; GO:0007165; GO:0009651; GO:0046777	hyperosmotic response [GO:0006972]; protein autophosphorylation [GO:0046777]; response to salt stress [GO:0009651]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30852_c0_g1_i1	Q8VZD5	KSG5_ARATH	62.8	269	92	7	804	1	74	335	4.80E-90	332.4	KSG5_ARATH	reviewed	Shaggy-related protein kinase epsilon (EC 2.7.11.1) (ASK-epsilon) (Shaggy-related protein kinase 13) (AtSK13)	ASK5 SK13 At5g14640 T15N1.130	Arabidopsis thaliana (Mouse-ear cress)	410	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; hyperosmotic response [GO:0006972]; protein autophosphorylation [GO:0046777]; response to salt stress [GO:0009651]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006972; GO:0007165; GO:0009651; GO:0046777	hyperosmotic response [GO:0006972]; protein autophosphorylation [GO:0046777]; response to salt stress [GO:0009651]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN16999_c0_g1_i1	Q40518	MSK1_TOBAC	65.7	140	47	1	2	418	159	298	4.60E-49	195.3	MSK1_TOBAC	reviewed	Shaggy-related protein kinase NtK-1 (EC 2.7.11.1)	NTK-1	Nicotiana tabacum (Common tobacco)	409	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN35937_c0_g1_i1	P29353	SHC1_HUMAN	100	106	0	0	2	319	478	583	1.50E-56	219.9	SHC1_HUMAN	reviewed	SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1)	SHC1 SHC SHCA	Homo sapiens (Human)	583	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; actin cytoskeleton reorganization [GO:0031532]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; IRE1-mediated unfolded protein response [GO:0036498]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; Ras protein signal transduction [GO:0007265]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]	ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0000165; GO:0000187; GO:0001525; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005543; GO:0005759; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007176; GO:0007265; GO:0007411; GO:0007507; GO:0008284; GO:0008286; GO:0016032; GO:0016525; GO:0019221; GO:0019901; GO:0030971; GO:0031532; GO:0035723; GO:0036498; GO:0038095; GO:0038110; GO:0038128; GO:0040008; GO:0042742; GO:0043066; GO:0043410; GO:0045892; GO:0045893; GO:0046579; GO:0046875; GO:0048408; GO:0050900; GO:0070374; GO:0070435; GO:0071363; GO:0071864; GO:0090322; GO:0098609	"actin cytoskeleton reorganization [GO:0031532]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; IRE1-mediated unfolded protein response [GO:0036498]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; Ras protein signal transduction [GO:0007265]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35833_c0_g1_i1	P98083	SHC1_MOUSE	65.7	108	37	0	369	46	470	577	5.70E-34	145.2	SHC1_MOUSE	reviewed	SHC-transforming protein 1 (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1)	Shc1 Shc ShcA	Mus musculus (Mouse)	579	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; regulation of superoxide metabolic process [GO:0090322]; response to endothelin [GO:1990839]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]	ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; receptor tyrosine kinase binding [GO:0030971]	GO:0000165; GO:0000187; GO:0001525; GO:0001784; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006940; GO:0007169; GO:0007173; GO:0007507; GO:0007568; GO:0008284; GO:0008286; GO:0010008; GO:0016525; GO:0019901; GO:0030036; GO:0030182; GO:0030971; GO:0031175; GO:0031532; GO:0040008; GO:0042127; GO:0042742; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045892; GO:0045893; GO:0045907; GO:0046875; GO:0048408; GO:0048661; GO:0051219; GO:0051721; GO:0070374; GO:0070435; GO:0071363; GO:0071864; GO:0090322; GO:0098609; GO:1990839	"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; regulation of superoxide metabolic process [GO:0090322]; response to endothelin [GO:1990839]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35063_c0_g1_i1	P98083	SHC1_MOUSE	100	123	0	0	2	370	457	579	3.40E-67	255.4	SHC1_MOUSE	reviewed	SHC-transforming protein 1 (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1)	Shc1 Shc ShcA	Mus musculus (Mouse)	579	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; regulation of superoxide metabolic process [GO:0090322]; response to endothelin [GO:1990839]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]	ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; receptor tyrosine kinase binding [GO:0030971]	GO:0000165; GO:0000187; GO:0001525; GO:0001784; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006940; GO:0007169; GO:0007173; GO:0007507; GO:0007568; GO:0008284; GO:0008286; GO:0010008; GO:0016525; GO:0019901; GO:0030036; GO:0030182; GO:0030971; GO:0031175; GO:0031532; GO:0040008; GO:0042127; GO:0042742; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045892; GO:0045893; GO:0045907; GO:0046875; GO:0048408; GO:0048661; GO:0051219; GO:0051721; GO:0070374; GO:0070435; GO:0071363; GO:0071864; GO:0090322; GO:0098609; GO:1990839	"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; regulation of superoxide metabolic process [GO:0090322]; response to endothelin [GO:1990839]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25402_c0_g1_i1	Q6S5L8	SHC4_HUMAN	53	202	87	6	26	625	189	384	6.40E-48	192.2	SHC4_HUMAN	reviewed	SHC-transforming protein 4 (Rai-like protein) (RaLP) (SHC-transforming protein D) (hShcD) (Src homology 2 domain-containing-transforming protein C4) (SH2 domain protein C4)	SHC4 SHCD UNQ6438/PRO21364	Homo sapiens (Human)	630	plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of cell population proliferation [GO:0008284]; regulation of gene expression [GO:0010468]; stem cell differentiation [GO:0048863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0005886; GO:0006915; GO:0007169; GO:0008284; GO:0010468; GO:0019901; GO:0019904; GO:0030971; GO:0035556; GO:0045211; GO:0048863	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of cell population proliferation [GO:0008284]; regulation of gene expression [GO:0010468]; stem cell differentiation [GO:0048863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN6392_c0_g1_i1	Q9JLV2	TP4AP_MOUSE	35.1	639	326	15	458	2308	183	754	2.50E-91	338.2	TP4AP_MOUSE	reviewed	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	Trpc4ap Trrp4ap	Mus musculus (Mouse)	797	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; phosphatase binding [GO:0019902]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]	phosphatase binding [GO:0019902]	GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820	hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6392_c0_g1_i2	Q9JLV2	TP4AP_MOUSE	35.2	677	350	15	17	1981	183	792	1.90E-100	368.2	TP4AP_MOUSE	reviewed	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	Trpc4ap Trrp4ap	Mus musculus (Mouse)	797	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; phosphatase binding [GO:0019902]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]	phosphatase binding [GO:0019902]	GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820	hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6392_c0_g1_i4	Q9JLV2	TP4AP_MOUSE	35.1	639	326	15	488	2338	183	754	1.90E-91	338.6	TP4AP_MOUSE	reviewed	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	Trpc4ap Trrp4ap	Mus musculus (Mouse)	797	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; phosphatase binding [GO:0019902]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]	phosphatase binding [GO:0019902]	GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820	hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN23191_c0_g1_i1	Q8TEL6	TP4AP_HUMAN	100	76	0	0	230	3	418	493	1.50E-38	159.5	TP4AP_HUMAN	reviewed	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	TRPC4AP C20orf188 TRRP4AP	Homo sapiens (Human)	797	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]	phosphatase binding [GO:0019902]	GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820; GO:0070588	calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35387_c0_g1_i1	Q8TEL6	TP4AP_HUMAN	98.6	74	1	0	3	224	658	731	1.20E-32	139.8	TP4AP_HUMAN	reviewed	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	TRPC4AP C20orf188 TRRP4AP	Homo sapiens (Human)	797	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]	phosphatase binding [GO:0019902]	GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820; GO:0070588	calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21876_c0_g1_i1	Q8TEL6	TP4AP_HUMAN	100	107	0	0	1	321	512	618	2.50E-55	215.7	TP4AP_HUMAN	reviewed	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	TRPC4AP C20orf188 TRRP4AP	Homo sapiens (Human)	797	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]	phosphatase binding [GO:0019902]	GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820; GO:0070588	calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN14630_c0_g1_i1	Q5EAD4	ACDSB_BOVIN	55.8	129	55	1	385	5	169	297	4.50E-35	148.7	ACDSB_BOVIN	reviewed	"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)"	ACADSB	Bos taurus (Bovine)	432	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]; fatty acid metabolic process [GO:0006631]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]	GO:0003995; GO:0005759; GO:0006631; GO:0050660; GO:0102035	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN39040_c0_g1_i1	Q5RF40	ACDSB_PONAB	70.1	164	49	0	492	1	156	319	1.20E-61	237.3	ACDSB_PONAB	reviewed	"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)"	ACADSB	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	432	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]; fatty acid metabolic process [GO:0006631]	mitochondrial matrix [GO:0005759]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]	GO:0003995; GO:0005759; GO:0006631; GO:0050660; GO:0102035	fatty acid metabolic process [GO:0006631]		NA	NA	NA	NA	NA	NA
TRINITY_DN29875_c0_g1_i1	P70584	ACDSB_RAT	74	77	20	0	240	10	356	432	6.30E-27	120.9	ACDSB_RAT	reviewed	"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)"	Acadsb	Rattus norvegicus (Rat)	432	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]; short-branched-chain-acyl-CoA dehydrogenase activity [GO:0016937]; acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]; short-branched-chain-acyl-CoA dehydrogenase activity [GO:0016937]	GO:0003995; GO:0005739; GO:0005759; GO:0006631; GO:0006635; GO:0006637; GO:0009055; GO:0016937; GO:0050660; GO:0102035	acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]		blue	blue	NA	NA	NA	NA
TRINITY_DN5022_c0_g1_i1	A5PJJ7	S16C6_BOVIN	49.5	194	95	2	628	50	15	206	6.10E-47	189.1	S16C6_BOVIN	reviewed	Short-chain dehydrogenase/reductase family 16C member 6 (EC 1.1.1.-)	SDR16C6	Bos taurus (Bovine)	316	"lipid droplet [GO:0005811]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	lipid droplet [GO:0005811]	"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005811; GO:0016616			brown	brown	NA	NA	NA	NA
TRINITY_DN5022_c0_g1_i3	Q05A13	S16C6_MOUSE	43.8	304	163	3	895	2	2	303	2.10E-60	234.2	S16C6_MOUSE	reviewed	Short-chain dehydrogenase/reductase family 16C member 6 (EC 1.1.1.-)	Sdr16c6	Mus musculus (Mouse)	316	"lipid droplet [GO:0005811]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	lipid droplet [GO:0005811]	"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005811; GO:0016616			NA	NA	1	NA	NA	NA
TRINITY_DN9124_c0_g1_i1	Q8WUS8	D42E1_HUMAN	46.8	62	33	0	282	97	178	239	5.40E-09	61.6	D42E1_HUMAN	reviewed	Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-)	SDR42E1 HSPC105	Homo sapiens (Human)	393	"integral component of membrane [GO:0016021]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]"	integral component of membrane [GO:0016021]	"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003854; GO:0006694; GO:0016021; GO:0016491; GO:0016616	steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN2385_c0_g1_i2	A8DZE7	D42E1_DANRE	42	207	84	5	623	3	11	181	1.50E-34	147.9	D42E1_DANRE	reviewed	Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-)	sdr42e1 si:ch211-79l17.4 zgc:123280	Danio rerio (Zebrafish) (Brachydanio rerio)	387	"integral component of membrane [GO:0016021]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]"	integral component of membrane [GO:0016021]	"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003854; GO:0006694; GO:0016021; GO:0016491; GO:0016616	steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN1210_c0_g1_i1	A8DZE7	D42E1_DANRE	40.6	128	75	1	123	506	246	372	7.20E-19	95.5	D42E1_DANRE	reviewed	Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-)	sdr42e1 si:ch211-79l17.4 zgc:123280	Danio rerio (Zebrafish) (Brachydanio rerio)	387	"integral component of membrane [GO:0016021]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]"	integral component of membrane [GO:0016021]	"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003854; GO:0006694; GO:0016021; GO:0016491; GO:0016616	steroid biosynthetic process [GO:0006694]		blue	blue	NA	NA	NA	NA
TRINITY_DN1210_c0_g1_i4	A8DZE7	D42E1_DANRE	40.6	128	75	1	108	491	246	372	7.10E-19	95.5	D42E1_DANRE	reviewed	Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-)	sdr42e1 si:ch211-79l17.4 zgc:123280	Danio rerio (Zebrafish) (Brachydanio rerio)	387	"integral component of membrane [GO:0016021]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]"	integral component of membrane [GO:0016021]	"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003854; GO:0006694; GO:0016021; GO:0016491; GO:0016616	steroid biosynthetic process [GO:0006694]		NA	NA	NA	NA	NA	NA
TRINITY_DN24506_c0_g1_i1	P16219	ACADS_HUMAN	100	160	0	0	1	480	253	412	1.80E-82	306.6	ACADS_HUMAN	reviewed	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	ACADS	Homo sapiens (Human)	412	centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0004085; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005813; GO:0006635; GO:0033539; GO:0046359; GO:0050660	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN29700_c0_g1_i1	P16219	ACADS_HUMAN	100	138	0	0	416	3	66	203	2.00E-73	276.2	ACADS_HUMAN	reviewed	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	ACADS	Homo sapiens (Human)	412	centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0004085; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005813; GO:0006635; GO:0033539; GO:0046359; GO:0050660	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]		NA	NA	NA	NA	NA	NA
TRINITY_DN2164_c0_g1_i1	P15651	ACADS_RAT	70.3	381	113	0	1235	93	32	412	7.50E-155	548.5	ACADS_RAT	reviewed	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	Acads	Rattus norvegicus (Rat)	412	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]	GO:0000062; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006635; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0046359; GO:0050660; GO:0051384	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN2164_c0_g1_i2	P15651	ACADS_RAT	70.3	381	113	0	1235	93	32	412	7.20E-155	548.5	ACADS_RAT	reviewed	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	Acads	Rattus norvegicus (Rat)	412	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]	GO:0000062; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006635; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0046359; GO:0050660; GO:0051384	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN2164_c0_g1_i3	P15651	ACADS_RAT	70.3	381	113	0	1235	93	32	412	7.20E-155	548.5	ACADS_RAT	reviewed	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	Acads	Rattus norvegicus (Rat)	412	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]	GO:0000062; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006635; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0046359; GO:0050660; GO:0051384	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN2164_c0_g1_i4	P15651	ACADS_RAT	70.3	381	113	0	1235	93	32	412	7.40E-155	548.5	ACADS_RAT	reviewed	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	Acads	Rattus norvegicus (Rat)	412	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]	GO:0000062; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006635; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0046359; GO:0050660; GO:0051384	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN24938_c0_g1_i2	Q9NRA2	S17A5_HUMAN	40.5	79	45	1	238	2	35	111	9.30E-06	51.2	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN14521_c0_g1_i2	Q9NRA2	S17A5_HUMAN	39.6	192	106	3	179	745	23	207	4.40E-29	129.8	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN4125_c0_g1_i1	Q9NRA2	S17A5_HUMAN	30.9	456	303	9	1497	151	35	485	1.30E-48	195.7	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN4125_c0_g1_i10	Q9NRA2	S17A5_HUMAN	40.2	97	52	4	371	84	35	126	3.20E-06	53.1	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN4125_c0_g1_i12	Q9NRA2	S17A5_HUMAN	32.5	342	222	6	1090	77	35	371	6.40E-36	153.3	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN4125_c0_g1_i14	Q9NRA2	S17A5_HUMAN	30.9	456	303	9	1497	151	35	485	1.10E-48	196.1	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN4125_c0_g1_i15	Q9NRA2	S17A5_HUMAN	36.4	176	106	4	606	82	35	205	2.70E-17	90.5	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN4125_c0_g1_i4	Q9NRA2	S17A5_HUMAN	32.5	342	222	6	1090	77	35	371	7.40E-36	152.9	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN11763_c0_g3_i1	Q9NRA2	S17A5_HUMAN	45.9	183	98	1	558	10	281	462	6.80E-40	165.2	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN35357_c0_g1_i1	Q9NRA2	S17A5_HUMAN	39.6	192	115	1	49	624	279	469	3.70E-29	129.8	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN35357_c0_g1_i2	Q9NRA2	S17A5_HUMAN	38.7	173	106	0	49	567	279	451	1.30E-25	117.9	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN35357_c0_g1_i3	Q9NRA2	S17A5_HUMAN	45.2	93	51	0	49	327	279	371	3.90E-15	82.4	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN7066_c0_g1_i1	Q9NRA2	S17A5_HUMAN	42.6	136	77	1	416	9	332	466	1.60E-25	117.1	S17A5_HUMAN	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	SLC17A5	Homo sapiens (Human)	495	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid:proton symporter activity [GO:0015538]; sialic acid transmembrane transporter activity [GO:0015136]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN11763_c0_g1_i1	Q8BN82	S17A5_MOUSE	43	79	45	0	254	18	192	270	8.40E-14	77.4	S17A5_MOUSE	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	Slc17a5	Mus musculus (Mouse)	495	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0022857; GO:0030672; GO:0031410	amino acid transport [GO:0006865]; anion transport [GO:0006820]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN11763_c0_g2_i1	Q8BN82	S17A5_MOUSE	38.5	91	52	1	263	3	76	166	6.20E-10	64.7	S17A5_MOUSE	reviewed	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	Slc17a5	Mus musculus (Mouse)	495	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0022857; GO:0030672; GO:0031410	amino acid transport [GO:0006865]; anion transport [GO:0006820]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]		NA	NA	NA	NA	NA	NA
TRINITY_DN5246_c0_g1_i1	Q9NXL6	SIDT1_HUMAN	45.4	782	393	10	2367	94	56	827	3.80E-184	646.7	SIDT1_HUMAN	reviewed	SID1 transmembrane family member 1	SIDT1	Homo sapiens (Human)	827	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; RNA transport [GO:0050658]	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]	GO:0003725; GO:0005764; GO:0005886; GO:0015485; GO:0016021; GO:0050658; GO:0051033	RNA transport [GO:0050658]		NA	NA	NA	NA	NA	NA
TRINITY_DN12331_c0_g1_i1	Q9NXL6	SIDT1_HUMAN	62.5	48	18	0	213	70	769	816	3.80E-10	65.1	SIDT1_HUMAN	reviewed	SID1 transmembrane family member 1	SIDT1	Homo sapiens (Human)	827	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; RNA transport [GO:0050658]	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]	GO:0003725; GO:0005764; GO:0005886; GO:0015485; GO:0016021; GO:0050658; GO:0051033	RNA transport [GO:0050658]		NA	NA	NA	NA	NA	NA
TRINITY_DN20571_c0_g1_i1	Q9H9B4	SFXN1_HUMAN	98.8	251	3	0	754	2	8	258	9.20E-141	500.7	SFXN1_HUMAN	reviewed	Sideroflexin-1	SFXN1	Homo sapiens (Human)	322	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542	D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN20571_c0_g1_i2	Q9H9B4	SFXN1_HUMAN	100	313	0	0	941	3	8	320	4.80E-179	628.2	SFXN1_HUMAN	reviewed	Sideroflexin-1	SFXN1	Homo sapiens (Human)	322	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542	D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN152_c0_g1_i1	A5A761	SFXN1_PIG	64.3	314	111	1	1035	97	9	322	1.30E-117	424.5	SFXN1_PIG	reviewed	Sideroflexin-1	SFXN1	Sus scrofa (Pig)	322	integral component of mitochondrial inner membrane [GO:0031305]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]	D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542	D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		blue	blue	NA	NA	NA	NA
TRINITY_DN152_c0_g1_i4	A5A761	SFXN1_PIG	64.3	314	111	1	1035	97	9	322	9.80E-118	424.9	SFXN1_PIG	reviewed	Sideroflexin-1	SFXN1	Sus scrofa (Pig)	322	integral component of mitochondrial inner membrane [GO:0031305]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]	D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542	D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN34485_c0_g1_i1	Q99JR1	SFXN1_MOUSE	100	153	0	0	460	2	1	153	1.60E-87	323.2	SFXN1_MOUSE	reviewed	Sideroflexin-1	Sfxn1	Mus musculus (Mouse)	322	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0005743; GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542	D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN5023_c0_g1_i1	Q925N2	SFXN2_MOUSE	55.8	319	136	3	61	1017	9	322	6.40E-95	349	SFXN2_MOUSE	reviewed	Sideroflexin-2	Sfxn2	Mus musculus (Mouse)	322	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0005743; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN5023_c0_g1_i2	Q9VVW3	SFXN2_DROME	56.9	153	66	0	360	818	175	327	2.30E-42	174.1	SFXN2_DROME	reviewed	Sideroflexin-2	Sfxn2 CG6812	Drosophila melanogaster (Fruit fly)	327	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN5023_c0_g1_i2	Q9VVW3	SFXN2_DROME	43.8	112	63	0	58	393	8	119	2.20E-21	104.4	SFXN2_DROME	reviewed	Sideroflexin-2	Sfxn2 CG6812	Drosophila melanogaster (Fruit fly)	327	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN5023_c0_g1_i3	Q925N2	SFXN2_MOUSE	55.8	319	136	3	60	1016	9	322	4.90E-95	349.4	SFXN2_MOUSE	reviewed	Sideroflexin-2	Sfxn2	Mus musculus (Mouse)	322	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0005743; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN5023_c0_g1_i4	Q925N2	SFXN2_MOUSE	68.4	57	18	0	60	230	54	110	5.70E-17	87.8	SFXN2_MOUSE	reviewed	Sideroflexin-2	Sfxn2	Mus musculus (Mouse)	322	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0005743; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN152_c0_g1_i2	Q91V61	SFXN3_MOUSE	62.5	315	116	2	1038	97	8	321	1.50E-113	411	SFXN3_MOUSE	reviewed	Sideroflexin-3	Sfxn3	Mus musculus (Mouse)	321	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0031966; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN152_c0_g1_i3	Q91V61	SFXN3_MOUSE	69.8	192	57	1	907	335	8	199	1.50E-76	287.7	SFXN3_MOUSE	reviewed	Sideroflexin-3	Sfxn3	Mus musculus (Mouse)	321	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0031966; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN152_c0_g1_i3	Q91V61	SFXN3_MOUSE	60	80	32	0	336	97	242	321	1.10E-21	105.5	SFXN3_MOUSE	reviewed	Sideroflexin-3	Sfxn3	Mus musculus (Mouse)	321	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0031966; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN152_c0_g1_i5	Q91V61	SFXN3_MOUSE	62.5	315	116	2	1038	97	8	321	1.90E-113	410.6	SFXN3_MOUSE	reviewed	Sideroflexin-3	Sfxn3	Mus musculus (Mouse)	321	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0031966; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN33378_c0_g1_i1	Q91V61	SFXN3_MOUSE	100	186	0	0	561	4	18	203	1.50E-103	376.7	SFXN3_MOUSE	reviewed	Sideroflexin-3	Sfxn3	Mus musculus (Mouse)	321	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0031966; GO:0140300; GO:1990542	mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]		NA	NA	NA	NA	NA	NA
TRINITY_DN3044_c0_g1_i1	C4Y3D4	SEC11_CLAL4	42.4	85	47	1	271	23	3	87	5.90E-13	74.7	SEC11_CLAL4	reviewed	Signal peptidase complex catalytic subunit SEC11 (EC 3.4.21.89) (Signal peptidase I)	SEC11 CLUG_03047	Clavispora lusitaniae (strain ATCC 42720) (Yeast) (Candida lusitaniae)	166	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; serine-type endopeptidase activity [GO:0004252]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0006465; GO:0016021; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN14778_c0_g1_i1	P67810	SC11A_BOVIN	100	108	0	0	3	326	10	117	5.70E-55	214.5	SC11A_BOVIN	reviewed	Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18)	SEC11A SEC11L1 SPC18	Bos taurus (Bovine)	179	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN14778_c0_g1_i2	Q9R0P6	SC11A_MOUSE	100	167	0	0	37	537	1	167	1.60E-91	336.7	SC11A_MOUSE	reviewed	Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18) (Sid 2895)	Sec11a Sec11l1 Sid2895 Spc18	Mus musculus (Mouse)	179	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN35393_c0_g1_i1	Q9R0P6	SC11A_MOUSE	81	179	34	0	563	27	1	179	1.20E-80	300.8	SC11A_MOUSE	reviewed	Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18) (Sid 2895)	Sec11a Sec11l1 Sid2895 Spc18	Mus musculus (Mouse)	179	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		blue	blue	NA	NA	NA	NA
TRINITY_DN38802_c0_g1_i1	Q9WTR7	SC11C_RAT	62	158	59	1	472	2	28	185	7.50E-48	191.4	SC11C_RAT	reviewed	Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)	Sec11c Sec11l3 Spc21	Rattus norvegicus (Rat)	192	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN16022_c0_g1_i1	Q9BY50	SC11C_HUMAN	100	192	0	0	599	24	1	192	1.00E-105	384	SC11C_HUMAN	reviewed	Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)	SEC11C SEC11L3 SPC21 SPCS4C	Homo sapiens (Human)	192	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN16022_c0_g2_i1	P13679	SC11C_CANLF	100	167	0	0	504	4	19	185	2.00E-91	336.3	SC11C_CANLF	reviewed	Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)	SEC11C SEC11L3 SPC21	Canis lupus familiaris (Dog) (Canis familiaris)	192	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN23135_c0_g1_i1	P13679	SC11C_CANLF	80.6	103	20	0	312	4	47	149	3.10E-42	172.2	SC11C_CANLF	reviewed	Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)	SEC11C SEC11L3 SPC21	Canis lupus familiaris (Dog) (Canis familiaris)	192	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021	signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN13591_c0_g1_i1	Q3T134	SPCS1_BOVIN	58.1	74	31	0	233	12	12	85	2.00E-19	97.1	SPCS1_BOVIN	reviewed	Signal peptidase complex subunit 1 (EC 3.4.-.-) (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit)	SPCS1	Bos taurus (Bovine)	102	integral component of endoplasmic reticulum membrane [GO:0030176]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	integral component of endoplasmic reticulum membrane [GO:0030176]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0006465; GO:0008233; GO:0030176; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		blue	blue	NA	NA	NA	NA
TRINITY_DN10605_c0_g1_i1	Q28250	SPCS2_CANLF	100	121	0	0	363	1	64	184	3.10E-65	248.8	SPCS2_CANLF	reviewed	Signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit)	SPCS2 SPC25	Canis lupus familiaris (Dog) (Canis familiaris)	226	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN10605_c0_g1_i2	Q28250	SPCS2_CANLF	100	148	0	0	444	1	37	184	7.50E-82	304.3	SPCS2_CANLF	reviewed	Signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit)	SPCS2 SPC25	Canis lupus familiaris (Dog) (Canis familiaris)	226	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN2471_c1_g1_i1	Q9VCA9	SPCS3_DROME	55.7	174	77	0	79	600	1	174	5.80E-52	205.7	SPCS3_DROME	reviewed	Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit)	Spase22-23 CG5677	Drosophila melanogaster (Fruit fly)	179	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN2471_c1_g1_i2	Q9VCA9	SPCS3_DROME	57.4	136	58	0	79	486	1	136	4.50E-41	169.1	SPCS3_DROME	reviewed	Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit)	Spase22-23 CG5677	Drosophila melanogaster (Fruit fly)	179	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]		brown	brown	NA	NA	NA	NA
TRINITY_DN36184_c0_g1_i1	Q3SZU5	SPCS3_BOVIN	100	180	0	0	27	566	1	180	7.80E-100	364.4	SPCS3_BOVIN	reviewed	Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit)	SPCS3	Bos taurus (Bovine)	180	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; viral protein processing [GO:0019082]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	peptidase activity [GO:0008233]	GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0019082; GO:0045047	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; viral protein processing [GO:0019082]		NA	NA	NA	NA	NA	NA
TRINITY_DN31115_c0_g1_i1	O81062	SIP_ARATH	59.3	91	37	0	357	85	164	254	1.20E-21	104	SIP_ARATH	reviewed	Signal peptide peptidase (AtSPP) (EC 3.4.23.-) (Intramembrane protease) (IMP) (IMPAS)	SPP At2g03120 T18E12.21	Arabidopsis thaliana (Mouse-ear cress)	344	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; membrane protein proteolysis [GO:0033619]; pollen development [GO:0009555]; pollen germination [GO:0009846]; signal peptide processing [GO:0006465]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]"	GO:0005783; GO:0005789; GO:0006465; GO:0009555; GO:0009846; GO:0033619; GO:0042500; GO:0071458; GO:0071556	membrane protein proteolysis [GO:0033619]; pollen development [GO:0009555]; pollen germination [GO:0009846]; signal peptide processing [GO:0006465]		NA	NA	NA	NA	NA	NA
TRINITY_DN26005_c0_g1_i1	Q8TCT8	SPP2A_HUMAN	100	78	0	0	1	234	292	369	6.00E-38	157.5	SPP2A_HUMAN	reviewed	Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2)	SPPL2A IMP3 PSL2 PSEC0147	Homo sapiens (Human)	520	"extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]"	extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0005765; GO:0005770; GO:0005886; GO:0006509; GO:0010803; GO:0016020; GO:0030660; GO:0031293; GO:0031902; GO:0033619; GO:0042500; GO:0042803; GO:0043231; GO:0050776; GO:0070062; GO:0071458; GO:0071556	membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]		NA	NA	NA	NA	NA	NA
TRINITY_DN1758_c0_g1_i1	Q5PQL3	SPP2B_RAT	39.1	486	273	8	1544	111	22	492	1.40E-75	285.4	SPP2B_RAT	reviewed	Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-)	Sppl2b	Rattus norvegicus (Rat)	577	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556	membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]		NA	NA	NA	NA	NA	NA
TRINITY_DN1758_c0_g1_i2	Q5PQL3	SPP2B_RAT	39.1	486	273	8	1536	103	22	492	1.00E-75	285.8	SPP2B_RAT	reviewed	Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-)	Sppl2b	Rattus norvegicus (Rat)	577	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; Golgi membrane [GO:0000139]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556	membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]		NA	NA	NA	NA	NA	NA
TRINITY_DN28534_c0_g1_i1	Q4V3B8	SIPL3_ARATH	58.3	60	22	1	6	185	368	424	1.50E-11	69.7	SIPL3_ARATH	reviewed	Signal peptide peptidase-like 3 (AtSPPL3) (EC 3.4.23.-)	SPPL3 At2g43070 F14B2 MLF8	Arabidopsis thaliana (Mouse-ear cress)	540	"endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; membrane protein proteolysis [GO:0033619]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]"	GO:0005765; GO:0005768; GO:0005774; GO:0010008; GO:0030660; GO:0033619; GO:0042500; GO:0071458; GO:0071556	membrane protein proteolysis [GO:0033619]		NA	NA	NA	NA	NA	NA
TRINITY_DN2358_c0_g1_i1	Q8TCT6	SPPL3_HUMAN	76.9	39	9	0	286	170	8	46	4.20E-09	62	SPPL3_HUMAN	reviewed	Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4)	SPPL3 IMP2 PSL4	Homo sapiens (Human)	384	"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]"	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0032092; GO:0033116; GO:0033619; GO:0035307; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0071458; GO:0071556	membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN2358_c0_g1_i2	Q8TCT6	SPPL3_HUMAN	69.1	376	106	5	1214	102	8	378	1.80E-141	503.8	SPPL3_HUMAN	reviewed	Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4)	SPPL3 IMP2 PSL4	Homo sapiens (Human)	384	"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]"	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0032092; GO:0033116; GO:0033619; GO:0035307; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0071458; GO:0071556	membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN1160_c0_g1_i1	P09132	SRP19_HUMAN	50.3	147	66	3	515	87	1	144	1.30E-25	117.9	SRP19_HUMAN	reviewed	Signal recognition particle 19 kDa protein (SRP19)	SRP19	Homo sapiens (Human)	144	"cytosol [GO:0005829]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006614; GO:0006617; GO:0008312; GO:0048500	"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1160_c0_g1_i2	P09132	SRP19_HUMAN	50.3	147	66	3	515	87	1	144	1.30E-25	117.9	SRP19_HUMAN	reviewed	Signal recognition particle 19 kDa protein (SRP19)	SRP19	Homo sapiens (Human)	144	"cytosol [GO:0005829]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006614; GO:0006617; GO:0008312; GO:0048500	"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25457_c0_g1_i1	P14576	SRP54_MOUSE	78.9	498	103	1	1599	112	1	498	7.70E-228	791.2	SRP54_MOUSE	reviewed	Signal recognition particle 54 kDa protein (SRP54) (EC 3.6.5.-)	Srp54	Mus musculus (Mouse)	504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]	GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0008144; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021	"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		blue	blue	NA	NA	NA	NA
TRINITY_DN12717_c0_g1_i1	Q2T9U1	SRP54_BOVIN	100	503	0	0	1511	3	1	503	1.20E-283	976.5	SRP54_BOVIN	reviewed	Signal recognition particle 54 kDa protein (SRP54) (EC 3.6.5.-)	SRP54	Bos taurus (Bovine)	504	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]	GO:0003924; GO:0005525; GO:0005634; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021; GO:0045047	"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12717_c0_g1_i2	Q2T9U1	SRP54_BOVIN	100	503	0	0	1511	3	1	503	1.20E-283	976.5	SRP54_BOVIN	reviewed	Signal recognition particle 54 kDa protein (SRP54) (EC 3.6.5.-)	SRP54	Bos taurus (Bovine)	504	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]	GO:0003924; GO:0005525; GO:0005634; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021; GO:0045047	"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8103_c0_g1_i1	Q2T9U1	SRP54_BOVIN	66.5	215	72	0	1	645	82	296	1.20E-83	310.8	SRP54_BOVIN	reviewed	Signal recognition particle 54 kDa protein (SRP54) (EC 3.6.5.-)	SRP54	Bos taurus (Bovine)	504	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]	GO:0003924; GO:0005525; GO:0005634; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021; GO:0045047	"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4913_c0_g1_i1	Q6AYB5	SRP54_RAT	56.1	253	110	1	758	3	71	323	3.10E-75	283.1	SRP54_RAT	reviewed	Signal recognition particle 54 kDa protein (SRP54) (EC 3.6.5.-)	Srp54	Rattus norvegicus (Rat)	504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribonucleoprotein complex binding [GO:0043021]	GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008144; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0042493; GO:0043021; GO:0045047	"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35478_c0_g1_i1	P49968	SR541_HORVU	47.6	82	42	1	3	248	342	422	2.20E-14	79.3	SR541_HORVU	reviewed	Signal recognition particle 54 kDa protein 1 (SRP54)	SRP54-1	Hordeum vulgare (Barley)	497	"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005786; GO:0006614; GO:0008312	SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN13_c0_g1_i1	P49967	SR543_ARATH	66.9	248	82	0	746	3	86	333	1.70E-94	347.1	SR543_ARATH	reviewed	Signal recognition particle 54 kDa protein 3 (SRP54)	SRP-54C At1g48900 F27K7.8	Arabidopsis thaliana (Mouse-ear cress)	495	"cytosol [GO:0005829]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytosol [GO:0005829]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0030942	"SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8103_c0_g2_i1	P49967	SR543_ARATH	53.4	88	40	1	263	3	302	389	1.70E-20	99.8	SR543_ARATH	reviewed	Signal recognition particle 54 kDa protein 3 (SRP54)	SRP-54C At1g48900 F27K7.8	Arabidopsis thaliana (Mouse-ear cress)	495	"cytosol [GO:0005829]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytosol [GO:0005829]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0030942	"SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32024_c0_g1_i1	Q3MHE8	SRPRA_BOVIN	38.9	90	52	1	2	262	548	637	1.40E-14	80.1	SRPRA_BOVIN	reviewed	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)	SRPRA SRPR	Bos taurus (Bovine)	639	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]	GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006614; GO:0016020; GO:0045047	protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN11807_c0_g1_i1	P08240	SRPRA_HUMAN	100	273	0	0	885	67	366	638	2.90E-149	529.3	SRPRA_HUMAN	reviewed	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)	SRPRA SRPR	Homo sapiens (Human)	638	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	GO:0003723; GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006613; GO:0006614; GO:0016020; GO:0036498; GO:0045047; GO:0070062	cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN11471_c0_g1_i1	Q3MHE8	SRPRA_BOVIN	42.9	119	64	2	1	354	15	130	9.50E-20	98.2	SRPRA_BOVIN	reviewed	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)	SRPRA SRPR	Bos taurus (Bovine)	639	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]	GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006614; GO:0016020; GO:0045047	protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		blue	blue	NA	NA	NA	NA
TRINITY_DN538_c0_g1_i1	Q3MHE8	SRPRA_BOVIN	62.3	215	66	3	661	56	426	638	4.60E-67	255.8	SRPRA_BOVIN	reviewed	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)	SRPRA SRPR	Bos taurus (Bovine)	639	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]	GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006614; GO:0016020; GO:0045047	protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN5068_c0_g1_i1	P08240	SRPRA_HUMAN	74.7	288	73	0	2	865	350	637	6.70E-120	431.8	SRPRA_HUMAN	reviewed	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)	SRPRA SRPR	Homo sapiens (Human)	638	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	GO:0003723; GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006613; GO:0006614; GO:0016020; GO:0036498; GO:0045047; GO:0070062	cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		blue	blue	NA	NA	NA	NA
TRINITY_DN16759_c0_g1_i1	O43032	SRPR_SCHPO	54	87	39	1	272	15	337	423	6.90E-20	97.8	SRPR_SCHPO	reviewed	Signal recognition particle receptor subunit alpha homolog (SR-alpha) (Docking protein alpha) (DP-alpha)	srp101 SPBC3B9.03	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	547	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]	GO:0003924; GO:0005047; GO:0005525; GO:0005634; GO:0005785; GO:0005789; GO:0005829; GO:0006605; GO:0006614; GO:0016020; GO:0045047	protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN918_c0_g1_i1	Q9Y5M8	SRPRB_HUMAN	42.3	272	141	6	859	86	2	271	6.90E-45	182.6	SRPRB_HUMAN	reviewed	Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1)	SRPRB PSEC0230	Homo sapiens (Human)	271	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; IRE1-mediated unfolded protein response [GO:0036498]; protein targeting to ER [GO:0045047]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005785; GO:0005789; GO:0005881; GO:0016020; GO:0016021; GO:0036498; GO:0045047	IRE1-mediated unfolded protein response [GO:0036498]; protein targeting to ER [GO:0045047]		blue	blue	NA	NA	NA	NA
TRINITY_DN4112_c0_g1_i1	Q9VSS2	SRP68_DROME	49.1	108	50	2	5	316	73	179	5.80E-21	102.1	SRP68_DROME	reviewed	Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)	Srp68 CG5064	Drosophila melanogaster (Fruit fly)	604	"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; signal recognition particle binding [GO:0005047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; signal recognition particle binding [GO:0005047]	GO:0005047; GO:0005786; GO:0006614; GO:0008312; GO:0030942	SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN4112_c0_g1_i2	Q9UHB9	SRP68_HUMAN	41.2	177	99	2	8	538	103	274	2.40E-32	140.2	SRP68_HUMAN	reviewed	Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)	SRP68	Homo sapiens (Human)	627	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	GO:0003723; GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0005840; GO:0005925; GO:0006614; GO:0008312; GO:0019904; GO:0030942; GO:0042493; GO:0048500	response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN4112_c0_g1_i3	Q9UHB9	SRP68_HUMAN	42.8	290	151	8	8	853	103	385	1.50E-54	214.5	SRP68_HUMAN	reviewed	Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)	SRP68	Homo sapiens (Human)	627	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	GO:0003723; GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0005840; GO:0005925; GO:0006614; GO:0008312; GO:0019904; GO:0030942; GO:0042493; GO:0048500	response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN29042_c0_g1_i1	Q00004	SRP68_CANLF	100	73	0	0	3	221	118	190	1.90E-33	142.5	SRP68_CANLF	reviewed	Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)	SRP68	Canis lupus familiaris (Dog) (Canis familiaris)	622	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]	GO:0005047; GO:0005730; GO:0005786; GO:0005829; GO:0005925; GO:0006614; GO:0008312; GO:0019904; GO:0030942; GO:0042493; GO:0043022	response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN37170_c0_g1_i1	P33731	SRP72_CANLF	42.6	94	52	1	2	283	96	187	7.30E-14	77.8	SRP72_CANLF	reviewed	Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)	SRP72	Canis lupus familiaris (Dog) (Canis familiaris)	671	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	7S RNA binding [GO:0008312]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]	GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022	SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		blue	blue	NA	NA	NA	NA
TRINITY_DN9880_c0_g1_i2	P42229	STA5A_HUMAN	99.5	192	1	0	2	577	388	579	7.90E-108	391	STA5A_HUMAN	reviewed	Signal transducer and activator of transcription 5A	STAT5A STAT5	Homo sapiens (Human)	794	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001938; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007595; GO:0019221; GO:0019530; GO:0035723; GO:0038026; GO:0038110; GO:0038111; GO:0038113; GO:0040014; GO:0042127; GO:0043434; GO:0043536; GO:0045944; GO:0060397	cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]		NA	NA	NA	NA	NA	NA
TRINITY_DN13342_c0_g1_i1	Q62771	STA5A_RAT	100	74	0	0	1	222	320	393	3.20E-33	141.7	STA5A_RAT	reviewed	Signal transducer and activator of transcription 5A (Mammary gland factor)	Stat5a Mgf	Rattus norvegicus (Rat)	793	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; phosphate ion binding [GO:0042301]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to cytokine stimulus [GO:0071345]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; mammary gland epithelium development [GO:0061180]; mammary gland involution [GO:0060056]; multicellular organismal reproductive process [GO:0048609]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mast cell apoptotic process [GO:0033026]; peptidyl-tyrosine phosphorylation [GO:0018108]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; receptor signaling pathway via JAK-STAT [GO:0007259]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; phosphate ion binding [GO:0042301]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001938; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0018108; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0031667; GO:0032743; GO:0032825; GO:0033026; GO:0033077; GO:0038026; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042301; GO:0043029; GO:0043066; GO:0043434; GO:0043536; GO:0043565; GO:0045471; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0048541; GO:0048609; GO:0050729; GO:0060056; GO:0060376; GO:0060397; GO:0060740; GO:0060742; GO:0061180; GO:0070668; GO:0071345; GO:0071407; GO:0097011	"cellular response to cytokine stimulus [GO:0071345]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; mammary gland epithelium development [GO:0061180]; mammary gland involution [GO:0060056]; multicellular organismal reproductive process [GO:0048609]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mast cell apoptotic process [GO:0033026]; peptidyl-tyrosine phosphorylation [GO:0018108]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; receptor signaling pathway via JAK-STAT [GO:0007259]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25769_c0_g1_i1	Q95115	STA5A_BOVIN	100	68	0	0	204	1	3	70	2.30E-33	142.1	STA5A_BOVIN	reviewed	Signal transducer and activator of transcription 5A (Mammary gland factor)	STAT5A MGF	Bos taurus (Bovine)	794	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; response to peptide hormone [GO:0043434]; T cell homeostasis [GO:0043029]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0032743; GO:0040018; GO:0042104; GO:0042127; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045647; GO:0045931; GO:0045944; GO:0046543; GO:0050729; GO:0060397	cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; response to peptide hormone [GO:0043434]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i1	P42232	STA5B_MOUSE	45.7	773	383	16	60	2321	1	755	9.90E-171	602.1	STA5B_MOUSE	reviewed	Signal transducer and activator of transcription 5B	Stat5b	Mus musculus (Mouse)	786	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001889; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006952; GO:0006953; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030155; GO:0030856; GO:0032355; GO:0032496; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0043029; GO:0043066; GO:0043434; GO:0043565; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0048661; GO:0050729; GO:0051272; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531	"acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i3	P42232	STA5B_MOUSE	44.9	793	381	17	92	2416	1	755	8.70E-170	599	STA5B_MOUSE	reviewed	Signal transducer and activator of transcription 5B	Stat5b	Mus musculus (Mouse)	786	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001889; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006952; GO:0006953; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030155; GO:0030856; GO:0032355; GO:0032496; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0043029; GO:0043066; GO:0043434; GO:0043565; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0048661; GO:0050729; GO:0051272; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531	"acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i4	P42232	STA5B_MOUSE	44.9	793	381	17	60	2384	1	755	1.50E-169	598.2	STA5B_MOUSE	reviewed	Signal transducer and activator of transcription 5B	Stat5b	Mus musculus (Mouse)	786	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001889; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006952; GO:0006953; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030155; GO:0030856; GO:0032355; GO:0032496; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0043029; GO:0043066; GO:0043434; GO:0043565; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0048661; GO:0050729; GO:0051272; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531	"acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i5	Q9TUM3	STA5B_BOVIN	45.1	689	325	15	118	2127	102	756	3.20E-147	523.9	STA5B_BOVIN	reviewed	Signal transducer and activator of transcription 5B	STAT5B	Bos taurus (Bovine)	787	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]	GO:0001553; GO:0001779; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0032743; GO:0040018; GO:0042104; GO:0042448; GO:0043029; GO:0043066; GO:0045579; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0046543; GO:0046544; GO:0046983; GO:0050729; GO:0060397; GO:0071363; GO:0071364	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i6	Q9TUM3	STA5B_BOVIN	45.1	689	325	15	80	2089	102	756	5.30E-147	523.1	STA5B_BOVIN	reviewed	Signal transducer and activator of transcription 5B	STAT5B	Bos taurus (Bovine)	787	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]	GO:0001553; GO:0001779; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0032743; GO:0040018; GO:0042104; GO:0042448; GO:0043029; GO:0043066; GO:0045579; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0046543; GO:0046544; GO:0046983; GO:0050729; GO:0060397; GO:0071363; GO:0071364	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i7	Q9TUM3	STA5B_BOVIN	46	669	327	14	118	2064	102	756	1.60E-148	528.1	STA5B_BOVIN	reviewed	Signal transducer and activator of transcription 5B	STAT5B	Bos taurus (Bovine)	787	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]	GO:0001553; GO:0001779; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0032743; GO:0040018; GO:0042104; GO:0042448; GO:0043029; GO:0043066; GO:0045579; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0046543; GO:0046544; GO:0046983; GO:0050729; GO:0060397; GO:0071363; GO:0071364	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN419_c0_g1_i8	P42232	STA5B_MOUSE	45.7	773	383	16	92	2353	1	755	7.70E-171	602.4	STA5B_MOUSE	reviewed	Signal transducer and activator of transcription 5B	Stat5b	Mus musculus (Mouse)	786	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001889; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006952; GO:0006953; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030155; GO:0030856; GO:0032355; GO:0032496; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0043029; GO:0043066; GO:0043434; GO:0043565; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0048661; GO:0050729; GO:0051272; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531	"acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39698_c0_g1_i1	P51692	STA5B_HUMAN	100	57	0	0	39	209	1	57	1.90E-27	122.5	STA5B_HUMAN	reviewed	Signal transducer and activator of transcription 5B	STAT5B	Homo sapiens (Human)	787	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045588; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0060397; GO:0070670; GO:0071363; GO:0071364; GO:0097531	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN9880_c0_g1_i1	P51692	STA5B_HUMAN	100	183	0	0	2	550	397	579	2.50E-103	375.9	STA5B_HUMAN	reviewed	Signal transducer and activator of transcription 5B	STAT5B	Homo sapiens (Human)	787	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045588; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0060397; GO:0070670; GO:0071363; GO:0071364; GO:0097531	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]		NA	NA	NA	NA	NA	NA
TRINITY_DN34581_c0_g1_i1	P42226	STAT6_HUMAN	100	106	0	0	318	1	346	451	1.70E-56	219.5	STAT6_HUMAN	reviewed	Signal transducer and activator of transcription 6 (IL-4 Stat)	STAT6	Homo sapiens (Human)	847	"cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-4-mediated signaling pathway [GO:0035771]; mammary gland epithelial cell proliferation [GO:0033598]; mammary gland morphogenesis [GO:0060443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296]"	cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002296; GO:0002829; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006952; GO:0007165; GO:0007259; GO:0019221; GO:0019903; GO:0032481; GO:0033598; GO:0035771; GO:0042127; GO:0042802; GO:0043434; GO:0045121; GO:0045944; GO:0048295; GO:0060397; GO:0060443; GO:0070301; GO:0120162; GO:1902170	cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-4-mediated signaling pathway [GO:0035771]; mammary gland epithelial cell proliferation [GO:0033598]; mammary gland morphogenesis [GO:0060443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296]		NA	NA	NA	NA	NA	NA
TRINITY_DN36826_c0_g1_i1	P52633	STAT6_MOUSE	100	76	0	0	229	2	375	450	3.80E-37	154.8	STAT6_MOUSE	reviewed	Signal transducer and transcription activator 6	Stat6	Mus musculus (Mouse)	837	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-4-mediated signaling pathway [GO:0035771]; mammary gland epithelial cell proliferation [GO:0033598]; mammary gland morphogenesis [GO:0060443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; response to cytokine [GO:0034097]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0002296; GO:0002829; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006952; GO:0007165; GO:0007259; GO:0019221; GO:0019903; GO:0033598; GO:0034097; GO:0035771; GO:0042127; GO:0042802; GO:0043434; GO:0043565; GO:0045121; GO:0045944; GO:0048295; GO:0060397; GO:0060443; GO:0070301; GO:0120162; GO:1902170	cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-4-mediated signaling pathway [GO:0035771]; mammary gland epithelial cell proliferation [GO:0033598]; mammary gland morphogenesis [GO:0060443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; response to cytokine [GO:0034097]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296]		NA	NA	NA	NA	NA	NA
TRINITY_DN32669_c0_g1_i1	Q92783	STAM1_HUMAN	45.8	107	55	2	2	322	39	142	4.20E-23	109	STAM1_HUMAN	reviewed	Signal transducing adapter molecule 1 (STAM-1)	STAM STAM1	Homo sapiens (Human)	540	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of exosomal secretion [GO:1903543]; protein deubiquitination [GO:0016579]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]	ubiquitin-like protein ligase binding [GO:0044389]	GO:0005829; GO:0007165; GO:0016197; GO:0016236; GO:0016579; GO:0031901; GO:0033565; GO:0036258; GO:0042059; GO:0043328; GO:0044389; GO:0061024; GO:1903543; GO:1903551	endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of exosomal secretion [GO:1903543]; protein deubiquitination [GO:0016579]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN32669_c0_g1_i2	P70297	STAM1_MOUSE	42.7	347	171	8	2	1030	39	361	1.70E-68	261.2	STAM1_MOUSE	reviewed	Signal transducing adapter molecule 1 (STAM-1)	Stam Stam1	Mus musculus (Mouse)	548	early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; ubiquitin-like protein ligase binding [GO:0044389]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]	early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]	ubiquitin-like protein ligase binding [GO:0044389]	GO:0031901; GO:0033565; GO:0043328; GO:0044389; GO:1903543; GO:1903551	positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]		NA	NA	NA	NA	NA	NA
TRINITY_DN15270_c0_g1_i1	Q8C0T5	SI1L1_MOUSE	31.5	327	163	10	871	2	202	504	7.10E-20	99.8	SI1L1_MOUSE	reviewed	Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1)	Sipa1l1 Kiaa0440	Mus musculus (Mouse)	1782	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of postsynaptic density assembly [GO:0099151]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]	actin filament binding [GO:0051015]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]	GO:0005096; GO:0005737; GO:0005856; GO:0014069; GO:0019901; GO:0031532; GO:0031625; GO:0032991; GO:0043025; GO:0043087; GO:0043197; GO:0044877; GO:0046875; GO:0048013; GO:0048167; GO:0048814; GO:0050770; GO:0051015; GO:0051056; GO:0061001; GO:0090630; GO:0098794; GO:0098974; GO:0098978; GO:0099151	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of postsynaptic density assembly [GO:0099151]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]		NA	NA	NA	NA	NA	NA
TRINITY_DN15345_c0_g1_i2	O43166	SI1L1_HUMAN	36.3	102	63	2	308	6	826	926	2.20E-12	73.2	SI1L1_HUMAN	reviewed	Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1)	SIPA1L1 E6TP1 KIAA0440	Homo sapiens (Human)	1804	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]	ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005856; GO:0014069; GO:0031532; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0050770; GO:0051056; GO:0061001; GO:0090630	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]		NA	NA	NA	NA	NA	NA
TRINITY_DN27448_c0_g1_i1	O43166	SI1L1_HUMAN	53.3	165	73	2	1	492	512	673	3.50E-43	176	SI1L1_HUMAN	reviewed	Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1)	SIPA1L1 E6TP1 KIAA0440	Homo sapiens (Human)	1804	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]	ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005856; GO:0014069; GO:0031532; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0050770; GO:0051056; GO:0061001; GO:0090630	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]		NA	NA	NA	NA	NA	NA
TRINITY_DN15345_c0_g1_i1	Q80TE4	SI1L2_MOUSE	55.1	225	95	4	674	6	703	923	2.90E-61	236.5	SI1L2_MOUSE	reviewed	Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2)	Sipa1l2 Kiaa0545	Mus musculus (Mouse)	1722	GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]		GTPase activator activity [GO:0005096]	GO:0005096; GO:0051056	regulation of small GTPase mediated signal transduction [GO:0051056]		NA	NA	NA	NA	NA	NA
TRINITY_DN25880_c0_g1_i1	Q96FS4	SIPA1_HUMAN	100	85	0	0	1	255	313	397	8.80E-43	173.7	SIPA1_HUMAN	reviewed	Signal-induced proliferation-associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1) (p130 SPA-1)	SIPA1 SPA1	Homo sapiens (Human)	1042	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]; GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]; cellular response to water deprivation [GO:0042631]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]	GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]	GO:0005096; GO:0005634; GO:0005829; GO:0007010; GO:0007162; GO:0007165; GO:0008022; GO:0016020; GO:0030133; GO:0030308; GO:0032991; GO:0035556; GO:0042631; GO:0045786; GO:0048471; GO:0051056	cellular response to water deprivation [GO:0042631]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30276_c0_g1_i1	Q96FS4	SIPA1_HUMAN	100	94	0	0	282	1	399	492	3.30E-51	201.8	SIPA1_HUMAN	reviewed	Signal-induced proliferation-associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1) (p130 SPA-1)	SIPA1 SPA1	Homo sapiens (Human)	1042	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]; GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]; cellular response to water deprivation [GO:0042631]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]	GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]	GO:0005096; GO:0005634; GO:0005829; GO:0007010; GO:0007162; GO:0007165; GO:0008022; GO:0016020; GO:0030133; GO:0030308; GO:0032991; GO:0035556; GO:0042631; GO:0045786; GO:0048471; GO:0051056	cellular response to water deprivation [GO:0042631]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37162_c0_g1_i1	Q9ZHC7	SILP_SALTM	64.2	123	44	0	1	369	368	490	1.90E-38	159.8	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN31234_c0_g1_i1	Q9ZHC7	SILP_SALTM	72.4	134	37	0	403	2	376	509	1.00E-48	194.1	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	1
TRINITY_DN37774_c0_g1_i1	Q9ZHC7	SILP_SALTM	68.3	63	20	0	7	195	388	450	1.00E-17	90.1	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN28330_c0_g1_i1	Q9ZHC7	SILP_SALTM	60.2	83	33	0	251	3	458	540	4.60E-20	98.2	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN35414_c0_g1_i1	Q9ZHC7	SILP_SALTM	64.3	98	35	0	301	8	332	429	6.00E-30	131.3	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN36063_c0_g1_i1	Q9ZHC7	SILP_SALTM	59.7	149	60	0	2	448	309	457	2.00E-45	183.3	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5015_c0_g1_i1	Q9ZHC7	SILP_SALTM	59	83	34	0	257	9	679	761	6.80E-19	94.4	SILP_SALTM	reviewed	Silver exporting P-type ATPase (EC 7.2.2.15)	silP	Salmonella typhimurium	824	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; silver transmembrane transporter activity, phosphorylative mechanism [GO:0015445]"	GO:0005524; GO:0005886; GO:0015445; GO:0016021; GO:0016491; GO:0046872			NA	NA	NA	NA	NA	1
TRINITY_DN1448_c0_g1_i1	A6H6W9	SDS3_BOVIN	43.3	127	65	1	452	93	164	290	2.10E-23	110.9	SDS3_BOVIN	reviewed	Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog)	SUDS3 SDS3	Bos taurus (Bovine)	328	nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]	nucleus [GO:0005634]; Sin3-type complex [GO:0070822]	histone deacetylase binding [GO:0042826]	GO:0000122; GO:0005634; GO:0006915; GO:0016575; GO:0042826; GO:0043065; GO:0070822	apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN1448_c0_g1_i2	A6H6W9	SDS3_BOVIN	43	165	87	1	560	87	164	328	1.20E-32	141.7	SDS3_BOVIN	reviewed	Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog)	SUDS3 SDS3	Bos taurus (Bovine)	328	nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]	nucleus [GO:0005634]; Sin3-type complex [GO:0070822]	histone deacetylase binding [GO:0042826]	GO:0000122; GO:0005634; GO:0006915; GO:0016575; GO:0042826; GO:0043065; GO:0070822	apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN25918_c0_g1_i1	Q9NP50	SHCAF_HUMAN	100	89	0	0	60	326	1	89	2.80E-49	195.7	SHCAF_HUMAN	reviewed	SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog)	SINHCAF C12orf14 FAM60A L4	Homo sapiens (Human)	221	Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]	Sin3 complex [GO:0016580]		GO:0008284; GO:0016580; GO:0030336; GO:0045596	negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN2400_c0_g1_i1	Q8C8M1	SHCAF_MOUSE	45.6	248	95	5	98	826	1	213	1.10E-49	198.7	SHCAF_MOUSE	reviewed	SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein)	Sinhcaf Fam60a Tera	Mus musculus (Mouse)	221	Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]	Sin3 complex [GO:0016580]		GO:0008284; GO:0016580; GO:0030336; GO:0045596	negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN2400_c0_g1_i2	Q8C8M1	SHCAF_MOUSE	45.6	248	95	5	95	823	1	213	1.10E-49	198.7	SHCAF_MOUSE	reviewed	SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein)	Sinhcaf Fam60a Tera	Mus musculus (Mouse)	221	Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]	Sin3 complex [GO:0016580]		GO:0008284; GO:0016580; GO:0030336; GO:0045596	negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]		blue	blue	NA	NA	NA	NA
TRINITY_DN7868_c0_g1_i13	Q6IA17	SIGIR_HUMAN	24.7	247	147	8	815	120	24	246	2.10E-08	62	SIGIR_HUMAN	reviewed	Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8)	SIGIRR UNQ301/PRO342	Homo sapiens (Human)	410	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acute-phase response [GO:0006953]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0001960; GO:0005886; GO:0006953; GO:0007165; GO:0016020; GO:0016021; GO:0031665; GO:0043433; GO:0045079; GO:0071345	acute-phase response [GO:0006953]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7868_c0_g1_i14	Q6IA17	SIGIR_HUMAN	24	288	173	9	1388	570	24	280	2.10E-09	65.9	SIGIR_HUMAN	reviewed	Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8)	SIGIRR UNQ301/PRO342	Homo sapiens (Human)	410	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acute-phase response [GO:0006953]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0001960; GO:0005886; GO:0006953; GO:0007165; GO:0016020; GO:0016021; GO:0031665; GO:0043433; GO:0045079; GO:0071345	acute-phase response [GO:0006953]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7868_c0_g1_i2	Q9JLZ8	SIGIR_MOUSE	30.4	181	106	6	638	120	77	245	4.00E-09	64.3	SIGIR_MOUSE	reviewed	Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8)	Sigirr Tir8	Mus musculus (Mouse)	409	integral component of membrane [GO:0016021]; membrane [GO:0016020]; acute-phase response [GO:0006953]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001960; GO:0006953; GO:0007165; GO:0016020; GO:0016021; GO:0043433; GO:0045079	acute-phase response [GO:0006953]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7868_c0_g1_i5	Q9JLZ8	SIGIR_MOUSE	28.4	222	132	7	1211	570	77	279	3.00E-10	68.6	SIGIR_MOUSE	reviewed	Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8)	Sigirr Tir8	Mus musculus (Mouse)	409	integral component of membrane [GO:0016021]; membrane [GO:0016020]; acute-phase response [GO:0006953]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001960; GO:0006953; GO:0007165; GO:0016020; GO:0016021; GO:0043433; GO:0045079	acute-phase response [GO:0006953]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7868_c0_g1_i8	Q9JLZ8	SIGIR_MOUSE	27.9	229	133	8	1238	570	77	279	1.40E-10	69.7	SIGIR_MOUSE	reviewed	Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8)	Sigirr Tir8	Mus musculus (Mouse)	409	integral component of membrane [GO:0016021]; membrane [GO:0016020]; acute-phase response [GO:0006953]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001960; GO:0006953; GO:0007165; GO:0016020; GO:0016021; GO:0043433; GO:0045079	acute-phase response [GO:0006953]; negative regulation of chemokine biosynthetic process [GO:0045079]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2806_c0_g1_i1	Q14190	SIM2_HUMAN	25.1	203	98	4	9	578	112	273	2.50E-08	60.5	SIM2_HUMAN	reviewed	Single-minded homolog 2 (Class E basic helix-loop-helix protein 15) (bHLHe15)	SIM2 BHLHE15	Homo sapiens (Human)	667	"nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; lung development [GO:0030324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005654; GO:0006357; GO:0007399; GO:0009880; GO:0016604; GO:0030154; GO:0030324; GO:0046982	cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; lung development [GO:0030324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN7076_c0_g1_i1	Q53HV7	SMUG1_HUMAN	52.6	154	70	2	1	459	110	261	6.70E-38	158.7	SMUG1_HUMAN	reviewed	Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-)	SMUG1	Homo sapiens (Human)	270	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; identical protein binding [GO:0042802]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; identical protein binding [GO:0042802]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0000703; GO:0001650; GO:0003677; GO:0004844; GO:0005654; GO:0005730; GO:0005829; GO:0006284; GO:0017065; GO:0019104; GO:0042802; GO:0045008	base-excision repair [GO:0006284]; depyrimidination [GO:0045008]		NA	NA	NA	NA	NA	NA
TRINITY_DN7076_c0_g1_i4	Q53HV7	SMUG1_HUMAN	52.6	154	70	2	1	459	110	261	6.70E-38	158.7	SMUG1_HUMAN	reviewed	Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-)	SMUG1	Homo sapiens (Human)	270	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; identical protein binding [GO:0042802]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; identical protein binding [GO:0042802]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0000703; GO:0001650; GO:0003677; GO:0004844; GO:0005654; GO:0005730; GO:0005829; GO:0006284; GO:0017065; GO:0019104; GO:0042802; GO:0045008	base-excision repair [GO:0006284]; depyrimidination [GO:0045008]		NA	NA	NA	NA	NA	NA
TRINITY_DN7076_c0_g1_i5	Q9YGN6	SMUG1_XENLA	47.1	157	82	1	1	471	121	276	4.80E-38	159.1	SMUG1_XENLA	reviewed	Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-)	smug1	Xenopus laevis (African clawed frog)	281	nucleus [GO:0005634]; DNA binding [GO:0003677]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; base-excision repair [GO:0006284]	nucleus [GO:0005634]	DNA binding [GO:0003677]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]	GO:0003677; GO:0005634; GO:0006284; GO:0017065	base-excision repair [GO:0006284]		NA	NA	NA	NA	NA	NA
TRINITY_DN1842_c0_g1_i1	Q9CYZ8	SSBP2_MOUSE	48.3	120	42	6	370	23	90	193	3.00E-07	56.2	SSBP2_MOUSE	reviewed	Single-stranded DNA-binding protein 2 (Sequence-specific single-stranded-DNA-binding protein 2)	Ssbp2 Ssdp2	Mus musculus (Mouse)	361	cytoplasm [GO:0005737]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0005634; GO:0005737; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN1842_c0_g1_i2	Q9CYZ8	SSBP2_MOUSE	51.7	118	29	6	395	54	90	183	3.70E-08	59.3	SSBP2_MOUSE	reviewed	Single-stranded DNA-binding protein 2 (Sequence-specific single-stranded-DNA-binding protein 2)	Ssbp2 Ssdp2	Mus musculus (Mouse)	361	cytoplasm [GO:0005737]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0005634; GO:0005737; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN11484_c1_g1_i1	P54622	SSBP_DROME	56.2	112	44	3	216	545	33	141	2.40E-28	127.1	SSBP_DROME	reviewed	"Single-stranded DNA-binding protein, mitochondrial (Dm mtSSB) (Mt-SSB) (MtSSB) (Protein low power)"	mtSSB lopo CG4337	Drosophila melanogaster (Fruit fly)	146	mitochondrial chromosome [GO:0000262]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoid [GO:0009295]; single-stranded DNA binding [GO:0003697]; DNA synthesis involved in DNA replication [GO:0090592]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of exodeoxyribonuclease activity [GO:1902394]; positive regulation of helicase activity [GO:0051096]; positive regulation of mitochondrial DNA replication [GO:0090297]	mitochondrial chromosome [GO:0000262]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoid [GO:0009295]	single-stranded DNA binding [GO:0003697]	GO:0000002; GO:0000262; GO:0003697; GO:0005739; GO:0006264; GO:0006268; GO:0009295; GO:0042645; GO:0051096; GO:0090297; GO:0090592; GO:1900264; GO:1902394	DNA synthesis involved in DNA replication [GO:0090592]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of exodeoxyribonuclease activity [GO:1902394]; positive regulation of helicase activity [GO:0051096]; positive regulation of mitochondrial DNA replication [GO:0090297]		NA	NA	NA	NA	NA	NA
TRINITY_DN2345_c0_g1_i1	Q66I84	DCC1_DANRE	38.3	389	232	4	1255	104	1	386	2.10E-74	281.2	DCC1_DANRE	reviewed	Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog)	dscc1 dcc1 zgc:103507	Danio rerio (Zebrafish) (Brachydanio rerio)	391	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]"	DNA binding [GO:0003677]	GO:0000775; GO:0000785; GO:0003677; GO:0005654; GO:0006260; GO:0006275; GO:0031390; GO:0034088	DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; regulation of DNA replication [GO:0006275]		blue	blue	NA	NA	NA	NA
TRINITY_DN1258_c0_g1_i1	Q5U241	PD5BB_XENLA	41.3	1209	659	18	3865	314	7	1189	6.60E-254	879	PD5BB_XENLA	reviewed	Sister chromatid cohesion protein PDS5 homolog B-B (Androgen-induced proliferation inhibitor B)	pds5b-b aprin-b	Xenopus laevis (African clawed frog)	1464	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007064; GO:0008285; GO:0051301	cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN1258_c0_g1_i5	Q5U241	PD5BB_XENLA	50.2	402	196	3	1228	26	7	405	2.80E-116	420.2	PD5BB_XENLA	reviewed	Sister chromatid cohesion protein PDS5 homolog B-B (Androgen-induced proliferation inhibitor B)	pds5b-b aprin-b	Xenopus laevis (African clawed frog)	1464	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007064; GO:0008285; GO:0051301	cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN1258_c0_g1_i6	Q5U241	PD5BB_XENLA	43.6	878	477	11	2703	82	7	870	2.80E-203	710.3	PD5BB_XENLA	reviewed	Sister chromatid cohesion protein PDS5 homolog B-B (Androgen-induced proliferation inhibitor B)	pds5b-b aprin-b	Xenopus laevis (African clawed frog)	1464	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007064; GO:0008285; GO:0051301	cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN1258_c0_g1_i7	Q5U241	PD5BB_XENLA	43.6	878	477	11	2703	82	7	870	2.80E-203	710.3	PD5BB_XENLA	reviewed	Sister chromatid cohesion protein PDS5 homolog B-B (Androgen-induced proliferation inhibitor B)	pds5b-b aprin-b	Xenopus laevis (African clawed frog)	1464	nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0007064; GO:0008285; GO:0051301	cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN27190_c0_g1_i1	Q02225	SKI_XENLA	46.5	273	116	8	790	32	61	323	3.90E-60	233.8	SKI_XENLA	reviewed	Ski oncogene (Proto-oncogene c-Ski)	ski	Xenopus laevis (African clawed frog)	717	"nucleus [GO:0005634]; SMAD binding [GO:0046332]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	SMAD binding [GO:0046332]	GO:0005634; GO:0006351; GO:0046332	"transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15475_c1_g1_i1	G5ECU1	SKR1_CAEEL	50	86	38	2	8	253	32	116	6.20E-17	87.8	SKR1_CAEEL	reviewed	Skp1-related protein	skr-1 F46A9.5	Caenorhabditis elegans	176	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; female sex differentiation [GO:0046660]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cullin family protein binding [GO:0097602]	GO:0005634; GO:0005737; GO:0007399; GO:0010629; GO:0010826; GO:0031146; GO:0031647; GO:0043065; GO:0043518; GO:0046660; GO:0097602; GO:1902230	"female sex differentiation [GO:0046660]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32117_c0_g1_i1	O94991	SLIK5_HUMAN	41.2	68	40	0	206	3	88	155	2.30E-05	49.7	SLIK5_HUMAN	reviewed	SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11)	SLITRK5 KIAA0918 LRRC11	Homo sapiens (Human)	958	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; adult behavior [GO:0030534]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; grooming behavior [GO:0007625]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; striatum development [GO:0021756]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]		GO:0005886; GO:0007268; GO:0007409; GO:0007625; GO:0009410; GO:0016021; GO:0021756; GO:0030534; GO:0043235; GO:0043588; GO:0045202; GO:0048813; GO:0051965; GO:1905606	adult behavior [GO:0030534]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; grooming behavior [GO:0007625]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; striatum development [GO:0021756]		NA	NA	NA	NA	NA	NA
TRINITY_DN37031_c0_g1_i1	O75093	SLIT1_HUMAN	35.2	88	56	1	294	34	557	644	4.70E-05	48.9	SLIT1_HUMAN	reviewed	Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)	SLIT1 KIAA0813 MEGF4 SLIL1	Homo sapiens (Human)	1534	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0022028; GO:0031290; GO:0033563; GO:0048495; GO:0048846; GO:0048853; GO:0050919; GO:0051964	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]		NA	NA	NA	NA	NA	NA
TRINITY_DN7432_c0_g1_i1	G5EFX6	SLIT1_CAEEL	41.5	82	45	2	210	455	495	573	9.80E-08	59.7	SLIT1_CAEEL	reviewed	Slit homolog 1 protein (Slt-1)	slt-1 F40E10.4	Caenorhabditis elegans	1410	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; sensory neuron axon guidance [GO:0097374]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]	GO:0001764; GO:0005102; GO:0005509; GO:0005576; GO:0007411; GO:0008201; GO:0016199; GO:0033563; GO:0048495; GO:0048843; GO:0097374; GO:1905489	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; sensory neuron axon guidance [GO:0097374]		NA	NA	NA	NA	NA	NA
TRINITY_DN24884_c0_g2_i2	Q9WVC1	SLIT2_RAT	28.4	208	144	2	1739	1116	58	260	7.00E-17	90.5	SLIT2_RAT	reviewed	Slit homolog 2 protein (Slit-2) (Fragment)	Slit2	Rattus norvegicus (Rat)	766	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; in utero embryonic development [GO:0001701]; induction of negative chemotaxis [GO:0050929]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	chemorepellent activity [GO:0045499]; follicle-stimulating hormone receptor activity [GO:0004963]; GTPase inhibitor activity [GO:0005095]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]	GO:0001656; GO:0001657; GO:0001701; GO:0001822; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0004963; GO:0005095; GO:0005615; GO:0005737; GO:0005886; GO:0007409; GO:0007411; GO:0007420; GO:0008045; GO:0008201; GO:0008285; GO:0009986; GO:0010593; GO:0010596; GO:0010629; GO:0014912; GO:0016021; GO:0021510; GO:0021772; GO:0021836; GO:0021972; GO:0022029; GO:0030308; GO:0030336; GO:0030517; GO:0030837; GO:0031290; GO:0031667; GO:0032870; GO:0033563; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0043395; GO:0045499; GO:0048495; GO:0048754; GO:0048812; GO:0048846; GO:0050728; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0060603; GO:0060763; GO:0061364; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288; GO:0098609	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; dorsal/ventral axon guidance [GO:0033563]; induction of negative chemotaxis [GO:0050929]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; mammary gland duct morphogenesis [GO:0060603]; metanephros development [GO:0001656]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of apoptotic process [GO:0043065]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; response to nutrient levels [GO:0031667]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]		NA	NA	NA	NA	NA	NA
TRINITY_DN885_c0_g1_i1	O43295	SRGP3_HUMAN	47.3	74	38	1	1551	1333	745	818	7.90E-12	73.6	SRGP3_HUMAN	reviewed	SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP)	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	Homo sapiens (Human)	1099	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056	negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN885_c0_g1_i2	O43295	SRGP3_HUMAN	47.3	74	38	1	1785	1567	745	818	9.00E-12	73.6	SRGP3_HUMAN	reviewed	SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP)	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	Homo sapiens (Human)	1099	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056	negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN885_c0_g1_i3	O43295	SRGP3_HUMAN	47.3	74	38	1	679	461	745	818	3.60E-12	73.6	SRGP3_HUMAN	reviewed	SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP)	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	Homo sapiens (Human)	1099	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056	negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN885_c0_g1_i4	O43295	SRGP3_HUMAN	47.3	74	38	1	1800	1582	745	818	9.10E-12	73.6	SRGP3_HUMAN	reviewed	SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP)	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	Homo sapiens (Human)	1099	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056	negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7580_c0_g1_i1	Q4P0I7	SAR1_USTMA	65.3	196	61	2	618	31	1	189	6.10E-69	261.9	SAR1_USTMA	reviewed	Small COPII coat GTPase SAR1 (EC 3.6.5.-)	SAR1 UMAG_06376	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	189	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; mitochondrial fission [GO:0000266]; mitochondrial membrane organization [GO:0007006]; nuclear envelope organization [GO:0006998]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000139; GO:0000266; GO:0003400; GO:0003924; GO:0005525; GO:0005739; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006998; GO:0007006; GO:0016050; GO:0030127; GO:0044233; GO:0061024; GO:0070863; GO:0070971	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; mitochondrial fission [GO:0000266]; mitochondrial membrane organization [GO:0007006]; nuclear envelope organization [GO:0006998]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]		NA	NA	NA	NA	NA	NA
TRINITY_DN9864_c0_g1_i1	A5JSS4	SERF2_CAPHI	52.4	63	23	2	275	93	2	59	4.60E-05	48.5	SERF2_CAPHI	reviewed	Small EDRK-rich factor 2	SERF2	Capra hircus (Goat)	59							blue	blue	NA	NA	NA	NA
TRINITY_DN13381_c0_g1_i1	Q96HU1	SGSM3_HUMAN	100	104	0	0	388	77	646	749	2.70E-59	229.2	SGSM3_HUMAN	reviewed	Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP)	SGSM3 MAP RABGAPLP RUTBC3	Homo sapiens (Human)	749	cytosol [GO:0005829]; gap junction [GO:0005921]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle arrest [GO:0007050]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of Rab protein signal transduction [GO:0032483]	cytosol [GO:0005829]; gap junction [GO:0005921]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005921; GO:0006886; GO:0007050; GO:0017137; GO:0032483; GO:0032486; GO:0043547; GO:0045732; GO:0048227; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle arrest [GO:0007050]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of Rab protein signal transduction [GO:0032483]		NA	NA	NA	NA	NA	NA
TRINITY_DN17767_c0_g1_i1	Q2KI13	SGSM3_BOVIN	75.2	113	28	0	419	81	633	745	3.90E-48	192.2	SGSM3_BOVIN	reviewed	Small G protein signaling modulator 3 (RUN and TBC1 domain-containing protein 3)	SGSM3 RUTBC3	Bos taurus (Bovine)	747	cytosol [GO:0005829]; gap junction [GO:0005921]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle arrest [GO:0007050]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of Rab protein signal transduction [GO:0032483]	cytosol [GO:0005829]; gap junction [GO:0005921]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005921; GO:0006886; GO:0007050; GO:0017137; GO:0032483; GO:0032486; GO:0045732; GO:0048227; GO:0090630	activation of GTPase activity [GO:0090630]; cell cycle arrest [GO:0007050]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of Rab protein signal transduction [GO:0032483]		NA	NA	NA	NA	NA	NA
TRINITY_DN8129_c0_g1_i1	O13797	SGT2_SCHPO	25.8	151	104	2	1100	1552	69	211	3.70E-06	54.7	SGT2_SCHPO	reviewed	Small glutamine-rich tetratricopeptide repeat-containing protein 2	sgt2 SPAC1142.02c SPAC17G6.19c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	317	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; TRC complex [GO:0072380]; molecular adaptor activity [GO:0060090]; positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; TRC complex [GO:0072380]	molecular adaptor activity [GO:0060090]	GO:0005634; GO:0005829; GO:0006620; GO:0016020; GO:0016192; GO:0030433; GO:0032991; GO:0060090; GO:0072380; GO:1903646	positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN10074_c0_g1_i10	P29778	OV251_ONCVO	42.6	61	33	1	465	289	81	141	8.00E-05	48.5	OV251_ONCVO	reviewed	Small heat shock protein OV25-1	OV25-1	Onchocerca volvulus	174							NA	NA	NA	NA	NA	NA
TRINITY_DN10074_c0_g1_i2	P29778	OV251_ONCVO	42.6	61	33	1	585	409	81	141	7.60E-05	48.9	OV251_ONCVO	reviewed	Small heat shock protein OV25-1	OV25-1	Onchocerca volvulus	174							NA	NA	NA	NA	NA	NA
TRINITY_DN10074_c0_g1_i5	P29778	OV251_ONCVO	42.6	61	33	1	563	387	81	141	9.60E-05	48.5	OV251_ONCVO	reviewed	Small heat shock protein OV25-1	OV25-1	Onchocerca volvulus	174							NA	NA	NA	NA	NA	NA
TRINITY_DN10074_c0_g1_i9	P29778	OV251_ONCVO	42.6	61	33	1	500	324	81	141	8.50E-05	48.5	OV251_ONCVO	reviewed	Small heat shock protein OV25-1	OV25-1	Onchocerca volvulus	174							NA	NA	NA	NA	NA	NA
TRINITY_DN10074_c0_g1_i1	P29778	OV251_ONCVO	42.6	61	33	1	284	108	81	141	4.90E-05	48.5	OV251_ONCVO	reviewed	Small heat shock protein OV25-1	OV25-1	Onchocerca volvulus	174							NA	NA	1	NA	NA	NA
TRINITY_DN38126_c0_g1_i1	Q91VT8	SIM14_MOUSE	100	71	0	0	10	222	1	71	1.30E-34	146.4	SIM14_MOUSE	reviewed	Small integral membrane protein 14	Smim14	Mus musculus (Mouse)	99	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; blastocyst hatching [GO:0001835]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0001835; GO:0005783; GO:0005789; GO:0016021	blastocyst hatching [GO:0001835]		NA	NA	NA	NA	NA	NA
TRINITY_DN9858_c0_g1_i1	Q2KIK3	SIM14_BOVIN	54.9	102	40	4	105	407	1	97	7.90E-24	111.7	SIM14_BOVIN	reviewed	Small integral membrane protein 14	SMIM14	Bos taurus (Bovine)	99	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; blastocyst hatching [GO:0001835]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0001835; GO:0005783; GO:0005789; GO:0016021	blastocyst hatching [GO:0001835]		NA	NA	NA	NA	NA	NA
TRINITY_DN15217_c0_g1_i1	Q28GF4	SMIM8_XENTR	45.5	66	34	1	217	26	2	67	7.10E-10	64.7	SMIM8_XENTR	reviewed	Small integral membrane protein 8	smim8 TEgg033e03.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	97	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN29767_c0_g1_i1	Q7ZUG0	RUXE_DANRE	64.7	85	30	0	260	6	8	92	4.80E-28	124.8	RUXE_DANRE	reviewed	Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)	snrpe zgc:56682	Danio rerio (Zebrafish) (Brachydanio rerio)	92	"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		red	red	NA	NA	NA	NA
TRINITY_DN18707_c0_g1_i1	A4FUI2	RUXE_BOVIN	100	90	0	0	271	2	2	91	5.80E-45	181	RUXE_BOVIN	reviewed	Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)	SNRPE	Bos taurus (Bovine)	92	"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0042633; GO:0046540; GO:0071005; GO:0071007; GO:0071011	"hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18707_c0_g1_i2	A4FUI2	RUXE_BOVIN	100	90	0	0	271	2	2	91	5.80E-45	181	RUXE_BOVIN	reviewed	Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)	SNRPE	Bos taurus (Bovine)	92	"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0042633; GO:0046540; GO:0071005; GO:0071007; GO:0071011	"hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26493_c0_g1_i1	Q24297	RUXF_DROME	76.2	84	19	1	340	89	6	88	2.70E-31	136.3	RUXF_DROME	reviewed	Small nuclear ribonucleoprotein F (snRNP-F) (Membrane-associated protein Deb-B) (Sm protein F) (Sm-F) (SmF)	SmF DebB CG16792	Drosophila melanogaster (Fruit fly)	88	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005681; GO:0005685; GO:0005732; GO:0030532; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		blue	blue	NA	NA	NA	NA
TRINITY_DN26493_c0_g1_i2	Q24297	RUXF_DROME	76.2	84	19	1	340	89	6	88	2.60E-31	136.3	RUXF_DROME	reviewed	Small nuclear ribonucleoprotein F (snRNP-F) (Membrane-associated protein Deb-B) (Sm protein F) (Sm-F) (SmF)	SmF DebB CG16792	Drosophila melanogaster (Fruit fly)	88	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005681; GO:0005685; GO:0005732; GO:0030532; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38536_c0_g1_i1	Q24297	RUXF_DROME	66	53	18	0	1	159	33	85	6.50E-15	80.9	RUXF_DROME	reviewed	Small nuclear ribonucleoprotein F (snRNP-F) (Membrane-associated protein Deb-B) (Sm protein F) (Sm-F) (SmF)	SmF DebB CG16792	Drosophila melanogaster (Fruit fly)	88	"catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005681; GO:0005685; GO:0005732; GO:0030532; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		red	red	NA	NA	NA	NA
TRINITY_DN17157_c0_g1_i1	Q3ZC10	SMD1_BOVIN	100	95	0	0	78	362	1	95	1.60E-46	186.8	SMD1_BOVIN	reviewed	Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1)	SNRPD1	Bos taurus (Bovine)	119	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17157_c0_g1_i2	Q3ZC10	SMD1_BOVIN	100	95	0	0	78	362	1	95	1.60E-46	186.8	SMD1_BOVIN	reviewed	Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1)	SNRPD1	Bos taurus (Bovine)	119	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16373_c0_g1_i1	P62318	SMD3_HUMAN	100	88	0	0	80	343	1	88	2.00E-44	179.9	SMD3_HUMAN	reviewed	Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)	SNRPD3	Homo sapiens (Human)	126	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U7 snRNA binding [GO:0071209]; histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U7 snRNA binding [GO:0071209]	GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0006369; GO:0006479; GO:0008334; GO:0008380; GO:0016604; GO:0019899; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0051170; GO:0070034; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0071208; GO:0071209; GO:0097526	"histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16373_c0_g1_i2	P62318	SMD3_HUMAN	100	88	0	0	80	343	1	88	2.00E-44	179.9	SMD3_HUMAN	reviewed	Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)	SNRPD3	Homo sapiens (Human)	126	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U7 snRNA binding [GO:0071209]; histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U7 snRNA binding [GO:0071209]	GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0006369; GO:0006479; GO:0008334; GO:0008380; GO:0016604; GO:0019899; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0051170; GO:0070034; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0071208; GO:0071209; GO:0097526	"histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33529_c0_g1_i1	O44437	SMD3_DROME	52.1	71	29	2	213	16	28	98	1.10E-14	80.1	SMD3_DROME	reviewed	Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)	SmD3 guf2 CG8427	Drosophila melanogaster (Fruit fly)	151	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; central nervous system development [GO:0007417]; lymph gland development [GO:0048542]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; pole plasm oskar mRNA localization [GO:0045451]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000243; GO:0000278; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0007417; GO:0007422; GO:0007517; GO:0030182; GO:0030532; GO:0034715; GO:0034719; GO:0045451; GO:0045495; GO:0048477; GO:0048542; GO:0071011; GO:0071013; GO:0097526	"central nervous system development [GO:0007417]; lymph gland development [GO:0048542]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; pole plasm oskar mRNA localization [GO:0045451]; spliceosomal snRNP assembly [GO:0000387]"		red	red	NA	NA	NA	NA
TRINITY_DN32993_c1_g1_i1	O44437	SMD3_DROME	78.5	107	22	1	361	44	1	107	1.50E-40	167.2	SMD3_DROME	reviewed	Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)	SmD3 guf2 CG8427	Drosophila melanogaster (Fruit fly)	151	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; central nervous system development [GO:0007417]; lymph gland development [GO:0048542]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; pole plasm oskar mRNA localization [GO:0045451]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000243; GO:0000278; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0007417; GO:0007422; GO:0007517; GO:0030182; GO:0030532; GO:0034715; GO:0034719; GO:0045451; GO:0045495; GO:0048477; GO:0048542; GO:0071011; GO:0071013; GO:0097526	"central nervous system development [GO:0007417]; lymph gland development [GO:0048542]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; pole plasm oskar mRNA localization [GO:0045451]; spliceosomal snRNP assembly [GO:0000387]"		blue	blue	NA	NA	NA	NA
TRINITY_DN32704_c0_g1_i1	Q9SY09	SMD1B_ARATH	64.2	95	34	0	305	21	1	95	9.80E-29	127.5	SMD1B_ARATH	reviewed	Small nuclear ribonucleoprotein SmD1b (AtSmD1-b)	SMD1B At4g02840 T5J8.16	Arabidopsis thaliana (Mouse-ear cress)	116	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000243; GO:0000387; GO:0003723; GO:0003729; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005730; GO:0005774; GO:0008380; GO:0016607; GO:0034715; GO:0034719; GO:0035194; GO:0043484; GO:0071011; GO:0071013; GO:0097526	post-transcriptional gene silencing by RNA [GO:0035194]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN5840_c0_g1_i1	Q9SY09	SMD1B_ARATH	57.3	75	32	0	295	71	9	83	1.60E-19	96.7	SMD1B_ARATH	reviewed	Small nuclear ribonucleoprotein SmD1b (AtSmD1-b)	SMD1B At4g02840 T5J8.16	Arabidopsis thaliana (Mouse-ear cress)	116	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; vacuolar membrane [GO:0005774]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; vacuolar membrane [GO:0005774]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000243; GO:0000387; GO:0003723; GO:0003729; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005730; GO:0005774; GO:0008380; GO:0016607; GO:0034715; GO:0034719; GO:0035194; GO:0043484; GO:0071011; GO:0071013; GO:0097526	post-transcriptional gene silencing by RNA [GO:0035194]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]		NA	NA	NA	NA	NA	NA
TRINITY_DN33868_c0_g1_i1	Q55A45	RSMB_DICDI	51.6	93	45	0	284	6	6	98	4.30E-22	105.1	RSMB_DICDI	reviewed	Small nuclear ribonucleoprotein-associated protein B (snRNP-B) (Sm protein B) (Sm-B) (SmB)	snrpb DDB_G0272320	Dictyostelium discoideum (Slime mold)	274	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0005829; GO:0046540; GO:0071004; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27409_c0_g1_i1	Q05856	RSMB_DROME	66.3	95	30	2	375	97	1	95	3.90E-30	132.5	RSMB_DROME	reviewed	Small nuclear ribonucleoprotein-associated protein B (snRNP-B) (Sm protein B) (Sm-B) (SmB)	SmB CG5352	Drosophila melanogaster (Fruit fly)	199	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; germ cell development [GO:0007281]; gonad development [GO:0008406]; mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pole plasm [GO:0045495]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0007281; GO:0007283; GO:0008406; GO:0015030; GO:0030532; GO:0045495; GO:0046540; GO:0071004; GO:0071011; GO:0071013	"germ cell development [GO:0007281]; gonad development [GO:0008406]; mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13676_c0_g1_i1	Q58DW4	RSMB_BOVIN	100	84	0	0	26	277	1	84	2.10E-42	172.6	RSMB_BOVIN	reviewed	Small nuclear ribonucleoprotein-associated protein B' (snRNP-B') (snRPB') (Sm protein B') (Sm-B') (SmB')	SNRPB	Bos taurus (Bovine)	240	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0005829; GO:0034709; GO:0034719; GO:0046540; GO:0071004; GO:0071005; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13676_c0_g1_i2	Q58DW4	RSMB_BOVIN	100	108	0	0	26	349	1	108	2.50E-56	219.2	RSMB_BOVIN	reviewed	Small nuclear ribonucleoprotein-associated protein B' (snRNP-B') (snRPB') (Sm protein B') (Sm-B') (SmB')	SNRPB	Bos taurus (Bovine)	240	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0005829; GO:0034709; GO:0034719; GO:0046540; GO:0071004; GO:0071005; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13676_c0_g2_i1	Q17QN3	RSMN_BOVIN	100	106	0	0	12	329	1	106	9.40E-56	217.2	RSMN_BOVIN	reviewed	Small nuclear ribonucleoprotein-associated protein N (snRNP-N) (Sm protein N) (Sm-N) (SmN)	SNRPN	Bos taurus (Bovine)	240	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0046540; GO:0071004; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26772_c0_g1_i1	Q7K175	HENMT_DROME	31.6	250	142	6	1118	408	48	281	4.40E-28	127.1	HENMT_DROME	reviewed	Small RNA 2'-O-methyltransferase (EC 2.1.1.n8) (HEN1 methyltransferase homolog) (DmHen1) (piRNA methyltransferase)	Hen1 Pimet CG12367	Drosophila melanogaster (Fruit fly)	391	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase [GO:0090486]; piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase [GO:0090486]	GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0046872; GO:0090486	piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]		NA	NA	NA	NA	NA	NA
TRINITY_DN30507_c0_g1_i1	P55853	SUMO_CAEEL	74.7	87	22	0	361	101	4	90	4.70E-31	135.6	SUMO_CAEEL	reviewed	Small ubiquitin-related modifier (SUMO) (Ubiquitin-like protein SMT3)	smo-1 smt3 sumo K12C11.2	Caenorhabditis elegans	91	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nematode larval development [GO:0002119]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]	identical protein binding [GO:0042802]; protein tag [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000122; GO:0002119; GO:0005634; GO:0005694; GO:0005737; GO:0005815; GO:0005819; GO:0007080; GO:0009792; GO:0010468; GO:0016925; GO:0031386; GO:0031647; GO:0034502; GO:0042802; GO:0044389; GO:0045892; GO:0046716; GO:0051306; GO:0070194; GO:0071965; GO:0110039	"embryo development ending in birth or egg hatching [GO:0009792]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid separation [GO:0051306]; multicellular organismal locomotion [GO:0071965]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nematode larval development [GO:0002119]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; protein localization to chromosome [GO:0034502]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; synaptonemal complex disassembly [GO:0070194]"		blue	blue	NA	NA	NA	NA
TRINITY_DN24501_c0_g1_i1	Q13126	MTAP_HUMAN	100	70	0	0	1	210	54	123	5.00E-36	151	MTAP_HUMAN	reviewed	S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)	MTAP MSAP	Homo sapiens (Human)	283	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; interleukin-12-mediated signaling pathway [GO:0035722]; L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]"	GO:0004645; GO:0004731; GO:0005634; GO:0005737; GO:0005829; GO:0006139; GO:0006166; GO:0017061; GO:0019509; GO:0032259; GO:0033574; GO:0035722; GO:0070062	interleukin-12-mediated signaling pathway [GO:0035722]; L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]		NA	NA	NA	NA	NA	NA
TRINITY_DN11202_c0_g1_i1	Q7ZV22	MTAP_DANRE	65	234	82	0	1	702	33	266	7.80E-89	328.2	MTAP_DANRE	reviewed	S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)	mtap zgc:66012	Danio rerio (Zebrafish) (Brachydanio rerio)	280	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]	GO:0004731; GO:0005634; GO:0005737; GO:0005829; GO:0006166; GO:0017061; GO:0019509	L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166]		blue	blue	NA	NA	NA	NA
TRINITY_DN11202_c0_g1_i2	Q16MW6	MTAP_AEDAE	74.4	82	21	0	1	246	31	112	5.30E-32	138.3	MTAP_AEDAE	reviewed	S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)	AAEL012172 AAEL012179	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	279	cytoplasm [GO:0005737]; nucleus [GO:0005634]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]	GO:0005634; GO:0005737; GO:0006166; GO:0017061; GO:0019509	L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166]		blue	blue	NA	NA	NA	NA
TRINITY_DN26994_c0_g1_i1	Q9CQ65	MTAP_MOUSE	100	90	0	0	271	2	56	145	6.10E-50	197.6	MTAP_MOUSE	reviewed	S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)	Mtap	Mus musculus (Mouse)	283	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]	GO:0004731; GO:0005634; GO:0005737; GO:0005829; GO:0006166; GO:0017061; GO:0019509; GO:0032259	L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN38753_c0_g1_i1	Q9CQ65	MTAP_MOUSE	100	74	0	0	3	224	184	257	9.20E-36	150.2	MTAP_MOUSE	reviewed	S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)	Mtap	Mus musculus (Mouse)	283	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; purine ribonucleoside salvage [GO:0006166]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]	GO:0004731; GO:0005634; GO:0005737; GO:0005829; GO:0006166; GO:0017061; GO:0019509; GO:0032259	L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; purine ribonucleoside salvage [GO:0006166]		NA	NA	NA	NA	NA	NA
TRINITY_DN2314_c0_g1_i1	P53814	SMTN_HUMAN	50	136	67	1	420	824	765	900	2.40E-33	144.1	SMTN_HUMAN	reviewed	Smoothelin	SMTN SMSMO	Homo sapiens (Human)	917	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0003779; GO:0005737; GO:0005815; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629; GO:0030036; GO:0031941	actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939]		NA	NA	NA	NA	NA	NA
TRINITY_DN2314_c0_g1_i2	Q921U8	SMTN_MOUSE	64.6	82	28	1	446	688	825	906	6.90E-26	119	SMTN_MOUSE	reviewed	Smoothelin	Smtn Smsmo	Mus musculus (Mouse)	923	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cardiac muscle contraction [GO:0060452]	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]	actin binding [GO:0003779]	GO:0003085; GO:0003779; GO:0005737; GO:0005815; GO:0030036; GO:0031941; GO:0060452	actin cytoskeleton organization [GO:0030036]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cardiac muscle contraction [GO:0060452]		NA	NA	NA	NA	NA	NA
TRINITY_DN16847_c0_g1_i2	P97698	SMO_RAT	51.7	118	55	2	396	743	65	182	3.60E-31	136.7	SMO_RAT	reviewed	Smoothened homolog (SMO)	Smo Smoh	Rattus norvegicus (Rat)	793	"axonal growth cone [GO:0044295]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]; anterior/posterior pattern specification [GO:0009952]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; axon extension involved in axon guidance [GO:0048846]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic organ development [GO:0048568]; epithelial-mesenchymal cell signaling [GO:0060684]; facial nerve development [GO:0021561]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of stem cell population maintenance [GO:2000036]; response to organic substance [GO:0010033]; response to wounding [GO:0009611]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; somite development [GO:0061053]; spermatogenesis [GO:0007283]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]"	axonal growth cone [GO:0044295]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]	GO:0000122; GO:0001503; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002053; GO:0003007; GO:0003140; GO:0003323; GO:0004930; GO:0005113; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0007224; GO:0007228; GO:0007283; GO:0007368; GO:0007371; GO:0007389; GO:0007417; GO:0007494; GO:0008144; GO:0008284; GO:0009611; GO:0009952; GO:0009953; GO:0010033; GO:0010468; GO:0010628; GO:0010629; GO:0014069; GO:0016021; GO:0021542; GO:0021561; GO:0021696; GO:0021794; GO:0021904; GO:0021910; GO:0021938; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030857; GO:0031069; GO:0031102; GO:0033687; GO:0034504; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043025; GO:0043066; GO:0043231; GO:0043392; GO:0043524; GO:0044294; GO:0044295; GO:0045880; GO:0045892; GO:0045893; GO:0045944; GO:0046622; GO:0048143; GO:0048468; GO:0048565; GO:0048568; GO:0048589; GO:0048741; GO:0048745; GO:0048846; GO:0048853; GO:0048873; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070986; GO:0071397; GO:0071679; GO:0072285; GO:0090190; GO:1901215; GO:1904754; GO:2000036; GO:2000179; GO:2000826	"anterior/posterior pattern specification [GO:0009952]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; axon extension involved in axon guidance [GO:0048846]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic organ development [GO:0048568]; epithelial-mesenchymal cell signaling [GO:0060684]; facial nerve development [GO:0021561]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of stem cell population maintenance [GO:2000036]; response to organic substance [GO:0010033]; response to wounding [GO:0009611]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spermatogenesis [GO:0007283]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16847_c0_g1_i3	Q99835	SMO_HUMAN	47	576	295	8	396	2102	61	633	6.50E-161	569.7	SMO_HUMAN	reviewed	Smoothened homolog (SMO) (Protein Gx)	SMO SMOH	Homo sapiens (Human)	787	ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]; anterior/posterior pattern specification [GO:0009952]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of stem cell population maintenance [GO:2000036]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; somite development [GO:0061053]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]	ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]	GO:0000122; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002053; GO:0003140; GO:0003323; GO:0004930; GO:0005113; GO:0005886; GO:0005929; GO:0007224; GO:0007228; GO:0007371; GO:0007417; GO:0007494; GO:0009952; GO:0010628; GO:0010629; GO:0016021; GO:0021542; GO:0021696; GO:0021794; GO:0021904; GO:0021910; GO:0021938; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030666; GO:0030857; GO:0031069; GO:0034504; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043066; GO:0043231; GO:0043392; GO:0045880; GO:0045944; GO:0046622; GO:0048143; GO:0048741; GO:0048745; GO:0048853; GO:0048873; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070062; GO:0070986; GO:0071397; GO:0071679; GO:0072285; GO:0090190; GO:0097542; GO:2000036; GO:2000826	anterior/posterior pattern specification [GO:0009952]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of stem cell population maintenance [GO:2000036]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]		NA	NA	NA	NA	NA	NA
TRINITY_DN10451_c0_g1_i2	A0A2I4HXH5	V5NTD_NAJAT	25.2	488	303	11	1884	592	5	487	2.60E-36	155.2	V5NTD_NAJAT	reviewed	Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (Fragment)		Naja atra (Chinese cobra)	529	anchored component of membrane [GO:0031225]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]	anchored component of membrane [GO:0031225]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0008253; GO:0009166; GO:0031225; GO:0046872	nucleotide catabolic process [GO:0009166]		NA	NA	NA	NA	NA	NA
TRINITY_DN10451_c0_g1_i3	A0A2I4HXH5	V5NTD_NAJAT	25.2	488	303	11	1792	500	5	487	2.50E-36	155.2	V5NTD_NAJAT	reviewed	Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (Fragment)		Naja atra (Chinese cobra)	529	anchored component of membrane [GO:0031225]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]	anchored component of membrane [GO:0031225]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0008253; GO:0009166; GO:0031225; GO:0046872	nucleotide catabolic process [GO:0009166]		NA	NA	NA	NA	NA	NA
TRINITY_DN10451_c0_g1_i4	A0A2I4HXH5	V5NTD_NAJAT	25.2	488	303	11	1792	500	5	487	2.50E-36	155.2	V5NTD_NAJAT	reviewed	Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (Fragment)		Naja atra (Chinese cobra)	529	anchored component of membrane [GO:0031225]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]	anchored component of membrane [GO:0031225]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0008253; GO:0009166; GO:0031225; GO:0046872	nucleotide catabolic process [GO:0009166]		NA	NA	NA	NA	NA	NA
TRINITY_DN10451_c0_g1_i5	A0A2I4HXH5	V5NTD_NAJAT	25.2	488	303	11	1884	592	5	487	2.70E-36	155.2	V5NTD_NAJAT	reviewed	Snake venom 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (Fragment)		Naja atra (Chinese cobra)	529	anchored component of membrane [GO:0031225]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]	anchored component of membrane [GO:0031225]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0008253; GO:0009166; GO:0031225; GO:0046872	nucleotide catabolic process [GO:0009166]		NA	NA	NA	NA	NA	NA
TRINITY_DN2334_c0_g1_i1	P60244	VM1A3_DEIAC	41.3	75	41	1	36	251	7	81	1.00E-07	57.4	VM1A3_DEIAC	reviewed	Snake venom metalloproteinase acutolysin-C (SVMP) (EC 3.4.24.-) (Hemorrhagin III)		Deinagkistrodon acutus (Hundred-pace snake) (Agkistrodon acutus)	197	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005509; GO:0005576; GO:0008270; GO:0090729			blue	blue	NA	NA	NA	NA
TRINITY_DN9545_c0_g1_i2	Q38997	KIN10_ARATH	59.6	166	67	0	2	499	66	231	2.90E-53	209.5	KIN10_ARATH	reviewed	SNF1-related protein kinase catalytic subunit alpha KIN10 (AKIN10) (EC 2.7.11.1) (AKIN alpha-2) (AKINalpha2) (SNF1-related kinase 1.1) (SnRK1.1)	KIN10 AK21 AKIN10 SKIN10 SNR2 SNRK1.1 At3g01090 T4P13.22	Arabidopsis thaliana (Mouse-ear cress)	512	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0001666; GO:0003006; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005982; GO:0006468; GO:0006633; GO:0006979; GO:0009507; GO:0009594; GO:0009635; GO:0009738; GO:0009749; GO:0009789; GO:0010050; GO:0010150; GO:0010182; GO:0010228; GO:0010508; GO:0016301; GO:0019900; GO:0019902; GO:0035556; GO:0042128; GO:0080022; GO:0099402; GO:1900055; GO:1902074	abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]		NA	NA	NA	NA	NA	NA
TRINITY_DN9545_c0_g1_i3	Q38997	KIN10_ARATH	60.8	166	65	0	6	503	66	231	2.80E-53	209.5	KIN10_ARATH	reviewed	SNF1-related protein kinase catalytic subunit alpha KIN10 (AKIN10) (EC 2.7.11.1) (AKIN alpha-2) (AKINalpha2) (SNF1-related kinase 1.1) (SnRK1.1)	KIN10 AK21 AKIN10 SKIN10 SNR2 SNRK1.1 At3g01090 T4P13.22	Arabidopsis thaliana (Mouse-ear cress)	512	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0001666; GO:0003006; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005982; GO:0006468; GO:0006633; GO:0006979; GO:0009507; GO:0009594; GO:0009635; GO:0009738; GO:0009749; GO:0009789; GO:0010050; GO:0010150; GO:0010182; GO:0010228; GO:0010508; GO:0016301; GO:0019900; GO:0019902; GO:0035556; GO:0042128; GO:0080022; GO:0099402; GO:1900055; GO:1902074	abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]		NA	NA	NA	NA	NA	NA
TRINITY_DN9545_c0_g1_i4	Q38997	KIN10_ARATH	57.1	70	30	0	22	231	162	231	1.20E-17	90.1	KIN10_ARATH	reviewed	SNF1-related protein kinase catalytic subunit alpha KIN10 (AKIN10) (EC 2.7.11.1) (AKIN alpha-2) (AKINalpha2) (SNF1-related kinase 1.1) (SnRK1.1)	KIN10 AK21 AKIN10 SKIN10 SNR2 SNRK1.1 At3g01090 T4P13.22	Arabidopsis thaliana (Mouse-ear cress)	512	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]; abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein serine/threonine kinase activity [GO:0004674]	GO:0001666; GO:0003006; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005982; GO:0006468; GO:0006633; GO:0006979; GO:0009507; GO:0009594; GO:0009635; GO:0009738; GO:0009749; GO:0009789; GO:0010050; GO:0010150; GO:0010182; GO:0010228; GO:0010508; GO:0016301; GO:0019900; GO:0019902; GO:0035556; GO:0042128; GO:0080022; GO:0099402; GO:1900055; GO:1902074	abscisic acid-activated signaling pathway [GO:0009738]; detection of nutrient [GO:0009594]; developmental process involved in reproduction [GO:0003006]; fatty acid biosynthetic process [GO:0006633]; intracellular signal transduction [GO:0035556]; leaf senescence [GO:0010150]; nitrate assimilation [GO:0042128]; plant organ development [GO:0099402]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; positive regulation of autophagy [GO:0010508]; primary root development [GO:0080022]; protein phosphorylation [GO:0006468]; regulation of leaf senescence [GO:1900055]; response to glucose [GO:0009749]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; starch metabolic process [GO:0005982]; sugar mediated signaling pathway [GO:0010182]; vegetative phase change [GO:0010050]; vegetative to reproductive phase transition of meristem [GO:0010228]		NA	NA	NA	NA	NA	NA
TRINITY_DN25423_c0_g1_i1	Q9NRH2	SNRK_HUMAN	100	82	0	0	2	247	19	100	8.00E-41	167.2	SNRK_HUMAN	reviewed	SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)	SNRK KIAA0096 SNFRK	Homo sapiens (Human)	765	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556	intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN25745_c0_g1_i1	Q9NRH2	SNRK_HUMAN	100	100	0	0	1	300	186	285	6.90E-55	214.2	SNRK_HUMAN	reviewed	SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)	SNRK KIAA0096 SNFRK	Homo sapiens (Human)	765	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556	intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2344_c0_g1_i1	Q9NRH2	SNRK_HUMAN	83	94	16	0	3	284	13	106	6.40E-40	164.5	SNRK_HUMAN	reviewed	SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)	SNRK KIAA0096 SNFRK	Homo sapiens (Human)	765	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556	intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2344_c0_g1_i2	Q9NRH2	SNRK_HUMAN	73.3	315	84	0	3	947	13	327	9.50E-135	481.1	SNRK_HUMAN	reviewed	SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)	SNRK KIAA0096 SNFRK	Homo sapiens (Human)	765	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556	intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]		NA	NA	NA	NA	NA	NA
TRINITY_DN15099_c0_g1_i1	Q8XZX8	UGPC_RALSO	94.6	74	4	0	224	3	110	183	3.00E-31	135.2	UGPC_RALSO	reviewed	sn-glycerol-3-phosphate import ATP-binding protein UgpC (EC 7.6.2.10)	ugpC RSc1267	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	365	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glycerol-3-phosphate transmembrane transporter activity [GO:0015430]; carbohydrate transport [GO:0008643]; glycerophosphodiester transmembrane transport [GO:0001407]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled glycerol-3-phosphate transmembrane transporter activity [GO:0015430]; ATP binding [GO:0005524]	GO:0001407; GO:0005524; GO:0005886; GO:0008643; GO:0015430; GO:0016887	carbohydrate transport [GO:0008643]; glycerophosphodiester transmembrane transport [GO:0001407]		NA	NA	NA	NA	NA	NA
TRINITY_DN215_c0_g1_i2	Q4R6Y6	SNPC3_MACFA	34.2	284	162	7	203	1021	138	407	2.60E-41	171	SNPC3_MACFA	reviewed	snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Small nuclear RNA-activating complex polypeptide 3)	SNAPC3 QtsA-16848	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	412	nuclear body [GO:0016604]; nucleolus [GO:0005730]; DNA binding [GO:0003677]	nuclear body [GO:0016604]; nucleolus [GO:0005730]	DNA binding [GO:0003677]	GO:0003677; GO:0005730; GO:0016604			NA	NA	NA	NA	NA	NA
TRINITY_DN215_c0_g1_i3	Q4R6Y6	SNPC3_MACFA	34.2	284	162	7	512	1330	138	407	3.20E-41	171	SNPC3_MACFA	reviewed	snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Small nuclear RNA-activating complex polypeptide 3)	SNAPC3 QtsA-16848	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	412	nuclear body [GO:0016604]; nucleolus [GO:0005730]; DNA binding [GO:0003677]	nuclear body [GO:0016604]; nucleolus [GO:0005730]	DNA binding [GO:0003677]	GO:0003677; GO:0005730; GO:0016604			NA	NA	NA	NA	NA	NA
TRINITY_DN1294_c2_g1_i1	Q5ZI43	SPN1_CHICK	43.8	308	156	5	1061	171	1	302	1.20E-68	261.9	SPN1_CHICK	reviewed	Snurportin-1 (RNA U transporter 1)	SNUPN RNUT1 RCJMB04_30h8	Gallus gallus (Chicken)	365	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; RNA binding [GO:0003723]; protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0006606; GO:0061015; GO:0061608	protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]		blue	blue	NA	NA	NA	NA
TRINITY_DN20991_c0_g1_i1	Q9CSN1	SNW1_MOUSE	100	111	0	0	2	334	26	136	1.80E-59	229.6	SNW1_MOUSE	reviewed	SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)	Snw1 Skiip	Mus musculus (Mouse)	536	"catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; Notch binding [GO:0005112]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]"	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; Notch binding [GO:0005112]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	GO:0000122; GO:0000398; GO:0000785; GO:0003713; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0016363; GO:0016604; GO:0016607; GO:0019899; GO:0030511; GO:0035257; GO:0035914; GO:0042771; GO:0042809; GO:0042974; GO:0043923; GO:0045892; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050681; GO:0050769; GO:0051571; GO:0070562; GO:0070564; GO:0071007; GO:0071013; GO:0071141; GO:0071300	"cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16882_c0_g1_i1	Q1JQE0	SNW1_BOVIN	100	142	0	0	428	3	168	309	2.60E-76	285.8	SNW1_BOVIN	reviewed	SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)	SNW1 SKIIP	Bos taurus (Bovine)	536	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]"	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0016363; GO:0030511; GO:0035257; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0051571; GO:0070562; GO:0071007	"intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16882_c0_g1_i2	Q1JQE0	SNW1_BOVIN	100	142	0	0	428	3	168	309	2.60E-76	285.8	SNW1_BOVIN	reviewed	SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)	SNW1 SKIIP	Bos taurus (Bovine)	536	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]"	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0016363; GO:0030511; GO:0035257; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0051571; GO:0070562; GO:0071007	"intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40480_c0_g1_i1	Q6K8D9	SKIPA_ORYSJ	56.2	137	60	0	416	6	185	321	3.90E-43	175.6	SKIPA_ORYSJ	reviewed	SNW/SKI-interacting protein A (OsSKIPa)	SKIPA Os02g0759800 LOC_Os02g52250 OJ1175_B01.11 OsJ_08462	Oryza sativa subsp. japonica (Rice)	607	"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of response to salt stress [GO:1901002]; positive regulation of response to water deprivation [GO:1902584]"	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]		GO:0000398; GO:0005634; GO:0005681; GO:1901002; GO:1902584	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of response to salt stress [GO:1901002]; positive regulation of response to water deprivation [GO:1902584]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i2	P48065	S6A12_HUMAN	53.8	279	111	6	975	166	32	301	2.30E-84	313.9	S6A12_HUMAN	reviewed	Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12)	SLC6A12	Homo sapiens (Human)	614	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]; amino acid transport [GO:0006865]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]	GO:0005332; GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015718; GO:0016021; GO:0035725; GO:0042165; GO:0043005	amino acid transport [GO:0006865]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i5	P48065	S6A12_HUMAN	54.8	221	87	4	718	71	32	244	1.90E-70	267.3	S6A12_HUMAN	reviewed	Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12)	SLC6A12	Homo sapiens (Human)	614	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]; amino acid transport [GO:0006865]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]	GO:0005332; GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015718; GO:0016021; GO:0035725; GO:0042165; GO:0043005	amino acid transport [GO:0006865]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN9490_c0_g1_i1	P27799	S6A12_CANLF	43.5	131	74	0	414	22	36	166	6.70E-28	125.2	S6A12_CANLF	reviewed	Sodium- and chloride-dependent betaine transporter (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12)	SLC6A12	Canis lupus familiaris (Dog) (Canis familiaris)	614	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]	GO:0005332; GO:0005886; GO:0005887; GO:0006836; GO:0035725; GO:0042165; GO:0043005	neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i1	O18875	SC6A8_BOVIN	49.5	331	159	2	1078	92	302	626	4.30E-87	323.2	SC6A8_BOVIN	reviewed	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	SLC6A8	Bos taurus (Bovine)	635	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine:sodium symporter activity [GO:0005309]	GO:0005309; GO:0005886; GO:0005887; GO:0006836; GO:0015881; GO:0035725	creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i4	O18875	SC6A8_BOVIN	49.5	329	158	2	1072	92	304	626	6.40E-87	323.2	SC6A8_BOVIN	reviewed	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	SLC6A8	Bos taurus (Bovine)	635	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine:sodium symporter activity [GO:0005309]	GO:0005309; GO:0005886; GO:0005887; GO:0006836; GO:0015881; GO:0035725	creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i4	O18875	SC6A8_BOVIN	48.5	231	116	1	1709	1026	49	279	1.10E-65	252.7	SC6A8_BOVIN	reviewed	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	SLC6A8	Bos taurus (Bovine)	635	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine:sodium symporter activity [GO:0005309]	GO:0005309; GO:0005886; GO:0005887; GO:0006836; GO:0015881; GO:0035725	creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i6	O18875	SC6A8_BOVIN	50.5	584	278	3	1828	92	49	626	1.70E-175	617.5	SC6A8_BOVIN	reviewed	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	SLC6A8	Bos taurus (Bovine)	635	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine:sodium symporter activity [GO:0005309]	GO:0005309; GO:0005886; GO:0005887; GO:0006836; GO:0015881; GO:0035725	creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i7	O18875	SC6A8_BOVIN	58.6	128	53	0	461	78	49	176	1.70E-46	187.2	SC6A8_BOVIN	reviewed	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	SLC6A8	Bos taurus (Bovine)	635	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine:sodium symporter activity [GO:0005309]	GO:0005309; GO:0005886; GO:0005887; GO:0006836; GO:0015881; GO:0035725	creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN26662_c0_g1_i1	Q9VR07	INE_DROME	75	40	9	1	47	163	334	373	2.40E-12	72.4	INE_DROME	reviewed	Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A)	ine rosA CG15444	Drosophila melanogaster (Fruit fly)	943	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; sodium ion transmembrane transport [GO:0035725]; transmission of nerve impulse [GO:0019226]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]	GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0035725; GO:0042065; GO:0042066; GO:0047484; GO:0050891	glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; sodium ion transmembrane transport [GO:0035725]; transmission of nerve impulse [GO:0019226]		NA	NA	NA	NA	NA	NA
TRINITY_DN23_c0_g1_i3	P48067	SC6A9_HUMAN	67.4	43	14	0	339	211	318	360	2.20E-10	66.6	SC6A9_HUMAN	reviewed	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	SLC6A9	Homo sapiens (Human)	706	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; glycine import across plasma membrane [GO:1903804]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter uptake [GO:0001504]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of iron ion import across plasma membrane [GO:1904440]; positive regulation of iron ion transmembrane transporter activity [GO:1904256]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]"	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	glycine:sodium symporter activity [GO:0015375]; glycine transmembrane transporter activity [GO:0015187]	GO:0001504; GO:0005768; GO:0005886; GO:0005887; GO:0009925; GO:0014069; GO:0015187; GO:0015375; GO:0015816; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0031045; GO:0035725; GO:0046985; GO:0061537; GO:0070455; GO:0098686; GO:0098688; GO:0099056; GO:0150104; GO:1903804; GO:1904256; GO:1904440; GO:1904782	"glycine import across plasma membrane [GO:1903804]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter uptake [GO:0001504]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of iron ion import across plasma membrane [GO:1904440]; positive regulation of iron ion transmembrane transporter activity [GO:1904256]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39279_c0_g1_i1	P28571	SC6A9_MOUSE	100	189	0	0	2	568	254	442	1.50E-106	386.7	SC6A9_MOUSE	reviewed	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	Slc6a9 Glyt1	Mus musculus (Mouse)	692	"apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; glycine import across plasma membrane [GO:1903804]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter uptake [GO:0001504]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of iron ion import across plasma membrane [GO:1904440]; positive regulation of iron ion transmembrane transporter activity [GO:1904256]; sodium ion transmembrane transport [GO:0035725]"	apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]	GO:0001504; GO:0005283; GO:0005768; GO:0005886; GO:0009925; GO:0014069; GO:0015187; GO:0015816; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0030285; GO:0031045; GO:0032279; GO:0035725; GO:0046985; GO:0061537; GO:0070455; GO:0098686; GO:0098688; GO:0099055; GO:0099056; GO:1903804; GO:1904256; GO:1904440; GO:1904782	"glycine import across plasma membrane [GO:1903804]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter uptake [GO:0001504]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of iron ion import across plasma membrane [GO:1904440]; positive regulation of iron ion transmembrane transporter activity [GO:1904256]; sodium ion transmembrane transport [GO:0035725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27274_c0_g1_i1	A7Y2W8	SC6A9_XENLA	51.4	288	130	3	898	35	18	295	6.10E-81	302.4	SC6A9_XENLA	reviewed	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	slc6a9 glyt1	Xenopus laevis (African clawed frog)	633	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter transport [GO:0006836]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]	GO:0005283; GO:0005887; GO:0006836	neurotransmitter transport [GO:0006836]		NA	NA	NA	NA	NA	NA
TRINITY_DN8831_c0_g1_i1	A7Y2X0	SC6A5_XENLA	49.1	460	213	9	87	1448	159	603	1.20E-117	424.9	SC6A5_XENLA	reviewed	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5)	slc6a5 glyt2	Xenopus laevis (African clawed frog)	790	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; symporter activity [GO:0015293]	GO:0005886; GO:0006836; GO:0015293; GO:0016021; GO:0046872	neurotransmitter transport [GO:0006836]		NA	NA	NA	NA	NA	NA
TRINITY_DN8831_c0_g1_i2	A7Y2X0	SC6A5_XENLA	46	289	137	7	87	938	159	433	9.80E-61	235.3	SC6A5_XENLA	reviewed	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5)	slc6a5 glyt2	Xenopus laevis (African clawed frog)	790	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; symporter activity [GO:0015293]	GO:0005886; GO:0006836; GO:0015293; GO:0016021; GO:0046872	neurotransmitter transport [GO:0006836]		NA	NA	NA	NA	NA	NA
TRINITY_DN37937_c0_g1_i1	O35316	SC6A6_MOUSE	100	85	0	0	257	3	207	291	1.90E-45	182.6	SC6A6_MOUSE	reviewed	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	Slc6a6 Taut	Mus musculus (Mouse)	621	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; gamma-aminobutyric acid import [GO:0051939]; import across plasma membrane [GO:0098739]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of cell differentiation [GO:0045597]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]	alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; taurine:sodium symporter activity [GO:0005369]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]	GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0006836; GO:0010940; GO:0015171; GO:0015185; GO:0015734; GO:0016323; GO:0016324; GO:0022858; GO:0030425; GO:0030977; GO:0031528; GO:0032328; GO:0035725; GO:0043025; GO:0045597; GO:0051939; GO:0071705; GO:0089718; GO:0098739; GO:0098797	alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; gamma-aminobutyric acid import [GO:0051939]; import across plasma membrane [GO:0098739]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of cell differentiation [GO:0045597]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]		NA	NA	NA	NA	NA	NA
TRINITY_DN32735_c0_g1_i1	O35316	SC6A6_MOUSE	98.9	95	1	0	34	318	77	171	8.30E-51	200.7	SC6A6_MOUSE	reviewed	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	Slc6a6 Taut	Mus musculus (Mouse)	621	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; gamma-aminobutyric acid import [GO:0051939]; import across plasma membrane [GO:0098739]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of cell differentiation [GO:0045597]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]	alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; taurine:sodium symporter activity [GO:0005369]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]	GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0006836; GO:0010940; GO:0015171; GO:0015185; GO:0015734; GO:0016323; GO:0016324; GO:0022858; GO:0030425; GO:0030977; GO:0031528; GO:0032328; GO:0035725; GO:0043025; GO:0045597; GO:0051939; GO:0071705; GO:0089718; GO:0098739; GO:0098797	alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; gamma-aminobutyric acid import [GO:0051939]; import across plasma membrane [GO:0098739]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of cell differentiation [GO:0045597]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]		NA	NA	NA	NA	NA	NA
TRINITY_DN39322_c0_g1_i1	Q9Y6M7	S4A7_HUMAN	100	119	0	0	3	359	558	676	1.60E-61	236.9	S4A7_HUMAN	reviewed	Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7)	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6	Homo sapiens (Human)	1214	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031410; GO:0032420; GO:0045202; GO:0050801; GO:0051453; GO:0055085; GO:0060117	auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN39322_c0_g1_i1	Q9Y6M7	S4A7_HUMAN	100	43	0	0	356	484	676	718	9.20E-17	88.2	S4A7_HUMAN	reviewed	Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7)	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6	Homo sapiens (Human)	1214	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031410; GO:0032420; GO:0045202; GO:0050801; GO:0051453; GO:0055085; GO:0060117	auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN33106_c0_g1_i1	Q9Y6M7	S4A7_HUMAN	100	84	0	0	255	4	849	932	1.00E-43	176.8	S4A7_HUMAN	reviewed	Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7)	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6	Homo sapiens (Human)	1214	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031410; GO:0032420; GO:0045202; GO:0050801; GO:0051453; GO:0055085; GO:0060117	auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN30933_c0_g1_i1	Q9Y6M7	S4A7_HUMAN	100	75	0	0	225	1	956	1030	6.60E-34	144.1	S4A7_HUMAN	reviewed	Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7)	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6	Homo sapiens (Human)	1214	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031410; GO:0032420; GO:0045202; GO:0050801; GO:0051453; GO:0055085; GO:0060117	auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN26541_c0_g1_i1	Q9W0Y8	SCN60_DROME	87.3	55	7	0	204	40	1963	2017	2.00E-21	102.4	SCN60_DROME	reviewed	Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2)	NaCP60E DIC60 DSC1 smi60E CG34405	Drosophila melanogaster (Fruit fly)	2844	plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; cation channel activity [GO:0005261]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]	cation channel activity [GO:0005261]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005248; GO:0005261; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0034765; GO:0035725; GO:0042048; GO:0086010	membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN28968_c0_g1_i2	P35500	SCNA_DROME	85.7	84	12	0	233	484	1835	1918	2.00E-35	150.2	SCNA_DROME	reviewed	Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1)	para CG9907	Drosophila melanogaster (Fruit fly)	2131	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]	calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005261; GO:0005272; GO:0005509; GO:0005886; GO:0005887; GO:0007638; GO:0009612; GO:0019228; GO:0034765; GO:0035725; GO:0045433; GO:0060078; GO:0086010	"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30605_c0_g1_i1	P35500	SCNA_DROME	85.1	87	13	0	265	5	1702	1788	1.40E-30	133.3	SCNA_DROME	reviewed	Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1)	para CG9907	Drosophila melanogaster (Fruit fly)	2131	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]	calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005261; GO:0005272; GO:0005509; GO:0005886; GO:0005887; GO:0007638; GO:0009612; GO:0019228; GO:0034765; GO:0035725; GO:0045433; GO:0060078; GO:0086010	"male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14508_c0_g1_i1	Q8IZF0	NALCN_HUMAN	56.3	373	157	3	1122	16	194	564	2.80E-117	423.3	NALCN_HUMAN	reviewed	Sodium leak channel non-selective protein (CanIon) (Voltage gated channel-like protein 1)	NALCN VGCNL1	Homo sapiens (Human)	1738	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN18372_c0_g1_i1	Q8IZF0	NALCN_HUMAN	76.1	247	58	1	1	738	1339	1585	1.30E-105	384	NALCN_HUMAN	reviewed	Sodium leak channel non-selective protein (CanIon) (Voltage gated channel-like protein 1)	NALCN VGCNL1	Homo sapiens (Human)	1738	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN17530_c0_g1_i15	Q8IZF0	NALCN_HUMAN	49.5	111	55	1	85	414	1	111	4.20E-27	122.5	NALCN_HUMAN	reviewed	Sodium leak channel non-selective protein (CanIon) (Voltage gated channel-like protein 1)	NALCN VGCNL1	Homo sapiens (Human)	1738	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN17530_c0_g1_i4	Q8IZF0	NALCN_HUMAN	48.4	95	49	0	129	413	17	111	1.10E-22	107.8	NALCN_HUMAN	reviewed	Sodium leak channel non-selective protein (CanIon) (Voltage gated channel-like protein 1)	NALCN VGCNL1	Homo sapiens (Human)	1738	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN18372_c0_g1_i5	Q8BXR5	NALCN_MOUSE	52.3	394	148	7	64	1203	1368	1735	4.70E-94	346.7	NALCN_MOUSE	reviewed	Sodium leak channel non-selective protein (Voltage gated channel-like protein 1)	Nalcn Vgcnl1	Mus musculus (Mouse)	1738	integral component of membrane [GO:0016021]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005272; GO:0016021; GO:0022840; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN18372_c0_g1_i9	Q8BXR5	NALCN_MOUSE	53.7	423	156	7	1	1227	1339	1735	5.40E-106	386.3	NALCN_MOUSE	reviewed	Sodium leak channel non-selective protein (Voltage gated channel-like protein 1)	Nalcn Vgcnl1	Mus musculus (Mouse)	1738	integral component of membrane [GO:0016021]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005272; GO:0016021; GO:0022840; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN29191_c0_g1_i1	P23685	NAC1_CANLF	65.2	69	24	0	2	208	815	883	7.20E-19	94	NAC1_CANLF	reviewed	Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)	SLC8A1 NCX1	Canis lupus familiaris (Dog) (Canis familiaris)	970	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]	ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]	GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005887; GO:0006883; GO:0007154; GO:0015491; GO:0016020; GO:0030001; GO:0030424; GO:0030501; GO:0030506; GO:0031226; GO:0035725; GO:0035994; GO:0042383; GO:0070588; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:1905060	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN29482_c0_g1_i1	P23685	NAC1_CANLF	72.2	54	15	0	30	191	792	845	1.10E-15	83.6	NAC1_CANLF	reviewed	Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)	SLC8A1 NCX1	Canis lupus familiaris (Dog) (Canis familiaris)	970	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]	ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]	GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005887; GO:0006883; GO:0007154; GO:0015491; GO:0016020; GO:0030001; GO:0030424; GO:0030501; GO:0030506; GO:0031226; GO:0035725; GO:0035994; GO:0042383; GO:0070588; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:1905060	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]		brown	brown	1	NA	NA	NA
TRINITY_DN29869_c0_g1_i1	P48765	NAC1_BOVIN	60	80	32	0	241	2	126	205	1.50E-20	99.8	NAC1_BOVIN	reviewed	Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)	SLC8A1	Bos taurus (Bovine)	970	caveola [GO:0005901]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	caveola [GO:0005901]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0002026; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005886; GO:0005901; GO:0006814; GO:0006816; GO:0006874; GO:0007154; GO:0007204; GO:0016021; GO:0031226; GO:0035725; GO:0042383; GO:0051924; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN31511_c0_g1_i1	P48765	NAC1_BOVIN	61.6	99	38	0	301	5	116	214	1.60E-27	123.2	NAC1_BOVIN	reviewed	Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)	SLC8A1	Bos taurus (Bovine)	970	caveola [GO:0005901]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	caveola [GO:0005901]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]	GO:0002026; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005886; GO:0005901; GO:0006814; GO:0006816; GO:0006874; GO:0007154; GO:0007204; GO:0016021; GO:0031226; GO:0035725; GO:0042383; GO:0051924; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN17822_c0_g1_i1	P23685	NAC1_CANLF	66.1	118	40	0	23	376	123	240	4.20E-36	152.1	NAC1_CANLF	reviewed	Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)	SLC8A1 NCX1	Canis lupus familiaris (Dog) (Canis familiaris)	970	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]	ankyrin binding [GO:0030506]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]	GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005887; GO:0006883; GO:0007154; GO:0015491; GO:0016020; GO:0030001; GO:0030424; GO:0030501; GO:0030506; GO:0031226; GO:0035725; GO:0035994; GO:0042383; GO:0070588; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:1905060	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN7848_c0_g1_i1	Q8K596	NAC2_MOUSE	37.9	915	461	18	2589	106	21	915	1.20E-145	518.8	NAC2_MOUSE	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	Slc8a2 Ncx2	Mus musculus (Mouse)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0032592; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099055; GO:0099608; GO:0106056; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN7848_c0_g1_i2	Q8K596	NAC2_MOUSE	37.9	915	461	18	2589	106	21	915	1.20E-145	518.8	NAC2_MOUSE	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	Slc8a2 Ncx2	Mus musculus (Mouse)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0032592; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099055; GO:0099608; GO:0106056; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN36369_c0_g1_i1	Q8K596	NAC2_MOUSE	60.7	107	42	0	384	64	740	846	2.10E-32	139.8	NAC2_MOUSE	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	Slc8a2 Ncx2	Mus musculus (Mouse)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0032592; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099055; GO:0099608; GO:0106056; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN36297_c0_g1_i1	Q9UPR5	NAC2_HUMAN	56.7	134	58	0	2	403	716	849	1.90E-39	163.3	NAC2_HUMAN	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	SLC8A2 KIAA1087 NCX2	Homo sapiens (Human)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:0150104; GO:1903779; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN33544_c0_g1_i1	Q8K596	NAC2_MOUSE	56.7	90	39	0	271	2	763	852	1.10E-22	107.1	NAC2_MOUSE	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	Slc8a2 Ncx2	Mus musculus (Mouse)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0032592; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099055; GO:0099608; GO:0106056; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN36097_c0_g1_i1	Q8K596	NAC2_MOUSE	57.5	127	54	0	3	383	720	846	2.20E-37	156.4	NAC2_MOUSE	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	Slc8a2 Ncx2	Mus musculus (Mouse)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of mitochondrial membrane [GO:0032592]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0032592; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099055; GO:0099608; GO:0106056; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]		NA	NA	NA	NA	NA	NA
TRINITY_DN18784_c0_g1_i1	Q9UPR5	NAC2_HUMAN	57.6	85	34	1	254	6	109	193	3.20E-21	102.1	NAC2_HUMAN	reviewed	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	SLC8A2 KIAA1087 NCX2	Homo sapiens (Human)	921	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:0150104; GO:1903779; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN34865_c0_g1_i1	S4R2P9	NAC3_MOUSE	57.9	145	58	1	8	433	72	216	3.20E-37	156	NAC3_MOUSE	reviewed	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	Slc8a3 Ncx3	Mus musculus (Mouse)	928	axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]; calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]; telencephalon development [GO:0021537]	axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]	calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]	GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0015491; GO:0016020; GO:0016528; GO:0021537; GO:0030001; GO:0030424; GO:0030425; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0071901; GO:0098703; GO:0098794; GO:0098815; GO:0099055; GO:0099580; GO:1905060; GO:1990034	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]; telencephalon development [GO:0021537]		NA	NA	NA	NA	NA	NA
TRINITY_DN4072_c0_g1_i1	C4N147	FABP1_DORPE	40.9	132	76	1	439	44	1	130	1.60E-22	107.5	FABP1_DORPE	reviewed	Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1)		Doryteuthis pealeii (Longfin inshore squid) (Loligo pealeii)	132	cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]	cytoplasm [GO:0005737]; membrane [GO:0016020]	lipid binding [GO:0008289]	GO:0005737; GO:0008289; GO:0016020			black	black	NA	NA	NA	1
TRINITY_DN7103_c0_g1_i1	C4N147	FABP1_DORPE	53.1	96	45	0	296	9	3	98	1.70E-23	110.2	FABP1_DORPE	reviewed	Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1)		Doryteuthis pealeii (Longfin inshore squid) (Loligo pealeii)	132	cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]	cytoplasm [GO:0005737]; membrane [GO:0016020]	lipid binding [GO:0008289]	GO:0005737; GO:0008289; GO:0016020			blue	blue	NA	NA	NA	NA
TRINITY_DN20313_c0_g1_i1	P31639	SC5A2_HUMAN	75.8	33	8	0	152	54	67	99	9.30E-06	50.4	SC5A2_HUMAN	reviewed	Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2)	SLC5A2 SGLT2	Homo sapiens (Human)	672	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]; alpha-glucoside transport [GO:0000017]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; hexose transmembrane transport [GO:0008645]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]	GO:0000017; GO:0005362; GO:0005412; GO:0005886; GO:0005975; GO:0006814; GO:0008645; GO:0015151; GO:0016021; GO:0055056; GO:0070062; GO:0098708; GO:0098719	alpha-glucoside transport [GO:0000017]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; hexose transmembrane transport [GO:0008645]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]		brown	brown	NA	NA	NA	NA
TRINITY_DN35168_c0_g1_i1	Q2M3M2	SC5A9_HUMAN	39.7	68	40	1	218	18	501	568	1.00E-07	57	SC5A9_HUMAN	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (hSGLT4) (Solute carrier family 5 member 9)	SLC5A9 SGLT4	Homo sapiens (Human)	681	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]; hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]	GO:0005362; GO:0005412; GO:0005886; GO:0006814; GO:0008645; GO:0016021; GO:0070062	hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN37450_c0_g1_i1	Q8VDT1	SC5A9_MOUSE	59.7	62	21	1	143	328	166	223	6.40E-10	65.1	SC5A9_MOUSE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (mSGLT4) (Solute carrier family 5 member 9)	Slc5a9 Sglt4	Mus musculus (Mouse)	685	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN36750_c0_g1_i1	Q8VDT1	SC5A9_MOUSE	62.9	105	39	0	68	382	295	399	6.50E-34	144.8	SC5A9_MOUSE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (mSGLT4) (Solute carrier family 5 member 9)	Slc5a9 Sglt4	Mus musculus (Mouse)	685	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN31659_c0_g1_i1	Q8VDT1	SC5A9_MOUSE	57	149	57	2	3	449	114	255	2.00E-37	156.8	SC5A9_MOUSE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (mSGLT4) (Solute carrier family 5 member 9)	Slc5a9 Sglt4	Mus musculus (Mouse)	685	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12772_c0_g1_i2	Q8VDT1	SC5A9_MOUSE	57	135	53	2	62	460	295	426	1.20E-36	154.5	SC5A9_MOUSE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (mSGLT4) (Solute carrier family 5 member 9)	Slc5a9 Sglt4	Mus musculus (Mouse)	685	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i4	Q8VDT1	SC5A9_MOUSE	59.2	476	184	4	1	1428	51	516	3.00E-158	560.5	SC5A9_MOUSE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (mSGLT4) (Solute carrier family 5 member 9)	Slc5a9 Sglt4	Mus musculus (Mouse)	685	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN16775_c0_g1_i1	Q8VDT1	SC5A9_MOUSE	30.8	107	66	2	127	432	519	622	5.00E-06	52.4	SC5A9_MOUSE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (mSGLT4) (Solute carrier family 5 member 9)	Slc5a9 Sglt4	Mus musculus (Mouse)	685	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN37007_c0_g1_i1	A8WHP3	SC5A9_DANRE	58.3	72	22	1	1	216	376	439	3.00E-12	72	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i1	A8WHP3	SC5A9_DANRE	52.5	670	282	12	142	2139	20	657	1.40E-189	664.5	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i2	A8WHP3	SC5A9_DANRE	52.4	645	271	12	86	2008	45	657	8.70E-181	635.2	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i3	A8WHP3	SC5A9_DANRE	47.8	464	211	10	981	2360	221	657	2.20E-114	414.8	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i3	A8WHP3	SC5A9_DANRE	56.6	281	112	4	142	984	20	290	3.20E-81	304.7	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i7	A8WHP3	SC5A9_DANRE	52.5	670	282	12	145	2142	20	657	3.20E-189	663.3	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN12932_c0_g1_i8	A8WHP3	SC5A9_DANRE	47.3	469	216	10	30	1424	216	657	2.70E-115	417.2	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN16775_c0_g1_i2	A8WHP3	SC5A9_DANRE	46	276	115	4	1	768	374	635	6.50E-57	222.2	SC5A9_DANRE	reviewed	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	slc5a9 si:dkey-7o6.5	Danio rerio (Zebrafish) (Brachydanio rerio)	657	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12772_c0_g1_i3	A0PJK1	SC5AA_HUMAN	60.7	56	22	0	5	172	348	403	9.50E-14	77.4	SC5AA_HUMAN	reviewed	Sodium/glucose cotransporter 5 (Na(+)/glucose cotransporter 5) (Solute carrier family 5 member 10)	SLC5A10 SGLT5	Homo sapiens (Human)	596	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; solute:sodium symporter activity [GO:0015370]; hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]; solute:sodium symporter activity [GO:0015370]	GO:0005412; GO:0005886; GO:0006814; GO:0008645; GO:0015370; GO:0016021; GO:0070062	hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN12772_c0_g1_i5	A0PJK1	SC5AA_HUMAN	60.7	56	22	0	5	172	348	403	1.30E-13	77	SC5AA_HUMAN	reviewed	Sodium/glucose cotransporter 5 (Na(+)/glucose cotransporter 5) (Solute carrier family 5 member 10)	SLC5A10 SGLT5	Homo sapiens (Human)	596	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; solute:sodium symporter activity [GO:0015370]; hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]; solute:sodium symporter activity [GO:0015370]	GO:0005412; GO:0005886; GO:0006814; GO:0008645; GO:0015370; GO:0016021; GO:0070062	hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN14387_c0_g1_i1	Q9UBY0	SL9A2_HUMAN	63.5	85	31	0	9	263	306	390	4.50E-26	118.2	SL9A2_HUMAN	reviewed	Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2)	SLC9A2 NHE2	Homo sapiens (Human)	812	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0006811; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN34032_c0_g1_i1	P48764	SL9A3_HUMAN	53.8	106	49	0	44	361	63	168	5.80E-24	111.7	SL9A3_HUMAN	reviewed	Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3)	SLC9A3 NHE3	Homo sapiens (Human)	834	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0005903; GO:0006811; GO:0009986; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0051453; GO:0070062; GO:0071805; GO:0098719	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN16783_c0_g1_i6	Q6AI14	SL9A4_HUMAN	30.6	121	69	3	22	384	490	595	5.70E-07	56.2	SL9A4_HUMAN	reviewed	Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4) (NHE-4) (Solute carrier family 9 member 4)	SLC9A4 NHE4	Homo sapiens (Human)	798	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0001696; GO:0002064; GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0051453; GO:0071805; GO:0098719	epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN16783_c0_g1_i7	Q6AI14	SL9A4_HUMAN	30.6	121	69	3	22	384	490	595	3.80E-07	56.2	SL9A4_HUMAN	reviewed	Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4) (NHE-4) (Solute carrier family 9 member 4)	SLC9A4 NHE4	Homo sapiens (Human)	798	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0001696; GO:0002064; GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0051453; GO:0071805; GO:0098719	epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN26371_c0_g1_i1	Q96T83	SL9A7_HUMAN	100	68	0	0	25	228	67	134	3.10E-31	135.2	SL9A7_HUMAN	reviewed	Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)	SLC9A7 NHE7	Homo sapiens (Human)	725	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN38439_c0_g1_i1	Q96T83	SL9A7_HUMAN	100	95	0	0	286	2	199	293	1.70E-47	189.5	SL9A7_HUMAN	reviewed	Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)	SLC9A7 NHE7	Homo sapiens (Human)	725	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN1084_c0_g1_i2	Q96T83	SL9A7_HUMAN	49.8	605	250	12	1950	244	67	653	1.30E-139	498.4	SL9A7_HUMAN	reviewed	Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)	SLC9A7 NHE7	Homo sapiens (Human)	725	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN1084_c0_g1_i3	Q96T83	SL9A7_HUMAN	49.2	612	252	12	1977	244	67	653	1.00E-139	498.8	SL9A7_HUMAN	reviewed	Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)	SLC9A7 NHE7	Homo sapiens (Human)	725	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN1084_c0_g1_i5	Q96T83	SL9A7_HUMAN	49.2	612	252	12	1872	139	67	653	9.50E-140	498.8	SL9A7_HUMAN	reviewed	Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)	SLC9A7 NHE7	Homo sapiens (Human)	725	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN1084_c0_g1_i6	Q96T83	SL9A7_HUMAN	49.8	605	250	12	1845	139	67	653	1.20E-139	498.4	SL9A7_HUMAN	reviewed	Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)	SLC9A7 NHE7	Homo sapiens (Human)	725	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]		NA	NA	NA	NA	NA	NA
TRINITY_DN37784_c0_g1_i1	Q9Y2E8	SL9A8_HUMAN	69	87	26	1	259	2	382	468	2.90E-25	115.5	SL9A8_HUMAN	reviewed	Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8)	SLC9A8 KIAA0939 NHE8	Homo sapiens (Human)	581	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005794; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN14016_c0_g2_i1	Q5ZJ75	SL9A8_CHICK	66.3	83	28	0	3	251	169	251	9.20E-21	100.5	SL9A8_CHICK	reviewed	Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8)		Gallus gallus (Chicken)	574	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005794; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805	potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN14016_c0_g1_i1	Q9Y2E8	SL9A8_HUMAN	74.3	70	18	0	211	2	112	181	1.00E-25	116.7	SL9A8_HUMAN	reviewed	Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8)	SLC9A8 KIAA0939 NHE8	Homo sapiens (Human)	581	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005794; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]		NA	NA	NA	NA	NA	NA
TRINITY_DN3963_c0_g1_i1	Q4ZJI4	SL9B1_HUMAN	44.7	152	77	3	656	219	68	218	2.70E-25	117.1	SL9B1_HUMAN	reviewed	"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)"	SLC9B1 NHA1 NHEDC1	Homo sapiens (Human)	515	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	solute:proton antiporter activity [GO:0015299]	GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0015672; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228	flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN3963_c0_g1_i1	Q4ZJI4	SL9B1_HUMAN	63.2	57	21	0	183	13	219	275	6.80E-13	75.9	SL9B1_HUMAN	reviewed	"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)"	SLC9B1 NHA1 NHEDC1	Homo sapiens (Human)	515	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	solute:proton antiporter activity [GO:0015299]	GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0015672; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228	flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN3963_c0_g1_i11	Q4ZJI4	SL9B1_HUMAN	49.8	209	98	3	1441	833	68	275	5.80E-46	186.8	SL9B1_HUMAN	reviewed	"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)"	SLC9B1 NHA1 NHEDC1	Homo sapiens (Human)	515	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	solute:proton antiporter activity [GO:0015299]	GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0015672; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228	flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN3963_c0_g1_i11	Q4ZJI4	SL9B1_HUMAN	37.4	214	128	2	780	139	290	497	1.20E-30	136	SL9B1_HUMAN	reviewed	"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)"	SLC9B1 NHA1 NHEDC1	Homo sapiens (Human)	515	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	solute:proton antiporter activity [GO:0015299]	GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0015672; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228	flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN3963_c0_g1_i8	Q4ZJI4	SL9B1_HUMAN	44.7	152	77	3	463	26	68	218	2.00E-25	117.9	SL9B1_HUMAN	reviewed	"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)"	SLC9B1 NHA1 NHEDC1	Homo sapiens (Human)	515	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; solute:proton antiporter activity [GO:0015299]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	solute:proton antiporter activity [GO:0015299]	GO:0005886; GO:0006814; GO:0007338; GO:0015299; GO:0015672; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228	flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN31996_c0_g1_i1	A4IHB9	SL9B2_XENTR	47.4	76	39	1	3	230	246	320	9.30E-12	70.5	SL9B2_XENTR	reviewed	Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	slc9b2 nha2 nhedc2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	539	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0010008; GO:0015385; GO:0015672; GO:0016021; GO:0030317; GO:0030672; GO:0031966	flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]		NA	NA	NA	NA	NA	NA
TRINITY_DN3963_c0_g1_i13	A4IHB9	SL9B2_XENTR	46.9	437	218	5	1431	142	96	525	2.20E-93	344.7	SL9B2_XENTR	reviewed	Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	slc9b2 nha2 nhedc2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	539	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0010008; GO:0015385; GO:0015672; GO:0016021; GO:0030317; GO:0030672; GO:0031966	flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]		NA	NA	NA	NA	NA	NA
TRINITY_DN4647_c0_g3_i1	A4IHB9	SL9B2_XENTR	42.7	478	252	7	590	1984	61	529	2.00E-95	351.7	SL9B2_XENTR	reviewed	Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	slc9b2 nha2 nhedc2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	539	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0010008; GO:0015385; GO:0015672; GO:0016021; GO:0030317; GO:0030672; GO:0031966	flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]		NA	NA	NA	NA	NA	NA
TRINITY_DN4647_c0_g3_i2	Q86UD5	SL9B2_HUMAN	48.5	68	32	2	80	277	463	529	1.30E-07	57.8	SL9B2_HUMAN	reviewed	Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	SLC9B2 NHA2 NHEDC2	Homo sapiens (Human)	537	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]	identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]	GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0015672; GO:0016021; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206	clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN40190_c0_g1_i1	Q5BKR2	SL9B2_MOUSE	91.4	70	6	0	211	2	233	302	3.70E-18	91.7	SL9B2_MOUSE	reviewed	Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	Slc9b2 Nha2 Nhedc2	Mus musculus (Mouse)	547	basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]	identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]	GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0015672; GO:0016021; GO:0016323; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:0097708; GO:2001206	clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; monovalent inorganic cation transport [GO:0015672]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN436_c5_g1_i11	P53793	SC5A3_BOVIN	48.9	139	60	4	4	387	156	294	1.60E-31	137.1	SC5A3_BOVIN	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Bos taurus (Bovine)	718	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006020; GO:0015798; GO:0016021	inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]		NA	NA	NA	NA	NA	NA
TRINITY_DN436_c5_g1_i2	P31637	SC5A3_CANLF	55.8	86	36	1	334	585	140	225	9.80E-19	95.5	SC5A3_CANLF	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Canis lupus familiaris (Dog) (Canis familiaris)	718	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]	GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016021; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1904659; GO:1905477	fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]		NA	NA	NA	NA	NA	NA
TRINITY_DN436_c5_g1_i2	P31637	SC5A3_CANLF	51.9	52	25	0	608	763	243	294	4.00E-12	73.6	SC5A3_CANLF	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Canis lupus familiaris (Dog) (Canis familiaris)	718	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]	GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016021; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1904659; GO:1905477	fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]		NA	NA	NA	NA	NA	NA
TRINITY_DN436_c5_g1_i8	P31637	SC5A3_CANLF	38.1	126	36	2	406	777	140	225	1.20E-13	78.6	SC5A3_CANLF	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Canis lupus familiaris (Dog) (Canis familiaris)	718	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]	GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016021; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1904659; GO:1905477	fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]		NA	NA	NA	NA	NA	NA
TRINITY_DN27166_c0_g1_i1	P53793	SC5A3_BOVIN	65.7	70	24	0	213	4	55	124	6.00E-21	100.9	SC5A3_BOVIN	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Bos taurus (Bovine)	718	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006020; GO:0015798; GO:0016021	inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]		NA	NA	NA	NA	NA	NA
TRINITY_DN36949_c0_g1_i1	P53793	SC5A3_BOVIN	60.8	102	40	0	306	1	271	372	2.30E-37	156	SC5A3_BOVIN	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Bos taurus (Bovine)	718	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006020; GO:0015798; GO:0016021	inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]		NA	NA	NA	NA	NA	NA
TRINITY_DN37315_c0_g1_i1	P53793	SC5A3_BOVIN	100	67	0	0	3	203	41	107	2.30E-30	132.1	SC5A3_BOVIN	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Bos taurus (Bovine)	718	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006020; GO:0015798; GO:0016021	inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]		NA	NA	NA	NA	NA	NA
TRINITY_DN35776_c0_g2_i1	Q9JKZ2	SC5A3_MOUSE	57.1	49	16	2	112	249	243	289	7.70E-11	67.8	SC5A3_MOUSE	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	Slc5a3	Mus musculus (Mouse)	718	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]	GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0015459; GO:0015798; GO:0016021; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1905477	inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]		NA	NA	NA	NA	NA	NA
TRINITY_DN436_c5_g1_i12	P53793	SC5A3_BOVIN	39.7	194	66	5	82	630	141	294	5.00E-32	139.4	SC5A3_BOVIN	reviewed	Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)	SLC5A3 SMIT	Bos taurus (Bovine)	718	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006020; GO:0015798; GO:0016021	inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]		NA	NA	1	NA	NA	NA
TRINITY_DN14226_c0_g1_i1	Q3ZC26	SC5AB_BOVIN	61.5	78	30	0	236	3	294	371	1.80E-21	102.8	SC5AB_BOVIN	reviewed	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	SLC5A11 SMIT2	Bos taurus (Bovine)	674	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; apoptotic process [GO:0006915]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006915; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN28298_c0_g1_i1	A8I1B9	SC5AB_PIG	55.6	63	28	0	224	36	420	482	3.10E-15	82	SC5AB_PIG	reviewed	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	SLC5A11 SMIT2	Sus scrofa (Pig)	674	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; carbohydrate transport [GO:0008643]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0006915; GO:0008643; GO:0015293; GO:0016021	apoptotic process [GO:0006915]; carbohydrate transport [GO:0008643]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN35432_c0_g1_i1	Q3ZC26	SC5AB_BOVIN	62.3	122	44	1	3	368	250	369	2.80E-42	172.6	SC5AB_BOVIN	reviewed	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	SLC5A11 SMIT2	Bos taurus (Bovine)	674	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; apoptotic process [GO:0006915]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006915; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN12772_c0_g1_i4	Q8K0E3	SC5AB_MOUSE	59.8	122	47	1	62	421	290	411	2.60E-36	153.3	SC5AB_MOUSE	reviewed	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	Slc5a11 Kst1 Smit2	Mus musculus (Mouse)	673	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; apoptotic process [GO:0006915]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006915; GO:0016021	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN16570_c3_g1_i1	Q8WWX8	SC5AB_HUMAN	50.7	75	32	2	45	269	222	291	2.20E-13	76.3	SC5AB_HUMAN	reviewed	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	SLC5A11 KST1 SLGTX SMIT2	Homo sapiens (Human)	675	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]; apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]	GO:0005412; GO:0005886; GO:0006915; GO:0015166; GO:0015798; GO:0016021	apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]		brown	brown	NA	NA	NA	NA
TRINITY_DN30901_c0_g1_i1	Q9MZT2	S28A1_RABIT	34.4	189	107	5	35	601	88	259	1.40E-15	84.7	S28A1_RABIT	reviewed	Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)	SLC28A1 CNT1	Oryctolagus cuniculus (Rabbit)	658	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside:sodium symporter activity [GO:0005415]; uridine transmembrane transporter activity [GO:0015213]; cytidine transport [GO:0015861]; uridine transport [GO:0015862]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytidine transmembrane transporter activity [GO:0015212]; nucleoside:sodium symporter activity [GO:0005415]; uridine transmembrane transporter activity [GO:0015213]	GO:0005415; GO:0005886; GO:0005887; GO:0015212; GO:0015213; GO:0015861; GO:0015862	cytidine transport [GO:0015861]; uridine transport [GO:0015862]		NA	NA	NA	NA	NA	NA
TRINITY_DN30901_c0_g1_i3	Q9MZT2	S28A1_RABIT	35.7	207	116	5	35	655	88	277	4.10E-20	99.8	S28A1_RABIT	reviewed	Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)	SLC28A1 CNT1	Oryctolagus cuniculus (Rabbit)	658	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside:sodium symporter activity [GO:0005415]; uridine transmembrane transporter activity [GO:0015213]; cytidine transport [GO:0015861]; uridine transport [GO:0015862]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytidine transmembrane transporter activity [GO:0015212]; nucleoside:sodium symporter activity [GO:0005415]; uridine transmembrane transporter activity [GO:0015213]	GO:0005415; GO:0005886; GO:0005887; GO:0015212; GO:0015213; GO:0015861; GO:0015862	cytidine transport [GO:0015861]; uridine transport [GO:0015862]		NA	NA	NA	NA	NA	NA
TRINITY_DN26382_c0_g1_i1	Q9IAL7	NCKX2_CHICK	64.6	79	28	0	3	239	502	580	1.30E-22	106.7	NCKX2_CHICK	reviewed	Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2)	SLC24A2 NCKX2	Gallus gallus (Chicken)	651	"integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]	"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"	GO:0001917; GO:0005262; GO:0005887; GO:0006874; GO:0007601; GO:0008273; GO:0015293; GO:0050896; GO:0060291; GO:0060292; GO:0070588; GO:0098703	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN33517_c0_g1_i1	Q9UI40	NCKX2_HUMAN	70.9	86	25	0	305	48	507	592	1.60E-27	123.2	NCKX2_HUMAN	reviewed	Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2)	SLC24A2 NCKX2	Homo sapiens (Human)	661	"integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; protein-containing complex assembly [GO:0065003]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]; visual perception [GO:0007601]"	integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]	"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"	GO:0001917; GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007601; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0034220; GO:0035725; GO:0050896; GO:0060291; GO:0060292; GO:0065003; GO:0070588; GO:0071805; GO:0098703	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; protein-containing complex assembly [GO:0065003]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN43_c0_g1_i1	Q9U6A0	NCKX_DROME	68.9	183	44	1	3	551	710	879	2.70E-64	246.5	NCKX_DROME	reviewed	Sodium/potassium/calcium exchanger Nckx30C (Na(+)/K(+)/Ca(2+)-exchange protein Nckx30C)	Nckx30C CG18660	Drosophila melanogaster (Fruit fly)	881	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium channel activity [GO:0005262]; symporter activity [GO:0015293]"	GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0048749; GO:0070588	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN428_c0_g1_i1	P13607	ATNA_DROME	83	1007	171	0	106	3126	35	1041	0	1694.1	ATNA_DROME	reviewed	Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)	Atpalpha Na-p CG5670	Drosophila melanogaster (Fruit fly)	1041	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]	ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573	"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"		blue	blue	NA	NA	NA	NA
TRINITY_DN428_c0_g1_i2	P13607	ATNA_DROME	81.2	1035	192	1	103	3207	10	1041	0	1689.9	ATNA_DROME	reviewed	Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)	Atpalpha Na-p CG5670	Drosophila melanogaster (Fruit fly)	1041	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]	ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573	"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"		blue	blue	NA	NA	NA	NA
TRINITY_DN14467_c0_g1_i1	P13607	ATNA_DROME	83.7	86	14	0	261	4	266	351	6.00E-31	134.4	ATNA_DROME	reviewed	Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)	Atpalpha Na-p CG5670	Drosophila melanogaster (Fruit fly)	1041	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]	ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573	"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18398_c0_g1_i1	P13607	ATNA_DROME	67.1	79	26	0	3	239	415	493	2.50E-23	109	ATNA_DROME	reviewed	Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)	Atpalpha Na-p CG5670	Drosophila melanogaster (Fruit fly)	1041	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]; ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]; adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202]	ATP binding [GO:0005524]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573	"adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic growth at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32398_c0_g1_i1	P05023	AT1A1_HUMAN	100	86	0	0	3	260	44	129	1.90E-45	182.6	AT1A1_HUMAN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	ATP1A1	Homo sapiens (Human)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0034220; GO:0036126; GO:0036376; GO:0042383; GO:0042470; GO:0042493; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055119; GO:0060081; GO:0060342; GO:0070062; GO:0071260; GO:0071383; GO:0086002; GO:0086004; GO:0086009; GO:0086013; GO:0086064; GO:1902600; GO:1903416; GO:1903561; GO:1903779; GO:1990239; GO:1990573	cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN25571_c0_g1_i1	Q92030	AT1A1_ANGAN	100	76	0	0	3	230	705	780	2.30E-34	145.6	AT1A1_ANGAN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	atp1a1	Anguilla anguilla (European freshwater eel) (Muraena anguilla)	1022	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0042383; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN24009_c0_g1_i1	P05023	AT1A1_HUMAN	100	162	0	0	3	488	309	470	4.00E-84	312	AT1A1_HUMAN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	ATP1A1	Homo sapiens (Human)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0034220; GO:0036126; GO:0036376; GO:0042383; GO:0042470; GO:0042493; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055119; GO:0060081; GO:0060342; GO:0070062; GO:0071260; GO:0071383; GO:0086002; GO:0086004; GO:0086009; GO:0086013; GO:0086064; GO:1902600; GO:1903416; GO:1903561; GO:1903779; GO:1990239; GO:1990573	cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN24009_c0_g1_i2	Q8VDN2	AT1A1_MOUSE	99.6	227	1	0	3	683	309	535	1.30E-122	440.3	AT1A1_MOUSE	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	Atp1a1	Mus musculus (Mouse)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0036126; GO:0036376; GO:0042383; GO:0042493; GO:0043209; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055085; GO:0060081; GO:0071260; GO:0071383; GO:0086004; GO:0086009; GO:1902600; GO:1990239; GO:1990573	cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN35129_c0_g1_i1	Q08DA1	AT1A1_BOVIN	100	125	0	0	1	375	897	1021	7.60E-71	267.7	AT1A1_BOVIN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	ATP1A1	Bos taurus (Bovine)	1021	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0006883; GO:0016021; GO:0030007; GO:0036376; GO:0042383; GO:0045121; GO:0046872; GO:1902600; GO:1990573	cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN33565_c0_g1_i1	P05023	AT1A1_HUMAN	100	102	0	0	2	307	590	691	2.10E-51	202.6	AT1A1_HUMAN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	ATP1A1	Homo sapiens (Human)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0034220; GO:0036126; GO:0036376; GO:0042383; GO:0042470; GO:0042493; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055119; GO:0060081; GO:0060342; GO:0070062; GO:0071260; GO:0071383; GO:0086002; GO:0086004; GO:0086009; GO:0086013; GO:0086064; GO:1902600; GO:1903416; GO:1903561; GO:1903779; GO:1990239; GO:1990573	cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN28589_c0_g1_i1	Q8VDN2	AT1A1_MOUSE	100	111	0	0	2	334	193	303	9.60E-58	223.8	AT1A1_MOUSE	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	Atp1a1	Mus musculus (Mouse)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0036126; GO:0036376; GO:0042383; GO:0042493; GO:0043209; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055085; GO:0060081; GO:0071260; GO:0071383; GO:0086004; GO:0086009; GO:1902600; GO:1990239; GO:1990573	cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN23471_c0_g1_i1	Q8VDN2	AT1A1_MOUSE	100	144	0	0	3	434	784	927	3.80E-78	292	AT1A1_MOUSE	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	Atp1a1	Mus musculus (Mouse)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0036126; GO:0036376; GO:0042383; GO:0042493; GO:0043209; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055085; GO:0060081; GO:0071260; GO:0071383; GO:0086004; GO:0086009; GO:1902600; GO:1990239; GO:1990573	cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; response to drug [GO:0042493]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN23471_c0_g1_i2	P05023	AT1A1_HUMAN	100	144	0	0	3	434	784	927	4.90E-78	291.6	AT1A1_HUMAN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	ATP1A1	Homo sapiens (Human)	1023	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]	ADP binding [GO:0043531]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; phosphatase activity [GO:0016791]; phosphatidylinositol 3-kinase binding [GO:0043548]; potassium ion binding [GO:0030955]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0005901; GO:0006883; GO:0008217; GO:0014069; GO:0014704; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0019901; GO:0019904; GO:0030007; GO:0030315; GO:0030506; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0034220; GO:0036126; GO:0036376; GO:0042383; GO:0042470; GO:0042493; GO:0043531; GO:0043548; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055119; GO:0060081; GO:0060342; GO:0070062; GO:0071260; GO:0071383; GO:0086002; GO:0086004; GO:0086009; GO:0086013; GO:0086064; GO:1902600; GO:1903416; GO:1903561; GO:1903779; GO:1990239; GO:1990573	cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; membrane hyperpolarization [GO:0060081]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to drug [GO:0042493]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN26616_c0_g1_i1	Q08DA1	AT1A1_BOVIN	98.6	73	1	0	2	220	144	216	1.60E-32	139.4	AT1A1_BOVIN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	ATP1A1	Bos taurus (Bovine)	1021	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0006883; GO:0016021; GO:0030007; GO:0036376; GO:0042383; GO:0045121; GO:0046872; GO:1902600; GO:1990573	cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN29656_c0_g1_i1	A2VDL6	AT1A2_BOVIN	84.4	32	5	0	149	54	814	845	2.30E-07	55.8	AT1A2_BOVIN	reviewed	Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2)	ATP1A2	Bos taurus (Bovine)	1020	cell projection [GO:0042995]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; potassium ion binding [GO:0030955]; sodium ion binding [GO:0031402]; sodium:potassium-exchanging ATPase activity [GO:0005391]; steroid hormone binding [GO:1990239]; adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cellular potassium ion homeostasis [GO:0030007]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]; visual learning [GO:0008542]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; potassium ion binding [GO:0030955]; sodium:potassium-exchanging ATPase activity [GO:0005391]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]	GO:0001504; GO:0001662; GO:0002026; GO:0002087; GO:0005391; GO:0005524; GO:0005737; GO:0005890; GO:0006883; GO:0006940; GO:0008144; GO:0008217; GO:0008344; GO:0008542; GO:0010996; GO:0016887; GO:0019229; GO:0021764; GO:0021989; GO:0030007; GO:0030315; GO:0030955; GO:0031090; GO:0031402; GO:0035641; GO:0036376; GO:0040011; GO:0042995; GO:0043025; GO:0045822; GO:0045988; GO:0046034; GO:0051087; GO:0051481; GO:0071383; GO:1902600; GO:1903416; GO:1990239; GO:1990573	adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cellular potassium ion homeostasis [GO:0030007]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; sodium ion export across plasma membrane [GO:0036376]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN37403_c0_g1_i1	P24798	AT1A3_CHICK	66.7	84	28	0	10	261	691	774	5.00E-25	114.8	AT1A3_CHICK	reviewed	Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3)	ATP1A3	Gallus gallus (Chicken)	1010	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]	GO:0005391; GO:0005524; GO:0005783; GO:0005794; GO:0005886; GO:0006883; GO:0016021; GO:0030007; GO:0036376; GO:0045202; GO:0046872; GO:1902600; GO:1990573	cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376]		NA	NA	NA	NA	NA	NA
TRINITY_DN3290_c0_g1_i3	P25169	AT1B1_ARTSF	49.7	302	142	7	996	97	22	315	1.00E-79	298.5	AT1B1_ARTSF	reviewed	Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit)		Artemia franciscana (Brine shrimp) (Artemia sanfranciscana)	315	sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	sodium:potassium-exchanging ATPase complex [GO:0005890]		GO:0005890; GO:0006813; GO:0006814	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN3290_c0_g1_i4	P25169	AT1B1_ARTSF	49.3	302	143	7	996	97	22	315	8.50E-79	295.4	AT1B1_ARTSF	reviewed	Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit)		Artemia franciscana (Brine shrimp) (Artemia sanfranciscana)	315	sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]	sodium:potassium-exchanging ATPase complex [GO:0005890]		GO:0005890; GO:0006813; GO:0006814	potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN5157_c0_g1_i1	A6MHQ4	NKAIN_DROME	52.7	203	93	2	854	246	1	200	4.70E-59	229.6	NKAIN_DROME	reviewed	Sodium/potassium-transporting ATPase subunit beta-1-interacting protein (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein) (dNKAIN)	NKAIN CG34413	Drosophila melanogaster (Fruit fly)	658	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0002028; GO:0005886; GO:0016021	regulation of sodium ion transport [GO:0002028]		NA	NA	NA	NA	NA	NA
TRINITY_DN5157_c0_g1_i2	A6MHQ4	NKAIN_DROME	60	65	26	0	249	55	1	65	3.50E-16	85.5	NKAIN_DROME	reviewed	Sodium/potassium-transporting ATPase subunit beta-1-interacting protein (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein) (dNKAIN)	NKAIN CG34413	Drosophila melanogaster (Fruit fly)	658	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0002028; GO:0005886; GO:0016021	regulation of sodium ion transport [GO:0002028]		NA	NA	NA	NA	NA	NA
TRINITY_DN5157_c0_g1_i3	A6MHQ4	NKAIN_DROME	55.1	178	78	1	1344	811	1	176	1.90E-54	214.9	NKAIN_DROME	reviewed	Sodium/potassium-transporting ATPase subunit beta-1-interacting protein (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein) (dNKAIN)	NKAIN CG34413	Drosophila melanogaster (Fruit fly)	658	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0002028; GO:0005886; GO:0016021	regulation of sodium ion transport [GO:0002028]		NA	NA	NA	NA	NA	NA
TRINITY_DN5157_c0_g1_i4	A6MHQ4	NKAIN_DROME	53	200	91	2	1411	812	1	197	4.90E-58	226.9	NKAIN_DROME	reviewed	Sodium/potassium-transporting ATPase subunit beta-1-interacting protein (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein) (dNKAIN)	NKAIN CG34413	Drosophila melanogaster (Fruit fly)	658	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0002028; GO:0005886; GO:0016021	regulation of sodium ion transport [GO:0002028]		NA	NA	NA	NA	NA	NA
TRINITY_DN3290_c0_g1_i1	Q24048	ATPB2_DROME	47.8	180	90	3	633	97	147	323	3.70E-46	186.4	ATPB2_DROME	reviewed	Sodium/potassium-transporting ATPase subunit beta-2 (Protein nervana 2) (Sodium/potassium-dependent ATPase subunit beta-2)	nrv2 CG9261	Drosophila melanogaster (Fruit fly)	323	"axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cation transport [GO:0006812]; cell adhesion involved in heart morphogenesis [GO:0061343]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; open tracheal system development [GO:0007424]; potassium ion import across plasma membrane [GO:1990573]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; regulation of tube size, open tracheal system [GO:0035151]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]"	axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]	ATPase activator activity [GO:0001671]	GO:0001671; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007424; GO:0007605; GO:0010248; GO:0019991; GO:0030007; GO:0030424; GO:0035151; GO:0035158; GO:0035159; GO:0036376; GO:0060857; GO:0061343; GO:1990573	"cation transport [GO:0006812]; cell adhesion involved in heart morphogenesis [GO:0061343]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; open tracheal system development [GO:0007424]; potassium ion import across plasma membrane [GO:1990573]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; regulation of tube size, open tracheal system [GO:0035151]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1_c216_g1_i1	Q5BL81	SC5A8_XENTR	48.4	64	33	0	118	309	10	73	1.80E-10	67	SC5A8_XENTR	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	slc5a8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	620	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN4886_c0_g1_i11	Q8BYF6	SC5A8_MOUSE	29.9	197	135	2	670	83	350	544	2.20E-14	80.9	SC5A8_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	Slc5a8 Smct Smct1	Mus musculus (Mouse)	611	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]	GO:0005343; GO:0006814; GO:0006915; GO:0015129; GO:0015293; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161	apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN4886_c0_g1_i13	Q8BYF6	SC5A8_MOUSE	30.9	152	103	1	576	121	350	499	3.40E-11	70.1	SC5A8_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	Slc5a8 Smct Smct1	Mus musculus (Mouse)	611	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]	GO:0005343; GO:0006814; GO:0006915; GO:0015129; GO:0015293; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161	apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN4886_c0_g1_i5	Q8BYF6	SC5A8_MOUSE	29.9	197	135	2	836	249	350	544	3.60E-14	80.5	SC5A8_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	Slc5a8 Smct Smct1	Mus musculus (Mouse)	611	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]	GO:0005343; GO:0006814; GO:0006915; GO:0015129; GO:0015293; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161	apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN4886_c0_g1_i8	Q8BYF6	SC5A8_MOUSE	32.4	222	147	2	911	249	325	544	4.00E-21	103.6	SC5A8_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	Slc5a8 Smct Smct1	Mus musculus (Mouse)	611	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; symporter activity [GO:0015293]	GO:0005343; GO:0006814; GO:0006915; GO:0015129; GO:0015293; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161	apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN238_c0_g1_i1	Q3ZMH1	SC5A8_DANRE	34.1	540	337	9	89	1687	15	542	4.40E-81	303.9	SC5A8_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8)	slc5a8 slc5a8l smcte zgc:152716	Danio rerio (Zebrafish) (Brachydanio rerio)	610	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN238_c0_g1_i2	Q3ZMH1	SC5A8_DANRE	34.5	534	330	10	89	1648	15	542	1.70E-80	302	SC5A8_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8)	slc5a8 slc5a8l smcte zgc:152716	Danio rerio (Zebrafish) (Brachydanio rerio)	610	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN27897_c0_g1_i1	Q3ZMH1	SC5A8_DANRE	42.9	133	73	3	396	4	4	135	3.20E-23	109.4	SC5A8_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8)	slc5a8 slc5a8l smcte zgc:152716	Danio rerio (Zebrafish) (Brachydanio rerio)	610	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN14934_c0_g1_i1	Q49B93	SC5AC_MOUSE	46.9	64	34	0	227	36	6	69	6.60E-09	61.6	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN14934_c0_g1_i4	Q49B93	SC5AC_MOUSE	48.4	64	33	0	220	29	6	69	5.60E-09	62	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN14934_c0_g1_i6	Q49B93	SC5AC_MOUSE	50	52	26	0	167	12	6	57	4.00E-06	52.4	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN14934_c0_g1_i7	Q49B93	SC5AC_MOUSE	48.4	64	33	0	220	29	6	69	5.00E-09	62	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN36970_c0_g1_i1	Q49B93	SC5AC_MOUSE	53.7	67	31	0	201	1	147	213	5.30E-11	67.8	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN8811_c0_g1_i5	Q49B93	SC5AC_MOUSE	35.2	108	70	0	174	497	6	113	4.60E-12	72.8	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN8811_c0_g1_i4	Q7T384	SC5AC_DANRE	45.7	70	36	1	162	365	1	70	1.50E-07	57.4	SC5AC_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (zSMCTn) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) (zSLC5A12)	slc5a12 smctn	Danio rerio (Zebrafish) (Brachydanio rerio)	623	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN8811_c0_g1_i7	Q7T384	SC5AC_DANRE	45.7	70	36	1	162	365	1	70	1.10E-07	57.8	SC5AC_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (zSMCTn) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) (zSLC5A12)	slc5a12 smctn	Danio rerio (Zebrafish) (Brachydanio rerio)	623	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN17913_c0_g1_i1	Q7T384	SC5AC_DANRE	56.1	57	25	0	61	231	291	347	1.40E-13	77	SC5AC_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (zSMCTn) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) (zSLC5A12)	slc5a12 smctn	Danio rerio (Zebrafish) (Brachydanio rerio)	623	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		brown	brown	1	NA	NA	1
TRINITY_DN22070_c0_g2_i1	Q7T384	SC5AC_DANRE	46	126	67	1	384	7	261	385	6.00E-27	121.7	SC5AC_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (zSMCTn) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) (zSLC5A12)	slc5a12 smctn	Danio rerio (Zebrafish) (Brachydanio rerio)	623	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN18715_c0_g1_i1	Q7T384	SC5AC_DANRE	38.7	163	98	1	33	521	286	446	4.70E-30	132.5	SC5AC_DANRE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (zSMCTn) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) (zSLC5A12)	slc5a12 smctn	Danio rerio (Zebrafish) (Brachydanio rerio)	623	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0015355; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN38533_c0_g1_i1	Q6DFK0	S38A9_XENLA	45.5	200	104	3	5	592	325	523	1.60E-42	174.1	S38A9_XENLA	reviewed	Sodium-coupled neutral amino acid transporter 9 (Solute carrier family 38 member 9)	slc38a9	Xenopus laevis (African clawed frog)	554	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]; amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]	GO:0003333; GO:0005764; GO:0005765; GO:0005770; GO:0015171; GO:0016021; GO:0031902; GO:0032008; GO:0046872; GO:0071230	amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN9586_c0_g1_i1	Q5M7S0	S38A9_XENTR	32.9	149	80	4	428	3	4	139	1.70E-14	81.3	S38A9_XENTR	reviewed	Sodium-coupled neutral amino acid transporter 9 (Solute carrier family 38 member 9)	slc38a9	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	554	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]; amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]	GO:0003333; GO:0005764; GO:0005765; GO:0005770; GO:0015171; GO:0016021; GO:0031902; GO:0032008; GO:0046872; GO:0071230	amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]		NA	NA	NA	NA	NA	NA
TRINITY_DN2741_c0_g1_i5	Q7K4Y6	DAT_DROME	41.8	79	43	1	513	286	518	596	1.80E-08	60.8	DAT_DROME	reviewed	Sodium-dependent dopamine transporter (Protein fumin)	DAT fmn CG8380	Drosophila melanogaster (Fruit fly)	631	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]	GO:0005330; GO:0005886; GO:0005887; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030431; GO:0032809; GO:0035725; GO:0042734; GO:0042745; GO:0043005; GO:0046872; GO:0051583; GO:0099509; GO:1990834	adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN2741_c0_g1_i8	Q7K4Y6	DAT_DROME	42.3	71	38	1	264	61	518	588	1.90E-07	56.6	DAT_DROME	reviewed	Sodium-dependent dopamine transporter (Protein fumin)	DAT fmn CG8380	Drosophila melanogaster (Fruit fly)	631	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]	GO:0005330; GO:0005886; GO:0005887; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030431; GO:0032809; GO:0035725; GO:0042734; GO:0042745; GO:0043005; GO:0046872; GO:0051583; GO:0099509; GO:1990834	adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN18938_c0_g1_i1	Q9Y289	SC5A6_HUMAN	47.9	71	36	1	256	44	124	193	7.70E-08	57.8	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN18938_c0_g1_i2	Q9Y289	SC5A6_HUMAN	50.7	71	34	1	256	44	124	193	6.90E-09	61.2	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN18938_c0_g1_i3	Q9Y289	SC5A6_HUMAN	50	68	33	1	204	1	124	190	1.80E-07	56.2	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN238_c1_g1_i1	Q9Y289	SC5A6_HUMAN	50	52	26	0	80	235	194	245	2.10E-07	56.6	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		brown	brown	1	NA	NA	NA
TRINITY_DN238_c2_g1_i1	Q9XT77	SC5A6_RABIT	49.3	67	33	1	202	2	135	200	7.70E-10	63.9	SC5A6_RABIT	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Oryctolagus cuniculus (Rabbit)	636	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN238_c1_g1_i2	Q9Y289	SC5A6_HUMAN	50	52	26	0	80	235	194	245	1.60E-07	57	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN238_c1_g1_i3	Q9Y289	SC5A6_HUMAN	48.1	52	27	0	80	235	194	245	1.10E-06	53.9	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN25609_c0_g1_i1	O70247	SC5A6_RAT	40.9	93	53	1	314	36	311	401	3.20E-12	72.8	SC5A6_RAT	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	Slc5a6 Smvt	Rattus norvegicus (Rat)	634	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0006814; GO:0008523; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0016021; GO:0031526; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN25609_c0_g1_i2	O70247	SC5A6_RAT	40.9	93	53	1	314	36	311	401	3.20E-12	72.8	SC5A6_RAT	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	Slc5a6 Smvt	Rattus norvegicus (Rat)	634	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0006814; GO:0008523; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0016021; GO:0031526; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN22070_c0_g1_i1	Q9Y289	SC5A6_HUMAN	50	52	23	1	419	273	515	566	5.60E-05	48.9	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN18715_c0_g2_i1	Q9XT77	SC5A6_RABIT	45.9	61	33	0	1	183	178	238	2.60E-10	65.5	SC5A6_RABIT	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Oryctolagus cuniculus (Rabbit)	636	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN8666_c0_g1_i1	Q9Y289	SC5A6_HUMAN	49	51	26	0	226	74	195	245	1.20E-06	53.5	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN30508_c0_g1_i1	Q9Y289	SC5A6_HUMAN	100	99	0	0	298	2	160	258	6.60E-50	197.6	SC5A6_HUMAN	reviewed	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	SLC5A6 SMVT	Homo sapiens (Human)	635	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006768; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0055085; GO:0150104; GO:1905135	biotin import across plasma membrane [GO:1905135]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN7697_c0_g1_i1	Q8BG16	S6A15_MOUSE	46.1	609	312	6	57	1859	59	659	2.00E-158	560.8	S6A15_MOUSE	reviewed	Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Solute carrier family 6 member 15) (Transporter v7-3)	Slc6a15 B0at2 Ntt73	Mus musculus (Mouse)	729	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; proline:sodium symporter activity [GO:0005298]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	proline:sodium symporter activity [GO:0005298]	GO:0005298; GO:0005886; GO:0005887; GO:0006836; GO:0015804; GO:0015820; GO:0015824; GO:0035725	leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN32080_c0_g1_i1	Q9XS59	S6A15_BOVIN	46.2	80	41	1	305	66	502	579	1.20E-12	73.9	S6A15_BOVIN	reviewed	Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Solute carrier family 6 member 15) (Transporter v7-3)	SLC6A15 B0AT2 NTT73	Bos taurus (Bovine)	729	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; proline:sodium symporter activity [GO:0005298]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	proline:sodium symporter activity [GO:0005298]	GO:0005298; GO:0005886; GO:0005887; GO:0006836; GO:0015804; GO:0015820; GO:0015824; GO:0035725	leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN26930_c0_g1_i1	Q9H1V8	S6A17_HUMAN	43.8	73	41	0	8	226	60	132	7.50E-14	77.4	S6A17_HUMAN	reviewed	Sodium-dependent neutral amino acid transporter SLC6A17 (Sodium-dependent neurotransmitter transporter NTT4) (Solute carrier family 6 member 17)	SLC6A17 NTT4	Homo sapiens (Human)	727	cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; symporter activity [GO:0015293]; alanine transport [GO:0032328]; brain development [GO:0007420]; glycine transport [GO:0015816]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]	cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	symporter activity [GO:0015293]	GO:0005887; GO:0006836; GO:0007420; GO:0008021; GO:0015293; GO:0015804; GO:0015816; GO:0015820; GO:0015824; GO:0030672; GO:0032328; GO:0035725; GO:0042995; GO:0098794; GO:0150104	alanine transport [GO:0032328]; brain development [GO:0007420]; glycine transport [GO:0015816]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN39336_c0_g1_i1	O55192	SC6A2_MOUSE	98.9	94	1	0	282	1	321	414	3.20E-46	185.3	SC6A2_MOUSE	reviewed	Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2)	Slc6a2	Mus musculus (Mouse)	617	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to drug [GO:0042493]; response to pain [GO:0048265]; sodium ion transmembrane transport [GO:0035725]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter:sodium symporter activity [GO:0005328]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]	GO:0003779; GO:0005326; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0009986; GO:0015844; GO:0015874; GO:0032809; GO:0035725; GO:0042493; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0051620	dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to drug [GO:0042493]; response to pain [GO:0048265]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN5410_c0_g1_i1	B4NDL8	NAAT1_DROWI	55.6	153	66	1	498	40	24	174	8.50E-45	181.4	NAAT1_DROWI	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GK25473	Drosophila willistoni (Fruit fly)	641	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN5410_c0_g1_i2	B3MRS1	NAAT1_DROAN	64.1	64	23	0	226	35	16	79	5.40E-18	91.3	NAAT1_DROAN	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GF20945	Drosophila ananassae (Fruit fly)	640	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN30401_c0_g1_i1	B4MEG2	NAAT1_DROVI	66.7	90	29	1	300	34	33	122	3.30E-31	135.6	NAAT1_DROVI	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GJ14810	Drosophila virilis (Fruit fly)	637	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i10	B4GVM9	NAAT1_DROPE	47.1	484	236	4	112	1509	136	617	1.40E-118	429.1	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i20	B4GVM9	NAAT1_DROPE	47.1	350	184	1	828	1874	268	617	1.10E-87	325.9	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i20	B4GVM9	NAAT1_DROPE	51.6	221	88	3	103	714	50	268	1.40E-58	229.2	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i23	B4GVM9	NAAT1_DROPE	47.1	484	236	4	112	1509	136	617	1.00E-118	429.1	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i27	B4GVM9	NAAT1_DROPE	48.9	570	271	4	103	1758	50	617	2.20E-154	548.1	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i31	B4GVM9	NAAT1_DROPE	47.1	484	236	4	112	1509	136	617	4.20E-119	429.9	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i33	B4GVM9	NAAT1_DROPE	48.9	570	271	4	103	1758	50	617	1.70E-154	548.1	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i35	B4GVM9	NAAT1_DROPE	48.9	570	271	4	103	1758	50	617	7.20E-155	548.9	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i36	B4GVM9	NAAT1_DROPE	47.1	350	184	1	828	1874	268	617	3.10E-87	325.1	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i36	B4GVM9	NAAT1_DROPE	51.6	221	88	3	103	714	50	268	2.30E-58	229.2	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i7	B4GVM9	NAAT1_DROPE	47.1	350	184	1	828	1874	268	617	2.40E-87	325.1	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i7	B4GVM9	NAAT1_DROPE	51.6	221	88	3	103	714	50	268	1.80E-58	229.2	NAAT1_DROPE	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GL14641	Drosophila persimilis (Fruit fly)	652	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7342_c1_g1_i1	B4NDL8	NAAT1_DROWI	45.2	73	40	0	29	247	386	458	9.00E-07	54.3	NAAT1_DROWI	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GK25473	Drosophila willistoni (Fruit fly)	641	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7342_c0_g1_i1	B3MRS1	NAAT1_DROAN	60.4	101	39	1	54	353	336	436	1.60E-26	120.2	NAAT1_DROAN	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GF20945	Drosophila ananassae (Fruit fly)	640	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7342_c0_g1_i2	B3NV41	NAAT1_DROER	59.8	234	93	1	1	699	204	437	1.90E-71	270.4	NAAT1_DROER	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GG18498	Drosophila erecta (Fruit fly)	641	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7342_c0_g1_i3	B3NV41	NAAT1_DROER	59.7	134	54	0	1	402	204	337	1.40E-37	157.1	NAAT1_DROER	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GG18498	Drosophila erecta (Fruit fly)	641	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN13702_c0_g1_i1	B4JMC1	NAAT1_DROGR	47.4	38	20	0	179	66	455	492	9.50E-05	47.4	NAAT1_DROGR	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GH24359	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	636	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		brown	brown	NA	NA	NA	NA
TRINITY_DN31017_c0_g1_i1	B3MRS1	NAAT1_DROAN	56.2	80	35	0	41	280	223	302	9.80E-22	104	NAAT1_DROAN	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GF20945	Drosophila ananassae (Fruit fly)	640	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN15915_c0_g1_i2	Q29GB8	NAAT1_DROPS	49.5	572	275	4	1909	224	51	618	4.80E-158	559.7	NAAT1_DROPS	reviewed	Sodium-dependent nutrient amino acid transporter 1	NAAT1 GA16959	Drosophila pseudoobscura pseudoobscura (Fruit fly)	653	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]	integral component of plasma membrane [GO:0005887]	amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005283; GO:0005887; GO:0006814; GO:0015175; GO:0015179; GO:0015804; GO:0042940; GO:0042943	D-amino acid transport [GO:0042940]; neutral amino acid transport [GO:0015804]; sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN914_c0_g2_i1	Q9W4C5	NAAT1_DROME	38.6	202	124	0	1	606	405	606	9.20E-39	161.8	NAAT1_DROME	reviewed	Sodium-dependent nutrient amino acid transporter 1 (DmNAT1)	NAAT1 CG3252	Drosophila melanogaster (Fruit fly)	641	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid:cation symporter activity [GO:0005416]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter transmembrane transporter activity [GO:0005326]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]; D-amino acid transport [GO:0042940]; L-amino acid transport [GO:0015807]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	amino acid:cation symporter activity [GO:0005416]; amino acid:sodium symporter activity [GO:0005283]; D-amino acid transmembrane transporter activity [GO:0042943]; L-amino acid transmembrane transporter activity [GO:0015179]; neurotransmitter transmembrane transporter activity [GO:0005326]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0003333; GO:0005283; GO:0005326; GO:0005416; GO:0005886; GO:0005887; GO:0006814; GO:0006836; GO:0015175; GO:0015179; GO:0015804; GO:0015807; GO:0016021; GO:0035725; GO:0042940; GO:0042943	amino acid transmembrane transport [GO:0003333]; D-amino acid transport [GO:0042940]; L-amino acid transport [GO:0015807]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]		black	black	1	NA	NA	1
TRINITY_DN12900_c0_g1_i1	Q62795	NPT1_RAT	35.4	130	81	1	396	7	110	236	7.80E-17	88.2	NPT1_RAT	reviewed	Sodium-dependent phosphate transport protein 1 (Na(+)/PI cotransporter 1) (Renal Na(+)-dependent phosphate cotransporter 1) (Renal sodium-dependent phosphate transport protein 1) (Renal sodium-phosphate transport protein 1) (Sodium/phosphate cotransporter 1) (Solute carrier family 17 member 1)	Slc17a1 Npt1	Rattus norvegicus (Rat)	465	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; phosphate ion transmembrane transporter activity [GO:0015114]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sialic acid transport [GO:0015739]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]	phosphate ion transmembrane transporter activity [GO:0015114]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]	GO:0005436; GO:0005764; GO:0005887; GO:0006820; GO:0015114; GO:0015136; GO:0015739; GO:0015747; GO:0016021; GO:0016324; GO:0022857; GO:0046415	anion transport [GO:0006820]; sialic acid transport [GO:0015739]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN411_c0_g1_i1	O82390	ANTR1_ARATH	32.2	394	251	8	1145	6	96	487	1.10E-50	202.2	ANTR1_ARATH	reviewed	"Sodium-dependent phosphate transport protein 1, chloroplastic (Anion transporter 1) (Na(+)/PI cotransporter 1) (Phosphate transporter PHT4;1) (Sodium/phosphate cotransporter 1)"	ANTR1 PHT4;1 At2g29650 T27A16.25	Arabidopsis thaliana (Mouse-ear cress)	512	chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; thylakoid [GO:0009579]; inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]; response to light stimulus [GO:0009416]; response to nematode [GO:0009624]; sodium ion transport [GO:0006814]	chloroplast thylakoid membrane [GO:0009535]; integral component of membrane [GO:0016021]; thylakoid [GO:0009579]	inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]	GO:0005315; GO:0006814; GO:0009416; GO:0009535; GO:0009579; GO:0009624; GO:0015293; GO:0016021	response to light stimulus [GO:0009416]; response to nematode [GO:0009624]; sodium ion transport [GO:0006814]		blue	blue	NA	NA	NA	NA
TRINITY_DN14072_c0_g1_i1	Q06495	NPT2A_HUMAN	65.7	70	24	0	212	3	178	247	5.90E-21	100.9	NPT2A_HUMAN	reviewed	Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1)	SLC34A1 NPT2 SLC17A2	Homo sapiens (Human)	639	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436]; arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436]	GO:0001503; GO:0001822; GO:0005436; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0009100; GO:0009986; GO:0010288; GO:0016324; GO:0016607; GO:0030165; GO:0030643; GO:0031526; GO:0031982; GO:0032026; GO:0032355; GO:0033189; GO:0035435; GO:0035864; GO:0042431; GO:0042493; GO:0042802; GO:0044267; GO:0044341; GO:0044877; GO:0045121; GO:0045838; GO:0046686; GO:0046689; GO:0048471; GO:0055062; GO:0060416; GO:0071248; GO:0071374; GO:0072350; GO:0072686; GO:0072734; GO:0097066; GO:0097187; GO:0098719; GO:1901128; GO:1901684; GO:2000120; GO:2000187	arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium-dependent phosphate transport [GO:0044341]; sodium ion import across plasma membrane [GO:0098719]; tricarboxylic acid metabolic process [GO:0072350]		NA	NA	NA	NA	NA	NA
TRINITY_DN3452_c0_g1_i1	Q06496	NPT2A_RAT	51	547	252	5	1793	159	76	608	1.20E-126	455.3	NPT2A_RAT	reviewed	Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1)	Slc34a1 Slc17a2	Rattus norvegicus (Rat)	637	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436]; arsenate ion transmembrane transport [GO:1901684]; bone remodeling [GO:0046849]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to parathyroid hormone [GO:0071107]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436]	GO:0001503; GO:0001822; GO:0005436; GO:0005768; GO:0005829; GO:0005886; GO:0005903; GO:0006817; GO:0007584; GO:0009100; GO:0009986; GO:0010288; GO:0016021; GO:0016323; GO:0016324; GO:0016607; GO:0030165; GO:0030643; GO:0031226; GO:0031526; GO:0031982; GO:0032026; GO:0032355; GO:0033189; GO:0035435; GO:0035864; GO:0042431; GO:0042493; GO:0042802; GO:0043434; GO:0044341; GO:0044877; GO:0045121; GO:0045838; GO:0046686; GO:0046689; GO:0046849; GO:0048471; GO:0055062; GO:0060416; GO:0071107; GO:0071248; GO:0071374; GO:0072350; GO:0072686; GO:0072734; GO:0097066; GO:0097187; GO:0098719; GO:1901128; GO:1901652; GO:1901684; GO:2000120; GO:2000187	arsenate ion transmembrane transport [GO:1901684]; bone remodeling [GO:0046849]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to nutrient [GO:0007584]; response to parathyroid hormone [GO:0071107]; response to peptide [GO:1901652]; response to peptide hormone [GO:0043434]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; sodium-dependent phosphate transport [GO:0044341]; sodium ion import across plasma membrane [GO:0098719]; tricarboxylic acid metabolic process [GO:0072350]		NA	NA	NA	NA	NA	NA
TRINITY_DN21384_c0_g1_i1	O95436	NPT2B_HUMAN	60.4	101	39	1	6	305	389	489	9.00E-26	117.5	NPT2B_HUMAN	reviewed	Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2)	SLC34A2	Homo sapiens (Human)	690	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	phosphate ion binding [GO:0042301]; sodium:phosphate symporter activity [GO:0005436]; sodium ion binding [GO:0031402]	GO:0001701; GO:0005436; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0016021; GO:0016324; GO:0030643; GO:0031402; GO:0031526; GO:0031982; GO:0042301; GO:0043627; GO:0044267; GO:0044341	cellular phosphate ion homeostasis [GO:0030643]; cellular protein metabolic process [GO:0044267]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341]		NA	NA	NA	NA	NA	NA
TRINITY_DN2768_c0_g1_i13	Q5SZA1	NPT3_MOUSE	25.2	206	149	2	679	68	153	355	4.40E-18	93.2	NPT3_MOUSE	reviewed	Sodium-dependent phosphate transport protein 3 (Na(+)/PI cotransporter 3) (Sodium/phosphate cotransporter 3) (Solute carrier family 17 member 2)	Slc17a2 Npt3	Mus musculus (Mouse)	478	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]	sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005764; GO:0005887; GO:0006814; GO:0006820; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0022857	anion transport [GO:0006820]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN2768_c0_g1_i5	Q5SZA1	NPT3_MOUSE	24.4	172	125	2	577	68	187	355	2.10E-13	77.4	NPT3_MOUSE	reviewed	Sodium-dependent phosphate transport protein 3 (Na(+)/PI cotransporter 3) (Sodium/phosphate cotransporter 3) (Solute carrier family 17 member 2)	Slc17a2 Npt3	Mus musculus (Mouse)	478	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]	sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005764; GO:0005887; GO:0006814; GO:0006820; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0022857	anion transport [GO:0006820]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN27559_c0_g1_i1	Q5SZA1	NPT3_MOUSE	40.7	86	50	1	257	3	87	172	5.80E-10	64.7	NPT3_MOUSE	reviewed	Sodium-dependent phosphate transport protein 3 (Na(+)/PI cotransporter 3) (Sodium/phosphate cotransporter 3) (Solute carrier family 17 member 2)	Slc17a2 Npt3	Mus musculus (Mouse)	478	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]	sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005764; GO:0005887; GO:0006814; GO:0006820; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0022857	anion transport [GO:0006820]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN9049_c0_g1_i1	Q8WUM9	S20A1_HUMAN	100	190	0	0	2	571	486	675	2.10E-105	382.9	S20A1_HUMAN	reviewed	Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1)	SLC20A1 GLVR1 PIT1	Homo sapiens (Human)	679	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]; biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; viral process [GO:0016032]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]	GO:0005315; GO:0005316; GO:0005436; GO:0005886; GO:0005887; GO:0006796; GO:0006811; GO:0016020; GO:0016032; GO:0031214; GO:0035435; GO:0038023; GO:0043123	biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate-containing compound metabolic process [GO:0006796]; phosphate ion transmembrane transport [GO:0035435]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN9049_c0_g1_i2	Q61609	S20A1_MOUSE	97.9	189	4	0	2	568	489	677	6.80E-104	377.9	S20A1_MOUSE	reviewed	Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1)	Slc20a1 Glvr1 Pit1	Mus musculus (Mouse)	681	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; biomineral tissue development [GO:0031214]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]	GO:0005315; GO:0005316; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0016021; GO:0031214; GO:0035435	biomineral tissue development [GO:0031214]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN27796_c0_g1_i1	Q8WUM9	S20A1_HUMAN	100	187	0	0	575	15	1	187	7.70E-95	347.8	S20A1_HUMAN	reviewed	Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1)	SLC20A1 GLVR1 PIT1	Homo sapiens (Human)	679	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]; biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; viral process [GO:0016032]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]	GO:0005315; GO:0005316; GO:0005436; GO:0005886; GO:0005887; GO:0006796; GO:0006811; GO:0016020; GO:0016032; GO:0031214; GO:0035435; GO:0038023; GO:0043123	biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate-containing compound metabolic process [GO:0006796]; phosphate ion transmembrane transport [GO:0035435]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN34716_c0_g1_i1	Q9JJP0	S20A1_RAT	53.1	64	30	0	193	2	570	633	2.00E-13	75.9	S20A1_RAT	reviewed	Sodium-dependent phosphate transporter 1 (Phosphate transporter 1) (PiT-1) (RPHO-1) (Solute carrier family 20 member 1)	Slc20a1 Pit1	Rattus norvegicus (Rat)	681	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; biomineral tissue development [GO:0031214]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]	GO:0005315; GO:0005316; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0016021; GO:0031214; GO:0035435	biomineral tissue development [GO:0031214]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN1864_c0_g1_i1	Q6PFM1	S20AB_DANRE	50.7	278	122	2	846	13	31	293	4.30E-74	279.6	S20AB_DANRE	reviewed	Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B)	slc20a1b slc20a1	Danio rerio (Zebrafish) (Brachydanio rerio)	665	integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]	integral component of plasma membrane [GO:0005887]	inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]	GO:0005315; GO:0005887; GO:0015293; GO:0035435	phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN1864_c0_g1_i2	Q6PFM1	S20AB_DANRE	41.8	636	254	7	1635	73	31	665	2.90E-129	463.8	S20AB_DANRE	reviewed	Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B)	slc20a1b slc20a1	Danio rerio (Zebrafish) (Brachydanio rerio)	665	integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]	integral component of plasma membrane [GO:0005887]	inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]	GO:0005315; GO:0005887; GO:0015293; GO:0035435	phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN1864_c0_g1_i3	Q6PFM1	S20AB_DANRE	56.2	233	102	0	849	151	31	263	7.40E-74	278.9	S20AB_DANRE	reviewed	Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B)	slc20a1b slc20a1	Danio rerio (Zebrafish) (Brachydanio rerio)	665	integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435]	integral component of plasma membrane [GO:0005887]	inorganic phosphate transmembrane transporter activity [GO:0005315]; symporter activity [GO:0015293]	GO:0005315; GO:0005887; GO:0015293; GO:0035435	phosphate ion transmembrane transport [GO:0035435]		NA	NA	NA	NA	NA	NA
TRINITY_DN32550_c0_g1_i1	Q99884	SC6A7_HUMAN	42.4	66	38	0	204	7	64	129	4.20E-09	61.6	SC6A7_HUMAN	reviewed	Sodium-dependent proline transporter (Solute carrier family 6 member 7)	SLC6A7 PROT	Homo sapiens (Human)	636	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]; neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]	GO:0005298; GO:0005886; GO:0005887; GO:0006836; GO:0015193; GO:0015824; GO:0016020; GO:0035725	neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]		brown	brown	1	NA	NA	NA
TRINITY_DN914_c0_g1_i12	Q99884	SC6A7_HUMAN	27.9	111	79	1	55	387	478	587	1.70E-08	62	SC6A7_HUMAN	reviewed	Sodium-dependent proline transporter (Solute carrier family 6 member 7)	SLC6A7 PROT	Homo sapiens (Human)	636	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]; neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]	GO:0005298; GO:0005886; GO:0005887; GO:0006836; GO:0015193; GO:0015824; GO:0016020; GO:0035725	neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN914_c0_g1_i30	Q99884	SC6A7_HUMAN	27.9	111	79	1	55	387	478	587	4.10E-09	62.8	SC6A7_HUMAN	reviewed	Sodium-dependent proline transporter (Solute carrier family 6 member 7)	SLC6A7 PROT	Homo sapiens (Human)	636	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]; neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]	GO:0005298; GO:0005886; GO:0005887; GO:0006836; GO:0015193; GO:0015824; GO:0016020; GO:0035725	neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]		brown	brown	NA	NA	NA	NA
TRINITY_DN10534_c0_g1_i1	Q32LP4	S4A10_BOVIN	53.2	417	183	7	1635	400	706	1115	6.10E-116	419.5	S4A10_BOVIN	reviewed	Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)	SLC4A10	Bos taurus (Bovine)	1117	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0021860; GO:0022857; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0050801; GO:0051453; GO:0055085; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:1902600	bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN10534_c0_g1_i2	Q32LP4	S4A10_BOVIN	51.2	894	394	15	2979	400	230	1115	5.30E-240	832.4	S4A10_BOVIN	reviewed	Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)	SLC4A10	Bos taurus (Bovine)	1117	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0021860; GO:0022857; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0050801; GO:0051453; GO:0055085; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:1902600	bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]		blue	blue	NA	NA	NA	NA
TRINITY_DN20228_c0_g1_i1	Q58DD2	S2611_BOVIN	48.8	80	40	1	43	282	394	472	4.60E-12	72	S2611_BOVIN	reviewed	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	SLC26A11	Bos taurus (Bovine)	602	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021	sulfate transport [GO:0008272]		NA	NA	NA	NA	NA	NA
TRINITY_DN8835_c0_g3_i1	Q80ZD3	S2611_MOUSE	43.5	260	135	4	3	776	295	544	1.60E-50	201.4	S2611_MOUSE	reviewed	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	Slc26a11	Mus musculus (Mouse)	593	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231	sulfate transport [GO:0008272]		NA	NA	NA	NA	NA	NA
TRINITY_DN8835_c0_g3_i2	Q80ZD3	S2611_MOUSE	43.5	260	135	4	3	776	295	544	1.40E-50	201.4	S2611_MOUSE	reviewed	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	Slc26a11	Mus musculus (Mouse)	593	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231	sulfate transport [GO:0008272]		NA	NA	NA	NA	NA	NA
TRINITY_DN8835_c0_g1_i2	Q86WA9	S2611_HUMAN	47.8	274	137	4	833	21	26	296	2.70E-57	223.8	S2611_HUMAN	reviewed	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	SLC26A11	Homo sapiens (Human)	606	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ion transport [GO:0006811]; sulfate transport [GO:0008272]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062	ion transport [GO:0006811]; sulfate transport [GO:0008272]		NA	NA	NA	NA	NA	NA
TRINITY_DN8835_c0_g1_i3	Q86WA9	S2611_HUMAN	45.3	225	117	4	686	21	75	296	5.10E-40	166	S2611_HUMAN	reviewed	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	SLC26A11	Homo sapiens (Human)	606	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ion transport [GO:0006811]; sulfate transport [GO:0008272]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anion:anion antiporter activity [GO:0015301]; anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062	ion transport [GO:0006811]; sulfate transport [GO:0008272]		NA	NA	NA	NA	NA	NA
TRINITY_DN13383_c0_g1_i1	Q8K4Y7	CANT1_RAT	59.1	320	126	4	1020	61	89	403	1.60E-111	404.4	CANT1_RAT	reviewed	Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog)	Cant1 Srapy	Rattus norvegicus (Rat)	403	endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]; proteoglycan biosynthetic process [GO:0030166]	endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]	GO:0004382; GO:0005509; GO:0005789; GO:0016020; GO:0016021; GO:0030166; GO:0032580; GO:0042803; GO:0043262; GO:0045134	proteoglycan biosynthetic process [GO:0030166]		NA	NA	NA	NA	NA	NA
TRINITY_DN12149_c0_g1_i1	Q9VEU5	GCYDB_DROME	45.8	284	148	3	2	841	383	664	1.50E-63	244.6	GCYDB_DROME	reviewed	Soluble guanylate cyclase 89Db (EC 4.6.1.2)	Gyc89Db Gyc-89Db CG14886	Drosophila melanogaster (Fruit fly)	669	"guanylate cyclase complex, soluble [GO:0008074]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]"	"guanylate cyclase complex, soluble [GO:0008074]"	enzyme binding [GO:0019899]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]	GO:0000302; GO:0001666; GO:0004383; GO:0005525; GO:0008074; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0046982; GO:0055093	cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]		NA	NA	NA	NA	NA	NA
TRINITY_DN12149_c0_g3_i2	Q9VEU5	GCYDB_DROME	46.3	242	124	3	741	28	383	622	2.20E-54	213.8	GCYDB_DROME	reviewed	Soluble guanylate cyclase 89Db (EC 4.6.1.2)	Gyc89Db Gyc-89Db CG14886	Drosophila melanogaster (Fruit fly)	669	"guanylate cyclase complex, soluble [GO:0008074]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]"	"guanylate cyclase complex, soluble [GO:0008074]"	enzyme binding [GO:0019899]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]	GO:0000302; GO:0001666; GO:0004383; GO:0005525; GO:0008074; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0046982; GO:0055093	cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]		NA	NA	NA	NA	NA	NA
TRINITY_DN12149_c0_g3_i3	Q9VEU5	GCYDB_DROME	45.5	123	57	2	370	2	383	495	1.30E-23	110.5	GCYDB_DROME	reviewed	Soluble guanylate cyclase 89Db (EC 4.6.1.2)	Gyc89Db Gyc-89Db CG14886	Drosophila melanogaster (Fruit fly)	669	"guanylate cyclase complex, soluble [GO:0008074]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]"	"guanylate cyclase complex, soluble [GO:0008074]"	enzyme binding [GO:0019899]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]	GO:0000302; GO:0001666; GO:0004383; GO:0005525; GO:0008074; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0046982; GO:0055093	cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]		NA	NA	NA	NA	NA	NA
TRINITY_DN29159_c0_g1_i1	A6QP84	SOAT_BOVIN	43.8	73	37	2	31	243	94	164	1.20E-09	63.5	SOAT_BOVIN	reviewed	Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter)	SLC10A6 SOAT	Bos taurus (Bovine)	377	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]	GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251	bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]		NA	NA	NA	NA	NA	NA
TRINITY_DN1645_c0_g1_i2	A6QP84	SOAT_BOVIN	34.5	319	197	5	180	1121	30	341	4.50E-44	180.3	SOAT_BOVIN	reviewed	Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter)	SLC10A6 SOAT	Bos taurus (Bovine)	377	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]	GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251	bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]		NA	NA	NA	NA	NA	NA
TRINITY_DN1645_c0_g1_i5	A6QP84	SOAT_BOVIN	34.5	319	197	5	93	1034	30	341	5.40E-44	179.9	SOAT_BOVIN	reviewed	Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter)	SLC10A6 SOAT	Bos taurus (Bovine)	377	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]	GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251	bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]		NA	NA	NA	NA	NA	NA
TRINITY_DN1645_c0_g1_i6	A6QP84	SOAT_BOVIN	33.6	318	189	5	180	1085	30	341	4.50E-41	170.2	SOAT_BOVIN	reviewed	Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter)	SLC10A6 SOAT	Bos taurus (Bovine)	377	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]	GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251	bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]		NA	NA	NA	NA	NA	NA
TRINITY_DN6911_c0_g1_i8	P55012	S12A2_MOUSE	54.3	291	131	2	947	81	575	865	4.60E-90	332.8	S12A2_MOUSE	reviewed	Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2)	Slc12a2 Nkcc1	Mus musculus (Mouse)	1205	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; ammonium transport [GO:0015696]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium:chloride symporter activity [GO:0015379]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005829; GO:0005886; GO:0006813; GO:0006814; GO:0006821; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015081; GO:0015377; GO:0015378; GO:0015379; GO:0015696; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0035264; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0045795; GO:0046873; GO:0050910; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0060444; GO:0060763; GO:0061044; GO:0070634; GO:0071944; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:1902476; GO:1904450; GO:1904464; GO:1990573; GO:1990869	ammonium transport [GO:0015696]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]		NA	NA	NA	NA	NA	NA
TRINITY_DN22505_c0_g1_i1	P55012	S12A2_MOUSE	62	92	35	0	5	280	633	724	6.00E-29	127.9	S12A2_MOUSE	reviewed	Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2)	Slc12a2 Nkcc1	Mus musculus (Mouse)	1205	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; ammonium transport [GO:0015696]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium:chloride symporter activity [GO:0015379]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005829; GO:0005886; GO:0006813; GO:0006814; GO:0006821; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015081; GO:0015377; GO:0015378; GO:0015379; GO:0015696; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0035264; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0045795; GO:0046873; GO:0050910; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0060444; GO:0060763; GO:0061044; GO:0070634; GO:0071944; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:1902476; GO:1904450; GO:1904464; GO:1990573; GO:1990869	ammonium transport [GO:0015696]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]		NA	NA	NA	NA	NA	NA
TRINITY_DN5766_c0_g1_i1	Q9JIS8	S12A4_MOUSE	64.6	517	181	2	55	1599	379	895	2.70E-198	693	S12A4_MOUSE	reviewed	Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (mKCC1)	Slc12a4 Kcc1	Mus musculus (Mouse)	1085	integral component of membrane [GO:0016021]; synapse [GO:0045202]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of membrane [GO:0016021]; synapse [GO:0045202]	potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0006884; GO:0007268; GO:0015379; GO:0016021; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN5766_c0_g1_i2	Q9JIS8	S12A4_MOUSE	62.9	159	58	1	34	507	737	895	7.10E-60	231.5	S12A4_MOUSE	reviewed	Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (mKCC1)	Slc12a4 Kcc1	Mus musculus (Mouse)	1085	integral component of membrane [GO:0016021]; synapse [GO:0045202]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of membrane [GO:0016021]; synapse [GO:0045202]	potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0006884; GO:0007268; GO:0015379; GO:0016021; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN5766_c0_g1_i6	Q9JIS8	S12A4_MOUSE	61.4	731	265	6	87	2240	169	895	2.00E-252	873.2	S12A4_MOUSE	reviewed	Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (mKCC1)	Slc12a4 Kcc1	Mus musculus (Mouse)	1085	integral component of membrane [GO:0016021]; synapse [GO:0045202]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of membrane [GO:0016021]; synapse [GO:0045202]	potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0006884; GO:0007268; GO:0015379; GO:0016021; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN31368_c0_g1_i1	Q9JIS8	S12A4_MOUSE	100	100	0	0	6	305	580	679	1.60E-51	203	S12A4_MOUSE	reviewed	Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (mKCC1)	Slc12a4 Kcc1	Mus musculus (Mouse)	1085	integral component of membrane [GO:0016021]; synapse [GO:0045202]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of membrane [GO:0016021]; synapse [GO:0045202]	potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0006884; GO:0007268; GO:0015379; GO:0016021; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN40664_c0_g1_i1	Q9H2X9	S12A5_HUMAN	57.6	66	28	0	199	2	156	221	8.00E-15	80.5	S12A5_HUMAN	reviewed	Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter)	SLC12A5 KCC2 KIAA1176	Homo sapiens (Human)	1139	cell periphery [GO:0071944]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to drug [GO:0042493]; thermosensory behavior [GO:0040040]	cell periphery [GO:0071944]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0005886; GO:0005887; GO:0006811; GO:0006873; GO:0006884; GO:0006971; GO:0007268; GO:0007612; GO:0015108; GO:0015379; GO:0016021; GO:0019901; GO:0030644; GO:0035264; GO:0040040; GO:0042493; GO:0043005; GO:0043025; GO:0045202; GO:0055064; GO:0055075; GO:0060996; GO:0071944; GO:1902476; GO:1990573	cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to drug [GO:0042493]; thermosensory behavior [GO:0040040]		NA	NA	NA	NA	NA	NA
TRINITY_DN26401_c0_g1_i1	Q9UHW9	S12A6_HUMAN	100	84	0	0	2	253	677	760	3.00E-43	175.3	S12A6_HUMAN	reviewed	Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)	SLC12A6 KCC3	Homo sapiens (Human)	1150	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]	GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:0071476; GO:0071477; GO:0140157; GO:1902476; GO:1990573	ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN5766_c0_g1_i4	Q9UHW9	S12A6_HUMAN	58.4	838	322	8	85	2535	129	960	4.30E-275	948.7	S12A6_HUMAN	reviewed	Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)	SLC12A6 KCC3	Homo sapiens (Human)	1150	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]	GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:0071476; GO:0071477; GO:0140157; GO:1902476; GO:1990573	ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN30635_c0_g1_i1	Q9WVL3	S12A7_MOUSE	99.1	106	1	0	1	318	573	678	3.00E-56	218.8	S12A7_MOUSE	reviewed	Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4)	Slc12a7 Kcc4	Mus musculus (Mouse)	1083	integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0005887; GO:0006884; GO:0007268; GO:0008519; GO:0015379; GO:0019901; GO:0032991; GO:0045202; GO:0055064; GO:0055075; GO:0140157; GO:1902476; GO:1990573	ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN30635_c0_g1_i2	Q9WVL3	S12A7_MOUSE	99.1	106	1	0	1	318	573	678	3.00E-56	218.8	S12A7_MOUSE	reviewed	Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4)	Slc12a7 Kcc4	Mus musculus (Mouse)	1083	integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0005887; GO:0006884; GO:0007268; GO:0008519; GO:0015379; GO:0019901; GO:0032991; GO:0045202; GO:0055064; GO:0055075; GO:0140157; GO:1902476; GO:1990573	ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN41055_c0_g1_i1	A0AV02	S12A8_HUMAN	52.2	67	32	0	203	3	210	276	2.40E-14	79	S12A8_HUMAN	reviewed	Solute carrier family 12 member 8 (Cation-chloride cotransporter 9)	SLC12A8 CCC9	Homo sapiens (Human)	714	integral component of membrane [GO:0016021]; potassium:chloride symporter activity [GO:0015379]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of membrane [GO:0016021]	potassium:chloride symporter activity [GO:0015379]	GO:0006884; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		NA	NA	NA	NA	NA	NA
TRINITY_DN37648_c0_g1_i1	Q0VGW6	S12A9_XENLA	60	90	36	0	1	270	71	160	1.10E-22	107.1	S12A9_XENLA	reviewed	Solute carrier family 12 member 9 (Cation-chloride cotransporter-interacting protein 1)	slc12a9 cip1	Xenopus laevis (African clawed frog)	899	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		blue	blue	NA	NA	NA	NA
TRINITY_DN35373_c0_g1_i1	Q99MR3	S12A9_MOUSE	52.4	82	39	0	6	251	248	329	9.00E-16	84	S12A9_MOUSE	reviewed	Solute carrier family 12 member 9 (Cation-chloride cotransporter-interacting protein 1) (Potassium-chloride transporter 9)	Slc12a9 Cip1 Slc12a8	Mus musculus (Mouse)	914	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	potassium:chloride symporter activity [GO:0015379]	GO:0005886; GO:0006884; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]		blue	blue	NA	NA	NA	NA
TRINITY_DN13482_c0_g1_i1	Q9ES88	S13A2_MOUSE	50	56	28	0	204	37	63	118	2.10E-10	66.6	S13A2_MOUSE	reviewed	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	Slc13a2 Nadc1 Sdct1	Mus musculus (Mouse)	586	integral component of membrane [GO:0016021]; succinate transmembrane transporter activity [GO:0015141]; symporter activity [GO:0015293]; anion transmembrane transport [GO:0098656]; sodium ion transport [GO:0006814]; succinate transmembrane transport [GO:0071422]	integral component of membrane [GO:0016021]	succinate transmembrane transporter activity [GO:0015141]; symporter activity [GO:0015293]	GO:0006814; GO:0015141; GO:0015293; GO:0016021; GO:0071422; GO:0098656	anion transmembrane transport [GO:0098656]; sodium ion transport [GO:0006814]; succinate transmembrane transport [GO:0071422]		NA	NA	NA	NA	NA	NA
TRINITY_DN13482_c0_g1_i1	Q9ES88	S13A2_MOUSE	33.9	118	55	2	2	331	16	118	2.80E-07	56.2	S13A2_MOUSE	reviewed	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	Slc13a2 Nadc1 Sdct1	Mus musculus (Mouse)	586	integral component of membrane [GO:0016021]; succinate transmembrane transporter activity [GO:0015141]; symporter activity [GO:0015293]; anion transmembrane transport [GO:0098656]; sodium ion transport [GO:0006814]; succinate transmembrane transport [GO:0071422]	integral component of membrane [GO:0016021]	succinate transmembrane transporter activity [GO:0015141]; symporter activity [GO:0015293]	GO:0006814; GO:0015141; GO:0015293; GO:0016021; GO:0071422; GO:0098656	anion transmembrane transport [GO:0098656]; sodium ion transport [GO:0006814]; succinate transmembrane transport [GO:0071422]		NA	NA	NA	NA	NA	NA
TRINITY_DN29948_c0_g1_i1	Q28615	S13A2_RABIT	52.8	89	42	0	294	28	484	572	6.70E-18	91.3	S13A2_RABIT	reviewed	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	SLC13A2 NADC1 SDCT1	Oryctolagus cuniculus (Rabbit)	593	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]	GO:0006814; GO:0015293; GO:0016021	sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN30827_c0_g1_i1	Q9ES88	S13A2_MOUSE	56.9	65	28	0	220	26	54	118	3.60E-13	75.1	S13A2_MOUSE	reviewed	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	Slc13a2 Nadc1 Sdct1	Mus musculus (Mouse)	586	integral component of membrane [GO:0016021]; succinate transmembrane transporter activity [GO:0015141]; symporter activity [GO:0015293]; anion transmembrane transport [GO:0098656]; sodium ion transport [GO:0006814]; succinate transmembrane transport [GO:0071422]	integral component of membrane [GO:0016021]	succinate transmembrane transporter activity [GO:0015141]; symporter activity [GO:0015293]	GO:0006814; GO:0015141; GO:0015293; GO:0016021; GO:0071422; GO:0098656	anion transmembrane transport [GO:0098656]; sodium ion transport [GO:0006814]; succinate transmembrane transport [GO:0071422]		NA	NA	NA	NA	NA	NA
TRINITY_DN15337_c0_g1_i2	Q9Z0Z5	S13A3_RAT	51.1	47	23	0	48	188	497	543	3.10E-07	55.5	S13A3_RAT	reviewed	Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (rNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)	Slc13a3 Nadc3 Sdct2	Rattus norvegicus (Rat)	600	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; L-aspartate transmembrane transporter activity [GO:0015183]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; L-aspartate transmembrane transporter activity [GO:0015183]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]	GO:0005310; GO:0005343; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015183; GO:0015362; GO:0015744; GO:0015746; GO:0015810; GO:0016020; GO:0016021; GO:0016323; GO:0017153; GO:0034634; GO:0034775; GO:0071422; GO:0098656	anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]		brown	brown	1	NA	NA	NA
TRINITY_DN15337_c0_g1_i1	Q9Z0Z5	S13A3_RAT	51.1	47	23	0	48	188	497	543	4.10E-07	55.1	S13A3_RAT	reviewed	Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (rNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)	Slc13a3 Nadc3 Sdct2	Rattus norvegicus (Rat)	600	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; L-aspartate transmembrane transporter activity [GO:0015183]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; L-aspartate transmembrane transporter activity [GO:0015183]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]	GO:0005310; GO:0005343; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015183; GO:0015362; GO:0015744; GO:0015746; GO:0015810; GO:0016020; GO:0016021; GO:0016323; GO:0017153; GO:0034634; GO:0034775; GO:0071422; GO:0098656	anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]		NA	NA	NA	NA	NA	NA
TRINITY_DN24561_c0_g1_i1	Q8CJ44	S13A5_RAT	58.8	51	21	0	192	40	114	164	7.50E-08	57.4	S13A5_RAT	reviewed	Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter)	Slc13a5 Nact	Rattus norvegicus (Rat)	572	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; citrate transmembrane transporter activity [GO:0015137]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; tricarboxylic acid transmembrane transporter activity [GO:0015142]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; succinate transport [GO:0015744]; tricarboxylic acid transport [GO:0006842]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	citrate transmembrane transporter activity [GO:0015137]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; tricarboxylic acid transmembrane transporter activity [GO:0015142]	GO:0005343; GO:0006842; GO:0015137; GO:0015141; GO:0015142; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0017153; GO:0098656	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; succinate transport [GO:0015744]; tricarboxylic acid transport [GO:0006842]		brown	brown	1	NA	NA	NA
TRINITY_DN6608_c0_g2_i1	Q16348	S15A2_HUMAN	64.9	194	65	3	658	77	42	232	7.90E-65	248.8	S15A2_HUMAN	reviewed	"Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)"	SLC15A2 PEPT2	Homo sapiens (Human)	729	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]	dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]	GO:0005886; GO:0005887; GO:0006811; GO:0015031; GO:0015333; GO:0015835; GO:0016324; GO:0042908; GO:0042938; GO:0044214; GO:0045087; GO:0070062; GO:0070293; GO:0070424; GO:0071916; GO:0140206; GO:0150104; GO:1990961	dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN6608_c0_g2_i2	B0S6T2	S15A2_DANRE	42.3	716	363	15	2205	100	28	707	2.20E-140	501.1	S15A2_DANRE	reviewed	Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2)	slc15a2	Danio rerio (Zebrafish) (Brachydanio rerio)	719	integral component of plasma membrane [GO:0005887]; dipeptide transmembrane transporter activity [GO:0071916]; symporter activity [GO:0015293]; dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; response to yeast [GO:0001878]	integral component of plasma membrane [GO:0005887]	dipeptide transmembrane transporter activity [GO:0071916]; symporter activity [GO:0015293]	GO:0001878; GO:0005887; GO:0015031; GO:0015293; GO:0015835; GO:0045087; GO:0070424; GO:0071916; GO:0140206	dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; response to yeast [GO:0001878]		NA	NA	NA	NA	NA	NA
TRINITY_DN3911_c0_g1_i4	Q8N697	S15A4_HUMAN	49.7	147	68	2	53	484	407	550	7.10E-32	139	S15A4_HUMAN	reviewed	Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1)	SLC15A4 PHT1 PTR4 FP12591	Homo sapiens (Human)	577	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; neutrophil degranulation [GO:0043312]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]	GO:0005290; GO:0005765; GO:0005886; GO:0006811; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0031303; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0035579; GO:0036020; GO:0043312; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206; GO:1905103	dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; neutrophil degranulation [GO:0043312]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]		NA	NA	NA	NA	NA	NA
TRINITY_DN31761_c0_g1_i1	Q8N697	S15A4_HUMAN	100	96	0	0	288	1	430	525	1.00E-47	190.3	S15A4_HUMAN	reviewed	Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1)	SLC15A4 PHT1 PTR4 FP12591	Homo sapiens (Human)	577	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; neutrophil degranulation [GO:0043312]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]	GO:0005290; GO:0005765; GO:0005886; GO:0006811; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0031303; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0035579; GO:0036020; GO:0043312; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206; GO:1905103	dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; neutrophil degranulation [GO:0043312]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]		NA	NA	NA	NA	NA	NA
TRINITY_DN3911_c0_g1_i3	Q91W98	S15A4_MOUSE	38.6	557	296	9	81	1703	25	551	3.10E-103	377.5	S15A4_MOUSE	reviewed	Solute carrier family 15 member 4 (Peptide/histidine transporter 1)	Slc15a4 Pht1	Mus musculus (Mouse)	574	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]	dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]	GO:0005290; GO:0005765; GO:0010008; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0031303; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206; GO:1905103	dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]		NA	NA	NA	NA	NA	NA
TRINITY_DN23099_c0_g1_i2	P27674	GTR1_BOVIN	100	107	0	0	1	321	380	486	2.70E-57	222.2	GTR1_BOVIN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1)"	SLC2A1 GLUT1	Bos taurus (Bovine)	492	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; vesicle [GO:0031982]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; vesicle [GO:0031982]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]	GO:0001917; GO:0001939; GO:0005324; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0007417; GO:0015911; GO:0016323; GO:0016324; GO:0030496; GO:0030864; GO:0031982; GO:0033300; GO:0042149; GO:0042802; GO:0043621; GO:0045121; GO:0045494; GO:0046323; GO:0055056; GO:0065003; GO:0098708; GO:0098793; GO:0150104; GO:1904659	cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN23605_c0_g1_i1	P11166	GTR1_HUMAN	100	137	0	0	411	1	107	243	2.50E-71	269.2	GTR1_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)"	SLC2A1 GLUT1	Homo sapiens (Human)	492	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; lactose biosynthetic process [GO:0005989]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000139; GO:0001666; GO:0001917; GO:0001939; GO:0005324; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005989; GO:0007417; GO:0007565; GO:0010827; GO:0014704; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0019852; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042470; GO:0042802; GO:0042910; GO:0043621; GO:0045494; GO:0050796; GO:0055056; GO:0065003; GO:0070062; GO:0071260; GO:0071474; GO:0072562; GO:0098708; GO:0098793; GO:0150104; GO:1904016; GO:1904659	cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; lactose biosynthetic process [GO:0005989]; L-ascorbic acid metabolic process [GO:0019852]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN15875_c0_g1_i1	P11166	GTR1_HUMAN	100	105	0	0	1	315	259	363	1.20E-49	196.8	GTR1_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)"	SLC2A1 GLUT1	Homo sapiens (Human)	492	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; lactose biosynthetic process [GO:0005989]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000139; GO:0001666; GO:0001917; GO:0001939; GO:0005324; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005989; GO:0007417; GO:0007565; GO:0010827; GO:0014704; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0019852; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042470; GO:0042802; GO:0042910; GO:0043621; GO:0045494; GO:0050796; GO:0055056; GO:0065003; GO:0070062; GO:0071260; GO:0071474; GO:0072562; GO:0098708; GO:0098793; GO:0150104; GO:1904016; GO:1904659	cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; lactose biosynthetic process [GO:0005989]; L-ascorbic acid metabolic process [GO:0019852]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN23099_c0_g1_i1	P11166	GTR1_HUMAN	100	129	0	0	3	389	358	486	4.40E-70	265	GTR1_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)"	SLC2A1 GLUT1	Homo sapiens (Human)	492	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; lactose biosynthetic process [GO:0005989]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000139; GO:0001666; GO:0001917; GO:0001939; GO:0005324; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005989; GO:0007417; GO:0007565; GO:0010827; GO:0014704; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0019852; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042470; GO:0042802; GO:0042910; GO:0043621; GO:0045494; GO:0050796; GO:0055056; GO:0065003; GO:0070062; GO:0071260; GO:0071474; GO:0072562; GO:0098708; GO:0098793; GO:0150104; GO:1904016; GO:1904659	cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; lactose biosynthetic process [GO:0005989]; L-ascorbic acid metabolic process [GO:0019852]; long-chain fatty acid import across plasma membrane [GO:0015911]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN24943_c0_g1_i3	Q8BFW9	GTR12_MOUSE	34.3	108	61	2	371	63	476	578	1.00E-07	57.8	GTR12_MOUSE	reviewed	"Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)"	Slc2a12 Glut12	Mus musculus (Mouse)	622	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; glucose transmembrane transport [GO:1904659]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0012505; GO:0016020; GO:0016021; GO:0022857; GO:0048471; GO:1904659	glucose transmembrane transport [GO:1904659]		NA	NA	NA	NA	NA	NA
TRINITY_DN36732_c0_g1_i1	P11169	GTR3_HUMAN	100	219	0	0	2	658	244	462	2.80E-117	422.5	GTR3_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)"	SLC2A3 GLUT3	Homo sapiens (Human)	496	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0016021; GO:0019852; GO:0030667; GO:0035579; GO:0042995; GO:0043204; GO:0043312; GO:0070062; GO:0070821; GO:0098708; GO:0101003; GO:0150104; GO:1904659	carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN40597_c0_g1_i1	P11169	GTR3_HUMAN	100	83	0	0	249	1	93	175	4.40E-39	161.4	GTR3_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)"	SLC2A3 GLUT3	Homo sapiens (Human)	496	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0016021; GO:0019852; GO:0030667; GO:0035579; GO:0042995; GO:0043204; GO:0043312; GO:0070062; GO:0070821; GO:0098708; GO:0101003; GO:0150104; GO:1904659	carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN39061_c0_g1_i1	P11169	GTR3_HUMAN	100	67	0	0	202	2	1	67	4.20E-31	134.8	GTR3_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)"	SLC2A3 GLUT3	Homo sapiens (Human)	496	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0016021; GO:0019852; GO:0030667; GO:0035579; GO:0042995; GO:0043204; GO:0043312; GO:0070062; GO:0070821; GO:0098708; GO:0101003; GO:0150104; GO:1904659	carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN36859_c0_g1_i1	P11169	GTR3_HUMAN	100	74	0	0	223	2	175	248	2.70E-35	148.7	GTR3_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)"	SLC2A3 GLUT3	Homo sapiens (Human)	496	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0016021; GO:0019852; GO:0030667; GO:0035579; GO:0042995; GO:0043204; GO:0043312; GO:0070062; GO:0070821; GO:0098708; GO:0101003; GO:0150104; GO:1904659	carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]; transport across blood-brain barrier [GO:0150104]		NA	NA	NA	NA	NA	NA
TRINITY_DN2826_c0_g1_i3	Q863Y9	GTR5_HORSE	34.9	467	299	1	1553	153	2	463	7.50E-74	279.6	GTR5_HORSE	reviewed	"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5)"	SLC2A5 GLUT5	Equus caballus (Horse)	501	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]	GO:0003044; GO:0005353; GO:0005886; GO:0005887; GO:0009750; GO:0015755; GO:0016324; GO:0042383; GO:0070061; GO:0071332; GO:1990539	cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750]		NA	NA	NA	NA	NA	NA
TRINITY_DN37413_c0_g1_i1	Q9NY64	GTR8_HUMAN	52.5	40	19	0	228	109	435	474	8.30E-07	54.3	GTR8_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Homo sapiens (Human)	477	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659	carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN37413_c0_g1_i2	Q9NY64	GTR8_HUMAN	52.5	40	19	0	276	157	435	474	9.80E-07	54.3	GTR8_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Homo sapiens (Human)	477	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659	carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN7623_c0_g1_i1	P58354	GTR8_BOVIN	41.8	55	32	0	24	188	73	127	2.80E-05	48.9	GTR8_BOVIN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Bos taurus (Bovine)	478	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]	GO:0005353; GO:0005355; GO:0005886; GO:0015755; GO:0016021; GO:0030659; GO:0033300; GO:0070837; GO:1904659	dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]		NA	NA	NA	NA	NA	NA
TRINITY_DN30716_c0_g1_i1	P58354	GTR8_BOVIN	54	87	39	1	5	265	144	229	4.90E-14	78.6	GTR8_BOVIN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Bos taurus (Bovine)	478	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]	GO:0005353; GO:0005355; GO:0005886; GO:0015755; GO:0016021; GO:0030659; GO:0033300; GO:0070837; GO:1904659	dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]		brown	brown	NA	NA	NA	NA
TRINITY_DN30716_c0_g1_i4	P58354	GTR8_BOVIN	42.4	139	72	2	5	421	144	274	3.60E-17	89.4	GTR8_BOVIN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Bos taurus (Bovine)	478	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]	GO:0005353; GO:0005355; GO:0005886; GO:0015755; GO:0016021; GO:0030659; GO:0033300; GO:0070837; GO:1904659	dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1087_c0_g1_i2	Q9NY64	GTR8_HUMAN	29.9	321	215	3	1082	120	34	344	3.70E-27	124	GTR8_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Homo sapiens (Human)	477	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659	carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN1087_c0_g1_i5	Q9NY64	GTR8_HUMAN	29.4	446	287	6	1376	87	34	467	1.30E-40	169.1	GTR8_HUMAN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Homo sapiens (Human)	477	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659	carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN1087_c0_g1_i7	P58354	GTR8_BOVIN	36.7	98	58	2	399	106	34	127	2.00E-06	53.9	GTR8_BOVIN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Bos taurus (Bovine)	478	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]	GO:0005353; GO:0005355; GO:0005886; GO:0015755; GO:0016021; GO:0030659; GO:0033300; GO:0070837; GO:1904659	dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]		NA	NA	NA	NA	NA	NA
TRINITY_DN40817_c0_g1_i1	P58354	GTR8_BOVIN	49.2	61	30	1	208	26	128	187	3.70E-07	55.1	GTR8_BOVIN	reviewed	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Bos taurus (Bovine)	478	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]	GO:0005353; GO:0005355; GO:0005886; GO:0015755; GO:0016021; GO:0030659; GO:0033300; GO:0070837; GO:1904659	dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i22	Q63089	S22A1_RAT	41.4	87	48	1	545	294	247	333	2.50E-10	67	S22A1_RAT	reviewed	Solute carrier family 22 member 1 (Organic cation transporter 1) (rOCT1)	Slc22a1 Oct1	Rattus norvegicus (Rat)	556	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]	acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005887; GO:0006812; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015844; GO:0015872; GO:0015874; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0090494; GO:0098655; GO:0098793; GO:1901998; GO:1990962	cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN17228_c0_g2_i1	Q63089	S22A1_RAT	40.8	71	42	0	10	222	262	332	2.80E-09	62.4	S22A1_RAT	reviewed	Solute carrier family 22 member 1 (Organic cation transporter 1) (rOCT1)	Slc22a1 Oct1	Rattus norvegicus (Rat)	556	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]	acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005887; GO:0006812; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015844; GO:0015872; GO:0015874; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0090494; GO:0098655; GO:0098793; GO:1901998; GO:1990962	cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN34588_c0_g1_i1	Q63089	S22A1_RAT	38	150	93	0	452	3	374	523	1.10E-19	97.8	S22A1_RAT	reviewed	Solute carrier family 22 member 1 (Organic cation transporter 1) (rOCT1)	Slc22a1 Oct1	Rattus norvegicus (Rat)	556	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]	acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005887; GO:0006812; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015844; GO:0015872; GO:0015874; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0090494; GO:0098655; GO:0098793; GO:1901998; GO:1990962	cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i20	Q8CFZ5	S22AC_MOUSE	30.9	340	222	3	1071	58	214	542	3.20E-33	144.1	S22AC_MOUSE	reviewed	Solute carrier family 22 member 12 (Renal-specific transporter) (RST) (Urate anion exchanger 1)	Slc22a12 Urat1	Mus musculus (Mouse)	553	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]; organic anion transport [GO:0015711]; response to drug [GO:0042493]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]	GO:0005886; GO:0015143; GO:0015711; GO:0015747; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042493; GO:0046415	organic anion transport [GO:0015711]; response to drug [GO:0042493]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i24	Q8CFZ5	S22AC_MOUSE	29.2	260	164	4	831	58	301	542	3.00E-20	100.9	S22AC_MOUSE	reviewed	Solute carrier family 22 member 12 (Renal-specific transporter) (RST) (Urate anion exchanger 1)	Slc22a12 Urat1	Mus musculus (Mouse)	553	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]; organic anion transport [GO:0015711]; response to drug [GO:0042493]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]	GO:0005886; GO:0015143; GO:0015711; GO:0015747; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042493; GO:0046415	organic anion transport [GO:0015711]; response to drug [GO:0042493]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i24	Q8CFZ5	S22AC_MOUSE	41.2	68	40	0	1001	798	236	303	4.60E-05	50.4	S22AC_MOUSE	reviewed	Solute carrier family 22 member 12 (Renal-specific transporter) (RST) (Urate anion exchanger 1)	Slc22a12 Urat1	Mus musculus (Mouse)	553	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]; organic anion transport [GO:0015711]; response to drug [GO:0042493]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]	GO:0005886; GO:0015143; GO:0015711; GO:0015747; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042493; GO:0046415	organic anion transport [GO:0015711]; response to drug [GO:0042493]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN3408_c0_g1_i2	Q9Y226	S22AD_HUMAN	40.8	76	45	0	270	43	322	397	4.40E-08	58.9	S22AD_HUMAN	reviewed	Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3)	SLC22A13 OCTL1 ORCTL3	Homo sapiens (Human)	551	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nicotinate transmembrane transporter activity [GO:0090416]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	nicotinate transmembrane transporter activity [GO:0090416]	GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015747; GO:0016021; GO:0016324; GO:0034356; GO:0045922; GO:0070062; GO:0090416; GO:2001142	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN3408_c0_g1_i8	Q9Y226	S22AD_HUMAN	40.5	74	44	0	270	49	322	395	1.20E-05	50.8	S22AD_HUMAN	reviewed	Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3)	SLC22A13 OCTL1 ORCTL3	Homo sapiens (Human)	551	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nicotinate transmembrane transporter activity [GO:0090416]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	nicotinate transmembrane transporter activity [GO:0090416]	GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015747; GO:0016021; GO:0016324; GO:0034356; GO:0045922; GO:0070062; GO:0090416; GO:2001142	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN3408_c0_g1_i9	Q9Y226	S22AD_HUMAN	33.3	150	100	0	504	55	322	471	4.00E-17	90.1	S22AD_HUMAN	reviewed	Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3)	SLC22A13 OCTL1 ORCTL3	Homo sapiens (Human)	551	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nicotinate transmembrane transporter activity [GO:0090416]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	nicotinate transmembrane transporter activity [GO:0090416]	GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015747; GO:0016021; GO:0016324; GO:0034356; GO:0045922; GO:0070062; GO:0090416; GO:2001142	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747]		NA	NA	NA	NA	NA	NA
TRINITY_DN16918_c0_g1_i1	Q6DFR1	S22AF_XENTR	43.5	69	35	1	16	210	373	441	2.00E-07	56.2	S22AF_XENTR	reviewed	Solute carrier family 22 member 15	slc22a15	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	534	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN16918_c0_g1_i3	Q6DFR1	S22AF_XENTR	49	51	26	0	57	209	391	441	2.00E-07	56.2	S22AF_XENTR	reviewed	Solute carrier family 22 member 15	slc22a15	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	534	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		brown	brown	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i10	Q504N2	S22AF_MOUSE	34.4	163	96	5	526	71	290	452	3.90E-16	87	S22AF_MOUSE	reviewed	Solute carrier family 22 member 15	Slc22a15	Mus musculus (Mouse)	544	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		brown	brown	NA	NA	NA	NA
TRINITY_DN222_c0_g1_i4	Q504N2	S22AF_MOUSE	37.9	116	64	4	394	71	337	452	1.60E-12	73.9	S22AF_MOUSE	reviewed	Solute carrier family 22 member 15	Slc22a15	Mus musculus (Mouse)	544	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN3408_c0_g1_i5	Q6DFR1	S22AF_XENTR	38.7	111	63	2	371	51	376	485	2.10E-10	67	S22AF_XENTR	reviewed	Solute carrier family 22 member 15	slc22a15	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	534	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN3408_c0_g1_i7	Q6DFR1	S22AF_XENTR	39.4	66	36	1	243	58	376	441	1.40E-05	50.4	S22AF_XENTR	reviewed	Solute carrier family 22 member 15	slc22a15	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	534	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN30389_c0_g1_i1	Q6NUB3	S22AF_XENLA	49.1	53	27	0	251	93	392	444	1.70E-06	53.5	S22AF_XENLA	reviewed	Solute carrier family 22 member 15	slc22a15	Xenopus laevis (African clawed frog)	531	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN40012_c0_g1_i2	Q6DFR1	S22AF_XENTR	44.8	96	52	1	60	347	392	486	2.40E-13	76.6	S22AF_XENTR	reviewed	Solute carrier family 22 member 15	slc22a15	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	534	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN28498_c0_g1_i1	Q504N2	S22AF_MOUSE	39.6	154	85	3	454	2	227	375	4.60E-18	92.4	S22AF_MOUSE	reviewed	Solute carrier family 22 member 15	Slc22a15	Mus musculus (Mouse)	544	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN28498_c0_g1_i2	Q504N2	S22AF_MOUSE	39.6	139	78	2	479	66	227	360	1.20E-16	87.8	S22AF_MOUSE	reviewed	Solute carrier family 22 member 15	Slc22a15	Mus musculus (Mouse)	544	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN30565_c0_g1_i1	Q504N2	S22AF_MOUSE	46	50	27	0	102	251	403	452	6.50E-05	48.1	S22AF_MOUSE	reviewed	Solute carrier family 22 member 15	Slc22a15	Mus musculus (Mouse)	544	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN5198_c0_g1_i16	Q8IZD6	S22AF_HUMAN	41.7	60	32	1	81	251	393	452	7.30E-05	47.8	S22AF_HUMAN	reviewed	Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)	SLC22A15 FLIPT1 UNQ9429/PRO34686	Homo sapiens (Human)	547	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN14152_c0_g1_i3	Q8IZD6	S22AF_HUMAN	50.8	65	32	0	220	26	400	464	9.60E-09	60.8	S22AF_HUMAN	reviewed	Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)	SLC22A15 FLIPT1 UNQ9429/PRO34686	Homo sapiens (Human)	547	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN30881_c0_g1_i1	Q8IZD6	S22AF_HUMAN	54.9	51	23	0	222	70	402	452	1.10E-08	60.5	S22AF_HUMAN	reviewed	Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)	SLC22A15 FLIPT1 UNQ9429/PRO34686	Homo sapiens (Human)	547	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN30881_c0_g1_i2	Q8IZD6	S22AF_HUMAN	54.9	51	23	0	224	72	402	452	8.80E-09	60.8	S22AF_HUMAN	reviewed	Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)	SLC22A15 FLIPT1 UNQ9429/PRO34686	Homo sapiens (Human)	547	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN14152_c0_g1_i1	Q28ES4	S22FL_XENTR	36.6	142	84	4	472	62	285	425	1.10E-14	81.3	S22FL_XENTR	reviewed	Solute carrier family 22 member 15-like	slc22a15b TGas054i12.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	487	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN5198_c0_g1_i13	Q66KG0	S22AG_XENLA	43.8	64	33	1	99	281	436	499	1.80E-08	60.1	S22AG_XENLA	reviewed	Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2)	slc22a16	Xenopus laevis (African clawed frog)	566	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN5198_c0_g1_i2	Q17QN9	S22AG_BOVIN	36.5	126	73	3	93	464	443	563	3.70E-08	59.7	S22AG_BOVIN	reviewed	Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2)	SLC22A16	Bos taurus (Bovine)	572	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; organic cation transmembrane transporter activity [GO:0015101]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	organic cation transmembrane transporter activity [GO:0015101]	GO:0005886; GO:0007275; GO:0007283; GO:0015101; GO:0015695; GO:0016021; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5198_c0_g1_i6	Q17QN9	S22AG_BOVIN	38.9	126	70	3	15	386	443	563	5.20E-11	68.9	S22AG_BOVIN	reviewed	Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2)	SLC22A16	Bos taurus (Bovine)	572	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; organic cation transmembrane transporter activity [GO:0015101]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	organic cation transmembrane transporter activity [GO:0015101]	GO:0005886; GO:0007275; GO:0007283; GO:0015101; GO:0015695; GO:0016021; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5198_c0_g1_i8	Q17QN9	S22AG_BOVIN	39.7	126	69	3	96	467	443	563	5.60E-12	72.4	S22AG_BOVIN	reviewed	Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2)	SLC22A16	Bos taurus (Bovine)	572	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; organic cation transmembrane transporter activity [GO:0015101]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	organic cation transmembrane transporter activity [GO:0015101]	GO:0005886; GO:0007275; GO:0007283; GO:0015101; GO:0015695; GO:0016021; GO:0030154	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic cation transport [GO:0015695]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i1	Q66KG0	S22AG_XENLA	34.3	67	44	0	149	349	337	403	3.80E-05	49.3	S22AG_XENLA	reviewed	Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2)	slc22a16	Xenopus laevis (African clawed frog)	566	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN39797_c0_g1_i1	Q80UJ1	S22AK_MOUSE	28.4	250	162	4	753	4	192	424	1.60E-23	111.3	S22AK_MOUSE	reviewed	Solute carrier family 22 member 20 (Organic anion transporter 6)	Slc22a20 Gm963 Oat6	Mus musculus (Mouse)	556	integral component of membrane [GO:0016021]; organic anion transmembrane transporter activity [GO:0008514]; organic anion transport [GO:0015711]	integral component of membrane [GO:0016021]	organic anion transmembrane transporter activity [GO:0008514]	GO:0008514; GO:0015711; GO:0016021	organic anion transport [GO:0015711]		NA	NA	NA	NA	NA	NA
TRINITY_DN39797_c0_g1_i2	Q80UJ1	S22AK_MOUSE	38.7	106	65	0	854	537	192	297	5.20E-15	83.2	S22AK_MOUSE	reviewed	Solute carrier family 22 member 20 (Organic anion transporter 6)	Slc22a20 Gm963 Oat6	Mus musculus (Mouse)	556	integral component of membrane [GO:0016021]; organic anion transmembrane transporter activity [GO:0008514]; organic anion transport [GO:0015711]	integral component of membrane [GO:0016021]	organic anion transmembrane transporter activity [GO:0008514]	GO:0008514; GO:0015711; GO:0016021	organic anion transport [GO:0015711]		NA	NA	NA	NA	NA	NA
TRINITY_DN39285_c0_g1_i1	A6NK97	S22AK_HUMAN	44	50	28	0	165	16	221	270	2.70E-05	48.9	S22AK_HUMAN	reviewed	Solute carrier family 22 member 20 (Organic anion transporter 6) (Solute carrier family 22 member 20 pseudogene)	SLC22A20P OAT6 SLC22A20	Homo sapiens (Human)	555	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i4	O75751	S22A3_HUMAN	39	282	151	2	134	976	142	403	2.20E-49	197.6	S22A3_HUMAN	reviewed	Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3)	SLC22A3 EMTH OCT3	Homo sapiens (Human)	556	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; dopamine:sodium symporter activity [GO:0005330]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; dopamine uptake [GO:0090494]; drug transmembrane transport [GO:0006855]; epinephrine uptake [GO:0051625]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	dopamine:sodium symporter activity [GO:0005330]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]	GO:0001692; GO:0005326; GO:0005330; GO:0005886; GO:0005887; GO:0006836; GO:0006855; GO:0008504; GO:0008514; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015711; GO:0015718; GO:0015844; GO:0016020; GO:0019534; GO:0032098; GO:0042908; GO:0043025; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098793; GO:0150104; GO:1901998	dopamine uptake [GO:0090494]; drug transmembrane transport [GO:0006855]; epinephrine uptake [GO:0051625]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN30170_c0_g1_i1	O88446	S22A3_RAT	46.3	54	27	1	226	387	125	176	2.90E-05	49.7	S22A3_RAT	reviewed	Solute carrier family 22 member 3 (Organic cation transporter 3)	Slc22a3 Oct3	Rattus norvegicus (Rat)	551	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; dopamine:sodium symporter activity [GO:0005330]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; organic hydroxy compound transport [GO:0015850]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	dopamine:sodium symporter activity [GO:0005330]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005326; GO:0005330; GO:0005886; GO:0006836; GO:0006837; GO:0008504; GO:0008514; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015711; GO:0015718; GO:0015844; GO:0015850; GO:0015872; GO:0016021; GO:0019534; GO:0022857; GO:0032098; GO:0042908; GO:0042910; GO:0043025; GO:0051608; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098793; GO:1901998	dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; histamine transport [GO:0051608]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; organic hydroxy compound transport [GO:0015850]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; xenobiotic transport [GO:0042908]		NA	NA	NA	NA	NA	NA
TRINITY_DN31935_c0_g1_i1	O76082	S22A5_HUMAN	44.6	65	29	1	37	210	266	330	4.10E-06	51.6	S22A5_HUMAN	reviewed	Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)	SLC22A5 OCTN2	Homo sapiens (Human)	557	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; (R)-carnitine transmembrane transporter activity [GO:1901235]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; (R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	(R)-carnitine transmembrane transporter activity [GO:1901235]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1901235; GO:1902270; GO:1902603; GO:1990961	(R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]		NA	NA	NA	NA	NA	NA
TRINITY_DN39652_c0_g1_i1	O76082	S22A5_HUMAN	39.3	61	37	0	64	246	419	479	6.30E-06	51.6	S22A5_HUMAN	reviewed	Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)	SLC22A5 OCTN2	Homo sapiens (Human)	557	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; (R)-carnitine transmembrane transporter activity [GO:1901235]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; (R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	(R)-carnitine transmembrane transporter activity [GO:1901235]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1901235; GO:1902270; GO:1902603; GO:1990961	(R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]		brown	brown	NA	NA	NA	NA
TRINITY_DN26851_c0_g1_i1	Q4U2R8	S22A6_HUMAN	54.4	68	30	1	208	8	101	168	1.60E-11	69.7	S22A6_HUMAN	reviewed	Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1)	SLC22A6 OAT1 PAHT	Homo sapiens (Human)	563	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0031427; GO:0032991; GO:0042802; GO:0043252; GO:0070062; GO:0097254	alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]		blue	blue	NA	NA	NA	NA
TRINITY_DN31649_c0_g1_i1	Q4U2R8	S22A6_HUMAN	39.4	71	33	1	48	230	477	547	1.40E-05	50.4	S22A6_HUMAN	reviewed	Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1)	SLC22A6 OAT1 PAHT	Homo sapiens (Human)	563	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0031427; GO:0032991; GO:0042802; GO:0043252; GO:0070062; GO:0097254	alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN11433_c0_g1_i3	Q6NYN7	S22A6_DANRE	34.1	170	104	5	284	784	2	166	6.70E-15	82.8	S22A6_DANRE	reviewed	Solute carrier family 22 member 6 (Organic anion transporter 1) (Renal organic anion transporter 1) (ROAT1)	slc22a6 oat zgc:77073	Danio rerio (Zebrafish) (Brachydanio rerio)	560	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; organic anion transmembrane transporter activity [GO:0008514]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	organic anion transmembrane transporter activity [GO:0008514]	GO:0005886; GO:0008514; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN17450_c0_g1_i1	Q8MK48	S22A6_PIG	31.4	105	67	1	363	49	113	212	7.60E-07	55.1	S22A6_PIG	reviewed	Solute carrier family 22 member 6 (Organic anion transporter 1) (Renal organic anion transporter 1) (ROAT1) (pOAT1)	SLC22A6 OAT1	Sus scrofa (Pig)	547	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]	inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005452; GO:0005887; GO:0008514; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0097254	alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]		NA	NA	NA	NA	NA	NA
TRINITY_DN12692_c0_g1_i7	Q66J54	S226A_XENLA	34.1	91	59	1	290	21	109	199	2.50E-08	60.1	S226A_XENLA	reviewed	Solute carrier family 22 member 6-A (Organic cation transporter 1-A) (Renal organic anion transporter 1-A) (ROAT1-A)	slc22a6-a oat1-a	Xenopus laevis (African clawed frog)	558	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN30504_c0_g1_i1	Q66J54	S226A_XENLA	35	117	67	2	117	467	440	547	1.10E-11	71.6	S226A_XENLA	reviewed	Solute carrier family 22 member 6-A (Organic cation transporter 1-A) (Renal organic anion transporter 1-A) (ROAT1-A)	slc22a6-a oat1-a	Xenopus laevis (African clawed frog)	558	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN3032_c1_g1_i2	Q1RPP5	S22A7_PIG	36.1	158	90	3	196	651	107	259	2.20E-21	104	S22A7_PIG	reviewed	Solute carrier family 22 member 7 (Organic anion transporter 2)	SLC22A7 OAT2	Sus scrofa (Pig)	547	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0016323; GO:0022857	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN6364_c0_g1_i16	Q2KIV1	S22A9_BOVIN	37.1	62	37	2	258	79	114	175	6.60E-07	55.5	S22A9_BOVIN	reviewed	Solute carrier family 22 member 9	SLC22A9	Bos taurus (Bovine)	552	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0009914; GO:0015301; GO:0015347; GO:0015636; GO:0015711; GO:0015913; GO:0016021; GO:0016323; GO:0043252	hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN6364_c0_g1_i3	Q2KIV1	S22A9_BOVIN	37.1	62	37	2	258	79	114	175	7.90E-07	55.5	S22A9_BOVIN	reviewed	Solute carrier family 22 member 9	SLC22A9	Bos taurus (Bovine)	552	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0009914; GO:0015301; GO:0015347; GO:0015636; GO:0015711; GO:0015913; GO:0016021; GO:0016323; GO:0043252	hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN6364_c0_g1_i4	Q2KIV1	S22A9_BOVIN	37.1	62	37	2	258	79	114	175	8.10E-07	55.5	S22A9_BOVIN	reviewed	Solute carrier family 22 member 9	SLC22A9	Bos taurus (Bovine)	552	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0009914; GO:0015301; GO:0015347; GO:0015636; GO:0015711; GO:0015913; GO:0016021; GO:0016323; GO:0043252	hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN12435_c0_g1_i1	Q9WTW7	S23A1_RAT	50	94	44	2	273	1	119	212	2.70E-13	75.9	S23A1_RAT	reviewed	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1)	Slc23a1 Svct1	Rattus norvegicus (Rat)	604	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN4729_c0_g1_i2	Q9WTW7	S23A1_RAT	48.9	550	267	5	19	1641	34	578	9.20E-152	538.5	S23A1_RAT	reviewed	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1)	Slc23a1 Svct1	Rattus norvegicus (Rat)	604	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN12431_c0_g1_i1	Q9UHI7	S23A1_HUMAN	53.7	54	25	0	196	35	171	224	3.90E-09	61.6	S23A1_HUMAN	reviewed	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	SLC23A1 SVCT1 YSPL3	Homo sapiens (Human)	598	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN37303_c0_g1_i1	Q9UHI7	S23A1_HUMAN	62.2	45	17	0	171	37	474	518	7.40E-08	57.4	S23A1_HUMAN	reviewed	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	SLC23A1 SVCT1 YSPL3	Homo sapiens (Human)	598	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN17240_c0_g1_i3	Q9Z2J0	S23A1_MOUSE	51.5	565	255	4	1735	80	35	593	1.00E-159	565.1	S23A1_MOUSE	reviewed	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	Slc23a1 Svct1 Yspl3	Mus musculus (Mouse)	605	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]		blue	blue	NA	NA	NA	NA
TRINITY_DN23742_c0_g1_i1	Q9UGH3	S23A2_HUMAN	100	67	0	0	1	201	380	446	2.70E-31	135.2	S23A2_HUMAN	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2)	SLC23A2 KIAA0238 NBTL1 SLC23A1 SVCT2 YSPL2	Homo sapiens (Human)	650	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006979; GO:0009925; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase transport [GO:0015851]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN33630_c0_g1_i1	B0JZG0	S23A2_XENTR	48.1	52	27	0	181	26	222	273	8.80E-06	50.4	S23A2_XENTR	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	slc23a2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	649	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]	integral component of membrane [GO:0016021]	sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0016021; GO:0019852; GO:0070890	L-ascorbic acid metabolic process [GO:0019852]		NA	NA	NA	NA	NA	NA
TRINITY_DN29489_c0_g1_i1	B0JZG0	S23A2_XENTR	53.1	81	37	1	252	13	449	529	4.10E-16	85.1	S23A2_XENTR	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	slc23a2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	649	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]	integral component of membrane [GO:0016021]	sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0016021; GO:0019852; GO:0070890	L-ascorbic acid metabolic process [GO:0019852]		NA	NA	NA	NA	NA	NA
TRINITY_DN17240_c0_g1_i1	Q9WTW8	S23A2_RAT	46.2	305	157	2	894	1	63	367	4.10E-72	273.1	S23A2_RAT	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	Slc23a2 Svct2	Rattus norvegicus (Rat)	647	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904; GO:0071361; GO:1901215; GO:1903861	cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		blue	blue	NA	NA	NA	NA
TRINITY_DN4729_c0_g1_i1	Q9EPR4	S23A2_MOUSE	43.4	143	78	2	31	450	89	231	1.90E-27	123.6	S23A2_MOUSE	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	Slc23a2 Kiaa0238 Svct2 Yspl2	Mus musculus (Mouse)	648	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904; GO:1901215; GO:1903861	L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN4729_c0_g1_i3	Q9EPR4	S23A2_MOUSE	44.9	185	99	2	31	576	89	273	7.50E-40	165.2	S23A2_MOUSE	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	Slc23a2 Kiaa0238 Svct2 Yspl2	Mus musculus (Mouse)	648	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904; GO:1901215; GO:1903861	L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN25407_c0_g1_i1	Q9EPR4	S23A2_MOUSE	100	68	0	0	204	1	443	510	5.20E-30	131	S23A2_MOUSE	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	Slc23a2 Kiaa0238 Svct2 Yspl2	Mus musculus (Mouse)	648	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904; GO:1901215; GO:1903861	L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN41036_c0_g1_i1	Q9EPR4	S23A2_MOUSE	42.3	71	39	1	21	227	161	231	1.20E-06	53.5	S23A2_MOUSE	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	Slc23a2 Kiaa0238 Svct2 Yspl2	Mus musculus (Mouse)	648	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904; GO:1901215; GO:1903861	L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN29120_c0_g1_i1	Q9EPR4	S23A2_MOUSE	100	90	0	0	3	272	526	615	2.40E-46	185.7	S23A2_MOUSE	reviewed	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	Slc23a2 Kiaa0238 Svct2 Yspl2	Mus musculus (Mouse)	648	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904; GO:1901215; GO:1903861	L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]		NA	NA	NA	NA	NA	NA
TRINITY_DN6298_c0_g1_i1	A3KPP4	S2535_DANRE	52.3	298	141	1	1012	119	1	297	2.60E-88	327	S2535_DANRE	reviewed	Solute carrier family 25 member 35	slc25a35 si:ch211-268m12.5	Danio rerio (Zebrafish) (Brachydanio rerio)	298	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN6298_c0_g1_i2	A3KPP4	S2535_DANRE	53.8	236	108	1	781	74	1	235	6.30E-69	262.3	S2535_DANRE	reviewed	Solute carrier family 25 member 35	slc25a35 si:ch211-268m12.5	Danio rerio (Zebrafish) (Brachydanio rerio)	298	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN40436_c0_g1_i1	Q96CQ1	S2536_HUMAN	100	69	0	0	3	209	243	311	1.50E-32	139.8	S2536_HUMAN	reviewed	Solute carrier family 25 member 36	SLC25A36	Homo sapiens (Human)	311	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]	GO:0000002; GO:0005347; GO:0005739; GO:0005743; GO:0006864; GO:0007005; GO:0015218; GO:0016021; GO:0051881; GO:1990519	mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]		NA	NA	NA	NA	NA	NA
TRINITY_DN10274_c0_g1_i1	Q6DG32	S2536_DANRE	63.4	41	14	1	211	92	129	169	7.00E-07	54.7	S2536_DANRE	reviewed	Solute carrier family 25 member 36-A	slc25a36a si:dkeyp-90g12.1 zgc:92447	Danio rerio (Zebrafish) (Brachydanio rerio)	311	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; pyrimidine nucleotide import into mitochondrion [GO:1990519]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]	GO:0005347; GO:0005743; GO:0015218; GO:0016021; GO:1990519	pyrimidine nucleotide import into mitochondrion [GO:1990519]		NA	NA	NA	NA	NA	NA
TRINITY_DN36709_c0_g1_i1	Q9BZJ4	S2539_HUMAN	98.5	67	1	0	1	201	165	231	2.10E-31	135.6	S2539_HUMAN	reviewed	Solute carrier family 25 member 39	SLC25A39 CGI-69 PRO2163	Homo sapiens (Human)	359	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; heme biosynthetic process [GO:0006783]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0006783; GO:0016021	heme biosynthetic process [GO:0006783]		NA	NA	NA	NA	NA	NA
TRINITY_DN35585_c0_g1_i1	Q9D8K8	S2539_MOUSE	100	111	0	0	334	2	150	260	1.50E-58	226.5	S2539_MOUSE	reviewed	Solute carrier family 25 member 39	Slc25a39 D11Ertd333e	Mus musculus (Mouse)	359	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; heme biosynthetic process [GO:0006783]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0006783; GO:0016021	heme biosynthetic process [GO:0006783]		NA	NA	NA	NA	NA	NA
TRINITY_DN815_c0_g1_i1	Q6DHC3	S2540_DANRE	51	343	150	6	18	1034	13	341	6.50E-90	332.4	S2540_DANRE	reviewed	Solute carrier family 25 member 40	slc25a40 zgc:92520	Danio rerio (Zebrafish) (Brachydanio rerio)	353	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN815_c0_g1_i2	Q6DHC3	S2540_DANRE	50.7	341	148	6	18	1016	13	341	3.20E-89	330.1	S2540_DANRE	reviewed	Solute carrier family 25 member 40	slc25a40 zgc:92520	Danio rerio (Zebrafish) (Brachydanio rerio)	353	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005743; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN7415_c0_g1_i1	Q5RD67	S2544_PONAB	42.6	312	175	2	134	1069	7	314	2.90E-69	263.8	S2544_PONAB	reviewed	Solute carrier family 25 member 44	SLC25A44	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	314	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; branched-chain amino acid transmembrane transporter activity [GO:0015658]; branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	ATP transmembrane transporter activity [GO:0005347]; branched-chain amino acid transmembrane transporter activity [GO:0015658]	GO:0005347; GO:0005739; GO:0009083; GO:0015658; GO:0015803; GO:0016021; GO:0031966; GO:0120161	branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161]		NA	NA	NA	NA	NA	NA
TRINITY_DN9757_c0_g1_i1	Q8CFJ7	S2545_MOUSE	39.9	148	80	3	101	523	5	150	1.00E-24	114.8	S2545_MOUSE	reviewed	Solute carrier family 25 member 45	Slc25a45	Mus musculus (Mouse)	288	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; ATP transmembrane transporter activity [GO:0005347]; acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	acyl carnitine transmembrane transporter activity [GO:0015227]; ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005739; GO:0005743; GO:0006844; GO:0006865; GO:0015227; GO:0016021	acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865]		blue	blue	NA	NA	NA	NA
TRINITY_DN24821_c0_g1_i1	Q96AG3	S2546_HUMAN	100	94	0	0	284	3	306	399	2.40E-49	195.7	S2546_HUMAN	reviewed	Solute carrier family 25 member 46	SLC25A46 TB1	Homo sapiens (Human)	418	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0000422; GO:0005739; GO:0005741; GO:0006839; GO:0007416; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0048936; GO:0090149	autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN24821_c1_g1_i1	Q9CQS4	S2546_MOUSE	100	86	0	0	2	259	308	393	9.50E-45	180.3	S2546_MOUSE	reviewed	Solute carrier family 25 member 46	Slc25a46	Mus musculus (Mouse)	418	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0000422; GO:0005739; GO:0005741; GO:0006839; GO:0007005; GO:0007416; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0048936; GO:0090149	autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1333_c0_g1_i1	Q9CQS4	S2546_MOUSE	40.3	233	136	1	232	921	60	292	5.90E-47	189.9	S2546_MOUSE	reviewed	Solute carrier family 25 member 46	Slc25a46	Mus musculus (Mouse)	418	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0000422; GO:0005739; GO:0005741; GO:0006839; GO:0007005; GO:0007416; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0048936; GO:0090149	autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1333_c0_g1_i1	Q9CQS4	S2546_MOUSE	60	70	28	0	947	1156	340	409	3.40E-18	94.4	S2546_MOUSE	reviewed	Solute carrier family 25 member 46	Slc25a46	Mus musculus (Mouse)	418	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]		GO:0000422; GO:0005739; GO:0005741; GO:0006839; GO:0007005; GO:0007416; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0048936; GO:0090149	autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1333_c0_g1_i2	Q5ZIG3	S2546_CHICK	46.8	316	165	2	331	1275	86	399	6.40E-79	296.2	S2546_CHICK	reviewed	Solute carrier family 25 member 46	SLC25A46 RCJMB04_26i24	Gallus gallus (Chicken)	408	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]		GO:0000422; GO:0005741; GO:0006839; GO:0007416; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0048936; GO:0090149	autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN1333_c0_g1_i4	Q5ZIG3	S2546_CHICK	46.8	316	165	2	331	1275	86	399	6.80E-79	296.2	S2546_CHICK	reviewed	Solute carrier family 25 member 46	SLC25A46 RCJMB04_26i24	Gallus gallus (Chicken)	408	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]		GO:0000422; GO:0005741; GO:0006839; GO:0007416; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0048936; GO:0090149	autophagy of mitochondrion [GO:0000422]; cerebellar Purkinje cell differentiation [GO:0021702]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; synapse assembly [GO:0007416]		NA	NA	NA	NA	NA	NA
TRINITY_DN12859_c0_g1_i1	Q6ZT89	S2548_HUMAN	49.4	89	45	0	16	282	215	303	2.30E-18	92.8	S2548_HUMAN	reviewed	Solute carrier family 25 member 48	SLC25A48	Homo sapiens (Human)	311	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; acyl carnitine transmembrane transporter activity [GO:0015227]; ATP transmembrane transporter activity [GO:0005347]; acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	acyl carnitine transmembrane transporter activity [GO:0015227]; ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005743; GO:0006844; GO:0006865; GO:0015227; GO:0016021	acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865]		blue	blue	NA	NA	NA	NA
TRINITY_DN33820_c0_g1_i1	Q5EBI0	S2610_MOUSE	57.8	83	35	0	26	274	78	160	1.80E-22	106.3	S2610_MOUSE	reviewed	Solute carrier family 26 member 10	Slc26a10	Mus musculus (Mouse)	676	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005887; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016323; GO:0019531			NA	NA	NA	NA	NA	NA
TRINITY_DN2329_c0_g1_i1	Q9UA35	S28A3_EPTST	44	530	264	10	1684	149	93	607	8.10E-108	392.5	S28A3_EPTST	reviewed	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)	SLC28A3 CNT3	Eptatretus stoutii (Pacific hagfish)	683	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]	integral component of plasma membrane [GO:0005887]	nucleoside transmembrane transporter activity [GO:0005337]	GO:0005337; GO:0005887			NA	NA	NA	NA	NA	NA
TRINITY_DN28156_c0_g1_i1	P78383	S35B1_HUMAN	100	139	0	0	417	1	78	216	7.80E-73	274.2	S35B1_HUMAN	reviewed	Solute carrier family 35 member B1 (UDP-galactose transporter-related protein 1) (UGTrel1) (hUGTrel1)	SLC35B1 UGTREL1	Homo sapiens (Human)	322	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; UDP-galactose transmembrane transport [GO:0072334]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]	transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]	GO:0005459; GO:0005460; GO:0008643; GO:0022857; GO:0030173; GO:0030176; GO:0043231; GO:0072334	carbohydrate transport [GO:0008643]; UDP-galactose transmembrane transport [GO:0072334]		NA	NA	NA	NA	NA	NA
TRINITY_DN1381_c0_g1_i1	Q9VDD7	S35B1_DROME	55	269	114	2	875	90	65	333	6.90E-71	268.9	S35B1_DROME	reviewed	Solute carrier family 35 member B1 homolog (Protein medial glomeruli)	meigo CG5802	Drosophila melanogaster (Fruit fly)	338	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; axon guidance [GO:0007411]; carbohydrate transport [GO:0008643]; dendrite guidance [GO:0070983]; protein N-linked glycosylation [GO:0006487]; response to endoplasmic reticulum stress [GO:0034976]; UDP-galactose transmembrane transport [GO:0072334]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]	GO:0005459; GO:0005460; GO:0005789; GO:0006487; GO:0007411; GO:0008643; GO:0022857; GO:0030173; GO:0030176; GO:0034976; GO:0070983; GO:0072334	axon guidance [GO:0007411]; carbohydrate transport [GO:0008643]; dendrite guidance [GO:0070983]; protein N-linked glycosylation [GO:0006487]; response to endoplasmic reticulum stress [GO:0034976]; UDP-galactose transmembrane transport [GO:0072334]		NA	NA	NA	NA	NA	NA
TRINITY_DN27678_c0_g1_i1	Q8VCX2	S35C2_MOUSE	49.3	304	154	0	1110	199	17	320	1.10E-73	278.5	S35C2_MOUSE	reviewed	Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein)	Slc35c2 Ovcov1	Mus musculus (Mouse)	364	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; fucosylation [GO:0036065]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0033116; GO:0036065; GO:0036066; GO:0045747	fucosylation [GO:0036065]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]		NA	NA	NA	NA	NA	NA
TRINITY_DN32371_c0_g1_i1	Q8VCX2	S35C2_MOUSE	100	72	0	0	216	1	86	157	1.40E-28	126.3	S35C2_MOUSE	reviewed	Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein)	Slc35c2 Ovcov1	Mus musculus (Mouse)	364	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; fucosylation [GO:0036065]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0033116; GO:0036065; GO:0036066; GO:0045747	fucosylation [GO:0036065]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]		NA	NA	NA	NA	NA	NA
TRINITY_DN40446_c0_g1_i1	Q9NQQ7	S35C2_HUMAN	100	82	0	0	248	3	76	157	1.10E-34	146.7	S35C2_HUMAN	reviewed	Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein)	SLC35C2 C20orf5 OVCOV1 CGI-15	Homo sapiens (Human)	365	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0033116; GO:0036066; GO:0045747	negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]		NA	NA	NA	NA	NA	NA
TRINITY_DN36323_c0_g1_i1	Q8CD26	S35E1_MOUSE	51.6	62	29	1	449	267	305	366	2.50E-08	60.1	S35E1_MOUSE	reviewed	Solute carrier family 35 member E1	Slc35e1	Mus musculus (Mouse)	409	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0015297; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN21332_c0_g1_i2	Q8C811	S35E2_MOUSE	47.8	184	91	1	587	51	192	375	2.20E-40	167.2	S35E2_MOUSE	reviewed	Solute carrier family 35 member E2A	Slc35e2a Slc35e2	Mus musculus (Mouse)	405	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; blastocyst hatching [GO:0001835]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0001835; GO:0005794; GO:0015297; GO:0016021; GO:0022857	blastocyst hatching [GO:0001835]		NA	NA	NA	NA	NA	NA
TRINITY_DN21332_c0_g1_i3	Q8C811	S35E2_MOUSE	55	60	27	0	219	40	192	251	8.20E-11	67.8	S35E2_MOUSE	reviewed	Solute carrier family 35 member E2A	Slc35e2a Slc35e2	Mus musculus (Mouse)	405	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; blastocyst hatching [GO:0001835]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0001835; GO:0005794; GO:0015297; GO:0016021; GO:0022857	blastocyst hatching [GO:0001835]		NA	NA	NA	NA	NA	NA
TRINITY_DN31158_c0_g1_i1	A6QL92	S35F5_BOVIN	48.4	95	49	0	2	286	223	317	1.70E-19	96.7	S35F5_BOVIN	reviewed	Solute carrier family 35 member F5	SLC35F5	Bos taurus (Bovine)	524	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN31158_c0_g1_i2	Q8WV83	S35F5_HUMAN	46.7	92	44	2	9	284	238	324	1.50E-14	80.1	S35F5_HUMAN	reviewed	Solute carrier family 35 member F5 (Hepatitis C virus NS5A-transactivated protein 3) (HCV NS5A-transactivated protein 3)	SLC35F5 NS5ATP3 UNQ2545/PRO6097	Homo sapiens (Human)	523	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN25751_c0_g1_i1	Q8N357	S35F6_HUMAN	100	85	0	0	255	1	212	296	6.30E-41	167.5	S35F6_HUMAN	reviewed	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	SLC35F6 C2orf18 UNQ3047/PRO9863	Homo sapiens (Human)	371	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN2397_c0_g1_i1	Q8N357	S35F6_HUMAN	65.7	102	35	0	3	308	235	336	1.70E-30	133.7	S35F6_HUMAN	reviewed	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	SLC35F6 C2orf18 UNQ3047/PRO9863	Homo sapiens (Human)	371	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN2397_c0_g1_i2	Q8N357	S35F6_HUMAN	65.7	102	35	0	3	308	235	336	1.70E-30	133.7	S35F6_HUMAN	reviewed	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	SLC35F6 C2orf18 UNQ3047/PRO9863	Homo sapiens (Human)	371	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		blue	blue	NA	NA	NA	NA
TRINITY_DN2397_c0_g1_i3	Q8N357	S35F6_HUMAN	65.7	102	35	0	3	308	235	336	1.70E-30	133.7	S35F6_HUMAN	reviewed	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	SLC35F6 C2orf18 UNQ3047/PRO9863	Homo sapiens (Human)	371	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN22333_c0_g1_i1	Q8N357	S35F6_HUMAN	71.4	56	16	0	214	47	212	267	2.00E-16	85.9	S35F6_HUMAN	reviewed	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	SLC35F6 C2orf18 UNQ3047/PRO9863	Homo sapiens (Human)	371	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]		brown	brown	NA	NA	NA	NA
TRINITY_DN2328_c0_g1_i1	Q8IVJ1	S41A1_HUMAN	60.4	455	170	3	111	1460	64	513	2.10E-139	497.3	S41A1_HUMAN	reviewed	Solute carrier family 41 member 1	SLC41A1	Homo sapiens (Human)	513	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; divalent metal ion transport [GO:0070838]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium:sodium antiporter activity [GO:0061768]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0032991; GO:0061768; GO:0070838; GO:0071286; GO:0072509; GO:1903830	cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; divalent metal ion transport [GO:0070838]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]		NA	NA	NA	NA	NA	NA
TRINITY_DN2328_c0_g1_i2	Q6DFC0	S41A2_XENLA	59.1	159	62	2	1	471	286	443	6.70E-42	171.8	S41A2_XENLA	reviewed	Solute carrier family 41 member 2	slc41a2	Xenopus laevis (African clawed frog)	561	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation transmembrane transporter activity [GO:0008324]	GO:0005886; GO:0008324; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN29496_c0_g1_i1	Q96GZ6	S41A3_HUMAN	100	73	0	0	220	2	190	262	4.60E-32	137.9	S41A3_HUMAN	reviewed	Solute carrier family 41 member 3	SLC41A3	Homo sapiens (Human)	507	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cation transmembrane transporter activity [GO:0008324]	GO:0005886; GO:0008324; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14993_c0_g1_i1	Q8K0H7	S45A3_MOUSE	31.8	277	125	2	67	708	268	543	5.80E-29	129.4	S45A3_MOUSE	reviewed	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	Slc45a3 Pcanap6 Prst	Mus musculus (Mouse)	553	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sucrose:proton symporter activity [GO:0008506]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	sucrose:proton symporter activity [GO:0008506]	GO:0008506; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713	positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]		NA	NA	NA	NA	NA	NA
TRINITY_DN14993_c0_g1_i2	Q96JT2	S45A3_HUMAN	48.3	58	30	0	76	249	486	543	7.50E-07	54.7	S45A3_HUMAN	reviewed	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	SLC45A3 PCANAP6 PRST	Homo sapiens (Human)	553	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]	GO:0005886; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713; GO:0051119	hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]		NA	NA	NA	NA	NA	NA
TRINITY_DN14993_c0_g1_i3	Q96JT2	S45A3_HUMAN	55.6	63	28	0	67	255	268	330	7.20E-13	74.7	S45A3_HUMAN	reviewed	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	SLC45A3 PCANAP6 PRST	Homo sapiens (Human)	553	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]	GO:0005886; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713; GO:0051119	hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]		NA	NA	NA	NA	NA	NA
TRINITY_DN14993_c0_g1_i4	Q8K0H7	S45A3_MOUSE	31.8	277	125	2	67	708	268	543	6.00E-29	129.4	S45A3_MOUSE	reviewed	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	Slc45a3 Pcanap6 Prst	Mus musculus (Mouse)	553	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sucrose:proton symporter activity [GO:0008506]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	sucrose:proton symporter activity [GO:0008506]	GO:0008506; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713	positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]		NA	NA	NA	NA	NA	NA
TRINITY_DN17086_c0_g1_i4	Q501I9	DIRC2_XENTR	32.1	209	133	3	31	639	223	428	7.20E-20	99	DIRC2_XENTR	reviewed	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	slc49a4 dirc2 TEgg084h23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	456	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0016021; GO:0022857; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN17086_c0_g1_i7	Q501I9	DIRC2_XENTR	35.2	122	79	0	31	396	223	344	1.10E-14	81.3	DIRC2_XENTR	reviewed	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	slc49a4 dirc2 TEgg084h23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	456	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0016021; GO:0022857; GO:0043231			NA	NA	NA	NA	NA	NA
TRINITY_DN5240_c0_g1_i1	Q501I9	DIRC2_XENTR	29.8	429	282	8	261	1502	28	452	3.20E-42	174.5	DIRC2_XENTR	reviewed	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	slc49a4 dirc2 TEgg084h23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	456	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	transmembrane transporter activity [GO:0022857]	GO:0005765; GO:0016021; GO:0022857; GO:0043231			pink	pink	NA	NA	NA	NA
TRINITY_DN886_c0_g1_i2	Q8CE47	S49A3_MOUSE	48.1	79	41	0	311	75	28	106	3.10E-12	73.6	S49A3_MOUSE	reviewed	Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7A)	Slc49a3 Mfsd7a	Mus musculus (Mouse)	516	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN4907_c0_g1_i1	Q8CE47	S49A3_MOUSE	48.1	52	23	1	422	267	414	461	7.40E-05	48.5	S49A3_MOUSE	reviewed	Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7A)	Slc49a3 Mfsd7a	Mus musculus (Mouse)	516	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			blue	blue	NA	NA	NA	NA
TRINITY_DN886_c0_g1_i3	Q28FF3	S49A3_XENTR	39.3	384	228	2	1171	29	34	415	1.90E-68	261.5	S49A3_XENTR	reviewed	Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5)	slc49a3 mfsd7-A mfsd7-B TEgg026p17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	482	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN886_c0_g1_i6	Q28FF3	S49A3_XENTR	39.3	384	228	2	1171	29	34	415	1.70E-68	261.5	S49A3_XENTR	reviewed	Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5)	slc49a3 mfsd7-A mfsd7-B TEgg026p17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	482	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	integral component of membrane [GO:0016021]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN40535_c0_g1_i1	Q9HAB3	S52A2_HUMAN	100	68	0	0	207	4	1	68	2.20E-32	139	S52A2_HUMAN	reviewed	"Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1) (PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3) (hRFT3)"	SLC52A2 GPR172A PAR1 RFT3	Homo sapiens (Human)	445	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; 4-hydroxybutyrate receptor activity [GO:0062124]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	4-hydroxybutyrate receptor activity [GO:0062124]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]	GO:0001618; GO:0005886; GO:0005887; GO:0006771; GO:0032217; GO:0032218; GO:0062124	riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]		NA	NA	NA	NA	NA	NA
TRINITY_DN25648_c0_g1_i1	Q9D6X5	S52A3_MOUSE	41.6	404	195	7	8	1120	59	454	5.40E-63	243	S52A3_MOUSE	reviewed	"Solute carrier family 52, riboflavin transporter, member 3 (Riboflavin transporter 2) (RFT2)"	Slc52a3 Rft2 RFVT3	Mus musculus (Mouse)	460	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; cellular response to heat [GO:0034605]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	riboflavin transmembrane transporter activity [GO:0032217]	GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007605; GO:0032217; GO:0032218; GO:0034605	cellular response to heat [GO:0034605]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN8518_c0_g1_i1	Q6NRS2	S66A2_XENLA	60.9	92	36	0	281	6	13	104	9.10E-26	117.9	S66A2_XENLA	reviewed	Solute carrier family 66 member 2 (PQ-loop repeat-containing protein 1)	slc66a2 pqlc1	Xenopus laevis (African clawed frog)	250	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN6020_c0_g1_i1	Q99J94	SO1A6_MOUSE	27.3	165	108	3	557	69	315	469	3.90E-07	56.6	SO1A6_MOUSE	reviewed	Solute carrier organic anion transporter family member 1A6 (Kidney-specific organic anion-transporting polypeptide 5) (OATP-5) (Solute carrier family 21 member 13)	Slco1a6 Oatp5 Slc21a13	Mus musculus (Mouse)	670	integral component of plasma membrane [GO:0005887]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; animal organ regeneration [GO:0031100]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; heme metabolic process [GO:0042168]; multicellular organism growth [GO:0035264]; response to drug [GO:0042493]; sodium-independent organic anion transport [GO:0043252]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]	integral component of plasma membrane [GO:0005887]	bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005887; GO:0006805; GO:0008206; GO:0015125; GO:0015347; GO:0015721; GO:0031100; GO:0035264; GO:0042168; GO:0042493; GO:0042632; GO:0043252; GO:0070328	animal organ regeneration [GO:0031100]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; heme metabolic process [GO:0042168]; multicellular organism growth [GO:0035264]; response to drug [GO:0042493]; sodium-independent organic anion transport [GO:0043252]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN2475_c0_g1_i1	Q96BD0	SO4A1_HUMAN	43.2	644	327	10	1995	106	96	714	6.20E-144	512.7	SO4A1_HUMAN	reviewed	Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12	Homo sapiens (Human)	722	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252	sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN36446_c0_g1_i1	Q96BD0	SO4A1_HUMAN	100	71	0	0	3	215	390	460	9.90E-32	136.7	SO4A1_HUMAN	reviewed	Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12	Homo sapiens (Human)	722	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252	sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN25857_c0_g1_i1	Q96BD0	SO4A1_HUMAN	100	78	0	0	3	236	591	668	1.30E-40	166.4	SO4A1_HUMAN	reviewed	Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12	Homo sapiens (Human)	722	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252	sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN26726_c0_g1_i1	Q8BGD4	SO4C1_MOUSE	47.1	68	36	0	263	60	126	193	8.20E-12	70.9	SO4C1_MOUSE	reviewed	Solute carrier organic anion transporter family member 4C1 (Oatp-R) (Solute carrier family 21 member 20)	Slco4c1 Oatp4c1 Slc21a20	Mus musculus (Mouse)	722	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005887; GO:0007275; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016021; GO:0016323; GO:0030154; GO:0043252	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN35747_c0_g1_i1	Q9H2Y9	SO5A1_HUMAN	31.1	122	84	0	406	41	251	372	6.80E-19	95.1	SO5A1_HUMAN	reviewed	Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4) (OATP-RP4) (OATPRP4) (Solute carrier family 21 member 15)	SLCO5A1 OATP5A1 SLC21A15	Homo sapiens (Human)	848	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005886; GO:0005887; GO:0015347; GO:0043231; GO:0043252	sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN5914_c7_g1_i1	Q9VVH9	SO74D_DROME	56.1	57	25	0	2	172	157	213	8.60E-12	70.5	SO74D_DROME	reviewed	Solute carrier organic anion transporter family member 74D (Ecdysone Importer) (EcI) (Organic anion transporting polypeptide 74D)	Oatp74D CG7571	Drosophila melanogaster (Fruit fly)	819	integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]; ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]	active transmembrane transporter activity [GO:0022804]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857]	GO:0002164; GO:0005886; GO:0005887; GO:0015347; GO:0022804; GO:0022857; GO:0035076; GO:0043229; GO:0043252; GO:0071702	ecdysone receptor-mediated signaling pathway [GO:0035076]; larval development [GO:0002164]; organic substance transport [GO:0071702]; sodium-independent organic anion transport [GO:0043252]		NA	NA	NA	NA	NA	NA
TRINITY_DN18985_c6_g1_i1	P42577	FRIS_LYMST	75.5	53	13	0	161	3	5	57	1.40E-16	86.7	FRIS_LYMST	reviewed	Soma ferritin (EC 1.16.3.1)		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	174	cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]	cytoplasm [GO:0005737]	ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]	GO:0004322; GO:0005737; GO:0006826; GO:0006879; GO:0008199	cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]		blue	blue	NA	NA	NA	NA
TRINITY_DN33683_c0_g1_i1	P34993	SSR2_BOVIN	62.7	67	25	0	106	306	43	109	2.40E-18	92.8	SSR2_BOVIN	reviewed	Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1)	SSTR2	Bos taurus (Bovine)	368	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; somatostatin receptor activity [GO:0004994]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	somatostatin receptor activity [GO:0004994]	GO:0004994; GO:0005737; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN7546_c0_g1_i1	Q6AXX4	SAS10_RAT	41.2	97	57	0	293	3	196	292	2.50E-10	67.8	SAS10_RAT	reviewed	Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Disrupter of silencing SAS10) (UTP3 homolog)	Utp3 Crlz1 Sas10	Rattus norvegicus (Rat)	470	"nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040	"brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32826_c0_g1_i1	Q07889	SOS1_HUMAN	100	214	0	0	643	2	763	976	1.30E-119	430.3	SOS1_HUMAN	reviewed	Son of sevenless homolog 1 (SOS-1)	SOS1	Homo sapiens (Human)	1333	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]	GO:0000165; GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005088; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007173; GO:0007186; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0038128; GO:0042129; GO:0043025; GO:0043065; GO:0045742; GO:0046982; GO:0048011; GO:0048514; GO:0050900; GO:0051056; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:2000973	axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]		NA	NA	NA	NA	NA	NA
TRINITY_DN40257_c0_g1_i1	Q07889	SOS1_HUMAN	99	97	1	0	3	293	437	533	4.50E-51	201.4	SOS1_HUMAN	reviewed	Son of sevenless homolog 1 (SOS-1)	SOS1	Homo sapiens (Human)	1333	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]	GO:0000165; GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005088; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007173; GO:0007186; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0038128; GO:0042129; GO:0043025; GO:0043065; GO:0045742; GO:0046982; GO:0048011; GO:0048514; GO:0050900; GO:0051056; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:2000973	axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]		NA	NA	NA	NA	NA	NA
TRINITY_DN9596_c0_g1_i1	Q62245	SOS1_MOUSE	66.2	231	74	1	701	9	776	1002	3.10E-83	309.7	SOS1_MOUSE	reviewed	Son of sevenless homolog 1 (SOS-1) (mSOS-1)	Sos1	Mus musculus (Mouse)	1319	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; SH3 domain binding [GO:0017124]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; heart trabecula morphogenesis [GO:0061384]; lymphocyte homeostasis [GO:0002260]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; small GTPase mediated signal transduction [GO:0007264]; vitellogenesis [GO:0007296]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; SH3 domain binding [GO:0017124]	GO:0001782; GO:0001942; GO:0002260; GO:0003007; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005088; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0007264; GO:0007265; GO:0007296; GO:0014069; GO:0017124; GO:0033081; GO:0035264; GO:0042129; GO:0043025; GO:0045742; GO:0046579; GO:0046982; GO:0048011; GO:0048514; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:2000973	B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; heart trabecula morphogenesis [GO:0061384]; lymphocyte homeostasis [GO:0002260]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; small GTPase mediated signal transduction [GO:0007264]; vitellogenesis [GO:0007296]		NA	NA	NA	NA	NA	NA
TRINITY_DN10_c0_g1_i1	Q07890	SOS2_HUMAN	62.2	90	34	0	1	270	134	223	5.70E-24	111.7	SOS2_HUMAN	reviewed	Son of sevenless homolog 2 (SOS-2)	SOS2	Homo sapiens (Human)	1332	cytosol [GO:0005829]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0005085; GO:0005829; GO:0007186; GO:0007264; GO:0043065; GO:0046982; GO:0051056; GO:0051057	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN10681_c0_g1_i2	Q07890	SOS2_HUMAN	51.9	183	81	3	677	138	422	600	1.40E-50	201.1	SOS2_HUMAN	reviewed	Son of sevenless homolog 2 (SOS-2)	SOS2	Homo sapiens (Human)	1332	cytosol [GO:0005829]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0005085; GO:0005829; GO:0007186; GO:0007264; GO:0043065; GO:0046982; GO:0051056; GO:0051057	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN10681_c0_g1_i3	Q07890	SOS2_HUMAN	54.5	88	35	2	317	57	422	505	9.60E-23	107.5	SOS2_HUMAN	reviewed	Son of sevenless homolog 2 (SOS-2)	SOS2	Homo sapiens (Human)	1332	cytosol [GO:0005829]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0005085; GO:0005829; GO:0007186; GO:0007264; GO:0043065; GO:0046982; GO:0051056; GO:0051057	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN10681_c0_g1_i4	Q07890	SOS2_HUMAN	56.3	213	86	3	630	1	422	630	3.70E-66	252.7	SOS2_HUMAN	reviewed	Son of sevenless homolog 2 (SOS-2)	SOS2	Homo sapiens (Human)	1332	cytosol [GO:0005829]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]	GO:0003677; GO:0005085; GO:0005829; GO:0007186; GO:0007264; GO:0043065; GO:0046982; GO:0051056; GO:0051057	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i4	Q62417	SRBS1_MOUSE	36.5	447	241	14	194	1474	863	1286	2.80E-59	231.1	SRBS1_MOUSE	reviewed	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	Sorbs1 Kiaa1296 Sh3d5	Mus musculus (Mouse)	1290	adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149]	adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]	insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	GO:0001725; GO:0005158; GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005899; GO:0005912; GO:0005925; GO:0008134; GO:0008286; GO:0016020; GO:0016363; GO:0019901; GO:0030055; GO:0030159; GO:0031625; GO:0032869; GO:0043149; GO:0045121; GO:0045202; GO:0045725; GO:0046326; GO:0046628; GO:0046889; GO:0048041; GO:0095500; GO:1903078; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i1	O35413	SRBS2_RAT	47.6	166	66	4	69	560	1050	1196	7.90E-32	138.7	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i10	O35413	SRBS2_RAT	47.9	163	64	4	103	585	1053	1196	2.80E-32	140.2	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i2	O35413	SRBS2_RAT	57	93	27	2	217	462	1106	1196	3.10E-21	103.2	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i2	O35413	SRBS2_RAT	54.5	44	18	1	69	194	1050	1093	1.70E-06	54.3	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i3	O35413	SRBS2_RAT	54.5	99	32	2	150	413	1100	1196	1.10E-20	101.3	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i6	O35413	SRBS2_RAT	57.8	90	25	2	79	315	1109	1196	5.10E-21	102.1	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i7	O35413	SRBS2_RAT	47.5	263	111	6	785	1549	953	1196	3.00E-59	231.1	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i8	O35413	SRBS2_RAT	47.5	263	111	6	575	1339	953	1196	2.60E-59	231.1	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN671_c1_g1_i9	O35413	SRBS2_RAT	47.5	263	111	6	358	1122	953	1196	2.20E-59	231.1	SRBS2_RAT	reviewed	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin)	Sorbs2 Argbp2	Rattus norvegicus (Rat)	1196	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0014069; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393	acetylcholine receptor signaling pathway [GO:0095500]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]		NA	NA	NA	NA	NA	NA
TRINITY_DN2797_c0_g1_i1	Q58D31	DHSO_BOVIN	63	349	127	1	74	1120	3	349	1.20E-131	471.1	DHSO_BOVIN	reviewed	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)	SORD	Bos taurus (Bovine)	356	mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062]	mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]	D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; zinc ion binding [GO:0008270]	GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526	flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062]		blue	blue	NA	NA	NA	NA
TRINITY_DN8881_c0_g1_i2	Q4R639	DHSO_MACFA	46.2	266	140	2	883	86	88	350	4.30E-63	243	DHSO_MACFA	reviewed	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)	SORD QtsA-19202	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	357	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; L-xylitol catabolic process [GO:0051160]; sorbitol catabolic process [GO:0006062]	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]	D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]	GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0051160; GO:0051287; GO:0070062	flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; L-xylitol catabolic process [GO:0051160]; sorbitol catabolic process [GO:0006062]		NA	NA	NA	NA	NA	NA
TRINITY_DN2797_c0_g1_i2	P0DMQ6	DHSO_CHICK	70.5	139	41	0	74	490	2	140	3.80E-54	212.6	DHSO_CHICK	reviewed	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	SORD	Gallus gallus (Chicken)	355	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]		NA	NA	NA	NA	NA	NA
TRINITY_DN8881_c0_g1_i1	P0DMQ6	DHSO_CHICK	46.8	346	181	2	1123	86	6	348	2.40E-84	313.9	DHSO_CHICK	reviewed	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	SORD	Gallus gallus (Chicken)	355	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]		NA	NA	NA	NA	NA	NA
TRINITY_DN29430_c0_g1_i1	P0DMQ6	DHSO_CHICK	67.9	56	18	0	209	42	32	87	1.20E-15	83.6	DHSO_CHICK	reviewed	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	SORD	Gallus gallus (Chicken)	355	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]		brown	brown	NA	NA	NA	NA
TRINITY_DN39290_c0_g1_i1	Q9FJ95	DHSO_ARATH	59.5	126	51	0	401	24	51	176	1.30E-45	183.7	DHSO_ARATH	reviewed	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)	SDH At5g51970 MSG15.7	Arabidopsis thaliana (Mouse-ear cress)	364	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; plastid [GO:0009536]; D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; ribitol 2-dehydrogenase activity [GO:0050255]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; plastid [GO:0009536]	D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; ribitol 2-dehydrogenase activity [GO:0050255]; zinc ion binding [GO:0008270]	GO:0003939; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0009506; GO:0009536; GO:0031966; GO:0046526; GO:0050255			NA	NA	NA	NA	NA	NA
TRINITY_DN30314_c0_g1_i1	Q95209	SORL_RABIT	95.6	158	7	0	475	2	1078	1235	9.40E-91	334	SORL_RABIT	reviewed	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA)	SORL1	Oryctolagus cuniculus (Rabbit)	2213	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]; adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; protein targeting [GO:0006605]; regulation of smooth muscle cell migration [GO:0014910]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]		GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0046628; GO:0055038; GO:1904179; GO:1990845	adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; protein targeting [GO:0006605]; regulation of smooth muscle cell migration [GO:0014910]		NA	NA	NA	NA	NA	NA
TRINITY_DN4179_c0_g1_i4	Q98930	SORL_CHICK	33.9	109	57	4	695	408	1105	1211	4.10E-06	53.9	SORL_CHICK	reviewed	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) (Fragment)	SORL1	Gallus gallus (Chicken)	1592	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]		GO:0000139; GO:0005576; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0016021; GO:0030658; GO:0031901; GO:0032585; GO:0045053; GO:0055038	endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN14908_c0_g1_i2	Q98930	SORL_CHICK	28.9	201	112	7	1021	482	1099	1289	1.60E-12	76.3	SORL_CHICK	reviewed	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) (Fragment)	SORL1	Gallus gallus (Chicken)	1592	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]		GO:0000139; GO:0005576; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0016021; GO:0030658; GO:0031901; GO:0032585; GO:0045053; GO:0055038	endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN14908_c0_g1_i3	Q98930	SORL_CHICK	25.1	342	213	13	1096	131	1032	1350	2.00E-18	95.9	SORL_CHICK	reviewed	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) (Fragment)	SORL1	Gallus gallus (Chicken)	1592	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]		GO:0000139; GO:0005576; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0016021; GO:0030658; GO:0031901; GO:0032585; GO:0045053; GO:0055038	endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN32974_c0_g1_i1	P0DSP1	SORL_RAT	25.3	395	247	14	198	1310	1845	2215	3.50E-13	77.8	SORL_RAT	reviewed	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA)	Sorl1	Rattus norvegicus (Rat)	2215	cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; transmembrane signaling receptor activity [GO:0004888]; adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]	cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; transmembrane signaling receptor activity [GO:0004888]	GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0008283; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0016477; GO:0030169; GO:0030306; GO:0030514; GO:0030658; GO:0031333; GO:0031901; GO:0031985; GO:0032091; GO:0032585; GO:0034067; GO:0038020; GO:0042923; GO:0043025; GO:0043407; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0051604; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137	adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]		NA	NA	NA	NA	NA	NA
TRINITY_DN2027_c0_g1_i2	Q2HJ55	SAM50_BOVIN	44.1	392	215	4	1175	3	47	435	1.50E-89	331.3	SAM50_BOVIN	reviewed	Sorting and assembly machinery component 50 homolog	SAMM50	Bos taurus (Bovine)	469	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]; cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]		GO:0001401; GO:0016021; GO:0033108; GO:0034622; GO:0042407; GO:0045040; GO:0065003	cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein-containing complex assembly [GO:0065003]; protein insertion into mitochondrial outer membrane [GO:0045040]		NA	NA	NA	NA	NA	NA
TRINITY_DN2027_c0_g1_i3	Q2HJ55	SAM50_BOVIN	42.5	200	103	3	635	36	47	234	1.20E-35	151.4	SAM50_BOVIN	reviewed	Sorting and assembly machinery component 50 homolog	SAMM50	Bos taurus (Bovine)	469	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]; cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein-containing complex assembly [GO:0065003]	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]		GO:0001401; GO:0016021; GO:0033108; GO:0034622; GO:0042407; GO:0045040; GO:0065003	cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein-containing complex assembly [GO:0065003]; protein insertion into mitochondrial outer membrane [GO:0045040]		NA	NA	NA	NA	NA	NA
TRINITY_DN28808_c0_g1_i1	Q13596	SNX1_HUMAN	98	149	3	0	449	3	131	279	3.30E-77	288.9	SNX1_HUMAN	reviewed	Sorting nexin-1	SNX1	Homo sapiens (Human)	522	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; vesicle [GO:0031982]"	cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]	GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031623; GO:0031901; GO:0031982; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0043231; GO:0045296; GO:0045732; GO:0046982; GO:0072673; GO:1990459; GO:1990460	"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33724_c0_g1_i1	Q5PNP1	SNX14_DANRE	34.4	450	260	11	1393	77	495	920	1.50E-56	221.9	SNX14_DANRE	reviewed	Sorting nexin-14	snx14	Danio rerio (Zebrafish) (Brachydanio rerio)	934	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902]"	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]"	GO:0005764; GO:0005765; GO:0005770; GO:0006914; GO:0016021; GO:0021680; GO:0030425; GO:0030902; GO:0031902; GO:0080025; GO:0097352	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902]		NA	NA	NA	NA	NA	NA
TRINITY_DN7425_c0_g1_i1	Q8C080	SNX16_MOUSE	45.8	168	73	3	448	900	112	278	1.20E-31	139	SNX16_MOUSE	reviewed	Sorting nexin-16	Snx16	Mus musculus (Mouse)	344	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0043231; GO:0045022	early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN7425_c0_g1_i2	Q8C080	SNX16_MOUSE	48.8	168	82	2	448	942	112	278	2.90E-36	154.5	SNX16_MOUSE	reviewed	Sorting nexin-16	Snx16	Mus musculus (Mouse)	344	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0043231; GO:0045022	early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN7425_c0_g1_i3	Q8C080	SNX16_MOUSE	57.3	89	37	1	448	714	112	199	4.40E-24	113.2	SNX16_MOUSE	reviewed	Sorting nexin-16	Snx16	Mus musculus (Mouse)	344	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0043231; GO:0045022	early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN7425_c0_g1_i5	Q8C080	SNX16_MOUSE	48.8	168	82	2	448	942	112	278	2.40E-36	154.5	SNX16_MOUSE	reviewed	Sorting nexin-16	Snx16	Mus musculus (Mouse)	344	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0043231; GO:0045022	early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]		NA	NA	NA	NA	NA	NA
TRINITY_DN37939_c0_g1_i1	Q5EA77	SNX17_BOVIN	100	64	0	0	29	220	1	64	1.70E-31	136	SNX17_BOVIN	reviewed	Sorting nexin-17	SNX17	Bos taurus (Bovine)	470	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; protein-containing complex [GO:0032991]	low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]	GO:0001822; GO:0003279; GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0030659; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0050750; GO:0060976; GO:1990126	"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21089_c0_g1_i1	Q15036	SNX17_HUMAN	100	69	0	0	2	208	188	256	3.30E-32	138.3	SNX17_HUMAN	reviewed	Sorting nexin-17	SNX17 KIAA0064	Homo sapiens (Human)	470	"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	GO:0001822; GO:0003279; GO:0005102; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006707; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0016020; GO:0016197; GO:0030100; GO:0030659; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0043231; GO:0050750; GO:0060976; GO:1990126	"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21089_c0_g1_i2	Q8BVL3	SNX17_MOUSE	100	78	0	0	2	235	188	265	3.00E-37	155.2	SNX17_MOUSE	reviewed	Sorting nexin-17	Snx17	Mus musculus (Mouse)	470	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]	GO:0001822; GO:0003279; GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0030659; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0043231; GO:0050750; GO:0060976; GO:1990126	"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36265_c0_g1_i1	Q15036	SNX17_HUMAN	100	135	0	0	405	1	271	405	1.40E-71	270	SNX17_HUMAN	reviewed	Sorting nexin-17	SNX17 KIAA0064	Homo sapiens (Human)	470	"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	GO:0001822; GO:0003279; GO:0005102; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006707; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0016020; GO:0016197; GO:0030100; GO:0030659; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0043231; GO:0050750; GO:0060976; GO:1990126	"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1905_c0_g1_i1	Q5RID7	SNX17_DANRE	51.3	261	123	3	99	875	1	259	4.30E-71	269.6	SNX17_DANRE	reviewed	Sorting nexin-17	snx17 si:ch211-101l18.2	Danio rerio (Zebrafish) (Brachydanio rerio)	473	"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]	phosphatidylinositol binding [GO:0035091]	GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0030659; GO:0031410; GO:0035091; GO:1990126	"intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1905_c0_g1_i2	Q5RID7	SNX17_DANRE	50.7	410	193	6	99	1316	1	405	3.50E-116	420.2	SNX17_DANRE	reviewed	Sorting nexin-17	snx17 si:ch211-101l18.2	Danio rerio (Zebrafish) (Brachydanio rerio)	473	"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]	phosphatidylinositol binding [GO:0035091]	GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0030659; GO:0031410; GO:0035091; GO:1990126	"intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29738_c0_g1_i1	Q9CWK8	SNX2_MOUSE	94.4	54	3	0	217	56	466	519	1.10E-20	100.1	SNX2_MOUSE	reviewed	Sorting nexin-2	Snx2	Mus musculus (Mouse)	519	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]"	epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]	GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0046982; GO:0072673; GO:1990459; GO:1990460	"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18802_c0_g1_i1	Q2TBW7	SNX2_BOVIN	100	85	0	0	1	255	196	280	8.20E-41	167.2	SNX2_BOVIN	reviewed	Sorting nexin-2	SNX2	Bos taurus (Bovine)	519	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; retromer complex [GO:0030904]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; retromer complex [GO:0030904]	phosphatidylinositol binding [GO:0035091]	GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0030027; GO:0030904; GO:0031901; GO:0035091; GO:0042147; GO:0072673	"endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39451_c0_g1_i1	Q2TBW7	SNX2_BOVIN	99.1	108	1	0	325	2	173	280	2.40E-53	209.1	SNX2_BOVIN	reviewed	Sorting nexin-2	SNX2	Bos taurus (Bovine)	519	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; retromer complex [GO:0030904]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; retromer complex [GO:0030904]	phosphatidylinositol binding [GO:0035091]	GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0030027; GO:0030904; GO:0031901; GO:0035091; GO:0042147; GO:0072673	"endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN807_c0_g1_i1	O60749	SNX2_HUMAN	55	398	174	3	1272	82	126	519	5.00E-113	409.5	SNX2_HUMAN	reviewed	Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9)	SNX2 TRG9	Homo sapiens (Human)	519	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]"	cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]	GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460	"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"		blue	blue	NA	NA	NA	NA
TRINITY_DN35170_c0_g1_i1	O60749	SNX2_HUMAN	100	68	0	0	205	2	275	342	1.40E-30	132.9	SNX2_HUMAN	reviewed	Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9)	SNX2 TRG9	Homo sapiens (Human)	519	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]"	cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]	GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460	"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8847_c0_g1_i1	Q9H3E2	SNX25_HUMAN	39	123	68	2	385	20	660	776	6.60E-18	91.7	SNX25_HUMAN	reviewed	Sorting nexin-25	SNX25 MSTP043	Homo sapiens (Human)	840	endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]	endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]	phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]	GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091; GO:0043231; GO:0060394	negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]		NA	NA	NA	NA	NA	NA
TRINITY_DN8847_c0_g1_i4	Q9H3E2	SNX25_HUMAN	40	55	33	0	172	8	768	822	2.70E-05	48.9	SNX25_HUMAN	reviewed	Sorting nexin-25	SNX25 MSTP043	Homo sapiens (Human)	840	endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]	endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]	phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]	GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091; GO:0043231; GO:0060394	negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]		NA	NA	NA	NA	NA	NA
TRINITY_DN8847_c0_g1_i5	Q9H3E2	SNX25_HUMAN	42.9	182	97	2	611	66	660	834	5.50E-35	149.1	SNX25_HUMAN	reviewed	Sorting nexin-25	SNX25 MSTP043	Homo sapiens (Human)	840	endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]	endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]	phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]	GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091; GO:0043231; GO:0060394	negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]		NA	NA	NA	NA	NA	NA
TRINITY_DN3053_c0_g1_i1	A5PKA5	SNX27_BOVIN	51.6	386	185	2	1218	64	139	523	2.90E-123	443.4	SNX27_BOVIN	reviewed	Sorting nexin-27	SNX27	Bos taurus (Bovine)	541	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; immunological synapse [GO:0001772]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; immunological synapse [GO:0001772]	phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]	GO:0001772; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0016197; GO:0031901; GO:0032266; GO:0035091; GO:1990126	"endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3053_c0_g1_i2	A5PKA5	SNX27_BOVIN	55.6	484	213	2	1512	64	41	523	5.60E-164	578.9	SNX27_BOVIN	reviewed	Sorting nexin-27	SNX27	Bos taurus (Bovine)	541	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; immunological synapse [GO:0001772]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; immunological synapse [GO:0001772]	phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]	GO:0001772; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0016197; GO:0031901; GO:0032266; GO:0035091; GO:1990126	"endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3338_c0_g2_i2	Q08DX0	SNX29_BOVIN	42	338	167	3	18	986	465	788	3.60E-64	246.9	SNX29_BOVIN	reviewed	Sorting nexin-29	SNX29	Bos taurus (Bovine)	817	phosphatidylinositol binding [GO:0035091]		phosphatidylinositol binding [GO:0035091]	GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN3338_c0_g2_i3	Q08DX0	SNX29_BOVIN	42.1	309	150	3	18	899	465	759	9.70E-58	225.3	SNX29_BOVIN	reviewed	Sorting nexin-29	SNX29	Bos taurus (Bovine)	817	phosphatidylinositol binding [GO:0035091]		phosphatidylinositol binding [GO:0035091]	GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN11790_c2_g1_i1	Q8TEQ0	SNX29_HUMAN	51.6	190	74	4	1328	771	9	184	3.40E-48	194.1	SNX29_HUMAN	reviewed	Sorting nexin-29 (RUN domain-containing protein 2A)	SNX29 RUNDC2A	Homo sapiens (Human)	813	phosphatidylinositol binding [GO:0035091]		phosphatidylinositol binding [GO:0035091]	GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN11790_c2_g1_i3	Q8TEQ0	SNX29_HUMAN	51.6	190	74	4	1474	917	9	184	3.80E-48	194.1	SNX29_HUMAN	reviewed	Sorting nexin-29 (RUN domain-containing protein 2A)	SNX29 RUNDC2A	Homo sapiens (Human)	813	phosphatidylinositol binding [GO:0035091]		phosphatidylinositol binding [GO:0035091]	GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN3157_c0_g1_i1	Q4VAA7	SNX33_MOUSE	43	300	170	1	946	47	266	564	1.10E-69	265	SNX33_MOUSE	reviewed	Sorting nexin-33 (SH3 and PX domain-containing protein 3)	Snx33 Sh3px3	Mus musculus (Mouse)	574	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0000281; GO:0005829; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0019898; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010	cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]		NA	NA	NA	NA	NA	NA
TRINITY_DN3157_c0_g1_i2	Q4VAA7	SNX33_MOUSE	42.3	307	176	1	976	56	266	571	7.70E-71	268.9	SNX33_MOUSE	reviewed	Sorting nexin-33 (SH3 and PX domain-containing protein 3)	Snx33 Sh3px3	Mus musculus (Mouse)	574	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0000281; GO:0005829; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0019898; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010	cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038]		NA	NA	NA	NA	NA	NA
TRINITY_DN15414_c0_g1_i1	Q9Y5X3	SNX5_HUMAN	100	245	0	0	2	736	8	252	4.60E-137	488.4	SNX5_HUMAN	reviewed	Sorting nexin-5	SNX5	Homo sapiens (Human)	404	"brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; ruffle [GO:0001726]; tubular endosome [GO:0097422]"	"cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]"	GO:0001726; GO:0001891; GO:0005768; GO:0005829; GO:0005903; GO:0006886; GO:0006907; GO:0007174; GO:0010314; GO:0016241; GO:0030659; GO:0030904; GO:0030905; GO:0031234; GO:0031313; GO:0031748; GO:0031901; GO:0034452; GO:0035091; GO:0035815; GO:0042147; GO:0043231; GO:0045296; GO:0045776; GO:0045893; GO:0046628; GO:0048471; GO:0070273; GO:0070685; GO:0080025; GO:0097422	"epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38221_c0_g1_i1	Q9Y5X3	SNX5_HUMAN	100	79	0	0	237	1	318	396	2.10E-35	149.1	SNX5_HUMAN	reviewed	Sorting nexin-5	SNX5	Homo sapiens (Human)	404	"brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; ruffle [GO:0001726]; tubular endosome [GO:0097422]"	"cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]"	GO:0001726; GO:0001891; GO:0005768; GO:0005829; GO:0005903; GO:0006886; GO:0006907; GO:0007174; GO:0010314; GO:0016241; GO:0030659; GO:0030904; GO:0030905; GO:0031234; GO:0031313; GO:0031748; GO:0031901; GO:0034452; GO:0035091; GO:0035815; GO:0042147; GO:0043231; GO:0045296; GO:0045776; GO:0045893; GO:0046628; GO:0048471; GO:0070273; GO:0070685; GO:0080025; GO:0097422	"epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38315_c0_g1_i1	Q9Y5X3	SNX5_HUMAN	100	92	0	0	276	1	236	327	1.30E-44	179.9	SNX5_HUMAN	reviewed	Sorting nexin-5	SNX5	Homo sapiens (Human)	404	"brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; ruffle [GO:0001726]; tubular endosome [GO:0097422]"	"cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylinositol binding [GO:0035091]"	GO:0001726; GO:0001891; GO:0005768; GO:0005829; GO:0005903; GO:0006886; GO:0006907; GO:0007174; GO:0010314; GO:0016241; GO:0030659; GO:0030904; GO:0030905; GO:0031234; GO:0031313; GO:0031748; GO:0031901; GO:0034452; GO:0035091; GO:0035815; GO:0042147; GO:0043231; GO:0045296; GO:0045776; GO:0045893; GO:0046628; GO:0048471; GO:0070273; GO:0070685; GO:0080025; GO:0097422	"epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39775_c0_g1_i1	Q9UNH7	SNX6_HUMAN	100	148	0	0	474	31	259	406	9.50E-75	280.8	SNX6_HUMAN	reviewed	"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]"	SNX6	Homo sapiens (Human)	406	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646	"cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2803_c0_g1_i2	Q9UNH7	SNX6_HUMAN	71.6	134	31	3	466	77	1	131	3.20E-44	179.5	SNX6_HUMAN	reviewed	"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]"	SNX6	Homo sapiens (Human)	406	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646	"cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	1	NA	NA	1
TRINITY_DN24773_c0_g1_i1	Q9UNH7	SNX6_HUMAN	100	224	0	0	3	674	30	253	5.40E-124	444.9	SNX6_HUMAN	reviewed	"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]"	SNX6	Homo sapiens (Human)	406	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646	"cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24773_c0_g1_i2	Q9UNH7	SNX6_HUMAN	100	224	0	0	3	674	30	253	5.40E-124	444.9	SNX6_HUMAN	reviewed	"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]"	SNX6	Homo sapiens (Human)	406	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646	"cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40214_c0_g1_i1	Q9UNH7	SNX6_HUMAN	100	117	0	0	1	351	257	373	5.00E-57	221.5	SNX6_HUMAN	reviewed	"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]"	SNX6	Homo sapiens (Human)	406	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646	"cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2803_c0_g1_i1	Q9UNH7	SNX6_HUMAN	65.8	406	131	4	1303	98	1	402	1.20E-138	494.6	SNX6_HUMAN	reviewed	"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]"	SNX6	Homo sapiens (Human)	406	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer, tubulation complex [GO:0030905]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646	"cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3020_c0_g1_i1	Q96AH0	SOSB2_HUMAN	64.8	88	31	0	114	377	11	98	1.10E-28	127.5	SOSB2_HUMAN	reviewed	SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2) (SOSS-B2) (Single-stranded DNA-binding protein 2) (hSSB2)	NABP1 OBFC2A SSB2	Homo sapiens (Human)	204	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA transcription by RNA polymerase II [GO:0042795]"	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000784; GO:0003677; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0042795; GO:0070876	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN3020_c0_g1_i2	Q96AH0	SOSB2_HUMAN	64.8	88	31	0	58	321	11	98	6.90E-29	127.9	SOSB2_HUMAN	reviewed	SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2) (SOSS-B2) (Single-stranded DNA-binding protein 2) (hSSB2)	NABP1 OBFC2A SSB2	Homo sapiens (Human)	204	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA transcription by RNA polymerase II [GO:0042795]"	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000784; GO:0003677; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0042795; GO:0070876	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]; snRNA transcription by RNA polymerase II [GO:0042795]		NA	NA	NA	NA	NA	NA
TRINITY_DN25323_c0_g1_i1	P34714	SPRC_CAEEL	42.9	212	119	2	750	121	51	262	5.50E-52	206.1	SPRC_CAEEL	reviewed	SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine)	ost-1 sparc C44B12.2	Caenorhabditis elegans	264	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]	basement membrane [GO:0005604]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]	GO:0005509; GO:0005518; GO:0005604; GO:0005615; GO:0007275; GO:0048856; GO:0050840	anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN25323_c0_g1_i2	P34714	SPRC_CAEEL	44.7	123	67	1	486	121	140	262	7.20E-29	128.6	SPRC_CAEEL	reviewed	SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine)	ost-1 sparc C44B12.2	Caenorhabditis elegans	264	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]	basement membrane [GO:0005604]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]	GO:0005509; GO:0005518; GO:0005604; GO:0005615; GO:0007275; GO:0048856; GO:0050840	anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN26061_c0_g1_i1	B3P8A3	SPAST_DROER	58.7	189	77	1	27	593	480	667	1.10E-59	231.1	SPAST_DROER	reviewed	Spastin (EC 5.6.1.1)	spas GG11247	Drosophila erecta (Fruit fly)	758	centrosome [GO:0005813]; chromosome [GO:0005694]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; adult locomotory behavior [GO:0008344]; cell division [GO:0051301]; hemocyte migration [GO:0035099]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle elongation [GO:0000022]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein hexamerization [GO:0034214]; regulation of terminal button organization [GO:2000331]	centrosome [GO:0005813]; chromosome [GO:0005694]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000022; GO:0005524; GO:0005694; GO:0005811; GO:0005813; GO:0005819; GO:0005874; GO:0007026; GO:0007079; GO:0008017; GO:0008021; GO:0008344; GO:0008568; GO:0016021; GO:0016853; GO:0016887; GO:0031117; GO:0031594; GO:0034214; GO:0035099; GO:0043195; GO:0045834; GO:0045886; GO:0045887; GO:0048691; GO:0050775; GO:0051013; GO:0051301; GO:1900074; GO:1900075; GO:2000331	adult locomotory behavior [GO:0008344]; cell division [GO:0051301]; hemocyte migration [GO:0035099]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle elongation [GO:0000022]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; protein hexamerization [GO:0034214]; regulation of terminal button organization [GO:2000331]		NA	NA	NA	NA	NA	NA
TRINITY_DN26807_c0_g1_i1	Q5ZK92	SPAST_CHICK	63.5	189	68	1	572	6	334	521	3.10E-64	246.1	SPAST_CHICK	reviewed	Spastin (EC 5.6.1.1)	SPAST SPG4 RCJMB04_12e12	Gallus gallus (Chicken)	613	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031122; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0090148; GO:1904115	anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN35171_c0_g1_i1	Q5ZK92	SPAST_CHICK	78.6	56	12	0	170	3	431	486	1.10E-20	100.1	SPAST_CHICK	reviewed	Spastin (EC 5.6.1.1)	SPAST SPG4 RCJMB04_12e12	Gallus gallus (Chicken)	613	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031122; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0090148; GO:1904115	anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN19168_c0_g1_i1	B7PXE3	SPAST_IXOSC	63.3	120	44	0	360	1	528	647	4.70E-34	145.2	SPAST_IXOSC	reviewed	Spastin (EC 5.6.1.1)	spas ISCW020482	Ixodes scapularis (Black-legged tick) (Deer tick)	648	centrosome [GO:0005813]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0016021; GO:0016853; GO:0016887; GO:0031117; GO:0031122; GO:0034214; GO:0051013	cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]		NA	NA	NA	NA	NA	NA
TRINITY_DN34026_c0_g1_i1	Q9UBP0	SPAST_HUMAN	100	82	0	0	1	246	480	561	2.80E-38	158.7	SPAST_HUMAN	reviewed	Spastin (EC 5.6.1.1) (Spastic paraplegia 4 protein)	SPAST ADPSP FSP2 KIAA1083 SPG4	Homo sapiens (Human)	616	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]	GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005811; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031122; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0044877; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0061640; GO:0070062; GO:0071782; GO:0090148; GO:1904115	anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]		NA	NA	NA	NA	NA	NA
TRINITY_DN7529_c0_g2_i1	A9JTS5	STPAP_XENTR	24.3	535	328	12	1760	333	26	542	2.10E-32	142.1	STPAP_XENTR	reviewed	Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52)	tut1 rbm21	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	843	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]	GO:0003723; GO:0003730; GO:0004652; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006378; GO:0006397; GO:0016180; GO:0016607; GO:0016779; GO:0046872; GO:0050265; GO:0098789	mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180]		NA	NA	NA	NA	NA	NA
TRINITY_DN30095_c0_g1_i1	P13395	SPTCA_DROME	86.7	90	12	0	3	272	30	119	5.80E-37	154.5	SPTCA_DROME	reviewed	Spectrin alpha chain	alpha-Spec SPEC-A CG1977	Drosophila melanogaster (Fruit fly)	2415	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]	GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051693	actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN8331_c0_g1_i1	P13395	SPTCA_DROME	77.8	216	48	0	648	1	332	547	3.40E-91	335.9	SPTCA_DROME	reviewed	Spectrin alpha chain	alpha-Spec SPEC-A CG1977	Drosophila melanogaster (Fruit fly)	2415	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]	GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051693	actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN753_c0_g2_i1	P13395	SPTCA_DROME	78.6	112	24	0	4	339	1219	1330	1.50E-44	180.3	SPTCA_DROME	reviewed	Spectrin alpha chain	alpha-Spec SPEC-A CG1977	Drosophila melanogaster (Fruit fly)	2415	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]	GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051693	actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN753_c0_g2_i2	P13395	SPTCA_DROME	78.7	1195	254	0	4	3588	1219	2413	0	1856.3	SPTCA_DROME	reviewed	Spectrin alpha chain	alpha-Spec SPEC-A CG1977	Drosophila melanogaster (Fruit fly)	2415	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]	GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051693	actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN39522_c0_g1_i1	P13395	SPTCA_DROME	74.6	67	17	0	202	2	682	748	2.80E-23	108.6	SPTCA_DROME	reviewed	Spectrin alpha chain	alpha-Spec SPEC-A CG1977	Drosophila melanogaster (Fruit fly)	2415	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrosome [GO:0045170]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]	GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005856; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051693	actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN29182_c0_g1_i1	Q13813	SPTN1_HUMAN	100	69	0	0	207	1	1410	1478	6.00E-34	144.1	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN37491_c0_g1_i1	Q13813	SPTN1_HUMAN	100	113	0	0	2	340	441	553	5.40E-56	218	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN29923_c0_g1_i1	Q13813	SPTN1_HUMAN	100	100	0	0	302	3	1316	1415	1.60E-51	203	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN37130_c0_g1_i1	Q13813	SPTN1_HUMAN	100	81	0	0	243	1	1988	2068	3.60E-38	158.3	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN18629_c0_g1_i1	Q13813	SPTN1_HUMAN	98.2	334	0	1	1	984	2128	2461	1.20E-180	633.6	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN32537_c0_g1_i1	Q13813	SPTN1_HUMAN	66.7	78	26	0	236	3	755	832	7.20E-23	107.5	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN31848_c0_g1_i1	Q13813	SPTN1_HUMAN	100	71	0	0	215	3	1689	1759	1.40E-30	132.9	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN39444_c0_g1_i1	Q13813	SPTN1_HUMAN	97	164	0	1	492	1	1476	1634	4.60E-80	298.5	SPTN1_HUMAN	reviewed	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	2472	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN692_c0_g1_i2	Q00963	SPTCB_DROME	73.3	2048	543	3	6164	24	44	2089	0	2984.9	SPTCB_DROME	reviewed	Spectrin beta chain	beta-Spec Spec-b CG5870	Drosophila melanogaster (Fruit fly)	2291	"axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]"	axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]	"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]"	GO:0003779; GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030424; GO:0030506; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0048790; GO:0050807; GO:0051693; GO:0072499; GO:1903729	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN692_c0_g1_i3	Q00963	SPTCB_DROME	73.5	2048	540	3	6191	51	44	2089	0	2991.4	SPTCB_DROME	reviewed	Spectrin beta chain	beta-Spec Spec-b CG5870	Drosophila melanogaster (Fruit fly)	2291	"axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]"	axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]	"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]"	GO:0003779; GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030424; GO:0030506; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0048790; GO:0050807; GO:0051693; GO:0072499; GO:1903729	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN9771_c0_g1_i1	Q00963	SPTCB_DROME	54.2	155	69	2	558	94	2139	2291	4.20E-38	159.5	SPTCB_DROME	reviewed	Spectrin beta chain	beta-Spec Spec-b CG5870	Drosophila melanogaster (Fruit fly)	2291	"axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]"	axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]	"actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]"	GO:0003779; GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030424; GO:0030506; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0048790; GO:0050807; GO:0051693; GO:0072499; GO:1903729	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN3828_c0_g1_i1	P11277	SPTB1_HUMAN	42.9	140	74	2	402	1	105	244	3.10E-26	119.4	SPTB1_HUMAN	reviewed	"Spectrin beta chain, erythrocytic (Beta-I spectrin)"	SPTB SPTB1	Homo sapiens (Human)	2137	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0003779; GO:0005200; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0009986; GO:0014731; GO:0015629; GO:0030506; GO:0031235; GO:0032991; GO:0051015; GO:0051693	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]		NA	NA	NA	NA	NA	NA
TRINITY_DN22397_c0_g1_i2	Q62261	SPTB2_MOUSE	97.8	92	2	0	279	4	852	943	2.10E-45	182.6	SPTB2_MOUSE	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain)"	Sptbn1 Elf Spnb-2 Spnb2 Sptb2	Mus musculus (Mouse)	2363	axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0007009; GO:0007182; GO:0008091; GO:0012505; GO:0014069; GO:0016020; GO:0030506; GO:0030673; GO:0030863; GO:0031430; GO:0032437; GO:0032743; GO:0032991; GO:0043001; GO:0044877; GO:0051020; GO:0051693; GO:0060390; GO:0071709; GO:0072659; GO:0098794; GO:0098978; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN21294_c0_g1_i1	Q62261	SPTB2_MOUSE	97.9	94	2	0	3	284	540	633	2.50E-46	185.7	SPTB2_MOUSE	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain)"	Sptbn1 Elf Spnb-2 Spnb2 Sptb2	Mus musculus (Mouse)	2363	axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0007009; GO:0007182; GO:0008091; GO:0012505; GO:0014069; GO:0016020; GO:0030506; GO:0030673; GO:0030863; GO:0031430; GO:0032437; GO:0032743; GO:0032991; GO:0043001; GO:0044877; GO:0051020; GO:0051693; GO:0060390; GO:0071709; GO:0072659; GO:0098794; GO:0098978; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN40617_c0_g1_i1	Q01082	SPTB2_HUMAN	100	67	0	0	202	2	1247	1313	2.10E-31	135.6	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN26447_c0_g1_i1	Q01082	SPTB2_HUMAN	100	78	0	0	236	3	1153	1230	6.60E-37	154.1	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN20564_c0_g1_i1	Q01082	SPTB2_HUMAN	99.1	223	2	0	1	669	1623	1845	5.50E-121	434.9	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN13788_c0_g1_i1	Q01082	SPTB2_HUMAN	100	83	0	0	252	4	78	160	3.30E-42	171.8	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN13788_c0_g1_i2	Q01082	SPTB2_HUMAN	100	83	0	0	252	4	78	160	3.30E-42	171.8	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN36636_c0_g1_i1	Q01082	SPTB2_HUMAN	100	101	0	0	1	303	179	279	6.30E-56	217.6	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN22397_c0_g1_i1	Q01082	SPTB2_HUMAN	100	76	0	0	229	2	852	927	1.70E-37	156	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN33775_c0_g1_i1	Q01082	SPTB2_HUMAN	100	70	0	0	210	1	1982	2051	8.00E-34	143.7	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN25060_c0_g1_i1	Q01082	SPTB2_HUMAN	98.6	69	1	0	208	2	457	525	1.70E-28	125.9	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN33373_c0_g1_i1	Q01082	SPTB2_HUMAN	100	119	0	0	358	2	612	730	3.70E-63	241.9	SPTB2_HUMAN	reviewed	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	2364	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032743; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1903076; GO:1903078	actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]		NA	NA	NA	NA	NA	NA
TRINITY_DN14976_c0_g1_i1	Q9PU13	SPD1A_XENLA	55.2	58	26	0	210	37	121	178	1.80E-14	79.7	SPD1A_XENLA	reviewed	Speedy protein 1-A (Spy1-A) (Protein Ls26) (Rapid inducer of G2/M progression in oocytes A) (RINGO-A) (XSpy1-A) (p33 ringo-A) (xRINGO-A)	spdya-a ls26 spdy1	Xenopus laevis (African clawed frog)	299	nucleus [GO:0005634]; cyclin binding [GO:0030332]; protein kinase binding [GO:0019901]; activation of MAPK activity [GO:0000187]; G2/MI transition of meiotic cell cycle [GO:0008315]; mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of meiotic cell cycle [GO:0051446]	nucleus [GO:0005634]	cyclin binding [GO:0030332]; protein kinase binding [GO:0019901]	GO:0000187; GO:0001556; GO:0005634; GO:0006378; GO:0007275; GO:0008315; GO:0019901; GO:0030332; GO:0045737; GO:0051446	activation of MAPK activity [GO:0000187]; G2/MI transition of meiotic cell cycle [GO:0008315]; mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of meiotic cell cycle [GO:0051446]		blue	blue	NA	NA	NA	NA
TRINITY_DN35458_c0_g1_i1	P16065	GCY_STRPU	57.9	57	24	0	173	3	849	905	1.00E-10	67	GCY_STRPU	reviewed	Speract receptor (EC 4.6.1.2) (Guanylate cyclase)		Strongylocentrotus purpuratus (Purple sea urchin)	1125	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0016021; GO:0035556	cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i1	Q26627	SUREJ_STRPU	31.3	134	83	4	229	615	201	330	5.30E-10	67	SUREJ_STRPU	reviewed	Sperm receptor for egg jelly (suREJ)	REJ	Strongylocentrotus purpuratus (Purple sea urchin)	1450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]	GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0050982	detection of mechanical stimulus [GO:0050982]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i12	Q26627	SUREJ_STRPU	33.3	108	65	3	229	543	201	304	8.70E-09	62	SUREJ_STRPU	reviewed	Sperm receptor for egg jelly (suREJ)	REJ	Strongylocentrotus purpuratus (Purple sea urchin)	1450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]	GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0050982	detection of mechanical stimulus [GO:0050982]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i3	Q26627	SUREJ_STRPU	31.3	134	83	4	229	615	201	330	4.10E-10	67.4	SUREJ_STRPU	reviewed	Sperm receptor for egg jelly (suREJ)	REJ	Strongylocentrotus purpuratus (Purple sea urchin)	1450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]	GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0050982	detection of mechanical stimulus [GO:0050982]		blue	blue	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i8	Q26627	SUREJ_STRPU	31.3	134	83	4	229	615	201	330	3.50E-10	67.4	SUREJ_STRPU	reviewed	Sperm receptor for egg jelly (suREJ)	REJ	Strongylocentrotus purpuratus (Purple sea urchin)	1450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]	GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0050982	detection of mechanical stimulus [GO:0050982]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i9	Q26627	SUREJ_STRPU	31.3	134	83	4	229	615	201	330	5.30E-10	67	SUREJ_STRPU	reviewed	Sperm receptor for egg jelly (suREJ)	REJ	Strongylocentrotus purpuratus (Purple sea urchin)	1450	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]	GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0050982	detection of mechanical stimulus [GO:0050982]		NA	NA	NA	NA	NA	NA
TRINITY_DN4739_c0_g1_i1	Q7TNE3	SPAG7_MOUSE	41.9	222	122	4	714	64	3	222	2.00E-37	157.5	SPAG7_MOUSE	reviewed	Sperm-associated antigen 7	Spag7	Mus musculus (Mouse)	227	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN33168_c0_g1_i1	O75391	SPAG7_HUMAN	100	87	0	0	262	2	60	146	2.60E-42	172.2	SPAG7_HUMAN	reviewed	Sperm-associated antigen 7	SPAG7	Homo sapiens (Human)	227	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN33161_c0_g1_i1	Q96SI9	STRBP_HUMAN	100	152	0	0	3	458	160	311	3.00E-86	318.9	STRBP_HUMAN	reviewed	Spermatid perinuclear RNA-binding protein	STRBP SPNR	Homo sapiens (Human)	672	cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mechanosensory behavior [GO:0007638]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0002177; GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005737; GO:0007275; GO:0007286; GO:0007638; GO:0008017	mechanosensory behavior [GO:0007638]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286]		NA	NA	NA	NA	NA	NA
TRINITY_DN5457_c0_g1_i1	Q8TB22	SPT20_HUMAN	49.5	728	355	10	2233	71	63	784	2.10E-199	697.2	SPT20_HUMAN	reviewed	Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)	SPATA20	Homo sapiens (Human)	786	extracellular region [GO:0005576]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	extracellular region [GO:0005576]		GO:0005576; GO:0005975; GO:0007275; GO:0007283; GO:0030154	carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5457_c0_g1_i3	Q8TB22	SPT20_HUMAN	48.2	706	353	10	2167	71	85	784	2.30E-185	650.6	SPT20_HUMAN	reviewed	Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)	SPATA20	Homo sapiens (Human)	786	extracellular region [GO:0005576]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	extracellular region [GO:0005576]		GO:0005576; GO:0005975; GO:0007275; GO:0007283; GO:0030154	carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5457_c0_g1_i3	Q8TB22	SPT20_HUMAN	84.6	26	4	0	2232	2155	63	88	5.50E-06	54.7	SPT20_HUMAN	reviewed	Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)	SPATA20	Homo sapiens (Human)	786	extracellular region [GO:0005576]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	extracellular region [GO:0005576]		GO:0005576; GO:0005975; GO:0007275; GO:0007283; GO:0030154	carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5457_c0_g1_i6	Q8TB22	SPT20_HUMAN	45.5	628	329	10	1933	71	163	784	3.90E-149	530	SPT20_HUMAN	reviewed	Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)	SPATA20	Homo sapiens (Human)	786	extracellular region [GO:0005576]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	extracellular region [GO:0005576]		GO:0005576; GO:0005975; GO:0007275; GO:0007283; GO:0030154	carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN27958_c0_g1_i1	Q8TB22	SPT20_HUMAN	100	67	0	0	203	3	145	211	1.40E-35	149.4	SPT20_HUMAN	reviewed	Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)	SPATA20	Homo sapiens (Human)	786	extracellular region [GO:0005576]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	extracellular region [GO:0005576]		GO:0005576; GO:0005975; GO:0007275; GO:0007283; GO:0030154	carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g1_i16	A7YSY2	SPA5L_BOVIN	50	74	37	0	86	307	502	575	3.00E-13	75.9	SPA5L_BOVIN	reviewed	Spermatogenesis-associated protein 5-like protein 1	SPATA5L1	Bos taurus (Bovine)	767	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN8256_c0_g1_i2	A7YSY2	SPA5L_BOVIN	38.1	126	78	0	85	462	450	575	3.40E-16	86.3	SPA5L_BOVIN	reviewed	Spermatogenesis-associated protein 5-like protein 1	SPATA5L1	Bos taurus (Bovine)	767	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN2046_c0_g1_i1	Q5TYV4	SPE39_DANRE	31.2	359	221	5	549	1619	149	483	1.10E-48	196.1	SPE39_DANRE	reviewed	Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)	vipas39 spe39 vipar si:ch211-20b12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	483	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007283; GO:0030154; GO:0055037; GO:0061008	cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2046_c0_g1_i3	Q5TYV4	SPE39_DANRE	31.2	359	221	5	538	1608	149	483	1.10E-48	196.1	SPE39_DANRE	reviewed	Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)	vipas39 spe39 vipar si:ch211-20b12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	483	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007283; GO:0030154; GO:0055037; GO:0061008	cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2046_c0_g1_i4	Q5TYV4	SPE39_DANRE	31.2	359	221	5	561	1631	149	483	1.10E-48	196.1	SPE39_DANRE	reviewed	Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)	vipas39 spe39 vipar si:ch211-20b12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	483	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007283; GO:0030154; GO:0055037; GO:0061008	cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2046_c0_g1_i5	Q5TYV4	SPE39_DANRE	31.2	359	221	5	550	1620	149	483	1.10E-48	196.1	SPE39_DANRE	reviewed	Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)	vipas39 spe39 vipar si:ch211-20b12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	483	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]		GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007283; GO:0030154; GO:0055037; GO:0061008	cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN25616_c0_g1_i1	Q9NWM0	SMOX_HUMAN	33.5	534	309	14	1816	314	26	546	1.80E-76	288.5	SMOX_HUMAN	reviewed	Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1)	SMOX C20orf16 SMO UNQ3039/PRO9854	Homo sapiens (Human)	555	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901	polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]		NA	NA	NA	NA	NA	NA
TRINITY_DN1308_c0_g1_i1	Q99K82	SMOX_MOUSE	31.3	533	294	13	2344	947	26	553	1.90E-57	225.7	SMOX_MOUSE	reviewed	Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1)	Smox Smo	Mus musculus (Mouse)	555	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]	GO:0005634; GO:0005654; GO:0005737; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901	polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]		NA	NA	NA	NA	NA	NA
TRINITY_DN1308_c0_g1_i2	Q99K82	SMOX_MOUSE	31.3	533	294	13	2344	947	26	553	2.00E-57	225.7	SMOX_MOUSE	reviewed	Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1)	Smox Smo	Mus musculus (Mouse)	555	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]	GO:0005634; GO:0005654; GO:0005737; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901	polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]		NA	NA	NA	NA	NA	NA
TRINITY_DN1308_c0_g1_i3	Q99K82	SMOX_MOUSE	31.3	533	294	13	3016	1619	26	553	2.50E-57	225.7	SMOX_MOUSE	reviewed	Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1)	Smox Smo	Mus musculus (Mouse)	555	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]	GO:0005634; GO:0005654; GO:0005737; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901	polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]		NA	NA	NA	NA	NA	NA
TRINITY_DN1308_c0_g1_i4	Q99K82	SMOX_MOUSE	31.3	533	294	13	3016	1619	26	553	2.40E-57	225.7	SMOX_MOUSE	reviewed	Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1)	Smox Smo	Mus musculus (Mouse)	555	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]	GO:0005634; GO:0005654; GO:0005737; GO:0006598; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901	polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]		NA	NA	NA	NA	NA	NA
TRINITY_DN4909_c1_g1_i1	Q3SZA5	SPSY_BOVIN	43.9	173	95	2	618	103	188	359	9.00E-41	168.3	SPSY_BOVIN	reviewed	Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase)	SMS	Bos taurus (Bovine)	365	spermine synthase activity [GO:0016768]; spermine biosynthetic process [GO:0006597]		spermine synthase activity [GO:0016768]	GO:0006597; GO:0016768	spermine biosynthetic process [GO:0006597]		NA	NA	NA	NA	NA	NA
TRINITY_DN4909_c1_g1_i3	Q3SZA5	SPSY_BOVIN	43.9	173	95	2	759	244	188	359	1.10E-40	168.3	SPSY_BOVIN	reviewed	Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase)	SMS	Bos taurus (Bovine)	365	spermine synthase activity [GO:0016768]; spermine biosynthetic process [GO:0006597]		spermine synthase activity [GO:0016768]	GO:0006597; GO:0016768	spermine biosynthetic process [GO:0006597]		brown	brown	NA	NA	NA	NA
TRINITY_DN8284_c0_g1_i1	P22974	H1L_MYTCA	35.8	81	52	0	86	328	40	120	2.60E-08	60.1	H1L_MYTCA	reviewed	Sperm-specific protein PHI-2B (PL-II*) (Sperm-specific linker histone H1-like protein)		Mytilus californianus (California mussel)	148	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; multicellular organism development [GO:0007275]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0007275; GO:0007283; GO:0030154; GO:0030261	cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; multicellular organism development [GO:0007275]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN11573_c1_g1_i1	Q3ZCF3	SKP1_BOVIN	73	163	43	1	90	575	1	163	2.10E-53	210.3	SKP1_BOVIN	reviewed	S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)	SKP1 SKP1A	Bos taurus (Bovine)	163	Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cullin family protein binding [GO:0097602]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cullin family protein binding [GO:0097602]	GO:0005634; GO:0005737; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0031467; GO:0097602	protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		blue	blue	NA	NA	NA	NA
TRINITY_DN5811_c0_g1_i1	Q9WTX5	SKP1_MOUSE	100	163	0	0	73	561	1	163	2.30E-62	240	SKP1_MOUSE	reviewed	S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)	Skp1 Skp1a	Mus musculus (Mouse)	163	centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]	beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008013; GO:0016567; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0031519; GO:0035518; GO:0051457; GO:0070936; GO:0097602; GO:1904668; GO:1990444; GO:1990756	histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5811_c0_g1_i2	Q3ZCF3	SKP1_BOVIN	100	163	0	0	73	561	1	163	3.10E-62	239.6	SKP1_BOVIN	reviewed	S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)	SKP1 SKP1A	Bos taurus (Bovine)	163	Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cullin family protein binding [GO:0097602]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cullin family protein binding [GO:0097602]	GO:0005634; GO:0005737; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0031467; GO:0097602	protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		NA	NA	NA	NA	NA	NA
TRINITY_DN20490_c0_g1_i1	O15121	DEGS1_HUMAN	99.6	257	1	0	771	1	51	307	3.30E-154	545.4	DEGS1_HUMAN	reviewed	Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1) (Membrane lipid desaturase)	DEGS1 DES1 MLD MIG15	Homo sapiens (Human)	323	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; electron transfer activity [GO:0009055]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; myelin maintenance [GO:0043217]; neutrophil degranulation [GO:0043312]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	electron transfer activity [GO:0009055]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]	GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006636; GO:0009055; GO:0016020; GO:0030148; GO:0031966; GO:0035579; GO:0042284; GO:0043217; GO:0043312; GO:0046513; GO:0050251	ceramide biosynthetic process [GO:0046513]; myelin maintenance [GO:0043217]; neutrophil degranulation [GO:0043312]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]		NA	NA	NA	NA	NA	NA
TRINITY_DN34706_c0_g1_i1	O09005	DEGS1_MOUSE	100	70	0	0	3	212	254	323	5.40E-38	157.5	DEGS1_MOUSE	reviewed	Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1)	Degs1 Degs Des1 Mdes	Mus musculus (Mouse)	323	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]; positive regulation of apoptotic process [GO:0043065]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]	GO:0005739; GO:0005789; GO:0006633; GO:0016021; GO:0031966; GO:0042284; GO:0043065; GO:0043217; GO:0046513; GO:0050251	ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN2890_c0_g1_i1	Q3ZBY7	DEGS1_BOVIN	57.5	318	135	0	1050	97	1	318	1.00E-114	414.8	DEGS1_BOVIN	reviewed	Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1)	DEGS1 DES1	Bos taurus (Bovine)	323	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; cis-trans isomerase activity [GO:0016859]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	cis-trans isomerase activity [GO:0016859]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]	GO:0005789; GO:0006633; GO:0016021; GO:0016859; GO:0031966; GO:0042284; GO:0043217; GO:0046513; GO:0050251	ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]		blue	blue	NA	NA	NA	NA
TRINITY_DN20490_c0_g1_i2	O09005	DEGS1_MOUSE	96.9	196	6	0	591	4	111	306	5.40E-112	404.8	DEGS1_MOUSE	reviewed	Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1)	Degs1 Degs Des1 Mdes	Mus musculus (Mouse)	323	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]; positive regulation of apoptotic process [GO:0043065]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]	GO:0005739; GO:0005789; GO:0006633; GO:0016021; GO:0031966; GO:0042284; GO:0043065; GO:0043217; GO:0046513; GO:0050251	ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN2068_c0_g1_i1	Q0VD19	ASM_BOVIN	39	531	316	6	1726	140	82	606	9.40E-113	409.1	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN2068_c0_g1_i2	Q0VD19	ASM_BOVIN	39.1	532	314	7	1726	140	82	606	9.40E-113	409.1	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN2068_c0_g1_i3	Q04519	ASM_MOUSE	43	344	188	5	1168	140	272	608	2.10E-84	314.3	ASM_MOUSE	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (ASMase)	Smpd1 Asm	Mus musculus (Mouse)	627	"endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0042220; GO:0042493; GO:0042599; GO:0043065; GO:0043407; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN16369_c0_g1_i1	Q0VD19	ASM_BOVIN	40.6	377	214	6	77	1195	237	607	1.70E-81	304.7	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN16369_c0_g1_i2	Q0VD19	ASM_BOVIN	40.2	418	240	6	112	1353	196	607	1.30E-90	335.1	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN16369_c0_g1_i3	Q0VD19	ASM_BOVIN	43	279	151	4	116	940	333	607	1.10E-62	241.9	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN16369_c0_g1_i5	Q0VD19	ASM_BOVIN	35.3	530	331	8	222	1796	85	607	2.40E-92	341.3	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN7667_c0_g1_i1	Q0VD19	ASM_BOVIN	44.8	522	281	6	554	2113	82	598	1.20E-138	495.4	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN7667_c0_g1_i11	Q0VD19	ASM_BOVIN	50.4	407	196	5	600	1814	196	598	8.60E-125	449.1	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN7667_c0_g1_i17	Q0VD19	ASM_BOVIN	44.8	522	281	6	796	2355	82	598	1.30E-138	495.4	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN7667_c0_g1_i2	Q0VD19	ASM_BOVIN	44.8	522	281	6	588	2147	82	598	1.20E-138	495.4	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN7667_c0_g1_i23	Q0VD19	ASM_BOVIN	50.4	407	196	5	634	1848	196	598	8.70E-125	449.1	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN39943_c0_g1_i1	Q04519	ASM_MOUSE	100	70	0	0	212	3	340	409	4.60E-37	154.5	ASM_MOUSE	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (ASMase)	Smpd1 Asm	Mus musculus (Mouse)	627	"endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0042220; GO:0042493; GO:0042599; GO:0043065; GO:0043407; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN5019_c1_g1_i1	Q0VD19	ASM_BOVIN	47.1	242	122	4	376	1101	368	603	6.10E-59	229.6	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN5019_c1_g1_i2	Q0VD19	ASM_BOVIN	41.6	531	300	8	271	1863	83	603	5.30E-116	419.9	ASM_BOVIN	reviewed	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	SMPD1	Bos taurus (Bovine)	625	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"	endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]"	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]		NA	NA	NA	NA	NA	NA
TRINITY_DN33247_c0_g1_i1	Q55C09	SGMA_DICDI	28.9	83	59	0	48	296	498	580	1.20E-05	51.6	SGMA_DICDI	reviewed	Sphingomyelin phosphodiesterase A (EC 3.1.4.-) (Acid sphingomyelinase A) (aSMase A)	sgmA DDB_G0270834	Dictyostelium discoideum (Slime mold)	583	"extracellular space [GO:0005615]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]"	extracellular space [GO:0005615]	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]"	GO:0004767; GO:0005615; GO:0006685; GO:0008081; GO:0016798; GO:0046513; GO:0046872	ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]		NA	NA	NA	NA	NA	NA
TRINITY_DN11671_c1_g1_i1	Q9DA37	SAMD8_MOUSE	41.4	292	157	3	15	887	99	377	1.40E-59	231.5	SAMD8_MOUSE	reviewed	Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8)	Samd8	Mus musculus (Mouse)	478	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]	GO:0002950; GO:0005783; GO:0005829; GO:0005887; GO:0006686; GO:0016021; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303	ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]		NA	NA	NA	NA	NA	NA
TRINITY_DN11671_c1_g1_i2	Q96LT4	SAMD8_HUMAN	45.2	325	158	5	15	977	36	344	3.70E-73	276.6	SAMD8_HUMAN	reviewed	Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8)	SAMD8	Homo sapiens (Human)	415	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]	GO:0002950; GO:0005783; GO:0005789; GO:0005829; GO:0005887; GO:0006686; GO:0016021; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303	ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]		NA	NA	NA	NA	NA	NA
TRINITY_DN34923_c0_g1_i1	Q8L7L1	SPHK1_ARATH	44.8	67	37	0	201	1	243	309	7.00E-11	67.4	SPHK1_ARATH	reviewed	Sphingosine kinase 1 (EC 2.7.1.91)	SPHK1 At4g21540 F18E5.160	Arabidopsis thaliana (Mouse-ear cress)	485	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plant-type vacuole membrane [GO:0009705]; vacuole [GO:0005773]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]; cellular response to abscisic acid stimulus [GO:0071215]; phosphorylation [GO:0016310]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plant-type vacuole membrane [GO:0009705]; vacuole [GO:0005773]	ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphinganine kinase activity [GO:0008481]	GO:0001727; GO:0003951; GO:0005524; GO:0005737; GO:0005773; GO:0006665; GO:0008481; GO:0009705; GO:0009737; GO:0009845; GO:0016020; GO:0016310; GO:0017050; GO:0043231; GO:0046512; GO:0071215	cellular response to abscisic acid stimulus [GO:0071215]; phosphorylation [GO:0016310]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]		NA	NA	NA	NA	NA	NA
TRINITY_DN5245_c0_g1_i1	Q9JIA7	SPHK2_MOUSE	36.4	198	120	2	221	796	56	253	3.50E-30	133.7	SPHK2_MOUSE	reviewed	Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91)	Sphk2	Mus musculus (Mouse)	617	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; nucleosomal histone binding [GO:0031493]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cytokine secretion involved in immune response [GO:0002374]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; interleukin-13 production [GO:0032616]; interleukin-6 production [GO:0032635]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; tumor necrosis factor secretion [GO:1990774]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; nucleosomal histone binding [GO:0031493]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0000786; GO:0001568; GO:0001727; GO:0002374; GO:0003951; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006665; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008284; GO:0008481; GO:0016020; GO:0016310; GO:0017050; GO:0030308; GO:0031064; GO:0031493; GO:0032616; GO:0032635; GO:0033008; GO:0038036; GO:0043065; GO:0043122; GO:0043231; GO:0043306; GO:0043977; GO:0043980; GO:0045815; GO:0046512; GO:0090037; GO:0090280; GO:1901726; GO:1903426; GO:1904628; GO:1904959; GO:1990774; GO:2000304; GO:2000617; GO:2001169	"blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cytokine secretion involved in immune response [GO:0002374]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; interleukin-13 production [GO:0032616]; interleukin-6 production [GO:0032635]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; tumor necrosis factor secretion [GO:1990774]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5245_c0_g1_i3	Q9JIA7	SPHK2_MOUSE	36.7	278	168	3	221	1030	56	333	1.50E-43	178.3	SPHK2_MOUSE	reviewed	Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91)	Sphk2	Mus musculus (Mouse)	617	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; nucleosomal histone binding [GO:0031493]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cytokine secretion involved in immune response [GO:0002374]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; interleukin-13 production [GO:0032616]; interleukin-6 production [GO:0032635]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; tumor necrosis factor secretion [GO:1990774]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; nucleosomal histone binding [GO:0031493]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0000786; GO:0001568; GO:0001727; GO:0002374; GO:0003951; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006665; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008284; GO:0008481; GO:0016020; GO:0016310; GO:0017050; GO:0030308; GO:0031064; GO:0031493; GO:0032616; GO:0032635; GO:0033008; GO:0038036; GO:0043065; GO:0043122; GO:0043231; GO:0043306; GO:0043977; GO:0043980; GO:0045815; GO:0046512; GO:0090037; GO:0090280; GO:1901726; GO:1903426; GO:1904628; GO:1904959; GO:1990774; GO:2000304; GO:2000617; GO:2001169	"blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cytokine secretion involved in immune response [GO:0002374]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; interleukin-13 production [GO:0032616]; interleukin-6 production [GO:0032635]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; tumor necrosis factor secretion [GO:1990774]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5245_c0_g1_i5	Q9JIA7	SPHK2_MOUSE	30.9	554	310	13	221	1693	56	599	4.60E-59	230.7	SPHK2_MOUSE	reviewed	Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91)	Sphk2	Mus musculus (Mouse)	617	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; nucleosomal histone binding [GO:0031493]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cytokine secretion involved in immune response [GO:0002374]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; interleukin-13 production [GO:0032616]; interleukin-6 production [GO:0032635]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; tumor necrosis factor secretion [GO:1990774]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; nucleosomal histone binding [GO:0031493]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0000786; GO:0001568; GO:0001727; GO:0002374; GO:0003951; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006665; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008284; GO:0008481; GO:0016020; GO:0016310; GO:0017050; GO:0030308; GO:0031064; GO:0031493; GO:0032616; GO:0032635; GO:0033008; GO:0038036; GO:0043065; GO:0043122; GO:0043231; GO:0043306; GO:0043977; GO:0043980; GO:0045815; GO:0046512; GO:0090037; GO:0090280; GO:1901726; GO:1903426; GO:1904628; GO:1904959; GO:1990774; GO:2000304; GO:2000617; GO:2001169	"blood vessel development [GO:0001568]; brain development [GO:0007420]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cytokine secretion involved in immune response [GO:0002374]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; interleukin-13 production [GO:0032616]; interleukin-6 production [GO:0032635]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; tumor necrosis factor secretion [GO:1990774]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9536_c0_g1_i1	Q9V7Y2	SGPL_DROME	61.3	106	41	0	324	7	330	435	1.70E-35	149.8	SGPL_DROME	reviewed	Sphingosine-1-phosphate lyase (S1PL) (SP-lyase) (SPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)	Sply Spl CG8946	Drosophila melanogaster (Fruit fly)	545	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; adult somatic muscle development [GO:0007527]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; multicellular organism development [GO:0007275]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]	GO:0001667; GO:0005783; GO:0005789; GO:0006665; GO:0007275; GO:0007527; GO:0008117; GO:0016021; GO:0016831; GO:0019752; GO:0030149; GO:0030170	adult somatic muscle development [GO:0007527]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; multicellular organism development [GO:0007275]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]		NA	NA	NA	NA	NA	NA
TRINITY_DN6867_c0_g1_i1	Q8R0X7	SGPL1_MOUSE	44.5	218	120	1	750	100	337	554	3.00E-54	213.4	SGPL1_MOUSE	reviewed	Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (mSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)	Sgpl1 Spl	Mus musculus (Mouse)	568	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]	GO:0001553; GO:0001570; GO:0001667; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006665; GO:0006672; GO:0006807; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0016021; GO:0016831; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190	ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN764_c0_g1_i1	Q9BX95	SGPP1_HUMAN	36.9	385	221	6	348	1478	70	440	4.50E-60	233.8	SGPP1_HUMAN	reviewed	Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1)	SGPP1 SPP1	Homo sapiens (Human)	441	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lipid phosphatase activity [GO:0042577]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; phospholipid dephosphorylation [GO:0046839]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	lipid phosphatase activity [GO:0042577]; sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0006668; GO:0006670; GO:0016020; GO:0016021; GO:0030148; GO:0035621; GO:0042392; GO:0042577; GO:0045616; GO:0045682; GO:0046839; GO:0097191; GO:0097193	ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; phospholipid dephosphorylation [GO:0046839]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]		NA	NA	NA	NA	NA	NA
TRINITY_DN8940_c0_g1_i1	B0BN28	SKA1_RAT	39.4	132	79	1	12	407	123	253	9.70E-22	104.8	SKA1_RAT	reviewed	Spindle and kinetochore-associated protein 1	Ska1	Rattus norvegicus (Rat)	254	condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110]	condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	microtubule binding [GO:0008017]	GO:0000278; GO:0000940; GO:0005737; GO:0005876; GO:0007059; GO:0008017; GO:0031110; GO:0051301; GO:0072686	cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN28354_c0_g1_i1	Q6FV07	IPL1_CANGA	48.5	101	51	1	5	307	199	298	2.80E-27	122.5	IPL1_CANGA	reviewed	Spindle assembly checkpoint kinase (EC 2.7.11.1) (Aurora kinase)	IPL1 CAGL0E05720g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	358	"chromosome passenger complex [GO:0032133]; condensed nuclear chromosome inner kinetochore [GO:0000941]; cytoplasm [GO:0005737]; kinetochore microtubule [GO:0005828]; meiotic spindle midzone [GO:1990385]; mitotic spindle midzone [GO:1990023]; nuclear chromosome, telomeric region [GO:0000784]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation [GO:0051316]; cellular response to nutrient [GO:0031670]; interphase mitotic telomere clustering [GO:0120110]; meiotic sister chromatid segregation [GO:0045144]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle disassembly [GO:0051228]; negative regulation of protein import into nucleus during spindle assembly checkpoint [GO:1901925]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic chromosome condensation [GO:1903380]; positive regulation of mitotic sister chromatid arm separation [GO:1905824]; positive regulation of mitotic sister chromatid biorientation [GO:0140429]; protein localization to kinetochore [GO:0034501]; protein localization to nucleolar rDNA repeats [GO:0034503]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle assembly [GO:1901673]; regulation of monopolar spindle attachment to meiosis I kinetochore [GO:1904967]"	"chromosome passenger complex [GO:0032133]; condensed nuclear chromosome inner kinetochore [GO:0000941]; cytoplasm [GO:0005737]; kinetochore microtubule [GO:0005828]; meiotic spindle midzone [GO:1990385]; mitotic spindle midzone [GO:1990023]; nuclear chromosome, telomeric region [GO:0000784]"	ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]	GO:0000784; GO:0000941; GO:0005524; GO:0005737; GO:0005828; GO:0007094; GO:0010971; GO:0018107; GO:0031670; GO:0032133; GO:0033316; GO:0034501; GO:0034503; GO:0035175; GO:0044774; GO:0045144; GO:0051228; GO:0051316; GO:0090267; GO:0120110; GO:0140429; GO:1901673; GO:1901925; GO:1902412; GO:1903380; GO:1904967; GO:1905824; GO:1990023; GO:1990385	attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation [GO:0051316]; cellular response to nutrient [GO:0031670]; interphase mitotic telomere clustering [GO:0120110]; meiotic sister chromatid segregation [GO:0045144]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic DNA integrity checkpoint [GO:0044774]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle disassembly [GO:0051228]; negative regulation of protein import into nucleus during spindle assembly checkpoint [GO:1901925]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic chromosome condensation [GO:1903380]; positive regulation of mitotic sister chromatid arm separation [GO:1905824]; positive regulation of mitotic sister chromatid biorientation [GO:0140429]; protein localization to kinetochore [GO:0034501]; protein localization to nucleolar rDNA repeats [GO:0034503]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle assembly [GO:1901673]; regulation of monopolar spindle attachment to meiosis I kinetochore [GO:1904967]		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g1_i1	Q13838	DX39B_HUMAN	99.5	424	2	0	1278	7	5	428	3.20E-242	838.6	DX39B_HUMAN	reviewed	Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)	DDX39B BAT1 UAP56	Homo sapiens (Human)	428	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0031124; GO:0032786; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573	"liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g1_i3	Q13838	DX39B_HUMAN	100	424	0	0	1278	7	5	428	6.40E-243	840.9	DX39B_HUMAN	reviewed	Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)	DDX39B BAT1 UAP56	Homo sapiens (Human)	428	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0031124; GO:0032786; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573	"liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1781_c0_g1_i1	Q5WR10	DX39B_CANLF	83.9	423	66	1	1369	101	5	425	4.50E-208	725.3	DX39B_CANLF	reviewed	Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56)	DDX39B BAT1 UAP56	Canis lupus familiaris (Dog) (Canis familiaris)	428	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]	ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0010501; GO:0016607; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1781_c0_g1_i2	Q5WR10	DX39B_CANLF	82.7	243	40	1	817	89	5	245	3.10E-114	412.9	DX39B_CANLF	reviewed	Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56)	DDX39B BAT1 UAP56	Canis lupus familiaris (Dog) (Canis familiaris)	428	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]	ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0010501; GO:0016607; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10196_c0_g1_i2	Q3T147	DX39B_BOVIN	98	151	3	0	454	2	5	155	1.20E-79	297	DX39B_BOVIN	reviewed	Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56)	DDX39B BAT1 UAP56	Bos taurus (Bovine)	428	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]	ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0010501; GO:0016607; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28606_c0_g1_i1	Q9Z1N5	DX39B_MOUSE	100	105	0	0	3	317	2	106	8.10E-54	210.7	DX39B_MOUSE	reviewed	Spliceosome RNA helicase Ddx39b (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)	Ddx39b Bat1 Bat1a Uap56	Mus musculus (Mouse)	428	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0032786; GO:0032991; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573	"liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9687_c0_g2_i1	P0DKL4	S130A_ARATH	66.7	81	27	0	245	3	278	358	1.10E-26	120.2	S130A_ARATH	reviewed	Spliceosome-associated protein 130 A (AtSAP130a) (SAP 130 A) (Pre-mRNA-splicing factor SF3b 130 kDa subunit A) (SF3b130 A)	SAP130A At3g55200 T26I12.80	Arabidopsis thaliana (Mouse-ear cress)	1214	"nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; microgametogenesis [GO:0055046]; mRNA splicing, via spliceosome [GO:0000398]; plant ovule development [GO:0048481]; pollen development [GO:0009555]; pollen germination [GO:0009846]"	nucleus [GO:0005634]	nucleic acid binding [GO:0003676]	GO:0000398; GO:0003676; GO:0005634; GO:0009555; GO:0009846; GO:0048481; GO:0055046	"microgametogenesis [GO:0055046]; mRNA splicing, via spliceosome [GO:0000398]; plant ovule development [GO:0048481]; pollen development [GO:0009555]; pollen germination [GO:0009846]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25487_c0_g1_i1	Q2KJD3	CWC15_BOVIN	98.6	73	1	0	257	39	159	231	2.50E-36	152.5	CWC15_BOVIN	reviewed	Spliceosome-associated protein CWC15 homolog	CWC15	Bos taurus (Bovine)	231	"catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005739; GO:0016607; GO:0045292; GO:0071007; GO:0071013	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33715_c0_g1_i1	Q9JHS9	CWC15_MOUSE	100	71	0	0	215	3	157	227	1.10E-35	149.8	CWC15_MOUSE	reviewed	Spliceosome-associated protein CWC15 homolog (Embryonic development factor 1) (mED1)	Cwc15 Ed1	Mus musculus (Mouse)	229	"catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005739; GO:0016607; GO:0045292; GO:0071007; GO:0071013	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4817_c0_g1_i1	Q3TKY6	CWC27_MOUSE	77.8	126	28	0	388	11	21	146	1.20E-56	220.3	CWC27_MOUSE	reviewed	Spliceosome-associated protein CWC27 homolog (Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog) (PPIase CWC27)	Cwc27 Sdccag10	Mus musculus (Mouse)	469	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0071005; GO:0071013	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]		NA	NA	NA	NA	NA	NA
TRINITY_DN292_c0_g1_i1	A2VDN6	SF3A1_BOVIN	63.2	163	54	4	109	588	388	547	3.10E-47	189.9	SF3A1_BOVIN	reviewed	Splicing factor 3A subunit 1	SF3A1	Bos taurus (Bovine)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25629_c0_g1_i1	A2VDN6	SF3A1_BOVIN	58.8	114	47	0	95	436	680	793	6.20E-35	148.7	SF3A1_BOVIN	reviewed	Splicing factor 3A subunit 1	SF3A1	Bos taurus (Bovine)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		blue	blue	NA	NA	NA	NA
TRINITY_DN31063_c0_g1_i1	A2VDN6	SF3A1_BOVIN	100	90	0	0	3	272	703	792	1.20E-45	183.3	SF3A1_BOVIN	reviewed	Splicing factor 3A subunit 1	SF3A1	Bos taurus (Bovine)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21891_c0_g1_i1	A2VDN6	SF3A1_BOVIN	100	143	0	0	1	429	392	534	3.80E-75	282	SF3A1_BOVIN	reviewed	Splicing factor 3A subunit 1	SF3A1	Bos taurus (Bovine)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21891_c0_g1_i2	A2VDN6	SF3A1_BOVIN	100	143	0	0	1	429	392	534	3.80E-75	282	SF3A1_BOVIN	reviewed	Splicing factor 3A subunit 1	SF3A1	Bos taurus (Bovine)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32439_c0_g1_i1	Q8K4Z5	SF3A1_MOUSE	52.9	70	32	1	31	237	31	100	1.50E-12	73.2	SF3A1_MOUSE	reviewed	Splicing factor 3A subunit 1 (SF3a120)	Sf3a1	Mus musculus (Mouse)	791	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37758_c0_g1_i1	Q15459	SF3A1_HUMAN	100	92	0	0	278	3	139	230	2.50E-46	185.7	SF3A1_HUMAN	reviewed	Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114)	SF3A1 SAP114	Homo sapiens (Human)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2152_c0_g1_i1	Q15459	SF3A1_HUMAN	61	282	108	1	131	976	37	316	8.90E-92	338.6	SF3A1_HUMAN	reviewed	Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114)	SF3A1 SAP114	Homo sapiens (Human)	793	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"		blue	blue	NA	NA	NA	NA
TRINITY_DN12488_c0_g1_i1	Q6AXT8	SF3A2_RAT	80.4	225	35	2	158	820	1	220	9.30E-100	364.8	SF3A2_RAT	reviewed	Splicing factor 3A subunit 2	Sf3a2	Rattus norvegicus (Rat)	471	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0003676; GO:0005634; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7212_c0_g1_i1	Q6AXT8	SF3A2_RAT	58.2	201	81	1	605	3	14	211	4.20E-59	229.2	SF3A2_RAT	reviewed	Splicing factor 3A subunit 2	Sf3a2	Rattus norvegicus (Rat)	471	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0003676; GO:0005634; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29099_c0_g1_i1	Q15428	SF3A2_HUMAN	100	67	0	0	3	203	125	191	8.60E-33	140.2	SF3A2_HUMAN	reviewed	Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62)	SF3A2 SAP62	Homo sapiens (Human)	464	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000245; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5630_c0_g1_i1	O75533	SF3B1_HUMAN	44.9	89	44	2	1	252	51	139	1.30E-12	74.7	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5630_c0_g1_i3	O75533	SF3B1_HUMAN	48.5	134	62	3	1	381	51	184	3.80E-25	116.3	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5630_c0_g1_i4	O75533	SF3B1_HUMAN	44.9	89	44	2	1	252	51	139	4.70E-13	75.1	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3816_c0_g1_i1	O75533	SF3B1_HUMAN	88.4	935	107	1	69	2873	371	1304	0	1661.7	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17160_c0_g1_i1	O75533	SF3B1_HUMAN	100	167	0	0	504	4	1138	1304	7.90E-96	350.9	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17160_c0_g2_i1	O75533	SF3B1_HUMAN	100	934	0	0	2805	4	371	1304	0	1861.3	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17160_c0_g2_i2	O75533	SF3B1_HUMAN	100	934	0	0	2805	4	371	1304	0	1860.5	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11862_c0_g1_i1	O75533	SF3B1_HUMAN	78	838	183	1	2522	9	468	1304	0	1343.6	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24005_c0_g1_i1	O75533	SF3B1_HUMAN	100	83	0	0	2	250	91	173	5.50E-42	171	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24005_c0_g1_i2	O75533	SF3B1_HUMAN	100	75	0	0	2	226	91	165	2.60E-38	158.7	SF3B1_HUMAN	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	SF3B1 SAP155	Homo sapiens (Human)	1304	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0008380; GO:0016607; GO:0034693; GO:0045815; GO:0071004; GO:0071005; GO:0071013; GO:1990935	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9687_c0_g1_i1	Q1LVE8	SF3B3_DANRE	69.7	208	59	2	613	2	4	211	3.40E-80	299.3	SF3B3_DANRE	reviewed	Splicing factor 3B subunit 3	sf3b3 zgc:55440	Danio rerio (Zebrafish) (Brachydanio rerio)	1217	"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]	GO:0000398; GO:0003676; GO:0005634; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1140_c0_g1_i1	Q1LVE8	SF3B3_DANRE	74.1	613	155	2	1	1833	607	1217	9.00E-265	914.1	SF3B3_DANRE	reviewed	Splicing factor 3B subunit 3	sf3b3 zgc:55440	Danio rerio (Zebrafish) (Brachydanio rerio)	1217	"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]	GO:0000398; GO:0003676; GO:0005634; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37671_c0_g1_i1	Q9W0M7	SF3B3_DROME	64.2	123	44	0	2	370	401	523	7.00E-41	167.9	SF3B3_DROME	reviewed	Splicing factor 3B subunit 3	Sf3b3 CG13900	Drosophila melanogaster (Fruit fly)	1227	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; small nuclear ribonucleoprotein complex [GO:0030532]; U2 snRNP [GO:0005686]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; small nuclear ribonucleoprotein complex [GO:0030532]; U2 snRNP [GO:0005686]	nucleic acid binding [GO:0003676]	GO:0000124; GO:0000398; GO:0003676; GO:0005634; GO:0005686; GO:0030532; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27615_c0_g1_i1	A0JN52	SF3B3_BOVIN	100	74	0	0	223	2	928	1001	1.40E-36	152.9	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16962_c0_g1_i1	A0JN52	SF3B3_BOVIN	99.1	113	1	0	341	3	466	578	1.30E-58	226.9	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16962_c0_g1_i3	A0JN52	SF3B3_BOVIN	100	247	0	0	743	3	332	578	2.40E-141	502.7	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16962_c0_g1_i4	A0JN52	SF3B3_BOVIN	100	247	0	0	743	3	332	578	2.40E-141	502.7	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27236_c0_g1_i1	A0JN52	SF3B3_BOVIN	100	147	0	0	3	443	166	312	5.50E-85	314.7	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17374_c0_g1_i1	A0JN52	SF3B3_BOVIN	100	146	0	0	440	3	1	146	2.40E-78	292.7	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17374_c0_g1_i2	A0JN52	SF3B3_BOVIN	100	146	0	0	440	3	1	146	2.40E-78	292.7	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24085_c0_g1_i1	A0JN52	SF3B3_BOVIN	100	221	0	0	665	3	624	844	3.00E-119	429.1	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24085_c0_g1_i2	A0JN52	SF3B3_BOVIN	100	221	0	0	665	3	624	844	3.00E-119	429.1	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36132_c0_g1_i1	A0JN52	SF3B3_BOVIN	59.1	110	45	0	335	6	1082	1191	7.70E-34	144.4	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1396_c0_g1_i1	A0JN52	SF3B3_BOVIN	86.7	596	79	0	92	1879	1	596	0	1089.7	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22330_c0_g1_i1	A0JN52	SF3B3_BOVIN	99.6	223	1	0	734	66	995	1217	1.60E-129	463.4	SF3B3_BOVIN	reviewed	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)	SF3B3	Bos taurus (Bovine)	1217	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]	GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0042177; GO:0044877; GO:0071005; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28817_c0_g1_i1	Q15427	SF3B4_HUMAN	61.5	195	73	2	632	54	6	200	3.20E-70	266.2	SF3B4_HUMAN	reviewed	Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)	SF3B4 SAP49	Homo sapiens (Human)	424	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33558_c0_g1_i1	Q15427	SF3B4_HUMAN	100	208	0	0	656	33	9	216	1.10E-118	427.2	SF3B4_HUMAN	reviewed	Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)	SF3B4 SAP49	Homo sapiens (Human)	424	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10347_c0_g1_i1	Q15427	SF3B4_HUMAN	96.1	229	9	0	49	735	1	229	1.30E-123	443.7	SF3B4_HUMAN	reviewed	Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)	SF3B4 SAP49	Homo sapiens (Human)	424	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4465_c0_g1_i1	Q15427	SF3B4_HUMAN	91.6	215	18	0	40	684	1	215	2.50E-114	412.9	SF3B4_HUMAN	reviewed	Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)	SF3B4 SAP49	Homo sapiens (Human)	424	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4359_c0_g1_i1	Q8JZX4	SPF45_MOUSE	35.7	126	61	5	456	100	1	113	9.30E-10	65.1	SPF45_MOUSE	reviewed	Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17)	Rbm17 Spf45	Mus musculus (Mouse)	405	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000375; GO:0000380; GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006281; GO:0032991	"alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4359_c0_g1_i2	Q8JZX4	SPF45_MOUSE	32.9	143	59	5	507	100	1	113	8.70E-09	62	SPF45_MOUSE	reviewed	Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17)	Rbm17 Spf45	Mus musculus (Mouse)	405	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000375; GO:0000380; GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006281; GO:0032991	"alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1565_c0_g1_i4	Q96DF8	ESS2_HUMAN	42.5	181	92	5	1022	492	212	384	9.80E-32	139	ESS2_HUMAN	reviewed	Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2)	ESS2 DGCR13 DGCR14 DGSH DGSI ES2	Homo sapiens (Human)	476	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]		GO:0000398; GO:0005634; GO:0007399; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6698_c0_g1_i1	O44424	ESS2_DROME	35.4	161	93	5	462	4	35	192	2.10E-16	87.4	ESS2_DROME	reviewed	Splicing factor ESS-2 homolog (Protein Es2) (dEs2)	Es2 CG1474	Drosophila melanogaster (Fruit fly)	501	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]		GO:0000398; GO:0005634; GO:0007399; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1565_c0_g1_i1	O44424	ESS2_DROME	37.8	230	104	7	773	99	306	501	6.60E-26	119.4	ESS2_DROME	reviewed	Splicing factor ESS-2 homolog (Protein Es2) (dEs2)	Es2 CG1474	Drosophila melanogaster (Fruit fly)	501	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]		GO:0000398; GO:0005634; GO:0007399; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"		brown	brown	NA	NA	NA	NA
TRINITY_DN1565_c0_g1_i2	O44424	ESS2_DROME	34.8	270	132	8	893	99	271	501	4.20E-26	120.2	ESS2_DROME	reviewed	Splicing factor ESS-2 homolog (Protein Es2) (dEs2)	Es2 CG1474	Drosophila melanogaster (Fruit fly)	501	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]		GO:0000398; GO:0005634; GO:0007399; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29044_c0_g1_i1	Q8WU68	U2AF4_HUMAN	57.4	195	47	5	531	55	1	195	6.90E-48	191.8	U2AF4_HUMAN	reviewed	Splicing factor U2AF 26 kDa subunit (U2 auxiliary factor 26) (U2 small nuclear RNA auxiliary factor 1-like protein 4) (U2AF1-like 4) (U2(RNU2) small nuclear RNA auxiliary factor 1-like protein 3) (U2 small nuclear RNA auxiliary factor 1-like protein 3) (U2AF1-like protein 3)	U2AF1L4 U2AF1-RS3 U2AF1L3	Homo sapiens (Human)	220	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000398; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0006406; GO:0016607; GO:0030628; GO:0031124; GO:0046872; GO:0089701	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11914_c0_g1_i1	A1A4K8	U2AF1_BOVIN	100	189	0	0	637	71	1	189	4.10E-111	402.1	U2AF1_BOVIN	reviewed	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit)	U2AF1	Bos taurus (Bovine)	237	"nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]	GO:0000398; GO:0005681; GO:0016607; GO:0030628; GO:0046872; GO:0050733; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11914_c0_g1_i2	A1A4K8	U2AF1_BOVIN	93.4	122	8	0	436	71	68	189	1.80E-64	246.5	U2AF1_BOVIN	reviewed	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit)	U2AF1	Bos taurus (Bovine)	237	"nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]	GO:0000398; GO:0005681; GO:0016607; GO:0030628; GO:0046872; GO:0050733; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11914_c0_g1_i3	A1A4K8	U2AF1_BOVIN	96.3	189	7	0	637	71	1	189	1.60E-107	390.2	U2AF1_BOVIN	reviewed	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit)	U2AF1	Bos taurus (Bovine)	237	"nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]	GO:0000398; GO:0005681; GO:0016607; GO:0030628; GO:0046872; GO:0050733; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36731_c0_g1_i1	Q94535	U2AF1_DROME	88.7	194	20	1	810	235	1	194	8.50E-100	364.8	U2AF1_DROME	reviewed	Splicing factor U2af 38 kDa subunit (U2 auxiliary factor 38 kDa subunit) (U2 snRNP auxiliary factor small subunit)	U2af38 CG3582	Drosophila melanogaster (Fruit fly)	264	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0008187; GO:0008380; GO:0030628; GO:0046872; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36731_c0_g1_i2	Q94535	U2AF1_DROME	85.4	130	19	0	624	235	65	194	3.40E-62	239.6	U2AF1_DROME	reviewed	Splicing factor U2af 38 kDa subunit (U2 auxiliary factor 38 kDa subunit) (U2 snRNP auxiliary factor small subunit)	U2af38 CG3582	Drosophila melanogaster (Fruit fly)	264	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0008187; GO:0008380; GO:0030628; GO:0046872; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26592_c0_g1_i1	Q94535	U2AF1_DROME	73.1	186	49	1	692	138	2	187	1.20E-77	291.2	U2AF1_DROME	reviewed	Splicing factor U2af 38 kDa subunit (U2 auxiliary factor 38 kDa subunit) (U2 snRNP auxiliary factor small subunit)	U2af38 CG3582	Drosophila melanogaster (Fruit fly)	264	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0008187; GO:0008380; GO:0030628; GO:0046872; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6242_c0_g1_i1	Q24562	U2AF2_DROME	77.9	195	41	1	841	1419	222	416	5.80E-83	309.7	U2AF2_DROME	reviewed	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	U2af50 CG9998	Drosophila melanogaster (Fruit fly)	416	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6242_c0_g1_i1	Q24562	U2AF2_DROME	73.9	211	27	2	101	733	40	222	2.90E-82	307.4	U2AF2_DROME	reviewed	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	U2af50 CG9998	Drosophila melanogaster (Fruit fly)	416	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6242_c0_g1_i2	Q24562	U2AF2_DROME	75.3	409	67	4	101	1321	40	416	6.20E-172	605.1	U2AF2_DROME	reviewed	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	U2af50 CG9998	Drosophila melanogaster (Fruit fly)	416	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6242_c0_g1_i3	Q24562	U2AF2_DROME	77.9	195	41	1	829	1407	222	416	5.70E-83	309.7	U2AF2_DROME	reviewed	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	U2af50 CG9998	Drosophila melanogaster (Fruit fly)	416	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6242_c0_g1_i3	Q24562	U2AF2_DROME	73.9	211	27	2	101	733	40	222	2.20E-82	307.8	U2AF2_DROME	reviewed	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	U2af50 CG9998	Drosophila melanogaster (Fruit fly)	416	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36312_c0_g1_i1	P26368	U2AF2_HUMAN	100	68	0	0	205	2	229	296	1.00E-33	143.3	U2AF2_HUMAN	reviewed	Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit)	U2AF2 U2AF65	Homo sapiens (Human)	475	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; RNA export from nucleus [GO:0006405]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0006405; GO:0006406; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031124; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37790_c0_g1_i1	P26368	U2AF2_HUMAN	97	134	0	1	392	3	285	418	1.10E-65	250.4	U2AF2_HUMAN	reviewed	Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit)	U2AF2 U2AF65	Homo sapiens (Human)	475	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; RNA export from nucleus [GO:0006405]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0006405; GO:0006406; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031124; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; RNA export from nucleus [GO:0006405]"		NA	NA	NA	NA	NA	NA
TRINITY_DN41034_c0_g1_i1	Q9ZQW8	U2AFA_ORYSJ	65.9	41	14	0	69	191	12	52	5.50E-10	64.7	U2AFA_ORYSJ	reviewed	Splicing factor U2af small subunit A (U2 auxiliary factor 35 kDa subunit A) (U2 small nuclear ribonucleoprotein auxiliary factor small subunit A) (U2 snRNP auxiliary factor small subunit A) (Zinc finger CCCH domain-containing protein 60) (OsC3H60)	U2AF35A Os09g0491756 LOC_Os09g31482 OsJ_028686	Oryza sativa subsp. japonica (Rice)	290	"spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000398; GO:0003677; GO:0005681; GO:0030628; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35861_c0_g1_i1	Q9ZQW8	U2AFA_ORYSJ	57.7	78	33	0	2	235	107	184	6.30E-22	104.4	U2AFA_ORYSJ	reviewed	Splicing factor U2af small subunit A (U2 auxiliary factor 35 kDa subunit A) (U2 small nuclear ribonucleoprotein auxiliary factor small subunit A) (U2 snRNP auxiliary factor small subunit A) (Zinc finger CCCH domain-containing protein 60) (OsC3H60)	U2AF35A Os09g0491756 LOC_Os09g31482 OsJ_028686	Oryza sativa subsp. japonica (Rice)	290	"spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000398; GO:0003677; GO:0005681; GO:0030628; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23171_c0_g1_i1	Q9ZQW8	U2AFA_ORYSJ	57.3	110	47	0	9	338	75	184	8.50E-33	141	U2AFA_ORYSJ	reviewed	Splicing factor U2af small subunit A (U2 auxiliary factor 35 kDa subunit A) (U2 small nuclear ribonucleoprotein auxiliary factor small subunit A) (U2 snRNP auxiliary factor small subunit A) (Zinc finger CCCH domain-containing protein 60) (OsC3H60)	U2AF35A Os09g0491756 LOC_Os09g31482 OsJ_028686	Oryza sativa subsp. japonica (Rice)	290	"spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]"	spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000398; GO:0003677; GO:0005681; GO:0030628; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6813_c0_g1_i1	Q9BW85	YJU2_HUMAN	63.1	168	62	0	22	525	1	168	7.90E-56	219.2	YJU2_HUMAN	reviewed	Splicing factor YJU2 (Coiled-coil domain-containing protein 94)	YJU2 CCDC94	Homo sapiens (Human)	323	"U2-type catalytic step 1 spliceosome [GO:0071006]; metal ion binding [GO:0046872]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]"	U2-type catalytic step 1 spliceosome [GO:0071006]	metal ion binding [GO:0046872]	GO:0000398; GO:0008380; GO:0043518; GO:0046872; GO:0071006	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN6813_c0_g1_i2	Q9BW85	YJU2_HUMAN	63.1	168	62	0	22	525	1	168	7.80E-56	219.2	YJU2_HUMAN	reviewed	Splicing factor YJU2 (Coiled-coil domain-containing protein 94)	YJU2 CCDC94	Homo sapiens (Human)	323	"U2-type catalytic step 1 spliceosome [GO:0071006]; metal ion binding [GO:0046872]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]"	U2-type catalytic step 1 spliceosome [GO:0071006]	metal ion binding [GO:0046872]	GO:0000398; GO:0008380; GO:0043518; GO:0046872; GO:0071006	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38675_c0_g1_i1	P23246	SFPQ_HUMAN	100	96	0	0	289	2	353	448	7.80E-48	190.7	SFPQ_HUMAN	reviewed	"Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)"	SFPQ PSF	Homo sapiens (Human)	707	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000380; GO:0000398; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0002218; GO:0003676; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0008380; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0042754; GO:0042803; GO:0042826; GO:0045087; GO:0045876; GO:0045892; GO:0045944; GO:0048511; GO:0070888; GO:0070932; GO:0090575; GO:1902177	"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN507_c2_g2_i1	Q12872	SFSWA_HUMAN	49.2	132	65	2	531	139	23	153	6.00E-26	119	SFSWA_HUMAN	reviewed	"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)"	SFSWAP SFRS8 SWAP	Homo sapiens (Human)	951	"nucleus [GO:0005634]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]"	nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]"		blue	blue	NA	NA	NA	NA
TRINITY_DN39765_c0_g1_i1	Q9WV75	SPON2_RAT	54.9	71	32	0	213	1	123	193	8.80E-18	90.5	SPON2_RAT	reviewed	Spondin-2 (Mindin)	Spon2	Rattus norvegicus (Rat)	330	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]	GO:0001530; GO:0002448; GO:0003823; GO:0005102; GO:0005615; GO:0007155; GO:0008228; GO:0031012; GO:0032496; GO:0032755; GO:0032760; GO:0042742; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0071222	cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN2416_c0_g1_i1	Q66JG9	SPRE1_XENTR	55.6	133	53	4	558	160	4	130	7.40E-35	148.7	SPRE1_XENTR	reviewed	"Sprouty-related, EVH1 domain-containing protein 1 (Spred-1)"	spred1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; blood vessel morphogenesis [GO:0048514]; inactivation of MAPK activity [GO:0000188]; lymph vessel development [GO:0001945]; negative regulation of angiogenesis [GO:0016525]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]"	plasma membrane [GO:0005886]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0000188; GO:0001945; GO:0005886; GO:0010801; GO:0010923; GO:0016525; GO:0019901; GO:0019902; GO:0030947; GO:0043517; GO:0048514; GO:0090311	"blood vessel morphogenesis [GO:0048514]; inactivation of MAPK activity [GO:0000188]; lymph vessel development [GO:0001945]; negative regulation of angiogenesis [GO:0016525]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2416_c0_g1_i2	Q66JG9	SPRE1_XENTR	55.6	133	53	4	574	176	4	130	4.40E-35	149.4	SPRE1_XENTR	reviewed	"Sprouty-related, EVH1 domain-containing protein 1 (Spred-1)"	spred1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; blood vessel morphogenesis [GO:0048514]; inactivation of MAPK activity [GO:0000188]; lymph vessel development [GO:0001945]; negative regulation of angiogenesis [GO:0016525]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]"	plasma membrane [GO:0005886]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0000188; GO:0001945; GO:0005886; GO:0010801; GO:0010923; GO:0016525; GO:0019901; GO:0019902; GO:0030947; GO:0043517; GO:0048514; GO:0090311	"blood vessel morphogenesis [GO:0048514]; inactivation of MAPK activity [GO:0000188]; lymph vessel development [GO:0001945]; negative regulation of angiogenesis [GO:0016525]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2416_c0_g1_i3	Q66JG9	SPRE1_XENTR	55.6	133	53	4	620	222	4	130	8.10E-35	148.7	SPRE1_XENTR	reviewed	"Sprouty-related, EVH1 domain-containing protein 1 (Spred-1)"	spred1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	406	"plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; blood vessel morphogenesis [GO:0048514]; inactivation of MAPK activity [GO:0000188]; lymph vessel development [GO:0001945]; negative regulation of angiogenesis [GO:0016525]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]"	plasma membrane [GO:0005886]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0000188; GO:0001945; GO:0005886; GO:0010801; GO:0010923; GO:0016525; GO:0019901; GO:0019902; GO:0030947; GO:0043517; GO:0048514; GO:0090311	"blood vessel morphogenesis [GO:0048514]; inactivation of MAPK activity [GO:0000188]; lymph vessel development [GO:0001945]; negative regulation of angiogenesis [GO:0016525]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8301_c0_g1_i1	Q2T9X3	SPRY7_BOVIN	49.5	194	95	2	105	680	3	195	5.60E-56	219.2	SPRY7_BOVIN	reviewed	SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein homolog) (CLL deletion region gene 6 protein homolog)	SPRYD7 CLLD6	Bos taurus (Bovine)	196							blue	blue	NA	NA	NA	NA
TRINITY_DN8301_c0_g1_i2	Q5ZHV7	SPRY7_CHICK	52.8	89	39	2	105	368	3	89	5.20E-19	95.5	SPRY7_CHICK	reviewed	SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein homolog) (CLL deletion region gene 6 protein homolog)	SPRYD7 CLLD6 RCJMB04_32l12	Gallus gallus (Chicken)	196							blue	blue	NA	NA	NA	NA
TRINITY_DN6838_c0_g1_i1	B3DJT0	SART3_DANRE	30.1	954	570	17	2849	90	60	950	2.70E-111	404.8	SART3_DANRE	reviewed	Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3)	sart3 egy si:ch211-191d15.4 wu:fc51h03	Danio rerio (Zebrafish) (Brachydanio rerio)	951	"ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]"	ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000381; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061574; GO:1903586	"exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31499_c0_g1_i1	Q66HL2	SRC8_RAT	100	128	0	0	1	384	177	304	4.80E-69	261.5	SRC8_RAT	reviewed	Src substrate cortactin	Cttn	Rattus norvegicus (Rat)	509	"cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; brain development [GO:0007420]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]"	cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064]	GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0007420; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0070064; GO:0071933; GO:0097062; GO:0097581; GO:0098871; GO:0098885; GO:0098978; GO:1903146; GO:1990023; GO:2001237	"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; brain development [GO:0007420]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31009_c0_g1_i1	Q60598	SRC8_MOUSE	100	86	0	0	3	260	71	156	2.40E-43	175.6	SRC8_MOUSE	reviewed	Src substrate cortactin	Cttn Ems1	Mus musculus (Mouse)	546	"actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]"	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064]	GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0070064; GO:0071933; GO:0097062; GO:0097581; GO:0098871; GO:0098885; GO:0098978; GO:1903146; GO:1990023; GO:2001237	"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3512_c1_g1_i1	Q01406	SRC8_CHICK	76.7	73	17	0	1	219	193	265	4.10E-25	114.8	SRC8_CHICK	reviewed	Src substrate protein p85 (Cortactin) (p80)	CTTN1 EMS1 P85.25	Gallus gallus (Chicken)	563	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]	actin filament binding [GO:0051015]	GO:0001726; GO:0002102; GO:0005783; GO:0005886; GO:0005905; GO:0005925; GO:0006886; GO:0006898; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097581	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]		NA	NA	NA	NA	NA	NA
TRINITY_DN3512_c0_g1_i1	Q01406	SRC8_CHICK	62.4	181	67	1	651	109	192	371	9.40E-57	221.5	SRC8_CHICK	reviewed	Src substrate protein p85 (Cortactin) (p80)	CTTN1 EMS1 P85.25	Gallus gallus (Chicken)	563	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]	actin filament binding [GO:0051015]	GO:0001726; GO:0002102; GO:0005783; GO:0005886; GO:0005905; GO:0005925; GO:0006886; GO:0006898; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097581	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]		NA	NA	NA	NA	NA	NA
TRINITY_DN3512_c0_g1_i2	Q01406	SRC8_CHICK	57.9	363	146	3	1182	109	11	371	2.60E-111	403.7	SRC8_CHICK	reviewed	Src substrate protein p85 (Cortactin) (p80)	CTTN1 EMS1 P85.25	Gallus gallus (Chicken)	563	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]	actin filament binding [GO:0051015]	GO:0001726; GO:0002102; GO:0005783; GO:0005886; GO:0005905; GO:0005925; GO:0006886; GO:0006898; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097581	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]		NA	NA	NA	NA	NA	NA
TRINITY_DN3512_c0_g1_i3	Q01406	SRC8_CHICK	50.7	363	128	5	1050	109	11	371	3.90E-90	333.2	SRC8_CHICK	reviewed	Src substrate protein p85 (Cortactin) (p80)	CTTN1 EMS1 P85.25	Gallus gallus (Chicken)	563	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]	actin filament binding [GO:0051015]	GO:0001726; GO:0002102; GO:0005783; GO:0005886; GO:0005905; GO:0005925; GO:0006886; GO:0006898; GO:0030027; GO:0030041; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097581	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]		blue	blue	NA	NA	NA	NA
TRINITY_DN34018_c0_g1_i1	Q13239	SLAP1_HUMAN	100	105	0	0	316	2	80	184	9.10E-58	223.8	SLAP1_HUMAN	reviewed	Src-like-adapter (Src-like-adapter protein 1) (SLAP-1) (hSLAP)	SLA SLAP SLAP1	Homo sapiens (Human)	276	dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell population proliferation [GO:0042127]; regulation of signal transduction [GO:0009966]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]	non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]	GO:0004715; GO:0005102; GO:0005768; GO:0005925; GO:0007169; GO:0009966; GO:0030154; GO:0031234; GO:0038083; GO:0042127; GO:0043197; GO:0045087	cell differentiation [GO:0030154]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell population proliferation [GO:0042127]; regulation of signal transduction [GO:0009966]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN20525_c0_g1_i1	Q503V3	CL049_DANRE	55.2	134	59	1	60	458	60	193	1.70E-41	170.6	SPRNG_DANRE	reviewed	SREBP regulating gene protein	spring zgc:110063	Danio rerio (Zebrafish) (Brachydanio rerio)	199	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; positive regulation of SREBP signaling pathway [GO:2000640]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0016021; GO:2000640	positive regulation of SREBP signaling pathway [GO:2000640]		NA	NA	NA	NA	NA	NA
TRINITY_DN36857_c0_g1_i1	Q9UPN6	SCAF8_HUMAN	100	122	0	0	366	1	479	600	1.70E-68	259.6	SCAF8_HUMAN	reviewed	SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16)	SCAF8 CCAP7 KIAA1116 RBM16	Homo sapiens (Human)	1271	"cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805	"mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5670_c0_g1_i1	Q6DID3	SCAF8_MOUSE	53.6	125	55	2	473	105	472	595	1.10E-33	144.4	SCAF8_MOUSE	reviewed	SR-related and CTD-associated factor 8 (RNA-binding motif protein 16)	Scaf8 Kiaa1116 Rbm16	Mus musculus (Mouse)	1268	"cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006366; GO:0006369; GO:0006378; GO:0006397; GO:0016363; GO:0019904; GO:0032786; GO:0043175; GO:0070063; GO:1990269; GO:2000805	"mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28652_c0_g1_i1	Q96SB4	SRPK1_HUMAN	89.2	102	11	0	3	308	483	584	2.80E-51	202.2	SRPK1_HUMAN	reviewed	SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)	SRPK1	Homo sapiens (Human)	655	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0010468; GO:0016032; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684	"chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27292_c0_g1_i1	Q96SB4	SRPK1_HUMAN	55.3	85	38	0	38	292	481	565	1.40E-23	110.2	SRPK1_HUMAN	reviewed	SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)	SRPK1	Homo sapiens (Human)	655	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0010468; GO:0016032; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684	"chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40969_c0_g1_i1	P78362	SRPK2_HUMAN	69.5	82	25	0	26	271	516	597	1.70E-28	126.3	SRPK2_HUMAN	reviewed	SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]	SRPK2	Homo sapiens (Human)	688	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010468; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40141_c0_g1_i1	P78362	SRPK2_HUMAN	61.9	84	31	1	250	2	507	590	6.50E-25	114.4	SRPK2_HUMAN	reviewed	SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]	SRPK2	Homo sapiens (Human)	688	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010468; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN798_c0_g1_i1	P78362	SRPK2_HUMAN	80.2	121	24	0	365	3	524	644	2.70E-57	223.8	SRPK2_HUMAN	reviewed	SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]	SRPK2	Homo sapiens (Human)	688	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010468; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN798_c0_g1_i2	P78362	SRPK2_HUMAN	80.2	121	24	0	365	3	524	644	2.60E-57	223.8	SRPK2_HUMAN	reviewed	SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]	SRPK2	Homo sapiens (Human)	688	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010468; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19033_c0_g1_i3	Q8CFM6	STAB2_RAT	25.4	193	107	7	9	515	485	664	2.60E-09	63.5	STAB2_RAT	reviewed	"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 175 kDa stabilin-2 (175 kDa hyaluronan receptor for endocytosis)] (Fragment)"	Stab2 Feel2 Hare	Rattus norvegicus (Rat)	1431	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]	calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]	GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005737; GO:0005887; GO:0006897; GO:0007155; GO:0009897; GO:0030169; GO:0042742; GO:0050830	cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]		NA	NA	NA	NA	NA	NA
TRINITY_DN2010_c0_g1_i1	Q7ZT42	SND1_DANRE	56.8	681	271	8	2037	40	6	678	1.50E-214	747.3	SND1_DANRE	reviewed	Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)	snd1 sn4tdr	Danio rerio (Zebrafish) (Brachydanio rerio)	897	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]	nuclease activity [GO:0004518]; RNA binding [GO:0003723]	GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0006401; GO:0016442; GO:0031047	gene silencing by RNA [GO:0031047]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN12366_c0_g1_i1	Q7KZF4	SND1_HUMAN	100	287	0	0	2	862	365	651	1.00E-159	563.9	SND1_HUMAN	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)	SND1 TDRD11	Homo sapiens (Human)	910	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]; cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]	cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0001649; GO:0003712; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016020; GO:0016032; GO:0016442; GO:0031047; GO:0042470; GO:0045296; GO:0070062; GO:0097433; GO:1905172	gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN27031_c0_g1_i1	Q7KZF4	SND1_HUMAN	100	107	0	0	3	323	4	110	7.90E-57	220.7	SND1_HUMAN	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)	SND1 TDRD11	Homo sapiens (Human)	910	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]; cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]	cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0001649; GO:0003712; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016020; GO:0016032; GO:0016442; GO:0031047; GO:0042470; GO:0045296; GO:0070062; GO:0097433; GO:1905172	gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN32866_c0_g1_i1	Q78PY7	SND1_MOUSE	97.6	82	2	0	247	2	581	662	4.80E-38	157.9	SND1_MOUSE	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator)	Snd1	Mus musculus (Mouse)	910	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]	endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]	GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172	gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN40757_c0_g1_i1	Q78PY7	SND1_MOUSE	100	76	0	0	1	228	257	332	9.00E-39	160.2	SND1_MOUSE	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator)	Snd1	Mus musculus (Mouse)	910	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]	endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]	GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172	gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN26974_c0_g1_i1	Q863B3	SND1_BOVIN	100	109	0	0	327	1	239	347	2.10E-57	222.6	SND1_BOVIN	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator)	SND1	Bos taurus (Bovine)	910	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; nucleus [GO:0005634]; RISC complex [GO:0016442]	endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]	GO:0003723; GO:0004518; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172	gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN2010_c0_g1_i2	Q9W0S7	SND1_DROME	53.3	912	397	12	2764	107	17	925	4.30E-268	925.6	SND1_DROME	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (Tudor staphylococcal nuclease)	Tudor-SN p100 SND1 TSN CG7008	Drosophila melanogaster (Fruit fly)	926	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; RNA catabolic process [GO:0006401]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RISC complex [GO:0016442]	endonuclease activity [GO:0004519]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]	GO:0003723; GO:0004518; GO:0004519; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0007283; GO:0010529; GO:0016442; GO:0031047	gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; RNA catabolic process [GO:0006401]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5983_c0_g1_i2	Q9Y3M8	STA13_HUMAN	53.2	141	64	2	482	63	974	1113	1.30E-41	171	STA13_HUMAN	reviewed	StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein) (DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13) (StARD13)	STARD13 DLC2 GT650	Homo sapiens (Human)	1113	cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]	GO:0005096; GO:0005811; GO:0005829; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0051056; GO:0090051; GO:0097498	actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5983_c0_g1_i3	Q923Q2	STA13_MOUSE	49	574	264	12	1763	63	562	1113	6.70E-146	519.2	STA13_MOUSE	reviewed	StAR-related lipid transfer protein 13 (START domain-containing protein 13) (StARD13)	Stard13	Mus musculus (Mouse)	1113	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]	GO:0005096; GO:0005811; GO:0007049; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0090051; GO:0097498; GO:1903671	actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5983_c0_g1_i4	Q923Q2	STA13_MOUSE	49.5	570	263	11	1751	63	562	1113	3.20E-148	526.9	STA13_MOUSE	reviewed	StAR-related lipid transfer protein 13 (START domain-containing protein 13) (StARD13)	Stard13	Mus musculus (Mouse)	1113	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]	GO:0005096; GO:0005811; GO:0007049; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0090051; GO:0097498; GO:1903671	actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN2359_c0_g2_i2	Q923Q2	STA13_MOUSE	52.5	118	47	2	905	579	57	174	3.00E-29	130.6	STA13_MOUSE	reviewed	StAR-related lipid transfer protein 13 (START domain-containing protein 13) (StARD13)	Stard13	Mus musculus (Mouse)	1113	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]	GO:0005096; GO:0005811; GO:0007049; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0090051; GO:0097498; GO:1903671	actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4747_c0_g1_i1	Q9NQZ5	STAR7_HUMAN	31	245	148	5	724	5	19	247	4.80E-26	120.2	STAR7_HUMAN	reviewed	"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)"	STARD7 GTT1	Homo sapiens (Human)	370	extracellular region [GO:0005576]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; phosphatidylcholine biosynthetic process [GO:0006656]; T-helper 2 cell cytokine production [GO:0035745]	extracellular region [GO:0005576]; mitochondrial outer membrane [GO:0005741]	lipid binding [GO:0008289]	GO:0001773; GO:0005576; GO:0005741; GO:0006656; GO:0006954; GO:0008289; GO:0035745; GO:0061436; GO:0120197	establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; phosphatidylcholine biosynthetic process [GO:0006656]; T-helper 2 cell cytokine production [GO:0035745]		NA	NA	NA	NA	NA	NA
TRINITY_DN40393_c0_g1_i1	O55092	SLK_CAVPO	100	105	0	0	1	315	155	259	1.30E-56	219.9	SLK_CAVPO	reviewed	STE20-like serine/threonine-protein kinase (STE20-like kinase) (EC 2.7.11.1) (STE20-related serine/threonine-protein kinase) (STE20-related kinase)	SLK	Cavia porcellus (Guinea pig)	1231	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0030334; GO:0031252; GO:0042803; GO:0046777; GO:0048471; GO:0051893	apoptotic process [GO:0006915]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]		NA	NA	NA	NA	NA	NA
TRINITY_DN4527_c0_g1_i1	O54988	SLK_MOUSE	69.7	66	20	0	18	215	30	95	2.30E-20	99	SLK_MOUSE	reviewed	STE20-like serine/threonine-protein kinase (STE20-like kinase) (mSLK) (EC 2.7.11.1) (Etk4) (STE20-related kinase SMAK) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)	Slk Kiaa0204 Stk2	Mus musculus (Mouse)	1233	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of histone phosphorylation [GO:0033129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0033129; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0046777; GO:0048471; GO:0051893	apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of histone phosphorylation [GO:0033129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]		blue	blue	NA	NA	NA	NA
TRINITY_DN4527_c0_g2_i1	O54988	SLK_MOUSE	90.9	22	2	0	18	83	30	51	8.60E-06	50.8	SLK_MOUSE	reviewed	STE20-like serine/threonine-protein kinase (STE20-like kinase) (mSLK) (EC 2.7.11.1) (Etk4) (STE20-related kinase SMAK) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)	Slk Kiaa0204 Stk2	Mus musculus (Mouse)	1233	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of histone phosphorylation [GO:0033129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0033129; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0046777; GO:0048471; GO:0051893	apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of histone phosphorylation [GO:0033129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]		NA	NA	NA	NA	NA	NA
TRINITY_DN2275_c2_g1_i1	Q5ZK47	STRAA_CHICK	39.7	343	194	4	1041	49	1	342	2.70E-60	234.2	STRAA_CHICK	reviewed	STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein)	STRADA STRAD RCJMB04_13d22	Gallus gallus (Chicken)	389	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0006611; GO:0007049; GO:0030295; GO:0032147	activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein export from nucleus [GO:0006611]		NA	NA	NA	NA	NA	NA
TRINITY_DN35684_c0_g1_i1	Q5VXD3	SAM13_HUMAN	42.7	96	54	1	195	479	20	115	5.10E-14	79.3	SAM13_HUMAN	reviewed	Sterile alpha motif domain-containing protein 13 (SAM domain-containing protein 13)	SAMD13 HSD-42 HSD42	Homo sapiens (Human)	122	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0042393; GO:0045892	"negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28805_c0_g1_i1	Q8K070	SAM14_MOUSE	47.9	73	37	1	46	261	323	395	3.50E-08	58.9	SAM14_MOUSE	reviewed	Sterile alpha motif domain-containing protein 14 (SAM domain-containing protein 14)	Samd14	Mus musculus (Mouse)	417	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]	actin filament binding [GO:0051015]	GO:0005737; GO:0007015; GO:0014069; GO:0015629; GO:0019722; GO:0030425; GO:0031175; GO:0051015	actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175]		NA	NA	NA	NA	NA	NA
TRINITY_DN29872_c0_g1_i1	I6XHI4	FADA5_MYCTU	51.2	86	42	0	275	18	306	391	1.90E-20	99.8	FADA5_MYCTU	reviewed	Steroid 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acetyltransferase FadA5) (Beta-ketoacyl-CoA thiolase)	fadA5 Rv3546 LH57_19345	Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)	391	acetyl-CoA C-acyltransferase activity [GO:0003988]; identical protein binding [GO:0042802]; cholesterol catabolic process [GO:0006707]; fatty acid beta-oxidation [GO:0006635]; pathogenesis [GO:0009405]; phenylacetate catabolic process [GO:0010124]		acetyl-CoA C-acyltransferase activity [GO:0003988]; identical protein binding [GO:0042802]	GO:0003988; GO:0006635; GO:0006707; GO:0009405; GO:0010124; GO:0042802	cholesterol catabolic process [GO:0006707]; fatty acid beta-oxidation [GO:0006635]; pathogenesis [GO:0009405]; phenylacetate catabolic process [GO:0010124]		NA	NA	NA	NA	NA	NA
TRINITY_DN1014_c0_g1_i1	P11475	ERR2_RAT	44.3	262	137	5	84	854	174	431	1.10E-47	191.8	ERR2_RAT	reviewed	Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)	Esrrb Err2 Esrl2 Nr3b2	Rattus norvegicus (Rat)	433	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000793; GO:0000978; GO:0000981; GO:0000987; GO:0000993; GO:0001228; GO:0001701; GO:0001831; GO:0001834; GO:0001892; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008134; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0048839; GO:0071931; GO:0090282; GO:1902459; GO:1990837; GO:2000035; GO:2000737	"cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1014_c0_g1_i2	P11475	ERR2_RAT	54	337	146	5	255	1250	99	431	1.20E-90	335.1	ERR2_RAT	reviewed	Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)	Esrrb Err2 Esrl2 Nr3b2	Rattus norvegicus (Rat)	433	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000793; GO:0000978; GO:0000981; GO:0000987; GO:0000993; GO:0001228; GO:0001701; GO:0001831; GO:0001834; GO:0001892; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008134; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0048839; GO:0071931; GO:0090282; GO:1902459; GO:1990837; GO:2000035; GO:2000737	"cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1014_c0_g1_i3	P11475	ERR2_RAT	54	337	146	5	381	1376	99	431	1.30E-90	335.1	ERR2_RAT	reviewed	Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)	Esrrb Err2 Esrl2 Nr3b2	Rattus norvegicus (Rat)	433	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000793; GO:0000978; GO:0000981; GO:0000987; GO:0000993; GO:0001228; GO:0001701; GO:0001831; GO:0001834; GO:0001892; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008134; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0048839; GO:0071931; GO:0090282; GO:1902459; GO:1990837; GO:2000035; GO:2000737	"cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1014_c0_g1_i4	P11475	ERR2_RAT	54	337	146	5	366	1361	99	431	1.30E-90	335.1	ERR2_RAT	reviewed	Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)	Esrrb Err2 Esrl2 Nr3b2	Rattus norvegicus (Rat)	433	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000793; GO:0000978; GO:0000981; GO:0000987; GO:0000993; GO:0001228; GO:0001701; GO:0001831; GO:0001834; GO:0001892; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008134; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0048839; GO:0071931; GO:0090282; GO:1902459; GO:1990837; GO:2000035; GO:2000737	"cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3176_c0_g1_i2	Q95L87	STF1_MACEU	52.9	68	30	1	288	85	13	78	1.10E-15	84.7	STF1_MACEU	reviewed	Steroidogenic factor 1 (SF-1) (STF-1) (Nuclear receptor subfamily 5 group A member 1)	NR5A1 SF1	Macropus eugenii (Tammar wallaby) (Notamacropus eugenii)	463	nucleus [GO:0005634]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]	nucleus [GO:0005634]	lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0007530; GO:0008270; GO:0008289; GO:0008584; GO:0008585; GO:0010628; GO:0043565	female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]		NA	NA	NA	NA	NA	NA
TRINITY_DN37856_c0_g1_i1	Q95L87	STF1_MACEU	45.6	79	41	1	33	269	13	89	3.10E-15	82.4	STF1_MACEU	reviewed	Steroidogenic factor 1 (SF-1) (STF-1) (Nuclear receptor subfamily 5 group A member 1)	NR5A1 SF1	Macropus eugenii (Tammar wallaby) (Notamacropus eugenii)	463	nucleus [GO:0005634]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]	nucleus [GO:0005634]	lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0007530; GO:0008270; GO:0008289; GO:0008584; GO:0008585; GO:0010628; GO:0043565	female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]		NA	NA	NA	NA	NA	NA
TRINITY_DN3522_c0_g1_i1	Q95L87	STF1_MACEU	41	105	57	3	678	992	10	109	4.20E-14	81.6	STF1_MACEU	reviewed	Steroidogenic factor 1 (SF-1) (STF-1) (Nuclear receptor subfamily 5 group A member 1)	NR5A1 SF1	Macropus eugenii (Tammar wallaby) (Notamacropus eugenii)	463	nucleus [GO:0005634]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]	nucleus [GO:0005634]	lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0004879; GO:0005634; GO:0007530; GO:0008270; GO:0008289; GO:0008584; GO:0008585; GO:0010628; GO:0043565	female gonad development [GO:0008585]; male gonad development [GO:0008584]; positive regulation of gene expression [GO:0010628]; sex determination [GO:0007530]		NA	NA	NA	NA	NA	NA
TRINITY_DN6565_c0_g1_i1	Q4W9V1	ERG6_ASPFU	31.6	117	68	4	651	337	132	248	2.10E-05	51.6	ERG6_ASPFU	reviewed	Sterol 24-C-methyltransferase (EC 2.1.1.-) (Delta(24)-sterol C-methyltransferase) (S-adenosyl-L-methionine:sterol C-24 methyl transferasee) (SAM:SMT)	erg6 AFUA_4G03630	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	377	endoplasmic reticulum [GO:0005783]; sterol 24-C-methyltransferase activity [GO:0003838]; ergosterol biosynthetic process [GO:0006696]; methylation [GO:0032259]; sterol biosynthetic process [GO:0016126]	endoplasmic reticulum [GO:0005783]	sterol 24-C-methyltransferase activity [GO:0003838]	GO:0003838; GO:0005783; GO:0006696; GO:0016126; GO:0032259	ergosterol biosynthetic process [GO:0006696]; methylation [GO:0032259]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN6565_c0_g1_i2	Q4W9V1	ERG6_ASPFU	31.6	117	68	4	771	457	132	248	2.30E-05	51.6	ERG6_ASPFU	reviewed	Sterol 24-C-methyltransferase (EC 2.1.1.-) (Delta(24)-sterol C-methyltransferase) (S-adenosyl-L-methionine:sterol C-24 methyl transferasee) (SAM:SMT)	erg6 AFUA_4G03630	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)	377	endoplasmic reticulum [GO:0005783]; sterol 24-C-methyltransferase activity [GO:0003838]; ergosterol biosynthetic process [GO:0006696]; methylation [GO:0032259]; sterol biosynthetic process [GO:0016126]	endoplasmic reticulum [GO:0005783]	sterol 24-C-methyltransferase activity [GO:0003838]	GO:0003838; GO:0005783; GO:0006696; GO:0016126; GO:0032259	ergosterol biosynthetic process [GO:0006696]; methylation [GO:0032259]; sterol biosynthetic process [GO:0016126]		NA	NA	NA	NA	NA	NA
TRINITY_DN2076_c0_g1_i1	Q61263	SOAT1_MOUSE	45.1	443	223	6	126	1436	110	538	2.10E-107	391	SOAT1_MOUSE	reviewed	Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1)	Soat1 Acact	Mus musculus (Mouse)	540	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]; cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]	GO:0000062; GO:0004772; GO:0005783; GO:0005789; GO:0008203; GO:0008374; GO:0010742; GO:0010878; GO:0015485; GO:0016020; GO:0016021; GO:0033344; GO:0034379; GO:0034435; GO:0034736; GO:0042632; GO:0042986	cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN2076_c0_g1_i3	O70536	SOAT1_RAT	34.4	125	78	1	126	488	115	239	7.00E-12	72	SOAT1_RAT	reviewed	Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1)	Soat1 Acact Acat	Rattus norvegicus (Rat)	545	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]; cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]	GO:0000062; GO:0004772; GO:0005789; GO:0008203; GO:0008374; GO:0010742; GO:0010878; GO:0015485; GO:0016020; GO:0016021; GO:0033344; GO:0034379; GO:0034435; GO:0034736; GO:0042632; GO:0042986	cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN2076_c0_g1_i6	Q61263	SOAT1_MOUSE	45.7	431	211	7	126	1391	110	526	1.60E-104	381.3	SOAT1_MOUSE	reviewed	Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1)	Soat1 Acact	Mus musculus (Mouse)	540	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]; cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]	GO:0000062; GO:0004772; GO:0005783; GO:0005789; GO:0008203; GO:0008374; GO:0010742; GO:0010878; GO:0015485; GO:0016020; GO:0016021; GO:0033344; GO:0034379; GO:0034435; GO:0034736; GO:0042632; GO:0042986	cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379]		NA	NA	NA	NA	NA	NA
TRINITY_DN27577_c0_g1_i1	O77760	SOAT1_CHLAE	100	97	0	0	3	293	362	458	6.50E-50	197.6	SOAT1_CHLAE	reviewed	Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1)	SOAT1 ACAT1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	550	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; sterol O-acyltransferase activity [GO:0004772]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; sterol O-acyltransferase activity [GO:0004772]	GO:0004772; GO:0005789; GO:0008203; GO:0015485; GO:0016021; GO:0034435; GO:0034736; GO:0042632	cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]		NA	NA	NA	NA	NA	NA
TRINITY_DN29945_c0_g1_i2	P56720	SRBP1_RAT	38.4	929	485	20	2650	74	219	1130	5.10E-141	503.4	SRBP1_RAT	reviewed	Sterol regulatory element-binding protein 1 (SREBP-1) (Adipocyte determination- and differentiation-dependent factor 1) (ADD1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)]	Srebf1 Srebp1	Rattus norvegicus (Rat)	1134	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of innate immune response [GO:0045089]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; SREBP signaling pathway [GO:0032933]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006355; GO:0006357; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009749; GO:0010867; GO:0010876; GO:0010883; GO:0012507; GO:0014070; GO:0016020; GO:0016021; GO:0019217; GO:0019901; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032868; GO:0032869; GO:0032933; GO:0032991; GO:0033762; GO:0033993; GO:0042493; GO:0042789; GO:0043231; GO:0043434; GO:0043565; GO:0044877; GO:0045089; GO:0045444; GO:0045471; GO:0045542; GO:0045893; GO:0045944; GO:0046676; GO:0046889; GO:0046983; GO:0050796; GO:0051591; GO:0070542; GO:0071398; GO:1902895; GO:1903146; GO:1903214; GO:1990837	"aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of innate immune response [GO:0045089]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; SREBP signaling pathway [GO:0032933]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12611_c0_g3_i1	P97260	SCAP_CRIGR	37.6	101	62	1	14	316	1036	1135	6.60E-11	68.2	SCAP_CRIGR	reviewed	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	SCAP	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1276	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SREBP-SCAP complex [GO:0032936]; SREBP-SCAP-Insig complex [GO:0032937]; vesicle coat [GO:0030120]; protein C-terminus binding [GO:0008022]; sterol binding [GO:0032934]; cellular response to sterol [GO:0036315]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; protein import into nucleus [GO:0006606]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SREBP-SCAP complex [GO:0032936]; SREBP-SCAP-Insig complex [GO:0032937]; vesicle coat [GO:0030120]	protein C-terminus binding [GO:0008022]; sterol binding [GO:0032934]	GO:0000139; GO:0005783; GO:0005789; GO:0006606; GO:0008022; GO:0008203; GO:0012507; GO:0016020; GO:0030120; GO:0032933; GO:0032934; GO:0032936; GO:0032937; GO:0036315; GO:0090110	cellular response to sterol [GO:0036315]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; protein import into nucleus [GO:0006606]; SREBP signaling pathway [GO:0032933]		NA	NA	NA	NA	NA	NA
TRINITY_DN12611_c0_g3_i2	P97260	SCAP_CRIGR	39.6	91	54	1	48	320	1046	1135	1.10E-10	67.4	SCAP_CRIGR	reviewed	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	SCAP	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1276	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SREBP-SCAP complex [GO:0032936]; SREBP-SCAP-Insig complex [GO:0032937]; vesicle coat [GO:0030120]; protein C-terminus binding [GO:0008022]; sterol binding [GO:0032934]; cellular response to sterol [GO:0036315]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; protein import into nucleus [GO:0006606]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SREBP-SCAP complex [GO:0032936]; SREBP-SCAP-Insig complex [GO:0032937]; vesicle coat [GO:0030120]	protein C-terminus binding [GO:0008022]; sterol binding [GO:0032934]	GO:0000139; GO:0005783; GO:0005789; GO:0006606; GO:0008022; GO:0008203; GO:0012507; GO:0016020; GO:0030120; GO:0032933; GO:0032934; GO:0032936; GO:0032937; GO:0036315; GO:0090110	cellular response to sterol [GO:0036315]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; protein import into nucleus [GO:0006606]; SREBP signaling pathway [GO:0032933]		NA	NA	NA	NA	NA	NA
TRINITY_DN12611_c0_g1_i2	A0JPH4	SCAP_XENLA	32.8	122	76	2	482	132	636	756	7.60E-09	62	SCAP_XENLA	reviewed	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	scap	Xenopus laevis (African clawed frog)	1311	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sterol binding [GO:0032934]	GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0016021; GO:0032933; GO:0032934; GO:0090110	cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; SREBP signaling pathway [GO:0032933]		NA	NA	NA	NA	NA	NA
TRINITY_DN12611_c0_g1_i4	A0JPH4	SCAP_XENLA	29.6	487	246	17	1400	66	636	1067	4.20E-33	144.1	SCAP_XENLA	reviewed	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	scap	Xenopus laevis (African clawed frog)	1311	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sterol binding [GO:0032934]	GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0016021; GO:0032933; GO:0032934; GO:0090110	cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; SREBP signaling pathway [GO:0032933]		NA	NA	NA	NA	NA	NA
TRINITY_DN12611_c0_g2_i2	Q12770	SCAP_HUMAN	33.2	620	354	15	70	1908	7	573	3.60E-80	300.8	SCAP_HUMAN	reviewed	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	SCAP KIAA0199 PSEC0227	Homo sapiens (Human)	1279	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0001666; GO:0005783; GO:0005789; GO:0005794; GO:0006955; GO:0007568; GO:0008203; GO:0012507; GO:0016021; GO:0032868; GO:0032933; GO:0032934; GO:0032991; GO:0042304; GO:0044255; GO:0044877; GO:0045541; GO:0045542; GO:0045716; GO:0051082; GO:0090110	aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933]		NA	NA	NA	NA	NA	NA
TRINITY_DN23116_c0_g1_i1	A6QM06	SCAP_BOVIN	37.8	148	90	2	13	450	1131	1278	2.40E-23	110.2	SCAP_BOVIN	reviewed	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	SCAP	Bos taurus (Bovine)	1278	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sterol binding [GO:0032934]	GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0016021; GO:0032933; GO:0032934; GO:0090110	cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; SREBP signaling pathway [GO:0032933]		NA	NA	NA	NA	NA	NA
TRINITY_DN9621_c0_g7_i1	P08842	STS_HUMAN	51.6	182	85	2	79	624	236	414	7.10E-44	178.7	STS_HUMAN	reviewed	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	STS ARSC1	Homo sapiens (Human)	583	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872	epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]		NA	NA	NA	NA	NA	NA
TRINITY_DN9621_c0_g4_i2	P08842	STS_HUMAN	45.5	110	58	1	74	403	238	345	1.00E-19	99	STS_HUMAN	reviewed	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	STS ARSC1	Homo sapiens (Human)	583	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872	epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]		NA	NA	NA	NA	NA	NA
TRINITY_DN9621_c0_g2_i2	P08842	STS_HUMAN	53.3	120	53	1	1	360	49	165	6.20E-29	129	STS_HUMAN	reviewed	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	STS ARSC1	Homo sapiens (Human)	583	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]	GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872	epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]		NA	NA	NA	NA	NA	NA
TRINITY_DN9849_c0_g1_i1	Q8ILC1	STI1L_PLAF7	63.3	90	33	0	7	276	368	457	3.00E-28	125.6	STI1L_PLAF7	reviewed	STI1-like protein	PF14_0324	Plasmodium falciparum (isolate 3D7)	564	cytosol [GO:0005829]; Hsp90 protein binding [GO:0051879]	cytosol [GO:0005829]	Hsp90 protein binding [GO:0051879]	GO:0005829; GO:0051879			NA	NA	NA	NA	NA	NA
TRINITY_DN29884_c0_g1_i1	Q9WUD1	CHIP_MOUSE	99.2	120	1	0	3	362	56	175	5.30E-62	238	CHIP_MOUSE	reviewed	STIP1 homology and U box-containing protein 1 (EC 2.3.2.27) (Carboxy terminus of Hsp70-interacting protein) (E3 ubiquitin-protein ligase CHIP) (RING-type E3 ubiquitin transferase CHIP)	Stub1 Chip	Mus musculus (Mouse)	304	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006457; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN31943_c0_g1_i1	Q9WUD1	CHIP_MOUSE	100	80	0	0	3	242	101	180	1.80E-37	156	CHIP_MOUSE	reviewed	STIP1 homology and U box-containing protein 1 (EC 2.3.2.27) (Carboxy terminus of Hsp70-interacting protein) (E3 ubiquitin-protein ligase CHIP) (RING-type E3 ubiquitin transferase CHIP)	Stub1 Chip	Mus musculus (Mouse)	304	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006457; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]		NA	NA	NA	NA	NA	NA
TRINITY_DN28359_c0_g1_i1	P54116	STOM_MOUSE	94.5	73	4	0	220	2	187	259	2.40E-25	115.5	STOM_MOUSE	reviewed	Stomatin (Erythrocyte band 7 integral membrane protein) (Erythrocyte membrane protein band 7.2) (Protein 7.2b)	Stom Epb7.2 Epb72	Mus musculus (Mouse)	284	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of acid-sensing ion channel activity [GO:1901585]; regulation of ion transmembrane transport [GO:0034765]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]	GO:0005737; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0034765; GO:0042470; GO:0042802; GO:0042803; GO:0044829; GO:0045121; GO:0048471; GO:0048524; GO:0070063; GO:0090314; GO:1901585	positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of acid-sensing ion channel activity [GO:1901585]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN29667_c0_g1_i1	P27105	STOM_HUMAN	100	103	0	0	1	309	150	252	1.20E-46	186.8	STOM_HUMAN	reviewed	Stomatin (Erythrocyte band 7 integral membrane protein) (Erythrocyte membrane protein band 7.2) (Protein 7.2b)	STOM BND7 EPB72	Homo sapiens (Human)	288	azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of acid-sensing ion channel activity [GO:1901585]	azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]	GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042802; GO:0042803; GO:0043312; GO:0044829; GO:0045121; GO:0048471; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585	neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of acid-sensing ion channel activity [GO:1901585]		NA	NA	NA	NA	NA	NA
TRINITY_DN33273_c0_g1_i1	Q19200	STO1_CAEEL	52.8	72	34	0	226	11	176	247	1.50E-12	73.2	STO1_CAEEL	reviewed	Stomatin-1	sto-1 F08C6.4	Caenorhabditis elegans	330	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN26989_c0_g1_i1	Q9UBI4	STML1_HUMAN	33.5	182	119	2	87	629	53	233	2.50E-25	117.1	STML1_HUMAN	reviewed	Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP)	STOML1 SLP1 UNC24 MSTP019	Homo sapiens (Human)	398	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]		GO:0005886; GO:0006869; GO:0016021; GO:0031902; GO:0045121	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN26989_c0_g1_i2	Q9UBI4	STML1_HUMAN	33.5	182	119	2	81	623	53	233	2.50E-25	117.1	STML1_HUMAN	reviewed	Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP)	STOML1 SLP1 UNC24 MSTP019	Homo sapiens (Human)	398	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]		GO:0005886; GO:0006869; GO:0016021; GO:0031902; GO:0045121	lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN2887_c0_g1_i1	Q32LL2	STML2_BOVIN	54.6	326	137	1	98	1042	4	329	9.80E-86	318.5	STML2_BOVIN	reviewed	"Stomatin-like protein 2, mitochondrial (SLP-2)"	STOML2	Bos taurus (Bovine)	356	"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]	cardiolipin binding [GO:1901612]	GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24195_c0_g2_i1	Q9UJZ1	STML2_HUMAN	100	194	0	0	3	584	17	210	4.40E-104	378.6	STML2_HUMAN	reviewed	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	Homo sapiens (Human)	356	"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]	cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32948_c0_g1_i1	Q9UJZ1	STML2_HUMAN	60.4	169	67	0	535	29	41	209	4.70E-54	212.2	STML2_HUMAN	reviewed	"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)"	STOML2 SLP2 HSPC108	Homo sapiens (Human)	356	"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]	cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24195_c0_g1_i1	Q99JB2	STML2_MOUSE	99.5	193	1	0	1	579	18	210	5.70E-104	378.3	STML2_MOUSE	reviewed	"Stomatin-like protein 2, mitochondrial (SLP-2) (mslp2)"	Stoml2 Slp2	Mus musculus (Mouse)	353	"actin cytoskeleton [GO:0015629]; COP9 signalosome [GO:0008180]; extrinsic component of plasma membrane [GO:0019897]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; T cell receptor complex [GO:0042101]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	actin cytoskeleton [GO:0015629]; COP9 signalosome [GO:0008180]; extrinsic component of plasma membrane [GO:0019897]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; T cell receptor complex [GO:0042101]	cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]	GO:0001772; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0006874; GO:0007005; GO:0008180; GO:0010876; GO:0010918; GO:0015629; GO:0019897; GO:0032623; GO:0034982; GO:0035710; GO:0042101; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13043_c0_g2_i1	Q86TL2	STIMA_HUMAN	37.3	161	80	5	551	93	118	265	3.80E-19	96.3	STIMA_HUMAN	reviewed	Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110)	STIMATE TMEM110	Homo sapiens (Human)	294	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium channel regulator activity [GO:0005246]	GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268	activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]		NA	NA	NA	NA	NA	NA
TRINITY_DN13043_c0_g1_i1	Q86TL2	STIMA_HUMAN	50	96	48	0	290	3	24	119	6.60E-23	108.2	STIMA_HUMAN	reviewed	Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110)	STIMATE TMEM110	Homo sapiens (Human)	294	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium channel regulator activity [GO:0005246]	GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268	activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]		NA	NA	NA	NA	NA	NA
TRINITY_DN4060_c0_g2_i1	Q96BY9	SARAF_HUMAN	95.1	122	6	0	369	4	42	163	1.10E-67	256.9	SARAF_HUMAN	reviewed	Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66)	SARAF TMEM66 XTP3 HSPC035 NPD003 PSEC0019 UNQ1967/PRO4499	Homo sapiens (Human)	339	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006816; GO:0030176; GO:0140268; GO:2001256	calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]		NA	NA	NA	NA	NA	NA
TRINITY_DN4060_c0_g1_i1	Q96BY9	SARAF_HUMAN	93.5	77	4	1	228	1	88	164	2.30E-36	152.5	SARAF_HUMAN	reviewed	Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66)	SARAF TMEM66 XTP3 HSPC035 NPD003 PSEC0019 UNQ1967/PRO4499	Homo sapiens (Human)	339	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006816; GO:0030176; GO:0140268; GO:2001256	calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]		NA	NA	NA	NA	NA	NA
TRINITY_DN4060_c0_g1_i1	Q96BY9	SARAF_HUMAN	100	25	0	0	286	212	10	34	3.50E-08	58.9	SARAF_HUMAN	reviewed	Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66)	SARAF TMEM66 XTP3 HSPC035 NPD003 PSEC0019 UNQ1967/PRO4499	Homo sapiens (Human)	339	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006816; GO:0030176; GO:0140268; GO:2001256	calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]		NA	NA	NA	NA	NA	NA
TRINITY_DN4060_c0_g1_i2	Q96BY9	SARAF_HUMAN	100	128	0	0	384	1	37	164	1.10E-73	276.9	SARAF_HUMAN	reviewed	Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66)	SARAF TMEM66 XTP3 HSPC035 NPD003 PSEC0019 UNQ1967/PRO4499	Homo sapiens (Human)	339	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006816; GO:0030176; GO:0140268; GO:2001256	calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]		NA	NA	NA	NA	NA	NA
TRINITY_DN30810_c0_g1_i1	F1QPC3	SARAF_DANRE	61.1	113	43	1	168	506	25	136	1.40E-35	151.4	SARAF_DANRE	reviewed	Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (Transmembrane protein 66)	saraf tmem66 zgc:153286	Danio rerio (Zebrafish) (Brachydanio rerio)	345	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0006816; GO:0030176; GO:0140268; GO:2001256	calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]		NA	NA	NA	NA	NA	NA
TRINITY_DN10454_c0_g1_i2	Q3ZCH0	GRP75_BOVIN	99.7	626	2	0	3	1880	46	671	0	1204.1	GRP75_BOVIN	reviewed	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)"	HSPA9	Bos taurus (Bovine)	679	cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0006611; GO:0006986; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:1902037; GO:1903707	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN174_c0_g1_i11	O35501	GRP75_CRIGR	80.3	315	62	0	1029	85	345	659	8.30E-136	485	GRP75_CRIGR	reviewed	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)"	HSPA9	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	679	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein folding [GO:0006457]; regulation of erythrocyte differentiation [GO:0045646]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005730; GO:0005739; GO:0006457; GO:0016226; GO:0030218; GO:0045646; GO:0045647; GO:0051082; GO:1902037; GO:1903707	erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein folding [GO:0006457]; regulation of erythrocyte differentiation [GO:0045646]		blue	blue	NA	NA	NA	1
TRINITY_DN37632_c0_g1_i1	O35501	GRP75_CRIGR	100	99	0	0	297	1	54	152	3.90E-50	198.4	GRP75_CRIGR	reviewed	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)"	HSPA9	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	679	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein folding [GO:0006457]; regulation of erythrocyte differentiation [GO:0045646]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005730; GO:0005739; GO:0006457; GO:0016226; GO:0030218; GO:0045646; GO:0045647; GO:0051082; GO:1902037; GO:1903707	erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein folding [GO:0006457]; regulation of erythrocyte differentiation [GO:0045646]		NA	NA	NA	NA	NA	NA
TRINITY_DN17811_c0_g1_i1	P38646	GRP75_HUMAN	100	106	0	0	3	320	192	297	7.40E-55	214.2	GRP75_HUMAN	reviewed	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (MOT) (Peptide-binding protein 74) (PBP74)"	HSPA9 GRP75 HSPA9B mt-HSP70	Homo sapiens (Human)	679	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; interleukin-12-mediated signaling pathway [GO:0035722]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001401; GO:0003723; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005925; GO:0006611; GO:0006986; GO:0007007; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0035722; GO:0042026; GO:0042645; GO:0043066; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0140275; GO:1902037	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; interleukin-12-mediated signaling pathway [GO:0035722]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN10454_c0_g1_i1	P38647	GRP75_MOUSE	99.8	587	1	0	3	1763	46	632	0	1138.3	GRP75_MOUSE	reviewed	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (Peptide-binding protein 74) (PBP74) (p66 MOT)"	Hspa9 Grp75 Hsp74 Hspa9a	Mus musculus (Mouse)	679	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cell death [GO:0060548]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006611; GO:0006986; GO:0016226; GO:0016887; GO:0017134; GO:0019899; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0043209; GO:0044183; GO:0045646; GO:0045647; GO:0046777; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0060548; GO:1902037; GO:1903707	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cell death [GO:0060548]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]		NA	NA	NA	NA	NA	NA
TRINITY_DN706_c0_g1_i5	Q9V719	SIN1_DROME	61.3	31	12	0	1085	993	1	31	4.60E-06	53.9	SIN1_DROME	reviewed	Stress-activated map kinase-interacting protein 1 (SAPK-interacting protein 1) (dSin1)	Sin1 CG10105	Drosophila melanogaster (Fruit fly)	569	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of protein phosphorylation [GO:0001932]; stress granule assembly [GO:0034063]; TORC2 signaling [GO:0038203]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]"	GO:0001932; GO:0001934; GO:0005546; GO:0005737; GO:0005886; GO:0006915; GO:0019901; GO:0030950; GO:0031932; GO:0032869; GO:0034063; GO:0038203; GO:0043539; GO:0045887; GO:0046628; GO:0048813; GO:0051897	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of protein phosphorylation [GO:0001932]; stress granule assembly [GO:0034063]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN706_c0_g1_i9	Q9V719	SIN1_DROME	61.3	31	12	0	1085	993	1	31	4.60E-06	53.9	SIN1_DROME	reviewed	Stress-activated map kinase-interacting protein 1 (SAPK-interacting protein 1) (dSin1)	Sin1 CG10105	Drosophila melanogaster (Fruit fly)	569	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of protein phosphorylation [GO:0001932]; stress granule assembly [GO:0034063]; TORC2 signaling [GO:0038203]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]"	GO:0001932; GO:0001934; GO:0005546; GO:0005737; GO:0005886; GO:0006915; GO:0019901; GO:0030950; GO:0031932; GO:0032869; GO:0034063; GO:0038203; GO:0043539; GO:0045887; GO:0046628; GO:0048813; GO:0051897	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of protein phosphorylation [GO:0001932]; stress granule assembly [GO:0034063]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN2635_c0_g1_i1	P92208	JNK_DROME	86.4	369	46	2	434	1540	3	367	3.10E-186	652.9	JNK_DROME	reviewed	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	Drosophila melanogaster (Fruit fly)	372	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0004705; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007258; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0009408; GO:0010468; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0035556; GO:0042060; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2635_c0_g1_i4	P92208	JNK_DROME	82.7	81	14	0	434	676	3	83	6.60E-32	139	JNK_DROME	reviewed	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	bsk JNK CG5680	Drosophila melanogaster (Fruit fly)	372	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0004705; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007258; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0009408; GO:0010468; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0035556; GO:0042060; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801	"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc fusion, thorax closure [GO:0046529]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6621_c0_g1_i1	Q3ZBZ8	STIP1_BOVIN	52.1	96	46	0	84	371	3	98	4.30E-22	105.9	STIP1_BOVIN	reviewed	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop)	STIP1	Bos taurus (Bovine)	543	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	Hsp90 protein binding [GO:0051879]	GO:0005634; GO:0005737; GO:0051879			NA	NA	NA	NA	NA	NA
TRINITY_DN6621_c0_g1_i2	Q4R8N7	STIP1_MACFA	42.1	190	105	1	84	653	3	187	2.80E-38	160.2	STIP1_MACFA	reviewed	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop)	STIP1 QtsA-11959	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	543	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN3328_c0_g1_i1	Q3ZBZ8	STIP1_BOVIN	58.8	221	88	1	654	1	322	542	4.20E-73	275.8	STIP1_BOVIN	reviewed	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop)	STIP1	Bos taurus (Bovine)	543	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	Hsp90 protein binding [GO:0051879]	GO:0005634; GO:0005737; GO:0051879			NA	NA	NA	NA	NA	NA
TRINITY_DN17424_c0_g1_i1	P31948	STIP1_HUMAN	98.6	72	1	0	217	2	456	527	2.20E-34	145.6	STIP1_HUMAN	reviewed	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	Homo sapiens (Human)	543	chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005794; GO:0005829; GO:0008022; GO:0030544; GO:0032991; GO:0051087; GO:0051879; GO:0098761; GO:0101031	cellular response to interleukin-7 [GO:0098761]		NA	NA	NA	NA	NA	NA
TRINITY_DN17424_c1_g1_i1	P31948	STIP1_HUMAN	100	206	0	0	3	620	333	538	7.90E-114	411	STIP1_HUMAN	reviewed	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	STIP1	Homo sapiens (Human)	543	chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005794; GO:0005829; GO:0008022; GO:0030544; GO:0032991; GO:0051087; GO:0051879; GO:0098761; GO:0101031	cellular response to interleukin-7 [GO:0098761]		NA	NA	NA	NA	NA	NA
TRINITY_DN17424_c0_g2_i1	Q60864	STIP1_MOUSE	98.7	76	1	0	231	4	342	417	2.20E-37	155.6	STIP1_MOUSE	reviewed	Stress-induced-phosphoprotein 1 (STI1) (mSTI1) (Hsc70/Hsp90-organizing protein) (Hop)	Stip1	Mus musculus (Mouse)	543	chaperone complex [GO:0101031]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; cellular response to interleukin-7 [GO:0098761]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]	GO:0005634; GO:0005829; GO:0008022; GO:0030544; GO:0032991; GO:0043209; GO:0051087; GO:0051879; GO:0098761; GO:0101031	cellular response to interleukin-7 [GO:0098761]		NA	NA	NA	NA	NA	NA
TRINITY_DN35507_c0_g1_i1	Q9ERG2	STRN3_MOUSE	64	164	55	2	556	71	411	572	1.80E-56	220.3	STRN3_MOUSE	reviewed	Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)	Strn3 Gs2na Sg2na	Mus musculus (Mouse)	796	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; Rho GTPase binding [GO:0017048]	GO:0000122; GO:0003700; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0017048; GO:0030425; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443	"negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35507_c0_g1_i2	Q13033	STRN3_HUMAN	64.8	182	60	2	540	1	412	591	1.60E-65	250.4	STRN3_HUMAN	reviewed	Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)	STRN3 GS2NA SG2NA	Homo sapiens (Human)	797	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; Rho GTPase binding [GO:0017048]	GO:0000122; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0017048; GO:0030425; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443	"negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30698_c0_g1_i1	Q9ERG2	STRN3_MOUSE	98.8	171	2	0	3	515	420	590	5.70E-97	354.8	STRN3_MOUSE	reviewed	Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)	Strn3 Gs2na Sg2na	Mus musculus (Mouse)	796	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein-containing complex binding [GO:0044877]; protein phosphatase 2A binding [GO:0051721]; Rho GTPase binding [GO:0017048]	GO:0000122; GO:0003700; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0017048; GO:0030425; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443	"negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26166_c0_g1_i1	Q0P5J8	STRP1_BOVIN	100	77	0	0	1	231	519	595	2.60E-33	142.1	STRP1_BOVIN	reviewed	Striatin-interacting protein 1 (Protein FAM40A)	STRIP1 FAM40A	Bos taurus (Bovine)	837	cytosol [GO:0005829]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]	cytosol [GO:0005829]		GO:0005829; GO:0007010; GO:0022604; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN2203_c0_g1_i1	Q8C079	STRP1_MOUSE	46.8	325	166	5	42	1013	47	365	4.00E-68	260	STRP1_MOUSE	reviewed	Striatin-interacting protein 1 (Protein FAM40A)	Strip1 Fam40a Kiaa1761	Mus musculus (Mouse)	837	cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]	GO:0005634; GO:0005829; GO:0007010; GO:0017048; GO:0019901; GO:0022604; GO:0030866	cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN4074_c0_g1_i1	Q803T2	STRP1_DANRE	65.3	464	128	2	1491	103	381	812	6.10E-168	592	STRP1_DANRE	reviewed	Striatin-interacting protein 1 homolog	strip1 fam40a	Danio rerio (Zebrafish) (Brachydanio rerio)	813	cytosol [GO:0005829]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; heart contraction [GO:0060047]; regulation of cell morphogenesis [GO:0022604]	cytosol [GO:0005829]		GO:0005829; GO:0007010; GO:0022604; GO:0030866; GO:0060047	cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; heart contraction [GO:0060047]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN15469_c0_g1_i1	Q9DCT5	SDF2_MOUSE	99.3	143	1	0	1	429	15	157	1.60E-81	303.1	SDF2_MOUSE	reviewed	Stromal cell-derived factor 2 (SDF-2)	Sdf2	Mus musculus (Mouse)	211	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005576; GO:0005789; GO:0035269; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]		NA	NA	NA	NA	NA	NA
TRINITY_DN15469_c0_g1_i2	Q99470	SDF2_HUMAN	100	127	0	0	1	381	31	157	4.20E-73	275	SDF2_HUMAN	reviewed	Stromal cell-derived factor 2 (SDF-2)	SDF2	Homo sapiens (Human)	211	extracellular space [GO:0005615]; membrane [GO:0016020]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; protein glycosylation [GO:0006486]	extracellular space [GO:0005615]; membrane [GO:0016020]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005615; GO:0006486; GO:0016020	protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN26526_c0_g1_i2	Q9DCT5	SDF2_MOUSE	54	200	92	0	727	128	1	200	1.80E-57	224.2	SDF2_MOUSE	reviewed	Stromal cell-derived factor 2 (SDF-2)	Sdf2	Mus musculus (Mouse)	211	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]	GO:0004169; GO:0005576; GO:0005789; GO:0035269; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]		blue	blue	NA	NA	NA	NA
TRINITY_DN13474_c0_g1_i2	Q9ESP1	SDF2L_MOUSE	100	150	0	0	1	450	18	167	7.30E-85	314.3	SDF2L_MOUSE	reviewed	Stromal cell-derived factor 2-like protein 1 (SDF2-like protein 1)	Sdf2l1	Mus musculus (Mouse)	221	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; misfolded protein binding [GO:0051787]; cellular response to misfolded protein [GO:0071218]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]	ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; misfolded protein binding [GO:0051787]	GO:0004169; GO:0005783; GO:0005788; GO:0005789; GO:0016020; GO:0034663; GO:0034976; GO:0035269; GO:0042981; GO:0051087; GO:0051117; GO:0051787; GO:0071218; GO:0071712	cellular response to misfolded protein [GO:0071218]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN26526_c0_g1_i1	Q9ESP1	SDF2L_MOUSE	66.7	60	20	0	267	88	36	95	7.40E-18	91.7	SDF2L_MOUSE	reviewed	Stromal cell-derived factor 2-like protein 1 (SDF2-like protein 1)	Sdf2l1	Mus musculus (Mouse)	221	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; misfolded protein binding [GO:0051787]; cellular response to misfolded protein [GO:0071218]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]	ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; misfolded protein binding [GO:0051787]	GO:0004169; GO:0005783; GO:0005788; GO:0005789; GO:0016020; GO:0034663; GO:0034976; GO:0035269; GO:0042981; GO:0051087; GO:0051117; GO:0051787; GO:0071218; GO:0071712	cellular response to misfolded protein [GO:0071218]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN13474_c0_g1_i1	Q9HCN8	SDF2L_HUMAN	100	125	0	0	2	376	36	160	2.30E-71	269.2	SDF2L_HUMAN	reviewed	Stromal cell-derived factor 2-like protein 1 (SDF2-like protein 1) (PWP1-interacting protein 8)	SDF2L1 UNQ1941/PRO4424	Homo sapiens (Human)	221	endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; misfolded protein binding [GO:0051787]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]; regulation of apoptotic process [GO:0042981]	endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]	ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; misfolded protein binding [GO:0051787]	GO:0004169; GO:0005788; GO:0005789; GO:0034663; GO:0035269; GO:0042981; GO:0051087; GO:0051117; GO:0051787; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]; regulation of apoptotic process [GO:0042981]		NA	NA	NA	NA	NA	NA
TRINITY_DN3961_c0_g1_i2	P83094	STIM_DROME	47.2	373	192	3	1257	154	145	517	5.60E-83	309.7	STIM_DROME	reviewed	Stromal interaction molecule homolog	Stim CG9126	Drosophila melanogaster (Fruit fly)	570	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium channel regulator activity [GO:0005246]; calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016021; GO:0022416; GO:0032237; GO:0048763; GO:0051924	activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]		NA	NA	NA	NA	NA	NA
TRINITY_DN3961_c0_g1_i3	P83094	STIM_DROME	47.2	373	192	3	1985	882	145	517	8.60E-83	309.7	STIM_DROME	reviewed	Stromal interaction molecule homolog	Stim CG9126	Drosophila melanogaster (Fruit fly)	570	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium channel regulator activity [GO:0005246]; calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016021; GO:0022416; GO:0032237; GO:0048763; GO:0051924	activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]		NA	NA	NA	NA	NA	NA
TRINITY_DN3961_c0_g1_i4	P83094	STIM_DROME	47.2	373	192	3	2401	1298	145	517	1.00E-82	309.7	STIM_DROME	reviewed	Stromal interaction molecule homolog	Stim CG9126	Drosophila melanogaster (Fruit fly)	570	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium channel regulator activity [GO:0005246]; calcium-induced calcium release activity [GO:0048763]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016021; GO:0022416; GO:0032237; GO:0048763; GO:0051924	activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]		NA	NA	NA	NA	NA	NA
TRINITY_DN7075_c0_g1_i1	Q8IYB5	SMAP1_HUMAN	50.7	69	34	0	208	2	25	93	5.70E-16	84.7	SMAP1_HUMAN	reviewed	Stromal membrane-associated protein 1	SMAP1	Homo sapiens (Human)	467	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0005886; GO:0030276; GO:0045648; GO:0046872; GO:2000369	positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]		NA	NA	NA	NA	NA	NA
TRINITY_DN39235_c0_g1_i1	Q8IYB5	SMAP1_HUMAN	100	137	0	0	414	4	1	137	1.50E-76	286.6	SMAP1_HUMAN	reviewed	Stromal membrane-associated protein 1	SMAP1	Homo sapiens (Human)	467	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0005886; GO:0030276; GO:0045648; GO:0046872; GO:2000369	positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]		NA	NA	NA	NA	NA	NA
TRINITY_DN338_c0_g4_i1	Q91VZ6	SMAP1_MOUSE	55.6	126	50	2	478	119	1	126	5.70E-34	145.6	SMAP1_MOUSE	reviewed	Stromal membrane-associated protein 1	Smap1	Mus musculus (Mouse)	440	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0005886; GO:0030276; GO:0045648; GO:0046872; GO:2000369	positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]		blue	blue	NA	NA	NA	NA
TRINITY_DN338_c0_g4_i2	Q91VZ6	SMAP1_MOUSE	66.4	128	43	0	592	209	1	128	5.70E-49	195.7	SMAP1_MOUSE	reviewed	Stromal membrane-associated protein 1	Smap1	Mus musculus (Mouse)	440	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0005886; GO:0030276; GO:0045648; GO:0046872; GO:2000369	positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369]		blue	blue	NA	NA	NA	NA
TRINITY_DN23269_c0_g1_i1	Q8WU79	SMAP2_HUMAN	100	143	0	0	33	461	1	143	3.00E-81	302.4	SMAP2_HUMAN	reviewed	Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like)	SMAP2 SMAP1L	Homo sapiens (Human)	429	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN23269_c0_g1_i2	Q8WU79	SMAP2_HUMAN	100	123	0	0	42	410	21	143	7.90E-70	264.2	SMAP2_HUMAN	reviewed	Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like)	SMAP2 SMAP1L	Homo sapiens (Human)	429	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	cytoplasm [GO:0005737]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27530_c0_g1_i1	O94383	SMC1_SCHPO	48.7	76	38	1	225	1	1120	1195	2.20E-13	75.9	SMC1_SCHPO	reviewed	Structural maintenance of chromosomes protein 1 (Chromosome segregation protein smc1) (Cohesin complex subunit psm1)	psm1 smc1 SPBC29A10.04	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1228	"chromosome [GO:0005694]; cohesin complex [GO:0008278]; condensed nuclear chromosome, centromeric region [GO:0000780]; mitotic cohesin complex [GO:0030892]; nuclear mitotic cohesin complex [GO:0034990]; ATP binding [GO:0005524]; cohesin ATPase activity [GO:0061775]; cell division [GO:0051301]; mitotic cohesin loading [GO:0061780]; mitotic cohesin ssDNA (lagging strand) loading [GO:0062022]; mitotic sister chromatid cohesion [GO:0007064]"	"chromosome [GO:0005694]; cohesin complex [GO:0008278]; condensed nuclear chromosome, centromeric region [GO:0000780]; mitotic cohesin complex [GO:0030892]; nuclear mitotic cohesin complex [GO:0034990]"	ATP binding [GO:0005524]; cohesin ATPase activity [GO:0061775]	GO:0000780; GO:0005524; GO:0005694; GO:0007064; GO:0008278; GO:0030892; GO:0034990; GO:0051301; GO:0061775; GO:0061780; GO:0062022	cell division [GO:0051301]; mitotic cohesin loading [GO:0061780]; mitotic cohesin ssDNA (lagging strand) loading [GO:0062022]; mitotic sister chromatid cohesion [GO:0007064]		NA	NA	NA	NA	NA	NA
TRINITY_DN36861_c0_g1_i1	O94383	SMC1_SCHPO	52.6	78	37	0	234	1	1099	1176	3.40E-17	88.6	SMC1_SCHPO	reviewed	Structural maintenance of chromosomes protein 1 (Chromosome segregation protein smc1) (Cohesin complex subunit psm1)	psm1 smc1 SPBC29A10.04	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1228	"chromosome [GO:0005694]; cohesin complex [GO:0008278]; condensed nuclear chromosome, centromeric region [GO:0000780]; mitotic cohesin complex [GO:0030892]; nuclear mitotic cohesin complex [GO:0034990]; ATP binding [GO:0005524]; cohesin ATPase activity [GO:0061775]; cell division [GO:0051301]; mitotic cohesin loading [GO:0061780]; mitotic cohesin ssDNA (lagging strand) loading [GO:0062022]; mitotic sister chromatid cohesion [GO:0007064]"	"chromosome [GO:0005694]; cohesin complex [GO:0008278]; condensed nuclear chromosome, centromeric region [GO:0000780]; mitotic cohesin complex [GO:0030892]; nuclear mitotic cohesin complex [GO:0034990]"	ATP binding [GO:0005524]; cohesin ATPase activity [GO:0061775]	GO:0000780; GO:0005524; GO:0005694; GO:0007064; GO:0008278; GO:0030892; GO:0034990; GO:0051301; GO:0061775; GO:0061780; GO:0062022	cell division [GO:0051301]; mitotic cohesin loading [GO:0061780]; mitotic cohesin ssDNA (lagging strand) loading [GO:0062022]; mitotic sister chromatid cohesion [GO:0007064]		NA	NA	NA	NA	NA	NA
TRINITY_DN2417_c0_g1_i1	O01789	SMC1_CAEEL	58.1	62	26	0	28	213	16	77	2.10E-15	82.8	SMC1_CAEEL	reviewed	Structural maintenance of chromosomes protein 1 (High incidence of males protein 1)	him-1 smc-1 F28B3.7	Caenorhabditis elegans	1262	cohesin complex [GO:0008278]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic sister chromatid cohesion [GO:0007064]; response to UV [GO:0009411]; response to X-ray [GO:0010165]	cohesin complex [GO:0008278]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000790; GO:0003677; GO:0005524; GO:0005634; GO:0006281; GO:0007059; GO:0007064; GO:0008278; GO:0009411; GO:0009792; GO:0010165; GO:0051301	cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic sister chromatid cohesion [GO:0007064]; response to UV [GO:0009411]; response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN3207_c0_g1_i1	O97593	SMC1A_BOVIN	44.7	76	42	0	347	120	729	804	4.10E-11	68.9	SMC1A_BOVIN	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A)	SMC1A SMC1 SMC1L1	Bos taurus (Bovine)	1233	cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; stem cell population maintenance [GO:0019827]	cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007064; GO:0009314; GO:0016363; GO:0019827; GO:0030893; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN19970_c1_g1_i1	O97593	SMC1A_BOVIN	100	81	0	0	2	244	1110	1190	7.80E-41	167.2	SMC1A_BOVIN	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A)	SMC1A SMC1 SMC1L1	Bos taurus (Bovine)	1233	cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; stem cell population maintenance [GO:0019827]	cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007064; GO:0009314; GO:0016363; GO:0019827; GO:0030893; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN20907_c0_g1_i1	O97593	SMC1A_BOVIN	100	76	0	0	231	4	15	90	5.00E-37	154.5	SMC1A_BOVIN	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A)	SMC1A SMC1 SMC1L1	Bos taurus (Bovine)	1233	cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; stem cell population maintenance [GO:0019827]	cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007064; GO:0009314; GO:0016363; GO:0019827; GO:0030893; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN2725_c0_g1_i1	O93308	SMC1A_XENLA	66.4	238	80	0	784	71	4	241	9.80E-76	285	SMC1A_XENLA	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A) (xSMC1)	smc1a smc1 smc1l1	Xenopus laevis (African clawed frog)	1232	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0006281; GO:0007064; GO:0009314; GO:0030893; GO:0051301; GO:0051321; GO:0072423	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN3207_c0_g1_i2	O93308	SMC1A_XENLA	48.9	274	132	4	941	126	535	802	3.60E-57	223.4	SMC1A_XENLA	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A) (xSMC1)	smc1a smc1 smc1l1	Xenopus laevis (African clawed frog)	1232	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0006281; GO:0007064; GO:0009314; GO:0030893; GO:0051301; GO:0051321; GO:0072423	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN3207_c0_g1_i4	O93308	SMC1A_XENLA	43.4	76	43	0	353	126	727	802	7.20E-11	68.2	SMC1A_XENLA	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A) (xSMC1)	smc1a smc1 smc1l1	Xenopus laevis (African clawed frog)	1232	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0006281; GO:0007064; GO:0009314; GO:0030893; GO:0051301; GO:0051321; GO:0072423	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19970_c0_g1_i1	O93308	SMC1A_XENLA	56.1	314	134	3	937	2	895	1206	5.40E-82	305.8	SMC1A_XENLA	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A) (xSMC1)	smc1a smc1 smc1l1	Xenopus laevis (African clawed frog)	1232	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0006281; GO:0007064; GO:0009314; GO:0030893; GO:0051301; GO:0051321; GO:0072423	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19970_c0_g1_i2	O93308	SMC1A_XENLA	56.1	314	134	3	937	2	895	1206	5.40E-82	305.8	SMC1A_XENLA	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1A) (xSMC1)	smc1a smc1 smc1l1	Xenopus laevis (African clawed frog)	1232	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]	kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0006281; GO:0007064; GO:0009314; GO:0030893; GO:0051301; GO:0051321; GO:0072423	cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN6100_c0_g1_i1	Q8NDV3	SMC1B_HUMAN	31.7	252	172	0	775	20	260	511	1.30E-28	128.3	SMC1B_HUMAN	reviewed	Structural maintenance of chromosomes protein 1B (SMC protein 1B) (SMC-1-beta) (SMC-1B)	SMC1B SMC1L2	Homo sapiens (Human)	1235	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]	GO:0000775; GO:0000800; GO:0003677; GO:0005524; GO:0005654; GO:0005829; GO:0007064; GO:0030893; GO:0034991; GO:0051321	meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]		NA	NA	NA	NA	NA	NA
TRINITY_DN11544_c0_g1_i1	Q54PK4	SMC2_DICDI	72.8	206	56	0	626	9	9	214	3.60E-82	305.8	SMC2_DICDI	reviewed	Structural maintenance of chromosomes protein 2	smc2 DDB_G0284499	Dictyostelium discoideum (Slime mold)	1184	chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]	chromosome [GO:0005694]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005694; GO:0007076; GO:0051301	cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN30489_c0_g1_i3	Q54PK4	SMC2_DICDI	65.4	81	28	0	266	24	1104	1184	2.30E-24	112.8	SMC2_DICDI	reviewed	Structural maintenance of chromosomes protein 2	smc2 DDB_G0284499	Dictyostelium discoideum (Slime mold)	1184	chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]	chromosome [GO:0005694]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005694; GO:0007076; GO:0051301	cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN7707_c0_g1_i1	P41003	SMC2_SCHPO	57.5	106	45	0	340	23	1064	1169	1.60E-26	120.2	SMC2_SCHPO	reviewed	Structural maintenance of chromosomes protein 2 (Cell untimely torn protein 14) (Chromosome segregation protein cut14)	cut14 smc2 SPBP4H10.06c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1172	"chromosome, centromeric core domain [GO:0034506]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear condensin complex [GO:0000799]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; DNA translocase activity [GO:0015616]; cell division [GO:0051301]; DNA rewinding [GO:0036292]; mitotic chromosome condensation [GO:0007076]"	"chromosome, centromeric core domain [GO:0034506]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear condensin complex [GO:0000799]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]"	ATP binding [GO:0005524]; DNA translocase activity [GO:0015616]	GO:0000778; GO:0000790; GO:0000799; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007076; GO:0015616; GO:0034506; GO:0035327; GO:0036292; GO:0051301	cell division [GO:0051301]; DNA rewinding [GO:0036292]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN26976_c0_g1_i1	P41003	SMC2_SCHPO	53.4	88	41	0	278	15	513	600	2.80E-18	92.4	SMC2_SCHPO	reviewed	Structural maintenance of chromosomes protein 2 (Cell untimely torn protein 14) (Chromosome segregation protein cut14)	cut14 smc2 SPBP4H10.06c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1172	"chromosome, centromeric core domain [GO:0034506]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear condensin complex [GO:0000799]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; ATP binding [GO:0005524]; DNA translocase activity [GO:0015616]; cell division [GO:0051301]; DNA rewinding [GO:0036292]; mitotic chromosome condensation [GO:0007076]"	"chromosome, centromeric core domain [GO:0034506]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear condensin complex [GO:0000799]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]"	ATP binding [GO:0005524]; DNA translocase activity [GO:0015616]	GO:0000778; GO:0000790; GO:0000799; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007076; GO:0015616; GO:0034506; GO:0035327; GO:0036292; GO:0051301	cell division [GO:0051301]; DNA rewinding [GO:0036292]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2081_c0_g1_i5	Q90988	SMC2_CHICK	32.2	655	444	0	2030	66	343	997	3.50E-86	320.9	SMC2_CHICK	reviewed	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII)	SMC2 SCII SMC2L1	Gallus gallus (Chicken)	1189	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0007049; GO:0030261; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]		NA	NA	NA	NA	NA	NA
TRINITY_DN25601_c0_g1_i1	Q90988	SMC2_CHICK	51.5	66	32	0	236	39	1	66	1.90E-14	79.7	SMC2_CHICK	reviewed	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII)	SMC2 SCII SMC2L1	Gallus gallus (Chicken)	1189	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0007049; GO:0030261; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]		NA	NA	NA	NA	NA	NA
TRINITY_DN2081_c0_g1_i2	Q8CG48	SMC2_MOUSE	48.9	1173	599	0	3589	71	1	1173	3.80E-288	992.6	SMC2_MOUSE	reviewed	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (FGF-inducible protein 16) (XCAP-E homolog)	Smc2 Cape Fin16 Smc2l1	Mus musculus (Mouse)	1191	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0000228; GO:0000793; GO:0000796; GO:0000797; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007076; GO:0010032; GO:0045132; GO:0051301; GO:0051383	cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2081_c0_g1_i6	Q8CG48	SMC2_MOUSE	65.2	328	114	0	1047	64	1	328	3.50E-115	416.4	SMC2_MOUSE	reviewed	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (FGF-inducible protein 16) (XCAP-E homolog)	Smc2 Cape Fin16 Smc2l1	Mus musculus (Mouse)	1191	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0000228; GO:0000793; GO:0000796; GO:0000797; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007076; GO:0010032; GO:0045132; GO:0051301; GO:0051383	cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN21947_c0_g1_i1	O95347	SMC2_HUMAN	100	185	0	0	36	590	1	185	3.60E-100	365.5	SMC2_HUMAN	reviewed	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (hCAP-E) (XCAP-E homolog)	SMC2 CAPE SMC2L1 PRO0324	Homo sapiens (Human)	1197	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0000228; GO:0000793; GO:0000796; GO:0000797; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0045132; GO:0051301; GO:0051383; GO:0070062	cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN21947_c0_g1_i2	O95347	SMC2_HUMAN	100	139	0	0	36	452	1	139	1.70E-73	276.6	SMC2_HUMAN	reviewed	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (hCAP-E) (XCAP-E homolog)	SMC2 CAPE SMC2L1 PRO0324	Homo sapiens (Human)	1197	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; condensin core heterodimer [GO:0000797]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0000228; GO:0000793; GO:0000796; GO:0000797; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0045132; GO:0051301; GO:0051383; GO:0070062	cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN30489_c0_g1_i1	Q9SN90	SMC22_ARATH	71.5	165	44	1	545	51	1009	1170	1.40E-58	227.3	SMC22_ARATH	reviewed	Structural maintenance of chromosomes protein 2-2 (AtSMC2-2) (Chromosome-associated protein E-2) (AtCAP-E2)	SMC2-2 CAP-E2 At3g47460 F1P2.10 T21L8.210	Arabidopsis thaliana (Mouse-ear cress)	1171	chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]	chromosome [GO:0005694]; nucleus [GO:0005634]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005694; GO:0030261; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]		NA	NA	NA	NA	NA	NA
TRINITY_DN24_c0_g1_i1	O93309	SMC3_XENLA	69.6	250	76	0	2817	2068	1	250	4.30E-93	344.4	SMC3_XENLA	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)	smc3 smc3l1	Xenopus laevis (African clawed frog)	1209	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]"	ATP binding [GO:0005524]	GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN24_c0_g1_i1	O93309	SMC3_XENLA	36.4	423	267	2	1268	3	482	903	3.00E-62	241.9	SMC3_XENLA	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)	smc3 smc3l1	Xenopus laevis (African clawed frog)	1209	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]"	ATP binding [GO:0005524]	GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN32803_c0_g1_i1	O93309	SMC3_XENLA	55.5	110	49	0	343	14	1090	1199	1.10E-27	124	SMC3_XENLA	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)	smc3 smc3l1	Xenopus laevis (African clawed frog)	1209	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]"	ATP binding [GO:0005524]	GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN2442_c0_g1_i1	O93309	SMC3_XENLA	74.2	264	59	1	3	767	946	1209	4.30E-102	372.5	SMC3_XENLA	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)	smc3 smc3l1	Xenopus laevis (African clawed frog)	1209	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]"	ATP binding [GO:0005524]	GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		blue	blue	NA	NA	NA	NA
TRINITY_DN28938_c0_g1_i1	O97594	SMC3_BOVIN	100	67	0	0	204	4	1094	1160	1.60E-31	136	SMC3_BOVIN	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chondroitin sulfate proteoglycan 6)	SMC3 CSPG6 SMC3L1	Bos taurus (Bovine)	1218	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; dynein complex binding [GO:0070840]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]"	ATP binding [GO:0005524]; dynein complex binding [GO:0070840]	GO:0000775; GO:0000785; GO:0005524; GO:0006275; GO:0006281; GO:0016363; GO:0030893; GO:0051276; GO:0051301; GO:0051321; GO:0070840; GO:0097431	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN24_c0_g1_i2	O97594	SMC3_BOVIN	43.7	904	507	2	2711	3	1	903	1.70E-155	551.6	SMC3_BOVIN	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chondroitin sulfate proteoglycan 6)	SMC3 CSPG6 SMC3L1	Bos taurus (Bovine)	1218	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; dynein complex binding [GO:0070840]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]"	ATP binding [GO:0005524]; dynein complex binding [GO:0070840]	GO:0000775; GO:0000785; GO:0005524; GO:0006275; GO:0006281; GO:0016363; GO:0030893; GO:0051276; GO:0051301; GO:0051321; GO:0070840; GO:0097431	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		blue	blue	NA	NA	NA	NA
TRINITY_DN36049_c0_g1_i1	O97594	SMC3_BOVIN	100	211	0	0	636	4	1	211	1.20E-113	410.6	SMC3_BOVIN	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chondroitin sulfate proteoglycan 6)	SMC3 CSPG6 SMC3L1	Bos taurus (Bovine)	1218	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; dynein complex binding [GO:0070840]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]"	ATP binding [GO:0005524]; dynein complex binding [GO:0070840]	GO:0000775; GO:0000785; GO:0005524; GO:0006275; GO:0006281; GO:0016363; GO:0030893; GO:0051276; GO:0051301; GO:0051321; GO:0070840; GO:0097431	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]		NA	NA	NA	NA	NA	NA
TRINITY_DN3409_c0_g1_i1	Q56YN8	SMC3_ARATH	49.4	85	31	2	12	254	1088	1164	4.40E-13	75.1	SMC3_ARATH	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chromosome segregation protein SMC-3) (Cohesin complex subunit SMC-3) (Protein TITAN7)	SMC3 TTN7 At2g27170 T22O13.6	Arabidopsis thaliana (Mouse-ear cress)	1204	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spindle [GO:0005819]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spindle [GO:0005819]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0006281; GO:0007059; GO:0007062; GO:0008278; GO:0009506; GO:0016363; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN6243_c0_g2_i1	Q56YN8	SMC3_ARATH	58.2	79	33	0	246	10	104	182	8.20E-22	104	SMC3_ARATH	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chromosome segregation protein SMC-3) (Cohesin complex subunit SMC-3) (Protein TITAN7)	SMC3 TTN7 At2g27170 T22O13.6	Arabidopsis thaliana (Mouse-ear cress)	1204	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spindle [GO:0005819]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spindle [GO:0005819]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0006281; GO:0007059; GO:0007062; GO:0008278; GO:0009506; GO:0016363; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN6243_c0_g1_i1	Q56YN8	SMC3_ARATH	65.7	108	36	1	3	326	1	107	1.80E-32	139.8	SMC3_ARATH	reviewed	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Chromosome segregation protein SMC-3) (Cohesin complex subunit SMC-3) (Protein TITAN7)	SMC3 TTN7 At2g27170 T22O13.6	Arabidopsis thaliana (Mouse-ear cress)	1204	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spindle [GO:0005819]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; spindle [GO:0005819]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0006281; GO:0007059; GO:0007062; GO:0008278; GO:0009506; GO:0016363; GO:0051301; GO:0051321	cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]		NA	NA	NA	NA	NA	NA
TRINITY_DN38168_c0_g1_i1	Q12267	SMC4_YEAST	55.2	67	30	0	249	49	152	218	4.40E-15	81.6	SMC4_YEAST	reviewed	Structural maintenance of chromosomes protein 4	SMC4 YLR086W L9449.5	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1418	cytoplasm [GO:0005737]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome separation [GO:0051307]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid segregation [GO:0000070]; rDNA condensation [GO:0070550]; synaptonemal complex assembly [GO:0007130]; tRNA gene clustering [GO:0070058]	cytoplasm [GO:0005737]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]	GO:0000070; GO:0000799; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0007076; GO:0007130; GO:0010032; GO:0051301; GO:0051307; GO:0070058; GO:0070550	cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome separation [GO:0051307]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid segregation [GO:0000070]; rDNA condensation [GO:0070550]; synaptonemal complex assembly [GO:0007130]; tRNA gene clustering [GO:0070058]		NA	NA	NA	NA	NA	NA
TRINITY_DN32431_c0_g1_i1	Q9FJL0	SMC4_ARATH	91.2	91	8	0	278	6	1114	1204	1.30E-42	173.3	SMC4_ARATH	reviewed	Structural maintenance of chromosomes protein 4 (AtSMC4) (SMC protein 4) (SMC-4) (Chromosome-associated protein C) (AtCAP-C)	SMC4 CAP-C At5g48600 K15N18.7	Arabidopsis thaliana (Mouse-ear cress)	1241	nuclear condensin complex [GO:0000799]; ATP binding [GO:0005524]; cell division [GO:0051301]; embryo development ending in seed dormancy [GO:0009793]; meiotic cell cycle [GO:0051321]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid segregation [GO:0000070]	nuclear condensin complex [GO:0000799]	ATP binding [GO:0005524]	GO:0000070; GO:0000799; GO:0005524; GO:0007076; GO:0009793; GO:0051301; GO:0051321	cell division [GO:0051301]; embryo development ending in seed dormancy [GO:0009793]; meiotic cell cycle [GO:0051321]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid segregation [GO:0000070]		NA	NA	NA	NA	NA	NA
TRINITY_DN40577_c0_g1_i1	P41004	SMC4_SCHPO	67	97	27	2	284	3	1197	1291	1.10E-30	133.7	SMC4_SCHPO	reviewed	Structural maintenance of chromosomes protein 4 (Cell untimely torn protein 3) (Chromosome segregation protein cut3)	cut3 smc4 SPBC146.03c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1324	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA translocase activity [GO:0015616]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA translocase activity [GO:0015616]	GO:0000790; GO:0000799; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007076; GO:0015616; GO:0051301	cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]		NA	NA	NA	NA	NA	NA
TRINITY_DN388_c0_g1_i1	Q805A1	SMC5_XENLA	46.7	107	53	2	313	5	933	1039	6.30E-20	98.2	SMC5_XENLA	reviewed	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5)	smc5 smc5l1	Xenopus laevis (African clawed frog)	1065	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]"	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]"	ATP binding [GO:0005524]	GO:0000722; GO:0000724; GO:0000781; GO:0005524; GO:0005634; GO:0007062; GO:0016605; GO:0030915; GO:0034184; GO:0051301; GO:0090398	cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]		NA	NA	NA	NA	NA	NA
TRINITY_DN5927_c0_g1_i1	Q8IY18	SMC5_HUMAN	40.5	131	77	1	393	1	89	218	1.00E-21	104.4	SMC5_HUMAN	reviewed	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (hSMC5)	SMC5 KIAA0594 SMC5L1	Homo sapiens (Human)	1101	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	ATP binding [GO:0005524]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6653_c0_g1_i1	Q8IY18	SMC5_HUMAN	40.7	243	141	2	776	57	851	1093	3.40E-46	186.8	SMC5_HUMAN	reviewed	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (hSMC5)	SMC5 KIAA0594 SMC5L1	Homo sapiens (Human)	1101	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	ATP binding [GO:0005524]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6653_c0_g1_i3	Q8IY18	SMC5_HUMAN	40.7	243	141	2	776	57	851	1093	3.40E-46	186.8	SMC5_HUMAN	reviewed	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (hSMC5)	SMC5 KIAA0594 SMC5L1	Homo sapiens (Human)	1101	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	ATP binding [GO:0005524]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6653_c0_g1_i7	Q8IY18	SMC5_HUMAN	40.7	243	141	2	776	57	851	1093	3.40E-46	186.8	SMC5_HUMAN	reviewed	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (hSMC5)	SMC5 KIAA0594 SMC5L1	Homo sapiens (Human)	1101	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	ATP binding [GO:0005524]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10370_c3_g1_i1	Q802R8	SMC6_TAKRU	26.4	958	651	10	3	2822	140	1061	5.50E-88	327.4	SMC6_TAKRU	reviewed	Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6)	smc6 smc6l1	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	1090	"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]"	"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]"	ATP binding [GO:0005524]	GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398	cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]		NA	NA	NA	NA	NA	NA
TRINITY_DN39011_c0_g1_i1	Q0IH86	SLX1_XENLA	49.6	274	120	4	871	101	5	277	1.50E-74	281.2	SLX1_XENLA	reviewed	Structure-specific endonuclease subunit slx1 (EC 3.1.-.-) (GIY-YIG domain-containing protein 1)	slx1a giyd1 slx1	Xenopus laevis (African clawed frog)	282	Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	Slx1-Slx4 complex [GO:0033557]	5'-flap endonuclease activity [GO:0017108]; metal ion binding [GO:0046872]	GO:0006281; GO:0006310; GO:0017108; GO:0033557; GO:0046872	DNA recombination [GO:0006310]; DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN37867_c0_g1_i1	Q9BQ83	SLX1_HUMAN	100	123	0	0	30	398	1	123	2.70E-70	265.8	SLX1_HUMAN	reviewed	Structure-specific endonuclease subunit SLX1 (EC 3.1.-.-) (GIY-YIG domain-containing protein 1)	SLX1A GIYD1 SLX1; SLX1B GIYD2 SLX1	Homo sapiens (Human)	275	nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; metal ion binding [GO:0046872]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of t-circle formation [GO:1904431]; t-circle formation [GO:0090656]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric D-loop disassembly [GO:0061820]	nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]	5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; metal ion binding [GO:0046872]	GO:0000724; GO:0005654; GO:0006281; GO:0008821; GO:0010792; GO:0010833; GO:0017108; GO:0033557; GO:0036297; GO:0046872; GO:0061820; GO:0090656; GO:1904357; GO:1904431	DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of t-circle formation [GO:1904431]; t-circle formation [GO:0090656]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric D-loop disassembly [GO:0061820]		NA	NA	NA	NA	NA	NA
TRINITY_DN9619_c0_g1_i1	Q5DUB3	NK1R_CANLF	27.1	203	128	5	650	66	132	322	1.00E-10	68.6	NK1R_CANLF	reviewed	Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)	TACR1	Canis lupus familiaris (Dog) (Canis familiaris)	407	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; substance P receptor activity [GO:0016496]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]; response to pain [GO:0048265]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]	substance P receptor activity [GO:0016496]	GO:0005886; GO:0007204; GO:0016021; GO:0016496; GO:0048265; GO:0061827; GO:0070472; GO:0097225; GO:1902093	positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]; response to pain [GO:0048265]		NA	NA	NA	NA	NA	NA
TRINITY_DN37733_c0_g1_i1	P33116	SPAT_BACIU	44.9	69	35	2	3	200	353	421	3.20E-08	58.5	SPAT_BACIU	reviewed	Subtilin transport ATP-binding protein SpaT	spaT spaB spaY	Bacillus subtilis	614	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bacteriocin transport [GO:0043213]; protein transport [GO:0015031]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0015031; GO:0016021; GO:0016887; GO:0042626; GO:0043213	bacteriocin transport [GO:0043213]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2323_c0_g1_i1	Q178L7	SDHF2_AEDAE	62	108	41	0	412	89	54	161	3.10E-35	149.4	SDHF2_AEDAE	reviewed	"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)"	AAEL005866	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	161	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]		GO:0005739; GO:0005759; GO:0006121; GO:0018293	"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]"		blue	blue	NA	NA	NA	NA
TRINITY_DN34008_c0_g1_i1	Q8SZ16	SDHF3_DROME	51.3	115	55	1	449	105	3	116	2.10E-25	117.1	SDHF3_DROME	reviewed	"Succinate dehydrogenase assembly factor 3, mitochondrial (SDH assembly factor 3) (SDHAF3)"	Sdhaf3 CG14898	Drosophila melanogaster (Fruit fly)	120	mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II assembly [GO:0034553]; musculoskeletal movement [GO:0050881]; response to hyperoxia [GO:0055093]; response to oxidative stress [GO:0006979]; succinate metabolic process [GO:0006105]	mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]		GO:0005758; GO:0005759; GO:0006105; GO:0006979; GO:0034553; GO:0050881; GO:0055093	mitochondrial respiratory chain complex II assembly [GO:0034553]; musculoskeletal movement [GO:0050881]; response to hyperoxia [GO:0055093]; response to oxidative stress [GO:0006979]; succinate metabolic process [GO:0006105]		blue	blue	NA	NA	NA	NA
TRINITY_DN557_c0_g1_i12	Q9VLU6	SDHF4_DROME	71.9	64	14	1	195	386	59	118	1.90E-19	97.4	SDHF4_DROME	reviewed	"Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4) (Starvation-upregulated protein)"	Sirup Sdhaf4 CG7224	Drosophila melanogaster (Fruit fly)	118	"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; cellular respiration [GO:0045333]; cellular response to reactive oxygen species [GO:0034614]; mitochondrial respiratory chain complex II assembly [GO:0034553]"	"mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]"		GO:0005739; GO:0005749; GO:0005759; GO:0034553; GO:0034614; GO:0045333	cellular respiration [GO:0045333]; cellular response to reactive oxygen species [GO:0034614]; mitochondrial respiratory chain complex II assembly [GO:0034553]		blue	blue	NA	NA	NA	NA
TRINITY_DN7544_c0_g1_i1	Q6F9G0	TGNE_ACIAD	75.3	77	19	0	232	2	226	302	1.00E-27	123.6	TGNE_ACIAD	reviewed	Succinate semialdehyde dehydrogenase (SSA dehydrogenase) (EC 1.2.1.24)	tgnE gabD ACIAD2539	Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)	483	succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450]		succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0009450	gamma-aminobutyric acid catabolic process [GO:0009450]		NA	NA	NA	NA	NA	NA
TRINITY_DN39969_c0_g1_i1	Q6F9G0	TGNE_ACIAD	70.2	114	34	0	342	1	362	475	1.00E-41	170.6	TGNE_ACIAD	reviewed	Succinate semialdehyde dehydrogenase (SSA dehydrogenase) (EC 1.2.1.24)	tgnE gabD ACIAD2539	Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)	483	succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450]		succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0009450	gamma-aminobutyric acid catabolic process [GO:0009450]		NA	NA	NA	NA	NA	NA
TRINITY_DN27978_c0_g1_i1	Q9WUM5	SUCA_MOUSE	100	113	0	0	375	37	234	346	5.40E-57	221.5	SUCA_MOUSE	reviewed	"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)"	Suclg1	Mus musculus (Mouse)	346	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; GDP binding [GO:0019003]; protein-containing complex binding [GO:0044877]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]	GDP binding [GO:0019003]; protein-containing complex binding [GO:0044877]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0004775; GO:0004776; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0009361; GO:0019003; GO:0032991; GO:0044877; GO:0045244	succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN27978_c0_g1_i2	P53597	SUCA_HUMAN	100	62	0	0	222	37	285	346	2.20E-26	119	SUCA_HUMAN	reviewed	"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)"	SUCLG1	Homo sapiens (Human)	346	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]	nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000166; GO:0003723; GO:0004775; GO:0004776; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006099; GO:0009361	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3272_c0_g1_i1	P36967	SUCA_DICDI	67.5	80	23	1	241	2	215	291	6.80E-21	100.9	SUCA_DICDI	reviewed	"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (p36)"	scsA DDB_G0289325	Dictyostelium discoideum (Slime mold)	315	membrane [GO:0016020]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	membrane [GO:0016020]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]	nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099; GO:0006104; GO:0009361; GO:0016020	succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN3272_c0_g2_i1	P36967	SUCA_DICDI	62.1	95	33	1	295	11	219	310	2.50E-25	115.9	SUCA_DICDI	reviewed	"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (p36)"	scsA DDB_G0289325	Dictyostelium discoideum (Slime mold)	315	membrane [GO:0016020]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	membrane [GO:0016020]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]	nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099; GO:0006104; GO:0009361; GO:0016020	succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN33540_c0_g1_i1	Q94522	SUCA_DROME	83.1	130	22	0	3	392	198	327	1.00E-55	217.6	SUCA_DROME	reviewed	"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (Succinyl-coenzyme A synthetase alpha subunit 1)"	Scsalpha1 Scsalpha CG1065	Drosophila melanogaster (Fruit fly)	328	mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA hydrolase activity [GO:0004778]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]	nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA hydrolase activity [GO:0004778]	GO:0000166; GO:0004775; GO:0004776; GO:0004778; GO:0005739; GO:0006099; GO:0009361; GO:0045244	tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN29245_c0_g1_i1	Q5HGI6	SUCD_STAAC	70	70	21	0	3	212	204	273	9.70E-22	103.6	SUCD_STAAC	reviewed	Succinate--CoA ligase [ADP-forming] subunit alpha (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)	sucD SACOL1263	Staphylococcus aureus (strain COL)	302	nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000166; GO:0004775; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN31617_c0_g1_i1	B3FHT4	SUCA_BLAHN	74.5	110	28	0	341	12	204	313	3.70E-41	168.7	SUCA_BLAHN	reviewed	Succinate--CoA ligase [ADP-forming] subunit alpha (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)	SCSa	Blastocystis sp. subtype 1 (strain ATCC 50177 / NandII)	318	hydrogenosome [GO:0042566]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]	hydrogenosome [GO:0042566]	nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000166; GO:0004775; GO:0006099; GO:0042566	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2302_c0_g1_i1	B2UGE2	SUCC_RALPJ	96.3	134	5	0	402	1	179	312	6.60E-69	261.2	SUCC_RALPJ	reviewed	Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta)	sucC Rpic_0474	Ralstonia pickettii (strain 12J)	388	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000287; GO:0004775; GO:0005524; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2302_c0_g1_i2	Q2G3G8	SUCC_NOVAD	87.9	99	12	0	300	4	298	396	1.30E-40	166.8	SUCC_NOVAD	reviewed	Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta)	sucC Saro_3170	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	399	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000287; GO:0004775; GO:0005524; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2302_c0_g1_i3	B2UGE2	SUCC_RALPJ	89.3	205	22	0	627	13	179	383	6.00E-101	368.2	SUCC_RALPJ	reviewed	Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta)	sucC Rpic_0474	Ralstonia pickettii (strain 12J)	388	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000287; GO:0004775; GO:0005524; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2302_c0_g1_i5	Q2G3G8	SUCC_NOVAD	86.7	188	25	0	567	4	209	396	4.90E-86	318.5	SUCC_NOVAD	reviewed	Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta)	sucC Saro_3170	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	399	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000287; GO:0004775; GO:0005524; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN2302_c0_g1_i6	Q2G3G8	SUCC_NOVAD	86.7	188	25	0	567	4	209	396	2.90E-86	319.3	SUCC_NOVAD	reviewed	Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta)	sucC Saro_3170	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	399	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000287; GO:0004775; GO:0005524; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN26666_c0_g1_i1	A5FYZ9	SUCC_ACICJ	80.8	73	14	0	221	3	189	261	9.10E-28	123.6	SUCC_ACICJ	reviewed	Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta)	sucC Acry_1625	Acidiphilium cryptum (strain JF-5)	398	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; tricarboxylic acid cycle [GO:0006099]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]	GO:0000287; GO:0004775; GO:0005524; GO:0006099	tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN37912_c0_g1_i1	Q9P2R7	SUCB1_HUMAN	100	117	0	0	352	2	330	446	2.30E-57	222.6	SUCB1_HUMAN	reviewed	"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA)"	SUCLA2	Homo sapiens (Human)	463	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; succinyl-CoA pathway [GO:0006781]; tricarboxylic acid cycle [GO:0006099]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005739; GO:0005759; GO:0006099; GO:0006104; GO:0006105; GO:0006781; GO:0042709; GO:0070062	succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; succinyl-CoA pathway [GO:0006781]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN6861_c0_g1_i1	Q9Z2I9	SUCB1_MOUSE	65.8	76	26	0	233	6	155	230	2.70E-22	105.5	SUCB1_MOUSE	reviewed	"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA)"	Sucla2	Mus musculus (Mouse)	463	mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; succinate-CoA ligase complex [GO:0042709]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-CoA ligase activity [GO:0004774]	GO:0000287; GO:0004774; GO:0004775; GO:0004776; GO:0005524; GO:0005739; GO:0006099; GO:0006104; GO:0006105; GO:0042709; GO:0043209	succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN108_c0_g1_i1	Q9Z2I9	SUCB1_MOUSE	67.4	221	72	0	28	690	243	463	5.30E-83	308.9	SUCB1_MOUSE	reviewed	"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA)"	Sucla2	Mus musculus (Mouse)	463	mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; succinate-CoA ligase complex [GO:0042709]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-CoA ligase activity [GO:0004774]	GO:0000287; GO:0004774; GO:0004775; GO:0004776; GO:0005524; GO:0005739; GO:0006099; GO:0006104; GO:0006105; GO:0042709; GO:0043209	succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN28489_c0_g1_i1	Q9P2R7	SUCB1_HUMAN	98.9	93	1	0	2	280	270	362	5.80E-48	191	SUCB1_HUMAN	reviewed	"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA)"	SUCLA2	Homo sapiens (Human)	463	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; succinyl-CoA pathway [GO:0006781]; tricarboxylic acid cycle [GO:0006099]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005739; GO:0005759; GO:0006099; GO:0006104; GO:0006105; GO:0006781; GO:0042709; GO:0070062	succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; succinyl-CoA pathway [GO:0006781]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN312_c0_g1_i1	Q84LB6	SUCB_SOLLC	62.9	205	76	0	629	15	210	414	6.40E-71	268.5	SUCB_SOLLC	reviewed	"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (Succinyl-CoA synthetase beta chain) (SCS-beta)"		Solanum lycopersicum (Tomato) (Lycopersicon esculentum)	417	mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; response to cadmium ion [GO:0046686]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]	ATP binding [GO:0005524]; copper ion binding [GO:0005507]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000287; GO:0004775; GO:0004776; GO:0005507; GO:0005524; GO:0005739; GO:0006099; GO:0006104; GO:0006105; GO:0042709; GO:0046686	response to cadmium ion [GO:0046686]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN26180_c0_g1_i1	Q9Z2I8	SUCB2_MOUSE	100	82	0	0	248	3	261	342	7.20E-42	170.6	SUCB2_MOUSE	reviewed	"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG)"	Suclg2	Mus musculus (Mouse)	433	mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]	ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0000287; GO:0004775; GO:0004776; GO:0004777; GO:0005524; GO:0005525; GO:0005739; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0019003; GO:0032991; GO:0042709; GO:0044877; GO:0045244	succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		NA	NA	NA	NA	NA	NA
TRINITY_DN108_c0_g2_i1	P53590	SUCB2_PIG	57.3	426	178	1	16	1281	6	431	1.70E-132	474.2	SUCB2_PIG	reviewed	"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG) (Fragment)"	SUCLG2	Sus scrofa (Pig)	433	mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0006099; GO:0006104; GO:0042709; GO:0046872	succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]		blue	blue	NA	NA	NA	NA
TRINITY_DN25784_c0_g1_i1	Q9HAC7	SUCHY_HUMAN	55.4	56	24	1	165	1	48	103	1.80E-12	72.8	SUCHY_HUMAN	reviewed	Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase)	SUGCT C7orf10 DERP13	Homo sapiens (Human)	445	mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]	mitochondrion [GO:0005739]	succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]	GO:0005739; GO:0047369			NA	NA	NA	NA	NA	NA
TRINITY_DN21726_c0_g1_i1	Q7TNE1	SUCHY_MOUSE	59.3	81	26	1	6	248	35	108	1.20E-20	100.1	SUCHY_MOUSE	reviewed	Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (SuccinylCoA:glutarate-CoA transferase)	Sugct	Mus musculus (Mouse)	436	mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]	mitochondrion [GO:0005739]	succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]	GO:0005739; GO:0047369			NA	NA	NA	NA	NA	NA
TRINITY_DN5503_c0_g1_i1	Q68FU4	SUCHY_RAT	58.8	403	165	1	1274	66	29	430	1.00E-139	498.4	SUCHY_RAT	reviewed	Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (SuccinylCoA:glutarate-CoA transferase)	Sugct	Rattus norvegicus (Rat)	436	mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]	mitochondrion [GO:0005739]	succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]	GO:0005739; GO:0047369			NA	NA	NA	NA	NA	NA
TRINITY_DN32608_c0_g1_i1	Q8GAI8	SSDH_PAENI	66.7	66	22	0	198	1	101	166	7.90E-18	90.5	SSDH_PAENI	reviewed	Succinate-semialdehyde dehydrogenase (SsaDH) (EC 1.2.1.16)	sad ORF58	Paenarthrobacter nicotinovorans (Arthrobacter nicotinovorans)	450	succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; nicotine catabolic process [GO:0019608]		succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0009013; GO:0019608	nicotine catabolic process [GO:0019608]		NA	NA	NA	NA	NA	NA
TRINITY_DN39822_c0_g1_i1	Q8GAI8	SSDH_PAENI	71.4	84	24	0	2	253	187	270	4.30E-26	118.2	SSDH_PAENI	reviewed	Succinate-semialdehyde dehydrogenase (SsaDH) (EC 1.2.1.16)	sad ORF58	Paenarthrobacter nicotinovorans (Arthrobacter nicotinovorans)	450	succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; nicotine catabolic process [GO:0019608]		succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0009013; GO:0019608	nicotine catabolic process [GO:0019608]		NA	NA	NA	NA	NA	NA
TRINITY_DN33981_c0_g1_i1	Q8GAI8	SSDH_PAENI	67.1	85	25	1	282	37	89	173	8.20E-26	117.5	SSDH_PAENI	reviewed	Succinate-semialdehyde dehydrogenase (SsaDH) (EC 1.2.1.16)	sad ORF58	Paenarthrobacter nicotinovorans (Arthrobacter nicotinovorans)	450	succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; nicotine catabolic process [GO:0019608]		succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0009013; GO:0019608	nicotine catabolic process [GO:0019608]		NA	NA	NA	NA	NA	NA
TRINITY_DN32743_c0_g1_i1	P25526	GABD_ECOLI	74.4	180	46	0	541	2	81	260	3.50E-73	275.8	GABD_ECOLI	reviewed	Succinate-semialdehyde dehydrogenase [NADP(+)] GabD (SSDH) (EC 1.2.1.79) (Glutarate-semialdehyde dehydrogenase) (EC 1.2.1.-)	gabD b2661 JW2636	Escherichia coli (strain K12)	482	glutarate-semialdehyde dehydrogenase (NADP+) activity [GO:0102810]; NADP binding [GO:0050661]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase (NADP+) activity [GO:0036243]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; nitrogen compound metabolic process [GO:0006807]; protein homotetramerization [GO:0051289]		glutarate-semialdehyde dehydrogenase (NADP+) activity [GO:0102810]; NADP binding [GO:0050661]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase (NADP+) activity [GO:0036243]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0006807; GO:0009013; GO:0009450; GO:0036243; GO:0050661; GO:0051289; GO:0102810	gamma-aminobutyric acid catabolic process [GO:0009450]; nitrogen compound metabolic process [GO:0006807]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	1
TRINITY_DN33459_c0_g1_i1	P25526	GABD_ECOLI	66.7	111	34	1	1	333	202	309	3.70E-36	152.1	GABD_ECOLI	reviewed	Succinate-semialdehyde dehydrogenase [NADP(+)] GabD (SSDH) (EC 1.2.1.79) (Glutarate-semialdehyde dehydrogenase) (EC 1.2.1.-)	gabD b2661 JW2636	Escherichia coli (strain K12)	482	glutarate-semialdehyde dehydrogenase (NADP+) activity [GO:0102810]; NADP binding [GO:0050661]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase (NADP+) activity [GO:0036243]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]; nitrogen compound metabolic process [GO:0006807]; protein homotetramerization [GO:0051289]		glutarate-semialdehyde dehydrogenase (NADP+) activity [GO:0102810]; NADP binding [GO:0050661]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase (NADP+) activity [GO:0036243]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0006807; GO:0009013; GO:0009450; GO:0036243; GO:0050661; GO:0051289; GO:0102810	gamma-aminobutyric acid catabolic process [GO:0009450]; nitrogen compound metabolic process [GO:0006807]; protein homotetramerization [GO:0051289]		NA	NA	NA	NA	NA	NA
TRINITY_DN1969_c0_g1_i1	Q9SAK4	SSDH_ARATH	63.7	91	33	0	308	36	161	251	2.50E-28	125.9	SSDH_ARATH	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (At-SSADH1) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member F1) (NAD(+)-dependent succinic semialdehyde dehydrogenase) (Protein ENLARGED FIL EXPRESSING DOMAIN 1)"	ALDH5F1 ENF1 SSADH1 At1g79440 T8K14.14	Arabidopsis thaliana (Mouse-ear cress)	528	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; copper ion binding [GO:0005507]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; adaxial/abaxial axis specification [GO:0009943]; cotyledon development [GO:0048825]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate decarboxylation to succinate [GO:0006540]; leaf development [GO:0048366]; maintenance of shoot apical meristem identity [GO:0010492]; reactive oxygen species metabolic process [GO:0072593]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; response to salt [GO:1902074]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	copper ion binding [GO:0005507]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0005507; GO:0005739; GO:0005759; GO:0005829; GO:0006540; GO:0009013; GO:0009408; GO:0009409; GO:0009416; GO:0009450; GO:0009507; GO:0009570; GO:0009943; GO:0010492; GO:0048366; GO:0048825; GO:0051287; GO:0072593; GO:1902074	adaxial/abaxial axis specification [GO:0009943]; cotyledon development [GO:0048825]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate decarboxylation to succinate [GO:0006540]; leaf development [GO:0048366]; maintenance of shoot apical meristem identity [GO:0010492]; reactive oxygen species metabolic process [GO:0072593]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN34120_c0_g1_i1	Q9SAK4	SSDH_ARATH	68.3	104	30	1	3	314	180	280	1.20E-30	133.7	SSDH_ARATH	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (At-SSADH1) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member F1) (NAD(+)-dependent succinic semialdehyde dehydrogenase) (Protein ENLARGED FIL EXPRESSING DOMAIN 1)"	ALDH5F1 ENF1 SSADH1 At1g79440 T8K14.14	Arabidopsis thaliana (Mouse-ear cress)	528	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; copper ion binding [GO:0005507]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; adaxial/abaxial axis specification [GO:0009943]; cotyledon development [GO:0048825]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate decarboxylation to succinate [GO:0006540]; leaf development [GO:0048366]; maintenance of shoot apical meristem identity [GO:0010492]; reactive oxygen species metabolic process [GO:0072593]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; response to salt [GO:1902074]	chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	copper ion binding [GO:0005507]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0005507; GO:0005739; GO:0005759; GO:0005829; GO:0006540; GO:0009013; GO:0009408; GO:0009409; GO:0009416; GO:0009450; GO:0009507; GO:0009570; GO:0009943; GO:0010492; GO:0048366; GO:0048825; GO:0051287; GO:0072593; GO:1902074	adaxial/abaxial axis specification [GO:0009943]; cotyledon development [GO:0048825]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate decarboxylation to succinate [GO:0006540]; leaf development [GO:0048366]; maintenance of shoot apical meristem identity [GO:0010492]; reactive oxygen species metabolic process [GO:0072593]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; response to salt [GO:1902074]		NA	NA	NA	NA	NA	NA
TRINITY_DN26114_c0_g1_i1	P51649	SSDH_HUMAN	60	120	48	0	9	368	173	292	8.70E-37	154.5	SSDH_HUMAN	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5A1 SSADH	Homo sapiens (Human)	535	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0005739; GO:0005759; GO:0006105; GO:0006536; GO:0007417; GO:0009013; GO:0009450; GO:0009791; GO:0042135; GO:0042802	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]		NA	NA	NA	NA	NA	NA
TRINITY_DN9980_c0_g1_i1	Q3MSM3	SSDH_HYLLA	59.8	199	78	1	682	86	56	252	2.90E-66	253.4	SSDH_HYLLA	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5A1	Hylobates lar (Common gibbon) (White-handed gibbon)	535	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0005739; GO:0007417; GO:0009450; GO:0042802; GO:0055114	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN9980_c0_g1_i2	Q3MSM3	SSDH_HYLLA	57.1	482	204	2	1483	41	56	535	1.40E-162	574.3	SSDH_HYLLA	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5A1	Hylobates lar (Common gibbon) (White-handed gibbon)	535	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0005739; GO:0007417; GO:0009450; GO:0042802; GO:0055114	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN9980_c0_g1_i3	Q3MSM3	SSDH_HYLLA	56.8	468	198	2	1441	41	71	535	3.60E-153	543.1	SSDH_HYLLA	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5A1	Hylobates lar (Common gibbon) (White-handed gibbon)	535	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0005739; GO:0007417; GO:0009450; GO:0042802; GO:0055114	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN9980_c0_g1_i5	Q3MSM3	SSDH_HYLLA	54.1	122	54	1	455	90	56	175	1.10E-33	144.8	SSDH_HYLLA	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5A1	Hylobates lar (Common gibbon) (White-handed gibbon)	535	mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]	mitochondrion [GO:0005739]	identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0005739; GO:0007417; GO:0009450; GO:0042802; GO:0055114	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN37324_c0_g1_i1	P51650	SSDH_RAT	58	119	48	1	3	353	368	486	8.70E-33	141	SSDH_RAT	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	Aldh5a1 Ssadh	Rattus norvegicus (Rat)	523	mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]	mitochondrion [GO:0005739]	carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0005739; GO:0006105; GO:0006536; GO:0007417; GO:0009013; GO:0009448; GO:0009450; GO:0009791; GO:0031406; GO:0042135; GO:0042802; GO:0051287; GO:0055114	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]		NA	NA	NA	NA	NA	NA
TRINITY_DN39873_c0_g1_i1	B9F3B6	SSDH_ORYSJ	63.6	66	24	0	244	47	462	527	5.00E-19	94.7	SSDH_ORYSJ	reviewed	"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member F1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5F1 SSADH1 Os02g0173900 LOC_Os02g07760 OsJ_05574	Oryza sativa subsp. japonica (Rice)	527	mitochondrial matrix [GO:0005759]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]	mitochondrial matrix [GO:0005759]	succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]	GO:0004777; GO:0005759; GO:0009013; GO:0009450	gamma-aminobutyric acid catabolic process [GO:0009450]		NA	NA	NA	NA	NA	NA
TRINITY_DN7983_c0_g1_i1	B2GV06	SCOT1_RAT	71	434	125	1	1406	105	86	518	9.10E-174	611.3	SCOT1_RAT	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	Oxct1 Oxct Scot	Rattus norvegicus (Rat)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN7983_c0_g1_i3	P55809	SCOT1_HUMAN	82	139	25	0	452	36	86	224	8.70E-62	237.7	SCOT1_HUMAN	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN36891_c0_g1_i1	P55809	SCOT1_HUMAN	100	97	0	0	1	291	362	458	3.20E-49	195.3	SCOT1_HUMAN	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN36663_c0_g1_i1	B2GV06	SCOT1_RAT	97.5	204	5	0	3	614	285	488	2.40E-110	399.4	SCOT1_RAT	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	Oxct1 Oxct Scot	Rattus norvegicus (Rat)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN28988_c0_g1_i1	P55809	SCOT1_HUMAN	100	75	0	0	227	3	429	503	9.30E-36	150.2	SCOT1_HUMAN	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN20868_c0_g1_i1	P55809	SCOT1_HUMAN	61.6	344	125	3	4	1014	105	448	7.80E-119	428.3	SCOT1_HUMAN	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN25541_c0_g1_i1	P55809	SCOT1_HUMAN	98.2	109	2	0	327	1	100	208	2.00E-55	216.1	SCOT1_HUMAN	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN27366_c0_g1_i1	P55809	SCOT1_HUMAN	100	73	0	0	3	221	196	268	4.00E-36	151.4	SCOT1_HUMAN	reviewed	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	520	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042493; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]		NA	NA	NA	NA	NA	NA
TRINITY_DN28012_c0_g1_i1	B0RVK4	SCOA_XANCB	73.2	71	19	0	10	222	168	238	9.10E-24	110.5	SCOA_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A (EC 2.8.3.5) (Succinyl-CoA:3-oxoacid CoA-transferase) (OXCT A)	lpsI wxcI xcc-b100_3728	Xanthomonas campestris pv. campestris (strain B100)	242	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN26473_c0_g1_i1	B0RVK4	SCOA_XANCB	80.4	92	18	0	277	2	68	159	5.10E-36	151.4	SCOA_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A (EC 2.8.3.5) (Succinyl-CoA:3-oxoacid CoA-transferase) (OXCT A)	lpsI wxcI xcc-b100_3728	Xanthomonas campestris pv. campestris (strain B100)	242	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN21303_c0_g2_i1	B0RVK4	SCOA_XANCB	73.5	83	22	0	2	250	82	164	1.70E-30	132.9	SCOA_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A (EC 2.8.3.5) (Succinyl-CoA:3-oxoacid CoA-transferase) (OXCT A)	lpsI wxcI xcc-b100_3728	Xanthomonas campestris pv. campestris (strain B100)	242	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN21303_c0_g1_i1	B0RVK4	SCOA_XANCB	70.3	145	43	0	2	436	82	226	7.50E-58	224.6	SCOA_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A (EC 2.8.3.5) (Succinyl-CoA:3-oxoacid CoA-transferase) (OXCT A)	lpsI wxcI xcc-b100_3728	Xanthomonas campestris pv. campestris (strain B100)	242	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN33139_c0_g1_i1	B0RVK3	SCOB_XANCB	77.6	156	30	3	1	465	13	164	9.00E-62	237.7	SCOB_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit B (EC 2.8.3.5) (OXCT B) (Succinyl-CoA:3-oxoacid CoA-transferase)	lpsJ wxcJ xcc-b100_3727	Xanthomonas campestris pv. campestris (strain B100)	213	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN6683_c1_g1_i1	B0RVK3	SCOB_XANCB	72	75	21	0	225	1	19	93	1.60E-24	112.8	SCOB_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit B (EC 2.8.3.5) (OXCT B) (Succinyl-CoA:3-oxoacid CoA-transferase)	lpsJ wxcJ xcc-b100_3727	Xanthomonas campestris pv. campestris (strain B100)	213	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN6683_c0_g1_i1	B0RVK3	SCOB_XANCB	74	131	34	0	394	2	1	131	3.50E-54	212.2	SCOB_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit B (EC 2.8.3.5) (OXCT B) (Succinyl-CoA:3-oxoacid CoA-transferase)	lpsJ wxcJ xcc-b100_3727	Xanthomonas campestris pv. campestris (strain B100)	213	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN6683_c0_g1_i2	B0RVK3	SCOB_XANCB	74.8	131	33	0	394	2	1	131	1.80E-55	216.5	SCOB_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit B (EC 2.8.3.5) (OXCT B) (Succinyl-CoA:3-oxoacid CoA-transferase)	lpsJ wxcJ xcc-b100_3727	Xanthomonas campestris pv. campestris (strain B100)	213	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN29460_c0_g1_i1	B0RVK3	SCOB_XANCB	73	74	20	0	1	222	51	124	6.50E-26	117.5	SCOB_XANCB	reviewed	Succinyl-CoA:3-ketoacid coenzyme A transferase subunit B (EC 2.8.3.5) (OXCT B) (Succinyl-CoA:3-oxoacid CoA-transferase)	lpsJ wxcJ xcc-b100_3727	Xanthomonas campestris pv. campestris (strain B100)	213	3-oxoacid CoA-transferase activity [GO:0008260]; lipopolysaccharide biosynthetic process [GO:0009103]		3-oxoacid CoA-transferase activity [GO:0008260]	GO:0008260; GO:0009103	lipopolysaccharide biosynthetic process [GO:0009103]		NA	NA	NA	NA	NA	NA
TRINITY_DN35002_c0_g1_i1	P07768	SUIS_RABIT	59	61	25	0	58	240	1170	1230	9.60E-17	87.4	SUIS_RABIT	reviewed	"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]"	SI	Oryctolagus cuniculus (Rabbit)	1827	"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; carbohydrate metabolic process [GO:0005975]"	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	"carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]"	GO:0004574; GO:0004575; GO:0005975; GO:0016021; GO:0016324; GO:0030246	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN7363_c0_g1_i1	P14410	SUIS_HUMAN	63.1	103	38	0	5	313	556	658	8.40E-37	154.5	SUIS_HUMAN	reviewed	"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]"	SI	Homo sapiens (Human)	1827	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]"	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]"	GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005975; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062	carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]		NA	NA	NA	NA	NA	NA
TRINITY_DN7363_c0_g1_i2	P14410	SUIS_HUMAN	43.7	332	181	3	5	982	556	887	1.50E-82	307.8	SUIS_HUMAN	reviewed	"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]"	SI	Homo sapiens (Human)	1827	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]"	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]"	GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005975; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062	carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]		NA	NA	NA	NA	NA	NA
TRINITY_DN37187_c0_g1_i1	P14410	SUIS_HUMAN	57.1	56	24	0	32	199	213	268	1.10E-14	80.5	SUIS_HUMAN	reviewed	"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]"	SI	Homo sapiens (Human)	1827	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]"	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"carbohydrate binding [GO:0030246]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]"	GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005975; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062	carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]		NA	NA	NA	NA	NA	NA
TRINITY_DN5037_c1_g2_i1	O04036	ERD6_ARATH	27.7	177	128	0	1	531	139	315	6.80E-13	75.5	ERD6_ARATH	reviewed	Sugar transporter ERD6 (Early-responsive to dehydration protein 6) (Sugar transporter-like protein 1)	ERD6 SUGTL1 At1g08930 F7G19.19	Arabidopsis thaliana (Mouse-ear cress)	496	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; sugar transmembrane transporter activity [GO:0051119]; response to abscisic acid [GO:0009737]; response to chitin [GO:0010200]; response to cold [GO:0009409]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	sugar transmembrane transporter activity [GO:0051119]	GO:0005783; GO:0009409; GO:0009414; GO:0009651; GO:0009737; GO:0010200; GO:0016021; GO:0051119	response to abscisic acid [GO:0009737]; response to chitin [GO:0010200]; response to cold [GO:0009409]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]		NA	NA	NA	NA	NA	NA
TRINITY_DN1087_c0_g1_i4	Q0WQ63	ERDL8_ARATH	30.1	93	65	0	293	15	127	219	7.10E-06	51.6	ERDL8_ARATH	reviewed	Sugar transporter ERD6-like 8	At3g05150 T12H1.11	Arabidopsis thaliana (Mouse-ear cress)	470	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]	transmembrane transporter activity [GO:0022857]	GO:0005634; GO:0008643; GO:0016021; GO:0022857	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1087_c0_g1_i8	Q0WQ63	ERDL8_ARATH	26.1	349	234	7	1100	87	127	462	2.40E-18	94.7	ERDL8_ARATH	reviewed	Sugar transporter ERD6-like 8	At3g05150 T12H1.11	Arabidopsis thaliana (Mouse-ear cress)	470	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]	transmembrane transporter activity [GO:0022857]	GO:0005634; GO:0008643; GO:0016021; GO:0022857	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN1595_c0_g1_i1	Q290X1	SWET1_DROPS	40.6	207	121	1	110	730	7	211	3.70E-37	156.8	SWET1_DROPS	reviewed	Sugar transporter SWEET1 (Protein saliva)	slv GA21278	Drosophila pseudoobscura pseudoobscura (Fruit fly)	226	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; salivary gland development [GO:0007431]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	sugar transmembrane transporter activity [GO:0051119]	GO:0000139; GO:0005886; GO:0007431; GO:0016021; GO:0051119	salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN1595_c0_g1_i2	Q290X1	SWET1_DROPS	40.6	207	121	1	110	730	7	211	3.60E-37	156.8	SWET1_DROPS	reviewed	Sugar transporter SWEET1 (Protein saliva)	slv GA21278	Drosophila pseudoobscura pseudoobscura (Fruit fly)	226	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; salivary gland development [GO:0007431]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	sugar transmembrane transporter activity [GO:0051119]	GO:0000139; GO:0005886; GO:0007431; GO:0016021; GO:0051119	salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN1595_c0_g1_i3	Q290X1	SWET1_DROPS	46.5	99	52	1	39	335	114	211	4.50E-18	92	SWET1_DROPS	reviewed	Sugar transporter SWEET1 (Protein saliva)	slv GA21278	Drosophila pseudoobscura pseudoobscura (Fruit fly)	226	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; salivary gland development [GO:0007431]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	sugar transmembrane transporter activity [GO:0051119]	GO:0000139; GO:0005886; GO:0007431; GO:0016021; GO:0051119	salivary gland development [GO:0007431]		NA	NA	NA	NA	NA	NA
TRINITY_DN744_c0_g1_i1	Q6AX23	QSOX2_XENLA	30.1	627	387	16	1958	165	32	636	2.20E-83	311.6	QSOX2_XENLA	reviewed	Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)	qsox2 qscn6l1	Xenopus laevis (African clawed frog)	661	integral component of membrane [GO:0016021]; flavin-linked sulfhydryl oxidase activity [GO:0016971]	integral component of membrane [GO:0016021]	flavin-linked sulfhydryl oxidase activity [GO:0016971]	GO:0016021; GO:0016971			NA	NA	NA	NA	NA	NA
TRINITY_DN744_c0_g1_i3	Q6AX23	QSOX2_XENLA	30.1	627	387	16	1951	158	32	636	2.20E-83	311.6	QSOX2_XENLA	reviewed	Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)	qsox2 qscn6l1	Xenopus laevis (African clawed frog)	661	integral component of membrane [GO:0016021]; flavin-linked sulfhydryl oxidase activity [GO:0016971]	integral component of membrane [GO:0016021]	flavin-linked sulfhydryl oxidase activity [GO:0016971]	GO:0016021; GO:0016971			NA	NA	NA	NA	NA	NA
TRINITY_DN744_c0_g1_i4	Q6AX23	QSOX2_XENLA	40	140	81	2	509	96	32	170	2.70E-29	130.2	QSOX2_XENLA	reviewed	Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)	qsox2 qscn6l1	Xenopus laevis (African clawed frog)	661	integral component of membrane [GO:0016021]; flavin-linked sulfhydryl oxidase activity [GO:0016971]	integral component of membrane [GO:0016021]	flavin-linked sulfhydryl oxidase activity [GO:0016971]	GO:0016021; GO:0016971			NA	NA	NA	NA	NA	NA
TRINITY_DN744_c0_g1_i5	Q6AX23	QSOX2_XENLA	30.1	627	387	16	1992	199	32	636	2.20E-83	311.6	QSOX2_XENLA	reviewed	Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)	qsox2 qscn6l1	Xenopus laevis (African clawed frog)	661	integral component of membrane [GO:0016021]; flavin-linked sulfhydryl oxidase activity [GO:0016971]	integral component of membrane [GO:0016021]	flavin-linked sulfhydryl oxidase activity [GO:0016971]	GO:0016021; GO:0016971			NA	NA	NA	NA	NA	NA
TRINITY_DN29939_c0_g1_i1	Q9Y6N5	SQOR_HUMAN	100	151	0	0	460	8	300	450	1.20E-85	317	SQOR_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)"	SQOR SQRDL CGI-44	Homo sapiens (Human)	450	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]	GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3710_c0_g1_i1	Q9Y6N5	SQOR_HUMAN	53.7	374	171	2	1212	91	78	449	1.70E-126	454.1	SQOR_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)"	SQOR SQRDL CGI-44	Homo sapiens (Human)	450	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]	GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3710_c0_g1_i2	Q9Y6N5	SQOR_HUMAN	52.5	415	195	2	1335	91	37	449	1.20E-136	488	SQOR_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)"	SQOR SQRDL CGI-44	Homo sapiens (Human)	450	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]	GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30596_c0_g1_i1	Q9Y6N5	SQOR_HUMAN	99.1	111	1	0	1	333	145	255	1.00E-59	230.3	SQOR_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)"	SQOR SQRDL CGI-44	Homo sapiens (Human)	450	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]	GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25239_c0_g1_i1	P07850	SUOX_CHICK	49.1	106	53	1	319	5	99	204	4.20E-26	118.6	SUOX_CHICK	reviewed	Sulfite oxidase (EC 1.8.3.1)	SUOX	Gallus gallus (Chicken)	459	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; sulfur compound metabolic process [GO:0006790]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]	GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546	sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN28943_c0_g1_i1	Q07116	SUOX_RAT	50.7	75	36	1	229	5	426	499	4.30E-17	88.2	SUOX_RAT	reviewed	"Sulfite oxidase, mitochondrial (EC 1.8.3.1)"	Suox	Rattus norvegicus (Rat)	546	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; response to nutrient [GO:0007584]; sulfur compound metabolic process [GO:0006790]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]	GO:0005739; GO:0005758; GO:0005829; GO:0006790; GO:0007584; GO:0008482; GO:0020037; GO:0030151; GO:0043546	response to nutrient [GO:0007584]; sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN26521_c0_g1_i1	Q8R086	SUOX_MOUSE	47.9	73	38	0	3	221	317	389	1.20E-16	86.7	SUOX_MOUSE	reviewed	"Sulfite oxidase, mitochondrial (EC 1.8.3.1)"	Suox	Mus musculus (Mouse)	546	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; response to nutrient [GO:0007584]; sulfur compound metabolic process [GO:0006790]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]	GO:0005739; GO:0005758; GO:0005829; GO:0006790; GO:0007584; GO:0008482; GO:0020037; GO:0030151; GO:0043546	response to nutrient [GO:0007584]; sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN2850_c0_g1_i1	Q9VWP4	SUOX_DROME	54.5	541	222	10	1679	96	43	572	1.30E-167	591.3	SUOX_DROME	reviewed	"Sulfite oxidase, mitochondrial (EC 1.8.3.1) (Protein shopper)"	shop CG7280	Drosophila melanogaster (Fruit fly)	573	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; sulfur compound metabolic process [GO:0006790]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]	GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546	sulfur compound metabolic process [GO:0006790]		blue	blue	NA	NA	NA	NA
TRINITY_DN34860_c0_g1_i1	Q9VWP4	SUOX_DROME	46	100	48	1	2	283	320	419	3.10E-20	99	SUOX_DROME	reviewed	"Sulfite oxidase, mitochondrial (EC 1.8.3.1) (Protein shopper)"	shop CG7280	Drosophila melanogaster (Fruit fly)	573	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; sulfur compound metabolic process [GO:0006790]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]	GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546	sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN35155_c0_g1_i1	A0KTH4	CYSJ_SHESA	51.9	77	37	0	236	6	428	504	4.60E-17	88.2	CYSJ_SHESA	reviewed	Sulfite reductase [NADPH] flavoprotein alpha-component (SiR-FP) (EC 1.8.1.2)	cysJ Shewana3_0855	Shewanella sp. (strain ANA-3)	604	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; sulfite reductase (NADPH) activity [GO:0004783]; cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation [GO:0000103]		flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; sulfite reductase (NADPH) activity [GO:0004783]	GO:0000103; GO:0004783; GO:0010181; GO:0019344; GO:0050660; GO:0070814	cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation [GO:0000103]		NA	NA	NA	NA	NA	NA
TRINITY_DN6121_c0_g1_i5	P32138	SQASE_ECOLI	47.9	259	130	4	904	128	422	675	4.70E-65	249.6	SQASE_ECOLI	reviewed	Sulfoquinovosidase (SQase) (EC 3.2.1.199)	yihQ squQ b3878 JW3849	Escherichia coli (strain K12)	678	"carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929]; 6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]"		"carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929]"	GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929	6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i5	P17988	ST1A1_RAT	39.6	230	117	10	716	39	76	287	9.30E-33	142.1	ST1A1_RAT	reviewed	Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Aryl sulfotransferase IV) (ASTIV) (Minoxidil sulfotransferase) (Mx-ST) (PST-1) (Phenol sulfotransferase) (Sulfokinase) (Tyrosine-ester sulfotransferase)	Sult1a1 St1a1	Rattus norvegicus (Rat)	291	cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; 4-nitrophenol metabolic process [GO:0018960]; catecholamine metabolic process [GO:0006584]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; regulation of blood pressure [GO:0008217]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to insecticide [GO:0017085]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]	GO:0000166; GO:0004062; GO:0005829; GO:0006068; GO:0006584; GO:0006805; GO:0008146; GO:0008210; GO:0008217; GO:0009812; GO:0014823; GO:0017085; GO:0017144; GO:0018960; GO:0042802; GO:0047894; GO:0050294; GO:0050427; GO:0050656; GO:0051384; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; 4-nitrophenol metabolic process [GO:0018960]; catecholamine metabolic process [GO:0006584]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; regulation of blood pressure [GO:0008217]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to insecticide [GO:0017085]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i8	P17988	ST1A1_RAT	38.2	178	96	5	563	39	121	287	1.00E-25	118.2	ST1A1_RAT	reviewed	Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Aryl sulfotransferase IV) (ASTIV) (Minoxidil sulfotransferase) (Mx-ST) (PST-1) (Phenol sulfotransferase) (Sulfokinase) (Tyrosine-ester sulfotransferase)	Sult1a1 St1a1	Rattus norvegicus (Rat)	291	cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; 4-nitrophenol metabolic process [GO:0018960]; catecholamine metabolic process [GO:0006584]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; regulation of blood pressure [GO:0008217]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to insecticide [GO:0017085]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]	GO:0000166; GO:0004062; GO:0005829; GO:0006068; GO:0006584; GO:0006805; GO:0008146; GO:0008210; GO:0008217; GO:0009812; GO:0014823; GO:0017085; GO:0017144; GO:0018960; GO:0042802; GO:0047894; GO:0050294; GO:0050427; GO:0050656; GO:0051384; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; 4-nitrophenol metabolic process [GO:0018960]; catecholamine metabolic process [GO:0006584]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; regulation of blood pressure [GO:0008217]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to insecticide [GO:0017085]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN18988_c0_g1_i1	P52840	ST1A1_MOUSE	34.2	292	153	8	170	1027	20	278	7.10E-36	152.9	ST1A1_MOUSE	reviewed	Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol/aryl sulfotransferase) (mSTp1) (ST1A4) (Sulfokinase)	Sult1a1 St1a1 Stp Stp1	Mus musculus (Mouse)	291	cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; sulfotransferase activity [GO:0008146]; 4-nitrophenol metabolic process [GO:0018960]; catecholamine metabolic process [GO:0006584]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; response to glucocorticoid [GO:0051384]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; sulfotransferase activity [GO:0008146]	GO:0000166; GO:0004062; GO:0005829; GO:0006584; GO:0006805; GO:0008146; GO:0008210; GO:0017144; GO:0018960; GO:0042802; GO:0050656; GO:0051384; GO:0051923	4-nitrophenol metabolic process [GO:0018960]; catecholamine metabolic process [GO:0006584]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; response to glucocorticoid [GO:0051384]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i5	P0DMM9	ST1A3_HUMAN	35.6	135	57	3	240	641	34	139	3.70E-13	76.6	ST1A3_HUMAN	reviewed	"Sulfotransferase 1A3 (ST1A3) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Catecholamine-sulfating phenol sulfotransferase) (HAST3) (M-PST) (Monoamine-sulfating phenol sulfotransferase) (Placental estrogen sulfotransferase) (Sulfotransferase 1A3/1A4) (Sulfotransferase, monoamine-preferring) (Thermolabile phenol sulfotransferase) (TL-PST)"	SULT1A3 STM	Homo sapiens (Human)	295	cytosol [GO:0005829]; amine sulfotransferase activity [GO:0047685]; aryl sulfotransferase activity [GO:0004062]; sulfate binding [GO:0043199]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; calcineurin-mediated signaling [GO:0097720]; cellular response to dopamine [GO:1903351]; dopamine catabolic process [GO:0042420]; dopamine receptor signaling pathway [GO:0007212]; ERK1 and ERK2 cascade [GO:0070371]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of neuron death [GO:1901215]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	amine sulfotransferase activity [GO:0047685]; aryl sulfotransferase activity [GO:0004062]; sulfate binding [GO:0043199]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0006805; GO:0007212; GO:0008146; GO:0008202; GO:0009812; GO:0036498; GO:0042420; GO:0043199; GO:0047685; GO:0050427; GO:0051923; GO:0070371; GO:0097720; GO:0098989; GO:1901215; GO:1903351	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; calcineurin-mediated signaling [GO:0097720]; cellular response to dopamine [GO:1903351]; dopamine catabolic process [GO:0042420]; dopamine receptor signaling pathway [GO:0007212]; ERK1 and ERK2 cascade [GO:0070371]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of neuron death [GO:1901215]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN1357_c1_g2_i1	P50237	ST1C1_RAT	39.5	124	74	1	526	155	178	300	6.30E-19	95.5	ST1C1_RAT	reviewed	Sulfotransferase 1C1 (ST1C1) (EC 2.8.2.-) (HAST-I) (N-hydroxyarylamine sulfotransferase)	Sult1c1 St1c1	Rattus norvegicus (Rat)	304	cytoplasm [GO:0005737]; cytosol [GO:0005829]; alcohol sulfotransferase activity [GO:0004027]; aryl sulfotransferase activity [GO:0004062]; sulfur compound metabolic process [GO:0006790]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	alcohol sulfotransferase activity [GO:0004027]; aryl sulfotransferase activity [GO:0004062]	GO:0004027; GO:0004062; GO:0005737; GO:0005829; GO:0006790	sulfur compound metabolic process [GO:0006790]		NA	NA	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i12	O00338	ST1C2_HUMAN	39.3	61	36	1	88	270	34	93	4.10E-05	48.9	ST1C2_HUMAN	reviewed	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	SULT1C2 SULT1C1	Homo sapiens (Human)	296	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	sulfotransferase activity [GO:0008146]	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i2	O00338	ST1C2_HUMAN	33.7	83	53	2	152	400	13	93	5.20E-06	52.4	ST1C2_HUMAN	reviewed	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	SULT1C2 SULT1C1	Homo sapiens (Human)	296	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	sulfotransferase activity [GO:0008146]	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i1	O75897	ST1C4_HUMAN	39.6	149	57	3	444	1	36	152	2.40E-22	107.1	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i11	O75897	ST1C4_HUMAN	33.7	309	154	5	944	39	36	300	1.20E-43	178.7	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i12	O75897	ST1C4_HUMAN	33.7	309	154	5	944	39	36	300	9.10E-44	179.1	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i3	O75897	ST1C4_HUMAN	33.7	309	154	5	944	39	36	300	4.10E-44	180.3	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i4	O75897	ST1C4_HUMAN	33.7	309	154	5	944	39	36	300	1.30E-43	178.7	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN2059_c0_g1_i6	O75897	ST1C4_HUMAN	44.2	77	39	2	333	103	36	108	1.60E-08	60.8	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i3	O75897	ST1C4_HUMAN	35.1	299	157	6	225	1112	36	300	3.10E-45	184.1	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		blue	blue	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i7	O75897	ST1C4_HUMAN	34.5	296	161	5	225	1106	36	300	6.80E-45	183	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN1598_c0_g1_i5	O75897	ST1C4_HUMAN	36.7	199	122	3	653	63	97	293	1.10E-31	138.3	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN1598_c0_g1_i6	O75897	ST1C4_HUMAN	37.2	172	105	2	561	49	97	266	3.60E-26	119.8	ST1C4_HUMAN	reviewed	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	SULT1C4 SULT1C2	Homo sapiens (Human)	302	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN23144_c0_g1_i1	P49888	ST1E1_HUMAN	35.7	154	79	4	13	465	32	168	5.40E-22	105.5	ST1E1_HUMAN	reviewed	"Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)"	SULT1E1 STE	Homo sapiens (Human)	294	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]	estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]	GO:0004304; GO:0005496; GO:0005829; GO:0006068; GO:0006711; GO:0008146; GO:0008202; GO:0008210; GO:0031965; GO:0045600; GO:0047894; GO:0050294; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]		NA	NA	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i11	P19217	ST1E1_BOVIN	34.4	128	81	2	64	444	167	292	2.70E-17	90.1	ST1E1_BOVIN	reviewed	"Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)"	SULT1E1 OST STE	Bos taurus (Bovine)	295	cytosol [GO:0005829]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; estrogen metabolic process [GO:0008210]	cytosol [GO:0005829]	estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]	GO:0004304; GO:0005496; GO:0005829; GO:0008210; GO:0050294	estrogen metabolic process [GO:0008210]		NA	NA	NA	NA	NA	NA
TRINITY_DN6892_c0_g1_i9	P19217	ST1E1_BOVIN	34.1	126	80	2	81	455	169	292	8.10E-17	88.6	ST1E1_BOVIN	reviewed	"Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)"	SULT1E1 OST STE	Bos taurus (Bovine)	295	cytosol [GO:0005829]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; estrogen metabolic process [GO:0008210]	cytosol [GO:0005829]	estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]	GO:0004304; GO:0005496; GO:0005829; GO:0008210; GO:0050294	estrogen metabolic process [GO:0008210]		NA	NA	NA	NA	NA	NA
TRINITY_DN434_c0_g1_i1	Q8JG30	ST1B1_CHICK	35.2	270	161	3	566	1348	28	292	2.30E-47	191.4	ST1B1_CHICK	reviewed	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	SULT1B1 SULT1B	Gallus gallus (Chicken)	296	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]	cytoplasm [GO:0005737]	sulfotransferase activity [GO:0008146]	GO:0005737; GO:0008146; GO:0008202	steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN9066_c0_g2_i4	Q8JG30	ST1B1_CHICK	38.3	94	50	2	359	87	173	261	9.90E-10	64.7	ST1B1_CHICK	reviewed	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	SULT1B1 SULT1B	Gallus gallus (Chicken)	296	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]	cytoplasm [GO:0005737]	sulfotransferase activity [GO:0008146]	GO:0005737; GO:0008146; GO:0008202	steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN1598_c0_g1_i4	Q8JG30	ST1B1_CHICK	39.1	110	65	1	410	81	173	280	4.20E-16	86.3	ST1B1_CHICK	reviewed	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	SULT1B1 SULT1B	Gallus gallus (Chicken)	296	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]	cytoplasm [GO:0005737]	sulfotransferase activity [GO:0008146]	GO:0005737; GO:0008146; GO:0008202	steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN9066_c0_g2_i2	Q9QWG7	ST1B1_MOUSE	34.5	116	72	2	633	298	77	192	2.80E-11	70.5	ST1B1_MOUSE	reviewed	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (DOPA/tyrosine sulfotransferase)	Sult1b1	Mus musculus (Mouse)	299	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN9066_c0_g2_i2	Q9QWG7	ST1B1_MOUSE	31.6	76	46	2	305	84	191	262	0.0021	44.3	ST1B1_MOUSE	reviewed	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (DOPA/tyrosine sulfotransferase)	Sult1b1	Mus musculus (Mouse)	299	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN7810_c0_g1_i1	Q8JGT5	SAE1_XENLA	49.6	268	127	3	112	891	1	268	2.40E-63	243.8	SAE1_XENLA	reviewed	SUMO-activating enzyme subunit 1 (SUMO-activating enzyme E1 N subunit) (Ubiquitin-like 1-activating enzyme E1A)	sae1 uble1a	Xenopus laevis (African clawed frog)	344	SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925]	SUMO activating enzyme complex [GO:0031510]	ubiquitin-like modifier activating enzyme activity [GO:0008641]	GO:0008641; GO:0016925; GO:0031510	protein sumoylation [GO:0016925]		blue	blue	NA	NA	NA	NA
TRINITY_DN33645_c0_g1_i1	Q8JGT5	SAE1_XENLA	64	50	18	0	173	24	9	58	1.40E-10	66.6	SAE1_XENLA	reviewed	SUMO-activating enzyme subunit 1 (SUMO-activating enzyme E1 N subunit) (Ubiquitin-like 1-activating enzyme E1A)	sae1 uble1a	Xenopus laevis (African clawed frog)	344	SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925]	SUMO activating enzyme complex [GO:0031510]	ubiquitin-like modifier activating enzyme activity [GO:0008641]	GO:0008641; GO:0016925; GO:0031510	protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN31686_c0_g1_i1	Q9UBE0	SAE1_HUMAN	99	96	1	0	1	288	18	113	7.30E-46	184.1	SAE1_HUMAN	reviewed	"SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A) [Cleaved into: SUMO-activating enzyme subunit 1, N-terminally processed]"	SAE1 AOS1 SUA1 UBLE1A	Homo sapiens (Human)	346	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO activating enzyme complex [GO:0031510]; ATP-dependent protein binding [GO:0043008]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; ubiquitin activating enzyme activity [GO:0004839]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO activating enzyme complex [GO:0031510]	ATP-dependent protein binding [GO:0043008]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005634; GO:0005654; GO:0005737; GO:0008022; GO:0008047; GO:0016925; GO:0031510; GO:0032446; GO:0033235; GO:0043008; GO:0044388; GO:0046982; GO:1903955	positive regulation of protein sumoylation [GO:0033235]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN39136_c0_g1_i1	Q9UBT2	SAE2_HUMAN	100	129	0	0	2	388	158	286	2.90E-74	278.9	SAE2_HUMAN	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	UBA2 SAE2 UBLE1B HRIHFB2115	Homo sapiens (Human)	640	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0008134; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982	positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN26479_c0_g1_i1	Q9UBT2	SAE2_HUMAN	59.7	554	202	4	1729	89	19	558	6.70E-190	665.2	SAE2_HUMAN	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	UBA2 SAE2 UBLE1B HRIHFB2115	Homo sapiens (Human)	640	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0008134; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982	positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN32879_c0_g1_i1	Q9Z1F9	SAE2_MOUSE	100	121	0	0	3	365	403	523	7.50E-64	244.2	SAE2_MOUSE	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	Uba2 Sae2 Uble1b	Mus musculus (Mouse)	638	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0008134; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982	positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN27779_c0_g1_i1	Q9UBT2	SAE2_HUMAN	99.1	109	1	0	329	3	347	455	2.40E-56	219.2	SAE2_HUMAN	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	UBA2 SAE2 UBLE1B HRIHFB2115	Homo sapiens (Human)	640	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0008134; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982	positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN30058_c0_g1_i1	Q9UBT2	SAE2_HUMAN	100	130	0	0	390	1	20	149	1.40E-68	260	SAE2_HUMAN	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	UBA2 SAE2 UBLE1B HRIHFB2115	Homo sapiens (Human)	640	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0008134; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982	positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN31367_c0_g1_i1	Q9Z1F9	SAE2_MOUSE	100	145	0	0	437	3	92	236	1.90E-82	306.2	SAE2_MOUSE	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	Uba2 Sae2 Uble1b	Mus musculus (Mouse)	638	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0008134; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982	positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN6571_c0_g2_i1	Q9SJT1	SAE2_ARATH	66.7	114	37	1	362	24	90	203	3.80E-39	162.2	SAE2_ARATH	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Protein EMBRYO DEFECTIVE 2764) (Ubiquitin-like 1-activating enzyme E1B)	SAE2 EMB2764 At2g21470 F3K23.23	Arabidopsis thaliana (Mouse-ear cress)	700	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; embryo development ending in seed dormancy [GO:0009793]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0009506; GO:0009793; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032446; GO:0046872	embryo development ending in seed dormancy [GO:0009793]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN40628_c0_g1_i1	Q7SXG4	SAE2_DANRE	54.7	75	33	1	16	237	349	423	1.60E-14	79.7	SAE2_DANRE	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354	Danio rerio (Zebrafish) (Brachydanio rerio)	650	cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]	GO:0005524; GO:0005737; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032446; GO:0046872	protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN6571_c0_g1_i1	Q7SXG4	SAE2_DANRE	68.8	77	24	0	263	33	13	89	1.80E-22	106.3	SAE2_DANRE	reviewed	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354	Danio rerio (Zebrafish) (Brachydanio rerio)	650	cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]	GO:0005524; GO:0005737; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032446; GO:0046872	protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN24252_c0_g2_i1	P63283	UBC9_CHICK	100	158	0	0	481	8	1	158	6.20E-93	341.3	UBC9_CHICK	reviewed	SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I)	UBE2I UBC9 UBCE9	Gallus gallus (Chicken)	158	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; sumoylated E2 ligase complex [GO:1990356]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; HLH domain binding [GO:0043398]; RING-like zinc finger domain binding [GO:0071535]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of SUMO transferase activity [GO:1903755]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; sumoylated E2 ligase complex [GO:1990356]; transferase complex [GO:1990234]	ATP binding [GO:0005524]; HLH domain binding [GO:0043398]; RING-like zinc finger domain binding [GO:0071535]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001221; GO:0005524; GO:0005634; GO:0005737; GO:0007049; GO:0007059; GO:0008134; GO:0016605; GO:0016925; GO:0043123; GO:0043398; GO:0044388; GO:0051301; GO:0061656; GO:0071535; GO:1903755; GO:1990234; GO:1990356	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of SUMO transferase activity [GO:1903755]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN24252_c0_g1_i1	P63283	UBC9_CHICK	100	156	0	0	475	8	3	158	3.80E-92	338.6	UBC9_CHICK	reviewed	SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I)	UBE2I UBC9 UBCE9	Gallus gallus (Chicken)	158	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; sumoylated E2 ligase complex [GO:1990356]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; HLH domain binding [GO:0043398]; RING-like zinc finger domain binding [GO:0071535]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of SUMO transferase activity [GO:1903755]; protein sumoylation [GO:0016925]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; sumoylated E2 ligase complex [GO:1990356]; transferase complex [GO:1990234]	ATP binding [GO:0005524]; HLH domain binding [GO:0043398]; RING-like zinc finger domain binding [GO:0071535]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001221; GO:0005524; GO:0005634; GO:0005737; GO:0007049; GO:0007059; GO:0008134; GO:0016605; GO:0016925; GO:0043123; GO:0043398; GO:0044388; GO:0051301; GO:0061656; GO:0071535; GO:1903755; GO:1990234; GO:1990356	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of SUMO transferase activity [GO:1903755]; protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN31246_c0_g1_i1	Q9NGP4	UBC9_DICDI	59.5	121	45	1	1	363	37	153	3.80E-39	162.2	UBC9_DICDI	reviewed	Sumo-conjugating enzyme ubc9 (EC 2.3.2.-) (Ubiquitin carrier protein 9)	ubc9 DDB_G0287693	Dictyostelium discoideum (Slime mold)	159	nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; protein sumoylation [GO:0016925]	nucleus [GO:0005634]	ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]	GO:0005524; GO:0005634; GO:0016925; GO:0061656	protein sumoylation [GO:0016925]		NA	NA	NA	NA	NA	NA
TRINITY_DN19833_c0_g1_i1	Q9DDJ0	UBC9B_DANRE	87.2	156	20	0	29	496	1	156	5.60E-84	311.6	UBC9B_DANRE	reviewed	SUMO-conjugating enzyme UBC9-B (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9-B) (SUMO-protein ligase B) (Ubiquitin carrier protein 9-B) (Ubiquitin carrier protein I-B) (Ubiquitin-conjugating enzyme E2 I-B) (Ubiquitin-protein ligase I-B)	ube2ib ubc9b ube2i2	Danio rerio (Zebrafish) (Brachydanio rerio)	157	nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; protein sumoylation [GO:0016925]	nucleus [GO:0005634]	ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]	GO:0001947; GO:0005524; GO:0005634; GO:0007049; GO:0007059; GO:0016925; GO:0036306; GO:0051301; GO:0060216; GO:0061656	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; protein sumoylation [GO:0016925]		blue	blue	NA	NA	NA	NA
TRINITY_DN30106_c0_g1_i1	Q9D666	SUN1_MOUSE	100	70	0	0	212	3	753	822	8.70E-36	150.2	SUN1_MOUSE	reviewed	SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1)	Sun1 Unc84a	Mus musculus (Mouse)	913	acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]	acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]	cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]	GO:0001503; GO:0002080; GO:0002081; GO:0005521; GO:0005634; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0009612; GO:0016021; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090292; GO:0140444	centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN36398_c0_g1_i1	O94901	SUN1_HUMAN	48.6	218	108	3	767	120	593	808	1.30E-54	214.9	SUN1_HUMAN	reviewed	SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1)	SUN1 KIAA0810 UNC84A	Homo sapiens (Human)	812	cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]	GO:0001503; GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0009612; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090292; GO:0140444	centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN40038_c0_g1_i1	Q9UH99	SUN2_HUMAN	100	73	0	0	1	219	559	631	2.50E-38	158.7	SUN2_HUMAN	reviewed	SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2)	SUN2 FRIGG KIAA0668 RAB5IP UNC84B	Homo sapiens (Human)	717	"condensed nuclear chromosome [GO:0000794]; endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]"	"condensed nuclear chromosome [GO:0000794]; endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]"	cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495]	GO:0000784; GO:0000794; GO:0005521; GO:0005635; GO:0005639; GO:0006998; GO:0007052; GO:0007097; GO:0008017; GO:0010008; GO:0021817; GO:0030335; GO:0031022; GO:0031965; GO:0034993; GO:0042802; GO:0043495; GO:0051321; GO:0051642; GO:0090292; GO:0140444	centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]		NA	NA	NA	NA	NA	NA
TRINITY_DN32843_c0_g1_i1	P81926	SODC_HALRO	58.6	70	28	1	6	215	76	144	6.50E-16	84.7	SODC_HALRO	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)		Halocynthia roretzi (Sea squirt) (Cynthia roretzi)	152	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5168_c0_g1_i1	O73872	SODC_DANRE	51.9	154	66	2	573	112	2	147	1.10E-36	155.2	SODC_DANRE	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	sod1 cuzn	Danio rerio (Zebrafish) (Brachydanio rerio)	154	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0009410; GO:0010038; GO:0019430; GO:0051597; GO:0070050	neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]		blue	blue	NA	NA	NA	NA
TRINITY_DN5168_c0_g1_i2	O73872	SODC_DANRE	51.9	154	66	2	573	112	2	147	1.00E-36	155.2	SODC_DANRE	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	sod1 cuzn	Danio rerio (Zebrafish) (Brachydanio rerio)	154	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0009410; GO:0010038; GO:0019430; GO:0051597; GO:0070050	neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]		blue	blue	NA	NA	NA	NA
TRINITY_DN8286_c0_g1_i1	Q8HXQ3	SODC_HYLLA	55.6	133	57	1	808	1206	20	150	1.50E-34	148.7	SODC_HYLLA	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	SOD1	Hylobates lar (Common gibbon) (White-handed gibbon)	154	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; protein phosphatase 2B binding [GO:0030346]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; protein phosphatase 2B binding [GO:0030346]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]	GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0002262; GO:0004784; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031410; GO:0032287; GO:0032839; GO:0032991; GO:0040014; GO:0042493; GO:0042542; GO:0043025; GO:0043085; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046716; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0072593	activation of MAPK activity [GO:0000187]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]		blue	blue	NA	NA	NA	NA
TRINITY_DN8286_c0_g1_i2	Q8HXQ3	SODC_HYLLA	55.6	133	57	1	498	100	20	150	8.00E-35	148.7	SODC_HYLLA	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	SOD1	Hylobates lar (Common gibbon) (White-handed gibbon)	154	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; protein phosphatase 2B binding [GO:0030346]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; protein phosphatase 2B binding [GO:0030346]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]	GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0002262; GO:0004784; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031410; GO:0032287; GO:0032839; GO:0032991; GO:0040014; GO:0042493; GO:0042542; GO:0043025; GO:0043085; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046716; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0072593	activation of MAPK activity [GO:0000187]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]		blue	blue	NA	NA	NA	NA
TRINITY_DN8286_c0_g1_i4	P41962	SODC_BRUPA	57.5	73	29	1	166	378	12	84	1.20E-19	97.4	SODC_BRUPA	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	SODC	Brugia pahangi (Filarial nematode worm)	158	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005737; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN13061_c1_g1_i1	P08228	SODC_MOUSE	45.3	117	56	2	130	480	5	113	3.40E-19	96.3	SODC_MOUSE	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	Sod1	Mus musculus (Mouse)	154	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0019899; GO:0030141; GO:0030346; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]		NA	NA	NA	NA	NA	NA
TRINITY_DN13061_c0_g1_i1	P80174	SODC_CARCR	56	84	32	1	257	6	76	154	2.60E-18	92.4	SODC_CARCR	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)		Caretta caretta (Loggerhead sea turtle)	167	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005634; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN31723_c0_g1_i1	P81926	SODC_HALRO	69.7	66	20	0	2	199	83	148	1.50E-18	93.2	SODC_HALRO	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)		Halocynthia roretzi (Sea squirt) (Cynthia roretzi)	152	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005737; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN35073_c0_g1_i1	P00441	SODC_HUMAN	100	81	0	0	243	1	6	86	8.90E-45	180.3	SODC_HUMAN	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1)	SOD1	Homo sapiens (Human)	154	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; platelet degranulation [GO:0002576]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]	GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001890; GO:0001895; GO:0001975; GO:0002262; GO:0002576; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005764; GO:0005777; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0033081; GO:0034465; GO:0034599; GO:0035722; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043065; GO:0043085; GO:0043087; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046620; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048538; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115	activation of MAPK activity [GO:0000187]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; platelet degranulation [GO:0002576]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226]		NA	NA	NA	NA	NA	NA
TRINITY_DN27808_c0_g1_i1	P00441	SODC_HUMAN	100	59	0	0	3	179	96	154	1.40E-26	119.8	SODC_HUMAN	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1)	SOD1	Homo sapiens (Human)	154	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; platelet degranulation [GO:0002576]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]	GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001890; GO:0001895; GO:0001975; GO:0002262; GO:0002576; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005764; GO:0005777; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0033081; GO:0034465; GO:0034599; GO:0035722; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043065; GO:0043085; GO:0043087; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046620; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048538; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115	activation of MAPK activity [GO:0000187]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; platelet degranulation [GO:0002576]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226]		NA	NA	NA	NA	NA	NA
TRINITY_DN17172_c0_g1_i1	P23345	SODC4_MAIZE	34.1	132	72	4	296	691	3	119	1.80E-08	62	SODC4_MAIZE	reviewed	Superoxide dismutase [Cu-Zn] 4A (EC 1.15.1.1)	SODCC.3 SOD4A	Zea mays (Maize)	152	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; removal of superoxide radicals [GO:0019430]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005737; GO:0019430	removal of superoxide radicals [GO:0019430]		NA	NA	NA	NA	NA	NA
TRINITY_DN31205_c0_g1_i1	O65198	SODCP_MEDSA	48.8	82	37	1	1	246	118	194	1.10E-11	70.5	SODCP_MEDSA	reviewed	"Superoxide dismutase [Cu-Zn], chloroplastic (EC 1.15.1.1)"	SODCP	Medicago sativa (Alfalfa)	202	chloroplast [GO:0009507]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	chloroplast [GO:0009507]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0009507; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34410_c0_g1_i1	Q8IAY6	SODF_PLAF7	57.3	75	32	0	263	39	122	196	1.40E-24	113.2	SODF_PLAF7	reviewed	Superoxide dismutase [Fe] (EC 1.15.1.1) (FeSOD)	SODB PF08_0071	Plasmodium falciparum (isolate 3D7)	198	cytosol [GO:0005829]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005829; GO:0006801; GO:0006979; GO:0046872	response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN29975_c0_g1_i1	Q8IAY6	SODF_PLAF7	68.8	64	20	0	2	193	129	192	1.00E-24	113.6	SODF_PLAF7	reviewed	Superoxide dismutase [Fe] (EC 1.15.1.1) (FeSOD)	SODB PF08_0071	Plasmodium falciparum (isolate 3D7)	198	cytosol [GO:0005829]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005829; GO:0006801; GO:0006979; GO:0046872	response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN41091_c0_g1_i1	Q9RUV2	SODM_DEIRA	68.3	60	17	1	1	174	151	210	1.40E-17	89.7	SODM_DEIRA	reviewed	Superoxide dismutase [Mn] (EC 1.15.1.1) (MnSOD)	sodA DR_1279	Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)	211	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]		metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15083_c0_g1_i1	P04179	SODM_HUMAN	100	222	0	0	731	66	1	222	3.50E-132	472.2	SODM_HUMAN	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	SOD2	Homo sapiens (Human)	222	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]; acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to reactive oxygen species [GO:0001315]; cellular response to ethanol [GO:0071361]; cellular response to oxidative stress [GO:0034599]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]	GO:0000303; GO:0001315; GO:0001666; GO:0001836; GO:0001889; GO:0003032; GO:0003069; GO:0003677; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006749; GO:0006801; GO:0007507; GO:0007626; GO:0008217; GO:0008285; GO:0008630; GO:0008631; GO:0009409; GO:0009791; GO:0010042; GO:0010043; GO:0010269; GO:0010332; GO:0014823; GO:0019430; GO:0019825; GO:0019899; GO:0022904; GO:0030097; GO:0030145; GO:0030335; GO:0032364; GO:0032496; GO:0033591; GO:0034021; GO:0034599; GO:0035722; GO:0035900; GO:0035902; GO:0042493; GO:0042542; GO:0042554; GO:0042645; GO:0042802; GO:0043524; GO:0045429; GO:0045599; GO:0046686; GO:0046872; GO:0048147; GO:0048666; GO:0048678; GO:0048773; GO:0050665; GO:0050790; GO:0051289; GO:0051602; GO:0051881; GO:0055072; GO:0055093; GO:0070062; GO:0071000; GO:0071361; GO:1902176; GO:1904706; GO:1905461; GO:1905932	acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to reactive oxygen species [GO:0001315]; cellular response to ethanol [GO:0071361]; cellular response to oxidative stress [GO:0034599]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]		NA	NA	NA	NA	NA	NA
TRINITY_DN15083_c0_g1_i3	P09671	SODM_MOUSE	100	210	0	0	688	59	13	222	6.50E-125	448	SODM_MOUSE	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	Sod2 Sod-2	Mus musculus (Mouse)	222	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]; acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to oxidative stress [GO:0001306]; age-dependent response to reactive oxygen species [GO:0001315]; apoptotic mitochondrial changes [GO:0008637]; cellular response to ethanol [GO:0071361]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide metabolic process [GO:0042743]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; vasodilation [GO:0042311]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]	GO:0000302; GO:0000303; GO:0001306; GO:0001315; GO:0001666; GO:0001836; GO:0001889; GO:0003032; GO:0003069; GO:0003677; GO:0004784; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006357; GO:0006749; GO:0006801; GO:0006979; GO:0007005; GO:0007507; GO:0007626; GO:0008217; GO:0008285; GO:0008630; GO:0008631; GO:0008637; GO:0009409; GO:0009791; GO:0010042; GO:0010043; GO:0010269; GO:0010332; GO:0010729; GO:0014823; GO:0016491; GO:0019430; GO:0019825; GO:0019899; GO:0022904; GO:0030097; GO:0030145; GO:0030335; GO:0031667; GO:0032364; GO:0032496; GO:0033591; GO:0034021; GO:0035900; GO:0035902; GO:0042311; GO:0042493; GO:0042542; GO:0042554; GO:0042645; GO:0042743; GO:0042802; GO:0043066; GO:0043209; GO:0043524; GO:0045429; GO:0045599; GO:0046686; GO:0046872; GO:0048147; GO:0048666; GO:0048678; GO:0048773; GO:0050665; GO:0050790; GO:0051289; GO:0051602; GO:0051881; GO:0055072; GO:0055093; GO:0071000; GO:0071361; GO:1902176; GO:1902631; GO:1904706; GO:1905461; GO:1905932	acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to oxidative stress [GO:0001306]; age-dependent response to reactive oxygen species [GO:0001315]; apoptotic mitochondrial changes [GO:0008637]; cellular response to ethanol [GO:0071361]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide metabolic process [GO:0042743]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; vasodilation [GO:0042311]		NA	NA	NA	NA	NA	NA
TRINITY_DN9934_c0_g1_i1	O96347	SODM_CHAFE	87.1	186	22	2	721	164	8	191	6.00E-90	332	SODM_CHAFE	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"		Charybdis feriata (Crucifix crab) (Cancer feriatus)	224	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005759; GO:0046872			blue	blue	NA	NA	NA	NA
TRINITY_DN9934_c0_g1_i2	O96347	SODM_CHAFE	86.5	104	13	1	394	83	8	110	7.00E-46	184.9	SODM_CHAFE	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"		Charybdis feriata (Crucifix crab) (Cancer feriatus)	224	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN2297_c0_g1_i1	P09671	SODM_MOUSE	61.5	200	77	0	334	933	23	222	7.90E-74	278.9	SODM_MOUSE	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	Sod2 Sod-2	Mus musculus (Mouse)	222	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]; acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to oxidative stress [GO:0001306]; age-dependent response to reactive oxygen species [GO:0001315]; apoptotic mitochondrial changes [GO:0008637]; cellular response to ethanol [GO:0071361]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide metabolic process [GO:0042743]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; vasodilation [GO:0042311]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]	GO:0000302; GO:0000303; GO:0001306; GO:0001315; GO:0001666; GO:0001836; GO:0001889; GO:0003032; GO:0003069; GO:0003677; GO:0004784; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006357; GO:0006749; GO:0006801; GO:0006979; GO:0007005; GO:0007507; GO:0007626; GO:0008217; GO:0008285; GO:0008630; GO:0008631; GO:0008637; GO:0009409; GO:0009791; GO:0010042; GO:0010043; GO:0010269; GO:0010332; GO:0010729; GO:0014823; GO:0016491; GO:0019430; GO:0019825; GO:0019899; GO:0022904; GO:0030097; GO:0030145; GO:0030335; GO:0031667; GO:0032364; GO:0032496; GO:0033591; GO:0034021; GO:0035900; GO:0035902; GO:0042311; GO:0042493; GO:0042542; GO:0042554; GO:0042645; GO:0042743; GO:0042802; GO:0043066; GO:0043209; GO:0043524; GO:0045429; GO:0045599; GO:0046686; GO:0046872; GO:0048147; GO:0048666; GO:0048678; GO:0048773; GO:0050665; GO:0050790; GO:0051289; GO:0051602; GO:0051881; GO:0055072; GO:0055093; GO:0071000; GO:0071361; GO:1902176; GO:1902631; GO:1904706; GO:1905461; GO:1905932	acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to oxidative stress [GO:0001306]; age-dependent response to reactive oxygen species [GO:0001315]; apoptotic mitochondrial changes [GO:0008637]; cellular response to ethanol [GO:0071361]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide metabolic process [GO:0042743]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; vasodilation [GO:0042311]		blue	blue	NA	NA	NA	NA
TRINITY_DN17733_c0_g1_i1	P28765	SODM_PALVU	68.8	96	30	0	293	6	19	114	1.70E-34	146.4	SODM_PALVU	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)"		Palinurus vulgaris (European spiny lobster)	144	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN23091_c0_g1_i1	P28765	SODM_PALVU	71.6	67	19	0	203	3	43	109	1.50E-24	112.8	SODM_PALVU	reviewed	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)"		Palinurus vulgaris (European spiny lobster)	144	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	mitochondrial matrix [GO:0005759]	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]	GO:0004784; GO:0005759; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12659_c0_g1_i1	Q8K4L3	SVIL_MOUSE	27.1	262	148	9	3	725	1091	1330	9.90E-07	55.5	SVIL_MOUSE	reviewed	Supervillin (Archvillin) (p205/p250)	Svil	Mus musculus (Mouse)	2170	"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]"	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]	"actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007519; GO:0008154; GO:0015629; GO:0030054; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0071437	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]		blue	blue	NA	NA	NA	NA
TRINITY_DN1601_c0_g1_i2	O46385	SVIL_BOVIN	41.3	496	263	8	1565	90	1723	2194	1.50E-103	378.3	SVIL_BOVIN	reviewed	Supervillin (Archvillin) (p205/p250)	SVIL	Bos taurus (Bovine)	2194	"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]"	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]	"actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0030054; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0051014; GO:0051015; GO:0051016; GO:0071437	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]		blue	blue	NA	NA	NA	NA
TRINITY_DN1601_c0_g1_i3	O46385	SVIL_BOVIN	41.4	872	462	18	2660	90	1357	2194	1.70E-181	637.9	SVIL_BOVIN	reviewed	Supervillin (Archvillin) (p205/p250)	SVIL	Bos taurus (Bovine)	2194	"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]"	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]	"actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0030054; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0051014; GO:0051015; GO:0051016; GO:0071437	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]		blue	blue	NA	NA	NA	NA
TRINITY_DN17367_c0_g1_i5	O14508	SOCS2_HUMAN	37.9	161	96	3	772	1251	41	198	1.80E-22	108.6	SOCS2_HUMAN	reviewed	Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2) (STAT-induced STAT inhibitor 2) (SSI-2)	SOCS2 CIS2 SSI2 STATI2	Homo sapiens (Human)	198	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; interleukin-7-mediated signaling pathway [GO:0038111]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]	GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0038111; GO:0040015; GO:0043066; GO:0043687; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749	cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; interleukin-7-mediated signaling pathway [GO:0038111]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]		NA	NA	NA	NA	NA	NA
TRINITY_DN17367_c0_g1_i7	O14508	SOCS2_HUMAN	37.9	161	96	3	662	1141	41	198	1.60E-22	108.6	SOCS2_HUMAN	reviewed	Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2) (STAT-induced STAT inhibitor 2) (SSI-2)	SOCS2 CIS2 SSI2 STATI2	Homo sapiens (Human)	198	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; interleukin-7-mediated signaling pathway [GO:0038111]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]	GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0038111; GO:0040015; GO:0043066; GO:0043687; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749	cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; interleukin-7-mediated signaling pathway [GO:0038111]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]		NA	NA	NA	NA	NA	NA
TRINITY_DN28081_c0_g1_i1	Q0VC91	SOCS4_BOVIN	98.7	79	1	0	239	3	322	400	3.10E-42	171.8	SOCS4_BOVIN	reviewed	Suppressor of cytokine signaling 4 (SOCS-4)	SOCS4	Bos taurus (Bovine)	440	phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]	phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]	GO:0005942; GO:0007175; GO:0016567; GO:0032436; GO:0035556; GO:0040008; GO:0046854; GO:0046935	intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN32400_c0_g1_i1	Q29RN6	SOCS5_BOVIN	38.3	81	47	1	248	6	382	459	7.30E-06	51.2	SOCS5_BOVIN	reviewed	Suppressor of cytokine signaling 5 (SOCS-5)	SOCS5	Bos taurus (Bovine)	536	epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]			GO:0007173; GO:0007175; GO:0007259; GO:0016567; GO:0032436; GO:0035556; GO:0040008	epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN2637_c0_g1_i1	Q29RN6	SOCS5_BOVIN	75	172	43	0	542	27	358	529	1.70E-73	276.9	SOCS5_BOVIN	reviewed	Suppressor of cytokine signaling 5 (SOCS-5)	SOCS5	Bos taurus (Bovine)	536	epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]			GO:0007173; GO:0007175; GO:0007259; GO:0016567; GO:0032436; GO:0035556; GO:0040008	epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN32792_c0_g1_i1	O14544	SOCS6_HUMAN	76.5	85	20	0	21	275	371	455	9.90E-32	137.1	SOCS6_HUMAN	reviewed	Suppressor of cytokine signaling 6 (SOCS-6) (Cytokine-inducible SH2 protein 4) (CIS-4) (Suppressor of cytokine signaling 4) (SOCS-4)	SOCS6 CIS4 SOCS4	Homo sapiens (Human)	535	cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; phosphatidylinositol phosphorylation [GO:0046854]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]	GO:0001772; GO:0005737; GO:0005829; GO:0005942; GO:0006952; GO:0007259; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0040008; GO:0043687; GO:0046854; GO:0046935; GO:0050868	defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; phosphatidylinositol phosphorylation [GO:0046854]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]		blue	blue	NA	NA	NA	NA
TRINITY_DN20470_c0_g2_i1	O14512	SOCS7_HUMAN	48.9	176	87	2	2052	2570	384	559	9.00E-42	174.1	SOCS7_HUMAN	reviewed	"Suppressor of cytokine signaling 7 (SOCS-7) (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4) (NAP-4)"	SOCS7 NAP4 SOCS6	Homo sapiens (Human)	581	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of growth [GO:0040008]	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0008286; GO:0009968; GO:0016567; GO:0017124; GO:0021819; GO:0021942; GO:0035556; GO:0040008; GO:0045444; GO:0046854; GO:0046935	fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN8076_c0_g1_i2	Q9Z0P7	SUFU_MOUSE	52.6	454	189	5	1368	55	33	476	1.70E-137	490.7	SUFU_MOUSE	reviewed	Suppressor of fused homolog	Sufu	Mus musculus (Mouse)	484	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of left/right symmetry [GO:0007368]; heart looping [GO:0001947]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; ventricular septum development [GO:0003281]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001843; GO:0001947; GO:0003281; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0007224; GO:0007368; GO:0008013; GO:0008134; GO:0019901; GO:0021513; GO:0021775; GO:0021776; GO:0035904; GO:0042994; GO:0043433; GO:0043588; GO:0045879; GO:0060976; GO:1901621; GO:2000059	aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of left/right symmetry [GO:0007368]; heart looping [GO:0001947]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; ventricular septum development [GO:0003281]		NA	NA	NA	NA	NA	NA
TRINITY_DN2839_c0_g1_i1	Q8W117	SMU1_ARATH	55	258	114	2	779	6	130	385	1.30E-84	314.3	SMU1_ARATH	reviewed	Suppressor of mec-8 and unc-52 protein homolog 1 (AtSMU-1) (RNA splicing protein SMU1) (WD40 repeat-containing protein SMU1)	SMU1 At1g73720 F25P22.14	Arabidopsis thaliana (Mouse-ear cress)	511	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]		GO:0005634; GO:0006397; GO:0008380; GO:0071011; GO:0080008	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN35038_c0_g1_i1	O48713	SMU2_ARATH	41.2	97	42	1	254	9	28	124	3.70E-09	62	SMU2_ARATH	reviewed	Suppressor of mec-8 and unc-52 protein homolog 2 (AtSMU-2) (Protein RED-like) (RNA splicing protein SMU2)	SMU2 At2g26460 T9J22.13	Arabidopsis thaliana (Mouse-ear cress)	585	"nucleus [GO:0005634]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	nucleus [GO:0005634]		GO:0000381; GO:0005634; GO:0008380	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1990_c0_g1_i1	Q9NQ55	SSF1_HUMAN	43.2	285	160	2	36	887	28	311	1.60E-59	231.5	SSF1_HUMAN	reviewed	Suppressor of SWI4 1 homolog (Ssf-1) (Brix domain-containing protein 3) (Peter Pan homolog)	PPAN BXDC3 SSF1	Homo sapiens (Human)	473	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]"	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000027; GO:0003723; GO:0005634; GO:0005730; GO:0019843; GO:0030687	ribosomal large subunit assembly [GO:0000027]		blue	blue	NA	NA	NA	NA
TRINITY_DN27964_c0_g1_i1	Q07DV5	ST7_AOTNA	97.6	85	2	0	289	35	238	322	1.00E-39	163.7	ST7_AOTNA	reviewed	Suppressor of tumorigenicity 7 protein	ST7	Aotus nancymaae (Ma's night monkey)	585	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2675_c0_g1_i1	A0M8U1	ST7_CHICK	73.2	549	144	3	1730	87	8	554	2.30E-233	809.7	ST7_CHICK	reviewed	Suppressor of tumorigenicity 7 protein homolog	ST7	Gallus gallus (Chicken)	554	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN34614_c0_g1_i1	Q8TDW4	ST7L_HUMAN	100	74	0	0	2	223	413	486	2.10E-40	165.6	ST7L_HUMAN	reviewed	Suppressor of tumorigenicity 7 protein-like (ST7-related protein)	ST7L ST7R	Homo sapiens (Human)	575	integral component of membrane [GO:0016021]; negative regulation of cell growth [GO:0030308]	integral component of membrane [GO:0016021]		GO:0016021; GO:0030308	negative regulation of cell growth [GO:0030308]		NA	NA	NA	NA	NA	NA
TRINITY_DN34117_c0_g1_i1	Q8K4P7	ST7L_MOUSE	100	78	0	0	235	2	237	314	2.50E-36	152.1	ST7L_MOUSE	reviewed	Suppressor of tumorigenicity 7 protein-like (ST7-related protein)	St7l St7r	Mus musculus (Mouse)	559	integral component of membrane [GO:0016021]; negative regulation of cell growth [GO:0030308]	integral component of membrane [GO:0016021]		GO:0016021; GO:0030308	negative regulation of cell growth [GO:0030308]		NA	NA	NA	NA	NA	NA
TRINITY_DN6510_c0_g1_i3	Q09803	VPS4_SCHPO	41	300	170	3	990	106	129	426	3.20E-62	240.7	VPS4_SCHPO	reviewed	Suppressor protein of bem1/bed5 double mutants (EC 3.6.4.6)	vps4 SPAC2G11.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; late endosome to vacuole transport [GO:0045324]; nuclear envelope organization [GO:0006998]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; vacuole organization [GO:0007033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006998; GO:0007033; GO:0010008; GO:0016887; GO:0043328; GO:0045324	late endosome to vacuole transport [GO:0045324]; nuclear envelope organization [GO:0006998]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN40501_c0_g1_i1	Q09803	VPS4_SCHPO	46.6	73	38	1	31	246	162	234	7.70E-12	70.9	VPS4_SCHPO	reviewed	Suppressor protein of bem1/bed5 double mutants (EC 3.6.4.6)	vps4 SPAC2G11.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; late endosome to vacuole transport [GO:0045324]; nuclear envelope organization [GO:0006998]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; vacuole organization [GO:0007033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006998; GO:0007033; GO:0010008; GO:0016887; GO:0043328; GO:0045324	late endosome to vacuole transport [GO:0045324]; nuclear envelope organization [GO:0006998]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN38366_c0_g1_i1	Q15526	SURF1_HUMAN	100	91	0	0	1	273	156	246	2.30E-49	195.7	SURF1_HUMAN	reviewed	Surfeit locus protein 1	SURF1 SURF-1	Homo sapiens (Human)	300	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; cytochrome-c oxidase activity [GO:0004129]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; respiratory chain complex IV assembly [GO:0008535]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]	cytochrome-c oxidase activity [GO:0004129]	GO:0004129; GO:0005746; GO:0006119; GO:0008535; GO:0009060; GO:0016021; GO:0033617; GO:0055114	aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN38100_c0_g1_i1	Q15526	SURF1_HUMAN	100	47	0	0	1	141	254	300	1.10E-22	106.7	SURF1_HUMAN	reviewed	Surfeit locus protein 1	SURF1 SURF-1	Homo sapiens (Human)	300	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; cytochrome-c oxidase activity [GO:0004129]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; respiratory chain complex IV assembly [GO:0008535]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]	cytochrome-c oxidase activity [GO:0004129]	GO:0004129; GO:0005746; GO:0006119; GO:0008535; GO:0009060; GO:0016021; GO:0033617; GO:0055114	aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN5797_c0_g1_i1	Q15526	SURF1_HUMAN	44.8	281	144	3	912	97	20	298	1.70E-63	244.6	SURF1_HUMAN	reviewed	Surfeit locus protein 1	SURF1 SURF-1	Homo sapiens (Human)	300	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; cytochrome-c oxidase activity [GO:0004129]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; respiratory chain complex IV assembly [GO:0008535]	integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]	cytochrome-c oxidase activity [GO:0004129]	GO:0004129; GO:0005746; GO:0006119; GO:0008535; GO:0009060; GO:0016021; GO:0033617; GO:0055114	aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; respiratory chain complex IV assembly [GO:0008535]		NA	NA	NA	NA	NA	NA
TRINITY_DN14_c0_g1_i1	Q8IWZ8	SUGP1_HUMAN	50.7	213	97	2	699	85	433	645	9.30E-52	205.3	SUGP1_HUMAN	reviewed	SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4)	SUGP1 SF4	Homo sapiens (Human)	645	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005681	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24298_c0_g1_i1	Q8IWZ8	SUGP1_HUMAN	100	67	0	0	2	202	516	582	4.50E-34	144.4	SUGP1_HUMAN	reviewed	SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4)	SUGP1 SF4	Homo sapiens (Human)	645	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005681	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24298_c0_g1_i2	Q8CH02	SUGP1_MOUSE	100	83	0	0	3	251	498	580	2.30E-43	175.6	SUGP1_MOUSE	reviewed	SURP and G-patch domain-containing protein 1 (Splicing factor 4)	Sugp1 Sf4	Mus musculus (Mouse)	643	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN10781_c0_g1_i1	Q9VV74	SMN_DROME	32	150	88	3	134	580	5	141	8.20E-10	65.5	SMN_DROME	reviewed	Survival motor neuron protein	Smn CG16725	Drosophila melanogaster (Fruit fly)	226	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic U snRNP body [GO:0071254]; Gemini of coiled bodies [GO:0097504]; I band [GO:0031674]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; SmD-containing SMN-Sm protein complex [GO:0034730]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; spliceosomal complex [GO:0005681]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; AMPA glutamate receptor clustering [GO:0097113]; basal protein localization [GO:0045175]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; cytoplasmic U snRNP body assembly [GO:1990194]; embryo development ending in birth or egg hatching [GO:0009792]; excitatory postsynaptic potential [GO:0060079]; larval development [GO:0002164]; larval locomotory behavior [GO:0008345]; lumen formation, open tracheal system [GO:0035149]; mRNA splicing, via spliceosome [GO:0000398]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; oocyte morphogenesis [GO:0048601]; P-body assembly [GO:0033962]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; ribonucleoprotein complex assembly [GO:0022618]; skeletal muscle thin filament assembly [GO:0030240]; spliceosomal snRNP assembly [GO:0000387]; stem cell differentiation [GO:0048863]; stem cell division [GO:0017145]; stem cell proliferation [GO:0072089]; terminal button organization [GO:0072553]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic U snRNP body [GO:0071254]; Gemini of coiled bodies [GO:0097504]; I band [GO:0031674]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; SmD-containing SMN-Sm protein complex [GO:0034730]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; spliceosomal complex [GO:0005681]; Z disc [GO:0030018]	alpha-actinin binding [GO:0051393]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0002164; GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0005886; GO:0007274; GO:0007417; GO:0007528; GO:0008345; GO:0009792; GO:0015030; GO:0017145; GO:0022618; GO:0030018; GO:0030240; GO:0031594; GO:0031674; GO:0032224; GO:0032797; GO:0033962; GO:0034718; GO:0034730; GO:0035149; GO:0042802; GO:0045175; GO:0045887; GO:0048601; GO:0048863; GO:0051276; GO:0051393; GO:0060079; GO:0071254; GO:0072089; GO:0072553; GO:0097113; GO:0097504; GO:0098794; GO:1990194	"AMPA glutamate receptor clustering [GO:0097113]; basal protein localization [GO:0045175]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; cytoplasmic U snRNP body assembly [GO:1990194]; embryo development ending in birth or egg hatching [GO:0009792]; excitatory postsynaptic potential [GO:0060079]; larval development [GO:0002164]; larval locomotory behavior [GO:0008345]; lumen formation, open tracheal system [GO:0035149]; mRNA splicing, via spliceosome [GO:0000398]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; oocyte morphogenesis [GO:0048601]; P-body assembly [GO:0033962]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; ribonucleoprotein complex assembly [GO:0022618]; skeletal muscle thin filament assembly [GO:0030240]; spliceosomal snRNP assembly [GO:0000387]; stem cell differentiation [GO:0048863]; stem cell division [GO:0017145]; stem cell proliferation [GO:0072089]; terminal button organization [GO:0072553]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8450_c0_g1_i1	Q6DEY1	SPF30_XENTR	40.2	241	130	5	813	100	1	230	6.10E-40	166	SPF30_XENTR	reviewed	Survival of motor neuron-related-splicing factor 30 (Survival motor neuron domain-containing protein 1)	smndc1 spf30 TGas076b22.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	238	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0015030; GO:0016607	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN5175_c1_g1_i3	Q8TER0	SNED1_HUMAN	50	40	20	0	113	232	751	790	1.30E-07	58.2	SNED1_HUMAN	reviewed	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)"	SNED1	Homo sapiens (Human)	1413	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0005112; GO:0005509; GO:0005576; GO:0007160	cell-matrix adhesion [GO:0007160]		NA	NA	NA	NA	NA	NA
TRINITY_DN5175_c1_g1_i6	Q8TER0	SNED1_HUMAN	50	40	20	0	113	232	751	790	1.30E-07	58.2	SNED1_HUMAN	reviewed	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)"	SNED1	Homo sapiens (Human)	1413	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0005112; GO:0005509; GO:0005576; GO:0007160	cell-matrix adhesion [GO:0007160]		NA	NA	NA	NA	NA	NA
TRINITY_DN39160_c0_g1_i1	Q8TER0	SNED1_HUMAN	98.6	74	1	0	2	223	358	431	1.10E-41	169.9	SNED1_HUMAN	reviewed	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)"	SNED1	Homo sapiens (Human)	1413	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0005112; GO:0005509; GO:0005576; GO:0007160	cell-matrix adhesion [GO:0007160]		NA	NA	NA	NA	NA	NA
TRINITY_DN14007_c0_g1_i3	P0C6B8	SVEP1_RAT	28.7	289	150	5	1097	384	1647	1930	5.50E-31	136.7	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193	cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]		NA	NA	NA	NA	NA	NA
TRINITY_DN14007_c0_g1_i5	P0C6B8	SVEP1_RAT	36.6	183	113	2	552	10	3345	3526	1.50E-35	151	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193	cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]		NA	NA	NA	NA	NA	NA
TRINITY_DN14007_c0_g1_i8	P0C6B8	SVEP1_RAT	27.9	319	182	5	1274	447	1646	1959	2.50E-37	158.3	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193	cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]		NA	NA	NA	NA	NA	NA
TRINITY_DN14007_c0_g1_i9	P0C6B8	SVEP1_RAT	31.1	190	118	5	632	87	1775	1959	6.50E-24	112.5	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193	cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]		NA	NA	NA	NA	NA	NA
TRINITY_DN20886_c0_g1_i1	A2AVA0	SVEP1_MOUSE	40.4	94	56	0	285	4	1927	2020	4.40E-18	92	SVEP1_MOUSE	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	Svep1	Mus musculus (Mouse)	3567	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0048014; GO:0090136; GO:0120193	cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]		NA	NA	NA	NA	NA	NA
TRINITY_DN8539_c0_g3_i1	Q6GR00	SZRD1_XENLA	36.9	122	67	4	59	415	5	119	1.20E-07	58.2	SZRD1_XENLA	reviewed	SUZ domain-containing protein 1	szrd1	Xenopus laevis (African clawed frog)	152							NA	NA	NA	NA	NA	NA
TRINITY_DN38179_c0_g1_i1	Q92922	SMRC1_HUMAN	100	84	0	0	253	2	624	707	2.50E-42	172.2	SMRC1_HUMAN	reviewed	SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)	SMARCC1 BAF155	Homo sapiens (Human)	1105	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008286; GO:0009887; GO:0016514; GO:0030850; GO:0032435; GO:0032991; GO:0042393; GO:0043044; GO:0045893; GO:0045944; GO:0047485; GO:0071564; GO:0071565	"animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19124_c0_g1_i1	Q92922	SMRC1_HUMAN	100	142	0	0	427	2	443	584	7.20E-82	304.3	SMRC1_HUMAN	reviewed	SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)	SMARCC1 BAF155	Homo sapiens (Human)	1105	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008286; GO:0009887; GO:0016514; GO:0030850; GO:0032435; GO:0032991; GO:0042393; GO:0043044; GO:0045893; GO:0045944; GO:0047485; GO:0071564; GO:0071565	"animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32891_c0_g1_i1	Q92922	SMRC1_HUMAN	100	71	0	0	2	214	122	192	2.00E-35	149.1	SMRC1_HUMAN	reviewed	SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)	SMARCC1 BAF155	Homo sapiens (Human)	1105	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008286; GO:0009887; GO:0016514; GO:0030850; GO:0032435; GO:0032991; GO:0042393; GO:0043044; GO:0045893; GO:0045944; GO:0047485; GO:0071564; GO:0071565	"animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31074_c0_g1_i1	Q92922	SMRC1_HUMAN	100	90	0	0	272	3	666	755	7.90E-42	170.6	SMRC1_HUMAN	reviewed	SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)	SMARCC1 BAF155	Homo sapiens (Human)	1105	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008286; GO:0009887; GO:0016514; GO:0030850; GO:0032435; GO:0032991; GO:0042393; GO:0043044; GO:0045893; GO:0045944; GO:0047485; GO:0071564; GO:0071565	"animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1123_c0_g1_i1	Q6PDG5	SMRC2_MOUSE	59.6	764	250	11	2249	81	5	750	1.30E-228	794.3	SMRC2_MOUSE	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	Smarcc2 Baf170	Mus musculus (Mouse)	1213	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000122; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1123_c0_g1_i10	Q6PDG5	SMRC2_MOUSE	59.1	770	250	12	2267	81	5	750	1.50E-226	787.3	SMRC2_MOUSE	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	Smarcc2 Baf170	Mus musculus (Mouse)	1213	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000122; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1123_c0_g1_i11	Q6PDG5	SMRC2_MOUSE	59.1	766	253	12	2283	103	5	749	2.70E-226	786.6	SMRC2_MOUSE	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	Smarcc2 Baf170	Mus musculus (Mouse)	1213	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000122; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1123_c0_g1_i3	Q6PDG5	SMRC2_MOUSE	59.6	760	253	11	2265	103	5	749	2.20E-228	793.5	SMRC2_MOUSE	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	Smarcc2 Baf170	Mus musculus (Mouse)	1213	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000122; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1123_c0_g1_i6	Q6PDG5	SMRC2_MOUSE	63.2	247	78	4	834	103	513	749	9.60E-81	301.6	SMRC2_MOUSE	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	Smarcc2 Baf170	Mus musculus (Mouse)	1213	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000122; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1123_c0_g1_i7	Q8TAQ2	SMRC2_HUMAN	63.5	74	27	0	295	74	5	78	1.50E-22	107.1	SMRC2_HUMAN	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	SMARCC2 BAF170	Homo sapiens (Human)	1214	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0032991; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27937_c0_g1_i1	Q8TAQ2	SMRC2_HUMAN	100	149	0	0	448	2	46	194	1.10E-83	310.5	SMRC2_HUMAN	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	SMARCC2 BAF170	Homo sapiens (Human)	1214	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0032991; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39671_c0_g1_i1	Q6PDG5	SMRC2_MOUSE	97.2	178	4	1	532	2	394	571	7.00E-98	357.8	SMRC2_MOUSE	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	Smarcc2 Baf170	Mus musculus (Mouse)	1213	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000122; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25844_c0_g1_i1	Q8TAQ2	SMRC2_HUMAN	100	82	0	0	1	246	627	708	4.30E-39	161.4	SMRC2_HUMAN	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	SMARCC2 BAF170	Homo sapiens (Human)	1214	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0032991; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32198_c0_g1_i1	Q8TAQ2	SMRC2_HUMAN	80.6	36	7	0	247	140	912	947	6.30E-06	51.2	SMRC2_HUMAN	reviewed	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	SMARCC2 BAF170	Homo sapiens (Human)	1214	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0032991; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11860_c0_g1_i1	Q09441	SWSN7_CAEEL	40.1	182	100	4	527	3	945	1124	1.40E-29	131.3	SWSN7_CAEEL	reviewed	SWI/SNF nucleosome remodeling complex component (ARID domain-containing protein C08B11.3)	C08B11.3	Caenorhabditis elegans	1244	"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"		DNA binding [GO:0003677]	GO:0003677; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11860_c0_g1_i3	Q09441	SWSN7_CAEEL	40.6	155	83	4	527	84	945	1097	1.00E-24	115.2	SWSN7_CAEEL	reviewed	SWI/SNF nucleosome remodeling complex component (ARID domain-containing protein C08B11.3)	C08B11.3	Caenorhabditis elegans	1244	"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"		DNA binding [GO:0003677]	GO:0003677; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11183_c0_g1_i2	Q09441	SWSN7_CAEEL	28.4	589	294	11	108	1868	19	481	5.00E-53	210.7	SWSN7_CAEEL	reviewed	SWI/SNF nucleosome remodeling complex component (ARID domain-containing protein C08B11.3)	C08B11.3	Caenorhabditis elegans	1244	"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"		DNA binding [GO:0003677]	GO:0003677; GO:0006355	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4144_c0_g1_i2	Q5FWR0	SMRCD_XENTR	49.5	303	123	3	916	11	706	979	5.00E-75	282.7	SMRCD_XENTR	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12)	smarcad1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1003	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ATP-dependent chromatin remodeling [GO:0043044]; DNA double-strand break processing [GO:0000729]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0000729; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0008094; GO:0035861; GO:0043044	ATP-dependent chromatin remodeling [GO:0043044]; DNA double-strand break processing [GO:0000729]		NA	NA	NA	NA	NA	NA
TRINITY_DN4144_c0_g1_i4	D3Z9Z9	SMRCD_RAT	48.2	680	318	6	2047	11	354	1000	1.20E-169	598.2	SMRCD_RAT	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12)	Smarcad1	Rattus norvegicus (Rat)	1024	heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ATP-dependent chromatin remodeling [GO:0043044]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]	heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0000018; GO:0000729; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0008094; GO:0035861; GO:0043044; GO:0043596; GO:0051304; GO:0070932; GO:0070933	ATP-dependent chromatin remodeling [GO:0043044]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]		NA	NA	NA	NA	NA	NA
TRINITY_DN28179_c0_g1_i1	Q9VL72	SMRCD_DROME	55.1	89	40	0	4	270	695	783	1.30E-23	110.2	SMRCD_DROME	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 homolog (EC 3.6.4.12) (Enhancer trap locus homolog 1) (Etl-1)	Etl1 CG5899	Drosophila melanogaster (Fruit fly)	844	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ATP-dependent chromatin remodeling [GO:0043044]; defense response to Gram-negative bacterium [GO:0050829]; DNA repair [GO:0006281]; positive regulation of innate immune response [GO:0045089]	nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0006281; GO:0008094; GO:0043044; GO:0045089; GO:0050829	ATP-dependent chromatin remodeling [GO:0043044]; defense response to Gram-negative bacterium [GO:0050829]; DNA repair [GO:0006281]; positive regulation of innate immune response [GO:0045089]		NA	NA	NA	NA	NA	NA
TRINITY_DN4144_c0_g1_i1	E7F1C4	SMRDB_DANRE	45	518	244	9	1632	82	289	766	4.70E-108	393.3	SMRDB_DANRE	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1B (EC 3.6.4.12)	smarcad1b si:dkey-76p7.6	Danio rerio (Zebrafish) (Brachydanio rerio)	954	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; ATP-dependent chromatin remodeling [GO:0043044]; DNA double-strand break processing [GO:0000729]	nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0000729; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0008094; GO:0035861; GO:0043044	ATP-dependent chromatin remodeling [GO:0043044]; DNA double-strand break processing [GO:0000729]		NA	NA	NA	NA	NA	NA
TRINITY_DN8252_c0_g1_i1	O60264	SMCA5_HUMAN	74	308	68	2	924	4	80	376	2.10E-133	476.9	SMCA5_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)	SMARCA5 SNF2H WCRF135	Homo sapiens (Human)	1052	"chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]	GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0006334; GO:0006338; GO:0006352; GO:0006357; GO:0008094; GO:0016584; GO:0016589; GO:0016887; GO:0031213; GO:0031491; GO:0034080; GO:0043044; GO:0045815; GO:0045944; GO:1990830	"ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27659_c0_g1_i1	O60264	SMCA5_HUMAN	100	160	0	0	2	481	466	625	5.20E-89	328.2	SMCA5_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)	SMARCA5 SNF2H WCRF135	Homo sapiens (Human)	1052	"chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]	GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0006334; GO:0006338; GO:0006352; GO:0006357; GO:0008094; GO:0016584; GO:0016589; GO:0016887; GO:0031213; GO:0031491; GO:0034080; GO:0043044; GO:0045815; GO:0045944; GO:1990830	"ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32928_c0_g1_i1	O60264	SMCA5_HUMAN	99.3	143	1	0	3	431	58	200	4.10E-77	288.5	SMCA5_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)	SMARCA5 SNF2H WCRF135	Homo sapiens (Human)	1052	"chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]	GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0006334; GO:0006338; GO:0006352; GO:0006357; GO:0008094; GO:0016584; GO:0016589; GO:0016887; GO:0031213; GO:0031491; GO:0034080; GO:0043044; GO:0045815; GO:0045944; GO:1990830	"ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32928_c0_g1_i2	O60264	SMCA5_HUMAN	98.3	358	6	0	3	1076	58	415	1.50E-205	716.5	SMCA5_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)	SMARCA5 SNF2H WCRF135	Homo sapiens (Human)	1052	"chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]	GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0006334; GO:0006338; GO:0006352; GO:0006357; GO:0008094; GO:0016584; GO:0016589; GO:0016887; GO:0031213; GO:0031491; GO:0034080; GO:0043044; GO:0045815; GO:0045944; GO:1990830	"ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11731_c0_g1_i1	Q8BJL0	SMAL1_MOUSE	44.8	252	129	4	750	25	602	853	2.60E-50	200.3	SMAL1_MOUSE	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (mharp) (Sucrose nonfermenting protein 2-like 1)	Smarcal1 Harp	Mus musculus (Mouse)	910	DNA replication factor A complex [GO:0005662]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; double-strand break repair via nonhomologous end joining [GO:0006303]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	DNA replication factor A complex [GO:0005662]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0003678; GO:0005524; GO:0005634; GO:0005662; GO:0006259; GO:0006281; GO:0006303; GO:0006357; GO:0006974; GO:0008094; GO:0031297; GO:0035861; GO:0036292; GO:0036310; GO:0043596; GO:0048478	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; double-strand break repair via nonhomologous end joining [GO:0006303]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN11731_c0_g1_i3	Q8BJL0	SMAL1_MOUSE	46.1	167	88	2	586	92	602	768	6.10E-31	135.6	SMAL1_MOUSE	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (mharp) (Sucrose nonfermenting protein 2-like 1)	Smarcal1 Harp	Mus musculus (Mouse)	910	DNA replication factor A complex [GO:0005662]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; double-strand break repair via nonhomologous end joining [GO:0006303]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	DNA replication factor A complex [GO:0005662]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0003678; GO:0005524; GO:0005634; GO:0005662; GO:0006259; GO:0006281; GO:0006303; GO:0006357; GO:0006974; GO:0008094; GO:0031297; GO:0035861; GO:0036292; GO:0036310; GO:0043596; GO:0048478	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; double-strand break repair via nonhomologous end joining [GO:0006303]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN28480_c0_g1_i1	B2ZFP3	SMAL1_DANRE	54.2	96	44	0	1	288	658	753	3.90E-23	108.6	SMAL1_DANRE	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (Sucrose nonfermenting protein 2-like 1)	smarcal1 harp si:ch211-239d11.1	Danio rerio (Zebrafish) (Brachydanio rerio)	807	nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; angiogenesis [GO:0001525]; cartilage development [GO:0051216]; cellular response to DNA damage stimulus [GO:0006974]; developmental growth [GO:0048589]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; embryonic body morphogenesis [GO:0010172]; hemopoiesis [GO:0030097]; mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]	nuclear replication fork [GO:0043596]; nucleus [GO:0005634]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]	GO:0000278; GO:0001525; GO:0003678; GO:0005524; GO:0005634; GO:0006259; GO:0006281; GO:0006357; GO:0006974; GO:0008094; GO:0010172; GO:0030097; GO:0031297; GO:0036292; GO:0036310; GO:0043596; GO:0048478; GO:0048589; GO:0051216	angiogenesis [GO:0001525]; cartilage development [GO:0051216]; cellular response to DNA damage stimulus [GO:0006974]; developmental growth [GO:0048589]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; embryonic body morphogenesis [GO:0010172]; hemopoiesis [GO:0030097]; mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN6755_c0_g1_i1	Q6DFM1	SNF5_XENTR	63.9	330	108	4	3	974	29	353	5.40E-117	422.2	SNF5_XENTR	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	smarcb1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	378	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0016514; GO:0035060; GO:0071564; GO:0071565	chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN24121_c0_g1_i1	Q5BIN2	SNF5_BOVIN	100	106	0	0	318	1	249	354	7.00E-58	224.2	SNF5_BOVIN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47)	SMARCB1 BAF47	Bos taurus (Bovine)	385	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0007049; GO:0007399; GO:0016514; GO:0035060; GO:0071564; GO:0071565	cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24121_c0_g1_i2	Q5BIN2	SNF5_BOVIN	100	102	0	0	308	3	249	350	1.40E-55	216.5	SNF5_BOVIN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47)	SMARCB1 BAF47	Bos taurus (Bovine)	385	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0007049; GO:0007399; GO:0016514; GO:0035060; GO:0071564; GO:0071565	cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28164_c0_g1_i1	Q5BIN2	SNF5_BOVIN	100	130	0	0	390	1	184	313	1.30E-69	263.5	SNF5_BOVIN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47)	SMARCB1 BAF47	Bos taurus (Bovine)	385	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0007049; GO:0007399; GO:0016514; GO:0035060; GO:0071564; GO:0071565	cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22977_c0_g1_i1	Q99JR8	SMRD2_MOUSE	100	74	0	0	224	3	409	482	2.90E-34	145.2	SMRD2_MOUSE	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B)	Smarcd2 Baf60b	Mus musculus (Mouse)	531	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]		GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0016514; GO:0043044; GO:0045944	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22977_c0_g2_i1	E1BJD1	SMRD2_BOVIN	100	170	0	0	524	15	362	531	8.50E-93	340.9	SMRD2_BOVIN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B)	SMARCD2	Bos taurus (Bovine)	531	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]		GO:0005634; GO:0005654; GO:0006337; GO:0006357; GO:0016514; GO:0043044; GO:0045944	ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31348_c0_g1_i1	Q92925	SMRD2_HUMAN	100	99	0	0	299	3	215	313	4.40E-54	211.5	SMRD2_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B)	SMARCD2 BAF60B PRO2451	Homo sapiens (Human)	531	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	transcription coactivator activity [GO:0003713]	GO:0000790; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0016514; GO:0032991; GO:0043044; GO:0045944	ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32411_c0_g1_i1	Q969G3	SMCE1_HUMAN	100	99	0	0	298	2	46	144	5.10E-42	171.4	SMCE1_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	SMARCE1 BAF57	Homo sapiens (Human)	411	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000228; GO:0000790; GO:0003677; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016514; GO:0016922; GO:0022008; GO:0032991; GO:0043044; GO:0045892; GO:0047485; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1336_c0_g1_i1	Q969G3	SMCE1_HUMAN	50	148	66	3	429	1	10	154	3.20E-23	110.2	SMCE1_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	SMARCE1 BAF57	Homo sapiens (Human)	411	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000228; GO:0000790; GO:0003677; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016514; GO:0016922; GO:0022008; GO:0032991; GO:0043044; GO:0045892; GO:0047485; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1336_c0_g1_i2	Q969G3	SMCE1_HUMAN	51	157	66	3	471	1	9	154	2.70E-24	113.6	SMCE1_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	SMARCE1 BAF57	Homo sapiens (Human)	411	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000228; GO:0000790; GO:0003677; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016514; GO:0016922; GO:0022008; GO:0032991; GO:0043044; GO:0045892; GO:0047485; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1336_c0_g1_i3	Q969G3	SMCE1_HUMAN	50	148	66	3	429	1	10	154	3.20E-23	110.2	SMCE1_HUMAN	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	SMARCE1 BAF57	Homo sapiens (Human)	411	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000228; GO:0000790; GO:0003677; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016514; GO:0016922; GO:0022008; GO:0032991; GO:0043044; GO:0045892; GO:0047485; GO:0071564; GO:0071565	"ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29476_c0_g1_i1	F4I2H2	CHR9_ARATH	62.5	88	33	0	3	266	578	665	3.30E-24	112.1	CHR9_ARATH	reviewed	Switch 2 (EC 3.6.4.-) (Protein CHROMATIN REMODELING 9) (AtCHR9)	SWI2 CHR9 At1g03750 F11M21.32	Arabidopsis thaliana (Mouse-ear cress)	862	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; DNA repair [GO:0006281]		ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN39550_c0_g1_i2	F4I2H2	CHR9_ARATH	55.6	54	24	0	13	174	129	182	8.20E-11	67.4	CHR9_ARATH	reviewed	Switch 2 (EC 3.6.4.-) (Protein CHROMATIN REMODELING 9) (AtCHR9)	SWI2 CHR9 At1g03750 F11M21.32	Arabidopsis thaliana (Mouse-ear cress)	862	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; DNA repair [GO:0006281]		ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0006281	DNA repair [GO:0006281]		NA	NA	NA	NA	NA	NA
TRINITY_DN38242_c0_g1_i1	Q9Y7N0	BDF1_SCHPO	50.6	79	39	0	1	237	99	177	6.40E-19	94.4	BDF1_SCHPO	reviewed	SWR1 complex bromodomain subunit bdf1	bdf1 brf1 SPCC1450.02 SPCC191.13	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	578	nucleus [GO:0005634]; Swr1 complex [GO:0000812]; chromatin remodeling [GO:0006338]; histone exchange [GO:0043486]	nucleus [GO:0005634]; Swr1 complex [GO:0000812]		GO:0000812; GO:0005634; GO:0006338; GO:0043486	chromatin remodeling [GO:0006338]; histone exchange [GO:0043486]		NA	NA	NA	NA	NA	NA
TRINITY_DN35287_c0_g1_i1	C6KYS2	SYMPP_STHOU	40.3	72	31	1	247	32	101	160	4.00E-07	55.5	SYMPP_STHOU	reviewed	Symplectin (EC 3.5.-.-)	sympp	Sthenoteuthis oualaniensis (Purpleback flying squid) (Symplectoteuthis oualaniensis)	501	hydrolase activity [GO:0016787]; bioluminescence [GO:0008218]; nitrogen compound metabolic process [GO:0006807]		hydrolase activity [GO:0016787]	GO:0006807; GO:0008218; GO:0016787	bioluminescence [GO:0008218]; nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN39174_c0_g1_i1	Q92797	SYMPK_HUMAN	90.8	76	7	0	230	3	834	909	2.20E-32	139	SYMPK_HUMAN	reviewed	Symplekin	SYMPK SPK	Homo sapiens (Human)	1274	"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]"	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006369; GO:0006378; GO:0006406; GO:0007155; GO:0031124; GO:0032091; GO:0035307; GO:0097165	"cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8028_c0_g1_i1	Q92797	SYMPK_HUMAN	43.5	1088	565	15	100	3270	31	1099	4.20E-233	809.7	SYMPK_HUMAN	reviewed	Symplekin	SYMPK SPK	Homo sapiens (Human)	1274	"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]"	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006369; GO:0006378; GO:0006406; GO:0007155; GO:0031124; GO:0032091; GO:0035307; GO:0097165	"cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21674_c0_g1_i1	Q96A49	SYAP1_HUMAN	100	78	0	0	3	236	118	195	1.30E-37	156.4	SYAP1_HUMAN	reviewed	Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA)	SYAP1 PRO3113	Homo sapiens (Human)	352	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]		GO:0005654; GO:0005794; GO:0005829; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0031234; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045211; GO:0045600; GO:0048471; GO:0070062; GO:0071364; GO:0071902; GO:1990314	cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN593_c0_g2_i2	Q960T2	SAP47_DROME	53.8	158	64	2	485	12	207	355	1.30E-37	157.9	SAP47_DROME	reviewed	Synapse-associated protein of 47 kDa	Sap47 CG8884	Drosophila melanogaster (Fruit fly)	551	synapse [GO:0045202]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	synapse [GO:0045202]		GO:0007268; GO:0008306; GO:0045202; GO:0048172	associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		NA	NA	NA	NA	NA	NA
TRINITY_DN207_c1_g1_i2	Q9JIS5	SV2A_MOUSE	37.2	317	186	5	1505	594	160	476	1.00E-51	206.1	SV2A_MOUSE	reviewed	Synaptic vesicle glycoprotein 2A (Synaptic vesicle protein 2) (Synaptic vesicle protein 2A) (Calcium regulator SV2A)	Sv2a Kiaa0736 Sv2	Mus musculus (Mouse)	742	cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; protein kinase binding [GO:0019901]; transmembrane transporter activity [GO:0022857]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of gamma-aminobutyric acid secretion [GO:0014052]	cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	protein kinase binding [GO:0019901]; transmembrane transporter activity [GO:0022857]	GO:0005783; GO:0005911; GO:0006836; GO:0006874; GO:0007268; GO:0008021; GO:0014052; GO:0016021; GO:0019901; GO:0022857; GO:0030285; GO:0030425; GO:0030672; GO:0031594; GO:0043005; GO:0043025; GO:0045202; GO:0048786	cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of gamma-aminobutyric acid secretion [GO:0014052]		NA	NA	NA	NA	NA	NA
TRINITY_DN207_c1_g1_i4	Q9JIS5	SV2A_MOUSE	35.7	359	213	6	1616	594	118	476	7.00E-54	213.4	SV2A_MOUSE	reviewed	Synaptic vesicle glycoprotein 2A (Synaptic vesicle protein 2) (Synaptic vesicle protein 2A) (Calcium regulator SV2A)	Sv2a Kiaa0736 Sv2	Mus musculus (Mouse)	742	cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; protein kinase binding [GO:0019901]; transmembrane transporter activity [GO:0022857]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of gamma-aminobutyric acid secretion [GO:0014052]	cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	protein kinase binding [GO:0019901]; transmembrane transporter activity [GO:0022857]	GO:0005783; GO:0005911; GO:0006836; GO:0006874; GO:0007268; GO:0008021; GO:0014052; GO:0016021; GO:0019901; GO:0022857; GO:0030285; GO:0030425; GO:0030672; GO:0031594; GO:0043005; GO:0043025; GO:0045202; GO:0048786	cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of gamma-aminobutyric acid secretion [GO:0014052]		NA	NA	NA	NA	NA	NA
TRINITY_DN207_c1_g1_i3	Q69ZS6	SV2C_MOUSE	35.5	138	89	0	446	33	590	727	2.30E-15	84.7	SV2C_MOUSE	reviewed	Synaptic vesicle glycoprotein 2C (Synaptic vesicle protein 2C)	Sv2c Kiaa1054	Mus musculus (Mouse)	727	integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]	integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	transmembrane transporter activity [GO:0022857]	GO:0006836; GO:0007268; GO:0008021; GO:0016021; GO:0022857; GO:0030285; GO:0030672; GO:0043005	chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]		NA	NA	NA	NA	NA	NA
TRINITY_DN38698_c0_g1_i1	Q3MIE4	VAT1_RAT	36.4	118	74	1	3	356	282	398	2.80E-16	86.3	VAT1_RAT	reviewed	Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-) (Mitofusin-binding protein) (Protein MIB)	Vat1	Rattus norvegicus (Rat)	404	mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; negative regulation of mitochondrial fusion [GO:0010637]	mitochondrial outer membrane [GO:0005741]	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]	GO:0005741; GO:0008270; GO:0010637; GO:0016491	negative regulation of mitochondrial fusion [GO:0010637]		NA	NA	NA	NA	NA	NA
TRINITY_DN1217_c0_g1_i1	Q9HCJ6	VAT1L_HUMAN	51.4	348	168	1	1083	40	40	386	7.50E-98	359	VAT1L_HUMAN	reviewed	Synaptic vesicle membrane protein VAT-1 homolog-like (EC 1.-.-.-)	VAT1L KIAA1576	Homo sapiens (Human)	419	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]		oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]	GO:0008270; GO:0016491			blue	blue	NA	NA	NA	NA
TRINITY_DN12226_c0_g1_i1	Q7ZUN8	YKT6_DANRE	56.4	195	85	0	119	703	1	195	5.10E-59	229.2	YKT6_DANRE	reviewed	Synaptobrevin homolog YKT6 (EC 2.3.1.-)	ykt6 zgc:55536	Danio rerio (Zebrafish) (Brachydanio rerio)	198	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	transferase activity [GO:0016740]	GO:0000139; GO:0005829; GO:0015031; GO:0016021; GO:0016192; GO:0016740; GO:0030659	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN8502_c0_g1_i1	Q7JYV2	SNG_DROME	56.6	182	76	2	664	125	14	194	7.30E-55	215.3	SNG_DROME	reviewed	Synaptogyrin	Syngr gyr CG10808	Drosophila melanogaster (Fruit fly)	241	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]		GO:0006897; GO:0016021; GO:0016079; GO:0030672; GO:0031594; GO:0048489	endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN8502_c0_g1_i2	Q7JYV2	SNG_DROME	54.3	151	66	2	571	125	45	194	2.30E-40	167.2	SNG_DROME	reviewed	Synaptogyrin	Syngr gyr CG10808	Drosophila melanogaster (Fruit fly)	241	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]		GO:0006897; GO:0016021; GO:0016079; GO:0030672; GO:0031594; GO:0048489	endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN8502_c0_g1_i2	Q7JYV2	SNG_DROME	68.8	32	10	0	665	570	14	45	7.40E-07	55.8	SNG_DROME	reviewed	Synaptogyrin	Syngr gyr CG10808	Drosophila melanogaster (Fruit fly)	241	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]		GO:0006897; GO:0016021; GO:0016079; GO:0030672; GO:0031594; GO:0048489	endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN8502_c0_g2_i1	Q7JYV2	SNG_DROME	64.5	93	32	1	48	326	14	105	1.70E-30	133.3	SNG_DROME	reviewed	Synaptogyrin	Syngr gyr CG10808	Drosophila melanogaster (Fruit fly)	241	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]		GO:0006897; GO:0016021; GO:0016079; GO:0030672; GO:0031594; GO:0048489	endocytosis [GO:0006897]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]		NA	NA	NA	NA	NA	NA
TRINITY_DN25611_c0_g1_i1	O43760	SNG2_HUMAN	100	81	0	0	3	245	85	165	7.90E-41	167.2	SNG2_HUMAN	reviewed	Synaptogyrin-2 (Cellugyrin)	SYNGR2 UNQ352/PRO615	Homo sapiens (Human)	224	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]		GO:0005811; GO:0016021; GO:0016032; GO:0030672; GO:0031594; GO:0045055; GO:0048499; GO:0070062	regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN33551_c0_g1_i1	O43426	SYNJ1_HUMAN	46.5	127	58	2	40	420	512	628	2.00E-23	110.2	SYNJ1_HUMAN	reviewed	"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)"	SYNJ1 KIAA0910	Homo sapiens (Human)	1573	"clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]"	clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]	"phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]"	GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0034595; GO:0043195; GO:0043647; GO:0043812; GO:0046488; GO:0046855; GO:0046856; GO:0048471; GO:0048488; GO:0048489; GO:0061024; GO:0097060; GO:0098793; GO:1904980	brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]		NA	NA	NA	NA	NA	NA
TRINITY_DN6324_c0_g1_i1	O89104	SYPL2_MOUSE	37.5	80	44	2	22	243	82	161	1.20E-06	53.9	SYPL2_MOUSE	reviewed	Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29)	Sypl2 Mg29	Mus musculus (Mouse)	264	integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; syntaxin-1 binding [GO:0017075]; cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; T-tubule organization [GO:0033292]	integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	syntaxin-1 binding [GO:0017075]	GO:0006874; GO:0007507; GO:0016021; GO:0017075; GO:0030672; GO:0033292	cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; T-tubule organization [GO:0033292]		NA	NA	NA	NA	NA	NA
TRINITY_DN6324_c0_g1_i2	O89104	SYPL2_MOUSE	36.2	163	100	2	22	498	82	244	1.50E-24	114.4	SYPL2_MOUSE	reviewed	Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29)	Sypl2 Mg29	Mus musculus (Mouse)	264	integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; syntaxin-1 binding [GO:0017075]; cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; T-tubule organization [GO:0033292]	integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	syntaxin-1 binding [GO:0017075]	GO:0006874; GO:0007507; GO:0016021; GO:0017075; GO:0030672; GO:0033292	cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; T-tubule organization [GO:0033292]		blue	blue	NA	NA	NA	NA
TRINITY_DN26923_c0_g1_i1	O00161	SNP23_HUMAN	100	102	0	0	307	2	14	115	4.60E-54	211.5	SNP23_HUMAN	reviewed	Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23)	SNAP23	Homo sapiens (Human)	211	"adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]"	adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0002479; GO:0002553; GO:0005484; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0005912; GO:0005925; GO:0006887; GO:0006892; GO:0006903; GO:0006906; GO:0015031; GO:0016082; GO:0019905; GO:0030670; GO:0031201; GO:0031629; GO:0035579; GO:0042581; GO:0042582; GO:0043005; GO:0043312; GO:0061025; GO:0070062; GO:0070821; GO:0098793	"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31431_c0_g1_i1	O00161	SNP23_HUMAN	88.7	106	12	0	1	318	106	211	1.70E-46	186.4	SNP23_HUMAN	reviewed	Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23)	SNAP23	Homo sapiens (Human)	211	"adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]"	adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0002479; GO:0002553; GO:0005484; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0005912; GO:0005925; GO:0006887; GO:0006892; GO:0006903; GO:0006906; GO:0015031; GO:0016082; GO:0019905; GO:0030670; GO:0031201; GO:0031629; GO:0035579; GO:0042581; GO:0042582; GO:0043005; GO:0043312; GO:0061025; GO:0070062; GO:0070821; GO:0098793	"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2985_c0_g1_i1	P36975	SNP25_DROME	72.4	199	54	1	71	664	14	212	4.30E-79	295.8	SNP25_DROME	reviewed	Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein)	Snap25 CG40452	Drosophila melanogaster (Fruit fly)	212	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2985_c0_g1_i2	P36975	SNP25_DROME	72.4	199	54	1	92	685	14	212	4.40E-79	295.8	SNP25_DROME	reviewed	Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein)	Snap25 CG40452	Drosophila melanogaster (Fruit fly)	212	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2998_c0_g2_i1	Q0II86	SNP29_BOVIN	30.7	257	154	5	860	99	23	258	7.70E-16	86.3	SNP29_BOVIN	reviewed	Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29)	SNAP29	Bos taurus (Bovine)	258	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000421; GO:0005484; GO:0005654; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006906; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031410; GO:0031629; GO:0060271; GO:0097352; GO:0098793	autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN2998_c0_g1_i1	Q0II86	SNP29_BOVIN	30.7	257	154	5	216	977	23	258	7.70E-16	86.3	SNP29_BOVIN	reviewed	Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29)	SNAP29	Bos taurus (Bovine)	258	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000421; GO:0005484; GO:0005654; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006906; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031410; GO:0031629; GO:0060271; GO:0097352; GO:0098793	autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN25317_c0_g1_i1	P21521	SY65_DROME	88.7	256	25	3	764	6	213	467	2.60E-130	466.1	SY65_DROME	reviewed	Synaptotagmin 1 (p65)	Syt1 syt CG3139	Drosophila melanogaster (Fruit fly)	474	axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073	calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN25317_c0_g1_i2	P21521	SY65_DROME	90.2	194	16	2	603	31	213	406	3.50E-98	359	SY65_DROME	reviewed	Synaptotagmin 1 (p65)	Syt1 syt CG3139	Drosophila melanogaster (Fruit fly)	474	axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073	calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12554_c0_g1_i1	A0A075F932	SYT1_ANSCY	45.5	99	51	2	45	335	268	365	9.90E-18	90.9	SYT1_ANSCY	reviewed	Synaptotagmin-1 (Synaptotagmin I) (SytI)	SYT1	Anser cygnoid (Swan goose)	421	chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543]; multicellular organismal reproductive process [GO:0048609]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of hormone secretion [GO:0046883]; regulation of regulated secretory pathway [GO:1903305]; response to calcium ion [GO:0051592]	chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]	GO:0005509; GO:0005543; GO:0005544; GO:0005737; GO:0005886; GO:0007269; GO:0008021; GO:0016021; GO:0017158; GO:0030672; GO:0042584; GO:0046883; GO:0048609; GO:0051592; GO:1903305; GO:1903861	multicellular organismal reproductive process [GO:0048609]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of hormone secretion [GO:0046883]; regulation of regulated secretory pathway [GO:1903305]; response to calcium ion [GO:0051592]		NA	NA	NA	NA	NA	NA
TRINITY_DN35335_c0_g1_i1	Q9BT88	SYT11_HUMAN	100	123	0	0	372	4	278	400	1.60E-64	246.5	SYT11_HUMAN	reviewed	Synaptotagmin-11 (Synaptotagmin XI) (SytXI)	SYT11 KIAA0080	Homo sapiens (Human)	431	axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of presynaptic active zone membrane [GO:0099059]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; establishment of vesicle localization [GO:0051650]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of clathrin-coated pit assembly [GO:1905469]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of endocytosis [GO:0045806]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of membrane invagination [GO:1905154]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synaptic vesicle endocytosis [GO:1900243]; negative regulation of tumor necrosis factor secretion [GO:1904468]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of presynaptic active zone membrane [GO:0099059]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]	beta-tubulin binding [GO:0048487]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]	GO:0000149; GO:0001778; GO:0001786; GO:0001891; GO:0005509; GO:0005544; GO:0005764; GO:0005765; GO:0005802; GO:0005886; GO:0006906; GO:0006914; GO:0007612; GO:0007613; GO:0008021; GO:0014059; GO:0014069; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0030424; GO:0030425; GO:0030665; GO:0031369; GO:0031625; GO:0031982; GO:0032009; GO:0032715; GO:0033602; GO:0042802; GO:0043005; GO:0043195; GO:0043197; GO:0043204; GO:0045202; GO:0045335; GO:0045806; GO:0046929; GO:0048471; GO:0048487; GO:0048787; GO:0050710; GO:0050765; GO:0051650; GO:0055037; GO:0055038; GO:0060076; GO:0060077; GO:0070382; GO:0071277; GO:0098685; GO:0098793; GO:0099059; GO:1900186; GO:1900243; GO:1900424; GO:1903979; GO:1904468; GO:1905154; GO:1905162; GO:1905171; GO:1905469; GO:1990927	autophagy [GO:0006914]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; establishment of vesicle localization [GO:0051650]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of clathrin-coated pit assembly [GO:1905469]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of endocytosis [GO:0045806]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of membrane invagination [GO:1905154]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synaptic vesicle endocytosis [GO:1900243]; negative regulation of tumor necrosis factor secretion [GO:1904468]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12554_c0_g1_i2	Q9BSW7	SYT17_HUMAN	52.2	157	70	2	28	498	263	414	4.90E-37	155.6	SYT17_HUMAN	reviewed	Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII) (SytXVII)	SYT17	Homo sapiens (Human)	474	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0048791; GO:0070382; GO:0071277; GO:0098793; GO:1903861	calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12554_c0_g1_i3	Q9BSW7	SYT17_HUMAN	50	52	26	0	28	183	263	314	1.20E-09	63.5	SYT17_HUMAN	reviewed	Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII) (SytXVII)	SYT17	Homo sapiens (Human)	474	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0048791; GO:0070382; GO:0071277; GO:0098793; GO:1903861	calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN12554_c0_g1_i4	Q9BSW7	SYT17_HUMAN	52.9	153	71	1	28	486	263	414	6.60E-39	161.8	SYT17_HUMAN	reviewed	Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII) (SytXVII)	SYT17	Homo sapiens (Human)	474	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0048791; GO:0070382; GO:0071277; GO:0098793; GO:1903861	calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN40797_c0_g1_i1	Q9BSW7	SYT17_HUMAN	61.6	73	26	1	215	3	194	266	8.30E-18	90.5	SYT17_HUMAN	reviewed	Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII) (SytXVII)	SYT17	Homo sapiens (Human)	474	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0048791; GO:0070382; GO:0071277; GO:0098793; GO:1903861	calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN30683_c0_g1_i1	O43581	SYT7_HUMAN	60.5	124	46	2	367	2	152	274	6.10E-37	154.8	SYT7_HUMAN	reviewed	Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)	SYT7 PCANAP7	Homo sapiens (Human)	403	"axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]"	axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"	GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030425; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0043025; GO:0043679; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098978; GO:0098982; GO:0099502; GO:1990926; GO:1990927	calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN39827_c0_g1_i1	Q9R0N7	SYT7_MOUSE	54.1	109	49	1	329	3	295	402	1.20E-28	127.1	SYT7_MOUSE	reviewed	Synaptotagmin-7 (Synaptotagmin VII) (SytVII)	Syt7	Mus musculus (Mouse)	403	"axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]"	axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	"calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"	GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030425; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0043025; GO:0043679; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098978; GO:0098982; GO:0099502; GO:1990926; GO:1990927	calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium ion regulated lysosome exocytosis [GO:1990927]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN40410_c0_g1_i1	Q9HCH5	SYTL2_HUMAN	100	72	0	0	218	3	652	723	2.90E-34	145.2	SYTL2_HUMAN	reviewed	Synaptotagmin-like protein 2 (Breast cancer-associated antigen SGA-72M) (Exophilin-4)	SYTL2 KIAA1597 SGA72M SLP2 SLP2A	Homo sapiens (Human)	934	"cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; neurexin family protein binding [GO:0042043]; phosphatase binding [GO:0019902]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of mucus secretion [GO:0070257]; protein localization to plasma membrane [GO:0072659]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"neurexin family protein binding [GO:0042043]; phosphatase binding [GO:0019902]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; Rab GTPase binding [GO:0017137]"	GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0006886; GO:0006887; GO:0006904; GO:0010923; GO:0016020; GO:0016192; GO:0017137; GO:0019897; GO:0019902; GO:0042043; GO:0042470; GO:0070257; GO:0070382; GO:0072659	exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of mucus secretion [GO:0070257]; protein localization to plasma membrane [GO:0072659]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1130_c0_g1_i1	Q8TDW5	SYTL5_HUMAN	39	300	163	4	144	986	347	645	5.20E-51	203	SYTL5_HUMAN	reviewed	Synaptotagmin-like protein 5	SYTL5 SLP5	Homo sapiens (Human)	730	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]	GO:0005543; GO:0005886; GO:0006886; GO:0006887; GO:0017137; GO:0042043; GO:0046872; GO:0070382	exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]		blue	blue	NA	NA	NA	NA
TRINITY_DN35377_c0_g1_i1	Q8CI71	VPS50_MOUSE	50	180	87	2	605	72	780	958	4.80E-47	189.1	VPS50_MOUSE	reviewed	Syndetin (Bcl2-like protein blm) (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)	Vps50 Ccdc132 Kiaa1861	Mus musculus (Mouse)	964	cytosol [GO:0005829]; EARP complex [GO:1990745]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]	cytosol [GO:0005829]; EARP complex [GO:1990745]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]	SNARE binding [GO:0000149]	GO:0000149; GO:0005829; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:1990745	endocytic recycling [GO:0032456]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN8730_c0_g1_i1	Q3TIR3	RIC8A_MOUSE	97.1	68	2	0	2	205	379	446	9.60E-32	136.7	RIC8A_MOUSE	reviewed	Synembryn-A (Protein Ric-8A)	Ric8a Ric8	Mus musculus (Mouse)	530	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to light stimulus [GO:0009416]; vasculature development [GO:0001944]; visual learning [GO:0008542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001701; GO:0001944; GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007193; GO:0007369; GO:0008277; GO:0008542; GO:0009416; GO:0016020; GO:0042074; GO:0070586; GO:0071711	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell-cell adhesion involved in gastrulation [GO:0070586]; cell migration involved in gastrulation [GO:0042074]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to light stimulus [GO:0009416]; vasculature development [GO:0001944]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN31102_c0_g1_i1	Q9NPQ8	RIC8A_HUMAN	100	74	0	0	223	2	445	518	9.40E-36	150.2	RIC8A_HUMAN	reviewed	Synembryn-A (Protein Ric-8A)	RIC8A	Homo sapiens (Human)	531	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; vasculature development [GO:0001944]; visual learning [GO:0008542]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001701; GO:0001944; GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0008542; GO:0042074; GO:0070586; GO:0071711	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell-cell adhesion involved in gastrulation [GO:0070586]; cell migration involved in gastrulation [GO:0042074]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; vasculature development [GO:0001944]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i1	Q642H7	RIC8A_DANRE	41	497	222	10	1	1458	110	546	1.30E-85	318.5	RIC8A_DANRE	reviewed	Synembryn-A (Protein Ric-8A)	ric8a zgc:92294	Danio rerio (Zebrafish) (Brachydanio rerio)	548	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i15	Q5ZL77	RIC8A_CHICK	34.7	354	175	6	1	1053	110	410	1.30E-41	172.2	RIC8A_CHICK	reviewed	Synembryn-A (Protein Ric-8A)	RIC8A RCJMB04_7f5	Gallus gallus (Chicken)	539	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; vasculature development [GO:0001944]; visual learning [GO:0008542]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001944; GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0008542; GO:0042074; GO:0070586; GO:0071711	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell-cell adhesion involved in gastrulation [GO:0070586]; cell migration involved in gastrulation [GO:0042074]; G protein-coupled receptor signaling pathway [GO:0007186]; vasculature development [GO:0001944]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i20	Q642H7	RIC8A_DANRE	28.9	190	90	4	7	567	228	375	3.10E-12	73.6	RIC8A_DANRE	reviewed	Synembryn-A (Protein Ric-8A)	ric8a zgc:92294	Danio rerio (Zebrafish) (Brachydanio rerio)	548	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i23	Q5ZL77	RIC8A_CHICK	35.8	355	172	6	1	1056	110	411	2.70E-43	177.6	RIC8A_CHICK	reviewed	Synembryn-A (Protein Ric-8A)	RIC8A RCJMB04_7f5	Gallus gallus (Chicken)	539	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; vasculature development [GO:0001944]; visual learning [GO:0008542]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001944; GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0008542; GO:0042074; GO:0070586; GO:0071711	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell-cell adhesion involved in gastrulation [GO:0070586]; cell migration involved in gastrulation [GO:0042074]; G protein-coupled receptor signaling pathway [GO:0007186]; vasculature development [GO:0001944]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i24	Q642H7	RIC8A_DANRE	53.4	88	30	2	90	338	465	546	4.50E-17	89	RIC8A_DANRE	reviewed	Synembryn-A (Protein Ric-8A)	ric8a zgc:92294	Danio rerio (Zebrafish) (Brachydanio rerio)	548	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i4	Q5ZL77	RIC8A_CHICK	34.7	354	175	6	1	1053	110	410	1.20E-41	172.2	RIC8A_CHICK	reviewed	Synembryn-A (Protein Ric-8A)	RIC8A RCJMB04_7f5	Gallus gallus (Chicken)	539	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; vasculature development [GO:0001944]; visual learning [GO:0008542]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001944; GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0008542; GO:0042074; GO:0070586; GO:0071711	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell-cell adhesion involved in gastrulation [GO:0070586]; cell migration involved in gastrulation [GO:0042074]; G protein-coupled receptor signaling pathway [GO:0007186]; vasculature development [GO:0001944]; visual learning [GO:0008542]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i8	Q642H7	RIC8A_DANRE	43.4	369	151	7	7	1089	228	546	1.90E-68	261.2	RIC8A_DANRE	reviewed	Synembryn-A (Protein Ric-8A)	ric8a zgc:92294	Danio rerio (Zebrafish) (Brachydanio rerio)	548	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i14	Q80XE1	RIC8B_MOUSE	35.8	232	127	6	25	708	229	442	1.80E-25	117.9	RIC8B_MOUSE	reviewed	Synembryn-B (Protein Ric-8B)	Ric8b	Mus musculus (Mouse)	520	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0005938; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN1563_c0_g1_i17	Q80XE1	RIC8B_MOUSE	34.6	243	124	7	87	797	229	442	2.30E-24	114.4	RIC8B_MOUSE	reviewed	Synembryn-B (Protein Ric-8B)	Ric8b	Mus musculus (Mouse)	520	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0005938; GO:0007186	G protein-coupled receptor signaling pathway [GO:0007186]		NA	NA	NA	NA	NA	NA
TRINITY_DN3236_c0_g1_i4	O60499	STX10_HUMAN	61.8	68	20	1	205	2	7	68	3.40E-14	79.7	STX10_HUMAN	reviewed	Syntaxin-10 (Syn10)	STX10 SYN10	Homo sapiens (Human)	249	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"	cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031982; GO:0032588; GO:0032880; GO:0042147; GO:0048193; GO:0048278; GO:0048471	"Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26334_c0_g1_i1	O60499	STX10_HUMAN	100	74	0	0	223	2	154	227	2.50E-33	142.1	STX10_HUMAN	reviewed	Syntaxin-10 (Syn10)	STX10 SYN10	Homo sapiens (Human)	249	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"	cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031982; GO:0032588; GO:0032880; GO:0042147; GO:0048193; GO:0048278; GO:0048471	"Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"		NA	NA	NA	NA	NA	NA
TRINITY_DN758_c1_g1_i1	O14662	STX16_HUMAN	36.2	199	118	3	695	105	109	300	4.10E-26	119.8	STX16_HUMAN	reviewed	Syntaxin-16 (Syn16)	STX16	Homo sapiens (Human)	325	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0031201; GO:0031985; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161	"Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"		NA	NA	NA	NA	NA	NA
TRINITY_DN758_c1_g1_i2	O14662	STX16_HUMAN	32.2	307	179	4	959	105	1	300	7.50E-37	156	STX16_HUMAN	reviewed	Syntaxin-16 (Syn16)	STX16	Homo sapiens (Human)	325	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0031201; GO:0031985; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161	"Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38820_c0_g1_i1	Q24547	STX1A_DROME	87.8	82	10	0	246	1	125	206	1.20E-33	143.3	STX1A_DROME	reviewed	Syntaxin-1A (dSynt1)	Syx1A syx-1A CG31136	Drosophila melanogaster (Fruit fly)	291	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000149; GO:0000281; GO:0005484; GO:0005765; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007269; GO:0007274; GO:0007317; GO:0007349; GO:0007482; GO:0008021; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0017157; GO:0030672; GO:0031201; GO:0031629; GO:0042734; GO:0043195; GO:0048278; GO:0048787	cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN18257_c0_g1_i1	Q24547	STX1A_DROME	48.4	250	127	1	88	831	1	250	1.40E-57	224.6	STX1A_DROME	reviewed	Syntaxin-1A (dSynt1)	Syx1A syx-1A CG31136	Drosophila melanogaster (Fruit fly)	291	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000149; GO:0000281; GO:0005484; GO:0005765; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007269; GO:0007274; GO:0007317; GO:0007349; GO:0007482; GO:0008021; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0017157; GO:0030672; GO:0031201; GO:0031629; GO:0042734; GO:0043195; GO:0048278; GO:0048787	cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN1015_c0_g1_i3	Q24509	STX5_DROME	42	405	198	7	253	1440	91	467	1.40E-66	255.4	STX5_DROME	reviewed	Syntaxin-5 (Sed5 protein) (dSed5)	Syx5 Sed5 CG4214	Drosophila melanogaster (Fruit fly)	467	cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cell morphogenesis [GO:0000902]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; spermatogenesis [GO:0007283]; synaptic vesicle docking [GO:0016081]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000139; GO:0000149; GO:0000281; GO:0000902; GO:0005484; GO:0005783; GO:0005794; GO:0005801; GO:0005886; GO:0006878; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007112; GO:0007269; GO:0007283; GO:0009306; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0031201; GO:0035167; GO:0042803; GO:0048278; GO:0055070; GO:0098793	cell morphogenesis [GO:0000902]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; spermatogenesis [GO:0007283]; synaptic vesicle docking [GO:0016081]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1015_c0_g1_i5	Q24509	STX5_DROME	42	405	198	7	289	1476	91	467	1.40E-66	255.4	STX5_DROME	reviewed	Syntaxin-5 (Sed5 protein) (dSed5)	Syx5 Sed5 CG4214	Drosophila melanogaster (Fruit fly)	467	cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cell morphogenesis [GO:0000902]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; spermatogenesis [GO:0007283]; synaptic vesicle docking [GO:0016081]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000139; GO:0000149; GO:0000281; GO:0000902; GO:0005484; GO:0005783; GO:0005794; GO:0005801; GO:0005886; GO:0006878; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007112; GO:0007269; GO:0007283; GO:0009306; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0031201; GO:0035167; GO:0042803; GO:0048278; GO:0055070; GO:0098793	cell morphogenesis [GO:0000902]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; spermatogenesis [GO:0007283]; synaptic vesicle docking [GO:0016081]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN31041_c0_g1_i1	Q24509	STX5_DROME	47.6	63	33	0	9	197	405	467	2.50E-10	65.9	STX5_DROME	reviewed	Syntaxin-5 (Sed5 protein) (dSed5)	Syx5 Sed5 CG4214	Drosophila melanogaster (Fruit fly)	467	cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cell morphogenesis [GO:0000902]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; spermatogenesis [GO:0007283]; synaptic vesicle docking [GO:0016081]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]	cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	protein homodimerization activity [GO:0042803]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000139; GO:0000149; GO:0000281; GO:0000902; GO:0005484; GO:0005783; GO:0005794; GO:0005801; GO:0005886; GO:0006878; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007112; GO:0007269; GO:0007283; GO:0009306; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0031201; GO:0035167; GO:0042803; GO:0048278; GO:0055070; GO:0098793	cell morphogenesis [GO:0000902]; cellular copper ion homeostasis [GO:0006878]; copper ion homeostasis [GO:0055070]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; larval lymph gland hemopoiesis [GO:0035167]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; spermatogenesis [GO:0007283]; synaptic vesicle docking [GO:0016081]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3236_c0_g1_i2	Q9JKK1	STX6_MOUSE	50.6	267	120	3	882	82	1	255	1.80E-61	237.7	STX6_MOUSE	reviewed	Syntaxin-6	Stx6	Mus musculus (Mouse)	255	"cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of cellular protein localization [GO:1903827]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0008021; GO:0012505; GO:0016020; GO:0016021; GO:0016189; GO:0016192; GO:0019905; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0055037; GO:0090161; GO:1903827	"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of cellular protein localization [GO:1903827]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3236_c0_g1_i7	Q9JKK1	STX6_MOUSE	46.9	192	96	2	657	82	70	255	1.50E-35	151.4	STX6_MOUSE	reviewed	Syntaxin-6	Stx6	Mus musculus (Mouse)	255	"cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of cellular protein localization [GO:1903827]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0008021; GO:0012505; GO:0016020; GO:0016021; GO:0016189; GO:0016192; GO:0019905; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0055037; GO:0090161; GO:1903827	"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of cellular protein localization [GO:1903827]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN41015_c0_g1_i1	O15400	STX7_HUMAN	100	67	0	0	2	202	178	244	4.30E-29	127.9	STX7_HUMAN	reviewed	Syntaxin-7	STX7	Homo sapiens (Human)	261	azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076	intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN12683_c0_g1_i1	Q3ZBT5	STX7_BOVIN	32.2	227	147	3	207	866	13	239	5.40E-24	113.2	STX7_BOVIN	reviewed	Syntaxin-7	STX7	Bos taurus (Bovine)	261	azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005770; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0042582; GO:0048278; GO:0048471; GO:0055037; GO:0070820; GO:0070925; GO:1902685; GO:1903076	intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN36150_c0_g1_i1	Q3ZBT5	STX7_BOVIN	43	249	130	6	987	250	2	241	1.40E-36	155.2	STX7_BOVIN	reviewed	Syntaxin-7	STX7	Bos taurus (Bovine)	261	azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005770; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0042582; GO:0048278; GO:0048471; GO:0055037; GO:0070820; GO:0070925; GO:1902685; GO:1903076	intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN36150_c0_g1_i2	Q3ZBT5	STX7_BOVIN	43	249	130	6	987	250	2	241	1.40E-36	155.2	STX7_BOVIN	reviewed	Syntaxin-7	STX7	Bos taurus (Bovine)	261	azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	azurophil granule [GO:0042582]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005770; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0042582; GO:0048278; GO:0048471; GO:0055037; GO:0070820; GO:0070925; GO:1902685; GO:1903076	intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN36477_c0_g1_i1	Q3T075	STX8_BOVIN	38.8	67	41	0	15	215	127	193	4.30E-08	58.9	STX8_BOVIN	reviewed	Syntaxin-8	STX8	Bos taurus (Bovine)	236	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0048278	intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]		NA	NA	NA	NA	NA	NA
TRINITY_DN5407_c1_g1_i1	O00560	SDCB1_HUMAN	45.3	53	28	1	31	186	246	298	1.50E-08	60.1	SDCB1_HUMAN	reviewed	Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)	SDCBP MDA9 SYCL	Homo sapiens (Human)	298	"adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"	adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]"	GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0043312; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0047485; GO:0048013; GO:0070062; GO:0072562; GO:1903543; GO:1903553; GO:1903561	"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5407_c1_g1_i3	O00560	SDCB1_HUMAN	45.3	53	28	1	31	186	246	298	1.20E-08	60.1	SDCB1_HUMAN	reviewed	Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)	SDCBP MDA9 SYCL	Homo sapiens (Human)	298	"adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"	adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]"	GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0043312; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0047485; GO:0048013; GO:0070062; GO:0072562; GO:1903543; GO:1903553; GO:1903561	"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14241_c0_g2_i1	O00560	SDCB1_HUMAN	100	210	0	0	3	632	89	298	5.30E-116	418.3	SDCB1_HUMAN	reviewed	Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)	SDCBP MDA9 SYCL	Homo sapiens (Human)	298	"adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"	adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]"	GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0043312; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0047485; GO:0048013; GO:0070062; GO:0072562; GO:1903543; GO:1903553; GO:1903561	"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14241_c0_g1_i1	O08992	SDCB1_MOUSE	100	214	0	0	3	644	85	298	3.20E-118	425.6	SDCB1_MOUSE	reviewed	Syntenin-1 (Scaffold protein Pbp1) (Syndecan-binding protein 1)	Sdcbp	Mus musculus (Mouse)	299	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]"	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]"	GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008284; GO:0010718; GO:0010862; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0099054; GO:1903543; GO:1903553	actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN5407_c1_g1_i2	Q9JI92	SDCB1_RAT	51.8	253	118	3	66	821	51	300	9.40E-73	275	SDCB1_RAT	reviewed	Syntenin-1 (Syndecan-binding protein 1)	Sdcbp	Rattus norvegicus (Rat)	300	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]"	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]"	GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008284; GO:0010718; GO:0010862; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0099054; GO:1903543; GO:1903553	actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c5_g2_i1	Q9Y6J9	TAF6L_HUMAN	28	329	225	6	1089	121	49	371	1.40E-26	122.1	TAF6L_HUMAN	reviewed	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha)	TAF6L PAF65A	Homo sapiens (Human)	622	"extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]	GO:0000118; GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006338; GO:0006355; GO:0006357; GO:0006367; GO:0016251; GO:0016573; GO:0030914; GO:0043966; GO:0045944; GO:0046695; GO:0046982; GO:0070062; GO:1904672	"chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN612_c5_g2_i3	Q9Y6J9	TAF6L_HUMAN	28.6	374	254	7	1224	121	5	371	1.80E-33	145.2	TAF6L_HUMAN	reviewed	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha)	TAF6L PAF65A	Homo sapiens (Human)	622	"extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]	GO:0000118; GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006338; GO:0006355; GO:0006357; GO:0006367; GO:0016251; GO:0016573; GO:0030914; GO:0043966; GO:0045944; GO:0046695; GO:0046982; GO:0070062; GO:1904672	"chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28503_c0_g1_i1	Q6IV76	TAZ_ERYPA	100	119	0	0	2	358	105	223	4.00E-70	265	TAZ_ERYPA	reviewed	Tafazzin	TAZ	Erythrocebus patas (Red guenon) (Cercopithecus patas)	262	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid metabolic process [GO:0006644]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0006644; GO:0016021; GO:0016746	phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN390_c0_g1_i1	Q6IV76	TAZ_ERYPA	50.8	242	119	0	834	109	21	262	4.80E-74	279.3	TAZ_ERYPA	reviewed	Tafazzin	TAZ	Erythrocebus patas (Red guenon) (Cercopithecus patas)	262	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid metabolic process [GO:0006644]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0006644; GO:0016021; GO:0016746	phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN390_c0_g1_i2	Q6IV76	TAZ_ERYPA	55	109	49	0	665	339	21	129	2.40E-31	137.1	TAZ_ERYPA	reviewed	Tafazzin	TAZ	Erythrocebus patas (Red guenon) (Cercopithecus patas)	262	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid metabolic process [GO:0006644]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0006644; GO:0016021; GO:0016746	phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN390_c0_g1_i2	Q6IV76	TAZ_ERYPA	40.3	77	46	0	339	109	186	262	1.40E-10	68.2	TAZ_ERYPA	reviewed	Tafazzin	TAZ	Erythrocebus patas (Red guenon) (Cercopithecus patas)	262	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid metabolic process [GO:0006644]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0006644; GO:0016021; GO:0016746	phospholipid metabolic process [GO:0006644]		NA	NA	NA	NA	NA	NA
TRINITY_DN390_c0_g1_i3	Q6IV76	TAZ_ERYPA	55	111	50	0	421	89	21	131	3.90E-32	139	TAZ_ERYPA	reviewed	Tafazzin	TAZ	Erythrocebus patas (Red guenon) (Cercopithecus patas)	262	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid metabolic process [GO:0006644]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0006644; GO:0016021; GO:0016746	phospholipid metabolic process [GO:0006644]		blue	blue	NA	NA	NA	NA
TRINITY_DN390_c0_g1_i4	Q16635	TAZ_HUMAN	48.5	134	69	0	510	109	159	292	8.40E-36	151.8	TAZ_HUMAN	reviewed	Tafazzin (Protein G4.5)	TAZ EFE2 G4.5	Homo sapiens (Human)	292	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; O-acyltransferase activity [GO:0008374]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue development [GO:0048738]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cristae formation [GO:0042407]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial respiratory chain complex I assembly [GO:0032981]; muscle contraction [GO:0006936]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cardiolipin metabolic process [GO:1900210]; skeletal muscle tissue development [GO:0007519]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; O-acyltransferase activity [GO:0008374]	GO:0003841; GO:0005739; GO:0005743; GO:0006936; GO:0007007; GO:0007507; GO:0007519; GO:0008374; GO:0016021; GO:0030097; GO:0031966; GO:0032049; GO:0032981; GO:0035965; GO:0042407; GO:0042775; GO:0047184; GO:0048738; GO:0060048; GO:1900210; GO:2001171	cardiac muscle contraction [GO:0060048]; cardiac muscle tissue development [GO:0048738]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cristae formation [GO:0042407]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial respiratory chain complex I assembly [GO:0032981]; muscle contraction [GO:0006936]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cardiolipin metabolic process [GO:1900210]; skeletal muscle tissue development [GO:0007519]		NA	NA	NA	NA	NA	NA
TRINITY_DN28860_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	72	0	0	217	2	1017	1088	2.70E-32	138.7	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN18930_c0_g1_i1	P54939	TLN1_CHICK	94.2	137	7	1	412	2	2357	2492	3.50E-57	222.2	TLN1_CHICK	reviewed	Talin-1	TLN1 TLN	Gallus gallus (Chicken)	2541	"cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]"	cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	"actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol binding [GO:0035091]; structural constituent of cytoskeleton [GO:0005200]"	GO:0001726; GO:0005200; GO:0005829; GO:0005856; GO:0005925; GO:0006897; GO:0007015; GO:0007155; GO:0009986; GO:0030136; GO:0030276; GO:0032051; GO:0032587; GO:0035091; GO:0035615; GO:0043231; GO:0043325; GO:0048260; GO:0048268; GO:0051015; GO:0080025	actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]		NA	NA	NA	NA	NA	NA
TRINITY_DN32820_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	94	0	0	283	2	1464	1557	6.80E-44	177.6	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN13021_c0_g1_i1	Q9Y490	TLN1_HUMAN	58.6	70	29	0	31	240	59	128	1.70E-19	96.3	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN25274_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	128	0	0	385	2	1	128	5.20E-69	261.5	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN25274_c0_g1_i2	Q9Y490	TLN1_HUMAN	99.6	263	1	0	789	1	1	263	1.60E-149	530	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN16178_c0_g1_i3	P54939	TLN1_CHICK	65.8	240	80	2	95	811	2291	2529	3.00E-71	270.4	TLN1_CHICK	reviewed	Talin-1	TLN1 TLN	Gallus gallus (Chicken)	2541	"cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]"	cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	"actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol binding [GO:0035091]; structural constituent of cytoskeleton [GO:0005200]"	GO:0001726; GO:0005200; GO:0005829; GO:0005856; GO:0005925; GO:0006897; GO:0007015; GO:0007155; GO:0009986; GO:0030136; GO:0030276; GO:0032051; GO:0032587; GO:0035091; GO:0035615; GO:0043231; GO:0043325; GO:0048260; GO:0048268; GO:0051015; GO:0080025	actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]		blue	blue	NA	NA	NA	NA
TRINITY_DN16178_c0_g1_i4	P54939	TLN1_CHICK	66.2	198	66	1	81	671	2332	2529	1.40E-56	221.5	TLN1_CHICK	reviewed	Talin-1	TLN1 TLN	Gallus gallus (Chicken)	2541	"cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]"	cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	"actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol binding [GO:0035091]; structural constituent of cytoskeleton [GO:0005200]"	GO:0001726; GO:0005200; GO:0005829; GO:0005856; GO:0005925; GO:0006897; GO:0007015; GO:0007155; GO:0009986; GO:0030136; GO:0030276; GO:0032051; GO:0032587; GO:0035091; GO:0035615; GO:0043231; GO:0043325; GO:0048260; GO:0048268; GO:0051015; GO:0080025	actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]		blue	blue	NA	NA	NA	NA
TRINITY_DN32709_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	73	0	0	221	3	1733	1805	6.10E-32	137.5	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN21941_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	193	0	0	3	581	2037	2229	8.20E-97	354.4	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN40523_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	77	0	0	3	233	546	622	2.00E-33	142.5	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29295_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	89	0	0	3	269	680	768	2.40E-38	159.1	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN34134_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	68	0	0	3	206	423	490	7.40E-32	137.1	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN39861_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	164	0	0	2	493	274	437	9.10E-89	327.4	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN39840_c0_g1_i1	Q9Y490	TLN1_HUMAN	100	158	0	0	476	3	1281	1438	1.20E-80	300.4	TLN1_HUMAN	reviewed	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	2541	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006936; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527; GO:0098609	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN38620_c0_g1_i1	P54939	TLN1_CHICK	94.8	210	10	1	630	1	2280	2488	7.10E-94	344.7	TLN1_CHICK	reviewed	Talin-1	TLN1 TLN	Gallus gallus (Chicken)	2541	"cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]"	cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	"actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol binding [GO:0035091]; structural constituent of cytoskeleton [GO:0005200]"	GO:0001726; GO:0005200; GO:0005829; GO:0005856; GO:0005925; GO:0006897; GO:0007015; GO:0007155; GO:0009986; GO:0030136; GO:0030276; GO:0032051; GO:0032587; GO:0035091; GO:0035615; GO:0043231; GO:0043325; GO:0048260; GO:0048268; GO:0051015; GO:0080025	actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]		NA	NA	NA	NA	NA	NA
TRINITY_DN16178_c0_g1_i1	Q9Y4G6	TLN2_HUMAN	61.2	505	186	4	88	1599	2	497	3.90E-176	619.4	TLN2_HUMAN	reviewed	Talin-2	TLN2 KIAA0320	Homo sapiens (Human)	2542	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001726; GO:0003779; GO:0005178; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015; GO:0098609	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]		blue	blue	NA	NA	NA	NA
TRINITY_DN16178_c0_g1_i5	Q9Y4G6	TLN2_HUMAN	54	2553	1147	12	88	7731	2	2531	0	2475.3	TLN2_HUMAN	reviewed	Talin-2	TLN2 KIAA0320	Homo sapiens (Human)	2542	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001726; GO:0003779; GO:0005178; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015; GO:0098609	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]		blue	blue	NA	NA	NA	NA
TRINITY_DN31121_c0_g1_i1	Q9Y4G6	TLN2_HUMAN	75.5	49	12	0	223	77	873	921	5.00E-10	64.7	TLN2_HUMAN	reviewed	Talin-2	TLN2 KIAA0320	Homo sapiens (Human)	2542	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001726; GO:0003779; GO:0005178; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015; GO:0098609	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]		NA	NA	NA	NA	NA	NA
TRINITY_DN1232_c0_g1_i1	Q13148	TADBP_HUMAN	59.3	275	74	4	823	2	1	238	3.00E-85	316.6	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1232_c0_g1_i2	Q13148	TADBP_HUMAN	68.6	185	55	2	793	242	1	183	2.10E-67	257.3	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1232_c0_g1_i3	Q13148	TADBP_HUMAN	69.4	183	53	2	811	266	1	181	3.60E-67	256.5	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1232_c0_g1_i4	Q28F51	TADBP_XENTR	75	48	12	0	144	1	135	182	7.80E-16	84	TADBP_XENTR	reviewed	TAR DNA-binding protein 43 (TDP-43)	tardbp tdp43 TGas087d21.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	409	nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0031647; GO:0042752; GO:0048511	mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1232_c0_g1_i5	Q13148	TADBP_HUMAN	67.9	240	73	3	715	2	1	238	7.90E-90	331.6	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1232_c0_g1_i6	Q13148	TADBP_HUMAN	66.3	246	73	4	733	2	1	238	4.40E-88	325.9	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN10112_c0_g1_i1	Q13148	TADBP_HUMAN	100	206	0	0	33	650	1	206	1.90E-118	426.4	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN10112_c0_g1_i2	Q13148	TADBP_HUMAN	100	191	0	0	1	573	16	206	1.40E-109	396.7	TADBP_HUMAN	reviewed	TAR DNA-binding protein 43 (TDP-43)	TARDBP TDP43	Homo sapiens (Human)	414	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN38609_c0_g1_i1	Q921F2	TADBP_MOUSE	100	117	0	0	352	2	80	196	6.20E-63	241.1	TADBP_MOUSE	reviewed	TAR DNA-binding protein 43 (TDP-43)	Tardbp Tdp43	Mus musculus (Mouse)	414	cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010467; GO:0010494; GO:0010629; GO:0031647; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157	3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN8308_c0_g1_i6	Q96GM8	TOE1_HUMAN	46.7	60	31	1	5	181	175	234	3.10E-08	59.3	TOE1_HUMAN	reviewed	Target of EGR1 protein 1	TOE1	Homo sapiens (Human)	510	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]	GO:0000175; GO:0003723; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503	"RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10615_c0_g1_i1	Q96GM8	TOE1_HUMAN	32.2	494	287	8	1535	129	33	503	1.30E-70	268.9	TOE1_HUMAN	reviewed	Target of EGR1 protein 1	TOE1	Homo sapiens (Human)	510	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]	GO:0000175; GO:0003723; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503	"RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32007_c0_g1_i1	O60784	TOM1_HUMAN	100	80	0	0	240	1	88	167	2.20E-40	165.6	TOM1_HUMAN	reviewed	Target of Myb protein 1	TOM1	Homo sapiens (Human)	492	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; clathrin binding [GO:0030276]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; signal transduction [GO:0007165]	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	clathrin binding [GO:0030276]	GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007165; GO:0015031; GO:0016020; GO:0016197; GO:0030276; GO:0035577; GO:0035579; GO:0043312; GO:0070062	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38817_c0_g1_i1	O60784	TOM1_HUMAN	100	68	0	0	206	3	246	313	8.20E-31	133.7	TOM1_HUMAN	reviewed	Target of Myb protein 1	TOM1	Homo sapiens (Human)	492	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; clathrin binding [GO:0030276]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; signal transduction [GO:0007165]	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	clathrin binding [GO:0030276]	GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007165; GO:0015031; GO:0016020; GO:0016197; GO:0030276; GO:0035577; GO:0035579; GO:0043312; GO:0070062	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN706_c0_g1_i13	Q8BKH7	SIN1_MOUSE	38.9	375	209	11	1474	377	1	364	1.70E-56	221.9	SIN1_MOUSE	reviewed	Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1)	Mapkap1 Mip1 Sin1	Mus musculus (Mouse)	522	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; TORC2 signaling [GO:0038203]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]	"phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]"	GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0017016; GO:0019901; GO:0030950; GO:0031410; GO:0031932; GO:0033138; GO:0038203; GO:0043325; GO:0046580; GO:0070300; GO:0080025; GO:1900407	establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN706_c0_g1_i16	Q8BKH7	SIN1_MOUSE	35.2	491	288	15	1422	4	1	479	2.00E-62	241.5	SIN1_MOUSE	reviewed	Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1)	Mapkap1 Mip1 Sin1	Mus musculus (Mouse)	522	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; TORC2 signaling [GO:0038203]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]	"phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]"	GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0017016; GO:0019901; GO:0030950; GO:0031410; GO:0031932; GO:0033138; GO:0038203; GO:0043325; GO:0046580; GO:0070300; GO:0080025; GO:1900407	establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN706_c0_g1_i3	Q8BKH7	SIN1_MOUSE	35.8	491	285	15	1422	4	1	479	3.00E-66	254.2	SIN1_MOUSE	reviewed	Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1)	Mapkap1 Mip1 Sin1	Mus musculus (Mouse)	522	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; TORC2 signaling [GO:0038203]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]	"phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]"	GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0017016; GO:0019901; GO:0030950; GO:0031410; GO:0031932; GO:0033138; GO:0038203; GO:0043325; GO:0046580; GO:0070300; GO:0080025; GO:1900407	establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; TORC2 signaling [GO:0038203]		NA	NA	NA	NA	NA	NA
TRINITY_DN2354_c0_g1_i2	Q803V5	LST8_DANRE	63.4	279	95	1	915	100	44	322	5.60E-109	395.6	LST8_DANRE	reviewed	"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)"	mlst8 gbl lst8 zgc:55455 zgc:85668	Danio rerio (Zebrafish) (Brachydanio rerio)	326	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031929; GO:0031931; GO:0031932; GO:0032956	regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN2354_c0_g1_i3	Q803V5	LST8_DANRE	62.8	317	111	1	1034	105	6	322	4.00E-124	446	LST8_DANRE	reviewed	"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)"	mlst8 gbl lst8 zgc:55455 zgc:85668	Danio rerio (Zebrafish) (Brachydanio rerio)	326	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031929; GO:0031931; GO:0031932; GO:0032956	regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN2354_c0_g1_i4	Q803V5	LST8_DANRE	62.8	317	111	1	1029	100	6	322	4.00E-124	446	LST8_DANRE	reviewed	"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)"	mlst8 gbl lst8 zgc:55455 zgc:85668	Danio rerio (Zebrafish) (Brachydanio rerio)	326	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031929; GO:0031931; GO:0031932; GO:0032956	regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN2354_c0_g1_i5	Q803V5	LST8_DANRE	63.4	279	95	1	920	105	44	322	7.30E-109	395.2	LST8_DANRE	reviewed	"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)"	mlst8 gbl lst8 zgc:55455 zgc:85668	Danio rerio (Zebrafish) (Brachydanio rerio)	326	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031929; GO:0031931; GO:0031932; GO:0032956	regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN2354_c0_g1_i1	Q17QU5	LST8_BOVIN	57.5	40	17	0	216	97	4	43	1.90E-07	56.6	LST8_BOVIN	reviewed	Target of rapamycin complex subunit LST8 (TORC subunit LST8) (G protein beta subunit-like) (Protein GbetaL) (Mammalian lethal with SEC13 protein 8) (mLST8)	MLST8 GBL LST8	Bos taurus (Bovine)	326	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; protein serine/threonine kinase activator activity [GO:0043539]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	protein serine/threonine kinase activator activity [GO:0043539]	GO:0005737; GO:0030838; GO:0031929; GO:0031931; GO:0031932; GO:0032008; GO:0032956; GO:0038202; GO:0043087; GO:0043539; GO:0050731	positive regulation of actin filament polymerization [GO:0030838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]		blue	blue	NA	NA	NA	NA
TRINITY_DN16190_c0_g1_i1	A6H6Z7	TPX2_BOVIN	37.2	290	168	5	980	141	416	701	1.40E-27	125.2	TPX2_BOVIN	reviewed	Targeting protein for Xklp2	TPX2	Bos taurus (Bovine)	704	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; apoptotic process [GO:0006915]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of mitotic spindle organization [GO:0060236]	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]	importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]	GO:0000922; GO:0005737; GO:0005880; GO:0006915; GO:0008017; GO:0030295; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307	apoptotic process [GO:0006915]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN16190_c0_g1_i6	A6H6Z7	TPX2_BOVIN	37.2	290	168	5	952	113	416	701	1.30E-27	125.2	TPX2_BOVIN	reviewed	Targeting protein for Xklp2	TPX2	Bos taurus (Bovine)	704	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; apoptotic process [GO:0006915]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of mitotic spindle organization [GO:0060236]	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]	importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]	GO:0000922; GO:0005737; GO:0005880; GO:0006915; GO:0008017; GO:0030295; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307	apoptotic process [GO:0006915]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN16190_c0_g1_i4	E2RYF8	TPX2_PATPE	37	135	84	1	521	120	756	890	1.30E-10	68.2	TPX2_PATPE	reviewed	Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)	TPX2	Patiria pectinifera (Starfish) (Asterina pectinifera)	891	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0032147; GO:0060236	activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN16488_c0_g1_i1	E2RYF8	TPX2_PATPE	29	373	177	13	1405	533	369	735	1.60E-17	92.4	TPX2_PATPE	reviewed	Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)	TPX2	Patiria pectinifera (Starfish) (Asterina pectinifera)	891	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0032147; GO:0060236	activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN16488_c0_g1_i3	E2RYF8	TPX2_PATPE	30.2	464	233	15	1393	245	369	822	1.40E-34	149.1	TPX2_PATPE	reviewed	Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)	TPX2	Patiria pectinifera (Starfish) (Asterina pectinifera)	891	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0032147; GO:0060236	activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN16488_c0_g1_i5	E2RYF8	TPX2_PATPE	31.6	528	272	14	1425	85	369	888	1.90E-39	165.2	TPX2_PATPE	reviewed	Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)	TPX2	Patiria pectinifera (Starfish) (Asterina pectinifera)	891	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]		GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0032147; GO:0060236	activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN32865_c0_g1_i1	Q6DIY4	TBPL1_XENTR	56.8	176	76	0	746	219	9	184	3.00E-49	197.2	TBPL1_XENTR	reviewed	TATA box-binding protein-like 1 (TBP-like 1) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor)	tbpl1 tlf trf2 TEgg016a11.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	186	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription, initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0000790; GO:0003677; GO:0005634; GO:0005737; GO:0006352; GO:0006366; GO:0009792	"DNA-templated transcription, initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366]"		blue	blue	NA	NA	NA	NA
TRINITY_DN21318_c0_g1_i1	Q32LB1	TBPL1_BOVIN	100	84	0	0	271	20	103	186	3.50E-42	171.8	TBPL1_BOVIN	reviewed	TATA box-binding protein-like 1 (TBP-like 1) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (TBP-related protein)	TBPL1 TLF TLP TRF2 TRP	Bos taurus (Bovine)	186	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; transcription factor TFIIA complex [GO:0005672]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; acrosome assembly [GO:0001675]; DNA-templated transcription, initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; transcription factor TFIIA complex [GO:0005672]	RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000790; GO:0000979; GO:0001675; GO:0005672; GO:0005737; GO:0006235; GO:0006352; GO:0007289; GO:0016251	"acrosome assembly [GO:0001675]; DNA-templated transcription, initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36142_c0_g1_i1	A6H907	TBPL2_PANTR	100	104	0	0	312	1	267	370	1.10E-52	206.8	TBPL2_PANTR	reviewed	TATA box-binding protein-like 2 (TBP-like 2) (TATA box-binding protein-related factor 3) (TBP-related factor 3)	TBPL2 TBP2 TRF3	Pan troglodytes (Chimpanzee)	376	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA-templated transcription, initiation [GO:0006352]; multicellular organism development [GO:0007275]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000790; GO:0003677; GO:0005737; GO:0006352; GO:0007275; GO:0016251	"DNA-templated transcription, initiation [GO:0006352]; multicellular organism development [GO:0007275]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39182_c0_g1_i1	O14981	BTAF1_HUMAN	87.2	86	10	1	356	102	1721	1806	3.50E-35	149.1	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39182_c0_g1_i3	O14981	BTAF1_HUMAN	86.1	151	20	1	551	102	1656	1806	3.10E-69	262.7	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29249_c0_g1_i1	O14981	BTAF1_HUMAN	100	81	0	0	35	277	1	81	9.90E-40	163.7	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16498_c0_g1_i2	O14981	BTAF1_HUMAN	35.2	219	132	4	630	1	137	354	3.00E-29	130.2	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		brown	brown	1	NA	NA	NA
TRINITY_DN16498_c0_g1_i3	O14981	BTAF1_HUMAN	39.2	352	201	5	1020	1	4	354	8.60E-60	232.3	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16498_c0_g2_i1	O14981	BTAF1_HUMAN	61.4	101	39	0	305	3	345	445	1.10E-28	127.1	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10574_c0_g1_i1	O14981	BTAF1_HUMAN	36.2	105	65	2	448	137	706	809	1.80E-07	57.8	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10574_c0_g1_i1	O14981	BTAF1_HUMAN	42.6	68	38	1	455	655	710	777	2.50E-04	47.4	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10574_c0_g1_i2	O14981	BTAF1_HUMAN	44.2	113	63	0	370	32	823	935	6.00E-19	96.3	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10574_c0_g1_i2	O14981	BTAF1_HUMAN	34.6	127	78	4	783	409	686	809	2.10E-08	61.2	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10574_c0_g1_i5	O14981	BTAF1_HUMAN	34.6	127	78	4	665	291	686	809	1.80E-08	61.2	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33429_c0_g1_i1	O14981	BTAF1_HUMAN	98.3	59	1	0	35	211	329	387	4.20E-27	121.3	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39434_c0_g1_i1	O14981	BTAF1_HUMAN	99.3	149	1	0	3	449	1651	1799	5.40E-80	298.1	BTAF1_HUMAN	reviewed	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	BTAF1 TAF172	Homo sapiens (Human)	1849	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0035562; GO:0043231; GO:0045892	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3670_c0_g1_i1	P32333	MOT1_YEAST	55.8	120	50	2	352	2	1679	1798	1.50E-32	140.2	MOT1_YEAST	reviewed	TATA-binding protein-associated factor MOT1 (TBP-associated factor MOT1) (EC 3.6.4.-) (Modifier of transcription 1)	MOT1 YPL082C LPF4C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1867	"mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]"	mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]	GO:0000228; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0006357; GO:0006364; GO:0008094; GO:0016887; GO:0017025; GO:0042790; GO:0045892; GO:0045898	"negative regulation of transcription, DNA-templated [GO:0045892]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11966_c0_g1_i1	P53361	TBP_SPOFR	81.8	231	29	3	63	728	81	307	4.30E-98	359	TBP_SPOFR	reviewed	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	Tbp	Spodoptera frugiperda (Fall armyworm)	307	"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]"	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]	GO:0000995; GO:0003677; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006383	"DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11966_c0_g1_i2	P53361	TBP_SPOFR	95.2	186	9	0	440	997	122	307	4.90E-97	355.9	TBP_SPOFR	reviewed	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	Tbp	Spodoptera frugiperda (Fall armyworm)	307	"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]"	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]	GO:0000995; GO:0003677; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006383	"DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]"		blue	blue	NA	NA	NA	NA
TRINITY_DN510_c0_g1_i1	P26354	TBP_ACACA	71.4	192	55	0	1	576	65	256	2.00E-74	280	TBP_ACACA	reviewed	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	TFIID	Acanthamoeba castellanii (Amoeba)	258	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription, initiation [GO:0006352]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006352	"DNA-templated transcription, initiation [GO:0006352]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36200_c0_g1_i1	P50158	TBP1_MAIZE	48.5	99	50	1	301	5	21	118	9.50E-20	97.4	TBP1_MAIZE	reviewed	TATA-box-binding protein 1 (TATA sequence-binding protein 1) (TBP-1) (TATA-binding factor 1) (TATA-box factor 1) (Transcription initiation factor TFIID TBP-1 subunit)	TBP1	Zea mays (Maize)	200	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA-templated transcription, initiation [GO:0006352]"	nuclear chromatin [GO:0000790]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000790; GO:0003677; GO:0006352; GO:0016251	"DNA-templated transcription, initiation [GO:0006352]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35330_c0_g1_i1	P26356	TBP1_WHEAT	52.6	76	36	0	229	2	149	224	2.00E-20	99.4	TBP1_WHEAT	reviewed	TATA-box-binding protein 1 (TATA sequence-binding protein 1) (TBP-1) (TATA-binding factor 1) (TATA-box factor 1) (Transcription initiation factor TFIID TBP-1 subunit)	TBP1 TFIID	Triticum aestivum (Wheat)	233	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA-templated transcription, initiation [GO:0006352]"	nuclear chromatin [GO:0000790]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000790; GO:0003677; GO:0006352; GO:0016251	"DNA-templated transcription, initiation [GO:0006352]"		NA	NA	NA	NA	NA	NA
TRINITY_DN394_c0_g1_i6	Q60949	TBCD1_MOUSE	45.7	506	249	7	1719	277	737	1241	1.10E-113	413.3	TBCD1_MOUSE	reviewed	TBC1 domain family member 1	Tbc1d1 Kiaa1108 Tbc1	Mus musculus (Mouse)	1255	cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]	cytosol [GO:0005829]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005634; GO:0005829; GO:0006886; GO:0017137; GO:0032880; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN394_c0_g1_i6	Q60949	TBCD1_MOUSE	34.9	252	149	4	2668	1952	280	529	6.30E-34	148.3	TBCD1_MOUSE	reviewed	TBC1 domain family member 1	Tbc1d1 Kiaa1108 Tbc1	Mus musculus (Mouse)	1255	cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]	cytosol [GO:0005829]; nucleus [GO:0005634]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005634; GO:0005829; GO:0006886; GO:0017137; GO:0032880; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]		NA	NA	NA	NA	NA	NA
TRINITY_DN394_c0_g1_i1	O97790	TBCD1_BOVIN	39.4	871	463	19	2736	292	285	1146	1.70E-151	538.9	TBCD1_BOVIN	reviewed	TBC1 domain family member 1 (Lyncein)	TBC1D1 LYN	Bos taurus (Bovine)	1165	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]	nucleus [GO:0005634]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN394_c0_g1_i3	O97790	TBCD1_BOVIN	44.7	530	259	9	1785	292	619	1146	3.70E-114	413.7	TBCD1_BOVIN	reviewed	TBC1 domain family member 1 (Lyncein)	TBC1D1 LYN	Bos taurus (Bovine)	1165	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]	nucleus [GO:0005634]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN394_c0_g1_i5	O97790	TBCD1_BOVIN	38.8	835	446	19	2628	292	321	1146	3.40E-139	498	TBCD1_BOVIN	reviewed	TBC1 domain family member 1 (Lyncein)	TBC1D1 LYN	Bos taurus (Bovine)	1165	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]	nucleus [GO:0005634]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN18815_c0_g1_i1	Q9BXI6	TB10A_HUMAN	100	187	0	0	561	1	115	301	2.80E-110	399.1	TB10A_HUMAN	reviewed	TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein) (Rab27A-GAP-alpha)	TBC1D10A EPI64 TBC1D10	Homo sapiens (Human)	508	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]	GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0005902; GO:0006886; GO:0017137; GO:0030165; GO:0042147; GO:0045296; GO:0045862; GO:0070062; GO:0090630; GO:0097202	"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18815_c0_g1_i2	Q9BXI6	TB10A_HUMAN	100	187	0	0	561	1	115	301	2.80E-110	399.1	TB10A_HUMAN	reviewed	TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein) (Rab27A-GAP-alpha)	TBC1D10A EPI64 TBC1D10	Homo sapiens (Human)	508	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]	GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0005902; GO:0006886; GO:0017137; GO:0030165; GO:0042147; GO:0045296; GO:0045862; GO:0070062; GO:0090630; GO:0097202	"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4518_c0_g1_i1	Q4KMP7	TB10B_HUMAN	57.4	197	79	2	615	40	288	484	1.40E-64	247.7	TB10B_HUMAN	reviewed	TBC1 domain family member 10B (Rab27A-GAP-beta)	TBC1D10B FP2461	Homo sapiens (Human)	808	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0017137; GO:0042147; GO:0043087; GO:0090630	"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4518_c0_g1_i2	Q4KMP7	TB10B_HUMAN	55.5	335	143	3	988	2	288	622	1.10E-110	401.4	TB10B_HUMAN	reviewed	TBC1 domain family member 10B (Rab27A-GAP-beta)	TBC1D10B FP2461	Homo sapiens (Human)	808	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0017137; GO:0042147; GO:0043087; GO:0090630	"activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37730_c0_g1_i1	Q8TC07	TBC15_HUMAN	100	139	0	0	419	3	491	629	3.70E-75	282	TBC15_HUMAN	reviewed	TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP)	TBC1D15	Homo sapiens (Human)	691	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005576; GO:0005737; GO:0006886; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN15950_c0_g1_i1	Q8TC07	TBC15_HUMAN	37.8	638	336	12	1792	32	11	638	8.80E-113	409.1	TBC15_HUMAN	reviewed	TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP)	TBC1D15	Homo sapiens (Human)	691	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005576; GO:0005737; GO:0006886; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN39529_c0_g1_i1	Q9CXF4	TBC15_MOUSE	100	73	0	0	219	1	376	448	1.50E-35	149.4	TBC15_MOUSE	reviewed	TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP)	Tbc1d15	Mus musculus (Mouse)	671	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005576; GO:0005737; GO:0005739; GO:0006886; GO:0017137; GO:0043087; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN19991_c1_g1_i3	Q8TBP0	TBC16_HUMAN	57.2	390	165	2	1227	64	296	685	4.30E-135	482.6	TBC16_HUMAN	reviewed	TBC1 domain family member 16	TBC1D16	Homo sapiens (Human)	767	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]	cytosol [GO:0005829]; early endosome [GO:0005769]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]		brown	brown	1	NA	NA	1
TRINITY_DN19991_c1_g1_i1	Q8TBP0	TBC16_HUMAN	48	171	88	1	548	39	296	466	1.80E-45	183.7	TBC16_HUMAN	reviewed	TBC1 domain family member 16	TBC1D16	Homo sapiens (Human)	767	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]	cytosol [GO:0005829]; early endosome [GO:0005769]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]		NA	NA	NA	NA	NA	NA
TRINITY_DN19991_c1_g1_i2	Q8TBP0	TBC16_HUMAN	57.2	428	181	2	1281	4	296	723	1.30E-150	534.3	TBC16_HUMAN	reviewed	TBC1 domain family member 16	TBC1D16	Homo sapiens (Human)	767	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]	cytosol [GO:0005829]; early endosome [GO:0005769]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0006886; GO:0017137; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]		NA	NA	NA	NA	NA	NA
TRINITY_DN29772_c0_g1_i1	Q8BYH7	TBC17_MOUSE	100	105	0	0	317	3	335	439	1.30E-56	219.9	TBC17_MOUSE	reviewed	TBC1 domain family member 17	Tbc1d17	Mus musculus (Mouse)	645	"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0017137; GO:0031410; GO:0042147; GO:0090630	"activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39460_c0_g1_i1	Q8BYH7	TBC17_MOUSE	100	81	0	0	244	2	513	593	1.20E-41	169.9	TBC17_MOUSE	reviewed	TBC1 domain family member 17	Tbc1d17	Mus musculus (Mouse)	645	"autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0017137; GO:0031410; GO:0042147; GO:0090630	"activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c6_g1_i1	Q8WUA7	TB22A_HUMAN	59.1	44	18	0	2	133	435	478	1.00E-09	63.5	TB22A_HUMAN	reviewed	TBC1 domain family member 22A	TBC1D22A C22orf4	Homo sapiens (Human)	517	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0042803; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN32089_c0_g1_i1	Q8WUA7	TB22A_HUMAN	100	102	0	0	3	308	243	344	3.50E-54	211.8	TB22A_HUMAN	reviewed	TBC1 domain family member 22A	TBC1D22A C22orf4	Homo sapiens (Human)	517	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0042803; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN4715_c2_g1_i1	Q9NU19	TB22B_HUMAN	60.9	350	134	2	115	1161	147	494	1.20E-123	444.5	TB22B_HUMAN	reviewed	TBC1 domain family member 22B	TBC1D22B C6orf197	Homo sapiens (Human)	505	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		blue	blue	NA	NA	NA	NA
TRINITY_DN2513_c0_g1_i1	Q9NU19	TB22B_HUMAN	48.4	436	200	6	1282	5	20	440	2.50E-109	397.1	TB22B_HUMAN	reviewed	TBC1 domain family member 22B	TBC1D22B C6orf197	Homo sapiens (Human)	505	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN2513_c0_g1_i2	Q9NU19	TB22B_HUMAN	43	321	160	5	1000	68	20	327	5.40E-62	239.6	TB22B_HUMAN	reviewed	TBC1 domain family member 22B	TBC1D22B C6orf197	Homo sapiens (Human)	505	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN2513_c0_g1_i4	Q9NU19	TB22B_HUMAN	48.4	436	200	6	1282	5	20	440	1.50E-109	397.9	TB22B_HUMAN	reviewed	TBC1 domain family member 22B	TBC1D22B C6orf197	Homo sapiens (Human)	505	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN37200_c0_g1_i1	Q9NU19	TB22B_HUMAN	98.9	89	1	0	268	2	199	287	6.10E-47	187.6	TB22B_HUMAN	reviewed	TBC1 domain family member 22B	TBC1D22B C6orf197	Homo sapiens (Human)	505	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0006886; GO:0017137; GO:0071889; GO:0090630	activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN4340_c0_g1_i1	A1A5B6	TBC25_MOUSE	42.9	226	114	8	647	3	90	311	1.00E-41	171.8	TBC25_MOUSE	reviewed	TBC1 domain family member 25	Tbc1d25	Mus musculus (Mouse)	742	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005776; GO:0006886; GO:0006914; GO:0017137; GO:0031410; GO:0090630; GO:1901096	activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096]		NA	NA	NA	NA	NA	NA
TRINITY_DN25213_c0_g1_i2	Q6NXY1	TBC31_MOUSE	27	618	426	8	222	2003	66	682	1.50E-71	272.3	TBC31_MOUSE	reviewed	TBC1 domain family member 31 (Protein 4-B-3) (WD repeat-containing protein 67)	Tbc1d31 Wdr67	Mus musculus (Mouse)	996	centrosome [GO:0005813]	centrosome [GO:0005813]		GO:0005813			NA	NA	NA	NA	NA	NA
TRINITY_DN25213_c0_g1_i3	Q29RL0	TBC31_BOVIN	34.1	205	133	2	72	683	479	682	7.10E-35	149.1	TBC31_BOVIN	reviewed	TBC1 domain family member 31 (WD repeat-containing protein 67)	TBC1D31 WDR67	Bos taurus (Bovine)	1063	centrosome [GO:0005813]	centrosome [GO:0005813]		GO:0005813			NA	NA	NA	NA	NA	NA
TRINITY_DN25213_c0_g1_i4	Q29RL0	TBC31_BOVIN	35.6	278	177	2	34	864	406	682	2.60E-52	207.2	TBC31_BOVIN	reviewed	TBC1 domain family member 31 (WD repeat-containing protein 67)	TBC1D31 WDR67	Bos taurus (Bovine)	1063	centrosome [GO:0005813]	centrosome [GO:0005813]		GO:0005813			NA	NA	NA	NA	NA	NA
TRINITY_DN38047_c0_g1_i1	O60343	TBCD4_HUMAN	100	72	0	0	217	2	345	416	2.70E-37	155.2	TBCD4_HUMAN	reviewed	TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160)	TBC1D4 AS160 KIAA0603	Homo sapiens (Human)	1298	cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; vesicle [GO:0031982]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0006886; GO:0016192; GO:0017137; GO:0031339; GO:0031982; GO:0032869; GO:0090630	activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN4123_c0_g1_i2	F1QRX7	TBCD7_DANRE	30	323	174	8	414	1355	6	285	2.80E-24	114.8	TBCD7_DANRE	reviewed	TBC1 domain family member 7	tbc1d7	Danio rerio (Zebrafish) (Brachydanio rerio)	294	cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; negative regulation of TOR signaling [GO:0032007]; response to growth factor [GO:0070848]	cytoplasmic vesicle [GO:0031410]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0017137; GO:0031410; GO:0032007; GO:0070848; GO:0090630	activation of GTPase activity [GO:0090630]; negative regulation of TOR signaling [GO:0032007]; response to growth factor [GO:0070848]		blue	blue	NA	NA	NA	NA
TRINITY_DN9051_c0_g1_i2	O95935	TBX18_HUMAN	53.3	195	89	2	9	593	143	335	7.00E-52	205.7	TBX18_HUMAN	reviewed	T-box transcription factor TBX18 (T-box protein 18)	TBX18	Homo sapiens (Human)	607	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell fate specification [GO:0001708]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060829]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; somitogenesis [GO:0001756]; ureter development [GO:0072189]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0001708; GO:0001756; GO:0005634; GO:0016331; GO:0042803; GO:0045944; GO:0060829; GO:0072189; GO:1990837	cell fate specification [GO:0001708]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060829]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; somitogenesis [GO:0001756]; ureter development [GO:0072189]		NA	NA	NA	NA	NA	NA
TRINITY_DN35054_c0_g1_i1	Q7ZTU9	TBX2_DANRE	35.8	95	46	3	304	23	46	126	6.20E-06	52	TBX2_DANRE	reviewed	T-box transcription factor TBX2b (T-box protein 2b)	tbx2b tbx-c	Danio rerio (Zebrafish) (Brachydanio rerio)	687	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; atrioventricular canal development [GO:0036302]; axial mesoderm development [GO:0048318]; brain development [GO:0007420]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cardiac chamber development [GO:0003205]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration involved in gastrulation [GO:0042074]; embryonic heart tube development [GO:0035050]; epithalamus development [GO:0021538]; heart looping [GO:0001947]; late distal convoluted tubule development [GO:0072068]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; notochord development [GO:0030903]; photoreceptor cell development [GO:0042461]; photoreceptor cell fate specification [GO:0043704]; pineal gland development [GO:0021982]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; proximal convoluted tubule development [GO:0072019]; regulation of heart contraction [GO:0008016]; retinal cone cell development [GO:0046549]; retinal cone cell fate commitment [GO:0046551]; retinal cone cell fate determination [GO:0042671]; retinal rod cell development [GO:0046548]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001708; GO:0001947; GO:0003205; GO:0007155; GO:0007420; GO:0008016; GO:0021538; GO:0021982; GO:0030903; GO:0035050; GO:0036302; GO:0042074; GO:0042461; GO:0042671; GO:0043704; GO:0045944; GO:0046548; GO:0046549; GO:0046551; GO:0048318; GO:0048663; GO:0048793; GO:0060219; GO:0072019; GO:0072068	atrioventricular canal development [GO:0036302]; axial mesoderm development [GO:0048318]; brain development [GO:0007420]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cardiac chamber development [GO:0003205]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration involved in gastrulation [GO:0042074]; embryonic heart tube development [GO:0035050]; epithalamus development [GO:0021538]; heart looping [GO:0001947]; late distal convoluted tubule development [GO:0072068]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; notochord development [GO:0030903]; photoreceptor cell development [GO:0042461]; photoreceptor cell fate specification [GO:0043704]; pineal gland development [GO:0021982]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; proximal convoluted tubule development [GO:0072019]; regulation of heart contraction [GO:0008016]; retinal cone cell development [GO:0046549]; retinal cone cell fate commitment [GO:0046551]; retinal cone cell fate determination [GO:0042671]; retinal rod cell development [GO:0046548]		NA	NA	NA	NA	NA	NA
TRINITY_DN40386_c0_g1_i1	Q7ZTU9	TBX2_DANRE	63	81	30	0	308	66	212	292	4.00E-21	102.1	TBX2_DANRE	reviewed	T-box transcription factor TBX2b (T-box protein 2b)	tbx2b tbx-c	Danio rerio (Zebrafish) (Brachydanio rerio)	687	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; atrioventricular canal development [GO:0036302]; axial mesoderm development [GO:0048318]; brain development [GO:0007420]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cardiac chamber development [GO:0003205]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration involved in gastrulation [GO:0042074]; embryonic heart tube development [GO:0035050]; epithalamus development [GO:0021538]; heart looping [GO:0001947]; late distal convoluted tubule development [GO:0072068]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; notochord development [GO:0030903]; photoreceptor cell development [GO:0042461]; photoreceptor cell fate specification [GO:0043704]; pineal gland development [GO:0021982]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; proximal convoluted tubule development [GO:0072019]; regulation of heart contraction [GO:0008016]; retinal cone cell development [GO:0046549]; retinal cone cell fate commitment [GO:0046551]; retinal cone cell fate determination [GO:0042671]; retinal rod cell development [GO:0046548]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001708; GO:0001947; GO:0003205; GO:0007155; GO:0007420; GO:0008016; GO:0021538; GO:0021982; GO:0030903; GO:0035050; GO:0036302; GO:0042074; GO:0042461; GO:0042671; GO:0043704; GO:0045944; GO:0046548; GO:0046549; GO:0046551; GO:0048318; GO:0048663; GO:0048793; GO:0060219; GO:0072019; GO:0072068	atrioventricular canal development [GO:0036302]; axial mesoderm development [GO:0048318]; brain development [GO:0007420]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cardiac chamber development [GO:0003205]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration involved in gastrulation [GO:0042074]; embryonic heart tube development [GO:0035050]; epithalamus development [GO:0021538]; heart looping [GO:0001947]; late distal convoluted tubule development [GO:0072068]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; notochord development [GO:0030903]; photoreceptor cell development [GO:0042461]; photoreceptor cell fate specification [GO:0043704]; pineal gland development [GO:0021982]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; proximal convoluted tubule development [GO:0072019]; regulation of heart contraction [GO:0008016]; retinal cone cell development [GO:0046549]; retinal cone cell fate commitment [GO:0046551]; retinal cone cell fate determination [GO:0042671]; retinal rod cell development [GO:0046548]		NA	NA	NA	NA	NA	NA
TRINITY_DN12501_c0_g1_i1	Q66JZ4	TCAIM_MOUSE	32.4	488	293	10	145	1527	15	492	7.70E-60	233	TCAIM_MOUSE	reviewed	"T-cell activation inhibitor, mitochondrial (Tolerance associated gene-1 protein) (TOAG-1)"	TCAIM D9Ertd402e Toag1	Mus musculus (Mouse)	499	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN30203_c0_g1_i1	Q99KW9	TIP_MOUSE	100	84	0	0	1	252	527	610	2.00E-42	172.6	TIP_MOUSE	reviewed	T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)	Itfg1 D8Wsu49e Lnkn-1 Tip	Mus musculus (Mouse)	610	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]		GO:0005576; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3796_c0_g2_i1	Q8TB96	TIP_HUMAN	38.5	600	327	14	137	1879	36	612	3.30E-111	404.1	TIP_HUMAN	reviewed	T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)	ITFG1 LNKN-1 TIP CDA08	Homo sapiens (Human)	612	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN3796_c0_g1_i1	Q8TB96	TIP_HUMAN	38.5	600	327	14	1958	216	36	612	3.30E-111	404.1	TIP_HUMAN	reviewed	T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)	ITFG1 LNKN-1 TIP CDA08	Homo sapiens (Human)	612	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN14004_c0_g1_i1	Q8SSC9	TCPA_ENCCU	44.2	86	46	1	254	3	353	438	2.30E-14	79.3	TCPA_ENCCU	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1 CCT1 ECU03_0220	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	540	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN8036_c0_g1_i1	P17987	TCPA_HUMAN	98.2	555	10	0	1686	22	2	556	1.60E-305	1049.3	TCPA_HUMAN	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1 CCT1 CCTA	Homo sapiens (Human)	556	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000242; GO:0001669; GO:0002199; GO:0003723; GO:0005524; GO:0005720; GO:0005794; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007021; GO:0007339; GO:0031625; GO:0032212; GO:0035722; GO:0044053; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874; GO:2000109	binding of sperm to zona pellucida [GO:0007339]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN8036_c0_g1_i2	P17987	TCPA_HUMAN	100	555	0	0	1686	22	2	556	0.00E+00	1062	TCPA_HUMAN	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1 CCT1 CCTA	Homo sapiens (Human)	556	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000242; GO:0001669; GO:0002199; GO:0003723; GO:0005524; GO:0005720; GO:0005794; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007021; GO:0007339; GO:0031625; GO:0032212; GO:0035722; GO:0044053; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874; GO:2000109	binding of sperm to zona pellucida [GO:0007339]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN20150_c1_g1_i1	Q32L40	TCPA_BOVIN	64.4	90	32	0	2	271	264	353	1.70E-23	109.8	TCPA_BOVIN	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1 CCT1	Bos taurus (Bovine)	556	chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005815; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN7979_c0_g1_i1	P28769	TCPA_ARATH	80.2	126	25	0	3	380	14	139	3.20E-49	195.7	TCPA_ARATH	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin CCT1)	CCT1 At3g20050 MAL21.5	Arabidopsis thaliana (Mouse-ear cress)	545	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN20552_c0_g1_i1	P28769	TCPA_ARATH	58.6	145	60	0	449	15	341	485	1.10E-40	167.5	TCPA_ARATH	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin CCT1)	CCT1 At3g20050 MAL21.5	Arabidopsis thaliana (Mouse-ear cress)	545	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN20552_c0_g2_i1	P12613	TCPA_DROME	59	61	25	0	233	51	490	550	2.90E-11	68.9	TCPA_DROME	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing TCP1 subunit 1)	CCT1 CCT-1 T-cp1 Tcp-1 CG5374	Drosophila melanogaster (Fruit fly)	557	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0030707; GO:0051082	ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN1804_c0_g1_i2	P12613	TCPA_DROME	73.6	553	146	0	1745	87	3	555	1.10E-224	780.8	TCPA_DROME	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing TCP1 subunit 1)	CCT1 CCT-1 T-cp1 Tcp-1 CG5374	Drosophila melanogaster (Fruit fly)	557	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0030707; GO:0051082	ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN26032_c0_g1_i2	P11983	TCPA_MOUSE	100	125	0	0	375	1	352	476	2.50E-62	239.2	TCPA_MOUSE	reviewed	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Tailless complex polypeptide 1A) (TCP-1-A) (Tailless complex polypeptide 1B) (TCP-1-B)	Tcp1 Cct1 Ccta	Mus musculus (Mouse)	556	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000242; GO:0000792; GO:0001669; GO:0002199; GO:0005524; GO:0005720; GO:0005794; GO:0005813; GO:0005815; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0043209; GO:0044053; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874; GO:2000109	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]		NA	NA	NA	NA	NA	NA
TRINITY_DN4742_c0_g1_i1	P80314	TCPB_MOUSE	65.2	66	23	0	334	137	470	535	4.80E-17	88.6	TCPB_MOUSE	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	Cct2 Cctb	Mus musculus (Mouse)	535	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0043209; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		blue	blue	NA	NA	NA	NA
TRINITY_DN27226_c0_g1_i1	Q8SQP2	TCPB_ENCCU	51.2	86	42	0	4	261	326	411	1.50E-18	93.2	TCPB_ENCCU	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 ECU09_0480	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	508	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN3786_c0_g1_i1	Q8SQP2	TCPB_ENCCU	54.3	92	42	0	282	7	26	117	2.30E-20	99.4	TCPB_ENCCU	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 ECU09_0480	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	508	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN14904_c0_g1_i1	P78371	TCPB_HUMAN	100	426	0	0	49	1326	1	426	7.90E-236	817.4	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN14904_c0_g1_i2	P80314	TCPB_MOUSE	99.2	395	3	0	1	1185	32	426	3.90E-218	758.4	TCPB_MOUSE	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	Cct2 Cctb	Mus musculus (Mouse)	535	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0043209; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1815_c0_g1_i1	P78371	TCPB_HUMAN	75.4	272	67	0	818	3	169	440	1.20E-114	414.1	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1815_c0_g1_i10	P78371	TCPB_HUMAN	75.4	272	67	0	818	3	169	440	1.20E-114	414.1	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1815_c0_g1_i2	P78371	TCPB_HUMAN	70.9	275	79	1	830	6	3	276	4.90E-104	379	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1815_c0_g1_i4	P78371	TCPB_HUMAN	75.5	278	68	0	836	3	163	440	8.10E-117	421.4	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1815_c0_g1_i5	P78371	TCPB_HUMAN	74.1	108	28	0	329	6	169	276	2.60E-39	162.5	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1815_c0_g1_i9	P78371	TCPB_HUMAN	72.9	439	118	1	1319	3	3	440	1.90E-179	630.2	TCPB_HUMAN	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2 99D8.1 CCTB	Homo sapiens (Human)	535	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0031625; GO:0032212; GO:0035578; GO:0043312; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; neutrophil degranulation [GO:0043312]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		blue	blue	NA	NA	NA	NA
TRINITY_DN30370_c0_g1_i1	Q940P8	TCPB_ARATH	61.4	427	161	2	34	1314	3	425	1.60E-143	510.8	TCPB_ARATH	reviewed	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) (Chaperonin CCT2)	CCT2 At5g20890 F22D1.60	Arabidopsis thaliana (Mouse-ear cress)	527	anchored component of plasma membrane [GO:0046658]; cell wall [GO:0005618]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; plastid [GO:0009536]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	anchored component of plasma membrane [GO:0046658]; cell wall [GO:0005618]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; plastid [GO:0009536]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005618; GO:0005829; GO:0005832; GO:0006457; GO:0009536; GO:0046658; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN39257_c0_g1_i1	P80315	TCPD_MOUSE	100	81	0	0	283	41	459	539	1.80E-36	152.9	TCPD_MOUSE	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (A45) (CCT-delta)	Cct4 Cctd	Mus musculus (Mouse)	539	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytosol [GO:0005829]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytosol [GO:0005829]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0032212; GO:0042470; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN8561_c0_g3_i1	Q2T9X2	TCPD_BOVIN	63.8	213	74	2	638	3	162	372	8.80E-68	258.1	TCPD_BOVIN	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)	CCT4	Bos taurus (Bovine)	542	chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0042470; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN8561_c0_g2_i1	P53451	TCPD_TAKRU	74.3	105	27	0	20	334	30	134	1.00E-38	160.6	TCPD_TAKRU	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)	cct4 cctd	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	536	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0001666; GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN38912_c0_g1_i1	Q8SSH3	TCPD_ENCCU	52.4	103	49	0	1	309	9	111	1.60E-25	116.7	TCPD_ENCCU	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)	CCT4 ECU02_0520	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	484	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]	GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN26468_c3_g2_i1	Q9NB32	TCPD_OCHTR	69.2	517	159	0	209	1759	17	533	1.40E-206	720.7	TCPD_OCHTR	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)		Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	533	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN26468_c3_g1_i1	Q9NB32	TCPD_OCHTR	69.2	517	159	0	1671	121	17	533	1.40E-206	720.7	TCPD_OCHTR	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)		Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	533	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN22507_c0_g1_i1	Q9NB32	TCPD_OCHTR	59.7	67	27	0	204	4	193	259	2.60E-16	85.5	TCPD_OCHTR	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)		Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	533	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN24960_c1_g1_i1	Q9NB32	TCPD_OCHTR	61.2	240	93	0	721	2	88	327	6.20E-78	292	TCPD_OCHTR	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)		Ochlerotatus triseriatus (Eastern treehole mosquito) (Aedes triseriatus)	533	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN24960_c2_g1_i1	Q2T9X2	TCPD_BOVIN	78.9	76	16	0	2	229	46	121	9.40E-28	123.6	TCPD_BOVIN	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)	CCT4	Bos taurus (Bovine)	542	chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0042470; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN15468_c0_g1_i1	Q9LV21	TCPD_ARATH	69.4	62	19	0	8	193	474	535	1.10E-16	87	TCPD_ARATH	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Chaperonin CCT4)	CCT4 At3g18190 MRC8	Arabidopsis thaliana (Mouse-ear cress)	536	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN8561_c0_g1_i1	Q9LV21	TCPD_ARATH	61.6	172	65	1	562	47	366	536	3.00E-51	203	TCPD_ARATH	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Chaperonin CCT4)	CCT4 At3g18190 MRC8	Arabidopsis thaliana (Mouse-ear cress)	536	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN8786_c0_g2_i1	P50991	TCPD_HUMAN	98.6	294	4	0	884	3	5	298	2.90E-154	545.8	TCPD_HUMAN	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4 CCTD SRB	Homo sapiens (Human)	539	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0042470; GO:0042995; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN8786_c0_g1_i1	P50991	TCPD_HUMAN	99.4	535	3	0	1648	44	5	539	9.00E-290	996.9	TCPD_HUMAN	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4 CCTD SRB	Homo sapiens (Human)	539	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0042470; GO:0042995; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN8786_c0_g1_i2	P50991	TCPD_HUMAN	100	535	0	0	1648	44	5	539	2.80E-291	1001.9	TCPD_HUMAN	reviewed	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4 CCTD SRB	Homo sapiens (Human)	539	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0042470; GO:0042995; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN8270_c0_g1_i1	P48643	TCPE_HUMAN	75.3	539	133	0	1709	93	1	539	2.20E-241	836.3	TCPE_HUMAN	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5 CCTE KIAA0098	Homo sapiens (Human)	541	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]	GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]		blue	blue	NA	NA	NA	NA
TRINITY_DN35957_c0_g1_i1	P48643	TCPE_HUMAN	42.2	128	70	2	9	392	25	148	2.70E-22	106.3	TCPE_HUMAN	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5 CCTE KIAA0098	Homo sapiens (Human)	541	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]	GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN7959_c0_g1_i1	P48643	TCPE_HUMAN	62.7	365	136	0	2	1096	169	533	7.70E-131	468.4	TCPE_HUMAN	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5 CCTE KIAA0098	Homo sapiens (Human)	541	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]	GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN35865_c0_g1_i1	P40413	TCPE_YEAST	58.5	65	27	0	8	202	273	337	4.80E-15	81.3	TCPE_YEAST	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5 TCP5 YJR064W J1752	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	562	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN6692_c0_g1_i1	P48643	TCPE_HUMAN	100	541	0	0	1666	44	1	541	2.20E-307	1055.4	TCPE_HUMAN	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5 CCTE KIAA0098	Homo sapiens (Human)	541	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]	GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN6692_c0_g2_i1	P80316	TCPE_MOUSE	100	541	0	0	1666	44	1	541	7.60E-308	1057	TCPE_MOUSE	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	Cct5 Ccte Kiaa0098	Mus musculus (Mouse)	541	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]	ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]	GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0031681; GO:0032212; GO:0043209; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN10545_c0_g1_i1	Q8SRP9	TCPE_ENCCU	56.7	104	45	0	314	3	235	338	2.10E-28	126.3	TCPE_ENCCU	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5 ECU06_0990	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	532	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN7959_c0_g2_i1	P40412	TCPE1_AVESA	69.2	130	40	0	390	1	7	136	1.40E-47	190.3	TCPE1_AVESA	reviewed	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) (TCP-K19)		Avena sativa (Oat)	535	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN28954_c0_g1_i1	Q8SR53	TCPH_ENCCU	66.1	109	37	0	36	362	184	292	1.30E-34	147.1	TCPH_ENCCU	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	CCT7 ECU10_0630	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	511	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN6946_c0_g1_i1	Q5ZJK8	TCPH_CHICK	73.1	539	145	0	78	1694	2	540	1.00E-233	810.8	TCPH_CHICK	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	CCT7 RCJMB04_17g3	Gallus gallus (Chicken)	553	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN5443_c0_g1_i1	Q8SR53	TCPH_ENCCU	62.8	78	29	0	235	2	336	413	1.00E-21	103.6	TCPH_ENCCU	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	CCT7 ECU10_0630	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	511	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN20577_c1_g1_i1	Q5ZJK8	TCPH_CHICK	64.2	95	34	0	289	5	260	354	6.20E-29	127.9	TCPH_CHICK	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	CCT7 RCJMB04_17g3	Gallus gallus (Chicken)	553	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN10640_c0_g4_i1	P80313	TCPH_MOUSE	62.1	124	47	0	373	2	339	462	1.00E-39	164.1	TCPH_MOUSE	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	Cct7 Ccth	Mus musculus (Mouse)	544	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0042802; GO:0044297; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN5868_c0_g1_i1	P80313	TCPH_MOUSE	100	539	0	0	1653	37	6	544	9.00E-306	1050	TCPH_MOUSE	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	Cct7 Ccth	Mus musculus (Mouse)	544	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0042802; GO:0044297; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN10640_c0_g1_i1	Q9SF16	TCPH_ARATH	68.3	126	39	1	378	4	1	126	2.60E-44	179.5	TCPH_ARATH	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)	CCT7 At3g11830 F26K24.12	Arabidopsis thaliana (Mouse-ear cress)	557	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN10640_c0_g3_i1	Q9SF16	TCPH_ARATH	58.1	74	31	0	279	58	463	536	8.20E-18	90.9	TCPH_ARATH	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)	CCT7 At3g11830 F26K24.12	Arabidopsis thaliana (Mouse-ear cress)	557	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN10640_c0_g2_i1	Q9SF16	TCPH_ARATH	73.6	148	39	0	42	485	198	345	6.30E-58	224.9	TCPH_ARATH	reviewed	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)	CCT7 At3g11830 F26K24.12	Arabidopsis thaliana (Mouse-ear cress)	557	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]	chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]		NA	NA	NA	NA	NA	NA
TRINITY_DN5868_c0_g2_i1	Q99832	TCPH_HUMAN	99.3	543	4	0	1652	24	1	543	7.00E-306	1050.4	TCPH_HUMAN	reviewed	"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]"	CCT7 CCTH NIP7-1	Homo sapiens (Human)	543	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0042802; GO:0044297; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN37881_c0_g1_i1	Q3T0K2	TCPG_BOVIN	100	66	0	0	200	3	470	535	1.90E-32	139	TCPG_BOVIN	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)	CCT3	Bos taurus (Bovine)	545	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN35538_c0_g1_i1	Q3T0K2	TCPG_BOVIN	51.9	81	39	0	3	245	256	336	4.40E-15	81.6	TCPG_BOVIN	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)	CCT3	Bos taurus (Bovine)	545	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN1769_c0_g1_i1	P50143	TCPG_XENLA	68.2	510	159	3	1591	65	20	527	5.60E-204	711.8	TCPG_XENLA	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)	cct3 cctg	Xenopus laevis (African clawed frog)	547	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN39280_c0_g1_i1	Q8SR76	TCPG_ENCCU	52.4	82	39	0	24	269	343	424	7.40E-19	94.4	TCPG_ENCCU	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)	CCT3 ECU10_0240	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	519	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN5843_c0_g1_i1	Q8SR76	TCPG_ENCCU	67.6	108	34	1	336	16	25	132	1.50E-34	146.7	TCPG_ENCCU	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)	CCT3 ECU10_0240	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	519	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN35655_c0_g1_i1	P54408	TCPG_TETPY	64.4	464	165	0	1393	2	32	495	2.40E-174	613.2	TCPG_TETPY	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)		Tetrahymena pyriformis	559	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN12426_c0_g1_i3	P49368	TCPG_HUMAN	100	157	0	0	472	2	7	163	1.30E-79	297	TCPG_HUMAN	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3 CCTG TRIC5	Homo sapiens (Human)	545	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0003723; GO:0005524; GO:0005829; GO:0005832; GO:0005856; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN10162_c0_g2_i1	P49368	TCPG_HUMAN	100	292	0	0	877	2	159	450	2.90E-162	572.4	TCPG_HUMAN	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3 CCTG TRIC5	Homo sapiens (Human)	545	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0003723; GO:0005524; GO:0005829; GO:0005832; GO:0005856; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN12426_c0_g1_i4	P80318	TCPG_MOUSE	100	149	0	0	449	3	7	155	3.60E-76	285.4	TCPG_MOUSE	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Matricin) (mTRiC-P5)	Cct3 Cctg	Mus musculus (Mouse)	545	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0043209; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN10162_c0_g1_i1	P80318	TCPG_MOUSE	100	275	0	0	826	2	176	450	4.00E-153	542	TCPG_MOUSE	reviewed	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Matricin) (mTRiC-P5)	Cct3 Cctg	Mus musculus (Mouse)	545	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0043209; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN39777_c0_g1_i1	Q552J0	TCPQ_DICDI	55.3	103	46	0	12	320	246	348	5.80E-28	124.8	TCPQ_DICDI	reviewed	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta)	cct8 DDB_G0276233	Dictyostelium discoideum (Slime mold)	537	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN13389_c0_g2_i1	P42932	TCPQ_MOUSE	99.7	330	1	0	990	1	144	473	1.40E-184	646.7	TCPQ_MOUSE	reviewed	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta)	Cct8 Cctq	Mus musculus (Mouse)	548	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0045111; GO:0046931; GO:0050821; GO:0051082; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN31839_c0_g1_i1	Q3ZCI9	TCPQ_BOVIN	61.3	111	43	0	338	6	10	120	4.90E-34	145.2	TCPQ_BOVIN	reviewed	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta)	CCT8	Bos taurus (Bovine)	548	chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; microtubule organizing center [GO:0005815]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN13389_c0_g1_i1	P50990	TCPQ_HUMAN	100	467	0	0	1401	1	1	467	1.80E-265	916	TCPQ_HUMAN	reviewed	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8 C21orf112 CCTQ KIAA0002	Homo sapiens (Human)	548	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; neutrophil degranulation [GO:0043312]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0034774; GO:0035578; GO:0043312; GO:0044297; GO:0045111; GO:0045296; GO:0046931; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904813; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; neutrophil degranulation [GO:0043312]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN13389_c0_g1_i2	P50990	TCPQ_HUMAN	99.8	467	1	0	1401	1	1	467	2.00E-264	912.5	TCPQ_HUMAN	reviewed	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8 C21orf112 CCTQ KIAA0002	Homo sapiens (Human)	548	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; neutrophil degranulation [GO:0043312]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0034774; GO:0035578; GO:0043312; GO:0044297; GO:0045111; GO:0045296; GO:0046931; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904813; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; neutrophil degranulation [GO:0043312]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN22059_c0_g1_i1	P50990	TCPQ_HUMAN	60.5	547	214	2	1732	92	1	545	5.30E-195	682.2	TCPQ_HUMAN	reviewed	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8 C21orf112 CCTQ KIAA0002	Homo sapiens (Human)	548	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; neutrophil degranulation [GO:0043312]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0034774; GO:0035578; GO:0043312; GO:0044297; GO:0045111; GO:0045296; GO:0046931; GO:0050821; GO:0051082; GO:0070062; GO:1901998; GO:1904813; GO:1904851; GO:1904871; GO:1904874	binding of sperm to zona pellucida [GO:0007339]; neutrophil degranulation [GO:0043312]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		blue	blue	NA	NA	NA	NA
TRINITY_DN6291_c0_g1_i1	P40227	TCPZ_HUMAN	100	492	0	0	1476	1	1	492	7.00E-273	940.6	TCPZ_HUMAN	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A CCT6 CCTZ	Homo sapiens (Human)	531	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0003723; GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0032212; GO:0050821; GO:0051082; GO:0070062; GO:0071987; GO:1904851; GO:1904871; GO:1904874	positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN4320_c0_g1_i1	Q5ZJ54	TCPZ_CHICK	62.8	188	70	0	6	569	6	193	9.00E-64	244.6	TCPZ_CHICK	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta)	CCT6 RCJMB04_20k5	Gallus gallus (Chicken)	530	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; toxin transport [GO:1901998]	chaperonin-containing T-complex [GO:0005832]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0051082; GO:1901998	protein folding [GO:0006457]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN4320_c0_g2_i1	Q76NU3	TCPZ_DICDI	64	86	31	0	259	2	349	434	3.10E-27	122.1	TCPZ_DICDI	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta)	cct6 DDB_G0277493	Dictyostelium discoideum (Slime mold)	539	chaperonin-containing T-complex [GO:0005832]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; phagocytic vesicle [GO:0045335]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0045335; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN11457_c0_g1_i1	O94515	TCPZ_SCHPO	46.1	76	35	1	28	237	274	349	1.10E-10	67	TCPZ_SCHPO	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta)	cct6 SPBC646.11	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	535	chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005829; GO:0005832; GO:0005856; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN20121_c0_g1_i1	Q3MHL7	TCPZ_BOVIN	79.5	73	15	0	220	2	1	73	1.40E-25	116.7	TCPZ_BOVIN	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta) (CCT-zeta-1)	CCT6A	Bos taurus (Bovine)	531	chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0032212; GO:0050821; GO:0051082; GO:0071987; GO:1904851	positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN10197_c0_g1_i1	Q3MHL7	TCPZ_BOVIN	100	177	0	0	533	3	1	177	7.90E-89	327.8	TCPZ_BOVIN	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta) (CCT-zeta-1)	CCT6A	Bos taurus (Bovine)	531	chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0032212; GO:0050821; GO:0051082; GO:0071987; GO:1904851	positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN3820_c1_g1_i1	P80317	TCPZ_MOUSE	69.7	531	160	1	1680	88	1	530	1.30E-217	757.3	TCPZ_MOUSE	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)	Cct6a Cct6 Cctz Cctz1	Mus musculus (Mouse)	531	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0050821; GO:0051082; GO:0071987; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		blue	blue	NA	NA	NA	NA
TRINITY_DN4320_c0_g3_i1	P80317	TCPZ_MOUSE	67.3	171	55	1	514	2	190	359	2.10E-59	229.9	TCPZ_MOUSE	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)	Cct6a Cct6 Cctz Cctz1	Mus musculus (Mouse)	531	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0050821; GO:0051082; GO:0071987; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN6291_c0_g1_i2	P80317	TCPZ_MOUSE	99.6	531	2	0	1620	28	1	531	4.90E-296	1017.7	TCPZ_MOUSE	reviewed	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)	Cct6a Cct6 Cctz Cctz1	Mus musculus (Mouse)	531	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0050821; GO:0051082; GO:0071987; GO:1901998; GO:1904851	binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]		NA	NA	NA	NA	NA	NA
TRINITY_DN40521_c0_g1_i1	Q9M888	TCPZA_ARATH	66.7	54	18	0	207	46	480	533	4.90E-15	81.3	TCPZA_ARATH	reviewed	T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A)	CCT6A At3g02530 F16B3.16	Arabidopsis thaliana (Mouse-ear cress)	535	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]		red	red	NA	NA	NA	NA
TRINITY_DN21612_c0_g1_i1	Q9M888	TCPZA_ARATH	60.5	81	27	1	253	11	346	421	2.50E-21	102.4	TCPZA_ARATH	reviewed	T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A)	CCT6A At3g02530 F16B3.16	Arabidopsis thaliana (Mouse-ear cress)	535	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0046686; GO:0051082	protein folding [GO:0006457]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]		NA	NA	NA	NA	NA	NA
TRINITY_DN12802_c0_g1_i2	Q9NUJ3	T11L1_HUMAN	38	466	269	7	1383	34	42	503	2.80E-82	307.8	T11L1_HUMAN	reviewed	T-complex protein 11-like protein 1	TCP11L1	Homo sapiens (Human)	509	microtubule [GO:0005874]; signal transduction [GO:0007165]	microtubule [GO:0005874]		GO:0005874; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12802_c0_g1_i6	Q9NUJ3	T11L1_HUMAN	45.4	229	123	1	891	205	42	268	7.00E-59	229.6	T11L1_HUMAN	reviewed	T-complex protein 11-like protein 1	TCP11L1	Homo sapiens (Human)	509	microtubule [GO:0005874]; signal transduction [GO:0007165]	microtubule [GO:0005874]		GO:0005874; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN12802_c0_g1_i7	Q9NUJ3	T11L1_HUMAN	42.1	335	175	6	1070	111	42	372	2.60E-70	267.7	T11L1_HUMAN	reviewed	T-complex protein 11-like protein 1	TCP11L1	Homo sapiens (Human)	509	microtubule [GO:0005874]; signal transduction [GO:0007165]	microtubule [GO:0005874]		GO:0005874; GO:0007165	signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN19988_c0_g2_i1	Q9U8W8	TL5A_TACTR	37.6	109	64	2	3	329	180	284	1.90E-15	83.6	TL5A_TACTR	reviewed	Techylectin-5A		Tachypleus tridentatus (Japanese horseshoe crab)	292	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN9502_c0_g2_i1	Q9U8W8	TL5A_TACTR	61.4	44	17	0	81	212	232	275	6.80E-12	70.9	TL5A_TACTR	reviewed	Techylectin-5A		Tachypleus tridentatus (Japanese horseshoe crab)	292	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN2054_c0_g1_i3	Q9U8W7	TL5B_TACTR	50.7	73	33	3	3	221	236	305	1.90E-12	72.8	TL5B_TACTR	reviewed	Techylectin-5B		Tachypleus tridentatus (Japanese horseshoe crab)	316	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i16	Q9U8W7	TL5B_TACTR	42.6	230	125	5	777	97	80	305	1.30E-47	191.8	TL5B_TACTR	reviewed	Techylectin-5B		Tachypleus tridentatus (Japanese horseshoe crab)	316	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		blue	blue	NA	NA	NA	NA
TRINITY_DN877_c0_g1_i8	Q9U8W7	TL5B_TACTR	40.9	215	122	4	738	97	95	305	4.60E-44	179.5	TL5B_TACTR	reviewed	Techylectin-5B		Tachypleus tridentatus (Japanese horseshoe crab)	316	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i2	Q9U8W7	TL5B_TACTR	42.7	192	105	3	131	697	80	269	1.60E-41	171	TL5B_TACTR	reviewed	Techylectin-5B		Tachypleus tridentatus (Japanese horseshoe crab)	316	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i4	Q9U8W7	TL5B_TACTR	47.1	153	80	1	19	474	117	269	1.10E-38	161	TL5B_TACTR	reviewed	Techylectin-5B		Tachypleus tridentatus (Japanese horseshoe crab)	316	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c0_g1_i6	Q9U8W7	TL5B_TACTR	43.1	188	102	3	179	733	84	269	3.60E-41	169.9	TL5B_TACTR	reviewed	Techylectin-5B		Tachypleus tridentatus (Japanese horseshoe crab)	316	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	extracellular region [GO:0005576]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0030246; GO:0046872; GO:0098609	cell-cell adhesion [GO:0098609]		NA	NA	NA	NA	NA	NA
TRINITY_DN822_c0_g1_i1	Q9VWB0	TECPR_DROME	31.8	1008	580	21	2873	6	138	1090	2.90E-134	481.1	TECPR_DROME	reviewed	Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein)	Pex23 CG32226	Drosophila melanogaster (Fruit fly)	1350	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266	peroxisome organization [GO:0007031]		NA	NA	NA	NA	NA	NA
TRINITY_DN822_c0_g1_i2	Q9VWB0	TECPR_DROME	30.4	336	223	3	983	6	756	1090	7.60E-48	192.6	TECPR_DROME	reviewed	Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein)	Pex23 CG32226	Drosophila melanogaster (Fruit fly)	1350	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266	peroxisome organization [GO:0007031]		NA	NA	NA	NA	NA	NA
TRINITY_DN822_c0_g1_i4	Q9VWB0	TECPR_DROME	55.6	275	122	0	877	53	1	275	5.80E-93	342.4	TECPR_DROME	reviewed	Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein)	Pex23 CG32226	Drosophila melanogaster (Fruit fly)	1350	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266	peroxisome organization [GO:0007031]		NA	NA	NA	NA	NA	NA
TRINITY_DN822_c0_g1_i6	Q9VWB0	TECPR_DROME	51.6	219	102	2	716	72	138	356	3.00E-62	240	TECPR_DROME	reviewed	Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein)	Pex23 CG32226	Drosophila melanogaster (Fruit fly)	1350	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266	peroxisome organization [GO:0007031]		NA	NA	NA	NA	NA	NA
TRINITY_DN822_c0_g1_i8	Q9VWB0	TECPR_DROME	34.9	510	255	12	1557	103	138	595	7.20E-66	253.1	TECPR_DROME	reviewed	Tectonin beta-propeller repeat-containing protein (Peroxin-23 protein)	Pex23 CG32226	Drosophila melanogaster (Fruit fly)	1350	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]; peroxisome organization [GO:0007031]	autophagosome membrane [GO:0000421]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	carbohydrate binding [GO:0030246]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005765; GO:0007031; GO:0016021; GO:0030246; GO:0032266	peroxisome organization [GO:0007031]		NA	NA	NA	NA	NA	NA
TRINITY_DN822_c0_g1_i7	Q3ZBA0	TCPR1_RAT	50	68	34	0	290	87	809	876	4.40E-14	79	TCPR1_RAT	reviewed	Tectonin beta-propeller repeat-containing protein 1	Tecpr1	Rattus norvegicus (Rat)	1166	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]	phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016021; GO:0031410; GO:0032266; GO:0097352	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]		NA	NA	NA	NA	NA	NA
TRINITY_DN33477_c0_g1_i1	E1BZR9	TCPR1_CHICK	36.8	261	153	4	3	752	902	1161	1.60E-45	184.5	TCPR1_CHICK	reviewed	Tectonin beta-propeller repeat-containing protein 1	TECPR1	Gallus gallus (Chicken)	1173	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000421; GO:0005765; GO:0006914; GO:0016021; GO:0031410; GO:0032266; GO:0097352	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]		NA	NA	NA	NA	NA	NA
TRINITY_DN3016_c0_g1_i2	O43156	TTI1_HUMAN	27.8	223	157	2	670	14	853	1075	2.20E-14	80.9	TTI1_HUMAN	reviewed	TELO2-interacting protein 1 homolog (Protein SMG10)	TTI1 KIAA0406 SMG10	Homo sapiens (Human)	1089	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of TOR signaling [GO:0032006]	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0070209	regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3016_c0_g1_i3	O43156	TTI1_HUMAN	27.4	215	153	1	691	56	853	1067	1.10E-13	78.6	TTI1_HUMAN	reviewed	TELO2-interacting protein 1 homolog (Protein SMG10)	TTI1 KIAA0406 SMG10	Homo sapiens (Human)	1089	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of TOR signaling [GO:0032006]	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0070209	regulation of TOR signaling [GO:0032006]		brown	brown	NA	NA	NA	NA
TRINITY_DN3016_c0_g1_i4	O43156	TTI1_HUMAN	27	222	159	1	712	56	846	1067	2.10E-13	77.8	TTI1_HUMAN	reviewed	TELO2-interacting protein 1 homolog (Protein SMG10)	TTI1 KIAA0406 SMG10	Homo sapiens (Human)	1089	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of TOR signaling [GO:0032006]	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0070209	regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN3016_c0_g1_i5	O43156	TTI1_HUMAN	27.4	230	163	2	691	14	846	1075	4.10E-14	80.1	TTI1_HUMAN	reviewed	TELO2-interacting protein 1 homolog (Protein SMG10)	TTI1 KIAA0406 SMG10	Homo sapiens (Human)	1089	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of TOR signaling [GO:0032006]	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]		GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0070209	regulation of TOR signaling [GO:0032006]		NA	NA	NA	NA	NA	NA
TRINITY_DN33357_c0_g1_i1	Q60525	TCAB1_MESAU	47.7	128	59	4	461	78	391	510	2.40E-22	106.7	TCAB1_MESAU	reviewed	Telomerase Cajal body protein 1 (Guanine nucleotide-binding protein beta 5) (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog)	Wrap53 Gnb5 Tcab1 Wdr79	Mesocricetus auratus (Golden hamster)	538	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]; chaperone binding [GO:0051087]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625]; Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]"	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]"	chaperone binding [GO:0051087]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625]	GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0051973; GO:0070034; GO:0090666; GO:0090671; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034	Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN14816_c0_g1_i1	Q3SWZ7	TCAB1_BOVIN	35.8	366	199	10	135	1193	20	362	7.00E-50	199.5	TCAB1_BOVIN	reviewed	Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog)	WRAP53 TCAB1 WDR79	Bos taurus (Bovine)	540	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]"	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]"	RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000781; GO:0003723; GO:0005697; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0032203; GO:0034337; GO:0035861; GO:0045739; GO:0051973; GO:0070034; GO:0090666; GO:1904867; GO:1905168; GO:2000781; GO:2001034	Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]		NA	NA	NA	NA	NA	NA
TRINITY_DN35418_c0_g1_i1	Q9BUR4	TCAB1_HUMAN	98.6	73	1	0	221	3	437	509	4.70E-37	154.5	TCAB1_HUMAN	reviewed	Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene) (WRAP53beta)	WRAP53 TCAB1 WDR79	Homo sapiens (Human)	548	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]; chaperone binding [GO:0051087]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625]; Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]; viral process [GO:0016032]"	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]"	chaperone binding [GO:0051087]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625]	GO:0000781; GO:0003723; GO:0005654; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0016032; GO:0016604; GO:0030576; GO:0031625; GO:0032203; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0051973; GO:0070034; GO:0090666; GO:0090671; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034	Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN14816_c0_g1_i2	Q6NL34	TCAB1_DROME	34.9	212	129	3	585	1211	179	384	1.10E-34	149.1	TCAB1_DROME	reviewed	Telomerase Cajal body protein 1 homolog (WD repeat-containing protein 79)	WDR79 CG9226	Drosophila melanogaster (Fruit fly)	543	Cajal body [GO:0015030]; box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]; Cajal body organization [GO:0030576]	Cajal body [GO:0015030]	box C/D snoRNA binding [GO:0034512]; RNA binding [GO:0003723]	GO:0003723; GO:0015030; GO:0030576; GO:0034512	Cajal body organization [GO:0030576]		NA	NA	NA	NA	NA	NA
TRINITY_DN20488_c0_g1_i1	Q3TQI7	TLS1_MOUSE	100	88	0	0	265	2	135	222	1.30E-41	169.9	TLS1_MOUSE	reviewed	Telomere length and silencing protein 1 homolog		Mus musculus (Mouse)	289	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]		GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0048024	"regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20488_c0_g1_i2	Q9NZ63	TLS1_HUMAN	100	77	0	0	232	2	146	222	6.20E-35	147.5	TLS1_HUMAN	reviewed	Telomere length and silencing protein 1 homolog (Hepatocellular carcinoma-associated antigen 59)	C9orf78 HCA59	Homo sapiens (Human)	289	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]		GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0048024	"regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4678_c0_g1_i1	Q9NZ63	TLS1_HUMAN	46.8	282	142	4	54	881	10	289	1.20E-52	208.4	TLS1_HUMAN	reviewed	Telomere length and silencing protein 1 homolog (Hepatocellular carcinoma-associated antigen 59)	C9orf78 HCA59	Homo sapiens (Human)	289	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]		GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0048024	"regulation of mRNA splicing, via spliceosome [GO:0048024]"		NA	NA	NA	NA	NA	NA
TRINITY_DN956_c2_g1_i1	Q1H9T6	TZAP_MOUSE	50.5	91	43	2	81	347	447	537	8.60E-22	104.8	TZAP_MOUSE	reviewed	Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48)	Zbtb48 Hkr3 Tzap	Mus musculus (Mouse)	681	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000781; GO:0000976; GO:0000981; GO:0003691; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0010833; GO:0042802; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]"		NA	NA	NA	NA	NA	NA
TRINITY_DN956_c2_g1_i4	Q1H9T6	TZAP_MOUSE	50.5	91	43	2	81	347	447	537	8.60E-22	104.8	TZAP_MOUSE	reviewed	Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48)	Zbtb48 Hkr3 Tzap	Mus musculus (Mouse)	681	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000781; GO:0000976; GO:0000981; GO:0003691; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0010833; GO:0042802; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10702_c0_g1_i1	Q9UQP3	TENN_HUMAN	31.3	131	77	4	3	395	1160	1277	5.90E-10	65.5	TENN_HUMAN	reviewed	Tenascin-N (TN-N) (Tenascin-W) (TN-W)	TNN TNW	Homo sapiens (Human)	1299	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0033689; GO:0042802; GO:0043025; GO:0045668; GO:0062023; GO:0070593; GO:0097442; GO:1905240; GO:1990026; GO:1990138; GO:2001223	axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]		NA	NA	NA	NA	NA	NA
TRINITY_DN15894_c1_g1_i1	Q80Z71	TENN_MOUSE	42.1	95	51	1	301	17	1448	1538	4.50E-17	88.6	TENN_MOUSE	reviewed	Tenascin-N (TN-N) (Tenascin-W) (TN-W)	Tnn Tnw	Mus musculus (Mouse)	1560	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001764; GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0031012; GO:0033689; GO:0042802; GO:0043005; GO:0043025; GO:0045668; GO:0062023; GO:0070593; GO:0097442; GO:1905240; GO:1990026; GO:1990138; GO:2001223	axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]		NA	NA	NA	NA	NA	NA
TRINITY_DN2054_c0_g1_i5	Q00546	TENR_CHICK	48.7	78	39	1	2	235	1239	1315	7.50E-15	80.9	TENR_CHICK	reviewed	Tenascin-R (TN-R) (Restrictin)	TNR	Gallus gallus (Chicken)	1353	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]	collagen-containing extracellular matrix [GO:0062023]		GO:0007155; GO:0050767; GO:0062023	cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]		NA	NA	NA	NA	NA	NA
TRINITY_DN29341_c0_g1_i1	Q9VYN8	TENA_DROME	74.3	74	19	0	6	227	835	908	1.00E-26	120.2	TENA_DROME	reviewed	Teneurin-a (Tena) (Tenascin-like protein)	Ten-a CG42338	Drosophila melanogaster (Fruit fly)	3004	axon [GO:0030424]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; central complex development [GO:0048036]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	axon [GO:0030424]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]	catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001941; GO:0003824; GO:0005576; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016021; GO:0016200; GO:0030424; GO:0031012; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042734; GO:0042803; GO:0043025; GO:0046982; GO:0048036; GO:0048499; GO:0048786; GO:0048788; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:2000331	cell adhesion [GO:0007155]; central complex development [GO:0048036]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; presynaptic membrane organization [GO:0097090]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		NA	NA	NA	NA	NA	NA
TRINITY_DN29176_c0_g1_i1	O61307	TENM_DROME	62.5	88	33	0	264	1	1283	1370	2.50E-32	139	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		NA	NA	NA	NA	NA	NA
TRINITY_DN26788_c0_g1_i1	O61307	TENM_DROME	42.6	176	99	1	4	531	1512	1685	5.10E-39	162.5	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		brown	brown	NA	NA	NA	NA
TRINITY_DN3106_c0_g3_i4	O61307	TENM_DROME	78.9	76	16	0	687	460	995	1070	3.30E-28	126.7	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		brown	brown	NA	NA	NA	NA
TRINITY_DN3106_c0_g5_i1	O61307	TENM_DROME	77.6	67	15	0	2	202	1004	1070	3.30E-23	109.4	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		brown	brown	NA	NA	NA	NA
TRINITY_DN29511_c0_g1_i1	O61307	TENM_DROME	58.4	77	31	1	4	231	1290	1366	2.60E-25	115.5	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		NA	NA	NA	NA	NA	NA
TRINITY_DN34005_c0_g1_i1	O61307	TENM_DROME	58.7	75	26	1	211	2	1210	1284	8.40E-19	94	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		NA	NA	NA	NA	NA	NA
TRINITY_DN31447_c0_g1_i1	O61307	TENM_DROME	41.6	101	59	0	2	304	2312	2412	1.30E-17	90.5	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		NA	NA	NA	NA	NA	NA
TRINITY_DN38701_c0_g1_i1	O61307	TENM_DROME	60	75	29	1	222	1	714	788	3.40E-25	115.2	TENM_DROME	reviewed	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]		NA	NA	NA	NA	NA	NA
TRINITY_DN38271_c0_g1_i1	Q04205	TENS_CHICK	56.5	46	20	0	231	94	218	263	1.60E-10	66.6	TENS_CHICK	reviewed	Tensin	TNS	Gallus gallus (Chicken)	1744	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0005912; GO:0009986			NA	NA	NA	NA	NA	NA
TRINITY_DN39200_c0_g1_i1	Q9GLM4	TENS1_BOVIN	56.2	288	111	6	854	3	1421	1697	4.00E-88	326.2	TENS1_BOVIN	reviewed	Tensin-1	TNS1 TNS	Bos taurus (Bovine)	1715	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0005925; GO:0009986			NA	NA	NA	NA	NA	NA
TRINITY_DN40698_c0_g1_i1	Q8CGB6	TNS2_MOUSE	100	89	0	0	268	2	1105	1193	2.50E-48	192.2	TNS2_MOUSE	reviewed	Tensin-2 (EC 3.1.3.48) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-like C1 domain-containing phosphatase)	Tns2 Tenc1	Mus musculus (Mouse)	1400	focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850]	focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]	GO:0001822; GO:0004725; GO:0005102; GO:0005886; GO:0005925; GO:0008285; GO:0014850; GO:0019725; GO:0019900; GO:0019901; GO:0032963; GO:0035264; GO:0035335; GO:0035556; GO:0042802; GO:0046627; GO:0046872; GO:0048871	cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; multicellular organismal homeostasis [GO:0048871]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850]		NA	NA	NA	NA	NA	NA
TRINITY_DN31762_c0_g1_i1	Q5SSZ5	TENS3_MOUSE	61.8	68	26	0	2	205	93	160	4.50E-21	101.3	TENS3_MOUSE	reviewed	Tensin-3 (Tensin-like SH2 domain-containing protein 1)	Tns3 Tens1	Mus musculus (Mouse)	1440	cytosol [GO:0005829]; focal adhesion [GO:0005925]; cell migration [GO:0016477]; lung alveolus development [GO:0048286]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; focal adhesion [GO:0005925]		GO:0005829; GO:0005925; GO:0008284; GO:0016477; GO:0048286	cell migration [GO:0016477]; lung alveolus development [GO:0048286]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN14201_c0_g1_i1	Q5XG87	PAPD7_HUMAN	45.9	98	50	1	288	4	361	458	6.00E-16	84.7	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN14201_c0_g1_i2	Q5XG87	PAPD7_HUMAN	46.8	94	47	1	278	6	361	454	2.20E-15	82.8	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c0_g1_i1	Q5XG87	PAPD7_HUMAN	41.9	93	50	2	271	5	381	473	7.00E-14	77.8	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN8674_c0_g2_i1	Q5XG87	PAPD7_HUMAN	39.8	83	46	2	237	1	355	437	1.90E-07	56.2	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN13221_c0_g3_i1	Q5XG87	PAPD7_HUMAN	38.7	124	73	1	371	9	338	461	9.30E-20	97.8	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN13221_c0_g2_i2	Q5XG87	PAPD7_HUMAN	36.8	106	62	2	309	1	367	470	4.10E-12	72.4	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN13221_c0_g4_i1	Q5XG87	PAPD7_HUMAN	33.5	161	95	2	519	58	341	496	4.00E-18	92.8	PAPD7_HUMAN	reviewed	Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7) (EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1)	TENT4A PAPD7 POLS TRF4	Homo sapiens (Human)	772	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]	Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]	GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0031499; GO:0031965; GO:0042493; GO:0043221; GO:0046872; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	double-strand break repair [GO:0006302]; histone mRNA catabolic process [GO:0071044]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to drug [GO:0042493]; RNA 3' uridylation [GO:0071076]; sister chromatid cohesion [GO:0007062]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN29878_c0_g1_i2	Q8NDF8	PAPD5_HUMAN	61.7	115	43	1	1277	936	324	438	5.60E-37	156.8	PAPD5_HUMAN	reviewed	Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2)	TENT4B GLD4 PAPD5 TRF4-2 TUT3	Homo sapiens (Human)	572	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0006364; GO:0006378; GO:0007049; GO:0010587; GO:0031499; GO:0032211; GO:0033500; GO:0043629; GO:0043630; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050]		NA	NA	NA	NA	NA	NA
TRINITY_DN853_c0_g1_i1	Q5TAX3	TUT4_HUMAN	36	1044	561	16	3223	398	284	1322	7.10E-176	619.8	TUT4_HUMAN	reviewed	Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)	TUT4 KIAA0191 ZCCHC11	Homo sapiens (Human)	1644	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]	GO:0000289; GO:0001556; GO:0003723; GO:0004652; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006378; GO:0006397; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0071076; GO:1990074	"miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN853_c0_g1_i3	Q5TAX3	TUT4_HUMAN	36	1044	561	16	3090	265	284	1322	6.90E-176	619.8	TUT4_HUMAN	reviewed	Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)	TUT4 KIAA0191 ZCCHC11	Homo sapiens (Human)	1644	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]	GO:0000289; GO:0001556; GO:0003723; GO:0004652; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006378; GO:0006397; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0071076; GO:1990074	"miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN853_c0_g1_i7	B2RX14	TUT4_MOUSE	36.1	1037	533	17	3142	407	304	1335	1.90E-173	611.7	TUT4_MOUSE	reviewed	Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)	Tut4 Kiaa0191 Zcchc11	Mus musculus (Mouse)	1644	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]	GO:0001556; GO:0001816; GO:0004652; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006378; GO:0006397; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032088; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:1990074	"cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN853_c0_g1_i8	B2RX14	TUT4_MOUSE	36.1	1037	533	17	3009	274	304	1335	1.80E-173	611.7	TUT4_MOUSE	reviewed	Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)	Tut4 Kiaa0191 Zcchc11	Mus musculus (Mouse)	1644	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]	GO:0001556; GO:0001816; GO:0004652; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006378; GO:0006397; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032088; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:1990074	"cytokine production [GO:0001816]; interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; stem cell population maintenance [GO:0019827]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32767_c0_g1_i1	Q5VYS8	TUT7_HUMAN	100	72	0	0	218	3	1188	1259	8.60E-39	160.2	TUT7_HUMAN	reviewed	Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6)	TUT7 HS2 KIAA1711 ZCCHC6	Homo sapiens (Human)	1495	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]	GO:0000289; GO:0001556; GO:0003723; GO:0004652; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006378; GO:0006397; GO:0008270; GO:0010526; GO:0010586; GO:0016779; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0071076; GO:1990074	"miRNA metabolic process [GO:0010586]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26709_c0_g1_i1	Q90YH9	TES_CHICK	39.5	185	99	4	1027	503	12	193	4.30E-32	140.2	TES_CHICK	reviewed	Testin	TES	Gallus gallus (Chicken)	422	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	zinc ion binding [GO:0008270]	GO:0005737; GO:0005925; GO:0008270; GO:0042127	regulation of cell population proliferation [GO:0042127]		NA	NA	NA	NA	NA	NA
TRINITY_DN29026_c0_g1_i1	Q2IBA3	TES_CHLAE	100	85	0	0	258	4	229	313	1.80E-51	202.6	TES_CHLAE	reviewed	Testin	TES	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	421	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	zinc ion binding [GO:0008270]	GO:0005737; GO:0005925; GO:0008270; GO:0008285	negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN511_c0_g1_i1	Q2IBC3	TES_RHIFE	47.5	198	100	3	727	134	223	416	1.40E-55	218.4	TES_RHIFE	reviewed	Testin	TES	Rhinolophus ferrumequinum (Greater horseshoe bat)	421	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	zinc ion binding [GO:0008270]	GO:0005737; GO:0005925; GO:0008270; GO:0008285	negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN34788_c0_g1_i1	Q2QLB2	TES_HORSE	97.8	93	2	0	281	3	252	344	7.60E-56	217.2	TES_HORSE	reviewed	Testin	TES	Equus caballus (Horse)	421	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	zinc ion binding [GO:0008270]	GO:0005737; GO:0005925; GO:0008270; GO:0008285	negative regulation of cell population proliferation [GO:0008285]		NA	NA	NA	NA	NA	NA
TRINITY_DN4661_c0_g1_i1	Q8VBT9	ASPC1_MOUSE	27.5	553	340	14	1574	51	9	545	1.10E-34	149.4	ASPC1_MOUSE	reviewed	Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein homolog)	Aspscr1 Tug	Mus musculus (Mouse)	550	cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324]	cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]		GO:0005654; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0019898; GO:0030659; GO:0031401; GO:0033116; GO:0042593; GO:0043231; GO:0046324; GO:0048471	glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324]		NA	NA	NA	NA	NA	NA
TRINITY_DN15042_c0_g1_i3	Q99J59	TSN1_MOUSE	30.9	243	147	4	734	6	5	226	5.00E-25	116.3	TSN1_MOUSE	reviewed	Tetraspanin-1 (Tspan-1)	Tspan1	Mus musculus (Mouse)	240	cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein stabilization [GO:0050821]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]		GO:0005654; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0016020; GO:0030054; GO:0031982; GO:0043231; GO:0048471; GO:0050821	protein stabilization [GO:0050821]		NA	NA	NA	NA	NA	NA
TRINITY_DN2394_c0_g1_i1	Q6AYR9	TSN1_RAT	27.7	253	165	3	853	107	3	241	3.90E-21	103.6	TSN1_RAT	reviewed	Tetraspanin-1 (Tspan-1)	Tspan1	Rattus norvegicus (Rat)	241	cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein stabilization [GO:0050821]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]		GO:0005654; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0016020; GO:0030054; GO:0031982; GO:0048471; GO:0050821	protein stabilization [GO:0050821]		blue	blue	NA	NA	NA	NA
TRINITY_DN38750_c0_g1_i2	Q9D8C2	TSN13_MOUSE	51.6	225	85	5	1	672	3	204	7.30E-29	129	TSN13_MOUSE	reviewed	Tetraspanin-13 (Tspan-13) (Transmembrane 4 superfamily member 13)	Tspan13 Tm4sf13	Mus musculus (Mouse)	204	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; regulation of calcium ion transmembrane transport [GO:1903169]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium channel regulator activity [GO:0005246]	GO:0005246; GO:0005886; GO:0005887; GO:1903169	regulation of calcium ion transmembrane transport [GO:1903169]		NA	NA	NA	NA	NA	NA
TRINITY_DN15042_c0_g1_i1	Q9UKR8	TSN16_HUMAN	32.2	115	67	2	353	9	126	229	7.10E-13	75.1	TSN16_HUMAN	reviewed	Tetraspanin-16 (Tspan-16) (Tetraspanin TM4-B) (Transmembrane 4 superfamily member 16)	TSPAN16 TM4SF16	Homo sapiens (Human)	245	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4581_c0_g1_i3	Q9D7W4	TSN17_MOUSE	44.4	311	131	4	89	1018	1	270	2.10E-72	274.2	TSN17_MOUSE	reviewed	Tetraspanin-17 (Tspan-17) (F-box only protein 23) (Tetraspan protein SB134) (Transmembrane 4 superfamily member 17)	Tspan17 Fbxo23 Tm4sf17	Mus musculus (Mouse)	270	integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; establishment of protein localization to organelle [GO:0072594]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	integral component of plasma membrane [GO:0005887]	enzyme binding [GO:0019899]	GO:0005887; GO:0019899; GO:0051604; GO:0072594; GO:0072659	establishment of protein localization to organelle [GO:0072594]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN4581_c0_g1_i4	Q9D7W4	TSN17_MOUSE	50.4	272	132	3	89	901	1	270	1.20E-76	288.1	TSN17_MOUSE	reviewed	Tetraspanin-17 (Tspan-17) (F-box only protein 23) (Tetraspan protein SB134) (Transmembrane 4 superfamily member 17)	Tspan17 Fbxo23 Tm4sf17	Mus musculus (Mouse)	270	integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; establishment of protein localization to organelle [GO:0072594]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	integral component of plasma membrane [GO:0005887]	enzyme binding [GO:0019899]	GO:0005887; GO:0019899; GO:0051604; GO:0072594; GO:0072659	establishment of protein localization to organelle [GO:0072594]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN17847_c0_g1_i1	O60637	TSN3_HUMAN	31.4	185	110	6	3	536	57	231	3.80E-17	89.7	TSN3_HUMAN	reviewed	Tetraspanin-3 (Tspan-3) (Tetraspanin TM4-A) (Transmembrane 4 superfamily member 8)	TSPAN3 TM4SF8	Homo sapiens (Human)	253	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN38750_c0_g1_i1	Q5RAP8	TSN31_PONAB	38.3	214	112	4	1	636	3	198	8.40E-18	92	TSN31_PONAB	reviewed	Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence homolog)	TSPAN31 SAS	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	210	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1451_c0_g1_i1	Q8R3S2	TSN33_MOUSE	36.3	201	125	2	702	100	67	264	1.00E-35	151.8	TSN33_MOUSE	reviewed	Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane)	Tspan33 Pen	Mus musculus (Mouse)	283	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]	enzyme binding [GO:0019899]	GO:0005737; GO:0005886; GO:0005887; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197	pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN1451_c0_g1_i2	Q8R3S2	TSN33_MOUSE	36.3	201	125	2	707	105	67	264	1.00E-35	151.8	TSN33_MOUSE	reviewed	Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane)	Tspan33 Pen	Mus musculus (Mouse)	283	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]	enzyme binding [GO:0019899]	GO:0005737; GO:0005886; GO:0005887; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197	pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN4581_c0_g1_i1	Q17QJ5	TSN5_BOVIN	53.1	262	119	4	122	904	10	268	7.30E-77	288.9	TSN5_BOVIN	reviewed	Tetraspanin-5 (Tspan-5)	TSPAN5	Bos taurus (Bovine)	268	integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	integral component of plasma membrane [GO:0005887]	enzyme binding [GO:0019899]	GO:0005887; GO:0019899; GO:0045747; GO:0051604; GO:0072659	positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN4581_c0_g1_i2	Q17QJ5	TSN5_BOVIN	52.6	209	96	3	122	745	10	216	6.50E-60	232.3	TSN5_BOVIN	reviewed	Tetraspanin-5 (Tspan-5)	TSPAN5	Bos taurus (Bovine)	268	integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	integral component of plasma membrane [GO:0005887]	enzyme binding [GO:0019899]	GO:0005887; GO:0019899; GO:0045747; GO:0051604; GO:0072659	positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN30874_c0_g1_i1	Q17QJ5	TSN5_BOVIN	100	67	0	0	236	36	202	268	3.80E-32	138.3	TSN5_BOVIN	reviewed	Tetraspanin-5 (Tspan-5)	TSPAN5	Bos taurus (Bovine)	268	integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]	integral component of plasma membrane [GO:0005887]	enzyme binding [GO:0019899]	GO:0005887; GO:0019899; GO:0045747; GO:0051604; GO:0072659	positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]		NA	NA	NA	NA	NA	NA
TRINITY_DN4349_c0_g1_i1	Q99614	TTC1_HUMAN	54	200	92	0	16	615	92	291	6.10E-54	212.2	TTC1_HUMAN	reviewed	Tetratricopeptide repeat protein 1 (TPR repeat protein 1)	TTC1 TPR1	Homo sapiens (Human)	292	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]	unfolded protein binding [GO:0051082]	GO:0005778; GO:0005829; GO:0006457; GO:0051082	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN31399_c0_g1_i1	Q99614	TTC1_HUMAN	100	105	0	0	323	9	188	292	2.60E-52	205.7	TTC1_HUMAN	reviewed	Tetratricopeptide repeat protein 1 (TPR repeat protein 1)	TTC1 TPR1	Homo sapiens (Human)	292	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]	unfolded protein binding [GO:0051082]	GO:0005778; GO:0005829; GO:0006457; GO:0051082	protein folding [GO:0006457]		NA	NA	NA	NA	NA	NA
TRINITY_DN28948_c0_g1_i1	Q96AE7	TTC17_HUMAN	100	79	0	0	238	2	1007	1085	1.90E-39	162.5	TTC17_HUMAN	reviewed	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	TTC17	Homo sapiens (Human)	1141	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782	actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]		NA	NA	NA	NA	NA	NA
TRINITY_DN6470_c0_g1_i2	E7F211	TTC17_DANRE	44.8	288	153	2	112	957	53	340	3.40E-63	243.4	TTC17_DANRE	reviewed	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	ttc17	Danio rerio (Zebrafish) (Brachydanio rerio)	1198	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371	actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]		NA	NA	NA	NA	NA	NA
TRINITY_DN6470_c0_g1_i5	E9PVB5	TTC17_MOUSE	45.1	226	112	4	112	762	36	258	1.50E-46	188	TTC17_MOUSE	reviewed	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	Ttc17	Mus musculus (Mouse)	1198	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782	actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]		NA	NA	NA	NA	NA	NA
TRINITY_DN10567_c0_g1_i1	E7F211	TTC17_DANRE	53.6	233	105	3	789	97	959	1190	2.60E-61	236.9	TTC17_DANRE	reviewed	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	ttc17	Danio rerio (Zebrafish) (Brachydanio rerio)	1198	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371	actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]		NA	NA	NA	NA	NA	NA
TRINITY_DN30189_c0_g1_i1	Q8SYD0	TTC19_DROME	33.9	327	201	5	75	1052	57	369	1.70E-45	184.9	TTC19_DROME	reviewed	"Tetratricopeptide repeat protein 19 homolog, mitochondrial"	Ttc19 CG15173	Drosophila melanogaster (Fruit fly)	369	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; jump response [GO:0007630]; mitochondrial respiratory chain complex III assembly [GO:0034551]; optomotor response [GO:0071632]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]		GO:0005739; GO:0005743; GO:0007630; GO:0034551; GO:0071632	jump response [GO:0007630]; mitochondrial respiratory chain complex III assembly [GO:0034551]; optomotor response [GO:0071632]		NA	NA	NA	NA	NA	NA
TRINITY_DN6196_c0_g1_i1	Q7Z4L5	TT21B_HUMAN	50	130	64	1	388	2	980	1109	2.70E-36	152.9	TT21B_HUMAN	reviewed	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	1316	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]		GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0060020; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN6196_c0_g1_i3	Q7Z4L5	TT21B_HUMAN	57.6	458	191	2	1452	82	860	1315	1.50E-158	560.8	TT21B_HUMAN	reviewed	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	1316	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]		GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0060020; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN6196_c0_g1_i5	Q7Z4L5	TT21B_HUMAN	47.2	282	136	3	883	41	860	1129	2.50E-73	276.9	TT21B_HUMAN	reviewed	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	1316	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]		GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0060020; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN6196_c0_g1_i6	Q7Z4L5	TT21B_HUMAN	50.8	315	152	2	1028	87	860	1172	9.10E-91	335.1	TT21B_HUMAN	reviewed	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	1316	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]		GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0060020; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN34175_c0_g1_i1	Q7Z4L5	TT21B_HUMAN	60	70	28	0	211	2	1246	1315	2.10E-18	92.4	TT21B_HUMAN	reviewed	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	1316	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]		GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0060020; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN712_c3_g1_i4	Q7Z4L5	TT21B_HUMAN	43.6	94	51	1	5	286	791	882	8.90E-12	71.2	TT21B_HUMAN	reviewed	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	1316	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]		GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0060020; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN18892_c0_g1_i1	Q6INU8	TT30A_XENLA	86.2	65	9	0	48	242	198	262	1.30E-23	110.2	TT30A_XENLA	reviewed	Tetratricopeptide repeat protein 30A (TPR repeat protein 30A)	ttc30a ttc30	Xenopus laevis (African clawed frog)	651	axonemal microtubule [GO:0005879]; cilium [GO:0005929]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]	axonemal microtubule [GO:0005879]; cilium [GO:0005929]		GO:0005879; GO:0005929; GO:0018095; GO:0042073	intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]		NA	NA	NA	NA	NA	NA
TRINITY_DN20735_c0_g1_i1	A4IHR1	TT30A_XENTR	76.9	117	26	1	368	18	225	340	5.10E-44	178.3	TT30A_XENTR	reviewed	Tetratricopeptide repeat protein 30A (TPR repeat protein 30A)	ttc30a ttc30	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	651	axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; tubulin-glycine ligase activity [GO:0070738]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment of planar polarity [GO:0001736]; intraciliary transport [GO:0042073]; opsin transport [GO:0036372]; protein polyglutamylation [GO:0018095]	axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]	intraciliary transport particle B binding [GO:0120170]; tubulin-glycine ligase activity [GO:0070738]	GO:0001736; GO:0005879; GO:0005929; GO:0007368; GO:0018095; GO:0030992; GO:0031514; GO:0036064; GO:0036372; GO:0042073; GO:0060271; GO:0070738; GO:0120170	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment of planar polarity [GO:0001736]; intraciliary transport [GO:0042073]; opsin transport [GO:0036372]; protein polyglutamylation [GO:0018095]		NA	NA	NA	NA	NA	NA
TRINITY_DN26244_c0_g1_i1	A7YE96	TT30A_DANRE	85.2	61	9	0	50	232	477	537	1.30E-22	106.7	TT30A_DANRE	reviewed	Tetratricopeptide repeat protein 30A (TPR repeat protein 30A) (Protein fleer)	ttc30a flr	Danio rerio (Zebrafish) (Brachydanio rerio)	651	axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; tubulin-glycine ligase activity [GO:0070738]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment of planar polarity [GO:0001736]; intraciliary transport [GO:0042073]; opsin transport [GO:0036372]; protein polyglutamylation [GO:0018095]	axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]	intraciliary transport particle B binding [GO:0120170]; tubulin-glycine ligase activity [GO:0070738]	GO:0001736; GO:0005879; GO:0005929; GO:0007368; GO:0018095; GO:0030992; GO:0031514; GO:0036064; GO:0036372; GO:0042073; GO:0060271; GO:0070738; GO:0120170	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment of planar polarity [GO:0001736]; intraciliary transport [GO:0042073]; opsin transport [GO:0036372]; protein polyglutamylation [GO:0018095]		NA	NA	NA	NA	NA	NA
TRINITY_DN20735_c0_g2_i1	A7YE96	TT30A_DANRE	63.6	151	52	2	3	446	387	537	1.20E-50	200.7	TT30A_DANRE	reviewed	Tetratricopeptide repeat protein 30A (TPR repeat protein 30A) (Protein fleer)	ttc30a flr	Danio rerio (Zebrafish) (Brachydanio rerio)	651	axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; tubulin-glycine ligase activity [GO:0070738]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment of planar polarity [GO:0001736]; intraciliary transport [GO:0042073]; opsin transport [GO:0036372]; protein polyglutamylation [GO:0018095]	axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]	intraciliary transport particle B binding [GO:0120170]; tubulin-glycine ligase activity [GO:0070738]	GO:0001736; GO:0005879; GO:0005929; GO:0007368; GO:0018095; GO:0030992; GO:0031514; GO:0036064; GO:0036372; GO:0042073; GO:0060271; GO:0070738; GO:0120170	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment of planar polarity [GO:0001736]; intraciliary transport [GO:0042073]; opsin transport [GO:0036372]; protein polyglutamylation [GO:0018095]		NA	NA	NA	NA	NA	NA
TRINITY_DN1730_c0_g3_i1	Q4QQS2	T30A2_RAT	86.1	72	10	0	57	272	421	492	8.00E-33	141	T30A2_RAT	reviewed	Tetratricopeptide repeat protein 30A2 (TPR repeat protein 30A2)	Ttc30a2 Ttc30a1	Rattus norvegicus (Rat)	664	axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; intraciliary transport [GO:0042073]	axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	intraciliary transport particle B binding [GO:0120170]	GO:0005813; GO:0005879; GO:0005929; GO:0030992; GO:0036064; GO:0042073; GO:0120170	intraciliary transport [GO:0042073]		NA	NA	NA	NA	NA	NA
TRINITY_DN221_c0_g1_i3	Q9DAC7	TTC32_MOUSE	27.7	130	78	3	128	514	19	133	2.10E-05	51.6	TTC32_MOUSE	reviewed	Tetratricopeptide repeat protein 32 (TPR repeat protein 32)	Ttc32	Mus musculus (Mouse)	148							NA	NA	NA	NA	NA	NA
TRINITY_DN221_c0_g1_i6	Q9DAC7	TTC32_MOUSE	27.7	130	78	3	128	514	19	133	1.70E-05	51.6	TTC32_MOUSE	reviewed	Tetratricopeptide repeat protein 32 (TPR repeat protein 32)	Ttc32	Mus musculus (Mouse)	148							blue	blue	NA	NA	NA	NA
TRINITY_DN27688_c0_g1_i1	Q6DI40	TTC33_DANRE	41.6	243	136	4	111	824	1	242	1.50E-39	164.9	TTC33_DANRE	reviewed	Tetratricopeptide repeat protein 33 (TPR repeat protein 33)	ttc33 si:dkey-204l11.4 zgc:86619	Danio rerio (Zebrafish) (Brachydanio rerio)	268							NA	NA	NA	NA	NA	NA
TRINITY_DN27688_c0_g1_i2	Q6DI40	TTC33_DANRE	41.6	243	136	4	111	824	1	242	2.00E-39	164.5	TTC33_DANRE	reviewed	Tetratricopeptide repeat protein 33 (TPR repeat protein 33)	ttc33 si:dkey-204l11.4 zgc:86619	Danio rerio (Zebrafish) (Brachydanio rerio)	268							NA	NA	NA	NA	NA	NA
TRINITY_DN25506_c0_g1_i1	A8E7I5	TTC36_DANRE	54	187	83	3	11	565	1	186	1.20E-45	184.5	TTC36_DANRE	reviewed	Tetratricopeptide repeat protein 36 (TPR repeat protein 36)	ttc36 si:rp71-52f21.2 zgc:103600	Danio rerio (Zebrafish) (Brachydanio rerio)	187	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271; GO:0061371	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN2335_c0_g1_i1	Q6DFB8	TTC37_XENLA	30	1248	801	25	3873	205	79	1279	2.90E-137	491.5	TTC37_XENLA	reviewed	Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (Thespin homolog)	ttc37	Xenopus laevis (African clawed frog)	1564	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]		GO:0005634; GO:0005737; GO:0006401; GO:0035327; GO:0055087	RNA catabolic process [GO:0006401]		NA	NA	NA	NA	NA	NA
TRINITY_DN3465_c0_g1_i2	Q28DB0	TT39B_XENTR	50.2	225	106	3	739	83	9	233	1.50E-61	237.7	TT39B_XENTR	reviewed	Tetratricopeptide repeat protein 39B (TPR repeat protein 39B)	ttc39b TEgg088o02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	588	lipid metabolic process [GO:0006629]			GO:0006629	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN3465_c0_g1_i3	Q5XHH9	TT39B_XENLA	47.8	312	156	4	918	1	5	315	5.50E-82	305.8	TT39B_XENLA	reviewed	Tetratricopeptide repeat protein 39B (TPR repeat protein 39B)	ttc39b	Xenopus laevis (African clawed frog)	586	lipid metabolic process [GO:0006629]			GO:0006629	lipid metabolic process [GO:0006629]		NA	NA	NA	NA	NA	NA
TRINITY_DN35144_c0_g1_i1	Q8N584	TT39C_HUMAN	54.3	81	37	0	246	4	198	278	1.50E-19	96.7	TT39C_HUMAN	reviewed	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	TTC39C C18orf17	Homo sapiens (Human)	583	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN9079_c0_g1_i1	Q8N584	TT39C_HUMAN	45.7	129	69	1	29	412	268	396	1.70E-29	131.3	TT39C_HUMAN	reviewed	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	TTC39C C18orf17	Homo sapiens (Human)	583	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN9079_c0_g1_i1	Q8N584	TT39C_HUMAN	38.1	134	81	2	441	842	446	577	3.40E-17	90.5	TT39C_HUMAN	reviewed	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	TTC39C C18orf17	Homo sapiens (Human)	583	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN9079_c0_g1_i2	Q1LXE6	TT39C_DANRE	59.5	37	15	0	80	190	537	573	2.10E-06	52.8	TT39C_DANRE	reviewed	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	ttc39c si:ch73-264b7.2	Danio rerio (Zebrafish) (Brachydanio rerio)	579	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271; GO:0061371	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN9079_c0_g1_i3	Q1LXE6	TT39C_DANRE	41	312	181	3	29	961	264	573	1.40E-64	248.1	TT39C_DANRE	reviewed	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	ttc39c si:ch73-264b7.2	Danio rerio (Zebrafish) (Brachydanio rerio)	579	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271; GO:0061371	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN31394_c0_g1_i1	Q8N584	TT39C_HUMAN	98.4	62	1	0	201	16	211	272	2.80E-28	125.2	TT39C_HUMAN	reviewed	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	TTC39C C18orf17	Homo sapiens (Human)	583	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]			GO:0032474; GO:0060271	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]		NA	NA	NA	NA	NA	NA
TRINITY_DN14980_c0_g1_i1	Q8R3H9	TTC4_MOUSE	38.8	363	204	6	1084	20	27	379	2.10E-63	244.6	TTC4_MOUSE	reviewed	Tetratricopeptide repeat protein 4 (TPR repeat protein 4)	Ttc4	Mus musculus (Mouse)	386	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Hsp90 protein binding [GO:0051879]	GO:0005634; GO:0005654; GO:0005737; GO:0045087; GO:0051607; GO:0051879	defense response to virus [GO:0051607]; innate immune response [GO:0045087]		NA	NA	NA	NA	NA	NA
TRINITY_DN14980_c0_g1_i3	Q8R3H9	TTC4_MOUSE	38.8	363	204	6	1084	20	27	379	2.20E-63	244.6	TTC4_MOUSE	reviewed	Tetratricopeptide repeat protein 4 (TPR repeat protein 4)	Ttc4	Mus musculus (Mouse)	386	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Hsp90 protein binding [GO:0051879]	GO:0005634; GO:0005654; GO:0005737; GO:0045087; GO:0051607; GO:0051879	defense response to virus [GO:0051607]; innate immune response [GO:0045087]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN58_c0_g1_i1	E9Q6P5	TTC7B_MOUSE	38.9	543	278	4	11	1639	313	801	2.20E-86	321.2	TTC7B_MOUSE	reviewed	Tetratricopeptide repeat protein 7B (TPR repeat protein 7B)	Ttc7b	Mus musculus (Mouse)	843	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005829; GO:0005886; GO:0046854; GO:0072659	phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN58_c0_g1_i2	E9Q6P5	TTC7B_MOUSE	42.2	490	276	2	11	1462	313	801	1.20E-91	338.6	TTC7B_MOUSE	reviewed	Tetratricopeptide repeat protein 7B (TPR repeat protein 7B)	Ttc7b	Mus musculus (Mouse)	843	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]		GO:0005829; GO:0005886; GO:0046854; GO:0072659	phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]		NA	NA	NA	NA	NA	NA
TRINITY_DN51_c0_g1_i3	P80204	TGFR1_RAT	59.1	482	184	8	261	1694	28	500	1.70E-161	570.9	TGFR1_RAT	reviewed	TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)	Tgfbr1	Rattus norvegicus (Rat)	501	"activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; aging [GO:0007568]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to prostaglandin E [GO:0034695]; response to toxic substance [GO:0009636]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000186; GO:0001501; GO:0001525; GO:0001666; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007399; GO:0007507; GO:0007566; GO:0007568; GO:0008284; GO:0008354; GO:0008584; GO:0009636; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0014070; GO:0016323; GO:0016324; GO:0016361; GO:0018105; GO:0018107; GO:0030199; GO:0030307; GO:0030324; GO:0030335; GO:0031100; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0032991; GO:0034695; GO:0035556; GO:0042118; GO:0043065; GO:0043066; GO:0043235; GO:0043393; GO:0043542; GO:0043627; GO:0044877; GO:0045121; GO:0045602; GO:0045893; GO:0046332; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0048538; GO:0048565; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051272; GO:0051491; GO:0051496; GO:0051602; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070411; GO:0070723; GO:0071363; GO:0071560; GO:1902894; GO:1902895; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237	"activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; aging [GO:0007568]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to prostaglandin E [GO:0034695]; response to toxic substance [GO:0009636]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21619_c0_g1_i1	P37173	TGFR2_HUMAN	100	94	0	0	284	3	351	444	3.10E-49	195.3	TGFR2_HUMAN	reviewed	TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II)	TGFBR2	Homo sapiens (Human)	567	"caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type II [GO:0005026]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714]; activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inferior endocardial cushion morphogenesis [GO:1905317]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]"	caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type III transforming growth factor beta receptor binding [GO:0034714]; type I transforming growth factor beta receptor binding [GO:0034713]"	GO:0001568; GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001947; GO:0002053; GO:0002088; GO:0002651; GO:0002663; GO:0002666; GO:0003148; GO:0003149; GO:0003151; GO:0003181; GO:0003186; GO:0003214; GO:0003274; GO:0003430; GO:0004674; GO:0004675; GO:0005024; GO:0005026; GO:0005524; GO:0005539; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006468; GO:0006898; GO:0006915; GO:0007179; GO:0007182; GO:0007219; GO:0007224; GO:0007369; GO:0007420; GO:0007507; GO:0007566; GO:0007568; GO:0007584; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0010468; GO:0010634; GO:0010718; GO:0016021; GO:0017002; GO:0018105; GO:0018107; GO:0030512; GO:0031100; GO:0031435; GO:0032147; GO:0034713; GO:0034714; GO:0035162; GO:0042060; GO:0042127; GO:0042493; GO:0043011; GO:0043235; GO:0043415; GO:0043627; GO:0045121; GO:0045766; GO:0046332; GO:0046872; GO:0048185; GO:0048545; GO:0048565; GO:0048661; GO:0048701; GO:0050431; GO:0051138; GO:0060044; GO:0060389; GO:0060412; GO:0060434; GO:0060440; GO:0060443; GO:0060463; GO:0062009; GO:0070723; GO:0071363; GO:1905007; GO:1905317; GO:1990086; GO:1990428; GO:2000379; GO:2000563	"activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; inferior endocardial cushion morphogenesis [GO:1905317]; in utero embryonic development [GO:0001701]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4475_c0_g1_i1	Q15750	TAB1_HUMAN	43.5	370	200	6	1109	15	16	381	4.60E-76	286.6	TAB1_HUMAN	reviewed	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1)	TAB1 MAP3K7IP1	Homo sapiens (Human)	504	cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart morphogenesis [GO:0003007]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; lung development [GO:0030324]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of protein kinase activity [GO:0006469]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein deubiquitination [GO:0016579]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme activator activity [GO:0008047]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000185; GO:0000187; GO:0001701; GO:0002223; GO:0002755; GO:0003007; GO:0003279; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006469; GO:0007179; GO:0007249; GO:0007254; GO:0008047; GO:0010008; GO:0016579; GO:0016607; GO:0019209; GO:0030324; GO:0032991; GO:0035904; GO:0038095; GO:0044877; GO:0048273; GO:0051092; GO:0060976; GO:0070423; GO:0070498	activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart morphogenesis [GO:0003007]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interleukin-1-mediated signaling pathway [GO:0070498]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung development [GO:0030324]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of protein kinase activity [GO:0006469]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein deubiquitination [GO:0016579]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN4475_c0_g1_i3	Q15750	TAB1_HUMAN	43.4	145	77	3	437	15	238	381	2.30E-24	113.6	TAB1_HUMAN	reviewed	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1)	TAB1 MAP3K7IP1	Homo sapiens (Human)	504	cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart morphogenesis [GO:0003007]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; lung development [GO:0030324]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of protein kinase activity [GO:0006469]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein deubiquitination [GO:0016579]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme activator activity [GO:0008047]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000185; GO:0000187; GO:0001701; GO:0002223; GO:0002755; GO:0003007; GO:0003279; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006469; GO:0007179; GO:0007249; GO:0007254; GO:0008047; GO:0010008; GO:0016579; GO:0016607; GO:0019209; GO:0030324; GO:0032991; GO:0035904; GO:0038095; GO:0044877; GO:0048273; GO:0051092; GO:0060976; GO:0070423; GO:0070498	activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart morphogenesis [GO:0003007]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interleukin-1-mediated signaling pathway [GO:0070498]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung development [GO:0030324]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of protein kinase activity [GO:0006469]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein deubiquitination [GO:0016579]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN5675_c0_g1_i1	Q8TBB0	THAP6_HUMAN	36	89	51	1	352	104	1	89	1.80E-09	63.9	THAP6_HUMAN	reviewed	THAP domain-containing protein 6	THAP6	Homo sapiens (Human)	222	microtubule cytoskeleton [GO:0015630]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	microtubule cytoskeleton [GO:0015630]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0015630; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5675_c0_g1_i3	Q8TBB0	THAP6_HUMAN	36	89	51	1	361	113	1	89	1.90E-09	63.9	THAP6_HUMAN	reviewed	THAP domain-containing protein 6	THAP6	Homo sapiens (Human)	222	microtubule cytoskeleton [GO:0015630]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	microtubule cytoskeleton [GO:0015630]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0015630; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1774_c0_g1_i1	Q9YA66	THSB_AERPE	19.4	396	300	8	422	1591	44	426	1.30E-10	70.1	THSB_AERPE	reviewed	Thermosome subunit beta (Chaperonin subunit beta) (Thermosome subunit 2)	thsB APE_2072.1	Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1)	548	ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]		ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0006457; GO:0051082	protein folding [GO:0006457]		blue	blue	NA	NA	NA	NA
TRINITY_DN9677_c0_g3_i1	Q7PCJ8	SAT2_BOVIN	39.8	161	88	2	539	84	6	166	3.00E-26	120.9	SAT2_BOVIN	reviewed	Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)	SAT2 SSAT2	Bos taurus (Bovine)	170	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]		NA	NA	NA	NA	NA	NA
TRINITY_DN9677_c0_g3_i2	Q7PCJ8	SAT2_BOVIN	39.8	161	88	2	539	84	6	166	3.70E-26	120.9	SAT2_BOVIN	reviewed	Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)	SAT2 SSAT2	Bos taurus (Bovine)	170	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]		NA	NA	NA	NA	NA	NA
TRINITY_DN9677_c0_g3_i3	Q7PCJ8	SAT2_BOVIN	39.8	161	88	2	539	84	6	166	3.30E-26	120.9	SAT2_BOVIN	reviewed	Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)	SAT2 SSAT2	Bos taurus (Bovine)	170	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]		NA	NA	NA	NA	NA	NA
TRINITY_DN9677_c0_g3_i4	Q7PCJ8	SAT2_BOVIN	39.8	161	88	2	539	84	6	166	3.40E-26	120.9	SAT2_BOVIN	reviewed	Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)	SAT2 SSAT2	Bos taurus (Bovine)	170	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]		NA	NA	NA	NA	NA	NA
TRINITY_DN4311_c0_g1_i1	Q7PCJ8	SAT2_BOVIN	34.1	126	74	2	20	370	40	165	5.00E-14	79	SAT2_BOVIN	reviewed	Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)	SAT2 SSAT2	Bos taurus (Bovine)	170	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]		NA	NA	NA	NA	NA	NA
TRINITY_DN4311_c0_g1_i2	Q7PCJ8	SAT2_BOVIN	34.1	126	74	2	20	370	40	165	6.50E-14	78.6	SAT2_BOVIN	reviewed	Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)	SAT2 SSAT2	Bos taurus (Bovine)	170	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]		NA	NA	NA	NA	NA	NA
TRINITY_DN29950_c0_g1_i1	Q5E9T4	TPK1_BOVIN	41.4	261	118	7	159	938	13	239	2.50E-46	187.6	TPK1_BOVIN	reviewed	Thiamin pyrophosphokinase 1 (EC 2.7.6.2) (Thiamine pyrophosphokinase 1)	TPK1	Bos taurus (Bovine)	243	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]		ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]	GO:0004788; GO:0005524; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0042802	thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]		blue	blue	NA	NA	NA	NA
TRINITY_DN5002_c0_g1_i1	O60779	S19A2_HUMAN	49	202	100	2	102	701	278	478	1.00E-45	185.3	S19A2_HUMAN	reviewed	Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)	SLC19A2 THT1 TRMA	Homo sapiens (Human)	497	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]	GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934	thiamine-containing compound metabolic process [GO:0042723]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN5002_c0_g1_i2	O60779	S19A2_HUMAN	49	202	100	2	41	640	278	478	9.40E-46	185.3	S19A2_HUMAN	reviewed	Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)	SLC19A2 THT1 TRMA	Homo sapiens (Human)	497	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]	GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934	thiamine-containing compound metabolic process [GO:0042723]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN5002_c0_g1_i4	O60779	S19A2_HUMAN	49	202	100	2	57	656	278	478	1.60E-45	184.5	S19A2_HUMAN	reviewed	Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)	SLC19A2 THT1 TRMA	Homo sapiens (Human)	497	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]	GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934	thiamine-containing compound metabolic process [GO:0042723]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN20482_c0_g1_i1	Q1JPJ8	THOP1_BOVIN	59	161	63	2	38	520	394	551	2.60E-49	196.4	THOP1_BOVIN	reviewed	Thimet oligopeptidase (EC 3.4.24.15)	THOP1	Bos taurus (Bovine)	687	mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]	mitochondrial intermembrane space [GO:0005758]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0046872	peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN32_c0_g1_i1	P24155	THOP1_RAT	55.1	651	292	0	2050	98	28	678	3.80E-219	762.7	THOP1_RAT	reviewed	Thimet oligopeptidase (EC 3.4.24.15) (Endo-oligopeptidase A) (Endopeptidase 24.15) (PZ-peptidase) (Soluble metallo-endopeptidase)	Thop1	Rattus norvegicus (Rat)	687	mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]	mitochondrial intermembrane space [GO:0005758]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]	GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0046872	intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN4048_c0_g1_i2	B5FEQ9	TPMT_ALIFM	32.3	217	122	6	769	122	6	198	1.10E-23	112.1	TPMT_ALIFM	reviewed	Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase)	tpm VFMJ11_1605	Aliivibrio fischeri (strain MJ11) (Vibrio fischeri)	213	cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]; response to metal ion [GO:0010038]	cytoplasm [GO:0005737]	thiopurine S-methyltransferase activity [GO:0008119]	GO:0005737; GO:0008119; GO:0010038; GO:0032259	methylation [GO:0032259]; response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN4048_c0_g1_i4	B5FEQ9	TPMT_ALIFM	34.5	203	122	6	727	122	6	198	5.50E-25	116.3	TPMT_ALIFM	reviewed	Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase)	tpm VFMJ11_1605	Aliivibrio fischeri (strain MJ11) (Vibrio fischeri)	213	cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]; response to metal ion [GO:0010038]	cytoplasm [GO:0005737]	thiopurine S-methyltransferase activity [GO:0008119]	GO:0005737; GO:0008119; GO:0010038; GO:0032259	methylation [GO:0032259]; response to metal ion [GO:0010038]		NA	NA	NA	NA	NA	NA
TRINITY_DN28031_c0_g1_i1	Q9X2T1	THIO_PSEAE	68.4	76	24	0	229	2	1	76	2.90E-27	122.1	THIO_PSEAE	reviewed	Thioredoxin (Trx)	trxA trx PA5240	Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)	108	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]"	GO:0005737; GO:0005829; GO:0006662; GO:0015035; GO:0016671; GO:0045454; GO:0047134	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		NA	NA	NA	NA	NA	NA
TRINITY_DN22978_c3_g1_i1	O97508	THIO_HORSE	56.2	64	28	0	2	193	33	96	7.80E-14	77.4	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN22978_c2_g1_i1	Q9DGI3	THIO_ICTPU	46.4	56	30	0	14	181	48	103	2.30E-08	59.3	THIO_ICTPU	reviewed	Thioredoxin (Trx)	txn trx	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	107	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; protein disulfide oxidoreductase activity [GO:0015035]; B cell proliferation [GO:0042100]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005576; GO:0005634; GO:0005737; GO:0006662; GO:0009314; GO:0015035; GO:0042100; GO:0043388; GO:0045454; GO:0055114	B cell proliferation [GO:0042100]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN22978_c0_g1_i1	O97680	THIO_BOVIN	53	66	31	0	2	199	8	73	6.10E-15	80.9	THIO_BOVIN	reviewed	Thioredoxin (Trx)	TXN	Bos taurus (Bovine)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN21123_c0_g1_i1	O97508	THIO_HORSE	52.9	104	49	0	350	39	1	104	1.20E-25	117.5	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN8177_c0_g1_i1	P52233	THIO_ACIFR	47.4	57	27	2	47	217	11	64	7.00E-09	60.8	THIO_ACIFR	reviewed	Thioredoxin (Trx)	trxA	Acidithiobacillus ferrooxidans (Thiobacillus ferrooxidans)	108	protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		protein disulfide oxidoreductase activity [GO:0015035]	GO:0006662; GO:0015035; GO:0045454	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		NA	NA	NA	NA	NA	NA
TRINITY_DN26758_c0_g1_i1	O96952	THIO_GEOCY	51.9	54	26	0	162	1	1	54	1.10E-11	70.1	THIO_GEOCY	reviewed	Thioredoxin (Trx)	THIO	Geodia cydonium (Sponge)	106	cytoplasm [GO:0005737]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]	cytoplasm [GO:0005737]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005737; GO:0006662; GO:0015035; GO:0045454	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		NA	NA	NA	NA	NA	NA
TRINITY_DN33070_c0_g1_i1	P50413	THIO_SHEEP	55	60	27	0	212	33	45	104	9.90E-11	67	THIO_SHEEP	reviewed	Thioredoxin (Trx)	TXN	Ovis aries (Sheep)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN28976_c0_g1_i1	O96952	THIO_GEOCY	41.1	56	31	1	4	171	31	84	2.60E-05	48.9	THIO_GEOCY	reviewed	Thioredoxin (Trx)	THIO	Geodia cydonium (Sponge)	106	cytoplasm [GO:0005737]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]	cytoplasm [GO:0005737]	protein disulfide oxidoreductase activity [GO:0015035]	GO:0005737; GO:0006662; GO:0015035; GO:0045454	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		NA	NA	NA	NA	NA	NA
TRINITY_DN19932_c1_g1_i1	O97508	THIO_HORSE	55.3	94	42	0	322	41	11	104	3.30E-23	109.4	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19932_c2_g1_i1	O97508	THIO_HORSE	51.9	104	50	0	30	341	1	104	1.50E-25	117.1	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19932_c0_g1_i1	O97508	THIO_HORSE	45.2	104	44	1	306	34	1	104	8.80E-20	97.8	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19932_c0_g1_i2	O97508	THIO_HORSE	48.1	104	54	0	345	34	1	104	1.40E-23	110.5	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19932_c0_g1_i5	O97508	THIO_HORSE	48.1	104	54	0	345	34	1	104	1.10E-23	110.9	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN19932_c0_g1_i6	O97508	THIO_HORSE	48.1	104	54	0	345	34	1	104	6.50E-24	111.7	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN36087_c0_g1_i2	O97508	THIO_HORSE	53.7	95	44	0	7	291	11	105	4.70E-24	111.7	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN35324_c5_g1_i1	O97508	THIO_HORSE	57.7	104	44	0	88	399	1	104	1.30E-29	131	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		blue	blue	NA	NA	NA	NA
TRINITY_DN20424_c0_g1_i1	O97508	THIO_HORSE	57.7	104	44	0	51	362	1	104	7.40E-29	128.3	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN20424_c0_g1_i2	O97508	THIO_HORSE	53.2	77	36	0	51	281	1	77	4.10E-17	88.6	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN20424_c0_g1_i4	O97508	THIO_HORSE	56.1	98	43	0	1	294	7	104	1.10E-25	117.5	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN20424_c2_g1_i1	O97508	THIO_HORSE	58.5	53	22	0	3	161	45	97	1.50E-11	69.7	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN20424_c1_g1_i1	O97508	THIO_HORSE	60.8	79	31	0	304	68	19	97	7.80E-22	104.4	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN20424_c3_g1_i1	O97508	THIO_HORSE	52.6	97	46	0	342	52	1	97	6.60E-23	108.2	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN31861_c0_g1_i1	O97508	THIO_HORSE	59.4	64	26	0	216	25	34	97	5.90E-16	84.3	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN21919_c0_g1_i1	O97508	THIO_HORSE	61.2	67	26	0	207	7	31	97	7.30E-19	94	THIO_HORSE	reviewed	Thioredoxin (Trx)	TXN	Equus caballus (Horse)	105	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005654; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN25801_c0_g1_i1	P10639	THIO_MOUSE	100	94	0	0	282	1	1	94	2.40E-50	199.1	THIO_MOUSE	reviewed	Thioredoxin (Trx) (ATL-derived factor) (ADF)	Txn Txn1	Mus musculus (Mouse)	105	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0019899; GO:0030424; GO:0030425; GO:0033138; GO:0042803; GO:0043025; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0055114; GO:0071731; GO:1903206; GO:2000170	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN36938_c0_g1_i1	P10599	THIO_HUMAN	100	96	0	0	43	330	1	96	8.70E-51	200.7	THIO_HUMAN	reviewed	Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP) (allergen Hom s Trx)	TXN TRDX TRX TRX1	Homo sapiens (Human)	105	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein homodimerization activity [GO:0042803]; protein-disulfide reductase activity [GO:0047134]; RNA binding [GO:0003723]; thioredoxin-disulfide reductase activity [GO:0004791]; activation of protein kinase B activity [GO:0032148]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; thioredoxin-disulfide reductase activity [GO:0004791]	GO:0000122; GO:0003723; GO:0004791; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006662; GO:0009314; GO:0015035; GO:0015037; GO:0032148; GO:0033138; GO:0042803; GO:0043388; GO:0045454; GO:0046826; GO:0047134; GO:0051897; GO:0055114; GO:0070062; GO:0071731; GO:1903206; GO:2000170	activation of protein kinase B activity [GO:0032148]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]		NA	NA	NA	NA	NA	NA
TRINITY_DN40952_c0_g1_i1	Q4N4N8	TXND_THEPA	42.3	78	44	1	233	3	32	109	6.30E-14	77.8	TXND_THEPA	reviewed	Thioredoxin domain-containing protein (Membrane protein 23) (mp23)	TP02_0602	Theileria parva (East coast fever infection agent)	220	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN17595_c0_g1_i1	H9D1R1	TXD12_EPICO	53.8	143	62	1	506	90	31	173	2.50E-40	166.8	TXD12_EPICO	reviewed	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	Txndc12	Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)	173	endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032]	endoplasmic reticulum lumen [GO:0005788]	electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]	GO:0005788; GO:0009055; GO:0016032; GO:0019153; GO:0051607; GO:0055114	defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032]		blue	blue	NA	NA	NA	NA
TRINITY_DN39002_c0_g1_i1	O95881	TXD12_HUMAN	100	100	0	0	2	301	28	127	1.40E-55	216.5	TXD12_HUMAN	reviewed	Thioredoxin domain-containing protein 12 (EC 1.8.4.2) (Endoplasmic reticulum resident protein 18) (ER protein 18) (ERp18) (Endoplasmic reticulum resident protein 19) (ER protein 19) (ERp19) (Thioredoxin-like protein p19) (hTLP19)	TXNDC12 TLP19 UNQ713/PRO1376	Homo sapiens (Human)	172	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein-disulfide reductase (glutathione) activity [GO:0019153]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	peptide disulfide oxidoreductase activity [GO:0015037]; protein-disulfide reductase (glutathione) activity [GO:0019153]	GO:0005783; GO:0005788; GO:0015037; GO:0019153; GO:0060548; GO:1902236	negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]		NA	NA	NA	NA	NA	NA
TRINITY_DN10256_c0_g1_i1	Q91W90	TXND5_MOUSE	100	108	0	0	3	326	300	407	1.20E-60	233.4	TXND5_MOUSE	reviewed	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	Mus musculus (Mouse)	417	endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]	endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0043277	apoptotic cell clearance [GO:0043277]		NA	NA	NA	NA	NA	NA
TRINITY_DN16464_c0_g1_i1	Q91W90	TXND5_MOUSE	100	123	0	0	369	1	159	281	2.50E-70	265.8	TXND5_MOUSE	reviewed	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	Mus musculus (Mouse)	417	endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]	endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0043277	apoptotic cell clearance [GO:0043277]		NA	NA	NA	NA	NA	NA
TRINITY_DN39880_c0_g1_i1	Q91W90	TXND5_MOUSE	99	103	1	0	310	2	45	147	2.80E-59	228.8	TXND5_MOUSE	reviewed	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	Txndc5 Tlp46	Mus musculus (Mouse)	417	endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]	endoplasmic reticulum lumen [GO:0005788]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005788; GO:0043277	apoptotic cell clearance [GO:0043277]		NA	NA	NA	NA	NA	NA
TRINITY_DN16464_c0_g1_i2	Q8NBS9	TXND5_HUMAN	96.3	135	5	0	406	2	174	308	3.10E-74	278.9	TXND5_HUMAN	reviewed	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)	TXNDC5 TLP46 UNQ364/PRO700	Homo sapiens (Human)	432	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0043312; GO:0070062	apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN6194_c0_g1_i2	Q8NBS9	TXND5_HUMAN	47.7	363	171	7	160	1203	66	424	4.80E-97	356.3	TXND5_HUMAN	reviewed	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)	TXNDC5 TLP46 UNQ364/PRO700	Homo sapiens (Human)	432	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0043312; GO:0070062	apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN6194_c0_g1_i3	Q8NBS9	TXND5_HUMAN	47.2	286	135	5	160	975	66	349	2.30E-73	277.3	TXND5_HUMAN	reviewed	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)	TXNDC5 TLP46 UNQ364/PRO700	Homo sapiens (Human)	432	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0043312; GO:0070062	apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]; neutrophil degranulation [GO:0043312]		NA	NA	NA	NA	NA	NA
TRINITY_DN6194_c0_g1_i1	Q9VYV3	TXND5_DROME	46.2	106	55	2	20	334	312	416	4.90E-24	112.1	TXND5_DROME	reviewed	Thioredoxin domain-containing protein 5 homolog (Protein pretaporter)	prtp CG1837	Drosophila melanogaster (Fruit fly)	416	cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; protein disulfide isomerase activity [GO:0003756]; apoptotic cell clearance [GO:0043277]; positive regulation of apoptotic cell clearance [GO:2000427]	cell surface [GO:0009986]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0009986; GO:0012505; GO:0043277; GO:2000427	apoptotic cell clearance [GO:0043277]; positive regulation of apoptotic cell clearance [GO:2000427]		NA	NA	NA	NA	NA	NA
TRINITY_DN23232_c0_g1_i1	Q9CQ79	TXND9_MOUSE	99.1	106	1	0	318	1	96	201	2.30E-56	219.2	TXND9_MOUSE	reviewed	Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation)	Txndc9 Apacd	Mus musculus (Mouse)	226	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0030496			NA	NA	NA	NA	NA	NA
TRINITY_DN3388_c0_g1_i1	Q9CQ79	TXND9_MOUSE	54.2	214	95	1	726	94	13	226	9.10E-65	248.4	TXND9_MOUSE	reviewed	Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation)	Txndc9 Apacd	Mus musculus (Mouse)	226	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0030496			blue	blue	NA	NA	NA	NA
TRINITY_DN23232_c0_g2_i1	O14530	TXND9_HUMAN	100	66	0	0	200	3	104	169	1.60E-31	136	TXND9_HUMAN	reviewed	Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4)	TXNDC9 APACD	Homo sapiens (Human)	226	centrosome [GO:0005813]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; cadherin binding [GO:0045296]	centrosome [GO:0005813]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]	cadherin binding [GO:0045296]	GO:0005634; GO:0005813; GO:0005829; GO:0030496; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN34589_c0_g1_i1	O64628	TXND9_ARATH	44.9	78	42	1	6	239	84	160	1.10E-13	77	TXND9_ARATH	reviewed	Thioredoxin domain-containing protein 9 homolog	At2g18990 F19F24.19	Arabidopsis thaliana (Mouse-ear cress)	211							NA	NA	NA	NA	NA	NA
TRINITY_DN37392_c0_g1_i1	Q8T6C4	TDX_ECHGR	44.3	70	33	2	5	211	112	176	2.30E-09	62.4	TDX_ECHGR	reviewed	Thioredoxin peroxidase (EC 1.11.1.24) (Peroxiredoxin) (TPx-Eg) (Thioredoxin-dependent peroxide reductase) (Thioredoxin-dependent peroxiredoxin)	TPX	Echinococcus granulosus (Hydatid tapeworm)	193	peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]		peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]	GO:0004601; GO:0051920			NA	NA	NA	NA	NA	NA
TRINITY_DN32022_c0_g1_i1	A6QP01	SELT_BOVIN	100	83	0	0	1	249	86	168	5.00E-43	174.5	SELT_BOVIN	reviewed	Thioredoxin reductase-like selenoprotein T (SelT) (EC 1.8.1.9)	SELENOT	Bos taurus (Bovine)	195	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; pancreas development [GO:0031016]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of growth hormone secretion [GO:0060124]; response to glucose [GO:0009749]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	thioredoxin-disulfide reductase activity [GO:0004791]	GO:0004791; GO:0005783; GO:0005789; GO:0007204; GO:0009749; GO:0016021; GO:0031016; GO:0035773; GO:0042593; GO:0045454; GO:0060124; GO:0098869	cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; pancreas development [GO:0031016]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of growth hormone secretion [GO:0060124]; response to glucose [GO:0009749]		NA	NA	NA	NA	NA	NA
TRINITY_DN32750_c0_g1_i1	Q9VMV6	SELT_DROME	52.5	162	77	0	117	602	25	186	3.00E-49	196.4	SELT_DROME	reviewed	Thioredoxin reductase-like selenoprotein T homolog CG3887 (EC 1.8.1.9)	SelT CG3887	Drosophila melanogaster (Fruit fly)	198	endomembrane system [GO:0012505]; thioredoxin-disulfide reductase activity [GO:0004791]	endomembrane system [GO:0012505]	thioredoxin-disulfide reductase activity [GO:0004791]	GO:0004791; GO:0012505			blue	blue	NA	NA	NA	NA
TRINITY_DN11212_c4_g1_i1	P97493	THIOM_MOUSE	41.9	117	68	0	444	94	49	165	2.20E-22	107.5	THIOM_MOUSE	reviewed	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	Txn2	Mus musculus (Mouse)	166	dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein disulfide oxidoreductase activity [GO:0015035]; protein-containing complex binding [GO:0044877]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]	dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0001666; GO:0005730; GO:0005739; GO:0006662; GO:0006979; GO:0008113; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0033743; GO:0042493; GO:0043025; GO:0044877; GO:0045454; GO:0048678	cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]		blue	blue	NA	NA	NA	NA
TRINITY_DN7670_c3_g1_i1	Q99757	THIOM_HUMAN	57	128	55	0	96	479	39	166	4.20E-37	156	THIOM_HUMAN	reviewed	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2 TRX2	Homo sapiens (Human)	166	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein disulfide oxidoreductase activity [GO:0015035]; protein-containing complex binding [GO:0044877]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; sulfur amino acid catabolic process [GO:0000098]	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0000098; GO:0001666; GO:0005730; GO:0005739; GO:0005759; GO:0006662; GO:0006979; GO:0008113; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0033743; GO:0042493; GO:0043025; GO:0044877; GO:0045454; GO:0048678	cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; sulfur amino acid catabolic process [GO:0000098]		blue	blue	NA	NA	NA	NA
TRINITY_DN19024_c0_g1_i1	Q99757	THIOM_HUMAN	99.2	123	1	0	425	57	44	166	4.20E-66	251.9	THIOM_HUMAN	reviewed	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2 TRX2	Homo sapiens (Human)	166	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein disulfide oxidoreductase activity [GO:0015035]; protein-containing complex binding [GO:0044877]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; sulfur amino acid catabolic process [GO:0000098]	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0000098; GO:0001666; GO:0005730; GO:0005739; GO:0005759; GO:0006662; GO:0006979; GO:0008113; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0033743; GO:0042493; GO:0043025; GO:0044877; GO:0045454; GO:0048678	cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; sulfur amino acid catabolic process [GO:0000098]		NA	NA	NA	NA	NA	NA
TRINITY_DN19024_c0_g1_i2	Q99757	THIOM_HUMAN	100	123	0	0	425	57	44	166	1.40E-66	253.4	THIOM_HUMAN	reviewed	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	TXN2 TRX2	Homo sapiens (Human)	166	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein disulfide oxidoreductase activity [GO:0015035]; protein-containing complex binding [GO:0044877]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; sulfur amino acid catabolic process [GO:0000098]	dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]	peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0000098; GO:0001666; GO:0005730; GO:0005739; GO:0005759; GO:0006662; GO:0006979; GO:0008113; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0033743; GO:0042493; GO:0043025; GO:0044877; GO:0045454; GO:0048678	cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; sulfur amino acid catabolic process [GO:0000098]		NA	NA	NA	NA	NA	NA
TRINITY_DN29910_c0_g1_i1	Q6XHI1	THIO2_DROYA	53	66	30	1	202	8	1	66	8.80E-13	73.9	THIO2_DROYA	reviewed	Thioredoxin-2 (Trx-2)	Trx-2	Drosophila yakuba (Fruit fly)	106	protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		protein disulfide oxidoreductase activity [GO:0015035]	GO:0006662; GO:0015035; GO:0045454	cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]		NA	NA	NA	NA	NA	NA
TRINITY_DN21228_c0_g1_i1	P30048	PRDX3_HUMAN	100	212	0	0	705	70	45	256	2.00E-121	436.4	PRDX3_HUMAN	reviewed	"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3)"	PRDX3 AOP1	Homo sapiens (Human)	256	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]	GO:0001893; GO:0005737; GO:0005739; GO:0005759; GO:0005769; GO:0005829; GO:0006979; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0008785; GO:0018171; GO:0019900; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0045454; GO:0051092; GO:0051881	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN21228_c0_g1_i2	P30048	PRDX3_HUMAN	98.4	124	2	0	375	4	45	168	9.80E-67	253.8	PRDX3_HUMAN	reviewed	"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3)"	PRDX3 AOP1	Homo sapiens (Human)	256	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]	GO:0001893; GO:0005737; GO:0005739; GO:0005759; GO:0005769; GO:0005829; GO:0006979; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0008785; GO:0018171; GO:0019900; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0045454; GO:0051092; GO:0051881	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN2304_c0_g1_i1	P35705	PRDX3_BOVIN	72.3	206	57	0	707	90	51	256	9.30E-86	318.2	PRDX3_BOVIN	reviewed	"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (Peroxiredoxin-3) (Protein SP-22) (Thioredoxin-dependent peroxiredoxin 3)"	PRDX3 AOP1	Bos taurus (Bovine)	257	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]	GO:0001893; GO:0005737; GO:0005739; GO:0005759; GO:0005769; GO:0005829; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0018171; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0045454; GO:0051092; GO:0051881	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN38496_c0_g1_i1	P20108	PRDX3_MOUSE	100	77	0	0	232	2	177	253	7.00E-39	160.6	PRDX3_MOUSE	reviewed	"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (PRX III) (Perioredoxin-3) (Protein MER5) (Thioredoxin-dependent peroxiredoxin 3)"	Prdx3 Aop1 Mer5	Mus musculus (Mouse)	257	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; protein-containing complex [GO:0032991]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]	GO:0001893; GO:0005737; GO:0005739; GO:0005769; GO:0005829; GO:0006979; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0018171; GO:0019900; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0043209; GO:0043524; GO:0045454; GO:0051092; GO:0051881	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]		NA	NA	NA	NA	NA	NA
TRINITY_DN25962_c0_g1_i1	O43396	TXNL1_HUMAN	100	71	0	0	214	2	49	119	1.50E-35	149.4	TXNL1_HUMAN	reviewed	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	Homo sapiens (Human)	289	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	disulfide oxidoreductase activity [GO:0015036]	GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036			NA	NA	NA	NA	NA	NA
TRINITY_DN35586_c0_g1_i1	O43396	TXNL1_HUMAN	50.2	285	138	4	846	1	5	288	3.70E-78	293.5	TXNL1_HUMAN	reviewed	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	Homo sapiens (Human)	289	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	disulfide oxidoreductase activity [GO:0015036]	GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036			NA	NA	NA	NA	NA	NA
TRINITY_DN35586_c0_g1_i2	O43396	TXNL1_HUMAN	50	284	138	4	418	1260	5	287	8.40E-78	292.4	TXNL1_HUMAN	reviewed	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	Homo sapiens (Human)	289	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	disulfide oxidoreductase activity [GO:0015036]	GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036			NA	NA	NA	NA	NA	NA
TRINITY_DN8579_c0_g1_i1	P83876	TXN4A_HUMAN	100	137	0	0	413	3	1	137	2.50E-78	292.7	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8579_c0_g2_i1	P83876	TXN4A_HUMAN	100	94	0	0	282	1	1	94	2.50E-51	202.6	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6546_c0_g1_i1	P83876	TXN4A_HUMAN	82.4	142	25	0	518	93	1	142	9.90E-69	261.2	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19076_c0_g1_i1	P83876	TXN4A_HUMAN	74.3	183	6	1	644	96	1	142	1.60E-73	277.3	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19076_c0_g1_i2	P83876	TXN4A_HUMAN	96.2	26	1	0	165	88	1	26	1.20E-07	57	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19076_c0_g1_i3	P83876	TXN4A_HUMAN	95.8	142	6	0	521	96	1	142	1.70E-79	297	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		blue	blue	NA	NA	NA	NA
TRINITY_DN19076_c1_g1_i1	P83876	TXN4A_HUMAN	94.9	99	5	0	1	297	44	142	9.40E-51	200.7	TXN4A_HUMAN	reviewed	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	TXNL4A DIM1 TXNL4	Homo sapiens (Human)	142	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]		GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3144_c0_g1_i1	Q0Z7W6	TMX1_BOVIN	53	181	85	0	232	774	34	214	2.40E-56	220.7	TMX1_BOVIN	reviewed	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1)	TMX1 TXNDC1	Bos taurus (Bovine)	278	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	disulfide oxidoreductase activity [GO:0015036]	GO:0005789; GO:0015036; GO:0016021; GO:0034976	response to endoplasmic reticulum stress [GO:0034976]		blue	blue	NA	NA	NA	NA
TRINITY_DN19176_c0_g1_i1	Q8VBT0	TMX1_MOUSE	100	102	0	0	308	3	22	123	4.70E-59	228	TMX1_MOUSE	reviewed	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1)	Tmx1 Txndc Txndc1	Mus musculus (Mouse)	278	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	disulfide oxidoreductase activity [GO:0015036]	GO:0005789; GO:0015036; GO:0016021; GO:0034976	response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN19176_c0_g2_i1	Q9H3N1	TMX1_HUMAN	98	101	2	0	303	1	33	133	1.40E-58	226.5	TMX1_HUMAN	reviewed	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	Homo sapiens (Human)	280	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	disulfide oxidoreductase activity [GO:0015036]	GO:0005789; GO:0015036; GO:0016021; GO:0034976	response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN39841_c0_g1_i1	Q9H3N1	TMX1_HUMAN	100	68	0	0	214	11	145	212	3.10E-33	141.7	TMX1_HUMAN	reviewed	Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)	TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268	Homo sapiens (Human)	280	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	disulfide oxidoreductase activity [GO:0015036]	GO:0005789; GO:0015036; GO:0016021; GO:0034976	response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN9506_c0_g1_i1	Q9D0B5	TSTD3_MOUSE	41.4	58	32	1	201	34	42	99	3.60E-05	48.9	TSTD3_MOUSE	reviewed	Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3)	Tstd3	Mus musculus (Mouse)	157	thiosulfate sulfurtransferase activity [GO:0004792]		thiosulfate sulfurtransferase activity [GO:0004792]	GO:0004792			NA	NA	NA	NA	NA	NA
TRINITY_DN2681_c0_g1_i1	Q8R3N6	THOC1_MOUSE	43.2	576	262	14	1772	114	1	534	1.00E-113	412.1	THOC1_MOUSE	reviewed	THO complex subunit 1 (Tho1) (Nuclear matrix protein p84)	Thoc1 Hpr1	Mus musculus (Mouse)	657	"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"	"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0000784; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002	"apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2681_c0_g1_i2	Q8R3N6	THOC1_MOUSE	43.2	576	262	14	1772	114	1	534	4.60E-114	413.3	THOC1_MOUSE	reviewed	THO complex subunit 1 (Tho1) (Nuclear matrix protein p84)	Thoc1 Hpr1	Mus musculus (Mouse)	657	"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"	"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0000784; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002	"apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23902_c0_g1_i1	Q86V81	THOC4_HUMAN	100	102	0	0	1	306	91	192	4.30E-52	204.9	THOC4_HUMAN	reviewed	THO complex subunit 4 (Tho4) (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF)	ALYREF ALY BEF THOC4	Homo sapiens (Human)	257	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; C5-methylcytidine-containing RNA binding [GO:0062153]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]; viral process [GO:0016032]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]	C5-methylcytidine-containing RNA binding [GO:0062153]; RNA binding [GO:0003723]	GO:0000018; GO:0000346; GO:0000398; GO:0001649; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016020; GO:0016032; GO:0016607; GO:0031124; GO:0031297; GO:0032786; GO:0046784; GO:0062153; GO:0070062; GO:0071013	"mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29028_c0_g1_i1	Q58EA2	THO4A_XENLA	100	68	0	0	207	4	109	176	8.70E-33	140.2	THO4A_XENLA	reviewed	THO complex subunit 4-A (Tho4-A) (Aly/REF export factor-A)	alyref-a thoc4-a	Xenopus laevis (African clawed frog)	256	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	C5-methylcytidine-containing RNA binding [GO:0062153]	GO:0005634; GO:0005737; GO:0006397; GO:0006405; GO:0008380; GO:0016607; GO:0051028; GO:0062153	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN3515_c0_g1_i1	Q6GLW1	THO4B_XENLA	53.4	131	48	4	532	146	60	179	1.20E-26	121.3	THO4B_XENLA	reviewed	THO complex subunit 4-B (Tho4-B) (Aly/REF export factor-B)	alyref-b thoc4-b	Xenopus laevis (African clawed frog)	256	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	C5-methylcytidine-containing RNA binding [GO:0062153]	GO:0005634; GO:0005737; GO:0006397; GO:0006405; GO:0008380; GO:0016607; GO:0051028; GO:0062153	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN951_c0_g1_i1	Q28DG8	THOC5_XENTR	38.5	491	267	6	1544	81	34	492	2.80E-71	271.2	THOC5_XENTR	reviewed	THO complex subunit 5 homolog	thoc5 TEgg015p03.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	678	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]	mRNA binding [GO:0003729]	GO:0000445; GO:0003729; GO:0005737; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0030154; GO:0032786	"cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN951_c0_g1_i3	Q6NY52	THOC5_DANRE	37.5	685	387	8	2135	90	38	684	5.10E-100	367.1	THOC5_DANRE	reviewed	THO complex subunit 5 homolog	thoc5 zgc:76912	Danio rerio (Zebrafish) (Brachydanio rerio)	684	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]	mRNA binding [GO:0003729]	GO:0000445; GO:0003729; GO:0005737; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0030154; GO:0032786	"cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32871_c0_g1_i1	Q6DGZ3	THOC7_DANRE	41.5	183	107	0	53	601	3	185	2.70E-34	147.1	THOC7_DANRE	reviewed	THO complex subunit 7 homolog	thoc7 zgc:92711	Danio rerio (Zebrafish) (Brachydanio rerio)	202	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]	RNA binding [GO:0003723]	GO:0000445; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006406; GO:0008380; GO:0016607	mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN3015_c0_g1_i7	Q5XH07	THNS2_XENLA	58.1	301	122	3	964	68	15	313	3.90E-91	336.3	THNS2_XENLA	reviewed	Threonine synthase-like 2 (TSH2) (EC 4.2.3.-)	thnsl2	Xenopus laevis (African clawed frog)	472	lyase activity [GO:0016829]		lyase activity [GO:0016829]	GO:0016829			NA	NA	NA	NA	NA	NA
TRINITY_DN3015_c0_g1_i8	Q5XH07	THNS2_XENLA	50.1	455	215	6	1573	227	23	471	3.30E-119	430.3	THNS2_XENLA	reviewed	Threonine synthase-like 2 (TSH2) (EC 4.2.3.-)	thnsl2	Xenopus laevis (African clawed frog)	472	lyase activity [GO:0016829]		lyase activity [GO:0016829]	GO:0016829			NA	NA	NA	NA	NA	NA
TRINITY_DN37485_c0_g1_i1	B2UGJ8	SYT_RALPJ	100	113	0	0	1	339	422	534	3.90E-62	238.4	SYT_RALPJ	reviewed	Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)	thrS Rpic_1977	Ralstonia pickettii (strain 12J)	635	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]	GO:0000049; GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0046872	threonyl-tRNA aminoacylation [GO:0006435]		NA	NA	NA	NA	NA	NA
TRINITY_DN31607_c0_g1_i1	Q2GBX1	SYT_NOVAD	97.5	79	2	0	238	2	471	549	4.00E-42	171.4	SYT_NOVAD	reviewed	Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)	thrS Saro_0204	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	664	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]	GO:0000049; GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0046872	threonyl-tRNA aminoacylation [GO:0006435]		NA	NA	NA	NA	NA	NA
TRINITY_DN36069_c0_g1_i1	B2UGJ8	SYT_RALPJ	99.3	140	1	0	420	1	269	408	7.10E-82	304.3	SYT_RALPJ	reviewed	Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)	thrS Rpic_1977	Ralstonia pickettii (strain 12J)	635	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]	GO:0000049; GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0046872	threonyl-tRNA aminoacylation [GO:0006435]		NA	NA	NA	NA	NA	NA
TRINITY_DN40873_c0_g1_i1	A7HWJ3	SYT_PARL1	85.3	68	10	0	8	211	333	400	7.50E-32	137.1	SYT_PARL1	reviewed	Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)	thrS Plav_2668	Parvibaculum lavamentivorans (strain DS-1 / DSM 13023 / NCIMB 13966)	652	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]	GO:0000049; GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0046872	threonyl-tRNA aminoacylation [GO:0006435]		NA	NA	NA	NA	NA	NA
TRINITY_DN37492_c0_g1_i1	Q9D0R2	SYTC_MOUSE	100	82	0	0	248	3	108	189	4.50E-44	177.9	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN10251_c0_g1_i1	Q9D0R2	SYTC_MOUSE	70	397	118	1	100	1287	326	722	3.80E-174	612.5	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN10251_c0_g1_i3	Q9D0R2	SYTC_MOUSE	68.7	681	209	2	27	2057	42	722	6.90E-295	1014.2	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16480_c0_g1_i2	Q9D0R2	SYTC_MOUSE	99	289	3	0	2	868	313	601	3.60E-173	608.6	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN311_c0_g1_i1	Q9D0R2	SYTC_MOUSE	63	292	104	3	888	13	296	583	4.90E-109	395.6	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN25014_c0_g1_i1	Q9D0R2	SYTC_MOUSE	100	83	0	0	2	250	640	722	5.30E-40	164.5	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN25014_c0_g1_i2	Q9D0R2	SYTC_MOUSE	99	98	1	0	3	296	625	722	3.30E-49	195.3	SYTC_MOUSE	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	Tars1 Tars	Mus musculus (Mouse)	722	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN16480_c0_g1_i1	P26639	SYTC_HUMAN	100	537	0	0	1	1611	66	602	0	1123.6	SYTC_HUMAN	reviewed	"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)"	TARS1 TARS	Homo sapiens (Human)	723	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004812; GO:0004829; GO:0005524; GO:0005829; GO:0006418; GO:0006435; GO:0008270; GO:0015629; GO:0042802; GO:0070062	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN10251_c0_g1_i2	P52709	SYTC_CAEEL	67	230	76	0	36	725	48	277	2.50E-93	343.2	SYTC_CAEEL	reviewed	"Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)"	tars-1 trs-1 C47D12.6	Caenorhabditis elegans	725	cytoplasm [GO:0005737]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; determination of adult lifespan [GO:0008340]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]	GO:0004812; GO:0004829; GO:0005524; GO:0005737; GO:0006418; GO:0006435; GO:0008340	determination of adult lifespan [GO:0008340]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN311_c0_g2_i1	P87144	SYTC_SCHPO	63	92	34	0	37	312	178	269	4.00E-29	128.6	SYTC_SCHPO	reviewed	"Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)"	ths1 SPBC25H2.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	703	cytosol [GO:0005829]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; cytoplasmic translation [GO:0002181]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]	aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]	GO:0002181; GO:0004812; GO:0004829; GO:0005524; GO:0005829; GO:0006418; GO:0006435	cytoplasmic translation [GO:0002181]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN28822_c0_g1_i1	Q9BW92	SYTM_HUMAN	100	85	0	0	3	257	399	483	5.00E-46	184.5	SYTM_HUMAN	reviewed	"Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1)"	TARS2 TARSL1	Homo sapiens (Human)	718	mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]	aminoacyl-tRNA editing activity [GO:0002161]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]	GO:0002161; GO:0004812; GO:0004829; GO:0005524; GO:0005759; GO:0006418; GO:0006435; GO:0042803; GO:0070159	mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN41035_c0_g1_i1	Q3UQ84	SYTM_MOUSE	100	84	0	0	2	253	411	494	7.60E-47	187.2	SYTM_MOUSE	reviewed	"Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1)"	Tars2 Tarsl1	Mus musculus (Mouse)	723	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]	GO:0002161; GO:0004812; GO:0004829; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006435; GO:0042803	threonyl-tRNA aminoacylation [GO:0006435]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN32392_c0_g1_i1	Q5VV42	CDKAL_HUMAN	98.7	76	1	0	1	228	335	410	1.20E-38	159.8	CDKAL_HUMAN	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)	CDKAL1	Homo sapiens (Human)	579	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]; tRNA modification [GO:0006400]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0005783; GO:0005789; GO:0005791; GO:0006400; GO:0016020; GO:0016021; GO:0035596; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712; GO:1990145	maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN35767_c0_g1_i1	Q5VV42	CDKAL_HUMAN	100	272	0	0	869	54	32	303	1.30E-159	563.5	CDKAL_HUMAN	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)	CDKAL1	Homo sapiens (Human)	579	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]; tRNA modification [GO:0006400]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0005783; GO:0005789; GO:0005791; GO:0006400; GO:0016020; GO:0016021; GO:0035596; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712; GO:1990145	maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN1798_c0_g1_i1	Q6PG34	CDKAL_DANRE	51.8	141	55	2	527	120	409	541	2.50E-32	140.2	CDKAL_DANRE	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)	cdkal1 zgc:65864	Danio rerio (Zebrafish) (Brachydanio rerio)	547	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; endocrine pancreas development [GO:0031018]; pancreas regeneration [GO:1990798]; tRNA methylthiolation [GO:0035600]; type B pancreatic cell development [GO:0003323]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0003323; GO:0005783; GO:0005789; GO:0016021; GO:0031018; GO:0035596; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712; GO:1990798	endocrine pancreas development [GO:0031018]; pancreas regeneration [GO:1990798]; tRNA methylthiolation [GO:0035600]; type B pancreatic cell development [GO:0003323]		blue	blue	NA	NA	NA	NA
TRINITY_DN1798_c0_g1_i2	Q6P4Y0	CDKAL_XENTR	57.6	205	87	0	710	96	349	553	1.90E-61	237.3	CDKAL_XENTR	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)	cdkal1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	553	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; tRNA methylthiolation [GO:0035600]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0005783; GO:0005789; GO:0016021; GO:0035596; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712	tRNA methylthiolation [GO:0035600]		NA	NA	NA	NA	NA	NA
TRINITY_DN1798_c0_g1_i3	Q6P4Y0	CDKAL_XENTR	67.5	501	163	0	1598	96	53	553	9.90E-205	714.5	CDKAL_XENTR	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)	cdkal1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	553	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; tRNA methylthiolation [GO:0035600]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methylthiotransferase activity [GO:0035596]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0005783; GO:0005789; GO:0016021; GO:0035596; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712	tRNA methylthiolation [GO:0035600]		NA	NA	NA	NA	NA	NA
TRINITY_DN36888_c0_g1_i1	Q291H5	CDKAL_DROPS	68.9	61	18	1	192	10	66	125	7.50E-18	90.9	CDKAL_DROPS	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDKAL1-like protein) (tRNA-t(6)A37 methylthiotransferase)	GA19679	Drosophila pseudoobscura pseudoobscura (Fruit fly)	553	"integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	integral component of membrane [GO:0016021]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0016021; GO:0035598; GO:0046872; GO:0051539; GO:0061712			NA	NA	NA	NA	NA	NA
TRINITY_DN30288_c0_g1_i1	Q291H5	CDKAL_DROPS	53.6	265	123	0	818	24	170	434	1.40E-81	304.3	CDKAL_DROPS	reviewed	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDKAL1-like protein) (tRNA-t(6)A37 methylthiotransferase)	GA19679	Drosophila pseudoobscura pseudoobscura (Fruit fly)	553	"integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	integral component of membrane [GO:0016021]	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0016021; GO:0035598; GO:0046872; GO:0051539; GO:0061712			NA	NA	NA	NA	NA	NA
TRINITY_DN383_c0_g1_i3	Q06684	THBI_RHOPR	38.7	106	57	3	411	97	3	101	1.80E-11	70.9	THBI_RHOPR	reviewed	Thrombin inhibitor rhodniin		Rhodnius prolixus (Triatomid bug)	103	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0007596	blood coagulation [GO:0007596]		blue	blue	NA	NA	NA	NA
TRINITY_DN40182_c0_g1_i1	A7MBS7	THS7A_DANRE	54	50	23	0	16	165	181	230	6.80E-09	60.8	THS7A_DANRE	reviewed	Thrombospondin type-1 domain-containing protein 7A	thsd7aa thsd7a si:dkey-12h3.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1686	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; glomerulus development [GO:0032835]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0016021; GO:0031532; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; glomerulus development [GO:0032835]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040]		NA	NA	NA	NA	NA	NA
TRINITY_DN30639_c0_g1_i1	A7MBS7	THS7A_DANRE	50.9	55	26	1	166	2	183	236	7.10E-09	60.8	THS7A_DANRE	reviewed	Thrombospondin type-1 domain-containing protein 7A	thsd7aa thsd7a si:dkey-12h3.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1686	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; glomerulus development [GO:0032835]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0016021; GO:0031532; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; glomerulus development [GO:0032835]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040]		NA	NA	NA	NA	NA	NA
TRINITY_DN32098_c0_g1_i1	P07996	TSP1_HUMAN	100	75	0	0	1	225	1017	1091	8.00E-40	163.7	TSP1_HUMAN	reviewed	Thrombospondin-1 (Glycoprotein G)	THBS1 TSP TSP1	Homo sapiens (Human)	1170	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]; activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of megakaryocyte differentiation [GO:0045652]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]	calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]	GO:0000187; GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002544; GO:0002576; GO:0002581; GO:0002605; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006954; GO:0006955; GO:0006986; GO:0007050; GO:0007155; GO:0008201; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030198; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032695; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0040037; GO:0042327; GO:0042493; GO:0042535; GO:0042802; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043394; GO:0043536; GO:0043537; GO:0043652; GO:0045652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237	activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of megakaryocyte differentiation [GO:0045652]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]		NA	NA	NA	NA	NA	NA
TRINITY_DN363_c0_g1_i1	Q8JHW2	TSP3A_DANRE	56.6	675	273	8	1144	3132	281	947	8.00E-189	662.5	TSP3A_DANRE	reviewed	Thrombospondin-3a (Thbs3a)	thbs3a thbs3 tsp3 zgc:103461	Danio rerio (Zebrafish) (Brachydanio rerio)	962	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; mesenchymal to epithelial transition [GO:0060231]; somite development [GO:0061053]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0005509; GO:0005576; GO:0007155; GO:0008201; GO:0060231; GO:0061053; GO:0062023	cell adhesion [GO:0007155]; mesenchymal to epithelial transition [GO:0060231]; somite development [GO:0061053]		blue	blue	NA	NA	NA	NA
TRINITY_DN363_c0_g1_i2	Q8JHW2	TSP3A_DANRE	56.6	675	273	8	1251	3239	281	947	8.30E-189	662.5	TSP3A_DANRE	reviewed	Thrombospondin-3a (Thbs3a)	thbs3a thbs3 tsp3 zgc:103461	Danio rerio (Zebrafish) (Brachydanio rerio)	962	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; mesenchymal to epithelial transition [GO:0060231]; somite development [GO:0061053]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0005509; GO:0005576; GO:0007155; GO:0008201; GO:0060231; GO:0061053; GO:0062023	cell adhesion [GO:0007155]; mesenchymal to epithelial transition [GO:0060231]; somite development [GO:0061053]		NA	NA	NA	NA	NA	NA
TRINITY_DN363_c0_g1_i4	Q8JHW2	TSP3A_DANRE	56.6	675	273	8	2431	4419	281	947	1.10E-188	662.5	TSP3A_DANRE	reviewed	Thrombospondin-3a (Thbs3a)	thbs3a thbs3 tsp3 zgc:103461	Danio rerio (Zebrafish) (Brachydanio rerio)	962	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; mesenchymal to epithelial transition [GO:0060231]; somite development [GO:0061053]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0005509; GO:0005576; GO:0007155; GO:0008201; GO:0060231; GO:0061053; GO:0062023	cell adhesion [GO:0007155]; mesenchymal to epithelial transition [GO:0060231]; somite development [GO:0061053]		blue	blue	NA	NA	NA	NA
TRINITY_DN1305_c0_g1_i1	O00142	KITM_HUMAN	49.2	195	96	2	195	776	53	245	1.20E-49	198.4	KITM_HUMAN	reviewed	"Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (Mt-TK)"	TK2	Homo sapiens (Human)	265	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; nucleoside kinase activity [GO:0019206]; thymidine kinase activity [GO:0004797]; deoxycytidine metabolic process [GO:0046092]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]	ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; nucleoside kinase activity [GO:0019206]; thymidine kinase activity [GO:0004797]	GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005759; GO:0006139; GO:0019136; GO:0019206; GO:0043097; GO:0046092; GO:0046104; GO:0071897	deoxycytidine metabolic process [GO:0046092]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]		NA	NA	NA	NA	NA	NA
TRINITY_DN1305_c0_g2_i1	Q9R088	KITM_MOUSE	49.5	212	106	1	237	869	50	261	9.90E-58	225.3	KITM_MOUSE	reviewed	"Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (Mt-TK)"	Tk2	Mus musculus (Mouse)	270	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; thymidine kinase activity [GO:0004797]; deoxycytidine metabolic process [GO:0046092]; deoxyribonucleotide metabolic process [GO:0009262]; DNA biosynthetic process [GO:0071897]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA replication [GO:0006264]; thymidine metabolic process [GO:0046104]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; thymidine kinase activity [GO:0004797]	GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0006264; GO:0009262; GO:0019136; GO:0032042; GO:0046092; GO:0046104; GO:0071897	deoxycytidine metabolic process [GO:0046092]; deoxyribonucleotide metabolic process [GO:0009262]; DNA biosynthetic process [GO:0071897]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA replication [GO:0006264]; thymidine metabolic process [GO:0046104]		NA	NA	NA	NA	NA	NA
TRINITY_DN19609_c0_g1_i1	P04183	KITH_HUMAN	71.7	106	27	1	309	1	81	186	5.00E-35	148.3	KITH_HUMAN	reviewed	"Thymidine kinase, cytosolic (EC 2.7.1.21)"	TK1	Homo sapiens (Human)	234	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]	cytosol [GO:0005829]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]	GO:0004797; GO:0005524; GO:0005829; GO:0006139; GO:0008270; GO:0042802; GO:0043097; GO:0046104; GO:0051289; GO:0071897	DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]		NA	NA	NA	NA	NA	NA
TRINITY_DN19609_c0_g1_i2	P04183	KITH_HUMAN	75.3	85	21	0	255	1	102	186	7.30E-29	127.9	KITH_HUMAN	reviewed	"Thymidine kinase, cytosolic (EC 2.7.1.21)"	TK1	Homo sapiens (Human)	234	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]	cytosol [GO:0005829]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]	GO:0004797; GO:0005524; GO:0005829; GO:0006139; GO:0008270; GO:0042802; GO:0043097; GO:0046104; GO:0051289; GO:0071897	DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]		blue	blue	NA	NA	NA	NA
TRINITY_DN38734_c0_g1_i1	P04183	KITH_HUMAN	100	103	0	0	312	4	78	180	5.70E-52	204.5	KITH_HUMAN	reviewed	"Thymidine kinase, cytosolic (EC 2.7.1.21)"	TK1	Homo sapiens (Human)	234	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]	cytosol [GO:0005829]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]	GO:0004797; GO:0005524; GO:0005829; GO:0006139; GO:0008270; GO:0042802; GO:0043097; GO:0046104; GO:0051289; GO:0071897	DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104]		NA	NA	NA	NA	NA	NA
TRINITY_DN38310_c0_g1_i1	P9WFS0	TYPH_MYCTO	75	76	19	0	9	236	161	236	2.50E-23	109	TYPH_MYCTO	reviewed	Thymidine phosphorylase (EC 2.4.2.4) (TdRPase)	deoA MT3415	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	427	"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]"		"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]"	GO:0004645; GO:0006206; GO:0006213; GO:0009032; GO:0016154	pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]		NA	NA	NA	NA	NA	NA
TRINITY_DN36121_c0_g1_i1	Q8UJ08	TYPH_AGRFC	63.8	47	17	0	66	206	183	229	1.70E-09	62.8	TYPH_AGRFC	reviewed	Thymidine phosphorylase (EC 2.4.2.4) (TdRPase)	deoA Atu0133 AGR_C_214	Agrobacterium fabrum (strain C58 / ATCC 33970) (Agrobacterium tumefaciens (strain C58))	438	"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; pyrimidine nucleobase metabolic process [GO:0006206]; thymidine metabolic process [GO:0046104]"		"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]"	GO:0004645; GO:0006206; GO:0009032; GO:0016154; GO:0046104	pyrimidine nucleobase metabolic process [GO:0006206]; thymidine metabolic process [GO:0046104]		NA	NA	NA	NA	NA	NA
TRINITY_DN37411_c0_g1_i1	P19971	TYPH_HUMAN	100	151	0	0	453	1	85	235	1.00E-78	293.9	TYPH_HUMAN	reviewed	Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)	TYMP ECGF1	Homo sapiens (Human)	482	"cytosol [GO:0005829]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside metabolic process [GO:0006213]; pyrimidine nucleoside salvage [GO:0043097]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]"	cytosol [GO:0005829]	"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]"	GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0043097; GO:0046135; GO:0051969; GO:1905333	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside metabolic process [GO:0006213]; pyrimidine nucleoside salvage [GO:0043097]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]		NA	NA	NA	NA	NA	NA
TRINITY_DN37383_c0_g1_i1	P07607	TYSY_MOUSE	100	95	0	0	286	2	162	256	1.60E-53	209.5	TYSY_MOUSE	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	Tyms	Mus musculus (Mouse)	307	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"drug binding [GO:0008144]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0003729; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0006417; GO:0007568; GO:0007623; GO:0008144; GO:0009636; GO:0017148; GO:0019048; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042493; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0097421; GO:1990825	aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c0_g2_i1	P04818	TYSY_HUMAN	75.3	279	68	1	842	6	28	305	5.10E-126	452.2	TYSY_HUMAN	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	TYMS TS OK/SW-cl.29	Homo sapiens (Human)	313	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000083; GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0007568; GO:0007623; GO:0008144; GO:0009636; GO:0015949; GO:0017148; GO:0019048; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042493; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0071897; GO:0097421; GO:1990825	aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]		blue	blue	NA	NA	NA	NA
TRINITY_DN2704_c0_g2_i2	P04818	TYSY_HUMAN	75.3	279	68	1	842	6	28	305	5.70E-126	452.2	TYSY_HUMAN	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	TYMS TS OK/SW-cl.29	Homo sapiens (Human)	313	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000083; GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0007568; GO:0007623; GO:0008144; GO:0009636; GO:0015949; GO:0017148; GO:0019048; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042493; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0071897; GO:0097421; GO:1990825	aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]		blue	blue	NA	NA	NA	NA
TRINITY_DN20610_c0_g1_i1	P04818	TYSY_HUMAN	97.4	229	6	0	690	4	28	256	1.30E-133	476.9	TYSY_HUMAN	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	TYMS TS OK/SW-cl.29	Homo sapiens (Human)	313	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000083; GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0007568; GO:0007623; GO:0008144; GO:0009636; GO:0015949; GO:0017148; GO:0019048; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042493; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0071897; GO:0097421; GO:1990825	aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]		NA	NA	NA	NA	NA	NA
TRINITY_DN20610_c0_g1_i2	P04818	TYSY_HUMAN	100	225	0	0	678	4	32	256	7.50E-134	477.6	TYSY_HUMAN	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	TYMS TS OK/SW-cl.29	Homo sapiens (Human)	313	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"drug binding [GO:0008144]; folic acid binding [GO:0005542]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000083; GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0007568; GO:0007623; GO:0008144; GO:0009636; GO:0015949; GO:0017148; GO:0019048; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042493; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0071897; GO:0097421; GO:1990825	aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; modulation by virus of host process [GO:0019048]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]		NA	NA	NA	NA	NA	NA
TRINITY_DN37329_c0_g1_i1	B9JXQ5	TYSY_AGRVS	89.6	67	7	0	201	1	163	229	7.40E-29	127.1	TYSY_AGRVS	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	thyA Avi_2822	Agrobacterium vitis (strain S4 / ATCC BAA-846) (Rhizobium vitis (strain S4))	264	cytoplasm [GO:0005737]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]	cytoplasm [GO:0005737]	thymidylate synthase activity [GO:0004799]	GO:0004799; GO:0005737; GO:0006231; GO:0006235; GO:0032259	dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN35370_c0_g1_i1	Q89G35	TYSY_BRADU	92.3	117	9	0	352	2	119	235	2.40E-59	229.2	TYSY_BRADU	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	thyA bll6512	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	264	cytosol [GO:0005829]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]	cytosol [GO:0005829]	thymidylate synthase activity [GO:0004799]	GO:0004799; GO:0005829; GO:0006231; GO:0006235; GO:0032259	dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN10993_c0_g1_i1	A4SVT7	TYSY_POLAQ	77	87	20	0	263	3	123	209	1.10E-35	150.2	TYSY_POLAQ	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	thyA Pnuc_0381	Polynucleobacter asymbioticus (strain DSM 18221 / CIP 109841 / QLW-P1DMWA-1) (Polynucleobacter necessarius subsp. asymbioticus)	264	cytoplasm [GO:0005737]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]	cytoplasm [GO:0005737]	thymidylate synthase activity [GO:0004799]	GO:0004799; GO:0005737; GO:0006231; GO:0006235; GO:0032259	dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN29389_c0_g1_i1	Q8Y0U6	TYSY_RALSO	94	67	4	0	204	4	3	69	3.30E-32	138.3	TYSY_RALSO	reviewed	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	thyA RSc0947 RS04447	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	264	cytoplasm [GO:0005737]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]	cytoplasm [GO:0005737]	thymidylate synthase activity [GO:0004799]	GO:0004799; GO:0005737; GO:0006231; GO:0006235; GO:0032259	dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN3718_c0_g1_i1	Q8SRG2	TYS3_ENCCU	62.8	188	70	0	2	565	71	258	1.80E-70	266.9	TYS3_ENCCU	reviewed	Thymidylate synthase 3 (TS 3) (TSase 3) (EC 2.1.1.45)	TS-3 ECU08_0090	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	294	thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]		thymidylate synthase activity [GO:0004799]	GO:0004799; GO:0006231; GO:0006235; GO:0032259	dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN11687_c1_g1_i1	O17389	TYB_CAEEL	41	83	49	0	1	249	39	121	2.90E-07	55.8	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c0_g1_i12	O17389	TYB_CAEEL	39.1	115	66	2	344	3	2	113	7.30E-10	65.1	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c0_g1_i13	O17389	TYB_CAEEL	32.5	120	77	1	386	27	24	139	7.10E-09	62.4	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c0_g1_i14	O17389	TYB_CAEEL	40.8	98	58	0	359	66	24	121	5.50E-11	69.3	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c0_g1_i15	O17389	TYB_CAEEL	38.4	99	61	0	362	66	23	121	1.90E-09	63.9	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c0_g1_i16	O17389	TYB_CAEEL	40	90	54	0	272	3	24	113	2.90E-09	62.8	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c0_g1_i9	O17389	TYB_CAEEL	40.4	99	59	0	348	52	23	121	2.50E-09	63.2	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN18923_c2_g1_i1	O17389	TYB_CAEEL	37	127	74	2	1064	690	2	124	6.10E-11	70.1	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		blue	blue	NA	NA	NA	NA
TRINITY_DN33632_c0_g1_i1	O17389	TYB_CAEEL	39	77	47	0	2	232	45	121	2.80E-05	49.3	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN23426_c0_g1_i1	O17389	TYB_CAEEL	38.5	91	56	0	6	278	23	113	9.90E-10	64.3	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN35515_c1_g1_i1	O17389	TYB_CAEEL	41	78	46	0	1	234	44	121	6.00E-06	51.2	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN26475_c9_g1_i1	O17389	TYB_CAEEL	39.3	145	80	3	569	138	2	139	1.00E-13	78.6	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		blue	blue	NA	NA	NA	NA
TRINITY_DN19206_c1_g1_i1	O17389	TYB_CAEEL	40.4	99	59	0	41	337	23	121	1.60E-10	67	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN21701_c0_g1_i1	O17389	TYB_CAEEL	45.2	124	62	2	8	373	2	121	3.70E-16	85.9	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN21701_c0_g1_i2	O17389	TYB_CAEEL	38.6	145	81	3	63	494	2	139	8.00E-12	72	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN21701_c0_g1_i3	O17389	TYB_CAEEL	39.3	145	80	3	63	494	2	139	1.10E-13	78.2	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN19952_c0_g2_i1	O17389	TYB_CAEEL	44.4	99	55	0	112	408	23	121	7.70E-13	75.1	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN19952_c0_g2_i2	O17389	TYB_CAEEL	44.4	99	55	0	112	408	23	121	7.70E-13	75.1	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN19952_c0_g2_i3	O17389	TYB_CAEEL	42.4	99	57	0	112	408	23	121	6.50E-12	72	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN20485_c1_g1_i1	O17389	TYB_CAEEL	42.2	90	52	0	31	300	24	113	8.50E-10	64.7	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		NA	NA	NA	NA	NA	NA
TRINITY_DN29641_c0_g1_i1	O17389	TYB_CAEEL	42.9	98	56	0	286	579	24	121	1.60E-12	74.3	TYB_CAEEL	reviewed	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	actin filament organization [GO:0007015]		blue	blue	NA	NA	NA	NA
TRINITY_DN39105_c0_g1_i1	O08710	THYG_MOUSE	43.1	65	32	3	150	344	116	175	9.10E-06	51.2	THYG_MOUSE	reviewed	Thyroglobulin (Tg)	Tg Tgn	Mus musculus (Mouse)	2766	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; anion binding [GO:0043168]; chaperone binding [GO:0051087]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; response to pH [GO:0009268]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; transcytosis [GO:0045056]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	anion binding [GO:0043168]; chaperone binding [GO:0051087]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005179; GO:0005615; GO:0005783; GO:0005794; GO:0006590; GO:0009268; GO:0015705; GO:0030878; GO:0031641; GO:0032991; GO:0042403; GO:0042446; GO:0042802; GO:0043168; GO:0044877; GO:0045056; GO:0048471; GO:0051087	hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; response to pH [GO:0009268]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; transcytosis [GO:0045056]		brown	brown	NA	NA	NA	NA
TRINITY_DN34263_c0_g1_i1	Q6YHU6	THADA_HUMAN	100	80	0	0	1	240	1122	1201	1.30E-40	166.4	THADA_HUMAN	reviewed	Thyroid adenoma-associated protein (Gene inducing thyroid adenomas protein)	THADA GITA KIAA1767	Homo sapiens (Human)	1953	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]		GO:0005829; GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1901895; GO:1990845	adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN38570_c0_g1_i1	A8C754	THADA_CHICK	32.6	1207	668	33	880	4146	271	1449	9.90E-152	539.7	THADA_CHICK	reviewed	Thyroid adenoma-associated protein homolog	THADA	Gallus gallus (Chicken)	1930							NA	NA	NA	NA	NA	NA
TRINITY_DN3567_c0_g1_i1	Q15643	TRIPB_HUMAN	29	458	311	6	1523	171	1436	1886	5.10E-31	137.5	TRIPB_HUMAN	reviewed	Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230)	TRIP11 CEV14	Homo sapiens (Human)	1979	cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]	cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]	transcription coactivator activity [GO:0003713]	GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006486; GO:0016607; GO:0030133; GO:0033116; GO:0035735; GO:0051216; GO:0060122; GO:0090161; GO:0099041	cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN37836_c0_g1_i1	Q3SX26	TRIP6_BOVIN	100	82	0	0	1	246	367	448	2.10E-46	185.7	TRIP6_BOVIN	reviewed	Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6)	TRIP6	Bos taurus (Bovine)	481	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; chordate embryonic development [GO:0043009]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]	GO:0001725; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0019900; GO:0030335; GO:0043009; GO:0046872; GO:1901224	cell adhesion [GO:0007155]; chordate embryonic development [GO:0043009]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38254_c0_g1_i1	Q15654	TRIP6_HUMAN	100	76	0	0	284	57	401	476	6.30E-42	171	TRIP6_HUMAN	reviewed	Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1)	TRIP6 OIP1	Homo sapiens (Human)	476	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]; chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]	GO:0001725; GO:0003723; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0019900; GO:0030335; GO:0043009; GO:0046872; GO:0046966; GO:0048041; GO:1901224	chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN37582_c0_g1_i1	Q15654	TRIP6_HUMAN	98.8	80	1	0	2	241	328	407	4.00E-45	181.4	TRIP6_HUMAN	reviewed	Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1)	TRIP6 OIP1	Homo sapiens (Human)	476	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]; chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]	GO:0001725; GO:0003723; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0019900; GO:0030335; GO:0043009; GO:0046872; GO:0046966; GO:0048041; GO:1901224	chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN25390_c0_g1_i1	Q9JLC6	TEF_MOUSE	100	69	0	0	1	207	191	259	1.30E-31	136.3	TEF_MOUSE	reviewed	Thyrotroph embryonic factor	Tef	Mus musculus (Mouse)	301	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000977; GO:0000978; GO:0001228; GO:0003690; GO:0005634; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048511; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]		NA	NA	NA	NA	NA	NA
TRINITY_DN29696_c0_g1_i1	P56495	TSHR_SHEEP	68.9	45	14	0	143	9	491	535	1.90E-12	72.8	TSHR_SHEEP	reviewed	Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R)	TSHR	Ovis aries (Sheep)	764	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; thyroid-stimulating hormone receptor activity [GO:0004996]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; inner ear receptor cell stereocilium organization [GO:0060122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of multicellular organism growth [GO:0040018]; regulation of locomotion [GO:0040012]; thyroid-stimulating hormone signaling pathway [GO:0038194]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; thyroid-stimulating hormone receptor activity [GO:0004996]	GO:0004996; GO:0005886; GO:0007166; GO:0007189; GO:0008344; GO:0016021; GO:0016323; GO:0030183; GO:0038023; GO:0038194; GO:0040012; GO:0040018; GO:0044877; GO:0060122; GO:0071542; GO:0090103; GO:0120162; GO:1904588; GO:1905229	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; inner ear receptor cell stereocilium organization [GO:0060122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of multicellular organism growth [GO:0040018]; regulation of locomotion [GO:0040012]; thyroid-stimulating hormone signaling pathway [GO:0038194]		NA	NA	NA	NA	NA	NA
TRINITY_DN39353_c0_g1_i1	Q10836	TRHDE_RAT	43	100	55	2	105	404	638	735	7.70E-17	88.2	TRHDE_RAT	reviewed	Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase)	Trhde	Rattus norvegicus (Rat)	1025	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN39301_c0_g1_i1	Q9UKU6	TRHDE_HUMAN	44.2	104	58	0	322	11	499	602	3.70E-22	105.5	TRHDE_HUMAN	reviewed	Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase)	TRHDE UNQ2507/PRO5995	Homo sapiens (Human)	1024	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062	cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN8989_c0_g1_i1	O42412	IOD3_CHICK	45.2	73	40	0	278	496	64	136	3.10E-10	66.6	IOD3_CHICK	reviewed	Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment)	DIO3	Gallus gallus (Chicken)	258	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]	GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0033798; GO:0042403; GO:0042446	hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]		NA	NA	NA	NA	NA	NA
TRINITY_DN8989_c0_g1_i2	O42412	IOD3_CHICK	51.8	56	27	0	108	275	81	136	1.20E-09	63.9	IOD3_CHICK	reviewed	Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment)	DIO3	Gallus gallus (Chicken)	258	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]	GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0033798; GO:0042403; GO:0042446	hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]		NA	NA	NA	NA	NA	NA
TRINITY_DN8989_c0_g1_i3	O42412	IOD3_CHICK	51.8	56	27	0	145	312	81	136	1.70E-09	63.5	IOD3_CHICK	reviewed	Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment)	DIO3	Gallus gallus (Chicken)	258	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]	GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0033798; GO:0042403; GO:0042446	hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]		NA	NA	NA	NA	NA	NA
TRINITY_DN7882_c0_g1_i1	Q96MW7	TIGD1_HUMAN	30.1	136	82	3	16	411	9	135	7.30E-07	55.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN7882_c0_g1_i3	Q96MW7	TIGD1_HUMAN	40.8	147	81	2	5	442	79	220	2.60E-26	119.8	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9132_c0_g1_i1	Q96MW7	TIGD1_HUMAN	37	135	84	1	409	5	228	361	4.60E-20	99	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9132_c0_g1_i2	Q96MW7	TIGD1_HUMAN	41.4	87	51	0	541	281	275	361	5.30E-14	79.3	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9132_c0_g1_i4	Q96MW7	TIGD1_HUMAN	34.1	135	88	1	685	281	228	361	6.00E-17	89.4	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9132_c0_g1_i5	Q96MW7	TIGD1_HUMAN	44.8	87	48	0	265	5	275	361	5.20E-16	85.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9132_c0_g1_i6	Q96MW7	TIGD1_HUMAN	42.9	98	56	0	298	5	264	361	2.90E-17	89.4	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN17812_c0_g1_i1	Q96MW7	TIGD1_HUMAN	38.7	315	182	4	1145	228	227	539	4.10E-55	216.9	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN17812_c0_g1_i5	Q96MW7	TIGD1_HUMAN	41.1	292	161	4	851	3	227	516	2.20E-53	210.7	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN17812_c0_g1_i6	Q96MW7	TIGD1_HUMAN	38.7	315	182	4	1209	292	227	539	4.30E-55	216.9	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN25723_c0_g1_i1	Q96MW7	TIGD1_HUMAN	39.6	91	55	0	1	273	256	346	1.80E-16	86.7	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2898_c0_g1_i1	Q96MW7	TIGD1_HUMAN	60.7	117	46	0	154	504	144	260	4.10E-36	152.5	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2898_c0_g1_i3	Q96MW7	TIGD1_HUMAN	46.5	260	131	3	133	912	9	260	4.40E-60	233	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN34318_c0_g1_i1	Q96MW7	TIGD1_HUMAN	58.9	90	35	1	272	3	177	264	1.90E-25	116.3	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4138_c0_g1_i8	Q96MW7	TIGD1_HUMAN	64.9	97	34	0	150	440	163	259	1.70E-33	143.7	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN3245_c0_g2_i3	Q96MW7	TIGD1_HUMAN	38.2	293	171	5	1	852	262	553	8.60E-49	196.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN3245_c0_g2_i4	Q96MW7	TIGD1_HUMAN	38.2	293	171	5	1	852	262	553	1.10E-48	196.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN3245_c0_g2_i5	Q96MW7	TIGD1_HUMAN	38.2	293	171	5	1	852	262	553	7.30E-49	196.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12944_c0_g1_i1	Q96MW7	TIGD1_HUMAN	54.9	91	41	0	320	48	234	324	4.40E-23	108.6	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12944_c0_g1_i3	Q96MW7	TIGD1_HUMAN	56.1	107	47	0	323	3	234	340	2.40E-29	129.4	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12944_c0_g1_i4	Q96MW7	TIGD1_HUMAN	54.9	91	41	0	328	56	234	324	3.50E-23	109	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12944_c1_g1_i1	Q96MW7	TIGD1_HUMAN	53.5	86	35	1	256	14	299	384	5.20E-19	94.7	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN21628_c0_g1_i1	Q96MW7	TIGD1_HUMAN	65.7	102	34	1	1	303	204	305	1.00E-29	130.6	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN8890_c0_g1_i1	Q96MW7	TIGD1_HUMAN	57	79	34	0	239	3	141	219	5.80E-20	97.8	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN8890_c0_g1_i2	Q96MW7	TIGD1_HUMAN	57	79	34	0	239	3	141	219	1.30E-19	96.7	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN26977_c0_g1_i1	Q96MW7	TIGD1_HUMAN	43.9	82	46	0	3	248	262	343	4.40E-15	81.6	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i13	Q96MW7	TIGD1_HUMAN	32	615	343	11	384	2195	7	557	2.30E-79	298.5	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i14	Q96MW7	TIGD1_HUMAN	36.8	402	190	6	197	1384	89	432	7.30E-67	256.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i17	Q96MW7	TIGD1_HUMAN	42.3	350	193	5	50	1081	86	432	4.40E-75	283.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i18	Q96MW7	TIGD1_HUMAN	32	610	340	11	399	2195	12	557	2.00E-78	295.4	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i22	Q96MW7	TIGD1_HUMAN	38.2	382	226	5	1	1122	153	532	5.10E-66	253.1	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i23	Q96MW7	TIGD1_HUMAN	35.1	555	340	10	399	2030	12	557	4.10E-86	320.9	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i24	Q96MW7	TIGD1_HUMAN	42.7	347	190	5	197	1219	89	432	1.40E-74	281.6	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1306_c0_g1_i29	Q96MW7	TIGD1_HUMAN	35.1	555	340	10	399	2030	12	557	5.40E-86	320.5	TIGD1_HUMAN	reviewed	Tigger transposable element-derived protein 1	TIGD1	Homo sapiens (Human)	591	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN17176_c0_g1_i1	Q4W5G0	TIGD2_HUMAN	36.1	155	97	2	459	1	95	249	2.60E-21	103.2	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN19377_c0_g1_i1	Q4W5G0	TIGD2_HUMAN	28.7	108	77	0	333	10	11	118	7.30E-13	74.7	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN19377_c0_g1_i2	Q4W5G0	TIGD2_HUMAN	28.7	108	77	0	333	10	11	118	2.10E-12	73.2	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN19377_c0_g1_i3	Q4W5G0	TIGD2_HUMAN	29.6	108	76	0	333	10	11	118	1.10E-13	77.4	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN5926_c0_g1_i2	Q4W5G0	TIGD2_HUMAN	39.4	94	57	0	49	330	4	97	3.20E-13	76.3	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN5926_c0_g1_i3	Q4W5G0	TIGD2_HUMAN	38.3	94	58	0	49	330	4	97	7.00E-13	75.1	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN5926_c0_g1_i4	Q4W5G0	TIGD2_HUMAN	39.4	94	57	0	49	330	4	97	1.40E-13	77.4	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN5926_c0_g1_i5	Q4W5G0	TIGD2_HUMAN	38.3	94	58	0	49	330	4	97	6.30E-12	71.6	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i13	Q0VBL1	TIGD2_MOUSE	31.5	89	40	2	125	391	160	227	6.90E-05	48.5	TIGD2_MOUSE	reviewed	Tigger transposable element-derived protein 2	Tigd2	Mus musculus (Mouse)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9045_c0_g1_i3	Q0VBL1	TIGD2_MOUSE	31.5	89	40	2	178	444	160	227	7.80E-05	48.5	TIGD2_MOUSE	reviewed	Tigger transposable element-derived protein 2	Tigd2	Mus musculus (Mouse)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c6_g1_i14	Q4W5G0	TIGD2_HUMAN	38.3	154	91	1	108	557	4	157	5.20E-26	119.4	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c6_g1_i3	Q4W5G0	TIGD2_HUMAN	43.1	65	37	0	87	281	4	68	1.50E-08	60.5	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c6_g1_i5	Q4W5G0	TIGD2_HUMAN	38.3	154	91	1	87	536	4	157	5.60E-26	119.4	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c6_g1_i6	Q4W5G0	TIGD2_HUMAN	38.3	154	91	1	86	535	4	157	5.00E-26	119.4	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c6_g1_i7	Q4W5G0	TIGD2_HUMAN	43.1	65	37	0	86	280	4	68	1.50E-08	60.5	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c6_g1_i8	Q4W5G0	TIGD2_HUMAN	40	75	45	0	87	311	4	78	1.40E-08	60.5	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4809_c0_g3_i1	Q4W5G0	TIGD2_HUMAN	47.2	53	28	0	3	161	163	215	2.10E-07	55.8	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN9737_c0_g1_i1	Q4W5G0	TIGD2_HUMAN	45.5	88	48	0	266	3	151	238	2.10E-18	92.8	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN927_c0_g1_i3	Q4W5G0	TIGD2_HUMAN	39.7	73	44	0	103	321	4	76	6.50E-07	55.1	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN927_c0_g1_i4	Q4W5G0	TIGD2_HUMAN	39.2	74	45	0	100	321	3	76	3.20E-06	52.8	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN927_c0_g1_i6	Q4W5G0	TIGD2_HUMAN	40.5	74	43	1	100	318	3	76	1.10E-06	54.3	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN927_c0_g1_i8	Q4W5G0	TIGD2_HUMAN	40	70	42	0	103	312	4	73	4.00E-06	52.4	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN927_c0_g1_i9	Q4W5G0	TIGD2_HUMAN	37.5	72	45	0	106	321	5	76	6.10E-05	48.5	TIGD2_HUMAN	reviewed	Tigger transposable element-derived protein 2	TIGD2	Homo sapiens (Human)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN911_c0_g5_i1	Q0VBL1	TIGD2_MOUSE	26.1	134	93	1	977	1378	10	137	1.30E-07	59.7	TIGD2_MOUSE	reviewed	Tigger transposable element-derived protein 2	Tigd2	Mus musculus (Mouse)	525	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN38953_c0_g1_i1	Q8IY51	TIGD4_HUMAN	38.4	432	246	7	637	1923	14	428	2.80E-77	291.2	TIGD4_HUMAN	reviewed	Tigger transposable element-derived protein 4	TIGD4	Homo sapiens (Human)	512	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN30592_c0_g1_i1	Q8BUZ3	TIGD4_MOUSE	49.5	95	48	0	325	41	182	276	5.90E-20	98.2	TIGD4_MOUSE	reviewed	Tigger transposable element-derived protein 4	Tigd4	Mus musculus (Mouse)	513	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4773_c0_g1_i3	Q17RP2	TIGD6_HUMAN	33.8	68	44	1	266	63	67	133	7.00E-05	48.1	TIGD6_HUMAN	reviewed	Tigger transposable element-derived protein 6	TIGD6	Homo sapiens (Human)	521	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12466_c0_g1_i2	Q6NT04	TIGD7_HUMAN	49.6	129	61	2	1	381	277	403	1.40E-28	127.5	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12466_c0_g1_i3	Q6NT04	TIGD7_HUMAN	52.3	86	39	1	1	252	277	362	4.50E-18	92	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2939_c0_g1_i12	Q6NT04	TIGD7_HUMAN	44.4	268	146	2	177	971	127	394	2.50E-64	247.3	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2939_c0_g1_i18	Q6NT04	TIGD7_HUMAN	36.8	435	250	9	177	1445	127	548	4.30E-76	287	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2939_c0_g1_i20	Q6NT04	TIGD7_HUMAN	37.2	435	249	8	177	1448	127	548	3.50E-78	293.9	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2939_c0_g1_i8	Q6NT04	TIGD7_HUMAN	37	435	250	8	177	1448	127	548	1.50E-76	288.5	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2939_c0_g1_i9	Q6NT04	TIGD7_HUMAN	30.2	242	146	7	1	696	320	548	5.40E-22	106.3	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN13848_c0_g1_i5	Q6NT04	TIGD7_HUMAN	43.9	66	37	0	202	5	6	71	6.00E-06	51.2	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN13848_c0_g1_i7	Q6NT04	TIGD7_HUMAN	43.3	60	34	0	184	5	12	71	2.70E-05	49.3	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			brown	brown	NA	NA	NA	NA
TRINITY_DN12792_c0_g1_i1	Q6NT04	TIGD7_HUMAN	47.7	151	79	0	11	463	281	431	9.80E-35	147.9	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN12792_c0_g1_i2	Q6NT04	TIGD7_HUMAN	56.2	73	32	0	11	229	281	353	8.30E-16	84	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN38548_c0_g1_i1	Q6NT04	TIGD7_HUMAN	39.6	424	241	6	7	1275	122	531	2.20E-82	307.8	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN36995_c0_g1_i1	Q6NT04	TIGD7_HUMAN	45.6	90	47	1	274	5	297	384	6.20E-18	91.3	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN16184_c0_g1_i1	Q6NT04	TIGD7_HUMAN	50	132	65	1	3	395	135	266	2.00E-33	143.3	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4108_c0_g1_i2	Q6NT04	TIGD7_HUMAN	58.8	51	21	0	989	837	299	349	4.50E-10	67	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4108_c0_g1_i5	Q6NT04	TIGD7_HUMAN	37.8	233	129	6	695	6	299	518	2.70E-33	143.7	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN4108_c0_g1_i6	Q6NT04	TIGD7_HUMAN	48.5	132	66	2	429	34	299	428	6.10E-28	125.2	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN38138_c0_g1_i1	Q6NT04	TIGD7_HUMAN	44	141	75	2	1	417	300	438	4.20E-26	119	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN2939_c0_g1_i1	Q6NT04	TIGD7_HUMAN	47.1	221	116	1	177	836	127	347	3.70E-57	223.4	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	1	NA	NA	NA
TRINITY_DN1095_c0_g1_i13	Q6NT04	TIGD7_HUMAN	55.6	45	20	0	118	252	6	50	1.70E-06	53.5	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			yellow	yellow	NA	NA	NA	NA
TRINITY_DN1095_c0_g1_i17	Q6NT04	TIGD7_HUMAN	53.3	45	21	0	374	508	6	50	1.50E-05	51.2	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN1095_c0_g1_i8	Q6NT04	TIGD7_HUMAN	55.6	45	20	0	118	252	6	50	5.00E-06	52	TIGD7_HUMAN	reviewed	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)	549	nucleus [GO:0005634]; DNA binding [GO:0003677]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN8367_c0_g1_i3	Q07157	ZO1_HUMAN	37.3	821	343	15	2369	405	15	829	9.60E-137	489.2	ZO1_HUMAN	reviewed	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	Homo sapiens (Human)	1748	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]	cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]	GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035329; GO:0035633; GO:0042995; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000250; GO:2000810	actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]		NA	NA	NA	NA	NA	NA
TRINITY_DN8367_c0_g1_i4	Q07157	ZO1_HUMAN	37.3	821	343	15	2326	362	15	829	9.40E-137	489.2	ZO1_HUMAN	reviewed	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	Homo sapiens (Human)	1748	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]	cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]	GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035329; GO:0035633; GO:0042995; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000250; GO:2000810	actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]		NA	NA	NA	NA	NA	NA
TRINITY_DN12541_c0_g1_i1	O97758	ZO1_CANLF	66	144	48	1	521	90	1627	1769	8.20E-50	198.7	ZO1_CANLF	reviewed	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	Canis lupus familiaris (Dog) (Canis familiaris)	1769	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]	GO:0005516; GO:0005886; GO:0005911; GO:0005921; GO:0005923; GO:0009986; GO:0031410; GO:0045216; GO:0050839; GO:0070160; GO:0070830; GO:0071277; GO:0090557; GO:0098609; GO:0150105; GO:1905605	bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN12541_c0_g1_i2	O97758	ZO1_CANLF	70	80	23	1	329	90	1691	1769	1.90E-25	116.7	ZO1_CANLF	reviewed	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	Canis lupus familiaris (Dog) (Canis familiaris)	1769	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]	GO:0005516; GO:0005886; GO:0005911; GO:0005921; GO:0005923; GO:0009986; GO:0031410; GO:0045216; GO:0050839; GO:0070160; GO:0070830; GO:0071277; GO:0090557; GO:0098609; GO:0150105; GO:1905605	bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN12541_c0_g1_i3	O97758	ZO1_CANLF	66	144	48	1	521	90	1627	1769	9.00E-50	198.7	ZO1_CANLF	reviewed	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	Canis lupus familiaris (Dog) (Canis familiaris)	1769	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]	GO:0005516; GO:0005886; GO:0005911; GO:0005921; GO:0005923; GO:0009986; GO:0031410; GO:0045216; GO:0050839; GO:0070160; GO:0070830; GO:0071277; GO:0090557; GO:0098609; GO:0150105; GO:1905605	bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]		NA	NA	NA	NA	NA	NA
TRINITY_DN9740_c0_g1_i1	Q6DBR4	TIPIN_DANRE	41.9	124	70	2	372	7	45	168	2.10E-18	94	TIPIN_DANRE	reviewed	TIMELESS-interacting protein	tipin zgc:91928	Danio rerio (Zebrafish) (Brachydanio rerio)	294	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	DNA binding [GO:0003677]	GO:0000076; GO:0000790; GO:0003677; GO:0005634; GO:0005737; GO:0008284; GO:0031298; GO:0031573; GO:0043111; GO:0044770; GO:0048478; GO:0051301	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN9740_c0_g1_i3	Q9BVW5	TIPIN_HUMAN	38.7	142	85	1	465	46	6	147	7.90E-18	92	TIPIN_HUMAN	reviewed	TIMELESS-interacting protein	TIPIN	Homo sapiens (Human)	301	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	DNA binding [GO:0003677]	GO:0000076; GO:0000790; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0009411; GO:0031298; GO:0031573; GO:0033262; GO:0043111; GO:0044770; GO:0048478; GO:0051301	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411]		NA	NA	NA	NA	NA	NA
TRINITY_DN13067_c0_g1_i1	Q8BH58	TIPRL_MOUSE	39.8	259	135	3	137	901	11	252	1.10E-52	208.4	TIPRL_MOUSE	reviewed	TIP41-like protein	Tiprl	Mus musculus (Mouse)	271	cytosol [GO:0005829]; DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]	cytosol [GO:0005829]		GO:0000077; GO:0005829; GO:0007165; GO:0031929; GO:0032515; GO:0043666	DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN23024_c0_g1_i1	O75663	TIPRL_HUMAN	100	102	0	0	2	307	101	202	4.30E-52	204.9	TIPRL_HUMAN	reviewed	TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP)	TIPRL	Homo sapiens (Human)	272	cytosol [GO:0005829]; DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]	cytosol [GO:0005829]		GO:0000077; GO:0005829; GO:0007165; GO:0031929; GO:0032515; GO:0043666	DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN23024_c0_g1_i2	O75663	TIPRL_HUMAN	100	102	0	0	2	307	101	202	4.30E-52	204.9	TIPRL_HUMAN	reviewed	TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP)	TIPRL	Homo sapiens (Human)	272	cytosol [GO:0005829]; DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]	cytosol [GO:0005829]		GO:0000077; GO:0005829; GO:0007165; GO:0031929; GO:0032515; GO:0043666	DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]		NA	NA	NA	NA	NA	NA
TRINITY_DN25894_c0_g1_i1	Q99LJ1	FUCO_MOUSE	100	199	0	0	599	3	74	272	3.90E-126	451.8	FUCO_MOUSE	reviewed	Tissue alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1) (Alpha-L-fucosidase 1)	Fuca1 Fuca	Mus musculus (Mouse)	452	lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; carbohydrate binding [GO:0030246]; fucosidase activity [GO:0015928]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]	lysosome [GO:0005764]	alpha-L-fucosidase activity [GO:0004560]; carbohydrate binding [GO:0030246]; fucosidase activity [GO:0015928]	GO:0004560; GO:0005764; GO:0006004; GO:0015928; GO:0016139; GO:0030246	fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]		NA	NA	NA	NA	NA	NA
TRINITY_DN2631_c0_g1_i6	Q2KIM0	FUCO_BOVIN	68.8	128	39	1	483	100	44	170	2.60E-53	209.9	FUCO_BOVIN	reviewed	Tissue alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1) (Alpha-L-fucosidase 1)	FUCA1	Bos taurus (Bovine)	468	lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]	lysosome [GO:0005764]	alpha-L-fucosidase activity [GO:0004560]	GO:0004560; GO:0005764; GO:0006004; GO:0016139; GO:0019377	fucose metabolic process [GO:0006004]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]		NA	NA	NA	NA	NA	NA
TRINITY_DN36893_c0_g1_i1	Q8IZ20	ZN683_HUMAN	80.4	102	0	1	247	2	337	438	1.00E-40	166.8	ZN683_HUMAN	reviewed	Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell) (Hobit) (Zinc finger protein 683)	ZNF683	Homo sapiens (Human)	524	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adaptive immune response [GO:0002250]; cellular response to ionomycin [GO:1904637]; innate immune response [GO:0045087]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000122; GO:0000790; GO:0000978; GO:0002250; GO:0003700; GO:0006357; GO:0010468; GO:0010628; GO:0016032; GO:0032689; GO:0032823; GO:0032826; GO:0033082; GO:0045087; GO:0046872; GO:0050852; GO:0051136; GO:1904637; GO:1990841	adaptive immune response [GO:0002250]; cellular response to ionomycin [GO:1904637]; innate immune response [GO:0045087]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN38266_c0_g1_i1	P00750	TPA_HUMAN	51.9	52	25	0	45	200	510	561	6.70E-13	74.3	TPA_HUMAN	reviewed	Tissue-type plasminogen activator (t-PA) (t-plasminogen activator) (tPA) (EC 3.4.21.68) (Alteplase) (Reteplase) [Cleaved into: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B]	PLAT	Homo sapiens (Human)	562	"apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; phosphoprotein binding [GO:0051219]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; cellular protein modification process [GO:0006464]; fibrinolysis [GO:0042730]; negative regulation of proteolysis [GO:0045861]; plasminogen activation [GO:0031639]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; proteolysis [GO:0006508]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]"	apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]	phosphoprotein binding [GO:0051219]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]	GO:0001666; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005737; GO:0006464; GO:0006508; GO:0007596; GO:0009986; GO:0014909; GO:0030141; GO:0031639; GO:0042730; GO:0045177; GO:0045861; GO:0048008; GO:0051219; GO:0070062; GO:0098685; GO:0098978; GO:0099183	"blood coagulation [GO:0007596]; cellular protein modification process [GO:0006464]; fibrinolysis [GO:0042730]; negative regulation of proteolysis [GO:0045861]; plasminogen activation [GO:0031639]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; proteolysis [GO:0006508]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32794_c0_g1_i1	Q9I7U4	TITIN_DROME	59.5	79	32	0	272	36	2897	2975	4.40E-24	111.7	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN32042_c0_g1_i1	Q9I7U4	TITIN_DROME	52.1	73	33	1	9	221	1758	1830	1.20E-08	60.1	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN15193_c0_g2_i1	Q9I7U4	TITIN_DROME	44.8	125	69	0	26	400	17756	17880	1.90E-23	110.2	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN15193_c0_g1_i3	Q9I7U4	TITIN_DROME	48	254	107	4	772	71	17880	18128	8.80E-62	238.4	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN15193_c0_g1_i5	Q9I7U4	TITIN_DROME	49.2	242	98	4	736	71	17892	18128	9.10E-59	228.4	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN3154_c0_g2_i1	Q9I7U4	TITIN_DROME	36.7	218	131	2	665	12	7085	7295	2.50E-29	130.6	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	1	NA	NA	NA
TRINITY_DN39003_c0_g1_i1	Q9I7U4	TITIN_DROME	63.2	117	43	0	2	352	726	842	5.10E-37	155.2	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN13528_c0_g1_i1	Q9I7U4	TITIN_DROME	52.6	135	62	2	10	411	1389	1522	3.70E-34	146	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN13528_c0_g1_i2	Q9I7U4	TITIN_DROME	47.3	148	64	4	37	444	1377	1522	2.50E-28	126.7	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN16531_c0_g1_i1	Q9I7U4	TITIN_DROME	56.5	62	27	0	7	192	2607	2668	1.70E-14	79.7	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN27896_c0_g1_i1	Q9I7U4	TITIN_DROME	68.3	63	20	0	218	30	2806	2868	1.50E-19	96.3	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN29383_c0_g1_i1	Q9I7U4	TITIN_DROME	46.9	49	26	0	148	294	239	287	1.10E-06	54.3	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN29383_c0_g1_i2	Q9I7U4	TITIN_DROME	46.9	49	26	0	220	74	239	287	1.10E-06	54.3	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN30360_c0_g1_i1	Q9I7U4	TITIN_DROME	70.6	51	15	0	244	92	85	135	1.50E-15	83.6	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN28506_c0_g1_i1	Q9I7U4	TITIN_DROME	64.4	73	25	1	221	3	4332	4403	4.50E-17	88.6	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN34100_c0_g1_i1	Q9I7U4	TITIN_DROME	67.3	113	37	0	1	339	4110	4222	7.10E-43	174.5	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN31862_c0_g1_i1	Q9I7U4	TITIN_DROME	56.8	74	32	0	230	9	2716	2789	2.00E-21	102.8	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN36393_c0_g1_i1	Q9I7U4	TITIN_DROME	59.4	101	40	1	305	6	1078	1178	2.60E-25	115.9	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]		NA	NA	NA	NA	NA	NA
TRINITY_DN20318_c0_g1_i1	A2ASS6	TITIN_MOUSE	34	100	65	1	57	353	30493	30592	7.50E-08	58.2	TITIN_MOUSE	reviewed	Titin (EC 2.7.11.1) (Connectin)	Ttn	Mus musculus (Mouse)	35213	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0097493; GO:1901897	adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i4	A2ASS6	TITIN_MOUSE	29.7	155	83	5	401	6	20151	20302	2.50E-07	56.6	TITIN_MOUSE	reviewed	Titin (EC 2.7.11.1) (Connectin)	Ttn	Mus musculus (Mouse)	35213	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0097493; GO:1901897	adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN1010_c0_g1_i2	A2ASS6	TITIN_MOUSE	23.8	210	144	5	723	124	20065	20268	7.70E-06	53.1	TITIN_MOUSE	reviewed	Titin (EC 2.7.11.1) (Connectin)	Ttn	Mus musculus (Mouse)	35213	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0097493; GO:1901897	adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN1010_c0_g1_i3	A2ASS6	TITIN_MOUSE	23.8	210	143	5	720	124	20065	20268	8.30E-05	50.4	TITIN_MOUSE	reviewed	Titin (EC 2.7.11.1) (Connectin)	Ttn	Mus musculus (Mouse)	35213	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0097493; GO:1901897	adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]		NA	NA	NA	NA	NA	NA
TRINITY_DN15193_c0_g1_i4	Q8WZ42	TITIN_HUMAN	40.3	77	45	1	266	36	31176	31251	3.30E-08	58.9	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i17	Q8WZ42	TITIN_HUMAN	34.4	941	598	14	2830	29	18103	19031	2.00E-146	521.5	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i7	Q8WZ42	TITIN_HUMAN	30.8	195	135	0	625	41	30559	30753	8.20E-24	112.5	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN36262_c0_g1_i1	Q8WZ42	TITIN_HUMAN	36.1	97	62	0	53	343	4564	4660	1.60E-10	67.4	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN34958_c0_g1_i1	Q8WZ42	TITIN_HUMAN	41.8	79	46	0	34	270	28784	28862	2.40E-14	79.3	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN24065_c0_g1_i1	Q8WZ42	TITIN_HUMAN	34.3	239	145	6	127	819	22343	22577	1.20E-29	131.7	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]		NA	NA	NA	NA	NA	NA
TRINITY_DN3154_c0_g2_i5	G4SLH0	TTN1_CAEEL	41.2	68	40	0	275	72	16729	16796	5.90E-06	52	TTN1_CAEEL	reviewed	Titin homolog (EC 2.7.11.1)	ttn-1 W06H8.8	Caenorhabditis elegans	18562	A band [GO:0031672]; I band [GO:0031674]; nuclear membrane [GO:0031965]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]	A band [GO:0031672]; I band [GO:0031674]; nuclear membrane [GO:0031965]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0017022; GO:0031672; GO:0031674; GO:0031965; GO:0046872; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN40058_c0_g1_i1	Q08117	TLE5_HUMAN	100	110	0	0	1	330	11	120	1.10E-56	220.3	TLE5_HUMAN	reviewed	"TLE family member 5 (Amino-terminal enhancer of split) (Amino enhancer of split) (Gp130-associated protein GAM) (Grg-5) (Groucho-related protein 5) (Protein ESP1) (Protein GRG) (TLE family member 5, transcriptional modulator)"	TLE5 AES GRG GRG5	Homo sapiens (Human)	197	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; cellular response to extracellular stimulus [GO:0031668]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001501; GO:0003714; GO:0005634; GO:0005667; GO:0007275; GO:0009887; GO:0010629; GO:0016055; GO:0031668; GO:0032091; GO:0040008; GO:0042802; GO:0045892; GO:0060761; GO:0070491; GO:0070555; GO:0090090; GO:2000210	"animal organ morphogenesis [GO:0009887]; cellular response to extracellular stimulus [GO:0031668]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13748_c0_g1_i1	Q08117	TLE5_HUMAN	100	101	0	0	306	4	15	115	1.60E-51	203	TLE5_HUMAN	reviewed	"TLE family member 5 (Amino-terminal enhancer of split) (Amino enhancer of split) (Gp130-associated protein GAM) (Grg-5) (Groucho-related protein 5) (Protein ESP1) (Protein GRG) (TLE family member 5, transcriptional modulator)"	TLE5 AES GRG GRG5	Homo sapiens (Human)	197	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; cellular response to extracellular stimulus [GO:0031668]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001501; GO:0003714; GO:0005634; GO:0005667; GO:0007275; GO:0009887; GO:0010629; GO:0016055; GO:0031668; GO:0032091; GO:0040008; GO:0042802; GO:0045892; GO:0060761; GO:0070491; GO:0070555; GO:0090090; GO:2000210	"animal organ morphogenesis [GO:0009887]; cellular response to extracellular stimulus [GO:0031668]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22567_c0_g1_i1	Q9BX74	TM2D1_HUMAN	100	68	0	0	2	205	120	187	1.50E-32	139.4	TM2D1_HUMAN	reviewed	TM2 domain-containing protein 1 (Amyloid-beta-binding protein) (hBBP)	TM2D1 BBP	Homo sapiens (Human)	207	integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; apoptotic signaling pathway [GO:0097190]	integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]	amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]	GO:0001540; GO:0004930; GO:0005654; GO:0005887; GO:0097190	apoptotic signaling pathway [GO:0097190]		NA	NA	NA	NA	NA	NA
TRINITY_DN41094_c0_g1_i1	Q8R0I4	TM2D2_MOUSE	100	90	0	0	3	272	113	202	2.50E-48	192.2	TM2D2_MOUSE	reviewed	TM2 domain-containing protein 2	Tm2d2	Mus musculus (Mouse)	213	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN27670_c0_g1_i1	Q9BX73	TM2D2_HUMAN	100	89	0	0	1	267	126	214	5.50E-50	198	TM2D2_HUMAN	reviewed	TM2 domain-containing protein 2 (Beta-amyloid-binding protein-like protein 1) (BBP-like protein 1)	TM2D2 BLP1	Homo sapiens (Human)	214	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN18438_c0_g1_i1	Q8BJ83	TM2D3_MOUSE	100	91	0	0	305	33	171	261	1.40E-50	199.9	TM2D3_MOUSE	reviewed	TM2 domain-containing protein 3	Tm2d3	Mus musculus (Mouse)	261	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN39092_c0_g1_i1	Q9BRN9	TM2D3_HUMAN	100	88	0	0	332	69	160	247	1.80E-48	193	TM2D3_HUMAN	reviewed	TM2 domain-containing protein 3 (Beta-amyloid-binding protein-like protein 2) (BBP-like protein 2)	TM2D3 BLP2	Homo sapiens (Human)	247	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5923_c0_g1_i1	Q9U4H5	AMX_DROME	59.2	169	65	2	321	821	118	284	5.80E-57	222.6	AMX_DROME	reviewed	TM2 domain-containing protein almondex	amx CG12127	Drosophila melanogaster (Fruit fly)	284	spanning component of plasma membrane [GO:0044214]; ectodermal cell fate determination [GO:0001713]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]	spanning component of plasma membrane [GO:0044214]		GO:0001713; GO:0007219; GO:0007498; GO:0044214; GO:0045747; GO:0046331	ectodermal cell fate determination [GO:0001713]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]		NA	NA	NA	NA	NA	NA
TRINITY_DN5923_c0_g1_i2	Q9U4H5	AMX_DROME	65.4	133	44	1	77	475	154	284	1.80E-48	193.7	AMX_DROME	reviewed	TM2 domain-containing protein almondex	amx CG12127	Drosophila melanogaster (Fruit fly)	284	spanning component of plasma membrane [GO:0044214]; ectodermal cell fate determination [GO:0001713]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]	spanning component of plasma membrane [GO:0044214]		GO:0001713; GO:0007219; GO:0007498; GO:0044214; GO:0045747; GO:0046331	ectodermal cell fate determination [GO:0001713]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]		NA	NA	NA	NA	NA	NA
TRINITY_DN5923_c0_g1_i4	Q9U4H5	AMX_DROME	59.2	169	65	2	321	821	118	284	4.50E-57	223	AMX_DROME	reviewed	TM2 domain-containing protein almondex	amx CG12127	Drosophila melanogaster (Fruit fly)	284	spanning component of plasma membrane [GO:0044214]; ectodermal cell fate determination [GO:0001713]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]	spanning component of plasma membrane [GO:0044214]		GO:0001713; GO:0007219; GO:0007498; GO:0044214; GO:0045747; GO:0046331	ectodermal cell fate determination [GO:0001713]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]		NA	NA	NA	NA	NA	NA
TRINITY_DN10492_c0_g1_i1	Q9W2H1	TM2D1_DROME	61.1	157	57	2	209	667	22	178	1.40E-51	204.5	TM2D1_DROME	reviewed	TM2 domain-containing protein CG10795	CG10795	Drosophila melanogaster (Fruit fly)	178	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN2472_c0_g1_i1	Q9VY86	TM2D2_DROME	61.7	149	57	0	64	510	76	224	5.90E-54	213.8	TM2D2_DROME	reviewed	TM2 domain-containing protein CG11103	CG11103	Drosophila melanogaster (Fruit fly)	224	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN33600_c0_g1_i1	Q86L04	TRAP1_DICDI	52.6	78	37	0	243	10	375	452	2.60E-20	99	TRAP1_DICDI	reviewed	"TNF receptor-associated protein 1 homolog, mitochondrial (TNFR-associated protein 1 homolog) (Trap1 homolog)"	trap1 DDB_G0276947	Dictyostelium discoideum (Slime mold)	711	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; spore wall [GO:0031160]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; sporulation resulting in formation of a cellular spore [GO:0030435]	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; spore wall [GO:0031160]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005730; GO:0005743; GO:0005856; GO:0005938; GO:0006457; GO:0007275; GO:0019901; GO:0030154; GO:0030435; GO:0031160; GO:0051082	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; sporulation resulting in formation of a cellular spore [GO:0030435]		NA	NA	NA	NA	NA	NA
TRINITY_DN21126_c0_g1_i1	Q3TYG6	TGRM2_MOUSE	36.3	212	135	0	11	646	493	704	1.30E-35	151.4	TGRM2_MOUSE	reviewed	TOG array regulator of axonemal microtubules protein 2 (Crescerin-2) (Protein FAM179A)	Togaram2 Fam179a	Mus musculus (Mouse)	1002	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	microtubule binding [GO:0008017]	GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0008017; GO:0031110; GO:0072686; GO:0090307	microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]		NA	NA	NA	NA	NA	NA
TRINITY_DN3827_c0_g1_i1	Q5ZK05	TOLIP_CHICK	48	198	98	3	91	684	1	193	2.00E-44	180.6	TOLIP_CHICK	reviewed	Toll-interacting protein	TOLLIP RCJMB04_14a3	Gallus gallus (Chicken)	274	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinase binding [GO:0019900]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	kinase binding [GO:0019900]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]	GO:0005737; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0019900; GO:0030855; GO:0031624; GO:0035325; GO:0036010; GO:0043130; GO:0045087; GO:0070062	autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3693_c0_g1_i1	Q9QZ06	TOLIP_MOUSE	55.2	58	24	1	3	176	215	270	1.50E-09	63.2	TOLIP_MOUSE	reviewed	Toll-interacting protein	Tollip	Mus musculus (Mouse)	274	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	"interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005150; GO:0005737; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0036010; GO:0043130; GO:0045087; GO:0048471; GO:0070498	autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN3827_c0_g1_i3	Q6INE3	TOIPB_XENLA	49.5	190	89	3	75	644	9	191	1.90E-44	180.6	TOIPB_XENLA	reviewed	Toll-interacting protein B	tollip-b	Xenopus laevis (African clawed frog)	269	cytoplasm [GO:0005737]; autophagy [GO:0006914]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]	cytoplasm [GO:0005737]		GO:0005737; GO:0006914; GO:0006954; GO:0016310; GO:0045087	autophagy [GO:0006914]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]		NA	NA	NA	NA	NA	NA
TRINITY_DN40610_c0_g1_i1	Q9VUN0	TOLL6_DROME	54.7	86	38	1	258	4	603	688	1.60E-20	99.8	TOLL6_DROME	reviewed	Toll-like receptor 6 (EC 3.2.2.6)	Toll-6 Tl-6 CG7250	Drosophila melanogaster (Fruit fly)	1514	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]; signal transduction [GO:0007165]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"heparin binding [GO:0008201]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"	GO:0003401; GO:0005030; GO:0005886; GO:0007165; GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050135; GO:0060026; GO:0061809; GO:0070983	axis elongation [GO:0003401]; axon guidance [GO:0007411]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN24442_c0_g1_i1	Q9VUN0	TOLL6_DROME	57.5	120	51	0	361	2	775	894	6.10E-42	171.4	TOLL6_DROME	reviewed	Toll-like receptor 6 (EC 3.2.2.6)	Toll-6 Tl-6 CG7250	Drosophila melanogaster (Fruit fly)	1514	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]; signal transduction [GO:0007165]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"heparin binding [GO:0008201]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"	GO:0003401; GO:0005030; GO:0005886; GO:0007165; GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050135; GO:0060026; GO:0061809; GO:0070983	axis elongation [GO:0003401]; axon guidance [GO:0007411]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5924_c0_g1_i3	Q9VUN0	TOLL6_DROME	24.1	166	122	2	142	627	282	447	4.30E-10	66.6	TOLL6_DROME	reviewed	Toll-like receptor 6 (EC 3.2.2.6)	Toll-6 Tl-6 CG7250	Drosophila melanogaster (Fruit fly)	1514	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]; signal transduction [GO:0007165]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"heparin binding [GO:0008201]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]"	GO:0003401; GO:0005030; GO:0005886; GO:0007165; GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050135; GO:0060026; GO:0061809; GO:0070983	axis elongation [GO:0003401]; axon guidance [GO:0007411]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7888_c0_g1_i1	P58681	TLR7_MOUSE	22.3	269	159	7	393	1061	701	965	9.30E-05	50.1	TLR7_MOUSE	reviewed	Toll-like receptor 7	Tlr7	Mus musculus (Mouse)	1050	cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; pattern recognition receptor activity [GO:0038187]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of chemokine production [GO:0032722]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of protein phosphorylation [GO:0001932]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; pattern recognition receptor activity [GO:0038187]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]	GO:0001774; GO:0001932; GO:0002224; GO:0002755; GO:0003725; GO:0003727; GO:0004888; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005886; GO:0006955; GO:0007249; GO:0007252; GO:0008144; GO:0010008; GO:0016021; GO:0032009; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032755; GO:0032757; GO:0034154; GO:0035197; GO:0038187; GO:0043235; GO:0045087; GO:0051607; GO:0071260; GO:1901224	cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of chemokine production [GO:0032722]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of protein phosphorylation [GO:0001932]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor signaling pathway [GO:0002224]		NA	NA	NA	NA	NA	NA
TRINITY_DN29051_c0_g1_i1	Q9V477	TOLL8_DROME	66.7	72	24	0	284	69	1146	1217	5.90E-24	111.3	TOLL8_DROME	reviewed	Toll-like receptor Tollo (EC 3.2.2.6) (Toll-like receptor 8)	Tollo Tl-8 Toll-8 CG6890	Drosophila melanogaster (Fruit fly)	1346	"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]"	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0045087; GO:0048935; GO:0050135; GO:0060026; GO:0060049; GO:0061809	axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36875_c0_g1_i1	Q9V477	TOLL8_DROME	51.8	112	54	0	2	337	222	333	9.30E-24	110.9	TOLL8_DROME	reviewed	Toll-like receptor Tollo (EC 3.2.2.6) (Toll-like receptor 8)	Tollo Tl-8 Toll-8 CG6890	Drosophila melanogaster (Fruit fly)	1346	"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]"	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0045087; GO:0048935; GO:0050135; GO:0060026; GO:0060049; GO:0061809	axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN36043_c0_g1_i1	Q9V477	TOLL8_DROME	38.1	541	321	5	142	1734	28	564	7.90E-95	349.4	TOLL8_DROME	reviewed	Toll-like receptor Tollo (EC 3.2.2.6) (Toll-like receptor 8)	Tollo Tl-8 Toll-8 CG6890	Drosophila melanogaster (Fruit fly)	1346	"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]"	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0045087; GO:0048935; GO:0050135; GO:0060026; GO:0060049; GO:0061809	axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN38745_c0_g1_i2	Q9V477	TOLL8_DROME	35.6	146	92	2	79	513	370	514	2.80E-09	63.5	TOLL8_DROME	reviewed	Toll-like receptor Tollo (EC 3.2.2.6) (Toll-like receptor 8)	Tollo Tl-8 Toll-8 CG6890	Drosophila melanogaster (Fruit fly)	1346	"apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]"	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0045087; GO:0048935; GO:0050135; GO:0060026; GO:0060049; GO:0061809	axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4534_c0_g1_i28	O43897	TLL1_HUMAN	29.1	103	67	1	93	401	910	1006	3.40E-07	56.6	TLL1_HUMAN	reviewed	Tolloid-like protein 1 (EC 3.4.24.-)	TLL1 TLL	Homo sapiens (Human)	1013	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0001501; GO:0004222; GO:0005509; GO:0005576; GO:0008270; GO:0022617; GO:0030154	cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN5753_c0_g1_i1	Q5SRX1	TM1L2_MOUSE	39.3	544	251	14	35	1540	1	507	1.60E-89	331.6	TM1L2_MOUSE	reviewed	TOM1-like protein 2 (Target of Myb-like protein 2)	Tom1l2	Mus musculus (Mouse)	507	endosome [GO:0005768]; membrane [GO:0016020]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]	endosome [GO:0005768]; membrane [GO:0016020]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0005768; GO:0006886; GO:0007165; GO:0016020; GO:0019901; GO:0030276; GO:0045839	intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5753_c0_g1_i2	Q5SRX1	TM1L2_MOUSE	39.4	533	249	14	35	1489	1	507	9.50E-87	322.4	TM1L2_MOUSE	reviewed	TOM1-like protein 2 (Target of Myb-like protein 2)	Tom1l2	Mus musculus (Mouse)	507	endosome [GO:0005768]; membrane [GO:0016020]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]	endosome [GO:0005768]; membrane [GO:0016020]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0005768; GO:0006886; GO:0007165; GO:0016020; GO:0019901; GO:0030276; GO:0045839	intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN5753_c0_g1_i3	Q6ZVM7	TM1L2_HUMAN	57.1	175	73	2	35	556	1	174	1.40E-54	214.2	TM1L2_HUMAN	reviewed	TOM1-like protein 2 (Target of Myb-like protein 2)	TOM1L2	Homo sapiens (Human)	507	endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]	endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0005768; GO:0006886; GO:0007165; GO:0016020; GO:0019901; GO:0030276; GO:0045839; GO:0070062	intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN31402_c0_g1_i1	Q5SRX1	TM1L2_MOUSE	100	68	0	0	206	3	229	296	4.00E-30	131.3	TM1L2_MOUSE	reviewed	TOM1-like protein 2 (Target of Myb-like protein 2)	Tom1l2	Mus musculus (Mouse)	507	endosome [GO:0005768]; membrane [GO:0016020]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]	endosome [GO:0005768]; membrane [GO:0016020]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0005768; GO:0006886; GO:0007165; GO:0016020; GO:0019901; GO:0030276; GO:0045839	intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN20191_c0_g1_i1	Q91590	TEFF1_XENLA	30.6	144	67	6	95	454	67	201	9.20E-11	68.2	TEFF1_XENLA	reviewed	Tomoregulin-1 (TR-1) (Transmembrane protein with EGF-like and one follistatin-like domain) (X7365)	tmeff1	Xenopus laevis (African clawed frog)	370	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0007275; GO:0016021	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8633_c0_g1_i1	Q99JY4	TRABD_MOUSE	49.5	218	103	3	805	164	132	346	3.50E-54	213.4	TRABD_MOUSE	reviewed	TraB domain-containing protein	Trabd	Mus musculus (Mouse)	376							NA	NA	NA	NA	NA	NA
TRINITY_DN8633_c0_g1_i2	Q99JY4	TRABD_MOUSE	51.2	291	135	3	1024	164	59	346	7.30E-78	292.4	TRABD_MOUSE	reviewed	TraB domain-containing protein	Trabd	Mus musculus (Mouse)	376							NA	NA	NA	NA	NA	NA
TRINITY_DN35288_c0_g1_i1	Q9H4I3	TRABD_HUMAN	100	69	0	0	209	3	197	265	2.10E-34	145.6	TRABD_HUMAN	reviewed	TraB domain-containing protein (Protein TTG2)	TRABD TTG2 PP2447	Homo sapiens (Human)	376							NA	NA	NA	NA	NA	NA
TRINITY_DN25554_c0_g1_i1	Q9H4I3	TRABD_HUMAN	100	124	0	0	1	372	75	198	2.90E-63	242.3	TRABD_HUMAN	reviewed	TraB domain-containing protein (Protein TTG2)	TRABD TTG2 PP2447	Homo sapiens (Human)	376							NA	NA	NA	NA	NA	NA
TRINITY_DN5231_c0_g1_i1	Q960V3	MILT_DROME	38.3	734	360	18	2628	643	136	848	6.10E-107	390.2	MILT_DROME	reviewed	Trafficking kinesin-binding protein milt (Protein milton)	milt CG43227	Drosophila melanogaster (Fruit fly)	1122	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; mitochondrion [GO:0005739]; myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]; axonal transport of mitochondrion [GO:0019896]; establishment of mitochondrion localization [GO:0051654]; mitochondrion distribution [GO:0048311]; Nebenkern assembly [GO:0007287]; oocyte dorsal/ventral axis specification [GO:0007310]; protein localization [GO:0008104]; protein targeting [GO:0006605]; sperm mitochondrion organization [GO:0030382]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; mitochondrion [GO:0005739]	myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005737; GO:0005739; GO:0006605; GO:0007287; GO:0007310; GO:0008104; GO:0017022; GO:0019896; GO:0030382; GO:0030674; GO:0031410; GO:0047496; GO:0048311; GO:0051654; GO:1904115	axonal transport of mitochondrion [GO:0019896]; establishment of mitochondrion localization [GO:0051654]; mitochondrion distribution [GO:0048311]; Nebenkern assembly [GO:0007287]; oocyte dorsal/ventral axis specification [GO:0007310]; protein localization [GO:0008104]; protein targeting [GO:0006605]; sperm mitochondrion organization [GO:0030382]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN5231_c0_g1_i4	Q960V3	MILT_DROME	46.9	256	99	11	1350	643	610	848	1.10E-44	182.6	MILT_DROME	reviewed	Trafficking kinesin-binding protein milt (Protein milton)	milt CG43227	Drosophila melanogaster (Fruit fly)	1122	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; mitochondrion [GO:0005739]; myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]; axonal transport of mitochondrion [GO:0019896]; establishment of mitochondrion localization [GO:0051654]; mitochondrion distribution [GO:0048311]; Nebenkern assembly [GO:0007287]; oocyte dorsal/ventral axis specification [GO:0007310]; protein localization [GO:0008104]; protein targeting [GO:0006605]; sperm mitochondrion organization [GO:0030382]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; mitochondrion [GO:0005739]	myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005737; GO:0005739; GO:0006605; GO:0007287; GO:0007310; GO:0008104; GO:0017022; GO:0019896; GO:0030382; GO:0030674; GO:0031410; GO:0047496; GO:0048311; GO:0051654; GO:1904115	axonal transport of mitochondrion [GO:0019896]; establishment of mitochondrion localization [GO:0051654]; mitochondrion distribution [GO:0048311]; Nebenkern assembly [GO:0007287]; oocyte dorsal/ventral axis specification [GO:0007310]; protein localization [GO:0008104]; protein targeting [GO:0006605]; sperm mitochondrion organization [GO:0030382]; vesicle transport along microtubule [GO:0047496]		NA	NA	NA	NA	NA	NA
TRINITY_DN10635_c0_g1_i1	Q5NCF2	TPPC1_MOUSE	53.8	143	66	0	525	97	1	143	3.00E-44	179.9	TPPC1_MOUSE	reviewed	Trafficking protein particle complex subunit 1	Trappc1	Mus musculus (Mouse)	145	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]		GO:0005783; GO:0005794; GO:0006888; GO:0030008	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN3778_c0_g1_i2	P48553	TPC10_HUMAN	50	170	82	2	69	572	15	183	2.10E-44	180.3	TPC10_HUMAN	reviewed	Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1)	TRAPPC10 EHOC1 TMEM1	Homo sapiens (Human)	1259	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; COPII vesicle coating [GO:0048208]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]		GO:0000139; GO:0005829; GO:0006891; GO:0030008; GO:0034498; GO:0048208; GO:1990071	COPII vesicle coating [GO:0048208]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]		NA	NA	NA	NA	NA	NA
TRINITY_DN3778_c0_g1_i1	Q3TLI0	TPC10_MOUSE	48.8	80	41	0	69	308	15	94	1.10E-17	90.9	TPC10_MOUSE	reviewed	Trafficking protein particle complex subunit 10 (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1)	Trappc10 Tmem1	Mus musculus (Mouse)	1259	cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]	cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]		GO:0005829; GO:0006891; GO:0030008; GO:0034498; GO:1990071	early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]		NA	NA	NA	NA	NA	NA
TRINITY_DN93_c0_g1_i1	Q1RLX4	TPC11_DANRE	41.2	226	130	3	3	677	389	612	2.70E-46	186.8	TPC11_DANRE	reviewed	Trafficking protein particle complex subunit 11 (Protein foie gras)	trappc11 fgr foigr zgc:136723 zgc:63684	Danio rerio (Zebrafish) (Brachydanio rerio)	1132	Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]		GO:0001889; GO:0005794; GO:0006487; GO:0007030; GO:0009306; GO:0016192; GO:0055088; GO:0060041; GO:1905897	Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38534_c0_g1_i1	Q1RLX4	TPC11_DANRE	55.9	256	111	2	1	765	98	352	2.90E-81	303.1	TPC11_DANRE	reviewed	Trafficking protein particle complex subunit 11 (Protein foie gras)	trappc11 fgr foigr zgc:136723 zgc:63684	Danio rerio (Zebrafish) (Brachydanio rerio)	1132	Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]		GO:0001889; GO:0005794; GO:0006487; GO:0007030; GO:0009306; GO:0016192; GO:0055088; GO:0060041; GO:1905897	Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN672_c0_g2_i1	Q8K2L8	TPC12_MOUSE	40.2	527	295	6	1640	102	276	796	2.70E-100	367.5	TPC12_MOUSE	reviewed	Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15)	Trappc12 Ttc15	Mus musculus (Mouse)	797	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]	endopeptidase activity [GO:0004175]	GO:0000776; GO:0004175; GO:0005634; GO:0005654; GO:0005793; GO:0005794; GO:0006888; GO:0007030; GO:0030008; GO:0048471; GO:0051310; GO:0090234; GO:1905342	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]		NA	NA	NA	NA	NA	NA
TRINITY_DN672_c0_g2_i2	Q8K2L8	TPC12_MOUSE	43.1	450	249	2	1439	102	350	796	3.00E-101	370.5	TPC12_MOUSE	reviewed	Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15)	Trappc12 Ttc15	Mus musculus (Mouse)	797	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]	endopeptidase activity [GO:0004175]	GO:0000776; GO:0004175; GO:0005634; GO:0005654; GO:0005793; GO:0005794; GO:0006888; GO:0007030; GO:0030008; GO:0048471; GO:0051310; GO:0090234; GO:1905342	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]		NA	NA	NA	NA	NA	NA
TRINITY_DN29108_c0_g1_i1	Q8WVT3	TPC12_HUMAN	100	82	0	0	247	2	418	499	4.10E-43	174.9	TPC12_HUMAN	reviewed	Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15) (TTC-15) (Trafficking of membranes and mitosis)	TRAPPC12 TRAMM TTC15 CGI-87	Homo sapiens (Human)	735	cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]	cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]	endopeptidase activity [GO:0004175]	GO:0000776; GO:0004175; GO:0005634; GO:0005654; GO:0005793; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0051310; GO:0090234; GO:1905342	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]		NA	NA	NA	NA	NA	NA
TRINITY_DN1049_c0_g1_i1	Q6PBY7	TPC13_DANRE	53.4	399	181	3	1352	162	8	403	2.00E-115	417.5	TPC13_DANRE	reviewed	Trafficking protein particle complex subunit 13	trappc13 zgc:73187	Danio rerio (Zebrafish) (Brachydanio rerio)	412							blue	blue	NA	NA	NA	NA
TRINITY_DN1049_c0_g1_i3	Q6PBY7	TPC13_DANRE	56.6	113	47	1	404	72	183	295	1.20E-30	134	TPC13_DANRE	reviewed	Trafficking protein particle complex subunit 13	trappc13 zgc:73187	Danio rerio (Zebrafish) (Brachydanio rerio)	412							NA	NA	NA	NA	NA	NA
TRINITY_DN1049_c0_g1_i4	Q6PBY7	TPC13_DANRE	52.2	224	104	2	827	162	181	403	6.00E-59	229.2	TPC13_DANRE	reviewed	Trafficking protein particle complex subunit 13	trappc13 zgc:73187	Danio rerio (Zebrafish) (Brachydanio rerio)	412							NA	NA	NA	NA	NA	NA
TRINITY_DN15196_c0_g1_i1	Q5RES6	TPPC2_PONAB	68.1	138	44	0	98	511	1	138	7.10E-55	214.9	TPPC2_PONAB	reviewed	Trafficking protein particle complex subunit 2	TRAPPC2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	140	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		GO:0005634; GO:0005793; GO:0006888; GO:0048471	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN26878_c0_g1_i1	P0DI81	TPC2A_HUMAN	45.7	81	41	1	23	256	7	87	4.20E-16	85.1	TPC2A_HUMAN	reviewed	Trafficking protein particle complex subunit 2 (Sedlin)	TRAPPC2 SEDL	Homo sapiens (Human)	140	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]	ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]	GO:0000139; GO:0001501; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0006355; GO:0006888; GO:0008134; GO:0030008; GO:0043231; GO:0044325; GO:0048208; GO:0048471	"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26340_c0_g1_i1	P0DI81	TPC2A_HUMAN	100	50	0	0	151	2	1	50	3.90E-23	108.2	TPC2A_HUMAN	reviewed	Trafficking protein particle complex subunit 2 (Sedlin)	TRAPPC2 SEDL	Homo sapiens (Human)	140	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]	ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]	GO:0000139; GO:0001501; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0006355; GO:0006888; GO:0008134; GO:0030008; GO:0043231; GO:0044325; GO:0048208; GO:0048471	"COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1186_c0_g1_i1	B5XGE7	TPC2L_SALSA	59.3	135	55	0	499	95	1	135	2.40E-43	176.8	TPC2L_SALSA	reviewed	Trafficking protein particle complex subunit 2-like protein	trappc2l tpc2l	Salmo salar (Atlantic salmon)	139	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]		GO:0005783; GO:0005794; GO:0006888; GO:0048471	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN1186_c0_g1_i2	B5XGE7	TPC2L_SALSA	58.3	72	30	0	292	77	1	72	5.00E-18	92	TPC2L_SALSA	reviewed	Trafficking protein particle complex subunit 2-like protein	trappc2l tpc2l	Salmo salar (Atlantic salmon)	139	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]		GO:0005783; GO:0005794; GO:0006888; GO:0048471	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN6754_c0_g1_i1	Q9UL33	TPC2L_HUMAN	100	113	0	0	341	3	28	140	2.80E-60	232.3	TPC2L_HUMAN	reviewed	Trafficking protein particle complex subunit 2-like protein	TRAPPC2L HSPC126	Homo sapiens (Human)	140	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0030008; GO:0043231; GO:0048208; GO:0048471	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN6754_c0_g1_i2	Q9UL33	TPC2L_HUMAN	99.3	140	1	0	422	3	1	140	1.40E-75	283.5	TPC2L_HUMAN	reviewed	Trafficking protein particle complex subunit 2-like protein	TRAPPC2L HSPC126	Homo sapiens (Human)	140	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0030008; GO:0043231; GO:0048208; GO:0048471	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN10679_c0_g1_i1	Q5ZI57	TPPC3_CHICK	65	180	62	1	616	80	1	180	1.70E-66	253.8	TPPC3_CHICK	reviewed	Trafficking protein particle complex subunit 3	TRAPPC3 RCJMB04_30c23	Gallus gallus (Chicken)	180	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]		GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]		blue	blue	NA	NA	NA	NA
TRINITY_DN26263_c0_g1_i1	O55013	TPPC3_MOUSE	100	83	0	0	2	250	45	127	1.70E-43	176	TPPC3_MOUSE	reviewed	Trafficking protein particle complex subunit 3 (BET3 homolog)	Trappc3 Bet3	Mus musculus (Mouse)	180	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]		NA	NA	NA	NA	NA	NA
TRINITY_DN22265_c0_g1_i1	O43617	TPPC3_HUMAN	100	141	0	0	426	4	1	141	2.60E-77	289.3	TPPC3_HUMAN	reviewed	Trafficking protein particle complex subunit 3 (BET3 homolog)	TRAPPC3 BET3 CDABP0066	Homo sapiens (Human)	180	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106; GO:0048208	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]		NA	NA	NA	NA	NA	NA
TRINITY_DN40271_c0_g1_i1	Q2TBL9	TPPC4_BOVIN	100	89	0	0	268	2	87	175	3.40E-45	181.8	TPPC4_BOVIN	reviewed	Trafficking protein particle complex subunit 4	TRAPPC4	Bos taurus (Bovine)	219	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; postsynaptic membrane [GO:0045211]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; postsynaptic membrane [GO:0045211]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005795; GO:0006888; GO:0006914; GO:0008021; GO:0016358; GO:0030008; GO:0030425; GO:0045211	autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN27548_c0_g1_i1	Q9Y296	TPPC4_HUMAN	100	200	0	0	1	600	20	219	2.00E-112	406.4	TPPC4_HUMAN	reviewed	Trafficking protein particle complex subunit 4 (Hematopoietic stem/progenitor cell protein 172) (Synbindin) (TRS23 homolog)	TRAPPC4 SBDN CGI-104 HSPC172 PTD009	Homo sapiens (Human)	219	cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005795; GO:0005829; GO:0006888; GO:0006914; GO:0008021; GO:0016358; GO:0030008; GO:0030425; GO:0045202; GO:0045211; GO:0048208	autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN23827_c0_g1_i1	Q9ES56	TPPC4_MOUSE	60.1	213	85	0	97	735	1	213	1.70E-76	287.7	TPPC4_MOUSE	reviewed	Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog)	Trappc4 Sbdn	Mus musculus (Mouse)	219	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005795; GO:0005886; GO:0006888; GO:0006914; GO:0008021; GO:0016192; GO:0016358; GO:0030008; GO:0030425; GO:0045202; GO:0045211; GO:0045212	autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN23827_c0_g1_i2	Q9ES56	TPPC4_MOUSE	60.1	213	85	0	97	735	1	213	1.50E-76	287.7	TPPC4_MOUSE	reviewed	Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog)	Trappc4 Sbdn	Mus musculus (Mouse)	219	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005795; GO:0005886; GO:0006888; GO:0006914; GO:0008021; GO:0016192; GO:0016358; GO:0030008; GO:0030425; GO:0045202; GO:0045211; GO:0045212	autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN23827_c0_g1_i3	Q9ES56	TPPC4_MOUSE	60.1	213	85	0	97	735	1	213	1.70E-76	287.7	TPPC4_MOUSE	reviewed	Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog)	Trappc4 Sbdn	Mus musculus (Mouse)	219	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005795; GO:0005886; GO:0006888; GO:0006914; GO:0008021; GO:0016192; GO:0016358; GO:0030008; GO:0030425; GO:0045202; GO:0045211; GO:0045212	autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neurotransmitter receptor biosynthetic process [GO:0045212]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2467_c0_g1_i2	Q5F359	TPPC5_CHICK	60.5	177	70	0	578	48	12	188	4.50E-59	229.2	TPPC5_CHICK	reviewed	Trafficking protein particle complex subunit 5	TRAPPC5 RCJMB04_33f11	Gallus gallus (Chicken)	188	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; TRAPPII protein complex [GO:1990071]; TRAPPI protein complex [GO:1990070]		GO:0005783; GO:0006888; GO:0030008; GO:1990070; GO:1990071; GO:1990072	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN2467_c0_g1_i3	Q5F359	TPPC5_CHICK	61.9	134	51	0	410	9	55	188	1.20E-46	187.2	TPPC5_CHICK	reviewed	Trafficking protein particle complex subunit 5	TRAPPC5 RCJMB04_33f11	Gallus gallus (Chicken)	188	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; TRAPPII protein complex [GO:1990071]; TRAPPI protein complex [GO:1990070]		GO:0005783; GO:0006888; GO:0030008; GO:1990070; GO:1990071; GO:1990072	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN2467_c0_g1_i4	Q5F359	TPPC5_CHICK	60.5	177	70	0	617	87	12	188	6.20E-59	228.8	TPPC5_CHICK	reviewed	Trafficking protein particle complex subunit 5	TRAPPC5 RCJMB04_33f11	Gallus gallus (Chicken)	188	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; TRAPPII protein complex [GO:1990071]; TRAPPI protein complex [GO:1990070]		GO:0005783; GO:0006888; GO:0030008; GO:1990070; GO:1990071; GO:1990072	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		blue	blue	NA	NA	NA	NA
TRINITY_DN16702_c0_g1_i1	Q2NL13	TPPC5_BOVIN	100	103	0	0	3	311	66	168	3.00E-53	208.8	TPPC5_BOVIN	reviewed	Trafficking protein particle complex subunit 5	TRAPPC5	Bos taurus (Bovine)	188	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; TRAPPII protein complex [GO:1990071]; TRAPPI protein complex [GO:1990070]		GO:0005783; GO:0006888; GO:0030008; GO:1990070; GO:1990071; GO:1990072	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]		NA	NA	NA	NA	NA	NA
TRINITY_DN19229_c0_g1_i1	O75865	TPC6A_HUMAN	99.2	131	1	0	18	410	29	159	2.20E-67	256.1	TPC6A_HUMAN	reviewed	Trafficking protein particle complex subunit 6A (TRAPP complex subunit 6A)	TRAPPC6A HSPC289	Homo sapiens (Human)	159	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; regulation of GTPase activity [GO:0043087]	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]		GO:0000139; GO:0005783; GO:0005801; GO:0005802; GO:0005829; GO:0006888; GO:0030008; GO:0043087; GO:0048208; GO:1903232	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN19229_c0_g1_i2	Q78XR0	TPC6A_MOUSE	89.3	84	9	0	1	252	76	159	1.20E-36	153.3	TPC6A_MOUSE	reviewed	Trafficking protein particle complex subunit 6A (TRAPP complex subunit 6A)	Trappc6a	Mus musculus (Mouse)	159	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; regulation of GTPase activity [GO:0043087]	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]		GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0030008; GO:0043087; GO:0043473; GO:1903232	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN26738_c0_g1_i1	Q32L78	TPC6B_BOVIN	61.4	158	56	2	85	546	1	157	4.00E-52	206.1	TPC6B_BOVIN	reviewed	Trafficking protein particle complex subunit 6B (TRAPP complex subunit 6B)	TRAPPC6B	Bos taurus (Bovine)	158	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]		GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008; GO:0043087	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]		blue	blue	NA	NA	NA	NA
TRINITY_DN32083_c0_g1_i1	Q9D289	TPC6B_MOUSE	100	101	0	0	356	54	58	158	2.90E-52	205.7	TPC6B_MOUSE	reviewed	Trafficking protein particle complex subunit 6B (TRAPP complex subunit 6B)	Trappc6b	Mus musculus (Mouse)	158	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]	cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]		GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008; GO:0043087	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]		NA	NA	NA	NA	NA	NA
TRINITY_DN9702_c0_g1_i1	Q9Y2L5	TPPC8_HUMAN	40.8	814	446	14	2453	60	1	794	2.30E-164	580.9	TPPC8_HUMAN	reviewed	Trafficking protein particle complex subunit 8 (Protein TRS85 homolog)	TRAPPC8 KIAA1012	Homo sapiens (Human)	1435	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]		GO:0000045; GO:0000407; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0030242; GO:0031410; GO:0034497; GO:1990072	autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN32992_c0_g1_i1	Q642M9	DHDH_DANRE	48.3	333	167	3	1061	72	4	334	1.80E-82	307.8	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN32992_c0_g1_i3	Q6DF30	DHDH_XENTR	54.9	153	68	1	882	427	3	155	4.80E-41	169.9	DHDH_XENTR	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	330	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0042843; GO:0047115; GO:0047837	D-xylose catabolic process [GO:0042843]		NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i11	Q642M9	DHDH_DANRE	48.9	333	167	1	1063	74	1	333	5.90E-83	309.3	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i12	Q642M9	DHDH_DANRE	49.2	248	123	1	889	155	1	248	1.70E-59	231.1	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i17	Q642M9	DHDH_DANRE	45.5	165	90	0	568	74	169	333	3.90E-33	143.7	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i17	Q642M9	DHDH_DANRE	56.1	123	51	1	935	576	1	123	3.10E-30	134	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i3	Q642M9	DHDH_DANRE	45.5	165	90	0	568	74	169	333	3.00E-33	143.7	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i4	Q642M9	DHDH_DANRE	49.2	248	123	1	817	83	1	248	2.10E-59	230.7	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i8	Q642M9	DHDH_DANRE	56.1	123	51	1	689	330	1	123	2.30E-30	134	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN1860_c0_g1_i8	Q642M9	DHDH_DANRE	42.5	80	46	0	322	83	169	248	1.30E-09	65.1	DHDH_DANRE	reviewed	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	dhdh ch211-203b17.3 zgc:101723	Danio rerio (Zebrafish) (Brachydanio rerio)	334	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0047115; GO:0047837			NA	NA	NA	NA	NA	NA
TRINITY_DN4516_c0_g1_i1	B1LXF6	TAM_METRJ	36.4	99	56	4	762	475	33	127	3.30E-06	53.9	TAM_METRJ	reviewed	Trans-aconitate 2-methyltransferase (EC 2.1.1.144)	tam Mrad2831_5330	Methylobacterium radiotolerans (strain ATCC 27329 / DSM 1819 / JCM 2831 / NBRC 15690 / NCIMB 10815 / 0-1)	260	cytoplasm [GO:0005737]; trans-aconitate 2-methyltransferase activity [GO:0030798]; methylation [GO:0032259]	cytoplasm [GO:0005737]	trans-aconitate 2-methyltransferase activity [GO:0030798]	GO:0005737; GO:0030798; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN24310_c0_g1_i1	P23771	GATA3_HUMAN	97.8	134	3	0	402	1	258	391	2.10E-74	279.6	GATA3_HUMAN	reviewed	Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3)	GATA3	Homo sapiens (Human)	443	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; blood coagulation [GO:0007596]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; inner ear morphogenesis [GO:0042472]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; protein deubiquitination [GO:0016579]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to virus [GO:0009615]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; type IV hypersensitivity [GO:0001806]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud formation [GO:0060676]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001701; GO:0001709; GO:0001764; GO:0001806; GO:0001822; GO:0001823; GO:0002088; GO:0002520; GO:0002572; GO:0003180; GO:0003215; GO:0003281; GO:0003677; GO:0003700; GO:0003713; GO:0005134; GO:0005634; GO:0005654; GO:0006338; GO:0006952; GO:0006959; GO:0007165; GO:0007411; GO:0007596; GO:0008134; GO:0008270; GO:0008285; GO:0008584; GO:0009615; GO:0009653; GO:0009791; GO:0009967; GO:0010332; GO:0010595; GO:0010719; GO:0010975; GO:0014065; GO:0016579; GO:0019221; GO:0030217; GO:0030218; GO:0030856; GO:0031929; GO:0032609; GO:0032633; GO:0032689; GO:0032703; GO:0032736; GO:0032753; GO:0032754; GO:0033600; GO:0035162; GO:0035457; GO:0035799; GO:0035898; GO:0042035; GO:0042421; GO:0042472; GO:0042493; GO:0042802; GO:0043370; GO:0043523; GO:0043583; GO:0043627; GO:0045061; GO:0045064; GO:0045087; GO:0045165; GO:0045471; GO:0045582; GO:0045599; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0048485; GO:0048538; GO:0048568; GO:0048589; GO:0048646; GO:0050728; GO:0050852; GO:0051569; GO:0051897; GO:0060017; GO:0060037; GO:0060065; GO:0060231; GO:0060374; GO:0060676; GO:0061085; GO:0061290; GO:0070888; GO:0071353; GO:0071356; GO:0071442; GO:0071599; GO:0071773; GO:0071837; GO:0072107; GO:0072178; GO:0072179; GO:0072182; GO:0072197; GO:0072676; GO:0090102; GO:1901536; GO:1902036; GO:1902895; GO:1990837; GO:2000114; GO:2000146; GO:2000352; GO:2000553; GO:2000607; GO:2000611; GO:2000617; GO:2000679; GO:2000683; GO:2000703; GO:2000734	"anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; blood coagulation [GO:0007596]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; innate immune response [GO:0045087]; inner ear morphogenesis [GO:0042472]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; protein deubiquitination [GO:0016579]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to virus [GO:0009615]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; type IV hypersensitivity [GO:0001806]; ureteric bud formation [GO:0060676]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20651_c0_g1_i1	B2U9W5	TAL_RALPJ	99.5	222	1	0	666	1	50	271	3.20E-121	435.6	TAL_RALPJ	reviewed	Transaldolase (EC 2.2.1.2)	tal Rpic_1075	Ralstonia pickettii (strain 12J)	319	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN34377_c0_g1_i1	P15019	TAL1_YEAST	60.3	68	27	0	204	1	68	135	1.40E-14	79.7	TAL1_YEAST	reviewed	Transaldolase (EC 2.2.1.2)	TAL1 YLR354C L9638.6	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	335	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005634; GO:0005737; GO:0005975; GO:0006098; GO:0009052	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15603_c0_g2_i1	Q8VI73	TALDO_CRIGR	73.5	102	27	0	308	3	133	234	6.40E-38	157.9	TALDO_CRIGR	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	337	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN15603_c0_g1_i1	Q2TBL6	TALDO_BOVIN	55.7	115	51	0	345	1	31	145	7.10E-31	134.8	TALDO_BOVIN	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1	Bos taurus (Bovine)	337	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN26791_c1_g1_i1	P15019	TAL1_YEAST	66.7	81	27	0	1	243	85	165	1.30E-22	106.7	TAL1_YEAST	reviewed	Transaldolase (EC 2.2.1.2)	TAL1 YLR354C L9638.6	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	335	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005634; GO:0005737; GO:0005975; GO:0006098; GO:0009052	"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15156_c0_g1_i1	Q2K414	TAL_RHIEC	63.1	249	88	2	9	755	73	317	3.70E-84	312.8	TAL_RHIEC	reviewed	Transaldolase (EC 2.2.1.2)	tal RHE_CH03667	Rhizobium etli (strain CFN 42 / ATCC 51251)	321	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN28758_c0_g1_i1	Q8VI73	TALDO_CRIGR	77.9	68	15	0	206	3	156	223	5.50E-27	120.9	TALDO_CRIGR	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	337	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN33844_c0_g1_i1	A6VLW0	TAL_ACTSZ	59.7	67	27	0	3	203	13	79	4.00E-14	78.2	TAL_ACTSZ	reviewed	Transaldolase (EC 2.2.1.2)	tal Asuc_0582	Actinobacillus succinogenes (strain ATCC 55618 / DSM 22257 / 130Z)	317	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		NA	NA	NA	NA	NA	NA
TRINITY_DN21220_c0_g1_i1	Q8VI73	TALDO_CRIGR	77.8	27	6	0	2	82	197	223	4.30E-06	51.6	TALDO_CRIGR	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	337	cytoplasm [GO:0005737]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005737; GO:0005975; GO:0006098	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]		blue	blue	NA	NA	NA	NA
TRINITY_DN7144_c0_g1_i1	Q93092	TALDO_MOUSE	99.3	282	2	0	52	897	1	282	1.20E-155	550.4	TALDO_MOUSE	reviewed	Transaldolase (EC 2.2.1.2)	Taldo1 Tal Taldo	Mus musculus (Mouse)	337	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005829; GO:0005975; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0030246; GO:0043231; GO:0048029	"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7144_c0_g1_i2	P37837	TALDO_HUMAN	97.9	282	6	0	38	883	1	282	1.50E-153	543.5	TALDO_HUMAN	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1 TAL TALDO TALDOR	Homo sapiens (Human)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0005999; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0035722; GO:0048029; GO:0070062	"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7144_c0_g1_i3	P37837	TALDO_HUMAN	97.9	337	7	0	52	1062	1	337	4.60E-186	651.7	TALDO_HUMAN	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1 TAL TALDO TALDOR	Homo sapiens (Human)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0005999; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0035722; GO:0048029; GO:0070062	"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7144_c0_g1_i4	P37837	TALDO_HUMAN	100	337	0	0	38	1048	1	337	2.60E-189	662.5	TALDO_HUMAN	reviewed	Transaldolase (EC 2.2.1.2)	TALDO1 TAL TALDO TALDOR	Homo sapiens (Human)	337	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0005999; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0035722; GO:0048029; GO:0070062	"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38643_c0_g1_i1	Q9EQS0	TALDO_RAT	67	330	109	0	1077	88	1	330	8.90E-127	454.9	TALDO_RAT	reviewed	Transaldolase (EC 2.2.1.2)	Taldo1	Rattus norvegicus (Rat)	337	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]	GO:0004801; GO:0005829; GO:0005975; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0030246; GO:0043231; GO:0048029	"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25742_c0_g1_i1	A7Z019	SMCA4_BOVIN	95.6	114	5	0	3	344	359	472	6.30E-44	177.9	SMCA4_BOVIN	reviewed	Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)	SMARCA4 BAF190A BRG1 SNF2B SNF2L4	Bos taurus (Bovine)	1606	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0007399; GO:0008094; GO:0008134; GO:0016514; GO:0042393; GO:0043044; GO:0045944; GO:0071564; GO:0071565	ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN37800_c0_g1_i1	A7Z019	SMCA4_BOVIN	93.4	91	6	0	273	1	418	508	1.30E-31	136.7	SMCA4_BOVIN	reviewed	Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)	SMARCA4 BAF190A BRG1 SNF2B SNF2L4	Bos taurus (Bovine)	1606	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0007399; GO:0008094; GO:0008134; GO:0016514; GO:0042393; GO:0043044; GO:0045944; GO:0071564; GO:0071565	ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN6215_c0_g1_i1	A7Z019	SMCA4_BOVIN	82.1	117	20	1	349	2	1104	1220	6.60E-49	194.5	SMCA4_BOVIN	reviewed	Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)	SMARCA4 BAF190A BRG1 SNF2B SNF2L4	Bos taurus (Bovine)	1606	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0007399; GO:0008094; GO:0008134; GO:0016514; GO:0042393; GO:0043044; GO:0045944; GO:0071564; GO:0071565	ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN6215_c0_g1_i4	A7Z019	SMCA4_BOVIN	82.1	117	20	1	349	2	1104	1220	6.60E-49	194.5	SMCA4_BOVIN	reviewed	Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)	SMARCA4 BAF190A BRG1 SNF2B SNF2L4	Bos taurus (Bovine)	1606	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0007399; GO:0008094; GO:0008134; GO:0016514; GO:0042393; GO:0043044; GO:0045944; GO:0071564; GO:0071565	ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN30171_c0_g1_i1	Q29RL9	TCEA1_BOVIN	100	49	0	0	213	67	253	301	5.30E-25	114.4	TCEA1_BOVIN	reviewed	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1)	TCEA1	Bos taurus (Bovine)	301	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006351; GO:0008270; GO:0045944	"positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35600_c0_g1_i1	Q29RL9	TCEA1_BOVIN	100	69	0	0	210	4	158	226	2.60E-32	138.7	TCEA1_BOVIN	reviewed	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1)	TCEA1	Bos taurus (Bovine)	301	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006351; GO:0008270; GO:0045944	"positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40525_c0_g1_i1	P23193	TCEA1_HUMAN	100	91	0	0	273	1	9	99	3.00E-41	168.7	TCEA1_HUMAN	reviewed	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o)	TCEA1 GTF2S TFIIS	Homo sapiens (Human)	301	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005654; GO:0005669; GO:0005730; GO:0006283; GO:0006366; GO:0006368; GO:0008270; GO:0045944; GO:1901919	positive regulation of exoribonuclease activity [GO:1901919]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN37970_c0_g1_i1	Q148K0	TCEA2_BOVIN	100	64	0	0	2	193	237	300	1.70E-33	142.9	TCEA2_BOVIN	reviewed	Transcription elongation factor A protein 2 (Transcription elongation factor S-II protein 2)	TCEA2	Bos taurus (Bovine)	300	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8031_c0_g1_i1	Q9VCP0	ELOA1_DROME	56.9	130	54	2	453	839	408	536	1.30E-34	148.3	ELOA1_DROME	reviewed	Transcription elongation factor B polypeptide 3 (Elongin-A) (RNA polymerase II transcription factor SIII subunit A) (dEloA)	EloA CG6755	Drosophila melanogaster (Fruit fly)	643	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]		GO:0005634; GO:0006368; GO:0007474; GO:0008023; GO:0032968; GO:0070449	imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN8031_c0_g1_i2	Q9VCP0	ELOA1_DROME	61.5	96	35	2	453	737	408	502	2.30E-26	120.9	ELOA1_DROME	reviewed	Transcription elongation factor B polypeptide 3 (Elongin-A) (RNA polymerase II transcription factor SIII subunit A) (dEloA)	EloA CG6755	Drosophila melanogaster (Fruit fly)	643	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]		GO:0005634; GO:0006368; GO:0007474; GO:0008023; GO:0032968; GO:0070449	imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN8031_c0_g1_i4	Q9VCP0	ELOA1_DROME	59	83	34	0	71	319	454	536	5.10E-24	111.7	ELOA1_DROME	reviewed	Transcription elongation factor B polypeptide 3 (Elongin-A) (RNA polymerase II transcription factor SIII subunit A) (dEloA)	EloA CG6755	Drosophila melanogaster (Fruit fly)	643	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]		GO:0005634; GO:0006368; GO:0007474; GO:0008023; GO:0032968; GO:0070449	imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN1530_c0_g1_i1	Q9VCP0	ELOA1_DROME	43.4	83	45	1	7	255	2	82	3.00E-09	62.8	ELOA1_DROME	reviewed	Transcription elongation factor B polypeptide 3 (Elongin-A) (RNA polymerase II transcription factor SIII subunit A) (dEloA)	EloA CG6755	Drosophila melanogaster (Fruit fly)	643	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]		GO:0005634; GO:0006368; GO:0007474; GO:0008023; GO:0032968; GO:0070449	imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]		blue	blue	NA	NA	NA	NA
TRINITY_DN5309_c1_g1_i1	P20232	TFS2_DROME	58.1	313	107	2	971	105	1	313	9.50E-75	282	TFS2_DROME	reviewed	Transcription elongation factor S-II (RNA polymerase II elongation factor DMS-II) (TFIIS)	TfIIS DmSII CG3710	Drosophila melanogaster (Fruit fly)	313	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006355; GO:0006368; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		blue	blue	NA	NA	NA	NA
TRINITY_DN2584_c0_g1_i1	P63271	SPT4A_MOUSE	66.7	111	37	0	87	419	2	112	5.40E-44	178.7	SPT4A_MOUSE	reviewed	Transcription elongation factor SPT4-A (DRB sensitivity-inducing factor small subunit 1) (DSIF small subunit 1) (Transcription elongation factor SPT4 1)	Supt4h1a Spt4h Supt4a Supt4h	Mus musculus (Mouse)	117	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000993; GO:0005654; GO:0006325; GO:0006368; GO:0006397; GO:0008270; GO:0032044; GO:0032785; GO:0032786; GO:0034243; GO:0034244; GO:0045944; GO:0046982	"chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		blue	blue	NA	NA	NA	NA
TRINITY_DN25172_c0_g1_i1	P63271	SPT4A_MOUSE	100	91	0	0	12	284	1	91	3.10E-49	195.3	SPT4A_MOUSE	reviewed	Transcription elongation factor SPT4-A (DRB sensitivity-inducing factor small subunit 1) (DSIF small subunit 1) (Transcription elongation factor SPT4 1)	Supt4h1a Spt4h Supt4a Supt4h	Mus musculus (Mouse)	117	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000993; GO:0005654; GO:0006325; GO:0006368; GO:0006397; GO:0008270; GO:0032044; GO:0032785; GO:0032786; GO:0034243; GO:0034244; GO:0045944; GO:0046982	"chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25172_c0_g1_i2	P63271	SPT4A_MOUSE	100	90	0	0	1	270	2	91	6.60E-49	194.1	SPT4A_MOUSE	reviewed	Transcription elongation factor SPT4-A (DRB sensitivity-inducing factor small subunit 1) (DSIF small subunit 1) (Transcription elongation factor SPT4 1)	Supt4h1a Spt4h Supt4a Supt4h	Mus musculus (Mouse)	117	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000993; GO:0005654; GO:0006325; GO:0006368; GO:0006397; GO:0008270; GO:0032044; GO:0032785; GO:0032786; GO:0034243; GO:0034244; GO:0045944; GO:0046982	"chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37507_c0_g1_i1	Q5ZI08	SPT5H_CHICK	94	83	4	1	246	1	676	758	1.70E-35	149.4	SPT5H_CHICK	reviewed	Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit)	SUPT5H RCJMB04_31j17	Gallus gallus (Chicken)	1079	"DSIF complex [GO:0032044]; mRNA binding [GO:0003729]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]	mRNA binding [GO:0003729]	GO:0003729; GO:0006357; GO:0006368; GO:0032044; GO:0032784	"regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33500_c0_g1_i1	O55201	SPT5H_MOUSE	100	114	0	0	343	2	964	1077	1.00E-57	223.8	SPT5H_MOUSE	reviewed	Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit)	Supt5h Supt5	Mus musculus (Mouse)	1082	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]	GO:0000122; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:1900364	"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33036_c0_g1_i1	O55201	SPT5H_MOUSE	100	67	0	0	1	201	694	760	1.80E-31	136	SPT5H_MOUSE	reviewed	Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit)	Supt5h Supt5	Mus musculus (Mouse)	1082	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]	GO:0000122; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:1900364	"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN375_c0_g1_i1	O55201	SPT5H_MOUSE	55	109	47	1	408	88	971	1079	5.60E-29	129.4	SPT5H_MOUSE	reviewed	Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit)	Supt5h Supt5	Mus musculus (Mouse)	1082	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]	GO:0000122; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:1900364	"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4076_c0_g1_i1	Q9V460	SPT5H_DROME	62.2	582	213	4	1735	2	140	718	5.70E-213	741.9	SPT5H_DROME	reviewed	Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (dSpt5)	Spt5 CG7626	Drosophila melanogaster (Fruit fly)	1078	"DSIF complex [GO:0032044]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; dosage compensation [GO:0007549]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]	chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0003682; GO:0003729; GO:0005700; GO:0005703; GO:0005705; GO:0006357; GO:0006368; GO:0007549; GO:0008023; GO:0032044; GO:0032785; GO:0032786; GO:0044877; GO:0045944; GO:0046982	"dosage compensation [GO:0007549]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5909_c0_g1_i1	Q9V460	SPT5H_DROME	65.2	69	23	1	315	109	738	805	2.00E-17	90.1	SPT5H_DROME	reviewed	Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (dSpt5)	Spt5 CG7626	Drosophila melanogaster (Fruit fly)	1078	"DSIF complex [GO:0032044]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; dosage compensation [GO:0007549]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; transcription elongation factor complex [GO:0008023]	chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0003682; GO:0003729; GO:0005700; GO:0005703; GO:0005705; GO:0006357; GO:0006368; GO:0007549; GO:0008023; GO:0032044; GO:0032785; GO:0032786; GO:0044877; GO:0045944; GO:0046982	"dosage compensation [GO:0007549]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21436_c0_g1_i1	O00267	SPT5H_HUMAN	100	322	0	0	3	968	307	628	3.50E-185	648.7	SPT5H_HUMAN	reviewed	Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein)	SUPT5H SPT5 SPT5H	Homo sapiens (Human)	1087	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006370; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:0050434; GO:1900364	"7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21436_c0_g1_i2	O00267	SPT5H_HUMAN	99.5	209	1	0	1	627	420	628	2.40E-118	426	SPT5H_HUMAN	reviewed	Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein)	SUPT5H SPT5 SPT5H	Homo sapiens (Human)	1087	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006370; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:0050434; GO:1900364	"7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30071_c0_g1_i1	O00267	SPT5H_HUMAN	100	204	0	0	613	2	140	343	1.20E-114	413.7	SPT5H_HUMAN	reviewed	Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein)	SUPT5H SPT5 SPT5H	Homo sapiens (Human)	1087	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006370; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:0050434; GO:1900364	"7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36644_c0_g1_i1	Q7KZ85	SPT6H_HUMAN	98.8	86	1	0	258	1	1166	1251	7.00E-48	190.7	SPT6H_HUMAN	reviewed	Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein)	SUPT6H KIAA0162 SPT6H	Homo sapiens (Human)	1726	nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]	nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006366; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0016032; GO:0031491; GO:0032968; GO:0034728; GO:0035327; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0061086; GO:0070827	blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4757_c0_g1_i1	Q8UVK2	SPT6H_DANRE	51.2	215	92	2	1	630	265	471	2.40E-51	203.8	SPT6H_DANRE	reviewed	Transcription elongation factor SPT6 (Protein pandora)	supt6h pan spt6	Danio rerio (Zebrafish) (Brachydanio rerio)	1726	transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; chromatin maintenance [GO:0070827]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of mRNA processing [GO:0050684]; somitogenesis [GO:0001756]; transcription elongation from RNA polymerase II promoter [GO:0006368]	transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]	GO:0001756; GO:0003677; GO:0006368; GO:0007507; GO:0008023; GO:0031491; GO:0032968; GO:0034728; GO:0035050; GO:0035327; GO:0042393; GO:0042789; GO:0050684; GO:0061086; GO:0070827; GO:0071599	chromatin maintenance [GO:0070827]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of mRNA processing [GO:0050684]; somitogenesis [GO:0001756]; transcription elongation from RNA polymerase II promoter [GO:0006368]		blue	blue	NA	NA	NA	NA
TRINITY_DN81_c0_g1_i1	Q8UVK2	SPT6H_DANRE	54.1	1020	455	9	3287	258	507	1523	0	1114	SPT6H_DANRE	reviewed	Transcription elongation factor SPT6 (Protein pandora)	supt6h pan spt6	Danio rerio (Zebrafish) (Brachydanio rerio)	1726	transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; chromatin maintenance [GO:0070827]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of mRNA processing [GO:0050684]; somitogenesis [GO:0001756]; transcription elongation from RNA polymerase II promoter [GO:0006368]	transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]	GO:0001756; GO:0003677; GO:0006368; GO:0007507; GO:0008023; GO:0031491; GO:0032968; GO:0034728; GO:0035050; GO:0035327; GO:0042393; GO:0042789; GO:0050684; GO:0061086; GO:0070827; GO:0071599	chromatin maintenance [GO:0070827]; embryonic heart tube development [GO:0035050]; heart development [GO:0007507]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; otic vesicle development [GO:0071599]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of mRNA processing [GO:0050684]; somitogenesis [GO:0001756]; transcription elongation from RNA polymerase II promoter [GO:0006368]		NA	NA	NA	NA	NA	NA
TRINITY_DN10811_c0_g1_i1	Q9ZVH8	RDO2_ARATH	70.7	41	12	0	197	75	338	378	4.30E-13	75.1	RDO2_ARATH	reviewed	Transcription elongation factor TFIIS (Protein REDUCED DORMANCY 2)	TFIIS RDO2 At2g38560	Arabidopsis thaliana (Mouse-ear cress)	378	"nucleus [GO:0005634]; translation elongation factor activity [GO:0003746]; zinc ion binding [GO:0008270]; negative regulation of flower development [GO:0009910]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gibberellin [GO:0009739]; seed dormancy process [GO:0010162]; seed germination [GO:0009845]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	translation elongation factor activity [GO:0003746]; zinc ion binding [GO:0008270]	GO:0003746; GO:0005634; GO:0006351; GO:0008270; GO:0009739; GO:0009845; GO:0009910; GO:0010162; GO:0034243	"negative regulation of flower development [GO:0009910]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gibberellin [GO:0009739]; seed dormancy process [GO:0010162]; seed germination [GO:0009845]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3240_c0_g1_i1	Q8CGF7	TCRG1_MOUSE	39.2	451	220	5	1399	110	432	849	4.30E-76	287	TCRG1_MOUSE	reviewed	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)	Tcerg1 Taf2s	Mus musculus (Mouse)	1100	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003700; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006397; GO:0008380; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	"mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3240_c0_g1_i3	Q8CGF7	TCRG1_MOUSE	37.4	398	195	5	1212	82	432	796	1.00E-60	235.7	TCRG1_MOUSE	reviewed	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)	Tcerg1 Taf2s	Mus musculus (Mouse)	1100	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003700; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006397; GO:0008380; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	"mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35577_c0_g1_i1	Q8CGF7	TCRG1_MOUSE	100	75	0	0	38	262	645	719	1.50E-34	146.4	TCRG1_MOUSE	reviewed	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)	Tcerg1 Taf2s	Mus musculus (Mouse)	1100	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003700; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006397; GO:0008380; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	"mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4396_c0_g2_i1	O14776	TCRG1_HUMAN	63.8	47	15	1	237	97	135	179	2.40E-09	63.9	TCRG1_HUMAN	reviewed	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	Homo sapiens (Human)	1098	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN4396_c0_g2_i2	O14776	TCRG1_HUMAN	63.8	47	15	1	237	97	135	179	1.50E-09	63.9	TCRG1_HUMAN	reviewed	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	Homo sapiens (Human)	1098	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN3240_c0_g1_i2	O14776	TCRG1_HUMAN	52.8	53	25	0	268	110	795	847	7.10E-08	58.2	TCRG1_HUMAN	reviewed	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	Homo sapiens (Human)	1098	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	1
TRINITY_DN3029_c0_g1_i1	O14776	TCRG1_HUMAN	56.4	202	88	0	683	78	894	1095	1.80E-59	231.1	TCRG1_HUMAN	reviewed	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	Homo sapiens (Human)	1098	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN3029_c0_g1_i2	O14776	TCRG1_HUMAN	56.4	202	88	0	683	78	894	1095	1.80E-59	231.1	TCRG1_HUMAN	reviewed	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	Homo sapiens (Human)	1098	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN26627_c0_g1_i1	O14776	TCRG1_HUMAN	100	138	0	0	434	21	894	1031	1.30E-70	266.9	TCRG1_HUMAN	reviewed	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	Homo sapiens (Human)	1098	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0000122; GO:0001103; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0070063; GO:0070064	mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24186_c0_g1_i1	Q9BQ70	TCF25_HUMAN	100	118	0	0	357	4	323	440	4.30E-64	245	TCF25_HUMAN	reviewed	Transcription factor 25 (TCF-25) (Nuclear localized protein 1)	TCF25 KIAA1049 NULP1 FKSG26	Homo sapiens (Human)	676	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007507	heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN24186_c0_g1_i2	Q8R3L2	TCF25_MOUSE	98.3	119	2	0	359	3	323	441	2.20E-63	242.7	TCF25_MOUSE	reviewed	Transcription factor 25 (TCF-25) (Nuclear localized protein 1)	Tcf25 D8Ertd325e Nulp1	Mus musculus (Mouse)	676	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000122; GO:0003677; GO:0003700; GO:0005634	negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN31558_c0_g1_i1	Q9BQ70	TCF25_HUMAN	98.8	85	1	0	258	4	229	313	1.80E-40	166	TCF25_HUMAN	reviewed	Transcription factor 25 (TCF-25) (Nuclear localized protein 1)	TCF25 KIAA1049 NULP1 FKSG26	Homo sapiens (Human)	676	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007507	heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1558_c0_g1_i1	Q9BQ70	TCF25_HUMAN	45	331	163	3	552	1544	174	485	2.30E-80	301.2	TCF25_HUMAN	reviewed	Transcription factor 25 (TCF-25) (Nuclear localized protein 1)	TCF25 KIAA1049 NULP1 FKSG26	Homo sapiens (Human)	676	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007507	heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN1558_c0_g1_i3	Q9BQ70	TCF25_HUMAN	43	542	270	8	552	2177	174	676	8.40E-121	436	TCF25_HUMAN	reviewed	Transcription factor 25 (TCF-25) (Nuclear localized protein 1)	TCF25 KIAA1049 NULP1 FKSG26	Homo sapiens (Human)	676	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007507	heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN29280_c0_g1_i1	Q9BQ70	TCF25_HUMAN	100	67	0	0	3	203	438	504	6.10E-31	134	TCF25_HUMAN	reviewed	Transcription factor 25 (TCF-25) (Nuclear localized protein 1)	TCF25 KIAA1049 NULP1 FKSG26	Homo sapiens (Human)	676	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0000122; GO:0003677; GO:0003700; GO:0005634; GO:0007507	heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN32741_c0_g1_i2	P56432	JUN_PIG	89.3	112	12	0	13	348	220	331	2.00E-43	176.4	JUN_PIG	reviewed	Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog)	JUN	Sus scrofa (Pig)	331	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0006955; GO:0007265; GO:0008134; GO:0042127; GO:0045893; GO:0051091; GO:0051726; GO:0071222	"cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9568_c0_g1_i1	P54864	JUN_SERCA	40.9	88	39	4	271	35	5	88	9.80E-05	47.8	JUN_SERCA	reviewed	Transcription factor AP-1 (Proto-oncogene c-Jun)	JUN	Serinus canaria (Island canary) (Fringilla canaria)	314	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; Ras protein signal transduction [GO:0007265]	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003700; GO:0005634; GO:0007265	Ras protein signal transduction [GO:0007265]		NA	NA	NA	NA	NA	NA
TRINITY_DN3974_c0_g1_i1	Q76HI7	AP2B_CANLF	35.2	125	77	2	265	627	233	357	6.70E-10	66.2	AP2B_CANLF	reviewed	Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta)	TFAP2B	Canis lupus familiaris (Dog) (Canis familiaris)	460	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonium homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001822; GO:0003091; GO:0003682; GO:0003700; GO:0005634; GO:0006006; GO:0006357; GO:0008284; GO:0008285; GO:0010628; GO:0010960; GO:0030510; GO:0035136; GO:0035137; GO:0035810; GO:0035909; GO:0042127; GO:0042593; GO:0043066; GO:0043525; GO:0043565; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048856; GO:0050796; GO:0055062; GO:0055074; GO:0055075; GO:0055078; GO:0072017; GO:0072044; GO:0097070; GO:0097275; GO:0097276; GO:0097277	"anatomical structure development [GO:0048856]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonium homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34248_c0_g1_i1	Q01664	TFAP4_HUMAN	77	87	20	0	57	317	31	117	2.20E-29	129.8	TFAP4_HUMAN	reviewed	Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41)	TFAP4 BHLHC41	Homo sapiens (Human)	338	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]"	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0006978; GO:0008285; GO:0017053; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071157; GO:0071549; GO:1901990; GO:1990837; GO:2001269	"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34248_c0_g1_i2	Q01664	TFAP4_HUMAN	75.3	97	24	0	137	427	21	117	8.40E-34	144.8	TFAP4_HUMAN	reviewed	Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41)	TFAP4 BHLHC41	Homo sapiens (Human)	338	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]"	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0006978; GO:0008285; GO:0017053; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071157; GO:0071549; GO:1901990; GO:1990837; GO:2001269	"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN128_c0_g1_i1	P52167	GATAB_BOMMO	77.3	66	15	0	920	1117	310	375	2.00E-23	111.7	GATAB_BOMMO	reviewed	Transcription factor BCFI (BmGATA-beta) (GATA-beta)	GATA-B	Bombyx mori (Silk moth)	508	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0043565	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33612_c0_g1_i1	Q64152	BTF3_MOUSE	97.9	145	3	0	438	4	39	183	1.30E-71	270.4	BTF3_MOUSE	reviewed	Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3)	Btf3	Mus musculus (Mouse)	204	cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; in utero embryonic development [GO:0001701]; protein transport [GO:0015031]	cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]		GO:0001701; GO:0005634; GO:0005829; GO:0005854; GO:0015031; GO:0042788	in utero embryonic development [GO:0001701]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN20390_c0_g1_i1	P20290	BTF3_HUMAN	98.6	140	2	0	421	2	44	183	9.00E-69	260.8	BTF3_HUMAN	reviewed	Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3)	BTF3 NACB OK/SW-cl.8	Homo sapiens (Human)	206	cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; protein transport [GO:0015031]; transcription by RNA polymerase II [GO:0006366]	cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]	GO:0001701; GO:0003723; GO:0005634; GO:0005829; GO:0005854; GO:0006366; GO:0015031; GO:0042788	in utero embryonic development [GO:0001701]; protein transport [GO:0015031]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN3752_c0_g1_i1	Q18885	BTF3_CAEEL	60.3	68	27	0	209	6	42	109	1.20E-18	93.2	BTF3_CAEEL	reviewed	Transcription factor BTF3 homolog (Inhibitor of cell death 1) (Nascent polypeptide-associated complex subunit beta) (NAC-beta)	icd-1 C56C10.8	Caenorhabditis elegans	161	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]		GO:0005634; GO:0005739; GO:0005829; GO:0005854; GO:0009792; GO:0042788; GO:0043066	embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]		NA	NA	NA	NA	NA	NA
TRINITY_DN3752_c0_g2_i1	Q18885	BTF3_CAEEL	62.5	80	30	0	240	1	42	121	2.10E-23	109.4	BTF3_CAEEL	reviewed	Transcription factor BTF3 homolog (Inhibitor of cell death 1) (Nascent polypeptide-associated complex subunit beta) (NAC-beta)	icd-1 C56C10.8	Caenorhabditis elegans	161	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]		GO:0005634; GO:0005739; GO:0005829; GO:0005854; GO:0009792; GO:0042788; GO:0043066	embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]		NA	NA	NA	NA	NA	NA
TRINITY_DN30837_c0_g1_i1	Q96K17	BT3L4_HUMAN	100	134	0	0	45	446	1	134	8.90E-67	254.2	BT3L4_HUMAN	reviewed	Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4)	BTF3L4	Homo sapiens (Human)	158							NA	NA	NA	NA	NA	NA
TRINITY_DN10942_c0_g2_i1	Q6PC91	BT3L4_DANRE	53.2	154	67	1	91	537	1	154	2.30E-36	153.7	BT3L4_DANRE	reviewed	Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4)	btf3l4	Danio rerio (Zebrafish) (Brachydanio rerio)	158							NA	NA	NA	NA	NA	NA
TRINITY_DN10942_c0_g1_i3	Q6PC91	BT3L4_DANRE	60.3	156	57	1	93	545	1	156	1.10E-43	177.9	BT3L4_DANRE	reviewed	Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4)	btf3l4	Danio rerio (Zebrafish) (Brachydanio rerio)	158							NA	NA	NA	NA	NA	NA
TRINITY_DN10942_c0_g1_i7	Q6PC91	BT3L4_DANRE	60.3	156	57	1	93	545	1	156	4.00E-43	176	BT3L4_DANRE	reviewed	Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4)	btf3l4	Danio rerio (Zebrafish) (Brachydanio rerio)	158							blue	blue	NA	NA	NA	NA
TRINITY_DN5500_c0_g1_i1	Q7T2U9	TFCP2_CHICK	43.2	463	206	7	639	1955	67	496	1.00E-101	372.5	TFCP2_CHICK	reviewed	Transcription factor CP2	TFCP2	Gallus gallus (Chicken)	496	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045944	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5204_c0_g1_i1	Q9VGZ5	CWO_DROME	47.1	138	52	4	1856	2266	63	180	1.10E-24	116.7	CWO_DROME	reviewed	Transcription factor cwo (Protein clockwork orange)	cwo CG17100	Drosophila melanogaster (Fruit fly)	698	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0032922; GO:0042752; GO:0046983; GO:0048813; GO:0050767	"anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5204_c0_g1_i1	Q9VGZ5	CWO_DROME	43.5	124	50	3	1850	1479	74	177	1.40E-19	99.8	CWO_DROME	reviewed	Transcription factor cwo (Protein clockwork orange)	cwo CG17100	Drosophila melanogaster (Fruit fly)	698	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0032922; GO:0042752; GO:0046983; GO:0048813; GO:0050767	"anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5204_c0_g1_i2	Q9VGZ5	CWO_DROME	47.1	138	52	4	396	806	63	180	4.20E-25	116.7	CWO_DROME	reviewed	Transcription factor cwo (Protein clockwork orange)	cwo CG17100	Drosophila melanogaster (Fruit fly)	698	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0032922; GO:0042752; GO:0046983; GO:0048813; GO:0050767	"anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35945_c0_g1_i1	Q14186	TFDP1_HUMAN	91.1	112	10	0	3	338	224	335	7.20E-51	201.1	TFDP1_HUMAN	reviewed	Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1)	TFDP1 DP1	Homo sapiens (Human)	410	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]"	GO:0000083; GO:0000790; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006366; GO:0006977; GO:0008134; GO:0008544; GO:0019904; GO:0043276; GO:0045944; GO:0051091; GO:0070317; GO:0070345; GO:0090575; GO:1900087; GO:1900740; GO:2000278	"anoikis [GO:0043276]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16_c0_g1_i1	Q64163	TFDP2_MOUSE	47.1	225	105	4	753	97	218	434	1.80E-43	177.6	TFDP2_MOUSE	reviewed	Transcription factor Dp-2 (Dp-3) (E2F dimerization partner 2)	Tfdp2 Dp2	Mus musculus (Mouse)	446	"mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]"	GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007049; GO:0008134; GO:0019904; GO:0045892; GO:0045944; GO:0051726; GO:0072686; GO:0090575	"cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16_c0_g2_i1	Q14188	TFDP2_HUMAN	71	100	27	2	687	986	107	204	7.30E-29	129.4	TFDP2_HUMAN	reviewed	Transcription factor Dp-2 (E2F dimerization partner 2)	TFDP2 DP2	Homo sapiens (Human)	446	"mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; heart development [GO:0007507]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]"	GO:0000083; GO:0000790; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0006977; GO:0007507; GO:0008134; GO:0019904; GO:0045892; GO:0045944; GO:0070317; GO:0072686; GO:0090575; GO:1900740	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; heart development [GO:0007507]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9656_c0_g1_i1	O00716	E2F3_HUMAN	45.3	86	44	1	254	6	180	265	9.60E-13	73.9	E2F3_HUMAN	reviewed	Transcription factor E2F3 (E2F-3)	E2F3 KIAA0075	Homo sapiens (Human)	465	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000082; GO:0000122; GO:0000790; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006367; GO:0006606; GO:0008134; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0070345; GO:0090575; GO:1905461; GO:1990837	G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN14437_c0_g1_i1	O00716	E2F3_HUMAN	35.8	400	161	12	1240	80	133	449	5.10E-47	190.3	E2F3_HUMAN	reviewed	Transcription factor E2F3 (E2F-3)	E2F3 KIAA0075	Homo sapiens (Human)	465	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000082; GO:0000122; GO:0000790; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006367; GO:0006606; GO:0008134; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0070345; GO:0090575; GO:1905461; GO:1990837	G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN16391_c0_g1_i1	Q16254	E2F4_HUMAN	100	198	0	0	596	3	15	212	8.20E-108	391	E2F4_HUMAN	reviewed	Transcription factor E2F4 (E2F-4)	E2F4	Homo sapiens (Human)	413	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000083; GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0002064; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006884; GO:0006977; GO:0008015; GO:0008134; GO:0009887; GO:0019904; GO:0042127; GO:0043565; GO:0044458; GO:0045944; GO:0046983; GO:0051726; GO:0090575; GO:0098534; GO:1903251; GO:1990837; GO:1990841	"animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16391_c0_g1_i2	Q8R0K9	E2F4_MOUSE	100	189	0	0	569	3	15	203	2.60E-103	375.9	E2F4_MOUSE	reviewed	Transcription factor E2F4 (E2F-4)	E2f4	Mus musculus (Mouse)	410	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; cilium assembly [GO:0060271]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000083; GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0002064; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006884; GO:0008015; GO:0008134; GO:0008361; GO:0009887; GO:0019904; GO:0042127; GO:0043565; GO:0044458; GO:0045944; GO:0046983; GO:0051726; GO:0060271; GO:0090575; GO:0098534; GO:1903251; GO:1990837; GO:1990841	"animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; cilium assembly [GO:0060271]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cell size [GO:0008361]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12095_c0_g1_i1	Q16254	E2F4_HUMAN	70.4	203	59	1	59	667	15	216	7.50E-73	275.8	E2F4_HUMAN	reviewed	Transcription factor E2F4 (E2F-4)	E2F4	Homo sapiens (Human)	413	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000083; GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0002064; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006884; GO:0006977; GO:0008015; GO:0008134; GO:0009887; GO:0019904; GO:0042127; GO:0043565; GO:0044458; GO:0045944; GO:0046983; GO:0051726; GO:0090575; GO:0098534; GO:1903251; GO:1990837; GO:1990841	"animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29123_c0_g1_i1	Q61502	E2F5_MOUSE	100	71	0	0	1	213	156	226	8.70E-36	150.2	E2F5_MOUSE	reviewed	Transcription factor E2F5 (E2F-5)	E2f5	Mus musculus (Mouse)	335	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; sarcoplasm [GO:0016528]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; cell projection organization [GO:0030030]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; sarcoplasm [GO:0016528]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"	GO:0000082; GO:0000122; GO:0000981; GO:0001216; GO:0001650; GO:0003677; GO:0003700; GO:0005634; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0008134; GO:0009887; GO:0016528; GO:0030030; GO:0043231; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0090575	"animal organ morphogenesis [GO:0009887]; cell projection organization [GO:0030030]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1065_c0_g1_i2	Q8CCE9	E4F1_MOUSE	40.3	134	56	3	253	591	147	277	6.60E-19	95.9	E4F1_MOUSE	reviewed	Transcription factor E4F1 (EC 2.3.2.27) (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (Transcription factor phi AP3) (p120E4F)	E4f1	Mus musculus (Mouse)	783	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	"cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0006355; GO:0006357; GO:0007049; GO:0009794; GO:0010564; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0045944; GO:0046872; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11057_c0_g1_i1	Q4V8R6	E4F1_DANRE	55.3	76	34	0	4	231	458	533	1.00E-18	93.6	E4F1_DANRE	reviewed	Transcription factor E4F1 (EC 2.3.2.27) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F)	e4f1 zgc:114190	Danio rerio (Zebrafish) (Brachydanio rerio)	719	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transferase activity [GO:0016740]"	GO:0000978; GO:0001227; GO:0005654; GO:0005737; GO:0006357; GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0046872; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN128_c0_g1_i2	Q91677	GATA4_XENLA	49.5	101	49	2	773	1072	137	236	2.90E-18	94.4	GATA4_XENLA	reviewed	Transcription factor GATA-4 (GATA-binding factor 4) (xGATA-4)	gata4	Xenopus laevis (African clawed frog)	392	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0008270; GO:0045893; GO:0045944; GO:0048738	"cardiac muscle tissue development [GO:0048738]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32781_c0_g1_i1	Q9BWX5	GATA5_HUMAN	81.6	49	9	0	157	11	237	285	1.90E-19	95.9	GATA5_HUMAN	reviewed	Transcription factor GATA-5 (GATA-binding factor 5)	GATA5	Homo sapiens (Human)	397	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; blood coagulation [GO:0007596]; cardiac muscle tissue development [GO:0048738]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion fusion [GO:0003274]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of gene expression [GO:0010629]; positive regulation of cardiac endothelial to mesenchymal transition [GO:0062000]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in heart development [GO:1901228]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003180; GO:0003274; GO:0003700; GO:0005634; GO:0005654; GO:0007596; GO:0008270; GO:0010614; GO:0010628; GO:0010629; GO:0035481; GO:0045165; GO:0045944; GO:0048738; GO:0060575; GO:0062000; GO:0071773; GO:1901228; GO:1990837	aortic valve morphogenesis [GO:0003180]; blood coagulation [GO:0007596]; cardiac muscle tissue development [GO:0048738]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion fusion [GO:0003274]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of gene expression [GO:0010629]; positive regulation of cardiac endothelial to mesenchymal transition [GO:0062000]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in heart development [GO:1901228]		NA	NA	NA	NA	NA	NA
TRINITY_DN34875_c0_g1_i1	Q92664	TF3A_HUMAN	100	82	0	0	3	248	57	138	2.80E-46	185.3	TF3A_HUMAN	reviewed	Transcription factor IIIA (TFIIIA)	GTF3A	Homo sapiens (Human)	365	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0005654; GO:0006383; GO:0008097; GO:0009303; GO:0042273; GO:0046872	ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]		NA	NA	NA	NA	NA	NA
TRINITY_DN40138_c0_g1_i1	Q8VHT7	TF3A_MOUSE	45.3	64	28	3	12	191	64	124	6.60E-05	47.8	TF3A_MOUSE	reviewed	Transcription factor IIIA (TFIIIA)	Gtf3a	Mus musculus (Mouse)	364	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; ribosomal large subunit biogenesis [GO:0042273]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0008097; GO:0042273; GO:0046872	ribosomal large subunit biogenesis [GO:0042273]		NA	NA	NA	NA	NA	NA
TRINITY_DN2061_c0_g1_i16	Q8CFK2	TF3B_MOUSE	71.7	53	15	0	285	443	6	58	3.00E-14	79.7	TF3B_MOUSE	reviewed	Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1)	Brf1	Mus musculus (Mouse)	676	"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"	nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]	metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]	GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898	"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2061_c0_g1_i18	Q8CFK2	TF3B_MOUSE	71.7	53	15	0	290	448	6	58	3.00E-14	79.7	TF3B_MOUSE	reviewed	Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1)	Brf1	Mus musculus (Mouse)	676	"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"	nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]	metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]	GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898	"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2061_c0_g1_i2	Q8CFK2	TF3B_MOUSE	71.7	53	15	0	312	470	6	58	3.20E-14	79.7	TF3B_MOUSE	reviewed	Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1)	Brf1	Mus musculus (Mouse)	676	"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"	nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]	metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]	GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898	"DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7143_c0_g1_i1	Q0VBZ5	JUNB_BOVIN	100	86	0	0	258	1	248	333	1.50E-37	157.1	JUNB_BOVIN	reviewed	Transcription factor jun-B	JUNB	Bos taurus (Bovine)	347	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001829; GO:0005654; GO:0005667; GO:0006357; GO:0008134; GO:0030316; GO:0033687; GO:0035976; GO:0042127; GO:0045597; GO:0046697; GO:0051726; GO:0060136; GO:0060716; GO:0071277	cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN7143_c0_g1_i1	Q0VBZ5	JUNB_BOVIN	98.5	67	1	0	254	454	236	302	4.10E-27	122.5	JUNB_BOVIN	reviewed	Transcription factor jun-B	JUNB	Bos taurus (Bovine)	347	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001829; GO:0005654; GO:0005667; GO:0006357; GO:0008134; GO:0030316; GO:0033687; GO:0035976; GO:0042127; GO:0045597; GO:0046697; GO:0051726; GO:0060136; GO:0060716; GO:0071277	cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN7143_c0_g1_i2	P17275	JUNB_HUMAN	100	98	0	0	294	1	236	333	2.90E-44	179.5	JUNB_HUMAN	reviewed	Transcription factor jun-B	JUNB	Homo sapiens (Human)	347	"chromatin [GO:0000785]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; cellular response to calcium ion [GO:0071277]; cytokine-mediated signaling pathway [GO:0019221]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"	chromatin [GO:0000785]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000785; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001829; GO:0003677; GO:0005654; GO:0005667; GO:0006357; GO:0008134; GO:0019221; GO:0030316; GO:0033687; GO:0035976; GO:0042127; GO:0045597; GO:0045944; GO:0046697; GO:0051726; GO:0060136; GO:0060716; GO:0071277; GO:1990837	cellular response to calcium ion [GO:0071277]; cytokine-mediated signaling pathway [GO:0019221]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN7143_c0_g2_i1	P09450	JUNB_MOUSE	100	88	0	0	2	265	240	327	1.80E-38	159.5	JUNB_MOUSE	reviewed	Transcription factor jun-B (MyD21)	Junb Jun-b	Mus musculus (Mouse)	344	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001701; GO:0001829; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006366; GO:0008134; GO:0009987; GO:0030316; GO:0033687; GO:0035976; GO:0042127; GO:0043565; GO:0045597; GO:0045944; GO:0046697; GO:0051726; GO:0060136; GO:0060716; GO:0071277; GO:1990837	"cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7143_c0_g3_i1	P09450	JUNB_MOUSE	100	102	0	0	306	1	226	327	3.50E-46	185.3	JUNB_MOUSE	reviewed	Transcription factor jun-B (MyD21)	Junb Jun-b	Mus musculus (Mouse)	344	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001701; GO:0001829; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006366; GO:0008134; GO:0009987; GO:0030316; GO:0033687; GO:0035976; GO:0042127; GO:0043565; GO:0045597; GO:0045944; GO:0046697; GO:0051726; GO:0060136; GO:0060716; GO:0071277; GO:1990837	"cellular process [GO:0009987]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; in utero embryonic development [GO:0001701]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3810_c0_g1_i1	P27921	JUND_CHICK	40.6	202	73	2	560	96	111	312	1.40E-28	127.9	JUND_CHICK	reviewed	Transcription factor jun-D	JUND	Gallus gallus (Chicken)	323	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; cellular response to calcium ion [GO:0071277]; osteoblast development [GO:0002076]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0002076; GO:0005654; GO:0005667; GO:0006357; GO:0008134; GO:0019899; GO:0035976; GO:0042127; GO:0045669; GO:0051726; GO:0071277	cellular response to calcium ion [GO:0071277]; osteoblast development [GO:0002076]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15365_c0_g1_i1	A7YY54	JUND_BOVIN	100	105	0	0	315	1	242	346	7.70E-49	194.1	JUND_BOVIN	reviewed	Transcription factor jun-D	JUND	Bos taurus (Bovine)	347	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15365_c0_g1_i2	A7YY54	JUND_BOVIN	100	105	0	0	315	1	242	346	7.70E-49	194.1	JUND_BOVIN	reviewed	Transcription factor jun-D	JUND	Bos taurus (Bovine)	347	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32741_c0_g1_i1	A7YY54	JUND_BOVIN	79.8	89	18	0	2	268	259	347	3.40E-30	132.1	JUND_BOVIN	reviewed	Transcription factor jun-D	JUND	Bos taurus (Bovine)	347	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26045_c0_g1_i1	Q292R5	KEN_DROPS	43.5	62	34	1	1	186	460	520	6.20E-11	67.8	KEN_DROPS	reviewed	Transcription factor Ken (Protein Ken and Barbie)	ken GA18980	Drosophila pseudoobscura pseudoobscura (Fruit fly)	569	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0030539; GO:0030540; GO:0045496; GO:0045497; GO:0046426; GO:0046872	"female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29709_c0_g1_i1	B0X9H6	KEN1_CULQU	44.6	56	28	1	39	206	557	609	2.90E-07	55.5	KEN1_CULQU	reviewed	Transcription factor Ken 1	ken1 CPIJ016082	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	653	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0030539; GO:0030540; GO:0045496; GO:0045497; GO:0046872	"female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34881_c0_g1_i1	Q90888	MAFB_CHICK	63.8	58	21	0	206	33	200	257	2.90E-11	68.9	MAFB_CHICK	reviewed	Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B)	MAFB	Gallus gallus (Chicken)	311	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; abducens nerve formation [GO:0021599]; brain segmentation [GO:0035284]; inner ear morphogenesis [GO:0042472]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of osteoclast differentiation [GO:0045671]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; rhombomere 5 development [GO:0021571]; rhombomere 6 development [GO:0021572]; segment specification [GO:0007379]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007379; GO:0007585; GO:0008134; GO:0021571; GO:0021572; GO:0021599; GO:0033077; GO:0035284; GO:0042472; GO:0043565; GO:0045647; GO:0045671; GO:0048538	"abducens nerve formation [GO:0021599]; brain segmentation [GO:0035284]; inner ear morphogenesis [GO:0042472]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of osteoclast differentiation [GO:0045671]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; rhombomere 5 development [GO:0021571]; rhombomere 6 development [GO:0021572]; segment specification [GO:0007379]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11613_c0_g1_i1	Q90596	MAFK_CHICK	60.8	97	36	1	424	134	24	118	2.30E-24	113.6	MAFK_CHICK	reviewed	Transcription factor MafK	MAFK	Gallus gallus (Chicken)	156	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN11613_c0_g1_i2	Q90596	MAFK_CHICK	60.8	97	36	1	424	134	24	118	2.50E-24	113.6	MAFK_CHICK	reviewed	Transcription factor MafK	MAFK	Gallus gallus (Chicken)	156	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0043565			blue	blue	NA	NA	NA	NA
TRINITY_DN11613_c0_g1_i3	Q90596	MAFK_CHICK	61.1	95	35	1	418	134	26	118	1.50E-23	110.9	MAFK_CHICK	reviewed	Transcription factor MafK	MAFK	Gallus gallus (Chicken)	156	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN11613_c0_g1_i4	Q90596	MAFK_CHICK	60.8	97	36	1	424	134	24	118	2.50E-24	113.6	MAFK_CHICK	reviewed	Transcription factor MafK	MAFK	Gallus gallus (Chicken)	156	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN7789_c0_g1_i1	Q8CIV7	OVOL2_MOUSE	53	66	29	1	12	203	144	209	1.50E-14	79.7	OVOL2_MOUSE	reviewed	Transcription factor Ovo-like 2 (mOvo2) (Zinc finger OVO2) (Zinc finger protein 339) (Zinc finger protein mOVO)	Ovol2 Ovo2 Zfp339 Znf339	Mus musculus (Mouse)	274	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0007507; GO:0008285; GO:0008544; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0043565; GO:0045617; GO:0045618; GO:0045746; GO:0045892; GO:0045893; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:1990837; GO:2000647	"angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i15	Q8CIV7	OVOL2_MOUSE	36	111	53	3	67	345	87	197	4.50E-10	65.9	OVOL2_MOUSE	reviewed	Transcription factor Ovo-like 2 (mOvo2) (Zinc finger OVO2) (Zinc finger protein 339) (Zinc finger protein mOVO)	Ovol2 Ovo2 Zfp339 Znf339	Mus musculus (Mouse)	274	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0007507; GO:0008285; GO:0008544; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0043565; GO:0045617; GO:0045618; GO:0045746; GO:0045892; GO:0045893; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:1990837; GO:2000647	"angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN210_c0_g2_i1	Q9P9I8	TFS_METTL	48.2	56	28	1	221	54	47	101	3.50E-06	52	TFS_METTL	reviewed	Transcription factor S (Transcription elongation factor IIS/RNA polymerase subunit homolog) (TFIIS/RPSU homolog)	tfs	Methanothermococcus thermolithotrophicus (Methanococcus thermolithotrophicus)	105	"DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"		DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0006351; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14997_c1_g1_i1	Q06831	SOX4_MOUSE	96.1	77	3	0	15	245	53	129	5.30E-37	154.5	SOX4_MOUSE	reviewed	Transcription factor SOX-4	Sox4 Sox-4	Mus musculus (Mouse)	440	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cellular response to glucose stimulus [GO:0071333]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocrine pancreas development [GO:0031018]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; kidney morphogenesis [GO:0060993]; limb bud formation [GO:0060174]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein ubiquitination [GO:0031397]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of insulin secretion [GO:0032024]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; spinal cord motor neuron differentiation [GO:0021522]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001666; GO:0001841; GO:0002328; GO:0003183; GO:0003211; GO:0003215; GO:0003289; GO:0003357; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0006355; GO:0006977; GO:0007507; GO:0008284; GO:0008285; GO:0009653; GO:0014009; GO:0021510; GO:0021522; GO:0021782; GO:0030154; GO:0030217; GO:0031018; GO:0031397; GO:0031647; GO:0032024; GO:0035019; GO:0035910; GO:0042593; GO:0042769; GO:0043065; GO:0045588; GO:0045727; GO:0045893; GO:0045944; GO:0048485; GO:0050821; GO:0060174; GO:0060412; GO:0060548; GO:0060563; GO:0060993; GO:0071333; GO:0090263; GO:1990837; GO:2000761	"anatomical structure morphogenesis [GO:0009653]; ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cellular response to glucose stimulus [GO:0071333]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocrine pancreas development [GO:0031018]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; kidney morphogenesis [GO:0060993]; limb bud formation [GO:0060174]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein ubiquitination [GO:0031397]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of insulin secretion [GO:0032024]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; spinal cord motor neuron differentiation [GO:0021522]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21127_c0_g1_i2	O70494	SP3_MOUSE	100	83	0	0	250	2	608	690	6.80E-48	190.7	SP3_MOUSE	reviewed	Transcription factor Sp3	Sp3	Mus musculus (Mouse)	783	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001503; GO:0001701; GO:0001779; GO:0001829; GO:0001889; GO:0001892; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030218; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0032993; GO:0043353; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:1990837	"B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN179_c0_g1_i1	O70494	SP3_MOUSE	62.3	167	52	4	707	234	556	720	1.30E-53	211.8	SP3_MOUSE	reviewed	Transcription factor Sp3	Sp3	Mus musculus (Mouse)	783	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001503; GO:0001701; GO:0001779; GO:0001829; GO:0001889; GO:0001892; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030218; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0032993; GO:0043353; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:1990837	"B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN179_c0_g1_i2	O70494	SP3_MOUSE	64.6	147	41	4	680	267	556	700	3.20E-49	197.2	SP3_MOUSE	reviewed	Transcription factor Sp3	Sp3	Mus musculus (Mouse)	783	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001503; GO:0001701; GO:0001779; GO:0001829; GO:0001889; GO:0001892; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030218; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0032993; GO:0043353; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:1990837	"B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21127_c0_g1_i1	Q02447	SP3_HUMAN	100	83	0	0	250	2	606	688	6.80E-48	190.7	SP3_HUMAN	reviewed	Transcription factor Sp3 (SPR-2)	SP3	Homo sapiens (Human)	781	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001503; GO:0001779; GO:0001829; GO:0001889; GO:0001892; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0032993; GO:0043353; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:1990837	"B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27145_c0_g1_i1	P52657	T2AG_HUMAN	100	109	0	0	63	389	1	109	2.00E-55	216.5	T2AG_HUMAN	reviewed	Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (TFIIA p12 subunit) (TFIIA-12) (TFIIAS) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma)	GTF2A2 TF2A2	Homo sapiens (Human)	109	cell junction [GO:0030054]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]	cell junction [GO:0030054]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]	protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]	GO:0001103; GO:0005654; GO:0005669; GO:0005672; GO:0006366; GO:0006367; GO:0008134; GO:0016032; GO:0016251; GO:0017025; GO:0030054; GO:0042795; GO:0042803; GO:0045944; GO:0046982; GO:0051123	positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2512_c0_g1_i1	B7Q1Q9	T2AG_IXOSC	72.1	104	29	0	392	81	1	104	5.50E-38	158.7	T2AG_IXOSC	reviewed	Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma)	IscW_ISCW010050	Ixodes scapularis (Black-legged tick) (Deer tick)	118	transcription factor TFIIA complex [GO:0005672]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; RNA polymerase II preinitiation complex assembly [GO:0051123]	transcription factor TFIIA complex [GO:0005672]	RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]	GO:0005672; GO:0016251; GO:0017025; GO:0051123	RNA polymerase II preinitiation complex assembly [GO:0051123]		blue	blue	NA	NA	NA	NA
TRINITY_DN23122_c0_g1_i2	Q2KIN8	TF2B_BOVIN	100	107	0	0	1	321	104	210	3.10E-53	208.8	TF2B_BOVIN	reviewed	Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB)	GTF2B	Bos taurus (Bovine)	316	chromosome [GO:0005694]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; acetyltransferase activity [GO:0016407]; core promoter sequence-specific DNA binding [GO:0001046]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]	chromosome [GO:0005694]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	acetyltransferase activity [GO:0016407]; core promoter sequence-specific DNA binding [GO:0001046]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270]	GO:0000979; GO:0000993; GO:0001046; GO:0001174; GO:0004402; GO:0005634; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0016407; GO:0017025; GO:0032993; GO:0043923; GO:0051123; GO:0060261; GO:1990114; GO:1990841	positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN23122_c0_g1_i1	Q00403	TF2B_HUMAN	100	213	0	0	1	639	104	316	2.70E-115	416	TF2B_HUMAN	reviewed	Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (S300-II)	GTF2B TF2B TFIIB	Homo sapiens (Human)	316	"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; acetyltransferase activity [GO:0016407]; core promoter sequence-specific DNA binding [GO:0001046]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of viral transcription [GO:0050434]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral process [GO:0016032]"	chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]	acetyltransferase activity [GO:0016407]; core promoter sequence-specific DNA binding [GO:0001046]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000979; GO:0000993; GO:0001046; GO:0001139; GO:0001174; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005694; GO:0006352; GO:0006366; GO:0006367; GO:0006473; GO:0008134; GO:0008270; GO:0016032; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0032993; GO:0042795; GO:0043923; GO:0046966; GO:0050434; GO:0051123; GO:0060261; GO:0090575; GO:0097550; GO:1904798; GO:1990114; GO:1990841	"DNA-templated transcription, initiation [GO:0006352]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of viral transcription [GO:0050434]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26111_c0_g1_i1	Q8SRP3	TF2B_ENCCU	57	79	34	0	246	10	127	205	2.40E-21	102.4	TF2B_ENCCU	reviewed	Transcription initiation factor IIB (General transcription factor TFIIB)	ECU06_1100i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	312	nucleus [GO:0005634]; metal ion binding [GO:0046872]; TBP-class protein binding [GO:0017025]; transcription preinitiation complex assembly [GO:0070897]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; TBP-class protein binding [GO:0017025]	GO:0005634; GO:0017025; GO:0046872; GO:0070897	transcription preinitiation complex assembly [GO:0070897]		NA	NA	NA	NA	NA	NA
TRINITY_DN27504_c0_g1_i1	P29052	TF2B_DROME	83.6	238	39	0	1	714	78	315	2.00E-109	396.7	TF2B_DROME	reviewed	Transcription initiation factor IIB (General transcription factor TFIIB)	TfIIB CG5193	Drosophila melanogaster (Fruit fly)	315	"nucleus [GO:0005634]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; regulation of DNA binding [GO:0051101]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]"	nucleus [GO:0005634]; transcription preinitiation complex [GO:0097550]	metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]	GO:0000979; GO:0001139; GO:0001174; GO:0005634; GO:0006352; GO:0006367; GO:0008134; GO:0017025; GO:0042789; GO:0046872; GO:0051101; GO:0051123; GO:0097550	"DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; regulation of DNA binding [GO:0051101]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		blue	blue	NA	NA	NA	NA
TRINITY_DN828_c0_g1_i1	P29084	T2EB_HUMAN	46.9	241	114	2	85	768	1	240	1.00E-56	221.9	T2EB_HUMAN	reviewed	Transcription initiation factor IIE subunit beta (TFIIE-beta) (General transcription factor IIE subunit 2)	GTF2E2 TF2E2	Homo sapiens (Human)	291	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0003677; GO:0003723; GO:0005654; GO:0005669; GO:0005673; GO:0005829; GO:0006366; GO:0006367; GO:0016251; GO:0016607; GO:0042795	snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN828_c0_g1_i2	P29084	T2EB_HUMAN	47.1	289	135	5	85	903	1	287	1.60E-65	251.1	T2EB_HUMAN	reviewed	Transcription initiation factor IIE subunit beta (TFIIE-beta) (General transcription factor IIE subunit 2)	GTF2E2 TF2E2	Homo sapiens (Human)	291	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0003677; GO:0003723; GO:0005654; GO:0005669; GO:0005673; GO:0005829; GO:0006366; GO:0006367; GO:0016251; GO:0016607; GO:0042795	snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN4051_c0_g1_i1	Q60544	TAF1_MESAU	39.8	128	68	3	648	268	11	130	5.20E-13	76.3	TAF1_MESAU	reviewed	Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250)	TAF1 CCG1	Mesocricetus auratus (Golden hamster)	1865	MLL1 complex [GO:0071339]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; cell cycle [GO:0007049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation from RNA polymerase II promoter [GO:0006367]	MLL1 complex [GO:0071339]; transcription factor TFIID complex [GO:0005669]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005669; GO:0006367; GO:0007049; GO:0016251; GO:0045944; GO:0071339	cell cycle [GO:0007049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN4051_c0_g1_i4	Q60544	TAF1_MESAU	41.5	106	53	3	440	126	11	108	2.90E-10	66.6	TAF1_MESAU	reviewed	Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250)	TAF1 CCG1	Mesocricetus auratus (Golden hamster)	1865	MLL1 complex [GO:0071339]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; cell cycle [GO:0007049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation from RNA polymerase II promoter [GO:0006367]	MLL1 complex [GO:0071339]; transcription factor TFIID complex [GO:0005669]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005669; GO:0006367; GO:0007049; GO:0016251; GO:0045944; GO:0071339	cell cycle [GO:0007049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN3301_c0_g1_i1	P51123	TAF1_DROME	39.9	238	124	5	707	3	243	464	4.30E-39	162.9	TAF1_DROME	reviewed	Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (TAFII250) (TBP-associated factor 230 kDa) (p230) (Transcription initiation factor TFIID 230 kDa subunit) (TAFII-230)	Taf1 TAF250 CG17603	Drosophila melanogaster (Fruit fly)	2129	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H3-K14 specific) [GO:0036408]; protein serine/threonine kinase activity [GO:0004674]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin activating enzyme activity [GO:0004839]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone monoubiquitination [GO:0010390]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; transcription factor TFIID complex [GO:0005669]	ATP binding [GO:0005524]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H3-K14 specific) [GO:0036408]; protein serine/threonine kinase activity [GO:0004674]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; ubiquitin activating enzyme activity [GO:0004839]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0004674; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006367; GO:0006468; GO:0007049; GO:0008134; GO:0010390; GO:0010485; GO:0017025; GO:0035102; GO:0036408; GO:0043565; GO:0043967; GO:0044154; GO:0051123; GO:0061631	cell cycle [GO:0007049]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone monoubiquitination [GO:0010390]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN9227_c0_g1_i1	P49906	TAF11_DROME	42.2	90	51	1	270	1	99	187	1.00E-12	73.9	TAF11_DROME	reviewed	Transcription initiation factor TFIID subunit 11 (TAFII30 beta) (Transcription initiation factor TFIID 28 kDa subunit beta) (p28-beta)	Taf11 TAF30-BETA CG4079	Drosophila melanogaster (Fruit fly)	196	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; positive regulation of RNA interference [GO:1900370]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578]; transcription factor TFIID complex [GO:0005669]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0003713; GO:0005634; GO:0005669; GO:0005737; GO:0006367; GO:0008134; GO:0046982; GO:0051123; GO:0070578; GO:1900370	positive regulation of RNA interference [GO:1900370]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN1727_c0_g1_i1	P49906	TAF11_DROME	74.5	110	26	1	544	873	88	195	6.30E-38	159.5	TAF11_DROME	reviewed	Transcription initiation factor TFIID subunit 11 (TAFII30 beta) (Transcription initiation factor TFIID 28 kDa subunit beta) (p28-beta)	Taf11 TAF30-BETA CG4079	Drosophila melanogaster (Fruit fly)	196	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; positive regulation of RNA interference [GO:1900370]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578]; transcription factor TFIID complex [GO:0005669]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0003713; GO:0005634; GO:0005669; GO:0005737; GO:0006367; GO:0008134; GO:0046982; GO:0051123; GO:0070578; GO:1900370	positive regulation of RNA interference [GO:1900370]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		blue	blue	NA	NA	NA	NA
TRINITY_DN36094_c0_g1_i1	Q3T174	TAF12_BOVIN	58	138	50	1	504	91	32	161	2.20E-37	156.8	TAF12_BOVIN	reviewed	Transcription initiation factor TFIID subunit 12 (Transcription initiation factor TFIID 20/15 kDa subunits) (TAFII-20/TAFII-15) (TAFII20/TAFII15)	TAF12	Bos taurus (Bovine)	161	SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; RNA polymerase II preinitiation complex assembly [GO:0051123]	SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003677; GO:0003713; GO:0004402; GO:0005669; GO:0016251; GO:0017025; GO:0030914; GO:0033276; GO:0043966; GO:0046695; GO:0046982; GO:0051091; GO:0051123	histone H3 acetylation [GO:0043966]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; RNA polymerase II preinitiation complex assembly [GO:0051123]		blue	blue	NA	NA	NA	NA
TRINITY_DN4110_c0_g1_i1	Q148M7	TAF13_BOVIN	71.1	121	30	1	133	495	7	122	5.00E-41	169.1	TAF13_BOVIN	reviewed	Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18)	TAF13	Bos taurus (Bovine)	124	nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]	GO:0005634; GO:0006366; GO:0046982	transcription by RNA polymerase II [GO:0006366]		blue	blue	NA	NA	NA	NA
TRINITY_DN4110_c0_g1_i2	Q148M7	TAF13_BOVIN	69.7	122	31	1	103	468	7	122	8.10E-41	168.3	TAF13_BOVIN	reviewed	Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18)	TAF13	Bos taurus (Bovine)	124	nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	protein heterodimerization activity [GO:0046982]	GO:0005634; GO:0006366; GO:0046982	transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN29851_c0_g1_i1	Q6P1X5	TAF2_HUMAN	100	270	0	0	2	811	148	417	7.30E-160	564.3	TAF2_HUMAN	reviewed	Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	TAF2 CIF150 TAF2B	Homo sapiens (Human)	1199	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000086; GO:0000976; GO:0003682; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0014070; GO:0016251; GO:0033276; GO:1901796	G2/M transition of mitotic cell cycle [GO:0000086]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN36916_c0_g1_i1	Q8C176	TAF2_MOUSE	98	101	2	0	3	305	657	757	3.90E-53	208.4	TAF2_MOUSE	reviewed	Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	Taf2	Mus musculus (Mouse)	1104	transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; G2/M transition of mitotic cell cycle [GO:0000086]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	chromatin binding [GO:0003682]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000086; GO:0000976; GO:0003682; GO:0005669; GO:0006367; GO:0033276	G2/M transition of mitotic cell cycle [GO:0000086]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN2045_c0_g1_i1	Q24325	TAF2_DROME	55.7	991	427	7	155	3115	13	995	0	1125.5	TAF2_DROME	reviewed	Transcription initiation factor TFIID subunit 2 (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	Taf2 TAF150 CG6711	Drosophila melanogaster (Fruit fly)	1221	"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000976; GO:0000979; GO:0003682; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006367; GO:0008134; GO:0008237; GO:0008270; GO:0017025; GO:0051123	"DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2045_c0_g1_i2	Q24325	TAF2_DROME	56	568	242	4	43	1743	435	995	5.20E-183	642.5	TAF2_DROME	reviewed	Transcription initiation factor TFIID subunit 2 (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	Taf2 TAF150 CG6711	Drosophila melanogaster (Fruit fly)	1221	"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000976; GO:0000979; GO:0003682; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006367; GO:0008134; GO:0008237; GO:0008270; GO:0017025; GO:0051123	"DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2045_c0_g1_i3	Q24325	TAF2_DROME	55.7	991	427	7	155	3115	13	995	0	1125.5	TAF2_DROME	reviewed	Transcription initiation factor TFIID subunit 2 (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	Taf2 TAF150 CG6711	Drosophila melanogaster (Fruit fly)	1221	"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000976; GO:0000979; GO:0003682; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006367; GO:0008134; GO:0008237; GO:0008270; GO:0017025; GO:0051123	"DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2045_c0_g1_i4	Q24325	TAF2_DROME	55.7	991	427	7	152	3112	13	995	0	1125.5	TAF2_DROME	reviewed	Transcription initiation factor TFIID subunit 2 (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	Taf2 TAF150 CG6711	Drosophila melanogaster (Fruit fly)	1221	"nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	chromatin binding [GO:0003682]; metallopeptidase activity [GO:0008237]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000976; GO:0000979; GO:0003682; GO:0005634; GO:0005669; GO:0006352; GO:0006366; GO:0006367; GO:0008134; GO:0008237; GO:0008270; GO:0017025; GO:0051123	"DNA-templated transcription, initiation [GO:0006352]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4789_c0_g1_i1	Q5HZG4	TAF3_MOUSE	48.9	88	37	2	346	83	849	928	1.30E-22	107.5	TAF3_MOUSE	reviewed	Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140)	Taf3	Mus musculus (Mouse)	932	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA-binding transcription factor inhibitor activity [GO:0140416]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA-binding transcription factor inhibitor activity [GO:0140416]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006357; GO:0006366; GO:0031965; GO:0043433; GO:0046872; GO:0046982; GO:0051457; GO:0140416	maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]		NA	NA	NA	NA	NA	NA
TRINITY_DN4789_c0_g1_i3	Q5VWG9	TAF3_HUMAN	67.6	37	12	0	194	84	856	892	1.20E-13	77	TAF3_HUMAN	reviewed	Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140)	TAF3	Homo sapiens (Human)	929	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA-binding transcription factor inhibitor activity [GO:0140416]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA-binding transcription factor inhibitor activity [GO:0140416]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0016251; GO:0031965; GO:0043433; GO:0046872; GO:0046982; GO:0051457; GO:0140416; GO:1901796	maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN4789_c0_g1_i4	Q5VWG9	TAF3_HUMAN	61.7	47	17	1	224	84	847	892	2.20E-13	76.3	TAF3_HUMAN	reviewed	Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140)	TAF3	Homo sapiens (Human)	929	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA-binding transcription factor inhibitor activity [GO:0140416]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA-binding transcription factor inhibitor activity [GO:0140416]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0016251; GO:0031965; GO:0043433; GO:0046872; GO:0046982; GO:0051457; GO:0140416; GO:1901796	maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN1891_c0_g1_i1	P47825	TAF4_DROME	43.1	153	72	5	1250	1669	292	442	8.70E-22	106.7	TAF4_DROME	reviewed	Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110)	Taf4 TAF110 CG5444	Drosophila melanogaster (Fruit fly)	921	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]	GO:0001092; GO:0003677; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0008134; GO:0046982	transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN1891_c0_g1_i3	P47825	TAF4_DROME	43.1	153	72	5	1169	1588	292	442	8.20E-22	106.7	TAF4_DROME	reviewed	Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110)	Taf4 TAF110 CG5444	Drosophila melanogaster (Fruit fly)	921	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]	GO:0001092; GO:0003677; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0008134; GO:0046982	transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN7128_c0_g1_i1	P47825	TAF4_DROME	69.5	59	18	0	46	222	672	730	2.20E-13	76.3	TAF4_DROME	reviewed	Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110)	Taf4 TAF110 CG5444	Drosophila melanogaster (Fruit fly)	921	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]	GO:0001092; GO:0003677; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0008134; GO:0046982	transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN7128_c0_g1_i2	P47825	TAF4_DROME	64.1	145	51	1	46	480	672	815	1.20E-40	167.5	TAF4_DROME	reviewed	Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110)	Taf4 TAF110 CG5444	Drosophila melanogaster (Fruit fly)	921	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]	GO:0001092; GO:0003677; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0008134; GO:0046982	transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN7128_c0_g2_i1	P47825	TAF4_DROME	58.6	111	40	2	2	319	812	921	9.80E-24	110.9	TAF4_DROME	reviewed	Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110)	Taf4 TAF110 CG5444	Drosophila melanogaster (Fruit fly)	921	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]	GO:0001092; GO:0003677; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0008134; GO:0046982	transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN7128_c0_g2_i2	P47825	TAF4_DROME	62.9	35	13	0	85	189	887	921	2.70E-06	52.4	TAF4_DROME	reviewed	Transcription initiation factor TFIID subunit 4 (110 kDa TBP-associated factor) (Transcription initiation factor TFIID 110 kDa subunit) (TAFII-110) (p110)	Taf4 TAF110 CG5444	Drosophila melanogaster (Fruit fly)	921	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TFIIA-class transcription factor complex binding [GO:0001092]; transcription factor binding [GO:0008134]	GO:0001092; GO:0003677; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0008134; GO:0046982	transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN27780_c0_g1_i1	Q8SQS4	TAF5_ENCCU	60.2	83	33	0	3	251	309	391	3.10E-27	122.1	TAF5_ENCCU	reviewed	Transcription initiation factor TFIID subunit 5	TAF5 ECU11_1750	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	556	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			NA	NA	NA	NA	NA	NA
TRINITY_DN37250_c0_g1_i1	P49848	TAF6_HUMAN	100	211	0	0	636	4	201	411	1.20E-117	423.7	TAF6_HUMAN	reviewed	Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80)	TAF6 TAF2E TAFII70	Homo sapiens (Human)	677	"cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of signal transduction by p53 class mediator [GO:1901796]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006352; GO:0006366; GO:0006367; GO:0006915; GO:0008285; GO:0016251; GO:0016573; GO:0017162; GO:0032991; GO:0033276; GO:0042795; GO:0043065; GO:0045786; GO:0045944; GO:0046695; GO:0046982; GO:0060261; GO:0071339; GO:1901796; GO:2001244	"apoptotic process [GO:0006915]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of signal transduction by p53 class mediator [GO:1901796]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1276_c0_g1_i1	P49847	TAF6_DROME	55.3	530	208	7	93	1625	20	539	3.20E-161	570.1	TAF6_DROME	reviewed	Transcription initiation factor TFIID subunit 6 (TAFII-60) (TAFII-62) (Transcription initiation factor TFIID 62 kDa subunit) (p62)	Taf6 Taf60 CG32211	Drosophila melanogaster (Fruit fly)	606	nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; histone acetylation [GO:0016573]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]	protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003713; GO:0005634; GO:0005669; GO:0006366; GO:0006367; GO:0016251; GO:0016573; GO:0045944; GO:0046695; GO:0046982	histone acetylation [GO:0016573]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN26281_c0_g1_i1	P53040	TAF6_YEAST	46.7	45	24	0	205	71	108	152	3.50E-08	58.5	TAF6_YEAST	reviewed	Transcription initiation factor TFIID subunit 6 (TBP-associated factor 6) (TBP-associated factor 60 kDa) (TAFII-60) (TAFII60)	TAF6 TAF60 YGL112C G2985	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	516	"cytosol [GO:0005829]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	cytosol [GO:0005829]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]	GO:0000124; GO:0001102; GO:0003682; GO:0003713; GO:0005634; GO:0005669; GO:0005829; GO:0006325; GO:0006366; GO:0006367; GO:0016251; GO:0016573; GO:0042802; GO:0045944; GO:0046695; GO:0046982; GO:0051123; GO:0060090; GO:2000144	"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7325_c0_g1_i1	Q9VHY5	TAF7_DROME	57.5	181	69	3	1004	465	52	225	4.20E-44	180.3	TAF7_DROME	reviewed	Transcription initiation factor TFIID subunit 7 (Transcription initiation factor TFIID 55 kDa subunit) (TAFII-55) (TAFII55)	Taf7 anon-84Ec TAF55 CG2670	Drosophila melanogaster (Fruit fly)	479	transcription factor TFIID complex [GO:0005669]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription factor TFIID complex [GO:0005669]	RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0005669; GO:0006367; GO:0016251; GO:0051123	RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN7325_c0_g1_i3	Q9VHY5	TAF7_DROME	57.5	181	69	3	1004	465	52	225	4.20E-44	180.3	TAF7_DROME	reviewed	Transcription initiation factor TFIID subunit 7 (Transcription initiation factor TFIID 55 kDa subunit) (TAFII-55) (TAFII55)	Taf7 anon-84Ec TAF55 CG2670	Drosophila melanogaster (Fruit fly)	479	transcription factor TFIID complex [GO:0005669]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription factor TFIID complex [GO:0005669]	RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0005669; GO:0006367; GO:0016251; GO:0051123	RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN7325_c0_g1_i4	Q9VHY5	TAF7_DROME	57.5	181	69	3	1004	465	52	225	4.20E-44	180.3	TAF7_DROME	reviewed	Transcription initiation factor TFIID subunit 7 (Transcription initiation factor TFIID 55 kDa subunit) (TAFII-55) (TAFII55)	Taf7 anon-84Ec TAF55 CG2670	Drosophila melanogaster (Fruit fly)	479	transcription factor TFIID complex [GO:0005669]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription factor TFIID complex [GO:0005669]	RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0005669; GO:0006367; GO:0016251; GO:0051123	RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		blue	blue	NA	NA	NA	NA
TRINITY_DN7325_c0_g1_i5	Q9VHY5	TAF7_DROME	57.5	181	69	3	1004	465	52	225	4.40E-44	180.3	TAF7_DROME	reviewed	Transcription initiation factor TFIID subunit 7 (Transcription initiation factor TFIID 55 kDa subunit) (TAFII-55) (TAFII55)	Taf7 anon-84Ec TAF55 CG2670	Drosophila melanogaster (Fruit fly)	479	transcription factor TFIID complex [GO:0005669]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription factor TFIID complex [GO:0005669]	RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0005669; GO:0006367; GO:0016251; GO:0051123	RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN3114_c0_g1_i1	Q7ZYA2	TAF8_XENLA	43.4	272	137	2	863	96	23	293	7.90E-55	215.7	TAF8_XENLA	reviewed	Transcription initiation factor TFIID subunit 8 (TBP-associated factor 8)	taf8	Xenopus laevis (African clawed frog)	293	cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669]	protein heterodimerization activity [GO:0046982]	GO:0005669; GO:0005737; GO:0007275; GO:0030154; GO:0046982	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN193_c0_g2_i1	Q17QQ4	TAF9_BOVIN	51.5	163	70	4	94	582	9	162	3.80E-38	160.2	TAF9_BOVIN	reviewed	Transcription initiation factor TFIID subunit 9	TAF9	Bos taurus (Bovine)	264	"MLL1 complex [GO:0071339]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; histone acetyltransferase activity [GO:0004402]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; box C/D snoRNP assembly [GO:0000492]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; response to interleukin-1 [GO:0070555]; transcription by RNA polymerase II [GO:0006366]"	MLL1 complex [GO:0071339]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; histone acetyltransferase activity [GO:0004402]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000124; GO:0000125; GO:0000492; GO:0000976; GO:0002039; GO:0003713; GO:0004402; GO:0005669; GO:0006352; GO:0006366; GO:0030914; GO:0032435; GO:0033276; GO:0033613; GO:0043066; GO:0043966; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339	"box C/D snoRNP assembly [GO:0000492]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; response to interleukin-1 [GO:0070555]; transcription by RNA polymerase II [GO:0006366]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33923_c0_g1_i1	Q16594	TAF9_HUMAN	98.5	130	2	0	392	3	3	132	5.40E-68	258.1	TAF9_HUMAN	reviewed	Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32)	TAF9 TAF2G TAFII31	Homo sapiens (Human)	264	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to interleukin-1 [GO:0070555]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000124; GO:0000125; GO:0000492; GO:0000976; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0006974; GO:0016251; GO:0030914; GO:0032435; GO:0033276; GO:0033613; GO:0042795; GO:0043066; GO:0043966; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339; GO:1901796; GO:1902166	box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to interleukin-1 [GO:0070555]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN38851_c0_g1_i1	Q16594	TAF9_HUMAN	96.7	120	4	0	1	360	32	151	1.20E-61	236.9	TAF9_HUMAN	reviewed	Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32)	TAF9 TAF2G TAFII31	Homo sapiens (Human)	264	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to interleukin-1 [GO:0070555]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000124; GO:0000125; GO:0000492; GO:0000976; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0006974; GO:0016251; GO:0030914; GO:0032435; GO:0033276; GO:0033613; GO:0042795; GO:0043066; GO:0043966; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339; GO:1901796; GO:1902166	box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone H3 acetylation [GO:0043966]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to interleukin-1 [GO:0070555]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN38851_c0_g1_i2	Q9HBM6	TAF9B_HUMAN	100	68	0	0	1	204	32	99	6.80E-33	141.4	TAF9B_HUMAN	reviewed	Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7) (DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L)	TAF9B TAF9L	Homo sapiens (Human)	251	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0016251; GO:0016579; GO:0030307; GO:0033276; GO:0043066; GO:0046982; GO:0050821; GO:1901796; GO:1902166	negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN38851_c0_g1_i2	Q9HBM6	TAF9B_HUMAN	71.9	64	16	2	168	359	88	149	4.70E-18	92	TAF9B_HUMAN	reviewed	Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7) (DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L)	TAF9B TAF9L	Homo sapiens (Human)	251	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0016251; GO:0016579; GO:0030307; GO:0033276; GO:0043066; GO:0046982; GO:0050821; GO:1901796; GO:1902166	negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g2_i1	O75486	SUPT3_HUMAN	34.4	186	106	5	267	818	133	304	2.10E-17	91.3	SUPT3_HUMAN	reviewed	Transcription initiation protein SPT3 homolog (SPT3-like protein)	SUPT3H SPT3	Homo sapiens (Human)	317	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982	"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g2_i1	O75486	SUPT3_HUMAN	37.1	62	39	0	19	204	17	78	1.40E-05	52	SUPT3_HUMAN	reviewed	Transcription initiation protein SPT3 homolog (SPT3-like protein)	SUPT3H SPT3	Homo sapiens (Human)	317	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982	"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g2_i3	O75486	SUPT3_HUMAN	37.3	193	116	2	19	597	17	204	2.10E-30	134	SUPT3_HUMAN	reviewed	Transcription initiation protein SPT3 homolog (SPT3-like protein)	SUPT3H SPT3	Homo sapiens (Human)	317	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982	"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g2_i4	O75486	SUPT3_HUMAN	35.7	305	177	6	19	927	17	304	1.00E-41	172.2	SUPT3_HUMAN	reviewed	Transcription initiation protein SPT3 homolog (SPT3-like protein)	SUPT3H SPT3	Homo sapiens (Human)	317	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982	"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16939_c0_g2_i6	O75486	SUPT3_HUMAN	39.2	232	135	3	19	714	17	242	1.50E-38	161.4	SUPT3_HUMAN	reviewed	Transcription initiation protein SPT3 homolog (SPT3-like protein)	SUPT3H SPT3	Homo sapiens (Human)	317	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982	"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10726_c0_g1_i1	O15164	TIF1A_HUMAN	40.1	222	110	7	81	689	822	1039	3.50E-37	156.8	TIF1A_HUMAN	reviewed	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	TRIM24 RNF82 TIF1 TIF1A	Homo sapiens (Human)	1050	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"	cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10726_c0_g1_i4	O15164	TIF1A_HUMAN	36.5	197	102	7	147	680	847	1039	3.70E-23	110.2	TIF1A_HUMAN	reviewed	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	TRIM24 RNF82 TIF1 TIF1A	Homo sapiens (Human)	1050	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"	cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25442_c0_g1_i1	Q9UNY4	TTF2_HUMAN	100	84	0	0	255	4	1058	1141	3.30E-42	171.8	TTF2_HUMAN	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2) (F2) (HuF2)	TTF2	Homo sapiens (Human)	1162	"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]"	cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]	GO:0003677; GO:0004386; GO:0005524; GO:0005681; GO:0005829; GO:0006353; GO:0006369; GO:0006397; GO:0008023; GO:0008094; GO:0008270; GO:0008380	"DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g1_i2	P34739	TTF2_DROME	34.3	405	213	9	1641	2831	271	630	1.20E-44	183.3	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g1_i3	P34739	TTF2_DROME	49.4	83	21	2	82	330	569	630	1.80E-11	70.1	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g2_i1	P34739	TTF2_DROME	46	263	135	4	104	883	592	850	2.10E-52	207.6	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g2_i2	P34739	TTF2_DROME	46.6	476	222	6	104	1453	592	1061	5.60E-105	382.9	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g2_i3	P34739	TTF2_DROME	50	52	24	1	43	198	1012	1061	1.40E-06	53.5	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g2_i4	P34739	TTF2_DROME	41.8	376	189	5	104	1153	592	963	1.40E-66	255	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3551_c0_g2_i6	P34739	TTF2_DROME	50	52	24	1	43	198	1012	1061	1.80E-06	53.1	TTF2_DROME	reviewed	Transcription termination factor 2 (EC 3.6.4.-) (Protein lodestar) (RNA polymerase II termination factor) (Transcription release factor 2)	lds CG2684	Drosophila melanogaster (Fruit fly)	1061	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006353; GO:0007143; GO:0007283; GO:0008094; GO:0034454	"DNA-templated transcription, termination [GO:0006353]; female meiotic nuclear division [GO:0007143]; microtubule anchoring at centrosome [GO:0034454]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i1	Q9VPD5	MTEF3_DROME	46.9	275	146	0	908	84	79	353	1.80E-73	278.5	MTEF3_DROME	reviewed	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTerf3)"	mTerf3 CG5047	Drosophila melanogaster (Fruit fly)	354	mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]	mitochondrion [GO:0005739]	double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]	GO:0003690; GO:0005739; GO:0061668; GO:0070131; GO:0070180; GO:1902775; GO:1903108	mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i13	Q9VPD5	MTEF3_DROME	46.9	275	146	0	908	84	79	353	2.30E-73	278.5	MTEF3_DROME	reviewed	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTerf3)"	mTerf3 CG5047	Drosophila melanogaster (Fruit fly)	354	mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]	mitochondrion [GO:0005739]	double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]	GO:0003690; GO:0005739; GO:0061668; GO:0070131; GO:0070180; GO:1902775; GO:1903108	mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i15	Q9VPD5	MTEF3_DROME	46.9	275	146	0	908	84	79	353	1.80E-73	278.5	MTEF3_DROME	reviewed	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTerf3)"	mTerf3 CG5047	Drosophila melanogaster (Fruit fly)	354	mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]	mitochondrion [GO:0005739]	double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]	GO:0003690; GO:0005739; GO:0061668; GO:0070131; GO:0070180; GO:1902775; GO:1903108	mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i21	Q9VPD5	MTEF3_DROME	46.9	275	146	0	908	84	79	353	1.90E-73	278.5	MTEF3_DROME	reviewed	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTerf3)"	mTerf3 CG5047	Drosophila melanogaster (Fruit fly)	354	mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]	mitochondrion [GO:0005739]	double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]	GO:0003690; GO:0005739; GO:0061668; GO:0070131; GO:0070180; GO:1902775; GO:1903108	mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN566_c0_g1_i3	Q9VPD5	MTEF3_DROME	46.9	275	146	0	908	84	79	353	1.90E-73	278.5	MTEF3_DROME	reviewed	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTerf3)"	mTerf3 CG5047	Drosophila melanogaster (Fruit fly)	354	mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]	mitochondrion [GO:0005739]	double-stranded DNA binding [GO:0003690]; large ribosomal subunit rRNA binding [GO:0070180]	GO:0003690; GO:0005739; GO:0061668; GO:0070131; GO:0070180; GO:1902775; GO:1903108	mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial transcription [GO:1903108]		NA	NA	NA	NA	NA	NA
TRINITY_DN39771_c0_g1_i1	Q96E29	MTEF3_HUMAN	100	70	0	0	3	212	150	219	2.60E-32	138.7	MTEF3_HUMAN	reviewed	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTERF3) (mTERF domain-containing protein 1, mitochondrial)"	MTERF3 MTERFD1 CGI-12	Homo sapiens (Human)	417	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; macroautophagy [GO:0016236]; mitochondrial ribosome assembly [GO:0061668]; negative regulation of transcription, DNA-templated [GO:0045892]"	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0005654; GO:0005739; GO:0005741; GO:0016236; GO:0045892; GO:0061668	"macroautophagy [GO:0016236]; mitochondrial ribosome assembly [GO:0061668]; negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40712_c0_g1_i1	Q02516	HAP5_YEAST	49.3	73	37	0	219	1	160	232	3.40E-13	75.5	HAP5_YEAST	reviewed	Transcriptional activator HAP5	HAP5 YOR358W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	242	"CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; carbon catabolite activation of transcription from RNA polymerase II promoter [GO:0000436]; regulation of cellular respiration [GO:0043457]; regulation of transcription, DNA-templated [GO:0006355]"	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]"	GO:0000436; GO:0001228; GO:0003677; GO:0005634; GO:0006355; GO:0016602; GO:0043457; GO:0046982	"carbon catabolite activation of transcription from RNA polymerase II promoter [GO:0000436]; regulation of cellular respiration [GO:0043457]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29741_c0_g1_i1	Q96QR8	PURB_HUMAN	45.2	188	67	5	551	96	98	285	3.50E-37	156.4	PURB_HUMAN	reviewed	Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B)	PURB	Homo sapiens (Human)	312	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of myeloid cell differentiation [GO:0045637]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA binding [GO:0003729]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]"	GO:0000977; GO:0001227; GO:0003690; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0008134; GO:0008283; GO:0030154; GO:0032422; GO:0043565; GO:0045637; GO:0046332	cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of myeloid cell differentiation [GO:0045637]		NA	NA	NA	NA	NA	NA
TRINITY_DN29741_c0_g1_i2	Q6PHK6	PURB_DANRE	46.2	277	110	7	824	96	6	277	2.00E-59	230.7	PURB_DANRE	reviewed	Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B)	purb	Danio rerio (Zebrafish) (Brachydanio rerio)	297	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]"	nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0001227; GO:0003690; GO:0005634; GO:0008283; GO:0030154; GO:0032422; GO:0043565	cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]		NA	NA	NA	NA	NA	NA
TRINITY_DN29741_c0_g1_i3	Q6PHK6	PURB_DANRE	46.9	273	110	6	812	96	6	277	2.70E-61	236.9	PURB_DANRE	reviewed	Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B)	purb	Danio rerio (Zebrafish) (Brachydanio rerio)	297	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]"	nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0001227; GO:0003690; GO:0005634; GO:0008283; GO:0030154; GO:0032422; GO:0043565	cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6400_c0_g1_i1	Q6NWA8	TADA1_DANRE	33.1	359	202	8	1175	105	8	330	5.70E-42	173.3	TADA1_DANRE	reviewed	Transcriptional adapter 1 (Transcriptional adapter 1-like protein)	tada1 tada1l zgc:85851	Danio rerio (Zebrafish) (Brachydanio rerio)	332	SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]	SAGA complex [GO:0000124]	transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003713; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6400_c0_g1_i3	Q6NWA8	TADA1_DANRE	34.3	248	155	4	842	105	89	330	5.60E-29	130.2	TADA1_DANRE	reviewed	Transcriptional adapter 1 (Transcriptional adapter 1-like protein)	tada1 tada1l zgc:85851	Danio rerio (Zebrafish) (Brachydanio rerio)	332	SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]	SAGA complex [GO:0000124]	transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003713; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6400_c0_g1_i3	Q6NWA8	TADA1_DANRE	47	66	34	1	1174	977	8	72	5.80E-10	67	TADA1_DANRE	reviewed	Transcriptional adapter 1 (Transcriptional adapter 1-like protein)	tada1 tada1l zgc:85851	Danio rerio (Zebrafish) (Brachydanio rerio)	332	SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]	SAGA complex [GO:0000124]	transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003713; GO:0006357	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9290_c0_g1_i1	O75478	TAD2A_HUMAN	35.4	364	215	8	1	1062	87	440	7.50E-49	196.1	TAD2A_HUMAN	reviewed	Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein)	TADA2A TADA2L KL04P	Homo sapiens (Human)	443	chromosome [GO:0005694]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; positive regulation of histone acetylation [GO:0035066]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA-type complex [GO:0070461]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]	GO:0000125; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005694; GO:0006338; GO:0006357; GO:0035066; GO:0043966; GO:0070461	chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; positive regulation of histone acetylation [GO:0035066]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9290_c0_g1_i3	O75478	TAD2A_HUMAN	35.4	364	215	8	1	1062	87	440	7.50E-49	196.1	TAD2A_HUMAN	reviewed	Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein)	TADA2A TADA2L KL04P	Homo sapiens (Human)	443	chromosome [GO:0005694]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; positive regulation of histone acetylation [GO:0035066]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA-type complex [GO:0070461]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]	GO:0000125; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005694; GO:0006338; GO:0006357; GO:0035066; GO:0043966; GO:0070461	chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; positive regulation of histone acetylation [GO:0035066]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28986_c0_g1_i1	Q5EAE2	TADA3_BOVIN	100	81	0	0	244	2	134	214	8.50E-43	173.7	TADA3_BOVIN	reviewed	Transcriptional adapter 3 (ADA3 homolog) (Transcriptional adapter 3-like) (ADA3-like protein)	TADA3 ADA3 TADA3L	Bos taurus (Bovine)	432	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]"	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]	GO:0000124; GO:0000278; GO:0001932; GO:0003713; GO:0004402; GO:0005671; GO:0006357; GO:0016922; GO:0019904; GO:0030374; GO:0030914; GO:0031063; GO:0031647; GO:0033276; GO:0043966; GO:0043967; GO:0045893; GO:0072686; GO:0090043	"histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11566_c0_g1_i1	Q66IZ5	TAD3B_XENLA	40.9	445	222	10	271	1530	3	431	8.60E-75	282.7	TAD3B_XENLA	reviewed	Transcriptional adapter 3-B (ADA3 homolog B) (Transcriptional adapter 3-like B) (ADA3-like protein B)	tada3-b ada3-b tada3l-b	Xenopus laevis (African clawed frog)	432	nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634			blue	blue	NA	NA	NA	NA
TRINITY_DN5793_c0_g1_i3	H2LBU8	YAP1_ORYLA	50.7	67	25	1	348	524	178	244	5.10E-12	72.8	YAP1_ORYLA	reviewed	Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)	yap1 hir	Oryzias latipes (Japanese rice fish) (Japanese killifish)	459	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0035329; GO:0045944	hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN5793_c0_g1_i3	H2LBU8	YAP1_ORYLA	64.3	42	15	0	190	65	178	219	9.50E-11	68.6	YAP1_ORYLA	reviewed	Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)	yap1 hir	Oryzias latipes (Japanese rice fish) (Japanese killifish)	459	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0035329; GO:0045944	hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN5793_c0_g1_i6	H2LBU8	YAP1_ORYLA	50.7	67	25	1	369	545	178	244	5.20E-12	72.8	YAP1_ORYLA	reviewed	Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)	yap1 hir	Oryzias latipes (Japanese rice fish) (Japanese killifish)	459	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0035329; GO:0045944	hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN16998_c1_g1_i2	P28347	TEAD1_HUMAN	93.8	80	5	0	205	444	311	390	5.70E-38	158.7	TEAD1_HUMAN	reviewed	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	TEAD1 TCF13 TEF1	Homo sapiens (Human)	426	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006367; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0071148; GO:1902895; GO:1990837	"embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16998_c1_g1_i3	P28347	TEAD1_HUMAN	93.5	62	4	0	205	390	311	372	2.60E-28	126.3	TEAD1_HUMAN	reviewed	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	TEAD1 TCF13 TEF1	Homo sapiens (Human)	426	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006367; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0071148; GO:1902895; GO:1990837	"embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29147_c0_g1_i1	P28347	TEAD1_HUMAN	51.8	56	24	1	169	2	172	224	8.50E-07	53.9	TEAD1_HUMAN	reviewed	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	TEAD1 TCF13 TEF1	Homo sapiens (Human)	426	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006367; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0071148; GO:1902895; GO:1990837	"embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22303_c0_g1_i1	P28347	TEAD1_HUMAN	87.7	57	7	0	198	28	255	311	2.20E-24	112.5	TEAD1_HUMAN	reviewed	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	TEAD1 TCF13 TEF1	Homo sapiens (Human)	426	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006367; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0071148; GO:1902895; GO:1990837	"embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22303_c0_g1_i2	P28347	TEAD1_HUMAN	80.7	88	16	1	288	28	224	311	1.60E-37	156.4	TEAD1_HUMAN	reviewed	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	TEAD1 TCF13 TEF1	Homo sapiens (Human)	426	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006367; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0071148; GO:1902895; GO:1990837	"embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30853_c0_g1_i1	Q90701	TEAD3_CHICK	83.3	42	7	0	33	158	392	433	4.70E-14	78.2	TEAD3_CHICK	reviewed	Transcriptional enhancer factor TEF-5 (Cardiac-enriched TEA domain transcription factor 1) (DTEF-1) (TEA domain family member 3) (TEAD-3)	TEAD3 DTEF1 TEF5	Gallus gallus (Chicken)	433	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005667; GO:0035329; GO:0045944; GO:0048568	embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN36082_c0_g1_i1	Q9GQN5	ATRX_DROME	70.6	85	25	0	264	10	604	688	1.50E-32	139.8	ATRX_DROME	reviewed	Transcriptional regulator ATRX homolog (EC 3.6.4.12) (ATP-dependent helicase XNP) (X-linked nuclear protein) (d-xnp) (dXNP)	XNP CG4548	Drosophila melanogaster (Fruit fly)	1311	"beta-heterochromatin [GO:0005722]; chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; axon guidance [GO:0007411]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; glial cell migration [GO:0008347]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intrinsic apoptotic signaling pathway [GO:0097193]; nervous system development [GO:0007399]; regulation of JNK cascade [GO:0046328]"	"beta-heterochromatin [GO:0005722]; chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]	GO:0000775; GO:0000792; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0005722; GO:0006281; GO:0006336; GO:0007399; GO:0007411; GO:0008347; GO:0015616; GO:0016887; GO:0042585; GO:0046328; GO:0051276; GO:0070868; GO:0097193	axon guidance [GO:0007411]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; glial cell migration [GO:0008347]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intrinsic apoptotic signaling pathway [GO:0097193]; nervous system development [GO:0007399]; regulation of JNK cascade [GO:0046328]		blue	blue	NA	NA	NA	NA
TRINITY_DN30950_c0_g1_i1	Q9GQN5	ATRX_DROME	71.5	123	35	0	2	370	957	1079	5.00E-47	188.3	ATRX_DROME	reviewed	Transcriptional regulator ATRX homolog (EC 3.6.4.12) (ATP-dependent helicase XNP) (X-linked nuclear protein) (d-xnp) (dXNP)	XNP CG4548	Drosophila melanogaster (Fruit fly)	1311	"beta-heterochromatin [GO:0005722]; chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; axon guidance [GO:0007411]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; glial cell migration [GO:0008347]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intrinsic apoptotic signaling pathway [GO:0097193]; nervous system development [GO:0007399]; regulation of JNK cascade [GO:0046328]"	"beta-heterochromatin [GO:0005722]; chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]"	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]	GO:0000775; GO:0000792; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005700; GO:0005722; GO:0006281; GO:0006336; GO:0007399; GO:0007411; GO:0008347; GO:0015616; GO:0016887; GO:0042585; GO:0046328; GO:0051276; GO:0070868; GO:0097193	axon guidance [GO:0007411]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; glial cell migration [GO:0008347]; heterochromatin organization involved in chromatin silencing [GO:0070868]; intrinsic apoptotic signaling pathway [GO:0097193]; nervous system development [GO:0007399]; regulation of JNK cascade [GO:0046328]		NA	NA	NA	NA	NA	NA
TRINITY_DN1946_c0_g1_i3	P81270	ERG_MOUSE	42.6	101	38	3	24	266	372	472	1.20E-10	67.4	ERG_MOUSE	reviewed	Transcriptional regulator ERG	Erg Erg-3	Mus musculus (Mouse)	486	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0030154; GO:0045944; GO:1990837; GO:1990904	cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40620_c0_g1_i1	P51521	OVO_DROME	83.3	36	6	0	75	182	1194	1229	5.70E-13	74.3	OVO_DROME	reviewed	Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)]	ovo svb CG6824	Drosophila melanogaster (Fruit fly)	1351	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]"	GO:0000122; GO:0001223; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896	"adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28754_c0_g1_i1	Q08705	CTCF_CHICK	42.6	115	63	1	17	361	322	433	5.90E-22	105.1	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33136_c0_g1_i1	Q08705	CTCF_CHICK	50.9	53	26	0	35	193	349	401	3.30E-10	65.5	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1594_c0_g1_i1	Q08705	CTCF_CHICK	45.4	273	94	2	55	870	334	552	9.60E-65	248.4	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1594_c0_g1_i2	Q08705	CTCF_CHICK	45.5	387	152	4	567	1712	220	552	1.90E-93	344.7	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1594_c0_g1_i3	Q08705	CTCF_CHICK	52.9	333	151	4	567	1547	220	552	9.60E-100	365.5	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1594_c0_g1_i4	Q08705	CTCF_CHICK	52.9	333	151	4	596	1576	220	552	9.70E-100	365.5	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1594_c0_g1_i5	Q08705	CTCF_CHICK	45.5	387	152	4	596	1741	220	552	2.00E-93	344.7	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN36841_c0_g1_i1	Q08705	CTCF_CHICK	40.5	116	68	1	348	4	311	426	6.60E-22	105.1	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i10	Q08705	CTCF_CHICK	37	100	61	1	463	762	315	412	1.20E-10	68.6	CTCF_CHICK	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Gallus gallus (Chicken)	728	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30816_c0_g1_i1	Q8NI51	CTCFL_HUMAN	35.5	107	66	2	419	108	320	426	1.50E-11	70.9	CTCFL_HUMAN	reviewed	Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27) (CT27) (Zinc finger protein CTCF-T)	CTCFL BORIS	Homo sapiens (Human)	663	"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell cycle [GO:0007049]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006349; GO:0006357; GO:0007049; GO:0010628; GO:0016571; GO:0016604; GO:0042393; GO:0043035; GO:0043046; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0051569	"cell cycle [GO:0007049]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35286_c0_g1_i1	A6QLA0	NFX1_BOVIN	100	38	0	0	115	2	724	761	4.40E-19	94.7	NFX1_BOVIN	reviewed	"Transcriptional repressor NF-X1 (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)"	NFX1	Bos taurus (Bovine)	1116	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630	"negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3945_c0_g1_i1	B1AY10	NFX1_MOUSE	32.9	398	203	8	1124	114	408	802	3.70E-56	220.3	NFX1_MOUSE	reviewed	"Transcriptional repressor NF-X1 (m-Nfx.1) (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)"	Nfx1	Mus musculus (Mouse)	1114	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630	"negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3945_c0_g1_i2	B1AY10	NFX1_MOUSE	33.6	384	251	2	1187	45	438	820	4.20E-63	243.4	NFX1_MOUSE	reviewed	"Transcriptional repressor NF-X1 (m-Nfx.1) (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)"	Nfx1	Mus musculus (Mouse)	1114	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630	"negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3945_c0_g1_i3	B1AY10	NFX1_MOUSE	32.9	416	215	8	1109	45	408	820	3.50E-59	230.3	NFX1_MOUSE	reviewed	"Transcriptional repressor NF-X1 (m-Nfx.1) (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)"	Nfx1	Mus musculus (Mouse)	1114	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630	"negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3945_c0_g1_i4	B1AY10	NFX1_MOUSE	33.6	366	239	2	1202	114	438	802	4.40E-60	233.4	NFX1_MOUSE	reviewed	"Transcriptional repressor NF-X1 (m-Nfx.1) (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)"	Nfx1	Mus musculus (Mouse)	1114	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630	"negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN290_c0_g1_i2	Q8VHR5	P66B_MOUSE	40.5	215	102	6	149	769	286	482	2.90E-27	124.4	P66B_MOUSE	reviewed	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	Gatad2b	Mus musculus (Mouse)	594	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000122; GO:0005654; GO:0008270; GO:0016581; GO:0016607; GO:0043565	negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN290_c0_g1_i3	Q8WXI9	P66B_HUMAN	47	149	63	3	269	706	346	481	2.70E-27	124.4	P66B_HUMAN	reviewed	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	GATAD2B KIAA1150	Homo sapiens (Human)	593	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0005654; GO:0008270; GO:0016581; GO:0016607; GO:0032991; GO:0043044; GO:0043565	ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN290_c0_g1_i5	Q8WXI9	P66B_HUMAN	47	149	63	3	269	706	346	481	2.70E-27	124.4	P66B_HUMAN	reviewed	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	GATAD2B KIAA1150	Homo sapiens (Human)	593	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0005654; GO:0008270; GO:0016581; GO:0016607; GO:0032991; GO:0043044; GO:0043565	ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN290_c0_g1_i6	Q8WXI9	P66B_HUMAN	40.7	194	95	4	269	829	346	526	5.30E-27	123.2	P66B_HUMAN	reviewed	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	GATAD2B KIAA1150	Homo sapiens (Human)	593	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of transcription by RNA polymerase II [GO:0000122]	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000790; GO:0005654; GO:0008270; GO:0016581; GO:0016607; GO:0032991; GO:0043044; GO:0043565	ATP-dependent chromatin remodeling [GO:0043044]; negative regulation of transcription by RNA polymerase II [GO:0000122]		NA	NA	NA	NA	NA	NA
TRINITY_DN9539_c0_g1_i1	P25490	TYY1_HUMAN	100	101	0	0	303	1	312	412	2.30E-58	225.7	TYY1_HUMAN	reviewed	Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1)	YY1 INO80S	Homo sapiens (Human)	414	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000400; GO:0000724; GO:0000790; GO:0000976; GO:0000978; GO:0000987; GO:0001217; GO:0001227; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0009952; GO:0010225; GO:0010629; GO:0016363; GO:0016579; GO:0030154; GO:0031011; GO:0031519; GO:0032688; GO:0034644; GO:0034696; GO:0043565; GO:0045944; GO:0046332; GO:0046872; GO:0048593; GO:0051276; GO:0061052; GO:0071347; GO:1902894; GO:1990837	anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN23304_c1_g2_i1	Q8I8U7	TRA1_DROME	57.7	769	303	10	2294	3	9	760	1.70E-236	820.5	TRA1_DROME	reviewed	Transcription-associated protein 1 (dTRA1)	Nipped-A Tra1 CG2905	Drosophila melanogaster (Fruit fly)	3790	"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; phosphorylation [GO:0016310]; regulation of transcription, DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222]"	cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]	transcription coregulator activity [GO:0003712]	GO:0000123; GO:0000124; GO:0000281; GO:0003712; GO:0005634; GO:0005700; GO:0005703; GO:0005737; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0035222; GO:0035267; GO:0043486; GO:0043966	"DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; phosphorylation [GO:0016310]; regulation of transcription, DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7171_c0_g1_i1	Q9R099	TBL2_MOUSE	41	371	217	2	276	1385	73	442	4.10E-84	313.5	TBL2_MOUSE	reviewed	Transducin beta-like protein 2	Tbl2	Mus musculus (Mouse)	442	endoplasmic reticulum [GO:0005783]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]	endoplasmic reticulum [GO:0005783]	phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; translation initiation factor binding [GO:0031369]	GO:0005783; GO:0019901; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456	cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]		NA	NA	NA	NA	NA	NA
TRINITY_DN18103_c0_g1_i1	O13168	TLE3B_DANRE	84.8	99	14	1	295	2	13	111	1.90E-41	169.5	TLE3B_DANRE	reviewed	Transducin-like enhancer protein 3-B (Protein groucho-1)	tle3b gro1 groucho1	Danio rerio (Zebrafish) (Brachydanio rerio)	771	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; myeloid cell differentiation [GO:0030099]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0005667; GO:0006355; GO:0030099; GO:0070491; GO:0090090	"myeloid cell differentiation [GO:0030099]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i1	Q02942	TRF_BLADI	26.5	691	407	20	47	1969	7	646	1.10E-56	223	TRF_BLADI	reviewed	Transferrin		Blaberus discoidalis (Tropical cockroach)	726	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i12	Q02942	TRF_BLADI	22.1	521	314	17	47	1486	7	476	2.80E-19	98.2	TRF_BLADI	reviewed	Transferrin		Blaberus discoidalis (Tropical cockroach)	726	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN3841_c0_g1_i15	Q02942	TRF_BLADI	31.9	317	188	9	92	982	368	676	4.40E-37	156.8	TRF_BLADI	reviewed	Transferrin		Blaberus discoidalis (Tropical cockroach)	726	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN3047_c1_g1_i1	Q26643	TRF_SARPE	33.3	81	53	1	242	3	94	174	4.30E-10	65.1	TRF_SARPE	reviewed	Transferrin		Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	629	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN6155_c0_g1_i1	Q02942	TRF_BLADI	50.5	105	49	1	1	306	531	635	3.10E-26	119	TRF_BLADI	reviewed	Transferrin		Blaberus discoidalis (Tropical cockroach)	726	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		NA	NA	NA	NA	NA	NA
TRINITY_DN6155_c0_g1_i2	Q02942	TRF_BLADI	56.2	64	28	0	32	223	572	635	7.30E-17	87.4	TRF_BLADI	reviewed	Transferrin		Blaberus discoidalis (Tropical cockroach)	726	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]	GO:0005615; GO:0006811; GO:0046872; GO:0055072	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]		blue	blue	NA	NA	NA	NA
TRINITY_DN23304_c1_g2_i2	Q9Y4A5	TRRAP_HUMAN	57.4	665	239	6	1913	3	145	793	6.80E-196	685.3	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23304_c1_g1_i1	Q9Y4A5	TRRAP_HUMAN	57.1	819	321	4	1	2370	798	1615	3.70E-268	925.6	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36090_c0_g1_i1	Q9Y4A5	TRRAP_HUMAN	100	90	0	0	270	1	3699	3788	8.10E-47	187.2	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i3	Q9Y4A5	TRRAP_HUMAN	62.8	121	45	0	3	365	3663	3783	3.60E-42	172.2	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i5	Q9Y4A5	TRRAP_HUMAN	58.3	120	44	1	1	360	3678	3791	5.40E-36	151.8	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i6	Q9Y4A5	TRRAP_HUMAN	59	2319	828	24	36	6884	1628	3859	0	2679	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i8	Q9Y4A5	TRRAP_HUMAN	59.1	2308	833	22	36	6851	1628	3859	0	2684.8	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i9	Q9Y4A5	TRRAP_HUMAN	59.1	2308	833	22	36	6851	1628	3859	0	2684.8	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32096_c0_g1_i1	Q9Y4A5	TRRAP_HUMAN	100	90	0	0	271	2	3290	3379	1.30E-47	189.9	TRRAP_HUMAN	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	TRRAP PAF400	Homo sapiens (Human)	3859	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016310; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; phosphorylation [GO:0016310]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37009_c0_g1_i1	Q80YV3	TRRAP_MOUSE	100	115	0	0	1	345	2370	2484	4.30E-61	235	TRRAP_MOUSE	reviewed	Transformation/transcription domain-associated protein (Tra1 homolog)	Trrap	Mus musculus (Mouse)	2565	"Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000123; GO:0000124; GO:0000812; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006281; GO:0006355; GO:0007093; GO:0016578; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968	"DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i10	Q80YV3	TRRAP_MOUSE	62.1	58	22	0	132	305	2508	2565	2.30E-14	79.7	TRRAP_MOUSE	reviewed	Transformation/transcription domain-associated protein (Tra1 homolog)	Trrap	Mus musculus (Mouse)	2565	"Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000123; GO:0000124; GO:0000812; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006281; GO:0006355; GO:0007093; GO:0016578; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968	"DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1869_c0_g1_i4	Q80YV3	TRRAP_MOUSE	59	571	220	6	3	1691	1259	1823	1.50E-197	690.6	TRRAP_MOUSE	reviewed	Transformation/transcription domain-associated protein (Tra1 homolog)	Trrap	Mus musculus (Mouse)	2565	"Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000123; GO:0000124; GO:0000812; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006281; GO:0006355; GO:0007093; GO:0016578; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968	"DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9809_c0_g1_i1	Q13595	TRA2A_HUMAN	69.8	106	32	0	381	64	110	215	5.20E-42	172.2	TRA2A_HUMAN	reviewed	Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A)	TRA2A	Homo sapiens (Human)	282	"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]"	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0043231; GO:0048026	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9809_c0_g2_i1	Q13595	TRA2A_HUMAN	97.9	95	2	0	348	64	121	215	4.20E-48	191.8	TRA2A_HUMAN	reviewed	Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A)	TRA2A	Homo sapiens (Human)	282	"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]"	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0043231; GO:0048026	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]"		NA	NA	NA	NA	NA	NA
TRINITY_DN483_c0_g1_i1	Q3ZBT6	TRA2B_BOVIN	68.8	109	34	0	119	445	104	212	3.50E-41	169.5	TRA2B_BOVIN	reviewed	"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	TRA2B SFRS10	Bos taurus (Bovine)	288	"nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]	GO:0000381; GO:0000398; GO:0003729; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0036002; GO:0042802; GO:0048026; GO:0071333; GO:1990403	"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		blue	blue	NA	NA	NA	NA
TRINITY_DN483_c0_g1_i2	Q3ZBT6	TRA2B_BOVIN	68.8	109	34	0	119	445	104	212	3.60E-41	169.5	TRA2B_BOVIN	reviewed	"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	TRA2B SFRS10	Bos taurus (Bovine)	288	"nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]	GO:0000381; GO:0000398; GO:0003729; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0036002; GO:0042802; GO:0048026; GO:0071333; GO:1990403	"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10158_c0_g1_i1	Q3ZBT6	TRA2B_BOVIN	100	125	0	0	414	40	100	224	8.40E-70	264.2	TRA2B_BOVIN	reviewed	"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	TRA2B SFRS10	Bos taurus (Bovine)	288	"nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]	GO:0000381; GO:0000398; GO:0003729; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0036002; GO:0042802; GO:0048026; GO:0071333; GO:1990403	"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10158_c0_g1_i2	Q3ZBT6	TRA2B_BOVIN	100	125	0	0	414	40	100	224	1.10E-69	263.8	TRA2B_BOVIN	reviewed	"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	TRA2B SFRS10	Bos taurus (Bovine)	288	"nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]	GO:0000381; GO:0000398; GO:0003729; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0036002; GO:0042802; GO:0048026; GO:0071333; GO:1990403	"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN998_c0_g1_i1	Q9Y6A5	TACC3_HUMAN	34.4	195	128	0	243	827	641	835	2.10E-25	117.9	TACC3_HUMAN	reviewed	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	838	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN998_c0_g1_i2	Q9Y6A5	TACC3_HUMAN	34.4	195	128	0	422	1006	641	835	2.50E-25	117.9	TACC3_HUMAN	reviewed	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	838	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN998_c0_g1_i3	Q9Y6A5	TACC3_HUMAN	34.4	195	128	0	242	826	641	835	2.10E-25	117.9	TACC3_HUMAN	reviewed	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	838	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN998_c0_g1_i4	Q9Y6A5	TACC3_HUMAN	34.4	195	128	0	407	991	641	835	2.40E-25	117.9	TACC3_HUMAN	reviewed	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	838	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN998_c0_g1_i5	Q9Y6A5	TACC3_HUMAN	34.4	195	128	0	325	909	641	835	2.20E-25	117.9	TACC3_HUMAN	reviewed	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	838	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN998_c0_g1_i6	Q9Y6A5	TACC3_HUMAN	34.4	195	128	0	257	841	641	835	2.10E-25	117.9	TACC3_HUMAN	reviewed	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	838	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		NA	NA	NA	NA	NA	NA
TRINITY_DN29723_c0_g2_i1	Q66IH2	TBRG1_XENTR	45.2	168	85	1	627	124	187	347	7.40E-38	158.7	TBRG1_XENTR	reviewed	Transforming growth factor beta regulator 1	tbrg1 TEgg020g14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	409	nucleus [GO:0005634]; cell cycle [GO:0007049]	nucleus [GO:0005634]		GO:0005634; GO:0007049	cell cycle [GO:0007049]		blue	blue	NA	NA	NA	NA
TRINITY_DN3415_c0_g1_i2	A7MB11	TGFA1_BOVIN	40.6	581	332	8	190	1902	46	623	2.30E-119	431	TGFA1_BOVIN	reviewed	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	TGFBRAP1	Bos taurus (Bovine)	859	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0017137; GO:0034058	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN3415_c0_g1_i3	A7MB11	TGFA1_BOVIN	37.9	359	214	5	43	1098	267	623	1.50E-62	241.5	TGFA1_BOVIN	reviewed	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	TGFBRAP1	Bos taurus (Bovine)	859	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0017137; GO:0034058	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN3415_c0_g1_i6	A7MB11	TGFA1_BOVIN	39.5	408	238	5	43	1245	218	623	4.00E-80	300.1	TGFA1_BOVIN	reviewed	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	TGFBRAP1	Bos taurus (Bovine)	859	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0017137; GO:0034058	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN3415_c0_g1_i8	A7MB11	TGFA1_BOVIN	42.6	183	101	3	190	729	46	227	9.50E-32	138.7	TGFA1_BOVIN	reviewed	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	TGFBRAP1	Bos taurus (Bovine)	859	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0017137; GO:0034058	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN3415_c0_g1_i9	A7MB11	TGFA1_BOVIN	45	120	64	2	3	359	378	496	2.80E-20	99.8	TGFA1_BOVIN	reviewed	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	TGFBRAP1	Bos taurus (Bovine)	859	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0017137; GO:0034058	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN1249_c0_g1_i1	Q8WUH2	TGFA1_HUMAN	38.7	222	122	4	9	671	636	844	6.80E-32	139	TGFA1_HUMAN	reviewed	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	TGFBRAP1	Homo sapiens (Human)	860	"CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]	GO:0005160; GO:0005737; GO:0005769; GO:0006355; GO:0006886; GO:0006914; GO:0007165; GO:0007179; GO:0008333; GO:0016020; GO:0017137; GO:0033263; GO:0034058; GO:0043231; GO:0046332	"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3415_c0_g1_i1	A4IG72	TGFA1_DANRE	46.4	110	58	1	2	331	272	380	2.10E-18	93.2	TGFA1_DANRE	reviewed	Transforming growth factor-beta receptor-associated protein 1 homolog (TGF-beta receptor-associated protein 1 homolog)	tgfbrap1 zgc:162302	Danio rerio (Zebrafish) (Brachydanio rerio)	863	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0017137; GO:0034058	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN6644_c0_g2_i1	P82198	BGH3_MOUSE	28.8	243	164	3	1	726	276	510	5.20E-23	110.2	BGH3_MOUSE	reviewed	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	Tgfbi	Mus musculus (Mouse)	683	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]	cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]		brown	brown	NA	NA	NA	NA
TRINITY_DN6644_c0_g2_i2	P82198	BGH3_MOUSE	26.2	382	260	9	1	1140	276	637	1.70E-29	132.1	BGH3_MOUSE	reviewed	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	Tgfbi	Mus musculus (Mouse)	683	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]	cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN6644_c0_g2_i4	P82198	BGH3_MOUSE	35	140	90	1	1	417	276	415	1.00E-18	94.7	BGH3_MOUSE	reviewed	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	Tgfbi	Mus musculus (Mouse)	683	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]	cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN6644_c0_g2_i5	P82198	BGH3_MOUSE	28.8	243	164	3	1	726	276	510	5.10E-23	110.2	BGH3_MOUSE	reviewed	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	Tgfbi	Mus musculus (Mouse)	683	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]	cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN19033_c0_g1_i2	O11780	BGH3_PIG	25.8	225	145	3	788	114	430	632	7.00E-14	79.3	BGH3_PIG	reviewed	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	TGFBI	Sus scrofa (Pig)	683	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]	GO:0005178; GO:0005518; GO:0005615; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840	cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]		NA	NA	NA	NA	NA	NA
TRINITY_DN10648_c0_g1_i1	Q9QUI0	RHOA_MOUSE	100	193	0	0	49	627	1	193	7.60E-110	397.9	RHOA_MOUSE	reviewed	Transforming protein RhoA (EC 3.6.5.2)	Rhoa Arha Arha2	Mus musculus (Mouse)	193	"apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; integrin-mediated signaling pathway [GO:0007229]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of modification of synaptic structure [GO:1905244]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; stress-activated protein kinase signaling cascade [GO:0031098]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]"	apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]	GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]	GO:0000902; GO:0001666; GO:0001998; GO:0002363; GO:0003100; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005739; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006357; GO:0007010; GO:0007015; GO:0007155; GO:0007160; GO:0007163; GO:0007229; GO:0007266; GO:0007519; GO:0008360; GO:0009612; GO:0009749; GO:0010812; GO:0010975; GO:0010977; GO:0016020; GO:0016477; GO:0017022; GO:0019003; GO:0019901; GO:0019904; GO:0021795; GO:0021861; GO:0030027; GO:0030036; GO:0030154; GO:0030307; GO:0030334; GO:0030424; GO:0030496; GO:0030521; GO:0030838; GO:0030865; GO:0031098; GO:0031122; GO:0031234; GO:0031410; GO:0031532; GO:0031982; GO:0032154; GO:0032467; GO:0032587; GO:0032956; GO:0033144; GO:0033688; GO:0034329; GO:0034446; GO:0035385; GO:0036089; GO:0038027; GO:0042476; GO:0042493; GO:0042995; GO:0043123; GO:0043124; GO:0043149; GO:0043197; GO:0043200; GO:0043231; GO:0043280; GO:0043296; GO:0043297; GO:0043366; GO:0043524; GO:0043525; GO:0043542; GO:0043931; GO:0044319; GO:0045198; GO:0045471; GO:0045665; GO:0045666; GO:0045727; GO:0045792; GO:0045987; GO:0046039; GO:0046638; GO:0048812; GO:0050773; GO:0050919; GO:0051022; GO:0051384; GO:0051496; GO:0051924; GO:0060193; GO:0060548; GO:0061383; GO:0070507; GO:0071222; GO:0071345; GO:0071803; GO:0071902; GO:0071944; GO:0090051; GO:0090307; GO:0090324; GO:0097498; GO:0098794; GO:0098978; GO:1901224; GO:1902766; GO:1903427; GO:1903673; GO:1904695; GO:1904996; GO:1905244; GO:1905274; GO:1990869; GO:2000177; GO:2000406	"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; integrin-mediated signaling pathway [GO:0007229]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of modification of synaptic structure [GO:1905244]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress-activated protein kinase signaling cascade [GO:0031098]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10648_c0_g2_i1	P61585	RHOA_BOVIN	100	193	0	0	66	644	1	193	1.70E-109	396.7	RHOA_BOVIN	reviewed	Transforming protein RhoA (EC 3.6.5.2) (Gb) (p21)	RHOA ARHA RHO12	Bos taurus (Bovine)	193	"apical junction complex [GO:0043296]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]"	apical junction complex [GO:0043296]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; protein kinase binding [GO:0019901]	GO:0001998; GO:0002363; GO:0003100; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006357; GO:0007015; GO:0007160; GO:0007163; GO:0007266; GO:0007519; GO:0008360; GO:0010812; GO:0010975; GO:0016477; GO:0017022; GO:0019901; GO:0021795; GO:0021861; GO:0030027; GO:0030036; GO:0030334; GO:0030496; GO:0030521; GO:0030865; GO:0031122; GO:0031234; GO:0031410; GO:0031532; GO:0031982; GO:0032154; GO:0032467; GO:0032587; GO:0032956; GO:0033144; GO:0033688; GO:0034329; GO:0034446; GO:0035385; GO:0036089; GO:0038027; GO:0042476; GO:0042995; GO:0043123; GO:0043149; GO:0043197; GO:0043231; GO:0043296; GO:0043297; GO:0043366; GO:0043524; GO:0043542; GO:0043931; GO:0044319; GO:0045198; GO:0045666; GO:0045792; GO:0046638; GO:0050919; GO:0051496; GO:0060193; GO:0061383; GO:0070507; GO:0071222; GO:0071803; GO:0071902; GO:0090051; GO:0090307; GO:0090324; GO:0097498; GO:1901224; GO:1902766; GO:1903427; GO:1903673; GO:1904695; GO:1904996; GO:1990869; GO:2000177; GO:2000406	"actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18696_c0_g2_i1	O14185	STG1_SCHPO	43.1	65	35	2	182	373	30	93	6.30E-05	48.5	STG1_SCHPO	reviewed	Transgelin (Calponin homolog 1)	stg1 SPAC4F8.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	174	actin cortical patch [GO:0030479]; actin filament [GO:0005884]; cell division site [GO:0032153]; cell tip [GO:0051286]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]	actin cortical patch [GO:0030479]; actin filament [GO:0005884]; cell division site [GO:0032153]; cell tip [GO:0051286]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]	actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]	GO:0000226; GO:0000281; GO:0005634; GO:0005829; GO:0005874; GO:0005884; GO:0008017; GO:0008093; GO:0030036; GO:0030479; GO:0032153; GO:0051015; GO:0051286; GO:0051764	actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]		blue	blue	NA	NA	NA	NA
TRINITY_DN36247_c1_g1_i1	P37802	TAGL2_HUMAN	47.3	74	36	1	214	2	45	118	5.70E-11	67.8	TAGL2_HUMAN	reviewed	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2 KIAA0120 CDABP0035	Homo sapiens (Human)	199	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]	cadherin binding [GO:0045296]	GO:0002576; GO:0005576; GO:0005829; GO:0030855; GO:0031982; GO:0045296; GO:0070062	epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN15249_c0_g1_i1	P37802	TAGL2_HUMAN	100	83	0	0	1	249	49	131	8.60E-43	173.7	TAGL2_HUMAN	reviewed	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2 KIAA0120 CDABP0035	Homo sapiens (Human)	199	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]	cadherin binding [GO:0045296]	GO:0002576; GO:0005576; GO:0005829; GO:0030855; GO:0031982; GO:0045296; GO:0070062	epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN15249_c0_g1_i2	P37802	TAGL2_HUMAN	100	83	0	0	1	249	49	131	8.60E-43	173.7	TAGL2_HUMAN	reviewed	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2 KIAA0120 CDABP0035	Homo sapiens (Human)	199	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]	cadherin binding [GO:0045296]	GO:0002576; GO:0005576; GO:0005829; GO:0030855; GO:0031982; GO:0045296; GO:0070062	epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN27376_c0_g1_i1	P37802	TAGL2_HUMAN	100	62	0	0	2	187	138	199	2.30E-30	132.1	TAGL2_HUMAN	reviewed	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2 KIAA0120 CDABP0035	Homo sapiens (Human)	199	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]	cadherin binding [GO:0045296]	GO:0002576; GO:0005576; GO:0005829; GO:0030855; GO:0031982; GO:0045296; GO:0070062	epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]		NA	NA	NA	NA	NA	NA
TRINITY_DN36247_c0_g1_i1	Q9WVA4	TAGL2_MOUSE	51.3	78	35	1	228	4	45	122	1.70E-13	76.3	TAGL2_MOUSE	reviewed	Transgelin-2 (SM22-beta)	Tagln2 Kiaa0120	Mus musculus (Mouse)	199	epithelial cell differentiation [GO:0030855]			GO:0030855	epithelial cell differentiation [GO:0030855]		NA	NA	NA	NA	NA	NA
TRINITY_DN16555_c1_g1_i1	Q9WVA4	TAGL2_MOUSE	39.1	115	62	2	344	3	75	182	7.60E-13	74.7	TAGL2_MOUSE	reviewed	Transgelin-2 (SM22-beta)	Tagln2 Kiaa0120	Mus musculus (Mouse)	199	epithelial cell differentiation [GO:0030855]			GO:0030855	epithelial cell differentiation [GO:0030855]		NA	NA	NA	NA	NA	NA
TRINITY_DN25762_c0_g1_i1	Q3ZBY2	TAGL3_BOVIN	52.1	73	29	2	240	37	128	199	4.30E-10	65.1	TAGL3_BOVIN	reviewed	Transgelin-3	TAGLN3	Bos taurus (Bovine)	199							blue	blue	NA	NA	NA	NA
TRINITY_DN10537_c0_g1_i2	Q18297	TRPA1_CAEEL	32.9	328	203	5	9	959	504	825	3.40E-39	163.7	TRPA1_CAEEL	reviewed	Transient receptor potential cation channel subfamily A member 1 homolog	trpa-1 C29E6.2	Caenorhabditis elegans	1211	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	ion channel activity [GO:0005216]	GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN4411_c0_g1_i1	Q18297	TRPA1_CAEEL	21.9	659	393	17	2518	791	476	1095	6.10E-21	104.8	TRPA1_CAEEL	reviewed	Transient receptor potential cation channel subfamily A member 1 homolog	trpa-1 C29E6.2	Caenorhabditis elegans	1211	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	ion channel activity [GO:0005216]	GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730	response to stimulus [GO:0050896]		NA	NA	NA	NA	NA	NA
TRINITY_DN7276_c1_g1_i1	A8DYE2	TRPCG_DROME	52.7	698	280	5	18	2102	670	1320	1.90E-196	688	TRPCG_DROME	reviewed	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	Trpm CG44240	Drosophila melanogaster (Fruit fly)	2023	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]	"cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"	GO:0005261; GO:0005385; GO:0005887; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN7276_c1_g1_i2	A8DYE2	TRPCG_DROME	51.3	462	176	4	1458	79	687	1101	9.20E-121	435.3	TRPCG_DROME	reviewed	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	Trpm CG44240	Drosophila melanogaster (Fruit fly)	2023	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]	"cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"	GO:0005261; GO:0005385; GO:0005887; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN7276_c1_g1_i3	A8DYE2	TRPCG_DROME	47.1	293	151	2	19	885	1028	1320	3.80E-68	261.2	TRPCG_DROME	reviewed	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	Trpm CG44240	Drosophila melanogaster (Fruit fly)	2023	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]	"cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"	GO:0005261; GO:0005385; GO:0005887; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN7276_c1_g1_i4	A8DYE2	TRPCG_DROME	49.7	578	241	5	1306	3030	790	1320	1.90E-145	518.8	TRPCG_DROME	reviewed	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	Trpm CG44240	Drosophila melanogaster (Fruit fly)	2023	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]	"cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"	GO:0005261; GO:0005385; GO:0005887; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN7276_c1_g1_i4	A8DYE2	TRPCG_DROME	48.6	405	159	4	1287	79	744	1101	3.70E-96	355.1	TRPCG_DROME	reviewed	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	Trpm CG44240	Drosophila melanogaster (Fruit fly)	2023	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]	"cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"	GO:0005261; GO:0005385; GO:0005887; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN7276_c1_g2_i1	A8DYE2	TRPCG_DROME	53.7	244	112	1	2170	1442	1077	1320	1.30E-67	259.2	TRPCG_DROME	reviewed	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	Trpm CG44240	Drosophila melanogaster (Fruit fly)	2023	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]	"cation channel activity [GO:0005261]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]"	GO:0005261; GO:0005385; GO:0005887; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN10695_c0_g1_i1	Q9W0T5	PYX_DROME	41.6	89	51	1	266	3	671	759	5.10E-09	61.6	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN9013_c0_g1_i1	Q9W0T5	PYX_DROME	29.3	690	414	14	286	2331	169	792	5.90E-53	211.1	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN1274_c0_g1_i1	Q9W0T5	PYX_DROME	33	557	317	12	311	1918	248	769	7.10E-59	230.3	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN1274_c0_g1_i2	Q9W0T5	PYX_DROME	33	557	317	12	309	1916	248	769	7.10E-59	230.3	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN1274_c0_g1_i4	Q9W0T5	PYX_DROME	33	557	317	12	214	1821	248	769	6.80E-59	230.3	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN1808_c0_g1_i1	Q9W0T5	PYX_DROME	25.7	674	389	20	2547	592	124	707	4.10E-32	141.7	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		NA	NA	NA	NA	NA	NA
TRINITY_DN4939_c0_g1_i1	Q9W0T5	PYX_DROME	35.3	153	95	1	31	477	600	752	9.50E-20	98.2	PYX_DROME	reviewed	Transient receptor potential channel pyrexia	pyx CG17142	Drosophila melanogaster (Fruit fly)	956	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005261; GO:0005262; GO:0006812; GO:0006813; GO:0006816; GO:0009408; GO:0016021; GO:0034703; GO:0048060	calcium ion transport [GO:0006816]; cation transport [GO:0006812]; negative gravitaxis [GO:0048060]; potassium ion transport [GO:0006813]; response to heat [GO:0009408]		blue	blue	NA	NA	NA	NA
TRINITY_DN39916_c0_g1_i1	Q9VJJ7	TRPG_DROME	82.3	62	11	0	36	221	579	640	1.30E-23	109.8	TRPG_DROME	reviewed	Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma)	Trpgamma CG5996	Drosophila melanogaster (Fruit fly)	1128	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]"	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]	"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]"	GO:0005261; GO:0005262; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635	adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]		NA	NA	NA	NA	NA	NA
TRINITY_DN6858_c0_g1_i1	P23787	TERA_XENLA	85.4	219	32	0	2	658	182	400	2.10E-104	379.8	TERA_XENLA	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP)	vcp	Xenopus laevis (African clawed frog)	805	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6858_c0_g1_i2	P23787	TERA_XENLA	95.3	214	10	0	2	643	182	395	1.30E-114	413.7	TERA_XENLA	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP)	vcp	Xenopus laevis (African clawed frog)	805	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043161; GO:0044877; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN3111_c0_g1_i1	Q3ZBT1	TERA_BOVIN	84.8	66	10	0	1	198	202	267	2.60E-29	129.4	TERA_BOVIN	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	Bos taurus (Bovine)	806	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0043161; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN3111_c0_g1_i1	Q3ZBT1	TERA_BOVIN	86.3	51	7	0	191	343	265	315	5.40E-19	95.1	TERA_BOVIN	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	Bos taurus (Bovine)	806	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0043161; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN8356_c0_g1_i1	Q3ZBT1	TERA_BOVIN	99.6	240	1	0	722	3	436	675	3.00E-136	485.7	TERA_BOVIN	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	Bos taurus (Bovine)	806	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0043161; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN8356_c0_g2_i1	Q3ZBT1	TERA_BOVIN	100	240	0	0	722	3	436	675	1.70E-136	486.5	TERA_BOVIN	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	Bos taurus (Bovine)	806	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0043161; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6302_c0_g1_i1	Q3ZBT1	TERA_BOVIN	100	206	0	0	2	619	190	395	3.00E-113	409.1	TERA_BOVIN	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	Bos taurus (Bovine)	806	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0043161; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN6302_c0_g1_i2	Q3ZBT1	TERA_BOVIN	100	197	0	0	2	592	199	395	7.30E-109	394.4	TERA_BOVIN	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	Bos taurus (Bovine)	806	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0043161; GO:0061857; GO:0097352; GO:1903843; GO:1905634	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN4707_c0_g1_i1	Q7ZU99	TERA_DANRE	91.9	173	14	0	2	520	505	677	2.50E-89	329.3	TERA_DANRE	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (Protein CDC48) (Valosin-containing protein) (VCP)	vcp cdc48 si:ch211-113n10.2	Danio rerio (Zebrafish) (Brachydanio rerio)	806	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; chordate embryonic development [GO:0043009]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; locomotory behavior [GO:0007626]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization to chromatin [GO:1905634]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; retrograde protein transport, ER to cytosol [GO:0030970]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0007626; GO:0008289; GO:0010506; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0030970; GO:0031593; GO:0032434; GO:0032510; GO:0034098; GO:0035861; GO:0036297; GO:0036503; GO:0043009; GO:0043161; GO:0051228; GO:0071712; GO:0097352; GO:1905634; GO:2000058	"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; chordate embryonic development [GO:0043009]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; interstrand cross-link repair [GO:0036297]; locomotory behavior [GO:0007626]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization to chromatin [GO:1905634]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; retrograde protein transport, ER to cytosol [GO:0030970]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4707_c0_g1_i2	Q7ZU99	TERA_DANRE	89.6	241	25	0	2	724	437	677	6.80E-125	448	TERA_DANRE	reviewed	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (Protein CDC48) (Valosin-containing protein) (VCP)	vcp cdc48 si:ch211-113n10.2	Danio rerio (Zebrafish) (Brachydanio rerio)	806	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; chordate embryonic development [GO:0043009]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; interstrand cross-link repair [GO:0036297]; locomotory behavior [GO:0007626]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization to chromatin [GO:1905634]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; retrograde protein transport, ER to cytosol [GO:0030970]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0007626; GO:0008289; GO:0010506; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030433; GO:0030970; GO:0031593; GO:0032434; GO:0032510; GO:0034098; GO:0035861; GO:0036297; GO:0036503; GO:0043009; GO:0043161; GO:0051228; GO:0071712; GO:0097352; GO:1905634; GO:2000058	"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; chordate embryonic development [GO:0043009]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; interstrand cross-link repair [GO:0036297]; locomotory behavior [GO:0007626]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization to chromatin [GO:1905634]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; retrograde protein transport, ER to cytosol [GO:0030970]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]"		blue	blue	NA	NA	NA	NA
TRINITY_DN16933_c0_g2_i1	P29401	TKT_HUMAN	99.6	273	1	0	820	2	299	571	5.10E-153	541.6	TKT_HUMAN	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT	Homo sapiens (Human)	623	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]; xylulose biosynthetic process [GO:0005999]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982]	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0000287; GO:0004802; GO:0005509; GO:0005654; GO:0005777; GO:0005789; GO:0005829; GO:0005999; GO:0006098; GO:0009052; GO:0016604; GO:0016607; GO:0030976; GO:0031982; GO:0040008; GO:0042803; GO:0046166; GO:0046390; GO:0070062	"glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]; xylulose biosynthetic process [GO:0005999]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33204_c0_g1_i1	Q60HC7	TKT_MACFA	63.3	79	29	0	239	3	15	93	4.50E-25	114.8	TKT_MACFA	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT QflA-15469	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	623	metal ion binding [GO:0046872]; transketolase activity [GO:0004802]		metal ion binding [GO:0046872]; transketolase activity [GO:0004802]	GO:0004802; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12111_c0_g1_i1	P29401	TKT_HUMAN	100	180	0	0	540	1	101	280	2.50E-103	375.9	TKT_HUMAN	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT	Homo sapiens (Human)	623	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]; xylulose biosynthetic process [GO:0005999]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982]	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0000287; GO:0004802; GO:0005509; GO:0005654; GO:0005777; GO:0005789; GO:0005829; GO:0005999; GO:0006098; GO:0009052; GO:0016604; GO:0016607; GO:0030976; GO:0031982; GO:0040008; GO:0042803; GO:0046166; GO:0046390; GO:0070062	"glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]; xylulose biosynthetic process [GO:0005999]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20421_c1_g1_i1	Q60HC7	TKT_MACFA	56.5	92	40	0	1	276	432	523	2.60E-24	112.5	TKT_MACFA	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT QflA-15469	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	623	metal ion binding [GO:0046872]; transketolase activity [GO:0004802]		metal ion binding [GO:0046872]; transketolase activity [GO:0004802]	GO:0004802; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15227_c0_g1_i1	Q60HC7	TKT_MACFA	56.7	90	39	0	272	3	450	539	2.20E-23	109.4	TKT_MACFA	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT QflA-15469	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	623	metal ion binding [GO:0046872]; transketolase activity [GO:0004802]		metal ion binding [GO:0046872]; transketolase activity [GO:0004802]	GO:0004802; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN13608_c0_g1_i1	Q6B855	TKT_BOVIN	62.6	626	227	3	50	1924	1	620	5.40E-233	808.5	TKT_BOVIN	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT TKT1	Bos taurus (Bovine)	623	"endoplasmic reticulum membrane [GO:0005789]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"	endoplasmic reticulum membrane [GO:0005789]	metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0004802; GO:0005789; GO:0009052; GO:0030976; GO:0040008; GO:0046390; GO:0046872	"pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"		blue	blue	NA	NA	NA	NA
TRINITY_DN13608_c0_g2_i1	Q6B855	TKT_BOVIN	62.3	616	225	3	1931	87	11	620	2.00E-227	790	TKT_BOVIN	reviewed	Transketolase (TK) (EC 2.2.1.1)	TKT TKT1	Bos taurus (Bovine)	623	"endoplasmic reticulum membrane [GO:0005789]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"	endoplasmic reticulum membrane [GO:0005789]	metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0004802; GO:0005789; GO:0009052; GO:0030976; GO:0040008; GO:0046390; GO:0046872	"pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"		blue	blue	NA	NA	NA	NA
TRINITY_DN16933_c0_g1_i1	P40142	TKT_MOUSE	100	283	0	0	850	2	289	571	6.50E-159	561.2	TKT_MOUSE	reviewed	Transketolase (TK) (EC 2.2.1.1) (P68)	Tkt	Mus musculus (Mouse)	623	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; magnesium ion binding [GO:0000287]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; magnesium ion binding [GO:0000287]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0000287; GO:0004802; GO:0005509; GO:0005654; GO:0005777; GO:0005789; GO:0006098; GO:0009052; GO:0016604; GO:0016607; GO:0030246; GO:0030976; GO:0040008; GO:0042803; GO:0043209; GO:0043231; GO:0046166; GO:0046390; GO:0048029	"glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12111_c0_g1_i2	P40142	TKT_MOUSE	98.7	227	3	0	684	4	53	279	2.20E-133	476.1	TKT_MOUSE	reviewed	Transketolase (TK) (EC 2.2.1.1) (P68)	Tkt	Mus musculus (Mouse)	623	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; magnesium ion binding [GO:0000287]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; magnesium ion binding [GO:0000287]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0000287; GO:0004802; GO:0005509; GO:0005654; GO:0005777; GO:0005789; GO:0006098; GO:0009052; GO:0016604; GO:0016607; GO:0030246; GO:0030976; GO:0040008; GO:0042803; GO:0043209; GO:0043231; GO:0046166; GO:0046390; GO:0048029	"glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21458_c0_g1_i1	Q2NKZ4	TKTL2_BOVIN	60.5	76	30	0	228	1	175	250	5.50E-20	97.8	TKTL2_BOVIN	reviewed	Transketolase-like protein 2 (EC 2.2.1.1)	TKTL2	Bos taurus (Bovine)	626	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0004802; GO:0005737; GO:0030976; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN23630_c0_g1_i1	Q9D4D4	TKTL2_MOUSE	51.7	172	79	3	518	6	229	397	8.90E-42	171.4	TKTL2_MOUSE	reviewed	Transketolase-like protein 2 (EC 2.2.1.1)	Tktl2	Mus musculus (Mouse)	627	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0004802; GO:0005737; GO:0030976; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15227_c1_g1_i1	Q9D4D4	TKTL2_MOUSE	79.1	86	18	0	6	263	384	469	5.20E-30	131.3	TKTL2_MOUSE	reviewed	Transketolase-like protein 2 (EC 2.2.1.1)	Tktl2	Mus musculus (Mouse)	627	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0004802; GO:0005737; GO:0030976; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN19008_c2_g1_i1	Q1HPK6	EF2_BOMMO	60.9	69	27	0	2	208	545	613	1.20E-18	93.2	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN19008_c0_g1_i1	Q1HPK6	EF2_BOMMO	77.6	76	17	0	228	1	356	431	2.90E-29	128.6	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN23041_c1_g1_i1	Q1HPK6	EF2_BOMMO	72.6	106	27	1	319	2	717	820	1.20E-41	170.2	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN25656_c1_g1_i1	Q1HPK6	EF2_BOMMO	75.7	70	15	1	3	212	761	828	6.30E-26	117.5	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20560_c0_g1_i1	Q1HPK6	EF2_BOMMO	74.8	147	37	0	442	2	490	636	5.30E-59	228.4	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c6_g1_i1	Q1HPK6	EF2_BOMMO	80	95	19	0	3	287	708	802	2.10E-37	156	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c0_g1_i4	Q1HPK6	EF2_BOMMO	84.7	85	13	0	3	257	709	793	1.20E-36	153.3	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c0_g1_i5	Q1HPK6	EF2_BOMMO	78.3	138	28	1	3	416	709	844	8.60E-59	227.6	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c0_g1_i6	Q1HPK6	EF2_BOMMO	77.1	70	16	0	3	212	687	756	2.80E-26	118.6	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c0_g1_i7	Q1HPK6	EF2_BOMMO	75.8	91	20	1	4	276	756	844	6.90E-36	151	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20533_c5_g1_i1	Q1HPK6	EF2_BOMMO	66.2	154	52	0	463	2	580	733	3.70E-59	229.2	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN26717_c0_g1_i1	Q1HPK6	EF2_BOMMO	73	115	29	1	2	346	732	844	1.50E-43	176.8	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN26719_c1_g1_i1	Q1HPK6	EF2_BOMMO	76.8	69	14	1	3	209	753	819	3.60E-26	118.2	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN16889_c1_g2_i1	Q1HPK6	EF2_BOMMO	83	159	27	0	480	4	446	604	1.80E-73	276.6	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20816_c3_g1_i1	Q1HPK6	EF2_BOMMO	76.1	71	17	0	1	213	709	779	8.10E-26	117.1	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN20816_c1_g1_i1	Q1HPK6	EF2_BOMMO	81.2	112	21	0	343	8	693	804	2.50E-48	192.6	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN35372_c1_g1_i1	Q1HPK6	EF2_BOMMO	88.6	211	24	0	635	3	1	211	7.50E-100	364.8	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN35321_c12_g1_i1	Q1HPK6	EF2_BOMMO	76.9	631	144	1	1983	91	216	844	7.20E-302	1037.3	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN21227_c3_g1_i1	Q1HPK6	EF2_BOMMO	68.2	66	21	0	199	2	42	107	7.00E-19	94	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17889_c0_g1_i1	Q1HPK6	EF2_BOMMO	76.2	80	17	1	286	47	767	844	6.00E-32	137.9	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN17889_c0_g1_i3	Q1HPK6	EF2_BOMMO	75	80	18	1	286	47	767	844	1.30E-31	136.7	EF2_BOMMO	reviewed	Translation elongation factor 2 (EF-2)	tef2	Bombyx mori (Silk moth)	844	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN28964_c0_g1_i1	B7PJS6	GUF1_IXOSC	59	100	41	0	3	302	85	184	3.60E-27	122.1	GUF1_IXOSC	reviewed	"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)"	ISCW003920	Ixodes scapularis (Black-legged tick) (Deer tick)	661	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN4261_c0_g1_i1	A6QLJ3	GUF1_BOVIN	59.6	649	257	3	1977	37	19	664	4.60E-222	772.3	GUF1_BOVIN	reviewed	"Translation factor GUF1, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1) (Ribosomal back-translocase)"	GUF1	Bos taurus (Bovine)	669	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN33530_c0_g1_i1	Q8N442	GUF1_HUMAN	98.7	75	1	0	228	4	92	166	3.50E-35	148.3	GUF1_HUMAN	reviewed	"Translation factor GUF1, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1) (Ribosomal back-translocase)"	GUF1	Homo sapiens (Human)	669	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0043022; GO:0045727	positive regulation of translation [GO:0045727]; translation [GO:0006412]		NA	NA	NA	NA	NA	NA
TRINITY_DN26132_c0_g1_i1	Q14232	EI2BA_HUMAN	100	90	0	0	271	2	131	220	1.00E-41	170.2	EI2BA_HUMAN	reviewed	Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha)	EIF2B1 EIF2BA	Homo sapiens (Human)	305	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]; oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0005886; GO:0006413; GO:0006446; GO:0009408; GO:0009749; GO:0014003; GO:0016020; GO:0042802; GO:0043434; GO:0050852	oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN5599_c0_g1_i1	Q99LC8	EI2BA_MOUSE	47.4	308	155	4	1011	97	1	304	8.70E-68	258.8	EI2BA_MOUSE	reviewed	Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha)	Eif2b1	Mus musculus (Mouse)	305	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; membrane [GO:0016020]; plasma membrane [GO:0005886]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005085; GO:0005525; GO:0005737; GO:0005850; GO:0005851; GO:0005886; GO:0006412; GO:0006413; GO:0006446; GO:0009408; GO:0009749; GO:0014003; GO:0016020; GO:0019003; GO:0042802; GO:0043434; GO:0050852; GO:1905098; GO:1990928	negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN4083_c0_g1_i1	P12754	EI2BD_YEAST	28.4	384	214	5	1086	115	265	647	2.50E-37	157.9	EI2BD_YEAST	reviewed	Translation initiation factor eIF-2B subunit delta (GCD complex subunit GCD2) (Guanine nucleotide exchange factor subunit GCD2) (eIF-2B GDP-GTP exchange factor subunit delta)	GCD2 TIF224 YGR083C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	651	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor complex [GO:0032045]; enzyme regulator activity [GO:0030234]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor complex [GO:0032045]	enzyme regulator activity [GO:0030234]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005829; GO:0005851; GO:0006446; GO:0030234; GO:0032045	regulation of translational initiation [GO:0006446]		NA	NA	NA	NA	NA	NA
TRINITY_DN107_c0_g1_i1	Q8CHW4	EI2BE_MOUSE	29	155	102	3	470	15	532	681	1.00E-07	58.2	EI2BE_MOUSE	reviewed	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5	Mus musculus (Mouse)	717	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708; GO:0050852	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN107_c0_g1_i2	Q8CHW4	EI2BE_MOUSE	29	155	102	3	470	15	532	681	1.00E-07	58.2	EI2BE_MOUSE	reviewed	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	Eif2b5	Mus musculus (Mouse)	717	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]	guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708; GO:0050852	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN16364_c0_g1_i1	Q5L0I8	IF2_GEOKA	79.5	78	15	1	1	234	284	360	1.60E-27	122.9	IF2_GEOKA	reviewed	Translation initiation factor IF-2	infB GK1263	Geobacillus kaustophilus (strain HTA426)	709	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN32486_c0_g1_i1	Q8EHL5	IF2_SHEON	87.4	87	11	0	1	261	385	471	5.20E-38	157.9	IF2_SHEON	reviewed	Translation initiation factor IF-2	infB SO_1204	Shewanella oneidensis (strain MR-1)	885	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0006413	translational initiation [GO:0006413]		NA	NA	NA	NA	NA	NA
TRINITY_DN12879_c0_g1_i1	A4X4N7	IF2_SALTO	82.6	86	11	1	2	259	499	580	3.70E-33	141.7	IF2_SALTO	reviewed	Translation initiation factor IF-2	infB Strop_1370	Salinispora tropica (strain ATCC BAA-916 / DSM 44818 / CNB-440)	999	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN12879_c0_g2_i1	A7HZ93	IF2_PARL1	85.1	94	14	0	1	282	394	487	2.60E-40	165.6	IF2_PARL1	reviewed	Translation initiation factor IF-2	infB Plav_3628	Parvibaculum lavamentivorans (strain DS-1 / DSM 13023 / NCIMB 13966)	887	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN6228_c0_g1_i1	Q6A7M5	IF2_CUTAK	100	119	0	0	3	359	454	572	6.50E-60	231.1	IF2_CUTAK	reviewed	Translation initiation factor IF-2	infB PPA1493	Cutibacterium acnes (strain DSM 16379 / KPA171202) (Propionibacterium acnes)	964	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]	GO:0003743; GO:0003924; GO:0005525; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN35775_c0_g1_i1	Q91YJ5	IF2M_MOUSE	57.1	326	134	1	27	986	179	504	6.70E-91	335.5	IF2M_MOUSE	reviewed	"Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt))"	Mtif2	Mus musculus (Mouse)	727	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]"	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0008135; GO:0032790; GO:0043024; GO:0070124	mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]		NA	NA	NA	NA	NA	NA
TRINITY_DN16543_c0_g1_i1	Q03195	RLI1_YEAST	58.7	46	19	0	41	178	365	410	4.20E-08	58.2	RLI1_YEAST	reviewed	Translation initiation factor RLI1 (ATP-binding cassette sub-family E member RLI1) (RNase L inhibitor)	RLI1 YDR091C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	608	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; translation initiation factor activity [GO:0003743]; positive regulation of translation [GO:0045727]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054]; ribosome disassembly [GO:0032790]; rRNA processing [GO:0006364]; translational initiation [GO:0006413]; translational termination [GO:0006415]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; translation initiation factor activity [GO:0003743]	GO:0000054; GO:0003743; GO:0005506; GO:0005524; GO:0005634; GO:0005737; GO:0006364; GO:0006413; GO:0006415; GO:0016887; GO:0032790; GO:0042273; GO:0043024; GO:0045727	positive regulation of translation [GO:0045727]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054]; ribosome disassembly [GO:0032790]; rRNA processing [GO:0006364]; translational initiation [GO:0006413]; translational termination [GO:0006415]		NA	NA	NA	NA	NA	NA
TRINITY_DN9115_c0_g1_i1	P79769	TSN_CHICK	40.3	226	134	1	84	758	1	226	3.10E-44	180.3	TSN_CHICK	reviewed	Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)	TSN	Gallus gallus (Chicken)	229	cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0004521; GO:0005634; GO:0005737; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN22058_c0_g1_i1	Q08DM8	TSN_BOVIN	100	71	0	0	214	2	136	206	9.00E-33	140.2	TSN_BOVIN	reviewed	Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)	TSN	Bos taurus (Bovine)	228	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0042802; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN22058_c0_g1_i2	Q08DM8	TSN_BOVIN	100	71	0	0	214	2	136	206	9.00E-33	140.2	TSN_BOVIN	reviewed	Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)	TSN	Bos taurus (Bovine)	228	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0042802; GO:0043565			NA	NA	NA	NA	NA	NA
TRINITY_DN8533_c0_g1_i1	Q9QZE7	TSNAX_MOUSE	40.9	264	138	4	151	897	28	288	1.90E-48	194.5	TSNAX_MOUSE	reviewed	Translin-associated protein X (Translin-associated factor X)	Tsnax Trax	Mus musculus (Mouse)	290	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0007275; GO:0007283; GO:0030154; GO:0031687; GO:0043565; GO:0044877; GO:0046872; GO:0048471	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8533_c0_g1_i2	Q9QZE7	TSNAX_MOUSE	40.8	169	85	2	80	541	120	288	2.10E-29	130.6	TSNAX_MOUSE	reviewed	Translin-associated protein X (Translin-associated factor X)	Tsnax Trax	Mus musculus (Mouse)	290	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0007275; GO:0007283; GO:0030154; GO:0031687; GO:0043565; GO:0044877; GO:0046872; GO:0048471	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN655_c0_g1_i1	Q5XI41	TRAM1_RAT	50	330	159	3	1173	190	5	330	9.70E-90	332	TRAM1_RAT	reviewed	Translocating chain-associated membrane protein 1	Tram1	Rattus norvegicus (Rat)	374	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006616; GO:0030176; GO:0045048	"protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		blue	blue	NA	NA	NA	NA
TRINITY_DN655_c0_g1_i2	Q5XI41	TRAM1_RAT	49.1	348	170	4	1191	157	5	348	3.40E-90	333.6	TRAM1_RAT	reviewed	Translocating chain-associated membrane protein 1	Tram1	Rattus norvegicus (Rat)	374	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006616; GO:0030176; GO:0045048	"protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36957_c0_g1_i1	Q91V04	TRAM1_MOUSE	100	121	0	0	3	365	62	182	8.90E-65	247.3	TRAM1_MOUSE	reviewed	Translocating chain-associated membrane protein 1	Tram1	Mus musculus (Mouse)	374	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006616; GO:0030176; GO:0045048	"protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20818_c0_g1_i1	Q5XI41	TRAM1_RAT	95.6	227	10	0	47	727	1	227	1.20E-121	437.2	TRAM1_RAT	reviewed	Translocating chain-associated membrane protein 1	Tram1	Rattus norvegicus (Rat)	374	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0005783; GO:0006616; GO:0030176; GO:0045048	"protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20818_c0_g1_i2	Q15629	TRAM1_HUMAN	100	227	0	0	10	690	1	227	5.50E-124	444.9	TRAM1_HUMAN	reviewed	Translocating chain-associated membrane protein 1	TRAM1 TRAM	Homo sapiens (Human)	374	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; viral process [GO:0016032]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]	signaling receptor activity [GO:0038023]	GO:0005783; GO:0006613; GO:0006616; GO:0016021; GO:0016032; GO:0030176; GO:0038023; GO:0045048	"cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11587_c0_g1_i1	Q99442	SEC62_HUMAN	55	120	54	0	343	702	169	288	8.40E-31	135.6	SEC62_HUMAN	reviewed	Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1)	SEC62 TLOC1	Homo sapiens (Human)	399	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	signaling receptor activity [GO:0038023]	GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023	"cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11587_c0_g1_i2	Q99442	SEC62_HUMAN	55	120	54	0	467	108	169	288	8.40E-31	135.6	SEC62_HUMAN	reviewed	Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1)	SEC62 TLOC1	Homo sapiens (Human)	399	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	signaling receptor activity [GO:0038023]	GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023	"cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7183_c0_g1_i1	Q99442	SEC62_HUMAN	58.7	92	33	2	354	94	16	107	1.10E-22	107.8	SEC62_HUMAN	reviewed	Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1)	SEC62 TLOC1	Homo sapiens (Human)	399	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	signaling receptor activity [GO:0038023]	GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023	"cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7183_c0_g1_i2	Q99442	SEC62_HUMAN	54.5	112	41	3	414	94	1	107	2.50E-24	113.2	SEC62_HUMAN	reviewed	Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1)	SEC62 TLOC1	Homo sapiens (Human)	399	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	signaling receptor activity [GO:0038023]	GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023	"cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"		blue	blue	NA	NA	NA	NA
TRINITY_DN17704_c0_g1_i1	P43307	SSRA_HUMAN	100	131	0	0	393	1	83	213	3.60E-72	271.9	SSRA_HUMAN	reviewed	Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)	SSR1 TRAPA PSEC0262	Homo sapiens (Human)	286	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell population proliferation [GO:0008284]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006613; GO:0008284; GO:0016021; GO:0036498	cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN17704_c0_g1_i2	P43307	SSRA_HUMAN	100	131	0	0	393	1	83	213	3.60E-72	271.9	SSRA_HUMAN	reviewed	Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)	SSR1 TRAPA PSEC0262	Homo sapiens (Human)	286	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell population proliferation [GO:0008284]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006613; GO:0008284; GO:0016021; GO:0036498	cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell population proliferation [GO:0008284]		NA	NA	NA	NA	NA	NA
TRINITY_DN14426_c0_g1_i1	Q9CY50	SSRA_MOUSE	49.8	213	101	2	303	941	78	284	1.80E-56	221.1	SSRA_MOUSE	reviewed	Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)	Ssr1	Mus musculus (Mouse)	286	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN3010_c0_g1_i1	P23438	SSRB_CANLF	48.1	181	93	1	639	97	3	182	4.90E-45	182.6	SSRB_CANLF	reviewed	Translocon-associated protein subunit beta (TRAP-beta) (Glycoprotein 25H) (gp25H) (Signal sequence receptor subunit beta) (SSR-beta)	SSR2	Canis lupus familiaris (Dog) (Canis familiaris)	183	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN10937_c0_g2_i1	P43308	SSRB_HUMAN	100	115	0	0	1	345	54	168	3.00E-62	238.8	SSRB_HUMAN	reviewed	Translocon-associated protein subunit beta (TRAP-beta) (Signal sequence receptor subunit beta) (SSR-beta)	SSR2 TRAPB HSD25	Homo sapiens (Human)	183	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006613; GO:0016021	cotranslational protein targeting to membrane [GO:0006613]		NA	NA	NA	NA	NA	NA
TRINITY_DN10937_c0_g1_i1	P43308	SSRB_HUMAN	100	115	0	0	1	345	54	168	3.00E-62	238.8	SSRB_HUMAN	reviewed	Translocon-associated protein subunit beta (TRAP-beta) (Signal sequence receptor subunit beta) (SSR-beta)	SSR2 TRAPB HSD25	Homo sapiens (Human)	183	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006613; GO:0016021	cotranslational protein targeting to membrane [GO:0006613]		NA	NA	NA	NA	NA	NA
TRINITY_DN21213_c0_g1_i1	Q3SZ87	SSRG_BOVIN	62.2	185	66	2	74	616	1	185	1.20E-54	214.5	SSRG_BOVIN	reviewed	Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)	SSR3	Bos taurus (Bovine)	185	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006614; GO:0016021	SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		blue	blue	NA	NA	NA	NA
TRINITY_DN21213_c0_g1_i2	Q3SZ87	SSRG_BOVIN	58.5	53	18	2	74	226	1	51	1.90E-06	53.1	SSRG_BOVIN	reviewed	Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)	SSR3	Bos taurus (Bovine)	185	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006614; GO:0016021	SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN17529_c0_g1_i1	Q9UNL2	SSRG_HUMAN	99.5	185	1	0	17	571	1	185	3.50E-92	339	SSRG_HUMAN	reviewed	Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)	SSR3 TRAPG	Homo sapiens (Human)	185	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0006614; GO:0016021	SRP-dependent cotranslational protein targeting to membrane [GO:0006614]		NA	NA	NA	NA	NA	NA
TRINITY_DN12047_c0_g1_i1	P58021	TM9S2_MOUSE	100	313	0	0	3	941	250	562	3.70E-179	628.6	TM9S2_MOUSE	reviewed	Transmembrane 9 superfamily member 2	Tm9sf2	Mus musculus (Mouse)	662	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]; protein localization to membrane [GO:0072657]	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005856; GO:0010008; GO:0016020; GO:0016021; GO:0072657; GO:0150051	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN11594_c0_g1_i2	P58021	TM9S2_MOUSE	99	104	1	0	1	312	125	228	3.70E-59	228.4	TM9S2_MOUSE	reviewed	Transmembrane 9 superfamily member 2	Tm9sf2	Mus musculus (Mouse)	662	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]; protein localization to membrane [GO:0072657]	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005856; GO:0010008; GO:0016020; GO:0016021; GO:0072657; GO:0150051	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN2429_c0_g1_i1	Q5R8Y6	TM9S2_PONAB	63.3	622	218	4	6	1871	52	663	2.10E-229	796.6	TM9S2_PONAB	reviewed	Transmembrane 9 superfamily member 2	TM9SF2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	663	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic Golgi apparatus [GO:0150051]	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005856; GO:0010008; GO:0016021; GO:0150051			blue	blue	NA	NA	NA	NA
TRINITY_DN2429_c0_g1_i3	Q5R8Y6	TM9S2_PONAB	46.1	241	121	3	6	728	52	283	2.40E-59	230.3	TM9S2_PONAB	reviewed	Transmembrane 9 superfamily member 2	TM9SF2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	663	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic Golgi apparatus [GO:0150051]	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005856; GO:0010008; GO:0016021; GO:0150051			NA	NA	NA	NA	NA	NA
TRINITY_DN2429_c0_g1_i5	Q5R8Y6	TM9S2_PONAB	56.7	342	138	4	6	1031	52	383	1.70E-111	404.1	TM9S2_PONAB	reviewed	Transmembrane 9 superfamily member 2	TM9SF2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	663	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic Golgi apparatus [GO:0150051]	cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005856; GO:0010008; GO:0016021; GO:0150051			NA	NA	NA	NA	NA	NA
TRINITY_DN12047_c0_g1_i2	Q99805	TM9S2_HUMAN	100	314	0	0	2	943	250	563	6.70E-181	634.4	TM9S2_HUMAN	reviewed	Transmembrane 9 superfamily member 2 (p76)	TM9SF2	Homo sapiens (Human)	663	cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]; protein localization to membrane [GO:0072657]	cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005768; GO:0005856; GO:0005887; GO:0010008; GO:0016020; GO:0070062; GO:0072657; GO:0150051	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN11594_c0_g1_i1	Q99805	TM9S2_HUMAN	100	159	0	0	2	478	71	229	6.30E-95	347.8	TM9S2_HUMAN	reviewed	Transmembrane 9 superfamily member 2 (p76)	TM9SF2	Homo sapiens (Human)	663	cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]; protein localization to membrane [GO:0072657]	cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005768; GO:0005856; GO:0005887; GO:0010008; GO:0016020; GO:0070062; GO:0072657; GO:0150051	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN27328_c0_g1_i1	Q99805	TM9S2_HUMAN	100	71	0	0	1	213	593	663	2.40E-31	136	TM9S2_HUMAN	reviewed	Transmembrane 9 superfamily member 2 (p76)	TM9SF2	Homo sapiens (Human)	663	cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]; protein localization to membrane [GO:0072657]	cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; postsynaptic Golgi apparatus [GO:0150051]		GO:0005768; GO:0005856; GO:0005887; GO:0010008; GO:0016020; GO:0070062; GO:0072657; GO:0150051	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN1039_c0_g1_i2	Q9ET30	TM9S3_MOUSE	77.3	543	123	0	123	1751	24	566	3.60E-236	818.9	TM9S3_MOUSE	reviewed	Transmembrane 9 superfamily member 3	Tm9sf3 Smbp	Mus musculus (Mouse)	587	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0072657	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN40639_c0_g1_i1	Q9HD45	TM9S3_HUMAN	100	103	0	0	345	37	382	484	2.70E-55	215.7	TM9S3_HUMAN	reviewed	Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein)	TM9SF3 SMBP UNQ245/PRO282	Homo sapiens (Human)	589	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0072657	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN8149_c0_g1_i1	Q9HD45	TM9S3_HUMAN	99.5	432	2	0	1298	3	117	548	2.20E-230	799.3	TM9S3_HUMAN	reviewed	Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein)	TM9SF3 SMBP UNQ245/PRO282	Homo sapiens (Human)	589	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0072657	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN8149_c0_g1_i2	Q9HD45	TM9S3_HUMAN	99.3	298	2	0	896	3	251	548	2.10E-147	523.1	TM9S3_HUMAN	reviewed	Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein)	TM9SF3 SMBP UNQ245/PRO282	Homo sapiens (Human)	589	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0072657	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN29395_c0_g1_i1	Q9HD45	TM9S3_HUMAN	52.1	71	34	0	233	21	195	265	2.60E-17	89	TM9S3_HUMAN	reviewed	Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein)	TM9SF3 SMBP UNQ245/PRO282	Homo sapiens (Human)	589	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0072657	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN39371_c0_g1_i1	A5D7E2	TM9S4_BOVIN	100	97	0	0	294	4	257	353	5.00E-50	198	TM9S4_BOVIN	reviewed	Transmembrane 9 superfamily member 4	TM9SF4	Bos taurus (Bovine)	642	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010	cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		NA	NA	NA	NA	NA	NA
TRINITY_DN36604_c0_g1_i1	A5D7E2	TM9S4_BOVIN	40.3	72	41	1	3	218	299	368	2.00E-11	69.3	TM9S4_BOVIN	reviewed	Transmembrane 9 superfamily member 4	TM9SF4	Bos taurus (Bovine)	642	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010	cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		NA	NA	NA	NA	NA	NA
TRINITY_DN2429_c1_g1_i1	A5D7E2	TM9S4_BOVIN	73.2	127	34	0	3	383	414	540	3.60E-48	192.2	TM9S4_BOVIN	reviewed	Transmembrane 9 superfamily member 4	TM9SF4	Bos taurus (Bovine)	642	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010	cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		NA	NA	NA	NA	NA	NA
TRINITY_DN15933_c0_g1_i3	A5D7E2	TM9S4_BOVIN	69.3	127	39	0	383	3	247	373	1.10E-49	197.2	TM9S4_BOVIN	reviewed	Transmembrane 9 superfamily member 4	TM9SF4	Bos taurus (Bovine)	642	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010	cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		NA	NA	NA	NA	NA	NA
TRINITY_DN15933_c0_g1_i4	A5D7E2	TM9S4_BOVIN	69	129	40	0	693	307	247	375	1.80E-50	200.7	TM9S4_BOVIN	reviewed	Transmembrane 9 superfamily member 4	TM9SF4	Bos taurus (Bovine)	642	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010	cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		NA	NA	NA	NA	NA	NA
TRINITY_DN15933_c0_g1_i5	A5D7E2	TM9S4_BOVIN	69	129	40	0	7	393	247	375	1.80E-50	200.7	TM9S4_BOVIN	reviewed	Transmembrane 9 superfamily member 4	TM9SF4	Bos taurus (Bovine)	642	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010	cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		NA	NA	NA	NA	NA	NA
TRINITY_DN27863_c0_g1_i1	Q9LIC2	TMN7_ARATH	64.7	153	54	0	5	463	392	544	5.90E-53	208.4	TMN7_ARATH	reviewed	Transmembrane 9 superfamily member 7 (Endomembrane protein 5) (Transmembrane nine protein 7) (AtTMN7)	TMN7 EMP5 At3g13772 MMM17.20	Arabidopsis thaliana (Mouse-ear cress)	641	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]; cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; ion transport [GO:0006811]; protein localization to membrane [GO:0072657]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]		GO:0000138; GO:0000139; GO:0005634; GO:0005737; GO:0005768; GO:0005774; GO:0005794; GO:0005802; GO:0006811; GO:0006878; GO:0006882; GO:0010008; GO:0016020; GO:0016021; GO:0072657	cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; ion transport [GO:0006811]; protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN34568_c0_g1_i1	F4KIB2	TMN8_ARATH	67.9	81	24	1	243	1	264	342	3.30E-26	118.6	TMN8_ARATH	reviewed	Transmembrane 9 superfamily member 8 (Endomembrane protein 1) (Transmembrane nine protein 8) (AtTMN8)	TMN8 EMP1 At5g10840 T30N20_110	Arabidopsis thaliana (Mouse-ear cress)	648	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type cell wall [GO:0009505]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]; protein localization to membrane [GO:0072657]	endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type cell wall [GO:0009505]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]		GO:0000139; GO:0005768; GO:0005774; GO:0005794; GO:0005797; GO:0005802; GO:0009505; GO:0010008; GO:0016020; GO:0016021; GO:0072657	protein localization to membrane [GO:0072657]		NA	NA	NA	NA	NA	NA
TRINITY_DN14862_c0_g1_i1	Q5TGY1	TMCO4_HUMAN	68.8	112	34	1	2	334	398	509	6.90E-40	164.5	TMCO4_HUMAN	reviewed	Transmembrane and coiled-coil domain-containing protein 4	TMCO4	Homo sapiens (Human)	634	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1009_c0_g1_i1	O94876	TMCC1_HUMAN	48.6	177	86	2	139	669	460	631	4.60E-29	129.8	TMCC1_HUMAN	reviewed	Transmembrane and coiled-coil domains protein 1	TMCC1 KIAA0779	Homo sapiens (Human)	653	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]	identical protein binding [GO:0042802]	GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016021; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285	endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]		NA	NA	NA	NA	NA	NA
TRINITY_DN1009_c0_g1_i2	Q69ZZ6	TMCC1_MOUSE	33.7	463	245	7	311	1534	176	631	3.40E-42	174.5	TMCC1_MOUSE	reviewed	Transmembrane and coiled-coil domains protein 1	Tmcc1 Kiaa0779	Mus musculus (Mouse)	649	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]	identical protein binding [GO:0042802]	GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016021; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285	endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]		NA	NA	NA	NA	NA	NA
TRINITY_DN1009_c0_g1_i3	Q69ZZ6	TMCC1_MOUSE	35.4	505	244	8	356	1771	176	631	1.10E-52	209.5	TMCC1_MOUSE	reviewed	Transmembrane and coiled-coil domains protein 1	Tmcc1 Kiaa0779	Mus musculus (Mouse)	649	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]	identical protein binding [GO:0042802]	GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016021; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285	endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]		NA	NA	NA	NA	NA	NA
TRINITY_DN1009_c0_g1_i4	Q69ZZ6	TMCC1_MOUSE	35.4	505	244	8	717	2132	176	631	1.30E-52	209.5	TMCC1_MOUSE	reviewed	Transmembrane and coiled-coil domains protein 1	Tmcc1 Kiaa0779	Mus musculus (Mouse)	649	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]	identical protein binding [GO:0042802]	GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016021; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285	endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148]		NA	NA	NA	NA	NA	NA
TRINITY_DN27296_c0_g1_i1	Q6NXT6	TAPT1_HUMAN	39.6	149	88	2	3	443	360	508	2.40E-20	101.3	TAPT1_HUMAN	reviewed	Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor)	TAPT1 CMVFR	Homo sapiens (Human)	567	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; growth hormone-releasing hormone receptor activity [GO:0016520]; cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724]; viral process [GO:0016032]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]	growth hormone-releasing hormone receptor activity [GO:0016520]	GO:0001503; GO:0005783; GO:0005813; GO:0014032; GO:0016021; GO:0016032; GO:0016520; GO:0030030; GO:0030176; GO:0035437; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012	cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2498_c0_g1_i2	Q6UXY8	TMC5_HUMAN	28	508	315	11	1056	2510	486	965	6.50E-44	181	TMC5_HUMAN	reviewed	Transmembrane channel-like protein 5	TMC5 UNQ8238/PRO33604	Homo sapiens (Human)	1006	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN2498_c0_g1_i3	Q6UXY8	TMC5_HUMAN	28	508	315	11	843	2297	486	965	6.00E-44	181	TMC5_HUMAN	reviewed	Transmembrane channel-like protein 5	TMC5 UNQ8238/PRO33604	Homo sapiens (Human)	1006	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381; GO:0070062			blue	blue	NA	NA	NA	NA
TRINITY_DN2498_c0_g1_i6	Q6UXY8	TMC5_HUMAN	28	508	315	11	1030	2484	486	965	6.40E-44	181	TMC5_HUMAN	reviewed	Transmembrane channel-like protein 5	TMC5 UNQ8238/PRO33604	Homo sapiens (Human)	1006	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN2138_c0_g1_i2	Q5YCC5	TMC7_CHICK	35	652	380	10	707	2632	97	714	2.70E-92	341.7	TMC7_CHICK	reviewed	Transmembrane channel-like protein 7	Tmc7	Gallus gallus (Chicken)	735	integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	integral component of plasma membrane [GO:0005887]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381			NA	NA	NA	NA	NA	NA
TRINITY_DN2138_c0_g1_i24	Q4R7U0	TMC7_MACFA	37.3	421	245	4	49	1287	305	714	1.10E-71	272.3	TMC7_MACFA	reviewed	Transmembrane channel-like protein 7	TMC7 QtsA-14390	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	723	integral component of plasma membrane [GO:0005887]; ion transport [GO:0006811]	integral component of plasma membrane [GO:0005887]		GO:0005887; GO:0006811	ion transport [GO:0006811]		NA	NA	NA	NA	NA	NA
TRINITY_DN21159_c0_g1_i1	Q7TN58	TMC8_MOUSE	28.8	146	103	1	441	7	186	331	1.60E-08	60.8	TMC8_MOUSE	reviewed	Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2 homolog)	Tmc8 Ever2	Mus musculus (Mouse)	722	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]	mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]	GO:0001558; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0008381; GO:0031333; GO:0031965; GO:0032091; GO:0043120; GO:0055069; GO:0140311; GO:1902041	negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN40592_c0_g1_i1	Q8IU68	TMC8_HUMAN	100	75	0	0	2	226	444	518	2.20E-37	155.6	TMC8_HUMAN	reviewed	Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2)	TMC8 EVER2 EVIN2	Homo sapiens (Human)	726	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]	mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]	GO:0001558; GO:0005615; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0008381; GO:0031333; GO:0031965; GO:0032091; GO:0043120; GO:0055069; GO:0070062; GO:0140311; GO:1902041	negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN21159_c0_g2_i1	Q8IU68	TMC8_HUMAN	31.4	239	156	3	33	725	337	575	1.30E-26	122.1	TMC8_HUMAN	reviewed	Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2)	TMC8 EVER2 EVIN2	Homo sapiens (Human)	726	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]	mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]	GO:0001558; GO:0005615; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0008381; GO:0031333; GO:0031965; GO:0032091; GO:0043120; GO:0055069; GO:0070062; GO:0140311; GO:1902041	negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]		NA	NA	NA	NA	NA	NA
TRINITY_DN18401_c0_g1_i1	Q500V2	FLY2_ARATH	46.2	52	25	1	9	155	505	556	6.70E-09	60.8	FLY2_ARATH	reviewed	Transmembrane E3 ubiquitin-protein ligase FLY2 (EC 2.3.2.27) (Protein FLYING SAUCER 2) (RING-type E3 ubiquitin transferase FLY2)	FLY2 At2g20650 F23N11.3	Arabidopsis thaliana (Mouse-ear cress)	559	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; plant-type cell wall modification [GO:0009827]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0009827; GO:0012505; GO:0016021; GO:0046872	plant-type cell wall modification [GO:0009827]		NA	NA	NA	NA	NA	NA
TRINITY_DN25286_c1_g1_i1	A7SXK3	TMED_NEMVE	85.1	47	7	0	202	62	145	191	2.50E-16	85.5	TMED_NEMVE	reviewed	Transmembrane emp24 domain-containing protein	v1g194562	Nematostella vectensis (Starlet sea anemone)	203	COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0030659	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN5602_c0_g1_i1	Q3V009	TMED1_MOUSE	35.8	193	121	2	690	112	33	222	6.30E-26	119.4	TMED1_MOUSE	reviewed	Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (p24gamma1)	Tmed1 Il1rl1l	Mus musculus (Mouse)	227	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN35582_c0_g1_i1	Q13445	TMED1_HUMAN	100	71	0	0	213	1	66	136	8.10E-34	143.7	TMED1_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (Tp24) (p24gamma1)	TMED1 IL1RL1L IL1RL1LG	Homo sapiens (Human)	227	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0007165; GO:0007267; GO:0016021; GO:0030134; GO:0033116	cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]		NA	NA	NA	NA	NA	NA
TRINITY_DN28753_c0_g1_i1	Q5E971	TMEDA_BOVIN	100	102	0	0	390	85	118	219	1.00E-50	200.7	TMEDA_BOVIN	reviewed	Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1)	TMED10 TMP21	Bos taurus (Bovine)	219	"COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; interleukin-1 production [GO:0032612]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]	protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905]	GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0016021; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0032612; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003	"COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; interleukin-1 production [GO:0032612]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36030_c0_g1_i1	Q5E971	TMEDA_BOVIN	100	102	0	0	383	78	118	219	1.30E-50	200.3	TMEDA_BOVIN	reviewed	Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1)	TMED10 TMP21	Bos taurus (Bovine)	219	"COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; interleukin-1 production [GO:0032612]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]	protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905]	GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0016021; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0032612; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003	"COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; interleukin-1 production [GO:0032612]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9615_c0_g1_i1	P49020	TMED2_CRIGR	100	180	0	0	3	542	17	196	5.40E-99	361.7	TMED2_CRIGR	reviewed	Transmembrane emp24 domain-containing protein 2 (COPI-coated vesicle membrane protein p24) (p24 family protein beta-1) (p24beta1) (Fragment)	TMED2 RNP24	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	196	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0007030; GO:0015031; GO:0016021; GO:0016192; GO:0030137; GO:0030663; GO:0032580; GO:0033116; GO:0034260; GO:0072659	Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN9615_c0_g1_i2	P49020	TMED2_CRIGR	100	140	0	0	3	422	57	196	1.30E-74	280.4	TMED2_CRIGR	reviewed	Transmembrane emp24 domain-containing protein 2 (COPI-coated vesicle membrane protein p24) (p24 family protein beta-1) (p24beta1) (Fragment)	TMED2 RNP24	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	196	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0007030; GO:0015031; GO:0016021; GO:0016192; GO:0030137; GO:0030663; GO:0032580; GO:0033116; GO:0034260; GO:0072659	Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN38993_c1_g1_i1	P49020	TMED2_CRIGR	66.5	194	59	1	2	583	9	196	1.10E-70	267.7	TMED2_CRIGR	reviewed	Transmembrane emp24 domain-containing protein 2 (COPI-coated vesicle membrane protein p24) (p24 family protein beta-1) (p24beta1) (Fragment)	TMED2 RNP24	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	196	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0007030; GO:0015031; GO:0016021; GO:0016192; GO:0030137; GO:0030663; GO:0032580; GO:0033116; GO:0034260; GO:0072659	Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN16486_c0_g1_i1	Q9Y3Q3	TMED3_HUMAN	98.6	73	1	0	2	220	2	74	1.00E-35	151	TMED3_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26)	TMED3 C15orf22 UNQ5357/PRO1078	Homo sapiens (Human)	217	"COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030133; GO:0030134; GO:0032580; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16486_c0_g1_i1	Q9Y3Q3	TMED3_HUMAN	100	70	0	0	213	422	72	141	1.70E-35	150.2	TMED3_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26)	TMED3 C15orf22 UNQ5357/PRO1078	Homo sapiens (Human)	217	"COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030133; GO:0030134; GO:0032580; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16486_c0_g1_i2	Q9Y3Q3	TMED3_HUMAN	95	140	7	0	2	421	2	141	1.90E-74	279.6	TMED3_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26)	TMED3 C15orf22 UNQ5357/PRO1078	Homo sapiens (Human)	217	"COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030133; GO:0030134; GO:0032580; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30065_c0_g1_i1	Q9Y3Q3	TMED3_HUMAN	100	79	0	0	238	2	129	207	1.50E-36	152.9	TMED3_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26)	TMED3 C15orf22 UNQ5357/PRO1078	Homo sapiens (Human)	217	"COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030133; GO:0030134; GO:0032580; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17911_c0_g1_i1	Q7Z7H5	TMED4_HUMAN	100	174	0	0	556	35	54	227	1.30E-97	357.1	TMED4_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3)	TMED4 ERS25	Homo sapiens (Human)	227	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0043123	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN17911_c0_g2_i1	Q7Z7H5	TMED4_HUMAN	100	224	0	0	692	21	4	227	2.50E-127	456.1	TMED4_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3)	TMED4 ERS25	Homo sapiens (Human)	227	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0043123	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		NA	NA	NA	NA	NA	NA
TRINITY_DN34429_c0_g1_i1	Q9Y3B3	TMED7_HUMAN	100	123	0	0	1	369	26	148	1.20E-69	263.5	TMED7_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	TMED7 CGI-109	Homo sapiens (Human)	224	"COPI vesicle coat [GO:0030126]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14709_c0_g1_i1	D3ZTX0	TMED7_RAT	63.5	63	23	0	111	299	39	101	6.00E-19	94.7	TMED7_RAT	reviewed	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	Tmed7	Rattus norvegicus (Rat)	226	COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]	COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012507; GO:0016021; GO:0030134; GO:0030663; GO:0033116	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]		NA	NA	NA	NA	NA	NA
TRINITY_DN2758_c0_g1_i1	Q9Y3B3	TMED7_HUMAN	61.2	183	71	0	659	111	34	216	6.90E-62	238.8	TMED7_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	TMED7 CGI-109	Homo sapiens (Human)	224	"COPI vesicle coat [GO:0030126]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; COPII vesicle coat [GO:0030127]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9952_c0_g1_i1	Q99KF1	TMED9_MOUSE	100	223	0	0	740	72	13	235	1.40E-120	433.7	TMED9_MOUSE	reviewed	Transmembrane emp24 domain-containing protein 9 (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2)	Tmed9 Gp25l2	Mus musculus (Mouse)	235	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; syntaxin binding [GO:0019905]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]	syntaxin binding [GO:0019905]	GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0008021; GO:0010638; GO:0016021; GO:0019905; GO:0030134; GO:0033116; GO:0048205	COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638]		NA	NA	NA	NA	NA	NA
TRINITY_DN9952_c0_g2_i1	Q9BVK6	TMED9_HUMAN	100	217	0	0	722	72	19	235	2.40E-117	422.9	TMED9_HUMAN	reviewed	Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25)	TMED9 GP25L2	Homo sapiens (Human)	235	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; syntaxin binding [GO:0019905]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]	syntaxin binding [GO:0019905]	GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008021; GO:0010638; GO:0016021; GO:0019905; GO:0030133; GO:0030134; GO:0030140; GO:0033116; GO:0048205; GO:0070062	"COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30738_c0_g1_i1	B4K4G5	TMEDA_DROMO	75.2	109	27	0	429	103	98	206	2.80E-41	169.5	TMEDA_DROMO	reviewed	Transmembrane emp24 domain-containing protein bai	bai GI23975	Drosophila mojavensis (Fruit fly)	206	integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]	integral component of membrane [GO:0016021]		GO:0009953; GO:0016021	dorsal/ventral pattern formation [GO:0009953]		blue	blue	NA	NA	NA	NA
TRINITY_DN13023_c0_g1_i1	B4KB41	TMEDE_DROMO	76.6	214	48	2	710	69	5	216	3.00E-94	346.3	TMEDE_DROMO	reviewed	Transmembrane emp24 domain-containing protein eca	eca GI10144	Drosophila mojavensis (Fruit fly)	216	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0009953; GO:0016021	dorsal/ventral pattern formation [GO:0009953]		NA	NA	NA	NA	NA	NA
TRINITY_DN13023_c0_g1_i2	B4JG34	TMEDE_DROGR	77.9	213	46	1	707	69	5	216	1.60E-95	350.5	TMEDE_DROGR	reviewed	Transmembrane emp24 domain-containing protein eca	eca GH18190	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	216	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0009953; GO:0016021	dorsal/ventral pattern formation [GO:0009953]		NA	NA	NA	NA	NA	NA
TRINITY_DN13023_c0_g1_i4	B4KB41	TMEDE_DROMO	76.6	214	48	2	719	78	5	216	1.10E-93	344.4	TMEDE_DROMO	reviewed	Transmembrane emp24 domain-containing protein eca	eca GI10144	Drosophila mojavensis (Fruit fly)	216	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0009953; GO:0016021	dorsal/ventral pattern formation [GO:0009953]		NA	NA	NA	NA	NA	NA
TRINITY_DN9195_c1_g1_i1	Q7YU24	MARF_DROME	61.1	72	26	1	74	283	467	538	2.00E-16	86.7	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		blue	blue	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i1	Q7YU24	MARF_DROME	47.7	413	201	5	1268	75	398	810	8.90E-104	378.6	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i10	Q7YU24	MARF_DROME	47.6	208	108	1	855	235	398	605	3.60E-48	193.4	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i12	Q7YU24	MARF_DROME	42.7	267	138	5	830	75	398	664	3.40E-51	203.4	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i15	Q7YU24	MARF_DROME	47.6	208	108	1	837	217	398	605	3.50E-48	193.4	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i16	Q7YU24	MARF_DROME	44.8	67	36	1	432	235	539	605	6.30E-09	62	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i2	Q7YU24	MARF_DROME	47.6	208	108	1	801	181	398	605	3.40E-48	193.4	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i21	Q7YU24	MARF_DROME	41	78	45	1	465	235	528	605	2.30E-10	67	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i3	Q7YU24	MARF_DROME	41	78	45	1	447	217	528	605	2.20E-10	67	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i4	Q7YU24	MARF_DROME	41.5	53	30	1	191	36	528	580	2.90E-05	48.9	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN531_c0_g1_i9	Q7YU24	MARF_DROME	47.7	413	201	5	1268	75	398	810	8.90E-104	378.6	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN7114_c0_g1_i1	Q7YU24	MARF_DROME	61.2	85	31	1	256	2	71	153	2.30E-19	96.7	MARF_DROME	reviewed	Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)	Marf dmfn CG3869	Drosophila melanogaster (Fruit fly)	810	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]	axon cytoplasm [GO:1904115]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115	adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN32281_c0_g1_i1	Q6IE14	TM11L_RAT	54.5	44	20	0	143	12	187	230	2.60E-07	55.8	TM11L_RAT	reviewed	Transmembrane protease serine 11B-like protein (EC 3.4.21.-) (Airway trypsin-like protease 5) (Transmembrane protease serine 11B)	Tmprss11bnl Hatl5 Tmprss11b	Rattus norvegicus (Rat)	420	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0008236			NA	NA	NA	NA	NA	NA
TRINITY_DN1652_c0_g1_i7	O60235	TM11D_HUMAN	50.8	63	29	1	286	98	354	414	1.40E-09	63.5	TM11D_HUMAN	reviewed	Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]	TMPRSS11D HAT	Homo sapiens (Human)	418	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0007585; GO:0008233; GO:0070062	proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]		blue	blue	NA	NA	NA	NA
TRINITY_DN14543_c0_g1_i1	O15393	TMPS2_HUMAN	40.9	66	35	2	6	200	328	390	3.60E-08	58.5	TMPS2_HUMAN	reviewed	Transmembrane protease serine 2 (EC 3.4.21.-) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]	TMPRSS2 PRSS10	Homo sapiens (Human)	492	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005044; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016540; GO:0046598; GO:0070062	positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN32264_c0_g1_i1	Q7Z410	TMPS9_HUMAN	51.4	72	35	0	271	56	988	1059	1.00E-18	94	TMPS9_HUMAN	reviewed	Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]	TMPRSS9	Homo sapiens (Human)	1059	integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]	integral component of plasma membrane [GO:0005887]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005887			NA	NA	NA	NA	NA	NA
TRINITY_DN35459_c0_g1_i1	Q8NE00	TM104_HUMAN	51.6	275	125	3	871	53	222	490	3.10E-71	270	TM104_HUMAN	reviewed	Transmembrane protein 104	TMEM104	Homo sapiens (Human)	496	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35459_c0_g1_i2	Q3TB48	TM104_MOUSE	54.1	85	39	0	301	47	222	306	5.40E-23	108.2	TM104_MOUSE	reviewed	Transmembrane protein 104	Tmem104	Mus musculus (Mouse)	496	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35459_c0_g1_i3	Q8NE00	TM104_HUMAN	53.5	228	98	3	683	6	222	443	1.50E-57	224.2	TM104_HUMAN	reviewed	Transmembrane protein 104	TMEM104	Homo sapiens (Human)	496	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1485_c0_g1_i1	Q6NWH5	TMM11_DANRE	58.8	160	64	1	571	98	26	185	1.60E-48	194.1	TMM11_DANRE	reviewed	"Transmembrane protein 11, mitochondrial"	tmem11 zgc:110086	Danio rerio (Zebrafish) (Brachydanio rerio)	187	integral component of mitochondrial inner membrane [GO:0031305]; inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]	integral component of mitochondrial inner membrane [GO:0031305]		GO:0007005; GO:0007007; GO:0031305	inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]		blue	blue	NA	NA	NA	NA
TRINITY_DN30399_c0_g1_i1	Q8BK08	TMM11_MOUSE	100	84	0	0	2	253	27	110	7.90E-44	177.2	TMM11_MOUSE	reviewed	"Transmembrane protein 11, mitochondrial (Protein PM1)"	Tmem11	Mus musculus (Mouse)	190	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]		GO:0005739; GO:0007005; GO:0007007; GO:0031305	inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN21685_c0_g1_i1	P17152	TMM11_HUMAN	100	81	0	0	244	2	112	192	7.10E-42	170.6	TMM11_HUMAN	reviewed	"Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)"	TMEM11 C17orf35 PM1	Homo sapiens (Human)	192	integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]	integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]		GO:0005739; GO:0005887; GO:0007005; GO:0007007; GO:0031305	inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN21685_c0_g1_i2	P17152	TMM11_HUMAN	100	81	0	0	244	2	112	192	7.10E-42	170.6	TMM11_HUMAN	reviewed	"Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)"	TMEM11 C17orf35 PM1	Homo sapiens (Human)	192	integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]	integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]		GO:0005739; GO:0005887; GO:0007005; GO:0007007; GO:0031305	inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]		NA	NA	NA	NA	NA	NA
TRINITY_DN29694_c0_g1_i1	Q9WUH1	TM115_MOUSE	45.6	259	135	4	83	859	3	255	2.80E-53	210.3	TM115_MOUSE	reviewed	Transmembrane protein 115 (Protein PL6 homolog)	Tmem115 Pl6	Mus musculus (Mouse)	350	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	identical protein binding [GO:0042802]	GO:0005634; GO:0005794; GO:0006890; GO:0016021; GO:0017119; GO:0032580; GO:0042802	"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		blue	blue	NA	NA	NA	NA
TRINITY_DN15451_c0_g1_i1	Q9U1M2	TM120_DROME	52.1	397	170	5	1314	151	1	386	1.30E-106	388.3	TM120_DROME	reviewed	Transmembrane protein 120 homolog	CG32795	Drosophila melanogaster (Fruit fly)	387	integral component of membrane [GO:0016021]; membrane [GO:0016020]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0045089; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]		blue	blue	NA	NA	NA	NA
TRINITY_DN15451_c0_g1_i2	Q9U1M2	TM120_DROME	52.8	386	175	3	1287	151	1	386	4.00E-108	393.3	TM120_DROME	reviewed	Transmembrane protein 120 homolog	CG32795	Drosophila melanogaster (Fruit fly)	387	integral component of membrane [GO:0016021]; membrane [GO:0016020]; defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021; GO:0045089; GO:0050829	defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]		NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g2_i3	Q5ZI25	TM129_CHICK	43.2	333	180	7	102	1094	1	326	3.70E-67	256.9	TM129_CHICK	reviewed	Transmembrane protein 129	TMEM129 RCJMB04_31c10	Gallus gallus (Chicken)	362	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]	GO:0005783; GO:0016021; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN5167_c0_g2_i4	Q5ZI25	TM129_CHICK	45.9	368	190	7	102	1199	1	361	5.60E-85	316.2	TM129_CHICK	reviewed	Transmembrane protein 129	TMEM129 RCJMB04_31c10	Gallus gallus (Chicken)	362	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]	GO:0005783; GO:0016021; GO:0061630			NA	NA	NA	NA	NA	NA
TRINITY_DN4325_c0_g1_i1	Q92545	TM131_HUMAN	30.1	767	477	11	44	2305	454	1174	1.20E-96	355.9	TM131_HUMAN	reviewed	Transmembrane protein 131 (Protein RW1)	TMEM131 KIAA0257 RW1	Homo sapiens (Human)	1883	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4325_c0_g1_i2	Q92545	TM131_HUMAN	31.9	408	229	7	77	1291	813	1174	9.30E-47	189.5	TM131_HUMAN	reviewed	Transmembrane protein 131 (Protein RW1)	TMEM131 KIAA0257 RW1	Homo sapiens (Human)	1883	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4672_c0_g1_i1	Q92545	TM131_HUMAN	48	344	176	3	1095	73	108	451	1.80E-87	324.3	TM131_HUMAN	reviewed	Transmembrane protein 131 (Protein RW1)	TMEM131 KIAA0257 RW1	Homo sapiens (Human)	1883	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN6771_c0_g1_i1	Q6GQ39	TM135_XENLA	34.6	445	273	6	94	1389	1	440	6.10E-67	256.5	TM135_XENLA	reviewed	Transmembrane protein 135 (Peroxisomal membrane protein 52) (PMP52)	tmem135	Xenopus laevis (African clawed frog)	453	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; regulation of mitochondrial fission [GO:0090140]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]		GO:0005739; GO:0005778; GO:0016021; GO:0031966; GO:0090140	regulation of mitochondrial fission [GO:0090140]		blue	blue	NA	NA	NA	NA
TRINITY_DN6065_c0_g1_i1	Q5U239	TM145_XENLA	44.7	338	184	3	74	1084	35	370	2.00E-80	301.2	TM145_XENLA	reviewed	Transmembrane protein 145	tmem145	Xenopus laevis (African clawed frog)	547	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]	integral component of membrane [GO:0016021]		GO:0007186; GO:0016021; GO:0019236	G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]		NA	NA	NA	NA	NA	NA
TRINITY_DN6065_c0_g1_i1	Q5U239	TM145_XENLA	37.2	78	40	2	1066	1287	405	477	3.10E-04	48.1	TM145_XENLA	reviewed	Transmembrane protein 145	tmem145	Xenopus laevis (African clawed frog)	547	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]	integral component of membrane [GO:0016021]		GO:0007186; GO:0016021; GO:0019236	G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]		NA	NA	NA	NA	NA	NA
TRINITY_DN6065_c0_g1_i2	Q5U239	TM145_XENLA	44.7	351	191	3	232	1281	22	370	1.30E-83	312	TM145_XENLA	reviewed	Transmembrane protein 145	tmem145	Xenopus laevis (African clawed frog)	547	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]	integral component of membrane [GO:0016021]		GO:0007186; GO:0016021; GO:0019236	G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]		NA	NA	NA	NA	NA	NA
TRINITY_DN6065_c0_g1_i2	Q5U239	TM145_XENLA	37.2	78	40	2	1263	1484	405	477	3.50E-04	48.1	TM145_XENLA	reviewed	Transmembrane protein 145	tmem145	Xenopus laevis (African clawed frog)	547	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]	integral component of membrane [GO:0016021]		GO:0007186; GO:0016021; GO:0019236	G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]		NA	NA	NA	NA	NA	NA
TRINITY_DN8679_c0_g1_i1	Q3SZR6	TM147_BOVIN	100	66	0	0	3	200	68	133	5.50E-32	137.5	TM147_BOVIN	reviewed	Transmembrane protein 147	TMEM147	Bos taurus (Bovine)	224	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8679_c1_g1_i1	Q6DGL7	TM147_DANRE	46.1	180	91	2	6	539	45	220	1.40E-36	154.5	TM147_DANRE	reviewed	Transmembrane protein 147	tmem147 zgc:92863	Danio rerio (Zebrafish) (Brachydanio rerio)	225	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN8679_c0_g1_i2	Q9BVK8	TM147_HUMAN	100	99	0	0	3	299	68	166	1.60E-51	203	TM147_HUMAN	reviewed	Transmembrane protein 147 (Protein NIFIE 14)	TMEM147	Homo sapiens (Human)	224	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]		GO:0005789; GO:0005886; GO:0016021; GO:0032991			NA	NA	NA	NA	NA	NA
TRINITY_DN8271_c0_g1_i2	Q9P0S9	TM14C_HUMAN	65.6	90	31	0	392	123	15	104	7.20E-26	118.6	TM14C_HUMAN	reviewed	Transmembrane protein 14C	TMEM14C C6orf53 HSPC194	Homo sapiens (Human)	112	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]		GO:0005743; GO:0006783; GO:0006839; GO:0016021; GO:0030218; GO:0031966; GO:0070453	erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]		blue	blue	NA	NA	NA	NA
TRINITY_DN8271_c0_g1_i6	Q5R751	TM14C_PONAB	66.7	72	24	0	338	123	33	104	2.10E-19	96.7	TM14C_PONAB	reviewed	Transmembrane protein 14C	TMEM14C	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	112	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; heme biosynthetic process [GO:0006783]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]		GO:0006783; GO:0016021; GO:0031966	heme biosynthetic process [GO:0006783]		blue	blue	NA	NA	NA	NA
TRINITY_DN8271_c0_g1_i7	Q9P0S9	TM14C_HUMAN	65.6	90	31	0	392	123	15	104	7.20E-26	118.6	TM14C_HUMAN	reviewed	Transmembrane protein 14C	TMEM14C C6orf53 HSPC194	Homo sapiens (Human)	112	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]		GO:0005743; GO:0006783; GO:0006839; GO:0016021; GO:0030218; GO:0031966; GO:0070453	erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]		NA	NA	NA	NA	NA	NA
TRINITY_DN8271_c0_g1_i1	Q9P0S9	TM14C_HUMAN	66.7	90	30	0	392	123	15	104	1.90E-26	120.6	TM14C_HUMAN	reviewed	Transmembrane protein 14C	TMEM14C C6orf53 HSPC194	Homo sapiens (Human)	112	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]		GO:0005743; GO:0006783; GO:0006839; GO:0016021; GO:0030218; GO:0031966; GO:0070453	erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]		black	black	1	NA	NA	NA
TRINITY_DN33169_c0_g1_i1	Q9P0S9	TM14C_HUMAN	100	97	0	0	2	292	16	112	8.60E-48	190.7	TM14C_HUMAN	reviewed	Transmembrane protein 14C	TMEM14C C6orf53 HSPC194	Homo sapiens (Human)	112	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]		GO:0005743; GO:0006783; GO:0006839; GO:0016021; GO:0030218; GO:0031966; GO:0070453	erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]		NA	NA	NA	NA	NA	NA
TRINITY_DN21221_c0_g2_i1	Q626N3	TM151_CAEBR	59.4	69	28	0	210	4	112	180	1.40E-21	103.2	TM151_CAEBR	reviewed	Transmembrane protein 151 homolog	CBG00907	Caenorhabditis briggsae	535	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN21221_c0_g1_i1	A3KN95	T151B_XENTR	42.7	96	55	0	94	381	37	132	3.70E-19	95.9	T151B_XENTR	reviewed	Transmembrane protein 151B	tmem151b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	514	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11285_c0_g1_i1	Q6GMB1	T161A_XENLA	59	61	25	0	194	12	1	61	1.30E-14	80.1	T161A_XENLA	reviewed	Transmembrane protein 161A	tmem161a	Xenopus laevis (African clawed frog)	489	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN13457_c0_g1_i1	Q8C2L6	T161B_MOUSE	42.4	417	231	6	48	1292	76	485	1.00E-89	332	T161B_MOUSE	reviewed	Transmembrane protein 161B	Tmem161b	Mus musculus (Mouse)	487	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN19965_c0_g1_i1	P52875	TM165_MOUSE	99.1	219	2	0	2	658	89	307	1.40E-113	410.2	TM165_MOUSE	reviewed	Transmembrane protein 165 (TPA-regulated locus protein) (Transmembrane protein PFT27) (Transmembrane protein TPARL)	Tmem165 Tparl	Mus musculus (Mouse)	323	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]	GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0015085; GO:0016021; GO:0031901; GO:0031902; GO:0032468; GO:0032472; GO:0032588; GO:0035751; GO:0043231; GO:0046873; GO:0070588; GO:0071421	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]		NA	NA	NA	NA	NA	NA
TRINITY_DN19965_c0_g1_i2	Q9HC07	TM165_HUMAN	100	110	0	0	2	331	89	198	3.90E-51	201.8	TM165_HUMAN	reviewed	Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL)	TMEM165 TPARL	Homo sapiens (Human)	324	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]	GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0015085; GO:0016021; GO:0031901; GO:0031902; GO:0032468; GO:0032472; GO:0032588; GO:0035751; GO:0043231; GO:0046873; GO:0070588; GO:0071421	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]		NA	NA	NA	NA	NA	NA
TRINITY_DN38389_c0_g1_i1	Q9HC07	TM165_HUMAN	55.4	83	37	0	17	265	236	318	3.70E-20	98.6	TM165_HUMAN	reviewed	Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL)	TMEM165 TPARL	Homo sapiens (Human)	324	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]	GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0015085; GO:0016021; GO:0031901; GO:0031902; GO:0032468; GO:0032472; GO:0032588; GO:0035751; GO:0043231; GO:0046873; GO:0070588; GO:0071421	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]		NA	NA	NA	NA	NA	NA
TRINITY_DN27289_c0_g1_i1	Q9HC07	TM165_HUMAN	62.4	242	83	2	790	83	81	320	8.90E-73	275.4	TM165_HUMAN	reviewed	Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL)	TMEM165 TPARL	Homo sapiens (Human)	324	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]	GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0015085; GO:0016021; GO:0031901; GO:0031902; GO:0032468; GO:0032472; GO:0032588; GO:0035751; GO:0043231; GO:0046873; GO:0070588; GO:0071421	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]		blue	blue	NA	NA	NA	NA
TRINITY_DN4129_c1_g1_i1	Q2TBG9	TM169_BOVIN	47.1	174	88	2	629	120	101	274	1.70E-36	155.2	TM169_BOVIN	reviewed	Transmembrane protein 169	TMEM169	Bos taurus (Bovine)	297	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4129_c1_g1_i2	Q2TBG9	TM169_BOVIN	47.1	174	88	2	631	122	101	274	1.70E-36	155.2	TM169_BOVIN	reviewed	Transmembrane protein 169	TMEM169	Bos taurus (Bovine)	297	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4129_c1_g1_i6	Q2TBG9	TM169_BOVIN	47.1	174	88	2	629	120	101	274	1.60E-36	155.2	TM169_BOVIN	reviewed	Transmembrane protein 169	TMEM169	Bos taurus (Bovine)	297	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN10897_c0_g1_i1	Q6AZD1	T179A_DANRE	31.2	218	137	5	737	114	1	215	1.10E-22	108.6	T179A_DANRE	reviewed	Transmembrane protein 179	tmem179 si:dkey-85n7.1 zgc:101058	Danio rerio (Zebrafish) (Brachydanio rerio)	232	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN6336_c0_g1_i1	A5D6V4	TM17B_DANRE	44	134	75	0	1	402	47	180	4.00E-24	112.8	TM17B_DANRE	reviewed	Transmembrane protein 17B	Tmem17b zgc:163141	Danio rerio (Zebrafish) (Brachydanio rerio)	191	ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224]	ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]		GO:0007224; GO:0016021; GO:0035869; GO:0036038; GO:0060170; GO:0060271; GO:1905515	cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224]		NA	NA	NA	NA	NA	NA
TRINITY_DN10597_c1_g1_i1	Q9P2C4	TM181_HUMAN	52.8	483	207	10	1512	79	144	610	1.80E-130	467.6	TM181_HUMAN	reviewed	Transmembrane protein 181	TMEM181 GPR178 KIAA1423	Homo sapiens (Human)	612	integral component of membrane [GO:0016021]; toxic substance binding [GO:0015643]; pathogenesis [GO:0009405]	integral component of membrane [GO:0016021]	toxic substance binding [GO:0015643]	GO:0009405; GO:0015643; GO:0016021	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN10597_c1_g1_i2	Q9P2C4	TM181_HUMAN	55.9	213	88	3	705	79	400	610	6.70E-56	218.8	TM181_HUMAN	reviewed	Transmembrane protein 181	TMEM181 GPR178 KIAA1423	Homo sapiens (Human)	612	integral component of membrane [GO:0016021]; toxic substance binding [GO:0015643]; pathogenesis [GO:0009405]	integral component of membrane [GO:0016021]	toxic substance binding [GO:0015643]	GO:0009405; GO:0015643; GO:0016021	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN31413_c0_g1_i1	Q9P2C4	TM181_HUMAN	100	72	0	0	2	217	359	430	2.70E-37	155.2	TM181_HUMAN	reviewed	Transmembrane protein 181	TMEM181 GPR178 KIAA1423	Homo sapiens (Human)	612	integral component of membrane [GO:0016021]; toxic substance binding [GO:0015643]; pathogenesis [GO:0009405]	integral component of membrane [GO:0016021]	toxic substance binding [GO:0015643]	GO:0009405; GO:0015643; GO:0016021	pathogenesis [GO:0009405]		NA	NA	NA	NA	NA	NA
TRINITY_DN1107_c0_g2_i1	A2VDL9	T184B_BOVIN	71.6	310	80	3	969	64	72	381	4.70E-121	435.6	T184B_BOVIN	reviewed	Transmembrane protein 184B	TMEM184B	Bos taurus (Bovine)	407	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1107_c0_g2_i2	A2VDL9	T184B_BOVIN	69.7	323	87	4	992	54	72	393	2.80E-121	436.4	T184B_BOVIN	reviewed	Transmembrane protein 184B	TMEM184B	Bos taurus (Bovine)	407	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN1107_c0_g2_i3	A2VDL9	T184B_BOVIN	73.4	297	74	2	956	81	72	368	6.10E-121	435.3	T184B_BOVIN	reviewed	Transmembrane protein 184B	TMEM184B	Bos taurus (Bovine)	407	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN21397_c0_g1_i1	A2VDL9	T184B_BOVIN	100	129	0	0	389	3	103	231	2.60E-70	265.8	T184B_BOVIN	reviewed	Transmembrane protein 184B	TMEM184B	Bos taurus (Bovine)	407	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN21397_c0_g2_i1	Q8BG09	T184B_MOUSE	100	72	0	0	217	2	103	174	3.20E-38	158.3	T184B_MOUSE	reviewed	Transmembrane protein 184B	Tmem184b	Mus musculus (Mouse)	407	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35415_c0_g1_i1	Q9Y519	T184B_HUMAN	100	83	0	0	3	251	306	388	1.50E-42	172.9	T184B_HUMAN	reviewed	Transmembrane protein 184B (Putative MAPK-activating protein FM08)	TMEM184B C22orf5 PSEC0108	Homo sapiens (Human)	407	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35509_c0_g1_i1	Q3TPR7	T184C_MOUSE	100	72	0	0	217	2	47	118	1.00E-36	153.3	T184C_MOUSE	reviewed	Transmembrane protein 184C (Transmembrane protein 34)	Tmem184c Tmem34	Mus musculus (Mouse)	525	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN40964_c0_g1_i1	Q9NVA4	T184C_HUMAN	98.6	71	1	0	215	3	43	113	1.60E-34	146	T184C_HUMAN	reviewed	Transmembrane protein 184C (Transmembrane protein 34)	TMEM184C TMEM34 PRO1355	Homo sapiens (Human)	438	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN5052_c0_g1_i1	Q6GQE1	T184C_XENLA	51.1	350	158	4	1260	217	5	343	2.70E-98	360.5	T184C_XENLA	reviewed	Transmembrane protein 184C (Transmembrane protein 34)	tmem184c tmem34	Xenopus laevis (African clawed frog)	444	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4432_c0_g1_i3	A2AF53	T185A_MOUSE	46.5	355	174	3	46	1077	1	350	8.40E-93	342	T185A_MOUSE	reviewed	Transmembrane protein 185A (Erythropoietin-induced EST 3) (Protein FAM11A)	Tmem185a Ee3 Fam11a	Mus musculus (Mouse)	350	dendrite [GO:0030425]; integral component of membrane [GO:0016021]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]		GO:0016021; GO:0030425			NA	NA	NA	NA	NA	NA
TRINITY_DN4432_c0_g1_i4	A2AF53	T185A_MOUSE	42.4	217	109	3	35	652	139	350	1.00E-40	168.3	T185A_MOUSE	reviewed	Transmembrane protein 185A (Erythropoietin-induced EST 3) (Protein FAM11A)	Tmem185a Ee3 Fam11a	Mus musculus (Mouse)	350	dendrite [GO:0030425]; integral component of membrane [GO:0016021]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]		GO:0016021; GO:0030425			NA	NA	NA	NA	NA	NA
TRINITY_DN5526_c0_g1_i1	Q96HH6	TMM19_HUMAN	47	313	162	3	6	938	19	329	7.30E-72	272.3	TMM19_HUMAN	reviewed	Transmembrane protein 19	TMEM19	Homo sapiens (Human)	336	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN10650_c1_g1_i3	Q6NYE7	TM192_DANRE	28.6	189	121	3	627	64	92	267	9.30E-12	72.4	TM192_DANRE	reviewed	Transmembrane protein 192	tmem192 zgc:77068	Danio rerio (Zebrafish) (Brachydanio rerio)	271	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]		GO:0005765; GO:0005770; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN30835_c0_g1_i1	Q6DFQ7	TM198_XENTR	51.3	76	33	1	3	218	55	130	3.60E-11	68.6	TM198_XENTR	reviewed	Transmembrane protein 198	tmem198	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	342	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; multicellular organism development [GO:0007275]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]		GO:0005886; GO:0007275; GO:0012506; GO:0016021; GO:0016055; GO:0031410; GO:0090263	multicellular organism development [GO:0007275]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN5027_c0_g1_i1	Q8N511	TM199_HUMAN	31.6	136	93	0	528	121	64	199	1.40E-14	81.6	TM199_HUMAN	reviewed	Transmembrane protein 199	TMEM199 C17orf32	Homo sapiens (Human)	208	COPI-coated vesicle membrane [GO:0030663]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	COPI-coated vesicle membrane [GO:0030663]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]		GO:0005764; GO:0005783; GO:0005789; GO:0006879; GO:0007042; GO:0012505; GO:0016021; GO:0016471; GO:0030663; GO:0033116; GO:0036295; GO:0070072; GO:1905146	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		blue	blue	NA	NA	NA	NA
TRINITY_DN11784_c0_g1_i1	Q22747	TM201_CAEEL	29.8	400	251	9	2159	1005	3	387	1.80E-38	162.5	TM201_CAEEL	reviewed	Transmembrane protein 201 homolog (Spindle-associated membrane protein homolog)	samp-1 T24F1.2	Caenorhabditis elegans	588	integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; actin filament binding [GO:0051015]; lamin binding [GO:0005521]; embryo development ending in birth or egg hatching [GO:0009792]; nuclear migration along microtubule [GO:0030473]	integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	actin filament binding [GO:0051015]; lamin binding [GO:0005521]	GO:0005521; GO:0005635; GO:0005639; GO:0009792; GO:0030473; GO:0031965; GO:0051015	embryo development ending in birth or egg hatching [GO:0009792]; nuclear migration along microtubule [GO:0030473]		NA	NA	NA	NA	NA	NA
TRINITY_DN11784_c0_g1_i2	Q22747	TM201_CAEEL	29.8	393	250	8	2129	1005	3	387	1.80E-38	162.5	TM201_CAEEL	reviewed	Transmembrane protein 201 homolog (Spindle-associated membrane protein homolog)	samp-1 T24F1.2	Caenorhabditis elegans	588	integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; actin filament binding [GO:0051015]; lamin binding [GO:0005521]; embryo development ending in birth or egg hatching [GO:0009792]; nuclear migration along microtubule [GO:0030473]	integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	actin filament binding [GO:0051015]; lamin binding [GO:0005521]	GO:0005521; GO:0005635; GO:0005639; GO:0009792; GO:0030473; GO:0031965; GO:0051015	embryo development ending in birth or egg hatching [GO:0009792]; nuclear migration along microtubule [GO:0030473]		NA	NA	NA	NA	NA	NA
TRINITY_DN4451_c0_g1_i1	Q6GNX5	TM203_XENLA	48.1	135	69	1	604	1005	1	135	1.30E-26	122.1	TM203_XENLA	reviewed	Transmembrane protein 203	tmem203	Xenopus laevis (African clawed frog)	136	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN31262_c0_g1_i1	Q9BTX3	TM208_HUMAN	100	92	0	0	3	278	55	146	2.70E-45	182.2	TM208_HUMAN	reviewed	Transmembrane protein 208	TMEM208 HSPC171	Homo sapiens (Human)	173	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuole [GO:0005773]; autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuole [GO:0005773]		GO:0005773; GO:0005789; GO:0006624; GO:0006914; GO:0016021; GO:0043231	autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]		NA	NA	NA	NA	NA	NA
TRINITY_DN1465_c0_g1_i1	Q6NYP0	TM208_DANRE	49.7	153	76	1	96	551	4	156	2.40E-34	147.1	TM208_DANRE	reviewed	Transmembrane protein 208	tmem208 zgc:77041	Danio rerio (Zebrafish) (Brachydanio rerio)	175	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuole [GO:0005773]; autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; vacuole [GO:0005773]		GO:0005773; GO:0005789; GO:0006624; GO:0006914; GO:0016021; GO:0043231	autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]		blue	blue	NA	NA	NA	NA
TRINITY_DN2457_c0_g2_i11	A2RU14	TM218_HUMAN	35.2	108	66	2	101	412	5	112	1.70E-06	54.7	TM218_HUMAN	reviewed	Transmembrane protein 218	TMEM218	Homo sapiens (Human)	115	cilium [GO:0005929]; integral component of membrane [GO:0016021]	cilium [GO:0005929]; integral component of membrane [GO:0016021]		GO:0005929; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2457_c0_g2_i8	A2RU14	TM218_HUMAN	35.2	108	66	2	101	412	5	112	1.40E-06	54.7	TM218_HUMAN	reviewed	Transmembrane protein 218	TMEM218	Homo sapiens (Human)	115	cilium [GO:0005929]; integral component of membrane [GO:0016021]	cilium [GO:0005929]; integral component of membrane [GO:0016021]		GO:0005929; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN2457_c0_g2_i9	A2RU14	TM218_HUMAN	35.2	108	66	2	101	412	5	112	1.80E-06	54.7	TM218_HUMAN	reviewed	Transmembrane protein 218	TMEM218	Homo sapiens (Human)	115	cilium [GO:0005929]; integral component of membrane [GO:0016021]	cilium [GO:0005929]; integral component of membrane [GO:0016021]		GO:0005929; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33723_c0_g1_i1	Q9H0R3	TM222_HUMAN	100	141	0	0	1	423	46	186	3.40E-84	312	TM222_HUMAN	reviewed	Transmembrane protein 222	TMEM222 C1orf160	Homo sapiens (Human)	208	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g1_i5	Q9H0R3	TM222_HUMAN	63.8	160	57	1	142	618	45	204	7.00E-58	226.1	TM222_HUMAN	reviewed	Transmembrane protein 222	TMEM222 C1orf160	Homo sapiens (Human)	208	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g1_i6	Q9H0R3	TM222_HUMAN	69.1	110	33	1	142	468	45	154	6.70E-42	171.8	TM222_HUMAN	reviewed	Transmembrane protein 222	TMEM222 C1orf160	Homo sapiens (Human)	208	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2204_c0_g1_i8	Q9H0R3	TM222_HUMAN	63.8	160	57	1	142	618	45	204	7.00E-58	226.1	TM222_HUMAN	reviewed	Transmembrane protein 222	TMEM222 C1orf160	Homo sapiens (Human)	208	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN3189_c0_g1_i1	Q6DC58	TM223_DANRE	40.4	109	63	1	420	100	138	246	3.20E-16	87	TM223_DANRE	reviewed	Transmembrane protein 223	tmem223 zgc:101024	Danio rerio (Zebrafish) (Brachydanio rerio)	248	integral component of membrane [GO:0016021]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007399; GO:0016021	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN3189_c0_g1_i2	Q6DC58	TM223_DANRE	37.8	180	105	3	618	100	67	246	2.90E-27	124	TM223_DANRE	reviewed	Transmembrane protein 223	tmem223 zgc:101024	Danio rerio (Zebrafish) (Brachydanio rerio)	248	integral component of membrane [GO:0016021]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007399; GO:0016021	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN3189_c0_g1_i3	Q6DC58	TM223_DANRE	37.8	180	105	3	618	100	67	246	2.90E-27	124	TM223_DANRE	reviewed	Transmembrane protein 223	tmem223 zgc:101024	Danio rerio (Zebrafish) (Brachydanio rerio)	248	integral component of membrane [GO:0016021]; nervous system development [GO:0007399]	integral component of membrane [GO:0016021]		GO:0007399; GO:0016021	nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN9762_c0_g1_i1	Q54ZG7	TM234_DICDI	45.1	122	67	0	104	469	6	127	1.10E-21	104.8	TM234_DICDI	reviewed	Transmembrane protein 234 homolog	DDB_G0277575	Dictyostelium discoideum (Slime mold)	128	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN26921_c0_g1_i1	Q24JQ0	TM241_HUMAN	35.7	238	141	4	737	36	10	239	1.20E-27	125.2	TM241_HUMAN	reviewed	Transmembrane protein 241	TMEM241 C18orf45	Homo sapiens (Human)	296	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]	GO:0005794; GO:0015297; GO:0016021; GO:0022857			NA	NA	NA	NA	NA	NA
TRINITY_DN8083_c0_g1_i1	Q5ZLR7	TM251_CHICK	35.2	108	60	3	460	152	2	104	1.90E-10	67.4	TM251_CHICK	reviewed	Transmembrane protein 251	TMEM251 RCJMB04_5b13	Gallus gallus (Chicken)	131	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN28402_c0_g1_i1	Q5F285	TM256_MOUSE	100	71	0	0	214	2	11	81	2.10E-34	145.6	TM256_MOUSE	reviewed	Transmembrane protein 256	Tmem256	Mus musculus (Mouse)	113	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2361_c0_g2_i2	A4K526	TM256_BUFGR	60.4	106	42	0	464	147	9	114	5.10E-30	132.9	TM256_BUFGR	reviewed	Transmembrane protein 256 homolog		Bufo gargarizans (Asian toad) (Bufo bufo gargarizans)	114	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN35764_c0_g1_i1	Q6ZUK4	TMM26_HUMAN	37.3	268	116	10	55	777	65	307	2.70E-27	125.2	TMM26_HUMAN	reviewed	Transmembrane protein 26	TMEM26	Homo sapiens (Human)	368	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8862_c0_g1_i11	Q6DC75	TM267_DANRE	38.1	126	66	5	233	592	83	202	1.60E-09	64.7	TM267_DANRE	reviewed	Transmembrane protein 267	tmem267 si:busm1-79m10.4 si:dz79m10.4	Danio rerio (Zebrafish) (Brachydanio rerio)	221	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN8862_c0_g1_i6	Q6DC75	TM267_DANRE	38.1	126	66	5	375	734	83	202	1.90E-09	64.7	TM267_DANRE	reviewed	Transmembrane protein 267	tmem267 si:busm1-79m10.4 si:dz79m10.4	Danio rerio (Zebrafish) (Brachydanio rerio)	221	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN38297_c0_g1_i1	Q9CR67	TMM33_MOUSE	100	70	0	0	210	1	166	235	6.10E-34	144.1	TMM33_MOUSE	reviewed	Transmembrane protein 33 (Protein DB83)	Tmem33 Db83	Mus musculus (Mouse)	247	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]; endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005783; GO:0005789; GO:0030176; GO:0034976; GO:0042470; GO:0061024; GO:0071786; GO:1903371; GO:1903896; GO:1903899	endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN15085_c0_g1_i1	Q9CR67	TMM33_MOUSE	100	97	0	0	3	293	38	134	2.80E-45	182.2	TMM33_MOUSE	reviewed	Transmembrane protein 33 (Protein DB83)	Tmem33 Db83	Mus musculus (Mouse)	247	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]; endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005783; GO:0005789; GO:0030176; GO:0034976; GO:0042470; GO:0061024; GO:0071786; GO:1903371; GO:1903896; GO:1903899	endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN15085_c0_g1_i2	P57088	TMM33_HUMAN	100	100	0	0	3	302	38	137	2.40E-47	189.1	TMM33_HUMAN	reviewed	Transmembrane protein 33 (Protein DB83) (SHINC-3)	TMEM33 DB83	Homo sapiens (Human)	247	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]; endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005783; GO:0005789; GO:0030176; GO:0034976; GO:0042470; GO:0061024; GO:0071786; GO:1903371; GO:1903896; GO:1903899	endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN26259_c0_g1_i1	P57088	TMM33_HUMAN	100	88	0	0	1	264	153	240	6.30E-44	177.6	TMM33_HUMAN	reviewed	Transmembrane protein 33 (Protein DB83) (SHINC-3)	TMEM33 DB83	Homo sapiens (Human)	247	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]; endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005783; GO:0005789; GO:0030176; GO:0034976; GO:0042470; GO:0061024; GO:0071786; GO:1903371; GO:1903896; GO:1903899	endoplasmic reticulum tubular network organization [GO:0071786]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN901_c0_g1_i1	Q6PH58	TM39A_DANRE	33.8	423	250	6	179	1366	48	467	2.80E-53	211.1	TM39A_DANRE	reviewed	Transmembrane protein 39A	tmem39a zgc:65781	Danio rerio (Zebrafish) (Brachydanio rerio)	481	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005789; GO:0006914; GO:0016020; GO:0016021; GO:1901097; GO:1902902	autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]		NA	NA	NA	NA	NA	NA
TRINITY_DN942_c1_g1_i2	Q9D8U2	TM41A_MOUSE	44.4	90	47	1	118	378	2	91	2.40E-07	58.5	TM41A_MOUSE	reviewed	Transmembrane protein 41A	Tmem41a	Mus musculus (Mouse)	264	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN942_c1_g1_i3	Q9D8U2	TM41A_MOUSE	48.4	246	123	2	118	846	2	246	2.40E-53	210.7	TM41A_MOUSE	reviewed	Transmembrane protein 41A	Tmem41a	Mus musculus (Mouse)	264	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN7365_c0_g1_i1	Q502G2	T41AA_DANRE	58	50	21	0	56	205	59	108	3.90E-08	58.5	T41AA_DANRE	reviewed	Transmembrane protein 41A-A	tmem41aa tmem41a si:dkeyp-30d5.3 zgc:112259	Danio rerio (Zebrafish) (Brachydanio rerio)	281	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN27686_c0_g1_i1	Q6NS09	TM45B_XENLA	50	60	29	1	52	228	183	242	1.00E-10	67	TM45B_XENLA	reviewed	Transmembrane protein 45B	tmem45b	Xenopus laevis (African clawed frog)	280	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11342_c0_g1_i1	Q5XGD7	TM45B_XENTR	44.3	97	53	1	498	211	150	246	2.70E-15	83.6	TM45B_XENTR	reviewed	Transmembrane protein 45B	tmem45b TNeu104l01.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	280	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11342_c0_g1_i2	Q5XGD7	TM45B_XENTR	44.2	154	85	1	669	211	93	246	1.80E-31	137.5	TM45B_XENTR	reviewed	Transmembrane protein 45B	tmem45b TNeu104l01.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	280	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2020_c0_g1_i2	O95807	TM50A_HUMAN	60.5	147	56	1	536	96	13	157	4.70E-51	202.6	TM50A_HUMAN	reviewed	Transmembrane protein 50A (Small membrane protein 1)	TMEM50A SMP1 UNQ386/PRO718	Homo sapiens (Human)	157	endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]	endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]		GO:0005783; GO:0016021; GO:0032511; GO:0043025; GO:0097386	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]		blue	blue	NA	NA	NA	NA
TRINITY_DN40657_c0_g1_i1	Q9CXL1	TM50A_MOUSE	100	91	0	0	1	273	38	128	3.70E-47	188.3	TM50A_MOUSE	reviewed	Transmembrane protein 50A (Small membrane protein 1)	Tmem50a Smp1	Mus musculus (Mouse)	157	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]		GO:0005737; GO:0005783; GO:0016021; GO:0032511; GO:0043025; GO:0097386	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38906_c0_g1_i1	O95807	TM50A_HUMAN	100	112	0	0	2	337	32	143	1.60E-60	233	TM50A_HUMAN	reviewed	Transmembrane protein 50A (Small membrane protein 1)	TMEM50A SMP1 UNQ386/PRO718	Homo sapiens (Human)	157	endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]	endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]		GO:0005783; GO:0016021; GO:0032511; GO:0043025; GO:0097386	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]		NA	NA	NA	NA	NA	NA
TRINITY_DN69_c0_g1_i1	Q6DJC8	TM53B_XENLA	36.8	261	142	5	133	876	25	275	2.00E-37	157.9	TM53B_XENLA	reviewed	Transmembrane protein 53-B	tmem53-b	Xenopus laevis (African clawed frog)	285	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN69_c0_g1_i2	Q6DJC8	TM53B_XENLA	34.1	302	157	6	16	882	3	275	1.20E-37	158.7	TM53B_XENLA	reviewed	Transmembrane protein 53-B	tmem53-b	Xenopus laevis (African clawed frog)	285	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN12012_c0_g1_i1	Q0P6H9	TMM62_HUMAN	29.7	464	266	18	1587	268	117	544	1.30E-43	179.1	TMM62_HUMAN	reviewed	Transmembrane protein 62	TMEM62	Homo sapiens (Human)	643	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN12001_c0_g1_i2	Q8BXJ9	TMM62_MOUSE	40.7	459	249	8	25	1374	182	626	3.60E-93	343.6	TMM62_MOUSE	reviewed	Transmembrane protein 62	Tmem62	Mus musculus (Mouse)	643	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN12001_c0_g1_i3	Q8BXJ9	TMM62_MOUSE	58.8	160	66	0	25	504	182	341	3.60E-54	212.6	TMM62_MOUSE	reviewed	Transmembrane protein 62	Tmem62	Mus musculus (Mouse)	643	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN12001_c0_g1_i4	Q8BXJ9	TMM62_MOUSE	40.7	459	249	8	25	1374	182	626	8.70E-93	342.4	TMM62_MOUSE	reviewed	Transmembrane protein 62	Tmem62	Mus musculus (Mouse)	643	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN12001_c0_g1_i5	Q8BXJ9	TMM62_MOUSE	47.5	276	140	3	25	846	182	454	7.40E-70	266.2	TMM62_MOUSE	reviewed	Transmembrane protein 62	Tmem62	Mus musculus (Mouse)	643	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN12001_c0_g2_i1	Q0P6H9	TMM62_HUMAN	54.1	111	51	0	368	36	52	162	6.00E-29	129	TMM62_HUMAN	reviewed	Transmembrane protein 62	TMEM62	Homo sapiens (Human)	643	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]	integral component of membrane [GO:0016021]	hydrolase activity [GO:0016787]	GO:0016021; GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN39693_c0_g1_i1	B3DHU2	TMM65_DANRE	47.1	68	34	1	199	2	72	139	6.00E-10	64.3	TMM65_DANRE	reviewed	Transmembrane protein 65	tmem65	Danio rerio (Zebrafish) (Brachydanio rerio)	212	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]		GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779	cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]		NA	NA	NA	NA	NA	NA
TRINITY_DN4080_c0_g1_i3	B3DHU2	TMM65_DANRE	51.8	110	52	1	359	30	104	212	1.90E-24	114.8	TMM65_DANRE	reviewed	Transmembrane protein 65	tmem65	Danio rerio (Zebrafish) (Brachydanio rerio)	212	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]		GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779	cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]		NA	NA	NA	NA	NA	NA
TRINITY_DN4080_c0_g1_i3	B3DHU2	TMM65_DANRE	62.9	35	13	0	454	350	77	111	5.60E-05	50.1	TMM65_DANRE	reviewed	Transmembrane protein 65	tmem65	Danio rerio (Zebrafish) (Brachydanio rerio)	212	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]		GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779	cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]		NA	NA	NA	NA	NA	NA
TRINITY_DN4080_c0_g1_i4	B3DHU2	TMM65_DANRE	56.7	90	39	0	299	30	123	212	2.30E-22	106.3	TMM65_DANRE	reviewed	Transmembrane protein 65	tmem65	Danio rerio (Zebrafish) (Brachydanio rerio)	212	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]		GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779	cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]		NA	NA	NA	NA	NA	NA
TRINITY_DN4080_c0_g1_i5	B3DHU2	TMM65_DANRE	56.6	136	59	0	437	30	77	212	2.50E-37	157.5	TMM65_DANRE	reviewed	Transmembrane protein 65	tmem65	Danio rerio (Zebrafish) (Brachydanio rerio)	212	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]		GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779	cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]		NA	NA	NA	NA	NA	NA
TRINITY_DN4080_c0_g1_i6	B3DHU2	TMM65_DANRE	53.9	102	47	0	335	30	111	212	3.80E-24	113.6	TMM65_DANRE	reviewed	Transmembrane protein 65	tmem65	Danio rerio (Zebrafish) (Brachydanio rerio)	212	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]		GO:0003231; GO:0005743; GO:0005886; GO:0007507; GO:0016021; GO:1903779	cardiac ventricle development [GO:0003231]; heart development [GO:0007507]; regulation of cardiac conduction [GO:1903779]		NA	NA	NA	NA	NA	NA
TRINITY_DN35790_c0_g1_i1	Q5ZJD8	TMM68_CHICK	39.5	291	166	5	980	111	43	324	7.20E-60	232.6	TMM68_CHICK	reviewed	Transmembrane protein 68	TMEM68 RCJMB04_19b17	Gallus gallus (Chicken)	332	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0016021; GO:0016746			NA	NA	NA	NA	NA	NA
TRINITY_DN35790_c0_g1_i3	Q5ZJD8	TMM68_CHICK	33.8	133	80	3	456	58	43	167	1.10E-17	91.7	TMM68_CHICK	reviewed	Transmembrane protein 68	TMEM68 RCJMB04_19b17	Gallus gallus (Chicken)	332	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]"	integral component of membrane [GO:0016021]	"transferase activity, transferring acyl groups [GO:0016746]"	GO:0016021; GO:0016746			NA	NA	NA	NA	NA	NA
TRINITY_DN3261_c0_g2_i1	Q0V9J0	TMM69_XENTR	51	145	68	2	578	153	94	238	1.80E-30	134.4	TMM69_XENTR	reviewed	Transmembrane protein 69	tmem69	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	253	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN3261_c0_g2_i2	Q0V9J0	TMM69_XENTR	51	145	68	2	578	153	94	238	1.90E-30	134.4	TMM69_XENTR	reviewed	Transmembrane protein 69	tmem69	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	253	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN34093_c0_g1_i1	Q5SWH9	TMM69_HUMAN	100	87	0	0	1	261	101	187	7.60E-42	170.6	TMM69_HUMAN	reviewed	Transmembrane protein 69	TMEM69 C1orf154 HSPC229	Homo sapiens (Human)	247	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN10617_c0_g1_i1	Q95SS8	TMM70_DROME	46	211	93	4	730	107	28	220	1.30E-40	168.3	TMM70_DROME	reviewed	"Transmembrane protein 70 homolog, mitochondrial"	CG7506	Drosophila melanogaster (Fruit fly)	236	integral component of mitochondrial membrane [GO:0032592]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	integral component of mitochondrial membrane [GO:0032592]		GO:0032592; GO:0033615	mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]		blue	blue	NA	NA	NA	NA
TRINITY_DN26133_c0_g1_i1	Q8NBN3	TM87A_HUMAN	100	108	0	0	1	324	235	342	7.70E-52	204.1	TM87A_HUMAN	reviewed	Transmembrane protein 87A	TMEM87A PSEC0094	Homo sapiens (Human)	555	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0032580; GO:0042147	"retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3133_c0_g1_i1	Q28EW0	TM87A_XENTR	40	570	282	14	1771	86	24	541	2.30E-103	377.9	TM87A_XENTR	reviewed	Transmembrane protein 87A	tmem87a TGas047b06.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	541	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0032580; GO:0042147	"retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3133_c0_g1_i4	Q28EW0	TM87A_XENTR	39.9	572	282	14	1777	86	24	541	3.00E-103	377.5	TM87A_XENTR	reviewed	Transmembrane protein 87A	tmem87a TGas047b06.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	541	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0032580; GO:0042147	"retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40034_c0_g1_i1	Q28EW0	TM87A_XENTR	82.6	69	12	0	3	209	334	402	1.60E-26	119.4	TM87A_XENTR	reviewed	Transmembrane protein 87A	tmem87a TGas047b06.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	541	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0032580; GO:0042147	"retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN41113_c0_g1_i1	Q8BKU8	TM87B_MOUSE	100	99	0	0	297	1	432	530	1.70E-50	199.5	TM87B_MOUSE	reviewed	Transmembrane protein 87B	Tmem87b	Mus musculus (Mouse)	555	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0000139; GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0042147	"retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33115_c0_g1_i1	Q8BKU8	TM87B_MOUSE	98.6	146	2	0	439	2	208	353	4.80E-73	275	TM87B_MOUSE	reviewed	Transmembrane protein 87B	Tmem87b	Mus musculus (Mouse)	555	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0000139; GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0042147	"retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8320_c0_g1_i1	A6QLK4	TMM8B_BOVIN	37.6	354	180	11	1257	2270	33	361	9.20E-54	213.4	TMM8B_BOVIN	reviewed	Transmembrane protein 8B (Protein NGX6)	TMEM8B	Bos taurus (Bovine)	472	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; regulation of growth [GO:0040008]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007155; GO:0016021; GO:0040008	cell adhesion [GO:0007155]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN8320_c0_g1_i2	A6QLK4	TMM8B_BOVIN	38.2	411	212	12	1257	2438	33	418	1.40E-69	266.2	TMM8B_BOVIN	reviewed	Transmembrane protein 8B (Protein NGX6)	TMEM8B	Bos taurus (Bovine)	472	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; regulation of growth [GO:0040008]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007155; GO:0016021; GO:0040008	cell adhesion [GO:0007155]; regulation of growth [GO:0040008]		NA	NA	NA	NA	NA	NA
TRINITY_DN7217_c0_g1_i2	A2AAE1	K1109_MOUSE	52.8	377	166	7	1122	4	3085	3453	1.40E-106	387.9	K1109_MOUSE	reviewed	Transmembrane protein KIAA1109 (Fragile site-associated protein homolog)	Kiaa1109 Fsa Kiaa1371	Mus musculus (Mouse)	5005	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]		GO:0001558; GO:0005634; GO:0006629; GO:0006909; GO:0007283; GO:0016021; GO:0016197; GO:0019915; GO:0032456; GO:0045444; GO:0048488; GO:0051647; GO:0060612; GO:0098793	adipose tissue development [GO:0060612]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN11678_c0_g2_i1	Q2LD37	K1109_HUMAN	38.8	232	136	3	109	789	29	259	4.10E-39	163.3	K1109_HUMAN	reviewed	Transmembrane protein KIAA1109 (Fragile site-associated protein)	KIAA1109 FSA KIAA1371	Homo sapiens (Human)	5005	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]		GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN11678_c0_g2_i2	Q2LD37	K1109_HUMAN	34.1	170	105	3	59	547	104	273	1.40E-21	104.4	K1109_HUMAN	reviewed	Transmembrane protein KIAA1109 (Fragile site-associated protein)	KIAA1109 FSA KIAA1371	Homo sapiens (Human)	5005	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]		GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN11678_c0_g2_i4	Q2LD37	K1109_HUMAN	38.6	246	145	3	109	831	29	273	1.20E-43	178.3	K1109_HUMAN	reviewed	Transmembrane protein KIAA1109 (Fragile site-associated protein)	KIAA1109 FSA KIAA1371	Homo sapiens (Human)	5005	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]		GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN15022_c0_g1_i2	Q2LD37	K1109_HUMAN	40.4	228	125	4	6	659	495	721	3.20E-44	179.9	K1109_HUMAN	reviewed	Transmembrane protein KIAA1109 (Fragile site-associated protein)	KIAA1109 FSA KIAA1371	Homo sapiens (Human)	5005	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]		GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN7217_c0_g1_i3	Q2LD37	K1109_HUMAN	54.6	269	114	4	907	104	3085	3346	4.10E-77	289.7	K1109_HUMAN	reviewed	Transmembrane protein KIAA1109 (Fragile site-associated protein)	KIAA1109 FSA KIAA1371	Homo sapiens (Human)	5005	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]		GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN16393_c0_g1_i1	A0A0R4IES7	K1109_DANRE	36.1	144	82	3	422	6	3690	3828	4.30E-08	59.3	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN16393_c0_g1_i2	A0A0R4IES7	K1109_DANRE	38	129	70	3	377	6	3705	3828	1.40E-08	60.8	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN16393_c0_g1_i4	A0A0R4IES7	K1109_DANRE	34.9	149	77	5	422	6	3690	3828	2.80E-07	56.6	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN16393_c0_g1_i7	A0A0R4IES7	K1109_DANRE	38	129	70	3	377	6	3705	3828	1.40E-08	60.8	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN7217_c0_g1_i4	A0A0R4IES7	K1109_DANRE	45.2	126	62	4	363	4	3279	3403	9.00E-23	107.8	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN18336_c0_g1_i3	A0A0R4IES7	K1109_DANRE	42.3	149	65	5	29	454	3464	3598	3.60E-17	89.7	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN38656_c0_g1_i1	A0A0R4IES7	K1109_DANRE	48.5	167	75	4	77	559	4076	4237	1.00E-27	124.8	K1109_DANRE	reviewed	Transmembrane protein KIAA1109 homolog	si:ch211-233a24.2	Danio rerio (Zebrafish) (Brachydanio rerio)	4923	integral component of membrane [GO:0016021]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; presynapse [GO:0098793]		GO:0006909; GO:0016021; GO:0016197; GO:0032456; GO:0048488; GO:0098793	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; synaptic vesicle endocytosis [GO:0048488]		NA	NA	NA	NA	NA	NA
TRINITY_DN8485_c0_g1_i1	Q8BI84	TGO1_MOUSE	26.8	239	159	4	775	101	1477	1713	1.60E-10	69.3	TGO1_MOUSE	reviewed	Transport and Golgi organization protein 1 homolog (TANGO1) (Melanoma inhibitory activity protein 3)	Mia3 Kiaa0268 Tango	Mus musculus (Mouse)	1930	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; cargo receptor activity [GO:0038024]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	cargo receptor activity [GO:0038024]	GO:0000139; GO:0002042; GO:0002063; GO:0002687; GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0007162; GO:0009306; GO:0015031; GO:0016021; GO:0030199; GO:0030336; GO:0030501; GO:0035459; GO:0038024; GO:0042060; GO:0042953; GO:0043231; GO:0070971; GO:0070973; GO:0090110; GO:0140052; GO:1903038; GO:2000402	cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN1680_c0_g1_i1	Q961C9	TNG11_DROME	33.6	268	130	7	758	96	11	277	6.10E-32	139.4	TNG11_DROME	reviewed	Transport and Golgi organization protein 11 (Tango-11)	Tango11 CG30404	Drosophila melanogaster (Fruit fly)	277	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; protein secretion [GO:0009306]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]		GO:0005737; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0009306; GO:0016021	protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1680_c0_g1_i2	Q961C9	TNG11_DROME	33.6	268	130	7	758	96	11	277	1.20E-31	138.7	TNG11_DROME	reviewed	Transport and Golgi organization protein 11 (Tango-11)	Tango11 CG30404	Drosophila melanogaster (Fruit fly)	277	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; protein secretion [GO:0009306]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]		GO:0005737; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0009306; GO:0016021	protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1680_c0_g1_i3	Q961C9	TNG11_DROME	32.5	271	123	6	740	96	11	277	3.00E-31	137.1	TNG11_DROME	reviewed	Transport and Golgi organization protein 11 (Tango-11)	Tango11 CG30404	Drosophila melanogaster (Fruit fly)	277	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; protein secretion [GO:0009306]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]		GO:0005737; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0009306; GO:0016021	protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1680_c0_g1_i4	Q961C9	TNG11_DROME	32.5	271	123	6	740	96	11	277	4.30E-31	136.7	TNG11_DROME	reviewed	Transport and Golgi organization protein 11 (Tango-11)	Tango11 CG30404	Drosophila melanogaster (Fruit fly)	277	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; protein secretion [GO:0009306]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]		GO:0005737; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0009306; GO:0016021	protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN14842_c0_g1_i1	Q8C3S2	TNG6_MOUSE	45.7	208	111	1	723	106	871	1078	8.50E-43	175.3	TNG6_MOUSE	reviewed	Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7)	Tango6 Kiaa1746 Tmco7	Mus musculus (Mouse)	1079	integral component of membrane [GO:0016021]; protein secretion [GO:0009306]	integral component of membrane [GO:0016021]		GO:0009306; GO:0016021	protein secretion [GO:0009306]		NA	NA	NA	NA	NA	NA
TRINITY_DN29917_c0_g1_i1	Q3SYU7	TNPO1_BOVIN	76.4	110	26	0	1	330	45	154	1.10E-43	177.2	TNPO1_BOVIN	reviewed	Transportin-1 (Importin beta-2) (Karyopherin beta-2)	TNPO1 KPNB2	Bos taurus (Bovine)	898	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN30921_c0_g1_i1	Q3SYU7	TNPO1_BOVIN	99.5	217	1	0	653	3	48	264	2.90E-122	439.1	TNPO1_BOVIN	reviewed	Transportin-1 (Importin beta-2) (Karyopherin beta-2)	TNPO1 KPNB2	Bos taurus (Bovine)	898	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]	GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN32002_c0_g1_i1	Q92973	TNPO1_HUMAN	100	82	0	0	247	2	263	344	1.00E-40	166.8	TNPO1_HUMAN	reviewed	Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP)	TNPO1 KPNB2 MIP1 TRN	Homo sapiens (Human)	898	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0008536; GO:0016032; GO:0035735; GO:0043488; GO:0061608; GO:0070062	intraciliary transport involved in cilium assembly [GO:0035735]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29917_c0_g1_i2	Q92973	TNPO1_HUMAN	73.9	318	81	2	1	951	45	361	2.10E-135	483.4	TNPO1_HUMAN	reviewed	Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP)	TNPO1 KPNB2 MIP1 TRN	Homo sapiens (Human)	898	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0008536; GO:0016032; GO:0035735; GO:0043488; GO:0061608; GO:0070062	intraciliary transport involved in cilium assembly [GO:0035735]; protein import into nucleus [GO:0006606]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN34194_c0_g1_i1	Q6P2B1	TNPO3_MOUSE	100	88	0	0	1	264	721	808	1.80E-43	176	TNPO3_MOUSE	reviewed	Transportin-3	Tnpo3	Mus musculus (Mouse)	923	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN384_c0_g1_i2	Q6P2B1	TNPO3_MOUSE	47.5	922	473	7	166	2928	11	922	8.80E-243	841.6	TNPO3_MOUSE	reviewed	Transportin-3	Tnpo3	Mus musculus (Mouse)	923	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN384_c0_g1_i3	Q6P2B1	TNPO3_MOUSE	46.7	938	473	8	166	2976	11	922	9.30E-240	831.6	TNPO3_MOUSE	reviewed	Transportin-3	Tnpo3	Mus musculus (Mouse)	923	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN26049_c0_g1_i1	Q9Y5L0	TNPO3_HUMAN	100	94	0	0	1	282	292	385	5.10E-52	204.5	TNPO3_HUMAN	reviewed	Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR)	TNPO3 IPO12	Homo sapiens (Human)	923	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN31134_c0_g1_i1	Q9Y5L0	TNPO3_HUMAN	99.1	113	1	0	340	2	615	727	5.00E-62	238	TNPO3_HUMAN	reviewed	Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR)	TNPO3 IPO12	Homo sapiens (Human)	923	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN30304_c0_g1_i1	Q9Y5L0	TNPO3_HUMAN	100	70	0	0	3	212	501	570	1.50E-32	139.4	TNPO3_HUMAN	reviewed	Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR)	TNPO3 IPO12	Homo sapiens (Human)	923	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231; GO:0061608	protein import into nucleus [GO:0006606]		NA	NA	NA	NA	NA	NA
TRINITY_DN3401_c0_g1_i1	P03934	TC1A_CAEEL	30.9	81	55	1	43	285	143	222	3.70E-07	55.8	TC1A_CAEEL	reviewed	Transposable element Tc1 transposase	tc1a tca T07D3.8	Caenorhabditis elegans	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3401_c0_g1_i2	P03934	TC1A_CAEEL	42.3	52	30	0	42	197	171	222	3.70E-07	55.5	TC1A_CAEEL	reviewed	Transposable element Tc1 transposase	tc1a tca T07D3.8	Caenorhabditis elegans	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3401_c0_g1_i3	P03934	TC1A_CAEEL	32.1	81	54	1	43	285	143	222	3.40E-08	59.3	TC1A_CAEEL	reviewed	Transposable element Tc1 transposase	tc1a tca T07D3.8	Caenorhabditis elegans	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3401_c0_g1_i6	P03934	TC1A_CAEEL	33.8	74	48	1	43	264	143	215	7.70E-08	57.8	TC1A_CAEEL	reviewed	Transposable element Tc1 transposase	tc1a tca T07D3.8	Caenorhabditis elegans	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5093_c0_g1_i1	P03934	TC1A_CAEEL	38.9	54	33	0	43	204	191	244	1.80E-07	56.2	TC1A_CAEEL	reviewed	Transposable element Tc1 transposase	tc1a tca T07D3.8	Caenorhabditis elegans	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6002_c0_g1_i1	P34257	TC3A_CAEEL	28.5	337	223	10	1067	75	5	329	4.50E-23	110.5	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN6002_c0_g1_i7	P34257	TC3A_CAEEL	28.5	337	223	10	1067	75	5	329	4.70E-23	110.5	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN6002_c0_g1_i8	P34257	TC3A_CAEEL	34.4	154	94	4	524	75	179	329	1.70E-15	84.3	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN688_c0_g1_i1	P34257	TC3A_CAEEL	28	246	155	8	63	773	76	308	2.80E-15	84	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN688_c0_g1_i2	P34257	TC3A_CAEEL	28.7	254	159	8	63	797	76	316	2.40E-17	90.9	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4323_c0_g1_i1	P34257	TC3A_CAEEL	25.5	282	186	11	813	1	53	321	3.40E-11	70.9	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4323_c0_g1_i3	P34257	TC3A_CAEEL	24.9	241	167	7	708	1	90	321	1.10E-12	75.9	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4323_c0_g1_i6	P34257	TC3A_CAEEL	25.3	281	187	10	810	1	53	321	2.60E-13	78.2	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN4323_c0_g1_i8	P34257	TC3A_CAEEL	25.5	282	186	11	813	1	53	321	3.20E-11	71.2	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN13169_c0_g1_i2	P34257	TC3A_CAEEL	33.6	113	69	3	16	351	166	273	5.50E-10	65.5	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN6002_c0_g1_i4	P34257	TC3A_CAEEL	28.4	338	222	11	1067	75	5	329	2.10E-23	111.7	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	1	NA	NA	NA
TRINITY_DN6666_c0_g1_i1	P34257	TC3A_CAEEL	29.7	155	100	4	465	7	182	329	4.90E-11	69.3	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN8495_c0_g1_i1	P34257	TC3A_CAEEL	33.3	96	47	3	49	309	228	315	1.40E-07	57	TC3A_CAEEL	reviewed	Transposable element Tc3 transposase	tc3a B0303.5	Caenorhabditis elegans	329	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006310; GO:0015074	DNA integration [GO:0015074]; DNA recombination [GO:0006310]		NA	NA	NA	NA	NA	NA
TRINITY_DN11958_c0_g1_i4	P35072	TCB1_CAEBR	38.3	107	65	1	74	394	168	273	1.20E-13	77.8	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23723_c0_g1_i1	P35072	TCB1_CAEBR	31.4	102	69	1	14	319	173	273	6.90E-12	71.6	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23723_c0_g1_i2	P35072	TCB1_CAEBR	30.7	101	69	1	14	316	173	272	1.20E-10	67.4	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6062_c0_g1_i3	P35072	TCB1_CAEBR	34.3	283	164	10	902	87	2	273	2.80E-30	134.4	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	1	NA	NA	NA
TRINITY_DN17699_c0_g1_i1	P35072	TCB1_CAEBR	37.3	83	52	0	252	4	177	259	4.10E-11	70.5	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17699_c0_g1_i2	P35072	TCB1_CAEBR	37.3	83	52	0	252	4	177	259	3.60E-11	70.5	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17699_c0_g1_i3	P35072	TCB1_CAEBR	25.3	217	140	5	620	3	62	267	3.70E-15	84	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17699_c0_g1_i7	P35072	TCB1_CAEBR	25.3	217	140	5	620	3	62	267	3.60E-15	84	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29754_c0_g1_i1	P35072	TCB1_CAEBR	38.2	76	45	1	479	700	148	223	4.80E-09	63.2	TCB1_CAEBR	reviewed	Transposable element Tcb1 transposase (Transposable element Barney transposase)		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6062_c0_g1_i1	Q04202	TCB2_CAEBR	34.7	199	120	5	668	87	80	273	3.90E-24	113.2	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11958_c0_g1_i2	Q04202	TCB2_CAEBR	46.6	58	29	2	80	250	170	226	2.30E-07	57	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11958_c0_g1_i6	Q04202	TCB2_CAEBR	44.6	56	30	1	80	247	170	224	1.70E-07	57.4	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24021_c0_g1_i1	Q04202	TCB2_CAEBR	37.9	58	36	0	179	6	180	237	1.20E-06	53.5	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17699_c0_g1_i18	Q04202	TCB2_CAEBR	30.9	81	56	0	245	3	187	267	2.40E-09	63.2	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38026_c0_g1_i1	Q04202	TCB2_CAEBR	30.6	62	43	0	194	9	180	241	1.80E-06	52.8	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12571_c0_g1_i1	Q04202	TCB2_CAEBR	42.9	42	24	0	206	81	174	215	6.30E-06	51.2	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12571_c0_g1_i2	Q04202	TCB2_CAEBR	42.9	42	24	0	206	81	174	215	1.30E-06	53.5	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4642_c0_g1_i1	Q04202	TCB2_CAEBR	45.8	48	21	2	210	341	176	222	5.40E-05	48.9	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4642_c0_g1_i3	Q04202	TCB2_CAEBR	47.9	48	24	1	248	391	176	222	7.50E-08	58.5	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4642_c0_g1_i4	Q04202	TCB2_CAEBR	47.9	48	24	1	248	391	176	222	7.60E-08	58.5	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4642_c0_g1_i7	Q04202	TCB2_CAEBR	47.9	48	24	1	248	391	176	222	6.70E-08	58.5	TCB2_CAEBR	reviewed	Transposable element Tcb2 transposase		Caenorhabditis briggsae	273	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"	nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39144_c0_g1_i1	Q99315	YG31B_YEAST	31.6	79	52	1	237	1	802	878	5.90E-07	54.7	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39144_c0_g1_i3	Q99315	YG31B_YEAST	29.4	68	46	1	207	4	812	877	8.80E-05	47.4	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12841_c0_g1_i3	Q99315	YG31B_YEAST	42.2	102	59	0	314	9	586	687	4.40E-20	99	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		brown	brown	1	NA	1	1
TRINITY_DN7506_c0_g1_i1	Q99315	YG31B_YEAST	39.7	73	43	1	220	5	584	656	1.20E-07	58.2	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7506_c0_g1_i3	Q99315	YG31B_YEAST	30.6	121	72	4	331	5	536	656	3.60E-08	60.5	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7506_c0_g1_i6	Q99315	YG31B_YEAST	39.7	73	43	1	220	5	584	656	1.60E-07	58.2	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13341_c0_g1_i2	Q99315	YG31B_YEAST	30.4	161	107	3	3	482	818	974	5.60E-14	79	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7337_c0_g1_i11	Q99315	YG31B_YEAST	27.4	212	138	6	629	24	1112	1317	3.10E-17	90.1	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7337_c0_g1_i4	Q99315	YG31B_YEAST	25.7	171	112	3	555	79	1112	1279	2.30E-11	70.5	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12841_c0_g1_i2	Q99315	YG31B_YEAST	51.6	62	30	0	194	9	626	687	7.50E-15	80.9	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29652_c0_g1_i1	Q99315	YG31B_YEAST	53.1	64	29	1	5	196	664	726	7.70E-13	73.9	YG31B_YEAST	reviewed	Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]	TY3B-G YGRWTy3-1 POL YGR109W-B G5984	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1547	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31080_c0_g1_i1	Q7LHG5	YI31B_YEAST	42.6	54	31	0	177	16	884	937	3.40E-05	48.5	YI31B_YEAST	reviewed	Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]	TY3B-I YILWTy3-1 POL YIL082W-A	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1498	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]	aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]	GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197	"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"		blue	blue	NA	NA	NA	NA
TRINITY_DN28905_c0_g1_i1	Q8MMG9	TREA_PIMHY	48.3	87	45	0	264	4	296	382	2.40E-19	95.9	TREA_PIMHY	reviewed	"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"	tre1	Pimpla hypochondriaca (Parasitoid wasp)	585	"extracellular region [GO:0005576]; alpha,alpha-trehalase activity [GO:0004555]; trehalose metabolic process [GO:0005991]"	extracellular region [GO:0005576]	"alpha,alpha-trehalase activity [GO:0004555]"	GO:0004555; GO:0005576; GO:0005991	trehalose metabolic process [GO:0005991]		NA	NA	NA	NA	NA	NA
TRINITY_DN26055_c0_g1_i1	A8J4S9	TREA_APIME	65.1	129	45	0	2	388	114	242	8.90E-47	187.6	TREA_APIME	reviewed	"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"		Apis mellifera (Honeybee)	626	"integral component of membrane [GO:0016021]; alpha,alpha-trehalase activity [GO:0004555]; trehalose metabolic process [GO:0005991]"	integral component of membrane [GO:0016021]	"alpha,alpha-trehalase activity [GO:0004555]"	GO:0004555; GO:0005991; GO:0016021	trehalose metabolic process [GO:0005991]		NA	NA	NA	NA	NA	NA
TRINITY_DN1593_c0_g1_i3	A8J4S9	TREA_APIME	44.4	538	292	5	244	1854	45	576	1.70E-136	488	TREA_APIME	reviewed	"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"		Apis mellifera (Honeybee)	626	"integral component of membrane [GO:0016021]; alpha,alpha-trehalase activity [GO:0004555]; trehalose metabolic process [GO:0005991]"	integral component of membrane [GO:0016021]	"alpha,alpha-trehalase activity [GO:0004555]"	GO:0004555; GO:0005991; GO:0016021	trehalose metabolic process [GO:0005991]		NA	NA	NA	NA	NA	NA
TRINITY_DN26963_c0_g1_i1	Q9JLT2	TREA_MOUSE	47.3	91	42	2	275	3	417	501	1.00E-20	100.5	TREA_MOUSE	reviewed	"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"	Treh	Mus musculus (Mouse)	576	"anchored component of membrane [GO:0031225]; brush border [GO:0005903]; plasma membrane [GO:0005886]; alpha,alpha-trehalase activity [GO:0004555]; animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]"	anchored component of membrane [GO:0031225]; brush border [GO:0005903]; plasma membrane [GO:0005886]	"alpha,alpha-trehalase activity [GO:0004555]"	GO:0004555; GO:0005886; GO:0005903; GO:0005993; GO:0009887; GO:0031225	animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]		NA	NA	NA	NA	NA	NA
TRINITY_DN31330_c0_g1_i1	A0R6E0	TRES_MYCS2	74.3	70	18	0	2	211	181	250	6.70E-28	124	TRES_MYCS2	reviewed	Trehalose synthase/amylase TreS (EC 3.2.1.1) (EC 5.4.99.16) (Maltose alpha-D-glucosyltransferase) (MTase)	treS MSMEG_6515 MSMEI_6343	Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium smegmatis)	593	alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; calcium ion binding [GO:0005509]; maltose alpha-D-glucosyltransferase activity [GO:0047471]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; maltose metabolic process [GO:0000023]; polysaccharide catabolic process [GO:0000272]; trehalose metabolic process [GO:0005991]		alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; calcium ion binding [GO:0005509]; maltose alpha-D-glucosyltransferase activity [GO:0047471]	GO:0000023; GO:0000272; GO:0004556; GO:0005509; GO:0005977; GO:0005978; GO:0005991; GO:0047471; GO:0103025	glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; maltose metabolic process [GO:0000023]; polysaccharide catabolic process [GO:0000272]; trehalose metabolic process [GO:0005991]		NA	NA	NA	NA	NA	NA
TRINITY_DN1337_c0_g1_i1	P55612	OTSA_SINFN	63.7	91	33	0	273	1	333	423	3.00E-28	125.6	OTSA_SINFN	reviewed	"Trehalose-6-phosphate synthase (TPS) (EC 2.4.1.15) (Alpha,alpha-trehalose-phosphate synthase [UDP-forming]) (Osmoregulatory trehalose synthesis protein A) (OtsA) (UDP-glucose-glucosephosphate glucosyltransferase)"	otsA NGR_a02090 y4pC	Sinorhizobium fredii (strain NBRC 101917 / NGR234)	464	"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; trehalose biosynthetic process [GO:0005992]"		"alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]"	GO:0003825; GO:0005992	trehalose biosynthetic process [GO:0005992]		NA	NA	NA	NA	NA	NA
TRINITY_DN24833_c0_g1_i1	Q8K4K4	TRIB1_MOUSE	100	89	0	0	269	3	214	302	8.10E-47	187.2	TRIB1_MOUSE	reviewed	Tribbles homolog 1 (TRB-1)	Trib1 Trb1	Mus musculus (Mouse)	372	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]	GO:0004860; GO:0005634; GO:0005737; GO:0006469; GO:0007254; GO:0008134; GO:0014912; GO:0031434; GO:0031625; GO:0031665; GO:0032436; GO:0032496; GO:0043405; GO:0043433; GO:0045645; GO:0045651; GO:0045659; GO:0048662; GO:0051443; GO:0055106	JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN24833_c0_g1_i2	Q96RU8	TRIB1_HUMAN	100	80	0	0	242	3	223	302	1.90E-42	172.6	TRIB1_HUMAN	reviewed	Tribbles homolog 1 (TRB-1) (G-protein-coupled receptor-induced gene 2 protein) (GIG-2) (SKIP1)	TRIB1 C8FW GIG2 TRB1	Homo sapiens (Human)	372	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]	GO:0004860; GO:0005634; GO:0005737; GO:0006469; GO:0007254; GO:0008134; GO:0014912; GO:0031434; GO:0031625; GO:0031665; GO:0032436; GO:0032496; GO:0043405; GO:0043433; GO:0045645; GO:0045651; GO:0045659; GO:0048662; GO:0055106	JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496]		NA	NA	NA	NA	NA	NA
TRINITY_DN38897_c0_g1_i1	Q28283	TRIB2_CANLF	63.3	139	49	2	633	223	171	309	3.60E-45	183	TRIB2_CANLF	reviewed	Tribbles homolog 2 (TRB-2)	TRIB2 C5FW	Canis lupus familiaris (Dog) (Canis familiaris)	343	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]	GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0008134; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106	negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]		NA	NA	NA	NA	NA	NA
TRINITY_DN24565_c0_g1_i1	P40939	ECHA_HUMAN	100	97	0	0	292	2	411	507	2.70E-48	192.2	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i1	P40939	ECHA_HUMAN	63.7	339	122	1	1018	5	388	726	9.60E-117	421.4	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i10	P40939	ECHA_HUMAN	64	339	121	1	1018	5	388	726	4.30E-117	422.5	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i11	P40939	ECHA_HUMAN	64.1	248	89	0	749	6	388	635	7.40E-82	305.1	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i12	P40939	ECHA_HUMAN	63.7	339	122	1	1018	5	388	726	9.60E-117	421.4	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i15	P40939	ECHA_HUMAN	64	339	121	1	1018	5	388	726	4.30E-117	422.5	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i2	P40939	ECHA_HUMAN	63.7	339	122	1	1018	5	388	726	9.60E-117	421.4	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i4	P40939	ECHA_HUMAN	63.7	339	122	1	1018	5	388	726	9.60E-117	421.4	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i6	P40939	ECHA_HUMAN	64.5	248	88	0	749	6	388	635	4.30E-82	305.8	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g1_i8	P40939	ECHA_HUMAN	63.7	339	122	1	1018	5	388	726	9.60E-117	421.4	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17392_c0_g2_i1	P40939	ECHA_HUMAN	100	153	0	0	460	2	504	656	3.80E-81	302	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN37775_c0_g1_i1	P40939	ECHA_HUMAN	99.5	192	1	0	576	1	61	252	2.90E-102	372.5	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN1668_c0_g1_i3	P40939	ECHA_HUMAN	52.1	336	156	5	997	2	1	335	2.50E-83	310.5	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN1668_c0_g1_i4	P40939	ECHA_HUMAN	52.1	336	156	5	997	2	1	335	2.50E-83	310.5	ECHA_HUMAN	reviewed	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"	HADHA HADH	Homo sapiens (Human)	763	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042493; GO:0042645; GO:0044877; GO:0051287	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN29239_c0_g1_i1	P55084	ECHB_HUMAN	100	116	0	0	348	1	356	471	3.60E-63	241.9	ECHB_HUMAN	reviewed	"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]"	HADHB MSTP029	Homo sapiens (Human)	474	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]	GO:0003723; GO:0003857; GO:0003988; GO:0004300; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0035965; GO:0042645; GO:0050633	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN27862_c0_g1_i1	Q99JY0	ECHB_MOUSE	99.3	139	1	0	1	417	126	264	2.30E-69	262.7	ECHB_MOUSE	reviewed	"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]"	Hadhb	Mus musculus (Mouse)	475	endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; protein-containing complex binding [GO:0044877]; fatty acid beta-oxidation [GO:0006635]	endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; protein-containing complex binding [GO:0044877]	GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0016507; GO:0042645; GO:0044877; GO:0050633	fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN6390_c0_g1_i1	O46629	ECHB_BOVIN	68.6	446	139	1	142	1479	30	474	2.30E-178	626.7	ECHB_BOVIN	reviewed	"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]"	HADHB	Bos taurus (Bovine)	475	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; fatty acid beta-oxidation [GO:0006635]	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]	GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0050633	fatty acid beta-oxidation [GO:0006635]		blue	blue	NA	NA	NA	NA
TRINITY_DN5764_c0_g1_i1	P55084	ECHB_HUMAN	100	333	0	0	1001	3	40	372	1.60E-183	643.3	ECHB_HUMAN	reviewed	"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]"	HADHB MSTP029	Homo sapiens (Human)	474	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]	GO:0003723; GO:0003857; GO:0003988; GO:0004300; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0035965; GO:0042645; GO:0050633	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN5764_c0_g1_i2	P55084	ECHB_HUMAN	98.8	333	4	0	1001	3	40	372	2.30E-182	639.4	ECHB_HUMAN	reviewed	"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]"	HADHB MSTP029	Homo sapiens (Human)	474	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]	GO:0003723; GO:0003857; GO:0003988; GO:0004300; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0035965; GO:0042645; GO:0050633	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN5764_c0_g1_i3	P55084	ECHB_HUMAN	100	333	0	0	1001	3	40	372	1.60E-183	643.3	ECHB_HUMAN	reviewed	"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]"	HADHB MSTP029	Homo sapiens (Human)	474	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]	endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; RNA binding [GO:0003723]	GO:0003723; GO:0003857; GO:0003988; GO:0004300; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0035965; GO:0042645; GO:0050633	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]		NA	NA	NA	NA	NA	NA
TRINITY_DN9618_c0_g1_i1	P16340	PUR2_DROPS	86	43	6	0	63	191	274	316	7.90E-15	80.9	PUR2_DROPS	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	ade3 gart GA16345	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1364	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0006189; GO:0009113; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c1_g1_i11	P21872	PUR2_CHICK	53	783	357	7	2370	40	82	859	2.20E-220	766.9	PUR2_CHICK	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART	Gallus gallus (Chicken)	1003	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0046084; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN2704_c1_g1_i6	P21872	PUR2_CHICK	52.4	494	226	6	1559	90	330	818	1.80E-130	467.6	PUR2_CHICK	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART	Gallus gallus (Chicken)	1003	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0046084; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN29916_c0_g1_i1	P22102	PUR2_HUMAN	100	91	0	0	273	1	573	663	1.30E-47	189.9	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN40264_c0_g1_i1	P21872	PUR2_CHICK	51.9	79	38	0	1	237	874	952	3.10E-18	92	PUR2_CHICK	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART	Gallus gallus (Chicken)	1003	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0046084; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN8365_c0_g1_i4	Q64737	PUR2_MOUSE	50	130	65	0	104	493	1	130	1.10E-30	134.4	PUR2_MOUSE	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	Gart	Mus musculus (Mouse)	1010	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009156; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN8365_c0_g1_i5	Q64737	PUR2_MOUSE	50	130	65	0	68	457	1	130	8.10E-31	134.8	PUR2_MOUSE	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	Gart	Mus musculus (Mouse)	1010	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009156; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN11454_c0_g1_i1	Q64737	PUR2_MOUSE	54.2	83	34	2	2	250	261	339	3.00E-19	95.5	PUR2_MOUSE	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	Gart	Mus musculus (Mouse)	1010	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009156; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN35048_c0_g1_i1	P22102	PUR2_HUMAN	100	73	0	0	1	219	57	129	8.90E-36	150.2	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN31559_c0_g1_i1	P22102	PUR2_HUMAN	100	79	0	0	239	3	196	274	1.40E-42	172.9	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN33278_c0_g1_i1	P22102	PUR2_HUMAN	100	134	0	0	1	402	435	568	3.20E-71	268.9	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4946_c0_g1_i1	P21872	PUR2_CHICK	61	187	73	0	646	86	814	1000	2.90E-58	226.5	PUR2_CHICK	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART	Gallus gallus (Chicken)	1003	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0046084; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN4946_c0_g1_i2	P22102	PUR2_HUMAN	53.6	151	61	1	525	100	855	1005	1.50E-39	164.1	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4946_c0_g1_i3	P22102	PUR2_HUMAN	58.2	153	64	0	535	77	855	1007	4.80E-46	185.7	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4946_c0_g1_i4	P22102	PUR2_HUMAN	58.2	153	64	0	535	77	855	1007	1.10E-45	184.5	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN4946_c0_g1_i5	P21872	PUR2_CHICK	61.3	168	65	0	636	133	814	981	6.80E-52	205.3	PUR2_CHICK	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART	Gallus gallus (Chicken)	1003	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0046084; GO:0046872	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; purine nucleotide biosynthetic process [GO:0006164]		NA	NA	NA	NA	NA	NA
TRINITY_DN37211_c0_g1_i1	P22102	PUR2_HUMAN	100	72	0	0	217	2	868	939	1.50E-35	149.4	PUR2_HUMAN	reviewed	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GART PGFT PRGS	Homo sapiens (Human)	1010	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0046084; GO:0046654; GO:0046872; GO:0070062	'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]		NA	NA	NA	NA	NA	NA
TRINITY_DN35550_c0_g1_i1	Q9NA75	T38B1_CAEEL	52.5	278	131	1	94	927	9	285	7.60E-82	305.4	T38B1_CAEEL	reviewed	Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1)	tric-1B.1 Y57A10A.10	Caenorhabditis elegans	295	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	potassium channel activity [GO:0005267]	GO:0005267; GO:0005789; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN22076_c0_g1_i1	Q923W1	TGS1_MOUSE	53.2	154	71	1	464	3	683	835	7.60E-40	164.9	TGS1_MOUSE	reviewed	Trimethylguanosine synthase (EC 2.1.1.-) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT)	Tgs1 Ncoa6ip Pimt	Mus musculus (Mouse)	853	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA trimethylguanosine synthase activity [GO:0071164]; 7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA trimethylguanosine synthase activity [GO:0071164]	GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0009452; GO:0015030; GO:0036261; GO:0071164	7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]		blue	blue	NA	NA	NA	NA
TRINITY_DN10955_c0_g1_i2	Q96UB1	TMLH_NEUCR	26.9	386	232	9	175	1215	82	456	8.60E-33	142.9	TMLH_NEUCR	reviewed	Trimethyllysine dioxygenase (EC 1.14.11.8) (Carnitine biosynthesis protein 1) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)	cbs-1 99H12.050 NCU03802	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	471	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]	mitochondrion [GO:0005739]	metal ion binding [GO:0046872]; trimethyllysine dioxygenase activity [GO:0050353]	GO:0005739; GO:0045329; GO:0046872; GO:0050353	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN5218_c0_g1_i1	Q9NVH6	TMLH_HUMAN	39.8	354	207	3	1238	189	69	420	2.90E-74	280.8	TMLH_HUMAN	reviewed	"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)"	TMLHE TMLH	Homo sapiens (Human)	421	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]"	GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353; GO:0051354; GO:0055114	carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN5218_c0_g1_i11	Q9NVH6	TMLH_HUMAN	39.4	302	177	3	1082	189	121	420	6.70E-61	236.1	TMLH_HUMAN	reviewed	"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)"	TMLHE TMLH	Homo sapiens (Human)	421	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]"	GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353; GO:0051354; GO:0055114	carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN5218_c0_g1_i5	Q9NVH6	TMLH_HUMAN	39.8	354	207	3	1238	189	69	420	2.70E-74	280.8	TMLH_HUMAN	reviewed	"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)"	TMLHE TMLH	Homo sapiens (Human)	421	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]"	GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353; GO:0051354; GO:0055114	carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN5218_c0_g1_i13	Q0VC74	TMLH_BOVIN	63.6	44	16	0	320	189	377	420	2.90E-11	69.7	TMLH_BOVIN	reviewed	"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)"	TMLHE	Bos taurus (Bovine)	421	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]"	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]"	GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353	carnitine biosynthetic process [GO:0045329]		NA	NA	NA	NA	NA	NA
TRINITY_DN39833_c0_g1_i1	Q8NDV7	TNR6A_HUMAN	66.3	83	28	0	138	386	1780	1862	4.10E-26	119	TNR6A_HUMAN	reviewed	Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa)	TNRC6A CAGH26 KIAA1460 TNRC6	Homo sapiens (Human)	1962	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RNA binding [GO:0003723]; cellular response to starvation [GO:0009267]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005654; GO:0005794; GO:0005829; GO:0007223; GO:0009267; GO:0010628; GO:0010629; GO:0016442; GO:0035194; GO:0035195; GO:0035278; GO:0043231; GO:0045652; GO:0060213; GO:0060964	"cellular response to starvation [GO:0009267]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36592_c0_g1_i1	Q3LXA3	TKFC_HUMAN	100	108	0	0	325	2	71	178	5.00E-51	201.4	TKFC_HUMAN	reviewed	Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)]	TKFC DAK	Homo sapiens (Human)	575	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]	GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0019563; GO:0034012; GO:0039534; GO:0044262; GO:0045087; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062	carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]		NA	NA	NA	NA	NA	NA
TRINITY_DN35662_c0_g1_i1	Q3LXA3	TKFC_HUMAN	41	585	325	9	1838	96	1	569	6.70E-103	376.3	TKFC_HUMAN	reviewed	Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)]	TKFC DAK	Homo sapiens (Human)	575	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]	GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0019563; GO:0034012; GO:0039534; GO:0044262; GO:0045087; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062	carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]		NA	NA	NA	NA	NA	NA
TRINITY_DN6765_c0_g2_i1	P17751	TPIS_MOUSE	100	170	0	0	510	1	130	299	4.40E-94	345.1	TPIS_MOUSE	reviewed	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase)	Tpi1 Tpi	Mus musculus (Mouse)	249	cytosol [GO:0005829]; isomerase activity [GO:0016853]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]; multicellular organism development [GO:0007275]	cytosol [GO:0005829]	isomerase activity [GO:0016853]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]	GO:0004807; GO:0005829; GO:0006006; GO:0006094; GO:0006096; GO:0007275; GO:0008929; GO:0016853; GO:0019242; GO:0019563; GO:0019682; GO:0031625; GO:0042803; GO:0046166	gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN6765_c0_g1_i1	P17751	TPIS_MOUSE	99	96	1	0	289	2	49	144	2.00E-51	202.6	TPIS_MOUSE	reviewed	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase)	Tpi1 Tpi	Mus musculus (Mouse)	249	cytosol [GO:0005829]; isomerase activity [GO:0016853]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]; multicellular organism development [GO:0007275]	cytosol [GO:0005829]	isomerase activity [GO:0016853]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]	GO:0004807; GO:0005829; GO:0006006; GO:0006094; GO:0006096; GO:0007275; GO:0008929; GO:0016853; GO:0019242; GO:0019563; GO:0019682; GO:0031625; GO:0042803; GO:0046166	gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN6765_c1_g1_i1	P60174	TPIS_HUMAN	100	258	0	0	3	776	29	286	5.80E-147	521.5	TPIS_HUMAN	reviewed	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase)	TPI1 TPI	Homo sapiens (Human)	249	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]	methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]	GO:0004807; GO:0005615; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0031625; GO:0042803; GO:0046166; GO:0061621; GO:0070062	canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]		NA	NA	NA	NA	NA	NA
TRINITY_DN17422_c0_g2_i1	Q10657	TPIS_CAEEL	71	31	7	1	59	151	4	32	2.40E-05	49.3	TPIS_CAEEL	reviewed	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase)	tpi-1 Y17G7B.7	Caenorhabditis elegans	247	cytosol [GO:0005829]; myofibril [GO:0030016]; methylglyoxal synthase activity [GO:0008929]; triose-phosphate isomerase activity [GO:0004807]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]	cytosol [GO:0005829]; myofibril [GO:0030016]	methylglyoxal synthase activity [GO:0008929]; triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0008340; GO:0008929; GO:0019563; GO:0030016; GO:0045454; GO:0046166	cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN36284_c0_g1_i1	P82204	TPIS_BOMMO	59.1	176	71	1	2	526	71	246	3.30E-53	209.5	TPIS_BOMMO	reviewed	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	Tpi	Bombyx mori (Silk moth)	248	triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN39402_c0_g1_i1	Q8XXP9	TPIS_RALSO	89.9	99	10	0	1	297	150	248	1.10E-41	170.2	TPIS_RALSO	reviewed	Triosephosphate isomerase (TIM) (TPI) (EC 5.3.1.1) (Triose-phosphate isomerase)	tpiA RSc2064 RS03629	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	248	cytoplasm [GO:0005737]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]	cytoplasm [GO:0005737]	triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0005737; GO:0006094; GO:0006096	gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]		NA	NA	NA	NA	NA	NA
TRINITY_DN25398_c0_g1_i1	Q90XG0	TPISB_DANRE	71.4	245	69	1	822	91	4	248	1.60E-99	364	TPISB_DANRE	reviewed	Triosephosphate isomerase B (TIM-B) (EC 5.3.1.1) (Methylglyoxal synthase B) (EC 4.2.3.3) (Triose-phosphate isomerase B)	tpi1b	Danio rerio (Zebrafish) (Brachydanio rerio)	248	cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	cytosol [GO:0005829]	methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0042803; GO:0046166	gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]		blue	blue	NA	NA	NA	NA
TRINITY_DN21900_c0_g1_i1	Q90XG0	TPISB_DANRE	67.6	204	65	1	26	634	4	207	6.90E-73	275	TPISB_DANRE	reviewed	Triosephosphate isomerase B (TIM-B) (EC 5.3.1.1) (Methylglyoxal synthase B) (EC 4.2.3.3) (Triose-phosphate isomerase B)	tpi1b	Danio rerio (Zebrafish) (Brachydanio rerio)	248	cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	cytosol [GO:0005829]	methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0042803; GO:0046166	gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]		NA	NA	NA	NA	NA	NA
TRINITY_DN17422_c0_g1_i1	Q90XG0	TPISB_DANRE	73.6	87	23	0	93	353	38	124	5.30E-31	135.2	TPISB_DANRE	reviewed	Triosephosphate isomerase B (TIM-B) (EC 5.3.1.1) (Methylglyoxal synthase B) (EC 4.2.3.3) (Triose-phosphate isomerase B)	tpi1b	Danio rerio (Zebrafish) (Brachydanio rerio)	248	cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	cytosol [GO:0005829]	methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0042803; GO:0046166	gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]		NA	NA	NA	NA	NA	NA
TRINITY_DN17422_c0_g1_i2	Q90XG0	TPISB_DANRE	76.7	60	14	0	245	424	65	124	1.70E-20	100.5	TPISB_DANRE	reviewed	Triosephosphate isomerase B (TIM-B) (EC 5.3.1.1) (Methylglyoxal synthase B) (EC 4.2.3.3) (Triose-phosphate isomerase B)	tpi1b	Danio rerio (Zebrafish) (Brachydanio rerio)	248	cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	cytosol [GO:0005829]	methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]	GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0042803; GO:0046166	gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i14	Q503I2	TRI13_DANRE	36.4	55	24	2	140	283	8	58	4.00E-05	48.9	TRI13_DANRE	reviewed	Tripartite motif-containing 13	trim13 zgc:110578	Danio rerio (Zebrafish) (Brachydanio rerio)	404	"chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ligase activity [GO:0016874]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of transcription, DNA-templated [GO:0045893]"	chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	ligase activity [GO:0016874]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000785; GO:0004842; GO:0005654; GO:0005789; GO:0008270; GO:0016021; GO:0016874; GO:0045893	"positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37446_c0_g1_i1	D2GXS7	TRIM2_AILME	78.3	69	15	0	208	2	649	717	1.60E-26	119.4	TRIM2_AILME	reviewed	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	TRIM2	Ailuropoda melanoleuca (Giant panda)	744	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]	cytoplasm [GO:0005737]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0008270; GO:0043523	regulation of neuron apoptotic process [GO:0043523]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i11	Q5ZMD4	TRI59_CHICK	31	84	41	3	160	372	8	87	2.00E-05	50.4	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i13	Q5ZMD4	TRI59_CHICK	29.8	84	42	3	84	296	8	87	1.60E-05	50.4	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i17	Q5ZMD4	TRI59_CHICK	29.8	84	42	3	111	323	8	87	1.80E-05	50.4	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i3	Q5ZMD4	TRI59_CHICK	31	84	41	3	187	399	8	87	2.10E-05	50.4	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c0_g2_i2	Q5ZMD4	TRI59_CHICK	27.8	79	41	3	31	228	8	83	1.80E-05	50.4	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c1_g1_i1	Q5ZMD4	TRI59_CHICK	29.3	82	41	3	3	209	10	87	3.00E-06	52.4	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c0_g3_i2	Q5ZMD4	TRI59_CHICK	27.4	84	44	3	83	295	8	87	4.60E-06	52	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c0_g1_i10	Q5ZMD4	TRI59_CHICK	33	88	47	4	83	322	8	91	1.70E-10	67	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c0_g1_i2	Q5ZMD4	TRI59_CHICK	31.8	88	43	4	83	307	8	91	5.70E-08	58.5	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c0_g1_i3	Q5ZMD4	TRI59_CHICK	33.3	96	45	5	72	320	2	91	2.60E-08	59.7	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		blue	blue	NA	NA	NA	NA
TRINITY_DN639_c0_g1_i5	Q5ZMD4	TRI59_CHICK	34.1	88	46	4	96	335	8	91	3.80E-10	65.9	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN639_c0_g1_i6	Q5ZMD4	TRI59_CHICK	33	88	42	4	82	306	8	91	9.60E-08	57.8	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		blue	blue	NA	NA	NA	NA
TRINITY_DN11046_c0_g1_i1	Q5ZMD4	TRI59_CHICK	34.4	61	25	2	193	342	10	66	7.50E-05	48.1	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN11046_c0_g1_i3	Q5ZMD4	TRI59_CHICK	33.3	69	29	3	48	221	4	66	4.90E-05	48.1	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN11046_c0_g1_i5	Q5ZMD4	TRI59_CHICK	34.4	61	25	2	178	327	10	66	7.20E-05	48.1	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN23150_c0_g1_i1	Q5ZMD4	TRI59_CHICK	33.3	87	41	3	293	72	10	92	6.60E-09	61.6	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN16493_c0_g1_i1	Q5ZMD4	TRI59_CHICK	30.9	68	34	2	12	176	20	87	3.40E-05	48.5	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN12852_c0_g1_i3	Q5ZMD4	TRI59_CHICK	29.8	84	42	3	263	51	8	87	2.00E-06	53.5	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN12852_c0_g1_i5	Q5ZMD4	TRI59_CHICK	30.5	82	40	3	257	51	10	87	4.30E-05	48.5	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN12852_c0_g1_i7	Q5ZMD4	TRI59_CHICK	29.8	84	42	3	263	51	8	87	1.40E-06	53.9	TRI59_CHICK	reviewed	Tripartite motif-containing protein 59	TRIM59 RCJMB04_2h17	Gallus gallus (Chicken)	408	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]		NA	NA	NA	NA	NA	NA
TRINITY_DN4505_c0_g1_i22	Q8IWR1	TRI59_HUMAN	31.7	82	39	4	140	346	8	85	2.20E-06	53.5	TRI59_HUMAN	reviewed	Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1)	TRIM59 RNF104 TRIM57 TSBF1	Homo sapiens (Human)	403	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0046597; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]		NA	NA	NA	NA	NA	NA
TRINITY_DN6273_c0_g1_i10	Q8IWR1	TRI59_HUMAN	27.5	80	41	3	624	424	10	85	4.70E-05	49.7	TRI59_HUMAN	reviewed	Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1)	TRIM59 RNF104 TRIM57 TSBF1	Homo sapiens (Human)	403	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0046597; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]		NA	NA	NA	NA	NA	NA
TRINITY_DN6273_c0_g1_i15	Q8IWR1	TRI59_HUMAN	27.5	80	41	3	307	107	10	85	2.40E-05	49.7	TRI59_HUMAN	reviewed	Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1)	TRIM59 RNF104 TRIM57 TSBF1	Homo sapiens (Human)	403	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0046597; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]		NA	NA	NA	NA	NA	NA
TRINITY_DN6273_c0_g1_i16	Q8IWR1	TRI59_HUMAN	27.5	80	41	3	519	319	10	85	4.00E-05	49.7	TRI59_HUMAN	reviewed	Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1)	TRIM59 RNF104 TRIM57 TSBF1	Homo sapiens (Human)	403	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0046597; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]		NA	NA	NA	NA	NA	NA
TRINITY_DN6273_c0_g1_i2	Q8IWR1	TRI59_HUMAN	27.5	80	41	3	329	129	10	85	7.30E-05	48.1	TRI59_HUMAN	reviewed	Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1)	TRIM59 RNF104 TRIM57 TSBF1	Homo sapiens (Human)	403	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0046597; GO:0061630	innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597]		NA	NA	NA	NA	NA	NA
TRINITY_DN40148_c0_g1_i1	Q6PJ69	TRI65_HUMAN	46.2	39	21	0	142	26	5	43	1.90E-05	49.7	TRI65_HUMAN	reviewed	Tripartite motif-containing protein 65	TRIM65	Homo sapiens (Human)	517	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; positive regulation of autophagy [GO:0010508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	zinc ion binding [GO:0008270]	GO:0005654; GO:0005829; GO:0008270; GO:0010508	positive regulation of autophagy [GO:0010508]		NA	NA	NA	NA	NA	NA
TRINITY_DN38937_c0_g1_i1	P29144	TPP2_HUMAN	99.3	151	1	0	2	454	352	502	1.90E-80	299.7	TPP2_HUMAN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Homo sapiens (Human)	1249	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0000209; GO:0004175; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802	protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN3246_c0_g1_i1	A5PK39	TPP2_BOVIN	51.6	91	44	0	339	67	831	921	2.00E-22	106.7	TPP2_BOVIN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Bos taurus (Bovine)	1249	cytosol [GO:0005829]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	cytosol [GO:0005829]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005634; GO:0005829; GO:0008240			NA	NA	NA	NA	NA	NA
TRINITY_DN3246_c0_g1_i4	A5PK39	TPP2_BOVIN	42.2	1247	663	18	3771	88	42	1249	4.90E-275	949.1	TPP2_BOVIN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Bos taurus (Bovine)	1249	cytosol [GO:0005829]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	cytosol [GO:0005829]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005634; GO:0005829; GO:0008240			NA	NA	NA	NA	NA	NA
TRINITY_DN3246_c0_g1_i7	A5PK39	TPP2_BOVIN	41.9	1260	661	20	3810	88	42	1249	1.40E-272	941	TPP2_BOVIN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Bos taurus (Bovine)	1249	cytosol [GO:0005829]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	cytosol [GO:0005829]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005634; GO:0005829; GO:0008240			NA	NA	NA	NA	NA	NA
TRINITY_DN36479_c0_g1_i1	Q64514	TPP2_MOUSE	100	107	0	0	323	3	367	473	5.70E-55	214.5	TPP2_MOUSE	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	Tpp2	Mus musculus (Mouse)	1262	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; proteolysis [GO:0006508]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005654; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042277; GO:0042802	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN3246_c0_g1_i6	A5PK39	TPP2_BOVIN	62.1	58	22	0	253	80	42	99	1.90E-13	76.3	TPP2_BOVIN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Bos taurus (Bovine)	1249	cytosol [GO:0005829]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	cytosol [GO:0005829]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005634; GO:0005829; GO:0008240			yellow	yellow	1	NA	NA	NA
TRINITY_DN39463_c0_g1_i1	A5PK39	TPP2_BOVIN	100	95	0	0	286	2	239	333	7.00E-49	194.1	TPP2_BOVIN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Bos taurus (Bovine)	1249	cytosol [GO:0005829]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	cytosol [GO:0005829]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005634; GO:0005829; GO:0008240			NA	NA	NA	NA	NA	NA
TRINITY_DN30581_c0_g1_i1	A5PK39	TPP2_BOVIN	100	82	0	0	247	2	841	922	2.10E-41	169.1	TPP2_BOVIN	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	Bos taurus (Bovine)	1249	cytosol [GO:0005829]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	cytosol [GO:0005829]; nucleus [GO:0005634]	serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005634; GO:0005829; GO:0008240			NA	NA	NA	NA	NA	NA
TRINITY_DN3246_c0_g1_i5	Q9V6K1	TPP2_DROME	33.6	125	80	1	462	88	1320	1441	5.50E-10	65.9	TPP2_DROME	reviewed	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) (dTPP II)	TppII CG3991	Drosophila melanogaster (Fruit fly)	1441	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; proteolysis [GO:0006508]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004252; GO:0005829; GO:0006508; GO:0008240; GO:0032991; GO:0042802	proteolysis [GO:0006508]		yellow	yellow	NA	NA	NA	1
TRINITY_DN3362_c0_g1_i1	Q1LUA6	TRIO_DANRE	47.1	376	189	6	177	1301	1878	2244	2.70E-85	317.4	TRIO_DANRE	reviewed	Triple functional domain protein (EC 2.7.11.1)	trio si:dkey-158b13.2	Danio rerio (Zebrafish) (Brachydanio rerio)	3028	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417	axon guidance [GO:0007411]; central nervous system development [GO:0007417]		NA	NA	NA	NA	NA	NA
TRINITY_DN19375_c0_g1_i8	O75962	TRIO_HUMAN	52.8	231	109	0	788	96	55	285	3.60E-69	263.1	TRIO_HUMAN	reviewed	Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein)	TRIO	Homo sapiens (Human)	3097	cell projection [GO:0042995]; cytosol [GO:0005829]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell projection [GO:0042995]; cytosol [GO:0005829]	ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005829; GO:0007185; GO:0007186; GO:0007411; GO:0007417; GO:0042995; GO:0043065; GO:0045599; GO:0051056	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]		blue	blue	NA	NA	NA	NA
TRINITY_DN19375_c0_g1_i6	O75962	TRIO_HUMAN	51.9	241	116	0	818	96	45	285	5.80E-70	265.8	TRIO_HUMAN	reviewed	Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein)	TRIO	Homo sapiens (Human)	3097	cell projection [GO:0042995]; cytosol [GO:0005829]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell projection [GO:0042995]; cytosol [GO:0005829]	ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005829; GO:0007185; GO:0007186; GO:0007411; GO:0007417; GO:0042995; GO:0043065; GO:0045599; GO:0051056	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]		NA	NA	1	NA	NA	NA
TRINITY_DN2916_c0_g1_i1	Q7Z2T5	TRM1L_HUMAN	36.2	472	257	7	1427	99	236	692	8.60E-77	289.3	TRM1L_HUMAN	reviewed	TRMT1-like protein (EC 2.1.1.-)	TRMT1L C1orf25 TRM1L MSTP070	Homo sapiens (Human)	733	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; behavior [GO:0007610]; tRNA N2-guanine methylation [GO:0002940]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]	GO:0000049; GO:0002940; GO:0003723; GO:0004809; GO:0005634; GO:0007610; GO:0046872	behavior [GO:0007610]; tRNA N2-guanine methylation [GO:0002940]		NA	NA	NA	NA	NA	NA
TRINITY_DN33079_c0_g1_i1	P0CS09	TRM61_CRYNB	49.4	77	35	2	1	225	171	245	5.50E-13	74.7	TRM61_CRYNB	reviewed	tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRM61 (EC 2.1.1.220) (tRNA(m1A58)-methyltransferase subunit TRM61) (tRNA(m1A58)MTase subunit TRM61)	TRM61 CNBL1390	Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) (Filobasidiella neoformans)	433	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]	tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]	GO:0005634; GO:0016429; GO:0031515			red	red	NA	NA	NA	NA
TRINITY_DN34422_c0_g1_i1	Q80XC2	TRM61_MOUSE	54.5	77	31	2	239	12	48	121	6.00E-17	87.8	TRM61_MOUSE	reviewed	tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A)	Trmt61a Trm61	Mus musculus (Mouse)	290	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]	mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]	GO:0005634; GO:0016429; GO:0030488; GO:0031515; GO:0061953; GO:0080009	mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN941_c0_g1_i2	Q96FX7	TRM61_HUMAN	44.2	344	135	5	1145	120	1	289	6.20E-73	276.2	TRM61_HUMAN	reviewed	tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A)	TRMT61A C14orf172 TRM61	Homo sapiens (Human)	289	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]	mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]	GO:0005634; GO:0005654; GO:0006400; GO:0016429; GO:0030488; GO:0031515; GO:0061953; GO:0080009	mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		blue	blue	NA	NA	NA	NA
TRINITY_DN37896_c0_g1_i1	Q9UJA5	TRM6_HUMAN	100	69	0	0	208	2	410	478	7.90E-34	143.7	TRM6_HUMAN	reviewed	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6)	TRMT6 KIAA1153 TRM6 CGI-09	Homo sapiens (Human)	497	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006400; GO:0030488; GO:0031515; GO:0080009	mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN10861_c0_g1_i1	Q8CE96	TRM6_MOUSE	54.1	85	38	1	2	253	379	463	3.30E-21	102.4	TRM6_MOUSE	reviewed	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6)	Trmt6 Kiaa1153 Trm6	Mus musculus (Mouse)	497	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]		GO:0005634; GO:0030488; GO:0031515; GO:0080009	mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN26589_c0_g1_i1	Q9UJA5	TRM6_HUMAN	38.4	245	141	4	108	842	20	254	1.50E-40	168.3	TRM6_HUMAN	reviewed	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6)	TRMT6 KIAA1153 TRM6 CGI-09	Homo sapiens (Human)	497	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006400; GO:0030488; GO:0031515; GO:0080009	mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN25428_c0_g1_i1	Q9W4M9	NSUN2_DROME	50.6	89	39	2	11	268	264	350	6.60E-17	87.8	NSUN2_DROME	reviewed	tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (NOP2/Sun domain family member 2 ortholog)	Nsun2 CG6133	Drosophila melanogaster (Fruit fly)	746	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0007614; GO:0008168; GO:0016428; GO:0030488	RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN26690_c0_g1_i1	Q9W4M9	NSUN2_DROME	46.5	686	332	8	133	2124	15	687	1.80E-174	614.4	NSUN2_DROME	reviewed	tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (NOP2/Sun domain family member 2 ortholog)	Nsun2 CG6133	Drosophila melanogaster (Fruit fly)	746	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0007614; GO:0008168; GO:0016428; GO:0030488	RNA methylation [GO:0001510]; short-term memory [GO:0007614]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2156_c0_g1_i1	Q7YS61	TRDMT_BOVIN	45	387	199	4	1126	2	4	388	1.40E-82	308.1	TRDMT_BOVIN	reviewed	tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2)	TRDMT1 DNMT2	Bos taurus (Bovine)	391	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]	GO:0003723; GO:0005737; GO:0016428; GO:0030488; GO:0036416	tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]		NA	NA	NA	NA	NA	NA
TRINITY_DN21116_c0_g1_i1	Q7TNK6	TRM11_RAT	98.8	86	1	0	2	259	155	240	2.30E-46	185.7	TRM11_RAT	reviewed	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	Trmt11	Rattus norvegicus (Rat)	463	cytoplasm [GO:0005737]; methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]	cytoplasm [GO:0005737]	methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]	GO:0000049; GO:0004809; GO:0005737; GO:0008168			NA	NA	NA	NA	NA	NA
TRINITY_DN6780_c0_g1_i1	Q5R962	TRM11_PONAB	48.3	460	225	6	124	1470	6	463	1.10E-117	425.2	TRM11_PONAB	reviewed	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	TRMT11	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	463	methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]; methylation [GO:0032259]; tRNA processing [GO:0008033]		methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]	GO:0000049; GO:0008033; GO:0008168; GO:0032259	methylation [GO:0032259]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN6780_c0_g1_i2	Q5R962	TRM11_PONAB	49.3	221	110	2	124	780	6	226	7.10E-56	219.9	TRM11_PONAB	reviewed	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	TRMT11	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	463	methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]; methylation [GO:0032259]; tRNA processing [GO:0008033]		methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]	GO:0000049; GO:0008033; GO:0008168; GO:0032259	methylation [GO:0032259]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN6780_c0_g1_i2	Q5R962	TRM11_PONAB	47.5	240	115	4	786	1478	226	463	6.70E-54	213.4	TRM11_PONAB	reviewed	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	TRMT11	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	463	methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]; methylation [GO:0032259]; tRNA processing [GO:0008033]		methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]	GO:0000049; GO:0008033; GO:0008168; GO:0032259	methylation [GO:0032259]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN31596_c0_g1_i1	Q6NS23	TRM11_XENLA	44.8	58	30	1	219	52	272	329	2.00E-07	56.2	TRM11_XENLA	reviewed	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	trmt11	Xenopus laevis (African clawed frog)	478	methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]; methylation [GO:0032259]; tRNA processing [GO:0008033]		methyltransferase activity [GO:0008168]; tRNA binding [GO:0000049]	GO:0000049; GO:0008033; GO:0008168; GO:0032259	methylation [GO:0032259]; tRNA processing [GO:0008033]		NA	NA	NA	NA	NA	NA
TRINITY_DN14058_c0_g3_i1	E3WPP8	TRM5_ANODA	46.7	422	189	6	288	1550	5	391	7.10E-101	369.4	TRM5_ANODA	reviewed	tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog)	AND_009348	Anopheles darlingi (Mosquito)	500	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]	GO:0005634; GO:0005759; GO:0052906			NA	NA	NA	NA	NA	NA
TRINITY_DN14058_c0_g3_i2	E3WPP8	TRM5_ANODA	50	368	175	4	288	1382	5	366	1.30E-99	365.2	TRM5_ANODA	reviewed	tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog)	AND_009348	Anopheles darlingi (Mosquito)	500	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]	GO:0005634; GO:0005759; GO:0052906			NA	NA	NA	NA	NA	NA
TRINITY_DN26417_c0_g1_i1	Q59Q39	TRM10_CANAL	58.9	56	23	0	174	7	218	273	2.80E-10	65.5	TRM10_CANAL	reviewed	tRNA (guanine(9)-N1)-methyltransferase (EC 2.1.1.221) (tRNA methyltransferase 10) (tRNA(m1G9)-methyltransferase) (tRNA(m1G9)MTase)	TRM10 CAALFM_C206480WA CaO19.25 CaO19.7696	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	323	mitochondrion [GO:0005739]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial tRNA processing [GO:0090646]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0005739; GO:0009019; GO:0052905; GO:0090646	mitochondrial tRNA processing [GO:0090646]		NA	NA	NA	NA	NA	NA
TRINITY_DN8821_c0_g2_i1	Q5XJ57	TRMB_DANRE	66.8	238	73	2	143	847	5	239	2.40E-93	343.6	TRMB_DANRE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)	mettl1 zgc:103636	Danio rerio (Zebrafish) (Brachydanio rerio)	241	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN8821_c0_g2_i4	Q5XJ57	TRMB_DANRE	59.8	264	74	3	143	925	5	239	6.60E-89	328.9	TRMB_DANRE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)	mettl1 zgc:103636	Danio rerio (Zebrafish) (Brachydanio rerio)	241	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN8821_c0_g1_i1	Q5XJ57	TRMB_DANRE	69.8	159	42	2	794	327	5	160	8.70E-64	245.4	TRMB_DANRE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)	mettl1 zgc:103636	Danio rerio (Zebrafish) (Brachydanio rerio)	241	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN8821_c0_g1_i1	Q5XJ57	TRMB_DANRE	59.2	71	29	0	327	115	169	239	7.20E-18	92.8	TRMB_DANRE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)	mettl1 zgc:103636	Danio rerio (Zebrafish) (Brachydanio rerio)	241	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN8821_c0_g1_i3	Q5XJ57	TRMB_DANRE	66.8	238	73	2	819	115	5	239	2.40E-93	343.6	TRMB_DANRE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)	mettl1 zgc:103636	Danio rerio (Zebrafish) (Brachydanio rerio)	241	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		blue	blue	NA	NA	NA	NA
TRINITY_DN38433_c0_g1_i1	Q9Z120	TRMB_MOUSE	100	88	0	0	2	265	80	167	3.90E-46	184.9	TRMB_MOUSE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)	Mettl1	Mus musculus (Mouse)	268	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN33705_c0_g1_i1	B6SHG7	TRMB_MAIZE	51.7	89	42	1	1	264	52	140	1.60E-18	93.2	TRMB_MAIZE	reviewed	tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)		Zea mays (Maize)	255	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]	tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0008176; GO:0030488; GO:0036265; GO:0043527	RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN32429_c0_g1_i1	Q96GJ1	TRM2_HUMAN	99	99	1	0	1	297	291	389	2.30E-50	199.1	TRM2_HUMAN	reviewed	tRNA (uracil(54)-C(5))-methyltransferase homolog (EC 2.1.1.35) (TRM2 homolog)	TRMT2B CXorf34	Homo sapiens (Human)	504	S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]		S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]	GO:0030697			NA	NA	NA	NA	NA	NA
TRINITY_DN9201_c0_g1_i3	Q96GJ1	TRM2_HUMAN	45.5	426	221	3	1303	47	83	504	4.00E-99	363.6	TRM2_HUMAN	reviewed	tRNA (uracil(54)-C(5))-methyltransferase homolog (EC 2.1.1.35) (TRM2 homolog)	TRMT2B CXorf34	Homo sapiens (Human)	504	S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]		S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]	GO:0030697			NA	NA	NA	NA	NA	NA
TRINITY_DN9201_c0_g1_i4	Q96GJ1	TRM2_HUMAN	45	416	218	3	1273	47	93	504	2.10E-95	350.9	TRM2_HUMAN	reviewed	tRNA (uracil(54)-C(5))-methyltransferase homolog (EC 2.1.1.35) (TRM2 homolog)	TRMT2B CXorf34	Homo sapiens (Human)	504	S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]		S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]	GO:0030697			NA	NA	NA	NA	NA	NA
TRINITY_DN9201_c0_g1_i5	A4QP75	TRM2B_DANRE	50.6	77	29	2	265	47	409	480	6.80E-13	74.7	TRM2B_DANRE	reviewed	tRNA (uracil(54)-C(5))-methyltransferase homolog-B (EC 2.1.1.35) (TRM2 homolog B)	trmt2b si:dkeyp-115d2.4 zgc:162982	Danio rerio (Zebrafish) (Brachydanio rerio)	480	S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]		S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]	GO:0030697			NA	NA	NA	NA	NA	NA
TRINITY_DN3819_c0_g1_i4	Q8IZ69	TRM2A_HUMAN	43.9	342	190	1	1418	399	257	598	1.30E-82	308.5	TRM2A_HUMAN	reviewed	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	TRMT2A HTF9C	Homo sapiens (Human)	625	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]	GO:0003723; GO:0006396; GO:0008173	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN3819_c0_g1_i5	Q8IZ69	TRM2A_HUMAN	43.9	342	190	1	1419	400	257	598	1.30E-82	308.5	TRM2A_HUMAN	reviewed	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	TRMT2A HTF9C	Homo sapiens (Human)	625	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]	GO:0003723; GO:0006396; GO:0008173	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN24464_c0_g1_i1	Q8IZ69	TRM2A_HUMAN	99.1	106	1	0	2	319	503	608	1.00E-56	220.3	TRM2A_HUMAN	reviewed	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	TRMT2A HTF9C	Homo sapiens (Human)	625	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]	GO:0003723; GO:0006396; GO:0008173	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN24464_c0_g1_i2	Q8IZ69	TRM2A_HUMAN	95	101	5	0	1	303	508	608	2.90E-53	208.8	TRM2A_HUMAN	reviewed	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	TRMT2A HTF9C	Homo sapiens (Human)	625	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]	GO:0003723; GO:0006396; GO:0008173	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN38167_c0_g1_i1	Q8IZ69	TRM2A_HUMAN	100	82	0	0	247	2	386	467	3.20E-42	171.8	TRM2A_HUMAN	reviewed	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	TRMT2A HTF9C	Homo sapiens (Human)	625	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]	GO:0003723; GO:0006396; GO:0008173	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN25504_c0_g1_i1	Q8BNV1	TRM2A_MOUSE	100	91	0	0	274	2	376	466	2.20E-47	189.1	TRM2A_MOUSE	reviewed	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	Trmt2a Htf9-c Htf9c	Mus musculus (Mouse)	574	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]	GO:0003723; GO:0006396; GO:0008173	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN12784_c0_g1_i1	Q80UN9	MOD5_MOUSE	41.9	217	119	3	744	94	216	425	9.40E-45	181.8	MOD5_MOUSE	reviewed	tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (tRNA isopentenyltransferase) (IPTase)	Trit1 Ipt	Mus musculus (Mouse)	467	mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tRNA dimethylallyltransferase activity [GO:0052381]; tRNA modification [GO:0006400]	mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tRNA dimethylallyltransferase activity [GO:0052381]	GO:0005524; GO:0005634; GO:0005739; GO:0006400; GO:0046872; GO:0052381	tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN25650_c0_g1_i1	Q66JJ4	TM10A_XENTR	44.3	183	96	4	557	15	98	276	5.40E-37	156	TM10A_XENTR	reviewed	tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A)	trmt10a rg9mtd2 TEgg011a17.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	334	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial tRNA processing [GO:0090646]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]	GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0009019; GO:0052905; GO:0090646	mitochondrial tRNA processing [GO:0090646]		NA	NA	NA	NA	NA	NA
TRINITY_DN5344_c0_g1_i2	Q501Z5	GTPB3_DANRE	44.9	519	206	7	181	1659	36	500	2.50E-109	397.5	GTPB3_DANRE	reviewed	"tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3)"	gtpbp3 zgc:112394	Danio rerio (Zebrafish) (Brachydanio rerio)	500	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0048568	embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5344_c0_g1_i3	Q501Z5	GTPB3_DANRE	47.3	465	188	5	92	1471	88	500	3.10E-106	387.1	GTPB3_DANRE	reviewed	"tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3)"	gtpbp3 zgc:112394	Danio rerio (Zebrafish) (Brachydanio rerio)	500	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0048568	embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5344_c0_g1_i4	Q501Z5	GTPB3_DANRE	48.4	519	209	6	181	1722	36	500	4.60E-122	439.9	GTPB3_DANRE	reviewed	"tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3)"	gtpbp3 zgc:112394	Danio rerio (Zebrafish) (Brachydanio rerio)	500	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0048568	embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN5344_c0_g1_i5	Q501Z5	GTPB3_DANRE	32.4	272	127	5	84	884	281	500	2.70E-28	127.5	GTPB3_DANRE	reviewed	"tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3)"	gtpbp3 zgc:112394	Danio rerio (Zebrafish) (Brachydanio rerio)	500	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0048568	embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]		brown	brown	NA	NA	NA	NA
TRINITY_DN26400_c0_g1_i1	Q1GP64	MNME_SPHAL	76.5	68	16	0	4	207	38	105	5.90E-21	100.9	MNME_SPHAL	reviewed	tRNA modification GTPase MnmE (EC 3.6.-.-)	mnmE trmE Sala_2853	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	419	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0005737; GO:0006400; GO:0046872	tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN32566_c0_g1_i1	Q1GP64	MNME_SPHAL	67.1	82	27	0	2	247	62	143	2.10E-20	99.4	MNME_SPHAL	reviewed	tRNA modification GTPase MnmE (EC 3.6.-.-)	mnmE trmE Sala_2853	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	419	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0005737; GO:0006400; GO:0046872	tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN31777_c0_g1_i1	Q2GC37	MNME_NOVAD	87.2	94	12	0	285	4	63	156	1.90E-38	159.5	MNME_NOVAD	reviewed	tRNA modification GTPase MnmE (EC 3.6.-.-)	mnmE trmE Saro_0137	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	437	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0003924; GO:0005525; GO:0005737; GO:0006400; GO:0046872	tRNA modification [GO:0006400]		NA	NA	NA	NA	NA	NA
TRINITY_DN28457_c0_g1_i1	B8GPT9	TSAD_THISH	53.9	89	38	1	267	1	95	180	1.60E-18	93.2	TSAD_THISH	reviewed	tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein TsaD) (tRNA threonylcarbamoyladenosine biosynthesis protein TsaD)	tsaD gcp Tgr7_3016	Thioalkalivibrio sulfidiphilus (strain HL-EbGR7)	336	cytoplasm [GO:0005737]; iron ion binding [GO:0005506]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	cytoplasm [GO:0005737]	iron ion binding [GO:0005506]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0002949; GO:0005506; GO:0005737; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN27621_c0_g1_i1	B2U928	TSAD_RALPJ	98.8	84	1	0	1	252	93	176	8.10E-41	167.2	TSAD_RALPJ	reviewed	tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein TsaD) (tRNA threonylcarbamoyladenosine biosynthesis protein TsaD)	tsaD gcp Rpic_2424	Ralstonia pickettii (strain 12J)	347	cytoplasm [GO:0005737]; iron ion binding [GO:0005506]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	cytoplasm [GO:0005737]	iron ion binding [GO:0005506]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0002949; GO:0005506; GO:0005737; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	NA
TRINITY_DN35172_c0_g1_i1	Q1GP42	TSAD_SPHAL	91.7	84	7	0	261	10	98	181	6.70E-38	157.5	TSAD_SPHAL	reviewed	tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein TsaD) (tRNA threonylcarbamoyladenosine biosynthesis protein TsaD)	tsaD gcp Sala_2875	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	344	cytoplasm [GO:0005737]; iron ion binding [GO:0005506]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	cytoplasm [GO:0005737]	iron ion binding [GO:0005506]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0002949; GO:0005506; GO:0005737; GO:0061711	tRNA threonylcarbamoyladenosine modification [GO:0002949]		NA	NA	NA	NA	NA	1
TRINITY_DN31494_c0_g1_i1	Q3MIT2	PUS10_HUMAN	40.8	71	42	0	1	213	449	519	1.20E-11	70.1	PUS10_HUMAN	reviewed	tRNA pseudouridine synthase Pus10 (Hup10) (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase)	PUS10 CCDC139 DOBI	Homo sapiens (Human)	529	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]	GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029	primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN3145_c2_g3_i1	Q3SX07	PUS3_BOVIN	39.3	394	198	6	492	1667	83	437	2.30E-73	278.1	PUS3_BOVIN	reviewed	tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3)	PUS3	Bos taurus (Bovine)	481	cytoplasm [GO:0005737]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]	GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0106029; GO:1990481	mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN3145_c2_g3_i1	Q3SX07	PUS3_BOVIN	50.5	103	50	1	187	495	12	113	2.50E-19	98.6	PUS3_BOVIN	reviewed	tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3)	PUS3	Bos taurus (Bovine)	481	cytoplasm [GO:0005737]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]	GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0106029; GO:1990481	mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN3145_c2_g3_i2	Q3SX07	PUS3_BOVIN	43.1	466	225	6	187	1584	12	437	2.50E-101	370.9	PUS3_BOVIN	reviewed	tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3)	PUS3	Bos taurus (Bovine)	481	cytoplasm [GO:0005737]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]	GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0106029; GO:1990481	mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]		NA	NA	NA	NA	NA	NA
TRINITY_DN1314_c0_g1_i1	Q80VC6	TSAP1_MOUSE	50.3	193	87	4	635	63	4	189	1.60E-44	181	TSAP1_MOUSE	reviewed	tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1)	Trnau1ap Secp43 Trspap1	Mus musculus (Mouse)	287	cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	tRNA binding [GO:0000049]	GO:0000049; GO:0001514; GO:0005634; GO:0005737	selenocysteine incorporation [GO:0001514]		blue	blue	NA	NA	NA	NA
TRINITY_DN27636_c0_g1_i1	Q2GC38	MNMG_NOVAD	85.5	83	12	0	250	2	332	414	8.20E-33	140.6	MNMG_NOVAD	reviewed	tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A)	mnmG gidA Saro_0136	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	619	cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005737; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN26436_c0_g1_i1	Q2N6I8	MNMG_ERYLH	89	82	9	0	7	252	2	83	3.50E-36	151.8	MNMG_ERYLH	reviewed	tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A)	mnmG gidA ELI_13055	Erythrobacter litoralis (strain HTCC2594)	621	cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005737; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN28110_c0_g1_i1	B2UGW0	MNMG_RALPJ	98.6	71	1	0	1	213	333	403	6.20E-34	144.1	MNMG_RALPJ	reviewed	tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A)	mnmG gidA Rpic_3523	Ralstonia pickettii (strain 12J)	649	cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005737; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN28110_c0_g1_i2	B2UGW0	MNMG_RALPJ	99.1	109	1	0	1	327	333	441	1.80E-56	219.5	MNMG_RALPJ	reviewed	tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A)	mnmG gidA Rpic_3523	Ralstonia pickettii (strain 12J)	649	cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005737; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN25790_c0_g1_i1	Q2GC38	MNMG_NOVAD	75	100	25	0	301	2	4	103	1.70E-36	153.3	MNMG_NOVAD	reviewed	tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (Glucose-inhibited division protein A)	mnmG gidA Saro_0136	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	619	cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]	flavin adenine dinucleotide binding [GO:0050660]	GO:0002098; GO:0005737; GO:0050660	tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	1
TRINITY_DN2026_c0_g2_i1	Q9NUP7	TRM13_HUMAN	32.4	148	95	3	486	926	136	279	1.10E-14	82.8	TRM13_HUMAN	reviewed	tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76)	TRMT13 CCDC76	Homo sapiens (Human)	481	metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]		metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]	GO:0008175; GO:0030488; GO:0046872; GO:0106050	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2026_c0_g2_i1	Q9NUP7	TRM13_HUMAN	35.9	117	70	2	115	459	19	132	3.00E-12	74.7	TRM13_HUMAN	reviewed	tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76)	TRMT13 CCDC76	Homo sapiens (Human)	481	metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]		metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]	GO:0008175; GO:0030488; GO:0046872; GO:0106050	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2026_c0_g2_i3	Q9NUP7	TRM13_HUMAN	49	49	22	1	115	261	19	64	1.40E-06	54.3	TRM13_HUMAN	reviewed	tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76)	TRMT13 CCDC76	Homo sapiens (Human)	481	metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]		metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]	GO:0008175; GO:0030488; GO:0046872; GO:0106050	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2026_c0_g2_i6	Q9NUP7	TRM13_HUMAN	30.4	467	266	7	115	1386	19	469	4.40E-54	213.8	TRM13_HUMAN	reviewed	tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76)	TRMT13 CCDC76	Homo sapiens (Human)	481	metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]		metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]	GO:0008175; GO:0030488; GO:0046872; GO:0106050	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2342_c0_g1_i1	Q9D7B1	DUS2L_MOUSE	47	445	220	5	87	1412	4	435	8.30E-106	385.6	DUS2L_MOUSE	reviewed	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (EC 1.3.1.91) (Dihydrouridine synthase 2) (tRNA-dihydrouridine synthase 2-like)	Dus2 Dus2l	Mus musculus (Mouse)	493	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0002943; GO:0003725; GO:0004860; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0060548; GO:0070402; GO:0102264	negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]		blue	blue	NA	NA	NA	NA
TRINITY_DN28829_c0_g1_i1	Q91XI1	DUS3L_MOUSE	100	100	0	0	300	1	465	564	2.80E-56	218.8	DUS3L_MOUSE	reviewed	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)	Dus3l	Mus musculus (Mouse)	637	flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]		flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0017150; GO:0046872; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN5123_c0_g1_i1	Q91XI1	DUS3L_MOUSE	69.1	55	16	1	37	201	451	504	1.60E-17	89.7	DUS3L_MOUSE	reviewed	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)	Dus3l	Mus musculus (Mouse)	637	flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]		flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0017150; GO:0046872; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN5123_c0_g1_i2	Q28BT8	DUS3L_XENTR	63.3	395	141	3	186	1367	247	638	9.40E-150	531.6	DUS3L_XENTR	reviewed	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)	dus3l TNeu105e03.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	639	flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]		flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0017150; GO:0046872; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN25600_c0_g1_i1	Q96G46	DUS3L_HUMAN	53.4	103	48	0	310	2	297	399	5.10E-28	125.2	DUS3L_HUMAN	reviewed	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)	DUS3L	Homo sapiens (Human)	650	flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]		flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0003723; GO:0017150; GO:0046872; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN33118_c0_g1_i1	Q96G46	DUS3L_HUMAN	100	91	0	0	275	3	440	530	2.50E-48	192.2	DUS3L_HUMAN	reviewed	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)	DUS3L	Homo sapiens (Human)	650	flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]		flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0003723; GO:0017150; GO:0046872; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN34619_c0_g1_i1	Q28BT8	DUS3L_XENTR	56.9	211	82	3	688	59	436	638	1.80E-66	253.8	DUS3L_XENTR	reviewed	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)	dus3l TNeu105e03.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	639	flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]		flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0017150; GO:0046872; GO:0050660			NA	NA	NA	NA	NA	NA
TRINITY_DN12709_c0_g1_i1	Q9BSV6	SEN34_HUMAN	34.6	133	77	3	379	2	177	306	1.90E-13	77	SEN34_HUMAN	reviewed	tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34)	TSEN34 LENG5 SEN34	Homo sapiens (Human)	310	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]	lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]	GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0006388; GO:0006397; GO:0016829	"mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2106_c0_g1_i1	O01479	TMOD_CAEEL	36.1	330	205	3	96	1067	30	359	5.10E-52	206.5	TMOD_CAEEL	reviewed	Tropomodulin (Tmod-like protein) (cTmd1) (Uncoordinated protein 94)	unc-94 tmd-1 C06A5.7	Caenorhabditis elegans	392	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; terminal web [GO:1990357]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; negative regulation of actin filament depolymerization [GO:0030835]; nematode larval development [GO:0002119]; pointed-end actin filament capping [GO:0051694]; sarcomere organization [GO:0045214]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; terminal web [GO:1990357]	actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]	GO:0002119; GO:0005523; GO:0005737; GO:0005856; GO:0005865; GO:0007015; GO:0009792; GO:0030016; GO:0030239; GO:0030835; GO:0040011; GO:0045214; GO:0051015; GO:0051694; GO:0071689; GO:1990357	actin filament organization [GO:0007015]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; negative regulation of actin filament depolymerization [GO:0030835]; nematode larval development [GO:0002119]; pointed-end actin filament capping [GO:0051694]; sarcomere organization [GO:0045214]		blue	blue	NA	NA	NA	NA
TRINITY_DN21298_c0_g1_i1	A4URH3	TPM_ERISI	96.3	27	1	0	164	84	258	284	2.00E-07	56.2	TPM_ERISI	reviewed	Tropomyosin (allergen Eri s 1.0101)		Eriocheir sinensis (Chinese mitten crab)	284	protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]		protein homodimerization activity [GO:0042803]	GO:0006937; GO:0042803	regulation of muscle contraction [GO:0006937]		blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i8	Q25456	TPM_METEN	100	45	0	0	85	219	71	115	3.60E-14	79.3	TPM_METEN	reviewed	Tropomyosin (Allergen Met e I) (allergen Met e 1)		Metapenaeus ensis (Greasyback shrimp) (Penaeus ensis)	274							NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i3	P86704	TPM_PANBO	63.3	248	50	1	142	885	78	284	1.60E-65	251.1	TPM_PANBO	reviewed	Tropomyosin (allergen Pan b 1)	TM1	Pandalus borealis (Northern red shrimp)	284							blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i1	A2V735	TPM_CHIOP	64	325	76	1	88	1062	1	284	2.30E-87	323.9	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	1
TRINITY_DN3593_c0_g1_i14	A2V735	TPM_CHIOP	65.3	245	44	1	151	885	81	284	1.40E-67	258.1	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i15	A2V735	TPM_CHIOP	83	223	35	1	37	696	62	284	9.20E-83	308.1	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i16	A2V735	TPM_CHIOP	74.8	325	41	1	88	1062	1	284	5.60E-97	355.9	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i2	A2V735	TPM_CHIOP	66.8	325	67	1	88	1062	1	284	1.60E-91	337.8	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	1
TRINITY_DN3593_c0_g1_i20	A2V735	TPM_CHIOP	90.1	284	28	0	88	939	1	284	3.40E-109	396.4	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i22	A2V735	TPM_CHIOP	81.6	125	23	0	88	462	1	125	3.40E-38	159.8	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i23	A2V735	TPM_CHIOP	64.9	325	73	1	88	1062	1	284	2.10E-88	327.4	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i24	A2V735	TPM_CHIOP	72	325	50	1	88	1062	1	284	8.30E-93	342	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i25	A2V735	TPM_CHIOP	100	27	0	0	78	158	258	284	8.90E-08	57.4	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i5	A2V735	TPM_CHIOP	60.2	264	61	2	37	819	62	284	1.00E-64	248.4	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i12	A2V735	TPM_CHIOP	93.3	223	12	1	37	696	62	284	2.50E-88	326.6	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			blue	blue	1	NA	1	1
TRINITY_DN3593_c0_g1_i4	A2V735	TPM_CHIOP	81	284	54	0	88	939	1	284	9.50E-104	378.3	TPM_CHIOP	reviewed	"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)"	TM1	Chionoecetes opilio (Crab-beetle)	284	protein homodimerization activity [GO:0042803]		protein homodimerization activity [GO:0042803]	GO:0042803			NA	NA	1	NA	NA	NA
TRINITY_DN11890_c0_g1_i1	P84335	TPM1_CHEAU	58.1	167	69	1	502	2	75	240	1.90E-23	110.5	TPM1_CHEAU	reviewed	Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)		Chelon auratus (Golden grey mullet) (Liza aurata)	284	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0015629; GO:0042802; GO:0042803; GO:0046982; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN11890_c0_g1_i2	P84335	TPM1_CHEAU	58.1	167	69	1	502	2	75	240	1.90E-23	110.5	TPM1_CHEAU	reviewed	Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)		Chelon auratus (Golden grey mullet) (Liza aurata)	284	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0015629; GO:0042802; GO:0042803; GO:0046982; GO:0051015			NA	NA	NA	NA	NA	NA
TRINITY_DN39577_c0_g1_i1	P09493	TPM1_HUMAN	84.9	152	23	0	458	3	87	238	2.60E-53	209.5	TPM1_HUMAN	reviewed	Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)	TPM1 C15orf13 TMSA	Homo sapiens (Human)	284	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]	GO:0001701; GO:0001725; GO:0003065; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005862; GO:0005884; GO:0006936; GO:0006937; GO:0007010; GO:0007015; GO:0008016; GO:0008092; GO:0008307; GO:0008360; GO:0015629; GO:0030017; GO:0030049; GO:0030336; GO:0031529; GO:0032059; GO:0032587; GO:0032781; GO:0034614; GO:0042060; GO:0042802; GO:0042803; GO:0045214; GO:0045785; GO:0046982; GO:0051015; GO:0051496; GO:0055010; GO:0060048; GO:1904706; GO:1904753	actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN21518_c0_g2_i1	Q6IRU2	TPM4_MOUSE	82.9	158	27	0	2	475	23	180	8.00E-54	211.5	TPM4_MOUSE	reviewed	Tropomyosin alpha-4 chain (Tropomyosin-4)	Tpm4	Mus musculus (Mouse)	248	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; podosome [GO:0002102]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; podosome [GO:0002102]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001725; GO:0002102; GO:0005737; GO:0005884; GO:0006936; GO:0007015; GO:0015629; GO:0030863; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0051015	actin filament organization [GO:0007015]; muscle contraction [GO:0006936]		NA	NA	NA	NA	NA	NA
TRINITY_DN21518_c0_g1_i1	Q6IRU2	TPM4_MOUSE	77.2	158	36	0	2	475	23	180	1.50E-36	154.1	TPM4_MOUSE	reviewed	Tropomyosin alpha-4 chain (Tropomyosin-4)	Tpm4	Mus musculus (Mouse)	248	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; podosome [GO:0002102]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; podosome [GO:0002102]; stress fiber [GO:0001725]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0001725; GO:0002102; GO:0005737; GO:0005884; GO:0006936; GO:0007015; GO:0015629; GO:0030863; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0051015	actin filament organization [GO:0007015]; muscle contraction [GO:0006936]		NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i17	Q3Y8M6	TPM_PENAT	58.2	268	67	2	28	819	58	284	9.10E-63	241.9	TPM_PENAT	reviewed	Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102)		Penaeus aztecus (Brown shrimp) (Farfantepenaeus aztecus)	284	IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]		IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]	GO:0006937; GO:0019863; GO:0042803	regulation of muscle contraction [GO:0006937]		blue	blue	NA	NA	NA	NA
TRINITY_DN3593_c0_g1_i18	Q3Y8M6	TPM_PENAT	69.4	268	37	2	28	819	58	284	1.80E-71	270.8	TPM_PENAT	reviewed	Tropomyosin Pen a 1.0102 (Allergen Pen a 1) (Tropomyosin Pen a 1) (allergen Pen a 1.0102)		Penaeus aztecus (Brown shrimp) (Farfantepenaeus aztecus)	284	IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]; regulation of muscle contraction [GO:0006937]		IgE binding [GO:0019863]; protein homodimerization activity [GO:0042803]	GO:0006937; GO:0019863; GO:0042803	regulation of muscle contraction [GO:0006937]		NA	NA	NA	NA	NA	NA
TRINITY_DN39981_c0_g1_i1	P15159	TNNC_TACTR	56.5	69	30	0	209	3	38	106	2.00E-14	79.3	TNNC_TACTR	reviewed	Troponin C		Tachypleus tridentatus (Japanese horseshoe crab)	153	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			NA	NA	NA	NA	NA	NA
TRINITY_DN33596_c0_g1_i1	P21798	TNNC2_BALNU	64.4	149	53	0	41	487	3	151	1.40E-47	190.7	TNNC2_BALNU	reviewed	"Troponin C, isoform 2"		Balanus nubilus (Giant acorn barnacle)	151	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			NA	NA	NA	NA	NA	NA
TRINITY_DN1704_c0_g1_i1	P29291	TNNCB_HOMAM	87.2	149	19	0	463	17	2	150	1.00E-65	250.8	TNNCB_HOMAM	reviewed	"Troponin C, isoform 2B"		Homarus americanus (American lobster)	150	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			NA	NA	NA	NA	NA	NA
TRINITY_DN5255_c0_g1_i1	P06708	TNNC2_ASTLP	87.3	150	19	0	65	514	1	150	1.20E-68	260.8	TNNC2_ASTLP	reviewed	"Troponin C, isotype gamma"		Astacus leptodactylus (Turkish narrow-clawed crayfish) (Pontastacus leptodactylus)	150	calcium ion binding [GO:0005509]		calcium ion binding [GO:0005509]	GO:0005509			blue	blue	NA	NA	NA	1
TRINITY_DN14509_c0_g1_i3	P19351	TNNT_DROME	59.3	177	72	0	22	552	138	314	1.50E-39	164.1	TNNT_DROME	reviewed	"Troponin T, skeletal muscle (Protein intended thorax) (Protein upheld)"	up int CG7107	Drosophila melanogaster (Fruit fly)	397	striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]; calcium ion binding [GO:0005509]; tropomyosin binding [GO:0005523]; cellular calcium ion homeostasis [GO:0006874]; mesoderm development [GO:0007498]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ morphogenesis [GO:0048644]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; sarcomere organization [GO:0045214]	striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]	calcium ion binding [GO:0005509]; tropomyosin binding [GO:0005523]	GO:0005509; GO:0005523; GO:0005861; GO:0005865; GO:0006874; GO:0006936; GO:0007005; GO:0007498; GO:0010882; GO:0030239; GO:0045214; GO:0046716; GO:0048644; GO:0071689	cellular calcium ion homeostasis [GO:0006874]; mesoderm development [GO:0007498]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ morphogenesis [GO:0048644]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; sarcomere organization [GO:0045214]		NA	NA	1	NA	NA	1
TRINITY_DN14509_c0_g1_i1	P19351	TNNT_DROME	61	177	69	0	22	552	138	314	1.00E-40	167.9	TNNT_DROME	reviewed	"Troponin T, skeletal muscle (Protein intended thorax) (Protein upheld)"	up int CG7107	Drosophila melanogaster (Fruit fly)	397	striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]; calcium ion binding [GO:0005509]; tropomyosin binding [GO:0005523]; cellular calcium ion homeostasis [GO:0006874]; mesoderm development [GO:0007498]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ morphogenesis [GO:0048644]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; sarcomere organization [GO:0045214]	striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]	calcium ion binding [GO:0005509]; tropomyosin binding [GO:0005523]	GO:0005509; GO:0005523; GO:0005861; GO:0005865; GO:0006874; GO:0006936; GO:0007005; GO:0007498; GO:0010882; GO:0030239; GO:0045214; GO:0046716; GO:0048644; GO:0071689	cellular calcium ion homeostasis [GO:0006874]; mesoderm development [GO:0007498]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle contraction [GO:0006936]; muscle organ morphogenesis [GO:0048644]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; sarcomere organization [GO:0045214]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g1_i3	Q7K556	TTD14_DROME	58.7	150	61	1	770	324	299	448	8.80E-46	185.3	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i10	Q7K556	TTD14_DROME	64.4	45	15	1	82	216	252	295	3.40E-07	56.6	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i11	Q7K556	TTD14_DROME	70.8	233	67	1	119	817	64	295	4.10E-99	362.8	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i13	Q7K556	TTD14_DROME	66.1	386	129	2	119	1273	64	448	3.30E-155	549.7	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i14	Q7K556	TTD14_DROME	64.4	45	15	1	82	216	252	295	2.60E-07	56.6	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i16	Q7K556	TTD14_DROME	60.1	198	77	2	82	672	252	448	3.50E-63	243.4	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i17	Q7K556	TTD14_DROME	64.3	42	14	1	1	126	255	295	3.00E-06	52.8	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i5	Q7K556	TTD14_DROME	66.1	386	129	2	119	1273	64	448	3.70E-155	549.7	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN894_c0_g2_i3	Q7K556	TTD14_DROME	64.3	42	14	1	1	126	255	295	4.10E-06	52.8	TTD14_DROME	reviewed	TRPL translocation defect protein 14	Ttd14 CG30118	Drosophila melanogaster (Fruit fly)	475	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	cytosol [GO:0005829]	GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]		brown	brown	1	NA	NA	NA
TRINITY_DN40486_c0_g1_i1	O97399	TRYP_PHACE	49.2	61	31	0	18	200	97	157	7.60E-08	57.8	TRYP_PHACE	reviewed	Trypsin (EC 3.4.21.4)		Phaedon cochleariae (Mustard beetle)	258	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0007586	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN2223_c0_g1_i2	P00764	TRYP_SQUAC	40	235	126	5	823	119	3	222	2.30E-43	177.6	TRYP_SQUAC	reviewed	Trypsin (EC 3.4.21.4)		Squalus acanthias (Spiny dogfish)	229	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN31769_c0_g1_i1	P24664	TRYP_SACER	51.5	68	32	1	1	204	153	219	5.50E-12	71.2	TRYP_SACER	reviewed	Trypsin (EC 3.4.21.4) (SET)		Saccharopolyspora erythraea (Streptomyces erythraeus)	227	serine-type endopeptidase activity [GO:0004252]		serine-type endopeptidase activity [GO:0004252]	GO:0004252			NA	NA	NA	NA	NA	NA
TRINITY_DN35714_c0_g1_i4	P35035	TRY1_ANOGA	56.8	74	27	2	493	272	204	272	1.40E-18	94.4	TRY1_ANOGA	reviewed	Trypsin-1 (EC 3.4.21.4) (Antryp1)	TRYP1 AGAP008296	Anopheles gambiae (African malaria mosquito)	274	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0007586	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN11690_c0_g1_i13	P00765	TRYP_ASTAS	50.2	269	95	3	123	914	1	235	7.60E-68	258.8	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN11690_c0_g1_i4	P00765	TRYP_ASTAS	60	235	89	2	123	812	1	235	6.70E-76	285.4	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	1
TRINITY_DN11690_c0_g1_i5	P00765	TRYP_ASTAS	57.5	174	69	2	5	511	62	235	1.40E-47	190.7	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	1	1
TRINITY_DN11690_c0_g1_i8	P00765	TRYP_ASTAS	64.5	138	44	2	2	400	98	235	2.20E-43	176.4	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	NA	1
TRINITY_DN11690_c0_g1_i9	P00765	TRYP_ASTAS	53.4	174	76	2	5	511	62	235	1.30E-45	184.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN13976_c0_g1_i1	P00765	TRYP_ASTAS	66	53	18	0	159	1	1	53	2.50E-14	79.3	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN13976_c0_g1_i3	P00765	TRYP_ASTAS	66.7	51	17	0	159	7	1	51	6.80E-14	77.8	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	1	1
TRINITY_DN30864_c0_g1_i1	P00765	TRYP_ASTAS	47.6	82	40	1	239	3	1	82	5.20E-15	81.6	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	NA	NA
TRINITY_DN12711_c0_g1_i10	P00765	TRYP_ASTAS	60	235	89	2	766	77	1	235	1.70E-77	290.8	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN12711_c0_g1_i11	P00765	TRYP_ASTAS	61.3	235	86	2	774	85	1	235	1.90E-76	287.3	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN12711_c0_g1_i14	P00765	TRYP_ASTAS	61.3	235	86	2	774	85	1	235	1.90E-76	287.3	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	1	1
TRINITY_DN12711_c0_g1_i2	P00765	TRYP_ASTAS	60.4	235	88	2	766	77	1	235	2.80E-76	286.6	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	1	1
TRINITY_DN12711_c0_g1_i4	P00765	TRYP_ASTAS	60.4	235	88	2	774	85	1	235	6.60E-77	288.9	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN12711_c0_g1_i7	P00765	TRYP_ASTAS	60.4	235	88	2	774	85	1	235	6.60E-77	288.9	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	1	1
TRINITY_DN12711_c0_g1_i9	P00765	TRYP_ASTAS	60.1	178	66	2	595	77	58	235	2.00E-53	210.3	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	1
TRINITY_DN11690_c0_g1_i12	P00765	TRYP_ASTAS	57	235	96	2	123	812	1	235	1.60E-72	274.2	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	1	NA	NA	NA
TRINITY_DN11690_c0_g1_i6	P00765	TRYP_ASTAS	60.7	107	38	1	5	313	129	235	3.30E-34	145.6	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	1	NA	1	1
TRINITY_DN11690_c0_g1_i7	P00765	TRYP_ASTAS	52.8	269	88	3	123	914	1	235	6.20E-70	265.8	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	1	NA	NA	1
TRINITY_DN12711_c0_g1_i13	P00765	TRYP_ASTAS	62.2	156	54	2	537	85	80	235	5.90E-49	195.3	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	1	NA	NA	NA
TRINITY_DN12711_c0_g1_i5	P00765	TRYP_ASTAS	60.3	209	78	2	688	77	27	235	2.10E-67	256.9	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	1	NA	NA	NA
TRINITY_DN13019_c0_g1_i1	P00765	TRYP_ASTAS	61.9	126	44	1	1	366	107	232	1.60E-39	163.7	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	1	1
TRINITY_DN35714_c0_g1_i3	P00765	TRYP_ASTAS	49.5	91	42	2	1	261	145	235	1.60E-19	97.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN21704_c0_g1_i2	P00765	TRYP_ASTAS	52.2	69	30	2	308	102	168	233	6.00E-13	75.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN21704_c0_g1_i3	P00765	TRYP_ASTAS	52.2	69	30	2	308	102	168	233	6.00E-13	75.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN21704_c0_g1_i5	P00765	TRYP_ASTAS	52.2	69	30	2	308	102	168	233	6.00E-13	75.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN11737_c0_g2_i1	P00765	TRYP_ASTAS	57.6	92	35	3	339	73	145	235	1.40E-22	107.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN1845_c1_g1_i1	P00765	TRYP_ASTAS	64.4	101	32	1	494	204	136	236	9.40E-33	141.4	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		black	black	NA	NA	NA	NA
TRINITY_DN1845_c1_g1_i2	P00765	TRYP_ASTAS	64.4	101	32	1	591	301	136	236	1.10E-32	141.4	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN1845_c1_g1_i7	P00765	TRYP_ASTAS	64.4	101	32	1	689	399	136	236	1.30E-32	141.4	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i1	P00765	TRYP_ASTAS	40.6	138	66	5	440	27	112	233	5.40E-20	99	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN793_c0_g1_i4	P00765	TRYP_ASTAS	56.2	64	25	2	218	27	173	233	1.20E-14	80.1	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		blue	blue	NA	NA	NA	NA
TRINITY_DN2223_c0_g1_i1	P00765	TRYP_ASTAS	55.1	107	43	2	418	110	130	235	1.10E-27	124.4	TRYP_ASTAS	reviewed	Trypsin-1 (EC 3.4.21.4) (Trypsin I)		Astacus astacus (Noble crayfish) (Astacus fluviatilis)	237	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586; GO:0046872	digestion [GO:0007586]		NA	NA	NA	NA	NA	NA
TRINITY_DN11737_c0_g1_i1	P15944	TRYT_CANLF	50	62	31	0	193	8	210	271	5.00E-16	84.7	TRYT_CANLF	reviewed	Tryptase (EC 3.4.21.59)		Canis lupus familiaris (Dog) (Canis familiaris)	275	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508	proteolysis [GO:0006508]		brown	brown	1	NA	NA	NA
TRINITY_DN1442_c0_g1_i1	Q9XSM2	TRYT_SHEEP	59	61	25	0	263	81	205	265	3.80E-17	88.6	TRYT_SHEEP	reviewed	Tryptase-2 (EC 3.4.21.59)		Ovis aries (Sheep)	273	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]	extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576			blue	blue	NA	NA	NA	NA
TRINITY_DN5286_c0_g1_i1	B4MSH7	T23O_DROWI	69.5	151	46	0	695	243	225	375	2.70E-57	223.4	T23O_DROWI	reviewed	"Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Protein vermilion) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)"	v GK19977	Drosophila willistoni (Fruit fly)	380	"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; ommochrome biosynthetic process [GO:0006727]; positive regulation of neuron death [GO:1901216]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441]"		"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]"	GO:0004833; GO:0006727; GO:0019441; GO:0020037; GO:0046872; GO:0051289; GO:1901216	ommochrome biosynthetic process [GO:0006727]; positive regulation of neuron death [GO:1901216]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441]		pink	pink	NA	NA	NA	NA
TRINITY_DN4151_c0_g2_i1	B4M818	T23O_DROVI	60.1	218	78	4	2	637	2	216	7.80E-64	245	T23O_DROVI	reviewed	"Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Protein vermilion) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)"	v GJ16721	Drosophila virilis (Fruit fly)	380	"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; ommochrome biosynthetic process [GO:0006727]; tryptophan catabolic process to kynurenine [GO:0019441]"		"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]"	GO:0004833; GO:0006727; GO:0019441; GO:0020037; GO:0046872	ommochrome biosynthetic process [GO:0006727]; tryptophan catabolic process to kynurenine [GO:0019441]		NA	NA	NA	NA	NA	NA
TRINITY_DN28713_c0_g1_i1	P17752	TPH1_HUMAN	93.2	44	3	0	53	184	225	268	8.50E-20	97.1	TPH1_HUMAN	reviewed	Tryptophan 5-hydroxylase 1 (EC 1.14.16.4) (Tryptophan 5-monooxygenase 1)	TPH1 TPH TPRH TRPH	Homo sapiens (Human)	444	cytosol [GO:0005829]; neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; bone remodeling [GO:0046849]; circadian rhythm [GO:0007623]; indolalkylamine biosynthetic process [GO:0046219]; mammary gland alveolus development [GO:0060749]; negative regulation of ossification [GO:0030279]; positive regulation of fat cell differentiation [GO:0045600]; response to immobilization stress [GO:0035902]; serotonin biosynthetic process [GO:0042427]	cytosol [GO:0005829]; neuron projection [GO:0043005]	iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004510; GO:0005506; GO:0005829; GO:0007623; GO:0009072; GO:0030279; GO:0035902; GO:0042427; GO:0043005; GO:0045600; GO:0046219; GO:0046849; GO:0060749	aromatic amino acid family metabolic process [GO:0009072]; bone remodeling [GO:0046849]; circadian rhythm [GO:0007623]; indolalkylamine biosynthetic process [GO:0046219]; mammary gland alveolus development [GO:0060749]; negative regulation of ossification [GO:0030279]; positive regulation of fat cell differentiation [GO:0045600]; response to immobilization stress [GO:0035902]; serotonin biosynthetic process [GO:0042427]		NA	NA	NA	NA	NA	NA
TRINITY_DN27852_c0_g1_i1	Q0EAB8	TPH2_HORSE	67.7	62	20	0	187	2	335	396	1.90E-19	95.9	TPH2_HORSE	reviewed	Tryptophan 5-hydroxylase 2 (EC 1.14.16.4) (Tryptophan 5-monooxygenase 2)	TPH2	Equus caballus (Horse)	491	neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; serotonin biosynthetic process [GO:0042427]	neuron projection [GO:0043005]	iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004510; GO:0005506; GO:0009072; GO:0042427; GO:0043005	aromatic amino acid family metabolic process [GO:0009072]; serotonin biosynthetic process [GO:0042427]		NA	NA	NA	NA	NA	NA
TRINITY_DN12771_c0_g1_i1	Q89W91	SYW_BRADU	67.7	99	25	1	279	4	95	193	1.30E-31	136.7	SYW_BRADU	reviewed	Tryptophan--tRNA ligase (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS)	trpS bll0802	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	350	cytosol [GO:0005829]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytosol [GO:0005829]	ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0004830; GO:0005524; GO:0005829; GO:0006436	tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN12771_c0_g2_i1	Q89W91	SYW_BRADU	68.3	101	22	1	274	2	106	206	1.50E-32	139.8	SYW_BRADU	reviewed	Tryptophan--tRNA ligase (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS)	trpS bll0802	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	350	cytosol [GO:0005829]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytosol [GO:0005829]	ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0004830; GO:0005524; GO:0005829; GO:0006436	tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN12771_c0_g2_i2	Q89W91	SYW_BRADU	62.9	97	26	1	263	3	106	202	4.80E-28	124.8	SYW_BRADU	reviewed	Tryptophan--tRNA ligase (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS)	trpS bll0802	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	350	cytosol [GO:0005829]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytosol [GO:0005829]	ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0004830; GO:0005524; GO:0005829; GO:0006436	tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN433_c0_g1_i1	P23381	SYWC_HUMAN	48.7	117	57	1	344	3	349	465	8.50E-25	114.4	SYWC_HUMAN	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	WARS1 IFI53 WARS WRS	Homo sapiens (Human)	471	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062	angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN3168_c0_g1_i1	P23381	SYWC_HUMAN	98.9	267	3	0	2	802	60	326	5.70E-157	554.7	SYWC_HUMAN	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	WARS1 IFI53 WARS WRS	Homo sapiens (Human)	471	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062	angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN3168_c0_g1_i2	P23381	SYWC_HUMAN	100	412	0	0	2	1237	60	471	2.00E-244	845.9	SYWC_HUMAN	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	WARS1 IFI53 WARS WRS	Homo sapiens (Human)	471	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062	angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN40562_c0_g1_i1	Q09692	SYWC_SCHPO	61.9	118	45	0	7	360	48	165	2.00E-40	166.4	SYWC_SCHPO	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS)"	wrs1 SPAC2F7.13c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	395	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; cytoplasmic translation [GO:0002181]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0002181; GO:0004830; GO:0005524; GO:0005737; GO:0005829; GO:0006436	cytoplasmic translation [GO:0002181]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN2802_c0_g1_i1	P17248	SYWC_BOVIN	70.2	410	113	3	231	1451	70	473	7.90E-163	575.1	SYWC_BOVIN	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	WARS1 WARS	Bos taurus (Bovine)	476	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006436; GO:0006469; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765	negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN2802_c0_g1_i2	P17248	SYWC_BOVIN	70.2	410	113	3	361	1581	70	473	6.60E-163	575.5	SYWC_BOVIN	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	WARS1 WARS	Bos taurus (Bovine)	476	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006436; GO:0006469; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765	negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN33498_c0_g1_i1	P32921	SYWC_MOUSE	100	86	0	0	258	1	203	288	6.60E-46	184.1	SYWC_MOUSE	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	Wars1 Wars Wrs	Mus musculus (Mouse)	481	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006436; GO:0006469; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765	angiogenesis [GO:0001525]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN35718_c0_g1_i1	Q6P7B0	SYWC_RAT	64.8	327	110	3	972	1	105	429	5.20E-120	432.2	SYWC_RAT	reviewed	"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"	Wars1 Wars	Rattus norvegicus (Rat)	481	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006436; GO:0006469; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765	angiogenesis [GO:0001525]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436]		NA	NA	NA	NA	NA	NA
TRINITY_DN32916_c0_g1_i2	Q9CYK1	SYWM_MOUSE	49.3	351	174	3	265	1314	13	360	4.10E-94	346.7	SYWM_MOUSE	reviewed	"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)"	Wars2	Mus musculus (Mouse)	360	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]	GO:0001570; GO:0004830; GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0006436; GO:0070183	mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN29698_c0_g1_i1	Q9Z2S7	T22D3_MOUSE	86.5	74	10	0	1	222	38	111	1.90E-25	115.9	T22D3_MOUSE	reviewed	TSC22 domain family protein 3 (Glucocorticoid-induced leucine zipper protein) (TSC22-related-inducible leucine zipper 3) (Tilz3)	Tsc22d3 Dsip1 Dsipi Gilz	Mus musculus (Mouse)	137	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; MRF binding [GO:0043426]; negative regulation of activation-induced cell death of T cells [GO:0070236]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to osmotic stress [GO:0006970]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; MRF binding [GO:0043426]	GO:0000122; GO:0003700; GO:0005634; GO:0005737; GO:0006970; GO:0043426; GO:0048642; GO:0070236	negative regulation of activation-induced cell death of T cells [GO:0070236]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to osmotic stress [GO:0006970]		NA	NA	NA	NA	NA	NA
TRINITY_DN5991_c0_g1_i1	P49816	TSC2_RAT	33.5	1095	597	20	3334	281	40	1080	4.00E-162	573.9	TSC2_RAT	reviewed	Tuberin (Tuberous sclerosis 2 protein homolog)	Tsc2	Rattus norvegicus (Rat)	1809	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]	GO:0001666; GO:0001843; GO:0001933; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005901; GO:0006469; GO:0006606; GO:0007165; GO:0007507; GO:0007568; GO:0008104; GO:0008285; GO:0010508; GO:0010719; GO:0010763; GO:0010976; GO:0014065; GO:0014067; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0019902; GO:0030010; GO:0030030; GO:0030100; GO:0030178; GO:0030425; GO:0030426; GO:0031267; GO:0032007; GO:0032869; GO:0032991; GO:0033596; GO:0034394; GO:0035176; GO:0042803; GO:0042995; GO:0043005; GO:0043025; GO:0043231; GO:0043276; GO:0043407; GO:0043491; GO:0044861; GO:0044877; GO:0045121; GO:0045184; GO:0045202; GO:0045785; GO:0045792; GO:0045944; GO:0046323; GO:0046626; GO:0046627; GO:0047485; GO:0048009; GO:0048147; GO:0048471; GO:0048550; GO:0050680; GO:0050771; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:0060999; GO:0071889; GO:0098978; GO:0099175; GO:1904262; GO:1905563	aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN5991_c0_g1_i2	P49816	TSC2_RAT	31.2	752	460	11	2314	80	40	741	2.40E-100	368.2	TSC2_RAT	reviewed	Tuberin (Tuberous sclerosis 2 protein homolog)	Tsc2	Rattus norvegicus (Rat)	1809	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]	GO:0001666; GO:0001843; GO:0001933; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005901; GO:0006469; GO:0006606; GO:0007165; GO:0007507; GO:0007568; GO:0008104; GO:0008285; GO:0010508; GO:0010719; GO:0010763; GO:0010976; GO:0014065; GO:0014067; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0019902; GO:0030010; GO:0030030; GO:0030100; GO:0030178; GO:0030425; GO:0030426; GO:0031267; GO:0032007; GO:0032869; GO:0032991; GO:0033596; GO:0034394; GO:0035176; GO:0042803; GO:0042995; GO:0043005; GO:0043025; GO:0043231; GO:0043276; GO:0043407; GO:0043491; GO:0044861; GO:0044877; GO:0045121; GO:0045184; GO:0045202; GO:0045785; GO:0045792; GO:0045944; GO:0046323; GO:0046626; GO:0046627; GO:0047485; GO:0048009; GO:0048147; GO:0048471; GO:0048550; GO:0050680; GO:0050771; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:0060999; GO:0071889; GO:0098978; GO:0099175; GO:1904262; GO:1905563	aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN5991_c0_g1_i5	Q61037	TSC2_MOUSE	35	391	241	5	1246	86	40	421	2.00E-64	248.1	TSC2_MOUSE	reviewed	Tuberin (Tuberous sclerosis 2 protein homolog)	Tsc2	Mus musculus (Mouse)	1814	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]	GO:0001666; GO:0001843; GO:0001933; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005856; GO:0005901; GO:0006469; GO:0006606; GO:0007165; GO:0007507; GO:0007568; GO:0008104; GO:0008285; GO:0010508; GO:0010719; GO:0010763; GO:0010976; GO:0014065; GO:0014067; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0019902; GO:0030010; GO:0030030; GO:0030100; GO:0030178; GO:0030425; GO:0030426; GO:0031267; GO:0032007; GO:0032869; GO:0032991; GO:0033596; GO:0034394; GO:0035176; GO:0042803; GO:0042995; GO:0043005; GO:0043025; GO:0043231; GO:0043276; GO:0043407; GO:0043491; GO:0044861; GO:0044877; GO:0045121; GO:0045184; GO:0045202; GO:0045785; GO:0045792; GO:0045944; GO:0046323; GO:0046626; GO:0046627; GO:0047485; GO:0048009; GO:0048147; GO:0048471; GO:0048550; GO:0050680; GO:0050771; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:0060999; GO:0071889; GO:0098978; GO:0099175; GO:1904262; GO:1905563	aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]		NA	NA	NA	NA	NA	NA
TRINITY_DN24183_c0_g1_i1	P49815	TSC2_HUMAN	50	58	27	1	32	199	1616	1673	1.10E-11	70.1	TSC2_HUMAN	reviewed	Tuberin (Tuberous sclerosis 2 protein)	TSC2 TSC4	Homo sapiens (Human)	1807	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]	GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0016020; GO:0016032; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525	anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN24183_c0_g1_i2	P49815	TSC2_HUMAN	50.6	77	36	1	1	225	1597	1673	2.40E-18	92.4	TSC2_HUMAN	reviewed	Tuberin (Tuberous sclerosis 2 protein)	TSC2 TSC4	Homo sapiens (Human)	1807	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]	GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0016020; GO:0016032; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525	anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN7571_c0_g1_i1	P49815	TSC2_HUMAN	46.7	210	109	3	2	628	1549	1756	4.30E-49	196.1	TSC2_HUMAN	reviewed	Tuberin (Tuberous sclerosis 2 protein)	TSC2 TSC4	Homo sapiens (Human)	1807	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TSC1-TSC2 complex [GO:0033596]	GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0016020; GO:0016032; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525	anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN54_c0_g1_i1	Q8SRI6	TBA_ENCCU	65.4	436	151	0	181	1488	1	436	4.10E-180	632.5	TBA_ENCCU	reviewed	Tubulin alpha chain	TUB1 ECU07_1190	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	441	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i17	P10872	TBA_TETPY	86.9	268	35	0	805	2	1	268	1.30E-140	500.4	TBA_TETPY	reviewed	Tubulin alpha chain		Tetrahymena pyriformis	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i18	P10872	TBA_TETPY	89.6	268	28	0	805	2	1	268	2.70E-144	512.7	TBA_TETPY	reviewed	Tubulin alpha chain		Tetrahymena pyriformis	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12653_c1_g1_i1	Q08114	TBA_EUPOC	94.5	109	6	0	328	2	336	444	5.70E-55	214.5	TBA_EUPOC	reviewed	Tubulin alpha chain		Euplotoides octocarinatus (Freshwater ciliate) (Euplotes octocarinatus)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12653_c0_g1_i1	Q08114	TBA_EUPOC	92.9	70	5	0	212	3	298	367	1.40E-35	149.8	TBA_EUPOC	reviewed	Tubulin alpha chain		Euplotoides octocarinatus (Freshwater ciliate) (Euplotes octocarinatus)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN38532_c0_g2_i1	P33625	TBA_EUGGR	90.7	108	10	0	325	2	26	133	1.70E-54	213	TBA_EUGGR	reviewed	Tubulin alpha chain	TUBA	Euglena gracilis	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN18310_c0_g1_i2	Q06331	TBA_ENTDO	97.2	71	2	0	3	215	136	206	4.00E-33	141.4	TBA_ENTDO	reviewed	Tubulin alpha chain		Enteroctopus dofleini (North Pacific giant octopus) (Octopus dofleini)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c2_g1_i10	Q8WQ47	TBA_LEPDS	93.1	450	31	0	115	1464	1	450	2.90E-253	875.5	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c2_g1_i18	Q8WQ47	TBA_LEPDS	92.9	450	32	0	115	1464	1	450	6.30E-253	874.4	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c0_g2_i3	Q8WQ47	TBA_LEPDS	77.6	76	16	1	330	103	1	75	1.00E-30	135.2	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c0_g2_i5	Q8WQ47	TBA_LEPDS	85.1	134	19	1	404	3	1	133	3.00E-65	250	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c0_g2_i6	Q8WQ47	TBA_LEPDS	85.1	134	19	1	404	3	1	133	3.40E-65	250	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN17138_c0_g3_i1	Q8WQ47	TBA_LEPDS	91.3	69	6	0	273	479	24	92	1.50E-32	140.6	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN13843_c7_g1_i1	Q8WQ47	TBA_LEPDS	89	164	18	0	492	1	1	164	2.40E-84	312.8	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN11259_c4_g1_i1	Q8WQ47	TBA_LEPDS	80.2	121	24	0	366	4	16	136	1.80E-52	206.5	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN5440_c0_g1_i1	Q8WQ47	TBA_LEPDS	69.6	69	20	1	232	26	8	75	2.50E-23	109	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN3530_c1_g1_i1	Q8WQ47	TBA_LEPDS	89.1	101	11	0	305	3	35	135	6.40E-48	191	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c7_g1_i1	Q8WQ47	TBA_LEPDS	88.5	87	10	0	264	4	24	110	4.20E-40	164.9	TBA_LEPDS	reviewed	Tubulin alpha chain (allergen Lep d ?)		Lepidoglyphus destructor (Storage mite) (Glycyphagus destructor)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i10	Q71G51	TBA_NEOCA	89.9	327	32	1	1029	52	127	453	2.10E-172	606.3	TBA_NEOCA	reviewed	Tubulin alpha chain (Alpha-tubulin)	TUBA	Neospora caninum (Coccidian parasite)	453	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i13	Q71G51	TBA_NEOCA	88.3	453	52	1	1407	52	1	453	9.40E-243	840.5	TBA_NEOCA	reviewed	Tubulin alpha chain (Alpha-tubulin)	TUBA	Neospora caninum (Coccidian parasite)	453	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i14	Q71G51	TBA_NEOCA	90.7	453	42	0	1387	29	1	453	3.10E-249	862.1	TBA_NEOCA	reviewed	Tubulin alpha chain (Alpha-tubulin)	TUBA	Neospora caninum (Coccidian parasite)	453	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i16	Q71G51	TBA_NEOCA	89.9	327	33	0	1009	29	127	453	2.90E-174	612.5	TBA_NEOCA	reviewed	Tubulin alpha chain (Alpha-tubulin)	TUBA	Neospora caninum (Coccidian parasite)	453	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		red	red	NA	NA	NA	NA
TRINITY_DN843_c0_g1_i4	Q71G51	TBA_NEOCA	90.9	453	40	1	1407	52	1	453	4.50E-248	858.2	TBA_NEOCA	reviewed	Tubulin alpha chain (Alpha-tubulin)	TUBA	Neospora caninum (Coccidian parasite)	453	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN24582_c2_g1_i1	Q52PV9	TBA_TYRPU	78.4	74	16	0	229	8	377	450	9.30E-28	123.6	TBA_TYRPU	reviewed	Tubulin alpha chain (Alpha-tubulin) (allergen Tyr p 33)		Tyrophagus putrescentiae (Mold mite) (Acarus putrescentiae)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c3_g1_i1	Q52PV9	TBA_TYRPU	89.1	119	13	0	1	357	1	119	7.60E-61	234.2	TBA_TYRPU	reviewed	Tubulin alpha chain (Alpha-tubulin) (allergen Tyr p 33)		Tyrophagus putrescentiae (Mold mite) (Acarus putrescentiae)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN34849_c0_g1_i1	P92120	TBA_ENCHE	57.8	128	54	0	8	391	58	185	3.60E-40	165.6	TBA_ENCHE	reviewed	Tubulin alpha chain (Fragment)	TUB1 ATUB	Encephalitozoon hellem (Microsporidian parasite)	380	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c4_g1_i7	P08537	TBA_XENLA	89.8	137	14	0	4	414	313	449	4.10E-67	255.4	TBA_XENLA	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]	tuba tuba1	Xenopus laevis (African clawed frog)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c0_g1_i1	P30436	TBA_ONCKE	88.9	99	11	0	1	297	311	409	5.80E-46	184.5	TBA_ONCKE	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]		Oncorhynchus keta (Chum salmon) (Salmo keta)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13843_c5_g1_i1	P08537	TBA_XENLA	83.6	61	10	0	243	61	389	449	7.30E-23	107.5	TBA_XENLA	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]	tuba tuba1	Xenopus laevis (African clawed frog)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c3_g1_i1	P30436	TBA_ONCKE	93.8	32	2	0	1	96	324	355	3.20E-11	68.6	TBA_ONCKE	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]		Oncorhynchus keta (Chum salmon) (Salmo keta)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN15194_c2_g1_i1	P08537	TBA_XENLA	91.2	113	10	0	344	6	337	449	4.20E-56	218.4	TBA_XENLA	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]	tuba tuba1	Xenopus laevis (African clawed frog)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN40365_c0_g1_i1	P30436	TBA_ONCKE	93.4	61	4	0	153	335	73	133	9.40E-28	124.4	TBA_ONCKE	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]		Oncorhynchus keta (Chum salmon) (Salmo keta)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN27144_c0_g1_i1	P08537	TBA_XENLA	85.1	67	10	0	1	201	383	449	2.70E-26	118.6	TBA_XENLA	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]	tuba tuba1	Xenopus laevis (African clawed frog)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN32984_c0_g1_i1	P30436	TBA_ONCKE	93.7	95	6	0	1	285	315	409	1.70E-47	189.5	TBA_ONCKE	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]		Oncorhynchus keta (Chum salmon) (Salmo keta)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21308_c1_g1_i1	P08537	TBA_XENLA	78.4	88	19	0	1	264	362	449	3.70E-33	142.1	TBA_XENLA	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]	tuba tuba1	Xenopus laevis (African clawed frog)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN33387_c0_g1_i1	Q91060	TBA_NOTVI	89.8	49	5	0	52	198	134	182	2.00E-18	92.8	TBA_NOTVI	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]		Notophthalmus viridescens (Eastern newt) (Triturus viridescens)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12828_c0_g1_i1	P08537	TBA_XENLA	86.2	58	8	0	3	176	392	449	1.90E-22	105.9	TBA_XENLA	reviewed	Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]	tuba tuba1	Xenopus laevis (African clawed frog)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13619_c3_g1_i1	P18288	TBAT_ONCMY	80	65	13	0	10	204	273	337	5.60E-24	110.9	TBAT_ONCMY	reviewed	"Tubulin alpha chain, testis-specific [Cleaved into: Detyrosinated tubulin alpha chain, testis-specific]"		Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN20728_c1_g1_i1	Q8T6A5	TBA1_APLCA	92.9	85	6	0	255	1	199	283	2.20E-38	159.1	TBA1_APLCA	reviewed	Tubulin alpha-1 chain		Aplysia californica (California sea hare)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c2_g1_i1	P06603	TBA1_DROME	94.7	450	23	1	115	1461	1	450	5.20E-255	881.3	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c1_g1_i1	Q8T6A5	TBA1_APLCA	89.8	59	6	0	250	74	393	451	1.40E-21	103.2	TBA1_APLCA	reviewed	Tubulin alpha-1 chain		Aplysia californica (California sea hare)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN17138_c2_g1_i1	P06603	TBA1_DROME	82.7	75	13	0	228	4	126	200	1.90E-28	125.9	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN13843_c0_g2_i1	Q8T6A5	TBA1_APLCA	81.6	76	14	0	239	12	354	429	1.10E-28	126.7	TBA1_APLCA	reviewed	Tubulin alpha-1 chain		Aplysia californica (California sea hare)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c2_g1_i1	P06603	TBA1_DROME	96.7	60	2	0	56	235	243	302	6.00E-28	124.4	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c2_g1_i2	P06603	TBA1_DROME	94.5	109	6	0	17	343	194	302	1.70E-55	216.5	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN23434_c1_g1_i1	P18258	TBA1_PARLI	90	80	8	0	26	265	1	80	8.80E-38	157.1	TBA1_PARLI	reviewed	Tubulin alpha-1 chain		Paracentrotus lividus (Common sea urchin)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23434_c1_g1_i2	P18258	TBA1_PARLI	87.5	80	10	0	1	240	1	80	3.00E-37	155.2	TBA1_PARLI	reviewed	Tubulin alpha-1 chain		Paracentrotus lividus (Common sea urchin)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23434_c3_g1_i1	P06603	TBA1_DROME	94	84	5	0	92	343	74	157	8.40E-41	167.5	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN21388_c0_g1_i1	P18258	TBA1_PARLI	90.3	72	7	0	74	289	1	72	1.70E-34	146.4	TBA1_PARLI	reviewed	Tubulin alpha-1 chain		Paracentrotus lividus (Common sea urchin)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN22803_c0_g1_i1	P06603	TBA1_DROME	98.3	60	1	0	61	240	243	302	3.10E-28	125.6	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN18486_c1_g1_i1	P06603	TBA1_DROME	87.5	72	9	0	216	1	234	305	1.40E-28	126.3	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN3530_c0_g2_i1	P06603	TBA1_DROME	94.8	58	3	0	229	56	76	133	3.90E-26	118.6	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		brown	brown	NA	NA	NA	NA
TRINITY_DN21657_c3_g1_i1	Q8T6A5	TBA1_APLCA	89.7	78	8	0	1	234	191	268	6.80E-34	144.1	TBA1_APLCA	reviewed	Tubulin alpha-1 chain		Aplysia californica (California sea hare)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN40813_c0_g1_i1	P06603	TBA1_DROME	98.1	103	2	0	309	1	32	134	9.30E-55	213.8	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN40813_c0_g1_i2	P06603	TBA1_DROME	100	59	0	0	177	1	76	134	8.50E-29	127.1	TBA1_DROME	reviewed	Tubulin alpha-1 chain	alphaTub84B tubA84B CG1913	Drosophila melanogaster (Fruit fly)	450	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	lysosome localization [GO:0032418]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN18310_c0_g1_i1	Q8T6A5	TBA1_APLCA	96.7	92	3	0	3	278	115	206	2.00E-45	182.6	TBA1_APLCA	reviewed	Tubulin alpha-1 chain		Aplysia californica (California sea hare)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN39780_c0_g1_i1	Q6VAG1	TBA1_GOSHI	91.5	47	3	1	221	84	404	450	3.00E-15	82	TBA1_GOSHI	reviewed	Tubulin alpha-1 chain (Alpha-1-tubulin)		Gossypium hirsutum (Upland cotton) (Gossypium mexicanum)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN13535_c0_g1_i1	O22347	TBA1_ELEIN	91.7	60	4	1	248	69	51	109	2.80E-25	115.5	TBA1_ELEIN	reviewed	Tubulin alpha-1 chain (Alpha-1-tubulin)	TUBA1 TUA1	Eleusine indica (Goosegrass) (Cynosurus indicus)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21510_c1_g1_i1	Q25008	TBA1_HOMAM	87	77	10	0	232	2	159	235	1.10E-31	136.7	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c0_g2_i1	Q25008	TBA1_HOMAM	93.8	81	5	0	3	245	81	161	4.80E-38	157.9	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c0_g2_i2	Q25008	TBA1_HOMAM	89.2	83	9	0	3	251	79	161	2.40E-37	155.6	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c1_g1_i1	Q25008	TBA1_HOMAM	85.9	71	10	0	3	215	72	142	3.60E-29	128.3	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c1_g1_i2	Q25008	TBA1_HOMAM	89.8	88	9	0	3	266	72	159	1.10E-40	166.8	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c0_g1_i2	Q25008	TBA1_HOMAM	93.4	196	13	0	1	588	214	409	2.40E-104	379.4	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN13843_c3_g2_i1	Q25008	TBA1_HOMAM	85.9	142	20	0	428	3	97	238	4.00E-64	245.4	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13843_c3_g1_i1	Q25008	TBA1_HOMAM	83.5	79	13	0	237	1	267	345	8.40E-32	137.1	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c4_g1_i1	Q25008	TBA1_HOMAM	95.9	74	3	0	223	2	268	341	2.70E-35	148.7	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c5_g1_i1	Q25008	TBA1_HOMAM	94.5	91	5	0	1	273	150	240	2.50E-43	175.6	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN11259_c1_g1_i1	Q25008	TBA1_HOMAM	91.8	73	6	0	221	3	174	246	3.50E-32	138.3	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN11259_c5_g1_i1	Q25008	TBA1_HOMAM	84.1	88	14	0	57	320	249	336	3.70E-38	158.7	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN15194_c4_g1_i1	Q25008	TBA1_HOMAM	78.3	83	18	0	3	251	158	240	2.70E-28	125.6	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN15194_c0_g1_i1	Q25008	TBA1_HOMAM	91.8	97	8	0	292	2	111	207	1.40E-44	179.9	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN15194_c0_g1_i2	Q25008	TBA1_HOMAM	91.9	160	13	0	481	2	48	207	6.80E-81	301.2	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN15194_c0_g2_i1	Q25008	TBA1_HOMAM	92.7	110	8	0	330	1	236	345	6.40E-54	211.1	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN15194_c5_g1_i1	Q25008	TBA1_HOMAM	89.6	96	10	0	289	2	222	317	2.60E-43	175.6	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN38532_c2_g1_i1	Q25008	TBA1_HOMAM	88.2	93	11	0	2	280	200	292	4.00E-41	168.3	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN38532_c3_g1_i1	Q25008	TBA1_HOMAM	88.2	68	8	0	206	3	338	405	1.20E-29	129.8	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21657_c0_g1_i1	Q25008	TBA1_HOMAM	88.2	68	8	0	3	206	269	336	4.50E-29	127.9	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c4_g1_i1	Q25008	TBA1_HOMAM	93.3	180	12	0	3	542	95	274	9.80E-92	337.4	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c2_g1_i1	Q25008	TBA1_HOMAM	94.4	90	5	0	270	1	236	325	2.20E-44	179.1	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23892_c1_g1_i1	Q25008	TBA1_HOMAM	81.2	64	12	0	193	2	307	370	1.40E-24	113.2	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23892_c1_g1_i1	Q25008	TBA1_HOMAM	90.9	22	2	0	258	193	285	306	3.60E-04	45.4	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21308_c0_g1_i1	Q25008	TBA1_HOMAM	95.7	70	3	0	3	212	369	438	2.90E-31	135.2	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21325_c0_g1_i1	Q25008	TBA1_HOMAM	86.7	75	10	0	1	225	114	188	5.70E-30	131	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13619_c4_g1_i1	Q25008	TBA1_HOMAM	90.7	75	7	0	1	225	360	434	4.70E-32	137.9	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13619_c5_g1_i1	Q25008	TBA1_HOMAM	88.5	87	10	0	262	2	148	234	6.70E-38	157.5	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13619_c2_g1_i1	Q25008	TBA1_HOMAM	84.9	152	23	0	5	460	168	319	2.60E-69	262.7	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN20114_c0_g1_i1	Q25008	TBA1_HOMAM	76.2	130	29	1	12	401	237	364	3.10E-53	209.1	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN38602_c3_g1_i1	Q25008	TBA1_HOMAM	88.1	84	10	0	254	3	129	212	1.60E-36	152.9	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN29625_c2_g1_i1	Q25008	TBA1_HOMAM	90.2	92	9	0	2	277	112	203	1.00E-41	170.2	TBA1_HOMAM	reviewed	Tubulin alpha-1 chain (Alpha-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN17138_c3_g1_i1	P49741	TBAA_SCHCO	77	61	14	0	1	183	388	448	1.70E-20	99.4	TBAA_SCHCO	reviewed	Tubulin alpha-1A chain	TUB-1A	Schizophyllum commune (Split gill fungus)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN29625_c0_g1_i1	P49741	TBAA_SCHCO	87.2	47	5	1	1	141	403	448	2.80E-15	82.4	TBAA_SCHCO	reviewed	Tubulin alpha-1A chain	TUB-1A	Schizophyllum commune (Split gill fungus)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN26127_c0_g1_i1	P68362	TBA1A_CRIGR	77.3	44	10	0	145	14	243	286	3.60E-13	75.1	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c4_g1_i1	P68362	TBA1A_CRIGR	98	51	1	0	3	155	401	451	6.50E-21	100.9	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c4_g1_i2	P68362	TBA1A_CRIGR	98	51	1	0	3	155	401	451	1.10E-20	100.1	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN24582_c1_g1_i1	P68362	TBA1A_CRIGR	86.7	75	10	0	225	1	344	418	1.80E-31	136	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c0_g1_i1	P68362	TBA1A_CRIGR	100	115	0	0	2	346	97	211	2.60E-61	235.7	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c0_g1_i2	P68362	TBA1A_CRIGR	100	137	0	0	3	413	75	211	4.80E-75	281.6	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c0_g1_i3	P68362	TBA1A_CRIGR	100	74	0	0	1	222	131	204	9.30E-36	150.6	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		blue	blue	NA	NA	NA	NA
TRINITY_DN549_c0_g1_i3	P68362	TBA1A_CRIGR	99.7	389	1	0	93	1259	1	389	2.20E-232	805.8	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN23892_c2_g1_i1	P68362	TBA1A_CRIGR	75.3	73	18	0	3	221	272	344	1.40E-25	116.3	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN13619_c3_g2_i1	P68362	TBA1A_CRIGR	91.7	72	6	0	3	218	348	419	1.70E-34	146	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN13619_c0_g1_i1	P68362	TBA1A_CRIGR	98.3	118	2	0	357	4	1	118	1.10E-64	247.3	TBA1A_CRIGR	reviewed	Tubulin alpha-1A chain (Alpha-tubulin 2) (Alpha-tubulin II) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	451	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]	cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037	microtubule-based process [GO:0007017]; regulation of synapse organization [GO:0050807]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c4_g1_i5	P81947	TBA1B_BOVIN	97.1	139	4	0	4	420	313	451	6.40E-74	278.1	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c4_g1_i6	P81947	TBA1B_BOVIN	97.1	139	4	0	4	420	313	451	1.10E-73	277.3	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN11259_c6_g1_i1	P81947	TBA1B_BOVIN	88.5	87	10	0	2	262	291	377	3.20E-40	165.2	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN20959_c0_g1_i1	P81947	TBA1B_BOVIN	92.6	94	7	0	320	39	321	414	5.60E-47	188	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN18486_c0_g1_i1	P81947	TBA1B_BOVIN	98.1	53	1	0	65	223	301	353	4.60E-26	118.2	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c0_g1_i1	P81947	TBA1B_BOVIN	100	352	0	0	93	1148	1	352	4.90E-210	731.5	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c0_g1_i2	P81947	TBA1B_BOVIN	100	389	0	0	93	1259	1	389	2.90E-232	805.4	TBA1B_BOVIN	reviewed	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]		Bos taurus (Bovine)	451	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN3530_c0_g1_i1	Q3ZCJ7	TBA1C_BOVIN	90	160	16	0	480	1	1	160	6.00E-84	311.6	TBA1C_BOVIN	reviewed	Tubulin alpha-1C chain [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	Bos taurus (Bovine)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		blue	blue	NA	NA	NA	NA
TRINITY_DN3530_c0_g1_i2	Q3ZCJ7	TBA1C_BOVIN	89.9	159	16	0	480	4	1	159	5.10E-83	308.5	TBA1C_BOVIN	reviewed	Tubulin alpha-1C chain [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	Bos taurus (Bovine)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN11259_c2_g1_i1	Q2HJ86	TBA1D_BOVIN	88.9	189	21	0	3	569	2	190	5.10E-99	361.7	TBA1D_BOVIN	reviewed	Tubulin alpha-1D chain [Cleaved into: Detyrosinated tubulin alpha-1D chain]	TUBA1D	Bos taurus (Bovine)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN38532_c1_g1_i1	Q2HJ86	TBA1D_BOVIN	97.5	40	1	0	122	3	1	40	2.80E-18	92	TBA1D_BOVIN	reviewed	Tubulin alpha-1D chain [Cleaved into: Detyrosinated tubulin alpha-1D chain]	TUBA1D	Bos taurus (Bovine)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN23892_c0_g1_i1	P06604	TBA2_DROME	85.5	138	19	1	465	55	312	449	8.70E-65	247.7	TBA2_DROME	reviewed	Tubulin alpha-2 chain	alphaTub85E TUBA85E CG9476	Drosophila melanogaster (Fruit fly)	449	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; spindle microtubule [GO:0005876]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; unidimensional cell growth [GO:0009826]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; spindle microtubule [GO:0005876]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005876; GO:0005881; GO:0007017; GO:0009826	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; unidimensional cell growth [GO:0009826]		blue	blue	NA	NA	NA	NA
TRINITY_DN38602_c0_g1_i1	P06604	TBA2_DROME	74.5	137	33	1	406	2	1	137	2.20E-58	226.5	TBA2_DROME	reviewed	Tubulin alpha-2 chain	alphaTub85E TUBA85E CG9476	Drosophila melanogaster (Fruit fly)	449	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; spindle microtubule [GO:0005876]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; unidimensional cell growth [GO:0009826]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; spindle microtubule [GO:0005876]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005876; GO:0005881; GO:0007017; GO:0009826	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; unidimensional cell growth [GO:0009826]		blue	blue	NA	NA	NA	NA
TRINITY_DN38532_c0_g1_i1	Q94570	TBA2_HOMAM	93.6	140	9	0	421	2	75	214	3.50E-73	275.4	TBA2_HOMAM	reviewed	Tubulin alpha-2 chain (Alpha-II tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN38602_c2_g1_i1	Q94570	TBA2_HOMAM	92.4	157	12	0	2	472	170	326	3.20E-83	308.9	TBA2_HOMAM	reviewed	Tubulin alpha-2 chain (Alpha-II tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c23_g1_i1	Q94572	TBA3_HOMAM	88.3	196	21	1	607	26	256	451	3.00E-97	355.9	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c4_g1_i3	Q94572	TBA3_HOMAM	90.1	81	8	0	2	244	367	447	7.80E-35	147.5	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c0_g1_i1	Q94572	TBA3_HOMAM	91.8	368	28	1	1111	8	81	446	1.70E-199	696.4	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN462_c0_g1_i3	Q94572	TBA3_HOMAM	87.4	198	23	1	601	8	251	446	2.50E-96	352.8	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c0_g1_i4	Q94572	TBA3_HOMAM	88.3	375	42	1	1132	8	74	446	1.40E-196	686.8	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN13843_c4_g1_i1	Q94572	TBA3_HOMAM	98.8	80	1	0	2	241	372	451	1.00E-38	160.2	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN13843_c0_g1_i1	Q94572	TBA3_HOMAM	91.7	169	13	1	580	77	283	451	5.40E-88	325.1	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12092_c1_g1_i1	Q94572	TBA3_HOMAM	96.4	138	5	0	415	2	149	286	1.10E-71	270.4	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN11259_c0_g1_i1	Q94572	TBA3_HOMAM	98	98	2	0	295	2	1	98	1.60E-53	209.9	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN15194_c1_g1_i1	Q94572	TBA3_HOMAM	94.5	73	4	0	2	220	108	180	1.40E-33	142.9	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN20959_c0_g1_i2	Q94572	TBA3_HOMAM	94.7	131	7	0	476	84	321	451	8.60E-68	257.7	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23726_c0_g1_i1	Q94572	TBA3_HOMAM	100	52	0	0	68	223	175	226	2.70E-24	112.1	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21657_c1_g1_i1	Q94572	TBA3_HOMAM	92.1	76	6	0	1	228	357	432	2.30E-34	145.6	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c6_g1_i1	Q94572	TBA3_HOMAM	84	100	14	1	306	13	352	451	1.30E-40	166.8	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c0_g3_i1	Q94572	TBA3_HOMAM	98.3	356	6	0	1	1068	40	395	4.30E-208	724.9	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN13619_c1_g1_i1	Q94572	TBA3_HOMAM	86	114	16	0	6	347	332	445	1.80E-51	203	TBA3_HOMAM	reviewed	Tubulin alpha-3 chain (Alpha-III tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21657_c2_g1_i1	Q32KN8	TBA3_BOVIN	82.6	69	12	0	207	1	361	429	7.90E-26	117.1	TBA3_BOVIN	reviewed	Tubulin alpha-3 chain (Alpha-tubulin 3) [Cleaved into: Detyrosinated tubulin alpha-3 chain]	TUBA3	Bos taurus (Bovine)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN11259_c1_g2_i1	P0DPH7	TBA3C_HUMAN	91.1	112	10	0	338	3	135	246	1.10E-51	203.8	TBA3C_HUMAN	reviewed	Tubulin alpha-3C chain (Alpha-tubulin 2) (Alpha-tubulin 3C) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-3C chain]	TUBA3C TUBA2	Homo sapiens (Human)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c21_g1_i1	P81948	TBA4A_BOVIN	100	86	0	0	260	3	126	211	9.20E-44	177.2	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN462_c21_g1_i2	P81948	TBA4A_BOVIN	100	122	0	0	368	3	90	211	6.20E-66	251.1	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN13843_c2_g1_i1	P81948	TBA4A_BOVIN	100	273	0	0	820	2	169	441	8.20E-159	560.8	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN16179_c0_g1_i1	P81948	TBA4A_BOVIN	100	61	0	0	3	185	388	448	6.20E-29	127.5	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c0_g2_i1	P81948	TBA4A_BOVIN	100	130	0	0	78	467	1	130	5.00E-76	285	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN21257_c0_g1_i1	P81948	TBA4A_BOVIN	94.1	102	6	0	364	59	31	132	8.60E-52	204.1	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN21257_c0_g1_i1	P81948	TBA4A_BOVIN	100	26	0	0	80	3	174	199	8.40E-07	54.7	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN21257_c0_g1_i2	P81948	TBA4A_BOVIN	99.2	120	1	0	360	1	31	150	1.60E-66	253.1	TBA4A_BOVIN	reviewed	Tubulin alpha-4A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain)	TUBA4A TUBA1	Bos taurus (Bovine)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0019901	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN15293_c0_g1_i1	P09644	TBA5_CHICK	77.1	70	16	0	74	283	70	139	3.80E-27	122.1	TBA5_CHICK	reviewed	Tubulin alpha-5 chain		Gallus gallus (Chicken)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		brown	brown	NA	NA	NA	NA
TRINITY_DN12828_c1_g1_i1	P09644	TBA5_CHICK	83.8	74	12	0	222	1	375	448	2.20E-29	129	TBA5_CHICK	reviewed	Tubulin alpha-5 chain		Gallus gallus (Chicken)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN549_c5_g1_i1	Q2HJB8	TBA8_BOVIN	89.7	68	7	0	1	204	224	291	6.50E-28	124	TBA8_BOVIN	reviewed	Tubulin alpha-8 chain (Alpha-tubulin 8)	TUBA8	Bos taurus (Bovine)	449	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		blue	blue	NA	NA	NA	NA
TRINITY_DN11259_c3_g1_i1	P09645	TBA8_CHICK	89.4	85	9	0	257	3	12	96	6.20E-36	151	TBA8_CHICK	reviewed	Tubulin alpha-8 chain (Fragment)		Gallus gallus (Chicken)	324	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c0_g1_i1	Q8SS99	TBB_ENCCU	66.8	437	140	1	1340	30	1	432	1.40E-179	630.6	TBB_ENCCU	reviewed	Tubulin beta chain (Beta-tubulin)	TUB2 ECU03_0820i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	439	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN34674_c0_g1_i1	P04107	TBB_TRYBR	63.7	102	29	1	39	344	1	94	8.70E-33	141	TBB_TRYBR	reviewed	Tubulin beta chain (Beta-tubulin)		Trypanosoma brucei rhodesiense	442	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g2_i1	P11833	TBB_PARLI	88.4	450	49	1	1384	35	1	447	2.40E-238	825.9	TBB_PARLI	reviewed	Tubulin beta chain (Beta-tubulin)		Paracentrotus lividus (Common sea urchin)	447	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN2278_c0_g1_i1	P33188	TBB1_PARTE	93.8	437	27	0	1384	74	1	437	2.30E-249	862.4	TBB1_PARTE	reviewed	Tubulin beta chain (Beta-tubulin)	bPT2 GSPATT00021361001; bPT3 GSPATT00036831001	Paramecium tetraurelia	442	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN33974_c0_g1_i1	P30668	TBB_SCHCO	56.6	76	33	0	6	233	206	281	4.00E-18	91.7	TBB_SCHCO	reviewed	Tubulin beta chain (Beta-tubulin)	TUB-2	Schizophyllum commune (Split gill fungus)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN9840_c0_g1_i1	A2AQ07	TBB1_MOUSE	100	408	0	0	1224	1	6	413	6.10E-243	840.9	TBB1_MOUSE	reviewed	Tubulin beta-1 chain	Tubb1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0051225	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN9840_c0_g1_i2	A2AQ07	TBB1_MOUSE	88.9	99	11	0	300	4	314	412	2.00E-46	186	TBB1_MOUSE	reviewed	Tubulin beta-1 chain	Tubb1	Mus musculus (Mouse)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0051225	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c1_g4_i1	Q24560	TBB1_DROME	94.9	138	7	0	415	2	67	204	1.80E-74	279.6	TBB1_DROME	reviewed	Tubulin beta-1 chain (Beta-1-tubulin)	betaTub56D CG9277	Drosophila melanogaster (Fruit fly)	447	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN2663_c1_g1_i2	P18241	TBB1_BRUPA	71	31	9	0	225	133	150	180	6.40E-05	47.8	TBB1_BRUPA	reviewed	Tubulin beta-1 chain (Beta-1-tubulin)		Brugia pahangi (Filarial nematode worm)	448	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN29994_c0_g1_i1	P29500	TBB1_PEA	63.3	180	66	0	4	543	99	278	7.10E-66	251.5	TBB1_PEA	reviewed	Tubulin beta-1 chain (Beta-1-tubulin)	TUBB1 TUB1	Pisum sativum (Garden pea)	450	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13226_c1_g3_i1	Q24560	TBB1_DROME	96.5	141	5	0	2	424	289	429	5.90E-76	284.6	TBB1_DROME	reviewed	Tubulin beta-1 chain (Beta-1-tubulin)	betaTub56D CG9277	Drosophila melanogaster (Fruit fly)	447	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN11812_c2_g1_i1	Q25009	TBB1_HOMAM	89.2	102	11	0	309	4	78	179	2.40E-47	189.1	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN11812_c1_g1_i1	Q25009	TBB1_HOMAM	89.8	98	10	0	39	332	308	405	4.20E-45	181.8	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN11812_c0_g1_i1	Q25009	TBB1_HOMAM	98.6	216	3	0	3	650	148	363	5.80E-123	441.4	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN35522_c0_g1_i1	Q25009	TBB1_HOMAM	87	92	12	0	1	276	182	273	5.30E-41	167.9	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN26465_c2_g1_i1	Q25009	TBB1_HOMAM	99.3	451	3	0	63	1415	1	451	8.80E-268	923.7	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN26465_c2_g1_i2	Q25009	TBB1_HOMAM	99.5	203	1	0	84	692	249	451	1.70E-113	410.2	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	1
TRINITY_DN34315_c0_g1_i1	Q25009	TBB1_HOMAM	88.8	80	9	0	241	2	7	86	2.10E-38	159.1	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN24453_c2_g1_i1	Q25009	TBB1_HOMAM	87.6	89	11	0	268	2	353	441	5.30E-38	157.9	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN24453_c1_g1_i1	Q25009	TBB1_HOMAM	96.3	82	3	0	2	247	370	451	6.70E-38	157.5	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN24456_c0_g1_i1	Q25009	TBB1_HOMAM	80.9	110	20	1	49	378	18	126	3.50E-48	192.2	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN24456_c0_g1_i2	Q25009	TBB1_HOMAM	83.5	127	20	1	40	420	1	126	4.90E-59	228.4	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g3_i1	Q25009	TBB1_HOMAM	93.6	280	17	1	843	4	27	305	4.80E-154	545	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g3_i2	Q25009	TBB1_HOMAM	93.6	280	17	1	843	4	27	305	4.80E-154	545	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g1_i1	Q25009	TBB1_HOMAM	95	357	17	1	1071	1	1	356	4.40E-203	708.4	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g1_i10	Q25009	TBB1_HOMAM	88.1	455	50	2	1404	40	1	451	6.50E-239	827.8	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN1729_c0_g1_i3	Q25009	TBB1_HOMAM	96.9	357	10	1	1071	1	1	356	3.90E-207	721.8	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g1_i7	Q25009	TBB1_HOMAM	91	357	31	1	1071	1	1	356	2.20E-194	679.5	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN39275_c0_g1_i2	Q25009	TBB1_HOMAM	86.6	82	11	0	273	28	20	101	1.10E-36	154.5	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN39275_c0_g1_i2	Q25009	TBB1_HOMAM	87.7	65	8	0	316	510	16	80	2.50E-28	126.7	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21293_c0_g1_i1	Q25009	TBB1_HOMAM	94.6	93	5	0	2	280	204	296	6.40E-47	187.6	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN5853_c2_g1_i1	Q25009	TBB1_HOMAM	85.1	67	10	0	2	202	135	201	4.20E-24	111.3	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN21894_c0_g1_i1	Q25009	TBB1_HOMAM	87	69	9	0	208	2	18	86	4.10E-30	131.3	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN20072_c0_g1_i1	Q25009	TBB1_HOMAM	91.2	91	8	0	102	374	244	334	1.50E-43	176.8	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN18410_c0_g1_i1	Q25009	TBB1_HOMAM	81.7	82	15	0	246	1	44	125	2.20E-35	149.1	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23106_c0_g1_i1	Q25009	TBB1_HOMAM	93.2	118	8	0	2	355	334	451	5.70E-57	221.5	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN23106_c2_g1_i1	Q25009	TBB1_HOMAM	92.4	66	5	0	199	2	282	347	2.80E-28	125.2	TBB1_HOMAM	reviewed	Tubulin beta-1 chain (Beta-I tubulin)		Homarus americanus (American lobster)	451	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN23813_c0_g1_i1	P09203	TBB1_CHICK	100	180	0	0	541	2	1	180	1.90E-103	376.3	TBB1_CHICK	reviewed	Tubulin beta-1 chain (Beta-tubulin class-I)		Gallus gallus (Chicken)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]		NA	NA	NA	NA	NA	NA
TRINITY_DN15132_c0_g1_i1	Q9ZRB1	TBB2_WHEAT	75	48	12	0	228	85	382	429	4.50E-14	78.2	TBB2_WHEAT	reviewed	Tubulin beta-2 chain (Beta-2-tubulin)	TUBB2	Triticum aestivum (Wheat)	447	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN26964_c0_g1_i1	P83130	TBB2_DROER	100	99	0	0	3	299	201	299	4.90E-53	208	TBB2_DROER	reviewed	Tubulin beta-2 chain (Beta-2-tubulin)	betaTub85D	Drosophila erecta (Fruit fly)	446	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c5_g1_i1	Q94571	TBB2_HOMAM	87	69	9	0	207	1	11	79	1.40E-30	132.9	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i1	Q94571	TBB2_HOMAM	77.6	49	11	0	149	3	146	194	3.10E-12	72	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i10	Q94571	TBB2_HOMAM	74.1	85	22	0	271	17	146	230	3.30E-28	125.9	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i12	Q94571	TBB2_HOMAM	45.7	92	32	2	224	3	103	194	1.20E-09	63.5	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i13	Q94571	TBB2_HOMAM	74.1	85	22	0	271	17	146	230	2.80E-28	125.9	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i14	Q94571	TBB2_HOMAM	77.6	49	11	0	149	3	146	194	3.80E-12	72	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i16	Q94571	TBB2_HOMAM	78	50	11	0	151	2	146	195	3.70E-13	75.1	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i17	Q94571	TBB2_HOMAM	75.3	85	21	0	271	17	146	230	8.40E-29	127.9	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i3	Q94571	TBB2_HOMAM	77.6	49	11	0	149	3	146	194	4.10E-12	71.6	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i4	Q94571	TBB2_HOMAM	75.3	85	21	0	271	17	146	230	8.40E-29	127.9	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i5	Q94571	TBB2_HOMAM	54.7	128	44	1	358	17	103	230	8.00E-29	127.9	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i6	Q94571	TBB2_HOMAM	79.1	43	9	0	153	25	146	188	4.20E-11	68.6	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN12277_c0_g1_i9	Q94571	TBB2_HOMAM	77.6	49	11	0	149	3	146	194	5.10E-12	71.6	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i1	Q94571	TBB2_HOMAM	67.1	85	24	1	244	486	146	230	4.50E-24	112.8	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i18	Q94571	TBB2_HOMAM	67.1	85	24	1	294	536	146	230	4.90E-24	112.8	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i19	Q94571	TBB2_HOMAM	71.8	85	24	0	294	548	146	230	6.70E-29	129	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i2	Q94571	TBB2_HOMAM	64.7	85	26	1	355	597	146	230	2.90E-22	107.1	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i22	Q94571	TBB2_HOMAM	64.7	85	26	1	115	357	146	230	2.00E-22	107.1	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i27	Q94571	TBB2_HOMAM	70.6	51	11	1	115	255	146	196	7.50E-10	64.3	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i6	Q94571	TBB2_HOMAM	67.1	76	21	1	1	216	155	230	6.00E-21	101.7	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i7	Q94571	TBB2_HOMAM	64.8	88	27	1	235	486	143	230	1.90E-23	110.5	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1414_c0_g1_i9	Q94571	TBB2_HOMAM	71.8	85	24	0	244	498	146	230	6.20E-29	129	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c0_g1_i2	Q94571	TBB2_HOMAM	96.9	357	11	0	1071	1	1	357	2.30E-207	722.6	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN13226_c1_g2_i1	Q94571	TBB2_HOMAM	96.1	154	5	1	3	464	300	452	8.80E-79	294.3	TBB2_HOMAM	reviewed	Tubulin beta-2 chain (Beta-II tubulin)		Homarus americanus (American lobster)	452	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		blue	blue	NA	NA	NA	NA
TRINITY_DN19394_c0_g1_i1	Q9NFZ6	TBB2_ECHMU	84.8	92	14	0	2	277	281	372	2.40E-41	169.1	TBB2_ECHMU	reviewed	Tubulin beta-2 chain (Beta-tubulin 2)	TUB-2	Echinococcus multilocularis (Fox tapeworm)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13226_c2_g1_i1	Q13885	TBB2A_HUMAN	96.5	85	3	0	276	22	161	245	6.80E-41	167.5	TBB2A_HUMAN	reviewed	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A TUBB2	Homo sapiens (Human)	445	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; microtubule [GO:0005874]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; microtubule [GO:0005874]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017; GO:0070062; GO:1903561	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]		NA	NA	NA	NA	NA	NA
TRINITY_DN25936_c0_g1_i1	P09206	TBB3_CHICK	100	60	0	0	88	267	1	60	1.80E-30	132.9	TBB3_CHICK	reviewed	Tubulin beta-3 chain (Beta-tubulin class-IV)		Gallus gallus (Chicken)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; dorsal root ganglion development [GO:1990791]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:1990791	dorsal root ganglion development [GO:1990791]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN38356_c0_g1_i1	Q3ZBU7	TBB4A_BOVIN	100	93	0	0	282	4	7	99	3.30E-51	201.8	TBB4A_BOVIN	reviewed	Tubulin beta-4A chain (Tubulin beta-4 chain)	TUBB4A TUBB4	Bos taurus (Bovine)	444	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; negative regulation of microtubule polymerization [GO:0031115]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]	calcium ion binding [GO:0005509]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005509; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0005930; GO:0007017; GO:0031115; GO:0033269; GO:0043025; GO:0043209	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of microtubule polymerization [GO:0031115]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c3_g1_i1	Q3MHM5	TBB4B_BOVIN	100	124	0	0	373	2	1	124	6.20E-70	264.6	TBB4B_BOVIN	reviewed	Tubulin beta-4B chain (Tubulin beta-2C chain)	TUBB4B TUBB2C	Bos taurus (Bovine)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	double-stranded RNA binding [GO:0003725]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN19318_c0_g1_i1	Q3MHM5	TBB4B_BOVIN	100	128	0	0	3	386	282	409	3.40E-70	265.4	TBB4B_BOVIN	reviewed	Tubulin beta-4B chain (Tubulin beta-2C chain)	TUBB4B TUBB2C	Bos taurus (Bovine)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	double-stranded RNA binding [GO:0003725]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13226_c1_g1_i1	Q3MHM5	TBB4B_BOVIN	100	78	0	0	3	236	368	445	3.20E-36	152.9	TBB4B_BOVIN	reviewed	Tubulin beta-4B chain (Tubulin beta-2C chain)	TUBB4B TUBB2C	Bos taurus (Bovine)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	double-stranded RNA binding [GO:0003725]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN13226_c0_g1_i1	Q3MHM5	TBB4B_BOVIN	97.9	143	3	0	429	1	276	418	4.10E-77	288.5	TBB4B_BOVIN	reviewed	Tubulin beta-4B chain (Tubulin beta-2C chain)	TUBB4B TUBB2C	Bos taurus (Bovine)	445	cytoplasm [GO:0005737]; microtubule [GO:0005874]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	double-stranded RNA binding [GO:0003725]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c1_g3_i1	Q2KJD0	TBB5_BOVIN	94.2	138	8	0	2	415	161	298	5.00E-72	271.6	TBB5_BOVIN	reviewed	Tubulin beta-5 chain	TUBB5	Bos taurus (Bovine)	444	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c1_g3_i2	Q2KJD0	TBB5_BOVIN	99.2	125	1	0	2	376	174	298	2.00E-67	256.1	TBB5_BOVIN	reviewed	Tubulin beta-5 chain	TUBB5	Bos taurus (Bovine)	444	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN15531_c0_g1_i1	Q2KJD0	TBB5_BOVIN	100	201	0	0	3	605	18	218	1.70E-116	419.9	TBB5_BOVIN	reviewed	Tubulin beta-5 chain	TUBB5	Bos taurus (Bovine)	444	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN12686_c0_g1_i1	Q2KJD0	TBB5_BOVIN	100	127	0	0	3	383	318	444	4.10E-66	251.9	TBB5_BOVIN	reviewed	Tubulin beta-5 chain	TUBB5	Bos taurus (Bovine)	444	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN1729_c1_g1_i1	Q2KJD0	TBB5_BOVIN	99.8	444	1	0	46	1377	1	444	4.00E-262	904.8	TBB5_BOVIN	reviewed	Tubulin beta-5 chain	TUBB5	Bos taurus (Bovine)	444	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c1_g1_i1	P09653	TBB5_CHICK	100	231	0	0	2	694	100	330	2.00E-134	479.6	TBB5_CHICK	reviewed	Tubulin beta-5 chain (Beta-tubulin class-V)		Gallus gallus (Chicken)	446	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c1_g2_i1	Q922F4	TBB6_MOUSE	100	73	0	0	52	270	1	73	1.30E-36	153.3	TBB6_MOUSE	reviewed	Tubulin beta-6 chain	Tubb6	Mus musculus (Mouse)	447	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN10881_c4_g1_i1	Q2HJ81	TBB6_BOVIN	98.7	78	1	0	234	1	35	112	4.90E-40	164.5	TBB6_BOVIN	reviewed	Tubulin beta-6 chain	TUBB6	Bos taurus (Bovine)	446	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN9840_c1_g1_i1	Q922F4	TBB6_MOUSE	100	86	0	0	2	259	347	432	4.00E-43	174.9	TBB6_MOUSE	reviewed	Tubulin beta-6 chain	Tubb6	Mus musculus (Mouse)	447	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN5853_c1_g1_i1	Q9BUF5	TBB6_HUMAN	100	84	0	0	252	1	144	227	2.30E-43	175.6	TBB6_HUMAN	reviewed	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Homo sapiens (Human)	446	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017; GO:0070062	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN13226_c0_g1_i2	Q9BUF5	TBB6_HUMAN	95.2	104	5	0	312	1	315	418	1.90E-52	206.1	TBB6_HUMAN	reviewed	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Homo sapiens (Human)	446	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017; GO:0070062	microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN11068_c0_g1_i1	Q9XFG3	TBG_PHYPA	75.8	451	102	3	20	1354	1	450	8.70E-198	691	TBG_PHYPA	reviewed	Tubulin gamma chain (Gamma-tubulin)	TUBG1 PHYPADRAFT_170153	Physcomitrium patens (Spreading-leaved earth moss) (Physcomitrella patens)	475	cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]	cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000930; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0007020; GO:0031122	cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]		NA	NA	NA	NA	NA	NA
TRINITY_DN4668_c0_g1_i1	Q8SRD2	TBG_ENCCU	47.1	102	53	1	313	8	100	200	1.30E-22	107.1	TBG_ENCCU	reviewed	Tubulin gamma chain (Gamma-tubulin)	TUB4 ECU08_0670	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	434	cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; spindle pole body [GO:0005816]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]	cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; spindle pole body [GO:0005816]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	GO:0000930; GO:0003924; GO:0005525; GO:0005737; GO:0005816; GO:0005874; GO:0007020; GO:0031122	cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]		NA	NA	NA	NA	NA	NA
TRINITY_DN36848_c0_g1_i1	Q0VCD2	TBG1_BOVIN	100	123	0	0	370	2	1	123	6.70E-70	264.6	TBG1_BOVIN	reviewed	Tubulin gamma-1 chain (Gamma-1-tubulin)	TUBG1	Bos taurus (Bovine)	451	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097730	cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN36848_c0_g1_i2	Q0VCD2	TBG1_BOVIN	100	39	0	0	117	1	1	39	1.00E-17	90.1	TBG1_BOVIN	reviewed	Tubulin gamma-1 chain (Gamma-1-tubulin)	TUBG1	Bos taurus (Bovine)	451	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097730	cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN7071_c0_g1_i1	P23258	TBG1_HUMAN	85.3	450	66	0	91	1440	1	450	3.60E-229	795.4	TBG1_HUMAN	reviewed	Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1)	TUBG1 TUBG	Homo sapiens (Human)	451	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000086; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0010389; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097711; GO:0097730	ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN17929_c0_g1_i1	P23258	TBG1_HUMAN	99.7	330	1	0	3	992	122	451	9.50E-186	650.6	TBG1_HUMAN	reviewed	Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1)	TUBG1 TUBG	Homo sapiens (Human)	451	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000086; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0010389; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097711; GO:0097730	ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]		NA	NA	NA	NA	NA	NA
TRINITY_DN17929_c0_g1_i2	P83887	TBG1_MOUSE	99.4	322	2	0	3	968	122	443	1.70E-179	629.8	TBG1_MOUSE	reviewed	Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1)	Tubg1 Tubg	Mus musculus (Mouse)	451	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000922; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0005819; GO:0005827; GO:0005874; GO:0005876; GO:0005881; GO:0005929; GO:0007017; GO:0007020; GO:0007052; GO:0007088; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097730	cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]		NA	NA	NA	NA	NA	NA
TRINITY_DN1191_c0_g1_i1	P42271	TBG2_DROME	50	64	20	2	50	208	4	66	5.40E-09	61.2	TBG2_DROME	reviewed	Tubulin gamma-2 chain (Gamma-2-tubulin)	gammaTub37C Tub37CD TubG2 TubG37C CG17566	Drosophila melanogaster (Fruit fly)	457	centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation [GO:0051316]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; spindle assembly involved in female meiosis I [GO:0007057]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin complex [GO:0000930]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000212; GO:0000226; GO:0000278; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0007020; GO:0007052; GO:0007057; GO:0007312; GO:0031122; GO:0051301; GO:0051316; GO:0072687	attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation [GO:0051316]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; spindle assembly involved in female meiosis I [GO:0007057]		NA	NA	NA	NA	NA	NA
TRINITY_DN34505_c0_g1_i1	Q8VCK3	TBG2_MOUSE	100	91	0	0	1	273	58	148	1.70E-47	189.5	TBG2_MOUSE	reviewed	Tubulin gamma-2 chain (Gamma-2-tubulin)	Tubg2	Mus musculus (Mouse)	451	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; spindle [GO:0005819]; spindle microtubule [GO:0005876]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005876; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0031122	cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]		NA	NA	NA	NA	NA	NA
TRINITY_DN14988_c0_g1_i2	Q9VM91	TTL3A_DROME	45	131	72	0	2	394	361	491	2.40E-32	139.8	TTL3A_DROME	reviewed	Tubulin glycylase 3A (dmTTLL3A) (EC 6.3.2.-)	TTLL3A CG11323	Drosophila melanogaster (Fruit fly)	992	"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737]; protein-glycine ligase activity, initiating [GO:0070736]; protein polyglycylation [GO:0018094]"	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005737; GO:0005874; GO:0015630; GO:0018094; GO:0070735; GO:0070736; GO:0070737	protein polyglycylation [GO:0018094]		NA	NA	NA	NA	NA	NA
TRINITY_DN34035_c0_g1_i1	Q9VM91	TTL3A_DROME	63.9	72	26	0	217	2	571	642	3.40E-19	95.1	TTL3A_DROME	reviewed	Tubulin glycylase 3A (dmTTLL3A) (EC 6.3.2.-)	TTLL3A CG11323	Drosophila melanogaster (Fruit fly)	992	"cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737]; protein-glycine ligase activity, initiating [GO:0070736]; protein polyglycylation [GO:0018094]"	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005737; GO:0005874; GO:0015630; GO:0018094; GO:0070735; GO:0070736; GO:0070737	protein polyglycylation [GO:0018094]		NA	NA	NA	NA	NA	NA
TRINITY_DN14988_c0_g1_i1	Q9Y4R7	TTLL3_HUMAN	55.9	68	28	2	102	299	257	324	1.40E-12	73.9	TTLL3_HUMAN	reviewed	Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (HOTTL) (Tubulin--tyrosine ligase-like protein 3)	TTLL3 PRO0207	Homo sapiens (Human)	772	"axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglycylation [GO:0018094]"	axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0035082; GO:0060271; GO:0070735; GO:0070736	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglycylation [GO:0018094]		NA	NA	NA	NA	NA	NA
TRINITY_DN14988_c0_g2_i1	Q1ECV4	TTLL3_DANRE	83.9	31	5	0	139	231	381	411	1.30E-10	67	TTLL3_DANRE	reviewed	Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3)	ttll3 zgc:136840	Danio rerio (Zebrafish) (Brachydanio rerio)	771	"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; tubulin-glycine ligase activity [GO:0070738]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; protein polyglycylation [GO:0018094]"	axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; tubulin-glycine ligase activity [GO:0070738]"	GO:0003341; GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0035082; GO:0060271; GO:0070735; GO:0070736; GO:0070738	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; protein polyglycylation [GO:0018094]		brown	brown	NA	NA	NA	NA
TRINITY_DN14988_c0_g1_i4	A4Q9E5	TTLL3_MOUSE	41.6	101	52	2	5	301	422	517	3.40E-14	79.3	TTLL3_MOUSE	reviewed	Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3)	Ttll3	Mus musculus (Mouse)	927	"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglycylation [GO:0018094]"	axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	"ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0035082; GO:0060271; GO:0070735; GO:0070736	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglycylation [GO:0018094]		NA	NA	NA	NA	NA	NA
TRINITY_DN37727_c0_g1_i1	Q8NHH1	TTL11_HUMAN	49.4	85	42	1	1	255	344	427	2.90E-17	89	TTL11_HUMAN	reviewed	Tubulin polyglutamylase TTLL11 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 11)	TTLL11 C9orf20	Homo sapiens (Human)	800	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; protein polyglutamylation [GO:0018095]	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	ATP binding [GO:0005524]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0051013; GO:0070740	microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; protein polyglutamylation [GO:0018095]		NA	NA	NA	NA	NA	NA
TRINITY_DN36020_c0_g1_i1	Q14679	TTLL4_HUMAN	53.8	52	24	0	178	23	885	936	3.80E-12	71.6	TTLL4_HUMAN	reviewed	Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4)	TTLL4 KIAA0173	Homo sapiens (Human)	1199	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739; GO:0070740; GO:0120222	microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]		NA	NA	NA	NA	NA	NA
TRINITY_DN740_c0_g1_i1	Q14679	TTLL4_HUMAN	44.6	588	284	6	2011	278	573	1128	1.30E-143	512.3	TTLL4_HUMAN	reviewed	Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4)	TTLL4 KIAA0173	Homo sapiens (Human)	1199	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739; GO:0070740; GO:0120222	microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]		NA	NA	NA	NA	NA	NA
TRINITY_DN740_c0_g1_i2	Q14679	TTLL4_HUMAN	48	529	250	6	2046	502	573	1090	2.00E-144	515	TTLL4_HUMAN	reviewed	Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4)	TTLL4 KIAA0173	Homo sapiens (Human)	1199	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739; GO:0070740; GO:0120222	microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]		NA	NA	NA	NA	NA	NA
TRINITY_DN27043_c0_g1_i1	Q8CHB8	TTLL5_MOUSE	50	70	35	0	2	211	200	269	1.50E-14	79.7	TTLL5_MOUSE	reviewed	Tubulin polyglutamylase TTLL5 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 5)	Ttll5 Kiaa0998	Mus musculus (Mouse)	1328	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0015631; GO:0018095; GO:0030317; GO:0060041; GO:0070740	fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]; spermatogenesis [GO:0007283]; sperm axoneme assembly [GO:0007288]		NA	NA	NA	NA	NA	NA
TRINITY_DN40374_c0_g1_i1	Q9VV43	TPPP_DROME	65.2	66	20	1	222	34	127	192	9.50E-17	87	TPPP_DROME	reviewed	Tubulin polymerization-promoting protein homolog (TPPP) (Protein ringmaker)	ringer CG45057	Drosophila melanogaster (Fruit fly)	192	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of synaptic growth at neuromuscular junction [GO:0008582]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]		GO:0000226; GO:0001578; GO:0005737; GO:0005856; GO:0008582; GO:0030424; GO:0031594; GO:0032273; GO:0043025; GO:0046785; GO:0098793	microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of synaptic growth at neuromuscular junction [GO:0008582]		NA	NA	NA	NA	NA	NA
TRINITY_DN36640_c0_g1_i1	Q9VV43	TPPP_DROME	62.9	70	24	2	38	247	22	89	9.90E-15	80.5	TPPP_DROME	reviewed	Tubulin polymerization-promoting protein homolog (TPPP) (Protein ringmaker)	ringer CG45057	Drosophila melanogaster (Fruit fly)	192	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of synaptic growth at neuromuscular junction [GO:0008582]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]		GO:0000226; GO:0001578; GO:0005737; GO:0005856; GO:0008582; GO:0030424; GO:0031594; GO:0032273; GO:0043025; GO:0046785; GO:0098793	microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of synaptic growth at neuromuscular junction [GO:0008582]		NA	NA	NA	NA	NA	NA
TRINITY_DN8792_c0_g1_i11	Q5E951	TBCB_BOVIN	45.3	243	128	2	815	90	6	244	1.60E-57	224.6	TBCB_BOVIN	reviewed	Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)	TBCB CKAP1	Bos taurus (Bovine)	244	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]		GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0030154	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN8792_c0_g1_i9	Q5E951	TBCB_BOVIN	39.6	111	66	1	392	63	6	116	3.90E-18	92.8	TBCB_BOVIN	reviewed	Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)	TBCB CKAP1	Bos taurus (Bovine)	244	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]		GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0030154	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		blue	blue	NA	NA	NA	NA
TRINITY_DN19993_c0_g1_i1	Q99426	TBCB_HUMAN	100	78	0	0	2	235	167	244	2.40E-42	172.2	TBCB_HUMAN	reviewed	Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)	TBCB CG22 CKAP1	Homo sapiens (Human)	244	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]		GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0015630; GO:0030154	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN19993_c0_g1_i2	Q9D1E6	TBCB_MOUSE	96.5	85	3	0	1	255	160	244	5.00E-46	184.5	TBCB_MOUSE	reviewed	Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)	Tbcb Ckap1	Mus musculus (Mouse)	244	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]		GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0030154	cell differentiation [GO:0030154]; nervous system development [GO:0007399]		NA	NA	NA	NA	NA	NA
TRINITY_DN20095_c0_g1_i1	Q8GRL7	TBCE_ARATH	30.5	266	170	5	215	982	141	401	1.00E-25	119	TBCE_ARATH	reviewed	Tubulin-folding cofactor E (AtTFCE) (Protein PFIFFERLING)	TFCE PFI TBCE At1g71440 F26A9.18	Arabidopsis thaliana (Mouse-ear cress)	531	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; alpha-tubulin binding [GO:0043014]; embryo development ending in seed dormancy [GO:0009793]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0007021; GO:0007023; GO:0009507; GO:0009793; GO:0043014	embryo development ending in seed dormancy [GO:0009793]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN20095_c0_g1_i2	Q8GRL7	TBCE_ARATH	31.4	220	137	4	215	844	141	356	6.60E-21	102.8	TBCE_ARATH	reviewed	Tubulin-folding cofactor E (AtTFCE) (Protein PFIFFERLING)	TFCE PFI TBCE At1g71440 F26A9.18	Arabidopsis thaliana (Mouse-ear cress)	531	chloroplast [GO:0009507]; cytoplasm [GO:0005737]; alpha-tubulin binding [GO:0043014]; embryo development ending in seed dormancy [GO:0009793]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	chloroplast [GO:0009507]; cytoplasm [GO:0005737]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0007021; GO:0007023; GO:0009507; GO:0009793; GO:0043014	embryo development ending in seed dormancy [GO:0009793]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN8099_c0_g1_i1	P80585	TBCA_CHICK	48.9	94	48	0	343	62	1	94	2.10E-17	90.1	TBCA_CHICK	reviewed	Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA)	TBCA	Gallus gallus (Chicken)	108	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]	GO:0005829; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0015631; GO:0048487	post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN8099_c0_g1_i2	P80585	TBCA_CHICK	54.6	97	44	0	409	119	1	97	1.40E-20	100.9	TBCA_CHICK	reviewed	Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA)	TBCA	Gallus gallus (Chicken)	108	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]	GO:0005829; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0015631; GO:0048487	post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		blue	blue	NA	NA	NA	NA
TRINITY_DN25479_c0_g1_i1	Q8VCN9	TBCC_MOUSE	35.8	285	159	4	909	103	64	340	2.00E-41	171.4	TBCC_MOUSE	reviewed	Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC)	Tbcc	Mus musculus (Mouse)	341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]	GTPase activity [GO:0003924]; tubulin binding [GO:0015631]	GO:0000902; GO:0003924; GO:0005737; GO:0005829; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391	cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		blue	blue	NA	NA	NA	NA
TRINITY_DN38444_c0_g1_i1	Q15814	TBCC_HUMAN	100	63	0	0	2	190	284	346	2.20E-34	145.6	TBCC_HUMAN	reviewed	Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC)	TBCC	Homo sapiens (Human)	346	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; chaperone binding [GO:0051087]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]	chaperone binding [GO:0051087]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]	GO:0000902; GO:0003924; GO:0005737; GO:0005829; GO:0005856; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391; GO:0051087	cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN37931_c0_g1_i1	Q9BTW9	TBCD_HUMAN	100	121	0	0	363	1	445	565	6.10E-66	251.1	TBCD_HUMAN	reviewed	Tubulin-specific chaperone D (Beta-tubulin cofactor D) (tfcD) (SSD-1) (Tubulin-folding cofactor D)	TBCD KIAA0988 SSD1 TFCD PP1096	Homo sapiens (Human)	1192	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]	beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]	GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0051087; GO:0070830	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN30722_c0_g1_i1	Q5ZI87	TBCD_CHICK	58.3	187	77	1	572	12	364	549	4.70E-60	232.3	TBCD_CHICK	reviewed	Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)	TBCD RCJMB04_29e8	Gallus gallus (Chicken)	1019	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule organizing center [GO:0005815]; beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule organizing center [GO:0005815]	beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]	GO:0000226; GO:0005096; GO:0005737; GO:0005815; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0070830	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN2105_c0_g1_i1	Q8BYA0	TBCD_MOUSE	42.1	1127	632	7	304	3639	67	1187	1.00E-256	888.3	TBCD_MOUSE	reviewed	Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)	Tbcd	Mus musculus (Mouse)	1196	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]	beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]	GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0070830	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN2105_c0_g1_i2	Q8BYA0	TBCD_MOUSE	41.2	1193	679	8	74	3604	1	1187	2.60E-260	900.2	TBCD_MOUSE	reviewed	Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)	Tbcd	Mus musculus (Mouse)	1196	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]	beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]	GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0070830	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1229_c0_g1_i1	Q5FVQ9	TBCE_RAT	50	58	28	1	317	144	468	524	1.70E-06	53.5	TBCE_RAT	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	Tbce	Rattus norvegicus (Rat)	524	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0007052; GO:0007409; GO:0008344; GO:0009791; GO:0014889; GO:0043014; GO:0048589; GO:0048936	adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1229_c0_g1_i3	Q5FVQ9	TBCE_RAT	50	58	28	1	267	94	468	524	1.40E-06	53.5	TBCE_RAT	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	Tbce	Rattus norvegicus (Rat)	524	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0007052; GO:0007409; GO:0008344; GO:0009791; GO:0014889; GO:0043014; GO:0048589; GO:0048936	adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1243_c0_g1_i1	Q55CN0	TBCE_DICDI	31.7	167	113	1	1	498	33	199	1.10E-17	91.3	TBCE_DICDI	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	tbce DDB_G0269990	Dictyostelium discoideum (Slime mold)	525	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1243_c0_g1_i11	Q55CN0	TBCE_DICDI	26.7	344	202	8	1	888	33	374	2.90E-24	114	TBCE_DICDI	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	tbce DDB_G0269990	Dictyostelium discoideum (Slime mold)	525	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1243_c0_g1_i4	Q5U378	TBCE_DANRE	36.7	417	249	5	104	1333	8	416	3.40E-69	263.8	TBCE_DANRE	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	tbce zgc:123075	Danio rerio (Zebrafish) (Brachydanio rerio)	521	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1243_c0_g1_i6	Q5U378	TBCE_DANRE	36.8	438	261	6	104	1396	8	436	4.50E-72	273.5	TBCE_DANRE	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	tbce zgc:123075	Danio rerio (Zebrafish) (Brachydanio rerio)	521	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1243_c0_g1_i7	Q5U378	TBCE_DANRE	36.7	417	249	5	104	1333	8	416	1.50E-69	265	TBCE_DANRE	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	tbce zgc:123075	Danio rerio (Zebrafish) (Brachydanio rerio)	521	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN1243_c0_g1_i9	Q5U378	TBCE_DANRE	36.7	417	249	5	104	1333	8	416	1.50E-69	265	TBCE_DANRE	reviewed	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	tbce zgc:123075	Danio rerio (Zebrafish) (Brachydanio rerio)	521	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	alpha-tubulin binding [GO:0043014]	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]		NA	NA	NA	NA	NA	NA
TRINITY_DN27085_c0_g1_i1	Q14166	TTL12_HUMAN	100	70	0	0	3	212	433	502	4.40E-32	137.9	TTL12_HUMAN	reviewed	Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12)	TTLL12 KIAA0153	Homo sapiens (Human)	644	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]; histone lysine methylation [GO:0034968]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]	GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0007346; GO:0015631; GO:0030496; GO:0034968; GO:0045087; GO:0060339; GO:1990889	histone lysine methylation [GO:0034968]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN8929_c0_g1_i1	Q3UDE2	TTL12_MOUSE	44.4	619	317	10	1904	102	26	635	8.80E-154	545.4	TTL12_MOUSE	reviewed	Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12)	Ttll12	Mus musculus (Mouse)	639	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]; cellular protein modification process [GO:0006464]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]	GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0006464; GO:0007346; GO:0015631; GO:0030496; GO:0045087; GO:0060339; GO:1990889	cellular protein modification process [GO:0006464]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]		NA	NA	NA	NA	NA	NA
TRINITY_DN32773_c1_g1_i1	Q9UJW2	TINAG_HUMAN	50	60	30	0	203	24	136	195	4.60E-11	68.2	TINAG_HUMAN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Homo sapiens (Human)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]	GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0007155	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c16_g1_i1	Q3SZI1	TINAG_BOVIN	38	158	84	4	460	8	112	262	2.10E-18	93.6	TINAG_BOVIN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Bos taurus (Bovine)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005604; GO:0005615; GO:0005764; GO:0007155; GO:0008234	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g2_i1	Q9UJW2	TINAG_HUMAN	33.9	121	76	3	47	403	111	229	2.40E-10	66.6	TINAG_HUMAN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Homo sapiens (Human)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]	GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0007155	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g2_i3	Q9UJW2	TINAG_HUMAN	33.9	121	76	3	47	403	111	229	2.40E-10	66.6	TINAG_HUMAN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Homo sapiens (Human)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]	GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0007155	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g2_i5	Q9UJW2	TINAG_HUMAN	33.9	121	76	3	47	403	111	229	2.40E-10	66.6	TINAG_HUMAN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Homo sapiens (Human)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]	GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0007155	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN16443_c0_g1_i1	Q3SZI1	TINAG_BOVIN	39	123	62	4	6	371	81	191	2.40E-17	89.7	TINAG_BOVIN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Bos taurus (Bovine)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005604; GO:0005615; GO:0005764; GO:0007155; GO:0008234	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN16443_c0_g1_i2	Q9UJW2	TINAG_HUMAN	43.8	64	30	1	4	177	149	212	2.30E-06	52.8	TINAG_HUMAN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Homo sapiens (Human)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]	GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0007155	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN16443_c0_g1_i4	Q3SZI1	TINAG_BOVIN	47.3	55	29	0	64	228	141	195	1.50E-07	56.6	TINAG_BOVIN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Bos taurus (Bovine)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005604; GO:0005615; GO:0005764; GO:0007155; GO:0008234	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN16443_c0_g1_i5	Q3SZI1	TINAG_BOVIN	41.2	80	46	1	60	296	112	191	1.00E-10	67.4	TINAG_BOVIN	reviewed	Tubulointerstitial nephritis antigen (TIN-Ag)	TINAG	Bos taurus (Bovine)	476	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell adhesion [GO:0007155]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005604; GO:0005615; GO:0005764; GO:0007155; GO:0008234	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c0_g1_i6	Q99JR5	TINAL_MOUSE	43	79	32	3	2	232	83	150	3.80E-11	68.6	TINAL_MOUSE	reviewed	Tubulointerstitial nephritis antigen-like (Adrenocortical zonation factor 1) (AZ-1) (Androgen-regulated gene 1 protein) (Tubulointerstitial nephritis antigen-related protein) (TARP)	Tinagl1 Arg1 Lcn7 Tinagl	Mus musculus (Mouse)	466	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; laminin binding [GO:0043236]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]; laminin binding [GO:0043236]	GO:0005615; GO:0005737; GO:0005764; GO:0008234; GO:0043236; GO:0062023			NA	NA	NA	NA	NA	NA
TRINITY_DN32323_c0_g1_i1	Q99JR5	TINAL_MOUSE	100	59	0	0	3	179	408	466	2.20E-33	142.1	TINAL_MOUSE	reviewed	Tubulointerstitial nephritis antigen-like (Adrenocortical zonation factor 1) (AZ-1) (Androgen-regulated gene 1 protein) (Tubulointerstitial nephritis antigen-related protein) (TARP)	Tinagl1 Arg1 Lcn7 Tinagl	Mus musculus (Mouse)	466	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; laminin binding [GO:0043236]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]; laminin binding [GO:0043236]	GO:0005615; GO:0005737; GO:0005764; GO:0008234; GO:0043236; GO:0062023			NA	NA	NA	NA	NA	NA
TRINITY_DN11660_c0_g1_i1	Q9VQ91	TDRKH_DROME	30.7	296	188	2	867	31	182	477	1.80E-34	147.9	TDRKH_DROME	reviewed	Tudor and KH domain-containing protein homolog (Partner of PIWIs protein)	papi Tdrd2 CG7082	Drosophila melanogaster (Fruit fly)	576	nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; negative regulation of transposon integration [GO:0070895]; positive regulation of cellular protein localization [GO:1903829]	nucleus [GO:0005634]; P-body [GO:0000932]; P granule [GO:0043186]; protein-containing complex [GO:0032991]	protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005634; GO:0032991; GO:0043186; GO:0047485; GO:0070895; GO:1903829	negative regulation of transposon integration [GO:0070895]; positive regulation of cellular protein localization [GO:1903829]		NA	NA	NA	NA	NA	NA
TRINITY_DN7241_c0_g1_i2	F1R237	TDRD6_DANRE	32.6	181	84	8	614	117	444	601	9.90E-08	59.7	TDRD6_DANRE	reviewed	Tudor domain-containing 6	tdrd6 tdrd6a	Danio rerio (Zebrafish) (Brachydanio rerio)	2117	chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186]; germ cell development [GO:0007281]; organelle assembly [GO:0070925]; P granule assembly [GO:1903863]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283]	chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186]		GO:0007281; GO:0007283; GO:0032019; GO:0033391; GO:0043186; GO:0060293; GO:0070925; GO:1903863; GO:1905879	germ cell development [GO:0007281]; organelle assembly [GO:0070925]; P granule assembly [GO:1903863]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4277_c0_g1_i1	Q0IIX9	TFP11_XENTR	38.7	692	407	9	2117	75	139	824	1.20E-141	505.4	TFP11_XENTR	reviewed	Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1)	tfip11 stip	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	825	spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; spliceosomal complex disassembly [GO:0000390]	spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]	nucleic acid binding [GO:0003676]	GO:0000390; GO:0003676; GO:0005681; GO:0071008	spliceosomal complex disassembly [GO:0000390]		NA	NA	NA	NA	NA	NA
TRINITY_DN33234_c0_g1_i1	Q9UBB9	TFP11_HUMAN	100	114	0	0	2	343	514	627	4.40E-64	245	TFP11_HUMAN	reviewed	Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1)	TFIP11 STIP HSPC006	Homo sapiens (Human)	837	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear chromosome, telomeric region [GO:0000784]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]"	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear chromosome, telomeric region [GO:0000784]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]"	nucleic acid binding [GO:0003676]	GO:0000390; GO:0000398; GO:0000784; GO:0003676; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006396; GO:0016607; GO:0031012; GO:0031214; GO:0031333; GO:0031848; GO:0032091; GO:0071008; GO:0071013; GO:1904876; GO:2001033	"biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28423_c0_g1_i1	Q921Z5	TFIP8_MOUSE	100	89	0	0	3	269	35	123	5.00E-41	167.9	TFIP8_MOUSE	reviewed	Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8)	Tnfaip8	Mus musculus (Mouse)	198	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; defense response to Gram-positive bacterium [GO:0050830]; interleukin-1 beta production [GO:0032611]; positive regulation of apoptotic process [GO:0043065]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]	GO:0005654; GO:0005737; GO:0032611; GO:0043027; GO:0043065; GO:0050830	defense response to Gram-positive bacterium [GO:0050830]; interleukin-1 beta production [GO:0032611]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN36335_c0_g1_i1	O95379	TFIP8_HUMAN	100	70	0	0	212	3	42	111	1.10E-30	133.3	TFIP8_HUMAN	reviewed	Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8) (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein) (NDED) (SCC-S2) (TNF-induced protein GG2-1)	TNFAIP8	Homo sapiens (Human)	198	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]	GO:0005654; GO:0005737; GO:0043027; GO:0043065; GO:0043066	negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN33818_c0_g1_i1	O95379	TFIP8_HUMAN	100	80	0	0	242	3	119	198	1.10E-42	173.3	TFIP8_HUMAN	reviewed	Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8) (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein) (NDED) (SCC-S2) (TNF-induced protein GG2-1)	TNFAIP8	Homo sapiens (Human)	198	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]	GO:0005654; GO:0005737; GO:0043027; GO:0043065; GO:0043066	negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN3702_c0_g3_i1	Q28ZG0	TFP8L_DROPS	61.5	39	15	0	171	55	6	44	3.20E-06	52.4	TFP8L_DROPS	reviewed	Tumor necrosis factor alpha-induced protein 8-like protein (TNF alpha-induced protein 8-like protein)	GA17951	Drosophila pseudoobscura pseudoobscura (Fruit fly)	188	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065]	cytoplasm [GO:0005737]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]	GO:0005737; GO:0043027; GO:0043065	positive regulation of apoptotic process [GO:0043065]		NA	NA	NA	NA	NA	NA
TRINITY_DN3702_c0_g3_i3	Q7KVH9	TFP8L_DROME	51.4	183	89	0	619	71	6	188	3.30E-47	189.9	TFP8L_DROME	reviewed	Tumor necrosis factor alpha-induced protein 8-like protein (TNF alpha-induced protein 8-like protein)	CG4091	Drosophila melanogaster (Fruit fly)	188	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; regulation of autophagy [GO:0010506]; regulation of microtubule cytoskeleton organization [GO:0070507]; salivary gland morphogenesis [GO:0007435]	cell projection [GO:0042995]; cytoplasm [GO:0005737]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]	GO:0005737; GO:0007435; GO:0010506; GO:0042995; GO:0043027; GO:0043065; GO:0046330; GO:0070507	positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; regulation of autophagy [GO:0010506]; regulation of microtubule cytoskeleton organization [GO:0070507]; salivary gland morphogenesis [GO:0007435]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN1159_c0_g1_i1	Q9H3D4	P63_HUMAN	34	259	150	8	657	1397	169	418	1.60E-32	142.9	P63_HUMAN	reviewed	Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51)	TP63 KET P63 P73H P73L TP73L	Homo sapiens (Human)	680	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	"chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; WW domain binding [GO:0050699]"	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001302; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005791; GO:0006338; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0008283; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0042981; GO:0043281; GO:0043589; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051262; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:1900740; GO:1901796; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773	"apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1159_c0_g1_i2	Q9H3D4	P63_HUMAN	34	259	150	8	559	1299	169	418	1.50E-32	142.9	P63_HUMAN	reviewed	Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51)	TP63 KET P63 P73H P73L TP73L	Homo sapiens (Human)	680	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	"chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; WW domain binding [GO:0050699]"	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001302; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005791; GO:0006338; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0008283; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0042981; GO:0043281; GO:0043589; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051262; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:1900740; GO:1901796; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773	"apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4077_c0_g1_i1	Q5T0D9	TPRGL_HUMAN	30.4	276	123	5	835	26	60	272	6.00E-33	143.3	TPRGL_HUMAN	reviewed	Tumor protein p63-regulated gene 1-like protein (Mossy fiber terminal-associated vertebrate-specific presynaptic protein) (Protein FAM79A)	TPRG1L FAM79A MOVER	Homo sapiens (Human)	272	"calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	identical protein binding [GO:0042802]	GO:0005737; GO:0008021; GO:0030672; GO:0042802; GO:0044305; GO:0048786; GO:0051966; GO:0070062	"regulation of synaptic transmission, glutamatergic [GO:0051966]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2724_c0_g1_i1	Q8BTV1	TUSC3_MOUSE	62.9	302	111	1	118	1020	46	347	8.00E-117	421.8	TUSC3_MOUSE	reviewed	Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)	Tusc3 N33	Mus musculus (Mouse)	347	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; magnesium ion transmembrane transporter activity [GO:0015095]; oligosaccharyltransferase complex binding [GO:0062062]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]	magnesium ion transmembrane transporter activity [GO:0015095]; oligosaccharyltransferase complex binding [GO:0062062]	GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062	cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]		blue	blue	NA	NA	NA	NA
TRINITY_DN34210_c0_g1_i1	Q13454	TUSC3_HUMAN	100	96	0	0	289	2	160	255	6.80E-52	204.1	TUSC3_HUMAN	reviewed	Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)	TUSC3 N33	Homo sapiens (Human)	348	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005739; GO:0005789; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0018279; GO:0050890; GO:0055085	cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN27758_c0_g1_i1	Q99816	TS101_HUMAN	95.7	70	3	0	8	217	321	390	2.50E-30	132.1	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN2700_c0_g1_i1	Q61187	TS101_MOUSE	48.9	180	92	0	20	559	212	391	1.00E-41	171.4	TS101_MOUSE	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	Tsg101	Mus musculus (Mouse)	391	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0030154; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0090543; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]		NA	NA	NA	NA	NA	NA
TRINITY_DN1599_c0_g1_i1	Q99816	TS101_HUMAN	46.9	160	80	1	113	592	11	165	7.00E-41	168.7	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN1599_c0_g1_i2	Q99816	TS101_HUMAN	49.2	120	61	0	113	472	11	130	1.30E-32	141	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN1599_c0_g1_i4	Q99816	TS101_HUMAN	45.6	160	82	1	113	592	11	165	1.50E-38	161	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN31004_c0_g1_i1	Q99816	TS101_HUMAN	100	85	0	0	3	257	306	390	1.40E-40	166.4	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN16742_c0_g2_i1	Q99816	TS101_HUMAN	89.8	127	12	1	2	382	35	160	4.20E-65	248.4	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN16742_c0_g1_i1	Q99816	TS101_HUMAN	100	88	0	0	1	264	67	154	3.80E-49	194.9	TS101_HUMAN	reviewed	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	390	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; host cell [GO:0043657]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0043657; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0075733; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; intracellular transport of virus [GO:0075733]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN882_c2_g1_i9	P0DKM8	TU91_IOTCI	47.8	46	23	1	305	168	1	45	4.90E-06	52.8	TU91_IOTCI	reviewed	Turripeptide Ici9.1 (Turripeptide OL11-like) (Fragment)		Iotyrris cingulifera (Sea snail) (Pleurotoma cingulifera)	47	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0090729			blue	blue	NA	NA	NA	NA
TRINITY_DN882_c2_g1_i10	P0DKT4	TU92_IOTCI	51.1	45	22	0	302	168	26	70	2.20E-08	59.7	TU92_IOTCI	reviewed	Turripeptide Ici9.2		Iotyrris cingulifera (Sea snail) (Pleurotoma cingulifera)	70	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0090729			blue	blue	NA	NA	NA	NA
TRINITY_DN31706_c0_g1_i1	P0DKM9	TU11_LOPAL	51.1	45	21	1	175	44	1	45	6.40E-08	58.2	TU11_LOPAL	reviewed	Turripeptide OL11-like (Fragment)		Lophiotoma albina (Sea snail) (Xenuroturris albina)	45	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0090729			blue	blue	NA	NA	NA	1
TRINITY_DN31706_c0_g1_i2	P0DKM9	TU11_LOPAL	51.1	45	21	1	182	51	1	45	5.00E-08	58.5	TU11_LOPAL	reviewed	Turripeptide OL11-like (Fragment)		Lophiotoma albina (Sea snail) (Xenuroturris albina)	45	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729]	GO:0004867; GO:0005576; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN20319_c0_g1_i1	A8X8I4	TWK12_CAEBR	26.1	157	93	5	466	47	112	262	1.80E-11	70.9	TWK12_CAEBR	reviewed	TWiK family of potassium channels protein 12	twk-12 CBG09670	Caenorhabditis briggsae	687	integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]	potassium ion leak channel activity [GO:0022841]	GO:0005887; GO:0022841; GO:0030322; GO:0071805	potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]		NA	NA	NA	NA	NA	NA
TRINITY_DN24931_c0_g1_i2	P34410	TWK7_CAEEL	27.9	201	118	3	13	600	282	460	3.40E-18	93.6	TWK7_CAEEL	reviewed	TWiK family of potassium channels protein 7	twk-7 twk-8 F22B7.7	Caenorhabditis elegans	557	integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]	potassium ion leak channel activity [GO:0022841]	GO:0005887; GO:0022841; GO:0030322; GO:0071805	potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]		NA	NA	NA	NA	NA	NA
TRINITY_DN24931_c0_g1_i3	P34410	TWK7_CAEEL	30.1	123	70	2	84	437	349	460	7.50E-13	75.5	TWK7_CAEEL	reviewed	TWiK family of potassium channels protein 7	twk-7 twk-8 F22B7.7	Caenorhabditis elegans	557	integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]	potassium ion leak channel activity [GO:0022841]	GO:0005887; GO:0022841; GO:0030322; GO:0071805	potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]		NA	NA	NA	NA	NA	NA
TRINITY_DN10764_c0_g1_i1	Q8CIW5	PEO1_MOUSE	49.8	257	126	2	247	1017	357	610	3.80E-65	250.4	PEO1_MOUSE	reviewed	"Twinkle protein, mitochondrial (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein homolog) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle mtDNA helicase)"	Twnk Peo1	Mus musculus (Mouse)	685	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]	GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0006264; GO:0006268; GO:0006390; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333	cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]		NA	NA	NA	NA	NA	NA
TRINITY_DN10764_c0_g1_i2	Q8CIW5	PEO1_MOUSE	48.6	292	147	2	247	1122	357	645	7.90E-73	275.8	PEO1_MOUSE	reviewed	"Twinkle protein, mitochondrial (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein homolog) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle mtDNA helicase)"	Twnk Peo1	Mus musculus (Mouse)	685	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]	GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0006264; GO:0006268; GO:0006390; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333	cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]		NA	NA	NA	NA	NA	NA
TRINITY_DN27784_c1_g1_i1	Q8WVJ9	TWST2_HUMAN	83.3	66	10	1	2	199	90	154	1.00E-24	114	TWST2_HUMAN	reviewed	Twist-related protein 2 (Class A basic helix-loop-helix protein 39) (bHLHa39) (Dermis-expressed protein 1) (Dermo-1)	TWIST2 BHLHA39 DERMO1	Homo sapiens (Human)	160	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0007275; GO:0030154; GO:0030335; GO:0032502; GO:0043066; GO:0045668; GO:0045892; GO:0046983	"cell differentiation [GO:0030154]; developmental process [GO:0032502]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]"		brown	brown	NA	NA	NA	NA
TRINITY_DN5604_c0_g1_i1	Q23551	UNC22_CAEEL	44.7	114	54	2	22	363	2282	2386	1.40E-22	107.1	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN5604_c0_g1_i2	Q23551	UNC22_CAEEL	33.2	289	179	4	562	1422	1813	2089	4.90E-42	173.7	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN400_c0_g1_i2	Q23551	UNC22_CAEEL	36.8	152	95	1	678	226	65	216	7.60E-23	109	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN400_c0_g1_i3	Q23551	UNC22_CAEEL	36	214	133	3	858	226	4	216	2.20E-31	137.9	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN15193_c0_g2_i2	Q23551	UNC22_CAEEL	46.2	104	53	2	26	337	3656	3756	1.40E-16	87.4	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN32396_c0_g1_i1	Q23551	UNC22_CAEEL	52.7	74	35	0	243	22	3928	4001	2.70E-17	89	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i16	Q23551	UNC22_CAEEL	41.6	101	59	0	417	115	4307	4407	1.00E-16	87.8	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i2	Q23551	UNC22_CAEEL	36	89	47	2	393	127	4290	4368	5.00E-07	56.6	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i3	Q23551	UNC22_CAEEL	42.2	102	59	0	416	111	4307	4408	4.60E-17	89	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g1_i6	Q23551	UNC22_CAEEL	38.5	143	65	3	436	8	4307	4426	1.50E-18	94	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN649_c0_g2_i1	Q23551	UNC22_CAEEL	51.7	176	81	3	569	48	5206	5379	1.10E-45	184.5	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN35481_c0_g1_i1	Q23551	UNC22_CAEEL	51.6	64	31	0	192	1	2292	2355	3.30E-14	79.3	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN13190_c0_g1_i2	Q23551	UNC22_CAEEL	48.3	458	228	5	3	1376	2185	2633	1.40E-123	444.5	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN22915_c0_g1_i1	Q23551	UNC22_CAEEL	49.3	148	75	0	6	449	2451	2598	2.90E-41	169.5	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN8104_c0_g1_i1	Q23551	UNC22_CAEEL	46.5	832	441	3	2	2494	5705	6533	1.10E-235	817.8	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN36612_c0_g1_i1	Q23551	UNC22_CAEEL	52.6	232	110	0	738	43	3026	3257	3.50E-68	259.6	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN6323_c0_g1_i1	Q23551	UNC22_CAEEL	53.7	162	75	0	487	2	3338	3499	2.80E-50	199.5	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN6323_c0_g1_i2	Q23551	UNC22_CAEEL	54.2	142	65	0	427	2	3358	3499	5.30E-44	178.7	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN10265_c0_g1_i1	Q23551	UNC22_CAEEL	47.4	542	281	3	1624	2	2681	3219	4.00E-149	529.6	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN10265_c0_g1_i2	Q23551	UNC22_CAEEL	47	489	255	3	1597	134	2681	3166	3.10E-130	466.8	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN39618_c0_g1_i1	Q23551	UNC22_CAEEL	52.5	236	111	1	11	718	2439	2673	2.20E-67	256.9	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN18732_c0_g1_i1	Q23551	UNC22_CAEEL	51.9	81	39	0	2	244	3340	3420	7.70E-20	97.4	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN18732_c0_g2_i1	Q23551	UNC22_CAEEL	49.6	141	69	2	3	422	2255	2394	1.80E-32	140.2	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c1_g1_i1	Q23551	UNC22_CAEEL	43.2	148	84	0	447	4	2329	2476	2.60E-30	133.3	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c1_g1_i2	Q23551	UNC22_CAEEL	48.4	380	196	0	1140	1	2169	2548	5.40E-108	392.5	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c1_g1_i3	Q23551	UNC22_CAEEL	48.1	79	41	0	240	4	2175	2253	4.10E-18	91.7	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c1_g1_i4	Q23551	UNC22_CAEEL	57.3	157	67	0	523	53	3346	3502	2.90E-48	193	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c1_g1_i6	Q23551	UNC22_CAEEL	43.9	173	91	1	507	7	2374	2546	4.10E-37	156	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c1_g1_i7	Q23551	UNC22_CAEEL	57.1	42	18	0	178	53	2284	2325	1.10E-07	57	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN1393_c0_g1_i4	Q23551	UNC22_CAEEL	53.8	78	36	0	296	529	2248	2325	9.10E-18	91.7	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN6238_c0_g1_i1	Q23551	UNC22_CAEEL	53	66	31	0	201	4	2923	2988	5.70E-13	74.3	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	A band [GO:0031672]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]	A band [GO:0031672]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0040017; GO:0045989; GO:0046872; GO:0051782; GO:0060298	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]		NA	NA	NA	NA	NA	NA
TRINITY_DN2924_c0_g1_i2	Q9ULQ1	TPC1_HUMAN	47.3	167	88	0	502	2	281	447	2.10E-39	163.7	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN2924_c0_g1_i3	Q9ULQ1	TPC1_HUMAN	43.6	133	75	0	492	94	315	447	4.00E-26	119.4	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN2924_c0_g1_i4	Q9ULQ1	TPC1_HUMAN	41.3	796	428	10	2544	214	11	786	2.20E-152	541.2	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN2924_c0_g1_i5	Q9ULQ1	TPC1_HUMAN	41.2	798	428	10	2550	214	11	786	6.30E-152	539.7	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN2924_c0_g1_i6	Q9ULQ1	TPC1_HUMAN	49.4	449	214	4	1437	94	11	447	3.10E-111	403.7	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN5502_c0_g1_i1	Q9ULQ1	TPC1_HUMAN	29	479	295	10	659	2032	201	655	2.00E-41	172.2	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN5502_c0_g1_i3	Q9ULQ1	TPC1_HUMAN	32.2	233	125	6	273	914	437	655	6.40E-19	96.3	TPC1_HUMAN	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	TPCN1 KIAA1169 TPC1	Homo sapiens (Human)	816	"endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN5502_c0_g1_i7	Q9EQJ0	TPC1_MOUSE	32.6	175	112	2	210	734	202	370	3.30E-17	90.5	TPC1_MOUSE	reviewed	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	Tpcn1 Kiaa1169 Tpc1	Mus musculus (Mouse)	817	"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]"	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]	"identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"	GO:0005245; GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034765; GO:0035725; GO:0042802; GO:0042803; GO:0072345; GO:0080025	positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN2003_c0_g1_i1	Q86T03	PP4P1_HUMAN	70.7	82	20	1	236	3	61	142	2.40E-29	129.8	PP4P1_HUMAN	reviewed	"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)"	PIP4P1 C14orf9 TMEM55B	Homo sapiens (Human)	277	"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]"	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"	GO:0005654; GO:0005765; GO:0005886; GO:0006644; GO:0006991; GO:0008203; GO:0016021; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1904263	cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]		NA	NA	NA	NA	NA	NA
TRINITY_DN2003_c0_g1_i2	Q86T03	PP4P1_HUMAN	70.7	82	20	1	236	3	61	142	2.20E-29	129.8	PP4P1_HUMAN	reviewed	"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)"	PIP4P1 C14orf9 TMEM55B	Homo sapiens (Human)	277	"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]"	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"	GO:0005654; GO:0005765; GO:0005886; GO:0006644; GO:0006991; GO:0008203; GO:0016021; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1904263	cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]		NA	NA	NA	NA	NA	NA
TRINITY_DN27819_c0_g1_i1	Q4V888	PP4P2_RAT	36.2	116	73	1	443	99	138	253	5.40E-16	85.5	PP4P2_RAT	reviewed	"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)"	Pip4p2 Tmem55a	Rattus norvegicus (Rat)	257	"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856]"	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"	GO:0005765; GO:0005886; GO:0016021; GO:0030670; GO:0031902; GO:0034597; GO:0046856; GO:0050765	negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856]		NA	NA	NA	NA	NA	NA
TRINITY_DN32393_c0_g1_i1	Q9FUR2	IP5P2_ARATH	40.8	71	40	1	229	17	497	565	1.70E-09	63.2	IP5P2_ARATH	reviewed	Type I inositol polyphosphate 5-phosphatase 2 (At5PTase2) (EC 3.1.3.56)	IP5P2 5P2 At4g18010 T6K21.190	Arabidopsis thaliana (Mouse-ear cress)	646	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; abscisic acid-activated signaling pathway [GO:0009738]; inositol phosphate dephosphorylation [GO:0046855]; inositol trisphosphate metabolic process [GO:0032957]; phosphatidylinositol dephosphorylation [GO:0046856]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; seedling development [GO:0090351]"		"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]"	GO:0004439; GO:0004445; GO:0009737; GO:0009738; GO:0009845; GO:0032957; GO:0034485; GO:0046855; GO:0046856; GO:0052658; GO:0052659; GO:0090351	abscisic acid-activated signaling pathway [GO:0009738]; inositol phosphate dephosphorylation [GO:0046855]; inositol trisphosphate metabolic process [GO:0032957]; phosphatidylinositol dephosphorylation [GO:0046856]; response to abscisic acid [GO:0009737]; seed germination [GO:0009845]; seedling development [GO:0090351]		NA	NA	NA	NA	NA	NA
TRINITY_DN17417_c0_g2_i1	Q8K337	I5P2_MOUSE	47.8	69	35	1	76	282	453	520	3.20E-11	69.3	I5P2_MOUSE	reviewed	"Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (Inositol polyphosphate-5-phosphatase B) (Phosphoinositide 5-phosphatase) (5PTase)"	Inpp5b	Mus musculus (Mouse)	993	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]	"inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]"	GO:0001701; GO:0004439; GO:0004445; GO:0005793; GO:0005829; GO:0007165; GO:0007283; GO:0016020; GO:0016021; GO:0030317; GO:0030670; GO:0031901; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0070613	flagellated sperm motility [GO:0030317]; inositol phosphate dephosphorylation [GO:0046855]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN517_c2_g1_i1	O35210	AGTR1_MERUN	24.8	214	146	6	130	747	21	227	2.00E-05	52	AGTR1_MERUN	reviewed	Type-1 angiotensin II receptor (Angiotensin II type-1 receptor) (AT1) (GkAT1)	AGTR1	Meriones unguiculatus (Mongolian jird) (Gerbillus unguiculatus)	359	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; regulation of vasoconstriction [GO:0019229]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	angiotensin type II receptor activity [GO:0004945]	GO:0004945; GO:0005886; GO:0016021; GO:0019229	regulation of vasoconstriction [GO:0019229]		NA	NA	NA	NA	NA	NA
TRINITY_DN517_c2_g1_i3	O35210	AGTR1_MERUN	24.8	214	146	6	130	747	21	227	2.20E-05	52	AGTR1_MERUN	reviewed	Type-1 angiotensin II receptor (Angiotensin II type-1 receptor) (AT1) (GkAT1)	AGTR1	Meriones unguiculatus (Mongolian jird) (Gerbillus unguiculatus)	359	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; regulation of vasoconstriction [GO:0019229]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	angiotensin type II receptor activity [GO:0004945]	GO:0004945; GO:0005886; GO:0016021; GO:0019229	regulation of vasoconstriction [GO:0019229]		NA	NA	NA	NA	NA	NA
TRINITY_DN3184_c0_g1_i1	Q6RW13	ATRAP_HUMAN	33.3	144	89	4	583	155	5	142	2.60E-09	63.9	ATRAP_HUMAN	reviewed	Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein)	AGTRAP ATRAP	Homo sapiens (Human)	159	cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; identical protein binding [GO:0042802]; regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666]	cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	angiotensin type II receptor activity [GO:0004945]; identical protein binding [GO:0042802]	GO:0000139; GO:0001666; GO:0004945; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005938; GO:0008217; GO:0016021; GO:0030659; GO:0042802; GO:0043231	regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666]		NA	NA	NA	NA	NA	NA
TRINITY_DN13496_c0_g1_i1	Q86B61	TBH1_DROME	46.9	49	22	1	241	95	347	391	6.70E-06	51.2	TBH1_DROME	reviewed	Tyramine beta-hydroxylase (EC 1.14.17.-)	Tbh CG1543	Drosophila melanogaster (Fruit fly)	670	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; aggressive behavior [GO:0002118]; behavioral response to ethanol [GO:0048149]; dopamine catabolic process [GO:0042420]; flight behavior [GO:0007629]; inter-male aggressive behavior [GO:0002121]; larval locomotory behavior [GO:0008345]; learning [GO:0007612]; locomotion [GO:0040011]; male courtship behavior [GO:0008049]; mating behavior, sex discrimination [GO:0048047]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine signaling pathway [GO:0071927]; ovulation [GO:0030728]; regulation of behavior [GO:0050795]; regulation of forward locomotion [GO:0043059]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	"copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]"	GO:0002118; GO:0002121; GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0007612; GO:0007613; GO:0007629; GO:0008049; GO:0008345; GO:0016021; GO:0016715; GO:0030667; GO:0030728; GO:0040011; GO:0042420; GO:0042421; GO:0043059; GO:0048047; GO:0048149; GO:0050795; GO:0071927	"aggressive behavior [GO:0002118]; behavioral response to ethanol [GO:0048149]; dopamine catabolic process [GO:0042420]; flight behavior [GO:0007629]; inter-male aggressive behavior [GO:0002121]; larval locomotory behavior [GO:0008345]; learning [GO:0007612]; locomotion [GO:0040011]; male courtship behavior [GO:0008049]; mating behavior, sex discrimination [GO:0048047]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; octopamine signaling pathway [GO:0071927]; ovulation [GO:0030728]; regulation of behavior [GO:0050795]; regulation of forward locomotion [GO:0043059]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i13	O30409	TYCC_BREPA	30.7	472	292	11	1487	81	1526	1965	1.90E-52	208.4	TYCC_BREPA	reviewed	Tyrocidine synthase 3 (Tyrocidine synthase III) [Includes: ATP-dependent asparagine adenylase (AsnA) (Asparagine activase); ATP-dependent glutamine adenylase (GlnA) (Glutamine activase); ATP-dependent tyrosine adenylase (TyrA) (Tyrosine activase); ATP-dependent valine adenylase (ValA) (Valine activase); ATP-dependent ornithine adenylase (OrnA) (Ornithine activase); ATP-dependent leucine adenylase (LeuA) (Leucine activase)]	tycC	Brevibacillus parabrevis	6486	"hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000]"		"hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]"	GO:0016788; GO:0016874; GO:0017000; GO:0031177	antibiotic biosynthetic process [GO:0017000]		NA	NA	NA	NA	NA	NA
TRINITY_DN7300_c1_g1_i6	O30409	TYCC_BREPA	31.7	341	215	7	1094	81	1640	1965	8.00E-41	169.5	TYCC_BREPA	reviewed	Tyrocidine synthase 3 (Tyrocidine synthase III) [Includes: ATP-dependent asparagine adenylase (AsnA) (Asparagine activase); ATP-dependent glutamine adenylase (GlnA) (Glutamine activase); ATP-dependent tyrosine adenylase (TyrA) (Tyrosine activase); ATP-dependent valine adenylase (ValA) (Valine activase); ATP-dependent ornithine adenylase (OrnA) (Ornithine activase); ATP-dependent leucine adenylase (LeuA) (Leucine activase)]	tycC	Brevibacillus parabrevis	6486	"hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000]"		"hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]"	GO:0016788; GO:0016874; GO:0017000; GO:0031177	antibiotic biosynthetic process [GO:0017000]		NA	NA	NA	NA	NA	NA
TRINITY_DN13863_c0_g1_i1	Q58CZ9	ATTY_BOVIN	57	86	37	0	3	260	232	317	1.20E-23	110.2	ATTY_BOVIN	reviewed	Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase)	TAT	Bos taurus (Bovine)	447	mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	mitochondrion [GO:0005739]	amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]	GO:0004838; GO:0005739; GO:0006520; GO:0006536; GO:0006559; GO:0006572; GO:0009058; GO:0016597; GO:0030170	biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN6296_c0_g1_i1	Q8QZR1	ATTY_MOUSE	53.3	122	57	0	593	228	321	442	4.10E-35	149.4	ATTY_MOUSE	reviewed	Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase)	Tat	Mus musculus (Mouse)	454	mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572]	mitochondrion [GO:0005739]	amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]	GO:0004838; GO:0005739; GO:0006103; GO:0006520; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0014070; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0051384	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572]		NA	NA	NA	NA	NA	NA
TRINITY_DN5325_c0_g1_i3	Q95ZS2	TDC1_CAEEL	65.3	490	169	1	101	1567	75	564	1.80E-199	697.2	TDC1_CAEEL	reviewed	Tyrosine decarboxylase (EC 4.1.1.25)	tdc-1 K01C8.3	Caenorhabditis elegans	705	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]; cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]	GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0030170; GO:0030424; GO:0043025; GO:0043204	cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]		NA	NA	NA	NA	NA	NA
TRINITY_DN5325_c0_g1_i4	Q95ZS2	TDC1_CAEEL	61	577	194	4	101	1741	75	650	3.00E-207	723	TDC1_CAEEL	reviewed	Tyrosine decarboxylase (EC 4.1.1.25)	tdc-1 K01C8.3	Caenorhabditis elegans	705	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]; cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]	GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0030170; GO:0030424; GO:0043025; GO:0043204	cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]		blue	blue	NA	NA	NA	NA
TRINITY_DN15399_c0_g2_i1	Q9VBW3	CAD96_DROME	55	171	66	3	692	183	446	606	2.70E-44	180.3	CAD96_DROME	reviewed	Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)	Cad96Ca HD-14 CG10244	Drosophila melanogaster (Fruit fly)	773	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0007275; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN15399_c0_g2_i2	Q9VBW3	CAD96_DROME	62.6	329	112	3	1120	137	446	764	3.90E-122	439.5	CAD96_DROME	reviewed	Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)	Cad96Ca HD-14 CG10244	Drosophila melanogaster (Fruit fly)	773	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0007275; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN2494_c0_g2_i1	Q9VBW3	CAD96_DROME	57	128	52	2	128	505	646	772	1.60E-36	154.5	CAD96_DROME	reviewed	Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)	Cad96Ca HD-14 CG10244	Drosophila melanogaster (Fruit fly)	773	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0007275; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN18246_c0_g1_i2	Q9VBW3	CAD96_DROME	33.5	182	113	2	647	123	582	762	5.50E-26	119.4	CAD96_DROME	reviewed	Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)	Cad96Ca HD-14 CG10244	Drosophila melanogaster (Fruit fly)	773	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0007275; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i12	P00522	ABL_DROME	66	94	32	0	292	11	548	641	3.00E-35	149.1	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i13	P00522	ABL_DROME	50.6	583	196	10	1852	329	382	947	3.30E-139	496.9	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i14	P00522	ABL_DROME	57.6	441	122	7	1391	213	382	805	2.20E-127	457.2	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i2	P00522	ABL_DROME	36.9	417	171	10	1354	329	548	947	5.10E-52	206.8	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i3	P00522	ABL_DROME	36.2	426	174	10	1390	329	548	947	1.70E-50	201.8	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i4	P00522	ABL_DROME	78.1	260	57	0	790	11	382	641	3.50E-122	439.1	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i7	P00522	ABL_DROME	49.8	592	199	10	1888	329	382	947	1.10E-137	491.9	ABL_DROME	reviewed	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	Abl ABL-1 Dash CG4032	Drosophila melanogaster (Fruit fly)	1620	"apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"	apical cortex [GO:0045179]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2871_c0_g1_i14	P03949	ABL1_CAEEL	55	40	18	0	211	92	351	390	6.60E-07	54.7	ABL1_CAEEL	reviewed	Tyrosine-protein kinase abl-1 (EC 2.7.10.2)	abl-1 M79.1	Caenorhabditis elegans	1224	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; DNA damage checkpoint [GO:0000077]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of engulfment of apoptotic cell [GO:1901075]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0000077; GO:0004715; GO:0005524; GO:0005737; GO:0005886; GO:0007283; GO:0010212; GO:0030336; GO:0043066; GO:0043518; GO:0050829; GO:0050832; GO:1901075	"defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; DNA damage checkpoint [GO:0000077]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of engulfment of apoptotic cell [GO:1901075]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i5	P00519	ABL1_HUMAN	45.3	223	87	6	920	330	410	623	2.30E-40	167.5	ABL1_HUMAN	reviewed	Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)	ABL1 ABL JTK7	Homo sapiens (Human)	1130	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of extracellular matrix organization [GO:1903053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"	actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]	GO:0000278; GO:0000287; GO:0000400; GO:0000405; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0003677; GO:0003713; GO:0003785; GO:0004515; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006298; GO:0006355; GO:0006464; GO:0006468; GO:0006897; GO:0006914; GO:0006974; GO:0006975; GO:0006979; GO:0007050; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008630; GO:0009791; GO:0010506; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030100; GO:0030145; GO:0030155; GO:0030425; GO:0030514; GO:0030516; GO:0031113; GO:0031252; GO:0031965; GO:0032489; GO:0032729; GO:0032743; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0034599; GO:0035791; GO:0038083; GO:0038096; GO:0038189; GO:0038191; GO:0042169; GO:0042770; GO:0042981; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043542; GO:0045184; GO:0045580; GO:0045930; GO:0045931; GO:0045944; GO:0046632; GO:0046777; GO:0046875; GO:0048471; GO:0048536; GO:0048538; GO:0048668; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051149; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051882; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070301; GO:0070373; GO:0070374; GO:0071103; GO:0071222; GO:0071901; GO:0090050; GO:0090135; GO:0098794; GO:1900026; GO:1900272; GO:1900275; GO:1901216; GO:1902036; GO:1903053; GO:1903351; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000145; GO:2000249; GO:2000251; GO:2000352; GO:2000773; GO:2001020	"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; autophagy [GO:0006914]; B-1 B cell homeostasis [GO:0001922]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of extracellular matrix organization [GO:1903053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i6	P00519	ABL1_HUMAN	54.5	145	58	3	433	5	410	548	8.70E-38	157.9	ABL1_HUMAN	reviewed	Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)	ABL1 ABL JTK7	Homo sapiens (Human)	1130	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of extracellular matrix organization [GO:1903053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"	actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]	GO:0000278; GO:0000287; GO:0000400; GO:0000405; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0003677; GO:0003713; GO:0003785; GO:0004515; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006298; GO:0006355; GO:0006464; GO:0006468; GO:0006897; GO:0006914; GO:0006974; GO:0006975; GO:0006979; GO:0007050; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008630; GO:0009791; GO:0010506; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030100; GO:0030145; GO:0030155; GO:0030425; GO:0030514; GO:0030516; GO:0031113; GO:0031252; GO:0031965; GO:0032489; GO:0032729; GO:0032743; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0034599; GO:0035791; GO:0038083; GO:0038096; GO:0038189; GO:0038191; GO:0042169; GO:0042770; GO:0042981; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043542; GO:0045184; GO:0045580; GO:0045930; GO:0045931; GO:0045944; GO:0046632; GO:0046777; GO:0046875; GO:0048471; GO:0048536; GO:0048538; GO:0048668; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051149; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051882; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070301; GO:0070373; GO:0070374; GO:0071103; GO:0071222; GO:0071901; GO:0090050; GO:0090135; GO:0098794; GO:1900026; GO:1900272; GO:1900275; GO:1901216; GO:1902036; GO:1903053; GO:1903351; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000145; GO:2000249; GO:2000251; GO:2000352; GO:2000773; GO:2001020	"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; autophagy [GO:0006914]; B-1 B cell homeostasis [GO:0001922]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of extracellular matrix organization [GO:1903053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13835_c0_g1_i8	P00519	ABL1_HUMAN	71.2	302	79	3	904	5	253	548	1.50E-124	447.2	ABL1_HUMAN	reviewed	Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)	ABL1 ABL JTK7	Homo sapiens (Human)	1130	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of extracellular matrix organization [GO:1903053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"	actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]	GO:0000278; GO:0000287; GO:0000400; GO:0000405; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0003677; GO:0003713; GO:0003785; GO:0004515; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006298; GO:0006355; GO:0006464; GO:0006468; GO:0006897; GO:0006914; GO:0006974; GO:0006975; GO:0006979; GO:0007050; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008630; GO:0009791; GO:0010506; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030100; GO:0030145; GO:0030155; GO:0030425; GO:0030514; GO:0030516; GO:0031113; GO:0031252; GO:0031965; GO:0032489; GO:0032729; GO:0032743; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0034599; GO:0035791; GO:0038083; GO:0038096; GO:0038189; GO:0038191; GO:0042169; GO:0042770; GO:0042981; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043542; GO:0045184; GO:0045580; GO:0045930; GO:0045931; GO:0045944; GO:0046632; GO:0046777; GO:0046875; GO:0048471; GO:0048536; GO:0048538; GO:0048668; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051149; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051882; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070301; GO:0070373; GO:0070374; GO:0071103; GO:0071222; GO:0071901; GO:0090050; GO:0090135; GO:0098794; GO:1900026; GO:1900272; GO:1900275; GO:1901216; GO:1902036; GO:1903053; GO:1903351; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000145; GO:2000249; GO:2000251; GO:2000352; GO:2000773; GO:2001020	"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; autophagy [GO:0006914]; B-1 B cell homeostasis [GO:0001922]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cerebellum morphogenesis [GO:0021587]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation blood vessel branching [GO:1905555]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of extracellular matrix organization [GO:1903053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24994_c0_g1_i2	Q9Z277	BAZ1B_MOUSE	35.9	153	91	1	47	484	1084	1236	4.30E-25	115.9	BAZ1B_MOUSE	reviewed	Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor homolog) (Williams-Beuren syndrome chromosomal region 9 protein homolog)	Baz1b Wbscr9 Wstf	Mus musculus (Mouse)	1479	condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]	condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0000793; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005721; GO:0006333; GO:0006338; GO:0006974; GO:0016572; GO:0016604; GO:0035173; GO:0042393; GO:0043596; GO:0046872	cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]		NA	NA	NA	NA	NA	NA
TRINITY_DN24994_c0_g1_i1	Q9UIG0	BAZ1B_HUMAN	35.7	255	155	3	120	857	982	1236	2.00E-41	171	BAZ1B_HUMAN	reviewed	Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2)	BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF	Homo sapiens (Human)	1483	"condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]; positive regulation of gene expression, epigenetic [GO:0045815]; regulation of transcription by RNA polymerase II [GO:0006357]"	condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]	ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]	GO:0000793; GO:0004713; GO:0004715; GO:0005524; GO:0005654; GO:0005721; GO:0006333; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0016572; GO:0016604; GO:0035173; GO:0042393; GO:0045815	"cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]; positive regulation of gene expression, epigenetic [GO:0045815]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN925_c4_g1_i1	P08630	BTKL_DROME	59	459	177	9	104	1468	308	759	2.90E-146	520	BTKL_DROME	reviewed	Tyrosine-protein kinase Btk29A (EC 2.7.10.2) (Dsrc28C) (Dsrc29a)	Btk29A Src2 Src29A Tec29 CG8049	Drosophila melanogaster (Fruit fly)	786	"apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; courtship behavior [GO:0007619]; determination of adult lifespan [GO:0008340]; DNA endoreduplication [GO:0042023]; dorsal closure [GO:0007391]; female germline ring canal formation [GO:0007301]; head involution [GO:0008258]; imaginal disc-derived male genitalia development [GO:0007485]; JNK cascade [GO:0007254]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; regulation of actin filament polymerization [GO:0030833]; salivary gland morphogenesis [GO:0007435]; sensitization [GO:0046960]; spiracle morphogenesis, open tracheal system [GO:0035277]"	apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005886; GO:0007254; GO:0007300; GO:0007301; GO:0007349; GO:0007391; GO:0007424; GO:0007435; GO:0007485; GO:0007619; GO:0008258; GO:0008340; GO:0018108; GO:0030036; GO:0030717; GO:0030723; GO:0030833; GO:0035277; GO:0038083; GO:0042023; GO:0045172; GO:0045177; GO:0046872; GO:0046960; GO:0048477; GO:0071944	"actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; courtship behavior [GO:0007619]; determination of adult lifespan [GO:0008340]; DNA endoreduplication [GO:0042023]; dorsal closure [GO:0007391]; female germline ring canal formation [GO:0007301]; head involution [GO:0008258]; imaginal disc-derived male genitalia development [GO:0007485]; JNK cascade [GO:0007254]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; regulation of actin filament polymerization [GO:0030833]; salivary gland morphogenesis [GO:0007435]; sensitization [GO:0046960]; spiracle morphogenesis, open tracheal system [GO:0035277]"		blue	blue	NA	NA	NA	NA
TRINITY_DN3065_c0_g1_i1	P41239	CSK_CHICK	56.8	324	134	3	1075	107	126	444	4.20E-102	372.9	CSK_CHICK	reviewed	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase)	CSK	Gallus gallus (Chicken)	450	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; adaptive immune response [GO:0002250]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0002250; GO:0004715; GO:0005524; GO:0005737; GO:0046872	adaptive immune response [GO:0002250]		NA	NA	NA	NA	NA	NA
TRINITY_DN3065_c0_g1_i2	P41239	CSK_CHICK	54.4	239	103	3	783	70	126	359	1.10E-64	248.1	CSK_CHICK	reviewed	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase)	CSK	Gallus gallus (Chicken)	450	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; adaptive immune response [GO:0002250]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0002250; GO:0004715; GO:0005524; GO:0005737; GO:0046872	adaptive immune response [GO:0002250]		NA	NA	NA	NA	NA	NA
TRINITY_DN24646_c0_g1_i1	P41240	CSK_HUMAN	95.5	154	7	0	23	484	288	441	1.60E-82	306.6	CSK_HUMAN	reviewed	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL)	CSK	Homo sapiens (Human)	450	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]	GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375	adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN24646_c0_g1_i2	P41240	CSK_HUMAN	100	105	0	0	3	317	337	441	3.20E-58	225.3	CSK_HUMAN	reviewed	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL)	CSK	Homo sapiens (Human)	450	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]	GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375	adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN34822_c0_g1_i1	P41240	CSK_HUMAN	100	93	0	0	1	279	172	264	1.40E-46	186.4	CSK_HUMAN	reviewed	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL)	CSK	Homo sapiens (Human)	450	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]	GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375	adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i3	Q9V422	RYK2_DROME	63.5	52	19	0	229	74	450	501	3.00E-15	82.4	RYK2_DROME	reviewed	Tyrosine-protein kinase Dnt (EC 2.7.10.1) (Protein doughnut)	dnt CG17559	Drosophila melanogaster (Fruit fly)	584	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; determination of muscle attachment site [GO:0016204]; multicellular organism development [GO:0007275]; muscle attachment [GO:0016203]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005524; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007435; GO:0016203; GO:0016204; GO:0018108; GO:0033674; GO:0043235; GO:0046982	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; determination of muscle attachment site [GO:0016204]; multicellular organism development [GO:0007275]; muscle attachment [GO:0016203]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN35996_c0_g1_i1	P09769	FGR_HUMAN	99.3	152	1	0	457	2	76	227	6.10E-87	321.2	FGR_HUMAN	reviewed	Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr)	FGR SRC2	Homo sapiens (Human)	529	actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of natural killer cell activation [GO:0032815]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0002768; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005576; GO:0005743; GO:0005758; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007229; GO:0008360; GO:0009615; GO:0014068; GO:0015629; GO:0016235; GO:0018108; GO:0019901; GO:0030154; GO:0030282; GO:0030335; GO:0031234; GO:0032587; GO:0032815; GO:0034774; GO:0034987; GO:0034988; GO:0038083; GO:0038096; GO:0042127; GO:0043306; GO:0043312; GO:0043552; GO:0045087; GO:0045088; GO:0045859; GO:0046777; GO:0048705; GO:0050715; GO:0050764; GO:0050830; GO:0070062	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of natural killer cell activation [GO:0032815]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN20109_c0_g1_i1	P09769	FGR_HUMAN	99.2	118	1	0	3	356	372	489	9.30E-67	253.8	FGR_HUMAN	reviewed	Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr)	FGR SRC2	Homo sapiens (Human)	529	actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of natural killer cell activation [GO:0032815]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0002768; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005576; GO:0005743; GO:0005758; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007229; GO:0008360; GO:0009615; GO:0014068; GO:0015629; GO:0016235; GO:0018108; GO:0019901; GO:0030154; GO:0030282; GO:0030335; GO:0031234; GO:0032587; GO:0032815; GO:0034774; GO:0034987; GO:0034988; GO:0038083; GO:0038096; GO:0042127; GO:0043306; GO:0043312; GO:0043552; GO:0045087; GO:0045088; GO:0045859; GO:0046777; GO:0048705; GO:0050715; GO:0050764; GO:0050830; GO:0070062	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of natural killer cell activation [GO:0032815]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN32730_c0_g1_i1	A0JNB0	FYN_BOVIN	100	172	0	0	2	517	73	244	1.30E-98	360.1	FYN_BOVIN	reviewed	Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn)	FYN	Bos taurus (Bovine)	537	actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; forebrain development [GO:0030900]; heart process [GO:0003015]; innate immune response [GO:0045087]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; response to ethanol [GO:0045471]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]	alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]	GO:0001664; GO:0001764; GO:0002250; GO:0003015; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005768; GO:0005829; GO:0005884; GO:0007169; GO:0008360; GO:0010629; GO:0010976; GO:0014069; GO:0018108; GO:0019899; GO:0030154; GO:0030425; GO:0030900; GO:0031234; GO:0031397; GO:0036120; GO:0038083; GO:0042127; GO:0042177; GO:0042531; GO:0042802; GO:0043014; GO:0043123; GO:0044297; GO:0044325; GO:0045087; GO:0045121; GO:0045471; GO:0046872; GO:0046875; GO:0048156; GO:0048813; GO:0050798; GO:0050804; GO:0050852; GO:0050966; GO:0070851; GO:0071560; GO:0090314; GO:0097386; GO:0097718; GO:0098685; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1904646; GO:1905664	activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; forebrain development [GO:0030900]; heart process [GO:0003015]; innate immune response [GO:0045087]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; response to ethanol [GO:0045471]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN29001_c0_g1_i1	A0JNB0	FYN_BOVIN	98.6	69	1	0	2	208	285	353	3.00E-33	141.7	FYN_BOVIN	reviewed	Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn)	FYN	Bos taurus (Bovine)	537	actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; forebrain development [GO:0030900]; heart process [GO:0003015]; innate immune response [GO:0045087]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; response to ethanol [GO:0045471]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]	alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]	GO:0001664; GO:0001764; GO:0002250; GO:0003015; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005768; GO:0005829; GO:0005884; GO:0007169; GO:0008360; GO:0010629; GO:0010976; GO:0014069; GO:0018108; GO:0019899; GO:0030154; GO:0030425; GO:0030900; GO:0031234; GO:0031397; GO:0036120; GO:0038083; GO:0042127; GO:0042177; GO:0042531; GO:0042802; GO:0043014; GO:0043123; GO:0044297; GO:0044325; GO:0045087; GO:0045121; GO:0045471; GO:0046872; GO:0046875; GO:0048156; GO:0048813; GO:0050798; GO:0050804; GO:0050852; GO:0050966; GO:0070851; GO:0071560; GO:0090314; GO:0097386; GO:0097718; GO:0098685; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1904646; GO:1905664	activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; forebrain development [GO:0030900]; heart process [GO:0003015]; innate immune response [GO:0045087]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; response to ethanol [GO:0045471]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN29987_c0_g1_i1	P06241	FYN_HUMAN	100	100	0	0	1	300	438	537	1.10E-56	220.3	FYN_HUMAN	reviewed	Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn)	FYN	Homo sapiens (Human)	537	actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; type 5 metabotropic glutamate receptor binding [GO:0031802]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; blood coagulation [GO:0007596]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; heart process [GO:0003015]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to singlet oxygen [GO:0000304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]	alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; T cell receptor binding [GO:0042608]; type 5 metabotropic glutamate receptor binding [GO:0031802]	GO:0000165; GO:0000304; GO:0001764; GO:0002223; GO:0002250; GO:0003015; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005739; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0006468; GO:0006816; GO:0007169; GO:0007411; GO:0007596; GO:0007612; GO:0007631; GO:0008360; GO:0010629; GO:0010730; GO:0010976; GO:0014068; GO:0014069; GO:0018108; GO:0019221; GO:0019899; GO:0030154; GO:0030168; GO:0030425; GO:0030900; GO:0031234; GO:0031295; GO:0031397; GO:0031802; GO:0035556; GO:0036120; GO:0038083; GO:0038096; GO:0042127; GO:0042177; GO:0042493; GO:0042531; GO:0042542; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043014; GO:0043123; GO:0043524; GO:0043548; GO:0044297; GO:0044325; GO:0045087; GO:0045121; GO:0045471; GO:0046872; GO:0046875; GO:0048010; GO:0048013; GO:0048156; GO:0048471; GO:0048813; GO:0050321; GO:0050690; GO:0050730; GO:0050798; GO:0050804; GO:0050852; GO:0050900; GO:0050966; GO:0051428; GO:0051897; GO:0070851; GO:0071375; GO:0071560; GO:0090314; GO:0097038; GO:0097062; GO:0097386; GO:0097718; GO:0098685; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1903202; GO:1903997; GO:1904645; GO:1904646; GO:1905232; GO:1905430; GO:1905477; GO:1905664; GO:2001056; GO:2001240	activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; blood coagulation [GO:0007596]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; heart process [GO:0003015]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to singlet oxygen [GO:0000304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN35005_c0_g1_i1	P08103	HCK_MOUSE	98.4	62	1	0	189	4	114	175	6.40E-29	127.9	HCK_MOUSE	reviewed	Tyrosine-protein kinase HCK (EC 2.7.10.2) (B-cell/myeloid kinase) (BMK) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p56-HCK/p59-HCK)	Hck	Mus musculus (Mouse)	524	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005654; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006887; GO:0006909; GO:0006954; GO:0007169; GO:0008284; GO:0008360; GO:0018108; GO:0030133; GO:0030154; GO:0031234; GO:0038083; GO:0042127; GO:0042995; GO:0043066; GO:0045087; GO:0046777; GO:0050764; GO:0050830; GO:0051090; GO:0071801; GO:2000251	cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN35005_c0_g1_i1	P08103	HCK_MOUSE	100	36	0	0	293	186	79	114	3.40E-14	79	HCK_MOUSE	reviewed	Tyrosine-protein kinase HCK (EC 2.7.10.2) (B-cell/myeloid kinase) (BMK) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p56-HCK/p59-HCK)	Hck	Mus musculus (Mouse)	524	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005654; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006887; GO:0006909; GO:0006954; GO:0007169; GO:0008284; GO:0008360; GO:0018108; GO:0030133; GO:0030154; GO:0031234; GO:0038083; GO:0042127; GO:0042995; GO:0043066; GO:0045087; GO:0046777; GO:0050764; GO:0050830; GO:0051090; GO:0071801; GO:2000251	cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN20109_c1_g1_i1	P08103	HCK_MOUSE	100	73	0	0	222	4	416	488	3.90E-39	161.4	HCK_MOUSE	reviewed	Tyrosine-protein kinase HCK (EC 2.7.10.2) (B-cell/myeloid kinase) (BMK) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p56-HCK/p59-HCK)	Hck	Mus musculus (Mouse)	524	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005654; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006887; GO:0006909; GO:0006954; GO:0007169; GO:0008284; GO:0008360; GO:0018108; GO:0030133; GO:0030154; GO:0031234; GO:0038083; GO:0042127; GO:0042995; GO:0043066; GO:0045087; GO:0046777; GO:0050764; GO:0050830; GO:0051090; GO:0071801; GO:2000251	cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; exocytosis [GO:0006887]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN16309_c0_g1_i1	P08631	HCK_HUMAN	59.7	139	54	1	419	3	352	488	3.30E-47	189.1	HCK_HUMAN	reviewed	Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)	HCK	Homo sapiens (Human)	526	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; integrin-mediated signaling pathway [GO:0007229]; interferon-gamma-mediated signaling pathway [GO:0060333]; leukocyte degranulation [GO:0043299]; leukocyte migration involved in immune response [GO:0002522]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; respiratory burst after phagocytosis [GO:0045728]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0002522; GO:0002758; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005654; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006954; GO:0007155; GO:0007169; GO:0007229; GO:0007498; GO:0008284; GO:0008360; GO:0018108; GO:0019221; GO:0030133; GO:0030154; GO:0030838; GO:0031234; GO:0031663; GO:0038083; GO:0038096; GO:0042127; GO:0042995; GO:0043066; GO:0043299; GO:0045087; GO:0045728; GO:0046777; GO:0050690; GO:0050727; GO:0050764; GO:0051090; GO:0060333; GO:0071801; GO:2000251	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; integrin-mediated signaling pathway [GO:0007229]; interferon-gamma-mediated signaling pathway [GO:0060333]; leukocyte degranulation [GO:0043299]; leukocyte migration involved in immune response [GO:0002522]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; respiratory burst after phagocytosis [GO:0045728]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN39968_c0_g1_i1	P08631	HCK_HUMAN	100	79	0	0	3	239	139	217	1.70E-40	166	HCK_HUMAN	reviewed	Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)	HCK	Homo sapiens (Human)	526	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; integrin-mediated signaling pathway [GO:0007229]; interferon-gamma-mediated signaling pathway [GO:0060333]; leukocyte degranulation [GO:0043299]; leukocyte migration involved in immune response [GO:0002522]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; respiratory burst after phagocytosis [GO:0045728]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001784; GO:0002522; GO:0002758; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005654; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006954; GO:0007155; GO:0007169; GO:0007229; GO:0007498; GO:0008284; GO:0008360; GO:0018108; GO:0019221; GO:0030133; GO:0030154; GO:0030838; GO:0031234; GO:0031663; GO:0038083; GO:0038096; GO:0042127; GO:0042995; GO:0043066; GO:0043299; GO:0045087; GO:0045728; GO:0046777; GO:0050690; GO:0050727; GO:0050764; GO:0051090; GO:0060333; GO:0071801; GO:2000251	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; integrin-mediated signaling pathway [GO:0007229]; interferon-gamma-mediated signaling pathway [GO:0060333]; leukocyte degranulation [GO:0043299]; leukocyte migration involved in immune response [GO:0002522]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; respiratory burst after phagocytosis [GO:0045728]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN5434_c0_g1_i1	Q24592	JAK_DROME	49.3	150	70	2	12	443	978	1127	6.40E-33	141.7	JAK_DROME	reviewed	Tyrosine-protein kinase hopscotch (EC 2.7.10.2)	hop HD-160 CG1594	Drosophila melanogaster (Fruit fly)	1177	cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; defense response to virus [GO:0051607]; equator specification [GO:0045317]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc morphogenesis [GO:0007455]; haltere disc morphogenesis [GO:0007481]; hemocyte differentiation [GO:0042386]; hindgut morphogenesis [GO:0007442]; larval lymph gland hemopoiesis [GO:0035167]; leg disc morphogenesis [GO:0007478]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; mediolateral intercalation [GO:0060031]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]; peptidyl-tyrosine autophosphorylation [GO:0038083]; periodic partitioning [GO:0007365]; positive regulation of heterochromatin assembly [GO:0031453]; primary sex determination [GO:0007538]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of embryonic cell shape [GO:0016476]; regulation of hemocyte proliferation [GO:0035206]; stem cell population maintenance [GO:0019827]; tyrosine phosphorylation of STAT protein [GO:0007260]; wing disc morphogenesis [GO:0007472]	cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]	ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001745; GO:0001751; GO:0004713; GO:0004715; GO:0005126; GO:0005524; GO:0005829; GO:0005856; GO:0007259; GO:0007260; GO:0007298; GO:0007350; GO:0007365; GO:0007399; GO:0007424; GO:0007442; GO:0007455; GO:0007472; GO:0007478; GO:0007481; GO:0007538; GO:0007616; GO:0009898; GO:0012505; GO:0016318; GO:0016476; GO:0019827; GO:0030707; GO:0030713; GO:0031453; GO:0035167; GO:0035206; GO:0038083; GO:0042067; GO:0042386; GO:0045317; GO:0045475; GO:0048749; GO:0051607; GO:0060031	blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; defense response to virus [GO:0051607]; equator specification [GO:0045317]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc morphogenesis [GO:0007455]; haltere disc morphogenesis [GO:0007481]; hemocyte differentiation [GO:0042386]; hindgut morphogenesis [GO:0007442]; larval lymph gland hemopoiesis [GO:0035167]; leg disc morphogenesis [GO:0007478]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; mediolateral intercalation [GO:0060031]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]; peptidyl-tyrosine autophosphorylation [GO:0038083]; periodic partitioning [GO:0007365]; positive regulation of heterochromatin assembly [GO:0031453]; primary sex determination [GO:0007538]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of embryonic cell shape [GO:0016476]; regulation of hemocyte proliferation [GO:0035206]; stem cell population maintenance [GO:0019827]; tyrosine phosphorylation of STAT protein [GO:0007260]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN5434_c0_g1_i2	Q24592	JAK_DROME	49.3	150	70	2	12	443	978	1127	6.40E-33	141.7	JAK_DROME	reviewed	Tyrosine-protein kinase hopscotch (EC 2.7.10.2)	hop HD-160 CG1594	Drosophila melanogaster (Fruit fly)	1177	cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; defense response to virus [GO:0051607]; equator specification [GO:0045317]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc morphogenesis [GO:0007455]; haltere disc morphogenesis [GO:0007481]; hemocyte differentiation [GO:0042386]; hindgut morphogenesis [GO:0007442]; larval lymph gland hemopoiesis [GO:0035167]; leg disc morphogenesis [GO:0007478]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; mediolateral intercalation [GO:0060031]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]; peptidyl-tyrosine autophosphorylation [GO:0038083]; periodic partitioning [GO:0007365]; positive regulation of heterochromatin assembly [GO:0031453]; primary sex determination [GO:0007538]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of embryonic cell shape [GO:0016476]; regulation of hemocyte proliferation [GO:0035206]; stem cell population maintenance [GO:0019827]; tyrosine phosphorylation of STAT protein [GO:0007260]; wing disc morphogenesis [GO:0007472]	cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]	ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]	GO:0001745; GO:0001751; GO:0004713; GO:0004715; GO:0005126; GO:0005524; GO:0005829; GO:0005856; GO:0007259; GO:0007260; GO:0007298; GO:0007350; GO:0007365; GO:0007399; GO:0007424; GO:0007442; GO:0007455; GO:0007472; GO:0007478; GO:0007481; GO:0007538; GO:0007616; GO:0009898; GO:0012505; GO:0016318; GO:0016476; GO:0019827; GO:0030707; GO:0030713; GO:0031453; GO:0035167; GO:0035206; GO:0038083; GO:0042067; GO:0042386; GO:0045317; GO:0045475; GO:0048749; GO:0051607; GO:0060031	blastoderm segmentation [GO:0007350]; border follicle cell migration [GO:0007298]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; defense response to virus [GO:0051607]; equator specification [GO:0045317]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc morphogenesis [GO:0007455]; haltere disc morphogenesis [GO:0007481]; hemocyte differentiation [GO:0042386]; hindgut morphogenesis [GO:0007442]; larval lymph gland hemopoiesis [GO:0035167]; leg disc morphogenesis [GO:0007478]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; mediolateral intercalation [GO:0060031]; nervous system development [GO:0007399]; ommatidial rotation [GO:0016318]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]; peptidyl-tyrosine autophosphorylation [GO:0038083]; periodic partitioning [GO:0007365]; positive regulation of heterochromatin assembly [GO:0031453]; primary sex determination [GO:0007538]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of embryonic cell shape [GO:0016476]; regulation of hemocyte proliferation [GO:0035206]; stem cell population maintenance [GO:0019827]; tyrosine phosphorylation of STAT protein [GO:0007260]; wing disc morphogenesis [GO:0007472]		NA	NA	NA	NA	NA	NA
TRINITY_DN3405_c0_g1_i1	P53356	HTK16_HYDVU	51.2	320	148	5	1054	98	440	752	5.10E-88	326.2	HTK16_HYDVU	reviewed	Tyrosine-protein kinase HTK16 (EC 2.7.10.2)	HTK16	Hydra vulgaris (Hydra) (Hydra attenuata)	757	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]		ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN34404_c0_g1_i1	Q08881	ITK_HUMAN	100	67	0	0	3	203	447	513	1.50E-32	139.4	ITK_HUMAN	reviewed	Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk)	ITK EMT LYK	Homo sapiens (Human)	620	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; cytokine production [GO:0001816]; Fc-epsilon receptor signaling pathway [GO:0038095]; gamma-delta T cell activation [GO:0046629]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; intracellular signal transduction [GO:0035556]; NK T cell differentiation [GO:0001865]; peptidyl-tyrosine autophosphorylation [GO:0038083]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0001816; GO:0001865; GO:0002250; GO:0004715; GO:0005524; GO:0005634; GO:0005829; GO:0005911; GO:0006968; GO:0007165; GO:0007202; GO:0032609; GO:0032633; GO:0035556; GO:0038083; GO:0038095; GO:0042110; GO:0046629; GO:0046872; GO:0050852; GO:0050853	activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; cytokine production [GO:0001816]; Fc-epsilon receptor signaling pathway [GO:0038095]; gamma-delta T cell activation [GO:0046629]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; intracellular signal transduction [GO:0035556]; NK T cell differentiation [GO:0001865]; peptidyl-tyrosine autophosphorylation [GO:0038083]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN33171_c0_g1_i1	Q08881	ITK_HUMAN	100	72	0	0	216	1	518	589	1.80E-36	152.5	ITK_HUMAN	reviewed	Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk)	ITK EMT LYK	Homo sapiens (Human)	620	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; cytokine production [GO:0001816]; Fc-epsilon receptor signaling pathway [GO:0038095]; gamma-delta T cell activation [GO:0046629]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; intracellular signal transduction [GO:0035556]; NK T cell differentiation [GO:0001865]; peptidyl-tyrosine autophosphorylation [GO:0038083]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0001816; GO:0001865; GO:0002250; GO:0004715; GO:0005524; GO:0005634; GO:0005829; GO:0005911; GO:0006968; GO:0007165; GO:0007202; GO:0032609; GO:0032633; GO:0035556; GO:0038083; GO:0038095; GO:0042110; GO:0046629; GO:0046872; GO:0050852; GO:0050853	activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; cytokine production [GO:0001816]; Fc-epsilon receptor signaling pathway [GO:0038095]; gamma-delta T cell activation [GO:0046629]; interferon-gamma production [GO:0032609]; interleukin-4 production [GO:0032633]; intracellular signal transduction [GO:0035556]; NK T cell differentiation [GO:0001865]; peptidyl-tyrosine autophosphorylation [GO:0038083]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]		NA	NA	NA	NA	NA	NA
TRINITY_DN27069_c0_g1_i1	P23458	JAK1_HUMAN	100	88	0	0	266	3	965	1052	3.90E-46	184.9	JAK1_HUMAN	reviewed	Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1)	JAK1 JAK1A JAK1B	Homo sapiens (Human)	1154	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]	ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]	GO:0000165; GO:0004713; GO:0004715; GO:0005131; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0019221; GO:0019903; GO:0031625; GO:0031730; GO:0034112; GO:0035556; GO:0035722; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0038114; GO:0046677; GO:0046872; GO:0060333; GO:0060334; GO:0060337; GO:0070102; GO:0070106; GO:0070757; GO:0150105; GO:1903672	cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]		NA	NA	NA	NA	NA	NA
TRINITY_DN39284_c0_g1_i1	O60674	JAK2_HUMAN	100	84	0	0	253	2	944	1027	2.10E-44	179.1	JAK2_HUMAN	reviewed	Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2)	JAK2	Homo sapiens (Human)	1132	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]; actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; activation of MAPKK activity [GO:0000186]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histone H3-Y41 phosphorylation [GO:0035409]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; MAPK cascade [GO:0000165]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell activation [GO:0050867]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]	GO:0000165; GO:0000186; GO:0000791; GO:0001774; GO:0002250; GO:0004672; GO:0004713; GO:0004715; GO:0005102; GO:0005131; GO:0005143; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006915; GO:0006919; GO:0007165; GO:0007167; GO:0007186; GO:0007204; GO:0007259; GO:0007260; GO:0007498; GO:0007596; GO:0008022; GO:0008285; GO:0008631; GO:0010667; GO:0010811; GO:0010870; GO:0014068; GO:0018108; GO:0019221; GO:0019901; GO:0020037; GO:0022408; GO:0030041; GO:0030154; GO:0030218; GO:0030335; GO:0031103; GO:0031702; GO:0031904; GO:0031959; GO:0032024; GO:0032496; GO:0032516; GO:0032731; GO:0032760; GO:0033130; GO:0033194; GO:0033209; GO:0034612; GO:0035401; GO:0035409; GO:0035556; GO:0035722; GO:0038155; GO:0042169; GO:0042307; GO:0042393; GO:0042531; GO:0042535; GO:0042802; GO:0042976; GO:0042981; GO:0043388; GO:0043392; GO:0043524; GO:0043548; GO:0043560; GO:0045121; GO:0045348; GO:0045428; GO:0045429; GO:0045597; GO:0045822; GO:0046425; GO:0046579; GO:0046677; GO:0046777; GO:0046872; GO:0048008; GO:0050727; GO:0050729; GO:0050731; GO:0050804; GO:0050867; GO:0051091; GO:0051428; GO:0051770; GO:0060333; GO:0060334; GO:0060391; GO:0060396; GO:0060397; GO:0060399; GO:0061180; GO:0070102; GO:0070106; GO:0070671; GO:0070757; GO:0097191; GO:0097296; GO:0098794; GO:0098978; GO:0099527; GO:0120162; GO:1902728; GO:1904037; GO:1904707	actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; activation of MAPKK activity [GO:0000186]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histone H3-Y41 phosphorylation [GO:0035409]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; MAPK cascade [GO:0000165]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell activation [GO:0050867]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260]		NA	NA	NA	NA	NA	NA
TRINITY_DN21248_c0_g2_i1	P06239	LCK_HUMAN	100	237	0	0	2	712	234	470	1.00E-136	487.3	LCK_HUMAN	reviewed	Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK)	LCK	Homo sapiens (Human)	509	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of defense response to virus by virus [GO:0050690]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]	ATPase binding [GO:0051117]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]	GO:0000242; GO:0001772; GO:0001784; GO:0004713; GO:0004715; GO:0004722; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0006882; GO:0006919; GO:0007169; GO:0008022; GO:0018108; GO:0019901; GO:0019903; GO:0030097; GO:0030154; GO:0030168; GO:0030217; GO:0031234; GO:0031295; GO:0034116; GO:0038083; GO:0042127; GO:0042169; GO:0042493; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043548; GO:0045087; GO:0045121; GO:0050690; GO:0050852; GO:0050853; GO:0050862; GO:0050870; GO:0050900; GO:0051117; GO:0051209; GO:0051249; GO:0051897; GO:0070062; GO:1903039; GO:2001244	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of defense response to virus by virus [GO:0050690]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN21248_c0_g1_i1	Q5PXS1	LCK_AOTNA	100	75	0	0	225	1	147	221	2.60E-38	158.7	LCK_AOTNA	reviewed	Tyrosine-protein kinase Lck (EC 2.7.10.2) (Lymphocyte cell-specific protein-tyrosine kinase) (Proto-oncogene Lck) (p56-LCK)	LCK	Aotus nancymaae (Ma's night monkey)	509	cytosol [GO:0005829]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular zinc ion homeostasis [GO:0006882]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of T cell activation [GO:0050870]; response to drug [GO:0042493]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]	GO:0000242; GO:0004713; GO:0004715; GO:0004722; GO:0005524; GO:0005829; GO:0005886; GO:0006882; GO:0006919; GO:0030217; GO:0042169; GO:0042493; GO:0045121; GO:0050870; GO:2001244	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular zinc ion homeostasis [GO:0006882]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of T cell activation [GO:0050870]; response to drug [GO:0042493]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN37160_c0_g1_i1	P07948	LYN_HUMAN	100	106	0	0	319	2	356	461	1.20E-57	223.4	LYN_HUMAN	reviewed	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	LYN JTK8	Homo sapiens (Human)	512	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]	GO:0001782; GO:0001817; GO:0001932; GO:0001933; GO:0001934; GO:0002223; GO:0002250; GO:0002431; GO:0002513; GO:0002553; GO:0002576; GO:0002762; GO:0002768; GO:0002774; GO:0002902; GO:0004713; GO:0004715; GO:0005102; GO:0005161; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005758; GO:0005794; GO:0005829; GO:0005886; GO:0005912; GO:0006468; GO:0006974; GO:0006991; GO:0007165; GO:0007169; GO:0007596; GO:0008284; GO:0008285; GO:0009636; GO:0009725; GO:0009743; GO:0010976; GO:0014003; GO:0014068; GO:0014069; GO:0014070; GO:0016032; GO:0016301; GO:0017124; GO:0018108; GO:0019899; GO:0030061; GO:0030154; GO:0030168; GO:0030218; GO:0030335; GO:0030889; GO:0031175; GO:0031234; GO:0031295; GO:0031625; GO:0031663; GO:0031668; GO:0032868; GO:0033003; GO:0033628; GO:0034136; GO:0034142; GO:0034144; GO:0034605; GO:0034666; GO:0035556; GO:0038083; GO:0038095; GO:0038096; GO:0042127; GO:0042493; GO:0042531; GO:0043015; GO:0043200; GO:0043208; GO:0043231; GO:0043304; GO:0043407; GO:0043552; GO:0044325; GO:0045087; GO:0045121; GO:0045646; GO:0046579; GO:0046777; GO:0046875; GO:0048013; GO:0048471; GO:0048678; GO:0050663; GO:0050707; GO:0050727; GO:0050777; GO:0050853; GO:0050855; GO:0050900; GO:0051219; GO:0051272; GO:0051279; GO:0060252; GO:0060369; GO:0060397; GO:0070062; GO:0070304; GO:0070372; GO:0070373; GO:0070447; GO:0070667; GO:0070668; GO:0071300; GO:0090025; GO:0090330; GO:0097028; GO:0140031; GO:1902532; GO:1902961; GO:2000670	adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN31795_c0_g1_i1	P07948	LYN_HUMAN	100	102	0	0	306	1	352	453	1.80E-55	216.1	LYN_HUMAN	reviewed	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	LYN JTK8	Homo sapiens (Human)	512	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]	GO:0001782; GO:0001817; GO:0001932; GO:0001933; GO:0001934; GO:0002223; GO:0002250; GO:0002431; GO:0002513; GO:0002553; GO:0002576; GO:0002762; GO:0002768; GO:0002774; GO:0002902; GO:0004713; GO:0004715; GO:0005102; GO:0005161; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005758; GO:0005794; GO:0005829; GO:0005886; GO:0005912; GO:0006468; GO:0006974; GO:0006991; GO:0007165; GO:0007169; GO:0007596; GO:0008284; GO:0008285; GO:0009636; GO:0009725; GO:0009743; GO:0010976; GO:0014003; GO:0014068; GO:0014069; GO:0014070; GO:0016032; GO:0016301; GO:0017124; GO:0018108; GO:0019899; GO:0030061; GO:0030154; GO:0030168; GO:0030218; GO:0030335; GO:0030889; GO:0031175; GO:0031234; GO:0031295; GO:0031625; GO:0031663; GO:0031668; GO:0032868; GO:0033003; GO:0033628; GO:0034136; GO:0034142; GO:0034144; GO:0034605; GO:0034666; GO:0035556; GO:0038083; GO:0038095; GO:0038096; GO:0042127; GO:0042493; GO:0042531; GO:0043015; GO:0043200; GO:0043208; GO:0043231; GO:0043304; GO:0043407; GO:0043552; GO:0044325; GO:0045087; GO:0045121; GO:0045646; GO:0046579; GO:0046777; GO:0046875; GO:0048013; GO:0048471; GO:0048678; GO:0050663; GO:0050707; GO:0050727; GO:0050777; GO:0050853; GO:0050855; GO:0050900; GO:0051219; GO:0051272; GO:0051279; GO:0060252; GO:0060369; GO:0060397; GO:0070062; GO:0070304; GO:0070372; GO:0070373; GO:0070447; GO:0070667; GO:0070668; GO:0071300; GO:0090025; GO:0090330; GO:0097028; GO:0140031; GO:1902532; GO:1902961; GO:2000670	adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29956_c0_g1_i1	P25911	LYN_MOUSE	100	143	0	0	3	431	67	209	8.10E-81	300.8	LYN_MOUSE	reviewed	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	Lyn	Mus musculus (Mouse)	512	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; erythropoietin receptor binding [GO:0005128]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; hemoglobin biosynthetic process [GO:0042541]; hemopoiesis [GO:0030097]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; protein-containing complex [GO:0032991]"	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; erythropoietin receptor binding [GO:0005128]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]	GO:0001782; GO:0001817; GO:0001933; GO:0001934; GO:0002250; GO:0002431; GO:0002513; GO:0002553; GO:0002576; GO:0002762; GO:0002768; GO:0002774; GO:0002902; GO:0004672; GO:0004713; GO:0004715; GO:0005102; GO:0005128; GO:0005161; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005758; GO:0005794; GO:0005829; GO:0005886; GO:0005912; GO:0006468; GO:0006974; GO:0006991; GO:0007165; GO:0007169; GO:0008284; GO:0008285; GO:0009636; GO:0009725; GO:0009743; GO:0010976; GO:0014003; GO:0014069; GO:0014070; GO:0016020; GO:0017124; GO:0018108; GO:0019899; GO:0030061; GO:0030097; GO:0030154; GO:0030218; GO:0030335; GO:0030889; GO:0031175; GO:0031234; GO:0031625; GO:0031663; GO:0031668; GO:0031966; GO:0032868; GO:0032991; GO:0033003; GO:0033628; GO:0034136; GO:0034142; GO:0034144; GO:0034605; GO:0034666; GO:0035556; GO:0038083; GO:0042127; GO:0042327; GO:0042493; GO:0042531; GO:0042541; GO:0043015; GO:0043200; GO:0043208; GO:0043231; GO:0043304; GO:0043407; GO:0043552; GO:0044325; GO:0044877; GO:0045087; GO:0045121; GO:0045646; GO:0046777; GO:0046875; GO:0048471; GO:0048678; GO:0050663; GO:0050707; GO:0050727; GO:0050853; GO:0050855; GO:0051219; GO:0051272; GO:0051279; GO:0060252; GO:0060369; GO:0070304; GO:0070372; GO:0070373; GO:0070447; GO:0070667; GO:0070668; GO:0071300; GO:0090025; GO:0090330; GO:0097028; GO:0098978; GO:0099091; GO:0140031; GO:1902532; GO:1902961; GO:2000670	adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; cytokine secretion [GO:0050663]; dendritic cell differentiation [GO:0097028]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; hemoglobin biosynthetic process [GO:0042541]; hemopoiesis [GO:0030097]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of cytokine secretion [GO:0050707]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of inflammatory response [GO:0050727]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN74_c0_g1_i2	Q06805	TIE1_BOVIN	29.8	262	137	9	276	995	89	325	3.60E-23	110.5	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN74_c0_g1_i6	Q06805	TIE1_BOVIN	31.9	248	132	9	433	1125	98	325	9.70E-25	115.9	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN74_c0_g1_i8	Q06805	TIE1_BOVIN	33.7	190	99	8	76	597	147	325	1.50E-19	97.8	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN8719_c0_g1_i4	Q06805	TIE1_BOVIN	36.8	95	56	2	298	20	230	322	9.10E-15	80.9	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN8719_c0_g1_i6	Q06805	TIE1_BOVIN	39.4	71	41	1	260	54	230	300	6.90E-11	67.8	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN8719_c0_g1_i7	Q06805	TIE1_BOVIN	37.9	95	55	2	298	20	230	322	1.60E-14	80.1	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN8719_c0_g1_i8	Q06805	TIE1_BOVIN	38.2	76	45	1	223	2	230	305	9.50E-09	60.5	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i1	Q06805	TIE1_BOVIN	57.8	45	19	0	106	240	213	257	3.00E-11	68.9	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i12	Q06805	TIE1_BOVIN	42	88	43	1	107	370	178	257	2.20E-13	76.6	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i13	Q06805	TIE1_BOVIN	41.3	126	64	4	53	403	206	330	3.40E-20	99.4	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i17	Q06805	TIE1_BOVIN	37.7	162	83	5	54	512	178	330	6.00E-22	105.5	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i18	Q06805	TIE1_BOVIN	51.9	52	25	0	56	211	206	257	2.60E-11	68.9	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i2	Q06805	TIE1_BOVIN	40.6	96	49	1	107	394	178	265	1.80E-14	80.5	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i21	Q06805	TIE1_BOVIN	39.5	119	62	4	106	435	213	330	2.20E-17	90.1	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i24	Q06805	TIE1_BOVIN	40.5	84	48	1	53	298	206	289	2.60E-14	79.3	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i26	Q06805	TIE1_BOVIN	50	60	30	0	53	232	206	265	8.30E-13	74.3	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i3	Q06805	TIE1_BOVIN	41.7	84	47	1	56	301	206	289	7.00E-15	81.3	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN1581_c0_g1_i5	Q06805	TIE1_BOVIN	44.3	79	36	1	1	237	184	254	1.60E-12	73.6	TIE1_BOVIN	reviewed	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	TIE1 TIE TIE-1	Bos taurus (Bovine)	1136	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0033674; GO:0043235; GO:0045766	angiogenesis [GO:0001525]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN31194_c0_g1_i1	Q00993	UFO_MOUSE	100	75	0	0	227	3	549	623	1.50E-38	159.5	UFO_MOUSE	reviewed	Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (Adhesion-related kinase)	Axl Ark Ufo	Mus musculus (Mouse)	888	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; viral entry into host cell [GO:0046718]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001764; GO:0001779; GO:0001786; GO:0001818; GO:0001961; GO:0001974; GO:0004713; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0007167; GO:0007169; GO:0007275; GO:0007283; GO:0007399; GO:0009986; GO:0015629; GO:0016477; GO:0021885; GO:0030154; GO:0030168; GO:0031100; GO:0031668; GO:0032036; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0033674; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043277; GO:0043491; GO:0043524; GO:0043548; GO:0044228; GO:0045087; GO:0046718; GO:0048469; GO:0048549; GO:0051250; GO:0051897; GO:0060068; GO:0070301; GO:0071222; GO:0097028; GO:0097350; GO:2000669	animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN31098_c0_g1_i1	Q00993	UFO_MOUSE	100	159	0	0	477	1	640	798	2.50E-91	335.9	UFO_MOUSE	reviewed	Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (Adhesion-related kinase)	Axl Ark Ufo	Mus musculus (Mouse)	888	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; viral entry into host cell [GO:0046718]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001764; GO:0001779; GO:0001786; GO:0001818; GO:0001961; GO:0001974; GO:0004713; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0007167; GO:0007169; GO:0007275; GO:0007283; GO:0007399; GO:0009986; GO:0015629; GO:0016477; GO:0021885; GO:0030154; GO:0030168; GO:0031100; GO:0031668; GO:0032036; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0033674; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043277; GO:0043491; GO:0043524; GO:0043548; GO:0044228; GO:0045087; GO:0046718; GO:0048469; GO:0048549; GO:0051250; GO:0051897; GO:0060068; GO:0070301; GO:0071222; GO:0097028; GO:0097350; GO:2000669	animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i1	P34925	RYK_HUMAN	76.1	46	11	0	214	77	526	571	9.50E-17	87.4	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i10	P34925	RYK_HUMAN	61.7	141	54	0	502	80	431	571	1.60E-52	207.2	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i12	P34925	RYK_HUMAN	67.6	68	22	0	206	3	526	593	6.00E-24	111.3	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i13	P34925	RYK_HUMAN	66.7	99	33	0	376	80	473	571	1.20E-39	164.1	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i14	P34925	RYK_HUMAN	55.8	95	42	0	356	72	431	525	2.70E-28	126.3	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i2	P34925	RYK_HUMAN	58.9	163	67	0	491	3	431	593	2.70E-58	226.5	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN3815_c0_g1_i8	P34925	RYK_HUMAN	63.6	121	44	0	365	3	473	593	9.70E-47	187.6	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN38891_c0_g1_i1	P34925	RYK_HUMAN	99.4	175	1	0	526	2	423	597	4.20E-100	365.2	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN25540_c0_g1_i1	P34925	RYK_HUMAN	51.9	189	83	1	1	543	419	607	1.50E-55	217.2	RYK_HUMAN	reviewed	Tyrosine-protein kinase RYK (EC 2.7.10.1)	RYK JTK5A	Homo sapiens (Human)	607	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007275; GO:0007399; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016055; GO:0016301; GO:0017147; GO:0018108; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; multicellular organism development [GO:0007275]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]		NA	NA	NA	NA	NA	NA
TRINITY_DN2387_c0_g1_i1	Q24145	SHARK_DROME	42.4	99	49	3	303	581	10	106	3.70E-11	70.5	SHARK_DROME	reviewed	Tyrosine-protein kinase Shark (EC 2.7.10.2)	Shark Tk7 CG18247	Drosophila melanogaster (Fruit fly)	939	"cell cortex [GO:0005938]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, elongation of leading edge cells [GO:0007394]; eggshell chorion assembly [GO:0007306]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]	GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005938; GO:0007169; GO:0007254; GO:0007306; GO:0007391; GO:0007394; GO:0030154; GO:0031234; GO:0038083; GO:0042127; GO:0043277; GO:0045087; GO:0045199; GO:0046843	"apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, elongation of leading edge cells [GO:0007394]; eggshell chorion assembly [GO:0007306]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell population proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i6	P13115	SRC1_XENLA	44.9	450	238	8	214	1548	86	530	2.40E-105	384.4	SRC1_XENLA	reviewed	Tyrosine-protein kinase Src-1 (EC 2.7.10.2) (p60-Src-1)	src-a src1	Xenopus laevis (African clawed frog)	532	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i13	P13116	SRC2_XENLA	44.7	450	239	8	214	1548	86	530	2.60E-104	380.9	SRC2_XENLA	reviewed	Tyrosine-protein kinase Src-2 (EC 2.7.10.2) (p60-Src-2)	src-b src2	Xenopus laevis (African clawed frog)	532	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524; GO:0005886			blue	blue	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i27	P13116	SRC2_XENLA	45.1	450	237	8	214	1548	86	530	6.10E-105	383.3	SRC2_XENLA	reviewed	Tyrosine-protein kinase Src-2 (EC 2.7.10.2) (p60-Src-2)	src-b src2	Xenopus laevis (African clawed frog)	532	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524; GO:0005886			NA	NA	NA	NA	NA	NA
TRINITY_DN2763_c0_g1_i1	Q9V9J3	SRC42_DROME	79.9	533	85	4	93	1682	1	514	3.20E-248	859	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		blue	blue	NA	NA	NA	NA
TRINITY_DN32687_c0_g1_i1	Q9V9J3	SRC42_DROME	61.6	73	28	0	235	453	69	141	3.70E-20	99.4	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i15	Q9V9J3	SRC42_DROME	44.8	471	239	10	28	1413	53	511	6.60E-106	386	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i2	Q9V9J3	SRC42_DROME	45	413	206	10	28	1239	53	453	1.30E-89	332	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i23	Q9V9J3	SRC42_DROME	43.6	443	225	12	76	1371	25	453	4.80E-90	333.6	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i7	Q9V9J3	SRC42_DROME	43.5	501	258	12	76	1545	25	511	2.50E-106	387.5	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32548_c0_g1_i1	Q9V9J3	SRC42_DROME	61.2	67	26	0	12	212	269	335	2.70E-16	85.5	SRC42_DROME	reviewed	Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41)	Src42A Src41 TK5 CG44128	Drosophila melanogaster (Fruit fly)	517	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0007623; GO:0016477; GO:0018108; GO:0030154; GO:0031234; GO:0034332; GO:0036335; GO:0038083; GO:0042059; GO:0042127; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136	"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc fusion, thorax closure [GO:0046529]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9040_c0_g2_i1	P00528	SRC64_DROME	57	393	167	1	1256	84	160	552	2.90E-139	496.5	SRC64_DROME	reviewed	Tyrosine-protein kinase Src64B (Dsrc64) (EC 2.7.10.2)	Src64B Src1 CG7524	Drosophila melanogaster (Fruit fly)	552	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]	GO:0000185; GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0007169; GO:0007293; GO:0007300; GO:0007301; GO:0007349; GO:0007411; GO:0007424; GO:0007435; GO:0007616; GO:0008064; GO:0008302; GO:0008335; GO:0016319; GO:0018108; GO:0030036; GO:0030046; GO:0030154; GO:0030708; GO:0030717; GO:0030723; GO:0031234; GO:0034332; GO:0036058; GO:0038083; GO:0042127; GO:0045087; GO:0045172; GO:0045742; GO:0045743; GO:0045874; GO:0045886; GO:0048167; GO:0048477; GO:0090136; GO:0120176	"actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9040_c0_g2_i4	P00528	SRC64_DROME	53.8	143	66	0	474	46	160	302	1.10E-43	177.6	SRC64_DROME	reviewed	Tyrosine-protein kinase Src64B (Dsrc64) (EC 2.7.10.2)	Src64B Src1 CG7524	Drosophila melanogaster (Fruit fly)	552	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]	GO:0000185; GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0007169; GO:0007293; GO:0007300; GO:0007301; GO:0007349; GO:0007411; GO:0007424; GO:0007435; GO:0007616; GO:0008064; GO:0008302; GO:0008335; GO:0016319; GO:0018108; GO:0030036; GO:0030046; GO:0030154; GO:0030708; GO:0030717; GO:0030723; GO:0031234; GO:0034332; GO:0036058; GO:0038083; GO:0042127; GO:0045087; GO:0045172; GO:0045742; GO:0045743; GO:0045874; GO:0045886; GO:0048167; GO:0048477; GO:0090136; GO:0120176	"actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9040_c0_g2_i7	P00528	SRC64_DROME	58.8	114	45	1	419	84	439	552	2.30E-39	163.3	SRC64_DROME	reviewed	Tyrosine-protein kinase Src64B (Dsrc64) (EC 2.7.10.2)	Src64B Src1 CG7524	Drosophila melanogaster (Fruit fly)	552	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]	GO:0000185; GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0007169; GO:0007293; GO:0007300; GO:0007301; GO:0007349; GO:0007411; GO:0007424; GO:0007435; GO:0007616; GO:0008064; GO:0008302; GO:0008335; GO:0016319; GO:0018108; GO:0030036; GO:0030046; GO:0030154; GO:0030708; GO:0030717; GO:0030723; GO:0031234; GO:0034332; GO:0036058; GO:0038083; GO:0042127; GO:0045087; GO:0045172; GO:0045742; GO:0045743; GO:0045874; GO:0045886; GO:0048167; GO:0048477; GO:0090136; GO:0120176	"actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9040_c0_g2_i8	P00528	SRC64_DROME	58.8	226	91	1	710	39	319	544	8.80E-78	291.6	SRC64_DROME	reviewed	Tyrosine-protein kinase Src64B (Dsrc64) (EC 2.7.10.2)	Src64B Src1 CG7524	Drosophila melanogaster (Fruit fly)	552	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; germline ring canal [GO:0045172]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]	GO:0000185; GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0007169; GO:0007293; GO:0007300; GO:0007301; GO:0007349; GO:0007411; GO:0007424; GO:0007435; GO:0007616; GO:0008064; GO:0008302; GO:0008335; GO:0016319; GO:0018108; GO:0030036; GO:0030046; GO:0030154; GO:0030708; GO:0030717; GO:0030723; GO:0031234; GO:0034332; GO:0036058; GO:0038083; GO:0042127; GO:0045087; GO:0045172; GO:0045742; GO:0045743; GO:0045874; GO:0045886; GO:0048167; GO:0048477; GO:0090136; GO:0120176	"actin cytoskeleton organization [GO:0030036]; activation of MAPKKK activity [GO:0000185]; adherens junction organization [GO:0034332]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cellularization [GO:0007349]; epithelial cell-cell adhesion [GO:0090136]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; female germline ring canal stabilization [GO:0008335]; filtration diaphragm assembly [GO:0036058]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; mushroom body development [GO:0016319]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]; parallel actin filament bundle assembly [GO:0030046]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of sevenless signaling pathway [GO:0045874]; positive regulation of torso signaling pathway [GO:0120176]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell population proliferation [GO:0042127]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"		NA	NA	NA	NA	NA	NA
TRINITY_DN973_c0_g1_i11	P42689	SRK3_SPOLA	51.6	244	113	3	8	727	91	333	1.50E-69	264.6	SRK3_SPOLA	reviewed	Tyrosine-protein kinase SRK3 (EC 2.7.10.2) (Fragment)	SRK3	Spongilla lacustris (Freshwater sponge)	334	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN30524_c0_g1_i1	P43405	KSYK_HUMAN	100	76	0	0	231	4	510	585	2.00E-41	169.1	KSYK_HUMAN	reviewed	Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)	SYK	Homo sapiens (Human)	635	B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]; activation of JUN kinase activity [GO:0007257]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process [GO:0045425]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]	B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]	GO:0001525; GO:0001784; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0004672; GO:0004674; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006606; GO:0007159; GO:0007169; GO:0007229; GO:0007257; GO:0009887; GO:0010543; GO:0010803; GO:0016032; GO:0016170; GO:0018105; GO:0018108; GO:0019370; GO:0019815; GO:0019901; GO:0019902; GO:0030154; GO:0030168; GO:0030593; GO:0031234; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0038063; GO:0038083; GO:0038095; GO:0038096; GO:0038110; GO:0038156; GO:0042101; GO:0042127; GO:0042169; GO:0042535; GO:0042742; GO:0043280; GO:0043306; GO:0043313; GO:0043366; GO:0045087; GO:0045425; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0048514; GO:0050715; GO:0050731; GO:0050764; GO:0050850; GO:0050853; GO:0051090; GO:0051712; GO:0070372; GO:0071226; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0120162	activation of JUN kinase activity [GO:0007257]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process [GO:0045425]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30524_c0_g1_i2	P43405	KSYK_HUMAN	100	76	0	0	231	4	510	585	2.00E-41	169.1	KSYK_HUMAN	reviewed	Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)	SYK	Homo sapiens (Human)	635	B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]; activation of JUN kinase activity [GO:0007257]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process [GO:0045425]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]	B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]	GO:0001525; GO:0001784; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0004672; GO:0004674; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006606; GO:0007159; GO:0007169; GO:0007229; GO:0007257; GO:0009887; GO:0010543; GO:0010803; GO:0016032; GO:0016170; GO:0018105; GO:0018108; GO:0019370; GO:0019815; GO:0019901; GO:0019902; GO:0030154; GO:0030168; GO:0030593; GO:0031234; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0038063; GO:0038083; GO:0038095; GO:0038096; GO:0038110; GO:0038156; GO:0042101; GO:0042127; GO:0042169; GO:0042535; GO:0042742; GO:0043280; GO:0043306; GO:0043313; GO:0043366; GO:0045087; GO:0045425; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0048514; GO:0050715; GO:0050731; GO:0050764; GO:0050850; GO:0050853; GO:0051090; GO:0051712; GO:0070372; GO:0071226; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0120162	activation of JUN kinase activity [GO:0007257]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-3-mediated signaling pathway [GO:0038156]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process [GO:0045425]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN21281_c0_g1_i1	P24604	TEC_MOUSE	46.9	64	34	0	8	199	520	583	2.20E-12	72.4	TEC_MOUSE	reviewed	Tyrosine-protein kinase Tec (EC 2.7.10.2)	Tec	Mus musculus (Mouse)	630	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0002250; GO:0004715; GO:0005524; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0007229; GO:0008289; GO:0010543; GO:0018108; GO:0035556; GO:0038083; GO:0042246; GO:0046872; GO:0050731; GO:0050852; GO:0050853	adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN22705_c0_g1_i1	P00529	ROS_AVISU	91.2	68	6	0	10	213	249	316	2.40E-33	142.1	ROS_AVISU	reviewed	Tyrosine-protein kinase transforming protein ros (EC 2.7.10.1)	V-ROS	UR2 sarcoma virus (UR2SV) (Avian sarcoma virus (strain UR2))	402	membrane [GO:0016020]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	membrane [GO:0016020]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0016020	transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN32048_c0_g1_i1	P00527	YES_AVISY	48.4	91	47	0	274	2	76	166	1.90E-22	106.7	YES_AVISY	reviewed	Tyrosine-protein kinase transforming protein Yes (EC 2.7.10.2) (Fragment)	V-YES	Avian sarcoma virus (strain Y73)	528	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]		ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]	GO:0004715; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN33484_c0_g1_i1	Q9V6K3	ROR2_DROME	51.2	553	221	7	3	1532	162	708	1.00E-165	584.7	ROR2_DROME	reviewed	Tyrosine-protein kinase transmembrane receptor Ror2 (dRor2) (EC 2.7.10.1) (Neurospecific receptor tyrosine kinase)	Nrk ROR2 CG4007	Drosophila melanogaster (Fruit fly)	724	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of kinase activity [GO:0033674]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0007169; GO:0007275; GO:0033674; GO:0038062; GO:0042052; GO:0043235; GO:0046716; GO:0072499	multicellular organism development [GO:0007275]; muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of kinase activity [GO:0033674]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN33484_c0_g1_i2	Q9V6K3	ROR2_DROME	51.3	497	194	6	47	1411	218	708	3.00E-148	526.6	ROR2_DROME	reviewed	Tyrosine-protein kinase transmembrane receptor Ror2 (dRor2) (EC 2.7.10.1) (Neurospecific receptor tyrosine kinase)	Nrk ROR2 CG4007	Drosophila melanogaster (Fruit fly)	724	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of kinase activity [GO:0033674]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0007169; GO:0007275; GO:0033674; GO:0038062; GO:0042052; GO:0043235; GO:0046716; GO:0072499	multicellular organism development [GO:0007275]; muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of kinase activity [GO:0033674]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN37599_c0_g1_i1	P43403	ZAP70_HUMAN	100	150	0	0	452	3	421	570	1.10E-85	317	ZAP70_HUMAN	reviewed	Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase)	ZAP70 SRK	Homo sapiens (Human)	619	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001772; GO:0001784; GO:0002250; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006955; GO:0007169; GO:0018108; GO:0030154; GO:0030217; GO:0031234; GO:0035556; GO:0038083; GO:0042101; GO:0042110; GO:0042113; GO:0042127; GO:0043366; GO:0045059; GO:0045060; GO:0045087; GO:0045582; GO:0046638; GO:0046641; GO:0050850; GO:0050852; GO:0070489; GO:0072678	adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN6995_c0_g1_i1	P35992	PTP10_DROME	38.5	257	154	3	779	9	1255	1507	3.40E-48	194.1	PTP10_DROME	reviewed	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	Ptp10D CG1817	Drosophila melanogaster (Fruit fly)	1990	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446	axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c0_g1_i10	P35992	PTP10_DROME	56.3	1480	626	10	4418	3	43	1509	0	1686.4	PTP10_DROME	reviewed	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	Ptp10D CG1817	Drosophila melanogaster (Fruit fly)	1990	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446	axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c0_g1_i11	P35992	PTP10_DROME	56.6	1471	626	9	4391	3	43	1509	0	1695.2	PTP10_DROME	reviewed	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	Ptp10D CG1817	Drosophila melanogaster (Fruit fly)	1990	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446	axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c0_g1_i12	P35992	PTP10_DROME	55.9	803	346	5	2395	2	619	1418	4.50E-258	892.1	PTP10_DROME	reviewed	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	Ptp10D CG1817	Drosophila melanogaster (Fruit fly)	1990	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446	axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14906_c0_g1_i6	P35992	PTP10_DROME	53.1	631	291	5	1928	48	43	672	1.20E-195	684.5	PTP10_DROME	reviewed	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	Ptp10D CG1817	Drosophila melanogaster (Fruit fly)	1990	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446	axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]		blue	blue	NA	NA	NA	NA
TRINITY_DN14906_c0_g1_i9	P35992	PTP10_DROME	53.5	587	269	4	1753	2	43	628	4.30E-184	646	PTP10_DROME	reviewed	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	Ptp10D CG1817	Drosophila melanogaster (Fruit fly)	1990	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446	axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN805_c0_g1_i5	P28203	PTP11_STYPL	34.5	110	66	2	324	13	1	110	5.60E-16	85.1	PTP11_STYPL	reviewed	Tyrosine-protein phosphatase 11 (EC 3.1.3.48) (Fragment)	STY-11	Styela plicata (Wrinkled sea squirt) (Ascidia plicata)	114	protein tyrosine phosphatase activity [GO:0004725]		protein tyrosine phosphatase activity [GO:0004725]	GO:0004725			NA	NA	NA	NA	NA	NA
TRINITY_DN15749_c1_g1_i2	P34138	PTP2_DICDI	48.9	47	23	1	4	144	249	294	5.00E-08	58.2	PTP2_DICDI	reviewed	Tyrosine-protein phosphatase 2 (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase 2) (PTPA)	ptpB ptp2 DDB_G0277865	Dictyostelium discoideum (Slime mold)	377	phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; aggregation involved in sorocarp development [GO:0031152]; protein dephosphorylation [GO:0006470]		phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0006470; GO:0016791; GO:0031152	aggregation involved in sorocarp development [GO:0031152]; protein dephosphorylation [GO:0006470]		blue	blue	NA	NA	NA	NA
TRINITY_DN1430_c0_g1_i1	P16620	PTP69_DROME	25.7	830	507	26	2301	73	38	844	9.80E-59	229.9	PTP69_DROME	reviewed	Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP)	Ptp69D DPTP CG10975	Drosophila melanogaster (Fruit fly)	1462	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007415; GO:0008045; GO:0009986; GO:0016021; GO:0016201; GO:0030424; GO:0035335; GO:0048813; GO:0097155	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]		NA	NA	NA	NA	NA	NA
TRINITY_DN1430_c0_g1_i2	P16620	PTP69_DROME	26.9	561	361	16	1661	78	38	582	5.40E-49	197.2	PTP69_DROME	reviewed	Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP)	Ptp69D DPTP CG10975	Drosophila melanogaster (Fruit fly)	1462	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007415; GO:0008045; GO:0009986; GO:0016021; GO:0016201; GO:0030424; GO:0035335; GO:0048813; GO:0097155	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]		NA	NA	NA	NA	NA	NA
TRINITY_DN1430_c0_g1_i5	P16620	PTP69_DROME	25.7	830	507	26	2301	73	38	844	1.00E-58	229.9	PTP69_DROME	reviewed	Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP)	Ptp69D DPTP CG10975	Drosophila melanogaster (Fruit fly)	1462	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007415; GO:0008045; GO:0009986; GO:0016021; GO:0016201; GO:0030424; GO:0035335; GO:0048813; GO:0097155	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]		NA	NA	NA	NA	NA	NA
TRINITY_DN10239_c0_g1_i1	P16620	PTP69_DROME	55.8	154	61	2	479	33	1012	1163	5.70E-46	185.3	PTP69_DROME	reviewed	Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP)	Ptp69D DPTP CG10975	Drosophila melanogaster (Fruit fly)	1462	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]	axon [GO:0030424]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007415; GO:0008045; GO:0009986; GO:0016021; GO:0016201; GO:0030424; GO:0035335; GO:0048813; GO:0097155	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic target inhibition [GO:0016201]		NA	NA	NA	NA	NA	NA
TRINITY_DN1384_c0_g1_i1	P35832	PTP99_DROME	51.1	454	211	4	1414	56	239	682	3.20E-132	473.4	PTP99_DROME	reviewed	Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A)	Ptp99A CG2005	Drosophila melanogaster (Fruit fly)	1301	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0035335	axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1384_c0_g1_i4	P35832	PTP99_DROME	49.8	492	232	5	1516	56	201	682	5.10E-138	492.7	PTP99_DROME	reviewed	Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A)	Ptp99A CG2005	Drosophila melanogaster (Fruit fly)	1301	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0035335	axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1384_c0_g1_i5	P35832	PTP99_DROME	50.8	835	380	10	2884	407	201	1013	1.10E-250	867.8	PTP99_DROME	reviewed	Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A)	Ptp99A CG2005	Drosophila melanogaster (Fruit fly)	1301	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0035335	axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1384_c0_g1_i6	P35832	PTP99_DROME	51	804	361	9	2806	407	239	1013	1.30E-243	844.3	PTP99_DROME	reviewed	Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A)	Ptp99A CG2005	Drosophila melanogaster (Fruit fly)	1301	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0035335	axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1384_c0_g1_i7	P35832	PTP99_DROME	50.2	842	382	10	2908	407	201	1013	2.70E-249	863.2	PTP99_DROME	reviewed	Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A)	Ptp99A CG2005	Drosophila melanogaster (Fruit fly)	1301	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0035335	axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1384_c0_g1_i8	P35832	PTP99_DROME	51.6	797	359	9	2782	407	239	1013	6.90E-245	848.6	PTP99_DROME	reviewed	Tyrosine-protein phosphatase 99A (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 99A) (DPTP99A)	Ptp99A CG2005	Drosophila melanogaster (Fruit fly)	1301	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0035335	axonal defasciculation [GO:0007414]; defasciculation of motor neuron axon [GO:0007415]; motor neuron axon guidance [GO:0008045]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN25461_c0_g1_i1	P29349	CSW_DROME	83.5	91	15	0	273	1	96	186	3.30E-40	165.2	CSW_DROME	reviewed	Tyrosine-protein phosphatase corkscrew (EC 3.1.3.48)	csw CG3954	Drosophila melanogaster (Fruit fly)	845	"cytoplasm [GO:0005737]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphotyrosine residue binding [GO:0001784]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; dephosphorylation [GO:0016311]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc development [GO:0007444]; mesoderm development [GO:0007498]; mitotic cell cycle [GO:0000278]; open tracheal system development [GO:0007424]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell development [GO:0042461]; protein dephosphorylation [GO:0006470]; R7 cell fate commitment [GO:0007465]; regulation of compound eye photoreceptor development [GO:0045314]; sevenless signaling pathway [GO:0045500]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; ventral midline development [GO:0007418]"	cytoplasm [GO:0005737]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphotyrosine residue binding [GO:0001784]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0000278; GO:0001784; GO:0004726; GO:0005068; GO:0005737; GO:0006470; GO:0006911; GO:0007173; GO:0007362; GO:0007418; GO:0007424; GO:0007427; GO:0007444; GO:0007465; GO:0007498; GO:0008069; GO:0008293; GO:0008543; GO:0016311; GO:0042461; GO:0045314; GO:0045500	"dephosphorylation [GO:0016311]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc development [GO:0007444]; mesoderm development [GO:0007498]; mitotic cell cycle [GO:0000278]; open tracheal system development [GO:0007424]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell development [GO:0042461]; protein dephosphorylation [GO:0006470]; R7 cell fate commitment [GO:0007465]; regulation of compound eye photoreceptor development [GO:0045314]; sevenless signaling pathway [GO:0045500]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; ventral midline development [GO:0007418]"		blue	blue	NA	NA	NA	NA
TRINITY_DN11341_c0_g1_i1	P16621	LAR_DROME	50.4	683	327	6	3	2051	621	1291	8.20E-200	698.4	LAR_DROME	reviewed	Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)	Lar CG10443	Drosophila melanogaster (Fruit fly)	2029	axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]	axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]	heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0006470; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0016021; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0035335; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386	axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]		NA	NA	NA	NA	NA	NA
TRINITY_DN14981_c0_g1_i1	P18031	PTN1_HUMAN	100	128	0	0	384	1	165	292	2.00E-70	266.2	PTN1_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B)	PTPN1 PTP1B	Homo sapiens (Human)	435	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0004725; GO:0005158; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0009968; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031532; GO:0032991; GO:0033157; GO:0034620; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0045296; GO:0046627; GO:0046875; GO:0051721; GO:0060338; GO:0060397; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903896; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]		NA	NA	NA	NA	NA	NA
TRINITY_DN26693_c0_g1_i1	P18031	PTN1_HUMAN	100	116	0	0	2	349	10	125	5.90E-66	251.1	PTN1_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B)	PTPN1 PTP1B	Homo sapiens (Human)	435	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0004725; GO:0005158; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0009968; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031532; GO:0032991; GO:0033157; GO:0034620; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0045296; GO:0046627; GO:0046875; GO:0051721; GO:0060338; GO:0060397; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903896; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]		NA	NA	NA	NA	NA	NA
TRINITY_DN922_c0_g1_i4	P35821	PTN1_MOUSE	51.3	312	144	5	1414	485	3	308	4.40E-81	303.5	PTN1_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) (Protein-tyrosine phosphatase HA2) (PTP-HA2)	Ptpn1	Mus musculus (Mouse)	432	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]	GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031410; GO:0031532; GO:0032991; GO:0033157; GO:0034976; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0046626; GO:0046875; GO:0051721; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]	x	NA	NA	NA	NA	NA	1
TRINITY_DN27759_c0_g1_i1	P35821	PTN1_MOUSE	100	120	0	0	1	360	34	153	9.40E-67	253.8	PTN1_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) (Protein-tyrosine phosphatase HA2) (PTP-HA2)	Ptpn1	Mus musculus (Mouse)	432	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]	GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031410; GO:0031532; GO:0032991; GO:0033157; GO:0034976; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0046626; GO:0046875; GO:0051721; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN14981_c0_g2_i1	P35821	PTN1_MOUSE	99.3	138	1	0	415	2	165	302	2.80E-75	282.3	PTN1_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) (Protein-tyrosine phosphatase HA2) (PTP-HA2)	Ptpn1	Mus musculus (Mouse)	432	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]	GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031410; GO:0031532; GO:0032991; GO:0033157; GO:0034976; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0046626; GO:0046875; GO:0051721; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN922_c0_g1_i2	P35821	PTN1_MOUSE	53.6	239	106	2	1044	328	3	236	1.30E-69	265	PTN1_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) (Protein-tyrosine phosphatase HA2) (PTP-HA2)	Ptpn1	Mus musculus (Mouse)	432	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]	GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031410; GO:0031532; GO:0032991; GO:0033157; GO:0034976; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0046626; GO:0046875; GO:0051721; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]		blue	blue	NA	NA	NA	NA
TRINITY_DN922_c0_g1_i3	P35821	PTN1_MOUSE	51.3	312	144	5	1377	448	3	308	4.30E-81	303.5	PTN1_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) (Protein-tyrosine phosphatase HA2) (PTP-HA2)	Ptpn1	Mus musculus (Mouse)	432	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; zinc ion binding [GO:0008270]	GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006470; GO:0007257; GO:0008270; GO:0008286; GO:0009966; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031410; GO:0031532; GO:0032991; GO:0033157; GO:0034976; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0046626; GO:0046875; GO:0051721; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903898; GO:1990264; GO:2000646	actin cytoskeleton reorganization [GO:0031532]; activation of JUN kinase activity [GO:0007257]; endoplasmic reticulum unfolded protein response [GO:0030968]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; response to endoplasmic reticulum stress [GO:0034976]		NA	NA	NA	NA	NA	NA
TRINITY_DN648_c54_g1_i1	Q90687	PTN11_CHICK	65.9	270	87	2	800	3	244	512	1.90E-99	363.6	PTN11_CHICK	reviewed	Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2)	PTPN11	Gallus gallus (Chicken)	593	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; triglyceride metabolic process [GO:0006641]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cadherin binding [GO:0045296]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000077; GO:0000187; GO:0001784; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005737; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0008543; GO:0009755; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0032331; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033629; GO:0035264; GO:0035265; GO:0035855; GO:0036302; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0061582; GO:0070374; GO:0071364	abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated signaling pathway [GO:0009755]; hormone metabolic process [GO:0042445]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organismal reproductive process [GO:0048609]; multicellular organism growth [GO:0035264]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet formation [GO:0030220]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein-containing complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641]		blue	blue	NA	NA	NA	NA
TRINITY_DN648_c54_g1_i2	Q90687	PTN11_CHICK	64	242	82	2	744	31	244	484	5.00E-86	318.9	PTN11_CHICK	reviewed	Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2)	PTPN11	Gallus gallus (Chicken)	593	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; triglyceride metabolic process [GO:0006641]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cadherin binding [GO:0045296]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000077; GO:0000187; GO:0001784; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005737; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0008543; GO:0009755; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0032331; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033629; GO:0035264; GO:0035265; GO:0035855; GO:0036302; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0061582; GO:0070374; GO:0071364	abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated signaling pathway [GO:0009755]; hormone metabolic process [GO:0042445]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organismal reproductive process [GO:0048609]; multicellular organism growth [GO:0035264]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet formation [GO:0030220]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein-containing complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641]		NA	NA	NA	NA	NA	NA
TRINITY_DN25387_c0_g1_i1	Q05209	PTN12_HUMAN	44.2	267	143	2	2	802	10	270	4.80E-63	242.7	PTN12_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1)	PTPN12	Homo sapiens (Human)	780	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]	GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0038128; GO:0042058; GO:0042246; GO:0042995; GO:0071345; GO:0071364; GO:1901185; GO:2000587	cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]		NA	NA	NA	NA	NA	NA
TRINITY_DN2521_c0_g1_i2	Q12923	PTN13_HUMAN	43.1	72	40	1	273	58	1797	1867	5.80E-11	68.6	PTN13_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1)	PTPN13 PNP1 PTP1E PTPL1	Homo sapiens (Human)	2485	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0006661; GO:0014066; GO:0030027; GO:0035335; GO:0036312; GO:0043005; GO:0044297; GO:0070062; GO:0071345	cellular response to cytokine stimulus [GO:0071345]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]		NA	NA	NA	NA	NA	NA
TRINITY_DN2521_c0_g1_i3	Q64512	PTN13_MOUSE	41.7	84	47	2	608	357	1773	1854	1.10E-10	68.6	PTN13_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP)	Ptpn13 Ptp14	Mus musculus (Mouse)	2453	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0030496; GO:0035335; GO:0036312; GO:0043005; GO:0044297	negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]		NA	NA	NA	NA	NA	NA
TRINITY_DN2521_c0_g1_i4	Q64512	PTN13_MOUSE	41.7	84	47	2	608	357	1773	1854	1.10E-10	68.6	PTN13_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP)	Ptpn13 Ptp14	Mus musculus (Mouse)	2453	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0030496; GO:0035335; GO:0036312; GO:0043005; GO:0044297	negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]		NA	NA	NA	NA	NA	NA
TRINITY_DN23378_c0_g1_i1	P17706	PTN2_HUMAN	100	101	0	0	1	303	44	144	4.10E-55	214.9	PTN2_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP)	PTPN2 PTPT	Homo sapiens (Human)	415	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]	GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0071345; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587	B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN23378_c0_g1_i2	P17706	PTN2_HUMAN	99	101	1	0	1	303	44	144	1.50E-54	213	PTN2_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP)	PTPN2 PTPT	Homo sapiens (Human)	415	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]	GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0071345; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587	B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN28203_c0_g1_i1	P17706	PTN2_HUMAN	100	118	0	0	356	3	155	272	1.50E-64	246.5	PTN2_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP)	PTPN2 PTPT	Homo sapiens (Human)	415	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]	GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0071345; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587	B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i14	Q9Y2R2	PTN22_HUMAN	36.5	197	110	5	476	1048	22	209	1.20E-27	125.6	PTN22_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)	PTPN22 PTPN8	Homo sapiens (Human)	807	"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0002230; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032715; GO:0032717; GO:0032720; GO:0032729; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035335; GO:0035644; GO:0043508; GO:0045088; GO:0048471; GO:0050852; GO:0050855; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1901222; GO:1902523; GO:1903753; GO:2000566	"autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i28	Q9Y2R2	PTN22_HUMAN	36.5	197	110	5	535	1107	22	209	1.30E-27	125.6	PTN22_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)	PTPN22 PTPN8	Homo sapiens (Human)	807	"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0002230; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032715; GO:0032717; GO:0032720; GO:0032729; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035335; GO:0035644; GO:0043508; GO:0045088; GO:0048471; GO:0050852; GO:0050855; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1901222; GO:1902523; GO:1903753; GO:2000566	"autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25926_c0_g1_i1	Q9Y2R2	PTN22_HUMAN	100	70	0	0	212	3	74	143	5.10E-36	151	PTN22_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)	PTPN22 PTPN8	Homo sapiens (Human)	807	"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0002230; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032715; GO:0032717; GO:0032720; GO:0032729; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035335; GO:0035644; GO:0043508; GO:0045088; GO:0048471; GO:0050852; GO:0050855; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1901222; GO:1902523; GO:1903753; GO:2000566	"autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29349_c0_g1_i1	Q9Y2R2	PTN22_HUMAN	100	76	0	0	3	230	185	260	2.70E-43	175.3	PTN22_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)	PTPN22 PTPN8	Homo sapiens (Human)	807	"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0002230; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032715; GO:0032717; GO:0032720; GO:0032729; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035335; GO:0035644; GO:0043508; GO:0045088; GO:0048471; GO:0050852; GO:0050855; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1901222; GO:1902523; GO:1903753; GO:2000566	"autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"		NA	NA	NA	NA	NA	NA
TRINITY_DN600_c0_g1_i1	Q9H3S7	PTN23_HUMAN	41.5	366	201	6	1460	393	351	713	1.20E-64	248.8	PTN23_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)	PTPN23 KIAA1471	Homo sapiens (Human)	1636	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0071345; GO:1903387; GO:1903393; GO:2000643	cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i19	Q9H3S7	PTN23_HUMAN	33.2	352	214	7	991	2019	1149	1488	4.20E-47	191.4	PTN23_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)	PTPN23 KIAA1471	Homo sapiens (Human)	1636	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0071345; GO:1903387; GO:1903393; GO:2000643	cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i20	Q9H3S7	PTN23_HUMAN	33.2	352	214	7	684	1712	1149	1488	3.70E-47	191.4	PTN23_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)	PTPN23 KIAA1471	Homo sapiens (Human)	1636	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0071345; GO:1903387; GO:1903393; GO:2000643	cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i4	Q9H3S7	PTN23_HUMAN	28.2	511	308	11	991	2418	1149	1635	7.00E-44	180.6	PTN23_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)	PTPN23 KIAA1471	Homo sapiens (Human)	1636	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0071345; GO:1903387; GO:1903393; GO:2000643	cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]		NA	NA	NA	NA	NA	NA
TRINITY_DN1491_c0_g1_i5	Q9H3S7	PTN23_HUMAN	28.2	511	308	11	684	2111	1149	1635	6.10E-44	180.6	PTN23_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14)	PTPN23 KIAA1471	Homo sapiens (Human)	1636	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0071345; GO:1903387; GO:1903393; GO:2000643	cellular response to cytokine stimulus [GO:0071345]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]		NA	NA	NA	NA	NA	NA
TRINITY_DN36628_c0_g1_i1	P29074	PTN4_HUMAN	54.9	246	108	1	907	179	121	366	1.50E-73	277.7	PTN4_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1)	PTPN4	Homo sapiens (Human)	926	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0071345	cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN29372_c0_g1_i1	P29074	PTN4_HUMAN	100	93	0	0	281	3	516	608	8.10E-50	197.2	PTN4_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1)	PTPN4	Homo sapiens (Human)	926	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0071345	cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN3276_c0_g1_i1	Q9WU22	PTN4_MOUSE	60	305	116	4	73	975	565	867	1.10E-98	361.3	PTN4_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Testis-enriched protein tyrosine phosphatase)	Ptpn4	Mus musculus (Mouse)	926	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]	cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005737; GO:0005856; GO:0008092; GO:0009898			NA	NA	NA	NA	NA	NA
TRINITY_DN3276_c0_g1_i2	Q9WU22	PTN4_MOUSE	61.5	366	133	5	43	1128	506	867	1.20E-123	444.5	PTN4_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Testis-enriched protein tyrosine phosphatase)	Ptpn4	Mus musculus (Mouse)	926	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]	cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005737; GO:0005856; GO:0008092; GO:0009898			NA	NA	NA	NA	NA	NA
TRINITY_DN603_c0_g1_i13	P29351	PTN6_MOUSE	58.3	48	19	1	569	709	266	313	1.30E-06	55.1	PTN6_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (70Z-SHP) (Hematopoietic cell protein-tyrosine phosphatase) (PTPTY-42) (Protein-tyrosine phosphatase 1C) (PTP-1C) (SH-PTP1) (SHP-1)	Ptpn6 Hcp Hcph Ptp1C	Mus musculus (Mouse)	595	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; natural killer cell lectin-like receptor binding [GO:0046703]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cell adhesion molecule binding [GO:0050839]; natural killer cell lectin-like receptor binding [GO:0046703]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001784; GO:0002244; GO:0002924; GO:0004725; GO:0005001; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005911; GO:0006470; GO:0008284; GO:0014068; GO:0017124; GO:0018108; GO:0019221; GO:0019901; GO:0030154; GO:0030220; GO:0032715; GO:0032720; GO:0032991; GO:0033277; GO:0033630; GO:0035335; GO:0035556; GO:0035855; GO:0042105; GO:0042130; GO:0042169; GO:0042267; GO:0043407; GO:0043409; GO:0045577; GO:0046703; GO:0050732; GO:0050839; GO:0050853; GO:0050860; GO:0051279; GO:0070372; GO:0070527; GO:0140031; GO:1905867; GO:2000045	abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]		NA	NA	NA	NA	NA	NA
TRINITY_DN34751_c0_g1_i1	P29350	PTN6_HUMAN	100	135	0	0	406	2	245	379	5.60E-76	284.6	PTN6_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)	PTPN6 HCP PTP1C	Homo sapiens (Human)	595	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cell adhesion molecule binding [GO:0050839]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cell adhesion molecule binding [GO:0050839]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001784; GO:0002244; GO:0002924; GO:0004725; GO:0005001; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005911; GO:0006470; GO:0007186; GO:0008284; GO:0008285; GO:0014068; GO:0016020; GO:0017124; GO:0018108; GO:0019221; GO:0019901; GO:0030154; GO:0030168; GO:0030220; GO:0031295; GO:0032715; GO:0032720; GO:0032991; GO:0033277; GO:0033630; GO:0035335; GO:0035556; GO:0035580; GO:0035855; GO:0042105; GO:0042130; GO:0042169; GO:0042267; GO:0042981; GO:0043312; GO:0043407; GO:0045577; GO:0050732; GO:0050839; GO:0050853; GO:0050860; GO:0050900; GO:0051279; GO:0060338; GO:0070062; GO:0070372; GO:0070527; GO:0071345; GO:0140031; GO:1904724; GO:1905867; GO:2000045	abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]		NA	NA	NA	NA	NA	NA
TRINITY_DN31688_c0_g1_i1	P29350	PTN6_HUMAN	100	86	0	0	258	1	414	499	2.10E-44	179.1	PTN6_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)	PTPN6 HCP PTP1C	Homo sapiens (Human)	595	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cell adhesion molecule binding [GO:0050839]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cell adhesion molecule binding [GO:0050839]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001784; GO:0002244; GO:0002924; GO:0004725; GO:0005001; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005911; GO:0006470; GO:0007186; GO:0008284; GO:0008285; GO:0014068; GO:0016020; GO:0017124; GO:0018108; GO:0019221; GO:0019901; GO:0030154; GO:0030168; GO:0030220; GO:0031295; GO:0032715; GO:0032720; GO:0032991; GO:0033277; GO:0033630; GO:0035335; GO:0035556; GO:0035580; GO:0035855; GO:0042105; GO:0042130; GO:0042169; GO:0042267; GO:0042981; GO:0043312; GO:0043407; GO:0045577; GO:0050732; GO:0050839; GO:0050853; GO:0050860; GO:0050900; GO:0051279; GO:0060338; GO:0070062; GO:0070372; GO:0070527; GO:0071345; GO:0140031; GO:1904724; GO:1905867; GO:2000045	abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]		NA	NA	NA	NA	NA	NA
TRINITY_DN29233_c0_g1_i1	P35236	PTN7_HUMAN	100	80	0	0	1	240	255	334	2.00E-41	169.1	PTN7_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 7 (EC 3.1.3.48) (Hematopoietic protein-tyrosine phosphatase) (HEPTP) (Protein-tyrosine phosphatase LC-PTP)	PTPN7	Homo sapiens (Human)	360	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0009898; GO:0071345	cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN33856_c0_g1_i1	P35236	PTN7_HUMAN	100	89	0	0	267	1	132	220	2.30E-49	195.7	PTN7_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 7 (EC 3.1.3.48) (Hematopoietic protein-tyrosine phosphatase) (HEPTP) (Protein-tyrosine phosphatase LC-PTP)	PTPN7	Homo sapiens (Human)	360	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0009898; GO:0071345	cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1477_c0_g1_i1	Q641Z2	PTN9_RAT	48.8	84	43	0	421	170	294	377	4.00E-16	85.9	PTN9_RAT	reviewed	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)	Ptpn9	Rattus norvegicus (Rat)	593	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078	negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN1477_c0_g1_i3	Q641Z2	PTN9_RAT	52.1	286	137	0	929	72	294	579	3.10E-85	316.6	PTN9_RAT	reviewed	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)	Ptpn9	Rattus norvegicus (Rat)	593	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078	negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]		blue	blue	NA	NA	NA	NA
TRINITY_DN1477_c0_g1_i4	Q641Z2	PTN9_RAT	49.4	237	120	0	766	56	294	530	1.10E-64	248.1	PTN9_RAT	reviewed	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)	Ptpn9	Rattus norvegicus (Rat)	593	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078	negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN48_c0_g1_i1	P43378	PTN9_HUMAN	54.9	153	69	0	527	69	71	223	1.40E-42	174.1	PTN9_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2)	PTPN9	Homo sapiens (Human)	593	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:0071345; GO:1903078	cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN48_c0_g1_i2	P43378	PTN9_HUMAN	52.3	176	84	0	777	250	71	246	1.10E-48	194.9	PTN9_HUMAN	reviewed	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2)	PTPN9	Homo sapiens (Human)	593	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:0071345; GO:1903078	cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]		blue	blue	NA	NA	NA	NA
TRINITY_DN35333_c0_g1_i1	Q2RSR3	SYY_RHORT	70.7	82	24	0	247	2	21	102	2.60E-28	125.6	SYY_RHORT	reviewed	Tyrosine--tRNA ligase (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS)	tyrS Rru_A2032	Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIB 8255 / S1)	418	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0003723; GO:0004831; GO:0005524; GO:0005737; GO:0006437	tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN28023_c0_g1_i1	Q91WQ3	SYYC_MOUSE	100	88	0	0	3	266	345	432	5.90E-42	171	SYYC_MOUSE	reviewed	"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]"	Yars1 Yars	Mus musculus (Mouse)	528	cytosol [GO:0005829]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytosol [GO:0005829]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0000049; GO:0004831; GO:0005524; GO:0005829; GO:0006437; GO:0016604	tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN27756_c0_g1_i1	P54577	SYYC_HUMAN	100	113	0	0	2	340	337	449	1.40E-56	219.9	SYYC_HUMAN	reviewed	"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]"	YARS1 YARS	Homo sapiens (Human)	528	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; apoptotic process [GO:0006915]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0000049; GO:0003723; GO:0004831; GO:0005153; GO:0005524; GO:0005615; GO:0005737; GO:0005829; GO:0006418; GO:0006437; GO:0006915; GO:0016604	apoptotic process [GO:0006915]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN2809_c0_g1_i1	Q29465	SYYC_BOVIN	43.3	526	285	9	1633	86	5	527	1.40E-112	408.3	SYYC_BOVIN	reviewed	"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]"	YARS1 TYRS YARS	Bos taurus (Bovine)	528	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0000049; GO:0004831; GO:0005524; GO:0005737; GO:0006437	tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN16966_c0_g1_i1	Q9W107	SYYM_DROME	50	152	76	0	80	535	302	453	8.30E-35	148.3	SYYM_DROME	reviewed	"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS)"	TyrRS-m Aats-tyr-m CG16912	Drosophila melanogaster (Fruit fly)	464	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184	mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN16966_c0_g1_i2	Q9W107	SYYM_DROME	52.8	443	207	2	166	1488	21	463	4.10E-135	483	SYYM_DROME	reviewed	"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS)"	TyrRS-m Aats-tyr-m CG16912	Drosophila melanogaster (Fruit fly)	464	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184	mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN16966_c0_g1_i3	Q9W107	SYYM_DROME	53.1	433	201	2	166	1458	21	453	5.40E-130	466.1	SYYM_DROME	reviewed	"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS)"	TyrRS-m Aats-tyr-m CG16912	Drosophila melanogaster (Fruit fly)	464	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184	mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN16966_c0_g1_i4	Q9W107	SYYM_DROME	52.4	229	108	1	166	849	21	249	5.90E-68	259.2	SYYM_DROME	reviewed	"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS)"	TyrRS-m Aats-tyr-m CG16912	Drosophila melanogaster (Fruit fly)	464	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184	mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]		NA	NA	NA	NA	NA	NA
TRINITY_DN30186_c0_g1_i1	Q9Y2Z4	SYYM_HUMAN	100	80	0	0	2	241	64	143	4.20E-39	161.4	SYYM_HUMAN	reviewed	"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS)"	YARS2 CGI-04	Homo sapiens (Human)	477	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]; tRNA aminoacylation for protein translation [GO:0006418]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0000049; GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006412; GO:0006418; GO:0016604; GO:0042803; GO:0043039; GO:0070184; GO:0072545	mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]; tRNA aminoacylation for protein translation [GO:0006418]		NA	NA	NA	NA	NA	NA
TRINITY_DN3054_c0_g1_i1	A7YWI9	TYDP2_BOVIN	35.8	352	210	7	1121	99	16	362	5.30E-58	226.5	TYDP2_BOVIN	reviewed	Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein)	TDP2 TTRAP	Bos taurus (Bovine)	364	aggresome [GO:0016235]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; 5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]; double-strand break repair [GO:0006302]; neuron development [GO:0048666]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PML body [GO:0016605]	5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]	GO:0000287; GO:0003697; GO:0004518; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0016235; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260	double-strand break repair [GO:0006302]; neuron development [GO:0048666]		blue	blue	NA	NA	NA	NA
TRINITY_DN34147_c0_g1_i1	Q1RMR2	RU17_BOVIN	63.6	121	42	1	375	13	82	200	2.30E-39	162.9	RU17_BOVIN	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	SNRNP70 SNRP70	Bos taurus (Bovine)	439	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0071004	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g1_i1	P17133	RU17_DROME	67.7	158	51	0	57	530	1	158	1.30E-57	224.6	RU17_DROME	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	snRNP-U1-70K snRNP27D snRNP70K CG8749	Drosophila melanogaster (Fruit fly)	448	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g1_i5	P17133	RU17_DROME	67.7	158	51	0	57	530	1	158	1.50E-57	224.6	RU17_DROME	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	snRNP-U1-70K snRNP27D snRNP70K CG8749	Drosophila melanogaster (Fruit fly)	448	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g1_i5	P17133	RU17_DROME	82.4	74	10	1	550	771	145	215	2.30E-26	120.9	RU17_DROME	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	snRNP-U1-70K snRNP27D snRNP70K CG8749	Drosophila melanogaster (Fruit fly)	448	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g1_i6	P17133	RU17_DROME	93.1	58	4	0	73	246	158	215	8.30E-25	114.4	RU17_DROME	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	snRNP-U1-70K snRNP27D snRNP70K CG8749	Drosophila melanogaster (Fruit fly)	448	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g1_i7	P17133	RU17_DROME	74.4	215	55	0	57	701	1	215	3.00E-89	329.7	RU17_DROME	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	snRNP-U1-70K snRNP27D snRNP70K CG8749	Drosophila melanogaster (Fruit fly)	448	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g1_i8	Q1RMR2	RU17_BOVIN	97.6	127	3	0	6	386	81	207	2.30E-68	259.6	RU17_BOVIN	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	SNRNP70 SNRP70	Bos taurus (Bovine)	439	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0071004	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN763_c0_g2_i1	Q1RMR2	RU17_BOVIN	99	99	1	0	336	40	125	223	2.70E-52	205.7	RU17_BOVIN	reviewed	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	SNRNP70 SNRP70	Bos taurus (Bovine)	439	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0071004	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15186_c0_g2_i1	Q2KIR1	SNRPA_BOVIN	100	82	0	0	40	285	201	282	9.70E-41	167.2	SNRPA_BOVIN	reviewed	U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)	SNRPA	Bos taurus (Bovine)	282	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005685; GO:0030619; GO:0042802	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15186_c0_g1_i1	P45429	SNRPA_XENLA	93.5	77	5	0	18	248	197	273	3.50E-36	151.8	SNRPA_XENLA	reviewed	U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)	snrpa	Xenopus laevis (African clawed frog)	282	spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U1 snRNA binding [GO:0030619]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	U1 snRNA binding [GO:0030619]	GO:0005681; GO:0005685; GO:0006397; GO:0008380; GO:0030619	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN29030_c0_g1_i1	Q62189	SNRPA_MOUSE	100	86	0	0	259	2	24	109	1.30E-41	169.9	SNRPA_MOUSE	reviewed	U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)	Snrpa Rnu1a-1	Mus musculus (Mouse)	287	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]	GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005685; GO:0030619; GO:0042802; GO:1900363; GO:1990446	"mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29314_c0_g1_i1	Q2KIR1	SNRPA_BOVIN	100	70	0	0	211	2	40	109	7.50E-32	137.1	SNRPA_BOVIN	reviewed	U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)	SNRPA	Bos taurus (Bovine)	282	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005685; GO:0030619; GO:0042802	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7711_c3_g1_i1	P43332	SNRPA_DROME	69.7	241	48	2	759	37	1	216	2.40E-76	287	SNRPA_DROME	reviewed	U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A) (Sex determination protein snf)	snf D25 fs(1)1621 liz CG4528	Drosophila melanogaster (Fruit fly)	216	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; female germ-line sex determination [GO:0019099]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]	GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0007539; GO:0008266; GO:0008380; GO:0019099; GO:0030532; GO:0030619; GO:0030620; GO:0032991; GO:0035614; GO:0042802; GO:0048477; GO:0070868; GO:0071011; GO:0071013; GO:0097158; GO:1990904	"female germ-line sex determination [GO:0019099]; heterochromatin organization involved in chromatin silencing [GO:0070868]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN33777_c0_g1_i1	A2Y0J7	RU1A_ORYSI	57.6	66	28	0	8	205	46	111	7.30E-19	94	RU1A_ORYSI	reviewed	U1 small nuclear ribonucleoprotein A (U1 snRNP protein A)	OsI_18512	Oryza sativa subsp. indica (Rice)	253	cytosol [GO:0005829]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	RNA binding [GO:0003723]	GO:0003723; GO:0005681; GO:0005685; GO:0005730; GO:0005829; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN25362_c0_g1_i1	P09661	RU2A_HUMAN	100	170	0	0	511	2	13	182	2.30E-90	332.8	RU2A_HUMAN	reviewed	U2 small nuclear ribonucleoprotein A' (U2 snRNP A')	SNRPA1	Homo sapiens (Human)	255	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0035722; GO:0071005; GO:0071007; GO:0071013	"interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25362_c0_g1_i2	P09661	RU2A_HUMAN	100	170	0	0	511	2	13	182	2.30E-90	332.8	RU2A_HUMAN	reviewed	U2 small nuclear ribonucleoprotein A' (U2 snRNP A')	SNRPA1	Homo sapiens (Human)	255	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0035722; GO:0071005; GO:0071007; GO:0071013	"interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11136_c0_g1_i1	P57784	RU2A_MOUSE	58.4	250	97	4	840	94	1	244	9.80E-68	258.5	RU2A_MOUSE	reviewed	U2 small nuclear ribonucleoprotein A' (U2 snRNP A')	Snrpa1	Mus musculus (Mouse)	255	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2 snRNA binding [GO:0030620]; mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	U2 snRNA binding [GO:0030620]	GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0016604; GO:0016607; GO:0030620; GO:0071005; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1288_c0_g1_i1	P09661	RU2A_HUMAN	56.3	71	31	0	213	1	1	71	1.80E-13	76.3	RU2A_HUMAN	reviewed	U2 small nuclear ribonucleoprotein A' (U2 snRNP A')	SNRPA1	Homo sapiens (Human)	255	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0035722; GO:0071005; GO:0071007; GO:0071013	"interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7099_c0_g1_i10	Q15696	U2AFM_HUMAN	50.9	234	109	3	10	711	139	366	5.50E-63	242.7	U2AFM_HUMAN	reviewed	"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)"	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	Homo sapiens (Human)	482	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7099_c0_g1_i2	Q15696	U2AFM_HUMAN	51.1	233	109	3	50	748	139	366	2.60E-63	243.8	U2AFM_HUMAN	reviewed	"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)"	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	Homo sapiens (Human)	482	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7099_c0_g1_i3	Q15696	U2AFM_HUMAN	51.1	233	109	3	10	708	139	366	1.50E-63	244.6	U2AFM_HUMAN	reviewed	"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)"	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	Homo sapiens (Human)	482	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7099_c0_g1_i4	Q15696	U2AFM_HUMAN	51.1	233	109	3	84	782	139	366	9.20E-64	245.4	U2AFM_HUMAN	reviewed	"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)"	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	Homo sapiens (Human)	482	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7099_c0_g1_i5	Q15696	U2AFM_HUMAN	51.1	233	109	3	10	708	139	366	1.50E-63	244.6	U2AFM_HUMAN	reviewed	"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)"	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	Homo sapiens (Human)	482	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7099_c0_g1_i9	Q15696	U2AFM_HUMAN	50.9	234	109	3	10	711	139	366	5.60E-63	242.7	U2AFM_HUMAN	reviewed	"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)"	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	Homo sapiens (Human)	482	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]	GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28925_c0_g1_i1	P08579	RU2B_HUMAN	100	77	0	0	233	3	8	84	2.30E-37	155.6	RU2B_HUMAN	reviewed	U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')	SNRPB2	Homo sapiens (Human)	225	"catalytic step 2 spliceosome [GO:0071013]; cytoplasmic ribonucleoprotein granule [GO:0036464]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasmic ribonucleoprotein granule [GO:0036464]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030619; GO:0036464; GO:0070990; GO:0071005; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36798_c0_g1_i1	P08579	RU2B_HUMAN	100	75	0	0	226	2	145	219	2.60E-38	158.7	RU2B_HUMAN	reviewed	U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')	SNRPB2	Homo sapiens (Human)	225	"catalytic step 2 spliceosome [GO:0071013]; cytoplasmic ribonucleoprotein granule [GO:0036464]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasmic ribonucleoprotein granule [GO:0036464]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030619; GO:0036464; GO:0070990; GO:0071005; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40772_c0_g1_i1	O15042	SR140_HUMAN	100	96	0	0	289	2	430	525	2.10E-53	209.1	SR140_HUMAN	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	Homo sapiens (Human)	1029	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33899_c0_g1_i1	O15042	SR140_HUMAN	99.3	145	1	0	435	1	245	389	3.60E-81	302	SR140_HUMAN	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	Homo sapiens (Human)	1029	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3084_c0_g1_i1	Q6NV83	SR140_MOUSE	50	46	23	0	250	113	840	885	5.80E-06	52.4	SR140_MOUSE	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2surp Sr140	Mus musculus (Mouse)	1029	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006396	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN3084_c0_g1_i2	Q6NV83	SR140_MOUSE	50	46	23	0	250	113	840	885	5.30E-06	52.8	SR140_MOUSE	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2surp Sr140	Mus musculus (Mouse)	1029	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006396	RNA processing [GO:0006396]		blue	blue	NA	NA	NA	NA
TRINITY_DN302_c0_g1_i1	O15042	SR140_HUMAN	51.1	329	134	6	92	1051	115	425	8.90E-69	262.3	SR140_HUMAN	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	Homo sapiens (Human)	1029	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	1
TRINITY_DN302_c0_g1_i2	O15042	SR140_HUMAN	54.6	553	223	7	92	1723	115	648	1.60E-151	537.7	SR140_HUMAN	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	Homo sapiens (Human)	1029	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN302_c0_g1_i3	O15042	SR140_HUMAN	54.6	553	223	7	92	1723	115	648	1.60E-151	537.7	SR140_HUMAN	reviewed	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	Homo sapiens (Human)	1029	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28793_c0_g1_i1	Q3T0M3	IMP3_BOVIN	57.6	66	28	0	2	199	111	176	8.00E-15	80.5	IMP3_BOVIN	reviewed	U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3)	IMP3	Bos taurus (Bovine)	184	Mpp10 complex [GO:0034457]; small-subunit processome [GO:0032040]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	Mpp10 complex [GO:0034457]; small-subunit processome [GO:0032040]	rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	GO:0006364; GO:0019843; GO:0030515; GO:0032040; GO:0034457	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN6735_c0_g1_i1	Q921Y2	IMP3_MOUSE	59.9	182	72	1	632	90	2	183	1.70E-63	244.2	IMP3_MOUSE	reviewed	U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3)	Imp3	Mus musculus (Mouse)	184	Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]	rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0019843; GO:0030515; GO:0030684; GO:0032040; GO:0034457	rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN38707_c0_g1_i1	Q9NV31	IMP3_HUMAN	99.5	184	1	0	6	557	1	184	5.90E-98	358.2	IMP3_HUMAN	reviewed	U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (BRMS2)	IMP3 C15orf12 MRPS4	Homo sapiens (Human)	184	Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0019843; GO:0030515; GO:0030684; GO:0032040; GO:0034457	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN35366_c0_g1_i1	O00566	MPP10_HUMAN	44.7	342	179	5	1127	105	337	669	7.30E-49	196.1	MPP10_HUMAN	reviewed	U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)	MPHOSPH10 MPP10	Homo sapiens (Human)	681	"chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]"	chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0006396; GO:0008380; GO:0010923; GO:0032040; GO:0034457	"negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36099_c0_g1_i1	Q12220	UTP12_YEAST	59.2	71	29	0	1	213	554	624	7.90E-21	100.5	UTP12_YEAST	reviewed	U3 small nucleolar RNA-associated protein 12 (U3 snoRNA-associated protein 12) (DOM34-interacting protein 2) (U three protein 12)	DIP2 UTP12 YLR129W L3116 L9233.1	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	943	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA methylation [GO:0031167]"	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]	GO:0000447; GO:0000462; GO:0000472; GO:0000480; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0030686; GO:0031167; GO:0032040; GO:0034388; GO:0034511	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA methylation [GO:0031167]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2165_c0_g1_i1	Q7ZXZ2	UTP15_XENLA	41.3	453	261	3	1678	323	1	449	1.00E-97	359	UTP15_XENLA	reviewed	U3 small nucleolar RNA-associated protein 15 homolog	utp15	Xenopus laevis (African clawed frog)	515	nucleolus [GO:0005730]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]		GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2396_c0_g1_i1	Q5SSI6	UTP18_MOUSE	33.4	500	306	11	305	1762	66	552	6.80E-65	250	UTP18_MOUSE	reviewed	U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50)	Utp18 Wdr50	Mus musculus (Mouse)	552	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]		GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2920_c0_g1_i1	O43818	U3IP2_HUMAN	50.9	371	175	5	48	1148	99	466	1.60E-99	364.4	U3IP2_HUMAN	reviewed	U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K)	RRP9 RNU3IP2 U355K	Homo sapiens (Human)	475	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364]	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040; GO:0034511	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN31728_c0_g1_i1	Q09856	PRP3_SCHPO	48.7	78	40	0	278	45	292	369	2.30E-12	72.8	PRP3_SCHPO	reviewed	U4/U5/U6 small nuclear ribonucleoprotein prp3 (Pre-mRNA-splicing factor 3)	prp3 SPAC29E6.02 SPAC30.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	542	"cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]"	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		GO:0000398; GO:0000922; GO:0005634; GO:0005681; GO:0005737; GO:0045292; GO:0046540; GO:0051028; GO:0072686	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2530_c0_g1_i1	Q922U1	PRPF3_MOUSE	45.1	690	351	11	86	2092	1	683	3.20E-141	503.8	PRPF3_MOUSE	reviewed	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	Prpf3	Mus musculus (Mouse)	683	"Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	identical protein binding [GO:0042802]	GO:0000244; GO:0000398; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016607; GO:0032991; GO:0042802; GO:0046540; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2530_c0_g1_i2	Q922U1	PRPF3_MOUSE	43.8	603	322	9	86	1864	1	596	2.50E-113	411	PRPF3_MOUSE	reviewed	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	Prpf3	Mus musculus (Mouse)	683	"Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	identical protein binding [GO:0042802]	GO:0000244; GO:0000398; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016607; GO:0032991; GO:0042802; GO:0046540; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2530_c0_g1_i3	Q922U1	PRPF3_MOUSE	45.1	690	351	11	107	2113	1	683	1.40E-141	505	PRPF3_MOUSE	reviewed	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	Prpf3	Mus musculus (Mouse)	683	"Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	identical protein binding [GO:0042802]	GO:0000244; GO:0000398; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016607; GO:0032991; GO:0042802; GO:0046540; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2530_c0_g1_i4	Q922U1	PRPF3_MOUSE	43.8	603	322	9	107	1885	1	596	1.10E-113	412.1	PRPF3_MOUSE	reviewed	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	Prpf3	Mus musculus (Mouse)	683	"Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	identical protein binding [GO:0042802]	GO:0000244; GO:0000398; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016607; GO:0032991; GO:0042802; GO:0046540; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35978_c0_g1_i1	Q2KIA6	PRPF3_BOVIN	100	95	0	0	285	1	541	635	1.60E-48	193	PRPF3_BOVIN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	PRPF3	Bos taurus (Bovine)	683	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26723_c0_g1_i1	Q7SXM7	PRP31_DANRE	51.3	76	35	1	223	2	100	175	7.10E-12	70.9	PRP31_DANRE	reviewed	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31)	prpf31	Danio rerio (Zebrafish) (Brachydanio rerio)	508	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	U4atac snRNA binding [GO:0030622]	GO:0000244; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071011; GO:0071339; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28844_c0_g1_i1	Q8WWY3	PRP31_HUMAN	100	121	0	0	1	363	186	306	1.00E-60	233.8	PRP31_HUMAN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)	PRPF31 PRP31	Homo sapiens (Human)	499	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38902_c0_g1_i1	Q8WWY3	PRP31_HUMAN	99.7	305	1	0	2	916	54	358	3.50E-166	585.5	PRP31_HUMAN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)	PRPF31 PRP31	Homo sapiens (Human)	499	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22155_c0_g1_i1	Q8WWY3	PRP31_HUMAN	99	99	1	0	298	2	380	478	5.80E-46	184.5	PRP31_HUMAN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)	PRPF31 PRP31	Homo sapiens (Human)	499	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22155_c0_g1_i2	Q8WWY3	PRP31_HUMAN	99.1	116	1	0	350	3	380	495	1.20E-55	216.9	PRP31_HUMAN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)	PRPF31 PRP31	Homo sapiens (Human)	499	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5301_c0_g1_i1	Q8WWY3	PRP31_HUMAN	57.8	493	202	3	77	1549	1	489	1.00E-147	525	PRP31_HUMAN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)	PRPF31 PRP31	Homo sapiens (Human)	499	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526	"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25263_c0_g1_i1	Q3MHE2	PRP4_BOVIN	100	85	0	0	253	507	382	466	2.80E-48	193	PRP4_BOVIN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)	PRPF4	Bos taurus (Bovine)	521	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; nuclear speck [GO:0016607]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000398; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25263_c0_g1_i1	Q3MHE2	PRP4_BOVIN	98.8	85	1	0	2	256	282	366	6.40E-45	181.8	PRP4_BOVIN	reviewed	U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)	PRPF4	Bos taurus (Bovine)	521	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; nuclear speck [GO:0016607]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000398; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35812_c0_g1_i1	Q9DAW6	PRP4_MOUSE	53.7	462	209	3	1469	87	61	518	1.60E-147	524.2	PRP4_MOUSE	reviewed	U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)	Prpf4	Mus musculus (Mouse)	521	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000398; GO:0005634; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525	"mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32051_c0_g1_i1	O43290	SNUT1_HUMAN	100	72	0	0	216	1	532	603	4.80E-34	144.4	SNUT1_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)	SART1	Homo sapiens (Human)	800	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013	"maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30421_c0_g1_i1	O43290	SNUT1_HUMAN	99.1	114	1	0	343	2	671	784	7.60E-58	224.2	SNUT1_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)	SART1	Homo sapiens (Human)	800	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013	"maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33404_c0_g1_i1	O43290	SNUT1_HUMAN	100	109	0	0	329	3	671	779	2.00E-55	216.1	SNUT1_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)	SART1	Homo sapiens (Human)	800	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013	"maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1202_c0_g1_i1	Q5XIW8	SNUT1_RAT	36.9	721	377	17	2143	101	113	795	2.90E-95	351.3	SNUT1_RAT	reviewed	U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1)	Sart1	Rattus norvegicus (Rat)	806	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		GO:0000398; GO:0000481; GO:0005634; GO:0005654; GO:0005794; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013	"maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3566_c0_g1_i1	Q3TIX9	SNUT2_MOUSE	44.3	88	48	1	72	332	300	387	1.90E-13	76.6	SNUT2_MOUSE	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39)	Usp39	Mus musculus (Mouse)	564	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0004843; GO:0005634; GO:0005654; GO:0005681; GO:0007049; GO:0008270; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3566_c0_g1_i2	Q3TIX9	SNUT2_MOUSE	58.8	342	120	5	79	1050	49	387	9.30E-107	388.3	SNUT2_MOUSE	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39)	Usp39	Mus musculus (Mouse)	564	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0004843; GO:0005634; GO:0005654; GO:0005681; GO:0007049; GO:0008270; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27631_c0_g1_i1	Q53GS9	SNUT2_HUMAN	100	98	0	0	295	2	170	267	7.10E-52	204.1	SNUT2_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K)	USP39 CGI-21 HSPC332 PRO2855	Homo sapiens (Human)	565	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27631_c0_g1_i2	Q53GS9	SNUT2_HUMAN	100	153	0	0	460	2	115	267	5.20E-86	318.2	SNUT2_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K)	USP39 CGI-21 HSPC332 PRO2855	Homo sapiens (Human)	565	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9210_c0_g1_i1	Q53GS9	SNUT2_HUMAN	67.2	125	41	0	441	67	432	556	3.90E-46	185.7	SNUT2_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K)	USP39 CGI-21 HSPC332 PRO2855	Homo sapiens (Human)	565	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		blue	blue	NA	NA	NA	NA
TRINITY_DN35117_c0_g1_i1	Q53GS9	SNUT2_HUMAN	100	68	0	0	3	206	278	345	1.60E-34	146	SNUT2_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K)	USP39 CGI-21 HSPC332 PRO2855	Homo sapiens (Human)	565	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26746_c0_g1_i1	Q53GS9	SNUT2_HUMAN	52.9	119	56	0	390	34	438	556	2.80E-35	149.4	SNUT2_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K)	USP39 CGI-21 HSPC332 PRO2855	Homo sapiens (Human)	565	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33073_c0_g1_i1	Q53GS9	SNUT2_HUMAN	100	120	0	0	363	4	446	565	7.30E-67	254.2	SNUT2_HUMAN	reviewed	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K)	USP39 CGI-21 HSPC332 PRO2855	Homo sapiens (Human)	565	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	zinc ion binding [GO:0008270]	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301	"cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26157_c0_g1_i1	O75643	U520_HUMAN	81.1	74	14	0	224	3	1096	1169	8.90E-31	133.7	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33654_c0_g1_i1	O75643	U520_HUMAN	100	112	0	0	338	3	768	879	1.50E-61	236.5	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26027_c0_g1_i1	O75643	U520_HUMAN	69.7	201	60	1	3	602	1390	1590	7.80E-77	288.1	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32394_c0_g1_i1	O75643	U520_HUMAN	100	93	0	0	282	4	1248	1340	1.40E-49	196.4	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33972_c0_g1_i1	O75643	U520_HUMAN	100	139	0	0	2	418	1651	1789	2.00E-81	302.8	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40327_c0_g1_i1	O75643	U520_HUMAN	99	98	1	0	2	295	901	998	7.70E-51	200.7	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37283_c0_g1_i1	O75643	U520_HUMAN	100	70	0	0	1	210	1311	1380	2.70E-34	145.2	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8159_c0_g1_i1	O75643	U520_HUMAN	75.6	82	18	1	248	3	1262	1341	9.20E-29	127.1	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35031_c0_g1_i1	O75643	U520_HUMAN	100	93	0	0	279	1	1086	1178	4.00E-49	194.9	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25875_c0_g1_i1	O75643	U520_HUMAN	76.2	223	53	0	670	2	481	703	6.80E-95	348.2	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29968_c0_g1_i1	O75643	U520_HUMAN	100	89	0	0	267	1	1414	1502	1.70E-44	179.5	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30035_c0_g1_i1	O75643	U520_HUMAN	73.4	184	49	0	3	554	782	965	1.10E-77	290.8	U520_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	2136	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15982_c0_g1_i1	Q96DI7	SNR40_HUMAN	99.6	232	1	0	740	45	126	357	5.20E-136	485	SNR40_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57)	SNRNP40 PRP8BP SFP38 WDR57	Homo sapiens (Human)	357	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003723; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40485_c0_g1_i1	Q96DI7	SNR40_HUMAN	44.3	79	43	1	12	248	220	297	2.00E-15	82.8	SNR40_HUMAN	reviewed	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57)	SNRNP40 PRP8BP SFP38 WDR57	Homo sapiens (Human)	357	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003723; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0071007; GO:0071013	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24225_c0_g1_i1	Q2HJH6	SNR40_BOVIN	100	113	0	0	3	341	68	180	9.90E-66	250.4	SNR40_BOVIN	reviewed	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (WD repeat-containing protein 57)	SNRNP40 WDR57	Bos taurus (Bovine)	358	spliceosomal complex [GO:0005681]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]		GO:0005681; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN24225_c0_g1_i2	Q2HJH6	SNR40_BOVIN	100	133	0	0	3	401	48	180	5.90E-78	291.2	SNR40_BOVIN	reviewed	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (WD repeat-containing protein 57)	SNRNP40 WDR57	Bos taurus (Bovine)	358	spliceosomal complex [GO:0005681]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]		GO:0005681; GO:0006397; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN1916_c0_g1_i1	Q6PE01	SNR40_MOUSE	61.9	354	123	3	1116	88	6	358	2.20E-131	470.3	SNR40_MOUSE	reviewed	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (WD repeat-containing protein 57)	Snrnp40 Wdr57	Mus musculus (Mouse)	358	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; U2-type catalytic step 2 spliceosome [GO:0071007]		GO:0005829; GO:0006397; GO:0008380; GO:0016607; GO:0071007; GO:0071013	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		blue	blue	NA	NA	NA	NA
TRINITY_DN9333_c0_g1_i5	Q290Z2	MET16_DROPS	37.1	105	64	1	392	84	182	286	3.90E-11	69.3	MET16_DROPS	reviewed	U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase (EC 2.1.1.346)	GA20428	Drosophila pseudoobscura pseudoobscura (Fruit fly)	305	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; methylation [GO:0032259]		methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0008168; GO:0032259	methylation [GO:0032259]		NA	NA	NA	NA	NA	NA
TRINITY_DN2696_c0_g1_i4	Q91W78	USB1_MOUSE	36.1	227	136	5	8	673	45	267	1.80E-37	157.9	USB1_MOUSE	reviewed	U6 snRNA phosphodiesterase (EC 3.1.4.-)	Usb1	Mus musculus (Mouse)	267	"intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]; RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]"	intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]"	GO:0000175; GO:0005634; GO:0005654; GO:0008380; GO:0034477; GO:0045171; GO:1990838	RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]		brown	brown	NA	NA	NA	NA
TRINITY_DN2696_c0_g1_i6	Q91W78	USB1_MOUSE	35.7	244	147	6	61	777	29	267	4.00E-38	160.2	USB1_MOUSE	reviewed	U6 snRNA phosphodiesterase (EC 3.1.4.-)	Usb1	Mus musculus (Mouse)	267	"intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]; RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]"	intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]"	GO:0000175; GO:0005634; GO:0005654; GO:0008380; GO:0034477; GO:0045171; GO:1990838	RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2696_c0_g1_i8	Q91W78	USB1_MOUSE	36.1	227	136	5	102	767	45	267	2.60E-37	157.5	USB1_MOUSE	reviewed	U6 snRNA phosphodiesterase (EC 3.1.4.-)	Usb1	Mus musculus (Mouse)	267	"intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]; RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]"	intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]"	GO:0000175; GO:0005634; GO:0005654; GO:0008380; GO:0034477; GO:0045171; GO:1990838	RNA splicing [GO:0008380]; U6 snRNA 3'-end processing [GO:0034477]		brown	brown	1	NA	NA	NA
TRINITY_DN33848_c0_g1_i1	Q5E9Z8	LSM1_BOVIN	100	88	0	0	34	297	1	88	6.40E-45	181	LSM1_BOVIN	reviewed	U6 snRNA-associated Sm-like protein LSm1	LSM1	Bos taurus (Bovine)	133	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]	RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000290; GO:0000339; GO:0000932; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0045665; GO:0071044; GO:1990726	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN4627_c0_g1_i1	Q5E9Z8	LSM1_BOVIN	66.4	122	41	0	495	130	1	122	6.10E-39	162.2	LSM1_BOVIN	reviewed	U6 snRNA-associated Sm-like protein LSm1	LSM1	Bos taurus (Bovine)	133	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]	RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000290; GO:0000339; GO:0000932; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0045665; GO:0071044; GO:1990726	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN4627_c0_g1_i2	Q5E9Z8	LSM1_BOVIN	66.4	122	41	0	495	130	1	122	8.00E-39	161.8	LSM1_BOVIN	reviewed	U6 snRNA-associated Sm-like protein LSm1	LSM1	Bos taurus (Bovine)	133	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]	RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000290; GO:0000339; GO:0000932; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0045665; GO:0071044; GO:1990726	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]		blue	blue	NA	NA	NA	NA
TRINITY_DN37941_c0_g1_i1	Q9Y333	LSM2_HUMAN	71.4	63	17	1	6	191	27	89	2.60E-18	92.4	LSM2_HUMAN	reviewed	U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5)	LSM2 C6orf28 G7B	Homo sapiens (Human)	95	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005737; GO:0005829; GO:0006402; GO:0017070; GO:0017160; GO:0043928; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		red	red	NA	NA	NA	NA
TRINITY_DN37483_c0_g1_i1	Q9Y333	LSM2_HUMAN	91.7	72	6	0	1	216	24	95	1.80E-31	136.3	LSM2_HUMAN	reviewed	U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5)	LSM2 C6orf28 G7B	Homo sapiens (Human)	95	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005737; GO:0005829; GO:0006402; GO:0017070; GO:0017160; GO:0043928; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		blue	blue	NA	NA	NA	NA
TRINITY_DN32315_c0_g1_i1	Q9Y333	LSM2_HUMAN	100	70	0	0	210	1	26	95	1.40E-33	142.9	LSM2_HUMAN	reviewed	U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5)	LSM2 C6orf28 G7B	Homo sapiens (Human)	95	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005737; GO:0005829; GO:0006402; GO:0017070; GO:0017160; GO:0043928; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19441_c0_g1_i1	Q32PE9	LSM3_BOVIN	100	102	0	0	49	354	1	102	7.70E-52	204.5	LSM3_BOVIN	reviewed	U6 snRNA-associated Sm-like protein LSm3	LSM3	Bos taurus (Bovine)	102	"catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"	catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	RNA binding [GO:0003723]	GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005688; GO:0033962; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726	"mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19441_c0_g1_i2	Q32PE9	LSM3_BOVIN	100	102	0	0	49	354	1	102	7.50E-52	204.5	LSM3_BOVIN	reviewed	U6 snRNA-associated Sm-like protein LSm3	LSM3	Bos taurus (Bovine)	102	"catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"	catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	RNA binding [GO:0003723]	GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005688; GO:0033962; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726	"mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1093_c0_g2_i1	Q32PE9	LSM3_BOVIN	79.4	102	21	0	405	100	1	102	1.90E-41	170.2	LSM3_BOVIN	reviewed	U6 snRNA-associated Sm-like protein LSm3	LSM3	Bos taurus (Bovine)	102	"catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"	catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	RNA binding [GO:0003723]	GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005688; GO:0033962; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726	"mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]"		blue	blue	NA	NA	NA	NA
TRINITY_DN7824_c0_g1_i1	Q8QZX5	LSM10_MOUSE	37.1	97	61	0	133	423	15	111	4.00E-11	69.7	LSM10_MOUSE	reviewed	U7 snRNA-associated Sm-like protein LSm10	Lsm10	Mus musculus (Mouse)	122	Cajal body [GO:0015030]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; snRNA binding [GO:0017069]; U7 snRNA binding [GO:0071209]; mRNA processing [GO:0006397]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380]	Cajal body [GO:0015030]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]	histone pre-mRNA DCP binding [GO:0071208]; snRNA binding [GO:0017069]; U7 snRNA binding [GO:0071209]	GO:0005654; GO:0005683; GO:0006397; GO:0008380; GO:0015030; GO:0016604; GO:0017069; GO:0071208; GO:0071209; GO:1900087	mRNA processing [GO:0006397]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN2333_c0_g1_i1	Q7T076	LSM11_XENLA	32.6	175	98	3	54	530	13	183	1.10E-14	82.4	LSM11_XENLA	reviewed	U7 snRNA-associated Sm-like protein LSm11	lsm11	Xenopus laevis (African clawed frog)	291	nucleus [GO:0005634]; U7 snRNA binding [GO:0071209]; mRNA processing [GO:0006397]	nucleus [GO:0005634]	U7 snRNA binding [GO:0071209]	GO:0005634; GO:0006397; GO:0071209	mRNA processing [GO:0006397]		NA	NA	NA	NA	NA	NA
TRINITY_DN29996_c0_g1_i1	Q96DE0	NUD16_HUMAN	43.3	164	88	4	480	1	7	169	2.40E-29	130.6	NUD16_HUMAN	reviewed	U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (Nudix hydrolase 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase)	NUDT16	Homo sapiens (Human)	195	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; inosine-diphosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]; adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; inosine-diphosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]"	GO:0000287; GO:0003729; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006402; GO:0008235; GO:0008284; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0034656; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0046709; GO:0050072; GO:0050897; GO:0090068; GO:0090502; GO:0098519; GO:1901639; GO:1901640; GO:1901641; GO:1990003; GO:1990174; GO:2000233; GO:2000781	"adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]"		blue	blue	NA	NA	NA	NA
TRINITY_DN260_c0_g1_i1	E7FB98	UBIA1_DANRE	65	40	14	0	130	11	43	82	7.30E-06	51.2	UBIA1_DANRE	reviewed	UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (Protein barolo) (Protein reddish)	ubiad1 bar reh	Danio rerio (Zebrafish) (Brachydanio rerio)	336	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]; antioxidant activity [GO:0016209]; nitric-oxide synthase activity [GO:0004517]; prenyltransferase activity [GO:0004659]; cellular response to fluid shear stress [GO:0071498]; circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]	antioxidant activity [GO:0016209]; nitric-oxide synthase activity [GO:0004517]; prenyltransferase activity [GO:0004659]	GO:0001885; GO:0004517; GO:0004659; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006744; GO:0009234; GO:0016209; GO:0030173; GO:0032194; GO:0042371; GO:0071498; GO:0072359	"cellular response to fluid shear stress [GO:0071498]; circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]"		NA	NA	NA	NA	NA	NA
TRINITY_DN260_c0_g1_i2	E7FB98	UBIA1_DANRE	65	40	14	0	130	11	43	82	4.70E-06	51.6	UBIA1_DANRE	reviewed	UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (Protein barolo) (Protein reddish)	ubiad1 bar reh	Danio rerio (Zebrafish) (Brachydanio rerio)	336	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]; antioxidant activity [GO:0016209]; nitric-oxide synthase activity [GO:0004517]; prenyltransferase activity [GO:0004659]; cellular response to fluid shear stress [GO:0071498]; circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]	antioxidant activity [GO:0016209]; nitric-oxide synthase activity [GO:0004517]; prenyltransferase activity [GO:0004659]	GO:0001885; GO:0004517; GO:0004659; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006744; GO:0009234; GO:0016209; GO:0030173; GO:0032194; GO:0042371; GO:0071498; GO:0072359	"cellular response to fluid shear stress [GO:0071498]; circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11593_c0_g1_i1	Q8R317	UBQL1_MOUSE	69.9	83	24	1	568	813	241	323	3.30E-25	117.1	UBQL1_MOUSE	reviewed	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	Ubqln1 Plic1	Mus musculus (Mouse)	582	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]	GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019215; GO:0019900; GO:0019904; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN28911_c0_g1_i1	Q9UMX0	UBQL1_HUMAN	72.1	43	12	0	92	220	542	584	1.10E-10	67.4	UBQL1_HUMAN	reviewed	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1)	UBQLN1 DA41 PLIC1	Homo sapiens (Human)	589	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN34740_c0_g1_i1	Q9UMX0	UBQL1_HUMAN	100	70	0	0	111	320	249	318	3.90E-32	138.7	UBQL1_HUMAN	reviewed	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1)	UBQLN1 DA41 PLIC1	Homo sapiens (Human)	589	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3909_c0_g1_i2	Q9UHD9	UBQL2_HUMAN	50.5	91	42	1	281	18	33	123	5.20E-18	92	UBQL2_HUMAN	reviewed	Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2) (PLIC-2) (hPLIC-2) (Ubiquitin-like product Chap1/Dsk2)	UBQLN2 N4BP4 PLIC2 HRIHFB2157	Homo sapiens (Human)	624	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0000045; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0006511; GO:0016241; GO:0030433; GO:0031410; GO:0031593; GO:0042802; GO:1900186; GO:1903071; GO:1904021; GO:2000785	autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31058_c0_g1_i1	Q9UHD9	UBQL2_HUMAN	100	77	0	0	80	310	245	321	2.40E-37	156	UBQL2_HUMAN	reviewed	Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2) (PLIC-2) (hPLIC-2) (Ubiquitin-like product Chap1/Dsk2)	UBQLN2 N4BP4 PLIC2 HRIHFB2157	Homo sapiens (Human)	624	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0000045; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0006511; GO:0016241; GO:0030433; GO:0031410; GO:0031593; GO:0042802; GO:1900186; GO:1903071; GO:1904021; GO:2000785	autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3909_c0_g1_i1	Q99NB8	UBQL4_MOUSE	50.8	65	30	1	230	42	1	65	4.10E-10	65.5	UBQL4_MOUSE	reviewed	Ubiquilin-4 (Ataxin-1 interacting ubiquitin-like protein) (A1Up) (Ataxin-1 ubiquitin-like-interacting protein A1U) (Connexin43-interacting protein of 75 kDa) (CIP75)	Ubqln4 Cip75 Ubin	Mus musculus (Mouse)	596	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; endoplasmic reticulum membrane [GO:0005789]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; endoplasmic reticulum membrane [GO:0005789]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]	identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005789; GO:0005829; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0031410; GO:0031593; GO:0031595; GO:0031597; GO:0032434; GO:0032991; GO:0036435; GO:0042802; GO:0048471; GO:0090734; GO:1901097; GO:2000042	autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35587_c0_g1_i1	Q99NB8	UBQL4_MOUSE	100	84	0	0	2	253	20	103	9.40E-40	163.7	UBQL4_MOUSE	reviewed	Ubiquilin-4 (Ataxin-1 interacting ubiquitin-like protein) (A1Up) (Ataxin-1 ubiquitin-like-interacting protein A1U) (Connexin43-interacting protein of 75 kDa) (CIP75)	Ubqln4 Cip75 Ubin	Mus musculus (Mouse)	596	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; endoplasmic reticulum membrane [GO:0005789]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; endoplasmic reticulum membrane [GO:0005789]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]	identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005789; GO:0005829; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0031410; GO:0031593; GO:0031595; GO:0031597; GO:0032434; GO:0032991; GO:0036435; GO:0042802; GO:0048471; GO:0090734; GO:1901097; GO:2000042	autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35909_c0_g1_i1	Q1RIA5	UCRI_RICBR	71.8	71	20	0	215	3	114	184	9.50E-30	130.2	UCRI_RICBR	reviewed	Ubiquinol-cytochrome c reductase iron-sulfur subunit (EC 7.1.1.8) (Rieske iron-sulfur protein) (RISP)	petA RBE_0828	Rickettsia bellii (strain RML369-C)	186	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005886; GO:0008121; GO:0016021; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN6428_c0_g1_i1	Q68FU7	COQ6_RAT	48.5	482	223	8	49	1455	5	474	6.00E-115	416	COQ6_RAT	reviewed	"Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6)"	Coq6	Rattus norvegicus (Rat)	476	"cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; ubiquinone biosynthetic process [GO:0006744]"	cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]	"FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"	GO:0005739; GO:0005794; GO:0006744; GO:0016491; GO:0016709; GO:0016712; GO:0031314; GO:0042995; GO:0071949	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN6511_c0_g1_i1	Q16FT5	COQ4_AEDAE	59.3	236	89	1	315	1001	34	269	5.30E-79	296.2	COQ4_AEDAE	reviewed	"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog)"	AAEL014646	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	274	extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]		GO:0006744; GO:0031314	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN6511_c0_g1_i3	Q16FT5	COQ4_AEDAE	59.3	236	89	1	315	1001	34	269	5.10E-79	296.2	COQ4_AEDAE	reviewed	"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog)"	AAEL014646	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	274	extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]		GO:0006744; GO:0031314	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN32095_c0_g1_i1	Q9Y3A0	COQ4_HUMAN	100	69	0	0	208	2	149	217	3.00E-33	141.7	COQ4_HUMAN	reviewed	"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog)"	COQ4 CGI-92	Homo sapiens (Human)	265	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]		GO:0005739; GO:0006744; GO:0031314; GO:0032991	ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN35894_c0_g1_i1	Q9X3X2	UBIE_ZYMMO	77	74	17	0	222	1	2	75	3.40E-28	125.2	UBIE_ZYMMO	reviewed	"Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE (EC 2.1.1.163) (EC 2.1.1.201) (2-methoxy-6-polyprenyl-1,4-benzoquinol methylase) (Demethylmenaquinone methyltransferase)"	ubiE ubm ZMO1188	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	242	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; demethylmenaquinone methyltransferase activity [GO:0043770]; S-adenosylmethionine:2-demethylmenaquinol methyltransferase activity [GO:0102094]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; S-adenosylmethionine:2-demethylquinol-8 methyltransferase activity [GO:0102027]; aerobic respiration [GO:0009060]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"		"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; demethylmenaquinone methyltransferase activity [GO:0043770]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; S-adenosylmethionine:2-demethylmenaquinol methyltransferase activity [GO:0102094]; S-adenosylmethionine:2-demethylquinol-8 methyltransferase activity [GO:0102027]"	GO:0006744; GO:0009060; GO:0009234; GO:0032259; GO:0043333; GO:0043770; GO:0102027; GO:0102094; GO:0102955	aerobic respiration [GO:0009060]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN38034_c0_g1_i1	Q9X3X2	UBIE_ZYMMO	68.5	130	41	0	391	2	110	239	1.70E-45	183.3	UBIE_ZYMMO	reviewed	"Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE (EC 2.1.1.163) (EC 2.1.1.201) (2-methoxy-6-polyprenyl-1,4-benzoquinol methylase) (Demethylmenaquinone methyltransferase)"	ubiE ubm ZMO1188	Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)	242	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; demethylmenaquinone methyltransferase activity [GO:0043770]; S-adenosylmethionine:2-demethylmenaquinol methyltransferase activity [GO:0102094]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; S-adenosylmethionine:2-demethylquinol-8 methyltransferase activity [GO:0102027]; aerobic respiration [GO:0009060]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"		"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; demethylmenaquinone methyltransferase activity [GO:0043770]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; S-adenosylmethionine:2-demethylmenaquinol methyltransferase activity [GO:0102094]; S-adenosylmethionine:2-demethylquinol-8 methyltransferase activity [GO:0102027]"	GO:0006744; GO:0009060; GO:0009234; GO:0032259; GO:0043333; GO:0043770; GO:0102027; GO:0102094; GO:0102955	aerobic respiration [GO:0009060]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]		NA	NA	NA	NA	NA	NA
TRINITY_DN11505_c0_g1_i1	Q14694	UBP10_HUMAN	100	93	0	0	1	279	385	477	6.90E-49	194.1	UBP10_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10)	USP10 KIAA0190	Homo sapiens (Human)	798	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002039; GO:0003723; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0019985; GO:0030330; GO:0032991; GO:0043124; GO:0044325; GO:0071347	"autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8882_c0_g1_i1	Q6DIJ4	UBP10_XENTR	43.8	475	247	8	1527	115	347	805	2.10E-102	374.8	UBP10_XENTR	reviewed	Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10)	usp10 TGas137m11.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	805	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0071347	"autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29022_c0_g1_i1	P51784	UBP11_HUMAN	98.8	81	1	0	3	245	363	443	1.60E-41	169.5	UBP11_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11)	USP11 UHX1	Homo sapiens (Human)	963	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; RNA polymerase II transcription corepressor binding [GO:0001226]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; RNA polymerase II transcription corepressor binding [GO:0001226]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001226; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN29022_c0_g1_i2	P51784	UBP11_HUMAN	81.5	81	1	1	3	203	363	443	5.20E-30	131	UBP11_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11)	USP11 UHX1	Homo sapiens (Human)	963	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; RNA polymerase II transcription corepressor binding [GO:0001226]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; RNA polymerase II transcription corepressor binding [GO:0001226]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001226; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN10080_c0_g1_i1	A5D9H7	UBP12_BOVIN	75.5	110	26	1	1	330	10	118	2.80E-41	169.1	UBP12_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin thioesterase 12) (Ubiquitin-specific-processing protease 12)	USP12	Bos taurus (Bovine)	369	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0046872	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN14539_c0_g1_i2	Q8L6Y1	UBP14_ARATH	58.6	169	61	3	504	4	175	336	1.50E-49	197.2	UBP14_ARATH	reviewed	Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (AtUBP14) (TITAN-6 protein) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)	UBP14 TTN6 At3g20630 F3H11_1 K10D20.17 K10D20.26	Arabidopsis thaliana (Mouse-ear cress)	797	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; embryo development ending in seed dormancy [GO:0009793]; protein deubiquitination [GO:0016579]; root hair elongation [GO:0048767]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0009793; GO:0016579; GO:0048767	embryo development ending in seed dormancy [GO:0009793]; protein deubiquitination [GO:0016579]; root hair elongation [GO:0048767]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10481_c0_g1_i1	Q0IIF7	UBP14_BOVIN	57.1	49	21	0	3	149	88	136	1.10E-11	70.1	UBP14_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)	USP14	Bos taurus (Bovine)	494	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; cysteine-type peptidase activity [GO:0008234]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]	cysteine-type peptidase activity [GO:0008234]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0004843; GO:0005634; GO:0005737; GO:0005886; GO:0006511; GO:0008234; GO:0016579; GO:0045087; GO:0070628	innate immune response [GO:0045087]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN39718_c0_g1_i1	Q2HJE4	UBP15_BOVIN	100	134	0	0	3	404	330	463	1.40E-74	280	UBP15_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)	USP15	Bos taurus (Bovine)	952	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389	BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN7624_c0_g1_i1	Q9Y4E8	UBP15_HUMAN	22.2	477	325	15	193	1575	419	865	4.20E-18	94.4	UBP15_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4)	USP15 KIAA0529	Homo sapiens (Human)	981	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016032; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0042802; GO:0046332; GO:0060389; GO:0061649; GO:1900246; GO:1990380	BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN7168_c0_g1_i1	Q99LG0	UBP16_MOUSE	41	249	109	7	840	103	195	408	6.50E-37	156	UBP16_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16)	Usp16	Mus musculus (Mouse)	825	"nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]"	nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000278; GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0006357; GO:0006511; GO:0006974; GO:0008270; GO:0016578; GO:0035522; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537; GO:0140014	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7168_c0_g1_i2	Q99LG0	UBP16_MOUSE	37.4	439	214	12	1398	103	24	408	2.40E-66	254.6	UBP16_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16)	Usp16	Mus musculus (Mouse)	825	"nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]"	nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000278; GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0006357; GO:0006511; GO:0006974; GO:0008270; GO:0016578; GO:0035522; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537; GO:0140014	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13420_c0_g1_i1	Q67XW5	UBP18_ARATH	44.2	43	23	1	186	61	61	103	9.50E-05	47.4	UBP18_ARATH	reviewed	Ubiquitin carboxyl-terminal hydrolase 18 (EC 3.4.19.12) (Deubiquitinating enzyme 18) (AtUBP18) (Ubiquitin thioesterase 18) (Ubiquitin-specific-processing protease 18)	UBP18 At4g31670 F28M20.140	Arabidopsis thaliana (Mouse-ear cress)	631	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016021; GO:0016579; GO:0046872	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		brown	brown	NA	NA	NA	NA
TRINITY_DN6030_c0_g1_i2	Q6J1Y9	UBP19_RAT	49.3	383	188	5	1207	68	534	913	4.80E-106	386.3	UBP19_RAT	reviewed	Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19)	Usp19	Rattus norvegicus (Rat)	1357	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005789; GO:0005829; GO:0008234; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0071108; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380	negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN5941_c0_g1_i2	Q6J1Y9	UBP19_RAT	47	215	112	2	704	66	1042	1256	1.40E-51	204.9	UBP19_RAT	reviewed	Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19)	Usp19	Rattus norvegicus (Rat)	1357	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005789; GO:0005829; GO:0008234; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0071108; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380	negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN36675_c0_g1_i1	O94966	UBP19_HUMAN	100	79	0	0	238	2	570	648	8.40E-40	163.7	UBP19_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)	USP19 KIAA0891 ZMYND9	Homo sapiens (Human)	1318	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005789; GO:0005829; GO:0008234; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380	negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN36814_c0_g1_i1	O94966	UBP19_HUMAN	100	67	0	0	52	252	490	556	1.10E-32	140.2	UBP19_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)	USP19 KIAA0891 ZMYND9	Homo sapiens (Human)	1318	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cysteine-type peptidase activity [GO:0008234]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005789; GO:0005829; GO:0008234; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380	negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN21_c0_g1_i1	O57429	UBP2_CHICK	53.7	201	88	4	301	900	17	213	7.90E-54	212.6	UBP2_CHICK	reviewed	Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)	USP2 UBP41	Gallus gallus (Chicken)	357	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0046872; GO:0048471; GO:0048511	protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN21_c0_g1_i1	O57429	UBP2_CHICK	60	65	26	0	908	1102	293	357	2.30E-16	88.2	UBP2_CHICK	reviewed	Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)	USP2 UBP41	Gallus gallus (Chicken)	357	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0046872; GO:0048471; GO:0048511	protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN21_c0_g1_i2	O57429	UBP2_CHICK	58.8	153	63	0	2	460	205	357	4.80E-46	185.7	UBP2_CHICK	reviewed	Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)	USP2 UBP41	Gallus gallus (Chicken)	357	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0046872; GO:0048471; GO:0048511	protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN32432_c0_g1_i1	A7Z056	UBP20_BOVIN	50.5	93	44	1	2	280	556	646	6.70E-20	97.8	UBP20_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20)	USP20	Bos taurus (Bovine)	912	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0001664; GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0048471; GO:0070536; GO:0071108	endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26706_c0_g1_i1	Q9Y2K6	UBP20_HUMAN	100	235	0	0	2	706	523	757	3.30E-140	498.8	UBP20_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2)	USP20 KIAA1003 LSFR3A VDU2	Homo sapiens (Human)	914	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0001664; GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0048471; GO:0070536; GO:0071108	endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN30537_c0_g1_i1	Q9Y2K6	UBP20_HUMAN	100	89	0	0	2	268	793	881	4.30E-48	191.4	UBP20_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2)	USP20 KIAA1003 LSFR3A VDU2	Homo sapiens (Human)	914	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0001664; GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0048471; GO:0070536; GO:0071108	endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31473_c0_g1_i1	Q2KJ72	UBP21_BOVIN	33.3	126	76	3	424	53	437	556	4.20E-14	79.3	UBP21_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 21 (EC 3.4.19.12) (Deubiquitinating enzyme 21) (Ubiquitin thioesterase 21) (Ubiquitin-specific-processing protease 21)	USP21	Bos taurus (Bovine)	565	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0008234; GO:0016578; GO:0019784; GO:0045893; GO:0046872	"histone deubiquitination [GO:0016578]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37894_c0_g1_i1	P0C8Z3	UBP22_BOVIN	100	119	0	0	1	357	210	328	3.10E-70	265.4	UBP22_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	USP22	Bos taurus (Bovine)	514	"SAGA complex [GO:0000124]; cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"	SAGA complex [GO:0000124]	cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000124; GO:0004843; GO:0006511; GO:0007049; GO:0008234; GO:0008270; GO:0010485; GO:0016574; GO:0016578; GO:0019899; GO:0030374; GO:0045893; GO:0045931	"cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28955_c0_g1_i1	Q5DU02	UBP22_MOUSE	97.3	73	2	0	1	219	453	525	1.90E-36	152.5	UBP22_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	Usp22 Kiaa1063	Mus musculus (Mouse)	525	"SAGA complex [GO:0000124]; cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"	SAGA complex [GO:0000124]	cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000124; GO:0003713; GO:0004843; GO:0006511; GO:0007049; GO:0008234; GO:0008270; GO:0010485; GO:0016574; GO:0016578; GO:0016579; GO:0019899; GO:0030374; GO:0045893; GO:0045931	"cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27619_c0_g1_i1	P0C8Z3	UBP22_BOVIN	100	73	0	0	221	3	132	204	9.60E-38	156.8	UBP22_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	USP22	Bos taurus (Bovine)	514	"SAGA complex [GO:0000124]; cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"	SAGA complex [GO:0000124]	cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000124; GO:0004843; GO:0006511; GO:0007049; GO:0008234; GO:0008270; GO:0010485; GO:0016574; GO:0016578; GO:0019899; GO:0030374; GO:0045893; GO:0045931	"cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8504_c1_g1_i2	Q9UPT9	UBP22_HUMAN	67.1	359	90	7	1105	92	174	525	5.60E-137	488.8	UBP22_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	USP22 KIAA1063 USP3L	Homo sapiens (Human)	525	"nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"	nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]	cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000124; GO:0003713; GO:0004843; GO:0005654; GO:0006511; GO:0007049; GO:0008234; GO:0008270; GO:0009792; GO:0016574; GO:0016578; GO:0016579; GO:0019899; GO:0030374; GO:0043967; GO:0045893; GO:0045931	"cell cycle [GO:0007049]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8504_c1_g1_i3	Q5DU02	UBP22_MOUSE	60.9	488	162	8	1489	92	45	525	2.20E-170	600.1	UBP22_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	Usp22 Kiaa1063	Mus musculus (Mouse)	525	"SAGA complex [GO:0000124]; cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"	SAGA complex [GO:0000124]	cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000124; GO:0003713; GO:0004843; GO:0006511; GO:0007049; GO:0008234; GO:0008270; GO:0010485; GO:0016574; GO:0016578; GO:0016579; GO:0019899; GO:0030374; GO:0045893; GO:0045931	"cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8504_c1_g1_i4	P0C8Z3	UBP22_BOVIN	59.3	236	94	2	821	117	34	268	1.30E-79	297.7	UBP22_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	USP22	Bos taurus (Bovine)	514	"SAGA complex [GO:0000124]; cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"	SAGA complex [GO:0000124]	cysteine-type peptidase activity [GO:0008234]; enzyme binding [GO:0019899]; H4 histone acetyltransferase activity [GO:0010485]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000124; GO:0004843; GO:0006511; GO:0007049; GO:0008234; GO:0008270; GO:0010485; GO:0016574; GO:0016578; GO:0019899; GO:0030374; GO:0045893; GO:0045931	"cell cycle [GO:0007049]; histone deubiquitination [GO:0016578]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6258_c0_g1_i8	Q9FPS4	UBP23_ARATH	25.7	253	151	7	23	730	103	335	2.50E-16	87.4	UBP23_ARATH	reviewed	Ubiquitin carboxyl-terminal hydrolase 23 (EC 3.4.19.12) (Deubiquitinating enzyme 23) (AtUBP23) (Ubiquitin thioesterase 23) (Ubiquitin-specific-processing protease 23)	UBP23 At5g57990 MTI20.25	Arabidopsis thaliana (Mouse-ear cress)	859	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1917_c0_g1_i2	Q9UPU5	UBP24_HUMAN	42.5	214	112	3	689	75	143	354	1.20E-41	171.4	UBP24_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	USP24 KIAA1057	Homo sapiens (Human)	2620	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1917_c0_g1_i4	Q9UPU5	UBP24_HUMAN	42	238	127	3	688	2	143	378	4.20E-47	189.5	UBP24_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	USP24 KIAA1057	Homo sapiens (Human)	2620	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6185_c0_g2_i1	B1AY13	UBP24_MOUSE	42.6	786	411	13	2279	3	1060	1832	6.50E-161	569.3	UBP24_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	Usp24	Mus musculus (Mouse)	2617	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6185_c0_g1_i1	Q9UPU5	UBP24_HUMAN	37	297	176	4	968	87	750	1038	9.10E-50	199.1	UBP24_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	USP24 KIAA1057	Homo sapiens (Human)	2620	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6185_c0_g1_i2	Q9UPU5	UBP24_HUMAN	38.1	365	215	4	1134	49	682	1038	1.90E-68	261.2	UBP24_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	USP24 KIAA1057	Homo sapiens (Human)	2620	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6185_c0_g1_i3	Q9UPU5	UBP24_HUMAN	38.1	365	215	4	1172	87	682	1038	1.10E-68	261.9	UBP24_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	USP24 KIAA1057	Homo sapiens (Human)	2620	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016032; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN6953_c0_g1_i1	P57080	UBP25_MOUSE	34.1	968	542	23	210	2996	88	998	3.80E-130	467.6	UBP25_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25)	Usp25	Mus musculus (Mouse)	1055	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; SUMO binding [GO:0032183]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; SUMO binding [GO:0032183]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0000502; GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0031625; GO:0032183; GO:0051117; GO:0070536; GO:0071108; GO:1904293	negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6953_c0_g1_i2	P57080	UBP25_MOUSE	34.1	968	542	23	210	2996	88	998	3.80E-130	467.6	UBP25_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25)	Usp25	Mus musculus (Mouse)	1055	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; SUMO binding [GO:0032183]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; SUMO binding [GO:0032183]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0000502; GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0031625; GO:0032183; GO:0051117; GO:0070536; GO:0071108; GO:1904293	negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11671_c0_g2_i1	A4QNN3	UBP30_XENTR	28.5	622	241	14	1869	91	58	504	2.40E-50	201.8	UBP30_XENTR	reviewed	Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30)	usp30 TEgg099b09.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	519	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000422; GO:0004197; GO:0004843; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006511; GO:0008053; GO:0016021; GO:0016579; GO:0035871; GO:0044313	autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9881_c0_g1_i1	Q70CQ4	UBP31_HUMAN	40.3	154	73	4	1665	1249	711	860	7.50E-18	93.6	UBP31_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31)	USP31 KIAA1203	Homo sapiens (Human)	1352	nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005634; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN162_c0_g1_i5	M9PD06	UBP32_DROME	41.5	325	165	9	335	1282	1406	1714	1.80E-62	241.5	UBP32_DROME	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12)	Usp32 Usp15 CG8334	Drosophila melanogaster (Fruit fly)	1715	Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	Golgi apparatus [GO:0005794]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN162_c0_g1_i5	M9PD06	UBP32_DROME	55.2	87	37	1	78	332	1405	1491	7.00E-22	106.7	UBP32_DROME	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12)	Usp32 Usp15 CG8334	Drosophila melanogaster (Fruit fly)	1715	Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	Golgi apparatus [GO:0005794]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN32694_c0_g1_i1	Q8NFA0	UBP32_HUMAN	92.8	83	6	0	3	251	1514	1596	6.10E-41	167.5	UBP32_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	USP32 USP10	Homo sapiens (Human)	1604	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0008234; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN162_c0_g1_i2	Q8NFA0	UBP32_HUMAN	47.1	155	78	2	92	547	1	154	1.90E-34	147.1	UBP32_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	USP32 USP10	Homo sapiens (Human)	1604	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0008234; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN162_c0_g1_i3	Q8NFA0	UBP32_HUMAN	41.7	1097	470	17	34	3081	594	1601	5.10E-233	809.3	UBP32_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	USP32 USP10	Homo sapiens (Human)	1604	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0008234; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN162_c0_g1_i4	Q8NFA0	UBP32_HUMAN	41.4	1114	483	17	80	3178	577	1601	1.60E-234	814.3	UBP32_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	USP32 USP10	Homo sapiens (Human)	1604	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0008234; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN162_c0_g1_i6	Q8NFA0	UBP32_HUMAN	42.1	1739	784	26	92	5053	1	1601	0	1303.1	UBP32_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	USP32 USP10	Homo sapiens (Human)	1604	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0008234; GO:0016020; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5807_c0_g1_i1	Q28CN3	UBP33_XENTR	44.2	887	432	13	3016	458	8	865	7.40E-200	699.1	UBP33_XENTR	reviewed	Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33)	usp33 TEgg041n23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	892	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108	axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5807_c0_g1_i2	Q28CN3	UBP33_XENTR	44.6	896	424	15	3043	458	8	865	1.10E-203	711.8	UBP33_XENTR	reviewed	Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33)	usp33 TEgg041n23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	892	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108	axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5807_c0_g1_i3	Q28CN3	UBP33_XENTR	44.6	896	424	15	2858	273	8	865	1.00E-203	711.8	UBP33_XENTR	reviewed	Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33)	usp33 TEgg041n23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	892	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108	axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5807_c0_g1_i4	Q28CN3	UBP33_XENTR	44.2	887	432	13	2831	273	8	865	6.90E-200	699.1	UBP33_XENTR	reviewed	Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33)	usp33 TEgg041n23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	892	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108	axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36751_c0_g1_i2	Q9P2H5	UBP35_HUMAN	55	100	45	0	22	321	440	539	1.30E-26	121.7	UBP35_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 35 (EC 3.4.19.12) (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35)	USP35 KIAA1372 USP34	Homo sapiens (Human)	1018	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4669_c0_g1_i1	B4MLR8	UBP36_DROWI	22.6	332	202	12	619	1506	213	525	1.70E-06	57	UBP36_DROWI	reviewed	Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Protein scrawny) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36)	Usp36 scny GK17299	Drosophila willistoni (Fruit fly)	1311	nucleolus [GO:0005730]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; germ-line stem cell population maintenance [GO:0030718]; negative regulation of macroautophagy [GO:0016242]; protein deubiquitination [GO:0016579]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleolus [GO:0005730]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005730; GO:0006511; GO:0008234; GO:0016242; GO:0016579; GO:0030718; GO:0035019	germ-line stem cell population maintenance [GO:0030718]; negative regulation of macroautophagy [GO:0016242]; protein deubiquitination [GO:0016579]; somatic stem cell population maintenance [GO:0035019]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24073_c0_g1_i1	A6QR55	UBP4_BOVIN	98	148	3	0	446	3	354	501	1.20E-82	307	UBP4_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4)	USP4	Bos taurus (Bovine)	963	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenosine receptor binding [GO:0031685]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0008234; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872	negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24073_c0_g1_i2	P35123	UBP4_MOUSE	100	124	0	0	374	3	378	501	1.00E-68	260.4	UBP4_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein)	Usp4 Unp	Mus musculus (Mouse)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenosine receptor binding [GO:0031685]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0008234; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872	negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6258_c0_g1_i6	P35123	UBP4_MOUSE	26.5	189	112	3	38	523	303	491	8.80E-09	62	UBP4_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein)	Usp4 Unp	Mus musculus (Mouse)	962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenosine receptor binding [GO:0031685]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0008234; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872	negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10030_c0_g1_i1	Q70EL4	UBP43_HUMAN	51.2	123	48	1	124	492	96	206	3.60E-31	136.3	UBP43_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)	USP43	Homo sapiens (Human)	1123	nucleoplasm [GO:0005654]; ISG15-specific protease activity [GO:0019785]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleoplasm [GO:0005654]	ISG15-specific protease activity [GO:0019785]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0019785; GO:0019985	protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10030_c0_g1_i3	Q70EL4	UBP43_HUMAN	51.2	123	48	1	124	492	96	206	4.00E-31	136.3	UBP43_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)	USP43	Homo sapiens (Human)	1123	nucleoplasm [GO:0005654]; ISG15-specific protease activity [GO:0019785]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleoplasm [GO:0005654]	ISG15-specific protease activity [GO:0019785]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0019785; GO:0019985	protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9881_c0_g1_i2	Q8BUM9	UBP43_MOUSE	43.5	69	32	1	1620	1435	670	738	1.30E-09	66.2	UBP43_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)	Usp43	Mus musculus (Mouse)	1132	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9011_c0_g1_i1	Q70EL2	UBP45_HUMAN	41.1	263	109	6	534	1307	593	814	4.10E-41	170.6	UBP45_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45)	USP45	Homo sapiens (Human)	814	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0001917; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006511; GO:0008234; GO:0008270; GO:0016579; GO:0045494; GO:0070911	DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10080_c0_g1_i3	P62068	UBP46_HUMAN	76.3	76	17	1	103	330	40	114	7.40E-26	117.9	UBP46_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 46 (EC 3.4.19.12) (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46)	USP46	Homo sapiens (Human)	366	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001662; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008343; GO:0016579; GO:0032228; GO:0046872; GO:0048149; GO:0060013; GO:0098978; GO:0099149	"adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38028_c0_g1_i1	P62068	UBP46_HUMAN	100	100	0	0	302	3	20	119	2.60E-54	212.2	UBP46_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 46 (EC 3.4.19.12) (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46)	USP46	Homo sapiens (Human)	366	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001662; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008343; GO:0016579; GO:0032228; GO:0046872; GO:0048149; GO:0060013; GO:0098978; GO:0099149	"adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN21687_c0_g1_i1	P62068	UBP46_HUMAN	98.6	72	1	0	218	3	244	315	1.70E-34	146	UBP46_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 46 (EC 3.4.19.12) (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46)	USP46	Homo sapiens (Human)	366	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001662; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008343; GO:0016579; GO:0032228; GO:0046872; GO:0048149; GO:0060013; GO:0098978; GO:0099149	"adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20013_c0_g1_i1	P62068	UBP46_HUMAN	70.4	203	60	0	666	58	164	366	9.50E-79	294.7	UBP46_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 46 (EC 3.4.19.12) (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46)	USP46	Homo sapiens (Human)	366	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001662; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008343; GO:0016579; GO:0032228; GO:0046872; GO:0048149; GO:0060013; GO:0098978; GO:0099149	"adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]"		brown	brown	NA	NA	NA	NA
TRINITY_DN27962_c0_g1_i1	P45974	UBP5_HUMAN	100	74	0	0	2	223	785	858	1.40E-40	166.4	UBP5_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	USP5 ISOT	Homo sapiens (Human)	858	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0043130; GO:0071108	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN14539_c0_g1_i1	P45974	UBP5_HUMAN	58.9	112	39	2	383	48	194	298	1.50E-30	133.7	UBP5_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	USP5 ISOT	Homo sapiens (Human)	858	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0043130; GO:0071108	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31933_c1_g1_i1	P45974	UBP5_HUMAN	100	68	0	0	206	3	251	318	5.10E-33	141	UBP5_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	USP5 ISOT	Homo sapiens (Human)	858	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0043130; GO:0071108	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31933_c0_g1_i1	P45974	UBP5_HUMAN	100	71	0	0	215	3	301	371	6.00E-37	154.1	UBP5_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	USP5 ISOT	Homo sapiens (Human)	858	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0043130; GO:0071108	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38822_c0_g1_i1	P56399	UBP5_MOUSE	100	86	0	0	260	3	164	249	3.80E-49	194.9	UBP5_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	Usp5 Isot	Mus musculus (Mouse)	858	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0071108	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4667_c0_g1_i1	P56399	UBP5_MOUSE	51.1	859	358	14	2516	99	7	856	1.50E-243	844	UBP5_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	Usp5 Isot	Mus musculus (Mouse)	858	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0071108	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN38944_c0_g1_i1	Q6U7I1	UBP7_CHICK	86.4	66	9	0	199	2	197	262	1.80E-27	122.5	UBP7_CHICK	reviewed	Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)	USP7	Gallus gallus (Chicken)	1101	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006511; GO:0007275; GO:0016579; GO:0016605; GO:0031647; GO:0035616; GO:0051090	histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6774_c0_g1_i8	P40818	UBP8_HUMAN	46.9	64	33	1	95	283	9	72	6.10E-06	51.6	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4039_c0_g1_i10	P40818	UBP8_HUMAN	42.7	393	208	9	1244	102	727	1114	5.00E-83	309.7	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4039_c0_g1_i2	P40818	UBP8_HUMAN	45.1	350	180	7	1121	102	767	1114	1.30E-80	301.6	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4039_c0_g1_i3	P40818	UBP8_HUMAN	45.2	343	176	7	1100	102	774	1114	3.10E-79	297	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4039_c0_g1_i5	P40818	UBP8_HUMAN	42.7	393	208	9	1154	12	727	1114	8.00E-83	308.9	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4039_c0_g1_i8	P40818	UBP8_HUMAN	42.7	393	208	9	1191	49	727	1114	4.80E-83	309.7	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4039_c0_g1_i9	P40818	UBP8_HUMAN	42.7	393	208	9	1244	102	727	1114	5.00E-83	309.7	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36075_c0_g1_i1	P40818	UBP8_HUMAN	100	67	0	0	203	3	777	843	1.40E-35	149.4	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7624_c0_g1_i2	Q80U87	UBP8_MOUSE	42.4	85	49	0	1140	1394	925	1009	1.70E-15	85.5	UBP8_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	Usp8 Kiaa0055 Ubpy	Mus musculus (Mouse)	1080	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0008234; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0070536; GO:0071108; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6774_c0_g1_i4	Q80U87	UBP8_MOUSE	36.8	106	62	3	238	549	179	281	1.10E-10	68.2	UBP8_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	Usp8 Kiaa0055 Ubpy	Mus musculus (Mouse)	1080	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0008234; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0070536; GO:0071108; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		pink	pink	NA	NA	NA	NA
TRINITY_DN6774_c0_g1_i6	Q80U87	UBP8_MOUSE	35.6	340	203	8	95	1087	9	341	6.90E-40	166.4	UBP8_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	Usp8 Kiaa0055 Ubpy	Mus musculus (Mouse)	1080	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0008234; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0070536; GO:0071108; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6774_c0_g1_i7	Q80U87	UBP8_MOUSE	35.3	331	200	7	95	1066	9	332	2.20E-37	157.9	UBP8_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	Usp8 Kiaa0055 Ubpy	Mus musculus (Mouse)	1080	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cysteine-type peptidase activity [GO:0008234]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0008234; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0070536; GO:0071108; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"		brown	brown	NA	NA	NA	NA
TRINITY_DN16087_c0_g1_i1	C4A0D9	BAP1_BRAFL	59	61	25	0	415	597	603	663	2.20E-13	77.4	BAP1_BRAFL	reviewed	Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1)	BAP1 BRAFLDRAFT_277645	Branchiostoma floridae (Florida lancelet) (Amphioxus)	694	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]	chromatin binding [GO:0003682]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0035517; GO:0035522; GO:0045892; GO:0051726; GO:0071108	"monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16087_c0_g1_i4	C4A0D9	BAP1_BRAFL	59	61	25	0	415	597	603	663	2.30E-13	77.4	BAP1_BRAFL	reviewed	Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1)	BAP1 BRAFLDRAFT_277645	Branchiostoma floridae (Florida lancelet) (Amphioxus)	694	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]	chromatin binding [GO:0003682]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0035517; GO:0035522; GO:0045892; GO:0051726; GO:0071108	"monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9884_c2_g1_i1	Q17N72	CALYP_AEDAE	72.7	264	67	2	801	10	1	259	4.10E-108	392.5	CALYP_AEDAE	reviewed	Ubiquitin carboxyl-terminal hydrolase calypso (EC 3.4.19.12) (BAP1 homolog)	calypso AAEL000787	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	478	nuclear chromatin [GO:0000790]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; chromatin silencing [GO:0006342]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; ubiquitin-dependent protein catabolic process [GO:0006511]	nuclear chromatin [GO:0000790]; PR-DUB complex [GO:0035517]	chromatin binding [GO:0003682]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000790; GO:0003682; GO:0004843; GO:0006342; GO:0006511; GO:0008234; GO:0035517; GO:0035522	chromatin silencing [GO:0006342]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11265_c0_g1_i1	Q96V54	CREB_EMENI	66.7	30	10	0	86	175	55	84	1.10E-05	50.4	CREB_EMENI	reviewed	Ubiquitin carboxyl-terminal hydrolase creB (EC 3.4.19.12) (Carbon catabolite repression protein B) (Deubiquitinating enzyme creB) (Ubiquitin thioesterase creB) (Ubiquitin-hydrolyzing enzyme creB) (Ubiquitin-specific-processing protease creB)	creB molB AN3587	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	766	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; carbon catabolite repression of transcription [GO:0045013]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0045013	carbon catabolite repression of transcription [GO:0045013]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN11265_c0_g1_i2	Q96V54	CREB_EMENI	66.7	30	10	0	57	146	55	84	9.60E-06	50.4	CREB_EMENI	reviewed	Ubiquitin carboxyl-terminal hydrolase creB (EC 3.4.19.12) (Carbon catabolite repression protein B) (Deubiquitinating enzyme creB) (Ubiquitin thioesterase creB) (Ubiquitin-hydrolyzing enzyme creB) (Ubiquitin-specific-processing protease creB)	creB molB AN3587	Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans)	766	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; carbon catabolite repression of transcription [GO:0045013]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0045013	carbon catabolite repression of transcription [GO:0045013]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN16044_c1_g1_i1	Q9NQC7	CYLD_HUMAN	50.8	183	86	2	94	630	507	689	3.70E-42	172.9	CYLD_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	CYLD CYLD1 KIAA0849 HSPC057	Homo sapiens (Human)	956	"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell cycle [GO:0007049]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006511; GO:0007049; GO:0007346; GO:0008234; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0031234; GO:0032088; GO:0032480; GO:0036064; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050862; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070423; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242	"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell cycle [GO:0007049]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16044_c1_g1_i2	Q1RMU2	CYLD_BOVIN	46.7	244	116	6	662	1375	451	686	4.40E-48	193.7	CYLD_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	CYLD CYLD1	Bos taurus (Bovine)	953	"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005881; GO:0006511; GO:0007346; GO:0008234; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0030496; GO:0031234; GO:0032088; GO:0036064; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050862; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242	"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16044_c1_g1_i4	Q1RMU2	CYLD_BOVIN	47.7	241	114	6	662	1363	451	686	1.50E-48	195.3	CYLD_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	CYLD CYLD1	Bos taurus (Bovine)	953	"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005881; GO:0006511; GO:0007346; GO:0008234; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0030496; GO:0031234; GO:0032088; GO:0036064; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050862; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242	"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11861_c0_g1_i1	Q91Y78	UCHL3_RAT	52.7	224	105	1	57	725	5	228	3.00E-65	250	UCHL3_RAT	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3)	Uchl3	Rattus norvegicus (Rat)	230	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitinyl hydrolase activity [GO:0101005]; adult walking behavior [GO:0007628]; cellular response to insulin stimulus [GO:0032869]; eating behavior [GO:0042755]; positive regulation of fat cell differentiation [GO:0045600]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; retina development in camera-type eye [GO:0060041]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitinyl hydrolase activity [GO:0101005]	GO:0004843; GO:0005737; GO:0006511; GO:0007628; GO:0008233; GO:0008234; GO:0016579; GO:0030163; GO:0032869; GO:0042755; GO:0043130; GO:0045600; GO:0060041; GO:0101005	adult walking behavior [GO:0007628]; cellular response to insulin stimulus [GO:0032869]; eating behavior [GO:0042755]; positive regulation of fat cell differentiation [GO:0045600]; protein catabolic process [GO:0030163]; protein deubiquitination [GO:0016579]; retina development in camera-type eye [GO:0060041]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN24941_c0_g1_i1	Q2TBG8	UCHL3_BOVIN	100	69	0	0	234	28	162	230	1.80E-34	146	UCHL3_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3)	UCHL3	Bos taurus (Bovine)	230	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN24941_c0_g1_i2	Q2TBG8	UCHL3_BOVIN	100	69	0	0	242	36	162	230	1.90E-34	146	UCHL3_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3)	UCHL3	Bos taurus (Bovine)	230	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40743_c0_g1_i1	Q9Y5K5	UCHL5_HUMAN	100	71	0	0	2	214	85	155	1.10E-33	143.3	UCHL5_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)	UCHL5 UCH37 AD-019 CGI-70	Homo sapiens (Human)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; cysteine-type peptidase activity [GO:0008234]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	cysteine-type peptidase activity [GO:0008234]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0003723; GO:0004843; GO:0004866; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0008234; GO:0016579; GO:0031011; GO:0032435; GO:0045880; GO:0061136; GO:0070628	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10704_c0_g1_i1	Q9WUP7	UCHL5_MOUSE	62.1	322	113	3	1053	112	3	323	8.90E-113	408.3	UCHL5_MOUSE	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)	Uchl5 Uch37	Mus musculus (Mouse)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0004866; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0008234; GO:0016579; GO:0021670; GO:0030901; GO:0031011; GO:0031597; GO:0032435; GO:0045880; GO:0048853; GO:0061136; GO:0070628	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN10704_c0_g1_i2	Q9XSJ0	UCHL5_BOVIN	61.1	298	108	2	984	112	26	322	3.50E-101	369.8	UCHL5_BOVIN	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)	UCHL5 UCH37	Bos taurus (Bovine)	328	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; cysteine-type peptidase activity [GO:0008234]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	cysteine-type peptidase activity [GO:0008234]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0008234; GO:0016579; GO:0021670; GO:0030901; GO:0031011; GO:0048853; GO:0070628	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36829_c0_g1_i1	Q9Y5K5	UCHL5_HUMAN	99.6	236	0	1	707	3	22	257	1.90E-132	473	UCHL5_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)	UCHL5 UCH37 AD-019 CGI-70	Homo sapiens (Human)	329	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; cysteine-type peptidase activity [GO:0008234]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	cysteine-type peptidase activity [GO:0008234]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0003723; GO:0004843; GO:0004866; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0008234; GO:0016579; GO:0031011; GO:0032435; GO:0045880; GO:0061136; GO:0070628	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35896_c0_g1_i1	Q54N38	UCHL5_DICDI	49.4	160	78	1	485	6	48	204	1.60E-37	157.1	UCHL5_DICDI	reviewed	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin thioesterase L5)	uch2 uchl5 DDB_G0285527	Dictyostelium discoideum (Slime mold)	343	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000502; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0008234; GO:0016579	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8396_c0_g1_i1	A3KQS4	MINY1_DANRE	42.2	45	26	0	24	158	333	377	4.70E-05	48.1	MINY1_DANRE	reviewed	Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A)	mindy1 fam63a si:ch211-210h11.5	Danio rerio (Zebrafish) (Brachydanio rerio)	520	nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA-binding transcription factor activity [GO:0003700]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; DNA-binding transcription factor activity [GO:0003700]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000978; GO:0003700; GO:0004843; GO:0005634; GO:0006357; GO:0008234; GO:0036435; GO:1990380	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38526_c0_g1_i1	Q8NBR6	MINY2_HUMAN	52.4	168	74	3	16	513	320	483	4.50E-41	169.1	MINY2_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B)	MINDY2 FAM63B KIAA1164	Homo sapiens (Human)	621	cell periphery [GO:0071944]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108]	cell periphery [GO:0071944]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cysteine-type carboxypeptidase activity [GO:0016807]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005654; GO:0005829; GO:0016807; GO:0036435; GO:0070530; GO:0071108; GO:0071795; GO:0071796; GO:0071944; GO:1990380	protein K48-linked deubiquitination [GO:0071108]		blue	blue	NA	NA	NA	NA
TRINITY_DN17725_c0_g1_i2	A0AUR5	MINY3_DANRE	38	266	130	6	110	877	7	247	6.50E-35	149.4	MINY3_DANRE	reviewed	Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP)	mindy3 carp fam188a zgc:153892	Danio rerio (Zebrafish) (Brachydanio rerio)	446	nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; apoptotic process [GO:0006915]	nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005634; GO:0006915; GO:0008234; GO:1990380	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN17725_c0_g1_i3	Q9VWN5	MINY3_DROME	36.7	480	264	6	104	1471	97	560	1.70E-83	311.6	MINY3_DROME	reviewed	Ubiquitin carboxyl-terminal hydrolase MINDY-3 homolog (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP homolog)	mindy3 CG7332	Drosophila melanogaster (Fruit fly)	560	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]		cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:1990380			NA	NA	NA	NA	NA	NA
TRINITY_DN17725_c0_g1_i4	Q9VWN5	MINY3_DROME	36.7	480	264	6	104	1471	97	560	3.70E-83	310.5	MINY3_DROME	reviewed	Ubiquitin carboxyl-terminal hydrolase MINDY-3 homolog (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP homolog)	mindy3 CG7332	Drosophila melanogaster (Fruit fly)	560	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]		cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:1990380			NA	NA	NA	NA	NA	NA
TRINITY_DN6258_c0_g1_i10	Q8IQ27	UBP2_DROME	30.1	336	199	10	5	916	605	936	1.80E-27	124.8	UBP2_DROME	reviewed	Ubiquitin carboxyl-terminal hydrolase Usp2 (EC 3.4.19.12) (Ubiquitin specific protease 2)	Usp2 CG14619	Drosophila melanogaster (Fruit fly)	938	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of eclosion [GO:0045805]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002785; GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0045087; GO:0045805; GO:0046872; GO:0051926; GO:0061060; GO:0070628; GO:0071108; GO:1901800; GO:1990380	innate immune response [GO:0045087]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of eclosion [GO:0045805]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6258_c0_g1_i2	Q8IQ27	UBP2_DROME	34.3	102	61	2	5	298	605	704	4.00E-07	55.8	UBP2_DROME	reviewed	Ubiquitin carboxyl-terminal hydrolase Usp2 (EC 3.4.19.12) (Ubiquitin specific protease 2)	Usp2 CG14619	Drosophila melanogaster (Fruit fly)	938	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of eclosion [GO:0045805]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]	cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002785; GO:0004843; GO:0005737; GO:0006511; GO:0008234; GO:0016579; GO:0045087; GO:0045805; GO:0046872; GO:0051926; GO:0061060; GO:0070628; GO:0071108; GO:1901800; GO:1990380	innate immune response [GO:0045087]; negative regulation of antimicrobial peptide production [GO:0002785]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of eclosion [GO:0045805]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN10604_c0_g1_i1	A5PKG6	UBE4A_BOVIN	33.8	938	570	17	25	2745	123	1040	1.00E-136	489.2	UBE4A_BOVIN	reviewed	Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A)	UBE4A	Bos taurus (Bovine)	1067	"cytoplasm [GO:0005737]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; ubiquitin ligase complex [GO:0000151]; snoRNA binding [GO:0030515]; ubiquitin-ubiquitin ligase activity [GO:0034450]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; ubiquitin ligase complex [GO:0000151]	snoRNA binding [GO:0030515]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000462; GO:0005737; GO:0006511; GO:0030515; GO:0032040; GO:0034388; GO:0034450	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2786_c0_g1_i4	O95155	UBE4B_HUMAN	44.6	942	479	10	2908	98	397	1300	6.60E-215	749.2	UBE4B_HUMAN	reviewed	Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)	UBE4B HDNB1 KIAA0684 UFD2	Homo sapiens (Human)	1302	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATPase binding [GO:0051117]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0043161; GO:0051117; GO:0051865	granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]		NA	NA	NA	NA	NA	NA
TRINITY_DN2786_c0_g1_i2	Q9ES00	UBE4B_MOUSE	51.7	120	57	1	408	52	768	887	2.00E-26	120.2	UBE4B_MOUSE	reviewed	Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)	Ube4b Ufd2 Ufd2a	Mus musculus (Mouse)	1173	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATPase binding [GO:0051117]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]	GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0034976; GO:0043161; GO:0044257; GO:0051082; GO:0051117; GO:0051865; GO:0061630	cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]		NA	NA	NA	NA	NA	NA
TRINITY_DN8227_c0_g1_i1	Q6DG43	UBTD2_DANRE	52.2	230	106	3	771	88	1	228	8.80E-62	238.4	UBTD2_DANRE	reviewed	Ubiquitin domain-containing protein 2	ubtd2 zgc:91797	Danio rerio (Zebrafish) (Brachydanio rerio)	240	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN8227_c0_g1_i2	Q6DG43	UBTD2_DANRE	54.9	204	88	3	795	1400	27	228	1.50E-57	225.3	UBTD2_DANRE	reviewed	Ubiquitin domain-containing protein 2	ubtd2 zgc:91797	Danio rerio (Zebrafish) (Brachydanio rerio)	240	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN26929_c0_g1_i1	O14562	UBFD1_HUMAN	100	84	0	0	2	253	188	271	3.90E-43	174.9	UBFD1_HUMAN	reviewed	Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog)	UBFD1 UBPH	Homo sapiens (Human)	309	cadherin binding [GO:0045296]; RNA binding [GO:0003723]		cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN40205_c0_g1_i1	O14562	UBFD1_HUMAN	100	77	0	0	3	233	233	309	1.50E-41	169.9	UBFD1_HUMAN	reviewed	Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog)	UBFD1 UBPH	Homo sapiens (Human)	309	cadherin binding [GO:0045296]; RNA binding [GO:0003723]		cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN1526_c0_g1_i1	O14562	UBFD1_HUMAN	56.9	253	99	3	50	793	61	308	4.60E-77	289.3	UBFD1_HUMAN	reviewed	Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog)	UBFD1 UBPH	Homo sapiens (Human)	309	cadherin binding [GO:0045296]; RNA binding [GO:0003723]		cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN1526_c0_g1_i2	O14562	UBFD1_HUMAN	56.8	250	98	3	50	784	61	305	1.20E-75	284.6	UBFD1_HUMAN	reviewed	Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog)	UBFD1 UBPH	Homo sapiens (Human)	309	cadherin binding [GO:0045296]; RNA binding [GO:0003723]		cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0045296			NA	NA	NA	NA	NA	NA
TRINITY_DN15265_c0_g1_i1	Q55BK0	UFD1_DICDI	58.9	190	76	1	620	57	16	205	1.50E-62	240.7	UFD1_DICDI	reviewed	Ubiquitin fusion degradation protein 1 homolog	ufd1 DDB_G0271122	Dictyostelium discoideum (Slime mold)	330	VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; polyubiquitin modification-dependent protein binding [GO:0031593]; ER-associated misfolded protein catabolic process [GO:0071712]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0006511; GO:0030433; GO:0031593; GO:0034098; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN37070_c0_g1_i1	Q92890	UFD1_HUMAN	99.3	151	1	0	453	1	46	196	7.20E-84	311.2	UFD1_HUMAN	reviewed	Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)	UFD1 UFD1L	Homo sapiens (Human)	307	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001501; GO:0004843; GO:0005102; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0044877; GO:0051117; GO:0070987; GO:0071712	"ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37070_c0_g1_i1	Q92890	UFD1_HUMAN	100	23	0	0	523	455	14	36	7.90E-06	52	UFD1_HUMAN	reviewed	Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)	UFD1 UFD1L	Homo sapiens (Human)	307	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001501; GO:0004843; GO:0005102; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0044877; GO:0051117; GO:0070987; GO:0071712	"ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29829_c1_g1_i1	Q92890	UFD1_HUMAN	58.6	307	112	7	998	108	1	302	4.70E-91	336.3	UFD1_HUMAN	reviewed	Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)	UFD1 UFD1L	Homo sapiens (Human)	307	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001501; GO:0004843; GO:0005102; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0044877; GO:0051117; GO:0070987; GO:0071712	"ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30958_c0_g1_i1	Q92890	UFD1_HUMAN	100	205	0	0	2	616	12	216	2.60E-117	422.5	UFD1_HUMAN	reviewed	Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)	UFD1 UFD1L	Homo sapiens (Human)	307	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0001501; GO:0004843; GO:0005102; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0044877; GO:0051117; GO:0070987; GO:0071712	"ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8296_c0_g1_i1	Q9VRJ9	OTU1_DROME	48	75	39	0	44	268	174	248	4.10E-15	82	OTU1_DROME	reviewed	Ubiquitin thioesterase OTU1 (EC 3.4.19.12)	CG4603	Drosophila melanogaster (Fruit fly)	347	cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein deubiquitination [GO:0016579]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005829; GO:0008234; GO:0016579; GO:0030433; GO:0030968; GO:0046872	endoplasmic reticulum unfolded protein response [GO:0030968]; protein deubiquitination [GO:0016579]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN8296_c0_g1_i2	Q0IH43	OTU1_XENLA	30.2	162	77	5	71	553	1	127	4.50E-10	66.2	OTU1_XENLA	reviewed	Ubiquitin thioesterase OTU1 (EC 3.4.19.12)	yod1	Xenopus laevis (African clawed frog)	304	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005737; GO:0008234; GO:0016236; GO:0030433; GO:0030968; GO:0035523; GO:0035871; GO:0046872; GO:0070536; GO:0071108; GO:1990167; GO:1990168	endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN8296_c0_g1_i5	Q29FC9	OTU1_DROPS	38.5	356	191	7	86	1081	7	358	8.10E-59	229.2	OTU1_DROPS	reviewed	Ubiquitin thioesterase OTU1 (EC 3.4.19.12)	GA18292	Drosophila pseudoobscura pseudoobscura (Fruit fly)	358	cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent ERAD pathway [GO:0030433]		cysteine-type peptidase activity [GO:0008234]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0008234; GO:0016579; GO:0030433; GO:0046872	protein deubiquitination [GO:0016579]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN39303_c0_g1_i1	Q96FW1	OTUB1_HUMAN	100	130	0	0	465	76	142	271	1.10E-70	267.3	OTUB1_HUMAN	reviewed	Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1)	OTUB1 OTB1 OTU1 HSPC263	Homo sapiens (Human)	271	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0002250; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0043130; GO:0070062; GO:0071108; GO:0071347; GO:1901315; GO:2000780	adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]		NA	NA	NA	NA	NA	NA
TRINITY_DN30051_c0_g1_i1	Q96FW1	OTUB1_HUMAN	57.9	159	67	0	566	90	113	271	3.60E-49	196.1	OTUB1_HUMAN	reviewed	Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1)	OTUB1 OTB1 OTU1 HSPC263	Homo sapiens (Human)	271	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0002250; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0043130; GO:0070062; GO:0071108; GO:0071347; GO:1901315; GO:2000780	adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]		blue	blue	NA	NA	NA	NA
TRINITY_DN307_c0_g1_i2	Q96BN8	OTUL_HUMAN	37.1	267	162	3	1675	2463	81	345	3.80E-45	184.9	OTUL_HUMAN	reviewed	Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)	OTULIN FAM105B	Homo sapiens (Human)	352	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002040; GO:0004843; GO:0005737; GO:0005829; GO:0008234; GO:0010803; GO:0016055; GO:0016567; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:0071797; GO:1990108	innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN307_c0_g1_i5	Q96BN8	OTUL_HUMAN	29.9	117	78	2	1675	2019	81	195	2.70E-12	75.5	OTUL_HUMAN	reviewed	Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)	OTULIN FAM105B	Homo sapiens (Human)	352	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002040; GO:0004843; GO:0005737; GO:0005829; GO:0008234; GO:0010803; GO:0016055; GO:0016567; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:0071797; GO:1990108	innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2636_c0_g1_i2	Q9VH90	TRBID_DROME	52.3	618	219	7	1899	52	235	778	2.50E-177	623.6	TRBID_DROME	reviewed	Ubiquitin thioesterase trabid (dTrbd) (EC 3.4.19.12)	trbd CG9448	Drosophila melanogaster (Fruit fly)	778	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0008234; GO:0016055; GO:0016477; GO:0016579; GO:0030177; GO:0035523; GO:0046872; GO:0061060; GO:0061578; GO:0070530; GO:0070536; GO:0071947; GO:0090263; GO:1990168	cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN2636_c0_g1_i3	Q9VH90	TRBID_DROME	52.3	593	207	7	1857	85	235	753	1.50E-171	604.4	TRBID_DROME	reviewed	Ubiquitin thioesterase trabid (dTrbd) (EC 3.4.19.12)	trbd CG9448	Drosophila melanogaster (Fruit fly)	778	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0008234; GO:0016055; GO:0016477; GO:0016579; GO:0030177; GO:0035523; GO:0046872; GO:0061060; GO:0061578; GO:0070530; GO:0070536; GO:0071947; GO:0090263; GO:1990168	cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN27595_c0_g1_i1	B1H2Q2	ZRAN1_XENTR	35.1	111	50	3	353	72	1	106	8.70E-11	68.2	ZRAN1_XENTR	reviewed	Ubiquitin thioesterase zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1)	zranb1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	701	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cysteine-type peptidase activity [GO:0008234]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0008234; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0046872; GO:0070530; GO:0070536; GO:0071947; GO:1990168	cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]		NA	NA	NA	NA	NA	NA
TRINITY_DN39226_c0_g1_i1	O14933	UB2L6_HUMAN	100	95	0	0	285	1	28	122	3.60E-53	208.4	UB2L6_HUMAN	reviewed	Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein) (RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6)	UBE2L6 UBCH8	Homo sapiens (Human)	153	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein metabolic process [GO:0044267]; cellular protein modification process [GO:0006464]; ISG15-protein conjugation [GO:0032020]; negative regulation of type I interferon production [GO:0032480]; protein polyubiquitination [GO:0000209]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006464; GO:0006511; GO:0019985; GO:0031625; GO:0032020; GO:0032480; GO:0042296; GO:0043130; GO:0044267; GO:0061631	cellular protein metabolic process [GO:0044267]; cellular protein modification process [GO:0006464]; ISG15-protein conjugation [GO:0032020]; negative regulation of type I interferon production [GO:0032480]; protein polyubiquitination [GO:0000209]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40826_c0_g1_i1	Q9QZU9	UB2L6_MOUSE	100	84	0	0	254	3	30	113	1.40E-45	183	UB2L6_MOUSE	reviewed	Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L6) (UbcM8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6)	Ube2l6 Ubce8	Mus musculus (Mouse)	153	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein transferase activity [GO:0019787]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0006511; GO:0019787; GO:0019941; GO:0031625; GO:0032020; GO:0042296; GO:0043130; GO:0061631	ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35793_c0_g1_i1	P52495	UBA1_CANAW	55.4	74	30	1	13	225	813	886	1.90E-12	72.8	UBA1_CANAW	reviewed	Ubiquitin-activating enzyme E1 1 (EC 6.2.1.45)	UBA1 CAWG_02960	Candida albicans (strain WO-1) (Yeast)	1021	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN2772_c0_g1_i1	O94609	UBA1_SCHPO	52	75	36	0	226	2	4	78	2.60E-16	85.9	UBA1_SCHPO	reviewed	Ubiquitin-activating enzyme E1 1 (EC 6.2.1.45) (Poly(A)+ RNA transport protein 3)	ptr3 SPBC1604.21c SPBC211.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1012	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; ubiquitin activating enzyme activity [GO:0004839]	GO:0000287; GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN20895_c0_g2_i1	P31251	UBE12_WHEAT	56.2	64	28	0	192	1	435	498	9.20E-14	77	UBE12_WHEAT	reviewed	Ubiquitin-activating enzyme E1 2 (EC 6.2.1.45)	UBA2	Triticum aestivum (Wheat)	1051	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0016567; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36074_c0_g1_i1	Q5ZJI9	UBAC1_CHICK	35.8	232	125	7	724	56	14	230	6.20E-25	116.3	UBAC1_CHICK	reviewed	Ubiquitin-associated domain-containing protein 1 (UBA domain-containing protein 1) (E3 ubiquitin-protein ligase subunit KPC2) (Kip1 ubiquitination-promoting complex protein 2)	UBAC1 KPC2 UBADC1 RCJMB04_17l24	Gallus gallus (Chicken)	408	cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]		GO:0005737; GO:0016567	protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN24181_c0_g1_i1	Q8NBM4	UBAC2_HUMAN	38.6	342	187	8	1073	102	7	343	2.60E-49	197.6	UBAC2_HUMAN	reviewed	Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1)	UBAC2 PHGDHL1 PSEC0110	Homo sapiens (Human)	344	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021; GO:0016055; GO:0070972; GO:0090090; GO:1904153	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"		blue	blue	NA	NA	NA	NA
TRINITY_DN24181_c0_g1_i3	Q8NBM4	UBAC2_HUMAN	37.5	275	156	6	881	102	70	343	9.00E-37	155.6	UBAC2_HUMAN	reviewed	Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1)	UBAC2 PHGDHL1 PSEC0110	Homo sapiens (Human)	344	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005783; GO:0005789; GO:0016021; GO:0016055; GO:0070972; GO:0090090; GO:1904153	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2137_c0_g1_i2	F6P6X0	UBAP1_DANRE	28.7	181	109	5	625	92	284	447	2.70E-08	62	UBAP1_DANRE	reviewed	Ubiquitin-associated protein 1 (UBAP-1)	ubap1	Danio rerio (Zebrafish) (Brachydanio rerio)	453	cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; ubiquitin binding [GO:0043130]; axon extension [GO:0048675]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	cytosol [GO:0005829]; ESCRT I complex [GO:0000813]	ubiquitin binding [GO:0043130]	GO:0000813; GO:0005829; GO:0015031; GO:0043130; GO:0043162; GO:0048675	axon extension [GO:0048675]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]		NA	NA	NA	NA	NA	NA
TRINITY_DN10431_c0_g1_i2	Q14157	UBP2L_HUMAN	38.5	104	51	4	112	393	2	102	7.10E-09	62	UBP2L_HUMAN	reviewed	Ubiquitin-associated protein 2-like (Protein NICE-4)	UBAP2L KIAA0144 NICE4	Homo sapiens (Human)	1087	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; RNA binding [GO:0003723]; binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0007339; GO:0010494; GO:0031519; GO:0034063; GO:0061484	binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]	x	blue	blue	1	NA	NA	1
TRINITY_DN23003_c0_g1_i1	Q14157	UBP2L_HUMAN	100	69	0	0	209	3	45	113	9.40E-35	146.7	UBP2L_HUMAN	reviewed	Ubiquitin-associated protein 2-like (Protein NICE-4)	UBAP2L KIAA0144 NICE4	Homo sapiens (Human)	1087	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; RNA binding [GO:0003723]; binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0007339; GO:0010494; GO:0031519; GO:0034063; GO:0061484	binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]		NA	NA	NA	NA	NA	NA
TRINITY_DN10431_c0_g1_i1	Q14157	UBP2L_HUMAN	37.5	120	62	4	112	441	2	118	5.60E-09	62.4	UBP2L_HUMAN	reviewed	Ubiquitin-associated protein 2-like (Protein NICE-4)	UBAP2L KIAA0144 NICE4	Homo sapiens (Human)	1087	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; RNA binding [GO:0003723]; binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0007339; GO:0010494; GO:0031519; GO:0034063; GO:0061484	binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]		blue	blue	NA	NA	NA	NA
TRINITY_DN33016_c0_g1_i1	P25865	UBC1_ARATH	50.5	93	42	1	280	2	47	135	2.70E-24	112.5	UBC1_ARATH	reviewed	Ubiquitin-conjugating enzyme E2 1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 1) (Ubiquitin carrier protein 1) (Ubiquitin-conjugating enzyme E2-17 kDa 1) (Ubiquitin-protein ligase 1)	UBC1 At1g14400 F14L17.17 F14L17_35	Arabidopsis thaliana (Mouse-ear cress)	152	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; histone H2B ubiquitination [GO:0033523]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]; vegetative to reproductive phase transition of meristem [GO:0010228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0006281; GO:0006511; GO:0010228; GO:0016574; GO:0033523; GO:0043161; GO:0061631	DNA repair [GO:0006281]; histone H2B ubiquitination [GO:0033523]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]; vegetative to reproductive phase transition of meristem [GO:0010228]		NA	NA	NA	NA	NA	NA
TRINITY_DN4935_c0_g1_i1	P52478	UBC1_CAEEL	85.4	164	23	1	578	87	1	163	8.30E-79	294.7	UBC1_CAEEL	reviewed	Ubiquitin-conjugating enzyme E2 1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 1) (Ubiquitin carrier protein 1) (Ubiquitin-protein ligase 1)	ubc-1 C35B1.1	Caenorhabditis elegans	192	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; ubiquitin conjugating enzyme complex [GO:0031371]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; ubiquitin conjugating enzyme complex [GO:0031371]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0000790; GO:0005524; GO:0006281; GO:0016567; GO:0016574; GO:0031371; GO:0031625; GO:0033503; GO:0043161; GO:0061631	DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		blue	blue	NA	NA	NA	NA
TRINITY_DN4935_c0_g1_i2	P52478	UBC1_CAEEL	85.4	151	21	1	539	87	14	163	2.80E-71	269.6	UBC1_CAEEL	reviewed	Ubiquitin-conjugating enzyme E2 1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 1) (Ubiquitin carrier protein 1) (Ubiquitin-protein ligase 1)	ubc-1 C35B1.1	Caenorhabditis elegans	192	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; ubiquitin conjugating enzyme complex [GO:0031371]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; ubiquitin conjugating enzyme complex [GO:0031371]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0000790; GO:0005524; GO:0006281; GO:0016567; GO:0016574; GO:0031371; GO:0031625; GO:0033503; GO:0043161; GO:0061631	DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN3561_c0_g1_i1	P35134	UBC11_ARATH	57.4	129	54	1	399	16	19	147	1.30E-40	167.2	UBC11_ARATH	reviewed	Ubiquitin-conjugating enzyme E2 11 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 11) (Ubiquitin carrier protein 11) (Ubiquitin-conjugating enzyme E2-17 kDa 11) (Ubiquitin-protein ligase 11)	UBC11 At3g08690 F17O14.16	Arabidopsis thaliana (Mouse-ear cress)	148	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN40622_c0_g1_i1	Q42541	UBC13_ARATH	59.7	67	26	1	1	201	48	113	1.50E-21	102.8	UBC13_ARATH	reviewed	Ubiquitin-conjugating enzyme E2 13 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 13) (Ubiquitin carrier protein 13) (Ubiquitin-protein ligase 13)	UBC13 At3g46460 F18L15.180	Arabidopsis thaliana (Mouse-ear cress)	166	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26819_c0_g1_i1	P35129	UBC2_CAEEL	50.6	89	44	0	15	281	52	140	4.00E-21	102.1	UBC2_CAEEL	reviewed	Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Lethal protein 70) (Ubiquitin carrier protein 2) (Ubiquitin-protein ligase 2)	let-70 ubc-2 M7.1	Caenorhabditis elegans	147	chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005694; GO:0006511; GO:0016567; GO:0031625; GO:0061631	protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN13613_c0_g1_i1	P35130	UBC2_MEDSA	69	142	44	0	1	426	8	149	1.90E-58	226.5	UBC2_MEDSA	reviewed	Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase 2)	UBC2	Medicago sativa (Alfalfa)	152	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]		ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0005524; GO:0061631			NA	NA	NA	NA	NA	NA
TRINITY_DN37230_c0_g1_i1	Q4PFA5	UBC2_USTMA	62.6	107	40	0	344	24	43	149	9.00E-35	147.5	UBC2_USTMA	reviewed	Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein UBC2) (Ubiquitin-protein ligase UBC2)	UBC2 UMAG_01208	Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus)	185	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; HULC complex [GO:0033503]; MUB1-RAD6-UBR2 ubiquitin ligase complex [GO:1990304]; nuclear chromatin [GO:0000790]; Rad6-Rad18 complex [GO:0097505]; UBR1-RAD6 ubiquitin ligase complex [GO:1990303]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; ubiquitin conjugating enzyme activity [GO:0061631]; cellular response to hyperoxia [GO:0071455]; chromatin silencing at telomere [GO:0006348]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA repair [GO:0006281]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair via homologous recombination [GO:0000724]; error-free postreplication DNA repair [GO:0042275]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; meiotic DNA double-strand break formation [GO:0042138]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of SREBP signaling pathway [GO:2000639]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of dipeptide transport [GO:0090089]; regulation of histone H3-K4 methylation [GO:0051569]; sporulation resulting in formation of a cellular spore [GO:0030435]; stress-induced homeostatically regulated protein degradation pathway [GO:0120174]; telomere maintenance via recombination [GO:0000722]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; HULC complex [GO:0033503]; MUB1-RAD6-UBR2 ubiquitin ligase complex [GO:1990304]; nuclear chromatin [GO:0000790]; Rad6-Rad18 complex [GO:0097505]; UBR1-RAD6 ubiquitin ligase complex [GO:1990303]"	ATP binding [GO:0005524]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0000722; GO:0000724; GO:0000781; GO:0000790; GO:0003697; GO:0005524; GO:0005737; GO:0006281; GO:0006348; GO:0006353; GO:0006366; GO:0010390; GO:0016574; GO:0017116; GO:0030433; GO:0030435; GO:0031571; GO:0033503; GO:0042138; GO:0042275; GO:0042276; GO:0043161; GO:0051569; GO:0061631; GO:0070534; GO:0070628; GO:0070987; GO:0071455; GO:0071596; GO:0071629; GO:0071894; GO:0090089; GO:0097505; GO:0120174; GO:1990303; GO:1990304; GO:2000639	"cellular response to hyperoxia [GO:0071455]; chromatin silencing at telomere [GO:0006348]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA repair [GO:0006281]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair via homologous recombination [GO:0000724]; error-free postreplication DNA repair [GO:0042275]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; meiotic DNA double-strand break formation [GO:0042138]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of SREBP signaling pathway [GO:2000639]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of dipeptide transport [GO:0090089]; regulation of histone H3-K4 methylation [GO:0051569]; sporulation resulting in formation of a cellular spore [GO:0030435]; stress-induced homeostatically regulated protein degradation pathway [GO:0120174]; telomere maintenance via recombination [GO:0000722]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12361_c0_g1_i2	Q93571	UBC25_CAEEL	47.2	89	46	1	77	340	1	89	3.90E-16	85.9	UBC25_CAEEL	reviewed	Ubiquitin-conjugating enzyme E2 25 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 25)	ubc-25 F25H2.8	Caenorhabditis elegans	387	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; locomotion [GO:0040011]; protein polyubiquitination [GO:0000209]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0005829; GO:0040011; GO:0043025; GO:0061631	locomotion [GO:0040011]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN12361_c0_g1_i4	Q93571	UBC25_CAEEL	40.8	240	120	4	77	745	1	235	2.30E-27	124.4	UBC25_CAEEL	reviewed	Ubiquitin-conjugating enzyme E2 25 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 25)	ubc-25 F25H2.8	Caenorhabditis elegans	387	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; locomotion [GO:0040011]; protein polyubiquitination [GO:0000209]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0005829; GO:0040011; GO:0043025; GO:0061631	locomotion [GO:0040011]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN26656_c0_g1_i1	Q9FI61	UBC27_ARATH	67.8	90	29	0	272	3	55	144	4.30E-32	138.3	UBC27_ARATH	reviewed	Ubiquitin-conjugating enzyme E2 27 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 27) (Ubiquitin carrier protein 27)	UBC27 UBC1 At5g50870 K3K7.1	Arabidopsis thaliana (Mouse-ear cress)	192	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0043161; GO:0061631	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN33022_c0_g1_i1	Q9LSP7	UBC32_ARATH	65	100	35	0	6	305	26	125	1.30E-37	156.8	UBC32_ARATH	reviewed	Ubiquitin-conjugating enzyme E2 32 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 32) (Ubiquitin carrier protein 32)	UBC32 At3g17000 K14A17.7	Arabidopsis thaliana (Mouse-ear cress)	309	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to water deprivation [GO:0042631]; negative regulation of stomatal opening [GO:1902457]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005783; GO:0006511; GO:0016020; GO:0016021; GO:0042631; GO:0048471; GO:0061631; GO:1902457	cellular response to water deprivation [GO:0042631]; negative regulation of stomatal opening [GO:1902457]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN6865_c0_g1_i1	P46595	UBC4_SCHPO	54.1	109	50	0	96	422	5	113	4.30E-27	122.5	UBC4_SCHPO	reviewed	Ubiquitin-conjugating enzyme E2 4 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 4) (Ubiquitin carrier protein 4) (Ubiquitin-protein ligase 4)	ubc4 SPBC119.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	147	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein polyubiquitination [GO:0000209]; regulation of protein glycosylation [GO:0060049]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0031146; GO:0031625; GO:0035103; GO:0043224; GO:0045842; GO:0060049; GO:0061631	positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein polyubiquitination [GO:0000209]; regulation of protein glycosylation [GO:0060049]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31675_c0_g1_i1	P46595	UBC4_SCHPO	78.1	146	32	0	464	27	1	146	1.20E-65	250.8	UBC4_SCHPO	reviewed	Ubiquitin-conjugating enzyme E2 4 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 4) (Ubiquitin carrier protein 4) (Ubiquitin-protein ligase 4)	ubc4 SPBC119.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	147	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein polyubiquitination [GO:0000209]; regulation of protein glycosylation [GO:0060049]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0031146; GO:0031625; GO:0035103; GO:0043224; GO:0045842; GO:0060049; GO:0061631	positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein polyubiquitination [GO:0000209]; regulation of protein glycosylation [GO:0060049]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sterol regulatory element binding protein cleavage [GO:0035103]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN37396_c0_g1_i1	Q6FQK7	UBC6_CANGA	57.7	123	52	0	380	12	3	125	2.70E-40	166	UBC6_CANGA	reviewed	Ubiquitin-conjugating enzyme E2 6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 6) (Ubiquitin carrier protein UBC6) (Ubiquitin-protein ligase UBC6)	UBC6 CAGL0I05478g	Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)	246	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005789; GO:0006513; GO:0016021; GO:0030433; GO:0061631	protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN37373_c0_g1_i1	Q9P7R4	UBC8_SCHPO	62.1	116	44	0	353	6	20	135	6.00E-42	171.4	UBC8_SCHPO	reviewed	Ubiquitin-conjugating enzyme E2 8 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 8) (Ubiquitin carrier protein 8) (Ubiquitin-protein ligase 8)	ubc8 SPBC211.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	184	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification by small protein conjugation or removal [GO:0070647]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0043161; GO:0061631; GO:0070647	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification by small protein conjugation or removal [GO:0070647]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9746_c0_g1_i1	P49459	UBE2A_HUMAN	100	106	0	0	369	52	47	152	6.90E-57	221.1	UBE2A_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A)	UBE2A RAD6A	Homo sapiens (Human)	152	chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; XY body [GO:0001741]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000785; GO:0000790; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0005654; GO:0005829; GO:0006281; GO:0006301; GO:0006511; GO:0008284; GO:0009411; GO:0016567; GO:0016574; GO:0031625; GO:0033503; GO:0033522; GO:0043161; GO:0051865; GO:0060135; GO:0061631; GO:0070936; GO:0070979	blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9746_c0_g1_i2	P49459	UBE2A_HUMAN	80.3	152	0	1	417	52	1	152	1.90E-61	236.5	UBE2A_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A)	UBE2A RAD6A	Homo sapiens (Human)	152	chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; XY body [GO:0001741]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000785; GO:0000790; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0005654; GO:0005829; GO:0006281; GO:0006301; GO:0006511; GO:0008284; GO:0009411; GO:0016567; GO:0016574; GO:0031625; GO:0033503; GO:0033522; GO:0043161; GO:0051865; GO:0060135; GO:0061631; GO:0070936; GO:0070979	blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35690_c0_g1_i1	Q32P99	UBE2B_BOVIN	100	152	0	0	521	66	1	152	8.60E-85	314.3	UBE2B_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (Ubiquitin carrier protein B) (Ubiquitin-protein ligase B)	UBE2B	Bos taurus (Bovine)	152	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000790; GO:0004842; GO:0005524; GO:0005886; GO:0006281; GO:0016574; GO:0033503; GO:0043161; GO:0061631; GO:0070534; GO:0070936; GO:0070979	DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN9553_c0_g1_i1	Q32P99	UBE2B_BOVIN	46.3	108	52	2	331	26	30	137	1.70E-22	106.7	UBE2B_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (Ubiquitin carrier protein B) (Ubiquitin-protein ligase B)	UBE2B	Bos taurus (Bovine)	152	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000790; GO:0004842; GO:0005524; GO:0005886; GO:0006281; GO:0016574; GO:0033503; GO:0043161; GO:0061631; GO:0070534; GO:0070936; GO:0070979	DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN26094_c0_g1_i1	O00762	UBE2C_HUMAN	98.7	157	2	0	481	11	23	179	1.50E-88	326.6	UBE2C_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C)	UBE2C UBCH10	Homo sapiens (Human)	179	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0005886; GO:0006511; GO:0010458; GO:0010994; GO:0016567; GO:0030071; GO:0031145; GO:0031536; GO:0044389; GO:0051301; GO:0061631; GO:0070936; GO:0070979; GO:1901990; GO:1904668	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36086_c0_g1_i1	Q9D1C1	UBE2C_MOUSE	99.3	152	1	0	462	7	28	179	1.40E-86	320.1	UBE2C_MOUSE	reviewed	Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C)	Ube2c Ubch10	Mus musculus (Mouse)	179	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of exit from mitosis [GO:0031536]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005680; GO:0005829; GO:0005886; GO:0006511; GO:0010458; GO:0010994; GO:0016567; GO:0030071; GO:0031145; GO:0031536; GO:0044389; GO:0051301; GO:0061631; GO:0070936; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of exit from mitosis [GO:0031536]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4947_c0_g1_i1	P56616	UBE2C_XENLA	68	172	53	1	622	107	3	172	1.40E-61	237.7	UBE2C_XENLA	reviewed	Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UBC-X) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C)	ube2c ubch10 ubcx	Xenopus laevis (African clawed frog)	179	anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0005524; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN37378_c0_g1_i1	Q95044	UBE2C_SPISO	52.1	119	57	0	359	3	53	171	1.80E-33	143.3	UBE2C_SPISO	reviewed	Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C)	UBE2C UBCH10	Spisula solidissima (Atlantic surf-clam)	177	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; cell division [GO:0051301]		ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0005524; GO:0007049; GO:0051301; GO:0061631	cell cycle [GO:0007049]; cell division [GO:0051301]		NA	NA	NA	NA	NA	NA
TRINITY_DN16840_c0_g1_i1	Q2TA10	UB2D1_BOVIN	100	147	0	0	26	466	1	147	2.80E-85	315.8	UB2D1_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Ubiquitin carrier protein D1) (Ubiquitin-protein ligase D1)	UBE2D1	Bos taurus (Bovine)	147	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of protein polyubiquitination [GO:1902916]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0031625; GO:0061631; GO:0070936; GO:1902916	positive regulation of protein polyubiquitination [GO:1902916]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN16840_c0_g1_i2	Q2TA10	UB2D1_BOVIN	100	147	0	0	26	466	1	147	2.80E-85	315.8	UB2D1_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Ubiquitin carrier protein D1) (Ubiquitin-protein ligase D1)	UBE2D1	Bos taurus (Bovine)	147	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of protein polyubiquitination [GO:1902916]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0031625; GO:0061631; GO:0070936; GO:1902916	positive regulation of protein polyubiquitination [GO:1902916]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2593_c0_g1_i1	Q1RMX2	UB2D2_BOVIN	100	147	0	0	33	473	1	147	1.40E-85	317	UB2D2_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-protein ligase D2)	UBE2D2 UBC4 UBCH4 UBCH5B	Bos taurus (Bovine)	147	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0051865; GO:0061631; GO:0070936; GO:0070979	protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN2593_c0_g1_i2	Q06AA9	UB2D2_PIG	100	147	0	0	33	473	1	147	8.00E-86	317.8	UB2D2_PIG	reviewed	Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-protein ligase D2)	UBE2D2 UBC4 UBCH4 UBCH5B	Sus scrofa (Pig)	147	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN29491_c0_g1_i1	Q1RMX2	UB2D2_BOVIN	94.3	35	2	0	163	59	67	101	2.70E-13	75.5	UB2D2_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-protein ligase D2)	UBE2D2 UBC4 UBCH4 UBCH5B	Bos taurus (Bovine)	147	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0051865; GO:0061631; GO:0070936; GO:0070979	protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN2593_c0_g1_i3	P61077	UB2D3_HUMAN	100	147	0	0	76	516	1	147	4.30E-85	315.5	UB2D3_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 D3 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D3) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-conjugating enzyme E2(17)KB 3) (Ubiquitin-conjugating enzyme E2-17 kDa 3) (Ubiquitin-protein ligase D3)	UBE2D3 UBC5C UBCH5C	Homo sapiens (Human)	147	cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular protein modification process [GO:0006464]; cellular response to cadmium ion [GO:0071276]; cellular response to mercury ion [GO:0071288]; DNA repair [GO:0006281]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000209; GO:0002756; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006464; GO:0006511; GO:0006513; GO:0006625; GO:0006915; GO:0010008; GO:0016567; GO:0030509; GO:0035666; GO:0043161; GO:0051865; GO:0061631; GO:0070062; GO:0070936; GO:0070979; GO:0071276; GO:0071288; GO:1903955	apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular protein modification process [GO:0006464]; cellular response to cadmium ion [GO:0071276]; cellular response to mercury ion [GO:0071288]; DNA repair [GO:0006281]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2593_c0_g1_i4	P61077	UB2D3_HUMAN	98.6	147	2	0	76	516	1	147	3.60E-84	312.4	UB2D3_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 D3 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D3) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-conjugating enzyme E2(17)KB 3) (Ubiquitin-conjugating enzyme E2-17 kDa 3) (Ubiquitin-protein ligase D3)	UBE2D3 UBC5C UBCH5C	Homo sapiens (Human)	147	cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular protein modification process [GO:0006464]; cellular response to cadmium ion [GO:0071276]; cellular response to mercury ion [GO:0071288]; DNA repair [GO:0006281]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000122; GO:0000209; GO:0002756; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006464; GO:0006511; GO:0006513; GO:0006625; GO:0006915; GO:0010008; GO:0016567; GO:0030509; GO:0035666; GO:0043161; GO:0051865; GO:0061631; GO:0070062; GO:0070936; GO:0070979; GO:0071276; GO:0071288; GO:1903955	apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular protein modification process [GO:0006464]; cellular response to cadmium ion [GO:0071276]; cellular response to mercury ion [GO:0071288]; DNA repair [GO:0006281]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2593_c0_g1_i5	Q3ZCF7	UB2D3_BOVIN	97.1	68	2	0	76	279	1	68	3.30E-35	149.1	UB2D3_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 D3 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D3) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-protein ligase D3)	UBE2D3	Bos taurus (Bovine)	147	endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]	endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005886; GO:0006281; GO:0006915; GO:0010008; GO:0061631; GO:0070936; GO:0070979	apoptotic process [GO:0006915]; DNA repair [GO:0006281]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN28302_c0_g1_i1	P52482	UB2E1_MOUSE	100	139	0	0	17	433	36	174	1.10E-77	290.4	UB2E1_MOUSE	reviewed	Ubiquitin-conjugating enzyme E2 E1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme E1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme E1) (UbcM3) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1)	Ube2e1 Ubce5 Ubcm3	Mus musculus (Mouse)	193	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; ISG15-protein conjugation [GO:0032020]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0010390; GO:0016567; GO:0032020; GO:0033523; GO:0042296; GO:0061631; GO:0070936	histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; ISG15-protein conjugation [GO:0032020]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN18431_c0_g1_i1	Q96LR5	UB2E2_HUMAN	100	63	0	0	229	41	58	120	3.40E-33	141.7	UB2E2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)	UBE2E2 UBCH8	Homo sapiens (Human)	201	nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087	cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN19182_c0_g1_i1	Q91W82	UB2E2_MOUSE	95.1	163	8	0	12	500	39	201	1.10E-87	323.9	UB2E2_MOUSE	reviewed	Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)	Ube2e2	Mus musculus (Mouse)	201	nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087	cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN19182_c0_g1_i2	Q91W82	UB2E2_MOUSE	95.1	163	8	0	12	500	39	201	1.10E-87	323.9	UB2E2_MOUSE	reviewed	Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)	Ube2e2	Mus musculus (Mouse)	201	nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087	cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN40006_c0_g1_i1	P62253	UB2G1_HUMAN	83.3	150	24	1	66	512	17	166	8.40E-75	281.2	UB2G1_HUMAN	reviewed	"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]"	UBE2G1 UBE2G	Homo sapiens (Human)	170	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0016567; GO:0031625; GO:0043161; GO:0044257; GO:0061631; GO:0070062; GO:0070534; GO:0070936	cellular protein catabolic process [GO:0044257]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN40290_c0_g1_i1	Q17QG5	UB2G2_BOVIN	97.9	48	1	0	2	145	34	81	7.00E-23	107.5	UB2G2_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)	UBE2G2 UBC7	Bos taurus (Bovine)	165	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0030433; GO:0035458; GO:0042802; GO:0061631; GO:0070936; GO:1904153	"cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9006_c1_g1_i1	P60604	UB2G2_HUMAN	86.1	151	21	0	576	124	15	165	6.30E-74	278.5	UB2G2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)	UBE2G2 UBC7	Homo sapiens (Human)	165	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0016567; GO:0030433; GO:0035458; GO:0042802; GO:0044257; GO:0061631; GO:0070936; GO:1904153	"cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9006_c1_g1_i3	P60604	UB2G2_HUMAN	86.7	165	22	0	618	124	1	165	3.20E-81	302.8	UB2G2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)	UBE2G2 UBC7	Homo sapiens (Human)	165	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0016567; GO:0030433; GO:0035458; GO:0042802; GO:0044257; GO:0061631; GO:0070936; GO:1904153	"cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9006_c1_g1_i4	Q17QG5	UB2G2_BOVIN	90.1	152	15	0	554	99	1	152	1.80E-78	293.5	UB2G2_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)	UBE2G2 UBC7	Bos taurus (Bovine)	165	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0030433; GO:0035458; GO:0042802; GO:0061631; GO:0070936; GO:1904153	"cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34855_c0_g1_i1	P60604	UB2G2_HUMAN	100	64	0	0	1	192	102	165	3.20E-29	128.6	UB2G2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)	UBE2G2 UBC7	Homo sapiens (Human)	165	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0016567; GO:0030433; GO:0035458; GO:0042802; GO:0044257; GO:0061631; GO:0070936; GO:1904153	"cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36965_c0_g1_i1	Q32LN1	UBE2H_BOVIN	100	98	0	0	294	1	66	163	7.00E-52	204.1	UBE2H_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H)	UBE2H	Bos taurus (Bovine)	183	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN23660_c0_g1_i1	Q32LN1	UBE2H_BOVIN	100	71	0	0	213	1	1	71	1.30E-36	152.9	UBE2H_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H)	UBE2H	Bos taurus (Bovine)	183	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN29715_c0_g1_i1	Q32LN1	UBE2H_BOVIN	80.4	184	35	1	630	79	1	183	3.20E-84	312.8	UBE2H_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H)	UBE2H	Bos taurus (Bovine)	183	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26516_c0_g1_i1	Q9Y385	UB2J1_HUMAN	63.4	194	66	2	56	622	1	194	3.90E-67	256.1	UB2J1_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e)	UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0042534; GO:0061631; GO:1904153	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29979_c0_g1_i1	Q9Y385	UB2J1_HUMAN	100	107	0	0	321	1	26	132	2.80E-62	238.8	UB2J1_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e)	UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205	Homo sapiens (Human)	318	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0042534; GO:0061631; GO:1904153	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29082_c0_g1_i1	Q8N2K1	UB2J2_HUMAN	100	158	0	0	1	474	29	186	5.50E-91	334.7	UB2J2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2)	UBE2J2 NCUBE2	Homo sapiens (Human)	259	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0031625; GO:0061631; GO:1903955	positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN29082_c0_g1_i2	Q8N2K1	UB2J2_HUMAN	87.2	156	17	1	2	460	31	186	5.60E-72	271.6	UB2J2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2)	UBE2J2 NCUBE2	Homo sapiens (Human)	259	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0031625; GO:0061631; GO:1903955	positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		NA	NA	NA	NA	NA	NA
TRINITY_DN1360_c0_g1_i1	Q8N2K1	UB2J2_HUMAN	76.1	159	38	0	620	144	12	170	4.40E-71	269.2	UB2J2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2)	UBE2J2 NCUBE2	Homo sapiens (Human)	259	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0031625; GO:0061631; GO:1903955	positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN9613_c2_g1_i1	P61085	UBE2K_BOVIN	88.9	90	10	0	4	273	34	123	7.90E-42	170.6	UBE2K_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase)	UBE2K HIP2	Bos taurus (Bovine)	200	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0010800; GO:0010994; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0061631; GO:0070936; GO:1903265	cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]		blue	blue	NA	NA	NA	NA
TRINITY_DN9613_c2_g1_i2	P61085	UBE2K_BOVIN	84.8	66	10	0	4	201	34	99	8.30E-30	130.6	UBE2K_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase)	UBE2K HIP2	Bos taurus (Bovine)	200	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0010800; GO:0010994; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0061631; GO:0070936; GO:1903265	cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]		NA	NA	NA	NA	NA	NA
TRINITY_DN25519_c0_g1_i1	P61085	UBE2K_BOVIN	100	73	0	0	2	220	39	111	1.60E-37	156	UBE2K_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase)	UBE2K HIP2	Bos taurus (Bovine)	200	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0010800; GO:0010994; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0061631; GO:0070936; GO:1903265	cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]		NA	NA	NA	NA	NA	NA
TRINITY_DN22317_c0_g1_i1	Q3MHP1	UB2L3_BOVIN	100	90	0	0	272	3	24	113	1.10E-48	193.4	UB2L3_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3)	UBE2L3	Bos taurus (Bovine)	154	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0003713; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006511; GO:0008283; GO:0016567; GO:0031625; GO:0044770; GO:0061631; GO:0070979; GO:0071383; GO:0071385	"cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22317_c0_g1_i2	Q3MHP1	UB2L3_BOVIN	100	90	0	0	272	3	24	113	1.10E-48	193.4	UB2L3_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3)	UBE2L3	Bos taurus (Bovine)	154	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0003713; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006511; GO:0008283; GO:0016567; GO:0031625; GO:0044770; GO:0061631; GO:0070979; GO:0071383; GO:0071385	"cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35983_c0_g1_i1	A0A1B0GUS4	UB2L5_HUMAN	85.7	98	14	0	294	1	24	121	7.20E-49	194.1	UB2L5_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 L5 (EC 2.3.2.23) (Ubiquitin-protein ligase L5)	UBE2L5	Homo sapiens (Human)	154	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ligase activity [GO:0016874]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0006511; GO:0016874; GO:0031625; GO:0061631; GO:0070979	protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN35893_c0_g1_i1	Q0P5K3	UBE2N_BOVIN	86.5	141	19	0	428	6	11	151	7.00E-69	261.2	UBE2N_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N)	UBE2N	Bos taurus (Bovine)	152	nucleus [GO:0005634]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006301; GO:0035370; GO:0061631; GO:0070534	postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		blue	blue	NA	NA	NA	NA
TRINITY_DN31562_c0_g1_i1	Q0P5K3	UBE2N_BOVIN	81.1	90	17	0	272	3	29	118	2.40E-38	159.1	UBE2N_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N)	UBE2N	Bos taurus (Bovine)	152	nucleus [GO:0005634]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006301; GO:0035370; GO:0061631; GO:0070534	postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN40860_c0_g1_i1	Q0P5K3	UBE2N_BOVIN	100	87	0	0	2	262	30	116	4.40E-45	181.4	UBE2N_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N)	UBE2N	Bos taurus (Bovine)	152	nucleus [GO:0005634]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006301; GO:0035370; GO:0061631; GO:0070534	postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN12361_c0_g1_i3	Q7TSS2	UB2Q1_MOUSE	51.6	399	155	4	95	1228	41	422	1.10E-99	365.2	UB2Q1_MOUSE	reviewed	Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Galactosyl transferase-associated protein) (GTAP) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1)	Ube2q1 Ube2q	Mus musculus (Mouse)	422	cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459	embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN18191_c0_g1_i1	Q7Z7E8	UB2Q1_HUMAN	100	107	0	0	1	321	316	422	3.40E-56	218.8	UB2Q1_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1)	UBE2Q1 NICE5 UBE2Q PRO3094	Homo sapiens (Human)	422	cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459	embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967]		NA	NA	NA	NA	NA	NA
TRINITY_DN13561_c0_g1_i1	Q32L27	UB2Q2_BOVIN	100	73	0	0	1	219	153	225	1.20E-35	149.8	UB2Q2_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 Q2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q2) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2)	UBE2Q2	Bos taurus (Bovine)	342	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN31359_c0_g1_i1	Q32L27	UB2Q2_BOVIN	100	85	0	0	255	1	230	314	5.10E-43	174.5	UB2Q2_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 Q2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q2) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2)	UBE2Q2	Bos taurus (Bovine)	342	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN40979_c0_g1_i1	Q712K3	UB2R2_HUMAN	50.7	69	34	0	9	215	50	118	1.90E-14	79.3	UB2R2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2)	UBE2R2 CDC34B UBC3B	Homo sapiens (Human)	238	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0006513; GO:0016567; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN31165_c0_g1_i1	Q712K3	UB2R2_HUMAN	83.2	125	21	0	2	376	33	157	2.90E-63	242.3	UB2R2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2)	UBE2R2 CDC34B UBC3B	Homo sapiens (Human)	238	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0006513; GO:0016567; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN33443_c0_g1_i1	Q712K3	UB2R2_HUMAN	100	81	0	0	245	3	41	121	7.40E-47	187.2	UB2R2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2)	UBE2R2 CDC34B UBC3B	Homo sapiens (Human)	238	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0006513; GO:0016567; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN9863_c0_g1_i1	Q712K3	UB2R2_HUMAN	42.7	89	51	0	268	2	37	125	7.80E-18	90.9	UB2R2_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2)	UBE2R2 CDC34B UBC3B	Homo sapiens (Human)	238	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0006513; GO:0016567; GO:0061631; GO:0070936	protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35053_c0_g1_i1	Q1RML1	UBE2S_BOVIN	100	90	0	0	1	270	39	128	3.00E-49	195.3	UBE2S_BOVIN	reviewed	Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S)	UBE2S	Bos taurus (Bovine)	223	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0035519; GO:0044314; GO:0051301; GO:0061631; GO:0070534; GO:0070979; GO:0085020; GO:1904668	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5836_c0_g1_i1	C3Z724	UBE2S_BRAFL	73.6	121	32	0	1	363	13	133	3.60E-50	198.7	UBE2S_BRAFL	reviewed	Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S)	BRAFLDRAFT_259979	Branchiostoma floridae (Florida lancelet) (Amphioxus)	213	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35748_c0_g1_i1	Q9NPD8	UBE2T_HUMAN	100	90	0	0	270	1	65	154	1.30E-47	189.9	UBE2T_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T)	UBE2T HSPC150 PIG50	Homo sapiens (Human)	197	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006513; GO:0006974; GO:0016567; GO:0031625; GO:0035519; GO:0036297; GO:0044314; GO:0051865; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:0085020	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein K6-linked ubiquitination [GO:0085020]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]		NA	NA	NA	NA	NA	NA
TRINITY_DN1259_c0_g1_i1	Q7ZY08	UBE2T_XENLA	50.5	186	87	2	627	85	2	187	2.50E-50	200.3	UBE2T_XENLA	reviewed	Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T)	ube2t	Xenopus laevis (African clawed frog)	192	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006974; GO:0051865; GO:0061631	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN1259_c0_g1_i2	Q7ZY08	UBE2T_XENLA	62.8	129	48	0	462	76	2	130	1.10E-45	184.5	UBE2T_XENLA	reviewed	Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T)	ube2t	Xenopus laevis (African clawed frog)	192	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]	nucleus [GO:0005634]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006974; GO:0051865; GO:0061631	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]		NA	NA	NA	NA	NA	NA
TRINITY_DN3153_c0_g1_i1	Q28FC1	UBE2W_XENTR	75.5	147	36	0	64	504	4	150	3.10E-67	256.1	UBE2W_XENTR	reviewed	Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (Ubiquitin carrier protein W) (Ubiquitin-protein ligase W)	ube2w TEgg096e02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	151	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0043161; GO:0061631; GO:0071218	cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN31427_c0_g1_i1	Q9H832	UBE2Z_HUMAN	100	81	0	0	246	4	150	230	1.20E-44	179.9	UBE2Z_HUMAN	reviewed	Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)	UBE2Z HOYS7	Homo sapiens (Human)	354	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043065; GO:0043066; GO:0061631	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5542_c0_g1_i1	O74196	UBC1_COLGL	63	146	54	0	456	19	1	146	5.90E-50	198.4	UBC1_COLGL	reviewed	Ubiquitin-conjugating enzyme E2-16 kDa (EC 2.3.2.23) (Colletotrichum hard-surface-induced protein 1) (E2 ubiquitin-conjugating enzyme 1) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	UBC1 CHIP1	Colletotrichum gloeosporioides (Anthracnose fungus) (Glomerella cingulata)	147	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]		ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0005524; GO:0061631			NA	NA	NA	NA	NA	NA
TRINITY_DN30944_c0_g1_i1	P15732	UBC5_YEAST	63.7	113	41	0	2	340	36	148	3.20E-40	165.6	UBC5_YEAST	reviewed	Ubiquitin-conjugating enzyme E2-16 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 5) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	UBC5 YDR059C D4234 YD9609.13C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	148	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to heat [GO:0034605]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0031625; GO:0034605; GO:0061631; GO:0070628	cellular response to heat [GO:0034605]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3300_c0_g1_i1	P25867	UBCD1_DROME	62.3	146	55	0	456	19	2	147	2.80E-51	203	UBCD1_DROME	reviewed	Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	eff UbcD1 CG7425	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039	anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]	x	black	black	1	NA	NA	1
TRINITY_DN3740_c0_g1_i1	P25867	UBCD1_DROME	96.4	139	5	0	1028	612	9	147	9.30E-78	292	UBCD1_DROME	reviewed	Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	eff UbcD1 CG7425	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039	anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN3740_c0_g1_i2	P25867	UBCD1_DROME	96.6	147	5	0	1052	612	1	147	5.00E-82	306.2	UBCD1_DROME	reviewed	Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	eff UbcD1 CG7425	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039	anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN32902_c0_g1_i1	P25867	UBCD1_DROME	75.5	147	36	0	74	514	1	147	3.20E-63	242.7	UBCD1_DROME	reviewed	Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	eff UbcD1 CG7425	Drosophila melanogaster (Fruit fly)	147	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039	anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN1983_c0_g1_i1	P52485	UBCD2_DROME	93.2	161	5	1	579	97	78	232	5.30E-84	312.4	UBCD2_DROME	reviewed	Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	Ubc2 UbcD2 CG6720	Drosophila melanogaster (Fruit fly)	232	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0019915; GO:0061631	lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN1983_c0_g1_i2	P52485	UBCD2_DROME	96.8	155	5	0	561	97	78	232	4.20E-86	319.3	UBCD2_DROME	reviewed	Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	Ubc2 UbcD2 CG6720	Drosophila melanogaster (Fruit fly)	232	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0019915; GO:0061631	lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]		blue	blue	NA	NA	NA	NA
TRINITY_DN10070_c0_g1_i1	Q9VM35	U2QL1_DROME	73.3	101	25	1	303	1	189	287	3.60E-35	148.7	U2QL1_DROME	reviewed	Ubiquitin-conjugating enzyme E2Q-like protein CG4502 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme CG4502)	CG4502	Drosophila melanogaster (Fruit fly)	306	nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0005634; GO:0061631	protein polyubiquitination [GO:0000209]		NA	NA	NA	NA	NA	NA
TRINITY_DN8590_c0_g1_i1	Q178A5	UFC1_AEDAE	85.4	164	24	0	85	576	1	164	3.70E-85	315.8	UFC1_AEDAE	reviewed	Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1)	AAEL005968	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	169							NA	NA	NA	NA	NA	NA
TRINITY_DN8590_c0_g1_i2	Q178A5	UFC1_AEDAE	85.4	164	24	0	89	580	1	164	4.90E-85	315.5	UFC1_AEDAE	reviewed	Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1)	AAEL005968	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	169							blue	blue	NA	NA	NA	NA
TRINITY_DN37831_c0_g1_i1	Q9SXC8	UFC1_ARATH	68.6	156	48	1	28	492	8	163	1.30E-64	247.3	UFC1_ARATH	reviewed	Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1)	At1g27530 T17H3.3	Arabidopsis thaliana (Mouse-ear cress)	174	UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592]		UFM1 transferase activity [GO:0071568]	GO:0071568; GO:1990592	protein K69-linked ufmylation [GO:1990592]		NA	NA	NA	NA	NA	NA
TRINITY_DN30690_c0_g1_i1	Q9Y3C8	UFC1_HUMAN	100	167	0	0	532	32	1	167	3.60E-92	339	UFC1_HUMAN	reviewed	Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1)	UFC1 CGI-126 HSPC155	Homo sapiens (Human)	167	extracellular exosome [GO:0070062]; UFM1 conjugating enzyme activity [GO:0061657]; UFM1 transferase activity [GO:0071568]; brain development [GO:0007420]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	extracellular exosome [GO:0070062]	UFM1 conjugating enzyme activity [GO:0061657]; UFM1 transferase activity [GO:0071568]	GO:0007420; GO:0034976; GO:0061657; GO:0061709; GO:0070062; GO:0071568; GO:0071569; GO:1990592	brain development [GO:0007420]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN17038_c0_g1_i1	Q8BGR9	UBCP1_MOUSE	98.5	136	2	0	408	1	129	264	5.30E-74	278.1	UBCP1_MOUSE	reviewed	Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)	Ublcp1	Mus musculus (Mouse)	318	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0006470	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN17038_c0_g1_i2	Q2KJD7	UBCP1_BOVIN	99.4	164	1	0	493	2	129	292	2.30E-92	339.3	UBCP1_BOVIN	reviewed	Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)	UBLCP1	Bos taurus (Bovine)	318	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0006470	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN6548_c0_g1_i1	Q6DI37	UBCP1_DANRE	53	100	46	1	6	302	201	300	2.20E-24	112.8	UBCP1_DANRE	reviewed	Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)	ublcp1 zgc:86634	Danio rerio (Zebrafish) (Brachydanio rerio)	318	nucleus [GO:0005634]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0006470	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14520_c0_g1_i1	Q5ZJJ8	UBCP1_CHICK	73.7	152	39	1	543	91	120	271	4.40E-60	232.3	UBCP1_CHICK	reviewed	Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)	UBLCP1 RCJMB04_17j14	Gallus gallus (Chicken)	318	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0006470	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14520_c0_g1_i2	Q28EX9	UBCP1_XENTR	68.8	192	59	1	661	89	120	311	1.50E-73	277.3	UBCP1_XENTR	reviewed	Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)	ublcp1 TGas135j05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	318	nucleus [GO:0005634]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0006470	protein dephosphorylation [GO:0006470]		NA	NA	NA	NA	NA	NA
TRINITY_DN14788_c0_g1_i1	P22314	UBA1_HUMAN	67.8	87	28	0	261	1	846	932	8.00E-26	117.5	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN36587_c0_g1_i1	P22314	UBA1_HUMAN	56.6	113	49	0	381	43	553	665	3.60E-32	139	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN27502_c0_g1_i1	P22314	UBA1_HUMAN	61.3	75	29	0	229	5	224	298	2.50E-20	99	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN33075_c0_g1_i1	P22314	UBA1_HUMAN	100	295	0	0	2	886	31	325	1.40E-167	590.1	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN20891_c0_g1_i1	P22314	UBA1_HUMAN	100	215	0	0	648	4	478	692	6.80E-124	444.5	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35639_c0_g1_i1	P22314	UBA1_HUMAN	99.4	354	2	0	2	1063	702	1055	5.00E-209	728	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN39541_c0_g1_i1	P22314	UBA1_HUMAN	100	109	0	0	328	2	373	481	3.30E-58	225.3	UBA1_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	Homo sapiens (Human)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN27629_c0_g1_i1	Q29504	UBA1_RABIT	45.8	144	69	1	409	5	571	714	4.80E-31	136	UBA1_RABIT	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	UBA1 UBE1	Oryctolagus cuniculus (Rabbit)	1058	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN5453_c0_g1_i1	A3KMV5	UBA1_BOVIN	58.6	128	53	0	390	7	543	670	1.60E-43	176.8	UBA1_BOVIN	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	UBA1 UBE1	Bos taurus (Bovine)	1058	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974; GO:0016567; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN2848_c0_g1_i1	Q29504	UBA1_RABIT	65.1	1020	348	2	3137	102	38	1057	0	1378.6	UBA1_RABIT	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	UBA1 UBE1	Oryctolagus cuniculus (Rabbit)	1058	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN2848_c0_g1_i3	Q29504	UBA1_RABIT	65.2	1017	346	2	3128	102	41	1057	0	1377.1	UBA1_RABIT	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	UBA1 UBE1	Oryctolagus cuniculus (Rabbit)	1058	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739			blue	blue	NA	NA	NA	NA
TRINITY_DN20895_c0_g1_i1	Q55C16	UBA1_DICDI	61.9	63	24	0	14	202	512	574	2.70E-18	92	UBA1_DICDI	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	uba1 uae1 DDB_G0270272	Dictyostelium discoideum (Slime mold)	1017	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006511; GO:0006974; GO:0016567; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4690_c0_g1_i1	Q29504	UBA1_RABIT	47.7	218	97	2	5	619	729	942	1.00E-45	184.9	UBA1_RABIT	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	UBA1 UBE1	Oryctolagus cuniculus (Rabbit)	1058	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN4690_c0_g1_i2	Q29504	UBA1_RABIT	43.9	335	162	5	5	946	729	1058	3.90E-62	240	UBA1_RABIT	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	UBA1 UBE1	Oryctolagus cuniculus (Rabbit)	1058	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN30098_c0_g1_i1	Q02053	UBA1_MOUSE	98.9	87	1	0	1	261	124	210	8.10E-44	177.2	UBA1_MOUSE	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) (Ubiquitin-activating enzyme E1 X) (Ubiquitin-like modifier-activating enzyme 1 X)	Uba1 Sbx Ube1 Ube1ax Ube1x	Mus musculus (Mouse)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0000792; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0006974; GO:0010008; GO:0016567; GO:0030057; GO:0030867; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21389_c0_g1_i1	Q02053	UBA1_MOUSE	44.1	111	58	2	360	37	354	463	4.00E-17	89	UBA1_MOUSE	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) (Ubiquitin-activating enzyme E1 X) (Ubiquitin-like modifier-activating enzyme 1 X)	Uba1 Sbx Ube1 Ube1ax Ube1x	Mus musculus (Mouse)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0000792; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0006974; GO:0010008; GO:0016567; GO:0030057; GO:0030867; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN34844_c0_g1_i1	Q02053	UBA1_MOUSE	100	69	0	0	1	207	621	689	9.30E-35	146.7	UBA1_MOUSE	reviewed	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) (Ubiquitin-activating enzyme E1 X) (Ubiquitin-like modifier-activating enzyme 1 X)	Uba1 Sbx Ube1 Ube1ax Ube1x	Mus musculus (Mouse)	1058	cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0000792; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0006974; GO:0010008; GO:0016567; GO:0030057; GO:0030867; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN21389_c0_g2_i1	P31254	UBA1Y_MOUSE	69.3	75	21	1	227	3	461	533	7.40E-22	104.4	UBA1Y_MOUSE	reviewed	Ubiquitin-like modifier-activating enzyme 1 Y (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) (Ubiquitin-activating enzyme E1 Y)	Uba1y Sby Ube1ay Ube1y Ube1y1	Mus musculus (Mouse)	1058	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0007283; GO:0016567; GO:0032446	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8375_c0_g2_i1	A8XEQ8	UBA5_CAEBR	77.8	99	22	0	305	9	50	148	2.40E-37	156	UBA5_CAEBR	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5)	uba-5 CBG11977	Caenorhabditis briggsae	432	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; UFM1 activating enzyme activity [GO:0071566]; determination of adult lifespan [GO:0008340]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; reproduction [GO:0000003]; stress response to metal ion [GO:0097501]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; UFM1 activating enzyme activity [GO:0071566]	GO:0000003; GO:0005524; GO:0005737; GO:0005829; GO:0008340; GO:0031624; GO:0032446; GO:0046872; GO:0071566; GO:0071569; GO:0097501	determination of adult lifespan [GO:0008340]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; reproduction [GO:0000003]; stress response to metal ion [GO:0097501]		NA	NA	NA	NA	NA	NA
TRINITY_DN5318_c0_g1_i2	Q3KQ23	UBA5_XENLA	78.8	217	45	1	743	96	5	221	7.80E-93	341.7	UBA5_XENLA	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme)	uba5	Xenopus laevis (African clawed frog)	397	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005789; GO:0005794; GO:0008270; GO:0030218; GO:0030219; GO:0034976; GO:0042803; GO:0061709; GO:0071566; GO:0071569; GO:1990592	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	x	NA	NA	1	NA	NA	NA
TRINITY_DN8375_c0_g1_i1	Q5R8X4	UBA5_PONAB	68.2	129	40	1	385	2	152	280	2.10E-43	176.4	UBA5_PONAB	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme)	UBA5	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	404	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0008270; GO:0030218; GO:0030219; GO:0033146; GO:0034976; GO:0042803; GO:0061709; GO:0071566; GO:0071569; GO:1990592	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN17279_c0_g1_i1	A7MAZ3	UBA5_BOVIN	95.3	149	7	0	3	449	32	180	4.70E-76	285	UBA5_BOVIN	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme)	UBA5	Bos taurus (Bovine)	404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008270; GO:0030218; GO:0030219; GO:0032446; GO:0033146; GO:0034976; GO:0042803; GO:0050905; GO:0061709; GO:0071566; GO:0071569; GO:1990592	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN17279_c0_g1_i2	Q5R8X4	UBA5_PONAB	99.7	295	1	0	3	887	32	326	3.00E-167	589	UBA5_PONAB	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme)	UBA5	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	404	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0008270; GO:0030218; GO:0030219; GO:0033146; GO:0034976; GO:0042803; GO:0061709; GO:0071566; GO:0071569; GO:1990592	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN5318_c0_g1_i1	Q6GLG7	UBA5_XENTR	64.6	240	78	4	796	89	163	399	8.20E-80	298.5	UBA5_XENTR	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme)	uba5 TNeu098a04.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	399	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008270; GO:0030218; GO:0030219; GO:0032446; GO:0034976; GO:0042803; GO:0061709; GO:0071566; GO:0071569; GO:1990592	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN5318_c0_g1_i4	Q6GLG7	UBA5_XENTR	69.8	398	111	5	1264	89	5	399	2.10E-151	537	UBA5_XENTR	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme)	uba5 TNeu098a04.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	399	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008270; GO:0030218; GO:0030219; GO:0032446; GO:0034976; GO:0042803; GO:0061709; GO:0071566; GO:0071569; GO:1990592	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]		NA	NA	NA	NA	NA	NA
TRINITY_DN40166_c0_g1_i1	A0AVT1	UBA6_HUMAN	100	145	0	0	2	436	530	674	8.20E-81	300.8	UBA6_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2)	UBA6 MOP4 UBE1L2	Homo sapiens (Human)	1052	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996	amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN35050_c0_g1_i1	Q8C7R4	UBA6_MOUSE	98.6	69	1	0	3	209	555	623	8.80E-33	140.2	UBA6_MOUSE	reviewed	Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2)	Uba6 Ube1l2	Mus musculus (Mouse)	1053	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996	amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26136_c0_g1_i1	P41226	UBA7_HUMAN	81.4	70	13	0	3	212	365	434	5.60E-27	120.9	UBA7_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (D8) (Ubiquitin-activating enzyme E1 homolog)	UBA7 UBE1L UBE2	Homo sapiens (Human)	1012	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446; GO:0032480	cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]		NA	NA	NA	NA	NA	NA
TRINITY_DN19708_c0_g1_i1	P41226	UBA7_HUMAN	100	111	0	0	333	1	774	884	2.10E-57	222.6	UBA7_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (D8) (Ubiquitin-activating enzyme E1 homolog)	UBA7 UBE1L UBE2	Homo sapiens (Human)	1012	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446; GO:0032480	cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]		NA	NA	NA	NA	NA	NA
TRINITY_DN35055_c0_g1_i1	P41226	UBA7_HUMAN	79.1	67	14	0	2	202	30	96	3.90E-22	104.8	UBA7_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (D8) (Ubiquitin-activating enzyme E1 homolog)	UBA7 UBE1L UBE2	Homo sapiens (Human)	1012	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446; GO:0032480	cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]		NA	NA	NA	NA	NA	NA
TRINITY_DN29666_c0_g1_i1	P41226	UBA7_HUMAN	100	115	0	0	347	3	409	523	1.80E-59	229.6	UBA7_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (D8) (Ubiquitin-activating enzyme E1 homolog)	UBA7 UBE1L UBE2	Homo sapiens (Human)	1012	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446; GO:0032480	cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of type I interferon production [GO:0032480]; protein modification by small protein conjugation [GO:0032446]		NA	NA	NA	NA	NA	NA
TRINITY_DN4367_c0_g1_i1	O95352	ATG7_HUMAN	48.5	66	32	1	137	328	6	71	6.60E-11	68.6	ATG7_HUMAN	reviewed	Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein)	ATG7 APG7L	Homo sapiens (Human)	703	axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; aging [GO:0007568]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to morphine [GO:0071315]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; neutrophil degranulation [GO:0043312]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; response to fluoride [GO:1902617]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]	axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]	Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]	GO:0000045; GO:0000407; GO:0000422; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0007568; GO:0008134; GO:0009267; GO:0009749; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0030424; GO:0031401; GO:0032446; GO:0034727; GO:0034774; GO:0039521; GO:0042752; GO:0042803; GO:0043065; GO:0043312; GO:0044805; GO:0045732; GO:0048511; GO:0051607; GO:0061684; GO:0071315; GO:0071455; GO:0075044; GO:0090298; GO:1902617; GO:1903204; GO:1904813	aging [GO:0007568]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to hyperoxia [GO:0071455]; cellular response to morphine [GO:0071315]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; neutrophil degranulation [GO:0043312]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; response to fluoride [GO:1902617]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]		NA	NA	NA	NA	NA	NA
TRINITY_DN4367_c0_g1_i3	Q9D906	ATG7_MOUSE	50.5	630	287	10	137	1969	2	625	9.40E-169	595.1	ATG7_MOUSE	reviewed	Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (mAGP7) (Ubiquitin-activating enzyme E1-like protein)	Atg7 Apg7l	Mus musculus (Mouse)	698	axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; adult walking behavior [GO:0007628]; amino acid homeostasis [GO:0080144]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell development [GO:0055013]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system neuron axonogenesis [GO:0021955]; cerebellar Purkinje cell layer development [GO:0021680]; cerebral cortex development [GO:0021987]; chaperone-mediated autophagy [GO:0061684]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of phagocytosis [GO:0050765]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative stranded viral RNA replication [GO:0039689]; nervous system process [GO:0050877]; neuron projection development [GO:0031175]; organelle organization [GO:0006996]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mucus secretion [GO:0070257]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; post-embryonic development [GO:0009791]; protein catabolic process [GO:0030163]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; pyramidal neuron development [GO:0021860]; regulation of cell development [GO:0060284]; regulation of circadian rhythm [GO:0042752]; regulation of hemopoiesis [GO:1903706]; regulation of neuron death [GO:1901214]; regulation of protein ubiquitination [GO:0031396]; response to starvation [GO:0042594]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]	axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]	Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]	GO:0000045; GO:0000407; GO:0000422; GO:0001889; GO:0005737; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0006996; GO:0007005; GO:0007628; GO:0008134; GO:0009267; GO:0009791; GO:0010508; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0021680; GO:0021860; GO:0021955; GO:0021987; GO:0030163; GO:0030424; GO:0031175; GO:0031396; GO:0031401; GO:0032436; GO:0032446; GO:0034614; GO:0034727; GO:0035774; GO:0039521; GO:0039689; GO:0042594; GO:0042752; GO:0042803; GO:0043065; GO:0043066; GO:0044805; GO:0045732; GO:0048471; GO:0048511; GO:0050765; GO:0050877; GO:0051607; GO:0055013; GO:0060284; GO:0060548; GO:0061024; GO:0061684; GO:0070257; GO:0071455; GO:0075044; GO:0080144; GO:0090155; GO:0090156; GO:0090298; GO:1901214; GO:1903204; GO:1903706; GO:2000619	adult walking behavior [GO:0007628]; amino acid homeostasis [GO:0080144]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cardiac muscle cell development [GO:0055013]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system neuron axonogenesis [GO:0021955]; cerebellar Purkinje cell layer development [GO:0021680]; cerebral cortex development [GO:0021987]; chaperone-mediated autophagy [GO:0061684]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of phagocytosis [GO:0050765]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative stranded viral RNA replication [GO:0039689]; nervous system process [GO:0050877]; neuron projection development [GO:0031175]; organelle organization [GO:0006996]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mucus secretion [GO:0070257]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; post-embryonic development [GO:0009791]; protein catabolic process [GO:0030163]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; pyramidal neuron development [GO:0021860]; regulation of cell development [GO:0060284]; regulation of circadian rhythm [GO:0042752]; regulation of hemopoiesis [GO:1903706]; regulation of neuron death [GO:1901214]; regulation of protein ubiquitination [GO:0031396]; response to starvation [GO:0042594]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]		blue	blue	NA	NA	NA	NA
TRINITY_DN12696_c0_g1_i1	P21126	UBL4A_MOUSE	34.3	143	91	1	522	94	1	140	3.90E-17	89.7	UBL4A_MOUSE	reviewed	Ubiquitin-like protein 4A (Ubiquitin-like protein GDX)	Ubl4a Gdx Ubl4	Mus musculus (Mouse)	157	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chaperone binding [GO:0051087]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0051087; GO:0071816; GO:0071818	tail-anchored membrane protein insertion into ER membrane [GO:0071816]		brown	brown	NA	NA	NA	NA
TRINITY_DN11605_c0_g1_i1	Q3T0Z3	UBL5_BOVIN	100	73	0	0	315	97	1	73	5.60E-38	158.3	UBL5_BOVIN	reviewed	Ubiquitin-like protein 5	UBL5	Bos taurus (Bovine)	73	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	protein tag [GO:0031386]	GO:0000398; GO:0005634; GO:0005737; GO:0006464; GO:0031386	"cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11605_c0_g2_i1	Q3T0Z3	UBL5_BOVIN	100	73	0	0	297	79	1	73	3.60E-38	158.7	UBL5_BOVIN	reviewed	Ubiquitin-like protein 5	UBL5	Bos taurus (Bovine)	73	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	protein tag [GO:0031386]	GO:0000398; GO:0005634; GO:0005737; GO:0006464; GO:0031386	"cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26782_c0_g1_i1	Q3T0Z3	UBL5_BOVIN	90.4	73	7	0	39	257	1	73	1.90E-35	149.8	UBL5_BOVIN	reviewed	Ubiquitin-like protein 5	UBL5	Bos taurus (Bovine)	73	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	protein tag [GO:0031386]	GO:0000398; GO:0005634; GO:0005737; GO:0006464; GO:0031386	"cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"		blue	blue	NA	NA	NA	NA
TRINITY_DN38572_c0_g1_i1	Q9FGZ9	UBL5_ARATH	89	73	8	0	306	88	1	73	8.70E-33	141	UBL5_ARATH	reviewed	Ubiquitin-like protein 5	UBL5 At5g42300 K5J14.10	Arabidopsis thaliana (Mouse-ear cress)	73	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein tag [GO:0031386]; cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	protein tag [GO:0031386]	GO:0000398; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0008380; GO:0031386	"cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6236_c0_g1_i1	Q91W67	UBL7_MOUSE	40.8	76	30	1	92	319	316	376	7.10E-05	48.5	UBL7_MOUSE	reviewed	Ubiquitin-like protein 7	Ubl7	Mus musculus (Mouse)	380	cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005829; GO:0006511; GO:0031593	ubiquitin-dependent protein catabolic process [GO:0006511]		blue	blue	NA	NA	NA	NA
TRINITY_DN26517_c0_g1_i1	Q9H0Y0	ATG10_HUMAN	37.3	201	117	3	715	128	12	208	7.30E-30	132.5	ATG10_HUMAN	reviewed	Ubiquitin-like-conjugating enzyme ATG10 (EC 2.3.2.-) (Autophagy-related protein 10) (APG10-like)	ATG10 APG10L PP12616	Homo sapiens (Human)	220	cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]	cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]	GO:0005829; GO:0006497; GO:0006914; GO:0006983; GO:0015031; GO:0016236; GO:0019777; GO:0031401; GO:0032446	autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4230_c0_g1_i1	Q0VCL3	ATG3_BOVIN	79.2	101	19	1	299	3	189	289	9.90E-42	170.6	ATG3_BOVIN	reviewed	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like)	ATG3	Bos taurus (Bovine)	314	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0016567; GO:0019776; GO:0019777; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN32689_c0_g1_i1	Q6PFS7	ATG3_DANRE	75.8	132	31	1	432	37	1	131	1.90E-53	209.9	ATG3_DANRE	reviewed	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like)	atg3 apg3l zgc:64156	Danio rerio (Zebrafish) (Brachydanio rerio)	317	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0019776; GO:0019777; GO:0043653; GO:0044804	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN35794_c0_g1_i1	Q0VCL3	ATG3_BOVIN	100	101	0	0	303	1	179	279	1.80E-55	216.1	ATG3_BOVIN	reviewed	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like)	ATG3	Bos taurus (Bovine)	314	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0016567; GO:0019776; GO:0019777; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN35794_c0_g1_i2	Q0VCL3	ATG3_BOVIN	100	89	0	0	267	1	191	279	4.30E-48	191.4	ATG3_BOVIN	reviewed	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like)	ATG3	Bos taurus (Bovine)	314	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0016567; GO:0019776; GO:0019777; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN32116_c0_g1_i1	Q9NT62	ATG3_HUMAN	100	104	0	0	3	314	8	111	7.00E-58	224.2	ATG3_HUMAN	reviewed	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like) (hApg3) (Protein PC3-96)	ATG3 APG3 APG3L	Homo sapiens (Human)	314	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; macroautophagy [GO:0016236]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0006464; GO:0006612; GO:0016236; GO:0016567; GO:0019776; GO:0019777; GO:0019787; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; macroautophagy [GO:0016236]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN32116_c0_g1_i2	Q9NT62	ATG3_HUMAN	100	104	0	0	3	314	8	111	7.00E-58	224.2	ATG3_HUMAN	reviewed	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like) (hApg3) (Protein PC3-96)	ATG3 APG3 APG3L	Homo sapiens (Human)	314	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; macroautophagy [GO:0016236]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0006464; GO:0006612; GO:0016236; GO:0016567; GO:0019776; GO:0019777; GO:0019787; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; macroautophagy [GO:0016236]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN26906_c0_g1_i1	Q05086	UBE3A_HUMAN	99.4	171	1	0	513	1	483	653	2.20E-93	342.8	UBE3A_HUMAN	reviewed	Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)	UBE3A E6AP EPVE6AP HPVE6A	Homo sapiens (Human)	875	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0016032; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0070936; GO:1905528; GO:1990416; GO:2000058	androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4001_c0_g1_i1	Q05086	UBE3A_HUMAN	53.3	75	35	0	257	33	801	875	1.30E-17	90.1	UBE3A_HUMAN	reviewed	Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)	UBE3A E6AP EPVE6AP HPVE6A	Homo sapiens (Human)	875	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0016032; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0070936; GO:1905528; GO:1990416; GO:2000058	androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2168_c0_g1_i1	Q05086	UBE3A_HUMAN	46	920	432	15	2811	82	11	875	4.00E-203	709.9	UBE3A_HUMAN	reviewed	Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)	UBE3A E6AP EPVE6AP HPVE6A	Homo sapiens (Human)	875	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0016032; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0070936; GO:1905528; GO:1990416; GO:2000058	androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN30908_c0_g1_i1	Q05086	UBE3A_HUMAN	100	164	0	0	498	7	712	875	1.20E-91	337	UBE3A_HUMAN	reviewed	Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)	UBE3A E6AP EPVE6AP HPVE6A	Homo sapiens (Human)	875	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0016032; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0070936; GO:1905528; GO:1990416; GO:2000058	androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN24616_c0_g1_i1	Q9ES34	UBE3B_MOUSE	97	67	2	0	202	2	212	278	1.70E-28	125.9	UBE3B_MOUSE	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	Ube3b	Mus musculus (Mouse)	1070	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8525_c0_g1_i1	Q7Z3V4	UBE3B_HUMAN	62.9	512	189	1	2	1534	557	1068	6.20E-196	685.3	UBE3B_HUMAN	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	UBE3B	Homo sapiens (Human)	1068	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN8525_c0_g1_i5	Q7Z3V4	UBE3B_HUMAN	46.6	176	94	0	2	529	557	732	6.70E-43	175.3	UBE3B_HUMAN	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	UBE3B	Homo sapiens (Human)	1068	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN39614_c0_g1_i1	Q7Z3V4	UBE3B_HUMAN	100	108	0	0	3	326	854	961	5.90E-60	231.1	UBE3B_HUMAN	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	UBE3B	Homo sapiens (Human)	1068	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN764_c1_g1_i2	Q08CZ0	UBE3B_XENTR	42	412	228	7	1288	59	1	403	1.60E-82	308.1	UBE3B_XENTR	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	ube3b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1072	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN764_c1_g1_i6	Q08CZ0	UBE3B_XENTR	40.1	364	203	6	1097	6	208	556	4.10E-63	243.4	UBE3B_XENTR	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	ube3b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1072	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN764_c1_g1_i9	Q08CZ0	UBE3B_XENTR	40	577	323	10	1730	6	1	556	2.50E-107	391	UBE3B_XENTR	reviewed	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	ube3b	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1072	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0006511; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26776_c0_g1_i1	Q15386	UBE3C_HUMAN	100	69	0	0	1	207	861	929	5.10E-33	141	UBE3C_HUMAN	reviewed	Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2)	UBE3C KIAA0010 KIAA10	Homo sapiens (Human)	1083	nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; proteasome complex [GO:0000502]	ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0000502; GO:0005634; GO:0006511; GO:0061630; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN5248_c0_g1_i1	Q15386	UBE3C_HUMAN	38.6	1112	612	23	3293	84	1	1083	1.30E-197	691.8	UBE3C_HUMAN	reviewed	Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2)	UBE3C KIAA0010 KIAA10	Homo sapiens (Human)	1083	nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; proteasome complex [GO:0000502]	ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0000502; GO:0005634; GO:0006511; GO:0061630; GO:0061631	protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN26013_c0_g1_i1	Q9BTM9	URM1_HUMAN	100	80	0	0	2	241	22	101	2.10E-42	172.6	URM1_HUMAN	reviewed	Ubiquitin-related modifier 1	URM1 C9orf74	Homo sapiens (Human)	101	cytosol [GO:0005829]; nucleus [GO:0005634]; protein tag [GO:0031386]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA modification [GO:0006400]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]; nucleus [GO:0005634]	protein tag [GO:0031386]; sulfur carrier activity [GO:0097163]	GO:0002098; GO:0005634; GO:0005829; GO:0006400; GO:0031386; GO:0032447; GO:0034227; GO:0097163	protein urmylation [GO:0032447]; tRNA modification [GO:0006400]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN1269_c0_g2_i1	Q7KU86	URM1_DROME	66.7	96	31	1	230	514	6	101	7.00E-32	138.7	URM1_DROME	reviewed	Ubiquitin-related modifier 1 homolog	Urm1 CG33276	Drosophila melanogaster (Fruit fly)	101	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein tag [GO:0031386]; negative regulation of JNK cascade [GO:0046329]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	protein tag [GO:0031386]	GO:0002098; GO:0005634; GO:0005737; GO:0005829; GO:0031386; GO:0032447; GO:0034227; GO:0046329	negative regulation of JNK cascade [GO:0046329]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]		NA	NA	NA	NA	NA	NA
TRINITY_DN4622_c0_g1_i1	Q92575	UBXN4_HUMAN	41.4	162	88	3	473	3	1	160	6.10E-20	99	UBXN4_HUMAN	reviewed	UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2)	UBXN4 KIAA0242 UBXD2 UBXDC1	Homo sapiens (Human)	508	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]		GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006986; GO:0030433	response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]		blue	blue	NA	NA	NA	NA
TRINITY_DN2481_c0_g1_i1	Q99PL6	UBXN6_MOUSE	40.5	420	238	7	459	1703	2	414	3.70E-74	280.8	UBXN6_MOUSE	reviewed	UBX domain-containing protein 6 (UBX domain-containing protein 1)	Ubxn6 Ubxd1 Ubxdc2	Mus musculus (Mouse)	442	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503	endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]		NA	NA	NA	NA	NA	NA
TRINITY_DN2481_c0_g1_i2	Q99PL6	UBXN6_MOUSE	40.5	420	238	7	553	1797	2	414	3.90E-74	280.8	UBXN6_MOUSE	reviewed	UBX domain-containing protein 6 (UBX domain-containing protein 1)	Ubxn6 Ubxd1 Ubxdc2	Mus musculus (Mouse)	442	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503	endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]		NA	NA	NA	NA	NA	NA
TRINITY_DN6061_c0_g1_i1	Q58DA6	S35A2_BOVIN	54.9	306	136	2	1005	91	35	339	1.70E-74	281.2	S35A2_BOVIN	reviewed	UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT)	SLC35A2	Bos taurus (Bovine)	393	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]	GO:0000139; GO:0008643; GO:0015165; GO:0016021	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN5938_c1_g1_i1	Q9VMU8	SENJU_DROME	56	352	136	2	1156	158	5	356	8.70E-99	362.1	SENJU_DROME	reviewed	UDP-galactose transporter senju	senju CG14040	Drosophila melanogaster (Fruit fly)	388	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; UDP-galactose transmembrane transport [GO:0072334]	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]	UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0008643; GO:0030173; GO:0045751; GO:0045824; GO:0060050; GO:0072334	carbohydrate transport [GO:0008643]; negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; UDP-galactose transmembrane transport [GO:0072334]		blue	blue	NA	NA	NA	NA
TRINITY_DN21262_c0_g1_i2	Q94B65	UTR7_ARATH	32.6	135	88	2	475	71	17	148	8.90E-10	65.1	UTR7_ARATH	reviewed	UDP-galactose/UDP-glucose transporter 7 (AtUTr7)	UTR7 At4g31600 F28M20.210	Arabidopsis thaliana (Mouse-ear cress)	323	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]	GO:0000139; GO:0005459; GO:0005460; GO:0005794; GO:0008643; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0048527; GO:0072334; GO:0080147	carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]		NA	NA	NA	NA	NA	NA
TRINITY_DN21262_c0_g1_i3	Q94B65	UTR7_ARATH	35.5	301	186	5	1033	143	17	313	8.50E-39	162.5	UTR7_ARATH	reviewed	UDP-galactose/UDP-glucose transporter 7 (AtUTr7)	UTR7 At4g31600 F28M20.210	Arabidopsis thaliana (Mouse-ear cress)	323	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]	GO:0000139; GO:0005459; GO:0005460; GO:0005794; GO:0008643; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0048527; GO:0072334; GO:0080147	carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i10	Q8K0J2	B3GN7_MOUSE	30.7	205	113	6	763	233	133	336	4.40E-16	87.8	B3GN7_MOUSE	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-)"	B3gnt7	Mus musculus (Mouse)	397	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008532; GO:0016021; GO:0016758; GO:0030311	poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i4	Q8K0J2	B3GN7_MOUSE	30.7	205	113	6	763	233	133	336	3.10E-16	87.8	B3GN7_MOUSE	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-)"	B3gnt7	Mus musculus (Mouse)	397	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008532; GO:0016021; GO:0016758; GO:0030311	poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN15364_c0_g1_i6	Q8K0J2	B3GN7_MOUSE	30.7	205	113	6	763	233	133	336	3.00E-16	87.8	B3GN7_MOUSE	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-)"	B3gnt7	Mus musculus (Mouse)	397	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008532; GO:0016021; GO:0016758; GO:0030311	poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN24016_c0_g2_i1	Q8R3I9	B3GN8_MOUSE	35.3	221	119	10	102	755	141	340	4.10E-19	97.1	B3GN8_MOUSE	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 (BGnT-8) (Beta-1,3-Gn-T8) (Beta-1,3-N-acetylglucosaminyltransferase 8) (Beta3Gn-T8) (EC 2.4.1.-)"	B3gnt8 B3galt7	Mus musculus (Mouse)	389	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; transferase activity, transferring hexosyl groups [GO:0016758]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; transferase activity, transferring hexosyl groups [GO:0016758]"	GO:0000139; GO:0005794; GO:0006486; GO:0008375; GO:0008376; GO:0008532; GO:0016021; GO:0016262; GO:0016758; GO:0030311	poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]		NA	NA	NA	NA	NA	NA
TRINITY_DN11673_c0_g1_i1	Q67FW5	B3GNL_HUMAN	60.6	104	41	0	2	313	90	193	3.20E-35	149.1	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN11673_c0_g1_i2	Q67FW5	B3GNL_HUMAN	61.2	134	52	0	2	403	90	223	1.40E-47	190.3	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN9821_c0_g1_i1	Q67FW5	B3GNL_HUMAN	58.7	143	58	1	1	426	219	361	3.50E-43	176	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN9821_c0_g1_i10	Q67FW5	B3GNL_HUMAN	58.7	143	58	1	1	426	219	361	2.70E-43	176.4	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN9821_c0_g1_i3	Q67FW5	B3GNL_HUMAN	58.7	143	58	1	1	426	219	361	2.70E-43	176.4	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN9821_c0_g1_i5	Q67FW5	B3GNL_HUMAN	58.1	117	48	1	1	348	219	335	3.00E-33	142.5	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN9821_c0_g1_i7	Q67FW5	B3GNL_HUMAN	58.1	117	48	1	1	348	219	335	1.20E-33	144.1	B3GNL_HUMAN	reviewed	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)"	B3GNTL1 B3GNT8	Homo sapiens (Human)	361	"transferase activity, transferring glycosyl groups [GO:0016757]"		"transferase activity, transferring glycosyl groups [GO:0016757]"	GO:0016757			NA	NA	NA	NA	NA	NA
TRINITY_DN8204_c0_g1_i1	Q59083	EXOB_AZOBR	61	82	31	1	256	11	191	271	4.00E-19	95.1	EXOB_AZOBR	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-galactose 4-epimerase)	exoB	Azospirillum brasilense	348	UDP-glucose 4-epimerase activity [GO:0003978]; galactose metabolic process [GO:0006012]; polysaccharide biosynthetic process [GO:0000271]		UDP-glucose 4-epimerase activity [GO:0003978]	GO:0000271; GO:0003978; GO:0006012	galactose metabolic process [GO:0006012]; polysaccharide biosynthetic process [GO:0000271]		NA	NA	NA	NA	NA	1
TRINITY_DN8204_c0_g1_i2	P55180	GALE_BACSU	64.4	132	46	1	400	5	144	274	6.60E-45	181.4	GALE_BACSU	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-galactose 4-epimerase)	galE BSU38860	Bacillus subtilis (strain 168)	339	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]	GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN14208_c0_g1_i1	P55180	GALE_BACSU	60.1	208	83	0	19	642	132	339	3.00E-74	279.6	GALE_BACSU	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-galactose 4-epimerase)	galE BSU38860	Bacillus subtilis (strain 168)	339	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]	GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN1088_c0_g1_i8	P55180	GALE_BACSU	46.9	81	43	0	455	213	259	339	1.10E-17	91.3	GALE_BACSU	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-galactose 4-epimerase)	galE BSU38860	Bacillus subtilis (strain 168)	339	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]	GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN21459_c0_g1_i1	Q14376	GALE_HUMAN	97.7	86	2	0	260	3	68	153	9.00E-43	173.7	GALE_HUMAN	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	GALE	Homo sapiens (Human)	348	cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0019388; GO:0033499; GO:0042802; GO:0042803	galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN6018_c0_g1_i1	Q9W0P5	GALE_DROME	60.2	83	33	0	12	260	268	350	1.50E-26	120.2	GALE_DROME	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	Gale CG12030	Drosophila melanogaster (Fruit fly)	350	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0033499; GO:0035167	galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN6018_c0_g1_i2	Q9W0P5	GALE_DROME	60.2	83	33	0	12	260	268	350	1.50E-26	120.2	GALE_DROME	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	Gale CG12030	Drosophila melanogaster (Fruit fly)	350	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0033499; GO:0035167	galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN1088_c0_g1_i1	Q9W0P5	GALE_DROME	56.7	344	142	2	1190	180	5	348	1.60E-116	421	GALE_DROME	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	Gale CG12030	Drosophila melanogaster (Fruit fly)	350	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0033499; GO:0035167	galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN1088_c0_g1_i3	Q9W0P5	GALE_DROME	55.2	344	147	2	1232	222	5	348	1.90E-112	407.5	GALE_DROME	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	Gale CG12030	Drosophila melanogaster (Fruit fly)	350	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0033499; GO:0035167	galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN1088_c0_g1_i4	Q9W0P5	GALE_DROME	55.2	344	147	2	1190	180	5	348	1.80E-112	407.5	GALE_DROME	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	Gale CG12030	Drosophila melanogaster (Fruit fly)	350	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0033499; GO:0035167	galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN1088_c0_g1_i5	Q9W0P5	GALE_DROME	56.7	344	142	2	1232	222	5	348	1.70E-116	421	GALE_DROME	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	Gale CG12030	Drosophila melanogaster (Fruit fly)	350	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0033499; GO:0035167	galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; larval lymph gland hemopoiesis [GO:0035167]		NA	NA	NA	NA	NA	NA
TRINITY_DN5164_c0_g1_i10	Q3T105	GALE_BOVIN	60.4	351	132	4	1279	227	1	344	5.50E-120	432.6	GALE_BOVIN	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase)	GALE	Bos taurus (Bovine)	348	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN5164_c0_g1_i2	Q3T105	GALE_BOVIN	60.1	338	128	4	1038	25	1	331	3.00E-113	409.8	GALE_BOVIN	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase)	GALE	Bos taurus (Bovine)	348	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN5164_c0_g1_i7	Q3T105	GALE_BOVIN	59.9	337	128	4	1012	2	1	330	4.40E-112	406	GALE_BOVIN	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase)	GALE	Bos taurus (Bovine)	348	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN5164_c0_g1_i8	Q3T105	GALE_BOVIN	59.9	337	128	4	1012	2	1	330	7.40E-112	405.2	GALE_BOVIN	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase)	GALE	Bos taurus (Bovine)	348	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN23107_c0_g1_i1	Q3T105	GALE_BOVIN	100	72	0	0	218	3	237	308	8.80E-36	150.2	GALE_BOVIN	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase)	GALE	Bos taurus (Bovine)	348	cytosol [GO:0005829]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process via UDP-galactose [GO:0033499]	cytosol [GO:0005829]	UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0033499	galactose catabolic process via UDP-galactose [GO:0033499]		NA	NA	NA	NA	NA	NA
TRINITY_DN23107_c0_g1_i2	Q8R059	GALE_MOUSE	100	106	0	0	320	3	202	307	1.00E-56	220.3	GALE_MOUSE	reviewed	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-galactose 4-epimerase)	Gale	Mus musculus (Mouse)	347	cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]	cytosol [GO:0005829]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0006012; GO:0019388; GO:0033499; GO:0042802; GO:0042803; GO:0061623	galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]		NA	NA	NA	NA	NA	NA
TRINITY_DN24241_c0_g1_i1	O70475	UGDH_MOUSE	100	143	0	0	2	430	251	393	1.40E-77	290	UGDH_MOUSE	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)	Ugdh	Mus musculus (Mouse)	493	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN24241_c0_g1_i2	O70475	UGDH_MOUSE	100	298	0	0	3	896	96	393	4.70E-168	591.7	UGDH_MOUSE	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)	Ugdh	Mus musculus (Mouse)	493	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN10089_c0_g1_i1	P12378	UGDH_BOVIN	51.9	77	34	2	232	11	392	468	4.00E-16	85.1	UGDH_BOVIN	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)	UGDH	Bos taurus (Bovine)	494	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN33055_c0_g1_i1	O70475	UGDH_MOUSE	99	99	1	0	298	2	1	99	4.50E-53	208.4	UGDH_MOUSE	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)	Ugdh	Mus musculus (Mouse)	493	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN513_c0_g1_i1	O02373	UGDH_DROME	70.1	469	140	0	1535	129	3	471	1.20E-193	677.6	UGDH_DROME	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Protein sugarless) (Protein suppenkasper)	sgl kiwi ska CG10072	Drosophila melanogaster (Fruit fly)	476	"cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0007367; GO:0007427; GO:0007509; GO:0008543; GO:0015014; GO:0016055; GO:0030206; GO:0051287	"chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN513_c0_g1_i2	O02373	UGDH_DROME	70.1	469	140	0	1490	84	3	471	9.00E-194	677.9	UGDH_DROME	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Protein sugarless) (Protein suppenkasper)	sgl kiwi ska CG10072	Drosophila melanogaster (Fruit fly)	476	"cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0007367; GO:0007427; GO:0007509; GO:0008543; GO:0015014; GO:0016055; GO:0030206; GO:0051287	"chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN513_c0_g1_i3	O02373	UGDH_DROME	70.1	469	140	0	1535	129	3	471	9.20E-194	677.9	UGDH_DROME	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Protein sugarless) (Protein suppenkasper)	sgl kiwi ska CG10072	Drosophila melanogaster (Fruit fly)	476	"cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0007367; GO:0007427; GO:0007509; GO:0008543; GO:0015014; GO:0016055; GO:0030206; GO:0051287	"chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN513_c0_g1_i4	O02373	UGDH_DROME	70.1	469	140	0	1490	84	3	471	1.10E-193	677.6	UGDH_DROME	reviewed	UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) (Protein sugarless) (Protein suppenkasper)	sgl kiwi ska CG10072	Drosophila melanogaster (Fruit fly)	476	"cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0007367; GO:0007427; GO:0007509; GO:0008543; GO:0015014; GO:0016055; GO:0030206; GO:0051287	"chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4894_c0_g3_i1	Q96558	UGDH1_SOYBN	72.9	155	42	0	49	513	150	304	2.00E-62	240	UGDH1_SOYBN	reviewed	UDP-glucose 6-dehydrogenase 1 (UDP-Glc dehydrogenase 1) (UDP-GlcDH 1) (UDPGDH 1) (EC 1.1.1.22) (Gm-UGD1)	UGD1	Glycine max (Soybean) (Glycine hispida)	480	cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0051287	glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN4894_c0_g1_i1	Q9FM01	UGDH4_ARATH	60	60	24	0	213	34	408	467	3.70E-16	85.5	UGDH4_ARATH	reviewed	UDP-glucose 6-dehydrogenase 4 (UDP-Glc dehydrogenase 4) (UDP-GlcDH 4) (UDPGDH 4) (EC 1.1.1.22) (At-UGD4)	UGD4 UGD1 At5g39320 K3K3.170	Arabidopsis thaliana (Mouse-ear cress)	480	cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0051287	glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN4894_c0_g2_i1	Q2QS14	UGDH4_ORYSJ	68.7	371	110	1	79	1191	3	367	4.70E-147	522.3	UGDH4_ORYSJ	reviewed	UDP-glucose 6-dehydrogenase 4 (UDP-Glc dehydrogenase 4) (UDP-GlcDH 4) (UDPGDH 4) (EC 1.1.1.22) (Os-UGD4)	UGD4 Os12g0443500 LOC_Os12g25690 OsJ_35985	Oryza sativa subsp. japonica (Rice)	480	cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0051287	glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN4894_c0_g4_i1	Q2QS13	UGDH5_ORYSJ	70.2	104	31	0	315	4	38	141	8.00E-38	157.5	UGDH5_ORYSJ	reviewed	UDP-glucose 6-dehydrogenase 5 (UDP-Glc dehydrogenase 5) (UDP-GlcDH 5) (UDPGDH 5) (EC 1.1.1.22) (Os-UGD5)	UGD5 Os12g0443600 LOC_Os12g25700 OsJ_35986	Oryza sativa subsp. japonica (Rice)	480	cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; nucleus [GO:0005634]	NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0003979; GO:0005634; GO:0005829; GO:0006024; GO:0006065; GO:0051287	glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucuronate biosynthetic process [GO:0006065]		NA	NA	NA	NA	NA	NA
TRINITY_DN40131_c0_g1_i1	Q6P5E4	UGGG1_MOUSE	100	135	0	0	406	2	1081	1215	3.40E-73	275.4	UGGG1_MOUSE	reviewed	UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)	Uggt1 Gt Ugcgl1 Uggt Ugt1 Ugtr	Mus musculus (Mouse)	1551	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; protein-containing complex [GO:0032991]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0051082; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5008_c0_g1_i4	Q6P5E4	UGGG1_MOUSE	47.4	1527	755	19	4546	50	45	1551	0	1379	UGGG1_MOUSE	reviewed	UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)	Uggt1 Gt Ugcgl1 Uggt Ugt1 Ugtr	Mus musculus (Mouse)	1551	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; protein-containing complex [GO:0032991]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0051082; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN5008_c0_g1_i8	Q6P5E4	UGGG1_MOUSE	47.4	1527	755	19	4546	50	45	1551	0	1379	UGGG1_MOUSE	reviewed	UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)	Uggt1 Gt Ugcgl1 Uggt Ugt1 Ugtr	Mus musculus (Mouse)	1551	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; protein-containing complex [GO:0032991]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0051082; GO:0071712	ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN27902_c0_g1_i1	Q9NYU2	UGGG1_HUMAN	100	73	0	0	221	3	1416	1488	5.70E-38	157.5	UGGG1_HUMAN	reviewed	UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (hUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)	UGGT1 GT UGCGL1 UGGT UGT1 UGTR	Homo sapiens (Human)	1555	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0051084; GO:0070062; GO:0071712; GO:1904380	'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]		NA	NA	NA	NA	NA	NA
TRINITY_DN35588_c0_g1_i1	Q8NBZ7	UXS1_HUMAN	98.9	182	2	0	50	595	90	271	3.80E-105	382.1	UXS1_HUMAN	reviewed	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1)	UXS1 UNQ2538/PRO6079	Homo sapiens (Human)	420	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]; UDP-D-xylose biosynthetic process [GO:0033320]	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042802; GO:0042803; GO:0048040; GO:0070062; GO:0070403; GO:1902494	UDP-D-xylose biosynthetic process [GO:0033320]		NA	NA	NA	NA	NA	NA
TRINITY_DN12273_c0_g1_i1	Q6GMI9	UXS1_DANRE	69.8	331	100	0	285	1277	36	366	2.50E-138	493.4	UXS1_DANRE	reviewed	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UXS-1)	uxs1 zgc:91980	Danio rerio (Zebrafish) (Brachydanio rerio)	418	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0001503; GO:0005737; GO:0015012; GO:0016021; GO:0030166; GO:0030198; GO:0030206; GO:0032580; GO:0033320; GO:0048040; GO:0050650; GO:0051216; GO:0070403	cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; UDP-D-xylose biosynthetic process [GO:0033320]		NA	NA	NA	NA	NA	NA
TRINITY_DN12273_c0_g1_i2	Q6GMI9	UXS1_DANRE	70.4	328	97	0	294	1277	40	367	7.00E-139	495.4	UXS1_DANRE	reviewed	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UXS-1)	uxs1 zgc:91980	Danio rerio (Zebrafish) (Brachydanio rerio)	418	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0001503; GO:0005737; GO:0015012; GO:0016021; GO:0030166; GO:0030198; GO:0030206; GO:0032580; GO:0033320; GO:0048040; GO:0050650; GO:0051216; GO:0070403	cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; UDP-D-xylose biosynthetic process [GO:0033320]		blue	blue	NA	NA	NA	NA
TRINITY_DN12273_c0_g1_i3	Q6GMI9	UXS1_DANRE	66.7	375	121	2	294	1415	40	411	2.70E-150	533.5	UXS1_DANRE	reviewed	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UXS-1)	uxs1 zgc:91980	Danio rerio (Zebrafish) (Brachydanio rerio)	418	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0001503; GO:0005737; GO:0015012; GO:0016021; GO:0030166; GO:0030198; GO:0030206; GO:0032580; GO:0033320; GO:0048040; GO:0050650; GO:0051216; GO:0070403	cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; UDP-D-xylose biosynthetic process [GO:0033320]		blue	blue	NA	NA	NA	NA
TRINITY_DN39316_c0_g1_i1	Q8VZC0	UXS1_ARATH	68.5	111	35	0	336	4	159	269	2.00E-42	172.9	UXS1_ARATH	reviewed	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-XYL synthase 1) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1)	UXS1 At3g53520 F4P12.220	Arabidopsis thaliana (Mouse-ear cress)	435	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042732; GO:0048040; GO:0070403	D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]		NA	NA	NA	NA	NA	NA
TRINITY_DN36890_c0_g1_i1	Q8S8T4	UXS4_ARATH	51.1	94	46	0	311	30	333	426	3.20E-21	102.4	UXS4_ARATH	reviewed	UDP-glucuronic acid decarboxylase 4 (EC 4.1.1.35) (UDP-XYL synthase 4) (UDP-glucuronate decarboxylase 4) (UGD) (UXS-4)	UXS4 At2g47650 T30B22.31	Arabidopsis thaliana (Mouse-ear cress)	443	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042732; GO:0048040; GO:0070403	D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]		NA	NA	NA	NA	NA	NA
TRINITY_DN36511_c0_g1_i1	Q9ZV36	UXS6_ARATH	62.5	128	47	1	383	3	23	150	1.80E-42	173.3	UXS6_ARATH	reviewed	UDP-glucuronic acid decarboxylase 6 (EC 4.1.1.35) (UDP-XYL synthase 6) (UDP-glucuronate decarboxylase 6) (UGD) (UXS-6)	UXS6 At2g28760 F8N16.5	Arabidopsis thaliana (Mouse-ear cress)	343	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0005737; GO:0005777; GO:0005886; GO:0033320; GO:0042732; GO:0048040; GO:0070403	D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]		NA	NA	NA	NA	NA	NA
TRINITY_DN7292_c0_g1_i1	Q9ZV36	UXS6_ARATH	74.6	122	31	0	1	366	75	196	1.90E-51	203	UXS6_ARATH	reviewed	UDP-glucuronic acid decarboxylase 6 (EC 4.1.1.35) (UDP-XYL synthase 6) (UDP-glucuronate decarboxylase 6) (UGD) (UXS-6)	UXS6 At2g28760 F8N16.5	Arabidopsis thaliana (Mouse-ear cress)	343	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]; D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040]	GO:0005737; GO:0005777; GO:0005886; GO:0033320; GO:0042732; GO:0048040; GO:0070403	D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320]		NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i16	Q91280	UGT3_PLEPL	41.3	189	108	2	21	584	233	419	7.90E-39	161.8	UGT3_PLEPL	reviewed	UDP-glucuronosyltransferase (UDPGT) (EC 2.4.1.17) (Fragment)	ugt3	Pleuronectes platessa (European plaice)	472	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN9878_c0_g1_i6	Q64550	UD11_RAT	40.7	91	54	0	358	86	437	527	5.50E-13	75.5	UD11_RAT	reviewed	UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (B1) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1)	Ugt1a1 Ugt1	Rattus norvegicus (Rat)	535	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hormone stimulus [GO:0032870]; cellular response to xenobiotic stimulus [GO:0071466]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; xenobiotic glucuronidation [GO:0052697]	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]	GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005783; GO:0005789; GO:0005887; GO:0006789; GO:0006953; GO:0007584; GO:0010033; GO:0014070; GO:0015020; GO:0019899; GO:0031100; GO:0032496; GO:0032870; GO:0034663; GO:0042493; GO:0042594; GO:0042803; GO:0043231; GO:0045471; GO:0046982; GO:0048545; GO:0051384; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:0070069; GO:0070980; GO:0071361; GO:0071385; GO:0071392; GO:0071466; GO:2001030	acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hormone stimulus [GO:0032870]; cellular response to xenobiotic stimulus [GO:0071466]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; xenobiotic glucuronidation [GO:0052697]		NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i7	Q63886	UD11_MOUSE	40.7	113	67	0	46	384	365	477	1.90E-20	100.1	UD11_MOUSE	reviewed	UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UGTBR1)	Ugt1a1 Ugt1	Mus musculus (Mouse)	535	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; xenobiotic glucuronidation [GO:0052697]	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]	GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005783; GO:0005789; GO:0005887; GO:0006953; GO:0007584; GO:0010033; GO:0015020; GO:0019899; GO:0031100; GO:0032496; GO:0034663; GO:0042493; GO:0042594; GO:0042803; GO:0043231; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:0070069; GO:0070980; GO:0071361; GO:0071385; GO:0071392; GO:2001030	acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; xenobiotic glucuronidation [GO:0052697]		NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i9	Q63886	UD11_MOUSE	41.8	91	53	0	247	519	438	528	7.60E-13	75.5	UD11_MOUSE	reviewed	UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UGTBR1)	Ugt1a1 Ugt1	Mus musculus (Mouse)	535	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; xenobiotic glucuronidation [GO:0052697]	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]	GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005783; GO:0005789; GO:0005887; GO:0006953; GO:0007584; GO:0010033; GO:0015020; GO:0019899; GO:0031100; GO:0032496; GO:0034663; GO:0042493; GO:0042594; GO:0042803; GO:0043231; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:0070069; GO:0070980; GO:0071361; GO:0071385; GO:0071392; GO:2001030	acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic substance [GO:0010033]; response to starvation [GO:0042594]; xenobiotic glucuronidation [GO:0052697]		NA	NA	NA	NA	NA	NA
TRINITY_DN40399_c0_g1_i1	Q80X89	UD2A1_MOUSE	40.6	69	41	0	32	238	439	507	5.00E-06	51.6	UD2A1_MOUSE	reviewed	UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17)	Ugt2a1	Mus musculus (Mouse)	528	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	glucuronosyltransferase activity [GO:0015020]	GO:0007608; GO:0015020; GO:0016021; GO:0043231; GO:0050896	response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		NA	NA	NA	NA	NA	NA
TRINITY_DN9673_c0_g1_i10	Q5RFJ3	UD2A3_PONAB	47.2	53	28	0	176	18	437	489	3.00E-08	58.9	UD2A3_PONAB	reviewed	UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) (EC 2.4.1.17)	UGT2A3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	527	integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN9673_c0_g1_i3	P36512	UDB13_RABIT	37.2	296	164	4	1260	397	250	531	9.00E-54	212.6	UDB13_RABIT	reviewed	UDP-glucuronosyltransferase 2B13 (UDPGT 2B13) (EC 2.4.1.17) (EGT10)	UGT2B13	Oryctolagus cuniculus (Rabbit)	531	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i1	P36513	UDB14_RABIT	36.3	273	142	3	3	818	259	500	2.10E-49	197.6	UDB14_RABIT	reviewed	UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12)	UGT2B14	Oryctolagus cuniculus (Rabbit)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i10	P36513	UDB14_RABIT	39.8	254	150	2	88	846	249	500	1.70E-54	214.5	UDB14_RABIT	reviewed	UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12)	UGT2B14	Oryctolagus cuniculus (Rabbit)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i14	P36513	UDB14_RABIT	35.7	283	150	3	88	933	249	500	1.40E-49	198.4	UDB14_RABIT	reviewed	UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12)	UGT2B14	Oryctolagus cuniculus (Rabbit)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN18602_c0_g1_i8	P36513	UDB14_RABIT	40.2	254	149	2	88	846	249	500	1.50E-55	218	UDB14_RABIT	reviewed	UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12)	UGT2B14	Oryctolagus cuniculus (Rabbit)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN35953_c0_g1_i1	P36513	UDB14_RABIT	45.1	71	39	0	216	4	315	385	9.60E-14	77	UDB14_RABIT	reviewed	UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12)	UGT2B14	Oryctolagus cuniculus (Rabbit)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN9673_c0_g1_i7	P54855	UDB15_HUMAN	42.1	126	73	0	407	30	363	488	6.70E-25	115.2	UDB15_HUMAN	reviewed	UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3)	UGT2B15 UGT2B8	Homo sapiens (Human)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0006805; GO:0008202; GO:0015020; GO:0016021; GO:0043231; GO:0052695	cellular glucuronidation [GO:0052695]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN7860_c0_g1_i4	P54855	UDB15_HUMAN	38.2	267	159	3	802	2	268	528	1.30E-53	211.5	UDB15_HUMAN	reviewed	UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3)	UGT2B15 UGT2B8	Homo sapiens (Human)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0006805; GO:0008202; GO:0015020; GO:0016021; GO:0043231; GO:0052695	cellular glucuronidation [GO:0052695]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN7860_c0_g1_i5	P54855	UDB15_HUMAN	38.2	267	159	3	802	2	268	528	1.60E-53	211.5	UDB15_HUMAN	reviewed	UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3)	UGT2B15 UGT2B8	Homo sapiens (Human)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0006805; GO:0008202; GO:0015020; GO:0016021; GO:0043231; GO:0052695	cellular glucuronidation [GO:0052695]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN9673_c0_g1_i4	P36511	UDB15_RAT	36.5	74	46	1	309	88	246	318	3.90E-10	65.9	UDB15_RAT	reviewed	UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (UDP-glucuronosyltransferase 2B36) (UDPGT 2B36)	Ugt2b15 Ugt2b12 Ugt2b36 Ugt2b4	Rattus norvegicus (Rat)	530	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; aromatic compound catabolic process [GO:0019439]; response to drug [GO:0042493]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0008202; GO:0015020; GO:0016021; GO:0019439; GO:0042493; GO:0043231	aromatic compound catabolic process [GO:0019439]; response to drug [GO:0042493]; steroid metabolic process [GO:0008202]		NA	NA	NA	NA	NA	NA
TRINITY_DN9878_c0_g1_i3	P36514	UD2C1_RABIT	33.8	355	217	5	1129	86	159	502	6.40E-54	213	UD2C1_RABIT	reviewed	UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17) (Fragment)	UGT2C1 UGT2A2	Oryctolagus cuniculus (Rabbit)	502	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN9878_c0_g1_i7	P36514	UD2C1_RABIT	31.3	434	274	7	1348	86	80	502	7.10E-55	216.5	UD2C1_RABIT	reviewed	UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17) (Fragment)	UGT2C1 UGT2A2	Oryctolagus cuniculus (Rabbit)	502	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0015020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN30575_c0_g1_i1	O64765	UAP2_ARATH	45.7	127	59	1	352	2	125	251	1.30E-25	117.1	UAP2_ARATH	reviewed	UDP-N-acetylglucosamine diphosphorylase 2 (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridylyltransferase 2) (UDP-N-acetylgalactosamine diphosphorylase 2) (EC 2.7.7.83) (UTP--glucose-1-phosphate uridylyltransferase 2) (EC 2.7.7.9)	GLCNAC1PUT2 ATUAP1 At2g35020 F19I3.25	Arabidopsis thaliana (Mouse-ear cress)	502	cytoplasm [GO:0005737]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; uridylyltransferase activity [GO:0070569]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; embryo development ending in seed dormancy [GO:0009793]; embryo sac development [GO:0009553]; nucleotide-sugar biosynthetic process [GO:0009226]; pollen development [GO:0009555]; UDP-glucose metabolic process [GO:0006011]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytoplasm [GO:0005737]	UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; uridylyltransferase activity [GO:0070569]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]	GO:0003977; GO:0003983; GO:0005737; GO:0006011; GO:0006047; GO:0006048; GO:0009226; GO:0009553; GO:0009555; GO:0009793; GO:0019276; GO:0052630; GO:0070569	embryo development ending in seed dormancy [GO:0009793]; embryo sac development [GO:0009553]; nucleotide-sugar biosynthetic process [GO:0009226]; pollen development [GO:0009555]; UDP-glucose metabolic process [GO:0006011]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN6138_c0_g1_i1	Q96F25	ALG14_HUMAN	42.7	220	113	5	729	88	4	216	3.60E-42	173.3	ALG14_HUMAN	reviewed	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	ALG14	Homo sapiens (Human)	216	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]		GO:0005789; GO:0006488; GO:0016021; GO:0031965; GO:0043541	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]		blue	blue	NA	NA	NA	NA
TRINITY_DN6138_c0_g1_i2	Q6AY85	ALG14_RAT	51.8	112	54	0	423	88	105	216	2.40E-29	130.2	ALG14_RAT	reviewed	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	Alg14	Rattus norvegicus (Rat)	216	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]		GO:0006488; GO:0016021; GO:0031965; GO:0043541	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]		NA	NA	NA	NA	NA	NA
TRINITY_DN5643_c0_g1_i1	Q6AXR5	S35A3_RAT	47	287	114	5	858	4	68	318	2.90E-61	236.9	S35A3_RAT	reviewed	UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3)	Slc35a3	Rattus norvegicus (Rat)	326	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]	UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0005459; GO:0005794; GO:0008643; GO:0030173; GO:1990569	carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]		NA	NA	NA	NA	NA	NA
TRINITY_DN5643_c0_g1_i2	O77592	S35A3_CANLF	50.9	106	51	1	318	4	213	318	6.10E-23	108.2	S35A3_CANLF	reviewed	UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3)	SLC35A3	Canis lupus familiaris (Dog) (Canis familiaris)	326	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]	UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0005459; GO:0005794; GO:0008643; GO:0030173; GO:1990569	carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]		NA	NA	NA	NA	NA	NA
TRINITY_DN25717_c0_g1_i1	Q9Y2D2	S35A3_HUMAN	100	71	0	0	3	215	56	126	1.00E-31	136.7	S35A3_HUMAN	reviewed	UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3)	SLC35A3	Homo sapiens (Human)	325	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine metabolic process [GO:0006047]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]	GO:0000139; GO:0005459; GO:0005462; GO:0005794; GO:0006047; GO:0008643; GO:0030173; GO:1990569	carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine metabolic process [GO:0006047]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]		NA	NA	NA	NA	NA	NA
TRINITY_DN28717_c0_g1_i1	Q6AXR5	S35A3_RAT	45.9	61	32	1	11	193	226	285	3.80E-08	58.5	S35A3_RAT	reviewed	UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3)	Slc35a3	Rattus norvegicus (Rat)	326	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]	UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0005459; GO:0005794; GO:0008643; GO:0030173; GO:1990569	carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]		NA	NA	NA	NA	NA	NA
TRINITY_DN38407_c0_g1_i1	Q6AXR5	S35A3_RAT	61.4	70	27	0	228	19	90	159	1.50E-14	79.7	S35A3_RAT	reviewed	UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3)	Slc35a3	Rattus norvegicus (Rat)	326	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]	UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0005459; GO:0005794; GO:0008643; GO:0030173; GO:1990569	carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]		NA	NA	NA	NA	NA	NA
TRINITY_DN33188_c0_g1_i1	Q5EA65	GPT_BOVIN	65.5	87	30	0	268	8	222	308	8.80E-31	134	GPT_BOVIN	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	DPAGT1	Bos taurus (Bovine)	408	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]"	GO:0003975; GO:0005789; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019408; GO:0042802; GO:0046872	dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]		NA	NA	NA	NA	NA	NA
TRINITY_DN31176_c0_g1_i1	Q9H3H5	GPT_HUMAN	36.6	82	48	1	2	235	326	407	7.10E-07	54.3	GPT_HUMAN	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	DPAGT1 DPAGT2	Homo sapiens (Human)	408	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]"	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"	GO:0003975; GO:0003976; GO:0005789; GO:0006047; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019348; GO:0030176; GO:0042802; GO:0043231; GO:0046872	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		red	red	NA	NA	NA	NA
TRINITY_DN33841_c0_g1_i1	P24140	GPT_CRIGR	53	66	31	0	200	3	97	162	2.60E-15	82.4	GPT_CRIGR	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	DPAGT1 DPAGT2 GNPTA GTR2	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	408	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]"	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"	GO:0003975; GO:0003976; GO:0005789; GO:0006488; GO:0008963; GO:0016021; GO:0016757; GO:0019408; GO:0030176; GO:0042802; GO:0046872	dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]		NA	NA	NA	NA	NA	NA
TRINITY_DN36854_c0_g1_i1	Q9H3H5	GPT_HUMAN	100	91	0	0	1	273	230	320	2.50E-48	192.2	GPT_HUMAN	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	DPAGT1 DPAGT2	Homo sapiens (Human)	408	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]"	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"	GO:0003975; GO:0003976; GO:0005789; GO:0006047; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019348; GO:0030176; GO:0042802; GO:0043231; GO:0046872	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN11339_c0_g1_i1	Q9H3H5	GPT_HUMAN	50.6	162	78	2	581	99	6	166	8.40E-37	155.2	GPT_HUMAN	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	DPAGT1 DPAGT2	Homo sapiens (Human)	408	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]"	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"	GO:0003975; GO:0003976; GO:0005789; GO:0006047; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019348; GO:0030176; GO:0042802; GO:0043231; GO:0046872	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN11339_c0_g1_i2	P42867	GPT_MOUSE	53.8	405	185	2	1299	88	5	408	4.90E-116	419.5	GPT_MOUSE	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	Dpagt1 Dpagt2 Gnpta	Mus musculus (Mouse)	410	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"	GO:0003975; GO:0003976; GO:0005789; GO:0006047; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019348; GO:0043231; GO:0046872	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		blue	blue	NA	NA	NA	NA
TRINITY_DN33390_c0_g1_i1	Q9H3H5	GPT_HUMAN	100	121	0	0	3	365	33	153	4.70E-66	251.5	GPT_HUMAN	reviewed	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	DPAGT1 DPAGT2	Homo sapiens (Human)	408	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]"	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]"	GO:0003975; GO:0003976; GO:0005789; GO:0006047; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019348; GO:0030176; GO:0042802; GO:0043231; GO:0046872	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichol metabolic process [GO:0019348]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN40669_c0_g1_i1	O15294	OGT1_HUMAN	100	64	0	0	193	2	1	64	5.40E-30	131	OGT1_HUMAN	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	OGT	Homo sapiens (Human)	1046	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]"	cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]	"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0017122; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i10	Q8CGY8	OGT1_MOUSE	77.3	1036	209	5	88	3174	20	1036	0	1627.1	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i11	Q8CGY8	OGT1_MOUSE	75.5	886	195	5	671	3307	166	1036	0	1358.6	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i11	Q8CGY8	OGT1_MOUSE	79.2	183	33	2	187	735	23	200	1.60E-75	286.2	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i13	Q8CGY8	OGT1_MOUSE	78.2	1024	209	4	88	3138	20	1036	0	1634.8	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i15	Q8CGY8	OGT1_MOUSE	72.9	735	185	4	36	2219	309	1036	0	1091.6	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i2	Q8CGY8	OGT1_MOUSE	78.3	1021	208	4	187	3228	23	1036	0	1630.9	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i3	P56558	OGT1_RAT	84.5	168	25	1	157	657	2	169	9.30E-77	288.1	OGT1_RAT	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Rattus norvegicus (Rat)	1036	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0005547; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0030900; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032869; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097237; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i4	Q8CGY8	OGT1_MOUSE	74.6	897	195	5	671	3340	166	1036	0	1355.5	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i4	Q8CGY8	OGT1_MOUSE	89	155	17	0	187	651	23	177	8.10E-75	283.9	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i6	Q8CGY8	OGT1_MOUSE	74.6	897	195	5	581	3250	166	1036	0	1355.5	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i6	Q8CGY8	OGT1_MOUSE	88.6	158	18	0	88	561	20	177	5.50E-76	287.7	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i8	Q8CGY8	OGT1_MOUSE	75.5	886	195	5	581	3217	166	1036	0	1358.6	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i8	Q8CGY8	OGT1_MOUSE	79	186	34	2	88	645	20	200	8.30E-77	290.4	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0003824; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008080; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; circadian regulation of gene expression [GO:0032922]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN248_c0_g1_i9	P56558	OGT1_RAT	86.3	256	33	2	157	921	2	256	2.70E-124	446.4	OGT1_RAT	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Rattus norvegicus (Rat)	1036	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; zymogen granule [GO:0042588]	"identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]"	GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0005547; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0008134; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0030900; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032869; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0048029; GO:0048312; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097237; GO:0097363; GO:0120162; GO:1900038; GO:1900182; GO:1903428	apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN31930_c0_g1_i1	O15294	OGT1_HUMAN	97.1	68	2	0	1	204	636	703	2.60E-32	138.7	OGT1_HUMAN	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	OGT	Homo sapiens (Human)	1046	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]"	cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]	"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0017122; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN19553_c0_g1_i1	O15294	OGT1_HUMAN	100	168	0	0	1	504	828	995	6.10E-96	351.3	OGT1_HUMAN	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	OGT	Homo sapiens (Human)	1046	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]"	cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]	"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0017122; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN19553_c0_g2_i1	O15294	OGT1_HUMAN	100	103	0	0	1	309	811	913	2.40E-55	215.7	OGT1_HUMAN	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	OGT	Homo sapiens (Human)	1046	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]"	cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]	"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0017122; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN14507_c0_g1_i1	O15294	OGT1_HUMAN	100	669	0	0	2010	4	68	736	0	1379	OGT1_HUMAN	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	OGT	Homo sapiens (Human)	1046	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]"	cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein N-acetylglucosaminyltransferase complex [GO:0017122]	"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0017122; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN22572_c0_g1_i1	Q16222	UAP1_HUMAN	97.6	85	2	0	257	3	80	164	1.70E-41	169.5	UAP1_HUMAN	reviewed	UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]	UAP1 SPAG2	Homo sapiens (Human)	522	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0030246; GO:0042802; GO:0052630	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN32688_c0_g1_i1	Q16222	UAP1_HUMAN	61.5	405	140	2	1278	112	107	511	8.00E-145	515	UAP1_HUMAN	reviewed	UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]	UAP1 SPAG2	Homo sapiens (Human)	522	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0030246; GO:0042802; GO:0052630	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN32722_c0_g1_i1	Q16222	UAP1_HUMAN	100	70	0	0	213	4	234	303	3.90E-36	151.4	UAP1_HUMAN	reviewed	UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]	UAP1 SPAG2	Homo sapiens (Human)	522	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0030246; GO:0042802; GO:0052630	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN32688_c0_g1_i2	Q16222	UAP1_HUMAN	61.3	406	141	2	1224	55	107	512	1.00E-144	514.6	UAP1_HUMAN	reviewed	UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]	UAP1 SPAG2	Homo sapiens (Human)	522	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0030246; GO:0042802; GO:0052630	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		brown	brown	1	NA	NA	NA
TRINITY_DN22572_c0_g1_i2	Q91YN5	UAP1_MOUSE	99.2	123	1	0	371	3	80	202	1.80E-65	249.6	UAP1_MOUSE	reviewed	UDP-N-acetylhexosamine pyrophosphorylase [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23)]	Uap1	Mus musculus (Mouse)	522	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006047; GO:0006048; GO:0030246; GO:0042802; GO:0052630	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN33432_c0_g1_i1	Q91YN5	UAP1_MOUSE	99.1	110	1	0	331	2	332	441	3.50E-60	231.9	UAP1_MOUSE	reviewed	UDP-N-acetylhexosamine pyrophosphorylase [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23)]	Uap1	Mus musculus (Mouse)	522	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006047; GO:0006048; GO:0030246; GO:0042802; GO:0052630	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]		NA	NA	NA	NA	NA	NA
TRINITY_DN39346_c0_g1_i1	Q3TW96	UAP1L_MOUSE	100	84	0	0	253	2	230	313	1.00E-43	176.8	UAP1L_MOUSE	reviewed	UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-)	Uap1l1	Mus musculus (Mouse)	507	UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0006048	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN37000_c0_g1_i1	Q3TW96	UAP1L_MOUSE	100	97	0	0	3	293	79	175	1.00E-50	200.3	UAP1L_MOUSE	reviewed	UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-)	Uap1l1	Mus musculus (Mouse)	507	UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0006048	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		NA	NA	NA	NA	NA	NA
TRINITY_DN2768_c1_g1_i1	Q9W429	S35B4_DROME	59.2	98	40	0	414	121	234	331	4.30E-23	109	S35B4_DROME	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (ER GDP-fucose transporter) (Solute carrier family 35 member B4 homolog)	Efr CG3774	Drosophila melanogaster (Fruit fly)	352	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0005457; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0008643; GO:0015012; GO:0015782; GO:0015783; GO:0015786; GO:0015787; GO:0015790; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0036066; GO:0036084; GO:1990569; GO:1990570	carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]		NA	NA	NA	NA	NA	NA
TRINITY_DN2768_c1_g1_i2	Q9W429	S35B4_DROME	59.2	98	40	0	396	103	234	331	4.10E-23	109	S35B4_DROME	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (ER GDP-fucose transporter) (Solute carrier family 35 member B4 homolog)	Efr CG3774	Drosophila melanogaster (Fruit fly)	352	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0005457; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0008643; GO:0015012; GO:0015782; GO:0015783; GO:0015786; GO:0015787; GO:0015790; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0036066; GO:0036084; GO:1990569; GO:1990570	carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]		NA	NA	NA	NA	NA	NA
TRINITY_DN2169_c0_g1_i1	Q7ZW46	S35B4_DANRE	54.5	323	139	3	115	1068	1	320	1.10E-94	348.2	S35B4_DANRE	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4)	slc35b4 zgc:55288	Danio rerio (Zebrafish) (Brachydanio rerio)	331	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0005462; GO:0005464; GO:0008643; GO:0022857; GO:0030173; GO:0030176	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN30959_c0_g1_i1	Q8CIA5	S35B4_MOUSE	98.6	69	1	0	51	257	1	69	1.70E-33	142.9	S35B4_MOUSE	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4)	Slc35b4 MNCb-4414	Mus musculus (Mouse)	331	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0006111; GO:0008643; GO:0015790; GO:0022857; GO:0030173; GO:0030176; GO:1990569	carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]		NA	NA	NA	NA	NA	NA
TRINITY_DN15895_c0_g1_i1	Q7ZW46	S35B4_DANRE	48.5	134	64	2	424	23	99	227	1.30E-26	120.9	S35B4_DANRE	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4)	slc35b4 zgc:55288	Danio rerio (Zebrafish) (Brachydanio rerio)	331	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0005462; GO:0005464; GO:0008643; GO:0022857; GO:0030173; GO:0030176	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN15895_c0_g1_i2	Q7ZW46	S35B4_DANRE	51.7	232	107	2	718	23	1	227	1.50E-58	227.6	S35B4_DANRE	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4)	slc35b4 zgc:55288	Danio rerio (Zebrafish) (Brachydanio rerio)	331	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0005462; GO:0005464; GO:0008643; GO:0022857; GO:0030173; GO:0030176	carbohydrate transport [GO:0008643]		NA	NA	NA	NA	NA	NA
TRINITY_DN41097_c0_g1_i1	Q969S0	S35B4_HUMAN	100	90	0	0	270	1	225	314	2.40E-43	175.6	S35B4_HUMAN	reviewed	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4) (YEA4 homolog)	SLC35B4 YEA4 PSEC0055	Homo sapiens (Human)	331	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]	GO:0000139; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0006111; GO:0008643; GO:0015790; GO:0022857; GO:0030173; GO:0030176; GO:1990569	carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]		NA	NA	NA	NA	NA	NA
TRINITY_DN21922_c0_g1_i1	Q6BDS2	URFB1_HUMAN	55.4	148	65	1	24	467	1	147	4.00E-39	162.5	URFB1_HUMAN	reviewed	UHRF1-binding protein 1 (ICBP90-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1)	UHRF1BP1 C6orf107	Homo sapiens (Human)	1440	histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]		histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]	GO:0042802; GO:0042826			NA	NA	NA	NA	NA	NA
TRINITY_DN21922_c0_g1_i2	Q6BDS2	URFB1_HUMAN	52.6	133	62	1	146	544	16	147	3.20E-32	139.8	URFB1_HUMAN	reviewed	UHRF1-binding protein 1 (ICBP90-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1)	UHRF1BP1 C6orf107	Homo sapiens (Human)	1440	histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]		histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]	GO:0042802; GO:0042826			NA	NA	NA	NA	NA	NA
TRINITY_DN7180_c0_g1_i1	Q6BDS2	URFB1_HUMAN	32.2	289	165	10	4	813	314	590	2.90E-32	140.6	URFB1_HUMAN	reviewed	UHRF1-binding protein 1 (ICBP90-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1)	UHRF1BP1 C6orf107	Homo sapiens (Human)	1440	histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]		histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]	GO:0042802; GO:0042826			NA	NA	NA	NA	NA	NA
TRINITY_DN21922_c0_g1_i3	Q6NRZ1	UH1BL_XENLA	50	290	140	3	24	881	1	289	2.00E-73	277.3	UH1BL_XENLA	reviewed	UHRF1-binding protein 1-like	uhrf1bp1l	Xenopus laevis (African clawed frog)	1415	cytosol [GO:0005829]; early endosome [GO:0005769]	cytosol [GO:0005829]; early endosome [GO:0005769]		GO:0005769; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN21922_c0_g1_i4	Q6NRZ1	UH1BL_XENLA	48	275	138	3	146	958	16	289	2.50E-66	253.8	UH1BL_XENLA	reviewed	UHRF1-binding protein 1-like	uhrf1bp1l	Xenopus laevis (African clawed frog)	1415	cytosol [GO:0005829]; early endosome [GO:0005769]	cytosol [GO:0005829]; early endosome [GO:0005769]		GO:0005769; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN28308_c0_g1_i1	A2RSJ4	UH1BL_MOUSE	97.3	75	2	0	227	3	10	84	1.60E-35	149.4	UH1BL_MOUSE	reviewed	UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa)	Uhrf1bp1l Kiaa0701 Ship164	Mus musculus (Mouse)	1457	cytosol [GO:0005829]; early endosome [GO:0005769]; GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803]	cytosol [GO:0005829]; early endosome [GO:0005769]	GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005829; GO:0042803; GO:0062069			NA	NA	NA	NA	NA	NA
TRINITY_DN27297_c0_g1_i1	P30085	KCY_HUMAN	100	171	0	0	515	3	1	171	2.70E-95	349.4	KCY_HUMAN	reviewed	UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)	CMPK1 CMK CMPK UCK UMK UMPK	Homo sapiens (Human)	196	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; UMP kinase activity [GO:0033862]; uridine kinase activity [GO:0004849]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; UMP kinase activity [GO:0033862]; uridine kinase activity [GO:0004849]	GO:0004127; GO:0004550; GO:0004849; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006163; GO:0006165; GO:0006207; GO:0006225; GO:0009142; GO:0009220; GO:0015949; GO:0033862; GO:0046705; GO:0070062	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; purine nucleotide metabolic process [GO:0006163]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225]		NA	NA	NA	NA	NA	NA
TRINITY_DN39448_c0_g1_i1	Q7ZX23	KCY_XENLA	49.6	123	60	1	370	8	50	172	7.50E-27	121.3	KCY_XENLA	reviewed	UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)	cmpk1 cmpk	Xenopus laevis (African clawed frog)	193	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]	GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006207; GO:0006221; GO:0009041; GO:0009142	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]		NA	NA	NA	NA	NA	NA
TRINITY_DN6814_c0_g1_i1	Q20230	KCY2_CAEEL	63.6	187	64	2	150	707	2	185	1.00E-65	251.5	KCY2_CAEEL	reviewed	UMP-CMP kinase 2 (EC 2.7.4.14) (Deoxycytidylate kinase 2) (CK 2) (dCMP kinase 2) (Uridine monophosphate/cytidine monophosphate kinase 2) (UMP/CMP kinase 2) (UMP/CMPK 2)	F40F8.1	Caenorhabditis elegans	191	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; UMP kinase activity [GO:0033862]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; purine nucleotide metabolic process [GO:0006163]; UDP biosynthetic process [GO:0006225]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; UMP kinase activity [GO:0033862]	GO:0004127; GO:0005524; GO:0005634; GO:0005737; GO:0006163; GO:0006207; GO:0006225; GO:0033862; GO:0046705	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; purine nucleotide metabolic process [GO:0006163]; UDP biosynthetic process [GO:0006225]		blue	blue	NA	NA	NA	NA
TRINITY_DN2628_c0_g1_i1	Q9VZI3	UN112_DROME	58	628	219	14	1890	109	91	707	2.80E-194	679.9	UN112_DROME	reviewed	Unc-112-related protein (Fermitin-1)	Fit1 CG14991	Drosophila melanogaster (Fruit fly)	708	cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]	cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]	cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]	GO:0005178; GO:0005737; GO:0007160; GO:0007229; GO:0030055; GO:0048738; GO:0050829; GO:0050839	cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]		blue	blue	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i11	Q9Y115	UN93L_DROME	51.6	93	45	0	47	325	326	418	1.30E-23	110.5	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i2	Q9Y115	UN93L_DROME	50.5	93	46	0	47	325	326	418	3.90E-22	105.5	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i4	Q9Y115	UN93L_DROME	51.6	93	45	0	3	281	326	418	3.40E-23	109	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i6	Q9Y115	UN93L_DROME	52.7	93	44	0	47	325	326	418	4.40E-24	112.1	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i7	Q9Y115	UN93L_DROME	49.5	107	54	0	47	367	326	432	1.70E-26	120.2	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c0_g1_i9	Q9Y115	UN93L_DROME	49.5	93	47	0	47	325	326	418	8.70E-23	107.8	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN3898_c1_g1_i1	Q9Y115	UN93L_DROME	54.3	94	43	0	315	34	323	416	2.20E-27	122.9	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN28009_c0_g1_i1	Q9Y115	UN93L_DROME	59.8	164	64	1	521	36	38	201	7.60E-47	188.3	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5184_c0_g1_i1	Q9Y115	UN93L_DROME	55.8	86	38	0	1	258	395	480	1.70E-22	106.7	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i1	Q9Y115	UN93L_DROME	49.2	236	117	2	710	9	245	479	3.30E-63	243	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i10	Q9Y115	UN93L_DROME	49	204	103	1	620	9	277	479	2.00E-54	213.8	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i14	Q9Y115	UN93L_DROME	50	72	36	0	275	60	409	480	1.40E-14	80.1	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i15	Q9Y115	UN93L_DROME	46.4	412	201	6	1259	60	77	480	1.90E-96	354.4	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i19	Q9Y115	UN93L_DROME	47.8	134	69	1	404	3	277	409	1.50E-32	140.6	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i23	Q9Y115	UN93L_DROME	48.5	237	119	2	764	60	245	480	3.90E-62	239.6	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i24	Q9Y115	UN93L_DROME	46.6	451	214	6	1319	9	42	479	2.70E-106	387.1	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i25	Q9Y115	UN93L_DROME	57.5	80	34	0	319	80	77	156	1.60E-17	90.5	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i5	Q9Y115	UN93L_DROME	49	204	103	1	620	9	277	479	4.10E-55	216.1	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5765_c1_g1_i8	Q9Y115	UN93L_DROME	45.7	341	165	6	989	3	77	409	2.60E-75	283.9	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5883_c0_g1_i1	Q9Y115	UN93L_DROME	55	40	18	0	76	195	156	195	1.20E-05	50.4	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN5883_c0_g1_i4	Q9Y115	UN93L_DROME	52.5	40	19	0	76	195	156	195	2.60E-05	49.3	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN6278_c0_g1_i2	Q9Y115	UN93L_DROME	50.6	83	41	0	271	23	77	159	1.40E-14	80.5	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN6278_c0_g1_i4	Q9Y115	UN93L_DROME	51.9	81	39	0	274	32	77	157	8.10E-15	81.3	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN6278_c0_g1_i5	Q9Y115	UN93L_DROME	53.1	81	38	0	274	32	77	157	1.60E-15	83.6	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN6278_c0_g1_i6	Q9Y115	UN93L_DROME	51.9	81	39	0	274	32	77	157	1.40E-14	80.5	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN6278_c0_g1_i7	Q9Y115	UN93L_DROME	50.6	83	41	0	271	23	77	159	1.40E-14	80.5	UN93L_DROME	reviewed	UNC93-like protein	CG4928	Drosophila melanogaster (Fruit fly)	538	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]	potassium channel regulator activity [GO:0015459]	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]		NA	NA	NA	NA	NA	NA
TRINITY_DN29706_c0_g1_i1	Q8BJ51	MFS11_MOUSE	46.8	436	212	4	1388	132	4	436	2.90E-106	387.1	MFS11_MOUSE	reviewed	UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET)	Mfsd11 Et	Mus musculus (Mouse)	449	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN226_c4_g1_i4	O14325	YB7A_SCHPO	37.2	298	159	6	812	3	239	536	5.30E-49	196.1	YB7A_SCHPO	reviewed	Uncharacterized AAA domain-containing protein C16E9.10c	SPBC16E9.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	779	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005730; GO:0016887; GO:0042254; GO:0051973; GO:1990275	positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c4_g1_i7	O14325	YB7A_SCHPO	40.1	242	118	5	645	1	309	550	3.60E-40	166.4	YB7A_SCHPO	reviewed	Uncharacterized AAA domain-containing protein C16E9.10c	SPBC16E9.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	779	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005730; GO:0016887; GO:0042254; GO:0051973; GO:1990275	positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN30300_c0_g1_i1	O14325	YB7A_SCHPO	62.8	121	38	1	618	277	466	586	3.70E-37	156.4	YB7A_SCHPO	reviewed	Uncharacterized AAA domain-containing protein C16E9.10c	SPBC16E9.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	779	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005730; GO:0016887; GO:0042254; GO:0051973; GO:1990275	positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN30300_c0_g1_i1	O14325	YB7A_SCHPO	61.4	101	39	0	320	18	585	685	3.50E-27	123.2	YB7A_SCHPO	reviewed	Uncharacterized AAA domain-containing protein C16E9.10c	SPBC16E9.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	779	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005730; GO:0016887; GO:0042254; GO:0051973; GO:1990275	positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN18812_c0_g1_i1	O14325	YB7A_SCHPO	55.9	68	30	0	209	6	499	566	7.50E-16	84	YB7A_SCHPO	reviewed	Uncharacterized AAA domain-containing protein C16E9.10c	SPBC16E9.10c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	779	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	GO:0000055; GO:0005524; GO:0005634; GO:0005730; GO:0016887; GO:0042254; GO:0051973; GO:1990275	positive regulation of telomerase activity [GO:0051973]; ribosomal large subunit export from nucleus [GO:0000055]; ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN14525_c1_g1_i1	Q7Z695	ADCK2_HUMAN	51.6	124	58	2	468	97	93	214	2.70E-28	127.5	ADCK2_HUMAN	reviewed	Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-)	ADCK2 AARF	Homo sapiens (Human)	626	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14525_c1_g1_i2	Q7Z695	ADCK2_HUMAN	53	83	37	2	249	1	134	214	1.20E-19	97.1	ADCK2_HUMAN	reviewed	Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-)	ADCK2 AARF	Homo sapiens (Human)	626	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14525_c1_g1_i3	Q7Z695	ADCK2_HUMAN	38.5	624	287	14	1948	80	93	620	5.00E-103	377.1	ADCK2_HUMAN	reviewed	Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-)	ADCK2 AARF	Homo sapiens (Human)	626	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN14525_c1_g1_i4	Q7Z695	ADCK2_HUMAN	36.1	521	237	13	1602	40	93	517	3.20E-74	281.2	ADCK2_HUMAN	reviewed	Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-)	ADCK2 AARF	Homo sapiens (Human)	626	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i1	Q80V03	ADCK5_MOUSE	48.7	556	265	6	1737	118	18	569	4.10E-147	523.1	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i2	Q80V03	ADCK5_MOUSE	44.8	592	285	9	1845	118	4	569	2.30E-135	484.2	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i3	Q80V03	ADCK5_MOUSE	45.2	591	281	10	1836	118	4	569	1.90E-134	481.1	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i4	Q80V03	ADCK5_MOUSE	51.2	422	194	4	1601	360	4	421	1.00E-120	435.3	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i5	Q80V03	ADCK5_MOUSE	46.1	505	238	7	2026	536	4	482	1.40E-122	441.8	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i5	Q80V03	ADCK5_MOUSE	33.8	204	121	4	690	118	367	569	8.50E-19	97.1	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN184_c0_g1_i6	Q80V03	ADCK5_MOUSE	51.8	407	185	3	1556	360	18	421	4.00E-120	433.3	ADCK5_MOUSE	reviewed	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	Adck5	Mus musculus (Mouse)	582	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN40300_c0_g1_i1	O42943	YBP8_SCHPO	62.2	82	31	0	5	250	203	284	8.10E-25	114	YBP8_SCHPO	reviewed	Uncharacterized ABC transporter ATP-binding protein C16H5.08c	SPBC16H5.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	618	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosomal small subunit export from nucleus [GO:0000056]	cytosol [GO:0005829]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0000056; GO:0005524; GO:0005829; GO:0016887	ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN12246_c0_g1_i1	O42943	YBP8_SCHPO	62.1	124	47	0	4	375	186	309	1.10E-41	170.6	YBP8_SCHPO	reviewed	Uncharacterized ABC transporter ATP-binding protein C16H5.08c	SPBC16H5.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	618	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosomal small subunit export from nucleus [GO:0000056]	cytosol [GO:0005829]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0000056; GO:0005524; GO:0005829; GO:0016887	ribosomal small subunit export from nucleus [GO:0000056]		NA	NA	NA	NA	NA	NA
TRINITY_DN3382_c0_g1_i1	Q57180	Y1051_HAEIN	80.8	104	20	0	7	318	476	579	4.90E-38	158.3	Y1051_HAEIN	reviewed	Uncharacterized ABC transporter ATP-binding protein HI_1051	HI_1051	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	614	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0034040; GO:0042626; GO:0055085	transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	1
TRINITY_DN32775_c0_g1_i1	P36879	YADG_ECOLI	54.5	66	30	0	199	2	4	69	6.50E-15	80.9	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN15204_c0_g1_i1	P36879	YADG_ECOLI	54.1	74	34	0	20	241	121	194	4.90E-19	94.7	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	1
TRINITY_DN38098_c0_g1_i1	P36879	YADG_ECOLI	47.6	82	43	0	5	250	5	86	2.70E-15	82.4	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN29008_c0_g1_i1	P36879	YADG_ECOLI	61.6	86	33	0	275	18	130	215	4.00E-25	115.2	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4923_c0_g1_i1	P36879	YADG_ECOLI	59.7	67	27	0	5	205	121	187	1.00E-17	90.1	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN4923_c0_g2_i1	P36879	YADG_ECOLI	66.2	80	27	0	5	244	121	200	4.70E-25	114.8	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN30601_c0_g1_i1	P36879	YADG_ECOLI	52.6	78	37	0	4	237	118	195	1.70E-19	96.3	YADG_ECOLI	reviewed	Uncharacterized ABC transporter ATP-binding protein YadG	yadG b0127 JW0123	Escherichia coli (strain K12)	308	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to X-ray [GO:0010165]	plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005886; GO:0010165; GO:0016887	response to X-ray [GO:0010165]		NA	NA	NA	NA	NA	NA
TRINITY_DN7933_c0_g1_i1	P0A9T9	YBBA_ECO57	64.7	68	24	0	1	204	130	197	2.70E-18	92	YBBA_ECO57	reviewed	Uncharacterized ABC transporter ATP-binding protein YbbA	ybbA Z0648 ECs0557	Escherichia coli O157:H7	228	ATP binding [GO:0005524]; ATPase activity [GO:0016887]		ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN35472_c0_g1_i1	C0SPB0	YTCI_BACSU	58.7	109	45	0	334	8	398	506	4.20E-29	128.6	YTCI_BACSU	reviewed	Uncharacterized acyl--CoA ligase YtcI (EC 6.2.1.-)	ytcI BSU29560	Bacillus subtilis (strain 168)	529	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]	GO:0003996; GO:0004321; GO:0005524; GO:0006633; GO:0006637; GO:0015645	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]		NA	NA	NA	NA	NA	NA
TRINITY_DN28160_c0_g1_i1	O60177	YG42_SCHPO	58.2	79	33	0	237	1	925	1003	4.40E-20	98.2	YG42_SCHPO	reviewed	Uncharacterized ATP-dependent helicase C23E6.02 (EC 3.6.4.-)	SPBC23E6.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1040	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-DNA unloading ATPase activity [GO:0140083]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic DNA replication maintenance of fidelity [GO:1990505]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein modification by small protein conjugation or removal [GO:0070647]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-DNA unloading ATPase activity [GO:0140083]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000724; GO:0000790; GO:0003678; GO:0005524; GO:0005634; GO:0005737; GO:0006281; GO:0008270; GO:0032435; GO:0061630; GO:0070647; GO:0140083; GO:1990505	DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic DNA replication maintenance of fidelity [GO:1990505]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein modification by small protein conjugation or removal [GO:0070647]		NA	NA	NA	NA	NA	NA
TRINITY_DN37242_c0_g1_i1	Q57568	Y104_METJA	38.5	78	43	1	234	1	584	656	3.30E-12	72	Y104_METJA	reviewed	Uncharacterized ATP-dependent helicase MJ0104 (EC 3.6.4.-)	MJ0104	Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)	663	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]		ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]	GO:0003677; GO:0004386; GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN29404_c0_g1_i1	Q550W1	CAPTC_DICDI	46.8	77	41	0	7	237	62	138	2.70E-14	79	CAPTC_DICDI	reviewed	Uncharacterized CDP-alcohol phosphatidyltransferase class-I family protein 3 (Developmental gene 1056 protein)	captC DG1056 lipB DDB_G0276763	Dictyostelium discoideum (Slime mold)	399	"integral component of membrane [GO:0016021]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; phospholipid biosynthetic process [GO:0008654]"	integral component of membrane [GO:0016021]	"phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0008654; GO:0016021; GO:0016780	phospholipid biosynthetic process [GO:0008654]		NA	NA	NA	NA	NA	NA
TRINITY_DN38128_c0_g1_i1	O13901	YF3A_SCHPO	62.3	61	23	0	185	3	78	138	2.70E-15	82	YF3A_SCHPO	reviewed	Uncharacterized CDP-alcohol phosphatidyltransferase class-I family protein C22A12.10	SPAC22A12.10	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	386	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]	GO:0004142; GO:0004307; GO:0005783; GO:0005789; GO:0006646; GO:0006656; GO:0016021	phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]		NA	NA	NA	NA	NA	NA
TRINITY_DN34086_c0_g1_i1	O94443	YFE9_SCHPO	45.2	62	34	0	202	17	279	340	4.10E-11	68.2	YFE9_SCHPO	reviewed	Uncharacterized exonuclease C637.09 (EC 3.1.-.-)	SPAC637.09	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	631	"nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; tRNA 3'-trailer cleavage, exonucleolytic [GO:0034415]; U5 snRNA 3'-end processing [GO:0034476]"	nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0000175; GO:0000467; GO:0003676; GO:0004527; GO:0005634; GO:0034415; GO:0034476	"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; tRNA 3'-trailer cleavage, exonucleolytic [GO:0034415]; U5 snRNA 3'-end processing [GO:0034476]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23125_c0_g1_i1	Q8W566	Y3514_ARATH	37.9	66	41	0	9	206	254	319	3.80E-07	55.1	Y3514_ARATH	reviewed	Uncharacterized exonuclease domain-containing protein At3g15140 (EC 3.1.-.-)	At3g15140 F4B12.5	Arabidopsis thaliana (Mouse-ear cress)	337	"mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of production of siRNA involved in RNA interference [GO:0090065]"	mitochondrion [GO:0005739]	"3'-5'-exoribonuclease activity [GO:0000175]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"	GO:0000175; GO:0000467; GO:0000738; GO:0003676; GO:0005739; GO:0016891; GO:0035194; GO:0046872; GO:0090065	"DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of production of siRNA involved in RNA interference [GO:0090065]"		NA	NA	NA	NA	NA	NA
TRINITY_DN728_c0_g1_i1	Q8IQC1	TVP23_DROME	45.7	188	94	3	637	86	37	220	3.90E-42	172.9	TVP23_DROME	reviewed	Uncharacterized Golgi apparatus membrane protein-like protein CG5021	CG5021	Drosophila melanogaster (Fruit fly)	223	integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	integral component of Golgi membrane [GO:0030173]		GO:0009306; GO:0016192; GO:0030173	protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN728_c0_g1_i2	Q8IQC1	TVP23_DROME	45.2	188	91	3	625	86	37	220	4.20E-41	169.5	TVP23_DROME	reviewed	Uncharacterized Golgi apparatus membrane protein-like protein CG5021	CG5021	Drosophila melanogaster (Fruit fly)	223	integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	integral component of Golgi membrane [GO:0030173]		GO:0009306; GO:0016192; GO:0030173	protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN33109_c0_g1_i1	P34280	YKK3_CAEEL	59.5	158	63	1	474	4	1	158	1.40E-47	190.7	YKK3_CAEEL	reviewed	Uncharacterized GTP-binding protein C02F5.3	C02F5.3	Caenorhabditis elegans	366	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]	GTP binding [GO:0005525]	GO:0002181; GO:0005525; GO:0005737	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN37043_c0_g1_i1	Q9P7T8	YIW2_SCHPO	57.9	76	32	0	229	2	1226	1301	2.50E-20	99	YIW2_SCHPO	reviewed	Uncharacterized helicase C694.02 (EC 3.6.4.-)	SPAC694.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1717	cytosol [GO:0005829]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	cytosol [GO:0005829]	ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN37107_c0_g1_i1	Q10209	YAY1_SCHPO	66.7	66	21	1	21	215	6	71	1.20E-16	86.7	YAY1_SCHPO	reviewed	Uncharacterized J domain-containing protein C4H3.01	SPAC4H3.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	392	cell division site [GO:0032153]; cell tip [GO:0051286]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; Hsp70 protein binding [GO:0030544]; protein import into peroxisome matrix [GO:0016558]; protein insertion into mitochondrial outer membrane [GO:0045040]	cell division site [GO:0032153]; cell tip [GO:0051286]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	Hsp70 protein binding [GO:0030544]	GO:0005739; GO:0005829; GO:0016558; GO:0030544; GO:0032153; GO:0045040; GO:0051286	protein import into peroxisome matrix [GO:0016558]; protein insertion into mitochondrial outer membrane [GO:0045040]		NA	NA	NA	NA	NA	NA
TRINITY_DN1347_c0_g1_i1	O42976	YGZ7_SCHPO	39.6	111	66	1	639	971	193	302	1.60E-19	99.4	YGZ7_SCHPO	reviewed	Uncharacterized membrane protein C20F10.07	SPBC20F10.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	764	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nucleus-vacuole junction [GO:0071561]; vacuole-mitochondrion membrane contact site [GO:1990816]; sterol transfer activity [GO:0120015]; intermembrane sterol transfer [GO:0120011]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nucleus-vacuole junction [GO:0071561]; vacuole-mitochondrion membrane contact site [GO:1990816]	sterol transfer activity [GO:0120015]	GO:0005737; GO:0016021; GO:0044233; GO:0071561; GO:0120011; GO:0120015; GO:1990816	intermembrane sterol transfer [GO:0120011]		NA	NA	NA	NA	NA	NA
TRINITY_DN1347_c0_g1_i2	O42976	YGZ7_SCHPO	39.6	111	66	1	317	649	193	302	1.30E-19	99.4	YGZ7_SCHPO	reviewed	Uncharacterized membrane protein C20F10.07	SPBC20F10.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	764	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nucleus-vacuole junction [GO:0071561]; vacuole-mitochondrion membrane contact site [GO:1990816]; sterol transfer activity [GO:0120015]; intermembrane sterol transfer [GO:0120011]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nucleus-vacuole junction [GO:0071561]; vacuole-mitochondrion membrane contact site [GO:1990816]	sterol transfer activity [GO:0120015]	GO:0005737; GO:0016021; GO:0044233; GO:0071561; GO:0120011; GO:0120015; GO:1990816	intermembrane sterol transfer [GO:0120011]		NA	NA	NA	NA	NA	NA
TRINITY_DN1347_c0_g1_i3	O42976	YGZ7_SCHPO	39.6	111	66	1	346	678	193	302	1.30E-19	99.4	YGZ7_SCHPO	reviewed	Uncharacterized membrane protein C20F10.07	SPBC20F10.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	764	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nucleus-vacuole junction [GO:0071561]; vacuole-mitochondrion membrane contact site [GO:1990816]; sterol transfer activity [GO:0120015]; intermembrane sterol transfer [GO:0120011]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nucleus-vacuole junction [GO:0071561]; vacuole-mitochondrion membrane contact site [GO:1990816]	sterol transfer activity [GO:0120015]	GO:0005737; GO:0016021; GO:0044233; GO:0071561; GO:0120011; GO:0120015; GO:1990816	intermembrane sterol transfer [GO:0120011]		NA	NA	NA	NA	NA	NA
TRINITY_DN11373_c0_g1_i1	P92523	M860_ARATH	42.7	75	42	1	226	450	49	122	1.60E-10	67.4	M860_ARATH	reviewed	Uncharacterized mitochondrial protein AtMg00860 (ORF158)	AtMg00860	Arabidopsis thaliana (Mouse-ear cress)	158	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN11373_c0_g1_i1	P92523	M860_ARATH	41.9	93	50	3	284	9	33	122	7.80E-10	65.1	M860_ARATH	reviewed	Uncharacterized mitochondrial protein AtMg00860 (ORF158)	AtMg00860	Arabidopsis thaliana (Mouse-ear cress)	158	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN11373_c0_g1_i2	P92523	M860_ARATH	42.7	75	42	1	233	9	49	122	1.60E-10	67.4	M860_ARATH	reviewed	Uncharacterized mitochondrial protein AtMg00860 (ORF158)	AtMg00860	Arabidopsis thaliana (Mouse-ear cress)	158	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN11373_c0_g1_i2	P92523	M860_ARATH	41.9	93	50	3	175	450	33	122	7.80E-10	65.1	M860_ARATH	reviewed	Uncharacterized mitochondrial protein AtMg00860 (ORF158)	AtMg00860	Arabidopsis thaliana (Mouse-ear cress)	158	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN5946_c0_g1_i1	P73056	YC64L_SYNY3	62.4	85	32	0	255	1	18	102	5.20E-27	121.3	YC64L_SYNY3	reviewed	Uncharacterized monothiol glutaredoxin ycf64-like	slr1846	Synechocystis sp. (strain PCC 6803 / Kazusa)	107	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]"	GO:0009055; GO:0015035; GO:0046872; GO:0051537			NA	NA	NA	NA	NA	NA
TRINITY_DN30219_c0_g1_i1	P25145	Y432_LISMO	55.6	54	24	0	45	206	3	56	2.70E-08	58.9	Y432_LISMO	reviewed	Uncharacterized oxidoreductase Lmo0432 (EC 1.-.-.-) (ORFA)	lmo0432	Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e)	248	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN37665_c0_g1_i1	A0QV10	Y2408_MYCS2	60.5	86	34	0	2	259	26	111	1.90E-24	112.8	Y2408_MYCS2	reviewed	Uncharacterized oxidoreductase MSMEG_2408/MSMEI_2347 (EC 1.-.-.-)	MSMEG_2408 MSMEI_2347	Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium smegmatis)	275	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN27590_c0_g1_i1	O05389	YRBE_BACSU	47.4	78	40	1	67	297	168	245	3.00E-14	79.3	YRBE_BACSU	reviewed	Uncharacterized oxidoreductase YrbE (EC 1.-.-.-)	yrbE BSU27770	Bacillus subtilis (strain 168)	341	cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740]	cytoplasm [GO:0005737]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0006740; GO:0016491	NADPH regeneration [GO:0006740]		brown	brown	NA	NA	NA	NA
TRINITY_DN35900_c0_g1_i1	P42317	YXJF_BACSU	47.4	57	30	0	5	175	133	189	2.20E-07	55.8	YXJF_BACSU	reviewed	Uncharacterized oxidoreductase YxjF (EC 1.-.-.-)	yxjF BSU38970 N15M	Bacillus subtilis (strain 168)	257	"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; oxidation-reduction process [GO:0055114]"		"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0003858; GO:0016616; GO:0055114	oxidation-reduction process [GO:0055114]		NA	NA	NA	NA	NA	NA
TRINITY_DN4694_c0_g1_i1	Q09632	YOF5_CAEEL	47.6	286	146	3	11	865	6	288	1.40E-74	281.2	YOF5_CAEEL	reviewed	Uncharacterized oxidoreductase ZK1290.5 (EC 1.-.-.-)	ZK1290.5	Caenorhabditis elegans	321	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN4694_c0_g1_i2	Q09632	YOF5_CAEEL	48.4	182	93	1	11	556	6	186	8.80E-50	198.7	YOF5_CAEEL	reviewed	Uncharacterized oxidoreductase ZK1290.5 (EC 1.-.-.-)	ZK1290.5	Caenorhabditis elegans	321	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN4694_c0_g1_i2	Q09632	YOF5_CAEEL	45.1	91	47	2	561	830	200	288	5.00E-13	76.6	YOF5_CAEEL	reviewed	Uncharacterized oxidoreductase ZK1290.5 (EC 1.-.-.-)	ZK1290.5	Caenorhabditis elegans	321	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN4694_c0_g1_i5	Q09632	YOF5_CAEEL	43.9	228	124	3	65	745	64	288	5.50E-51	202.6	YOF5_CAEEL	reviewed	Uncharacterized oxidoreductase ZK1290.5 (EC 1.-.-.-)	ZK1290.5	Caenorhabditis elegans	321	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN4694_c0_g1_i6	Q09632	YOF5_CAEEL	45.7	105	54	2	58	369	186	288	9.50E-18	91.3	YOF5_CAEEL	reviewed	Uncharacterized oxidoreductase ZK1290.5 (EC 1.-.-.-)	ZK1290.5	Caenorhabditis elegans	321	cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	cytosol [GO:0005829]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]	GO:0004032; GO:0005829; GO:0008106; GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN28777_c1_g1_i1	P90850	YCF2E_CAEEL	44	75	39	1	253	38	343	417	2.30E-11	69.3	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN32773_c3_g1_i1	P90850	YCF2E_CAEEL	45.7	81	40	2	234	4	312	392	5.10E-13	74.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN32773_c0_g1_i1	P90850	YCF2E_CAEEL	41.4	58	30	2	1	174	390	443	1.10E-06	53.5	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN21115_c0_g1_i1	P90850	YCF2E_CAEEL	43.9	66	32	2	5	190	348	412	7.70E-09	61.2	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN21115_c0_g1_i2	P90850	YCF2E_CAEEL	41.9	86	44	3	5	250	348	431	2.00E-11	70.1	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN21115_c1_g1_i1	P90850	YCF2E_CAEEL	50	44	22	0	40	171	312	355	2.20E-07	55.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN23370_c0_g1_i1	P90850	YCF2E_CAEEL	50	66	32	1	273	76	367	431	2.70E-13	75.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN24052_c0_g1_i1	P90850	YCF2E_CAEEL	49.2	61	30	1	194	12	372	431	2.20E-10	65.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN23985_c0_g1_i1	P90850	YCF2E_CAEEL	39.4	137	66	4	367	5	193	328	3.10E-17	89.4	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN22238_c0_g1_i1	P90850	YCF2E_CAEEL	44.3	219	103	6	606	4	205	422	8.50E-44	178.3	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN22238_c5_g1_i1	P90850	YCF2E_CAEEL	50.8	59	28	1	34	210	374	431	1.70E-10	66.6	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN21435_c0_g1_i1	P90850	YCF2E_CAEEL	49.3	69	31	2	201	7	324	392	1.70E-09	62.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN21435_c1_g1_i1	P90850	YCF2E_CAEEL	44.1	93	39	2	2	241	263	355	1.80E-14	79.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c4_g1_i1	P90850	YCF2E_CAEEL	42.5	233	115	6	647	3	193	424	3.40E-43	176.4	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c6_g1_i1	P90850	YCF2E_CAEEL	38.7	344	186	8	33	1007	94	431	7.30E-62	239.2	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c11_g1_i1	P90850	YCF2E_CAEEL	40.2	343	182	8	22	996	94	431	4.90E-66	253.1	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c13_g1_i1	P90850	YCF2E_CAEEL	42.1	214	105	6	3	590	210	422	8.90E-38	158.3	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c15_g1_i1	P90850	YCF2E_CAEEL	38.7	186	94	5	1	510	262	443	1.50E-28	127.5	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c8_g1_i1	P90850	YCF2E_CAEEL	37.7	440	229	15	103	1365	30	443	1.10E-70	268.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c23_g1_i1	P90850	YCF2E_CAEEL	52.5	59	27	1	203	27	374	431	1.30E-12	73.2	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c10_g1_i1	P90850	YCF2E_CAEEL	42	269	135	7	813	61	181	446	2.20E-48	195.3	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c0_g1_i1	P90850	YCF2E_CAEEL	42.4	165	80	4	8	457	191	355	9.30E-27	121.3	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c0_g1_i2	P90850	YCF2E_CAEEL	45.8	118	50	3	3	314	238	355	1.20E-20	100.5	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c0_g1_i3	P90850	YCF2E_CAEEL	44.4	153	69	3	1	411	260	412	1.80E-29	130.2	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN9915_c0_g1_i4	P90850	YCF2E_CAEEL	40.2	301	148	8	2	859	72	355	6.80E-55	215.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN9915_c0_g1_i5	P90850	YCF2E_CAEEL	44.8	192	88	5	5	526	221	412	8.70E-37	154.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN16905_c2_g1_i1	P90850	YCF2E_CAEEL	41.2	442	216	14	1358	90	27	443	7.70E-88	325.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN16905_c2_g1_i10	P90850	YCF2E_CAEEL	41.3	441	214	14	1355	90	29	443	6.80E-87	322.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN16905_c2_g1_i3	P90850	YCF2E_CAEEL	41.2	442	216	14	1358	90	27	443	8.20E-88	325.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	1
TRINITY_DN16905_c2_g1_i8	P90850	YCF2E_CAEEL	41.2	442	216	14	1358	90	27	443	7.60E-88	325.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN19907_c7_g1_i1	P90850	YCF2E_CAEEL	42.8	159	74	5	32	463	181	337	9.40E-27	121.3	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g4_i2	P90850	YCF2E_CAEEL	42.9	438	209	13	140	1408	15	426	4.50E-97	356.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g4_i3	P90850	YCF2E_CAEEL	47.8	209	97	4	82	684	222	426	2.00E-51	204.1	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g3_i1	P90850	YCF2E_CAEEL	45.9	111	56	2	2	325	322	431	2.00E-21	103.2	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g3_i2	P90850	YCF2E_CAEEL	42.7	75	40	1	2	217	338	412	4.90E-10	64.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g3_i3	P90850	YCF2E_CAEEL	40	90	50	2	2	262	343	431	2.00E-11	69.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g3_i4	P90850	YCF2E_CAEEL	42.2	90	48	2	2	262	343	431	4.70E-13	75.1	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c6_g1_i1	P90850	YCF2E_CAEEL	37	319	163	11	42	950	29	325	1.00E-43	178.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g1_i1	P90850	YCF2E_CAEEL	40.8	76	32	2	157	345	253	328	3.60E-07	55.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g1_i2	P90850	YCF2E_CAEEL	45.1	204	94	5	8	565	201	404	4.50E-39	162.5	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN19907_c1_g1_i3	P90850	YCF2E_CAEEL	54.4	79	34	2	8	238	201	279	6.50E-16	84.7	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN19907_c1_g1_i4	P90850	YCF2E_CAEEL	49.5	93	44	1	54	323	312	404	1.00E-19	97.4	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			blue	blue	NA	NA	NA	NA
TRINITY_DN19907_c5_g1_i1	P90850	YCF2E_CAEEL	41.9	234	114	7	10	657	214	443	3.80E-40	166.4	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN25553_c0_g1_i1	P90850	YCF2E_CAEEL	43.6	78	31	2	198	4	251	328	7.90E-10	63.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN16443_c3_g1_i1	P90850	YCF2E_CAEEL	55.4	56	24	1	41	208	372	426	1.70E-12	72.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN20509_c0_g1_i1	P90850	YCF2E_CAEEL	47.7	88	43	1	1	255	330	417	2.70E-18	92.4	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN32558_c0_g1_i1	P90850	YCF2E_CAEEL	55.6	54	23	1	29	190	374	426	8.20E-12	70.9	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN16629_c0_g1_i2	P90850	YCF2E_CAEEL	40.4	359	188	9	146	1168	94	444	3.10E-69	263.8	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN32170_c0_g1_i1	P90850	YCF2E_CAEEL	44.6	74	38	1	6	218	342	415	4.10E-12	71.6	YCF2E_CAEEL	reviewed	Uncharacterized peptidase C1-like protein F26E4.3	F26E4.3	Caenorhabditis elegans	452	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]	extracellular space [GO:0005615]; lysosome [GO:0005764]	cysteine-type peptidase activity [GO:0008234]	GO:0005615; GO:0005764; GO:0008234			NA	NA	NA	NA	NA	NA
TRINITY_DN332_c0_g1_i1	P34258	YKA7_CAEEL	32.9	164	89	4	562	77	194	338	7.20E-18	93.6	YKA7_CAEEL	reviewed	Uncharacterized protein B0303.7	B0303.7	Caenorhabditis elegans	493							NA	NA	NA	NA	NA	NA
TRINITY_DN332_c0_g1_i2	P34258	YKA7_CAEEL	30.8	143	78	4	499	77	215	338	4.80E-12	72.8	YKA7_CAEEL	reviewed	Uncharacterized protein B0303.7	B0303.7	Caenorhabditis elegans	493							NA	NA	NA	NA	NA	NA
TRINITY_DN5457_c0_g1_i8	Q09214	YP65_CAEEL	71.3	115	33	0	357	13	43	157	3.10E-46	185.7	YP65_CAEEL	reviewed	Uncharacterized protein B0495.5	B0495.5	Caenorhabditis elegans	729	carbohydrate metabolic process [GO:0005975]			GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN10245_c0_g1_i1	P48053	YPD1_CAEEL	61.2	147	57	0	3	443	20	166	1.70E-49	196.8	YPD1_CAEEL	reviewed	Uncharacterized protein C05D11.1	C05D11.1	Caenorhabditis elegans	995	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]		metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN32911_c0_g1_i1	P48053	YPD1_CAEEL	31.2	218	148	2	678	25	192	407	2.30E-21	104	YPD1_CAEEL	reviewed	Uncharacterized protein C05D11.1	C05D11.1	Caenorhabditis elegans	995	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]		metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN35646_c0_g1_i1	P48053	YPD1_CAEEL	63.4	142	52	0	427	2	55	196	1.80E-48	193.4	YPD1_CAEEL	reviewed	Uncharacterized protein C05D11.1	C05D11.1	Caenorhabditis elegans	995	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]		metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6374_c0_g1_i1	O42895	YBQ2_SCHPO	51.8	83	40	0	1	249	198	280	4.30E-18	91.7	YBQ2_SCHPO	reviewed	Uncharacterized protein C115.02c	SPBC115.02c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	454	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0006515; GO:0016887	protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]		NA	NA	NA	NA	NA	NA
TRINITY_DN4676_c0_g1_i2	Q9JJ93	CN119_MOUSE	32.1	112	73	2	809	480	32	142	8.20E-11	69.3	CN119_MOUSE	reviewed	Uncharacterized protein C14orf119 homolog	MNCb-2990	Mus musculus (Mouse)	142	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]		GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN2662_c0_g1_i2	A6NNL5	CO061_HUMAN	48.4	91	37	2	249	7	38	128	2.20E-17	89.4	CO061_HUMAN	reviewed	Uncharacterized protein C15orf61	C15orf61	Homo sapiens (Human)	157	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN2662_c0_g1_i3	A6NNL5	CO061_HUMAN	64.4	87	31	0	267	7	42	128	2.00E-29	129.4	CO061_HUMAN	reviewed	Uncharacterized protein C15orf61	C15orf61	Homo sapiens (Human)	157	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			blue	blue	NA	NA	NA	NA
TRINITY_DN2662_c0_g1_i1	Q0VG49	CO061_MOUSE	52.9	87	34	1	246	7	42	128	2.10E-17	89.4	CO061_MOUSE	reviewed	Uncharacterized protein C15orf61 homolog		Mus musculus (Mouse)	157	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN7960_c0_g1_i1	Q6GR34	CP52A_XENLA	50.6	168	80	2	85	585	1	166	4.00E-42	172.9	CP52A_XENLA	reviewed	Uncharacterized protein C16orf52 homolog A		Xenopus laevis (African clawed frog)	167							blue	blue	NA	NA	NA	NA
TRINITY_DN7960_c0_g1_i2	Q6GR34	CP52A_XENLA	82.8	29	5	0	85	171	1	29	1.00E-05	50.8	CP52A_XENLA	reviewed	Uncharacterized protein C16orf52 homolog A		Xenopus laevis (African clawed frog)	167							NA	NA	NA	NA	NA	NA
TRINITY_DN4663_c0_g1_i2	Q1MTD4	CR19A_DANRE	53.9	76	34	1	80	304	118	193	2.90E-16	85.9	CR19A_DANRE	reviewed	Uncharacterized protein C18orf19 homolog A	si:ch211-105d11.2	Danio rerio (Zebrafish) (Brachydanio rerio)	242	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]		GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN4663_c0_g1_i3	Q1MTD4	CR19A_DANRE	41.4	174	96	3	15	524	22	193	3.90E-29	129.4	CR19A_DANRE	reviewed	Uncharacterized protein C18orf19 homolog A	si:ch211-105d11.2	Danio rerio (Zebrafish) (Brachydanio rerio)	242	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]		GO:0005739; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN9920_c1_g1_i1	Q8N9M1	CS047_HUMAN	26	423	228	12	57	1169	29	418	1.00E-17	92.8	CS047_HUMAN	reviewed	Uncharacterized protein C19orf47	C19orf47	Homo sapiens (Human)	422	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654			blue	blue	NA	NA	NA	NA
TRINITY_DN3216_c0_g1_i2	Q3SYX3	CB042_BOVIN	43	242	112	7	1207	515	44	270	3.00E-48	194.1	CB042_BOVIN	reviewed	Uncharacterized protein C2orf42 homolog		Bos taurus (Bovine)	574	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0031965			NA	NA	NA	NA	NA	NA
TRINITY_DN3216_c0_g1_i5	Q3SYX3	CB042_BOVIN	43	242	112	7	1209	517	44	270	3.00E-48	194.1	CB042_BOVIN	reviewed	Uncharacterized protein C2orf42 homolog		Bos taurus (Bovine)	574	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0031965			NA	NA	NA	NA	NA	NA
TRINITY_DN3216_c0_g1_i6	Q3SYX3	CB042_BOVIN	43	242	112	7	1253	561	44	270	3.10E-48	194.1	CB042_BOVIN	reviewed	Uncharacterized protein C2orf42 homolog		Bos taurus (Bovine)	574	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0031965			NA	NA	NA	NA	NA	NA
TRINITY_DN3216_c0_g1_i8	Q3SYX3	CB042_BOVIN	43	242	112	7	1216	524	44	270	3.00E-48	194.1	CB042_BOVIN	reviewed	Uncharacterized protein C2orf42 homolog		Bos taurus (Bovine)	574	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0031965			NA	NA	NA	NA	NA	NA
TRINITY_DN34098_c0_g1_i1	Q4R907	CB042_MACFA	54.3	127	54	2	2	370	433	559	9.30E-30	131.7	CB042_MACFA	reviewed	Uncharacterized protein C2orf42 homolog	QtsA-11015	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	574							NA	NA	NA	NA	NA	NA
TRINITY_DN7566_c0_g1_i1	Q9USK7	YJ2I_SCHPO	43.6	307	169	2	969	61	4	310	2.60E-61	237.3	YJ2I_SCHPO	reviewed	Uncharacterized protein C4B3.18	SPCC4B3.18	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	316	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphopantothenate--cysteine ligase activity [GO:0004632]; acetyl-CoA biosynthetic process from pantothenate [GO:1990181]; coenzyme A biosynthetic process [GO:0015937]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	phosphopantothenate--cysteine ligase activity [GO:0004632]	GO:0004632; GO:0005634; GO:0005737; GO:0005829; GO:0015937; GO:1990181	acetyl-CoA biosynthetic process from pantothenate [GO:1990181]; coenzyme A biosynthetic process [GO:0015937]		NA	NA	NA	NA	NA	NA
TRINITY_DN1647_c0_g1_i1	P87137	YDM6_SCHPO	33.8	142	91	2	572	150	786	925	1.80E-15	85.1	YDM6_SCHPO	reviewed	Uncharacterized protein C57A7.06	SPAC57A7.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	929	nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA [GO:0030490]	nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]		GO:0005634; GO:0005730; GO:0030490; GO:0032040	maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN1647_c0_g1_i2	P87137	YDM6_SCHPO	38.3	81	48	1	392	150	847	925	3.50E-07	56.2	YDM6_SCHPO	reviewed	Uncharacterized protein C57A7.06	SPAC57A7.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	929	nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA [GO:0030490]	nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]		GO:0005634; GO:0005730; GO:0030490; GO:0032040	maturation of SSU-rRNA [GO:0030490]		NA	NA	NA	NA	NA	NA
TRINITY_DN1171_c0_g1_i2	Q96MD7	CI085_HUMAN	58.5	106	44	0	733	416	1	106	5.10E-31	136.3	CI085_HUMAN	reviewed	Uncharacterized protein C9orf85	C9orf85	Homo sapiens (Human)	179							NA	NA	NA	NA	NA	NA
TRINITY_DN1171_c0_g1_i3	Q96MD7	CI085_HUMAN	58.5	106	44	0	733	416	1	106	5.10E-31	136.3	CI085_HUMAN	reviewed	Uncharacterized protein C9orf85	C9orf85	Homo sapiens (Human)	179							blue	blue	NA	NA	NA	NA
TRINITY_DN14357_c0_g1_i1	Q9CQ90	CI085_MOUSE	45.5	55	28	1	59	217	73	127	4.80E-08	58.2	CI085_MOUSE	reviewed	Uncharacterized protein C9orf85 homolog		Mus musculus (Mouse)	155							NA	NA	NA	NA	NA	NA
TRINITY_DN430_c0_g1_i1	Q9VNA4	Y1161_DROME	51.5	136	60	4	498	94	97	227	2.20E-27	124	Y1161_DROME	reviewed	Uncharacterized protein CG1161	CG1161	Drosophila melanogaster (Fruit fly)	227	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN5856_c0_g1_i1	Q0KIC3	Y3427_DROME	39.8	113	52	4	95	412	105	208	7.00E-08	58.5	Y3427_DROME	reviewed	Uncharacterized protein CG43427	CG43427	Drosophila melanogaster (Fruit fly)	1372							NA	NA	NA	NA	NA	NA
TRINITY_DN40199_c0_g1_i1	Q9W5D0	Y34F_DROME	91.4	35	3	0	50	154	1112	1146	7.70E-13	73.9	Y34F_DROME	reviewed	Uncharacterized protein CG43867	CG43867	Drosophila melanogaster (Fruit fly)	1820	cytoskeleton [GO:0005856]	cytoskeleton [GO:0005856]		GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN40358_c0_g1_i1	Q9W5D0	Y34F_DROME	62.2	74	24	2	3	218	1192	1263	6.50E-15	80.9	Y34F_DROME	reviewed	Uncharacterized protein CG43867	CG43867	Drosophila melanogaster (Fruit fly)	1820	cytoskeleton [GO:0005856]	cytoskeleton [GO:0005856]		GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN35104_c0_g1_i1	Q9W5D0	Y34F_DROME	69.2	91	28	0	274	2	936	1026	6.10E-34	144.4	Y34F_DROME	reviewed	Uncharacterized protein CG43867	CG43867	Drosophila melanogaster (Fruit fly)	1820	cytoskeleton [GO:0005856]	cytoskeleton [GO:0005856]		GO:0005856			NA	NA	NA	NA	NA	NA
TRINITY_DN4066_c0_g1_i1	Q93408	YRGK_CAEEL	49.4	83	42	0	205	453	45	127	5.40E-17	89	YRGK_CAEEL	reviewed	Uncharacterized protein D2005.3	D2005.3	Caenorhabditis elegans	130	cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]	cytosol [GO:0005829]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN679_c0_g1_i1	Q09531	YQP4_CAEEL	30.5	282	164	7	12	845	260	513	1.70E-11	71.6	YQP4_CAEEL	reviewed	Uncharacterized protein F07F6.4	F07F6.4	Caenorhabditis elegans	529	Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]	Golgi membrane [GO:0000139]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0046872; GO:0048205	COPI coating of Golgi vesicle [GO:0048205]		NA	NA	NA	NA	NA	NA
TRINITY_DN679_c0_g1_i3	Q09531	YQP4_CAEEL	30.1	289	170	7	12	866	260	520	3.60E-12	73.9	YQP4_CAEEL	reviewed	Uncharacterized protein F07F6.4	F07F6.4	Caenorhabditis elegans	529	Golgi membrane [GO:0000139]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]	Golgi membrane [GO:0000139]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0000139; GO:0005096; GO:0046872; GO:0048205	COPI coating of Golgi vesicle [GO:0048205]		NA	NA	NA	NA	NA	NA
TRINITY_DN1048_c0_g1_i1	P55326	YZG1_CAEEL	42.5	106	48	2	300	10	56	157	2.40E-11	70.1	YZG1_CAEEL	reviewed	Uncharacterized protein F13E6.1	F13E6.1	Caenorhabditis elegans	195							blue	blue	NA	NA	NA	NA
TRINITY_DN7978_c0_g1_i1	Q1NZ26	YSMU_CAEEL	44.8	221	118	2	30	683	57	276	1.40E-51	204.5	YSMU_CAEEL	reviewed	"Uncharacterized protein F13E9.13, mitochondrial"	F13E9.13	Caenorhabditis elegans	277	mitochondrion [GO:0005739]; catalytic activity [GO:0003824]	mitochondrion [GO:0005739]	catalytic activity [GO:0003824]	GO:0003824; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN7978_c0_g1_i2	Q1NZ26	YSMU_CAEEL	46.7	199	102	2	30	617	57	254	1.00E-45	184.9	YSMU_CAEEL	reviewed	"Uncharacterized protein F13E9.13, mitochondrial"	F13E9.13	Caenorhabditis elegans	277	mitochondrion [GO:0005739]; catalytic activity [GO:0003824]	mitochondrion [GO:0005739]	catalytic activity [GO:0003824]	GO:0003824; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN16383_c0_g1_i1	Q09575	YRD6_CAEEL	38.7	62	38	0	6	191	546	607	6.10E-10	64.3	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN16383_c0_g1_i2	Q09575	YRD6_CAEEL	40.8	71	42	0	8	220	537	607	7.30E-12	70.9	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3437_c0_g1_i1	Q09575	YRD6_CAEEL	25.7	226	159	4	682	8	725	942	1.80E-16	89	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN3437_c0_g1_i5	Q09575	YRD6_CAEEL	25.7	226	159	4	682	8	725	942	4.10E-16	87.8	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN27943_c0_g1_i1	Q09575	YRD6_CAEEL	51.9	54	26	0	49	210	900	953	4.00E-10	65.1	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10201_c0_g1_i31	Q09575	YRD6_CAEEL	32.2	230	152	4	3219	2536	775	1002	4.50E-25	119	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN10201_c0_g1_i31	Q09575	YRD6_CAEEL	32.2	230	152	4	1445	2128	775	1002	5.90E-25	118.6	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	1	NA	NA	NA
TRINITY_DN10201_c0_g1_i30	Q09575	YRD6_CAEEL	32.2	230	152	4	3018	2335	775	1002	4.60E-25	119	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN10201_c0_g1_i30	Q09575	YRD6_CAEEL	32.2	230	152	4	1244	1927	775	1002	6.00E-25	118.6	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN28580_c0_g1_i1	Q09575	YRD6_CAEEL	41.7	84	49	0	3	254	770	853	1.40E-16	86.7	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN19546_c0_g1_i1	Q09575	YRD6_CAEEL	49.3	69	35	0	369	163	885	953	2.30E-12	73.6	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN34797_c0_g1_i1	Q09575	YRD6_CAEEL	51.1	45	22	0	199	65	783	827	2.20E-07	55.8	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN31342_c0_g1_i1	Q09575	YRD6_CAEEL	44.1	59	33	0	184	8	759	817	1.80E-09	62.8	YRD6_CAEEL	reviewed	Uncharacterized protein K02A2.6	K02A2.6	Caenorhabditis elegans	1268	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0015074	DNA integration [GO:0015074]		NA	NA	NA	NA	NA	NA
TRINITY_DN6171_c0_g1_i2	Q80U59	K0232_MOUSE	42.3	97	39	2	492	782	102	181	3.90E-07	57	K0232_MOUSE	reviewed	Uncharacterized protein KIAA0232	Kiaa0232 D5Ertd579e	Mus musculus (Mouse)	1396	ATP binding [GO:0005524]		ATP binding [GO:0005524]	GO:0005524			NA	NA	NA	NA	NA	NA
TRINITY_DN1951_c0_g2_i5	O60268	K0513_HUMAN	52.1	121	48	3	1073	1405	288	408	1.50E-25	119	K0513_HUMAN	reviewed	Uncharacterized protein KIAA0513	KIAA0513	Homo sapiens (Human)	411	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN1951_c0_g2_i7	O60268	K0513_HUMAN	52.1	121	48	3	647	979	288	408	6.40E-26	119.8	K0513_HUMAN	reviewed	Uncharacterized protein KIAA0513	KIAA0513	Homo sapiens (Human)	411	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN32514_c0_g1_i1	Q8IYS2	K2013_HUMAN	100	72	0	0	1	216	423	494	1.40E-36	152.9	K2013_HUMAN	reviewed	Uncharacterized protein KIAA2013	KIAA2013	Homo sapiens (Human)	634	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN6422_c0_g1_i1	A4IH88	K2013_XENTR	29.7	454	299	10	1432	101	65	508	3.10E-48	194.5	K2013_XENTR	reviewed	Uncharacterized protein KIAA2013 homolog		Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	608	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			brown	brown	NA	NA	NA	NA
TRINITY_DN6422_c0_g1_i2	A4IH88	K2013_XENTR	32.7	550	339	13	1674	61	65	595	4.20E-73	277.3	K2013_XENTR	reviewed	Uncharacterized protein KIAA2013 homolog		Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	608	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN6422_c0_g1_i3	A4IH88	K2013_XENTR	32.7	550	339	13	1673	60	65	595	4.20E-73	277.3	K2013_XENTR	reviewed	Uncharacterized protein KIAA2013 homolog		Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	608	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33704_c0_g1_i1	P75863	YCBX_ECOLI	42.4	132	67	2	500	105	141	263	1.80E-21	104	YCBX_ECOLI	reviewed	Uncharacterized protein YcbX	ycbX b0947 JW5126	Escherichia coli (strain K12)	369	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; response to toxic substance [GO:0009636]; toxin catabolic process [GO:0009407]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]"	GO:0009055; GO:0009407; GO:0009636; GO:0030151; GO:0030170; GO:0051537	response to toxic substance [GO:0009636]; toxin catabolic process [GO:0009407]		NA	NA	NA	NA	NA	NA
TRINITY_DN40018_c0_g1_i1	P37512	YYAL_BACSU	63.7	91	33	0	1	273	15	105	3.30E-32	138.7	YYAL_BACSU	reviewed	Uncharacterized protein YyaL	yyaL BSU40820	Bacillus subtilis (strain 168)	689	carbohydrate metabolic process [GO:0005975]			GO:0005975	carbohydrate metabolic process [GO:0005975]		NA	NA	NA	NA	NA	NA
TRINITY_DN16365_c0_g1_i1	O02485	YDJ1_CAEEL	46.3	82	42	1	247	2	33	112	2.00E-15	82.8	YDJ1_CAEEL	reviewed	Uncharacterized protein ZK1073.1	ZK1073.1	Caenorhabditis elegans	325							blue	blue	NA	NA	NA	NA
TRINITY_DN276_c1_g1_i1	O02485	YDJ1_CAEEL	49.7	197	90	4	2	589	123	311	7.60E-47	188.7	YDJ1_CAEEL	reviewed	Uncharacterized protein ZK1073.1	ZK1073.1	Caenorhabditis elegans	325							blue	blue	NA	NA	NA	NA
TRINITY_DN276_c1_g1_i2	O02485	YDJ1_CAEEL	48	123	56	3	2	367	123	238	7.60E-25	115.2	YDJ1_CAEEL	reviewed	Uncharacterized protein ZK1073.1	ZK1073.1	Caenorhabditis elegans	325							blue	blue	NA	NA	NA	NA
TRINITY_DN12969_c1_g1_i10	P34648	YOT2_CAEEL	43.1	130	67	3	455	87	71	200	3.40E-22	106.3	YOT2_CAEEL	reviewed	Uncharacterized protein ZK632.2	ZK632.2	Caenorhabditis elegans	710	mRNA binding [GO:0003729]		mRNA binding [GO:0003729]	GO:0003729			NA	NA	NA	NA	NA	NA
TRINITY_DN12969_c1_g1_i12	P34648	YOT2_CAEEL	40.8	142	77	3	491	87	59	200	1.30E-22	109	YOT2_CAEEL	reviewed	Uncharacterized protein ZK632.2	ZK632.2	Caenorhabditis elegans	710	mRNA binding [GO:0003729]		mRNA binding [GO:0003729]	GO:0003729			NA	NA	NA	NA	NA	NA
TRINITY_DN12969_c1_g1_i4	P34648	YOT2_CAEEL	40.8	142	77	3	491	87	59	200	8.70E-23	109	YOT2_CAEEL	reviewed	Uncharacterized protein ZK632.2	ZK632.2	Caenorhabditis elegans	710	mRNA binding [GO:0003729]		mRNA binding [GO:0003729]	GO:0003729			NA	NA	NA	NA	NA	NA
TRINITY_DN12969_c1_g1_i6	P34648	YOT2_CAEEL	43.1	130	67	3	455	87	71	200	2.90E-22	106.7	YOT2_CAEEL	reviewed	Uncharacterized protein ZK632.2	ZK632.2	Caenorhabditis elegans	710	mRNA binding [GO:0003729]		mRNA binding [GO:0003729]	GO:0003729			NA	NA	NA	NA	NA	NA
TRINITY_DN12969_c1_g1_i8	P34648	YOT2_CAEEL	40.8	152	81	4	515	87	49	200	2.30E-22	108.2	YOT2_CAEEL	reviewed	Uncharacterized protein ZK632.2	ZK632.2	Caenorhabditis elegans	710	mRNA binding [GO:0003729]		mRNA binding [GO:0003729]	GO:0003729			NA	NA	NA	NA	NA	NA
TRINITY_DN50_c0_g1_i1	P30629	YOU2_CAEEL	35.6	135	84	1	52	447	6	140	8.90E-24	111.7	YOU2_CAEEL	reviewed	Uncharacterized protein ZK637.2	ZK637.2	Caenorhabditis elegans	143	cytoplasm [GO:0005737]; striated muscle dense body [GO:0055120]	cytoplasm [GO:0005737]; striated muscle dense body [GO:0055120]		GO:0005737; GO:0055120			blue	blue	NA	NA	NA	NA
TRINITY_DN50_c0_g1_i3	P30629	YOU2_CAEEL	30.8	159	86	1	52	528	6	140	2.10E-21	104	YOU2_CAEEL	reviewed	Uncharacterized protein ZK637.2	ZK637.2	Caenorhabditis elegans	143	cytoplasm [GO:0005737]; striated muscle dense body [GO:0055120]	cytoplasm [GO:0005737]; striated muscle dense body [GO:0055120]		GO:0005737; GO:0055120			NA	NA	NA	NA	NA	NA
TRINITY_DN8586_c0_g1_i1	O94323	YGK5_SCHPO	55.9	68	29	1	8	208	77	144	5.40E-15	81.3	YGK5_SCHPO	reviewed	Uncharacterized pyrophosphatase/phosphodiesterase C725.05c (EC 3.-.-.-)	SPBC725.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	485	integral component of membrane [GO:0016021]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; nucleoside triphosphate metabolic process [GO:0009141]	integral component of membrane [GO:0016021]	nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]	GO:0004551; GO:0009141; GO:0016021; GO:0017111; GO:0047429	nucleoside triphosphate metabolic process [GO:0009141]		NA	NA	NA	NA	NA	NA
TRINITY_DN3819_c0_g1_i3	Q8XIK5	Y2114_CLOPE	22.7	141	102	3	461	42	165	299	2.40E-05	50.4	Y2114_CLOPE	reviewed	Uncharacterized RNA methyltransferase CPE2114 (EC 2.1.1.-)	CPE2114	Clostridium perfringens (strain 13 / Type A)	451	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]"		"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; RNA methyltransferase activity [GO:0008173]"	GO:0006396; GO:0008173; GO:0046872; GO:0051539	RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN37409_c0_g1_i1	Q45826	Y901_CHLAA	56.4	55	23	1	190	29	229	283	1.40E-10	66.6	Y901_CHLAA	reviewed	Uncharacterized RNA pseudouridine synthase Caur_0901 (EC 5.4.99.-) (RNA pseudouridylate synthase) (RNA-uridine isomerase)	Caur_0901	Chloroflexus aurantiacus (strain ATCC 29366 / DSM 635 / J-10-fl)	316	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]		pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000455; GO:0003723; GO:0009982	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]		red	red	NA	NA	NA	NA
TRINITY_DN37564_c0_g1_i1	O94432	YHKF_SCHPO	54.8	62	28	0	10	195	246	307	8.30E-15	80.5	YHKF_SCHPO	reviewed	Uncharacterized RNA-binding protein C660.15	SPBC660.15	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	474	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]	GO:0003730; GO:0005634; GO:0005737; GO:0005849; GO:0006378; GO:0006379	mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]		NA	NA	NA	NA	NA	NA
TRINITY_DN971_c2_g1_i1	Q9HFE6	YNW6_SCHPO	34.3	105	68	1	606	292	6	109	4.10E-11	70.9	YNW6_SCHPO	reviewed	Uncharacterized RNA-binding protein P16F5.06	SPBP16F5.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	478	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN971_c2_g1_i4	Q9HFE6	YNW6_SCHPO	34.3	105	68	1	606	292	6	109	3.10E-11	70.9	YNW6_SCHPO	reviewed	Uncharacterized RNA-binding protein P16F5.06	SPBP16F5.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	478	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN971_c2_g1_i7	Q9HFE6	YNW6_SCHPO	34.3	105	68	1	606	292	6	109	3.10E-11	70.9	YNW6_SCHPO	reviewed	Uncharacterized RNA-binding protein P16F5.06	SPBP16F5.06	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	478	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	1
TRINITY_DN29359_c0_g1_i1	Q53217	Y4VI_SINFN	47.3	74	39	0	223	2	149	222	7.90E-11	67.4	Y4VI_SINFN	reviewed	Uncharacterized short-chain type dehydrogenase/reductase y4vI (EC 1.-.-.-)	NGR_a01150 y4vI	Sinorhizobium fredii (strain NBRC 101917 / NGR234)	548	oxidoreductase activity [GO:0016491]		oxidoreductase activity [GO:0016491]	GO:0016491			NA	NA	NA	NA	NA	NA
TRINITY_DN28547_c0_g1_i1	P44849	Y736_HAEIN	74.6	59	15	0	178	2	9	67	1.20E-19	96.7	Y736_HAEIN	reviewed	Uncharacterized sodium-dependent transporter HI_0736	HI_0736	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	508	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	symporter activity [GO:0015293]	GO:0005886; GO:0015293; GO:0016021; GO:0035725	sodium ion transmembrane transport [GO:0035725]		NA	NA	NA	NA	NA	NA
TRINITY_DN37514_c0_g1_i1	Q03567	SL172_CAEEL	56.1	66	29	0	91	288	180	245	7.90E-19	94.4	SL172_CAEEL	reviewed	Uncharacterized transporter slc-17.2	C38C10.2	Caenorhabditis elegans	493	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0006814; GO:0006820; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN9992_c0_g1_i1	Q03567	SL172_CAEEL	40.6	69	41	0	48	254	178	246	1.70E-12	73.2	SL172_CAEEL	reviewed	Uncharacterized transporter slc-17.2	C38C10.2	Caenorhabditis elegans	493	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0006814; GO:0006820; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN9992_c0_g1_i2	Q03567	SL172_CAEEL	39.1	69	42	0	48	254	178	246	1.30E-10	67	SL172_CAEEL	reviewed	Uncharacterized transporter slc-17.2	C38C10.2	Caenorhabditis elegans	493	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0006814; GO:0006820; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7376_c1_g1_i5	Q03567	SL172_CAEEL	32.8	122	81	1	466	104	303	424	1.30E-08	61.2	SL172_CAEEL	reviewed	Uncharacterized transporter slc-17.2	C38C10.2	Caenorhabditis elegans	493	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0006814; GO:0006820; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN7376_c1_g1_i6	Q03567	SL172_CAEEL	32.8	122	81	1	466	104	303	424	1.70E-08	60.8	SL172_CAEEL	reviewed	Uncharacterized transporter slc-17.2	C38C10.2	Caenorhabditis elegans	493	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]	symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0006814; GO:0006820; GO:0015293; GO:0016021; GO:0022857	anion transport [GO:0006820]; sodium ion transport [GO:0006814]		NA	NA	NA	NA	NA	NA
TRINITY_DN25825_c0_g1_i1	P94408	YCLF_BACSU	52.6	76	31	1	10	222	18	93	3.30E-14	78.6	YCLF_BACSU	reviewed	Uncharacterized transporter YclF	yclF BSU03670	Bacillus subtilis (strain 168)	492	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; peptide transmembrane transporter activity [GO:1904680]; oligopeptide transport [GO:0006857]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	peptide transmembrane transporter activity [GO:1904680]	GO:0005886; GO:0006857; GO:0016021; GO:1904680	oligopeptide transport [GO:0006857]		NA	NA	NA	NA	NA	NA
TRINITY_DN3814_c0_g1_i4	Q8YRI1	YY46_NOSS1	36.8	114	60	1	537	196	1215	1316	8.00E-16	85.5	YY46_NOSS1	reviewed	Uncharacterized WD repeat-containing protein alr3466	alr3466	Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576)	1526							NA	NA	NA	NA	NA	NA
TRINITY_DN9249_c0_g1_i11	Q9USZ0	WDR6_SCHPO	27.1	155	84	5	761	318	808	940	3.90E-05	50.4	WDR6_SCHPO	reviewed	Uncharacterized WD repeat-containing protein C1306.02	SPBC1306.02 SPBC4.08	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	984	cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methylation [GO:0030488]	cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0030488	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN9249_c0_g1_i3	Q9USZ0	WDR6_SCHPO	27.1	155	84	5	761	318	808	940	4.00E-05	50.4	WDR6_SCHPO	reviewed	Uncharacterized WD repeat-containing protein C1306.02	SPBC1306.02 SPBC4.08	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	984	cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methylation [GO:0030488]	cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0030488	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN9249_c0_g1_i7	Q9USZ0	WDR6_SCHPO	24.6	203	116	7	902	318	767	940	5.50E-06	54.7	WDR6_SCHPO	reviewed	Uncharacterized WD repeat-containing protein C1306.02	SPBC1306.02 SPBC4.08	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	984	cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methylation [GO:0030488]	cytosol [GO:0005829]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0030488	tRNA methylation [GO:0030488]		NA	NA	NA	NA	NA	NA
TRINITY_DN2892_c0_g1_i1	Q23979	MY61F_DROME	55.6	1046	448	10	61	3183	1	1035	0	1113.2	MY61F_DROME	reviewed	Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C)	Myo61F Myo1C CG9155	Drosophila melanogaster (Fruit fly)	1035	"actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0032528; GO:0042742; GO:0048803; GO:0051015	actin filament organization [GO:0007015]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	1
TRINITY_DN2892_c0_g1_i4	Q23979	MY61F_DROME	55.8	1038	443	10	86	3184	9	1035	0	1113.6	MY61F_DROME	reviewed	Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C)	Myo61F Myo1C CG9155	Drosophila melanogaster (Fruit fly)	1035	"actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0032528; GO:0042742; GO:0048803; GO:0051015	actin filament organization [GO:0007015]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528]; vesicle transport along actin filament [GO:0030050]		blue	blue	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i14	Q23978	MY31D_DROME	64.4	610	212	2	4	1833	1	605	2.70E-237	822.8	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i15	Q23978	MY31D_DROME	62.6	804	296	2	4	2415	1	799	3.30E-307	1055.4	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i16	Q23978	MY31D_DROME	57.6	1015	415	7	4	3021	1	1009	0	1191.4	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i17	Q23978	MY31D_DROME	49.3	460	223	5	79	1431	551	1009	6.40E-125	449.1	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i18	Q23978	MY31D_DROME	47.7	407	203	5	86	1279	604	1009	3.60E-103	376.7	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i19	Q23978	MY31D_DROME	41.2	330	184	5	64	1026	681	1009	1.90E-65	251.1	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i20	Q23978	MY31D_DROME	51.9	509	235	5	98	1597	502	1009	3.20E-149	530	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i22	Q23978	MY31D_DROME	39.8	284	157	6	54	866	727	1009	9.00E-53	208.8	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i4	Q23978	MY31D_DROME	64.2	561	196	2	4	1686	1	556	6.40E-217	755	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g2_i1	Q23978	MY31D_DROME	67.2	58	19	0	200	373	629	686	1.40E-17	90.9	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g2_i2	Q23978	MY31D_DROME	67.2	58	19	0	200	373	629	686	1.40E-17	90.9	MY31D_DROME	reviewed	Unconventional myosin ID (MyoID) (Brush border myosin IA) (BBMIA) (Myosin 1D) (Myo1D) (Myosin-IA) (MIA) (MyoIA)	Myo31DF Myo1D CG7438	Drosophila melanogaster (Fruit fly)	1011	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005912; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031982; GO:0048803; GO:0051015; GO:0061525; GO:0071907	actin filament organization [GO:0007015]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; hindgut development [GO:0061525]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN23250_c0_g1_i1	O00159	MYO1C_HUMAN	100	88	0	0	265	2	640	727	1.00E-46	186.8	MYO1C_HUMAN	reviewed	Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)	MYO1C	Homo sapiens (Human)	1063	"actin cytoskeleton [GO:0015629]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; Ral GTPase binding [GO:0017160]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; mRNA transport [GO:0051028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting [GO:0006605]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; Ral GTPase binding [GO:0017160]; signaling receptor binding [GO:0005102]	GO:0000146; GO:0005102; GO:0005516; GO:0005524; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0006605; GO:0006612; GO:0007015; GO:0008022; GO:0009925; GO:0015629; GO:0016020; GO:0016328; GO:0016461; GO:0016604; GO:0017160; GO:0030050; GO:0030335; GO:0030659; GO:0030838; GO:0030898; GO:0031941; GO:0031982; GO:0032587; GO:0038089; GO:0038096; GO:0045121; GO:0045335; GO:0045815; GO:0051015; GO:0051028; GO:0060171; GO:0070062; GO:0071346; GO:0090314; GO:1900078; GO:1900748; GO:2000810	"actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; mRNA transport [GO:0051028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting [GO:0006605]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16112_c0_g1_i1	Q27966	MYO1C_BOVIN	100	89	0	0	268	2	64	152	9.80E-45	180.3	MYO1C_BOVIN	reviewed	Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)	MYO1C	Bos taurus (Bovine)	1063	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015031; GO:0015629; GO:0016459; GO:0030050; GO:0030898; GO:0031410; GO:0031982; GO:0051015; GO:0051028; GO:0060171	actin filament organization [GO:0007015]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i13	Q63357	MYO1D_RAT	59.4	249	101	0	79	825	556	804	1.50E-87	324.3	MYO1D_RAT	reviewed	Unconventional myosin-Id (Myosin heavy chain myr 4)	Myo1d Myr4	Rattus norvegicus (Rat)	1006	actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; smooth endoplasmic reticulum [GO:0005790]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; actin filament organization [GO:0007015]; cellular localization [GO:0051641]; forebrain development [GO:0030900]; negative regulation of phosphatase activity [GO:0010923]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; smooth endoplasmic reticulum [GO:0005790]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005769; GO:0005790; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0010923; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030050; GO:0030424; GO:0030673; GO:0030898; GO:0030900; GO:0031410; GO:0031982; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0044853; GO:0048306; GO:0051015; GO:0051641; GO:0097440	actin filament organization [GO:0007015]; cellular localization [GO:0051641]; forebrain development [GO:0030900]; negative regulation of phosphatase activity [GO:0010923]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i12	Q6GPA1	MYO1D_XENLA	42.5	73	42	0	66	284	740	812	4.20E-12	72.4	MYO1D_XENLA	reviewed	Unconventional myosin-Id (Unconventional myosin 1d)	myo1d XELAEV_18043319mg	Xenopus laevis (African clawed frog)	1007	cell cortex [GO:0005938]; dendrite [GO:0030425]; early endosome [GO:0005769]; myosin complex [GO:0016459]; perikaryon [GO:0043204]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]	cell cortex [GO:0005938]; dendrite [GO:0030425]; early endosome [GO:0005769]; myosin complex [GO:0016459]; perikaryon [GO:0043204]	actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]	GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005769; GO:0005938; GO:0007275; GO:0015031; GO:0016459; GO:0030425; GO:0043204	multicellular organism development [GO:0007275]; protein transport [GO:0015031]		NA	NA	1	NA	NA	NA
TRINITY_DN20793_c0_g1_i1	Q63356	MYO1E_RAT	99.2	125	1	0	377	3	16	140	1.10E-65	250.4	MYO1E_RAT	reviewed	Unconventional myosin-Ie (Myosin heavy chain myr 3) (Unconventional myosin 1E)	Myo1e Myr3	Rattus norvegicus (Rat)	1107	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0030136; GO:0030898; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0048008; GO:0051015; GO:0072015; GO:0098858	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN20793_c0_g1_i2	Q63356	MYO1E_RAT	100	102	0	0	308	3	39	140	2.30E-53	209.1	MYO1E_RAT	reviewed	Unconventional myosin-Ie (Myosin heavy chain myr 3) (Unconventional myosin 1E)	Myo1e Myr3	Rattus norvegicus (Rat)	1107	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0030136; GO:0030898; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0048008; GO:0051015; GO:0072015; GO:0098858	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN2840_c0_g1_i1	Q12965	MYO1E_HUMAN	56.4	55	24	0	210	46	1054	1108	1.50E-12	73.6	MYO1E_HUMAN	reviewed	Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E)	MYO1E MYO1C	Homo sapiens (Human)	1108	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]	GO:0000146; GO:0001570; GO:0001701; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030048; GO:0030050; GO:0030136; GO:0030898; GO:0031982; GO:0032836; GO:0035091; GO:0035166; GO:0048008; GO:0051015; GO:0070062; GO:0072015; GO:0098858	actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c1_g1_i2	Q12965	MYO1E_HUMAN	57.5	1005	412	4	2986	14	9	1012	0	1147.1	MYO1E_HUMAN	reviewed	Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E)	MYO1E MYO1C	Homo sapiens (Human)	1108	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]	GO:0000146; GO:0001570; GO:0001701; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030048; GO:0030050; GO:0030136; GO:0030898; GO:0031982; GO:0032836; GO:0035091; GO:0035166; GO:0048008; GO:0051015; GO:0070062; GO:0072015; GO:0098858	actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN27965_c0_g1_i1	E9Q634	MYO1E_MOUSE	100	66	0	0	1	198	389	454	2.10E-32	139	MYO1E_MOUSE	reviewed	Unconventional myosin-Ie (Unconventional myosin 1E)	Myo1e Myr3	Mus musculus (Mouse)	1107	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0030898; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015; GO:0098858	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN3593_c1_g1_i1	E9Q634	MYO1E_MOUSE	68.8	423	132	0	1345	77	9	431	1.80E-169	597	MYO1E_MOUSE	reviewed	Unconventional myosin-Ie (Unconventional myosin 1E)	Myo1e Myr3	Mus musculus (Mouse)	1107	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0030898; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015; GO:0098858	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN19467_c0_g1_i1	E9Q634	MYO1E_MOUSE	97.4	115	3	0	1	345	122	236	1.60E-60	233	MYO1E_MOUSE	reviewed	Unconventional myosin-Ie (Unconventional myosin 1E)	Myo1e Myr3	Mus musculus (Mouse)	1107	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0030898; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015; GO:0098858	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN35294_c0_g1_i1	P70248	MYO1F_MOUSE	91.9	74	6	0	224	3	635	708	3.00E-34	145.2	MYO1F_MOUSE	reviewed	Unconventional myosin-If	Myo1f	Mus musculus (Mouse)	1099	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cell adhesion [GO:0007162]; neutrophil degranulation [GO:0043312]; neutrophil mediated immunity [GO:0002446]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0002446; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0007162; GO:0009617; GO:0015629; GO:0016459; GO:0030050; GO:0030335; GO:0030864; GO:0030898; GO:0031941; GO:0031982; GO:0032956; GO:0043312; GO:0045088; GO:0050830; GO:0051015; GO:0098858	actin filament organization [GO:0007015]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cell adhesion [GO:0007162]; neutrophil degranulation [GO:0043312]; neutrophil mediated immunity [GO:0002446]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN32764_c0_g1_i1	O00160	MYO1F_HUMAN	100	328	0	0	986	3	477	804	7.50E-191	667.5	MYO1F_HUMAN	reviewed	Unconventional myosin-If (Myosin-Ie)	MYO1F	Homo sapiens (Human)	1098	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0030898; GO:0031982; GO:0051015; GO:0098858	actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN4803_c2_g1_i1	O00160	MYO1F_HUMAN	100	233	0	0	2	700	2	234	6.00E-134	478	MYO1F_HUMAN	reviewed	Unconventional myosin-If (Myosin-Ie)	MYO1F	Homo sapiens (Human)	1098	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0030898; GO:0031982; GO:0051015; GO:0098858	actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN21672_c0_g1_i1	O00160	MYO1F_HUMAN	100	132	0	0	397	2	339	470	1.80E-71	269.6	MYO1F_HUMAN	reviewed	Unconventional myosin-If (Myosin-Ie)	MYO1F	Homo sapiens (Human)	1098	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin-based cell projection [GO:0098858]; actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0030898; GO:0031982; GO:0051015; GO:0098858	actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN37203_c0_g1_i1	Q5SUA5	MYO1G_MOUSE	100	72	0	0	2	217	564	635	4.70E-37	154.5	MYO1G_MOUSE	reviewed	Unconventional myosin-Ig	Myo1g	Mus musculus (Mouse)	1024	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis [GO:0006909]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0003774; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0006909; GO:0007015; GO:0015629; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0071976; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phagocytosis [GO:0006909]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN284_c0_g1_i10	B0I1T2	MYO1G_HUMAN	39.5	205	119	4	92	697	815	1017	1.70E-28	127.9	MYO1G_HUMAN	reviewed	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)]	MYO1G HA2	Homo sapiens (Human)	1018	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN37734_c0_g1_i1	B0I1T2	MYO1G_HUMAN	100	75	0	0	3	227	892	966	3.40E-38	158.3	MYO1G_HUMAN	reviewed	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)]	MYO1G HA2	Homo sapiens (Human)	1018	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g2_i5	B0I1T2	MYO1G_HUMAN	61.6	680	218	10	2000	3	26	676	2.70E-227	789.6	MYO1G_HUMAN	reviewed	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)]	MYO1G HA2	Homo sapiens (Human)	1018	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g2_i6	B0I1T2	MYO1G_HUMAN	99.7	352	1	0	1058	3	325	676	1.20E-207	723.4	MYO1G_HUMAN	reviewed	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)]	MYO1G HA2	Homo sapiens (Human)	1018	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN32199_c0_g1_i1	B0I1T2	MYO1G_HUMAN	100	72	0	0	1	216	674	745	2.20E-34	145.6	MYO1G_HUMAN	reviewed	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)]	MYO1G HA2	Homo sapiens (Human)	1018	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN39450_c0_g1_i1	B0I1T2	MYO1G_HUMAN	100	230	0	0	692	3	5	234	4.20E-132	471.9	MYO1G_HUMAN	reviewed	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)]	MYO1G HA2	Homo sapiens (Human)	1018	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0030898; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN4032_c0_g1_i2	B2RTY4	MYO9A_HUMAN	38.2	89	55	0	347	81	962	1050	2.00E-13	76.6	MYO9A_HUMAN	reviewed	Unconventional myosin-IXa (Unconventional myosin-9a)	MYO9A MYR7	Homo sapiens (Human)	2548	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; motor activity [GO:0003774]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]	actin binding [GO:0003779]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; motor activity [GO:0003774]	GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005829; GO:0007601; GO:0016021; GO:0016461; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0051056; GO:0150011	cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7068_c0_g1_i1	Q8C170	MYO9A_MOUSE	50.8	457	186	9	93	1388	10	452	2.00E-117	424.1	MYO9A_MOUSE	reviewed	Unconventional myosin-IXa (Unconventional myosin-9a)	Myo9a Myr7	Mus musculus (Mouse)	2542	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; myosin complex [GO:0016459]; synapse [GO:0045202]; actin binding [GO:0003779]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; motor activity [GO:0003774]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; myosin complex [GO:0016459]; synapse [GO:0045202]	actin binding [GO:0003779]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; motor activity [GO:0003774]	GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005737; GO:0016021; GO:0016459; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0150011	cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]		NA	NA	NA	NA	NA	NA
TRINITY_DN4032_c0_g1_i1	Q13459	MYO9B_HUMAN	33.8	160	102	1	620	141	902	1057	5.50E-22	105.9	MYO9B_HUMAN	reviewed	Unconventional myosin-IXb (Unconventional myosin-9b)	MYO9B MYR5	Homo sapiens (Human)	2157	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Rho GTPase binding [GO:0017048]; Roundabout binding [GO:0048495]; actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Rho GTPase binding [GO:0017048]; Roundabout binding [GO:0048495]	GO:0000146; GO:0003779; GO:0005096; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005884; GO:0005938; GO:0007266; GO:0015629; GO:0016020; GO:0016459; GO:0016887; GO:0017048; GO:0030048; GO:0035023; GO:0035385; GO:0043531; GO:0046872; GO:0048471; GO:0048495; GO:0051056	actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]		NA	NA	NA	NA	NA	NA
TRINITY_DN37844_c0_g1_i1	Q13459	MYO9B_HUMAN	100	96	0	0	3	290	216	311	1.60E-48	193	MYO9B_HUMAN	reviewed	Unconventional myosin-IXb (Unconventional myosin-9b)	MYO9B MYR5	Homo sapiens (Human)	2157	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Rho GTPase binding [GO:0017048]; Roundabout binding [GO:0048495]; actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Rho GTPase binding [GO:0017048]; Roundabout binding [GO:0048495]	GO:0000146; GO:0003779; GO:0005096; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005884; GO:0005938; GO:0007266; GO:0015629; GO:0016020; GO:0016459; GO:0016887; GO:0017048; GO:0030048; GO:0035023; GO:0035385; GO:0043531; GO:0046872; GO:0048471; GO:0048495; GO:0051056	actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]		NA	NA	NA	NA	NA	NA
TRINITY_DN5925_c0_g1_i3	Q9Y4I1	MYO5A_HUMAN	53.5	217	90	3	718	71	1649	1855	1.60E-58	227.6	MYO5A_HUMAN	reviewed	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)"	MYO5A MYH12	Homo sapiens (Human)	1855	"actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]"	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0000146; GO:0001726; GO:0001750; GO:0003723; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005882; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0015629; GO:0016020; GO:0016192; GO:0016461; GO:0017137; GO:0030048; GO:0030050; GO:0030073; GO:0030318; GO:0030426; GO:0030898; GO:0031585; GO:0031987; GO:0032252; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0035371; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042759; GO:0042802; GO:0043005; GO:0043025; GO:0048820; GO:0050808; GO:0051015; GO:0070062; GO:0072659; GO:0097718; GO:0098794; GO:0098978; GO:0099089; GO:0099566	"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5925_c0_g1_i5	Q9Y4I1	MYO5A_HUMAN	55.6	372	153	4	1180	71	1494	1855	1.20E-114	414.8	MYO5A_HUMAN	reviewed	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)"	MYO5A MYH12	Homo sapiens (Human)	1855	"actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]"	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0000146; GO:0001726; GO:0001750; GO:0003723; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005882; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0015629; GO:0016020; GO:0016192; GO:0016461; GO:0017137; GO:0030048; GO:0030050; GO:0030073; GO:0030318; GO:0030426; GO:0030898; GO:0031585; GO:0031987; GO:0032252; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0035371; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042759; GO:0042802; GO:0043005; GO:0043025; GO:0048820; GO:0050808; GO:0051015; GO:0070062; GO:0072659; GO:0097718; GO:0098794; GO:0098978; GO:0099089; GO:0099566	"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17301_c0_g1_i2	Q9Y4I1	MYO5A_HUMAN	50.9	55	27	0	1	165	892	946	8.70E-06	51.2	MYO5A_HUMAN	reviewed	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)"	MYO5A MYH12	Homo sapiens (Human)	1855	"actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]"	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; unconventional myosin complex [GO:0016461]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]	GO:0000146; GO:0001726; GO:0001750; GO:0003723; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005882; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0015629; GO:0016020; GO:0016192; GO:0016461; GO:0017137; GO:0030048; GO:0030050; GO:0030073; GO:0030318; GO:0030426; GO:0030898; GO:0031585; GO:0031987; GO:0032252; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0035371; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042759; GO:0042802; GO:0043005; GO:0043025; GO:0048820; GO:0050808; GO:0051015; GO:0070062; GO:0072659; GO:0097718; GO:0098794; GO:0098978; GO:0099089; GO:0099566	"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33623_c0_g1_i1	Q02440	MYO5A_CHICK	78.1	73	16	0	2	220	419	491	1.70E-26	119.4	MYO5A_CHICK	reviewed	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain p190) (Myosin-V)"	MYO5A	Gallus gallus (Chicken)	1829	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]	GO:0000139; GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0015629; GO:0016192; GO:0016459; GO:0030050; GO:0030898; GO:0031941; GO:0031982; GO:0032593; GO:0032869; GO:0051015; GO:0060001; GO:0072659	actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN5925_c0_g1_i2	Q02440	MYO5A_CHICK	51.5	227	103	2	767	90	1446	1666	2.70E-63	243.4	MYO5A_CHICK	reviewed	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain p190) (Myosin-V)"	MYO5A	Gallus gallus (Chicken)	1829	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]	GO:0000139; GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0015629; GO:0016192; GO:0016459; GO:0030050; GO:0030898; GO:0031941; GO:0031982; GO:0032593; GO:0032869; GO:0051015; GO:0060001; GO:0072659	actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN36578_c0_g1_i1	Q02440	MYO5A_CHICK	60.3	68	27	0	213	10	432	499	1.10E-18	93.6	MYO5A_CHICK	reviewed	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain p190) (Myosin-V)"	MYO5A	Gallus gallus (Chicken)	1829	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]	GO:0000139; GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0015629; GO:0016192; GO:0016459; GO:0030050; GO:0030898; GO:0031941; GO:0031982; GO:0032593; GO:0032869; GO:0051015; GO:0060001; GO:0072659	actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN35882_c0_g1_i1	Q9ULV0	MYO5B_HUMAN	51.5	103	50	0	310	2	709	811	7.20E-23	107.8	MYO5B_HUMAN	reviewed	Unconventional myosin-Vb	MYO5B KIAA1119	Homo sapiens (Human)	1848	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0003091; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0017137; GO:0030050; GO:0030659; GO:0030898; GO:0031982; GO:0032991; GO:0045179; GO:0051015; GO:0070062	actin filament organization [GO:0007015]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN34523_c0_g1_i1	P21271	MYO5B_MOUSE	81.8	66	12	0	222	25	633	698	2.80E-26	119	MYO5B_MOUSE	reviewed	Unconventional myosin-Vb	Myo5b Kiaa1119	Mus musculus (Mouse)	1818	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic recycling endosome membrane [GO:0098944]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic recycling endosome membrane [GO:0098944]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098871; GO:0098944; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543	"actin filament organization [GO:0007015]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34523_c0_g1_i2	P21271	MYO5B_MOUSE	81.8	66	12	0	222	25	633	698	4.50E-26	118.2	MYO5B_MOUSE	reviewed	Unconventional myosin-Vb	Myo5b Kiaa1119	Mus musculus (Mouse)	1818	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic recycling endosome membrane [GO:0098944]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic recycling endosome membrane [GO:0098944]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098871; GO:0098944; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543	"actin filament organization [GO:0007015]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN890_c0_g1_i1	P70569	MYO5B_RAT	36.9	103	61	2	100	399	816	917	1.20E-05	52.4	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN890_c0_g1_i2	P70569	MYO5B_RAT	36.9	103	61	2	45	344	816	917	7.10E-06	52.4	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN890_c0_g1_i4	P70569	MYO5B_RAT	32.6	138	87	3	3	401	781	917	1.60E-05	52	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13708_c0_g1_i1	P70569	MYO5B_RAT	39.7	73	40	2	237	25	679	749	4.00E-05	48.5	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g1_i1	P70569	MYO5B_RAT	80.3	66	13	0	198	1	200	265	3.10E-24	112.1	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g1_i2	P70569	MYO5B_RAT	76.3	139	33	0	420	4	126	264	1.30E-54	213.8	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g1_i3	P70569	MYO5B_RAT	81.3	139	26	0	420	4	126	264	2.20E-59	229.6	MYO5B_RAT	reviewed	Unconventional myosin-Vb (Myosin heavy chain myr 6)	Myo5b	Rattus norvegicus (Rat)	1846	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]"	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; ionotropic glutamate receptor binding [GO:0035255]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005903; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0016887; GO:0017137; GO:0030050; GO:0030898; GO:0031982; GO:0032880; GO:0032991; GO:0035255; GO:0043005; GO:0043025; GO:0043197; GO:0045179; GO:0045773; GO:0048471; GO:0050775; GO:0050804; GO:0051015; GO:0060997; GO:0098685; GO:0098978; GO:0099003; GO:0099159; GO:0099639; GO:1903078; GO:1903543; GO:1905430	"actin filament organization [GO:0007015]; cellular response to glycine [GO:1905430]; dendritic spine morphogenesis [GO:0060997]; endosomal transport [GO:0016197]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g2_i7	E1BPK6	MYO6_BOVIN	67.4	396	127	1	1184	3	408	803	4.50E-161	568.9	MYO6_BOVIN	reviewed	Unconventional myosin-VI (Unconventional myosin-6)	MYO6	Bos taurus (Bovine)	1295	actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005905; GO:0006897; GO:0007015; GO:0007605; GO:0015031; GO:0015629; GO:0016020; GO:0016459; GO:0030050; GO:0030136; GO:0030139; GO:0030175; GO:0030898; GO:0031982; GO:0032587; GO:0042472; GO:0042491; GO:0042995; GO:0048471; GO:0051015	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]		brown	brown	1	NA	NA	NA
TRINITY_DN36252_c0_g1_i1	Q9I8D1	MYO6_CHICK	52.4	82	36	1	6	251	142	220	8.30E-18	90.9	MYO6_CHICK	reviewed	Unconventional myosin-VI (Unconventional myosin-6)	MYO6 CMY6	Gallus gallus (Chicken)	1276	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; plus-end directed microfilament motor activity [GO:0060002]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]"	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]"	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; plus-end directed microfilament motor activity [GO:0060002]	GO:0000146; GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0016591; GO:0030048; GO:0030050; GO:0030136; GO:0030139; GO:0030175; GO:0030330; GO:0030665; GO:0030898; GO:0031410; GO:0031941; GO:0031965; GO:0031982; GO:0032587; GO:0042472; GO:0042491; GO:0042995; GO:0043531; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060002	"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9701_c0_g2_i4	Q9I8D1	MYO6_CHICK	65.2	749	257	3	2243	3	57	803	8.80E-296	1017.3	MYO6_CHICK	reviewed	Unconventional myosin-VI (Unconventional myosin-6)	MYO6 CMY6	Gallus gallus (Chicken)	1276	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; plus-end directed microfilament motor activity [GO:0060002]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]"	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]"	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; plus-end directed microfilament motor activity [GO:0060002]	GO:0000146; GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0016591; GO:0030048; GO:0030050; GO:0030136; GO:0030139; GO:0030175; GO:0030330; GO:0030665; GO:0030898; GO:0031410; GO:0031941; GO:0031965; GO:0031982; GO:0032587; GO:0042472; GO:0042491; GO:0042995; GO:0043531; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060002	"actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40932_c0_g1_i1	Q6PIF6	MYO7B_HUMAN	54.4	68	31	0	1	204	185	252	1.60E-15	82.8	MYO7B_HUMAN	reviewed	Unconventional myosin-VIIb	MYO7B	Homo sapiens (Human)	2116	actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007423; GO:0007605; GO:0015629; GO:0016459; GO:0030050; GO:0030154; GO:0030898; GO:0031982; GO:0051015; GO:0090651; GO:1904970	actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN33647_c0_g1_i1	Q5SV80	MYO19_MOUSE	54.4	68	31	0	25	228	406	473	1.40E-15	83.2	MYO19_MOUSE	reviewed	Unconventional myosin-XIX (Myosin head domain-containing protein 1)	Myo19 Myohd1	Mus musculus (Mouse)	963	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002]; actin filament organization [GO:0007015]; mitochondrion migration along actin filament [GO:0034642]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002]	GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030898; GO:0031982; GO:0032027; GO:0032465; GO:0034642; GO:0051015; GO:0060002; GO:0090140	actin filament organization [GO:0007015]; mitochondrion migration along actin filament [GO:0034642]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]; vesicle transport along actin filament [GO:0030050]		NA	NA	NA	NA	NA	NA
TRINITY_DN965_c0_g1_i1	D3ZFD0	MY18A_RAT	26	277	196	3	1511	705	1487	1762	4.90E-09	64.3	MY18A_RAT	reviewed	Unconventional myosin-XVIIIa	Myo18a	Rattus norvegicus (Rat)	2044	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0000139; GO:0003774; GO:0005524; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN965_c0_g1_i2	D3ZFD0	MY18A_RAT	26	277	196	3	1628	822	1487	1762	5.20E-09	64.3	MY18A_RAT	reviewed	Unconventional myosin-XVIIIa	Myo18a	Rattus norvegicus (Rat)	2044	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0000139; GO:0003774; GO:0005524; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN965_c0_g1_i3	D3ZFD0	MY18A_RAT	26	285	209	2	1673	822	1479	1762	4.10E-11	71.2	MY18A_RAT	reviewed	Unconventional myosin-XVIIIa	Myo18a	Rattus norvegicus (Rat)	2044	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0000139; GO:0003774; GO:0005524; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN965_c0_g1_i4	D3ZFD0	MY18A_RAT	26	285	209	2	1556	705	1479	1762	3.80E-11	71.2	MY18A_RAT	reviewed	Unconventional myosin-XVIIIa	Myo18a	Rattus norvegicus (Rat)	2044	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0000139; GO:0003774; GO:0005524; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN33696_c0_g1_i1	D3ZFD0	MY18A_RAT	66.7	69	23	0	208	2	388	456	2.30E-20	99	MY18A_RAT	reviewed	Unconventional myosin-XVIIIa	Myo18a	Rattus norvegicus (Rat)	2044	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; motor activity [GO:0003774]	GO:0000139; GO:0003774; GO:0005524; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i1	Q92614	MY18A_HUMAN	41.3	184	99	3	546	16	681	862	4.80E-30	132.5	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i10	Q92614	MY18A_HUMAN	46.6	73	39	0	270	52	765	837	2.90E-14	79.3	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i11	Q92614	MY18A_HUMAN	36.3	91	52	1	257	3	681	771	8.40E-05	47.8	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i2	Q92614	MY18A_HUMAN	44.8	306	158	5	906	16	559	862	3.40E-65	250	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i4	Q92614	MY18A_HUMAN	44	100	53	2	312	16	765	862	1.40E-17	90.5	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i6	Q92614	MY18A_HUMAN	39.2	130	73	1	375	4	681	810	4.60E-16	85.5	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN9523_c0_g1_i7	Q92614	MY18A_HUMAN	44.1	213	111	3	617	3	559	771	1.70E-39	164.1	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN40439_c0_g1_i1	Q92614	MY18A_HUMAN	56.1	66	29	0	210	13	1192	1257	1.40E-17	89.7	MY18A_HUMAN	reviewed	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ	Homo sapiens (Human)	2054	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynaptic Golgi apparatus [GO:0150051]; trans-Golgi network [GO:0005802]	actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:0150051; GO:1903028	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]		NA	NA	NA	NA	NA	NA
TRINITY_DN6154_c0_g1_i1	Q14146	URB2_HUMAN	24.1	162	123	0	588	103	1352	1513	3.70E-09	65.5	URB2_HUMAN	reviewed	Unhealthy ribosome biogenesis protein 2 homolog	URB2 KIAA0133	Homo sapiens (Human)	1524	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]		GO:0005730; GO:0016235; GO:0030496; GO:0042254	ribosome biogenesis [GO:0042254]		NA	NA	NA	NA	NA	NA
TRINITY_DN6883_c0_g1_i2	Q18161	YBPT_CAEEL	37.5	72	44	1	308	96	15	86	5.10E-08	58.9	YBPT_CAEEL	reviewed	UPF0046 protein C25E10.12	C25E10.12	Caenorhabditis elegans	281	hydrolase activity [GO:0016787]		hydrolase activity [GO:0016787]	GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN6883_c0_g1_i5	Q18161	YBPT_CAEEL	52.4	42	20	0	221	96	45	86	5.00E-06	51.6	YBPT_CAEEL	reviewed	UPF0046 protein C25E10.12	C25E10.12	Caenorhabditis elegans	281	hydrolase activity [GO:0016787]		hydrolase activity [GO:0016787]	GO:0016787			NA	NA	NA	NA	NA	NA
TRINITY_DN9921_c0_g1_i1	P0A2L2	YJBQ_SALTI	55.1	136	61	0	125	532	2	137	3.10E-39	163.3	YJBQ_SALTI	reviewed	UPF0047 protein YjbQ	yjbQ STY4446 t4156	Salmonella typhi	138							NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g2_i1	Q9VSH9	U183_DROME	68.5	143	45	0	96	524	1	143	7.30E-54	211.8	U183_DROME	reviewed	UPF0183 protein CG7083	CG7083	Drosophila melanogaster (Fruit fly)	438	trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]	trans-Golgi network [GO:0005802]		GO:0005802; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g2_i2	Q9VSH9	U183_DROME	75.5	49	12	0	96	242	1	49	3.30E-14	79	U183_DROME	reviewed	UPF0183 protein CG7083	CG7083	Drosophila melanogaster (Fruit fly)	438	trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]	trans-Golgi network [GO:0005802]		GO:0005802; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g2_i3	Q9VSH9	U183_DROME	58	419	163	5	96	1325	1	415	6.20E-138	492.3	U183_DROME	reviewed	UPF0183 protein CG7083	CG7083	Drosophila melanogaster (Fruit fly)	438	trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]	trans-Golgi network [GO:0005802]		GO:0005802; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g2_i5	Q9VSH9	U183_DROME	53.9	451	163	6	96	1421	1	415	8.40E-133	475.3	U183_DROME	reviewed	UPF0183 protein CG7083	CG7083	Drosophila melanogaster (Fruit fly)	438	trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]	trans-Golgi network [GO:0005802]		GO:0005802; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g2_i6	Q9VSH9	U183_DROME	54.4	447	163	5	96	1409	1	415	1.20E-134	481.5	U183_DROME	reviewed	UPF0183 protein CG7083	CG7083	Drosophila melanogaster (Fruit fly)	438	trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]	trans-Golgi network [GO:0005802]		GO:0005802; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN1603_c0_g2_i7	Q9VSH9	U183_DROME	58.6	415	163	4	96	1313	1	415	8.60E-140	498.4	U183_DROME	reviewed	UPF0183 protein CG7083	CG7083	Drosophila melanogaster (Fruit fly)	438	trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001]	trans-Golgi network [GO:0005802]		GO:0005802; GO:0043001	Golgi to plasma membrane protein transport [GO:0043001]		NA	NA	NA	NA	NA	NA
TRINITY_DN38347_c0_g1_i1	Q505I4	CO040_RAT	51.9	79	37	1	319	86	47	125	4.00E-13	75.5	CO040_RAT	reviewed	UPF0235 protein C15orf40 homolog		Rattus norvegicus (Rat)	126	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN3525_c0_g1_i1	Q3T197	CX056_BOVIN	56	218	90	4	91	726	1	218	2.20E-61	237.3	CX056_BOVIN	reviewed	UPF0428 protein CXorf56 homolog		Bos taurus (Bovine)	222	cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0044297			blue	blue	NA	NA	NA	NA
TRINITY_DN2142_c0_g1_i1	Q5M845	CD033_RAT	50	194	90	3	1333	767	1	192	7.80E-48	193	CD033_RAT	reviewed	UPF0462 protein C4orf33 homolog		Rattus norvegicus (Rat)	199							NA	NA	NA	NA	NA	NA
TRINITY_DN2142_c0_g1_i2	Q5M845	CD033_RAT	50	194	90	3	1301	735	1	192	7.70E-48	193	CD033_RAT	reviewed	UPF0462 protein C4orf33 homolog		Rattus norvegicus (Rat)	199							NA	NA	NA	NA	NA	NA
TRINITY_DN1628_c0_g1_i1	Q9D9H8	CB069_MOUSE	40.4	292	153	7	947	81	88	361	1.10E-53	212.2	CB069_MOUSE	reviewed	UPF0565 protein C2orf69 homolog		Mus musculus (Mouse)	365	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN1628_c0_g1_i2	Q9D9H8	CB069_MOUSE	40.6	288	150	7	935	81	92	361	4.20E-53	210.3	CB069_MOUSE	reviewed	UPF0565 protein C2orf69 homolog		Mus musculus (Mouse)	365	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN1628_c0_g1_i3	Q9D9H8	CB069_MOUSE	37.3	276	110	4	737	81	92	361	3.80E-46	186.4	CB069_MOUSE	reviewed	UPF0565 protein C2orf69 homolog		Mus musculus (Mouse)	365	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN1628_c0_g1_i4	Q9D9H8	CB069_MOUSE	38.8	317	173	7	1022	81	63	361	1.20E-55	218.8	CB069_MOUSE	reviewed	UPF0565 protein C2orf69 homolog		Mus musculus (Mouse)	365	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN495_c2_g1_i1	A7SJ66	U587_NEMVE	40	145	85	2	92	523	6	149	1.80E-27	124	U587_NEMVE	reviewed	UPF0587 protein v1g245604	v1g245604	Nematostella vectensis (Starlet sea anemone)	159	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN495_c2_g1_i4	A7SJ66	U587_NEMVE	40	145	85	2	92	523	6	149	1.50E-27	124.4	U587_NEMVE	reviewed	UPF0587 protein v1g245604	v1g245604	Nematostella vectensis (Starlet sea anemone)	159	zinc ion binding [GO:0008270]		zinc ion binding [GO:0008270]	GO:0008270			blue	blue	NA	NA	NA	NA
TRINITY_DN693_c0_g1_i1	Q6P1X6	CH082_HUMAN	53.4	193	83	4	157	732	24	210	1.10E-54	215.3	CH082_HUMAN	reviewed	UPF0598 protein C8orf82	C8orf82	Homo sapiens (Human)	216							NA	NA	NA	NA	NA	NA
TRINITY_DN693_c0_g1_i4	Q6P1X6	CH082_HUMAN	53.4	193	83	4	157	732	24	210	1.10E-54	215.3	CH082_HUMAN	reviewed	UPF0598 protein C8orf82	C8orf82	Homo sapiens (Human)	216							NA	NA	NA	NA	NA	NA
TRINITY_DN34461_c0_g1_i1	Q811S7	UBIP1_MOUSE	100	160	0	0	480	1	51	210	6.60E-92	337.8	UBIP1_MOUSE	reviewed	Upstream-binding protein 1 (Nuclear factor 2d9) (NF2d9)	Ubp1 Cp2b Nf2d9	Mus musculus (Mouse)	540	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0043565; GO:0045944; GO:1990837	angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34635_c0_g1_i1	Q8RD94	UPP_CALS4	60	50	20	0	212	63	160	209	1.90E-11	69.3	UPP_CALS4	reviewed	Uracil phosphoribosyltransferase (EC 2.4.2.9) (UMP pyrophosphorylase) (UPRTase)	upp TTE0147	Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) (Thermoanaerobacter tengcongensis)	210	GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; uracil phosphoribosyltransferase activity [GO:0004845]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]; uracil salvage [GO:0006223]		GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; uracil phosphoribosyltransferase activity [GO:0004845]	GO:0000287; GO:0004845; GO:0005525; GO:0006223; GO:0009116; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]; uracil salvage [GO:0006223]		red	red	NA	NA	NA	NA
TRINITY_DN16664_c0_g1_i1	A5H0J4	UPP_LACKL	50	54	27	0	162	1	21	74	1.60E-07	56.2	UPP_LACKL	reviewed	Uracil phosphoribosyltransferase (UPRTase) (EC 2.4.2.9) (Pyrimidine-degrading protein 16) (UMP pyrophosphorylase) (Uracil catabolism protein 6)	FUR1 PYD16 URC6	Lachancea kluyveri (Yeast) (Saccharomyces kluyveri)	216	GTP binding [GO:0005525]; uracil phosphoribosyltransferase activity [GO:0004845]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		GTP binding [GO:0005525]; uracil phosphoribosyltransferase activity [GO:0004845]	GO:0004845; GO:0005525; GO:0009116; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN5200_c0_g1_i1	Q6NYU7	UPP_DANRE	70.4	203	60	0	141	749	55	257	9.20E-81	301.6	UPP_DANRE	reviewed	Uracil phosphoribosyltransferase homolog	uprt zgc:77421	Danio rerio (Zebrafish) (Brachydanio rerio)	257	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; nucleoside metabolic process [GO:0009116]	cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]; kinase activity [GO:0016301]	GO:0005525; GO:0005634; GO:0005829; GO:0009116; GO:0016301	nucleoside metabolic process [GO:0009116]		NA	NA	NA	NA	NA	NA
TRINITY_DN5200_c0_g1_i2	Q6NYU7	UPP_DANRE	72.3	166	46	0	287	784	92	257	1.30E-66	254.6	UPP_DANRE	reviewed	Uracil phosphoribosyltransferase homolog	uprt zgc:77421	Danio rerio (Zebrafish) (Brachydanio rerio)	257	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; nucleoside metabolic process [GO:0009116]	cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]; kinase activity [GO:0016301]	GO:0005525; GO:0005634; GO:0005829; GO:0009116; GO:0016301	nucleoside metabolic process [GO:0009116]		NA	NA	NA	NA	NA	NA
TRINITY_DN5200_c0_g1_i3	Q6NYU7	UPP_DANRE	70.4	203	60	0	138	746	55	257	1.20E-80	301.2	UPP_DANRE	reviewed	Uracil phosphoribosyltransferase homolog	uprt zgc:77421	Danio rerio (Zebrafish) (Brachydanio rerio)	257	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; nucleoside metabolic process [GO:0009116]	cytosol [GO:0005829]; nucleus [GO:0005634]	GTP binding [GO:0005525]; kinase activity [GO:0016301]	GO:0005525; GO:0005634; GO:0005829; GO:0009116; GO:0016301	nucleoside metabolic process [GO:0009116]		NA	NA	NA	NA	NA	NA
TRINITY_DN34261_c0_g1_i1	Q96BW1	UPP_HUMAN	100	80	0	0	2	241	117	196	2.90E-40	165.2	UPP_HUMAN	reviewed	Uracil phosphoribosyltransferase homolog	UPRT	Homo sapiens (Human)	309	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	GTP binding [GO:0005525]; kinase activity [GO:0016301]	GO:0005525; GO:0005654; GO:0005829; GO:0006222; GO:0007565; GO:0007595; GO:0009116; GO:0016301; GO:0032868; GO:0043231	female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222]		NA	NA	NA	NA	NA	NA
TRINITY_DN5618_c0_g1_i1	Q92LU5	UNG_RHIME	80.2	121	24	0	7	369	49	169	9.40E-54	210.7	UNG_RHIME	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	ung R02926 SMc03195	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	241	cytoplasm [GO:0005737]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]	cytoplasm [GO:0005737]	uracil DNA N-glycosylase activity [GO:0004844]	GO:0004844; GO:0005737; GO:0006284	base-excision repair [GO:0006284]		NA	NA	NA	NA	NA	NA
TRINITY_DN7519_c0_g1_i1	Q8EB78	UNG_SHEON	54.3	94	37	2	269	6	15	108	3.10E-22	105.5	UNG_SHEON	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	ung SO_3654	Shewanella oneidensis (strain MR-1)	218	"cytoplasm [GO:0005737]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]"	cytoplasm [GO:0005737]	uracil DNA N-glycosylase activity [GO:0004844]	GO:0004844; GO:0005737; GO:0097510	"base-excision repair, AP site formation via deaminated base removal [GO:0097510]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20002_c0_g1_i1	Q92LU5	UNG_RHIME	82.4	102	18	0	306	1	72	173	1.10E-47	190.3	UNG_RHIME	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	ung R02926 SMc03195	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	241	cytoplasm [GO:0005737]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]	cytoplasm [GO:0005737]	uracil DNA N-glycosylase activity [GO:0004844]	GO:0004844; GO:0005737; GO:0006284	base-excision repair [GO:0006284]		NA	NA	NA	NA	NA	NA
TRINITY_DN33807_c0_g1_i1	P13051	UNG_HUMAN	100	159	0	0	1	477	127	285	3.70E-95	348.6	UNG_HUMAN	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	UNG DGU UNG1 UNG15	Homo sapiens (Human)	313	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; viral process [GO:0016032]"	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0016032; GO:0016446; GO:0043024; GO:0043066; GO:0045008; GO:0045190; GO:0097510	"base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36410_c0_g1_i1	A7I0A8	UNG_CAMHC	47.4	78	36	1	1	219	55	132	8.70E-15	80.5	UNG_CAMHC	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	ung CHAB381_0347	Campylobacter hominis (strain ATCC BAA-381 / LMG 19568 / NCTC 13146 / CH001A)	235	cytoplasm [GO:0005737]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]	cytoplasm [GO:0005737]	uracil DNA N-glycosylase activity [GO:0004844]	GO:0004844; GO:0005737; GO:0006284	base-excision repair [GO:0006284]		NA	NA	NA	NA	NA	NA
TRINITY_DN15992_c0_g1_i1	P13051	UNG_HUMAN	57.2	276	110	2	858	31	46	313	3.40E-91	336.3	UNG_HUMAN	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	UNG DGU UNG1 UNG15	Homo sapiens (Human)	313	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; viral process [GO:0016032]"	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0016032; GO:0016446; GO:0043024; GO:0043066; GO:0045008; GO:0045190; GO:0097510	"base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15992_c0_g1_i4	P13051	UNG_HUMAN	66	106	36	0	348	31	208	313	2.80E-40	166	UNG_HUMAN	reviewed	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	UNG DGU UNG1 UNG15	Homo sapiens (Human)	313	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; viral process [GO:0016032]"	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]	GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0016032; GO:0016446; GO:0043024; GO:0043066; GO:0045008; GO:0045190; GO:0097510	"base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38923_c0_g1_i1	P32528	DUR1_YEAST	56.6	152	66	0	2	457	747	898	6.00E-42	171.8	DUR1_YEAST	reviewed	Urea amidolyase [Includes: Urea carboxylase (EC 6.3.4.6); Allophanate hydrolase (EC 3.5.1.54)]	"DUR1,2 YBR208C YBR1448"	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1835	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; allophanate hydrolase activity [GO:0004039]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; urea carboxylase activity [GO:0004847]; allantoin catabolic process [GO:0000256]; urea catabolic process [GO:0043419]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	allophanate hydrolase activity [GO:0004039]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; urea carboxylase activity [GO:0004847]	GO:0000256; GO:0004039; GO:0004485; GO:0004847; GO:0005524; GO:0005737; GO:0005739; GO:0016421; GO:0043419; GO:0046872	allantoin catabolic process [GO:0000256]; urea catabolic process [GO:0043419]		NA	NA	NA	NA	NA	NA
TRINITY_DN31124_c0_g1_i1	P32528	DUR1_YEAST	57.4	129	54	1	14	400	825	952	4.80E-38	158.7	DUR1_YEAST	reviewed	Urea amidolyase [Includes: Urea carboxylase (EC 6.3.4.6); Allophanate hydrolase (EC 3.5.1.54)]	"DUR1,2 YBR208C YBR1448"	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1835	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; allophanate hydrolase activity [GO:0004039]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; urea carboxylase activity [GO:0004847]; allantoin catabolic process [GO:0000256]; urea catabolic process [GO:0043419]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	allophanate hydrolase activity [GO:0004039]; ATP binding [GO:0005524]; CoA carboxylase activity [GO:0016421]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; urea carboxylase activity [GO:0004847]	GO:0000256; GO:0004039; GO:0004485; GO:0004847; GO:0005524; GO:0005737; GO:0005739; GO:0016421; GO:0043419; GO:0046872	allantoin catabolic process [GO:0000256]; urea catabolic process [GO:0043419]		NA	NA	NA	NA	NA	NA
TRINITY_DN36427_c0_g1_i1	P16163	URIC_DROME	49.1	342	142	5	1014	85	7	348	4.20E-83	309.7	URIC_DROME	reviewed	Uricase (EC 1.7.3.3) (Urate oxidase)	Uro UO CG7171	Drosophila melanogaster (Fruit fly)	352	peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]	peroxisome [GO:0005777]	urate oxidase activity [GO:0004846]	GO:0004846; GO:0005777; GO:0006144; GO:0019428; GO:0019628	allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]		NA	NA	NA	NA	NA	1
TRINITY_DN21120_c0_g1_i2	P11172	UMPS_HUMAN	100	89	0	0	268	2	236	324	1.90E-43	176	UMPS_HUMAN	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (EC 4.1.1.23) (OMPdecase)]	UMPS OK/SW-cl.21	Homo sapiens (Human)	480	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleoside biosynthetic process [GO:0046134]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006222; GO:0007565; GO:0007595; GO:0019856; GO:0035690; GO:0042802; GO:0044205; GO:0046134	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleoside biosynthetic process [GO:0046134]; UMP biosynthetic process [GO:0006222]		NA	NA	NA	NA	NA	NA
TRINITY_DN3992_c3_g1_i1	P11172	UMPS_HUMAN	49.8	472	222	3	115	1503	12	477	1.50E-122	441.4	UMPS_HUMAN	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (EC 4.1.1.23) (OMPdecase)]	UMPS OK/SW-cl.21	Homo sapiens (Human)	480	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleoside biosynthetic process [GO:0046134]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006222; GO:0007565; GO:0007595; GO:0019856; GO:0035690; GO:0042802; GO:0044205; GO:0046134	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleoside biosynthetic process [GO:0046134]; UMP biosynthetic process [GO:0006222]		brown	brown	NA	NA	NA	NA
TRINITY_DN3992_c3_g1_i5	P11172	UMPS_HUMAN	49.8	472	222	3	115	1503	12	477	1.50E-122	441.4	UMPS_HUMAN	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (EC 4.1.1.23) (OMPdecase)]	UMPS OK/SW-cl.21	Homo sapiens (Human)	480	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleoside biosynthetic process [GO:0046134]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006222; GO:0007565; GO:0007595; GO:0019856; GO:0035690; GO:0042802; GO:0044205; GO:0046134	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleoside biosynthetic process [GO:0046134]; UMP biosynthetic process [GO:0006222]		brown	brown	1	NA	NA	NA
TRINITY_DN21120_c0_g1_i1	P13439	UMPS_MOUSE	98.2	113	2	0	339	1	237	349	6.40E-57	221.1	UMPS_MOUSE	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)]	Umps	Mus musculus (Mouse)	481	cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0006207; GO:0006222; GO:0007565; GO:0007595; GO:0009116; GO:0019856; GO:0035690; GO:0042802; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]		NA	NA	NA	NA	NA	NA
TRINITY_DN3992_c3_g1_i2	Q8RZA1	UMPS2_ORYSJ	52.4	82	39	0	88	333	1	82	1.90E-18	93.6	UMPS2_ORYSJ	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)]	UMPS2 Os01g0951400 LOC_Os01g72250 B1147A04.39	Oryza sativa subsp. japonica (Rice)	475	orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]		orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0006207; GO:0006222; GO:0009116; GO:0019856; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]		NA	NA	NA	NA	NA	NA
TRINITY_DN3992_c3_g1_i3	Q5R514	UMPS_PONAB	47.7	197	90	2	1	570	179	369	5.70E-42	172.2	UMPS_PONAB	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)]	UMPS	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	480	orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; nucleoside metabolic process [GO:0009116]		orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0006207; GO:0009116; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; nucleoside metabolic process [GO:0009116]		NA	NA	NA	NA	NA	NA
TRINITY_DN3992_c3_g1_i4	P13439	UMPS_MOUSE	52	179	84	1	88	618	3	181	7.00E-44	178.7	UMPS_MOUSE	reviewed	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)]	Umps	Mus musculus (Mouse)	481	cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0006207; GO:0006222; GO:0007565; GO:0007595; GO:0009116; GO:0019856; GO:0035690; GO:0042802; GO:0044205	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]		NA	NA	NA	NA	NA	NA
TRINITY_DN4346_c0_g1_i12	Q9D142	NUD14_MOUSE	43.2	227	103	4	928	296	1	217	6.50E-46	186	NUD14_MOUSE	reviewed	Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14)	Nudt14	Mus musculus (Mouse)	222	cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]	cytoplasm [GO:0005737]	ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	GO:0005737; GO:0006753; GO:0008768; GO:0019693; GO:0042802; GO:0046872; GO:0047631	nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]		blue	blue	NA	NA	NA	NA
TRINITY_DN4346_c0_g1_i2	Q9D142	NUD14_MOUSE	43.2	227	103	4	910	278	1	217	3.70E-46	186.8	NUD14_MOUSE	reviewed	Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14)	Nudt14	Mus musculus (Mouse)	222	cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]	cytoplasm [GO:0005737]	ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	GO:0005737; GO:0006753; GO:0008768; GO:0019693; GO:0042802; GO:0046872; GO:0047631	nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]		NA	NA	NA	NA	NA	NA
TRINITY_DN4346_c0_g1_i4	Q9D142	NUD14_MOUSE	43.2	227	103	4	859	227	1	217	3.50E-46	186.8	NUD14_MOUSE	reviewed	Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14)	Nudt14	Mus musculus (Mouse)	222	cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]	cytoplasm [GO:0005737]	ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	GO:0005737; GO:0006753; GO:0008768; GO:0019693; GO:0042802; GO:0046872; GO:0047631	nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]		NA	NA	NA	NA	NA	NA
TRINITY_DN4346_c0_g1_i5	Q9D142	NUD14_MOUSE	43.2	227	103	4	877	245	1	217	6.10E-46	186	NUD14_MOUSE	reviewed	Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14)	Nudt14	Mus musculus (Mouse)	222	cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]	cytoplasm [GO:0005737]	ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	GO:0005737; GO:0006753; GO:0008768; GO:0019693; GO:0042802; GO:0046872; GO:0047631	nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693]		NA	NA	NA	NA	NA	NA
TRINITY_DN15131_c0_g1_i1	Q6P9U1	NUD22_RAT	36.1	241	144	4	985	275	16	250	1.10E-34	149.1	NUD22_RAT	reviewed	Uridine diphosphate glucose pyrophosphatase NUDT22 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 22) (Nudix motif 22)	Nudt22	Rattus norvegicus (Rat)	308	nucleoplasm [GO:0005654]; GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	nucleoplasm [GO:0005654]	GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	GO:0005654; GO:0008768; GO:0046872; GO:0052751			NA	NA	NA	NA	NA	NA
TRINITY_DN39427_c0_g1_i1	Q9SJM7	URH1_ARATH	37.9	95	56	1	299	15	23	114	3.30E-10	65.9	URH1_ARATH	reviewed	Uridine nucleosidase 1 (EC 3.2.2.3) (Uridine ribohydrolase 1)	URH1 At2g36310 F2H17.8	Arabidopsis thaliana (Mouse-ear cress)	336	cytosol [GO:0005829]; adenosine nucleosidase activity [GO:0047622]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585]; purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218]	cytosol [GO:0005829]	adenosine nucleosidase activity [GO:0047622]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585]	GO:0005829; GO:0006152; GO:0006218; GO:0008477; GO:0045437; GO:0047622; GO:0047724; GO:0072585	purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218]		NA	NA	NA	NA	NA	NA
TRINITY_DN7229_c0_g1_i1	P52624	UPP1_MOUSE	48.4	157	81	0	590	120	153	309	3.30E-37	156.4	UPP1_MOUSE	reviewed	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	Upp1 Up Upp	Mus musculus (Mouse)	311	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005654; GO:0005737; GO:0006218; GO:0006220; GO:0009166; GO:0042149; GO:0042802; GO:0044206; GO:0046108	cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]		NA	NA	NA	NA	NA	NA
TRINITY_DN7229_c0_g1_i3	P52624	UPP1_MOUSE	49.8	271	135	1	898	86	13	282	1.30E-75	284.6	UPP1_MOUSE	reviewed	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	Upp1 Up Upp	Mus musculus (Mouse)	311	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005654; GO:0005737; GO:0006218; GO:0006220; GO:0009166; GO:0042149; GO:0042802; GO:0044206; GO:0046108	cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]		NA	NA	NA	NA	NA	NA
TRINITY_DN7229_c0_g1_i6	P52624	UPP1_MOUSE	47.1	70	37	0	293	84	13	82	4.60E-14	78.6	UPP1_MOUSE	reviewed	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	Upp1 Up Upp	Mus musculus (Mouse)	311	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005654; GO:0005737; GO:0006218; GO:0006220; GO:0009166; GO:0042149; GO:0042802; GO:0044206; GO:0046108	cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]		NA	NA	NA	NA	NA	NA
TRINITY_DN7229_c0_g1_i7	P52624	UPP1_MOUSE	48.4	157	81	0	588	118	153	309	3.30E-37	156.4	UPP1_MOUSE	reviewed	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	Upp1 Up Upp	Mus musculus (Mouse)	311	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005654; GO:0005737; GO:0006218; GO:0006220; GO:0009166; GO:0042149; GO:0042802; GO:0044206; GO:0046108	cellular response to glucose starvation [GO:0042149]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]		NA	NA	NA	NA	NA	NA
TRINITY_DN35629_c0_g1_i1	Q16831	UPP1_HUMAN	100	140	0	0	437	18	171	310	3.10E-72	272.3	UPP1_HUMAN	reviewed	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	UPP1 UP	Homo sapiens (Human)	310	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005654; GO:0005829; GO:0006139; GO:0006218; GO:0009166; GO:0042149; GO:0042802; GO:0043097; GO:0044206; GO:0046135	cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]		NA	NA	NA	NA	NA	NA
TRINITY_DN7229_c0_g1_i4	O95045	UPP2_HUMAN	52	148	70	1	454	11	25	171	8.30E-42	171.4	UPP2_HUMAN	reviewed	Uridine phosphorylase 2 (UPase 2) (UrdPase 2) (EC 2.4.2.3)	UPP2	Homo sapiens (Human)	317	cytosol [GO:0005829]; type III intermediate filament [GO:0045098]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]	cytosol [GO:0005829]; type III intermediate filament [GO:0045098]	identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005829; GO:0006218; GO:0009116; GO:0009166; GO:0042802; GO:0043097; GO:0044206; GO:0045098; GO:0046108; GO:0046135	nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108]		NA	NA	NA	NA	NA	NA
TRINITY_DN25320_c0_g1_i1	P52623	UCK1_MOUSE	98.7	154	2	0	464	3	84	237	1.10E-83	310.5	UCK1_MOUSE	reviewed	Uridine-cytidine kinase 1 (UCK 1) (EC 2.7.1.48) (Cytidine monophosphokinase 1) (Uridine monophosphokinase 1)	Uck1 Umpk	Mus musculus (Mouse)	277	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]	cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN25320_c0_g1_i2	P52623	UCK1_MOUSE	99.3	147	1	0	443	3	91	237	2.30E-78	292.7	UCK1_MOUSE	reviewed	Uridine-cytidine kinase 1 (UCK 1) (EC 2.7.1.48) (Cytidine monophosphokinase 1) (Uridine monophosphokinase 1)	Uck1 Umpk	Mus musculus (Mouse)	277	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]	cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN35820_c0_g1_i1	Q9BZX2	UCK2_HUMAN	100	121	0	0	365	3	62	182	2.40E-62	239.2	UCK2_HUMAN	reviewed	Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2)	UCK2 UMPK	Homo sapiens (Human)	261	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]	cytosol [GO:0005829]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0042802; GO:0043097; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN10971_c0_g1_i1	Q7SYM0	UCK2A_DANRE	67.8	236	75	1	719	15	2	237	1.10E-86	321.6	UCK2A_DANRE	reviewed	Uridine-cytidine kinase 2-A (UCK 2-A) (EC 2.7.1.48) (Cytidine monophosphokinase 2-A) (Uridine monophosphokinase 2-A)	uck2a si:ch211-216k22.2	Danio rerio (Zebrafish) (Brachydanio rerio)	261	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]	cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN10971_c0_g1_i2	Q7SYM0	UCK2A_DANRE	68.8	231	71	1	693	4	2	232	3.00E-86	320.1	UCK2A_DANRE	reviewed	Uridine-cytidine kinase 2-A (UCK 2-A) (EC 2.7.1.48) (Cytidine monophosphokinase 2-A) (Uridine monophosphokinase 2-A)	uck2a si:ch211-216k22.2	Danio rerio (Zebrafish) (Brachydanio rerio)	261	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]	cytosol [GO:0005829]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN32838_c0_g1_i1	Q9NWZ5	UCKL1_HUMAN	100	120	0	0	2	361	65	184	8.80E-65	247.3	UCKL1_HUMAN	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	UCKL1 URKL1 F538	Homo sapiens (Human)	548	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005829; GO:0016032; GO:0016301; GO:0043097; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN3794_c0_g1_i1	Q91YL3	UCKL1_MOUSE	65.9	396	135	0	346	1533	138	533	2.20E-147	523.9	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN3794_c0_g1_i1	Q91YL3	UCKL1_MOUSE	55	60	20	3	171	347	49	102	3.20E-05	51.6	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN3794_c0_g1_i2	Q91YL3	UCKL1_MOUSE	65.8	491	161	3	171	1640	49	533	3.40E-178	626.3	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN3794_c0_g1_i3	Q91YL3	UCKL1_MOUSE	67.3	339	111	0	346	1362	195	533	2.80E-125	450.3	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN3794_c0_g1_i3	Q91YL3	UCKL1_MOUSE	54.2	59	20	3	171	344	49	101	1.90E-04	48.9	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN3794_c0_g1_i4	Q91YL3	UCKL1_MOUSE	59.1	491	137	4	171	1469	49	533	1.90E-148	527.3	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN29822_c0_g1_i1	Q91YL3	UCKL1_MOUSE	99.2	266	2	0	800	3	43	308	5.70E-149	528.1	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN38069_c0_g1_i1	Q91YL3	UCKL1_MOUSE	100	113	0	0	340	2	322	434	1.10E-59	230.3	UCKL1_MOUSE	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	Uckl1 Urkl1	Mus musculus (Mouse)	548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0009116; GO:0016301; GO:0044206	nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]		NA	NA	NA	NA	NA	NA
TRINITY_DN26288_c0_g1_i1	Q9NWZ5	UCKL1_HUMAN	100	98	0	0	300	7	451	548	1.50E-49	196.4	UCKL1_HUMAN	reviewed	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	UCKL1 URKL1 F538	Homo sapiens (Human)	548	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005634; GO:0005829; GO:0016032; GO:0016301; GO:0043097; GO:0044206; GO:0044211	CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN22009_c0_g1_i1	Q8VC12	HUTU_MOUSE	68.3	142	45	0	1	426	100	241	9.40E-53	207.6	HUTU_MOUSE	reviewed	Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	Uroc1	Mus musculus (Mouse)	676	cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytosol [GO:0005829]	urocanate hydratase activity [GO:0016153]	GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557	histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN26697_c0_g1_i1	A6VDL7	HUTU_PSEA7	90.5	116	11	0	3	350	75	190	1.00E-57	223.8	HUTU_PSEA7	reviewed	Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	hutU PSPA7_5833	Pseudomonas aeruginosa (strain PA7)	559	cytoplasm [GO:0005737]; urocanate hydratase activity [GO:0016153]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytoplasm [GO:0005737]	urocanate hydratase activity [GO:0016153]	GO:0005737; GO:0016153; GO:0019556; GO:0019557	histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN9783_c0_g1_i1	Q8VC12	HUTU_MOUSE	69.5	673	203	2	2102	87	3	674	2.70E-281	969.1	HUTU_MOUSE	reviewed	Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	Uroc1	Mus musculus (Mouse)	676	cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytosol [GO:0005829]	urocanate hydratase activity [GO:0016153]	GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557	histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN9783_c0_g1_i3	Q8VC12	HUTU_MOUSE	69.5	673	203	2	2102	87	3	674	2.00E-281	969.5	HUTU_MOUSE	reviewed	Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	Uroc1	Mus musculus (Mouse)	676	cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytosol [GO:0005829]	urocanate hydratase activity [GO:0016153]	GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557	histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN27823_c0_g1_i1	Q8VC12	HUTU_MOUSE	69.9	146	43	1	34	468	484	629	3.10E-54	212.6	HUTU_MOUSE	reviewed	Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	Uroc1	Mus musculus (Mouse)	676	cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytosol [GO:0005829]	urocanate hydratase activity [GO:0016153]	GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557	histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]		NA	NA	NA	NA	NA	NA
TRINITY_DN4105_c0_g1_i11	P15120	UROK_CHICK	28.1	242	139	10	758	81	198	420	2.20E-15	84.3	UROK_CHICK	reviewed	Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator chain A; Urokinase-type plasminogen activator chain B]	PLAU	Gallus gallus (Chicken)	434	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; plasminogen activation [GO:0031639]; proteolysis [GO:0006508]; regulation of cell adhesion mediated by integrin [GO:0033628]	extracellular space [GO:0005615]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508; GO:0031639; GO:0033628	plasminogen activation [GO:0031639]; proteolysis [GO:0006508]; regulation of cell adhesion mediated by integrin [GO:0033628]		NA	NA	NA	NA	NA	NA
TRINITY_DN33832_c0_g1_i1	Q9Y2C2	UST_HUMAN	35.4	96	54	3	30	311	171	260	5.70E-12	71.6	UST_HUMAN	reviewed	Uronyl 2-sulfotransferase (EC 2.8.2.-)	UST DS2ST	Homo sapiens (Human)	406	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770	dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]		NA	NA	NA	NA	NA	NA
TRINITY_DN33832_c0_g1_i2	Q9Y2C2	UST_HUMAN	32.5	160	98	4	3	476	109	260	3.20E-22	106.3	UST_HUMAN	reviewed	Uronyl 2-sulfotransferase (EC 2.8.2.-)	UST DS2ST	Homo sapiens (Human)	406	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770	dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770]		NA	NA	NA	NA	NA	NA
TRINITY_DN24581_c0_g1_i1	B2UGT5	DCUP_RALPJ	99.2	124	1	0	3	374	2	125	3.50E-64	245.4	DCUP_RALPJ	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	hemE Rpic_3498	Ralstonia pickettii (strain 12J)	367	cytoplasm [GO:0005737]; uroporphyrinogen decarboxylase activity [GO:0004853]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005737; GO:0006782	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN2537_c0_g1_i1	Q5RDK5	DCUP_PONAB	59	266	109	0	48	845	97	362	8.90E-93	341.7	DCUP_PONAB	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	UROD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	367	cytoplasm [GO:0005737]; uroporphyrinogen decarboxylase activity [GO:0004853]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005737; GO:0006782	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN2537_c0_g1_i2	Q8HY31	DCUP_SHEEP	62.5	357	134	0	224	1294	6	362	7.60E-133	475.3	DCUP_SHEEP	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	UROD	Ovis aries (Sheep)	367	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005654; GO:0005829; GO:0006782	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN2537_c0_g1_i3	P06132	DCUP_HUMAN	58.7	155	64	0	439	903	208	362	3.60E-52	206.8	DCUP_HUMAN	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	UROD	Homo sapiens (Human)	367	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005654; GO:0005829; GO:0006782; GO:0006783	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN2537_c0_g1_i3	P06132	DCUP_HUMAN	58.6	116	48	0	48	395	97	212	2.90E-33	144.1	DCUP_HUMAN	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	UROD	Homo sapiens (Human)	367	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005654; GO:0005829; GO:0006782; GO:0006783	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN23715_c0_g1_i1	P06132	DCUP_HUMAN	100	333	0	0	1048	50	35	367	3.40E-194	678.7	DCUP_HUMAN	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	UROD	Homo sapiens (Human)	367	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005654; GO:0005829; GO:0006782; GO:0006783	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN36076_c0_g1_i1	Q2GC56	DCUP_NOVAD	85.9	99	14	0	1	297	9	107	4.20E-44	178.3	DCUP_NOVAD	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	hemE Saro_0118	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	341	cytoplasm [GO:0005737]; uroporphyrinogen decarboxylase activity [GO:0004853]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005737; GO:0006782	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN31842_c0_g1_i1	A1SMY9	DCUP_NOCSJ	75.3	81	20	0	246	4	32	112	3.10E-29	128.6	DCUP_NOCSJ	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	hemE Noca_3674	Nocardioides sp. (strain ATCC BAA-499 / JS614)	345	cytoplasm [GO:0005737]; uroporphyrinogen decarboxylase activity [GO:0004853]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005737; GO:0006782	protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN32137_c0_g1_i1	P32347	DCUP_YEAST	60.6	99	36	2	3	296	11	107	3.00E-26	119	DCUP_YEAST	reviewed	Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)	HEM12 HEM6 POP3 YDR047W YD9609.03	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	362	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005634; GO:0005737; GO:0005829; GO:0006782; GO:0006783	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]		NA	NA	NA	NA	NA	NA
TRINITY_DN20827_c0_g1_i1	Q495M9	USH1G_HUMAN	33.3	87	53	1	379	119	61	142	1.80E-05	50.4	USH1G_HUMAN	reviewed	Usher syndrome type-1G protein (Scaffold protein containing ankyrin repeats and SAM domain)	USH1G SANS	Homo sapiens (Human)	461	actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; spectrin binding [GO:0030507]; equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]	actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; spectrin binding [GO:0030507]	GO:0001917; GO:0005829; GO:0005886; GO:0007605; GO:0015629; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0045494; GO:0050953; GO:0050957; GO:0060122	equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN2231_c0_g1_i2	Q80XC3	US6NL_MOUSE	56.9	276	115	3	95	919	3	275	9.90E-90	331.6	US6NL_MOUSE	reviewed	USP6 N-terminal-like protein	Usp6nl Kiaa0019	Mus musculus (Mouse)	819	"cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005794; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"		NA	NA	1	NA	NA	NA
TRINITY_DN2231_c0_g1_i1	Q80XC3	US6NL_MOUSE	55.4	372	162	3	95	1207	3	371	1.10E-120	435.6	US6NL_MOUSE	reviewed	USP6 N-terminal-like protein	Usp6nl Kiaa0019	Mus musculus (Mouse)	819	"cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005794; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2231_c0_g1_i3	Q80XC3	US6NL_MOUSE	55.4	372	162	3	95	1207	3	371	6.80E-121	435.6	US6NL_MOUSE	reviewed	USP6 N-terminal-like protein	Usp6nl Kiaa0019	Mus musculus (Mouse)	819	"cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005794; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2231_c0_g1_i5	Q80XC3	US6NL_MOUSE	55.3	374	163	3	95	1213	3	373	4.40E-122	439.5	US6NL_MOUSE	reviewed	USP6 N-terminal-like protein	Usp6nl Kiaa0019	Mus musculus (Mouse)	819	"cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005794; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2231_c0_g1_i4	Q92738	US6NL_HUMAN	75	40	8	1	98	217	136	173	2.30E-10	66.2	US6NL_HUMAN	reviewed	USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre)	USP6NL KIAA0019	Homo sapiens (Human)	828	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17079_c0_g1_i3	P46939	UTRO_HUMAN	53.4	178	68	5	12	509	3179	3353	7.20E-37	155.2	UTRO_HUMAN	reviewed	Utrophin (Dystrophin-related protein 1) (DRP-1)	UTRN DMDL DRP1	Homo sapiens (Human)	3433	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; response to denervation involved in regulation of muscle adaptation [GO:0014894]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]	GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006936; GO:0007517; GO:0007528; GO:0008270; GO:0014894; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030175; GO:0030426; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0042383; GO:0045211; GO:0051015; GO:0070062; GO:2000649	muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; response to denervation involved in regulation of muscle adaptation [GO:0014894]		NA	NA	NA	NA	NA	NA
TRINITY_DN7431_c0_g1_i1	Q8K245	UVRAG_MOUSE	31.8	443	268	9	1436	120	41	453	7.80E-48	193.4	UVRAG_MOUSE	reviewed	UV radiation resistance-associated protein	Uvrag Uvrag1	Mus musculus (Mouse)	698	"autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]; SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]"	"autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]"	SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]	GO:0000149; GO:0000323; GO:0000421; GO:0000775; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035493; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0071900; GO:0097352; GO:0097680	"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7431_c0_g1_i2	Q8K245	UVRAG_MOUSE	31.2	465	281	10	1483	116	41	475	2.10E-48	195.3	UVRAG_MOUSE	reviewed	UV radiation resistance-associated protein	Uvrag Uvrag1	Mus musculus (Mouse)	698	"autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]; SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]"	"autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]"	SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]	GO:0000149; GO:0000323; GO:0000421; GO:0000775; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035493; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0071900; GO:0097352; GO:0097680	"autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15324_c0_g1_i1	Q9D479	UVSSA_MOUSE	32.6	711	389	17	135	2012	5	710	4.40E-76	287.3	UVSSA_MOUSE	reviewed	UV-stimulated scaffold protein A	Uvssa Kiaa1530	Mus musculus (Mouse)	717	chromosome [GO:0005694]; RNA polymerase II complex binding [GO:0000993]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]	chromosome [GO:0005694]	RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0005694; GO:0006283; GO:0009411; GO:0016567	protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]		NA	NA	NA	NA	NA	NA
TRINITY_DN29724_c0_g1_i1	B8JLV7	VMA21_DANRE	40.8	98	52	3	36	326	5	97	4.20E-10	65.9	VMA21_DANRE	reviewed	Vacuolar ATPase assembly integral membrane protein vma21	vma21 si:ch73-26o5.1	Danio rerio (Zebrafish) (Brachydanio rerio)	104	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; vacuole [GO:0005773]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; vacuole [GO:0005773]		GO:0005773; GO:0005789; GO:0012507; GO:0016021; GO:0033116; GO:0070072	vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]		blue	blue	NA	NA	NA	NA
TRINITY_DN33518_c0_g1_i1	Q12697	YPK9_YEAST	45.8	83	45	0	255	7	461	543	1.10E-13	77	YPK9_YEAST	reviewed	Vacuolar cation-transporting ATPase YPK9 (EC 7.2.2.-) (PARK9 homolog)	YPK9 YOR291W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1472	"fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuole-mitochondrion membrane contact site [GO:1990816]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cupric ion binding [GO:1903135]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; cellular zinc ion homeostasis [GO:0006882]; transmembrane transport [GO:0055085]"	fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuole-mitochondrion membrane contact site [GO:1990816]	"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cupric ion binding [GO:1903135]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]"	GO:0000329; GO:0005524; GO:0006812; GO:0006874; GO:0006882; GO:0008270; GO:0015662; GO:0016021; GO:0016887; GO:0030026; GO:0030145; GO:0055085; GO:1903135; GO:1990816	cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; cellular zinc ion homeostasis [GO:0006882]; transmembrane transport [GO:0055085]		NA	NA	NA	NA	NA	NA
TRINITY_DN12055_c1_g1_i1	Q5ZLN2	CCZ1_CHICK	29	248	158	3	702	4	110	354	4.80E-28	126.3	CCZ1_CHICK	reviewed	Vacuolar fusion protein CCZ1 homolog	CCZ1 RCJMB04_5g18	Gallus gallus (Chicken)	476	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; vesicle-mediated transport [GO:0016192]	intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]		GO:0005765; GO:0016192; GO:0035658; GO:0043231	vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN27000_c0_g1_i1	Q01294	CARP_NEUCR	51.6	157	72	2	465	1	75	229	3.40E-40	166	CARP_NEUCR	reviewed	Vacuolar protease A (EC 3.4.23.-)	pep-4 B13D24.090 NCU02273	Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)	396	fungal-type vacuole [GO:0000324]; aspartic-type endopeptidase activity [GO:0004190]	fungal-type vacuole [GO:0000324]	aspartic-type endopeptidase activity [GO:0004190]	GO:0000324; GO:0004190			NA	NA	NA	NA	NA	NA
TRINITY_DN1751_c0_g1_i6	Q91W86	VPS11_MOUSE	56.5	147	64	0	487	47	334	480	8.90E-44	177.9	VPS11_MOUSE	reviewed	Vacuolar protein sorting-associated protein 11 homolog	Vps11	Mus musculus (Mouse)	941	actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0046872; GO:1901998; GO:1902115; GO:1903364; GO:2000643	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN1751_c0_g1_i8	Q91W86	VPS11_MOUSE	58.7	104	43	0	369	58	376	479	4.50E-29	129	VPS11_MOUSE	reviewed	Vacuolar protein sorting-associated protein 11 homolog	Vps11	Mus musculus (Mouse)	941	actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0046872; GO:1901998; GO:1902115; GO:1903364; GO:2000643	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN1751_c0_g1_i1	Q9H270	VPS11_HUMAN	52	269	118	3	831	31	334	593	3.50E-72	273.1	VPS11_HUMAN	reviewed	Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108)	VPS11 RNF108 PP3476	Homo sapiens (Human)	941	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0034058; GO:0035542; GO:0046872; GO:1902115; GO:1903364; GO:1903955; GO:2000643	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN1751_c0_g1_i2	Q9H270	VPS11_HUMAN	44.9	127	60	2	408	31	476	593	4.30E-22	105.9	VPS11_HUMAN	reviewed	Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108)	VPS11 RNF108 PP3476	Homo sapiens (Human)	941	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0034058; GO:0035542; GO:0046872; GO:1902115; GO:1903364; GO:1903955; GO:2000643	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN1751_c0_g1_i5	Q9H270	VPS11_HUMAN	45.3	137	64	3	435	31	466	593	2.30E-23	110.2	VPS11_HUMAN	reviewed	Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108)	VPS11 RNF108 PP3476	Homo sapiens (Human)	941	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0034058; GO:0035542; GO:0046872; GO:1902115; GO:1903364; GO:1903955; GO:2000643	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN6799_c0_g1_i1	A1Z713	VPS13_DROME	30.2	348	204	8	991	5	6	333	7.60E-35	149.4	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN6799_c0_g1_i2	A1Z713	VPS13_DROME	38.1	63	37	1	320	138	53	115	1.10E-06	54.3	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN6799_c0_g1_i5	A1Z713	VPS13_DROME	28.5	295	178	7	832	5	53	333	7.80E-25	115.9	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN12741_c0_g1_i1	A1Z713	VPS13_DROME	35.8	240	142	4	47	733	443	681	1.50E-31	137.9	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN18661_c0_g1_i2	A1Z713	VPS13_DROME	20.6	310	149	6	103	963	1332	1567	1.40E-08	62	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN18661_c0_g1_i3	A1Z713	VPS13_DROME	26.3	186	110	6	1	492	1274	1454	1.80E-09	65.1	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN18661_c0_g1_i4	A1Z713	VPS13_DROME	20.9	369	182	9	1	1002	1274	1567	3.20E-11	70.9	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN9887_c1_g1_i1	A1Z713	VPS13_DROME	46.5	127	67	1	477	100	2356	2482	2.10E-29	130.2	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2298_c0_g2_i1	A1Z713	VPS13_DROME	21.3	912	528	22	307	2880	2032	2807	6.10E-42	174.5	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2298_c0_g2_i2	A1Z713	VPS13_DROME	21.5	1075	632	27	307	3330	2032	2961	1.90E-49	199.5	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2298_c0_g2_i3	A1Z713	VPS13_DROME	21.7	1079	634	29	307	3357	2032	2961	7.50E-49	197.6	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2298_c0_g3_i1	A1Z713	VPS13_DROME	39.2	286	170	3	1149	295	2962	3244	1.30E-53	211.8	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN17497_c0_g1_i1	A1Z713	VPS13_DROME	55.9	145	64	0	458	24	3065	3209	2.30E-41	169.9	VPS13_DROME	reviewed	Vacuolar protein sorting-associated protein 13	Vps13 CG2093	Drosophila melanogaster (Fruit fly)	3321	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]		GO:0006623; GO:0019538; GO:0019898; GO:0031902; GO:0045053	protein metabolic process [GO:0019538]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN26474_c0_g1_i1	Q5H8C4	VP13A_MOUSE	24	458	325	9	1485	142	347	791	1.10E-34	149.4	VP13A_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13A (Chorea-acanthocytosis protein homolog) (Chorein)	Vps13a Chac Kiaa0986	Mus musculus (Mouse)	3166	dense core granule [GO:0031045]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]; autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382]	dense core granule [GO:0031045]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]		GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006914; GO:0007399; GO:0007626; GO:0010008; GO:0019898; GO:0030317; GO:0030382; GO:0031045; GO:0031966; GO:0035176; GO:0045053; GO:0097225; GO:0099013; GO:1905146	autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382]		NA	NA	NA	NA	NA	NA
TRINITY_DN22353_c0_g1_i1	Q7Z7G8	VP13B_HUMAN	46	213	106	2	3	614	85	297	2.20E-47	190.3	VP13B_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1)	VPS13B CHS1 COH1 KIAA0532	Homo sapiens (Human)	4022	protein transport [GO:0015031]			GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN22353_c0_g1_i2	Q7Z7G8	VP13B_HUMAN	47.7	109	57	0	20	346	189	297	4.10E-25	115.5	VP13B_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1)	VPS13B CHS1 COH1 KIAA0532	Homo sapiens (Human)	4022	protein transport [GO:0015031]			GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN32522_c0_g1_i1	Q7Z7G8	VP13B_HUMAN	67.9	53	17	0	159	1	2	54	1.40E-16	86.7	VP13B_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1)	VPS13B CHS1 COH1 KIAA0532	Homo sapiens (Human)	4022	protein transport [GO:0015031]			GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN9887_c1_g1_i2	Q8BX70	VP13C_MOUSE	40.4	374	201	8	1088	3	2766	3129	6.10E-69	262.7	VP13C_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13C	Vps13c Kiaa3021	Mus musculus (Mouse)	3748	cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]	cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]		GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0032127; GO:0032868; GO:0045053; GO:1905090	mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN9887_c1_g1_i4	Q8BX70	VP13C_MOUSE	39.4	350	192	7	1182	169	2766	3107	1.20E-62	241.9	VP13C_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13C	Vps13c Kiaa3021	Mus musculus (Mouse)	3748	cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]	cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]		GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0032127; GO:0032868; GO:0045053; GO:1905090	mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN9887_c1_g1_i5	Q8BX70	VP13C_MOUSE	51.1	92	43	1	278	3	3040	3129	2.30E-19	96.3	VP13C_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13C	Vps13c Kiaa3021	Mus musculus (Mouse)	3748	cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]	cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]		GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0032127; GO:0032868; GO:0045053; GO:1905090	mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]		NA	NA	NA	NA	NA	NA
TRINITY_DN17393_c0_g2_i1	Q9VU08	VP13D_DROME	32.2	227	119	6	793	125	994	1189	7.30E-19	95.9	VP13D_DROME	reviewed	Vacuolar protein sorting-associated protein 13D	Vps13D CG32113	Drosophila melanogaster (Fruit fly)	3919	extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; carbohydrate binding [GO:0030246]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]	carbohydrate binding [GO:0030246]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]	GO:0000423; GO:0005764; GO:0006623; GO:0007005; GO:0019898; GO:0030246; GO:0043130; GO:0045053; GO:0070530	mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN17393_c0_g1_i1	Q9VU08	VP13D_DROME	61.2	67	24	1	3	203	926	990	1.50E-11	70.1	VP13D_DROME	reviewed	Vacuolar protein sorting-associated protein 13D	Vps13D CG32113	Drosophila melanogaster (Fruit fly)	3919	extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; carbohydrate binding [GO:0030246]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]	carbohydrate binding [GO:0030246]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]	GO:0000423; GO:0005764; GO:0006623; GO:0007005; GO:0019898; GO:0030246; GO:0043130; GO:0045053; GO:0070530	mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN13199_c0_g3_i1	Q5THJ4	VP13D_HUMAN	45.5	123	54	2	3	332	2897	3019	6.40E-23	108.2	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN13199_c0_g3_i2	Q5THJ4	VP13D_HUMAN	41.3	75	42	1	21	239	3017	3091	1.00E-06	53.9	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN13199_c0_g3_i3	Q5THJ4	VP13D_HUMAN	43.1	195	83	3	3	503	2897	3091	3.00E-34	146.4	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN3574_c0_g1_i1	Q5THJ4	VP13D_HUMAN	56.1	123	50	4	138	497	3617	3738	1.60E-25	117.5	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN3574_c0_g1_i3	Q5THJ4	VP13D_HUMAN	42.5	809	415	20	138	2534	3617	4385	3.70E-149	530.4	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN3574_c0_g1_i4	Q5THJ4	VP13D_HUMAN	55.6	126	52	4	138	506	3617	3741	3.30E-26	119.8	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2657_c0_g1_i1	Q5THJ4	VP13D_HUMAN	40.4	394	219	3	89	1270	1	378	6.70E-83	309.3	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2657_c0_g1_i2	Q5THJ4	VP13D_HUMAN	73	37	10	0	89	199	1	37	5.60E-08	58.2	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN2657_c0_g1_i3	Q5THJ4	VP13D_HUMAN	33.6	298	182	3	83	976	97	378	2.50E-45	184.1	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN3574_c0_g1_i2	Q5THJ4	VP13D_HUMAN	55.6	126	52	4	138	506	3617	3741	3.30E-26	119.8	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	1	NA	NA	NA
TRINITY_DN34655_c0_g1_i1	Q5THJ4	VP13D_HUMAN	100	67	0	0	4	204	1	67	1.80E-30	132.5	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN16042_c0_g1_i1	Q5THJ4	VP13D_HUMAN	36.1	388	206	8	2	1048	1793	2177	3.00E-55	217.2	VP13D_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13D	VPS13D KIAA0453	Homo sapiens (Human)	4388	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		NA	NA	NA	NA	NA	NA
TRINITY_DN36351_c0_g1_i1	Q9H269	VPS16_HUMAN	99.2	129	1	0	388	2	20	148	2.30E-71	269.2	VPS16_HUMAN	reviewed	Vacuolar protein sorting-associated protein 16 homolog (hVPS16)	VPS16	Homo sapiens (Human)	839	"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"	autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0032889; GO:0035542; GO:0043025; GO:0051015; GO:0055037; GO:0097352	"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1531_c0_g1_i10	Q9H269	VPS16_HUMAN	41.9	461	255	6	55	1407	6	463	2.40E-102	374	VPS16_HUMAN	reviewed	Vacuolar protein sorting-associated protein 16 homolog (hVPS16)	VPS16	Homo sapiens (Human)	839	"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"	autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0032889; GO:0035542; GO:0043025; GO:0051015; GO:0055037; GO:0097352	"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1531_c0_g1_i5	Q9H269	VPS16_HUMAN	39.5	468	262	7	55	1404	6	470	1.20E-93	345.1	VPS16_HUMAN	reviewed	Vacuolar protein sorting-associated protein 16 homolog (hVPS16)	VPS16	Homo sapiens (Human)	839	"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"	autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0032889; GO:0035542; GO:0043025; GO:0051015; GO:0055037; GO:0097352	"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1531_c0_g1_i8	Q9H269	VPS16_HUMAN	40.9	435	244	6	55	1329	6	437	2.00E-93	344.4	VPS16_HUMAN	reviewed	Vacuolar protein sorting-associated protein 16 homolog (hVPS16)	VPS16	Homo sapiens (Human)	839	"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"	autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0032889; GO:0035542; GO:0043025; GO:0051015; GO:0055037; GO:0097352	"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1531_c0_g1_i9	Q9H269	VPS16_HUMAN	40.9	435	244	6	55	1329	6	437	2.00E-93	344.4	VPS16_HUMAN	reviewed	Vacuolar protein sorting-associated protein 16 homolog (hVPS16)	VPS16	Homo sapiens (Human)	839	"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"	autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0032889; GO:0035542; GO:0043025; GO:0051015; GO:0055037; GO:0097352	"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9561_c0_g1_i1	P59015	VPS18_DANRE	40.2	991	555	15	3015	103	1	973	1.60E-218	761.1	VPS18_DANRE	reviewed	Vacuolar protein sorting-associated protein 18 homolog	vps18	Danio rerio (Zebrafish) (Brachydanio rerio)	974	endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]	metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007033; GO:0007040; GO:0007634; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0035542; GO:0043485; GO:0045176; GO:0046872; GO:0048069; GO:0048757; GO:0060036	apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]		NA	NA	NA	NA	NA	NA
TRINITY_DN22615_c0_g1_i1	Q9P253	VPS18_HUMAN	100	67	0	0	2	202	770	836	2.10E-31	135.6	VPS18_HUMAN	reviewed	Vacuolar protein sorting-associated protein 18 homolog (hVPS18)	VPS18 KIAA1475	Homo sapiens (Human)	973	actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718]	actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0007040; GO:0008333; GO:0019905; GO:0030123; GO:0030136; GO:0030674; GO:0030897; GO:0031902; GO:0033263; GO:0035542; GO:0046718; GO:0046872; GO:0098978; GO:2000300	autophagy [GO:0006914]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN28544_c0_g1_i1	O35075	VP26C_MOUSE	100	76	0	0	3	230	222	297	2.00E-38	159.1	VP26C_MOUSE	reviewed	Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3 homolog) (Down syndrome critical region protein A homolog)	Vps26c Dcra Dscr3 Dscra	Mus musculus (Mouse)	297	"endosome [GO:0005768]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]		GO:0005768; GO:0006886; GO:0032456; GO:1990126	"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28045_c0_g1_i1	O14972	VP26C_HUMAN	100	73	0	0	219	1	152	224	1.30E-34	146.4	VP26C_HUMAN	reviewed	Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3) (Down syndrome critical region protein A)	VPS26C DCRA DSCR3 DSCRA	Homo sapiens (Human)	297	"endosome [GO:0005768]; nucleus [GO:0005634]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]; nucleus [GO:0005634]		GO:0005634; GO:0005768; GO:0006886; GO:0032456; GO:1990126	"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4387_c0_g1_i1	O14972	VP26C_HUMAN	53.7	298	136	2	983	90	1	296	1.50E-93	344.4	VP26C_HUMAN	reviewed	Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3) (Down syndrome critical region protein A)	VPS26C DCRA DSCR3 DSCRA	Homo sapiens (Human)	297	"endosome [GO:0005768]; nucleus [GO:0005634]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]; nucleus [GO:0005634]		GO:0005634; GO:0005768; GO:0006886; GO:0032456; GO:1990126	"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c4_g1_i3	Q9D2N9	VP33A_MOUSE	50.7	605	285	5	1949	138	3	595	6.10E-168	592.4	VP33A_MOUSE	reviewed	Vacuolar protein sorting-associated protein 33A	Vps33a Bf Buff	Mus musculus (Mouse)	598	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	protein-containing complex binding [GO:0044877]	GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031410; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0097352	autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c4_g1_i5	Q9D2N9	VP33A_MOUSE	47.2	299	154	2	981	85	3	297	2.60E-69	263.8	VP33A_MOUSE	reviewed	Vacuolar protein sorting-associated protein 33A	Vps33a Bf Buff	Mus musculus (Mouse)	598	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	protein-containing complex binding [GO:0044877]	GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031410; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0097352	autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN2650_c4_g1_i7	Q9D2N9	VP33A_MOUSE	50.7	605	285	5	1899	88	3	595	7.80E-168	592	VP33A_MOUSE	reviewed	Vacuolar protein sorting-associated protein 33A	Vps33a Bf Buff	Mus musculus (Mouse)	598	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	protein-containing complex binding [GO:0044877]	GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031410; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0097352	autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN37464_c0_g1_i1	Q96AX1	VP33A_HUMAN	100	96	0	0	288	1	171	266	1.90E-49	196.1	VP33A_HUMAN	reviewed	Vacuolar protein sorting-associated protein 33A (hVPS33A)	VPS33A	Homo sapiens (Human)	596	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]		GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0048070; GO:0048471; GO:0097352	autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3467_c0_g1_i2	Q2HJ18	VP33B_BOVIN	35.4	568	346	7	1733	72	52	612	2.80E-90	334.3	VP33B_BOVIN	reviewed	Vacuolar protein sorting-associated protein 33B	VPS33B	Bos taurus (Bovine)	617	clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]		GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0006886; GO:0006904; GO:0015031; GO:0016192; GO:0017185; GO:0030136; GO:0030199; GO:0030897; GO:0031091; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0033263; GO:0035855; GO:0048471; GO:0055037; GO:0061025; GO:0070889; GO:0090330	collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN3467_c0_g1_i3	Q58EN8	VP33B_DANRE	37.2	608	363	8	1847	63	14	615	1.80E-103	378.3	VP33B_DANRE	reviewed	Vacuolar protein sorting-associated protein 33B	vps33b	Danio rerio (Zebrafish) (Brachydanio rerio)	617	CORVET complex [GO:0033263]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; intracellular protein transport [GO:0006886]; intrahepatic bile duct development [GO:0035622]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	CORVET complex [GO:0033263]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]		GO:0005764; GO:0005765; GO:0006886; GO:0006904; GO:0016192; GO:0031902; GO:0033263; GO:0035622	intracellular protein transport [GO:0006886]; intrahepatic bile duct development [GO:0035622]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN4753_c0_g1_i1	Q54C24	VPS35_DICDI	56.8	125	54	0	12	386	175	299	1.10E-36	154.1	VPS35_DICDI	reviewed	Vacuolar protein sorting-associated protein 35	vps35 DDB_G0293218	Dictyostelium discoideum (Slime mold)	781	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; pathogen-containing vacuole [GO:0140220]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; intracellular protein transport [GO:0006886]; protein retention in Golgi apparatus [GO:0045053]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; pathogen-containing vacuole [GO:0140220]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]"		GO:0005770; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0030906; GO:0042147; GO:0045053; GO:0140220	"intracellular protein transport [GO:0006886]; protein retention in Golgi apparatus [GO:0045053]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16177_c0_g1_i1	Q96QK1	VPS35_HUMAN	100	85	0	0	257	3	468	552	1.40E-43	176.4	VPS35_HUMAN	reviewed	Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35)	VPS35 MEM3 TCCCTA00141	Homo sapiens (Human)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016032; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1905606; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39559_c0_g1_i1	Q96QK1	VPS35_HUMAN	99.1	112	1	0	338	3	228	339	7.50E-58	224.2	VPS35_HUMAN	reviewed	Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35)	VPS35 MEM3 TCCCTA00141	Homo sapiens (Human)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016032; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1905606; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35917_c0_g1_i1	Q9EQH3	VPS35_MOUSE	100	69	0	0	3	209	727	795	4.40E-32	137.9	VPS35_MOUSE	reviewed	Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35)	Vps35 Mem3	Mus musculus (Mouse)	796	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; protein localization to organelle [GO:0033365]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; synapse [GO:0045202]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016021; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032463; GO:0033365; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; protein localization to organelle [GO:0033365]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20636_c0_g1_i1	Q2HJG5	VPS35_BOVIN	98.3	235	4	0	706	2	2	236	1.00E-125	450.7	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20636_c0_g1_i2	Q2HJG5	VPS35_BOVIN	98.3	235	4	0	706	2	2	236	1.00E-125	450.7	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4223_c0_g1_i1	Q2HJG5	VPS35_BOVIN	70.4	793	232	1	88	2466	7	796	0	1132.9	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39699_c0_g1_i1	Q2HJG5	VPS35_BOVIN	100	106	0	0	320	3	567	672	3.40E-52	205.3	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17369_c0_g1_i1	Q2HJG5	VPS35_BOVIN	100	177	0	0	2	532	552	728	2.00E-97	356.3	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14594_c0_g1_i1	Q2HJG5	VPS35_BOVIN	100	110	0	0	333	4	332	441	1.50E-55	216.5	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34575_c0_g1_i1	Q2HJG5	VPS35_BOVIN	100	76	0	0	46	273	1	76	1.50E-35	149.8	VPS35_BOVIN	reviewed	Vacuolar protein sorting-associated protein 35 (Vesicle protein sorting 35)	VPS35	Bos taurus (Bovine)	796	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]"	D1 dopamine receptor binding [GO:0031748]	GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0061357; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1990126; GO:2000331	"intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4753_c0_g2_i1	Q7X659	VP35A_ARATH	60.9	138	54	0	415	2	27	164	3.70E-43	175.6	VP35A_ARATH	reviewed	Vacuolar protein sorting-associated protein 35A (Protein ZIG SUPPRESSOR 3) (Vesicle protein sorting 35A)	VPS35A ZIP3 At2g17790 T17A5.7	Arabidopsis thaliana (Mouse-ear cress)	787	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; retromer, cargo-selective complex [GO:0030906]; retromer complex [GO:0030904]"		GO:0005739; GO:0005770; GO:0005794; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0030906; GO:0031902; GO:0042147	"intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2838_c0_g1_i1	Q9H9H4	VP37B_HUMAN	39.5	147	89	0	136	576	17	163	2.20E-21	104	VP37B_HUMAN	reviewed	Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B)	VPS37B	Homo sapiens (Human)	285	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; intracellular transport of virus [GO:0075733]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]	GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016197; GO:0016236; GO:0019058; GO:0030496; GO:0031902; GO:0032509; GO:0036258; GO:0039702; GO:0043162; GO:0043231; GO:0043657; GO:0048306; GO:0070062; GO:0075733; GO:1902188; GO:1903774	endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; intracellular transport of virus [GO:0075733]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN1097_c0_g1_i6	Q5AG40	VPS4_CANAL	32.4	145	88	3	493	83	129	271	3.30E-15	84.3	VPS4_CANAL	reviewed	Vacuolar protein sorting-associated protein 4	VPS4 CAALFM_C503090WA CaO19.11814 CaO19.4339	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	439	endosome membrane [GO:0010008]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to lithium ion [GO:0071285]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; hyphal growth [GO:0030448]; late endosome to vacuole transport [GO:0045324]; pathogenesis [GO:0009405]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vacuole organization [GO:0007033]	endosome membrane [GO:0010008]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0006623; GO:0007033; GO:0009306; GO:0009405; GO:0010008; GO:0016887; GO:0030447; GO:0030448; GO:0044182; GO:0045324; GO:0071285	cellular response to lithium ion [GO:0071285]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms [GO:0044182]; hyphal growth [GO:0030448]; late endosome to vacuole transport [GO:0045324]; pathogenesis [GO:0009405]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN10773_c0_g2_i1	P52917	VPS4_YEAST	44.8	67	37	0	207	7	261	327	1.10E-11	70.1	VPS4_YEAST	reviewed	Vacuolar protein sorting-associated protein 4 (DOA4-independent degradation protein 6) (Protein END13) (Vacuolar protein-targeting protein 10)	VPS4 CSC1 DID6 END13 GRD13 VPL4 VPT10 YPR173C P9705.10	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	437	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; ESCRT IV complex [GO:1990621]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; intralumenal vesicle formation [GO:0070676]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; reticulophagy [GO:0061709]; sterol metabolic process [GO:0016125]; vacuole organization [GO:0007033]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; ESCRT IV complex [GO:1990621]; membrane [GO:0016020]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0007033; GO:0015031; GO:0016020; GO:0016125; GO:0016236; GO:0016887; GO:0032511; GO:0042802; GO:0042803; GO:0045053; GO:0045324; GO:0061709; GO:0070676; GO:1990621	intralumenal vesicle formation [GO:0070676]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; protein retention in Golgi apparatus [GO:0045053]; protein transport [GO:0015031]; reticulophagy [GO:0061709]; sterol metabolic process [GO:0016125]; vacuole organization [GO:0007033]		NA	NA	NA	NA	NA	NA
TRINITY_DN6282_c0_g1_i1	Q54PT2	VPS4_DICDI	51.1	88	41	2	70	333	1	86	5.50E-14	78.6	VPS4_DICDI	reviewed	Vacuolar protein sorting-associated protein 4 (EC 3.6.4.6)	vps4 DDB_G0284347	Dictyostelium discoideum (Slime mold)	444	endosome [GO:0005768]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vacuole organization [GO:0007033]	endosome [GO:0005768]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005768; GO:0007033; GO:0015031; GO:0016197; GO:0016887; GO:0031902	endosomal transport [GO:0016197]; protein transport [GO:0015031]; vacuole organization [GO:0007033]		blue	blue	NA	NA	NA	NA
TRINITY_DN4405_c0_g1_i13	P49754	VPS41_HUMAN	41.7	441	254	3	1401	82	400	838	2.20E-95	350.9	VPS41_HUMAN	reviewed	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	854	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016236; GO:0017137; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4405_c0_g1_i15	P49754	VPS41_HUMAN	42.7	316	179	2	1026	82	524	838	7.10E-67	255.8	VPS41_HUMAN	reviewed	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	854	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016236; GO:0017137; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4405_c0_g1_i2	P49754	VPS41_HUMAN	60.3	116	46	0	488	141	659	774	1.70E-33	144.1	VPS41_HUMAN	reviewed	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	854	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016236; GO:0017137; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4405_c0_g1_i3	P49754	VPS41_HUMAN	42.7	316	179	2	1026	82	524	838	7.10E-67	255.8	VPS41_HUMAN	reviewed	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	854	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016236; GO:0017137; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4405_c0_g1_i4	P49754	VPS41_HUMAN	41.7	441	254	3	1401	82	400	838	2.20E-95	350.9	VPS41_HUMAN	reviewed	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	854	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016236; GO:0017137; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]		NA	NA	NA	NA	NA	NA
TRINITY_DN4405_c0_g1_i5	P49754	VPS41_HUMAN	37.2	261	163	1	784	2	400	659	9.90E-45	181.8	VPS41_HUMAN	reviewed	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	854	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; Rab GTPase binding [GO:0017137]	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016236; GO:0017137; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulated exocytosis [GO:0045055]		NA	NA	NA	NA	NA	NA
TRINITY_DN20902_c0_g1_i1	Q54GE3	VPS45_DICDI	60	50	20	0	62	211	210	259	1.80E-12	72.8	VPS45_DICDI	reviewed	Vacuolar protein sorting-associated protein 45	vps45 DDB_G0290213	Dictyostelium discoideum (Slime mold)	563	endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; unfolded protein binding [GO:0051082]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]	unfolded protein binding [GO:0051082]	GO:0000139; GO:0006886; GO:0006896; GO:0006904; GO:0010008; GO:0016192; GO:0045335; GO:0051082	Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN28557_c0_g1_i1	Q9NRW7	VPS45_HUMAN	99.4	166	1	0	3	500	211	376	5.10E-87	321.6	VPS45_HUMAN	reviewed	Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45)	VPS45 VPS45A VPS45B	Homo sapiens (Human)	570	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0007596; GO:0010008; GO:0016021; GO:0016192	blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5510_c1_g1_i1	Q9NRW7	VPS45_HUMAN	54.6	348	151	3	25	1065	209	550	6.00E-102	372.5	VPS45_HUMAN	reviewed	Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45)	VPS45 VPS45A VPS45B	Homo sapiens (Human)	570	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0007596; GO:0010008; GO:0016021; GO:0016192	blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5510_c1_g1_i3	Q9NRW7	VPS45_HUMAN	56	557	237	4	88	1755	1	550	5.60E-171	602.4	VPS45_HUMAN	reviewed	Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45)	VPS45 VPS45A VPS45B	Homo sapiens (Human)	570	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0007596; GO:0010008; GO:0016021; GO:0016192	blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN5510_c1_g1_i2	O08700	VPS45_RAT	50.5	97	47	1	88	378	1	96	3.80E-22	105.9	VPS45_RAT	reviewed	Vacuolar protein sorting-associated protein 45 (rVps45)	Vps45 Vps45a	Rattus norvegicus (Rat)	570	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0010008; GO:0016021; GO:0016192	intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN33208_c0_g1_i1	Q9UN37	VPS4A_HUMAN	100	243	0	0	3	731	195	437	1.50E-138	493.4	VPS4A_HUMAN	reviewed	Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4)	VPS4A VPS4	Homo sapiens (Human)	437	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000916; GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0048471; GO:0051301; GO:0061640; GO:0061738; GO:0061952; GO:0070062; GO:0072319; GO:0090543; GO:0090611; GO:1902188; GO:1903076; GO:1903543; GO:1903774; GO:1903902; GO:1904896; GO:1904903	abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192]; vesicle uncoating [GO:0072319]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN40953_c0_g1_i1	Q9UN37	VPS4A_HUMAN	100	87	0	0	263	3	104	190	8.60E-45	180.6	VPS4A_HUMAN	reviewed	Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4)	VPS4A VPS4	Homo sapiens (Human)	437	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000916; GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0048471; GO:0051301; GO:0061640; GO:0061738; GO:0061952; GO:0070062; GO:0072319; GO:0090543; GO:0090611; GO:1902188; GO:1903076; GO:1903543; GO:1903774; GO:1903902; GO:1904896; GO:1904903	abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192]; vesicle uncoating [GO:0072319]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN1332_c0_g1_i1	Q9UN37	VPS4A_HUMAN	34.7	72	45	1	421	636	270	339	4.90E-05	50.1	VPS4A_HUMAN	reviewed	Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4)	VPS4A VPS4	Homo sapiens (Human)	437	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000916; GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0048471; GO:0051301; GO:0061640; GO:0061738; GO:0061952; GO:0070062; GO:0072319; GO:0090543; GO:0090611; GO:1902188; GO:1903076; GO:1903543; GO:1903774; GO:1903902; GO:1904896; GO:1904903	abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192]; vesicle uncoating [GO:0072319]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN1332_c0_g1_i2	Q9UN37	VPS4A_HUMAN	34.7	72	45	1	421	636	270	339	4.80E-05	50.1	VPS4A_HUMAN	reviewed	Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4)	VPS4A VPS4	Homo sapiens (Human)	437	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000916; GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0048471; GO:0051301; GO:0061640; GO:0061738; GO:0061952; GO:0070062; GO:0072319; GO:0090543; GO:0090611; GO:1902188; GO:1903076; GO:1903543; GO:1903774; GO:1903902; GO:1904896; GO:1904903	abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192]; vesicle uncoating [GO:0072319]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN10818_c0_g1_i2	Q0VD48	VPS4B_BOVIN	100	147	0	0	1	441	146	292	7.30E-79	295	VPS4B_BOVIN	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6)	VPS4B	Bos taurus (Bovine)	444	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007080; GO:0008022; GO:0008568; GO:0010971; GO:0015031; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044877; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN10818_c0_g1_i2	Q0VD48	VPS4B_BOVIN	92.9	84	6	0	426	677	361	444	5.10E-40	166	VPS4B_BOVIN	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6)	VPS4B	Bos taurus (Bovine)	444	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007080; GO:0008022; GO:0008568; GO:0010971; GO:0015031; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044877; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN24563_c0_g1_i1	Q5R658	VPS4B_PONAB	79.4	68	14	0	12	215	1	68	8.80E-20	97.1	VPS4B_PONAB	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6)	VPS4B	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	444	late endosome membrane [GO:0031902]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein transport [GO:0015031]	late endosome membrane [GO:0031902]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0007049; GO:0015031; GO:0016887; GO:0031902; GO:0051301	cell cycle [GO:0007049]; cell division [GO:0051301]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN10773_c0_g1_i1	Q0VD48	VPS4B_BOVIN	62.5	104	35	3	13	324	152	251	1.90E-29	129.8	VPS4B_BOVIN	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6)	VPS4B	Bos taurus (Bovine)	444	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007080; GO:0008022; GO:0008568; GO:0010971; GO:0015031; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044877; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN7078_c0_g1_i1	Q0VD48	VPS4B_BOVIN	37.8	82	50	1	245	3	133	214	8.20E-09	60.8	VPS4B_BOVIN	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6)	VPS4B	Bos taurus (Bovine)	444	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007080; GO:0008022; GO:0008568; GO:0010971; GO:0015031; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044877; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		blue	blue	NA	NA	NA	NA
TRINITY_DN10818_c0_g1_i1	O75351	VPS4B_HUMAN	100	133	0	0	1	399	312	444	1.80E-72	273.1	VPS4B_HUMAN	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)	VPS4B SKD1 VPS42 MIG1	Homo sapiens (Human)	444	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007080; GO:0008022; GO:0008568; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0048524; GO:0050792; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0070062; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1903902; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN35974_c0_g1_i1	P46467	VPS4B_MOUSE	75	64	16	0	193	2	4	67	2.80E-09	62.4	VPS4B_MOUSE	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)	Vps4b Skd1	Mus musculus (Mouse)	444	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007032; GO:0007080; GO:0008022; GO:0008568; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0048524; GO:0050792; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1903902; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN7320_c0_g2_i1	P46467	VPS4B_MOUSE	77.4	332	75	0	1090	95	113	444	4.10E-148	525.8	VPS4B_MOUSE	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)	Vps4b Skd1	Mus musculus (Mouse)	444	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007032; GO:0007080; GO:0008022; GO:0008568; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0048524; GO:0050792; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1903902; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN27353_c0_g1_i1	P46467	VPS4B_MOUSE	95.8	71	3	0	214	2	279	349	2.60E-32	138.7	VPS4B_MOUSE	reviewed	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)	Vps4b Skd1	Mus musculus (Mouse)	444	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007032; GO:0007080; GO:0008022; GO:0008568; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016887; GO:0019076; GO:0030301; GO:0031122; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0048524; GO:0050792; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1903902; GO:1904903	cholesterol transport [GO:0030301]; cytoplasmic microtubule organization [GO:0031122]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]		NA	NA	NA	NA	NA	NA
TRINITY_DN12224_c1_g1_i1	Q8CCB4	VPS53_MOUSE	52.3	237	112	1	710	3	22	258	8.50E-62	238.4	VPS53_MOUSE	reviewed	Vacuolar protein sorting-associated protein 53 homolog	Vps53	Mus musculus (Mouse)	832	"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]		GO:0000938; GO:0005794; GO:0005802; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0016020; GO:0032456; GO:0042147; GO:0048471; GO:0055037; GO:1990745	"endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32130_c0_g1_i1	Q5VIR6	VPS53_HUMAN	100	67	0	0	3	203	146	212	2.10E-31	135.6	VPS53_HUMAN	reviewed	Vacuolar protein sorting-associated protein 53 homolog	VPS53 PP13624	Homo sapiens (Human)	832	"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]		GO:0000938; GO:0005794; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0016020; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0055037; GO:1990745	"endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"		NA	NA	NA	NA	NA	NA
TRINITY_DN824_c0_g1_i1	Q9VLC0	VPS54_DROME	36	611	340	9	1778	9	23	603	5.40E-97	356.7	VPS54_DROME	reviewed	Vacuolar protein sorting-associated protein 54 (Protein scattered)	scat CG3766	Drosophila melanogaster (Fruit fly)	940	"cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]; syntaxin binding [GO:0019905]; acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]"	cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]	syntaxin binding [GO:0019905]	GO:0000138; GO:0000938; GO:0001675; GO:0005794; GO:0005829; GO:0006896; GO:0007290; GO:0007291; GO:0015031; GO:0019905; GO:0032456; GO:0042147	"acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; spermatid nucleus elongation [GO:0007290]; sperm individualization [GO:0007291]"		NA	NA	NA	NA	NA	NA
TRINITY_DN824_c0_g1_i2	Q9VLC0	VPS54_DROME	37	389	217	4	1186	62	23	397	7.50E-66	252.7	VPS54_DROME	reviewed	Vacuolar protein sorting-associated protein 54 (Protein scattered)	scat CG3766	Drosophila melanogaster (Fruit fly)	940	"cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]; syntaxin binding [GO:0019905]; acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]"	cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]	syntaxin binding [GO:0019905]	GO:0000138; GO:0000938; GO:0001675; GO:0005794; GO:0005829; GO:0006896; GO:0007290; GO:0007291; GO:0015031; GO:0019905; GO:0032456; GO:0042147	"acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; spermatid nucleus elongation [GO:0007290]; sperm individualization [GO:0007291]"		NA	NA	NA	NA	NA	NA
TRINITY_DN824_c0_g1_i3	Q9VLC0	VPS54_DROME	37.5	538	301	6	1671	121	23	546	1.30E-92	342	VPS54_DROME	reviewed	Vacuolar protein sorting-associated protein 54 (Protein scattered)	scat CG3766	Drosophila melanogaster (Fruit fly)	940	"cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]; syntaxin binding [GO:0019905]; acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]"	cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; Golgi trans cisterna [GO:0000138]	syntaxin binding [GO:0019905]	GO:0000138; GO:0000938; GO:0001675; GO:0005794; GO:0005829; GO:0006896; GO:0007290; GO:0007291; GO:0015031; GO:0019905; GO:0032456; GO:0042147	"acrosome assembly [GO:0001675]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; spermatid nucleus elongation [GO:0007290]; sperm individualization [GO:0007291]"		brown	brown	NA	NA	NA	NA
TRINITY_DN25493_c0_g1_i1	Q9VKM6	VPS72_DROME	50.5	107	47	3	442	137	238	343	6.00E-22	105.5	VPS72_DROME	reviewed	Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1)	YL-1 CG4621	Drosophila melanogaster (Fruit fly)	351	"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]"	NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006355; GO:0010629; GO:0016573; GO:0035267; GO:0043486	"histone acetylation [GO:0016573]; histone exchange [GO:0043486]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38840_c0_g1_i1	Q62481	VPS72_MOUSE	35.3	150	88	3	129	575	83	224	1.10E-09	65.1	VPS72_MOUSE	reviewed	Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1)	Vps72 Tcfl1 Yl1	Mus musculus (Mouse)	368	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA binding [GO:0003677]; histone binding [GO:0042393]	GO:0003677; GO:0005634; GO:0006355; GO:0016607; GO:0032991; GO:0035019; GO:0042393; GO:0043486	"histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11679_c0_g3_i1	Q0P5W1	VPS8_MOUSE	50	104	52	0	317	6	676	779	2.40E-24	112.8	VPS8_MOUSE	reviewed	Vacuolar protein sorting-associated protein 8 homolog	Vps8 Kiaa0804	Mus musculus (Mouse)	1427	CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]	CORVET complex [GO:0033263]; early endosome [GO:0005769]	metal ion binding [GO:0046872]	GO:0005769; GO:0033263; GO:0034058; GO:0046872	endosomal vesicle fusion [GO:0034058]		NA	NA	NA	NA	NA	NA
TRINITY_DN11679_c0_g4_i1	Q8N3P4	VPS8_HUMAN	51.3	76	36	1	3	230	786	860	3.50E-14	78.6	VPS8_HUMAN	reviewed	Vacuolar protein sorting-associated protein 8 homolog	VPS8 KIAA0804	Homo sapiens (Human)	1428	CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]	CORVET complex [GO:0033263]; early endosome [GO:0005769]	metal ion binding [GO:0046872]	GO:0005769; GO:0015031; GO:0033263; GO:0034058; GO:0046872	endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN11679_c0_g1_i1	Q8N3P4	VPS8_HUMAN	35	60	39	0	310	131	906	965	4.00E-07	55.8	VPS8_HUMAN	reviewed	Vacuolar protein sorting-associated protein 8 homolog	VPS8 KIAA0804	Homo sapiens (Human)	1428	CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]	CORVET complex [GO:0033263]; early endosome [GO:0005769]	metal ion binding [GO:0046872]	GO:0005769; GO:0015031; GO:0033263; GO:0034058; GO:0046872	endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN11679_c0_g1_i2	Q8N3P4	VPS8_HUMAN	34.1	82	54	0	376	131	884	965	6.90E-12	71.6	VPS8_HUMAN	reviewed	Vacuolar protein sorting-associated protein 8 homolog	VPS8 KIAA0804	Homo sapiens (Human)	1428	CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]	CORVET complex [GO:0033263]; early endosome [GO:0005769]	metal ion binding [GO:0046872]	GO:0005769; GO:0015031; GO:0033263; GO:0034058; GO:0046872	endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3188_c0_g1_i1	Q32L63	VTA1_BOVIN	62.6	99	37	0	200	496	76	174	1.10E-31	137.9	VTA1_BOVIN	reviewed	Vacuolar protein sorting-associated protein VTA1 homolog	VTA1	Bos taurus (Bovine)	307	endosome membrane [GO:0010008]; protein transport [GO:0015031]	endosome membrane [GO:0010008]		GO:0010008; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN3188_c0_g1_i2	Q32L63	VTA1_BOVIN	57.3	171	73	0	88	600	4	174	3.80E-55	216.1	VTA1_BOVIN	reviewed	Vacuolar protein sorting-associated protein VTA1 homolog	VTA1	Bos taurus (Bovine)	307	endosome membrane [GO:0010008]; protein transport [GO:0015031]	endosome membrane [GO:0010008]		GO:0010008; GO:0015031	protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN32332_c0_g1_i1	Q9NP79	VTA1_HUMAN	100	66	0	0	201	4	67	132	1.60E-31	136	VTA1_HUMAN	reviewed	Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein) (DRG-1) (LYST-interacting protein 5) (LIP5) (SKD1-binding protein 1) (SBP1)	VTA1 C6orf55 HSPC228 My012	Homo sapiens (Human)	307	cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; protein C-terminus binding [GO:0008022]; endosomal transport [GO:0016197]; ESCRT III complex disassembly [GO:1904903]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]; viral budding [GO:0046755]; viral life cycle [GO:0019058]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]	protein C-terminus binding [GO:0008022]	GO:0005654; GO:0005771; GO:0005829; GO:0008022; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0032511; GO:0036258; GO:0043231; GO:0046755; GO:0070062; GO:0071985; GO:1904903	endosomal transport [GO:0016197]; ESCRT III complex disassembly [GO:1904903]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]; viral budding [GO:0046755]; viral life cycle [GO:0019058]		NA	NA	NA	NA	NA	NA
TRINITY_DN923_c0_g1_i1	Q9CR26	VTA1_MOUSE	54.5	66	27	1	46	234	244	309	4.00E-10	65.5	VTA1_MOUSE	reviewed	Vacuolar protein sorting-associated protein VTA1 homolog (SKD1-binding protein 1) (SBP1)	Vta1	Mus musculus (Mouse)	309	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; protein C-terminus binding [GO:0008022]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]; viral budding [GO:0046755]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]	protein C-terminus binding [GO:0008022]	GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0008022; GO:0010008; GO:0015031; GO:0032511; GO:0043231; GO:0046755; GO:0071985	late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]; viral budding [GO:0046755]		blue	blue	NA	NA	NA	NA
TRINITY_DN5113_c0_g1_i1	Q6NWF4	VPS25_DANRE	49.4	79	40	0	239	3	16	94	9.80E-15	80.9	VPS25_DANRE	reviewed	Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25)	vps25	Danio rerio (Zebrafish) (Brachydanio rerio)	174	ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]	ESCRT II complex [GO:0000814]	protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]	GO:0000814; GO:0005198; GO:0042803; GO:0043328	protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]		NA	NA	NA	NA	NA	NA
TRINITY_DN5113_c0_g1_i2	Q6NWF4	VPS25_DANRE	55.4	92	41	0	278	3	3	94	2.40E-24	112.8	VPS25_DANRE	reviewed	Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25)	vps25	Danio rerio (Zebrafish) (Brachydanio rerio)	174	ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]	ESCRT II complex [GO:0000814]	protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]	GO:0000814; GO:0005198; GO:0042803; GO:0043328	protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]		blue	blue	NA	NA	NA	NA
TRINITY_DN10677_c0_g1_i1	Q6DDF4	VPS36_XENLA	44.9	390	207	5	1244	93	1	388	1.30E-89	331.6	VPS36_XENLA	reviewed	Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36)	vps36	Xenopus laevis (African clawed frog)	388	endosome [GO:0005768]; ESCRT II complex [GO:0000814]; mRNA 3'-UTR binding [GO:0003730]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein transport [GO:0015031]	endosome [GO:0005768]; ESCRT II complex [GO:0000814]	mRNA 3'-UTR binding [GO:0003730]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]	GO:0000814; GO:0003730; GO:0005768; GO:0015031; GO:0032266; GO:0032509; GO:0043130	endosome transport via multivesicular body sorting pathway [GO:0032509]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN835_c0_g3_i1	Q54E04	VATM_DICDI	52.5	61	29	0	236	54	750	810	2.40E-11	69.3	VATM_DICDI	reviewed	Vacuolar proton translocating ATPase 100 kDa subunit (Clathrin-coated vesicle/synaptic vesicle proton pump 100 kDa subunit) (Vacuolar ATPase transmembrane subunit)	vatM DDB_G0291858	Dictyostelium discoideum (Slime mold)	815	"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; phagocytosis, engulfment [GO:0006911]; regulation of intracellular pH [GO:0051453]; vacuolar acidification [GO:0007035]"	"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0000331; GO:0005764; GO:0005765; GO:0006911; GO:0007035; GO:0010008; GO:0016021; GO:0016471; GO:0030139; GO:0030666; GO:0030670; GO:0031164; GO:0032009; GO:0045335; GO:0046961; GO:0051117; GO:0051453; GO:0140220	"phagocytosis, engulfment [GO:0006911]; regulation of intracellular pH [GO:0051453]; vacuolar acidification [GO:0007035]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37339_c0_g1_i1	Q54E04	VATM_DICDI	51.2	123	57	1	376	8	695	814	2.90E-26	119.4	VATM_DICDI	reviewed	Vacuolar proton translocating ATPase 100 kDa subunit (Clathrin-coated vesicle/synaptic vesicle proton pump 100 kDa subunit) (Vacuolar ATPase transmembrane subunit)	vatM DDB_G0291858	Dictyostelium discoideum (Slime mold)	815	"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; phagocytosis, engulfment [GO:0006911]; regulation of intracellular pH [GO:0051453]; vacuolar acidification [GO:0007035]"	"contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0000331; GO:0005764; GO:0005765; GO:0006911; GO:0007035; GO:0010008; GO:0016021; GO:0016471; GO:0030139; GO:0030666; GO:0030670; GO:0031164; GO:0032009; GO:0045335; GO:0046961; GO:0051117; GO:0051453; GO:0140220	"phagocytosis, engulfment [GO:0006911]; regulation of intracellular pH [GO:0051453]; vacuolar acidification [GO:0007035]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7067_c0_g1_i2	Q86WA6	BPHL_HUMAN	52.4	254	121	0	125	886	37	290	1.30E-78	294.7	BPHL_HUMAN	reviewed	Valacyclovir hydrolase (VACVase) (Valacyclovirase) (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA)	BPHL MCNAA	Homo sapiens (Human)	291	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; alpha-amino-acid esterase activity [GO:0047658]; cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	alpha-amino-acid esterase activity [GO:0047658]	GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0047658	cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN7067_c0_g1_i3	Q86WA6	BPHL_HUMAN	54.4	217	99	0	141	791	74	290	3.40E-70	266.5	BPHL_HUMAN	reviewed	Valacyclovir hydrolase (VACVase) (Valacyclovirase) (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA)	BPHL MCNAA	Homo sapiens (Human)	291	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; alpha-amino-acid esterase activity [GO:0047658]; cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	alpha-amino-acid esterase activity [GO:0047658]	GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0047658	cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	1
TRINITY_DN839_c0_g1_i11	Q9Z1Q9	SYVC_MOUSE	36.3	289	156	8	371	1186	587	864	4.30E-39	163.7	SYVC_MOUSE	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	Vars1 Bat6 G7a Vars Vars2	Mus musculus (Mouse)	1263	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i25	P26640	SYVC_HUMAN	55.3	367	148	4	2	1054	306	672	1.70E-118	427.9	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i25	P26640	SYVC_HUMAN	41	200	96	5	1099	1659	683	873	7.20E-29	130.2	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN14743_c0_g1_i2	P26640	SYVC_HUMAN	99.7	300	1	0	900	1	279	578	4.60E-179	628.2	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN30272_c0_g1_i1	P26640	SYVC_HUMAN	98.6	72	1	0	1	216	692	763	3.40E-40	164.9	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN23516_c0_g1_i1	Q9Z1Q9	SYVC_MOUSE	100	76	0	0	230	3	770	845	6.20E-40	164.1	SYVC_MOUSE	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	Vars1 Bat6 G7a Vars Vars2	Mus musculus (Mouse)	1263	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN23516_c0_g1_i2	P26640	SYVC_HUMAN	98.5	130	2	0	391	2	771	900	8.90E-71	267.3	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN4490_c0_g1_i1	P26640	SYVC_HUMAN	68.1	216	66	2	643	2	680	894	1.20E-85	317.4	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN4490_c0_g1_i2	Q9Z1Q9	SYVC_MOUSE	60.7	145	52	3	456	28	679	820	3.40E-45	182.6	SYVC_MOUSE	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	Vars1 Bat6 G7a Vars Vars2	Mus musculus (Mouse)	1263	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN40478_c0_g1_i1	P26640	SYVC_HUMAN	100	76	0	0	2	229	753	828	5.30E-39	161	SYVC_HUMAN	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)	VARS1 G7A VARS VARS2	Homo sapiens (Human)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN17075_c0_g1_i1	Q1GUM2	SYV_SPHAL	82.8	99	17	0	297	1	203	301	1.00E-42	173.7	SYV_SPHAL	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS Sala_0932	Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis)	931	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN17075_c0_g2_i1	Q474E1	SYV_CUPPJ	87.8	90	11	0	270	1	207	296	2.50E-40	165.6	SYV_CUPPJ	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS Reut_A0863	Cupriavidus pinatubonensis (strain JMP 134 / LMG 1197) (Cupriavidus necator (strain JMP 134))	955	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i2	Q04462	SYVC_RAT	50.6	85	36	1	374	610	588	672	4.70E-18	92.8	SYVC_RAT	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	Vars1 Vars Vars2	Rattus norvegicus (Rat)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN14743_c0_g1_i1	Q04462	SYVC_RAT	97.7	307	7	0	924	4	271	577	7.30E-180	630.9	SYVC_RAT	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	Vars1 Vars Vars2	Rattus norvegicus (Rat)	1264	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN5405_c0_g1_i1	Q9U1Q4	SYV_CAEEL	53.6	125	57	1	375	1	234	357	8.50E-34	144.4	SYV_CAEEL	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	glp-4 vars-2 vrs-2 Y87G2A.5	Caenorhabditis elegans	1050	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; determination of adult lifespan [GO:0008340]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438; GO:0008340	determination of adult lifespan [GO:0008340]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN3112_c0_g1_i1	Q8XX80	SYV_RALSO	94	151	9	0	3	455	393	543	1.20E-82	307	SYV_RALSO	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS RSc2236 RS01363	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	968	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN3112_c1_g1_i1	Q7X2N3	SYV_SPHEL	75.3	73	18	0	14	232	442	514	6.10E-27	120.9	SYV_SPHEL	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS	Sphingomonas elodea	811	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN3112_c1_g1_i2	Q7X2N3	SYV_SPHEL	89.6	77	8	0	1	231	438	514	5.50E-36	151	SYV_SPHEL	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS	Sphingomonas elodea	811	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN37714_c0_g1_i1	Q8YGX8	SYV_BRUME	75.8	95	23	0	1	285	458	552	8.70E-39	160.6	SYV_BRUME	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS BMEI1027	Brucella melitensis biotype 1 (strain 16M / ATCC 23456 / NCTC 10094)	910	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN3278_c2_g1_i1	P49696	SYVC_TAKRU	74.1	301	77	1	239	1138	223	523	9.40E-137	488	SYVC_TAKRU	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	vars1 vars	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	1217	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN10980_c0_g1_i1	P49696	SYVC_TAKRU	38.9	36	22	0	109	2	617	652	9.90E-06	50.4	SYVC_TAKRU	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	vars1 vars	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	1217	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN35389_c0_g1_i1	Q8XX80	SYV_RALSO	94.8	154	8	0	464	3	46	199	4.20E-83	308.5	SYV_RALSO	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS RSc2236 RS01363	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	968	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN32151_c0_g1_i1	P67600	SYV_MYCBO	92.1	101	8	0	3	305	142	242	5.70E-49	194.5	SYV_MYCBO	reviewed	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	valS BQ2027_MB2475C	Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)	886	cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	cytoplasm [GO:0005737]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005737; GO:0006438	valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i17	Q3U2A8	SYVM_MOUSE	48.4	161	70	4	732	1202	520	671	3.90E-32	140.6	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i17	Q3U2A8	SYVM_MOUSE	44.7	85	40	2	358	591	389	473	7.60E-12	73.2	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i17	Q3U2A8	SYVM_MOUSE	29.4	201	121	6	596	1174	475	662	5.10E-08	60.5	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i21	Q3U2A8	SYVM_MOUSE	48.4	161	70	4	745	1215	520	671	3.90E-32	140.6	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i21	Q3U2A8	SYVM_MOUSE	44.7	85	40	2	371	604	389	473	7.70E-12	73.2	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i21	Q3U2A8	SYVM_MOUSE	29.4	201	121	6	609	1187	475	662	5.20E-08	60.5	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i22	Q3U2A8	SYVM_MOUSE	48.4	161	70	4	620	1090	520	671	3.50E-32	140.6	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i22	Q3U2A8	SYVM_MOUSE	29.4	201	121	6	484	1062	475	662	4.60E-08	60.5	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i5	Q3U2A8	SYVM_MOUSE	48.4	161	70	4	619	1089	520	671	3.50E-32	140.6	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN839_c0_g1_i5	Q3U2A8	SYVM_MOUSE	31.8	245	140	7	369	1061	431	662	8.40E-18	92.8	SYVM_MOUSE	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)"	Vars2 Kiaa1885 Vars2l	Mus musculus (Mouse)	1060	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN22111_c0_g1_i1	Q5ST30	SYVM_HUMAN	96.8	93	3	0	1	279	321	413	5.80E-48	191	SYVM_HUMAN	reviewed	"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) (Valyl-tRNA synthetase-like)"	VARS2 KIAA1885 VARS2L VARSL	Homo sapiens (Human)	1063	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006418; GO:0006438	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]		NA	NA	NA	NA	NA	NA
TRINITY_DN8827_c0_g1_i2	Q8R5L3	VPS39_MOUSE	34	212	127	4	71	691	652	855	1.10E-23	111.7	VPS39_MOUSE	reviewed	Vam6/Vps39-like protein	Vps39 Pldn Vam6	Mus musculus (Mouse)	886	"cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]"	cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0016020; GO:0017137; GO:0030897; GO:0031902; GO:0034058; GO:1902774; GO:1990126	"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8827_c0_g1_i3	Q8R5L3	VPS39_MOUSE	42.5	883	453	16	82	2649	1	855	3.90E-186	653.3	VPS39_MOUSE	reviewed	Vam6/Vps39-like protein	Vps39 Pldn Vam6	Mus musculus (Mouse)	886	"cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]"	cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0016020; GO:0017137; GO:0030897; GO:0031902; GO:0034058; GO:1902774; GO:1990126	"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8827_c0_g1_i1	Q96JC1	VPS39_HUMAN	50	200	81	5	82	645	1	193	2.10E-46	187.2	VPS39_HUMAN	reviewed	Vam6/Vps39-like protein (TRAP1-like protein) (hVam6p)	VPS39 KIAA0770 TLP VAM6	Homo sapiens (Human)	886	"AP-3 adaptor complex [GO:0030123]; cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]"	AP-3 adaptor complex [GO:0030123]; cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	Rab GTPase binding [GO:0017137]	GO:0005737; GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0016020; GO:0017137; GO:0030123; GO:0030897; GO:0031902; GO:0034058; GO:1902774; GO:1990126	"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36414_c0_g1_i1	Q9ZRD6	YKT61_ARATH	48.3	60	31	0	3	182	137	196	5.90E-10	64.3	YKT61_ARATH	reviewed	VAMP-like protein YKT61 (AtYKT61) (Geranylgeranylated protein 1) (AtGP1)	YKT61 At5g58060 K21L19.5 K21L19_40	Arabidopsis thaliana (Mouse-ear cress)	199	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN8601_c2_g1_i1	Q9ULK5	VANG2_HUMAN	53.3	137	64	0	482	72	385	521	7.60E-38	158.3	VANG2_HUMAN	reviewed	Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2)	VANGL2 KIAA1215 STB1	Homo sapiens (Human)	521	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell pole [GO:0060187]; cell-cell junction [GO:0005911]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in neural plate elongation [GO:0022007]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron axon guidance [GO:0036514]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity involved in neural tube closure [GO:0090177]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; glomerulus development [GO:0032835]; hair follicle development [GO:0001942]; heart looping [GO:0001947]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney morphogenesis [GO:0060993]; lateral sprouting involved in lung morphogenesis [GO:0060490]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in heart morphogenesis [GO:0061346]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; positive regulation of JUN kinase activity [GO:0043507]; post-anal tail morphogenesis [GO:0036342]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Wnt signaling pathway [GO:0030111]; Rho protein signal transduction [GO:0007266]; serotonergic neuron axon guidance [GO:0036515]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cell pole [GO:0060187]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]		GO:0001725; GO:0001736; GO:0001843; GO:0001942; GO:0001947; GO:0003149; GO:0003150; GO:0003402; GO:0005886; GO:0005911; GO:0007266; GO:0009952; GO:0015012; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0022007; GO:0030111; GO:0030134; GO:0032835; GO:0032956; GO:0035019; GO:0035787; GO:0036342; GO:0036514; GO:0036515; GO:0042060; GO:0043507; GO:0045176; GO:0045197; GO:0048103; GO:0048105; GO:0048546; GO:0060028; GO:0060071; GO:0060122; GO:0060187; GO:0060488; GO:0060489; GO:0060490; GO:0060993; GO:0061346; GO:0090103; GO:0090177; GO:0090179; GO:1904938; GO:1905515	"anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in neural plate elongation [GO:0022007]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron axon guidance [GO:0036514]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity involved in neural tube closure [GO:0090177]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; glomerulus development [GO:0032835]; hair follicle development [GO:0001942]; heart looping [GO:0001947]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney morphogenesis [GO:0060993]; lateral sprouting involved in lung morphogenesis [GO:0060490]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in heart morphogenesis [GO:0061346]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; positive regulation of JUN kinase activity [GO:0043507]; post-anal tail morphogenesis [GO:0036342]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Wnt signaling pathway [GO:0030111]; Rho protein signal transduction [GO:0007266]; serotonergic neuron axon guidance [GO:0036515]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8601_c2_g1_i2	Q8UVJ6	VANG2_DANRE	42.5	73	42	0	290	72	454	526	2.10E-11	70.1	VANG2_DANRE	reviewed	Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2)	vangl2 stbm tri	Danio rerio (Zebrafish) (Brachydanio rerio)	526	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin filament organization [GO:0007015]; anterior/posterior axon guidance [GO:0033564]; axis elongation [GO:0003401]; cell migration in hindbrain [GO:0021535]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; cloaca development [GO:0035844]; commissural neuron axon guidance [GO:0071679]; convergent extension [GO:0060026]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in gastrulation [GO:0060027]; dorsal convergence [GO:0060030]; embryonic eye morphogenesis [GO:0048048]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; left/right pattern formation [GO:0060972]; motor neuron migration [GO:0097475]; muscle cell migration [GO:0014812]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural plate morphogenesis [GO:0001839]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; neuron migration [GO:0001764]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; otolith development [GO:0048840]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0000132; GO:0000902; GO:0001654; GO:0001736; GO:0001756; GO:0001764; GO:0001839; GO:0001841; GO:0003401; GO:0005886; GO:0007015; GO:0007163; GO:0014812; GO:0016021; GO:0021535; GO:0021915; GO:0030010; GO:0030198; GO:0030903; GO:0033564; GO:0035844; GO:0035845; GO:0036342; GO:0042074; GO:0044782; GO:0045813; GO:0048048; GO:0048570; GO:0048840; GO:0055002; GO:0060026; GO:0060027; GO:0060028; GO:0060030; GO:0060071; GO:0060271; GO:0060972; GO:0071679; GO:0090090; GO:0097475	"actin filament organization [GO:0007015]; anterior/posterior axon guidance [GO:0033564]; axis elongation [GO:0003401]; cell migration in hindbrain [GO:0021535]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; cloaca development [GO:0035844]; commissural neuron axon guidance [GO:0071679]; convergent extension [GO:0060026]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in gastrulation [GO:0060027]; dorsal convergence [GO:0060030]; embryonic eye morphogenesis [GO:0048048]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; left/right pattern formation [GO:0060972]; motor neuron migration [GO:0097475]; muscle cell migration [GO:0014812]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural plate morphogenesis [GO:0001839]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; neuron migration [GO:0001764]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; otolith development [GO:0048840]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		brown	brown	1	NA	NA	NA
TRINITY_DN13432_c0_g1_i1	P83548	VNNL3_DROME	46.1	115	60	2	14	355	141	254	4.20E-22	105.5	VNNL3_DROME	reviewed	Vanin-like protein 3 (EC 3.5.1.-)	CG32750	Drosophila melanogaster (Fruit fly)	523	"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; nitrogen compound metabolic process [GO:0006807]"	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"	GO:0005886; GO:0006807; GO:0016811; GO:0031225	nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN13432_c0_g1_i2	P83548	VNNL3_DROME	31.2	292	175	10	14	871	141	412	2.80E-27	124	VNNL3_DROME	reviewed	Vanin-like protein 3 (EC 3.5.1.-)	CG32750	Drosophila melanogaster (Fruit fly)	523	"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; nitrogen compound metabolic process [GO:0006807]"	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]"	GO:0005886; GO:0006807; GO:0016811; GO:0031225	nitrogen compound metabolic process [GO:0006807]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i41	Q8QHL3	VGFR1_CHICK	38.6	220	124	7	68	721	711	921	4.30E-27	123.6	VGFR1_CHICK	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1)	FLT1 VEGFR1	Gallus gallus (Chicken)	1327	endosome [GO:0005768]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	endosome [GO:0005768]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0002244; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005768; GO:0005887; GO:0006935; GO:0007169; GO:0007275; GO:0016477; GO:0033674; GO:0043235; GO:0045766; GO:0048010	angiogenesis [GO:0001525]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN7939_c0_g1_i2	Q8QHL3	VGFR1_CHICK	50.5	93	45	1	285	10	799	891	1.50E-19	96.7	VGFR1_CHICK	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1)	FLT1 VEGFR1	Gallus gallus (Chicken)	1327	endosome [GO:0005768]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	endosome [GO:0005768]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0002244; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005768; GO:0005887; GO:0006935; GO:0007169; GO:0007275; GO:0016477; GO:0033674; GO:0043235; GO:0045766; GO:0048010	angiogenesis [GO:0001525]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i11	P35969	VGFR1_MOUSE	52.6	78	36	1	236	6	978	1055	7.40E-14	78.6	VGFR1_MOUSE	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT)	Flt1 Emrk2 Flt Vegfr1	Mus musculus (Mouse)	1333	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036328; GO:0036332; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:1901534; GO:1905563; GO:1990384	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i11	P35969	VGFR1_MOUSE	66	50	17	0	391	242	998	1047	2.00E-11	70.5	VGFR1_MOUSE	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT)	Flt1 Emrk2 Flt Vegfr1	Mus musculus (Mouse)	1333	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036328; GO:0036332; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:1901534; GO:1905563; GO:1990384	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i7	P35969	VGFR1_MOUSE	53	166	75	3	727	236	1001	1165	2.20E-46	187.2	VGFR1_MOUSE	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT)	Flt1 Emrk2 Flt Vegfr1	Mus musculus (Mouse)	1333	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036328; GO:0036332; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:1901534; GO:1905563; GO:1990384	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i7	P35969	VGFR1_MOUSE	52.6	78	36	1	236	6	978	1055	1.10E-13	78.6	VGFR1_MOUSE	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT)	Flt1 Emrk2 Flt Vegfr1	Mus musculus (Mouse)	1333	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036328; GO:0036332; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:1901534; GO:1905563; GO:1990384	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i8	P35969	VGFR1_MOUSE	45.8	212	103	5	867	262	1001	1210	4.00E-47	189.9	VGFR1_MOUSE	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT)	Flt1 Emrk2 Flt Vegfr1	Mus musculus (Mouse)	1333	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036328; GO:0036332; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:1901534; GO:1905563; GO:1990384	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN1430_c0_g1_i4	P17948	VGFR1_HUMAN	32.4	136	75	4	605	219	613	738	1.70E-09	64.7	VGFR1_HUMAN	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor)	FLT1 FLT FRT VEGFR1	Homo sapiens (Human)	1338	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]	GO:0001525; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005886; GO:0005887; GO:0005925; GO:0007169; GO:0007275; GO:0008284; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:1905563; GO:1990384	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN8769_c0_g1_i6	P53767	VGFR1_RAT	29.6	807	434	22	2421	100	453	1158	1.80E-89	332	VGFR1_RAT	reviewed	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT)	Flt1 Flt-1 Vegfr1	Rattus norvegicus (Rat)	1336	endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]; activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; female pregnancy [GO:0007565]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; intracellular receptor signaling pathway [GO:0030522]; liver regeneration [GO:0097421]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of vascular endothelial growth factor production [GO:1904046]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of smooth muscle cell proliferation [GO:0048661]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of smooth muscle contraction [GO:0006940]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor-activated receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-A-activated receptor activity [GO:0036326]; VEGF-B-activated receptor activity [GO:0036327]	GO:0000186; GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0006468; GO:0006940; GO:0007169; GO:0007275; GO:0007565; GO:0007568; GO:0010863; GO:0014068; GO:0014823; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0030522; GO:0032355; GO:0033674; GO:0035924; GO:0036323; GO:0036326; GO:0036327; GO:0036332; GO:0042802; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045471; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:0048661; GO:0060252; GO:0071456; GO:0097421; GO:1901534; GO:1903671; GO:1904046; GO:1905563; GO:1990384	activation of MAPKK activity [GO:0000186]; aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; female pregnancy [GO:0007565]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; intracellular receptor signaling pathway [GO:0030522]; liver regeneration [GO:0097421]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of vascular endothelial growth factor production [GO:1904046]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of smooth muscle cell proliferation [GO:0048661]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of smooth muscle contraction [GO:0006940]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		blue	blue	NA	NA	NA	NA
TRINITY_DN4228_c0_g1_i4	P52583	VGFR2_COTJA	26.2	122	85	2	818	462	616	735	1.80E-07	58.2	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN4228_c0_g1_i5	P52583	VGFR2_COTJA	26.2	122	85	2	818	462	616	735	1.80E-07	58.2	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN4228_c0_g1_i6	P52583	VGFR2_COTJA	34.8	69	43	1	270	64	669	735	1.20E-05	50.8	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN8203_c0_g1_i1	P52583	VGFR2_COTJA	40.6	69	39	1	65	271	669	735	1.40E-08	60.5	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN8203_c0_g1_i2	P52583	VGFR2_COTJA	40.6	69	39	1	41	247	669	735	1.30E-08	60.5	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN1747_c0_g1_i1	P52583	VGFR2_COTJA	31.1	698	320	15	78	2144	617	1162	1.50E-80	302.4	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i2	P52583	VGFR2_COTJA	42.6	258	136	8	813	61	960	1212	5.30E-49	196.1	VGFR2_COTJA	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Endothelial kinase receptor EK1) (Quek 1) (Quek1)	KDR EK1 FLK-1	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	1348	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001934; GO:0005021; GO:0005524; GO:0005769; GO:0005783; GO:0005886; GO:0016021; GO:0019838; GO:0030054; GO:0030154; GO:0035924; GO:0046777; GO:0048010	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i13	P35968	VGFR2_HUMAN	25.7	966	575	39	242	2896	32	935	1.60E-49	199.9	VGFR2_HUMAN	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	KDR FLK1 VEGFR2	Homo sapiens (Human)	1356	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	GO:0001525; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0002042; GO:0002244; GO:0003158; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0008360; GO:0010595; GO:0010629; GO:0014068; GO:0016032; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030198; GO:0030335; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043491; GO:0043536; GO:0045121; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0061042; GO:0070371; GO:0070374; GO:0090050; GO:0090141; GO:0097443; GO:1904881; GO:2000352; GO:2001214	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i37	P35968	VGFR2_HUMAN	25.9	969	569	34	242	2896	32	935	4.00E-53	211.8	VGFR2_HUMAN	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	KDR FLK1 VEGFR2	Homo sapiens (Human)	1356	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	GO:0001525; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0002042; GO:0002244; GO:0003158; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0008360; GO:0010595; GO:0010629; GO:0014068; GO:0016032; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030198; GO:0030335; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043491; GO:0043536; GO:0045121; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0061042; GO:0070371; GO:0070374; GO:0090050; GO:0090141; GO:0097443; GO:1904881; GO:2000352; GO:2001214	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i39	P35968	VGFR2_HUMAN	26	965	569	34	242	2884	32	935	5.70E-52	208	VGFR2_HUMAN	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	KDR FLK1 VEGFR2	Homo sapiens (Human)	1356	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	GO:0001525; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0002042; GO:0002244; GO:0003158; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0008360; GO:0010595; GO:0010629; GO:0014068; GO:0016032; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030198; GO:0030335; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043491; GO:0043536; GO:0045121; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0061042; GO:0070371; GO:0070374; GO:0090050; GO:0090141; GO:0097443; GO:1904881; GO:2000352; GO:2001214	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i8	P35968	VGFR2_HUMAN	25.7	966	575	39	242	2896	32	935	1.60E-49	199.9	VGFR2_HUMAN	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	KDR FLK1 VEGFR2	Homo sapiens (Human)	1356	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	GO:0001525; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0002042; GO:0002244; GO:0003158; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0008360; GO:0010595; GO:0010629; GO:0014068; GO:0016032; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030198; GO:0030335; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043491; GO:0043536; GO:0045121; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0061042; GO:0070371; GO:0070374; GO:0090050; GO:0090141; GO:0097443; GO:1904881; GO:2000352; GO:2001214	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of cell shape [GO:0008360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i10	O08775	VGFR2_RAT	25	960	589	32	239	2902	31	931	3.50E-51	205.3	VGFR2_RAT	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	Kdr Flk1	Rattus norvegicus (Rat)	1343	cell junction [GO:0030054]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; aging [GO:0007568]; branching involved in blood vessel morphogenesis [GO:0001569]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endochondral bone growth [GO:0003416]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; hyaluronan metabolic process [GO:0030212]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lymph vessel development [GO:0001945]; male gonad development [GO:0008584]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]	cell junction [GO:0030054]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	GO:0001541; GO:0001569; GO:0001570; GO:0001666; GO:0001934; GO:0001938; GO:0001945; GO:0002042; GO:0002053; GO:0002244; GO:0003157; GO:0003158; GO:0003416; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007204; GO:0007275; GO:0007568; GO:0008284; GO:0008360; GO:0008584; GO:0009897; GO:0009986; GO:0010595; GO:0010629; GO:0014068; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030097; GO:0030212; GO:0030324; GO:0030335; GO:0030513; GO:0032008; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042493; GO:0042802; GO:0043005; GO:0043025; GO:0043066; GO:0043129; GO:0043235; GO:0043410; GO:0043491; GO:0043524; GO:0043536; GO:0045121; GO:0045165; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0048170; GO:0048286; GO:0048469; GO:0048597; GO:0048754; GO:0048812; GO:0050679; GO:0050769; GO:0050850; GO:0050927; GO:0051770; GO:0051894; GO:0051901; GO:0055074; GO:0061042; GO:0070371; GO:0070374; GO:0070482; GO:0071944; GO:0090050; GO:0090141; GO:0097443; GO:0097755; GO:1901532; GO:1903010; GO:1904881; GO:2000352; GO:2001214	aging [GO:0007568]; branching involved in blood vessel morphogenesis [GO:0001569]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endochondral bone growth [GO:0003416]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; hyaluronan metabolic process [GO:0030212]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lymph vessel development [GO:0001945]; male gonad development [GO:0008584]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection morphogenesis [GO:0048812]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]		NA	NA	NA	NA	NA	NA
TRINITY_DN7939_c0_g1_i1	Q5GIT4	VGFR2_DANRE	50.7	75	36	1	225	4	843	917	2.40E-12	72.8	VGFR2_DANRE	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B)	kdr flk1b kdrb si:busm1-205d10.1 si:ch211-254j6.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1357	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell differentiation [GO:0045446]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001568; GO:0002244; GO:0004714; GO:0005021; GO:0005524; GO:0005634; GO:0005769; GO:0005783; GO:0005887; GO:0007169; GO:0007275; GO:0016477; GO:0019838; GO:0030054; GO:0033674; GO:0035924; GO:0043235; GO:0045446; GO:0045766; GO:0048010	angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell differentiation [GO:0045446]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN7939_c0_g1_i3	Q5GIT4	VGFR2_DANRE	51.6	95	45	1	285	4	823	917	1.20E-19	97.1	VGFR2_DANRE	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B)	kdr flk1b kdrb si:busm1-205d10.1 si:ch211-254j6.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1357	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell differentiation [GO:0045446]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001568; GO:0002244; GO:0004714; GO:0005021; GO:0005524; GO:0005634; GO:0005769; GO:0005783; GO:0005887; GO:0007169; GO:0007275; GO:0016477; GO:0019838; GO:0030054; GO:0033674; GO:0035924; GO:0043235; GO:0045446; GO:0045766; GO:0048010	angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell differentiation [GO:0045446]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i10	P35916	VGFR3_HUMAN	49.5	99	47	2	2	295	851	947	1.90E-18	94	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i11	P35916	VGFR3_HUMAN	49.5	99	47	2	2	295	851	947	1.90E-18	94	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i2	P35916	VGFR3_HUMAN	49.5	99	47	2	2	295	851	947	2.50E-18	94	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i3	P35916	VGFR3_HUMAN	46.3	95	48	2	9	290	855	947	3.90E-16	86.3	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i4	P35916	VGFR3_HUMAN	50.5	99	46	2	2	295	851	947	8.40E-19	95.1	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i5	P35916	VGFR3_HUMAN	50.5	99	46	2	2	295	851	947	8.40E-19	95.1	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i7	P35916	VGFR3_HUMAN	45.3	95	49	2	9	290	855	947	1.20E-15	85.1	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN3742_c0_g1_i9	P35916	VGFR3_HUMAN	46.3	95	48	2	9	290	855	947	3.90E-16	86.3	VGFR3_HUMAN	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	Homo sapiens (Human)	1363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; VEGF-C-activated receptor activity [GO:0036328]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007275; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0036328; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i19	Q8AXB3	VGFR4_DANRE	25.6	578	369	15	1098	2744	365	910	3.80E-39	165.2	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN212_c0_g1_i44	Q8AXB3	VGFR4_DANRE	25.1	756	467	22	548	2668	205	910	2.50E-43	179.1	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i13	Q8AXB3	VGFR4_DANRE	41.9	167	81	5	834	337	1034	1185	1.60E-29	131.3	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i14	Q8AXB3	VGFR4_DANRE	41.9	167	81	5	834	337	1034	1185	1.60E-29	131.3	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i3	Q8AXB3	VGFR4_DANRE	45.9	218	101	6	1199	552	983	1185	2.80E-46	187.6	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i5	Q8AXB3	VGFR4_DANRE	49.2	195	90	5	907	347	979	1172	3.60E-47	190.3	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i6	Q8AXB3	VGFR4_DANRE	48.7	113	56	2	626	291	1034	1145	7.20E-29	129	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i6	Q8AXB3	VGFR4_DANRE	54.7	75	32	2	228	7	979	1052	7.70E-15	82.4	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN373_c0_g1_i6	Q8AXB3	VGFR4_DANRE	63.6	33	12	0	736	638	983	1015	9.40E-05	48.9	VGFR4_DANRE	reviewed	Vascular endothelial growth factor receptor kdr-like (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor-A) (Kinase insert domain receptor-like) (Protein-tyrosine kinase receptor flk-1) (Vascular endothelial growth factor receptor 4) (VEGFR-4)	kdrl flk flk-1 flk1 flka kdr kdra vegfr2 vegfr4 vegr2 si:ch211-276g21.4	Danio rerio (Zebrafish) (Brachydanio rerio)	1302	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001568; GO:0002040; GO:0002244; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007275; GO:0018108; GO:0030878; GO:0033674; GO:0035050; GO:0043235; GO:0048844	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; embryonic heart tube development [GO:0035050]; hematopoietic progenitor cell differentiation [GO:0002244]; multicellular organism development [GO:0007275]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		NA	NA	NA	NA	NA	NA
TRINITY_DN32914_c0_g1_i1	Q05108	VA5_DOLAR	47.4	57	28	1	33	203	129	183	4.50E-08	58.2	VA5_DOLAR	reviewed	Venom allergen 5 (Allergen Dol a V) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (allergen Dol a 5)		Dolichovespula arenaria (Yellow hornet) (Aerial yellowjacket)	203	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN20152_c0_g1_i1	P35786	VA5_VESSQ	44.6	83	36	3	221	3	2	84	3.60E-11	68.9	VA5_VESSQ	reviewed	Venom allergen 5 (Allergen Ves s V) (Antigen 5) (Ag5) (Cysteine-rich venom protein) (CRVP) (allergen Ves s 5)		Vespula squamosa (Southern yellow jacket) (Wasp)	205	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN4719_c0_g1_i2	B2D0J5	EST6_APIME	31.2	410	254	11	1365	175	162	556	1.30E-47	192.2	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN14804_c0_g1_i1	B2D0J5	EST6_APIME	53.3	122	56	1	2	364	110	231	1.80E-32	140.2	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN8067_c0_g1_i4	B2D0J5	EST6_APIME	31.1	563	358	16	139	1773	6	556	4.90E-71	270.4	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			blue	blue	NA	NA	NA	NA
TRINITY_DN22038_c0_g1_i1	B2D0J5	EST6_APIME	68.3	60	19	0	204	25	170	229	7.10E-19	94	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN7225_c2_g1_i6	B2D0J5	EST6_APIME	55.5	110	47	1	24	353	124	231	2.30E-28	126.3	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i2	B2D0J5	EST6_APIME	24.3	552	330	23	1647	169	28	550	1.30E-31	139.4	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i3	B2D0J5	EST6_APIME	30.6	402	242	14	1317	169	167	550	1.20E-43	179.5	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i3	B2D0J5	EST6_APIME	36.1	147	87	2	1841	1401	28	167	5.00E-21	104.4	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i4	B2D0J5	EST6_APIME	31.9	548	329	16	1755	169	28	550	1.20E-72	275.8	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN1853_c0_g1_i7	B2D0J5	EST6_APIME	43.1	239	129	2	1666	950	28	259	2.70E-50	201.4	EST6_APIME	reviewed	Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)		Apis mellifera (Honeybee)	557	extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030]	extracellular region [GO:0005576]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005576; GO:0080030			NA	NA	NA	NA	NA	NA
TRINITY_DN40786_c0_g1_i1	B2D0J4	VDPP4_APIME	49.2	65	30	2	201	7	662	723	2.40E-10	65.9	VDPP4_APIME	reviewed	Venom dipeptidyl peptidase 4 (Allergen C) (Venom dipeptidyl peptidase IV) (EC 3.4.14.5) (allergen Api m 5)		Apis mellifera (Honeybee)	775	extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	extracellular region [GO:0005576]	aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005576; GO:0008236			NA	NA	NA	NA	NA	NA
TRINITY_DN24075_c0_g1_i1	B2D0J4	VDPP4_APIME	39	154	92	1	549	88	619	770	9.30E-30	131.7	VDPP4_APIME	reviewed	Venom dipeptidyl peptidase 4 (Allergen C) (Venom dipeptidyl peptidase IV) (EC 3.4.14.5) (allergen Api m 5)		Apis mellifera (Honeybee)	775	extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	extracellular region [GO:0005576]	aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005576; GO:0008236			NA	NA	NA	NA	NA	NA
TRINITY_DN4326_c0_g2_i1	B1A4F7	VDDP4_VESVU	36	786	474	13	70	2406	8	771	8.40E-138	492.7	VDDP4_VESVU	reviewed	Venom dipeptidyl peptidase 4 (EC 3.4.14.5) (Venom dipeptidyl peptidase IV) (allergen Ves v 3)		Vespula vulgaris (Yellow jacket) (Wasp)	776	extracellular region [GO:0005576]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	extracellular region [GO:0005576]	aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005576; GO:0008236			blue	blue	NA	NA	NA	NA
TRINITY_DN38896_c0_g1_i1	W8E7D1	PDE_MACLB	43.6	346	182	6	1014	4	181	522	7.90E-74	278.9	PDE_MACLB	reviewed	Venom phosphodiesterase (PDE) (VLPDE) (EC 3.6.1.-)		Macrovipera lebetina (Levantine viper) (Vipera lebetina)	851	extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; toxin activity [GO:0090729]	GO:0003676; GO:0005576; GO:0016787; GO:0046872; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN6123_c0_g1_i1	W8E7D1	PDE_MACLB	49.4	156	76	2	2	463	132	286	6.00E-42	171.8	PDE_MACLB	reviewed	Venom phosphodiesterase (PDE) (VLPDE) (EC 3.6.1.-)		Macrovipera lebetina (Levantine viper) (Vipera lebetina)	851	extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; toxin activity [GO:0090729]	GO:0003676; GO:0005576; GO:0016787; GO:0046872; GO:0090729			NA	NA	NA	NA	NA	NA
TRINITY_DN11983_c0_g1_i3	J3SEZ3	PDE1_CROAD	35.4	738	409	20	165	2255	139	849	5.70E-112	406.8	PDE1_CROAD	reviewed	Venom phosphodiesterase 1 (PDE) (EC 3.6.1.-)		Crotalus adamanteus (Eastern diamondback rattlesnake)	851	extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; toxin activity [GO:0090729]	extracellular region [GO:0005576]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; toxin activity [GO:0090729]	GO:0003676; GO:0005576; GO:0016787; GO:0046872; GO:0090729			NA	NA	NA	NA	NA	1
TRINITY_DN27327_c0_g1_i1	Q8MQS8	SP34_APIME	33.1	133	84	3	389	3	188	319	3.30E-13	76.3	SP34_APIME	reviewed	Venom serine protease 34 (SP34) (EC 3.4.21.-) (allergen Api m 7)		Apis mellifera (Honeybee)	405	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]	extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576			blue	blue	NA	NA	NA	NA
TRINITY_DN9454_c0_g1_i4	A2BID5	MELT_DANRE	72.3	65	18	0	243	49	52	116	6.20E-22	104.4	MELT_DANRE	reviewed	Ventricular zone-expressed PH domain-containing protein (Protein melted homolog)	veph si:ch211-283j23.5	Danio rerio (Zebrafish) (Brachydanio rerio)	813	plasma membrane [GO:0005886]; phosphatidylinositol-5-phosphate binding [GO:0010314]; brain development [GO:0007420]; ear morphogenesis [GO:0042471]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]	GO:0005886; GO:0007420; GO:0009966; GO:0010314; GO:0042471	brain development [GO:0007420]; ear morphogenesis [GO:0042471]; regulation of signal transduction [GO:0009966]		NA	NA	NA	NA	NA	NA
TRINITY_DN9454_c0_g1_i5	Q14D04	MELT_HUMAN	62.9	62	23	0	227	42	118	179	2.50E-15	82.8	MELT_HUMAN	reviewed	Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted)	VEPH1 KIAA1692 VEPH	Homo sapiens (Human)	833	plasma membrane [GO:0005886]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	phosphatidylinositol-5-phosphate binding [GO:0010314]	GO:0005886; GO:0009966; GO:0010314; GO:0030512; GO:0060392	negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966]		brown	brown	NA	NA	NA	NA
TRINITY_DN39430_c0_g1_i1	P13611	CSPG2_HUMAN	100	74	0	0	222	1	3090	3163	1.60E-43	176	CSPG2_HUMAN	reviewed	Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)	VCAN CSPG2	Homo sapiens (Human)	3396	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; cellular protein metabolic process [GO:0044267]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; post-translational protein modification [GO:0043687]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]	GO:0001501; GO:0001649; GO:0001750; GO:0005509; GO:0005539; GO:0005540; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0007155; GO:0007275; GO:0007417; GO:0008037; GO:0008347; GO:0016020; GO:0030021; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0033165; GO:0043202; GO:0043687; GO:0044267; GO:0062023	cell adhesion [GO:0007155]; cell recognition [GO:0008037]; cellular protein metabolic process [GO:0044267]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; post-translational protein modification [GO:0043687]; skeletal system development [GO:0001501]		NA	NA	NA	NA	NA	NA
TRINITY_DN28928_c0_g1_i1	P50544	ACADV_MOUSE	100	105	0	0	3	317	260	364	2.60E-52	205.7	ACADV_MOUSE	reviewed	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.9) (MVLCAD) (VLCAD)"	Acadvl Vlcad	Mus musculus (Mouse)	656	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005829; GO:0006635; GO:0009062; GO:0009409; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]		NA	NA	NA	NA	NA	NA
TRINITY_DN17055_c0_g1_i1	P50544	ACADV_MOUSE	100	126	0	0	378	1	121	246	1.90E-65	249.6	ACADV_MOUSE	reviewed	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.9) (MVLCAD) (VLCAD)"	Acadvl Vlcad	Mus musculus (Mouse)	656	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005829; GO:0006635; GO:0009062; GO:0009409; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]		NA	NA	NA	NA	NA	NA
TRINITY_DN39732_c0_g1_i1	P49748	ACADV_HUMAN	100	81	0	0	1	243	540	620	5.60E-39	161	ACADV_HUMAN	reviewed	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)"	ACADVL VLCAD	Homo sapiens (Human)	655	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001659; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006635; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0036498; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]		NA	NA	NA	NA	NA	NA
TRINITY_DN26506_c0_g1_i1	P49748	ACADV_HUMAN	100	251	0	0	2	754	110	360	9.70E-141	500.7	ACADV_HUMAN	reviewed	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)"	ACADVL VLCAD	Homo sapiens (Human)	655	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001659; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006635; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0036498; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]		NA	NA	NA	NA	NA	NA
TRINITY_DN26506_c0_g1_i2	P49748	ACADV_HUMAN	100	395	0	0	2	1186	110	504	3.90E-226	785	ACADV_HUMAN	reviewed	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)"	ACADVL VLCAD	Homo sapiens (Human)	655	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001659; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006635; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0036498; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]		NA	NA	NA	NA	NA	NA
TRINITY_DN1091_c0_g1_i1	P49748	ACADV_HUMAN	62.7	585	216	2	1842	94	70	654	2.30E-202	706.8	ACADV_HUMAN	reviewed	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)"	ACADVL VLCAD	Homo sapiens (Human)	655	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001659; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006635; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0036498; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]		NA	NA	NA	NA	NA	NA
TRINITY_DN21542_c0_g1_i2	Q9V3S9	BGM_DROME	50.7	67	32	1	44	241	599	665	4.40E-12	72	BGM_DROME	reviewed	Very long-chain-fatty-acid--CoA ligase bubblegum (EC 6.2.1.3)	bgm CG4501	Drosophila melanogaster (Fruit fly)	666	"cytoplasm [GO:0005737]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; neuron cellular homeostasis [GO:0070050]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; response to endoplasmic reticulum stress [GO:0034976]"	cytoplasm [GO:0005737]	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0006631; GO:0006633; GO:0015645; GO:0016405; GO:0034976; GO:0042759; GO:0045938; GO:0070050; GO:0102391	"fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; neuron cellular homeostasis [GO:0070050]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; response to endoplasmic reticulum stress [GO:0034976]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2499_c0_g1_i1	Q5ZM57	HACD3_CHICK	39.1	363	216	3	108	1196	5	362	1.30E-70	268.5	HACD3_CHICK	reviewed	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	HACD3 PTPLAD1 RCJMB04_3b6	Gallus gallus (Chicken)	362	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005783; GO:0007249; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]		NA	NA	NA	NA	NA	NA
TRINITY_DN2499_c0_g1_i2	Q5ZM57	HACD3_CHICK	44.3	221	122	1	425	1087	143	362	2.40E-47	191	HACD3_CHICK	reviewed	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	HACD3 PTPLAD1 RCJMB04_3b6	Gallus gallus (Chicken)	362	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005783; GO:0007249; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]		NA	NA	NA	NA	NA	NA
TRINITY_DN2499_c0_g1_i3	Q5ZM57	HACD3_CHICK	39	367	215	5	108	1208	5	362	4.30E-69	263.5	HACD3_CHICK	reviewed	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	HACD3 PTPLAD1 RCJMB04_3b6	Gallus gallus (Chicken)	362	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005783; GO:0007249; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]		NA	NA	NA	NA	NA	NA
TRINITY_DN40338_c0_g1_i1	Q9P035	HACD3_HUMAN	100	91	0	0	3	275	232	322	1.30E-47	189.9	HACD3_HUMAN	reviewed	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	HACD3 BIND1 PTPLAD1	Homo sapiens (Human)	362	endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; activation of JUN kinase activity [GO:0007257]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005096; GO:0005783; GO:0005925; GO:0007249; GO:0007257; GO:0007264; GO:0007266; GO:0016601; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	activation of JUN kinase activity [GO:0007257]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]		NA	NA	NA	NA	NA	NA
TRINITY_DN1348_c0_g1_i1	Q4R5G7	DHB12_MACFA	46.3	108	55	1	342	19	14	118	4.00E-17	89.4	DHB12_MACFA	reviewed	Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62)	HSD17B12 QnpA-11752	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	312	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]	GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342	estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]		blue	blue	NA	NA	NA	NA
TRINITY_DN29905_c0_g1_i1	Q8AVY8	DH12B_XENLA	51.9	77	37	0	234	4	166	242	7.20E-15	80.9	DH12B_XENLA	reviewed	Very-long-chain 3-oxoacyl-CoA reductase-B (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12-B) (17-beta-HSD 12-B) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12-B) (EC 1.1.1.62)	hsd17b12-b	Xenopus laevis (African clawed frog)	318	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]	GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342	estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]		blue	blue	NA	NA	NA	NA
TRINITY_DN14307_c0_g1_i1	Q2YDE3	GOT1B_BOVIN	91.1	45	4	0	141	7	94	138	7.30E-16	84	GOT1B_BOVIN	reviewed	Vesicle transport protein GOT1B (Golgi transport 1 homolog B)	GOLT1B	Bos taurus (Bovine)	138	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14307_c0_g1_i1	Q2YDE3	GOT1B_BOVIN	96.4	28	1	0	202	119	14	41	2.40E-06	52.4	GOT1B_BOVIN	reviewed	Vesicle transport protein GOT1B (Golgi transport 1 homolog B)	GOLT1B	Bos taurus (Bovine)	138	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN14307_c0_g1_i2	Q2YDE3	GOT1B_BOVIN	100	65	0	0	201	7	74	138	3.30E-29	128.3	GOT1B_BOVIN	reviewed	Vesicle transport protein GOT1B (Golgi transport 1 homolog B)	GOLT1B	Bos taurus (Bovine)	138	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN13616_c0_g1_i1	Q9CR60	GOT1B_MOUSE	47.4	137	72	0	72	482	1	137	9.00E-29	128.3	GOT1B_MOUSE	reviewed	Vesicle transport protein GOT1B (Golgi transport 1 homolog B)	Golt1b	Mus musculus (Mouse)	138	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]		GO:0000139; GO:0005783; GO:0015031; GO:0016021; GO:0016192; GO:0032991	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		blue	blue	NA	NA	NA	NA
TRINITY_DN11601_c0_g1_i1	Q12981	SEC20_HUMAN	26.1	115	85	0	405	61	1	115	4.10E-06	52.8	SEC20_HUMAN	reviewed	Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein) (TRG-8)	BNIP1 NIP1 SEC20L TRG8	Homo sapiens (Human)	228	"COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; apoptotic process [GO:0006915]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; response to activity [GO:0014823]; response to oxygen-glucose deprivation [GO:0090649]; response to starvation [GO:0042594]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032]"	COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]	GO:0005484; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0006890; GO:0006915; GO:0007029; GO:0014823; GO:0016032; GO:0016320; GO:0030137; GO:0030176; GO:0031201; GO:0031966; GO:0042594; GO:0043066; GO:0043231; GO:0090649; GO:0097194	"apoptotic process [GO:0006915]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; response to activity [GO:0014823]; response to oxygen-glucose deprivation [GO:0090649]; response to starvation [GO:0042594]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16864_c0_g1_i2	Q5U3Y5	SFT2A_RAT	97.8	93	2	0	279	1	53	145	1.00E-44	180.3	SFT2A_RAT	reviewed	Vesicle transport protein SFT2A (SFT2 domain-containing protein 1)	Sft2d1	Rattus norvegicus (Rat)	159	integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5826_c0_g1_i1	Q5U3Y5	SFT2A_RAT	56.5	170	60	2	578	69	1	156	2.10E-41	170.6	SFT2A_RAT	reviewed	Vesicle transport protein SFT2A (SFT2 domain-containing protein 1)	Sft2d1	Rattus norvegicus (Rat)	159	integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5826_c0_g1_i2	Q5U3Y5	SFT2A_RAT	59.3	162	60	1	554	69	1	156	1.30E-43	177.9	SFT2A_RAT	reviewed	Vesicle transport protein SFT2A (SFT2 domain-containing protein 1)	Sft2d1	Rattus norvegicus (Rat)	159	integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN16864_c0_g1_i1	Q8WV19	SFT2A_HUMAN	100	107	0	0	370	50	53	159	8.50E-55	214.2	SFT2A_HUMAN	reviewed	Vesicle transport protein SFT2A (SFT2 domain-containing protein 1) (pRGR1)	SFT2D1 C6orf83	Homo sapiens (Human)	159	integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17674_c0_g1_i1	Q8VD57	SFT2B_MOUSE	100	76	0	0	2	229	20	95	4.20E-36	151.4	SFT2B_MOUSE	reviewed	Vesicle transport protein SFT2B (SFT2 domain-containing protein 2)	Sft2d2	Mus musculus (Mouse)	159	integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN34083_c0_g1_i1	O95562	SFT2B_HUMAN	100	74	0	0	222	1	31	104	2.60E-35	148.7	SFT2B_HUMAN	reviewed	Vesicle transport protein SFT2B (SFT2 domain-containing protein 2)	SFT2D2 UNQ512/PRO1027	Homo sapiens (Human)	160	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192; GO:0070062	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN5394_c0_g1_i1	Q9CSV6	SFT2C_MOUSE	32.6	233	128	7	45	719	1	212	3.10E-14	80.5	SFT2C_MOUSE	reviewed	Vesicle transport protein SFT2C (SFT2 domain-containing protein 3)	Sft2d3	Mus musculus (Mouse)	212	integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	integral component of membrane [GO:0016021]		GO:0015031; GO:0016021; GO:0016192	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN1544_c0_g1_i1	P47193	VAMP2_XENLA	41.6	77	45	0	231	1	6	82	5.00E-08	58.5	VAMP2_XENLA	reviewed	Vesicle-associated membrane protein 2 (VAMP-2) (SYBII) (Synaptobrevin-2)	vamp2	Xenopus laevis (African clawed frog)	114	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]		GO:0005886; GO:0006906; GO:0016021; GO:0016079; GO:0030672; GO:0048488	synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]		blue	blue	NA	NA	NA	1
TRINITY_DN1544_c0_g1_i2	P47193	VAMP2_XENLA	45.5	66	36	0	198	1	17	82	4.10E-08	58.9	VAMP2_XENLA	reviewed	Vesicle-associated membrane protein 2 (VAMP-2) (SYBII) (Synaptobrevin-2)	vamp2	Xenopus laevis (African clawed frog)	114	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]		GO:0005886; GO:0006906; GO:0016021; GO:0016079; GO:0030672; GO:0048488	synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]		blue	blue	NA	NA	NA	NA
TRINITY_DN15612_c0_g1_i1	P70280	VAMP7_MOUSE	99.3	142	1	0	428	3	61	202	1.80E-69	263.1	VAMP7_MOUSE	reviewed	Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1)	Vamp7 Sybl1	Mus musculus (Mouse)	220	"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008021; GO:0008333; GO:0009986; GO:0016020; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030133; GO:0030141; GO:0030175; GO:0030285; GO:0030667; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043231; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595	"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15612_c0_g1_i2	P70280	VAMP7_MOUSE	98.6	142	2	0	428	3	61	202	4.10E-69	261.9	VAMP7_MOUSE	reviewed	Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1)	Vamp7 Sybl1	Mus musculus (Mouse)	220	"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008021; GO:0008333; GO:0009986; GO:0016020; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030133; GO:0030141; GO:0030175; GO:0030285; GO:0030667; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043231; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595	"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33092_c0_g1_i1	Q17QI5	VAMP7_BOVIN	100	100	0	0	30	329	1	100	1.10E-53	210.3	VAMP7_BOVIN	reviewed	Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1)	VAMP7 SYBL1	Bos taurus (Bovine)	220	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0015031; GO:0016021; GO:0016192; GO:0017156; GO:0030658; GO:0030670; GO:0031201; GO:0031902; GO:0043005; GO:0043308; GO:0043312; GO:0045202; GO:0045335	"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35426_c0_g1_i1	P70280	VAMP7_MOUSE	56.9	218	92	2	87	737	1	217	6.30E-66	252.3	VAMP7_MOUSE	reviewed	Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1)	Vamp7 Sybl1	Mus musculus (Mouse)	220	"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"	apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008021; GO:0008333; GO:0009986; GO:0016020; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030133; GO:0030141; GO:0030175; GO:0030285; GO:0030667; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043231; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595	"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]; vesicle transport along microtubule [GO:0047496]"		blue	blue	NA	NA	NA	NA
TRINITY_DN8837_c0_g1_i1	O48850	VA725_ARATH	38.1	84	52	0	210	461	195	278	2.90E-11	70.1	VA725_ARATH	reviewed	Vesicle-associated membrane protein 725 (AtVAMP725)	VAMP725 At2g32670 F24L7.19	Arabidopsis thaliana (Mouse-ear cress)	285	early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005768; GO:0005886; GO:0015031; GO:0016021; GO:0016192; GO:0031901	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN23334_c0_g1_i1	Q3T0Y8	VAMP8_BOVIN	95.2	63	3	0	216	28	14	76	2.60E-27	122.1	VAMP8_BOVIN	reviewed	Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB)	VAMP8	Bos taurus (Bovine)	100	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mucin granule [GO:0098594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; defense response to virus [GO:0051607]; mucus secretion [GO:0070254]; negative regulation of secretion by cell [GO:1903531]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; regulation of protein localization to plasma membrane [GO:1903076]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; viral entry into host cell [GO:0046718]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mucin granule [GO:0098594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0005484; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006906; GO:0015031; GO:0016021; GO:0016240; GO:0019869; GO:0019905; GO:0031201; GO:0031901; GO:0031902; GO:0035493; GO:0035577; GO:0046718; GO:0048471; GO:0051607; GO:0055037; GO:0070254; GO:0097352; GO:0098594; GO:1903076; GO:1903531; GO:1903595	autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; defense response to virus [GO:0051607]; mucus secretion [GO:0070254]; negative regulation of secretion by cell [GO:1903531]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; regulation of protein localization to plasma membrane [GO:1903076]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; viral entry into host cell [GO:0046718]		NA	NA	NA	NA	NA	NA
TRINITY_DN12516_c0_g1_i1	Q9P0L0	VAPA_HUMAN	99.3	138	1	0	13	426	1	138	5.90E-76	284.6	VAPA_HUMAN	reviewed	Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33)	VAPA VAP33	Homo sapiens (Human)	249	azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; cell death [GO:0008219]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingolipid biosynthetic process [GO:0030148]; viral process [GO:0016032]	azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	GO:0000139; GO:0005783; GO:0005789; GO:0005886; GO:0005923; GO:0006888; GO:0008017; GO:0008219; GO:0015630; GO:0016021; GO:0016032; GO:0019904; GO:0030148; GO:0031175; GO:0031965; GO:0031982; GO:0033149; GO:0035577; GO:0043123; GO:0043312; GO:0044791; GO:0044828; GO:0044829; GO:0045296; GO:0046982; GO:0061025; GO:0070972; GO:0090114	cell death [GO:0008219]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingolipid biosynthetic process [GO:0030148]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN12516_c0_g1_i2	Q9P0L0	VAPA_HUMAN	100	138	0	0	13	426	1	138	1.50E-76	286.6	VAPA_HUMAN	reviewed	Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33)	VAPA VAP33	Homo sapiens (Human)	249	azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; cell death [GO:0008219]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingolipid biosynthetic process [GO:0030148]; viral process [GO:0016032]	azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	GO:0000139; GO:0005783; GO:0005789; GO:0005886; GO:0005923; GO:0006888; GO:0008017; GO:0008219; GO:0015630; GO:0016021; GO:0016032; GO:0019904; GO:0030148; GO:0031175; GO:0031965; GO:0031982; GO:0033149; GO:0035577; GO:0043123; GO:0043312; GO:0044791; GO:0044828; GO:0044829; GO:0045296; GO:0046982; GO:0061025; GO:0070972; GO:0090114	cell death [GO:0008219]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral release from host cell [GO:0044791]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingolipid biosynthetic process [GO:0030148]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN2366_c0_g2_i1	A2VDZ9	VAPB_BOVIN	100	88	0	0	16	279	20	107	1.40E-46	186.4	VAPB_BOVIN	reviewed	Vesicle-associated membrane protein-associated protein B (VAMP-B) (VAMP-associated protein B) (VAP-B)	VAPB	Bos taurus (Bovine)	243	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; FFAT motif binding [GO:0033149]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	FFAT motif binding [GO:0033149]	GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0016021; GO:0033149; GO:0036498; GO:0061817; GO:0090158	cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]		NA	NA	NA	NA	NA	NA
TRINITY_DN1892_c0_g1_i1	A2VDZ9	VAPB_BOVIN	55.8	249	96	7	804	82	1	243	9.80E-49	195.3	VAPB_BOVIN	reviewed	Vesicle-associated membrane protein-associated protein B (VAMP-B) (VAMP-associated protein B) (VAP-B)	VAPB	Bos taurus (Bovine)	243	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; FFAT motif binding [GO:0033149]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	FFAT motif binding [GO:0033149]	GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0016021; GO:0033149; GO:0036498; GO:0061817; GO:0090158	cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]		blue	blue	NA	NA	NA	NA
TRINITY_DN1892_c0_g1_i2	A2VDZ9	VAPB_BOVIN	54.5	255	96	7	822	82	1	243	5.50E-47	189.5	VAPB_BOVIN	reviewed	Vesicle-associated membrane protein-associated protein B (VAMP-B) (VAMP-associated protein B) (VAP-B)	VAPB	Bos taurus (Bovine)	243	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; FFAT motif binding [GO:0033149]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	FFAT motif binding [GO:0033149]	GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0016021; GO:0033149; GO:0036498; GO:0061817; GO:0090158	cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]		NA	NA	NA	NA	NA	NA
TRINITY_DN35245_c0_g1_i1	P18708	NSF_CRIGR	52.5	99	40	2	3	287	151	246	1.30E-21	103.6	NSF_CRIGR	reviewed	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	NSF	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	744	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]	GO:0000149; GO:0001921; GO:0005524; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0016887; GO:0017075; GO:0019901; GO:0030165; GO:0030496; GO:0035255; GO:0035494; GO:0042802; GO:0044877; GO:0045732; GO:0046872	intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]		NA	NA	NA	NA	NA	NA
TRINITY_DN36320_c0_g1_i1	P18708	NSF_CRIGR	99.1	111	1	0	336	4	343	453	5.90E-55	214.5	NSF_CRIGR	reviewed	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	NSF	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	744	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]	GO:0000149; GO:0001921; GO:0005524; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0016887; GO:0017075; GO:0019901; GO:0030165; GO:0030496; GO:0035255; GO:0035494; GO:0042802; GO:0044877; GO:0045732; GO:0046872	intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]		NA	NA	NA	NA	NA	NA
TRINITY_DN36521_c0_g1_i1	P18708	NSF_CRIGR	100	157	0	0	2	472	234	390	5.30E-86	318.2	NSF_CRIGR	reviewed	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	NSF	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	744	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]	GO:0000149; GO:0001921; GO:0005524; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0016887; GO:0017075; GO:0019901; GO:0030165; GO:0030496; GO:0035255; GO:0035494; GO:0042802; GO:0044877; GO:0045732; GO:0046872	intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]		NA	NA	NA	NA	NA	NA
TRINITY_DN331_c0_g1_i3	Q94392	NSF_CAEEL	67.2	64	21	0	288	97	277	340	2.10E-21	103.2	NSF_CAEEL	reviewed	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	nsf-1 H15N14.2	Caenorhabditis elegans	824	Golgi stack [GO:0005795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]	Golgi stack [GO:0005795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005795; GO:0006891; GO:0016887; GO:0035494; GO:0043001; GO:0046872; GO:0048211	Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]		NA	NA	NA	NA	NA	NA
TRINITY_DN29616_c0_g1_i1	P18708	NSF_CRIGR	100	90	0	0	270	1	548	637	4.40E-45	181.4	NSF_CRIGR	reviewed	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	NSF	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	744	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]	cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]	GO:0000149; GO:0001921; GO:0005524; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0016887; GO:0017075; GO:0019901; GO:0030165; GO:0030496; GO:0035255; GO:0035494; GO:0042802; GO:0044877; GO:0045732; GO:0046872	intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]		NA	NA	NA	NA	NA	NA
TRINITY_DN35993_c0_g1_i1	Q9M0Y8	NSF_ARATH	66.2	240	77	3	715	2	217	454	6.20E-86	318.5	NSF_ARATH	reviewed	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (Vesicular-fusion protein NSF)	NSF At4g04910 T1J1.4	Arabidopsis thaliana (Mouse-ear cress)	742	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; vacuole [GO:0005773]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005773; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006891; GO:0009506; GO:0016887; GO:0035494; GO:0043001; GO:0046872; GO:0048211	Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]		NA	NA	NA	NA	NA	NA
TRINITY_DN33620_c0_g1_i1	P46461	NSF1_DROME	55.2	87	38	1	264	4	562	647	1.30E-20	100.1	NSF1_DROME	reviewed	Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1)	comt Nsf Nsf1 CG1618	Drosophila melanogaster (Fruit fly)	745	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005737; GO:0005795; GO:0005829; GO:0006891; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:1900073	autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN331_c0_g1_i1	P46461	NSF1_DROME	61.5	481	181	2	1535	96	262	739	3.40E-169	596.3	NSF1_DROME	reviewed	Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1)	comt Nsf Nsf1 CG1618	Drosophila melanogaster (Fruit fly)	745	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005737; GO:0005795; GO:0005829; GO:0006891; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:1900073	autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN331_c0_g1_i4	P46461	NSF1_DROME	54.7	738	329	3	2303	96	5	739	5.00E-233	808.9	NSF1_DROME	reviewed	Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1)	comt Nsf Nsf1 CG1618	Drosophila melanogaster (Fruit fly)	745	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005737; GO:0005795; GO:0005829; GO:0006891; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:1900073	autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN9856_c0_g1_i1	P46461	NSF1_DROME	39.8	113	68	0	12	350	1	113	4.00E-22	105.5	NSF1_DROME	reviewed	Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1)	comt Nsf Nsf1 CG1618	Drosophila melanogaster (Fruit fly)	745	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005737; GO:0005795; GO:0005829; GO:0006891; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:1900073	autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN9856_c0_g1_i2	P46461	NSF1_DROME	39.7	78	47	0	12	245	1	78	2.80E-13	76.3	NSF1_DROME	reviewed	Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1)	comt Nsf Nsf1 CG1618	Drosophila melanogaster (Fruit fly)	745	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; neuromuscular junction of somatic muscle [GO:0098527]; terminal bouton [GO:0043195]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005737; GO:0005795; GO:0005829; GO:0006891; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:1900073	autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]		NA	NA	NA	NA	NA	NA
TRINITY_DN4758_c0_g1_i1	Q96IW7	SC22A_HUMAN	30.9	246	139	4	323	1060	69	283	3.20E-22	107.5	SC22A_HUMAN	reviewed	Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2)	SEC22A SEC22L2	Homo sapiens (Human)	307	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transporter activity [GO:0005215]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	transporter activity [GO:0005215]	GO:0005215; GO:0005789; GO:0006888; GO:0015031; GO:0016021	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN4758_c0_g1_i2	Q96IW7	SC22A_HUMAN	30.3	314	186	5	90	1031	3	283	1.20E-29	132.1	SC22A_HUMAN	reviewed	Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2)	SEC22A SEC22L2	Homo sapiens (Human)	307	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transporter activity [GO:0005215]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	transporter activity [GO:0005215]	GO:0005215; GO:0005789; GO:0006888; GO:0015031; GO:0016021	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN17220_c0_g1_i1	O08595	SC22B_CRIGR	100	114	0	0	1	342	102	215	7.30E-56	217.6	SC22B_CRIGR	reviewed	Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B)	Sec22b Ers-24	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	215	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]		GO:0005789; GO:0005794; GO:0015031; GO:0016021; GO:0016192; GO:0033116; GO:0042470	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN17220_c0_g1_i2	O08595	SC22B_CRIGR	99.1	110	1	0	1	330	106	215	9.60E-53	207.2	SC22B_CRIGR	reviewed	Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B)	Sec22b Ers-24	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	215	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]		GO:0005789; GO:0005794; GO:0015031; GO:0016021; GO:0016192; GO:0033116; GO:0042470	protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		NA	NA	NA	NA	NA	NA
TRINITY_DN39828_c0_g1_i1	O75396	SC22B_HUMAN	100	66	0	0	19	216	1	66	3.60E-29	128.3	SC22B_HUMAN	reviewed	Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1)	SEC22B SEC22L1	Homo sapiens (Human)	215	"COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990668]; vesicle fusion with Golgi apparatus [GO:0048280]"	COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; transport vesicle [GO:0030133]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0000139; GO:0002479; GO:0005484; GO:0005783; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0008021; GO:0012507; GO:0015031; GO:0016021; GO:0019905; GO:0030133; GO:0030137; GO:0030670; GO:0031201; GO:0033116; GO:0042470; GO:0045732; GO:0048208; GO:0048280; GO:1902902; GO:1990668	"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990668]; vesicle fusion with Golgi apparatus [GO:0048280]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8088_c0_g1_i2	Q7SXP0	S22BB_DANRE	60.3	209	83	0	83	709	1	209	7.70E-69	261.9	S22BB_DANRE	reviewed	Vesicle-trafficking protein SEC22b-B (SEC22 vesicle-trafficking protein homolog B-B)	sec22bb sec22l1b	Danio rerio (Zebrafish) (Brachydanio rerio)	215	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]	SNAP receptor activity [GO:0005484]	GO:0000139; GO:0005484; GO:0005783; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0012507; GO:0015031; GO:0016021; GO:0031201; GO:0033116; GO:0042470; GO:0048280	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5624_c0_g1_i1	Q12907	LMAN2_HUMAN	50.8	183	87	3	551	6	72	252	4.80E-54	212.2	LMAN2_HUMAN	reviewed	Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36)	LMAN2 C5orf8	Homo sapiens (Human)	356	"cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]	carbohydrate binding [GO:0030246]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0000139; GO:0005537; GO:0005615; GO:0005789; GO:0005793; GO:0005794; GO:0005887; GO:0006888; GO:0006890; GO:0007029; GO:0007030; GO:0009986; GO:0015031; GO:0030134; GO:0030246; GO:0031072; GO:0033116; GO:0046872; GO:0050766; GO:0070062	"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		blue	blue	NA	NA	NA	NA
TRINITY_DN29974_c0_g1_i1	P49256	LMAN2_CANLF	100	133	0	0	401	3	95	227	8.30E-80	297.4	LMAN2_CANLF	reviewed	Vesicular integral-membrane protein VIP36 (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36)	LMAN2	Canis lupus familiaris (Dog) (Canis familiaris)	356	"cell surface [GO:0009986]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cell surface [GO:0009986]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum membrane [GO:0005789]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]	heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0000139; GO:0005537; GO:0005615; GO:0005789; GO:0005793; GO:0005794; GO:0005887; GO:0006888; GO:0006890; GO:0007029; GO:0007030; GO:0009986; GO:0015031; GO:0030134; GO:0030137; GO:0031072; GO:0031410; GO:0046872; GO:0048471; GO:0050766; GO:0070382	"endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7481_c0_g1_i2	Q9P7Q4	SEC18_SCHPO	66.7	234	76	1	696	1	273	506	7.90E-86	318.2	SEC18_SCHPO	reviewed	Vesicular-fusion protein sec18	sec18 SPAC1834.11c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	792	"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; SNARE complex disassembly [GO:0035494]; vacuole fusion, non-autophagic [GO:0042144]"	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005795; GO:0006886; GO:0006888; GO:0006891; GO:0016887; GO:0035494; GO:0042144; GO:0043001; GO:0048211	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]; vacuole fusion, non-autophagic [GO:0042144]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7481_c0_g1_i3	Q9P7Q4	SEC18_SCHPO	63	146	52	1	432	1	361	506	5.70E-45	181.8	SEC18_SCHPO	reviewed	Vesicular-fusion protein sec18	sec18 SPAC1834.11c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	792	"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; SNARE complex disassembly [GO:0035494]; vacuole fusion, non-autophagic [GO:0042144]"	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005795; GO:0006886; GO:0006888; GO:0006891; GO:0016887; GO:0035494; GO:0042144; GO:0043001; GO:0048211	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]; vacuole fusion, non-autophagic [GO:0042144]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7481_c0_g1_i4	Q9P7Q4	SEC18_SCHPO	64.7	139	47	1	420	10	365	503	1.30E-43	177.2	SEC18_SCHPO	reviewed	Vesicular-fusion protein sec18	sec18 SPAC1834.11c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	792	"cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; SNARE complex disassembly [GO:0035494]; vacuole fusion, non-autophagic [GO:0042144]"	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005795; GO:0006886; GO:0006888; GO:0006891; GO:0016887; GO:0035494; GO:0042144; GO:0043001; GO:0048211	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; SNARE complex disassembly [GO:0035494]; vacuole fusion, non-autophagic [GO:0042144]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36325_c0_g1_i1	Q00341	VIGLN_HUMAN	100	192	0	0	578	3	297	488	3.20E-104	379	VIGLN_HUMAN	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	HDLBP HBP VGL	Homo sapiens (Human)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0034384; GO:0045296	cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN24407_c0_g1_i1	Q00341	VIGLN_HUMAN	99.4	156	1	0	469	2	1028	1183	4.90E-84	311.6	VIGLN_HUMAN	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	HDLBP HBP VGL	Homo sapiens (Human)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0034384; GO:0045296	cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN24407_c0_g1_i3	Q8VDJ3	VIGLN_MOUSE	99.4	156	1	0	469	2	1028	1183	4.90E-84	311.6	VIGLN_MOUSE	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	Hdlbp	Mus musculus (Mouse)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]; mRNA binding [GO:0003729]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006869; GO:0008203; GO:0034364	cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN34963_c0_g1_i1	Q00341	VIGLN_HUMAN	100	85	0	0	2	256	938	1022	2.30E-43	175.6	VIGLN_HUMAN	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	HDLBP HBP VGL	Homo sapiens (Human)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0034384; GO:0045296	cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN25922_c0_g1_i1	Q8VDJ3	VIGLN_MOUSE	100	69	0	0	1	207	129	197	5.60E-32	137.5	VIGLN_MOUSE	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	Hdlbp	Mus musculus (Mouse)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]; mRNA binding [GO:0003729]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006869; GO:0008203; GO:0034364	cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN1582_c0_g1_i3	Q00341	VIGLN_HUMAN	53.4	1189	535	9	3637	104	31	1211	0	1246.9	VIGLN_HUMAN	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	HDLBP HBP VGL	Homo sapiens (Human)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0034384; GO:0045296	cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN37224_c0_g1_i1	Q00341	VIGLN_HUMAN	100	78	0	0	236	3	759	836	8.70E-37	153.7	VIGLN_HUMAN	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	HDLBP HBP VGL	Homo sapiens (Human)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0034384; GO:0045296	cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN18405_c0_g1_i1	Q8VDJ3	VIGLN_MOUSE	100	134	0	0	1	402	794	927	1.80E-71	269.6	VIGLN_MOUSE	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	Hdlbp	Mus musculus (Mouse)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]; mRNA binding [GO:0003729]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006869; GO:0008203; GO:0034364	cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN18405_c0_g1_i2	Q8VDJ3	VIGLN_MOUSE	99	99	1	0	1	297	794	892	1.70E-50	199.5	VIGLN_MOUSE	reviewed	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	Hdlbp	Mus musculus (Mouse)	1268	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]; mRNA binding [GO:0003729]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]	mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006869; GO:0008203; GO:0034364	cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]		NA	NA	NA	NA	NA	NA
TRINITY_DN40899_c0_g1_i1	O65039	CYSEP_RICCO	69.6	69	19	2	2	202	256	324	6.80E-22	104	CYSEP_RICCO	reviewed	Vignain (EC 3.4.22.-) (Cysteine endopeptidase)	CYSEP	Ricinus communis (Castor bean)	360	cytoplasmic vesicle [GO:0031410]; cysteine-type peptidase activity [GO:0008234]	cytoplasmic vesicle [GO:0031410]	cysteine-type peptidase activity [GO:0008234]	GO:0008234; GO:0031410			NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g1_i10	P02640	VILI_CHICK	46.9	239	118	4	52	741	588	826	1.70E-54	214.2	VILI_CHICK	reviewed	Villin-1	VIL1 VIL	Gallus gallus (Chicken)	826	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]"	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g1_i6	P02640	VILI_CHICK	47.3	469	231	7	16	1389	363	826	1.30E-116	421.4	VILI_CHICK	reviewed	Villin-1	VIL1 VIL	Gallus gallus (Chicken)	826	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]"	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN7440_c0_g1_i8	Q62468	VILI_MOUSE	54.1	74	32	1	50	265	532	605	5.20E-15	82.4	VILI_MOUSE	reviewed	Villin-1	Vil1 Vil	Mus musculus (Mouse)	827	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]"	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"	GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]		NA	NA	NA	NA	NA	NA
TRINITY_DN40036_c0_g1_i1	P02640	VILI_CHICK	44.6	83	44	1	245	3	599	681	3.50E-12	72	VILI_CHICK	reviewed	Villin-1	VIL1 VIL	Gallus gallus (Chicken)	826	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]"	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN29080_c0_g1_i1	P02640	VILI_CHICK	43	86	47	1	1	252	597	682	1.90E-10	66.2	VILI_CHICK	reviewed	Villin-1	VIL1 VIL	Gallus gallus (Chicken)	826	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]"	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN8529_c0_g1_i1	O46037	VINC_DROME	72.6	266	73	0	4	801	46	311	2.70E-106	386.3	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN247_c0_g1_i1	O46037	VINC_DROME	60	320	106	5	998	84	649	961	9.80E-82	305.1	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN247_c0_g1_i2	O46037	VINC_DROME	58	331	116	5	1061	84	649	961	2.80E-79	297	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN247_c0_g1_i3	O46037	VINC_DROME	48.2	390	123	7	1247	84	649	961	2.90E-75	283.9	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN247_c0_g2_i1	O46037	VINC_DROME	53.9	332	146	1	1007	12	320	644	1.90E-93	344	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592	cell adhesion [GO:0007155]		blue	blue	NA	NA	NA	NA
TRINITY_DN12250_c1_g1_i1	O46037	VINC_DROME	50	42	21	0	22	147	571	612	3.10E-05	48.9	VINC_DROME	reviewed	Vinculin	Vinc CG3299	Drosophila melanogaster (Fruit fly)	961	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]	actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592	cell adhesion [GO:0007155]		NA	NA	NA	NA	NA	NA
TRINITY_DN40515_c0_g1_i1	P12003	VINC_CHICK	100	85	0	0	257	3	100	184	2.20E-41	169.1	VINC_CHICK	reviewed	Vinculin (Metavinculin)	VCL VINC1	Gallus gallus (Chicken)	1135	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; costamere [GO:0043034]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; mitochondrial inner membrane [GO:0005743]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723]; stress fiber [GO:0001725]; terminal web [GO:1990357]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]; adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; morphogenesis of an epithelium [GO:0002009]; protein localization to cell surface [GO:0034394]; regulation of cell migration [GO:0030334]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; costamere [GO:0043034]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; mitochondrial inner membrane [GO:0005743]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723]; stress fiber [GO:0001725]; terminal web [GO:1990357]; Z disc [GO:0030018]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]	GO:0001725; GO:0002009; GO:0002102; GO:0002162; GO:0005198; GO:0005743; GO:0005886; GO:0005903; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0005927; GO:0008013; GO:0015629; GO:0017166; GO:0030018; GO:0030032; GO:0030334; GO:0031594; GO:0031625; GO:0032991; GO:0034333; GO:0034394; GO:0042383; GO:0042803; GO:0043034; GO:0043297; GO:0045294; GO:0045296; GO:0048675; GO:0051015; GO:0051371; GO:0051393; GO:0051893; GO:0090136; GO:0090636; GO:0090637; GO:0097110; GO:0098723; GO:1903140; GO:1904702; GO:1990357	adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; morphogenesis of an epithelium [GO:0002009]; protein localization to cell surface [GO:0034394]; regulation of cell migration [GO:0030334]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]		NA	NA	NA	NA	NA	NA
TRINITY_DN25727_c0_g1_i1	P18206	VINC_HUMAN	100	154	0	0	480	19	981	1134	2.70E-77	289.3	VINC_HUMAN	reviewed	Vinculin (Metavinculin) (MV)	VCL	Homo sapiens (Human)	1134	adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; muscle contraction [GO:0006936]; negative regulation of cell migration [GO:0030336]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]	adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]	actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]	GO:0002009; GO:0002102; GO:0002162; GO:0002576; GO:0003779; GO:0005198; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0006936; GO:0007155; GO:0007160; GO:0008013; GO:0030032; GO:0030055; GO:0030336; GO:0031625; GO:0032991; GO:0034333; GO:0034394; GO:0034774; GO:0035580; GO:0035633; GO:0042383; GO:0043034; GO:0043297; GO:0043312; GO:0044291; GO:0045121; GO:0045294; GO:0045296; GO:0048675; GO:0051893; GO:0070062; GO:0070527; GO:0090136; GO:0090636; GO:0090637; GO:1903140; GO:1903561; GO:1904702; GO:1904813; GO:1990357	adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; muscle contraction [GO:0006936]; negative regulation of cell migration [GO:0030336]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]		NA	NA	NA	NA	NA	NA
TRINITY_DN35072_c0_g1_i1	P18206	VINC_HUMAN	98.7	78	1	0	237	4	1005	1082	3.10E-34	145.2	VINC_HUMAN	reviewed	Vinculin (Metavinculin) (MV)	VCL	Homo sapiens (Human)	1134	adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; muscle contraction [GO:0006936]; negative regulation of cell migration [GO:0030336]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]	adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]	actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]	GO:0002009; GO:0002102; GO:0002162; GO:0002576; GO:0003779; GO:0005198; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0006936; GO:0007155; GO:0007160; GO:0008013; GO:0030032; GO:0030055; GO:0030336; GO:0031625; GO:0032991; GO:0034333; GO:0034394; GO:0034774; GO:0035580; GO:0035633; GO:0042383; GO:0043034; GO:0043297; GO:0043312; GO:0044291; GO:0045121; GO:0045294; GO:0045296; GO:0048675; GO:0051893; GO:0070062; GO:0070527; GO:0090136; GO:0090636; GO:0090637; GO:1903140; GO:1903561; GO:1904702; GO:1904813; GO:1990357	adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; muscle contraction [GO:0006936]; negative regulation of cell migration [GO:0030336]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]		NA	NA	NA	NA	NA	NA
TRINITY_DN2283_c0_g1_i5	Q6VVX0	CP2R1_HUMAN	41.2	148	86	1	470	27	298	444	1.90E-31	137.1	CP2R1_HUMAN	reviewed	Vitamin D 25-hydroxylase (EC 1.14.14.24) (Cytochrome P450 2R1)	CYP2R1	Homo sapiens (Human)	501	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; D3 vitamins binding [GO:1902271]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; protein homodimerization activity [GO:0042803]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; calcitriol biosynthetic process from calciol [GO:0036378]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to cesium ion [GO:0010164]; response to ionizing radiation [GO:0010212]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]"	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"D3 vitamins binding [GO:1902271]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; protein homodimerization activity [GO:0042803]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]"	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006766; GO:0006805; GO:0008395; GO:0010164; GO:0010212; GO:0016712; GO:0020037; GO:0030343; GO:0036378; GO:0042359; GO:0042738; GO:0042803; GO:0043231; GO:0055114; GO:1902271	calcitriol biosynthetic process from calciol [GO:0036378]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to cesium ion [GO:0010164]; response to ionizing radiation [GO:0010212]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]		NA	NA	NA	NA	NA	NA
TRINITY_DN28439_c0_g1_i1	Q9CRC0	VKOR1_MOUSE	100	75	0	0	3	227	18	92	8.30E-37	153.7	VKOR1_MOUSE	reviewed	"Vitamin K epoxide reductase complex subunit 1 (EC 1.17.4.4) (Vitamin K1 2,3-epoxide reductase subunit 1)"	Vkorc1	Mus musculus (Mouse)	161	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-insensitive) activity [GO:0047058]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]; blood coagulation [GO:0007596]; bone development [GO:0060348]; drug metabolic process [GO:0017144]; peptidyl-glutamic acid carboxylation [GO:0017187]; positive regulation of coagulation [GO:0050820]; regulation of blood coagulation [GO:0030193]; response to antibiotic [GO:0046677]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; vitamin K biosynthetic process [GO:0042371]; vitamin K metabolic process [GO:0042373]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-insensitive) activity [GO:0047058]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]	GO:0005783; GO:0005789; GO:0007596; GO:0010243; GO:0014070; GO:0016021; GO:0017144; GO:0017187; GO:0030193; GO:0042371; GO:0042373; GO:0043231; GO:0046677; GO:0047057; GO:0047058; GO:0048038; GO:0050820; GO:0060348	blood coagulation [GO:0007596]; bone development [GO:0060348]; drug metabolic process [GO:0017144]; peptidyl-glutamic acid carboxylation [GO:0017187]; positive regulation of coagulation [GO:0050820]; regulation of blood coagulation [GO:0030193]; response to antibiotic [GO:0046677]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; vitamin K biosynthetic process [GO:0042371]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN8551_c0_g1_i2	Q8N0U8	VKORL_HUMAN	47.9	117	61	0	128	478	16	132	5.50E-22	105.5	VKORL_HUMAN	reviewed	Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4)	VKORC1L1	Homo sapiens (Human)	176	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]; cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]	GO:0005783; GO:0005789; GO:0016021; GO:0017187; GO:0034599; GO:0042373; GO:0047057; GO:0048038	cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373]		NA	NA	NA	NA	NA	NA
TRINITY_DN5304_c1_g1_i1	Q07175	VKGC_BOVIN	52.1	73	35	0	311	93	358	430	2.80E-15	82.8	VKGC_BOVIN	reviewed	Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase)	GGCX GC	Bos taurus (Bovine)	758	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; gamma-glutamyl carboxylase activity [GO:0008488]; peptidyl-glutamic acid carboxylation [GO:0017187]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	gamma-glutamyl carboxylase activity [GO:0008488]	GO:0005789; GO:0008488; GO:0016021; GO:0017187	peptidyl-glutamic acid carboxylation [GO:0017187]		NA	NA	NA	NA	NA	NA
TRINITY_DN5304_c1_g1_i2	Q07175	VKGC_BOVIN	54.3	46	21	0	230	93	385	430	4.00E-08	58.9	VKGC_BOVIN	reviewed	Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase)	GGCX GC	Bos taurus (Bovine)	758	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; gamma-glutamyl carboxylase activity [GO:0008488]; peptidyl-glutamic acid carboxylation [GO:0017187]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	gamma-glutamyl carboxylase activity [GO:0008488]	GO:0005789; GO:0008488; GO:0016021; GO:0017187	peptidyl-glutamic acid carboxylation [GO:0017187]		brown	brown	NA	NA	NA	NA
TRINITY_DN40071_c0_g1_i1	Q28661	PROC_RABIT	41.2	68	39	1	227	24	255	321	3.90E-08	58.9	PROC_RABIT	reviewed	Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide] (Fragment)	PROC	Oryctolagus cuniculus (Rabbit)	458	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005509; GO:0005576; GO:0005783; GO:0005794; GO:0007596; GO:0043066; GO:0050728; GO:0050819; GO:1903142	blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]		NA	NA	NA	NA	NA	NA
TRINITY_DN39050_c0_g1_i1	Q6RG02	VIT_PENME	48.6	70	36	0	219	10	2451	2520	8.30E-13	73.9	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN34311_c0_g1_i1	Q6RG02	VIT_PENME	34.8	89	58	0	5	271	722	810	1.60E-10	66.6	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i1	Q6RG02	VIT_PENME	27.8	1074	757	9	57	3239	1178	2246	1.60E-133	478.8	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i10	Q6RG02	VIT_PENME	32.3	1710	1114	18	2	5041	550	2246	3.30E-274	946.8	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i11	Q6RG02	VIT_PENME	30.5	727	490	7	100	2247	1314	2036	1.00E-102	375.9	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i13	Q6RG02	VIT_PENME	30.2	616	424	4	83	1924	1635	2246	3.70E-85	317.4	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i2	Q6RG02	VIT_PENME	39.1	700	401	9	2	2050	550	1241	2.30E-144	514.2	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i5	Q6RG02	VIT_PENME	38.2	672	391	8	177	2141	577	1241	4.60E-135	483.4	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i6	Q6RG02	VIT_PENME	31.9	1682	1104	17	177	5132	577	2246	6.30E-265	916	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i7	Q6RG02	VIT_PENME	39.1	700	401	9	2	2050	550	1241	3.00E-144	513.8	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN2258_c0_g1_i8	Q6RG02	VIT_PENME	38.2	672	391	8	177	2141	577	1241	4.60E-135	483.4	VIT_PENME	reviewed	Vitellogenin [Cleaved into: Vitellin]		Penaeus merguiensis (Banana prawn) (Fenneropenaeus merguiensis)	2586	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]		lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	oogenesis [GO:0048477]		NA	NA	NA	NA	NA	NA
TRINITY_DN24332_c0_g1_i1	Q94920	VDAC_DROME	69.1	55	17	0	234	70	227	281	9.90E-17	87	VDAC_DROME	reviewed	Voltage-dependent anion-selective channel (DmVDAC) (Porin)	porin POR-1 VDAC CG6647	Drosophila melanogaster (Fruit fly)	282	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; ion transport [GO:0006811]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; Nebenkern [GO:0016006]; pore complex [GO:0046930]	porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0005739; GO:0005741; GO:0006811; GO:0006839; GO:0007005; GO:0007291; GO:0007602; GO:0008308; GO:0015288; GO:0016006; GO:0030382; GO:0043066; GO:0046930; GO:0110099	ion transport [GO:0006811]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; phototransduction [GO:0007602]; sperm individualization [GO:0007291]; sperm mitochondrion organization [GO:0030382]		NA	NA	NA	NA	NA	NA
TRINITY_DN28737_c0_g1_i1	P45879	VDAC1_BOVIN	100	73	0	0	221	3	47	119	1.50E-35	149.4	VDAC1_BOVIN	reviewed	Voltage-dependent anion-selective channel protein 1 (VDAC-1) (Brain-derived voltage-dependent anion channel 1) (BR1-VDAC) (Plasmalemmal porin)	VDAC1	Bos taurus (Bovine)	283	membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; anion transport [GO:0006820]; apoptotic process [GO:0006915]	membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0005739; GO:0005741; GO:0005757; GO:0005886; GO:0006820; GO:0006915; GO:0008308; GO:0015288; GO:0016020; GO:0045121	anion transport [GO:0006820]; apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN34039_c0_g1_i1	P45879	VDAC1_BOVIN	100	56	0	0	220	53	228	283	1.90E-25	115.9	VDAC1_BOVIN	reviewed	Voltage-dependent anion-selective channel protein 1 (VDAC-1) (Brain-derived voltage-dependent anion channel 1) (BR1-VDAC) (Plasmalemmal porin)	VDAC1	Bos taurus (Bovine)	283	membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; anion transport [GO:0006820]; apoptotic process [GO:0006915]	membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0005739; GO:0005741; GO:0005757; GO:0005886; GO:0006820; GO:0006915; GO:0008308; GO:0015288; GO:0016020; GO:0045121	anion transport [GO:0006820]; apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN29879_c0_g1_i1	P21796	VDAC1_HUMAN	100	114	0	0	343	2	118	231	3.50E-63	241.9	VDAC1_HUMAN	reviewed	Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM)	VDAC1 VDAC	Homo sapiens (Human)	283	extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; synaptic vesicle [GO:0008021]; ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; voltage-gated anion channel activity [GO:0008308]; anion transport [GO:0006820]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; epithelial cell differentiation [GO:0030855]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of mitophagy [GO:1901526]; pyruvate metabolic process [GO:0006090]; regulation of autophagy of mitochondrion [GO:1903146]; viral process [GO:0016032]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; synaptic vesicle [GO:0008021]	ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; voltage-gated anion channel activity [GO:0008308]	GO:0001662; GO:0005634; GO:0005739; GO:0005741; GO:0005757; GO:0005886; GO:0006090; GO:0006820; GO:0006851; GO:0006915; GO:0007270; GO:0007612; GO:0008021; GO:0008308; GO:0015288; GO:0015485; GO:0016020; GO:0016032; GO:0016236; GO:0019901; GO:0030855; GO:0031210; GO:0031966; GO:0042645; GO:0042802; GO:0043066; GO:0044325; GO:0044877; GO:0045121; GO:0046930; GO:0070062; GO:0097001; GO:0110099; GO:1901526; GO:1903146; GO:2000378	anion transport [GO:0006820]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; epithelial cell differentiation [GO:0030855]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of mitophagy [GO:1901526]; pyruvate metabolic process [GO:0006090]; regulation of autophagy of mitochondrion [GO:1903146]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN15640_c0_g1_i1	P45880	VDAC2_HUMAN	99.6	237	1	0	787	77	58	294	2.90E-137	489.2	VDAC2_HUMAN	reviewed	Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2)	VDAC2	Homo sapiens (Human)	294	acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; synaptic vesicle [GO:0008021]; ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; anion transport [GO:0006820]; binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272]	acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; synaptic vesicle [GO:0008021]	ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0001669; GO:0005634; GO:0005739; GO:0005741; GO:0006820; GO:0007339; GO:0008021; GO:0008308; GO:0015288; GO:0015485; GO:0016020; GO:0031210; GO:0031966; GO:0032272; GO:0042645; GO:0045121; GO:0046930; GO:0097001; GO:0097345; GO:2001243	anion transport [GO:0006820]; binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272]		NA	NA	NA	NA	NA	NA
TRINITY_DN15640_c0_g1_i2	Q60930	VDAC2_MOUSE	98.7	237	3	0	787	77	59	295	5.00E-137	488.4	VDAC2_MOUSE	reviewed	Voltage-dependent anion-selective channel protein 2 (VDAC-2) (mVDAC2) (Outer mitochondrial membrane protein porin 2) (Voltage-dependent anion-selective channel protein 6) (VDAC-6) (mVDAC6)	Vdac2 Vdac6	Mus musculus (Mouse)	295	acrosomal vesicle [GO:0001669]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pore complex [GO:0046930]; synaptic vesicle [GO:0008021]; ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; anion transport [GO:0006820]; binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272]	acrosomal vesicle [GO:0001669]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; pore complex [GO:0046930]; synaptic vesicle [GO:0008021]	ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0001669; GO:0005739; GO:0005741; GO:0005743; GO:0006820; GO:0007339; GO:0008021; GO:0008308; GO:0015288; GO:0015485; GO:0031210; GO:0032272; GO:0042645; GO:0043209; GO:0045121; GO:0046930; GO:0097001; GO:0097345; GO:2001243	anion transport [GO:0006820]; binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272]		NA	NA	NA	NA	NA	NA
TRINITY_DN5744_c0_g1_i1	P82013	VDAC2_MELGA	61.4	246	95	0	821	84	37	282	8.40E-87	321.6	VDAC2_MELGA	reviewed	Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2)	VDAC2	Meleagris gallopavo (Wild turkey)	282	mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]	nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930			blue	blue	NA	NA	NA	NA
TRINITY_DN24088_c0_g1_i1	Q9Y277	VDAC3_HUMAN	100	237	0	0	773	63	47	283	1.90E-136	486.5	VDAC3_HUMAN	reviewed	Voltage-dependent anion-selective channel protein 3 (VDAC-3) (hVDAC3) (Outer mitochondrial membrane protein porin 3)	VDAC3	Homo sapiens (Human)	283	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; synapse [GO:0045202]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; adenine transport [GO:0015853]; behavioral fear response [GO:0001662]; learning [GO:0007612]; neuron-neuron synaptic transmission [GO:0007270]; regulation of cilium assembly [GO:1902017]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; synapse [GO:0045202]	nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0001662; GO:0005634; GO:0005739; GO:0005741; GO:0007270; GO:0007612; GO:0008308; GO:0015288; GO:0015853; GO:0016020; GO:0045202; GO:0046930; GO:0070062; GO:1902017	adenine transport [GO:0015853]; behavioral fear response [GO:0001662]; learning [GO:0007612]; neuron-neuron synaptic transmission [GO:0007270]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN35212_c0_g1_i1	Q60931	VDAC3_MOUSE	100	154	0	0	527	66	129	282	1.00E-85	317.4	VDAC3_MOUSE	reviewed	Voltage-dependent anion-selective channel protein 3 (VDAC-3) (mVDAC3) (Outer mitochondrial membrane protein porin 3)	Vdac3	Mus musculus (Mouse)	283	mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; neuron-neuron synaptic transmission [GO:0007270]; regulation of cilium assembly [GO:1902017]	mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021]	nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]	GO:0000166; GO:0001662; GO:0005739; GO:0005741; GO:0005743; GO:0005791; GO:0007268; GO:0007270; GO:0007612; GO:0008021; GO:0008308; GO:0015288; GO:0046930; GO:1902017	behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; neuron-neuron synaptic transmission [GO:0007270]; regulation of cilium assembly [GO:1902017]		NA	NA	NA	NA	NA	NA
TRINITY_DN33248_c0_g1_i1	Q8IZS8	CA2D3_HUMAN	53.4	103	47	1	370	62	362	463	8.80E-27	121.3	CA2D3_HUMAN	reviewed	Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3]	CACNA2D3	Homo sapiens (Human)	1091	plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; cardiac conduction [GO:0061337]; regulation of ion transmembrane transport [GO:0034765]	plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]	metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005886; GO:0005891; GO:0034765; GO:0046872; GO:0061337	cardiac conduction [GO:0061337]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN33248_c0_g1_i2	Q5RJF7	CA2D4_MOUSE	50.4	242	119	1	802	77	232	472	5.50E-67	255.8	CA2D4_MOUSE	reviewed	Voltage-dependent calcium channel subunit alpha-2/delta-4 (Voltage-gated calcium channel subunit alpha-2/delta-4) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-4; Voltage-dependent calcium channel subunit delta-4]	Cacna2d4	Mus musculus (Mouse)	1116	voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport [GO:0070588]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of ion transmembrane transport [GO:0034765]	voltage-gated calcium channel complex [GO:0005891]	metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891; GO:0034765; GO:0046872; GO:0050908; GO:0070588	calcium ion transmembrane transport [GO:0070588]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN35637_c0_g1_i1	Q24270	CAC1D_DROME	57.8	83	33	1	62	304	2299	2381	2.80E-16	86.7	CAC1D_DROME	reviewed	Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D)	Ca-alpha1D DroCa1 l(2)35Fa CG4894	Drosophila melanogaster (Fruit fly)	2516	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]	metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588	calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN34231_c0_g1_i1	O88427	CAC1H_MOUSE	51.3	78	38	0	1	234	1281	1358	1.30E-16	87	CAC1H_MOUSE	reviewed	Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2)	Cacna1h Kiaa1120	Mus musculus (Mouse)	2365	caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; cation channel activity [GO:0005261]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]	caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]	cation channel activity [GO:0005261]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005261; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016021; GO:0019228; GO:0019233; GO:0030425; GO:0032342; GO:0034651; GO:0034765; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0099055; GO:0099059; GO:0106134; GO:2000344	aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]		NA	NA	NA	NA	NA	NA
TRINITY_DN34940_c0_g1_i1	Q9P0X4	CAC1I_HUMAN	75	52	13	0	70	225	1285	1336	1.00E-12	73.9	CAC1I_HUMAN	reviewed	Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3)	CACNA1I KIAA1120	Homo sapiens (Human)	2223	neuron projection [GO:0043005]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; cation channel activity [GO:0005261]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431]	neuron projection [GO:0043005]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]	cation channel activity [GO:0005261]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005245; GO:0005248; GO:0005261; GO:0005886; GO:0005891; GO:0007165; GO:0008332; GO:0019228; GO:0030317; GO:0030431; GO:0034765; GO:0043005; GO:0045956; GO:0070509; GO:0086010	calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431]		NA	NA	NA	NA	NA	NA
TRINITY_DN3450_c0_g1_i1	Q5M8L8	HVCN1_XENTR	38.5	161	97	1	3	479	66	226	1.80E-22	107.5	HVCN1_XENTR	reviewed	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1)	hvcn1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	230	integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]	integral component of plasma membrane [GO:0005887]	voltage-gated proton channel activity [GO:0030171]	GO:0005887; GO:0030171; GO:0034765; GO:0071294; GO:0071467; GO:1902600	cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN3450_c0_g1_i2	Q5M8L8	HVCN1_XENTR	44.9	118	63	1	3	350	66	183	8.00E-21	101.3	HVCN1_XENTR	reviewed	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1)	hvcn1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	230	integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]	integral component of plasma membrane [GO:0005887]	voltage-gated proton channel activity [GO:0030171]	GO:0005887; GO:0030171; GO:0034765; GO:0071294; GO:0071467; GO:1902600	cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]		NA	NA	NA	NA	NA	NA
TRINITY_DN37936_c0_g1_i1	Q4PJK1	KCAB1_BOVIN	65.7	70	24	0	224	15	202	271	1.60E-21	103.2	KCAB1_BOVIN	reviewed	Voltage-gated potassium channel subunit beta-1 (EC 1.1.1.-) (K(+) channel subunit beta-1) (Kv-beta-1)	KCNAB1	Bos taurus (Bovine)	401	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; oxidation-reduction process [GO:0055114]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]	aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]	GO:0004033; GO:0005249; GO:0005829; GO:0008076; GO:0015459; GO:0031234; GO:0034705; GO:0044224; GO:0044325; GO:0055114; GO:0070402; GO:1901379; GO:1902259; GO:1902260	negative regulation of delayed rectifier potassium channel activity [GO:1902260]; oxidation-reduction process [GO:0055114]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379]		NA	NA	NA	NA	NA	NA
TRINITY_DN28371_c0_g1_i1	Q9PWR1	KCAB1_CHICK	60.3	73	29	0	279	61	86	158	1.80E-21	103.2	KCAB1_CHICK	reviewed	Voltage-gated potassium channel subunit beta-1 (EC 1.1.1.-) (K(+) channel subunit beta-1) (Kv-beta-1)	KCNAB1 KVB1.1	Gallus gallus (Chicken)	401	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; voltage-gated potassium channel activity [GO:0005249]; learning or memory [GO:0007611]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; oxidation-reduction process [GO:0055114]; regulation of potassium ion transmembrane transport [GO:1901379]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]	aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; voltage-gated potassium channel activity [GO:0005249]	GO:0004033; GO:0005249; GO:0005829; GO:0007611; GO:0008076; GO:0015459; GO:0019904; GO:0031234; GO:0034705; GO:0044224; GO:0044325; GO:0055114; GO:0070402; GO:1901379; GO:1902260	learning or memory [GO:0007611]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; oxidation-reduction process [GO:0055114]; regulation of potassium ion transmembrane transport [GO:1901379]		brown	brown	1	NA	NA	NA
TRINITY_DN35232_c0_g1_i1	Q27955	KCAB2_BOVIN	65	40	14	0	48	167	128	167	3.60E-07	55.1	KCAB2_BOVIN	reviewed	Voltage-gated potassium channel subunit beta-2 (EC 1.1.1.-) (K(+) channel subunit beta-2) (Kv-beta-2)	KCNAB2 KVB2	Bos taurus (Bovine)	367	axon [GO:0030424]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; pinceau fiber [GO:1990031]; potassium channel complex [GO:0034705]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; NADPH oxidation [GO:0070995]; oxidation-reduction process [GO:0055114]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]	axon [GO:0030424]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; pinceau fiber [GO:1990031]; potassium channel complex [GO:0034705]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]	aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]	GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0008076; GO:0015459; GO:0016020; GO:0030424; GO:0031234; GO:0034705; GO:0043005; GO:0044224; GO:0044325; GO:0045202; GO:0055114; GO:0070995; GO:0098900; GO:1901379; GO:1990031; GO:2000008	NADPH oxidation [GO:0070995]; oxidation-reduction process [GO:0055114]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]		NA	NA	NA	NA	NA	NA
TRINITY_DN21567_c0_g1_i1	Q70UZ7	VWA2_MOUSE	37.5	88	42	4	26	262	231	314	8.10E-05	47.8	VWA2_MOUSE	reviewed	von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO)	Vwa2 Amaco	Mus musculus (Mouse)	791	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007161; GO:0042802; GO:0046626; GO:0062023	calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626]		blue	blue	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i1	O00534	VMA5A_HUMAN	38.8	201	110	4	569	3	225	424	1.10E-29	131.3	VMA5A_HUMAN	reviewed	von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)	VWA5A BCSC1 LOH11CR2A	Homo sapiens (Human)	786	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i17	O00534	VMA5A_HUMAN	37.9	438	233	8	1282	29	20	438	5.00E-70	266.5	VMA5A_HUMAN	reviewed	von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)	VWA5A BCSC1 LOH11CR2A	Homo sapiens (Human)	786	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i20	O00534	VMA5A_HUMAN	37.7	438	234	8	1282	29	20	438	1.50E-69	265	VMA5A_HUMAN	reviewed	von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)	VWA5A BCSC1 LOH11CR2A	Homo sapiens (Human)	786	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i6	O00534	VMA5A_HUMAN	38.1	431	241	8	1279	29	20	438	9.40E-69	262.3	VMA5A_HUMAN	reviewed	von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)	VWA5A BCSC1 LOH11CR2A	Homo sapiens (Human)	786	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i7	O00534	VMA5A_HUMAN	38.9	208	114	4	616	29	232	438	4.40E-32	139.4	VMA5A_HUMAN	reviewed	von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)	VWA5A BCSC1 LOH11CR2A	Homo sapiens (Human)	786	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654			NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i13	Q75WE7	VWA5A_RAT	32.8	332	196	8	955	2	121	439	7.90E-42	172.6	VWA5A_RAT	reviewed	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)	Vwa5a Loh11cr2a Masa1	Rattus norvegicus (Rat)	822							NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i14	Q75WE7	VWA5A_RAT	37	265	151	6	754	2	177	439	5.20E-38	159.5	VWA5A_RAT	reviewed	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)	Vwa5a Loh11cr2a Masa1	Rattus norvegicus (Rat)	822							NA	NA	NA	NA	NA	NA
TRINITY_DN5042_c0_g1_i21	Q75WE7	VWA5A_RAT	34.2	433	258	8	1258	2	20	439	7.60E-63	242.7	VWA5A_RAT	reviewed	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)	Vwa5a Loh11cr2a Masa1	Rattus norvegicus (Rat)	822							NA	NA	NA	NA	NA	NA
TRINITY_DN16416_c0_g1_i2	Q0V8J4	VWA7_BOVIN	36.5	370	212	7	1151	72	143	499	4.20E-55	216.9	VWA7_BOVIN	reviewed	von Willebrand factor A domain-containing protein 7 (Protein G7c)	VWA7 G7C	Bos taurus (Bovine)	891	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN16416_c0_g1_i3	Q0V8J4	VWA7_BOVIN	40.1	162	83	4	505	26	143	292	7.80E-25	115.2	VWA7_BOVIN	reviewed	von Willebrand factor A domain-containing protein 7 (Protein G7c)	VWA7 G7C	Bos taurus (Bovine)	891	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN39137_c0_g1_i1	Q9JHA8	VWA7_MOUSE	55.1	78	25	2	2	235	218	285	3.20E-15	82	VWA7_MOUSE	reviewed	von Willebrand factor A domain-containing protein 7 (Protein G7c)	Vwa7 D17h6s56e-3 G7c	Mus musculus (Mouse)	891	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN3989_c4_g1_i1	Q9JHA8	VWA7_MOUSE	36.9	195	105	3	570	1	300	481	6.40E-25	115.5	VWA7_MOUSE	reviewed	von Willebrand factor A domain-containing protein 7 (Protein G7c)	Vwa7 D17h6s56e-3 G7c	Mus musculus (Mouse)	891	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN9061_c0_g1_i1	Q6MG64	VWA7_RAT	36.7	313	177	7	997	71	30	325	3.50E-42	173.7	VWA7_RAT	reviewed	von Willebrand factor A domain-containing protein 7 (Protein G7c)	Vwa7 G7c	Rattus norvegicus (Rat)	892	extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576			NA	NA	NA	NA	NA	NA
TRINITY_DN15438_c0_g1_i1	B0R0T1	VWA8_DANRE	70.2	188	56	0	194	757	45	232	1.00E-70	268.1	VWA8_DANRE	reviewed	von Willebrand factor A domain-containing protein 8	si:dkey-18l1.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1896	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN15438_c0_g1_i2	B0R0T1	VWA8_DANRE	75.6	160	39	0	71	550	73	232	1.00E-64	247.7	VWA8_DANRE	reviewed	von Willebrand factor A domain-containing protein 8	si:dkey-18l1.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1896	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN15438_c0_g1_i3	B0R0T1	VWA8_DANRE	69	168	52	0	194	697	45	212	2.40E-61	236.9	VWA8_DANRE	reviewed	von Willebrand factor A domain-containing protein 8	si:dkey-18l1.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1896	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN6007_c0_g1_i1	B0R0T1	VWA8_DANRE	49.6	278	133	3	3	824	247	521	3.30E-68	260	VWA8_DANRE	reviewed	von Willebrand factor A domain-containing protein 8	si:dkey-18l1.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1896	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN6007_c0_g1_i2	B0R0T1	VWA8_DANRE	57.5	510	211	3	3	1520	523	1030	1.10E-170	601.3	VWA8_DANRE	reviewed	von Willebrand factor A domain-containing protein 8	si:dkey-18l1.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1896	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN6007_c0_g1_i3	B0R0T1	VWA8_DANRE	50.1	1664	772	21	3	4868	247	1893	0	1541.2	VWA8_DANRE	reviewed	von Willebrand factor A domain-containing protein 8	si:dkey-18l1.1	Danio rerio (Zebrafish) (Brachydanio rerio)	1896	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN39164_c0_g1_i1	Q8CC88	VWA8_MOUSE	99.2	129	1	0	388	2	59	187	9.20E-68	257.3	VWA8_MOUSE	reviewed	von Willebrand factor A domain-containing protein 8	Vwa8 Kiaa0564	Mus musculus (Mouse)	1905	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005739; GO:0005777; GO:0016887			NA	NA	NA	NA	NA	NA
TRINITY_DN2134_c0_g1_i2	A4VCH4	VP35L_DANRE	62.8	78	29	0	90	323	678	755	6.30E-18	91.7	VP35L_DANRE	reviewed	VPS35 endosomal protein-sorting factor-like	vps35l zgc:163107	Danio rerio (Zebrafish) (Brachydanio rerio)	963	"cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"	"cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]"		GO:0005768; GO:0005829; GO:0015031; GO:0030906; GO:0032456; GO:0042147; GO:1990126	"endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2134_c0_g1_i3	A4VCH4	VP35L_DANRE	45.9	329	175	2	2	988	430	755	8.70E-73	275.4	VP35L_DANRE	reviewed	VPS35 endosomal protein-sorting factor-like	vps35l zgc:163107	Danio rerio (Zebrafish) (Brachydanio rerio)	963	"cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"	"cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]"		GO:0005768; GO:0005829; GO:0015031; GO:0030906; GO:0032456; GO:0042147; GO:1990126	"endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN303_c0_g1_i2	A4VCH4	VP35L_DANRE	38.3	149	67	3	454	8	118	241	7.10E-17	89.4	VP35L_DANRE	reviewed	VPS35 endosomal protein-sorting factor-like	vps35l zgc:163107	Danio rerio (Zebrafish) (Brachydanio rerio)	963	"cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"	"cytosol [GO:0005829]; endosome [GO:0005768]; retromer, cargo-selective complex [GO:0030906]"		GO:0005768; GO:0005829; GO:0015031; GO:0030906; GO:0032456; GO:0042147; GO:1990126	"endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34273_c0_g1_i1	Q7Z3J2	VP35L_HUMAN	100	80	0	0	1	240	633	712	9.40E-39	160.2	VP35L_HUMAN	reviewed	VPS35 endosomal protein-sorting factor-like (Esophageal cancer-associated protein)	VPS35L C16orf62 101F10.2	Homo sapiens (Human)	963	"endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005768; GO:0005886; GO:0006893; GO:0015031; GO:0016021; GO:0032456; GO:0043312; GO:0101003; GO:1990126	"endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2134_c0_g1_i1	Q7Z3J2	VP35L_HUMAN	64.3	70	25	0	5	214	689	758	5.20E-16	84.7	VP35L_HUMAN	reviewed	VPS35 endosomal protein-sorting factor-like (Esophageal cancer-associated protein)	VPS35L C16orf62 101F10.2	Homo sapiens (Human)	963	"endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005768; GO:0005886; GO:0006893; GO:0015031; GO:0016021; GO:0032456; GO:0043312; GO:0101003; GO:1990126	"endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN303_c0_g1_i3	Q7Z3J2	VP35L_HUMAN	40.5	148	73	3	451	8	108	240	3.60E-18	93.6	VP35L_HUMAN	reviewed	VPS35 endosomal protein-sorting factor-like (Esophageal cancer-associated protein)	VPS35L C16orf62 101F10.2	Homo sapiens (Human)	963	"endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"	endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005768; GO:0005886; GO:0006893; GO:0015031; GO:0016021; GO:0032456; GO:0043312; GO:0101003; GO:1990126	"endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19969_c0_g2_i1	Q9HBG4	VPP4_HUMAN	67.1	70	23	0	8	217	376	445	1.00E-23	110.2	VPP4_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a isoform 4 (V-ATPase 116 kDa isoform a4) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform)	ATP6V0A4 ATP6N1B ATP6N2	Homo sapiens (Human)	840	"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; excretion [GO:0007588]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; ossification [GO:0001503]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sensory perception of sound [GO:0007605]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0001503; GO:0005765; GO:0005768; GO:0005886; GO:0006885; GO:0007035; GO:0007588; GO:0007605; GO:0008286; GO:0010008; GO:0016021; GO:0016324; GO:0016471; GO:0030670; GO:0031526; GO:0033572; GO:0034220; GO:0045177; GO:0046961; GO:0051117; GO:0070062; GO:0090383; GO:1902600	excretion [GO:0007588]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; ossification [GO:0001503]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sensory perception of sound [GO:0007605]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		blue	blue	NA	NA	NA	NA
TRINITY_DN46_c0_g2_i1	Q9Z1G4	VPP1_MOUSE	57	853	332	7	90	2594	4	839	8.10E-272	937.9	VPP1_MOUSE	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	Atp6v0a1 Atp6n1	Mus musculus (Mouse)	839	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030285; GO:0042470; GO:0043229; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:1901998	regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]		blue	blue	NA	NA	NA	NA
TRINITY_DN46_c0_g1_i1	Q9Z1G4	VPP1_MOUSE	69.7	353	100	2	68	1105	1	353	3.30E-139	496.1	VPP1_MOUSE	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	Atp6v0a1 Atp6n1	Mus musculus (Mouse)	839	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030285; GO:0042470; GO:0043229; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:1901998	regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN46_c0_g1_i3	Q9Z1G4	VPP1_MOUSE	69.7	353	100	2	68	1105	1	353	3.30E-139	496.1	VPP1_MOUSE	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	Atp6v0a1 Atp6n1	Mus musculus (Mouse)	839	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030285; GO:0042470; GO:0043229; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:1901998	regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN46_c0_g1_i4	Q9Z1G4	VPP1_MOUSE	69.3	355	105	2	68	1126	1	353	1.10E-137	491.1	VPP1_MOUSE	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	Atp6v0a1 Atp6n1	Mus musculus (Mouse)	839	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030285; GO:0042470; GO:0043229; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:1901998	regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN46_c0_g1_i5	Q9Z1G4	VPP1_MOUSE	69.3	355	105	2	68	1126	1	353	1.10E-137	491.1	VPP1_MOUSE	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	Atp6v0a1 Atp6n1	Mus musculus (Mouse)	839	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030285; GO:0042470; GO:0043229; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:1901998	regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN835_c0_g2_i1	Q29466	VPP1_BOVIN	47.5	59	31	0	223	47	780	838	1.40E-07	56.6	VPP1_BOVIN	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	ATP6V0A1 ATP6N1 VPP1	Bos taurus (Bovine)	838	"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; vacuolar acidification [GO:0007035]"	"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005886; GO:0007035; GO:0016021; GO:0016471; GO:0030659; GO:0042470; GO:0046961; GO:0051117	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN37022_c0_g1_i1	Q93050	VPP1_HUMAN	100	85	0	0	1	255	718	802	4.50E-39	161.4	VPP1_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	ATP6V0A1 ATP6N1 ATP6N1A VPP1	Homo sapiens (Human)	837	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030667; GO:0030670; GO:0033572; GO:0034220; GO:0042470; GO:0043231; GO:0043312; GO:0046961; GO:0048471; GO:0051117; GO:0070062; GO:0090383; GO:0101003; GO:1901998	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN19969_c0_g1_i1	Q93050	VPP1_HUMAN	55.2	210	77	6	615	1	452	649	1.20E-53	211.1	VPP1_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	ATP6V0A1 ATP6N1 ATP6N1A VPP1	Homo sapiens (Human)	837	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030667; GO:0030670; GO:0033572; GO:0034220; GO:0042470; GO:0043231; GO:0043312; GO:0046961; GO:0048471; GO:0051117; GO:0070062; GO:0090383; GO:0101003; GO:1901998	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		blue	blue	NA	NA	NA	NA
TRINITY_DN1007_c0_g1_i1	Q93050	VPP1_HUMAN	69.4	124	37	1	435	64	708	830	6.50E-42	171.8	VPP1_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a1 (V-ATPase 116 kDa subunit a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	ATP6V0A1 ATP6N1 ATP6N1A VPP1	Homo sapiens (Human)	837	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030667; GO:0030670; GO:0033572; GO:0034220; GO:0042470; GO:0043231; GO:0043312; GO:0046961; GO:0048471; GO:0051117; GO:0070062; GO:0090383; GO:0101003; GO:1901998	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		blue	blue	NA	NA	NA	NA
TRINITY_DN26322_c0_g1_i1	P15920	VPP2_MOUSE	100	165	0	0	495	1	276	440	3.40E-91	335.5	VPP2_MOUSE	reviewed	V-type proton ATPase 116 kDa subunit a2 (V-ATPase 116 kDa subunit a2) (Immune suppressor factor J6B7) (ISF) (Lysosomal H(+)-transporting ATPase V0 subunit a2) (ShIF) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2)	Atp6v0a2 Atp6n1b Tj6	Mus musculus (Mouse)	856	"acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; vacuolar acidification [GO:0007035]"	"acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0001669; GO:0005886; GO:0006879; GO:0007035; GO:0010008; GO:0016021; GO:0016471; GO:0036295; GO:0043229; GO:0046961; GO:0048471; GO:0051117	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN26197_c0_g1_i1	Q13488	VPP3_HUMAN	100	67	0	0	1	201	497	563	3.80E-33	141.4	VPP3_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a3 (V-ATPase 116 kDa subunit a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)	TCIRG1 ATP6N1C ATP6V0A3	Homo sapiens (Human)	830	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000220; GO:0001503; GO:0002158; GO:0002377; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0008284; GO:0008286; GO:0010008; GO:0010155; GO:0010272; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0032609; GO:0033572; GO:0034220; GO:0035709; GO:0035711; GO:0043029; GO:0043312; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600	apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN25614_c0_g1_i1	Q13488	VPP3_HUMAN	89.5	76	8	0	277	50	755	830	1.90E-30	132.9	VPP3_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a3 (V-ATPase 116 kDa subunit a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)	TCIRG1 ATP6N1C ATP6V0A3	Homo sapiens (Human)	830	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000220; GO:0001503; GO:0002158; GO:0002377; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0008284; GO:0008286; GO:0010008; GO:0010155; GO:0010272; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0032609; GO:0033572; GO:0034220; GO:0035709; GO:0035711; GO:0043029; GO:0043312; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600	apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN16204_c0_g1_i1	Q13488	VPP3_HUMAN	86.1	79	11	0	2	238	6	84	8.40E-32	137.1	VPP3_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a3 (V-ATPase 116 kDa subunit a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)	TCIRG1 ATP6N1C ATP6V0A3	Homo sapiens (Human)	830	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000220; GO:0001503; GO:0002158; GO:0002377; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0008284; GO:0008286; GO:0010008; GO:0010155; GO:0010272; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0032609; GO:0033572; GO:0034220; GO:0035709; GO:0035711; GO:0043029; GO:0043312; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600	apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN33420_c0_g1_i1	Q13488	VPP3_HUMAN	100	79	0	0	240	4	1	79	7.40E-37	154.1	VPP3_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a3 (V-ATPase 116 kDa subunit a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)	TCIRG1 ATP6N1C ATP6V0A3	Homo sapiens (Human)	830	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000220; GO:0001503; GO:0002158; GO:0002377; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0008284; GO:0008286; GO:0010008; GO:0010155; GO:0010272; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0032609; GO:0033572; GO:0034220; GO:0035709; GO:0035711; GO:0043029; GO:0043312; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600	apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN39935_c0_g1_i1	Q13488	VPP3_HUMAN	99.3	142	1	0	2	427	689	830	2.10E-71	269.6	VPP3_HUMAN	reviewed	V-type proton ATPase 116 kDa subunit a3 (V-ATPase 116 kDa subunit a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)	TCIRG1 ATP6N1C ATP6V0A3	Homo sapiens (Human)	830	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000220; GO:0001503; GO:0002158; GO:0002377; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0008284; GO:0008286; GO:0010008; GO:0010155; GO:0010272; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0032609; GO:0033572; GO:0034220; GO:0035709; GO:0035711; GO:0043029; GO:0043312; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600	apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; immunoglobulin production [GO:0002377]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; interferon-gamma production [GO:0032609]; ion transmembrane transport [GO:0034220]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; neutrophil degranulation [GO:0043312]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN9271_c0_g1_i1	P63082	VATL_MOUSE	100	155	0	0	493	29	1	155	2.90E-72	272.7	VATL_MOUSE	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (PL16) (Vacuolar proton pump 16 kDa proteolipid subunit)	Atp6v0c Atp6c Atp6l Atpl Mvp	Mus musculus (Mouse)	155	"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]; lysosomal lumen acidification [GO:0007042]; negative regulation of autophagic cell death [GO:1904093]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Wnt signaling pathway [GO:0030177]; vacuolar acidification [GO:0007035]"	"Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005764; GO:0005794; GO:0007035; GO:0007042; GO:0008021; GO:0008553; GO:0016021; GO:0016471; GO:0030177; GO:0031625; GO:0033179; GO:0046961; GO:0070374; GO:1904093	lysosomal lumen acidification [GO:0007042]; negative regulation of autophagic cell death [GO:1904093]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Wnt signaling pathway [GO:0030177]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN10856_c0_g1_i1	Q43362	VATL_CHRCT	69.7	155	43	1	1	453	4	158	3.70E-42	172.6	VATL_CHRCT	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit)	VAP	Chrysotila carterae (Marine alga) (Syracosphaera carterae)	164	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]"	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	proton transmembrane transporter activity [GO:0015078]	GO:0005774; GO:0015078; GO:0016021; GO:0033179			NA	NA	NA	NA	NA	NA
TRINITY_DN34406_c0_g1_i1	P27449	VATL_HUMAN	100	111	0	0	372	40	45	155	5.40E-49	194.9	VATL_HUMAN	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit)	ATP6V0C ATP6C ATP6L ATPL	Homo sapiens (Human)	155	"azurophil granule membrane [GO:0035577]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; tertiary granule membrane [GO:0070821]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]; viral process [GO:0016032]"	"azurophil granule membrane [GO:0035577]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; tertiary granule membrane [GO:0070821]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005765; GO:0005886; GO:0005925; GO:0008286; GO:0010008; GO:0016021; GO:0016032; GO:0016241; GO:0030177; GO:0030670; GO:0031625; GO:0033179; GO:0033572; GO:0034220; GO:0035577; GO:0043312; GO:0046933; GO:0046961; GO:0070062; GO:0070821; GO:0090383; GO:0101003; GO:1902600	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN4273_c0_g1_i1	Q26250	VATL_NEPNO	86	157	21	1	585	115	4	159	9.90E-65	248.1	VATL_NEPNO	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit)		Nephrops norvegicus (Norway lobster)	159	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]"	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	proton transmembrane transporter activity [GO:0015078]	GO:0005774; GO:0015078; GO:0016021; GO:0033179			blue	blue	NA	NA	NA	NA
TRINITY_DN32711_c0_g1_i1	Q26250	VATL_NEPNO	91	156	13	1	550	83	5	159	7.10E-67	255	VATL_NEPNO	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit)		Nephrops norvegicus (Norway lobster)	159	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]"	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	proton transmembrane transporter activity [GO:0015078]	GO:0005774; GO:0015078; GO:0016021; GO:0033179			blue	blue	NA	NA	NA	NA
TRINITY_DN36669_c0_g1_i1	Q26250	VATL_NEPNO	57.4	136	57	1	409	2	12	146	2.80E-33	142.9	VATL_NEPNO	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit)		Nephrops norvegicus (Norway lobster)	159	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]"	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	proton transmembrane transporter activity [GO:0015078]	GO:0005774; GO:0015078; GO:0016021; GO:0033179			NA	NA	NA	NA	NA	NA
TRINITY_DN33069_c0_g1_i1	Q43362	VATL_CHRCT	72.3	155	39	1	10	462	4	158	3.70E-45	182.6	VATL_CHRCT	reviewed	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit)	VAP	Chrysotila carterae (Marine alga) (Syracosphaera carterae)	164	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]"	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	proton transmembrane transporter activity [GO:0015078]	GO:0005774; GO:0015078; GO:0016021; GO:0033179			NA	NA	NA	NA	NA	NA
TRINITY_DN37484_c0_g1_i1	Q91V37	VATO_MOUSE	57.5	153	61	1	21	479	51	199	1.30E-40	167.5	VATO_MOUSE	reviewed	V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (23 kDa subunit of V-ATPase) (Vacuolar proton pump 21 kDa proteolipid subunit)	Atp6v0b Atp6f	Mus musculus (Mouse)	205	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]"	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005768; GO:0008553; GO:0016021; GO:0016471; GO:0033179; GO:0046961; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN8428_c0_g1_i3	Q91V37	VATO_MOUSE	99.5	184	1	0	3	554	22	205	2.20E-97	356.3	VATO_MOUSE	reviewed	V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (23 kDa subunit of V-ATPase) (Vacuolar proton pump 21 kDa proteolipid subunit)	Atp6v0b Atp6f	Mus musculus (Mouse)	205	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]"	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005768; GO:0008553; GO:0016021; GO:0016471; GO:0033179; GO:0046961; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN8428_c0_g1_i1	Q2TA24	VATO_BOVIN	100	184	0	0	3	554	22	205	4.60E-98	358.6	VATO_BOVIN	reviewed	V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (Vacuolar proton pump 21 kDa proteolipid subunit)	ATP6V0B	Bos taurus (Bovine)	205	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005768; GO:0005774; GO:0016021; GO:0033179; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN25375_c0_g1_i2	Q99437	VATO_HUMAN	62.1	195	73	1	773	1357	12	205	5.40E-60	233.4	VATO_HUMAN	reviewed	V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (Vacuolar proton pump 21 kDa proteolipid subunit) (hATPL)	ATP6V0B ATP6F	Homo sapiens (Human)	205	"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]"	"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0005215; GO:0005774; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0030670; GO:0033179; GO:0033572; GO:0034220; GO:0046961; GO:0090383; GO:1902600	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN25375_c0_g1_i1	Q99437	VATO_HUMAN	62.1	195	73	1	704	120	12	205	5.40E-60	233.4	VATO_HUMAN	reviewed	V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (Vacuolar proton pump 21 kDa proteolipid subunit) (hATPL)	ATP6V0B ATP6F	Homo sapiens (Human)	205	"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]"	"endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0005215; GO:0005774; GO:0008286; GO:0010008; GO:0016021; GO:0016241; GO:0030670; GO:0033179; GO:0033572; GO:0034220; GO:0046961; GO:0090383; GO:1902600	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]		NA	NA	1	NA	NA	NA
TRINITY_DN38567_c0_g1_i1	Q39291	VATA_BRANA	70.1	107	32	0	321	1	22	128	7.40E-39	161	VATA_BRANA	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (BN59) (Tonoplast ATPase 70 kDa subunit) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)		Brassica napus (Rape)	623	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN19853_c0_g1_i1	Q8SQU9	VATA_ENCCU	81.5	65	12	0	197	3	243	307	2.80E-23	108.6	VATA_ENCCU	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (Vacuolar proton pump subunit alpha)	VMA1 ECU11_1280i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	607	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN32739_c0_g1_i1	Q8SQU9	VATA_ENCCU	67.6	71	23	0	2	214	26	96	8.70E-20	97.1	VATA_ENCCU	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (Vacuolar proton pump subunit alpha)	VMA1 ECU11_1280i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	607	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	1	NA	NA	NA
TRINITY_DN16667_c0_g1_i1	Q8SQU9	VATA_ENCCU	70.3	212	56	2	627	13	339	550	3.20E-78	292.7	VATA_ENCCU	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (Vacuolar proton pump subunit alpha)	VMA1 ECU11_1280i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	607	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN16667_c0_g1_i3	Q8SQU9	VATA_ENCCU	67.6	139	40	1	414	13	412	550	2.20E-47	190.3	VATA_ENCCU	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (Vacuolar proton pump subunit alpha)	VMA1 ECU11_1280i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	607	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN16667_c0_g1_i3	Q8SQU9	VATA_ENCCU	75.7	74	16	1	626	411	339	412	1.00E-23	111.7	VATA_ENCCU	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (Vacuolar proton pump subunit alpha)	VMA1 ECU11_1280i	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	607	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN2364_c0_g1_i1	O16109	VATA_AEDAE	79.7	612	123	1	115	1950	4	614	1.90E-294	1012.7	VATA_AEDAE	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	VhaA AAEL008787	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	614	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN2364_c0_g1_i2	Q5TTG1	VATA_ANOGA	82.8	256	44	0	2	769	359	614	1.40E-123	443.7	VATA_ANOGA	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	Vha68-2 AGAP003153	Anopheles gambiae (African malaria mosquito)	614	"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005774; GO:0005886; GO:0033180; GO:0046933; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN35757_c0_g1_i1	Q76NM6	VATA_PLAF7	69.8	374	112	1	1130	9	179	551	1.80E-156	553.5	VATA_PLAF7	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	vapA PF13_0065	Plasmodium falciparum (isolate 3D7)	611	"food vacuole [GO:0020020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]"	"food vacuole [GO:0020020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000221; GO:0005524; GO:0005774; GO:0005886; GO:0007035; GO:0020020; GO:0046933; GO:0046961; GO:1902600	proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN21647_c0_g1_i1	P31404	VATA_BOVIN	100	135	0	0	3	407	395	529	6.40E-72	271.2	VATA_BOVIN	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	ATP6V1A ATP6A1 ATP6V1A1	Bos taurus (Bovine)	617	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]"	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005774; GO:0005829; GO:0005886; GO:0006879; GO:0033180; GO:0036295; GO:0046933; GO:0046961	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]		NA	NA	NA	NA	NA	NA
TRINITY_DN21647_c0_g1_i2	P31404	VATA_BOVIN	100	135	0	0	3	407	395	529	6.40E-72	271.2	VATA_BOVIN	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	ATP6V1A ATP6A1 ATP6V1A1	Bos taurus (Bovine)	617	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]"	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005774; GO:0005829; GO:0005886; GO:0006879; GO:0033180; GO:0036295; GO:0046933; GO:0046961	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]		NA	NA	NA	NA	NA	NA
TRINITY_DN34127_c0_g1_i1	P50516	VATA_MOUSE	99.5	192	1	0	3	578	18	209	8.80E-107	387.5	VATA_MOUSE	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	Atp6v1a Atp6a1 Atp6a2 Atp6v1a1	Mus musculus (Mouse)	617	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005739; GO:0005774; GO:0005829; GO:0005886; GO:0005902; GO:0006879; GO:0016324; GO:0033180; GO:0036295; GO:0043209; GO:0046933; GO:0046961	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]		NA	NA	NA	NA	NA	NA
TRINITY_DN8478_c0_g1_i1	Q90647	VATA_CHICK	95.5	111	5	0	357	25	188	298	8.80E-57	220.7	VATA_CHICK	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	ATP6V1A	Gallus gallus (Chicken)	617	"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]"	"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005774; GO:0005886; GO:0006879; GO:0033180; GO:0036295; GO:0046933; GO:0046961	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]		NA	NA	NA	NA	NA	NA
TRINITY_DN8478_c0_g1_i2	Q90647	VATA_CHICK	100	166	0	0	499	2	188	353	6.40E-90	331.3	VATA_CHICK	reviewed	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	ATP6V1A	Gallus gallus (Chicken)	617	"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]"	"plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]"	"ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0005524; GO:0005774; GO:0005886; GO:0006879; GO:0033180; GO:0036295; GO:0046933; GO:0046961	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]		NA	NA	NA	NA	NA	NA
TRINITY_DN13459_c0_g1_i1	O13742	VPH1_SCHPO	60.3	63	25	0	239	51	697	759	1.40E-13	76.6	VPH1_SCHPO	reviewed	V-type proton ATPase subunit a (V-ATPase a subunit) (Vacuolar ATPase 91 kDa subunit) (Vacuolar proton pump a subunit) (Vacuolar proton translocating ATPase subunit a)	vph1 SPAC16E8.07c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	831	"endoplasmic reticulum [GO:0005783]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]"	"endoplasmic reticulum [GO:0005783]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0000329; GO:0005524; GO:0005783; GO:0007035; GO:0016021; GO:0016471; GO:0046961; GO:0051117; GO:1902600	proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN5623_c0_g1_i1	P37296	STV1_YEAST	46.2	117	53	1	384	64	770	886	5.20E-22	105.5	STV1_YEAST	reviewed	"V-type proton ATPase subunit a, Golgi isoform (V-ATPase a 2 subunit) (Similar to VPH1 protein 1) (V-ATPase 101 kDa subunit) (V-ATPase subunit AC115) (Vacuolar proton translocating ATPase subunit a 2)"	STV1 YMR054W YM9796.07	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	890	"endosome membrane [GO:0010008]; fungal-type vacuole membrane [GO:0000329]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; phosphatidylinositol-4-phosphate binding [GO:0070273]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; vacuolar acidification [GO:0007035]"	"endosome membrane [GO:0010008]; fungal-type vacuole membrane [GO:0000329]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; phosphatidylinositol-4-phosphate binding [GO:0070273]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000139; GO:0000220; GO:0000329; GO:0005770; GO:0005794; GO:0007035; GO:0010008; GO:0016021; GO:0016471; GO:0046961; GO:0051117; GO:0070273	vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN835_c0_g1_i1	P32563	VPH1_YEAST	56.1	66	29	0	1	198	693	758	7.70E-13	73.9	VPH1_YEAST	reviewed	"V-type proton ATPase subunit a, vacuolar isoform (V-ATPase a 1 subunit) (V-ATPase 95 kDa subunit) (Vacuolar pH protein 1) (Vacuolar proton pump a subunit) (Vacuolar proton translocating ATPase subunit a 1)"	VPH1 YOR270C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	840	"fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular hyperosmotic response [GO:0071474]; cellular protein-containing complex assembly [GO:0034622]; cellular response to alkaline pH [GO:0071469]; cellular response to salt stress [GO:0071472]; polyphosphate metabolic process [GO:0006797]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]"	"fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase binding [GO:0051117]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0000324; GO:0000329; GO:0006797; GO:0007035; GO:0016021; GO:0016471; GO:0034622; GO:0046961; GO:0051117; GO:0071469; GO:0071472; GO:0071474; GO:0080025; GO:1902600	cellular hyperosmotic response [GO:0071474]; cellular protein-containing complex assembly [GO:0034622]; cellular response to alkaline pH [GO:0071469]; cellular response to salt stress [GO:0071472]; polyphosphate metabolic process [GO:0006797]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN13459_c0_g2_i1	Q8W4S4	VHAA3_ARATH	57.1	49	21	0	194	48	772	820	1.90E-11	69.3	VHAA3_ARATH	reviewed	V-type proton ATPase subunit a3 (V-ATPase subunit a3) (V-type proton ATPase 95 kDa subunit a isoform 3) (V-ATPase 95 kDa isoform a3) (Vacuolar H(+)-ATPase subunit a isoform 3) (Vacuolar proton pump subunit a3) (Vacuolar proton translocating ATPase 95 kDa subunit a isoform 3)	VHA-a3 At4g39080 F19H22.180	Arabidopsis thaliana (Mouse-ear cress)	821	"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plant-type vacuole [GO:0000325]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuole [GO:0005773]; ATPase binding [GO:0051117]; nutrient reservoir activity [GO:0045735]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]; ATP synthesis coupled proton transport [GO:0015986]; sequestering of zinc ion [GO:0032119]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]; vacuolar sequestering [GO:0043181]"	"chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plant-type vacuole [GO:0000325]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuole [GO:0005773]"	"ATPase binding [GO:0051117]; nutrient reservoir activity [GO:0045735]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO:0009678]"	GO:0000220; GO:0000325; GO:0005773; GO:0005774; GO:0005794; GO:0005886; GO:0007035; GO:0009507; GO:0009678; GO:0009705; GO:0009941; GO:0015986; GO:0016021; GO:0016471; GO:0032119; GO:0043181; GO:0045735; GO:0046961; GO:0051117; GO:0070072	ATP synthesis coupled proton transport [GO:0015986]; sequestering of zinc ion [GO:0032119]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]; vacuolar sequestering [GO:0043181]		NA	NA	NA	NA	NA	NA
TRINITY_DN283_c0_g1_i1	Q8SR34	VATB_ENCCU	76.3	469	111	0	1426	20	1	469	3.80E-215	748.8	VATB_ENCCU	reviewed	V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)	VMA2 ECU10_1040	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	477	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:1902600	ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN33077_c0_g1_i1	Q25691	VATB_PLAFA	75.7	477	116	0	1454	24	14	490	1.70E-220	766.5	VATB_PLAFA	reviewed	V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)	VAPB	Plasmodium falciparum	494	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:1902600	ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN656_c0_g1_i1	P31409	VATB_DROME	91.2	479	42	0	111	1547	9	487	4.50E-257	888.3	VATB_DROME	reviewed	V-type proton ATPase subunit B (V-ATPase subunit B) (V-ATPase 55 kDa subunit) (Vacuolar proton pump subunit B)	Vha55 CG17369	Drosophila melanogaster (Fruit fly)	490	"brush border [GO:0005903]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]"	"brush border [GO:0005903]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	GO:0000221; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005903; GO:0007035; GO:0016787; GO:0033181; GO:0046034; GO:0048471; GO:1902600	ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]		blue	blue	NA	NA	NA	NA
TRINITY_DN656_c1_g1_i1	P21281	VATB2_HUMAN	99.4	177	1	0	549	19	335	511	9.80E-100	364	VATB2_HUMAN	reviewed	"V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)"	ATP6V1B2 ATP6B2 VPP3	Homo sapiens (Human)	511	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]"	"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0001726; GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0008286; GO:0012505; GO:0015078; GO:0016021; GO:0016241; GO:0016324; GO:0016787; GO:0033180; GO:0033572; GO:0034220; GO:0042470; GO:0043231; GO:0046034; GO:0046961; GO:0070062; GO:0090383; GO:1902600	ATP metabolic process [GO:0046034]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN20486_c0_g1_i2	P21281	VATB2_HUMAN	100	322	0	0	1	966	16	337	5.10E-184	644.8	VATB2_HUMAN	reviewed	"V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)"	ATP6V1B2 ATP6B2 VPP3	Homo sapiens (Human)	511	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]"	"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0001726; GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0008286; GO:0012505; GO:0015078; GO:0016021; GO:0016241; GO:0016324; GO:0016787; GO:0033180; GO:0033572; GO:0034220; GO:0042470; GO:0043231; GO:0046034; GO:0046961; GO:0070062; GO:0090383; GO:1902600	ATP metabolic process [GO:0046034]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN20486_c0_g1_i1	P31408	VATB2_BOVIN	100	258	0	0	2	775	80	337	4.90E-145	515	VATB2_BOVIN	reviewed	"V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (Vacuolar proton pump subunit B 2)"	ATP6V1B2 ATP6B2	Bos taurus (Bovine)	511	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]	GO:0001726; GO:0005524; GO:0005829; GO:0005886; GO:0005902; GO:0012505; GO:0016324; GO:0016787; GO:0033180; GO:0042470; GO:0043231; GO:0046034; GO:1902600	ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN3504_c0_g1_i1	Q9U5N1	VATC_MANSE	69	381	114	2	1247	114	2	381	3.60E-151	536.2	VATC_MANSE	reviewed	V-type proton ATPase subunit C (V-ATPase subunit C) (Vacuolar proton pump subunit C)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	385	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	proton transmembrane transporter activity [GO:0015078]	GO:0015078; GO:0033180			NA	NA	NA	NA	NA	NA
TRINITY_DN34164_c0_g1_i1	Q9Z1G3	VATC1_MOUSE	100	90	0	0	270	1	206	295	2.00E-45	182.6	VATC1_MOUSE	reviewed	V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1)	Atp6v1c1 Atp6c Atp6c1 Vatc	Mus musculus (Mouse)	382	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0005737; GO:0005886; GO:0008553; GO:0031410; GO:0045177; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN21893_c0_g1_i1	Q5FVI6	VATC1_RAT	98.7	151	2	0	1	453	232	382	3.90E-81	302	VATC1_RAT	reviewed	V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1)	Atp6v1c1	Rattus norvegicus (Rat)	382	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0005737; GO:0005886; GO:0008553; GO:0031410; GO:0045177; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN14012_c0_g1_i1	P21283	VATC1_HUMAN	100	144	0	0	432	1	1	144	4.20E-76	285.4	VATC1_HUMAN	reviewed	V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1)	ATP6V1C1 ATP6C ATP6D VATC	Homo sapiens (Human)	382	"apical part of cell [GO:0045177]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]"	"apical part of cell [GO:0045177]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000221; GO:0005215; GO:0005765; GO:0005829; GO:0005886; GO:0008286; GO:0008553; GO:0016241; GO:0016469; GO:0031410; GO:0033572; GO:0034220; GO:0045177; GO:0046961; GO:0070062; GO:0090383; GO:1902600	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN14012_c0_g1_i2	Q9Z1G3	VATC1_MOUSE	100	144	0	0	432	1	1	144	7.10E-76	284.6	VATC1_MOUSE	reviewed	V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1)	Atp6v1c1 Atp6c Atp6c1 Vatc	Mus musculus (Mouse)	382	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0005737; GO:0005886; GO:0008553; GO:0031410; GO:0045177; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN30739_c0_g1_i1	Q5XIY6	VTC1B_DANRE	47.1	70	33	2	227	24	272	339	1.70E-11	69.7	VTC1B_DANRE	reviewed	V-type proton ATPase subunit C 1-B (V-ATPase subunit C 1-B) (Vacuolar proton pump subunit C 1-B)	atp6v1c1b atp6v1c1l si:ch211-215i13.2 zgc:92684	Danio rerio (Zebrafish) (Brachydanio rerio)	381	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0008553; GO:0046961			red	red	NA	NA	NA	NA
TRINITY_DN32830_c0_g1_i1	Q25531	VA0D_MANSE	83.2	220	37	0	745	86	128	347	1.10E-106	387.5	VA0D_MANSE	reviewed	V-type proton ATPase subunit d (V-ATPase subunit d) (M40) (V-ATPase 40 kDa subunit) (Vacuolar proton pump subunit d)		Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	348	"proton-transporting V-type ATPase, V0 domain [GO:0033179]; proton transmembrane transporter activity [GO:0015078]"	"proton-transporting V-type ATPase, V0 domain [GO:0033179]"	proton transmembrane transporter activity [GO:0015078]	GO:0015078; GO:0033179			blue	blue	NA	NA	NA	NA
TRINITY_DN30320_c0_g1_i1	P61420	VA0D1_BOVIN	100	215	0	0	731	87	137	351	4.50E-124	445.3	VA0D1_BOVIN	reviewed	V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (32 kDa accessory protein) (P39) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit) (Vacuolar proton pump subunit d 1)	ATP6V0D1 ATP6D VPATPD	Bos taurus (Bovine)	351	"early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]"	"early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0008553; GO:0016471; GO:0033179; GO:0033181; GO:0036295; GO:0046961; GO:0060271	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]		blue	blue	NA	NA	NA	NA
TRINITY_DN25474_c0_g1_i1	P31402	VATE_MANSE	64.4	225	79	1	88	762	1	224	5.20E-71	269.2	VATE_MANSE	reviewed	V-type proton ATPase subunit E (V-ATPase subunit E) (V-ATPase 26 kDa subunit) (Vacuolar proton pump subunit E)	VHA26	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	226	"proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0033178; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN40728_c0_g1_i1	P50518	VATE1_MOUSE	100	124	0	0	2	373	103	226	1.10E-63	243.8	VATE1_MOUSE	reviewed	V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1)	Atp6v1e1 Atp6e Atp6e2	Mus musculus (Mouse)	226	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; ATPase binding [GO:0051117]; hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]"	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]"	"ATPase binding [GO:0051117]; hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005737; GO:0005739; GO:0005768; GO:0005829; GO:0005902; GO:0008553; GO:0016324; GO:0016787; GO:0033178; GO:0046961; GO:0051117; GO:1902600	proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN36567_c0_g1_i1	P36543	VATE1_HUMAN	100	112	0	0	1	336	115	226	4.30E-57	221.9	VATE1_HUMAN	reviewed	V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1)	ATP6V1E1 ATP6E ATP6E2	Homo sapiens (Human)	226	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; ATPase binding [GO:0051117]; hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]"	"ATPase binding [GO:0051117]; hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005765; GO:0005768; GO:0005829; GO:0005902; GO:0008286; GO:0008553; GO:0016241; GO:0016324; GO:0016469; GO:0016787; GO:0033178; GO:0033572; GO:0034220; GO:0046961; GO:0051117; GO:0070062; GO:0090383; GO:1902600	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN20471_c0_g1_i1	P11019	VATE1_BOVIN	100	89	0	0	67	333	1	89	1.30E-38	160.2	VATE1_BOVIN	reviewed	V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (P31) (Vacuolar proton pump subunit E 1)	ATP6V1E1 ATP6E	Bos taurus (Bovine)	226	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome [GO:0005768]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome [GO:0005768]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]"	"hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005768; GO:0005829; GO:0008553; GO:0016324; GO:0016787; GO:0033178; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN20471_c0_g1_i2	P11019	VATE1_BOVIN	100	86	0	0	3	260	4	89	3.30E-37	155.2	VATE1_BOVIN	reviewed	V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (P31) (Vacuolar proton pump subunit E 1)	ATP6V1E1 ATP6E	Bos taurus (Bovine)	226	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome [GO:0005768]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome [GO:0005768]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]"	"hydrolase activity [GO:0016787]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005768; GO:0005829; GO:0008553; GO:0016324; GO:0016787; GO:0033178; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN28729_c0_g1_i1	Q55AH5	VATF_DICDI	48.2	56	26	1	217	50	68	120	2.40E-09	62.4	VATF_DICDI	reviewed	V-type proton ATPase subunit F (V-ATPase subunit F) (Vacuolar proton pump subunit F)	vatF DDB_G0271882	Dictyostelium discoideum (Slime mold)	120	"contractile vacuolar membrane [GO:0031164]; membrane [GO:0016020]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"contractile vacuolar membrane [GO:0031164]; membrane [GO:0016020]; proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0016020; GO:0031164; GO:0033180; GO:0042625; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN2936_c0_g1_i1	Q1HQK8	VATF_AEDAE	76.7	120	27	1	60	419	4	122	8.90E-49	194.5	VATF_AEDAE	reviewed	V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F)	AAEL002464	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	127	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"proton-transporting V-type ATPase, V1 domain [GO:0033180]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0033180; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN12752_c0_g1_i1	Q9D1K2	VATF_MOUSE	100	119	0	0	59	415	1	119	2.40E-62	239.6	VATF_MOUSE	reviewed	V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F)	Atp6v1f Atp6s14 Vatf	Mus musculus (Mouse)	119	"membrane [GO:0016020]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"membrane [GO:0016020]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0016020; GO:0016471; GO:0033180; GO:0042625; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN12752_c0_g1_i2	Q16864	VATF_HUMAN	100	119	0	0	59	415	1	119	3.10E-62	239.2	VATF_HUMAN	reviewed	V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F)	ATP6V1F ATP6S14 VATF	Homo sapiens (Human)	119	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase activity [GO:0016887]; ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; transferrin transport [GO:0033572]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]"	"ATPase activity [GO:0016887]; ATPase-coupled ion transmembrane transporter activity [GO:0042625]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0005829; GO:0008286; GO:0015078; GO:0016020; GO:0016469; GO:0016471; GO:0016887; GO:0033180; GO:0033572; GO:0034220; GO:0042625; GO:0046961; GO:0070062; GO:0090383; GO:1902600	insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; transferrin transport [GO:0033572]		NA	NA	NA	NA	NA	NA
TRINITY_DN3499_c0_g1_i1	Q9XZH6	VATG_DROME	65.5	113	39	0	444	106	1	113	1.70E-18	94	VATG_DROME	reviewed	V-type proton ATPase subunit G (V-ATPase subunit G) (V-ATPase 13 kDa subunit) (Vacuolar proton pump subunit G)	Vha13 CG6213	Drosophila melanogaster (Fruit fly)	117	"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; liquid clearance, open tracheal system [GO:0035002]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]"	plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]	"proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]"	GO:0007430; GO:0008553; GO:0016471; GO:0033181; GO:0035002; GO:1902600	"liquid clearance, open tracheal system [GO:0035002]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]"		blue	blue	NA	NA	NA	NA
TRINITY_DN23842_c0_g1_i1	Q9UI12	VATH_HUMAN	100	91	0	0	274	2	239	329	1.40E-43	176.4	VATH_HUMAN	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (Nef-binding protein 1) (NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	ATP6V1H CGI-11	Homo sapiens (Human)	483	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; endocytosis [GO:0006897]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of defense response to virus by virus [GO:0050690]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006897; GO:0007035; GO:0008286; GO:0016241; GO:0030234; GO:0033572; GO:0034220; GO:0046961; GO:0050690; GO:0070062; GO:0090383; GO:1902600	endocytosis [GO:0006897]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of defense response to virus by virus [GO:0050690]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN23842_c0_g1_i2	Q9UI12	VATH_HUMAN	100	71	0	0	215	3	239	309	2.60E-32	138.7	VATH_HUMAN	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (Nef-binding protein 1) (NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	ATP6V1H CGI-11	Homo sapiens (Human)	483	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; endocytosis [GO:0006897]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of defense response to virus by virus [GO:0050690]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006897; GO:0007035; GO:0008286; GO:0016241; GO:0030234; GO:0033572; GO:0034220; GO:0046961; GO:0050690; GO:0070062; GO:0090383; GO:1902600	endocytosis [GO:0006897]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of defense response to virus by virus [GO:0050690]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]		NA	NA	NA	NA	NA	NA
TRINITY_DN5108_c0_g1_i1	Q9V3J1	VATH_DROME	65	460	156	3	1477	98	4	458	8.60E-173	608.2	VATH_DROME	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	VhaSFD CG17332	Drosophila melanogaster (Fruit fly)	468	"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]"	"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0008340; GO:0033181; GO:0033227; GO:0046961; GO:1902600	determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN5108_c0_g1_i2	Q9V3J1	VATH_DROME	66.4	423	138	2	1366	98	40	458	7.80E-165	581.6	VATH_DROME	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	VhaSFD CG17332	Drosophila melanogaster (Fruit fly)	468	"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]"	"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0008340; GO:0033181; GO:0033227; GO:0046961; GO:1902600	determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]		NA	NA	NA	NA	NA	NA
TRINITY_DN15222_c0_g1_i1	O46563	VATH_BOVIN	100	106	0	0	365	48	378	483	1.90E-54	213	VATH_BOVIN	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	ATP6V1H	Bos taurus (Bovine)	483	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN15222_c0_g1_i2	O46563	VATH_BOVIN	100	106	0	0	365	48	378	483	1.90E-54	213	VATH_BOVIN	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	ATP6V1H	Bos taurus (Bovine)	483	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN34827_c0_g1_i1	O46563	VATH_BOVIN	80.2	91	0	1	219	1	151	241	1.50E-35	149.4	VATH_BOVIN	reviewed	V-type proton ATPase subunit H (V-ATPase subunit H) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	ATP6V1H	Bos taurus (Bovine)	483	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	"vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0046961			NA	NA	NA	NA	NA	NA
TRINITY_DN29849_c0_g1_i1	O54715	VAS1_RAT	24.9	462	277	20	1352	99	22	457	1.60E-16	89	VAS1_RAT	reviewed	V-type proton ATPase subunit S1 (V-ATPase subunit S1) (C7-1 protein) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)	Atp6ap1 Atp6ip1 Atp6s1	Rattus norvegicus (Rat)	463	"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; Rab GTPase binding [GO:0017137]; aging [GO:0007568]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]"	"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V1 domain [GO:0033180]"	ATP binding [GO:0005524]; Rab GTPase binding [GO:0017137]	GO:0005524; GO:0005789; GO:0006879; GO:0007568; GO:0008219; GO:0016021; GO:0017137; GO:0030641; GO:0033116; GO:0033180; GO:0033181; GO:0036295; GO:0045669; GO:0045780; GO:0045851; GO:0045921; GO:0051656; GO:0070374; GO:1902600; GO:2001206	aging [GO:0007568]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]		blue	blue	NA	NA	NA	NA
TRINITY_DN10295_c1_g1_i5	Q5VU97	CAHD1_HUMAN	30.9	1270	726	32	3911	249	41	1208	2.70E-160	568.2	CAHD1_HUMAN	reviewed	VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)	CACHD1 KIAA1573 VWCD1	Homo sapiens (Human)	1274	voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]	voltage-gated calcium channel complex [GO:0005891]	voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891			NA	NA	NA	NA	NA	NA
TRINITY_DN10295_c1_g1_i7	Q5VU97	CAHD1_HUMAN	36.5	633	310	16	2096	249	651	1208	9.70E-101	369.4	CAHD1_HUMAN	reviewed	VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)	CACHD1 KIAA1573 VWCD1	Homo sapiens (Human)	1274	voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]	voltage-gated calcium channel complex [GO:0005891]	voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891			NA	NA	NA	NA	NA	NA
TRINITY_DN10295_c1_g1_i8	Q5VU97	CAHD1_HUMAN	31.6	1084	609	28	3365	249	212	1208	4.30E-140	500.7	CAHD1_HUMAN	reviewed	VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)	CACHD1 KIAA1573 VWCD1	Homo sapiens (Human)	1274	voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]	voltage-gated calcium channel complex [GO:0005891]	voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891			NA	NA	NA	NA	NA	NA
TRINITY_DN36855_c0_g1_i1	A8K0Z3	WASH1_HUMAN	45.5	77	36	1	255	25	153	223	7.10E-09	61.2	WASH1_HUMAN	reviewed	WASH complex subunit 1 (CXYorf1-like protein on chromosome 9) (Protein FAM39E) (WAS protein family homolog 1)	WASHC1 FAM39E WASH1	Homo sapiens (Human)	465	"autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; invadopodium [GO:0071437]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ubiquitin protein ligase binding [GO:0031625]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; negative regulation of autophagy [GO:0010507]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; positive regulation of cell migration [GO:0030335]; positive regulation of pseudopodium assembly [GO:0031274]; protein transport [GO:0015031]; regulation of protein ubiquitination [GO:0031396]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"	autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; invadopodium [GO:0071437]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ubiquitin protein ligase binding [GO:0031625]	GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0006887; GO:0010507; GO:0015031; GO:0016197; GO:0022617; GO:0030335; GO:0031274; GO:0031396; GO:0031625; GO:0031901; GO:0034314; GO:0042147; GO:0043014; GO:0043231; GO:0043553; GO:0055037; GO:0055038; GO:0071203; GO:0071437; GO:1990126	"Arp2/3 complex-mediated actin nucleation [GO:0034314]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; negative regulation of autophagy [GO:0010507]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; positive regulation of cell migration [GO:0030335]; positive regulation of pseudopodium assembly [GO:0031274]; protein transport [GO:0015031]; regulation of protein ubiquitination [GO:0031396]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35851_c0_g1_i1	Q9CR27	WASC3_MOUSE	37.9	203	105	1	116	724	13	194	1.00E-27	125.2	WASC3_MOUSE	reviewed	WASH complex subunit 3 (Coiled-coil domain-containing protein 53)	Washc3 Ccdc53	Mus musculus (Mouse)	194	early endosome [GO:0005769]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]; protein transport [GO:0015031]	early endosome [GO:0005769]; WASH complex [GO:0071203]		GO:0005769; GO:0006887; GO:0015031; GO:0030041; GO:0071203	actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]; protein transport [GO:0015031]		blue	blue	NA	NA	NA	NA
TRINITY_DN35851_c0_g1_i2	Q9CR27	WASC3_MOUSE	39.7	199	103	2	116	712	13	194	2.70E-28	127.1	WASC3_MOUSE	reviewed	WASH complex subunit 3 (Coiled-coil domain-containing protein 53)	Washc3 Ccdc53	Mus musculus (Mouse)	194	early endosome [GO:0005769]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]; protein transport [GO:0015031]	early endosome [GO:0005769]; WASH complex [GO:0071203]		GO:0005769; GO:0006887; GO:0015031; GO:0030041; GO:0071203	actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN2535_c0_g1_i1	Q2M389	WASC4_HUMAN	43.9	907	503	5	2	2707	41	946	2.80E-224	780	WASC4_HUMAN	reviewed	WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP)	WASHC4 KIAA1033	Homo sapiens (Human)	1173	early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]	early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]		GO:0005654; GO:0005768; GO:0005769; GO:0007032; GO:0015031; GO:0016197; GO:0071203	endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN19478_c0_g1_i1	Q2M389	WASC4_HUMAN	98.9	90	1	0	3	272	853	942	4.10E-46	184.9	WASC4_HUMAN	reviewed	WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP)	WASHC4 KIAA1033	Homo sapiens (Human)	1173	early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]	early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]		GO:0005654; GO:0005768; GO:0005769; GO:0007032; GO:0015031; GO:0016197; GO:0071203	endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN30152_c0_g1_i1	Q12768	WASC5_HUMAN	100	81	0	0	3	245	95	175	4.30E-39	161.4	WASC5_HUMAN	reviewed	WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin)	WASHC5 KIAA0196	Homo sapiens (Human)	1159	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]		GO:0001556; GO:0005654; GO:0005769; GO:0005783; GO:0005829; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494	cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN37340_c0_g1_i1	Q12768	WASC5_HUMAN	100	124	0	0	1	372	182	305	3.00E-68	258.8	WASC5_HUMAN	reviewed	WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin)	WASHC5 KIAA0196	Homo sapiens (Human)	1159	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]		GO:0001556; GO:0005654; GO:0005769; GO:0005783; GO:0005829; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494	cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN31484_c0_g1_i1	Q12768	WASC5_HUMAN	100	91	0	0	274	2	725	815	2.30E-49	195.7	WASC5_HUMAN	reviewed	WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin)	WASHC5 KIAA0196	Homo sapiens (Human)	1159	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]		GO:0001556; GO:0005654; GO:0005769; GO:0005783; GO:0005829; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494	cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i6	Q12768	WASC5_HUMAN	45.8	96	52	0	392	105	822	917	1.80E-18	93.6	WASC5_HUMAN	reviewed	WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin)	WASHC5 KIAA0196	Homo sapiens (Human)	1159	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]		GO:0001556; GO:0005654; GO:0005769; GO:0005783; GO:0005829; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494	cellular protein-containing complex localization [GO:0034629]; endosomal transport [GO:0016197]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN40234_c0_g1_i1	Q8C2E7	WASC5_MOUSE	98.6	74	1	0	224	3	745	818	5.70E-38	157.5	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN39233_c0_g1_i1	Q8C2E7	WASC5_MOUSE	100	68	0	0	2	205	269	336	3.00E-33	141.7	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN2428_c0_g1_i1	Q7ZVM1	WASC5_DANRE	55.5	602	266	1	1808	3	2	601	3.20E-198	693	WASC5_DANRE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	washc5 zgc:55908	Danio rerio (Zebrafish) (Brachydanio rerio)	1159	early endosome [GO:0005769]; WASH complex [GO:0071203]; axonogenesis [GO:0007409]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]	early endosome [GO:0005769]; WASH complex [GO:0071203]		GO:0005769; GO:0007409; GO:0015031; GO:0048666; GO:0060047; GO:0071203	axonogenesis [GO:0007409]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i1	Q8C2E7	WASC5_MOUSE	49.2	557	278	3	1778	108	600	1151	3.00E-150	533.5	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i10	Q8C2E7	WASC5_MOUSE	60.6	315	123	1	1061	117	600	913	2.00E-104	380.6	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i11	Q8C2E7	WASC5_MOUSE	49.2	557	278	3	1778	108	600	1151	3.00E-150	533.5	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i12	Q8C2E7	WASC5_MOUSE	49.2	557	278	3	1778	108	600	1151	3.00E-150	533.5	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i13	Q8C2E7	WASC5_MOUSE	49.2	557	278	3	1778	108	600	1151	3.00E-150	533.5	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i14	Q8C2E7	WASC5_MOUSE	60.6	315	123	1	1061	117	600	913	2.00E-104	380.6	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN1547_c0_g1_i2	Q8C2E7	WASC5_MOUSE	49.2	557	278	3	1778	108	600	1151	3.00E-150	533.5	WASC5_MOUSE	reviewed	WASH complex subunit 5 (WASH complex subunit strumpellin)	Washc5 Kiaa0196	Mus musculus (Mouse)	1159	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; identical protein binding [GO:0042802]; cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; protein-containing complex subunit organization [GO:0043933]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]	identical protein binding [GO:0042802]	GO:0001556; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0006887; GO:0006909; GO:0007040; GO:0010976; GO:0015031; GO:0016197; GO:0034629; GO:0040038; GO:0042632; GO:0042802; GO:0043005; GO:0043025; GO:0043933; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285	cellular protein-containing complex localization [GO:0034629]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; exocytosis [GO:0006887]; lysosome organization [GO:0007040]; oocyte maturation [GO:0001556]; phagocytosis [GO:0006909]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex subunit organization [GO:0043933]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of vesicle size [GO:0097494]; spindle assembly involved in meiosis [GO:0090306]		NA	NA	NA	NA	NA	NA
TRINITY_DN12011_c0_g1_i1	Q8IZQ1	WDFY3_HUMAN	33.3	156	96	3	464	3	2195	2344	9.00E-17	88.2	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN39761_c0_g1_i1	Q8IZQ1	WDFY3_HUMAN	53.8	80	36	1	239	3	2795	2874	1.60E-17	89.7	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN13505_c0_g1_i1	Q8IZQ1	WDFY3_HUMAN	71.6	74	20	1	51	269	191	264	6.70E-24	111.3	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN13505_c0_g1_i2	Q8IZQ1	WDFY3_HUMAN	59.3	386	149	1	76	1233	11	388	8.30E-123	441.8	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN13505_c0_g1_i4	Q8IZQ1	WDFY3_HUMAN	58.4	377	149	1	76	1206	11	379	3.90E-118	426.4	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN13505_c0_g1_i5	Q8IZQ1	WDFY3_HUMAN	69.6	125	38	0	51	425	191	315	6.30E-46	184.9	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN14945_c0_g3_i1	Q8IZQ1	WDFY3_HUMAN	69.8	63	18	1	36	224	414	475	1.30E-15	84.3	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN14945_c0_g4_i1	Q8IZQ1	WDFY3_HUMAN	69.8	63	18	1	319	131	414	475	1.00E-15	84.3	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g3_i1	Q8IZQ1	WDFY3_HUMAN	41.3	225	82	5	537	4	927	1148	8.90E-37	154.8	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g3_i2	Q8IZQ1	WDFY3_HUMAN	46.8	62	32	1	186	1	1089	1149	4.70E-12	71.6	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g1_i1	Q8IZQ1	WDFY3_HUMAN	52.7	374	171	3	107	1210	1184	1557	4.00E-107	389.8	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g1_i2	Q8IZQ1	WDFY3_HUMAN	53.7	177	81	1	2	529	1381	1557	1.80E-44	180.6	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g1_i4	Q8IZQ1	WDFY3_HUMAN	52.7	374	171	3	107	1210	1184	1557	4.00E-107	389.8	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g2_i1	Q8IZQ1	WDFY3_HUMAN	41.4	314	157	5	23	886	1557	1869	8.80E-58	225.3	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN11432_c0_g2_i2	Q8IZQ1	WDFY3_HUMAN	42.2	296	144	5	23	832	1557	1851	7.60E-54	212.2	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN10761_c0_g1_i1	Q8IZQ1	WDFY3_HUMAN	64.7	479	157	5	1435	17	2780	3252	6.00E-181	635.2	WDFY3_HUMAN	reviewed	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	WDFY3 KIAA0993	Homo sapiens (Human)	3526	"autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN13505_c0_g1_i7	Q6VNB8	WDFY3_MOUSE	46.4	56	30	0	44	211	319	374	1.40E-06	53.1	WDFY3_MOUSE	reviewed	"WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1)"	Wdfy3	Mus musculus (Mouse)	3508	"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0034274; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN13505_c0_g1_i9	Q6VNB8	WDFY3_MOUSE	56.9	51	22	0	56	208	279	329	2.20E-08	59.3	WDFY3_MOUSE	reviewed	"WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1)"	Wdfy3	Mus musculus (Mouse)	3508	"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0034274; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN14945_c0_g2_i1	Q6VNB8	WDFY3_MOUSE	53.7	300	133	2	1358	474	427	725	1.30E-79	298.5	WDFY3_MOUSE	reviewed	"WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1)"	Wdfy3	Mus musculus (Mouse)	3508	"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0034274; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN14945_c0_g2_i2	Q6VNB8	WDFY3_MOUSE	53.7	285	126	2	918	79	427	710	3.70E-75	283.1	WDFY3_MOUSE	reviewed	"WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1)"	Wdfy3	Mus musculus (Mouse)	3508	"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0034274; GO:0035973; GO:0043204; GO:0046872; GO:0097635	aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN36071_c0_g1_i1	E9Q2M9	WDFY4_MOUSE	100	70	0	0	39	248	2709	2778	3.70E-38	158.3	WDFY4_MOUSE	reviewed	WD repeat- and FYVE domain-containing protein 4	Wdfy4	Mus musculus (Mouse)	3183	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]		GO:0005769; GO:0005783; GO:0006914; GO:0019882; GO:0036037; GO:0098586	"antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11273_c0_g1_i1	P59328	WDHD1_MOUSE	40.7	172	99	2	578	66	134	303	3.20E-34	146.7	WDHD1_MOUSE	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	Wdhd1 And1	Mus musculus (Mouse)	1117	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]"	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000278; GO:0000775; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0006261; GO:0006281; GO:0006396; GO:0006974; GO:0031298; GO:0033044; GO:0043596; GO:0070063; GO:0070829	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN11273_c0_g1_i2	P59328	WDHD1_MOUSE	41.3	172	98	2	578	66	134	303	3.20E-34	146.7	WDHD1_MOUSE	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	Wdhd1 And1	Mus musculus (Mouse)	1117	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]"	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000278; GO:0000775; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0006261; GO:0006281; GO:0006396; GO:0006974; GO:0031298; GO:0033044; GO:0043596; GO:0070063; GO:0070829	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN11273_c0_g1_i4	P59328	WDHD1_MOUSE	39.6	202	120	2	729	130	17	218	1.80E-40	167.5	WDHD1_MOUSE	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	Wdhd1 And1	Mus musculus (Mouse)	1117	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]"	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000278; GO:0000775; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0006261; GO:0006281; GO:0006396; GO:0006974; GO:0031298; GO:0033044; GO:0043596; GO:0070063; GO:0070829	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN11273_c0_g1_i5	P59328	WDHD1_MOUSE	36.7	289	179	3	926	66	17	303	3.30E-55	216.9	WDHD1_MOUSE	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	Wdhd1 And1	Mus musculus (Mouse)	1117	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]"	"chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000278; GO:0000775; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0006261; GO:0006281; GO:0006396; GO:0006974; GO:0031298; GO:0033044; GO:0043596; GO:0070063; GO:0070829	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i1	O75717	WDHD1_HUMAN	42.9	63	36	0	687	499	448	510	7.20E-09	63.2	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i1	O75717	WDHD1_HUMAN	42.9	63	36	0	977	789	448	510	9.40E-09	62.8	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i1	O75717	WDHD1_HUMAN	39.7	63	35	1	181	2	463	525	3.70E-05	50.8	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i10	O75717	WDHD1_HUMAN	40.3	62	36	1	389	207	449	510	1.70E-05	50.8	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i11	O75717	WDHD1_HUMAN	46.2	93	50	0	606	328	418	510	9.90E-18	92	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i11	O75717	WDHD1_HUMAN	38.5	78	45	1	226	2	448	525	1.00E-09	65.5	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i6	O75717	WDHD1_HUMAN	38.5	78	45	1	226	2	448	525	1.20E-09	65.5	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i6	O75717	WDHD1_HUMAN	42.9	63	36	0	516	328	448	510	6.10E-09	63.2	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i6	O75717	WDHD1_HUMAN	42.9	63	36	0	806	618	448	510	8.00E-09	62.8	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i9	O75717	WDHD1_HUMAN	46.8	94	50	0	474	193	418	511	1.00E-18	94.7	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN7101_c0_g1_i9	O75717	WDHD1_HUMAN	39.7	63	35	1	181	2	463	525	1.30E-05	51.2	WDHD1_HUMAN	reviewed	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	WDHD1 AND1	Homo sapiens (Human)	1129	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006974; GO:0031298; GO:0043596	cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]		NA	NA	NA	NA	NA	NA
TRINITY_DN28709_c0_g1_i1	Q5MNZ9	WIPI1_HUMAN	100	82	0	0	3	248	73	154	3.60E-41	168.3	WIPI1_HUMAN	reviewed	WD repeat domain phosphoinositide-interacting protein 1 (WIPI-1) (Atg18 protein homolog) (WD40 repeat protein interacting with phosphoinositides of 49 kDa) (WIPI 49 kDa)	WIPI1 WIPI49	Homo sapiens (Human)	446	"autophagosome membrane [GO:0000421]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; trans-Golgi network [GO:0005802]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; signaling receptor binding [GO:0005102]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; IRE1-mediated unfolded protein response [GO:0036498]; macroautophagy [GO:0016236]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; vesicle targeting, trans-Golgi to endosome [GO:0048203]"	autophagosome membrane [GO:0000421]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; trans-Golgi network [GO:0005802]	"androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; signaling receptor binding [GO:0005102]"	GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000422; GO:0005102; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0006497; GO:0006914; GO:0009267; GO:0010008; GO:0016236; GO:0019898; GO:0030136; GO:0030331; GO:0032266; GO:0034045; GO:0034497; GO:0036498; GO:0044804; GO:0048203; GO:0050681; GO:0080025	"autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; IRE1-mediated unfolded protein response [GO:0036498]; macroautophagy [GO:0016236]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; vesicle targeting, trans-Golgi to endosome [GO:0048203]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36985_c0_g1_i1	Q80W47	WIPI2_MOUSE	100	93	0	0	281	3	129	221	2.90E-47	188.7	WIPI2_MOUSE	reviewed	WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2)	Wipi2	Mus musculus (Mouse)	445	"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]"	autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]"	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0010314; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0044804; GO:0061739; GO:0080025; GO:0098792	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]		NA	NA	NA	NA	NA	NA
TRINITY_DN7230_c0_g1_i1	Q6AY57	WIPI2_RAT	71.1	242	65	3	174	893	1	239	1.30E-91	337.8	WIPI2_RAT	reviewed	WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2)	Wipi2	Rattus norvegicus (Rat)	445	"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]"	autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]"	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0010314; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0044804; GO:0061739; GO:0080025; GO:0098792	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]		NA	NA	NA	NA	NA	NA
TRINITY_DN1849_c0_g1_i1	Q7ZWU5	WIPI2_XENLA	59.1	115	44	2	3	347	249	360	1.60E-32	140.2	WIPI2_XENLA	reviewed	WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2)	wipi2	Xenopus laevis (African clawed frog)	435	"cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"	GO:0000045; GO:0005829; GO:0009267; GO:0032266; GO:0034045; GO:0034497; GO:0080025	autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN29973_c0_g1_i1	Q5ZHN3	WIPI2_CHICK	100	124	0	0	3	374	111	234	2.90E-66	252.3	WIPI2_CHICK	reviewed	WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2)	WIPI2 RCJMB04_35d18	Gallus gallus (Chicken)	436	"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]"	autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"	GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0044804; GO:0061739; GO:0080025; GO:0098792	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]		NA	NA	NA	NA	NA	NA
TRINITY_DN3953_c0_g1_i1	Q640T2	WIPI3_XENTR	78.7	127	27	0	433	53	1	127	9.00E-58	224.6	WIPI3_XENTR	reviewed	WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B)	wdr45b wdr45l wipi3 TGas091f07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	344	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"	GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN3953_c0_g1_i2	Q640T2	WIPI3_XENTR	77.3	344	77	1	1150	119	1	343	3.00E-160	566.2	WIPI3_XENTR	reviewed	WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B)	wdr45b wdr45l wipi3 TGas091f07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	344	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]"	GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN22970_c0_g1_i1	Q5MNZ6	WIPI3_HUMAN	100	101	0	0	3	305	3	103	1.20E-57	223.4	WIPI3_HUMAN	reviewed	WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B) (WIPI49-like protein)	WDR45B WDR45L WIPI3	Homo sapiens (Human)	344	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]"	GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0062078; GO:0080025	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN36339_c0_g1_i1	Q5MNZ6	WIPI3_HUMAN	99	102	1	0	1	306	243	344	6.40E-55	214.5	WIPI3_HUMAN	reviewed	WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B) (WIPI49-like protein)	WDR45B WDR45L WIPI3	Homo sapiens (Human)	344	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]"	GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0062078; GO:0080025	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN40517_c0_g1_i1	Q5MNZ6	WIPI3_HUMAN	100	146	0	0	3	440	100	245	3.10E-80	298.9	WIPI3_HUMAN	reviewed	WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B) (WIPI49-like protein)	WDR45B WDR45L WIPI3	Homo sapiens (Human)	344	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]"	GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0062078; GO:0080025	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN17137_c1_g1_i1	Q91VM3	WIPI4_MOUSE	100	72	0	0	2	217	177	248	5.70E-35	147.5	WIPI4_MOUSE	reviewed	WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat domain X-linked 1) (WD repeat-containing protein 45)	Wdr45 DXImx38e Wdrx1 Wipi4	Mus musculus (Mouse)	360	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]; protein kinase binding [GO:0019901]"	GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN34418_c0_g1_i1	Q91VM3	WIPI4_MOUSE	98.2	113	2	0	339	1	30	142	2.60E-58	225.7	WIPI4_MOUSE	reviewed	WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat domain X-linked 1) (WD repeat-containing protein 45)	Wdr45 DXImx38e Wdrx1 Wipi4	Mus musculus (Mouse)	360	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]; protein kinase binding [GO:0019901]"	GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN9534_c0_g1_i2	Q91VM3	WIPI4_MOUSE	59.9	354	125	4	1109	93	9	360	3.90E-120	433	WIPI4_MOUSE	reviewed	WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat domain X-linked 1) (WD repeat-containing protein 45)	Wdr45 DXImx38e Wdrx1 Wipi4	Mus musculus (Mouse)	360	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]; protein kinase binding [GO:0019901]"	GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN17137_c0_g1_i1	Q9Y484	WIPI4_HUMAN	100	118	0	0	355	2	191	308	1.80E-62	239.6	WIPI4_HUMAN	reviewed	WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45)	WDR45 WDRX1 WDRXI4 WIPI4 JM5	Homo sapiens (Human)	360	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol phosphate binding [GO:1901981]; protein kinase binding [GO:0019901]"	GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]		NA	NA	NA	NA	NA	NA
TRINITY_DN9113_c1_g1_i1	Q6DH44	WDR83_DANRE	58.7	300	123	1	117	1016	14	312	4.90E-101	369.4	WDR83_DANRE	reviewed	WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1)	wdr83 morg1 zgc:92654	Danio rerio (Zebrafish) (Brachydanio rerio)	315	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737			NA	NA	NA	NA	NA	NA
TRINITY_DN31940_c0_g1_i1	Q9BRX9	WDR83_HUMAN	50	58	29	0	195	22	217	274	2.20E-09	62.4	WDR83_HUMAN	reviewed	WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1)	WDR83 MORG1	Homo sapiens (Human)	315	"catalytic step 2 spliceosome [GO:0071013]; endosome membrane [GO:0010008]; spliceosomal complex [GO:0005681]; inflammatory response to wounding [GO:0090594]; interleukin-6 production [GO:0032635]; MAPK cascade [GO:0000165]; mRNA splicing, via spliceosome [GO:0000398]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; RNA splicing, via transesterification reactions [GO:0000375]; tumor necrosis factor production [GO:0032640]"	catalytic step 2 spliceosome [GO:0071013]; endosome membrane [GO:0010008]; spliceosomal complex [GO:0005681]		GO:0000165; GO:0000375; GO:0000398; GO:0001666; GO:0005681; GO:0010008; GO:0032496; GO:0032635; GO:0032640; GO:0043122; GO:0071013; GO:0090594	"inflammatory response to wounding [GO:0090594]; interleukin-6 production [GO:0032635]; MAPK cascade [GO:0000165]; mRNA splicing, via spliceosome [GO:0000398]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; RNA splicing, via transesterification reactions [GO:0000375]; tumor necrosis factor production [GO:0032640]"		red	red	NA	NA	NA	NA
TRINITY_DN27405_c0_g1_i1	Q9DAJ4	WDR83_MOUSE	100	117	0	0	1	351	179	295	1.10E-64	246.9	WDR83_MOUSE	reviewed	WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1)	Wdr83 Morg1	Mus musculus (Mouse)	315	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; inflammatory response to wounding [GO:0090594]; interleukin-6 production [GO:0032635]; mRNA splicing, via spliceosome [GO:0000398]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; RNA splicing, via transesterification reactions [GO:0000375]; tumor necrosis factor production [GO:0032640]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]		GO:0000375; GO:0000398; GO:0001666; GO:0005634; GO:0005681; GO:0005737; GO:0009611; GO:0032496; GO:0032635; GO:0032640; GO:0043122; GO:0071013; GO:0090594	"inflammatory response to wounding [GO:0090594]; interleukin-6 production [GO:0032635]; mRNA splicing, via spliceosome [GO:0000398]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; RNA splicing, via transesterification reactions [GO:0000375]; tumor necrosis factor production [GO:0032640]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3814_c0_g1_i1	Q5FVN8	WSDU1_RAT	41	317	169	7	1146	202	11	311	2.60E-54	214.2	WSDU1_RAT	reviewed	"WD repeat, SAM and U-box domain-containing protein 1"	Wdsub1	Rattus norvegicus (Rat)	476	ubiquitin-protein transferase activity [GO:0004842]		ubiquitin-protein transferase activity [GO:0004842]	GO:0004842			NA	NA	NA	NA	NA	NA
TRINITY_DN3814_c0_g1_i2	A0AUS0	WSDU1_DANRE	40.7	226	119	4	758	81	272	482	4.20E-38	159.8	WSDU1_DANRE	reviewed	"WD repeat, SAM and U-box domain-containing protein 1"	wdsub1 zgc:154085	Danio rerio (Zebrafish) (Brachydanio rerio)	487	ubiquitin-protein transferase activity [GO:0004842]		ubiquitin-protein transferase activity [GO:0004842]	GO:0004842			NA	NA	NA	NA	NA	NA
TRINITY_DN3814_c0_g1_i3	Q5FVN8	WSDU1_RAT	40.3	506	256	10	1583	72	11	472	4.50E-89	330.1	WSDU1_RAT	reviewed	"WD repeat, SAM and U-box domain-containing protein 1"	Wdsub1	Rattus norvegicus (Rat)	476	ubiquitin-protein transferase activity [GO:0004842]		ubiquitin-protein transferase activity [GO:0004842]	GO:0004842			NA	NA	NA	NA	NA	NA
TRINITY_DN3814_c0_g1_i5	Q5FVN8	WSDU1_RAT	39.9	243	121	5	746	72	237	472	1.20E-36	154.8	WSDU1_RAT	reviewed	"WD repeat, SAM and U-box domain-containing protein 1"	Wdsub1	Rattus norvegicus (Rat)	476	ubiquitin-protein transferase activity [GO:0004842]		ubiquitin-protein transferase activity [GO:0004842]	GO:0004842			NA	NA	NA	NA	NA	NA
TRINITY_DN17852_c0_g1_i1	Q9VQ36	FRITZ_DROME	38.1	63	39	0	257	69	77	139	1.10E-07	57.4	FRITZ_DROME	reviewed	WD repeat-containing and planar cell polarity effector protein fritz	frtz CG17657	Drosophila melanogaster (Fruit fly)	951	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; establishment of protein localization [GO:0045184]; imaginal disc-derived wing hair site selection [GO:0035320]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]		GO:0005737; GO:0005856; GO:0005886; GO:0005929; GO:0035320; GO:0045184	establishment of protein localization [GO:0045184]; imaginal disc-derived wing hair site selection [GO:0035320]		NA	NA	NA	NA	NA	NA
TRINITY_DN17852_c0_g1_i3	Q9VQ36	FRITZ_DROME	37.1	593	340	11	1829	123	2	585	7.30E-102	372.9	FRITZ_DROME	reviewed	WD repeat-containing and planar cell polarity effector protein fritz	frtz CG17657	Drosophila melanogaster (Fruit fly)	951	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; establishment of protein localization [GO:0045184]; imaginal disc-derived wing hair site selection [GO:0035320]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]		GO:0005737; GO:0005856; GO:0005886; GO:0005929; GO:0035320; GO:0045184	establishment of protein localization [GO:0045184]; imaginal disc-derived wing hair site selection [GO:0035320]		NA	NA	NA	NA	NA	NA
TRINITY_DN26959_c0_g1_i1	O88342	WDR1_MOUSE	100	70	0	0	212	3	515	584	9.10E-38	156.8	WDR1_MOUSE	reviewed	WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1)	Wdr1	Mus musculus (Mouse)	606	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; podosome [GO:0002102]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0002102; GO:0002446; GO:0003779; GO:0005884; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0015629; GO:0030036; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043209; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:1990266	actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]		NA	NA	NA	NA	NA	NA
TRINITY_DN8689_c0_g1_i1	Q8K1X1	WDR11_MOUSE	35.9	415	229	6	1577	348	766	1148	5.40E-66	253.4	WDR11_MOUSE	reviewed	WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2)	Wdr11 Brwd2 Kiaa1351	Mus musculus (Mouse)	1223	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]		GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041	cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]		NA	NA	NA	NA	NA	NA
TRINITY_DN26821_c0_g1_i1	Q91V09	WDR13_MOUSE	100	71	0	0	1	213	291	361	5.30E-33	141	WDR13_MOUSE	reviewed	WD repeat-containing protein 13	Wdr13	Mus musculus (Mouse)	485	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691]	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	promoter-specific chromatin binding [GO:1990841]	GO:0005654; GO:0005886; GO:0034451; GO:1904691; GO:1990841	negative regulation of type B pancreatic cell proliferation [GO:1904691]		NA	NA	NA	NA	NA	NA
TRINITY_DN23747_c0_g1_i1	Q9H1Z4	WDR13_HUMAN	96.9	64	2	0	193	2	174	237	1.80E-29	129.4	WDR13_HUMAN	reviewed	WD repeat-containing protein 13	WDR13	Homo sapiens (Human)	485	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691]	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	promoter-specific chromatin binding [GO:1990841]	GO:0005654; GO:0005886; GO:0034451; GO:1904691; GO:1990841	negative regulation of type B pancreatic cell proliferation [GO:1904691]		NA	NA	NA	NA	NA	NA
TRINITY_DN23747_c0_g1_i2	Q9H1Z4	WDR13_HUMAN	100	76	0	0	229	2	162	237	1.40E-39	162.9	WDR13_HUMAN	reviewed	WD repeat-containing protein 13	WDR13	Homo sapiens (Human)	485	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691]	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	promoter-specific chromatin binding [GO:1990841]	GO:0005654; GO:0005886; GO:0034451; GO:1904691; GO:1990841	negative regulation of type B pancreatic cell proliferation [GO:1904691]		NA	NA	NA	NA	NA	NA
TRINITY_DN6417_c0_g1_i1	Q91V09	WDR13_MOUSE	51.8	481	218	4	1489	89	3	483	1.10E-132	474.9	WDR13_MOUSE	reviewed	WD repeat-containing protein 13	Wdr13	Mus musculus (Mouse)	485	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691]	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	promoter-specific chromatin binding [GO:1990841]	GO:0005654; GO:0005886; GO:0034451; GO:1904691; GO:1990841	negative regulation of type B pancreatic cell proliferation [GO:1904691]		NA	NA	NA	NA	NA	NA
TRINITY_DN37265_c0_g1_i1	Q9H1Z4	WDR13_HUMAN	100	91	0	0	273	1	361	451	1.30E-47	189.9	WDR13_HUMAN	reviewed	WD repeat-containing protein 13	WDR13	Homo sapiens (Human)	485	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691]	centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	promoter-specific chromatin binding [GO:1990841]	GO:0005654; GO:0005886; GO:0034451; GO:1904691; GO:1990841	negative regulation of type B pancreatic cell proliferation [GO:1904691]		NA	NA	NA	NA	NA	NA
TRINITY_DN2243_c0_g2_i1	Q8IZU2	WDR17_HUMAN	37.5	312	180	6	894	4	110	421	6.80E-58	225.7	WDR17_HUMAN	reviewed	WD repeat-containing protein 17	WDR17	Homo sapiens (Human)	1322							NA	NA	NA	NA	NA	NA
TRINITY_DN39130_c0_g1_i1	Q9D5R2	WDR20_MOUSE	38.6	207	105	7	734	153	364	561	9.80E-26	118.6	WDR20_MOUSE	reviewed	WD repeat-containing protein 20	Wdr20 Wdr20b Wdr20rt	Mus musculus (Mouse)	567							NA	NA	NA	NA	NA	NA
TRINITY_DN26601_c0_g1_i1	Q8TBZ3	WDR20_HUMAN	65.8	114	37	2	27	368	64	175	8.40E-39	161	WDR20_HUMAN	reviewed	WD repeat-containing protein 20 (Protein DMR)	WDR20	Homo sapiens (Human)	569	nucleoplasm [GO:0005654]; protein deubiquitination [GO:0016579]	nucleoplasm [GO:0005654]		GO:0005654; GO:0016579	protein deubiquitination [GO:0016579]		blue	blue	NA	NA	NA	NA
TRINITY_DN16068_c1_g1_i4	Q28D01	WDR26_XENTR	52.9	401	162	2	3	1130	99	497	6.10E-120	432.2	WDR26_XENTR	reviewed	WD repeat-containing protein 26	wdr26 TGas059a07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	614	mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005739			NA	NA	NA	NA	NA	NA
TRINITY_DN16068_c1_g1_i7	F1LTR1	WDR26_RAT	62.4	149	56	0	59	505	249	397	4.90E-53	208.8	WDR26_RAT	reviewed	WD repeat-containing protein 26	Wdr26	Rattus norvegicus (Rat)	514	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]		GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829			NA	NA	NA	NA	NA	NA
TRINITY_DN2553_c0_g1_i3	Q9UNX4	WDR3_HUMAN	39.2	961	530	16	205	3021	1	929	5.10E-185	649.8	WDR3_HUMAN	reviewed	WD repeat-containing protein 3	WDR3	Homo sapiens (Human)	943	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388	maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2553_c0_g1_i4	Q9UNX4	WDR3_HUMAN	39.2	926	510	15	7	2721	36	929	9.40E-178	625.5	WDR3_HUMAN	reviewed	WD repeat-containing protein 3	WDR3	Homo sapiens (Human)	943	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388	maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN2553_c0_g1_i6	Q9UNX4	WDR3_HUMAN	45	140	70	1	88	507	105	237	3.40E-35	149.8	WDR3_HUMAN	reviewed	WD repeat-containing protein 3	WDR3	Homo sapiens (Human)	943	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388	maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN40483_c0_g1_i1	Q9UNX4	WDR3_HUMAN	100	89	0	0	268	2	634	722	1.40E-46	186.4	WDR3_HUMAN	reviewed	WD repeat-containing protein 3	WDR3	Homo sapiens (Human)	943	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388	maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN15030_c0_g1_i1	Q8BND3	WDR35_MOUSE	52.6	171	68	2	32	529	881	1043	1.10E-43	177.9	WDR35_MOUSE	reviewed	WD repeat-containing protein 35	Wdr35	Mus musculus (Mouse)	1181	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN15030_c0_g1_i2	Q8BND3	WDR35_MOUSE	49.8	289	120	3	32	883	881	1149	4.70E-75	282.7	WDR35_MOUSE	reviewed	WD repeat-containing protein 35	Wdr35	Mus musculus (Mouse)	1181	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN21306_c0_g1_i1	Q8BND3	WDR35_MOUSE	52.8	72	34	0	50	265	1022	1093	4.30E-16	85.1	WDR35_MOUSE	reviewed	WD repeat-containing protein 35	Wdr35	Mus musculus (Mouse)	1181	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN15038_c0_g1_i1	Q9P2L0	WDR35_HUMAN	68.3	164	49	1	490	8	1	164	2.00E-62	240	WDR35_HUMAN	reviewed	WD repeat-containing protein 35 (Intraflagellar transport protein 121 homolog)	WDR35 IFT121 KIAA1336	Homo sapiens (Human)	1181	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]		GO:0005813; GO:0005929; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0035735; GO:0036064; GO:0042073; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097542; GO:0097756; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN15030_c0_g1_i5	A6N6J5	WDR35_RAT	62.2	828	303	5	21	2477	1	827	0	1121.7	WDR35_RAT	reviewed	WD repeat-containing protein 35 (Naofen)	Wdr35	Rattus norvegicus (Rat)	1170	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN15030_c0_g1_i6	A6N6J5	WDR35_RAT	59	1111	427	6	100	3408	49	1138	0	1386.7	WDR35_RAT	reviewed	WD repeat-containing protein 35 (Naofen)	Wdr35	Rattus norvegicus (Rat)	1170	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN15030_c0_g1_i7	A6N6J5	WDR35_RAT	59.4	1159	441	7	21	3470	1	1138	0	1459.1	WDR35_RAT	reviewed	WD repeat-containing protein 35 (Naofen)	Wdr35	Rattus norvegicus (Rat)	1170	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN30861_c0_g1_i1	A6N6J5	WDR35_RAT	48.7	113	52	1	327	7	533	645	1.10E-29	130.6	WDR35_RAT	reviewed	WD repeat-containing protein 35 (Naofen)	Wdr35	Rattus norvegicus (Rat)	1170	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN30692_c0_g1_i1	A6N6J5	WDR35_RAT	58.4	77	31	1	232	2	302	377	2.00E-22	105.9	WDR35_RAT	reviewed	WD repeat-containing protein 35 (Naofen)	Wdr35	Rattus norvegicus (Rat)	1170	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN34617_c0_g1_i1	A6N6J5	WDR35_RAT	53.2	158	71	2	14	481	649	805	9.90E-43	174.5	WDR35_RAT	reviewed	WD repeat-containing protein 35 (Naofen)	Wdr35	Rattus norvegicus (Rat)	1170	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]		GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]		NA	NA	NA	NA	NA	NA
TRINITY_DN409_c0_g1_i2	Q6DDF0	WDR37_XENLA	51.7	487	207	10	1535	120	14	487	8.00E-129	462.2	WDR37_XENLA	reviewed	WD repeat-containing protein 37	wdr37	Xenopus laevis (African clawed frog)	495	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737			blue	blue	NA	NA	NA	NA
TRINITY_DN1338_c0_g1_i1	Q9XSC3	WDR44_BOVIN	54.8	602	230	7	1528	3297	338	909	6.10E-184	646.4	WDR44_BOVIN	reviewed	WD repeat-containing protein 44 (Rab11-binding protein) (Rabphilin-11)	WDR44 RAB11BP	Bos taurus (Bovine)	912	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471			blue	blue	NA	NA	NA	NA
TRINITY_DN1338_c0_g1_i2	Q9XSC3	WDR44_BOVIN	56.3	586	230	6	1528	3249	338	909	7.60E-187	656	WDR44_BOVIN	reviewed	WD repeat-containing protein 44 (Rab11-binding protein) (Rabphilin-11)	WDR44 RAB11BP	Bos taurus (Bovine)	912	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN1338_c0_g1_i3	Q9XSC3	WDR44_BOVIN	59.7	62	25	0	1528	1713	338	399	2.50E-11	72	WDR44_BOVIN	reviewed	WD repeat-containing protein 44 (Rab11-binding protein) (Rabphilin-11)	WDR44 RAB11BP	Bos taurus (Bovine)	912	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN1338_c0_g1_i4	Q9XSC3	WDR44_BOVIN	46.8	79	25	1	1528	1764	338	399	2.70E-08	62	WDR44_BOVIN	reviewed	WD repeat-containing protein 44 (Rab11-binding protein) (Rabphilin-11)	WDR44 RAB11BP	Bos taurus (Bovine)	912	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN40452_c0_g1_i1	Q5JSH3	WDR44_HUMAN	100	82	0	0	248	3	777	858	2.80E-41	168.7	WDR44_HUMAN	reviewed	WD repeat-containing protein 44 (Rabphilin-11)	WDR44	Homo sapiens (Human)	913	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	Rab GTPase binding [GO:0017137]	GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471			NA	NA	NA	NA	NA	NA
TRINITY_DN27593_c0_g1_i2	Q5TJE7	WDR46_CANLF	42.6	54	31	0	38	199	374	427	1.40E-06	53.5	WDR46_CANLF	reviewed	WD repeat-containing protein 46	WDR46 C12H6orf11	Canis lupus familiaris (Dog) (Canis familiaris)	612	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27593_c0_g1_i1	Q9Z0H1	WDR46_MOUSE	53.2	109	51	0	13	339	317	425	3.40E-28	125.9	WDR46_MOUSE	reviewed	WD repeat-containing protein 46 (WD repeat-containing protein BING4)	Wdr46 Bing4	Mus musculus (Mouse)	622	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22224_c0_g1_i1	O15213	WDR46_HUMAN	100	69	0	0	210	4	342	410	4.20E-35	147.9	WDR46_HUMAN	reviewed	WD repeat-containing protein 46 (WD repeat-containing protein BING4)	WDR46 BING4 C6orf11 FP221	Homo sapiens (Human)	610	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22224_c0_g1_i2	Q9Z0H1	WDR46_MOUSE	98.7	77	1	0	232	2	341	417	3.50E-38	158.3	WDR46_MOUSE	reviewed	WD repeat-containing protein 46 (WD repeat-containing protein BING4)	Wdr46 Bing4	Mus musculus (Mouse)	622	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11528_c0_g1_i1	Q9Z0H1	WDR46_MOUSE	53.3	75	35	0	70	294	151	225	8.60E-18	90.9	WDR46_MOUSE	reviewed	WD repeat-containing protein 46 (WD repeat-containing protein BING4)	Wdr46 Bing4	Mus musculus (Mouse)	622	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11528_c0_g1_i2	Q9Z0H1	WDR46_MOUSE	52	98	47	0	1	294	128	225	4.90E-21	101.7	WDR46_MOUSE	reviewed	WD repeat-containing protein 46 (WD repeat-containing protein BING4)	Wdr46 Bing4	Mus musculus (Mouse)	622	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		GO:0000462; GO:0005730; GO:0032040	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8896_c0_g1_i2	Q8CGF6	WDR47_MOUSE	54	235	108	0	12	716	559	793	2.80E-73	276.6	WDR47_MOUSE	reviewed	WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin)	Wdr47 Kiaa0893	Mus musculus (Mouse)	920	cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; microtubule [GO:0005874]		GO:0005737; GO:0005874; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8896_c0_g1_i4	Q8CGF6	WDR47_MOUSE	50	142	71	0	12	437	559	700	7.20E-36	151.8	WDR47_MOUSE	reviewed	WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin)	Wdr47 Kiaa0893	Mus musculus (Mouse)	920	cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; microtubule [GO:0005874]		GO:0005737; GO:0005874; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8896_c0_g1_i1	O94967	WDR47_HUMAN	60.6	94	37	0	47	328	699	792	1.40E-30	133.7	WDR47_HUMAN	reviewed	WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin)	WDR47 KIAA0893	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; microtubule [GO:0005874]		GO:0005737; GO:0005874; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN8896_c0_g1_i5	O94967	WDR47_HUMAN	55.2	58	26	0	47	220	699	756	2.80E-14	79.3	WDR47_HUMAN	reviewed	WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin)	WDR47 KIAA0893	Homo sapiens (Human)	919	cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; microtubule [GO:0005874]		GO:0005737; GO:0005874; GO:0007275	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN4863_c0_g1_i1	Q32PG3	WDR48_BOVIN	57.5	285	111	5	1	849	397	673	4.90E-78	292.7	WDR48_BOVIN	reviewed	WD repeat-containing protein 48 (USP1-associated factor 1)	WDR48 UAF1	Bos taurus (Bovine)	677	late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; protein deubiquitination [GO:0016579]	late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]		GO:0005634; GO:0005764; GO:0005770; GO:0016579	protein deubiquitination [GO:0016579]		blue	blue	NA	NA	NA	NA
TRINITY_DN4863_c0_g1_i2	Q32PG3	WDR48_BOVIN	57.1	289	110	6	1	861	397	673	1.20E-76	288.1	WDR48_BOVIN	reviewed	WD repeat-containing protein 48 (USP1-associated factor 1)	WDR48 UAF1	Bos taurus (Bovine)	677	late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; protein deubiquitination [GO:0016579]	late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]		GO:0005634; GO:0005764; GO:0005770; GO:0016579	protein deubiquitination [GO:0016579]		NA	NA	NA	NA	NA	NA
TRINITY_DN25746_c0_g1_i1	Q2KIG2	WDR5_BOVIN	88.4	233	27	0	52	750	20	252	3.90E-123	442.2	WDR5_BOVIN	reviewed	WD repeat-containing protein 5	WDR5	Bos taurus (Bovine)	334	histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; methylated histone binding [GO:0035064]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	methylated histone binding [GO:0035064]	GO:0000123; GO:0005634; GO:0035064; GO:0035097; GO:0043981; GO:0043982; GO:0043984; GO:0048188; GO:0051568; GO:0071339	histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		blue	blue	NA	NA	NA	NA
TRINITY_DN28238_c0_g1_i1	Q2KIG2	WDR5_BOVIN	100	118	0	0	2	355	45	162	3.30E-64	245.4	WDR5_BOVIN	reviewed	WD repeat-containing protein 5	WDR5	Bos taurus (Bovine)	334	histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; methylated histone binding [GO:0035064]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	methylated histone binding [GO:0035064]	GO:0000123; GO:0005634; GO:0035064; GO:0035097; GO:0043981; GO:0043982; GO:0043984; GO:0048188; GO:0051568; GO:0071339	histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]		NA	NA	NA	NA	NA	NA
TRINITY_DN5910_c0_g1_i3	B4JSW8	WDR55_DROGR	39.7	247	149	0	148	888	147	393	4.90E-54	213	WDR55_DROGR	reviewed	WD repeat-containing protein 55 homolog	GH23127	Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi)	503							NA	NA	NA	NA	NA	NA
TRINITY_DN5910_c0_g1_i4	B4PU14	WDR55_DROYA	38.6	352	214	2	148	1200	147	497	1.10E-75	285.4	WDR55_DROYA	reviewed	WD repeat-containing protein 55 homolog	GE24201	Drosophila yakuba (Fruit fly)	499	defense response to Gram-negative bacterium [GO:0050829]			GO:0050829	defense response to Gram-negative bacterium [GO:0050829]		NA	NA	NA	NA	NA	NA
TRINITY_DN32876_c0_g1_i1	Q58D06	WDR74_BOVIN	42.2	334	177	8	1009	35	1	327	3.60E-61	236.9	WDR74_BOVIN	reviewed	WD repeat-containing protein 74	WDR74	Bos taurus (Bovine)	385	"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]"	"nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"		GO:0000176; GO:0001825; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273	blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]		blue	blue	NA	NA	NA	NA
TRINITY_DN8251_c0_g1_i2	Q6DFC6	WDR75_XENLA	29.4	793	500	20	103	2400	9	768	6.00E-78	293.9	WDR75_XENLA	reviewed	WD repeat-containing protein 75	wdr75	Xenopus laevis (African clawed frog)	832	nucleolus [GO:0005730]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]		GO:0005730; GO:0006364	rRNA processing [GO:0006364]		NA	NA	NA	NA	NA	NA
TRINITY_DN5316_c0_g1_i1	Q4KLQ5	WDR76_XENLA	38.3	193	108	6	652	98	389	578	3.00E-25	117.1	WDR76_XENLA	reviewed	WD repeat-containing protein 76	wdr76	Xenopus laevis (African clawed frog)	580	cellular response to DNA damage stimulus [GO:0006974]			GO:0006974	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN5316_c0_g1_i4	Q4KLQ5	WDR76_XENLA	35.1	490	279	15	1525	98	114	578	9.30E-62	239.6	WDR76_XENLA	reviewed	WD repeat-containing protein 76	wdr76	Xenopus laevis (African clawed frog)	580	cellular response to DNA damage stimulus [GO:0006974]			GO:0006974	cellular response to DNA damage stimulus [GO:0006974]		NA	NA	NA	NA	NA	NA
TRINITY_DN4444_c0_g1_i1	Q562E7	WDR81_HUMAN	55.1	147	59	1	420	1	387	533	1.40E-40	168.3	WDR81_HUMAN	reviewed	WD repeat-containing protein 81	WDR81	Homo sapiens (Human)	1941	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010923; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530	aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4444_c0_g1_i4	E7FEV0	WDR81_DANRE	38.6	355	148	5	990	4	229	539	1.80E-57	224.6	WDR81_DANRE	reviewed	WD repeat-containing protein 81	wdr81	Danio rerio (Zebrafish) (Brachydanio rerio)	2065	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022	aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4444_c0_g1_i5	Q562E7	WDR81_HUMAN	55.7	140	55	1	399	1	394	533	2.00E-39	164.5	WDR81_HUMAN	reviewed	WD repeat-containing protein 81	WDR81	Homo sapiens (Human)	1941	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010923; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530	aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN4444_c0_g1_i7	E7FEV0	WDR81_DANRE	37.9	380	166	5	1065	4	204	539	1.70E-60	234.6	WDR81_DANRE	reviewed	WD repeat-containing protein 81	wdr81	Danio rerio (Zebrafish) (Brachydanio rerio)	2065	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022	aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]		NA	NA	NA	NA	NA	NA
TRINITY_DN7131_c0_g1_i2	Q86TI4	WDR86_HUMAN	44.7	141	71	1	426	4	209	342	2.40E-29	129.8	WDR86_HUMAN	reviewed	WD repeat-containing protein 86	WDR86	Homo sapiens (Human)	376							NA	NA	NA	NA	NA	NA
TRINITY_DN26511_c0_g1_i1	Q3ZBK1	WDR89_BOVIN	32	244	144	7	193	885	43	277	3.80E-26	120.6	WDR89_BOVIN	reviewed	WD repeat-containing protein 89	WDR89	Bos taurus (Bovine)	386							NA	NA	NA	NA	NA	NA
TRINITY_DN3899_c0_g1_i1	Q2HJE1	WDR91_BOVIN	36.4	442	250	8	47	1303	5	438	4.70E-66	253.4	WDR91_BOVIN	reviewed	WD repeat-containing protein 91	WDR91	Bos taurus (Bovine)	746	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]	phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022	early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]		NA	NA	NA	NA	NA	NA
TRINITY_DN3899_c0_g1_i2	Q6TEN6	WDR91_DANRE	36.8	745	423	17	41	2206	3	722	5.90E-122	439.9	WDR91_DANRE	reviewed	WD repeat-containing protein 91	wdr91 hspc049l	Danio rerio (Zebrafish) (Brachydanio rerio)	724	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]	phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022	early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]		NA	NA	NA	NA	NA	NA
TRINITY_DN6208_c0_g1_i1	Q5M7F6	WDR92_XENLA	54.2	118	53	1	353	3	52	169	3.20E-35	149.1	WDR92_XENLA	reviewed	WD repeat-containing protein 92	wdr92	Xenopus laevis (African clawed frog)	358	apoptotic process [GO:0006915]			GO:0006915	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN13206_c0_g1_i1	Q8BGF3	WDR92_MOUSE	64.3	350	125	0	97	1146	5	354	6.20E-142	505.4	WDR92_MOUSE	reviewed	WD repeat-containing protein 92 (WD repeat-containing protein Monad)	Wdr92	Mus musculus (Mouse)	357	ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]		ubiquitin binding [GO:0043130]	GO:0006915; GO:0043130	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN3139_c0_g1_i1	P78972	SLP1_SCHPO	51.8	56	26	1	170	6	160	215	3.30E-09	62	SLP1_SCHPO	reviewed	WD repeat-containing protein slp1	slp1 SPAC821.08c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	488	anaphase-promoting complex [GO:0005680]; cell division site [GO:0032153]; mitotic checkpoint complex [GO:0033597]; mitotic spindle [GO:0072686]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of metaphase/anaphase transition of meiosis II [GO:1905191]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]	anaphase-promoting complex [GO:0005680]; cell division site [GO:0032153]; mitotic checkpoint complex [GO:0033597]; mitotic spindle [GO:0072686]; mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005634; GO:0005680; GO:0007049; GO:0010997; GO:0031145; GO:0032153; GO:0033597; GO:0044732; GO:0045842; GO:0051301; GO:0072686; GO:1905188; GO:1905191; GO:1905786; GO:1990757	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of metaphase/anaphase transition of meiosis II [GO:1905191]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]		NA	NA	NA	NA	NA	NA
TRINITY_DN5971_c0_g1_i7	Q9P2S5	WRP73_HUMAN	52.5	177	79	2	591	61	1	172	2.10E-51	203.8	WRP73_HUMAN	reviewed	WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene)	WRAP73 WDR8	Homo sapiens (Human)	460	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]; cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]		GO:0000070; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0036064; GO:0072686; GO:0090307; GO:1902440; GO:1902857; GO:1990811	cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]		brown	brown	1	NA	NA	NA
TRINITY_DN5971_c0_g1_i1	Q9P2S5	WRP73_HUMAN	51.2	121	54	2	407	45	1	116	3.90E-31	136	WRP73_HUMAN	reviewed	WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene)	WRAP73 WDR8	Homo sapiens (Human)	460	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]; cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]		GO:0000070; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0036064; GO:0072686; GO:0090307; GO:1902440; GO:1902857; GO:1990811	cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]		brown	brown	NA	NA	NA	NA
TRINITY_DN5971_c0_g1_i3	Q9P2S5	WRP73_HUMAN	52.5	177	79	2	1089	559	1	172	3.60E-51	203.8	WRP73_HUMAN	reviewed	WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene)	WRAP73 WDR8	Homo sapiens (Human)	460	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]; cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]		GO:0000070; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0036064; GO:0072686; GO:0090307; GO:1902440; GO:1902857; GO:1990811	cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]		NA	NA	NA	NA	NA	NA
TRINITY_DN5971_c0_g1_i6	Q9P2S5	WRP73_HUMAN	52.5	177	79	2	1089	559	1	172	3.50E-51	203.8	WRP73_HUMAN	reviewed	WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene)	WRAP73 WDR8	Homo sapiens (Human)	460	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]; cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]		GO:0000070; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0036064; GO:0072686; GO:0090307; GO:1902440; GO:1902857; GO:1990811	cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440]		NA	NA	NA	NA	NA	NA
TRINITY_DN2096_c0_g1_i1	Q5ZME8	SMU1_CHICK	78	513	113	0	64	1602	1	513	7.40E-239	827.8	SMU1_CHICK	reviewed	WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)	SMU1 RCJMB04_2e22	Gallus gallus (Chicken)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9109_c0_g1_i1	Q6NRT3	SMU1_XENLA	56.7	67	29	0	2	202	14	80	3.00E-17	88.6	SMU1_XENLA	reviewed	WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)	smu1	Xenopus laevis (African clawed frog)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0016607; GO:0071005	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9296_c0_g1_i1	Q2TBS9	SMU1_BOVIN	100	244	0	0	6	737	1	244	1.10E-133	477.2	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9296_c0_g1_i2	Q2TBS9	SMU1_BOVIN	100	218	0	0	6	659	1	218	4.00E-116	418.7	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9296_c0_g1_i3	Q2TBS9	SMU1_BOVIN	100	90	0	0	6	275	1	90	8.90E-41	167.2	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19058_c0_g1_i1	Q2TBS9	SMU1_BOVIN	98.2	218	4	0	657	4	228	445	2.40E-121	436	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19058_c0_g1_i2	Q2TBS9	SMU1_BOVIN	98.2	218	4	0	657	4	228	445	2.40E-121	436	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15984_c0_g1_i1	Q2TBS9	SMU1_BOVIN	100	99	0	0	327	31	415	513	3.40E-55	215.3	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15984_c0_g2_i1	Q2TBS9	SMU1_BOVIN	100	99	0	0	331	35	415	513	2.00E-55	216.1	SMU1_BOVIN	reviewed	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	SMU1	Bos taurus (Bovine)	513	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5858_c0_g1_i1	P54350	WEE1_DROME	46.2	535	257	9	193	1740	38	560	2.80E-112	407.5	WEE1_DROME	reviewed	Wee1-like protein kinase (Dwee1) (EC 2.7.10.2)	Wee1 wee CG4488	Drosophila melanogaster (Fruit fly)	609	nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]	nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]	GO:0000287; GO:0001700; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0006468; GO:0007093; GO:0018108; GO:0045736; GO:0051225; GO:0051299; GO:0051301; GO:0051642	cell division [GO:0051301]; centrosome localization [GO:0051642]; centrosome separation [GO:0051299]; embryonic development via the syncytial blastoderm [GO:0001700]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]; spindle assembly [GO:0051225]		NA	NA	NA	NA	NA	NA
TRINITY_DN31974_c0_g1_i1	P30291	WEE1_HUMAN	100	73	0	0	220	2	455	527	1.30E-37	156.4	WEE1_HUMAN	reviewed	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	Homo sapiens (Human)	646	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]	GO:0000086; GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007093; GO:0016301; GO:0030010; GO:0048812; GO:0051301; GO:2000134	cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN29560_c0_g1_i1	P30291	WEE1_HUMAN	100	81	0	0	245	3	342	422	6.10E-41	167.5	WEE1_HUMAN	reviewed	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	Homo sapiens (Human)	646	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]	GO:0000086; GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007093; GO:0016301; GO:0030010; GO:0048812; GO:0051301; GO:2000134	cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]		NA	NA	NA	NA	NA	NA
TRINITY_DN36199_c0_g1_i1	O93530	WRN_XENLA	58.7	75	29	1	235	17	590	664	2.40E-18	92.4	WRN_XENLA	reviewed	Werner syndrome ATP-dependent helicase homolog (EC 3.6.4.12) (Exonuclease WRN) (EC 3.1.-.-) (Focus-forming activity 1) (FFA-1)	wrn ffa1	Xenopus laevis (African clawed frog)	1436	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]	GO:0000287; GO:0003677; GO:0005524; GO:0005654; GO:0005730; GO:0006259; GO:0006260; GO:0006281; GO:0006310; GO:0008408; GO:0030145; GO:0043138	DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN38558_c0_g1_i1	O93530	WRN_XENLA	38.8	744	408	15	3088	887	470	1176	3.10E-140	501.1	WRN_XENLA	reviewed	Werner syndrome ATP-dependent helicase homolog (EC 3.6.4.12) (Exonuclease WRN) (EC 3.1.-.-) (Focus-forming activity 1) (FFA-1)	wrn ffa1	Xenopus laevis (African clawed frog)	1436	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]	GO:0000287; GO:0003677; GO:0005524; GO:0005654; GO:0005730; GO:0006259; GO:0006260; GO:0006281; GO:0006310; GO:0008408; GO:0030145; GO:0043138	DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]		NA	NA	NA	NA	NA	NA
TRINITY_DN13161_c0_g1_i1	Q0IIJ3	WASF1_BOVIN	57.1	56	24	0	258	91	492	547	4.80E-07	55.5	WASF1_BOVIN	reviewed	Wiskott-Aldrich syndrome protein family member 1 (WASP family protein member 1) (Protein WAVE-1)	WASF1	Bos taurus (Bovine)	559	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; pronucleus [GO:0045120]; SCAR complex [GO:0031209]; synapse [GO:0045202]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; lamellipodium morphogenesis [GO:0072673]; mitochondrion morphogenesis [GO:0070584]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; pronuclear migration [GO:0035046]; receptor-mediated endocytosis [GO:0006898]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; pronucleus [GO:0045120]; SCAR complex [GO:0031209]; synapse [GO:0045202]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0005925; GO:0005938; GO:0006898; GO:0030027; GO:0030036; GO:0031209; GO:0032154; GO:0034237; GO:0035046; GO:0045120; GO:0045202; GO:0070584; GO:0071933; GO:0072673; GO:1990416; GO:2000601	actin cytoskeleton organization [GO:0030036]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; lamellipodium morphogenesis [GO:0072673]; mitochondrion morphogenesis [GO:0070584]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; pronuclear migration [GO:0035046]; receptor-mediated endocytosis [GO:0006898]		NA	NA	NA	NA	NA	NA
TRINITY_DN11025_c0_g1_i1	A2VDK6	WASF2_BOVIN	96.5	173	6	0	2	520	5	177	2.10E-91	336.3	WASF2_BOVIN	reviewed	Wiskott-Aldrich syndrome protein family member 2 (WASP family protein member 2)	WASF2	Bos taurus (Bovine)	493	basolateral plasma membrane [GO:0016323]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]	basolateral plasma membrane [GO:0016323]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0003779; GO:0005856; GO:0016323; GO:0030027; GO:0030036; GO:0031209; GO:0034237; GO:0071933; GO:2000601	actin cytoskeleton organization [GO:0030036]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11025_c0_g1_i2	Q8BH43	WASF2_MOUSE	100	75	0	0	2	226	103	177	1.20E-38	159.8	WASF2_MOUSE	reviewed	Wiskott-Aldrich syndrome protein family member 2 (WASP family protein member 2) (Protein WAVE-2)	Wasf2 Wave2	Mus musculus (Mouse)	497	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124]	GO:0001525; GO:0001667; GO:0001726; GO:0003779; GO:0005769; GO:0005856; GO:0005911; GO:0006897; GO:0010592; GO:0016323; GO:0016601; GO:0017124; GO:0030027; GO:0030032; GO:0030036; GO:0030048; GO:0031209; GO:0032991; GO:0034237; GO:0035855; GO:0051018; GO:0051497; GO:0071933; GO:0072673; GO:0098974; GO:2000601	actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]		NA	NA	NA	NA	NA	NA
TRINITY_DN136_c0_g1_i2	Q8VHI6	WASF3_MOUSE	47.7	107	38	2	394	74	1	89	5.50E-14	79	WASF3_MOUSE	reviewed	Wiskott-Aldrich syndrome protein family member 3 (WASP family protein member 3) (Protein WAVE-3)	Wasf3 Wave3	Mus musculus (Mouse)	501	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031209; GO:0031643; GO:0034237; GO:0071933; GO:0098794; GO:2000601	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN136_c0_g1_i3	Q8VHI6	WASF3_MOUSE	49.3	227	97	2	876	196	1	209	1.20E-47	191.8	WASF3_MOUSE	reviewed	Wiskott-Aldrich syndrome protein family member 3 (WASP family protein member 3) (Protein WAVE-3)	Wasf3 Wave3	Mus musculus (Mouse)	501	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031209; GO:0031643; GO:0034237; GO:0071933; GO:0098794; GO:2000601	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN136_c0_g1_i1	Q9UPY6	WASF3_HUMAN	48.9	227	98	2	978	298	1	209	1.70E-47	191.4	WASF3_HUMAN	reviewed	Wiskott-Aldrich syndrome protein family member 3 (WASP family protein member 3) (Protein WAVE-3) (Verprolin homology domain-containing protein 3)	WASF3 KIAA0900 SCAR3 WAVE3	Homo sapiens (Human)	502	cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]	cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0031209; GO:0031643; GO:0034237; GO:0065003; GO:0070062; GO:0071933; GO:0098794; GO:2000601	actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]		NA	NA	NA	NA	NA	NA
TRINITY_DN37384_c0_g1_i1	Q0IIY2	WSCD1_XENTR	50.9	53	26	0	167	9	352	404	7.00E-10	64.3	WSCD1_XENTR	reviewed	WSC domain-containing protein 1	wscd1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	573	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2246_c0_g1_i3	Q0IIY2	WSCD1_XENTR	39.1	235	123	3	827	123	353	567	2.00E-39	165.2	WSCD1_XENTR	reviewed	WSC domain-containing protein 1	wscd1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	573	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2246_c0_g1_i5	Q0IIY2	WSCD1_XENTR	38.8	245	130	3	857	123	343	567	2.00E-39	164.9	WSCD1_XENTR	reviewed	WSC domain-containing protein 1	wscd1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	573	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN2246_c0_g1_i6	Q0IIY2	WSCD1_XENTR	38.8	245	130	3	415	1149	343	567	2.00E-39	164.9	WSCD1_XENTR	reviewed	WSC domain-containing protein 1	wscd1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	573	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN33454_c0_g1_i1	Q16WU7	WSCD_AEDAE	44.4	304	129	4	969	154	16	311	2.20E-66	254.2	WSCD_AEDAE	reviewed	WSCD family member AAEL009094	AAEL009094	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	317	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN21277_c0_g1_i2	Q7Q297	WSCD_ANOGA	67.6	37	12	0	180	70	108	144	1.50E-07	57.8	WSCD_ANOGA	reviewed	WSCD family member AGAP003962	AGAP003962	Anopheles gambiae (African malaria mosquito)	319	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			pink	pink	NA	NA	NA	NA
TRINITY_DN15790_c1_g1_i1	Q9VXV9	WCSD_DROME	62.2	45	13	1	73	195	106	150	3.60E-08	58.5	WCSD_DROME	reviewed	WSCD family member CG9164	CG9164	Drosophila melanogaster (Fruit fly)	317	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN15790_c1_g1_i2	Q9VXV9	WCSD_DROME	62.2	45	13	1	73	195	106	150	2.70E-08	58.9	WCSD_DROME	reviewed	WSCD family member CG9164	CG9164	Drosophila melanogaster (Fruit fly)	317	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			blue	blue	NA	NA	NA	NA
TRINITY_DN21277_c0_g1_i5	Q9VXV9	WCSD_DROME	34	215	126	5	768	133	107	308	3.50E-19	97.4	WCSD_DROME	reviewed	WSCD family member CG9164	CG9164	Drosophila melanogaster (Fruit fly)	317	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]	integral component of membrane [GO:0016021]	sulfotransferase activity [GO:0008146]	GO:0008146; GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN26333_c0_g1_i1	Q969T9	WBP2_HUMAN	99	98	1	0	3	296	47	144	3.80E-50	198.4	WBP2_HUMAN	reviewed	WW domain-binding protein 2 (WBP-2)	WBP2	Homo sapiens (Human)	261	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0000978; GO:0003713; GO:0005634; GO:0005737; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045184; GO:0045815; GO:0045893; GO:0045944; GO:0050847; GO:0071391; GO:0071442	"cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]"		NA	NA	NA	NA	NA	NA
TRINITY_DN317_c0_g1_i15	Q969T9	WBP2_HUMAN	51.5	136	62	3	449	51	1	135	2.20E-31	136.7	WBP2_HUMAN	reviewed	WW domain-binding protein 2 (WBP-2)	WBP2	Homo sapiens (Human)	261	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	GO:0000790; GO:0000978; GO:0003713; GO:0005634; GO:0005737; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045184; GO:0045815; GO:0045893; GO:0045944; GO:0050847; GO:0071391; GO:0071442	"cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32724_c0_g1_i1	Q5F457	WBP4_CHICK	52.7	91	40	1	265	2	1	91	1.90E-22	106.7	WBP4_CHICK	reviewed	WW domain-binding protein 4 (WBP-4)	WBP4 RCJMB04_3a20	Gallus gallus (Chicken)	398	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0005634; GO:0008270; GO:0008380; GO:0016607; GO:0071005; GO:0071011	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		blue	blue	NA	NA	NA	NA
TRINITY_DN1188_c0_g1_i1	Q5U4Q0	WAC_XENTR	63.4	93	34	0	455	733	535	627	3.20E-24	113.6	WAC_XENTR	reviewed	WW domain-containing adapter protein with coiled-coil	wac	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	628	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003682; GO:0005634; GO:0006974; GO:0010390; GO:0044783; GO:0045893; GO:0071894	"cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1188_c0_g1_i2	Q5U4Q0	WAC_XENTR	63.4	93	34	0	470	748	535	627	3.20E-24	113.6	WAC_XENTR	reviewed	WW domain-containing adapter protein with coiled-coil	wac	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	628	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003682; GO:0005634; GO:0006974; GO:0010390; GO:0044783; GO:0045893; GO:0071894	"cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35501_c0_g1_i1	Q7ZUK7	WAC_DANRE	91.7	48	4	0	63	206	117	164	1.40E-19	96.3	WAC_DANRE	reviewed	WW domain-containing adapter protein with coiled-coil	waca wac	Danio rerio (Zebrafish) (Brachydanio rerio)	558	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003682; GO:0005634; GO:0006974; GO:0010390; GO:0044783; GO:0045893; GO:0071894	"cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10071_c0_g2_i1	Q5U4Q0	WAC_XENTR	85.7	42	5	1	135	260	128	168	2.70E-13	76.3	WAC_XENTR	reviewed	WW domain-containing adapter protein with coiled-coil	wac	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	628	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003682; GO:0005634; GO:0006974; GO:0010390; GO:0044783; GO:0045893; GO:0071894	"cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN275_c0_g1_i1	Q9EPK5	WWTR1_MOUSE	32.7	107	60	3	98	385	270	375	1.60E-07	57.8	WWTR1_MOUSE	reviewed	WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif)	Wwtr1 Taz	Mus musculus (Mouse)	395	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cilium assembly [GO:0060271]; glomerulus development [GO:0032835]; heart process [GO:0003015]; hippo signaling [GO:0035329]; kidney morphogenesis [GO:0060993]; mesenchymal cell differentiation [GO:0048762]; multicellular organism growth [GO:0035264]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription, DNA-templated [GO:0006355]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; tissue homeostasis [GO:0001894]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001649; GO:0001894; GO:0001933; GO:0003015; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006469; GO:0008284; GO:0010718; GO:0016567; GO:0016604; GO:0017145; GO:0031146; GO:0032835; GO:0035264; GO:0035329; GO:0042803; GO:0045599; GO:0045944; GO:0048762; GO:0060271; GO:0060390; GO:0060828; GO:0060993; GO:0072307; GO:0090090	"cilium assembly [GO:0060271]; glomerulus development [GO:0032835]; heart process [GO:0003015]; hippo signaling [GO:0035329]; kidney morphogenesis [GO:0060993]; mesenchymal cell differentiation [GO:0048762]; multicellular organism growth [GO:0035264]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription, DNA-templated [GO:0006355]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; tissue homeostasis [GO:0001894]"		NA	NA	NA	NA	NA	NA
TRINITY_DN275_c0_g1_i3	Q9EPK5	WWTR1_MOUSE	32.7	107	60	3	98	385	270	375	5.90E-08	59.3	WWTR1_MOUSE	reviewed	WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif)	Wwtr1 Taz	Mus musculus (Mouse)	395	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cilium assembly [GO:0060271]; glomerulus development [GO:0032835]; heart process [GO:0003015]; hippo signaling [GO:0035329]; kidney morphogenesis [GO:0060993]; mesenchymal cell differentiation [GO:0048762]; multicellular organism growth [GO:0035264]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription, DNA-templated [GO:0006355]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; tissue homeostasis [GO:0001894]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001649; GO:0001894; GO:0001933; GO:0003015; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006469; GO:0008284; GO:0010718; GO:0016567; GO:0016604; GO:0017145; GO:0031146; GO:0032835; GO:0035264; GO:0035329; GO:0042803; GO:0045599; GO:0045944; GO:0048762; GO:0060271; GO:0060390; GO:0060828; GO:0060993; GO:0072307; GO:0090090	"cilium assembly [GO:0060271]; glomerulus development [GO:0032835]; heart process [GO:0003015]; hippo signaling [GO:0035329]; kidney morphogenesis [GO:0060993]; mesenchymal cell differentiation [GO:0048762]; multicellular organism growth [GO:0035264]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription, DNA-templated [GO:0006355]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; tissue homeostasis [GO:0001894]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25285_c1_g1_i1	Q6P1B1	XPP1_MOUSE	99.1	117	1	0	351	1	446	562	8.60E-65	247.3	XPP1_MOUSE	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	Xpnpep1	Mus musculus (Mouse)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN25285_c0_g1_i1	Q1JPJ2	XPP1_BOVIN	100	201	0	0	1	603	373	573	1.70E-116	419.9	XPP1_BOVIN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1	Bos taurus (Bovine)	623	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0010815; GO:0030145; GO:0070006	bradykinin catabolic process [GO:0010815]		NA	NA	NA	NA	NA	NA
TRINITY_DN31908_c0_g1_i1	Q9NQW7	XPP1_HUMAN	97.5	81	2	0	244	2	167	247	1.90E-39	162.5	XPP1_HUMAN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN1267_c0_g1_i11	Q1JPJ2	XPP1_BOVIN	44.4	586	312	6	1759	41	35	619	4.40E-134	479.9	XPP1_BOVIN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1	Bos taurus (Bovine)	623	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0010815; GO:0030145; GO:0070006	bradykinin catabolic process [GO:0010815]		NA	NA	NA	NA	NA	NA
TRINITY_DN1267_c0_g1_i4	Q1JPJ2	XPP1_BOVIN	44.2	615	324	7	1831	41	6	619	2.10E-139	497.7	XPP1_BOVIN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1	Bos taurus (Bovine)	623	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0010815; GO:0030145; GO:0070006	bradykinin catabolic process [GO:0010815]		NA	NA	NA	NA	NA	NA
TRINITY_DN1267_c0_g1_i6	Q1JPJ2	XPP1_BOVIN	44.2	615	324	7	1831	41	6	619	2.20E-139	497.7	XPP1_BOVIN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1	Bos taurus (Bovine)	623	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0010815; GO:0030145; GO:0070006	bradykinin catabolic process [GO:0010815]		NA	NA	NA	NA	NA	NA
TRINITY_DN963_c0_g1_i1	Q9NQW7	XPP1_HUMAN	54.3	623	269	5	1925	93	1	619	5.40E-204	712.2	XPP1_HUMAN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN963_c0_g1_i3	Q9NQW7	XPP1_HUMAN	54.3	623	269	5	1925	93	1	619	5.50E-204	712.2	XPP1_HUMAN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN963_c0_g1_i4	Q9NQW7	XPP1_HUMAN	54.3	623	269	5	1925	93	1	619	9.30E-204	711.4	XPP1_HUMAN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i10	O54975	XPP1_RAT	47	330	172	3	1101	118	291	619	9.10E-87	322	XPP1_RAT	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	Xpnpep1 App	Rattus norvegicus (Rat)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i15	Q6P1B1	XPP1_MOUSE	41.7	628	345	10	1971	118	3	619	2.20E-141	504.2	XPP1_MOUSE	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	Xpnpep1	Mus musculus (Mouse)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i2	Q6P1B1	XPP1_MOUSE	47.5	198	103	1	708	118	422	619	4.60E-52	206.1	XPP1_MOUSE	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	Xpnpep1	Mus musculus (Mouse)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i4	Q9NQW7	XPP1_HUMAN	41.1	587	316	11	1759	56	3	578	1.70E-124	448	XPP1_HUMAN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i5	Q54G06	XPP1_DICDI	38.3	355	197	6	1118	75	19	358	3.50E-62	240.4	XPP1_DICDI	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	xpnpep1 xpnpepl xpnpepl1 DDB_G0290501	Dictyostelium discoideum (Slime mold)	627	cytoplasm [GO:0005737]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]	cytoplasm [GO:0005737]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]	GO:0005737; GO:0010815; GO:0030145; GO:0070006	bradykinin catabolic process [GO:0010815]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i8	Q9NQW7	XPP1_HUMAN	40.2	482	268	9	1644	226	3	473	4.80E-97	356.7	XPP1_HUMAN	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN35594_c0_g1_i1	Q6P1B1	XPP1_MOUSE	100	115	0	0	346	2	137	251	1.90E-64	246.1	XPP1_MOUSE	reviewed	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	Xpnpep1	Mus musculus (Mouse)	623	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i13	Q99MA2	XPP2_RAT	64.2	53	19	0	381	223	457	509	3.30E-12	72.8	XPP2_RAT	reviewed	Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (mAPP) (X-prolyl aminopeptidase 2)	Xpnpep2	Rattus norvegicus (Rat)	674	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005886; GO:0031225; GO:0046872; GO:0070006; GO:0070062			NA	NA	NA	NA	NA	NA
TRINITY_DN5403_c0_g1_i1	B7ZMP1	XPP3_MOUSE	69	58	18	0	345	172	411	468	1.20E-16	87.4	XPP3_MOUSE	reviewed	Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3)	Xpnpep3	Mus musculus (Mouse)	506	mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]	mitochondrion [GO:0005739]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]	GO:0003094; GO:0004177; GO:0005739; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006	glomerular filtration [GO:0003094]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN5403_c0_g1_i1	B7ZMP1	XPP3_MOUSE	41	39	23	0	188	72	463	501	4.10E-04	45.8	XPP3_MOUSE	reviewed	Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3)	Xpnpep3	Mus musculus (Mouse)	506	mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]	mitochondrion [GO:0005739]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]	GO:0003094; GO:0004177; GO:0005739; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006	glomerular filtration [GO:0003094]; protein processing [GO:0016485]		blue	blue	NA	NA	NA	NA
TRINITY_DN5403_c0_g1_i3	B7ZMP1	XPP3_MOUSE	47.7	172	87	2	587	72	333	501	4.80E-42	172.6	XPP3_MOUSE	reviewed	Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3)	Xpnpep3	Mus musculus (Mouse)	506	mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]	mitochondrion [GO:0005739]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]	GO:0003094; GO:0004177; GO:0005739; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006	glomerular filtration [GO:0003094]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN5403_c0_g1_i5	B7ZMP1	XPP3_MOUSE	50.5	204	98	2	683	72	301	501	1.30E-56	221.1	XPP3_MOUSE	reviewed	Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3)	Xpnpep3	Mus musculus (Mouse)	506	mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]	mitochondrion [GO:0005739]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]	GO:0003094; GO:0004177; GO:0005739; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006	glomerular filtration [GO:0003094]; protein processing [GO:0016485]		NA	NA	NA	NA	NA	NA
TRINITY_DN8991_c0_g1_i18	Q9VJG0	XPP_DROME	46.4	179	96	0	539	3	288	466	8.90E-43	174.9	XPP_DROME	reviewed	Xaa-Pro aminopeptidase ApepP (EC 3.4.11.9) (Aminopeptidase P) (AP-P)	ApepP CG6291	Drosophila melanogaster (Fruit fly)	613	cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; proteolysis [GO:0006508]	cytosol [GO:0005829]	metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0005829; GO:0006508; GO:0046872; GO:0070006	proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN4595_c0_g1_i1	Q5I0D7	PEPD_RAT	51.3	154	72	2	460	2	9	160	9.60E-39	161.4	PEPD_RAT	reviewed	Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)	Pepd	Rattus norvegicus (Rat)	492	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009]; collagen catabolic process [GO:0030574]		manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009]	GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0102009	collagen catabolic process [GO:0030574]		blue	blue	NA	NA	NA	NA
TRINITY_DN31118_c0_g1_i1	P12955	PEPD_HUMAN	97.1	69	2	0	2	208	29	97	6.10E-34	144.1	PEPD_HUMAN	reviewed	Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)	PEPD PRD	Homo sapiens (Human)	493	extracellular exosome [GO:0070062]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]	extracellular exosome [GO:0070062]	manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009]	GO:0004181; GO:0006508; GO:0006520; GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0070062; GO:0102009	cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]		NA	NA	NA	NA	NA	NA
TRINITY_DN5610_c0_g1_i1	Q6AUV1	XDH_ORYSJ	33.9	756	451	14	2266	83	567	1301	3.40E-106	387.5	XDH_ORYSJ	reviewed	Xanthine dehydrogenase (EC 1.17.1.4)	XDH Os03g0429800 LOC_Os03g31550 OsJ_11360 OSJNBa0091B22.11	Oryza sativa subsp. japonica (Rice)	1369	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004854; GO:0005506; GO:0009055; GO:0051537; GO:0071949			NA	NA	NA	NA	NA	NA
TRINITY_DN5610_c0_g1_i5	Q6AUV1	XDH_ORYSJ	31.5	1085	669	23	3232	119	293	1350	3.40E-131	471.1	XDH_ORYSJ	reviewed	Xanthine dehydrogenase (EC 1.17.1.4)	XDH Os03g0429800 LOC_Os03g31550 OsJ_11360 OSJNBa0091B22.11	Oryza sativa subsp. japonica (Rice)	1369	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004854; GO:0005506; GO:0009055; GO:0051537; GO:0071949			NA	NA	NA	NA	NA	NA
TRINITY_DN5610_c0_g1_i6	Q6AUV1	XDH_ORYSJ	31.5	1085	669	23	3232	119	293	1350	3.40E-131	471.1	XDH_ORYSJ	reviewed	Xanthine dehydrogenase (EC 1.17.1.4)	XDH Os03g0429800 LOC_Os03g31550 OsJ_11360 OSJNBa0091B22.11	Oryza sativa subsp. japonica (Rice)	1369	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]"		"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004854; GO:0005506; GO:0009055; GO:0051537; GO:0071949			NA	NA	NA	NA	NA	NA
TRINITY_DN15278_c0_g2_i1	Q54FB7	XDH_DICDI	45	149	81	1	452	6	1190	1337	1.20E-30	134.4	XDH_DICDI	reviewed	Xanthine dehydrogenase (XD) (EC 1.17.1.4)	xdh DDB_G0291047	Dictyostelium discoideum (Slime mold)	1358	"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine catabolic process [GO:0009115]"	peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004854; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949	xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g1_i3	Q54FB7	XDH_DICDI	49.4	158	79	1	116	589	1192	1348	7.70E-35	148.7	XDH_DICDI	reviewed	Xanthine dehydrogenase (XD) (EC 1.17.1.4)	xdh DDB_G0291047	Dictyostelium discoideum (Slime mold)	1358	"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine catabolic process [GO:0009115]"	peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004854; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949	xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g2_i1	P22811	XDH_DROPS	41.5	176	102	1	602	78	14	189	4.80E-35	149.4	XDH_DROPS	reviewed	Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Protein rosy locus)	ry XDH GA20500	Drosophila pseudoobscura pseudoobscura (Fruit fly)	1343	"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]"	peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0006206; GO:0006525; GO:0006568; GO:0006650; GO:0008340; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949	arginine metabolic process [GO:0006525]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; pyrimidine nucleobase metabolic process [GO:0006206]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN30641_c0_g1_i1	R4ZGN4	XDH_BLAAD	59.8	87	31	2	10	270	90	172	1.70E-23	109.8	XDH_BLAAD	reviewed	Xanthine dehydrogenase (XD) (EC 1.17.1.4) (Xanthine oxidoreductase) (Axorp) (XOR)	AXOR GNLVRS02_ARAD1D12518g	Blastobotrys adeninivorans (Yeast) (Arxula adeninivorans)	1405	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; cellular response to ammonium ion [GO:0071242]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to iron ion [GO:0071281]; cellular response to nitrate [GO:0071249]; cellular response to zinc ion [GO:0071294]; guanine catabolic process [GO:0006147]; hypoxanthine oxidation [GO:0006150]; purine nucleobase catabolic process [GO:0006145]; xanthine oxidation [GO:0006151]"	cytoplasm [GO:0005737]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]"	GO:0004854; GO:0005506; GO:0005737; GO:0006145; GO:0006147; GO:0006150; GO:0006151; GO:0009055; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071242; GO:0071249; GO:0071276; GO:0071280; GO:0071281; GO:0071294; GO:0071949	cellular response to ammonium ion [GO:0071242]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to iron ion [GO:0071281]; cellular response to nitrate [GO:0071249]; cellular response to zinc ion [GO:0071294]; guanine catabolic process [GO:0006147]; hypoxanthine oxidation [GO:0006150]; purine nucleobase catabolic process [GO:0006145]; xanthine oxidation [GO:0006151]		NA	NA	NA	NA	NA	NA
TRINITY_DN25313_c0_g1_i1	Q00519	XDH_MOUSE	52.4	82	39	0	277	32	911	992	3.10E-17	89	XDH_MOUSE	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	Xdh	Mus musculus (Mouse)	1335	"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrite reductase (NO-forming) activity [GO:0050421]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; hypoxanthine oxidation [GO:0006150]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; oxidation-reduction process [GO:0055114]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrite reductase (NO-forming) activity [GO:0050421]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006150; GO:0006919; GO:0007595; GO:0009055; GO:0009115; GO:0010044; GO:0010629; GO:0016491; GO:0016529; GO:0030151; GO:0030856; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0055114; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; hypoxanthine oxidation [GO:0006150]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; oxidation-reduction process [GO:0055114]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN40551_c0_g1_i1	P47990	XDH_CHICK	67.4	89	28	1	2	268	1180	1267	6.40E-28	124.4	XDH_CHICK	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	XDH	Gallus gallus (Chicken)	1358	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]; peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g1_i2	P47990	XDH_CHICK	36.5	554	310	10	70	1683	809	1336	1.60E-82	308.5	XDH_CHICK	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	XDH	Gallus gallus (Chicken)	1358	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]; peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g1_i5	P47990	XDH_CHICK	35.8	762	437	14	16	2247	609	1336	2.20E-116	421.4	XDH_CHICK	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	XDH	Gallus gallus (Chicken)	1358	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]; peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g1_i7	P47990	XDH_CHICK	36.6	612	344	11	83	1864	751	1336	6.70E-95	349.7	XDH_CHICK	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	XDH	Gallus gallus (Chicken)	1358	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]; peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN17451_c0_g1_i9	P47990	XDH_CHICK	36	577	327	10	93	1775	786	1336	1.40E-86	322	XDH_CHICK	reviewed	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	XDH	Gallus gallus (Chicken)	1358	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"	cytosol [GO:0005829]; peroxisome [GO:0005777]	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]		NA	NA	NA	NA	NA	NA
TRINITY_DN21618_c0_g1_i1	P17861	XBP1_HUMAN	100	68	0	0	205	2	37	104	1.40E-27	122.9	XBP1_HUMAN	reviewed	"X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]"	XBP1 TREB5 XBP2	Homo sapiens (Human)	261	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; ATF6-mediated unfolded protein response [GO:0036500]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; organelle organization [GO:0006996]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of immunoglobulin secretion [GO:0051024]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001558; GO:0001889; GO:0001934; GO:0001935; GO:0002020; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006366; GO:0006511; GO:0006633; GO:0006914; GO:0006955; GO:0006990; GO:0006996; GO:0007517; GO:0008284; GO:0010506; GO:0010508; GO:0010832; GO:0014065; GO:0015031; GO:0016021; GO:0019901; GO:0030176; GO:0030331; GO:0030335; GO:0030512; GO:0030968; GO:0031017; GO:0031062; GO:0031490; GO:0031625; GO:0031647; GO:0031648; GO:0031670; GO:0032008; GO:0032755; GO:0032869; GO:0034599; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0036498; GO:0036500; GO:0042149; GO:0042307; GO:0042632; GO:0042803; GO:0043066; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0048010; GO:0048666; GO:0051024; GO:0051897; GO:0055089; GO:0055092; GO:0060394; GO:0060612; GO:0060691; GO:0070059; GO:0070373; GO:0071073; GO:0071222; GO:0071230; GO:0071332; GO:0071333; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:1900100; GO:1900102; GO:1900103; GO:1901985; GO:1902236; GO:1903071; GO:1903489; GO:1904707; GO:1904754; GO:1990418; GO:1990440; GO:1990830; GO:1990837; GO:2000347; GO:2000353	adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; ATF6-mediated unfolded protein response [GO:0036500]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; organelle organization [GO:0006996]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of immunoglobulin secretion [GO:0051024]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		NA	NA	NA	NA	NA	NA
TRINITY_DN27387_c0_g1_i1	P17861	XBP1_HUMAN	66.7	57	18	1	200	367	48	104	1.10E-08	61.2	XBP1_HUMAN	reviewed	"X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]"	XBP1 TREB5 XBP2	Homo sapiens (Human)	261	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; ATF6-mediated unfolded protein response [GO:0036500]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; organelle organization [GO:0006996]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of immunoglobulin secretion [GO:0051024]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001558; GO:0001889; GO:0001934; GO:0001935; GO:0002020; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006366; GO:0006511; GO:0006633; GO:0006914; GO:0006955; GO:0006990; GO:0006996; GO:0007517; GO:0008284; GO:0010506; GO:0010508; GO:0010832; GO:0014065; GO:0015031; GO:0016021; GO:0019901; GO:0030176; GO:0030331; GO:0030335; GO:0030512; GO:0030968; GO:0031017; GO:0031062; GO:0031490; GO:0031625; GO:0031647; GO:0031648; GO:0031670; GO:0032008; GO:0032755; GO:0032869; GO:0034599; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0036498; GO:0036500; GO:0042149; GO:0042307; GO:0042632; GO:0042803; GO:0043066; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0048010; GO:0048666; GO:0051024; GO:0051897; GO:0055089; GO:0055092; GO:0060394; GO:0060612; GO:0060691; GO:0070059; GO:0070373; GO:0071073; GO:0071222; GO:0071230; GO:0071332; GO:0071333; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:1900100; GO:1900102; GO:1900103; GO:1901985; GO:1902236; GO:1903071; GO:1903489; GO:1904707; GO:1904754; GO:1990418; GO:1990440; GO:1990830; GO:1990837; GO:2000347; GO:2000353	adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; ATF6-mediated unfolded protein response [GO:0036500]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; organelle organization [GO:0006996]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of immunoglobulin secretion [GO:0051024]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]		blue	blue	NA	NA	NA	NA
TRINITY_DN9441_c0_g1_i1	Q28CY9	XPR1_XENTR	60.3	277	102	3	92	898	1	277	2.50E-84	313.5	XPR1_XENTR	reviewed	Xenotropic and polytropic retrovirus receptor 1 homolog	xpr1 TGas047j19.2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	692	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]	GO:0000822; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435	cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]		NA	NA	NA	NA	NA	NA
TRINITY_DN9441_c0_g1_i2	Q9QZ70	XPR1_CRIGR	84.6	26	4	0	92	169	1	26	1.70E-06	53.1	XPR1_CRIGR	reviewed	Xenotropic and polytropic retrovirus receptor 1 homolog	XPR1	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	696	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; response to virus [GO:0009615]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]	efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; virus receptor activity [GO:0001618]	GO:0000822; GO:0001618; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0030643; GO:0031226; GO:0035435	cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; response to virus [GO:0009615]		NA	NA	NA	NA	NA	NA
TRINITY_DN9441_c0_g1_i3	Q6DD44	XPR1_XENLA	73	74	20	0	92	313	1	74	8.00E-27	121.3	XPR1_XENLA	reviewed	Xenotropic and polytropic retrovirus receptor 1 homolog	xpr1	Xenopus laevis (African clawed frog)	692	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]	efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]	GO:0000822; GO:0015114; GO:0015562; GO:0016021; GO:0030643; GO:0031226; GO:0035435	cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]		blue	blue	NA	NA	NA	NA
TRINITY_DN11721_c0_g1_i4	Q49LS8	XKR6_TETNG	31.3	380	225	9	1164	73	76	435	3.00E-38	161	XKR6_TETNG	reviewed	XK-related protein 6	xkr6 xrg6 GSTENG00030285001 GSTENG00030286001	Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis)	578	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021			NA	NA	NA	NA	NA	NA
TRINITY_DN11721_c0_g1_i5	Q5GH73	XKR6_HUMAN	60	45	17	1	204	73	280	324	1.00E-05	51.2	XKR6_HUMAN	reviewed	XK-related protein 6	XKR6 C8orf21 C8orf5 C8orf7 XRG6	Homo sapiens (Human)	641	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742	apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]		NA	NA	NA	NA	NA	NA
TRINITY_DN33312_c0_g1_i1	Q5GH64	XKR7_MOUSE	36.8	57	36	0	219	49	346	402	1.50E-06	53.1	XKR7_MOUSE	reviewed	XK-related protein 7	Xkr7 Xrg7	Mus musculus (Mouse)	580	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]		GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742	apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]		NA	NA	NA	NA	NA	NA
TRINITY_DN19961_c0_g1_i1	Q92834	RPGR_HUMAN	57.7	111	47	0	334	2	8	118	1.40E-34	147.1	RPGR_HUMAN	reviewed	X-linked retinitis pigmentosa GTPase regulator	RPGR RP3 XLRP3	Homo sapiens (Human)	1020	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]	guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0001750; GO:0003723; GO:0005085; GO:0005794; GO:0005813; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN19961_c0_g1_i3	Q92834	RPGR_HUMAN	58.9	95	39	0	365	81	8	102	6.10E-31	135.2	RPGR_HUMAN	reviewed	X-linked retinitis pigmentosa GTPase regulator	RPGR RP3 XLRP3	Homo sapiens (Human)	1020	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]	guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0001750; GO:0003723; GO:0005085; GO:0005794; GO:0005813; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c1_g3_i1	Q92834	RPGR_HUMAN	48.3	116	58	2	848	507	144	259	2.20E-24	114.4	RPGR_HUMAN	reviewed	X-linked retinitis pigmentosa GTPase regulator	RPGR RP3 XLRP3	Homo sapiens (Human)	1020	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]	guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0001750; GO:0003723; GO:0005085; GO:0005794; GO:0005813; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271	cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c1_g3_i2	Q9R0X5	RPGR_MOUSE	35.9	128	81	1	513	130	242	368	3.20E-13	77	RPGR_MOUSE	reviewed	X-linked retinitis pigmentosa GTPase regulator (mRpgr)	Rpgr	Mus musculus (Mouse)	1001	cell projection [GO:0042995]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to light stimulus [GO:0071482]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601]	cell projection [GO:0042995]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001750; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0005929; GO:0007601; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0042995; GO:0060042; GO:0060271; GO:0071482; GO:0120206	cellular response to light stimulus [GO:0071482]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c1_g3_i2	Q9R0X5	RPGR_MOUSE	56.9	51	21	1	656	507	209	259	6.90E-08	59.3	RPGR_MOUSE	reviewed	X-linked retinitis pigmentosa GTPase regulator (mRpgr)	Rpgr	Mus musculus (Mouse)	1001	cell projection [GO:0042995]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to light stimulus [GO:0071482]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601]	cell projection [GO:0042995]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001750; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0005929; GO:0007601; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0042995; GO:0060042; GO:0060271; GO:0071482; GO:0120206	cellular response to light stimulus [GO:0071482]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN39905_c0_g1_i1	Q5DX34	RPGRH_CAEEL	39.5	76	43	2	260	33	731	803	2.70E-05	49.3	RPGRH_CAEEL	reviewed	X-linked retinitis pigmentosa GTPase regulator homolog (Gut granule loss protein 4)	glo-4 F07C3.4	Caenorhabditis elegans	1386	axon [GO:0030424]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of axon extension [GO:0030517]	axon [GO:0030424]; synapse [GO:0045202]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0030424; GO:0030517; GO:0045202	negative regulation of axon extension [GO:0030517]		NA	NA	NA	NA	NA	NA
TRINITY_DN12313_c0_g4_i1	Q96KN7	RPGR1_HUMAN	27.5	218	148	5	741	109	1054	1268	3.10E-17	90.5	RPGR1_HUMAN	reviewed	X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGR-interacting protein 1)	RPGRIP1	Homo sapiens (Human)	1286	axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]	axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]		GO:0005930; GO:0007601; GO:0032391; GO:0035869; GO:0046548; GO:0050896; GO:0061351; GO:0120206; GO:1905515	neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN29474_c0_g1_i1	P13010	XRCC5_HUMAN	97.6	83	2	0	249	1	369	451	3.00E-40	165.2	XRCC5_HUMAN	reviewed	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))	XRCC5 G22P2	Homo sapiens (Human)	732	"cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]"	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]	GO:0000723; GO:0000783; GO:0000784; GO:0000976; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008047; GO:0008094; GO:0008283; GO:0016020; GO:0031625; GO:0032040; GO:0032204; GO:0032212; GO:0032481; GO:0032991; GO:0032993; GO:0034462; GO:0034511; GO:0034774; GO:0042162; GO:0042493; GO:0043085; GO:0043312; GO:0043564; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051973; GO:0060218; GO:0070198; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0075713; GO:0090734; GO:1904430; GO:1990830; GO:1990904	"activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2186_c0_g1_i1	P27641	XRCC5_MOUSE	32.9	654	387	20	1953	61	106	730	6.60E-69	263.5	XRCC5_MOUSE	reviewed	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku autoantigen protein p86 homolog) (Ku80) (Nuclear factor IV)	Xrcc5 G22p2	Mus musculus (Mouse)	732	"cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded telomeric DNA binding [GO:0003691]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]"	"cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]"	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded telomeric DNA binding [GO:0003691]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]	GO:0000723; GO:0000784; GO:0000976; GO:0002218; GO:0003678; GO:0003684; GO:0003691; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008283; GO:0031625; GO:0032040; GO:0032212; GO:0032991; GO:0032993; GO:0034462; GO:0034511; GO:0042162; GO:0042493; GO:0043564; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051575; GO:0060218; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0090734; GO:1904430; GO:1990830; GO:1990904	"activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18447_c0_g2_i1	Q9FKK7	XYLA_ARATH	54.5	242	110	0	2	727	191	432	9.10E-77	288.1	XYLA_ARATH	reviewed	Xylose isomerase (EC 5.3.1.5)	XYLA At5g57655 MUA2.25	Arabidopsis thaliana (Mouse-ear cress)	477	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose catabolic process [GO:0042843]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]	GO:0005773; GO:0005774; GO:0005783; GO:0005794; GO:0009045; GO:0009536; GO:0042843; GO:0046872; GO:0099503	D-xylose catabolic process [GO:0042843]		NA	NA	NA	NA	NA	NA
TRINITY_DN18447_c0_g1_i1	Q92LW9	XYLA_RHIME	56.4	133	55	3	2	400	6	135	1.60E-35	150.2	XYLA_RHIME	reviewed	Xylose isomerase (EC 5.3.1.5)	xylA R02894 SMc03163	Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium meliloti)	436	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; xylose isomerase activity [GO:0009045]	GO:0000287; GO:0005737; GO:0009045; GO:0042732	D-xylose metabolic process [GO:0042732]		NA	NA	NA	NA	NA	NA
TRINITY_DN978_c0_g1_i1	Q9FKK7	XYLA_ARATH	48.4	95	48	1	376	92	42	135	1.20E-22	107.8	XYLA_ARATH	reviewed	Xylose isomerase (EC 5.3.1.5)	XYLA At5g57655 MUA2.25	Arabidopsis thaliana (Mouse-ear cress)	477	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose catabolic process [GO:0042843]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]	GO:0005773; GO:0005774; GO:0005783; GO:0005794; GO:0009045; GO:0009536; GO:0042843; GO:0046872; GO:0099503	D-xylose catabolic process [GO:0042843]		NA	NA	NA	NA	NA	NA
TRINITY_DN978_c0_g1_i2	Q9FKK7	XYLA_ARATH	54.6	427	193	1	1425	145	42	467	6.60E-141	502.3	XYLA_ARATH	reviewed	Xylose isomerase (EC 5.3.1.5)	XYLA At5g57655 MUA2.25	Arabidopsis thaliana (Mouse-ear cress)	477	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose catabolic process [GO:0042843]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]	metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]	GO:0005773; GO:0005774; GO:0005783; GO:0005794; GO:0009045; GO:0009536; GO:0042843; GO:0046872; GO:0099503	D-xylose catabolic process [GO:0042843]		NA	NA	NA	NA	NA	NA
TRINITY_DN31341_c0_g1_i1	Q2GAB9	XYLA_NOVAD	87.1	85	11	0	256	2	197	281	1.20E-39	163.3	XYLA_NOVAD	reviewed	Xylose isomerase (EC 5.3.1.5)	xylA Saro_0757	Novosphingobium aromaticivorans (strain ATCC 700278 / DSM 12444 / CIP 105152 / NBRC 16084 / F199)	437	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732]	cytoplasm [GO:0005737]	magnesium ion binding [GO:0000287]; xylose isomerase activity [GO:0009045]	GO:0000287; GO:0005737; GO:0009045; GO:0042732	D-xylose metabolic process [GO:0042732]		NA	NA	NA	NA	NA	NA
TRINITY_DN36218_c0_g1_i1	Q3U4G3	XXLT1_MOUSE	38.5	278	157	6	323	1129	95	367	8.80E-53	209.1	XXLT1_MOUSE	reviewed	"Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)"	Xxylt1	Mus musculus (Mouse)	392	integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of endoplasmic reticulum membrane [GO:0030176]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]	GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN36218_c0_g1_i2	Q3U4G3	XXLT1_MOUSE	38.3	277	157	6	323	1126	95	366	3.40E-52	207.2	XXLT1_MOUSE	reviewed	"Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)"	Xxylt1	Mus musculus (Mouse)	392	integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of endoplasmic reticulum membrane [GO:0030176]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]	GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN36218_c0_g1_i3	Q3U4G3	XXLT1_MOUSE	39.6	303	169	6	323	1204	95	392	7.00E-64	246.1	XXLT1_MOUSE	reviewed	"Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)"	Xxylt1	Mus musculus (Mouse)	392	integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	integral component of endoplasmic reticulum membrane [GO:0030176]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]	GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252	O-glycan processing [GO:0016266]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i1	Q3MIF4	XYLB_RAT	52	300	137	5	96	983	236	532	1.10E-81	305.1	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i11	Q3MIF4	XYLB_RAT	52	300	137	5	96	983	236	532	6.20E-82	305.8	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i12	Q3MIF4	XYLB_RAT	56.6	182	78	1	144	689	11	191	1.90E-55	217.6	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i12	Q3MIF4	XYLB_RAT	71.7	46	13	0	733	870	191	236	2.90E-11	70.9	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i13	Q3MIF4	XYLB_RAT	61.3	284	108	2	144	992	11	293	1.30E-96	354.8	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i19	Q3SYZ6	XYLB_BOVIN	70.7	58	16	1	96	266	236	293	2.90E-14	79.7	XYLB_BOVIN	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	XYLB	Bos taurus (Bovine)	490	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i6	Q3MIF4	XYLB_RAT	56.3	439	185	5	97	1401	97	532	2.90E-138	493.4	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN2048_c0_g1_i8	Q3MIF4	XYLB_RAT	55.3	526	227	6	144	1709	11	532	2.60E-165	583.6	XYLB_RAT	reviewed	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	Xylb	Rattus norvegicus (Rat)	536	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]"	cytosol [GO:0005829]	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0016773; GO:0042732	D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]		NA	NA	NA	NA	NA	NA
TRINITY_DN25911_c0_g1_i1	Q9UM01	YLAT1_HUMAN	100	122	0	0	1	366	231	352	3.80E-63	241.9	YLAT1_HUMAN	reviewed	Y+L amino acid transporter 1 (Monocyte amino acid permease 2) (MOP-2) (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1)	SLC7A7	Homo sapiens (Human)	511	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; regulation of arginine metabolic process [GO:0000821]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0000821; GO:0005886; GO:0005887; GO:0006865; GO:0015174; GO:0015179; GO:0016323; GO:0050900; GO:1990822	amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; regulation of arginine metabolic process [GO:0000821]		NA	NA	NA	NA	NA	NA
TRINITY_DN33099_c0_g1_i1	Q9UM01	YLAT1_HUMAN	100	88	0	0	1	264	39	126	2.90E-41	168.7	YLAT1_HUMAN	reviewed	Y+L amino acid transporter 1 (Monocyte amino acid permease 2) (MOP-2) (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1)	SLC7A7	Homo sapiens (Human)	511	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; regulation of arginine metabolic process [GO:0000821]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0000821; GO:0005886; GO:0005887; GO:0006865; GO:0015174; GO:0015179; GO:0016323; GO:0050900; GO:1990822	amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; regulation of arginine metabolic process [GO:0000821]		NA	NA	NA	NA	NA	NA
TRINITY_DN17073_c1_g1_i2	Q92536	YLAT2_HUMAN	54	100	46	0	7	306	266	365	2.20E-20	99.8	YLAT2_HUMAN	reviewed	"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)"	SLC7A6 KIAA0245	Homo sapiens (Human)	515	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016323; GO:0043231; GO:0050900; GO:1990822	amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN17073_c1_g1_i4	Q92536	YLAT2_HUMAN	53.3	107	50	0	7	327	266	372	1.20E-22	107.5	YLAT2_HUMAN	reviewed	"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)"	SLC7A6 KIAA0245	Homo sapiens (Human)	515	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016323; GO:0043231; GO:0050900; GO:1990822	amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN6022_c0_g1_i9	Q92536	YLAT2_HUMAN	49.3	75	37	1	56	280	99	172	1.80E-12	73.2	YLAT2_HUMAN	reviewed	"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)"	SLC7A6 KIAA0245	Homo sapiens (Human)	515	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016323; GO:0043231; GO:0050900; GO:1990822	amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN14808_c0_g1_i1	Q92536	YLAT2_HUMAN	100	94	0	0	2	283	22	115	1.10E-43	176.8	YLAT2_HUMAN	reviewed	"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)"	SLC7A6 KIAA0245	Homo sapiens (Human)	515	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016323; GO:0043231; GO:0050900; GO:1990822	amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN14808_c0_g1_i2	Q92536	YLAT2_HUMAN	96.8	94	3	0	2	283	22	115	4.80E-42	171.4	YLAT2_HUMAN	reviewed	"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)"	SLC7A6 KIAA0245	Homo sapiens (Human)	515	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016323; GO:0043231; GO:0050900; GO:1990822	amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; basic amino acid transmembrane transport [GO:1990822]; leukocyte migration [GO:0050900]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN17073_c1_g1_i5	Q8BGK6	YLAT2_MOUSE	53	66	31	0	66	263	307	372	1.50E-13	77	YLAT2_MOUSE	reviewed	Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)	Slc7a6 Kiaa0245	Mus musculus (Mouse)	515	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; basic amino acid transmembrane transport [GO:1990822]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0005886; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016021; GO:0016323; GO:0043231; GO:1990822	basic amino acid transmembrane transport [GO:1990822]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN36661_c0_g1_i1	Q8BGK6	YLAT2_MOUSE	100	68	0	0	3	206	179	246	1.30E-33	142.9	YLAT2_MOUSE	reviewed	Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)	Slc7a6 Kiaa0245	Mus musculus (Mouse)	515	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; basic amino acid transmembrane transport [GO:1990822]; ornithine transport [GO:0015822]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0005886; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016021; GO:0016323; GO:0043231; GO:1990822	basic amino acid transmembrane transport [GO:1990822]; ornithine transport [GO:0015822]		NA	NA	NA	NA	NA	NA
TRINITY_DN6022_c0_g1_i2	Q59I64	YLAT2_DANRE	54.7	75	33	1	54	278	61	134	3.80E-15	82	YLAT2_DANRE	reviewed	Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (zfSlc7a6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)	slc7a6	Danio rerio (Zebrafish) (Brachydanio rerio)	468	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	L-amino acid transmembrane transporter activity [GO:0015179]	GO:0015179; GO:0016021; GO:0016323			NA	NA	NA	NA	NA	NA
TRINITY_DN17652_c0_g1_i1	P67808	YBOX1_BOVIN	98.9	93	1	0	288	10	63	155	7.10E-49	194.1	YBOX1_BOVIN	reviewed	Y-box-binding protein 1 (YB-1) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor)	YBX1 YB1	Bos taurus (Bovine)	324	"CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone pre-mRNA 3'end processing complex [GO:0071204]; messenger ribonucleoprotein complex [GO:1990124]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]; C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]"	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone pre-mRNA 3'end processing complex [GO:0071204]; messenger ribonucleoprotein complex [GO:1990124]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]	"C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]"	GO:0000122; GO:0000978; GO:0001228; GO:0001701; GO:0003676; GO:0003682; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005689; GO:0005829; GO:0006397; GO:0008380; GO:0008544; GO:0010468; GO:0010494; GO:0017148; GO:0031965; GO:0035198; GO:0048255; GO:0048598; GO:0050658; GO:0051020; GO:0051031; GO:0051154; GO:0051781; GO:0062153; GO:0070062; GO:0070934; GO:0070937; GO:0071204; GO:0098761; GO:1903608; GO:1990124; GO:1990428; GO:1990904; GO:2000773	cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]		NA	NA	NA	NA	NA	NA
TRINITY_DN17652_c0_g1_i2	P67808	YBOX1_BOVIN	100	110	0	0	339	10	46	155	9.70E-59	227.3	YBOX1_BOVIN	reviewed	Y-box-binding protein 1 (YB-1) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor)	YBX1 YB1	Bos taurus (Bovine)	324	"CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone pre-mRNA 3'end processing complex [GO:0071204]; messenger ribonucleoprotein complex [GO:1990124]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]; C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]"	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone pre-mRNA 3'end processing complex [GO:0071204]; messenger ribonucleoprotein complex [GO:1990124]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]	"C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]"	GO:0000122; GO:0000978; GO:0001228; GO:0001701; GO:0003676; GO:0003682; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005689; GO:0005829; GO:0006397; GO:0008380; GO:0008544; GO:0010468; GO:0010494; GO:0017148; GO:0031965; GO:0035198; GO:0048255; GO:0048598; GO:0050658; GO:0051020; GO:0051031; GO:0051154; GO:0051781; GO:0062153; GO:0070062; GO:0070934; GO:0070937; GO:0071204; GO:0098761; GO:1903608; GO:1990124; GO:1990428; GO:1990904; GO:2000773	cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]		NA	NA	NA	NA	NA	NA
TRINITY_DN13914_c0_g1_i1	P16989	YBOX3_HUMAN	98.9	92	1	0	27	302	86	177	3.10E-47	188.7	YBOX3_HUMAN	reviewed	Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB)	YBX3 CSDA DBPA	Homo sapiens (Human)	372	"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; polysome binding [GO:1905538]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]"	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; polysome binding [GO:1905538]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003676; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005923; GO:0007283; GO:0008584; GO:0009566; GO:0010468; GO:0017048; GO:0046622; GO:0048471; GO:0048642; GO:0060546; GO:0070935; GO:0071356; GO:0071474; GO:1902219; GO:1905538; GO:2000767	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN13914_c0_g1_i2	P16989	YBOX3_HUMAN	99	97	1	0	27	317	86	182	3.40E-50	198.7	YBOX3_HUMAN	reviewed	Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB)	YBX3 CSDA DBPA	Homo sapiens (Human)	372	"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; polysome binding [GO:1905538]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]"	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; polysome binding [GO:1905538]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0001701; GO:0003676; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005923; GO:0007283; GO:0008584; GO:0009566; GO:0010468; GO:0017048; GO:0046622; GO:0048471; GO:0048642; GO:0060546; GO:0070935; GO:0071356; GO:0071474; GO:1902219; GO:1905538; GO:2000767	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11821_c0_g1_i1	P49750	YLPM1_HUMAN	46.2	106	50	3	393	94	2042	2146	4.90E-18	92.4	YLPM1_HUMAN	reviewed	YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113)	YLPM1 C14orf170 ZAP3	Homo sapiens (Human)	2146	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; regulation of telomere maintenance [GO:0032204]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0032204	regulation of telomere maintenance [GO:0032204]		NA	NA	NA	NA	NA	NA
TRINITY_DN38341_c0_g1_i1	Q9BYJ9	YTHD1_HUMAN	100	102	0	0	2	307	356	457	8.30E-56	217.2	YTHD1_HUMAN	reviewed	YTH domain-containing family protein 1 (Dermatomyositis associated with cancer putative autoantigen 1) (DACA-1)	YTHDF1 C20orf21	Homo sapiens (Human)	559	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]	GO:0002376; GO:0002577; GO:0003723; GO:0003729; GO:0005737; GO:0007612; GO:0007613; GO:0043022; GO:0045727; GO:0045948; GO:0061157; GO:1900271; GO:1902667; GO:1990247	immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]		NA	NA	NA	NA	NA	NA
TRINITY_DN26927_c0_g1_i1	Q0VCZ3	YTHD2_BOVIN	75.3	194	45	1	103	684	380	570	3.50E-82	306.2	YTHD2_BOVIN	reviewed	YTH domain-containing family protein 2	YTHDF2	Bos taurus (Bovine)	580	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translational initiation [GO:0045948]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]	GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0034451; GO:0043488; GO:0045087; GO:0045746; GO:0045948; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247	embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translational initiation [GO:0045948]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]		NA	NA	NA	NA	NA	NA
TRINITY_DN30289_c0_g1_i1	Q0VCZ3	YTHD2_BOVIN	100	157	0	0	3	473	424	580	7.50E-89	327.8	YTHD2_BOVIN	reviewed	YTH domain-containing family protein 2	YTHDF2	Bos taurus (Bovine)	580	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translational initiation [GO:0045948]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]	GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0034451; GO:0043488; GO:0045087; GO:0045746; GO:0045948; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247	embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translational initiation [GO:0045948]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]		NA	NA	NA	NA	NA	NA
TRINITY_DN30289_c0_g1_i2	Q0VCZ3	YTHD2_BOVIN	100	199	0	0	3	599	382	580	2.00E-115	416.4	YTHD2_BOVIN	reviewed	YTH domain-containing family protein 2	YTHDF2	Bos taurus (Bovine)	580	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translational initiation [GO:0045948]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]	GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0034451; GO:0043488; GO:0045087; GO:0045746; GO:0045948; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247	embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translational initiation [GO:0045948]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]		NA	NA	NA	NA	NA	NA
TRINITY_DN35280_c0_g1_i1	Q7Z739	YTHD3_HUMAN	100	116	0	0	2	349	462	577	1.00E-62	240.4	YTHD3_HUMAN	reviewed	YTH domain-containing family protein 3	YTHDF3	Homo sapiens (Human)	585	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005737; GO:0005829; GO:0043022; GO:0045727; GO:0045948; GO:0060339; GO:0061157; GO:1990247	mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]		NA	NA	NA	NA	NA	NA
TRINITY_DN2609_c0_g1_i2	Q9VZQ1	YTDC1_DROME	67.2	180	59	0	141	680	238	417	1.70E-72	274.6	YTDC1_DROME	reviewed	YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B)	Ythdc1 CG12076	Drosophila melanogaster (Fruit fly)	721	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]; cell differentiation [GO:0030154]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]	GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0007530; GO:0007548; GO:0030154; GO:0036002; GO:0048024; GO:1990247	"cell differentiation [GO:0030154]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2609_c0_g1_i4	Q9VZQ1	YTDC1_DROME	67.2	180	59	0	141	680	238	417	1.90E-72	274.2	YTDC1_DROME	reviewed	YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B)	Ythdc1 CG12076	Drosophila melanogaster (Fruit fly)	721	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]; cell differentiation [GO:0030154]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA binding [GO:0036002]	GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0007530; GO:0007548; GO:0030154; GO:0036002; GO:0048024; GO:1990247	"cell differentiation [GO:0030154]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; sex determination [GO:0007530]; sex differentiation [GO:0007548]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4345_c0_g1_i1	Q8IY57	YAF2_HUMAN	58.8	136	46	2	623	246	1	136	1.70E-24	114.4	YAF2_HUMAN	reviewed	YY1-associated factor 2	YAF2	Homo sapiens (Human)	180	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0045892; GO:0045893; GO:0046872; GO:0070317	"negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4345_c0_g1_i2	Q8IY57	YAF2_HUMAN	70.7	41	12	0	205	83	11	51	1.70E-11	70.1	YAF2_HUMAN	reviewed	YY1-associated factor 2	YAF2	Homo sapiens (Human)	180	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0045892; GO:0045893; GO:0046872; GO:0070317	"negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4345_c0_g1_i3	Q8IY57	YAF2_HUMAN	60.3	126	42	1	599	246	11	136	1.50E-23	111.3	YAF2_HUMAN	reviewed	YY1-associated factor 2	YAF2	Homo sapiens (Human)	180	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0045892; GO:0045893; GO:0046872; GO:0070317	"negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c2_g1_i2	Q96DT7	ZBT10_HUMAN	37.3	59	34	1	102	278	713	768	3.60E-05	48.9	ZBT10_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF)	ZBTB10 RINZF RINZFC	Homo sapiens (Human)	871	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i3	Q96DT7	ZBT10_HUMAN	33.3	63	39	1	205	17	713	772	7.10E-05	47.8	ZBT10_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF)	ZBTB10 RINZF RINZFC	Homo sapiens (Human)	871	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33606_c0_g1_i1	O43829	ZBT14_HUMAN	100	74	0	0	222	1	282	355	3.20E-41	168.3	ZBT14_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog) (ZF5) (Zfp-5) (hZF5)	ZBTB14 ZFP161 ZNF478	Homo sapiens (Human)	449	"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001822; GO:0003170; GO:0003279; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0016235; GO:0043565; GO:0045892; GO:0046872; GO:0060976; GO:1990837	"cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34514_c0_g1_i1	Q05516	ZBT16_HUMAN	100	71	0	0	2	214	543	613	2.00E-40	165.6	ZBT16_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF)	ZBTB16 PLZF ZNF145	Homo sapiens (Human)	673	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0001823; GO:0003677; GO:0005634; GO:0005829; GO:0005886; GO:0006357; GO:0006915; GO:0007417; GO:0008022; GO:0008285; GO:0009880; GO:0009952; GO:0016567; GO:0016604; GO:0016605; GO:0016607; GO:0017053; GO:0019904; GO:0030097; GO:0030099; GO:0032332; GO:0032991; GO:0034504; GO:0035116; GO:0035136; GO:0042733; GO:0042802; GO:0042803; GO:0043065; GO:0043687; GO:0045600; GO:0045638; GO:0045778; GO:0045892; GO:0045893; GO:0046872; GO:0048133; GO:0051138; GO:0051216; GO:0061036	"anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i6	Q13105	ZBT17_HUMAN	51.2	43	21	0	94	222	376	418	4.40E-06	51.6	ZBT17_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60)	ZBTB17 MIZ1 ZNF151 ZNF60	Homo sapiens (Human)	803	"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]	"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001046; GO:0001223; GO:0001227; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0006357; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158	ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i11	Q13105	ZBT17_HUMAN	43.8	89	49	1	1	267	355	442	4.70E-14	79	ZBT17_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60)	ZBTB17 MIZ1 ZNF151 ZNF60	Homo sapiens (Human)	803	"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]	"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001046; GO:0001223; GO:0001227; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0006357; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158	ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i20	Q13105	ZBT17_HUMAN	45.3	53	29	0	4	162	384	436	2.40E-07	56.2	ZBT17_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60)	ZBTB17 MIZ1 ZNF151 ZNF60	Homo sapiens (Human)	803	"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]	"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001046; GO:0001223; GO:0001227; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0006357; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158	ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i8	Q9HC78	ZBT20_HUMAN	43.4	83	47	0	3	251	587	669	1.80E-16	86.3	ZBT20_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288)	ZBTB20 DPZF ZNF288	Homo sapiens (Human)	741	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0045821; GO:0046872; GO:0046889; GO:0055088; GO:0071333; GO:1990837	cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2145_c0_g1_i3	Q3B725	ZBT24_RAT	39	59	34	1	287	117	4	62	7.90E-05	48.5	ZBT24_RAT	reviewed	Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450)	Zbtb24 Bif1 Znf450	Rattus norvegicus (Rat)	705	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0002244; GO:0003700; GO:0005654; GO:0006355; GO:0006357; GO:0046872	"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29107_c0_g1_i1	Q52KB5	ZBT24_DANRE	45.8	72	38	1	217	2	242	312	6.80E-12	70.9	ZBT24_DANRE	reviewed	Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450)	zbtb24 zfp450 zgc:194556	Danio rerio (Zebrafish) (Brachydanio rerio)	672	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29336_c0_g1_i1	Q9Y2Y4	ZBT32_HUMAN	100	75	0	0	227	3	367	441	9.50E-41	166.8	ZBT32_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 32 (FANCC-interacting protein) (Fanconi anemia zinc finger protein) (Testis zinc finger protein) (Zinc finger protein 538)	ZBTB32 FAZF TZFP ZNF538	Homo sapiens (Human)	487	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i15	Q6ZSB9	ZBT49_HUMAN	51.7	58	28	0	333	160	500	557	8.60E-14	77.8	ZBT49_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	ZBTB49 ZNF509	Homo sapiens (Human)	765	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001223; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i18	Q6ZSB9	ZBT49_HUMAN	47.1	68	36	0	248	45	400	467	3.50E-12	72	ZBT49_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	ZBTB49 ZNF509	Homo sapiens (Human)	765	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001223; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i5	Q6ZSB9	ZBT49_HUMAN	49.1	53	27	0	164	6	394	446	9.20E-09	61.2	ZBT49_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	ZBTB49 ZNF509	Homo sapiens (Human)	765	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001223; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i5	Q6ZSB9	ZBT49_HUMAN	48.6	37	19	0	277	167	402	438	0.0012	44.3	ZBT49_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	ZBTB49 ZNF509	Homo sapiens (Human)	765	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]"	GO:0000978; GO:0001223; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40513_c0_g1_i1	O95365	ZBT7A_HUMAN	100	94	0	0	1	282	373	466	2.70E-53	208.8	ZBT7A_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (Pokemon 1) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A)	ZBTB7A FBI1 LRF ZBTB7 ZNF857A	Homo sapiens (Human)	584	"cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"activating transcription factor binding [GO:0033613]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]"	GO:0000122; GO:0000381; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006110; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0030183; GO:0030512; GO:0033613; GO:0034504; GO:0035035; GO:0035861; GO:0042981; GO:0043249; GO:0045444; GO:0045746; GO:0045892; GO:0046332; GO:0046872; GO:0050681; GO:0051090; GO:0051092; GO:0060766; GO:0070418; GO:0097680; GO:1990837; GO:2000677	"B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6575_c0_g1_i3	O93567	ZBT7A_CHICK	21.2	486	334	8	115	1557	6	447	1.40E-16	89.4	ZBT7A_CHICK	reviewed	Zinc finger and BTB domain-containing protein 7A (Leukemia/lymphoma-related factor) (cLRF)	ZBTB7A LRF ZBTB7	Gallus gallus (Chicken)	546	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]"	GO:0000122; GO:0000978; GO:0000981; GO:0001222; GO:0003700; GO:0005634; GO:0006338; GO:0006357; GO:0045892; GO:0046872; GO:2000677	"chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2783_c0_g1_i1	O15156	ZBT7B_HUMAN	44.2	86	48	0	74	331	347	432	7.90E-19	94.7	ZBT7B_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK)	ZBTB7B ZBTB15 ZFP67 ZNF857B	Homo sapiens (Human)	539	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; interleukin-17 production [GO:0032620]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000987; GO:0001228; GO:0001865; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0007398; GO:0007595; GO:0010628; GO:0010629; GO:0031065; GO:0032620; GO:0032868; GO:0042803; GO:0042826; GO:0043372; GO:0043377; GO:0046628; GO:0046872; GO:0051141; GO:0060850; GO:0090336; GO:0120162; GO:1990837; GO:1990845; GO:2000320; GO:2000640	"adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; interleukin-17 production [GO:0032620]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28505_c0_g1_i1	O15156	ZBT7B_HUMAN	55.7	61	26	1	218	39	347	407	2.80E-13	75.5	ZBT7B_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK)	ZBTB7B ZBTB15 ZFP67 ZNF857B	Homo sapiens (Human)	539	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; interleukin-17 production [GO:0032620]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000987; GO:0001228; GO:0001865; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0007398; GO:0007595; GO:0010628; GO:0010629; GO:0031065; GO:0032620; GO:0032868; GO:0042803; GO:0042826; GO:0043372; GO:0043377; GO:0046628; GO:0046872; GO:0051141; GO:0060850; GO:0090336; GO:0120162; GO:1990837; GO:1990845; GO:2000320; GO:2000640	"adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; interleukin-17 production [GO:0032620]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in cell fate commitment [GO:0060850]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38773_c0_g1_i1	A1YPR0	ZBT7C_HUMAN	45.2	62	33	1	263	78	354	414	5.50E-10	65.1	ZBT7C_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 7C (Affected by papillomavirus DNA integration in ME180 cells protein 1) (APM-1) (Zinc finger and BTB domain-containing protein 36) (Zinc finger protein 857C)	ZBTB7C APM1 ZBTB36 ZNF857C	Homo sapiens (Human)	619	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0008285; GO:0045600; GO:0045944; GO:0046872; GO:1903025	negative regulation of cell population proliferation [GO:0008285]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i2	Q6P882	ZB8AL_XENTR	52.6	38	18	0	130	17	299	336	9.80E-05	47.4	ZB8AL_XENTR	reviewed	Zinc finger and BTB domain-containing protein 8A.2	zbtb8a.2 zbtb8.2	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	455	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000977; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4254_c0_g1_i1	Q96SZ4	ZSC10_HUMAN	41.3	63	37	0	193	5	545	607	4.90E-09	61.6	ZSC10_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	ZSCAN10 ZNF206	Homo sapiens (Human)	725	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0035019; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i8	Q3URR7	ZSC10_MOUSE	44.6	56	27	2	541	708	727	778	5.20E-06	53.1	ZSC10_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	Zscan10 Zfp206	Mus musculus (Mouse)	782	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045892; GO:0046872; GO:0048863	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i7	Q96SZ4	ZSC10_HUMAN	42.4	85	49	0	281	27	517	601	9.10E-17	87.4	ZSC10_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	ZSCAN10 ZNF206	Homo sapiens (Human)	725	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0035019; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4440_c0_g1_i1	Q3URR7	ZSC10_MOUSE	44.6	56	31	0	91	258	660	715	3.70E-09	62.4	ZSC10_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	Zscan10 Zfp206	Mus musculus (Mouse)	782	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045892; GO:0046872; GO:0048863	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4440_c0_g1_i2	Q3URR7	ZSC10_MOUSE	44.6	56	31	0	91	258	660	715	3.00E-09	62.8	ZSC10_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	Zscan10 Zfp206	Mus musculus (Mouse)	782	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045892; GO:0046872; GO:0048863	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i8	Q9Z1D7	ZSC12_MOUSE	43.8	64	34	1	193	2	291	352	5.90E-09	61.6	ZSC12_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 96) (Zfp-96)	Zscan12 Zfp96 Znf96	Mus musculus (Mouse)	501	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13346_c0_g1_i1	Q9Z1D7	ZSC12_MOUSE	44.9	69	38	0	215	9	298	366	6.60E-13	74.3	ZSC12_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 96) (Zfp-96)	Zscan12 Zfp96 Znf96	Mus musculus (Mouse)	501	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i9	Q5RCD9	ZSCA2_PONAB	48.1	81	42	0	251	9	387	467	6.30E-18	91.3	ZSCA2_PONAB	reviewed	Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29)	ZSCAN2 ZFP29	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i17	Q7Z7L9	ZSCA2_HUMAN	42.8	145	83	0	21	455	239	383	6.00E-34	145.6	ZSCA2_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854)	ZSCAN2 ZFP29 ZNF854	Homo sapiens (Human)	614	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3817_c0_g1_i2	Q07230	ZSCA2_MOUSE	33.9	251	161	3	874	1623	250	496	4.80E-35	151	ZSCA2_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29) (Zfp-29)	Zscan2 Zfp-29 Zfp29	Mus musculus (Mouse)	614	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN10860_c0_g1_i6	P17040	ZSC20_HUMAN	47.4	57	30	0	202	32	732	788	4.70E-10	64.7	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i8	P17040	ZSC20_HUMAN	44.7	103	57	0	6	314	907	1009	4.60E-22	105.9	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i11	P17040	ZSC20_HUMAN	46.2	117	63	0	359	9	893	1009	1.80E-25	116.7	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i8	P17040	ZSC20_HUMAN	43.2	81	46	0	251	9	929	1009	4.40E-15	81.6	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c1_g2_i1	P17040	ZSC20_HUMAN	46.7	92	49	0	386	111	924	1015	2.20E-22	107.1	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g1_i9	P17040	ZSC20_HUMAN	65.2	46	16	0	1	138	728	773	2.80E-13	75.9	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1848_c0_g2_i1	P17040	ZSC20_HUMAN	45.5	134	73	0	2	403	876	1009	1.40E-31	137.1	ZSC20_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	1043	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN21563_c1_g1_i1	Q07231	ZSC21_MOUSE	77.9	149	32	1	9	455	405	552	5.30E-67	255	ZSC21_MOUSE	reviewed	Zinc finger and SCAN domain-containing protein 21 (CtFIN51) (Transcription factor RU49) (Zinc finger protein 38) (Zfp-38)	Zscan21 Zfp-38 Zfp38 Zipro1 Znf38	Mus musculus (Mouse)	555	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007275; GO:0007283; GO:0045893; GO:0045944; GO:0046872; GO:0048477	"multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i10	P10073	ZSC22_HUMAN	42.9	105	60	0	417	103	302	406	5.30E-21	102.1	ZSC22_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50)	ZSCAN22 HKR2 ZNF50	Homo sapiens (Human)	491	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g1_i2	P10073	ZSC22_HUMAN	48.6	74	38	0	1	222	322	395	2.10E-16	85.9	ZSC22_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50)	ZSCAN22 HKR2 ZNF50	Homo sapiens (Human)	491	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34490_c0_g1_i1	P10073	ZSC22_HUMAN	50	72	35	1	219	4	338	408	7.20E-17	87.4	ZSC22_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50)	ZSCAN22 HKR2 ZNF50	Homo sapiens (Human)	491	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g6_i1	P10073	ZSC22_HUMAN	54.4	103	47	0	2	310	325	427	4.40E-28	125.2	ZSC22_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50)	ZSCAN22 HKR2 ZNF50	Homo sapiens (Human)	491	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29494_c0_g1_i1	Q6NSZ9	ZSC25_HUMAN	100	96	0	0	288	1	355	450	1.00E-55	216.9	ZSC25_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498)	ZSCAN25 ZNF498	Homo sapiens (Human)	544	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i4	Q6NSZ9	ZSC25_HUMAN	49.3	67	28	1	526	708	473	539	3.40E-10	67	ZSC25_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498)	ZSCAN25 ZNF498	Homo sapiens (Human)	544	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31570_c0_g1_i1	Q9NX65	ZSC32_HUMAN	42.9	91	52	0	16	288	510	600	2.90E-18	92.4	ZSC32_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein) (HCCS-5) (Zinc finger protein 434)	ZSCAN32 ZNF434 HCCS5	Homo sapiens (Human)	697	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i7	Q9NX65	ZSC32_HUMAN	45.6	90	39	1	321	52	536	615	1.20E-18	94.4	ZSC32_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein) (HCCS-5) (Zinc finger protein 434)	ZSCAN32 ZNF434 HCCS5	Homo sapiens (Human)	697	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i13	Q9NX65	ZSC32_HUMAN	41.6	89	42	1	3	269	534	612	1.30E-12	73.6	ZSC32_HUMAN	reviewed	Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein) (HCCS-5) (Zinc finger protein 434)	ZSCAN32 ZNF434 HCCS5	Homo sapiens (Human)	697	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i1	P23607	ZFA_MOUSE	38.9	54	32	1	598	756	487	540	7.10E-06	52.8	ZFA_MOUSE	reviewed	Zinc finger autosomal protein	Zfa	Mus musculus (Mouse)	742	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN20075_c0_g1_i1	P23607	ZFA_MOUSE	49.1	53	26	1	65	220	487	539	8.10E-10	64.3	ZFA_MOUSE	reviewed	Zinc finger autosomal protein	Zfa	Mus musculus (Mouse)	742	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40618_c0_g1_i1	Q80WQ9	ZBED4_MOUSE	39.5	86	46	2	115	363	1082	1164	9.90E-09	61.2	ZBED4_MOUSE	reviewed	Zinc finger BED domain-containing protein 4	Zbed4 Kiaa0637	Mus musculus (Mouse)	1168	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN36051_c0_g1_i1	Q80WQ9	ZBED4_MOUSE	33.3	111	72	2	15	347	860	968	1.60E-10	67	ZBED4_MOUSE	reviewed	Zinc finger BED domain-containing protein 4	Zbed4 Kiaa0637	Mus musculus (Mouse)	1168	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN19044_c0_g1_i1	O75132	ZBED4_HUMAN	36.9	103	63	2	329	21	861	961	2.30E-11	69.7	ZBED4_HUMAN	reviewed	Zinc finger BED domain-containing protein 4	ZBED4 KIAA0637	Homo sapiens (Human)	1171	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000981; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983	positive regulation of transcription by RNA polymerase II [GO:0045944]		NA	NA	NA	NA	NA	NA
TRINITY_DN15450_c0_g1_i1	A4Z943	ZBED5_BOVIN	42.1	178	103	0	535	2	274	451	6.40E-38	158.7	ZBED5_BOVIN	reviewed	Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein)	ZBED5	Bos taurus (Bovine)	694	DNA binding [GO:0003677]; metal ion binding [GO:0046872]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN15450_c0_g1_i5	A4Z943	ZBED5_BOVIN	41.3	184	108	0	563	12	274	457	3.60E-39	162.9	ZBED5_BOVIN	reviewed	Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein)	ZBED5	Bos taurus (Bovine)	694	DNA binding [GO:0003677]; metal ion binding [GO:0046872]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i16	A4Z943	ZBED5_BOVIN	36.7	109	67	1	12	332	471	579	2.10E-12	73.2	ZBED5_BOVIN	reviewed	Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein)	ZBED5	Bos taurus (Bovine)	694	DNA binding [GO:0003677]; metal ion binding [GO:0046872]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN27379_c0_g1_i1	Q8SV95	Z6B5_ENCCU	49.3	69	33	1	240	40	25	93	1.90E-15	82.8	Z6B5_ENCCU	reviewed	Zinc finger C2H2 protein ECU06_1150	ECU06_1150	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	145	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8041_c0_g1_i1	Q8SUR9	Z856_ENCCU	70.5	61	18	0	33	215	214	274	1.40E-21	103.2	Z856_ENCCU	reviewed	Zinc finger C2H2 protein ECU08_0560	ECU08_0560	Encephalitozoon cuniculi (strain GB-M1) (Microsporidian parasite)	295	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4679_c0_g1_i1	Q5PPV5	ZC21A_XENLA	42.4	132	57	5	434	78	8	133	1.60E-19	97.4	ZC21A_XENLA	reviewed	Zinc finger C2HC domain-containing protein 1A	zc2hc1a fam164a	Xenopus laevis (African clawed frog)	323	metal ion binding [GO:0046872]		metal ion binding [GO:0046872]	GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN868_c0_g1_i1	Q9NQZ6	ZC4H2_HUMAN	42.4	264	108	6	847	59	1	221	5.10E-29	129.8	ZC4H2_HUMAN	reviewed	Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127)	ZC4H2 HCA127 KIAA1166	Homo sapiens (Human)	224	cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0007399; GO:0007528; GO:0021522; GO:0045211; GO:0045666; GO:0046872	nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN868_c0_g1_i2	Q9NQZ6	ZC4H2_HUMAN	43.1	260	108	6	835	59	1	221	1.70E-29	131.3	ZC4H2_HUMAN	reviewed	Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127)	ZC4H2 HCA127 KIAA1166	Homo sapiens (Human)	224	cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0007399; GO:0007528; GO:0021522; GO:0045211; GO:0045666; GO:0046872	nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN868_c0_g1_i4	Q9NQZ6	ZC4H2_HUMAN	45	249	108	5	802	59	1	221	4.70E-32	139.8	ZC4H2_HUMAN	reviewed	Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127)	ZC4H2 HCA127 KIAA1166	Homo sapiens (Human)	224	cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0007399; GO:0007528; GO:0021522; GO:0045211; GO:0045666; GO:0046872	nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]		NA	NA	NA	NA	NA	NA
TRINITY_DN32834_c0_g1_i3	Q96K80	ZC3HA_HUMAN	41	83	44	3	286	47	61	141	2.20E-10	66.2	ZC3HA_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 10	ZC3H10 ZC3HDC10	Homo sapiens (Human)	434	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799	"negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32834_c0_g1_i4	Q96K80	ZC3HA_HUMAN	44.7	114	55	5	615	283	61	169	2.50E-19	97.1	ZC3HA_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 10	ZC3H10 ZC3HDC10	Homo sapiens (Human)	434	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799	"negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1533_c0_g1_i2	Q96K80	ZC3HA_HUMAN	42.9	126	64	6	2008	1649	41	164	3.70E-20	101.7	ZC3HA_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 10	ZC3H10 ZC3HDC10	Homo sapiens (Human)	434	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799	"negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17001_c0_g1_i1	Q5TYQ8	ZC3HE_DANRE	34.6	130	63	3	377	3	450	562	2.20E-06	53.9	ZC3HE_DANRE	reviewed	Zinc finger CCCH domain-containing protein 14	zc3h14 si:dkey-199i12.4 zgc:136266	Danio rerio (Zebrafish) (Brachydanio rerio)	669	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0008143; GO:0016607; GO:0043488; GO:0046872; GO:1900364	negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]		NA	NA	NA	NA	NA	NA
TRINITY_DN27239_c0_g1_i1	Q6PJT7	ZC3HE_HUMAN	65.5	84	29	0	19	270	3	86	7.20E-23	108.2	ZC3HE_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37)	ZC3H14	Homo sapiens (Human)	736	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0008143; GO:0016607; GO:0032839; GO:0043488; GO:0046872; GO:1900364; GO:1904115; GO:1990904	negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]		blue	blue	NA	NA	NA	NA
TRINITY_DN27708_c0_g1_i1	Q1RMM1	ZC3HF_BOVIN	93.8	64	4	0	19	210	1	64	9.20E-22	103.6	ZC3HF_BOVIN	reviewed	Zinc finger CCCH domain-containing protein 15	ZC3H15	Bos taurus (Bovine)	426	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0002181; GO:0005634; GO:0005829; GO:0046872	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN2300_c0_g1_i1	A4IGY3	ZC3HF_XENTR	60.9	253	91	6	747	4	1	250	6.80E-76	285.4	ZC3HF_XENTR	reviewed	Zinc finger CCCH domain-containing protein 15	zc3h15 TGas113m05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	426	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0002181; GO:0005634; GO:0005829; GO:0046872	cytoplasmic translation [GO:0002181]		blue	blue	NA	NA	NA	NA
TRINITY_DN27474_c0_g1_i1	A4IGY3	ZC3HF_XENTR	90.3	145	14	0	436	2	62	206	5.30E-72	271.6	ZC3HF_XENTR	reviewed	Zinc finger CCCH domain-containing protein 15	zc3h15 TGas113m05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	426	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0002181; GO:0005634; GO:0005829; GO:0046872	cytoplasmic translation [GO:0002181]		NA	NA	NA	NA	NA	NA
TRINITY_DN8759_c0_g2_i1	Q6K4V3	C3H15_ORYSJ	55.7	79	29	2	267	31	166	238	4.20E-19	95.1	C3H15_ORYSJ	reviewed	Zinc finger CCCH domain-containing protein 15 (OsC3H15)	Os02g0301000 LOC_Os02g19804 OSJNBa0010K08.8-1	Oryza sativa subsp. japonica (Rice)	326	U2-type spliceosomal complex [GO:0005684]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; snoRNA splicing [GO:0034247]	U2-type spliceosomal complex [GO:0005684]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005684; GO:0034247; GO:0046872	snoRNA splicing [GO:0034247]		NA	NA	NA	NA	NA	NA
TRINITY_DN3658_c0_g1_i1	Q86VM9	ZCH18_HUMAN	41.7	168	92	4	34	519	225	392	1.20E-25	118.2	ZCH18_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)	ZC3H18 NHN1	Homo sapiens (Human)	953	nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0016607; GO:0032991; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3658_c0_g1_i2	Q86VM9	ZCH18_HUMAN	41.6	173	78	5	34	498	225	392	2.90E-27	123.6	ZCH18_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)	ZC3H18 NHN1	Homo sapiens (Human)	953	nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0016607; GO:0032991; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN533_c0_g1_i4	Q0JD07	C3H28_ORYSJ	41.1	56	32	1	95	262	285	339	2.10E-07	56.6	C3H28_ORYSJ	reviewed	Zinc finger CCCH domain-containing protein 28 (OsC3H28)	Os04g0438700 LOC_Os04g35800 OJ000114_01.2	Oryza sativa subsp. japonica (Rice)	346	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0046872	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN533_c0_g1_i5	Q0JD07	C3H28_ORYSJ	41.1	56	32	1	101	268	285	339	2.10E-07	56.6	C3H28_ORYSJ	reviewed	Zinc finger CCCH domain-containing protein 28 (OsC3H28)	Os04g0438700 LOC_Os04g35800 OJ000114_01.2	Oryza sativa subsp. japonica (Rice)	346	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0046872	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1528_c0_g1_i1	Q8IXZ2	ZC3H3_HUMAN	49.2	177	81	5	1550	2068	644	815	6.20E-44	180.6	ZC3H3_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor)	ZC3H3 KIAA0150 SMICL ZC3HDC3	Homo sapiens (Human)	948	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]	GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046872; GO:0051028; GO:0070412; GO:1900363	mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]		NA	NA	NA	NA	NA	NA
TRINITY_DN1528_c0_g1_i2	Q8IXZ2	ZC3H3_HUMAN	31.3	438	228	12	665	1942	439	815	5.50E-42	174.1	ZC3H3_HUMAN	reviewed	Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor)	ZC3H3 KIAA0150 SMICL ZC3HDC3	Homo sapiens (Human)	948	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]	GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046872; GO:0051028; GO:0070412; GO:1900363	mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]		NA	NA	NA	NA	NA	NA
TRINITY_DN38979_c0_g1_i1	Q7PYU6	ZGPAT_ANOGA	39.8	236	135	4	17	709	310	543	1.50E-35	151.4	ZGPAT_ANOGA	reviewed	Zinc finger CCCH-type with G patch domain-containing protein	AGAP002111	Anopheles gambiae (African malaria mosquito)	543	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35446_c0_g1_i2	Q69ZB8	ZCHC2_MOUSE	30.8	185	80	3	147	557	107	291	1.10E-14	82.4	ZCHC2_MOUSE	reviewed	Zinc finger CCHC domain-containing protein 2	Zcchc2 Kiaa1744	Mus musculus (Mouse)	1166	cytoplasm [GO:0005737]; nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005737; GO:0008270; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN35446_c0_g1_i3	Q69ZB8	ZCHC2_MOUSE	30.8	185	80	3	147	557	107	291	7.30E-15	82.4	ZCHC2_MOUSE	reviewed	Zinc finger CCHC domain-containing protein 2	Zcchc2 Kiaa1744	Mus musculus (Mouse)	1166	cytoplasm [GO:0005737]; nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]	nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005737; GO:0008270; GO:0035091			NA	NA	NA	NA	NA	NA
TRINITY_DN5258_c0_g1_i1	Q6DJI9	ZCRB1_XENLA	60.8	222	81	2	258	923	3	218	1.50E-49	198.4	ZCRB1_XENLA	reviewed	Zinc finger CCHC-type and RNA-binding motif-containing protein 1 (U11/U12 small nuclear ribonucleoprotein 31 kDa protein) (U11/U12 snRNP 31 kDa protein)	zcrb1	Xenopus laevis (African clawed frog)	218	spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005681; GO:0006397; GO:0008270; GO:0008380	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		NA	NA	NA	NA	NA	NA
TRINITY_DN39764_c0_g1_i1	Q8TBF4	ZCRB1_HUMAN	100	130	0	0	404	15	1	130	4.60E-70	265	ZCRB1_HUMAN	reviewed	Zinc finger CCHC-type and RNA-binding motif-containing protein 1 (U11/U12 small nuclear ribonucleoprotein 31 kDa protein) (U11/U12 snRNP 31 kDa protein) (U11/U12-31K)	ZCRB1	Homo sapiens (Human)	217	"nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0005654; GO:0005689; GO:0008270; GO:0008380	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32311_c0_g1_i1	P37275	ZEB1_HUMAN	100	83	0	0	3	251	231	313	9.30E-45	180.3	ZEB1_HUMAN	reviewed	Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8) (TCF-8)	ZEB1 AREB6 TCF8	Homo sapiens (Human)	1124	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; cellular response to amino acid stimulus [GO:0071230]; central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; cytokine-mediated signaling pathway [GO:0019221]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; semicircular canal morphogenesis [GO:0048752]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000981; GO:0001227; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007389; GO:0007417; GO:0008270; GO:0008285; GO:0010464; GO:0017015; GO:0019221; GO:0033081; GO:0045602; GO:0045666; GO:0045892; GO:0045944; GO:0048596; GO:0048704; GO:0048752; GO:0051150; GO:0051216; GO:0070888; GO:0071230; GO:0090103	"cartilage development [GO:0051216]; cellular response to amino acid stimulus [GO:0071230]; central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; cytokine-mediated signaling pathway [GO:0019221]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; semicircular canal morphogenesis [GO:0048752]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2065_c0_g1_i1	G5EBU4	ZAG1_CAEEL	80.9	94	18	0	379	98	480	573	1.00E-42	174.9	ZAG1_CAEEL	reviewed	Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1)	zag-1 F28F9.1	Caenorhabditis elegans	596	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0007411; GO:0045773; GO:0046872	axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]		NA	NA	NA	NA	NA	NA
TRINITY_DN2065_c0_g1_i2	G5EBU4	ZAG1_CAEEL	90.2	51	5	0	271	119	516	566	5.50E-22	105.9	ZAG1_CAEEL	reviewed	Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1)	zag-1 F28F9.1	Caenorhabditis elegans	596	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0007411; GO:0045773; GO:0046872	axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]		NA	NA	NA	NA	NA	NA
TRINITY_DN2065_c0_g1_i2	G5EBU4	ZAG1_CAEEL	84.6	26	4	0	344	267	480	505	7.30E-06	52.4	ZAG1_CAEEL	reviewed	Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1)	zag-1 F28F9.1	Caenorhabditis elegans	596	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0007411; GO:0045773; GO:0046872	axon guidance [GO:0007411]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of axon extension [GO:0045773]		NA	NA	NA	NA	NA	NA
TRINITY_DN38305_c0_g1_i1	Q9HBF4	ZFYV1_HUMAN	98.8	81	1	0	243	1	216	296	1.90E-39	162.5	ZFYV1_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1)	ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436	Homo sapiens (Human)	777	"autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]"	autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]	"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]"	GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0010923; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:0140042; GO:1990462	cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]		NA	NA	NA	NA	NA	NA
TRINITY_DN4866_c0_g1_i1	Q9HBF4	ZFYV1_HUMAN	47.8	627	300	9	1915	101	151	772	4.10E-171	603.2	ZFYV1_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1)	ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436	Homo sapiens (Human)	777	"autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]"	autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]	"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]"	GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0010923; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:0140042; GO:1990462	cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]		NA	NA	NA	NA	NA	NA
TRINITY_DN4866_c0_g1_i2	Q9HBF4	ZFYV1_HUMAN	60.7	61	22	1	236	54	151	209	1.70E-13	77.8	ZFYV1_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1)	ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436	Homo sapiens (Human)	777	"autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]"	autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]	"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]"	GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0010923; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:0140042; GO:1990462	cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]		NA	NA	NA	NA	NA	NA
TRINITY_DN7641_c0_g1_i1	Q9BQ24	ZFY21_HUMAN	38.8	227	126	5	73	729	12	233	2.70E-40	167.2	ZFY21_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 21 (ZF21)	ZFYVE21	Homo sapiens (Human)	234	endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872]	endosome [GO:0005768]; focal adhesion [GO:0005925]	metal ion binding [GO:0046872]	GO:0005768; GO:0005925; GO:0046872			yellow	yellow	NA	NA	NA	NA
TRINITY_DN7641_c0_g1_i2	Q9BQ24	ZFY21_HUMAN	38.8	227	126	5	73	729	12	233	3.40E-40	166.8	ZFY21_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 21 (ZF21)	ZFYVE21	Homo sapiens (Human)	234	endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872]	endosome [GO:0005768]; focal adhesion [GO:0005925]	metal ion binding [GO:0046872]	GO:0005768; GO:0005925; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN5916_c0_g1_i1	E1BLZ4	ZFY26_BOVIN	26.9	1104	639	23	3227	24	1495	2466	2.50E-94	348.6	ZFY26_BOVIN	reviewed	Zinc finger FYVE domain-containing protein 26	ZFYVE26	Bos taurus (Bovine)	2515	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000281; GO:0000724; GO:0005737; GO:0005813; GO:0030496; GO:0032266; GO:0032465; GO:0046872	double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN5916_c0_g1_i2	E1BLZ4	ZFY26_BOVIN	27	1126	651	24	3281	21	1495	2488	1.50E-94	349.4	ZFY26_BOVIN	reviewed	Zinc finger FYVE domain-containing protein 26	ZFYVE26	Bos taurus (Bovine)	2515	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000281; GO:0000724; GO:0005737; GO:0005813; GO:0030496; GO:0032266; GO:0032465; GO:0046872	double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]		NA	NA	NA	NA	NA	NA
TRINITY_DN8081_c0_g1_i1	O95405	ZFYV9_HUMAN	45.1	71	36	1	8	211	1308	1378	2.10E-08	59.7	ZFYV9_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	1425	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN8081_c0_g1_i2	O95405	ZFYV9_HUMAN	47.8	115	57	1	8	343	1308	1422	3.60E-24	112.5	ZFYV9_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	1425	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN4159_c1_g1_i2	O95405	ZFYV9_HUMAN	56.4	349	147	2	2	1048	942	1285	4.70E-114	412.5	ZFYV9_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	1425	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN4159_c1_g1_i3	O95405	ZFYV9_HUMAN	54.5	211	91	2	2	634	942	1147	2.30E-64	246.9	ZFYV9_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	1425	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN4159_c1_g1_i4	O95405	ZFYV9_HUMAN	58.2	330	136	1	78	1067	958	1285	5.30E-113	409.1	ZFYV9_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	1425	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN4159_c1_g1_i5	O95405	ZFYV9_HUMAN	53.1	162	71	2	2	487	942	1098	2.10E-44	180.3	ZFYV9_HUMAN	reviewed	Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	1425	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN9810_c0_g1_i1	Q2KIH1	ZNHI3_BOVIN	32.4	173	79	4	518	111	2	173	2.40E-14	80.5	ZNHI3_BOVIN	reviewed	Zinc finger HIT domain-containing protein 3	ZNHIT3	Bos taurus (Bovine)	179	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; metal ion binding [GO:0046872]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; snoRNA localization [GO:0048254]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]	metal ion binding [GO:0046872]	GO:0000463; GO:0000492; GO:0005634; GO:0005737; GO:0046872; GO:0048254; GO:0070761	"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; snoRNA localization [GO:0048254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26622_c0_g1_i1	Q9ULJ6	ZMIZ1_HUMAN	82.9	111	19	0	20	352	674	784	5.30E-52	204.9	ZMIZ1_HUMAN	reviewed	Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17)	ZMIZ1 KIAA1224 RAI17 ZIMP10	Homo sapiens (Human)	1067	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of nucleic acid-templated transcription [GO:1903508]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration [GO:0021852]; regulation of protein sumoylation [GO:0033233]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0001570; GO:0001701; GO:0003007; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0007179; GO:0007296; GO:0007569; GO:0008270; GO:0021852; GO:0030374; GO:0030521; GO:0033233; GO:0043231; GO:0045582; GO:0045747; GO:0045944; GO:0046332; GO:0048096; GO:0048146; GO:0048589; GO:0048844; GO:0060395; GO:1903508	androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of nucleic acid-templated transcription [GO:1903508]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration [GO:0021852]; regulation of protein sumoylation [GO:0033233]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]		NA	NA	NA	NA	NA	NA
TRINITY_DN26622_c0_g1_i2	Q9ULJ6	ZMIZ1_HUMAN	67.2	189	58	2	20	586	674	858	2.90E-69	263.1	ZMIZ1_HUMAN	reviewed	Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17)	ZMIZ1 KIAA1224 RAI17 ZIMP10	Homo sapiens (Human)	1067	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of nucleic acid-templated transcription [GO:1903508]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration [GO:0021852]; regulation of protein sumoylation [GO:0033233]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear receptor transcription coactivator activity [GO:0030374]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0001570; GO:0001701; GO:0003007; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0007179; GO:0007296; GO:0007569; GO:0008270; GO:0021852; GO:0030374; GO:0030521; GO:0033233; GO:0043231; GO:0045582; GO:0045747; GO:0045944; GO:0046332; GO:0048096; GO:0048146; GO:0048589; GO:0048844; GO:0060395; GO:1903508	androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of nucleic acid-templated transcription [GO:1903508]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration [GO:0021852]; regulation of protein sumoylation [GO:0033233]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]		NA	NA	NA	NA	NA	NA
TRINITY_DN6880_c0_g1_i1	Q5SVZ6	ZMYM1_HUMAN	38	71	44	0	276	488	1064	1134	6.10E-06	52.4	ZMYM1_HUMAN	reviewed	Zinc finger MYM-type protein 1	ZMYM1	Homo sapiens (Human)	1142	nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	GO:0005634; GO:0008270; GO:0046983			NA	NA	NA	NA	NA	NA
TRINITY_DN6880_c0_g1_i3	Q5SVZ6	ZMYM1_HUMAN	38	71	44	0	587	799	1064	1134	9.70E-06	52.4	ZMYM1_HUMAN	reviewed	Zinc finger MYM-type protein 1	ZMYM1	Homo sapiens (Human)	1142	nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	GO:0005634; GO:0008270; GO:0046983			NA	NA	NA	NA	NA	NA
TRINITY_DN27644_c0_g1_i1	Q5SVZ6	ZMYM1_HUMAN	38	79	45	1	245	21	1059	1137	1.90E-06	53.1	ZMYM1_HUMAN	reviewed	Zinc finger MYM-type protein 1	ZMYM1	Homo sapiens (Human)	1142	nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	GO:0005634; GO:0008270; GO:0046983			brown	brown	1	NA	NA	NA
TRINITY_DN34394_c0_g1_i1	O95789	ZMYM6_HUMAN	41	78	45	1	246	16	945	1022	6.10E-12	71.2	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN14323_c2_g1_i1	O95789	ZMYM6_HUMAN	44.3	61	34	0	25	207	1106	1166	3.00E-07	55.8	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i3	O95789	ZMYM6_HUMAN	45.1	144	79	0	492	61	1029	1172	7.90E-32	138.3	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i4	O95789	ZMYM6_HUMAN	44.4	144	80	0	492	61	1029	1172	1.80E-31	137.1	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i5	O95789	ZMYM6_HUMAN	49.5	107	54	0	363	43	1029	1135	8.10E-26	117.9	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN7908_c0_g1_i1	O95789	ZMYM6_HUMAN	52.1	48	23	0	9	152	1084	1131	1.50E-05	50.8	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN7908_c0_g1_i3	O95789	ZMYM6_HUMAN	42	88	51	0	9	272	1084	1171	9.00E-14	77.4	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN11955_c0_g1_i8	O95789	ZMYM6_HUMAN	41.7	163	95	0	494	6	1029	1191	5.50E-33	142.1	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	1	NA	NA	NA
TRINITY_DN7279_c0_g1_i1	O95789	ZMYM6_HUMAN	50.8	65	32	0	195	1	1069	1133	1.60E-10	66.2	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN40184_c0_g1_i1	O95789	ZMYM6_HUMAN	44	75	40	1	3	221	876	950	2.80E-09	62.4	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN1669_c0_g1_i11	O95789	ZMYM6_HUMAN	43.5	62	35	0	3	188	1106	1167	5.80E-08	58.9	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		NA	NA	NA	NA	NA	NA
TRINITY_DN13213_c0_g1_i1	O95789	ZMYM6_HUMAN	42.7	89	50	1	318	55	945	1033	4.90E-14	78.6	ZMYM6_HUMAN	reviewed	Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258)	ZMYM6 Buster2 KIAA1353 ZNF258	Homo sapiens (Human)	1325	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0007010; GO:0007275; GO:0008270; GO:0022604	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		blue	blue	NA	NA	NA	NA
TRINITY_DN2619_c0_g1_i2	Q8R5C8	ZMY11_MOUSE	34.2	196	85	4	487	32	407	602	9.00E-24	111.7	ZMY11_MOUSE	reviewed	Zinc finger MYND domain-containing protein 11	Zmynd11	Mus musculus (Mouse)	602	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0008270; GO:0034243; GO:0035064; GO:0042393; GO:0043124; GO:0046329; GO:0051607; GO:2001237	chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]		NA	NA	NA	NA	NA	NA
TRINITY_DN6112_c0_g1_i5	Q15326	ZMY11_HUMAN	46.6	146	75	2	97	525	1	146	9.20E-31	135.2	ZMY11_HUMAN	reviewed	Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69)	ZMYND11 BRAM1 BS69	Homo sapiens (Human)	602	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0016032; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237	"cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6112_c0_g1_i6	Q15326	ZMY11_HUMAN	44.4	178	89	4	97	618	1	172	3.30E-35	149.8	ZMY11_HUMAN	reviewed	Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69)	ZMYND11 BRAM1 BS69	Homo sapiens (Human)	602	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0016032; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237	"cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10254_c0_g1_i3	P08042	ZFP1_MOUSE	47.1	87	46	0	699	439	289	375	3.00E-17	90.5	ZFP1_MOUSE	reviewed	Zinc finger protein 1 (Zfp-1) (Protein mKR1)	Zfp1 Fnp-1 Zfp-1	Mus musculus (Mouse)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN571_c0_g1_i1	P28166	ZFH1_DROME	55.2	143	52	1	322	714	319	461	6.60E-35	150.6	ZFH1_DROME	reviewed	Zinc finger protein 1 (Zinc finger homeodomain protein 1)	zfh1 zfh-1 CG1322	Drosophila melanogaster (Fruit fly)	1054	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007399; GO:0007413; GO:0007498; GO:0007516; GO:0008045; GO:0008354; GO:0046716; GO:0046872; GO:0048103; GO:0048542; GO:0051148; GO:0061321	axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]		NA	NA	NA	NA	NA	NA
TRINITY_DN571_c0_g1_i1	P28166	ZFH1_DROME	48.8	43	22	0	1651	1779	714	756	2.70E-04	48.9	ZFH1_DROME	reviewed	Zinc finger protein 1 (Zinc finger homeodomain protein 1)	zfh1 zfh-1 CG1322	Drosophila melanogaster (Fruit fly)	1054	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007399; GO:0007413; GO:0007498; GO:0007516; GO:0008045; GO:0008354; GO:0046716; GO:0046872; GO:0048103; GO:0048542; GO:0051148; GO:0061321	axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]		NA	NA	NA	NA	NA	NA
TRINITY_DN571_c0_g1_i2	P28166	ZFH1_DROME	55.2	143	52	1	220	612	319	461	6.30E-35	150.6	ZFH1_DROME	reviewed	Zinc finger protein 1 (Zinc finger homeodomain protein 1)	zfh1 zfh-1 CG1322	Drosophila melanogaster (Fruit fly)	1054	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007399; GO:0007413; GO:0007498; GO:0007516; GO:0008045; GO:0008354; GO:0046716; GO:0046872; GO:0048103; GO:0048542; GO:0051148; GO:0061321	axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]		NA	NA	NA	NA	NA	NA
TRINITY_DN571_c0_g1_i2	P28166	ZFH1_DROME	48.8	43	22	0	1549	1677	714	756	2.60E-04	48.9	ZFH1_DROME	reviewed	Zinc finger protein 1 (Zinc finger homeodomain protein 1)	zfh1 zfh-1 CG1322	Drosophila melanogaster (Fruit fly)	1054	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0005634; GO:0007399; GO:0007413; GO:0007498; GO:0007516; GO:0008045; GO:0008354; GO:0046716; GO:0046872; GO:0048103; GO:0048542; GO:0051148; GO:0061321	axonal fasciculation [GO:0007413]; garland nephrocyte differentiation [GO:0061321]; germ cell migration [GO:0008354]; hemocyte development [GO:0007516]; lymph gland development [GO:0048542]; mesoderm development [GO:0007498]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; somatic stem cell division [GO:0048103]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i29	Q6P2D0	ZFP1_HUMAN	38.9	113	60	3	335	6	286	392	2.70E-15	82.8	ZFP1_HUMAN	reviewed	Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475)	ZFP1 ZNF475	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2338_c0_g1_i1	Q6P2D0	ZFP1_HUMAN	23.9	205	116	6	587	3	208	382	7.70E-14	79	ZFP1_HUMAN	reviewed	Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475)	ZFP1 ZNF475	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i18	Q6P2D0	ZFP1_HUMAN	45.5	165	90	0	558	64	186	350	5.30E-35	149.1	ZFP1_HUMAN	reviewed	Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475)	ZFP1 ZNF475	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i5	Q6P2D0	ZFP1_HUMAN	37.8	196	111	3	568	2	186	377	3.80E-28	126.3	ZFP1_HUMAN	reviewed	Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475)	ZFP1 ZNF475	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i5	Q6P2D0	ZFP1_HUMAN	51.9	154	74	0	2	463	217	370	1.70E-44	180.3	ZFP1_HUMAN	reviewed	Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475)	ZFP1 ZNF475	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i13	P21506	ZNF10_HUMAN	50.4	115	57	0	351	7	281	395	4.90E-28	125.2	ZNF10_HUMAN	reviewed	Zinc finger protein 10 (Zinc finger protein KOX1)	ZNF10 KOX1	Homo sapiens (Human)	573	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032991; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c3_g1_i1	P21506	ZNF10_HUMAN	60.4	48	19	0	234	91	269	316	1.70E-11	69.7	ZNF10_HUMAN	reviewed	Zinc finger protein 10 (Zinc finger protein KOX1)	ZNF10 KOX1	Homo sapiens (Human)	573	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032991; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g3_i1	P21506	ZNF10_HUMAN	52.2	69	33	0	1	207	275	343	2.20E-15	82.4	ZNF10_HUMAN	reviewed	Zinc finger protein 10 (Zinc finger protein KOX1)	ZNF10 KOX1	Homo sapiens (Human)	573	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032991; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i6	Q8IYN0	ZN100_HUMAN	51.8	228	108	1	4	687	289	514	3.90E-69	262.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i1	Q8IYN0	ZN100_HUMAN	47.9	167	75	1	503	3	237	391	1.80E-39	163.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i15	Q8IYN0	ZN100_HUMAN	48.1	81	42	0	330	88	295	375	1.60E-17	90.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i22	Q8IYN0	ZN100_HUMAN	52.4	187	89	0	570	10	266	452	3.00E-53	210.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i22	Q8IYN0	ZN100_HUMAN	46.2	208	98	4	1195	575	265	459	1.20E-44	182.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10894_c0_g1_i1	Q8IYN0	ZN100_HUMAN	46.9	177	84	1	2	532	242	408	9.70E-44	177.9	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10894_c0_g1_i2	Q8IYN0	ZN100_HUMAN	51.8	139	67	0	240	656	270	408	8.90E-39	161.8	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10894_c0_g1_i3	Q8IYN0	ZN100_HUMAN	51.8	139	67	0	146	562	270	408	7.60E-39	161.8	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i15	Q8IYN0	ZN100_HUMAN	51.1	131	56	1	395	3	255	377	8.90E-34	144.4	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i24	Q8IYN0	ZN100_HUMAN	46.7	167	81	1	503	3	219	377	6.00E-38	158.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i29	Q8IYN0	ZN100_HUMAN	51.3	115	56	0	388	44	255	369	3.80E-30	132.5	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i7	Q8IYN0	ZN100_HUMAN	57.5	87	37	0	288	28	283	369	4.20E-25	115.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c1_g1_i2	Q8IYN0	ZN100_HUMAN	49.6	113	57	0	2	340	402	514	2.20E-28	126.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17028_c0_g1_i1	Q8IYN0	ZN100_HUMAN	52.4	103	49	0	2	310	277	379	2.10E-27	122.9	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g1_i1	Q8IYN0	ZN100_HUMAN	48.8	80	41	0	2	241	429	508	5.80E-20	97.8	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g2_i2	Q8IYN0	ZN100_HUMAN	50.9	106	48	1	3	320	281	382	2.50E-26	119.4	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g2_i1	Q8IYN0	ZN100_HUMAN	61.8	123	47	0	62	430	258	380	6.70E-43	174.9	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g2_i2	Q8IYN0	ZN100_HUMAN	58.5	147	61	0	1	441	262	408	1.30E-49	197.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g2_i4	Q8IYN0	ZN100_HUMAN	61	146	57	0	2	439	235	380	4.00E-51	202.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i4	Q8IYN0	ZN100_HUMAN	50.8	128	62	1	2	385	265	391	1.80E-31	136.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i25	Q8IYN0	ZN100_HUMAN	49	143	73	0	198	626	266	408	3.60E-39	163.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i25	Q8IYN0	ZN100_HUMAN	56.1	66	29	0	1	198	261	326	4.60E-18	93.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c3_g2_i1	Q8IYN0	ZN100_HUMAN	47.2	106	56	0	4	321	261	366	4.00E-24	112.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i12	Q8IYN0	ZN100_HUMAN	47.7	86	45	0	5	262	281	366	9.60E-21	100.5	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g1_i1	Q8IYN0	ZN100_HUMAN	47	234	107	4	720	22	310	527	2.90E-56	220.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g1_i5	Q8IYN0	ZN100_HUMAN	50.4	260	125	1	781	2	254	509	5.10E-75	282.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g2_i2	Q8IYN0	ZN100_HUMAN	49.5	97	49	0	305	15	287	383	1.40E-23	110.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i7	Q8IYN0	ZN100_HUMAN	50	126	63	0	379	2	241	366	4.20E-33	142.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8010_c0_g2_i1	Q8IYN0	ZN100_HUMAN	53.3	45	19	1	141	7	333	375	1.30E-06	54.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16611_c0_g1_i5	Q8IYN0	ZN100_HUMAN	48	75	39	0	417	193	348	422	4.30E-15	82.4	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16611_c0_g1_i6	Q8IYN0	ZN100_HUMAN	50	76	38	0	242	15	348	423	3.90E-16	85.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g2_i1	Q8IYN0	ZN100_HUMAN	56.8	81	35	0	244	2	289	369	4.80E-22	104.8	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i14	Q8IYN0	ZN100_HUMAN	46.2	186	100	0	163	720	290	475	1.90E-50	200.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i14	Q8IYN0	ZN100_HUMAN	51.9	52	25	0	9	164	311	362	8.60E-11	68.9	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i7	Q8IYN0	ZN100_HUMAN	49.1	218	111	0	163	816	262	479	6.40E-63	242.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i7	Q8IYN0	ZN100_HUMAN	51.9	52	25	0	9	164	311	362	9.80E-11	68.9	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10683_c0_g2_i1	Q8IYN0	ZN100_HUMAN	54.2	155	71	0	468	4	254	408	1.00E-44	181	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10683_c0_g2_i2	Q8IYN0	ZN100_HUMAN	54.8	146	66	0	441	4	263	408	1.50E-42	173.7	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2872_c1_g1_i1	Q8IYN0	ZN100_HUMAN	45.6	79	43	0	245	9	345	423	1.20E-17	90.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10790_c0_g1_i1	Q8IYN0	ZN100_HUMAN	52.4	143	68	0	450	22	281	423	5.30E-43	175.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10790_c0_g1_i2	Q8IYN0	ZN100_HUMAN	52.8	199	94	0	618	22	281	479	8.30E-63	241.5	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g1_i1	Q8IYN0	ZN100_HUMAN	52.5	160	76	0	3	482	264	423	5.60E-49	195.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g1_i2	Q8IYN0	ZN100_HUMAN	53.5	144	67	0	3	434	264	407	1.20E-44	180.6	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i2	Q8IYN0	ZN100_HUMAN	47.5	200	92	3	591	1	254	443	2.90E-49	196.4	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g2_i1	Q8IYN0	ZN100_HUMAN	52.8	142	67	0	428	3	261	402	5.20E-40	165.2	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12597_c0_g2_i1	Q8IYN0	ZN100_HUMAN	46.4	110	56	1	321	1	402	511	2.00E-23	109.8	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i5	Q8IYN0	ZN100_HUMAN	48.4	155	79	1	468	4	270	423	1.30E-39	164.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i6	Q8IYN0	ZN100_HUMAN	50	112	55	1	337	2	270	380	1.20E-26	120.6	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g2_i2	Q8IYN0	ZN100_HUMAN	46.4	252	135	0	758	3	255	506	3.50E-63	243	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c2_g1_i2	Q8IYN0	ZN100_HUMAN	48.6	70	36	0	3	212	313	382	2.90E-15	82	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g2_i1	Q8IYN0	ZN100_HUMAN	48.1	104	53	1	314	3	238	340	3.30E-23	109	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7346_c2_g1_i1	Q8IYN0	ZN100_HUMAN	57.1	98	42	0	300	7	423	520	9.30E-31	134	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g3_i1	Q8IYN0	ZN100_HUMAN	55.2	87	39	0	2	262	313	399	1.60E-23	109.8	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i10	Q8IYN0	ZN100_HUMAN	51.1	88	43	0	264	1	303	390	1.10E-22	107.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5360_c0_g1_i1	Q8IYN0	ZN100_HUMAN	61.3	75	29	0	2	226	331	405	1.50E-22	106.3	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN9347_c0_g1_i3	Q8IYN0	ZN100_HUMAN	62.6	115	43	0	1	345	255	369	9.40E-40	164.1	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9347_c0_g1_i5	Q8IYN0	ZN100_HUMAN	61	146	55	1	36	473	254	397	8.10E-50	198	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9347_c0_g1_i6	Q8IYN0	ZN100_HUMAN	51.9	154	64	1	36	497	254	397	1.10E-41	171	ZN100_HUMAN	reviewed	Zinc finger protein 100	ZNF100	Homo sapiens (Human)	542	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30590_c0_g1_i1	Q8IZC7	ZN101_HUMAN	100	79	0	0	2	238	171	249	2.60E-44	178.7	ZN101_HUMAN	reviewed	Zinc finger protein 101 (Zinc finger protein HZF12)	ZNF101	Homo sapiens (Human)	436	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN251_c0_g3_i1	Q9UII5	ZN107_HUMAN	48	102	47	2	354	49	426	521	6.30E-23	108.2	ZN107_HUMAN	reviewed	Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25)	ZNF107 ZFD25 ZNF588	Homo sapiens (Human)	783	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i4	P10751	ZFP11_MOUSE	47.7	86	42	1	273	16	333	415	2.30E-19	97.4	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i4	P10751	ZFP11_MOUSE	49.3	69	35	0	529	735	418	486	3.20E-13	77	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10439_c0_g2_i2	P10751	ZFP11_MOUSE	46.2	80	43	0	56	295	191	270	9.50E-17	87.4	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i30	P10751	ZFP11_MOUSE	37.9	177	96	4	412	939	124	287	1.50E-26	121.7	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i46	P10751	ZFP11_MOUSE	34.9	269	135	8	451	1251	57	287	2.20E-38	161.4	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10917_c0_g2_i1	P10751	ZFP11_MOUSE	43	93	51	2	311	33	197	287	5.30E-15	82	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i10	P10751	ZFP11_MOUSE	39	159	68	3	177	596	114	262	4.90E-28	125.9	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i11	P10751	ZFP11_MOUSE	40.2	194	89	4	6	506	69	262	1.70E-34	147.1	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26572_c0_g1_i1	P10751	ZFP11_MOUSE	41.1	248	142	3	762	25	58	303	9.60E-56	218.4	ZFP11_MOUSE	reviewed	Zinc finger protein 11 (Zfp-11) (Zinc finger protein Krox-6.1A/6.1B+/6.1B-)	Zfp11 Krox-6.1a Krox-6.1b	Mus musculus (Mouse)	647	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3502_c0_g1_i1	Q9UJU3	ZN112_HUMAN	49.7	149	74	1	450	7	551	699	6.70E-44	178.3	ZN112_HUMAN	reviewed	Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228)	ZNF112 ZFP112 ZNF228	Homo sapiens (Human)	913	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c4_g1_i1	Q7TSI0	ZNF12_MOUSE	45.6	307	158	3	155	1075	337	634	3.70E-74	280	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i22	Q7TSI0	ZNF12_MOUSE	48.6	72	37	0	216	1	371	442	2.00E-14	80.9	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i26	Q7TSI0	ZNF12_MOUSE	48.6	72	37	0	216	1	371	442	1.10E-14	81.3	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i28	Q7TSI0	ZNF12_MOUSE	48.6	72	37	0	216	1	371	442	2.00E-14	80.9	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26137_c0_g1_i1	Q7TSI0	ZNF12_MOUSE	54.3	81	35	2	239	3	369	449	2.50E-18	92.4	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c5_g1_i1	Q7TSI0	ZNF12_MOUSE	52.6	97	46	0	3	293	369	465	6.70E-24	111.3	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8239_c1_g1_i1	Q7TSI0	ZNF12_MOUSE	52.4	105	50	0	3	317	418	522	7.10E-26	117.9	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i1	Q7TSI0	ZNF12_MOUSE	49.5	97	49	0	8	298	340	436	2.80E-24	112.5	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c5_g1_i2	Q7TSI0	ZNF12_MOUSE	52.9	70	33	0	211	2	414	483	1.40E-14	79.7	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i3	Q7TSI0	ZNF12_MOUSE	49.7	171	78	2	52	543	368	537	1.80E-43	177.2	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c0_g2_i2	Q7TSI0	ZNF12_MOUSE	43.8	89	50	0	105	371	343	431	7.20E-16	85.1	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4336_c0_g2_i2	Q7TSI0	ZNF12_MOUSE	49.4	79	40	0	238	2	414	492	1.60E-14	79.7	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38575_c0_g1_i1	Q7TSI0	ZNF12_MOUSE	44.5	209	115	1	18	644	321	528	1.10E-49	198	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i2	Q7TSI0	ZNF12_MOUSE	56.1	82	36	0	6	251	312	393	4.40E-22	105.5	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g2_i1	Q7TSI0	ZNF12_MOUSE	55.9	111	49	0	3	335	315	425	5.90E-31	134.8	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i1	Q7TSI0	ZNF12_MOUSE	50	116	58	0	424	77	359	474	3.00E-27	122.9	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i8	Q7TSI0	ZNF12_MOUSE	57.1	84	33	1	2	253	397	477	4.80E-20	98.2	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25222_c0_g1_i7	Q7TSI0	ZNF12_MOUSE	56.6	76	33	0	4	231	403	478	1.10E-19	97.4	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16138_c0_g1_i2	Q7TSI0	ZNF12_MOUSE	53.9	152	70	0	5	460	403	554	5.40E-43	175.3	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g1_i10	Q7TSI0	ZNF12_MOUSE	59.6	99	40	0	3	299	432	530	3.60E-27	122.1	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i16	Q7TSI0	ZNF12_MOUSE	43	121	59	1	194	526	305	425	6.10E-22	105.5	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11097_c0_g1_i3	Q7TSI0	ZNF12_MOUSE	47.3	131	68	1	395	3	353	482	9.10E-26	117.9	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10236_c0_g1_i5	Q7TSI0	ZNF12_MOUSE	47.9	117	37	1	2	280	397	513	1.90E-22	106.3	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7554_c0_g1_i1	Q7TSI0	ZNF12_MOUSE	59.8	174	70	0	523	2	449	622	9.20E-55	214.5	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17290_c0_g1_i3	Q7TSI0	ZNF12_MOUSE	60	40	16	0	228	109	387	426	5.40E-07	54.7	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i12	Q7TSI0	ZNF12_MOUSE	50.3	189	94	0	2	568	293	481	5.90E-52	205.7	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i6	Q7TSI0	ZNF12_MOUSE	56.3	87	38	0	4	264	377	463	1.00E-22	107.1	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g2_i4	Q7TSI0	ZNF12_MOUSE	54.6	227	101	2	6	683	397	622	3.80E-62	239.6	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g1_i1	Q7TSI0	ZNF12_MOUSE	51.1	139	62	3	1	417	380	512	1.40E-29	130.6	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i9	Q7TSI0	ZNF12_MOUSE	47.5	118	62	0	354	1	359	476	3.60E-24	112.5	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c0_g1_i2	Q7TSI0	ZNF12_MOUSE	60.9	69	25	1	246	40	403	469	1.40E-16	86.7	ZNF12_MOUSE	reviewed	Zinc finger protein 12	Znf12 Zfp12	Mus musculus (Mouse)	686	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i3	P17014	ZNF12_HUMAN	51.6	345	159	2	2	1033	270	607	3.30E-96	353.2	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i11	P17014	ZNF12_HUMAN	53.5	144	67	0	434	3	256	399	3.80E-41	169.1	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c7_g3_i1	P17014	ZNF12_HUMAN	56.1	82	36	0	8	253	374	455	2.80E-20	99	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i13	P17014	ZNF12_HUMAN	58.1	93	39	0	327	49	581	673	6.60E-27	121.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i5	P17014	ZNF12_HUMAN	47.4	192	101	0	1	576	266	457	1.90E-48	193.7	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i26	P17014	ZNF12_HUMAN	50.6	77	38	0	236	6	365	441	3.80E-14	78.6	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8239_c1_g1_i2	P17014	ZNF12_HUMAN	57.4	94	40	0	3	284	508	601	1.30E-23	110.2	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20252_c0_g2_i1	P17014	ZNF12_HUMAN	100	80	0	0	241	2	530	609	1.00E-45	183.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20252_c0_g1_i1	P17014	ZNF12_HUMAN	100	81	0	0	245	3	275	355	1.60E-46	186	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i2	P17014	ZNF12_HUMAN	53.8	78	30	2	236	3	567	638	2.90E-16	85.5	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g1_i1	P17014	ZNF12_HUMAN	48.6	144	74	0	2	433	287	430	5.20E-38	158.7	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g1_i2	P17014	ZNF12_HUMAN	47.3	91	48	0	9	281	340	430	2.50E-20	99.4	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g1_i9	P17014	ZNF12_HUMAN	47.9	144	75	0	2	433	287	430	1.50E-37	157.1	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i8	P17014	ZNF12_HUMAN	51.1	223	108	1	3	668	276	498	7.10E-60	231.9	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g1_i1	P17014	ZNF12_HUMAN	53.4	191	89	0	7	579	290	480	6.20E-52	205.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g1_i2	P17014	ZNF12_HUMAN	58	157	66	0	3	473	438	594	2.10E-45	183.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i12	P17014	ZNF12_HUMAN	54.5	99	45	0	7	303	346	444	5.20E-26	118.2	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i2	P17014	ZNF12_HUMAN	48.5	130	57	1	8	367	291	420	5.10E-29	129	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i5	P17014	ZNF12_HUMAN	49	157	70	1	8	448	291	447	1.20E-37	157.5	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i9	P17014	ZNF12_HUMAN	47.5	162	70	2	8	463	291	447	6.50E-36	151.8	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g4_i1	P17014	ZNF12_HUMAN	48.2	114	59	0	347	6	318	431	3.50E-29	129.4	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7554_c0_g1_i3	P17014	ZNF12_HUMAN	59.6	146	59	0	439	2	511	656	7.30E-45	181.4	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7554_c0_g1_i4	P17014	ZNF12_HUMAN	57.6	158	67	0	475	2	499	656	9.30E-46	184.5	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i6	P17014	ZNF12_HUMAN	44.3	106	52	2	20	316	342	447	7.20E-18	91.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c6_g1_i1	P17014	ZNF12_HUMAN	100	88	0	0	264	1	372	459	1.20E-50	199.9	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c0_g3_i1	P17014	ZNF12_HUMAN	90.8	87	8	0	266	6	597	683	1.50E-45	183	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g1_i4	P17014	ZNF12_HUMAN	53.1	113	53	0	3	341	343	455	5.70E-28	125.6	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i1	P17014	ZNF12_HUMAN	52.3	172	82	0	1	516	298	469	2.20E-45	183.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i1	P17014	ZNF12_HUMAN	47.4	57	30	0	176	6	365	421	2.60E-07	55.8	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i10	P17014	ZNF12_HUMAN	50	94	47	0	283	2	365	458	9.60E-18	91.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i15	P17014	ZNF12_HUMAN	50	94	47	0	283	2	365	458	3.30E-18	92.4	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i16	P17014	ZNF12_HUMAN	50	94	47	0	283	2	365	458	2.60E-19	96.7	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i4	P17014	ZNF12_HUMAN	50	94	47	0	283	2	365	458	1.70E-18	93.2	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i7	P17014	ZNF12_HUMAN	50	94	47	0	283	2	365	458	1.40E-17	90.5	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i9	P17014	ZNF12_HUMAN	50	94	47	0	283	2	365	458	1.30E-17	90.5	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g2_i2	P17014	ZNF12_HUMAN	55.3	199	88	1	3	599	346	543	2.10E-55	217.2	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g2_i3	P17014	ZNF12_HUMAN	57.7	194	82	0	3	584	346	539	8.20E-60	231.5	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i3	P17014	ZNF12_HUMAN	50.9	108	53	0	327	4	318	425	3.90E-27	122.1	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g1_i3	P17014	ZNF12_HUMAN	54.7	159	72	0	479	3	297	455	3.20E-46	186	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g1_i4	P17014	ZNF12_HUMAN	56.3	103	45	0	311	3	353	455	4.80E-27	121.7	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g1_i6	P17014	ZNF12_HUMAN	55.1	158	71	0	476	3	298	455	2.10E-45	183.3	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9362_c1_g1_i1	P17014	ZNF12_HUMAN	52.4	359	171	0	1078	2	271	629	7.30E-107	388.7	ZNF12_HUMAN	reviewed	Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	697	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17803_c0_g1_i3	Q8BZW4	ZN120_MOUSE	59.7	176	43	1	448	5	158	333	1.80E-59	229.9	ZN120_MOUSE	reviewed	Zinc finger protein 120 (Zinc finger protein 31) (mZF31)	Zfp120	Mus musculus (Mouse)	436	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i16	P58317	ZN121_HUMAN	48.7	78	40	0	2	235	145	222	2.20E-17	90.1	ZN121_HUMAN	reviewed	Zinc finger protein 121 (Zinc finger protein 20)	ZNF121 ZNF20	Homo sapiens (Human)	390	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27341_c0_g1_i1	P58317	ZN121_HUMAN	60.4	91	34	2	276	4	284	372	8.60E-28	124	ZN121_HUMAN	reviewed	Zinc finger protein 121 (Zinc finger protein 20)	ZNF121 ZNF20	Homo sapiens (Human)	390	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i21	P10754	ZFP13_MOUSE	37.8	90	48	1	12	281	364	445	2.20E-13	76.3	ZFP13_MOUSE	reviewed	Zinc finger protein 13 (Zfp-13) (Zinc finger protein Krox-8)	Zfp13 Krox-8 Zfp-13	Mus musculus (Mouse)	512	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]"	mitochondrion [GO:0005739]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005739; GO:0006357; GO:0010729; GO:0046872; GO:1901030	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2136_c0_g2_i1	P10754	ZFP13_MOUSE	47.5	59	31	0	305	129	254	312	1.20E-09	64.3	ZFP13_MOUSE	reviewed	Zinc finger protein 13 (Zfp-13) (Zinc finger protein Krox-8)	Zfp13 Krox-8 Zfp-13	Mus musculus (Mouse)	512	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]"	mitochondrion [GO:0005739]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005739; GO:0006357; GO:0010729; GO:0046872; GO:1901030	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3354_c0_g1_i4	P52740	ZN132_HUMAN	50.9	53	26	0	161	3	341	393	1.70E-11	70.1	ZN132_HUMAN	reviewed	Zinc finger protein 132	ZNF132	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25822_c0_g1_i1	P52736	ZN133_HUMAN	100	87	0	0	2	262	286	372	4.20E-48	191.4	ZN133_HUMAN	reviewed	Zinc finger protein 133 (Zinc finger protein 150)	ZNF133 ZNF150	Homo sapiens (Human)	654	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i2	P52741	ZN134_HUMAN	48.8	129	66	0	392	6	178	306	4.80E-32	138.7	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i8	P52741	ZN134_HUMAN	49.6	129	65	0	392	6	178	306	2.10E-32	139.8	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i11	P52741	ZN134_HUMAN	52.6	78	37	0	2	235	180	257	2.10E-19	95.9	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i17	P52741	ZN134_HUMAN	52.8	36	17	0	106	213	222	257	2.70E-05	48.9	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13052_c0_g2_i1	P52741	ZN134_HUMAN	47.2	53	28	0	165	7	198	250	3.00E-09	62	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c2_g1_i3	P52741	ZN134_HUMAN	52.9	70	33	0	210	1	180	249	7.60E-16	84	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30587_c0_g1_i1	P52741	ZN134_HUMAN	100	71	0	0	1	213	340	410	3.80E-39	161.4	ZN134_HUMAN	reviewed	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	427	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4971_c0_g1_i1	Q08DG8	ZN135_BOVIN	32.1	274	158	8	118	939	243	488	1.00E-33	145.6	ZN135_BOVIN	reviewed	Zinc finger protein 135	ZNF135	Bos taurus (Bovine)	657	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i11	P52742	ZN135_HUMAN	48.5	99	48	1	299	595	294	389	1.80E-22	107.5	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i1	P52742	ZN135_HUMAN	46.3	134	59	3	8	388	368	495	2.50E-25	116.3	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i11	P52742	ZN135_HUMAN	50	374	187	0	12	1133	285	658	2.20E-112	407.1	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i18	P52742	ZN135_HUMAN	51.3	374	182	0	12	1133	285	658	1.70E-114	414.1	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8500_c1_g2_i1	P52742	ZN135_HUMAN	58.2	91	38	0	273	1	327	417	4.70E-26	118.2	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i6	P52742	ZN135_HUMAN	44.7	85	47	0	278	24	292	376	6.20E-17	88.6	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c0_g2_i1	P52742	ZN135_HUMAN	69.7	66	20	0	3	200	453	518	3.60E-23	108.2	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g2_i6	P52742	ZN135_HUMAN	53.9	76	35	0	335	562	294	369	2.00E-18	94	ZN135_HUMAN	reviewed	Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1)	ZNF135 ZNF61 ZNF78L1	Homo sapiens (Human)	658	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872	cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24137_c0_g2_i1	P17017	ZNF14_HUMAN	66	94	32	0	287	6	549	642	3.80E-34	145.2	ZNF14_HUMAN	reviewed	Zinc finger protein 14 (Gonadotropin-inducible ovary transcription repressor 4) (GIOT-4) (Zinc finger protein KOX6)	ZNF14 GIOT4 KOX6	Homo sapiens (Human)	642	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3745_c0_g1_i1	P52738	ZN140_HUMAN	57.7	52	22	0	166	11	212	263	3.20E-11	69.3	ZN140_HUMAN	reviewed	Zinc finger protein 140	ZNF140	Homo sapiens (Human)	457	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0043565; GO:0046872; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i5	P52738	ZN140_HUMAN	42.2	187	97	2	572	45	165	351	6.40E-41	168.7	ZN140_HUMAN	reviewed	Zinc finger protein 140	ZNF140	Homo sapiens (Human)	457	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0043565; GO:0046872; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34064_c0_g1_i1	P52738	ZN140_HUMAN	100	68	0	0	206	3	156	223	3.10E-38	158.3	ZN140_HUMAN	reviewed	Zinc finger protein 140	ZNF140	Homo sapiens (Human)	457	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0043565; GO:0046872; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN240_c0_g1_i1	G5E869	ZN142_MOUSE	31.6	98	60	2	579	851	542	639	3.80E-06	53.9	ZN142_MOUSE	reviewed	Zinc finger protein 142	Znf142 Kiaa0236 Zfp142	Mus musculus (Mouse)	1843	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN240_c0_g1_i5	G5E869	ZN142_MOUSE	31.6	98	60	2	903	1175	542	639	5.10E-06	53.9	ZN142_MOUSE	reviewed	Zinc finger protein 142	Znf142 Kiaa0236 Zfp142	Mus musculus (Mouse)	1843	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN5063_c0_g1_i1	G5E869	ZN142_MOUSE	29.8	242	146	6	1447	725	1582	1800	4.60E-26	121.3	ZN142_MOUSE	reviewed	Zinc finger protein 142	Znf142 Kiaa0236 Zfp142	Mus musculus (Mouse)	1843	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN21113_c0_g1_i1	P52747	ZN143_HUMAN	98.6	71	1	0	2	214	343	413	6.50E-39	160.6	ZN143_HUMAN	reviewed	Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor) (hStaf)	ZNF143 SBF STAF	Homo sapiens (Human)	638	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0006355; GO:0006357; GO:0006359; GO:0042795; GO:0045944; GO:0045945; GO:0046872; GO:1905382	"positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; snRNA transcription by RNA polymerase II [GO:0042795]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27791_c0_g1_i1	Q3Y4E1	ZN148_BOVIN	100	79	0	0	237	1	157	235	8.70E-45	180.3	ZN148_BOVIN	reviewed	Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89)	ZNF148 ZBP89	Bos taurus (Bovine)	794	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN30488_c0_g1_i1	Q3Y4E1	ZN148_BOVIN	37.5	72	38	2	344	129	153	217	4.70E-07	55.5	ZN148_BOVIN	reviewed	Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89)	ZNF148 ZBP89	Bos taurus (Bovine)	794	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8990_c0_g2_i1	Q13106	ZN154_HUMAN	43.8	105	59	0	352	38	191	295	4.80E-23	108.6	ZN154_HUMAN	reviewed	Zinc finger protein 154	ZNF154 KIAA2003	Homo sapiens (Human)	437	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i2	Q13106	ZN154_HUMAN	44.8	58	32	0	124	297	195	252	3.30E-09	62.4	ZN154_HUMAN	reviewed	Zinc finger protein 154	ZNF154 KIAA2003	Homo sapiens (Human)	437	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i2	Q13106	ZN154_HUMAN	52.4	42	20	0	3	128	183	224	9.10E-07	54.3	ZN154_HUMAN	reviewed	Zinc finger protein 154	ZNF154 KIAA2003	Homo sapiens (Human)	437	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i6	Q13106	ZN154_HUMAN	44.2	86	48	0	3	260	183	268	5.00E-17	88.2	ZN154_HUMAN	reviewed	Zinc finger protein 154	ZNF154 KIAA2003	Homo sapiens (Human)	437	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i5	Q12901	ZN155_HUMAN	42	81	47	0	429	187	370	450	1.00E-14	81.3	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i8	Q12901	ZN155_HUMAN	47	66	35	0	1	198	385	450	6.20E-11	67.8	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g1_i4	Q12901	ZN155_HUMAN	45.6	57	31	0	11	181	394	450	3.80E-10	65.1	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g1_i5	Q12901	ZN155_HUMAN	44.8	58	32	0	8	181	393	450	1.70E-10	66.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g1_i2	Q12901	ZN155_HUMAN	42.5	113	65	0	387	49	338	450	9.00E-23	107.8	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g1_i4	Q12901	ZN155_HUMAN	47.2	89	47	0	268	2	366	454	1.50E-16	86.7	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8500_c0_g1_i1	Q12901	ZN155_HUMAN	44.8	58	32	0	218	45	393	450	4.50E-11	68.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i1	Q12901	ZN155_HUMAN	46.2	93	50	0	279	1	334	426	7.40E-19	94.4	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i4	Q12901	ZN155_HUMAN	41.9	117	68	0	359	9	334	450	1.70E-23	110.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i6	Q12901	ZN155_HUMAN	47.7	65	34	0	345	151	362	426	3.10E-11	69.3	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i6	Q12901	ZN155_HUMAN	44.7	47	26	0	149	9	404	450	3.00E-06	52.8	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12336_c3_g1_i1	Q12901	ZN155_HUMAN	100	80	0	0	242	3	421	500	3.10E-45	181.8	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i1	Q12901	ZN155_HUMAN	48.6	70	36	0	210	1	394	463	2.50E-14	79	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i5	Q12901	ZN155_HUMAN	45.2	62	34	0	292	107	369	430	2.10E-08	59.7	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i7	Q12901	ZN155_HUMAN	42.7	110	63	0	389	60	369	478	4.60E-19	95.5	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18037_c0_g1_i2	Q12901	ZN155_HUMAN	43.2	111	63	0	337	5	321	431	2.70E-23	109.4	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5058_c0_g1_i5	Q12901	ZN155_HUMAN	41.7	72	42	0	2	217	379	450	4.80E-11	68.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i1	Q12901	ZN155_HUMAN	44.3	79	41	1	270	34	367	442	1.00E-12	73.9	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i10	Q12901	ZN155_HUMAN	48.6	105	54	0	344	30	367	471	1.20E-23	110.5	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c1_g1_i2	Q12901	ZN155_HUMAN	42.2	64	37	0	6	197	387	450	3.00E-10	66.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c1_g1_i4	Q12901	ZN155_HUMAN	43.6	55	31	0	35	199	396	450	9.60E-09	61.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g2_i1	Q12901	ZN155_HUMAN	42.5	127	73	0	383	3	303	429	2.10E-24	113.2	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g2_i3	Q12901	ZN155_HUMAN	45.3	117	64	0	355	5	362	478	1.00E-23	110.9	ZN155_HUMAN	reviewed	Zinc finger protein 155	ZNF155	Homo sapiens (Human)	538	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g1_i3	P51786	ZN157_HUMAN	41.9	93	51	1	6	284	225	314	5.60E-14	78.2	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c4_g1_i1	P51786	ZN157_HUMAN	45.1	82	45	0	247	2	199	280	6.10E-15	81.3	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i7	P51786	ZN157_HUMAN	54.8	115	50	1	377	33	194	306	3.70E-29	129	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i11	P51786	ZN157_HUMAN	52.3	86	32	1	259	2	166	242	3.20E-16	85.5	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i12	P51786	ZN157_HUMAN	47.3	131	58	1	516	157	166	296	1.40E-26	120.9	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i30	P51786	ZN157_HUMAN	58.9	90	37	0	275	6	166	255	2.00E-24	112.8	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i6	P51786	ZN157_HUMAN	47.3	131	58	1	446	87	166	296	5.80E-26	118.6	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g1_i5	P51786	ZN157_HUMAN	54.9	144	65	0	1	432	161	304	3.30E-42	172.6	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c0_g1_i1	P51786	ZN157_HUMAN	48.9	94	48	0	314	33	241	334	8.00E-22	104.4	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g1_i7	P51786	ZN157_HUMAN	45.8	96	52	0	5	292	229	324	3.20E-21	102.4	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i7	P51786	ZN157_HUMAN	54.7	86	39	0	1	258	187	272	9.60E-21	100.5	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c1_g1_i1	P51786	ZN157_HUMAN	48.3	58	30	0	820	993	240	297	4.20E-08	60.5	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g2_i2	P51786	ZN157_HUMAN	42	69	40	0	161	367	202	270	1.10E-09	64.3	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g2_i5	P51786	ZN157_HUMAN	42	69	40	0	194	400	202	270	1.20E-09	64.3	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i3	P51786	ZN157_HUMAN	45.6	103	56	0	368	60	222	324	5.60E-22	105.1	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g1_i6	P51786	ZN157_HUMAN	58.2	79	33	0	239	3	246	324	8.80E-21	101.3	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g1_i3	P51786	ZN157_HUMAN	55.3	132	55	1	1	396	240	367	2.20E-37	157.1	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g1_i5	P51786	ZN157_HUMAN	59.6	89	33	1	1	267	240	325	4.50E-24	112.5	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g1_i9	P51786	ZN157_HUMAN	54.3	151	69	0	1	453	240	390	1.20E-45	184.1	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g1_i1	P51786	ZN157_HUMAN	48.5	99	51	0	299	3	199	297	4.10E-24	112.1	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3354_c0_g2_i1	P51786	ZN157_HUMAN	43.6	94	47	1	287	6	205	292	2.70E-16	85.9	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i1	P51786	ZN157_HUMAN	59.5	116	47	0	3	350	194	309	6.00E-34	144.8	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i14	P51786	ZN157_HUMAN	59.2	103	35	2	8	307	211	309	2.40E-26	119.4	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i18	P51786	ZN157_HUMAN	46.3	147	76	1	56	487	156	302	8.40E-30	131.7	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i24	P51786	ZN157_HUMAN	58.5	147	60	1	3	443	166	311	1.60E-44	180.3	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i7	P51786	ZN157_HUMAN	52.2	92	33	1	6	281	250	330	1.10E-19	97.4	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i8	P51786	ZN157_HUMAN	57.8	135	56	1	3	407	194	327	8.50E-39	161.4	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i1	P51786	ZN157_HUMAN	55.7	115	51	0	170	514	206	320	1.30E-32	141	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g1_i4	P51786	ZN157_HUMAN	47.2	195	102	1	6	587	131	325	7.20E-48	191.8	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i2	P51786	ZN157_HUMAN	49.2	118	60	0	358	5	181	298	3.00E-28	125.9	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i13	P51786	ZN157_HUMAN	44.2	86	48	0	1	258	194	279	1.60E-16	86.7	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i16	P51786	ZN157_HUMAN	40.6	197	117	0	476	1066	246	442	4.00E-41	170.2	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i18	P51786	ZN157_HUMAN	55	60	27	0	3	182	163	222	4.40E-14	78.6	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i4	P51786	ZN157_HUMAN	45.9	229	124	0	68	754	180	408	7.50E-59	228.8	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i2	P51786	ZN157_HUMAN	48.5	99	51	0	299	3	204	302	1.70E-20	100.9	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i29	P51786	ZN157_HUMAN	49.5	99	50	0	299	3	204	302	2.60E-21	103.2	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i7	P51786	ZN157_HUMAN	56.1	41	18	0	127	5	230	270	2.40E-06	53.5	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i9	P51786	ZN157_HUMAN	56.7	97	42	0	293	3	190	286	1.00E-26	120.6	ZN157_HUMAN	reviewed	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	506	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3678_c0_g1_i1	A2T759	ZNF16_PANTR	30.6	399	265	10	1320	130	240	628	2.50E-52	208	ZNF16_PANTR	reviewed	Zinc finger protein 16	ZNF16	Pan troglodytes (Chimpanzee)	682	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3678_c0_g1_i3	A2T759	ZNF16_PANTR	30.6	399	265	10	1320	130	240	628	5.00E-52	208	ZNF16_PANTR	reviewed	Zinc finger protein 16	ZNF16	Pan troglodytes (Chimpanzee)	682	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6444_c0_g1_i1	A2T759	ZNF16_PANTR	41.8	141	81	1	13	435	342	481	1.30E-30	135.6	ZNF16_PANTR	reviewed	Zinc finger protein 16	ZNF16	Pan troglodytes (Chimpanzee)	682	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22826_c0_g1_i1	P17020	ZNF16_HUMAN	100	85	0	0	1	255	449	533	5.30E-48	191	ZNF16_HUMAN	reviewed	Zinc finger protein 16 (Zinc finger protein KOX9)	ZNF16 HZF1 KOX9	Homo sapiens (Human)	682	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i4	Q9HCG1	ZN160_HUMAN	43.8	130	72	1	8	394	458	587	7.70E-31	134.8	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i1	Q9HCG1	ZN160_HUMAN	56.7	67	29	0	309	509	499	565	2.40E-15	83.6	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i5	Q9HCG1	ZN160_HUMAN	56.7	67	29	0	122	322	499	565	1.50E-15	83.6	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i1	Q9HCG1	ZN160_HUMAN	40.2	117	61	1	354	4	627	734	6.10E-18	91.7	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7886_c0_g1_i1	Q9HCG1	ZN160_HUMAN	50	64	32	0	5	196	524	587	9.60E-14	77	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g4_i1	Q9HCG1	ZN160_HUMAN	43.9	66	37	0	41	238	718	783	1.50E-12	73.2	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g2_i2	Q9HCG1	ZN160_HUMAN	43.4	106	57	1	3	320	709	811	3.60E-20	99	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i10	Q9HCG1	ZN160_HUMAN	43.6	179	101	0	3	539	625	803	1.60E-41	170.6	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i2	Q9HCG1	ZN160_HUMAN	48.8	80	41	0	248	9	504	583	2.70E-17	89	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6587_c0_g1_i4	Q9HCG1	ZN160_HUMAN	43.3	141	80	0	439	17	671	811	1.20E-31	137.5	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7284_c0_g1_i1	Q9HCG1	ZN160_HUMAN	39.6	328	171	2	24	926	453	780	1.50E-68	261.2	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26278_c0_g1_i1	Q9HCG1	ZN160_HUMAN	100	82	0	0	246	1	522	603	2.10E-46	185.7	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i3	Q9HCG1	ZN160_HUMAN	53.1	130	61	0	394	5	658	787	3.90E-37	155.6	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i1	Q9HCG1	ZN160_HUMAN	57.1	49	21	0	211	65	511	559	2.50E-11	68.9	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7326_c0_g2_i2	Q9HCG1	ZN160_HUMAN	50	126	63	0	383	6	281	406	9.00E-31	134.4	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i15	Q9HCG1	ZN160_HUMAN	49.4	89	40	1	270	4	482	565	7.20E-19	94.4	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14462_c0_g1_i3	Q9HCG1	ZN160_HUMAN	51.9	54	26	0	92	253	262	315	1.20E-10	67	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i1	Q9HCG1	ZN160_HUMAN	45.9	122	66	0	12	377	490	611	8.30E-29	127.9	ZN160_HUMAN	reviewed	Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)	ZNF160 KIAA1611	Homo sapiens (Human)	818	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872	hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i7	P49910	ZN165_HUMAN	60	55	22	0	50	214	339	393	2.50E-13	76.3	ZN165_HUMAN	reviewed	Zinc finger protein 165 (Cancer/testis antigen 53) (CT53) (LD65) (Zinc finger and SCAN domain-containing protein 7)	ZNF165 ZPF165 ZSCAN7	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7116_c0_g1_i1	Q14929	ZN169_HUMAN	32.3	251	152	6	741	7	223	461	1.60E-24	114.8	ZN169_HUMAN	reviewed	Zinc finger protein 169	ZNF169	Homo sapiens (Human)	603	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c1_g1_i1	P17021	ZNF17_HUMAN	47.3	74	39	0	19	240	196	269	6.30E-14	77.8	ZNF17_HUMAN	reviewed	Zinc finger protein 17 (Zinc finger protein HPF3) (Zinc finger protein KOX10)	ZNF17 KIAA1947 KOX10	Homo sapiens (Human)	662	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i10	P17021	ZNF17_HUMAN	45.9	61	33	0	9	191	208	268	1.10E-11	70.9	ZNF17_HUMAN	reviewed	Zinc finger protein 17 (Zinc finger protein HPF3) (Zinc finger protein KOX10)	ZNF17 KIAA1947 KOX10	Homo sapiens (Human)	662	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i3	Q9Y473	ZN175_HUMAN	53.5	71	33	0	518	306	503	573	4.40E-17	89.4	ZN175_HUMAN	reviewed	Zinc finger protein 175 (Zinc finger protein OTK18)	ZNF175	Homo sapiens (Human)	711	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045111; GO:0045944; GO:0046872; GO:0051607	defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i1	Q9Y473	ZN175_HUMAN	47.4	78	41	0	236	3	459	536	2.80E-14	79.3	ZN175_HUMAN	reviewed	Zinc finger protein 175 (Zinc finger protein OTK18)	ZNF175	Homo sapiens (Human)	711	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045111; GO:0045944; GO:0046872; GO:0051607	defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1848_c0_g1_i1	Q9Y473	ZN175_HUMAN	46.1	152	82	0	1	456	430	581	2.90E-36	152.9	ZN175_HUMAN	reviewed	Zinc finger protein 175 (Zinc finger protein OTK18)	ZNF175	Homo sapiens (Human)	711	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045111; GO:0045944; GO:0046872; GO:0051607	defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g3_i1	Q9Y473	ZN175_HUMAN	47.7	111	58	0	11	343	409	519	1.10E-24	114	ZN175_HUMAN	reviewed	Zinc finger protein 175 (Zinc finger protein OTK18)	ZNF175	Homo sapiens (Human)	711	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045111; GO:0045944; GO:0046872; GO:0051607	defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g2_i1	Q13360	ZN177_HUMAN	48.4	93	48	0	279	1	299	391	1.50E-19	96.7	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i9	Q13360	ZN177_HUMAN	45.7	129	69	1	14	397	275	403	3.10E-31	136	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18204_c0_g1_i2	Q13360	ZN177_HUMAN	57.5	113	48	0	15	353	286	398	6.60E-35	148.3	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN28684_c0_g1_i1	Q13360	ZN177_HUMAN	36.8	125	78	1	6	377	321	445	4.60E-24	112.1	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4115_c0_g1_i1	Q13360	ZN177_HUMAN	39.1	128	72	3	388	8	270	392	4.70E-18	92.4	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4115_c0_g1_i3	Q13360	ZN177_HUMAN	50	66	33	0	205	8	299	364	8.10E-15	80.5	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g2_i6	Q13360	ZN177_HUMAN	46.2	104	56	0	60	371	280	383	1.30E-23	110.5	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i11	Q13360	ZN177_HUMAN	42.6	108	54	1	8	307	284	391	3.80E-24	112.5	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22064_c1_g1_i1	Q13360	ZN177_HUMAN	51.9	77	37	0	342	112	342	418	7.70E-18	91.3	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i6	Q13360	ZN177_HUMAN	50.9	108	51	1	3	320	298	405	2.60E-28	125.9	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34869_c0_g1_i1	Q13360	ZN177_HUMAN	40.6	69	40	1	2	208	295	362	3.40E-10	65.5	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g2_i4	Q13360	ZN177_HUMAN	48.1	79	41	0	238	2	353	431	1.10E-15	83.6	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9339_c1_g1_i1	Q13360	ZN177_HUMAN	40.7	118	69	1	2	352	327	444	1.20E-24	114.4	ZN177_HUMAN	reviewed	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	481	"blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	blood microparticle [GO:0072562]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:0072562; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24908_c0_g1_i1	Q642B9	ZNF18_RAT	51.1	47	23	0	232	92	443	489	6.30E-08	58.9	ZNF18_RAT	reviewed	Zinc finger protein 18 (Zinc finger protein 535)	Znf18 Zfp18 Zfp535	Rattus norvegicus (Rat)	556	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g1_i4	Q9UJW8	ZN180_HUMAN	47.1	104	55	0	319	8	526	629	2.00E-23	109.8	ZN180_HUMAN	reviewed	Zinc finger protein 180 (HHZ168)	ZNF180	Homo sapiens (Human)	692	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g1_i1	Q9UJW8	ZN180_HUMAN	71	107	31	0	324	4	543	649	3.80E-43	175.3	ZN180_HUMAN	reviewed	Zinc finger protein 180 (HHZ168)	ZNF180	Homo sapiens (Human)	692	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i8	Q9UJW8	ZN180_HUMAN	51.6	64	31	0	232	423	508	571	3.60E-12	72.8	ZN180_HUMAN	reviewed	Zinc finger protein 180 (HHZ168)	ZNF180	Homo sapiens (Human)	692	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g2_i2	Q2KI58	ZN181_BOVIN	54.5	66	30	0	199	2	251	316	6.00E-16	84.3	ZN181_BOVIN	reviewed	Zinc finger protein 181	ZNF181	Bos taurus (Bovine)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i1	Q2KI58	ZN181_BOVIN	50.6	81	40	0	6	248	262	342	3.50E-21	102.1	ZN181_BOVIN	reviewed	Zinc finger protein 181	ZNF181	Bos taurus (Bovine)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5698_c0_g1_i9	Q2M3W8	ZN181_HUMAN	51.4	72	35	0	1	216	259	330	9.40E-17	87	ZN181_HUMAN	reviewed	Zinc finger protein 181 (HHZ181)	ZNF181	Homo sapiens (Human)	571	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23993_c0_g1_i1	Q2M3W8	ZN181_HUMAN	52.2	90	43	0	271	2	239	328	9.80E-24	110.5	ZN181_HUMAN	reviewed	Zinc finger protein 181 (HHZ181)	ZNF181	Homo sapiens (Human)	571	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3745_c0_g1_i4	Q2M3W8	ZN181_HUMAN	52.7	55	26	0	166	2	260	314	4.90E-12	72	ZN181_HUMAN	reviewed	Zinc finger protein 181 (HHZ181)	ZNF181	Homo sapiens (Human)	571	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i15	Q2M3W8	ZN181_HUMAN	54.1	85	39	0	261	7	255	339	1.50E-24	113.2	ZN181_HUMAN	reviewed	Zinc finger protein 181 (HHZ181)	ZNF181	Homo sapiens (Human)	571	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9516_c0_g1_i2	Q2M3W8	ZN181_HUMAN	52.5	61	29	0	8	190	259	319	9.70E-13	74.3	ZN181_HUMAN	reviewed	Zinc finger protein 181 (HHZ181)	ZNF181	Homo sapiens (Human)	571	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i5	Q2M3W8	ZN181_HUMAN	48.5	97	50	0	293	3	234	330	9.80E-25	114	ZN181_HUMAN	reviewed	Zinc finger protein 181 (HHZ181)	ZNF181	Homo sapiens (Human)	571	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g2_i1	Q6P560	ZN182_MOUSE	51.8	85	40	1	7	258	537	621	1.40E-19	96.7	ZN182_MOUSE	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	Znf182 Zfp182 Znf21	Mus musculus (Mouse)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i12	Q5R9S5	ZN182_PONAB	43.1	181	81	3	548	6	249	407	1.10E-34	147.9	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i1	Q6P560	ZN182_MOUSE	45.6	79	42	1	9	245	240	317	2.70E-12	72.4	ZN182_MOUSE	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	Znf182 Zfp182 Znf21	Mus musculus (Mouse)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i4	Q5R9S5	ZN182_PONAB	62.2	37	14	0	88	198	289	325	8.40E-07	54.7	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c1_g1_i1	Q5R9S5	ZN182_PONAB	51.4	107	52	0	1	321	292	398	3.80E-27	122.1	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g2_i1	Q5R9S5	ZN182_PONAB	40	100	50	1	3	302	247	336	7.50E-17	87.8	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i1	Q5R9S5	ZN182_PONAB	52.3	86	41	0	259	2	292	377	3.30E-21	102.8	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i10	Q5R9S5	ZN182_PONAB	43.5	115	44	2	317	6	292	396	5.90E-18	91.7	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i3	Q5R9S5	ZN182_PONAB	54	139	64	0	419	3	275	413	7.40E-39	161.4	ZN182_PONAB	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	ZNF182 ZNF21	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	620	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g1_i11	P17025	ZN182_HUMAN	37.1	89	54	2	16	282	328	414	1.20E-06	53.9	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i6	P17025	ZN182_HUMAN	50.5	101	50	0	306	4	320	420	8.40E-24	110.9	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i9	P17025	ZN182_HUMAN	54.1	37	17	0	124	14	392	428	2.30E-05	49.3	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i3	P17025	ZN182_HUMAN	50	58	29	0	176	3	284	341	3.00E-11	69.3	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i6	P17025	ZN182_HUMAN	50	58	29	0	176	3	284	341	7.40E-11	68.6	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i9	P17025	ZN182_HUMAN	50	58	29	0	176	3	284	341	4.30E-11	69.3	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i24	P17025	ZN182_HUMAN	35.8	151	92	3	445	2	314	462	6.50E-17	88.6	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i24	P17025	ZN182_HUMAN	36.9	111	64	1	356	24	300	404	5.70E-13	75.5	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i7	P17025	ZN182_HUMAN	57.8	116	49	0	1	348	283	398	1.00E-33	144.1	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i17	P17025	ZN182_HUMAN	35.1	134	83	2	400	2	214	344	2.60E-18	94	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i8	P17025	ZN182_HUMAN	35.1	134	83	2	400	2	214	344	3.40E-18	94	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i1	P17025	ZN182_HUMAN	49.3	138	70	0	3	416	319	456	1.30E-32	140.6	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i8	P17025	ZN182_HUMAN	50.7	146	72	0	8	445	311	456	1.50E-37	157.1	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i5	P17025	ZN182_HUMAN	31.6	196	108	5	3	545	264	448	7.50E-23	108.6	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i12	P17025	ZN182_HUMAN	51.2	123	56	1	371	3	314	432	4.50E-29	129	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i14	P17025	ZN182_HUMAN	42.1	152	73	4	452	3	322	460	8.60E-25	114.8	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i9	P17025	ZN182_HUMAN	50.9	110	54	0	2	331	364	473	1.60E-23	110.9	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g1_i4	P17025	ZN182_HUMAN	50.3	177	88	0	6	536	252	428	4.10E-45	182.6	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12160_c0_g1_i3	P17025	ZN182_HUMAN	55.6	135	58	2	401	3	235	369	5.60E-36	151.8	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i2	P17025	ZN182_HUMAN	45	131	72	0	419	27	322	452	1.60E-30	134	ZN182_HUMAN	reviewed	Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14)	ZNF182 KOX14 ZNF21	Homo sapiens (Human)	639	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17793_c1_g2_i1	A6QLU5	ZN184_BOVIN	49.6	133	67	0	402	4	408	540	2.60E-33	142.9	ZN184_BOVIN	reviewed	Zinc finger protein 184	ZNF184	Bos taurus (Bovine)	752	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c1_g1_i1	A6QLU5	ZN184_BOVIN	53.7	123	57	0	375	7	396	518	3.80E-34	145.6	ZN184_BOVIN	reviewed	Zinc finger protein 184	ZNF184	Bos taurus (Bovine)	752	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN357_c0_g1_i1	Q99676	ZN184_HUMAN	40.1	426	254	1	34	1308	299	724	6.40E-100	365.9	ZN184_HUMAN	reviewed	Zinc finger protein 184	ZNF184	Homo sapiens (Human)	751	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16009_c0_g1_i2	A6QLU5	ZN184_BOVIN	83.1	89	15	0	2	268	284	372	7.10E-43	174.1	ZN184_BOVIN	reviewed	Zinc finger protein 184	ZNF184	Bos taurus (Bovine)	752	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34883_c0_g1_i1	O75820	ZN189_HUMAN	100	71	0	0	3	215	471	541	4.90E-39	161	ZN189_HUMAN	reviewed	Zinc finger protein 189	ZNF189	Homo sapiens (Human)	626	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30018_c0_g1_i1	O75820	ZN189_HUMAN	42.9	77	43	1	236	6	191	266	3.00E-14	79	ZN189_HUMAN	reviewed	Zinc finger protein 189	ZNF189	Homo sapiens (Human)	626	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c2_g1_i4	Q5R7I8	ZNF19_PONAB	35.5	76	49	0	233	6	322	397	9.10E-10	63.9	ZNF19_PONAB	reviewed	Zinc finger protein 19	ZNF19	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	446	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3897_c0_g1_i1	P17023	ZNF19_HUMAN	41.3	223	126	4	1050	391	157	377	2.40E-42	174.9	ZNF19_HUMAN	reviewed	Zinc finger protein 19 (Zinc finger protein KOX12)	ZNF19 KOX12	Homo sapiens (Human)	458	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c2_g1_i3	P17023	ZNF19_HUMAN	39.2	79	48	0	253	17	302	380	9.40E-13	73.9	ZNF19_HUMAN	reviewed	Zinc finger protein 19 (Zinc finger protein KOX12)	ZNF19 KOX12	Homo sapiens (Human)	458	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37879_c0_g1_i1	O14628	ZN195_HUMAN	34.6	52	34	0	188	33	480	531	1.10E-06	53.5	ZN195_HUMAN	reviewed	Zinc finger protein 195	ZNF195 ZNFP104	Homo sapiens (Human)	629	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34876_c0_g1_i1	O14628	ZN195_HUMAN	55.4	56	25	0	174	7	412	467	1.40E-10	66.6	ZN195_HUMAN	reviewed	Zinc finger protein 195	ZNF195 ZNFP104	Homo sapiens (Human)	629	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5698_c0_g1_i10	Q29RZ4	ZNF2_BOVIN	50.6	85	42	0	3	257	195	279	2.10E-21	103.6	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5698_c0_g1_i8	Q29RZ4	ZNF2_BOVIN	54.1	85	39	0	3	257	195	279	2.70E-23	109.4	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i19	Q29RZ4	ZNF2_BOVIN	61.8	55	21	0	311	147	261	315	1.80E-13	76.6	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i7	Q29RZ4	ZNF2_BOVIN	54.7	95	43	0	287	3	285	379	2.90E-26	119	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i10	Q29RZ4	ZNF2_BOVIN	48.5	165	76	3	497	3	247	402	1.90E-41	170.2	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3354_c0_g1_i1	Q29RZ4	ZNF2_BOVIN	51	98	48	0	296	3	262	359	9.60E-25	114	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i1	Q29RZ4	ZNF2_BOVIN	48.4	64	33	0	3	194	300	363	3.30E-13	75.9	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i2	Q29RZ4	ZNF2_BOVIN	48.4	64	33	0	3	194	300	363	4.00E-13	75.9	ZNF2_BOVIN	reviewed	Zinc finger protein 2	ZNF2	Bos taurus (Bovine)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g2_i1	P08043	ZFP2_MOUSE	48.4	93	48	0	280	2	206	298	3.90E-23	108.6	ZFP2_MOUSE	reviewed	Zinc finger protein 2 (Zfp-2) (Protein mKR2)	Zfp2 Fnp-2 Mkr2 Zfp-2	Mus musculus (Mouse)	459	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i3	P08043	ZFP2_MOUSE	50.7	69	34	0	224	18	330	398	8.10E-16	84	ZFP2_MOUSE	reviewed	Zinc finger protein 2 (Zfp-2) (Protein mKR2)	Zfp2 Fnp-2 Mkr2 Zfp-2	Mus musculus (Mouse)	459	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11917_c0_g1_i1	P08043	ZFP2_MOUSE	46.2	117	63	0	353	3	269	385	1.80E-25	116.7	ZFP2_MOUSE	reviewed	Zinc finger protein 2 (Zfp-2) (Protein mKR2)	Zfp2 Fnp-2 Mkr2 Zfp-2	Mus musculus (Mouse)	459	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i6	P08043	ZFP2_MOUSE	58.5	41	17	0	256	134	346	386	4.90E-09	61.6	ZFP2_MOUSE	reviewed	Zinc finger protein 2 (Zfp-2) (Protein mKR2)	Zfp2 Fnp-2 Mkr2 Zfp-2	Mus musculus (Mouse)	459	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i4	P08043	ZFP2_MOUSE	47.3	74	39	0	74	295	357	430	1.10E-15	84	ZFP2_MOUSE	reviewed	Zinc finger protein 2 (Zfp-2) (Protein mKR2)	Zfp2 Fnp-2 Mkr2 Zfp-2	Mus musculus (Mouse)	459	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i15	P08043	ZFP2_MOUSE	47.6	124	65	0	376	5	303	426	9.00E-28	124.4	ZFP2_MOUSE	reviewed	Zinc finger protein 2 (Zfp-2) (Protein mKR2)	Zfp2 Fnp-2 Mkr2 Zfp-2	Mus musculus (Mouse)	459	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i11	Q9BSG1	ZNF2_HUMAN	42.9	177	101	0	5	535	174	350	4.00E-40	166	ZNF2_HUMAN	reviewed	Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661)	ZNF2 ZNF661	Homo sapiens (Human)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i1	Q9BSG1	ZNF2_HUMAN	46	87	47	0	1	261	189	275	4.10E-19	95.1	ZNF2_HUMAN	reviewed	Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661)	ZNF2 ZNF661	Homo sapiens (Human)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i6	Q9BSG1	ZNF2_HUMAN	42	150	63	3	142	546	251	391	4.20E-26	119.8	ZNF2_HUMAN	reviewed	Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661)	ZNF2 ZNF661	Homo sapiens (Human)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i6	Q9BSG1	ZNF2_HUMAN	54.8	31	14	0	50	142	196	226	2.70E-04	47.4	ZNF2_HUMAN	reviewed	Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661)	ZNF2 ZNF661	Homo sapiens (Human)	425	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4115_c0_g1_i4	Q8BIQ3	ZNF2_MOUSE	41.4	99	58	0	304	8	207	305	1.10E-18	94.7	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i2	Q8BIQ3	ZNF2_MOUSE	63.6	44	16	0	141	272	260	303	1.80E-09	63.2	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i2	Q8BIQ3	ZNF2_MOUSE	65.6	32	11	0	50	145	276	307	4.10E-06	52	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i4	Q8BIQ3	ZNF2_MOUSE	51	49	24	0	6	152	201	249	1.80E-10	66.2	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g2_i1	Q8BIQ3	ZNF2_MOUSE	44.8	116	62	2	3	347	190	304	2.20E-22	106.7	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g1_i1	Q8BIQ3	ZNF2_MOUSE	52	75	36	0	2	226	173	247	3.80E-19	95.5	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26637_c0_g1_i1	Q8BIQ3	ZNF2_MOUSE	36.6	82	46	2	25	270	271	346	4.30E-06	52	ZNF2_MOUSE	reviewed	Zinc finger protein 2 (Zinc finger protein 661) (Zfp-661)	Znf2 Zfp661	Mus musculus (Mouse)	427	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i4	Q6ZN57	ZFP2_HUMAN	46.2	359	187	1	1	1059	103	461	7.50E-96	352.1	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c1_g1_i1	Q6ZN57	ZFP2_HUMAN	46.5	101	53	1	2	301	188	288	7.50E-20	97.8	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23993_c0_g2_i1	Q6ZN57	ZFP2_HUMAN	47.1	87	46	0	262	2	292	378	3.20E-19	95.5	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i2	Q6ZN57	ZFP2_HUMAN	52	50	23	1	223	74	322	370	5.20E-07	54.7	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16138_c0_g1_i1	Q6ZN57	ZFP2_HUMAN	46.4	112	50	1	1	306	321	432	1.20E-22	107.1	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16195_c1_g1_i1	Q6ZN57	ZFP2_HUMAN	51.5	103	46	2	318	10	307	405	1.30E-22	107.1	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c3_g1_i2	Q6ZN57	ZFP2_HUMAN	52.4	84	40	0	263	12	321	404	2.50E-21	102.4	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g2_i3	Q6ZN57	ZFP2_HUMAN	52.9	85	40	0	262	8	320	404	1.30E-20	100.1	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN137_c1_g1_i1	Q6ZN57	ZFP2_HUMAN	45.5	314	151	4	213	1115	155	461	3.70E-80	300.4	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i2	Q6ZN57	ZFP2_HUMAN	46.2	106	52	1	323	6	333	433	2.00E-20	99.8	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18222_c0_g2_i1	Q6ZN57	ZFP2_HUMAN	49.6	141	71	0	2	424	309	449	5.90E-36	151.8	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5363_c0_g1_i1	Q6ZN57	ZFP2_HUMAN	56.1	41	18	0	2	124	326	366	9.00E-09	60.5	ZFP2_HUMAN	reviewed	Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751)	ZFP2 ZNF751	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25995_c0_g1_i1	P17024	ZNF20_HUMAN	72.8	103	27	1	3	311	425	526	9.80E-44	177.2	ZNF20_HUMAN	reviewed	Zinc finger protein 20 (Zinc finger protein KOX13)	ZNF20 KOX13	Homo sapiens (Human)	532	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28098_c0_g1_i1	P98182	ZN200_HUMAN	100	101	0	0	2	304	237	337	4.40E-57	221.5	ZN200_HUMAN	reviewed	Zinc finger protein 200	ZNF200 ZNFMF	Homo sapiens (Human)	395	nucleus [GO:0005634]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i51	O43345	ZN208_HUMAN	36.6	142	85	3	433	8	283	419	3.40E-22	106.3	ZN208_HUMAN	reviewed	Zinc finger protein 208 (Zinc finger protein 91-like)	ZNF208 ZNF91L	Homo sapiens (Human)	1280	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22387_c0_g1_i12	O43345	ZN208_HUMAN	51.1	94	46	0	35	316	216	309	9.50E-23	107.5	ZN208_HUMAN	reviewed	Zinc finger protein 208 (Zinc finger protein 91-like)	ZNF208 ZNF91L	Homo sapiens (Human)	1280	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22387_c0_g1_i8	O43345	ZN208_HUMAN	56	91	40	0	2	274	599	689	1.80E-24	113.6	ZN208_HUMAN	reviewed	Zinc finger protein 208 (Zinc finger protein 91-like)	ZNF208 ZNF91L	Homo sapiens (Human)	1280	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22387_c0_g1_i9	O43345	ZN208_HUMAN	44.9	89	49	0	2	268	627	715	4.00E-18	92	ZN208_HUMAN	reviewed	Zinc finger protein 208 (Zinc finger protein 91-like)	ZNF208 ZNF91L	Homo sapiens (Human)	1280	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i8	O43345	ZN208_HUMAN	44.3	131	73	0	437	45	585	715	4.30E-32	139	ZN208_HUMAN	reviewed	Zinc finger protein 208 (Zinc finger protein 91-like)	ZNF208 ZNF91L	Homo sapiens (Human)	1280	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g2_i1	O43345	ZN208_HUMAN	50	86	43	0	9	266	490	575	5.70E-20	98.2	ZN208_HUMAN	reviewed	Zinc finger protein 208 (Zinc finger protein 91-like)	ZNF208 ZNF91L	Homo sapiens (Human)	1280	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5195_c0_g1_i1	Q13398	ZN211_HUMAN	51.3	150	72	1	396	842	330	479	2.40E-42	174.9	ZN211_HUMAN	reviewed	Zinc finger protein 211 (Zinc finger protein C2H2-25)	ZNF211	Homo sapiens (Human)	564	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i3	Q13398	ZN211_HUMAN	44.4	81	42	1	260	27	313	393	3.70E-16	85.5	ZN211_HUMAN	reviewed	Zinc finger protein 211 (Zinc finger protein C2H2-25)	ZNF211	Homo sapiens (Human)	564	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18445_c1_g1_i1	Q9UL59	ZN214_HUMAN	50.6	89	43	1	94	360	486	573	6.50E-23	108.2	ZN214_HUMAN	reviewed	Zinc finger protein 214 (BWSCR2-associated zinc finger protein 1) (BAZ-1)	ZNF214 BAZ1	Homo sapiens (Human)	606	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18445_c1_g1_i3	Q9UL59	ZN214_HUMAN	57.5	106	44	1	3	320	469	573	1.20E-36	153.7	ZN214_HUMAN	reviewed	Zinc finger protein 214 (BWSCR2-associated zinc finger protein 1) (BAZ-1)	ZNF214 BAZ1	Homo sapiens (Human)	606	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37276_c0_g1_i1	O75362	ZN217_HUMAN	41	78	46	0	253	20	459	536	9.60E-13	73.9	ZN217_HUMAN	reviewed	Zinc finger protein 217	ZNF217 ZABC1	Homo sapiens (Human)	1048	"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000118; GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0016607; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25958_c0_g1_i1	Q9P2Y4	ZN219_HUMAN	42.9	63	34	1	5	187	487	549	4.10E-10	65.1	ZN219_HUMAN	reviewed	Zinc finger protein 219	ZNF219	Homo sapiens (Human)	722	"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]"	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001505; GO:0003677; GO:0003700; GO:0004969; GO:0005634; GO:0005654; GO:0006355; GO:0016021; GO:0032332; GO:0045892; GO:0045944; GO:0046872; GO:0060174	"limb bud formation [GO:0060174]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26387_c0_g1_i1	Q6IQX8	ZN219_MOUSE	43.3	67	36	1	260	60	487	551	6.40E-09	61.2	ZN219_MOUSE	reviewed	Zinc finger protein 219	Znf219 Zfp219	Mus musculus (Mouse)	726	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0032332; GO:0045892; GO:0045944; GO:0046872; GO:0060174	"cell differentiation [GO:0030154]; limb bud formation [GO:0060174]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28836_c0_g1_i1	F1QQA8	ZN219_DANRE	56.6	53	23	0	38	196	701	753	3.50E-12	72	ZN219_DANRE	reviewed	Zinc finger protein 219 (Zinc finger protein 219-like)	znf219 znf219l	Danio rerio (Zebrafish) (Brachydanio rerio)	1095	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0030903; GO:0046872	"notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i12	F1QQA8	ZN219_DANRE	35.1	94	57	3	391	672	661	750	1.30E-08	61.6	ZN219_DANRE	reviewed	Zinc finger protein 219 (Zinc finger protein 219-like)	znf219 znf219l	Danio rerio (Zebrafish) (Brachydanio rerio)	1095	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0030903; GO:0046872	"notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i2	F1QQA8	ZN219_DANRE	32.4	142	69	5	379	726	635	775	9.80E-10	65.5	ZN219_DANRE	reviewed	Zinc finger protein 219 (Zinc finger protein 219-like)	znf219 znf219l	Danio rerio (Zebrafish) (Brachydanio rerio)	1095	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0030903; GO:0046872	"notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i8	F1QQA8	ZN219_DANRE	35.1	97	48	3	373	663	669	750	1.00E-08	62	ZN219_DANRE	reviewed	Zinc finger protein 219 (Zinc finger protein 219-like)	znf219 znf219l	Danio rerio (Zebrafish) (Brachydanio rerio)	1095	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0030903; GO:0046872	"notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27350_c0_g1_i1	F1QQA8	ZN219_DANRE	43.3	67	35	2	248	48	693	756	1.40E-08	60.1	ZN219_DANRE	reviewed	Zinc finger protein 219 (Zinc finger protein 219-like)	znf219 znf219l	Danio rerio (Zebrafish) (Brachydanio rerio)	1095	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0030903; GO:0046872	"notochord development [GO:0030903]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12382_c0_g3_i1	P17026	ZNF22_HUMAN	95	139	7	0	2	418	47	185	1.10E-77	290.4	ZNF22_HUMAN	reviewed	Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26)	ZNF22 KOX15 KROX26	Homo sapiens (Human)	224	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; odontogenesis [GO:0042476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0042476	"odontogenesis [GO:0042476]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16611_c0_g1_i10	Q9UK13	ZN221_HUMAN	41.7	84	49	0	352	101	285	368	4.40E-16	85.5	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16611_c0_g1_i14	Q9UK13	ZN221_HUMAN	44	84	47	0	407	156	285	368	1.00E-16	87.8	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16611_c0_g1_i9	Q9UK13	ZN221_HUMAN	41.7	84	49	0	407	156	285	368	5.00E-16	85.5	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i3	Q9UK13	ZN221_HUMAN	45.6	57	31	0	10	180	276	332	2.70E-12	72.4	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7151_c1_g2_i1	Q9UK13	ZN221_HUMAN	45.3	75	41	0	1	225	258	332	7.80E-13	75.1	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i3	Q9UK13	ZN221_HUMAN	52.6	57	27	0	311	141	276	332	3.10E-13	75.9	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i7	Q9UK13	ZN221_HUMAN	52.6	57	27	0	266	96	276	332	2.60E-13	75.9	ZN221_HUMAN	reviewed	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	617	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31917_c0_g1_i1	Q9UK12	ZN222_HUMAN	48.4	64	31	2	18	209	201	262	4.00E-09	61.6	ZN222_HUMAN	reviewed	Zinc finger protein 222	ZNF222	Homo sapiens (Human)	451	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i4	Q9NZL3	ZN224_HUMAN	46.6	58	31	0	179	6	210	267	1.50E-08	60.1	ZN224_HUMAN	reviewed	Zinc finger protein 224 (Bone marrow zinc finger 2) (BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)	ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27	Homo sapiens (Human)	707	"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38038_c0_g1_i1	Q9NZL3	ZN224_HUMAN	74.6	67	17	0	221	21	309	375	3.00E-23	108.6	ZN224_HUMAN	reviewed	Zinc finger protein 224 (Bone marrow zinc finger 2) (BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)	ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27	Homo sapiens (Human)	707	"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c9_g1_i1	Q9NZL3	ZN224_HUMAN	86.4	88	12	0	1	264	337	424	3.30E-45	181.8	ZN224_HUMAN	reviewed	Zinc finger protein 224 (Bone marrow zinc finger 2) (BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)	ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27	Homo sapiens (Human)	707	"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c4_g1_i1	Q9NZL3	ZN224_HUMAN	40	70	42	0	214	5	299	368	3.70E-10	65.1	ZN224_HUMAN	reviewed	Zinc finger protein 224 (Bone marrow zinc finger 2) (BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)	ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27	Homo sapiens (Human)	707	"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5698_c0_g1_i3	Q9UK10	ZN225_HUMAN	44.9	78	43	0	2	235	325	402	4.70E-15	81.6	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i9	Q9UK10	ZN225_HUMAN	46.8	77	41	0	247	17	234	310	1.20E-15	83.6	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i5	Q9UK10	ZN225_HUMAN	44.3	88	49	0	133	396	215	302	9.80E-17	87.8	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i7	Q9UK10	ZN225_HUMAN	39.2	125	66	1	97	441	178	302	1.30E-17	90.9	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i12	Q9UK10	ZN225_HUMAN	54.2	83	35	1	3	242	458	540	4.20E-19	95.9	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c2_g1_i1	Q9UK10	ZN225_HUMAN	50.6	79	39	0	11	247	471	549	7.20E-18	90.9	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c2_g1_i1	Q9UK10	ZN225_HUMAN	52.8	89	42	0	8	274	474	562	6.10E-22	104.8	ZN225_HUMAN	reviewed	Zinc finger protein 225	ZNF225	Homo sapiens (Human)	706	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12336_c2_g1_i1	Q9NYT6	ZN226_HUMAN	96.2	106	4	0	1	318	350	455	1.50E-60	233	ZN226_HUMAN	reviewed	Zinc finger protein 226	ZNF226	Homo sapiens (Human)	803	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24443_c0_g1_i1	Q9NYT6	ZN226_HUMAN	100	64	0	0	9	200	493	556	3.40E-34	144.8	ZN226_HUMAN	reviewed	Zinc finger protein 226	ZNF226	Homo sapiens (Human)	803	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g1_i3	A0JNB1	ZN227_BOVIN	43.2	95	46	2	1	273	485	575	8.20E-15	81.3	ZN227_BOVIN	reviewed	Zinc finger protein 227	ZNF227	Bos taurus (Bovine)	787	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9430_c0_g1_i1	Q86WZ6	ZN227_HUMAN	44.9	107	55	3	353	33	688	790	5.50E-19	95.1	ZN227_HUMAN	reviewed	Zinc finger protein 227	ZNF227	Homo sapiens (Human)	799	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i6	Q86WZ6	ZN227_HUMAN	46.7	169	86	3	9	515	518	682	2.90E-44	179.9	ZN227_HUMAN	reviewed	Zinc finger protein 227	ZNF227	Homo sapiens (Human)	799	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i19	P17027	ZNF23_HUMAN	49.2	61	31	0	344	162	448	508	1.10E-11	70.9	ZNF23_HUMAN	reviewed	Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16)	ZNF23 KOX16 ZNF359 ZNF612	Homo sapiens (Human)	643	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30373_c0_g1_i1	A6NK53	ZN233_HUMAN	46.9	96	49	1	12	293	438	533	7.20E-21	101.3	ZN233_HUMAN	reviewed	Zinc finger protein 233	ZNF233	Homo sapiens (Human)	670	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10037_c0_g1_i2	Q14588	ZN234_HUMAN	47.1	51	27	0	76	228	592	642	4.10E-07	55.1	ZN234_HUMAN	reviewed	Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4)	ZNF234 ZNF269	Homo sapiens (Human)	700	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10037_c0_g1_i3	Q14588	ZN234_HUMAN	47.1	51	27	0	176	328	592	642	5.80E-07	55.1	ZN234_HUMAN	reviewed	Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4)	ZNF234 ZNF269	Homo sapiens (Human)	700	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10037_c0_g1_i5	Q14588	ZN234_HUMAN	47.1	51	27	0	176	328	592	642	5.80E-07	55.1	ZN234_HUMAN	reviewed	Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4)	ZNF234 ZNF269	Homo sapiens (Human)	700	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26685_c0_g1_i1	Q14588	ZN234_HUMAN	100	129	0	0	2	388	161	289	9.70E-78	290.4	ZN234_HUMAN	reviewed	Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4)	ZNF234 ZNF269	Homo sapiens (Human)	700	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11450_c1_g1_i1	Q14590	ZN235_HUMAN	51.2	168	82	0	535	32	461	628	7.60E-53	208.4	ZN235_HUMAN	reviewed	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	ZNF235 ZFP93 ZNF270	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN5342_c0_g1_i1	Q14590	ZN235_HUMAN	40.7	339	195	5	1894	881	344	677	2.80E-77	291.2	ZN235_HUMAN	reviewed	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	ZNF235 ZFP93 ZNF270	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5342_c0_g1_i2	Q14590	ZN235_HUMAN	39.9	368	215	5	1981	881	315	677	5.60E-82	307	ZN235_HUMAN	reviewed	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	ZNF235 ZFP93 ZNF270	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g2_i4	Q61116	ZN235_MOUSE	37.8	74	40	1	2	223	363	430	7.00E-09	61.2	ZN235_MOUSE	reviewed	Zinc finger protein 235 (Zinc finger protein 93) (Zfp-93)	Znf235 Zfp93	Mus musculus (Mouse)	645	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33644_c0_g1_i1	Q9UL36	ZN236_HUMAN	55.4	65	27	1	198	4	191	253	3.40E-13	75.1	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9112_c1_g1_i1	Q9UL36	ZN236_HUMAN	49.4	81	41	0	26	268	197	277	2.50E-19	95.9	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39045_c0_g1_i1	Q9UL36	ZN236_HUMAN	35.5	341	190	9	1724	714	1116	1430	4.30E-43	177.6	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37747_c0_g1_i1	Q9UL36	ZN236_HUMAN	46.8	62	30	1	25	201	198	259	1.60E-10	66.2	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27464_c0_g1_i1	Q9UL36	ZN236_HUMAN	55.7	106	45	1	3	320	470	573	1.10E-31	137.1	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i6	Q9UL36	ZN236_HUMAN	40.5	79	43	2	475	708	203	278	9.50E-08	58.9	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i9	Q9UL36	ZN236_HUMAN	44.3	61	31	1	59	241	221	278	2.20E-08	59.7	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i14	Q9UL36	ZN236_HUMAN	36.4	77	49	0	475	705	1732	1808	9.80E-10	65.5	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i4	Q9UL36	ZN236_HUMAN	37.3	75	41	1	106	330	181	249	1.40E-08	60.5	ZN236_HUMAN	reviewed	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	1845	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35_c0_g1_i1	Q16600	ZN239_HUMAN	31.3	265	167	9	3192	3983	179	429	1.60E-30	137.1	ZN239_HUMAN	reviewed	Zinc finger protein 239 (Zinc finger protein HOK-2) (Zinc finger protein MOK-2)	ZNF239 HOK2 MOK2	Homo sapiens (Human)	458	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003723; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31495_c0_g1_i1	P17028	ZNF24_HUMAN	100	117	0	0	351	1	239	355	1.40E-67	256.5	ZNF24_HUMAN	reviewed	Zinc finger protein 24 (Retinoic acid suppression protein A) (RSG-A) (Zinc finger and SCAN domain-containing protein 3) (Zinc finger protein 191) (Zinc finger protein KOX17)	ZNF24 KOX17 ZNF191 ZSCAN3	Homo sapiens (Human)	368	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0042552; GO:0042802; GO:0043565; GO:0045892; GO:0045944; GO:0046872	"myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i4	Q8NDW4	ZN248_HUMAN	49.6	137	62	1	411	1	436	565	4.60E-33	142.1	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i4	Q5REN4	ZN248_PONAB	48.3	180	93	0	4	543	391	570	3.50E-51	203	ZN248_PONAB	reviewed	Zinc finger protein 248	ZNF248	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	578	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16301_c0_g2_i2	Q8NDW4	ZN248_HUMAN	49.1	173	88	0	521	3	382	554	3.30E-52	206.1	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i10	Q8NDW4	ZN248_HUMAN	53.4	161	74	1	484	2	385	544	4.20E-46	185.7	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i12	Q8NDW4	ZN248_HUMAN	53.5	155	71	1	470	6	385	538	3.80E-44	179.1	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i6	Q8NDW4	ZN248_HUMAN	55.8	163	70	2	490	2	384	544	3.90E-47	189.1	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g1_i7	Q8NDW4	ZN248_HUMAN	51.1	88	41	1	266	3	384	469	9.80E-21	100.5	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i5	Q8NDW4	ZN248_HUMAN	51	96	44	1	3	290	374	466	6.80E-24	111.3	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10052_c0_g1_i1	Q8NDW4	ZN248_HUMAN	50	72	36	0	261	46	374	445	2.20E-15	82.8	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i11	Q8NDW4	ZN248_HUMAN	52.7	93	44	0	281	3	392	484	2.50E-22	105.9	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g2_i1	Q8NDW4	ZN248_HUMAN	47.7	86	45	0	342	85	374	459	4.60E-18	92	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i27	Q8NDW4	ZN248_HUMAN	53.2	79	35	1	104	340	388	464	9.10E-19	94.7	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i5	Q8NDW4	ZN248_HUMAN	55.2	87	39	0	262	2	374	460	7.50E-24	110.9	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i16	Q8NDW4	ZN248_HUMAN	38.4	151	81	3	1	441	401	543	7.40E-21	101.7	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i3	Q8NDW4	ZN248_HUMAN	61.8	110	42	0	331	2	401	510	1.60E-36	153.3	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i7	Q8NDW4	ZN248_HUMAN	58.2	122	45	1	367	2	395	510	3.00E-36	152.5	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16009_c1_g1_i1	Q8NDW4	ZN248_HUMAN	70.2	84	25	0	3	254	409	492	3.50E-31	135.2	ZN248_HUMAN	reviewed	Zinc finger protein 248	ZNF248	Homo sapiens (Human)	579	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g1_i1	P17030	ZNF25_HUMAN	55.8	147	65	0	1	441	214	360	5.30E-43	175.3	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c71_g1_i1	P17030	ZNF25_HUMAN	58.2	55	23	0	46	210	250	304	5.40E-14	77.8	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g2_i3	P17030	ZNF25_HUMAN	52.4	82	39	0	1	246	248	329	5.10E-19	94.7	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i9	P17030	ZNF25_HUMAN	52.7	131	62	0	1	393	241	371	2.70E-36	152.9	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i5	P17030	ZNF25_HUMAN	46.5	159	84	1	198	674	179	336	1.30E-40	167.9	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i9	P17030	ZNF25_HUMAN	46.4	125	67	0	376	2	214	338	1.20E-25	117.5	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13392_c0_g1_i1	P17030	ZNF25_HUMAN	37.6	327	191	3	93	1055	130	449	1.60E-59	231.5	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i8	P17030	ZNF25_HUMAN	48.2	114	59	0	350	9	223	336	1.70E-28	126.7	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g2_i3	P17030	ZNF25_HUMAN	52.9	85	40	0	257	3	251	335	2.10E-20	99.4	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i4	P17030	ZNF25_HUMAN	48.2	197	101	1	598	11	192	388	2.00E-50	200.3	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7326_c0_g2_i1	P17030	ZNF25_HUMAN	49.5	105	53	0	320	6	191	295	1.90E-26	119.8	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c2_g1_i1	P17030	ZNF25_HUMAN	56.4	94	41	0	8	289	251	344	2.80E-24	112.5	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i10	P17030	ZNF25_HUMAN	56.9	102	44	0	19	324	259	360	9.80E-31	134	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g2_i1	P17030	ZNF25_HUMAN	46.9	162	73	3	19	468	116	276	7.10E-30	131.7	ZNF25_HUMAN	reviewed	Zinc finger protein 25 (Zinc finger protein KOX19)	ZNF25 KOX19	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN15188_c0_g1_i3	Q9BRH9	ZN251_HUMAN	30.9	333	207	9	120	1109	199	511	5.20E-39	163.3	ZN251_HUMAN	reviewed	Zinc finger protein 251	ZNF251	Homo sapiens (Human)	671	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i5	Q9BRH9	ZN251_HUMAN	41.2	102	60	0	473	168	287	388	4.60E-19	95.9	ZN251_HUMAN	reviewed	Zinc finger protein 251	ZNF251	Homo sapiens (Human)	671	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i5	Q9XSR1	ZN252_CANLF	44.7	85	47	0	76	330	534	618	1.30E-18	94	ZN252_CANLF	reviewed	Zinc finger protein 252	ZNF252 BC3	Canis lupus familiaris (Dog) (Canis familiaris)	873	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g1_i1	O75346	ZN253_HUMAN	48.7	78	40	0	282	49	397	474	1.10E-15	84	ZN253_HUMAN	reviewed	Zinc finger protein 253 (Bone marrow zinc finger 1) (BMZF-1) (Zinc finger protein 411)	ZNF253 BMZF1 ZNF411	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i2	O75346	ZN253_HUMAN	47.3	129	68	0	1	387	314	442	7.00E-31	134.8	ZN253_HUMAN	reviewed	Zinc finger protein 253 (Bone marrow zinc finger 1) (BMZF-1) (Zinc finger protein 411)	ZNF253 BMZF1 ZNF411	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i3	O75346	ZN253_HUMAN	47.2	127	56	1	3	350	316	442	4.30E-27	122.1	ZN253_HUMAN	reviewed	Zinc finger protein 253 (Bone marrow zinc finger 1) (BMZF-1) (Zinc finger protein 411)	ZNF253 BMZF1 ZNF411	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c3_g1_i1	O75346	ZN253_HUMAN	40.4	114	50	2	2	289	233	346	9.00E-20	97.4	ZN253_HUMAN	reviewed	Zinc finger protein 253 (Bone marrow zinc finger 1) (BMZF-1) (Zinc finger protein 411)	ZNF253 BMZF1 ZNF411	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g2_i3	O75437	ZN254_HUMAN	46.9	98	52	0	2	295	346	443	1.60E-22	106.7	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g2_i4	O75437	ZN254_HUMAN	46.9	98	52	0	2	295	346	443	2.00E-22	106.3	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g3_i1	O75437	ZN254_HUMAN	51.3	78	38	0	1	234	351	428	4.00E-18	91.7	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i22	O75437	ZN254_HUMAN	46.6	103	55	0	312	4	364	466	2.50E-21	103.2	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i4	O75437	ZN254_HUMAN	52.4	105	42	1	320	6	336	432	3.60E-25	115.5	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i1	O75437	ZN254_HUMAN	51.1	94	45	1	1	279	350	443	1.10E-25	117.1	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i1	O75437	ZN254_HUMAN	54	100	46	0	3	302	363	462	1.30E-25	117.5	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14253_c0_g1_i2	O75437	ZN254_HUMAN	50.8	65	32	0	44	238	351	415	2.40E-13	75.9	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i14	O75437	ZN254_HUMAN	35.2	338	199	8	422	1423	307	628	8.30E-61	236.1	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13052_c0_g1_i1	O75437	ZN254_HUMAN	51.4	70	34	0	219	10	333	402	1.20E-16	86.7	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i8	O75437	ZN254_HUMAN	48	100	52	0	303	4	348	447	5.40E-23	108.2	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g2_i2	O75437	ZN254_HUMAN	50.5	99	49	0	4	300	340	438	3.10E-23	109	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i53	O75437	ZN254_HUMAN	35.2	338	199	8	413	1414	307	628	6.40E-60	233.4	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		brown	brown	1	NA	NA	NA
TRINITY_DN9785_c0_g1_i3	O75437	ZN254_HUMAN	54.5	88	40	0	266	3	348	435	1.10E-22	107.1	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i9	O75437	ZN254_HUMAN	51.4	109	53	0	335	9	348	456	3.90E-30	132.1	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g3_i1	O75437	ZN254_HUMAN	52.9	68	32	0	3	206	344	411	3.60E-18	91.7	ZN254_HUMAN	reviewed	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35526_c0_g1_i3	Q9Y2P7	ZN256_HUMAN	27.4	95	65	2	97	381	211	301	2.60E-06	53.1	ZN256_HUMAN	reviewed	Zinc finger protein 256 (Bone marrow zinc finger 3) (BMZF-3)	ZNF256 BMZF3	Homo sapiens (Human)	627	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i7	Q9Y2P7	ZN256_HUMAN	46.2	130	69	1	387	1	416	545	4.00E-31	135.6	ZN256_HUMAN	reviewed	Zinc finger protein 256 (Bone marrow zinc finger 3) (BMZF-3)	ZNF256 BMZF3	Homo sapiens (Human)	627	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i3	Q9Y2P7	ZN256_HUMAN	52.1	73	35	0	8	226	498	570	3.50E-17	88.6	ZN256_HUMAN	reviewed	Zinc finger protein 256 (Bone marrow zinc finger 3) (BMZF-3)	ZNF256 BMZF3	Homo sapiens (Human)	627	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c0_g2_i1	Q9Y2Q1	ZN257_HUMAN	53.2	77	36	0	233	3	433	509	3.50E-22	105.1	ZN257_HUMAN	reviewed	Zinc finger protein 257 (Bone marrow zinc finger 4) (BMZF-4)	ZNF257 BMZF4	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i16	Q9Y2Q1	ZN257_HUMAN	50.7	73	36	0	162	380	203	275	5.10E-18	92	ZN257_HUMAN	reviewed	Zinc finger protein 257 (Bone marrow zinc finger 4) (BMZF-4)	ZNF257 BMZF4	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i7	Q9Y2Q1	ZN257_HUMAN	41.2	68	40	0	6	209	327	394	2.00E-12	72.8	ZN257_HUMAN	reviewed	Zinc finger protein 257 (Bone marrow zinc finger 4) (BMZF-4)	ZNF257 BMZF4	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g2_i8	P10076	ZFP26_MOUSE	57.6	66	27	1	2	196	575	640	1.10E-17	90.9	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19793_c0_g1_i1	P10076	ZFP26_MOUSE	52.2	69	33	0	212	6	551	619	3.80E-16	85.1	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c1_g1_i4	P10076	ZFP26_MOUSE	55.1	78	35	0	2	235	583	660	7.60E-20	97.4	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN637_c0_g1_i9	P10076	ZFP26_MOUSE	36.5	159	90	1	707	231	705	852	3.60E-28	126.7	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i22	P10076	ZFP26_MOUSE	42.4	229	129	2	168	848	392	619	1.70E-45	184.5	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6633_c0_g2_i2	P10076	ZFP26_MOUSE	38.6	101	60	1	309	7	300	398	1.20E-16	87.4	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38011_c0_g1_i1	P10076	ZFP26_MOUSE	100	78	0	0	2	235	605	682	2.30E-42	172.2	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17290_c0_g1_i4	P10076	ZFP26_MOUSE	52	123	59	0	371	3	482	604	2.90E-34	146	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c0_g1_i1	P10076	ZFP26_MOUSE	50	156	78	0	475	8	464	619	3.90E-44	179.1	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c1_g2_i1	P10076	ZFP26_MOUSE	47.5	61	32	0	275	93	544	604	7.60E-14	77.8	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i1	P10076	ZFP26_MOUSE	49.4	89	45	0	426	160	516	604	1.30E-22	107.5	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i2	P10076	ZFP26_MOUSE	49.4	89	45	0	322	56	516	604	4.50E-23	108.6	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i3	P10076	ZFP26_MOUSE	50.6	85	42	0	414	160	520	604	1.40E-21	104	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i4	P10076	ZFP26_MOUSE	52.3	107	51	0	480	160	526	632	1.80E-28	127.1	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i10	P10076	ZFP26_MOUSE	62.1	58	22	0	328	155	547	604	6.90E-16	84.7	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i11	P10076	ZFP26_MOUSE	56.1	57	25	0	205	35	547	603	2.60E-13	75.5	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i12	P10076	ZFP26_MOUSE	58.6	58	24	0	269	96	547	604	3.70E-15	82	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i14	P10076	ZFP26_MOUSE	58.6	58	24	0	260	87	547	604	3.60E-15	82	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i2	P10076	ZFP26_MOUSE	55.2	58	26	0	260	87	547	604	1.80E-14	79.7	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i4	P10076	ZFP26_MOUSE	62.1	58	22	0	260	87	547	604	5.50E-16	84.7	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i5	P17031	ZNF26_HUMAN	53.5	43	20	0	3	131	307	349	1.10E-07	57	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g3_i1	P17031	ZNF26_HUMAN	54.5	55	24	1	140	304	279	332	8.00E-10	65.1	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g3_i1	P17031	ZNF26_HUMAN	55.8	52	22	1	306	461	279	329	3.00E-09	63.2	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g3_i1	P17031	ZNF26_HUMAN	54.3	46	21	0	1	138	455	500	1.40E-06	54.3	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24443_c0_g2_i1	P17031	ZNF26_HUMAN	95.7	92	4	0	1	276	425	516	1.00E-49	196.8	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i12	P17031	ZNF26_HUMAN	44.4	72	40	0	3	218	283	354	5.30E-12	71.2	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c2_g1_i2	P17031	ZNF26_HUMAN	45.8	96	52	0	136	423	248	343	1.30E-17	91.3	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c2_g1_i7	P17031	ZNF26_HUMAN	45.8	96	52	0	136	423	248	343	1.50E-17	91.3	ZNF26_HUMAN	reviewed	Zinc finger protein 26 (Zinc finger protein KOX20)	ZNF26 KOX20	Homo sapiens (Human)	533	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25399_c0_g1_i1	Q62513	ZN260_MOUSE	100	67	0	0	259	59	341	407	6.20E-36	151	ZN260_MOUSE	reviewed	Zinc finger protein 260 (Zfp-260)	Znf260 Zfp260	Mus musculus (Mouse)	407	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33107_c0_g1_i1	Q3ZCT1	ZN260_HUMAN	86.6	67	9	0	203	3	176	242	2.00E-29	129	ZN260_HUMAN	reviewed	Zinc finger protein 260 (Zfp-260)	ZNF260 ZFP260	Homo sapiens (Human)	412	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40539_c0_g1_i1	Q62513	ZN260_MOUSE	42.7	75	43	0	230	6	296	370	2.20E-12	72.8	ZN260_MOUSE	reviewed	Zinc finger protein 260 (Zfp-260)	Znf260 Zfp260	Mus musculus (Mouse)	407	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i6	O14978	ZN263_HUMAN	50	48	24	0	1	144	437	484	3.50E-10	65.1	ZN263_HUMAN	reviewed	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25596_c0_g1_i1	O14978	ZN263_HUMAN	100	71	0	0	2	214	561	631	6.50E-39	160.6	ZN263_HUMAN	reviewed	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10698_c0_g1_i1	O14978	ZN263_HUMAN	96.7	120	4	0	1	360	433	552	2.40E-70	265.8	ZN263_HUMAN	reviewed	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10698_c0_g1_i2	O14978	ZN263_HUMAN	100	112	0	0	4	339	441	552	6.10E-68	257.7	ZN263_HUMAN	reviewed	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g1_i2	O14978	ZN263_HUMAN	46.7	105	56	0	1	315	435	539	5.10E-24	111.7	ZN263_HUMAN	reviewed	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18222_c0_g1_i2	O14978	ZN263_HUMAN	51	51	25	0	22	174	430	480	1.60E-12	73.2	ZN263_HUMAN	reviewed	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1990837	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i1	O43296	ZN264_HUMAN	56.2	73	32	0	375	593	225	297	5.40E-19	95.9	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7828_c0_g1_i1	O43296	ZN264_HUMAN	47.5	61	31	1	249	67	509	568	9.70E-10	66.2	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16337_c0_g1_i1	O43296	ZN264_HUMAN	45	111	61	0	334	2	259	369	8.80E-25	114.4	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8500_c1_g1_i1	O43296	ZN264_HUMAN	48.6	72	36	1	215	3	214	285	1.60E-11	69.7	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g3_i1	O43296	ZN264_HUMAN	54.1	85	39	0	258	4	212	296	1.30E-22	106.7	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i20	O43296	ZN264_HUMAN	46.7	75	36	2	5	229	207	277	6.50E-13	75.1	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10683_c0_g1_i1	O43296	ZN264_HUMAN	50	108	54	0	324	1	202	309	6.70E-27	121.3	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i4	O43296	ZN264_HUMAN	47.5	120	60	1	419	60	445	561	2.50E-29	129.8	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i8	O43296	ZN264_HUMAN	46.3	136	70	1	467	60	429	561	2.60E-32	139.8	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i12	O43296	ZN264_HUMAN	51.7	87	42	0	282	542	449	535	5.30E-21	102.4	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i14	O43296	ZN264_HUMAN	49.1	116	59	0	282	629	449	564	8.00E-29	128.6	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c2_g1_i1	O43296	ZN264_HUMAN	54.7	75	34	0	228	4	225	299	2.50E-20	99	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i7	O43296	ZN264_HUMAN	52.9	70	33	0	253	462	449	518	2.10E-16	87.4	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i7	O43296	ZN264_HUMAN	38.7	142	50	2	429	4	224	328	1.40E-21	104	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g2_i1	O43296	ZN264_HUMAN	39	123	74	1	32	397	214	336	6.60E-21	101.7	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i17	O43296	ZN264_HUMAN	48.2	114	58	1	266	607	210	322	4.40E-26	119.8	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i3	O43296	ZN264_HUMAN	55.2	87	39	0	5	265	207	293	3.80E-22	105.9	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g2_i1	O43296	ZN264_HUMAN	43.1	116	64	1	346	5	186	301	1.30E-20	100.5	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g2_i2	O43296	ZN264_HUMAN	46.2	104	54	1	306	1	186	289	4.80E-19	95.1	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18222_c0_g2_i3	O43296	ZN264_HUMAN	52	75	36	0	18	242	246	320	4.90E-19	94.7	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i9	O43296	ZN264_HUMAN	46.8	156	82	1	467	3	225	380	1.40E-36	154.1	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g2_i1	O43296	ZN264_HUMAN	56	91	40	0	275	3	202	292	7.30E-25	114.4	ZN264_HUMAN	reviewed	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i32	Q14584	ZN266_HUMAN	50.8	120	54	1	366	7	348	462	5.50E-30	131.7	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i41	Q14584	ZN266_HUMAN	51.6	93	40	1	286	8	367	454	2.80E-21	102.8	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c14_g1_i1	Q14584	ZN266_HUMAN	52.9	68	32	0	206	3	357	424	2.10E-13	75.9	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c23_g1_i1	Q14584	ZN266_HUMAN	50	70	35	0	3	212	383	452	1.00E-15	83.6	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16290_c0_g2_i1	Q14584	ZN266_HUMAN	47.6	82	43	0	3	248	359	440	1.20E-15	83.6	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g3_i1	Q14584	ZN266_HUMAN	54.2	72	33	0	6	221	346	417	3.00E-18	92	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26889_c0_g1_i1	Q14584	ZN266_HUMAN	40.1	177	104	1	533	3	239	413	9.20E-40	164.9	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i12	Q14584	ZN266_HUMAN	51	102	49	1	5	307	329	430	7.40E-25	115.2	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c1_g1_i1	Q14584	ZN266_HUMAN	48.5	66	34	0	4	201	365	430	8.20E-12	70.5	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11951_c0_g1_i1	Q14584	ZN266_HUMAN	51.4	70	34	0	3	212	353	422	1.10E-14	80.1	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8010_c0_g2_i5	Q14584	ZN266_HUMAN	58.5	41	15	1	123	1	346	384	3.90E-07	55.8	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i5	Q14584	ZN266_HUMAN	49.6	141	62	3	499	77	342	473	1.80E-36	153.7	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g1_i6	Q14584	ZN266_HUMAN	43	128	65	1	368	9	359	486	2.80E-24	112.8	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12336_c0_g2_i1	Q14584	ZN266_HUMAN	100	69	0	0	2	208	354	422	2.90E-36	151.8	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25222_c0_g1_i4	Q14584	ZN266_HUMAN	49.5	101	51	0	4	306	352	452	9.00E-26	117.5	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25222_c0_g1_i6	Q14584	ZN266_HUMAN	50	108	54	0	18	341	345	452	1.60E-28	126.7	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i13	Q14584	ZN266_HUMAN	47.8	92	47	1	158	433	340	430	3.60E-20	99.4	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i21	Q14584	ZN266_HUMAN	46.9	81	35	1	20	262	352	424	3.00E-14	79	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11097_c0_g1_i4	Q14584	ZN266_HUMAN	44.7	114	63	0	344	3	318	431	2.00E-25	116.7	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i1	Q14584	ZN266_HUMAN	52.2	115	53	1	347	3	342	454	6.50E-31	135.6	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6614_c1_g1_i1	Q14584	ZN266_HUMAN	50.7	69	34	0	7	213	346	414	1.10E-17	90.1	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i2	Q14584	ZN266_HUMAN	48.5	97	50	0	10	300	346	442	9.70E-25	114	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18037_c0_g1_i1	Q14584	ZN266_HUMAN	47.8	138	72	0	421	8	329	466	1.20E-33	144.1	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i1	Q14584	ZN266_HUMAN	52.3	107	51	0	324	4	352	458	8.00E-29	128.3	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i1	Q14584	ZN266_HUMAN	52.2	46	19	1	482	345	417	459	5.60E-06	52.4	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g2_i2	Q14584	ZN266_HUMAN	53.8	91	42	0	270	542	353	443	5.60E-23	109	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i16	Q14584	ZN266_HUMAN	47.2	127	67	0	414	34	347	473	3.30E-31	136	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i20	Q14584	ZN266_HUMAN	53	66	31	0	200	3	339	404	8.50E-17	87	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28200_c0_g1_i1	Q14584	ZN266_HUMAN	50.7	75	35	1	2	226	382	454	4.00E-18	91.7	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18222_c0_g2_i2	Q14584	ZN266_HUMAN	49.2	128	62	2	3	386	362	486	3.30E-29	129.4	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i10	Q14584	ZN266_HUMAN	50.5	105	52	0	1	315	326	430	9.70E-27	121.3	ZN266_HUMAN	reviewed	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	549	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g1_i3	Q14586	ZN267_HUMAN	81.6	255	47	0	767	3	375	629	9.20E-128	457.6	ZN267_HUMAN	reviewed	Zinc finger protein 267 (Zinc finger protein HZF2)	ZNF267	Homo sapiens (Human)	743	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g1_i4	Q14586	ZN267_HUMAN	80.3	147	29	0	444	4	375	521	1.60E-68	260	ZN267_HUMAN	reviewed	Zinc finger protein 267 (Zinc finger protein HZF2)	ZNF267	Homo sapiens (Human)	743	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9822_c1_g1_i1	Q14586	ZN267_HUMAN	100	99	0	0	298	2	558	656	9.50E-57	220.3	ZN267_HUMAN	reviewed	Zinc finger protein 267 (Zinc finger protein HZF2)	ZNF267	Homo sapiens (Human)	743	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32036_c0_g1_i1	Q14587	ZN268_HUMAN	100	90	0	0	2	271	401	490	5.40E-51	201.1	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37424_c0_g1_i1	Q14587	ZN268_HUMAN	100	80	0	0	2	241	640	719	5.80E-44	177.6	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i13	Q14587	ZN268_HUMAN	51.2	82	40	0	2	247	753	834	4.10E-16	85.1	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i23	Q14587	ZN268_HUMAN	43.5	405	208	2	1	1152	416	820	8.80E-98	358.6	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6587_c0_g1_i1	Q14587	ZN268_HUMAN	50.6	89	44	0	440	174	410	498	6.90E-19	95.1	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g3_i4	Q14587	ZN268_HUMAN	45.6	160	87	0	485	6	475	634	5.60E-38	158.7	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c13_g1_i1	Q14587	ZN268_HUMAN	81.8	77	14	0	2	232	362	438	1.10E-34	146.7	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i30	Q14587	ZN268_HUMAN	42.6	101	43	2	291	548	674	774	6.90E-14	79	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i3	Q14587	ZN268_HUMAN	53.9	76	35	0	354	127	465	540	2.80E-18	92.8	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g2_i4	Q14587	ZN268_HUMAN	48.7	261	134	0	785	3	546	806	2.40E-67	257.3	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i19	Q14587	ZN268_HUMAN	47.3	275	145	0	12	836	556	830	8.50E-72	271.9	ZN268_HUMAN	reviewed	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	947	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0015629; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0071157; GO:0071356; GO:0090073; GO:1901224	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g2_i5	P10077	ZFP27_MOUSE	49.1	106	53	1	5	322	695	799	4.60E-25	115.5	ZFP27_MOUSE	reviewed	Zinc finger protein 27 (Zfp-27) (Protein mKR4)	Zfp27 Mkr4 Zfp-27	Mus musculus (Mouse)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5209_c0_g1_i1	P10077	ZFP27_MOUSE	48.8	43	22	0	226	354	499	541	2.10E-05	50.1	ZFP27_MOUSE	reviewed	Zinc finger protein 27 (Zfp-27) (Protein mKR4)	Zfp27 Mkr4 Zfp-27	Mus musculus (Mouse)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6598_c1_g1_i1	P10077	ZFP27_MOUSE	49.5	111	56	0	2	334	696	806	6.00E-23	108.2	ZFP27_MOUSE	reviewed	Zinc finger protein 27 (Zfp-27) (Protein mKR4)	Zfp27 Mkr4 Zfp-27	Mus musculus (Mouse)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i9	P10077	ZFP27_MOUSE	46.1	89	34	1	1	267	653	727	1.50E-16	86.7	ZFP27_MOUSE	reviewed	Zinc finger protein 27 (Zfp-27) (Protein mKR4)	Zfp27 Mkr4 Zfp-27	Mus musculus (Mouse)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3678_c0_g1_i2	Q5R5U3	ZN271_PONAB	34.5	168	106	4	735	232	247	410	2.20E-26	122.9	ZN271_PONAB	reviewed	Zinc finger protein 271	ZNF271	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	672	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN637_c0_g1_i1	Q5R5U3	ZN271_PONAB	36.7	196	107	1	749	213	160	355	4.00E-32	140.6	ZN271_PONAB	reviewed	Zinc finger protein 271	ZNF271	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	672	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i13	Q5R5U3	ZN271_PONAB	49	96	49	0	191	478	145	240	2.30E-26	120.6	ZN271_PONAB	reviewed	Zinc finger protein 271	ZNF271	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	672	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i13	Q5R5U3	ZN271_PONAB	24.1	199	144	3	24	599	181	379	7.70E-06	52.4	ZN271_PONAB	reviewed	Zinc finger protein 271	ZNF271	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	672	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN36158_c0_g1_i1	Q5R5U3	ZN271_PONAB	54.8	84	38	0	292	41	382	465	2.20E-21	102.8	ZN271_PONAB	reviewed	Zinc finger protein 271	ZNF271	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	672	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3226_c0_g1_i1	P15620	ZN271_MOUSE	42.7	150	85	1	636	187	358	506	3.10E-33	144.1	ZN271_MOUSE	reviewed	Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35)	Znf271 Zfp-35 Zfp35	Mus musculus (Mouse)	580	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0002437; GO:0002829; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872	cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3226_c0_g1_i5	P15620	ZN271_MOUSE	42.7	150	85	1	636	187	358	506	3.20E-33	144.1	ZN271_MOUSE	reviewed	Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35)	Znf271 Zfp-35 Zfp35	Mus musculus (Mouse)	580	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0002437; GO:0002829; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872	cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3226_c0_g1_i6	P15620	ZN271_MOUSE	42.7	150	85	1	636	187	358	506	3.10E-33	144.1	ZN271_MOUSE	reviewed	Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35)	Znf271 Zfp-35 Zfp35	Mus musculus (Mouse)	580	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0002437; GO:0002829; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872	cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c1_g1_i1	P15620	ZN271_MOUSE	87.4	111	14	0	2	334	175	285	9.10E-56	217.2	ZN271_MOUSE	reviewed	Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35)	Znf271 Zfp-35 Zfp35	Mus musculus (Mouse)	580	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0002437; GO:0002829; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872	cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c3_g1_i3	Q14593	ZN273_HUMAN	86.7	83	11	0	249	1	376	458	5.80E-39	161	ZN273_HUMAN	reviewed	Zinc finger protein 273 (Zinc finger protein HZF9)	ZNF273	Homo sapiens (Human)	569	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i9	Q14593	ZN273_HUMAN	59.6	52	21	0	15	170	332	383	5.50E-13	74.7	ZN273_HUMAN	reviewed	Zinc finger protein 273 (Zinc finger protein HZF9)	ZNF273	Homo sapiens (Human)	569	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1351_c2_g1_i1	Q9NRM2	ZN277_HUMAN	37.4	380	213	9	390	1517	58	416	1.10E-61	239.6	ZN277_HUMAN	reviewed	Zinc finger protein 277 (Nuclear receptor-interacting factor 4)	ZNF277 NRIF4 ZNF277P	Homo sapiens (Human)	450	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772	cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]		NA	NA	NA	NA	NA	NA
TRINITY_DN18505_c0_g1_i1	P10078	ZFP28_MOUSE	100	67	0	0	203	3	626	692	6.70E-38	157.1	ZFP28_MOUSE	reviewed	Zinc finger protein 28 (Zfp-28) (Protein mKR5)	Zfp28 Mkr5 Zfp-28	Mus musculus (Mouse)	825	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35506_c0_g1_i1	P17035	ZNF28_HUMAN	28.9	256	162	10	1031	294	303	548	8.40E-12	73.2	ZNF28_HUMAN	reviewed	Zinc finger protein 28 (Zinc finger protein KOX24)	ZNF28 KOX24	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7886_c0_g1_i2	Q8NHY6	ZFP28_HUMAN	46.2	65	35	0	5	199	603	667	1.20E-11	70.1	ZFP28_HUMAN	reviewed	Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6)	ZFP28 KIAA1431	Homo sapiens (Human)	868	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8273_c3_g1_i1	Q8NHY6	ZFP28_HUMAN	32.7	226	141	5	214	891	589	803	2.10E-26	121.7	ZFP28_HUMAN	reviewed	Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6)	ZFP28 KIAA1431	Homo sapiens (Human)	868	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i15	Q8NHY6	ZFP28_HUMAN	48.7	78	40	0	2	235	590	667	8.40E-17	88.2	ZFP28_HUMAN	reviewed	Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6)	ZFP28 KIAA1431	Homo sapiens (Human)	868	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i5	Q8NHY6	ZFP28_HUMAN	47.4	78	41	0	2	235	590	667	8.70E-17	87.4	ZFP28_HUMAN	reviewed	Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6)	ZFP28 KIAA1431	Homo sapiens (Human)	868	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c1_g1_i3	Q8NHY6	ZFP28_HUMAN	46.2	65	35	0	12	206	603	667	3.90E-12	71.6	ZFP28_HUMAN	reviewed	Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6)	ZFP28 KIAA1431	Homo sapiens (Human)	868	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37113_c0_g1_i1	Q9Y2X9	ZN281_HUMAN	100	84	0	0	254	3	279	362	3.40E-47	188.3	ZN281_HUMAN	reviewed	Zinc finger protein 281 (GC-box-binding zinc finger protein 1) (Transcription factor ZBP-99) (Zinc finger DNA-binding protein 99)	ZNF281 GZP1 ZBP99	Homo sapiens (Human)	895	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]"	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0010172; GO:0010629; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0048863; GO:1990837	"embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c11_g2_i1	Q8N7M2	ZN283_HUMAN	57.8	64	27	0	197	6	263	326	5.00E-17	87.8	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i15	Q8N7M2	ZN283_HUMAN	49.2	59	30	0	282	458	509	567	1.40E-11	70.9	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i18	Q8N7M2	ZN283_HUMAN	47.5	59	31	0	282	458	509	567	1.20E-10	67.8	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i22	Q8N7M2	ZN283_HUMAN	47.5	59	31	0	282	458	509	567	1.20E-10	67.8	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i2	Q8N7M2	ZN283_HUMAN	50	82	41	0	256	11	312	393	8.20E-20	97.4	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7346_c0_g2_i2	Q8N7M2	ZN283_HUMAN	41.6	77	45	0	480	250	209	285	1.50E-14	80.9	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7346_c0_g2_i3	Q8N7M2	ZN283_HUMAN	41.6	77	45	0	491	261	209	285	1.60E-14	80.9	ZN283_HUMAN	reviewed	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7410_c0_g2_i1	Q96NJ3	ZN285_HUMAN	38.1	252	153	3	792	37	314	562	7.00E-52	206.5	ZN285_HUMAN	reviewed	Zinc finger protein 285 (Zinc finger protein 285A)	ZNF285 ZNF285A	Homo sapiens (Human)	590	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3745_c0_g2_i1	Q9HBT8	Z286A_HUMAN	58.4	77	32	0	231	1	372	448	9.10E-23	107.1	Z286A_HUMAN	reviewed	Zinc finger protein 286A	ZNF286A KIAA1874 ZNF286	Homo sapiens (Human)	521	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i3	Q9HBT8	Z286A_HUMAN	56.5	69	30	0	280	74	330	398	1.50E-16	86.7	Z286A_HUMAN	reviewed	Zinc finger protein 286A	ZNF286A KIAA1874 ZNF286	Homo sapiens (Human)	521	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i20	Q9HBT8	Z286A_HUMAN	58.5	53	22	0	3	161	383	435	7.90E-14	77.4	Z286A_HUMAN	reviewed	Zinc finger protein 286A	ZNF286A KIAA1874 ZNF286	Homo sapiens (Human)	521	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19600_c0_g1_i11	Q9EQB9	ZN287_MOUSE	38.7	393	221	6	1360	185	379	752	1.60E-82	308.9	ZN287_MOUSE	reviewed	Zinc finger protein 287 (Zfp-287) (Zinc finger protein SKAT-2)	Znf287 Skat2 Zfp287	Mus musculus (Mouse)	759	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042035; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19600_c0_g1_i4	Q9EQB9	ZN287_MOUSE	38.7	393	221	6	1360	185	379	752	1.70E-82	308.9	ZN287_MOUSE	reviewed	Zinc finger protein 287 (Zfp-287) (Zinc finger protein SKAT-2)	Znf287 Skat2 Zfp287	Mus musculus (Mouse)	759	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042035; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1848_c0_g3_i1	Q8BLB0	ZFP3_MOUSE	43.1	65	36	1	57	251	149	212	1.80E-08	59.7	ZFP3_MOUSE	reviewed	Zinc finger protein 3 (Zfp-3)	Zfp3	Mus musculus (Mouse)	497	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c0_g1_i1	P17036	ZNF3_HUMAN	100	141	0	0	426	4	250	390	7.40E-87	320.9	ZNF3_HUMAN	reviewed	Zinc finger protein 3 (Zinc finger protein HF.12) (Zinc finger protein HZF3.1) (Zinc finger protein KOX25)	ZNF3 KOX25	Homo sapiens (Human)	446	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; leukocyte activation [GO:0045321]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0006357; GO:0007275; GO:0008270; GO:0030154; GO:0042802; GO:0045321	cell differentiation [GO:0030154]; leukocyte activation [GO:0045321]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1845_c1_g2_i1	Q96NJ6	ZFP3_HUMAN	43.8	80	44	1	287	48	146	224	1.60E-12	73.6	ZFP3_HUMAN	reviewed	Zinc finger protein 3 homolog (Zfp-3) (Zinc finger protein 752)	ZFP3 ZNF752	Homo sapiens (Human)	502	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4355_c0_g1_i10	P17039	ZNF30_HUMAN	48.6	109	56	0	332	6	413	521	1.40E-24	113.6	ZNF30_HUMAN	reviewed	Zinc finger protein 30 (Zinc finger protein KOX28)	ZNF30 KOX28	Homo sapiens (Human)	623	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c1_g1_i1	P17039	ZNF30_HUMAN	49.4	79	40	0	242	6	428	506	2.70E-17	89	ZNF30_HUMAN	reviewed	Zinc finger protein 30 (Zinc finger protein KOX28)	ZNF30 KOX28	Homo sapiens (Human)	623	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i9	P17039	ZNF30_HUMAN	47.1	70	37	0	211	2	271	340	1.30E-12	73.2	ZNF30_HUMAN	reviewed	Zinc finger protein 30 (Zinc finger protein KOX28)	ZNF30 KOX28	Homo sapiens (Human)	623	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1721_c0_g1_i1	Q9Y2G7	ZFP30_HUMAN	35.5	93	43	1	515	237	439	514	2.10E-09	64.3	ZFP30_HUMAN	reviewed	Zinc finger protein 30 homolog (Zfp-30) (Zinc finger protein 745)	ZFP30 KIAA0961 ZNF745	Homo sapiens (Human)	519	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1721_c0_g1_i3	Q9Y2G7	ZFP30_HUMAN	35.5	93	43	1	891	613	439	514	3.20E-09	64.3	ZFP30_HUMAN	reviewed	Zinc finger protein 30 homolog (Zfp-30) (Zinc finger protein 745)	ZFP30 KIAA0961 ZNF745	Homo sapiens (Human)	519	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1721_c0_g1_i7	Q9Y2G7	ZFP30_HUMAN	35.5	93	43	1	883	605	439	514	3.10E-09	64.3	ZFP30_HUMAN	reviewed	Zinc finger protein 30 homolog (Zfp-30) (Zinc finger protein 745)	ZFP30 KIAA0961 ZNF745	Homo sapiens (Human)	519	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c2_g1_i1	Q96RE9	ZN300_HUMAN	40.8	76	45	0	117	344	402	477	2.40E-11	69.7	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g2_i5	Q96RE9	ZN300_HUMAN	50.3	187	93	0	570	10	353	539	7.90E-52	204.9	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i12	Q96RE9	ZN300_HUMAN	38.2	136	70	3	2	376	409	541	3.90E-21	102.4	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i15	Q96RE9	ZN300_HUMAN	44.8	192	102	1	1	576	354	541	1.10E-43	177.9	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g1_i15	Q96RE9	ZN300_HUMAN	53.3	45	21	0	137	3	449	493	1.30E-07	58.2	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g1_i17	Q96RE9	ZN300_HUMAN	53.3	45	21	0	137	3	449	493	1.20E-07	58.2	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g1_i2	Q96RE9	ZN300_HUMAN	53.3	45	21	0	137	3	449	493	8.50E-08	57.8	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g1_i8	Q96RE9	ZN300_HUMAN	53.3	45	21	0	137	3	449	493	1.30E-07	58.2	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4306_c0_g1_i1	Q96RE9	ZN300_HUMAN	38.5	143	83	3	548	123	465	603	1.90E-23	111.7	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6598_c0_g1_i3	Q96RE9	ZN300_HUMAN	44.7	85	47	0	14	268	421	505	1.40E-14	80.1	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13724_c0_g1_i1	Q96RE9	ZN300_HUMAN	48.8	164	83	1	539	48	381	543	6.40E-46	185.3	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c2_g1_i2	Q96RE9	ZN300_HUMAN	53.5	71	33	0	3	215	413	483	1.60E-16	86.3	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c2_g1_i3	Q96RE9	ZN300_HUMAN	56.3	71	31	0	3	215	413	483	1.10E-17	90.1	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i3	Q96RE9	ZN300_HUMAN	47.3	110	58	0	335	6	455	564	1.70E-25	116.7	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i18	Q96RE9	ZN300_HUMAN	46.5	99	50	1	296	9	385	483	4.90E-21	101.7	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i2	Q96RE9	ZN300_HUMAN	44.4	187	86	1	515	9	297	483	1.50E-41	170.6	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i22	Q96RE9	ZN300_HUMAN	40.9	159	85	2	503	51	329	486	1.30E-26	120.9	ZN300_HUMAN	reviewed	Zinc finger protein 300	ZNF300	Homo sapiens (Human)	604	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c3_g1_i3	Q9NR11	ZN302_HUMAN	51.5	66	32	0	3	200	292	357	1.60E-15	82.8	ZN302_HUMAN	reviewed	Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327)	ZNF302 ZNF135L ZNF140L ZNF327	Homo sapiens (Human)	478	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i1	Q9NR11	ZN302_HUMAN	47.2	89	46	1	277	11	295	382	2.70E-19	96.3	ZN302_HUMAN	reviewed	Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327)	ZNF302 ZNF135L ZNF140L ZNF327	Homo sapiens (Human)	478	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i1	Q9NR11	ZN302_HUMAN	51.9	52	25	0	384	229	302	353	1.40E-10	67.4	ZN302_HUMAN	reviewed	Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327)	ZNF302 ZNF135L ZNF140L ZNF327	Homo sapiens (Human)	478	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5550_c0_g1_i5	Q9NR11	ZN302_HUMAN	53.3	75	35	0	151	375	294	368	6.20E-17	88.6	ZN302_HUMAN	reviewed	Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327)	ZNF302 ZNF135L ZNF140L ZNF327	Homo sapiens (Human)	478	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i8	Q9NR11	ZN302_HUMAN	53.4	131	61	0	403	11	308	438	2.30E-37	156.4	ZN302_HUMAN	reviewed	Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327)	ZNF302 ZNF135L ZNF140L ZNF327	Homo sapiens (Human)	478	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g3_i1	Q9HCX3	ZN304_HUMAN	44.6	92	51	0	278	3	445	536	2.30E-20	99.4	ZN304_HUMAN	reviewed	Zinc finger protein 304 (KRAB-containing zinc finger protein)	ZNF304	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001525; GO:0005634; GO:0006325; GO:0006357; GO:0007229; GO:0007265; GO:0030335; GO:0035562; GO:0045766; GO:0045944; GO:0046872; GO:0050679; GO:0090309; GO:1900114; GO:1902466; GO:1990841; GO:2000811	angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5956_c0_g1_i1	Q9HCX3	ZN304_HUMAN	48.8	123	61	1	377	9	392	512	1.30E-31	137.1	ZN304_HUMAN	reviewed	Zinc finger protein 304 (KRAB-containing zinc finger protein)	ZNF304	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001525; GO:0005634; GO:0006325; GO:0006357; GO:0007229; GO:0007265; GO:0030335; GO:0035562; GO:0045766; GO:0045944; GO:0046872; GO:0050679; GO:0090309; GO:1900114; GO:1902466; GO:1990841; GO:2000811	angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29830_c0_g1_i1	Q9HCX3	ZN304_HUMAN	49.3	136	69	0	468	61	307	442	2.50E-39	163.3	ZN304_HUMAN	reviewed	Zinc finger protein 304 (KRAB-containing zinc finger protein)	ZNF304	Homo sapiens (Human)	659	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001525; GO:0005634; GO:0006325; GO:0006357; GO:0007229; GO:0007265; GO:0030335; GO:0035562; GO:0045766; GO:0045944; GO:0046872; GO:0050679; GO:0090309; GO:1900114; GO:1902466; GO:1990841; GO:2000811	angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i3	A6NFI3	ZN316_HUMAN	59.2	49	20	0	511	657	373	421	1.70E-11	71.2	ZN316_HUMAN	reviewed	Zinc finger protein 316	ZNF316	Homo sapiens (Human)	1004	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i3	A6NFI3	ZN316_HUMAN	47.3	55	29	0	272	108	375	429	8.10E-10	64.3	ZN316_HUMAN	reviewed	Zinc finger protein 316	ZNF316	Homo sapiens (Human)	1004	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14324_c2_g1_i1	Q96PQ6	ZN317_HUMAN	51.5	66	32	0	231	34	293	358	6.60E-16	84.3	ZN317_HUMAN	reviewed	Zinc finger protein 317	ZNF317 KIAA1588	Homo sapiens (Human)	595	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26594_c0_g1_i1	Q96PQ6	ZN317_HUMAN	94.9	138	7	0	415	2	439	576	4.20E-79	295	ZN317_HUMAN	reviewed	Zinc finger protein 317	ZNF317 KIAA1588	Homo sapiens (Human)	595	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i15	Q9ERR8	ZN319_MOUSE	54.2	48	21	1	74	217	485	531	1.40E-08	60.1	ZN319_MOUSE	reviewed	Zinc finger protein 319	Znf319 Zfp319	Mus musculus (Mouse)	581	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8932_c1_g1_i1	Q9P2F9	ZN319_HUMAN	57.4	47	20	0	261	401	486	532	1.80E-09	63.9	ZN319_HUMAN	reviewed	Zinc finger protein 319	ZNF319 KIAA1388	Homo sapiens (Human)	582	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i16	P17041	ZNF32_HUMAN	39.8	128	74	1	378	4	95	222	1.80E-20	100.1	ZNF32_HUMAN	reviewed	Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30)	ZNF32 KOX30	Homo sapiens (Human)	273	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37499_c0_g1_i1	P17041	ZNF32_HUMAN	100	104	0	0	314	3	157	260	8.70E-61	233.8	ZNF32_HUMAN	reviewed	Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30)	ZNF32 KOX30	Homo sapiens (Human)	273	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26318_c0_g1_i1	P17041	ZNF32_HUMAN	100	91	0	0	1	273	65	155	5.50E-51	201.1	ZNF32_HUMAN	reviewed	Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30)	ZNF32 KOX30	Homo sapiens (Human)	273	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g3_i1	Q80V23	ZNF32_MOUSE	52.9	85	40	0	3	257	74	158	1.30E-20	100.1	ZNF32_MOUSE	reviewed	Zinc finger protein 32 (Zinc finger protein 637)	Znf32 Zfp637	Mus musculus (Mouse)	272	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c14_g2_i1	Q80V23	ZNF32_MOUSE	50	82	41	0	253	8	81	162	3.00E-19	95.5	ZNF32_MOUSE	reviewed	Zinc finger protein 32 (Zinc finger protein 637)	Znf32 Zfp637	Mus musculus (Mouse)	272	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27605_c0_g1_i1	Q80V23	ZNF32_MOUSE	100	146	0	0	3	440	69	214	2.20E-86	319.3	ZNF32_MOUSE	reviewed	Zinc finger protein 32 (Zinc finger protein 637)	Znf32 Zfp637	Mus musculus (Mouse)	272	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i13	A2RRD8	ZN320_HUMAN	45.6	57	31	0	181	11	381	437	1.40E-07	57	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i16	A2RRD8	ZN320_HUMAN	45.6	57	31	0	181	11	381	437	3.00E-07	57	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i35	A2RRD8	ZN320_HUMAN	43.9	57	32	0	181	11	381	437	2.50E-06	53.9	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i47	A2RRD8	ZN320_HUMAN	45.6	57	31	0	181	11	381	437	1.20E-07	57	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i51	A2RRD8	ZN320_HUMAN	46.7	45	24	0	142	8	381	425	7.30E-05	47.8	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i54	A2RRD8	ZN320_HUMAN	45.6	57	31	0	181	11	381	437	2.90E-07	57	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i4	A2RRD8	ZN320_HUMAN	44.8	58	32	0	177	4	381	438	4.00E-08	59.7	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i5	A2RRD8	ZN320_HUMAN	42.6	68	39	0	334	131	381	448	9.40E-09	62	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i3	A2RRD8	ZN320_HUMAN	42.3	71	40	1	93	305	368	437	3.20E-07	55.8	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i5	A2RRD8	ZN320_HUMAN	33	103	65	1	39	335	335	437	2.70E-07	56.2	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i8	A2RRD8	ZN320_HUMAN	35	103	63	1	39	335	335	437	4.10E-08	58.9	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c0_g2_i1	A2RRD8	ZN320_HUMAN	38.2	68	42	0	105	308	381	448	1.00E-08	60.8	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i8	A2RRD8	ZN320_HUMAN	43.4	53	30	0	103	261	385	437	3.10E-06	52.4	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13056_c0_g1_i5	A2RRD8	ZN320_HUMAN	41.1	56	33	0	120	287	381	436	2.80E-05	49.3	ZN320_HUMAN	reviewed	Zinc finger protein 320	ZNF320	Homo sapiens (Human)	509	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40444_c0_g1_i1	O75467	Z324A_HUMAN	100	78	0	0	3	236	371	448	1.60E-43	176	Z324A_HUMAN	reviewed	Zinc finger protein 324A (Zinc finger protein ZF5128)	ZNF324 ZNF324A	Homo sapiens (Human)	553	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000082; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008283; GO:0046872	cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15569_c0_g1_i2	Q6GQR8	ZN329_MOUSE	45.6	90	48	1	278	9	342	430	1.10E-16	87.4	ZN329_MOUSE	reviewed	Zinc finger protein 329	Znf329 Zfp329	Mus musculus (Mouse)	522	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9294_c0_g2_i1	Q5RES8	ZN334_PONAB	49.1	55	27	1	169	5	247	300	8.40E-08	57.4	ZN334_PONAB	reviewed	Zinc finger protein 334	ZNF334	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	678	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i1	Q9Y3M9	ZN337_HUMAN	46.5	71	38	0	214	2	254	324	4.00E-10	65.9	ZN337_HUMAN	reviewed	Zinc finger protein 337	ZNF337	Homo sapiens (Human)	751	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i5	Q9Y3M9	ZN337_HUMAN	48.2	56	29	0	169	2	269	324	1.40E-07	57.4	ZN337_HUMAN	reviewed	Zinc finger protein 337	ZNF337	Homo sapiens (Human)	751	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g2_i1	Q9Y3M9	ZN337_HUMAN	50	72	36	0	221	6	450	521	3.00E-15	82	ZN337_HUMAN	reviewed	Zinc finger protein 337	ZNF337	Homo sapiens (Human)	751	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i12	Q9Y3M9	ZN337_HUMAN	33.7	175	95	4	32	502	254	425	3.20E-21	103.2	ZN337_HUMAN	reviewed	Zinc finger protein 337	ZNF337	Homo sapiens (Human)	751	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5654_c0_g2_i1	Q06730	ZN33A_HUMAN	58.2	110	46	0	6	335	433	542	1.70E-33	143.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g2_i1	Q06730	ZN33A_HUMAN	54	161	70	1	8	490	461	617	1.50E-43	177.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c3_g1_i3	Q06730	ZN33A_HUMAN	50	112	56	0	1	336	512	623	4.90E-25	115.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i2	Q06730	ZN33A_HUMAN	54.5	132	60	0	3	398	421	552	8.10E-35	147.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i3	Q06730	ZN33A_HUMAN	51.9	135	63	1	80	478	418	552	3.40E-32	139.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i14	Q06730	ZN33A_HUMAN	54.7	86	39	0	263	6	474	559	1.70E-20	99.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c86_g1_i1	Q06730	ZN33A_HUMAN	54.2	72	33	0	3	218	418	489	1.60E-16	86.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c25_g1_i1	Q06730	ZN33A_HUMAN	48.5	68	35	0	9	212	466	533	1.40E-14	79.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c25_g2_i1	Q06730	ZN33A_HUMAN	51.4	70	34	0	7	216	417	486	6.40E-17	87.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c2_g2_i1	Q06730	ZN33A_HUMAN	57.6	99	42	0	5	301	388	486	4.20E-31	135.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c2_g2_i2	Q06730	ZN33A_HUMAN	56.6	99	43	0	5	301	388	486	9.30E-31	134	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i21	Q06730	ZN33A_HUMAN	46.7	321	138	5	1230	268	332	619	5.30E-77	289.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i36	Q06730	ZN33A_HUMAN	52.3	86	41	0	261	4	410	495	2.80E-20	99	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i8	Q06730	ZN33A_HUMAN	46	189	74	3	507	7	424	606	2.40E-39	163.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i13	Q06730	ZN33A_HUMAN	49	104	53	0	360	671	442	545	1.60E-22	107.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i2	Q06730	ZN33A_HUMAN	49	104	53	0	587	898	442	545	2.10E-22	107.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g2_i9	Q06730	ZN33A_HUMAN	58.8	68	28	0	206	3	470	537	4.60E-18	91.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10832_c0_g1_i1	Q06730	ZN33A_HUMAN	49.4	81	41	0	21	263	546	626	6.60E-17	87.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10832_c0_g1_i2	Q06730	ZN33A_HUMAN	51.4	109	53	0	21	347	490	598	6.00E-26	118.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10832_c0_g1_i3	Q06730	ZN33A_HUMAN	45.1	91	50	0	43	315	536	626	8.70E-16	84.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10832_c0_g1_i4	Q06730	ZN33A_HUMAN	50.5	109	54	0	21	347	490	598	5.10E-25	115.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10832_c0_g1_i5	Q06730	ZN33A_HUMAN	51.4	109	53	0	21	347	490	598	6.00E-26	118.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10832_c0_g1_i6	Q06730	ZN33A_HUMAN	53.4	133	62	0	4	402	466	598	9.70E-36	151	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10812_c0_g1_i4	Q06730	ZN33A_HUMAN	53.2	190	83	1	15	584	451	634	8.70E-54	211.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g2_i1	Q06730	ZN33A_HUMAN	52.3	109	52	0	5	331	489	597	2.30E-27	122.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c2_g1_i2	Q06730	ZN33A_HUMAN	54.8	104	47	0	6	317	389	492	1.20E-28	127.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c8_g1_i1	Q06730	ZN33A_HUMAN	50.6	87	43	0	265	5	546	632	1.20E-18	93.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i12	Q06730	ZN33A_HUMAN	47.2	271	129	1	3	815	402	658	5.10E-72	272.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7886_c0_g2_i1	Q06730	ZN33A_HUMAN	54	87	40	0	4	264	444	530	1.20E-21	103.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g2_i3	Q06730	ZN33A_HUMAN	53.1	177	79	1	9	539	417	589	1.90E-47	190.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g2_i5	Q06730	ZN33A_HUMAN	54.5	77	35	0	2	232	470	546	4.70E-19	94.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15569_c0_g1_i1	Q06730	ZN33A_HUMAN	45.2	146	79	1	446	9	514	658	4.80E-32	139	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i6	Q06730	ZN33A_HUMAN	48.6	70	29	1	3	212	564	626	1.80E-12	72.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i8	Q06730	ZN33A_HUMAN	57.6	158	65	2	479	6	471	626	1.60E-45	183.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g1_i5	Q06730	ZN33A_HUMAN	48.2	85	44	0	303	49	574	658	1.60E-19	96.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g2_i1	Q06730	ZN33A_HUMAN	51.7	87	36	1	264	4	451	531	8.40E-20	97.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g3_i1	Q06730	ZN33A_HUMAN	46.7	182	97	0	590	45	421	602	4.70E-47	189.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g3_i2	Q06730	ZN33A_HUMAN	50.7	136	67	0	408	1	421	556	1.70E-35	150.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i10	Q06730	ZN33A_HUMAN	52.7	243	114	1	42	770	385	626	3.10E-67	256.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i11	Q06730	ZN33A_HUMAN	49.4	89	45	0	14	280	398	486	8.00E-21	100.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i4	Q06730	ZN33A_HUMAN	50	92	46	0	44	319	395	486	4.20E-21	102.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i5	Q06730	ZN33A_HUMAN	50	116	58	0	56	403	371	486	3.90E-29	129	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i7	Q06730	ZN33A_HUMAN	54.4	103	46	1	42	350	385	486	4.30E-27	122.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20326_c0_g1_i2	Q06730	ZN33A_HUMAN	34.5	139	87	2	1379	966	580	715	5.30E-15	84	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8500_c0_g3_i1	Q06730	ZN33A_HUMAN	44.7	85	47	0	359	105	546	630	2.40E-17	89.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c1_g1_i3	Q06730	ZN33A_HUMAN	48	75	39	0	253	29	556	630	5.40E-16	84.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c1_g1_i4	Q06730	ZN33A_HUMAN	49.3	75	38	0	253	29	556	630	2.40E-16	85.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c1_g1_i6	Q06730	ZN33A_HUMAN	50.7	75	37	0	253	29	556	630	1.10E-16	87	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i8	Q06730	ZN33A_HUMAN	54.5	77	35	0	233	3	369	445	1.50E-20	99.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i11	Q06730	ZN33A_HUMAN	50.7	134	65	1	408	7	494	626	2.70E-33	142.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i12	Q06730	ZN33A_HUMAN	51.5	134	64	1	408	7	494	626	5.40E-34	145.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i4	Q06730	ZN33A_HUMAN	52.9	119	56	0	363	7	508	626	2.70E-30	132.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i7	Q06730	ZN33A_HUMAN	53.7	67	31	0	319	119	400	466	3.30E-15	82.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i7	Q06730	ZN33A_HUMAN	56.2	137	58	1	3	413	397	531	1.10E-37	157.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10690_c0_g1_i1	Q06730	ZN33A_HUMAN	47.2	89	47	0	15	281	454	542	9.50E-17	87.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10690_c0_g1_i2	Q06730	ZN33A_HUMAN	53.8	117	54	0	15	365	454	570	2.50E-30	132.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i12	Q06730	ZN33A_HUMAN	48.3	211	109	0	3	635	399	609	2.80E-53	209.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i13	Q06730	ZN33A_HUMAN	50.8	183	90	0	3	551	427	609	1.30E-46	187.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i10	Q06730	ZN33A_HUMAN	50.5	101	50	0	1	303	469	569	3.70E-24	112.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i17	Q06730	ZN33A_HUMAN	51.1	135	63	1	31	435	316	447	7.40E-34	144.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12930_c0_g1_i8	Q06730	ZN33A_HUMAN	55.6	63	28	0	68	256	471	533	1.80E-14	79.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i9	Q06730	ZN33A_HUMAN	49	102	45	1	481	176	453	547	3.30E-22	106.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10220_c1_g1_i1	Q06730	ZN33A_HUMAN	48.6	179	92	0	553	17	368	546	1.10E-47	191	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10220_c1_g1_i4	Q06730	ZN33A_HUMAN	52.7	131	62	0	399	7	368	498	1.10E-36	154.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g4_i2	Q06730	ZN33A_HUMAN	50.7	134	66	0	407	6	385	518	3.30E-36	152.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g3_i2	Q06730	ZN33A_HUMAN	54.1	135	62	0	407	3	360	494	1.40E-34	147.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38849_c0_g1_i1	Q06730	ZN33A_HUMAN	53.5	86	39	1	5	262	694	778	1.30E-20	100.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20794_c0_g1_i1	Q06730	ZN33A_HUMAN	43.8	400	217	1	66	1265	357	748	1.30E-97	358.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i4	Q06730	ZN33A_HUMAN	52	123	59	0	377	9	368	490	1.30E-34	147.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i10	Q06730	ZN33A_HUMAN	40.7	189	96	3	157	699	368	548	3.50E-33	143.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i11	Q06730	ZN33A_HUMAN	51.4	220	107	0	534	1193	413	632	9.40E-63	242.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i17	Q06730	ZN33A_HUMAN	54.7	106	45	2	3	320	429	531	9.10E-29	127.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i21	Q06730	ZN33A_HUMAN	50.7	278	137	0	371	1204	355	632	1.00E-80	302	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i5	Q06730	ZN33A_HUMAN	54.5	123	53	2	3	371	429	548	3.50E-32	139	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i2	Q06730	ZN33A_HUMAN	37.3	134	75	4	392	3	310	438	8.50E-13	75.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i4	Q06730	ZN33A_HUMAN	47.3	167	77	2	503	3	458	613	2.60E-38	159.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i15	Q06730	ZN33A_HUMAN	43.2	271	139	6	49	840	316	578	3.00E-55	216.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11304_c1_g1_i1	Q06730	ZN33A_HUMAN	59.3	81	33	0	2	244	470	550	1.90E-23	109.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i12	Q06730	ZN33A_HUMAN	56.9	58	25	0	2	175	469	526	5.50E-14	78.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i5	Q06730	ZN33A_HUMAN	53.7	82	38	0	2	247	469	550	2.10E-20	99.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i4	Q06730	ZN33A_HUMAN	51.4	148	72	0	539	96	400	547	2.30E-40	166.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i8	Q06730	ZN33A_HUMAN	50.5	97	48	0	293	3	434	530	1.00E-25	117.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i8	Q06730	ZN33A_HUMAN	62.5	48	18	0	453	310	501	548	1.90E-11	70.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i12	Q06730	ZN33A_HUMAN	46.3	121	65	0	367	5	396	516	1.70E-25	117.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i3	Q06730	ZN33A_HUMAN	45.5	121	66	0	367	5	396	516	1.60E-24	113.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i5	Q06730	ZN33A_HUMAN	43.7	151	85	0	457	5	480	630	6.50E-32	138.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g2_i2	Q06730	ZN33A_HUMAN	50	114	57	0	345	4	377	490	3.70E-28	125.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i12	Q06730	ZN33A_HUMAN	50.9	57	27	1	293	126	463	519	1.90E-09	63.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i13	Q06730	ZN33A_HUMAN	50.4	121	53	2	366	7	490	604	4.90E-26	118.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i2	Q06730	ZN33A_HUMAN	49.4	87	44	0	263	3	490	576	1.90E-19	96.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i6	Q06730	ZN33A_HUMAN	51.7	87	42	0	263	3	490	576	8.50E-20	97.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i7	Q06730	ZN33A_HUMAN	47.9	121	56	2	366	7	490	604	1.90E-25	116.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i4	Q06730	ZN33A_HUMAN	48.7	154	79	0	503	42	421	574	2.30E-40	166.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c2_g1_i1	Q06730	ZN33A_HUMAN	46.2	160	78	3	2	478	441	593	3.10E-36	152.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g1_i4	Q06730	ZN33A_HUMAN	49.3	73	37	0	1	219	414	486	1.00E-15	83.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i1	Q06730	ZN33A_HUMAN	56.6	83	36	0	249	1	421	503	1.90E-21	103.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i13	Q06730	ZN33A_HUMAN	57.5	80	34	0	240	1	424	503	1.10E-20	101.3	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5058_c0_g1_i1	Q06730	ZN33A_HUMAN	52.3	174	83	0	3	524	444	617	2.00E-49	196.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5058_c0_g1_i4	Q06730	ZN33A_HUMAN	51.9	187	90	0	3	563	444	630	3.90E-54	212.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8943_c0_g1_i1	Q06730	ZN33A_HUMAN	56.7	150	65	0	2	451	440	589	1.20E-47	190.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8943_c0_g1_i2	Q06730	ZN33A_HUMAN	52.7	150	63	1	2	427	440	589	3.60E-41	169.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i10	Q06730	ZN33A_HUMAN	41.8	146	81	1	429	4	371	516	1.60E-28	127.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i10	Q06730	ZN33A_HUMAN	63.2	38	14	0	242	129	561	598	1.00E-06	54.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i13	Q06730	ZN33A_HUMAN	57.6	198	84	0	746	153	427	624	5.30E-64	245.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i20	Q06730	ZN33A_HUMAN	44.2	172	92	1	505	2	371	542	1.40E-36	154.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i20	Q06730	ZN33A_HUMAN	63.2	38	14	0	318	205	561	598	1.20E-06	54.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c2_g1_i1	Q06730	ZN33A_HUMAN	57.9	57	24	0	175	5	514	570	3.30E-13	75.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c2_g1_i2	Q06730	ZN33A_HUMAN	52.8	106	50	0	321	4	435	540	1.70E-27	123.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i10	Q06730	ZN33A_HUMAN	49.4	87	44	0	5	265	410	496	8.30E-20	97.4	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i4	Q06730	ZN33A_HUMAN	52.5	80	38	0	9	248	417	496	5.10E-19	94.7	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i9	Q06730	ZN33A_HUMAN	58.6	99	41	0	6	302	388	486	1.20E-27	123.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i10	Q06730	ZN33A_HUMAN	47.1	85	45	0	260	6	425	509	2.50E-16	85.9	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i3	Q06730	ZN33A_HUMAN	58.3	48	20	0	149	6	462	509	7.20E-11	67.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i7	Q06730	ZN33A_HUMAN	53.7	82	38	0	311	66	458	539	3.60E-22	105.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i8	Q06730	ZN33A_HUMAN	55.2	145	65	0	436	2	458	602	2.70E-44	179.5	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i1	Q06730	ZN33A_HUMAN	40.3	139	81	1	413	3	386	524	5.60E-23	108.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i11	Q06730	ZN33A_HUMAN	44.5	110	41	2	584	255	552	641	7.40E-17	89	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i11	Q06730	ZN33A_HUMAN	60	50	20	0	255	106	473	522	1.40E-10	68.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i18	Q06730	ZN33A_HUMAN	44.2	113	43	2	593	255	549	641	5.10E-17	90.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i18	Q06730	ZN33A_HUMAN	60	50	20	0	255	106	473	522	2.10E-10	68.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i27	Q06730	ZN33A_HUMAN	44.2	113	43	2	593	255	549	641	4.40E-17	90.1	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i27	Q06730	ZN33A_HUMAN	60	50	20	0	255	106	473	522	1.80E-10	68.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c1_g1_i1	Q06730	ZN33A_HUMAN	46.9	64	34	0	200	9	567	630	9.90E-13	73.6	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i1	Q06730	ZN33A_HUMAN	43.8	128	70	2	386	3	409	534	2.90E-23	109.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i2	Q06730	ZN33A_HUMAN	43.8	128	70	2	386	3	409	534	2.80E-23	109.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i6	Q06730	ZN33A_HUMAN	49.5	111	56	0	1	333	436	546	5.40E-28	125.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c1_g1_i1	Q06730	ZN33A_HUMAN	55.7	131	58	0	4	396	427	557	5.40E-39	161.8	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32097_c0_g1_i1	Q06730	ZN33A_HUMAN	100	108	0	0	326	3	669	776	2.20E-62	239.2	ZN33A_HUMAN	reviewed	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	810	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g1_i2	Q06732	ZN33B_HUMAN	56	84	32	2	26	262	493	576	7.10E-16	85.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g2_i6	Q06732	ZN33B_HUMAN	53.1	194	91	0	2	583	434	627	2.80E-60	233	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5698_c0_g1_i13	Q06732	ZN33B_HUMAN	50.6	85	42	0	1	255	547	631	1.50E-22	107.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i1	Q06732	ZN33B_HUMAN	53	134	63	0	2	403	470	603	6.00E-36	151.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i2	Q06732	ZN33B_HUMAN	52.5	242	115	0	2	727	470	711	1.60E-69	264.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i2	Q06732	ZN33B_HUMAN	53.3	135	59	2	682	1074	365	499	2.20E-34	147.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i4	Q06732	ZN33B_HUMAN	53.3	199	92	1	2	598	358	555	3.50E-58	226.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i5	Q06732	ZN33B_HUMAN	52.9	204	96	0	2	613	470	673	3.20E-58	226.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i7	Q06732	ZN33B_HUMAN	53.5	157	73	0	2	472	498	654	6.70E-44	179.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12404_c0_g1_i7	Q06732	ZN33B_HUMAN	53.3	135	60	1	430	825	365	499	6.10E-37	156	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i4	Q06732	ZN33B_HUMAN	51.7	143	65	2	80	499	391	532	5.30E-36	152.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i6	Q06732	ZN33B_HUMAN	52.5	139	66	0	3	419	394	532	9.10E-37	154.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i23	Q06732	ZN33B_HUMAN	54.1	222	95	2	803	138	445	659	5.00E-61	236.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i25	Q06732	ZN33B_HUMAN	44.3	106	42	1	588	322	471	576	1.70E-17	90.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i30	Q06732	ZN33B_HUMAN	59.6	99	40	0	344	48	389	487	5.20E-30	131.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i35	Q06732	ZN33B_HUMAN	44.1	177	79	2	538	8	335	491	2.50E-39	163.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i38	Q06732	ZN33B_HUMAN	52.3	128	61	0	394	11	463	590	7.00E-34	145.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i38	Q06732	ZN33B_HUMAN	40.5	111	55	2	692	384	504	611	3.60E-14	80.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i4	Q06732	ZN33B_HUMAN	47.9	188	88	1	574	11	413	590	3.30E-47	190.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i43	Q06732	ZN33B_HUMAN	48.4	128	54	2	391	8	512	627	8.30E-28	124.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c14_g3_i3	Q06732	ZN33B_HUMAN	50.5	285	139	2	849	1	362	646	8.70E-79	295	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i1	Q06732	ZN33B_HUMAN	44.3	122	68	0	383	748	481	602	3.20E-24	113.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i10	Q06732	ZN33B_HUMAN	44.3	122	68	0	306	671	481	602	2.80E-24	113.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i23	Q06732	ZN33B_HUMAN	44.3	122	68	0	306	671	481	602	2.80E-24	113.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i4	Q06732	ZN33B_HUMAN	43.8	121	68	0	213	575	454	574	1.00E-22	108.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i5	Q06732	ZN33B_HUMAN	44.3	122	68	0	189	554	481	602	2.30E-24	113.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i7	Q06732	ZN33B_HUMAN	44.3	122	68	0	207	572	481	602	2.40E-24	113.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c11_g1_i1	Q06732	ZN33B_HUMAN	53.1	113	53	0	9	347	434	546	9.80E-29	127.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10860_c0_g1_i2	Q06732	ZN33B_HUMAN	45.5	112	51	2	367	32	530	631	7.90E-21	101.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10860_c0_g1_i5	Q06732	ZN33B_HUMAN	43.5	115	55	1	349	5	574	678	7.70E-21	101.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i12	Q06732	ZN33B_HUMAN	47.1	104	40	2	88	354	339	442	1.90E-19	96.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i12	Q06732	ZN33B_HUMAN	64.3	42	15	0	2	127	586	627	6.70E-09	61.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i2	Q06732	ZN33B_HUMAN	59.3	91	37	0	2	274	380	470	1.80E-25	116.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i3	Q06732	ZN33B_HUMAN	47.1	104	40	2	112	378	339	442	2.00E-19	96.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i3	Q06732	ZN33B_HUMAN	56	50	22	0	2	151	382	431	3.80E-10	65.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i5	Q06732	ZN33B_HUMAN	57	114	49	0	1	342	329	442	7.60E-34	144.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g3_i1	Q06732	ZN33B_HUMAN	53	132	62	0	1	396	386	517	6.10E-35	148.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c1_g1_i10	Q06732	ZN33B_HUMAN	55.2	192	86	0	2	577	386	577	1.30E-59	231.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c1_g1_i4	Q06732	ZN33B_HUMAN	55.2	192	86	0	2	577	386	577	1.30E-59	231.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i23	Q06732	ZN33B_HUMAN	42.2	83	41	1	407	159	689	764	6.40E-14	79.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i16	Q06732	ZN33B_HUMAN	51	100	35	1	3	302	530	615	7.60E-22	105.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i16	Q06732	ZN33B_HUMAN	34.5	168	90	3	44	502	555	717	3.90E-18	92.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i18	Q06732	ZN33B_HUMAN	50.4	115	53	1	16	360	325	435	5.50E-30	132.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g2_i4	Q06732	ZN33B_HUMAN	51.7	116	56	0	3	350	414	529	2.10E-31	136.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16337_c0_g2_i1	Q06732	ZN33B_HUMAN	54.3	81	37	0	250	8	411	491	1.20E-18	93.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16337_c0_g2_i2	Q06732	ZN33B_HUMAN	44.8	125	59	1	381	7	426	540	2.40E-22	106.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16337_c0_g2_i3	Q06732	ZN33B_HUMAN	49.6	139	69	1	417	4	369	507	1.90E-32	140.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16337_c0_g2_i4	Q06732	ZN33B_HUMAN	46.5	172	91	1	519	7	369	540	6.90E-37	155.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15569_c1_g1_i1	Q06732	ZN33B_HUMAN	57	107	46	0	5	325	546	652	3.70E-30	132.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i12	Q06732	ZN33B_HUMAN	53	230	107	1	2	688	361	590	7.30E-68	258.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i3	Q06732	ZN33B_HUMAN	46.1	178	68	2	4	468	443	615	5.90E-37	155.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i7	Q06732	ZN33B_HUMAN	53.5	241	112	0	727	5	326	566	1.00E-74	281.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19389_c0_g1_i6	Q06732	ZN33B_HUMAN	51.6	217	104	1	3	653	334	549	2.20E-61	236.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i2	Q06732	ZN33B_HUMAN	52.5	139	66	0	2	418	355	493	1.30E-40	167.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10439_c0_g1_i2	Q06732	ZN33B_HUMAN	58.3	103	43	0	332	24	518	620	4.40E-30	132.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14223_c0_g1_i1	Q06732	ZN33B_HUMAN	55.6	142	63	0	427	2	519	660	1.60E-44	180.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c7_g1_i1	Q06732	ZN33B_HUMAN	51.2	84	41	0	254	3	331	414	2.50E-21	102.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i14	Q06732	ZN33B_HUMAN	48	171	82	1	1	492	490	660	3.00E-39	162.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i27	Q06732	ZN33B_HUMAN	44.9	287	137	2	56	853	450	736	1.10E-65	251.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14352_c0_g2_i1	Q06732	ZN33B_HUMAN	53.2	94	44	0	282	1	428	521	3.10E-25	115.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14352_c0_g2_i2	Q06732	ZN33B_HUMAN	54.3	94	43	0	282	1	400	493	4.10E-25	115.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c0_g1_i2	Q06732	ZN33B_HUMAN	54.7	117	49	1	349	11	427	543	2.30E-30	132.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g2_i1	Q06732	ZN33B_HUMAN	47.1	85	45	0	259	5	454	538	4.40E-16	85.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i3	Q06732	ZN33B_HUMAN	43.6	78	44	0	103	336	693	770	1.20E-15	84	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i4	Q06732	ZN33B_HUMAN	46.2	78	42	0	103	336	693	770	2.70E-15	82.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g1_i4	Q06732	ZN33B_HUMAN	49.1	163	83	0	493	5	325	487	3.60E-46	186.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i13	Q06732	ZN33B_HUMAN	54.8	155	70	0	470	6	492	646	4.00E-46	186	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i8	Q06732	ZN33B_HUMAN	51.9	133	53	1	404	6	497	618	1.40E-34	147.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i10	Q06732	ZN33B_HUMAN	55.2	143	64	0	429	1	429	571	3.30E-42	172.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13052_c0_g3_i1	Q06732	ZN33B_HUMAN	47.1	119	63	0	364	8	369	487	6.40E-26	118.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13052_c0_g3_i2	Q06732	ZN33B_HUMAN	57.3	103	44	0	316	8	385	487	3.10E-29	129	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13040_c0_g1_i1	Q06732	ZN33B_HUMAN	51.5	99	48	0	8	304	462	560	6.30E-25	114.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i19	Q06732	ZN33B_HUMAN	35.3	221	116	5	6	656	574	771	6.20E-32	139	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i1	Q06732	ZN33B_HUMAN	53.3	135	55	1	564	184	361	495	1.60E-33	144.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i11	Q06732	ZN33B_HUMAN	52.9	170	69	1	512	3	369	527	5.70E-44	178.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i4	Q06732	ZN33B_HUMAN	54	161	72	2	589	110	389	548	1.20E-39	164.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3758_c1_g1_i9	Q06732	ZN33B_HUMAN	50	198	80	2	572	3	341	527	2.80E-47	189.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c0_g3_i1	Q06732	ZN33B_HUMAN	54.8	157	71	0	6	476	425	581	2.80E-43	176.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c0_g2_i1	Q06732	ZN33B_HUMAN	51.1	176	86	0	9	536	456	631	1.10E-45	184.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i19	Q06732	ZN33B_HUMAN	49	155	79	0	252	716	397	551	3.00E-40	166.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i20	Q06732	ZN33B_HUMAN	50.6	89	44	0	282	548	407	495	5.30E-21	102.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i23	Q06732	ZN33B_HUMAN	51	145	71	0	282	716	407	551	1.40E-40	167.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i10	Q06732	ZN33B_HUMAN	53.2	111	52	0	112	444	489	599	6.20E-28	125.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i4	Q06732	ZN33B_HUMAN	52.5	101	41	2	8	307	418	512	1.10E-22	107.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i5	Q06732	ZN33B_HUMAN	52.7	167	78	1	316	813	336	502	3.50E-45	183.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i5	Q06732	ZN33B_HUMAN	55.9	102	45	0	8	313	418	519	7.40E-27	122.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i6	Q06732	ZN33B_HUMAN	48.5	171	83	2	8	511	418	586	1.10E-39	164.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g1_i1	Q06732	ZN33B_HUMAN	48.6	185	95	0	96	650	341	525	4.80E-45	182.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g1_i4	Q06732	ZN33B_HUMAN	48.5	241	124	0	96	818	341	581	9.30E-62	238.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g1_i7	Q06732	ZN33B_HUMAN	48.5	241	124	0	197	919	341	581	1.00E-61	238.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11111_c2_g1_i1	Q06732	ZN33B_HUMAN	50.5	97	48	0	299	9	436	532	1.10E-20	100.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i7	Q06732	ZN33B_HUMAN	53.1	145	68	0	458	24	431	575	9.20E-43	174.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g3_i3	Q06732	ZN33B_HUMAN	49.7	159	80	0	482	6	389	547	1.10E-38	161	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g3_i5	Q06732	ZN33B_HUMAN	51.3	187	91	0	566	6	361	547	2.10E-49	196.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19829_c0_g1_i1	Q06732	ZN33B_HUMAN	56	91	40	0	3	275	541	631	1.40E-22	106.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19829_c0_g1_i2	Q06732	ZN33B_HUMAN	56	91	40	0	3	275	541	631	8.40E-23	107.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i10	Q06732	ZN33B_HUMAN	52.5	99	47	0	308	12	369	467	1.00E-24	114	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i5	Q06732	ZN33B_HUMAN	54.7	75	34	0	231	7	369	443	1.40E-18	93.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g2_i1	Q06732	ZN33B_HUMAN	43.9	173	85	3	279	785	370	534	1.40E-35	151.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i2	Q06732	ZN33B_HUMAN	41.6	209	122	0	223	849	341	549	3.80E-42	173.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i9	Q06732	ZN33B_HUMAN	56.5	131	57	0	1	393	361	491	5.40E-39	161.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g1_i3	Q06732	ZN33B_HUMAN	48.3	234	121	0	3	704	430	663	1.80E-61	237.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g2_i1	Q06732	ZN33B_HUMAN	47.7	130	68	0	5	394	635	764	8.80E-34	144.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c3_g1_i1	Q06732	ZN33B_HUMAN	54.7	75	34	0	227	3	335	409	7.10E-20	97.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g2_i1	Q06732	ZN33B_HUMAN	54.2	83	38	0	255	7	425	507	5.70E-21	101.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i8	Q06732	ZN33B_HUMAN	52.4	63	30	0	318	130	447	509	4.60E-13	75.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i8	Q06732	ZN33B_HUMAN	33.5	158	101	4	470	3	368	523	3.90E-12	72.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c2_g1_i1	Q06732	ZN33B_HUMAN	55	111	49	1	5	334	517	627	3.70E-28	125.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i1	Q06732	ZN33B_HUMAN	55.4	184	82	0	4	555	441	624	1.60E-53	210.7	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i12	Q06732	ZN33B_HUMAN	51.3	117	49	1	240	566	508	624	3.90E-27	122.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i14	Q06732	ZN33B_HUMAN	45.9	244	119	5	46	753	397	635	1.20E-50	201.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i21	Q06732	ZN33B_HUMAN	52.7	165	78	0	1	495	446	610	1.40E-44	181	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i21	Q06732	ZN33B_HUMAN	63.4	41	15	0	507	629	575	615	1.20E-08	61.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i13	Q06732	ZN33B_HUMAN	48.7	113	57	1	582	917	325	437	3.10E-29	130.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i13	Q06732	ZN33B_HUMAN	48.1	52	25	2	428	577	319	370	1.80E-05	51.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i8	Q06732	ZN33B_HUMAN	53.1	130	59	2	428	811	319	448	1.50E-35	151.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i9	Q06732	ZN33B_HUMAN	48.7	113	57	1	139	474	325	437	1.60E-29	130.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i9	Q06732	ZN33B_HUMAN	46.7	45	23	1	3	134	326	370	5.50E-06	52.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16511_c0_g1_i1	Q06732	ZN33B_HUMAN	50.4	129	64	0	398	12	359	487	1.20E-35	150.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i17	Q06732	ZN33B_HUMAN	34.9	252	125	4	694	2	345	578	1.30E-35	151.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i17	Q06732	ZN33B_HUMAN	51.1	45	22	0	314	180	731	775	2.90E-06	53.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7326_c0_g1_i1	Q06732	ZN33B_HUMAN	50	92	46	0	294	19	456	547	4.10E-20	98.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i9	Q06732	ZN33B_HUMAN	56.3	103	45	0	404	96	502	604	2.30E-29	129.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1848_c0_g1_i3	Q06732	ZN33B_HUMAN	46.3	201	107	1	15	617	322	521	2.50E-46	186.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i13	Q06732	ZN33B_HUMAN	50.4	226	112	0	719	42	378	603	4.90E-67	255.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g1_i1	Q06732	ZN33B_HUMAN	50.5	109	54	0	6	332	494	602	1.30E-25	117.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g1_i3	Q06732	ZN33B_HUMAN	56.7	134	58	0	6	407	469	602	7.20E-39	161.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g2_i2	Q06732	ZN33B_HUMAN	51.8	114	55	0	345	4	413	526	1.80E-30	133.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g2_i3	Q06732	ZN33B_HUMAN	51.5	68	33	0	209	6	484	551	1.20E-13	76.6	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g2_i5	Q06732	ZN33B_HUMAN	53	100	47	0	300	1	428	527	6.50E-26	118.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g1_i3	Q06732	ZN33B_HUMAN	50	80	37	1	1	240	471	547	2.50E-15	82.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i9	Q06732	ZN33B_HUMAN	47.1	187	82	1	514	5	469	655	1.10E-41	171	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c1_g1_i3	Q06732	ZN33B_HUMAN	60.4	91	36	0	2	274	372	462	2.50E-27	122.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i2	Q06732	ZN33B_HUMAN	51.3	150	70	1	1	441	325	474	8.90E-43	174.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i4	Q06732	ZN33B_HUMAN	52.7	93	44	0	2	280	682	774	2.80E-26	119	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i9	Q06732	ZN33B_HUMAN	53.2	94	44	0	1	282	353	446	3.10E-25	115.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i3	Q06732	ZN33B_HUMAN	58.6	99	41	0	6	302	529	627	3.60E-27	122.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i3	Q06732	ZN33B_HUMAN	30.4	125	70	4	73	408	476	596	4.30E-04	46.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i9	Q06732	ZN33B_HUMAN	58.6	99	41	0	6	302	529	627	3.30E-27	122.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i9	Q06732	ZN33B_HUMAN	52.7	55	26	0	307	471	703	757	8.10E-10	65.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g1_i1	Q06732	ZN33B_HUMAN	52	177	85	0	23	553	351	527	3.30E-50	199.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i3	Q06732	ZN33B_HUMAN	37.2	223	106	3	628	2	557	759	3.20E-36	153.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i16	Q06732	ZN33B_HUMAN	57.3	206	82	1	840	223	428	627	3.20E-65	250	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i16	Q06732	ZN33B_HUMAN	38.9	90	36	2	259	2	404	478	7.70E-11	69.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i18	Q06732	ZN33B_HUMAN	60.3	116	46	0	357	10	512	627	5.00E-36	151.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i21	Q06732	ZN33B_HUMAN	56.9	116	50	0	349	2	344	459	1.70E-36	153.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i4	Q06732	ZN33B_HUMAN	52.1	119	57	0	358	2	344	462	6.30E-31	134.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i5	Q06732	ZN33B_HUMAN	48.7	187	84	1	562	2	375	549	2.80E-49	196.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i6	Q06732	ZN33B_HUMAN	52.6	133	63	0	401	3	407	539	1.70E-35	150.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c3_g1_i2	Q06732	ZN33B_HUMAN	60	85	34	0	2	256	543	627	2.50E-24	112.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i16	Q06732	ZN33B_HUMAN	52.2	161	69	1	588	106	455	607	2.00E-41	171	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i31	Q06732	ZN33B_HUMAN	45	278	125	4	852	46	462	720	8.50E-58	225.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i32	Q06732	ZN33B_HUMAN	52.5	179	77	1	642	106	437	607	5.90E-47	189.5	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i38	Q06732	ZN33B_HUMAN	49.2	122	62	0	369	4	455	576	7.70E-30	132.1	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i4	Q06732	ZN33B_HUMAN	51.8	112	54	0	338	3	498	609	5.70E-29	128.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i6	Q06732	ZN33B_HUMAN	50.8	179	80	1	642	106	437	607	3.30E-46	186.8	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i8	Q06732	ZN33B_HUMAN	59.3	59	24	0	299	123	495	553	7.20E-15	82.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i12	Q06732	ZN33B_HUMAN	52.6	154	73	0	464	3	465	618	2.10E-42	173.3	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i4	Q06732	ZN33B_HUMAN	51.9	154	74	0	464	3	465	618	4.70E-42	172.2	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i11	Q06732	ZN33B_HUMAN	52.8	106	50	0	1	318	386	491	2.60E-27	122.9	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c1_g1_i3	Q06732	ZN33B_HUMAN	53.5	129	60	0	5	391	430	558	2.20E-37	156.4	ZN33B_HUMAN	reviewed	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	778	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c1_g1_i3	Q8IZ26	ZNF34_HUMAN	48.9	47	24	0	146	6	273	319	1.80E-07	56.2	ZNF34_HUMAN	reviewed	Zinc finger protein 34 (Zinc finger protein KOX32)	ZNF34 KOX32	Homo sapiens (Human)	560	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32790_c0_g1_i1	Q9BYN7	ZN341_HUMAN	35.6	104	49	3	728	417	1	86	2.30E-09	64.3	ZN341_HUMAN	reviewed	Zinc finger protein 341	ZNF341	Homo sapiens (Human)	854	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13148_c0_g1_i1	Q9BYN7	ZN341_HUMAN	49.2	368	157	6	1289	264	316	679	2.90E-100	367.1	ZN341_HUMAN	reviewed	Zinc finger protein 341	ZNF341	Homo sapiens (Human)	854	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g3_i1	Q3SYV7	ZN345_BOVIN	53.1	96	45	0	290	3	301	396	2.50E-25	115.9	ZN345_BOVIN	reviewed	Zinc finger protein 345	ZNF345	Bos taurus (Bovine)	487	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15968_c0_g1_i1	Q3SYV7	ZN345_BOVIN	46.2	78	40	1	3	236	330	405	1.30E-13	76.6	ZN345_BOVIN	reviewed	Zinc finger protein 345	ZNF345	Bos taurus (Bovine)	487	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16009_c0_g1_i1	Q3SYV7	ZN345_BOVIN	100	79	0	0	1	237	258	336	9.60E-44	176.8	ZN345_BOVIN	reviewed	Zinc finger protein 345	ZNF345	Bos taurus (Bovine)	487	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g2_i6	Q96SE7	ZN347_HUMAN	49.6	137	69	0	415	5	431	567	4.40E-36	152.1	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i5	Q96SE7	ZN347_HUMAN	50.8	118	57	1	1	354	475	591	4.20E-28	125.6	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i12	Q96SE7	ZN347_HUMAN	50.6	89	44	0	271	5	451	539	1.70E-21	104	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i9	Q96SE7	ZN347_HUMAN	54	63	29	0	196	8	447	509	3.70E-15	81.6	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i12	Q96SE7	ZN347_HUMAN	50.3	171	85	0	198	710	378	548	1.50E-48	194.5	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i12	Q96SE7	ZN347_HUMAN	51.5	68	33	0	1	204	485	552	2.00E-16	87.8	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i20	Q96SE7	ZN347_HUMAN	49.2	130	59	1	55	423	423	552	1.80E-32	140.6	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24667_c0_g1_i1	Q96SE7	ZN347_HUMAN	50.3	145	72	0	3	437	391	535	8.90E-41	167.9	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i1	Q96SE7	ZN347_HUMAN	52.3	128	60	1	570	187	461	587	3.30E-33	143.3	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i1	Q96SE7	ZN347_HUMAN	49.2	59	30	0	179	3	535	593	2.30E-10	67.4	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1363_c10_g1_i1	Q96SE7	ZN347_HUMAN	51.6	62	30	0	198	13	358	419	6.30E-11	67.8	ZN347_HUMAN	reviewed	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN20075_c0_g2_i1	Q9NW07	ZN358_HUMAN	57.1	56	21	1	205	47	311	366	7.80E-12	70.9	ZN358_HUMAN	reviewed	Zinc finger protein 358	ZNF358	Homo sapiens (Human)	568	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0019827; GO:0021915; GO:0035115; GO:0046872	embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN20075_c0_g2_i2	Q9NW07	ZN358_HUMAN	51.5	66	29	1	238	50	311	376	3.00E-12	72.4	ZN358_HUMAN	reviewed	Zinc finger protein 358	ZNF358	Homo sapiens (Human)	568	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0019827; GO:0021915; GO:0035115; GO:0046872	embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g2_i1	Q8N895	ZN366_HUMAN	42.6	61	35	0	5	187	439	499	1.70E-10	66.2	ZN366_HUMAN	reviewed	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	ZNF366	Homo sapiens (Human)	744	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000790; GO:0000978; GO:0003700; GO:0003714; GO:0005634; GO:0006357; GO:0030331; GO:0033147; GO:0043627; GO:0046872	negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c2_g1_i1	Q8N895	ZN366_HUMAN	48	98	51	0	6	299	258	355	2.80E-19	95.9	ZN366_HUMAN	reviewed	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	ZNF366	Homo sapiens (Human)	744	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000790; GO:0000978; GO:0003700; GO:0003714; GO:0005634; GO:0006357; GO:0030331; GO:0033147; GO:0043627; GO:0046872	negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g4_i1	Q8N895	ZN366_HUMAN	41.3	126	74	0	20	397	251	376	2.90E-24	112.8	ZN366_HUMAN	reviewed	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	ZNF366	Homo sapiens (Human)	744	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000790; GO:0000978; GO:0003700; GO:0003714; GO:0005634; GO:0006357; GO:0030331; GO:0033147; GO:0043627; GO:0046872	negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i16	Q8N895	ZN366_HUMAN	42.3	123	67	1	392	24	381	499	3.80E-27	122.5	ZN366_HUMAN	reviewed	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	ZNF366	Homo sapiens (Human)	744	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000790; GO:0000978; GO:0003700; GO:0003714; GO:0005634; GO:0006357; GO:0030331; GO:0033147; GO:0043627; GO:0046872	negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i4	Q8N895	ZN366_HUMAN	39.8	123	70	1	392	24	381	499	3.40E-25	115.9	ZN366_HUMAN	reviewed	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	ZNF366	Homo sapiens (Human)	744	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000790; GO:0000978; GO:0003700; GO:0003714; GO:0005634; GO:0006357; GO:0030331; GO:0033147; GO:0043627; GO:0046872	negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]		NA	NA	NA	NA	NA	NA
TRINITY_DN10278_c0_g1_i1	Q567C6	ZN367_DANRE	56	116	47	2	1499	1161	141	255	1.50E-28	129	ZN367_DANRE	reviewed	Zinc finger protein 367	znf367 zgc:112157	Danio rerio (Zebrafish) (Brachydanio rerio)	316	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10278_c0_g1_i2	Q567C6	ZN367_DANRE	53.2	220	83	6	1769	1161	39	255	4.30E-54	214.2	ZN367_DANRE	reviewed	Zinc finger protein 367	znf367 zgc:112157	Danio rerio (Zebrafish) (Brachydanio rerio)	316	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i4	P17141	ZFP37_MOUSE	49	149	68	1	468	22	333	473	8.50E-39	161.4	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i13	P17141	ZFP37_MOUSE	45.6	90	35	1	2	229	370	459	4.90E-14	79	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8549_c1_g1_i1	P17141	ZFP37_MOUSE	52.8	36	17	0	108	1	494	529	8.90E-05	47.4	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i11	P17141	ZFP37_MOUSE	49.4	87	44	0	30	290	473	559	4.60E-19	95.1	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN13767_c1_g1_i1	P17141	ZFP37_MOUSE	43.9	66	37	0	20	217	380	445	2.00E-11	69.3	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN17691_c0_g1_i3	P17141	ZFP37_MOUSE	48.7	78	40	0	318	85	508	585	6.00E-17	88.2	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN22460_c0_g1_i2	P17141	ZFP37_MOUSE	51	104	51	0	328	17	343	446	7.90E-28	124.4	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i3	P17141	ZFP37_MOUSE	47.6	63	33	0	199	11	519	581	1.20E-10	66.6	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i5	P17141	ZFP37_MOUSE	51.9	81	39	0	2	244	501	581	2.60E-20	99	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i7	P17141	ZFP37_MOUSE	47.6	105	55	0	3	317	334	438	1.50E-26	120.2	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8990_c0_g1_i1	P17141	ZFP37_MOUSE	41.2	97	47	1	661	371	481	567	6.20E-16	85.9	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6287_c0_g1_i1	P17141	ZFP37_MOUSE	40.2	112	61	1	327	10	249	360	2.60E-16	86.3	ZFP37_MOUSE	reviewed	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	Zfp37 Zfp-37	Mus musculus (Mouse)	594	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0007275; GO:0007281; GO:0007283; GO:0008270	germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i6	Q9Y6Q3	ZFP37_HUMAN	45.4	119	65	0	357	1	315	433	1.50E-25	117.5	ZFP37_HUMAN	reviewed	Zinc finger protein 37 homolog (Zfp-37)	ZFP37	Homo sapiens (Human)	630	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0006357; GO:0008270	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i7	Q9Y6Q3	ZFP37_HUMAN	45.4	119	65	0	357	1	315	433	1.60E-25	117.5	ZFP37_HUMAN	reviewed	Zinc finger protein 37 homolog (Zfp-37)	ZFP37	Homo sapiens (Human)	630	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0006357; GO:0008270	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g1_i1	Q9Y6Q3	ZFP37_HUMAN	49.6	129	65	0	388	2	354	482	5.30E-31	135.2	ZFP37_HUMAN	reviewed	Zinc finger protein 37 homolog (Zfp-37)	ZFP37	Homo sapiens (Human)	630	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0006357; GO:0008270	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3518_c3_g1_i1	Q9Y6Q3	ZFP37_HUMAN	49.2	120	61	0	2	361	452	571	4.20E-30	132.1	ZFP37_HUMAN	reviewed	Zinc finger protein 37 homolog (Zfp-37)	ZFP37	Homo sapiens (Human)	630	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0006357; GO:0008270	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g1_i8	Q9Y6Q3	ZFP37_HUMAN	50	46	23	0	3	140	311	356	2.70E-08	59.3	ZFP37_HUMAN	reviewed	Zinc finger protein 37 homolog (Zfp-37)	ZFP37	Homo sapiens (Human)	630	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0006357; GO:0008270	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g1_i1	P17032	ZN37A_HUMAN	54.1	146	67	0	438	1	264	409	1.40E-43	177.2	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i27	P17032	ZN37A_HUMAN	43.3	150	74	3	510	79	317	461	7.60E-30	131.7	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i27	P17032	ZN37A_HUMAN	52	102	49	0	312	7	336	437	6.20E-23	109	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i28	P17032	ZN37A_HUMAN	46.8	77	33	3	425	216	275	350	9.90E-07	54.7	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i7	P17032	ZN37A_HUMAN	49.3	140	66	1	406	2	340	479	1.50E-34	147.1	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c2_g4_i1	P17032	ZN37A_HUMAN	54.4	103	43	1	4	312	331	429	3.50E-25	115.5	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g3_i2	P17032	ZN37A_HUMAN	54.4	158	72	0	1	474	272	429	3.60E-45	182.6	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i3	P17032	ZN37A_HUMAN	52.6	114	54	0	343	2	327	440	1.60E-31	136.7	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i7	P17032	ZN37A_HUMAN	52.9	102	48	0	307	2	339	440	7.10E-26	117.9	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g2_i3	P17032	ZN37A_HUMAN	51.9	129	61	1	254	637	318	446	6.00E-32	139	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g2_i3	P17032	ZN37A_HUMAN	54.6	108	49	0	3	326	334	441	1.10E-28	128.3	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i11	P17032	ZN37A_HUMAN	49.6	117	53	1	2	352	325	435	4.90E-28	125.2	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i5	P17032	ZN37A_HUMAN	49	147	72	1	8	448	264	407	1.40E-35	150.6	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17793_c0_g1_i1	P17032	ZN37A_HUMAN	53	115	54	0	2	346	267	381	9.50E-32	137.5	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17793_c0_g1_i2	P17032	ZN37A_HUMAN	53.3	107	50	0	2	322	267	373	4.60E-28	125.2	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3745_c0_g1_i2	P17032	ZN37A_HUMAN	55.6	63	28	0	190	2	378	440	8.60E-15	81.3	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25306_c0_g1_i1	P17032	ZN37A_HUMAN	85.7	112	16	0	6	341	260	371	1.10E-56	220.3	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i12	P17032	ZN37A_HUMAN	50	120	60	0	519	160	283	402	1.10E-26	121.3	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i13	P17032	ZN37A_HUMAN	53	115	54	0	282	626	321	435	2.70E-29	130.2	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g1_i2	P17032	ZN37A_HUMAN	52.7	74	35	0	63	284	342	415	4.90E-18	91.7	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i12	P17032	ZN37A_HUMAN	54.7	86	39	0	424	167	320	405	6.40E-22	105.1	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i5	P17032	ZN37A_HUMAN	54.5	112	49	1	338	3	320	429	6.60E-30	131.3	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c2_g1_i1	P17032	ZN37A_HUMAN	49.2	128	65	0	396	13	321	448	1.10E-28	127.5	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c0_g1_i4	P17032	ZN37A_HUMAN	52.3	65	31	0	1	195	415	479	9.50E-16	83.6	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20881_c0_g1_i1	P17032	ZN37A_HUMAN	57.4	108	46	0	325	2	321	428	2.20E-30	132.9	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i8	P17032	ZN37A_HUMAN	52.8	53	25	0	67	225	265	317	1.10E-09	63.5	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g3_i1	P17032	ZN37A_HUMAN	57	86	37	0	284	27	264	349	5.30E-23	108.2	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i18	P17032	ZN37A_HUMAN	56.1	123	51	1	4	372	327	446	1.10E-34	147.9	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i18	P17032	ZN37A_HUMAN	56.9	58	24	1	380	553	381	437	3.90E-11	69.7	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i8	P17032	ZN37A_HUMAN	50	130	55	4	263	652	318	437	1.50E-25	117.9	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7056_c0_g2_i1	P17032	ZN37A_HUMAN	55.7	115	51	0	12	356	264	378	6.50E-36	151.4	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i1	P17032	ZN37A_HUMAN	46.1	128	54	2	208	546	334	461	8.80E-24	112.1	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i1	P17032	ZN37A_HUMAN	67.7	31	10	0	50	142	406	436	8.20E-06	52.4	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c0_g1_i1	P17032	ZN37A_HUMAN	52	148	69	1	3	446	289	434	6.60E-38	158.3	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i4	P17032	ZN37A_HUMAN	44.8	87	48	0	287	27	403	489	1.30E-16	87	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g2_i1	P17032	ZN37A_HUMAN	46.7	107	57	0	323	3	356	462	1.80E-24	113.2	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g2_i2	P17032	ZN37A_HUMAN	47.2	106	56	0	326	9	384	489	2.80E-25	115.9	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i23	P17032	ZN37A_HUMAN	39.8	166	72	2	415	2	264	429	3.00E-24	112.8	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i8	P17032	ZN37A_HUMAN	43.4	143	77	1	418	2	287	429	3.80E-27	122.5	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c4_g1_i1	P17032	ZN37A_HUMAN	45.9	74	40	0	229	8	265	338	1.50E-12	73.9	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7165_c0_g1_i1	P17032	ZN37A_HUMAN	55.9	145	64	0	2	436	300	444	2.70E-44	179.5	ZN37A_HUMAN	reviewed	Zinc finger protein 37A (Zinc finger protein KOX21)	ZNF37A KOX21 ZNF37	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10860_c0_g2_i1	A0JPL0	ZN382_RAT	58.3	48	20	0	148	5	485	532	1.30E-10	66.6	ZN382_RAT	reviewed	Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1) (KS1) (Multiple zinc finger and krueppel-associated box protein KS1)	Znf382 Zfp382	Rattus norvegicus (Rat)	549	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000790; GO:0000978; GO:0001227; GO:0001558; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c3_g1_i5	A0JPL0	ZN382_RAT	48.3	151	78	0	3	455	391	541	7.50E-37	154.8	ZN382_RAT	reviewed	Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1) (KS1) (Multiple zinc finger and krueppel-associated box protein KS1)	Znf382 Zfp382	Rattus norvegicus (Rat)	549	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000790; GO:0000978; GO:0001227; GO:0001558; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27023_c0_g1_i1	Q96SR6	ZN382_HUMAN	34.4	93	58	2	613	885	335	426	2.40E-08	61.2	ZN382_HUMAN	reviewed	Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1) (KS1) (Multiple zinc finger and krueppel-associated box protein KS1)	ZNF382	Homo sapiens (Human)	550	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i5	Q8NA42	ZN383_HUMAN	47	134	71	0	1	402	311	444	3.50E-34	146.4	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15052_c0_g1_i1	Q8NA42	ZN383_HUMAN	51.9	133	64	0	3	401	277	409	3.90E-37	155.6	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i14	Q8NA42	ZN383_HUMAN	48.3	211	109	0	3	635	207	417	2.50E-54	213.4	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i6	Q8NA42	ZN383_HUMAN	60	40	15	1	238	119	300	338	9.40E-07	53.9	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i9	Q8NA42	ZN383_HUMAN	55	100	45	0	302	3	300	399	1.10E-28	127.1	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16138_c0_g1_i7	Q8NA42	ZN383_HUMAN	54.8	157	71	0	1	471	249	405	1.10E-46	187.6	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g3_i1	Q8NA42	ZN383_HUMAN	53.6	183	85	0	4	552	275	457	4.80E-54	212.2	ZN383_HUMAN	reviewed	Zinc finger protein 383	ZNF383 HSD17	Homo sapiens (Human)	475	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26295_c0_g1_i1	Q8TF68	ZN384_HUMAN	90.9	77	7	0	1	231	326	402	7.00E-39	160.6	ZN384_HUMAN	reviewed	Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein)	ZNF384 CAGH1 CIZ NMP4 TNRC1	Homo sapiens (Human)	577	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN75_c0_g1_i9	Q6AXX3	Z385D_RAT	21.1	289	109	5	242	883	57	301	1.20E-06	55.8	Z385D_RAT	reviewed	Zinc finger protein 385D (Zinc finger protein 659)	Znf385d Znf659	Rattus norvegicus (Rat)	395	nucleus [GO:0005634]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]	sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]	GO:0005634; GO:0008270; GO:1990837			NA	NA	NA	NA	NA	NA
TRINITY_DN70_c51_g1_i1	Q02525	ZFP39_MOUSE	47.7	65	34	0	195	1	431	495	6.40E-12	70.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c65_g1_i1	Q02525	ZFP39_MOUSE	52.1	73	32	1	3	221	554	623	5.30E-15	81.3	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i14	Q02525	ZFP39_MOUSE	55	100	45	0	300	1	603	702	3.60E-27	122.1	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN20649_c0_g1_i1	Q02525	ZFP39_MOUSE	56.8	81	35	0	244	2	437	517	5.90E-20	97.8	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i10	Q02525	ZFP39_MOUSE	52.2	253	121	0	319	1077	455	707	6.10E-77	289.3	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i12	Q02525	ZFP39_MOUSE	52.2	253	121	0	316	1074	455	707	6.10E-77	289.3	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g3_i1	Q02525	ZFP39_MOUSE	57.8	109	46	0	328	2	437	545	1.10E-32	140.6	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g3_i2	Q02525	ZFP39_MOUSE	59	105	43	0	316	2	441	545	6.60E-32	137.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c27_g1_i1	Q02525	ZFP39_MOUSE	57.4	68	29	0	204	1	640	707	1.30E-15	83.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i20	Q02525	ZFP39_MOUSE	50.3	145	55	3	443	9	577	704	1.90E-32	140.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i22	Q02525	ZFP39_MOUSE	55.7	115	51	0	353	9	590	704	7.90E-33	141.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i25	Q02525	ZFP39_MOUSE	49	96	38	2	263	9	609	704	3.00E-18	92.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i3	Q02525	ZFP39_MOUSE	58.5	82	34	0	254	9	623	704	1.50E-24	113.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i9	Q02525	ZFP39_MOUSE	46.7	167	74	2	485	9	545	704	1.30E-36	154.8	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		blue	blue	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i12	Q02525	ZFP39_MOUSE	54.7	137	62	0	411	1	411	547	8.50E-41	167.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN16301_c0_g1_i1	Q02525	ZFP39_MOUSE	51.1	92	45	0	310	35	426	517	2.50E-23	109.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g1_i1	Q02525	ZFP39_MOUSE	52.6	135	64	0	4	408	465	599	1.20E-38	161	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN14809_c0_g1_i1	Q02525	ZFP39_MOUSE	53	115	54	0	345	1	439	553	4.20E-32	138.7	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i1	Q02525	ZFP39_MOUSE	49.3	138	70	0	59	472	574	711	4.60E-37	155.6	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i4	Q02525	ZFP39_MOUSE	48.8	125	64	0	63	437	587	711	1.40E-32	140.6	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i5	Q02525	ZFP39_MOUSE	49.6	125	63	0	62	436	587	711	3.20E-32	139.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i7	Q02525	ZFP39_MOUSE	46.7	75	40	0	103	327	549	623	1.70E-14	80.1	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i10	Q02525	ZFP39_MOUSE	43.6	133	60	2	50	406	455	586	2.40E-27	123.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i17	Q02525	ZFP39_MOUSE	47.9	142	70	1	2	427	556	693	1.20E-34	147.5	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g2_i2	Q02525	ZFP39_MOUSE	52.5	120	57	0	361	2	567	686	1.00E-31	137.5	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g3_i3	Q02525	ZFP39_MOUSE	51.4	185	90	0	559	5	499	683	7.00E-53	208.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g3_i4	Q02525	ZFP39_MOUSE	51.6	157	76	0	475	5	527	683	2.30E-44	179.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g1_i4	Q02525	ZFP39_MOUSE	51.9	108	51	1	2	322	455	562	1.30E-26	120.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g1_i7	Q02525	ZFP39_MOUSE	54.5	77	35	0	2	232	455	531	1.30E-21	103.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c1_g1_i1	Q02525	ZFP39_MOUSE	55.1	78	35	0	1	234	439	516	1.50E-20	99.8	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g1_i4	Q02525	ZFP39_MOUSE	49	102	52	0	1	306	582	683	7.10E-26	117.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c0_g1_i4	Q02525	ZFP39_MOUSE	37.2	86	44	1	5	262	476	551	4.90E-10	65.1	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c0_g1_i5	Q02525	ZFP39_MOUSE	53.1	98	46	0	5	298	476	573	6.60E-26	117.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c0_g1_i6	Q02525	ZFP39_MOUSE	51.2	160	78	0	8	487	421	580	2.90E-45	183	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN10367_c0_g1_i1	Q02525	ZFP39_MOUSE	56.1	82	36	0	249	4	455	536	4.50E-23	108.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g1_i2	Q02525	ZFP39_MOUSE	48.3	147	76	0	6	446	455	601	5.90E-37	155.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g2_i3	Q02525	ZFP39_MOUSE	54.5	121	55	0	6	368	584	704	8.20E-34	144.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN8824_c1_g1_i1	Q02525	ZFP39_MOUSE	56	50	22	0	50	199	549	598	8.40E-12	70.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN17290_c0_g1_i2	Q02525	ZFP39_MOUSE	55.1	98	44	0	296	3	448	545	6.60E-26	117.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN7056_c0_g3_i1	Q02525	ZFP39_MOUSE	56.4	55	24	0	1	165	635	689	9.80E-12	70.5	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i16	Q02525	ZFP39_MOUSE	47.7	109	50	2	311	6	431	539	3.40E-23	109	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i26	Q02525	ZFP39_MOUSE	47.4	76	26	1	257	72	436	511	7.80E-13	74.7	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i3	Q02525	ZFP39_MOUSE	46.9	81	29	1	272	72	431	511	1.40E-13	77.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i21	Q02525	ZFP39_MOUSE	52	75	36	0	2	226	609	683	1.60E-16	86.3	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i30	Q02525	ZFP39_MOUSE	53.2	62	29	0	2	187	581	642	2.20E-13	76.3	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15305_c0_g1_i3	Q02525	ZFP39_MOUSE	51.8	166	79	1	742	245	554	718	2.20E-46	187.2	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15305_c0_g1_i3	Q02525	ZFP39_MOUSE	54.8	104	47	0	315	4	444	547	2.80E-28	127.1	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN15305_c0_g1_i4	Q02525	ZFP39_MOUSE	53.9	141	65	0	424	2	554	694	2.50E-42	172.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i16	Q02525	ZFP39_MOUSE	49.7	195	89	1	8	592	427	612	2.70E-55	216.5	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i3	Q02525	ZFP39_MOUSE	52.2	186	89	0	8	565	455	640	1.40E-56	220.7	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i8	Q02525	ZFP39_MOUSE	51.9	77	37	0	1	231	603	679	7.70E-17	87.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i21	Q02525	ZFP39_MOUSE	51.8	85	41	0	3	257	570	654	3.80E-19	95.9	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i25	Q02525	ZFP39_MOUSE	52.5	80	36	1	3	236	608	687	5.10E-18	92	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i7	Q02525	ZFP39_MOUSE	61	41	16	0	99	221	667	707	1.70E-07	56.6	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i9	Q02525	ZFP39_MOUSE	46.6	103	43	1	299	27	431	533	2.30E-21	102.8	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2211_c1_g1_i1	Q02525	ZFP39_MOUSE	52.5	139	66	0	479	63	521	659	1.70E-39	163.7	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2211_c1_g1_i3	Q02525	ZFP39_MOUSE	53.1	81	38	0	302	60	608	688	1.10E-20	100.5	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c1_g1_i3	Q02525	ZFP39_MOUSE	44	50	28	0	152	3	449	498	4.40E-05	48.1	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c2_g1_i1	Q02525	ZFP39_MOUSE	54.4	79	36	0	240	4	439	517	4.90E-19	94.7	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i14	Q02525	ZFP39_MOUSE	49.7	155	68	1	173	637	515	659	2.70E-40	166.8	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i14	Q02525	ZFP39_MOUSE	47.8	67	27	1	1	177	497	563	2.90E-10	67	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i15	Q02525	ZFP39_MOUSE	54.8	73	33	0	149	367	477	549	4.40E-19	95.5	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i3	Q02525	ZFP39_MOUSE	44.9	127	48	1	180	494	421	547	3.00E-26	119.8	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i5	Q02525	ZFP39_MOUSE	54.7	150	68	0	1	450	437	586	2.30E-46	186.4	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i9	Q02525	ZFP39_MOUSE	49.1	173	73	3	1	486	437	605	1.70E-42	173.7	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i12	Q02525	ZFP39_MOUSE	43.2	95	54	0	521	237	421	515	1.40E-17	91.3	ZFP39_MOUSE	reviewed	Zinc finger protein 39 (Zfp-39) (CtFIN33)	Zfp39 Zfp-39	Mus musculus (Mouse)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007275; GO:0007283; GO:0030154; GO:0046872	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c5_g2_i1	Q9UJN7	ZN391_HUMAN	48.4	93	48	0	2	280	151	243	1.50E-21	103.6	ZN391_HUMAN	reviewed	Zinc finger protein 391	ZNF391	Homo sapiens (Human)	358	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8238_c0_g2_i1	Q53GI3	ZN394_HUMAN	47.6	82	43	0	252	497	354	435	1.40E-13	78.2	ZN394_HUMAN	reviewed	Zinc finger protein 394 (Zinc finger protein with KRAB and SCAN domains 14)	ZNF394 ZKSCAN14	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8238_c0_g2_i2	Q53GI3	ZN394_HUMAN	47.6	82	43	0	253	498	354	435	1.40E-13	78.2	ZN394_HUMAN	reviewed	Zinc finger protein 394 (Zinc finger protein with KRAB and SCAN domains 14)	ZNF394 ZKSCAN14	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12382_c0_g2_i1	Q53GI3	ZN394_HUMAN	94.1	68	4	0	206	3	478	545	2.70E-34	145.2	ZN394_HUMAN	reviewed	Zinc finger protein 394 (Zinc finger protein with KRAB and SCAN domains 14)	ZNF394 ZKSCAN14	Homo sapiens (Human)	561	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i5	Q1LZ87	ZN397_BOVIN	36	164	80	7	3	461	378	527	8.30E-15	81.6	ZN397_BOVIN	reviewed	Zinc finger protein 397	ZNF397	Bos taurus (Bovine)	534	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c0_g2_i2	Q8NF99	ZN397_HUMAN	98.6	69	1	0	208	2	424	492	1.70E-36	152.5	ZN397_HUMAN	reviewed	Zinc finger protein 397 (Zinc finger and SCAN domain-containing protein 15) (Zinc finger protein 47)	ZNF397 ZNF47 ZSCAN15	Homo sapiens (Human)	534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0015630; GO:0042803; GO:0045892; GO:0046872; GO:0046982	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25222_c0_g1_i2	Q494X3	ZN404_HUMAN	50	108	54	0	21	344	321	428	5.90E-26	118.2	ZN404_HUMAN	reviewed	Zinc finger protein 404	ZNF404	Homo sapiens (Human)	552	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3518_c1_g1_i3	Q494X3	ZN404_HUMAN	42.1	57	33	0	171	1	181	237	1.10E-08	60.8	ZN404_HUMAN	reviewed	Zinc finger protein 404	ZNF404	Homo sapiens (Human)	552	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2211_c0_g1_i1	Q494X3	ZN404_HUMAN	45.3	75	40	1	12	236	368	441	7.30E-12	70.9	ZN404_HUMAN	reviewed	Zinc finger protein 404	ZNF404	Homo sapiens (Human)	552	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26356_c0_g1_i1	Q9H9D4	ZN408_HUMAN	100	106	0	0	320	3	494	599	2.50E-63	242.3	ZN408_HUMAN	reviewed	Zinc finger protein 408 (PR domain zinc finger protein 17)	ZNF408 PFM14 PRDM17	Homo sapiens (Human)	720	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34832_c0_g1_i1	Q9H9D4	ZN408_HUMAN	99.2	122	1	0	367	2	355	476	7.90E-69	260.8	ZN408_HUMAN	reviewed	Zinc finger protein 408 (PR domain zinc finger protein 17)	ZNF408 PFM14 PRDM17	Homo sapiens (Human)	720	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i39	P51814	ZNF41_HUMAN	34.1	132	77	3	388	14	521	649	3.20E-15	82.8	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c2_g1_i2	P51814	ZNF41_HUMAN	48.7	76	39	0	1	228	483	558	1.10E-15	83.6	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10812_c0_g1_i2	P51814	ZNF41_HUMAN	52.4	145	69	0	11	445	419	563	8.40E-41	167.9	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10812_c0_g1_i3	P51814	ZNF41_HUMAN	52.6	173	82	0	4	522	419	591	2.30E-50	199.9	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i11	P51814	ZNF41_HUMAN	42.1	247	135	1	4	720	423	669	2.50E-53	210.3	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c3_g2_i1	P51814	ZNF41_HUMAN	57.7	71	30	0	214	2	397	467	1.40E-17	89.7	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN213_c0_g3_i1	P51814	ZNF41_HUMAN	37.1	463	286	4	2	1381	350	810	2.20E-92	340.9	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN14324_c1_g1_i1	P51814	ZNF41_HUMAN	48.3	87	45	0	261	1	503	589	2.70E-19	95.9	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i17	P51814	ZNF41_HUMAN	51.1	135	66	0	2	406	455	589	8.70E-37	154.5	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16182_c0_g1_i3	P51814	ZNF41_HUMAN	50	88	44	0	267	4	529	616	1.80E-22	106.3	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g3_i1	P51814	ZNF41_HUMAN	52.8	53	25	0	44	202	447	499	7.40E-11	67.4	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7056_c0_g1_i1	P51814	ZNF41_HUMAN	49.5	109	55	0	1	327	453	561	1.90E-29	129.8	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14822_c0_g1_i1	P51814	ZNF41_HUMAN	29.8	373	236	10	1385	309	365	725	1.80E-38	162.2	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c2_g1_i1	P51814	ZNF41_HUMAN	45.6	114	61	1	3	344	398	510	1.10E-23	110.9	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c1_g1_i1	P51814	ZNF41_HUMAN	48.9	90	46	0	271	2	446	535	6.60E-20	97.8	ZNF41_HUMAN	reviewed	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	821	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15207_c0_g1_i1	Q86VK4	ZN410_HUMAN	100	71	0	0	3	215	304	374	1.30E-36	152.9	ZN410_HUMAN	reviewed	Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1)	ZNF410 APA1	Homo sapiens (Human)	478	nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN21991_c0_g1_i1	Q86VK4	ZN410_HUMAN	100	97	0	0	293	3	256	352	1.00E-55	216.9	ZN410_HUMAN	reviewed	Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1)	ZNF410 APA1	Homo sapiens (Human)	478	nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g1_i8	Q09FC8	ZN415_HUMAN	40.8	98	56	1	296	3	506	601	3.20E-19	95.9	ZN415_HUMAN	reviewed	Zinc finger protein 415	ZNF415	Homo sapiens (Human)	603	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g3_i1	Q09FC8	ZN415_HUMAN	47.6	63	33	0	9	197	478	540	1.10E-11	70.1	ZN415_HUMAN	reviewed	Zinc finger protein 415	ZNF415	Homo sapiens (Human)	603	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i4	Q09FC8	ZN415_HUMAN	67.9	78	25	0	3	236	482	559	6.90E-29	127.5	ZN415_HUMAN	reviewed	Zinc finger protein 415	ZNF415	Homo sapiens (Human)	603	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g2_i1	Q09FC8	ZN415_HUMAN	47.6	185	97	0	3	557	383	567	4.70E-49	195.7	ZN415_HUMAN	reviewed	Zinc finger protein 415	ZNF415	Homo sapiens (Human)	603	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23149_c0_g1_i1	Q8TAU3	ZN417_HUMAN	84.8	92	14	0	12	287	438	529	2.50E-44	179.1	ZN417_HUMAN	reviewed	Zinc finger protein 417	ZNF417	Homo sapiens (Human)	575	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g1_i18	Q8TF45	ZN418_HUMAN	51.6	184	85	1	558	7	245	424	1.30E-49	197.6	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g2_i10	Q8TF45	ZN418_HUMAN	56.9	130	56	0	3	392	259	388	1.30E-40	167.2	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c2_g3_i1	Q8TF45	ZN418_HUMAN	53.6	69	31	1	11	217	420	487	5.00E-15	81.3	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c10_g2_i1	Q8TF45	ZN418_HUMAN	46.2	91	49	0	21	293	280	370	3.50E-19	95.5	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i17	Q8TF45	ZN418_HUMAN	49.2	59	30	0	186	10	336	394	9.30E-10	63.5	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g1_i6	Q8TF45	ZN418_HUMAN	41.3	92	54	0	324	49	301	392	2.10E-17	89.7	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g3_i1	Q8TF45	ZN418_HUMAN	51.4	107	51	1	2	322	288	393	2.80E-25	115.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9461_c0_g1_i2	Q8TF45	ZN418_HUMAN	56.9	72	31	0	217	2	342	413	2.40E-20	99	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i10	Q8TF45	ZN418_HUMAN	53.5	198	89	1	39	632	263	457	9.70E-59	228	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i6	Q8TF45	ZN418_HUMAN	54.6	185	84	0	108	662	244	428	3.10E-55	216.5	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i9	Q8TF45	ZN418_HUMAN	55.9	177	78	0	5	535	252	428	1.00E-56	221.1	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14223_c0_g1_i2	Q8TF45	ZN418_HUMAN	56.9	116	48	1	351	4	252	365	7.10E-35	147.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g2_i2	Q8TF45	ZN418_HUMAN	45.7	199	108	0	599	3	360	558	3.50E-50	199.5	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g2_i3	Q8TF45	ZN418_HUMAN	49.5	186	94	0	558	1	304	489	3.90E-51	202.6	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i8	Q8TF45	ZN418_HUMAN	46.8	79	42	0	5	241	398	476	7.50E-17	87.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN226_c5_g2_i1	Q8TF45	ZN418_HUMAN	46.2	78	42	0	258	25	399	476	7.10E-16	84.3	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g2_i1	Q8TF45	ZN418_HUMAN	46.9	81	43	0	2	244	272	352	6.10E-17	87.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c1_g1_i1	Q8TF45	ZN418_HUMAN	44.2	52	28	1	306	151	342	392	3.30E-07	55.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c1_g1_i2	Q8TF45	ZN418_HUMAN	46.2	52	27	1	306	151	342	392	3.80E-08	58.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c1_g1_i3	Q8TF45	ZN418_HUMAN	48.1	52	26	1	306	151	342	392	5.90E-09	61.6	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i12	Q8TF45	ZN418_HUMAN	56.8	81	35	0	3	245	308	388	1.90E-22	106.3	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i6	Q8TF45	ZN418_HUMAN	45.2	115	48	1	3	347	420	519	2.60E-21	102.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i3	Q8TF45	ZN418_HUMAN	33.3	123	58	4	368	3	304	403	2.40E-09	63.2	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i2	Q8TF45	ZN418_HUMAN	38.6	127	67	2	391	29	386	507	1.80E-18	93.6	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19703_c0_g1_i2	Q8TF45	ZN418_HUMAN	54	87	40	0	6	266	398	484	1.20E-21	103.6	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14556_c0_g1_i2	Q8TF45	ZN418_HUMAN	53.9	89	41	0	11	277	392	480	3.10E-22	105.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i6	Q8TF45	ZN418_HUMAN	42.4	184	106	0	18	569	272	455	6.30E-41	168.7	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10367_c0_g1_i2	Q8TF45	ZN418_HUMAN	56.6	76	33	0	234	7	276	351	3.90E-21	101.7	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i1	Q8TF45	ZN418_HUMAN	38.6	83	36	2	199	447	298	365	1.60E-11	70.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i20	Q8TF45	ZN418_HUMAN	37.2	86	36	3	124	381	298	365	4.50E-10	65.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN137_c0_g1_i2	Q8TF45	ZN418_HUMAN	40.5	363	204	8	1098	22	199	553	2.80E-67	257.7	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN137_c0_g1_i3	Q8TF45	ZN418_HUMAN	40.5	363	204	8	1098	22	199	553	2.80E-67	257.7	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN137_c0_g1_i4	Q8TF45	ZN418_HUMAN	48.4	223	106	2	732	73	288	504	9.30E-61	236.1	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i18	Q8TF45	ZN418_HUMAN	51.3	78	38	0	253	486	280	357	3.10E-17	90.1	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i3	Q8TF45	ZN418_HUMAN	47.9	219	114	0	817	161	251	469	2.10E-61	237.3	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i12	Q8TF45	ZN418_HUMAN	49.2	120	61	0	316	675	254	373	5.50E-28	125.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i7	Q8TF45	ZN418_HUMAN	49.2	120	61	0	135	494	254	373	4.10E-28	125.9	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i15	Q8TF45	ZN418_HUMAN	55.1	78	35	0	3	236	287	364	1.00E-22	107.5	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i29	Q8TF45	ZN418_HUMAN	53.3	75	35	0	4	228	290	364	1.90E-18	93.2	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11353_c0_g1_i1	Q8TF45	ZN418_HUMAN	51.8	85	41	0	598	344	281	365	5.70E-21	102.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11353_c0_g1_i4	Q8TF45	ZN418_HUMAN	51.8	85	41	0	601	347	281	365	5.70E-21	102.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11353_c0_g1_i7	Q8TF45	ZN418_HUMAN	51.8	85	41	0	602	348	281	365	5.70E-21	102.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11353_c0_g1_i9	Q8TF45	ZN418_HUMAN	51.8	85	41	0	601	347	281	365	5.70E-21	102.8	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i10	Q8TF45	ZN418_HUMAN	46.9	145	76	1	437	3	239	382	1.20E-35	151	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i14	Q8TF45	ZN418_HUMAN	46.6	133	70	1	400	2	239	370	1.60E-31	137.1	ZN418_HUMAN	reviewed	Zinc finger protein 418	ZNF418 KIAA1956	Homo sapiens (Human)	676	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c63_g1_i1	A2VDQ7	ZN420_BOVIN	54.3	94	43	0	286	5	392	485	4.60E-24	111.7	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11295_c0_g1_i1	Q8TAQ5	ZN420_HUMAN	60.2	93	37	0	60	338	554	646	6.20E-28	124.8	ZN420_HUMAN	reviewed	Zinc finger protein 420	ZNF420	Homo sapiens (Human)	688	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0042981; GO:0046872	regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9427_c0_g1_i3	A2VDQ7	ZN420_BOVIN	30.9	356	213	12	1029	34	133	479	1.10E-40	169.5	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9427_c0_g1_i4	A2VDQ7	ZN420_BOVIN	30.9	366	219	14	1278	253	133	488	4.90E-40	167.5	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40763_c0_g1_i1	A2VDQ7	ZN420_BOVIN	97.4	77	2	0	3	233	140	216	7.50E-41	167.2	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37175_c0_g1_i1	A2VDQ7	ZN420_BOVIN	68	100	32	0	304	5	377	476	9.20E-39	160.6	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i1	A2VDQ7	ZN420_BOVIN	54.2	120	55	0	3	362	375	494	3.90E-32	139	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i10	A2VDQ7	ZN420_BOVIN	52.8	127	60	0	3	383	375	501	7.30E-33	141.7	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i2	A2VDQ7	ZN420_BOVIN	47.7	111	58	0	63	395	384	494	5.90E-26	118.6	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5989_c2_g1_i1	A2VDQ7	ZN420_BOVIN	53	100	47	0	1	300	392	491	1.10E-25	117.1	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g1_i3	A2VDQ7	ZN420_BOVIN	53.7	121	55	1	2	361	363	483	2.20E-31	136.3	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g1_i4	A2VDQ7	ZN420_BOVIN	48.2	170	79	1	4	513	347	507	9.10E-39	161.4	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g2_i3	A2VDQ7	ZN420_BOVIN	44.8	96	53	0	3	290	173	268	2.10E-21	102.8	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i3	A2VDQ7	ZN420_BOVIN	50	98	49	0	298	5	311	408	6.50E-21	101.3	ZN420_BOVIN	reviewed	Zinc finger protein 420	ZNF420	Bos taurus (Bovine)	687	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN36360_c0_g1_i1	Q8R1D1	ZN426_MOUSE	40.4	99	57	1	302	6	420	516	8.80E-18	90.9	ZN426_MOUSE	reviewed	Zinc finger protein 426	Znf426 Kiaa4237 Zfp426	Mus musculus (Mouse)	550	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i2	Q9BUY5	ZN426_HUMAN	41.2	119	65	2	353	12	317	435	1.10E-19	97.4	ZN426_HUMAN	reviewed	Zinc finger protein 426	ZNF426	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32564_c0_g1_i1	Q9BUY5	ZN426_HUMAN	100	95	0	0	290	6	377	471	8.70E-55	213.8	ZN426_HUMAN	reviewed	Zinc finger protein 426	ZNF426	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25878_c0_g1_i1	Q86V71	ZN429_HUMAN	49.2	191	96	1	573	1	414	603	1.60E-52	207.2	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c3_g1_i4	Q86V71	ZN429_HUMAN	86.4	110	15	0	333	4	297	406	2.90E-54	212.2	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i1	Q86V71	ZN429_HUMAN	58.3	36	15	0	1	108	356	391	2.80E-06	52.8	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i5	Q86V71	ZN429_HUMAN	58.3	36	15	0	1	108	356	391	3.60E-06	52.4	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i6	Q86V71	ZN429_HUMAN	58.3	36	15	0	1	108	356	391	3.60E-06	52.4	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i7	Q86V71	ZN429_HUMAN	58.3	36	15	0	1	108	356	391	3.20E-06	52.4	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		yellow	yellow	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i8	Q86V71	ZN429_HUMAN	58.3	36	15	0	1	108	356	391	3.60E-06	52.4	ZN429_HUMAN	reviewed	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i15	P17038	ZNF43_HUMAN	50.4	133	66	0	2	400	484	616	9.00E-34	144.4	ZNF43_HUMAN	reviewed	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	ZNF43 KOX27 ZNF39 ZNF39L1	Homo sapiens (Human)	809	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c3_g1_i1	P17038	ZNF43_HUMAN	54.5	66	30	0	214	17	523	588	4.50E-16	84.7	ZNF43_HUMAN	reviewed	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	ZNF43 KOX27 ZNF39 ZNF39L1	Homo sapiens (Human)	809	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11169_c0_g1_i1	P17038	ZNF43_HUMAN	48.5	274	136	3	870	55	398	668	1.30E-70	268.1	ZNF43_HUMAN	reviewed	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	ZNF43 KOX27 ZNF39 ZNF39L1	Homo sapiens (Human)	809	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i10	P17038	ZNF43_HUMAN	47.1	189	91	3	123	686	477	657	4.80E-43	176	ZNF43_HUMAN	reviewed	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	ZNF43 KOX27 ZNF39 ZNF39L1	Homo sapiens (Human)	809	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i10	P17038	ZNF43_HUMAN	52.5	40	19	0	416	535	461	500	2.00E-04	47.8	ZNF43_HUMAN	reviewed	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	ZNF43 KOX27 ZNF39 ZNF39L1	Homo sapiens (Human)	809	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i2	P17038	ZNF43_HUMAN	57.4	183	76	1	123	671	477	657	7.90E-59	228.4	ZNF43_HUMAN	reviewed	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	ZNF43 KOX27 ZNF39 ZNF39L1	Homo sapiens (Human)	809	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31963_c0_g1_i1	Q9H8G1	ZN430_HUMAN	50.8	122	60	0	11	376	239	360	8.00E-32	137.9	ZN430_HUMAN	reviewed	Zinc finger protein 430	ZNF430	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0021762; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i13	Q9H8G1	ZN430_HUMAN	52.7	226	107	0	679	2	281	506	1.90E-68	260.4	ZN430_HUMAN	reviewed	Zinc finger protein 430	ZNF430	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0021762; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c3_g1_i1	Q9H8G1	ZN430_HUMAN	88	108	13	0	325	2	413	520	7.40E-55	214.2	ZN430_HUMAN	reviewed	Zinc finger protein 430	ZNF430	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0021762; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c3_g1_i2	Q9H8G1	ZN430_HUMAN	89.1	220	24	0	661	2	217	436	4.60E-120	431.8	ZN430_HUMAN	reviewed	Zinc finger protein 430	ZNF430	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0021762; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c3_g1_i6	Q9H8G1	ZN430_HUMAN	95.4	173	8	0	519	1	217	389	4.20E-100	365.2	ZN430_HUMAN	reviewed	Zinc finger protein 430	ZNF430	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0021762; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g2_i2	Q8TF32	ZN431_HUMAN	38	92	55	1	3	272	485	576	4.20E-13	75.9	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g1_i10	Q8TF32	ZN431_HUMAN	56.2	80	35	0	359	598	451	530	1.70E-23	110.9	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g1_i15	Q8TF32	ZN431_HUMAN	56.2	80	35	0	424	663	451	530	2.40E-23	110.5	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g1_i19	Q8TF32	ZN431_HUMAN	56.2	80	35	0	424	663	451	530	1.80E-23	110.9	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i11	Q8TF32	ZN431_HUMAN	47.2	125	66	0	383	9	406	530	4.40E-30	132.1	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g1_i3	Q8TF32	ZN431_HUMAN	58.2	79	33	0	238	2	457	535	1.40E-21	103.2	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26599_c0_g1_i1	Q8TF32	ZN431_HUMAN	44.4	117	61	4	7	348	387	502	5.90E-21	101.7	ZN431_HUMAN	reviewed	Zinc finger protein 431	ZNF431 KIAA1969	Homo sapiens (Human)	576	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i28	E9QAG8	ZN431_MOUSE	49	51	26	0	239	87	132	182	2.70E-09	62.4	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i8	E9QAG8	ZN431_MOUSE	49	51	26	0	236	84	132	182	4.60E-09	61.6	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i3	E9QAG8	ZN431_MOUSE	43.1	65	29	2	37	219	402	462	7.00E-08	57.8	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c0_g1_i7	E9QAG8	ZN431_MOUSE	40.3	72	41	1	220	5	145	214	4.10E-10	65.5	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17803_c1_g1_i1	E9QAG8	ZN431_MOUSE	67.6	71	23	0	6	218	351	421	6.00E-24	110.9	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i8	E9QAG8	ZN431_MOUSE	55.2	58	26	0	318	145	125	182	1.40E-13	77	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9392_c0_g1_i9	E9QAG8	ZN431_MOUSE	55.2	58	26	0	260	87	125	182	1.10E-13	77	ZN431_MOUSE	reviewed	Zinc finger protein 431 (Zinc finger protein 932)	Znf431 Zfp431 Zfp932	Mus musculus (Mouse)	526	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c1_g1_i1	O94892	ZN432_HUMAN	54	63	29	0	2	190	416	478	4.10E-12	72	ZN432_HUMAN	reviewed	Zinc finger protein 432	ZNF432 KIAA0798	Homo sapiens (Human)	652	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g1_i2	O94892	ZN432_HUMAN	51	100	49	0	302	3	409	508	2.60E-23	109.4	ZN432_HUMAN	reviewed	Zinc finger protein 432	ZNF432 KIAA0798	Homo sapiens (Human)	652	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2109_c0_g1_i1	Q8N7K0	ZN433_HUMAN	26.1	468	279	14	1381	2655	225	668	8.40E-34	147.9	ZN433_HUMAN	reviewed	Zinc finger protein 433	ZNF433	Homo sapiens (Human)	673	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c0_g1_i2	Q9C0F3	ZN436_HUMAN	52.4	84	40	0	297	46	245	328	6.40E-21	101.3	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c0_g1_i3	Q9C0F3	ZN436_HUMAN	52.4	84	40	0	297	46	245	328	2.20E-21	102.8	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c0_g1_i5	Q9C0F3	ZN436_HUMAN	53.6	84	39	0	297	46	245	328	2.00E-22	106.3	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15569_c2_g1_i2	Q9C0F3	ZN436_HUMAN	56.2	89	35	2	270	4	240	324	9.00E-22	104	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c1_g2_i1	Q9C0F3	ZN436_HUMAN	56.2	73	32	0	3	221	243	315	3.20E-20	98.6	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18445_c0_g1_i1	Q9C0F3	ZN436_HUMAN	48.3	118	48	1	355	2	176	280	1.60E-27	123.6	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i5	Q9C0F3	ZN436_HUMAN	47.5	122	64	0	407	42	207	328	3.60E-28	125.9	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6633_c0_g1_i1	Q9C0F3	ZN436_HUMAN	38	137	80	2	408	1	220	352	2.10E-23	110.2	ZN436_HUMAN	reviewed	Zinc finger protein 436	ZNF436 KIAA1710	Homo sapiens (Human)	470	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i33	Q8BPP0	ZN436_MOUSE	51.5	99	48	0	300	4	152	250	6.90E-25	114.8	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c1_g1_i2	Q8BPP0	ZN436_MOUSE	49	200	87	1	556	2	120	319	1.20E-52	207.6	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i2	Q8BPP0	ZN436_MOUSE	51.4	105	51	0	316	2	146	250	2.80E-28	126.3	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i2	Q8BPP0	ZN436_MOUSE	61.5	39	15	0	444	328	208	246	1.60E-07	57.4	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i3	Q8BPP0	ZN436_MOUSE	50.4	127	63	0	382	2	124	250	1.70E-34	146.7	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g1_i1	Q8BPP0	ZN436_MOUSE	45.1	233	122	2	706	11	191	418	1.00E-56	221.5	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g1_i2	Q8BPP0	ZN436_MOUSE	44.4	241	128	2	730	11	183	418	1.80E-56	220.7	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13330_c0_g1_i1	Q8BPP0	ZN436_MOUSE	43.5	200	113	0	6	605	113	312	8.00E-50	198.4	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14851_c0_g1_i1	Q8BPP0	ZN436_MOUSE	44	193	108	0	584	6	114	306	7.90E-47	188.3	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28601_c0_g1_i1	Q8BPP0	ZN436_MOUSE	56.4	78	34	0	3	236	231	308	4.60E-22	104.8	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6474_c0_g1_i1	Q8BPP0	ZN436_MOUSE	49.7	159	76	2	6	482	180	334	8.20E-42	171.4	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14462_c0_g1_i1	Q8BPP0	ZN436_MOUSE	54.4	114	52	0	1	342	178	291	1.30E-30	133.7	ZN436_MOUSE	reviewed	Zinc finger protein 436 (Zinc finger protein 46) (Zfp-46) (Zinc finger protein MLZ-4)	Znf436 Kiaa1710 Mlz-4 Zfp46	Mus musculus (Mouse)	452	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i13	Q8N8Z8	ZN441_HUMAN	50	60	30	0	231	52	271	330	6.30E-14	77.8	ZN441_HUMAN	reviewed	Zinc finger protein 441	ZNF441	Homo sapiens (Human)	693	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33996_c0_g1_i1	Q9Y2A4	ZN443_HUMAN	87.1	101	13	0	3	305	175	275	6.10E-51	201.1	ZN443_HUMAN	reviewed	Zinc finger protein 443 (Krueppel-type zinc finger protein ZK1)	ZNF443	Homo sapiens (Human)	671	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0006915; GO:0046872	apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16182_c0_g1_i2	P59923	ZN445_HUMAN	46.9	64	30	1	186	7	827	890	1.60E-10	66.2	ZN445_HUMAN	reviewed	Zinc finger protein 445 (ZFP445) (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15)	ZNF445 ZFP445 ZKSCAN15 ZNF168	Homo sapiens (Human)	1031	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; maintenance of DNA methylation [GO:0010216]; maintenance of imprinting at mating-type locus [GO:0071517]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0010216; GO:0010385; GO:0046872; GO:0071517; GO:2000653	maintenance of DNA methylation [GO:0010216]; maintenance of imprinting at mating-type locus [GO:0071517]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i15	A1YEQ3	ZN449_GORGO	50.8	59	29	0	280	104	345	403	1.40E-11	70.9	ZN449_GORGO	reviewed	Zinc finger protein 449	ZNF449	Gorilla gorilla gorilla (Western lowland gorilla)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g1_i1	A1YEQ3	ZN449_GORGO	60.6	33	13	0	162	260	459	491	1.70E-06	53.1	ZN449_GORGO	reviewed	Zinc finger protein 449	ZNF449	Gorilla gorilla gorilla (Western lowland gorilla)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i8	Q02386	ZNF45_HUMAN	30.2	189	115	3	25	567	345	524	8.50E-14	78.6	ZNF45_HUMAN	reviewed	Zinc finger protein 45 (BRC1744) (Zinc finger protein 13) (Zinc finger protein KOX5)	ZNF45 KOX5 ZNF13	Homo sapiens (Human)	682	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN31227_c0_g1_i1	Q02386	ZNF45_HUMAN	50	64	32	0	200	9	278	341	8.00E-15	80.5	ZNF45_HUMAN	reviewed	Zinc finger protein 45 (BRC1744) (Zinc finger protein 13) (Zinc finger protein KOX5)	ZNF45 KOX5 ZNF13	Homo sapiens (Human)	682	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0007275; GO:0046872	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g2_i1	Q14592	ZN460_HUMAN	42.2	128	74	0	2	385	311	438	1.80E-26	120.2	ZN460_HUMAN	reviewed	Zinc finger protein 460 (Zinc finger protein 272) (Zinc finger protein HZF8)	ZNF460 ZNF272	Homo sapiens (Human)	562	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g2_i4	Q14592	ZN460_HUMAN	44.9	78	43	0	2	235	311	388	1.50E-15	83.2	ZN460_HUMAN	reviewed	Zinc finger protein 460 (Zinc finger protein 272) (Zinc finger protein HZF8)	ZNF460 ZNF272	Homo sapiens (Human)	562	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8830_c0_g1_i1	Q14592	ZN460_HUMAN	47.8	67	35	0	203	3	386	452	9.00E-14	77.4	ZN460_HUMAN	reviewed	Zinc finger protein 460 (Zinc finger protein 272) (Zinc finger protein HZF8)	ZNF460 ZNF272	Homo sapiens (Human)	562	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34608_c0_g1_i1	Q14592	ZN460_HUMAN	82.8	93	16	0	281	3	214	306	1.70E-42	172.9	ZN460_HUMAN	reviewed	Zinc finger protein 460 (Zinc finger protein 272) (Zinc finger protein HZF8)	ZNF460 ZNF272	Homo sapiens (Human)	562	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11917_c0_g2_i2	Q8TAF7	ZN461_HUMAN	48.6	72	37	0	217	2	263	334	3.10E-15	82	ZN461_HUMAN	reviewed	Zinc finger protein 461 (Gonadotropin-inducible ovary transcription repressor 1) (GIOT-1)	ZNF461 GIOT1	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c7_g1_i1	Q8TAF7	ZN461_HUMAN	51.6	62	30	0	4	189	277	338	3.30E-13	75.1	ZN461_HUMAN	reviewed	Zinc finger protein 461 (Gonadotropin-inducible ovary transcription repressor 1) (GIOT-1)	ZNF461 GIOT1	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i13	Q8TAF7	ZN461_HUMAN	58	69	29	0	1	207	263	331	3.70E-18	92.4	ZN461_HUMAN	reviewed	Zinc finger protein 461 (Gonadotropin-inducible ovary transcription repressor 1) (GIOT-1)	ZNF461 GIOT1	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i7	Q8TAF7	ZN461_HUMAN	58	69	29	0	1	207	263	331	6.50E-18	92	ZN461_HUMAN	reviewed	Zinc finger protein 461 (Gonadotropin-inducible ovary transcription repressor 1) (GIOT-1)	ZNF461 GIOT1	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g2_i1	Q7Z7K2	ZN467_HUMAN	50.8	61	28	1	2	184	212	270	6.20E-11	67.8	ZN467_HUMAN	reviewed	Zinc finger protein 467	ZNF467	Homo sapiens (Human)	595	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g2_i2	Q7Z7K2	ZN467_HUMAN	43.8	73	41	0	2	220	212	284	6.60E-11	67.8	ZN467_HUMAN	reviewed	Zinc finger protein 467	ZNF467	Homo sapiens (Human)	595	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g2_i3	Q7Z7K2	ZN467_HUMAN	50	78	39	0	2	235	212	289	1.40E-16	86.7	ZN467_HUMAN	reviewed	Zinc finger protein 467	ZNF467	Homo sapiens (Human)	595	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7478_c0_g1_i1	Q7Z7K2	ZN467_HUMAN	56.2	48	20	1	194	51	218	264	6.00E-09	61.6	ZN467_HUMAN	reviewed	Zinc finger protein 467	ZNF467	Homo sapiens (Human)	595	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11097_c0_g2_i1	Q5VIY5	ZN468_HUMAN	52.5	59	28	0	182	6	377	435	1.10E-11	70.1	ZN468_HUMAN	reviewed	Zinc finger protein 468	ZNF468	Homo sapiens (Human)	522	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10538_c2_g1_i2	Q5VIY5	ZN468_HUMAN	47.1	119	61	1	231	587	394	510	4.20E-28	126.3	ZN468_HUMAN	reviewed	Zinc finger protein 468	ZNF468	Homo sapiens (Human)	522	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10439_c0_g5_i1	Q6ECI4	ZN470_HUMAN	52.1	71	34	0	222	10	541	611	9.50E-17	87	ZN470_HUMAN	reviewed	Zinc finger protein 470 (Chondrogenesis zinc finger protein 1) (CZF-1)	ZNF470 CZF1	Homo sapiens (Human)	717	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33566_c0_g1_i1	Q6ECI4	ZN470_HUMAN	100	66	0	0	200	3	346	411	9.70E-37	153.3	ZN470_HUMAN	reviewed	Zinc finger protein 470 (Chondrogenesis zinc finger protein 1) (CZF-1)	ZNF470 CZF1	Homo sapiens (Human)	717	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i18	Q6ECI4	ZN470_HUMAN	48	102	42	2	203	502	267	359	4.40E-21	102.8	ZN470_HUMAN	reviewed	Zinc finger protein 470 (Chondrogenesis zinc finger protein 1) (CZF-1)	ZNF470 CZF1	Homo sapiens (Human)	717	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i23	Q6ECI4	ZN470_HUMAN	48	102	42	2	102	401	267	359	3.70E-21	102.8	ZN470_HUMAN	reviewed	Zinc finger protein 470 (Chondrogenesis zinc finger protein 1) (CZF-1)	ZNF470 CZF1	Homo sapiens (Human)	717	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i3	Q6ECI4	ZN470_HUMAN	48	102	42	2	114	413	267	359	3.80E-21	102.8	ZN470_HUMAN	reviewed	Zinc finger protein 470 (Chondrogenesis zinc finger protein 1) (CZF-1)	ZNF470 CZF1	Homo sapiens (Human)	717	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9461_c1_g1_i3	Q9BX82	ZN471_HUMAN	48.1	79	41	0	242	6	495	573	2.30E-16	85.9	ZN471_HUMAN	reviewed	Zinc finger protein 471 (EZFIT-related protein 1)	ZNF471 ERP1 KIAA1396	Homo sapiens (Human)	626	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i9	Q9BX82	ZN471_HUMAN	50	78	39	0	1	234	516	593	2.70E-18	92.4	ZN471_HUMAN	reviewed	Zinc finger protein 471 (EZFIT-related protein 1)	ZNF471 ERP1 KIAA1396	Homo sapiens (Human)	626	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i11	Q9BX82	ZN471_HUMAN	53.4	88	41	0	264	1	491	578	1.20E-23	110.2	ZN471_HUMAN	reviewed	Zinc finger protein 471 (EZFIT-related protein 1)	ZNF471 ERP1 KIAA1396	Homo sapiens (Human)	626	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g2_i1	Q8WV37	ZN480_HUMAN	85.5	76	11	0	230	3	294	369	4.70E-35	147.9	ZN480_HUMAN	reviewed	Zinc finger protein 480	ZNF480	Homo sapiens (Human)	535	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i12	Q8TF39	ZN483_HUMAN	51.9	52	25	0	148	303	467	518	2.90E-08	59.3	ZN483_HUMAN	reviewed	Zinc finger protein 483 (Zinc finger protein with KRAB and SCAN domains 16)	ZNF483 KIAA1962 ZKSCAN16	Homo sapiens (Human)	744	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9676_c0_g1_i1	Q5JVG2	ZN484_HUMAN	55.6	54	23	1	198	37	664	716	6.60E-13	74.3	ZN484_HUMAN	reviewed	Zinc finger protein 484	ZNF484	Homo sapiens (Human)	852	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14324_c1_g1_i4	Q5JVG2	ZN484_HUMAN	49.6	137	69	0	414	4	551	687	3.50E-33	142.5	ZN484_HUMAN	reviewed	Zinc finger protein 484	ZNF484	Homo sapiens (Human)	852	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30426_c0_g1_i1	Q5JVG2	ZN484_HUMAN	44.1	102	56	1	44	349	689	789	4.80E-23	108.6	ZN484_HUMAN	reviewed	Zinc finger protein 484	ZNF484	Homo sapiens (Human)	852	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN530_c1_g3_i1	Q5JVG2	ZN484_HUMAN	50.6	79	39	0	1	237	682	760	2.30E-19	95.9	ZN484_HUMAN	reviewed	Zinc finger protein 484	ZNF484	Homo sapiens (Human)	852	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i25	Q5JVG2	ZN484_HUMAN	49.4	79	39	1	238	2	689	766	6.70E-16	84.3	ZN484_HUMAN	reviewed	Zinc finger protein 484	ZNF484	Homo sapiens (Human)	852	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i3	Q5JVG2	ZN484_HUMAN	49.6	117	59	0	5	355	654	770	8.40E-34	144.8	ZN484_HUMAN	reviewed	Zinc finger protein 484	ZNF484	Homo sapiens (Human)	852	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i18	Q96H40	ZN486_HUMAN	47.2	125	63	2	381	7	337	458	9.30E-28	124.4	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i1	Q96H40	ZN486_HUMAN	52.8	89	42	0	3	269	364	452	5.50E-21	102.4	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i1	Q96H40	ZN486_HUMAN	40.6	101	59	1	232	531	328	428	3.40E-18	93.2	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i10	Q96H40	ZN486_HUMAN	38.6	101	61	1	51	350	328	428	3.30E-17	89.4	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i6	Q96H40	ZN486_HUMAN	39.6	101	60	1	51	350	328	428	6.70E-18	91.7	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i8	Q96H40	ZN486_HUMAN	53.2	109	51	0	9	335	344	452	2.30E-28	126.7	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c0_g1_i1	Q96H40	ZN486_HUMAN	50.7	75	37	0	315	91	350	424	4.60E-17	88.6	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6598_c1_g1_i2	Q96H40	ZN486_HUMAN	48.6	107	55	0	2	322	337	443	5.90E-23	108.2	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6598_c0_g1_i1	Q96H40	ZN486_HUMAN	50	122	61	0	4	369	320	441	1.10E-30	134	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i9	Q96H40	ZN486_HUMAN	45.5	101	55	0	162	464	324	424	1.30E-23	110.9	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i8	Q96H40	ZN486_HUMAN	46.6	116	48	2	17	322	337	452	5.70E-23	108.2	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7784_c0_g1_i2	Q96H40	ZN486_HUMAN	47.7	128	67	0	387	4	329	456	2.20E-29	129.8	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i14	Q96H40	ZN486_HUMAN	50.7	69	34	0	4	210	345	413	6.20E-18	90.9	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i5	Q96H40	ZN486_HUMAN	52.3	86	35	1	4	261	345	424	1.30E-20	100.1	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i6	Q96H40	ZN486_HUMAN	46.4	84	45	0	4	255	345	428	3.20E-21	102.4	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i10	Q96H40	ZN486_HUMAN	46.9	98	52	0	696	989	359	456	2.00E-22	108.2	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i10	Q96H40	ZN486_HUMAN	37.4	99	52	1	386	682	364	452	2.60E-14	81.3	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i14	Q96H40	ZN486_HUMAN	40.5	79	37	1	68	304	359	427	4.00E-10	65.5	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i4	Q96H40	ZN486_HUMAN	49.3	73	37	0	3	221	385	457	1.50E-14	80.1	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN4972_c0_g1_i5	Q96H40	ZN486_HUMAN	50.9	110	50	2	1	330	355	460	1.60E-23	110.2	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g2_i1	Q96H40	ZN486_HUMAN	50	74	37	0	297	76	354	427	7.90E-15	81.3	ZN486_HUMAN	reviewed	Zinc finger protein 486 (KRAB domain only protein 2)	ZNF486 KRBO2	Homo sapiens (Human)	463	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN22244_c0_g1_i1	Q8N8L2	ZN491_HUMAN	44.8	67	37	0	201	1	125	191	1.30E-09	63.2	ZN491_HUMAN	reviewed	Zinc finger protein 491	ZNF491	Homo sapiens (Human)	437	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i44	Q9P255	ZN492_HUMAN	53.8	106	44	1	328	11	246	346	1.50E-29	130.2	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10812_c0_g1_i1	Q9P255	ZN492_HUMAN	51.8	195	94	0	10	594	169	363	1.00E-57	224.6	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i5	Q9P255	ZN492_HUMAN	52.5	179	84	1	538	2	184	361	5.80E-52	205.3	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i2	Q9P255	ZN492_HUMAN	52.9	87	41	0	271	11	269	355	1.50E-21	103.2	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i1	Q9P255	ZN492_HUMAN	40.4	171	84	2	505	47	273	443	2.30E-34	146.7	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i14	Q9P255	ZN492_HUMAN	39.3	178	90	2	526	47	266	443	2.40E-34	146.7	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i5	Q9P255	ZN492_HUMAN	50	136	66	2	408	7	198	333	1.70E-32	140.2	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i8	Q9P255	ZN492_HUMAN	50.6	164	79	2	488	3	198	361	3.00E-42	172.9	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN357_c0_g2_i1	Q9P255	ZN492_HUMAN	43.3	120	68	0	2	361	272	391	1.60E-25	117.1	ZN492_HUMAN	reviewed	Zinc finger protein 492 (Zinc finger protein 115)	ZNF492 KIAA1473 ZNF115	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5650_c0_g1_i14	Q6ZR52	ZN493_HUMAN	46.2	52	24	1	108	263	535	582	8.30E-06	51.2	ZN493_HUMAN	reviewed	Zinc finger protein 493	ZNF493	Homo sapiens (Human)	646	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g1_i8	Q6ZR52	ZN493_HUMAN	46.2	52	24	1	218	63	535	582	8.30E-06	51.2	ZN493_HUMAN	reviewed	Zinc finger protein 493	ZNF493	Homo sapiens (Human)	646	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i59	Q6ZR52	ZN493_HUMAN	40.4	89	49	1	268	2	306	390	1.30E-15	83.6	ZN493_HUMAN	reviewed	Zinc finger protein 493	ZNF493	Homo sapiens (Human)	646	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i11	Q6ZR52	ZN493_HUMAN	39	159	86	1	488	45	197	355	1.60E-29	130.6	ZN493_HUMAN	reviewed	Zinc finger protein 493	ZNF493	Homo sapiens (Human)	646	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5870_c0_g1_i6	Q6ZR52	ZN493_HUMAN	50	86	43	0	262	5	243	328	1.90E-19	96.3	ZN493_HUMAN	reviewed	Zinc finger protein 493	ZNF493	Homo sapiens (Human)	646	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6981_c0_g1_i1	Q6ZNH5	ZN497_HUMAN	40.7	123	72	1	4	369	274	396	1.40E-20	100.5	ZN497_HUMAN	reviewed	Zinc finger protein 497	ZNF497	Homo sapiens (Human)	498	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10917_c0_g1_i5	Q6ZNH5	ZN497_HUMAN	44.9	69	37	1	211	5	356	423	1.20E-12	73.6	ZN497_HUMAN	reviewed	Zinc finger protein 497	ZNF497	Homo sapiens (Human)	498	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i18	O60304	ZN500_HUMAN	47.8	90	44	1	554	814	314	403	1.30E-16	88.6	ZN500_HUMAN	reviewed	Zinc finger protein 500 (Zinc finger protein with KRAB and SCAN domains 18)	ZNF500 KIAA0557 ZKSCAN18	Homo sapiens (Human)	480	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i22	Q5RF70	ZN501_PONAB	39.4	142	69	4	83	508	31	155	7.80E-23	108.6	ZN501_PONAB	reviewed	Zinc finger protein 501	ZNF501	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	271	nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; Golgi organization [GO:0007030]	nucleolus [GO:0005730]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0005634; GO:0005730; GO:0007030; GO:0046872; GO:1990837	Golgi organization [GO:0007030]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c10_g1_i2	Q8TBZ5	ZN502_HUMAN	48.9	45	23	0	120	254	213	257	4.70E-07	55.1	ZN502_HUMAN	reviewed	Zinc finger protein 502	ZNF502	Homo sapiens (Human)	544	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0044791; GO:0044794; GO:0046872	"positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i2	Q5JVG8	ZN506_HUMAN	64.9	37	13	0	77	187	198	234	1.20E-09	63.2	ZN506_HUMAN	reviewed	Zinc finger protein 506	ZNF506	Homo sapiens (Human)	444	"nucleolus [GO:0005730]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleolus [GO:0005730]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005730; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g2_i9	Q9Y2H8	ZN510_HUMAN	54	113	52	0	2	340	425	537	1.90E-32	139.8	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g2_i1	Q9Y2H8	ZN510_HUMAN	58.3	108	45	0	326	3	408	515	2.30E-32	139.4	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c21_g1_i1	Q9Y2H8	ZN510_HUMAN	51.1	90	44	0	275	6	432	521	8.90E-25	114	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i13	Q9Y2H8	ZN510_HUMAN	33.1	178	103	6	502	2	488	660	1.80E-15	84	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i13	Q9Y2H8	ZN510_HUMAN	34	103	57	2	452	177	371	473	3.30E-09	63.2	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i1	Q9Y2H8	ZN510_HUMAN	50.6	160	79	0	483	4	422	581	4.70E-45	182.2	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i14	Q9Y2H8	ZN510_HUMAN	47.4	76	40	0	231	4	506	581	4.50E-17	88.2	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i3	Q9Y2H8	ZN510_HUMAN	51.9	104	50	0	315	4	478	581	2.60E-28	125.9	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i3	Q9Y2H8	ZN510_HUMAN	51.2	209	102	0	8	634	397	605	3.80E-61	236.1	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14223_c0_g1_i3	Q9Y2H8	ZN510_HUMAN	54.6	119	54	0	357	1	426	544	1.20E-37	157.1	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i11	Q9Y2H8	ZN510_HUMAN	39.8	181	90	3	168	680	410	581	3.20E-30	133.7	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i11	Q9Y2H8	ZN510_HUMAN	29.5	183	76	3	268	798	418	553	1.90E-14	81.3	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i14	Q9Y2H8	ZN510_HUMAN	42.7	143	72	2	2	400	411	553	6.20E-27	121.7	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i3	Q9Y2H8	ZN510_HUMAN	40.2	169	86	1	135	641	428	581	1.00E-34	148.3	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i7	Q9Y2H8	ZN510_HUMAN	40.2	169	86	1	99	605	428	581	1.20E-34	147.9	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c1_g1_i1	Q9Y2H8	ZN510_HUMAN	63.6	66	24	0	205	8	432	497	2.90E-20	98.6	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9294_c0_g2_i2	Q9Y2H8	ZN510_HUMAN	51.5	132	64	0	400	5	422	553	3.30E-36	152.5	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14556_c0_g1_i3	Q9Y2H8	ZN510_HUMAN	53.3	137	64	0	1	411	406	542	1.30E-40	167.2	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14556_c0_g1_i4	Q9Y2H8	ZN510_HUMAN	53.3	150	70	0	1	450	434	583	7.40E-45	181.4	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13767_c1_g1_i5	Q9Y2H8	ZN510_HUMAN	43.7	87	49	0	2	262	439	525	1.20E-18	93.6	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10367_c0_g1_i3	Q9Y2H8	ZN510_HUMAN	54.1	122	49	1	394	50	422	543	1.50E-33	143.7	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10367_c0_g1_i4	Q9Y2H8	ZN510_HUMAN	56.9	123	53	0	430	62	422	544	7.60E-39	161.4	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i2	Q9Y2H8	ZN510_HUMAN	51.6	159	77	0	478	2	411	569	4.80E-44	179.5	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i20	Q9Y2H8	ZN510_HUMAN	46.9	175	81	2	496	2	397	569	7.30E-41	168.3	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i12	Q9Y2H8	ZN510_HUMAN	47.9	167	79	1	8	484	404	570	1.20E-45	184.1	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i28	Q9Y2H8	ZN510_HUMAN	47.5	139	65	1	8	400	404	542	1.20E-35	150.6	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i2	Q9Y2H8	ZN510_HUMAN	44.8	58	30	1	178	11	397	454	5.90E-08	58.2	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i10	Q9Y2H8	ZN510_HUMAN	51.7	147	71	0	215	655	444	590	1.20E-43	177.9	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i10	Q9Y2H8	ZN510_HUMAN	50	62	25	1	3	188	416	471	6.60E-10	65.9	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i2	Q9Y2H8	ZN510_HUMAN	36.6	131	60	4	3	362	472	590	5.60E-19	95.1	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i2	Q9Y2H8	ZN510_HUMAN	39.3	84	49	1	76	321	454	537	8.70E-12	71.2	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i6	Q9Y2H8	ZN510_HUMAN	43.4	106	51	1	3	320	406	502	8.50E-19	94.4	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i7	Q9Y2H8	ZN510_HUMAN	53.8	91	42	0	3	275	472	562	2.80E-26	119.4	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i9	Q9Y2H8	ZN510_HUMAN	52.6	175	83	0	3	527	472	646	1.90E-55	216.9	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15305_c0_g1_i2	Q9Y2H8	ZN510_HUMAN	55.5	191	85	0	576	4	408	598	5.60E-61	235.3	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i10	Q9Y2H8	ZN510_HUMAN	54.3	116	53	0	5	352	422	537	6.40E-36	151.4	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i8	Q9Y2H8	ZN510_HUMAN	53.5	129	59	1	5	391	422	549	5.30E-39	161.8	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i10	Q9Y2H8	ZN510_HUMAN	44.8	116	49	1	3	305	401	516	1.30E-24	113.6	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i8	Q9Y2H8	ZN510_HUMAN	59.5	84	34	0	200	451	459	542	3.90E-25	115.9	ZN510_HUMAN	reviewed	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	683	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3795_c0_g1_i1	Q7ZZ00	ZN511_DANRE	37.4	187	114	2	809	255	86	271	2.20E-28	127.9	ZN511_DANRE	reviewed	Zinc finger protein 511	znf511	Danio rerio (Zebrafish) (Brachydanio rerio)	277	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN34271_c0_g1_i1	Q8NB15	ZN511_HUMAN	100	79	0	0	3	239	93	171	5.60E-44	177.6	ZN511_HUMAN	reviewed	Zinc finger protein 511	ZNF511	Homo sapiens (Human)	252	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	nuclear chromatin [GO:0000790]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000790; GO:0000981; GO:0003677; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN11700_c0_g2_i1	Q8N8E2	ZN513_HUMAN	48.4	93	47	1	340	62	375	466	3.70E-20	99	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c4_g1_i1	Q8N8E2	ZN513_HUMAN	43.6	78	44	0	111	344	149	226	2.30E-16	86.7	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i16	Q6PD29	ZN513_MOUSE	40.7	108	55	1	373	50	368	466	2.80E-18	94	ZN513_MOUSE	reviewed	Zinc finger protein 513	Znf513 Zfp513	Mus musculus (Mouse)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041	"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i5	Q8N8E2	ZN513_HUMAN	41.2	80	47	0	305	66	149	228	2.60E-16	87.4	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN9112_c0_g1_i1	Q8N8E2	ZN513_HUMAN	54.8	62	28	0	307	122	167	228	4.90E-16	85.1	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN36753_c0_g1_i1	Q6PD29	ZN513_MOUSE	98.6	142	2	0	426	1	347	488	2.30E-88	325.9	ZN513_MOUSE	reviewed	Zinc finger protein 513	Znf513 Zfp513	Mus musculus (Mouse)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041	"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g3_i2	Q8N8E2	ZN513_HUMAN	38.8	67	41	0	5	205	162	228	1.10E-12	73.9	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i13	Q8N8E2	ZN513_HUMAN	42.5	127	73	0	518	898	340	466	1.20E-28	128.6	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i2	Q8N8E2	ZN513_HUMAN	44.3	79	44	0	614	850	416	494	1.30E-13	78.6	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i7	Q8N8E2	ZN513_HUMAN	42.1	95	55	0	518	802	340	434	6.70E-18	92.8	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN7943_c0_g1_i2	Q6PD29	ZN513_MOUSE	48.8	84	43	0	375	124	145	228	4.20E-20	100.1	ZN513_MOUSE	reviewed	Zinc finger protein 513	Znf513 Zfp513	Mus musculus (Mouse)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041	"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27461_c0_g1_i1	Q8N8E2	ZN513_HUMAN	49.4	83	39	1	107	346	341	423	1.10E-17	90.9	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN3513_c0_g1_i1	Q8N8E2	ZN513_HUMAN	44.9	78	43	0	173	406	389	466	7.60E-18	91.7	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN14147_c1_g1_i1	Q8N8E2	ZN513_HUMAN	46.1	76	41	0	347	120	149	224	2.50E-17	90.1	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN30731_c0_g1_i1	Q8N8E2	ZN513_HUMAN	45.7	81	44	0	306	64	358	438	1.70E-16	86.7	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN11782_c0_g1_i6	Q8N8E2	ZN513_HUMAN	40	60	36	0	425	246	380	439	1.80E-08	60.5	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN34525_c0_g1_i1	Q6PD29	ZN513_MOUSE	38.5	78	48	0	260	27	153	230	3.90E-14	78.6	ZN513_MOUSE	reviewed	Zinc finger protein 513	Znf513 Zfp513	Mus musculus (Mouse)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041	"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34624_c0_g1_i1	Q8N8E2	ZN513_HUMAN	48.1	77	40	0	287	57	362	438	3.20E-17	89	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN956_c2_g1_i3	Q8N8E2	ZN513_HUMAN	51.9	77	34	1	70	300	365	438	8.10E-18	91.3	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i2	Q6PD29	ZN513_MOUSE	26.8	235	127	7	535	1122	180	408	9.30E-10	66.2	ZN513_MOUSE	reviewed	Zinc finger protein 513	Znf513 Zfp513	Mus musculus (Mouse)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041	"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10538_c1_g1_i1	Q8N8E2	ZN513_HUMAN	54.3	35	16	0	165	269	389	423	2.00E-05	50.4	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN32660_c0_g1_i1	Q8N8E2	ZN513_HUMAN	47.1	87	46	0	322	62	353	439	9.80E-21	100.9	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN28181_c0_g1_i1	Q8N8E2	ZN513_HUMAN	53.3	45	21	0	229	95	180	224	8.70E-08	57.4	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN28213_c0_g1_i1	Q8N8E2	ZN513_HUMAN	53.8	65	30	0	1	195	359	423	6.20E-18	90.9	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN15956_c0_g1_i1	Q6PD29	ZN513_MOUSE	48.1	54	28	0	265	104	147	200	2.80E-10	66.2	ZN513_MOUSE	reviewed	Zinc finger protein 513	Znf513 Zfp513	Mus musculus (Mouse)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041	"regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14029_c0_g1_i1	Q8N8E2	ZN513_HUMAN	45.8	83	45	0	61	309	147	229	1.00E-17	90.9	ZN513_HUMAN	reviewed	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	541	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN37926_c0_g1_i1	Q92618	ZN516_HUMAN	58.3	48	20	0	151	8	34	81	8.20E-12	70.5	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28038_c0_g1_i1	Q7TSH3	ZN516_MOUSE	41.5	65	38	0	274	80	18	82	5.20E-12	71.6	ZN516_MOUSE	reviewed	Zinc finger protein 516	Znf516 Kiaa0222 Zfp516	Mus musculus (Mouse)	1157	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30155_c0_g1_i1	Q7TSH3	ZN516_MOUSE	42	69	36	2	41	247	18	82	5.00E-09	62	ZN516_MOUSE	reviewed	Zinc finger protein 516	Znf516 Kiaa0222 Zfp516	Mus musculus (Mouse)	1157	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35955_c0_g1_i1	Q7TSH3	ZN516_MOUSE	50	56	25	1	245	78	35	87	4.20E-09	62	ZN516_MOUSE	reviewed	Zinc finger protein 516	Znf516 Kiaa0222 Zfp516	Mus musculus (Mouse)	1157	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37827_c0_g1_i1	Q92618	ZN516_HUMAN	47.4	78	33	2	234	1	34	103	1.20E-13	77	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i1	Q92618	ZN516_HUMAN	54.2	59	21	2	1411	1578	28	83	1.10E-11	73.2	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i10	Q92618	ZN516_HUMAN	38.9	72	41	1	72	287	36	104	1.00E-09	64.3	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i11	Q92618	ZN516_HUMAN	38.9	72	41	1	145	360	36	104	1.60E-09	63.9	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i7	Q92618	ZN516_HUMAN	38.9	72	41	1	550	765	36	104	1.90E-09	64.7	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g2_i1	Q7TSH3	ZN516_MOUSE	45.5	55	30	0	202	38	34	88	3.40E-10	65.5	ZN516_MOUSE	reviewed	Zinc finger protein 516	Znf516 Kiaa0222 Zfp516	Mus musculus (Mouse)	1157	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27782_c0_g1_i1	Q7TSH3	ZN516_MOUSE	49.1	57	28	1	348	178	30	85	2.20E-11	70.1	ZN516_MOUSE	reviewed	Zinc finger protein 516	Znf516 Kiaa0222 Zfp516	Mus musculus (Mouse)	1157	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34188_c0_g1_i1	Q92618	ZN516_HUMAN	44.8	58	32	0	223	50	34	91	1.20E-11	70.5	ZN516_HUMAN	reviewed	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	1163	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18393_c0_g2_i1	Q7TSH3	ZN516_MOUSE	46.3	67	33	1	2	202	18	81	1.30E-10	67	ZN516_MOUSE	reviewed	Zinc finger protein 516	Znf516 Kiaa0222 Zfp516	Mus musculus (Mouse)	1157	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"activating transcription factor binding [GO:0033613]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0033613; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"		blue	blue	NA	NA	NA	NA
TRINITY_DN30280_c0_g1_i1	Q8TB69	ZN519_HUMAN	49.7	165	82	1	535	44	374	538	1.10E-45	184.5	ZN519_HUMAN	reviewed	Zinc finger protein 519	ZNF519	Homo sapiens (Human)	540	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7745_c0_g1_i13	Q96C55	ZN524_HUMAN	34.7	72	47	0	222	7	132	203	6.80E-08	58.5	ZN524_HUMAN	reviewed	Zinc finger protein 524	ZNF524	Homo sapiens (Human)	264	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34169_c0_g1_i1	Q96C55	ZN524_HUMAN	52	50	24	0	205	56	172	221	1.20E-09	63.5	ZN524_HUMAN	reviewed	Zinc finger protein 524	ZNF524	Homo sapiens (Human)	264	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11111_c0_g2_i2	Q8N782	ZN525_HUMAN	43.3	67	38	0	203	3	57	123	1.40E-11	70.9	ZN525_HUMAN	reviewed	Zinc finger protein 525	ZNF525 KIAA1979	Homo sapiens (Human)	197	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11111_c0_g2_i4	Q8N782	ZN525_HUMAN	43.3	67	38	0	203	3	57	123	7.10E-12	71.2	ZN525_HUMAN	reviewed	Zinc finger protein 525	ZNF525 KIAA1979	Homo sapiens (Human)	197	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i2	Q8N782	ZN525_HUMAN	45	100	46	1	1	300	74	164	1.10E-20	100.5	ZN525_HUMAN	reviewed	Zinc finger protein 525	ZNF525 KIAA1979	Homo sapiens (Human)	197	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i8	Q8N782	ZN525_HUMAN	39.4	66	33	1	179	3	45	110	6.20E-08	58.2	ZN525_HUMAN	reviewed	Zinc finger protein 525	ZNF525 KIAA1979	Homo sapiens (Human)	197	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i3	Q8BI66	ZN526_MOUSE	45.3	64	30	1	341	165	495	558	1.70E-10	67	ZN526_MOUSE	reviewed	Zinc finger protein 526	Znf526 Kiaa1951 Zfp526	Mus musculus (Mouse)	675	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16562_c0_g1_i1	Q8BI66	ZN526_MOUSE	49.1	57	29	0	1	171	499	555	1.20E-11	70.1	ZN526_MOUSE	reviewed	Zinc finger protein 526	Znf526 Kiaa1951 Zfp526	Mus musculus (Mouse)	675	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9362_c3_g1_i1	Q8BI66	ZN526_MOUSE	41.8	67	35	1	205	5	493	555	2.10E-09	62.8	ZN526_MOUSE	reviewed	Zinc finger protein 526	Znf526 Kiaa1951 Zfp526	Mus musculus (Mouse)	675	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c3_g1_i1	Q6P9A1	ZN530_HUMAN	36.5	170	108	0	4	513	256	425	1.50E-28	127.5	ZN530_HUMAN	reviewed	Zinc finger protein 530	ZNF530 KIAA1508	Homo sapiens (Human)	599	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c0_g1_i1	Q6P9A1	ZN530_HUMAN	40.8	103	61	0	2	310	473	575	3.40E-18	92.4	ZN530_HUMAN	reviewed	Zinc finger protein 530	ZNF530 KIAA1508	Homo sapiens (Human)	599	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14556_c0_g1_i7	Q6P9A1	ZN530_HUMAN	50.8	61	30	0	11	193	513	573	1.70E-12	73.2	ZN530_HUMAN	reviewed	Zinc finger protein 530	ZNF530 KIAA1508	Homo sapiens (Human)	599	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9076_c2_g1_i1	Q6P9A1	ZN530_HUMAN	43.5	46	26	0	144	7	240	285	5.30E-05	48.1	ZN530_HUMAN	reviewed	Zinc finger protein 530	ZNF530 KIAA1508	Homo sapiens (Human)	599	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g3_i1	Q76KX8	ZN534_HUMAN	52.9	102	48	0	1	306	428	529	5.00E-27	121.7	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g3_i2	Q76KX8	ZN534_HUMAN	50.8	61	30	0	1	183	428	488	3.30E-12	72	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i8	Q76KX8	ZN534_HUMAN	43.7	151	85	0	120	572	287	437	6.30E-33	142.1	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g4_i1	Q76KX8	ZN534_HUMAN	47.1	136	72	0	411	4	329	464	2.30E-32	139.8	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i7	Q76KX8	ZN534_HUMAN	41.5	171	88	2	2	514	329	487	1.10E-33	144.4	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i10	Q76KX8	ZN534_HUMAN	52.9	87	39	1	263	3	385	469	9.10E-19	94.4	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6614_c0_g2_i1	Q76KX8	ZN534_HUMAN	44.9	78	43	0	234	1	436	513	2.50E-15	82.4	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i11	Q76KX8	ZN534_HUMAN	44.3	253	141	0	808	50	389	641	7.30E-59	228.8	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c5_g1_i1	Q76KX8	ZN534_HUMAN	47.5	99	49	2	1	291	428	525	4.10E-23	108.6	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i3	Q76KX8	ZN534_HUMAN	42.4	66	29	1	96	293	389	445	1.10E-08	61.2	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i8	Q76KX8	ZN534_HUMAN	50.5	101	50	0	2	304	425	525	3.70E-24	112.1	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8990_c0_g1_i3	Q76KX8	ZN534_HUMAN	42.3	78	35	1	244	11	407	474	6.50E-11	67.8	ZN534_HUMAN	reviewed	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	674	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5684_c0_g1_i3	O15090	ZN536_HUMAN	64.6	48	17	0	957	814	130	177	2.60E-11	71.2	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28008_c0_g1_i1	O15090	ZN536_HUMAN	47.1	70	29	2	27	221	132	198	2.90E-10	65.5	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8729_c0_g1_i1	O15090	ZN536_HUMAN	65.3	49	17	0	248	394	129	177	2.00E-13	77	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36677_c0_g1_i1	O15090	ZN536_HUMAN	54.9	51	20	1	26	178	132	179	9.20E-09	60.5	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27606_c0_g1_i1	O15090	ZN536_HUMAN	45.9	61	30	1	210	28	745	802	2.60E-08	58.9	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7695_c0_g1_i1	O15090	ZN536_HUMAN	54.9	51	23	0	160	8	753	803	8.20E-11	67.8	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40731_c0_g1_i1	O15090	ZN536_HUMAN	51	49	21	1	29	175	132	177	3.00E-08	58.9	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30371_c0_g1_i1	O15090	ZN536_HUMAN	46.2	65	31	2	70	264	757	817	5.00E-08	58.5	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18903_c0_g1_i2	O15090	ZN536_HUMAN	44	91	43	2	268	528	108	194	2.30E-14	80.5	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18903_c0_g1_i2	O15090	ZN536_HUMAN	54	50	23	0	77	226	128	177	9.90E-10	65.1	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39602_c0_g1_i1	O15090	ZN536_HUMAN	53.1	49	20	1	124	270	132	177	2.40E-10	66.2	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i5	O15090	ZN536_HUMAN	48.4	64	31	1	535	726	121	182	2.00E-11	71.2	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i8	O15090	ZN536_HUMAN	48.4	64	31	1	276	467	121	182	1.40E-11	71.2	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i8	O15090	ZN536_HUMAN	44.3	61	34	0	49	231	753	813	1.30E-09	64.7	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c2_g1_i1	O15090	ZN536_HUMAN	50	54	22	2	702	541	132	180	1.90E-08	61.2	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29392_c0_g1_i1	O15090	ZN536_HUMAN	48.5	68	28	2	236	39	121	183	5.10E-11	68.2	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i13	O15090	ZN536_HUMAN	33.8	145	66	6	268	702	689	803	1.10E-10	68.6	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i6	O15090	ZN536_HUMAN	49	51	25	1	70	222	753	802	1.00E-08	60.5	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33320_c0_g1_i1	O15090	ZN536_HUMAN	45.9	61	32	1	49	231	743	802	1.00E-09	63.9	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15257_c0_g1_i2	O15090	ZN536_HUMAN	54.9	51	22	1	217	65	753	802	5.80E-10	64.7	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4440_c0_g1_i3	O15090	ZN536_HUMAN	65.3	49	17	0	359	505	132	180	2.00E-15	84	ZN536_HUMAN	reviewed	Zinc finger protein 536	ZNF536 KIAA0390	Homo sapiens (Human)	1300	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387	"negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10917_c0_g1_i2	E9PW05	ZFP54_MOUSE	41.5	65	37	1	196	2	493	556	1.90E-10	66.2	ZFP54_MOUSE	reviewed	Zinc finger protein 54 (Krueppel-associated box protein 10) (KRAB10)	Zfp54	Mus musculus (Mouse)	585	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g2_i1	Q8NDQ6	ZN540_HUMAN	47.8	67	35	0	2	202	349	415	8.70E-13	74.3	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19784_c1_g1_i1	Q8NDQ6	ZN540_HUMAN	49.2	59	30	0	235	59	440	498	4.80E-11	68.2	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g1_i6	Q8NDQ6	ZN540_HUMAN	43.8	89	50	0	4	270	541	629	7.40E-20	97.8	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14352_c0_g1_i1	Q8NDQ6	ZN540_HUMAN	46.8	173	92	0	524	6	377	549	7.10E-47	188.3	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN25222_c0_g1_i1	Q8NDQ6	ZN540_HUMAN	56	84	37	0	18	269	320	403	1.30E-23	110.5	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i4	Q8NDQ6	ZN540_HUMAN	41	105	62	0	3	317	532	636	6.90E-21	101.3	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7554_c0_g1_i2	Q8NDQ6	ZN540_HUMAN	52.2	69	33	0	217	11	501	569	6.60E-15	80.9	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11304_c1_g1_i2	Q8NDQ6	ZN540_HUMAN	55.6	81	36	0	2	244	525	605	8.10E-22	104	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i11	Q8NDQ6	ZN540_HUMAN	46.5	101	52	2	395	93	499	597	2.50E-20	99.8	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c2_g1_i1	Q8NDQ6	ZN540_HUMAN	50.5	99	49	0	304	8	518	616	1.30E-24	113.6	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c3_g3_i1	Q8NDQ6	ZN540_HUMAN	41.6	77	45	0	1	231	497	573	3.50E-14	78.6	ZN540_HUMAN	reviewed	Zinc finger protein 540	ZNF540 Nbla10512	Homo sapiens (Human)	660	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c2_g1_i1	Q08ER8	ZN543_HUMAN	53.1	81	38	0	249	7	227	307	5.40E-21	101.3	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g2_i6	Q08ER8	ZN543_HUMAN	48.5	132	68	0	14	409	328	459	8.60E-32	137.9	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i3	Q08ER8	ZN543_HUMAN	48.3	87	41	1	469	729	294	376	1.40E-16	88.2	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i9	Q08ER8	ZN543_HUMAN	54.3	70	32	0	144	353	221	290	1.00E-17	90.9	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i11	Q08ER8	ZN543_HUMAN	50	52	25	1	157	2	217	267	8.60E-10	63.9	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i1	Q08ER8	ZN543_HUMAN	47.3	110	54	1	18	347	328	433	7.70E-25	114.8	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i7	Q08ER8	ZN543_HUMAN	45.9	196	106	0	5	592	220	415	2.80E-50	199.9	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g2_i2	Q08ER8	ZN543_HUMAN	47.6	82	43	0	2	247	331	412	5.00E-19	94.7	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g2_i5	Q08ER8	ZN543_HUMAN	49.6	123	60	1	6	374	313	433	1.50E-31	137.5	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g2_i6	Q08ER8	ZN543_HUMAN	49.4	87	44	0	6	266	313	399	2.30E-22	105.9	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g2_i8	Q08ER8	ZN543_HUMAN	48.3	89	46	0	6	272	311	399	4.10E-22	105.1	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i11	Q08ER8	ZN543_HUMAN	45.6	160	76	2	1	480	340	488	1.50E-38	161	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i4	Q08ER8	ZN543_HUMAN	45.6	160	76	2	1	480	340	488	1.40E-38	161	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i7	Q08ER8	ZN543_HUMAN	45.6	160	76	2	1	480	340	488	1.00E-38	161.4	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i8	Q08ER8	ZN543_HUMAN	45.7	105	57	0	4	318	313	417	1.90E-24	113.2	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i5	Q08ER8	ZN543_HUMAN	51.4	105	51	0	318	4	382	486	3.60E-28	125.6	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9208_c1_g1_i1	Q08ER8	ZN543_HUMAN	52.1	73	35	0	220	2	468	540	6.90E-20	97.4	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13075_c0_g1_i1	Q08ER8	ZN543_HUMAN	45.1	82	45	0	47	292	393	474	1.30E-17	90.5	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6587_c0_g2_i1	Q08ER8	ZN543_HUMAN	51	96	47	0	291	4	441	536	1.70E-24	113.2	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c1_g1_i1	Q08ER8	ZN543_HUMAN	48.8	80	41	0	1	240	322	401	2.90E-19	95.5	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12597_c0_g2_i3	Q08ER8	ZN543_HUMAN	42.1	126	68	2	372	7	407	531	4.70E-25	115.5	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g1_i2	Q08ER8	ZN543_HUMAN	48.3	201	104	0	2	604	200	400	5.60E-56	218.8	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g1_i5	Q08ER8	ZN543_HUMAN	48.7	152	78	0	1	456	389	540	9.20E-43	174.5	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g1_i7	Q08ER8	ZN543_HUMAN	48.9	180	92	0	1	540	361	540	1.90E-50	200.3	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c3_g1_i1	Q08ER8	ZN543_HUMAN	52.9	70	32	1	209	3	220	289	3.10E-17	88.6	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4972_c0_g2_i5	Q08ER8	ZN543_HUMAN	38	200	117	5	6	590	221	418	7.30E-33	142.1	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i6	Q08ER8	ZN543_HUMAN	48	100	52	0	346	47	305	404	8.70E-24	111.3	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i8	Q08ER8	ZN543_HUMAN	44.5	128	71	0	416	33	305	432	8.10E-29	128.3	ZN543_HUMAN	reviewed	Zinc finger protein 543	ZNF543	Homo sapiens (Human)	600	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30895_c0_g1_i1	Q6NX49	ZN544_HUMAN	95.8	72	3	0	217	2	407	478	1.10E-38	159.8	ZN544_HUMAN	reviewed	Zinc finger protein 544	ZNF544	Homo sapiens (Human)	715	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i14	Q86UE3	ZN546_HUMAN	45.5	99	49	1	304	8	422	515	2.40E-18	92.8	ZN546_HUMAN	reviewed	Zinc finger protein 546 (Zinc finger protein 49)	ZNF546 ZNF49	Homo sapiens (Human)	836	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c10_g1_i1	Q86UE3	ZN546_HUMAN	49.1	57	29	0	53	223	323	379	1.50E-10	66.6	ZN546_HUMAN	reviewed	Zinc finger protein 546 (Zinc finger protein 49)	ZNF546 ZNF49	Homo sapiens (Human)	836	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i63	Q86UE3	ZN546_HUMAN	31.3	329	183	9	982	8	398	687	3.30E-43	177.6	ZN546_HUMAN	reviewed	Zinc finger protein 546 (Zinc finger protein 49)	ZNF546 ZNF49	Homo sapiens (Human)	836	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i3	Q86UE3	ZN546_HUMAN	49.4	77	39	0	43	273	735	811	4.00E-17	88.6	ZN546_HUMAN	reviewed	Zinc finger protein 546 (Zinc finger protein 49)	ZNF546 ZNF49	Homo sapiens (Human)	836	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i8	Q86UE3	ZN546_HUMAN	53.1	98	46	0	2	295	435	532	3.00E-26	119	ZN546_HUMAN	reviewed	Zinc finger protein 546 (Zinc finger protein 49)	ZNF546 ZNF49	Homo sapiens (Human)	836	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i1	Q5RCX4	ZN547_PONAB	42.1	76	44	0	100	327	295	370	7.30E-13	74.7	ZN547_PONAB	reviewed	Zinc finger protein 547	ZNF547	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	402	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11889_c0_g1_i9	Q5RCX4	ZN547_PONAB	42.1	76	44	0	100	327	295	370	7.30E-13	74.7	ZN547_PONAB	reviewed	Zinc finger protein 547	ZNF547	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	402	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c1_g1_i1	Q5RCX4	ZN547_PONAB	54.3	105	44	1	327	13	270	370	9.60E-26	117.5	ZN547_PONAB	reviewed	Zinc finger protein 547	ZNF547	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	402	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g1_i9	Q5RCX4	ZN547_PONAB	49	98	50	0	329	36	262	359	2.40E-24	112.8	ZN547_PONAB	reviewed	Zinc finger protein 547	ZNF547	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	402	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i25	Q8IVP9	ZN547_HUMAN	51.1	90	44	0	3	272	160	249	7.60E-22	104.4	ZN547_HUMAN	reviewed	Zinc finger protein 547	ZNF547	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c0_g1_i4	Q5RCX4	ZN547_PONAB	51.5	66	32	0	91	288	310	375	4.60E-14	78.6	ZN547_PONAB	reviewed	Zinc finger protein 547	ZNF547	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	402	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i22	Q7Z398	ZN550_HUMAN	54.5	55	25	0	166	2	279	333	1.30E-12	73.6	ZN550_HUMAN	reviewed	Zinc finger protein 550	ZNF550	Homo sapiens (Human)	422	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19784_c0_g1_i1	B2RUI1	ZN551_MOUSE	43.2	74	42	0	224	3	349	422	1.80E-10	66.2	ZN551_MOUSE	reviewed	Zinc finger protein 551	Znf551 Zfp551	Mus musculus (Mouse)	696	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c1_g1_i1	B2RUI1	ZN551_MOUSE	43.3	90	51	0	290	21	341	430	4.00E-15	82	ZN551_MOUSE	reviewed	Zinc finger protein 551	Znf551 Zfp551	Mus musculus (Mouse)	696	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c1_g1_i5	B2RUI1	ZN551_MOUSE	44	50	28	0	178	29	366	415	6.80E-07	54.7	ZN551_MOUSE	reviewed	Zinc finger protein 551	Znf551 Zfp551	Mus musculus (Mouse)	696	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c1_g1_i7	B2RUI1	ZN551_MOUSE	36.8	106	66	1	360	43	341	445	1.90E-11	70.1	ZN551_MOUSE	reviewed	Zinc finger protein 551	Znf551 Zfp551	Mus musculus (Mouse)	696	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11097_c0_g1_i2	B2RUI1	ZN551_MOUSE	49.1	55	28	0	167	3	334	388	4.30E-07	55.1	ZN551_MOUSE	reviewed	Zinc finger protein 551	Znf551 Zfp551	Mus musculus (Mouse)	696	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22460_c0_g1_i3	B2RUI1	ZN551_MOUSE	54.2	59	27	0	259	83	370	428	7.30E-13	74.3	ZN551_MOUSE	reviewed	Zinc finger protein 551	Znf551 Zfp551	Mus musculus (Mouse)	696	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c2_g1_i1	Q7Z340	ZN551_HUMAN	52.6	78	37	0	1	234	477	554	9.90E-17	87	ZN551_HUMAN	reviewed	Zinc finger protein 551 (Zinc finger protein KOX23)	ZNF551 KOX23	Homo sapiens (Human)	670	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g2_i1	Q7Z340	ZN551_HUMAN	43.4	53	30	0	262	104	497	549	1.90E-08	59.7	ZN551_HUMAN	reviewed	Zinc finger protein 551 (Zinc finger protein KOX23)	ZNF551 KOX23	Homo sapiens (Human)	670	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2621_c0_g1_i1	Q7Z340	ZN551_HUMAN	50	108	54	0	1212	1535	444	551	3.20E-29	131.3	ZN551_HUMAN	reviewed	Zinc finger protein 551 (Zinc finger protein KOX23)	ZNF551 KOX23	Homo sapiens (Human)	670	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2621_c0_g1_i5	Q7Z340	ZN551_HUMAN	50	108	54	0	1217	1540	444	551	3.20E-29	131.3	ZN551_HUMAN	reviewed	Zinc finger protein 551 (Zinc finger protein KOX23)	ZNF551 KOX23	Homo sapiens (Human)	670	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g3_i1	Q7Z340	ZN551_HUMAN	45.6	57	31	0	200	30	609	665	7.20E-11	67.4	ZN551_HUMAN	reviewed	Zinc finger protein 551 (Zinc finger protein KOX23)	ZNF551 KOX23	Homo sapiens (Human)	670	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10254_c0_g1_i5	Q9H707	ZN552_HUMAN	46.7	90	46	1	351	82	270	357	4.80E-20	100.1	ZN552_HUMAN	reviewed	Zinc finger protein 552	ZNF552	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10254_c0_g1_i6	Q9H707	ZN552_HUMAN	46.7	90	46	1	311	42	270	357	4.60E-20	100.1	ZN552_HUMAN	reviewed	Zinc finger protein 552	ZNF552	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10254_c0_g1_i7	Q9H707	ZN552_HUMAN	41.8	110	62	1	768	439	270	377	3.70E-21	104	ZN552_HUMAN	reviewed	Zinc finger protein 552	ZNF552	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10254_c0_g1_i8	Q9H707	ZN552_HUMAN	41.8	110	62	1	768	439	270	377	4.70E-21	104	ZN552_HUMAN	reviewed	Zinc finger protein 552	ZNF552	Homo sapiens (Human)	407	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i8	Q86TJ5	ZN554_HUMAN	42.9	147	64	3	2	397	349	490	2.60E-25	116.3	ZN554_HUMAN	reviewed	Zinc finger protein 554	ZNF554	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33416_c0_g1_i1	Q86TJ5	ZN554_HUMAN	52.1	48	22	1	21	161	351	398	1.50E-07	56.6	ZN554_HUMAN	reviewed	Zinc finger protein 554	ZNF554	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i19	Q86TJ5	ZN554_HUMAN	44.2	104	46	2	301	2	331	426	7.90E-18	91.3	ZN554_HUMAN	reviewed	Zinc finger protein 554	ZNF554	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i6	Q86TJ5	ZN554_HUMAN	46.9	113	56	1	365	39	331	443	1.00E-24	114.4	ZN554_HUMAN	reviewed	Zinc finger protein 554	ZNF554	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c2_g1_i1	Q8NEP9	ZN555_HUMAN	36.4	77	49	0	3	233	258	334	5.60E-12	71.2	ZN555_HUMAN	reviewed	Zinc finger protein 555	ZNF555	Homo sapiens (Human)	628	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23535_c0_g1_i2	Q8NEP9	ZN555_HUMAN	38	142	88	0	430	5	232	373	1.20E-32	141.4	ZN555_HUMAN	reviewed	Zinc finger protein 555	ZNF555	Homo sapiens (Human)	628	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13681_c0_g1_i1	Q8NEP9	ZN555_HUMAN	39.5	76	46	0	232	5	258	333	3.90E-13	75.1	ZN555_HUMAN	reviewed	Zinc finger protein 555	ZNF555	Homo sapiens (Human)	628	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g1_i7	Q9HAH1	ZN556_HUMAN	48.1	79	41	0	187	423	148	226	1.00E-13	78.2	ZN556_HUMAN	reviewed	Zinc finger protein 556	ZNF556	Homo sapiens (Human)	456	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i6	Q96NG5	ZN558_HUMAN	43.7	126	70	1	378	4	230	355	2.70E-27	123.2	ZN558_HUMAN	reviewed	Zinc finger protein 558	ZNF558	Homo sapiens (Human)	402	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i7	Q96NG5	ZN558_HUMAN	41.8	98	56	1	294	4	230	327	1.10E-18	94.4	ZN558_HUMAN	reviewed	Zinc finger protein 558	ZNF558	Homo sapiens (Human)	402	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32540_c0_g1_i1	Q96NG5	ZN558_HUMAN	100	68	0	0	206	3	216	283	2.20E-36	152.1	ZN558_HUMAN	reviewed	Zinc finger protein 558	ZNF558	Homo sapiens (Human)	402	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c24_g1_i1	Q9BR84	ZN559_HUMAN	60	40	16	0	120	1	340	379	1.50E-08	59.7	ZN559_HUMAN	reviewed	Zinc finger protein 559	ZNF559	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34384_c0_g1_i1	Q9BR84	ZN559_HUMAN	100	96	0	0	290	3	370	465	1.50E-54	213	ZN559_HUMAN	reviewed	Zinc finger protein 559	ZNF559	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29853_c0_g1_i1	Q9BR84	ZN559_HUMAN	37.8	180	110	1	898	365	276	455	8.60E-35	149.1	ZN559_HUMAN	reviewed	Zinc finger protein 559	ZNF559	Homo sapiens (Human)	538	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN490_c7_g1_i3	Q96MR9	ZN560_HUMAN	57.8	109	46	0	332	6	544	652	8.00E-31	134.4	ZN560_HUMAN	reviewed	Zinc finger protein 560	ZNF560	Homo sapiens (Human)	790	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19389_c0_g1_i1	Q96MR9	ZN560_HUMAN	47.7	109	57	0	34	360	510	618	1.70E-23	110.2	ZN560_HUMAN	reviewed	Zinc finger protein 560	ZNF560	Homo sapiens (Human)	790	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19389_c0_g1_i4	Q96MR9	ZN560_HUMAN	49.2	126	64	0	3	380	493	618	1.20E-30	134	ZN560_HUMAN	reviewed	Zinc finger protein 560	ZNF560	Homo sapiens (Human)	790	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5956_c0_g1_i2	Q96MR9	ZN560_HUMAN	58.5	65	27	0	203	9	573	637	1.10E-16	86.7	ZN560_HUMAN	reviewed	Zinc finger protein 560	ZNF560	Homo sapiens (Human)	790	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5956_c0_g1_i3	Q96MR9	ZN560_HUMAN	57.5	87	35	1	270	10	545	629	2.80E-23	109	ZN560_HUMAN	reviewed	Zinc finger protein 560	ZNF560	Homo sapiens (Human)	790	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10439_c0_g4_i1	Q8N587	ZN561_HUMAN	52.6	116	55	0	4	351	302	417	4.30E-32	138.7	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c1_g1_i1	Q8N587	ZN561_HUMAN	48.6	111	57	0	5	337	274	384	6.80E-27	121.3	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9208_c0_g1_i1	Q8N587	ZN561_HUMAN	50	110	55	0	2	331	282	391	4.70E-28	125.2	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i6	Q8N587	ZN561_HUMAN	41.8	146	71	2	36	431	266	411	5.10E-27	122.1	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i4	Q8N587	ZN561_HUMAN	47.2	106	56	0	394	77	275	380	2.80E-25	116.3	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i5	Q8N587	ZN561_HUMAN	54.7	53	23	1	241	83	355	406	2.40E-10	65.9	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i8	Q8N587	ZN561_HUMAN	46.2	91	43	1	285	13	327	411	7.50E-18	92	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i5	Q8N587	ZN561_HUMAN	40	150	89	1	49	498	266	414	1.10E-27	124.8	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15685_c0_g1_i1	Q8N587	ZN561_HUMAN	46.7	105	56	0	1	315	311	415	8.90E-24	110.9	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8943_c0_g1_i3	Q8N587	ZN561_HUMAN	46.3	121	65	0	2	364	282	402	1.20E-29	130.6	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i3	Q8N587	ZN561_HUMAN	46.4	69	37	0	8	214	358	426	5.60E-14	77.8	ZN561_HUMAN	reviewed	Zinc finger protein 561	ZNF561	Homo sapiens (Human)	486	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN20253_c1_g1_i1	Q6V9R5	ZN562_HUMAN	38.9	90	55	0	6	275	281	370	4.90E-15	81.6	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g2_i5	Q6V9R5	ZN562_HUMAN	44.6	74	41	0	102	323	278	351	3.40E-15	82.4	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g2_i7	Q6V9R5	ZN562_HUMAN	47.7	130	68	0	12	401	278	407	9.60E-36	151	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g1_i2	Q6V9R5	ZN562_HUMAN	49.1	57	29	0	172	2	281	337	1.40E-10	66.6	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g1_i3	Q6V9R5	ZN562_HUMAN	43.3	127	67	2	385	5	288	409	1.50E-25	117.1	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18858_c0_g1_i1	Q6V9R5	ZN562_HUMAN	50.7	69	31	1	11	217	290	355	3.10E-15	82	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i10	Q6V9R5	ZN562_HUMAN	50.4	119	59	0	465	109	306	424	3.70E-31	136	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i9	Q6V9R5	ZN562_HUMAN	50	106	53	0	329	12	313	418	2.60E-27	123.6	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i9	Q6V9R5	ZN562_HUMAN	51.5	101	49	0	634	332	306	406	7.50E-27	122.1	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5550_c0_g1_i1	Q6V9R5	ZN562_HUMAN	48.1	81	41	1	124	363	264	344	4.50E-16	85.5	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i8	Q6V9R5	ZN562_HUMAN	42.7	89	51	0	271	5	306	394	5.00E-20	98.2	ZN562_HUMAN	reviewed	Zinc finger protein 562	ZNF562	Homo sapiens (Human)	426	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g1_i7	Q8N9K5	ZN565_HUMAN	50	66	32	1	211	14	321	385	1.50E-11	69.7	ZN565_HUMAN	reviewed	Zinc finger protein 565	ZNF565	Homo sapiens (Human)	539	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10790_c0_g1_i3	Q8N9K5	ZN565_HUMAN	51.8	114	55	0	363	22	312	425	1.90E-30	133.3	ZN565_HUMAN	reviewed	Zinc finger protein 565	ZNF565	Homo sapiens (Human)	539	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i11	Q8N9K5	ZN565_HUMAN	44.7	85	47	0	296	42	341	425	1.80E-18	93.2	ZN565_HUMAN	reviewed	Zinc finger protein 565	ZNF565	Homo sapiens (Human)	539	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i10	Q969W8	ZN566_HUMAN	42.4	132	71	1	34	414	230	361	1.60E-26	120.6	ZN566_HUMAN	reviewed	Zinc finger protein 566	ZNF566	Homo sapiens (Human)	418	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i6	Q8N184	ZN567_HUMAN	36	175	104	1	2	526	372	538	1.30E-27	124.4	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i6	Q8N184	ZN567_HUMAN	45.8	59	32	0	162	338	502	560	8.20E-11	68.6	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8728_c0_g1_i1	Q8N184	ZN567_HUMAN	32.4	253	145	8	414	1166	355	583	2.50E-32	141.4	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16301_c0_g2_i1	A2VDP4	ZN567_BOVIN	32.6	276	185	1	830	3	321	595	2.90E-42	173.7	ZN567_BOVIN	reviewed	Zinc finger protein 567	ZNF567	Bos taurus (Bovine)	647	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16301_c0_g2_i1	A2VDP4	ZN567_BOVIN	23.5	230	160	3	672	25	248	475	1.10E-12	75.5	ZN567_BOVIN	reviewed	Zinc finger protein 567	ZNF567	Bos taurus (Bovine)	647	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12050_c0_g1_i1	A2VDP4	ZN567_BOVIN	46.7	152	80	1	461	9	307	458	2.40E-41	169.9	ZN567_BOVIN	reviewed	Zinc finger protein 567	ZNF567	Bos taurus (Bovine)	647	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c4_g1_i1	Q8N184	ZN567_HUMAN	51.3	78	38	0	8	241	398	475	1.60E-17	89.7	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4081_c0_g1_i1	Q8N184	ZN567_HUMAN	33.9	236	148	4	1912	2610	335	565	3.10E-35	152.1	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g3_i1	Q8N184	ZN567_HUMAN	48.8	82	41	1	6	251	395	475	9.00E-16	84	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c0_g1_i3	A2VDP4	ZN567_BOVIN	48.6	144	74	0	5	436	299	442	1.10E-37	157.5	ZN567_BOVIN	reviewed	Zinc finger protein 567	ZNF567	Bos taurus (Bovine)	647	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i3	Q8N184	ZN567_HUMAN	40.1	237	133	6	4	705	293	523	4.30E-39	162.9	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c0_g2_i1	A2VDP4	ZN567_BOVIN	47.2	89	47	0	7	273	355	443	6.00E-21	101.3	ZN567_BOVIN	reviewed	Zinc finger protein 567	ZNF567	Bos taurus (Bovine)	647	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c1_g1_i1	Q8N184	ZN567_HUMAN	49.1	161	82	0	491	9	395	555	1.60E-43	177.2	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3518_c0_g1_i1	Q8N184	ZN567_HUMAN	50	88	44	0	269	6	486	573	1.90E-19	96.3	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3354_c0_g3_i1	Q8N184	ZN567_HUMAN	50.7	144	71	0	432	1	470	613	2.20E-38	159.8	ZN567_HUMAN	reviewed	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	647	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5550_c0_g2_i1	A2VDP4	ZN567_BOVIN	52.1	48	23	0	6	149	540	587	1.00E-07	57	ZN567_BOVIN	reviewed	Zinc finger protein 567	ZNF567	Bos taurus (Bovine)	647	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35722_c0_g1_i1	Q3ZCX4	ZN568_HUMAN	51.2	80	39	0	265	26	443	522	2.50E-19	95.9	ZN568_HUMAN	reviewed	Zinc finger protein 568	ZNF568	Homo sapiens (Human)	644	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0045892; GO:0046872; GO:0060669	"embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c1_g1_i1	E9PYI1	ZN568_MOUSE	49.3	67	34	0	208	8	599	665	1.50E-13	76.6	ZN568_MOUSE	reviewed	Zinc finger protein 568	Znf568 chato Zfp568	Mus musculus (Mouse)	671	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in neural plate elongation [GO:0022007]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell communication [GO:0010646]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001701; GO:0005634; GO:0006357; GO:0010646; GO:0022007; GO:0045892; GO:0046872; GO:0060028; GO:0060669	"convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in neural plate elongation [GO:0022007]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell communication [GO:0010646]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33622_c0_g1_i1	Q5MCW4	ZN569_HUMAN	52.3	109	52	0	1	327	352	460	2.10E-33	142.9	ZN569_HUMAN	reviewed	Zinc finger protein 569	ZNF569	Homo sapiens (Human)	686	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g4_i1	Q5MCW4	ZN569_HUMAN	50	68	34	0	208	5	243	310	4.10E-14	78.2	ZN569_HUMAN	reviewed	Zinc finger protein 569	ZNF569	Homo sapiens (Human)	686	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i65	Q5MCW4	ZN569_HUMAN	31.3	147	67	5	446	784	522	668	2.20E-12	74.3	ZN569_HUMAN	reviewed	Zinc finger protein 569	ZNF569	Homo sapiens (Human)	686	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c4_g1_i1	Q80W31	ZN569_MOUSE	55.6	72	32	0	314	99	242	313	2.70E-17	89.4	ZN569_MOUSE	reviewed	Zinc finger protein 569 (Mszf21) (Zinc finger protein 74) (Zfp-74)	Znf569 Zfp74	Mus musculus (Mouse)	679	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3678_c0_g1_i4	Q9NU63	ZFP57_HUMAN	36.5	104	63	3	415	110	91	193	1.60E-12	73.9	ZFP57_HUMAN	reviewed	Zinc finger protein 57 homolog (Zfp-57) (Zinc finger protein 698)	ZFP57 C6orf40 ZNF698	Homo sapiens (Human)	452	"nuclear chromatin [GO:0000790]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; DNA methylation involved in embryo development [GO:0043045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003682; GO:0006349; GO:0006357; GO:0043045; GO:0046872	DNA methylation involved in embryo development [GO:0043045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i2	Q96NI8	ZN570_HUMAN	39	123	68	2	372	4	388	503	1.40E-17	90.5	ZN570_HUMAN	reviewed	Zinc finger protein 570	ZNF570	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38557_c0_g1_i1	Q96NI8	ZN570_HUMAN	47.7	88	45	1	267	4	269	355	2.00E-22	106.3	ZN570_HUMAN	reviewed	Zinc finger protein 570	ZNF570	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3745_c0_g1_i5	Q96NI8	ZN570_HUMAN	55.6	63	28	0	190	2	353	415	6.60E-15	81.6	ZN570_HUMAN	reviewed	Zinc finger protein 570	ZNF570	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN507_c0_g2_i1	Q96NI8	ZN570_HUMAN	49	253	128	1	760	5	223	475	1.20E-76	287.7	ZN570_HUMAN	reviewed	Zinc finger protein 570	ZNF570	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14851_c0_g1_i2	Q96NI8	ZN570_HUMAN	41.5	193	113	0	584	6	296	488	1.60E-44	180.6	ZN570_HUMAN	reviewed	Zinc finger protein 570	ZNF570	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN421_c0_g1_i1	Q7Z3V5	ZN571_HUMAN	51.4	74	36	0	232	11	531	604	8.80E-18	90.5	ZN571_HUMAN	reviewed	Zinc finger protein 571	ZNF571 HSPC059	Homo sapiens (Human)	609	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c0_g2_i1	Q5R5Q6	ZN571_PONAB	46.2	145	76	2	441	7	194	336	7.90E-31	134.8	ZN571_PONAB	reviewed	Zinc finger protein 571	ZNF571	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	608	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c0_g2_i2	Q5R5Q6	ZN571_PONAB	46	150	79	2	453	4	194	341	3.60E-31	136	ZN571_PONAB	reviewed	Zinc finger protein 571	ZNF571	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	608	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c0_g2_i5	Q5R5Q6	ZN571_PONAB	46.9	145	75	2	441	7	194	336	1.20E-31	137.5	ZN571_PONAB	reviewed	Zinc finger protein 571	ZNF571	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	608	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15968_c0_g2_i1	Q5R5Q6	ZN571_PONAB	53.4	73	33	1	2	217	507	579	1.50E-14	79.7	ZN571_PONAB	reviewed	Zinc finger protein 571	ZNF571	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	608	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9165_c0_g1_i1	Q7Z3I7	ZN572_HUMAN	54.7	75	34	0	399	175	218	292	3.10E-19	97.1	ZN572_HUMAN	reviewed	Zinc finger protein 572	ZNF572	Homo sapiens (Human)	529	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042802; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i6	Q32KN0	ZN572_BOVIN	45.5	66	34	1	200	9	280	345	1.30E-09	64.3	ZN572_BOVIN	reviewed	Zinc finger protein 572	ZNF572	Bos taurus (Bovine)	529	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c3_g1_i1	Q7Z3I7	ZN572_HUMAN	47.2	89	47	0	2	268	206	294	3.30E-18	92.8	ZN572_HUMAN	reviewed	Zinc finger protein 572	ZNF572	Homo sapiens (Human)	529	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042802; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c3_g1_i1	Q7Z3I7	ZN572_HUMAN	42.4	85	49	0	180	434	210	294	5.00E-14	79	ZN572_HUMAN	reviewed	Zinc finger protein 572	ZNF572	Homo sapiens (Human)	529	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042802; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6940_c1_g1_i1	Q86YE8	ZN573_HUMAN	54.4	57	26	0	9	179	436	492	1.10E-13	77	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8500_c0_g2_i1	Q86YE8	ZN573_HUMAN	44.2	86	48	0	302	45	407	492	4.20E-15	82	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i2	Q86YE8	ZN573_HUMAN	50.5	99	40	2	8	289	386	480	3.00E-23	109	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i9	Q86YE8	ZN573_HUMAN	48.1	106	41	3	8	316	386	480	3.10E-21	102.4	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g3_i2	Q86YE8	ZN573_HUMAN	49.2	118	60	0	355	2	348	465	8.40E-29	127.9	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g1_i1	Q86YE8	ZN573_HUMAN	47.1	138	73	0	417	4	389	526	1.30E-33	144.1	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g1_i2	Q86YE8	ZN573_HUMAN	47.1	140	74	0	420	1	388	527	1.30E-35	150.6	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22460_c0_g1_i4	Q86YE8	ZN573_HUMAN	49.6	137	59	1	397	17	357	493	2.90E-30	132.9	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c3_g2_i1	Q86YE8	ZN573_HUMAN	47.1	85	45	0	7	261	436	520	5.20E-18	91.7	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18303_c0_g1_i2	Q86YE8	ZN573_HUMAN	47	83	44	0	254	6	429	511	4.80E-17	88.2	ZN573_HUMAN	reviewed	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	665	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25551_c0_g1_i1	Q6ZN55	ZN574_HUMAN	100	107	0	0	322	2	732	838	1.00E-62	240.4	ZN574_HUMAN	reviewed	Zinc finger protein 574	ZNF574	Homo sapiens (Human)	896	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g2_i1	Q9BSK1	ZN577_HUMAN	47	83	44	0	2	250	182	264	1.70E-17	89.7	ZN577_HUMAN	reviewed	Zinc finger protein 577	ZNF577	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g2_i2	Q9BSK1	ZN577_HUMAN	47	83	44	0	2	250	182	264	1.70E-17	89.7	ZN577_HUMAN	reviewed	Zinc finger protein 577	ZNF577	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c10_g1_i3	Q9BSK1	ZN577_HUMAN	41	78	46	0	6	239	284	361	1.20E-09	63.5	ZN577_HUMAN	reviewed	Zinc finger protein 577	ZNF577	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c3_g1_i4	Q9BSK1	ZN577_HUMAN	51.9	81	39	0	210	452	156	236	1.30E-17	90.9	ZN577_HUMAN	reviewed	Zinc finger protein 577	ZNF577	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g2_i3	Q9BSK1	ZN577_HUMAN	50.6	79	39	0	25	261	188	266	1.40E-19	96.7	ZN577_HUMAN	reviewed	Zinc finger protein 577	ZNF577	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9294_c0_g1_i4	Q9BSK1	ZN577_HUMAN	55.4	74	33	0	223	2	191	264	1.70E-18	92.8	ZN577_HUMAN	reviewed	Zinc finger protein 577	ZNF577	Homo sapiens (Human)	485	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN36868_c0_g1_i1	Q96N58	ZN578_HUMAN	45.6	79	42	1	282	49	343	421	6.50E-18	91.3	ZN578_HUMAN	reviewed	Zinc finger protein 578	ZNF578	Homo sapiens (Human)	590	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5550_c0_g1_i2	Q96N58	ZN578_HUMAN	55.1	127	57	0	2	382	297	423	1.10E-33	144.1	ZN578_HUMAN	reviewed	Zinc finger protein 578	ZNF578	Homo sapiens (Human)	590	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i9	P16372	ZFP58_MOUSE	43.2	74	42	0	2	223	139	212	4.70E-13	75.5	ZFP58_MOUSE	reviewed	Zinc finger protein 58 (Zfp-58) (Regulator of sex-limitation candidate 5) (Zinc finger protein Mfg-1)	Zfp58 Mfg-1 Rslcan5 Zfp817	Mus musculus (Mouse)	489	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i14	Q9P0T4	ZN581_HUMAN	47.2	36	19	0	48	155	143	178	1.70E-05	50.4	ZN581_HUMAN	reviewed	Zinc finger protein 581	ZNF581 HSPC189	Homo sapiens (Human)	197	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i19	Q9P0T4	ZN581_HUMAN	47.2	36	19	0	48	155	143	178	1.80E-05	50.4	ZN581_HUMAN	reviewed	Zinc finger protein 581	ZNF581 HSPC189	Homo sapiens (Human)	197	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i5	Q9P0T4	ZN581_HUMAN	44.4	36	20	0	48	155	143	178	4.20E-05	48.5	ZN581_HUMAN	reviewed	Zinc finger protein 581	ZNF581 HSPC189	Homo sapiens (Human)	197	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i7	Q9P0T4	ZN581_HUMAN	47.2	36	19	0	48	155	143	178	1.20E-05	50.8	ZN581_HUMAN	reviewed	Zinc finger protein 581	ZNF581 HSPC189	Homo sapiens (Human)	197	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i16	Q3V080	ZN583_MOUSE	43.5	108	54	3	3	326	373	473	1.20E-20	100.5	ZN583_MOUSE	reviewed	Zinc finger protein 583	Znf583 Zfp583	Mus musculus (Mouse)	568	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11589_c0_g1_i1	Q96ND8	ZN583_HUMAN	32.6	230	144	5	1295	606	238	456	1.40E-31	139	ZN583_HUMAN	reviewed	Zinc finger protein 583 (Zinc finger protein L3-5)	ZNF583	Homo sapiens (Human)	569	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i16	Q5RDX1	Z585A_PONAB	45.3	75	30	1	275	84	662	736	4.70E-10	65.1	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i18	Q5RDX1	Z585A_PONAB	45.3	75	30	1	348	157	662	736	3.50E-10	65.9	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i25	Q5RDX1	Z585A_PONAB	45.3	75	30	1	278	87	662	736	1.60E-10	66.6	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i34	Q6P3V2	Z585A_HUMAN	46.5	101	47	1	307	5	648	741	2.50E-20	99.4	Z585A_HUMAN	reviewed	Zinc finger protein 585A	ZNF585A	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN490_c1_g1_i2	Q6P3V2	Z585A_HUMAN	43	79	45	0	2	238	369	447	6.80E-13	74.7	Z585A_HUMAN	reviewed	Zinc finger protein 585A	ZNF585A	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i7	Q5RDX1	Z585A_PONAB	46.3	227	107	2	96	773	524	736	4.90E-56	219.5	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i7	Q5RDX1	Z585A_PONAB	42.6	47	27	0	5	145	326	372	2.50E-04	47.8	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7861_c0_g1_i1	Q5RDX1	Z585A_PONAB	35.6	295	187	3	210	1088	435	728	2.40E-52	207.6	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9461_c1_g1_i7	Q5RDX1	Z585A_PONAB	47.2	72	35	1	221	6	536	604	1.10E-12	73.6	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c0_g1_i3	Q5RDX1	Z585A_PONAB	46.6	176	92	1	3	530	480	653	9.00E-42	171.4	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i6	Q6P3V2	Z585A_HUMAN	41.8	134	78	0	22	423	534	667	2.50E-26	119.8	Z585A_HUMAN	reviewed	Zinc finger protein 585A	ZNF585A	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g3_i1	Q6P3V2	Z585A_HUMAN	50	82	40	1	246	1	187	267	1.50E-18	93.2	Z585A_HUMAN	reviewed	Zinc finger protein 585A	ZNF585A	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i14	Q6P3V2	Z585A_HUMAN	46.1	76	41	0	234	7	210	285	5.80E-17	87.8	Z585A_HUMAN	reviewed	Zinc finger protein 585A	ZNF585A	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27320_c0_g1_i1	Q5RDX1	Z585A_PONAB	41.4	99	58	0	298	2	570	668	2.00E-19	96.7	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i10	Q5RDX1	Z585A_PONAB	53.8	65	30	0	197	3	662	726	1.50E-16	86.3	Z585A_PONAB	reviewed	Zinc finger protein 585A	ZNF585A	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	737	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i2	Q5RB30	Z585B_PONAB	44.4	108	60	0	3	326	392	499	1.20E-23	110.5	Z585B_PONAB	reviewed	Zinc finger protein 585B	ZNF585B	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	769	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g2_i1	Q52M93	Z585B_HUMAN	44.8	116	64	0	349	2	184	299	1.10E-26	121.7	Z585B_HUMAN	reviewed	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i38	Q52M93	Z585B_HUMAN	46.1	89	48	0	269	3	462	550	1.70E-19	97.8	Z585B_HUMAN	reviewed	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i39	Q52M93	Z585B_HUMAN	44.9	89	49	0	269	3	462	550	2.80E-19	96.7	Z585B_HUMAN	reviewed	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i40	Q52M93	Z585B_HUMAN	44.9	89	49	0	269	3	462	550	3.90E-19	96.7	Z585B_HUMAN	reviewed	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i13	Q52M93	Z585B_HUMAN	48.1	77	40	0	2	232	212	288	2.00E-17	89.4	Z585B_HUMAN	reviewed	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7056_c0_g3_i2	Q52M93	Z585B_HUMAN	42.9	77	38	1	1	213	692	768	2.20E-11	69.3	Z585B_HUMAN	reviewed	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	769	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c9_g1_i1	Q9NXT0	ZN586_HUMAN	42	88	46	2	99	347	184	271	1.40E-11	70.5	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17793_c1_g1_i1	Q9NXT0	ZN586_HUMAN	51.9	77	37	0	233	3	180	256	9.80E-17	87	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i37	Q9NXT0	ZN586_HUMAN	32.4	173	91	6	240	758	236	382	1.10E-13	78.6	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i48	Q9NXT0	ZN586_HUMAN	32.4	173	91	6	245	763	236	382	1.50E-13	78.2	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g1_i1	Q9NXT0	ZN586_HUMAN	40.8	130	69	1	374	9	185	314	1.80E-23	110.2	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15777_c0_g1_i4	Q9NXT0	ZN586_HUMAN	48.9	135	69	0	413	9	180	314	1.30E-35	150.6	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40189_c0_g1_i1	Q9NXT0	ZN586_HUMAN	100	86	0	0	258	1	146	231	3.80E-46	184.9	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25160_c0_g1_i1	Q9NXT0	ZN586_HUMAN	85.1	67	10	0	201	1	255	321	6.10E-31	134	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5989_c0_g1_i1	Q9NXT0	ZN586_HUMAN	56.9	72	31	0	1	216	178	249	2.20E-18	92.4	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i4	Q9NXT0	ZN586_HUMAN	46.2	78	42	0	439	206	179	256	3.70E-17	89.4	ZN586_HUMAN	reviewed	Zinc finger protein 586	ZNF586	Homo sapiens (Human)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g2_i4	Q96SQ5	ZN587_HUMAN	45.8	59	32	0	191	367	262	320	4.60E-08	58.9	ZN587_HUMAN	reviewed	Zinc finger protein 587	ZNF587	Homo sapiens (Human)	575	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13300_c4_g1_i1	Q9W3Y0	ZN593_DROME	67.5	117	37	1	101	451	6	121	1.20E-39	164.5	ZN593_DROME	reviewed	Zinc finger protein 593 homolog	CG3224	Drosophila melanogaster (Fruit fly)	162	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270			blue	blue	NA	NA	NA	NA
TRINITY_DN9461_c0_g1_i1	Q96JF6	ZN594_HUMAN	54.3	94	43	0	283	2	574	667	1.00E-23	110.5	ZN594_HUMAN	reviewed	Zinc finger protein 594 (Zinc finger protein HZF18)	ZNF594 KIAA1871	Homo sapiens (Human)	807	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i15	Q96JF6	ZN594_HUMAN	52.2	67	32	0	253	453	426	492	1.10E-14	81.3	ZN594_HUMAN	reviewed	Zinc finger protein 594 (Zinc finger protein HZF18)	ZNF594 KIAA1871	Homo sapiens (Human)	807	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1594_c0_g1_i7	Q8IYB9	ZN595_HUMAN	45.3	128	68	2	199	582	209	334	9.40E-27	121.7	ZN595_HUMAN	reviewed	Zinc finger protein 595	ZNF595	Homo sapiens (Human)	648	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6575_c0_g1_i4	Q8TC21	ZN596_HUMAN	35.1	148	94	1	1276	1719	212	357	8.50E-20	100.1	ZN596_HUMAN	reviewed	Zinc finger protein 596	ZNF596	Homo sapiens (Human)	504	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37650_c0_g1_i1	Q8TC21	ZN596_HUMAN	37.4	91	57	0	300	28	355	445	7.40E-17	87.8	ZN596_HUMAN	reviewed	Zinc finger protein 596	ZNF596	Homo sapiens (Human)	504	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27336_c0_g1_i1	Q8TC21	ZN596_HUMAN	44.3	194	108	0	41	622	303	496	1.20E-49	198	ZN596_HUMAN	reviewed	Zinc finger protein 596	ZNF596	Homo sapiens (Human)	504	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35651_c0_g1_i2	Q8TC21	ZN596_HUMAN	43.2	88	50	0	353	90	416	503	9.10E-17	87.8	ZN596_HUMAN	reviewed	Zinc finger protein 596	ZNF596	Homo sapiens (Human)	504	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i6	Q96NL3	ZN599_HUMAN	51.9	160	77	0	5	484	303	462	2.80E-47	189.9	ZN599_HUMAN	reviewed	Zinc finger protein 599	ZNF599	Homo sapiens (Human)	588	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c0_g2_i3	Q96NL3	ZN599_HUMAN	32.9	140	67	5	375	10	373	503	2.20E-10	66.6	ZN599_HUMAN	reviewed	Zinc finger protein 599	ZNF599	Homo sapiens (Human)	588	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c1_g1_i1	P16374	ZFP60_MOUSE	49.3	71	35	1	213	1	450	519	3.80E-13	75.1	ZFP60_MOUSE	reviewed	Zinc finger protein 60 (Zfp-60) (Zinc finger protein Mfg-3)	Zfp60 Mfg3	Mus musculus (Mouse)	707	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14356_c0_g1_i2	Q6ZNG1	ZN600_HUMAN	51.5	68	33	0	7	210	359	426	1.10E-14	80.1	ZN600_HUMAN	reviewed	Zinc finger protein 600	ZNF600	Homo sapiens (Human)	722	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24494_c1_g1_i1	Q6ZNG1	ZN600_HUMAN	84.9	73	11	0	220	2	457	529	1.30E-31	136.3	ZN600_HUMAN	reviewed	Zinc finger protein 600	ZNF600	Homo sapiens (Human)	722	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g4_i1	Q6ZNG1	ZN600_HUMAN	95.9	97	4	0	313	23	355	451	2.10E-54	212.6	ZN600_HUMAN	reviewed	Zinc finger protein 600	ZNF600	Homo sapiens (Human)	722	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10216_c0_g1_i1	Q6ZNG1	ZN600_HUMAN	40	75	45	0	226	2	299	373	1.20E-13	77	ZN600_HUMAN	reviewed	Zinc finger protein 600	ZNF600	Homo sapiens (Human)	722	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN5_c25_g3_i1	Q86T29	ZN605_HUMAN	55.4	65	29	0	3	197	459	523	2.90E-12	72	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i18	Q86T29	ZN605_HUMAN	41.5	142	64	3	393	25	341	482	1.20E-20	102.1	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i19	Q86T29	ZN605_HUMAN	60.8	51	18	1	155	9	442	492	2.50E-08	60.8	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i19	Q86T29	ZN605_HUMAN	61.2	49	12	1	255	130	453	501	2.50E-08	60.8	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i21	Q86T29	ZN605_HUMAN	61.2	49	12	1	320	195	453	501	2.70E-08	60.8	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i10	Q86T29	ZN605_HUMAN	42.9	56	32	0	53	220	221	276	1.40E-07	56.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i9	Q86T29	ZN605_HUMAN	45.5	55	30	0	171	335	279	333	9.20E-08	57.8	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g1_i2	Q86T29	ZN605_HUMAN	61	59	23	0	1	177	454	512	3.90E-14	79.3	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g1_i6	Q86T29	ZN605_HUMAN	48	102	53	0	32	337	454	555	1.50E-24	114	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g1_i2	Q86T29	ZN605_HUMAN	48.7	78	40	0	1	234	450	527	3.30E-16	85.9	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c6_g2_i1	Q86T29	ZN605_HUMAN	44.1	68	38	0	206	3	432	499	1.50E-07	57	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c0_g1_i3	Q86T29	ZN605_HUMAN	45	80	44	0	240	1	365	444	3.50E-17	88.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i12	Q86T29	ZN605_HUMAN	49.4	85	43	0	256	2	419	503	2.80E-18	93.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i27	Q86T29	ZN605_HUMAN	49.4	85	43	0	256	2	419	503	4.80E-18	93.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i39	Q86T29	ZN605_HUMAN	49.4	85	43	0	256	2	419	503	4.50E-18	93.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i47	Q86T29	ZN605_HUMAN	49.4	85	43	0	256	2	419	503	2.80E-18	93.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN607_c0_g1_i6	Q86T29	ZN605_HUMAN	49.4	85	43	0	256	2	419	503	2.30E-18	93.6	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i18	Q86T29	ZN605_HUMAN	48.6	109	41	2	8	334	421	514	1.70E-22	106.7	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2872_c5_g1_i1	Q86T29	ZN605_HUMAN	54.9	71	32	0	1	213	428	498	8.40E-15	80.5	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4115_c0_g1_i5	Q86T29	ZN605_HUMAN	46.6	88	47	0	265	2	302	389	2.20E-16	86.3	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28319_c0_g1_i1	Q86T29	ZN605_HUMAN	46.5	71	34	3	242	36	357	425	7.10E-08	57.8	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22460_c0_g1_i1	Q86T29	ZN605_HUMAN	56.8	74	32	0	224	3	426	499	2.50E-17	89	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1269_c3_g1_i2	Q86T29	ZN605_HUMAN	38.5	130	77	2	194	583	179	305	3.20E-22	106.7	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i2	Q86T29	ZN605_HUMAN	48.2	141	73	0	12	434	365	505	3.30E-34	146	ZN605_HUMAN	reviewed	Zinc finger protein 605	ZNF605	Homo sapiens (Human)	641	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g2_i3	Q8WXB4	ZN606_HUMAN	50	78	38	1	245	12	594	670	1.70E-14	79.7	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i1	Q8WXB4	ZN606_HUMAN	49.3	136	65	2	409	2	562	693	3.00E-32	139.4	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6598_c0_g1_i4	Q8WXB4	ZN606_HUMAN	44.4	108	60	0	4	327	566	673	2.90E-24	113.2	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c2_g1_i1	Q8WXB4	ZN606_HUMAN	45.9	74	39	1	220	2	603	676	7.60E-11	67.4	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i4	Q8WXB4	ZN606_HUMAN	38.9	113	56	3	2	334	430	531	2.10E-15	83.2	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i10	Q8WXB4	ZN606_HUMAN	50	66	32	1	197	3	555	620	1.60E-11	70.5	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i10	Q8WXB4	ZN606_HUMAN	46.4	56	30	0	355	188	429	484	1.90E-09	63.5	ZN606_HUMAN	reviewed	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	792	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN226_c5_g1_i1	Q8N823	ZN611_HUMAN	44.7	76	42	0	229	2	487	562	4.60E-11	68.2	ZN611_HUMAN	reviewed	Zinc finger protein 611	ZNF611	Homo sapiens (Human)	705	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19472_c0_g1_i1	Q8N823	ZN611_HUMAN	41.5	53	31	0	55	213	482	534	1.90E-06	52.8	ZN611_HUMAN	reviewed	Zinc finger protein 611	ZNF611	Homo sapiens (Human)	705	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35931_c0_g1_i1	Q6PF04	ZN613_HUMAN	86	86	12	0	2	259	287	372	1.10E-40	166.8	ZN613_HUMAN	reviewed	Zinc finger protein 613	ZNF613	Homo sapiens (Human)	617	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g2_i1	Q6PF04	ZN613_HUMAN	50.5	93	46	0	1	279	334	426	2.30E-20	99.4	ZN613_HUMAN	reviewed	Zinc finger protein 613	ZNF613	Homo sapiens (Human)	617	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i7	Q8N883	ZN614_HUMAN	49.3	209	106	0	107	733	265	473	5.30E-53	209.5	ZN614_HUMAN	reviewed	Zinc finger protein 614	ZNF614	Homo sapiens (Human)	585	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c6_g2_i7	Q8N883	ZN614_HUMAN	51.4	74	36	0	708	929	354	427	7.40E-15	82.8	ZN614_HUMAN	reviewed	Zinc finger protein 614	ZNF614	Homo sapiens (Human)	585	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16182_c0_g1_i1	Q95K49	ZN614_MACFA	52.2	115	55	0	351	7	360	474	1.90E-32	139.8	ZN614_MACFA	reviewed	Zinc finger protein 614	ZNF614 QtrA-10780	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	582	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i13	Q8N8J6	ZN615_HUMAN	49.6	125	60	2	416	42	331	452	4.60E-28	125.6	ZN615_HUMAN	reviewed	Zinc finger protein 615	ZNF615	Homo sapiens (Human)	731	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5654_c0_g1_i1	Q08AN1	ZN616_HUMAN	43.4	83	47	0	3	251	293	375	3.00E-17	89.7	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5654_c0_g1_i10	Q08AN1	ZN616_HUMAN	43.4	83	47	0	3	251	293	375	3.00E-17	89.7	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5654_c0_g1_i5	Q08AN1	ZN616_HUMAN	43.4	83	47	0	3	251	293	375	3.00E-17	89.7	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5654_c0_g1_i6	Q08AN1	ZN616_HUMAN	43.4	83	47	0	3	251	293	375	2.90E-17	89.7	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3817_c0_g1_i3	Q08AN1	ZN616_HUMAN	41.6	113	65	1	859	1197	236	347	1.90E-23	112.1	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3817_c0_g1_i4	Q08AN1	ZN616_HUMAN	41.6	113	65	1	859	1197	236	347	2.40E-23	112.1	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g1_i1	Q08AN1	ZN616_HUMAN	37.7	61	38	0	4	186	315	375	1.90E-09	62.8	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g1_i2	Q08AN1	ZN616_HUMAN	39.7	58	35	0	8	181	318	375	4.20E-09	61.6	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26853_c0_g1_i1	Q08AN1	ZN616_HUMAN	27.3	396	219	15	1148	6	211	552	5.70E-27	124.4	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN26853_c0_g1_i2	Q08AN1	ZN616_HUMAN	31.9	188	104	8	530	6	376	552	6.40E-14	79	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16522_c0_g2_i1	Q08AN1	ZN616_HUMAN	42.2	64	37	0	218	27	312	375	3.40E-11	68.6	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i16	Q08AN1	ZN616_HUMAN	48.6	105	49	1	3	317	670	769	3.30E-23	109	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i6	Q08AN1	ZN616_HUMAN	52.3	111	51	1	2	334	661	769	4.20E-29	128.6	ZN616_HUMAN	reviewed	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	781	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN36565_c0_g1_i1	Q8C827	ZFP62_MOUSE	98.6	72	1	0	217	2	448	519	9.40E-38	156.8	ZFP62_MOUSE	reviewed	Zinc finger protein 62 (Zfp-62) (ZT3)	Zfp62	Mus musculus (Mouse)	914	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35651_c0_g1_i1	Q8C827	ZFP62_MOUSE	35	143	84	2	680	252	436	569	1.50E-20	101.3	ZFP62_MOUSE	reviewed	Zinc finger protein 62 (Zfp-62) (ZT3)	Zfp62	Mus musculus (Mouse)	914	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33578_c0_g1_i1	Q8NB50	ZFP62_HUMAN	44	84	45	2	1	252	504	585	8.80E-14	77.4	ZFP62_HUMAN	reviewed	Zinc finger protein 62 homolog (Zfp-62)	ZFP62	Homo sapiens (Human)	900	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3678_c0_g1_i6	Q8NB50	ZFP62_HUMAN	29	303	165	13	933	139	360	650	3.60E-18	95.1	ZFP62_HUMAN	reviewed	Zinc finger protein 62 homolog (Zfp-62)	ZFP62	Homo sapiens (Human)	900	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN251_c0_g1_i1	Q8NB50	ZFP62_HUMAN	53.5	200	93	0	732	133	220	419	5.60E-63	243	ZFP62_HUMAN	reviewed	Zinc finger protein 62 homolog (Zfp-62)	ZFP62	Homo sapiens (Human)	900	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i1	Q8NB50	ZFP62_HUMAN	36.7	98	51	1	61	354	217	303	1.30E-11	71.2	ZFP62_HUMAN	reviewed	Zinc finger protein 62 homolog (Zfp-62)	ZFP62	Homo sapiens (Human)	900	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c0_g2_i3	Q8NB50	ZFP62_HUMAN	51	49	24	0	154	8	816	864	4.50E-09	61.6	ZFP62_HUMAN	reviewed	Zinc finger protein 62 homolog (Zfp-62)	ZFP62	Homo sapiens (Human)	900	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i3	Q6ZSS3	ZN621_HUMAN	42.2	83	48	0	148	396	158	240	5.00E-13	75.5	ZN621_HUMAN	reviewed	Zinc finger protein 621	ZNF621	Homo sapiens (Human)	439	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3233_c0_g2_i7	Q6ZSS3	ZN621_HUMAN	42.2	83	48	0	3	251	158	240	3.20E-13	75.5	ZN621_HUMAN	reviewed	Zinc finger protein 621	ZNF621	Homo sapiens (Human)	439	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2415_c0_g1_i1	Q969S3	ZN622_HUMAN	40	125	67	3	3	362	343	464	3.20E-17	89.4	ZN622_HUMAN	reviewed	Zinc finger protein 622 (Zinc finger-like protein 9)	ZNF622 ZPR9	Homo sapiens (Human)	477	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]"	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0008270; GO:0008631; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330	intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]		blue	blue	NA	NA	NA	NA
TRINITY_DN264_c0_g1_i1	O75123	ZN623_HUMAN	47.3	186	95	3	550	2	252	437	5.20E-48	192.2	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4355_c0_g1_i8	O75123	ZN623_HUMAN	45.3	128	70	0	389	6	201	328	1.90E-27	124.4	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29807_c0_g1_i1	O75123	ZN623_HUMAN	94.1	185	11	0	3	557	186	370	1.70E-107	389.8	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g2_i1	O75123	ZN623_HUMAN	50.6	79	39	0	1	237	347	425	1.20E-17	90.1	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i16	O75123	ZN623_HUMAN	46.6	191	96	3	1	558	268	457	1.20E-44	181	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c0_g1_i1	O75123	ZN623_HUMAN	52.6	78	37	0	90	323	369	446	1.60E-17	90.1	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g2_i1	O75123	ZN623_HUMAN	54.7	117	53	0	2	352	257	373	3.30E-35	149.1	ZN623_HUMAN	reviewed	Zinc finger protein 623	ZNF623 KIAA0628	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i15	Q9P2J8	ZN624_HUMAN	48.4	64	33	0	24	215	795	858	3.40E-13	75.9	ZN624_HUMAN	reviewed	Zinc finger protein 624	ZNF624 KIAA1349	Homo sapiens (Human)	865	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i4	Q9P2J8	ZN624_HUMAN	50	64	32	0	24	215	795	858	2.40E-14	79.7	ZN624_HUMAN	reviewed	Zinc finger protein 624	ZNF624 KIAA1349	Homo sapiens (Human)	865	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i8	Q9P2J8	ZN624_HUMAN	50	64	32	0	24	215	795	858	4.30E-14	79.3	ZN624_HUMAN	reviewed	Zinc finger protein 624	ZNF624 KIAA1349	Homo sapiens (Human)	865	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i18	Q9P2J8	ZN624_HUMAN	34.6	136	64	3	361	8	730	858	6.80E-17	88.2	ZN624_HUMAN	reviewed	Zinc finger protein 624	ZNF624 KIAA1349	Homo sapiens (Human)	865	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i6	Q9P2J8	ZN624_HUMAN	51.3	76	37	0	239	12	686	761	1.20E-20	100.1	ZN624_HUMAN	reviewed	Zinc finger protein 624	ZNF624 KIAA1349	Homo sapiens (Human)	865	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c1_g2_i1	Q68DY1	ZN626_HUMAN	45.8	48	26	0	235	92	232	279	7.10E-07	54.3	ZN626_HUMAN	reviewed	Zinc finger protein 626	ZNF626	Homo sapiens (Human)	528	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37873_c0_g1_i1	Q7L945	ZN627_HUMAN	68.6	70	22	0	1	210	218	287	3.00E-25	115.2	ZN627_HUMAN	reviewed	Zinc finger protein 627	ZNF627	Homo sapiens (Human)	461	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2136_c0_g3_i6	Q5EBL2	ZN628_HUMAN	43.2	88	48	1	471	214	174	261	1.00E-12	75.1	ZN628_HUMAN	reviewed	Zinc finger protein 628	ZNF628	Homo sapiens (Human)	1059	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35062_c0_g1_i1	Q9UEG4	ZN629_HUMAN	46.4	84	42	3	253	5	376	457	3.10E-16	85.5	ZN629_HUMAN	reviewed	Zinc finger protein 629 (Zinc finger protein 65)	ZNF629 KIAA0326 ZNF65	Homo sapiens (Human)	869	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i4	Q2M218	ZN630_HUMAN	47.1	119	63	0	367	11	359	477	1.00E-25	117.9	ZN630_HUMAN	reviewed	Zinc finger protein 630	ZNF630	Homo sapiens (Human)	657	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31055_c0_g1_i1	Q2M218	ZN630_HUMAN	49.1	57	29	0	221	51	427	483	3.10E-12	72	ZN630_HUMAN	reviewed	Zinc finger protein 630	ZNF630	Homo sapiens (Human)	657	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8238_c0_g3_i1	Q9NTW7	ZF64B_HUMAN	44.4	81	45	0	267	509	175	255	2.10E-16	87.4	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2791_c0_g1_i1	Q9NTW7	ZF64B_HUMAN	40.5	37	22	0	320	210	161	197	6.40E-06	51.6	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN37852_c0_g1_i1	Q9NTW7	ZF64B_HUMAN	39.3	61	37	0	227	45	373	433	4.50E-09	61.6	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN2386_c0_g2_i1	Q9NTW7	ZF64B_HUMAN	49.5	196	84	5	590	33	264	454	2.60E-51	203.8	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c0_g1_i9	Q9NTW7	ZF64B_HUMAN	23.3	339	234	8	186	1175	144	465	1.20E-08	62.8	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN39212_c0_g1_i1	Q9NTW7	ZF64B_HUMAN	92.2	77	6	0	240	10	390	466	3.20E-39	161.8	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN29310_c0_g1_i1	Q9NTW7	ZF64B_HUMAN	40.3	67	40	0	227	27	167	233	8.30E-11	67.4	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN28566_c0_g1_i1	Q9NTW7	ZF64B_HUMAN	100	69	0	0	210	4	168	236	1.80E-38	159.1	ZF64B_HUMAN	reviewed	Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338)	ZFP64 ZNF338	Homo sapiens (Human)	645	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]		NA	NA	NA	NA	NA	NA
TRINITY_DN31237_c0_g1_i1	Q5T619	ZN648_HUMAN	45.2	93	50	1	31	306	266	358	9.10E-17	87.8	ZN648_HUMAN	reviewed	Zinc finger protein 648	ZNF648	Homo sapiens (Human)	568	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i2	Q9BS31	ZN649_HUMAN	40	140	61	3	391	5	200	327	4.10E-21	102.4	ZN649_HUMAN	reviewed	Zinc finger protein 649	ZNF649	Homo sapiens (Human)	505	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i8	Q9BS31	ZN649_HUMAN	46.8	171	89	1	511	5	200	370	5.10E-40	165.6	ZN649_HUMAN	reviewed	Zinc finger protein 649	ZNF649	Homo sapiens (Human)	505	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i16	Q9BS31	ZN649_HUMAN	52.2	90	43	0	272	3	252	341	7.70E-21	100.9	ZN649_HUMAN	reviewed	Zinc finger protein 649	ZNF649	Homo sapiens (Human)	505	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c1_g1_i1	Q9BS31	ZN649_HUMAN	50	70	35	0	213	4	230	299	1.40E-14	79.7	ZN649_HUMAN	reviewed	Zinc finger protein 649	ZNF649	Homo sapiens (Human)	505	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular space [GO:0005615]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i29	Q5TYW1	ZN658_HUMAN	52	100	48	0	302	3	683	782	5.90E-28	124.8	ZN658_HUMAN	reviewed	Zinc finger protein 658	ZNF658	Homo sapiens (Human)	1059	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042254; GO:0045892; GO:0046872; GO:0071294	"cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i34	Q4V348	Z658B_HUMAN	47	83	44	0	249	1	666	748	1.40E-18	93.6	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i56	Q4V348	Z658B_HUMAN	45.8	83	45	0	249	1	666	748	9.20E-18	92	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i11	Q4V348	Z658B_HUMAN	33.6	321	212	1	1	960	452	772	3.10E-48	193.7	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i11	Q4V348	Z658B_HUMAN	43.1	160	91	0	2	481	285	444	8.50E-38	159.1	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i3	Q4V348	Z658B_HUMAN	34.7	349	227	1	1	1044	452	800	1.80E-57	224.6	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i3	Q4V348	Z658B_HUMAN	27.5	338	231	1	2	973	285	622	2.10E-37	157.9	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i2	Q4V348	Z658B_HUMAN	49.3	71	36	0	223	11	282	352	6.80E-15	80.9	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c16_g2_i1	Q4V348	Z658B_HUMAN	48.6	72	37	0	3	218	285	356	1.60E-15	83.2	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN8239_c6_g1_i1	Q4V348	Z658B_HUMAN	59.3	54	22	0	4	165	707	760	6.50E-13	74.7	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i7	Q4V348	Z658B_HUMAN	48.9	227	116	0	11	691	552	778	1.50E-65	250.8	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3656_c0_g2_i3	Q4V348	Z658B_HUMAN	31.2	253	157	5	12	767	525	761	1.30E-28	128.3	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN213_c0_g2_i1	Q4V348	Z658B_HUMAN	44.8	252	136	3	10	756	514	765	2.40E-64	246.9	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i14	Q4V348	Z658B_HUMAN	38.5	231	111	1	694	2	412	611	3.70E-43	176.4	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i15	Q4V348	Z658B_HUMAN	42.3	234	134	1	703	2	519	751	6.80E-54	212.2	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i14	Q4V348	Z658B_HUMAN	44.6	92	50	1	112	387	666	756	3.00E-18	92.8	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i3	Q4V348	Z658B_HUMAN	44	91	51	0	135	407	666	756	4.10E-18	92.4	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i23	Q4V348	Z658B_HUMAN	42.7	75	35	1	8	208	502	576	1.80E-13	76.6	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6447_c0_g1_i2	Q4V348	Z658B_HUMAN	44.8	310	166	4	941	18	485	791	8.50E-83	308.5	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6447_c0_g1_i8	Q4V348	Z658B_HUMAN	43.8	249	136	3	752	12	485	731	1.20E-63	244.6	Z658B_HUMAN	reviewed	Zinc finger protein 658B	ZNF658B	Homo sapiens (Human)	819	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g2_i1	Q6AZW8	ZN660_HUMAN	47.3	146	77	0	1	438	52	197	8.00E-36	151.4	ZN660_HUMAN	reviewed	Zinc finger protein 660	ZNF660	Homo sapiens (Human)	331	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3730_c0_g1_i3	Q6AZW8	ZN660_HUMAN	48.1	133	69	0	2	400	52	184	3.40E-33	142.5	ZN660_HUMAN	reviewed	Zinc finger protein 660	ZNF660	Homo sapiens (Human)	331	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c0_g2_i2	Q6AZW8	ZN660_HUMAN	52.3	107	51	0	328	8	50	156	1.00E-27	124	ZN660_HUMAN	reviewed	Zinc finger protein 660	ZNF660	Homo sapiens (Human)	331	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29122_c0_g1_i1	Q8N3J9	ZN664_HUMAN	100	79	0	0	238	2	61	139	1.00E-45	183.3	ZN664_HUMAN	reviewed	Zinc finger protein 664 (Zinc finger protein 176) (Zinc finger protein from organ of Corti)	ZNF664 ZFOC1 ZNF176	Homo sapiens (Human)	261	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4254_c0_g1_i2	Q5R8X1	ZN665_PONAB	41	144	67	1	380	3	145	288	4.50E-27	122.1	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4254_c0_g1_i7	Q5R8X1	ZN665_PONAB	41.3	143	74	1	429	1	201	333	5.10E-27	122.1	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN14352_c0_g1_i3	Q5R8X1	ZN665_PONAB	49.7	159	80	0	799	323	219	377	2.10E-42	174.1	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN12597_c0_g2_i2	Q5R8X1	ZN665_PONAB	45.5	55	30	0	171	7	275	329	1.30E-09	63.5	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN25545_c0_g1_i1	Q5R8X1	ZN665_PONAB	50.5	196	97	0	73	660	110	305	1.60E-62	240.7	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i3	Q5R8X1	ZN665_PONAB	42.5	200	93	2	32	595	170	359	1.50E-42	174.5	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN28574_c0_g1_i1	Q5R8X1	ZN665_PONAB	47.1	85	44	1	1	252	223	307	1.30E-15	83.6	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g1_i8	Q5R8X1	ZN665_PONAB	50	106	53	0	1	318	142	247	1.70E-26	120.2	ZN665_PONAB	reviewed	Zinc finger protein 665	ZNF665	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	613	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i2	Q9H7R5	ZN665_HUMAN	46.9	130	68	1	8	394	211	340	4.50E-31	135.6	ZN665_HUMAN	reviewed	Zinc finger protein 665 (Zinc finger protein 160-like)	ZNF665 ZFP160L	Homo sapiens (Human)	678	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29617_c0_g1_i1	Q9H7R5	ZN665_HUMAN	40.6	411	239	3	1393	176	178	588	4.20E-100	366.7	ZN665_HUMAN	reviewed	Zinc finger protein 665 (Zinc finger protein 160-like)	ZNF665 ZFP160L	Homo sapiens (Human)	678	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3922_c0_g1_i4	Q8K2R5	ZN668_MOUSE	37.1	116	73	0	350	3	287	402	5.50E-19	95.1	ZN668_MOUSE	reviewed	Zinc finger protein 668	Znf668 Zfp668	Mus musculus (Mouse)	619	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16562_c0_g1_i2	Q2TA17	ZN668_BOVIN	45.6	57	31	0	1	171	358	414	9.40E-09	60.5	ZN668_BOVIN	reviewed	Zinc finger protein 668	ZNF668	Bos taurus (Bovine)	619	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13056_c0_g1_i9	Q96K58	ZN668_HUMAN	38.9	54	33	0	160	321	541	594	1.10E-05	50.8	ZN668_HUMAN	reviewed	Zinc finger protein 668	ZNF668	Homo sapiens (Human)	619	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c1_g1_i1	Q2TA17	ZN668_BOVIN	45	80	37	2	9	227	304	383	8.10E-11	67.4	ZN668_BOVIN	reviewed	Zinc finger protein 668	ZNF668	Bos taurus (Bovine)	619	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i7	Q2TA17	ZN668_BOVIN	46	63	34	0	246	58	298	360	1.10E-11	70.5	ZN668_BOVIN	reviewed	Zinc finger protein 668	ZNF668	Bos taurus (Bovine)	619	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31725_c0_g1_i1	Q2TA17	ZN668_BOVIN	36	75	48	0	6	230	252	326	2.50E-10	67	ZN668_BOVIN	reviewed	Zinc finger protein 668	ZNF668	Bos taurus (Bovine)	619	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32543_c0_g1_i1	Q9BS34	ZN670_HUMAN	100	96	0	0	288	1	280	375	3.00E-55	215.3	ZN670_HUMAN	reviewed	Zinc finger protein 670	ZNF670	Homo sapiens (Human)	389	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c2_g1_i1	Q9BS34	ZN670_HUMAN	40	150	90	0	2	451	206	355	2.40E-27	123.2	ZN670_HUMAN	reviewed	Zinc finger protein 670	ZNF670	Homo sapiens (Human)	389	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i3	Q8TD23	ZN675_HUMAN	55.8	104	36	1	74	355	252	355	7.00E-30	131.3	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"		yellow	yellow	1	NA	NA	NA
TRINITY_DN38935_c0_g1_i1	Q8TD23	ZN675_HUMAN	42.9	338	190	3	1783	773	230	565	3.10E-89	330.9	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35528_c0_g1_i1	Q8TD23	ZN675_HUMAN	47.9	303	144	3	1134	2003	254	555	6.70E-84	313.5	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i1	Q8TD23	ZN675_HUMAN	62.1	58	20	1	3	170	306	363	2.00E-15	82.8	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i1	Q8TD23	ZN675_HUMAN	63.6	33	12	0	148	246	269	301	4.80E-06	51.6	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i6	Q8TD23	ZN675_HUMAN	62.1	66	25	0	43	240	252	317	6.80E-21	100.9	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	"bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5698_c0_g1_i12	Q8N7Q3	ZN676_HUMAN	54.1	85	39	0	3	257	499	583	2.00E-22	106.3	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i42	Q8N7Q3	ZN676_HUMAN	52.5	101	46	1	307	5	474	572	3.20E-26	119	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i11	Q8N7Q3	ZN676_HUMAN	44.8	87	48	0	277	17	497	583	7.30E-19	94.4	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i1	Q8N7Q3	ZN676_HUMAN	47.8	92	48	0	6	281	492	583	2.50E-21	102.8	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i7	Q8N7Q3	ZN676_HUMAN	52	50	24	0	2	151	534	583	5.70E-11	67.8	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14352_c0_g1_i2	Q8N7Q3	ZN676_HUMAN	49	145	71	1	488	63	443	587	3.40E-35	149.4	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14352_c0_g1_i5	Q8N7Q3	ZN676_HUMAN	50	130	65	0	715	326	443	572	2.10E-33	144.1	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c1_g1_i1	Q8N7Q3	ZN676_HUMAN	43.4	76	43	0	232	5	497	572	1.70E-13	76.3	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c1_g1_i8	Q8N7Q3	ZN676_HUMAN	43	79	45	0	241	5	494	572	2.60E-15	83.2	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i5	Q8N7Q3	ZN676_HUMAN	42.3	97	56	0	313	23	490	586	1.10E-18	94	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1978_c0_g1_i1	Q8N7Q3	ZN676_HUMAN	48.7	76	39	0	3	230	495	570	4.70E-18	91.7	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c1_g1_i5	Q8N7Q3	ZN676_HUMAN	46.9	96	49	1	54	341	490	583	4.20E-20	99.4	ZN676_HUMAN	reviewed	Zinc finger protein 676	ZNF676	Homo sapiens (Human)	588	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i2	Q5SXM1	ZN678_HUMAN	53.4	73	34	0	90	308	351	423	5.00E-14	79	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i3	Q5SXM1	ZN678_HUMAN	51.4	105	51	0	162	476	351	455	2.30E-26	120.2	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i6	Q5SXM1	ZN678_HUMAN	50.3	159	75	1	5	469	297	455	9.50E-41	167.9	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c3_g1_i2	Q5SXM1	ZN678_HUMAN	46.7	105	56	0	26	340	297	401	2.10E-23	109.8	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38935_c0_g1_i2	Q5SXM1	ZN678_HUMAN	47.2	271	139	3	1564	752	201	467	6.50E-75	283.1	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26545_c0_g1_i1	Q5SXM1	ZN678_HUMAN	47.3	319	167	1	3	959	185	502	2.00E-90	334	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i4	Q5SXM1	ZN678_HUMAN	46.9	179	77	2	229	711	96	274	8.70E-40	165.2	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i4	Q5SXM1	ZN678_HUMAN	52.1	71	33	1	18	230	112	181	2.00E-12	74.3	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c1_g1_i1	Q5SXM1	ZN678_HUMAN	54.4	68	29	1	205	2	338	403	4.00E-14	78.2	ZN678_HUMAN	reviewed	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	525	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c3_g1_i1	Q8IYX0	ZN679_HUMAN	52.8	193	90	1	730	152	208	399	1.50E-59	231.5	ZN679_HUMAN	reviewed	Zinc finger protein 679	ZNF679	Homo sapiens (Human)	411	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7498_c0_g1_i1	Q8IYX0	ZN679_HUMAN	52	202	97	0	70	675	203	404	2.80E-64	246.5	ZN679_HUMAN	reviewed	Zinc finger protein 679	ZNF679	Homo sapiens (Human)	411	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		blue	blue	NA	NA	NA	NA
TRINITY_DN18445_c3_g1_i1	Q8IYX0	ZN679_HUMAN	55.4	56	25	0	170	3	237	292	1.70E-14	79.7	ZN679_HUMAN	reviewed	Zinc finger protein 679	ZNF679	Homo sapiens (Human)	411	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i6	Q96N22	ZN681_HUMAN	46.6	73	39	0	221	3	485	557	2.10E-13	75.9	ZN681_HUMAN	reviewed	Zinc finger protein 681	ZNF681	Homo sapiens (Human)	645	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11584_c0_g1_i1	Q96N22	ZN681_HUMAN	39.8	274	158	3	72	872	366	639	1.10E-55	218.4	ZN681_HUMAN	reviewed	Zinc finger protein 681	ZNF681	Homo sapiens (Human)	645	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18445_c1_g1_i2	Q96N22	ZN681_HUMAN	56.6	76	33	0	38	265	306	381	1.40E-22	106.7	ZN681_HUMAN	reviewed	Zinc finger protein 681	ZNF681	Homo sapiens (Human)	645	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g1_i5	Q5T5D7	ZN684_HUMAN	49.2	63	32	0	191	3	315	377	1.70E-12	73.6	ZN684_HUMAN	reviewed	Zinc finger protein 684	ZNF684	Homo sapiens (Human)	378	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i31	Q8BKK5	ZN689_MOUSE	32.1	109	72	1	430	104	291	397	8.50E-14	78.2	ZN689_MOUSE	reviewed	Zinc finger protein 689	Znf689 Zfp689	Mus musculus (Mouse)	500	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035914; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i15	Q96CS4	ZN689_HUMAN	43.1	130	64	1	18	377	249	378	6.50E-29	128.3	ZN689_HUMAN	reviewed	Zinc finger protein 689	ZNF689	Homo sapiens (Human)	500	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035914; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN29458_c0_g1_i1	Q96CS4	ZN689_HUMAN	100	107	0	0	324	4	325	431	1.50E-60	233	ZN689_HUMAN	reviewed	Zinc finger protein 689	ZNF689	Homo sapiens (Human)	500	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035914; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i6	A2A761	ZFP69_MOUSE	50.4	113	48	2	65	379	322	434	1.10E-25	117.5	ZFP69_MOUSE	reviewed	Zinc finger protein 69 (Zinc finger protein 642)	Zfp69 Znf642	Mus musculus (Mouse)	587	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g2_i1	Q49AA0	ZFP69_HUMAN	47.5	61	32	0	6	188	321	381	1.00E-07	57	ZFP69_HUMAN	reviewed	Zinc finger protein 69 homolog (Zinc finger protein 642)	ZFP69 ZNF642	Homo sapiens (Human)	526	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g2_i1	Q49AA0	ZFP69_HUMAN	42.3	52	29	1	34	186	302	353	5.20E-04	44.7	ZFP69_HUMAN	reviewed	Zinc finger protein 69 homolog (Zinc finger protein 642)	ZFP69 ZNF642	Homo sapiens (Human)	526	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10573_c2_g1_i1	Q49AA0	ZFP69_HUMAN	50	64	32	0	206	15	289	352	1.00E-12	73.6	ZFP69_HUMAN	reviewed	Zinc finger protein 69 homolog (Zinc finger protein 642)	ZFP69 ZNF642	Homo sapiens (Human)	526	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10579_c0_g1_i1	Q49AA0	ZFP69_HUMAN	47.3	55	29	0	246	82	323	377	7.20E-10	64.3	ZFP69_HUMAN	reviewed	Zinc finger protein 69 homolog (Zinc finger protein 642)	ZFP69 ZNF642	Homo sapiens (Human)	526	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9461_c1_g1_i1	Q9UJL9	ZF69B_HUMAN	46.5	101	51	1	305	3	427	524	2.40E-23	109.4	ZF69B_HUMAN	reviewed	Zinc finger protein 69 homolog B (Zinc finger protein 643)	ZFP69B ZNF643	Homo sapiens (Human)	534	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0046872	Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i5	Q9UJL9	ZF69B_HUMAN	53.5	71	33	0	5	217	411	481	8.40E-18	90.5	ZF69B_HUMAN	reviewed	Zinc finger protein 69 homolog B (Zinc finger protein 643)	ZFP69B ZNF643	Homo sapiens (Human)	534	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0046872	Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28868_c0_g1_i1	Q9H7X3	ZN696_HUMAN	84.2	76	12	0	229	2	236	311	2.70E-35	148.7	ZN696_HUMAN	reviewed	Zinc finger protein 696	ZNF696	Homo sapiens (Human)	374	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i5	Q32M78	ZN699_HUMAN	51.8	114	55	0	9	350	413	526	1.10E-27	124	ZN699_HUMAN	reviewed	Zinc finger protein 699 (Hangover homolog)	ZNF699	Homo sapiens (Human)	642	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12597_c0_g1_i1	Q32M78	ZN699_HUMAN	47.2	89	46	1	272	9	469	557	2.10E-15	83.2	ZN699_HUMAN	reviewed	Zinc finger protein 699 (Hangover homolog)	ZNF699	Homo sapiens (Human)	642	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6204_c0_g2_i2	Q32M78	ZN699_HUMAN	48.7	113	58	0	12	350	301	413	2.30E-26	119.8	ZN699_HUMAN	reviewed	Zinc finger protein 699 (Hangover homolog)	ZNF699	Homo sapiens (Human)	642	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i12	Q9UC06	ZNF70_HUMAN	64.9	57	20	0	173	343	147	203	3.30E-16	85.9	ZNF70_HUMAN	reviewed	Zinc finger protein 70 (Zinc finger protein N27C7-1)	ZNF70	Homo sapiens (Human)	446	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8943_c0_g2_i1	Q9UC06	ZNF70_HUMAN	54.8	73	33	0	1	219	142	214	6.00E-19	94.4	ZNF70_HUMAN	reviewed	Zinc finger protein 70 (Zinc finger protein N27C7-1)	ZNF70	Homo sapiens (Human)	446	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g1_i6	Q9NV72	ZN701_HUMAN	44.9	118	65	0	457	104	342	459	3.00E-25	116.3	ZN701_HUMAN	reviewed	Zinc finger protein 701	ZNF701	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i11	Q9NV72	ZN701_HUMAN	37.6	149	86	1	55	480	374	522	8.50E-23	108.2	ZN701_HUMAN	reviewed	Zinc finger protein 701	ZNF701	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g2_i2	P17019	ZN708_HUMAN	51.8	139	67	0	426	10	124	262	2.00E-39	163.3	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g2_i4	P17019	ZN708_HUMAN	48.8	242	124	0	735	10	105	346	1.30E-67	257.7	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g2_i7	P17019	ZN708_HUMAN	49.7	157	79	0	480	10	106	262	1.50E-43	177.2	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g1_i2	P17019	ZN708_HUMAN	52.7	112	53	0	2	337	254	365	6.20E-28	124.8	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8255_c0_g1_i3	P17019	ZN708_HUMAN	46.1	206	96	2	3	575	113	318	4.90E-49	195.7	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8556_c0_g1_i1	P17019	ZN708_HUMAN	52	75	36	0	3	227	164	238	1.00E-18	93.6	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6700_c0_g1_i13	P17019	ZN708_HUMAN	48.4	246	127	0	1	738	133	378	1.10E-66	254.6	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i18	P17019	ZN708_HUMAN	35.8	288	161	8	449	1303	98	364	3.80E-49	197.2	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6587_c0_g1_i2	P17019	ZN708_HUMAN	44.2	113	63	0	355	17	154	266	5.80E-24	111.7	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19122_c0_g1_i1	P17019	ZN708_HUMAN	40.6	133	78	1	2	397	134	266	1.40E-26	120.6	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c0_g1_i12	P17019	ZN708_HUMAN	48.2	85	44	0	296	42	154	238	3.00E-21	102.4	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c0_g1_i1	P17019	ZN708_HUMAN	51.9	104	50	0	2	313	128	231	2.60E-28	125.9	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c0_g1_i3	P17019	ZN708_HUMAN	52.2	113	54	0	6	344	119	231	3.20E-32	139	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c0_g1_i5	P17019	ZN708_HUMAN	52.1	96	46	0	1	288	136	231	1.90E-25	116.3	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g3_i1	P17019	ZN708_HUMAN	56.3	126	55	0	4	381	126	251	1.80E-39	163.3	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i14	P17019	ZN708_HUMAN	52	75	36	0	229	5	218	292	2.10E-16	87	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g1_i5	P17019	ZN708_HUMAN	47.7	220	114	1	6	662	160	379	1.20E-59	231.1	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c1_g1_i1	P17019	ZN708_HUMAN	57.8	102	43	0	2	307	161	262	8.60E-32	137.5	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c3_g2_i1	P17019	ZN708_HUMAN	52.3	65	31	0	6	200	218	282	3.20E-14	78.6	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i23	P17019	ZN708_HUMAN	51.5	103	50	0	312	4	165	267	1.00E-25	117.5	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9347_c0_g1_i12	P17019	ZN708_HUMAN	61.1	175	68	0	1	525	150	324	5.40E-63	241.9	ZN708_HUMAN	reviewed	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	499	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g1_i1	Q8N1W2	ZN710_HUMAN	38.3	60	37	0	30	209	478	537	8.70E-09	60.8	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40693_c0_g1_i1	Q8N1W2	ZN710_HUMAN	50	50	25	0	181	32	549	598	4.80E-10	64.7	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN39019_c0_g1_i1	Q8N1W2	ZN710_HUMAN	43.8	64	33	1	18	209	540	600	8.50E-10	63.9	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c3_g2_i1	Q8N1W2	ZN710_HUMAN	43.1	65	37	0	211	17	477	541	1.40E-12	73.2	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2497_c0_g1_i4	Q8N1W2	ZN710_HUMAN	44	50	28	0	94	243	549	598	3.50E-08	58.9	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7323_c0_g1_i1	Q8N1W2	ZN710_HUMAN	46.8	47	25	0	390	250	467	513	2.40E-07	56.6	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7323_c0_g1_i2	Q8N1W2	ZN710_HUMAN	46.8	47	25	0	377	237	467	513	2.30E-07	56.6	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7323_c0_g1_i4	Q8N1W2	ZN710_HUMAN	46.8	47	25	0	414	274	467	513	2.50E-07	56.6	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7323_c0_g1_i5	Q8N1W2	ZN710_HUMAN	46.8	47	25	0	355	215	467	513	2.20E-07	56.6	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31788_c0_g1_i1	Q8N1W2	ZN710_HUMAN	41.5	53	28	1	215	57	549	598	8.60E-07	54.3	ZN710_HUMAN	reviewed	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	664	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37929_c0_g1_i1	A2ANX9	ZN711_MOUSE	48.9	47	24	0	192	52	511	557	2.80E-07	56.2	ZN711_MOUSE	reviewed	Zinc finger protein 711	Znf711 Zfp711	Mus musculus (Mouse)	761	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27177_c0_g1_i1	A2ANX9	ZN711_MOUSE	41.6	77	38	2	274	44	507	576	3.50E-10	65.9	ZN711_MOUSE	reviewed	Zinc finger protein 711	Znf711 Zfp711	Mus musculus (Mouse)	761	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26425_c0_g1_i1	A2ANX9	ZN711_MOUSE	50.9	53	26	0	5	163	510	562	1.00E-09	63.5	ZN711_MOUSE	reviewed	Zinc finger protein 711	Znf711 Zfp711	Mus musculus (Mouse)	761	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i4	A2ANX9	ZN711_MOUSE	48.1	52	27	0	640	795	505	556	9.10E-10	65.9	ZN711_MOUSE	reviewed	Zinc finger protein 711	Znf711 Zfp711	Mus musculus (Mouse)	761	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31773_c0_g1_i1	A2ANX9	ZN711_MOUSE	41.1	107	57	2	10	330	461	561	4.70E-12	72	ZN711_MOUSE	reviewed	Zinc finger protein 711	Znf711 Zfp711	Mus musculus (Mouse)	761	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000790; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0043565; GO:0045893; GO:0046872	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g3_i3	A7Y7X5	ZN711_DANRE	48	50	26	0	46	195	507	556	1.00E-09	63.5	ZN711_DANRE	reviewed	Zinc finger protein 711 (Vitelline envelope protein)	znf711 zvep	Danio rerio (Zebrafish) (Brachydanio rerio)	761	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045893; GO:0046872; GO:0060388	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10921_c0_g1_i1	A7Y7X5	ZN711_DANRE	36.5	85	25	2	231	64	472	556	8.80E-09	61.6	ZN711_DANRE	reviewed	Zinc finger protein 711 (Vitelline envelope protein)	znf711 zvep	Danio rerio (Zebrafish) (Brachydanio rerio)	761	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; vitelline envelope [GO:0060388]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045893; GO:0046872; GO:0060388	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18536_c0_g1_i1	Q8N859	ZN713_HUMAN	36.2	149	88	2	303	749	273	414	9.30E-24	113.2	ZN713_HUMAN	reviewed	Zinc finger protein 713	ZNF713	Homo sapiens (Human)	430	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i8	Q96N38	ZN714_HUMAN	51.8	139	67	0	666	250	344	482	2.40E-39	163.7	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i8	Q96N38	ZN714_HUMAN	53.1	81	38	0	245	3	345	425	1.90E-20	100.9	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c57_g1_i1	Q96N38	ZN714_HUMAN	55.4	65	25	1	25	207	434	498	2.20E-15	82.4	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i1	Q96N38	ZN714_HUMAN	47.3	91	41	1	275	3	191	274	2.60E-19	95.9	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c1_g1_i2	Q96N38	ZN714_HUMAN	54.6	97	34	1	2	292	356	442	2.60E-25	115.9	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c1_g1_i5	Q96N38	ZN714_HUMAN	61.5	117	45	0	2	352	356	472	2.00E-40	166.4	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3605_c0_g4_i1	Q96N38	ZN714_HUMAN	50.6	79	39	0	1	237	397	475	2.40E-18	92.4	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2762_c0_g1_i4	Q96N38	ZN714_HUMAN	43.4	129	66	1	388	2	242	363	1.60E-24	113.6	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c3_g3_i1	Q96N38	ZN714_HUMAN	51.6	95	46	0	2	286	388	482	1.10E-25	117.1	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c3_g3_i2	Q96N38	ZN714_HUMAN	50.7	136	66	1	1	405	347	482	3.60E-38	159.1	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10266_c0_g1_i1	Q96N38	ZN714_HUMAN	45.3	137	75	0	12	422	340	476	1.40E-37	157.1	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i1	Q96N38	ZN714_HUMAN	55.7	97	43	0	123	413	391	487	1.20E-28	127.5	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i11	Q96N38	ZN714_HUMAN	57.5	87	35	1	89	349	403	487	3.00E-25	115.9	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i13	Q96N38	ZN714_HUMAN	54.7	106	48	0	123	440	391	496	3.00E-30	133.3	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i13	Q96N38	ZN714_HUMAN	57.9	57	24	0	416	586	431	487	1.40E-14	81.3	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1200_c1_g1_i8	Q96N38	ZN714_HUMAN	57.5	87	35	1	108	368	403	487	3.10E-25	115.9	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c2_g1_i1	Q96N38	ZN714_HUMAN	47.5	99	52	0	3	299	400	498	6.30E-24	111.3	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i2	Q96N38	ZN714_HUMAN	51.5	171	83	0	515	3	316	486	2.50E-52	206.5	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c1_g1_i2	Q96N38	ZN714_HUMAN	58.3	84	35	0	256	5	357	440	1.40E-24	113.2	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c0_g2_i1	Q96N38	ZN714_HUMAN	54.9	91	41	0	274	2	388	478	1.90E-27	122.9	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c0_g2_i2	Q96N38	ZN714_HUMAN	52.1	119	57	0	358	2	360	478	3.90E-36	152.1	ZN714_HUMAN	reviewed	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	554	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g1_i21	A6NP11	ZN716_HUMAN	53.1	162	76	0	488	3	294	455	2.40E-48	193.4	ZN716_HUMAN	reviewed	Zinc finger protein 716	ZNF716	Homo sapiens (Human)	495	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i12	A6NP11	ZN716_HUMAN	44.3	79	44	0	237	1	292	370	3.10E-15	82.4	ZN716_HUMAN	reviewed	Zinc finger protein 716	ZNF716	Homo sapiens (Human)	495	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5650_c0_g2_i5	Q9BY31	ZN717_HUMAN	57	151	65	0	55	507	731	881	1.70E-45	183.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i22	Q9BY31	ZN717_HUMAN	56.2	80	35	0	344	105	804	883	2.90E-20	99.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i26	Q9BY31	ZN717_HUMAN	58.6	70	29	0	210	1	748	817	2.90E-18	92	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN5_c10_g1_i1	Q9BY31	ZN717_HUMAN	47.1	70	37	0	96	305	494	563	2.80E-11	69.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8718_c0_g1_i10	Q9BY31	ZN717_HUMAN	47.6	105	55	0	2	316	472	576	4.70E-23	108.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i13	Q9BY31	ZN717_HUMAN	46.4	125	67	0	376	2	512	636	2.30E-26	119.8	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i17	Q9BY31	ZN717_HUMAN	47.8	67	35	0	201	1	494	560	1.60E-12	73.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i1	Q9BY31	ZN717_HUMAN	58	81	34	0	247	5	560	640	5.40E-21	101.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g2_i1	Q9BY31	ZN717_HUMAN	56.3	71	31	0	291	79	568	638	1.10E-17	90.5	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c8_g1_i2	Q9BY31	ZN717_HUMAN	49.4	85	43	0	256	2	386	470	3.40E-18	92	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i8	Q9BY31	ZN717_HUMAN	38.5	109	52	2	410	90	718	813	2.30E-12	73.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i2	Q9BY31	ZN717_HUMAN	48.8	125	64	0	27	401	704	828	3.80E-25	115.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c1_g1_i1	Q9BY31	ZN717_HUMAN	63.6	99	36	0	8	304	760	858	4.60E-30	131.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c1_g1_i2	Q9BY31	ZN717_HUMAN	58.1	148	62	0	5	448	731	878	1.30E-44	180.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g2_i2	Q9BY31	ZN717_HUMAN	54.4	149	66	1	3	449	361	507	3.90E-42	172.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15594_c0_g1_i1	Q9BY31	ZN717_HUMAN	37.8	90	53	1	174	443	468	554	2.20E-09	63.5	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i1	Q9BY31	ZN717_HUMAN	59.1	93	38	0	1	279	738	830	1.60E-26	120.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i1	Q9BY31	ZN717_HUMAN	48.9	88	44	1	218	478	478	565	1.20E-16	87.8	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i4	Q9BY31	ZN717_HUMAN	56.1	132	58	0	1	396	738	869	1.70E-37	156.8	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i5	Q9BY31	ZN717_HUMAN	58	150	63	0	1	450	738	887	1.10E-46	187.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c1_g1_i1	Q9BY31	ZN717_HUMAN	53.8	80	27	1	2	241	432	501	1.10E-15	83.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c1_g1_i3	Q9BY31	ZN717_HUMAN	62.2	98	37	0	2	295	404	501	3.40E-30	132.1	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c1_g1_i1	Q9BY31	ZN717_HUMAN	55.2	58	26	0	220	47	829	886	1.50E-14	79.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15029_c0_g1_i2	Q9BY31	ZN717_HUMAN	41.3	138	59	2	1	387	745	869	1.10E-20	100.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14253_c0_g1_i1	Q9BY31	ZN717_HUMAN	50	52	26	0	44	199	557	608	1.10E-08	60.1	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c0_g1_i18	Q9BY31	ZN717_HUMAN	43.5	92	51	1	1	276	350	440	9.20E-14	77.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i3	Q9BY31	ZN717_HUMAN	52.3	88	42	0	268	5	465	552	1.70E-21	103.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i4	Q9BY31	ZN717_HUMAN	53.3	60	26	1	178	5	493	552	1.80E-11	70.5	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12648_c0_g1_i4	Q9BY31	ZN717_HUMAN	46.2	80	40	2	407	174	326	404	8.30E-09	61.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c3_g1_i1	Q9BY31	ZN717_HUMAN	39.1	69	41	1	206	3	540	608	8.60E-07	53.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i11	Q9BY31	ZN717_HUMAN	50	78	31	1	2	211	558	635	6.50E-14	78.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11808_c2_g1_i1	Q9BY31	ZN717_HUMAN	50	98	48	1	292	2	744	841	2.30E-21	103.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10043_c0_g2_i1	Q9BY31	ZN717_HUMAN	54.4	147	67	0	442	2	490	636	1.00E-41	171	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5209_c0_g2_i1	Q9BY31	ZN717_HUMAN	45.8	48	26	0	198	341	494	541	1.20E-07	57.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g1_i2	Q9BY31	ZN717_HUMAN	54.3	164	71	1	481	2	496	659	2.80E-42	172.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g1_i4	Q9BY31	ZN717_HUMAN	56.5	115	50	0	351	7	356	470	1.30E-31	137.1	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14556_c0_g1_i1	Q9BY31	ZN717_HUMAN	53.3	105	49	0	1	315	446	550	8.90E-29	127.5	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13767_c1_g1_i3	Q9BY31	ZN717_HUMAN	48.4	128	66	0	2	385	395	522	8.90E-31	134.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19208_c0_g1_i1	Q9BY31	ZN717_HUMAN	59.4	69	28	0	211	5	336	404	2.40E-17	89	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c0_g1_i1	Q9BY31	ZN717_HUMAN	54.5	77	35	0	3	233	448	524	7.90E-19	94.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g1_i8	Q9BY31	ZN717_HUMAN	54.7	190	86	0	9	578	316	505	1.90E-53	210.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g2_i4	Q9BY31	ZN717_HUMAN	50.8	193	95	0	587	9	354	546	4.60E-50	199.1	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g2_i5	Q9BY31	ZN717_HUMAN	47.8	224	117	0	674	3	354	577	3.90E-53	209.5	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3355_c0_g1_i7	Q9BY31	ZN717_HUMAN	51.1	176	83	2	3	527	350	523	8.10E-43	174.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i5	Q9BY31	ZN717_HUMAN	43.8	96	54	0	124	411	540	635	9.20E-18	91.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i10	Q9BY31	ZN717_HUMAN	51.4	70	34	0	135	344	412	481	4.30E-16	85.5	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i11	Q9BY31	ZN717_HUMAN	52.9	70	33	0	114	323	412	481	1.80E-16	86.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i13	Q9BY31	ZN717_HUMAN	44.9	89	44	1	2	268	559	642	5.70E-16	84.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i8	Q9BY31	ZN717_HUMAN	48.4	91	47	0	114	386	552	642	2.50E-20	99.8	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g2_i3	Q9BY31	ZN717_HUMAN	53.1	98	46	0	187	480	354	451	1.00E-23	111.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29414_c0_g1_i1	Q9BY31	ZN717_HUMAN	43.1	51	29	0	47	199	528	578	4.80E-07	54.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i6	Q9BY31	ZN717_HUMAN	49.4	89	45	0	331	65	794	882	6.10E-20	98.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c1_g1_i1	Q9BY31	ZN717_HUMAN	47.8	115	60	0	347	3	494	608	1.80E-25	116.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i4	Q9BY31	ZN717_HUMAN	47.3	91	48	0	460	188	494	584	3.30E-19	96.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1063_c0_g1_i9	Q9BY31	ZN717_HUMAN	47.3	91	48	0	380	108	494	584	2.70E-19	96.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i1	Q9BY31	ZN717_HUMAN	59.6	114	46	0	347	6	465	578	7.00E-35	147.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN15305_c0_g1_i1	Q9BY31	ZN717_HUMAN	46.6	174	88	1	525	4	690	858	3.40E-37	156.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15305_c0_g1_i1	Q9BY31	ZN717_HUMAN	53.8	78	36	0	589	356	532	609	1.60E-18	94.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i12	Q9BY31	ZN717_HUMAN	44.5	200	80	3	536	6	444	635	1.60E-38	160.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c0_g1_i7	Q9BY31	ZN717_HUMAN	54.1	85	39	0	261	7	425	509	2.40E-19	95.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i12	Q9BY31	ZN717_HUMAN	56	84	37	0	3	254	426	509	3.80E-20	98.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i3	Q9BY31	ZN717_HUMAN	42	169	86	3	22	507	400	563	9.90E-30	131.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i9	Q9BY31	ZN717_HUMAN	52.9	70	33	0	3	212	426	495	3.70E-14	78.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i4	Q9BY31	ZN717_HUMAN	60.6	94	37	0	2	283	764	857	1.10E-27	123.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i13	Q9BY31	ZN717_HUMAN	39	154	67	3	6	467	752	878	7.90E-21	101.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i11	Q9BY31	ZN717_HUMAN	50	114	57	0	421	80	426	539	2.30E-27	123.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i7	Q9BY31	ZN717_HUMAN	46.8	141	68	1	502	80	406	539	1.10E-31	137.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i8	Q9BY31	ZN717_HUMAN	46.8	158	77	1	675	202	406	556	3.40E-36	153.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i5	Q9BY31	ZN717_HUMAN	47.6	307	136	6	960	43	336	618	1.90E-66	254.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2211_c1_g1_i2	Q9BY31	ZN717_HUMAN	59	83	34	0	311	63	776	858	8.10E-22	104.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i11	Q9BY31	ZN717_HUMAN	54.9	91	41	0	279	551	422	512	2.20E-22	107.1	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i5	Q9BY31	ZN717_HUMAN	53.3	105	49	0	5	319	448	552	1.70E-27	123.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i20	Q9BY31	ZN717_HUMAN	48.5	171	78	1	71	583	478	638	8.60E-41	168.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i20	Q9BY31	ZN717_HUMAN	55.6	36	16	0	1	108	455	490	8.40E-04	45.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i21	Q9BY31	ZN717_HUMAN	51.9	133	61	1	402	4	501	630	4.90E-33	142.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i3	Q9BY31	ZN717_HUMAN	39.1	156	91	2	489	34	494	649	4.10E-22	106.7	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18286_c0_g1_i7	Q9BY31	ZN717_HUMAN	52.3	107	51	0	480	160	444	550	6.10E-29	128.6	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c0_g1_i1	Q9BY31	ZN717_HUMAN	44.8	58	32	0	63	236	494	551	3.10E-08	58.9	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17447_c0_g1_i1	Q9BY31	ZN717_HUMAN	60	75	30	0	6	230	748	822	1.70E-21	102.8	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6272_c0_g1_i1	Q9BY31	ZN717_HUMAN	45.5	343	173	1	1078	50	306	634	7.50E-102	372.1	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i13	Q9BY31	ZN717_HUMAN	46.7	92	49	0	280	5	412	503	1.00E-20	101.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i18	Q9BY31	ZN717_HUMAN	47.8	90	47	0	270	1	412	501	2.50E-18	93.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i4	Q9BY31	ZN717_HUMAN	47.2	89	47	0	270	4	412	500	4.30E-18	92.4	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i5	Q9BY31	ZN717_HUMAN	47.8	90	47	0	270	1	412	501	2.50E-18	93.2	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i6	Q9BY31	ZN717_HUMAN	46.7	92	49	0	280	5	412	503	9.50E-21	101.3	ZN717_HUMAN	reviewed	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	904	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5262_c0_g1_i1	Q8TF20	ZN721_HUMAN	38.3	193	117	2	689	114	211	402	1.00E-34	149.8	ZN721_HUMAN	reviewed	Zinc finger protein 721	ZNF721 KIAA1982	Homo sapiens (Human)	911	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5262_c0_g1_i2	Q8TF20	ZN721_HUMAN	38.3	193	117	2	689	114	211	402	5.60E-35	149.4	ZN721_HUMAN	reviewed	Zinc finger protein 721	ZNF721 KIAA1982	Homo sapiens (Human)	911	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c1_g1_i2	Q8TF20	ZN721_HUMAN	63.2	106	11	1	239	6	113	218	4.50E-33	141.4	ZN721_HUMAN	reviewed	Zinc finger protein 721	ZNF721 KIAA1982	Homo sapiens (Human)	911	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c1_g1_i3	Q8TF20	ZN721_HUMAN	78.3	138	30	0	419	6	585	722	1.60E-62	240	ZN721_HUMAN	reviewed	Zinc finger protein 721	ZNF721 KIAA1982	Homo sapiens (Human)	911	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c4_g3_i1	P0DPD5	ZN723_HUMAN	50	66	33	0	6	203	326	391	1.70E-14	79.7	ZN723_HUMAN	reviewed	Zinc finger protein 723	ZNF723	Homo sapiens (Human)	513	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6713_c0_g1_i1	P0DPD5	ZN723_HUMAN	43.8	137	77	0	11	421	242	378	5.70E-31	135.2	ZN723_HUMAN	reviewed	Zinc finger protein 723	ZNF723	Homo sapiens (Human)	513	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3004_c0_g1_i3	P0DPD5	ZN723_HUMAN	55.8	95	42	0	2	286	326	420	1.20E-27	123.6	ZN723_HUMAN	reviewed	Zinc finger protein 723	ZNF723	Homo sapiens (Human)	513	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c1_g1_i1	A8MTY0	ZN724_HUMAN	45.7	129	70	0	399	13	316	444	5.10E-29	128.6	ZN724_HUMAN	reviewed	Zinc finger protein 724	ZNF724 ZNF724P	Homo sapiens (Human)	619	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8114_c0_g1_i1	A8MTY0	ZN724_HUMAN	52.6	194	92	0	1030	449	305	498	1.40E-60	235.3	ZN724_HUMAN	reviewed	Zinc finger protein 724	ZNF724 ZNF724P	Homo sapiens (Human)	619	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i12	A8MTY0	ZN724_HUMAN	49.3	140	71	0	422	3	416	555	5.60E-36	152.1	ZN724_HUMAN	reviewed	Zinc finger protein 724	ZNF724 ZNF724P	Homo sapiens (Human)	619	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2124_c0_g1_i5	A8MTY0	ZN724_HUMAN	50.4	115	57	0	371	27	360	474	1.70E-28	127.1	ZN724_HUMAN	reviewed	Zinc finger protein 724	ZNF724 ZNF724P	Homo sapiens (Human)	619	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN31269_c0_g1_i1	A8MTY0	ZN724_HUMAN	42.9	191	107	2	3	569	331	521	1.50E-47	190.7	ZN724_HUMAN	reviewed	Zinc finger protein 724	ZNF724 ZNF724P	Homo sapiens (Human)	619	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9655_c4_g1_i1	A6NNF4	ZN726_HUMAN	35.7	171	107	3	623	114	311	479	4.50E-33	143.3	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g4_i1	A6NNF4	ZN726_HUMAN	53	66	31	0	241	44	550	615	2.30E-16	85.9	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i2	A6NNF4	ZN726_HUMAN	46	137	64	1	414	4	469	595	7.10E-34	144.8	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16240_c0_g1_i4	A6NNF4	ZN726_HUMAN	43	128	63	2	354	1	441	568	2.00E-24	113.2	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN264_c0_g2_i3	A6NNF4	ZN726_HUMAN	51.8	191	90	2	578	12	425	615	2.30E-54	213.4	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i57	A6NNF4	ZN726_HUMAN	33.3	472	267	12	397	1752	183	626	1.90E-71	272.7	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN25653_c0_g1_i1	A6NNF4	ZN726_HUMAN	43.1	202	115	0	7	612	382	583	1.10E-49	198	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33906_c0_g1_i1	A6NNF4	ZN726_HUMAN	70.4	71	21	0	3	215	361	431	3.30E-27	121.7	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i18	A6NNF4	ZN726_HUMAN	47.1	140	73	1	133	552	477	615	2.20E-37	157.1	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i18	A6NNF4	ZN726_HUMAN	55.3	38	17	0	533	646	554	591	7.50E-06	52.4	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN772_c0_g2_i5	A6NNF4	ZN726_HUMAN	50.6	81	40	0	1	243	477	557	2.20E-22	105.9	ZN726_HUMAN	reviewed	Zinc finger protein 726	ZNF726	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c14_g3_i1	P0DKX0	ZN728_HUMAN	46.5	228	120	2	684	7	344	571	1.30E-56	221.1	ZN728_HUMAN	reviewed	Zinc finger protein 728	ZNF728	Homo sapiens (Human)	622	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g1_i1	P0DKX0	ZN728_HUMAN	47.6	170	89	0	11	520	241	410	1.00E-40	167.9	ZN728_HUMAN	reviewed	Zinc finger protein 728	ZNF728	Homo sapiens (Human)	622	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g1_i3	P0DKX0	ZN728_HUMAN	56.6	53	23	0	126	284	390	442	6.00E-11	68.2	ZN728_HUMAN	reviewed	Zinc finger protein 728	ZNF728	Homo sapiens (Human)	622	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10236_c0_g1_i2	P0DKX0	ZN728_HUMAN	56.9	72	30	1	1	213	397	468	2.70E-16	85.5	ZN728_HUMAN	reviewed	Zinc finger protein 728	ZNF728	Homo sapiens (Human)	622	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g5_i1	P0DKX0	ZN728_HUMAN	50	74	37	0	395	174	398	471	3.50E-14	79.3	ZN728_HUMAN	reviewed	Zinc finger protein 728	ZNF728	Homo sapiens (Human)	622	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1344_c0_g1_i5	P0DKX0	ZN728_HUMAN	44.4	142	79	0	474	49	392	533	4.70E-34	146.4	ZN728_HUMAN	reviewed	Zinc finger protein 728	ZNF728	Homo sapiens (Human)	622	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37401_c0_g1_i1	A6NN14	ZN729_HUMAN	44.2	77	43	0	231	1	643	719	1.20E-14	80.1	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3656_c0_g2_i2	A6NN14	ZN729_HUMAN	37.4	230	141	3	3	689	335	562	1.60E-42	174.5	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g2_i3	A6NN14	ZN729_HUMAN	45.3	64	35	0	145	336	473	536	3.10E-11	69.3	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29693_c0_g1_i1	A6NN14	ZN729_HUMAN	44.6	323	177	1	986	18	386	706	1.90E-86	320.9	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29693_c0_g1_i2	A6NN14	ZN729_HUMAN	46.6	307	164	0	938	18	400	706	3.40E-87	323.2	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11353_c0_g1_i10	A6NN14	ZN729_HUMAN	40.8	255	140	1	760	29	317	571	1.50E-56	221.1	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1848_c0_g1_i4	A6NN14	ZN729_HUMAN	53.2	94	44	0	16	297	1091	1184	2.10E-24	112.8	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g2_i1	A6NN14	ZN729_HUMAN	58.8	85	35	0	3	257	1127	1211	1.90E-24	112.8	ZN729_HUMAN	reviewed	Zinc finger protein 729	ZNF729	Homo sapiens (Human)	1252	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN264_c0_g2_i2	B4DXR9	ZN732_HUMAN	43.8	251	137	3	761	12	305	552	1.60E-60	234.2	ZN732_HUMAN	reviewed	Zinc finger protein 732	ZNF732	Homo sapiens (Human)	585	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i13	B4DXR9	ZN732_HUMAN	42.7	150	78	4	444	4	306	450	2.20E-25	116.7	ZN732_HUMAN	reviewed	Zinc finger protein 732	ZNF732	Homo sapiens (Human)	585	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g2_i1	O75373	ZN737_HUMAN	48.8	166	83	2	492	1	255	420	1.60E-37	157.1	ZN737_HUMAN	reviewed	Zinc finger protein 737 (Zinc finger protein 102)	ZNF737 ZNF102	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4355_c0_g1_i5	O75373	ZN737_HUMAN	45	129	71	0	389	3	195	323	1.90E-28	127.5	ZN737_HUMAN	reviewed	Zinc finger protein 737 (Zinc finger protein 102)	ZNF737 ZNF102	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i8	O75373	ZN737_HUMAN	48.5	136	70	0	478	71	195	330	1.20E-35	151	ZN737_HUMAN	reviewed	Zinc finger protein 737 (Zinc finger protein 102)	ZNF737 ZNF102	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i6	O75373	ZN737_HUMAN	49.6	127	55	2	383	3	158	275	9.80E-30	131	ZN737_HUMAN	reviewed	Zinc finger protein 737 (Zinc finger protein 102)	ZNF737 ZNF102	Homo sapiens (Human)	536	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23350_c0_g2_i1	Q16587	ZNF74_HUMAN	100	102	0	0	306	1	465	566	6.60E-61	234.2	ZNF74_HUMAN	reviewed	Zinc finger protein 74 (Zinc finger protein 520) (hZNF7)	ZNF74 ZNF520	Homo sapiens (Human)	644	"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007275; GO:0015629; GO:0046872	"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN507_c0_g1_i1	Q16587	ZNF74_HUMAN	39.3	178	105	3	542	9	239	413	2.30E-31	137.9	ZNF74_HUMAN	reviewed	Zinc finger protein 74 (Zinc finger protein 520) (hZNF7)	ZNF74 ZNF520	Homo sapiens (Human)	644	"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007275; GO:0015629; GO:0046872	"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34303_c0_g1_i1	Q3U133	ZN746_MOUSE	50.9	57	26	1	13	183	544	598	5.40E-11	67.8	ZN746_MOUSE	reviewed	Zinc finger protein 746	Znf746 Zfp746	Mus musculus (Mouse)	652	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005737; GO:0006357; GO:0031625; GO:0045892; GO:0045944; GO:0046872; GO:1901216	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18118_c0_g1_i4	Q96N20	ZN75A_HUMAN	50.9	53	26	0	101	259	183	235	3.40E-10	65.5	ZN75A_HUMAN	reviewed	Zinc finger protein 75A	ZNF75A	Homo sapiens (Human)	296	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872; GO:1990837	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28740_c0_g1_i1	P36508	ZNF76_HUMAN	100	157	0	0	2	472	175	331	3.90E-97	355.1	ZNF76_HUMAN	reviewed	Zinc finger protein 76 (Zinc finger protein 523)	ZNF76 D6S229E ZNF523	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0043565; GO:0045944; GO:0046872; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]		NA	NA	NA	NA	NA	NA
TRINITY_DN5973_c0_g1_i1	P36508	ZNF76_HUMAN	53.8	290	108	5	146	943	88	375	1.10E-84	315.1	ZNF76_HUMAN	reviewed	Zinc finger protein 76 (Zinc finger protein 523)	ZNF76 D6S229E ZNF523	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0043565; GO:0045944; GO:0046872; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]		NA	NA	NA	NA	NA	NA
TRINITY_DN5973_c0_g1_i2	P36508	ZNF76_HUMAN	34.5	168	80	6	146	565	88	253	6.90E-19	95.5	ZNF76_HUMAN	reviewed	Zinc finger protein 76 (Zinc finger protein 523)	ZNF76 D6S229E ZNF523	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0043565; GO:0045944; GO:0046872; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]		NA	NA	NA	NA	NA	NA
TRINITY_DN5973_c0_g1_i3	P36508	ZNF76_HUMAN	69.9	193	54	2	128	694	183	375	7.70E-78	292	ZNF76_HUMAN	reviewed	Zinc finger protein 76 (Zinc finger protein 523)	ZNF76 D6S229E ZNF523	Homo sapiens (Human)	570	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0043565; GO:0045944; GO:0046872; GO:1990837	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c1_g1_i1	Q86XN6	ZN761_HUMAN	43.9	57	32	0	171	1	460	516	4.30E-08	58.2	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c3_g1_i11	Q86XN6	ZN761_HUMAN	45	109	60	0	378	704	292	400	3.90E-24	113.2	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i16	Q86XN6	ZN761_HUMAN	49.2	59	30	0	178	2	460	518	6.10E-11	67.8	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c1_g1_i16	Q86XN6	ZN761_HUMAN	43.8	73	29	2	220	5	309	370	5.10E-07	55.5	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c1_g1_i25	Q86XN6	ZN761_HUMAN	43.8	73	29	2	220	5	309	370	5.30E-07	55.5	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c1_g1_i3	Q86XN6	ZN761_HUMAN	43.8	73	29	2	220	5	309	370	6.40E-07	55.5	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c1_g1_i7	Q86XN6	ZN761_HUMAN	43.8	73	29	2	220	5	309	370	7.10E-07	55.5	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i68	Q86XN6	ZN761_HUMAN	33	315	167	10	451	1383	298	572	1.30E-41	172.9	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i68	Q86XN6	ZN761_HUMAN	41.2	114	65	2	1391	1729	408	520	1.70E-20	102.8	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i68	Q86XN6	ZN761_HUMAN	41.2	114	65	2	2183	1845	408	520	1.70E-20	102.8	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g3_i1	Q86XN6	ZN761_HUMAN	48.8	86	44	0	265	8	460	545	7.40E-19	94.4	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4355_c0_g1_i11	Q86XN6	ZN761_HUMAN	51.3	78	38	0	237	4	467	544	3.50E-17	89.4	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4355_c0_g1_i3	Q86XN6	ZN761_HUMAN	43.9	57	32	0	171	1	292	348	2.00E-08	60.5	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4355_c0_g1_i6	Q86XN6	ZN761_HUMAN	48.2	85	44	0	258	4	460	544	1.60E-17	90.9	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13058_c0_g1_i1	Q86XN6	ZN761_HUMAN	54	50	23	0	60	209	467	516	1.80E-09	62.8	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13058_c0_g1_i3	Q86XN6	ZN761_HUMAN	50.9	57	28	0	221	391	460	516	6.70E-10	65.1	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10643_c0_g1_i9	Q86XN6	ZN761_HUMAN	50.6	79	39	0	310	74	460	538	9.20E-19	94.4	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12597_c0_g2_i4	Q86XN6	ZN761_HUMAN	43.3	67	38	0	203	3	478	544	1.10E-08	60.5	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g1_i1	Q86XN6	ZN761_HUMAN	60.6	33	13	0	101	3	467	499	1.00E-05	51.2	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g1_i2	Q86XN6	ZN761_HUMAN	60.6	33	13	0	101	3	467	499	9.10E-06	51.2	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g1_i3	Q86XN6	ZN761_HUMAN	60.6	33	13	0	101	3	467	499	8.40E-06	51.2	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4966_c0_g1_i4	Q86XN6	ZN761_HUMAN	45.7	81	44	0	52	294	460	540	8.10E-16	84.3	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g4_i3	Q86XN6	ZN761_HUMAN	48.8	86	44	0	92	349	460	545	2.70E-18	92.8	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c3_g2_i1	Q86XN6	ZN761_HUMAN	49.4	81	41	0	21	263	460	540	1.70E-17	89.7	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c3_g2_i2	Q86XN6	ZN761_HUMAN	48.4	64	33	0	21	212	460	523	9.60E-11	67	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2211_c0_g2_i1	Q86XN6	ZN761_HUMAN	47.1	85	45	0	1	255	328	412	1.50E-18	93.2	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i11	Q86XN6	ZN761_HUMAN	49.4	87	44	0	266	6	460	546	4.30E-20	99	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10193_c1_g1_i3	Q86XN6	ZN761_HUMAN	47.1	70	37	0	224	15	292	361	3.30E-14	79.3	ZN761_HUMAN	reviewed	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	746	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c1_g1_i1	Q7L2R6	ZN765_HUMAN	43.7	103	56	2	335	27	301	401	2.00E-18	93.2	ZN765_HUMAN	reviewed	Zinc finger protein 765	ZNF765	Homo sapiens (Human)	523	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16290_c0_g1_i1	Q7L2R6	ZN765_HUMAN	41.7	60	34	1	381	560	293	351	1.20E-07	58.2	ZN765_HUMAN	reviewed	Zinc finger protein 765	ZNF765	Homo sapiens (Human)	523	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16290_c0_g1_i10	Q7L2R6	ZN765_HUMAN	41.7	60	34	1	287	466	293	351	9.80E-08	58.2	ZN765_HUMAN	reviewed	Zinc finger protein 765	ZNF765	Homo sapiens (Human)	523	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5958_c2_g1_i1	Q7L2R6	ZN765_HUMAN	54.7	53	24	0	299	141	293	345	2.40E-10	66.2	ZN765_HUMAN	reviewed	Zinc finger protein 765	ZNF765	Homo sapiens (Human)	523	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11097_c0_g1_i1	Q7L2R6	ZN765_HUMAN	49.1	114	58	0	344	3	293	406	1.00E-25	117.5	ZN765_HUMAN	reviewed	Zinc finger protein 765	ZNF765	Homo sapiens (Human)	523	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16522_c0_g1_i1	Q5HY98	ZN766_HUMAN	49.5	107	54	0	361	41	327	433	9.60E-27	120.9	ZN766_HUMAN	reviewed	Zinc finger protein 766	ZNF766	Homo sapiens (Human)	468	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g3_i1	Q5HY98	ZN766_HUMAN	100	71	0	0	215	3	252	322	8.50E-39	160.2	ZN766_HUMAN	reviewed	Zinc finger protein 766	ZNF766	Homo sapiens (Human)	468	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39533_c0_g1_i1	Q8R0T2	ZN768_MOUSE	39.2	153	89	2	575	126	274	425	9.30E-24	111.7	ZN768_MOUSE	reviewed	Zinc finger protein 768	Znf768 Zfp768	Mus musculus (Mouse)	568	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006366; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"		NA	NA	NA	NA	NA	NA
TRINITY_DN251_c0_g2_i1	Q7L3S4	ZN771_HUMAN	45.5	88	48	0	270	7	65	152	5.60E-19	94.7	ZN771_HUMAN	reviewed	Zinc finger protein 771 (Mesenchymal stem cell protein DSC43)	ZNF771	Homo sapiens (Human)	317	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5370_c0_g1_i1	Q7L3S4	ZN771_HUMAN	49.1	53	24	1	48	206	90	139	6.00E-09	61.2	ZN771_HUMAN	reviewed	Zinc finger protein 771 (Mesenchymal stem cell protein DSC43)	ZNF771	Homo sapiens (Human)	317	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0046872; GO:1990837	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15496_c0_g1_i1	Q6PK81	ZN773_HUMAN	78.2	147	32	0	443	3	212	358	5.90E-71	268.1	ZN773_HUMAN	reviewed	Zinc finger protein 773 (Zinc finger protein 419B)	ZNF773 ZNF419B	Homo sapiens (Human)	442	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c2_g1_i5	Q6NX45	ZN774_HUMAN	50.6	81	37	2	238	2	236	315	3.00E-16	85.5	ZN774_HUMAN	reviewed	Zinc finger protein 774	ZNF774	Homo sapiens (Human)	483	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9165_c0_g1_i2	Q96BV0	ZN775_HUMAN	58.2	55	21	1	215	51	304	356	1.30E-10	68.2	ZN775_HUMAN	reviewed	Zinc finger protein 775	ZNF775	Homo sapiens (Human)	537	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14139_c0_g1_i1	Q96BV0	ZN775_HUMAN	52.1	48	23	0	15	158	309	356	1.10E-08	60.8	ZN775_HUMAN	reviewed	Zinc finger protein 775	ZNF775	Homo sapiens (Human)	537	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i2	Q68DI1	ZN776_HUMAN	43.9	107	60	0	507	187	404	510	8.20E-24	111.7	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i3	Q68DI1	ZN776_HUMAN	42.5	73	42	0	405	187	438	510	2.00E-12	73.6	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i7	Q68DI1	ZN776_HUMAN	44	75	42	0	411	187	436	510	4.80E-14	79	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i8	Q68DI1	ZN776_HUMAN	43.9	57	32	0	357	187	454	510	6.90E-10	65.5	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i9	Q68DI1	ZN776_HUMAN	41.4	70	41	0	396	187	441	510	3.50E-12	72.8	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i20	Q68DI1	ZN776_HUMAN	52.4	147	70	0	462	22	252	398	1.90E-43	176.8	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c7_g1_i1	Q68DI1	ZN776_HUMAN	46.2	117	47	1	7	357	381	481	1.10E-22	107.5	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6943_c0_g2_i1	Q68DI1	ZN776_HUMAN	42.1	152	80	6	5	460	311	454	1.60E-24	114	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16337_c0_g3_i1	Q68DI1	ZN776_HUMAN	45.7	70	38	0	218	9	441	510	1.80E-12	72.8	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5194_c0_g2_i1	Q68DI1	ZN776_HUMAN	46.3	67	36	0	7	207	416	482	1.20E-11	70.1	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g4_i1	Q68DI1	ZN776_HUMAN	47.3	74	39	0	266	45	437	510	1.60E-15	83.2	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11249_c0_g1_i10	Q68DI1	ZN776_HUMAN	52.9	104	49	0	16	327	310	413	3.90E-27	122.1	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10409_c0_g1_i1	Q68DI1	ZN776_HUMAN	44.6	56	31	0	2	169	397	452	7.00E-10	65.1	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i4	Q68DI1	ZN776_HUMAN	42.9	70	40	0	7	216	441	510	6.60E-12	71.2	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c0_g1_i1	Q68DI1	ZN776_HUMAN	51.4	210	97	2	1	630	314	518	4.40E-59	229.2	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c8_g1_i2	Q68DI1	ZN776_HUMAN	39.8	88	39	2	325	101	432	518	6.60E-11	68.2	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6656_c0_g1_i1	Q68DI1	ZN776_HUMAN	48	204	106	0	612	1	292	495	3.70E-64	246.1	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN22387_c0_g1_i5	Q68DI1	ZN776_HUMAN	44.9	78	39	1	67	288	405	482	7.10E-13	74.7	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i1	Q68DI1	ZN776_HUMAN	56.4	39	17	0	278	162	314	352	5.70E-06	51.6	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i4	Q68DI1	ZN776_HUMAN	55.2	67	30	0	389	189	286	352	3.20E-15	82.8	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i2	Q68DI1	ZN776_HUMAN	43.6	78	44	0	180	413	377	454	2.30E-14	80.1	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c0_g1_i8	Q68DI1	ZN776_HUMAN	43.6	78	44	0	177	410	377	454	2.30E-14	80.1	ZN776_HUMAN	reviewed	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	518	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i10	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	1.10E-14	81.3	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i11	Q96MU6	ZN778_HUMAN	41.4	70	41	0	6	215	402	471	9.00E-14	77.8	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i13	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	7.90E-14	78.2	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i14	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	3.90E-14	79	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i17	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	3.10E-14	79.3	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i18	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	8.80E-14	77.8	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i19	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	1.90E-14	80.5	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i20	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	4.60E-14	79	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i23	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	4.00E-14	79	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i24	Q96MU6	ZN778_HUMAN	41.4	70	41	0	6	215	402	471	5.30E-14	78.6	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i3	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	2.80E-13	76.6	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN70_c2_g1_i9	Q96MU6	ZN778_HUMAN	42.9	70	40	0	6	215	402	471	2.50E-14	80.1	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i24	Q96MU6	ZN778_HUMAN	48.5	97	43	1	297	7	414	503	1.10E-20	100.5	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c1_g1_i1	Q96MU6	ZN778_HUMAN	49.4	87	44	0	1	261	555	641	2.40E-19	95.9	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c6_g1_i1	Q96MU6	ZN778_HUMAN	48.6	72	37	0	217	2	440	511	2.70E-16	85.5	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN281_c6_g1_i2	Q96MU6	ZN778_HUMAN	47.4	76	40	0	229	2	436	511	5.30E-18	91.3	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10378_c4_g1_i1	Q96MU6	ZN778_HUMAN	42.9	49	28	0	1	147	451	499	2.20E-07	55.8	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29025_c0_g1_i1	Q96MU6	ZN778_HUMAN	46.9	64	33	1	18	206	548	611	3.40E-11	68.9	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3354_c0_g1_i2	Q96MU6	ZN778_HUMAN	51.6	126	61	0	380	3	370	495	1.10E-33	144.1	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2205_c0_g1_i17	Q96MU6	ZN778_HUMAN	56.4	110	48	0	391	62	408	517	5.10E-34	145.2	ZN778_HUMAN	reviewed	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	729	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3656_c0_g2_i1	Q9Y6R6	Z780B_HUMAN	32.7	392	215	7	15	1136	357	717	2.70E-57	224.2	Z780B_HUMAN	reviewed	Zinc finger protein 780B (Zinc finger protein 779)	ZNF780B ZNF779	Homo sapiens (Human)	833	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN86_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	43.6	243	113	5	71	799	479	697	1.80E-58	227.6	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i11	Q6ZMW2	ZN782_HUMAN	41.7	103	60	0	311	3	488	590	1.60E-19	97.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i24	Q6ZMW2	ZN782_HUMAN	43.8	89	50	0	269	3	586	674	1.00E-19	98.6	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i5	Q6ZMW2	ZN782_HUMAN	50.7	282	139	0	368	1213	411	692	1.40E-85	318.2	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i7	Q6ZMW2	ZN782_HUMAN	50.7	282	139	0	313	1158	411	692	1.30E-85	318.2	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i11	Q6ZMW2	ZN782_HUMAN	44.3	131	59	1	5	355	398	528	3.10E-25	116.3	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g3_i1	Q6ZMW2	ZN782_HUMAN	49.3	69	35	0	5	211	608	676	4.70E-13	74.7	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16316_c0_g3_i2	Q6ZMW2	ZN782_HUMAN	49.4	77	39	0	5	235	608	684	2.90E-16	85.5	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15456_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	35.5	262	157	6	41	826	414	663	2.20E-38	161.8	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15456_c0_g1_i2	Q6ZMW2	ZN782_HUMAN	35.4	263	158	6	861	73	414	664	1.20E-38	161.8	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c1_g2_i1	Q6ZMW2	ZN782_HUMAN	44	100	56	0	151	450	532	631	6.80E-22	105.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4254_c0_g1_i11	Q6ZMW2	ZN782_HUMAN	42.5	167	78	2	453	7	510	676	5.00E-33	142.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4254_c0_g1_i3	Q6ZMW2	ZN782_HUMAN	47.3	93	49	0	285	7	584	676	2.90E-20	99.4	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3677_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	29.6	294	190	7	1046	1897	386	672	1.40E-27	126.7	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4025_c0_g1_i31	Q6ZMW2	ZN782_HUMAN	47.2	89	41	2	317	69	564	652	1.00E-16	87.4	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9294_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	41.4	111	65	0	334	2	530	640	1.40E-23	110.5	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9294_c0_g1_i3	Q6ZMW2	ZN782_HUMAN	41.4	111	65	0	334	2	530	640	6.20E-23	108.6	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8372_c0_g1_i2	Q6ZMW2	ZN782_HUMAN	40.1	162	81	1	9	446	491	652	9.90E-34	144.4	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8372_c0_g1_i4	Q6ZMW2	ZN782_HUMAN	46.9	162	86	0	9	494	491	652	2.10E-45	183.3	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	1	NA	NA
TRINITY_DN8377_c0_g1_i5	Q6ZMW2	ZN782_HUMAN	50.9	112	55	0	6	341	443	554	6.70E-28	124.8	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4115_c0_g1_i7	Q6ZMW2	ZN782_HUMAN	47.1	85	45	0	262	8	558	642	5.80E-19	94.7	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i3	Q6ZMW2	ZN782_HUMAN	54.7	64	29	0	4	195	562	625	2.60E-14	80.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i6	Q6ZMW2	ZN782_HUMAN	50	76	38	0	4	231	562	637	1.20E-14	81.3	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN34606_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	46.9	98	52	0	2	295	572	669	4.40E-22	105.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3389_c0_g1_i8	Q6ZMW2	ZN782_HUMAN	40.3	149	80	3	452	12	556	697	1.90E-24	114	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	61.5	39	15	0	160	276	563	601	1.50E-09	63.9	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i5	Q6ZMW2	ZN782_HUMAN	42.4	144	62	3	112	483	530	672	1.80E-28	127.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i6	Q6ZMW2	ZN782_HUMAN	29.5	207	129	5	2	604	481	676	3.00E-17	90.1	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i17	Q6ZMW2	ZN782_HUMAN	58.8	51	21	0	1	153	593	643	6.10E-11	67.8	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i5	Q6ZMW2	ZN782_HUMAN	46.7	120	58	1	7	366	583	696	2.40E-30	133.3	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10538_c2_g1_i1	Q6ZMW2	ZN782_HUMAN	47.1	306	162	0	255	1172	391	696	2.00E-94	348.2	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN33304_c0_g1_i1	Q6ZMW2	ZN782_HUMAN	44.6	186	102	1	8	565	424	608	1.70E-44	180.6	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i18	Q6ZMW2	ZN782_HUMAN	50.4	123	60	1	225	593	392	513	1.50E-32	141	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i19	Q6ZMW2	ZN782_HUMAN	49.6	125	62	1	160	534	390	513	1.10E-31	137.9	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i20	Q6ZMW2	ZN782_HUMAN	49.6	125	62	1	160	534	390	513	8.60E-32	138.3	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c0_g1_i5	Q6ZMW2	ZN782_HUMAN	58.4	77	32	0	5	235	437	513	2.80E-22	105.5	ZN782_HUMAN	reviewed	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	699	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN32106_c0_g1_i1	Q8BI69	ZN784_MOUSE	58	50	21	0	218	69	193	242	9.60E-13	73.9	ZN784_MOUSE	reviewed	Zinc finger protein 784	Znf784 Zfp784	Mus musculus (Mouse)	297	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000977; GO:0000981; GO:0002244; GO:0005634; GO:0006357; GO:0046872; GO:1990837	hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN38274_c0_g1_i1	A8K8V0	ZN785_HUMAN	98.5	67	1	0	204	4	227	293	3.40E-37	154.8	ZN785_HUMAN	reviewed	Zinc finger protein 785	ZNF785	Homo sapiens (Human)	405	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1772_c0_g1_i4	Q8N393	ZN786_HUMAN	51.7	60	29	0	14	193	577	636	6.20E-15	81.6	ZN786_HUMAN	reviewed	Zinc finger protein 786	ZNF786	Homo sapiens (Human)	782	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31450_c0_g1_i1	Q8N393	ZN786_HUMAN	100	127	0	0	2	382	557	683	1.10E-76	287	ZN786_HUMAN	reviewed	Zinc finger protein 786	ZNF786	Homo sapiens (Human)	782	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9455_c0_g1_i3	Q6PG37	ZN790_HUMAN	40.9	154	75	1	424	11	231	384	2.30E-27	123.2	ZN790_HUMAN	reviewed	Zinc finger protein 790	ZNF790	Homo sapiens (Human)	636	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16611_c0_g1_i15	Q6PG37	ZN790_HUMAN	48	75	39	0	362	138	453	527	3.40E-16	85.9	ZN790_HUMAN	reviewed	Zinc finger protein 790	ZNF790	Homo sapiens (Human)	636	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3231_c3_g1_i1	Q6PG37	ZN790_HUMAN	52.2	67	32	0	207	7	283	349	8.60E-15	80.5	ZN790_HUMAN	reviewed	Zinc finger protein 790	ZNF790	Homo sapiens (Human)	636	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c3_g1_i1	Q6PG37	ZN790_HUMAN	54.1	98	45	0	298	5	259	356	2.30E-26	119.4	ZN790_HUMAN	reviewed	Zinc finger protein 790	ZNF790	Homo sapiens (Human)	636	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17803_c0_g1_i2	Q3KP31	ZN791_HUMAN	90	70	7	0	215	6	428	497	1.50E-35	149.4	ZN791_HUMAN	reviewed	Zinc finger protein 791	ZNF791	Homo sapiens (Human)	576	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17803_c0_g1_i4	Q3KP31	ZN791_HUMAN	91	78	7	0	238	5	428	505	2.00E-41	169.1	ZN791_HUMAN	reviewed	Zinc finger protein 791	ZNF791	Homo sapiens (Human)	576	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12336_c0_g3_i1	Q3KP31	ZN791_HUMAN	75.9	79	19	0	1	237	477	555	5.50E-31	134.4	ZN791_HUMAN	reviewed	Zinc finger protein 791	ZNF791	Homo sapiens (Human)	576	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12336_c0_g1_i1	Q3KP31	ZN791_HUMAN	85.9	78	11	0	237	4	474	551	1.00E-37	156.8	ZN791_HUMAN	reviewed	Zinc finger protein 791	ZNF791	Homo sapiens (Human)	576	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28930_c0_g1_i1	Q6ZN11	ZN793_HUMAN	60.4	53	21	0	65	223	281	333	1.30E-14	80.1	ZN793_HUMAN	reviewed	Zinc finger protein 793	ZNF793	Homo sapiens (Human)	406	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i10	Q6ZN11	ZN793_HUMAN	49.5	109	55	0	2	328	281	389	2.40E-27	123.2	ZN793_HUMAN	reviewed	Zinc finger protein 793	ZNF793	Homo sapiens (Human)	406	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17290_c0_g1_i6	Q6ZN11	ZN793_HUMAN	59.5	74	30	0	224	3	288	361	1.20E-20	100.1	ZN793_HUMAN	reviewed	Zinc finger protein 793	ZNF793	Homo sapiens (Human)	406	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c10_g1_i1	P51503	ZNF80_GORGO	50	74	37	0	1	222	163	236	4.10E-15	81.6	ZNF80_GORGO	reviewed	Zinc finger protein 80	ZNF80	Gorilla gorilla gorilla (Western lowland gorilla)	273	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c0_g1_i3	P51503	ZNF80_GORGO	49.4	79	40	0	1	237	133	211	7.10E-18	90.9	ZNF80_GORGO	reviewed	Zinc finger protein 80	ZNF80	Gorilla gorilla gorilla (Western lowland gorilla)	273	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c1_g1_i1	P51504	ZNF80_HUMAN	42.9	70	40	0	309	100	144	213	4.10E-10	65.5	ZNF80_HUMAN	reviewed	Zinc finger protein 80 (ZNFpT17)	ZNF80	Homo sapiens (Human)	273	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000790; GO:0000977; GO:0000981; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g2_i7	Q5CZA5	ZN805_HUMAN	50.7	71	35	0	5	217	469	539	5.40E-16	85.1	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g1_i12	Q5CZA5	ZN805_HUMAN	45.8	118	57	2	248	601	410	520	2.80E-23	110.2	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c4_g2_i1	Q5CZA5	ZN805_HUMAN	49.4	81	41	0	11	253	459	539	8.70E-19	94	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c4_g2_i2	Q5CZA5	ZN805_HUMAN	46.8	109	58	0	11	337	431	539	1.70E-25	116.7	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c4_g2_i3	Q5CZA5	ZN805_HUMAN	49.5	109	55	0	2	328	431	539	3.90E-27	122.1	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c57_g1_i2	Q5CZA5	ZN805_HUMAN	53.3	60	28	0	37	216	473	532	2.10E-13	75.9	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c0_g1_i1	Q5CZA5	ZN805_HUMAN	55.8	95	42	0	302	18	451	545	1.80E-26	119.8	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c0_g1_i2	Q5CZA5	ZN805_HUMAN	59.7	67	27	0	218	18	479	545	4.90E-18	91.3	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19389_c0_g1_i2	Q5CZA5	ZN805_HUMAN	49.5	91	46	0	11	283	473	563	8.50E-23	107.5	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN19389_c0_g1_i5	Q5CZA5	ZN805_HUMAN	47	115	61	0	34	378	449	563	9.00E-28	124.4	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN20253_c0_g1_i1	Q5CZA5	ZN805_HUMAN	49.1	53	27	0	79	237	477	529	4.10E-10	65.1	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN299_c0_g1_i9	Q5CZA5	ZN805_HUMAN	36.7	109	60	1	6	305	453	561	1.30E-18	94	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g1_i2	Q5CZA5	ZN805_HUMAN	46.2	143	67	1	430	2	431	563	1.40E-32	140.6	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11868_c1_g1_i7	Q5CZA5	ZN805_HUMAN	52.6	97	46	0	292	2	467	563	5.00E-26	118.2	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g2_i1	Q5CZA5	ZN805_HUMAN	53.2	77	36	0	241	11	481	557	1.70E-19	96.3	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i4	Q5CZA5	ZN805_HUMAN	57.1	56	24	0	350	183	462	517	1.30E-13	77.8	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7468_c0_g1_i2	Q5CZA5	ZN805_HUMAN	50	68	34	0	19	222	451	518	3.60E-13	75.5	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7468_c0_g1_i3	Q5CZA5	ZN805_HUMAN	50	70	35	0	19	228	451	520	2.50E-15	82.4	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18854_c0_g1_i4	Q5CZA5	ZN805_HUMAN	47.4	114	59	1	19	360	449	561	9.80E-28	124.4	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7784_c0_g1_i1	Q5CZA5	ZN805_HUMAN	50	84	42	0	253	2	462	545	1.40E-19	96.7	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16138_c0_g1_i3	Q5CZA5	ZN805_HUMAN	57.5	80	34	0	1	240	478	557	3.40E-23	108.6	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17691_c0_g1_i2	Q5CZA5	ZN805_HUMAN	46.2	78	42	0	318	85	484	561	1.20E-17	90.5	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7346_c2_g2_i1	Q5CZA5	ZN805_HUMAN	48.5	68	35	0	226	23	494	561	8.30E-13	73.9	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6474_c1_g1_i1	Q5CZA5	ZN805_HUMAN	51.3	76	37	0	237	10	226	301	1.80E-17	89.7	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN17882_c0_g1_i5	Q5CZA5	ZN805_HUMAN	54.9	51	23	0	158	6	457	507	9.00E-12	70.5	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g2_i2	Q5CZA5	ZN805_HUMAN	48.1	106	55	0	468	151	445	550	1.20E-24	114.4	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g2_i3	Q5CZA5	ZN805_HUMAN	49	96	49	0	290	3	467	562	4.90E-21	101.7	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g2_i5	Q5CZA5	ZN805_HUMAN	50	70	35	0	421	212	492	561	7.00E-13	75.1	ZN805_HUMAN	reviewed	Zinc finger protein 805	ZNF805	Homo sapiens (Human)	627	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN16253_c1_g1_i1	Q8N4W9	ZN808_HUMAN	55.4	56	25	0	171	4	281	336	5.70E-11	67.8	ZN808_HUMAN	reviewed	Zinc finger protein 808	ZNF808	Homo sapiens (Human)	903	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18603_c0_g2_i1	Q8N4W9	ZN808_HUMAN	44.9	69	38	0	209	3	281	349	4.80E-13	74.7	ZN808_HUMAN	reviewed	Zinc finger protein 808	ZNF808	Homo sapiens (Human)	903	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11873_c0_g1_i1	Q8N4W9	ZN808_HUMAN	29.9	384	225	15	1144	11	288	633	1.00E-37	159.5	ZN808_HUMAN	reviewed	Zinc finger protein 808	ZNF808	Homo sapiens (Human)	903	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11873_c0_g1_i2	Q8N4W9	ZN808_HUMAN	31.6	316	184	12	943	11	345	633	4.70E-34	146.7	ZN808_HUMAN	reviewed	Zinc finger protein 808	ZNF808	Homo sapiens (Human)	903	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i5	Q8N4W9	ZN808_HUMAN	48.7	113	58	0	10	348	281	393	1.10E-27	124.4	ZN808_HUMAN	reviewed	Zinc finger protein 808	ZNF808	Homo sapiens (Human)	903	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i11	G3X9G7	ZN809_MOUSE	45.8	72	39	0	1	216	214	285	1.60E-13	76.3	ZN809_MOUSE	reviewed	Zinc finger protein 809	Zfp809	Mus musculus (Mouse)	402	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0045087; GO:0045869; GO:0046872	innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c1_g1_i1	Q5RER9	ZN813_PONAB	47.5	141	74	0	425	3	300	440	1.50E-34	147.1	ZN813_PONAB	reviewed	Zinc finger protein 813	ZNF813	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	617	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i9	Q6ZN06	ZN813_HUMAN	53.7	41	19	0	111	233	264	304	2.20E-06	52.8	ZN813_HUMAN	reviewed	Zinc finger protein 813	ZNF813	Homo sapiens (Human)	617	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4787_c0_g3_i2	B7Z6K7	ZN814_HUMAN	45.8	96	52	0	2	289	449	544	2.30E-21	102.8	ZN814_HUMAN	reviewed	Zinc finger protein 814	ZNF814	Homo sapiens (Human)	855	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10403_c0_g1_i1	B7Z6K7	ZN814_HUMAN	47.3	91	48	0	277	5	454	544	1.90E-19	96.3	ZN814_HUMAN	reviewed	Zinc finger protein 814	ZNF814	Homo sapiens (Human)	855	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5729_c0_g1_i1	B7Z6K7	ZN814_HUMAN	46.6	58	31	0	184	11	481	538	1.30E-11	70.1	ZN814_HUMAN	reviewed	Zinc finger protein 814	ZNF814	Homo sapiens (Human)	855	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7162_c0_g1_i1	B7Z6K7	ZN814_HUMAN	29.8	429	268	11	1998	3227	435	849	5.60E-46	188.3	ZN814_HUMAN	reviewed	Zinc finger protein 814	ZNF814	Homo sapiens (Human)	855	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c0_g1_i1	B7Z6K7	ZN814_HUMAN	50	70	35	0	211	2	486	555	4.40E-16	84.7	ZN814_HUMAN	reviewed	Zinc finger protein 814	ZNF814	Homo sapiens (Human)	855	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i1	Q0VGE8	ZN816_HUMAN	50.4	113	52	1	3	341	287	395	3.00E-25	115.9	ZN816_HUMAN	reviewed	Zinc finger protein 816	ZNF816 ZNF816A	Homo sapiens (Human)	651	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c0_g1_i17	Q0VGE8	ZN816_HUMAN	51.3	113	51	1	3	341	287	395	2.10E-26	119.8	ZN816_HUMAN	reviewed	Zinc finger protein 816	ZNF816 ZNF816A	Homo sapiens (Human)	651	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12336_c4_g1_i1	Q8N141	ZFP82_HUMAN	100	66	0	0	199	2	443	508	2.40E-35	148.7	ZFP82_HUMAN	reviewed	Zinc finger protein 82 homolog (Zfp-82) (Zinc finger protein 545)	ZFP82 KIAA1948 ZNF545	Homo sapiens (Human)	532	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i37	P51522	ZNF83_HUMAN	32.9	167	85	4	503	3	99	238	3.00E-18	93.2	ZNF83_HUMAN	reviewed	Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)	ZNF83 ZNF816B	Homo sapiens (Human)	516	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c5_g1_i1	P51522	ZNF83_HUMAN	51.7	60	28	1	183	4	283	341	7.90E-11	67.4	ZNF83_HUMAN	reviewed	Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)	ZNF83 ZNF816B	Homo sapiens (Human)	516	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN35338_c0_g1_i1	P51522	ZNF83_HUMAN	51.2	82	40	0	277	32	342	423	1.20E-18	93.6	ZNF83_HUMAN	reviewed	Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)	ZNF83 ZNF816B	Homo sapiens (Human)	516	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1562_c1_g1_i13	P51522	ZNF83_HUMAN	35.1	114	57	2	3	326	209	311	5.30E-13	75.5	ZNF83_HUMAN	reviewed	Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)	ZNF83 ZNF816B	Homo sapiens (Human)	516	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g4_i1	P51522	ZNF83_HUMAN	44.1	68	38	0	92	295	311	378	9.30E-12	70.9	ZNF83_HUMAN	reviewed	Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)	ZNF83 ZNF816B	Homo sapiens (Human)	516	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11010_c0_g1_i1	Q6DJ13	ZN830_XENTR	33.8	71	47	0	289	77	13	83	4.50E-09	62.4	ZN830_XENTR	reviewed	Zinc finger protein 830 (Coiled-coil domain-containing protein 16)	znf830 ccdc16 TGas069h14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	357	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; mitotic DNA damage checkpoint [GO:0044773]; mitotic DNA replication checkpoint [GO:0033314]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0000278; GO:0003676; GO:0005634; GO:0005681; GO:0005694; GO:0007275; GO:0008270; GO:0016607; GO:0033260; GO:0033314; GO:0044773; GO:0048478; GO:0051301	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; mitotic DNA damage checkpoint [GO:0044773]; mitotic DNA replication checkpoint [GO:0033314]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN11010_c0_g1_i2	Q6DJ13	ZN830_XENTR	29.7	320	185	8	923	36	13	316	3.80E-20	100.5	ZN830_XENTR	reviewed	Zinc finger protein 830 (Coiled-coil domain-containing protein 16)	znf830 ccdc16 TGas069h14.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	357	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; mitotic DNA damage checkpoint [GO:0044773]; mitotic DNA replication checkpoint [GO:0033314]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0000278; GO:0003676; GO:0005634; GO:0005681; GO:0005694; GO:0007275; GO:0008270; GO:0016607; GO:0033260; GO:0033314; GO:0044773; GO:0048478; GO:0051301	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; mitotic DNA damage checkpoint [GO:0044773]; mitotic DNA replication checkpoint [GO:0033314]; multicellular organism development [GO:0007275]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]		NA	NA	NA	NA	NA	NA
TRINITY_DN4567_c0_g2_i1	Q6ZNA1	ZN836_HUMAN	40.5	252	147	2	878	129	274	524	7.20E-57	223	ZN836_HUMAN	reviewed	Zinc finger protein 836	ZNF836	Homo sapiens (Human)	936	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29768_c0_g1_i1	Q6ZNA1	ZN836_HUMAN	27.8	417	278	13	285	1502	220	624	2.70E-37	158.3	ZN836_HUMAN	reviewed	Zinc finger protein 836	ZNF836	Homo sapiens (Human)	936	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i2	Q6ZNA1	ZN836_HUMAN	42.1	95	55	0	326	42	818	912	3.00E-19	95.9	ZN836_HUMAN	reviewed	Zinc finger protein 836	ZNF836	Homo sapiens (Human)	936	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4751_c0_g1_i1	P51523	ZNF84_HUMAN	45.2	73	40	0	467	249	437	509	5.40E-14	79	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4751_c0_g1_i4	P51523	ZNF84_HUMAN	45.2	73	40	0	479	261	437	509	4.20E-14	79.3	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4751_c0_g1_i6	P51523	ZNF84_HUMAN	45.2	73	40	0	443	225	437	509	5.10E-14	79	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g4_i1	P51523	ZNF84_HUMAN	49.3	73	37	0	220	2	583	655	4.40E-14	78.2	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4777_c0_g2_i1	P51523	ZNF84_HUMAN	48.6	70	36	0	5	214	586	655	2.70E-13	75.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c0_g2_i2	P51523	ZNF84_HUMAN	50.6	87	43	0	376	116	480	566	2.50E-22	106.3	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i40	P51523	ZNF84_HUMAN	38.4	99	50	3	295	5	421	510	3.70E-10	66.2	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3887_c1_g1_i13	P51523	ZNF84_HUMAN	45.9	425	205	3	3	1277	246	645	4.20E-109	396.4	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8704_c0_g1_i1	P51523	ZNF84_HUMAN	43.5	69	39	0	208	2	443	511	6.70E-10	64.3	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8717_c0_g1_i10	P51523	ZNF84_HUMAN	56.2	80	35	0	69	308	434	513	8.10E-22	104.4	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c1_g1_i14	P51523	ZNF84_HUMAN	57.3	89	38	0	269	3	557	645	1.40E-24	113.6	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i7	P51523	ZNF84_HUMAN	44.8	67	32	1	122	322	600	661	6.80E-08	58.2	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11283_c0_g1_i8	P51523	ZNF84_HUMAN	51.4	146	71	0	8	445	515	660	4.40E-42	172.2	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9427_c0_g1_i1	P51523	ZNF84_HUMAN	37.3	169	101	2	816	310	456	619	2.90E-32	141.7	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9461_c1_g1_i5	P51523	ZNF84_HUMAN	47.3	110	55	1	335	6	467	573	9.80E-26	117.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14324_c1_g1_i2	P51523	ZNF84_HUMAN	51.5	103	50	0	319	11	487	589	3.60E-25	115.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14324_c1_g1_i3	P51523	ZNF84_HUMAN	51.1	131	64	0	403	11	459	589	3.40E-33	142.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i3	P51523	ZNF84_HUMAN	47.4	171	90	0	11	523	397	567	3.30E-44	179.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i5	P51523	ZNF84_HUMAN	52.4	84	40	0	256	5	271	354	1.60E-20	99.8	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18204_c0_g2_i1	P51523	ZNF84_HUMAN	48.2	251	129	1	1	750	474	724	1.70E-70	267.3	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18204_c0_g1_i1	P51523	ZNF84_HUMAN	51.4	210	102	0	15	644	489	698	3.90E-63	242.7	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i19	P51523	ZNF84_HUMAN	54.5	145	66	0	3	437	481	625	1.70E-41	170.6	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i4	P51523	ZNF84_HUMAN	51	147	72	0	2	442	522	668	2.80E-40	166.4	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8025_c0_g1_i1	P51523	ZNF84_HUMAN	46.3	82	44	0	246	1	519	600	2.90E-14	79	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g2_i1	P51523	ZNF84_HUMAN	52.5	80	36	1	240	1	487	564	6.00E-17	87.8	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4336_c0_g1_i7	P51523	ZNF84_HUMAN	47.1	138	73	0	414	1	424	561	2.20E-35	149.8	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN9294_c0_g1_i2	P51523	ZNF84_HUMAN	54.5	77	35	0	232	2	433	509	9.40E-20	97.1	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i1	P51523	ZNF84_HUMAN	41.3	143	78	2	429	1	401	537	7.90E-25	115.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i10	P51523	ZNF84_HUMAN	37.5	240	126	7	699	13	279	505	1.80E-34	147.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i3	P51523	ZNF84_HUMAN	35.4	209	108	8	737	144	279	471	1.70E-22	107.8	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i3	P51523	ZNF84_HUMAN	47.7	86	45	0	625	368	426	511	5.10E-19	96.3	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6555_c0_g1_i3	P51523	ZNF84_HUMAN	51.1	47	23	0	141	1	407	453	1.20E-07	58.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i6	P51523	ZNF84_HUMAN	38.9	247	120	6	2	742	237	452	5.10E-43	176	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i6	P51523	ZNF84_HUMAN	45.6	68	37	0	510	713	655	722	7.50E-10	65.9	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i1	P51523	ZNF84_HUMAN	43.7	71	40	0	252	464	443	513	2.50E-11	70.1	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i10	P51523	ZNF84_HUMAN	45.1	71	39	0	252	464	443	513	1.50E-11	70.9	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5964_c0_g1_i8	P51523	ZNF84_HUMAN	43.7	71	40	0	252	464	443	513	2.50E-11	70.1	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i1	P51523	ZNF84_HUMAN	45.5	143	78	0	6	434	396	538	1.40E-32	140.6	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i7	P51523	ZNF84_HUMAN	47.6	143	75	0	4	432	424	566	1.10E-34	147.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c1_g2_i1	P51523	ZNF84_HUMAN	46.9	96	51	0	6	293	424	519	1.10E-20	100.5	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10220_c1_g1_i5	P51523	ZNF84_HUMAN	46.4	112	60	0	401	66	387	498	1.70E-24	113.6	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15621_c0_g1_i3	P51523	ZNF84_HUMAN	49.6	127	64	0	383	3	440	566	4.60E-33	142.1	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN7351_c1_g1_i7	P51523	ZNF84_HUMAN	48.3	145	75	0	437	3	365	509	1.40E-37	157.1	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12160_c0_g1_i1	P51523	ZNF84_HUMAN	50.9	106	51	1	414	100	572	677	1.30E-27	124	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4680_c2_g1_i2	P51523	ZNF84_HUMAN	52.9	68	32	0	8	211	424	491	1.30E-15	83.2	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN757_c1_g1_i2	P51523	ZNF84_HUMAN	52	127	61	0	3	383	572	698	1.30E-34	147.1	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8990_c0_g3_i1	P51523	ZNF84_HUMAN	53.5	71	33	0	220	8	435	505	3.20E-17	88.6	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c2_g2_i1	P51523	ZNF84_HUMAN	53.4	73	34	0	8	226	387	459	1.10E-15	83.6	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i1	P51523	ZNF84_HUMAN	47.4	114	60	0	578	237	480	593	1.10E-27	124.8	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1378_c0_g1_i6	P51523	ZNF84_HUMAN	47.4	114	60	0	547	206	480	593	7.70E-28	125.2	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30587_c1_g1_i1	P51523	ZNF84_HUMAN	100	74	0	0	224	3	537	610	3.60E-40	164.9	ZNF84_HUMAN	reviewed	Zinc finger protein 84 (Zinc finger protein HPF2)	ZNF84	Homo sapiens (Human)	738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i21	Q96IR2	ZN845_HUMAN	46.7	90	47	1	291	22	485	573	6.30E-21	101.3	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN213_c0_g1_i1	Q96IR2	ZN845_HUMAN	34.5	591	381	6	55	1812	380	969	1.70E-111	404.8	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN40260_c0_g1_i1	Q96IR2	ZN845_HUMAN	51.2	82	39	1	3	245	628	709	3.30E-16	85.5	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i4	Q96IR2	ZN845_HUMAN	34.8	115	71	2	3	344	653	764	3.50E-10	66.2	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23663_c0_g1_i6	Q96IR2	ZN845_HUMAN	92	87	7	0	262	2	741	827	7.30E-45	180.6	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g2_i1	Q96IR2	ZN845_HUMAN	50	68	29	1	190	2	489	556	2.80E-12	72.8	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g2_i2	Q96IR2	ZN845_HUMAN	52.6	57	22	1	157	2	500	556	7.50E-10	64.7	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g2_i3	Q96IR2	ZN845_HUMAN	51.1	45	22	0	144	10	489	533	3.60E-08	58.9	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g2_i4	Q96IR2	ZN845_HUMAN	50	68	29	1	190	2	489	556	2.60E-12	72.8	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g2_i5	Q96IR2	ZN845_HUMAN	51.1	45	22	0	144	10	489	533	3.30E-08	58.9	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c4_g1_i1	Q96IR2	ZN845_HUMAN	42.3	78	45	0	268	35	357	434	3.60E-15	82	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN31698_c0_g1_i1	Q96IR2	ZN845_HUMAN	38	200	114	3	604	5	362	551	1.80E-41	170.6	ZN845_HUMAN	reviewed	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	970	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN6598_c0_g1_i2	Q147U1	ZN846_HUMAN	51.8	137	66	0	4	414	336	472	1.30E-35	150.6	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4190_c0_g1_i9	Q147U1	ZN846_HUMAN	50	82	41	0	4	249	275	356	7.30E-18	90.9	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN24137_c0_g1_i1	Q147U1	ZN846_HUMAN	69.1	94	29	0	282	1	244	337	3.00E-36	152.1	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29848_c0_g1_i1	Q147U1	ZN846_HUMAN	25.5	149	92	4	2258	2686	310	445	6.40E-09	64.7	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN29848_c0_g1_i2	Q147U1	ZN846_HUMAN	25.5	149	92	4	874	1302	310	445	3.30E-09	64.7	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN137_c2_g1_i1	Q147U1	ZN846_HUMAN	58.3	72	30	0	6	221	375	446	9.10E-21	100.5	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i1	Q147U1	ZN846_HUMAN	49.7	143	72	0	430	2	220	362	5.50E-37	155.2	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i2	Q147U1	ZN846_HUMAN	39.5	266	124	4	867	118	276	520	2.10E-48	194.1	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i5	Q147U1	ZN846_HUMAN	50	80	40	0	367	128	276	355	1.90E-17	90.1	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2159_c0_g1_i6	Q147U1	ZN846_HUMAN	44.3	167	84	2	484	2	339	502	5.70E-35	148.7	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18037_c0_g1_i3	Q147U1	ZN846_HUMAN	44	166	93	0	505	8	343	508	6.00E-35	148.7	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4981_c1_g1_i2	Q147U1	ZN846_HUMAN	60	65	26	0	2	196	423	487	8.00E-18	90.5	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i1	Q147U1	ZN846_HUMAN	41.6	89	52	0	270	4	390	478	1.60E-16	86.7	ZN846_HUMAN	reviewed	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	533	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i10	Q03923	ZNF85_HUMAN	51.2	172	84	0	750	235	262	433	3.70E-49	196.4	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i10	Q03923	ZNF85_HUMAN	53.1	81	38	0	245	3	235	315	6.20E-20	99.4	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4755_c0_g1_i14	Q03923	ZNF85_HUMAN	44.2	398	208	2	1203	10	178	561	1.80E-90	334.3	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i10	Q03923	ZNF85_HUMAN	48.5	101	52	0	308	6	232	332	2.20E-24	112.8	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i13	Q03923	ZNF85_HUMAN	46.5	101	54	0	308	6	232	332	1.40E-23	110.2	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i6	Q03923	ZNF85_HUMAN	48.2	85	44	0	260	6	248	332	6.00E-19	95.5	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10847_c0_g1_i6	Q03923	ZNF85_HUMAN	41.9	117	64	1	426	76	248	360	8.60E-18	91.7	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10236_c0_g1_i1	Q03923	ZNF85_HUMAN	53.2	109	47	1	1	327	264	368	1.00E-27	124	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13394_c1_g1_i1	Q03923	ZNF85_HUMAN	79.4	68	14	0	206	3	453	520	5.40E-27	120.9	ZNF85_HUMAN	reviewed	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	ZNF85	Homo sapiens (Human)	595	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4203_c0_g1_i1	A6NHJ4	ZN860_HUMAN	54.5	55	25	0	196	32	337	391	3.70E-13	75.9	ZN860_HUMAN	reviewed	Zinc finger protein 860	ZNF860	Homo sapiens (Human)	632	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15711_c0_g1_i1	Q3U3I9	ZN865_MOUSE	49.1	57	29	0	48	218	352	408	1.70E-11	69.7	ZN865_MOUSE	reviewed	Zinc finger protein 865	Znf865 Zfp865	Mus musculus (Mouse)	1058	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c43_g1_i1	P10072	ZN875_HUMAN	45.7	94	51	0	290	9	406	499	2.50E-17	89.4	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i9	P10072	ZN875_HUMAN	58.2	67	28	0	585	385	397	463	2.00E-17	91.7	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i9	P10072	ZN875_HUMAN	42.6	94	54	0	335	54	454	547	1.70E-13	78.6	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c2_g1_i1	P10072	ZN875_HUMAN	56.1	66	29	0	199	2	428	493	9.40E-16	83.6	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38268_c0_g1_i1	P10072	ZN875_HUMAN	100	125	0	0	377	3	305	429	6.80E-76	284.3	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13921_c0_g1_i3	P10072	ZN875_HUMAN	48.1	79	41	0	440	204	445	523	1.90E-16	87	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10439_c0_g2_i1	P10072	ZN875_HUMAN	48.8	162	83	0	2	487	409	570	2.70E-40	166.4	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8568_c0_g1_i6	P10072	ZN875_HUMAN	53.4	58	27	0	1	174	417	474	4.20E-11	68.9	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14356_c0_g2_i1	P10072	ZN875_HUMAN	52.9	70	33	0	2	211	450	519	4.20E-15	81.6	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g1_i6	P10072	ZN875_HUMAN	53.7	67	31	0	211	11	421	487	1.10E-14	80.9	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN685_c0_g1_i7	P10072	ZN875_HUMAN	53.7	67	31	0	211	11	421	487	2.10E-14	80.9	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i10	P10072	ZN875_HUMAN	50.7	67	33	0	136	336	431	497	5.60E-13	75.1	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i4	P10072	ZN875_HUMAN	50.6	81	40	0	6	248	445	525	1.60E-17	89.7	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11894_c0_g1_i6	P10072	ZN875_HUMAN	54.3	127	58	0	385	5	406	532	3.20E-36	152.5	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6350_c0_g1_i7	P10072	ZN875_HUMAN	50.4	115	55	1	347	3	431	543	9.80E-29	127.5	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10236_c0_g1_i4	P10072	ZN875_HUMAN	54.3	94	38	2	6	284	462	551	4.80E-21	101.7	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c1_g2_i1	P10072	ZN875_HUMAN	52.9	121	57	0	364	2	441	561	4.40E-32	138.7	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3570_c1_g2_i2	P10072	ZN875_HUMAN	54.2	153	70	0	460	2	409	561	3.20E-43	176	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3058_c0_g2_i1	P10072	ZN875_HUMAN	47	83	43	1	123	371	425	506	8.60E-15	81.3	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18118_c0_g1_i2	P10072	ZN875_HUMAN	45.2	62	34	0	74	259	426	487	2.20E-09	62.8	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18118_c0_g1_i3	P10072	ZN875_HUMAN	46.8	62	33	0	74	259	426	487	2.60E-10	65.9	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i19	P10072	ZN875_HUMAN	42.2	135	68	2	1	384	434	565	2.30E-22	107.1	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i2	P10072	ZN875_HUMAN	50	126	48	1	4	381	441	551	2.70E-27	122.9	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18222_c0_g2_i4	P10072	ZN875_HUMAN	53	100	47	0	2	301	424	523	2.20E-24	112.8	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN17531_c0_g1_i1	P10072	ZN875_HUMAN	46.2	78	42	0	248	15	441	518	2.90E-14	79	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c1_g1_i1	P10072	ZN875_HUMAN	49.7	163	78	1	491	3	329	487	8.40E-42	171.4	ZN875_HUMAN	reviewed	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	659	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006355; GO:0006357; GO:0007275; GO:0046872	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6651_c0_g1_i1	C9JN71	ZN878_HUMAN	32.5	274	167	8	1318	521	117	380	7.40E-35	149.8	ZN878_HUMAN	reviewed	Zinc finger protein 878	ZNF878	Homo sapiens (Human)	531	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18123_c0_g1_i11	Q6PDB4	ZN880_HUMAN	55.3	47	21	0	187	47	272	318	7.90E-09	60.5	ZN880_HUMAN	reviewed	Zinc finger protein 880	ZNF880	Homo sapiens (Human)	577	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i19	P0CJ79	ZN888_HUMAN	42.2	90	52	0	273	4	294	383	6.60E-18	91.7	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i10	P0CJ79	ZN888_HUMAN	39.7	78	40	1	3	236	282	352	4.00E-11	68.6	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN15188_c0_g1_i1	P0CJ79	ZN888_HUMAN	32.4	281	167	8	69	902	385	645	1.10E-32	142.1	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN10685_c0_g1_i1	P0CJ79	ZN888_HUMAN	37.4	171	94	2	2	514	512	669	1.60E-29	131	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN3399_c0_g1_i2	P0CJ79	ZN888_HUMAN	40.7	172	90	2	124	639	478	637	2.30E-31	137.1	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1071_c0_g1_i6	P0CJ79	ZN888_HUMAN	42.4	151	87	0	457	5	478	628	2.10E-31	136.7	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i1	P0CJ79	ZN888_HUMAN	46.5	86	46	0	8	265	316	401	2.10E-18	92.8	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5001_c0_g1_i12	P0CJ79	ZN888_HUMAN	44.2	86	48	0	1	258	316	401	1.90E-16	86.3	ZN888_HUMAN	reviewed	Zinc finger protein 888	ZNF888	Homo sapiens (Human)	718	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c4_g1_i5	A8MT65	ZN891_HUMAN	45.7	70	38	0	216	7	344	413	8.30E-15	81.6	ZN891_HUMAN	reviewed	Zinc finger protein 891	ZNF891	Homo sapiens (Human)	544	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i4	A8MT65	ZN891_HUMAN	42	81	42	1	8	250	437	512	7.10E-13	74.3	ZN891_HUMAN	reviewed	Zinc finger protein 891	ZNF891	Homo sapiens (Human)	544	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN2461_c0_g1_i9	A8MT65	ZN891_HUMAN	42.2	83	48	0	5	253	430	512	1.40E-16	86.7	ZN891_HUMAN	reviewed	Zinc finger protein 891	ZNF891	Homo sapiens (Human)	544	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i12	A8MT65	ZN891_HUMAN	37.3	67	42	0	201	1	344	410	2.00E-09	63.2	ZN891_HUMAN	reviewed	Zinc finger protein 891	ZNF891	Homo sapiens (Human)	544	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i14	A8MT65	ZN891_HUMAN	37.3	67	42	0	201	1	344	410	2.60E-09	63.2	ZN891_HUMAN	reviewed	Zinc finger protein 891	ZNF891	Homo sapiens (Human)	544	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8463_c0_g1_i7	A8MT65	ZN891_HUMAN	37.3	67	42	0	201	1	344	410	2.40E-09	63.2	ZN891_HUMAN	reviewed	Zinc finger protein 891	ZNF891	Homo sapiens (Human)	544	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c0_g1_i4	Q61967	ZFP90_MOUSE	43.2	111	61	2	4	336	272	380	2.00E-19	96.7	ZFP90_MOUSE	reviewed	Zinc finger protein 90 (Zfp-90) (Zinc finger protein NK10)	Zfp90 Nk10	Mus musculus (Mouse)	636	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0043392; GO:0045892; GO:0045893; GO:0046872	"negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2969_c4_g1_i1	Q03938	ZNF90_HUMAN	44.3	61	34	0	34	216	503	563	3.20E-09	62	ZNF90_HUMAN	reviewed	Zinc finger protein 90 (Zinc finger protein HTF9)	ZNF90	Homo sapiens (Human)	601	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN14491_c0_g1_i1	Q03938	ZNF90_HUMAN	41.1	56	33	0	3	170	533	588	1.90E-08	59.3	ZNF90_HUMAN	reviewed	Zinc finger protein 90 (Zinc finger protein HTF9)	ZNF90	Homo sapiens (Human)	601	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i10	Q8TF47	ZFP90_HUMAN	51.5	101	46	1	294	1	515	615	2.40E-24	112.8	ZFP90_HUMAN	reviewed	Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756)	ZFP90 KIAA1954 ZNF756	Homo sapiens (Human)	636	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0043392; GO:0045893; GO:0046872	"negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6064_c0_g1_i1	Q8TF47	ZFP90_HUMAN	49	104	51	2	306	1	510	613	1.20E-22	107.1	ZFP90_HUMAN	reviewed	Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756)	ZFP90 KIAA1954 ZNF756	Homo sapiens (Human)	636	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0043392; GO:0045893; GO:0046872	"negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3745_c0_g1_i6	Q8TF47	ZFP90_HUMAN	55.6	63	28	0	190	2	520	582	3.90E-15	82.4	ZFP90_HUMAN	reviewed	Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756)	ZFP90 KIAA1954 ZNF756	Homo sapiens (Human)	636	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0043392; GO:0045893; GO:0046872	"negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20061_c0_g1_i1	Q8TF47	ZFP90_HUMAN	52.2	46	22	0	11	148	351	396	1.10E-07	57	ZFP90_HUMAN	reviewed	Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756)	ZFP90 KIAA1954 ZNF756	Homo sapiens (Human)	636	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0043392; GO:0045893; GO:0046872	"negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g1_i4	Q05481	ZNF91_HUMAN	59.8	102	41	0	211	516	912	1013	2.40E-31	136.7	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5625_c0_g1_i4	Q05481	ZNF91_HUMAN	45.3	86	46	1	23	277	1073	1158	2.60E-17	90.1	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4751_c0_g1_i2	Q05481	ZNF91_HUMAN	47.8	46	24	0	335	198	999	1044	6.60E-06	51.6	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4751_c0_g1_i5	Q05481	ZNF91_HUMAN	47.8	46	24	0	369	232	999	1044	7.30E-06	51.6	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4751_c0_g1_i7	Q05481	ZNF91_HUMAN	47.8	46	24	0	404	267	999	1044	8.00E-06	51.6	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i1	Q05481	ZNF91_HUMAN	48.7	187	96	0	5	565	970	1156	5.40E-51	202.2	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i10	Q05481	ZNF91_HUMAN	47.1	104	54	1	5	316	998	1100	2.10E-23	109.8	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2093_c0_g1_i7	Q05481	ZNF91_HUMAN	46.3	67	36	0	1	201	1034	1100	1.30E-11	70.1	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7847_c0_g1_i17	Q05481	ZNF91_HUMAN	37.6	178	109	2	10	540	504	680	1.90E-28	127.5	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6057_c1_g2_i4	Q05481	ZNF91_HUMAN	48.1	129	59	2	6	392	931	1051	8.50E-29	127.9	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5236_c0_g1_i7	Q05481	ZNF91_HUMAN	54.7	137	60	1	414	4	939	1073	2.00E-39	163.7	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12968_c0_g3_i1	Q05481	ZNF91_HUMAN	55.6	117	52	0	2	352	940	1056	1.40E-35	150.2	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c0_g1_i1	Q05481	ZNF91_HUMAN	59.8	117	46	1	11	361	932	1047	1.60E-37	156.8	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c0_g1_i2	Q05481	ZNF91_HUMAN	63.5	74	27	0	5	226	958	1031	3.40E-24	112.5	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1476_c0_g1_i2	Q05481	ZNF91_HUMAN	51.9	52	24	1	207	362	773	823	2.90E-07	56.2	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g2_i1	Q05481	ZNF91_HUMAN	46.7	105	56	0	2	316	996	1100	1.50E-24	113.6	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i5	Q05481	ZNF91_HUMAN	50.6	85	40	1	5	253	940	1024	1.40E-18	93.6	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1037_c0_g1_i5	Q05481	ZNF91_HUMAN	65.8	38	13	0	181	294	944	981	9.70E-09	60.8	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN310_c1_g3_i9	Q05481	ZNF91_HUMAN	50	70	35	0	210	1	975	1044	2.00E-15	82.8	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5872_c1_g2_i2	Q05481	ZNF91_HUMAN	54.1	74	34	0	21	242	972	1045	4.60E-17	88.2	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2284_c0_g1_i8	Q05481	ZNF91_HUMAN	51.4	74	36	0	3	224	944	1017	1.10E-17	90.1	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i1	Q05481	ZNF91_HUMAN	45	80	43	1	241	5	905	984	5.40E-16	84.7	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2282_c0_g1_i4	Q05481	ZNF91_HUMAN	49.1	114	58	0	346	5	905	1018	1.60E-29	130.2	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15857_c0_g1_i1	Q05481	ZNF91_HUMAN	62.5	64	24	0	5	196	966	1029	4.00E-18	91.7	ZNF91_HUMAN	reviewed	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	ZNF91	Homo sapiens (Human)	1191	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i8	Q03936	ZNF92_HUMAN	52.9	70	33	0	213	4	195	264	2.90E-17	89.4	ZNF92_HUMAN	reviewed	Zinc finger protein 92 (Zinc finger protein HTF12)	ZNF92	Homo sapiens (Human)	586	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8377_c0_g1_i3	Q03936	ZNF92_HUMAN	44.8	67	36	1	3	200	214	280	2.30E-09	63.2	ZNF92_HUMAN	reviewed	Zinc finger protein 92 (Zinc finger protein HTF12)	ZNF92	Homo sapiens (Human)	586	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4591_c0_g1_i1	P35789	ZNF93_HUMAN	46.2	385	206	1	1189	38	203	587	5.90E-105	382.5	ZNF93_HUMAN	reviewed	Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34)	ZNF93 ZNF505	Homo sapiens (Human)	620	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4591_c0_g1_i6	P35789	ZNF93_HUMAN	46.2	385	206	1	1189	38	203	587	5.90E-105	382.5	ZNF93_HUMAN	reviewed	Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34)	ZNF93 ZNF505	Homo sapiens (Human)	620	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10917_c0_g1_i1	P35789	ZNF93_HUMAN	39.1	128	74	3	404	21	283	406	1.10E-19	97.8	ZNF93_HUMAN	reviewed	Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34)	ZNF93 ZNF505	Homo sapiens (Human)	620	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i19	A6NK75	ZNF98_HUMAN	48.5	68	35	0	241	38	329	396	3.90E-11	68.6	ZNF98_HUMAN	reviewed	Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175)	ZNF98 ZNF739	Homo sapiens (Human)	572	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12597_c0_g2_i5	A6NK75	ZNF98_HUMAN	51.9	81	39	0	253	11	316	396	1.80E-19	96.7	ZNF98_HUMAN	reviewed	Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175)	ZNF98 ZNF739	Homo sapiens (Human)	572	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN40886_c0_g1_i1	A6NK75	ZNF98_HUMAN	66.2	68	23	0	204	1	200	267	5.20E-23	107.8	ZNF98_HUMAN	reviewed	Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175)	ZNF98 ZNF739	Homo sapiens (Human)	572	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i9	A6NK75	ZNF98_HUMAN	51.7	116	53	1	419	72	429	541	6.90E-29	128.3	ZNF98_HUMAN	reviewed	Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175)	ZNF98 ZNF739	Homo sapiens (Human)	572	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9019_c0_g1_i1	A8MXY4	ZNF99_HUMAN	39.2	189	115	0	583	17	539	727	2.30E-46	186.8	ZNF99_HUMAN	reviewed	Zinc finger protein 99	ZNF99 C19orf9	Homo sapiens (Human)	864	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23983_c0_g1_i1	A2VDW9	IKZF3_BOVIN	48.2	56	29	0	202	35	145	200	1.20E-10	66.6	IKZF3_BOVIN	reviewed	Zinc finger protein Aiolos (Ikaros family zinc finger protein 3)	IKZF3 ZNFN1A3	Bos taurus (Bovine)	509	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; B cell activation [GO:0042113]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of B cell proliferation [GO:0030888]; regulation of lymphocyte differentiation [GO:0045619]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000790; GO:0000978; GO:0001228; GO:0003700; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0009617; GO:0030888; GO:0042113; GO:0042803; GO:0042826; GO:0042981; GO:0043565; GO:0045577; GO:0045619; GO:0046872; GO:1990841	B cell activation [GO:0042113]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of B cell proliferation [GO:0030888]; regulation of lymphocyte differentiation [GO:0045619]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]		NA	NA	NA	NA	NA	NA
TRINITY_DN37165_c0_g1_i1	Q01954	BNC1_HUMAN	52.9	119	56	0	365	9	80	198	1.10E-29	131	BNC1_HUMAN	reviewed	Zinc finger protein basonuclin-1	BNC1 BNC	Homo sapiens (Human)	994	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity [GO:0001216]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription activator activity [GO:0001216]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000182; GO:0000977; GO:0001216; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0007283; GO:0008284; GO:0008544; GO:0030154; GO:0043231; GO:0045943; GO:0046872; GO:1900195	cell differentiation [GO:0030154]; epidermis development [GO:0008544]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]		NA	NA	NA	NA	NA	NA
TRINITY_DN13759_c0_g1_i1	Q9P370	BUD20_SCHPO	52.3	88	42	0	25	288	26	113	1.20E-19	97.1	BUD20_SCHPO	reviewed	Zinc finger protein bud20	bud20 SPAC19B12.11c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	124	nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005634; GO:0005730; GO:0008270; GO:0042254	ribosome biogenesis [GO:0042254]		red	red	NA	NA	NA	NA
TRINITY_DN6842_c0_g2_i1	Q9VQ30	CHNMO_DROME	37.1	143	90	0	96	524	5	147	5.30E-22	106.3	CHNMO_DROME	reviewed	Zinc finger protein chinmo (Protein chronologically inappropriate morphogenesis)	chinmo CG31666	Drosophila melanogaster (Fruit fly)	604	nucleus [GO:0005634]; metal ion binding [GO:0046872]; eye-antennal disc development [GO:0035214]; import into nucleus [GO:0051170]; male somatic sex determination [GO:0019102]; mushroom body development [GO:0016319]; negative regulation of protein phosphorylation [GO:0001933]; neuron development [GO:0048666]; positive regulation of actin filament polymerization [GO:0030838]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0001933; GO:0005634; GO:0006357; GO:0007548; GO:0016319; GO:0019102; GO:0030838; GO:0035214; GO:0046872; GO:0048666; GO:0051170; GO:2000035	eye-antennal disc development [GO:0035214]; import into nucleus [GO:0051170]; male somatic sex determination [GO:0019102]; mushroom body development [GO:0016319]; negative regulation of protein phosphorylation [GO:0001933]; neuron development [GO:0048666]; positive regulation of actin filament polymerization [GO:0030838]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]		NA	NA	NA	NA	NA	NA
TRINITY_DN28888_c0_g1_i1	P30373	CKR1_CHICK	43.1	72	41	0	11	226	192	263	1.20E-11	70.1	CKR1_CHICK	reviewed	Zinc finger protein CKR1		Gallus gallus (Chicken)	509	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c2_g2_i2	Q9W747	DRL_DANRE	52.1	48	23	0	10	153	42	89	6.60E-10	64.3	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c2_g2_i3	Q9W747	DRL_DANRE	52.4	42	20	0	10	135	42	83	4.10E-08	58.5	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i1	Q9W747	DRL_DANRE	48.1	52	27	0	233	78	38	89	3.20E-10	65.5	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i2	Q9W747	DRL_DANRE	47.2	53	27	1	233	75	38	89	1.80E-08	59.7	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i3	Q9W747	DRL_DANRE	47.2	53	27	1	236	78	38	89	1.40E-08	60.1	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c6_g1_i31	Q9W747	DRL_DANRE	47.2	53	27	1	306	148	38	89	1.80E-08	60.1	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN495_c1_g3_i1	Q9W747	DRL_DANRE	36.1	119	76	0	361	5	144	262	3.40E-16	86.3	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN37429_c0_g1_i1	Q9W747	DRL_DANRE	43.1	51	28	1	156	4	34	83	7.80E-05	47.4	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12160_c0_g1_i4	Q9W747	DRL_DANRE	51.1	45	22	0	225	91	45	89	2.80E-08	58.9	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN12858_c1_g1_i2	Q9W747	DRL_DANRE	46.9	49	25	1	245	99	42	89	3.40E-07	55.5	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c1_g1_i3	Q9W747	DRL_DANRE	46.9	49	25	1	248	102	42	89	3.40E-07	55.5	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN15900_c1_g1_i1	Q9W747	DRL_DANRE	37.1	70	43	1	212	6	129	198	2.60E-08	58.9	DRL_DANRE	reviewed	Zinc finger protein draculin	drl dra si:dkey-261j4.2	Danio rerio (Zebrafish) (Brachydanio rerio)	411	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0001702; GO:0003677; GO:0005634; GO:0006357; GO:0043565; GO:0046872	gastrulation with mouth forming second [GO:0001702]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN27565_c0_g1_i1	Q9VJS8	ELBOW_DROME	52.9	85	29	4	60	296	429	508	6.90E-15	81.3	ELBOW_DROME	reviewed	Zinc finger protein Elbow	elB CG4220	Drosophila melanogaster (Fruit fly)	553	"nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; imaginal disc-derived appendage development [GO:0048737]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; open tracheal system development [GO:0007424]; wing disc development [GO:0035220]"	nuclear chromosome [GO:0000228]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]	GO:0000228; GO:0001752; GO:0005634; GO:0007219; GO:0007424; GO:0010629; GO:0035214; GO:0035220; GO:0045892; GO:0046872; GO:0048737; GO:0070491	"compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; imaginal disc-derived appendage development [GO:0048737]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; open tracheal system development [GO:0007424]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN37925_c0_g1_i1	Q5DWN0	GFI1_CANLF	47.9	48	22	1	60	203	342	386	3.20E-06	52	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g2_i1	Q5DWN0	GFI1_CANLF	45.5	55	30	0	195	31	327	381	1.90E-08	59.7	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g2_i3	Q5DWN0	GFI1_CANLF	40.6	64	38	0	240	49	327	390	2.60E-09	62.8	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN13916_c0_g3_i1	Q5DWN0	GFI1_CANLF	66.7	27	9	0	25	105	388	414	5.10E-05	48.5	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28985_c0_g1_i1	Q5DWN0	GFI1_CANLF	97.7	88	2	0	266	3	335	422	5.00E-49	194.5	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6485_c0_g1_i4	Q5DWN0	GFI1_CANLF	45.9	61	33	0	9	191	330	390	1.20E-11	70.1	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN796_c0_g2_i1	Q5DWN0	GFI1_CANLF	52	50	24	0	2	151	321	370	1.60E-08	59.7	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30569_c0_g1_i1	Q5DWN0	GFI1_CANLF	100	86	0	0	1	258	249	334	1.30E-46	186.4	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0043565; GO:0046872; GO:0051569; GO:0070105; GO:0071222	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2207_c0_g1_i13	Q5VTD9	GFI1B_HUMAN	39.7	58	35	0	179	6	265	322	5.10E-08	58.5	GFI1B_HUMAN	reviewed	Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML)	GFI1B	Homo sapiens (Human)	330	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001085; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005886; GO:0006325; GO:0006357; GO:0007275; GO:0016363; GO:0046872; GO:1903706; GO:1990837; GO:2000134	chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g2_i2	O42409	GFI1B_CHICK	46.2	80	43	0	270	31	217	296	2.60E-16	85.9	GFI1B_CHICK	reviewed	Zinc finger protein Gfi-1b (Growth factor-independent protein 1B)	GFI1B GFI	Gallus gallus (Chicken)	337	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]"	GO:0000978; GO:0001085; GO:0001227; GO:0005654; GO:0005667; GO:0005886; GO:0006325; GO:0006357; GO:0007275; GO:0016363; GO:0046872	chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN14759_c0_g2_i4	O42409	GFI1B_CHICK	42.7	89	51	0	315	49	217	305	4.60E-17	88.6	GFI1B_CHICK	reviewed	Zinc finger protein Gfi-1b (Growth factor-independent protein 1B)	GFI1B GFI	Gallus gallus (Chicken)	337	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]"	GO:0000978; GO:0001085; GO:0001227; GO:0005654; GO:0005667; GO:0005886; GO:0006325; GO:0006357; GO:0007275; GO:0016363; GO:0046872	chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6674_c0_g1_i18	P53849	GIS2_YEAST	41.3	46	22	1	791	928	94	134	8.40E-05	49.7	GIS2_YEAST	reviewed	Zinc finger protein GIS2	GIS2 YNL255C N0852	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	153	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; polysomal ribosome [GO:0042788]; mRNA binding [GO:0003729]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0000932; GO:0003697; GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0010494; GO:0042788; GO:0045182; GO:2000767	positive regulation of cytoplasmic translation [GO:2000767]		NA	NA	1	NA	NA	NA
TRINITY_DN35188_c0_g1_i1	P55878	GLI1_CHICK	39.7	58	35	0	51	224	313	370	5.50E-09	61.2	GLI1_CHICK	reviewed	Zinc finger protein GLI1 (GLI) (Fragment)	GLI1 GLI	Gallus gallus (Chicken)	556	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; pituitary gland development [GO:0021983]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; smoothened signaling pathway [GO:0007224]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0003682; GO:0005634; GO:0005737; GO:0007224; GO:0010628; GO:0021983; GO:0030154; GO:0043565; GO:0045893; GO:0045944; GO:0046872	"cell differentiation [GO:0030154]; pituitary gland development [GO:0021983]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smoothened signaling pathway [GO:0007224]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24824_c0_g1_i1	P10075	GLI4_HUMAN	84.8	92	14	0	277	2	179	270	5.50E-46	184.5	GLI4_HUMAN	reviewed	Zinc finger protein GLI4 (Krueppel-related zinc finger protein 4) (Protein HKR4)	GLI4 HKR4	Homo sapiens (Human)	376	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear chromatin [GO:0000790]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28723_c0_g1_i1	Q98T94	GLIS2_XENLA	76.2	42	10	0	61	186	209	250	1.80E-12	72.8	GLIS2_XENLA	reviewed	Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein)	glis2 nkl	Xenopus laevis (African clawed frog)	492	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005737; GO:0007399; GO:0016607; GO:0030154; GO:0045892; GO:0045893; GO:0046872	"cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription, DNA-templated [GO:0045893]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11782_c0_g1_i4	Q9UKS7	IKZF2_HUMAN	44.4	54	30	0	407	246	138	191	1.00E-08	61.2	IKZF2_HUMAN	reviewed	Zinc finger protein Helios (Ikaros family zinc finger protein 2)	IKZF2 HELIOS ZNFN1A2	Homo sapiens (Human)	526	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0042802; GO:0045944; GO:0046872	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6778_c0_g1_i1	Q80YP6	ZIK1_MOUSE	30.8	143	87	3	400	5	161	302	8.40E-08	60.5	ZIK1_MOUSE	reviewed	Zinc finger protein interacting with ribonucleoprotein K	Zik1	Mus musculus (Mouse)	463	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6778_c0_g1_i2	Q80YP6	ZIK1_MOUSE	30.8	143	87	3	400	5	161	302	8.50E-08	60.5	ZIK1_MOUSE	reviewed	Zinc finger protein interacting with ribonucleoprotein K	Zik1	Mus musculus (Mouse)	463	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN39580_c0_g1_i1	Q7KHG2	JING_DROME	54.3	116	45	2	34	363	1127	1240	2.90E-29	129.4	JING_DROME	reviewed	Zinc finger protein jing (Zinc finger protein rhumba)	jing rhumba CG9397 CG9403	Drosophila melanogaster (Fruit fly)	1486	"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]"	ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0000122; GO:0005634; GO:0006325; GO:0007298; GO:0007382; GO:0007411; GO:0007417; GO:0007418; GO:0007424; GO:0007474; GO:0007479; GO:0008347; GO:0035098; GO:0042246; GO:0045944; GO:0046872	"axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]"		NA	NA	NA	NA	NA	NA
TRINITY_DN39580_c0_g1_i2	Q7KHG2	JING_DROME	66.2	74	23	1	26	247	1169	1240	3.80E-23	108.6	JING_DROME	reviewed	Zinc finger protein jing (Zinc finger protein rhumba)	jing rhumba CG9397 CG9403	Drosophila melanogaster (Fruit fly)	1486	"ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]"	ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0000122; GO:0005634; GO:0006325; GO:0007298; GO:0007382; GO:0007411; GO:0007417; GO:0007418; GO:0007424; GO:0007474; GO:0007479; GO:0008347; GO:0035098; GO:0042246; GO:0045944; GO:0046872	"axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; glial cell migration [GO:0008347]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; open tracheal system development [GO:0007424]; positive regulation of transcription by RNA polymerase II [GO:0045944]; specification of segmental identity, maxillary segment [GO:0007382]; tissue regeneration [GO:0042246]; ventral midline development [GO:0007418]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30954_c0_g1_i1	Q17PR1	JING_AEDAE	37.1	151	78	5	557	108	1353	1487	9.90E-15	81.6	JING_AEDAE	reviewed	Zinc finger protein jing homolog	AAEL000263	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1605	nucleus [GO:0005634]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006325; GO:0046872	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN30954_c0_g1_i2	Q17PR1	JING_AEDAE	39.2	143	78	5	533	108	1353	1487	6.60E-16	85.5	JING_AEDAE	reviewed	Zinc finger protein jing homolog	AAEL000263	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	1605	nucleus [GO:0005634]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]	nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0006325; GO:0046872	chromatin organization [GO:0006325]		NA	NA	NA	NA	NA	NA
TRINITY_DN5400_c0_g3_i2	Q92782	DPF1_HUMAN	63	54	15	1	27	173	319	372	7.20E-16	84.3	DPF1_HUMAN	reviewed	"Zinc finger protein neuro-d4 (BRG1-associated factor 45B) (BAF45B) (D4, zinc and double PHD fingers family 1)"	DPF1 BAF45B NEUD4	Homo sapiens (Human)	380	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]	histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000790; GO:0003712; GO:0005737; GO:0006915; GO:0007399; GO:0008270; GO:0042393; GO:0045892; GO:0045944; GO:0071565; GO:1990837	"apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35684_c0_g1_i5	Q9QX66	DPF1_MOUSE	39	105	64	0	329	643	274	378	4.20E-22	107.1	DPF1_MOUSE	reviewed	"Zinc finger protein neuro-d4 (BRG1-associated factor 45B) (BAF45B) (D4, zinc and double PHD fingers family 1)"	Dpf1 Baf45b Neud4	Mus musculus (Mouse)	387	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]	histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000790; GO:0003712; GO:0005737; GO:0007399; GO:0008270; GO:0042393; GO:0045892; GO:0045944; GO:0071565; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35684_c0_g1_i6	Q9QX66	DPF1_MOUSE	39	105	64	0	114	428	274	378	3.40E-22	107.1	DPF1_MOUSE	reviewed	"Zinc finger protein neuro-d4 (BRG1-associated factor 45B) (BAF45B) (D4, zinc and double PHD fingers family 1)"	Dpf1 Baf45b Neud4	Mus musculus (Mouse)	387	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]	histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000790; GO:0003712; GO:0005737; GO:0007399; GO:0008270; GO:0042393; GO:0045892; GO:0045944; GO:0071565; GO:1990837	"negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN36214_c0_g1_i1	Q24423	NOC_DROME	78.5	65	10	3	6	188	1	65	7.40E-17	87.4	NOC_DROME	reviewed	Zinc finger protein Noc (Zinc finger protein NocA)	noc nocA CG4491	Drosophila melanogaster (Fruit fly)	537	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]	GO:0001752; GO:0003677; GO:0005634; GO:0007219; GO:0007420; GO:0007424; GO:0007430; GO:0008056; GO:0010629; GO:0035214; GO:0035218; GO:0035220; GO:0045892; GO:0046872; GO:0070491	"brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN27931_c0_g1_i1	Q24423	NOC_DROME	55.7	61	26	1	63	245	311	370	1.50E-15	83.2	NOC_DROME	reviewed	Zinc finger protein Noc (Zinc finger protein NocA)	noc nocA CG4491	Drosophila melanogaster (Fruit fly)	537	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]	GO:0001752; GO:0003677; GO:0005634; GO:0007219; GO:0007420; GO:0007424; GO:0007430; GO:0008056; GO:0010629; GO:0035214; GO:0035218; GO:0035220; GO:0045892; GO:0046872; GO:0070491	"brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN29348_c0_g1_i1	Q24423	NOC_DROME	55.8	52	22	1	199	47	311	362	7.60E-12	70.9	NOC_DROME	reviewed	Zinc finger protein Noc (Zinc finger protein NocA)	noc nocA CG4491	Drosophila melanogaster (Fruit fly)	537	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]	GO:0001752; GO:0003677; GO:0005634; GO:0007219; GO:0007420; GO:0007424; GO:0007430; GO:0008056; GO:0010629; GO:0035214; GO:0035218; GO:0035220; GO:0045892; GO:0046872; GO:0070491	"brain development [GO:0007420]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8749_c1_g1_i1	Q15072	OZF_HUMAN	45.8	72	39	0	3	218	18	89	6.20E-13	74.3	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN495_c6_g1_i6	Q15072	OZF_HUMAN	52	102	49	0	306	1	44	145	7.70E-26	117.9	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN30854_c0_g1_i1	Q28151	OZF_BOVIN	100	120	0	0	3	362	173	292	3.20E-70	265.4	OZF_BOVIN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Bos taurus (Bovine)	292	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8024_c0_g1_i15	Q15072	OZF_HUMAN	43.3	150	78	1	135	563	12	161	9.60E-32	138.3	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8372_c0_g1_i1	Q15072	OZF_HUMAN	55.7	115	51	0	121	465	48	162	3.90E-33	142.5	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN8372_c0_g1_i3	Q15072	OZF_HUMAN	57.1	91	39	0	157	429	72	162	1.30E-25	117.5	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN19703_c0_g1_i1	Q15072	OZF_HUMAN	52.8	72	34	0	6	221	72	143	7.40E-17	87.4	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN11018_c1_g1_i1	Q15072	OZF_HUMAN	47.8	67	35	0	203	3	38	104	2.20E-15	82.4	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9785_c0_g1_i6	Q8BQN6	OZF_MOUSE	52.4	63	30	0	199	11	28	90	1.10E-11	70.1	OZF_MOUSE	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	Znf146 Ozf Zfp146	Mus musculus (Mouse)	292	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005730; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1245_c0_g1_i1	Q8BQN6	OZF_MOUSE	31.7	271	160	13	1609	809	41	290	1.30E-28	129.8	OZF_MOUSE	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	Znf146 Ozf Zfp146	Mus musculus (Mouse)	292	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005730; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1245_c0_g1_i3	Q8BQN6	OZF_MOUSE	31.7	271	160	13	1609	809	41	290	1.30E-28	129.8	OZF_MOUSE	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	Znf146 Ozf Zfp146	Mus musculus (Mouse)	292	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005730; GO:0005829; GO:0006357; GO:0046872	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN1340_c2_g2_i2	Q15072	OZF_HUMAN	50.6	83	41	0	3	251	46	128	2.80E-17	89	OZF_HUMAN	reviewed	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	292	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28901_c0_g1_i1	Q6DBW0	IKZF5_DANRE	42.7	82	45	1	5	250	74	153	1.40E-16	86.7	IKZF5_DANRE	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5 zgc:92405	Danio rerio (Zebrafish) (Brachydanio rerio)	419	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003140; GO:0003700; GO:0006357; GO:0007368; GO:0035469; GO:0046872; GO:0071908	determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i1	Q6DBW0	IKZF5_DANRE	40	100	58	1	493	194	81	178	6.50E-17	89.7	IKZF5_DANRE	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5 zgc:92405	Danio rerio (Zebrafish) (Brachydanio rerio)	419	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003140; GO:0003700; GO:0006357; GO:0007368; GO:0035469; GO:0046872; GO:0071908	determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2956_c1_g1_i2	Q6DBW0	IKZF5_DANRE	40	100	58	1	797	498	81	178	8.50E-17	89.7	IKZF5_DANRE	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5 zgc:92405	Danio rerio (Zebrafish) (Brachydanio rerio)	419	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003140; GO:0003700; GO:0006357; GO:0007368; GO:0035469; GO:0046872; GO:0071908	determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN8238_c0_g1_i1	Q6NRM0	IKZF5_XENLA	29	107	68	2	117	416	71	176	3.40E-09	63.2	IKZF5_XENLA	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5	Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN8238_c0_g1_i2	A0JPB4	IKZF5_XENTR	28.8	118	76	2	229	561	41	157	1.90E-09	64.3	IKZF5_XENTR	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5 TEgg054g02.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	434	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003700; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN6315_c0_g1_i1	Q6NRM0	IKZF5_XENLA	40.2	87	52	0	286	26	106	192	2.70E-16	85.9	IKZF5_XENLA	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5	Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6315_c0_g1_i2	Q6NRM0	IKZF5_XENLA	43.5	69	39	0	232	26	124	192	7.60E-13	74.3	IKZF5_XENLA	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5	Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN6315_c0_g2_i1	Q6NRM0	IKZF5_XENLA	44.6	92	50	1	345	70	85	175	7.60E-18	91.7	IKZF5_XENLA	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5	Xenopus laevis (African clawed frog)	453	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN35011_c0_g1_i1	A4IFJ6	IKZF5_BOVIN	54.8	62	28	0	204	19	100	161	5.80E-16	84.3	IKZF5_BOVIN	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	IKZF5	Bos taurus (Bovine)	419	"nuclear chromatin [GO:0000790]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear chromatin [GO:0000790]; protein-containing complex [GO:0032991]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000790; GO:0000978; GO:0001227; GO:0003700; GO:0006357; GO:0008270; GO:0019904; GO:0032991	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN39785_c0_g1_i1	Q6DBW0	IKZF5_DANRE	37.7	69	43	0	7	213	90	158	1.10E-09	63.5	IKZF5_DANRE	reviewed	Zinc finger protein Pegasus (Ikaros family zinc finger protein 5)	ikzf5 zgc:92405	Danio rerio (Zebrafish) (Brachydanio rerio)	419	nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0003140; GO:0003700; GO:0006357; GO:0007368; GO:0035469; GO:0046872; GO:0071908	determination of intestine left/right asymmetry [GO:0071908]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of pancreatic left/right asymmetry [GO:0035469]; regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i3	Q9N658	GFI1_DROME	39.7	58	35	0	517	690	434	491	4.70E-06	53.1	GFI1_DROME	reviewed	Zinc finger protein sens (Protein senseless)	sens Lyra CG32120	Drosophila melanogaster (Fruit fly)	541	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; visual perception [GO:0007601]"	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0007219; GO:0007411; GO:0007422; GO:0007423; GO:0007601; GO:0008407; GO:0008594; GO:0016360; GO:0042051; GO:0043066; GO:0043425; GO:0043565; GO:0045872; GO:0045944; GO:0046530; GO:0046872	axon guidance [GO:0007411]; chaeta morphogenesis [GO:0008407]; compound eye photoreceptor development [GO:0042051]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; visual perception [GO:0007601]		NA	NA	NA	NA	NA	NA
TRINITY_DN6122_c1_g1_i1	O95863	SNAI1_HUMAN	52.1	48	20	1	296	153	182	226	1.80E-08	60.8	SNAI1_HUMAN	reviewed	Zinc finger protein SNAI1 (Protein snail homolog 1) (Protein sna)	SNAI1 SNAH	Homo sapiens (Human)	264	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration [GO:0016477]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle morphogenesis [GO:0031069]; heterochromatin organization [GO:0070828]; left/right pattern formation [GO:0060972]; mesoderm formation [GO:0001707]; negative regulation of cell differentiation involved in embryonic placenta development [GO:0060806]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; Notch signaling involved in heart development [GO:0061314]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; trophoblast giant cell differentiation [GO:0060707]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0001227; GO:0001649; GO:0001707; GO:0001837; GO:0003180; GO:0003198; GO:0003700; GO:0005634; GO:0005654; GO:0005721; GO:0005737; GO:0005829; GO:0006357; GO:0010718; GO:0010957; GO:0016477; GO:0019900; GO:0030335; GO:0031069; GO:0043518; GO:0045893; GO:0046872; GO:0060021; GO:0060536; GO:0060707; GO:0060806; GO:0060972; GO:0061314; GO:0070828; GO:0070888; GO:1902230; GO:1990837; GO:2000810	"aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration [GO:0016477]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle morphogenesis [GO:0031069]; heterochromatin organization [GO:0070828]; left/right pattern formation [GO:0060972]; mesoderm formation [GO:0001707]; negative regulation of cell differentiation involved in embryonic placenta development [GO:0060806]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; Notch signaling involved in heart development [GO:0061314]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; trophoblast giant cell differentiation [GO:0060707]"		NA	NA	NA	NA	NA	NA
TRINITY_DN10921_c0_g1_i2	O43623	SNAI2_HUMAN	49.1	57	29	0	598	428	178	234	2.20E-10	67.4	SNAI2_HUMAN	reviewed	Zinc finger protein SNAI2 (Neural crest transcription factor Slug) (Protein snail homolog 2)	SNAI2 SLUG SLUGH	Homo sapiens (Human)	268	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to ionizing radiation [GO:0071479]; desmosome disassembly [GO:0035921]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; epithelium development [GO:0060429]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; neural crest cell development [GO:0014032]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; osteoblast differentiation [GO:0001649]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of histone acetylation [GO:0035066]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]; regulation of chemokine production [GO:0032642]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001649; GO:0001837; GO:0003180; GO:0003198; GO:0003273; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006933; GO:0007219; GO:0007605; GO:0010839; GO:0010957; GO:0014032; GO:0030335; GO:0032331; GO:0032642; GO:0033629; GO:0035066; GO:0035921; GO:0043473; GO:0043518; GO:0043565; GO:0045600; GO:0045667; GO:0046872; GO:0050872; GO:0060021; GO:0060429; GO:0060536; GO:0060693; GO:0061314; GO:0070563; GO:0070888; GO:0071364; GO:0071479; GO:0090090; GO:1902230; GO:1990837; GO:2000647; GO:2000810; GO:2000811; GO:2001240	"aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to ionizing radiation [GO:0071479]; desmosome disassembly [GO:0035921]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; epithelium development [GO:0060429]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; neural crest cell development [GO:0014032]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; osteoblast differentiation [GO:0001649]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of histone acetylation [GO:0035066]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]; regulation of chemokine production [GO:0032642]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; white fat cell differentiation [GO:0050872]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1486_c0_g1_i2	Q9VIV2	SWM_DROME	71.4	49	14	0	96	242	592	640	4.40E-14	79.3	SWM_DROME	reviewed	Zinc finger protein swm (Protein second mitotic wave missing)	swm CG10084	Drosophila melanogaster (Fruit fly)	1062	nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA export from nucleus [GO:0046833]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0006397; GO:0007275; GO:0010628; GO:0046833; GO:0046872; GO:0051028; GO:1900364	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA export from nucleus [GO:0046833]		NA	NA	NA	NA	NA	NA
TRINITY_DN1486_c0_g1_i4	Q9VIV2	SWM_DROME	72.2	79	22	0	95	331	562	640	2.80E-28	126.7	SWM_DROME	reviewed	Zinc finger protein swm (Protein second mitotic wave missing)	swm CG10084	Drosophila melanogaster (Fruit fly)	1062	nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA export from nucleus [GO:0046833]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0003729; GO:0005634; GO:0006397; GO:0007275; GO:0010628; GO:0046833; GO:0046872; GO:0051028; GO:1900364	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA export from nucleus [GO:0046833]		NA	NA	NA	NA	NA	NA
TRINITY_DN5400_c0_g3_i1	Q61103	REQU_MOUSE	76	104	25	0	2	313	278	381	4.90E-48	191.8	REQU_MOUSE	reviewed	"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)"	Dpf2 Baf45d Req Ubid4	Mus musculus (Mouse)	391	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006325; GO:0006915; GO:0007399; GO:0042393; GO:0043231; GO:0045892; GO:0045944; GO:0046872; GO:0062072; GO:0070577; GO:0071565; GO:1905454	"apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN35738_c0_g1_i1	Q92785	REQU_HUMAN	37.6	85	53	0	536	282	2	86	6.00E-16	85.9	REQU_HUMAN	reviewed	"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)"	DPF2 BAF45D REQ UBID4	Homo sapiens (Human)	391	"centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000790; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006325; GO:0006915; GO:0007399; GO:0042393; GO:0043231; GO:0045892; GO:0045944; GO:0046872; GO:0062072; GO:0070577; GO:0071565; GO:0097190; GO:1905454	"apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN28491_c0_g1_i1	Q61103	REQU_MOUSE	100	97	0	0	291	1	277	373	8.40E-58	223.8	REQU_MOUSE	reviewed	"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)"	Dpf2 Baf45d Req Ubid4	Mus musculus (Mouse)	391	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006325; GO:0006915; GO:0007399; GO:0042393; GO:0043231; GO:0045892; GO:0045944; GO:0046872; GO:0062072; GO:0070577; GO:0071565; GO:1905454	"apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5400_c0_g1_i1	P58268	REQU_CHICK	67.4	86	28	0	143	400	268	353	1.10E-30	134.4	REQU_CHICK	reviewed	Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (Protein requiem)	REQ	Gallus gallus (Chicken)	405	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005737; GO:0006915; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071565	"apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5400_c0_g1_i2	P58268	REQU_CHICK	72.1	122	34	0	143	508	268	389	5.30E-54	212.2	REQU_CHICK	reviewed	Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (Protein requiem)	REQ	Gallus gallus (Chicken)	405	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005737; GO:0006915; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071565	"apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5400_c0_g1_i3	P58268	REQU_CHICK	72.1	122	34	0	143	508	268	389	8.40E-54	211.5	REQU_CHICK	reviewed	Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (Protein requiem)	REQ	Gallus gallus (Chicken)	405	"cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000790; GO:0003712; GO:0005737; GO:0006915; GO:0007399; GO:0042393; GO:0045892; GO:0045944; GO:0046872; GO:0071565	"apoptotic process [GO:0006915]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5400_c0_g2_i1	Q9W638	REQUA_XENLA	69	29	9	0	35	121	199	227	9.80E-07	54.3	REQUA_XENLA	reviewed	Zinc finger protein ubi-d4 A (Apoptosis response zinc finger protein A) (Protein requiem A) (xReq A)	req-a req1	Xenopus laevis (African clawed frog)	388	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0006915; GO:0046872	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN25998_c0_g1_i1	Q9W636	REQUB_XENLA	100	45	0	0	126	260	288	332	4.60E-23	108.2	REQUB_XENLA	reviewed	Zinc finger protein ubi-d4 B (Apoptosis response zinc finger protein B) (Protein requiem B) (xReq B) (Fragment)	req-b req2	Xenopus laevis (African clawed frog)	366	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0006915; GO:0046872	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN25998_c0_g1_i1	Q9W636	REQUB_XENLA	90.7	43	4	0	1	129	246	288	3.10E-19	95.5	REQUB_XENLA	reviewed	Zinc finger protein ubi-d4 B (Apoptosis response zinc finger protein B) (Protein requiem B) (xReq B) (Fragment)	req-b req2	Xenopus laevis (African clawed frog)	366	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0006915; GO:0046872	apoptotic process [GO:0006915]		NA	NA	NA	NA	NA	NA
TRINITY_DN8558_c0_g2_i1	Q9VPQ6	USH_DROME	31.9	483	247	14	1447	113	717	1155	6.60E-56	219.9	USH_DROME	reviewed	Zinc finger protein ush (Protein U-shaped)	ush CG2762	Drosophila melanogaster (Fruit fly)	1191	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; amnioserosa maintenance [GO:0046665]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; germ-band shortening [GO:0007390]; heart development [GO:0007507]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001085; GO:0001102; GO:0003677; GO:0005634; GO:0006355; GO:0006963; GO:0007390; GO:0007507; GO:0008134; GO:0022416; GO:0030154; GO:0035167; GO:0035169; GO:0035170; GO:0043433; GO:0045611; GO:0045944; GO:0046665; GO:0046872; GO:0048542; GO:0048749	"amnioserosa maintenance [GO:0046665]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; germ-band shortening [GO:0007390]; heart development [GO:0007507]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26607_c0_g1_i2	Q9VPQ6	USH_DROME	29	286	137	9	83	751	213	495	2.20E-18	94.4	USH_DROME	reviewed	Zinc finger protein ush (Protein U-shaped)	ush CG2762	Drosophila melanogaster (Fruit fly)	1191	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; amnioserosa maintenance [GO:0046665]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; germ-band shortening [GO:0007390]; heart development [GO:0007507]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001085; GO:0001102; GO:0003677; GO:0005634; GO:0006355; GO:0006963; GO:0007390; GO:0007507; GO:0008134; GO:0022416; GO:0030154; GO:0035167; GO:0035169; GO:0035170; GO:0043433; GO:0045611; GO:0045944; GO:0046665; GO:0046872; GO:0048542; GO:0048749	"amnioserosa maintenance [GO:0046665]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; germ-band shortening [GO:0007390]; heart development [GO:0007507]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i20	P17029	ZKSC1_HUMAN	36.8	152	75	3	398	6	351	502	4.90E-20	99.4	ZKSC1_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18)	ZKSCAN1 KOX18 ZNF139 ZNF36	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN5_c0_g1_i20	P17029	ZKSC1_HUMAN	36.2	105	49	2	597	337	383	487	4.90E-12	72.8	ZKSC1_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18)	ZKSCAN1 KOX18 ZNF139 ZNF36	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN827_c0_g1_i17	P17029	ZKSC1_HUMAN	51.2	86	34	2	12	266	420	498	7.10E-19	94.4	ZKSC1_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18)	ZKSCAN1 KOX18 ZNF139 ZNF36	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2198_c0_g2_i1	P17029	ZKSC1_HUMAN	92.9	84	6	0	255	4	460	543	1.10E-42	173.3	ZKSC1_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18)	ZKSCAN1 KOX18 ZNF139 ZNF36	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN23949_c0_g1_i1	P17029	ZKSC1_HUMAN	51.6	91	44	0	2	274	406	496	1.30E-20	100.1	ZKSC1_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18)	ZKSCAN1 KOX18 ZNF139 ZNF36	Homo sapiens (Human)	563	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12382_c0_g1_i1	Q91VW9	ZKSC3_MOUSE	87.1	101	13	0	1	303	303	403	2.20E-48	192.6	ZKSC3_MOUSE	reviewed	Zinc finger protein with KRAB and SCAN domains 3 (SCAN-KRAB-zinc finger protein) (Zinc finger protein 306) (Zinc finger protein 307) (Zinc finger protein 47 homolog) (Zf47) (Zfp-47)	Zkscan3 Skz1 Zfp306 Zfp307 Zfp47	Mus musculus (Mouse)	553	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006914; GO:0007040; GO:0010507; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000773	"autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12382_c0_g1_i2	Q91VW9	ZKSC3_MOUSE	100	116	0	0	1	348	303	418	7.00E-67	254.2	ZKSC3_MOUSE	reviewed	Zinc finger protein with KRAB and SCAN domains 3 (SCAN-KRAB-zinc finger protein) (Zinc finger protein 306) (Zinc finger protein 307) (Zinc finger protein 47 homolog) (Zf47) (Zfp-47)	Zkscan3 Skz1 Zfp306 Zfp307 Zfp47	Mus musculus (Mouse)	553	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006914; GO:0007040; GO:0010507; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000773	"autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i25	Q91VW9	ZKSC3_MOUSE	54.3	35	16	0	301	405	384	418	2.40E-05	50.1	ZKSC3_MOUSE	reviewed	Zinc finger protein with KRAB and SCAN domains 3 (SCAN-KRAB-zinc finger protein) (Zinc finger protein 306) (Zinc finger protein 307) (Zinc finger protein 47 homolog) (Zf47) (Zfp-47)	Zkscan3 Skz1 Zfp306 Zfp307 Zfp47	Mus musculus (Mouse)	553	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006914; GO:0007040; GO:0010507; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000773	"autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1525_c3_g1_i6	Q9BRR0	ZKSC3_HUMAN	41.4	87	51	0	3	263	346	432	1.50E-13	76.6	ZKSC3_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 3 (Zinc finger and SCAN domain-containing protein 13) (Zinc finger protein 306) (Zinc finger protein 309) (Zinc finger protein 47 homolog) (Zf47) (Zfp-47)	ZKSCAN3 ZFP47 ZNF306 ZNF309 ZSCAN13	Homo sapiens (Human)	538	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006914; GO:0007040; GO:0010507; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000773	"autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7016_c0_g1_i2	Q969J2	ZKSC4_HUMAN	57.1	56	23	1	234	398	343	398	2.60E-13	76.6	ZKSC4_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 4 (P373c6.1) (Zinc finger protein 307) (Zinc finger protein 427)	ZKSCAN4 ZNF307 ZNF427	Homo sapiens (Human)	545	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0042802; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN28933_c0_g1_i1	Q9Y2L8	ZKSC5_HUMAN	48.6	74	37	1	6	227	551	623	1.00E-15	84	ZKSC5_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95)	ZKSCAN5 KIAA1015 ZFP95	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2136_c0_g3_i2	Q9Y2L8	ZKSC5_HUMAN	44.8	58	32	0	262	89	600	657	2.20E-10	67	ZKSC5_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95)	ZKSCAN5 KIAA1015 ZFP95	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2136_c0_g3_i3	Q9Y2L8	ZKSC5_HUMAN	44.8	58	32	0	262	89	600	657	2.20E-10	67	ZKSC5_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95)	ZKSCAN5 KIAA1015 ZFP95	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2136_c0_g3_i4	Q9Y2L8	ZKSC5_HUMAN	44.8	58	32	0	262	89	600	657	3.00E-10	67	ZKSC5_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95)	ZKSCAN5 KIAA1015 ZFP95	Homo sapiens (Human)	839	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270	"regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN24443_c0_g1_i2	Q9P0L1	ZKSC7_HUMAN	72.8	92	25	0	3	278	623	714	4.90E-39	161.4	ZKSC7_HUMAN	reviewed	Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64)	ZKSCAN7 ZNF167 ZNF448 ZNF64	Homo sapiens (Human)	754	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4741_c0_g1_i7	P08045	XFIN_XENLA	49.4	85	43	0	9	263	1186	1270	1.00E-18	94	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i4	P08045	XFIN_XENLA	45.7	81	44	0	254	12	561	641	5.00E-14	78.2	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN70_c12_g1_i6	P08045	XFIN_XENLA	42.1	107	62	0	507	187	615	721	3.50E-22	106.3	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN26150_c0_g1_i1	P08045	XFIN_XENLA	59.2	49	20	0	193	47	1192	1240	1.70E-11	69.7	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN6011_c0_g1_i7	P08045	XFIN_XENLA	42.1	57	33	0	135	305	1160	1216	5.50E-07	55.1	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4254_c0_g1_i8	P08045	XFIN_XENLA	42.6	61	35	0	193	11	581	641	1.60E-07	56.6	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN224_c0_g2_i5	P08045	XFIN_XENLA	45.7	81	44	0	608	850	380	460	2.30E-16	87.8	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3126_c0_g1_i2	P08045	XFIN_XENLA	42.6	94	48	1	6	269	589	682	3.70E-15	82	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18843_c0_g1_i1	P08045	XFIN_XENLA	49.4	87	44	0	263	3	367	453	6.10E-23	107.8	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN20177_c0_g1_i1	P08045	XFIN_XENLA	29	1271	734	21	87	3635	104	1294	2.90E-166	587.8	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1796_c0_g1_i1	P08045	XFIN_XENLA	50	62	30	1	16	201	212	272	2.80E-11	68.9	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38035_c0_g1_i1	P08045	XFIN_XENLA	38.4	99	60	1	2	298	163	260	1.40E-15	83.6	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN9752_c0_g1_i7	P08045	XFIN_XENLA	48.1	81	42	0	2	244	1190	1270	1.30E-17	90.5	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN3089_c0_g1_i2	P08045	XFIN_XENLA	27.3	984	637	16	155	2947	345	1303	3.00E-110	401.7	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN1230_c1_g2_i1	P08045	XFIN_XENLA	42.9	56	32	0	1	168	1215	1270	2.30E-09	62.4	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN16515_c0_g1_i2	P08045	XFIN_XENLA	46.1	89	46	1	267	7	1156	1244	2.60E-18	93.2	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN32932_c0_g1_i1	P08045	XFIN_XENLA	49.3	71	36	0	228	16	156	226	1.20E-13	77.4	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i9	P08045	XFIN_XENLA	46.5	71	38	0	583	795	222	292	2.90E-12	73.9	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18009_c1_g1_i2	P08045	XFIN_XENLA	49.1	112	57	0	351	16	170	281	1.20E-28	127.5	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18009_c1_g1_i3	P08045	XFIN_XENLA	44.1	102	53	1	321	16	184	281	2.10E-17	90.1	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18009_c1_g1_i5	P08045	XFIN_XENLA	46.7	90	47	1	285	16	193	281	5.90E-18	92	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12858_c0_g1_i4	P08045	XFIN_XENLA	43.4	53	22	1	311	177	564	616	9.80E-05	47.8	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c2_g1_i3	P08045	XFIN_XENLA	42.3	78	45	0	132	365	624	701	2.60E-11	69.7	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5352_c2_g1_i3	P08045	XFIN_XENLA	48.8	43	22	0	2	130	596	638	0.002	43.5	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN34007_c0_g1_i1	P08045	XFIN_XENLA	45.2	62	34	0	15	200	207	268	1.30E-09	63.5	XFIN_XENLA	reviewed	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)		Xenopus laevis (African clawed frog)	1350	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38540_c0_g1_i1	P38621	ZN12_MICSA	50	52	23	1	69	224	246	294	2.30E-07	55.8	ZN12_MICSA	reviewed	Zinc finger protein ZFMSA12A		Micropterus salmoides (Largemouth bass) (Labrus salmoides)	415	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN992_c0_g1_i2	P34447	ZFP1_CAEEL	64.2	67	23	1	296	496	590	655	2.10E-15	84	ZFP1_CAEEL	reviewed	Zinc finger protein zfp-1 (Protein AF-10 homolog)	zfp-1 F54F2.2	Caenorhabditis elegans	867	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; RNA interference [GO:0016246]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000785; GO:0000793; GO:0003677; GO:0003682; GO:0005634; GO:0006325; GO:0016246; GO:0035064; GO:0046872	chromatin organization [GO:0006325]; RNA interference [GO:0016246]		NA	NA	NA	NA	NA	NA
TRINITY_DN992_c0_g1_i4	P34447	ZFP1_CAEEL	64.2	67	23	1	953	1153	590	655	4.50E-15	84	ZFP1_CAEEL	reviewed	Zinc finger protein zfp-1 (Protein AF-10 homolog)	zfp-1 F54F2.2	Caenorhabditis elegans	867	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; RNA interference [GO:0016246]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000785; GO:0000793; GO:0003677; GO:0003682; GO:0005634; GO:0006325; GO:0016246; GO:0035064; GO:0046872	chromatin organization [GO:0006325]; RNA interference [GO:0016246]		NA	NA	NA	NA	NA	NA
TRINITY_DN11306_c0_g1_i1	Q2TBX0	ZPR1_BOVIN	55.9	68	30	0	60	263	143	210	4.00E-14	78.6	ZPR1_BOVIN	reviewed	Zinc finger protein ZPR1 (Zinc finger protein 259)	ZNF259 ZPR1	Bos taurus (Bovine)	459	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]	GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672	apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]		NA	NA	NA	NA	NA	NA
TRINITY_DN11306_c0_g1_i2	Q62384	ZPR1_MOUSE	54.7	161	72	1	2	481	50	210	4.00E-44	179.1	ZPR1_MOUSE	reviewed	Zinc finger protein ZPR1 (Zinc finger protein 259)	Zpr1 Zfp259 Znf259	Mus musculus (Mouse)	459	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]	GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008283; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672	apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]		NA	NA	NA	NA	NA	NA
TRINITY_DN371_c0_g1_i1	Q9N4Y9	ZFPL1_CAEEL	38.6	101	59	3	371	667	203	302	4.90E-09	63.2	ZFPL1_CAEEL	reviewed	Zinc finger protein-like 1 homolog	Y45G12B.2	Caenorhabditis elegans	309	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	metal ion binding [GO:0046872]	GO:0005794; GO:0016021; GO:0046872			NA	NA	NA	NA	NA	NA
TRINITY_DN39783_c0_g1_i1	O88532	ZFR_MOUSE	87.7	81	10	0	244	2	734	814	1.00E-27	123.6	ZFR_MOUSE	reviewed	Zinc finger RNA-binding protein	Zfr	Mus musculus (Mouse)	1074	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN5820_c0_g1_i3	Q562A2	ZFR_RAT	59.3	248	82	2	93	836	716	944	2.60E-73	276.9	ZFR_RAT	reviewed	Zinc finger RNA-binding protein	Zfr	Rattus norvegicus (Rat)	1073	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		NA	NA	1	NA	NA	NA
TRINITY_DN36010_c0_g1_i1	Q6GPM1	ZFR_XENLA	46.7	319	95	2	157	888	295	613	6.20E-68	259.2	ZFR_XENLA	reviewed	Zinc finger RNA-binding protein	zfr	Xenopus laevis (African clawed frog)	1054	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN5820_c0_g1_i1	O88532	ZFR_MOUSE	60.2	357	123	2	93	1163	717	1054	7.30E-114	412.1	ZFR_MOUSE	reviewed	Zinc finger RNA-binding protein	Zfr	Mus musculus (Mouse)	1074	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN5820_c0_g1_i2	Q5U231	ZFR_XENTR	59.6	136	37	2	93	500	708	825	2.00E-26	120.6	ZFR_XENTR	reviewed	Zinc finger RNA-binding protein	zfr	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1065	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN5820_c0_g1_i4	O88532	ZFR_MOUSE	59.7	362	127	2	93	1178	717	1059	3.30E-114	413.3	ZFR_MOUSE	reviewed	Zinc finger RNA-binding protein	Zfr	Mus musculus (Mouse)	1074	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		blue	blue	NA	NA	NA	NA
TRINITY_DN27739_c0_g1_i1	Q96KR1	ZFR_HUMAN	100	84	0	0	253	2	837	920	4.30E-42	171.4	ZFR_HUMAN	reviewed	Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog)	ZFR	Homo sapiens (Human)	1074	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN28194_c0_g1_i1	Q96KR1	ZFR_HUMAN	96.1	128	5	0	384	1	311	438	3.90E-63	241.9	ZFR_HUMAN	reviewed	Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog)	ZFR	Homo sapiens (Human)	1074	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN27345_c0_g1_i1	Q96KR1	ZFR_HUMAN	100	141	0	0	423	1	919	1059	4.50E-76	285	ZFR_HUMAN	reviewed	Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog)	ZFR	Homo sapiens (Human)	1074	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	multicellular organism development [GO:0007275]		NA	NA	NA	NA	NA	NA
TRINITY_DN30817_c0_g1_i1	Q9P217	ZSWM5_HUMAN	41.8	184	88	4	92	637	480	646	5.00E-31	136	ZSWM5_HUMAN	reviewed	Zinc finger SWIM domain-containing protein 5	ZSWIM5 KIAA1511	Homo sapiens (Human)	1185	Cul2-RING ubiquitin ligase complex [GO:0031462]; extracellular space [GO:0005615]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]; extracellular space [GO:0005615]	zinc ion binding [GO:0008270]	GO:0005615; GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN7224_c0_g1_i1	Q80TC6	ZSWM5_MOUSE	66.5	227	76	0	684	4	223	449	3.00E-88	326.2	ZSWM5_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 5	Zswim5 Kiaa1511	Mus musculus (Mouse)	1188	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN7224_c0_g1_i2	Q80TC6	ZSWM5_MOUSE	63.8	58	21	0	184	11	321	378	3.50E-14	78.6	ZSWM5_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 5	Zswim5 Kiaa1511	Mus musculus (Mouse)	1188	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN7224_c0_g1_i3	Q80TC6	ZSWM5_MOUSE	63.5	85	31	0	258	4	365	449	2.70E-29	129	ZSWM5_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 5	Zswim5 Kiaa1511	Mus musculus (Mouse)	1188	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN28828_c0_g1_i1	A7E305	ZSWM8_BOVIN	100	84	0	0	255	4	825	908	7.90E-44	177.2	ZSWM8_BOVIN	reviewed	Zinc finger SWIM domain-containing protein 8	ZSWIM8	Bos taurus (Bovine)	1413	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN30201_c0_g1_i2	A7E305	ZSWM8_BOVIN	71.1	83	24	0	3	251	71	153	2.70E-27	122.5	ZSWM8_BOVIN	reviewed	Zinc finger SWIM domain-containing protein 8	ZSWIM8	Bos taurus (Bovine)	1413	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN30201_c0_g1_i3	A7E305	ZSWM8_BOVIN	74.1	116	29	1	85	429	153	268	1.20E-39	164.1	ZSWM8_BOVIN	reviewed	Zinc finger SWIM domain-containing protein 8	ZSWIM8	Bos taurus (Bovine)	1413	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN30201_c0_g1_i4	Q3UHH1	ZSWM8_MOUSE	64.5	262	84	2	86	844	7	268	3.80E-82	306.2	ZSWM8_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 8	Zswim8 Kiaa0913	Mus musculus (Mouse)	1832	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]	zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN6177_c0_g1_i1	Q3UHH1	ZSWM8_MOUSE	69	216	64	1	505	1143	1213	1428	2.10E-81	304.3	ZSWM8_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 8	Zswim8 Kiaa0913	Mus musculus (Mouse)	1832	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]	zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN6177_c0_g1_i2	Q3UHH1	ZSWM8_MOUSE	68.4	174	52	1	538	1050	1213	1386	8.70E-63	242.3	ZSWM8_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 8	Zswim8 Kiaa0913	Mus musculus (Mouse)	1832	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]	zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN6177_c0_g1_i3	Q3UHH1	ZSWM8_MOUSE	68.4	174	52	1	505	1017	1213	1386	8.50E-63	242.3	ZSWM8_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 8	Zswim8 Kiaa0913	Mus musculus (Mouse)	1832	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]	zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN6177_c0_g1_i4	A7E305	ZSWM8_BOVIN	71.3	167	48	0	32	532	844	1010	5.10E-68	258.8	ZSWM8_BOVIN	reviewed	Zinc finger SWIM domain-containing protein 8	ZSWIM8	Bos taurus (Bovine)	1413	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN6177_c0_g1_i5	Q3UHH1	ZSWM8_MOUSE	69	216	64	1	538	1176	1213	1428	1.60E-81	304.7	ZSWM8_MOUSE	reviewed	Zinc finger SWIM domain-containing protein 8	Zswim8 Kiaa0913	Mus musculus (Mouse)	1832	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]	zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN6177_c0_g1_i6	A7E305	ZSWM8_BOVIN	71.2	125	36	0	32	406	844	968	3.00E-49	196.1	ZSWM8_BOVIN	reviewed	Zinc finger SWIM domain-containing protein 8	ZSWIM8	Bos taurus (Bovine)	1413	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	Cul2-RING ubiquitin ligase complex [GO:0031462]	zinc ion binding [GO:0008270]	GO:0008270; GO:0031462; GO:1902667	regulation of axon guidance [GO:1902667]		NA	NA	NA	NA	NA	NA
TRINITY_DN3_c2_g3_i1	O62836	ZFX_BOVIN	48.2	56	29	0	215	48	544	599	2.50E-11	69.3	ZFX_BOVIN	reviewed	Zinc finger X-chromosomal protein	ZFX	Bos taurus (Bovine)	800	"nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000790; GO:0000978; GO:0000981; GO:0001541; GO:0005654; GO:0005730; GO:0006355; GO:0007283; GO:0009566; GO:0009791; GO:0035264; GO:0046872; GO:0048599; GO:0048872; GO:0060746	"fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"		NA	NA	NA	NA	NA	NA
TRINITY_DN7734_c0_g2_i1	A2CE44	ZXDB_MOUSE	45.8	310	156	5	455	1366	340	643	3.10E-84	314.3	ZXDB_MOUSE	reviewed	Zinc finger X-linked protein ZXDB	Zxdb	Mus musculus (Mouse)	873	"nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	C2H2 zinc finger domain binding [GO:0070742]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0045893; GO:0046872; GO:0070742	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"		NA	NA	NA	NA	NA	NA
TRINITY_DN13861_c0_g1_i1	Q95LI3	ZFY_BOVIN	51.7	60	29	0	199	20	543	602	1.20E-11	70.1	ZFY_BOVIN	reviewed	Zinc finger Y-chromosomal protein	ZFY	Bos taurus (Bovine)	801	chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; nucleus [GO:0005634]	chromatin insulator sequence binding [GO:0043035]; metal ion binding [GO:0046872]	GO:0005634; GO:0005694; GO:0006357; GO:0043035; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11143_c0_g1_i1	P08048	ZFY_HUMAN	47.1	51	27	0	69	221	546	596	1.80E-09	63.2	ZFY_HUMAN	reviewed	Zinc finger Y-chromosomal protein	ZFY	Homo sapiens (Human)	801	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2608_c0_g1_i3	Q52V16	ZFY_GORGO	53.6	56	26	0	493	660	544	599	9.20E-13	75.5	ZFY_GORGO	reviewed	Zinc finger Y-chromosomal protein	ZFY	Gorilla gorilla gorilla (Western lowland gorilla)	801	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2608_c0_g1_i5	Q6B4Z5	ZFY_PANTR	52.6	57	26	1	529	696	546	602	1.50E-10	68.2	ZFY_PANTR	reviewed	Zinc finger Y-chromosomal protein	ZFY	Pan troglodytes (Chimpanzee)	801	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN11381_c0_g1_i3	Q52V16	ZFY_GORGO	50.9	55	24	1	631	795	544	595	5.00E-09	63.5	ZFY_GORGO	reviewed	Zinc finger Y-chromosomal protein	ZFY	Gorilla gorilla gorilla (Western lowland gorilla)	801	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN4687_c0_g1_i1	P08048	ZFY_HUMAN	48.1	54	28	0	502	663	542	595	1.40E-10	68.2	ZFY_HUMAN	reviewed	Zinc finger Y-chromosomal protein	ZFY	Homo sapiens (Human)	801	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN18393_c0_g1_i1	Q52V16	ZFY_GORGO	49.1	53	24	1	59	217	546	595	4.60E-08	58.5	ZFY_GORGO	reviewed	Zinc finger Y-chromosomal protein	ZFY	Gorilla gorilla gorilla (Western lowland gorilla)	801	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		blue	blue	NA	NA	NA	NA
TRINITY_DN30564_c0_g1_i1	Q52V16	ZFY_GORGO	48.1	54	28	0	66	227	543	596	1.50E-11	70.1	ZFY_GORGO	reviewed	Zinc finger Y-chromosomal protein	ZFY	Gorilla gorilla gorilla (Western lowland gorilla)	801	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN30634_c0_g1_i1	P08048	ZFY_HUMAN	47.1	51	27	0	116	268	545	595	9.70E-10	64.3	ZFY_HUMAN	reviewed	Zinc finger Y-chromosomal protein	ZFY	Homo sapiens (Human)	801	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0043565; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN2608_c0_g1_i1	P10925	ZFY1_MOUSE	49.2	61	31	0	448	630	519	579	6.30E-11	69.3	ZFY1_MOUSE	reviewed	Zinc finger Y-chromosomal protein 1	Zfy1 Zfy-1	Mus musculus (Mouse)	782	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	regulation of transcription by RNA polymerase II [GO:0006357]		NA	NA	NA	NA	NA	NA
TRINITY_DN12296_c1_g1_i1	Q01611	ZFY1_XENLA	39.6	53	32	0	56	214	537	589	9.00E-06	50.8	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN12296_c1_g1_i2	Q01611	ZFY1_XENLA	39.6	53	32	0	56	214	537	589	5.80E-06	51.6	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN18903_c0_g1_i1	Q01611	ZFY1_XENLA	46.4	69	37	0	41	247	523	591	1.70E-13	77	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN5973_c0_g2_i1	Q01611	ZFY1_XENLA	50.9	53	26	0	18	176	537	589	2.20E-12	72.4	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2608_c0_g1_i2	Q01611	ZFY1_XENLA	47.3	55	29	0	466	630	538	592	3.30E-12	73.6	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2608_c0_g1_i6	Q01611	ZFY1_XENLA	56	50	22	0	472	621	539	588	2.00E-09	64.3	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN33307_c0_g1_i1	Q01611	ZFY1_XENLA	52	50	24	0	40	189	539	588	1.30E-11	70.1	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN15257_c0_g1_i1	Q01611	ZFY1_XENLA	48	50	26	0	214	65	539	588	4.10E-10	65.1	ZFY1_XENLA	reviewed	Zinc finger Y-chromosomal protein 1 (ZFY-1)	zfy1	Xenopus laevis (African clawed frog)	794	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"regulation of transcription, DNA-templated [GO:0006355]"		NA	NA	NA	NA	NA	NA
TRINITY_DN38273_c0_g1_i1	Q20191	NAS13_CAEEL	56.4	101	43	1	310	8	174	273	3.50E-28	125.6	NAS13_CAEEL	reviewed	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN19648_c0_g1_i2	Q20191	NAS13_CAEEL	43.8	178	89	7	48	575	134	302	8.50E-31	135.2	NAS13_CAEEL	reviewed	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN2118_c0_g1_i1	Q20191	NAS13_CAEEL	32.7	294	148	7	815	81	158	450	2.20E-37	157.5	NAS13_CAEEL	reviewed	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN2118_c0_g1_i3	Q20191	NAS13_CAEEL	33.8	400	204	10	1118	81	58	450	5.10E-54	213.4	NAS13_CAEEL	reviewed	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN2118_c0_g1_i4	Q20191	NAS13_CAEEL	33.8	278	134	7	767	81	174	450	4.90E-37	156.4	NAS13_CAEEL	reviewed	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN2118_c0_g1_i6	Q20191	NAS13_CAEEL	35.5	355	178	8	995	81	97	450	1.50E-53	211.8	NAS13_CAEEL	reviewed	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN7242_c0_g4_i1	Q19269	NAS14_CAEEL	52.2	67	31	1	240	43	183	249	1.80E-11	69.7	NAS14_CAEEL	reviewed	Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)	nas-14 F09E8.6	Caenorhabditis elegans	503	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN38359_c0_g1_i1	P55115	NAS15_CAEEL	58.6	99	41	0	298	2	196	294	1.00E-29	130.6	NAS15_CAEEL	reviewed	Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)	nas-15 T04G9.2	Caenorhabditis elegans	571	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN19648_c0_g1_i1	P55115	NAS15_CAEEL	47.4	133	66	3	114	512	178	306	3.60E-28	126.3	NAS15_CAEEL	reviewed	Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)	nas-15 T04G9.2	Caenorhabditis elegans	571	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN27539_c0_g1_i2	P55115	NAS15_CAEEL	38.3	206	112	6	35	649	123	314	5.90E-34	146	NAS15_CAEEL	reviewed	Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)	nas-15 T04G9.2	Caenorhabditis elegans	571	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			NA	NA	NA	NA	NA	NA
TRINITY_DN7400_c0_g1_i1	P55112	NAS4_CAEEL	39.4	226	121	6	188	832	69	289	8.40E-43	175.6	NAS4_CAEEL	reviewed	Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4)	nas-4 C05D11.6	Caenorhabditis elegans	315	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270			black	black	NA	NA	NA	NA
TRINITY_DN29942_c0_g1_i1	Q9U3S9	NAS6_CAEEL	52.4	82	39	0	294	49	120	201	1.30E-21	103.6	NAS6_CAEEL	reviewed	Zinc metalloproteinase nas-6 (EC 3.4.24.-) (Nematode astacin 6)	nas-6 4R79.1	Caenorhabditis elegans	344	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]	extracellular region [GO:0005576]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270; GO:0043050; GO:0060465	pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]		NA	NA	NA	NA	NA	NA
TRINITY_DN15467_c0_g1_i1	Q9Y6M5	ZNT1_HUMAN	38.6	290	107	8	4	711	190	462	2.10E-38	160.6	ZNT1_HUMAN	reviewed	Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1)	SLC30A1 ZNT1	Homo sapiens (Human)	507	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]	calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0070509; GO:0070574; GO:0071577; GO:0071584; GO:0071585; GO:0090281	cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN38390_c0_g1_i1	Q9BRI3	ZNT2_HUMAN	43.5	69	39	0	217	11	155	223	5.10E-10	64.7	ZNT2_HUMAN	reviewed	Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2)	SLC30A2 ZNT2	Homo sapiens (Human)	323	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0010043; GO:0016021; GO:0042802; GO:0043231; GO:0061088; GO:0061090; GO:0071577	positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]		NA	NA	NA	NA	NA	NA
TRINITY_DN4416_c1_g1_i1	Q2HJ10	ZNT2_MOUSE	45.5	345	162	3	1110	88	45	367	7.00E-74	279.6	ZNT2_MOUSE	reviewed	Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2)	Slc30a2 Znt2	Mus musculus (Mouse)	371	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005737; GO:0005770; GO:0005774; GO:0005886; GO:0006829; GO:0010043; GO:0016021; GO:0031410; GO:0042802; GO:0043231; GO:0061088; GO:0061090; GO:0071577	positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2600_c0_g1_i2	Q28CE7	ZNT5_XENTR	40.3	499	283	7	2	1456	39	536	1.70E-101	371.3	ZNT5_XENTR	reviewed	Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5)	slc30a5 znt5 TTpA003b13.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	777	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cation transmembrane transporter activity [GO:0008324]	GO:0005794; GO:0006829; GO:0008324; GO:0016021	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2600_c0_g1_i4	Q28CE7	ZNT5_XENTR	43.5	628	314	8	2	1765	39	665	2.30E-121	437.6	ZNT5_XENTR	reviewed	Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5)	slc30a5 znt5 TTpA003b13.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	777	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cation transmembrane transporter activity [GO:0008324]	GO:0005794; GO:0006829; GO:0008324; GO:0016021	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN2600_c0_g1_i8	Q28CE7	ZNT5_XENTR	42.5	702	363	8	2	1987	39	739	3.30E-137	490.3	ZNT5_XENTR	reviewed	Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5)	slc30a5 znt5 TTpA003b13.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	777	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cation transmembrane transporter activity [GO:0008324]	GO:0005794; GO:0006829; GO:0008324; GO:0016021	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN24301_c0_g1_i1	Q8TAD4	ZNT5_HUMAN	98.4	124	2	0	373	2	400	523	6.50E-63	241.1	ZNT5_HUMAN	reviewed	Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5) (ZnT-like transporter 1) (hZTL1)	SLC30A5 ZNT5 ZNTL1 ZTL1 UNQ863/PRO1879	Homo sapiens (Human)	765	apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; regulation of proton transport [GO:0010155]; response to zinc ion [GO:0010043]; zinc ion transport [GO:0006829]	apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]	zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005654; GO:0005730; GO:0005794; GO:0005887; GO:0006824; GO:0006829; GO:0006882; GO:0008270; GO:0010043; GO:0010155; GO:0016020; GO:0016324; GO:0030141; GO:0030667	cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; regulation of proton transport [GO:0010155]; response to zinc ion [GO:0010043]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN28373_c0_g1_i1	A4IFD7	ZNT7_BOVIN	96.9	65	2	0	3	197	103	167	1.50E-29	129.4	ZNT7_BOVIN	reviewed	Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)	SLC30A7 ZNT7	Bos taurus (Bovine)	376	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; cation transmembrane transporter activity [GO:0008324]; sequestering of zinc ion [GO:0032119]; zinc ion transport [GO:0006829]	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	cation transmembrane transporter activity [GO:0008324]	GO:0005794; GO:0006829; GO:0008324; GO:0016021; GO:0031410; GO:0032119; GO:0048471	sequestering of zinc ion [GO:0032119]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN29739_c0_g1_i1	Q6NRI1	ZNT7B_XENLA	53.3	394	138	2	1144	89	1	390	2.10E-97	357.5	ZNT7B_XENLA	reviewed	Zinc transporter 7-B (ZnT-7-B) (Solute carrier family 30 member 7-B)	slc30a7-b znt7-b	Xenopus laevis (African clawed frog)	390	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cation transmembrane transporter activity [GO:0008324]	GO:0005794; GO:0006829; GO:0008324; GO:0016021	zinc ion transport [GO:0006829]		blue	blue	NA	NA	NA	NA
TRINITY_DN33145_c0_g1_i1	Q6PML9	ZNT9_HUMAN	64.2	81	29	0	287	45	488	568	7.10E-25	114.4	ZNT9_HUMAN	reviewed	Zinc transporter 9 (ZnT-9) (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9)	SLC30A9 C4orf1 HUEL	Homo sapiens (Human)	568	cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829]	cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]	GO:0003682; GO:0005634; GO:0005783; GO:0005856; GO:0006289; GO:0006829; GO:0006882; GO:0008324; GO:0016021; GO:0016922; GO:0030374; GO:0031410; GO:0045944	cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN38876_c0_g1_i1	Q9VSL7	FOI_DROME	30.6	474	265	11	271	1596	261	702	1.70E-38	162.2	FOI_DROME	reviewed	Zinc transporter foi (Protein fear-of-intimacy) (Protein kastchen)	foi CG6817	Drosophila melanogaster (Fruit fly)	706	"basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; gonadal mesoderm development [GO:0007506]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]"	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007280; GO:0007417; GO:0007506; GO:0008354; GO:0008406; GO:0009986; GO:0016323; GO:0016477; GO:0030154; GO:0035147; GO:0035262; GO:0071578	"branch fusion, open tracheal system [GO:0035147]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular zinc ion homeostasis [GO:0006882]; central nervous system development [GO:0007417]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; gonad development [GO:0008406]; gonad morphogenesis [GO:0035262]; pole cell migration [GO:0007280]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]"		NA	NA	NA	NA	NA	NA
TRINITY_DN2526_c0_g1_i1	Q9QZ03	S39A1_MOUSE	33.9	348	177	7	1193	153	27	322	8.90E-43	176	S39A1_MOUSE	reviewed	Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (mZIP1)	Slc39a1 Zip1 Zirtl	Mus musculus (Mouse)	324	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001701; GO:0005102; GO:0005385; GO:0005886; GO:0006829; GO:0016020; GO:0016021; GO:0048701; GO:0060173; GO:0071577	embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]		blue	blue	NA	NA	NA	NA
TRINITY_DN2526_c0_g1_i2	Q9QZ03	S39A1_MOUSE	34.2	316	155	7	1038	94	27	290	1.30E-34	148.7	S39A1_MOUSE	reviewed	Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (mZIP1)	Slc39a1 Zip1 Zirtl	Mus musculus (Mouse)	324	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001701; GO:0005102; GO:0005385; GO:0005886; GO:0006829; GO:0016020; GO:0016021; GO:0048701; GO:0060173; GO:0071577	embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN3676_c0_g1_i1	Q2YDD4	S39AB_BOVIN	54.3	46	21	0	196	59	1	46	8.30E-07	54.3	S39AB_BOVIN	reviewed	Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11)	SLC39A11 ZIP11	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0071577	zinc ion transmembrane transport [GO:0071577]		NA	NA	NA	NA	NA	NA
TRINITY_DN3676_c0_g1_i2	Q2YDD4	S39AB_BOVIN	58.9	129	47	2	462	85	1	126	1.50E-31	137.5	S39AB_BOVIN	reviewed	Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11)	SLC39A11 ZIP11	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0071577	zinc ion transmembrane transport [GO:0071577]		NA	NA	NA	NA	NA	NA
TRINITY_DN3676_c0_g1_i3	Q2YDD4	S39AB_BOVIN	50.3	173	74	4	498	7	1	170	1.20E-31	137.9	S39AB_BOVIN	reviewed	Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11)	SLC39A11 ZIP11	Bos taurus (Bovine)	341	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0071577	zinc ion transmembrane transport [GO:0071577]		NA	NA	NA	NA	NA	NA
TRINITY_DN636_c1_g1_i1	Q5ZIU9	S39A9_CHICK	50.8	305	130	4	910	56	1	305	1.60E-76	287.7	S39A9_CHICK	reviewed	Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9)	SLC39A9 ZIP9 RCJMB04_23h6	Gallus gallus (Chicken)	305	integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]	metal ion transmembrane transporter activity [GO:0046873]	GO:0006829; GO:0016021; GO:0046873	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN636_c1_g1_i2	Q5ZIU9	S39A9_CHICK	55.1	207	87	2	658	56	99	305	1.10E-58	228	S39A9_CHICK	reviewed	Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9)	SLC39A9 ZIP9 RCJMB04_23h6	Gallus gallus (Chicken)	305	integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]	metal ion transmembrane transporter activity [GO:0046873]	GO:0006829; GO:0016021; GO:0046873	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN28733_c0_g1_i1	Q8BFU1	S39A9_MOUSE	100	64	0	0	16	207	1	64	1.10E-27	123.2	S39A9_MOUSE	reviewed	Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9)	Slc39a9 Zip9	Mus musculus (Mouse)	308	integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]	metal ion transmembrane transporter activity [GO:0046873]	GO:0006829; GO:0016021; GO:0046873	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN35343_c0_g1_i1	Q5ZIU9	S39A9_CHICK	100	68	0	0	205	2	159	226	4.90E-28	124.4	S39A9_CHICK	reviewed	Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9)	SLC39A9 ZIP9 RCJMB04_23h6	Gallus gallus (Chicken)	305	integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]	metal ion transmembrane transporter activity [GO:0046873]	GO:0006829; GO:0016021; GO:0046873	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN38446_c0_g1_i1	O31688	ZOSA_BACSU	63.8	69	25	0	1	207	507	575	6.30E-18	90.9	ZOSA_BACSU	reviewed	Zinc-transporting ATPase (EC 7.2.2.-) (Zn(2+)-translocating P-type ATPase)	zosA ykvW BSU13850	Bacillus subtilis (strain 168)	637	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; zinc ion transport [GO:0006829]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006829; GO:0016021; GO:0019829; GO:0046872	zinc ion transport [GO:0006829]		NA	NA	NA	NA	NA	NA
TRINITY_DN36103_c0_g1_i1	Q7ZXZ0	MCM3Z_XENLA	87.9	214	26	0	9	650	279	492	1.60E-101	370.2	MCM3Z_XENLA	reviewed	Zygotic DNA replication licensing factor mcm3 (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 3) (zMCM3)	zmcm3	Xenopus laevis (African clawed frog)	806	CMG complex [GO:0071162]; MCM complex [GO:0042555]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	CMG complex [GO:0071162]; MCM complex [GO:0042555]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0071162	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN635_c0_g1_i5	Q6P1V8	MCM6Z_XENTR	62.3	831	269	8	2520	91	15	822	1.40E-297	1023.5	MCM6Z_XENTR	reviewed	Zygotic DNA replication licensing factor mcm6 (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6) (zMCM6)	zmcm6	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	823	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:1902969	DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]		NA	NA	NA	NA	NA	NA
TRINITY_DN30039_c0_g1_i1	Q498J7	MC6ZA_XENLA	60	80	30	1	2	235	426	505	3.10E-18	92	MC6ZA_XENLA	reviewed	Zygotic DNA replication licensing factor mcm6-A (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-A) (zMCM6-A) (zMCM6a)	zmcm6-a zmcm6a	Xenopus laevis (African clawed frog)	823	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	MCM complex [GO:0042555]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872	cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]		NA	NA	NA	NA	NA	NA
TRINITY_DN7283_c0_g1_i1	Q62523	ZYX_MOUSE	100	149	0	0	2	448	416	564	6.30E-93	341.3	ZYX_MOUSE	reviewed	Zyxin	Zyx	Mus musculus (Mouse)	564	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; stress fiber [GO:0001725]	metal ion binding [GO:0046872]	GO:0001725; GO:0005634; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0007160; GO:0007165; GO:0007179; GO:0007229; GO:0043149; GO:0045335; GO:0046872; GO:0050727; GO:0071346	cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]		NA	NA	NA	NA	NA	NA
TRINITY_DN7283_c0_g2_i1	Q15942	ZYX_HUMAN	100	154	0	0	1	462	419	572	2.80E-96	352.4	ZYX_HUMAN	reviewed	Zyxin (Zyxin-2)	ZYX	Homo sapiens (Human)	572	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; stress fiber [GO:0001725]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0001725; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0007160; GO:0007165; GO:0007179; GO:0007229; GO:0007267; GO:0016032; GO:0043149; GO:0045335; GO:0046872; GO:0050727; GO:0071346	cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]		NA	NA	NA	NA	NA	NA
TRINITY_DN1936_c0_g1_i2	Q8IYH5	ZZZ3_HUMAN	37.5	280	140	7	1081	332	522	796	3.00E-34	147.5	ZZZ3_HUMAN	reviewed	ZZ-type zinc finger-containing protein 3	ZZZ3	Homo sapiens (Human)	903	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; histone H4 acetylation [GO:0043967]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005654; GO:0005671; GO:0005730; GO:0008270; GO:0043967	histone H4 acetylation [GO:0043967]		NA	NA	NA	NA	NA	NA
TRINITY_DN1936_c0_g1_i5	Q8IYH5	ZZZ3_HUMAN	36.9	347	184	7	1282	332	455	796	2.60E-45	184.5	ZZZ3_HUMAN	reviewed	ZZ-type zinc finger-containing protein 3	ZZZ3	Homo sapiens (Human)	903	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; histone H4 acetylation [GO:0043967]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005654; GO:0005671; GO:0005730; GO:0008270; GO:0043967	histone H4 acetylation [GO:0043967]		NA	NA	NA	NA	NA	NA